editor preferred label editor preferred label editor preferred term editor preferred term editor preferred term~editor preferred label 编辑首选术语 编辑首选标签 The concise, meaningful, and human-friendly name for a class or property preferred by the ontology developers. (US-English) 对于一类或属性的简洁的、有意义的、与人类友好的名称由本体开发商首选。 （美国英语） PERSON:Daniel Schober GROUP:OBI:<http://purl.obolibrary.org/obo/obi> editor preferred label editor preferred label editor preferred term editor preferred term editor preferred term~editor preferred label editor preferred term~editor preferred label 编辑首选术语 编辑首选术语 编辑首选术语~编辑首选标签 编辑首选标签 编辑首选标签 has curation status 有管理状态 PERSON:Alan Ruttenberg PERSON:Bill Bug PERSON:Melanie Courtot OBI_0000281 has curation status has curation status 有管理状态 有管理状态 definition definition textual definition textual definition 定义 A property representing the English language definitions of what NCI means by the concept. They may also include information about the definition's source and attribution in a form that can easily be interpreted by software. OBI的官方定义，解释类或属性的含义。应该是亚里士多德式的，形式化和规范化的。 可以通过口语定义进行扩充。 The official OBI definition, explaining the meaning of a class or property. Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions. The official definition, explaining the meaning of a class or property. Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions. The official definition, explaining the meaning of a class or property. Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions. 官方的定义，解释类或属性的含义。应该是亚里士多德式的，形式化和规范化的。 可以通过口语定义进行扩充。 2012-04-05: Barry Smith OBI的官方定义解释了一个类或属性的含义：'应该是亚里士多德式的，形式化和规范化的。可以用口语定义'是糟糕的。 您能解决这样的问题吗？ 解释关于类或属性的表达含义的必要和充分条件的陈述。 Alan Ruttenberg 您提出的定义是一个合理的备选，除非它很常见，没有给出必要和充分的条件。大多数情况下它们是必要的，偶尔是必要的，充分的或者仅仅仅充分的。它们通常使用不是自己定义的术语，因此它们实际上不能通过这些标准进行评估。 关于拟议定义的具体内容： 我们没有“含义”，或“表达”或“属性”的定义。对于在预期意义上的“参考”，我认为我们使用术语“指示”。对于'表达'，我认为我们和你的意思是符号，或标识符。对于“含义”，它不同于类和属性。对于类，我们希望文档能够让读者确定一个实体是否是该类的实例。对于属性，让我们的目标读者决定，给定一对潜在的关系，判断关系成立的断言正确与否。 “目标读者”部分表明我们也指定了我们期望的能够理解定义的人，并且概括了人类和计算机读者以包含文本和逻辑定义。 就我个人而言，我更愿意削弱对文档的定义，并指出什么是可取的。 我们还有一个悬而未决的问题，就是如何针对不同的受众定位不同的定义。临床读者阅读chebi需要来自受过化学训练的受众的不同类型的定义文档/定义，同样需要一个适合本体工作者的定义。 2012-04-05: Barry Smith The official OBI definition, explaining the meaning of a class or property: 'Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions' is terrible. Can you fix to something like: A statement of necessary and sufficient conditions explaining the meaning of an expression referring to a class or property. Alan Ruttenberg Your proposed definition is a reasonable candidate, except that it is very common that necessary and sufficient conditions are not given. Mostly they are necessary, occasionally they are necessary and sufficient or just sufficient. Often they use terms that are not themselves defined and so they effectively can't be evaluated by those criteria. On the specifics of the proposed definition: We don't have definitions of 'meaning' or 'expression' or 'property'. For 'reference' in the intended sense I think we use the term 'denotation'. For 'expression', I think we you mean symbol, or identifier. For 'meaning' it differs for class and property. For class we want documentation that let's the intended reader determine whether an entity is instance of the class, or not. For property we want documentation that let's the intended reader determine, given a pair of potential relata, whether the assertion that the relation holds is true. The 'intended reader' part suggests that we also specify who, we expect, would be able to understand the definition, and also generalizes over human and computer reader to include textual and logical definition. Personally, I am more comfortable weakening definition to documentation, with instructions as to what is desirable. We also have the outstanding issue of how to aim different definitions to different audiences. A clinical audience reading chebi wants a different sort of definition documentation/definition from a chemistry trained audience, and similarly there is a need for a definition that is adequate for an ontologist to work with. PERSON:Daniel Schober GROUP:OBI:<http://purl.obolibrary.org/obo/obi> DEFINITION definition definition textual definition textual definition 定义 定义 文本定义 文本定义 editor note 编者注 An administrative note intended for its editor. It may not be included in the publication version of the ontology, so it should contain nothing necessary for end users to understand the ontology. 管理者注释用于其编辑器。它可能不包含在本体的出版版本中，所以它应该不包含最终用户了解本体所需的信息。 PERSON:Daniel Schober GROUP:OBI:<http://purl.obfoundry.org/obo/obi> IAO:0000116 IAO:0000116 uberon uberon editor_note editor_note 编辑_注释 true editor_note editor_note 编辑_注释 IAO:0000116 IAO:0000116 uberon uberon editor_note editor_note 1 editor_note editor_note editor note editor note 编者注 编者注 definition editor term editor 术语编辑者 Name of editor entering the definition in the file. The definition editor is a point of contact for information regarding the term. The definition editor may be, but is not always, the author of the definition, which may have been worked upon by several people Name of editor entering the term in the file. The term editor is a point of contact for information regarding the term. The term editor may be, but is not always, the author of the definition, which may have been worked upon by several people 输入文件中术语编辑者的名称。术语编辑者是有关术语的信息交汇点。术语编辑者可以是，但并不总是，定义的作者，这可能是由几个人完成 20110707, MC: label update to term editor and definition modified accordingly. See http://code.google.com/p/information-artifact-ontology/issues/detail?id=115. 20110707, MC: label update to term editor and definition modified accordingly. See https://github.com/information-artifact-ontology/IAO/issues/115. 20110707，MC：术语编辑和定义进行相应的修改。见http://code.google.com/p/information-artifact-ontology/issues/detail?id=115。 PERSON:Daniel Schober GROUP:OBI:<http://purl.obolibrary.org/obo/obi> definition editor definition editor term editor term editor 术语编辑者 术语编辑者 alternative term 替代术语 An alternative name for a class or property which means the same thing as the preferred name (semantically equivalent) 一类或属性的替代名称，这意味着与所述首选名称同样的事物（语义上等价） PERSON:Daniel Schober GROUP:OBI:<http://purl.obolibrary.org/obo/obi> alternative term alternative term 替代术语 替代术语 definition source 定义来源 formal citation, e.g. identifier in external database to indicate / attribute source(s) for the definition. Free text indicate / attribute source(s) for the definition. EXAMPLE: Author Name, URI, MeSH Term C04, PUBMED ID, Wiki uri on 31.01.2007 正式引用，例如在外部数据库中的标识符，用于表示/定义的属性源（S）。自由文本表示/为定义属性源（S）。实例：在2007年1月31日的作者姓名，URI，MeSH术语C04，PUBMEDID，维基uri PERSON:Daniel Schober Discussion on obo-discuss mailing-list, see http://bit.ly/hgm99w Discussion on obo-discuss mailing-list, see http://bit.ly/hgm99w GROUP:OBI:<http://purl.obolibrary.org/obo/obi> 论OBO-讨论邮件-列表，请参阅http://bit.ly/hgm99w definition source definition source 定义来源 定义来源 imported from An association that indicates that a finding or lab test is related to a gene, possibly through a variant or product. A13 Conceptual Entity Related_To_Genetic_Biomarker Related_To_Genetic_Biomarker Related_To_Genetic_Biomarker An association that indicates that a neoplastic disease can have the characteristics defined by a Neoplasm by Special Category concept. A14 Conceptual Entity Neoplasm_Has_Special_Category Neoplasm_Has_Special_Category Neoplasm_Has_Special_Category An association that specifies one of three data types for a particular variable, String, Code or Number. A23 Conceptual Entity Has_PCDC_Data_Type Has_PCDC_Data_Type Has_PCDC_Data_Type An association that indicates a PCDC AML concept is an Authorized Value for a PCDC AML Variable concept. A24 Conceptual Entity Is_PCDC_AML_Authorized_Value_For_Variable Is_PCDC_AML_Authorized_Value_For_Variable Is_PCDC_AML_Authorized_Value_For_Variable An association that shows which PCDC AML Authorized Values are possible for a specific Variable. A26 Conceptual Entity Has_PCDC_AML_Authorized_Value Has_PCDC_AML_Authorized_Value Has_PCDC_AML_Authorized_Value An association that indicates a PCDC EWS concept is an Authorized Value for a specific PCDC EWS Variable concept. A28 Conceptual Entity Is_PCDC_EWS_Authorized_Value_For_Variable Is_PCDC_EWS_Authorized_Value_For_Variable Is_PCDC_EWS_Authorized_Value_For_Variable An association that shows which Authorized Values are possible for a specific PCDC EWS Variable concept. A29 Conceptual Entity Has_PCDC_EWS_Authorized_Value Has_PCDC_EWS_Authorized_Value Has_PCDC_EWS_Authorized_Value An association that connects a concept representing a GDC property to its dedicated value concept(s). A31 Conceptual Entity Has_GDC_Value Has_GDC_Value Has_GDC_Value An association that that connects a concept representing a GDC value to any associated GDC property concept(s). A32 Conceptual Entity Is_Value_For_GDC_Property Is_Value_For_GDC_Property Is_Value_For_GDC_Property An association that indicates a concept is a dedicated Authorized Value concept for a specific PCDC GCT Variable. A33 Conceptual Entity Is_PCDC_GCT_Authorized_Value_For_Variable Is_PCDC_GCT_Authorized_Value_For_Variable Is_PCDC_GCT_Authorized_Value_For_Variable An association that shows which Authorized Values are possible for a specific PCDC GCT Variable. A34 Conceptual Entity Has_PCDC_GCT_Authorized_Value Has_PCDC_GCT_Authorized_Value Has_PCDC_GCT_Authorized_Value An association that indicates a PCDC ALL concept is a Authorized Value for an PCDC ALL Variable concept. A35 Conceptual Entity Is_PCDC_ALL_Authorized_Value_For_Variable Is_PCDC_ALL_Authorized_Value_For_Variable Is_PCDC_ALL_Authorized_Value_For_Variable An association that shows which PCDC ALL Authorized Values are possible for a specific Variable. A36 Conceptual Entity Has_PCDC_ALL_Authorized_Value Has_PCDC_ALL_Authorized_Value Has_PCDC_ALL_Authorized_Value An association that shows which Authorized Values are possible for a specific SeroNet Variable. A37 Conceptual Entity Has_SeroNet_Authorized_Value Has_SeroNet_Authorized_Value Has_SeroNet_Authorized_Value An association that shows which Authorized Values are possible for a specific PCDC OS Variable. A38 Conceptual Entity Has_PCDC_OS_Authorized_Value Has_PCDC_OS_Authorized_Value Has_PCDC_OS_Authorized_Value An association that shows which Authorized Values are possible for a specific PCDC HL Variable. A39 Conceptual Entity Has_PCDC_HL_Authorized_Value Has_PCDC_HL_Authorized_Value Has_PCDC_HL_Authorized_Value An association that shows which Authorized Values are possible for a specific DIPG/DMG Variable. A40 Conceptual Entity Has_DIPG_DMG_Authorized_Value Has_DIPG_DMG_Authorized_Value Has_DIPG_DMG_Authorized_Value An association specifying the Values for a specific OORO Prostate Cancer (PC) Attribute. A42 Conceptual Entity Has_OORO_PC_Value Has_OORO_PC_Value Has_OORO_PC_Value An association that shows which Authorized Values are possible for a specific ACC/AHA SARS2 Variable. A48 Conceptual Entity Has_ACC-AHA_SARS2_Authorized_Value Has_ACC-AHA_SARS2_Authorized_Value Has_ACC-AHA_SARS2_Authorized_Value true A property representing a concept unique identifier within the NCI Enterprise Vocabulary Service's NCI Thesaurus. NHC0 Conceptual Entity code code code A property that represents a description of the sort of thing or category to which a concept belongs in the context of the UMLS semantic network. P106 Conceptual Entity Semantic Type Semantic_Type In general, applying semantic types aids in allowing users (or computer programs) to draw conclusions about concepts by virtue of the categories to which they have been assigned. We use a set of semantic types developed for the UMLS Metathesaurus. There are currently 134 semantic types in the UMLS. Semantic_Type Semantic_Type A property representing an alternative Preferred Name for use in some NCI systems. P107 Conceptual Entity Display Name Display_Name Display Name Display_Name Display_Name A property representing the word or phrase that NCI uses by preference to refer to the concept. P108 Conceptual Entity Preferred Name Preferred_Name Preferred Name Preferred Term Preferred_Name Preferred_Name A property representing the concept unique identifier (CUI) assigned by the National Library of Medicine (NLM). If a concept in any NCI-maintained knowledgebase exists in the NLM Unified Medical Language System (UMLS), NCI includes the NLM CUI among the information we provide about the concept. P207 Conceptual Entity UMLS CUI UMLS_CUI UMLS_CUI UMLS_CUI A property representing the concept unique identifier (CUI) for those concepts that appear in NCI Metathesaurus but not in the National Library of Medicine Unified Medical Language System (NLM UMLS). P208 Conceptual Entity NCI Metathesaurus CUI NCI_META_CUI NCI_META_CUI NCI_META_CUI A property used to indicate the standing of a concept in relation to currently accepted classifications and concepts. In NCI Thesaurus concept status subtype indicates concepts with unusual and problematic characteristics that should be evaluated by people and/or programs before those concept are used. P310 Conceptual Entity Concept Status Concept_Status Concept_Status Concept_Status A property used to flag terms that are part of an FDA data standard manual, including Route of Administration, Dosage Form, Package Type and Potency. P317 Conceptual Entity FDA Table FDA_Table FDA_Table FDA_Table A property is used to indicate when a non-EVS entity has contributed to, and has a stake in, a concept. This is used where such entities, within or outside NCI, have indicated the need to be able to track their own concepts. A single concept can have multiple instances of this property if multiple entities have such a defined stake. P322 Conceptual Entity Contributing Source Contributing_Source Contributing_Source Contributing_Source A property representing the English language definition of a concept from a source other than NCI. P325 Conceptual Entity [source] Definition ALT_DEFINITION ALT_DEFINITION ALT_DEFINITION A property representing the matching ICD-O-3 code for the NCI Thesaurus concept. P334 Conceptual Entity ICD-O-3 Code ICD-O-3_Code ICD-O-3_Code ICD-O-3_Code A property representing the morphologic, clinical, and genetic profile of a neoplastic growth that defines it as benign, malignant, or of uncertain cancerous potential. P363 Conceptual Entity Neoplastic Status Neoplastic_Status FDA Neoplastic_Status Neoplastic_Status true A property representing a retired unique concept identifier created and stored as Concept Name by legacy EVS software. Use of these values was long discouraged, but continued as late as 2009 when creation of new values ceased and Concept Name was retired. Legacy values are intended solely to help resolve and update earlier coding. P366 Conceptual Entity Legacy Concept Name Legacy Concept Name Legacy_Concept_Name Legacy Concept Name A property representing whether a value set is ready for publication in the browser. P372 Conceptual Entity Publish_Value_Set Publish_Value_Set Publish_Value_Set A property representing that a term in another terminology has been mapped to a term in NCIt and describes the relationship between the mapped terms. P375 Conceptual Entity Maps_To Maps_To Maps_To A property representing notations made by NCI vocabulary curators. They are intended to provide supplemental, unstructured information to the user or additional insight about the concept. P98 Conceptual Entity DesignNote DesignNote DesignNote DesignNote has_alternative_id A property representing a reference to an identical or very similar object in another database. Conceptual Entity xRef database_cross_reference database_cross_reference xRef 数据库_交叉_引用 数据库_交叉_引用 A property representing a fully qualified synonym, contains the string, term type, source, and an optional source code if appropriate. Each subfield is deliniated to facilitate interpretation by software. An alternative label for a given entity such as a commonly used abbreviation or synonym. FULL_SYN Synonym with Source Data alternative_term has exact synonym has_exact_synonym disease_ontology has_obo_namespace has_obo_namespace 有_obo_命名空间 有_obo_命名空间 has_related_synonym id An association that connects the concept defining a particular terminology subset with concepts that belong to this subset. Concept_In_Subset in subset shorthand shorthand label label label 标签 Renal cell carcinoma that develops in patients who are long-term survivors of childhood neuroblastoma. C100051 Neoplastic Process Renal Cell Carcinoma Associated with Neuroblastoma Renal Cell Carcinoma Associated with Neuroblastoma C3272295 CTRP Malignant Renal Cell Cancer Associated with Neuroblastoma Renal Cell Carcinoma Associated with Neuroblastoma Renal Cell Carcinoma Associated with Neuroblastoma A spectrum of neoplastic changes that occur in the conjunctiva and range from melanocytic hyperplasia through degrees of atypia to melanoma in situ. The lesions are generally unilateral but often multifocal and appear as flat, irregular brown discolorations of the conjunctiva. They usually affect middle-aged and elderly Caucasians. (WHO 2018) C100054 Neoplastic Process Conjunctival Melanocytic Intraepithelial Lesion C1868740 Undetermined C-MIL C-MIN Conjunctival Melanocytic Intraepithelial Lesion Conjunctival Melanocytic Intraepithelial Neoplasia Conjunctival Primary Acquired Melanosis with Atypia PAM with Atypia Primary Acquired Melanosis with Atypia Conjunctival Melanocytic Intraepithelial Lesion The passage of a catheter into the aortic root or other great vessel for the purpose of angiography of the native coronary arteries or bypass grafts supplying native coronary arteries. (ACC) C100085 Diagnostic Procedure Coronary Angiography Coronary Angiography C0085532 ACC/AHA CDISC CTRP A procedure in which the catheter is passed into the aortic root or other great vessels for the purpose of angiography of the native coronary arteries or bypass grafts supplying native coronary arteries. Documented findings from coronary angiography CORONARY ANGIOGRAPHY Coronary Angiography Coronary angiography Coronary Angiography A diagnostic X-ray procedure on an arteriovenous (AV) fistula following the infusion of a radiopaque contrast material. C100092 Diagnostic Procedure Fistulagram C0202613 AV Fistulagram AV Fistulogram Fistulagram Fistulogram Fistulagram Germ cell tumors of the central nervous system other than germinoma. This category includes teratoma, choriocarcinoma, embryonal carcinoma, and yolk sac tumor. C100093 Neoplastic Process Central Nervous System Nongerminomatous Germ Cell Tumor C1696109 CTEP Undetermined Central Nervous System Nongerminomatous Germ Cell Tumor Nongerminomatous GCT - CNS Nongerminomatous germ cell tumor of the CNS Central Nervous System Nongerminomatous Germ Cell Tumor Stage I includes: Any T, Any N, M0. M0: No evidence of distant metastasis. (from AJCC 7th Ed.) C101539 Neoplastic Process Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7 Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7 C3640140 CTRP Malignant Stage I Differentiated Thyroid Gland Cancer Under 45 Years Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7 Stage I Thyroid Gland Papillary or Follicular Carcinoma Under 45 Years Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7 Stage I includes: T1, N0, M0. T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland. N0: No regional lymph node metastasis. M0: No evidence of distant metastasis. (from AJCC 7th Ed.) C101540 Neoplastic Process Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7 Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7 C3640141 CTRP Malignant Stage I Differentiated Thyroid Gland Cancer 45 Years and Older Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7 Stage I Thyroid Gland Papillary or Follicular Carcinoma 45 Years and Older Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7 Stage II includes: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 7th Ed.) C101541 Neoplastic Process Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7 Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7 C3640142 CTRP Malignant Stage II Differentiated Thyroid Gland Cancer Under 45 Years Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7 Stage II Thyroid Gland Papillary or Follicular Carcinoma Under 45 Years Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7 Stage II includes: T2, N0, M0. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland. N0: No regional lymph node metastasis. M0: No evidence of distant metastasis. (from AJCC 7th Ed.) C101542 Neoplastic Process Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7 Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7 C3640143 CTRP Malignant Stage II Differentiated Thyroid Gland Cancer 45 Years and Older Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7 Stage II Thyroid Gland Papillary or Follicular Carcinoma 45 Years and Older Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7 A lymph node located in the area around the hilum of an organ. C102330 Body Part, Organ, or Organ Component Perihilar Lymph Node C3640700 CDISC GDC PCDC A lymph node located in the area around the hilum. Hilar Lymph Node(s) Hilar Hilar Nodes Lymph Node(s) Hilar PERIHILAR LYMPH NODE Perihilar Lymph Node Perihilar Lymph Node An extremely rare adenosarcoma that arises from the broad ligament. C102570 Neoplastic Process Broad Ligament Adenosarcoma C3640823 Malignant Broad Ligament Adenosarcoma Broad Ligament Adenosarcoma A lymph node located in a superficial part of the body. C102716 Body Part, Organ, or Organ Component Superficial Lymph Node C0229697 CDISC A lymph node located in a superficial part of the body. SUPERFICIAL LYMPH NODE Superficial Lymph Node Superficial Lymph Node Localized tumor with incomplete gross excision; representative ipsilateral nonadherent lymph nodes negative for tumor microscopically. (cancer.gov) C102845 Neoplastic Process Stage 2A Neuroblastoma Stage 2A Neuroblastoma C3640961 CTRP Malignant Stage 2A Neuroblastoma Stage IIA Neuroblastoma Stage 2A Neuroblastoma Localized tumor with or without complete gross excision, with ipsilateral nonadherent lymph nodes positive for tumor. Enlarged contralateral lymph nodes must be negative microscopically. (cancer.gov) C102846 Neoplastic Process Stage 2B Neuroblastoma Stage 2B Neuroblastoma C3640962 CTRP Malignant Stage 2B Neuroblastoma Stage IIB Neuroblastoma Stage 2B Neuroblastoma A malignant germ cell tumor other than dysgerminoma that arises from the ovary. C102870 Neoplastic Process Ovarian Non-Dysgerminomatous Germ Cell Tumor C3640983 CTEP Malignant Ovarian Non-Dysgerminomatous Germ Cell Tumor Ovarian Nondysgerminomatous Germ Cell Tumor Ovarian nondysgerm. GCT, NOS Ovarian nondysgerminomatous germ cell tumor, NOS Ovarian Non-Dysgerminomatous Germ Cell Tumor A benign or malignant neoplasm that arises from the brain or the spinal cord. C102871 Neoplastic Process Primary Central Nervous System Neoplasm C0751620 CTEP Undetermined CNS primary tumor, NOS Primary Central Nervous System Neoplasm Primary Central Nervous System Neoplasm A squamous cell carcinoma that arises from the pharynx. C102872 Neoplastic Process Pharyngeal Squamous Cell Carcinoma Pharyngeal Squamous Cell Carcinoma CL437176 CTEP CTRP Cellosaurus Malignant Pharyngeal (including Hypopharyngeal and Oropharyngeal) squamous cell carcinoma Pharyngeal Squamous Cell Carcinoma Pharyngeal Throat Squamous Cell Cancer Pharyngeal squam. cell carcinoma Pharyngeal Squamous Cell Carcinoma An astrocytic tumor exhibiting high-grade morphological characteristics. This category includes anaplastic astrocytoma, glioblastoma, and astrocytoma, IDH-mutant, grade 4. C102897 Neoplastic Process High Grade Astrocytic Tumor C3640999 CPTAC Malignant High Grade Astrocytic Neoplasm High Grade Astrocytic Tumor High-Grade Astrocytic Neoplasm High-Grade Astrocytic Tumor High Grade Astrocytic Tumor A lymph node located adjacent to the common iliac artery. (NCI) C103384 Body Part, Organ, or Organ Component Common Iliac Lymph Node CL438194 CDISC GDC UBERON mCode A lymph node located adjacent to the common iliac artery. (NCI) Iliac-common Lymph Node(s) Iliac-Common UBERON:0015878 COMMON ILIAC LYMPH NODE Common Iliac Lymph Node Common iliac lymph node group (body structure) Lymph Node(s) Iliac-Common common iliac lymph node common iliac node Common Iliac Lymph Node An imaging technique that utilizes positron emission tomography to produce a three-dimensional image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on the biologically active molecule (fludeoxyglucose) FDG. FDG is an analogue of glucose which when imaged will give tissue metabolic activity, in terms of regional glucose uptake. C103400 Diagnostic Procedure FDG-Positron Emission Tomography FDG-Positron Emission Tomography C3641247 ACC/AHA CTRP DIPG/DMG NCCN Documented findings from FDG-PET FDG FDG-PET FDG-PET Imaging FDG-Positron Emission Tomography FDG-Positron Emission Tomography An imaging technique that utilizes positron emission tomography to produce a three-dimensional image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on the biologically active molecule fluoro-L-thymidine (FLT). FLT when imaged will give tissue metabolic activity, in terms of cell proliferation. C103401 Diagnostic Procedure FLT-Positron Emission Tomography FLT-Positron Emission Tomography C3641248 CTRP FLT-PET FLT-Positron Emission Tomography Fluoro-L-Thymidine-Positron Emission Tomography FLT-Positron Emission Tomography A lymph node located in the median or lower region of the neck. (NCI) C103417 Body Part, Organ, or Organ Component Median Or Lower Cervical Lymph Node C3641257 CDISC A lymph node located in the median or lower region of the neck. (NCI) MEDIAN OR LOWER CERVICAL LYMPH NODE Median Or Lower Cervical Lymph Node Median Or Lower Cervical Lymph Node A lymph node located adjacent to the trachea within the mediastinum. (NCI) C103426 Body Part, Organ, or Organ Component Paratracheal Lymph Node C0229754 CDISC A lymph node located adjacent to the trachea within the mediastinum. (NCI) PARATRACHEAL LYMPH NODE Paratracheal Lymph Node Paratracheal Lymph Node A lymph node located in the posterior region of the neck. (NCI) C103428 Body Part, Organ, or Organ Component Posterior Cervical Lymph Node C3641262 CDISC A lymph node located in the posterior region of the neck. (NCI) POSTERIOR CERVICAL LYMPH NODE Posterior Cervical Lymph Node Posterior Cervical Lymph Node A lymph node located anterior to the auricle of the ear. C103429 Body Part, Organ, or Organ Component Preauricular Lymph Node C0229713 CDISC PCDC A lymph node located anterior to the auricle of the ear. (NCI) PREAURICULAR LYMPH NODE Pre-auricular Nodes Preauricular Lymph Node Preauricular Nodes Preauricular Lymph Node A lymph node located within the most inferior portion of the posterior mediastinum. (NCI) C103439 Body Part, Organ, or Organ Component Retrocrural Lymph Node C2953130 CDISC A lymph node located within the most inferior portion of the posterior mediastinum. (NCI) RETROCRURAL LYMPH NODE Retrocrural Lymph Node Retrocrural Lymph Node A lymph node located in the upper region of the neck. (NCI) C103447 Body Part, Organ, or Organ Component Upper Cervical Lymph Node C3641267 CDISC A lymph node located in the upper region of the neck. (NCI) UPPER CERVICAL LYMPH NODE Upper Cervical Lymph Node Upper Cervical Lymph Node The occipital region of the skin that covers the top of the head. C103456 Anatomical Structure Occipital Scalp C0748512 CDISC The occipital region of the skin that covers the top of the head. (NCI) OCCIPITAL SCALP Occipital Scalp Occipital Scalp An imaging technique that utilizes positron emission tomography and computed tomography in a single machine. C103512 Diagnostic Procedure Positron Emission Tomography and Computed Tomography Scan Positron Emission Tomography and Computed Tomography Scan C1699633 CDISC CTRP PCDC An imaging technique that utilizes positron emission tomography and computed tomography in a single machine. PET-CT Scan PET/CT SCAN Positron Emission Tomography and Computed Tomography Scan Positron Emission Tomography/Computed Tomography Positron Emission Tomography and Computed Tomography Scan An imaging technique that utilizes positron emission tomography and magnetic resonance imaging in a single machine. C103514 Diagnostic Procedure Positron Emission Tomography and Magnetic Resonance Imaging Positron Emission Tomography and Magnetic Resonance Imaging CL471723 CDISC CTRP PCDC An imaging technique that utilizes positron emission tomography and magnetic resonance imaging in a single machine. PET-MRI Scan PET/MRI PET/MRI SCAN Positron Emission Tomography and Magnetic Resonance Imaging Positron Emission Tomography/Magnetic Resonance Imaging Hybrid Imaging Positron Emission Tomography and Magnetic Resonance Imaging Prostate carcinoma that has developed in relatives of patients with a history of prostate carcinoma. C103817 Neoplastic Process Hereditary Prostate Carcinoma Hereditary Prostate Carcinoma C2931456 CTRP GDC Malignant Hereditary Prostate Cancer Hereditary Prostate Cancer Hereditary Prostate Carcinoma Hereditary Prostate Carcinoma A term that refers to the staging of adrenal cortical carcinoma according to the European Network for the Study of Adrenal Tumors (ENSAT). C104030 Neoplastic Process Adrenal Cortical Carcinoma by ENSAT Stage C3641708 Malignant Adrenal Cortex Carcinoma by ENSAT Stage Adrenal Cortical Carcinoma by ENSAT Stage Adrenal Cortical Carcinoma by ENSAT Stage Stage I includes: T1, N0, M0. Tumor 5 cm or less in greatest dimension. The tumor has not invaded the surrounding tissues or organs and has not spread to lymph nodes or distant organs or tissues. (ENSAT 7th Ed, 2009) C104031 Neoplastic Process ENSAT Stage I Adrenal Cortex Carcinoma ENSAT Stage I Adrenal Cortical Carcinoma C3641709 CTRP GDC Malignant Stage I ENSAT Stage I Adrenal Cortex Cancer ENSAT Stage I Adrenal Cortex Carcinoma ENSAT Stage I Adrenal Cortical Carcinoma ENSAT Stage I Adrenal Cortical Carcinoma Stage II includes: T2, N0, M0. Tumor greater than 5 cm. The tumor has not invaded surrounding tissues or organs and has not spread to lymph nodes or distant organs or tissues. (ENSAT 7th Ed, 2009) C104032 Neoplastic Process ENSAT Stage II Adrenal Cortex Carcinoma ENSAT Stage II Adrenal Cortical Carcinoma C3641710 CTRP GDC Malignant Stage II ENSAT Stage II Adrenal Cortex Cancer ENSAT Stage II Adrenal Cortex Carcinoma ENSAT Stage II Adrenal Cortical Carcinoma ENSAT Stage II Adrenal Cortical Carcinoma Stage III includes: T3/T4, N0/N1, M0. Tumor of any size that has spread to the fat outside the adrenal gland or into nearby organs or tissues and/or has spread to the regional lymph nodes. (ENSAT 7th Ed, 2009) C104033 Neoplastic Process ENSAT Stage III Adrenal Cortex Carcinoma ENSAT Stage III Adrenal Cortical Carcinoma C3641711 CTRP GDC Malignant Stage III ENSAT Stage III Adrenal Cortex Cancer ENSAT Stage III Adrenal Cortex Carcinoma ENSAT Stage III Adrenal Cortical Carcinoma ENSAT Stage III Adrenal Cortical Carcinoma Stage IV includes: Any T, Any N, M1. Tumor of any size that involves distant organs such as liver, bone or brain. The tumor may or may not involve nearby organs, tissues or lymph nodes. (ENSAT 7th Ed, 2009) C104034 Neoplastic Process ENSAT Stage IV Adrenal Cortex Carcinoma ENSAT Stage IV Adrenal Cortical Carcinoma C3641712 CTRP GDC Malignant Stage IV ENSAT Stage IV Adrenal Cortex Cancer ENSAT Stage IV Adrenal Cortex Carcinoma ENSAT Stage IV Adrenal Cortical Carcinoma ENSAT Stage IV Adrenal Cortical Carcinoma A rapidly growing serous adenocarcinoma that arises from the ovary. It is characterized by the presence of high grade cytologic features and frequent mitotic figures. C105555 Neoplastic Process High Grade Ovarian Serous Adenocarcinoma Ovarian High Grade Serous Adenocarcinoma C3642254 CTRP Cellosaurus Malignant High grade serous carcinoma High Grade Ovarian Serous Adenocarcinoma High-Grade Ovarian Serous Adenocarcinoma Ovarian High Grade Serous Adenocarcinoma Ovarian High-Grade Serous Adenocarcinoma Ovarian High Grade Serous Adenocarcinoma A slow-growing serous adenocarcinoma that arises from the ovary. It usually originates from borderline neoplastic processes or adenofibromas. It is characterized by the presence of low grade cytologic features and infrequent mitotic figures. C105556 Neoplastic Process Invasive Ovarian Micropapillary Serous Carcinoma Ovarian Low Grade Serous Adenocarcinoma C3642255 CTRP Cellosaurus Malignant Invasive Ovarian Micropapillary Serous Carcinoma Low Grade Ovarian Serous Adenocarcinoma Low-Grade Ovarian Serous Adenocarcinoma Ovarian Low Grade Serous Adenocarcinoma Ovarian Low-Grade Serous Adenocarcinoma Ovarian Low Grade Serous Adenocarcinoma A lymph node located distant to the anatomic site of interest. C106042 Body Part, Organ, or Organ Component Distant Lymph Node C3830456 CDISC GDC Lymph node(s) that is distant to the anatomic region of interest. Distant Nodes Lymph Node(s) Distant DISTANT LYMPH NODE Distant Lymph Node Lymph Node(s) Distant Distant Lymph Node Gene expression profiling that classifies uveal melanomas into a low-grade group. C111020 Neoplastic Process Uveal Class 1 Melanoma C3831088 Malignant Class 1 Uveal Melanoma Uveal Class 1 Melanoma Uveal Class 1 Melanoma Gene expression profiling that classifies uveal melanomas into a high-grade group. C111021 Neoplastic Process Uveal Class 2 Melanoma C3831087 Malignant Class 2 Uveal Melanoma Uveal Class 2 Melanoma Uveal Class 2 Melanoma Uveal melanoma with low metastatic risk as defined by gene expression profiling. C111022 Neoplastic Process Uveal Class 1a Melanoma C3831090 Malignant Class 1a Uveal Melanoma Uveal Class 1a Melanoma Uveal Class 1a Melanoma Uveal melanoma with intermediate metastatic risk as defined by gene expression profiling. C111023 Neoplastic Process Uveal Class 1b Melanoma C3831089 Malignant Class 1b Uveal Melanoma Uveal Class 1b Melanoma Uveal Class 1b Melanoma C111030 Neoplastic Process Uveal Melanoma by Gene Expression Profile C3827193 Malignant Uveal Melanoma by Gene Expression Profile Uveal Melanoma by Gene Expression Profile A diffusion MRI technique in which diffusion-sensitizing gradients are applied to the imaging sequence. C111116 Diagnostic Procedure Diffusion Weighted Imaging Diffusion Weighted Imaging C0598801 CDISC CTRP DIPG/DMG A type of MRI technique in which diffusion-sensitizing gradients are applied to the imaging sequence. DIFFUSION WEIGHTED MRI DW-MRI DWI DWI MRI DWI-MRI Diffusion Weighted Imaging Diffusion Weighted MRI Diffusion-Weighted MR Imaging Diffusion-Weighted MRI Diffusion-Weighted Magnetic Resonance Imaging MR Diffusion-Weighted Imaging Diffusion Weighted Imaging An imaging technique that utilizes positron emission tomography and single-photon emission computed tomography in a single machine. C111297 Diagnostic Procedure Positron Emission Tomography and Single Photon Emission Computed Tomography Scan C3828509 CDISC An imaging technique that utilizes positron emission tomography and single-photon emission computed tomography in a single machine. PET/SPECT SCAN Positron Emission Tomography and Single Photon Emission Computed Tomography Scan Positron Emission Tomography and Single Photon Emission Computed Tomography Scan Classification of glioblastoma into molecular subtypes as defined by gene expression profiling. C111691 Neoplastic Process Glioblastoma by Gene Expression Profile C3827194 Malignant Glioblastoma by Gene Expression Profile Glioblastoma by Gene Expression Profile A molecular subtype of glioblastoma that is associated with younger age at presentation and is characterized by p53 mutations and PDGFRa amplifications. C111692 Neoplastic Process Proneural Glioblastoma C3828464 Malignant Proneural Glioblastoma Proneural Glioblastoma A molecular subtype of glioblastoma characterized by the expression of the neural markers NEFL, GABRA1, SYT1, and SLC12A5. C111693 Neoplastic Process Neural Glioblastoma C3828832 Malignant Neural Glioblastoma Neural Glioblastoma A molecular subtype of glioblastoma characterized by lack of p53 mutations, chromosome 7 amplifications or deletions, and high levels of EGFR amplification. C111694 Neoplastic Process Classical Glioblastoma C3827253 Malignant Classical Glioblastoma Classical Glioblastoma A molecular subtype of glioblastoma characterized by the presence of NF1 mutations. C111695 Neoplastic Process Mesenchymal Glioblastoma C3829122 Malignant Mesenchymal Glioblastoma Mesenchymal Glioblastoma A staging system for thymoma based on the anatomic extent of disease at the time of surgery. C112006 Neoplastic Process Thymoma by Masaoka-Koga Stage C3827366 Malignant Masaoka Staging Masaoka Staging System Masaoka Staging System for Thymoma Masaoka-Koga Staging System for Thymoma Thymoma by Masaoka-Koga Stage Thymoma by Masaoka-Koga Stage The tumor is completely encapsulated. C112007 Neoplastic Process Masaoka Stage I Masaoka-Koga Stage I C3829188 CTRP GDC Malignant Stage I Masaoka Stage I Masaoka-Koga Stage I Stage I Masaoka-Koga Stage I The tumor shows microscopic invasion into the capsule. C112008 Neoplastic Process Masaoka-Koga Stage IIa C3829187 GDC Malignant Stage IIa Masaoka Stage IIa Masaoka-Koga Stage IIa Stage IIa Masaoka-Koga Stage IIa The tumor shows invasion through the capsule and into the surrounding fatty tissue. C112009 Neoplastic Process Masaoka-Koga Stage IIb C3829186 GDC Malignant Stage IIb Masaoka Stage IIb Masaoka-Koga Stage IIb Stage IIb Masaoka-Koga Stage IIb The tumor shows invasion into the neighboring tissues and organs of the lower neck or upper chest. C112010 Neoplastic Process Masaoka Stage III Masaoka-Koga Stage III C3829185 CTRP GDC Malignant Stage III Masaoka Stage III Masaoka-Koga Stage III Stage III Masaoka-Koga Stage III The tumor shows metastasis throughout the pleural and/or pericardial spaces. C112011 Neoplastic Process Masaoka Stage IVa Masaoka-Koga Stage IVa C3829184 CTRP GDC Malignant Stage IVa Masaoka Stage IVa Masaoka-Koga Stage IVa Stage IVa Masaoka-Koga Stage IVa The tumor shows lymphogenous or hematogenous metastasis to distant sites. C112012 Neoplastic Process Masaoka Stage IVb Masaoka-Koga Stage IVb C3829183 CTRP GDC Malignant Stage IVb Masaoka Stage IVb Masaoka-Koga Stage IVb Stage IVb Masaoka-Koga Stage IVb A carcinosarcoma of the uterus characterized by the presence of sarcomatous elements that arise from the tissues of the uterus. C113238 Neoplastic Process Uterine Carcinosarcoma, Homologous Type C3827677 Malignant Uterine Carcinosarcoma, Homologous Type Uterine Carcinosarcoma, Homologous Type A carcinosarcoma of the uterus characterized by the presence of sarcomatous elements composed of tissues that are not found in the uterus (e.g., bone, cartilage, skeletal muscle). C113239 Neoplastic Process Uterine Carcinosarcoma, Heterologous Type C3827678 Malignant Uterine Carcinosarcoma, Heterologous Type Uterine Carcinosarcoma, Heterologous Type An intraductal papillary-mucinous neoplasm of the pancreas that arises from the main pancreatic duct. C113664 Neoplastic Process Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm C3826981 Undetermined Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm Pancreatic MD-IPMN Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm An intraductal papillary-mucinous neoplasm of the pancreas that arises in one of the branches of the main pancreatic duct. It usually has an indolent behavior. C113665 Neoplastic Process Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm C3826890 Undetermined Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm Pancreatic BD-IPMN Pancreatic SB-IPMN Side Branch Pancreatic Intraductal Papillary-Mucinous Neoplasm Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm An intraductal papillary-mucinous neoplasm of the pancreas that arises primarily from the main pancreatic duct and extends to the branch ducts. C113667 Neoplastic Process Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm C3829003 Undetermined Mixed Type Pancreatic IPMN Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm A small duct that originates from the main duct. C113668 Body Part, Organ, or Organ Component Branch Duct C3831279 Branch Duct Branch Duct A group of lymph nodes located in the inferior part of the mediastinum. C113695 Anatomical Structure Inferior Mediastinal Lymph Node C3829541 CDISC A group of lymph nodes located in the inferior part of the mediastinum. (NCI) INFERIOR MEDIASTINAL LYMPH NODE Inferior Mediastinal Lymph Node Inferior Mediastinal Lymph Node A non-invasive procedure in which magnetic resonance imaging is used to visualize the intrahepatic and extrahepatic bile ducts, the pancreatic duct, and the surrounding parenchyma. C113775 Diagnostic Procedure Magnetic Resonance Cholangiopancreatography Magnetic Resonance Cholangiopancreatography C0994163 CDISC CTRP A type of magnetic resonance imaging that is used to construct images of the intrahepatic and extrahepatic bile ducts, the pancreatic duct, and the surrounding parenchyma. MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY MRCP Magnetic Resonance Cholangiopancreatography Magnetic Resonance Cholangiopancreatography An antenatal ultrasonographic method that measures blood flow velocity through either maternal or fetal vessels. C114080 Diagnostic Procedure Fetal Doppler Velocimetry C2052183 NICHD An antenatal ultrasonographic method that measures blood flow velocity through either maternal or fetal vessels. Fetal Doppler Velocimetry Fetal Doppler Velocimetry A technique that utilizes a Doppler transducer to monitor fetal heart rate. The transducer is placed on the maternal abdomen and detects fetal cardiac motion using ultrasound. C114081 Diagnostic Procedure Fetal Doppler Monitoring C3827010 NICHD A technique that utilizes a Doppler transducer to monitor fetal heart rate. The transducer is placed on the maternal abdomen and detects fetal cardiac motion using ultrasound. EFM External Fetal Heart Rate Monitoring Fetal Doppler Monitoring Fetal Doppler Monitoring At least one dose of corticosteroids administered to accelerate fetal maturation. (adapted from reVITALize) C114131 Therapeutic or Preventive Procedure Antenatal Steroid Therapy Initiated C3831529 NICHD At least one dose of corticosteroids administered to accelerate fetal maturation. [adapted from reVITALize] Antenatal Steroid Therapy Initiated Antenatal Steroids Initiated Antenatal Steroid Therapy Initiated A technique that uses radiofrequency waves and a magnet to image the body, in which the images are not enhanced by the addition of contrast agents. C114184 Diagnostic Procedure MRI Without Contrast C0202670 CDISC A technique that uses radiofrequency waves and a magnet to image the body, in which the images are not enhanced by the addition of contrast agents. MRI WITHOUT CONTRAST MRI Without Contrast Magnetic Resonance Imaging Without Contrast MRI Without Contrast Langerhans cell histiocytosis that occurs during childhood. C114483 Neoplastic Process Childhood Langerhans Cell Histiocytosis Childhood Langerhans Cell Histiocytosis CL412477 CTRP Cellosaurus NICHD Langerhans cell histiocytosis that occurs during childhood. Undetermined Childhood Langerhans Cell Histiocytosis Langerhans Cell Histiocytosis Childhood Langerhans Cell Histiocytosis An undifferentiated pleomorphic sarcoma that occurs during adulthood. C114541 Neoplastic Process Adult Undifferentiated Pleomorphic Sarcoma Adult Undifferentiated Pleomorphic Sarcoma C0279546 CTRP Malignant Adult Malignant Fibrous Histiocytoma Adult Undifferentiated Pleomorphic Sarcoma Undifferentiated Pleomorphic Sarcoma Adult Undifferentiated Pleomorphic Sarcoma A rare endometrial carcinoma characterized by the presence of both malignant glandular and malignant squamous cellular components. C114656 Neoplastic Process Endometrial Adenosquamous Carcinoma Endometrial Adenosquamous Carcinoma C3896969 CTRP Cellosaurus Malignant Endometrial Adenosquamous Cancer Endometrial Adenosquamous Carcinoma Endometrial Adenosquamous Carcinoma An undifferentiated pleomorphic sarcoma that occurs during childhood. C114749 Neoplastic Process Childhood Undifferentiated Pleomorphic Sarcoma Childhood Undifferentiated Pleomorphic Sarcoma C3899638 CTRP Malignant Childhood Malignant Fibrous Histiocytoma Childhood Unclassified Pleomorphic Sarcoma Childhood Undifferentiated Pleomorphic Sarcoma Undifferentiated Pleomorphic Sarcoma Childhood Undifferentiated Pleomorphic Sarcoma An undifferentiated high grade pleomorphic sarcoma that arises from the bone and occurs during childhood. C114750 Neoplastic Process Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone CL336909 CTRP Malignant Childhood Malignant Fibrous Histiocytoma of Bone Childhood Undifferentiated High Grade Pleomorphic Sarcoma Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone Undifferentiated High Grade Pleomorphic Sarcoma of Bone Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone A gliosarcoma that arises from the brain stem and occurs during childhood. C114759 Neoplastic Process Childhood Brain Stem Gliosarcoma Childhood Brain Stem Gliosarcoma C3887517 CTRP NICHD A gliosarcoma that arises from the brain stem and occurs during childhood. Malignant Brain Stem Gliosarcoma Childhood Brain Stem Gliosarcoma Childhood Brain Stem Gliosarcoma A mixed glioma that arises from the brain stem and occurs during childhood. C114760 Neoplastic Process Childhood Brain Stem Mixed Glioma Childhood Brain Stem Mixed Glioma C3887516 CTRP NICHD A mixed glioma that arises from the brain stem and occurs during childhood. Undetermined Brain Stem Mixed Glioma Childhood Brain Stem Mixed Glioma Childhood Brain Stem Mixed Glioma An oligodendroglioma that arises from the brain and occurs during childhood. C114773 Neoplastic Process Childhood Brain Oligodendroglioma Childhood Brain Oligodendroglioma C3899674 CTRP Undetermined Brain Oligodendroglioma Childhood Brain Oligodendroglioma Childhood Brain Oligodendroglioma A supratentorial embryonal tumor, not otherwise specified that occurs in childhood. C114774 Neoplastic Process Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified CL343570 CTRP NICHD A supratentorial, primitive, neuroectodermal tumor that occurs during childhood. Malignant Childhood Supratentorial Embryonal Tumor, NOS Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified Childhood Supratentorial PNET Childhood Supratentorial Primitive Neuroectodermal Tumor Supratentorial Embryonal Tumor, NOS Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified A neuroblastoma that arises from the central nervous system and occurs during childhood. C114775 Neoplastic Process Childhood Central Nervous System Neuroblastoma Childhood Central Nervous System Neuroblastoma C3887519 CTRP NICHD Malignant Central Nervous System Neuroblastoma Childhood Central Nervous System Neuroblastoma Childhood Central Nervous System Neuroblastoma A germ cell tumor that arises within the cranium and occurs during adulthood. C114778 Neoplastic Process Adult Intracranial Germ Cell Tumor Adult Intracranial Germ Cell Tumor C1370508 CTRP Undetermined Adult Intracranial Germ Cell Tumor Intracranial Germ Cell Tumor Adult Intracranial Germ Cell Tumor A non-Hodgkin lymphoma that arises from the central nervous system. C114779 Neoplastic Process Central Nervous System Non-Hodgkin Lymphoma Central Nervous System Non-Hodgkin Lymphoma C2213246 CTRP Malignant Central Nervous System Non-Hodgkin Lymphoma Primary Central Nervous System Non-Hodgkin Lymphoma Central Nervous System Non-Hodgkin Lymphoma An undifferentiated high grade pleomorphic sarcoma that arises from the bone and occurs during adulthood. C114782 Neoplastic Process Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone CL376106 CTRP Malignant Adult Malignant Fibrous Histiocytoma of Bone Adult Undifferentiated High Grade Pleomorphic Sarcoma Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone Undifferentiated High Grade Pleomorphic Sarcoma of Bone Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone Hodgkin lymphoma that occurs during pregnancy. C114783 Neoplastic Process Hodgkin Lymphoma During Pregnancy Hodgkin Lymphoma During Pregnancy CL034308 CTRP Malignant Hodgkin Lymphoma During Pregnancy Hodgkin Lymphoma During Pregnancy Non-Hodgkin lymphoma that occurs during pregnancy. C114784 Neoplastic Process Non-Hodgkin Lymphoma During Pregnancy Non-Hodgkin Lymphoma During Pregnancy CL034394 CTRP Malignant Non-Hodgkin Lymphoma During Pregnancy Non-Hodgkin Lymphoma During Pregnancy Subependymal giant cell astrocytoma that occurs during childhood. C114785 Neoplastic Process Childhood Subependymal Giant Cell Astrocytoma Childhood Subependymal Giant Cell Astrocytoma C1832034 CTRP Undetermined Childhood Subependymal Giant Cell Astrocytoma Subependymal Giant Cell Astrocytoma Childhood Subependymal Giant Cell Astrocytoma A germ cell tumor that arises from the testis or ovary and occurs during childhood. C114801 Neoplastic Process Childhood Gonadal Germ Cell Tumor Childhood Gonadal Germ Cell Tumor C4228804 CTRP NICHD A germ cell tumor that arises from the testis or ovary and occurs during childhood. Undetermined Childhood Gonadal Germ Cell Tumor Gonadal Germ Cell Tumor Childhood Gonadal Germ Cell Tumor A Hodgkin lymphoma with favorable prognosis that occurs during childhood. C114806 Neoplastic Process Childhood Favorable Prognosis Hodgkin Lymphoma Childhood Favorable Prognosis Hodgkin Lymphoma CL376151 CTRP Malignant Childhood Favorable Prognosis Hodgkin Lymphoma Favorable Prognosis Hodgkin Lymphoma Childhood Favorable Prognosis Hodgkin Lymphoma A Hodgkin lymphoma with favorable prognosis that occurs during adulthood. C114807 Neoplastic Process Adult Favorable Prognosis Hodgkin Lymphoma Adult Favorable Prognosis Hodgkin Lymphoma CL376153 CTRP Malignant Adult Favorable Prognosis Hodgkin Lymphoma Favorable Prognosis Hodgkin Lymphoma Adult Favorable Prognosis Hodgkin Lymphoma A Hodgkin lymphoma with unfavorable prognosis that occurs during childhood. C114808 Neoplastic Process Childhood Unfavorable Prognosis Hodgkin Lymphoma Childhood Unfavorable Prognosis Hodgkin Lymphoma CL376152 CTRP Malignant Childhood Unfavorable Prognosis Hodgkin Lymphoma Unfavorable Prognosis Hodgkin Lymphoma Childhood Unfavorable Prognosis Hodgkin Lymphoma A Hodgkin lymphoma with unfavorable prognosis that occurs during adulthood. C114809 Neoplastic Process Adult Unfavorable Prognosis Hodgkin Lymphoma Adult Unfavorable Prognosis Hodgkin Lymphoma CL376154 CTRP Malignant Adult Unfavorable Prognosis Hodgkin Lymphoma Unfavorable Prognosis Hodgkin Lymphoma Adult Unfavorable Prognosis Hodgkin Lymphoma A pineoblastoma that occurs during childhood. C114812 Neoplastic Process Childhood Pineoblastoma Childhood Pineoblastoma C3887520 CTRP Cellosaurus NICHD A pineoblastoma that occurs during childhood. Malignant Childhood Pineoblastoma Pineoblastoma Childhood Pineoblastoma A B acute lymphoblastic leukemia that occurs during adulthood. It is characterized by the presence of lymphoblasts that carry a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome. C114819 Neoplastic Process Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 C3900106 CTRP Cellosaurus Malignant Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR::ABL1 Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1 B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 A central nervous system embryonal tumor that occurs during childhood. C114833 Neoplastic Process Childhood Central Nervous System Embryonal Neoplasm Childhood Central Nervous System Embryonal Tumor C3899672 CTRP NICHD A central nervous system embryonal tumor that occurs during childhood. Malignant Central Nervous System Embryonal Neoplasm Childhood Central Nervous System Embryonal Neoplasm Childhood Central Nervous System Embryonal Tumor Childhood Central Nervous System Embryonal Tumor The reemergence of childhood central nervous system embryonal neoplasm after a period of remission. C114836 Neoplastic Process Recurrent Childhood Central Nervous System Embryonal Neoplasm Recurrent Childhood Central Nervous System Embryonal Neoplasm C3897757 CTRP Malignant Recurrent Central Nervous System Embryonal Neoplasm Recurrent Childhood Central Nervous System Embryonal Neoplasm Recurrent Childhood Central Nervous System Embryonal Neoplasm An epithelioid hemangioendothelioma that occurs during childhood. C114926 Neoplastic Process Childhood Epithelioid Hemangioendothelioma Childhood Epithelioid Hemangioendothelioma CL412304 CTRP Malignant Childhood Epithelioid Hemangioendothelioma Epithelioid Hemangioendothelioma Childhood Epithelioid Hemangioendothelioma Langerhans cell histiocytosis that occurs during adulthood. C114929 Neoplastic Process Adult Langerhans Cell Histiocytosis Adult Langerhans Cell Histiocytosis CL412310 CTRP Undetermined Adult Langerhans Cell Histiocytosis Langerhans Cell Histiocytosis Adult Langerhans Cell Histiocytosis Breast adenocarcinoma that does not respond to hormone therapy. C114932 Neoplastic Process Hormone-Resistant Breast Cancer Hormone-Resistant Breast Carcinoma CL412374 CTRP Malignant Hormone-Refractory Breast Cancer Hormone-Resistant Breast Adenocarcinoma Hormone-Resistant Breast Cancer Hormone-Resistant Breast Carcinoma Hormone-Resistant Breast Carcinoma Prostate carcinoma that does not respond to hormone therapy. C114933 Neoplastic Process Hormone-Resistant Prostate Carcinoma Hormone-Resistant Prostate Carcinoma CL412375 CTRP Malignant Hormone-Resistant Prostate Cancer Hormone-Resistant Prostate Carcinoma Hormone-Resistant Prostate Carcinoma A Hodgkin lymphoma that has spread to the central nervous system following the initial presentation in another nodal or extranodal site. C114949 Neoplastic Process Secondary Central Nervous System Hodgkin Lymphoma Secondary Central Nervous System Hodgkin Lymphoma CL416259 CTRP Malignant Secondary Central Nervous System Hodgkin Lymphoma Secondary Central Nervous System Hodgkin Lymphoma A non-Hodgkin lymphoma that has spread to the central nervous system following the initial presentation in another nodal or extranodal site. C114950 Neoplastic Process Secondary Central Nervous System Non-Hodgkin Lymphoma Secondary Central Nervous System Non-Hodgkin Lymphoma CL416260 CTRP Malignant Secondary Central Nervous System Non-Hodgkin Lymphoma Secondary Central Nervous System Non-Hodgkin Lymphoma A Hodgkin lymphoma that arises from the central nervous system. C114951 Neoplastic Process Central Nervous System Hodgkin Lymphoma Central Nervous System Hodgkin Lymphoma C2046622 CTRP Malignant Central Nervous System Hodgkin Lymphoma Central Nervous System Hodgkin Lymphoma The reemergence of a childhood astrocytic tumor after a period of remission. C114956 Neoplastic Process Recurrent Childhood Astrocytic Tumor Recurrent Childhood Astrocytic Tumor C3897758 CTRP Undetermined Recurrent Astrocytic Tumor Recurrent Childhood Astrocytic Tumor Recurrent Childhood Astrocytic Tumor A fibrillary astrocytoma that occurs during childhood. C114963 Neoplastic Process Childhood Fibrillary Astrocytoma Childhood Fibrillary Astrocytoma CL433903 CTRP NICHD A fibrillary astrocytoma that occurs during childhood. Undetermined Childhood Fibrillary Astrocytoma Fibrillary Astrocytoma Childhood Fibrillary Astrocytoma A gemistocytic astrocytoma that occurs during childhood. C114964 Neoplastic Process Childhood Gemistocytic Astrocytoma Childhood Gemistocytic Astrocytoma CL433906 CTRP NICHD A gemistocytic astrocytoma that occurs during childhood. Undetermined Childhood Gemistocytic Astrocytoma Gemistocytic Astrocytoma Childhood Gemistocytic Astrocytoma A giant cell glioblastoma that occurs during childhood. C114966 Neoplastic Process Childhood Giant Cell Glioblastoma Childhood Giant Cell Glioblastoma CL433909 CTRP NICHD A giant cell glioblastoma that occurs during childhood. Malignant Childhood Giant Cell Glioblastoma Giant Cell Glioblastoma Childhood Giant Cell Glioblastoma A diffuse astrocytoma that occurs during childhood. C114967 Neoplastic Process Childhood Diffuse Astrocytoma Childhood Diffuse Astrocytoma CL433914 CTRP DIPG/DMG NICHD A diffuse astrocytoma that occurs during childhood. Undetermined Childhood Diffuse Astrocytoma Diffuse Astrocytoma Childhood Diffuse Astrocytoma A gliosarcoma that occurs during childhood. C114968 Neoplastic Process Childhood Gliosarcoma Childhood Gliosarcoma CL433917 CTRP NICHD A gliosarcoma that occurs during childhood. Malignant Childhood Gliosarcoma Gliosarcoma Childhood Gliosarcoma Gliomatosis cerebri that occurs during childhood. C114969 Neoplastic Process Childhood Gliomatosis Cerebri Childhood Gliomatosis Cerebri CL433930 CTRP NICHD Gliomatosis cerebri that occurs during childhood. Malignant Childhood Gliomatosis Cerebri Gliomatosis Cerebri Childhood Gliomatosis Cerebri A pilomyxoid astrocytoma that occurs during childhood. C114970 Neoplastic Process Childhood Pilomyxoid Astrocytoma Childhood Pilomyxoid Astrocytoma CL433939 CTRP NICHD A pilomyxoid astrocytoma that occurs during childhood. Undetermined Childhood Pilomyxoid Astrocytoma Pilomyxoid Astrocytoma Childhood Pilomyxoid Astrocytoma A pleomorphic xanthoastrocytoma that occurs during childhood. C114971 Neoplastic Process Childhood Pleomorphic Xanthoastrocytoma Childhood Pleomorphic Xanthoastrocytoma CL433942 CTRP NICHD A pleomorphic xanthoastrocytoma that occurs during childhood. Undetermined Childhood Pleomorphic Xanthoastrocytoma Pleomorphic Xanthoastrocytoma Childhood Pleomorphic Xanthoastrocytoma A protoplasmic astrocytoma that occurs during childhood. C114972 Neoplastic Process Childhood Protoplasmic Astrocytoma Childhood Protoplasmic Astrocytoma CL433945 CTRP NICHD A protoplasmic astrocytoma that occurs during childhood. Undetermined Childhood Protoplasmic Astrocytoma Protoplasmic Astrocytoma Childhood Protoplasmic Astrocytoma An anaplastic oligoastrocytoma that occurs during childhood. C114973 Neoplastic Process Childhood Anaplastic Oligoastrocytoma Childhood Anaplastic Oligoastrocytoma CL433948 CTRP NICHD An anaplastic oligoastrocytoma that occurs during childhood. Malignant Anaplastic Oligoastrocytoma Childhood Anaplastic Oligoastrocytoma Childhood Anaplastic Oligoastrocytoma An oligoastrocytoma that occurs during childhood. C114974 Neoplastic Process Childhood Oligoastrocytoma Childhood Oligoastrocytoma CL433951 CTRP NICHD An oligoastrocytoma that occurs during childhood. Undetermined Childhood Oligoastrocytoma Oligoastrocytoma Childhood Oligoastrocytoma A combined hepatocellular carcinoma and cholangiocarcinoma that occurs during adulthood. C114987 Neoplastic Process Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma C3900105 CTRP Malignant Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma Combined Hepatocellular Cancer and Cholangiocarcinoma Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma Fibrolamellar variant of hepatocellular carcinoma that occurs during adulthood. C114992 Neoplastic Process Adult Fibrolamellar Carcinoma Adult Fibrolamellar Carcinoma C3900102 CTRP Malignant Adult Fibrolamellar Carcinoma Fibrolamellar Cancer Adult Fibrolamellar Carcinoma A pleomorphic hepatocellular carcinoma that occurs during adulthood. C114993 Neoplastic Process Adult Pleomorphic Hepatocellular Carcinoma Adult Pleomorphic Hepatocellular Carcinoma C3900095 CTRP Malignant Adult Pleomorphic Hepatocellular Carcinoma Pleomorphic Hepatocellular Cancer Adult Pleomorphic Hepatocellular Carcinoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C115029 Neoplastic Process Ann Arbor Stage I Noncutaneous Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage I Noncutaneous Childhood Anaplastic Large Cell Lymphoma CL376202 CTRP Malignant Ann Arbor Stage I Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage I Noncutaneous Childhood Anaplastic Large Cell Lymphoma Stage I Anaplastic Large Cell Lymphoma Stage I Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage I Noncutaneous Childhood Anaplastic Large Cell Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C115030 Neoplastic Process Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma CL376203 CTRP Malignant Ann Arbor Stage II Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma Stage II Anaplastic Large Cell Lymphoma Stage II Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C115031 Neoplastic Process Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma CL376204 CTRP Malignant Ann Arbor Stage III Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma Stage III Anaplastic Large Cell Lymphoma Stage III Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C115032 Neoplastic Process Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell Lymphoma CL376205 CTRP Malignant Ann Arbor Stage IV Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell Lymphoma Stage IV Anaplastic Large Cell Lymphoma Stage IV Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell Lymphoma The tumor shows invasion into the capsule. C115033 Neoplastic Process Masaoka Stage II Masaoka-Koga Stage II C3898463 CTRP Malignant Masaoka Stage II Masaoka-Koga Stage II Masaoka-Koga Stage II The tumor shows metastasis throughout the pleural and/or pericardial spaces or metastasis to distant sites. C115034 Neoplastic Process Masaoka Stage IV Masaoka-Koga Stage IV C3898462 CTRP Malignant Masaoka Stage IV Masaoka-Koga Stage IV Masaoka-Koga Stage IV Stage IVA includes: (T4a, N0, M0); (T4a, N1a, M0); (T1, N1b, M0); (T2, N1b, M0); (T3, N1b, M0); (T4a, N1b, M0). T4a: Moderately advanced local disease. Tumor of any size extending beyond the thyroid gland capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve. T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland. T3: Tumor more than 4 cm in greatest dimension and limited to the thyroid gland, or tumor of any size with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues). N0: No regional lymph node metastasis. N1a: Metastasis to pretracheal, paratracheal or prelaryngeal/Delphian lymph nodes (Level VI lymph nodes). N1b: Metastasis to unilateral, bilateral or contralateral cervical (Levels I, II, III, IV, or V) or retropharyngeal or superior mediastinal lymph nodes (Level VII). M0: No distant metastasis. (AJCC 7th ed.) C115035 Neoplastic Process Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7 Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7 C3897519 CTRP Malignant Stage IVA Thyroid Gland Follicular Cancer Stage IVA Thyroid Gland Follicular Carcinoma Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7 Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7 Stage IVB includes: T4b, Any N, M0. T4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels. M0: No distant metastasis. (AJCC 7th ed.) C115036 Neoplastic Process Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7 Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7 C3897512 CTRP Malignant Stage IVB Thyroid Gland Follicular Cancer Stage IVB Thyroid Gland Follicular Carcinoma Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7 Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C115037 Neoplastic Process Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7 Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7 C3897507 CTRP Malignant Stage IVC Thyroid Gland Follicular Cancer Stage IVC Thyroid Gland Follicular Carcinoma Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7 Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7 Stage IVA includes: (T4a, N0, M0); (T4a, N1a, M0); (T1, N1b, M0); (T2, N1b, M0); (T3, N1b, M0); (T4a, N1b, M0). T4a: Moderately advanced local disease. Tumor of any size extending beyond the thyroid gland capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve. T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland. T3: Tumor more than 4 cm in greatest dimension and limited to the thyroid gland, or tumor of any size with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues). N0: No regional lymph node metastasis. N1a: Metastasis to pretracheal, paratracheal or prelaryngeal/Delphian lymph nodes (Level VI lymph nodes). N1b: Metastasis to unilateral, bilateral or contralateral cervical (Levels I, II, III, IV, or V) or retropharyngeal or superior mediastinal lymph nodes (Level VII). M0: No distant metastasis. (AJCC 7th ed.) C115038 Neoplastic Process Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7 Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7 C3897518 CTRP Malignant Stage IVA Thyroid Gland Papillary Cancer Stage IVA Thyroid Gland Papillary Carcinoma Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7 Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7 Stage IVB includes: T4b, Any N, M0. T4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels. M0: No distant metastasis. (AJCC 7th ed.) C115039 Neoplastic Process Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7 Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7 C3897511 CTRP Malignant Stage IVB Thyroid Gland Papillary Cancer Stage IVB Thyroid Gland Papillary Carcinoma Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7 Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C115040 Neoplastic Process Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7 Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7 C3897506 CTRP Malignant Stage IVC Thyroid Gland Papillary Cancer Stage IVC Thyroid Gland Papillary Carcinoma Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7 Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7 Stage IIA includes: T3, N0, M0. T3: Tumor invades through the muscularis propria into pericolorectal tissues. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C115041 Neoplastic Process Stage IIA Colon Cancer AJCC v7 Stage IIA Colon Cancer AJCC v7 CL433741 CTRP Malignant Stage IIA Colon Cancer Stage IIA Colon Cancer AJCC v7 Stage IIA Colon Cancer AJCC v7 Stage IIB includes: T4a, N0, M0. T4a: Tumor penetrates to the surface of the visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C115042 Neoplastic Process Stage IIB Colon Cancer AJCC v7 Stage IIB Colon Cancer AJCC v7 CL433742 CTRP Malignant Stage IIB Colon Cancer Stage IIB Colon Cancer AJCC v7 Stage IIB Colon Cancer AJCC v7 Stage IIC includes: T4b, N0, M0. T4b: Tumor directly invades or is adherent to other organs or structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C115043 Neoplastic Process Stage IIC Colon Cancer AJCC v7 Stage IIC Colon Cancer AJCC v7 CL433743 CTRP Malignant Stage IIC Colon Cancer Stage IIC Colon Cancer AJCC v7 Stage IIC Colon Cancer AJCC v7 Stage IIA includes: T3, N0, M0. T3: Tumor invades through the muscularis propria into pericolorectal tissues. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C115044 Neoplastic Process Stage IIA Rectal Cancer AJCC v7 Stage IIA Rectal Cancer AJCC v7 CL433749 CTRP Malignant Stage IIA Rectal Cancer Stage IIA Rectal Cancer AJCC v7 Stage IIA Rectal Cancer AJCC v7 Stage IIB includes: T4a, N0, M0. T4a: Tumor penetrates to the surface of the visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C115045 Neoplastic Process Stage IIB Rectal Cancer AJCC v7 Stage IIB Rectal Cancer AJCC v7 CL433750 CTRP Malignant Stage IIB Rectal Cancer Stage IIB Rectal Cancer AJCC v7 Stage IIB Rectal Cancer AJCC v7 Stage IIC includes: T4b, N0, M0. T4b: Tumor directly invades or is adherent to other organs or structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C115046 Neoplastic Process Stage IIC Rectal Cancer AJCC v7 Stage IIC Rectal Cancer AJCC v7 CL433751 CTRP Malignant Stage IIC Rectal Cancer Stage IIC Rectal Cancer AJCC v7 Stage IIC Rectal Cancer AJCC v7 Stage IIIA includes: (T1-T2, N1/N1c, M0); (T1, N2a, M0). T1: Tumor invades submucosa. T2: Tumor invades muscularis propria. N1: Metastasis in 1-3 regional lymph nodes. N1c: Tumor deposit(s) in the subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional lymph node metastasis. N2a: Metastasis in 4-6 regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C115047 Neoplastic Process Stage IIIA Colon Cancer AJCC v7 Stage IIIA Colon Cancer AJCC v7 CL433744 CTRP Malignant Stage IIIA Colon Cancer Stage IIIA Colon Cancer AJCC v7 Stage IIIA Colon Cancer AJCC v7 Stage IIIB includes: (T3-T4a, N1/N1c, M0); (T2-T3, N2a, M0); (T1-T2, N2b, M0). T1: Tumor invades submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor penetrates to the surface of the visceral peritoneum. N1: Metastasis in 1-3 regional lymph nodes. N1c: Tumor deposit(s) in the subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional lymph node metastasis. N2a: Metastasis in 4-6 regional lymph nodes. N2b: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C115048 Neoplastic Process Stage IIIB Colon Cancer AJCC v7 Stage IIIB Colon Cancer AJCC v7 CL433745 CTRP Malignant Stage IIIB Colon Cancer Stage IIIB Colon Cancer AJCC v7 Stage IIIB Colon Cancer AJCC v7 Stage IIIC includes: (T4a, N2a, M0); (T3-T4a, N2b, M0); (T4b, N1-N2, M0). T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor penetrates to the surface of the visceral peritoneum. T4b: Tumor directly invades or is adherent to other organs or structures. N1: Metastasis in 1-3 regional lymph nodes. N2: Metastasis in four or more regional lymph nodes. N2a: Metastasis in 4-6 regional lymph nodes. N2b: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C115049 Neoplastic Process Stage IIIC Colon Cancer AJCC v7 Stage IIIC Colon Cancer AJCC v7 CL433746 CTRP Malignant Stage IIIC Colon Cancer Stage IIIC Colon Cancer AJCC v7 Stage IIIC Colon Cancer AJCC v7 Stage IIIA includes: (T1-T2, N1/N1c, M0); (T1, N2a, M0). T1: Tumor invades submucosa. T2: Tumor invades muscularis propria. N1: Metastasis in 1-3 regional lymph nodes. N1c: Tumor deposit(s) in the subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional lymph node metastasis. N2a: Metastasis in 4-6 regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C115050 Neoplastic Process Stage IIIA Rectal Cancer AJCC v7 Stage IIIA Rectal Cancer AJCC v7 CL433752 CTRP Malignant Stage IIIA Rectal Cancer Stage IIIA Rectal Cancer AJCC v7 Stage IIIA Rectal Cancer AJCC v7 Stage IIIB includes: (T3-T4a, N1/N1c, M0); (T2-T3, N2a, M0); (T1-T2, N2b, M0). T1: Tumor invades submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor penetrates to the surface of the visceral peritoneum. N1: Metastasis in 1-3 regional lymph nodes. N1c: Tumor deposit(s) in the subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional lymph node metastasis. N2a: Metastasis in 4-6 regional lymph nodes. N2b: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C115051 Neoplastic Process Stage IIIB Rectal Cancer AJCC v7 Stage IIIB Rectal Cancer AJCC v7 CL433753 CTRP Malignant Stage IIIB Rectal Cancer Stage IIIB Rectal Cancer AJCC v7 Stage IIIB Rectal Cancer AJCC v7 Stage IIIC includes: (T4a, N2a, M0); (T3-T4a, N2b, M0); (T4b, N1-N2, M0). T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor penetrates to the surface of the visceral peritoneum. T4b: Tumor directly invades or is adherent to other organs or structures. N1: Metastasis in 1-3 regional lymph nodes. N2: Metastasis in four or more regional lymph nodes. N2a: Metastasis in 4-6 regional lymph nodes. N2b: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C115052 Neoplastic Process Stage IIIC Rectal Cancer AJCC v7 Stage IIIC Rectal Cancer AJCC v7 CL433754 CTRP Malignant Stage IIIC Rectal Cancer Stage IIIC Rectal Cancer AJCC v7 Stage IIIC Rectal Cancer AJCC v7 Stage IVA includes: Any T, Any N, M1a. M1a: Metastasis confined to one organ or site (e.g., liver, lung, ovary, nonregional node). (AJCC 7th ed.) C115053 Neoplastic Process Stage IVA Colon Cancer AJCC v7 Stage IVA Colon Cancer AJCC v7 CL433747 CTRP Malignant Stage IVA Colon Cancer Stage IVA Colon Cancer AJCC v7 Stage IVA Colon Cancer AJCC v7 Stage IVB includes: Any T, Any N, M1b. M1b: Metastases in more than one organ/site or the peritoneum. (AJCC 7th ed.) C115054 Neoplastic Process Stage IVB Colon Cancer AJCC v7 Stage IVB Colon Cancer AJCC v7 CL433748 CTRP Malignant Stage IVB Colon Cancer Stage IVB Colon Cancer AJCC v7 Stage IVB Colon Cancer AJCC v7 Stage IVA includes: Any T, Any N, M1a. M1a: Metastasis confined to one organ or site (e.g., liver, lung, ovary, nonregional node). (AJCC 7th ed.) C115055 Neoplastic Process Stage IVA Rectal Cancer AJCC v7 Stage IVA Rectal Cancer AJCC v7 CL433755 CTRP Malignant Stage IVA Rectal Cancer Stage IVA Rectal Cancer AJCC v7 Stage IVA Rectal Cancer AJCC v7 Stage IVB includes: Any T, Any N, M1b. M1b: Metastases in more than one organ/site or the peritoneum. (AJCC 7th ed.) C115056 Neoplastic Process Stage IVB Rectal Cancer AJCC v7 Stage IVB Rectal Cancer AJCC v7 CL433756 CTRP Malignant Stage IVB Rectal Cancer Stage IVB Rectal Cancer AJCC v7 Stage IVB Rectal Cancer AJCC v7 Stage I includes: T1, N0, M0. T1: Tumor 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C115057 Neoplastic Process Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 C0280343 CTRP Malignant Stage I Lip and Oral Cavity Squamous Cell Cancer Stage I Lip and Oral Cavity Squamous Cell Carcinoma Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v7 Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C115058 Neoplastic Process Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 C0280348 CTRP Malignant Stage II Lip and Oral Cavity Squamous Cell Cancer Stage II Lip and Oral Cavity Squamous Cell Carcinoma Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v7 Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor more than 4 cm in greatest dimension. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 6th and 7th eds.) C115059 Neoplastic Process Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 C0280353 CTRP Malignant Stage III Lip and Oral Cavity Squamous Cell Cancer Stage III Lip and Oral Cavity Squamous Cell Carcinoma Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v7 Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IV includes: IVA (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0);. IVB (Any T, N3, M0); (T4b, Any N, M0); IVC (Any T, Any N, M1). T4a (lip): Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin of face, i.e., chin or nose. T4a (oral cavity): Tumor invades adjacent structures (e.g., through cortical bone, into deep [extrinsic] muscles of tongue, maxillary sinus, skin of face). T4b: Tumor invades masticator space, pterygoid plates, or skull base and/or encases internal carotid artery. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension; or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension; or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N2a: Metastasis in a single ipsilateral lymph node more than 3 cm but not more than 6 cm in dimension. N2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension. N2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a lymph node more than 6 cm in greatest dimension. M1: Distant metastasis. (AJCC 6th and 7th eds.) C115060 Neoplastic Process Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 C0280358 CTRP Malignant Stage IV Lip and Oral Cavity Squamous Cell Cancer Stage IV Lip and Oral Cavity Squamous Cell Carcinoma Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v7 Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a: Lip and oral cavity cancer with moderately advanced local disease. Lip: Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin of face, i.e., chin or nose. Oral cavity: Tumor invades adjacent structures only (e.g., through cortical bone [mandible or maxilla] into deep [extrinsic] muscle of tongue [genioglossus, hyoglossus, palatoglossus, and styloglossus], maxillary sinus, skin of face). T1: Tumor 2 cm or less in greatest dimension. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3: Tumor more than 4 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension; or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension; or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C115061 Neoplastic Process Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 CL433873 CTRP Malignant Stage IVA Lip and Oral Cavity Squamous Cell Cancer Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v7 Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVB includes: (Any T, N3, M0); (T4b, Any N, M0). T4b: Lip and oral cavity cancer with very advanced local disease. Tumor invades masticator space, pterygoid plates, or skull base and/or encases internal carotid artery. N3: Metastasis in a lymph node more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C115062 Neoplastic Process Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 CL433874 CTRP Malignant Stage IVB Lip and Oral Cavity Squamous Cell Cancer Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v7 Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C115063 Neoplastic Process Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 CL433875 CTRP Malignant Stage IVC Lip and Oral Cavity Squamous Cell Cancer Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v7 Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage I includes: T1, N0, M0. T1: Maxillary sinus: Tumor limited to the maxillary sinus mucosa with no erosion or destruction of bone. Nasal cavity and ethmoid sinus: Tumor restricted to any one subsite, with or without bony invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C115070 Neoplastic Process Stage I Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 Stage I Sinonasal Squamous Cell Carcinoma AJCC v6 and v7 C0280403 CTRP Malignant Stage I Nasal Cavity and Paranasal Sinus Squamous Cell Cancer Stage I Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Stage I Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 Stage I Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 Stage I Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 Stage I Sinonasal Squamous Cell Carcinoma AJCC v6 and v7 Stage I Sinonasal Squamous Cell Carcinoma AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: Maxillary sinus: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates. Nasal cavity and ethmoid sinus: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th ed.) C115071 Neoplastic Process Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 Stage II Sinonasal Squamous Cell Carcinoma AJCC v6 and v7 C0280407 CTRP Malignant Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Cancer Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 Stage II Sinonasal Squamous Cell Carcinoma AJCC v6 and v7 Stage II Sinonasal Squamous Cell Carcinoma AJCC v6 and v7 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Maxillary sinus: Tumor invading any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, or ethmoid sinuses. Nasal cavity and ethmoid sinus: Tumor invading the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate. T1: Maxillary sinus: Tumor limited to the maxillary sinus mucosa with no erosion or destruction of bone. Nasal cavity and ethmoid sinus: Tumor restricted to any one subsite, with or without bony invasion. T2: Maxillary sinus: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates. Nasal cavity and ethmoid sinus: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 6th and 7th eds.) C115072 Neoplastic Process Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7 C0280411 CTRP Malignant Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Cancer Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7 Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7 Stage IV includes: IVA: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB: (T4b, Any N, M0); (Any T, N3, M0); IVC: (Any T, Any N, M1). T4a: Maxillary sinus: Moderately advanced local disease. Tumor invades anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid or frontal sinuses. Nasal cavity and ethmoid sinus: Moderately advanced local disease. Tumor invades any of the following: anterior orbital contents, skin of nose or cheek, minimal extension to anterior cranial fossa, pterygoid plates, sphenoid or frontal sinuses. T4b: Very advanced local disease. Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve, nasopharynx, or clivus. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a lymph node, more than 6 cm in greatest dimension. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C115073 Neoplastic Process Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 Stage IV Sinonasal Squamous Cell Carcinoma AJCC v7 C0280415 CTRP Malignant Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Cancer Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 Stage IV Sinonasal Squamous Cell Carcinoma AJCC v7 Stage IV Sinonasal Squamous Cell Carcinoma AJCC v7 Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); T4a: Maxillary sinus: Moderately advanced local disease. Tumor invades anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid or frontal sinuses. Nasal cavity and ethmoid sinus: Moderately advanced local disease. Tumor invades any of the following: anterior orbital contents, skin of nose or cheek, minimal extension to anterior cranial fossa, pterygoid plates, sphenoid or frontal sinuses. T1: Maxillary sinus: Tumor limited to the maxillary sinus mucosa with no erosion or destruction of bone. Nasal cavity and ethmoid sinus: Tumor restricted to any one subsite, with or without bony invasion. T2: Maxillary sinus: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates. Nasal cavity and ethmoid sinus: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion. T3: Maxillary sinus: Tumor invading any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, or ethmoid sinuses. Nasal cavity and ethmoid sinus: Tumor invading the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C115074 Neoplastic Process Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7 CL433801 CTRP Malignant Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Cancer Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7 Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7 Stage IVB includes: (T4b, Any N, M0); (Any T, N3, M0). T4b: Very advanced local disease. Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve, nasopharynx, or clivus. N3: Metastasis in a lymph node, more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C115075 Neoplastic Process Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 Stage IVB Sinonasal Squamous Cell Carcinoma AJCC v7 CL433803 CTRP Malignant Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Cancer Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 Stage IVB Sinonasal Squamous Cell Carcinoma AJCC v7 Stage IVB Sinonasal Squamous Cell Carcinoma AJCC v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C115076 Neoplastic Process Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 Stage IVC Sinonasal Squamous Cell Carcinoma AJCC v7 CL433802 CTRP Malignant Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Cancer Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 Stage IVC Sinonasal Squamous Cell Carcinoma AJCC v7 Stage IVC Sinonasal Squamous Cell Carcinoma AJCC v7 Stage I includes: T1, N0, M0. T1: Tumor 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C115086 Neoplastic Process Stage I Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7 Stage I Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7 C0280369 CTRP Malignant Stage I Oropharyngeal Lymphoepithelioma Stage I Oropharyngeal Lymphoepithelioma AJCC v6 Stage I Oropharyngeal Lymphoepithelioma AJCC v7 Stage I Oropharyngeal Undifferentiated Carcinoma Stage I Oropharyngeal Undifferentiated Carcinoma AJCC v6 Stage I Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7 Stage I Oropharyngeal Undifferentiated Carcinoma AJCC v7 Stage I Undifferentiated Oropharyngeal Throat Cancer Stage I Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C115087 Neoplastic Process Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7 Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7 C0280371 CTRP Malignant Stage II Oropharyngeal Lymphoepithelioma Stage II Oropharyngeal Lymphoepithelioma AJCC v6 Stage II Oropharyngeal Lymphoepithelioma AJCC v7 Stage II Oropharyngeal Undifferentiated Carcinoma Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7 Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v7 Stage II Undifferentiated Oropharyngeal Throat Cancer Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T1: Tumor 2 cm or less in greatest dimension. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3: Tumor measuring more than 4 centimeters in greatest dimension or extension to lingual surface of epiglottis. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C115088 Neoplastic Process Stage III Oropharyngeal Undifferentiated Carcinoma AJCC v7 Stage III Oropharyngeal Undifferentiated Carcinoma AJCC v7 C0280373 CTRP Malignant Stage III Oropharyngeal Lymphoepithelioma Stage III Oropharyngeal Lymphoepithelioma AJCC v7 Stage III Oropharyngeal Undifferentiated Carcinoma Stage III Oropharyngeal Undifferentiated Carcinoma AJCC v7 Stage III Undifferentiated Oropharyngeal Throat Cancer Stage III Oropharyngeal Undifferentiated Carcinoma AJCC v7 Stage IV includes: IVA (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB (T4b, Any N, M0); (Any T, N3, M0); IVC (Any T, Any N, M1). T4a: Tumor with moderately advanced local disease. Tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible. Mucosal extension to lingual surface of epiglottis from primary tumors of the base of the tongue and vallecula does not constitute invasion of larynx. T1: Tumor 2 cm or less in greatest dimension. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3: Tumor measuring more than 4 centimeters in greatest dimension or extension to lingual surface of epiglottis. T4b: Tumor with very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Tumor with metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Tumor with metastasis in a lymph node more than 6 cm in greatest dimension. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C115089 Neoplastic Process Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7 Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7 C0280375 CTRP Malignant Stage IV Oropharyngeal Lymphoepithelioma Stage IV Oropharyngeal Lymphoepithelioma AJCC v7 Stage IV Oropharyngeal Undifferentiated Carcinoma Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7 Stage IV Undifferentiated Oropharyngeal Throat Cancer Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7 Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a: Tumor with moderately advanced local disease. Tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible. Mucosal extension to lingual surface of epiglottis from primary tumors of the base of the tongue and vallecula does not constitute invasion of larynx. T1: Tumor 2 cm or less in greatest dimension. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3: Tumor measuring more than 4 centimeters in greatest dimension or extension to lingual surface of epiglottis. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Tumor with metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C115090 Neoplastic Process Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7 Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7 C3897521 CTRP Malignant Stage IVA Oropharyngeal Lymphoepithelioma Stage IVA Oropharyngeal Lymphoepithelioma AJCC v7 Stage IVA Oropharyngeal Undifferentiated Carcinoma Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7 Stage IVA Undifferentiated Oropharyngeal Throat Cancer Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7 Stage IVB includes: (T4b, Any N, M0); (Any T, N3, M0). T4b: Tumor with very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery. N3: Tumor with metastasis in a lymph node more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C115091 Neoplastic Process Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7 Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7 C3897514 CTRP Malignant Stage IVB Oropharyngeal Lymphoepithelioma Stage IVB Oropharyngeal Lymphoepithelioma AJCC v7 Stage IVB Oropharyngeal Undifferentiated Carcinoma Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7 Stage IVB Undifferentiated Oropharyngeal Throat Cancer Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C115092 Neoplastic Process Stage IVC Oropharyngeal Undifferentiated Carcinoma AJCC v7 Stage IVC Oropharyngeal Undifferentiated Carcinoma AJCC v7 C3897508 CTRP Malignant Stage IVC Oropharyngeal Lymphoepithelioma Stage IVC Oropharyngeal Lymphoepithelioma AJCC v7 Stage IVC Oropharyngeal Undifferentiated Carcinoma Stage IVC Oropharyngeal Undifferentiated Carcinoma AJCC v7 Stage IVC Undifferentiated Oropharyngeal Throat Cancer Stage IVC Oropharyngeal Undifferentiated Carcinoma AJCC v7 The reemergence of oropharyngeal undifferentiated carcinoma after a period of remission. C115093 Neoplastic Process Recurrent Oropharyngeal Undifferentiated Carcinoma Recurrent Oropharyngeal Undifferentiated Carcinoma C0280377 CTRP Malignant Recurrent Oropharyngeal Lymphoepithelioma Recurrent Oropharyngeal Throat Undifferentiated Carcinoma Recurrent Oropharyngeal Undifferentiated Carcinoma Recurrent Oropharyngeal Undifferentiated Carcinoma Stage III includes: T3, N0, M0. T3: Microscopically confirmed peritoneal tumor outside pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th Ed.) C115094 Neoplastic Process Stage III Primary Peritoneal Cancer AJCC v7 Stage III Primary Peritoneal Cancer AJCC v7 C3897533 CTRP Malignant Stage III Primary Peritoneal Cancer Stage III Primary Peritoneal Cancer AJCC v7 Stage III Primary Peritoneal Cancer AJCC v7 Stage IIIA includes: T3a, N0, M0. T3a: Microscopic peritoneal tumor beyond pelvis (no macroscopic tumor). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th Ed.) C115095 Neoplastic Process Stage IIIA Primary Peritoneal Cancer AJCC v7 Stage IIIA Primary Peritoneal Cancer AJCC v7 C3897532 CTRP Malignant Stage IIIA Primary Peritoneal Cancer Stage IIIA Primary Peritoneal Cancer AJCC v7 Stage IIIA Primary Peritoneal Cancer AJCC v7 Stage IIIB includes: T3b, N0, M0. T3b: Macroscopic peritoneal tumor beyond pelvis 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th Ed.) C115096 Neoplastic Process Stage IIIB Primary Peritoneal Cancer AJCC v7 Stage IIIB Primary Peritoneal Cancer AJCC v7 C3897529 CTRP Malignant Stage IIIB Primary Peritoneal Cancer Stage IIIB Primary Peritoneal Cancer AJCC v7 Stage IIIB Primary Peritoneal Cancer AJCC v7 Stage IIIC includes: (T3c, N0, M0); (Any T, N1, M0). T3c: Peritoneal tumor beyond pelvis more than 2cm in greatest dimension and/or regional lymph node metastasis. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th Ed.) C115097 Neoplastic Process Stage IIIC Primary Peritoneal Cancer AJCC v7 Stage IIIC Primary Peritoneal Cancer AJCC v7 C3897526 CTRP Malignant Stage IIIC Primary Peritoneal Cancer Stage IIIC Primary Peritoneal Cancer AJCC v7 Stage IIIC Primary Peritoneal Cancer AJCC v7 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis (excludes peritoneal metastasis). (AJCC 7th Ed.) C115098 Neoplastic Process Stage IV Primary Peritoneal Cancer AJCC v7 Stage IV Primary Peritoneal Cancer AJCC v7 C3897083 CTRP Malignant Stage IV Primary Peritoneal Cancer Stage IV Primary Peritoneal Cancer AJCC v7 Stage IV Primary Peritoneal Cancer AJCC v7 Stage IA includes: For squamous cell carcinoma: T1, N0, M0, G1, GX, Tumor location: Any. T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated. GX: Grade cannot be assessed-stage grouping as G1. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. For adenocarcinoma: T1, N0, M0, G1-2, X. T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated. G2: Moderately differentiated. GX: Grade cannot be assessed-stage grouping as G1. (AJCC 7th ed.) C115117 Neoplastic Process Stage IA Esophageal Cancer AJCC v7 Stage IA Esophageal Cancer AJCC v7 CL433920 CTRP Malignant Stage IA Esophageal Cancer Stage IA Esophageal Cancer AJCC v7 Stage IA Esophageal Cancer AJCC v7 Stage IB includes: For squamous cell carcinoma: (T1, N0, M0, G2-3, Tumor location: Any); (T2-3, N0, M0, G1, GX, Tumor location: Lower, X). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated. GX: Grade cannot be assessed-stage grouping as G1. G2: Moderately differentiated. G3: Poorly differentiated. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. For adenocarcinoma: (T1, N0, M0, G3); (T2, N0, M0, G1-2, GX). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated. G2: Moderately differentiated. G3: Poorly differentiated. GX: Grade cannot be assessed-stage grouping as G1. (AJCC 7th ed.) C115118 Neoplastic Process Stage IB Esophageal Cancer AJCC v7 Stage IB Esophageal Cancer AJCC v7 CL433921 CTRP Malignant Stage IB Esophageal Cancer Stage IB Esophageal Cancer AJCC v7 Stage IB Esophageal Cancer AJCC v7 Stage IIIA includes: For squamous cell carcinoma: (T1-2, N2, M0, Any G, Tumor location: Any); (T3, N1, M0, Any G, Tumor location: Any); (T4a, N0, M0, Any G, Tumor location: Any). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades adventitia. T4a: Resectable tumor invading pleura, pericardium, or diaphragm. N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. N2: Metastasis in 3-6 regional lymph nodes. M0: No distant metastasis. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. For adenocarcinoma: (T1-2, N2, M0, Any G); (T3, N1, M0, Any G); (T4a, N0, M0, Any G). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades adventitia. T4a: Resectable tumor invading pleura, pericardium, or diaphragm. N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. N2: Metastasis in 3-6 regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C115119 Neoplastic Process Stage IIIA Esophageal Cancer AJCC v7 Stage IIIA Esophageal Cancer AJCC v7 CL433925 CTRP Malignant Stage IIIA Esophageal Cancer Stage IIIA Esophageal Cancer AJCC v7 Stage IIIA Esophageal Cancer AJCC v7 Stage IIIB includes: For squamous cell carcinoma: T3, N2, M0, Any G, Tumor location: Any. T3: Tumor invades adventitia. N2: Metastasis in 3-6 regional lymph nodes. M0: No distant metastasis. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. For adenocarcinoma: T3, N2, M0, Any G. T3: Tumor invades adventitia. N2: Metastasis in 3-6 regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C115120 Neoplastic Process Stage IIIB Esophageal Cancer AJCC v7 Stage IIIB Esophageal Cancer AJCC v7 CL433926 CTRP Malignant Stage IIIB Esophageal Cancer Stage IIIB Esophageal Cancer AJCC v7 Stage IIIB Esophageal Cancer AJCC v7 Stage IIIC includes: For squamous cell carcinoma: (T4a, N1-2, M0, Any G, Tumor location: Any); (T4b, Any N, M0, Any G, Tumor location: Any); (Any T, N3, M0, Any G, Tumor location: Any). T4a: Resectable tumor invading pleura, pericardium, or diaphragm. T4b: Unresectable tumor invading other adjacent structures, such as aorta, vertebral body, trachea, etc. N1: Metastasis in 1-2 regional lymph nodes. N2: Metastasis in 3-6 regional lymph nodes. N3: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. For adenocarcinoma: (T4a, N1-2, M0, Any G); (T4b, Any N, M0, Any G); (Any T, N3, M0, Any G). T4a: Resectable tumor invading pleura, pericardium, or diaphragm. T4b: Unresectable tumor invading other adjacent structures, such as aorta, vertebral body, trachea, etc. N1: Metastasis in 1-2 regional lymph nodes. N2: Metastasis in 3-6 regional lymph nodes. N3: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C115121 Neoplastic Process Stage IIIC Esophageal Cancer AJCC v7 Stage IIIC Esophageal Cancer AJCC v7 CL433927 CTRP Malignant Stage IIIC Esophageal Cancer Stage IIIC Esophageal Cancer AJCC v7 Stage IIIC Esophageal Cancer AJCC v7 Tumor involves adnexa. No regional lymph node or distant metastasis. C115130 Neoplastic Process Stage IIA Uterine Sarcoma AJCC v7 Stage IIA Uterine Sarcoma AJCC v7 CL446656 CTRP Malignant Stage IIA Uterine Sarcoma Stage IIA Uterine Sarcoma AJCC v7 Stage IIA Uterine Sarcoma AJCC v7 Tumor involves other pelvic tissues. No regional lymph node or distant metastasis. C115131 Neoplastic Process Stage IIB Uterine Sarcoma AJCC v7 Stage IIB Uterine Sarcoma AJCC v7 CL446657 CTRP Malignant Stage IIB Uterine Sarcoma Stage IIB Uterine Sarcoma AJCC v7 Stage IIB Uterine Sarcoma AJCC v7 A staging classification system for hepatocellular carcinoma that uses variables related to tumor stage, liver functional status, physical status, and cancer-related symptoms, and links the stages with a treatment algorithm. (HPB (Oxford) 2005; 7(1):35-41) C115132 Neoplastic Process Hepatocellular Carcinoma by BCLC Stage C3898888 Malignant BCLC Staging for Hepatocellular Carcinoma Barcelona Clinic Liver Cancer Staging for Hepatocellular Carcinoma Hepatocellular Carcinoma BCLC Staging Hepatocellular Carcinoma Barcelona Clinic Liver Cancer Staging Hepatocellular Carcinoma by BCLC Stage Hepatocellular Carcinoma by Barcelona Clinic Liver Cancer Stage Hepatocellular Carcinoma by BCLC Stage Very early hepatocellular carcinoma. Patients are optimal candidates for resection. (HPB (Oxford) 2005; 7(1):35-41) C115133 Neoplastic Process BCLC Stage 0 Hepatocellular Carcinoma BCLC Stage 0 Hepatocellular Carcinoma C3899982 CTRP Malignant BCLC Stage 0 Hepatocellular Cancer BCLC Stage 0 Hepatocellular Carcinoma Barcelona Clinic Liver Cancer Stage 0 Hepatocellular Carcinoma BCLC Stage 0 Hepatocellular Carcinoma Early hepatocellular carcinoma. Patients are candidates for radical therapies (resection, liver transplantation, or percutaneous treatments). (HPB (Oxford) 2005; 7(1):35-41) C115135 Neoplastic Process BCLC Stage A Hepatocellular Carcinoma BCLC Stage A Hepatocellular Carcinoma C3897124 CTRP Malignant BCLC Stage A Hepatocellular Cancer BCLC Stage A Hepatocellular Carcinoma Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma BCLC Stage A Hepatocellular Carcinoma Intermediate hepatocellular carcinoma. Patients may benefit from chemoembolization. (HPB (Oxford) 2005; 7(1):35-41) C115136 Neoplastic Process BCLC Stage B Hepatocellular Carcinoma BCLC Stage B Hepatocellular Carcinoma C3899979 CTRP Malignant BCLC Stage B Hepatocellular Cancer BCLC Stage B Hepatocellular Carcinoma Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma BCLC Stage B Hepatocellular Carcinoma Advanced hepatocellular carcinoma. Patients may receive new agents in the setting of randomized controlled trials. (HPB (Oxford) 2005; 7(1):35-41) C115137 Neoplastic Process BCLC Stage C Hepatocellular Carcinoma BCLC Stage C Hepatocellular Carcinoma C3899977 CTRP Malignant BCLC Stage C Hepatocellular Cancer BCLC Stage C Hepatocellular Carcinoma Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma BCLC Stage C Hepatocellular Carcinoma End-stage hepatocellular carcinoma. Patients will receive symptomatic treatment. (HPB (Oxford) 2005; 7(1):35-41) C115138 Neoplastic Process BCLC Stage D Hepatocellular Carcinoma BCLC Stage D Hepatocellular Carcinoma C3899975 CTRP Malignant BCLC Stage D Hepatocellular Cancer BCLC Stage D Hepatocellular Carcinoma Barcelona Clinic Liver Cancer Stage D Hepatocellular Carcinoma BCLC Stage D Hepatocellular Carcinoma Very early hepatocellular carcinoma. Patients are optimal candidates for resection. (HPB (Oxford) 2005; 7(1):35-41) C115139 Neoplastic Process BCLC Stage 0 Adult Hepatocellular Carcinoma BCLC Stage 0 Adult Hepatocellular Carcinoma C3899983 CTRP Malignant BCLC Stage 0 Adult Hepatocellular Carcinoma BCLC Stage 0 Hepatocellular Cancer Barcelona Clinic Liver Cancer Stage 0 Adult Hepatocellular Carcinoma BCLC Stage 0 Adult Hepatocellular Carcinoma Early hepatocellular carcinoma. Patients are candidates for radical therapies (resection, liver transplantation, or percutaneous treatments). (HPB (Oxford) 2005; 7(1):35-41) C115140 Neoplastic Process BCLC Stage A Adult Hepatocellular Carcinoma BCLC Stage A Adult Hepatocellular Carcinoma C3899981 CTRP Malignant BCLC Stage A Adult Hepatocellular Carcinoma BCLC Stage A Hepatocellular Cancer Barcelona Clinic Liver Cancer Stage A Adult Hepatocellular Carcinoma BCLC Stage A Adult Hepatocellular Carcinoma Intermediate hepatocellular carcinoma. Patients may benefit from chemoembolization. (HPB (Oxford) 2005; 7(1):35-41) C115141 Neoplastic Process BCLC Stage B Adult Hepatocellular Carcinoma BCLC Stage B Adult Hepatocellular Carcinoma C3899980 CTRP Malignant BCLC Stage B Adult Hepatocellular Carcinoma BCLC Stage B Hepatocellular Cancer Barcelona Clinic Liver Cancer Stage B Adult Hepatocellular Carcinoma BCLC Stage B Adult Hepatocellular Carcinoma Advanced hepatocellular carcinoma. Patients may receive new agents in the setting of randomized controlled trials. (HPB (Oxford) 2005; 7(1):35-41) C115143 Neoplastic Process BCLC Stage C Adult Hepatocellular Carcinoma BCLC Stage C Adult Hepatocellular Carcinoma C3899978 CTRP Malignant BCLC Stage C Adult Hepatocellular Carcinoma BCLC Stage C Hepatocellular Cancer Barcelona Clinic Liver Cancer Stage C Adult Hepatocellular Carcinoma BCLC Stage C Adult Hepatocellular Carcinoma End-stage hepatocellular carcinoma. Patients will receive symptomatic treatment. (HPB (Oxford) 2005; 7(1):35-41) C115144 Neoplastic Process BCLC Stage D Adult Hepatocellular Carcinoma BCLC Stage D Adult Hepatocellular Carcinoma C3899976 CTRP Malignant BCLC Stage D Adult Hepatocellular Carcinoma BCLC Stage D Hepatocellular Cancer Barcelona Clinic Liver Cancer Stage D Adult Hepatocellular Carcinoma BCLC Stage D Adult Hepatocellular Carcinoma Grade III lymphomatoid granulomatosis that occurs in adulthood. C115150 Neoplastic Process Adult Grade III Lymphomatoid Granulomatosis Adult Grade III Lymphomatoid Granulomatosis C1541468 CTRP Malignant Adult Grade III Lymphomatoid Granulomatosis Grade III Lymphomatoid Granulomatosis Adult Grade III Lymphomatoid Granulomatosis Myelodysplastic syndrome that occurs in adulthood. C115153 Neoplastic Process Adult Myelodysplastic Syndrome Adult Myelodysplastic Syndrome CL446663 CTRP Malignant Adult Myelodysplastic Syndrome Myelodysplastic Syndrome Adult Myelodysplastic Syndrome Nasal type extranodal NK/T-cell lymphoma that occurs in adulthood. C115154 Neoplastic Process Adult Nasal Type Extranodal NK/T-Cell Lymphoma Adult Nasal Type Extranodal NK/T-Cell Lymphoma C1879279 CTRP Malignant Adult Nasal Type Extranodal NK/T-Cell Lymphoma Nasal Type Extranodal NK/T-Cell Lymphoma Adult Nasal Type Extranodal NK/T-Cell Lymphoma An ependymal tumor that occurs during childhood. C115192 Neoplastic Process Childhood Ependymal Tumor Childhood Ependymal Tumor C3899667 CTRP NICHD An ependymal tumor that occurs during childhood. Undetermined Childhood Ependymal Tumor Ependymal Tumor Childhood Ependymal Tumor A mixed glioma that occurs during childhood. C115195 Neoplastic Process Childhood Mixed Glioma Childhood Mixed Glioma CL388429 CTRP NICHD A mixed glioma that occurs during childhood. Undetermined Childhood Mixed Glioma Mixed Glioma Childhood Mixed Glioma A pineal parenchymal cell neoplasm that occurs during childhood. C115196 Neoplastic Process Childhood Pineal Parenchymal Cell Neoplasm Childhood Pineal Parenchymal Cell Neoplasm C3897068 CTRP NICHD A pineal parenchymal cell neoplasm that occurs during childhood. Undetermined Childhood Pineal Parenchymal Cell Neoplasm Childhood Pineocytic Neoplasm Childhood Pineocytic Tumor Pineal Parenchymal Cell Neoplasm Childhood Pineal Parenchymal Cell Neoplasm A cerebellar anaplastic astrocytoma that occurs during childhood. C115201 Neoplastic Process Childhood Cerebellar Anaplastic Astrocytoma Childhood Cerebellar Anaplastic Astrocytoma C3899671 CTRP Malignant Cerebellar Anaplastic Astrocytoma Childhood Cerebellar Anaplastic Astrocytoma Childhood Cerebellar Anaplastic Astrocytoma A cerebral anaplastic astrocytoma that occurs during childhood. C115202 Neoplastic Process Childhood Cerebral Anaplastic Astrocytoma Childhood Cerebral Anaplastic Astrocytoma C3899670 CTRP Malignant Anaplastic Hemispheric Astrocytoma Childhood Cerebral Anaplastic Astrocytoma Childhood Cerebral Anaplastic Astrocytoma An embryonal tumor with multilayered rosettes, C19MC-altered that occurs during childhood. C115203 Neoplastic Process Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered CL383485 CTRP Cellosaurus NICHD An ependymoblastoma that occurs during childhood. Malignant Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered Childhood Ependymoblastoma Embryonal Tumor with Multilayered Rosettes, C19MC-Altered Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered Grade III lymphomatoid granulomatosis that occurs during childhood. C115204 Neoplastic Process Childhood Grade III Lymphomatoid Granulomatosis Childhood Grade III Lymphomatoid Granulomatosis C1541446 CTRP Malignant Childhood Grade III Lymphomatoid Granulomatosis Grade III Lymphomatoid Granulomatosis Childhood Grade III Lymphomatoid Granulomatosis A carcinoma that arises from the distal part of the urethra. C115210 Neoplastic Process Distal Urethral Carcinoma Distal Urethral Carcinoma C3899345 CTRP Malignant Distal Urethra Carcinoma Distal Urethral Cancer Distal Urethral Carcinoma Distal Urethral Carcinoma Germ cell tumor that arises from the testis and is diagnosed in at least two relatives. C115211 Neoplastic Process Familial Testicular Germ Cell Tumor Familial Testicular Germ Cell Tumor CL412448 CTRP Undetermined FTGCT Familial Testicular Germ Cell Tumor Familial Testicular Germ Cell Tumor Waldenstrom macroglobulinemia in a patient who has at least one first degree relative with either Waldenstrom macroglobulinemia or another B-cell lymphoproliferative disorder. C115212 Neoplastic Process Familial Waldenstrom Macroglobulinemia Familial Waldenstrom Macroglobulinemia C2936755 CTRP Malignant Familial Waldenstrom Macroglobulinemia Familial Waldenström Macroglobulinemia Familial Waldenstrom Macroglobulinemia Genetic inheritance of neuroblastoma caused by mutations in the ALK or PHOX2B genes. Familial neuroblastomas have a higher incidence of multiple primary tumors and are diagnosed at an earlier age. C115225 Neoplastic Process Familial Neuroblastoma Hereditary Neuroblastoma CL433972 CTRP Malignant Familial Neuroblastoma Hereditary Neuroblastoma Hereditary Neuroblastoma Digestive system neuroendocrine tumor G1 that has spread to other anatomic sites. C115245 Neoplastic Process Metastatic Gastrointestinal Neuroendocrine Tumor G1 Metastatic Digestive System Neuroendocrine Tumor G1 C0278749 CTRP Malignant Metastatic Digestive System Neuroendocrine Tumor G1 Metastatic Gastrointestinal Carcinoid Tumor Metastatic Gastrointestinal Neuroendocrine Tumor G1 Metastatic Digestive System Neuroendocrine Tumor G1 A mixed glioma that occurs during adulthood. C115250 Neoplastic Process Adult Mixed Glioma Adult Mixed Glioma CL388499 CTRP Undetermined Adult Mixed Glioma Mixed Glioma Adult Mixed Glioma A melanocytic neoplasm that arises from the leptomeninges and occurs during adulthood. C115253 Neoplastic Process Adult Primary Melanocytic Lesion of Meninges Adult Central Nervous System Melanocytic Neoplasm C3897028 CTRP Undetermined Adult Central Nervous System Melanocytic Neoplasm Adult Central Nervous System Melanocytic Tumor Adult Primary Central Nervous System Melanocytic Neoplasm Adult Primary Meningeal Melanocytic Neoplasm Primary Meningeal Melanocytic Neoplasm Adult Central Nervous System Melanocytic Neoplasm A myxopapillary ependymoma that occurs during adulthood. C115263 Neoplastic Process Adult Myxopapillary Ependymoma Adult Myxopapillary Ependymoma C3887518 CTRP Undetermined Adult Myxopapillary Ependymoma Myxopapillary Ependymoma Adult Myxopapillary Ependymoma A soft tissue sarcoma that occurs during childhood and is confined to a specific site without evidence of spread to other anatomic sites. C115292 Neoplastic Process Non-Metastatic Childhood Soft Tissue Sarcoma Localized Childhood Soft Tissue Sarcoma C3898127 CTRP NICHD A soft tissue sarcoma that occurs during childhood, and has not spread beyond its original site of growth. Malignant Localized Childhood Soft Tissue Sarcoma Non-Metastatic Childhood Soft Tissue Sarcoma Soft Tissue Sarcoma Localized Childhood Soft Tissue Sarcoma A pineal gland astrocytoma that occurs during adulthood. C115327 Neoplastic Process Adult Pineal Gland Astrocytoma Adult Pineal Gland Astrocytoma C3900096 CTRP Undetermined Adult Pineal Gland Astrocytoma Pineal Gland Astrocytoma Adult Pineal Gland Astrocytoma A carcinoma that arises from the proximal part of the urethra. C115334 Neoplastic Process Proximal Urethral Carcinoma Proximal Urethral Carcinoma C3897815 CTRP Malignant Proximal Urethral Cancer Proximal Urethral Carcinoma Proximal Urethral Carcinoma The reemergence of grade III lymphomatoid granulomatosis in adulthood after a period of remission. C115349 Neoplastic Process Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Grade III Lymphomatoid Granulomatosis C1541469 CTRP Malignant Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Grade III Lymphomatoid Granulomatosis Recurrent Adult Grade III Lymphomatoid Granulomatosis The reemergence of undifferentiated high grade pleomorphic sarcoma of bone in adulthood after a period of remission. C115351 Neoplastic Process Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone C4054114 CTRP Malignant Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone Recurrent Undifferentiated High Grade Pleomorphic Sarcoma of Bone Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone The reemergence of borderline ovarian epithelial tumor after a period of remission. C115352 Neoplastic Process Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor CL376175 CTRP Uncertain Malignant Potential Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor The reemergence of anaplastic astrocytoma in childhood after a period of remission. C115356 Neoplastic Process Recurrent Childhood Anaplastic Astrocytoma Recurrent Childhood Anaplastic Astrocytoma CL433902 CTRP Malignant Recurrent Anaplastic Astrocytoma Recurrent Childhood Anaplastic Astrocytoma Recurrent Childhood Anaplastic Astrocytoma The reemergence of anaplastic large cell lymphoma in childhood after a period of remission. C115357 Neoplastic Process Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Anaplastic Large Cell Lymphoma CL376206 CTRP Malignant Recurrent Anaplastic Large Cell Lymphoma Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Anaplastic Large Cell Lymphoma The reemergence of anaplastic oligoastrocytoma in childhood after a period of remission. C115358 Neoplastic Process Recurrent Childhood Anaplastic Oligoastrocytoma Recurrent Childhood Anaplastic Oligoastrocytoma CL433949 CTRP Malignant Recurrent Anaplastic Oligoastrocytoma Recurrent Childhood Anaplastic Oligoastrocytoma Recurrent Childhood Anaplastic Oligoastrocytoma The reemergence of anaplastic oligodendroglioma in childhood after a period of remission. C115359 Neoplastic Process Recurrent Childhood Anaplastic Oligodendroglioma Recurrent Childhood Anaplastic Oligodendroglioma CL433924 CTRP Malignant Recurrent Anaplastic Oligodendroglioma Recurrent Childhood Anaplastic Oligodendroglioma Recurrent Childhood Anaplastic Oligodendroglioma The reemergence of diffuse astrocytoma in childhood after a period of remission. C115360 Neoplastic Process Recurrent Childhood Diffuse Astrocytoma Recurrent Childhood Diffuse Astrocytoma CL433915 CTRP Undetermined Recurrent Childhood Diffuse Astrocytoma Recurrent Diffuse Astrocytoma Recurrent Childhood Diffuse Astrocytoma The reemergence of fibrillary astrocytoma in childhood after a period of remission. C115361 Neoplastic Process Recurrent Childhood Fibrillary Astrocytoma Recurrent Childhood Fibrillary Astrocytoma CL433904 CTRP Undetermined Recurrent Childhood Fibrillary Astrocytoma Recurrent Fibrillary Astrocytoma Recurrent Childhood Fibrillary Astrocytoma The reemergence of gemistocytic astrocytoma in childhood after a period of remission. C115362 Neoplastic Process Recurrent Childhood Gemistocytic Astrocytoma Recurrent Childhood Gemistocytic Astrocytoma CL433907 CTRP Undetermined Recurrent Childhood Gemistocytic Astrocytoma Recurrent Gemistocytic Astrocytoma Recurrent Childhood Gemistocytic Astrocytoma The reemergence of giant cell glioblastoma in childhood after a period of remission. C115363 Neoplastic Process Recurrent Childhood Giant Cell Glioblastoma Recurrent Childhood Giant Cell Glioblastoma CL433910 CTRP Malignant Recurrent Childhood Giant Cell Glioblastoma Recurrent Giant Cell Glioblastoma Recurrent Childhood Giant Cell Glioblastoma The reemergence of glioblastoma in childhood after a period of remission. C115364 Neoplastic Process Recurrent Childhood Glioblastoma Recurrent Childhood Glioblastoma CL433913 CTRP Malignant Recurrent Childhood Glioblastoma Recurrent Glioblastoma Recurrent Childhood Glioblastoma The reemergence of gliosarcoma in childhood after a period of remission. C115365 Neoplastic Process Recurrent Childhood Gliosarcoma Recurrent Childhood Gliosarcoma CL433918 CTRP Malignant Recurrent Childhood Gliosarcoma Recurrent Gliosarcoma Recurrent Childhood Gliosarcoma The reemergence of gliomatosis cerebri in childhood after a period of remission. C115366 Neoplastic Process Recurrent Childhood Gliomatosis Cerebri Recurrent Childhood Gliomatosis Cerebri CL433932 CTRP Malignant Recurrent Childhood Gliomatosis Cerebri Recurrent Gliomatosis Cerebri Recurrent Childhood Gliomatosis Cerebri The reemergence of grade III lymphomatoid granulomatosis in childhood after a period of remission. C115367 Neoplastic Process Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Grade III Lymphomatoid Granulomatosis C1541447 CTRP Malignant Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Grade III Lymphomatoid Granulomatosis Recurrent Childhood Grade III Lymphomatoid Granulomatosis The reemergence of undifferentiated high grade pleomorphic sarcoma of bone in childhood after a period of remission. C115368 Neoplastic Process Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone C4054112 CTRP Malignant Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone Recurrent Undifferentiated High Grade Pleomorphic Sarcoma of Bone Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone The reemergence of non-Hodgkin lymphoma in childhood after a period of remission. C115369 Neoplastic Process Recurrent Childhood Non-Hodgkin Lymphoma Recurrent Childhood Non-Hodgkin Lymphoma CL376186 CTRP Malignant Recurrent Childhood Non-Hodgkin Lymphoma Recurrent Non-Hodgkin Lymphoma Recurrent Childhood Non-Hodgkin Lymphoma The reemergence of oligoastrocytoma in childhood after a period of remission. C115370 Neoplastic Process Recurrent Childhood Oligoastrocytoma Recurrent Childhood Oligoastrocytoma CL433952 CTRP Undetermined Recurrent Childhood Oligoastrocytoma Recurrent Oligoastrocytoma Recurrent Childhood Oligoastrocytoma The reemergence of oligodendroglioma in childhood after a period of remission. C115371 Neoplastic Process Recurrent Childhood Oligodendroglioma Recurrent Childhood Oligodendroglioma CL433935 CTRP Undetermined Recurrent Childhood Oligodendroglioma Recurrent Oligodendroglioma Recurrent Childhood Oligodendroglioma The reemergence of pilocytic astrocytoma in childhood after a period of remission. C115372 Neoplastic Process Recurrent Childhood Pilocytic Astrocytoma Recurrent Childhood Pilocytic Astrocytoma CL433937 CTRP Undetermined Recurrent Childhood Pilocytic Astrocytoma Recurrent Pilocytic Astrocytoma Recurrent Childhood Pilocytic Astrocytoma The reemergence of pilomyxoid astrocytoma in childhood after a period of remission. C115373 Neoplastic Process Recurrent Childhood Pilomyxoid Astrocytoma Recurrent Childhood Pilomyxoid Astrocytoma CL433940 CTRP Undetermined Recurrent Childhood Pilomyxoid Astrocytoma Recurrent Pilomyxoid Astrocytoma Recurrent Childhood Pilomyxoid Astrocytoma The reemergence of pineoblastoma in childhood after a period of remission. C115374 Neoplastic Process Recurrent Childhood Pineoblastoma Recurrent Childhood Pineoblastoma CL376167 CTRP Malignant Recurrent Childhood Pineoblastoma Recurrent Pineoblastoma Recurrent Childhood Pineoblastoma The reemergence of pleomorphic xanthoastrocytoma in childhood after a period of remission. C115375 Neoplastic Process Recurrent Childhood Pleomorphic Xanthoastrocytoma Recurrent Childhood Pleomorphic Xanthoastrocytoma CL433943 CTRP Undetermined Recurrent Childhood Pleomorphic Xanthoastrocytoma Recurrent Pleomorphic Xanthoastrocytoma Recurrent Childhood Pleomorphic Xanthoastrocytoma The reemergence of protoplasmic astrocytoma in childhood after a period of remission. C115376 Neoplastic Process Recurrent Childhood Protoplasmic Astrocytoma Recurrent Childhood Protoplasmic Astrocytoma CL433946 CTRP Undetermined Recurrent Childhood Protoplasmic Astrocytoma Recurrent Protoplasmic Astrocytoma Recurrent Childhood Protoplasmic Astrocytoma The reemergence of subependymal giant cell astrocytoma in childhood after a period of remission. C115380 Neoplastic Process Recurrent Childhood Subependymal Giant Cell Astrocytoma Recurrent Childhood Subependymal Giant Cell Astrocytoma CL388361 CTRP Undetermined Recurrent Childhood Subependymal Giant Cell Astrocytoma Recurrent Subependymal Giant Cell Astrocytoma Recurrent Childhood Subependymal Giant Cell Astrocytoma The reemergence of supratentorial embryonal tumor, not otherwise specified in childhood after a period of remission. C115381 Neoplastic Process Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified CL343504 CTRP Malignant Recurrent Childhood Supratentorial Embryonal Tumor, NOS Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Supratentorial Embryonal Tumor, NOS Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified The reemergence of olfactory neuroblastoma after a period of remission. C115384 Neoplastic Process Recurrent Olfactory Neuroblastoma Recurrent Olfactory Neuroblastoma C3897734 CTRP Malignant Recurrent Olfactory Neuroblastoma Recurrent Olfactory Neuroblastoma The reemergence of fallopian tube carcinoma after a period of remission. C115429 Neoplastic Process Recurrent Fallopian Tube Carcinoma Recurrent Fallopian Tube Carcinoma CL433821 CTRP Malignant Recurrent Fallopian Tube Cancer Recurrent Fallopian Tube Carcinoma Recurrent Fallopian Tube Carcinoma The reemergence of grade I lymphomatoid granulomatosis after a period of remission. C115430 Neoplastic Process Recurrent Grade I Lymphomatoid Granulomatosis Recurrent Grade I Lymphomatoid Granulomatosis C1541448 CTRP Uncertain Malignant Potential Recurrent Grade I Lymphomatoid Granulomatosis Recurrent Grade I Lymphomatoid Granulomatosis The reemergence of grade II lymphomatoid granulomatosis after a period of remission. C115431 Neoplastic Process Recurrent Grade II Lymphomatoid Granulomatosis Recurrent Grade II Lymphomatoid Granulomatosis C1541449 CTRP Uncertain Malignant Potential Recurrent Grade II Lymphomatoid Granulomatosis Recurrent Grade II Lymphomatoid Granulomatosis The reemergence of inverted Schneiderian papilloma after a period of remission. C115432 Neoplastic Process Recurrent Inverted Schneiderian Papilloma Recurrent Sinonasal Inverted Papilloma C3897737 CTRP Benign Recurrent Inverted Schneiderian Papilloma Recurrent Sinonasal Inverted Papilloma Recurrent Sinonasal Inverted Schneiderian Papilloma Recurrent Sinonasal Inverted Papilloma The reemergence of pancreatic neuroendocrine carcinoma after a period of remission. C115433 Neoplastic Process Recurrent Pancreatic Neuroendocrine Carcinoma Recurrent Pancreatic Neuroendocrine Carcinoma C3897732 CTRP Malignant Recurrent Pancreatic Neuroendocrine Cancer Recurrent Pancreatic Neuroendocrine Carcinoma Recurrent Pancreatic Neuroendocrine Carcinoma The reemergence of mycosis fungoides/Sezary syndrome after a period of remission. C115439 Neoplastic Process Recurrent Mycosis Fungoides and Sezary Syndrome Recurrent Mycosis Fungoides and Sezary Syndrome C0862200 CTRP Malignant Recurrent Mycosis Fungoides and Sezary Syndrome Recurrent Mycosis Fungoides and Sézary Syndrome Recurrent Mycosis Fungoides and Sezary Syndrome The reemergence of Merkel cell carcinoma after a period of remission. C115440 Neoplastic Process Recurrent Merkel Cell Carcinoma Recurrent Merkel Cell Carcinoma CL343405 CTRP Malignant Recurrent Merkel Cell Cancer Recurrent Merkel Cell Carcinoma Recurrent Merkel Cell Carcinoma The reemergence of primary peritoneal carcinoma after a period of remission. C115441 Neoplastic Process Recurrent Primary Peritoneal Carcinoma Recurrent Primary Peritoneal Carcinoma C3897731 CTRP Malignant Recurrent Primary Peritoneal Cancer Recurrent Primary Peritoneal Carcinoma Recurrent Primary Peritoneal Carcinoma The reemergence of lip and oral cavity squamous cell carcinoma after a period of remission. C115442 Neoplastic Process Recurrent Lip and Oral Cavity Squamous Cell Carcinoma Recurrent Lip and Oral Cavity Squamous Cell Carcinoma C0280363 CTRP Malignant Recurrent Lip and Oral Cavity Squamous Cell Cancer Recurrent Lip and Oral Cavity Squamous Cell Carcinoma Recurrent Lip and Oral Cavity Squamous Cell Carcinoma The reemergence of nasal cavity and paranasal sinus squamous cell carcinoma after a period of remission. C115443 Neoplastic Process Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Recurrent Sinonasal Squamous Cell Carcinoma C0280419 CTRP Malignant Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Cancer Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Recurrent Sinonasal Squamous Cell Carcinoma Recurrent Sinonasal Squamous Cell Carcinoma The reemergence of combined thymic epithelial neoplasm after a period of remission. C115444 Neoplastic Process Recurrent Combined Thymic Epithelial Neoplasm Recurrent Combined Thymic Epithelial Neoplasm C3897740 CTRP Malignant Recurrent Combined Thymic Carcinoma Recurrent Combined Thymic Epithelial Neoplasm Recurrent Combined Thymic Epithelial Tumor Recurrent Composite Thymoma-Thymic Carcinoma Recurrent Combined Thymic Epithelial Neoplasm The reemergence of renal neoplasm in childhood after a period of remission. C115445 Neoplastic Process Recurrent Childhood Renal Neoplasm Recurrent Childhood Kidney Neoplasm C3897743 CTRP Undetermined Recurrent Childhood Kidney Neoplasm Recurrent Childhood Renal Neoplasm Recurrent Kidney Neoplasm Recurrent Childhood Kidney Neoplasm Hodgkin lymphoma that occurs during childhood and is resistant to treatment. C115458 Neoplastic Process Refractory Childhood Hodgkin Lymphoma Refractory Childhood Hodgkin Lymphoma C3897729 CTRP Malignant Refractory Childhood Hodgkin Lymphoma Refractory Hodgkin Lymphoma Refractory Childhood Hodgkin Lymphoma Toxicity that impairs or damages the kidney. This condition is often caused by the administration of a pharmaceutical agent that causes damage to the kidney. C115459 Sign or Symptom Renal Toxicity Renal Toxicity C0599918 CTRP PCDC Kidney Toxicity Renal Toxicity Renal Toxicity Slowly progressive systemic mastocytosis with uncertain prognosis. It is characterized by organomegaly and absence of aggressive disease. C115460 Neoplastic Process Smoldering Systemic Mastocytosis Smoldering Systemic Mastocytosis CL388369 CTRP Undetermined Smoldering Systemic Mastocytosis Smoldering Systemic Mastocytosis Magnetic resonance imaging of a study participant as part of a clinical trial. C115539 Diagnostic Procedure Study Subject Magnetic Resonance Imaging C3897461 CareLex Magnetic Resonance Image of a study participant for a specific study. Study Subj MRI Study Subject MRI Study Subject Magnetic Resonance Imaging Study Subject Magnetic Resonance Imaging A subependymoma that occurs during adulthood. C115623 Neoplastic Process Adult Subependymoma Adult Subependymoma C0281328 CTRP Undetermined Adult Subependymoma Subependymoma Adult Subependymoma Invasive urothelial carcinoma of the bladder which is associated with the presence of in situ or infiltrating urethral carcinoma. C115966 Neoplastic Process Infiltrating Bladder Urothelial Carcinoma Associated with Urethral Carcinoma Invasive Bladder Urothelial Carcinoma Associated with Urethral Carcinoma C3898764 CTRP Malignant Infiltrating Bladder Urothelial Cancer Associated with Urethral Cancer Infiltrating Bladder Urothelial Carcinoma Associated with Urethral Carcinoma Invasive Bladder Urothelial Carcinoma Associated with Urethral Carcinoma Invasive Bladder Urothelial Carcinoma Associated with Urethral Carcinoma An undifferentiated high grade pleomorphic sarcoma of bone that occurs in adulthood and has not spread to other anatomic sites. C115997 Neoplastic Process Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone C4054601 CTRP Malignant Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone Undifferentiated High Grade Pleomorphic Sarcoma of Bone Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone An undifferentiated high grade pleomorphic sarcoma of bone that occurs in childhood and has not spread to other anatomic sites. C115998 Neoplastic Process Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone C4054600 CTRP Malignant Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone Undifferentiated High Grade Pleomorphic Sarcoma of Bone Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone The skin or integument surrounding the axilla, or underarm. C116164 Anatomical Structure Skin Of The Axilla CL497335 CDISC The integument that covers the underarm. SKIN OF THE AXILLA Skin Of The Axilla Skin Of The Axilla A lymph node located in the aortopulmonary window. C116165 Body Part, Organ, or Organ Component Aortopulmonary Window Lymph Node C1268054 CDISC mCode A lymph node located in the aortopulmonary window. AORTOPULMONARY WINDOW LYMPH NODE AP Window Lymph Node Aortopulmonary Window Lymph Node Lymph node of aortopulmonary window (body structure) Aortopulmonary Window Lymph Node An adenocarcinoma that arises from the nasal cavity and paranasal sinuses. Histologically it resembles intestinal adenocarcinoma. It is associated with lengthy occupational exposure to dust. C116316 Neoplastic Process Intestinal-Type Sinonasal Adenocarcinoma Sinonasal Adenocarcinoma, Intestinal-Type C3898709 CTRP Cellosaurus Malignant Enteric-Type Sinonasal Adenocarcinoma Intestinal-Type Sinonasal Adenocarcinoma Nasal Cavity and Paranasal Sinus Adenocarcinoma, Intestinal-Type Sinonasal Adenocarcinoma, Intestinal-Type Sinonasal Adenocarcinoma, Intestinal-Type A very rare small cell neuroendocrine carcinoma that arises from the kidney. C116317 Neoplastic Process Kidney Small Cell Neuroendocrine Carcinoma C2212425 Cellosaurus Malignant Kidney Small Cell Carcinoma Kidney Small Cell Neuroendocrine Carcinoma Renal Small Cell Carcinoma Kidney Small Cell Neuroendocrine Carcinoma A very rare small cell neuroendocrine carcinoma that arises from the nose and paranasal sinuses. C116318 Neoplastic Process Nasal Cavity and Paranasal Sinus Small Cell Neuroendocrine Carcinoma Sinonasal Small Cell Neuroendocrine Carcinoma C3898157 CTRP Cellosaurus Malignant Nasal Cavity and Paranasal Sinus Small Cell Carcinoma Nasal Cavity and Paranasal Sinus Small Cell Neuroendocrine Cancer Nasal Cavity and Paranasal Sinus Small Cell Neuroendocrine Carcinoma Sinonasal Small Cell Carcinoma Sinonasal Small Cell Neuroendocrine Carcinoma Sinonasal Small Cell Neuroendocrine Carcinoma A grade I or grade II astrocytoma. This category includes pilocytic astrocytoma (grade I), subependymal giant cell astrocytoma (grade I), and diffuse astrocytoma (grade II). C116342 Neoplastic Process Low Grade Astrocytoma C3898569 Undetermined Low Grade Astrocytic Neoplasm Low Grade Astrocytic Tumor Low Grade Astrocytoma Low-Grade Astrocytic Neoplasm Low-Grade Astrocytic Tumor Low-Grade Astrocytoma Low Grade Astrocytoma The quantitative computation of data obtained via ultrasonography to create a three dimensional map of the imaged tissue. C116448 Diagnostic Procedure Ultrasound Tomography Ultrasound Tomography CL433887 CTRP Ultrasound Tomography Ultrasound Tomography A functional nuclear medicine test that utilizes a radioactive tracer, most commonly the radiolabeled sugar fluorodeoxyglucose, to identify tumors and metastasis. C116449 Diagnostic Procedure Positron Emission Tomography with Radiolabeled Targeting Agent Positron Emission Tomography with Radiolabeled Targeting Agent CL446643 CTRP Positron Emission Tomography with Radiolabeled Targeting Agent Positron Emission Tomography with Radiolabeled Targeting Agents Positron Emission Tomography with Radiolabeled Targeting Agent An application of functional MRI used to measure cerebral blood flow. ASL uses magnetically labeled water as the tracer. C116450 Diagnostic Procedure Arterial Spin Labeling Magnetic Resonance Imaging Arterial Spin Labeling Magnetic Resonance Imaging CL446664 CDISC CTRP DIPG/DMG A noninvasive fMRI technique that uses arterial water as an endogenous tracer to measure cerebral blood flow by magnetically labeling the proton spins of the arterial water prior to reaching the imaged volume. ARTERIAL SPIN LABELING FUNCTIONAL MRI ASL ASL fMRI Arterial Spin Labeling MRI Arterial Spin Labeling Magnetic Resonance Imaging Arterial Spin Labeling Magnetic Resonance Imaging An acquisition technique of MRI that uses differences in the tissue microenvironment, like protein concentration or intracellular pH, to generate contrast differences. C116451 Diagnostic Procedure Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Chemical Exchange Saturation Transfer Magnetic Resonance Imaging CL446667 CTRP Chemical Exchange Saturation Transfer MRI Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Chemical Exchange Saturation Transfer Magnetic Resonance Imaging A type of magnetic resonance imaging that uses the transient signal reduction induced by the first pass of gadolinium chelate through the brain vessels to calculate cerebral blood flow maps, and to determine the ratio between the cerebral blood volume in the lesion and the cerebral blood volume in normal tissue. C116453 Diagnostic Procedure Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging CL471721 CDISC CTRP DIPG/DMG A type of MRI that uses the transient signal reduction induced by the first pass of gadolinium chelate through the brain vessels to calculate cerebral blood flow maps, and to determine the ratio between the cerebral blood volume in the lesion and the cerebral blood volume in normal tissue. DSC DSC-MRI DYNAMIC SUSCEPTIBILITY-CONTRAST MRI Dynamic Susceptibility Contrast-Enhanced MRI Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging A technique that monitors blood oxygen level dependent (BOLD) signals to map distant brain regions that work together while performing a task. C116454 Diagnostic Procedure Functional Connectivity Magnetic Resonance Imaging Functional Connectivity Magnetic Resonance Imaging CL471734 CTRP Functional Connectivity MRI Functional Connectivity Magnetic Resonance Imaging fcMRI Functional Connectivity Magnetic Resonance Imaging A type of magnetic resonance imaging that uses larger, stronger magnets to generate faster scans and higher resolution images. C116455 Diagnostic Procedure High Field Strength Magnetic Resonance Imaging High Field Strength Magnetic Resonance Imaging CL446619 CTRP High Field Strength MRI High Field Strength Magnetic Resonance Imaging High Field Strength Magnetic Resonance Imaging A type of magnetic resonance imaging that uses a weaker magnet (less than or equal to 0.3 Tesla) than is used in conventional magnetic resonance imaging. This is typical of open MRI machines and office-based MRI units. C116456 Diagnostic Procedure Low Field Strength Magnetic Resonance Imaging Low Field Strength Magnetic Resonance Imaging CL471761 CTRP Low Field Strength MRI Low Field Strength Magnetic Resonance Imaging Low Field Strength Magnetic Resonance Imaging A type of magnetic resonance imaging that involves the transfer of longitudinal magnetization of hydrogen nuclei between restricted motion water and free motion water, allowing for the calculation of the magnetization transfer ratio (MTR), an indicator of the structural integrity of the imaged tissue. C116457 Diagnostic Procedure Magnetization Transfer Magnetic Resonance Imaging Magnetization Transfer Magnetic Resonance Imaging CL471729 CTRP Magnetization Transfer MRI Magnetization Transfer Magnetic Resonance Imaging Magnetization Transfer Magnetic Resonance Imaging The combination of multiple magnetic resonance techniques, including diffusion weighted imaging, dynamic contrast-enhanced imaging, and spectroscopy, to achieve an image that will allow for better identification of tumor size and location, as well as possibly identifying cancer spread and aggressiveness. C116458 Diagnostic Procedure Multiparametric Magnetic Resonance Imaging Multiparametric Magnetic Resonance Imaging CL433777 CTRP MP-MRI Multi-parametric MRI Multiparametric MRI Multiparametric Magnetic Resonance Imaging mpMRI Multiparametric Magnetic Resonance Imaging An imaging technique that requires the intravenous administration of secretin immediately prior to a magnetic resonance cholangiopancreatography, allowing for a qualitative assessment of exocrine pancreatic function. C116459 Diagnostic Procedure Secretin-Enhanced Magnetic Resonance Imaging Secretin-Enhanced Magnetic Resonance Imaging CL416282 CTRP Secretin-Enhanced MRI Secretin-Enhanced Magnetic Resonance Imaging Secretin-Enhanced Magnetic Resonance Imaging A type of magnetic resonance imaging that uses very high field stength to provide a very detailed image of the targeted tissue. C116460 Diagnostic Procedure Specimen Ultra-High-Field Magnetic Resonance Imaging Specimen Ultra-High-Field Magnetic Resonance Imaging CL412385 CTRP Specimen Ultra-High-Field MRI Specimen Ultra-High-Field Magnetic Resonance Imaging Specimen Ultra-High-Field Magnetic Resonance Imaging A magnetic resonance imaging technique that uses superparamagnetic iron oxide particles as a contrast agent to aid in the identification of multiple disorders, including atherosclerosis, blood-brain barrier dysfunction, and cancer. C116461 Diagnostic Procedure Superparamagnetic Iron Oxide Magnetic Resonance Imaging Superparamagnetic Iron Oxide Magnetic Resonance Imaging CL412368 CTRP SPIO-MRI Superparamagnetic Iron Oxide MRI Superparamagnetic Iron Oxide Magnetic Resonance Imaging Superparamagnetic Iron Oxide Magnetic Resonance Imaging An extension of conventional diffusion tension imaging, which estimates the kurtosis of the water diffusion probability distribution function. This technique is most commonly used to study the brain. C116487 Diagnostic Procedure Diffusion Kurtosis Imaging Diffusion Kurtosis Imaging CL433731 CTRP DKI Diffusion Kurtosis Imaging Diffusion Kurtosis Imaging A functional imaging technique that uses the combination of sonography and microbubble contrast agents to render the desired image. C116488 Diagnostic Procedure Dynamic Contrast-Enhanced Ultrasound Imaging Dynamic Contrast-Enhanced Ultrasound Imaging CL388454 CTRP Dynamic Contrast-Enhanced Ultrasound Imaging Dynamic Contrast-Enhanced Ultrasound Imaging A type of magnetic resonance imaging that provides a temperature map of the tissue being imaged. C116494 Diagnostic Procedure Magnetic Resonance Thermal Imaging Magnetic Resonance Thermal Imaging CL388340 CTRP Magnetic Resonance Thermal Imaging Magnetic Resonance Thermal Imaging The use of ultrasonography to measure the elastic properties of soft tissue. C116499 Diagnostic Procedure Ultrasound Elasticity Imaging Ultrasound Elasticity Imaging CL388342 CTRP Ultrasound Elasticity Imaging Ultrasound Elasticity Imaging A type of doppler ultrasound that uses microbubble contrast to image perfusion and microvasculature within tissues. C116502 Diagnostic Procedure Contrast-Enhanced Harmonic Endoscopic Ultrasound Contrast-Enhanced Harmonic Endoscopic Ultrasound CL433813 CTRP CH-EUS Contrast-Enhanced Harmonic Endoscopic Ultrasound Contrast-Enhanced Harmonic Endoscopic Ultrasound A technique used to improve the efficacy of radioimmunotherapy that targets the tumor with both an antibody construct and a radiolabeled hapten prior to the administration of radiation therapy. C116541 Therapeutic or Preventive Procedure Pretargeted Radioimmunotherapy Pretargeted Radioimmunotherapy CL412303 CTRP Pretargeted Radioimmunotherapy Pretargeted Radioimmunotherapy The administration of exogenous hormones via bolus injection into the tissue layer immediately deep to the dermis. C116543 Therapeutic or Preventive Procedure Subcutaneous Hormonal Therapy Subcutaneous Hormonal Therapy CL446614 CTRP Subcutaneous Hormonal Therapy Subcutaneous Hormonal Therapy The application of steroid medications to the skin for the treatment of various conditions. C116545 Therapeutic or Preventive Procedure Topical Steroid Therapy Topical Steroid Therapy CL383597 CTRP Topical Steroid Therapy Topical Steroid Therapy An imaging technique that utilizes a radiolabeled sugar given intravenously to help define the size, shape, and location of a breast tumor. C116559 Diagnostic Procedure Positron Emission Mammography Positron Emission Mammography CL412797 CTRP Positron Emission Mammography Positron Emission Mammography A type of nuclear medicine study that utilizes a radioactive tracer to identify possible tumors. C116560 Diagnostic Procedure Radiomammography Radiomammography CL412263 CTRP Radiomammography Radiomammography Diffusion-weighted imaging done under conditions of high diffusion gradients. C116754 Diagnostic Procedure High-B-Value Diffusion-Weighted Imaging C3898884 High B-Value High-B-Value Diffusion-Weighted Imaging High-B-Value Diffusion-Weighted MR Imaging High-B-Value Diffusion-Weighted Magnetic Resonance Imaging High-B-Value Diffusion-Weighted Imaging A congenital lymphatic malformation usually arising from the neck and characterized by cystic dilation of the lymphatic vessels. C116899 Neoplastic Process Congenital Cystic Hygroma C3899506 Cellosaurus NICHD A congenital lymphatic malformation usually arising from the neck and characterized by cystic dilation of the lymphatic vessels. Benign Cervicofacial Lymphatic Malformation Congenital Cystic Hygroma Congenital Cystic Hygroma A lymph node located adjacent to the lumbar region of the spine, along the right lateral aspect of the inferior vena cava. C117869 Anatomical Structure Paracaval Lymph Node C0933345 CDISC A lymph node located adjacent to the lumbar region of the spine, along the right lateral aspect of the inferior vena cava. (NCI) PARACAVAL LYMPH NODE Paracaval Lymph Node Paracaval Lymph Node A lymph node located anterior to the pericardium, posterior to the xiphoid process, and in the right and left cardiophrenic fat. C117870 Anatomical Structure Pericardial Lymph Node C3897951 CDISC A lymph node located anterior to the pericardium, posterior to the xiphoid process, and in the right and left cardiophrenic fat. (NCI) PERICARDIAL LYMPH NODE Pericardial Lymph Node Pericardial Lymph Node A lymph node located in the transverse fissure of the liver. C117871 Body Part, Organ, or Organ Component Porta Hepatis Lymph Node C3897880 CDISC mCode A lymph node located in the transverse fissure of the liver. (NCI) PORTA HEPATIS LYMPH NODE Porta Hepatis Lymph Node Portahepatis lymph node group (body structure) Porta Hepatis Lymph Node A lymph node located in the space between the portal vein and inferior vena cava, along the hepatoduodenal ligament. C117872 Anatomical Structure Portacaval Lymph Node C2952211 CDISC A lymph node located in the space between the portal vein and inferior vena cava, along the hepatoduodenal ligament. (NCI) PORTACAVAL LYMPH NODE Portacaval Lymph Node Portocaval Lymph Node Portacaval Lymph Node A lymph node located in the thoracic cavity between the lungs. It is bordered by the carina of the trachea, lower lobe bronchus on the left and the bronchus intermedius on the right. C117873 Anatomical Structure Subcarinal Lymph Node C0229753 CDISC GDC A lymph node located in the thoracic cavity between the lungs. It is bordered by the carina of the trachea, lower lobe bronchus on the left and the bronchus intermedius on the right. (NCI) Lymph Node, Subcarinal Lymph Node, Subcarinal SUBCARINAL LYMPH NODE Subcarinal Lymph Node Subcarinal Lymph Node An anatomical structure comprising of trachea, bronchi, and bronchioles that terminate with the alveolar ducts, sacs, and alveoli. C117875 Body Part, Organ, or Organ Component Tracheobronchial Tree C0458580 CDISC An anatomical structure comprised of trachea, bronchi, and bronchioles that terminate with the alveolar ducts, sacs, and alveoli. (NCI) TRACHEOBRONCHIAL TREE Tracheobronchial Tree Tracheobronchial Tree A procedure in which the catheter is passed into a peripheral vessel (usually in the groin) for the purpose of angiography of the abdomen, hands, arms, feet and legs. C117879 Diagnostic Procedure Peripheral Angiography C0412290 CDISC A procedure in which the catheter is passed into a peripheral vessel (usually in the groin) for the purpose of angiography of the abdomen, hands, arms, feet and legs. PERIPHERAL ANGIOGRAPHY Peripheral Angiography Peripheral Angiography Stereotactic radiation therapy in which one or several maximum dose radiation treatments are delivered targeting cancers of the body, excluding the brain or spine. C118286 Therapeutic or Preventive Procedure Stereotactic Body Radiation Therapy Stereotactic Body Radiation Therapy C1273404 CTRP OORO A type of external radiation therapy that uses special equipment to position a patient and precisely deliver radiation to tumors in the body (except the brain). The total dose of radiation is divided into smaller doses given over several days. This type of radiation therapy helps spare normal tissue. SABR SBRT Stereotactic Ablative Body Radiation Therapy Stereotactic Body Radiation Therapy stereotactic body radiation therapy Stereotactic Body Radiation Therapy A plasmacytoma characterized by the presence of malignant plasma cells with anaplastic features. C118421 Neoplastic Process Anaplastic Plasmacytoma C2931517 Malignant Anaplastic Plasmacytoma Anaplastic Plasmacytoma A magnetic resonance imaging modality that uses a gradient echo pulse sequence with data acquisition after an initial 180 degree preparation pulse for contrast enhancement. TFE provides contrast at shorter echo times and acquisition times, thus reducing related image artifacts. C118461 Diagnostic Procedure Turbo Field Echo MRI C3889656 TFE TFE MRI Turbo Field Echo Turbo Field Echo MRI Turbo field echo MRI Turbo Field Echo MRI A magnetic resonance imaging modality that offers rapid imaging time, easy reconstruction of any plane, and three-dimensional surface contour rendering with cut away postprocessing. Especially useful for imaging brain, MP-RAGE captures high tissue contrast and provides high spatial resolution with whole brain coverage in a short scan time. C118462 Diagnostic Procedure Magnetization-Prepared Rapid Gradient Echo MRI C3898475 MP RAGE MP-RAGE MP-RAGE MRI MPRAGE Magnetization-Prepared Rapid Gradient Echo Magnetization-Prepared Rapid Gradient Echo MRI Magnetization-prepared rapid gradient echo MRI Magnetization-Prepared Rapid Gradient Echo MRI A magnetic resonance imaging modality that uses acquisition in the steady state with semi-random changes in the phase of the radio frequency pulses to produce a spatially independent phase shift. This optimizes the signal-to-noise ratio to provide high resolution and a decrease in the partial volume phenomenon. C118463 Diagnostic Procedure Three-Dimensional Spoiled Gradient MRI Three-Dimensional Spoiled Gradient MRI C3897360 CTRP 3-Dimensional Fast Spoiled Gradient 3D FSPGR 3D Fast Spoiled Gradient Recalled MRI 3DFSPGR FSPGR FSPGR MRI SPGR SPGR MRI Three-Dimensional Spoiled Gradient MRI Three-Dimensional Spoiled Gradient-Echo MR Three-dimensional spoiled gradient MRI Three-Dimensional Spoiled Gradient MRI A magnetic resonance imaging modality that uses an inversion-recovery pulse sequence to nullify the signal from fluids. C118465 Diagnostic Procedure T2 and Fluid Attenuated Inversion Recovery MRI C3897397 DIPG/DMG T2 and Fluid Attenuated Inversion Recovery Brain MRI T2 and Fluid Attenuated Inversion Recovery MRI T2/FLAIR T2/FLAIR MRI T2/FLAIR Signal Transverse relaxation time/Fluid attenuated inversion recovery MRI T2 and Fluid Attenuated Inversion Recovery MRI A rare carcinoma that arises from the intrahepatic bile ducts and is composed of malignant glandular cells and malignant squamous cells. C118630 Neoplastic Process Liver Adenosquamous Carcinoma Liver Adenosquamous Carcinoma C3898586 CTRP Cellosaurus Malignant Liver Adenosquamous Cancer Liver Adenosquamous Carcinoma Liver Adenosquamous Carcinoma A lymph node located in the gastrohepatic ligament. C118774 Anatomical Structure Gastrohepatic Lymph Node C3899039 Gastrohepatic Lymph Node Gastrohepatic Lymph Node A lymph node located in the area between the abdominal aorta and inferior vena cava. C118775 Anatomical Structure Aortocaval Lymph Node C0229790 CDISC A lymph node located in the area between the abdominal aorta and inferior vena cava. (NCI) AORTOCAVAL LYMPH NODE Aortocaval Lymph Node Aortocaval Lymph Node A rare colorectal carcinoma that occurs during childhood. C118808 Neoplastic Process Childhood Colorectal Carcinoma Childhood Colorectal Carcinoma C3899669 CTRP NICHD A colorectal carcinoma occurring during childhood. Malignant Childhood Colorectal Carcinoma Colorectal (Colon or Rectal) Cancer Childhood Colorectal Carcinoma A rare breast carcinoma that occurs during childhood. C118809 Neoplastic Process Childhood Breast Carcinoma Childhood Breast Carcinoma C3897071 CTRP NICHD A rare breast carcinoma that occurs during childhood. Malignant Breast Cancer Childhood Breast Carcinoma Childhood Breast Carcinoma A neuroendocrine tumor grade 1 that occurs during childhood. C118810 Neoplastic Process Childhood Neuroendocrine Tumor G1 C3899673 NICHD A carcinoid tumor that occurs during childhood. Undetermined Childhood Carcinoid Tumor Childhood Neuroendocrine Tumor G1 Pediatric Neuroendocrine Tumor G1 Childhood Neuroendocrine Tumor G1 A rare carcinoma of the larynx that occurs during childhood. C118811 Neoplastic Process Childhood Laryngeal Carcinoma Childhood Laryngeal Carcinoma C3899654 CTRP NICHD A rare carcinoma of the larynx that occurs during childhood. Malignant Childhood Laryngeal Carcinoma Laryngeal Throat Cancer Childhood Laryngeal Carcinoma A rare carcinoma of the esophagus that occurs during childhood. C118812 Neoplastic Process Childhood Esophageal Carcinoma Childhood Esophageal Carcinoma C3899664 CTRP NICHD A rare carcinoma of the esophagus that occurs during childhood. Malignant Childhood Esophageal Carcinoma Esophageal Cancer Childhood Esophageal Carcinoma A rare carcinoma of the stomach that occurs during childhood. C118813 Neoplastic Process Childhood Gastric Carcinoma Childhood Gastric Carcinoma C3899661 CTRP NICHD A gastric carcinoma occurring during childhood. Malignant Childhood Carcinoma of the Stomach Childhood Gastric Carcinoma Gastric (Stomach) Cancer Childhood Gastric Carcinoma A rare non-small cell carcinoma of the lung that occurs during childhood. C118814 Neoplastic Process Childhood Lung Non-Small Cell Carcinoma C3899650 Malignant Childhood Lung Non-Small Cell Carcinoma Childhood Non-Small Cell Lung Cancer Childhood Non-Small Cell Lung Carcinoma Childhood Lung Non-Small Cell Carcinoma A rare small cell carcinoma of the lung that occurs during childhood. C118815 Neoplastic Process Childhood Lung Small Cell Carcinoma C3899641 Malignant Childhood Lung Small Cell Carcinoma Childhood Small Cell Lung Cancer Childhood Small Cell Lung Carcinoma Childhood Lung Small Cell Carcinoma A rare carcinoma of the bladder that occurs during childhood. C118816 Neoplastic Process Childhood Bladder Carcinoma Childhood Bladder Carcinoma C3899675 CTRP Malignant Bladder Cancer Childhood Bladder Carcinoma Childhood Bladder Carcinoma A rare carcinoma of the nasal cavity that occurs during childhood. C118817 Neoplastic Process Childhood Nasal Cavity Carcinoma C3899651 NICHD A rare carcinoma of the nasal cavity that occurs during childhood. Malignant Childhood Nasal Cavity Carcinoma Childhood Nasal Cavity Carcinoma A rare carcinoma of the paranasal sinus that occurs during childhood. C118818 Neoplastic Process Childhood Paranasal Sinus Carcinoma C3899648 NICHD A rare carcinoma of the paranasal sinus that occurs during childhood. Malignant Childhood Paranasal Sinus Carcinoma Childhood Paranasal Sinus Carcinoma A rare carcinoma of the parathyroid gland that occurs during childhood. C118819 Neoplastic Process Childhood Parathyroid Gland Carcinoma C3899647 NICHD A rare carcinoma of the parathyroid gland that occurs during childhood. Malignant Childhood Parathyroid Gland Carcinoma Childhood Parathyroid Gland Carcinoma A carcinoma of the penis that occurs during adulthood. C118820 Neoplastic Process Adult Penile Carcinoma Adult Penile Carcinoma C3900097 CTRP Malignant Adult Penile Carcinoma Penile Cancer Adult Penile Carcinoma A rare malignant neoplasm of the penis that occurs during childhood. C118821 Neoplastic Process Childhood Malignant Penile Neoplasm C3899653 Malignant Childhood Malignant Penile Neoplasm Malignant Childhood Penile Neoplasm Childhood Malignant Penile Neoplasm A rare pheochromocytoma of the adrenal gland that occurs during childhood. C118822 Neoplastic Process Childhood Adrenal Gland Pheochromocytoma CL495771 Undetermined Childhood Adrenal Gland Pheochromocytoma Childhood Pheochromocytoma Pediatric Adrenal Gland Pheochromocytoma Pediatric Pheochromocytoma Childhood Adrenal Gland Pheochromocytoma A rare carcinoma of the rectum that occurs during childhood. C118823 Neoplastic Process Childhood Rectal Carcinoma Childhood Rectal Carcinoma C3899643 CTRP Malignant Childhood Rectal Carcinoma Rectal Cancer Childhood Rectal Carcinoma A rare carcinoma of the salivary gland that occurs during childhood. C118824 Neoplastic Process Childhood Salivary Gland Carcinoma C3899642 NICHD A rare carcinoma of the salivary gland that occurs during childhood. Malignant Childhood Salivary Gland Carcinoma Childhood Salivary Gland Carcinoma A carcinoma of the salivary gland that occurs during adulthood. C118825 Neoplastic Process Adult Salivary Gland Carcinoma C3900094 Malignant Adult Salivary Gland Carcinoma Adult Salivary Gland Carcinoma A rare malignant small intestinal neoplasm that occurs during childhood. C118826 Neoplastic Process Childhood Malignant Small Intestinal Neoplasm C3897069 Malignant Childhood Malignant Small Intestinal Neoplasm Childhood Malignant Small Intestinal Neoplasm A rare carcinoma of the thyroid gland that occurs during childhood. C118827 Neoplastic Process Childhood Thyroid Gland Carcinoma Childhood Thyroid Gland Carcinoma C3899640 CTRP NICHD Malignant tumor occurring in the thyroid gland in children. There are 3 types: papillary, follicular and medullary. Malignant Childhood Thyroid Carcinoma Childhood Thyroid Gland Carcinoma Thyroid Gland Cancer Childhood Thyroid Gland Carcinoma A melanoma that arises from the structures of the orbit. C118828 Neoplastic Process Orbital Melanoma C3898089 CPTAC Malignant Orbital Melanoma Orbital Melanoma A papillary or follicular thyroid gland carcinoma with a genetic component that develops within the same family. Current studies suggest that it is inherited in an autosomal dominant pattern. It is often multifocal and bilateral and usually affects younger patients. C118829 Neoplastic Process Familial Nonmedullary Thyroid Gland Carcinoma Hereditary Nonmedullary Thyroid Gland Carcinoma C3896673 CTRP Malignant FNMTC Familial Non-medullary Thyroid Gland Carcinoma Familial Nonmedullary Thyroid Gland Carcinoma Hereditary Nonmedullary Thyroid Gland Carcinoma NSFNMTC Non-Syndromic Familial Thyroid Cancer Hereditary Nonmedullary Thyroid Gland Carcinoma The eye positioned in the right orbit. C119333 Body Part, Organ, or Organ Component Right Eye C0229089 CDISC The eye positioned in the right orbit, Oculus Dexter. OD Oculus Dexter Oculus Dexter (Right Eye) Right Eye Right Eye The eye positioned in the left orbit. C119334 Body Part, Organ, or Organ Component Left Eye C0229090 CDISC The eye positioned in the left orbit, Oculus Sinister. Left Eye OS Oculus Sinister Oculus Sinister (Left Eye) Left Eye Of or pertaining to both the left and right eyes, C119335 Body Part, Organ, or Organ Component Both Eyes C0229118 CDISC Of or pertaining to both the left and right eyes, Oculus Uterque. Both Eyes OU Oculus Uterque Oculus Uterque (Both Eyes) Both Eyes A technique that uses high-energy and low-energy digital mammography with administration of an iodinated contrast agent. The differences between X-ray attenuation of iodine and breast tissues at these two energy levels are used to suppress the background breast tissue. This technique is useful in identifying lesions in dense breasts that are not visible using standard mammography. C119679 Diagnostic Procedure Dual-Energy Contrast-Enhanced Digital Spectral Mammography Dual-Energy Contrast-Enhanced Digital Spectral Mammography C3899334 CTRP Dual-Energy CEDM Dual-Energy Contrast-Enhanced Digital Spectral Mammography Dual-Energy Contrast-Enhanced Digital Subtraction Mammography Dual-Energy Contrast-Enhanced Digital Spectral Mammography An injury to the bone marrow resulting from exposure to high levels of ionizing radiation or exposure to other hazardous material. C120064 Finding Marrow Toxic Injury C3896997 Marrow Toxic Injury Toxic Marrow Injury Marrow Toxic Injury An undifferentiated, high grade small round cell sarcoma affecting predominantly young adults. It is characterized by a recurrent translocation involving the CIC gene on chromosome 19 and either DUX4 gene on chromosome 4 or DUX4L gene on chromosome 10. The translocation results in either CIC-DUX4, t(4;19)(q35;q13) or CIC-DUX4L, t(10;19)(q26;q13) fusions. C120224 Neoplastic Process CIC-Rearranged Sarcoma C3899764 Malignant CIC-DUX Sarcoma CIC-Rearranged Sarcoma CIC-Rearranged Sarcoma Skin that is naturally hairless. C120320 Anatomical Structure Glabrous Skin C1180283 Glabrous Skin Glabrous Skin Hairy skin. C120321 Anatomical Structure Non-Glabrous Skin C3898129 Non-Glabrous Skin Non-Glabrous Skin An axillary lymph node located along the lower edge of the pectoralis minor. C120322 Body Part, Organ, or Organ Component Pectoral Lymph Node C0229843 CDISC PCDC mCode An axillary lymph node located along the lower edge of the pectoralis minor. (NCI) PECTORAL LYMPH NODE Pectoral Lymph Node Pectoral Nodes Structure of pectoral axillary lymph node (body structure) Pectoral Lymph Node A malignant neoplasm that affects the area of the nipple in males. C120454 Neoplastic Process Male Malignant Nipple Neoplasm C0948587 CPTAC mCode Malignant Malignant neoplasm of nipple and areola of male breast Male Malignant Nipple Neoplasm Malignant neoplasm of nipple and areola, unspecified male breast Male Malignant Nipple Neoplasm A malignant neoplasm that affects the area of the nipple in females. C120455 Neoplastic Process Female Malignant Nipple Neoplasm C0948966 CPTAC mCode Malignant Malignant neoplasm of nipple and areola of female breast Malignant neoplasm of nipple and areola, unspecified female breast Female Malignant Nipple Neoplasm Malignant neoplasm of nipple and areola, unspecified female breast Female Malignant Nipple Neoplasm A malignant neoplasm that affects the renal parenchyma but not the pelvis. C120456 Neoplastic Process Malignant Kidney Neoplasm Except Pelvis C0494158 CPTAC Malignant Malignant neoplasm of kidney, except pelvis Malignant neoplasm of kidney, except renal pelvis Malignant neoplasm of left kidney, except renal pelvis Malignant neoplasm of right kidney, except renal pelvis Malignant neoplasm of unspecified kidney, except renal pelvis Malignant Kidney Neoplasm Except Pelvis Malignant Neoplasm of Kidney Except Pelvis Malignant Kidney Neoplasm Except Pelvis A type of angiographic procedure that allows for direct quantitative assessment of the native coronary arteries or bypass grafts supplying native coronary arteries. C120701 Diagnostic Procedure Quantitative Coronary Angiography C4054139 CDISC A type of angiographic procedure that allows for direct quantitative assessment of the native coronary arteries or bypass grafts supplying native coronary arteries. QUANTITATIVE CORONARY ANGIOGRAPHY Quantitative Coronary Angiography Quantitative Coronary Angiography A type of angiographic procedure that allows for direct quantitative assessment of the vessels of the hands, arms, feet and legs. C120702 Diagnostic Procedure Quantitative Peripheral Angiography C4054138 CDISC A type of angiographic procedure that allows for direct quantitative assessment of the vessels of the hands, arms, feet and legs. QUANTITATIVE PERIPHERAL ANGIOGRAPHY Quantitative Peripheral Angiography Quantitative Peripheral Angiography An infiltrating lipoma that affects skeletal muscle. It has a higher rate of local recurrence. C121131 Neoplastic Process Infiltrating Intramuscular Lipoma C4054724 Benign Infiltrating Intramuscular Lipoma Infiltrating Intramuscular Lipoma A pituitary neuroendocrine tumor that produces follicle-stimulating hormone (FSH). C121152 Neoplastic Process FSH-Producing Pituitary Neuroendocrine Tumor C4055021 NICHD A pituitary neuroendocrine tumor that produces follicle-stimulating hormone (FSH). Undetermined FSH-Producing Pituitary Gland Adenoma FSH-Producing Pituitary Neuroendocrine Tumor FSH-producing Adenoma Follicle Stimulating Hormone-Producing Adenoma Follicle Stimulating Hormone-Producing Gonadotroph Adenoma FSH-Producing Pituitary Neuroendocrine Tumor A pituitary neuroendocrine tumor that produces luteinizing hormone (LH). C121153 Neoplastic Process LH-Producing Pituitary Neuroendocrine Tumor C4054682 NICHD A pituitary neuroendocrine tumor that produces luteinizing hormone (LH). Undetermined LH-Producing Pituitary Gland Adenoma LH-Producing Pituitary Neuroendocrine Tumor LH-producing Adenoma Luteinizing Hormone-Producing Adenoma Luteinizing Hormone-Producing Gonadotroph Adenoma LH-Producing Pituitary Neuroendocrine Tumor A rapidly growing, poorly circumscribed, mass-forming proliferation that arises from the skeletal muscle. It is characterized by the presence of spindle-shaped fibroblasts, round ganglion-like cells, myxoid to collagenous stroma formation, and high mitotic activity. It recurs only rarely following local excision and does not metastasize. C121154 Neoplastic Process Proliferative Myositis C0544796 Benign Proliferative Myositis Proliferative Myositis A benign mesenchymal neoplasm characterized by the presence of spindle shaped myofibroblasts and mast cells in a collagenous stroma. It is histologically identical to the myofibroblastoma of breast. It usually arises from the subcutaneous tissue and the most common sites of involvement are the inguinal/groin, paratesticular, and vulvovaginal areas. C121181 Neoplastic Process Mammary-Type Myofibroblastoma C4054575 Benign Mammary-Type Myofibroblastoma Mammary-Type Myofibroblastoma An imaging technique that uses phase differences between tissues due to differences in magnetic susceptibilities to produce an enhanced contrast magnitude image. These phase differences can provide excellent contrast between gray matter and white matter, iron-laden tissues, venous blood vessels, and other tissues with susceptibilities that are different from the background tissue. The technique is commonly used for imaging in cases of traumatic brain injuries and for high resolution brain venographies. C121377 Diagnostic Procedure Susceptibility Weighted Imaging Susceptibility Weighted Imaging CL471823 CDISC CTRP DIPG/DMG An MRI-based imaging technique that uses phase differences between tissues, due to differences in magnetic susceptibilities, to produce an enhanced contrast magnitude image. BOLD Venographic Imaging BOLD Venography SUSCEPTIBILITY WEIGHTED MRI SWI SWI MRI SWI-Phase Susceptibility Weighted Imaging Susceptibility Weighted Imaging A fibrohistiocytic neoplasm that metastasizes to other anatomic sites. C121500 Neoplastic Process Malignant Fibrohistiocytic Neoplasm C4054579 CPTAC Malignant Malignant Fibrohistiocytic Neoplasm Malignant Fibrohistiocytic Neoplasm A lymph node located in the angle between the heart and diaphragm. C121555 Body Part, Organ, or Organ Component Cardiophrenic Lymph Node C4055271 CDISC A lymph node located in the angle between the heart and diaphragm. CARDIOPHRENIC LYMPH NODE Cardiophrenic Angle Lymph Node Cardiophrenic Lymph Node Cardiophrenic Lymph Node A rare leiomyosarcoma that arises from the deep soft tissue in the retroperitoneum or abdominal cavity. C121571 Neoplastic Process Leiomyosarcoma of Deep Soft Tissue C4054654 Malignant Leiomyosarcoma of Deep Soft Tissue Leiomyosarcoma of the Deep Soft Tissue Leiomyosarcoma of Deep Soft Tissue An uncommon variant of rhabdomyosarcoma with spindle cell or sclerosing morphology. It affects both children and adults and it is more common in males. C121654 Neoplastic Process Spindle Cell/Sclerosing Rhabdomyosarcoma Spindle Cell/Sclerosing Rhabdomyosarcoma C4053999 CTRP Cellosaurus Malignant Spindle Cell/Sclerosing Rhabdomyosarcoma Spindle Cell/Sclerosing Rhabdomyosarcoma An uncommon variant of rhabdomyosarcoma with sclerosing morphology. It usually arises from the limbs. C121655 Neoplastic Process Sclerosing Rhabdomyosarcoma C4048700 GDC Malignant Sclerosing rhabdomyosarcoma Sclerosing Rhabdomyosarcoma Sclerosing rhabdomyosarcoma Sclerosing Rhabdomyosarcoma A rare syndrome characterized by telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting. It is best classified as a type of plasma cell dyscrasia with paraneoplastic manifestations. C121656 Neoplastic Process TEMPI Syndrome C3854394 Malignant TEMPI Syndrome TEMPI Syndrome An intermediate, rarely metastasizing blood vessel neoplasm that more frequently affects young adult males and usually arises in the lower limbs. In approximately half of the affected patients the tumor is painful and in two-thirds of the patients the tumor is multifocal. Morphologically it is characterized by the presence of sheets and fascicles of spindle cells with abundant eosinophilic cytoplasm and vesicular nuclei. Cytologic atypia is usually mild. Approximately 60% of the patients develop local recurrences or additional tumors in the same anatomic region. C121668 Neoplastic Process Pseudomyogenic Hemangioendothelioma C3840252 Undetermined Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma Epithelioid Sarcoma-Like Hemangioendothelioma Pseudomyogenic (Epithelioid Sarcoma-Like) Hemangioendothelioma Pseudomyogenic Hemangioendothelioma Pseudomyogenic Hemangioendothelioma An angiosarcoma that arises from the soft tissues, usually in the deep muscles of the lower extremities, retroperitoneum, mediastinum, and mesentery. C121671 Neoplastic Process Soft Tissue Angiosarcoma C4055466 Malignant Angiosarcoma of Soft Tissue Soft Tissue Angiosarcoma Soft Tissue Angiosarcoma A common, usually encapsulated benign nerve sheath tumor composed of well-differentiated Schwann cells. C121677 Neoplastic Process Conventional Schwannoma C4055182 Benign Conventional Schwannoma Conventional Schwannoma A pituitary neuroendocrine tumor/microadenoma not associated with a hormonal syndrome. C121678 Neoplastic Process Non-Functioning Pituitary Neuroendocrine Tumor/Microadenoma C4053795 NICHD A non-malignant pituitary tumor with diameter less than 10 millimeters that does not secrete pituitary hormone(s). Undetermined Non-Functioning PitNET/Microadenoma Non-Functioning Pituitary Gland Microadenoma Non-Functioning Pituitary Neuroendocrine Tumor/Microadenoma Nonfunctional Pituitary Gland Microadenoma Nonfunctional Pituitary Microadenoma Nonfunctioning Pituitary Gland Microadenoma Non-Functioning Pituitary Neuroendocrine Tumor/Microadenoma A pituitary neuroendocrine tumor/microadenoma associated with a hormonal syndrome. C121679 Neoplastic Process Functioning Pituitary Neuroendocrine Tumor/Microadenoma C4054916 NICHD A non-malignant pituitary tumor with diameter less than 10 millimeters that secretes pituitary hormone(s). Undetermined Functional Pituitary Microadenoma Functioning PitNET/Microadenoma Functioning Pituitary Gland Microadenoma Functioning Pituitary Neuroendocrine Tumor/Microadenoma Functioning Pituitary Neuroendocrine Tumor/Microadenoma A usually painless, slow growing benign tumor that most often arises from the extremities. It is characterized by the presence of abundant myxoid matrix and small epithelioid neoplastic Schwann cells. C121680 Neoplastic Process Dermal Nerve Sheath Myxoma C1275265 Benign Classic Variant of Neurothekeoma Dermal Nerve Sheath Myxoma Myxoid Variant of Neurothekeoma Dermal Nerve Sheath Myxoma A benign peripheral nerve sheath tumor characterized by the presence of Schwann cells, axons, and perineurial fibroblasts. It usually arises from the skin of the head and neck or the oral mucosa. It presents as a solitary and painless nodular mass. C121681 Neoplastic Process Solitary Circumscribed Neuroma C0431126 Benign Palisaded Encapsulated Neuroma SCN Solitary Circumscribed Neuroma Solitary Circumscribed Neuroma A benign nerve sheath tumor characterized by the combination of histologic features seen in schwannomas, neurofibromas, and perineuriomas. C121686 Neoplastic Process Hybrid Nerve Sheath Tumor C3839433 Benign Hybrid Nerve Sheath Neoplasm Hybrid Nerve Sheath Tumor Hybrid Neurofibroma-Perineurioma Hybrid Neurofibroma-Schwannoma Hybrid Schwannoma-Perineurioma Hybrid Nerve Sheath Tumor A benign fibroblastic neoplasm that arises from acral sites, usually the periungual area of the digits. It is characterized by the proliferation of spindled and stellate-shaped fibroblasts in the dermis in a myxoid or collagenous stroma. Nuclear atypia is usually minimal. It usually presents as a solitary and slow-growing dome-shaped mass on a digit. The recurrence rate is low. C121713 Neoplastic Process Acral Fibromyxoma C4055500 Benign Acral Fibromyxoma Cellular Digital Fibroma Digital Fibromyxoma SAF Superficial Acral Fibromyxoma Acral Fibromyxoma A pituitary neuroendocrine tumor/macroadenoma associated with a hormonal syndrome. C121720 Neoplastic Process Functioning Pituitary Neuroendocrine Tumor/Macroadenoma C4054917 NICHD A non-malignant pituitary tumor with diameter 10 millimeters or greater that secretes pituitary hormone(s). Undetermined Functional Pituitary Macroadenoma Functioning PitNET/Macroadenoma Functioning Pituitary Gland Macroadenoma Functioning Pituitary Neuroendocrine Tumor/Macroadenoma Functioning Pituitary Neuroendocrine Tumor/Macroadenoma A pituitary neuroendocrine tumor/macroadenoma not associated with a hormonal syndrome. C121721 Neoplastic Process Non-Functioning Pituitary Neuroendocrine Tumor/Macroadenoma C4054344 Cellosaurus NICHD A non-malignant pituitary tumor with diameter 10 millimeters or greater that does not secrete pituitary hormone(s). Undetermined Non-Functioning PitNET/Macroadenoma Non-Functioning Pituitary Gland Macroadenoma Non-Functioning Pituitary Neuroendocrine Tumor/Macroadenoma Nonfunctional Pituitary Gland Macroadenoma Nonfunctional Pituitary Macroadenoma Nonfunctioning Pituitary Gland Macroadenoma Non-Functioning Pituitary Neuroendocrine Tumor/Macroadenoma A soft tissue neoplasm of uncertain differentiation which is locally aggressive but rarely metastasizes. C121738 Neoplastic Process Intermediate Soft Tissue Tumor of Uncertain Differentiation C4054705 Undetermined Intermediate Soft Tissue Neoplasm of Uncertain Differentiation Intermediate Soft Tissue Tumor of Uncertain Differentiation Intermediate Soft Tissue Tumor of Uncertain Differentiation A non-encapsulated, slow-growing, locally aggressive subcutaneous tumor characterized by the presence of adipocytes, hemosiderin-laden spindle cells, hemosiderin-laden macrophages, osteoclast-like giant cells, and scattered chronic inflammatory cells. It usually arises from the dorsum of the foot, ankle, dorsum of the hand, thigh, calf, or cheek. It may recur if it is not completely excised but does not metastasize. C121752 Neoplastic Process Hemosiderotic Fibrolipomatous Tumor C4053521 Undetermined HFLT Hemosiderotic Fibrohistiocytic Lipomatous Lesion Hemosiderotic Fibrolipomatous Tumor Hemosiderotic Fibrolipomatous Tumor An ossifying fibromyxoid tumor characterized by the presence of high grade nuclear features or increased cellularity and more than two mitotic figures per 50 HPFs. C121774 Neoplastic Process Malignant Ossifying Fibromyxoid Tumor C3839955 GDC Malignant Ossifying fibromyxoid tumor, malignant Malignant Ossifying Fibromyxoid Tumor Ossifying fibromyxoid tumor, malignant Malignant Ossifying Fibromyxoid Tumor A rare, well circumscribed, non-encapsulated tumor that arises in the oral cavity, most often the anterior tongue. It is characterized by the presence of round to spindle cells in a chondromyxoid or hyalinized stroma. Recurrences have been observed in a minority of patients. C121785 Neoplastic Process Ectomesenchymal Chondromyxoid Tumor C4050504 Benign EMCMT Ectomesenchymal Chondromyxoid Tumor Ectomesenchymal Chondromyxoid Tumor A benign myoepithelioma characterized by the presence of a minor ductal component. C121786 Neoplastic Process Mixed Tumor, Not Otherwise Specified C4049618 GDC Benign Mixed tumor, NOS Mixed Tumor, NOS Mixed Tumor, Not Otherwise Specified Mixed tumor, NOS Mixed Tumor, Not Otherwise Specified A malignant myoepithelioma characterized by the presence of a minor ductal component. C121787 Neoplastic Process Malignant Mixed Tumor, Not Otherwise Specified C4054577 Malignant Malignant Mixed Tumor, Not Otherwise Specified Malignant Mixed Tumor, Not Otherwise Specified A phosphaturic mesenchymal tumor with benign histologic features. It may recur locally but does not metastasize. Complete excision is curative. C121788 Neoplastic Process Benign Phosphaturic Mesenchymal Tumor C3814879 Benign Benign Phosphaturic Mesenchymal Tumor Benign Phosphaturic Mesenchymal Tumor A phosphaturic mesenchymal tumor characterized by the presence of nuclear atypia, high mitotic activity, increased cellularity, marked pleomorphism, and necrosis. It usually develops in lesions that have recurred locally and metastasizes to other sites. C121789 Neoplastic Process Malignant Phosphaturic Mesenchymal Tumor C3839061 GDC Malignant Phosphaturic mesenchymal tumor, malignant Malignant Phosphaturic Mesenchymal Tumor Phosphaturic mesenchymal tumor, malignant Malignant Phosphaturic Mesenchymal Tumor A tumor with perivascular epithelioid cell differentiation characterized by the presence of cords of neoplastic cells in a densely collagenous stroma. C121790 Neoplastic Process Sclerosing PEComa C4054048 Undetermined Sclerosing PEComa Sclerosing PEComa A tumor with perivascular epithelioid cell differentiation characterized by the absence of pleomorphism and scarcity or absence of mitotic figures. C121791 Neoplastic Process Benign PEComa C3839685 Benign Perivascular epithelioid tumor, benign Benign PEComa Benign PEComa, NOS Benign PEComa, Not Otherwise Specified Typical PEComa Benign PEComa A usually large and aggressive tumor with perivascular epithelioid cell differentiation characterized by the presence of marked nuclear atypia, pleomorphism, increased mitotic activity, necrosis, and infiltrative margins. The most common metastatic sites are liver, lungs, lymph nodes, and bone. C121792 Neoplastic Process Malignant PEComa C3839062 GDC Malignant PEComa, malignant Perivascular epithelioid cell tumor, malignant Perivascular epithelioid tumor, malignant Malignant PEComa PEComa, malignant Perivascular epithelioid cell tumor, malignant Malignant PEComa A term that refers to a heterogeneous group of uncommon soft tissue sarcomas that do not show an identifiable line of differentiation using currently available technologies. This is a diagnosis of exclusion and includes undifferentiated pleomorphic sarcoma (also known as malignant fibrous histiocytoma), undifferentiated spindle cell sarcoma, undifferentiated round cell sarcoma, and undifferentiated epithelioid sarcoma. C121793 Neoplastic Process Undifferentiated Soft Tissue Sarcoma Undifferentiated Soft Tissue Sarcoma C2188153 CTRP GDC Malignant 8805/3 Undifferentiated sarcoma USTS Undifferentiated Sarcoma Undifferentiated Soft Tissue Sarcoma Undifferentiated sarcoma Undifferentiated/Unclassified Sarcoma Undifferentiated/Unclassified Soft Tissue Sarcoma Undifferentiated Soft Tissue Sarcoma An undifferentiated soft tissue sarcoma characterized by the presence of a malignant spindle cell infiltrate with amphophilic or palely eosinophilic cytoplasm. C121797 Neoplastic Process Undifferentiated Spindle Cell Sarcoma C4048234 GDC Malignant Undifferentiated spindle cell sarcoma Undifferentiated Spindle Cell Sarcoma Undifferentiated spindle cell sarcoma Undifferentiated Spindle Cell Sarcoma An undifferentiated soft tissue sarcoma characterized by the presence of uniform round or ovoid malignant cells with a high nuclear to cytoplasmic ratio. C121799 Neoplastic Process Undifferentiated Round Cell Sarcoma C4048304 GDC PCDC Malignant Undifferentiated round cell sarcoma Undifferentiated Ewing Tumor Undifferentiated Round Cell Sarcoma Undifferentiated round cell sarcoma Undifferentiated Round Cell Sarcoma An undifferentiated soft tissue sarcoma characterized by the presence of a malignant cellular infiltrate with epithelioid morphology. C121802 Neoplastic Process Undifferentiated Epithelioid Sarcoma C4053898 GDC Malignant Undifferentiated epithelioid sarcoma Undifferentiated Epithelioid Sarcoma Undifferentiated epithelioid sarcoma Undifferentiated Epithelioid Sarcoma An undifferentiated soft tissue sarcoma which cannot be further characterized. C121804 Neoplastic Process Undifferentiated Sarcoma, Not Otherwise Specified C4053897 Malignant Undifferentiated Sarcoma, NOS Undifferentiated Sarcoma, Not Otherwise Specified Undifferentiated Sarcoma, Not Otherwise Specified A rare benign chondroid and osteoid matrix-producing neoplasm of bone characterized by extensive myxoid changes. It may be a locally destructive neoplasm and has been reported in patients with Carney complex. C121842 Neoplastic Process Osteochondromyxoma C3839106 Benign Osteochondromyxoma Carney Bone Tumor Osteochondromyxoma Osteochondromyxoma A benign tumor that affects the distal phalanx, most often the great toe. Grossly it consists of a cartilage cap and a bony stalk. Microscopically it is characterized by an osteochondromatous proliferation with a gradual transition of a peripheral spindle-cell proliferation to hyaline cartilage to trabecular bone. Pain and swelling are present. Simple resection is usually curative. C121844 Neoplastic Process Subungual Exostosis C0038604 Benign Subungual exostosis Dupuytren Exostosis Subungual Exostosis Subungual Exostosis A benign lesion that usually affects the proximal small bones of the hands or feet. Grossly it consists of a cartilage cap and a bony stalk. Microscopically it is characterized by the presence of spindle cells, cartilage, and bone, usually in a disorganized pattern compared to subungual exostosis. Enlarged (bizarre) chondrocytes are present in the cartilage. Swelling with or without pain is present. Recurrences following resection have been reported in approximately half of cases. C121845 Neoplastic Process Bizarre Parosteal Osteochondromatous Proliferation C2960319 Benign Bizarre parosteal osteochondromatous proliferation BPOP Bizarre Parosteal Osteochondromatous Proliferation Nora Lesion Nora's Lesion Bizarre Parosteal Osteochondromatous Proliferation A locally aggressive or rarely metastasizing cartilaginous matrix-producing neoplasm characterized by the presence of neoplastic chondrocytes. C121846 Neoplastic Process Intermediate Chondrogenic Neoplasm C4054708 Uncertain Malignant Potential Intermediate Chondrogenic Neoplasm Intermediate Chondrogenic Neoplasm An intermediate-grade chondrosarcoma arising in the medulla of bone or within the cartilaginous cap of a pre-existing osteochondroma. It is characterized by the presence of increased cellularity and a greater degree of nuclear atypia and hyperchromasia as compared to grade 1 chondrosarcoma. Mitotic activity is present. C121870 Neoplastic Process Chondrosarcoma, Grade 2 C4054892 Malignant Chondrosarcoma, Grade 2 Grade II Chondrosarcoma Intermediate Grade Chondrosarcoma Intermediate-Grade Chondrosarcoma Chondrosarcoma, Grade 2 A high-grade chondrosarcoma arising in the medulla of bone or within the cartilaginous cap of a pre-existing osteochondroma. It is characterized by the presence of increased cellularity and a greater degree of nuclear atypia, hyperchromasia, and mitotic activity as compared to grade 2 chondrosarcoma. C121871 Neoplastic Process Chondrosarcoma, Grade 3 C4054891 Malignant Chondrosarcoma, Grade 3 Grade III Chondrosarcoma High Grade Chondrosarcoma High-Grade Chondrosarcoma Chondrosarcoma, Grade 3 A chondrosarcoma that arises in a pre-existing enchondroma. C121881 Neoplastic Process Secondary Central Chondrosarcoma C4054046 Malignant Secondary Central Chondrosarcoma Secondary Central Chondrosarcoma A chondrosarcoma arising within the cartilaginous cap of a pre-existing osteochondroma. C121882 Neoplastic Process Secondary Peripheral Chondrosarcoma C4054043 Malignant Secondary Peripheral Chondrosarcoma Secondary Peripheral Chondrosarcoma A rare tumor-like lesion of the hands and feet characterized by the presence of hemorrhagic fibrous tissue, hemosiderin deposition, osteoclast-like giant cells which are irregularly distributed, and reactive bone formation. Pain and swelling are the most frequent symptoms. It may recur following curettage, but is usually cured after a second procedure. C121893 Neoplastic Process Giant Cell Lesion of Small Bones C0162375 Benign GCLSB Giant Cell Lesion of Small Bones Giant Cell Reparative Granuloma Giant Cell Lesion of Small Bones An intraosseous benign tumor of notochord origin that arises in the bones of the base of the skull, vertebral bodies, sacrum or coccyx. It contains vacuolated tumor cells without atypia, but lacks myxoid matrix, necrosis, and lobular architecture, which are features that characterize its malignant counterpart, chordoma. Most lesions are incidental findings. C121901 Neoplastic Process Benign Notochordal Cell Tumor C4050147 Benign Benign notochordal cell tumor BNCT Benign Notochordal Cell Tumor Intraosseous Benign Notochordal Cell Tumor Benign Notochordal Cell Tumor A non-metastasizing, locally aggressive, bone-forming neoplasm. C121925 Neoplastic Process Intermediate Osteogenic Neoplasm C4054706 Uncertain Malignant Potential Intermediate Osteogenic Neoplasm Intermediate Osteogenic Neoplasm A locally aggressive or rarely metastasizing neoplasm that arises from the bone. C121926 Neoplastic Process Intermediate Bone Neoplasm C4054709 Undetermined Intermediate Bone Neoplasm Intermediate Bone Neoplasm A tumor histologically indistinguishable from, but larger than, benign fibrous histiocytoma of bone. C121929 Neoplastic Process Non-Ossifying Fibroma C0334067 Benign NOF Non-Ossifying Fibroma Non-Ossifying Fibroma A non-Hodgkin lymphoma that arises from the bone, without lymph node or other extranodal involvement. The femur, spine, and pelvic bones are the most frequently affected areas. The majority of cases are diffuse large B-cell lymphomas. Most patients present with pain in the affected area. Systemic symptoms are rare. C121930 Neoplastic Process Primary Bone Non-Hodgkin Lymphoma C4054154 Malignant Primary Bone Non-Hodgkin Lymphoma Primary Non-Hodgkin Lymphoma of Bone Primary Non-Hodgkin Lymphoma of the Bone Primary Bone Non-Hodgkin Lymphoma A benign but locally aggressive giant cell tumor that arises from the bone. C121931 Neoplastic Process Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone C4054707 Undetermined Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone Intermediate Osteoclastic Giant Cell-Rich Tumor of the Bone Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone A benign but locally aggressive tumor that arises from the bone and is composed of mononuclear cells admixed with macrophages and osteoclast-like giant cells. It usually arises from the ends of long bones or the vertebrae. Clinical presentation includes pain, edema, and decreased range of motion in the affected joint. C121932 Neoplastic Process Giant Cell Tumor of Bone C0206638 CDISC Cellosaurus GDC A benign neoplasm of bone comprised of giant cells (osteoclast-like) and mononuclear cells. Undetermined 9250/1 Giant cell tumor of bone, NOS Benign Bone Giant Cell Tumor GCTB GIANT CELL TUMOR, BENIGN Giant Cell Tumor of Bone Giant Cell Tumor of the Bone Giant cell tumor of bone, NOS Osteoclastoma Osteoclastoma, Benign Giant Cell Tumor of Bone A giant cell tumor that arises from the bone and is characterized by the presence of a malignant cellular component. C121933 Neoplastic Process Malignant Osteoclastic Giant Cell-Rich Tumor of Bone C4054576 Malignant Malignant Osteoclastic Giant Cell-Rich Tumor of Bone Malignant Osteoclastic Giant Cell-Rich Tumor of Bone A low-grade malignant blood vessel neoplasm arising from the bone. It is characterized by the presence of epithelioid endothelial cells. The neoplastic cells are arranged in cords and nests, which are embedded in a myxoid to hyalinized stroma. C121941 Neoplastic Process Bone Epithelioid Hemangioendothelioma C4055374 Malignant Bone Epithelioid Hemangioendothelioma Bone Epithelioid Hemangioendothelioma A benign, unilateral tumor that arises from the ovary and is characterized by the presence of conspicuous microcystic changes, cellular areas, and a fibrous stroma. C121953 Neoplastic Process Ovarian Microcystic Stromal Tumor C4054287 Benign Ovarian Microcystic Stromal Tumor Ovarian Microcystic Stromal Tumor An encapsulated epithelial neoplasm that arises from the kidney. It is composed of cytologically bland epithelial cells with clear cytoplasm forming tubular and papillary patterns. The nuclei are arranged linearly away from the basement membrane. Tumor necrosis, perirenal invasion, and vascular invasion are not present. The clinical course is indolent. C121955 Neoplastic Process Clear Cell Papillary Renal Tumor C4054076 Uncertain Malignant Potential Clear cell papillary renal cell carcinoma CCPRCT Clear Cell Papillary Renal Cell Carcinoma Clear Cell Papillary Renal Neoplasm Clear Cell Papillary Renal Tumor Clear Cell Tubulopapillary Renal Cell Carcinoma Renal Angiomyoadenomatous Tumor Clear Cell Papillary Renal Tumor A very rare, nonrhabdoid, intraventricular tumor with relatively favorable prognosis. It is characterized by the presence of neuroepithelial cells forming cribriform patterns, trabeculae, epithelial membrane antigen immunopositivity on epithelial surfaces, and loss of nuclear INI 1 expression. C121963 Neoplastic Process Cribriform Neuroepithelial Tumor C4053528 Undetermined CRINET Cribriform Neuroepithelial Tumor Cribriform Neuroepithelial Tumor Gene expression-based patient cluster groups in acute lymphoblastic leukemia. C121973 Neoplastic Process Acute Lymphoblastic Leukemia by Gene Expression Profile C4055498 Malignant ALL Gene Expression Cluster Subtype ALL Gene Expression Subtype ALL by Gene Expression Profile ALL by Gene Expression Signature Acute Lymphoblastic Leukemia Gene Expression Subtype Acute Lymphoblastic Leukemia by Gene Expression Profile Acute Lymphoblastic Leukemia by Gene Expression Signature Acute Lymphoblastic Leukemia by Gene Expression Profile B acute lymphoblastic leukemia characterized by a gene-expression profile similar to that of BCR-ABL1-positive B acute lymphoblastic leukemia, absence of the pathognomonic BCR-ABL1 rearrangement, alterations of lymphoid transcription factor genes, and a poor outcome. C121974 Neoplastic Process B Acute Lymphoblastic Leukemia, BCR-ABL1-Like C4054188 NICHD A subtype of high risk B cell acute lymphoblastic leukemia (ALL) in which patients have a gene-expression profile similar to that of BCR-ABL1 positive ALL, but who all lack the BCR-ABL1 fusion gene. Similar to patients with BCR-ABL1 positive ALL, patients with Ph-like ALL frequently harbor alterations in lymphoid transcription factors. This is clinically important because of the presence of kinase-activating alterations that are amenable to treatment with currently available tyrosine kinase inhibitors. This subtype occurs in 10-15% of pediatric ALL patients and increases in frequency with age. Malignant B Acute Lymphoblastic Leukemia with BCR-ABL1-Like Features B Acute Lymphoblastic Leukemia with BCR::ABL1-Like Features B Acute Lymphoblastic Leukemia, BCR-ABL1-Like B Acute Lymphoblastic Leukemia, BCR::ABL1-Like B Lymphoblastic Leukemia, Philadelphia-like B-Acute Lymphoblastic Leukemia with BCR-ABL1-Like Features B-Acute Lymphoblastic Leukemia with BCR::ABL1-Like Features B-Acute Lymphoblastic Leukemia, BCR-ABL1-Like B-Acute Lymphoblastic Leukemia, BCR::ABL1-Like B-Lymphoblastic Leukemia, Philadelphia-like BCR-ABL1-like ALL BCR-ABL1-like Acute Lymphoblastic Leukemia BCR::ABL1-like features Ph-Like Ph-Like ALL Ph-Like Acute Lymphoblastic Leukemia Ph-like ALL Philadelphia-Like Acute Lymphoblastic Leukemia Philadelphia-like ALL B Acute Lymphoblastic Leukemia, BCR-ABL1-Like A gene expression subtype of acute lymphoblastic leukemia characterized by its expression level of the DDIT4L gene. C121975 Neoplastic Process DDIT4L Acute Lymphoblastic Leukemia C4050413 Malignant DDIT4L DDIT4L ALL DDIT4L Acute Lymphoblastic Leukemia DDIT4L Acute Lymphoblastic Leukemia Unique gene expression-based patient cluster groups in high-risk B-precursor acute lymphoblastic leukemia determined by Recognition of Outliers by Sampling Ends (ROSE). C121978 Neoplastic Process Acute Lymphoblastic Leukemia by ROSE Cluster C4055497 Malignant ALL Gene Expression Cluster ALL ROSE Cluster Acute Lymphoblastic Leukemia Gene Expression Cluster Acute Lymphoblastic Leukemia ROSE Cluster Acute Lymphoblastic Leukemia by ROSE Cluster Acute Lymphoblastic Leukemia by ROSE Cluster Gene expression cluster 1 as determined by Recognition of Outliers by Sampling Ends (ROSE) in high-risk B-precursor acute lymphoblastic leukemia. C121980 Neoplastic Process ROSE Cluster 1 CL973075 Malignant R1 ROSE Cluster 1 ROSE Cluster 1 Gene expression cluster 2 as determined by Recognition of Outliers by Sampling Ends (ROSE) in high-risk B-precursor acute lymphoblastic leukemia. C121981 Neoplastic Process ROSE Cluster 2 C4050313 Malignant R2 ROSE Cluster 2 ROSE Cluster 2 Gene expression cluster 3 as determined by Recognition of Outliers by Sampling Ends (ROSE) in high-risk B-precursor acute lymphoblastic leukemia. C121982 Neoplastic Process ROSE Cluster 3 C4050314 Malignant R3 ROSE Cluster 3 ROSE Cluster 3 Gene expression cluster 4 as determined by Recognition of Outliers by Sampling Ends (ROSE) in high-risk B-precursor acute lymphoblastic leukemia. C121983 Neoplastic Process ROSE Cluster 4 C4049710 Malignant R4 ROSE Cluster 4 ROSE Cluster 4 Gene expression cluster 5 as determined by Recognition of Outliers by Sampling Ends (ROSE) in high-risk B-precursor acute lymphoblastic leukemia. C121984 Neoplastic Process ROSE Cluster 5 C4050064 Malignant R5 ROSE Cluster 5 ROSE Cluster 5 Gene expression cluster 6 as determined by Recognition of Outliers by Sampling Ends (ROSE) in high-risk B-precursor acute lymphoblastic leukemia. C121985 Neoplastic Process ROSE Cluster 6 C4054130 Malignant R6 ROSE Cluster 6 ROSE Cluster 6 Gene expression cluster 7 as determined by Recognition of Outliers by Sampling Ends (ROSE) in high-risk B-precursor acute lymphoblastic leukemia. C121986 Neoplastic Process ROSE Cluster 7 C4050315 Malignant R7 ROSE Cluster 7 ROSE Cluster 7 Gene expression cluster 8 as determined by Recognition of Outliers by Sampling Ends (ROSE) in high-risk B-precursor acute lymphoblastic leukemia. C121988 Neoplastic Process ROSE Cluster 8 C4054129 Malignant R8 ROSE Cluster 8 ROSE Cluster 8 One of a pair of major salivary glands located below the floor of the mouth. C12233 Body Part, Organ, or Organ Component Submandibular Gland Submandibular Salivary Gland CL1773628 CDISC CTDC GDC UBERON mCode Either of the paired compound tubuloalveolar (aka tubuloacinar) major salivary glands composed of both serous and mucous secretory cells and situated beneath the mandible. The salivary gland located adjacent to the mandible. Submandibular_Gland Submandibular Gland Submandibular gland UBERON:0001736 GLAND, SALIVARY, SUBMANDIBULAR Gland, Salivary, Mandibular SUBMANDIBULAR GLAND Submandibular Submandibular Gland Submandibular Salivary Gland Submandibular gland Submandibular salivary gland structure (body structure) Submaxillary Gland mandibular gland mandibular salivary gland submandibular gland submandibular salivary gland Submandibular Salivary Gland A salivary gland located under the tongue in the floor of the oral cavity. C12234 Body Part, Organ, or Organ Component Sublingual Gland Sublingual Salivary Gland C0038553 CDISC GDC UBERON mCode The salivary gland located under the tongue in the floor of the oral cavity or adjacent to the submandibular salivary gland. The small mucin-producing salivary glands in the floor of the mouth beneath the tongue, anterior to the submandibular gland. Sublingual_Salivary_Gland Sublingual Gland Sublingual gland UBERON:0001832 GLAND, SALIVARY, SUBLINGUAL Rivinus' gland SALIVARY GLAND, SUBLINGUAL Sublingual Gland Sublingual Salivary Gland Sublingual gland Sublingual gland structure (body structure) ductus sublingualis sublingual gland Sublingual Salivary Gland A non-invasive serous neoplasm that arises from the ovary and shows greater cellular proliferation and cytologic atypia as compared to benign ovarian serous tumors, but less as compared to low-grade ovarian serous carcinoma. C122584 Neoplastic Process Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor C4053505 CTRP Uncertain Malignant Potential Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor SBT/APST Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor A non-invasive serous neoplasm that arises from the ovary and shows micropapillary and/or cribriform architectural patterns. It is composed of round epithelial cells with scant cytoplasm and moderate nuclear atypia. C122585 Neoplastic Process Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma C4055371 GDC Uncertain Malignant Potential Low grade serous carcinoma Serous borderline tumor-micropapillary variant Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma A non-invasive neoplasm that arises from the ovary and is composed of gastrointestinal-type, mucin-containing epithelial cells. It shows greater cellular proliferation and cytologic atypia as compared to benign ovarian mucinous tumors. C122586 Neoplastic Process Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor C4053516 Uncertain Malignant Potential Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor MBT/APMT Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor An acute lymphoblastic or acute myeloid leukemia that occurs in infancy. C122603 Neoplastic Process Infant Leukemia C4054726 NICHD Leukemia diagnosed at less than one year of age. Malignant Infant Leukemia Leukemia in Infancy Infant Leukemia An acute lymphoblastic leukemia that occurs in infancy. C122614 Neoplastic Process Infant Acute Lymphoblastic Leukemia C4054727 NICHD Acute lymphoblastic leukemia occurring in children less than one year of age. The majority of the cases are associated with t(11q23)/MLL (Mixed Lineage Leukemia) gene rearrangements. Malignant Infant ALL Infant Acute Lymphoblastic Leukemia Infant Acute Lymphoblastic Leukemia An acute lymphoblastic leukemia with rearrangement of the KMT2A gene that occurs in infancy. C122617 Neoplastic Process Infant Acute Lymphoblastic Leukemia with KMT2A Rearrangement C4054729 Cellosaurus NICHD A type of acute lymphoblastic leukemia that is seen more frequently in infants younger than six months of age, as compared to those between six months of age and one year; it is characterized by very high white blood cell counts and increased incidence of central nervous system involvement. Malignant Infant ALL with MLL Rearrangement Infant Acute Lymphoblastic Leukemia with KMT2A Rearrangement Infant Acute Lymphoblastic Leukemia with MLL Gene Rearrangement Infant Acute Lymphoblastic Leukemia with MLL Rearrangement Infant Acute Lymphoblastic Leukemia with KMT2A Rearrangement An acute lymphoblastic leukemia without rearrangement of the KMT2A gene that occurs in infancy. C122621 Neoplastic Process Infant Acute Lymphoblastic Leukemia without KMT2A Rearrangement C4054728 NICHD Acute lymphoblastic leukemia (ALL) occurring in children less than 1 year of age; leukemic blasts show germline MLL gene configuration. Malignant Infant ALL without MLL Rearrangement Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement Infant Acute Lymphoblastic Leukemia without KMT2A Rearrangement Infant Acute Lymphoblastic Leukemia without MLL Gene Rearrangement Infant Acute Lymphoblastic Leukemia without MLL Rearrangement Infant Acute Lymphoblastic Leukemia without KMT2A Rearrangement Acute lymphoblastic leukemia that occurs in childhood and does not respond to treatment. C122624 Neoplastic Process Refractory Childhood Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia C4054085 CTRP Malignant Refractory Acute Lymphoblastic Leukemia (ALL) Refractory Childhood Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Acute myeloid leukemias that occur in childhood and do not fulfill the criteria for inclusion in the group of acute myeloid leukemias which have recurrent genetic abnormalities or myelodysplastic changes, or are therapy-related. This category includes entities classified according to the French-American-British classification scheme. C122625 Neoplastic Process Childhood Acute Myeloid Leukemia Not Otherwise Specified C4055251 NICHD Acute myeloid leukemias that occur during childhood and do not fulfill the criteria for inclusion in the group of acute myeloid leukemias that have recurrent genetic abnormalities, myelodysplastic changes, or are therapy-related. This category includes entities classified according to the French-American-British classification scheme. Malignant Childhood AML, NOS Childhood Acute Myeloid Leukemia Defined by Differentiation Childhood Acute Myeloid Leukemia Not Otherwise Specified Childhood Acute Myeloid Leukemia, NOC Childhood Acute Myeloid Leukemia, NOS Childhood Acute Myeloid Leukemia, Not Otherwise Characterized Childhood Acute Myeloid Leukemia, Not Otherwise Specified Childhood Acute Myeloid Leukemia Not Otherwise Specified An imaging method that combines in-phase and out-of-phase echoes to create water-only and fat-only images. This technique is particularly useful in abdominal imaging at 3T. C122667 Diagnostic Procedure Dixon MRI Dixon MRI C4055121 CTRP Dixon Fat-Suppression MRI Dixon MRI Dixon MRI An imaging method for the mapping of oxygen in tissues. It is based on higher solubility of oxygen in lipids than in water. By monitoring changes in the R1 relaxation rate of the lipid peak rather than those of water, estimates of variations in tissue oxygenation are obtained. C122668 Diagnostic Procedure Lipid R1 MRI Lipid R1 MRI C4049704 CTRP Lipid R1 MRI MOBILE Mapping of Oxygen by Imaging Lipids Relaxation Enhancement Lipid R1 MRI Myelodysplastic syndrome characterized by decreased cellularity in the bone marrow. C122686 Neoplastic Process Hypoplastic Myelodysplastic Syndrome C4054752 Malignant Hypocellular Myelodysplastic Syndrome Hypoplastic Myelodysplastic Syndrome MDS-h Myelodysplastic Neoplasm, Hypoplastic Hypoplastic Myelodysplastic Syndrome Acute myeloid leukemia not associated with cytogenetic abnormalities. C122687 Neoplastic Process Cytogenetically Normal Acute Myeloid Leukemia C3839868 Malignant CN-AML Cytogenetically Normal Acute Myeloid Leukemia Normal Karyotype Acute Myeloid Leukemia Cytogenetically Normal Acute Myeloid Leukemia Acute myeloid leukemia characterized by the presence of t(8;21)(q22;q22) or inv(16)(p13q22)/t(16;16)(p13;q22). These cytogenetic abnormalities result in disruption of the transcription factor CBF, which is a regulator of normal hematopoiesis. C122688 Neoplastic Process Core Binding Factor Acute Myeloid Leukemia C3839741 Malignant CBF-AML Core Binding Factor Acute Myeloid Leukemia Core Binding Factor Acute Myeloid Leukemia An acute myeloid leukemia in infancy characterized by t(7;12)(q36;p13) and fusion of the homeobox gene HLXB9 (MNX1) with the ETV6 gene. C122690 Neoplastic Process Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6 C4055493 NICHD An acute myeloid leukemia in infancy characterized by t(7;12)(q36;p13) and fusion of the homeobox gene HLXB9 with the ETV6 gene. This is seen in 3% of children with AML. Malignant AML with t(7;12)(q36;p13); HLXB9-ETV6 AML with t(7;12)(q36;p13); MNX1-ETV6 Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6 Acute Myeloid Leukemia with t(7;12)(q36;p13); MNX1-ETV6 Acute Myeloid Leukemia with t(7;12)(q36;p13); MNX1::ETV6 Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6 An acute myeloid leukemia that occurs in childhood and is characterized by the rearrangement of the NUP98 gene. C122691 Neoplastic Process Childhood Acute Myeloid Leukemia with NUP98 Rearrangement C4055248 NICHD An acute myeloid leukemia that occurs during childhood, and is characterized by the rearrangement of the NUP98 gene. Malignant Childhood AML with NUP98 Rearrangement Childhood Acute Myeloid Leukemia with NUP98 Rearrangement Childhood Acute Myeloid Leukemia with NUP98 Rearrangement An acute myeloid leukemia associated with inv(3)(q21.3q26.2) resulting in the reposition of a distal GATA2 enhancer to activate MECOM expression. It may present de novo or follow a myelodysplastic syndrome. The clinical course is aggressive. C122716 Neoplastic Process Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM C4053754 Malignant Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, EVI1 Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM(EVI1) Acute Myeloid Leukemia with inv(3)(q21.3;q26.2); GATA2::MECOM Acute Myeloid Leukemia with inv(3)(q21q26.2); RPN1-EVI1 Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM An acute myeloid leukemia associated with t(3;3)(q21.3;q26.2) resulting in the reposition of a distal GATA2 enhancer to activate MECOM expression. It may present de novo or follow a myelodysplastic syndrome. The clinical course is aggressive. C122717 Neoplastic Process Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM C4055495 CPTAC Malignant AML with inv(3)(q21;q26.2) or t(3;3) (q21;q26.2);RPNI-EVI1 Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, EVI1 Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM(EVI1) Acute Myeloid Leukemia with t(3;3)(q21.3;q26.2); GATA2::MECOM Acute Myeloid Leukemia with t(3;3)(q21;q26.2); RPN1-EVI1 Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM A duct joining the pancreas to the common bile duct to supply pancreatic juices. C12272 Body Part, Organ, or Organ Component Pancreatic Duct Pancreatic Duct C0030288 CDISC GDC A duct that conveys pancreatic secretions from the pancreas to the duodenum. Part of a system of ducts in the pancreas. Pancreatic juices containing enzymes are released into these ducts and flow into the small intestine. Pancreatic_Duct Pancreatic duct Canal of Wirsung Main Pancreatic Duct PANCREATIC DUCT Pancreatic Duct Pancreatic duct pancreatic duct Pancreatic Duct A rare acute myeloid leukemia that occurs in childhood and is characterized primarily by deletions of 5q. C122725 Neoplastic Process Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q C4055250 CTRP NICHD Childhood acute myeloid leukemia (AML) characterized primarily by deletions of 5q(-5/5q-). This subtype occurs in 2% of children with AML. Malignant Acute Myeloid Leukemia (AML) with Abnormalities of Chromosome 5q Childhood AML with Abnormalities of Chromosome 5q Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q A rare acute myeloid leukemia that occurs in childhood and is characterized by deletion of chromosome 7. C122726 Neoplastic Process Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7 Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7 C4055249 CTRP NICHD Childhood acute myeloid leukemia (AML) characterized by deletion of chromosome 7. This subgroup occurs in 4% of children with AML. Malignant Acute Myeloid Leukemia (AML) with Abnormalities of Chromosome 7 Childhood AML with Abnormalities of Chromosome 7 Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7 Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7 The skin portion of the lip that contains hair. C12291 Anatomical Structure Skin of Lip, NOS Skin of the Lip C0222101 CDISC GDC The skin portion of the lip that contains hair. Skin_of_the_Lip Skin of lip, NOS Hair Bearing Lip SKIN OF THE LIP Skin of Lip Skin of lip, NOS Skin of the Lip Skin of the Lip A diagnostic technique that uses pulsed Doppler ultrasound to measure the velocity of blood flow through the major blood vessels of the brain. C122930 Diagnostic Procedure Transcranial Doppler Ultrasonography Transcranial Doppler Ultrasonography C0206077 CTRP Non-imaging TCD TCD Transcranial Doppler Transcranial Doppler (TCD) Ultrasonography Transcranial Doppler Sonography Transcranial Doppler Ultrasonography Transcranial Doppler Ultrasound Transcranial Doppler Ultrasonography A diagnostic technique that uses pulsed Doppler ultrasound to both identify blood vessels in the brain and measure the velocity of blood flow through those vessels. It allows a more accurate estimation of stroke risk because it allows outlining of parenchymal structures and visualization of the examined vessels. C122931 Diagnostic Procedure Imaging Transcranial Doppler Ultrasonography C4054740 Imaging TCD Imaging Transcranial Doppler (iTCD) Ultrasonography Imaging Transcranial Doppler Sonography Imaging Transcranial Doppler Ultrasonography TCDI iTCD Imaging Transcranial Doppler Ultrasonography The integumentary covering of the scalp and neck. C12294 Anatomical Structure Skin of Scalp and Neck Skin of the Scalp and Neck C1522650 GDC Skin_of_the_Scalp_and_Neck Skin of scalp and neck Skin of Scalp and Neck Skin of scalp and neck Skin of the Scalp and Neck Skin of the Scalp and Neck The skin or integument surrounding the trunk of the body. C12295 Anatomical Structure Skin of Trunk Skin of the Trunk C0205031 CDISC CPTAC GDC The integument that covers the trunk of the body. Skin_of_the_Trunk Skin of trunk Skin, trunk, local SKIN OF THE TRUNK Skin of Trunk Skin of the Trunk Skin of trunk Skin, trunk, local Superficial trunk Skin of the Trunk The integumentary covering of the upper limb and shoulder region. C12296 Anatomical Structure Skin of Upper Limb and Shoulder Skin of the Upper Limb and Shoulder C0222212 GDC Skin_of_the_Upper_Limb_and_Shoulder Skin of upper limb and shoulder Skin of Upper Limb and Shoulder Skin of the Upper Limb and Shoulder Skin of upper limb and shoulder Skin of the Upper Limb and Shoulder The integumentary covering of the lower limb and hip region. C12297 Anatomical Structure Skin of Lower Limb and Hip Skin of the Lower Limb and Hip C0222268 GDC Skin_of_the_Lower_Limb_and_Hip Skin of lower limb and hip Skin of Lower Limb and Hip Skin of lower limb and hip Skin of the Lower Limb and Hip Skin of the Lower Limb and Hip A lung adenocarcinoma characterized by the presence of mildly and moderately differentiated adenocarcinoma cells across the alveolar walls with at least one focus of invasive carcinoma measuring more than 5 mm in greatest dimension. C123160 Neoplastic Process Lepidic Adenocarcinoma C4049711 CPTAC GDC Malignant Lepidic adenocarcinoma Lepidic predominant adenocarcinoma LPA Lepidic Adenocarcinoma Lepidic Predominant Adenocarcinoma Lepidic Predominant Lung Adenocarcinoma Lepidic adenocarcinoma Lepidic predominant adenocarcinoma Lepidic Adenocarcinoma A covering fold of skin, often used alone to designate the preputium penis. C12323 Anatomical Structure Prepuce Prepuce CL415279 CDISC GDC A fold of skin covering the end of the penis. Prepuce Prepuce PREPUCE Prepuce Preputium Penis Prepuce A crescent-like structure located in the upper and posterior surfaces of the testis. It consists of the efferent ductules and the duct of the epididymis. It facilitates the maturation of sperm that is produced in the testis. C12328 Body Part, Organ, or Organ Component Epididymis Epididymis C0014533 CDISC GDC PCDC UBERON A crescent-like structure located adjacent to the testis. It consists of a single highly coiled duct and is divided into 3 regions: caput (head), corpus (body) and cauda (tail). A narrow, tightly-coiled tube that is attached to each of the testicles (the male sex glands that produce sperm). Sperm cells (male reproductive cells) move from the testicles into the epididymis, where they finish maturing and are stored. The elongated structure connected to the posterior surface of the testis that transports, stores, and matures spermatozoa between testis and vas deferens. Epididymis Epididymis UBERON:0001301 EPIDIDYMIS Epididymal Epididymis epididymis Epididymis A side effect of a drug or other treatment that is serious enough to necessitate a dose modification. C123282 Finding Regimen-Limiting Toxicity C4054080 ICDC DLT Dose Limiting Toxicity Dose-Limiting Toxicity RLT Regimen-Limiting Toxicity dose limiting toxicity dose_limiting_toxicity Regimen-Limiting Toxicity A tube-like structure composed of the vas deferens and surrounding tissue layers, that runs from the abdomen to each of the testicles. C12329 Body Part, Organ, or Organ Component Spermatic Cord Spermatic Cord C0037855 GDC A cord-like structure in the male reproductive system that contains nerves, blood and lymph vessels, and the vas deferens (a coiled tube that carries sperm out of the testicle). It runs from the abdomen to the testicle, and connects to the testicle in the scrotum (external sac). Spermatic_Cord Spermatic cord Spermatic Cord Spermatic cord spermatic cord testicular cord Spermatic Cord Multiple endocrine neoplasia caused by mutation of the RET gene. It includes the following neoplastic processes: multiple endocrine neoplasia type 2A, multiple endocrine neoplasia type 2B, and hereditary thyroid gland medullary carcinoma. C123329 Neoplastic Process Multiple Endocrine Neoplasia Type 2 C4048306 CCPS Cellosaurus Undetermined Multiple Endocrine Neoplasia Type 2 Multiple Endocrine Neoplasia Type 2 A rare, low-grade carcinoma of the salivary gland with favorable clinical outcome. It usually arises from the parotid gland and less often from the minor salivary glands. It shares the same histopathologic features and molecular characteristics (ETV6 gene rearrangement) with secretory breast carcinoma. C123384 Neoplastic Process Salivary Gland Secretory Carcinoma CL512709 Malignant Mammary Analogue Secretory Carcinoma of Salivary Gland Salivary Gland MASC Salivary Gland Secretory Carcinoma Salivary Gland Secretory Carcinoma Any of the glands that secrete mucus into the urethra including the Cowper, Skene, and Littre glands. C12339 Body Part, Organ, or Organ Component Paraurethral Gland Urethral Gland CL512949 Paraurethral_Gland Urethra Gland Urethral Gland Urethral Gland Lymphomatoid granulomatosis that occurs during childhood. C123392 Neoplastic Process Childhood Lymphomatoid Granulomatosis C4055244 NICHD An Epstein-Barr virus-associated B-cell lymphoproliferative disorder in children that nearly always affects the lungs, with skin involvement in 50% of the cases. Morphologically, three grades are recognized: grade I, II, and III. Uncertain Malignant Potential Childhood Lymphomatoid Granulomatosis Childhood Lymphomatoid Granulomatosis The reemergence of lymphomatoid granulomatosis in childhood after a period of remission. C123393 Neoplastic Process Recurrent Childhood Lymphomatoid Granulomatosis C4054113 Uncertain Malignant Potential Recurrent Childhood Lymphomatoid Granulomatosis Recurrent Childhood Lymphomatoid Granulomatosis An extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue that occurs during childhood. C123394 Neoplastic Process Childhood Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue C4055247 NICHD An extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue that occurs during childhood. Malignant Childhood Extranodal Marginal Zone Lymphoma of MALT Childhood Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Childhood MALT Lymphoma Childhood MALToma Childhood Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Langerhans cell histiocytosis that occurs during childhood and involves the bone marrow, spleen, liver, or lung. C123395 Neoplastic Process Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement C4055246 NICHD Langerhans cell histiocytosis that occurs during childhood, and involves the bone marrow, spleen, liver, or lung. Undetermined Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement High Risk Childhood Langerhans Cell Histiocytosis High-Risk Childhood Langerhans Cell Histiocytosis Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement Langerhans cell histiocytosis that occurs during childhood and does not involve the bone marrow, spleen, liver, or lung. C123396 Neoplastic Process Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement C4055245 NICHD Langerhans cell histiocytosis that occurs during childhood, and which does not involve the bone marrow, spleen, liver, or lung. Undetermined Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement A spindle cell rhabdomyosarcoma occurring in children. C123397 Neoplastic Process Childhood Spindle Cell Rhabdomyosarcoma C4055242 NICHD A spindle cell rhabdomyosarcoma occurring in children. Malignant Childhood Spindle Cell Rhabdomyosarcoma Childhood Spindle Cell Rhabdomyosarcoma A periosteal osteosarcoma occurring in childhood. C123398 Neoplastic Process Childhood Periosteal Osteosarcoma C4055243 NICHD A periosteal osteosarcoma occurring during childhood. Malignant Childhood Periosteal Osteosarcoma Childhood Periosteal Osteosarcoma Paired, almond-shaped exocrine glands situated superior and posterior to each orbit of the eye that produce and secrete the watery serous component of tears. C12346 Body Part, Organ, or Organ Component Lacrimal Gland Lacrimal Gland C0022907 CDISC GDC UBERON mCode A gland that secretes tears. The lacrimal glands are found in the upper, outer part of each eye socket. The exocrine glands that produce the watery serous component of tears. The lacrimal glands are paired almond-shaped glands, located in or near the orbital region, that secrete the aqueous layer of the tear film. Lacrimal_Gland Lacrimal Gland Lacrimal gland UBERON:0001817 GLAND, LACRIMAL LACRIMAL GLAND Lacrimal Gland Lacrimal gland Lacrimal gland structure (body structure) glandula lacrimalis lacrimal gland lacrimal-preorbital gland Lacrimal Gland Axillary lymph nodes located inferolateral to the pectoralis minor. C123461 Body Part, Organ, or Organ Component Axillary Lymph Node Level I C0507880 CDISC Axillary lymph nodes located inferolateral to pectoralis minor. AXILLARY LYMPH NODE LEVEL I Axillary Lymph Node Level I Axillary Lymph Node Level I Axillary lymph nodes located posterior to the pectoralis minor. C123462 Body Part, Organ, or Organ Component Axillary Lymph Node Level II C0507881 CDISC Axillary lymph nodes located posterior to pectoralis minor. AXILLARY LYMPH NODE LEVEL II Axillary Lymph Node Level II Axillary Lymph Node Level II Axillary lymph nodes located superomedial to pectoralis minor. C123463 Body Part, Organ, or Organ Component Axillary Lymph Node Level III C0507882 CDISC Axillary lymph nodes located superomedial to pectoralis minor. AXILLARY LYMPH NODE LEVEL III Axillary Lymph Node Level III Axillary Lymph Node Level III A type of mammography that uses contrast medium to visualize the ducts of the breast. C123465 Diagnostic Procedure Ductography C0948161 CDISC A type of mammography that uses contrast medium to visualize the ducts of the breast. DUCTOGRAPHY Ductography Galactography Ductography Lymph nodes found within the head and neck region of the body, which drain into the deep cervical nodes, either directly or indirectly. These include the occipital, mastoid, parotid, facial, retropharyngeal, submandibular, submental, lingual and cervical lymph nodes. Any lymph node located in the head or neck. C12358 Body Part, Organ, or Organ Component Head and Neck Lymph Node Lymph Node of Head, Face and Neck Head and Neck Lymph Node C1185605 CTRP GDC Head_and_Neck_Lymph_Node Lymph nodes of head, face and neck Head and Neck Lymph Node Lymph Node of Head, Face and Neck Lymph Nodes of Head, Face and Neck Lymph nodes of head, face and neck Head and Neck Lymph Node Any lymph node within the thoracic cavity. C12359 Body Part, Organ, or Organ Component Intrathoracic Lymph Node Intrathoracic Lymph Node C1517562 CDISC GDC Any lymph node within the thoracic cavity. Intrathoracic_Lymph_Node Intrathoracic lymph nodes INTRATHORACIC LYMPH NODE Intra-Thoracic Lymph Node Intrathoracic Lymph Node Intrathoracic Lymph Nodes Intrathoracic lymph nodes Intrathoracic Lymph Node Any lymph node within the abdomen. C12360 Body Part, Organ, or Organ Component Intra-abdominal Lymph Node Intra-Abdominal Lymph Node C0588058 CDISC GDC Any lymph node within the abdomen. Intra-abdominal_Lymph_Node Intra-abdominal lymph nodes ABDOMINAL LYMPH NODE Intra-Abdominal Lymph Node Intra-Abdominal Lymph Nodes Intra-abdominal lymph nodes Intra-Abdominal Lymph Node Any lymph node that is located in the inguinal region or in either leg. C12362 Body Part, Organ, or Organ Component Lymph Node of Inguinal Region or Leg Lymph Node of Inguinal Region or Leg C1518054 GDC Lymph_Node_of_Inguinal_Region_or_Leg Lymph nodes of inguinal region or leg Lymph Node of Inguinal Region or Leg Lymph Nodes of Inguinal Region or Leg Lymph nodes of inguinal region or leg Lymph Node of Inguinal Region or Leg Any lymph node within the abdominal pelvic region. C12363 Body Part, Organ, or Organ Component Pelvic Lymph Node Pelvic Lymph Node CL455365 CDISC GDC UBERON mCode Any lymph node within the abdominal pelvic region. Any lymph node within the pelvic region. (NCI) Pelvic_Lymph_Node Lymph Node(s) Pelvic Pelvic Lymph Node(s) Pelvic lymph nodes Pelvis, NOS UBERON:0015876 Lymph Node(s) Pelvic PELVIC LYMPH NODE Pelvic Lymph Node Pelvic Lymph Node(s) Pelvic Lymph Nodes Pelvic lymph node group (body structure) Pelvic lymph nodes lymph node of pelvis pelvic lymph node Pelvic Lymph Node In humans, the glands of the breast, consisting of fibrous tissue connecting the lobes and fatty tissue in between the lobes. C12367 Body Part, Organ, or Organ Component Mammary Gland Mammary Gland C0929301 CDISC Glandular organ located on the chest. The mammary gland is made up of connective tissue, fat, and tissue that contains the glands that can make milk. The exocrine glands of the mammae that produce milk in females, and are composed of lobules, alveolar ducts and alveoli. Mammary_Gland ICD-O3: excludes skin of breast C44.5 GLAND, MAMMARY MAMMARY GLAND Mammary Gland mammary gland Mammary Gland An alveolar rhabdomyosarcoma characterized by the presence of chromosomal translocation t(1;13)(p36;q14) that results in PAX7-FOXO1 gene fusion; or translocation t(2;13)(q35;q14) that results in PAX3-FOXO1 gene fusion. Approximately 80% of alveolar rhabdomyosarcomas are fusion-positive. C123731 Neoplastic Process Fusion-Positive Alveolar Rhabdomyosarcoma C4054912 NICHD A subtype of alveolar rhabdomyosarcoma associated with translocations between the FOXO1 gene on chromosome 13, and either the PAX3 gene on chromosome 2 (t(2;13)(q35;q14)) or the PAX7 gene on chromosome 1 (t(1:13)(p36;q14)). Malignant Fusion Gene Positive Alveolar Rhabdomyosarcoma Fusion-Positive Alveolar Rhabdomyosarcoma Fusion-Positive Alveolar Rhabdomyosarcoma An alveolar rhabdomyosarcoma characterized by the absence of chromosomal translocation t(1;13)(p36;q14) or t(2;13)(q35;q14) and therefore the absence of PAX7-FOXO1 or PAX3-FOXO1 gene fusion. C123732 Neoplastic Process Fusion-Negative Alveolar Rhabdomyosarcoma C4054914 NICHD A subtype of alveolar rhabdomyosarcoma that is not associated with translocations of the FOXO1 gene. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. Malignant Fusion Gene Negative Alveolar Rhabdomyosarcoma Fusion-Negative Alveolar Rhabdomyosarcoma Fusion-Negative Alveolar Rhabdomyosarcoma A rhabdomyosarcoma characterized by the presence of chromosomal translocation t(1;13)(p36;q14) that results in PAX7-FOXO1 gene fusion; or translocation t(2;13)(q35;q14) that results in PAX3-FOXO1 gene fusion. C123735 Neoplastic Process Fusion-Positive Rhabdomyosarcoma C4054911 Malignant Fusion-Positive Rhabdomyosarcoma Fusion-Positive Rhabdomyosarcoma A rhabdomyosarcoma characterized by the absence of chromosomal translocation t(1;13)(p36;q14) or t(2;13)(q35;q14) and therefore the absence of PAX7-FOXO1 or PAX3-FOXO1 gene fusion. C123736 Neoplastic Process Fusion-Negative Rhabdomyosarcoma C4054913 Malignant Fusion-Negative Rhabdomyosarcoma Fusion-Negative Rhabdomyosarcoma Any of the ducts conveying bile between the liver and the intestine, including hepatic, cystic, and common bile duct. C12376 Body Part, Organ, or Organ Component Bile Duct Bile Duct C0005400 CDISC GDC UBERON A tube through which bile passes in and out of the liver. Any of the ducts conveying bile between the liver and the intestine, including hepatic, cystic, and common bile duct. Any of the ducts that form the biliary tree, carrying bile from the liver to the small intestine. Bile_Duct Bile Duct UBERON:0002394 BILE DUCT Bile Duct DUCT, BILE bile duct Bile Duct A pear-shaped organ located under the liver that stores and concentrates bile secreted by the liver. From the gallbladder the bile is delivered through the bile ducts into the intestine thereby aiding the digestion of fat-containing foods. C12377 Body Part, Organ, or Organ Component Gall Bladder Gallbladder C0016976 CDISC GDC PCDC UBERON mCode A sac-like organ located adjacent to the liver that stores and concentrates bile produced by the liver. An organ that aids digestion and stores bile produced by the liver. The pear-shaped organ found below the liver. Bile is concentrated and stored in the gallbladder. Gallbladder Gallbladder UBERON:0002110 GALLBLADDER Gallbladder Gallbladder / Biliar Gallbladder structure (body structure) Gastrointestinal Tract, Gall Bladder cholecyst gall bladder gallbladder Gallbladder An immature teratoma that arises from the testis and occurs in children. C123835 Neoplastic Process Childhood Testicular Immature Teratoma C4086173 NICHD An immature teratoma that arises from the testis during childhood. Undetermined Childhood Testicular Immature Teratoma Childhood Testicular Immature Teratoma A mature teratoma that arises from the testis and occurs in children. C123837 Neoplastic Process Childhood Testicular Mature Teratoma C4086174 NICHD A mature teratoma that arises from the testis during childhood. Benign Childhood Testicular Mature Teratoma Childhood Testicular Mature Teratoma A nongerminomatous germ cell tumor that arises in the ovary and occurs in children. C123842 Neoplastic Process Childhood Ovarian Nongerminomatous Germ Cell Tumor C4086168 NICHD A non-germinomatous germ cell tumor that arises from the ovary during childhood. Undetermined Childhood Ovarian Non-Germinomatous Germ Cell Tumor Childhood Ovarian Nongerminomatous Germ Cell Tumor Childhood Ovarian Nongerminomatous Germ Cell Tumor A non-seminomatous germ cell tumor that arises in the testis and occurs in children. C123843 Neoplastic Process Childhood Testicular Non-Seminomatous Germ Cell Tumor C4086175 NICHD A non-seminomatous germ cell tumor that arises from the testis during childhood. Undetermined Childhood Testicular Non-Germinomatous Germ Cell Tumor Childhood Testicular Non-Seminomatous Germ Cell Tumor Childhood Testicular Non-Seminomatous Germ Cell Tumor A mixed germ cell tumor that arises from the ovary and occurs in children. C123849 Neoplastic Process Childhood Ovarian Mixed Germ Cell Tumor C4086167 NICHD A mixed germ cell tumor that arises from the ovary during childhood. Malignant Childhood Ovarian Mixed Germ Cell Tumor Childhood Ovarian Mixed Germ Cell Tumor The portion of the digestive canal between the pharynx and stomach. It is about 25 cm long and consists of three parts: the cervical part, from the cricoid cartilage to the thoracic inlet; thoracic part, from thoracic inlet to the diaphragm; and abdominal part, below the diaphragm to the cardiac opening of the stomach. C12389 Body Part, Organ, or Organ Component Esophagus Esophagus C0014876 CDISC GDC PCDC UBERON mCode The muscular tube through which food passes from the throat to the stomach. The portion of the digestive tract between the pharynx and stomach. Tube that connects the pharynx to the stomach. In mammals, the esophagus connects the buccal cavity with the stomach. The stratified squamous non-keratinized epithelium lining the buccal cavity is continued through the pharynx down into the esophagus. The lowest part of the esophagus (ca. 2 cm) is lined with gastric mucosa and covered by peritoneum. The main body of the esophagus is lined with small, simple mucous glands. Each gland opens into the lumen by a long duct which pierces the muscularis mucosae (Wilson and Washington, 1989). A sphincter is situated at the point where the esophagus enters the stomach to prevent gastro-esophageal reflux, i.e. to prevent acidic gastric contents from reaching stratified epithelia of the esophagus, where they can cause inflammation and irritation (Wilson and Washington, 1989; Brown et al., 1993). Esophagus Esophagus Esophagus, NOS UBERON:0001043 ESOPHAGUS Esophageal structure (body structure) Esophagus Esophagus, NOS Gastrointestinal Tract, Esophagus Oesophagus esophagus gullet Esophagus A papillary thyroid gland carcinoma occurring during childhood. C123903 Neoplastic Process Childhood Thyroid Gland Papillary Carcinoma C4086178 NICHD A papillary thyroid gland carcinoma occurring during childhood. Malignant Childhood Papillary Thyroid Carcinoma Childhood Thyroid Gland Papillary Carcinoma Childhood Thyroid Gland Papillary Carcinoma A follicular thyroid gland carcinoma occurring in childhood. C123904 Neoplastic Process Childhood Thyroid Gland Follicular Carcinoma C4086176 NICHD A follicular thyroid carcinoma occurring during childhood. Malignant Childhood Follicular Thyroid Carcinoma Childhood Thyroid Gland Follicular Carcinoma Childhood Thyroid Gland Follicular Carcinoma A medullary thyroid gland carcinoma occurring in childhood. C123905 Neoplastic Process Childhood Thyroid Gland Medullary Carcinoma C4086177 NICHD A medullary thyroid carcinoma occurring during childhood. Malignant Childhood Medullary Thyroid Carcinoma Childhood Thyroid Gland Medullary Carcinoma Childhood Thyroid Gland Medullary Carcinoma A gastrointestinal stromal tumor (GIST) occurring in childhood. Pediatric GISTs differ biologically from adult GISTs in that only 11% of pediatric GISTs have activating mutations of KIT and PDGFRA. C123906 Neoplastic Process Childhood Gastrointestinal Stromal Tumor Childhood Gastrointestinal Stromal Tumor C4086159 CTRP NICHD A gastrointestinal stromal tumor occurring during childhood. Pediatric GIST differ biologically from adult GIST in that only 11% of pediatric GIST have activating mutations of KIT and PDGFRA. Undetermined Childhood GIST Childhood Gastrointestinal Stromal Tumor Gastrointestinal Stromal Tumor (GIST) Childhood Gastrointestinal Stromal Tumor A malignant neoplasm that affects the kidney and occurs in childhood. C123907 Neoplastic Process Childhood Malignant Kidney Neoplasm C4086162 NICHD A malignant renal tumor occurring during childhood. Malignant Childhood Malignant Kidney Neoplasm Childhood Malignant Kidney Tumor Childhood Malignant Renal Neoplasm Childhood Malignant Renal Tumor Childhood Malignant Kidney Neoplasm The primary organ of food digestion. It is located under the diaphragm, between the liver and the spleen as well as between the esophagus and the small intestine. C12391 Body Part, Organ, or Organ Component Stomach Stomach C0038351 CDISC CPTAC CTDC GDC PCDC UBERON mCode An expanded region of the vertebrate alimentary tract that serves as a food storage compartment and digestive organ. A stomach is lined, in whole or in part by a glandular epithelium. An organ that is part of the digestive system. It helps in the digestion of food by mixing it with digestive juices and churning it into a thin liquid. The portion of the gastrointestinal tract located between the esophagus and the proximal duodenum. Stomach Stomach Stomach, NOS UBERON:0000945 Gastric Gastrointestinal Tract, Stomach STOMACH Stomach Stomach structure (body structure) Stomach, NOS stomach Stomach A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate. C12392 Body Part, Organ, or Organ Component Liver Liver C0023884 CDISC CPTAC CTDC GDC PCDC UBERON mCode A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile. An abdominal organ that has variable lobation which are composed mainly of hepatic lobules. An exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes. Liver Liver UBERON:0002107 Body System, Hepatic Gastrointestinal Tract, Liver Hepatic Body System Hepatic Organ System LIVER Liver Liver structure (body structure) Organ System, Hepatic liver Liver An organ behind the lower part of the stomach that is the shape of a fish and about the size of a hand. It is a compound gland composed of both exocrine and endocrine tissues. The endocrine pancreas makes insulin so that the body can use glucose (sugar) for energy. The exocrine pancreas makes enzymes that help the body digest food. Spread all over the pancreas are areas called the Islets of Langerhans. The cells in these areas each have a special purpose. The alpha cells make glucagon, which raises the level of glucose in the blood; the beta cells make insulin; the delta cells make somatostatin. There are also PP cells and D1 cells, about which little is known. C12393 Body Part, Organ, or Organ Component Pancreas Pancreas C0030274 CDISC GDC PCDC UBERON mCode A digestive organ in the abdomen that has both endocrine and exocrine functions. A glandular organ located in the abdomen. It makes pancreatic juices, which contain enzymes that aid in digestion, and it produces several hormones, including insulin. The pancreas is surrounded by the stomach, intestines, and other organs. An endoderm derived structure that produces precursors of digestive enzymes and blood glucose regulating hormones. Pancreas Pancreas Pancreas, NOS UBERON:0001264 Gastrointestinal Tract, Pancreas PANCREAS Pancreas Pancreas, NOS Pancreatic structure (body structure) pancreas Pancreas A small intestinal leiomyosarcoma occurring in childhood. C123932 Neoplastic Process Childhood Small Intestinal Leiomyosarcoma C4086172 NICHD A small intestinal leiomyosarcoma occurring during childhood. Malignant Childhood Small Intestinal Leiomyosarcoma Childhood Small Intestine Leiomyosarcoma Childhood Small Intestinal Leiomyosarcoma A small intestinal carcinoma occurring in childhood. C123933 Neoplastic Process Childhood Small Intestinal Carcinoma Childhood Small Intestinal Carcinoma C4086171 CTRP NICHD A small intestinal carcinoma occurring during childhood. Malignant Childhood Small Intestinal Carcinoma Small Intestinal Cancer Childhood Small Intestinal Carcinoma A sense organ needed for the detection of sound and for establishing balance. The outer ear consists of the auricle, the ear canal as well as the tympanic membrane. The middle ear is made up of an air-filled cavity behind the tympanic membrane that contains the ossicles (malleus, incus and stapes). The inner ear is made up of the cochlea needed for hearing and the vestibular apparatus required for balance. C12394 Body Part, Organ, or Organ Component Ear Ear C0013443 CDISC GDC UBERON mCode A sensory organ that contains auditory and vestibular apparatuses. Sense organ in vertebrates that is specialized for the detection of sound, and the maintenance of balance. Includes the outer ear and middle ear, which collect and transmit sound waves; and the inner ear, which contains the organs of balance and (except in fish) hearing. Also includes the pinna, the visible part of the outer ear, present in some mammals. Ear Ear IMDRF:E09 UBERON:0001690 EAR Ear Ear structure (body structure) ear Ear A small endocrine gland in the brain, situated beneath the back part of the corpus callosum, that secretes melatonin. C12398 Body Part, Organ, or Organ Component Pineal Gland Pineal Gland C0031939 CDISC GDC PCDC UBERON mCode A midline, cone like structure located in the dorso-caudal roof of the 3rd ventricle, attached by peduncles to the habenular and posterior commissures. The stalk contains nerve fibers, blood vessels, connective tissue and parenchymal cells (Paxinos, The Rat Central Nervous System, 2nd ed, pg 399). A small endocrine gland that arises from the central posterior aspect of the diencephalon. A tiny organ in the cerebrum that produces melatonin. Pineal_Gland Pineal Pineal Gland Pineal gland UBERON:0001905 GLAND, PINEAL PINEAL GLAND Pineal Pineal Body Pineal Gland Pineal gland Pineal structure (body structure) corpus pineale glandula pinealis pineal body pineal gland pineal organ Pineal Gland Pea-sized endocrine gland located at the base of the brain in the pituitary fossa. It produces and secretes hormones such as oxytocin and vasopressin, to regulate the activities of the hypothalamus. C12399 Body Part, Organ, or Organ Component Pituitary Gland Pituitary Gland C0032005 CDISC GDC UBERON mCode A small endocrine gland extending from the hypothalamus at the base of the brain. An endocrine gland located ventral to the diencephalon and derived from mixed neuroectodermal and non neuroectodermal origin. The main endocrine gland. It produces hormones that control other glands and many body functions, especially growth. Pituitary_Gland Pituitary Gland Pituitary gland UBERON:0000007 GLAND, PITUITARY Hypophysis Hypophysis Cerebri Nervous System, Pituitary PITUITARY GLAND Pituitary Pituitary Gland Pituitary gland Pituitary structure (body structure) glandula pituitaria pituitary pituitary body pituitary gland Pituitary Gland An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control. C12400 Body Part, Organ, or Organ Component Thyroid Thyroid Gland C0040132 CDISC CPTAC GDC PCDC UBERON mCode A gland located beneath the larynx (voice box) that makes thyroid hormone and calcitonin. The thyroid gland helps regulate growth and metabolism. A two-lobed endocrine gland found in all vertebrates, located in front of and on either side of the trachea in humans, and producing various hormones, such as triiodothyronine and calcitonin. Endocrine gland(s) adjacent to the trachea in mammals that produce thyroxine and other hormones. Thyroid_Gland Thyroid Thyroid gland UBERON:0002046 GLAND, THYROID Head and Neck, Thyroid THYROID GLAND Thyroid Thyroid Gland Thyroid gland Thyroid structure (body structure) Total Thyroid thyroid thyroid gland Thyroid Gland The organ of sight or vision. C12401 Body Part, Organ, or Organ Component Eye Eye C0015392 CDISC GDC UBERON mCode An organ that detects light. Having to do with the eye. The sensory organ of vision. Eye Eye Eye, NOS IMDRF:E08 UBERON:0000970 EYE Eye Eye, NOS Eyeball Ocular Ophthalmic Optic Structure of eye proper (body structure) eye ophthalmic Eye One of a pair of tubes that extend from the uterus to each of the ovaries. Following ovulation the egg travels down the fallopian tube to the uterus where fertilization may or may not occur. C12403 Body Part, Organ, or Organ Component Fallopian Tube Fallopian Tube C0015560 CDISC GDC PCDC UBERON A slender tube through which eggs pass from an ovary to the uterus. In the female reproductive tract, there is one ovary and one fallopian tube on each side of the uterus. Initial section of the oviduct through which the ova pass from the ovary to the uterus. The tube through which eggs pass from an ovary. Fallopian_Tube Fallopian Tube Fallopian Tube, NOS Fallopian tube UBERON:0003889 FALLOPIAN TUBE Fallopian Tube Fallopian Tube, NOS Fallopian Tubes Fallopian tube OVIDUCT Oviduct fallopian tube mammalian oviduct uterine tube Fallopian Tube One of the paired female reproductive glands containing the ova or germ cells; the ovary's stroma is a vascular connective tissue containing numbers of ovarian follicles enclosing the ova. C12404 Body Part, Organ, or Organ Component Ovary Ovary C0029939 CDISC GDC PCDC UBERON mCode The female gonad. The gonad of a female organism which contains germ cells. The pair of female reproductive glands in which the ova, or eggs, are formed. The ovaries are located in the pelvis, one on each side of the uterus. Ovary Ovary Ovary, NOS UBERON:0000992 Genital System, Female, Ovary OVARY Ovarian structure (body structure) Ovaries Ovary Ovary, NOS animal ovary female gonad female organism genitalia gonad female organism genitalia gonada female organism reproductive system gonad female organism reproductive system gonada female reproductive system gonad female reproductive system gonada genitalia of female organism gonad genitalia of female organism gonada gonad of female organism genitalia gonad of female organism reproductive system gonad of female reproductive system gonad of genitalia of female organism gonad of reproductive system of female organism gonada of female organism genitalia gonada of female organism reproductive system gonada of female reproductive system gonada of genitalia of female organism gonada of reproductive system of female organism ovary ovum-producing ovary reproductive system of female organism gonad reproductive system of female organism gonada Ovary A hollow, thick-walled, muscular organ located within the pelvic cavity of a woman. Within the uterus the fertilized egg implants and the fetus develops during pregnancy. C12405 Body Part, Organ, or Organ Component Uterus Uterus C0042149 CDISC CPTAC GDC PCDC UBERON mCode A hollow muscular organ within which the fertilized egg implants and the embryo/fetus develops during pregnancy. The female muscular organ of gestation in which the developing embryo or fetus is nourished until birth. The small, hollow, pear-shaped organ in a woman's pelvis. This is the organ in which a fetus develops. Uterus Uterus Uterus, NOS UBERON:0000995 Genital System, Female, Uterus UTERUS Uterine Uterine structure (body structure) Utero Uterus Uterus, NOS Womb uterus womb Uterus A uterus containing one or more viable embryos or fetuses. C12406 Body Part, Organ, or Organ Component Pregnant Uterus Pregnant Uterus C1514389 Pregnant_Uterus Pregnant Uterus Pregnant Uterus The female genital canal, extending from the uterus to the vulva. C12407 Body Part, Organ, or Organ Component Vagina Vagina C0042232 CDISC GDC PCDC UBERON mCode A fibromuscular tubular tract leading from the uterus to the exterior of the body in female placental mammals and marsupials, or to the cloaca in female birds, monotremes, and some reptiles. The female genital canal, extending from the uterus to the vulva. (NCI) The muscular canal extending from the uterus to the exterior of the body. Vagina Vagina Vagina, NOS UBERON:0000996 Genital System, Female, Vagina VAGINA Vagina Vagina, NOS Vaginal structure (body structure) birth canal vagina Vagina The external, visible part of the female genitalia surrounding the urethral and vaginal opening. The vulva includes the clitoris and inner as well as outer labia. C12408 Body Part, Organ, or Organ Component Vulva Vulva C0042993 CDISC GDC PCDC UBERON mCode External genital organs of the female mammal. The external female genital organs, including the clitoris, vaginal lips, and the opening to the vagina. The external, visible part of the female genitalia surrounding the urethral and vaginal opening(s). Vulva Vulva Vulva, NOS UBERON:0000997 External Genitalia VULVA Vulva Vulva, NOS Vulval structure (body structure) female pudendum mammalian vulva puboperineal region pudendum femininum vulva Vulva The male organ of urination and copulation. C12409 Body Part, Organ, or Organ Component Penis Penis C0030851 CDISC GDC PCDC UBERON mCode An external male reproductive organ. It contains a tube called the urethra, which carries semen and urine to the outside of the body. An intromittent organ in certain biologically male organisms. In placental mammals, this also serves as the organ of urination. The male organ of urination and copulation. (NCI) Penis Penis Penis, NOS UBERON:0000989 Genital System, Male, Penis PENIS Penile structure (body structure) Penis Penis, NOS penis Penis The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen. C12410 Body Part, Organ, or Organ Component Prostate Prostate Gland C0033572 CDISC CPTAC GDC PCDC UBERON mCode A gland in the male reproductive system. The prostate surrounds the part of the urethra (the tube that empties the bladder) just below the bladder, and produces a fluid that forms part of the semen. The male reproductive accessory gland that produces prostatic fluid and is located adjacent to or around the urethra distal to the urinary bladder in mammals. The prostate gland is a partly muscular, partly glandular body that is situated near the base of the mammalian male urethra and secretes an alkaline viscid fluid which is a major constituent of the ejaculatory fluid. Prostate_Gland Prostate Prostate gland UBERON:0002367 GLAND, PROSTATE Genital System, Male, Prostate PROSTATE GLAND Prostate Prostate Gland Prostate gland Prostatic Gland Prostatic structure (body structure) male prostate prostate prostate gland Prostate Gland Either of the paired male reproductive glands that produce the male germ cells and the male hormones. C12412 Body Part, Organ, or Organ Component Testis Testis C0039597 CDISC CTDC GDC PCDC UBERON mCode A gonad of a male animal. A gonad produces and releases sperm. One of two egg-shaped glands inside the scrotum that produce sperm and male hormones. The male gonad. Testis Testes Testis Testis, NOS UBERON:0000473 Genital System, Male, Testis TESTIS Testes Testicle Testicles Testis Testis structure (body structure) Testis, NOS gonad of male genitalia gonad of male reproductive system male gonad testicle testis Testis A pineal parenchymal tumor of intermediate differentiation that occurs during childhood. C124137 Neoplastic Process Childhood Pineal Parenchymal Tumor of Intermediate Differentiation C4086169 NICHD A pineal parenchymal tumor of intermediate differentiation that occurs during childhood. Undetermined Childhood Pineal Parenchymal Tumor of Intermediate Differentiation Childhood Pineal Parenchymal Tumor of Intermediate Differentiation The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra. C12414 Body Part, Organ, or Organ Component Bladder Bladder C0005682 CDISC CPTAC GDC PCDC UBERON mCode Distensible musculomembranous organ situated in the anterior part of the pelvic cavity in which urine collects before excretion. The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra. (NCI) The organ that stores urine. Bladder Bladder Bladder, NOS UBERON:0001255 BLADDER Bladder Bladder, NOS URINARY BLADDER Urinary Bladder Urinary System, Bladder Urinary bladder structure (body structure) bladder urinary bladder vesica urinaria Bladder One of the two bean-shaped organs located on each side of the spine in the retroperitoneum. The right kidney is located below the liver and the left kidney below the diaphragm. The kidneys filter and secrete metabolic products and minerals from the blood, thus maintaining homeostasis. On the superior pole of each kidney there is an adrenal gland. Each kidney and adrenal gland is surrounded by fat. C12415 Body Part, Organ, or Organ Component Kidney Kidney C0022646 CDISC CPTAC CTDC GDC PCDC UBERON mCode A paired organ of the urinary tract which has the production of urine as its primary function. One of a pair of organs in the abdomen. Kidneys remove waste from the blood (as urine), produce erythropoietin (a substance that stimulates red blood cell production), and play a role in blood pressure regulation. The organs of the urinary tract located in the retroperitoneal cavity adjacent to the spine and composed of the renal cortex and the renal medulla. Kidney Kidney Kidney, NOS Renal UBERON:0002113 KIDNEY Kidney Kidney structure (body structure) Kidney, NOS Kidneys Urinary System, Kidney kidney Kidney The thick-walled tube that carries urine from each kidney to the bladder. C12416 Body Part, Organ, or Organ Component Ureter Ureter C0041951 CDISC GDC PCDC UBERON mCode Muscular duct that propels urine from the kidneys to the urinary bladder, or related organs. The tube that carries urine from the kidney to the bladder. The tube that extends from each kidney to the urinary bladder. Ureter Ureter UBERON:0000056 URETER Ureter Ureteric structure (body structure) ureter Ureter The tube carrying urine from the bladder to outside of the body. C12417 Body Part, Organ, or Organ Component Urethra Urethra C0041967 CDISC GDC UBERON mCode The fibromuscular tubular canal through which urine is discharged from the bladder to the exterior via the external urinary meatus; in males, the urethra is joined by the ejaculatory ducts and serves as a passageway for semen during ejaculation, as well as a canal for urine during voiding; in females, the urethra is shorter and emerges above the vaginal opening. The tube that extends from the urinary bladder to the urethral opening. The tube through which urine leaves the body. It empties urine from the bladder. Urethra Urethra UBERON:0000057 URETHRA Urethra Urethral structure (body structure) urethra Urethra The muscular organ located in the floor of the mouth and serving as the principal organ of taste and modification of the voice in speech. C12422 Body Part, Organ, or Organ Component Tongue Tongue C0040408 CDISC CPTAC GDC UBERON mCode A muscular organ in the floor of the mouth. The muscular organ in the mouth used in taste perception and food ingestion. Tongue Tongue Tongue, NOS UBERON:0001723 Entire tongue (body structure) TONGUE Tongue Tongue structure (body structure) Tongue, NOS tongue Tongue An exocrine gland that secretes saliva. Salivary glands are mostly located in and around the oral cavity. C12426 Body Part, Organ, or Organ Component Salivary Gland Salivary Gland C0036098 CDISC GDC PCDC A gland in the mouth that produces saliva. Any number of exocrine glands that secrete saliva into the oral cavity. Salivary_Gland Major salivary gland, NOS Salivary Gland Salivary gland ICDO3: excludes minor salivary gland, NOS C06.9 GLAND, SALIVARY Head and Neck, Salivary Glands Major salivary gland, NOS SALIVARY GLAND Salivary Gland Salivary Glands salivary gland Salivary Gland A myxopapillary ependymoma that occurs during childhood. C124269 Neoplastic Process Childhood Myxopapillary Ependymoma C4087096 NICHD A myxopapillary ependymoma that occurs during childhood. Undetermined Childhood Myxopapillary Ependymoma Childhood Myxopapillary Ependymoma The largest of the three paired salivary glands, located in front of the ear. C12427 Body Part, Organ, or Organ Component Parotid Parotid Gland C0030580 CDISC CTDC GDC UBERON mCode The parotid gland is the largest of the salivary glands. It is found wrapped around the mandibular ramus, and it secretes saliva through Stensen's duct into the oral cavity, to facilitate mastication and swallowing. [WP,unvetted]. The salivary gland located adjacent to the ear. Parotid_Gland Parotid Gland Parotid gland UBERON:0001831 GLAND, SALIVARY, PAROTID PAROTID GLAND Parotid Parotid Gland Parotid Salivary Gland Parotid gland Parotid gland structure (body structure) parotid parotid gland Parotid Gland A neuroblastoma that occurs during childhood. C124270 Neoplastic Process Childhood Neuroblastoma Childhood Neuroblastoma C4086165 CTRP NICHD A neuroblastoma that occurs during childhood. Malignant Childhood Neuroblastoma Neuroblastoma Childhood Neuroblastoma A ganglioneuroblastoma that occurs during childhood. C124271 Neoplastic Process Childhood Ganglioneuroblastoma Childhood Ganglioneuroblastoma C4086158 CTRP NICHD A ganglioneuroblastoma that occurs during childhood. Malignant Childhood Ganglioneuroblastoma Ganglioneuroblastoma Childhood Ganglioneuroblastoma A central nervous system ganglioneuroblastoma that occurs during childhood. C124272 Neoplastic Process Childhood Central Nervous System Ganglioneuroblastoma Childhood Central Nervous System Ganglioneuroblastoma CL502654 CTRP Malignant Central Nervous System Ganglioneuroblastoma Childhood Central Nervous System Ganglioneuroblastoma Childhood Cerebral Ganglioneuroblastoma Childhood Central Nervous System Ganglioneuroblastoma An intermixed ganglioneuroblastoma that occurs during childhood. C124273 Neoplastic Process Childhood Ganglioneuroblastoma, Intermixed C4087006 NICHD An intermixed ganglioneuroblastoma that occurs during childhood. Malignant Childhood Ganglioneuroblastoma, Intermixed Childhood Intermixed Ganglioneuroblastoma Childhood Ganglioneuroblastoma, Intermixed A nodular ganglioneuroblastoma that occurs during childhood. C124274 Neoplastic Process Childhood Ganglioneuroblastoma, Nodular C4086157 NICHD A nodular ganglioneuroblastoma that occurs during childhood. Malignant Childhood Ganglioneuroblastoma, Nodular Childhood Nodular Ganglioneuroblastoma Childhood Ganglioneuroblastoma, Nodular An astrocytoma that occurs during childhood. C124275 Neoplastic Process Childhood Astrocytoma Childhood Astrocytoma CL413560 CTRP NICHD An astrocytoma that occurs during childhood. Undetermined Astrocytoma Childhood Astrocytoma Childhood Astrocytoma The fibrocartilaginous, mucous-lined tube passing from the larynx to the bronchi. C12428 Body Part, Organ, or Organ Component Trachea Trachea C0040578 CDISC GDC PCDC UBERON mCode The airway that leads from the larynx (voice box) to the bronchi (large airways that lead to the lungs). The fibrocartilaginous tube extending from the larynx to the bronchi. The trachea is the portion of the airway that attaches to the bronchi as it branches. Trachea Trachea UBERON:0003126 TRACHEA Trachea Tracheal structure (body structure) Windpipe cartilaginous trachea trachea vertebrate trachea windpipe Trachea An atypical choroid plexus papilloma that occurs during childhood. C124291 Neoplastic Process Childhood Atypical Choroid Plexus Papilloma C4086153 NICHD An atypical choroid plexus papilloma that occurs during childhood. Undetermined Childhood Atypical Choroid Plexus Papilloma Childhood Atypical Choroid Plexus Papilloma A choroid plexus carcinoma that occurs during childhood. C124292 Neoplastic Process Childhood Choroid Plexus Carcinoma C0280623 NICHD A choroid plexus carcinoma that occurs during childhood. Malignant Childhood Choroid Plexus Carcinoma Childhood Choroid Plexus Carcinoma An anaplastic ependymoma that occurs during childhood. C124293 Neoplastic Process Childhood Anaplastic Ependymoma Childhood Anaplastic Ependymoma C4086151 CTRP NICHD An anaplastic ependymoma that occurs during childhood. Malignant Anaplastic Ependymoma Childhood Anaplastic Ependymoma Childhood Anaplastic Ependymoma The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes. C12431 Body Part, Organ, or Organ Component Bone Marrow Bone Marrow C0005953 CDISC CPTAC CTDC GDC PCDC UBERON mCode The soft tissue that fills the cavities of bones. The soft, sponge-like tissue in the center of most bones. It produces white blood cells, red blood cells, and platelets. The tissue occupying the spaces of some bones. It consists of blood vessel sinuses and a network of hematopoietic cells. Bone_Marrow Bone Marrow Bone marrow UBERON:0002371 BONE MARROW Bone Marrow Bone marrow Bone marrow structure (body structure) Marrow Reticuloendothelial System, Bone Marrow bone marrow medulla ossea medulla ossium Bone Marrow An organ that is part of the hematopoietic and immune systems. It is composed of the white pulp and the red pulp and is surrounded by a capsule. It is located in the left hypochondriac region. Its functions include lymphocyte production, blood cell storage, and blood cell destruction. C12432 Body Part, Organ, or Organ Component Spleen Spleen C0037993 CDISC GDC PCDC UBERON mCode An abdominal organ that is part of the hematopoietic and immune systems. It is composed of the white pulp and the red pulp and is surrounded by a capsule. An organ that is part of the lymphatic system. The spleen produces lymphocytes, filters the blood, stores blood cells, and destroys old blood cells. It is located on the left side of the abdomen near the stomach. The organ that functions to filter blood and to store red corpuscles and platelets. Spleen Spleen UBERON:0002106 Reticuloendothelial System, Spleen SPLEEN Spleen Splenic Splenic structure (body structure) spleen splenic Spleen A bi-lobed organ surrounded by a connective tissue capsule. It is located in the upper anterior portion of the chest, behind the sternum. It is composed predominantly of lymphocytes and fewer epithelial cells. Connective tissue septa separate the lobes into lobules. The lobules contain an outer portion (cortical zone) which is rich in lymphocytes and an inner portion (medullary zone) which is rich in epithelial cells. It is an organ essential for the development of the immune system. Its function is the maturation of the progenitor lymphoid cells to thymocytes and subsequently to mature T-cells. It reaches its greatest weight at puberty and subsequently begins to involute. C12433 Body Part, Organ, or Organ Component Thymus Gland Thymus Gland C0040113 CDISC GDC PCDC UBERON mCode A primary lymphoid organ generally located in the mediastinum near the thoracic inlet and/or along lateral aspects of the neck. An organ that is part of the lymphatic system, in which T lymphocytes grow and multiply. The thymus is in the chest behind the breastbone. Anatomical structure of largely lymphoid tissue that functions in cell-mediated immunity by being the site where T cells develop. Thymus_Gland Thymus UBERON:0002370 Reticuloendothelial System, Thymus THYMUS THYMUS GLAND Thymus Thymus Gland Thymus gland structure (body structure) thymus thymus gland thymus organ Thymus Gland An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium. C12439 Body Part, Organ, or Organ Component Brain Brain C0006104 CDISC CPTAC CTDC DIPG/DMG GDC PCDC UBERON mCode An organ composed of gray and white matter that is the center for intelligence and reasoning. It is protected by the bony cranium. The brain is the center of the nervous system in all vertebrate, and most invertebrate, animals. Some primitive animals such as jellyfish and starfish have a decentralized nervous system without a brain, while sponges lack any nervous system at all. In vertebrates, the brain is located in the head, protected by the skull and close to the primary sensory apparatus of vision, hearing, balance, taste, and smell. Brain Brain Brain, NOS UBERON:0000955 BRAIN Brain Brain structure (body structure) Brain, NOS CNS-Brain Nervous System, Brain brain Brain The elongated, approximately cylindrical part of the central nervous system of vertebrates that lies in the vertebral canal and from which the spinal nerves emerge. C12464 Body Part, Organ, or Organ Component Spinal Cord Spinal Cord C0037925 CDISC DIPG/DMG GDC PCDC UBERON mCode A column of nerve tissue that runs from the base of the skull down the back. It is surrounded by three protective membranes, and is enclosed within the vertebrae (back bones). The spinal cord and the brain make up the central nervous system, and spinal cord nerves carry most messages between the brain and the rest of the body. Part of the central nervous system located in the vertebral canal continuous with and caudal to the brain; demarcated from brain by plane of foramen magnum. It is composed of an inner core of gray matter in which nerve cells predominate, and an outer layer of white matter in which myelinated nerve fibers predominate, and surrounds the central canal. The portion of the central nervous system that lies within the vertebral canal and from which the spinal nerves emerge. Spinal_Cord Spinal Cord Spinal cord UBERON:0002240 Medulla Spinalis SPINAL CORD Spinal Cord Spinal cord Spinal cord structure (body structure) spinal cord Spinal Cord One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. C12468 Body Part, Organ, or Organ Component Lung Lung C0024109 CDISC CPTAC CTDC GDC PCDC UBERON mCode A thoracic organ that has variable lobation and is the primary respiratory organ of mammals. One of a pair of organs in the chest that supplies the body with oxygen, and removes carbon dioxide from the body. Respiration organ that develops as an outpocketing of the esophagus. Lung Lung Lung, NOS UBERON:0002048 LUNG Lung Lung structure (body structure) Lung, NOS Lungs Respiratory System, Lung lung pulmo Lung An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages. C12470 Body Part, Organ, or Organ Component Skin Skin C1123023 CDISC CTDC FDA GDC PCDC UBERON mCode An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages. (NCI) The organ covering the body that consists of the dermis and epidermis. Skin Skin Skin, NOS Skin, total ICDO3: excludes skin of vulva C51._, skin of penis C60.9, skin of scrotum C63.2 UBERON:0000014 UBERON:0002097 Human Skin Integument SKIN Skin Skin structure (body structure) Skin, NOS Skin, total entire skin skin of body skin organ Skin Positron emission tomography imaging collected over time. It is designed to capture the internal movement of organs and the metabolism of the tumor. It creates the most complete and accurate information on the tumor and provides information how the tumor moves with breathing and other body motions. C125609 Diagnostic Procedure 4D PET Scan 4D PET Scan C4085919 CTRP 4D Gated PET 4D Gated PET Scan 4D PET 4D PET Scan 4D PET Scan The reemergence of acute myeloid leukemia, myelodysplasia-related after a period of remission. C125715 Neoplastic Process Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes Recurrent Acute Myeloid Leukemia, Myelodysplasia-Related C4086782 CTRP Malignant Recurrent Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes Recurrent Acute Myeloid Leukemia, Myelodysplasia-Related Recurrent HRMDS Recurrent Myelodysplastic Syndrome Relapsed or Refractory HRMDS Relapsed or Refractory High-Risk Myelodysplastic Syndrome Recurrent Acute Myeloid Leukemia, Myelodysplasia-Related A morphologic variant of glioblastoma characterized by the presence of a highly proliferative and monotonous population of malignant small glial cells. C125890 Neoplastic Process Small Cell Glioblastoma C1272516 Malignant Small Cell Glioblastoma Small Cell Glioblastoma Paired glands located on either side of the anus of most carnivores that secrete a noxious-smelling liquid, thus allowing members of the same species to identify one another. C125896 Anatomical Structure Anal Sac C0002759 CDISC One of two pouches located on either side of the anus of most carnivores that contain the secretions of the anal sac glands. Anal Sac SAC, ANAL Anal Sac High-grade B-cell lymphoma characterized by the abnormal rearrangement of two genes, MYC gene and either BCL2 or BCL6 genes. Patients with this type of lymphoma usually respond poorly to standard treatments and have a poor prognosis. C125904 Neoplastic Process Double-Hit Lymphoma High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements CL504553 CTRP Cellosaurus GDC Malignant DH Lymphoma DHL Double Hit Lymphoma Double-Hit Lymphoma HGBCL-DH High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements High-Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements double hit lymphoma double_hit_lymphoma High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements A fluoroscopic procedure that examines a person's swallowing pattern. Liquid and solid food that contains barium sulfate is digested to determine if it is entering a person's larynx and trachea. C125909 Diagnostic Procedure Modified Barium Swallow Modified Barium Swallow CL504558 CTRP MBS Modified Barium Swallow VFSS Videofluoroscopic Swallowing Study Modified Barium Swallow A carcinoma that arises from the urothelium and has spread from its original site of growth to another anatomic site. C126109 Neoplastic Process Metastatic Urothelial Carcinoma Metastatic Urothelial Carcinoma CL504702 CTRP Malignant Metastatic Transitional Cell Carcinoma of the Urinary Tract Metastatic Urothelial Cancer Metastatic Urothelial Carcinoma Metastatic Urothelial Carcinoma An acute undifferentiated leukemia that occurs in infancy. C126110 Neoplastic Process Infant Acute Undifferentiated Leukemia Infant Acute Undifferentiated Leukemia CL504703 CTRP Malignant Acute Undifferentiated Leukemia Infant Acute Undifferentiated Leukemia Infant Acute Undifferentiated Leukemia An acute biphenotypic leukemia that occurs in infancy. C126111 Neoplastic Process Infant Acute Biphenotypic Leukemia Infant Acute Biphenotypic Leukemia CL504704 CTRP Malignant Acute Biphenotypic Leukemia Infant Acute Biphenotypic Leukemia Infant Acute Biphenotypic Leukemia A T-acute lymphoblastic leukemia that occurs in infancy. C126112 Neoplastic Process Infant T Acute Lymphoblastic Leukemia Infant T Acute Lymphoblastic Leukemia CL504705 CTRP Malignant Infant Precursor T Lymphoblastic Leukemia Infant Precursor T-Lymphoblastic Leukemia Infant T Acute Lymphoblastic Leukemia Infant T-ALL Infant T-Acute Lymphoblastic Leukemia T Acute Lymphoblastic Leukemia Infant T Acute Lymphoblastic Leukemia A rare, cytologically high grade carcinoma that arises from the renal parenchyma. It is characterized by the presence of prominently dilated cystic spaces in a bland, fibrotic stroma. The lining cells have large irregular nuclei with prominent nucleoli and abundant eosinophilic cytoplasm. Necrosis and mitotic figures are not present. It rarely metastasizes. C126303 Neoplastic Process Tubulocystic Renal Cell Carcinoma Tubulocystic Renal Cell Carcinoma CL504875 CTRP GDC Malignant Tubulocystic renal cell carcinoma TcRCC Tubulocystic Renal Cell Cancer Tubulocystic Renal Cell Carcinoma Tubulocystic renal cell carcinoma Tubulocystic Renal Cell Carcinoma The reemergence of glioblastoma after a period of remission. C126306 Neoplastic Process Recurrent Glioblastoma Recurrent Glioblastoma CL504877 CTRP Malignant Recurrent Glioblastoma Recurrent Glioblastoma The reemergence of bladder urothelial carcinoma after a period of remission. C126307 Neoplastic Process Recurrent Bladder Urothelial Carcinoma Recurrent Bladder Urothelial Carcinoma C1739113 CTRP Malignant Recurrent Bladder Transitional Cell Carcinoma Recurrent Bladder Urothelial Cancer Recurrent Bladder Urothelial Carcinoma Recurrent Bladder Urothelial Carcinoma A non-invasive clear cell adenofibromatous neoplasm that arises from the ovary. It is characterized by the presence of atypia in the glandular epithelium. C126308 Neoplastic Process Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor CL504878 Uncertain Malignant Potential Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor Acute lymphoblastic leukemia that occurs in adulthood and does not respond to treatment. C126309 Neoplastic Process Refractory Adult Acute Lymphoblastic Leukemia Refractory Adult Acute Lymphoblastic Leukemia CL504879 CTRP Malignant Refractory Acute Lymphoblastic Leukemia (ALL) Refractory Adult Acute Lymphoblastic Leukemia Refractory Adult Acute Lymphoblastic Leukemia A non-metastasizing cystic mixed epithelial neoplasm that arises from the ovary. It is characterized by the presence of more than one epithelial cell type, most often serous and endocervical-type mucinous. C126310 Neoplastic Process Ovarian Seromucinous Cystadenoma CL504880 Benign Seromucinous cystadenoma Ovarian Seromucinous Cystadenoma Ovarian Seromucinous Cystadenoma A non-metastasizing mixed epithelial neoplasm that arises from the ovary. It is characterized by the presence of more than one epithelial cell type, most often serous and endocervical-type mucinous and prominent fibrous stroma.. C126311 Neoplastic Process Ovarian Seromucinous Adenofibroma CL504881 Benign Ovarian Seromucinous Adenofibroma Ovarian Seromucinous Adenofibroma A rare usually bilateral luteinized thecoma that arises from the ovary and is associated with sclerosing peritonitis. It occurs mostly in premenopausal women. The ovarian tumor is benign but patients may develop intestinal obstruction due to the sclerosing peritonitis. C126321 Neoplastic Process Ovarian Luteinized Thecoma Associated with Sclerosing Peritonitis CL504891 Benign Ovarian Luteinized Thecoma Associated with Sclerosing Peritonitis Ovarian Luteinized Thecoma Associated with Sclerosing Peritonitis A retiform Sertoli-Leydig cell tumor that arises from the ovary. It is characterized by the presence of an epithelial and/or mesenchymal heterologous component. C126322 Neoplastic Process Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements CL504892 Undetermined Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the gastroesophageal junction. It is characterized by the presence of malignant large cells. C126323 Neoplastic Process Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma CL504893 Cellosaurus Malignant Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the gastroesophageal junction. The mitotic count is more than 20 per 10 HPF. It is classified as either small or large cell neuroendocrine carcinoma based on the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm. C126324 Neoplastic Process Gastroesophageal Junction Neuroendocrine Carcinoma CL504894 Malignant Gastroesophageal Junction Neuroendocrine Carcinoma Gastroesophageal Junction Neuroendocrine Carcinoma An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the gastroesophageal junction. It is characterized by the presence of malignant small cells. C126325 Neoplastic Process Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma CL504895 Malignant Gastroesophageal Junction Small Cell Carcinoma Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma A rare benign mesothelial tumor that arises from the ovary. It is characterized by the presence of gland-like structures. C126331 Neoplastic Process Ovarian Adenomatoid Tumor CL504897 Benign Benign Ovarian Mesothelioma Ovarian Adenomatoid Tumor Ovarian Adenomatoid Tumor Chronic eosinophilic leukemia characterized by the rearrangement of the PDGFRA gene, most often resulting in the formation of FIP1L1-PDGFRA fusion transcripts. C126351 Neoplastic Process Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA CL504912 Malignant Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA Chronic Eosinophilic Leukemia with FIP1L1::PDGFRA Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA A serous adenocarcinoma that arises from the lining of the peritoneum. It is characterized by high grade histopathologic features. C126353 Neoplastic Process Primary Peritoneal High Grade Serous Adenocarcinoma Primary Peritoneal High Grade Serous Adenocarcinoma CL504913 CTRP Malignant Primary Peritoneal High Grade Serous Adenocarcinoma Primary Peritoneal High-Grade Serous Adenocarcinoma Primary Peritoneal High Grade Serous Adenocarcinoma A serous adenocarcinoma that arises from the lining of the peritoneum. It is characterized by low grade histopathologic features. C126354 Neoplastic Process Invasive Micropapillary Serous Carcinoma of the Peritoneum Primary Peritoneal Low Grade Serous Adenocarcinoma CL504914 CTRP Malignant Invasive Micropapillary Serous Carcinoma of the Peritoneum Primary Peritoneal Low Grade Serous Adenocarcinoma Primary Peritoneal Low-Grade Serous Adenocarcinoma Primary Peritoneal Low Grade Serous Adenocarcinoma A desmoplastic small round cell tumor that occurs in the abdominal and/or pelvic peritoneum. C126356 Neoplastic Process Peritoneal Desmoplastic Small Round Cell Tumor CL504916 Malignant Peritoneal DSRCT Peritoneal Desmoplastic Small Round Cell Tumor Peritoneal Desmoplastic Small Round Cell Tumor A rare, usually benign fibroblastic neoplasm that arises from the peritoneum. It is characterized by the presence of prominent hemangiopericytoma-like vessels. C126357 Neoplastic Process Peritoneal Solitary Fibrous Tumor CL504917 Undetermined Peritoneal SFT Peritoneal Solitary Fibrous Tumor Peritoneal Solitary Fibrous Tumor Fibromatosis that occurs in the pelvis. It affects almost always females. It is characterized by the presence of elongated spindle-shaped fibroblasts, collagenous stroma formation, and an infiltrative growth pattern. It recurs if incompletely resected but lacks metastatic potential. C126358 Neoplastic Process Pelvic Fibromatosis CL504918 Undetermined Pelvic Desmoid Tumor Pelvic Fibromatosis Pelvic Fibromatosis Inflammatory myofibroblastic tumor that arises from the abdominal cavity. C126359 Neoplastic Process Abdominal Inflammatory Myofibroblastic Tumor CL504919 Undetermined Abdominal Inflammatory Myofibroblastic Tumor Abdominal Inflammatory Myofibroblastic Tumor A thyroid gland carcinoma characterized by the presence of cribriform, trabecular, follicular, papillary, and solid growth patterns and squamoid morulae formation. It may occur with familial adenomatous polyposis or sporadically. C126408 Neoplastic Process Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma Thyroid Gland Cribriform Morular Carcinoma CL504949 CTRP Malignant CMTC Cribriform Morular Thyroid Gland Carcinoma Cribriform-Morular Variant Thyroid Gland Papillary Cancer Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma Thyroid Gland Cribriform Morular Carcinoma Thyroid Gland Cribriform Morular Carcinoma A rare variant of papillary thyroid gland carcinoma characterized by the presence of eosinophilic large cells lining the papillae and a brisk lymphoplasmacytic infiltrate in the papillary stalks. C126409 Neoplastic Process Warthin Tumor-Like Variant Thyroid Gland Papillary Carcinoma Warthin-Like Variant Thyroid Gland Papillary Carcinoma CL504950 CTRP Malignant Warthin Tumor-Like Variant Thyroid Gland Papillary Cancer Warthin Tumor-Like Variant Thyroid Gland Papillary Carcinoma Warthin-Like Variant Thyroid Gland Papillary Carcinoma Warthin-Like Variant Thyroid Gland Papillary Carcinoma A rare morphologic variant of papillary thyroid gland carcinoma characterized by the presence of abundant and cellular stroma resembling nodular fasciitis, fibromatosis, or other proliferative myofibroblastic processes. (WHO) C126410 Neoplastic Process Nodular Fasciitis-like Stroma Variant Thyroid Gland Papillary Carcinoma Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like/Desmoid-Type Stroma CL504951 CTRP Malignant Nodular Fasciitis-Like Stroma Variant Thyroid Gland Papillary Carcinoma Nodular Fasciitis-like Stroma Variant Thyroid Gland Papillary Cancer Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like/Desmoid-Type Stroma Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like/Desmoid-Type Stroma A non-invasive serous carcinoma arising from the fallopian tube. C126449 Neoplastic Process Serous Tubal Intraepithelial Carcinoma CL504982 GDC Malignant Serous tubal intraepithelial carcinoma Serous tubal intraepithelial carcinoma (STIC) STIC Serous Tubal Intraepithelial Carcinoma Serous tubal intraepithelial carcinoma Serous tubal intraepithelial carcinoma (STIC) Serous Tubal Intraepithelial Carcinoma A rapidly growing serous adenocarcinoma that arises from the fallopian tube. It is characterized by the presence of high grade cytologic features and frequent mitotic figures. C126456 Neoplastic Process High Grade Fallopian Tube Serous Adenocarcinoma Fallopian Tube High Grade Serous Adenocarcinoma CL504987 CTRP Malignant Fallopian Tube High Grade Serous Adenocarcinoma Fallopian Tube High-Grade Serous Adenocarcinoma High Grade Fallopian Tube Serous Adenocarcinoma High Grade Fallopian Tube Serous Carcinoma Fallopian Tube High Grade Serous Adenocarcinoma An exceedingly rare lymphoma that arises from the fallopian tube. C126464 Neoplastic Process Fallopian Tube Lymphoma CL504993 Malignant Fallopian Tube Lymphoma Primary Fallopian Tube Lymphoma Fallopian Tube Lymphoma A carcinoma that arises from the head and neck and has spread from the original site of growth to another anatomic site. C126465 Neoplastic Process Metastatic Head and Neck Carcinoma Metastatic Head and Neck Carcinoma CL504994 CTRP Malignant Metastatic Head and Neck Cancer Metastatic Head and Neck Carcinoma Metastatic Head and Neck Carcinoma A rare non-invasive tumor that arises from the broad ligament. It is characterized by the presence of serous epithelial cell proliferation and cytological atypia. C126469 Neoplastic Process Borderline Broad Ligament Serous Tumor CL504996 Uncertain Malignant Potential Borderline Broad Ligament Serous Tumor Serous Borderline Broad Ligament Tumor/Atypical Proliferative Serous Broad Ligament Tumor Borderline Broad Ligament Serous Tumor A rare serous cystadenoma arising from the broad ligament. C126476 Neoplastic Process Broad Ligament Serous Cystadenoma CL505000 Benign Broad Ligament Serous Cystadenoma Broad Ligament Serous Cystadenoma A rare serous adenocarcinoma that arises from the broad ligament. C126479 Neoplastic Process Broad Ligament Serous Adenocarcinoma CL505003 Malignant Broad Ligament Serous Adenocarcinoma High-Grade Broad Ligament Serous Adenocarcinoma Broad Ligament Serous Adenocarcinoma A neoplasm that arises from the broad or other uterine ligaments and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C126493 Neoplastic Process Benign Uterine Ligament Neoplasm C0865093 Benign Benign Uterine Ligament Neoplasm Benign Uterine Ligament Neoplasm A primary or metastatic malignant neoplasm that affects the broad or other uterine ligaments. C126498 Neoplastic Process Malignant Uterine Ligament Neoplasm C0864950 CPTAC Malignant Malignant neoplasm of round ligament of uterus Malignant Uterine Ligament Neoplasm Malignant Uterine Ligament Neoplasm An encapsulated or nonencapsulated variant of papillary carcinoma of the thyroid gland characterized by the predominance of follicular structures. The malignant follicular cells display the nuclear features that characterize the papillary adenocarcinomas of the thyroid gland. C126594 Neoplastic Process Follicular Variant Thyroid Gland Papillary Carcinoma C0346398 CPTAC GDC Malignant 8340/3 Papillary carcinoma, follicular variant FVPTC Follicular Variant Thyroid Gland Papillary Carcinoma Papillary Thyroid Carcinoma, Follicular Variant Papillary carcinoma, follicular variant Follicular Variant Thyroid Gland Papillary Carcinoma A non-invasive neoplasm of thyroid follicular cells with a follicular growth pattern and nuclear features of papillary thyroid carcinoma that has an extremely low malignant potential. These tumors were formerly classified as non-invasive encapsulated follicular variant of papillary thyroid carcinoma or well-differentiated tumor of uncertain malignant potential. (WHO) C126598 Neoplastic Process Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features CL505049 GDC NICHD A benign or malignant thyroid tumor arising from follicular cells. Uncertain Malignant Potential Non-invasive EFVPTC Non-invasive FTP Non-invasive encapsulated follicular variant of papillary thyroid carcinoma (non-invasive EFVPTC) Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) Follicular Thyroid Tumor NIEFVPTC NIFTP Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) Noninvasive Encapsulated Follicular Variant Papillary Thyroid Gland Carcinoma Noninvasive Encapsulated Follicular Variant Thyroid Gland Papillary Carcinoma Noninvasive Follicular Thyroid Gland Neoplasm with Papillary-Like Nuclear Features Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features Thyroid Gland Noninvasive Follicular Tumor with Papillary-Like Nuclear Features Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features A flattened, roughly triangular body resting upon the upper end of each kidney; it is one of the ductless glands furnishing internal secretions (epinephrine and norepinephrine from the medulla and steroid hormones from the cortex). C12666 Body Part, Organ, or Organ Component Adrenal Gland Adrenal Gland C0001625 CDISC CTDC GDC PCDC UBERON mCode A small gland that makes steroid hormones, adrenaline, and noradrenaline. These hormones help control heart rate, blood pressure, and other important body functions. There are two adrenal glands, one on top of each kidney. Either of a pair of complex endocrine organs near the anterior medial border of the kidney consisting of a mesodermal cortex that produces glucocorticoid, mineralocorticoid, and androgenic hormones and an ectodermal medulla that produces epinephrine and norepinephrine. The endocrine glands adjacent to the kidneys that consist of the outer adrenal cortex and the inner adrenal medulla in mammals. Adrenal_Gland Adrenal Adrenal gland Adrenal gland, NOS UBERON:0002369 ADRENAL GLAND Adrenal Adrenal Gland Adrenal Glands Adrenal gland Adrenal gland, NOS Adrenal structure (body structure) Adrenals GLAND, ADRENAL adrenal gland glandula adrenalis glandula suprarenalis suprarenal gland Adrenal Gland An imaging technique in which multiple X-rays of an object are take from a discrete number of angles. These cross-sectional images are used to reconstruct 3-D images of the object being scanned. Tomosynthesis differs from computed tomography because the range of angles used is less than 360 degrees, as used in computed tomography. C126695 Diagnostic Procedure Digital Tomosynthesis CL474518 DT Digital Tomosynthesis Digital Tomosynthesis Digital tomosynthesis that uses an array of x-ray sources to obtain cross-sectional images of an object for 3-D image construction. Stationary digital tomosynthesis eliminates the blur associated with a moving x-ray source and also decreases the time needed to obtain the images. C126696 Diagnostic Procedure Stationary Digital Tomosynthesis Stationary Digital Tomosynthesis CL508093 CTRP Stationary Digital Tomosynthesis s-DT Stationary Digital Tomosynthesis Digital tomosynthesis used to image structures in the thoracic cavity. C126697 Diagnostic Procedure Digital Chest Tomosynthesis Digital Chest Tomosynthesis CL412434 Digital Chest Tomosynthesis Digital Tomosynthesis of Chest Digital Tomosynthesis of Thorax Digital Chest Tomosynthesis Stationary digital tomography used to image structures in the thoracic cavity. C126698 Diagnostic Procedure Stationary Digital Chest Tomosynthesis Stationary Digital Chest Tomosynthesis CL508092 CTRP Stationary Digital Chest Tomosynthesis s-DCT Stationary Digital Chest Tomosynthesis The skin above the pubic area. C126736 Anatomical Structure Suprapubic Skin CL508100 Suprapubic Skin Suprapubic skin Suprapubic Skin Acute myeloid leukemia characterized by the presence of a FLT3-internal tandem duplication (ITD) mutation. Patients with this mutation usually present with more aggressive disease and have higher rates of relapse after remission. C126748 Neoplastic Process Acute Myeloid Leukemia with FLT3/ITD Acute Myeloid Leukemia with FLT3/ITD Mutation CL507965 CTRP Malignant Acute Myeloid Leukemia (AML) with FLT3/ITD Acute Myeloid Leukemia with FLT3/ITD Mutation Acute Myeloid Leukemia with FLT3/ITD Mutation The two mucous secreting glands on either side of the vaginal opening. C12675 Body Part, Organ, or Organ Component Bartholin's Gland Bartholin Gland C0004768 Bartholin_s_Gland Bartholin Gland Bartholin's Gland Bartholin Gland A high-grade carcinoma that arises from the oropharynx. It is characterized by the presence of malignant cells which bear minimal resemblance to the cells from which they arose. C126750 Neoplastic Process Oropharyngeal Poorly Differentiated Carcinoma Oropharyngeal Poorly Differentiated Carcinoma CL508198 CTRP Malignant Oropharyngeal Poorly Differentiated Carcinoma Poorly Differentiated Oropharyngeal Throat Cancer Oropharyngeal Poorly Differentiated Carcinoma A high-grade variant of squamous cell carcinoma that arises from the oropharynx. It is characterized by the presence of small malignant cells with hyperchromatic nuclei and scant amount of cytoplasm forming lobules with peripheral palisading. C126751 Neoplastic Process Oropharyngeal Basaloid Carcinoma Oropharyngeal Basaloid Squamous Cell Carcinoma CL508197 CTRP Malignant Oropharyngeal Basaloid Carcinoma Oropharyngeal Basaloid Squamous Cell Carcinoma Oropharyngeal Basaloid Squamous Cell Carcinoma The skin surrounding a stoma and on which the pouching system is placed. C126756 Anatomical Structure Peristomal Skin Peristomal Skin CL507992 CTRP Healthy Peristomal Skin Peristomal Skin Peristomal Skin A carcinoma that arises from the endometrium and is characterized by the presence of an undifferentiated carcinomatous component and a second component of either FIGO grade 1 or 2 endometrioid carcinoma. C126769 Neoplastic Process Endometrial Dedifferentiated Carcinoma CL507996 Malignant Endometrial Dedifferentiated Carcinoma Endometrial Dedifferentiated Carcinoma The bile ducts which are located within the liver. They include the small interlobular bile ducts, intrahepatic large bile ducts, and the intrahepatic portions of the left and right hepatic ducts. C12677 Body Part, Organ, or Organ Component Intrahepatic Bile Duct Intrahepatic Bile Duct C0005401 CDISC GDC The bile ducts that pass through and drain bile from the liver. The bile ducts that pass through and drain bile from the liver. (NCI) Intrahepatic_Bile_Duct Intrahepatic bile duct INTRAHEPATIC BILE DUCT Intrahepatic Bile Duct Intrahepatic bile duct intrahepatic bile duct Intrahepatic Bile Duct An epithelial neoplasm with neuroendocrine differentiation that arises from the uterine corpus. It includes neuroendocrine tumor G1 (carcinoid tumor), small cell carcinoma pulmonary type, and large cell neuroendocrine carcinoma. C126771 Neoplastic Process Uterine Corpus Neuroendocrine Neoplasm CL508215 Undetermined Uterine Corpus Neuroendocrine Neoplasm Uterine Corpus Neuroendocrine Tumor Uterine Corpus Neuroendocrine Neoplasm A high grade neuroendocrine carcinoma that arises from the endometrium. It is composed of large polygonal cells arranged in well-demarcated nests, trabeculae or cords with peripheral palisading. C126772 Neoplastic Process Endometrial Large Cell Neuroendocrine Carcinoma CL507997 Malignant Endometrial Large Cell Neuroendocrine Carcinoma Endometrial Large Cell Neuroendocrine Carcinoma A very rare, well-differentiated, low-grade neuroendocrine neoplasm that arises from the uterine corpus. C126773 Neoplastic Process Uterine Corpus Neuroendocrine Tumor G1 CL508212 Undetermined Uterine Corpus Carcinoid Tumor Uterine Corpus Neuroendocrine Tumor G1 Uterine Corpus Neuroendocrine Tumor Grade 1 Uterine Corpus Well Differentiated Neuroendocrine Tumor, Grade 1 Uterine Corpus Neuroendocrine Tumor G1 The system that transports bile from the hepatocytes in the liver to the small intestine. It is comprised of the intrahepatic bile ducts, hepatic ducts, common bile duct, cystic duct, and the gallbladder. C12678 Body Part, Organ, or Organ Component Biliary Tract Biliary Tract C0005423 CDISC GDC The duct system that transports bile from its origination by hepatocytes in the liver to the small intestine. It is comprised of the common bile duct that connects the liver and gall bladder to the small intestine and the cystic duct that connects the gall bladder to the common bile duct. (NCI) The organs and ducts that make and store bile (a fluid made by the liver that helps digest fat), and release it into the small intestine. The biliary tract includes the gallbladder and bile ducts inside and outside the liver. Biliary_Tract Biliary tract, NOS IMDRF:E11 BILIARY TRACT Bile Tract Biliary System Biliary Tract Biliary tract, NOS Tract, Biliary biliary system biliary tract Biliary Tract Myelofibrosis that develops in a patient with history of essential thrombocythemia. C126806 Neoplastic Process Myelofibrosis Transformation in Essential Thrombocythemia Post-Essential Thrombocythemia Myelofibrosis C3805233 CTRP Malignant Myelofibrosis Transformation in Essential Thrombocythemia Post-ET MF Post-ET Myelofibrosis Post-Essential Thrombocythemia Myelofibrosis Post-Essential Thrombocythemia Myelofibrosis A variant of leiomyoma arising from the uterine corpus. It is characterized by conspicuous zonal edema. Hyalinization may also be present. C126975 Neoplastic Process Uterine Corpus Hydropic Leiomyoma CL508214 Benign Uterine Corpus Hydropic Leiomyoma Uterine Corpus Hydropic Leiomyoma Bile ducts are passageways that carry bile. Two major bile ducts come together into a "trunk"-the common bile duct which empties into the upper part of the small intestine (the part next to the stomach). C12698 Body Part, Organ, or Organ Component Common Bile Duct Common Bile Duct C0009437 CDISC GDC UBERON mCode A duct that conveys bile from the convergence of the cystic and hepatic duct to the duodenum. A tube that carries bile from the liver and the gallbladder through the pancreas and into the duodenum (the upper part of the small intestine). It is formed where the ducts from the liver and gallbladder are joined. It is part of the biliary duct system. The part of the biliary tree formed by the union of the cystic duct and the common hepatic duct. Common_Bile_Duct Common Duct UBERON:0001174 COMMON BILE DUCT Common Bile Duct Common Duct Common bile duct structure (body structure) DUCT, COMMON BILE Ductus Communis Choledochus common bile duct ductus choledochus (biliaris) Common Bile Duct A rare, high grade sarcoma that arises from the endometrial stroma. It is characterized by round cell morphology. It was previously also known as undifferentiated uterine sarcoma. In 2014, high grade endometrial stromal sarcoma was reclassified and is currently considered a distinct and rare neoplasm. It appears to have a prognosis that falls between low grade endometrial stromal sarcoma and undifferentiated sarcoma. C126998 Neoplastic Process Uterine Corpus High Grade Endometrial Stromal Sarcoma CL508195 GDC Malignant 8930/3 Endometrial stromal sarcoma, high grade Endometrial Stromal Sarcoma, High Grade High Grade ESS Uterine Corpus High Grade ESS Uterine Corpus High Grade Endometrial Stromal Sarcoma YWHAE-FAM22 ESS YWHAE-FAM22 Endometrial Stromal Sarcoma YWHAE::FAM22 Endometrial Stromal Sarcoma Uterine Corpus High Grade Endometrial Stromal Sarcoma A usually benign neoplasm that arises from the uterine corpus. It resembles ovarian sex cord tumors. It lacks a component of recognizable endometrial stroma and the JAZF1-SUZ12 fusion which is characteristic of the endometrial stromal neoplasms. C127005 Neoplastic Process Uterine Corpus Tumor Resembling Ovarian Sex Cord Tumor CL508217 Undetermined Uterine Corpus Tumor Resembling Ovarian Sex Cord Tumor Uterine Corpus Tumor Resembling Ovarian Sex Cord Tumor Ductless glands that secrete substances which are released directly into the circulation and which influence metabolism and other body functions. C12704 Body Part, Organ, or Organ Component Endocrine Gland Endocrine Gland C0014133 GDC UBERON Endocrine glands are glands of the endocrine system that secrete their products directly into the circulatory system rather than through a duct. Endocrine_Gland Endocrine Gland Endocrine gland, NOS UBERON:0002368 Endocrine Gland Endocrine Organs Endocrine gland, NOS ductless gland endocrine gland glandula endocrina Endocrine Gland A rare malignant heterologous neoplasm with skeletal muscle differentiation arising from the uterine corpus. It usually manifests with vaginal bleeding. The prognosis is poor. C127058 Neoplastic Process Uterine Corpus Rhabdomyosarcoma CL508216 Malignant Uterine Corpus Rhabdomyosarcoma Uterine Corpus Rhabdomyosarcoma A benign neoplasm with perivascular epithelioid cell differentiation arising from the uterine corpus. It is characterized by the absence of pleomorphism and scarcity or absence of mitotic figures. It usually affects perimenopausal women. Patients present with a pelvic mass or abnormal bleeding. C127071 Neoplastic Process Benign Uterine Corpus PEComa CL508224 Benign Benign Uterine Corpus PEComa Benign Uterine Corpus Perivascular Epithelioid Cell Tumor Uterine Corpus Benign PEComa Uterine Corpus Benign Perivascular Epithelioid Cell Tumor Benign Uterine Corpus PEComa A malignant neoplasm with perivascular epithelioid cell differentiation arising from the uterine corpus. The neoplasm is usually a large size, and charcaterized by the presence of marked nuclear atypia, pleomorphism, increased mitotic activity, necrosis, and infiltrative margins. The most common metastatic sites are lungs, lymph nodes, and bone. Patients present with a pelvic mass or abnormal bleeding. C127072 Neoplastic Process Uterine Corpus Malignant PEComa CL508057 Malignant Malignant Uterine Corpus PEComa Malignant Uterine Corpus Perivascular Epithelioid Cell Tumor Uterine Corpus Malignant PEComa Uterine Corpus Malignant Perivascular Epithelioid Cell Tumor Uterine Corpus Malignant PEComa A benign or malignant germ cell tumor that arises from the uterine corpus. Representative examples include teratoma and yolk sac tumor. C127077 Neoplastic Process Uterine Corpus Germ Cell Tumor CL508213 Undetermined Uterine Corpus Germ Cell Tumor Uterine Corpus Germ Cell Tumor A gland from which secretions reach a free surface of the body by ducts. C12712 Body Part, Organ, or Organ Component Exocrine Gland Exocrine Gland C0015282 A type of gland that is found in the skin, breast, eyelid, and ear. Apocrine glands in the breast secrete fat droplets into breast milk and those in the ear help form earwax. Apocrine glands in the skin and eyelid are sweat glands. Most apocrine glands in the skin are in the armpits, the groin, and the area around the nipples of the breast. Apocrine glands in the skin are scent glands, and their secretions usually have an odor. Another type of gland (eccrine gland or simple sweat gland) produces most sweat. Exocrine_Gland Apocrine Apocrine Gland Exocrine Gland apocrine gland Exocrine Gland A pituitary neuroendocrine tumor that produces both growth hormone and prolactin. C127194 Neoplastic Process Somatotroph-Lactotroph Pituitary Neuroendocrine Tumor CL509740 NICHD A pituitary neuroendocrine tumor that produces both growth hormone and prolactin. Undetermined Growth Hormone and Prolactin-Producing Adenoma Somatotroph-Lactotroph PitNET/Adenoma Somatotroph-Lactotroph Pituitary Neuroendocrine Tumor Somatotroph-Lactotroph Pituitary Neuroendocrine Tumor/Adenoma Somatotroph/Lactotroph Adenoma Somatotroph-Lactotroph Pituitary Neuroendocrine Tumor A reproductive system organ that produces and releases either sperm (testis) or eggs (ovary). C12725 Body Part, Organ, or Organ Component Gonad Gonad C0018067 CDISC A reproductive organ that produces gametes. The part of the reproductive system that produces and releases eggs (ovaries) or sperm (testicles/testes). Gonad GONAD Gonad Gonadal Gonads gonad Gonad A hollow organ located slightly to the left of the middle portion of the chest. It is composed of muscle and it is divided by a septum into two sides: the right side which receives de-oxygenated blood from the body and the left side which sends newly oxygenated blood to the body. Each side is composed of two chambers: the atrium (receiving blood) and ventricle (ejecting blood). C12727 Body Part, Organ, or Organ Component Heart Heart C0018787 CDISC GDC PCDC UBERON mCode A hollow muscular organ which receives the blood from the veins and pumps it into the arteries. A myogenic muscular circulatory organ found in the vertebrate cardiovascular system composed of chambers of cardiac muscle. It is the primary circulatory organ. Heart Heart IMDRF:E06 UBERON:0000948 Cardiac HEART Heart Heart structure (body structure) chambered heart heart vertebrate heart Heart An application of conventional frequency spectroscopic ultrasound data that uses ultrasound backscattered radiofrequency (RF) signals to determine the bioacoustic properties of the underlying tissue for characterizing its microstructure. C127309 Health Care Activity Quantitative Ultrasound Spectroscopy Quantitative Ultrasound Spectroscopy CL509650 CTRP QUS Quantitative Ultrasound Imaging Quantitative Ultrasound Spectroscopy Quantitative Ultrasound Spectroscopy The portion of the gastrointestinal tract between the stomach and the anus. It includes the small intestine and large intestine. C12736 Body Part, Organ, or Organ Component Intestine Intestine C0021853 CDISC GDC mCode The long, tube-shaped organ in the abdomen that completes the process of digestion. The intestine has two parts, the small intestine and the large intestine. The portion of the gastrointestinal tract that includes the small and large intestines. Intestine Bowel Intestinal tract, NOS Bowel INTESTINE Intestinal structure (body structure) Intestinal tract, NOS Intestine Intestines bowel intestine Intestine A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found throughout the body. It is composed predominantly of lymphocytes and its main function is immune protection. C12745 Body Part, Organ, or Organ Component Lymph Node Lymph Node C0024204 CDISC CPTAC CTDC GDC PCDC UBERON mCode A rounded mass of lymphatic tissue that is surrounded by a capsule of connective tissue. Lymph nodes filter lymph (lymphatic fluid), and they store lymphocytes (white blood cells). They are located along lymphatic vessels. Any of the rounded masses of lymphoid tissue that are surrounded by a capsule of connective tissue, are distributed along the lymphatic vessels, and contain numerous lymphocytes which filter the flow of lymph. Secondary lymphoid organ associated with lymphatic vessels and consisting of an outer cortex, inner medulla and sinuses. Lymph_Node Lymph Noce Lymph Node Lymph node, NOS Lymph nodes UBERON:0000029 LYMPH NODE Lymph Gland Lymph Node Lymph Node(s) Lymph Node, NOS Lymph Nodes Lymph node, NOS Lymph nodes Lymphatic Gland Reticuloendothelial System, Lymph Node Structure of lymph node (body structure) lymph gland lymph node Lymph Node A structure of special sense serving as an organ of the sense of smell and as an entrance to the respiratory tract. C12756 Body Part, Organ, or Organ Component Nose Nose C0028429 CDISC mCode A structure of special sense serving as an organ of the sense of smell and as an entrance to the respiratory tract. (NCI) Nose NOSE Nasal structure (body structure) Nose Nose One of two small paired endocrine glands, superior and inferior, usually found embedded in the connective tissue capsule on the posterior surface of the thyroid gland; these glands secrete parathyroid hormone that regulates the metabolism of calcium and phosphorus. The parenchyma is composed of chief and oxyphilic cells arranged in anastomosing cords. C12765 Body Part, Organ, or Organ Component Parathyroid Gland Parathyroid Gland C0030518 CDISC GDC UBERON mCode Endocrine gland, usually in close proximity to the thyroid gland, that produces parathyroid hormone. Parathyroid_Gland Parathyroid Parathyroid gland Inadvertent removal of all parathyroid glands, as during thyroidectomy, produces tetany and death. UBERON:0001132 GLAND, PARATHYROID Head and Neck, Parathyroid PARATHYROID GLAND Parathyroid Parathyroid Gland Parathyroid gland Parathyroid structure (body structure) parathyroid parathyroid gland Parathyroid Gland A group of malignant gliomas that includes anaplastic astrocytoma, anaplastic oligodendroglioma, anaplastic oligoastrocytoma, and anaplastic ependymoma. C127816 Neoplastic Process WHO Grade III Glioma WHO Grade 3 Glioma CL509578 CTRP Malignant Anaplastic Glioma WHO Grade 3 Glioma WHO Grade III Glioma WHO Grade 3 Glioma A three-dimensional application of magnetic resonance spectroscopic imaging that uses an alternating gradient applied along one of the spatial readout directions to simultaneously encode the space and chemical shift, thereby reducing the phase-encoding dimension by one and increasing speed. C127837 Diagnostic Procedure Three-Dimensional Echo-Planar Spectroscopic Imaging Three-Dimensional Echo-Planar Spectroscopic Imaging CL509003 CTRP 3D-EPSI Three-Dimensional Echo-Planar Spectroscopic Imaging Volumetric Echo-Planar Spectroscopic Imaging Three-Dimensional Echo-Planar Spectroscopic Imaging The reemergence of Waldenstrom macroglobulinemia after a period of remission. C127840 Neoplastic Process Recurrent Waldenstrom Macroglobulinemia Recurrent Waldenstrom Macroglobulinemia C0853709 CTRP Malignant Recurrent Waldenstrom Macroglobulinemia Recurrent Waldenstrom Macroglobulinemia The musculocutaneous pouch that encloses the testicles. C12785 Body Part, Organ, or Organ Component Scrotum Scrotum C0036471 CDISC GDC UBERON mCode In males, the external sac that contains the testicles. The external sac of skin that encloses the testes. It is an extension of the abdomen, and in placentals is located between the penis and anus. The pouch that encloses the testicles. Scrotum Scrotum Scrotum, NOS UBERON:0001300 SCROTUM Scrotal structure (body structure) Scrotum Scrotum, NOS scrotum Scrotum One of the two paired glands in the male genitourinary system, posterior to the bladder and superior to the prostate gland, that produces fructose-rich seminal fluid which is a component of semen. These glands join the ipsilateral ductus deferens to form the ejaculatory duct. C12787 Body Part, Organ, or Organ Component Seminal Vesicle Seminal Vesicle C0036628 CDISC GDC UBERON mCode A gland that helps produce semen. A mammalian male reproductive accessory gland located adjacent to the urinary bladder and proximal to the prostate. Either of a pair of glandular pouches that lie one on either side of the male reproductive tract posterolateral to the urinary bladder and in the human male secrete a sugar- and protein-containing fluid into the ejaculatory duct. Seminal_Vesicle Seminal Vesicle UBERON:0000998 GLAND, SEMINAL VESICLE SEMINAL VESICLE Seminal Sacs Seminal Vesicle Seminal Vesicles Seminal vesicle structure (body structure) seminal vesicle Seminal Vesicle A cervical adenocarcinoma in which 0-50% of malignant cells contain intracytoplasmic mucin. It is the most common subtype of cervical adenocarcinoma and represents 75% of all invasive cervical adenocarcinomas. The neoplastic epithelium shows a pseudostratified architecture and the malignant cells have enlarged, elongated, and hyperchromatic nuclei. Historically, usual-type cervical adenocarcinomas were termed "endocervical-type". C127907 Neoplastic Process Endocervical Adenocarcinoma, Usual-Type Endocervical Adenocarcinoma, Usual-Type C1266079 CTRP GDC 8384/3 8482/3 Malignant 8384/3 8482/3 Adenocarcinoma, endocervical type Adenocarcinoma, endocervical type, NOS Endocervical adenocarcinoma usual type Mucinous adenocarcinoma, endocervical type Adenocarcinoma, Endocervical Type Adenocarcinoma, endocervical type Cervical Adenocarcinoma, Usual Type Cervical Adenocarcinoma, Usual-Type Cervical Mucinous Adenocarcinoma, Endocervical Type Cervical Mucinous Adenocarcinoma, Endocervical-Type Endocervical Adenocarcinoma, Usual Type Endocervical Adenocarcinoma, Usual-Type Endocervical adenocarcinoma usual type Mucinous adenocarcinoma, endocervical type UEA Endocervical Adenocarcinoma, Usual-Type A carcinoma that arises from the cervix and is characterized by the presence of a cervical adenocarcinoma variant and a neuroendocrine carcinoma component. C127915 Neoplastic Process Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma CL509697 GDC Malignant Adenocarcinoma admixed with neuroendocrine carcinoma Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma The two organs situated in the throat on either side of the narrow passage from the mouth to the pharynx. They are composed of lymphoid tissues. C12802 Body Part, Organ, or Organ Component Tonsil Tonsil C0836921 CDISC CPTAC GDC PCDC UBERON mCode A secondary lymphoid tissue in the mucosa of the pharynx. Either of the two small almond-shaped masses of lymph tissue found on either side of the oropharynx. One of two small masses of lymphoid tissue on either side of the throat. excludes lingual tonsil C02.4 and pharyngeal tonsil C11.1 Tonsil Tonsil UBERON:0002372 TONSIL Tonsil Tonsillar structure (palatine) (body structure) Tonsils tonsil Tonsil A neuroendocrine neoplasm that arises from the cervix. This category includes neuroendocrine tumor grade 1, neuroendocrine tumor grade 2, and neuroendocrine carcinoma (small cell and large cell neuroendocrine carcinoma). C128041 Neoplastic Process Cervical Neuroendocrine Neoplasm CL509706 Undetermined Cervical Neuroendocrine Neoplasm Cervical Neuroendocrine Neoplasm A well-differentiated, low grade neuroendocrine neoplasm that arises from the cervix. C128043 Neoplastic Process Cervical Neuroendocrine Tumor G1 CL509034 Undetermined Cervical Carcinoid Tumor Cervical Low Grade Neuroendocrine Tumor, Grade 1 Cervical Neuroendocrine Tumor G1 Cervical Neuroendocrine Tumor G1 A well-differentiated, intermediate grade neuroendocrine neoplasm arising from the cervix. C128044 Neoplastic Process Cervical Neuroendocrine Tumor G2 CL509033 Undetermined Cervical Low Grade Neuroendocrine Tumor, Grade 2 Cervical Neuroendocrine Tumor G2 Cervical Neuroendocrine Tumor G2 A malignant, high grade neuroendocrine neoplasm that arises from the cervix. This category includes small cell and large cell neuroendocrine carcinoma. C128045 Neoplastic Process Cervical Neuroendocrine Carcinoma Cervical Neuroendocrine Carcinoma C4013425 CTRP Cellosaurus Malignant Cervical High Grade Neuroendocrine Neoplasm Cervical Neuroendocrine Cancer Cervical Neuroendocrine Carcinoma Cervical Neuroendocrine Carcinoma An uncommon benign smooth muscle neoplasm that arises from the cervix. C128046 Neoplastic Process Cervical Leiomyoma CL509700 Benign Cervical Leiomyoma Cervical Leiomyoma A malignant neoplasm with smooth muscle differentiation arising from the cervix. C128047 Neoplastic Process Cervical Leiomyosarcoma CL509701 Malignant Cervical Leiomyosarcoma Cervical Leiomyosarcoma A rare malignant neoplasm with skeletal muscle differentiation arising from the cervix. C128048 Neoplastic Process Cervical Rhabdomyosarcoma CL509707 Malignant Cervical Rhabdomyosarcoma Cervical Rhabdomyosarcoma A highly aggressive malignant vascular neoplasm that arises from the cervix and shows endothelial cell differentiation. C128049 Neoplastic Process Cervical Angiosarcoma CL509698 Malignant Cervical Angiosarcoma Cervical Angiosarcoma A rare malignant neoplasm with nerve sheath differentiation arising from the cervix. C128050 Neoplastic Process Cervical Malignant Peripheral Nerve Sheath Tumor CL509702 Malignant Cervical Malignant Peripheral Nerve Sheath Tumor Cervical Malignant Peripheral Nerve Sheath Tumor A rare benign mesenchymal neoplasm that arises from the cervix. C128053 Neoplastic Process Benign Cervical Soft Tissue Neoplasm CL509694 Benign Benign Cervical Soft Tissue Neoplasm Benign Cervical Soft Tissue Neoplasm A rare malignant mesenchymal neoplasm that arises from the cervix. C128054 Neoplastic Process Malignant Cervical Soft Tissue Neoplasm CL509750 Malignant Malignant Cervical Soft Tissue Neoplasm Malignant Cervical Soft Tissue Neoplasm A yolk sac tumor that arises from the cervix. Patients present with abnormal vaginal bleeding and a polypoid, friable mass, protruding into the vagina. C128055 Neoplastic Process Cervical Yolk Sac Tumor CL509035 Malignant Cervical Endodermal Sinus Tumor Cervical Yolk Sac Tumor Cervical Yolk Sac Tumor A magnetic resonance imaging modality used to quantify the blood supply to an organ or tissue using signal measurement as detected from a parenterally administered contrast agent. C128056 Diagnostic Procedure Perfusion-Weighted Magnetic Resonance Imaging Perfusion-Weighted Magnetic Resonance Imaging C0879554 CTRP PWI Perfusion-Weighted MR Perfusion-Weighted MRI Perfusion-Weighted Magnetic Resonance Imaging Perfusion-Weighted Magnetic Resonance Imaging A rare squamous cell carcinoma that arises from the vagina resembling transitional cell carcinoma of the urinary tract. C128060 Neoplastic Process Vaginal Papillary Carcinoma CL509357 Malignant Vaginal Papillary Carcinoma Vaginal Squamotransitional Carcinoma Vaginal Squamotransitional Cell Carcinoma Vaginal Papillary Carcinoma A rare neuroendocrine carcinoma that arises from the vagina. This category includes small cell and large cell neuroendocrine carcinoma. C128073 Neoplastic Process Vaginal Neuroendocrine Carcinoma Vaginal Neuroendocrine Carcinoma CL509356 CTRP Malignant Vaginal High Grade Neuroendocrine Carcinoma Vaginal High Grade Neuroendocrine Neoplasm Vaginal Neuroendocrine Cancer Vaginal Neuroendocrine Carcinoma Vaginal Neuroendocrine Carcinoma A rare, aggressive neuroendocrine carcinoma that arises from the vagina and is characterized by the presence of malignant cells with abundant cytoplasm, large nuclei, and prominent nucleoli. C128075 Neoplastic Process Vaginal Large Cell Neuroendocrine Carcinoma CL509795 Malignant Vaginal Large Cell Neuroendocrine Carcinoma Vaginal Large Cell Neuroendocrine Carcinoma An uncommon, benign, well circumscribed mesenchymal neoplasm that grows beneath the vaginal epithelium. It is characterized by the presence of cells containing bland ovoid, spindle, or stellate-shaped nuclei in a collagenous stroma. C128079 Neoplastic Process Vaginal Superficial Myofibroblastoma CL509348 Benign Superficial Myofibroblastoma of the Lower Female Genital Tract Vaginal Myofibroblastoma Vaginal Superficial Myofibroblastoma Vaginal Superficial Myofibroblastoma A malignant mesenchymal neoplasm with skeletal muscle differentiation arising from the vagina. C128080 Neoplastic Process Vaginal Rhabdomyosarcoma CL509796 Malignant Vaginal Rhabdomyosarcoma Vaginal Rhabdomyosarcoma A category of staging terms for ovarian cancer according to the International Federation of Gynecology and Obstetrics (FIGO), 2014. AJCC ovarian cancer stage terms from the 6th and 7th editions that are synonymous to the FIGO ovarian cancer staging classification of 2014 are included as preferred terms. C128081 Neoplastic Process Ovarian Cancer by FIGO Stage CL508916 Malignant Ovarian Cancer by FIGO Stage Ovarian Carcinoma by FIGO Stage 2014 Ovarian Cancer by FIGO Stage Stage IC ovarian cancer with surgical spill. (FIGO, 2014) C128082 Neoplastic Process FIGO Stage IC1 Ovarian Cancer FIGO Stage IC1 Ovarian Cancer CL508830 CTRP Malignant FIGO Stage IC1 Ovarian Cancer FIGO Stage IC1 Ovarian Carcinoma FIGO Stage IC1 Ovarian Cancer Stage IC ovarian cancer with capsule rupture before surgery or tumor on ovarian surface. (FIGO, 2014) C128083 Neoplastic Process FIGO Stage IC2 Ovarian Cancer FIGO Stage IC2 Ovarian Cancer CL508832 CTRP Malignant FIGO Stage IC2 Ovarian Cancer FIGO Stage IC2 Ovarian Carcinoma FIGO Stage IC2 Ovarian Cancer Stage IC ovarian cancer with malignant cells in the ascites or peritoneal washings. (FIGO, 2014) C128084 Neoplastic Process FIGO Stage IC3 Ovarian Cancer FIGO Stage IC3 Ovarian Cancer CL508834 CTRP Malignant FIGO Stage IC3 Ovarian Cancer FIGO Stage IC3 Ovarian Carcinoma FIGO Stage IC3 Ovarian Cancer Ovarian cancer involving one or both ovaries with pelvic extension (below the pelvic brim) or primary peritoneal cancer. (FIGO, 2014) C128085 Neoplastic Process FIGO Stage II Ovarian Cancer FIGO Stage II Ovarian Cancer CL508836 CTRP Malignant FIGO Stage II Ovarian Cancer FIGO Stage II Ovarian Carcinoma FIGO Stage II Ovarian Cancer Ovarian cancer involving 1 or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes. (FIGO, 2014) C128086 Neoplastic Process FIGO Stage III Ovarian Cancer FIGO Stage III Ovarian Cancer CL508837 CTRP Malignant FIGO Stage III Ovarian Cancer FIGO Stage III Ovarian Carcinoma FIGO Stage III Ovarian Cancer Ovarian cancer with positive retroperitoneal lymph nodes and/or microscopic metastasis beyond the pelvis. (FIGO, 2014) C128087 Neoplastic Process FIGO Stage IIIA Ovarian Cancer FIGO Stage IIIA Ovarian Cancer CL508838 CTRP Malignant FIGO Stage IIIA Ovarian Cancer FIGO Stage IIIA Ovarian Carcinoma FIGO Stage IIIA Ovarian Cancer Ovarian cancer with positive retroperitoneal lymph nodes only. (FIGO, 2014) C128088 Neoplastic Process FIGO Stage IIIA1 Ovarian Cancer FIGO Stage IIIA1 Ovarian Cancer CL508839 CTRP Malignant FIGO Stage IIIA1 Ovarian Cancer FIGO Stage IIIA1 Ovarian Carcinoma FIGO Stage IIIA1 Ovarian Cancer Ovarian cancer with positive retroperitoneal lymph nodes only. Metastasis equal or less than 10 mm. (FIGO, 2014) C128089 Neoplastic Process FIGO Stage IIIA1(i) Ovarian Cancer FIGO Stage IIIA1(i) Ovarian Cancer CL508840 CTRP Malignant FIGO Stage IIIA1(i) Ovarian Cancer FIGO Stage IIIA1(i) Ovarian Carcinoma FIGO Stage IIIA1(i) Ovarian Cancer Ovarian cancer with positive retroperitoneal lymph nodes only. Metastasis greater than 10 mm. (FIGO, 2014) C128090 Neoplastic Process FIGO Stage IIIA1(ii) Ovarian Cancer FIGO Stage IIIA1(ii) Ovarian Cancer CL508842 CTRP Malignant FIGO Stage IIIA1(ii) Ovarian Cancer FIGO Stage IIIA1(ii) Ovarian Carcinoma FIGO Stage IIIA1(ii) Ovarian Cancer Ovarian cancer with microscopic, extrapelvic (above the brim) peritoneal involvement +/- positive retroperitoneal lymph nodes. (FIGO, 2014) C128091 Neoplastic Process FIGO Stage IIIA2 Ovarian Cancer FIGO Stage IIIA2 Ovarian Cancer CL508845 CTRP Malignant FIGO Stage IIIA2 Ovarian Cancer FIGO Stage IIIA2 Ovarian Carcinoma FIGO Stage IIIA2 Ovarian Cancer Ovarian cancer with macroscopic, extrapelvic, peritoneal metastasis equal or less than 2 cm +/- positive retroperitoneal lymph nodes. Includes extension to capsule of liver/spleen. (FIGO, 2014) C128092 Neoplastic Process FIGO Stage IIIB Ovarian Cancer FIGO Stage IIIB Ovarian Cancer CL508847 CTRP Malignant FIGO Stage IIIB Ovarian Cancer FIGO Stage IIIB Ovarian Carcinoma FIGO Stage IIIB Ovarian Cancer Ovarian cancer with macroscopic, extrapelvic, peritoneal metastasis greater than 2 cm +/- positive retroperitoneal lymph nodes. Includes extension to capsule of liver/spleen. (FIGO, 2014) C128093 Neoplastic Process FIGO Stage IIIC Ovarian Cancer FIGO Stage IIIC Ovarian Cancer CL508848 CTRP Malignant FIGO Stage IIIC Ovarian Cancer FIGO Stage IIIC Ovarian Carcinoma FIGO Stage IIIC Ovarian Cancer Ovarian cancer with pleural effusion with positive cytology. (FIGO, 2014) C128094 Neoplastic Process FIGO Stage IVA Ovarian Cancer FIGO Stage IVA Ovarian Cancer CL507823 CTRP Malignant FIGO Stage IVA Ovarian Cancer FIGO Stage IVA Ovarian Carcinoma Stage IVA Ovarian Epithelial Cancer FIGO Stage IVA Ovarian Cancer Ovarian cancer with hepatic and/or splenic parenchymal metastasis, metastasis to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside of the abdominal cavity). (FIGO, 2014) C128095 Neoplastic Process FIGO Stage IVB Ovarian Cancer FIGO Stage IVB Ovarian Cancer CL507824 CTRP Malignant FIGO Stage IVB Ovarian Cancer FIGO Stage IVB Ovarian Carcinoma Stage IVB Ovarian Epithelial Cancer FIGO Stage IVB Ovarian Cancer A category of staging terms for ovarian cancer according to the American Joint Committee on cancer (AJCC) 6th and 7th editions. International Federation of Gynecology and Obstetrics (FIGO) ovarian cancer staging terms prior to 2014 are included in this category if synonymous with the AJCC terms. C128106 Neoplastic Process Ovarian Cancer by AJCC v6 and v7 Stage CL508915 Malignant Ovarian Cancer by AJCC v6 and v7 Stage Ovarian Carcinoma by AJCC v6 and v7 Stage Ovarian Cancer by AJCC v6 and v7 Stage A germ tumor that arises from the vagina. C128112 Neoplastic Process Vaginal Germ Cell Tumor CL509794 Undetermined Vaginal Germ Cell Tumor Vaginal Germ Cell Tumor A rare benign cystic teratoma that arises from the vagina. It presents as a slow growing cyst in the vaginal wall that contains sebaceous material and hair. The cyst is lined by squamous epithelium. Skin adnexal structures and sometimes smooth and skeletal muscle are present. C128113 Neoplastic Process Vaginal Dermoid Cyst CL509355 Benign Vaginal Dermoid Cyst Vaginal Mature Cystic Teratoma Vaginal Teratoma Vaginal Dermoid Cyst A high angular resolution diffusion MRI technique that maps complex tissue structures at the scale of single MRI voxels. C128124 Diagnostic Procedure Diffusion Spectrum Imaging Diffusion Spectrum Imaging CL509812 CTRP DSI Diffusion Spectrum Imaging Diffusion Spectrum Imaging Duct carrying spermatozoa. C12813 Body Part, Organ, or Organ Component Vas Deferens Vas Deferens C0042360 CDISC GDC UBERON A coiled tube that carries the sperm out of the testes. A duct carrying spermatozoa from the epididymides to the urethra. A secretory duct that transports sperm from the testis. In mammals this is a continuation of the epididymis and ends in the prostatic urethra where it terminates to form ejaculatory duct. Vas_Deferens Vas Deferens UBERON:0001000 Ductus Deferens VAS DEFERENS Vas Deferens deferent duct ductus deferens vas deferen vas deferens Vas Deferens An intraepithelial lesion of the vulvar squamous epithelium associated with HPV infection. It is characterized by maturation abnormalities and nuclear hyperchromasia that are confined to the basement membrane. C128142 Neoplastic Process Vulvar Squamous Intraepithelial Lesion, HPV-Associated CL509577 Undetermined Vulvar Intraepithelial Neoplasia, HPV-Associated Vulvar SIL Vulvar Squamous Intraepithelial Lesion Vulvar Squamous Intraepithelial Lesion, HPV-Associated Vulvar Squamous Intraepithelial Lesion, HPV-Associated A primary invasive malignant epithelial neoplasm of the vulva showing morphological features of recognized breast adenocarcinomas. (WHO, 2014) C128162 Neoplastic Process Vulvar Adenocarcinoma of Mammary Gland Type CL509013 Malignant AGMLGs Adenocarcinoma of Anogenital Mammary-Like Glands Adenocarcinoma of Anogenital Mammary-Type Glands Adenocarcinoma of the Vulva with Breast Carcinoma Features Vulvar Adenocarcinoma of Mammary Gland Type Vulvar Adenocarcinoma of Mammary Gland Type A rare adenocarcinoma arising from vulvar skin sweat glands. C128164 Neoplastic Process Vulvar Adenocarcinoma of Sweat Gland Origin CL509566 Malignant Vulvar Adenocarcinoma of Sweat Gland Origin Vulvar Adenocarcinoma of Sweat Gland Type Vulvar Adenocarcinoma of Sweat Gland Origin A rare malignant phyllodes tumor arising from the vulva. C128165 Neoplastic Process Malignant Vulvar Phyllodes Tumor CL509751 Malignant Malignant Vulvar Phyllodes Tumor Malignant Vulvar Phyllodes Tumor A rare vulvar mucinous adenocarcinoma that resembles a large intestinal adenocarcinoma. C128166 Neoplastic Process Vulvar Mucinous Adenocarcinoma, Intestinal-Type CL509363 Malignant Primary Villoglandular Mucinous Adenocarcinoma Arising in the Surface Epithelium of the Vulva Vulvar Adenocarcinoma of Intestinal Type Vulvar Adenocarcinoma, Intestinal-Type Vulvar Cloacogenic Adenocarcinoma Vulvar Cloacogenic Carcinoma Vulvar Mucinous Adenocarcinoma, Intestinal-Type Vulvar Mucinous Adenocarcinoma, Intestinal-Type A keratoacanthoma that arises from the vulva. It grows rapidly and may regress spontaneously. It is considered a variant of well-differentiated squamous cell carcinoma with distinct clinical behavior. C128167 Neoplastic Process Vulvar Keratoacanthoma CL509571 Malignant Vulvar_Keratoacanthoma-like_Carcinoma Vulvar Keratoacanthoma Vulvar Keratoacanthoma An adenoma that arises from the colon. It is characterized by the presence of severe epithelial dysplasia. C128171 Neoplastic Process Colon Adenoma with Severe Dysplasia CL509713 Benign Colon Adenoma with Severe Dysplasia Colon Adenoma with Severe Dysplasia A benign glandular neoplasm that arises from the vulva. It presents as a mass or cystic lesion in or adjacent to the interlabial sulcus. It is characterized by the presence of complex branching papillae with fibrovascular stalks, lined by uniform columnar epithelial secretory cells and myoepithelial cells. C128240 Neoplastic Process Vulvar Hidradenoma Papilliferum CL509365 Benign Vulvar Hidradenoma Papilliferum Vulvar Papillary Hidradenoma Vulvar Hidradenoma Papilliferum A benign epithelial-stromal neoplasm that arises from the vulva and resembles the breast fibroadenoma. C128242 Neoplastic Process Vulvar Fibroadenoma CL509568 Benign Vulvar Ectopic Fibroadenoma Vulvar Fibroadenoma Vulvar Fibroadenoma A neuroendocrine carcinoma that arises from the vulva. This category includes small cell and large cell neuroendocrine carcinoma. Most small cell neuroendocrine carcinomas of the vulva are Merkel cell carcinomas. C128243 Neoplastic Process Vulvar Neuroendocrine Carcinoma Vulvar Neuroendocrine Carcinoma CL509366 CTRP Malignant Vulvar High Grade Neuroendocrine Carcinoma Vulvar High Grade Neuroendocrine Neoplasm Vulvar Neuroendocrine Cancer Vulvar Neuroendocrine Carcinoma Vulvar Neuroendocrine Carcinoma A rare small cell neuroendocrine carcinoma that arises from the vulva. C128244 Neoplastic Process Vulvar Small Cell Neuroendocrine Carcinoma CL509576 Malignant Vulvar Small Cell Carcinoma Vulvar Small Cell Neuroendocrine Carcinoma Vulvar Small Cell Neuroendocrine Carcinoma A high grade neuroendocrine carcinoma that arises from the vulva. It is characterized by the presence of malignant large cells. C128245 Neoplastic Process Vulvar Large Cell Neuroendocrine Carcinoma CL509572 Malignant Vulvar Large Cell Neuroendocrine Carcinoma Vulvar Large Cell Neuroendocrine Carcinoma A Merkel cell carcinoma that arises from the vulva. It usually presents as a cutaneous nodular lesion. Most small cell neuroendocrine carcinomas of the vulva are Merkel cell carcinomas. C128247 Neoplastic Process Vulvar Merkel Cell Carcinoma CL509575 Malignant Vulvar Merkel Cell Carcinoma Vulvar Merkel Cell Carcinoma An uncommon benign neoplasm of the vulva, composed of lobules of mature adipocytes. C128270 Neoplastic Process Vulvar Lipoma CL509573 Benign Vulvar Lipoma Vulvar Lipoma A lipoma of the vulva with a predominant fibrous component. C128271 Neoplastic Process Vulvar Fibrolipoma CL509569 Benign Vulvar Fibrolipoma Vulvar Fibrolipoma An uncommon benign polypoid or nodular mesenchymal neoplasm that arises in the vulvar region. It is characterized by the presence of oval or spindle-shaped cells in a collagenous stroma and is separated from the epidermis by a variably thick Grenz zone. C128272 Neoplastic Process Vulvar Superficial Myofibroblastoma CL509367 Benign Vulvar Superficial Myofibroblastoma Vulvar Superficial Myofibroblastoma An extremely rare malignant mesenchymal neoplasm of the vulva exhibiting skeletal muscle differentiation with an alveolar pattern. C128273 Neoplastic Process Vulvar Alveolar Rhabdomyosarcoma CL509567 Malignant Vulvar Alveolar Rhabdomyosarcoma Vulvar Alveolar Rhabdomyosarcoma A benign, atypical, or dysplastic melanocytic nevus that arises from the vulva. C128289 Neoplastic Process Vulvar Melanocytic Nevus CL509574 Undetermined Vulvar Melanocytic Nevus Vulvar Melanocytic Nevus A rare germ cell tumor that arises from the vulva. C128294 Neoplastic Process Vulvar Germ Cell Tumor CL509570 Undetermined Vulvar Germ Cell Tumor Vulvar Germ Cell Tumor A rare yolk sac tumor that arises from the vulva. C128295 Neoplastic Process Vulvar Yolk Sac Tumor CL509364 Malignant Vulvar Endodermal Sinus Tumor Vulvar Yolk Sac Tumor Vulvar Yolk Sac Tumor A neurofibroma that grows along small branches of nerves in the dermis in patients with neurofibromatosis. It presents as a solid cutaneous tumor. C128451 Neoplastic Process Cutaneous Neurofibroma Cutaneous Neurofibroma C3279069 CTRP Cellosaurus Benign Cutaneous (Skin) Neurofibroma Cutaneous Neurofibroma Dermal Neurofibroma Cutaneous Neurofibroma The reemergence of a gastrointestinal stromal tumor after a period of remission. C128460 Neoplastic Process Recurrent Gastrointestinal Stromal Tumor Recurrent Gastrointestinal Stromal Tumor CL509774 CTRP Undetermined Recurrent Gastrointestinal Stromal Tumor Recurrent Gastrointestinal Stromal Tumor (GIST) Recurrent Gastrointestinal Stromal Tumor The organ of milk secretion; one of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest of the mature female; it is rudimentary in the male. C12851 Body Part, Organ, or Organ Component Breast, Female Female Breast C0222603 Female_Breast Breast, Female Female Breast Female Breast A type of fractionated stereotactic radiotherapy that does not involve the use of a frame to hold the patient's head still or provide external reference points. C128555 Therapeutic or Preventive Procedure Frameless Fractionated Stereotactic Radiation Therapy Frameless Fractionated Stereotactic Radiation Therapy CL512086 CTRP FFSRT FSRS Frameless Fractionated Stereotactic Radiation Therapy Frameless SRT Frameless Fractionated Stereotactic Radiation Therapy A carcinoma that arises from the esophagus and is not amenable to surgical resection. C128563 Neoplastic Process Unresectable Esophageal Carcinoma Unresectable Esophageal Carcinoma CL509679 CTRP Malignant Esophageal Cancer Unresectable Esophageal Carcinoma Unresectable Unresectable Cancer of Esophagus Unresectable Cancer of the Esophagus Unresectable Esophageal Cancer Unresectable Esophageal Carcinoma Unresectable Esophageal Carcinoma The seminal gland that is located to the anatomical left of the bladder. C128598 Body Part, Organ, or Organ Component Left Seminal Vesicle C0227980 PI-RADS L SV Left Seminal Vesicle Left Seminal Vesicle The seminal gland that is located to the anatomical right of the bladder. C128611 Body Part, Organ, or Organ Component Right Seminal Vesicle C0227979 PI-RADS R SV Right Seminal Vesicle Right Seminal Vesicle A B-acute lymphoblastic leukemia (B-ALL) that does not have the cytogenetic abnormality t(9;22)(q34;q11.2). Most cases of B-ALL do not have this translocation. C128629 Neoplastic Process Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative CL509011 CTRP Malignant Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Ph1-Negative ALL Ph1-Negative Acute Lymphoblastic Leukemia Philadelphia Chromosome Negative ALL Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Philadelphia-Negative ALL Philadelphia-Negative Acute Lymphoblastic Leukemia Precursor B Lymphoblastic Leukemia, Philadelphia Chromosome Negative Precursor B-Lymphoblastic Leukemia, Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative A very rare NK-cell lymphoma with pathologic and clinical features posing difficulty in its exact diagnosis and classification. C128697 Neoplastic Process NK-Cell Lymphoma, Unclassifiable NK-Cell Lymphoma, Unclassifiable CL509501 CTRP Malignant NK-Cell Lymphoma, Unclassifiable NK-Cell Lymphoma, Unclassifiable The reemergence of non-squamous non-small cell lung carcinoma after a period of remission. C128797 Neoplastic Process Recurrent Lung Non-Squamous Non-Small Cell Carcinoma CL509666 Malignant Recurrent Lung Non-Squamous Non-Small Cell Carcinoma Recurrent Non-Squamous Non-Small Cell Lung Cancer Recurrent Non-Squamous Non-Small Cell Lung Carcinoma Recurrent Lung Non-Squamous Non-Small Cell Carcinoma A non-squamous non-small cell carcinoma that arises from the lung and has metastasized to another anatomic site. C128798 Neoplastic Process Metastatic Lung Non-Squamous Non-Small Cell Carcinoma CL509628 Malignant Metastatic Lung Non-Squamous Non-Small Cell Carcinoma Metastatic Non-Squamous Non-Small Cell Lung Cancer Metastatic Non-Squamous Non-Small Cell Lung Carcinoma Metastatic Lung Non-Squamous Non-Small Cell Carcinoma An autosomal dominant genetic disorder caused by mutations in the CDKN2A gene, encoding cyclin-dependent kinase inhibitor 2A. The condition is characterized by cutaneous malignant melanoma associated with this genetic alteration. C128801 Neoplastic Process Cutaneous Malignant Melanoma 2 C1835044 Cellosaurus Malignant CMM2 Cutaneous Malignant Melanoma 2 Cutaneous Malignant Melanoma 2 The reemergence of intrahepatic cholangiocarcinoma after a period of remission. C128807 Neoplastic Process Recurrent Intrahepatic Cholangiocarcinoma Recurrent Intrahepatic Cholangiocarcinoma C3544265 CTRP Malignant Recurrent Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) Recurrent Intrahepatic Cholangiocarcinoma Recurrent Intrahepatic Cholangiocarcinoma An aggressive variant of lung adenocarcinoma that exhibits a micropapillary architectural pattern. The prognosis is usually poor. C128847 Neoplastic Process Lung Micropapillary Adenocarcinoma CL536215 CPTAC Cellosaurus GDC Malignant 8265/3 Micropapillary carcinoma, NOS Lung Micropapillary Adenocarcinoma Micropapillary adenocarcinoma Micropapillary carcinoma, NOS Lung Micropapillary Adenocarcinoma An imaging modality that combines ultrasound imaging with diffused light imaging by near-infrared (NIR) optical tomography to obtain coregistered ultrasound and NIR diffusive light images in order to improve optical imaging reconstruction and location certainty. The use of NIR in this combination can also be used to assess functional parameters of a tissue. C128880 Diagnostic Procedure Ultrasound-Guided Near-Infrared Optical Tomography Ultrasound-Guided Near-Infrared Optical Tomography CL512305 CTRP NIR/US Ultrasound-Guided Near-Infrared Optical Tomography Ultrasound-Guided Near-Infrared Tomography Ultrasound-Guided Near-Infrared Optical Tomography A lymph node which is located above the clavicle. C12903 Body Part, Organ, or Organ Component Supraclavicular Lymph Node Supraclavicular Lymph Node C0229730 CDISC GDC PCDC UBERON mCode A lymph node which is located above the clavicle. A lymph node which is located above the clavicle. (NCI) Lymph nodes located above the clavicle (collarbone). Supraclavicular_Lymph_Node Lymph Node(s) Supraclavicular Supraclavicular Supraclavicular lymph nodes UBERON:0035279 Lymph Node(s) Supraclavicular SUPRACLAVICULAR LYMPH NODE Structure of supraclavicular lymph node (body structure) Supraclavicular Lymph Node Supraclavicular Lymph Nodes Supraclavicular Nodes Supraclavicular lymph nodes nodus lymphaticus supraclavicularis axillae supraclavicular lymph node supraclavicular node Supraclavicular Lymph Node One of approximately 20-30 lymph nodes in chain formation that traverse the concavity of the underarm to the clavicle. C12904 Body Part, Organ, or Organ Component Axillary Lymph Node Axillary Lymph Node C0729594 CDISC GDC PCDC mCode A lymph node in the armpit region that drains lymph from the breast and nearby areas. Lymph node(s) in the axillary region. Axillary_Lymph_Node Axillary Axillary lymph nodes Lymph Node(s) Axilla Lymph Node, Axillary Lymph nodes of axilla or arm ALN AXILLARY LYMPH NODE Axillary Lymph Node Axillary Lymph Nodes Axillary Node Axillary Nodes Axillary lymph node structure (body structure) Axillary lymph nodes LYMPH NODE, AXILLARY Lymph Node(s) Axilla Lymph Node, Axillary Lymph nodes of axilla or arm axillary lymph node Axillary Lymph Node IDH-mutant astrocytoma characterized by the presence of well-differentiated fibrillary glial cells diffusely infiltrating the central nervous system. C129271 Neoplastic Process Astrocytoma, IDH-Mutant, Grade 2 CL512140 CPTAC Cellosaurus GDC Undetermined Diffuse astrocytoma, IDH-mutant Astrocytoma, IDH-Mutant, Grade 2 Astrocytoma, IDH-Mutant, Grade II Diffuse Astrocytoma, IDH Mutant Diffuse Astrocytoma, IDH-Mutant Diffuse astrocytoma, IDH-mutant Astrocytoma, IDH-Mutant, Grade 2 Gemistocytic astrocytoma carrying IDH mutations. C129272 Neoplastic Process Gemistocytic Astrocytoma, IDH-Mutant CL512354 CPTAC Undetermined Gemistocytic Astrocytoma, IDH Mutant Gemistocytic Astrocytoma, IDH-Mutant Gemistocytic Astrocytoma, IDH-Mutant Diffuse astrocytoma lacking mutations in IDH1 or IDH2 genes. C129274 Neoplastic Process Diffuse Astrocytoma, IDH-Wildtype CL512141 CPTAC Cellosaurus GDC Undetermined Diffuse astrocytoma, IDH-wildtype Diffuse Astrocytoma, IDH Wild Type Diffuse Astrocytoma, IDH-Wildtype Diffuse astrocytoma, IDH-wildtype Diffuse Astrocytoma, IDH-Wildtype A central nervous system tumor with morphological features of diffuse astrocytoma in which there is insufficient information on the IDH genes status. C129277 Neoplastic Process Diffuse Astrocytoma, Not Otherwise Specified CL512142 CPTAC Undetermined Diffuse Astrocytoma, NOS Diffuse Astrocytoma, Not Otherwise Specified Diffuse Astrocytoma, Not Otherwise Specified A poorly differentiated squamous cell carcinoma that arises from the gingiva. It is characterized by the presence of malignant pleomorphic spindle cells. C129289 Neoplastic Process Gingival Spindle Cell Carcinoma CL512355 Cellosaurus Malignant Gingival Spindle Cell Carcinoma Gingival Spindle Cell Carcinoma IDH-mutant astrocytoma characterized by the presence of increased mitotic activity and anaplastic features. C129290 Neoplastic Process Astrocytoma, IDH-Mutant, Grade 3 CL512333 CPTAC GDC Malignant Anaplastic astrocytoma, IDH-mutant Anaplastic Astrocytoma, IDH Mutant Anaplastic Astrocytoma, IDH-Mutant Anaplastic astrocytoma, IDH-mutant Astrocytoma, IDH-Mutant, Grade 3 Astrocytoma, IDH-Mutant, Grade III Astrocytoma, IDH-Mutant, Grade 3 Anaplastic astrocytoma lacking mutations in IDH1 or IDH2 genes. C129291 Neoplastic Process Anaplastic Astrocytoma, IDH-Wildtype CL512334 CPTAC GDC Malignant Anaplastic astrocytoma, IDH-wildtype Anaplastic Astrocytoma, IDH Wild Type Anaplastic Astrocytoma, IDH-Wildtype Anaplastic astrocytoma, IDH-wildtype Anaplastic Astrocytoma, IDH-Wildtype A central nervous system tumor with morphological features of anaplastic astrocytoma in which there is insufficient information on the IDH genes status. C129292 Neoplastic Process Anaplastic Astrocytoma, Not Otherwise Specified CL512335 CPTAC Malignant Anaplastic Astrocytoma, NOS Anaplastic Astrocytoma, Not Otherwise Specified Anaplastic Astrocytoma, Not Otherwise Specified An IDH-wildtype glioblastoma characterized by the presence of large epithelioid cells with abundant eosinophilic cytoplasm, vesicular chromatin, and prominent nucleoli. C129293 Neoplastic Process Epithelioid Glioblastoma CL512400 GDC Malignant Epithelioid glioblastoma E-GB E-GBM Epithelioid Glioblastoma Epithelioid glioblastoma e-GB e-GBM Epithelioid Glioblastoma A central nervous system tumor with morphological features of glioblastoma in which there is insufficient information on the IDH genes status. C129295 Neoplastic Process Glioblastoma, Not Otherwise Specified CL512283 Malignant Glioblastoma, NOS Glioblastoma, Not Otherwise Specified Glioblastoma, Not Otherwise Specified A glioblastoma characterized by the presence of well-demarcated nodules which contain primitive cells exhibiting neuronal differentiation. C129296 Neoplastic Process Glioblastoma with Primitive Neuronal Component CL512282 Malignant Glioblastoma with PNET-Like Component Glioblastoma with Primitive Neuronal Component Glioblastoma with Primitive Neuronal Component A diffuse midline glioma characterized by the presence of histone H3 K27M mutation. C129309 Neoplastic Process Diffuse Midline Glioma, H3 K27M-Mutant Diffuse Midline Glioma, H3 K27M-Mutant CL512144 CTRP DIPG/DMG GDC Malignant 9385/3 Diffuse midline glioma, H3 K27M-mutant Diffuse Midline Glioma H3 K27M Diffuse Midline Glioma, H3 K27M-Mutant Diffuse midline glioma, H3 K27M-mutant Non-DIPG Diffuse Midline Glioma, H3 K27M-Mutant An oligodendroglioma carrying IDH gene family mutation and combined whole-arm losses of 1p and 19q (1p/19q codeletion). C129318 Neoplastic Process Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted CL512489 CPTAC CTRP GDC Undetermined Oligodendroglioma, IDH-mutant and 1p/19q-codeleted Oligodendroglioma, IDH Mutant and 1p/19q Codeleted Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted Oligodendroglioma, IDH-mutant and 1p/19q-codeleted Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted A central nervous system tumor with morphological features of oligodendroglioma in which there is insufficient information on the IDH genes and 1p/19q codeletion status. C129319 Neoplastic Process Oligodendroglioma, Not Otherwise Specified C2732301 CPTAC GDC Undetermined 9450/3 Oligodendroglioma, NOS Oligodendroglioma, NOS Oligodendroglioma, Not Otherwise Specified Oligodendroglioma, Not Otherwise Specified An anaplastic oligodendroglioma carrying IDH gene family mutation and combined whole-arm losses of 1p and 19q (1p/19q codeletion). C129321 Neoplastic Process Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted CL512337 CPTAC GDC Malignant Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted Anaplastic Oligodendroglioma, IDH mutant and 1p/19q Codeleted Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted Anaplastic oligodendroglioma, IDH-mutant and 1p/19q-codeleted Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted A central nervous system tumor with morphological features of anaplastic oligodendroglioma in which there is insufficient information on the IDH genes and 1p/19q codeletion status. C129322 Neoplastic Process Anaplastic Oligodendroglioma, Not Otherwise Specified CL512338 CPTAC Malignant Anaplastic Oligodendroglioma, NOS Anaplastic Oligodendroglioma, Not Otherwise Specified Anaplastic Oligodendroglioma, Not Otherwise Specified A central nervous system tumor with morphological features of oligoastrocytoma in which there is insufficient information on the IDH genes status. C129323 Neoplastic Process Oligoastrocytoma, Not Otherwise Specified CL512388 CPTAC Undetermined Oligoastrocytoma, NOS Oligoastrocytoma, Not Otherwise Specified Oligoastrocytoma, Not Otherwise Specified A central nervous system tumor with morphological features of anaplastic oligoastrocytoma in which there is insufficient information on the IDH genes status. C129324 Neoplastic Process Anaplastic Oligoastrocytoma, Not Otherwise Specified CL512336 CPTAC Malignant Anaplastic Oligoastrocytoma, NOS Anaplastic Oligoastrocytoma, Not Otherwise Specified Anaplastic Oligoastrocytoma, Not Otherwise Specified A glioma that has diffusely infiltrated the surrounding central nervous system tissues. C129325 Neoplastic Process Diffuse Glioma CL512143 Undetermined Diffuse Glioma Diffuse Glioma A technique that monitors blood oxygen level dependent (BOLD) signals to map brain regions that active while not performing any specific task. C129326 Diagnostic Procedure Resting State Functional Connectivity Magnetic Resonance Imaging Resting State Functional Connectivity Magnetic Resonance Imaging CL512231 CTRP RS-fcMRI Resting State Functional Connectivity MRI Resting State Functional Connectivity Magnetic Resonance Imaging Resting fcMRI Resting State Functional Connectivity Magnetic Resonance Imaging A WHO grade 3 pleomorphic xanthoastrocytoma characterized by the presence of five or more mitoses per 10 high-power fields. Necrosis may be present. Patients have shorter survival rates when compared to those with WHO grade 2 pleomorphic xanthoastrocytoma. C129327 Neoplastic Process Anaplastic Pleomorphic Xanthoastrocytoma Anaplastic Pleomorphic Xanthoastrocytoma CL512339 CTRP GDC Malignant Anaplastic pleomorphic xanthroastrocytoma APX Anaplastic Pleomorphic Xanthoastrocytoma Anaplastic pleomorphic xanthroastrocytoma WHO Grade 3 Pleomorphic Xanthoastrocytoma WHO Grade III Pleomorphic Xanthoastrocytoma Anaplastic Pleomorphic Xanthoastrocytoma A supratentorial ependymoma characterized by a gene fusion involving ZFTA and RELA genes. It accounts for the majority of supratentorial ependymomas in children. It has an unfavorable outcome when compared to other ependymoma subtypes. C129351 Neoplastic Process Supratentorial Ependymoma, ZFTA-RELA Fusion-Positive CL512399 GDC Malignant 9396/3 Ependymoma, RELA fusion positive Ependymoma, RELA fusion-positive Ependymoma, RELA Fusion-Positive Ependymoma, RELA fusion-positive Ependymoma, ZFTA-RELA Fusion-Positive Supratentorial Ependymoma, RELA Fusion-Positive Supratentorial Ependymoma, ZFTA-RELA Fusion-Positive Supratentorial Ependymoma, ZFTA::RELA Fusion-Positive Supratentorial Ependymoma, ZFTA-RELA Fusion-Positive A relatively slow growing diffuse leptomeningeal neoplasm usually affecting children and adolescents. It is characterized by the presence of clear glial neoplastic cells reminiscent of oligodendroglioma. A neuronal component may be present. The prognosis is variable. C129424 Neoplastic Process Diffuse Leptomeningeal Glioneuronal Tumor CL512526 GDC Undetermined Diffuse leptomeningeal glioneuronal tumor DLGNT Diffuse Leptomeningeal Glioneuronal Tumor Diffuse leptomeningeal glioneuronal tumor Disseminated Oligodendroglial-Like Leptomeningeal Tumor of Childhood Diffuse Leptomeningeal Glioneuronal Tumor A low-grade tumor affecting the cerebral hemispheres. It is composed of cells with glial and/or neuronal differentiation forming multiple nodules with prominent vacuolation. C129427 Neoplastic Process Multinodular and Vacuolated Tumor of the Cerebrum Multinodular and Vacuolated Neuronal Tumor CL512565 CTRP Undetermined MVNT Multinodular and Vacuolated Neuronal Tumor Multinodular and Vacuolated Neuronal Tumor of the Cerebrum Multinodular and Vacuolated Tumor of the Cerebrum Multinodular and Vacuolating Neuronal Tumor Multinodular and Vacuolated Neuronal Tumor A central nervous system neoplasm mostly occurring in the fourth ventricle region. It is characterized by the presence of neurocytes forming pseudorosettes and astrocytes which contain Rosenthal fibers. Cytologic atypia is minimal. C129431 Neoplastic Process Rosette-Forming Glioneuronal Tumor CL497922 GDC Undetermined 9509/1 Rosette-forming glioneuronal tumor RGNT Rosette-Forming Glioneuronal Tumor Rosette-forming glioneuronal tumor Rosette-Forming Glioneuronal Tumor A medulloblastoma composed of sheets of large cells mixed with cells characterized by marked nuclear pleomorphism and high mitotic activity. C129436 Neoplastic Process Large Cell/Anaplastic Medulloblastoma CL512780 Malignant Large Cell/Anaplastic Medulloblastoma Large Cell/Anaplastic Medulloblastoma A term that refers to the classification of medulloblastomas according to their molecular characteristics. C129439 Neoplastic Process Medulloblastoma Molecular Subtypes CL512710 GDC Malignant Medulloblastoma Molecular Subtypes Medulloblastoma, Genetically Defined Medulloblastoma, Molecularly Defined Molecular Subtypes of Medulloblastoma medulloblastoma molecular classification medulloblastoma_molecular_classification Medulloblastoma Molecular Subtypes A cervical lymph node located above the medial region of the clavicle. C12944 Body Part, Organ, or Organ Component Medial Supraclavicular Lymph Nodes Medial Supraclavicular Lymph Node C1513048 A lymph node located above the collar bone and between the center of the body and a line drawn through the nipple to the shoulder. Medial_Supraclavicular_Lymph_Node Medial Supraclavicular Lymph Node Medial Supraclavicular Lymph Nodes medial supraclavicular lymph node Medial Supraclavicular Lymph Node A molecular subtype of medulloblastoma associated with activation of the WNT pathway. TP53 mutations may be present or absent. WNT pathway activation in medulloblastomas is associated with good outcome. C129440 Neoplastic Process Medulloblastoma, WNT-Activated CL512718 Cellosaurus GDC Malignant 9475/3 Medulloblastoma, WNT-activated Medulloblastoma, WNT-activated, NOS WNT-Activated Medulloblastoma, WNT-Activated Medulloblastoma, WNT-activated WNT Signaling Pathway Aberrant Medulloblastoma WNT-Activated Medulloblastoma, WNT-Activated A molecular subtype of medulloblastoma associated with activation of the sonic hedgehog (SHH) pathway. TP53 mutations may be present or absent. Patients in this group are young children and adults. Overall survival is variable and depends on the presence or absence of metastatic disease, histology, and the age at diagnosis. C129441 Neoplastic Process Medulloblastoma, SHH-Activated CL512717 GDC Malignant SHH-Activated Medulloblastoma, SHH-Activated SHH-Activated Medulloblastoma, SHH-Activated Medulloblastoma associated with activation of the sonic hedgehog (SHH) pathway and the presence of TP53 mutations. C129442 Neoplastic Process Medulloblastoma, SHH-Activated, TP53-Mutant CL512715 Cellosaurus GDC Malignant 9476/3 Medulloblastoma, SHH-activated and TP53-mutant Medulloblastoma, SHH-Activated, TP53-Mutant Medulloblastoma, SHH-activated and TP53-mutant Medulloblastoma, SHH-Activated, TP53-Mutant Medulloblastoma associated with activation of the sonic hedgehog (SHH) pathway and the absence of TP53 mutations. C129443 Neoplastic Process Medulloblastoma, SHH-Activated, TP53-Wildtype CL512716 Cellosaurus GDC Malignant Medulloblastoma, SHH-activated and TP53-wildtype Medulloblastoma, SHH-Activated, TP53-Wildtype Medulloblastoma, SHH-activated and TP53-wildtype Medulloblastoma, SHH-Activated, TP53-Wildtype Medulloblastoma not associated with activation of the WNT pathway or sonic hedgehog (SHH) pathway. TP53 mutations are absent. This molecular subtype includes medulloblastomas numerically designated as "group 3" and "group 4". C129444 Neoplastic Process Medulloblastoma, Non-WNT/Non-SHH CL512713 GDC Malignant 9477/3 Medulloblastoma, non-WNT/non-SHH Non-WNT/non-SHH Activated Medulloblastoma, Non-WNT/Non-SHH Medulloblastoma, non-WNT/non-SHH Non-WNT/Non-SHH Medulloblastoma Non-WNT/non-SHH Activated Medulloblastoma, Non-WNT/Non-SHH Medulloblastoma not associated with activation of the WNT pathway or sonic hedgehog (SHH) pathway. MYC amplifications may be present. TP53 mutations are absent. Patients in this group are usually young children. The overall survival is the worst among all the molecular groups. C129445 Neoplastic Process Medulloblastoma, Non-WNT/Non-SHH, Group 3 CL512711 Cellosaurus GDC Malignant Medulloblastoma, group 3 Medulloblastoma, Non-WNT/Non-SHH, Group 3 Medulloblastoma, group 3 Medulloblastoma, Non-WNT/Non-SHH, Group 3 Medulloblastoma not associated with activation of the WNT pathway or sonic hedgehog (SHH) pathway. MYC amplifications are absent. TP53 mutations are absent. Chromosome 17 abnormalities may be present. C129446 Neoplastic Process Medulloblastoma, Non-WNT/Non-SHH, Group 4 CL512712 Cellosaurus GDC Malignant Medulloblastoma, group 4 Medulloblastoma, Non-WNT/Non-SHH, Group 4 Medulloblastoma, group 4 Medulloblastoma, Non-WNT/Non-SHH, Group 4 A medulloblastoma which has not been further characterized. C129447 Neoplastic Process Medulloblastoma, Not Otherwise Specified Medulloblastoma, Not Otherwise Specified CL512714 CTRP GDC Malignant 9470/3 Medulloblastoma, NOS Not Determined Medulloblastoma, NOS Medulloblastoma, Not Otherwise Specified Not Determined Medulloblastoma, Not Otherwise Specified The first lymph node that is affected by cancer spread from the primary site. Sentinel lymph node biopsy is part of the staging work-up to determine early metastasis to regional lymph nodes in patients with breast carcinoma or melanoma. C12947 Body Part, Organ, or Organ Component Sentinel Lymph Node Sentinel Lymph Node C0677944 The first lymph node to which cancer is likely to spread from the primary tumor. Cancer cells may appear first in the sentinel node before spreading to other lymph nodes. Sentinel_Lymph_Node SLN Sentinel Lymph Node Sentinel Node sentinel lymph node Sentinel Lymph Node A tube that carries various secretions from one part of the body to another. C12948 Body Part, Organ, or Organ Component Duct C0687028 CDISC A tube that carries various secretions from one part of the body to another. (NCI) In medicine, a tube or vessel of the body through which fluids pass. Duct DUCT Duct duct Duct An embryonal tumor with multilayered rosettes characterized by the absence of C19MC amplification. Approximately half of embryonal tumors with multilayered rosettes that lack a C19MC alteration carry DICER1 mutations. C129499 Neoplastic Process Embryonal Tumor with Multilayered Rosettes without C19MC Alteration C3267147 Malignant Embryonal Tumor with Multilayered Rosettes without C19MC Alteration Embryonal Tumor with Multilayered Rosettes without C19MC Alteration A central nervous system embryonal neoplasm characterized by the presence of histological features consistent with atypical teratoid/rhabdoid tumor and absence of mutations of the INI1 gene or SMARCA4 (BRG1) gene. C129501 Neoplastic Process Central Nervous System Embryonal Tumor with Rhabdoid Features CL512681 GDC Malignant CNS Embryonal tumor with rhabdoid features Embryonal tumor with rhabdoid features CNS Embryonal Tumor with Rhabdoid Features CNS Embryonal tumor with rhabdoid features Central Nervous System Embryonal Tumor with Rhabdoid Features Central Nervous System Embryonal Tumor with Rhabdoid Features A mesenchymal, non-meningothelial neoplasm arising from the central nervous system. It is characterized by a collagenous and low cellularity spindle cell and/or hemangiopericytomatous histopathological pattern, recurrent intrachromosomal rearrangement on chromosome 12q that results in the fusion of the NAB2 and STAT6 genes, high recurrence rates, and long-term risk of systemic metastasis. C129526 Neoplastic Process Central Nervous System Solitary Fibrous Tumor CL512688 Undetermined CNS Solitary Fibrous Tumor CNS Solitary Fibrous Tumor/Hemangiopericytoma Central Nervous System Solitary Fibrous Tumor Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma Central Nervous System Solitary Fibrous Tumor A solitary fibrous tumor that arises from the central nervous system. It most often corresponds to the tumor previously diagnosed as anaplastic hemangiopericytoma. C129527 Neoplastic Process Central Nervous System Solitary Fibrous Tumor, Grade 3 CL512610 GDC Malignant Solitary fibrous tumor/hemangiopericytoma Grade 3 (CNS) CNS Solitary Fibrous Tumor, Grade 3 CNS Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3 Central Nervous System Anaplastic Hemangiopericytoma Central Nervous System Malignant Hemangiopericytoma Central Nervous System Solitary Fibrous Tumor, Grade 3 Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3 Solitary fibrous tumor/hemangiopericytoma Grade 3 (CNS) Central Nervous System Solitary Fibrous Tumor, Grade 3 A solitary fibrous tumor that arises from the central nervous system. It corresponds to the more cellular, less collagenous tumor with plump cells and staghorn vasculature which was diagnosed as central nervous system hemangiopericytoma in the past. C129528 Neoplastic Process Central Nervous System Solitary Fibrous Tumor, Grade 2 CL512611 GDC Undetermined Solitary fibrous tumor/hemangiopericytoma Grade 2 (CNS) CNS Solitary Fibrous Tumor, Grade 2 CNS Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2 Central Nervous System Hemangiopericytoma Central Nervous System Solitary Fibrous Tumor, Grade 2 Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2 Solitary fibrous tumor/hemangiopericytoma Grade 2 (CNS) Central Nervous System Solitary Fibrous Tumor, Grade 2 A solitary fibrous tumor that arises from the central nervous system. It corresponds most often to the collagenous and low cellularity spindle cell tumor which was diagnosed as central nervous system solitary fibrous tumor in the past. C129530 Neoplastic Process Central Nervous System Solitary Fibrous Tumor, Grade 1 CL512613 GDC Undetermined Solitary fibrous tumor/Hemangiopericytoma, grade 1 Solitary fibrous tumor/hemangiopericytoma Grade 1 (CNS) CNS Solitary Fibrous Tumor, Grade 1 CNS Solitary Fibrous Tumor/Hemangiopericytoma, Grade 1 Central Nervous System Solitary Fibrous Tumor Central Nervous System Solitary Fibrous Tumor, Grade 1 Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 1 Solitary fibrous tumor/hemangiopericytoma Grade 1 (CNS) Central Nervous System Solitary Fibrous Tumor, Grade 1 A mesenchymal chondrosarcoma that arises from the central nervous system. C129534 Neoplastic Process Central Nervous System Mesenchymal Chondrosarcoma CL512686 Malignant Central Nervous System Mesenchymal Chondrosarcoma Central Nervous System Mesenchymal Chondrosarcoma A low-grade malignant blood vessel neoplasm that arises from the central nervous system. It is characterized by the presence of epithelioid endothelial cells. C129536 Neoplastic Process Central Nervous System Epithelioid Hemangioendothelioma CL512682 Malignant Central Nervous System Epithelioid Hemangioendothelioma Central Nervous System Epithelioid Hemangioendothelioma A rare Ewing sarcoma/peripheral primitive neuroectodermal tumor that affects the central nervous system either as a primary dural neoplasm or by direct extension from adjacent soft tissues or bone. C129537 Neoplastic Process Central Nervous System Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor CL512683 CPTAC Malignant Central Nervous System Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Central Nervous System Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor An angiolipoma that arises from the central nervous system. C129538 Neoplastic Process Central Nervous System Angiolipoma CL512679 Benign Central Nervous System Angiolipoma Central Nervous System Angiolipoma Intracranial and/or spinal involvement by desmoid fibromatosis. C129548 Neoplastic Process Central Nervous System Desmoid Fibromatosis CL512680 Undetermined Central Nervous System Desmoid Fibromatosis Central Nervous System Desmoid-Type Fibromatosis Central Nervous System Desmoid Fibromatosis A benign fibrous histiocytoma involving the dura or cranial bone. C129549 Neoplastic Process Intracranial Fibrous Histiocytoma CL512777 Benign Intracranial Benign Fibrous Histiocytoma Intracranial Fibrous Histiocytoma Intracranial Fibrous Histiocytoma A rare myofibroblastoma affecting the central nervous system. C129551 Neoplastic Process Central Nervous System Myofibroblastoma CL512687 Benign Central Nervous System Myofibroblastoma Central Nervous System Myofibroblastoma A rare undifferentiated pleomorphic sarcoma (formerly known as malignant fibrous histiocytoma) involving the central nervous system. C129566 Neoplastic Process Central Nervous System Undifferentiated Pleomorphic Sarcoma CL512612 Malignant Central Nervous System Malignant Fibrous Histiocytoma Central Nervous System Undifferentiated Pleomorphic Sarcoma Central Nervous System Undifferentiated Pleomorphic Sarcoma A benign bone-forming neoplasm arising from the skull. C129569 Neoplastic Process Skull Osteoma C1828336 Benign Skull Osteoma Skull Osteoma An anaplastic large cell lymphoma, ALK-positive, arising from the central nervous system. C129598 Neoplastic Process Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive CL512678 Malignant Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive Primary Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive An anaplastic large cell lymphoma, ALK-negative, arising from the central nervous system. C129599 Neoplastic Process Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative CL512677 Malignant Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative Primary Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative A primary central nervous system non-Hodgkin lymphoma derived from mature or post-thymic T-cells or NK-cells. C129600 Neoplastic Process Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma CL512685 Malignant Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma of the Central Nervous System Primary Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma A rare extranodal B-cell non-Hodgkin lymphoma that affects the central nervous system. It is characterized by the presence of lymphoma cells exclusively in the lumina of small vessels, particularly capillaries. C129602 Neoplastic Process Central Nervous System Intravascular Large B-Cell Lymphoma CL512684 Malignant Central Nervous System Intravascular Large B-Cell Lymphoma Central Nervous System Intravascular Large B-Cell Lymphoma An adenocarcinoma that arises from the gastrointestinal system and is not amenable to surgical resection. C129654 Neoplastic Process Unresectable Digestive System Adenocarcinoma Unresectable Digestive System Adenocarcinoma CL512661 CTRP Malignant Unresectable Digestive System Adenocarcinoma Unresectable Gastrointestinal System Adenocarcinoma Unresectable Digestive System Adenocarcinoma One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest. C12971 Body Part, Organ, or Organ Component Breast Breast C0006141 CDISC GDC PCDC mCode Glandular organ located on the chest. The breast is made up of connective tissue, fat, and breast tissue that contains the glands that can make milk. One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest. (NCI) Breast Breast Breast, NOS BREAST Breast Breast structure (body structure) Breast, NOS Breasts breast Breast An acute myeloid leukemia with double mutations of the CEBPA gene. C129782 Neoplastic Process Acute Myeloid Leukemia with Biallelic CEBPA Mutation CL512856 PCDC Malignant Acute myeloid leukemia with biallelic mutation of CEBPA AML with biallelic mutations of CEBPA Acute Myeloid Leukemia with Biallelic CEBPA Mutation Acute Myeloid Leukemia with Biallelic Mutations of CEBPA Acute Myeloid Leukemia with Biallelic CEBPA Mutation An acute myeloid leukemia with single mutations of the CEBPA gene. C129783 Neoplastic Process Acute Myeloid Leukemia with Monoallelic CEBPA Mutation CL512857 Malignant Acute Myeloid Leukemia with Monoallelic CEBPA Mutation Acute Myeloid Leukemia with Monoallelic Mutations of CEBPA Acute Myeloid Leukemia with Monoallelic CEBPA Mutation A carcinoma that arises from the thyroid gland and is not amenable to surgical resection. C129784 Neoplastic Process Unresectable Thyroid Gland Carcinoma Unresectable Thyroid Gland Carcinoma CL513044 CTRP Malignant Unresectable Thyroid Gland Cancer Unresectable Thyroid Gland Carcinoma Unresectable Thyroid Gland Carcinoma A rare, de novo acute myeloid leukemia in which the blasts harbor BCR-ABL1 translocation in the absence of a history and clinical and laboratory features of chronic myelogenous leukemia. C129785 Neoplastic Process Acute Myeloid Leukemia with BCR-ABL1 CL512855 PCDC Malignant Acute myeleoid leukemia with BCR-ABL1 Acute Myeloid Leukemia with BCR-ABL1 Acute Myeloid Leukemia with BCR-ABL1 Fusion Acute Myeloid Leukemia with BCR::ABL1 Acute Myeloid Leukemia with BCR::ABL1 Fusion Provisional Entity: AML with BCR-ABL1 Acute Myeloid Leukemia with BCR-ABL1 Acute myeloid leukemia characterized by the presence of RUNX1 gene mutation. C129786 Neoplastic Process Acute Myeloid Leukemia with RUNX1 Mutation CL512858 PCDC Malignant Acute myeloid leukemia with mutated RUNX1 Acute Myeloid Leukemia with Mutated RUNX1 Acute Myeloid Leukemia with Non-Germline Mutated RUNX1 Acute Myeloid Leukemia with RUNX1 Gene Mutation Acute Myeloid Leukemia with RUNX1 Mutation Provisional entity: AML with mutated RUNX1 Acute Myeloid Leukemia with RUNX1 Mutation B lymphoblastic leukemia/lymphoma characterized by a gene-expression profile similar to that of BCR-ABL1-positive B lymphoblastic leukemia/lymphoma, absence of the pathognomonic BCR-ABL1 rearrangement, alterations of lymphoid transcription factor genes, and a poor outcome. C129787 Neoplastic Process B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like CL512919 Malignant B lymphoblastic leukemia/lymphoma, BCR-ABL1-like B Lymphoblastic Leukemia/Lymphoma with BCR-ABL1-Like Features B Lymphoblastic Leukemia/Lymphoma with BCR::ABL1-Like Features B Lymphoblastic Leukemia/Lymphoma with Translocations Involving Tyrosine Kinases or Cytokine Receptors B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like B Lymphoblastic Leukemia/Lymphoma, BCR::ABL1-Like B Lymphoblastic Leukemia/Lymphoma, Philadelphia-like B-Lymphoblastic Leukemia/Lymphoma with BCR-ABL1-Like Features B-Lymphoblastic Leukemia/Lymphoma with BCR::ABL1-Like Features B-Lymphoblastic Leukemia/Lymphoma, Philadelphia-like B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like Rare involvement of the central nervous system by Langerhans cell histiocytosis. C129806 Neoplastic Process Central Nervous System Langerhans Cell Histiocytosis CL513026 Undetermined Central Nervous System Langerhans Cell Histiocytosis Central Nervous System Langerhans Cell Histiocytosis Rare involvement of the central nervous system by histiocytic sarcoma. C129807 Neoplastic Process Central Nervous System Histiocytic Sarcoma CL513025 Malignant Central Nervous System Histiocytic Sarcoma Central Nervous System Histiocytic Sarcoma Erdheim-Chester disease that affects the central nervous system. C129808 Neoplastic Process Central Nervous System Erdheim-Chester Disease CL513024 Undetermined Central Nervous System Erdheim-Chester Disease Central Nervous System Erdheim-Chester Disease One of the nodes that lie along the course of a lymphatic vessel between a primary melanoma site and a recognized node field. (from Medscape) C12984 Body Part, Organ, or Organ Component Interval Lymph Node Interval Lymph Node C1512904 Interval_Lymph_Node Interval Lymph Node Interval Lymph Node Chronic myelomonocytic leukemia characterized by the presence of eosinophilia, PDGFRB gene rearrangement, and t(5;12)(q31;p12). C129852 Neoplastic Process Chronic Myelomonocytic Leukemia with Eosinophilia Associated with t(5;12)(q31;p12) CL512922 Malignant Myeloid neoplasm with PDGFRB rearrangement Chronic Myelomonocytic Leukemia with Eosinophilia Associated with t(5;12) Chronic Myelomonocytic Leukemia with Eosinophilia Associated with t(5;12)(q31;p12) Chronic Myelomonocytic Leukemia with Eosinophilia Associated with t(5;12)(q31;p12) Hematologic neoplasms characterized by the presence of t(8;9)(p22;p24.1) that results in PCM1-JAK2 fusion gene expression. It is associated with eosinophilia, bone marrow findings of left-shifted erythroid predominance, lymphoid aggregates, and often myelofibrosis. Rare cases present as T- or B-acute lymphoblastic leukemia. C129853 Neoplastic Process Myeloid/Lymphoid Neoplasms with PCM1-JAK2 Myeloid/Lymphoid Neoplasms with JAK2 Rearrangement CL512939 CTRP Malignant Myeloid or lymphoid neoplasm with PCM1-JAK2 M/LN-eo with t(8;9)(p22;p24.1)/PCM1/JAK2 M/LN-eo with t(8;9)(p22;p24.1)/PCM1::JAK2 Myeloid and Lymphoid Neoplasms with t(8;9)(p22;p24.1);PCM1-JAK2 Myeloid and Lymphoid Neoplasms with t(8;9)(p22;p24.1);PCM1::JAK2 Myeloid/Lymphoid Neoplasm with JAK2 Rearrangement Myeloid/Lymphoid Neoplasm with JAK2-PCM1 Fusion Myeloid/Lymphoid Neoplasm with PCM1- JAK2 Fusion Myeloid/Lymphoid Neoplasms with JAK2 Rearrangement Myeloid/Lymphoid Neoplasms with PCM1-JAK2 Myeloid/Lymphoid Neoplasms with PCM1::JAK2 Myeloid/Lymphoid Neoplasms with JAK2 Rearrangement A squamous cell carcinoma that arises from the gingival mucosa. It presents as an ulcerated lesion or exophytic mass. The prognosis is usually poor. C129857 Neoplastic Process Gingival Squamous Cell Carcinoma CL512930 Cellosaurus Malignant Gingival SCC Gingival Squamous Cell Carcinoma Gingival Squamous Cell Carcinoma A head and neck carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C129861 Neoplastic Process Advanced Head and Neck Carcinoma Advanced Head and Neck Carcinoma CL512860 CTRP Malignant Advanced Head and Neck Cancer Advanced Head and Neck Carcinoma Advanced Head and Neck Carcinoma An aggressive variant of squamous cell carcinoma that arises from the floor of the mouth. It is characterized by the presence of small malignant cells with hyperchromatic nuclei and scant amount of cytoplasm forming lobules with peripheral palisading. C129873 Neoplastic Process Floor of Mouth Basaloid Squamous Cell Carcinoma CL513002 Cellosaurus Malignant Floor of Mouth BSCC Floor of Mouth Basaloid Squamous Cell Carcinoma Floor of Mouth Basaloid Squamous Cell Carcinoma A chordoma that arises from the sacral area. C129927 Neoplastic Process Sacral Chordoma CL512990 Cellosaurus Malignant Sacral Chordoma Sacral Chordoma One of the three larger salivary glands including the parotid, submandibular and sublingual glands. C12999 Body Part, Organ, or Organ Component Major Salivary Gland, NOS Major Salivary Gland C0930553 Major_Salivary_Gland Major Salivary Gland Major Salivary Gland A chronic myelomonocytic leukemia characterized by the presence of less than 5 percent blasts in the bone marrow and less than 2 percent blasts in the peripheral blood. C130035 Neoplastic Process Chronic Myelomonocytic Leukemia-0 CL513815 Malignant CMML-0 Chronic Myelomonocytic Leukemia-0 Chronic Myelomonocytic Leukemia-0 A term that refers to myelodysplastic syndromes, myelodysplastic/myeloproliferative neoplasms, and acute myeloid leukemias that are associated with germline mutations and are familial. C130038 Neoplastic Process Hematologic Neoplasm with Germline Predisposition CL514062 Malignant Hematologic Neoplasm with Germline Predisposition Myeloid Neoplasm with Germline Predisposition Hematologic Neoplasm with Germline Predisposition B lymphoblastic leukemia/lymphoma characterized by amplification of a portion of chromosome 21. It usually occurs in children and is associated with an adverse prognosis. C130039 Neoplastic Process B Lymphoblastic Leukemia/Lymphoma with Intrachromosomal Amplification of Chromosome 21 CL513772 Malignant B Lymphoblastic Leukemia/Lymphoma with Intrachromosomal Amplification of Chromosome 21 B Lymphoblastic Leukemia/Lymphoma with iAMP21 B-Lymphoblastic Leukemia/Lymphoma with Intrachromosomal Amplification of Chromosome 21 B-Lymphoblastic Leukemia/Lymphoma with iAMP21 B Lymphoblastic Leukemia/Lymphoma with Intrachromosomal Amplification of Chromosome 21 B-acute lymphoblastic leukemia characterized by amplification of a portion of chromosome 21. It usually occurs in children and is associated with an adverse prognosis. C130040 Neoplastic Process B Acute Lymphoblastic Leukemia with Intrachromosomal Amplification of Chromosome 21 CL513771 Malignant B Acute Lymphoblastic Leukemia with Intrachromosomal Amplification of Chromosome 21 B Acute Lymphoblastic Leukemia with iAMP21 B-ALL with iAMP21 B-Acute Lymphoblastic Leukemia with Intrachromosomal Amplification of Chromosome 21 B Acute Lymphoblastic Leukemia with Intrachromosomal Amplification of Chromosome 21 A digital mammography technique that incorporates the administration of an iodinated contrast agent to enhance lesions that are not visible on standard mammograms. C130042 Diagnostic Procedure Contrast Enhanced Digital Mammography Contrast Enhanced Digital Mammography CL514042 CTRP CEDM Contrast Enhanced Digital Mammography Contrast Enhanced Spectral Mammography Contrast-Enhanced Digital Mammography Contrast Enhanced Digital Mammography T acute lymphoblastic leukemia in which the blasts have unique immunophenotypic and genetic characteristics suggesting only limited early T-cell differentiation. C130043 Neoplastic Process Early T Precursor Acute Lymphoblastic Leukemia CL514044 Cellosaurus Malignant ETP ALL ETP-ALL Early T Acute Lymphoblastic Leukemia Early T Precursor Acute Lymphoblastic Leukemia Early T-Acute Lymphoblastic Leukemia Early T-Cell Precursor Acute Lymphoblastic Leukemia Early T-Cell Precursor Lymphoblastic Leukemia Early T-Precursor Acute Lymphoblastic Leukemia Early T Precursor Acute Lymphoblastic Leukemia Compound, tubular, submucosal glands located in the duodenum proximal to the sphincter of Oddi; these glands produce alkaline-rich secretions that function to both protect the duodenum from the acidic content of the stomach and to enable intestinal enzymes to activate, thus enabling absorption to start. C13010 Body Part, Organ, or Organ Component Brunner's Gland Brunner's Gland C0006323 CDISC A compound tubular gland located in the submucosa of the proximal part of the duodenum. Brunner_s_Gland Brunner's Gland Brunner's Glands GLAND, BRUNNER'S Brunner's Gland A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues. An organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus. C13018 Body Part, Organ, or Organ Component Organ Organ C0178784 A part of the body that performs a specific function. For example, the heart is an organ. Organ Organ Organs organ Organ A form of magnetic resonance imaging (MRI) in which images are taken during three distinct timing points (phases) following the injection of contrast material: arterial, venous, and delayed. C130184 Diagnostic Procedure Triple Phase MRI CL513382 CDISC A type of magnetic resonance imaging (MRI) in which images are taken during three distinct timing points (phases) following the injection of contrast material: arterial, venous, and delayed. TRIPLE-PHASE MRI SCAN Triple Phase MRI Triple Phase MRI Prostate carcinoma that grows and continues to spread despite the surgical removal of the testes or medical intervention to block androgen production. C130234 Neoplastic Process Castration-Resistant Prostate Carcinoma Castration-Resistant Prostate Carcinoma C3658266 CTRP Malignant CRPC Castration-Resistant Prostate Cancer Castration-Resistant Prostate Carcinoma Metastatic Castration-Resistant Prostate Carcinoma Castration-Resistant Prostate Carcinoma Stage IB includes: T2, N0, M0, B0-1. T2: Patches, papules, or plaques covering 10% or more of the skin surface. May further stratify into T2a (patch only) vs. T2b (plaque +/- patch). N0: No clinically abnormal peripheral lymph nodes; biopsy not required. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 7th ed.) C130237 Neoplastic Process Stage IB Mycosis Fungoides Stage IB Mycosis Fungoides AJCC v7 CL514001 CTRP Malignant Stage IB Mycosis Fungoides Stage IB Mycosis Fungoides AJCC v7 Stage IB Mycosis Fungoides AJCC v7 A neoplasm that arises from the posterior cranial fossa. Examples include meningiomas and medulloblastomas. C130950 Neoplastic Process Posterior Cranial Fossa Neoplasm Posterior Fossa Neoplasm CL513187 CTRP Undetermined Posterior Cranial Fossa Neoplasm Posterior Cranial Fossa Tumor Posterior Fossa Neoplasm Posterior Fossa Tumor Posterior Fossa Neoplasm Stage IA includes: T1, N0, M0, B0-1. T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. May further stratify into T1a (patch only) vs. T1b (plaque +/- patch). N0: No clinically abnormal peripheral lymph nodes; biopsy not required. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 7th ed.) C130951 Neoplastic Process Stage IA Mycosis Fungoides AJCC v7 Stage IA Mycosis Fungoides AJCC v7 CL514000 CTRP Malignant Stage IA Mycosis Fungoides Stage IA Mycosis Fungoides AJCC v7 Stage IA Mycosis Fungoides AJCC v7 A small canal that receives prostatic secretions from the glandular tubules and discharges it through the prostatic portion of the urethra. C13102 Body Part, Organ, or Organ Component Human Prostatic Duct Prostatic Duct C0227965 Prostatic_Duct Prostatic Duct Prostatic Duct Any type of immunotherapy that targets and blocks the immune checkpoint pathways to activate immune responses against tumor cells. C131060 Therapeutic or Preventive Procedure Checkpoint Blockade Immunotherapy Checkpoint Blockade Immunotherapy CL514038 CTRP Checkpoint Blockade Immunotherapy Checkpoint Blockade Immunotherapy The reemergence of gliosarcoma after a period of remission. C131209 Neoplastic Process Recurrent Gliosarcoma CL514181 Malignant Recurrent Gliosarcoma Recurrent Gliosarcoma The reemergence of urethral urothelial carcinoma after a period of remission. C131218 Neoplastic Process Recurrent Urethral Urothelial Carcinoma Recurrent Urethral Urothelial Carcinoma C0862468 CTRP Malignant Recurrent Urethral Urothelial Cancer Recurrent Urethral Urothelial Carcinoma Recurrent Urothelial Carcinoma of the Urethra Recurrent Urethral Urothelial Carcinoma Acute myeloid leukemia with often cytogenetically cryptic fusion of NUP98 (chromosome 11p15) with NSD1 (chromosome 5q35). This alteration occurs in 4% of pediatric AML cases. C131502 Neoplastic Process Childhood Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1 CL514481 NICHD Acute myeloid leukemia (AML) with often cytogenetically cryptic fusion of NUP98 (chromosome 11p15) with NSD1 (chromosome 5q35). This alteration occurs in 4% of pediatric AML cases. Malignant AML with t(5;11)(q35;p15); NUP98-NSD1 Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1 Childhood AML with t(5;11)(q35;p15); NUP98-NSD1 Childhood AML with t(5;11)(q35;p15); NUP98::NSD1 Childhood Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1 Childhood Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1 Fusion Childhood Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98::NSD1 Fusion Childhood Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1 Acute myeloid leukemia with a cytogenetically cryptic fusion of NUP98 to JARID1A, t(11;15)(p15;q35). It typically has a megakaryocytic phenotype and occurs in 10% of pediatric, non-Down syndrome-related acute megakaryoblastic leukemia cases. C131504 Neoplastic Process Childhood Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A CL514480 NICHD Acute myeloid leukemia (AML) with a cytogenetically, cryptic fusion of NUP98 to JARID1A, t(11;15)(p15;q35). It typically has an megakaryocytic phenotype and occurs in 10% of pediatric, non-Down Syndrome-related acute megakaryoblastic leukemia (AMKL) cases. Malignant AML with t(11;15)(p15;q35); NUP98-JARID1A Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A Childhood AML with t(11;15)(p15;q35); NUP98-JARID1A Childhood AML with t(11;15)(p15;q35); NUP98::JARID1A Childhood Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A Childhood Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A Fusion Childhood Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98::JARID1A Fusion Childhood Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A The reemergence of an ependymal tumor after a period of remission. C131617 Neoplastic Process Recurrent Ependymal Tumor CL514678 Undetermined Recurrent Ependymal Tumor Recurrent Ependymal Tumor An unusual variant of capillary hemangioma. It is characterized by a unique anastomosing sinusoidal-like architecture which may mimic angiosarcoma. It was originally described in the kidney but rare cases have been reported in other sites. C131760 Neoplastic Process Anastomosing Hemangioma CL514236 Benign Anastomosing Hemangioma Anastomosing Hemangioma The reemergence of chronic lymphocytic leukemia/small lymphocytic lymphoma after a period of remission. C131873 Neoplastic Process Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma CL520224 Malignant Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma The reemergence of T-acute lymphoblastic leukemia in childhood after a period of remission. C131875 Neoplastic Process Recurrent Childhood T Acute Lymphoblastic Leukemia Recurrent Childhood T Acute Lymphoblastic Leukemia CL520223 CTRP Malignant Recurrent Childhood T Acute Lymphoblastic Leukemia Recurrent Childhood T-Acute Lymphoblastic Leukemia Recurrent T Acute Lymphoblastic Leukemia Recurrent Childhood T Acute Lymphoblastic Leukemia A rare Epstein-Barr virus-positive B-cell lymphoproliferative disorder that affects mucosal sites (including oral mucosa, palate, tonsils, and gastrointestinal tract) and skin. It presents with well-circumscribed, often painful ulcers. It is associated with immune suppression, including age-related and drug-induced immunosuppression. In the majority of cases the lesions regress either spontaneously or following withdrawal of the immunosuppression therapy. C131906 Neoplastic Process Epstein-Barr Virus-Positive Mucocutaneous Ulcer EBV-Positive Mucocutaneous Ulcer CL519556 CTRP Undetermined EBV positive mucocutaneous ulcer EBV-Positive Mucocutaneous Ulcer EBVMCU Epstein-Barr Virus-Positive Mucocutaneous Ulcer EBV-Positive Mucocutaneous Ulcer A molecularly distinct large B-cell lymphoma reminiscent of Burkitt lymphoma. It is characterized by the absence of MYC translocation and the presence of chromosome 11q aberrations. C131911 Neoplastic Process MYC-Negative B-Cell Lymphoma with 11q Aberration Resembling Burkitt Lymphoma Large B-Cell Lymphoma with 11q Aberration CL520452 Provisional_Concept CTRP Malignant B-Cell Lymphoma with 11q Aberration Resembling Burkitt Lymphoma Burkitt-Like Lymphoma with 11q Aberration High Grade B-Cell Lymphoma with 11q Aberrations High-Grade B-Cell Lymphoma with 11q Aberrations Large B-Cell Lymphoma with 11q Aberration MYC-Negative B-Cell Lymphoma with 11q Aberration Resembling Burkitt Lymphoma MYC-Negative High-Grade B-Cell Lymphoma with 11q Aberration Resembling Burkitt Lymphoma Large B-Cell Lymphoma with 11q Aberration High-grade B-cell lymphoma characterized by the abnormal rearrangement of MYC gene, BCL2 gene, and BCL6 gene. Patients with this type of lymphoma usually respond poorly to standard treatments and have a poor prognosis. C131913 Neoplastic Process High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements CL524351 CTRP Cellosaurus Malignant HGBCL-TH High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements High-Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements Triple Hit Lymphoma Triple-Hit Lymphoma High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements Squamous cell carcinoma of the head and neck which is amendable to surgical removal. C132012 Neoplastic Process Resectable Head and Neck Squamous Cell Carcinoma Resectable Head and Neck Squamous Cell Carcinoma CL520238 CTRP Malignant Resectable Head and Neck Squamous Cell Cancer Resectable Head and Neck Squamous Cell Carcinoma Resectable Head and Neck Squamous Cell Carcinoma A type of contrast-enhanced ultrasound imaging that captures the nonlinear second harmonic signal from microbubble contrast agents flowing in the vasculature to create a 3-dimensional image. C132048 Diagnostic Procedure Volumetric Contrast-Enhanced Ultrasound Imaging Volumetric Contrast-Enhanced Ultrasound Imaging CL520308 CTRP VCEUS VCEUS Imaging Volumetric Contrast-Enhanced Ultrasound Volumetric Contrast-Enhanced Ultrasound Imaging Volumetric Contrast-Enhanced Ultrasound Imaging A grade I or grade II glioma arising from the central nervous system. This category includes pilocytic astrocytoma, diffuse astrocytoma, subependymal giant cell astrocytoma, ependymoma, oligodendroglioma, oligoastrocytoma, and angiocentric glioma. C132067 Neoplastic Process Low Grade Glioma Low Grade Glioma C1997217 CTRP GDC Undetermined CNS, low grade glioma (LGG) CNS, low grade glioma (LGG) LGG Low Grade Glial Neoplasm Low Grade Glioma Low-Grade Glioma Low Grade Glioma An acute myeloid leukemia characterized by t(10;11)(p12.3;q23.3) resulting in MLLT10-KMT2A gene fusion. It is associated with an unfavorable prognosis. C132101 Neoplastic Process Acute Myeloid Leukemia with t(10;11)(p12;q23); MLL-MLLT10 Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-KMT2A CL521169 CTRP Malignant Acute Myeloid Leukemia (AML) with t(10;11)(p12.3;q23.3); KMT2A::MLLT10 Acute Myeloid Leukemia (AML) with t(10;11)(p12.3;q23.3); MLL-MLLT10 Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLL-MLLT10 Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-KMT2A Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-KMT2A Fusion Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-MLL Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10::KMT2A Fusion Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-KMT2A An acute myeloid leukemia characterized by t(6;11)(q27;q23.3) resulting in MLLT4-KMT2A gene fusion. It is associated with an unfavorable prognosis. C132105 Neoplastic Process Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4 Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A CL521170 CTRP Cellosaurus Malignant Acute Myeloid Leukemia (AML) with t(6;11)(q27;q23.3); KMT2A-MLLT4 Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4 Acute Myeloid Leukemia with t(6;11)(q27;q23); MLL-MLLT4 Acute Myeloid Leukemia with t(6;11)(q27;q23.3); KMT2A-MLLT4 Acute Myeloid Leukemia with t(6;11)(q27;q23.3); KMT2A::MLLT4 Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A Fusion Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-MLL Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4::KMT2A Fusion Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A A non-Down syndrome acute megakaryoblastic leukemia that occurs in childhood. It is associated with CBFA2T3-GLIS2 chimeric oncogene and has an unfavorable prognosis. C132109 Neoplastic Process Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2 Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2 CL521167 CTRP Malignant Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2 Acute Megakaryoblastic Leukemia with CBFA2T3::GLIS2 Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2 A non-Down syndrome acute megakaryoblastic leukemia that occurs in childhood. It is associated with t(11;12)(p15;p13) which results in the presence of NUP98-KDM5A chimeric oncogene. C132111 Neoplastic Process Acute Megakaryoblastic Leukemia with NUP98-KDM5A Childhood Acute Megakaryoblastic Leukemia with NUP98-KDM5A CL521168 CTRP Malignant Acute Megakaryoblastic Leukemia with NUP98-KDM5A Childhood Acute Megakaryoblastic Leukemia with NUP98-KDM5A Childhood Acute Megakaryoblastic Leukemia with NUP98-KDM5A Fusion Childhood Acute Megakaryoblastic Leukemia with NUP98::KDM5A Childhood Acute Megakaryoblastic Leukemia with NUP98::KDM5A Fusion Childhood Acute Megakaryoblastic Leukemia with NUP98-KDM5A A leiomyosarcoma which is not amenable to surgical resection. C132147 Neoplastic Process Unresectable Leiomyosarcoma Unresectable Leiomyosarcoma CL520294 CTRP Malignant Unresectable Leiomyosarcoma Unresectable Leiomyosarcoma A liposarcoma which is not amenable to surgical resection. C132148 Neoplastic Process Unresectable Liposarcoma Unresectable Liposarcoma CL520295 CTRP Malignant Unresectable Liposarcoma Unresectable Liposarcoma An extramedullary myeloid tumor that arises from the small intestine. It often presents with abdominal pain and obstruction. C132260 Neoplastic Process Small Intestinal Myeloid Sarcoma CL521122 Malignant Myeloid Sarcoma of the Small Intestine Small Intestinal Myeloid Sarcoma Small Intestinal Myeloid Sarcoma The reemergence of endometrial serous adenocarcinoma after a period of remission. C132294 Neoplastic Process Recurrent Endometrial Serous Adenocarcinoma Recurrent Endometrial Serous Adenocarcinoma CL520226 CTRP Malignant Recurrent Endometrial Serous Adenocarcinoma Recurrent Uterine Corpus Serous Carcinoma Recurrent Endometrial Serous Adenocarcinoma A usually aggressive and invasive pituitary neuroendocrine tumor characterized by excessive p53 immunoreactivity, increased mitotic activity, and MIB-1 proliferative index greater than 3%. C132296 Neoplastic Process Atypical Pituitary Neuroendocrine Tumor CL520582 Uncertain Malignant Potential Atypical PitNET/Adenoma Atypical Pituitary Gland Adenoma Atypical Pituitary Neuroendocrine Tumor Atypical Pituitary Neuroendocrine Tumor/Adenoma Atypical Pituitary Neuroendocrine Tumor Lymph node located adjacent to the diaphragm. C132391 Body Part, Organ, or Organ Component Diaphragmatic Lymph Node C0229762 CDISC mCode Lymph node located adjacent to the diaphragm. DIAPHRAGMATIC LYMPH NODE Diaphragmatic Lymph Node Structure of diaphragmatic lymph node (body structure) Diaphragmatic Lymph Node The anatomical structures that define the neck lymph node boundaries. C132494 Finding Neck Lymph Node Boundary Levels and Sublevels CL520467 Neck Lymph Node Boundary Levels and Sublevels Neck Lymph Node Boundary Levels and Sublevels The following anatomical structures define the neck lymph node boundary for sublevel IA: Superior: symphysis of the mandible; inferior: body of the hyoid; anterior (medial): anterior belly of the contralateral digastric muscle; posterior (lateral): anterior belly of the ipsilateral digastric muscle. (AJCC 8th ed.) C132495 Finding Neck Lymph Node Boundary Sublevel IA CL521212 Neck Lymph Node Boundary Sublevel IA Neck Lymph Node Boundary Sublevel IA The following anatomical structures define the neck lymph node boundary for sublevel IB: Superior: body of the mandible; inferior: posterior belly of the digastric muscle; anterior (medial): anterior belly of the digastric muscle; posterior (lateral): stylohyoid muscle. (AJCC 8th ed.) C132496 Finding Neck Lymph Node Boundary Sublevel IB CL521213 Neck Lymph Node Boundary Sublevel IB Neck Lymph Node Boundary Sublevel IB The following anatomical structures define the neck lymph node boundary for sublevel IIA: Superior: skull base; inferior: horizontal plane defined by the inferior border of the hyoid bone; anterior (medial): stylohyoid muscle; posterior (lateral): vertical plane defined by the spinal accessory nerve. (AJCC 8th ed.) C132497 Finding Neck Lymph Node Boundary Sublevel IIA CL521214 Neck Lymph Node Boundary Sublevel IIA Neck Lymph Node Boundary Sublevel IIA The following anatomical structures define the neck lymph node boundary for sublevel IIB: Superior: skull base; inferior: horizontal plane defined by the inferior body of the hyoid bone; anterior (medial): vertical plane defined by the spinal accessory nerve; posterior (lateral): lateral border of the sternocleidomastoid muscle. (AJCC 8th ed.) C132498 Finding Neck Lymph Node Boundary Sublevel IIB CL521215 Neck Lymph Node Boundary Sublevel IIB Neck Lymph Node Boundary Sublevel IIB The following anatomical structures define the neck lymph node boundary for level III: Superior: horizontal plane defined by the inferior body of the hyoid; inferior: horizontal plane defined by the inferior border of the cricoid cartilage; anterior (medial): lateral border of the sternohyoid muscle; posterior (lateral): lateral border of the sternocleidomastoid or sensory branches of the cervical plexus. (AJCC 8th ed.) C132499 Finding Neck Lymph Node Boundary Level III CL521208 Neck Lymph Node Boundary Level III Neck Lymph Node Boundary Level III The following anatomical structures define the neck lymph node boundary for level IV: Superior: horizontal plane defined by the inferior border of the cricoid cartilage; inferior: clavicle; anterior (medial): lateral border of the sternohyoid muscle; posterior (lateral): lateral border of the sternocleidomastoid or sensory branches of the cervical plexus. (AJCC 8th ed.) C132500 Finding Neck Lymph Node Boundary Level IV CL521209 Neck Lymph Node Boundary Level IV Neck Lymph Node Boundary Level IV The following anatomical structures define the neck lymph node boundary for sublevel VA: Superior: apex of the convergence of the sternocleidomastoid and trapezius muscles; inferior: horizontal plane defined by the lower border of the cricoid cartilage; anterior (medial): posterior border of the sternocleidomastoid muscle or sensory branches of the cervical plexus; posterior (lateral): anterior border of the trapezius muscle. (AJCC 8th ed.) C132501 Finding Neck Lymph Node Boundary Sublevel VA CL521216 Neck Lymph Node Boundary Sublevel VA Neck Lymph Node Boundary Sublevel VA The following anatomical structures define the neck lymph node boundary for sublevel VB: Superior: horizontal plane defined by the lower border of the cricoid cartilage; inferior: clavicle; anterior (medial): posterior border of the sternocleidomastoid muscle; posterior (lateral): anterior border of the trapezius muscle. (AJCC 8th ed.) C132502 Finding Neck Lymph Node Boundary Sublevel VB CL521217 Neck Lymph Node Boundary Sublevel VB Neck Lymph Node Boundary Sublevel VB The following anatomical structures define the neck lymph node boundary for level VI: Superior: hyoid bone; inferior: suprasternal notch; anterior (medial): common carotid artery; posterior (lateral): common carotid artery. (AJCC 8th ed.) C132503 Finding Neck Lymph Node Boundary Level VI CL521211 Neck Lymph Node Boundary Level VI Neck Lymph Node Boundary Level VI The following anatomical structures define the neck lymph node boundary for level VII: Superior: suprasternal notch; inferior: innominate artery; anterior (medial): sternum; posterior (lateral): trachea, esophagus, and prevertebral fascia. (AJCC 8th ed.) C132504 Finding Neck Lymph Node Boundary Level VII CL521210 Neck Lymph Node Boundary Level VII Neck Lymph Node Boundary Level VII A category of low grade gliomas that includes diffuse astrocytoma, ependymoma, oligodendroglioma, and oligoastrocytoma. C132505 Neoplastic Process Grade II Glioma WHO Grade 2 Glioma CL520717 CTRP Undetermined Grade 2 Glioma Grade II Glioma WHO Grade 2 Glioma WHO Grade II Glioma WHO Grade 2 Glioma The reemergence of a glioma after a period of remission. C132506 Neoplastic Process Recurrent Glioma Recurrent Glioma CL520228 CTRP Undetermined Recurrent Glioma Recurrent Glioma Lymph node groups found within the seven levels and sublevels of the neck. (AJCC 8th ed.) C132507 Body Part, Organ, or Organ Component Neck Lymph Node Groups CL520468 Neck Lymph Node Groups Neck Lymph Node Groups Lymph nodes within the triangular boundary of the anterior belly of the digastric muscles and the hyoid bone. These nodes are at greatest risk for harboring metastases from cancers arising from the floor of mouth, anterior oral tongue, anterior mandibular alveolar ridge, and lower lip. (AJCC 8th ed.) C132508 Body Part, Organ, or Organ Component Submental Lymph Node Group (Sublevel IA) CL520991 mCode Lymph node level IA (qualifier value) Submental Lymph Node Group (Sublevel IA) Submental Lymph Node Group (Sublevel IA) Lymph nodes within the boundaries of the anterior and posterior bellies of the digastric muscle, the stylohyoid muscle, and the body of the mandible. These include the preglandular and the postglandular nodes and the prevascular and postvascular nodes. The submandibular gland is included in the specimen when the lymph nodes within the triangle are removed. These nodes are at greatest risk for harboring metastases from cancers arising from the oral cavity, anterior nasal cavity, skin, and soft tissue structures of the midface, as well as from the submandibular gland. (AJCC 8th ed.) C132509 Body Part, Organ, or Organ Component Submandibular Lymph Node Group (Sublevel IB) CL520990 mCode Lymph node level IB (qualifier value) Submandibular Lymph Node Group (Sublevel IB) Submandibular Lymph Node Group (Sublevel IB) Lymph nodes located around the upper third of the internal jugular vein and adjacent spinal accessory nerve, extending from the level of the skull base (above) to the level of the inferior border of the hyoid bone (below). The anterior (medial) boundary is the stylohyoid muscle (the radiologic correlate is the vertical plane defined by the posterior surface of the submandibular gland) and the posterior (lateral) boundary is the posterior border of the sternocleidomastoid muscle. Sublevel IIA nodes are located anterior (medial) to the vertical plain defined by the spinal accessory nerve. Sublevel IIB nodes are located posterior (lateral) to the vertical plane defined by the spinal accessory nerve (the radiologic correlate is the lateral border of the internal jugular on a contrast-enhanced CT scan). The upper jugular nodes are at greatest risk for harboring metastases from cancers arising from the oral cavity, nasal cavity, nasopharynx, oropharynx, hypopharynx, larynx, and parotid gland. (AJCC 8th ed.) C132510 Body Part, Organ, or Organ Component Upper Jugular Lymph Node Group (Sublevels IIA and IIB) CL520301 Upper Jugular Lymph Node Group (Sublevels IIA and IIB) Upper Jugular Lymph Node Group (Sublevels IIA and IIB) Lymph nodes located around the middle third of the internal jugular vein, extending from the inferior border of the hyoid bone (above) to the inferior border of the cricoid cartilage (below). The anterior (medial) boundary is the lateral border of the sternohyoid muscle, and the posterior (lateral) boundary is the posterior border of the sternocleidomastoid muscle. These nodes are at greatest risk for harboring metastases from cancers arising from the oral cavity, nasopharynx, oropharynx, hypopharynx, and larynx. (AJCC 8th ed.) C132511 Body Part, Organ, or Organ Component Middle Jugular Lymph Node Group (Level III) CL520060 CDISC Any lymph nodes located within close proximity to the middle third of the internal jugular vein, extending from the inferior border of the hyoid bone (superiorly) to the inferior border of the cricoid cartilage (inferiorly). The anterior (medial) boundary is the lateral border of the sternohyoid muscle, and the posterior (lateral) boundary is the posterior border of the sternocleidomastoid muscle. (AJCC 8th ed.) MID-JUGULAR LYMPH NODE Middle Jugular Lymph Node Group (Level III) Middle Jugular Lymph Node Group (Level III) Lymph nodes located around the lower third of the internal jugular vein, extending from the inferior border of the cricoid cartilage (above) to the clavicle below. The anterior (medial) boundary is the lateral border of the sternohyoid muscle and the posterior (lateral) boundary is the posterior border of the sternocleidomastoid muscle. These nodes are at greatest risk for harboring metastases from cancers arising from the hypopharynx, thyroid, cervical esophagus, and larynx. (AJCC 8th ed.) C132512 Body Part, Organ, or Organ Component Lower Jugular Lymph Node Group (Level IV) C0447166 CDISC Any lymph nodes located within close proximity to the lower third of the internal jugular vein, extending from the inferior border of the cricoid cartilage (superiorly) to the clavicle (inferiorly). The anterior (medial) boundary is the lateral border of the sternohyoid muscle and the posterior (lateral) boundary is the posterior border of the sternocleidomastoid muscle. (AJCC 8th ed.) LOWER JUGULAR LYMPH NODE Lower Jugular Lymph Node Group (Level IV) Lower Jugular Lymph Node Group (Level IV) This group is composed predominantly of the lymph nodes located along the lower half of the spinal accessory nerve and the transverse cervical artery. The supraclavicular nodes also are included in the posterior triangle group. The superior boundary is the apex formed by the convergence of the sternocleidomastoid and trapezius muscles; the inferior boundary is the clavicle; the anterior (medial) boundary is the posterior border of the sternocleidomastoid muscle; and the posterior (lateral) boundary is the anterior border of the trapezius muscle. Thus, sublevel VA includes the spinal accessory nodes, whereas sublevel VB includes the nodes following the transverse cervical vessels and the supraclavicular nodes, with the exception of the Virchow node, which is located in level IV. The posterior triangle nodes are at greatest risk for harboring metastases from cancers arising from the nasopharynx, oropharynx, and cutaneous structures of the posterior scalp and neck. (AJCC 8th ed.) C132513 Body Part, Organ, or Organ Component Posterior Triangle Lymph Node Group (Sublevels VA and VB) CL520922 Posterior Triangle Lymph Node Group (Sublevels VA and VB) Posterior Triangle Lymph Node Group (Sublevels VA and VB) Lymph nodes in this compartment include the pretracheal and paratracheal nodes, precricoid (Delphian) node, and the perithyroidal nodes, including the lymph nodes along the recurrent laryngeal nerves. The superior boundary is the hyoid bone; the inferior boundary is the suprasternal notch; and the lateral boundaries are the common carotid arteries. These nodes are at greatest risk for harboring metastases from cancers arising from the thyroid gland, glottic and subglottic larynx, apex of the piriform sinus, and cervical esophagus. (AJCC 8th ed.) C132514 Body Part, Organ, or Organ Component Anterior Compartment Lymph Node Group (Level VI) CL520569 Anterior Compartment Lymph Node Group (Level VI) Anterior Compartment Lymph Node Group (Level VI) Lymph nodes in this group include pretracheal, paratracheal, and esophageal groove lymph nodes, extending from the level of the suprasternal notch cephalad and up to the innominate artery caudad. These nodes are at greatest risk of involvement by thyroid cancer and cancer of the esophagus. (AJCC 8th ed.) C132515 Body Part, Organ, or Organ Component Superior Mediastinal Lymph Node Group (Level VII) CL520993 CDISC Lymph nodes in this group include pretracheal, paratracheal, and esophageal groove lymph nodes, extending from the level of the suprasternal notch cephalad and up to the innominate artery caudad. These nodes are at greatest risk of involvement by thyroid cancer and cancer of the esophagus. (AJCC 8th ed.) SUPERIOR MEDIASTINAL LYMPH NODE LEVEL VII Superior Mediastinal Lymph Node Group (Level VII) Superior Mediastinal Lymph Node Group (Level VII) A pair of embryonic tubular structures that extend along the genital ridge and continue toward the cloaca, which in females will develop into the vagina, uterus, and fallopian tubes, and which will degenerate and be resorbed in males. C13260 Embryonic Structure Mullerian Duct C0026732 Mullerian_Duct Mullerian Duct Müllerian Duct Paramesonephric Duct Mullerian Duct A term that refers to the staging of lip and oral cavity carcinoma according to the American Joint Committee on Cancer, 8th edition. C132728 Neoplastic Process Lip and Oral Cavity Cancer by AJCC v8 Stage CL520729 Malignant Lip and Oral Cavity Cancer by AJCC v8 Stage Lip and Oral Cavity Carcinoma by AJCC v8 Stage Lip and Oral Cavity Cancer by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Tumor size 2 cm or less in greatest dimension and 5 mm or less depth of invasion (DOI). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C132729 Neoplastic Process Stage I Lip and Oral Cavity Cancer AJCC v8 Stage I Lip and Oral Cavity Cancer AJCC v8 CL521151 CTRP Malignant Stage I Lip and Oral Cavity Cancer Stage I Lip and Oral Cavity Cancer AJCC v8 Stage I Lip and Oral Cavity Carcinoma AJCC v8 Stage I Lip and Oral Cavity Cancer AJCC v8 Stage II includes: T2, N0, M0. T2: Tumor size 2 cm or less in greatest dimension, DOI greater than 5 mm and equal or less than 10 mm or tumor greater than 2 cm but 4 cm or less in greatest dimension and 10 mm or less DOI. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C132730 Neoplastic Process Stage II Lip and Oral Cavity Cancer AJCC v8 Stage II Lip and Oral Cavity Cancer AJCC v8 CL520502 CTRP Malignant Stage II Lip and Oral Cavity Cancer Stage II Lip and Oral Cavity Cancer AJCC v8 Stage II Lip and Oral Cavity Carcinoma AJCC v8 Stage II Lip and Oral Cavity Cancer AJCC v8 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor size greater than 4 cm or any tumor greater than 10 mm DOI. T1: Tumor size 2 cm or less in greatest dimension and 5 mm or less DOI. T2: Tumor size 2 cm or less in greatest dimension, DOI greater than 5 mm and equal or less than 10 mm or tumor greater than 2 cm but 4 cm or less in greatest dimension and 10 mm or less DOI N1: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE (extranodal extension)(-). M0: No distant metastasis. (AJCC 8th Ed.) C132731 Neoplastic Process Stage III Lip and Oral Cavity Cancer AJCC v8 Stage III Lip and Oral Cavity Cancer AJCC v8 CL520506 CTRP Malignant Stage III Lip and Oral Cavity Cancer Stage III Lip and Oral Cavity Cancer AJCC v8 Stage III Lip and Oral Cavity Carcinoma AJCC v8 Stage III Lip and Oral Cavity Cancer AJCC v8 Stage IV includes: IVA (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB (Any T, N3, M0); (T4b, Any N, M0); IVC (Any T, Any N, M1). T4a (lip): Tumor invades through cortical bone or involves the inferior alveolar nerve, floor of mouth, or skin of face (i.e., chin or nose). T4a (oral cavity): Tumor invades adjacent structures only (e.g., through cortical bone of the mandible or maxilla, or involves the maxillary sinus or skin of face). Note: Superficial erosion of bone/tooth socket (alone) by a gingival primary is not sufficient to classify a tumor as T4. T1: Tumor size 2 cm or less in greatest dimension and 5 mm or less DOI. T2: Tumor size 2 cm or less in greatest dimension, DOI greater than 5 mm and equal or less than 10 mm or tumor greater than 2 cm but 4 cm or less in greatest dimension and 10 mm or less DOI. T3: Tumor size greater than 4 cm or any tumor greater than 10 mm DOI. T4b: Tumor invades masticator space, pterygoid plates, or skull base and/or encases the internal carotid artery. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(-). N2: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(+); or larger than 3 cm but not larger than 6 cm in greatest dimension and ENE (-); or metastases in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-); or metastases in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension, ENE(-). N3: Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE (-); or in a single ipsilateral lymph node larger than 3 cm in greatest dimension and ENE(+); or metastases in multiple ipsilateral, contralateral or bilateral lymph nodes any with ENE(+). M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th Ed.) C132732 Neoplastic Process Stage IV Lip and Oral Cavity Cancer AJCC v8 Stage IV Lip and Oral Cavity Cancer AJCC v8 CL520510 CTRP Malignant Stage IV Lip and Oral Cavity Cancer Stage IV Lip and Oral Cavity Cancer AJCC v8 Stage IV Lip and Oral Cavity Carcinoma AJCC v8 Stage IV Lip and Oral Cavity Cancer AJCC v8 Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a (lip): Tumor invades through cortical bone or involves the inferior alveolar nerve, floor of mouth, or skin of face (i.e., chin or nose). T4a (oral cavity): Tumor invades adjacent structures only (e.g., through cortical bone of the mandible or maxilla, or involves the maxillary sinus or skin of face). Note: Superficial erosion of bone/tooth socket (alone) by a gingival primary is not sufficient to classify a tumor as T4. T1: Tumor size 2 cm or less in greatest dimension and 5 mm or less DOI. T2: Tumor size 2 cm or less in greatest dimension, DOI greater than 5 mm and equal or less than 10 mm or tumor greater than 2 cm but 4 cm or less in greatest dimension and 10 mm or less DOI. T3: Tumor size greater than 4 cm or any tumor greater than 10 mm DOI. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(-). N2: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(+); or larger than 3 cm but not larger than 6 cm in greatest dimension and ENE (-); or metastases in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-); or metastases in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension, ENE(-). M0: No distant metastasis. (AJCC 8th Ed.) C132733 Neoplastic Process Stage IVA Lip and Oral Cavity Cancer AJCC v8 Stage IVA Lip and Oral Cavity Cancer AJCC v8 CL520514 CTRP Malignant Stage IVA Lip and Oral Cavity Cancer Stage IVA Lip and Oral Cavity Cancer AJCC v8 Stage IVA Lip and Oral Cavity Carcinoma AJCC v8 Stage IVA Lip and Oral Cavity Cancer AJCC v8 Stage IVB includes: (Any T, N3, M0); (T4b, Any N, M0). T4b: Tumor invades masticator space, pterygoid plates, or skull base and/or encases the internal carotid artery. N3: Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE (-); or in a single ipsilateral lymph node larger than 3 cm in greatest dimension and ENE(+); or metastases in multiple ipsilateral, contralateral or bilateral lymph nodes any with ENE(+). M0: No distant metastasis. (AJCC 8th Ed.) C132734 Neoplastic Process Stage IVB Lip and Oral Cavity Cancer AJCC v8 Stage IVB Lip and Oral Cavity Cancer AJCC v8 CL520518 CTRP Malignant Stage IVB Lip and Oral Cavity Cancer Stage IVB Lip and Oral Cavity Cancer AJCC v8 Stage IVB Lip and Oral Cavity Carcinoma AJCC v8 Stage IVB Lip and Oral Cavity Cancer AJCC v8 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th Ed.) C132735 Neoplastic Process Stage IVC Lip and Oral Cavity Cancer AJCC v8 Stage IVC Lip and Oral Cavity Cancer AJCC v8 CL520522 CTRP Malignant Stage IVC Lip and Oral Cavity Cancer Stage IVC Lip and Oral Cavity Cancer AJCC v8 Stage IVC Lip and Oral Cavity Carcinoma AJCC v8 Stage IVC Lip and Oral Cavity Cancer AJCC v8 A term that refers to the staging of lip and oral cavity carcinoma according to the American Joint Committee on Cancer, 6th and 7th editions. C132736 Neoplastic Process Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage CL520728 Malignant Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage A term that refers to the staging of major salivary gland cancer according to the American Joint Committee on Cancer, 7th edition. C132778 Neoplastic Process Major Salivary Gland Cancer by AJCC v7 Stage CL520777 Malignant Major Salivary Gland Cancer by AJCC v7 Stage Major Salivary Gland Cancer by AJCC v7 Stage A term that refers to the staging of major salivary gland cancer according to the American Joint Committee on Cancer, 8th edition. C132779 Neoplastic Process Major Salivary Gland Cancer by AJCC v8 Stage CL520778 Malignant Major Salivary Gland Cancer by AJCC v8 Stage Major Salivary Gland Carcinoma by AJCC v8 Stage Major Salivary Gland Cancer by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Tumor measuring 2 cm or less in greatest dimension without extraparenchymal extension. Extraparenchymal extension is clinical or macroscopic evidence of invasion of soft tissues. Microscopic evidence alone does not constitute extraparenchymal extension for classification purposes. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C132781 Neoplastic Process Stage I Major Salivary Gland Cancer AJCC v8 Stage I Major Salivary Gland Cancer AJCC v8 CL521152 CTRP Malignant Stage I Major Salivary Gland Cancer Stage I Major Salivary Gland Cancer AJCC v8 Stage I Major Salivary Gland Carcinoma AJCC v8 Stage I Major Salivary Gland Cancer AJCC v8 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C132783 Neoplastic Process Stage 0 Major Salivary Gland Cancer AJCC v8 Stage 0 Major Salivary Gland Cancer AJCC v8 CL521149 CTRP Malignant Stage 0 Major Salivary Gland Cancer Stage 0 Major Salivary Gland Cancer AJCC v8 Stage 0 Major Salivary Gland Carcinoma AJCC v8 Stage 0 Major Salivary Gland Cancer AJCC v8 Stage II includes: T2, N0, M0. T2: Tumor measuring more than 2 cm, but not more than 4 cm in greatest dimension without extraparenchymal extension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C132785 Neoplastic Process Stage II Major Salivary Gland Cancer AJCC v8 Stage II Major Salivary Gland Cancer AJCC v8 CL520503 CTRP Malignant Stage II Major Salivary Gland Cancer Stage II Major Salivary Gland Cancer AJCC v8 Stage II Major Salivary Gland Carcinoma AJCC v8 Stage II Major Salivary Gland Cancer AJCC v8 Stage III includes: (T3, N0, M0); (T0, N1, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor measuring more than 4 cm in greatest dimension, and/or tumor having extraparenchymal extension. T0: No evidence of primary tumor. T1: Tumor measuring 2 cm or less in greatest dimension without extraparenchymal extension. T2: Tumor measuring more than 2 cm, but not more than 4 cm in greatest dimension without extraparenchymal extension. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension and ENE(-). M0: No distant metastasis. (AJCC 8th ed.) C132786 Neoplastic Process Stage III Major Salivary Gland Cancer AJCC v8 Stage III Major Salivary Gland Cancer AJCC v8 CL520507 CTRP Malignant Stage III Major Salivary Gland Cancer Stage III Major Salivary Gland Cancer AJCC v8 Stage III Major Salivary Gland Carcinoma AJCC v8 Stage III Major Salivary Gland Cancer AJCC v8 Stage IV includes: IVA (T4a, N0, M0); (T4a, N1, M0); (T0, N2, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB (T4b, Any N, M0); (Any T, N3, M0); IVC (Any T, Any N, M1). T4a: Moderately advanced disease. Tumor invades skin, mandible, ear canal, and/or facial nerve. T0: No evidence of primary tumor. T1: Tumor measuring 2 cm or less in greatest dimension without extraparenchymal extension. T2: Tumor measuring more than 2 cm, but not more than 4 cm in greatest dimension without extraparenchymal extension. T3: Tumor measuring more than 4 cm in greatest dimension, and/or tumor having extraparenchymal extension. T4b: Very advanced disease. Tumor invades skull base and/or pterygoid plates and/or encases carotid artery. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension and ENE(+); or more than 3 cm but not more than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension and ENE(-), or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension and ENE(-). N3: Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(-); or in a single ipsilateral node larger than 3 cm in greatest dimension and ENE(+); or multiple ipsilateral, contralateral, or bilateral nodes any with ENE(+). M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C132787 Neoplastic Process Stage IV Major Salivary Gland Cancer AJCC v8 Stage IV Major Salivary Gland Cancer AJCC v8 CL520511 CTRP Malignant Stage IV Major Salivary Gland Cancer Stage IV Major Salivary Gland Cancer AJCC v8 Stage IV Major Salivary Gland Carcinoma AJCC v8 Stage IV Major Salivary Gland Cancer AJCC v8 Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T0, N2, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a: Moderately advanced disease. Tumor invades skin, mandible, ear canal, and/or facial nerve. T0: No evidence of primary tumor. T1: Tumor measuring 2 cm or less in greatest dimension without extraparenchymal extension. T2: Tumor measuring more than 2 cm, but not more than 4 cm in greatest dimension without extraparenchymal extension. T3: Tumor measuring more than 4 cm in greatest dimension, and/or tumor having extraparenchymal extension. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension and ENE(+); or more than 3 cm but not more than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension and ENE(-), or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension and ENE(-). M0: No distant metastasis. (AJCC 8th ed.) C132788 Neoplastic Process Stage IVA Major Salivary Gland Cancer AJCC v8 Stage IVA Major Salivary Gland Cancer AJCC v8 CL520515 CTRP Malignant Stage IVA Major Salivary Gland Cancer Stage IVA Major Salivary Gland Cancer AJCC v8 Stage IVA Major Salivary Gland Carcinoma AJCC v8 Stage IVA Major Salivary Gland Cancer AJCC v8 Stage IVB includes: (T4b, Any N, M0); (Any T, N3, M0). T4b: Very advanced disease. Tumor invades skull base and/or pterygoid plates and/or encases carotid artery. N0: No regional lymph node metastasis. N3: Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(-); or in a single ipsilateral node larger than 3 cm in greatest dimension and ENE(+); or multiple ipsilateral, contralateral, or bilateral nodes any with ENE(+). M0: No distant metastasis. (AJCC 8th ed.) C132789 Neoplastic Process Stage IVB Major Salivary Gland Cancer AJCC v8 Stage IVB Major Salivary Gland Cancer AJCC v8 CL520519 CTRP Malignant Stage IVB Major Salivary Gland Cancer Stage IVB Major Salivary Gland Cancer AJCC v8 Stage IVB Major Salivary Gland Carcinoma AJCC v8 Stage IVB Major Salivary Gland Cancer AJCC v8 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C132790 Neoplastic Process Stage IVC Major Salivary Gland Cancer AJCC v8 Stage IVC Major Salivary Gland Cancer AJCC v8 CL520523 CTRP Malignant Stage IVC Major Salivary Gland Cancer Stage IVC Major Salivary Gland Cancer AJCC v8 Stage IVC Major Salivary Gland Carcinoma AJCC v8 Stage IVC Major Salivary Gland Cancer AJCC v8 A term that refers to the staging of pharyngeal carcinoma according to the American Joint Committee on Cancer, 8th edition. C132814 Neoplastic Process Pharyngeal Carcinoma by AJCC v8 Stage CL520490 Malignant Pharyngeal Carcinoma by AJCC v8 Stage Pharyngeal Carcinoma by AJCC v8 Stage A term that refers to the staging of nasopharyngeal carcinoma according to the American Joint Committee on Cancer, 8th edition. C132816 Neoplastic Process Nasopharyngeal Carcinoma by AJCC v8 Stage CL520178 Malignant Nasopharyngeal Carcinoma by AJCC v8 Stage Nasopharyngeal Carcinoma by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal involvement. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C132817 Neoplastic Process Stage I Nasopharyngeal Carcinoma AJCC v8 Stage I Nasopharyngeal Carcinoma AJCC v8 CL521278 CTRP Malignant Stage I Nasopharyngeal Carcinoma AJCC v8 Stage I Nasopharyngeal Throat Cancer Stage I Nasopharyngeal Carcinoma AJCC v8 Stage II includes: (T1, N1, M0); (T0, N1, M0); (T2, N0, M0); (T2, N1, M0). T1: Tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal involvement. T0: No tumor identified, but EBV-positive cervical node(s) involvement is present. T2: Tumor with extension to parapharyngeal space, and/or adjacent soft tissue involvement (medial pterygoid, lateral pterygoid, prevertebral muscles). N0: No regional lymph node metastasis. N1: Tumor with unilateral metastasis in cervical lymph node(s), and/or unilateral or bilateral metastasis in retropharyngeal lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage. M0: No distant metastasis. (AJCC 8th ed.) C132818 Neoplastic Process Stage II Nasopharyngeal Carcinoma AJCC v8 Stage II Nasopharyngeal Carcinoma AJCC v8 CL521282 CTRP Malignant Stage II Nasopharyngeal Carcinoma AJCC v8 Stage II Nasopharyngeal Throat Cancer Stage II Nasopharyngeal Carcinoma AJCC v8 Stage III includes: (T1, N2, M0); (T0, N2, M0); (T2, N2, M0); (T3, N0, M0); (T3, N1, M0); (T3, N2, M0). T1: Tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal involvement. T0: No tumor identified, but EBV-positive cervical node(s) involvement is present. T2: Tumor with extension to parapharyngeal space, and/or adjacent soft tissue involvement (medial pterygoid, lateral pterygoid, prevertebral muscles). T3: Tumor infiltrating bony structures at skull base, cervical vertebrae, pterygoid structures, and/or paranasal sinuses. N0: No regional lymph node metastasis. N1: Tumor with unilateral metastasis in cervical lymph node(s), and/or unilateral or bilateral metastasis in retropharyngeal lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage. N2: Tumor with bilateral metastasis in cervical lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage. M0: No distant metastasis. (AJCC 8th ed.) C132819 Neoplastic Process Stage III Nasopharyngeal Carcinoma AJCC v8 Stage III Nasopharyngeal Carcinoma AJCC v8 CL520958 CTRP Malignant Stage III Nasopharyngeal Carcinoma AJCC v8 Stage III Nasopharyngeal Throat Cancer Stage III Nasopharyngeal Carcinoma AJCC v8 Stage IV includes: IVA: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0); (Any T, N3, M0); IVB (Any T, Any N, M1). T4: Tumor with intracranial extension, involvement of cranial nerves, hypopharynx, orbit, parotid gland, and/or extensive soft tissue infiltration beyond the lateral surface of the lateral pterygoid muscle. N0: No regional lymph node metastasis. N1: Tumor with unilateral metastasis in cervical lymph node(s), and/or unilateral or bilateral metastasis in retropharyngeal lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage. N2: Tumor with bilateral metastasis in cervical lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage. N3: Tumor with unilateral or bilateral metastasis in cervical lymph node(s), larger than 6 cm in greatest dimension, and/or extension below the caudal border of cricoid cartilage. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C132820 Neoplastic Process Stage IV Nasopharyngeal Carcinoma AJCC v8 Stage IV Nasopharyngeal Carcinoma AJCC v8 CL520963 CTRP Malignant Stage IV Nasopharyngeal Carcinoma AJCC v8 Stage IV Nasopharyngeal Throat Cancer Stage IV Nasopharyngeal Carcinoma AJCC v8 Stage IVA includes: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0); (Any T, N3, M0); T4: Tumor with intracranial extension, involvement of cranial nerves, hypopharynx, orbit, parotid gland, and/or extensive soft tissue infiltration beyond the lateral surface of the lateral pterygoid muscle. N0: No regional lymph node metastasis. N1: Tumor with unilateral metastasis in cervical lymph node(s), and/or unilateral or bilateral metastasis in retropharyngeal lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage. N2: Tumor with bilateral metastasis in cervical lymph node(s), 6 cm or smaller in greatest dimension, above the caudal border of cricoid cartilage. N3: Tumor with unilateral or bilateral metastasis in cervical lymph node(s), larger than 6 cm in greatest dimension, and/or extension below the caudal border of cricoid cartilage. M0: No distant metastasis. (AJCC 8th ed.) C132821 Neoplastic Process Stage IVA Nasopharyngeal Carcinoma AJCC v8 Stage IVA Nasopharyngeal Carcinoma AJCC v8 CL520966 CTRP Malignant Stage IVA Nasopharyngeal Carcinoma AJCC v8 Stage IVA Nasopharyngeal Throat Cancer Stage IVA Nasopharyngeal Carcinoma AJCC v8 Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C132822 Neoplastic Process Stage IVB Nasopharyngeal Carcinoma AJCC v8 Stage IVB Nasopharyngeal Carcinoma AJCC v8 CL520970 CTRP Malignant Stage IVB Nasopharyngeal Carcinoma AJCC v8 Stage IVB Nasopharyngeal Throat Cancer Stage IVB Nasopharyngeal Carcinoma AJCC v8 A Ewing sarcoma which is not amenable to surgical resection. C132849 Neoplastic Process Unresectable Ewing Sarcoma Unresectable Ewing Sarcoma CL520293 CTRP Malignant Unresectable Ewing Sarcoma Unresectable Ewing Sarcoma An osteosarcoma which is not amenable to surgical resection. C132850 Neoplastic Process Unresectable Osteosarcoma Unresectable Osteosarcoma CL520296 CTRP Malignant Unresectable Osteosarcoma Unresectable Osteosarcoma A carcinoma that arises from the prostate gland and has spread to the soft tissues. C132881 Neoplastic Process Metastatic Prostate Carcinoma in the Soft Tissue Prostate Carcinoma Metastatic in the Soft Tissue CL520052 CTRP Malignant Metastatic Prostate Cancer in the Soft Tissue Metastatic Prostate Carcinoma in the Soft Tissue Prostate Carcinoma Metastatic in the Soft Tissue Prostate Carcinoma Metastatic in the Soft Tissue A term that refers to the staging of HPV-mediated (p16-positive) oropharyngeal carcinoma according to the American Joint Committee on Cancer, 8th edition. C132882 Neoplastic Process HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Stage CL519931 Malignant HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Stage HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Stage A term that refers to the clinical staging of HPV-mediated (p16-positive) oropharyngeal carcinoma according to the American Joint Committee on Cancer, 8th edition. C132883 Neoplastic Process HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage CL519929 Malignant HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 cTNM Stage HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage A term that refers to the pathologic staging of HPV-mediated (p16-positive) oropharyngeal carcinoma according to the American Joint Committee on Cancer, 8th edition. C132884 Neoplastic Process HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage CL519930 Malignant HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 pTNM Stage HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage Stage I includes: (T0, N0, M0); (T0, N1, M0); (T1, N0, M0); (T1, N1, M0); (T2, N0, M0); (T2, N1, M0). T0: No primary identified. T1: Tumor 2 cm or smaller in greatest dimension. T2: Tumor larger than 2 cm but not larger than 4 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or more ipsilateral lymph nodes, none larger than 6 cm. M0: No distant metastasis. (AJCC 8th ed.) C132885 Neoplastic Process Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 CL520613 CTRP Malignant Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Stage I HPV-Mediated (p16-Positive) Oropharyngeal Throat Cancer Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Stage II includes: (T0, N2, M0); (T1, N2, M0) ;(T2, N2, M0); (T3, N0, M0); (T3, N1, M0); (T3, N2, M0). T0: No primary identified. T1: Tumor 2 cm or smaller in greatest dimension. T2: Tumor larger than 2 cm but not larger than 4 cm in greatest dimension. T3: Tumor larger than 4 cm in greatest dimension or extension to lingual surface of epiglottis. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or more ipsilateral lymph nodes, none larger than 6 cm. N2: Tumor with contralateral or bilateral lymph nodes metastasis, none larger than 6 cm. M0: No distant metastasis. (AJCC 8th ed.) C132886 Neoplastic Process Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 CL520618 CTRP Malignant Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Stage II HPV-Mediated (p16-Positive) Oropharyngeal Throat Cancer Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Stage III includes: (T0, N3, M0); (T1, N3, M0); (T2, N3, M0); (T3, N3, M0); (T4, N0, M0); (T4, N1, M0); (T4, N2, M0); (T4, N3, M0). T0: No primary identified. T1: Tumor 2 cm or smaller in greatest dimension. T2: Tumor larger than 2 cm but not larger than 4 cm in greatest dimension. T3: Tumor larger than 4 cm in greatest dimension or extension to lingual surface of epiglottis. T4: Tumor with moderately advanced local disease. Tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible or beyond. Mucosal extension to lingual surface of epiglottis from primary tumors of the base of the tongue and vallecula does not constitute invasion of the larynx. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or more ipsilateral lymph nodes, none larger than 6 cm. N2: Tumor with contralateral or bilateral lymph nodes metastasis, none larger than 6 cm. N3: Tumor with lymph node(s) metastasis, larger than 6 cm. M0: No distant metastasis. (AJCC 8th ed.) C132891 Neoplastic Process Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 CL520629 CTRP Malignant Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Stage III HPV-Mediated (p16-Positive) Oropharyngeal Throat Cancer Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C132893 Neoplastic Process Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 CL520634 CTRP Malignant Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Throat Cancer Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Stage I includes: (T0, N0, M0); (T0, N1, M0); (T1, N0, M0); (T1, N1, M0); (T2, N0, M0); (T2, N1, M0). T0: No primary identified. T1: Tumor 2 cm or smaller in greatest dimension. T2: Tumor larger than 2 cm but not larger than 4 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Tumor with metastasis in four or fewer lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C132898 Neoplastic Process Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 CL520851 CTRP Malignant Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Stage I HPV-Mediated (p16-Positive) Oropharyngeal Throat Cancer Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Stage II includes: (T0, N2, M0); (T1, N2, M0); (T2, N2, M0); (T3, N0, M0); (T3, N1, M0); (T4, N0, M0); (T4, N1, M0). T0: No primary identified. T1: Tumor 2 cm or smaller in greatest dimension. T2: Tumor larger than 2 cm but not larger than 4 cm in greatest dimension. T3: Tumor larger than 4 cm in greatest dimension or extension to lingual surface of epiglottis. T4: Moderately advanced local disease. Tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible or beyond. Mucosal extension to lingual surface of epiglottis from primary tumors of the base of the tongue and vallecula does not constitute invasion of the larynx. N0: No regional lymph node metastasis. N1: Tumor with metastasis in four or fewer lymph nodes. N2: Tumor with metastasis in more than four lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C132899 Neoplastic Process Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 CL520863 CTRP Malignant Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Stage II HPV-Mediated (p16-Positive) Oropharyngeal Throat Cancer Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Stage III includes: (T3, N2, M0); (T4, N2, M0). T3: Tumor larger than 4 cm in greatest dimension or extension to lingual surface of epiglottis. T4: Moderately advanced local disease. Tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible or beyond. Mucosal extension to lingual surface of epiglottis from primary tumors of the base of the tongue and vallecula does not constitute invasion of the larynx. N2: Tumor with metastasis in more than four lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C132900 Neoplastic Process Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 CL520873 CTRP Malignant Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Stage III HPV-Mediated (p16-Positive) Oropharyngeal Throat Cancer Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C132901 Neoplastic Process Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 CL520883 CTRP Malignant Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Throat Cancer Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 A glioblastoma characterized by the absence of DNA methylation in the promoter region of the MGMT gene. It is associated with a poor outcome. C132902 Neoplastic Process MGMT-Unmethylated Glioblastoma CL520767 Malignant MGMT-Unmethylated Glioblastoma Unmethylated MGMT Glioblastoma MGMT-Unmethylated Glioblastoma A term that refers to the staging of p16-negative oropharyngeal carcinoma according to the American Joint Committee on Cancer, 8th edition. C132994 Neoplastic Process Oropharyngeal (p16-Negative) Carcinoma by AJCC v8 Stage CL521268 Malignant Oropharyngeal (p16-Negative) Carcinoma by AJCC v8 Stage Oropharyngeal (p16-Negative) Carcinoma by AJCC v8 Stage Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C132995 Neoplastic Process Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8 CL521275 CTRP Malignant Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage 0 Oropharyngeal (p16-Negative) Throat Cancer Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage I includes: T1, N0, M0. T1: Tumor 2 cm or smaller in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C132996 Neoplastic Process Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8 CL521279 CTRP Malignant Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage I Oropharyngeal (p16-Negative) Throat Cancer Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage II includes: T2, N0, M0. T2: Tumor larger than 2 cm but not larger than 4 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C132997 Neoplastic Process Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8 CL521283 CTRP Malignant Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage II Oropharyngeal (p16-Negative) Throat Cancer Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor larger than 4 cm in greatest dimension or extension to lingual surface of epiglottis. T1: Tumor 2 cm or smaller in greatest dimension. T2: Tumor larger than 2 cm but not larger than 4 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Tumor with metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE (-). M0: No distant metastasis. (AJCC 8th ed.) C132998 Neoplastic Process Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 CL520959 CTRP Malignant Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage III Oropharyngeal (p16-Negative) Throat Cancer Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage IV includes: IVA: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB: (Any T, N3, M0); (T4b, Any N, M0); IVC: (Any T, Any N, M1). T4a: Moderately advanced local disease. Tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible. Mucosal extension to lingual surface of epiglottis from primary tumors of the base of the tongue and vallecula does not constitute invasion of the larynx. T1: Tumor 2 cm or smaller in greatest dimension. T2: Tumor larger than 2 cm but not larger than 4 cm in greatest dimension. T3: Tumor larger than 4 cm in greatest dimension or extension to lingual surface of epiglottis. T4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery. N0: No regional lymph node metastasis. N1: Tumor with metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE (-). N2: Tumor with metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(+); or larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-); or metastases in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-). N3: Tumor with metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(-); or metastasis in a single ipsilateral lymph node larger than 3 cm in greatest dimension and ENE(+); or metastases in multiple ipsilateral, contralateral, or bilateral lymph nodes any with ENE(+). M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C132999 Neoplastic Process Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 CL520964 CTRP Malignant Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage IV Oropharyngeal (p16-Negative) Throat Cancer Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a: Moderately advanced local disease. Tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible. Mucosal extension to lingual surface of epiglottis from primary tumors of the base of the tongue and vallecula does not constitute invasion of the larynx. T1: Tumor 2 cm or smaller in greatest dimension. T2: Tumor larger than 2 cm but not larger than 4 cm in greatest dimension. T3: Tumor larger than 4 cm in greatest dimension or extension to lingual surface of epiglottis. N0: No regional lymph node metastasis. N1: Tumor with metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(-). N2: Tumor with metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(+); or larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-); or metastases in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-). M0: No distant metastasis. (AJCC 8th ed.) C133000 Neoplastic Process Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 CL520967 CTRP Malignant Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage IVA Oropharyngeal (p16-Negative) Throat Cancer Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage IVB includes: (Any T, N3, M0); (T4b, Any N, M0). T4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery. N3: Tumor with metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(-); or metastasis in a single ipsilateral lymph node larger than 3 cm in greatest dimension and ENE(+); or metastases in multiple ipsilateral, contralateral, or bilateral lymph nodes any with ENE(+). M0: No distant metastasis. (AJCC 8th ed.) C133001 Neoplastic Process Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8 CL520971 CTRP Malignant Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage IVB Oropharyngeal (p16-Negative) Throat Cancer Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage IVC includes: Any T, Any N, M1. M1: distant metastasis. (AJCC 8th ed.) C133002 Neoplastic Process Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8 CL520974 CTRP Malignant Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage IVC Oropharyngeal (p16-Negative) Throat Cancer Stage IVC Oropharyngeal (p16-Negative) Carcinoma AJCC v8 A term that refers to the staging of hypopharyngeal carcinoma according to the American Joint Committee on Cancer, 8th edition. C133003 Neoplastic Process Hypopharyngeal Carcinoma by AJCC v8 Stage CL520039 Malignant Hypopharyngeal Carcinoma by AJCC v8 Stage Hypopharyngeal Carcinoma by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Tumor limited to one subsite of hypopharynx and/or 2 cm or smaller in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133005 Neoplastic Process Stage I Hypopharyngeal Carcinoma AJCC v8 Stage I Hypopharyngeal Carcinoma AJCC v8 CL521277 CTRP Malignant Stage I Hypopharyngeal Carcinoma AJCC v8 Stage I Hypopharyngeal Throat Cancer Stage I Hypopharyngeal Carcinoma AJCC v8 Stage II includes: T2, N0, M0. T2: Tumor invading more than one subsite of hypopharynx or an adjacent site, or measuring more than 2 cm but not more than 4 cm in greatest dimension without fixation of hemilarynx. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133006 Neoplastic Process Stage II Hypopharyngeal Carcinoma AJCC v8 Stage II Hypopharyngeal Carcinoma AJCC v8 CL521281 CTRP Malignant Stage II Hypopharyngeal Carcinoma AJCC v8 Stage II Hypopharyngeal Throat Cancer Stage II Hypopharyngeal Carcinoma AJCC v8 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor larger than 4 cm in greatest dimension or with fixation of hemilarynx or extension to esophagus. T1: Tumor limited to one subsite of hypopharynx and/or 2 cm or smaller in greatest dimension. T2: Tumor invading more than one subsite of hypopharynx or an adjacent site, or measuring more than 2 cm but not more than 4 cm in greatest dimension without fixation of hemilarynx. N0: No regional lymph node metastasis. N1: Tumor with metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE (-). M0: No distant metastasis. (AJCC 8th ed.) C133007 Neoplastic Process Stage III Hypopharyngeal Carcinoma AJCC v8 Stage III Hypopharyngeal Carcinoma AJCC v8 CL520957 CTRP Malignant Stage III Hypopharyngeal Carcinoma AJCC v8 Stage III Hypopharyngeal Throat Cancer Stage III Hypopharyngeal Carcinoma AJCC v8 Stage IV includes: IVA: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB: (Any T, N3, M0); (T4b, Any N, M0); IVC: (Any T, Any N, M1). T4a: Moderately advanced local disease. Tumor invades thyroid/cricoid cartilage, hyoid bone, thyroid gland, or central compartment soft tissue. Central compartment soft tissue includes prelaryngeal strap muscles and subcutaneous fat. T1: Tumor limited to one subsite of hypopharynx and/or 2 cm or smaller in greatest dimension. T2: Tumor invading more than one subsite of hypopharynx or an adjacent site, or measuring more than 2 cm but not more than 4 cm in greatest dimension without fixation of hemilarynx. T3: Tumor larger than 4 cm in greatest dimension or with fixation of hemilarynx or extension to esophagus. T4b: Very advanced local disease. Tumor invades prevertebral fascia, encases carotid artery, or involves mediastinal structures. N0: No regional lymph node metastasis. N1: Tumor with metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE (-). N2: Tumor with metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(+); or larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-); or metastases in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-). N3: Tumor with metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(-); or metastasis in a single ipsilateral lymph node larger than 3 cm in greatest dimension and ENE(+); or metastases in multiple ipsilateral, contralateral, or bilateral lymph nodes any with ENE(+). M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C133008 Neoplastic Process Stage IV Hypopharyngeal Carcinoma AJCC v8 Stage IV Hypopharyngeal Carcinoma AJCC v8 CL520962 CTRP Malignant Stage IV Hypopharyngeal Carcinoma AJCC v8 Stage IV Hypopharyngeal Throat Cancer Stage IV Hypopharyngeal Carcinoma AJCC v8 Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a: Moderately advanced local disease. Tumor invades thyroid/cricoid cartilage, hyoid bone, thyroid gland, or central compartment soft tissue. Central compartment soft tissue includes prelaryngeal strap muscles and subcutaneous fat. T1: Tumor limited to one subsite of hypopharynx and/or 2 cm or smaller in greatest dimension. T2: Tumor invading more than one subsite of hypopharynx or an adjacent site, or measuring more than 2 cm but not more than 4 cm in greatest dimension without fixation of hemilarynx. T3: Tumor larger than 4 cm in greatest dimension or with fixation of hemilarynx or extension to esophagus. N0: No regional lymph node metastasis. N1: Tumor with metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(-). N2: Tumor with metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(+); or larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-); or metastases in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-). M0: No distant metastasis. (AJCC 8th ed.) C133009 Neoplastic Process Stage IVA Hypopharyngeal Carcinoma AJCC v8 Stage IVA Hypopharyngeal Carcinoma AJCC v8 CL520965 CTRP Malignant Stage IVA Hypopharyngeal Carcinoma AJCC v8 Stage IVA Hypopharyngeal Throat Cancer Stage IVA Hypopharyngeal Carcinoma AJCC v8 Stage IVB includes: (Any T, N3, M0); (T4b, Any N, M0). T4b: Very advanced local disease. Tumor invades prevertebral fascia, encases carotid artery, or involves mediastinal structures. N3: Tumor with metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(-); or metastasis in a single ipsilateral lymph node larger than 3 cm in greatest dimension and ENE(+); or metastases in multiple ipsilateral, contralateral, or bilateral lymph nodes any with ENE(+). M0: No distant metastasis. (AJCC 8th ed.) C133010 Neoplastic Process Stage IVB Hypopharyngeal Carcinoma AJCC v8 Stage IVB Hypopharyngeal Carcinoma AJCC v8 CL520969 CTRP Malignant Stage IVB Hypopharyngeal Carcinoma AJCC v8 Stage IVB Hypopharyngeal Throat Cancer Stage IVB Hypopharyngeal Carcinoma AJCC v8 Stage IVC includes: Any T, Any N, M1. M1: distant metastasis. (AJCC 8th ed.) C133011 Neoplastic Process Stage IVC Hypopharyngeal Carcinoma AJCC v8 Stage IVC Hypopharyngeal Carcinoma AJCC v8 CL520973 CTRP Malignant Stage IVC Hypopharyngeal Carcinoma AJCC v8 Stage IVC Hypopharyngeal Throat Cancer Stage IVC Hypopharyngeal Carcinoma AJCC v8 A term that refers to the staging of nasal cavity and paranasal sinus carcinoma according to the American Joint Committee on Cancer, 8th edition. C133074 Neoplastic Process Sinonasal Cancer by AJCC v8 Stage CL520125 Malignant Nasal Cavity and Paranasal Sinus Cancer by AJCC v8 Stage Nasal Cavity and Paranasal Sinus Carcinoma by AJCC v8 Stage Sinonasal Cancer by AJCC v8 Stage Sinonasal Carcinoma by AJCC v8 Stage Sinonasal Cancer by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Maxillary sinus: Tumor limited to the maxillary sinus mucosa with no erosion or destruction of bone. Nasal cavity and ethmoid sinus: Tumor restricted to any one subsite, with or without bony invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133076 Neoplastic Process Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v8 Stage I Sinonasal Cancer AJCC v8 CL521153 CTRP Malignant Stage I Nasal Cavity and Paranasal Sinus Cancer Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v8 Stage I Nasal Cavity and Paranasal Sinus Carcinoma AJCC v8 Stage I Sinonasal Cancer AJCC v8 Stage I Sinonasal Carcinoma AJCC v8 Stage I Sinonasal Cancer AJCC v8 Stage II includes: T2, N0, M0. T2: Maxillary sinus: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates. Nasal cavity and ethmoid sinus: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133077 Neoplastic Process Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v8 Stage II Sinonasal Cancer AJCC v8 CL520504 CTRP Malignant Stage II Nasal Cavity and Paranasal Sinus Cancer Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v8 Stage II Nasal Cavity and Paranasal Sinus Carcinoma AJCC v8 Stage II Sinonasal Cancer AJCC v8 Stage II Sinonasal Carcinoma AJCC v8 Stage II Sinonasal Cancer AJCC v8 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Maxillary sinus: Tumor invading any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, or ethmoid sinuses. Nasal cavity and ethmoid sinus: Tumor invading the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate. T1: Maxillary sinus: Tumor limited to the maxillary sinus mucosa with no erosion or destruction of bone. Nasal cavity and ethmoid sinus: Tumor restricted to any one subsite, with or without bony invasion. T2: Maxillary sinus: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates. Nasal cavity and ethmoid sinus: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension and ENE(-). M0: No distant metastasis. (AJCC 8th ed.) C133078 Neoplastic Process Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8 Stage III Sinonasal Cancer AJCC v8 CL520508 CTRP Malignant Stage III Nasal Cavity and Paranasal Sinus Cancer Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8 Stage III Nasal Cavity and Paranasal Sinus Carcinoma AJCC v8 Stage III Sinonasal Cancer AJCC v8 Stage III Sinonasal Carcinoma AJCC v8 Stage III Sinonasal Cancer AJCC v8 Stage IV includes: IVA: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB: (T4b, Any N, M0); (Any T, N3, M0); IVC: (Any T, Any N, M1). T4a: Maxillary sinus: Moderately advanced local disease. Tumor invades anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid or frontal sinuses. Nasal cavity and ethmoid sinus: Moderately advanced local disease. Tumor invades any of the following: anterior orbital contents, skin of nose or cheek, minimal extension to anterior cranial fossa, pterygoid plates, sphenoid or frontal sinuses. T4b: Very advanced local disease. Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve (V2), nasopharynx, or clivus. T1: Maxillary sinus: Tumor limited to the maxillary sinus mucosa with no erosion or destruction of bone. Nasal cavity and ethmoid sinus: Tumor restricted to any one subsite, with or without bony invasion. T2: Maxillary sinus: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates. Nasal cavity and ethmoid sinus: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion. T3: Maxillary sinus: Tumor invading any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, or ethmoid sinuses. Nasal cavity and ethmoid sinus: Tumor invading the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension and ENE(-). N2: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(+); or metastasis in a single ipsilateral lymph node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral lymph nodes , none larger than 6 cm in greatest dimension and ENE(-); or metastases in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-). N3: Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(-); or metastasis in a single ipsilateral node larger than 3 cm in greatest dimension and ENE(+); or metastases in multiple ipsilateral, contralateral or bilateral nodes, any with ENE(+). M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C133079 Neoplastic Process Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8 Stage IV Sinonasal Cancer AJCC v8 CL520512 CTRP Malignant Stage IV Nasal Cavity and Paranasal Sinus Cancer Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8 Stage IV Nasal Cavity and Paranasal Sinus Carcinoma AJCC v8 Stage IV Sinonasal Cancer AJCC v8 Stage IV Sinonasal Carcinoma AJCC v8 Stage IV Sinonasal Cancer AJCC v8 Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a: Maxillary sinus: Moderately advanced local disease. Tumor invades anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid or frontal sinuses. Nasal cavity and ethmoid sinus: Moderately advanced local disease. Tumor invades any of the following: anterior orbital contents, skin of nose or cheek, minimal extension to anterior cranial fossa, pterygoid plates, sphenoid or frontal sinuses. T1: Maxillary sinus: Tumor limited to the maxillary sinus mucosa with no erosion or destruction of bone. Nasal cavity and ethmoid sinus: Tumor restricted to any one subsite, with or without bony invasion. T2: Maxillary sinus: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates. Nasal cavity and ethmoid sinus: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion. T3: Maxillary sinus: Tumor invading any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, or ethmoid sinuses. Nasal cavity and ethmoid sinus: Tumor invading the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension and ENE(-). N2: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(+); or metastasis in a single ipsilateral lymph node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral lymph nodes , none larger than 6 cm in greatest dimension and ENE(-); or metastases in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-). M0: No distant metastasis. (AJCC 8th ed.) C133080 Neoplastic Process Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8 Stage IVA Sinonasal Cancer AJCC v8 CL520516 CTRP Malignant Stage IVA Nasal Cavity and Paranasal Sinus Cancer Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8 Stage IVA Nasal Cavity and Paranasal Sinus Carcinoma AJCC v8 Stage IVA Sinonasal Cancer AJCC v8 Stage IVA Sinonasal Carcinoma AJCC v8 Stage IVA Sinonasal Cancer AJCC v8 Stage IVB includes: (T4b, Any N, M0); (Any T, N3, M0). T4b: Very advanced local disease. Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve (V2), nasopharynx, or clivus. N3: Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(-); or metastasis in a single ipsilateral node larger than 3 cm in greatest dimension and ENE(+); or metastases in multiple ipsilateral, contralateral or bilateral nodes, any with ENE(+). M0: No distant metastasis. (AJCC 8th ed.) C133081 Neoplastic Process Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v8 Stage IVB Sinonasal Cancer AJCC v8 CL520520 CTRP Malignant Stage IVB Nasal Cavity and Paranasal Sinus Cancer Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v8 Stage IVB Nasal Cavity and Paranasal Sinus Carcinoma AJCC v8 Stage IVB Sinonasal Cancer AJCC v8 Stage IVB Sinonasal Carcinoma AJCC v8 Stage IVB Sinonasal Cancer AJCC v8 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C133082 Neoplastic Process Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v8 Stage IVC Sinonasal Cancer AJCC v8 CL520524 CTRP Malignant Stage IVC Nasal Cavity and Paranasal Sinus Cancer Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v8 Stage IVC Nasal Cavity and Paranasal Sinus Carcinoma AJCC v8 Stage IVC Sinonasal Cancer AJCC v8 Stage IVC Sinonasal Carcinoma AJCC v8 Stage IVC Sinonasal Cancer AJCC v8 A very rare benign neoplasm that arises from the lung. It is characterized by the presence of a stromal and an epithelial component. It resembles the adenofibromas that arise from the organs of the female reproductive system. C133091 Neoplastic Process Lung Adenofibroma CL520765 Benign Lung Adenofibroma Pulmonary Adenofibroma Lung Adenofibroma The reemergence of breast angiosarcoma after a period of remission. C133092 Neoplastic Process Recurrent Breast Angiosarcoma CL520222 Malignant Recurrent Breast Angiosarcoma Recurrent Breast Angiosarcoma A carcinoma arising from the anal canal and occurring in HIV-positive patients. C133095 Neoplastic Process AIDS-Related Anal Canal Carcinoma AIDS-Related Anal Canal Carcinoma CL521160 CTRP Malignant AIDS-Related Anal Canal Cancer AIDS-Related Anal Canal Carcinoma AIDS-Related Anal Canal Carcinoma A term that refers to the staging of laryngeal carcinoma according to the American Joint Committee on Cancer, 8th edition. C133156 Neoplastic Process Laryngeal Cancer by AJCC v8 Stage CL521088 Malignant Laryngeal Cancer by AJCC v8 Stage Laryngeal Carcinoma by AJCC v8 Stage Laryngeal Cancer by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Supraglottis: Tumor is limited to one subsite of supraglottis with normal vocal cord mobility. Glottis: Tumor is limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility. Subglottis: Tumor is limited to the subglottis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133158 Neoplastic Process Stage I Laryngeal Cancer AJCC v8 Stage I Laryngeal Cancer AJCC v8 CL521150 CTRP Malignant Stage I Laryngeal Cancer AJCC v8 Stage I Laryngeal Carcinoma AJCC v8 Stage I Laryngeal Throat Cancer Stage I Laryngeal Cancer AJCC v8 Stage II includes: T2, N0, M0. T2: Supraglottis: Tumor invades the mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of the tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx. Glottis: Tumor extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility. Subglottis: Tumor extends to vocal cord(s) with normal or impaired mobility. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133159 Neoplastic Process Stage II Laryngeal Cancer AJCC v8 Stage II Laryngeal Cancer AJCC v8 CL520501 CTRP Malignant Stage II Laryngeal Cancer AJCC v8 Stage II Laryngeal Carcinoma AJCC v8 Stage II Laryngeal Throat Cancer Stage II Laryngeal Cancer AJCC v8 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Supraglottis: Tumor is limited to larynx with vocal cord fixation and/or invades any of the following: postcricoid area, preepiglottic space, paraglottic space, and/or inner cortex of thyroid cartilage. Glottis: Tumor is limited to the larynx with vocal cord fixation and /or invades the paraglottic space, and/or inner cortex of the thyroid cartilage. Subglottis: Tumor is limited to the larynx with vocal cord fixation and/or invades the paraglottic space and/or inner cortex of the thyroid cartilage. T1: Supraglottis: Tumor is limited to one subsite of supraglottis with normal vocal cord mobility. Glottis: Tumor is limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility. Subglottis: Tumor is limited to the subglottis. T2: Supraglottis: Tumor invades the mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of the tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx. Glottis: Tumor extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility. Subglottis: Tumor extends to vocal cord(s) with normal or impaired mobility. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension and ENE(-). M0: No distant metastasis. (AJCC 8th ed.) C133160 Neoplastic Process Stage III Laryngeal Cancer AJCC v8 Stage III Laryngeal Cancer AJCC v8 CL520505 CTRP Malignant Stage III Laryngeal Cancer AJCC v8 Stage III Laryngeal Carcinoma AJCC v8 Stage III Laryngeal Throat Cancer Stage III Laryngeal Cancer AJCC v8 Stage IV includes: IVA: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB: (Any T, N3, M0); (T4b, Any N, M0); IVC: (Any T, Any N, M1). T4a: Supraglottis: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus). Glottis: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, cricoid cartilage, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus). Subglottis: Moderately advanced local disease. Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus). T3: Supraglottis: Tumor is limited to larynx with vocal cord fixation and/or invades any of the following: postcricoid area, preepiglottic space, paraglottic space, and/or inner cortex of thyroid cartilage. Glottis: Tumor is limited to the larynx with vocal cord fixation and /or invades the paraglottic space, and/or inner cortex of the thyroid cartilage. Subglottis: Tumor is limited to the larynx with vocal cord fixation and/or invades the paraglottic space and/or inner cortex of the thyroid cartilage. T1: Supraglottis: Tumor is limited to one subsite of supraglottis with normal vocal cord mobility. Glottis: Tumor is limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility. Subglottis: Tumor is limited to the subglottis. T2: Supraglottis: Tumor invades the mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of the tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx. Glottis: Tumor extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility. Subglottis: Tumor extends to vocal cord(s) with normal or impaired mobility. T4b: Supraglottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. Glottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. Subglottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension and ENE(-). N2: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension and ENE(+); or metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension and ENE(-); or metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension and ENE(-). N3: metastasis in a lymph node, more than 6 cm in greatest dimension and ENE(-); or metastasis in a single ipsilateral lymph node, more than 3 cm in greatest dimension and ENE(+); or metastases in multiple ipsilateral, contralateral, or bilateral lymph nodes and any with ENE(+). M0: No distant metastasis. M1: distant metastasis. (AJCC 8th ed.) C133161 Neoplastic Process Stage IV Laryngeal Cancer AJCC v8 Stage IV Laryngeal Cancer AJCC v8 CL520509 CTRP Malignant Stage IV Laryngeal Cancer AJCC v8 Stage IV Laryngeal Carcinoma AJCC v8 Stage IV Laryngeal Throat Cancer Stage IV Laryngeal Cancer AJCC v8 Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a: Supraglottis: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus). Glottis: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, cricoid cartilage, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus). Subglottis: Moderately advanced local disease. Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus). T3: Supraglottis: Tumor is limited to larynx with vocal cord fixation and/or invades any of the following: postcricoid area, preepiglottic space, paraglottic space, and/or inner cortex of thyroid cartilage. Glottis: Tumor is limited to the larynx with vocal cord fixation and /or invades the paraglottic space, and/or inner cortex of the thyroid cartilage. Subglottis: Tumor is limited to the larynx with vocal cord fixation and/or invades the paraglottic space and/or inner cortex of the thyroid cartilage. T1: Supraglottis: Tumor is limited to one subsite of supraglottis with normal vocal cord mobility. Glottis: Tumor is limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility. Subglottis: Tumor is limited to the subglottis. T2: Supraglottis: Tumor invades the mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of the tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx. Glottis: Tumor extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility. Subglottis: Tumor extends to vocal cord(s) with normal or impaired mobility. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension and ENE(-). N2: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension and ENE(+); or metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension and ENE(-); or metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension and ENE(-). M0: No distant metastasis. (AJCC 8th ed.) C133162 Neoplastic Process Stage IVA Laryngeal Cancer AJCC v8 Stage IVA Laryngeal Cancer AJCC v8 CL520513 CTRP Malignant Stage IVA Laryngeal Cancer AJCC v8 Stage IVA Laryngeal Carcinoma AJCC v8 Stage IVA Laryngeal Throat Cancer Stage IVA Laryngeal Cancer AJCC v8 Stage IVB includes: (Any T, N3, M0); (T4b, Any N, M0). T4b: Supraglottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. Glottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. Subglottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. N3: metastasis in a lymph node, more than 6 cm in greatest dimension and ENE(-); or metastasis in a single ipsilateral lymph node, more than 3 cm in greatest dimension and ENE(+); or metastases in multiple ipsilateral, contralateral, or bilateral lymph nodes and any with ENE(+). M0: No distant metastasis. (AJCC 8th ed.) C133163 Neoplastic Process Stage IVB Laryngeal Cancer AJCC v8 Stage IVB Laryngeal Cancer AJCC v8 CL520517 CTRP Malignant Stage IVB Laryngeal Cancer AJCC v8 Stage IVB Laryngeal Carcinoma AJCC v8 Stage IVB Laryngeal Throat Cancer Stage IVB Laryngeal Cancer AJCC v8 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C133164 Neoplastic Process Stage IVC Laryngeal Cancer AJCC v8 Stage IVC Laryngeal Cancer AJCC v8 CL520521 CTRP Malignant Stage IVC Laryngeal Cancer AJCC v8 Stage IVC Laryngeal Carcinoma AJCC v8 Stage IVC Laryngeal Throat Cancer Stage IVC Laryngeal Cancer AJCC v8 A term that refers to the staging of mucosal melanoma of the head and neck according to the American Joint Committee on Cancer, 7th edition. No prognostic stage grouping is proposed in the 8th edition. C133186 Neoplastic Process Mucosal Melanoma of the Head and Neck by AJCC v7 Stage CL520074 Malignant Mucosal Melanoma of the Head and Neck by AJCC v7 Stage Mucosal Melanoma of the Head and Neck by AJCC v7 Stage A melanoma that arises in the mucosa of the nasal cavity, paranasal sinuses, oral cavity, oropharynx, nasopharynx, larynx, and hypopharynx. C133187 Neoplastic Process Mucosal Melanoma of the Head and Neck Mucosal Melanoma of the Head and Neck CL520085 CTRP Malignant Mucosal Melanoma of the Head and Neck Mucosal Melanoma of the Head and Neck An organ that produces and secretes hormones (e.g. endocrine gland), saliva or sweat (e.g. exocrine gland). C13319 Body Part, Organ, or Organ Component Gland C1285092 An organ that makes one or more substances, such as hormones, digestive juices, sweat, tears, saliva, or milk. Endocrine glands release the substances directly into the bloodstream. Exocrine glands release the substances into a duct or opening to the inside or outside of the body. Gland Gland Glandular gland Gland A precancerous neoplastic process affecting the oral mucosa. It is characterized by the presence of dysplasia in the mucosal epithelium. C133192 Neoplastic Process Oral Intraepithelial Neoplasia Oral Intraepithelial Neoplasia CL521227 CTRP Undetermined Oral Intraepithelial Neoplasia Oral Intraepithelial Neoplasia Thyroid gland carcinoma that has spread from its original site of growth to another anatomic site. C133193 Neoplastic Process Metastatic Thyroid Gland Carcinoma Metastatic Thyroid Gland Carcinoma CL520053 CTRP Malignant Metastatic Thyroid Gland Cancer Metastatic Thyroid Gland Carcinoma Metastatic Thyroid Gland Carcinoma A squamous cell carcinoma that arises from the skin of the head and neck. C133252 Neoplastic Process Cutaneous Squamous Cell Carcinoma of the Head and Neck CL519811 CPTAC Malignant Squamous cell carcinoma of scalp and skin of neck Squamous cell carcinoma of skin of other and unspecified parts of face Cutaneous Squamous Cell Carcinoma of the Head and Neck Cutaneous Squamous Cell Carcinoma of the Head and Neck A term that refers to the staging of cutaneous squamous cell carcinoma of the head and neck according to the American Joint Committee on Cancer, 8th edition. C133253 Neoplastic Process Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage CL519779 CPTAC Malignant Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage Tumor Stage (Pathological) Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage A squamous cell carcinoma that arises from the lung. It is characterized by the presence of large malignant cells. It includes the clear cell and papillary variants of squamous cell carcinoma. C133254 Neoplastic Process Non-Small Cell Squamous Lung Carcinoma Lung Non-Small Cell Squamous Carcinoma CL521148 CTRP Malignant Lung Non-Small Cell Squamous Carcinoma Non-Small Cell Squamous Lung Cancer Non-Small Cell Squamous Lung Carcinoma Squamous Non-Small Cell Lung Carcinoma Lung Non-Small Cell Squamous Carcinoma Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133255 Neoplastic Process Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 CL521274 CTRP Malignant Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 Stage 0 Head and Neck Squamous Cell Cancer Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 Stage I includes: T1, N0, M0. T1: Tumor smaller than 2 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133256 Neoplastic Process Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 CL521276 CPTAC CTRP Malignant Stage I Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 Stage I Head and Neck Squamous Cell Cancer Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 Stage II includes: T2, N0, M0. T2: Tumor 2 cm or larger, but smaller than 4 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133257 Neoplastic Process Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 CL521280 CPTAC CTRP Malignant Stage II Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 Stage II Head and Neck Squamous Cell Cancer Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor 4 cm or larger in greatest dimension or minor bone erosion or perineural invasion or deep invasion. Deep invasion is defined as invasion beyond the subcutaneous fat or larger than 6 mm; perineural invasion for T3 classification is defined as tumor cells within the nerve sheath of a nerve lying deeper than the dermis or measuring 0.1 mm or larger in caliber, or presenting with clinical or radiographic involvement of named nerves without skull base invasion or transgression. T1: Tumor smaller than 2 cm in greatest dimension. T2: Tumor 2 cm or larger, but smaller than 4 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(-). M0: No distant metastasis. (AJCC 8th ed.) C133258 Neoplastic Process Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 CL520956 CPTAC CTRP Malignant Stage III Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 Stage III Head and Neck Squamous Cell Cancer Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 Stage IV includes: (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (Any T, N3, M0); (T4, Any N, M0); (Any T, Any N, M1). T1: Tumor smaller than 2 cm in greatest dimension. T2: Tumor 2 cm or larger, but smaller than 4 cm in greatest dimension. T3: Tumor 4 cm or larger in greatest dimension or minor bone erosion or perineural invasion or deep invasion. Deep invasion is defined as invasion beyond the subcutaneous fat or larger than 6 mm; perineural invasion for T3 classification is defined as tumor cells within the nerve sheath of a nerve lying deeper than the dermis or measuring 0.1 mm or larger in caliber, or presenting with clinical or radiographic involvement of named nerves without skull base invasion or transgression. T4: Tumor with gross cortical bone/marrow, skull base invasion and/or skull base foramen invasion. N2: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(+); or metastasis in a single ipsilateral lymph node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-); or metastases in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-). N3: Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(-); or metastasis in a single ipsilateral lymph node larger than 3 cm in greatest dimension and ENE(+); or metastases in multiple ipsilateral, contralateral, or bilateral lymph nodes, any with ENE(+). M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C133259 Neoplastic Process Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 CL520961 CPTAC CTRP Malignant Stage IV Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 Stage IV Head and Neck Squamous Cell Cancer Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 A term that refers to the staging of esophageal carcinoma according to the American Joint Committee on Cancer, 8th edition. C133399 Neoplastic Process Esophageal Cancer by AJCC v8 Stage CL521047 Malignant Esophageal Cancer by AJCC v8 Stage Esophageal Carcinoma by AJCC v8 Stage Esophageal Cancer by AJCC v8 Stage A term that refers to the staging of esophageal adenocarcinoma according to the American Joint Committee on Cancer, 8th edition. C133400 Neoplastic Process Esophageal Adenocarcinoma by AJCC v8 Stage CL521046 Malignant Esophageal Adenocarcinoma by AJCC v8 Stage Esophageal Adenocarcinoma by AJCC v8 Stage A term that refers to the clinical staging of esophageal adenocarcinoma according to the American Joint Committee on Cancer, 8th edition. C133401 Neoplastic Process Esophageal Adenocarcinoma by AJCC v8 Clinical Stage CL521043 Malignant Esophageal Adenocarcinoma by AJCC v8 Clinical Stage Esophageal Adenocarcinoma by AJCC v8 cTNM Stage Esophageal Adenocarcinoma by AJCC v8 Clinical Stage Stage 0 includes: Tis, N0, M0. Tis: High-grade dysplasia, defined as malignant cells confined to the epithelium by the basement membrane. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133402 Neoplastic Process Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8 Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8 CL520605 CTRP Malignant Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8 Stage 0 Esophageal Adenocarcinoma Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8 Stage I includes: T1, N0, M0. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133403 Neoplastic Process Clinical Stage I Esophageal Adenocarcinoma AJCC v8 Clinical Stage I Esophageal Adenocarcinoma AJCC v8 CL520609 CTRP Malignant Clinical Stage I Esophageal Adenocarcinoma AJCC v8 Stage I Esophageal Adenocarcinoma Clinical Stage I Esophageal Adenocarcinoma AJCC v8 Stage II includes: IIA: T1, N1, M0; IIB: T2, N0, M0. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133404 Neoplastic Process Clinical Stage II Esophageal Adenocarcinoma AJCC v8 Clinical Stage II Esophageal Adenocarcinoma AJCC v8 CL520614 CTRP Malignant Clinical Stage II Esophageal Adenocarcinoma AJCC v8 Stage II Esophageal Adenocarcinoma Clinical Stage II Esophageal Adenocarcinoma AJCC v8 Stage IIA includes: T1, N1, M0. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133405 Neoplastic Process Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8 Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8 CL520619 CTRP Malignant Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8 Stage IIA Esophageal Adenocarcinoma Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8 Stage IIB includes: T2, N0, M0. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133406 Neoplastic Process Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8 Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8 CL520622 CTRP Malignant Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8 Stage IIB Esophageal Adenocarcinoma Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8 Stage III includes: (T2, N1, M0); (T3, N0-1, M0); (T4a, N0-1, M0). T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133407 Neoplastic Process Clinical Stage III Esophageal Adenocarcinoma AJCC v8 Clinical Stage III Esophageal Adenocarcinoma AJCC v8 CL520625 CTRP Malignant Clinical Stage III Esophageal Adenocarcinoma AJCC v8 Stage III Esophageal Adenocarcinoma Clinical Stage III Esophageal Adenocarcinoma AJCC v8 Stage IV includes: IVA: (T1-4a, N2, M0); (T4b, N0-2, M0); (Any T, N3, M0); IVB: (Any T, Any N, M1). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C133408 Neoplastic Process Clinical Stage IV Esophageal Adenocarcinoma AJCC v8 Clinical Stage IV Esophageal Adenocarcinoma AJCC v8 CL520630 CTRP Malignant Clinical Stage IV Esophageal Adenocarcinoma AJCC v8 Stage IV Esophageal Adenocarcinoma Clinical Stage IV Esophageal Adenocarcinoma AJCC v8 Stage IVA includes: (T1-4a, N2, M0); (T4b, N0-2, M0); (Any T, N3, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133409 Neoplastic Process Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8 Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8 CL520635 CTRP Malignant Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8 Stage IVA Esophageal Adenocarcinoma Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8 Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C133410 Neoplastic Process Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8 Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8 CL520639 CTRP Malignant Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8 Stage IVB Esophageal Adenocarcinoma Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8 A term that refers to the staging of esophageal adenocarcinoma according to the American Joint Committee on Cancer, 7th edition. C133411 Neoplastic Process Esophageal Adenocarcinoma by AJCC v7 Stage CL521042 Malignant Esophageal Adenocarcinoma by AJCC v7 Stage Esophageal Adenocarcinoma by AJCC v7 Stage A term that refers to the pathologic staging of esophageal adenocarcinoma according to the American Joint Committee on Cancer, 8th edition. C133412 Neoplastic Process Esophageal Adenocarcinoma by AJCC v8 Pathologic Stage CL521044 CPTAC Malignant Esophageal Adenocarcinoma Tumor Stage Pathologic Esophageal Adenocarcinoma by AJCC v8 Pathologic Stage Esophageal Adenocarcinoma by AJCC v8 pTNM Stage Esophageal Adenocarcinoma by AJCC v8 Pathologic Stage Stage 0 includes: Tis, N0, M0, GN/A. Tis: High-grade dysplasia, defined as malignant cells confined to the epithelium by the basement membrane. N0: No regional lymph node metastasis. M0: No distant metastasis. GN/A: Grade non-applicable. (AJCC 8th ed.) C133413 Neoplastic Process Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8 Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8 CL520845 CPTAC CTRP Malignant 0 Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8 Stage 0 Esophageal Adenocarcinoma Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8 Stage I includes: IA: (T1a, N0, M0, G1); (T1a, N0, M0, GX); IB: (T1a, N0, M0, G2); (T1b, N0, M0, G1-2); (T1b, N0, M0, GX); IC: (T1, N0, M0, G3); (T2, N0, M0, G1-2). T1a: Tumor invades the lamina propria or muscularis mucosae. T1b: Tumor invades the submucosa. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.) C133414 Neoplastic Process Pathologic Stage I Esophageal Adenocarcinoma AJCC v8 Pathologic Stage I Esophageal Adenocarcinoma AJCC v8 CL520848 CPTAC CTRP Malignant I Pathologic Stage I Esophageal Adenocarcinoma AJCC v8 Stage I Esophageal Adenocarcinoma Pathologic Stage I Esophageal Adenocarcinoma AJCC v8 Stage IA includes: (T1a, N0, M0, G1); (T1a, N0, M0, GX). T1a: Tumor invades the lamina propria or muscularis mucosae. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. (AJCC 8th ed.) C133415 Neoplastic Process Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8 Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8 CL520852 CPTAC CTRP Malignant IA Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8 Stage IA Esophageal Adenocarcinoma Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8 Stage IB includes: (T1a, N0, M0, G2); (T1b, N0, M0, G1-2); (T1b, N0, M0, GX). T1a: Tumor invades the lamina propria or muscularis mucosae. T1b: Tumor invades the submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. G2: Moderately differentiated. (AJCC 8th ed.) C133416 Neoplastic Process Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8 Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8 CL520855 CPTAC CTRP Malignant IB Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8 Stage IB Esophageal Adenocarcinoma Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8 Stage IC includes: (T1, N0, M0, G3); (T2, N0, M0, G1-2). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.) C133417 Neoplastic Process Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8 Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8 CL520858 CPTAC CTRP Malignant IC Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8 Stage IC Esophageal Adenocarcinoma Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8 Stage II includes: IIA: (T2, N0, M0, G3); (T2, N0, M0, GX); IIB: (T1, N1, M0, Any G); (T3, N0, M0, Any G). T2: Tumor invades the muscularis propria. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. GX: Grade cannot be assessed. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.) C133418 Neoplastic Process Pathologic Stage II Esophageal Adenocarcinoma AJCC v8 Pathologic Stage II Esophageal Adenocarcinoma AJCC v8 CL520860 CPTAC CTRP Malignant II Pathologic Stage II Esophageal Adenocarcinoma AJCC v8 Stage II Esophageal Adenocarcinoma Pathologic Stage II Esophageal Adenocarcinoma AJCC v8 Stage IIA includes: (T2, N0, M0, G3); (T2, N0, M0, GX). T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. GX: Grade cannot be assessed. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.) C133419 Neoplastic Process Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8 Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8 CL520864 CPTAC CTRP Malignant IIA Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8 Stage IIA Esophageal Adenocarcinoma Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8 Stage IIB includes: (T1, N1, M0, Any G); (T3, N0, M0, Any G). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133420 Neoplastic Process Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8 Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8 CL520867 CPTAC CTRP Malignant IIB Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8 Stage IIB Esophageal Adenocarcinoma Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8 Stage III includes: IIIA: (T1, N2, M0, Any G); (T2, N1, M0, Any G); IIIB: (T2, N2, M0, Any G); (T3, N1-2, M0, Any G); (T4a, N0-1, M0, Any G). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133421 Neoplastic Process Pathologic Stage III Esophageal Adenocarcinoma AJCC v8 Pathologic Stage III Esophageal Adenocarcinoma AJCC v8 CL520870 CPTAC CTRP Malignant III Pathologic Stage III Esophageal Adenocarcinoma AJCC v8 Stage III Esophageal Adenocarcinoma Pathologic Stage III Esophageal Adenocarcinoma AJCC v8 Stage IIIA includes: (T1, N2, M0, Any G); (T2, N1, M0, Any G). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133422 Neoplastic Process Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8 Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8 CL520874 CPTAC CTRP Malignant IIIA Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8 Stage IIIA Esophageal Adenocarcinoma Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8 Stage IIIB includes: (T2, N2, M0, Any G); (T3, N1-2, M0, Any G); (T4a, N0-1, M0, Any G). T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133423 Neoplastic Process Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8 Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8 CL520877 CPTAC CTRP Malignant IIIB Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8 Stage IIIB Esophageal Adenocarcinoma Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8 Stage IV includes: IVA: (T4a, N2, M0, Any G); (T4b, N0-2, M0, Any G); (Any T, N3, M0, Any G); IVB: (Any T, Any N, M1, Any G). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C133424 Neoplastic Process Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8 Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8 CL520880 CPTAC CTRP Malignant IV Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8 Stage IV Esophageal Adenocarcinoma Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8 Stage IVA includes: (T4a, N2, M0, Any G); (T4b, N0-2, M0, Any G); (Any T, N3, M0, Any G). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133425 Neoplastic Process Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8 Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8 CL520884 CPTAC CTRP Malignant IVA Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8 Stage IVA Esophageal Adenocarcinoma Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8 Stage IVB includes: Any T, Any N, M1, Any G. M1: Distant metastasis. (AJCC 8th ed.) C133426 Neoplastic Process Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8 Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8 CL520887 CPTAC CTRP Malignant IVB Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8 Stage IVB Esophageal Adenocarcinoma Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8 A term that refers to the postneoadjuvant therapy staging of esophageal adenocarcinoma according to the American Joint Committee on Cancer, 8th edition. C133432 Neoplastic Process Esophageal Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage CL521045 Malignant Esophageal Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage Esophageal Adenocarcinoma by AJCC v8 ypTNM Stage Esophageal Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage Stage I includes: T0-2, N0, M0. T0: No evidence of primary tumor. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133433 Neoplastic Process Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8 Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8 CL520923 CTRP Malignant Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8 Stage I Esophageal Adenocarcinoma Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8 Stage II includes: T3, N0, M0. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133434 Neoplastic Process Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8 Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8 CL520927 CTRP Malignant Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8 Stage II Esophageal Adenocarcinoma Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8 Stage III includes: IIIA: (T0-2, N1, M0); IIIB: (T3, N1, M0); (T0-3, N2, M0); (T4a, N0, M0). T0: No evidence of primary tumor. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133435 Neoplastic Process Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8 Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8 CL520931 CTRP Malignant Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8 Stage III Esophageal Adenocarcinoma Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8 Stage IIIA includes: T0-2, N1, M0. T0: No evidence of primary tumor. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133436 Neoplastic Process Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8 Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8 CL520935 CTRP Malignant Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8 Stage IIIA Esophageal Adenocarcinoma Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8 Stage IIIB includes: (T3, N1, M0); (T0-3, N2, M0); (T4a, N0, M0). T0: No evidence of primary tumor. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133437 Neoplastic Process Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8 Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8 CL520938 CTRP Malignant Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8 Stage IIIB Esophageal Adenocarcinoma Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8 Stage IV includes: IVA: (T4a, N1-2, M0); (T4a, NX, M0); (T4b, N0-2, M0); (Any T, N3, M0); IVB: (Any T, Any N, M1). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. NX: Regional lymph nodes cannot be assessed. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C133438 Neoplastic Process Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8 Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8 CL520941 CTRP Malignant Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8 Stage IV Esophageal Adenocarcinoma Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8 Stage IVA includes: (T4a, N1-2, M0); (T4a, NX, M0); (T4b, N0-2, M0); (Any T, N3, M0). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. NX: Regional lymph nodes cannot be assessed. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133439 Neoplastic Process Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8 Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8 CL520945 CTRP Malignant Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8 Stage IVA Esophageal Adenocarcinoma Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8 Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C133440 Neoplastic Process Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8 Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8 CL520948 CTRP Malignant Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8 Stage IVB Esophageal Adenocarcinoma Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8 A term that refers to the staging of esophageal squamous cell carcinoma according to the American Joint Committee on Cancer, 7th edition. C133442 Neoplastic Process Esophageal Squamous Cell Carcinoma by AJCC v7 Stage CL521049 Malignant Esophageal Squamous Cell Carcinoma by AJCC v7 Stage Esophageal Squamous Cell Carcinoma by AJCC v7 Stage A term that refers to the staging of esophageal squamous cell carcinoma according to the American Joint Committee on Cancer, 8th edition. C133443 Neoplastic Process Esophageal Squamous Cell Carcinoma by AJCC v8 Stage CL521053 Malignant Esophageal Squamous Cell Carcinoma by AJCC v8 Stage Esophageal Squamous Cell Carcinoma by AJCC v8 Stage A term that refers to the clinical staging of esophageal squamous cell carcinoma according to the American Joint Committee on Cancer, 8th edition. C133444 Neoplastic Process Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage CL521050 Malignant Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage Esophageal Squamous Cell Carcinoma by AJCC v8 cTNM Stage Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage A term that refers to the pathologic staging of esophageal squamous cell carcinoma according to the American Joint Committee on Cancer, 8th edition. C133445 Neoplastic Process Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage CL521051 CPTAC Malignant Esophageal Squamous Cell Carcinoma Tumor Stage Pathologic Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage Esophageal Squamous Cell Carcinoma by AJCC v8 pTNM Stage Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage A term that refers to the postneoadjuvant therapy staging of esophageal squamous cell carcinoma according to the American Joint Committee on Cancer, 8th edition. C133446 Neoplastic Process Esophageal Squamous Cell Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage CL521052 Malignant Esophageal Squamous Cell Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage Esophageal Squamous Cell Carcinoma by AJCC v8 ypTNM Stage Esophageal Squamous Cell Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage Stage 0 includes: Tis, N0, M0. Tis: High-grade dysplasia, defined as malignant cells confined to the epithelium by the basement membrane. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133447 Neoplastic Process Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8 Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8 CL520606 CTRP Malignant Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8 Stage 0 Esophageal Squamous Cell Cancer Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8 Stage I includes: T1, N0-1, M0. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133448 Neoplastic Process Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8 Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8 CL520610 CTRP Malignant Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8 Stage I Esophageal Squamous Cell Cancer Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8 Stage II includes: (T2, N0-1, M0); (T3, N0, M0). T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133449 Neoplastic Process Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8 Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8 CL520615 CTRP Malignant Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8 Stage II Esophageal Squamous Cell Cancer Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8 Stage III includes: (T3, N1, M0); (T1-3, N2, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133450 Neoplastic Process Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8 Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8 CL520626 CTRP Malignant Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8 Stage III Esophageal Squamous Cell Cancer Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8 Stage IV includes: IVA: (T4, N0-2, M0); (Any T, N3, M0); IVB: (Any T, Any N, M1). T4: Tumor invades adjacent structures. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C133451 Neoplastic Process Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8 Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8 CL520631 CTRP Malignant Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8 Stage IV Esophageal Squamous Cell Cancer Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8 Stage IVA includes: (T4, N0-2, M0); (Any T, N3, M0). T4: Tumor invades adjacent structures. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133452 Neoplastic Process Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8 Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8 CL520636 CTRP Malignant Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8 Stage IVA Esophageal Squamous Cell Cancer Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8 Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C133453 Neoplastic Process Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8 Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8 CL520640 CTRP Malignant Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8 Stage IVB Esophageal Squamous Cell Cancer Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8 Stage I includes: T0-2, N0, M0. T0: No evidence of primary tumor. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133454 Neoplastic Process Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8 Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8 CL520924 CTRP Malignant Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8 Stage I Esophageal Squamous Cell Cancer Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8 Stage II includes: T3, N0, M0. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133455 Neoplastic Process Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8 Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8 CL520928 CTRP Malignant Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8 Stage II Esophageal Squamous Cell Cancer Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8 Stage III includes: IIIA: (T0-2, N1, M0); IIIB: (T3, N1, M0); (T0-3, N2, M0); (T4a, N0, M0). T0: No evidence of primary tumor. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133456 Neoplastic Process Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8 Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8 CL520932 CTRP Malignant Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8 Stage III Esophageal Squamous Cell Cancer Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8 Stage IIIA includes: T0-2, N1, M0. T0: No evidence of primary tumor. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133457 Neoplastic Process Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8 Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8 CL520936 CTRP Malignant Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8 Stage IIIA Esophageal Squamous Cell Cancer Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8 Stage IIIB includes: (T3, N1, M0); (T0-3, N2, M0); (T4a, N0, M0). T0: No evidence of primary tumor. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133458 Neoplastic Process Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8 Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8 CL520939 CTRP Malignant Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8 Stage IIIB Esophageal Squamous Cell Cancer Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8 Stage IV includes: IVA: (T4a, N1-2, M0); (T4a, NX, M0); (T4b, N0-2, M0); (Any T, N3, M0); IVB: (Any T, Any N, M1). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. NX: Regional lymph nodes cannot be assessed. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C133459 Neoplastic Process Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8 Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8 CL520942 CTRP Malignant Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8 Stage IV Esophageal Squamous Cell Cancer Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8 Stage IVA includes: (T4a, N1-2, M0); (T4a, NX, M0); (T4b, N0-2, M0); (Any T, N3, M0). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. NX: Regional lymph nodes cannot be assessed. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133460 Neoplastic Process Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8 Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8 CL520946 CTRP Malignant Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8 Stage IVA Esophageal Squamous Cell Cancer Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8 Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C133461 Neoplastic Process Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8 Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8 CL520949 CTRP Malignant Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8 Stage IVB Esophageal Squamous Cell Cancer Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8 A large B-cell lymphoma that usually affects the Waldeyer ring and/or cervical lymph nodes and less often the gastrointestinal tract. It occurs most commonly in children and young adults and is low stage. It is characterized by a follicular, follicular and diffuse, or pure diffuse growth pattern resembling follicular lymphoma grade 3B or a diffuse large B-cell lymphoma. Most cases have IG/IRF4 rearrangements. BCL2 rearrangements are not present. Some cases that belong in this category lack an IRF4 rearrangement but have strong IRF4/MUM1 expression. This lymphoma is more aggressive than pediatric-type follicular lymphomas. C133494 Neoplastic Process Large B-Cell Lymphoma with IRF4 Rearrangement Large B-Cell Lymphoma with IRF4 Rearrangement CL521195 CTRP Malignant LBCL with IRF4 Rearrangement Large B-Cell Lymphoma with IRF4 Rearrangement Large B-Cell Lymphoma with IRF4 Rearrangement The reemergence of an atypical teratoid/rhabdoid tumor after a period of remission. C133499 Neoplastic Process Recurrent Atypical Teratoid/Rhabdoid Tumor Recurrent Atypical Teratoid/Rhabdoid Tumor CL520221 CTRP Malignant Recurrent Atypical Teratoid/Rhabdoid Tumor Recurrent Atypical Teratoid/Rhabdoid Tumor A carcinoma that has spread to the central nervous system from its original site in the breast, through the hematogenous route. C133501 Neoplastic Process Breast Carcinoma Metastatic in the Central Nervous System Metastatic Breast Carcinoma in the Central Nervous System CL519699 CTRP Malignant Breast Carcinoma Metastatic in the CNS Breast Carcinoma Metastatic in the Central Nervous System Metastatic Breast Cancer in the Central Nervous System Metastatic Breast Carcinoma in the Central Nervous System Metastatic Breast Carcinoma in the Central Nervous System A carcinoma that has spread to the central nervous system from its original site in the lung, through the hematogenous route. C133503 Neoplastic Process Lung Carcinoma Metastatic in the Central Nervous System Metastatic Lung Carcinoma in the Central Nervous System CL520766 CTRP Malignant Lung Carcinoma Metastatic in the CNS Lung Carcinoma Metastatic in the Central Nervous System Metastatic Lung Cancer in the Central Nervous System Metastatic Lung Carcinoma in the Central Nervous System Metastatic Lung Carcinoma in the Central Nervous System A melanoma that has spread to the central nervous system from its original site of growth, through the hematogenous route. C133504 Neoplastic Process Melanoma Metastatic in the Central Nervous System Metastatic Melanoma in the Central Nervous System CL520843 CTRP Malignant Melanoma Metastatic in the CNS Melanoma Metastatic in the Central Nervous System Metastatic Melanoma in the Central Nervous System Metastatic Melanoma in the Central Nervous System Stage 0 includes: Tis, N0, M0, GN/A, Tumor location: Any. Tis: High-grade dysplasia, defined as malignant cells confined to the epithelium by the basement membrane. N0: No regional lymph node metastasis. M0: No distant metastasis. GN/A: Grade non-applicable. (AJCC 8th ed.) C133519 Neoplastic Process Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8 Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8 CL520846 CPTAC CTRP Malignant 0 Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8 Stage 0 Esophageal Squamous Cell Cancer Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8 Stage I includes: IA: (T1a, N0, M0, G1, Tumor location: Any); (T1a, N0, M0, GX, Tumor location: Any); IB: (T1a, N0, M0, G2-3, Tumor location: Any); (T1b, N0, M0, G1-3, Tumor location: Any); (T1b, N0, M0, GX, Tumor location: Any); (T2, N0, M0, G1, Tumor location: Any). T1a: Tumor invades the lamina propria or muscularis mucosae. T1b: Tumor invades the submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.) C133521 Neoplastic Process Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8 Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8 CL520849 CTRP Malignant Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8 Stage I Esophageal Squamous Cell Cancer Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8 Stage IA includes: (T1a, N0, M0, G1, Tumor location: Any); (T1a, N0, M0, GX, Tumor location: Any). T1a: Tumor invades the lamina propria or muscularis mucosae. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. (AJCC 8th ed.) C133525 Neoplastic Process Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8 Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8 CL520853 CPTAC CTRP Malignant IA Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8 Stage IA Esophageal Squamous Cell Cancer Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8 Stage IB includes: (T1a, N0, M0, G2-3, Tumor location: Any); (T1b, N0, M0, G1-3, Tumor location: Any); (T1b, N0, M0, GX, Tumor location: Any); (T2, N0, M0, G1, Tumor location: Any). T1a: Tumor invades the lamina propria or muscularis mucosae. T1b: Tumor invades the submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.) C133530 Neoplastic Process Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8 Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8 CL520856 CPTAC CTRP Malignant IB Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8 Stage IB Esophageal Squamous Cell Cancer Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8 Stage II includes: IIA: (T2, N0, M0, G2-3, Tumor location: Any); (T2, N0, M0, GX, Tumor location: Any); (T3, N0, M0, Any G, Tumor location: Lower); (T3, N0, M0, G1, Tumor location: Upper/middle); IIB: (T3, N0, M0, G2-3, Tumor location: Upper/middle); (T3, N0, M0, GX, Tumor location: Any); (T3, N0, M0, Any G, Tumor location: Unknown); (T1, N1, M0, Any G, Tumor location: Any). T2: Tumor invades the muscularis propria. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. GX: Grade cannot be assessed. G1: Well-differentiated. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.) C133532 Neoplastic Process Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8 Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8 CL520861 CTRP Malignant Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8 Stage II Esophageal Squamous Cell Cancer Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8 Stage IIA includes: (T2, N0, M0, G2-3, Tumor location: Any); (T2, N0, M0, GX, Tumor location: Any); (T3, N0, M0, Any G, Tumor location: Lower); (T3, N0, M0, G1, Tumor location: Upper/middle). T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. M0: No distant metastasis. GX: Grade cannot be assessed. G1: Well-differentiated. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.) C133534 Neoplastic Process Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8 Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8 CL520865 CPTAC CTRP Malignant IIA Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8 Stage IIA Esophageal Squamous Cell Cancer Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8 Stage IIB includes: (T3, N0, M0, G2-3, Tumor location: Upper/middle); (T3, N0, M0, GX, Tumor location: Any); (T3, N0, M0, Any G, Tumor location: Unknown); (T1, N1, M0, Any G, Tumor location: Any). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. GX: Grade cannot be assessed. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated (AJCC 8th ed.) C133535 Neoplastic Process Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8 Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8 CL520868 CPTAC CTRP Malignant IIB Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8 Stage IIB Esophageal Squamous Cell Cancer Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8 Stage III includes: IIIA: (T1, N2, M0, Any G, Tumor location: Any); (T2, N1, M0, Any G, Tumor location: Any); IIIB: (T2, N2, M0, Any G, Tumor location: Any); (T3, N1-2, M0, Any G, Tumor location: Any); (T4a, N0-1, M0, Any G, Tumor location: Any). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133536 Neoplastic Process Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8 Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8 CL520871 CTRP Malignant Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8 Stage III Esophageal Squamous Cell Cancer Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8 Stage IIIA includes: (T1, N2, M0, Any G, Tumor location: Any); (T2, N1, M0, Any G, Tumor location: Any). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133537 Neoplastic Process Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8 Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8 CL520875 CPTAC CTRP Malignant IIIA Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8 Stage IIIA Esophageal Squamous Cell Cancer Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8 Stage IIIB includes: (T2, N2, M0, Any G, Tumor location: Any); (T3, N1-2, M0, Any G, Tumor location: Any); (T4a, N0-1, M0, Any G, Tumor location: Any). T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133538 Neoplastic Process Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8 Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8 CL520878 CPTAC CTRP Malignant IIIB Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8 Stage IIIB Esophageal Squamous Cell Cancer Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8 Stage IV includes: IVA: (T4a, N2, M0, Any G, Tumor location: Any); (T4b, N0-2, M0, Any G, Tumor location: Any); (Any T, N3, M0, Any G, Tumor location: Any); IVB: (Any T, Any N, M1, Any G, Tumor location: Any). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C133539 Neoplastic Process Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8 Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8 CL520881 CTRP Malignant Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8 Stage IV Esophageal Squamous Cell Cancer Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8 Stage IVA includes: (T4a, N2, M0, Any G, Tumor location: Any); (T4b, N0-2, M0, Any G, Tumor location: Any); (Any T, N3, M0, Any G, Tumor location: Any). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133541 Neoplastic Process Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8 Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8 CL520885 CPTAC CTRP Malignant IVA Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8 Stage IVA Esophageal Squamous Cell Cancer Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8 Stage IVB includes: Any T, Any N, M1, Any G, Tumor location: Any. M1: Distant metastasis. (AJCC 8th ed.) C133542 Neoplastic Process Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8 Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8 CL520888 CPTAC CTRP Malignant IVB Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8 Stage IVB Esophageal Squamous Cell Cancer Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8 A term that refers to the staging of gastroesophageal junction adenocarcinoma according to the American Joint Committee on Cancer, 8th edition. C133548 Neoplastic Process Gastroesophageal Junction Adenocarcinoma by AJCC v8 Stage CL520702 Malignant Gastroesophageal Junction Adenocarcinoma by AJCC v8 Stage Gastroesophageal Junction Adenocarcinoma by AJCC v8 Stage A term that refers to the clinical staging of gastroesophageal junction adenocarcinoma according to the American Joint Committee on Cancer, 8th edition. C133549 Neoplastic Process Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage CL520699 Malignant Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage Gastroesophageal Junction Adenocarcinoma by AJCC v8 cTNM Stage Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage Stage 0 includes: Tis, N0, M0. Tis: High-grade dysplasia, defined as malignant cells confined to the epithelium by the basement membrane. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133550 Neoplastic Process Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520608 Malignant Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage I includes: T1, N0, M0. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133552 Neoplastic Process Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520612 Malignant Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage II includes: IIA: T1, N1, M0; IIB: T2, N0, M0. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133553 Neoplastic Process Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520617 Malignant Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage IIA includes: T1, N1, M0. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133554 Neoplastic Process Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520621 Malignant Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage IIB includes: T2, N0, M0. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133555 Neoplastic Process Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520624 Malignant Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage III includes: (T2, N1, M0); (T3, N0-1, M0); (T4a, N0-1, M0). T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133556 Neoplastic Process Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520628 Malignant Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage IV includes: IVA: (T1-4a, N2, M0); (T4b, N0-2, M0); (Any T, N3, M0); IVB: (Any T, Any N, M1). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C133557 Neoplastic Process Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520633 Malignant Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage IVA includes: (T1-4a, N2, M0); (T4b, N0-2, M0); (Any T, N3, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133558 Neoplastic Process Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520638 Malignant Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C133560 Neoplastic Process Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520642 Malignant Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 A term that refers to the pathologic staging of gastroesophageal junction adenocarcinoma according to the American Joint Committee on Cancer, 8th edition. C133563 Neoplastic Process Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage CL520700 Malignant Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage Gastroesophageal Junction Adenocarcinoma by AJCC v8 pTNM Stage Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage Stage 0 includes: Tis, N0, M0, GN/A. Tis: High-grade dysplasia, defined as malignant cells confined to the epithelium by the basement membrane. N0: No regional lymph node metastasis. M0: No distant metastasis. GN/A: Grade non-applicable. (AJCC 8th ed.) C133564 Neoplastic Process Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520847 Malignant Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage I includes: IA: (T1a, N0, M0, G1); (T1a, N0, M0, GX); IB: (T1a, N0, M0, G2); (T1b, N0, M0, G1-2); (T1b, N0, M0, GX); IC: (T1, N0, M0, G3); (T2, N0, M0, G1-2). T1a: Tumor invades the lamina propria or muscularis mucosae. T1b: Tumor invades the submucosa. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.) C133565 Neoplastic Process Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520850 Malignant Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage IA includes: (T1a, N0, M0, G1); (T1a, N0, M0, GX). T1a: Tumor invades the lamina propria or muscularis mucosae. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. (AJCC 8th ed.) C133566 Neoplastic Process Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520854 Malignant Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage IB includes: (T1a, N0, M0, G2); (T1b, N0, M0, G1-2); (T1b, N0, M0, GX). T1a: Tumor invades the lamina propria or muscularis mucosae. T1b: Tumor invades the submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. G2: Moderately differentiated. (AJCC 8th ed.) C133567 Neoplastic Process Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520857 Malignant Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage IC includes: (T1, N0, M0, G3); (T2, N0, M0, G1-2). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.) C133568 Neoplastic Process Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520859 Malignant Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage II includes: IIA: (T2, N0, M0, G3); (T2, N0, M0, GX); IIB: (T1, N1, M0, Any G); (T3, N0, M0, Any G). T2: Tumor invades the muscularis propria. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. GX: Grade cannot be assessed. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.) C133570 Neoplastic Process Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520862 Malignant Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage IIA includes: (T2, N0, M0, G3); (T2, N0, M0, GX). T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. GX: Grade cannot be assessed. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.) C133572 Neoplastic Process Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520866 Malignant Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage IIB includes: (T1, N1, M0, Any G); (T3, N0, M0, Any G). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133573 Neoplastic Process Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520869 Malignant Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage III includes: IIIA: (T1, N2, M0, Any G); (T2, N1, M0, Any G); IIIB: (T2, N2, M0, Any G); (T3, N1-2, M0, Any G); (T4a, N0-1, M0, Any G). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133575 Neoplastic Process Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520872 Malignant Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage IIIA includes: (T1, N2, M0, Any G); (T2, N1, M0, Any G). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133577 Neoplastic Process Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520876 Malignant Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage IIIB includes: (T2, N2, M0, Any G); (T3, N1-2, M0, Any G); (T4a, N0-1, M0, Any G). T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133579 Neoplastic Process Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520879 Malignant Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage IV includes: IVA: (T4a, N2, M0, Any G); (T4b, N0-2, M0, Any G); (Any T, N3, M0, Any G); IVB: (Any T, Any N, M1, Any G). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C133580 Neoplastic Process Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520882 Malignant Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage IVA includes: (T4a, N2, M0, Any G); (T4b, N0-2, M0, Any G); (Any T, N3, M0, Any G). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133581 Neoplastic Process Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520886 Malignant Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage IVB includes: Any T, Any N, M1, Any G. M1: Distant metastasis. (AJCC 8th ed.) C133582 Neoplastic Process Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520889 Malignant Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 A term that refers to the postneoadjuvant therapy staging of gastroesophageal junction adenocarcinoma according to the American Joint Committee on Cancer, 8th edition. C133583 Neoplastic Process Gastroesophageal Junction Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage CL520701 Malignant Gastroesophageal Junction Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage Gastroesophageal Junction Adenocarcinoma by AJCC v8 ypTNM Stage Gastroesophageal Junction Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage Stage I includes: T0-2, N0, M0. T0: No evidence of primary tumor. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133584 Neoplastic Process Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520926 Malignant Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage II includes: T3, N0, M0. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133585 Neoplastic Process Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520930 Malignant Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage III includes: IIIA: (T0-2, N1, M0); IIIB: (T3, N1, M0); (T0-3, N2, M0); (T4a, N0, M0). T0: No evidence of primary tumor. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133586 Neoplastic Process Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520934 Malignant Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage IIIA includes: T0-2, N1, M0. T0: No evidence of primary tumor. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133587 Neoplastic Process Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520937 Malignant Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8 Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage IIIB includes: (T3, N1, M0); (T0-3, N2, M0); (T4a, N0, M0). T0: No evidence of primary tumor. T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133588 Neoplastic Process Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520940 Malignant Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8 Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage IV includes: IVA: (T4a, N1-2, M0); (T4a, NX, M0); (T4b, N0-2, M0); (Any T, N3, M0); IVB: (Any T, Any N, M1). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. NX: Regional lymph nodes cannot be assessed. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C133589 Neoplastic Process Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520944 Malignant Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage IVA includes: (T4a, N1-2, M0); (T4a, NX, M0); (T4b, N0-2, M0); (Any T, N3, M0). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. NX: Regional lymph nodes cannot be assessed. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133590 Neoplastic Process Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520947 Malignant Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C133591 Neoplastic Process Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 CL520950 Malignant Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 The reemergence of classic Hodgkin lymphoma after a period of remission. C133592 Neoplastic Process Recurrent Classic Hodgkin Lymphoma Recurrent Classic Hodgkin Lymphoma CL520225 CTRP Malignant Recurrent Classic Hodgkin Lymphoma Recurrent Classical Hodgkin Lymphoma Relapsed Classical Hodgkin Lymphoma Recurrent Classic Hodgkin Lymphoma A term that refers to the staging of gastric cancer according to the American Joint Committee on Cancer, 8th edition. C133638 Neoplastic Process Gastric Cancer by AJCC v8 Stage CL520677 Malignant Gastric Cancer by AJCC v8 Stage Gastric Carcinoma by AJCC v8 Stage Gastric Cancer by AJCC v8 Stage A term that refers to the clinical staging of gastric cancer according to the American Joint Committee on Cancer, 8th edition. C133639 Neoplastic Process Gastric Cancer by AJCC v8 Clinical Stage CL520674 Malignant Gastric Cancer by AJCC v8 Clinical Stage Gastric Cancer by AJCC v8 cTNM Stage Gastric Carcinoma by AJCC v8 Clinical Stage Gastric Cancer by AJCC v8 Clinical Stage A term that refers to the pathologic staging of gastric cancer according to the American Joint Committee on Cancer, 8th edition. C133640 Neoplastic Process Gastric Cancer by AJCC v8 Pathologic Stage CL520675 CPTAC Malignant Gastric Cancer by AJCC v8 Pathologic Stage Gastric Cancer by AJCC v8 pTNM Stage Gastric Carcinoma by AJCC v8 Pathologic Stage Tumor Stage (Pathologic) Gastric Cancer by AJCC v8 Pathologic Stage A term that refers to the postneoadjuvant therapy staging of gastric cancer according to the American Joint Committee on Cancer, 8th edition. C133641 Neoplastic Process Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage CL520676 Malignant Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage Gastric Cancer by AJCC v8 ypTNM Stage Gastric Carcinoma by AJCC v8 Postneoadjuvant Therapy Stage Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria, high grade dysplasia. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133647 Neoplastic Process Clinical Stage 0 Gastric Cancer AJCC v8 Clinical Stage 0 Gastric Cancer AJCC v8 CL520607 CTRP Malignant Clinical Stage 0 Gastric Cancer AJCC v8 Clinical Stage 0 Gastric Carcinoma AJCC v8 Stage 0 Gastric (Stomach) Cancer Clinical Stage 0 Gastric Cancer AJCC v8 Stage I includes: (T1, N0, M0); (T2, N0, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133648 Neoplastic Process Clinical Stage I Gastric Cancer AJCC v8 Clinical Stage I Gastric Cancer AJCC v8 CL520611 CTRP Malignant Clinical Stage I Gastric Cancer AJCC v8 Clinical Stage I Gastric Carcinoma AJCC v8 Stage I Gastric (Stomach) Cancer Clinical Stage I Gastric Cancer AJCC v8 Stage II includes: IIA: (T1, N1, N2, or N3, M0); (T2, N1, N2, or N3, M0); IIB: (T3, N0, M0); (T4a, N0, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133649 Neoplastic Process Clinical Stage II Gastric Cancer AJCC v8 Clinical Stage II Gastric Cancer AJCC v8 CL520616 CTRP Malignant Clinical Stage II Gastric Cancer AJCC v8 Clinical Stage II Gastric Carcinoma AJCC v8 Stage II Gastric (Stomach) Cancer Clinical Stage II Gastric Cancer AJCC v8 Stage III includes: (T3, N1, N2, or N3, M0); (T4a, N1, N2, or N3, M0). T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133650 Neoplastic Process Clinical Stage III Gastric Cancer AJCC v8 Clinical Stage III Gastric Cancer AJCC v8 CL520627 CTRP Malignant Clinical Stage III Gastric Cancer AJCC v8 Clinical Stage III Gastric Carcinoma AJCC v8 Stage III Gastric (Stomach) Cancer Clinical Stage III Gastric Cancer AJCC v8 Stage IV includes: IVA: (T4b, Any N, M0); IVB: (Any T, Any N, M1). T4b: Tumor invades adjacent structures/organs. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C133651 Neoplastic Process Clinical Stage IV Gastric Cancer AJCC v8 Clinical Stage IV Gastric Cancer AJCC v8 CL520632 CTRP Malignant Clinical Stage IV Gastric Cancer AJCC v8 Clinical Stage IV Gastric Carcinoma AJCC v8 Stage IV Gastric (Stomach) Cancer Clinical Stage IV Gastric Cancer AJCC v8 Stage IVA includes: (T4b, Any N, M0): T4b: Tumor invades adjacent structures/organs. M0: No distant metastasis. (AJCC 8th ed.) C133652 Neoplastic Process Clinical Stage IVA Gastric Cancer AJCC v8 Clinical Stage IVA Gastric Cancer AJCC v8 CL520637 CTRP Malignant Clinical Stage IVA Gastric Cancer AJCC v8 Clinical Stage IVA Gastric Carcinoma AJCC v8 Stage IVA Gastric (Stomach) Cancer Clinical Stage IVA Gastric Cancer AJCC v8 Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C133653 Neoplastic Process Clinical Stage IVB Gastric Cancer AJCC v8 Clinical Stage IVB Gastric Cancer AJCC v8 CL520641 CTRP Malignant Clinical Stage IVB Gastric Cancer AJCC v8 Clinical Stage IVB Gastric Carcinoma AJCC v8 Stage IVB Gastric (Stomach) Cancer Clinical Stage IVB Gastric Cancer AJCC v8 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria, high grade dysplasia. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133654 Neoplastic Process Pathologic Stage 0 Gastric Cancer AJCC v8 Pathologic Stage 0 Gastric Cancer AJCC v8 CL520473 CPTAC CTRP Malignant 0 Pathologic Stage 0 Gastric Cancer AJCC v8 Pathologic Stage 0 Gastric Carcinoma AJCC v8 Stage 0 Gastric (Stomach) Cancer Pathologic Stage 0 Gastric Cancer AJCC v8 Stage I includes: IA: (T1, N0, M0); IB: (T1, N1, M0); (T2, N0, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133655 Neoplastic Process Pathologic Stage I Gastric Cancer AJCC v8 Pathologic Stage I Gastric Cancer AJCC v8 CL520474 CTRP Malignant Pathologic Stage I Gastric Cancer AJCC v8 Pathologic Stage I Gastric Carcinoma AJCC v8 Stage I Gastric (Stomach) Cancer Pathologic Stage I Gastric Cancer AJCC v8 Stage IA includes: (T1, N0, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133656 Neoplastic Process Pathologic Stage IA Gastric Cancer AJCC v8 Pathologic Stage IA Gastric Cancer AJCC v8 CL520475 CPTAC CTRP Malignant IA Pathologic Stage IA Gastric Cancer AJCC v8 Pathologic Stage IA Gastric Carcinoma AJCC v8 Stage IA Gastric (Stomach) Cancer Pathologic Stage IA Gastric Cancer AJCC v8 Stage IB includes: (T1, N1, M0); (T2, N0, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133657 Neoplastic Process Pathologic Stage IB Gastric Cancer AJCC v8 Pathologic Stage IB Gastric Cancer AJCC v8 CL520476 CPTAC CTRP Malignant IB Pathologic Stage IB Gastric Cancer AJCC v8 Pathologic Stage IB Gastric Carcinoma AJCC v8 Stage IB Gastric (Stomach) Cancer Pathologic Stage IB Gastric Cancer AJCC v8 Stage II includes: IIA: (T1, N2, M0); (T2, N1, M0); (T3, N0, M0); IIB: (T1, N3a, M0); (T2, N2, M0); (T3, N1, M0); (T4a, N0, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3a: Tumor with metastasis in seven to fifteen regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133659 Neoplastic Process Pathologic Stage II Gastric Cancer AJCC v8 Pathologic Stage II Gastric Cancer AJCC v8 CL520477 CTRP Malignant Pathologic Stage II Gastric Cancer AJCC v8 Pathologic Stage II Gastric Carcinoma AJCC v8 Stage II Gastric (Stomach) Cancer Pathologic Stage II Gastric Cancer AJCC v8 Stage IIA includes: (T1, N2, M0); (T2, N1, M0); (T3, N0, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133660 Neoplastic Process Pathologic Stage IIA Gastric Cancer AJCC v8 Pathologic Stage IIA Gastric Cancer AJCC v8 CL520478 CPTAC CTRP Malignant IIA Pathologic Stage IIA Gastric Cancer AJCC v8 Pathologic Stage IIA Gastric Carcinoma AJCC v8 Stage IIA Gastric (Stomach) Cancer Pathologic Stage IIA Gastric Cancer AJCC v8 Stage IIB includes: (T1, N3a, M0); (T2, N2, M0); (T3, N1, M0); (T4a, N0, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3a: Tumor with metastasis in seven to fifteen regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133662 Neoplastic Process Pathologic Stage IIB Gastric Cancer AJCC v8 Pathologic Stage IIB Gastric Cancer AJCC v8 CL520479 CPTAC CTRP Malignant IIB Pathologic Stage IIB Gastric Cancer AJCC v8 Pathologic Stage IIB Gastric Carcinoma AJCC v8 Stage IIB Gastric (Stomach) Cancer Pathologic Stage IIB Gastric Cancer AJCC v8 Stage III includes: IIIA: (T2, N3a, M0); (T3, N2, M0); (T4a, N1, M0); (T4a, N2, M0); (T4b, N0, M0); IIIB: (T1, N3b, M0); (T2, N3b, M0); (T3, N3a, M0); (T4a, N3a, M0); (T4b, N1, M0); (T4b, N2, M0); IIIC: (T3, N3b, M0); (T4a, N3b, M0); (T4b, N3a, M0); (T4b, N3b, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). T4b: Tumor invades adjacent structures/organs. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3a: Tumor with metastasis in seven to fifteen regional lymph nodes. N3b: Tumor with metastasis in sixteen or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133663 Neoplastic Process Pathologic Stage III Gastric Cancer AJCC v8 Pathologic Stage III Gastric Cancer AJCC v8 CL520480 CTRP Malignant Pathologic Stage III Gastric Cancer AJCC v8 Pathologic Stage III Gastric Carcinoma AJCC v8 Stage III Gastric (Stomach) Cancer Pathologic Stage III Gastric Cancer AJCC v8 Stage IIIA includes: (T2, N3a, M0); (T3, N2, M0); (T4a, N1, M0); (T4a, N2, M0); (T4b, N0, M0). T2: Tumor invades the muscularis propria. T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). T4b: Tumor invades adjacent structures/organs. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3a: Tumor with metastasis in seven to fifteen regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133665 Neoplastic Process Pathologic Stage IIIA Gastric Cancer AJCC v8 Pathologic Stage IIIA Gastric Cancer AJCC v8 CL520481 CPTAC CTRP Malignant IIIA Pathologic Stage IIIA Gastric Cancer AJCC v8 Pathologic Stage IIIA Gastric Carcinoma AJCC v8 Stage IIIA Gastric (Stomach) Cancer Pathologic Stage IIIA Gastric Cancer AJCC v8 Stage IIIB includes: (T1, N3b, M0); (T2, N3b, M0); (T3, N3a, M0); (T4a, N3a, M0); (T4b, N1, M0); (T4b, N2, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). T4b: Tumor invades adjacent structures/organs. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3a: Tumor with metastasis in seven to fifteen regional lymph nodes. N3b: Tumor with metastasis in sixteen or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133666 Neoplastic Process Pathologic Stage IIIB Gastric Cancer AJCC v8 Pathologic Stage IIIB Gastric Cancer AJCC v8 CL520482 CPTAC CTRP Malignant IIIB Pathologic Stage IIIB Gastric Cancer AJCC v8 Pathologic Stage IIIB Gastric Carcinoma AJCC v8 Stage IIIB Gastric (Stomach) Cancer Pathologic Stage IIIB Gastric Cancer AJCC v8 Stage IIIC includes: (T3, N3b, M0); (T4a, N3b, M0); (T4b, N3a, M0); (T4b, N3b, M0). T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). T4b: Tumor invades adjacent structures/organs. N3a: Tumor with metastasis in seven to fifteen regional lymph nodes. N3b: Tumor with metastasis in sixteen or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133667 Neoplastic Process Pathologic Stage IIIC Gastric Cancer AJCC v8 Pathologic Stage IIIC Gastric Cancer AJCC v8 CL520483 CPTAC CTRP Malignant IIIC Pathologic Stage IIIC Gastric Cancer AJCC v8 Pathologic Stage IIIC Gastric Carcinoma AJCC v8 Stage IIIC Gastric (Stomach) Cancer Pathologic Stage IIIC Gastric Cancer AJCC v8 Stage IV includes: Any T, Any N. M1: Distant metastasis. (AJCC 8th ed.) C133668 Neoplastic Process Pathologic Stage IV Gastric Cancer AJCC v8 Pathologic Stage IV Gastric Cancer AJCC v8 CL520484 CPTAC CTRP Malignant IV Pathologic Stage IV Gastric Cancer AJCC v8 Pathologic Stage IV Gastric Carcinoma AJCC v8 Stage IV Gastric (Stomach) Cancer Pathologic Stage IV Gastric Cancer AJCC v8 Stage I includes: (T1, N0, M0); (T2, N0, M0); (T1, N1, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133670 Neoplastic Process Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8 Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8 CL520925 CTRP Malignant Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8 Postneoadjuvant Therapy Stage I Gastric Carcinoma AJCC v8 Stage I Gastric (Stomach) Cancer Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8 Stage II includes: (T3, N0, M0); (T2, N1, M0); (T1, N2, M0); (T4a, N0, M0); (T3, N1, M0); (T2, N2, M0); (T1, N3, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133671 Neoplastic Process Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8 Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8 CL520929 CTRP Malignant Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8 Postneoadjuvant Therapy Stage II Gastric Carcinoma AJCC v8 Stage II Gastric (Stomach) Cancer Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8 Stage III includes: (T4a, N1, M0); (T3, N2, M0); (T2, N3, M0); (T4b, N0, M0); (T4b, N1, M0); (T4a, N2, M0); (T3, N3, M0); (T4b, N2, M0); (T4b, N3, M0); (T4a, N3, M0). T2: Tumor invades the muscularis propria. T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). T4b: Tumor invades adjacent structures/organs. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133672 Neoplastic Process Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8 Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8 CL520933 CTRP Malignant Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8 Postneoadjuvant Therapy Stage III Gastric Carcinoma AJCC v8 Stage III Gastric (Stomach) Cancer Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C133673 Neoplastic Process Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8 Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8 CL520943 CTRP Malignant Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8 Postneoadjuvant Therapy Stage IV Gastric Carcinoma AJCC v8 Stage IV Gastric (Stomach) Cancer Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8 Stage IIA includes: (T1, N1, N2, or N3, M0); (T2, N1, N2, or N3, M0). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133681 Neoplastic Process Clinical Stage IIA Gastric Cancer AJCC v8 Clinical Stage IIA Gastric Cancer AJCC v8 CL520620 CTRP Malignant Clinical Stage IIA Gastric Cancer AJCC v8 Clinical Stage IIA Gastric Carcinoma AJCC v8 Stage IIA Gastric (Stomach) Cancer Clinical Stage IIA Gastric Cancer AJCC v8 Stage IIB includes: (T3, N0, M0); (T4a, N0, M0). T3: Tumor penetrates the subserosal connective tissue without invasion of the visceral peritoneum or adjacent structures. T4a: Tumor invades the serosa (visceral peritoneum). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133682 Neoplastic Process Clinical Stage IIB Gastric Cancer AJCC v8 Clinical Stage IIB Gastric Cancer AJCC v8 CL520623 CTRP Malignant Clinical Stage IIB Gastric Cancer AJCC v8 Clinical Stage IIB Gastric Carcinoma AJCC v8 Stage IIB Gastric (Stomach) Cancer Clinical Stage IIB Gastric Cancer AJCC v8 The reemergence of squamous cell carcinoma in the head and neck region after a period of remission. C133709 Neoplastic Process Recurrent Head and Neck Squamous Cell Carcinoma Recurrent Head and Neck Squamous Cell Carcinoma CL520229 CTRP Malignant Recurrent Head and Neck Squamous Cell Cancer Recurrent Head and Neck Squamous Cell Carcinoma Recurrent Squamous Cell Carcinoma of the Head and Neck Recurrent Head and Neck Squamous Cell Carcinoma A paraganglioma that has spread from its original site of growth to nearby tissues or lymph nodes. C133713 Neoplastic Process Locally Advanced Paraganglioma Locally Advanced Paraganglioma CL520759 CTRP Malignant Locally Advanced Malignant Paraganglioma Locally Advanced Paraganglioma Locally Advanced Paraganglioma A term that refers to the staging of small intestinal cancer according to the American Joint Committee on Cancer, 7th edition. C133716 Neoplastic Process Small Intestinal Cancer by AJCC v7 Stage CL521141 Malignant Small Intestinal Cancer by AJCC v7 Stage Small Intestinal Carcinoma by AJCC v7 Stage Small Intestinal Cancer by AJCC v7 Stage A variation of contrast-enhanced ultrasound imaging that centers the receiving bandwidth at half the transmitting frequency in order to suppress tissue signals during vascular imaging studies. C133723 Health Care Activity Contrast-Enhanced Subharmonic Ultrasound Imaging Contrast-Enhanced Subharmonic Ultrasound Imaging CL519753 CTRP Contrast-Enhanced Subharmonic Ultrasound Imaging Contrast-Enhanced Subharmonic Ultrasound Imaging Primary amyloidosis that does not respond to treatment. C133731 Neoplastic Process Refractory Primary Amyloidosis Refractory Primary Amyloidosis CL521670 CTRP Malignant Refractory Primary Amyloidosis Refractory Primary Amyloidosis The reemergence of primary amyloidosis after a period of remission. C133732 Neoplastic Process Recurrent Primary Amyloidosis Recurrent Primary Amyloidosis CL521671 CTRP Malignant Recurrent Primary Amyloidosis Recurrent Primary Amyloidosis A term that refers to the staging of appendiceal carcinoma according to the American Joint Committee on Cancer, 7th edition. Carcinoid tumors are staged separately. (from AJCC 7th Ed.) C133733 Neoplastic Process Appendix Carcinoma by AJCC v7 Stage CL521672 Malignant Appendiceal Carcinoma by AJCC v7 Stage Appendix Carcinoma by AJCC v7 Stage Appendix Carcinoma by AJCC v7 Stage Classic Hodgkin lymphoma that is resistant to treatment. C133736 Neoplastic Process Refractory Classical Hodgkin Lymphoma Refractory Classic Hodgkin Lymphoma CL521674 CTRP Malignant Refractory Classic Hodgkin Lymphoma Refractory Classical Hodgkin Lymphoma Refractory Classic Hodgkin Lymphoma A wedge-shaped fibrovascular lesion arising from the bulbar conjunctiva and extending to the cornea. It is caused by chronic exposure to solar ultraviolet radiation, heat, and dust. It may cause severe vision loss. Studies have linked pterygium to neoplastic proliferation and suggest that it may be a stem cell disorder. C133744 Neoplastic Process Pterygium C0033999 Cellosaurus Benign Pterygium Pterygium of Conjunctiva and Cornea Pterygium A term that refers to the staging of anal canal cancer according to the American Joint Committee on Cancer, 6th and 7th editions. This staging system applies to carcinomas arising in the anal canal only; melanomas, carcinoid tumors, sarcomas, and perianal tumors are not included. (from AJCC 6th and 7th Eds.) C133787 Neoplastic Process Anal Canal Cancer by AJCC v6 and v7 Stage CL521716 Malignant Anal Canal Cancer by AJCC v6 and v7 Stage Anal Canal Carcinoma by AJCC v6 and v7 Stage Anal Carcinoma by AJCC v6 and v7 Stage Anal Canal Cancer by AJCC v6 and v7 Stage A term that refers to the staging of anal cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to all carcinomas arising in the anal canal, including carcinomas that arise within anorectal fistulas and those arising in the perianal area (anal margin). High-grade neuroendocrine carcinomas (small cell neuroendocrine carcinoma and large cell neuroendocrine carcinoma) are staged using this system. There is no AJCC staging system for anal mucosal melanomas and anal well-differentiated neuroendocrine tumors. (from AJCC 8th Ed.) C133794 Neoplastic Process Anal Cancer by AJCC v8 Stage CL521719 Malignant Anal Canal and Perianal (Anal Margin) Carcinoma by AJCC v8 Stage Anal Cancer by AJCC v8 Stage Anal Carcinoma by AJCC v8 Stage Anal Cancer by AJCC v8 Stage Stage 0 includes: Tis, N0, M0. Tis: High-grade squamous intraepithelial lesion (previously termed carcinoma in situ, Bowen disease, anal intraepithelial neoplasia II-III, high-grade anal intraepithelial neoplasia). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133795 Neoplastic Process Stage 0 Anal Cancer AJCC v8 Stage 0 Anal Cancer AJCC v8 CL521720 CTRP Malignant Stage 0 Anal Canal and Perianal (Anal Margin) Carcinoma AJCC v8 Stage 0 Anal Cancer Stage 0 Anal Cancer AJCC v8 Stage 0 Anal Carcinoma AJCC v8 Stage 0 Anal Cancer AJCC v8 Stage I includes: T1, N0, M0. T1: Tumor 2 cm or smaller. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133796 Neoplastic Process Stage I Anal Cancer AJCC v8 Stage I Anal Cancer AJCC v8 CL521721 CTRP Malignant Stage I Anal Canal and Perianal (Anal Margin) Carcinoma AJCC v8 Stage I Anal Cancer Stage I Anal Cancer AJCC v8 Stage I Anal Carcinoma AJCC v8 Stage I Anal Cancer AJCC v8 Stage II includes: IIA: T2, N0, M0; IIB: T3, N0, M0. T2: Tumor larger than 2 cm but equal to or smaller than 5 cm. T3: Tumor larger than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133797 Neoplastic Process Stage II Anal Cancer AJCC v8 Stage II Anal Cancer AJCC v8 CL521722 CTRP Malignant Stage II Anal Canal and Perianal (Anal Margin) Carcinoma AJCC v8 Stage II Anal Cancer Stage II Anal Cancer AJCC v8 Stage II Anal Carcinoma AJCC v8 Stage II Anal Cancer AJCC v8 Stage IIA includes: T2, N0, M0. T2: Tumor larger than 2 cm but equal to or smaller than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133798 Neoplastic Process Stage IIA Anal Cancer AJCC v8 Stage IIA Anal Cancer AJCC v8 CL521723 CTRP Malignant Stage IIA Anal Canal and Perianal (Anal Margin) Carcinoma AJCC v8 Stage IIA Anal Cancer Stage IIA Anal Cancer AJCC v8 Stage IIA Anal Carcinoma AJCC v8 Stage IIA Anal Cancer AJCC v8 Stage IIB includes: T3, N0, M0. T3: Tumor larger than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133799 Neoplastic Process Stage IIB Anal Cancer AJCC v8 Stage IIB Anal Cancer AJCC v8 CL521724 CTRP Malignant Stage IIB Anal Canal and Perianal (Anal Margin) Carcinoma AJCC v8 Stage IIB Anal Cancer Stage IIB Anal Cancer AJCC v8 Stage IIB Anal Carcinoma AJCC v8 Stage IIB Anal Cancer AJCC v8 Stage III includes: IIIA: (T1, N1, M0); (T2, N1, M0); IIIB: (T4, N0, M0); IIIC: (T3, N1, M0); (T4, N1, M0). T1: Tumor 2 cm or smaller. T2: Tumor larger than 2 cm but equal to or smaller than 5 cm. T3: Tumor larger than 5 cm. T4: Tumor of any size invading adjacent organ(s), such as the vagina, urethra, or bladder. N0: No regional lymph node metastasis. N1: Metastasis in inguinal, mesorectal, internal iliac, or external iliac nodes. M0: No distant metastasis. (AJCC 8th ed.) C133800 Neoplastic Process Stage III Anal Cancer AJCC v8 Stage III Anal Cancer AJCC v8 CL521725 CTRP Malignant Stage III Anal Canal and Perianal (Anal Margin) Carcinoma AJCC v8 Stage III Anal Cancer Stage III Anal Cancer AJCC v8 Stage III Anal Carcinoma AJCC v8 Stage III Anal Cancer AJCC v8 Stage IIIA includes: (T1, N1, M0); (T2, N1, M0). T1: Tumor 2 cm or smaller. T2: Tumor larger than 2 cm but equal to or smaller than 5 cm. N1: Metastasis in inguinal, mesorectal, internal iliac, or external iliac nodes. M0: No distant metastasis. (AJCC 8th ed.) C133801 Neoplastic Process Stage IIIA Anal Cancer AJCC v8 Stage IIIA Anal Cancer AJCC v8 CL521726 CTRP Malignant Stage IIIA Anal Canal and Perianal (Anal Margin) Carcinoma AJCC v8 Stage IIIA Anal Cancer Stage IIIA Anal Cancer AJCC v8 Stage IIIA Anal Carcinoma AJCC v8 Stage IIIA Anal Cancer AJCC v8 Stage IIIB includes: T4, N0, M0. T4: Tumor of any size invading adjacent organ(s), such as the vagina, urethra, or bladder. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133802 Neoplastic Process Stage IIIB Anal Cancer AJCC v8 Stage IIIB Anal Cancer AJCC v8 CL521727 CTRP Malignant Stage IIIB Anal Canal and Perianal (Anal Margin) Carcinoma AJCC v8 Stage IIIB Anal Cancer Stage IIIB Anal Cancer AJCC v8 Stage IIIB Anal Carcinoma AJCC v8 Stage IIIB Anal Cancer AJCC v8 Stage IIIC includes: (T3, N1, M0); (T4, N1, M0). T3: Tumor larger than 5 cm. T4: Tumor of any size invading adjacent organ(s), such as the vagina, urethra, or bladder. N1: Metastasis in inguinal, mesorectal, internal iliac, or external iliac nodes. M0: No distant metastasis. (AJCC 8th ed.) C133803 Neoplastic Process Stage IIIC Anal Cancer AJCC v8 Stage IIIC Anal Cancer AJCC v8 CL521728 CTRP Malignant Stage IIIC Anal Canal and Perianal (Anal Margin) Carcinoma AJCC v8 Stage IIIC Anal Cancer Stage IIIC Anal Cancer AJCC v8 Stage IIIC Anal Carcinoma AJCC v8 Stage IIIC Anal Cancer AJCC v8 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C133804 Neoplastic Process Stage IV Anal Cancer AJCC v8 Stage IV Anal Cancer AJCC v8 CL521729 CTRP Malignant Stage IV Anal Canal and Perianal (Anal Margin) Carcinoma AJCC v8 Stage IV Anal Cancer Stage IV Anal Cancer AJCC v8 Stage IV Anal Carcinoma AJCC v8 Stage IV Anal Cancer AJCC v8 A carcinoma that arises from the gastrointestinal system and has metastasized to other anatomic sites. C133839 Neoplastic Process Metastatic Digestive System Carcinoma Metastatic Digestive System Carcinoma CL521760 CTRP Malignant Metastatic Digestive System Cancer Metastatic Digestive System Carcinoma Metastatic Gastrointestinal Carcinoma Metastatic Gastrointestinal System Cancer Metastatic Gastrointestinal System Carcinoma Metastatic Digestive System Carcinoma A term that refers to the staging of small intestinal adenocarcinoma according to the American Joint Committee on Cancer, 8th edition. Nonadenocarcinomas arising in the small intestine should have a TNM assigned but are not assigned a stage classification. (from AJCC 8th Ed.) C133893 Neoplastic Process Small Intestinal Adenocarcinoma by AJCC v8 Stage CL521803 Malignant Small Intestinal Adenocarcinoma by AJCC v8 Stage Small Intestinal Adenocarcinoma by AJCC v8 Stage Stage 0 includes: Tis, N0, M0. Tis: High grade dysplasia/carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133894 Neoplastic Process Stage 0 Small Intestinal Adenocarcinoma AJCC v8 Stage 0 Small Intestinal Adenocarcinoma AJCC v8 CL521804 CTRP Malignant Stage 0 Small Intestinal Adenocarcinoma Stage 0 Small Intestinal Adenocarcinoma AJCC v8 Stage 0 Small Intestinal Adenocarcinoma AJCC v8 Stage I includes: T1-2, N0, M0. T1: Tumor invading the lamina propria or submucosa. T2: Tumor invading the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133895 Neoplastic Process Stage I Small Intestinal Adenocarcinoma AJCC v8 Stage I Small Intestinal Adenocarcinoma AJCC v8 CL521805 CTRP Malignant Stage I Small Intestinal Adenocarcinoma Stage I Small Intestinal Adenocarcinoma AJCC v8 Stage I Small Intestinal Adenocarcinoma AJCC v8 Stage II includes: IIA: T3, N0, M0; IIB: T4, N0, M0. T3: Tumor invading through the muscularis propria into the subserosa, or extending into nonperitonealized perimuscular tissue (mesentery or retroperitoneum) without serosal penetration. For T3 tumors, the nonperitonealized perimuscular tissue is, for the jejunum and ileum, part of the mesentery and, for the duodenum in areas where serosa is lacking, part of the interface with the pancreas. T4: Tumor perforating the visceral peritoneum or directly invading other organs or structures (e.g., other loops of small intestine, mesentery of adjacent loops of bowel, and abdominal wall by way of serosa; for duodenum only, invasion of pancreas or bile duct). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133896 Neoplastic Process Stage II Small Intestinal Adenocarcinoma AJCC v8 Stage II Small Intestinal Adenocarcinoma AJCC v8 CL521806 CTRP Malignant Stage II Small Intestinal Adenocarcinoma Stage II Small Intestinal Adenocarcinoma AJCC v8 Stage II Small Intestinal Adenocarcinoma AJCC v8 Stage IIA includes: T3, N0, M0. T3: Tumor invading through the muscularis propria into the subserosa, or extending into nonperitonealized perimuscular tissue (mesentery or retroperitoneum) without serosal penetration. For T3 tumors, the nonperitonealized perimuscular tissue is, for the jejunum and ileum, part of the mesentery and, for the duodenum in areas where serosa is lacking, part of the interface with the pancreas. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133897 Neoplastic Process Stage IIA Small Intestinal Adenocarcinoma AJCC v8 Stage IIA Small Intestinal Adenocarcinoma AJCC v8 CL521807 CTRP Malignant Stage IIA Small Intestinal Adenocarcinoma Stage IIA Small Intestinal Adenocarcinoma AJCC v8 Stage IIA Small Intestinal Adenocarcinoma AJCC v8 Stage IIB includes: T4, N0, M0. T4: Tumor perforating the visceral peritoneum or directly invading other organs or structures (e.g., other loops of small intestine, mesentery of adjacent loops of bowel, and abdominal wall by way of serosa; for duodenum only, invasion of pancreas or bile duct). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C133898 Neoplastic Process Stage IIB Small Intestinal Adenocarcinoma AJCC v8 Stage IIB Small Intestinal Adenocarcinoma AJCC v8 CL521808 CTRP Malignant Stage IIB Small Intestinal Adenocarcinoma Stage IIB Small Intestinal Adenocarcinoma AJCC v8 Stage IIB Small Intestinal Adenocarcinoma AJCC v8 Stage III includes: IIIA: Any T, N1, M0; IIIB: Any T, N2, M0. N1: Metastasis in one or two regional lymph nodes. N2: Metastasis in three or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133899 Neoplastic Process Stage III Small Intestinal Adenocarcinoma AJCC v8 Stage III Small Intestinal Adenocarcinoma AJCC v8 CL521809 CTRP Malignant Stage III Small Intestinal Adenocarcinoma Stage III Small Intestinal Adenocarcinoma AJCC v8 Stage III Small Intestinal Adenocarcinoma AJCC v8 Stage IIIA includes: Any T, N1, M0. N1: Metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133900 Neoplastic Process Stage IIIA Small Intestinal Adenocarcinoma AJCC v8 Stage IIIA Small Intestinal Adenocarcinoma AJCC v8 CL521810 CTRP Malignant Stage IIIA Small Intestinal Adenocarcinoma Stage IIIA Small Intestinal Adenocarcinoma AJCC v8 Stage IIIA Small Intestinal Adenocarcinoma AJCC v8 Stage IIIB includes: Any T, N2, M0. N2: Metastasis in three or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C133901 Neoplastic Process Stage IIIB Small Intestinal Adenocarcinoma AJCC v8 Stage IIIB Small Intestinal Adenocarcinoma AJCC v8 CL521811 CTRP Malignant Stage IIIB Small Intestinal Adenocarcinoma Stage IIIB Small Intestinal Adenocarcinoma AJCC v8 Stage IIIB Small Intestinal Adenocarcinoma AJCC v8 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C133902 Neoplastic Process Stage IV Small Intestinal Adenocarcinoma AJCC v8 Stage IV Small Intestinal Adenocarcinoma AJCC v8 CL521812 CTRP Malignant Stage IV Small Intestinal Adenocarcinoma Stage IV Small Intestinal Adenocarcinoma AJCC v8 Stage IV Small Intestinal Adenocarcinoma AJCC v8 A term that refers to the staging of appendiceal carcinoma according to the American Joint Committee on Cancer, 8th edition. This staging system applies to carcinomas of the appendix, including high-grade neuroendocrine carcinomas, mixed adenoneuroendocrine carcinomas, and goblet cell carcinoids. Well-differentiated neuroendocrine tumors (carcinoids) are staged according to the classification for neuroendocrine tumors of the appendix. (from AJCC 8th Ed.) C134117 Neoplastic Process Appendix Carcinoma by AJCC v8 Stage CL521900 Malignant Appendiceal Carcinoma by AJCC v8 Stage Appendix Carcinoma by AJCC v8 Stage Appendix Carcinoma by AJCC v8 Stage Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ (intramucosal carcinoma; invasion of the lamina propria or extension into but not through the muscularis mucosae). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134118 Neoplastic Process Stage 0 Appendix Carcinoma AJCC v8 Stage 0 Appendix Carcinoma AJCC v8 CL521901 CTRP Malignant Stage 0 Appendiceal Carcinoma AJCC v8 Stage 0 Appendix Cancer Stage 0 Appendix Carcinoma AJCC v8 Stage 0 Appendix Carcinoma AJCC v8 Stage 0 includes: Tis(LAMN), N0, M0. Tis(LAMN): Low-grade appendiceal mucinous neoplasm confined by the muscularis propria. Acellular mucin or mucinous epithelium may invade into the muscularis propria. T1 and T2 are not applicable to LAMN. Acellular mucin or mucinous epithelium that extends into the subserosa or serosa should be classified as T3 or T4a, respectively. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134119 Neoplastic Process Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8 Stage 0 Low Grade Appendix Mucinous Neoplasm (LAMN) AJCC v8 CL521902 CTRP Malignant Stage 0 Low Grade Appendiceal Mucinous Neoplasm (LAMN) Stage 0 Low Grade Appendix Mucinous Neoplasm (LAMN) AJCC v8 Stage 0 Low-Grade Appendix Mucinous Neoplasm (LAMN) AJCC v8 Stage 0 Low Grade Appendix Mucinous Neoplasm (LAMN) AJCC v8 Stage I includes: (T1, N0, M0); (T2, N0, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134120 Neoplastic Process Stage I Appendix Carcinoma AJCC v8 Stage I Appendix Carcinoma AJCC v8 CL521903 CTRP Malignant Stage I Appendiceal Carcinoma AJCC v8 Stage I Appendix Cancer Stage I Appendix Carcinoma AJCC v8 Stage I Appendix Carcinoma AJCC v8 Stage II includes: IIA: T3, N0, M0; IIB: T4a, N0, M0; IIC: T4b, N0, M0. T3: Tumor invades through the muscularis propria into the subserosa or the mesoappendix. T4a: Tumor invades through the visceral peritoneum, including the acellular mucin or mucinous epithelium involving the serosa of the appendix or serosa of the mesoappendix. T4b: Tumor directly invades or adheres to adjacent organs or structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134121 Neoplastic Process Stage II Appendix Carcinoma AJCC v8 Stage II Appendix Carcinoma AJCC v8 CL521904 CTRP Malignant Stage II Appendiceal Carcinoma AJCC v8 Stage II Appendix Cancer Stage II Appendix Carcinoma AJCC v8 Stage II Appendix Carcinoma AJCC v8 Stage IIA includes: T3, N0, M0. T3: Tumor invades through the muscularis propria into the subserosa or the mesoappendix. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134122 Neoplastic Process Stage IIA Appendix Carcinoma AJCC v8 Stage IIA Appendix Carcinoma AJCC v8 CL521905 CTRP Malignant Stage IIA Appendiceal Carcinoma AJCC v8 Stage IIA Appendix Cancer Stage IIA Appendix Carcinoma AJCC v8 Stage IIA Appendix Carcinoma AJCC v8 Stage IIB includes: T4a, N0, M0. T4a: Tumor invades through the visceral peritoneum, including the acellular mucin or mucinous epithelium involving the serosa of the appendix or serosa of the mesoappendix. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134123 Neoplastic Process Stage IIB Appendix Carcinoma AJCC v8 Stage IIB Appendix Carcinoma AJCC v8 CL521906 CTRP Malignant Stage IIB Appendiceal Carcinoma AJCC v8 Stage IIB Appendix Cancer Stage IIB Appendix Carcinoma AJCC v8 Stage IIB Appendix Carcinoma AJCC v8 Stage IIC includes: T4b, N0, M0. T4b: Tumor directly invades or adheres to adjacent organs or structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134124 Neoplastic Process Stage IIC Appendix Carcinoma AJCC v8 Stage IIC Appendix Carcinoma AJCC v8 CL521907 CTRP Malignant Stage IIC Appendiceal Carcinoma AJCC v8 Stage IIC Appendix Cancer Stage IIC Appendix Carcinoma AJCC v8 Stage IIC Appendix Carcinoma AJCC v8 Stage III includes: IIIA: (T1, N1, M0); (T2, N1, M0); IIIB: (T3, N1, M0); (T4, N1, M0); IIIC: (Any T, N2, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. T3: Tumor invades through the muscularis propria into the subserosa or the mesoappendix. T4: Tumor invades the visceral peritoneum, including the acellular mucin or mucinous epithelium involving the serosa of the appendix or mesoappendix, and/or directly invades adjacent organs or structures. N1: One to three regional lymph nodes are positive (tumor in lymph node measuring 0.2 mm or more) or any number of tumor deposits is present, and all identifiable lymph nodes are negative. N2: Four or more regional lymph nodes are positive. M0: No distant metastasis. (AJCC 8th ed.) C134125 Neoplastic Process Stage III Appendix Carcinoma AJCC v8 Stage III Appendix Carcinoma AJCC v8 CL521908 CTRP Malignant Stage III Appendiceal Carcinoma AJCC v8 Stage III Appendix Cancer Stage III Appendix Carcinoma AJCC v8 Stage III Appendix Carcinoma AJCC v8 Stage IIIA includes: (T1, N1, M0); (T2, N1, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. N1: One to three regional lymph nodes are positive (tumor in lymph node measuring 0.2 mm or more) or any number of tumor deposits is present, and all identifiable lymph nodes are negative. M0: No distant metastasis. (AJCC 8th ed.) C134126 Neoplastic Process Stage IIIA Appendix Carcinoma AJCC v8 Stage IIIA Appendix Carcinoma AJCC v8 CL521909 CTRP Malignant Stage IIIA Appendiceal Carcinoma AJCC v8 Stage IIIA Appendix Cancer Stage IIIA Appendix Carcinoma AJCC v8 Stage IIIA Appendix Carcinoma AJCC v8 Stage IIIB includes: (T3, N1, M0); (T4, N1, M0). T3: Tumor invades through the muscularis propria into the subserosa or the mesoappendix. T4: Tumor invades the visceral peritoneum, including the acellular mucin or mucinous epithelium involving the serosa of the appendix or mesoappendix, and/or directly invades adjacent organs or structures. N1: One to three regional lymph nodes are positive (tumor in lymph node measuring 0.2 mm or more) or any number of tumor deposits is present, and all identifiable lymph nodes are negative. M0: No distant metastasis. (AJCC 8th ed.) C134127 Neoplastic Process Stage IIIB Appendix Carcinoma AJCC v8 Stage IIIB Appendix Carcinoma AJCC v8 CL521910 CTRP Malignant Stage IIIB Appendiceal Carcinoma AJCC v8 Stage IIIB Appendix Cancer Stage IIIB Appendix Carcinoma AJCC v8 Stage IIIB Appendix Carcinoma AJCC v8 Stage IIIC includes: Any T, N2, M0. N2: Four or more regional lymph nodes are positive. M0: No distant metastasis. (AJCC 8th ed.) C134128 Neoplastic Process Stage IIIC Appendix Carcinoma AJCC v8 Stage IIIC Appendix Carcinoma AJCC v8 CL521911 CTRP Malignant Stage IIIC Appendiceal Carcinoma AJCC v8 Stage IIIC Appendix Cancer Stage IIIC Appendix Carcinoma AJCC v8 Stage IIIC Appendix Carcinoma AJCC v8 Stage IV includes: IVA: (Any T, N0, M1a); (Any T, Any N, M1b, G1); IVB: (Any T, Any N, M1b, G2, G3, or GX); IVC: (Any T, Any N, M1c, Any G). N0: No regional lymph node metastasis. M1a: Intraperitoneal acellular mucin, without identifiable tumor cells in the disseminated peritoneal mucinous deposits. M1b: Intraperitoneal metastasis only, including peritoneal mucinous deposits containing tumor cells. M1c: Metastasis to sites other than peritoneum. G1: Well differentiated. G2: Moderately differentiated. G3: Poorly differentiated. GX: Grade cannot be assessed. (AJCC 8th ed.) C134129 Neoplastic Process Stage IV Appendix Carcinoma AJCC v8 Stage IV Appendix Carcinoma AJCC v8 CL521912 CTRP Malignant Stage IV Appendiceal Carcinoma AJCC v8 Stage IV Appendix Cancer Stage IV Appendix Carcinoma AJCC v8 Stage IV Appendix Carcinoma AJCC v8 Stage IVA includes: (Any T, N0, M1a); (Any T, Any N, M1b, G1). N0: No regional lymph node metastasis. M1a: Intraperitoneal acellular mucin, without identifiable tumor cells in the disseminated peritoneal mucinous deposits. M1b: Intraperitoneal metastasis only, including peritoneal mucinous deposits containing tumor cells. G1: Well differentiated. (AJCC 8th ed.) C134130 Neoplastic Process Stage IVA Appendix Carcinoma AJCC v8 Stage IVA Appendix Carcinoma AJCC v8 CL521913 CTRP Malignant Stage IVA Appendiceal Carcinoma AJCC v8 Stage IVA Appendix Cancer Stage IVA Appendix Carcinoma AJCC v8 Stage IVA Appendix Carcinoma AJCC v8 Stage IVB includes: Any T, Any N, M1b, G2, G3, or GX. M1b: Intraperitoneal metastasis only, including peritoneal mucinous deposits containing tumor cells. G2: Moderately differentiated. G3: Poorly differentiated. GX: Grade cannot be assessed. (AJCC 8th ed.) C134131 Neoplastic Process Stage IVB Appendix Carcinoma AJCC v8 Stage IVB Appendix Carcinoma AJCC v8 CL521914 CTRP Malignant Stage IVB Appendiceal Carcinoma AJCC v8 Stage IVB Appendix Cancer Stage IVB Appendix Carcinoma AJCC v8 Stage IVB Appendix Carcinoma AJCC v8 Stage IVC includes: Any T, Any N, M1c, Any G. M1c: Metastasis to sites other than peritoneum. (AJCC 8th ed.) C134132 Neoplastic Process Stage IVC Appendix Carcinoma AJCC v8 Stage IVC Appendix Carcinoma AJCC v8 CL521915 CTRP Malignant Stage IVC Appendiceal Carcinoma AJCC v8 Stage IVC Appendix Cancer Stage IVC Appendix Carcinoma AJCC v8 Stage IVC Appendix Carcinoma AJCC v8 A neuroblastoma that does not respond to treatment. C134153 Neoplastic Process Refractory Neuroblastoma Refractory Neuroblastoma CL521932 CTRP Malignant Refractory Neuroblastoma Refractory Neuroblastoma A lymphoma that does not respond to treatment. C134154 Neoplastic Process Refractory Lymphoma Refractory Lymphoma CL521933 CPTAC CTRP Malignant Refractory Lymphoma Refractory Lymphoma The reemergence of a lymphoma after a period of remission. C134157 Neoplastic Process Recurrent Lymphoma Recurrent Lymphoma CL521935 CPTAC CTRP Malignant Recurrent Lymphoma Recurrent Lymphoma A histiocytic and dendritic cell neoplasm that does not respond to treatment. C134168 Neoplastic Process Refractory Histiocytic and Dendritic Cell Neoplasm Refractory Histiocytic and Dendritic Cell Neoplasm CL521946 CTRP Undetermined Refractory Histiocytic and Dendritic Cell Neoplasm Refractory Histiocytic and Dendritic Cell Neoplasm The reemergence of a histiocytic and dendritic cell neoplasm after a period of remission. C134172 Neoplastic Process Recurrent Histiocytic and Dendritic Cell Neoplasm Recurrent Histiocytic and Dendritic Cell Neoplasm CL521950 CTRP Undetermined Recurrent Histiocytic and Dendritic Cell Neoplasm Recurrent Histiocytic and Dendritic Cell Neoplasm The reemergence of Langerhans cell histiocytosis after a period of remission. C134175 Neoplastic Process Recurrent Langerhans Cell Histiocytosis Recurrent Langerhans Cell Histiocytosis CL521953 CTRP Undetermined Recurrent Langerhans Cell Histiocytosis Recurrent Langerhans Cell Histiocytosis Langerhans cell histiocytosis that does not respond to treatment. C134177 Neoplastic Process Refractory Langerhans Cell Histiocytosis Refractory Langerhans Cell Histiocytosis CL521955 CTRP Undetermined Refractory Langerhans Cell Histiocytosis Refractory Langerhans Cell Histiocytosis A term that refers to the staging of colorectal cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to adenocarcinomas, high-grade neuroendocrine carcinomas, and squamous cell carcinomas of the colon and rectum. Appendiceal carcinomas, anal carcinomas, and well-differentiated neuroendocrine tumors (carcinoids) are not covered by this staging system. (from AJCC 8th Ed.) C134180 Neoplastic Process Colorectal Cancer by AJCC v8 Stage CL521958 Malignant Colorectal Cancer by AJCC v8 Stage Colorectal Carcinoma by AJCC v8 Stage Colorectal Cancer by AJCC v8 Stage Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ, intramucosal carcinoma (involvement of lamina propria with no extension through muscularis mucosae). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134182 Neoplastic Process Stage 0 Colorectal Cancer AJCC v8 Stage 0 Colorectal Cancer AJCC v8 CL521959 CTRP Malignant Stage 0 Colorectal (Colon or Rectal) Cancer Stage 0 Colorectal Cancer AJCC v8 Stage 0 Colorectal Carcinoma AJCC v8 Stage 0 Colorectal Cancer AJCC v8 Stage I includes: (T1, N0, M0); (T2, N0, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134185 Neoplastic Process Stage I Colorectal Cancer AJCC v8 Stage I Colorectal Cancer AJCC v8 CL521961 CTRP Malignant Stage I Colorectal (Colon or Rectal) Cancer Stage I Colorectal Cancer AJCC v8 Stage I Colorectal Carcinoma AJCC v8 Stage I Colorectal Cancer AJCC v8 Stage II includes: IIA: T3, N0, M0; IIB: T4a, N0, M0; IIC: T4b, N0, M0. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). T4b: Tumor directly invades or adheres to adjacent organs or structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134186 Neoplastic Process Stage II Colorectal Cancer AJCC v8 Stage II Colorectal Cancer AJCC v8 CL521962 CTRP Malignant Stage II Colorectal (Colon or Rectal) Cancer Stage II Colorectal Cancer AJCC v8 Stage II Colorectal Carcinoma AJCC v8 Stage II Colorectal Cancer AJCC v8 Stage IIA includes: T3, N0, M0. T3: Tumor invades through the muscularis propria into pericolorectal tissues. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134187 Neoplastic Process Stage IIA Colorectal Cancer AJCC v8 Stage IIA Colorectal Cancer AJCC v8 CL521963 CTRP Malignant Stage IIA Colorectal (Colon or Rectal) Cancer Stage IIA Colorectal Cancer AJCC v8 Stage IIA Colorectal Carcinoma AJCC v8 Stage IIA Colorectal Cancer AJCC v8 Stage IIB includes: T4a, N0, M0. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134188 Neoplastic Process Stage IIB Colorectal Cancer AJCC v8 Stage IIB Colorectal Cancer AJCC v8 CL521964 CTRP Malignant Stage IIB Colorectal (Colon or Rectal) Cancer Stage IIB Colorectal Cancer AJCC v8 Stage IIB Colorectal Carcinoma AJCC v8 Stage IIB Colorectal Cancer AJCC v8 Stage IIC includes: T4b, N0, M0. T4b: Tumor directly invades or adheres to adjacent organs or structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134190 Neoplastic Process Stage IIC Colorectal Cancer AJCC v8 Stage IIC Colorectal Cancer AJCC v8 CL521966 CTRP Malignant Stage IIC Colorectal (Colon or Rectal) Cancer Stage IIC Colorectal Cancer AJCC v8 Stage IIC Colorectal Carcinoma AJCC v8 Stage IIC Colorectal Cancer AJCC v8 Stage III includes: IIIA: (T1-T2, N1/N1c, M0); (T1, N2a, M0); IIIB: (T3-T4a, N1/N1c, M0); (T2-T3, N2a, M0); (T1-T2, N2b, M0); IIIC: (T4a, N2a, M0); (T3-T4a, N2b, M0); (T4b, N1-N2, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). T4b: Tumor directly invades or adheres to adjacent organs or structures. N1: One to three regional lymph nodes are positive (tumor in lymph nodes measuring 0.2 mm or more), or any number of tumor deposits are present and all identifiable lymph nodes are negative. N1c: No regional lymph nodes are positive, but there are tumor deposits in the subserosa, mesentery, or nonperitonealized pericolic, or perirectal/mesorectal tissues. N2: Four or more regional lymph nodes are positive. N2a: Four to six regional lymph nodes are positive. N2b: Seven or more regional lymph nodes are positive. M0: No distant metastasis. (AJCC 8th ed.) C134191 Neoplastic Process Stage III Colorectal Cancer AJCC v8 Stage III Colorectal Cancer AJCC v8 CL521967 CTRP Malignant Stage III Colorectal (Colon or Rectal) Cancer Stage III Colorectal Cancer AJCC v8 Stage III Colorectal Carcinoma AJCC v8 Stage III Colorectal Cancer AJCC v8 Stage IIIA includes: (T1-T2, N1/N1c, M0); (T1, N2a, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. N1: One to three regional lymph nodes are positive (tumor in lymph nodes measuring 0.2 mm or more), or any number of tumor deposits are present and all identifiable lymph nodes are negative. N1c: No regional lymph nodes are positive, but there are tumor deposits in the subserosa, mesentery, or nonperitonealized pericolic, or perirectal/mesorectal tissues. N2a: Four to six regional lymph nodes are positive. M0: No distant metastasis. (AJCC 8th ed.) C134192 Neoplastic Process Stage IIIA Colorectal Cancer AJCC v8 Stage IIIA Colorectal Cancer AJCC v8 CL521968 CTRP Malignant Stage IIIA Colorectal (Colon or Rectal) Cancer Stage IIIA Colorectal Cancer AJCC v8 Stage IIIA Colorectal Carcinoma AJCC v8 Stage IIIA Colorectal Cancer AJCC v8 Stage IIIB includes: (T3-T4a, N1/N1c, M0); (T2-T3, N2a, M0); (T1-T2, N2b, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). N1: One to three regional lymph nodes are positive (tumor in lymph nodes measuring 0.2 mm or more), or any number of tumor deposits are present and all identifiable lymph nodes are negative. N1c: No regional lymph nodes are positive, but there are tumor deposits in the subserosa, mesentery, or nonperitonealized pericolic, or perirectal/mesorectal tissues. N2a: Four to six regional lymph nodes are positive. N2b: Seven or more regional lymph nodes are positive. M0: No distant metastasis. (AJCC 8th ed.) C134193 Neoplastic Process Stage IIIB Colorectal Cancer AJCC v8 Stage IIIB Colorectal Cancer AJCC v8 CL521969 CTRP Malignant Stage IIIB Colorectal (Colon or Rectal) Cancer Stage IIIB Colorectal Cancer AJCC v8 Stage IIIB Colorectal Carcinoma AJCC v8 Stage IIIB Colorectal Cancer AJCC v8 Stage IIIC includes: (T4a, N2a, M0); (T3-T4a, N2b, M0); (T4b, N1-N2, M0). T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). T4b: Tumor directly invades or adheres to adjacent organs or structures. N1: One to three regional lymph nodes are positive (tumor in lymph nodes measuring 0.2 mm or more), or any number of tumor deposits are present and all identifiable lymph nodes are negative. N2: Four or more regional lymph nodes are positive. N2a: Four to six regional lymph nodes are positive. N2b: Seven or more regional lymph nodes are positive. M0: No distant metastasis. (AJCC 8th ed.) C134194 Neoplastic Process Stage IIIC Colorectal Cancer AJCC v8 Stage IIIC Colorectal Cancer AJCC v8 CL521970 CTRP Malignant Stage IIIC Colorectal (Colon or Rectal) Cancer Stage IIIC Colorectal Cancer AJCC v8 Stage IIIC Colorectal Carcinoma AJCC v8 Stage IIIC Colorectal Cancer AJCC v8 Stage IV includes: IVA: (Any T, Any N, M1a); IVB: (Any T, Any N, M1b); IVC: (Any T, Any N, M1c). M1a: Metastasis to one site or organ without peritoneal metastasis. M1b: Metastasis to two or more sites or organs without peritoneal metastasis. M1c: Metastasis to the peritoneal surface alone or with other site or organ metastases. (AJCC 8th ed.) C134195 Neoplastic Process Stage IV Colorectal Cancer AJCC v8 Stage IV Colorectal Cancer AJCC v8 CL521971 CTRP Malignant Stage IV Colorectal (Colon or Rectal) Cancer Stage IV Colorectal Cancer AJCC v8 Stage IV Colorectal Carcinoma AJCC v8 Stage IV Colorectal Cancer AJCC v8 Stage IVA includes: Any T, Any N, M1a. M1a: Metastasis to one site or organ without peritoneal metastasis. (AJCC 8th ed.) C134196 Neoplastic Process Stage IVA Colorectal Cancer AJCC v8 Stage IVA Colorectal Cancer AJCC v8 CL521972 CTRP Malignant Stage IVA Colorectal (Colon or Rectal) Cancer Stage IVA Colorectal Cancer AJCC v8 Stage IVA Colorectal Carcinoma AJCC v8 Stage IVA Colorectal Cancer AJCC v8 Stage IVB includes: Any T, Any N, M1b. M1b: Metastasis to two or more sites or organs without peritoneal metastasis. (AJCC 8th ed.) C134197 Neoplastic Process Stage IVB Colorectal Cancer AJCC v8 Stage IVB Colorectal Cancer AJCC v8 CL521973 CTRP Malignant Stage IVB Colorectal (Colon or Rectal) Cancer Stage IVB Colorectal Cancer AJCC v8 Stage IVB Colorectal Carcinoma AJCC v8 Stage IVB Colorectal Cancer AJCC v8 Stage IVC includes: Any T, Any N, M1c. M1c: Metastasis to the peritoneal surface alone or with other site or organ metastases. (AJCC 8th ed.) C134198 Neoplastic Process Stage IVC Colorectal Cancer AJCC v8 Stage IVC Colorectal Cancer AJCC v8 CL521974 CTRP Malignant Stage IVC Colorectal (Colon or Rectal) Cancer Stage IVC Colorectal Cancer AJCC v8 Stage IVC Colorectal Carcinoma AJCC v8 Stage IVC Colorectal Cancer AJCC v8 A term that refers to the staging of colon cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to adenocarcinomas, high-grade neuroendocrine carcinomas, and squamous cell carcinomas of the colon. (from AJCC 8th Ed.) C134251 Neoplastic Process Colon Cancer by AJCC v8 Stage CL521983 Malignant Colon Cancer by AJCC v8 Stage Colon Carcinoma by AJCC v8 Stage Colon Cancer by AJCC v8 Stage A term that refers to the staging of rectal cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to adenocarcinomas, high-grade neuroendocrine carcinomas, and squamous cell carcinomas of the rectum. (from AJCC 8th Ed.) C134258 Neoplastic Process Rectal Cancer by AJCC v8 Stage CL521988 Malignant Rectal Cancer by AJCC v8 Stage Rectal Carcinoma by AJCC v8 Stage Rectal Cancer by AJCC v8 Stage Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ, intramucosal carcinoma (involvement of lamina propria with no extension through muscularis mucosae). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134271 Neoplastic Process Stage 0 Colon Cancer AJCC v8 Stage 0 Colon Cancer AJCC v8 CL521999 CTRP Malignant Stage 0 Colon Cancer Stage 0 Colon Cancer AJCC v8 Stage 0 Colon Cancer AJCC v8 Stage I includes: (T1, N0, M0); (T2, N0, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134273 Neoplastic Process Stage I Colon Cancer AJCC v8 Stage I Colon Cancer AJCC v8 CL522001 CTRP Malignant Stage I Colon Cancer Stage I Colon Cancer AJCC v8 Stage I Colon Cancer AJCC v8 Stage II includes: IIA: T3, N0, M0; IIB: T4a, N0, M0; IIC: T4b, N0, M0. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). T4b: Tumor directly invades or adheres to adjacent organs or structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134274 Neoplastic Process Stage II Colon Cancer AJCC v8 Stage II Colon Cancer AJCC v8 CL522002 CTRP Malignant Stage II Colon Cancer Stage II Colon Cancer AJCC v8 Stage II Colon Cancer AJCC v8 Stage IIA includes: T3, N0, M0. T3: Tumor invades through the muscularis propria into pericolorectal tissues. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134280 Neoplastic Process Stage IIA Colon Cancer AJCC v8 Stage IIA Colon Cancer AJCC v8 CL522006 CTRP Malignant Stage IIA Colon Cancer Stage IIA Colon Cancer AJCC v8 Stage IIA Colon Cancer AJCC v8 Stage IIB includes: T4a, N0, M0. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134281 Neoplastic Process Stage IIB Colon Cancer AJCC v8 Stage IIB Colon Cancer AJCC v8 CL522007 CTRP Malignant Stage IIB Colon Cancer Stage IIB Colon Cancer AJCC v8 Stage IIB Colon Cancer AJCC v8 Stage IIC includes: T4b, N0, M0. T4b: Tumor directly invades or adheres to adjacent organs or structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134282 Neoplastic Process Stage IIC Colon Cancer AJCC v8 Stage IIC Colon Cancer AJCC v8 CL522008 CTRP Malignant Stage IIC Colon Cancer Stage IIC Colon Cancer AJCC v8 Stage IIC Colon Cancer AJCC v8 Stage III includes: IIIA: (T1-T2, N1/N1c, M0); (T1, N2a, M0); IIIB: (T3-T4a, N1/N1c, M0); (T2-T3, N2a, M0); (T1-T2, N2b, M0); IIIC: (T4a, N2a, M0); (T3-T4a, N2b, M0); (T4b, N1-N2, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). T4b: Tumor directly invades or adheres to adjacent organs or structures. N1: One to three regional lymph nodes are positive (tumor in lymph nodes measuring 0.2 mm or more), or any number of tumor deposits are present and all identifiable lymph nodes are negative. N1c: No regional lymph nodes are positive, but there are tumor deposits in the subserosa, mesentery, or nonperitonealized pericolic, or perirectal/mesorectal tissues. N2: Four or more regional lymph nodes are positive. N2a: Four to six regional lymph nodes are positive. N2b: Seven or more regional lymph nodes are positive. M0: No distant metastasis. (AJCC 8th ed.) C134283 Neoplastic Process Stage III Colon Cancer AJCC v8 Stage III Colon Cancer AJCC v8 CL522009 CTRP Malignant Stage III Colon Cancer Stage III Colon Cancer AJCC v8 Stage III Colon Cancer AJCC v8 Stage IIIA includes: (T1-T2, N1/N1c, M0); (T1, N2a, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. N1: One to three regional lymph nodes are positive (tumor in lymph nodes measuring 0.2 mm or more), or any number of tumor deposits are present and all identifiable lymph nodes are negative. N1c: No regional lymph nodes are positive, but there are tumor deposits in the subserosa, mesentery, or nonperitonealized pericolic, or perirectal/mesorectal tissues. N2a: Four to six regional lymph nodes are positive. M0: No distant metastasis. (AJCC 8th ed.) C134284 Neoplastic Process Stage IIIA Colon Cancer AJCC v8 Stage IIIA Colon Cancer AJCC v8 CL522010 CTRP Malignant Stage IIIA Colon Cancer Stage IIIA Colon Cancer AJCC v8 Stage IIIA Colon Cancer AJCC v8 Stage IIIB includes: (T3-T4a, N1/N1c, M0); (T2-T3, N2a, M0); (T1-T2, N2b, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). N1: One to three regional lymph nodes are positive (tumor in lymph nodes measuring 0.2 mm or more), or any number of tumor deposits are present and all identifiable lymph nodes are negative. N1c: No regional lymph nodes are positive, but there are tumor deposits in the subserosa, mesentery, or nonperitonealized pericolic, or perirectal/mesorectal tissues. N2a: Four to six regional lymph nodes are positive. N2b: Seven or more regional lymph nodes are positive. M0: No distant metastasis. (AJCC 8th ed.) C134285 Neoplastic Process Stage IIIB Colon Cancer AJCC v8 Stage IIIB Colon Cancer AJCC v8 CL522011 CTRP Malignant Stage IIIB Colon Cancer Stage IIIB Colon Cancer AJCC v8 Stage IIIB Colon Cancer AJCC v8 Stage IIIC includes: (T4a, N2a, M0); (T3-T4a, N2b, M0); (T4b, N1-N2, M0). T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). T4b: Tumor directly invades or adheres to adjacent organs or structures. N1: One to three regional lymph nodes are positive (tumor in lymph nodes measuring 0.2 mm or more), or any number of tumor deposits are present and all identifiable lymph nodes are negative. N2: Four or more regional lymph nodes are positive. N2a: Four to six regional lymph nodes are positive. N2b: Seven or more regional lymph nodes are positive. M0: No distant metastasis. (AJCC 8th ed.) C134286 Neoplastic Process Stage IIIC Colon Cancer AJCC v8 Stage IIIC Colon Cancer AJCC v8 CL522012 CTRP Malignant Stage IIIC Colon Cancer Stage IIIC Colon Cancer AJCC v8 Stage IIIC Colon Cancer AJCC v8 Stage IV includes: IVA: (Any T, Any N, M1a); IVB: (Any T, Any N, M1b); IVC: (Any T, Any N, M1c). M1a: Metastasis to one site or organ without peritoneal metastasis. M1b: Metastasis to two or more sites or organs without peritoneal metastasis. M1c: Metastasis to the peritoneal surface alone or with other site or organ metastases. (AJCC 8th ed.) C134287 Neoplastic Process Stage IV Colon Cancer AJCC v8 Stage IV Colon Cancer AJCC v8 CL522013 CTRP Malignant Stage IV Colon Cancer Stage IV Colon Cancer AJCC v8 Stage IV Colon Cancer AJCC v8 Stage IVA includes: Any T, Any N, M1a. M1a: Metastasis to one site or organ without peritoneal metastasis. (AJCC 8th ed.) C134288 Neoplastic Process Stage IVA Colon Cancer AJCC v8 Stage IVA Colon Cancer AJCC v8 CL522014 CTRP Malignant Stage IVA Colon Cancer Stage IVA Colon Cancer AJCC v8 Stage IVA Colon Cancer AJCC v8 Stage IVB includes: Any T, Any N, M1b. M1b: Metastasis to two or more sites or organs without peritoneal metastasis. (AJCC 8th ed.) C134289 Neoplastic Process Stage IVB Colon Cancer AJCC v8 Stage IVB Colon Cancer AJCC v8 CL522015 CTRP Malignant Stage IVB Colon Cancer Stage IVB Colon Cancer AJCC v8 Stage IVB Colon Cancer AJCC v8 Stage IVC includes: Any T, Any N, M1c. M1c: Metastasis to the peritoneal surface alone or with other site or organ metastases. (AJCC 8th ed.) C134290 Neoplastic Process Stage IVC Colon Cancer AJCC v8 Stage IVC Colon Cancer AJCC v8 CL522016 CTRP Malignant Stage IVC Colon Cancer Stage IVC Colon Cancer AJCC v8 Stage IVC Colon Cancer AJCC v8 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ, intramucosal carcinoma (involvement of lamina propria with no extension through muscularis mucosae). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134291 Neoplastic Process Stage 0 Rectal Cancer AJCC v8 Stage 0 Rectal Cancer AJCC v8 CL522017 CTRP Malignant Stage 0 Rectal Cancer Stage 0 Rectal Cancer AJCC v8 Stage 0 Rectal Cancer AJCC v8 Stage I includes: (T1, N0, M0); (T2, N0, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134292 Neoplastic Process Stage I Rectal Cancer AJCC v8 Stage I Rectal Cancer AJCC v8 CL522018 CTRP Malignant Stage I Rectal Cancer Stage I Rectal Cancer AJCC v8 Stage I Rectal Cancer AJCC v8 Stage II includes: IIA: T3, N0, M0; IIB: T4a, N0, M0; IIC: T4b, N0, M0. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). T4b: Tumor directly invades or adheres to adjacent organs or structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134293 Neoplastic Process Stage II Rectal Cancer AJCC v8 Stage II Rectal Cancer AJCC v8 CL522019 CTRP Malignant Stage II Rectal Cancer Stage II Rectal Cancer AJCC v8 Stage II Rectal Cancer AJCC v8 Stage IIA includes: T3, N0, M0. T3: Tumor invades through the muscularis propria into pericolorectal tissues. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134294 Neoplastic Process Stage IIA Rectal Cancer AJCC v8 Stage IIA Rectal Cancer AJCC v8 CL522020 CTRP Malignant Stage IIA Rectal Cancer Stage IIA Rectal Cancer AJCC v8 Stage IIA Rectal Cancer AJCC v8 Stage IIB includes: T4a, N0, M0. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134295 Neoplastic Process Stage IIB Rectal Cancer AJCC v8 Stage IIB Rectal Cancer AJCC v8 CL522021 CTRP Malignant Stage IIB Rectal Cancer Stage IIB Rectal Cancer AJCC v8 Stage IIB Rectal Cancer AJCC v8 Stage IIC includes: T4b, N0, M0. T4b: Tumor directly invades or adheres to adjacent organs or structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134296 Neoplastic Process Stage IIC Rectal Cancer AJCC v8 Stage IIC Rectal Cancer AJCC v8 CL522022 CTRP Malignant Stage IIC Rectal Cancer Stage IIC Rectal Cancer AJCC v8 Stage IIC Rectal Cancer AJCC v8 Stage III includes: IIIA: (T1-T2, N1/N1c, M0); (T1, N2a, M0); IIIB: (T3-T4a, N1/N1c, M0); (T2-T3, N2a, M0); (T1-T2, N2b, M0); IIIC: (T4a, N2a, M0); (T3-T4a, N2b, M0); (T4b, N1-N2, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). T4b: Tumor directly invades or adheres to adjacent organs or structures. N1: One to three regional lymph nodes are positive (tumor in lymph nodes measuring 0.2 mm or more), or any number of tumor deposits are present and all identifiable lymph nodes are negative. N1c: No regional lymph nodes are positive, but there are tumor deposits in the subserosa, mesentery, or nonperitonealized pericolic, or perirectal/mesorectal tissues. N2: Four or more regional lymph nodes are positive. N2a: Four to six regional lymph nodes are positive. N2b: Seven or more regional lymph nodes are positive. M0: No distant metastasis. (AJCC 8th ed.) C134297 Neoplastic Process Stage III Rectal Cancer AJCC v8 Stage III Rectal Cancer AJCC v8 CL522023 CTRP Malignant Stage III Rectal Cancer Stage III Rectal Cancer AJCC v8 Stage III Rectal Cancer AJCC v8 Stage IIIA includes: (T1-T2, N1/N1c, M0); (T1, N2a, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. N1: One to three regional lymph nodes are positive (tumor in lymph nodes measuring 0.2 mm or more), or any number of tumor deposits are present and all identifiable lymph nodes are negative. N1c: No regional lymph nodes are positive, but there are tumor deposits in the subserosa, mesentery, or nonperitonealized pericolic, or perirectal/mesorectal tissues. N2a: Four to six regional lymph nodes are positive. M0: No distant metastasis. (AJCC 8th ed.) C134298 Neoplastic Process Stage IIIA Rectal Cancer AJCC v8 Stage IIIA Rectal Cancer AJCC v8 CL522024 CTRP Malignant Stage IIIA Rectal Cancer Stage IIIA Rectal Cancer AJCC v8 Stage IIIA Rectal Cancer AJCC v8 Stage IIIB includes: (T3-T4a, N1/N1c, M0); (T2-T3, N2a, M0); (T1-T2, N2b, M0). T1: Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria). T2: Tumor invades the muscularis propria. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). N1: One to three regional lymph nodes are positive (tumor in lymph nodes measuring 0.2 mm or more), or any number of tumor deposits are present and all identifiable lymph nodes are negative. N1c: No regional lymph nodes are positive, but there are tumor deposits in the subserosa, mesentery, or nonperitonealized pericolic, or perirectal/mesorectal tissues. N2a: Four to six regional lymph nodes are positive. N2b: Seven or more regional lymph nodes are positive. M0: No distant metastasis. (AJCC 8th ed.) C134299 Neoplastic Process Stage IIIB Rectal Cancer AJCC v8 Stage IIIB Rectal Cancer AJCC v8 CL522025 CTRP Malignant Stage IIIB Rectal Cancer Stage IIIB Rectal Cancer AJCC v8 Stage IIIB Rectal Cancer AJCC v8 Stage IIIC includes: (T4a, N2a, M0); (T3-T4a, N2b, M0); (T4b, N1-N2, M0). T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor invades through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum). T4b: Tumor directly invades or adheres to adjacent organs or structures. N1: One to three regional lymph nodes are positive (tumor in lymph nodes measuring 0.2 mm or more), or any number of tumor deposits are present and all identifiable lymph nodes are negative. N2: Four or more regional lymph nodes are positive. N2a: Four to six regional lymph nodes are positive. N2b: Seven or more regional lymph nodes are positive. M0: No distant metastasis. (AJCC 8th ed.) C134300 Neoplastic Process Stage IIIC Rectal Cancer AJCC v8 Stage IIIC Rectal Cancer AJCC v8 CL522026 CTRP Malignant Stage IIIC Rectal Cancer Stage IIIC Rectal Cancer AJCC v8 Stage IIIC Rectal Cancer AJCC v8 Stage IV includes: IVA: (Any T, Any N, M1a); IVB: (Any T, Any N, M1b); IVC: (Any T, Any N, M1c). M1a: Metastasis to one site or organ without peritoneal metastasis. M1b: Metastasis to two or more sites or organs without peritoneal metastasis. M1c: Metastasis to the peritoneal surface alone or with other site or organ metastases. (AJCC 8th ed.) C134301 Neoplastic Process Stage IV Rectal Cancer AJCC v8 Stage IV Rectal Cancer AJCC v8 CL522027 CTRP Malignant Stage IV Rectal Cancer Stage IV Rectal Cancer AJCC v8 Stage IV Rectal Cancer AJCC v8 Stage IVA includes: Any T, Any N, M1a. M1a: Metastasis to one site or organ without peritoneal metastasis. (AJCC 8th ed.) C134302 Neoplastic Process Stage IVA Rectal Cancer AJCC v8 Stage IVA Rectal Cancer AJCC v8 CL522028 CTRP Malignant Stage IVA Rectal Cancer Stage IVA Rectal Cancer AJCC v8 Stage IVA Rectal Cancer AJCC v8 Stage IVB includes: Any T, Any N, M1b. M1b: Metastasis to two or more sites or organs without peritoneal metastasis. (AJCC 8th ed.) C134303 Neoplastic Process Stage IVB Rectal Cancer AJCC v8 Stage IVB Rectal Cancer AJCC v8 CL522029 CTRP Malignant Stage IVB Rectal Cancer Stage IVB Rectal Cancer AJCC v8 Stage IVB Rectal Cancer AJCC v8 Stage IVC includes: Any T, Any N, M1c. M1c: Metastasis to the peritoneal surface alone or with other site or organ metastases. (AJCC 8th ed.) C134304 Neoplastic Process Stage IVC Rectal Cancer AJCC v8 Stage IVC Rectal Cancer AJCC v8 CL522030 CTRP Malignant Stage IVC Rectal Cancer Stage IVC Rectal Cancer AJCC v8 Stage IVC Rectal Cancer AJCC v8 Acute myeloid leukemia that does not respond to treatment. C134319 Neoplastic Process Refractory Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia CL522037 CTRP Malignant Refractory AML Refractory Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia (AML) Refractory Acute Myeloid Leukemia A term that refers to the staging of intrahepatic cholangiocarcinoma according to the American Joint Committee on Cancer, 7th edition. C134514 Neoplastic Process Intrahepatic Cholangiocarcinoma by AJCC v7 Stage CL522095 Malignant Intrahepatic Cholangiocarcinoma by AJCC v7 Stage Intrahepatic Cholangiocarcinoma by AJCC v7 Stage A term that refers to the staging of hepatocellular carcinoma according to the American Joint Committee on Cancer, 8th edition. This staging system applies to hepatocellular carcinomas and fibrolamellar carcinomas (fibrolamellar variant of hepatocellular carcinoma). Intrahepatic cholangiocarcinomas, combined hepatocellular-cholangiocarcinomas, and sarcomas of the liver are not staged using this staging system. (from AJCC 8th Ed.) C134515 Neoplastic Process Hepatocellular Carcinoma by AJCC v8 Stage CL522096 CPTAC Malignant Hepatocellular Carcinoma by AJCC v8 Stage Liver Cell Carcinoma by AJCC v8 Stage Tumor Stage (Pathologic) Hepatocellular Carcinoma by AJCC v8 Stage Stage I includes: IA (T1a, N0, M0); IB (T1b, N0, M0). T1a: Solitary tumor equal to or less than 2 cm. T1b: Solitary tumor larger than 2 cm without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134516 Neoplastic Process Stage I Hepatocellular Carcinoma AJCC v8 Stage I Hepatocellular Carcinoma AJCC v8 CL522097 CTRP Malignant Stage I Hepatocellular Cancer Stage I Hepatocellular Carcinoma AJCC v8 Stage I Liver Cell Carcinoma AJCC v8 Stage I Hepatocellular Carcinoma AJCC v8 Stage IA includes: T1a, N0, M0. T1a: Solitary tumor equal to or less than 2 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134517 Neoplastic Process Stage IA Hepatocellular Carcinoma AJCC v8 Stage IA Hepatocellular Carcinoma AJCC v8 CL522098 CPTAC CTRP Malignant IA Stage IA Hepatocellular Cancer Stage IA Hepatocellular Carcinoma AJCC v8 Stage IA Liver Cell Carcinoma AJCC v8 Stage IA Hepatocellular Carcinoma AJCC v8 Stage IB includes: T1b, N0, M0. T1b: Solitary tumor larger than 2 cm without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134518 Neoplastic Process Stage IB Hepatocellular Carcinoma AJCC v8 Stage IB Hepatocellular Carcinoma AJCC v8 CL522099 CPTAC CTRP Malignant IB Stage IB Hepatocellular Cancer Stage IB Hepatocellular Carcinoma AJCC v8 Stage IB Liver Cell Carcinoma AJCC v8 Stage IB Hepatocellular Carcinoma AJCC v8 Stage II includes: T2, N0, M0. T2: Solitary tumor larger than 2 cm with vascular invasion, or multiple tumors, none larger than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134519 Neoplastic Process Stage II Hepatocellular Carcinoma AJCC v8 Stage II Hepatocellular Carcinoma AJCC v8 CL522100 CPTAC CTRP Malignant II Stage II Hepatocellular Cancer Stage II Hepatocellular Carcinoma AJCC v8 Stage II Liver Cell Carcinoma AJCC v8 Stage II Hepatocellular Carcinoma AJCC v8 Stage III includes: IIIA: (T3, N0, M0); IIIB: (T4, N0, M0). T3: Multiple tumors, at least one of which is larger than 5 cm. T4: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein, or tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134520 Neoplastic Process Stage III Hepatocellular Carcinoma AJCC v8 Stage III Hepatocellular Carcinoma AJCC v8 CL522101 CTRP Malignant Stage III Hepatocellular Cancer Stage III Hepatocellular Carcinoma AJCC v8 Stage III Liver Cell Carcinoma AJCC v8 Stage III Hepatocellular Carcinoma AJCC v8 Stage IIIA includes: T3, N0, M0. T3: Multiple tumors, at least one of which is larger than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134521 Neoplastic Process Stage IIIA Hepatocellular Carcinoma AJCC v8 Stage IIIA Hepatocellular Carcinoma AJCC v8 CL522102 CPTAC CTRP Malignant IIIA Stage IIIA Hepatocellular Cancer Stage IIIA Hepatocellular Carcinoma AJCC v8 Stage IIIA Liver Cell Carcinoma AJCC v8 Stage IIIA Hepatocellular Carcinoma AJCC v8 Stage IIIB includes: T4, N0, M0. T4: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein, or tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134522 Neoplastic Process Stage IIIB Hepatocellular Carcinoma AJCC v8 Stage IIIB Hepatocellular Carcinoma AJCC v8 CL522103 CPTAC CTRP Malignant IIIB Stage IIIB Hepatocellular Cancer Stage IIIB Hepatocellular Carcinoma AJCC v8 Stage IIIB Liver Cell Carcinoma AJCC v8 Stage IIIB Hepatocellular Carcinoma AJCC v8 Stage IV includes: IVA: (Any T, N1, M0); IVB: (Any T, Any N, M1). N1: Regional lymph node metastasis. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C134523 Neoplastic Process Stage IV Hepatocellular Carcinoma AJCC v8 Stage IV Hepatocellular Carcinoma AJCC v8 CL522104 CTRP Malignant Stage IV Hepatocellular Cancer Stage IV Hepatocellular Carcinoma AJCC v8 Stage IV Liver Cell Carcinoma AJCC v8 Stage IV Hepatocellular Carcinoma AJCC v8 Stage IVA includes: Any T, N1, M0. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134524 Neoplastic Process Stage IVA Hepatocellular Carcinoma AJCC v8 Stage IVA Hepatocellular Carcinoma AJCC v8 CL522105 CPTAC CTRP Malignant IVA Stage IVA Hepatocellular Cancer Stage IVA Hepatocellular Carcinoma AJCC v8 Stage IVA Liver Cell Carcinoma AJCC v8 Stage IVA Hepatocellular Carcinoma AJCC v8 Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C134525 Neoplastic Process Stage IVB Hepatocellular Carcinoma AJCC v8 Stage IVB Hepatocellular Carcinoma AJCC v8 CL522106 CPTAC CTRP Malignant IVB Stage IVB Hepatocellular Cancer Stage IVB Hepatocellular Carcinoma AJCC v8 Stage IVB Liver Cell Carcinoma AJCC v8 Stage IVB Hepatocellular Carcinoma AJCC v8 A term that refers to the staging of intrahepatic bile duct cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to intrahepatic cholangiocarcinomas, combined hepatocellular-cholangiocarcinomas (mixed hepatocholangiocarcinomas), and primary neuroendocrine tumors of the liver. Primary sarcomas of the liver, pure hepatocellular carcinomas, hilar cholangiocarcinomas, and gallbladder carcinomas are not staged using this staging system. (from AJCC 8th Ed.) C134604 Neoplastic Process Intrahepatic Bile Duct Cancer by AJCC v8 Stage CL522159 CPTAC Malignant Intrahepatic Bile Duct Cancer Tumor Stage (Pathologic) Intrahepatic Bile Duct Cancer by AJCC v8 Stage Intrahepatic Bile Duct Carcinoma by AJCC v8 Stage Intrahepatic Bile Duct Cancer by AJCC v8 Stage Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ (intraductal tumor). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134609 Neoplastic Process Stage 0 Intrahepatic Bile Duct Cancer AJCC v8 Stage 0 Intrahepatic Bile Duct Cancer AJCC v8 CL522162 CPTAC CTRP Malignant Carcinoma in situ of liver and biliary system Stage 0 Intrahepatic Bile Duct Cancer Stage 0 Intrahepatic Bile Duct Cancer AJCC v8 Stage 0 Intrahepatic Bile Duct Carcinoma AJCC v8 Stage 0 Intrahepatic Bile Duct Cancer AJCC v8 Stage I includes: IA (T1a, N0, M0); IB (T1b, N0, M0). T1a: Solitary tumor equal to or less than 5 cm without vascular invasion. T1b: Solitary tumor larger than 5 cm without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134610 Neoplastic Process Stage I Intrahepatic Bile Duct Cancer AJCC v8 Stage I Intrahepatic Bile Duct Cancer AJCC v8 CL522163 CTRP Malignant Stage I Intrahepatic Bile Duct Cancer Stage I Intrahepatic Bile Duct Cancer AJCC v8 Stage I Intrahepatic Bile Duct Carcinoma AJCC v8 Stage I Intrahepatic Bile Duct Cancer AJCC v8 Stage IA includes: T1a, N0, M0. T1a: Solitary tumor equal to or less than 5 cm without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134611 Neoplastic Process Stage IA Intrahepatic Bile Duct Cancer AJCC v8 Stage IA Intrahepatic Bile Duct Cancer AJCC v8 CL522164 CTRP Malignant Stage IA Intrahepatic Bile Duct Cancer Stage IA Intrahepatic Bile Duct Cancer AJCC v8 Stage IA Intrahepatic Bile Duct Carcinoma AJCC v8 Stage IA Intrahepatic Bile Duct Cancer AJCC v8 Stage IB includes: T1b, N0, M0. T1b: Solitary tumor larger than 5 cm without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134612 Neoplastic Process Stage IB Intrahepatic Bile Duct Cancer AJCC v8 Stage IB Intrahepatic Bile Duct Cancer AJCC v8 CL522165 CTRP Malignant Stage IB Intrahepatic Bile Duct Cancer Stage IB Intrahepatic Bile Duct Cancer AJCC v8 Stage IB Intrahepatic Bile Duct Carcinoma AJCC v8 Stage IB Intrahepatic Bile Duct Cancer AJCC v8 Stage II includes: T2, N0, M0. T2: Solitary tumor with intrahepatic vascular invasion, or multiple tumors, with or without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134614 Neoplastic Process Stage II Intrahepatic Bile Duct Cancer AJCC v8 Stage II Intrahepatic Bile Duct Cancer AJCC v8 CL522166 CTRP Malignant Stage II Intrahepatic Bile Duct Cancer Stage II Intrahepatic Bile Duct Cancer AJCC v8 Stage II Intrahepatic Bile Duct Carcinoma AJCC v8 Stage II Intrahepatic Bile Duct Cancer AJCC v8 Stage III includes: IIIA: (T3, N0, M0); IIIB: (T4, N0, M0); (Any T, N1, M0). T3: Tumor perforating the visceral peritoneum. T4: Tumor involving local extrahepatic structures by direct invasion. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134615 Neoplastic Process Stage III Intrahepatic Bile Duct Cancer AJCC v8 Stage III Intrahepatic Bile Duct Cancer AJCC v8 CL522167 CTRP Malignant Stage III Intrahepatic Bile Duct Cancer Stage III Intrahepatic Bile Duct Cancer AJCC v8 Stage III Intrahepatic Bile Duct Carcinoma AJCC v8 Stage III Intrahepatic Bile Duct Cancer AJCC v8 Stage IIIA includes: T3, N0, M0. T3: Tumor perforating the visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134616 Neoplastic Process Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8 Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8 CL522168 CTRP Malignant Stage IIIA Intrahepatic Bile Duct Cancer Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8 Stage IIIA Intrahepatic Bile Duct Carcinoma AJCC v8 Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8 Stage IIIB includes: (T4, N0, M0); (Any T, N1, M0). T4: Tumor involving local extrahepatic structures by direct invasion. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134618 Neoplastic Process Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8 Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8 CL522170 CTRP Malignant Stage IIIB Intrahepatic Bile Duct Cancer Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8 Stage IIIB Intrahepatic Bile Duct Carcinoma AJCC v8 Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C134619 Neoplastic Process Stage IV Intrahepatic Bile Duct Cancer AJCC v8 Stage IV Intrahepatic Bile Duct Cancer AJCC v8 CL522171 CTRP Malignant Stage IV Intrahepatic Bile Duct Cancer Stage IV Intrahepatic Bile Duct Cancer AJCC v8 Stage IV Intrahepatic Bile Duct Carcinoma AJCC v8 Stage IV Intrahepatic Bile Duct Cancer AJCC v8 A term that refers to the staging of gallbladder cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to gallbladder carcinomas. Well-differentiated neuroendocrine tumors and sarcomas are not staged using this staging system. (from AJCC 8th Ed.) C134660 Neoplastic Process Gallbladder Cancer by AJCC v8 Stage CL522207 Malignant Gallbladder Cancer by AJCC v8 Stage Gallbladder Carcinoma by AJCC v8 Stage Gallbladder Cancer by AJCC v8 Stage Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134663 Neoplastic Process Stage 0 Gallbladder Cancer AJCC v8 Stage 0 Gallbladder Cancer AJCC v8 CL522209 CTRP Malignant Stage 0 Gallbladder Cancer Stage 0 Gallbladder Cancer AJCC v8 Stage 0 Gallbladder Carcinoma AJCC v8 Stage 0 Gallbladder Cancer AJCC v8 Stage I includes: T1, N0, M0. T1: Tumor invading the lamina propria or muscular layer. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134665 Neoplastic Process Stage I Gallbladder Cancer AJCC v8 Stage I Gallbladder Cancer AJCC v8 CL522210 CTRP Malignant Stage I Gallbladder Cancer Stage I Gallbladder Cancer AJCC v8 Stage I Gallbladder Carcinoma AJCC v8 Stage I Gallbladder Cancer AJCC v8 Stage II includes: IIA: T2a, N0, M0; IIB: T2b, N0, M0. T2a: Tumor invading the perimuscular connective tissue on the peritoneal side, without involvement of the serosa (visceral peritoneum). T2b: Tumor invading the perimuscular connective tissue on the hepatic side, with no extension into the liver. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134667 Neoplastic Process Stage II Gallbladder Cancer AJCC v8 Stage II Gallbladder Cancer AJCC v8 CL522211 CTRP Malignant Stage II Gallbladder Cancer Stage II Gallbladder Cancer AJCC v8 Stage II Gallbladder Carcinoma AJCC v8 Stage II Gallbladder Cancer AJCC v8 Stage IIA includes: T2a, N0, M0. T2a: Tumor invading the perimuscular connective tissue on the peritoneal side, without involvement of the serosa (visceral peritoneum). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134670 Neoplastic Process Stage IIA Gallbladder Cancer AJCC v8 Stage IIA Gallbladder Cancer AJCC v8 CL522213 CTRP Malignant Stage IIA Gallbladder Cancer Stage IIA Gallbladder Cancer AJCC v8 Stage IIA Gallbladder Carcinoma AJCC v8 Stage IIA Gallbladder Cancer AJCC v8 Stage IIB includes: T2b, N0, M0. T2b: Tumor invading the perimuscular connective tissue on the hepatic side, with no extension into the liver. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134671 Neoplastic Process Stage IIB Gallbladder Cancer AJCC v8 Stage IIB Gallbladder Cancer AJCC v8 CL522214 CTRP Malignant Stage IIB Gallbladder Cancer Stage IIB Gallbladder Cancer AJCC v8 Stage IIB Gallbladder Carcinoma AJCC v8 Stage IIB Gallbladder Cancer AJCC v8 Stage III includes: IIIA: (T3, N0, M0); IIIB: (T1-3, N1, M0). T1: Tumor invading the lamina propria or muscular layer. T2: Tumor invading the perimuscular connective tissue on the peritoneal side, without involvement of the serosa (visceral peritoneum); or tumor invading the perimuscular connective tissue on the hepatic side, with no extension into the liver. T3: Tumor perforating the serosa (visceral peritoneum) and/or directly invading the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts. N0: No regional lymph node metastasis. N1: Metastases to one to three regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C134672 Neoplastic Process Stage III Gallbladder Cancer AJCC v8 Stage III Gallbladder Cancer AJCC v8 CL522215 CTRP Malignant Stage III Gallbladder Cancer Stage III Gallbladder Cancer AJCC v8 Stage III Gallbladder Carcinoma AJCC v8 Stage III Gallbladder Cancer AJCC v8 Stage IIIA includes: T3, N0, M0. T3: Tumor perforating the serosa (visceral peritoneum) and/or directly invading the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134673 Neoplastic Process Stage IIIA Gallbladder Cancer AJCC v8 Stage IIIA Gallbladder Cancer AJCC v8 CL522216 CTRP Malignant Stage IIIA Gallbladder Cancer Stage IIIA Gallbladder Cancer AJCC v8 Stage IIIA Gallbladder Carcinoma AJCC v8 Stage IIIA Gallbladder Cancer AJCC v8 Stage IIIB includes: T1-3, N1, M0. T1: Tumor invading the lamina propria or muscular layer. T2: Tumor invading the perimuscular connective tissue on the peritoneal side, without involvement of the serosa (visceral peritoneum); or tumor invading the perimuscular connective tissue on the hepatic side, with no extension into the liver. T3: Tumor perforating the serosa (visceral peritoneum) and/or directly invading the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts. N1: Metastases to one to three regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C134674 Neoplastic Process Stage IIIB Gallbladder Cancer AJCC v8 Stage IIIB Gallbladder Cancer AJCC v8 CL522217 CTRP Malignant Stage IIIB Gallbladder Cancer Stage IIIB Gallbladder Cancer AJCC v8 Stage IIIB Gallbladder Carcinoma AJCC v8 Stage IIIB Gallbladder Cancer AJCC v8 Stage IV includes: IVA: T4, N0-1, M0; IVB: (Any T, N2, M0); (Any T, Any N, M1). T4: Tumor invading the main portal vein or hepatic artery or invading two or more extrahepatic organs or structures. N0: No regional lymph node metastasis. N1: Metastases to one to three regional lymph nodes. N2: Metastases to four or more regional lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C134675 Neoplastic Process Stage IV Gallbladder Cancer AJCC v8 Stage IV Gallbladder Cancer AJCC v8 CL522218 CTRP Malignant Stage IV Gallbladder Cancer Stage IV Gallbladder Cancer AJCC v8 Stage IV Gallbladder Carcinoma AJCC v8 Stage IV Gallbladder Cancer AJCC v8 Stage IVA includes: T4, N0-1, M0. T4: Tumor invading the main portal vein or hepatic artery or invading two or more extrahepatic organs or structures. N0: No regional lymph node metastasis. N1: Metastases to one to three regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C134676 Neoplastic Process Stage IVA Gallbladder Cancer AJCC v8 Stage IVA Gallbladder Cancer AJCC v8 CL522219 CTRP Malignant Stage IVA Gallbladder Cancer Stage IVA Gallbladder Cancer AJCC v8 Stage IVA Gallbladder Carcinoma AJCC v8 Stage IVA Gallbladder Cancer AJCC v8 Stage IVB includes: (Any T, N2, M0); (Any T, Any N, M1). N2: Metastases to four or more regional lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C134678 Neoplastic Process Stage IVB Gallbladder Cancer AJCC v8 Stage IVB Gallbladder Cancer AJCC v8 CL522220 CTRP Malignant Stage IVB Gallbladder Cancer Stage IVB Gallbladder Cancer AJCC v8 Stage IVB Gallbladder Carcinoma AJCC v8 Stage IVB Gallbladder Cancer AJCC v8 A term that refers to the staging of hilar cholangiocarcinoma according to the American Joint Committee on Cancer, 7th edition. C134742 Neoplastic Process Hilar Cholangiocarcinoma by AJCC v7 Stage CL522269 Malignant Hilar Cholangiocarcinoma by AJCC v7 Stage Perihilar Cholangiocarcinoma by AJCC v7 Stage Hilar Cholangiocarcinoma by AJCC v7 Stage A term that refers to the staging of hilar cholangiocarcinoma according to the American Joint Committee on Cancer, 8th edition. Hilar well-differentiated neuroendocrine tumors and sarcomas are not staged using this staging system. (from AJCC 8th Ed.) C134743 Neoplastic Process Hilar Cholangiocarcinoma by AJCC v8 Stage CL522270 CPTAC Malignant Hilar Cholangiocarcinoma Tumor Stage (Pathologic) Hilar Cholangiocarcinoma by AJCC v8 Stage Perihilar Cholangiocarcinoma by AJCC v8 Stage Hilar Cholangiocarcinoma by AJCC v8 Stage Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ/high grade dysplasia. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134744 Neoplastic Process Stage 0 Hilar Cholangiocarcinoma AJCC v8 Stage 0 Hilar Cholangiocarcinoma AJCC v8 CL522271 CPTAC CTRP Malignant 0 Stage 0 Hilar Cholangiocarcinoma Stage 0 Hilar Cholangiocarcinoma AJCC v8 Stage 0 Perihilar Cholangiocarcinoma AJCC v8 Stage 0 Hilar Cholangiocarcinoma AJCC v8 Stage I includes: T1, N0, M0. T1: Tumor confined to the bile duct, with extension up to the muscle layer or fibrous tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134745 Neoplastic Process Stage I Hilar Cholangiocarcinoma AJCC v8 Stage I Hilar Cholangiocarcinoma AJCC v8 CL522272 CPTAC CTRP Malignant I Stage I Hilar Cholangiocarcinoma Stage I Hilar Cholangiocarcinoma AJCC v8 Stage I Perihilar Cholangiocarcinoma AJCC v8 Stage I Hilar Cholangiocarcinoma AJCC v8 Stage II includes: T2a-b, N0, M0. T2a: Tumor invading beyond the wall of the bile duct to surrounding adipose tissue. T2b: Tumor invading adjacent hepatic parenchyma. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134746 Neoplastic Process Stage II Hilar Cholangiocarcinoma AJCC v8 Stage II Hilar Cholangiocarcinoma AJCC v8 CL522273 CPTAC CTRP Malignant II Stage II Hilar Cholangiocarcinoma Stage II Hilar Cholangiocarcinoma AJCC v8 Stage II Perihilar Cholangiocarcinoma AJCC v8 Stage II Hilar Cholangiocarcinoma AJCC v8 Stage III includes: IIIA: (T3, N0, M0); IIIB: (T4, N0, M0); IIIC: (Any T, N1, M0). T3: Tumor invading unilateral branches of the portal vein or hepatic artery. T4: Tumor invading the main portal vein or its branches bilaterally, or the common hepatic artery; or unilateral second-order biliary radicals with contralateral portal vein or hepatic artery involvement. N0: No regional lymph node metastasis. N1: One to three positive lymph nodes typically involving the hilar, cystic duct, common bile duct, hepatic artery, posterior pancreatoduodenal, and portal vein lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C134747 Neoplastic Process Stage III Hilar Cholangiocarcinoma AJCC v8 Stage III Hilar Cholangiocarcinoma AJCC v8 CL522274 CPTAC CTRP Malignant III Stage III Hilar Cholangiocarcinoma Stage III Hilar Cholangiocarcinoma AJCC v8 Stage III Perihilar Cholangiocarcinoma AJCC v8 Stage III Hilar Cholangiocarcinoma AJCC v8 Stage IIIA includes: T3, N0, M0. T3: Tumor invading unilateral branches of the portal vein or hepatic artery. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134748 Neoplastic Process Stage IIIA Hilar Cholangiocarcinoma AJCC v8 Stage IIIA Hilar Cholangiocarcinoma AJCC v8 CL522275 CPTAC CTRP Malignant IIIA Stage IIIA Hilar Cholangiocarcinoma Stage IIIA Hilar Cholangiocarcinoma AJCC v8 Stage IIIA Perihilar Cholangiocarcinoma AJCC v8 Stage IIIA Hilar Cholangiocarcinoma AJCC v8 Stage IIIB includes: T4, N0, M0. T4: Tumor invading the main portal vein or its branches bilaterally, or the common hepatic artery; or unilateral second-order biliary radicals with contralateral portal vein or hepatic artery involvement. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134749 Neoplastic Process Stage IIIB Hilar Cholangiocarcinoma AJCC v8 Stage IIIB Hilar Cholangiocarcinoma AJCC v8 CL522276 CPTAC CTRP Malignant IIIB Stage IIIB Hilar Cholangiocarcinoma Stage IIIB Hilar Cholangiocarcinoma AJCC v8 Stage IIIB Perihilar Cholangiocarcinoma AJCC v8 Stage IIIB Hilar Cholangiocarcinoma AJCC v8 Stage IIIC includes: Any T, N1, M0. N1: One to three positive lymph nodes typically involving the hilar, cystic duct, common bile duct, hepatic artery, posterior pancreatoduodenal, and portal vein lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C134750 Neoplastic Process Stage IIIC Hilar Cholangiocarcinoma AJCC v8 Stage IIIC Hilar Cholangiocarcinoma AJCC v8 CL522277 CPTAC CTRP Malignant IIIC Stage IIIC Hilar Cholangiocarcinoma Stage IIIC Hilar Cholangiocarcinoma AJCC v8 Stage IIIC Perihilar Cholangiocarcinoma AJCC v8 Stage IIIC Hilar Cholangiocarcinoma AJCC v8 Stage IV includes: IVA: (Any T, N2, M0); IVB: (Any T, Any N, M1). N2: Four or more positive lymph nodes involving the hilar, cystic duct, common bile duct, hepatic artery, posterior pancreatoduodenal, and portal vein lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C134751 Neoplastic Process Stage IV Hilar Cholangiocarcinoma AJCC v8 Stage IV Hilar Cholangiocarcinoma AJCC v8 CL522278 CPTAC CTRP Malignant IV Stage IV Hilar Cholangiocarcinoma Stage IV Hilar Cholangiocarcinoma AJCC v8 Stage IV Perihilar Cholangiocarcinoma AJCC v8 Stage IV Hilar Cholangiocarcinoma AJCC v8 Stage IVA includes: Any T, N2, M0. N2: Four or more positive lymph nodes involving the hilar, cystic duct, common bile duct, hepatic artery, posterior pancreatoduodenal, and portal vein lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C134752 Neoplastic Process Stage IVA Hilar Cholangiocarcinoma AJCC v8 Stage IVA Hilar Cholangiocarcinoma AJCC v8 CL522279 CPTAC CTRP Malignant IVA Stage IVA Hilar Cholangiocarcinoma Stage IVA Hilar Cholangiocarcinoma AJCC v8 Stage IVA Perihilar Cholangiocarcinoma AJCC v8 Stage IVA Hilar Cholangiocarcinoma AJCC v8 Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C134753 Neoplastic Process Stage IVB Hilar Cholangiocarcinoma AJCC v8 Stage IVB Hilar Cholangiocarcinoma AJCC v8 CL522280 CPTAC CTRP Malignant IVB Stage IVB Hilar Cholangiocarcinoma Stage IVB Hilar Cholangiocarcinoma AJCC v8 Stage IVB Perihilar Cholangiocarcinoma AJCC v8 Stage IVB Hilar Cholangiocarcinoma AJCC v8 A term that refers to the staging of intrahepatic cholangiocarcinoma according to the American Joint Committee on Cancer, 8th edition. C134755 Neoplastic Process Intrahepatic Cholangiocarcinoma by AJCC v8 Stage CL522281 Malignant Intrahepatic Cholangiocarcinoma by AJCC v8 Stage Intrahepatic Cholangiocarcinoma by AJCC v8 Stage Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ (intraductal tumor). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134756 Neoplastic Process Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8 Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8 CL522282 CPTAC CTRP Malignant 0 Stage 0 Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8 Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8 Stage I includes: IA (T1a, N0, M0); IB (T1b, N0, M0). T1a: Solitary tumor equal or less than 5 cm without vascular invasion. T1b: Solitary tumor larger than 5 cm without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134757 Neoplastic Process Stage I Intrahepatic Cholangiocarcinoma AJCC v8 Stage I Intrahepatic Cholangiocarcinoma AJCC v8 CL522283 CPTAC CTRP Malignant I Stage I Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) Stage I Intrahepatic Cholangiocarcinoma AJCC v8 Stage I Intrahepatic Cholangiocarcinoma AJCC v8 Stage IA includes: T1a, N0, M0. T1a: Solitary tumor equal or less than 5 cm without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134758 Neoplastic Process Stage IA Intrahepatic Cholangiocarcinoma AJCC v8 Stage IA Intrahepatic Cholangiocarcinoma AJCC v8 CL522284 CPTAC CTRP Malignant IA Stage IA Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) Stage IA Intrahepatic Cholangiocarcinoma AJCC v8 Stage IA Intrahepatic Cholangiocarcinoma AJCC v8 Stage IB includes: T1b, N0, M0. T1b: Solitary tumor larger than 5 cm without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134759 Neoplastic Process Stage IB Intrahepatic Cholangiocarcinoma AJCC v8 Stage IB Intrahepatic Cholangiocarcinoma AJCC v8 CL522285 CPTAC CTRP Malignant IB Stage IB Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) Stage IB Intrahepatic Cholangiocarcinoma AJCC v8 Stage IB Intrahepatic Cholangiocarcinoma AJCC v8 Stage II includes: T2, N0, M0. T2: Solitary tumor with intrahepatic vascular invasion, or multiple tumors, with or without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134760 Neoplastic Process Stage II Intrahepatic Cholangiocarcinoma AJCC v8 Stage II Intrahepatic Cholangiocarcinoma AJCC v8 CL522286 CPTAC CTRP Malignant II Stage II Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) Stage II Intrahepatic Cholangiocarcinoma AJCC v8 Stage II Intrahepatic Cholangiocarcinoma AJCC v8 Stage III includes: IIIA: (T3, N0, M0); IIIB: (T4, N0, M0); (Any T, N1, M0). T3: Tumor perforating the visceral peritoneum. T4: Tumor involving local extrahepatic structures by direct invasion. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134761 Neoplastic Process Stage III Intrahepatic Cholangiocarcinoma AJCC v8 Stage III Intrahepatic Cholangiocarcinoma AJCC v8 CL522287 CPTAC CTRP Malignant III Stage III Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) Stage III Intrahepatic Cholangiocarcinoma AJCC v8 Stage III Intrahepatic Cholangiocarcinoma AJCC v8 Stage IIIA includes: T3, N0, M0. T3: Tumor perforating the visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134762 Neoplastic Process Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 CL522288 CPTAC CTRP Malignant IIIA Stage IIIA Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 Stage IIIB includes: (T4, N0, M0); (Any T, N1, M0). T4: Tumor involving local extrahepatic structures by direct invasion. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134763 Neoplastic Process Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 CL522289 CPTAC CTRP Malignant IIIB Stage IIIB Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C134764 Neoplastic Process Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 CL522290 CPTAC CTRP Malignant IV Stage IV Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 A term that refers to the staging of distal bile duct cancer according to the American Joint Committee on Cancer, 7th edition. C134810 Neoplastic Process Distal Bile Duct Cancer by AJCC v7 Stage CL522331 Malignant Distal Bile Duct Cancer by AJCC v7 Stage Distal Bile Duct Carcinoma by AJCC v7 Stage Distal Bile Duct Cancer by AJCC v7 Stage A term that refers to the staging of distal bile duct cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to bile duct adenocarcinomas, biliary intraepithelial neoplasia, high-grade neuroendocrine carcinomas, and papillary carcinomas that arise from the distal bile duct. Tumors arising in the ampulla of Vater, sarcomas, and well-differentiated neuroendocrine tumors (carcinoids) are not staged using this staging system. (from AJCC 8th Ed.) C134811 Neoplastic Process Distal Bile Duct Cancer by AJCC v8 Stage CL522332 CPTAC Malignant Distal Bile Duct Cancer Tumor Stage (Pathologic) Distal Bile Duct Cancer by AJCC v8 Stage Distal Bile Duct Carcinoma by AJCC v8 Stage Distal Bile Duct Cancer by AJCC v8 Stage Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ/high-grade dysplasia. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134812 Neoplastic Process Stage 0 Distal Bile Duct Cancer AJCC v8 Stage 0 Distal Bile Duct Cancer AJCC v8 CL522333 CPTAC CTRP Malignant 0 Stage 0 Distal Bile Duct Cancer AJCC v8 Stage 0 Distal Bile Duct Carcinoma AJCC v8 Stage 0 Extrahepatic (Distal) Bile Duct Cancer Stage 0 Distal Bile Duct Cancer AJCC v8 Stage I includes: T1, N0, M0. T1: Tumor invading the bile duct wall with a depth less than 5 mm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134813 Neoplastic Process Stage I Distal Bile Duct Cancer AJCC v8 Stage I Distal Bile Duct Cancer AJCC v8 CL522334 CPTAC CTRP Malignant I Stage I Distal Bile Duct Cancer AJCC v8 Stage I Distal Bile Duct Carcinoma AJCC v8 Stage I Extrahepatic (Distal) Bile Duct Cancer Stage I Distal Bile Duct Cancer AJCC v8 Stage II includes: IIA: (T1, N1, M0); (T2, N0, M0); IIB: (T2, N1, M0); (T3, N0, M0); (T3, N1, M0). T1: Tumor invading the bile duct wall with a depth less than 5 mm. T2: Tumor invading the bile duct wall with a depth of 5-12 mm. T3: Tumor invading the bile duct wall with a depth greater than 12 mm. N0: No regional lymph node metastasis. N1: Metastasis in one to three regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C134814 Neoplastic Process Stage II Distal Bile Duct Cancer AJCC v8 Stage II Distal Bile Duct Cancer AJCC v8 CL522335 CPTAC CTRP Malignant II Stage II Distal Bile Duct Cancer AJCC v8 Stage II Distal Bile Duct Carcinoma AJCC v8 Stage II Extrahepatic (Distal) Bile Duct Cancer Stage II Distal Bile Duct Cancer AJCC v8 Stage IIA includes: (T1, N1, M0); (T2, N0, M0). T1: Tumor invading the bile duct wall with a depth less than 5 mm. T2: Tumor invading the bile duct wall with a depth of 5-12 mm. N0: No regional lymph node metastasis. N1: Metastasis in one to three regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C134815 Neoplastic Process Stage IIA Distal Bile Duct Cancer AJCC v8 Stage IIA Distal Bile Duct Cancer AJCC v8 CL522336 CPTAC CTRP Malignant IIA Stage IIA Distal Bile Duct Cancer AJCC v8 Stage IIA Distal Bile Duct Carcinoma AJCC v8 Stage IIA Extrahepatic (Distal) Bile Duct Cancer Stage IIA Distal Bile Duct Cancer AJCC v8 Stage IIB includes: (T2, N1, M0); (T3, N0, M0); (T3, N1, M0). T2: Tumor invading the bile duct wall with a depth of 5-12 mm. T3: Tumor invading the bile duct wall with a depth greater than 12 mm. N0: No regional lymph node metastasis. N1: Metastasis in one to three regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C134816 Neoplastic Process Stage IIB Distal Bile Duct Cancer AJCC v8 Stage IIB Distal Bile Duct Cancer AJCC v8 CL522337 CPTAC CTRP Malignant IIB Stage IIB Distal Bile Duct Cancer AJCC v8 Stage IIB Distal Bile Duct Carcinoma AJCC v8 Stage IIB Extrahepatic (Distal) Bile Duct Cancer Stage IIB Distal Bile Duct Cancer AJCC v8 Stage III includes: IIIA: (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); IIIB: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0). T1: Tumor invading the bile duct wall with a depth less than 5 mm. T2: Tumor invading the bile duct wall with a depth of 5-12 mm. T3: Tumor invading the bile duct wall with a depth greater than 12 mm. T4: Tumor involving the celiac axis, superior mesenteric artery, and/or common hepatic artery. N0: No regional lymph node metastasis. N1: Metastasis in one to three regional lymph nodes. N2: Metastasis in four or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C134817 Neoplastic Process Stage III Distal Bile Duct Cancer AJCC v8 Stage III Distal Bile Duct Cancer AJCC v8 CL522338 CPTAC CTRP Malignant III Stage III Distal Bile Duct Cancer AJCC v8 Stage III Distal Bile Duct Carcinoma AJCC v8 Stage III Extrahepatic (Distal) Bile Duct Cancer Stage III Distal Bile Duct Cancer AJCC v8 Stage IIIA includes: (T1, N2, M0); (T2, N2, M0); (T3, N2, M0). T1: Tumor invading the bile duct wall with a depth less than 5 mm. T2: Tumor invading the bile duct wall with a depth of 5-12 mm. T3: Tumor invading the bile duct wall with a depth greater than 12 mm. N2: Metastasis in four or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C134818 Neoplastic Process Stage IIIA Distal Bile Duct Cancer AJCC v8 Stage IIIA Distal Bile Duct Cancer AJCC v8 CL522339 CPTAC CTRP Malignant IIIA Stage IIIA Distal Bile Duct Cancer AJCC v8 Stage IIIA Distal Bile Duct Carcinoma AJCC v8 Stage IIIA Extrahepatic (Distal) Bile Duct Cancer Stage IIIA Distal Bile Duct Cancer AJCC v8 Stage IIIB includes: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0). T4: Tumor involving the celiac axis, superior mesenteric artery, and/or common hepatic artery. N0: No regional lymph node metastasis. N1: Metastasis in one to three regional lymph nodes. N2: Metastasis in four or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C134819 Neoplastic Process Stage IIIB Distal Bile Duct Cancer AJCC v8 Stage IIIB Distal Bile Duct Cancer AJCC v8 CL522340 CPTAC CTRP Malignant IIIB Stage IIIB Distal Bile Duct Cancer AJCC v8 Stage IIIB Distal Bile Duct Carcinoma AJCC v8 Stage IIIB Extrahepatic (Distal) Bile Duct Cancer Stage IIIB Distal Bile Duct Cancer AJCC v8 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C134820 Neoplastic Process Stage IV Distal Bile Duct Cancer AJCC v8 Stage IV Distal Bile Duct Cancer AJCC v8 CL522341 CPTAC CTRP Malignant IV Stage IV Distal Bile Duct Cancer AJCC v8 Stage IV Distal Bile Duct Carcinoma AJCC v8 Stage IV Extrahepatic (Distal) Bile Duct Cancer Stage IV Distal Bile Duct Cancer AJCC v8 A sebaceous gland carcinoma affecting the eyelid. It arises from the meibomian glands, glands of Zeis, or glands associated with the caruncle. It usually affects elderly women and is characterized by high rate of local recurrence, regional, and distant metastases. C134831 Neoplastic Process Eyelid Sebaceous Gland Carcinoma CL522348 Malignant Eyelid SGC Eyelid Sebaceous Gland Carcinoma Sebaceous Gland Carcinoma of the Eyelid Eyelid Sebaceous Gland Carcinoma The reemergence of B-acute lymphoblastic leukemia, BCR-ABL1-like after a period of remission. C134834 Neoplastic Process Recurrent Ph-Like Acute Lymphoblastic Leukemia Recurrent B Acute Lymphoblastic Leukemia, BCR-ABL1-Like CL522350 CTRP Malignant Recurrent B Acute Lymphoblastic Leukemia with BCR-ABL1-Like Features Recurrent B Acute Lymphoblastic Leukemia with BCR::ABL1-Like Features Recurrent B Acute Lymphoblastic Leukemia, BCR-ABL1-Like Recurrent B Acute Lymphoblastic Leukemia, BCR::ABL1-Like Recurrent B-Acute Lymphoblastic Leukemia, BCR-ABL1-Like Recurrent B-Acute Lymphoblastic Leukemia, BCR::ABL1-Like Recurrent Ph-Like Acute Lymphoblastic Leukemia Recurrent B Acute Lymphoblastic Leukemia, BCR-ABL1-Like B-acute lymphoblastic leukemia, BCR-ABL1-like that does not respond to treatment. C134835 Neoplastic Process Refractory Ph-Like Acute Lymphoblastic Leukemia Refractory B Acute Lymphoblastic Leukemia, BCR-ABL1-Like CL522351 CTRP Malignant Refractory B Acute Lymphoblastic Leukemia with BCR-ABL1-Like Features Refractory B Acute Lymphoblastic Leukemia, BCR-ABL1-Like Refractory B Acute Lymphoblastic Leukemia, BCR::ABL1-Like Refractory B-Acute Lymphoblastic Leukemia with BCR::ABL1-Like Features Refractory B-Acute Lymphoblastic Leukemia, BCR::ABL1-Like Refractory Ph-Like Acute Lymphoblastic Leukemia Refractory B Acute Lymphoblastic Leukemia, BCR-ABL1-Like A term that refers to the staging of ampulla of Vater cancer according to the American Joint Committee on Cancer, 7th edition. C134863 Neoplastic Process Ampulla of Vater Cancer by AJCC v7 Stage CL522379 Malignant Ampulla of Vater Cancer by AJCC v7 Stage Ampulla of Vater Carcinoma by AJCC v7 Stage Ampulla of Vater Cancer by AJCC v7 Stage A term that refers to the staging of ampulla of Vater cancer according to the American Joint Committee on Cancer, 8th edition. This staging system does not apply to well-differentiated neuroendocrine (carcinoid) tumors but does apply to high-grade neuroendocrine carcinomas, such as small cell carcinoma and large cell neuroendocrine carcinoma. (from AJCC 8th Ed.) C134864 Neoplastic Process Ampulla of Vater Cancer by AJCC v8 Stage CL522380 Malignant Ampulla of Vater Cancer by AJCC v8 Stage Ampulla of Vater Carcinoma by AJCC v8 Stage Ampulla of Vater Cancer by AJCC v8 Stage Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134865 Neoplastic Process Stage 0 Ampulla of Vater Cancer AJCC v8 Stage 0 Ampulla of Vater Cancer AJCC v8 CL522381 CTRP Malignant Stage 0 Ampulla of Vater Cancer Stage 0 Ampulla of Vater Cancer AJCC v8 Stage 0 Ampulla of Vater Carcinoma AJCC v8 Stage 0 Ampulla of Vater Cancer AJCC v8 Stage I includes: IA: (T1a, N0, M0); IB: (T1b, N0, M0); (T2, N0, M0). T1a: Tumor limited to ampulla of Vater or sphincter of Oddi. T1b: Tumor invading beyond the sphincter of Oddi (perisphincteric invasion) and/or into the duodenal submucosa. T2: Tumor invading into the muscularis propria of the duodenum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134866 Neoplastic Process Stage I Ampulla of Vater Cancer AJCC v8 Stage I Ampulla of Vater Cancer AJCC v8 CL522382 CTRP Malignant Stage I Ampulla of Vater Cancer Stage I Ampulla of Vater Cancer AJCC v8 Stage I Ampulla of Vater Carcinoma AJCC v8 Stage I Ampulla of Vater Cancer AJCC v8 Stage IA includes: T1a, N0, M0. T1a: Tumor limited to ampulla of Vater or sphincter of Oddi. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134867 Neoplastic Process Stage IA Ampulla of Vater Cancer AJCC v8 Stage IA Ampulla of Vater Cancer AJCC v8 CL522383 CTRP Malignant Stage IA Ampulla of Vater Cancer Stage IA Ampulla of Vater Cancer AJCC v8 Stage IA Ampulla of Vater Carcinoma AJCC v8 Stage IA Ampulla of Vater Cancer AJCC v8 Stage IB includes: (T1b, N0, M0); (T2, N0, M0). T1b: Tumor invading beyond the sphincter of Oddi (perisphincteric invasion) and/or into the duodenal submucosa. T2: Tumor invading into the muscularis propria of the duodenum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134868 Neoplastic Process Stage IB Ampulla of Vater Cancer AJCC v8 Stage IB Ampulla of Vater Cancer AJCC v8 CL522384 CTRP Malignant Stage IB Ampulla of Vater Cancer Stage IB Ampulla of Vater Cancer AJCC v8 Stage IB Ampulla of Vater Carcinoma AJCC v8 Stage IB Ampulla of Vater Cancer AJCC v8 Stage II includes: IIA: T3a, N0, M0; IIB: T3b, N0, M0. T3a: Tumor directly invading the pancreas (up to 0.5 cm). T3b: Tumor extending more than 0.5 cm into the pancreas, or extending into peripancreatic tissue or duodenal serosa without involvement of the celiac axis or superior mesenteric artery. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134869 Neoplastic Process Stage II Ampulla of Vater Cancer AJCC v8 Stage II Ampulla of Vater Cancer AJCC v8 CL522385 CTRP Malignant Stage II Ampulla of Vater Cancer Stage II Ampulla of Vater Cancer AJCC v8 Stage II Ampulla of Vater Carcinoma AJCC v8 Stage II Ampulla of Vater Cancer AJCC v8 Stage IIA includes: T3a, N0, M0. T3a: Tumor directly invading the pancreas (up to 0.5 cm). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134870 Neoplastic Process Stage IIA Ampulla of Vater Cancer AJCC v8 Stage IIA Ampulla of Vater Cancer AJCC v8 CL522386 CTRP Malignant Stage IIA Ampulla of Vater Cancer Stage IIA Ampulla of Vater Cancer AJCC v8 Stage IIA Ampulla of Vater Carcinoma AJCC v8 Stage IIA Ampulla of Vater Cancer AJCC v8 Stage IIB includes: T3b, N0, M0. T3b: Tumor extending more than 0.5 cm into the pancreas, or extending into peripancreatic tissue or duodenal serosa without involvement of the celiac axis or superior mesenteric artery. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134871 Neoplastic Process Stage IIB Ampulla of Vater Cancer AJCC v8 Stage IIB Ampulla of Vater Cancer AJCC v8 CL522387 CTRP Malignant Stage IIB Ampulla of Vater Cancer Stage IIB Ampulla of Vater Cancer AJCC v8 Stage IIB Ampulla of Vater Carcinoma AJCC v8 Stage IIB Ampulla of Vater Cancer AJCC v8 Stage III includes: IIIA: (T1a, N1, M0); (T1b, N1, M0); (T2, N1, M0); (T3a, N1, M0); (T3b, N1, M0); IIIB: (T4, Any N, M0); (Any T, N2, M0). T1a: Tumor limited to ampulla of Vater or sphincter of Oddi. T1b: Tumor invading beyond the sphincter of Oddi (perisphincteric invasion) and/or into the duodenal submucosa. T2: Tumor invading into the muscularis propria of the duodenum. T3a: Tumor directly invading the pancreas (up to 0.5 cm). T3b: Tumor extending more than 0.5 cm into the pancreas, or extending into peripancreatic tissue or duodenal serosa without involvement of the celiac axis or superior mesenteric artery. T4: Tumor involving the celiac axis, superior mesenteric artery, and/or common hepatic artery, irrespective of size. N1: Metastasis to one to three regional lymph nodes. N2: Metastasis to four or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C134872 Neoplastic Process Stage III Ampulla of Vater Cancer AJCC v8 Stage III Ampulla of Vater Cancer AJCC v8 CL522388 CTRP Malignant Stage III Ampulla of Vater Cancer Stage III Ampulla of Vater Cancer AJCC v8 Stage III Ampulla of Vater Carcinoma AJCC v8 Stage III Ampulla of Vater Cancer AJCC v8 Stage IIIA includes: (T1a, N1, M0); (T1b, N1, M0); (T2, N1, M0); (T3a, N1, M0); (T3b, N1, M0). T1a: Tumor limited to ampulla of Vater or sphincter of Oddi. T1b: Tumor invading beyond the sphincter of Oddi (perisphincteric invasion) and/or into the duodenal submucosa. T2: Tumor invading into the muscularis propria of the duodenum. T3a: Tumor directly invading the pancreas (up to 0.5 cm). T3b: Tumor extending more than 0.5 cm into the pancreas, or extending into peripancreatic tissue or duodenal serosa without involvement of the celiac axis or superior mesenteric artery. N1: Metastasis to one to three regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C134873 Neoplastic Process Stage IIIA Ampulla of Vater Cancer AJCC v8 Stage IIIA Ampulla of Vater Cancer AJCC v8 CL522389 CTRP Malignant Stage IIIA Ampulla of Vater Cancer Stage IIIA Ampulla of Vater Cancer AJCC v8 Stage IIIA Ampulla of Vater Carcinoma AJCC v8 Stage IIIA Ampulla of Vater Cancer AJCC v8 Stage IIIB includes: (T4, Any N, M0); (Any T, N2, M0). T4: Tumor involving the celiac axis, superior mesenteric artery, and/or common hepatic artery, irrespective of size. N2: Metastasis to four or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C134874 Neoplastic Process Stage IIIB Ampulla of Vater Cancer AJCC v8 Stage IIIB Ampulla of Vater Cancer AJCC v8 CL522390 CTRP Malignant Stage IIIB Ampulla of Vater Cancer Stage IIIB Ampulla of Vater Cancer AJCC v8 Stage IIIB Ampulla of Vater Carcinoma AJCC v8 Stage IIIB Ampulla of Vater Cancer AJCC v8 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C134875 Neoplastic Process Stage IV Ampulla of Vater Cancer AJCC v8 Stage IV Ampulla of Vater Cancer AJCC v8 CL522391 CTRP Malignant Stage IV Ampulla of Vater Cancer Stage IV Ampulla of Vater Cancer AJCC v8 Stage IV Ampulla of Vater Carcinoma AJCC v8 Stage IV Ampulla of Vater Cancer AJCC v8 A term that refers to the staging of exocrine and endocrine pancreatic cancer including well-differentiated neuroendocrine tumors according to the American Joint Committee on Cancer, 6th and 7th editions. C134902 Neoplastic Process Pancreatic Cancer by AJCC v6 and v7 Stage CL522418 Malignant Exocrine and Endocrine Pancreatic Cancer by AJCC v6 and v7 Stage Exocrine and Endocrine Pancreatic Carcinoma by AJCC v6 and v7 Stage Pancreatic Cancer by AJCC v6 and v7 Stage Pancreatic Carcinoma by AJCC v6 and v7 Stage Pancreatic Cancer by AJCC v6 and v7 Stage A term that refers to the staging of exocrine pancreatic cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to pancreatic ductal adenocarcinoma, acinar cell carcinoma, intraductal papillary mucinous neoplasm with associated invasive carcinoma, intraductal tubulopapillary neoplasm with associated invasive carcinoma, colloid carcinoma, mucinous cystic neoplasm with associated invasive carcinoma, solid pseudopapillary neoplasm, large cell neuroendocrine carcinoma, small cell neuroendocrine carcinoma, and pancreatoblastoma. Well-differentiated neuroendocrine tumors are not staged using this staging system. (from AJCC 8th Ed.) C134909 Neoplastic Process Pancreatic Cancer by AJCC v8 Stage CL522425 CPTAC Malignant Exocrine Pancreatic Cancer by AJCC v8 Stage Exocrine Pancreatic Carcinoma by AJCC v8 Stage Pancreatic Cancer by AJCC v8 Stage Tumor Stage (Pathological) Pancreatic Cancer by AJCC v8 Stage Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. This includes high-grade pancreatic intraepithelial neoplasia (PanIn-3), intraductal papillary mucinous neoplasm with high-grade dysplasia, intraductal tubulopapillary neoplasm with high-grade dysplasia, and mucinous cystic neoplasm with high-grade dysplasia. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134914 Neoplastic Process Stage 0 Pancreatic Cancer AJCC v8 Stage 0 Pancreatic Cancer AJCC v8 CL522429 CTRP Malignant Stage 0 Exocrine Pancreatic Cancer AJCC v8 Stage 0 Exocrine Pancreatic Carcinoma AJCC v8 Stage 0 Pancreatic Cancer Stage 0 Pancreatic Cancer AJCC v8 Stage 0 Pancreatic Cancer AJCC v8 Stage I includes: IA: (T1, N0, M0); IB: (T2, N0, M0). T1: Tumor measuring 2 cm or less in greatest dimension. T2: Tumor measuring more than 2 cm and 4 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134915 Neoplastic Process Stage I Pancreatic Cancer AJCC v8 Stage I Pancreatic Cancer AJCC v8 CL522430 CTRP Malignant Stage I Exocrine Pancreatic Cancer AJCC v8 Stage I Exocrine Pancreatic Carcinoma AJCC v8 Stage I Pancreatic Cancer Stage I Pancreatic Cancer AJCC v8 Stage I Pancreatic Cancer AJCC v8 Stage IA includes: T1, N0, M0. T1: Tumor measuring 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134917 Neoplastic Process Stage IA Pancreatic Cancer AJCC v8 Stage IA Pancreatic Cancer AJCC v8 CL522432 CPTAC CTRP Malignant Stage IA Stage IA Exocrine Pancreatic Cancer AJCC v8 Stage IA Exocrine Pancreatic Carcinoma AJCC v8 Stage IA Pancreatic Cancer Stage IA Pancreatic Cancer AJCC v8 Stage IA Pancreatic Cancer AJCC v8 Stage IB includes: T2, N0, M0. T2: Tumor measuring more than 2 cm and 4 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134920 Neoplastic Process Stage IB Pancreatic Cancer AJCC v8 Stage IB Pancreatic Cancer AJCC v8 CL522435 CPTAC CTRP Malignant Stage IB Stage IB Exocrine Pancreatic Cancer AJCC v8 Stage IB Exocrine Pancreatic Carcinoma AJCC v8 Stage IB Pancreatic Cancer Stage IB Pancreatic Cancer AJCC v8 Stage IB Pancreatic Cancer AJCC v8 Stage II includes: IIA: (T3, N0, M0); IIB: (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T1: Tumor measuring 2 cm or less in greatest dimension. T2: Tumor measuring more than 2 cm and 4 cm or less in greatest dimension. T3: Tumor measuring more than 4 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Metastasis in one to three regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C134921 Neoplastic Process Stage II Pancreatic Cancer AJCC v8 Stage II Pancreatic Cancer AJCC v8 CL522436 CTRP Malignant Stage II Exocrine Pancreatic Cancer AJCC v8 Stage II Exocrine Pancreatic Carcinoma AJCC v8 Stage II Pancreatic Cancer Stage II Pancreatic Cancer AJCC v8 Stage II Pancreatic Cancer AJCC v8 Stage IIA includes: T3, N0, M0. T3: Tumor measuring more than 4 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C134925 Neoplastic Process Stage IIA Pancreatic Cancer AJCC v8 Stage IIA Pancreatic Cancer AJCC v8 CL522440 CPTAC CTRP Malignant Stage IIA Stage IIA Exocrine Pancreatic Cancer AJCC v8 Stage IIA Exocrine Pancreatic Carcinoma AJCC v8 Stage IIA Pancreatic Cancer Stage IIA Pancreatic Cancer AJCC v8 Stage IIA Pancreatic Cancer AJCC v8 Stage IIB includes: (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T1: Tumor measuring 2 cm or less in greatest dimension. T2: Tumor measuring more than 2 cm and 4 cm or less in greatest dimension. T3: Tumor measuring more than 4 cm in greatest dimension. N1: Metastasis in one to three regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C134927 Neoplastic Process Stage IIB Pancreatic Cancer AJCC v8 Stage IIB Pancreatic Cancer AJCC v8 CL522442 CPTAC CTRP Malignant Stage IIB Stage IIB Exocrine Pancreatic Cancer AJCC v8 Stage IIB Exocrine Pancreatic Carcinoma AJCC v8 Stage IIB Pancreatic Cancer Stage IIB Pancreatic Cancer AJCC v8 Stage IIB Pancreatic Cancer AJCC v8 Stage III includes: (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4, Any N, M0). T1: Tumor measuring 2 cm or less in greatest dimension. T2: Tumor measuring more than 2 cm and 4 cm or less in greatest dimension. T3: Tumor measuring more than 4 cm in greatest dimension. T4: Tumor involving the celiac axis, superior mesenteric artery, and/or common hepatic artery, regardless of size. N2: Metastasis in four or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C134928 Neoplastic Process Stage III Pancreatic Cancer AJCC v8 Stage III Pancreatic Cancer AJCC v8 CL522443 CPTAC CTRP Malignant Stage III Stage III Exocrine Pancreatic Cancer AJCC v8 Stage III Exocrine Pancreatic Carcinoma AJCC v8 Stage III Pancreatic Cancer Stage III Pancreatic Cancer AJCC v8 Stage III Pancreatic Cancer AJCC v8 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C134930 Neoplastic Process Stage IV Pancreatic Cancer AJCC v8 Stage IV Pancreatic Cancer AJCC v8 CL522445 CPTAC CTRP Malignant Stage IV Stage IV Exocrine Pancreatic Cancer AJCC v8 Stage IV Exocrine Pancreatic Carcinoma AJCC v8 Stage IV Pancreatic Cancer Stage IV Pancreatic Cancer AJCC v8 Stage IV Pancreatic Cancer AJCC v8 A non-small cell lung carcinoma without evidence of squamous differentiation. C135017 Neoplastic Process Non-Squamous Non-Small Cell Lung Carcinoma Lung Non-Squamous Non-Small Cell Carcinoma CL522614 CTRP Malignant Lung Non-Squamous Non-Small Cell Carcinoma Non-Squamous Non-Small Cell Lung Cancer Non-Squamous Non-Small Cell Lung Carcinoma Non-squamous Lung Non-Squamous Non-Small Cell Carcinoma A term that refers to the staging of a gastric neuroendocrine tumor according to the American Joint Committee on Cancer, 8th edition. This staging system applies to gastric "carcinoid" tumors (NET G1 and G2, and rare well-differentiated G3). Gastric high-grade neuroendocrine carcinoma and gastric mixed adenoneuroendocrine carcinoma are not included in this staging system. (from AJCC 8th Ed.) C135045 Neoplastic Process Gastric Neuroendocrine Tumor by AJCC v8 Stage CL522525 Malignant Gastric Neuroendocrine Tumor by AJCC v8 Stage Gastric Neuroendocrine Tumor by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Tumor invading the lamina propria or submucosa and is less than or equal to 1 cm in size. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135046 Neoplastic Process Stage I Gastric Neuroendocrine Tumor AJCC v8 Stage I Gastric Neuroendocrine Tumor AJCC v8 CL522641 CTRP Malignant Stage I Gastric Neuroendocrine Tumor Stage I Gastric Neuroendocrine Tumor AJCC v8 Stage I Gastric Neuroendocrine Tumor AJCC v8 Stage II includes: (T2, N0, M0); (T3, N0, M0). T2: Tumor invading the muscularis propria or is greater than 1 cm in size. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135047 Neoplastic Process Stage II Gastric Neuroendocrine Tumor AJCC v8 Stage II Gastric Neuroendocrine Tumor AJCC v8 CL522642 CTRP Malignant Stage II Gastric Neuroendocrine Tumor Stage II Gastric Neuroendocrine Tumor AJCC v8 Stage II Gastric Neuroendocrine Tumor AJCC v8 Stage III includes: (T1, N1, M0); (T2, N1, M0); (T3, N1, M0); (T4, N0, M0); (T4, N1, M0). T1: Tumor invading the lamina propria or submucosa and is less than or equal to 1 cm in size. T2: Tumor invading the muscularis propria or is greater than 1 cm in size. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. T4: Tumor invading visceral peritoneum (serosa) or other organs or adjacent structures. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135048 Neoplastic Process Stage III Gastric Neuroendocrine Tumor AJCC v8 Stage III Gastric Neuroendocrine Tumor AJCC v8 CL522643 CTRP Malignant Stage III Gastric Neuroendocrine Tumor Stage III Gastric Neuroendocrine Tumor AJCC v8 Stage III Gastric Neuroendocrine Tumor AJCC v8 Stage IV includes: (T1, N0, N1, M1); (T2, N0, N1, M1); (T3, N0, N1, M1); (T4, N0, N1, M1). T1: Tumor invading the lamina propria or submucosa and is less than or equal to 1 cm in size. T2: Tumor invading the muscularis propria or is greater than 1 cm in size. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. T4: Tumor invading visceral peritoneum (serosa) or other organs or adjacent structures. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M1: Distant metastasis. (AJCC 8th ed.) C135049 Neoplastic Process Stage IV Gastric Neuroendocrine Tumor AJCC v8 Stage IV Gastric Neuroendocrine Tumor AJCC v8 CL522644 CTRP Malignant Stage IV Gastric Neuroendocrine Tumor Stage IV Gastric Neuroendocrine Tumor AJCC v8 Stage IV Gastric Neuroendocrine Tumor AJCC v8 A term that refers to the staging of a duodenal neuroendocrine tumor according to the American Joint Committee on Cancer, 8th edition. This staging system applies to well-differentiated neuroendocrine tumors of the duodenum. Carcinomas of the duodenum, including high-grade (grade 3), poorly differentiated neuroendocrine carcinomas are not included in this staging system. (from AJCC 8th Ed.) C135075 Neoplastic Process Duodenal Neuroendocrine Tumor by AJCC v8 Stage CL522527 Malignant Duodenal Neuroendocrine Tumor by AJCC v8 Stage Duodenal Neuroendocrine Tumor by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Tumor invading the mucosa or submucosa only and is equal or less than 1 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135076 Neoplastic Process Stage I Duodenal Neuroendocrine Tumor AJCC v8 Stage I Duodenal Neuroendocrine Tumor AJCC v8 CL522669 CTRP Malignant Stage I Duodenal Neuroendocrine Tumor Stage I Duodenal Neuroendocrine Tumor AJCC v8 Stage I Duodenal Neuroendocrine Tumor AJCC v8 Stage II includes: (T2, N0, M0); (T3, N0, M0). T2: Tumor invading the muscularis propria or measuring more than 1 cm. T3: Tumor invading the pancreas or peripancreatic adipose tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135077 Neoplastic Process Stage II Duodenal Neuroendocrine Tumor AJCC v8 Stage II Duodenal Neuroendocrine Tumor AJCC v8 CL522670 CTRP Malignant Stage II Duodenal Neuroendocrine Tumor Stage II Duodenal Neuroendocrine Tumor AJCC v8 Stage II Duodenal Neuroendocrine Tumor AJCC v8 Stage III includes: (T4, N0, M0); (Any T, N1, M0). T4: Tumor invading the visceral peritoneum (serosa) or other organs. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135078 Neoplastic Process Stage III Duodenal Neuroendocrine Tumor AJCC v8 Stage III Duodenal Neuroendocrine Tumor AJCC v8 CL522671 CTRP Malignant Stage III Duodenal Neuroendocrine Tumor Stage III Duodenal Neuroendocrine Tumor AJCC v8 Stage III Duodenal Neuroendocrine Tumor AJCC v8 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C135079 Neoplastic Process Stage IV Duodenal Neuroendocrine Tumor AJCC v8 Stage IV Duodenal Neuroendocrine Tumor AJCC v8 CL522672 CTRP Malignant Stage IV Duodenal Neuroendocrine Tumor Stage IV Duodenal Neuroendocrine Tumor AJCC v8 Stage IV Duodenal Neuroendocrine Tumor AJCC v8 A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the duodenum. C135080 Neoplastic Process Duodenal Neuroendocrine Tumor CL522673 Cellosaurus Undetermined Duodenal Neuroendocrine Tumor Duodenal Well Differentiated Neuroendocrine Neoplasm Duodenal Well-Differentiated Neuroendocrine Neoplasm Duodenal Neuroendocrine Tumor A term that refers to the staging of an ampulla of Vater neuroendocrine tumor according to the American Joint Committee on Cancer, 8th edition. This staging system applies to well-differentiated neuroendocrine tumors of the ampulla of Vater. Carcinomas of the ampulla of Vater, including high-grade (grade 3), poorly differentiated neuroendocrine carcinomas are not included in this staging system. (from AJCC 8th Ed.) C135081 Neoplastic Process Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage CL522674 Malignant Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Tumor measuring 1 cm or less and is confined within the sphincter of Oddi. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135082 Neoplastic Process Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8 Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8 CL522675 CTRP Malignant Stage I Ampulla of Vater Neuroendocrine Tumor Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8 Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8 Stage II includes: (T2, N0, M0); (T3, N0, M0). T2: Tumor invading through the sphincter of Oddi into duodenal submucosa or muscularis propria, or measuring more than 1 cm. T3: Tumor invading the pancreas or peripancreatic adipose tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135083 Neoplastic Process Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8 Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8 CL522676 CTRP Malignant Stage II Ampulla of Vater Neuroendocrine Tumor Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8 Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8 Stage III includes: (T4, N0, M0); (Any T, N1, M0). T4: Tumor invading the visceral peritoneum (serosa) or other organs. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135084 Neoplastic Process Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8 Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8 CL522677 CTRP Malignant Stage III Ampulla of Vater Neuroendocrine Tumor Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8 Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C135085 Neoplastic Process Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8 Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8 CL522678 CTRP Malignant Stage IV Ampulla of Vater Neuroendocrine Tumor Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8 Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8 A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the jejunum. C135090 Neoplastic Process Jejunal Neuroendocrine Tumor CL522679 Undetermined Jejunal Neuroendocrine Tumor Jejunal Well Differentiated Neuroendocrine Neoplasm Jejunal Well-Differentiated Neuroendocrine Neoplasm Jejunal Neuroendocrine Tumor A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the ileum. C135092 Neoplastic Process Ileal Neuroendocrine Tumor CL522680 Undetermined Ileal Neuroendocrine Tumor Ileal Well Differentiated Neuroendocrine Neoplasm Ileal Well-Differentiated Neuroendocrine Neoplasm Ileal Neuroendocrine Tumor A term that refers to the staging of a jejunal neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system. This classification system applies to small bowel "carcinoid" tumors (NET G1 and G2, and rare well-differentiated G3) arising in the jejunum. This classification system does not apply to high-grade neuroendocrine carcinomas, mixed adenoneuroendocrine carcinomas, and neuroendocrine tumors of the duodenum. (from AJCC 8th Ed.) C135119 Neoplastic Process Jejunal Neuroendocrine Tumor by AJCC v8 Stage CL522530 Malignant Jejunal Neuroendocrine Tumor by AJCC v8 Stage Jejunal Neuroendocrine Tumor by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Tumor invading lamina propria or submucosa and measuring 1 cm or less in size. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135120 Neoplastic Process Stage I Jejunal Neuroendocrine Tumor AJCC v8 Stage I Jejunal Neuroendocrine Tumor AJCC v8 CL522707 CTRP Malignant Stage I Jejunal Neuroendocrine Tumor Stage I Jejunal Neuroendocrine Tumor AJCC v8 Stage I Jejunal Neuroendocrine Tumor AJCC v8 Stage II includes: (T2, N0, M0); (T3, N0, M0). T2: Tumor invading muscularis propria or measuring more than 1 cm in size. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135121 Neoplastic Process Stage II Jejunal Neuroendocrine Tumor AJCC v8 Stage II Jejunal Neuroendocrine Tumor AJCC v8 CL522708 CTRP Malignant Stage II Jejunal Neuroendocrine Tumor Stage II Jejunal Neuroendocrine Tumor AJCC v8 Stage II Jejunal Neuroendocrine Tumor AJCC v8 Stage III includes: (T1, N1, N2, M0); (T2, N1, N2, M0); (T3, N1, N2, M0); (T4, N0, M0); (T4, N1, N2, M0). T1: Tumor invading lamina propria or submucosa and measuring 1 cm or less in size. T2: Tumor invading muscularis propria or measuring more than 1 cm in size. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. T4: Tumor invading visceral peritoneum (serosa) or other organs or adjacent structures. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis in less than 12 nodes. N2: Large mesenteric masses (larger than 2 cm) and/or extensive nodal deposits (12 or greater), especially those that encase the superior mesenteric vessels. M0: No distant metastasis. (AJCC 8th ed.) C135122 Neoplastic Process Stage III Jejunal Neuroendocrine Tumor AJCC v8 Stage III Jejunal Neuroendocrine Tumor AJCC v8 CL522709 CTRP Malignant Stage III Jejunal Neuroendocrine Tumor Stage III Jejunal Neuroendocrine Tumor AJCC v8 Stage III Jejunal Neuroendocrine Tumor AJCC v8 Stage IV includes: (T1, N0, N1, N2, M1); (T2, N0, N1, N2, M1); (T3, N0, N1, N2, M1); (T4, N0, N1, N2, M1). T1: Tumor invading lamina propria or submucosa and measuring 1 cm or less in size. T2: Tumor invading muscularis propria or measuring more than 1 cm in size. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. T4: Tumor invading visceral peritoneum (serosa) or other organs or adjacent structures. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis in less than 12 nodes. N2: Large mesenteric masses (larger than 2 cm) and/or extensive nodal deposits (12 or greater), especially those that encase the superior mesenteric vessels. M1: Distant metastasis. (AJCC 8th ed.) C135123 Neoplastic Process Stage IV Jejunal Neuroendocrine Tumor AJCC v8 Stage IV Jejunal Neuroendocrine Tumor AJCC v8 CL522710 CTRP Malignant Stage IV Jejunal Neuroendocrine Tumor Stage IV Jejunal Neuroendocrine Tumor AJCC v8 Stage IV Jejunal Neuroendocrine Tumor AJCC v8 A term that refers to the staging of an ileal neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system. This classification system applies to small bowel "carcinoid" tumors (NET G1 and G2, and rare well-differentiated G3) arising in the ileum. This classification system does not apply to high-grade neuroendocrine carcinomas, mixed adenoneuroendocrine carcinomas, and neuroendocrine tumors of the duodenum. (from AJCC 8th Ed.) C135124 Neoplastic Process Ileal Neuroendocrine Tumor by AJCC v8 Stage CL522531 Malignant Ileal Neuroendocrine Tumor by AJCC v8 Stage Ileal Neuroendocrine Tumor by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Tumor invading lamina propria or submucosa and measuring 1 cm or less in size. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135125 Neoplastic Process Stage I Ileal Neuroendocrine Tumor AJCC v8 Stage I Ileal Neuroendocrine Tumor AJCC v8 CL522711 CTRP Malignant Stage I Ileal Neuroendocrine Tumor Stage I Ileal Neuroendocrine Tumor AJCC v8 Stage I Ileal Neuroendocrine Tumor AJCC v8 Stage II includes: (T2, N0, M0); (T3, N0, M0). T2: Tumor invading muscularis propria or measuring more than 1 cm in size. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135126 Neoplastic Process Stage II Ileal Neuroendocrine Tumor AJCC v8 Stage II Ileal Neuroendocrine Tumor AJCC v8 CL522712 CTRP Malignant Stage II Ileal Neuroendocrine Tumor Stage II Ileal Neuroendocrine Tumor AJCC v8 Stage II Ileal Neuroendocrine Tumor AJCC v8 Stage III includes: (T1, N1, N2, M0); (T2, N1, N2, M0); (T3, N1, N2, M0); (T4, N0, M0); (T4, N1, N2, M0). T1: Tumor invading lamina propria or submucosa and measuring 1 cm or less in size. T2: Tumor invading muscularis propria or measuring more than 1 cm in size. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. T4: Tumor invading visceral peritoneum (serosa) or other organs or adjacent structures. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis in less than 12 nodes. N2: Large mesenteric masses (larger than 2 cm) and/or extensive nodal deposits (12 or greater), especially those that encase the superior mesenteric vessels. M0: No distant metastasis. (AJCC 8th ed.) C135127 Neoplastic Process Stage III Ileal Neuroendocrine Tumor AJCC v8 Stage III Ileal Neuroendocrine Tumor AJCC v8 CL522713 CTRP Malignant Stage III Ileal Neuroendocrine Tumor Stage III Ileal Neuroendocrine Tumor AJCC v8 Stage III Ileal Neuroendocrine Tumor AJCC v8 Stage IV includes: (T1, N0, N1, N2, M1); (T2, N0, N1, N2, M1); (T3, N0, N1, N2, M1); (T4, N0, N1, N2, M1). T1: Tumor invading lamina propria or submucosa and measuring 1 cm or less in size. T2: Tumor invading muscularis propria or measuring more than 1 cm in size. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. T4: Tumor invading visceral peritoneum (serosa) or other organs or adjacent structures. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis in less than 12 nodes. N2: Large mesenteric masses (larger than 2 cm) and/or extensive nodal deposits (12 or greater), especially those that encase the superior mesenteric vessels. M1: Distant metastasis. (AJCC 8th ed.) C135128 Neoplastic Process Stage IV Ileal Neuroendocrine Tumor AJCC v8 Stage IV Ileal Neuroendocrine Tumor AJCC v8 CL522714 CTRP Malignant Stage IV Ileal Neuroendocrine Tumor Stage IV Ileal Neuroendocrine Tumor AJCC v8 Stage IV Ileal Neuroendocrine Tumor AJCC v8 A term that refers to the staging of a digestive system neuroendocrine tumor, following the rules of the TNM AJCC v7 classification system. C135129 Neoplastic Process Digestive System Neuroendocrine Tumor by AJCC v7 Stage CL522532 Malignant Digestive System Neuroendocrine Neoplasm by AJCC v7 Stage Digestive System Neuroendocrine Tumor by AJCC v7 Stage Digestive System Neuroendocrine Tumor by AJCC v7 Stage A term that refers to the staging of an appendiceal neuroendocrine tumor, following the rules of the TNM AJCC v7 classification system. C135155 Neoplastic Process Appendix Neuroendocrine Tumor by AJCC v7 Stage CL522533 Malignant Appendix Neuroendocrine Tumor by AJCC v7 Stage Appendix Neuroendocrine Tumor by AJCC v7 Stage A term that refers to the staging of an appendiceal neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system. This staging system applies to appendiceal NETs (carcinoid tumors) (NET G1 and G2, and rare well-differentiated G3). High-grade neuroendocrine carcinomas (NEC), goblet cell carcinoids, mixed adenocarcinomas, and adenocarcinomas of the appendix are not staged using this staging system. (from AJCC 8th Ed.) C135156 Neoplastic Process Appendix Neuroendocrine Tumor by AJCC v8 Stage CL522534 Malignant Appendix Neuroendocrine Tumor by AJCC v8 Stage Appendix Neuroendocrine Tumor by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Tumor measuring 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135157 Neoplastic Process Stage I Appendix Neuroendocrine Tumor AJCC v8 Stage I Appendix Neuroendocrine Tumor AJCC v8 CL522740 CTRP Malignant Stage I Appendix Neuroendocrine Tumor Stage I Appendix Neuroendocrine Tumor AJCC v8 Stage I Appendix Neuroendocrine Tumor AJCC v8 Stage II includes: (T2, N0, M0); (T3, N0, M0). T2: Tumor measuring more than 2 cm but less than or equal to 4 cm. T3: Tumor measuring more than 4 cm or with subserosal invasion or involvement of the mesoappendix. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135158 Neoplastic Process Stage II Appendix Neuroendocrine Tumor AJCC v8 Stage II Appendix Neuroendocrine Tumor AJCC v8 CL522741 CTRP Malignant Stage II Appendix Neuroendocrine Tumor Stage II Appendix Neuroendocrine Tumor AJCC v8 Stage II Appendix Neuroendocrine Tumor AJCC v8 Stage III includes: (T1, N1, M0); (T2, N1, M0); (T3, N1, M0); (T4, N0, M0); (T4, N1, M0). T1: Tumor measuring 2 cm or less in greatest dimension. T2: Tumor measuring more than 2 cm but less than or equal to 4 cm. T3: Tumor measuring more than 4 cm or with subserosal invasion or involvement of the mesoappendix. T4: Tumor perforating the peritoneum or directly invading other adjacent organs or structures (excluding direct mural extension to adjacent subserosa of adjacent bowel), e.g., abdominal wall and skeletal muscle. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135159 Neoplastic Process Stage III Appendix Neuroendocrine Tumor AJCC v8 Stage III Appendix Neuroendocrine Tumor AJCC v8 CL522742 CTRP Malignant Stage III Appendix Neuroendocrine Tumor Stage III Appendix Neuroendocrine Tumor AJCC v8 Stage III Appendix Neuroendocrine Tumor AJCC v8 Stage IV includes: (T1, N0, N1, M1); (T2, N0, N1, M1); (T3, N0, N1, M1); (T4, N0, N1, M1). T1: Tumor measuring 2 cm or less in greatest dimension. T2: Tumor measuring more than 2 cm but less than or equal to 4 cm. T3: Tumor measuring more than 4 cm or with subserosal invasion or involvement of the mesoappendix. T4: Tumor perforating the peritoneum or directly invading other adjacent organs or structures (excluding direct mural extension to adjacent subserosa of adjacent bowel), e.g., abdominal wall and skeletal muscle. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M1: Distant metastasis. (AJCC 8th ed.) C135160 Neoplastic Process Stage IV Appendix Neuroendocrine Tumor AJCC v8 Stage IV Appendix Neuroendocrine Tumor AJCC v8 CL522743 CTRP Malignant Stage IV Appendix Neuroendocrine Tumor Stage IV Appendix Neuroendocrine Tumor AJCC v8 Stage IV Appendix Neuroendocrine Tumor AJCC v8 A term that refers to the staging of a colorectal neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system. This staging system applies to colorectal "carcinoid" tumors (neuroendocrine tumor G1 and G2, and rare-well differentiated G3). High-grade neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas of the colon and rectum are not staged using this staging system. (from AJCC 8th Ed.) C135205 Neoplastic Process Colorectal Neuroendocrine Tumor by AJCC v8 Stage CL522535 Malignant Colorectal Neuroendocrine Tumor by AJCC v8 Stage Colorectal Neuroendocrine Tumor by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Tumor invading the lamina propria or submucosa and measuring 2 cm or less. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135206 Neoplastic Process Stage I Colorectal Neuroendocrine Tumor AJCC v8 Stage I Colorectal Neuroendocrine Tumor AJCC v8 CL522783 CTRP Malignant Stage I Colorectal Neuroendocrine Tumor Stage I Colorectal Neuroendocrine Tumor AJCC v8 Stage I Colorectal Neuroendocrine Tumor AJCC v8 Stage IIA includes: T2, N0, M0. T2: Tumor invading the muscularis propria or measuring more than 2 cm with invasion of the lamina propria or submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135207 Neoplastic Process Stage IIA Colorectal Neuroendocrine Tumor AJCC v8 Stage IIA Colorectal Neuroendocrine Tumor AJCC v8 CL522784 CTRP Malignant Stage IIA Colorectal Neuroendocrine Tumor Stage IIA Colorectal Neuroendocrine Tumor AJCC v8 Stage IIA Colorectal Neuroendocrine Tumor AJCC v8 Stage IIB includes: T3, N0, M0. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135208 Neoplastic Process Stage IIB Colorectal Neuroendocrine Tumor AJCC v8 Stage IIB Colorectal Neuroendocrine Tumor AJCC v8 CL522785 CTRP Malignant Stage IIB Colorectal Neuroendocrine Tumor Stage IIB Colorectal Neuroendocrine Tumor AJCC v8 Stage IIB Colorectal Neuroendocrine Tumor AJCC v8 Stage IIIA includes: T4, N0, M0. T4: Tumor invading the visceral peritoneum (serosa) or other organs or adjacent structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135209 Neoplastic Process Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8 Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8 CL522786 CTRP Malignant Stage IIIA Colorectal Neuroendocrine Tumor Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8 Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8 Stage IIIB includes: (T1, N1, M0); (T2, N1, M0); (T3, N1, M0); (T4, N1, M0). T1: Tumor invading the lamina propria or submucosa and measuring 2 cm or less. T2: Tumor invading the muscularis propria or measuring more than 2 cm with invasion of the lamina propria or submucosa. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. T4: Tumor invading the visceral peritoneum (serosa) or other organs or adjacent structures. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135210 Neoplastic Process Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8 Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8 CL522787 CTRP Malignant Stage IIIB Colorectal Neuroendocrine Tumor Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8 Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8 Stage IV includes: (T1, Any N, M1); (T2, Any N, M1); (T3, Any N, M1); (T4, Any N, M1). T1: Tumor invading the lamina propria or submucosa and measuring 2 cm or less. T2: Tumor invading the muscularis propria or measuring more than 2 cm with invasion of the lamina propria or submucosa. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. T4: Tumor invading the visceral peritoneum (serosa) or other organs or adjacent structures. M1: Distant metastasis. (AJCC 8th ed.) C135211 Neoplastic Process Stage IV Colorectal Neuroendocrine Tumor AJCC v8 Stage IV Colorectal Neuroendocrine Tumor AJCC v8 CL522788 CTRP Malignant Stage IV Colorectal Neuroendocrine Tumor Stage IV Colorectal Neuroendocrine Tumor AJCC v8 Stage IV Colorectal Neuroendocrine Tumor AJCC v8 A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the colon. C135212 Neoplastic Process Colon Neuroendocrine Tumor CL522789 Undetermined Colon Neuroendocrine Tumor Colon Well Differentiated Neuroendocrine Neoplasm Colon Well-Differentiated Neuroendocrine Neoplasm Colon Neuroendocrine Tumor A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the rectum. C135213 Neoplastic Process Rectal Neuroendocrine Tumor CL522790 Cellosaurus Undetermined Rectal Neuroendocrine Tumor Rectal Well Differentiated Neuroendocrine Neoplasm Rectal Well-Differentiated Neuroendocrine Neoplasm Rectal Neuroendocrine Tumor A term that refers to the staging of a colon neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system. This staging system applies to colon "carcinoid" tumors (neuroendocrine tumor G1 and G2, and rare-well differentiated G3). High-grade neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas of the colon are not staged using this staging system. (from AJCC 8th Ed.) C135214 Neoplastic Process Colon Neuroendocrine Tumor by AJCC v8 Stage CL522536 Malignant Colon Neuroendocrine Tumor by AJCC v8 Stage Colon Neuroendocrine Tumor by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Tumor invading the lamina propria or submucosa and measuring 2 cm or less. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135368 Neoplastic Process Stage I Colon Neuroendocrine Tumor AJCC v8 Stage I Colon Neuroendocrine Tumor AJCC v8 CL522791 CTRP Malignant Stage I Colon Neuroendocrine Tumor Stage I Colon Neuroendocrine Tumor AJCC v8 Stage I Colon Neuroendocrine Tumor AJCC v8 Stage IIA includes: T2, N0, M0. T2: Tumor invading the muscularis propria or measuring more than 2 cm with invasion of the lamina propria or submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135369 Neoplastic Process Stage IIA Colon Neuroendocrine Tumor AJCC v8 Stage IIA Colon Neuroendocrine Tumor AJCC v8 CL522792 CTRP Malignant Stage IIA Colon Neuroendocrine Tumor Stage IIA Colon Neuroendocrine Tumor AJCC v8 Stage IIA Colon Neuroendocrine Tumor AJCC v8 Stage IIB includes: T3, N0, M0. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135370 Neoplastic Process Stage IIB Colon Neuroendocrine Tumor AJCC v8 Stage IIB Colon Neuroendocrine Tumor AJCC v8 CL522793 CTRP Malignant Stage IIB Colon Neuroendocrine Tumor Stage IIB Colon Neuroendocrine Tumor AJCC v8 Stage IIB Colon Neuroendocrine Tumor AJCC v8 A form of MRI in which a phase shift between flowing tissue and static tissue is generated in order to determine the quantity and velocity of blood flow. C135456 Diagnostic Procedure Phase-Contrast Magnetic Resonance Imaging CL522829 CDISC A type of MRI in which a phase shift between flowing tissue and static tissue is generated in order to determine the quantity and velocity of body fluid. PCMR PHASE-CONTRAST MRI Phase-Contrast MRI Phase-Contrast Magnetic Resonance Imaging Phase-Contrast Magnetic Resonance Imaging Stage IIIA includes: T4, N0, M0. T4: Tumor invading the visceral peritoneum (serosa) or other organs or adjacent structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135524 Neoplastic Process Stage IIIA Colon Neuroendocrine Tumor AJCC v8 Stage IIIA Colon Neuroendocrine Tumor AJCC v8 CL522886 CTRP Malignant Stage IIIA Colon Neuroendocrine Tumor Stage IIIA Colon Neuroendocrine Tumor AJCC v8 Stage IIIA Colon Neuroendocrine Tumor AJCC v8 Stage IIIB includes: (T1, N1, M0); (T2, N1, M0); (T3, N1, M0); (T4, N1, M0). T1: Tumor invading the lamina propria or submucosa and measuring 2 cm or less. T2: Tumor invading the muscularis propria or measuring more than 2 cm with invasion of the lamina propria or submucosa. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. T4: Tumor invading the visceral peritoneum (serosa) or other organs or adjacent structures. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135525 Neoplastic Process Stage IIIB Colon Neuroendocrine Tumor AJCC v8 Stage IIIB Colon Neuroendocrine Tumor AJCC v8 CL522887 CTRP Malignant Stage IIIB Colon Neuroendocrine Tumor Stage IIIB Colon Neuroendocrine Tumor AJCC v8 Stage IIIB Colon Neuroendocrine Tumor AJCC v8 Stage IV includes: (T1, Any N, M1); (T2, Any N, M1); (T3, Any N, M1); (T4, Any N, M1). T1: Tumor invading the lamina propria or submucosa and measuring 2 cm or less. T2: Tumor invading the muscularis propria or measuring more than 2 cm with invasion of the lamina propria or submucosa. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. T4: Tumor invading the visceral peritoneum (serosa) or other organs or adjacent structures. M1: Distant metastasis. (AJCC 8th ed.) C135526 Neoplastic Process Stage IV Colon Neuroendocrine Tumor AJCC v8 Stage IV Colon Neuroendocrine Tumor AJCC v8 CL522888 CTRP Malignant Stage IV Colon Neuroendocrine Tumor Stage IV Colon Neuroendocrine Tumor AJCC v8 Stage IV Colon Neuroendocrine Tumor AJCC v8 A term that refers to the staging of a rectal neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system. This staging system applies to rectal "carcinoid" tumors (neuroendocrine tumor G1 and G2, and rare-well differentiated G3). High-grade neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas of the rectum are not staged using this staging system. (from AJCC 8th Ed.) C135527 Neoplastic Process Rectal Neuroendocrine Tumor by AJCC v8 Stage CL522889 Malignant Rectal Neuroendocrine Tumor by AJCC v8 Stage Rectal Neuroendocrine Tumor by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Tumor invading the lamina propria or submucosa and measuring 2 cm or less. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135528 Neoplastic Process Stage I Rectal Neuroendocrine Tumor AJCC v8 Stage I Rectal Neuroendocrine Tumor AJCC v8 CL522890 CTRP Malignant Stage I Rectal Neuroendocrine Tumor Stage I Rectal Neuroendocrine Tumor AJCC v8 Stage I Rectal Neuroendocrine Tumor AJCC v8 Stage IIA includes: T2, N0, M0. T2: Tumor invading the muscularis propria or measuring more than 2 cm with invasion of the lamina propria or submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135529 Neoplastic Process Stage IIA Rectal Neuroendocrine Tumor AJCC v8 Stage IIA Rectal Neuroendocrine Tumor AJCC v8 CL522891 CTRP Malignant Stage IIA Rectal Neuroendocrine Tumor Stage IIA Rectal Neuroendocrine Tumor AJCC v8 Stage IIA Rectal Neuroendocrine Tumor AJCC v8 Stage IIB includes: T3, N0, M0. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135530 Neoplastic Process Stage IIB Rectal Neuroendocrine Tumor AJCC v8 Stage IIB Rectal Neuroendocrine Tumor AJCC v8 CL522892 CTRP Malignant Stage IIB Rectal Neuroendocrine Tumor Stage IIB Rectal Neuroendocrine Tumor AJCC v8 Stage IIB Rectal Neuroendocrine Tumor AJCC v8 Stage IIIA includes: T4, N0, M0. T4: Tumor invading the visceral peritoneum (serosa) or other organs or adjacent structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135531 Neoplastic Process Stage IIIA Rectal Neuroendocrine Tumor AJCC v8 Stage IIIA Rectal Neuroendocrine Tumor AJCC v8 CL522893 CTRP Malignant Stage IIIA Rectal Neuroendocrine Tumor Stage IIIA Rectal Neuroendocrine Tumor AJCC v8 Stage IIIA Rectal Neuroendocrine Tumor AJCC v8 Stage IIIB includes: (T1, N1, M0); (T2, N1, M0); (T3, N1, M0); (T4, N1, M0). T1: Tumor invading the lamina propria or submucosa and measuring 2 cm or less. T2: Tumor invading the muscularis propria or measuring more than 2 cm with invasion of the lamina propria or submucosa. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. T4: Tumor invading the visceral peritoneum (serosa) or other organs or adjacent structures. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C135532 Neoplastic Process Stage IIIB Rectal Neuroendocrine Tumor AJCC v8 Stage IIIB Rectal Neuroendocrine Tumor AJCC v8 CL522894 CTRP Malignant Stage IIIB Rectal Neuroendocrine Tumor Stage IIIB Rectal Neuroendocrine Tumor AJCC v8 Stage IIIB Rectal Neuroendocrine Tumor AJCC v8 Stage IV includes: (T1, Any N, M1); (T2, Any N, M1); (T3, Any N, M1); (T4, Any N, M1). T1: Tumor invading the lamina propria or submucosa and measuring 2 cm or less. T2: Tumor invading the muscularis propria or measuring more than 2 cm with invasion of the lamina propria or submucosa. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. T4: Tumor invading the visceral peritoneum (serosa) or other organs or adjacent structures. M1: Distant metastasis. (AJCC 8th ed.) C135533 Neoplastic Process Stage IV Rectal Neuroendocrine Tumor AJCC v8 Stage IV Rectal Neuroendocrine Tumor AJCC v8 CL522895 CTRP Malignant Stage IV Rectal Neuroendocrine Tumor Stage IV Rectal Neuroendocrine Tumor AJCC v8 Stage IV Rectal Neuroendocrine Tumor AJCC v8 A term that refers to the staging of a pancreatic neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system. This staging system applies to well-differentiated neuroendocrine tumors arising in the pancreas. Carcinomas of the pancreas, including high-grade (grade 3), poorly differentiated neuroendocrine carcinomas are not staged using this staging system. (from AJCC 8th Ed.) C135560 Neoplastic Process Pancreatic Neuroendocrine Tumor by AJCC v8 Stage CL522921 Malignant Pancreatic Neuroendocrine Tumor by AJCC v8 Stage Pancreatic Neuroendocrine Tumor by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Tumor limited to the pancreas and measuring less than 2 cm. N0: No regional lymph node involvement. M0: No distant metastasis. (AJCC 8th ed.) C135561 Neoplastic Process Stage I Pancreatic Neuroendocrine Tumor AJCC v8 Stage I Pancreatic Neuroendocrine Tumor AJCC v8 CL522922 CTRP Malignant Stage I Pancreatic Neuroendocrine Tumor Stage I Pancreatic Neuroendocrine Tumor AJCC v8 Stage I Pancreatic Neuroendocrine Tumor AJCC v8 Stage II includes: (T2, N0, M0); (T3, N0, M0). T2: Tumor limited to the pancreas and measuring 2-4 cm. T3: Tumor limited to the pancreas and measuring more than 4 cm; or tumor invading the duodenum or bile duct. N0: No regional lymph node involvement. M0: No distant metastasis. (AJCC 8th ed.) C135562 Neoplastic Process Stage II Pancreatic Neuroendocrine Tumor AJCC v8 Stage II Pancreatic Neuroendocrine Tumor AJCC v8 CL522923 CTRP Malignant Stage II Pancreatic Neuroendocrine Tumor Stage II Pancreatic Neuroendocrine Tumor AJCC v8 Stage II Pancreatic Neuroendocrine Tumor AJCC v8 Stage III includes: (T4, N0, M0); (Any T, N1, M0). T4: Tumor invading adjacent organs (stomach, spleen, colon, adrenal gland) or the wall of large vessels (celiac axis or the superior mesenteric artery). N0: No regional lymph node involvement. N1: Regional lymph node involvement. M0: No distant metastasis. (AJCC 8th ed.) C135563 Neoplastic Process Stage III Pancreatic Neuroendocrine Tumor AJCC v8 Stage III Pancreatic Neuroendocrine Tumor AJCC v8 CL522924 CTRP Malignant Stage III Pancreatic Neuroendocrine Tumor Stage III Pancreatic Neuroendocrine Tumor AJCC v8 Stage III Pancreatic Neuroendocrine Tumor AJCC v8 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C135564 Neoplastic Process Stage IV Pancreatic Neuroendocrine Tumor AJCC v8 Stage IV Pancreatic Neuroendocrine Tumor AJCC v8 CL522925 CTRP Malignant Stage IV Pancreatic Neuroendocrine Tumor Stage IV Pancreatic Neuroendocrine Tumor AJCC v8 Stage IV Pancreatic Neuroendocrine Tumor AJCC v8 A carcinoma that originates from the rectum and has spread to the liver. C136240 Neoplastic Process Rectal Carcinoma Metastatic in the Liver CL523551 Malignant Rectal Carcinoma Metastatic in the Liver Rectal Carcinoma Metastatic in the Liver A term that refers to the staging of a thymic epithelial neoplasm, following the rules of the TNM AJCC v8 classification system. This staging system applies to thymomas, thymic carcinomas, thymic neuroendocrine tumors, and combined thymic carcinomas. (from AJCC 8th Ed.) C136320 Neoplastic Process Thymic Epithelial Neoplasm by AJCC v8 Stage CL523629 Malignant Thymic Epithelial Neoplasm by AJCC v8 Stage Thymus Epithelial Neoplasm by AJCC v8 Stage Thymic Epithelial Neoplasm by AJCC v8 Stage Stage I includes: T1a, b, N0, M0. T1a: Tumor with no mediastinal pleura involvement. T1b: Tumor with direct invasion of mediastinal pleura. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C136322 Neoplastic Process Stage I Thymus Epithelial Neoplasm AJCC v8 Stage I Thymic Epithelial Neoplasm AJCC v8 CL523631 CTRP Malignant Stage I Thymic Epithelial Neoplasm AJCC v8 Stage I Thymus Epithelial Neoplasm Stage I Thymus Epithelial Neoplasm AJCC v8 Stage I Thymic Epithelial Neoplasm AJCC v8 Stage II includes: T2, N0, M0. T2: Tumor with direct invasion of the pericardium (either partial or full thickness). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C136323 Neoplastic Process Stage II Thymus Epithelial Neoplasm AJCC v8 Stage II Thymic Epithelial Neoplasm AJCC v8 CL523632 CTRP Malignant Stage II Thymic Epithelial Neoplasm AJCC v8 Stage II Thymus Epithelial Neoplasm Stage II Thymus Epithelial Neoplasm AJCC v8 Stage II Thymic Epithelial Neoplasm AJCC v8 Stage III includes: IIIA: (T3, N0, M0); IIIB: (T4, N0, M0). T3: Tumor with direct invasion into any of the following: lung, brachiocephalic vein, superior vena cava, phrenic nerve, chest wall, or extrapericardial pulmonary artery or veins. T4: Tumor with invasion into any of the following: aorta (ascending, arch, or descending), arch vessels, intrapericardial pulmonary artery, myocardium, trachea, esophagus. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C136325 Neoplastic Process Stage III Thymus Epithelial Neoplasm AJCC v8 Stage III Thymic Epithelial Neoplasm AJCC v8 CL523634 CTRP Malignant Stage III Thymic Epithelial Neoplasm AJCC v8 Stage III Thymus Epithelial Neoplasm Stage III Thymus Epithelial Neoplasm AJCC v8 Stage III Thymic Epithelial Neoplasm AJCC v8 Stage IIIA includes: T3, N0, M0. T3: Tumor with direct invasion into any of the following: lung, brachiocephalic vein, superior vena cava, phrenic nerve, chest wall, or extrapericardial pulmonary artery or veins. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C136327 Neoplastic Process Stage IIIA Thymic Epithelial Neoplasm AJCC v8 CL523636 Malignant Stage IIIA Thymic Epithelial Neoplasm AJCC v8 Stage IIIA Thymus Epithelial Neoplasm AJCC v8 Stage IIIA Thymic Epithelial Neoplasm AJCC v8 Stage IIIB includes: T4, N0, M0. T4: Tumor with invasion into any of the following: aorta (ascending, arch, or descending), arch vessels, intrapericardial pulmonary artery, myocardium, trachea, esophagus. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C136328 Neoplastic Process Stage IIIB Thymic Epithelial Neoplasm AJCC v8 CL523637 Malignant Stage IIIB Thymic Epithelial Neoplasm AJCC v8 Stage IIIB Thymus Epithelial Neoplasm AJCC v8 Stage IIIB Thymic Epithelial Neoplasm AJCC v8 Stage IV includes: IVA: (Any T, N1, M0); (Any T, N0,1, M1a); IVB: (Any T, N2, M0, M1a); (Any T, Any N, M1b). N0: No regional lymph node metastasis. N1: Metastasis in anterior (perithymic) lymph nodes. N2: Metastasis in deep intrathoracic or cervical lymph nodes. M0: No distant metastasis. M1a: Separate pleural or pericardial nodule(s). M1b: Pulmonary intraparenchymal nodule or distant organ metastasis. (AJCC 8th ed.) C136329 Neoplastic Process Stage IV Thymus Epithelial Neoplasm AJCC v8 Stage IV Thymic Epithelial Neoplasm AJCC v8 CL523638 CTRP Malignant Stage IV Thymic Epithelial Neoplasm AJCC v8 Stage IV Thymus Epithelial Neoplasm Stage IV Thymus Epithelial Neoplasm AJCC v8 Stage IV Thymic Epithelial Neoplasm AJCC v8 Stage IVA includes: (Any T, N1, M0); (Any T, N0,1, M1a). N0: No regional lymph node metastasis. N1: Metastasis in anterior (perithymic) lymph nodes. M0: No distant metastasis. M1a: Separate pleural or pericardial nodule(s). (AJCC 8th ed.) C136330 Neoplastic Process Stage IVA Thymus Epithelial Neoplasm AJCC v8 Stage IVA Thymic Epithelial Neoplasm AJCC v8 CL523639 CTRP Malignant Stage IVA Thymic Epithelial Neoplasm AJCC v8 Stage IVA Thymus Epithelial Neoplasm Stage IVA Thymus Epithelial Neoplasm AJCC v8 Stage IVA Thymic Epithelial Neoplasm AJCC v8 Stage IVB includes: (Any T, N2, M0, M1a); (Any T, Any N, M1b). N2: Metastasis in deep intrathoracic or cervical lymph nodes. M0: No distant metastasis. M1a: Separate pleural or pericardial nodule(s). M1b: Pulmonary intraparenchymal nodule or distant organ metastasis. (AJCC 8th ed.) C136331 Neoplastic Process Stage IVB Thymus Epithelial Neoplasm AJCC v8 Stage IVB Thymic Epithelial Neoplasm AJCC v8 CL523640 CTRP Malignant Stage IVB Thymic Epithelial Neoplasm AJCC v8 Stage IVB Thymus Epithelial Neoplasm Stage IVB Thymus Epithelial Neoplasm AJCC v8 Stage IVB Thymic Epithelial Neoplasm AJCC v8 A term that refers to the staging of thymoma, following the rules of the TNM AJCC v8 classification system. C136345 Neoplastic Process Thymoma by AJCC v8 Stage CL523652 Malignant Thymoma by AJCC v8 Stage Thymoma by AJCC v8 Stage Stage I includes: T1a, b, N0, M0. T1a: Tumor with no mediastinal pleura involvement. T1b: Tumor with direct invasion of mediastinal pleura. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C136348 Neoplastic Process Stage I Thymoma AJCC v8 Stage I Thymoma AJCC v8 CL523655 CTRP Malignant Stage I Thymoma Stage I Thymoma AJCC v8 Stage I Thymoma AJCC v8 Stage II includes: T2, N0, M0. T2: Tumor with direct invasion of the pericardium (either partial or full thickness). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C136349 Neoplastic Process Stage II Thymoma AJCC v8 Stage II Thymoma AJCC v8 CL523656 CTRP Malignant Stage II Thymoma Stage II Thymoma AJCC v8 Stage II Thymoma AJCC v8 Stage III includes: IIIA: (T3, N0, M0); IIIB: (T4, N0, M0). T3: Tumor with direct invasion into any of the following: lung, brachiocephalic vein, superior vena cava, phrenic nerve, chest wall, or extrapericardial pulmonary artery or veins. T4: Tumor with invasion into any of the following: aorta (ascending, arch, or descending), arch vessels, intrapericardial pulmonary artery, myocardium, trachea, esophagus. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C136350 Neoplastic Process Stage III Thymoma AJCC v8 Stage III Thymoma AJCC v8 CL523657 CTRP Malignant Stage III Thymoma Stage III Thymoma AJCC v8 Stage III Thymoma AJCC v8 Stage IIIA includes: T3, N0, M0. T3: Tumor with direct invasion into any of the following: lung, brachiocephalic vein, superior vena cava, phrenic nerve, chest wall, or extrapericardial pulmonary artery or veins. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C136351 Neoplastic Process Stage IIIA Thymoma AJCC v8 Stage IIIA Thymoma AJCC v8 CL523658 CTRP Malignant Stage IIIA Thymoma Stage IIIA Thymoma AJCC v8 Stage IIIA Thymoma AJCC v8 Stage IIIB includes: T4, N0, M0. T4: Tumor with invasion into any of the following: aorta (ascending, arch, or descending), arch vessels, intrapericardial pulmonary artery, myocardium, trachea, esophagus. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C136352 Neoplastic Process Stage IIIB Thymoma AJCC v8 Stage IIIB Thymoma AJCC v8 CL523659 CTRP Malignant Stage IIIB Thymoma Stage IIIB Thymoma AJCC v8 Stage IIIB Thymoma AJCC v8 Stage IV includes: IVA: (Any T, N1, M0); (Any T, N0,1, M1a); IVB: (Any T, N2, M0, M1a); (Any T, Any N, M1b). N0: No regional lymph node metastasis. N1: Metastasis in anterior (perithymic) lymph nodes. N2: Metastasis in deep intrathoracic or cervical lymph nodes. M0: No distant metastasis. M1a: Separate pleural or pericardial nodule(s). M1b: Pulmonary intraparenchymal nodule or distant organ metastasis. (AJCC 8th ed.) C136353 Neoplastic Process Stage IV Thymoma AJCC v8 Stage IV Thymoma AJCC v8 CL523660 CTRP Malignant Stage IV Thymoma Stage IV Thymoma AJCC v8 Stage IV Thymoma AJCC v8 Stage IVA includes: (Any T, N1, M0); (Any T, N0,1, M1a). N0: No regional lymph node metastasis. N1: Metastasis in anterior (perithymic) lymph nodes. M0: No distant metastasis. M1a: Separate pleural or pericardial nodule(s). (AJCC 8th ed.) C136354 Neoplastic Process Stage IVA Thymoma AJCC v8 Stage IVA Thymoma AJCC v8 CL523661 CTRP Malignant Stage IVA Thymoma Stage IVA Thymoma AJCC v8 Stage IVA Thymoma AJCC v8 Stage IVB includes: (Any T, N2, M0, M1a); (Any T, Any N, M1b). N2: Metastasis in deep intrathoracic or cervical lymph nodes. M0: No distant metastasis. M1a: Separate pleural or pericardial nodule(s). M1b: Pulmonary intraparenchymal nodule or distant organ metastasis. (AJCC 8th ed.) C136356 Neoplastic Process Stage IVB Thymoma AJCC v8 Stage IVB Thymoma AJCC v8 CL523663 CTRP Malignant Stage IVB Thymoma Stage IVB Thymoma AJCC v8 Stage IVB Thymoma AJCC v8 A term that refers to the staging of pleural malignant mesothelioma, following the rules of the TNM AJCC v7 classification system. C136374 Neoplastic Process Pleural Malignant Mesothelioma by AJCC v7 Stage CL523681 Malignant Pleural Malignant Mesothelioma by AJCC v7 Stage Pleural Malignant Mesothelioma by AJCC v7 Stage A term that refers to the staging of pleural malignant mesothelioma, following the rules of the TNM AJCC v8 classification system. This staging system applies to pleural diffuse malignant mesothelioma only. Localized pleural malignant mesotheliomas and other primary tumors of the pleura are not staged using this staging system. (from AJCC 8th Ed.) C136399 Neoplastic Process Pleural Malignant Mesothelioma by AJCC v8 Stage CL523705 Malignant Pleural Malignant Mesothelioma by AJCC v8 Stage Pleural Malignant Mesothelioma by AJCC v8 Stage Stage I includes: IA: (T1, N0, M0); IB: (T2 or T3, N0, M0). T1: Tumor limited to the ipsilateral parietal with or without involvement of visceral pleura, mediastinal pleura, and diaphragmatic pleura. T2: Tumor involving each of the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least one of the following features: involvement of diaphragmatic muscle and/or extension of tumor from visceral pleura into the underlying pulmonary parenchyma. T3: Tumor is locally advanced but potentially resectable. The tumor involves all the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least one of the following features: involvement of the endothoracic fascia, extension into the mediastinal fat, solitary, completely resectable focus of tumor extending into the soft tissues of the chest wall, and/or nontransmural involvement of the pericardium. N0: No regional lymph node metastases. M0: No distant metastasis. (AJCC 8th ed.) C136400 Neoplastic Process Stage I Pleural Malignant Mesothelioma AJCC v8 Stage I Pleural Malignant Mesothelioma AJCC v8 CL523706 CTRP Malignant Stage I Pleural Malignant Mesothelioma Stage I Pleural Malignant Mesothelioma AJCC v8 Stage I Pleural Malignant Mesothelioma AJCC v8 Stage IB includes: T2 or T3, N0, M0. T2: Tumor involving each of the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least one of the following features: involvement of diaphragmatic muscle and/or extension of tumor from visceral pleura into the underlying pulmonary parenchyma. T3: Tumor is locally advanced but potentially resectable. The tumor involves all the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least one of the following features: involvement of the endothoracic fascia, extension into the mediastinal fat, solitary, completely resectable focus of tumor extending into the soft tissues of the chest wall, and/or nontransmural involvement of the pericardium. N0: No regional lymph node metastases. M0: No distant metastasis. (AJCC 8th ed.) C136401 Neoplastic Process Stage IB Pleural Malignant Mesothelioma AJCC v8 Stage IB Pleural Malignant Mesothelioma AJCC v8 CL523707 CTRP Malignant Stage IB Pleural Malignant Mesothelioma Stage IB Pleural Malignant Mesothelioma AJCC v8 Stage IB Pleural Malignant Mesothelioma AJCC v8 Stage II includes: (T1, N1, M0); (T2, N1, M0). T1: Tumor limited to the ipsilateral parietal with or without involvement of visceral pleura, mediastinal pleura, and diaphragmatic pleura. T2: Tumor involving each of the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least one of the following features: involvement of diaphragmatic muscle and/or extension of tumor from visceral pleura into the underlying pulmonary parenchyma. N1: Metastases in the ipsilateral bronchopulmonary, hilar, or mediastinal (including the internal mammary, peridiaphragmatic, pericardial fat pad, or intercostal) lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C136402 Neoplastic Process Stage II Pleural Malignant Mesothelioma AJCC v8 Stage II Pleural Malignant Mesothelioma AJCC v8 CL523708 CTRP Malignant Stage II Pleural Malignant Mesothelioma Stage II Pleural Malignant Mesothelioma AJCC v8 Stage II Pleural Malignant Mesothelioma AJCC v8 Stage III includes: IIIA: (T3, N1, M0); IIIB: (T1-3, N2, M0); (T4, Any N, M0). T1: Tumor limited to the ipsilateral parietal with or without involvement of visceral pleura, mediastinal pleura, and diaphragmatic pleura. T2: Tumor involving each of the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least one of the following features: involvement of diaphragmatic muscle and/or extension of tumor from visceral pleura into the underlying pulmonary parenchyma. T3: Tumor is locally advanced but potentially resectable. The tumor involves all the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least one of the following features: involvement of the endothoracic fascia, extension into the mediastinal fat, solitary, completely resectable focus of tumor extending into the soft tissues of the chest wall, and/or nontransmural involvement of the pericardium. T4: Tumor is locally advanced and technically unresectable. The tumor involves all the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least one of the following features: diffuse extension or multifocal masses of tumor in the chest wall, with or without associated rib destruction, direct transdiaphragmatic extension of tumor to the peritoneum, direct extension of tumor to the contralateral pleura, direct extension of tumor to mediastinal organs, direct extension of tumor into the spine, and/or tumor extending through to the internal surface of the pericardium with or without a pericardial effusion; or tumor involving the myocardium. N1: Metastases in the ipsilateral bronchopulmonary, hilar, or mediastinal (including the internal mammary, peridiaphragmatic, pericardial fat pad, or intercostal) lymph nodes. N2: Metastases in the contralateral mediastinal, ipsilateral, or contralateral supraclavicular lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C136403 Neoplastic Process Stage III Pleural Malignant Mesothelioma AJCC v8 Stage III Pleural Malignant Mesothelioma AJCC v8 CL523709 CTRP Malignant Stage III Pleural Malignant Mesothelioma Stage III Pleural Malignant Mesothelioma AJCC v8 Stage III Pleural Malignant Mesothelioma AJCC v8 Stage IIIA includes: T3, N1, M0. T3: Tumor is locally advanced but potentially resectable. The tumor involves all the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least one of the following features: involvement of the endothoracic fascia, extension into the mediastinal fat, solitary, completely resectable focus of tumor extending into the soft tissues of the chest wall, and/or nontransmural involvement of the pericardium. N1: Metastases in the ipsilateral bronchopulmonary, hilar, or mediastinal (including the internal mammary, peridiaphragmatic, pericardial fat pad, or intercostal) lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C136404 Neoplastic Process Stage IIIA Pleural Malignant Mesothelioma AJCC v8 Stage IIIA Pleural Malignant Mesothelioma AJCC v8 CL523710 CTRP Malignant Stage IIIA Pleural Malignant Mesothelioma Stage IIIA Pleural Malignant Mesothelioma AJCC v8 Stage IIIA Pleural Malignant Mesothelioma AJCC v8 Stage IIIB includes: (T1-3, N2, M0); (T4, Any N, M0). T1: Tumor limited to the ipsilateral parietal with or without involvement of visceral pleura, mediastinal pleura, and diaphragmatic pleura. T2: Tumor involving each of the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least one of the following features: involvement of diaphragmatic muscle and/or extension of tumor from visceral pleura into the underlying pulmonary parenchyma. T3: Tumor is locally advanced but potentially resectable. The tumor involves all the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least one of the following features: involvement of the endothoracic fascia, extension into the mediastinal fat, solitary, completely resectable focus of tumor extending into the soft tissues of the chest wall, and/or nontransmural involvement of the pericardium. T4: Tumor is locally advanced and technically unresectable. The tumor involves all the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least one of the following features: diffuse extension or multifocal masses of tumor in the chest wall, with or without associated rib destruction, direct transdiaphragmatic extension of tumor to the peritoneum, direct extension of tumor to the contralateral pleura, direct extension of tumor to mediastinal organs, direct extension of tumor into the spine, and/or tumor extending through to the internal surface of the pericardium with or without a pericardial effusion; or tumor involving the myocardium. N2: Metastases in the contralateral mediastinal, ipsilateral, or contralateral supraclavicular lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C136405 Neoplastic Process Stage IIIB Pleural Malignant Mesothelioma AJCC v8 Stage IIIB Pleural Malignant Mesothelioma AJCC v8 CL523711 CTRP Malignant Stage IIIB Pleural Malignant Mesothelioma Stage IIIB Pleural Malignant Mesothelioma AJCC v8 Stage IIIB Pleural Malignant Mesothelioma AJCC v8 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis present. (AJCC 8th ed.) C136406 Neoplastic Process Stage IV Pleural Malignant Mesothelioma AJCC v8 Stage IV Pleural Malignant Mesothelioma AJCC v8 CL523712 CTRP Malignant Stage IV Pleural Malignant Mesothelioma Stage IV Pleural Malignant Mesothelioma AJCC v8 Stage IV Pleural Malignant Mesothelioma AJCC v8 Stage IA includes: T1, N0, M0. T1: Tumor limited to the ipsilateral parietal with or without involvement of visceral pleura, mediastinal pleura, and diaphragmatic pleura. N0: No regional lymph node metastases. M0: No distant metastasis. (AJCC 8th ed.) C136409 Neoplastic Process Stage IA Pleural Malignant Mesothelioma AJCC v8 Stage IA Pleural Malignant Mesothelioma AJCC v8 CL523714 CTRP Malignant Stage IA Pleural Malignant Mesothelioma Stage IA Pleural Malignant Mesothelioma AJCC v8 Stage IA Pleural Malignant Mesothelioma AJCC v8 A malignant germ cell tumor that affects the peritoneum. C136410 Neoplastic Process Malignant Peritoneal Germ Cell Tumor Malignant Peritoneal Germ Cell Tumor CL523715 CTRP Malignant Malignant Peritoneal Germ Cell Tumor Malignant Peritoneal Germ Cell Tumor A squamous cell carcinoma that arises from the head and neck region and is not amenable to surgical resection. C136427 Neoplastic Process Unresectable Head and Neck Squamous Cell Carcinoma CL523730 Malignant Unresectable Head and Neck Squamous Cell Carcinoma Unresectable Head and Neck Squamous Cell Carcinoma A term that refers to the staging of lung cancer, following the rules of the TNM AJCC v8 classification system. This staging system derives from analyses of the new retrospective and prospective databases of the International Association for the Study of Lung Cancer (IASLC). These databases contain information on patients diagnosed with lung cancer from 1999 to 2010 originating from 35 different databases in 16 countries around the world. This staging system applies to carcinomas of the lung, including non-small cell and small cell carcinomas, and bronchopulmonary carcinoid tumors. It does not apply to sarcomas or other rare tumors of the lung. (from AJCC 8th Ed.) C136467 Neoplastic Process Lung Cancer by AJCC v8 Stage CL523770 CPTAC Malignant Lung Cancer by AJCC v8 Stage Tumor Stage (Pathological) Lung Cancer by AJCC v8 Stage Occult lung cancer includes: TX, N0, M0. TX: Primary tumor cannot be assessed. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C136468 Neoplastic Process Occult Lung Cancer AJCC v8 Occult Lung Cancer AJCC v8 CL523771 CTRP Malignant Occult Lung Cancer Occult Lung Cancer AJCC v8 Occult Lung Carcinoma AJCC v8 Occult Lung Cancer AJCC v8 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. Squamous cell carcinoma in situ (SCIS). Adenocarcinoma in situ (AIS): adenocarcinoma with pure lepidic pattern, 3 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C136469 Neoplastic Process Stage 0 Lung Cancer AJCC v8 Stage 0 Lung Cancer AJCC v8 CL523772 CTRP Malignant Stage 0 Lung Cancer Stage 0 Lung Cancer AJCC v8 Stage 0 Lung Carcinoma AJCC v8 Stage 0 Lung Cancer AJCC v8 Stage I includes: IA1: (T1mi, N0, M0); (T1a, N0, M0); IA2: (T1b, N0, M0); IA3: (T1c, N0, M0); IB: (T2a, N0, M0). T1mi: Minimally invasive adenocarcinoma: adenocarcinoma (3 cm or less in greatest dimension) with a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. T1a: Tumor measuring 1 cm or less in greatest dimension. A superficial, spreading tumor of any size whose invasive component is limited to the bronchial wall and may extend proximal to the main bronchus also is classified as T1a, but these tumors are uncommon. T1b: Tumor measuring more than 1 cm but 2 cm or less in greatest dimension. T1c: Tumor measuring more than 2 cm but 3 cm or less in greatest dimension. T2a: Tumor measuring more than 3 cm but 4 cm or less in greatest dimension. N0: No regional lymph node metastases. M0: No distant metastasis. (AJCC 8th ed.) C136470 Neoplastic Process Stage I Lung Cancer AJCC v8 Stage I Lung Cancer AJCC v8 CL523773 CPTAC CTRP Malignant Stage I Stage I Lung Cancer Stage I Lung Cancer AJCC v8 Stage I Lung Cancer AJCC v8 Stage IA1 includes: IA1: (T1mi, N0, M0); (T1a, N0, M0). T1mi: Minimally invasive adenocarcinoma: adenocarcinoma (3 cm or less in greatest dimension) with a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. T1a: Tumor measuring 1 cm or less in greatest dimension. A superficial, spreading tumor of any size whose invasive component is limited to the bronchial wall and may extend proximal to the main bronchus also is classified as T1a, but these tumors are uncommon. N0: No regional lymph node metastases. M0: No distant metastasis. (AJCC 8th ed.) C136471 Neoplastic Process Stage IA1 Lung Cancer AJCC v8 Stage IA1 Lung Cancer AJCC v8 CL523774 CTRP Malignant Stage IA1 Lung Cancer Stage IA1 Lung Cancer AJCC v8 Stage IA1 Lung Cancer AJCC v8 Stage IA2 includes: T1b, N0, M0. T1b: Tumor measuring more than 1 cm but 2 cm or less in greatest dimension. N0: No regional lymph node metastases. M0: No distant metastasis. (AJCC 8th ed.) C136472 Neoplastic Process Stage IA2 Lung Cancer AJCC v8 Stage IA2 Lung Cancer AJCC v8 CL523775 CTRP Malignant Stage IA2 Lung Cancer Stage IA2 Lung Cancer AJCC v8 Stage IA2 Lung Cancer AJCC v8 Stage IA3 includes: T1c, N0, M0. T1c: Tumor measuring more than 2 cm but 3 cm or less in greatest dimension. N0: No regional lymph node metastases. M0: No distant metastasis. (AJCC 8th ed.) C136473 Neoplastic Process Stage IA3 Lung Cancer AJCC v8 Stage IA3 Lung Cancer AJCC v8 CL523776 CTRP Malignant Stage IA3 Lung Cancer Stage IA3 Lung Cancer AJCC v8 Stage IA3 Lung Cancer AJCC v8 Stage IB includes: T2a, N0, M0. T2a: Tumor measuring more than 3 cm but 4 cm or less in greatest dimension. N0: No regional lymph node metastases. M0: No distant metastasis. (AJCC 8th ed.) C136474 Neoplastic Process Stage IB Lung Cancer AJCC v8 Stage IB Lung Cancer AJCC v8 CL523777 CPTAC CTRP Malignant Stage IB Stage IB Lung Cancer Stage IB Lung Cancer AJCC v8 Stage IB Lung Cancer AJCC v8 Stage II includes: IIA: (T2b, N0, M0); IIB: (T1a, N1, M0); (T1b, N1, M0); (T1c, N1, M0); (T2a, N1, M0); (T2b, N1, M0); (T3, N0, M0). T2b: Tumor measuring more than 4 cm but 5 cm or less in greatest dimension. T1a: Tumor measuring 1 cm or less in greatest dimension. A superficial, spreading tumor of any size whose invasive component is limited to the bronchial wall and may extend proximal to the main bronchus also is classified as T1a, but these tumors are uncommon. T1b: Tumor measuring more than 1 cm but 2 cm or less in greatest dimension. T1c: Tumor measuring more than 2 cm but 3 cm or less in greatest dimension. T2a: Tumor measuring more than 3 cm but 4 cm or less in greatest dimension. T3: Tumor measuring more than 5 cm but 7 cm or less in greatest dimension or directly invading any of the following: parietal pleura (PL3), chest wall (including superior sulcus tumors), phrenic nerve, parietal pericardium; or separate tumor nodule(s) in the same lobe as the primary. N0: No regional lymph node metastases. N1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 8th ed.) C136475 Neoplastic Process Stage II Lung Cancer AJCC v8 Stage II Lung Cancer AJCC v8 CL523778 CPTAC CTRP Malignant Stage II Stage II Lung Cancer Stage II Lung Cancer AJCC v8 Stage II Lung Cancer AJCC v8 Stage IIA includes: T2b, N0, M0. T2b: Tumor measuring more than 4 cm but 5 cm or less in greatest dimension. N0: No regional lymph node metastases. M0: No distant metastasis. (AJCC 8th ed.) C136476 Neoplastic Process Stage IIA Lung Cancer AJCC v8 Stage IIA Lung Cancer AJCC v8 CL523779 CPTAC CTRP Malignant Stage IIA Stage IIA Lung Cancer Stage IIA Lung Cancer AJCC v8 Stage IIA Lung Cancer AJCC v8 Stage IIB includes: (T1a, N1, M0); (T1b, N1, M0); (T1c, N1, M0); (T2a, N1, M0); (T2b, N1, M0); (T3, N0, M0). T1a: Tumor measuring 1 cm or less in greatest dimension. A superficial, spreading tumor of any size whose invasive component is limited to the bronchial wall and may extend proximal to the main bronchus also is classified as T1a, but these tumors are uncommon. T1b: Tumor measuring more than 1 cm but 2 cm or less in greatest dimension. T1c: Tumor measuring more than 2 cm but 3 cm or less in greatest dimension. T2a: Tumor measuring more than 3 cm but 4 cm or less in greatest dimension. T2b: Tumor measuring more than 4 cm but 5 cm or less in greatest dimension. T3: Tumor measuring more than 5 cm but 7 cm or less in greatest dimension or directly invading any of the following: parietal pleura (PL3), chest wall (including superior sulcus tumors), phrenic nerve, parietal pericardium; or separate tumor nodule(s) in the same lobe as the primary. N0: No regional lymph node metastases. N1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 8th ed.) C136477 Neoplastic Process Stage IIB Lung Cancer AJCC v8 Stage IIB Lung Cancer AJCC v8 CL523780 CPTAC CTRP Malignant Stage IIB Stage IIB Lung Cancer Stage IIB Lung Cancer AJCC v8 Stage IIB Lung Cancer AJCC v8 Stage III includes: IIIA: (T1a, N2, M0); (T1b, N2, M0); (T1c, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T4, N0, M0); (T4, N1, M0); IIIB: (T1a, N3, M0); (T1b, N3, M0); (T1c, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N2, M0); (T4, N2, M0); IIIC: (T3, N3, M0); (T4, N3, M0). T1a: Tumor measuring 1 cm or less in greatest dimension. A superficial, spreading tumor of any size whose invasive component is limited to the bronchial wall and may extend proximal to the main bronchus also is classified as T1a, but these tumors are uncommon. T1b: Tumor measuring more than 1 cm but 2 cm or less in greatest dimension. T1c: Tumor measuring more than 2 cm but 3 cm or less in greatest dimension. T2a: Tumor measuring more than 3 cm but 4 cm or less in greatest dimension. T2b: Tumor measuring more than 4 cm but 5 cm or less in greatest dimension. T3: Tumor measuring more than 5 cm but 7 cm or less in greatest dimension or directly invading any of the following: parietal pleura (PL3), chest wall (including superior sulcus tumors), phrenic nerve, parietal pericardium; or separate tumor nodule(s) in the same lobe as the primary. T4: Tumor measuring more than 7 cm or tumor of any size invading one or more of the following: diaphragm, mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, or carina; separate tumor nodule(s) in an ipsilateral lobe different from that of the primary. N0: No regional lymph node metastases. N1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension. N2: Metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s). N3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s). M0: No distant metastasis. (AJCC 8th ed.) C136478 Neoplastic Process Stage III Lung Cancer AJCC v8 Stage III Lung Cancer AJCC v8 CL523781 CPTAC CTRP Malignant Stage III Stage III Lung Cancer Stage III Lung Cancer AJCC v8 Stage III Lung Cancer AJCC v8 Stage IIIA includes: (T1a, N2, M0); (T1b, N2, M0); (T1c, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T4, N0, M0); (T4, N1, M0). T1a: Tumor measuring 1 cm or less in greatest dimension. A superficial, spreading tumor of any size whose invasive component is limited to the bronchial wall and may extend proximal to the main bronchus also is classified as T1a, but these tumors are uncommon. T1b: Tumor measuring more than 1 cm but 2 cm or less in greatest dimension. T1c: Tumor measuring more than 2 cm but 3 cm or less in greatest dimension. T2a: Tumor measuring more than 3 cm but 4 cm or less in greatest dimension. T2b: Tumor measuring more than 4 cm but 5 cm or less in greatest dimension. T3: Tumor measuring more than 5 cm but 7 cm or less in greatest dimension or directly invading any of the following: parietal pleura (PL3), chest wall (including superior sulcus tumors), phrenic nerve, parietal pericardium; or separate tumor nodule(s) in the same lobe as the primary. T4: Tumor measuring more than 7 cm or tumor of any size invading one or more of the following: diaphragm, mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, or carina; separate tumor nodule(s) in an ipsilateral lobe different from that of the primary. N0: No regional lymph node metastases. N1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension. N2: Metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s). M0: No distant metastasis. (AJCC 8th ed.) C136479 Neoplastic Process Stage IIIA Lung Cancer AJCC v8 Stage IIIA Lung Cancer AJCC v8 CL523782 CPTAC CTRP Malignant Stage IIIA Stage IIIA Lung Cancer Stage IIIA Lung Cancer AJCC v8 Stage IIIA Lung Cancer AJCC v8 Stage IIIB includes: (T1a, N3, M0); (T1b, N3, M0); (T1c, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N2, M0); (T4, N2, M0). T1a: Tumor measuring 1 cm or less in greatest dimension. A superficial, spreading tumor of any size whose invasive component is limited to the bronchial wall and may extend proximal to the main bronchus also is classified as T1a, but these tumors are uncommon. T1b: Tumor measuring more than 1 cm but 2 cm or less in greatest dimension. T1c: Tumor measuring more than 2 cm but 3 cm or less in greatest dimension. T2a: Tumor measuring more than 3 cm but 4 cm or less in greatest dimension. T2b: Tumor measuring more than 4 cm but 5 cm or less in greatest dimension. T3: Tumor measuring more than 5 cm but 7 cm or less in greatest dimension or directly invading any of the following: parietal pleura (PL3), chest wall (including superior sulcus tumors), phrenic nerve, parietal pericardium; or separate tumor nodule(s) in the same lobe as the primary. T4: Tumor measuring more than 7 cm or tumor of any size invading one or more of the following: diaphragm, mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, or carina; separate tumor nodule(s) in an ipsilateral lobe different from that of the primary. N2: Metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s). N3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s). M0: No distant metastasis. (AJCC 8th ed.) C136480 Neoplastic Process Stage IIIB Lung Cancer AJCC v8 Stage IIIB Lung Cancer AJCC v8 CL523783 CPTAC CTRP Malignant Stage IIIB Stage IIIB Lung Cancer Stage IIIB Lung Cancer AJCC v8 Stage IIIB Lung Cancer AJCC v8 Stage IIIC includes: (T3, N3, M0); (T4, N3, M0). T3: Tumor measuring more than 5 cm but 7 cm or less in greatest dimension or directly invading any of the following: parietal pleura (PL3), chest wall (including superior sulcus tumors), phrenic nerve, parietal pericardium; or separate tumor nodule(s) in the same lobe as the primary. T4: Tumor measuring more than 7 cm or tumor of any size invading one or more of the following: diaphragm, mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, or carina; separate tumor nodule(s) in an ipsilateral lobe different from that of the primary. N3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s). M0: No distant metastasis. (AJCC 8th ed.) C136481 Neoplastic Process Stage IIIC Lung Cancer AJCC v8 Stage IIIC Lung Cancer AJCC v8 CL523784 CTRP Malignant Stage IIIC Lung Cancer Stage IIIC Lung Cancer AJCC v8 Stage IIIC Lung Cancer AJCC v8 Stage IV includes: IVA: (Any T, Any N, M1a); (Any T, Any N, M1b); IVB: (Any T, Any N, M1c). M1a: Tumor with separate tumor nodule(s) in a contralateral lobe; tumor with pleural or pericardial nodules or malignant pleural or pericardial effusion. Most pleural (pericardial) effusions with lung cancer are a result of the tumor. In a few patients, however, multiple microscopic examinations of pleural (pericardial) fluid are negative for tumor, and the fluid is nonbloody and not an exudate. If these elements and clinical judgment dictate that the effusion is not related to the tumor, the effusion should be excluded as a staging descriptor. M1b: Tumor with single extrathoracic metastasis in a single organ (including involvement of a single nonregional node). M1c: Tumor with multiple extrathoracic metastases in a single organ or in multiple organs. (AJCC 8th ed.) C136482 Neoplastic Process Stage IV Lung Cancer AJCC v8 Stage IV Lung Cancer AJCC v8 CL523785 CPTAC CTRP Malignant Stage IV Stage IV Lung Cancer Stage IV Lung Cancer AJCC v8 Stage IV Lung Cancer AJCC v8 Stage IVA includes: (Any T, Any N, M1a); (Any T, Any N, M1b). M1a: Tumor with separate tumor nodule(s) in a contralateral lobe; tumor with pleural or pericardial nodules or malignant pleural or pericardial effusion. Most pleural (pericardial) effusions with lung cancer are a result of the tumor. In a few patients, however, multiple microscopic examinations of pleural (pericardial) fluid are negative for tumor, and the fluid is nonbloody and not an exudate. If these elements and clinical judgment dictate that the effusion is not related to the tumor, the effusion should be excluded as a staging descriptor. M1b: Tumor with single extrathoracic metastasis in a single organ (including involvement of a single nonregional node). (AJCC 8th ed.) C136483 Neoplastic Process Stage IVA Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 CL523786 CTRP Malignant Stage IVA Lung Cancer Stage IVA Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB includes: Any T, Any N, M1c. M1c: Tumor with multiple extrathoracic metastases in a single organ or in multiple organs. (AJCC 8th ed.) C136484 Neoplastic Process Stage IVB Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8 CL523787 CTRP Malignant Stage IVB Lung Cancer Stage IVB Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8 A localized non-invasive adenocarcinoma of the lung measuring 3 cm or less. It is characterized by a pure lepidic growth pattern and the lack of stromal, vascular, or pleural invasion. C136486 Neoplastic Process Lung Adenocarcinoma In Situ Lung Adenocarcinoma In Situ CL523789 CTRP Malignant Bronchioloalveolar Carcinoma Lung Adenocarcinoma In Situ Lung Adenocarcinoma In Situ Acute lymphoblastic leukemia that does not respond to treatment. C136488 Neoplastic Process Refractory Acute Lymphoblastic Leukemia Refractory Acute Lymphoblastic Leukemia CL523791 CTRP Malignant Refractory Acute Lymphoblastic Leukemia Refractory Acute Lymphoblastic Leukemia (ALL) Refractory Acute Lymphoblastic Leukemia Erdheim-Chester disease that does not respond to treatment. C136489 Neoplastic Process Refractory Erdheim-Chester Disease Refractory Erdheim-Chester Disease CL523792 CTRP Undetermined Refractory Erdheim-Chester Disease Refractory Erdheim-Chester Disease A term that refers to the staging of lung adenocarcinoma, following the rules of the TNM AJCC v7 classification system. C136490 Neoplastic Process Lung Adenocarcinoma by AJCC v7 Stage CL523793 Malignant Lung Adenocarcinoma by AJCC v7 Stage Lung Adenocarcinoma by AJCC v7 Stage A term that refers to the staging of non-small cell lung carcinoma, following the rules of the TNM AJCC v7 classification system. C136491 Neoplastic Process Lung Non-Small Cell Cancer by AJCC v7 Stage CL523794 Malignant Lung Non-Small Cell Cancer by AJCC v7 Stage Lung Non-Small Cell Carcinoma by AJCC v7 Stage Lung Non-Small Cell Cancer by AJCC v7 Stage A term that refers to the staging of adenosquamous lung carcinoma, following the rules of the TNM AJCC v7 classification system. C136492 Neoplastic Process Lung Adenosquamous Carcinoma by AJCC v7 Stage CL523795 Malignant Lung Adenosquamous Carcinoma by AJCC v7 Stage Lung Adenosquamous Carcinoma by AJCC v7 Stage A term that refers to the staging of large cell lung carcinoma, following the rules of the TNM AJCC v7 classification system. C136493 Neoplastic Process Lung Large Cell Carcinoma by AJCC v7 Stage CL523796 Malignant Lung Large Cell Carcinoma by AJCC v7 Stage Lung Large Cell Carcinoma by AJCC v7 Stage A term that refers to the staging of squamous cell lung carcinoma, following the rules of the TNM AJCC v7 classification system. C136494 Neoplastic Process Lung Squamous Cell Carcinoma by AJCC v7 Stage CL523797 Malignant Lung Squamous Cell Carcinoma by AJCC v7 Stage Lung Squamous Cell Carcinoma by AJCC v7 Stage A term that refers to the staging of small cell lung carcinoma, following the rules of the TNM AJCC v7 classification system. C136496 Neoplastic Process Lung Small Cell Carcinoma by AJCC v7 Stage CL523798 Malignant Lung Small Cell Carcinoma by AJCC v7 Stage Small Cell Lung Carcinoma by AJCC v7 Stage Lung Small Cell Carcinoma by AJCC v7 Stage The reemergence of anaplastic astrocytoma after a period of remission. C136517 Neoplastic Process Recurrent Anaplastic Astrocytoma Recurrent Anaplastic Astrocytoma CL524369 CTRP Malignant Recurrent Anaplastic Astrocytoma Recurrent Anaplastic Astrocytoma The reemergence of diffuse intrinsic pontine glioma after a period of remission. C136518 Neoplastic Process Recurrent Diffuse Intrinsic Pontine Glioma Recurrent Diffuse Intrinsic Pontine Glioma CL524367 CTRP Malignant Recurrent Diffuse Intrinsic Pontine Glioma Recurrent Diffuse Intrinsic Pontine Glioma (DIPG) Recurrent Diffuse Intrinsic Pontine Glioma Diffuse intrinsic pontine glioma that is resistant to treatment. C136519 Neoplastic Process Refractory Diffuse Intrinsic Pontine Glioma Refractory Diffuse Intrinsic Pontine Glioma CL524368 CTRP Malignant Refractory Diffuse Intrinsic Pontine Glioma Refractory Diffuse Intrinsic Pontine Glioma (DIPG) Refractory Diffuse Intrinsic Pontine Glioma A term that refers to the staging of bone cancer, following the rules of the TNM AJCC v7 classification system. C136610 Neoplastic Process Bone Cancer by AJCC v7 Stage CL524482 Malignant Bone Cancer by AJCC v7 Stage Bone Cancer by AJCC v7 Stage A term that refers to the staging of appendicular skeleton, trunk, skull, and facial bones cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to osteosarcoma, chondrosarcoma, Ewing sarcoma, spindle cell sarcoma, hemangioendothelioma, angiosarcoma, fibrosarcoma/myofibroid sarcoma, chordoma, adamantinoma, and other cancers arising in the bone. It does not apply to primary malignant lymphoma of the bone and multiple myeloma. There are no AJCC prognostic stage groupings for spine and pelvis. (from AJCC 8th Ed.) C136612 Neoplastic Process Bone Cancer by AJCC v8 Stage CL524488 Malignant Appendicular Skeleton, Trunk, Skull, and Facial Bones Cancer by AJCC v8 Stage Bone Cancer by AJCC v8 Stage Bone Cancer by AJCC v8 Stage Stage I includes: IA: (T1, N0, M0, G1 or GX); IB: (T2, N0, M0, G1 or GX); (T3, N0, M0, G1 or GX). T1: Tumor measuring 8 cm or less in greatest dimension. T2: Tumor measuring more than 8 cm in greatest dimension. T3: Discontinuous tumors in the primary bone site. N0: No regional lymph node metastasis. M0: No distant metastasis. GX: Grade cannot be assessed. G1: Well differentiated, low grade. (AJCC 8th ed.) C136613 Neoplastic Process Stage I Bone Cancer AJCC v8 Stage I Bone Cancer AJCC v8 CL524489 CTRP Malignant Stage I Appendicular Skeleton, Trunk, Skull, and Facial Bones Cancer AJCC v8 Stage I Bone Cancer Stage I Bone Cancer AJCC v8 Stage I Bone Cancer AJCC v8 Stage IA includes: T1, N0, M0, G1 or GX. T1: Tumor measuring 8 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. GX: Grade cannot be assessed. G1: Well differentiated, low grade. (AJCC 8th ed.) C136614 Neoplastic Process Stage IA Bone Cancer AJCC v8 Stage IA Bone Cancer AJCC v8 CL524486 CTRP Malignant Stage IA Appendicular Skeleton, Trunk, Skull, and Facial Bones Cancer AJCC v8 Stage IA Bone Cancer Stage IA Bone Cancer AJCC v8 Stage IA Bone Cancer AJCC v8 Stage IB includes: (T2, N0, M0, G1 or GX); (T3, N0, M0, G1 or GX). T2: Tumor measuring more than 8 cm in greatest dimension. T3: Discontinuous tumors in the primary bone site. N0: No regional lymph node metastasis. M0: No distant metastasis. GX: Grade cannot be assessed. G1: Well differentiated, low grade. (AJCC 8th ed.) C136615 Neoplastic Process Stage IB Bone Cancer AJCC v8 Stage IB Bone Cancer AJCC v8 CL524487 CTRP Malignant Stage IB Appendicular Skeleton, Trunk, Skull, and Facial Bones Cancer AJCC v8 Stage IB Bone Cancer Stage IB Bone Cancer AJCC v8 Stage IB Bone Cancer AJCC v8 Stage II includes: IIA: (T1, N0, M0, G2 or G3); IIB: (T2, N0, M0, G2 or G3). T1: Tumor measuring 8 cm or less in greatest dimension. T2: Tumor measuring more than 8 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G2: Moderately differentiated, high grade. G3: Poorly differentiated, high grade. (AJCC 8th ed.) C136616 Neoplastic Process Stage II Bone Cancer AJCC v8 Stage II Bone Cancer AJCC v8 CL524492 CTRP Malignant Stage II Appendicular Skeleton, Trunk, Skull, and Facial Bones Cancer AJCC v8 Stage II Bone Cancer Stage II Bone Cancer AJCC v8 Stage II Bone Cancer AJCC v8 Stage IIA includes: T1, N0, M0, G2 or G3. T1: Tumor measuring 8 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G2: Moderately differentiated, high grade. G3: Poorly differentiated, high grade. (AJCC 8th ed.) C136617 Neoplastic Process Stage IIA Bone Cancer AJCC v8 Stage IIA Bone Cancer AJCC v8 CL524493 CTRP Malignant Stage IIA Appendicular Skeleton, Trunk, Skull, and Facial Bones Cancer AJCC v8 Stage IIA Bone Cancer Stage IIA Bone Cancer AJCC v8 Stage IIA Bone Cancer AJCC v8 Stage IIB includes: T2, N0, M0, G2 or G3. T2: Tumor measuring more than 8 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G2: Moderately differentiated, high grade. G3: Poorly differentiated, high grade. (AJCC 8th ed.) C136618 Neoplastic Process Stage IIB Bone Cancer AJCC v8 Stage IIB Bone Cancer AJCC v8 CL524490 CTRP Malignant Stage IIB Appendicular Skeleton, Trunk, Skull, and Facial Bones Cancer AJCC v8 Stage IIB Bone Cancer Stage IIB Bone Cancer AJCC v8 Stage IIB Bone Cancer AJCC v8 Stage III includes: T3, N0, M0, G2 or G3. T3: Discontinuous tumors in the primary bone site. N0: No regional lymph node metastasis. M0: No distant metastasis. G2: Moderately differentiated, high grade. G3: Poorly differentiated, high grade. (AJCC 8th ed.) C136619 Neoplastic Process Stage III Bone Cancer AJCC v8 Stage III Bone Cancer AJCC v8 CL524491 CTRP Malignant Stage III Appendicular Skeleton, Trunk, Skull, and Facial Bones Cancer AJCC v8 Stage III Bone Cancer Stage III Bone Cancer AJCC v8 Stage III Bone Cancer AJCC v8 Stage IV includes: IVA: (Any T, N0, M1a, Any G); IVB: (Any T, N1, Any M, Any G); (Any T, Any N, M1b, Any G). N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M1a: Metastasis in the lung. M1b: Metastasis in the bone or other distant sites. (AJCC 8th ed.) C136620 Neoplastic Process Stage IV Bone Cancer AJCC v8 Stage IV Bone Cancer AJCC v8 CL524496 CTRP Malignant Stage IV Appendicular Skeleton, Trunk, Skull, and Facial Bones Cancer AJCC v8 Stage IV Bone Cancer Stage IV Bone Cancer AJCC v8 Stage IV Bone Cancer AJCC v8 Stage IVA includes: Any T, N0, M1a, Any G. N0: No regional lymph node metastasis. M1a: Metastasis in the lung. (AJCC 8th ed.) C136621 Neoplastic Process Stage IVA Bone Cancer AJCC v8 Stage IVA Bone Cancer AJCC v8 CL524497 CTRP Malignant Stage IVA Appendicular Skeleton, Trunk, Skull, and Facial Bones Cancer AJCC v8 Stage IVA Bone Cancer Stage IVA Bone Cancer AJCC v8 Stage IVA Bone Cancer AJCC v8 Stage IVB includes: (Any T, N1, Any M, Any G); (Any T, Any N, M1b, Any G). N1: Regional lymph node metastasis. M1b: Metastasis in the bone or other distant sites. (AJCC 8th ed.) C136622 Neoplastic Process Stage IVB Bone Cancer AJCC v8 Stage IVB Bone Cancer AJCC v8 CL524494 CTRP Malignant Stage IVB Appendicular Skeleton, Trunk, Skull, and Facial Bones Cancer AJCC v8 Stage IVB Bone Cancer Stage IVB Bone Cancer AJCC v8 Stage IVB Bone Cancer AJCC v8 A term that refers to the staging of bone sarcoma, following the rules of the TNM AJCC v7 classification system. C136632 Neoplastic Process Bone Sarcoma by AJCC v7 Stage CL524476 Malignant Bone Sarcoma by AJCC v7 Stage Bone Sarcoma by AJCC v7 Stage A term that refers to the staging of osteosarcoma, following the rules of the TNM AJCC v7 classification system. C136633 Neoplastic Process Osteosarcoma by AJCC v7 Stage CL524477 Malignant Osteosarcoma by AJCC v7 Stage Primary Bone Osteosarcoma by AJCC v7 Stage Osteosarcoma by AJCC v7 Stage The reemergence of cervical squamous cell carcinoma after a period of remission. C136649 Neoplastic Process Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified Recurrent Cervical Squamous Cell Carcinoma CL524462 CTRP Malignant Recurrent Cervical Squamous Cell Cancer Recurrent Cervical Squamous Cell Carcinoma Relapsed Cervical Squamous Cell Carcinoma Recurrent Cervical Squamous Cell Carcinoma The reemergence of cervical adenosquamous carcinoma after a period of remission. C136650 Neoplastic Process Recurrent Cervical Adenosquamous Carcinoma Recurrent Cervical Adenosquamous Carcinoma CL524459 CTRP Malignant Recurrent Cervical Adenosquamous Cancer Recurrent Cervical Adenosquamous Carcinoma Relapsed Cervical Adenosquamous Carcinoma Recurrent Cervical Adenosquamous Carcinoma The reemergence of cervical adenocarcinoma after a period of remission. C136651 Neoplastic Process Recurrent Cervical Adenocarcinoma Recurrent Cervical Adenocarcinoma CL524460 CTRP Malignant Recurrent Cervical Adenocarcinoma Relapsed Cervical Adenocarcinoma Recurrent Cervical Adenocarcinoma A term that refers to the staging of soft tissue sarcoma, following the rules of the TNM AJCC v8 classification system. C136693 Neoplastic Process Soft Tissue Sarcoma by AJCC v8 Stage Soft Tissue Sarcoma by AJCC v8 Stage CL524529 CTRP Malignant Soft Tissue Sarcoma by AJCC v8 Stage Soft Tissue Sarcoma by AJCC v8 Stage A term that refers to the staging of soft tissue sarcoma of the trunk and extremities, following the rules of the TNM AJCC v8 classification system. C136694 Neoplastic Process Soft Tissue Sarcoma of the Trunk and Extremities by AJCC v8 Stage CL524534 Malignant Soft Tissue Sarcoma Trunk and Extremities by AJCC v8 Stage Soft Tissue Sarcoma of the Trunk and Extremities by AJCC v8 Stage Soft Tissue Sarcoma of the Trunk and Extremities by AJCC v8 Stage Stage I includes: IA: (T1, N0, M0, G1, GX); IB: (T2, T3, T4, N0, M0, G1, GX). T1: Tumor measuring 5 cm or less in greatest dimension. T2: Tumor measuring more than 5 cm and less than or equal to 10 cm in greatest dimension. T3: Tumor measuring more than 10 cm and less than or equal to 15 cm in greatest dimension. T4: Tumor measuring more than 15 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. GX: Grade cannot be assessed. G1: Total differentiation, mitotic count and necrosis score of 2 or 3. (AJCC 8th ed.) C136696 Neoplastic Process Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 CL524532 CTRP Malignant Stage I Soft Tissue Sarcoma of the Trunk and Extremities Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage IA includes: T1, N0, M0, G1, GX. T1: Tumor measuring 5 cm or less in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. GX: Grade cannot be assessed. G1: Total differentiation, mitotic count and necrosis score of 2 or 3. (AJCC 8th ed.) C136698 Neoplastic Process Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 CL524538 CTRP Malignant Stage IA Soft Tissue Sarcoma of the Trunk and Extremities Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage IB includes: T2, T3, T4, N0, M0, G1, GX. T2: Tumor measuring more than 5 cm and less than or equal to 10 cm in greatest dimension. T3: Tumor measuring more than 10 cm and less than or equal to 15 cm in greatest dimension. T4: Tumor measuring more than 15 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. GX: Grade cannot be assessed. G1: Total differentiation, mitotic count and necrosis score of 2 or 3. (AJCC 8th ed.) C136700 Neoplastic Process Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 CL524539 CTRP Malignant Stage IB Soft Tissue Sarcoma of the Trunk and Extremities Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage II includes: T1, N0, M0, G2, G3. T1: Tumor measuring 5 cm or less in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. G2: Total differentiation, mitotic count and necrosis score of 4 or 5. G3: Total differentiation, mitotic count and necrosis score of 6, 7, or 8. (AJCC 8th ed.) C136701 Neoplastic Process Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 CL524536 CTRP Malignant Stage II Soft Tissue Sarcoma of the Trunk and Extremities Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage III includes: IIIA: (T2, N0, M0, G2, G3); IIIB: (T3, T4, N0, M0, G2, G3). T2: Tumor measuring more than 5 cm and less than or equal to 10 cm in greatest dimension. T3: Tumor measuring more than 10 cm and less than or equal to 15 cm in greatest dimension. T4: Tumor measuring more than 15 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. G2: Total differentiation, mitotic count and necrosis score of 4 or 5. G3: Total differentiation, mitotic count and necrosis score of 6, 7, or 8. (AJCC 8th ed.) C136702 Neoplastic Process Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 CL524537 CTRP Malignant Stage III Soft Tissue Sarcoma of the Trunk and Extremities Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage IIIA includes: T2, N0, M0, G2, G3. T2: Tumor measuring more than 5 cm and less than or equal to 10 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. G2: Total differentiation, mitotic count and necrosis score of 4 or 5. G3: Total differentiation, mitotic count and necrosis score of 6, 7, or 8. (AJCC 8th ed.) C136703 Neoplastic Process Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 CL524542 CTRP Malignant Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage IIIB includes: T3, T4, N0, M0, G2, G3. T3: Tumor measuring more than 10 cm and less than or equal to 15 cm in greatest dimension. T4: Tumor measuring more than 15 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. G2: Total differentiation, mitotic count and necrosis score of 4 or 5. G3: Total differentiation, mitotic count and necrosis score of 6, 7, or 8. (AJCC 8th ed.) C136705 Neoplastic Process Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 CL524543 CTRP Malignant Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage IV includes: (Any T, N1, M0, Any G); (Any T, Any N, M1, Any G). N1: Regional lymph node metastasis. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C136706 Neoplastic Process Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 CL524540 CTRP Malignant Stage IV Soft Tissue Sarcoma of the Trunk and Extremities Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 A term that refers to the staging of soft tissue sarcoma, following the rules of the TNM AJCC v7 classification system. C136707 Neoplastic Process Soft Tissue Sarcoma by AJCC v7 Stage CL524541 Malignant Soft Tissue Sarcoma by AJCC v7 Stage Soft Tissue Sarcoma by AJCC v7 Stage A term that refers to the staging of uterine corpus sarcoma, following the rules of the TNM AJCC v7 classification system. C136708 Neoplastic Process Uterine Corpus Sarcoma by AJCC v7 Stage CL524516 Malignant Uterine Corpus Sarcoma by AJCC v7 Stage Uterine Corpus Sarcoma by AJCC v7 Stage An invasive adenocarcinoma that arises from the lung. It is characterized by the presence of tall columnar cells and mucin production. This category refers to cases formerly classified as mucinous bronchioloalveolar carcinoma, excluding cases that meet the criteria for adenocarcinoma in situ or mucinous minimally invasive adenocarcinoma. C136709 Neoplastic Process Invasive Lung Mucinous Adenocarcinoma Invasive Lung Mucinous Adenocarcinoma CL524517 CPTAC CTRP GDC Malignant 8253/3 Adenocarcinoma of lung, mucinous Bronchio-alveolar carcinoma, mucinous Bronchiolo-alveolar carcinoma, mucinous Invasive mucinous adenocarcinoma Invasive Lung Mucinous Adenocarcinoma Invasive mucinous adenocarcinoma Mucinous Bronchioloalveolar Carcinoma Mucinous Invasive Lung Adenocarcinoma Invasive Lung Mucinous Adenocarcinoma A well-differentiated adenocarcinoma located in the lung periphery. It resembles colorectal adenocarcinoma with acinar and/or cribriform architecture and papillotubular structures. C136710 Neoplastic Process Lung Enteric Adenocarcinoma CL524514 CPTAC Malignant Enteric adenocarcinoma Lung Enteric Adenocarcinoma Pulmonary Intestinal-Type Adenocarcinoma Lung Enteric Adenocarcinoma A squamous cell lung carcinoma characterized by the presence of keratinization, pearl formation, and/or intercellular bridges. C136713 Neoplastic Process Lung Keratinizing Squamous Cell Carcinoma CL554695 CPTAC Malignant Keratinizing Squamous Cell Lung Carcinoma Keratinizing squamous cell carcinoma Lung Keratinizing Squamous Cell Carcinoma Lung Keratinizing Squamous Cell Carcinoma A squamous cell lung carcinoma characterized by the absence of keratinization, pearl formation, and intercellular bridges. C136714 Neoplastic Process Lung Non-Keratinizing Squamous Cell Carcinoma CL554694 CPTAC Malignant Lung Non-Keratinizing Squamous Cell Carcinoma Lung Nonkeratinizing Squamous Cell Carcinoma Non-Keratinizing Squamous Cell Lung Carcinoma Non-keratinizing squamous cell carcinoma Lung Non-Keratinizing Squamous Cell Carcinoma Lung adenocarcinoma in situ characterized by the presence of type II pneumocyte and/or Clara cell differentiation. Almost all cases of lung adenocarcinoma in situ are non-mucinous. C136716 Neoplastic Process Lung Non-Mucinous Adenocarcinoma In Situ CL554697 GDC Malignant Adenocarcinoma in situ of lung, non-mucinous Adenocarcinoma in situ, non-mucinous Lung Non-Mucinous Adenocarcinoma In Situ Lung Non-Mucinous Adenocarcinoma In Situ A very rare lung adenocarcinoma in situ variant characterized by the presence of tall columnar cells with basal nuclei and abundant cytoplasmic mucin. C136717 Neoplastic Process Lung Mucinous Adenocarcinoma In Situ CL554698 GDC Malignant Adenocarcinoma in situ of lung, mucinous Adenocarcinoma in situ, mucinous Lung Mucinous Adenocarcinoma In Situ Lung Mucinous Adenocarcinoma In Situ A preinvasive bronchial neoplastic lesion affecting the squamous epithelium. It is characterized by the absence of progression of maturation from base to luminal surface, basilar zone expansion with cellular crowding throughout the epithelium, absence of the intermediate zone, and surface flattening confined to the most superficial cells. The nuclear-to-cytoplasmic ratio is often high and variable, the chromatin is coarse and uneven, and mitotic figures are present through full thickness. The cell size may be markedly increased. Anisocytosis and pleomorphism may be present. (Adapted from WHO, 2015) C136719 Neoplastic Process Lung Squamous Cell Carcinoma In Situ Lung Squamous Cell Carcinoma In Situ CL554696 CTRP Malignant LUSC-CIS Lung Squamous Cell Carcinoma In Situ Squamous Cell Lung Carcinoma In Situ Lung Squamous Cell Carcinoma In Situ A term that refers to the staging of gastrointestinal stromal tumor (GIST), following the rules of the TNM AJCC v8 classification system. This staging system does not apply to pediatric GIST, familial GIST (germline mutant KIT or PDGFRA), or syndromic GIST (no AJCC staging system available). (from AJCC 8th Ed.) C136767 Neoplastic Process Gastrointestinal Stromal Tumor by AJCC v8 Stage CL524599 Malignant GIST by AJCC v8 Stage Gastrointestinal Stromal Tumor by AJCC v8 Stage Gastrointestinal Stromal Tumor by AJCC v8 Stage A term that refers to the staging of gastric and omental gastrointestinal stromal tumor (GIST), following the rules of the TNM AJCC v8 classification system. (from AJCC 8th Ed.) C136768 Neoplastic Process Gastric and Omental Gastrointestinal Stromal Tumor by AJCC v8 Stage CL524604 Malignant Gastric and Omental GIST by AJCC v8 Stage Gastric and Omental Gastrointestinal Stromal Tumor by AJCC v8 Stage Gastric and Omental Gastrointestinal Stromal Tumor by AJCC v8 Stage A term that refers to the staging of small intestinal, esophageal, colorectal, mesenteric, and peritoneal gastrointestinal stromal tumor (GIST), following the rules of the TNM AJCC v8 classification system. (from AJCC 8th Ed.) C136769 Neoplastic Process Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor by AJCC v8 Stage CL524605 Malignant Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal GIST by AJCC v8 Stage Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor by AJCC v8 Stage Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor by AJCC v8 Stage Stage I includes: IA: (T1 or T2, N0, M0, Low Mitotic Rate); IB: (T3, N0, M0, Low Mitotic Rate). T1: Tumor measuring 2 cm or less. T2: Tumor measuring more than 2 cm but not more than 5 cm. T3: Tumor measuring more than 5 cm but not more than 10 cm. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. Low Mitotic Rate: Five or fewer mitoses per 5 square millimeters, or per 50 HPF. (AJCC 8th ed.) C136770 Neoplastic Process Stage I Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage I Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 CL524602 CTRP Malignant Stage I Gastric (Stomach) and Omental Gastrointestinal Stromal Tumor (GIST) Stage I Gastric and Omental GIST AJCC v8 Stage I Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage I Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage IA includes: T1 or T2, N0, M0, Low Mitotic Rate. T1: Tumor measuring 2 cm or less. T2: Tumor measuring more than 2 cm but not more than 5 cm. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. Low Mitotic Rate: Five or fewer mitoses per 5 square millimeters, or per 50 HPF. (AJCC 8th ed.) C136771 Neoplastic Process Stage IA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage IA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 CL524603 CTRP Malignant Stage IA Gastric (Stomach) and Omental Gastrointestinal Stromal Tumor (GIST) Stage IA Gastric and Omental GIST AJCC v8 Stage IA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage IA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage IB includes: T3, N0, M0, Low Mitotic Rate. T3: Tumor measuring more than 5 cm but not more than 10 cm. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. Low Mitotic Rate: Five or fewer mitoses per 5 square millimeters, or per 50 HPF. (AJCC 8th ed.) C136772 Neoplastic Process Stage IB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage IB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 CL524576 CTRP Malignant Stage IB Gastric (Stomach) and Omental Gastrointestinal Stromal Tumor (GIST) Stage IB Gastric and Omental GIST AJCC v8 Stage IB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage IB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage II includes: (T1, N0, M0, High Mitotic Rate); (T2, N0, M0, High Mitotic Rate); (T4, N0, M0, Low Mitotic Rate). T1: Tumor measuring 2 cm or less. T2: Tumor measuring more than 2 cm but not more than 5 cm. T4: Tumor measuring more than 10 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. High Mitotic Rate: Over 5 mitoses per 5 square millimeters, or per 50 HPF. Low Mitotic Rate: Five or fewer mitoses per 5 square millimeters, or per 50 HPF. (AJCC 8th ed.) C136773 Neoplastic Process Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 CL524577 CTRP Malignant Stage II Gastric (Stomach) and Omental Gastrointestinal Stromal Tumor (GIST) Stage II Gastric and Omental GIST AJCC v8 Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage III includes: IIIA: (T3, N0, M0, High Mitotic Rate); IIIB: (T4, N0, M0, High Mitotic Rate). T3: Tumor measuring more than 5 cm but not more than 10 cm. T4: Tumor measuring more than 10 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. High Mitotic Rate: Over 5 mitoses per 5 square millimeters, or per 50 HPF. (AJCC 8th ed.) C136774 Neoplastic Process Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 CL524574 CTRP Malignant Stage III Gastric (Stomach) and Omental Gastrointestinal Stromal Tumor (GIST) Stage III Gastric and Omental GIST AJCC v8 Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage IIIA includes: T3, N0, M0, High Mitotic Rate. T3: Tumor measuring more than 5 cm but not more than 10 cm. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. High Mitotic Rate: Over 5 mitoses per 5 square millimeters, or per 50 HPF. (AJCC 8th ed.) C136775 Neoplastic Process Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 CL524575 CTRP Malignant Stage IIIA Gastric (Stomach) and Omental Gastrointestinal Stromal Tumor (GIST) Stage IIIA Gastric and Omental GIST AJCC v8 Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage IIIA Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage IIIB includes: T4, N0, M0, High Mitotic Rate. T4: Tumor measuring more than 10 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. High Mitotic Rate: Over 5 mitoses per 5 square millimeters, or per 50 HPF. (AJCC 8th ed.) C136777 Neoplastic Process Stage IIIB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage IIIB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 CL524581 CTRP Malignant Stage IIIB Gastric (Stomach) and Omental Gastrointestinal Stromal Tumor (GIST) Stage IIIB Gastric and Omental GIST AJCC v8 Stage IIIB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage IIIB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage IV includes: (Any T, N1, M0, Any Mitotic Rate); (Any T, Any N, M1, Any Mitotic Rate). N1: Regional lymph node metastasis. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C136778 Neoplastic Process Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 CL524578 CTRP Malignant Stage IV Gastric (Stomach) and Omental Gastrointestinal Stromal Tumor (GIST) Stage IV Gastric and Omental GIST AJCC v8 Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8 Stage I includes: T1 or T2, N0, M0, Low Mitotic Rate. T1: Tumor measuring 2 cm or less. T2: Tumor measuring more than 2 cm but not more than 5 cm. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. Low Mitotic Rate: Five or fewer mitoses per 5 square millimeters, or per 50 HPF. (AJCC 8th ed.) C136780 Neoplastic Process Stage I Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 Stage I Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 CL524584 CTRP Malignant Stage I Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal GIST AJCC v8 Stage I Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor (GIST) Stage I Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 Stage I Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 Stage II includes: T3, N0, M0, Low Mitotic Rate. T3: Tumor measuring more than 5 cm but not more than 10 cm. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. Low Mitotic Rate: Five or fewer mitoses per 5 square millimeters, or per 50 HPF. (AJCC 8th ed.) C136781 Neoplastic Process Stage II Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 Stage II Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 CL524585 CTRP Malignant Stage II Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal GIST AJCC v8 Stage II Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor (GIST) Stage II Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 Stage II Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 Stage III includes: IIIA: (T1, N0, M0, High Mitotic Rate); (T4, N0, M0, Low Mitotic Rate); IIIB: (T2, N0, M0, High Mitotic Rate); (T3, N0, M0, High Mitotic Rate); (T4, N0, M0, High Mitotic Rate). T1: Tumor measuring 2 cm or less. T2: Tumor measuring more than 2 cm but not more than 5 cm. T3: Tumor measuring more than 5 cm but not more than 10 cm. T4: Tumor measuring more than 10 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. High Mitotic Rate: Over 5 mitoses per 5 square millimeters, or per 50 HPF. Low Mitotic Rate: Five or fewer mitoses per 5 square millimeters, or per 50 HPF. (AJCC 8th ed.) C136783 Neoplastic Process Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 CL524583 CTRP Malignant Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal GIST AJCC v8 Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor (GIST) Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 Stage IIIA includes: (T1, N0, M0, High Mitotic Rate); (T4, N0, M0, Low Mitotic Rate). T1: Tumor measuring 2 cm or less. T4: Tumor measuring more than 10 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. High Mitotic Rate: Over 5 mitoses per 5 square millimeters, or per 50 HPF. Low Mitotic Rate: Five or fewer mitoses per 5 square millimeters, or per 50 HPF. (AJCC 8th ed.) C136784 Neoplastic Process Stage IIIA Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 Stage IIIA Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 CL524588 CTRP Malignant Stage IIIA Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal GIST AJCC v8 Stage IIIA Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor (GIST) Stage IIIA Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 Stage IIIA Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 Stage IIIB includes: (T2, N0, M0, High Mitotic Rate); (T3, N0, M0, High Mitotic Rate); (T4, N0, M0, High Mitotic Rate). T2: Tumor measuring more than 2 cm but not more than 5 cm. T3: Tumor measuring more than 5 cm but not more than 10 cm. T4: Tumor measuring more than 10 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. High Mitotic Rate: Over 5 mitoses per 5 square millimeters, or per 50 HPF. (AJCC 8th ed.) C136785 Neoplastic Process Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 CL524589 CTRP Malignant Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal GIST AJCC v8 Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor (GIST) Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 Stage IV includes: (Any T, N1, M0, Any Mitotic Rate); (Any T, Any N, M1, Any Mitotic Rate). N1: Regional lymph node metastasis. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C136786 Neoplastic Process Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 CL524586 CTRP Malignant Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal GIST AJCC v8 Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor (GIST) Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8 A term that refers to the staging of retroperitoneal soft tissue sarcoma, following the rules of the TNM AJCC v8 classification system. This staging system applies to common sarcomas in the retroperitoneum. (from AJCC 8th Ed.) C136811 Neoplastic Process Retroperitoneal Sarcoma by AJCC v8 Stage CL524669 Malignant Retroperitoneal Sarcoma by AJCC v8 Stage Soft Tissue Sarcoma Retroperitoneum by AJCC v8 Stage Retroperitoneal Sarcoma by AJCC v8 Stage Stage I includes: IA: (T1, N0, M0, G1, GX); IB: (T2, T3, T4, N0, M0, G1, GX). T1: Tumor measuring 5 cm or less in greatest dimension. T2: Tumor measuring more than 5 cm and less than or equal to 10 cm in greatest dimension. T3: Tumor measuring more than 10 cm and less than or equal to 15 cm in greatest dimension. T4: Tumor measuring more than 15 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. GX: Grade cannot be assessed. G1: Total differentiation, mitotic count and necrosis score of 2 or 3. (AJCC 8th ed.) C136812 Neoplastic Process Stage I Retroperitoneal Sarcoma AJCC v8 Stage I Retroperitoneal Sarcoma AJCC v8 CL524674 CTRP Malignant Stage I Retroperitoneal Sarcoma Stage I Retroperitoneal Sarcoma AJCC v8 Stage I Retroperitoneal Sarcoma AJCC v8 Stage IA includes: T1, N0, M0, G1, GX. T1: Tumor measuring 5 cm or less in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. GX: Grade cannot be assessed. G1: Total differentiation, mitotic count and necrosis score of 2 or 3. (AJCC 8th ed.) C136813 Neoplastic Process Stage IA Retroperitoneal Sarcoma AJCC v8 Stage IA Retroperitoneal Sarcoma AJCC v8 CL524675 CTRP Malignant Stage IA Retroperitoneal Sarcoma Stage IA Retroperitoneal Sarcoma AJCC v8 Stage IA Soft Tissue Retroperitoneal Sarcoma AJCC v8 Stage IA Retroperitoneal Sarcoma AJCC v8 Stage IB includes: T2, T3, T4, N0, M0, G1, GX. T2: Tumor measuring more than 5 cm and less than or equal to 10 cm in greatest dimension. T3: Tumor measuring more than 10 cm and less than or equal to 15 cm in greatest dimension. T4: Tumor measuring more than 15 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. GX: Grade cannot be assessed. G1: Total differentiation, mitotic count and necrosis score of 2 or 3. (AJCC 8th ed.) C136814 Neoplastic Process Stage IB Retroperitoneal Sarcoma AJCC v8 Stage IB Retroperitoneal Sarcoma AJCC v8 CL524672 CTRP Malignant Stage IB Retroperitoneal Sarcoma Stage IB Retroperitoneal Sarcoma AJCC v8 Stage IB Soft Tissue Retroperitoneal Sarcoma AJCC v8 Stage IB Retroperitoneal Sarcoma AJCC v8 Stage II includes: T1, N0, M0, G2, G3. T1: Tumor measuring 5 cm or less in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. G2: Total differentiation, mitotic count and necrosis score of 4 or 5. G3: Total differentiation, mitotic count and necrosis score of 6, 7, or 8. (AJCC 8th ed.) C136815 Neoplastic Process Stage II Retroperitoneal Sarcoma AJCC v8 Stage II Retroperitoneal Sarcoma AJCC v8 CL524673 CTRP Malignant Stage II Retroperitoneal Sarcoma Stage II Retroperitoneal Sarcoma AJCC v8 Stage II Soft Tissue Retroperitoneal Sarcoma AJCC v8 Stage II Retroperitoneal Sarcoma AJCC v8 Stage III includes: IIIA: (T2, N0, M0, G2, G3); IIIB: (T3, T4, N0, M0, G2, G3); (Any T, N1, M0, Any G). T2: Tumor measuring more than 5 cm and less than or equal to 10 cm in greatest dimension. T3: Tumor measuring more than 10 cm and less than or equal to 15 cm in greatest dimension. T4: Tumor measuring more than 15 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. N1: Regional lymph node metastasis. M0: No distant metastasis. G2: Total differentiation, mitotic count and necrosis score of 4 or 5. G3: Total differentiation, mitotic count and necrosis score of 6, 7, or 8. (AJCC 8th ed.) C136816 Neoplastic Process Stage III Retroperitoneal Sarcoma AJCC v8 Stage III Retroperitoneal Sarcoma AJCC v8 CL524678 CTRP Malignant Stage III Retroperitoneal Sarcoma Stage III Retroperitoneal Sarcoma AJCC v8 Stage III Retroperitoneal Sarcoma AJCC v8 Stage IIIA includes: T2, N0, M0, G2, G3. T2: Tumor measuring more than 5 cm and less than or equal to 10 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. G2: Total differentiation, mitotic count and necrosis score of 4 or 5. G3: Total differentiation, mitotic count and necrosis score of 6, 7, or 8. (AJCC 8th ed.) C136817 Neoplastic Process Stage IIIA Retroperitoneal Sarcoma AJCC v8 Stage IIIA Retroperitoneal Sarcoma AJCC v8 CL524679 CTRP Malignant Stage IIIA Retroperitoneal Sarcoma Stage IIIA Retroperitoneal Sarcoma AJCC v8 Stage IIIA Soft Tissue Retroperitoneal Sarcoma AJCC v8 Stage IIIA Retroperitoneal Sarcoma AJCC v8 Stage IIIB includes: (T3, T4, N0, M0, G2, G3); (Any T, N1, M0, Any G). T3: Tumor measuring more than 10 cm and less than or equal to 15 cm in greatest dimension. T4: Tumor measuring more than 15 cm in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. N1: Regional lymph node metastasis. M0: No distant metastasis. G2: Total differentiation, mitotic count and necrosis score of 4 or 5. G3: Total differentiation, mitotic count and necrosis score of 6, 7, or 8. (AJCC 8th ed.) C136818 Neoplastic Process Stage IIIB Retroperitoneal Sarcoma AJCC v8 Stage IIIB Retroperitoneal Sarcoma AJCC v8 CL524676 CTRP Malignant Stage IIIB Retroperitoneal Sarcoma Stage IIIB Retroperitoneal Sarcoma AJCC v8 Stage IIIB Soft Tissue Retroperitoneal Sarcoma AJCC v8 Stage IIIB Retroperitoneal Sarcoma AJCC v8 Stage IV includes: Any T, Any N, M1, Any G. M1: Distant metastasis. (AJCC 8th ed.) C136819 Neoplastic Process Stage IV Retroperitoneal Sarcoma AJCC v8 Stage IV Retroperitoneal Sarcoma AJCC v8 CL524677 CTRP Malignant Stage IV Retroperitoneal Sarcoma Stage IV Retroperitoneal Sarcoma AJCC v8 Stage IV Soft Tissue Retroperitoneal Sarcoma AJCC v8 Stage IV Retroperitoneal Sarcoma AJCC v8 A junctional or compound melanocytic neoplasm not fulfilling the histopathologic criteria of melanoma but with one of the following features: asymmetry, predominance of single melanocytes over nests in lesions 4 mm or larger, ulceration, large dermal sheets of melanocytes, lack of maturation in dermis, deep dermal mitotic figures, extensive involvement of subcutis, and nuclear pleomorphism. (Mod Pathol 2006;19: S21) C136825 Neoplastic Process Spitz Melanocytoma CL524657 Undetermined AST Atypical Spitz Nevus Atypical Spitz Tumor Atypical Spitz Tumor of Uncertain Malignant Potential Melanocytic Tumor of Unknown Malignant Potential Pagetoid Spitz Nevus STUMP Spitz Melanocytoma Spitz Tumor with One or More Atypical Features Spitzoid Tumor of Uncertain Malignant Potential Spitz Melanocytoma A term that refers to the staging of Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma), following the rules of the TNM AJCC v7 classification system. C136869 Neoplastic Process Cutaneous Merkel Cell Carcinoma by AJCC v7 Stage CL524731 Malignant Cutaneous Merkel Cell Carcinoma by AJCC v7 Stage Cutaneous Neuroendocrine Carcinoma of the Skin by AJCC v7 Stage Cutaneous Merkel Cell Carcinoma by AJCC v7 Stage A term that refers to the staging of Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma), following the rules of the TNM AJCC v8 classification system. C136870 Neoplastic Process Cutaneous Merkel Cell Carcinoma by AJCC v8 Stage CL524728 Malignant Cutaneous Merkel Cell Carcinoma by AJCC v8 Stage Neuroendocrine Carcinoma of the Skin by AJCC v8 Stage Cutaneous Merkel Cell Carcinoma by AJCC v8 Stage A term that refers to the clinical staging of Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma), following the rules of the TNM AJCC v8 classification system. C136871 Neoplastic Process Cutaneous Merkel Cell Carcinoma by AJCC v8 Clinical Stage CL524729 Malignant Cutaneous Merkel Cell Carcinoma by AJCC v8 Clinical Stage Neuroendocrine Carcinoma of the Skin by AJCC v8 Clinical Stage Cutaneous Merkel Cell Carcinoma by AJCC v8 Clinical Stage Stage 0 includes: Tis, N0, M0. Tis: In situ primary tumor. N0: No regional lymph node metastasis detected on clinical and/or radiologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.) C136872 Neoplastic Process Clinical Stage 0 Cutaneous Merkel Cell Carcinoma AJCC v8 CL524734 Malignant Clinical Stage 0 Cutaneous Merkel Cell Carcinoma AJCC v8 Clinical Stage 0 Neuroendocrine Carcinoma of the Skin AJCC v8 Clinical Stage 0 Cutaneous Merkel Cell Carcinoma AJCC v8 Stage I includes: T1, N0, M0. T1: Maximum clinical tumor diameter equal to or less than 2 cm. N0: No regional lymph node metastasis detected on clinical and/or radiologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.) C136873 Neoplastic Process Clinical Stage I Cutaneous Merkel Cell Carcinoma AJCC v8 CL524735 Malignant Clinical Stage I Cutaneous Merkel Cell Carcinoma AJCC v8 Clinical Stage I Neuroendocrine Carcinoma of the Skin AJCC v8 Clinical Stage I Cutaneous Merkel Cell Carcinoma AJCC v8 Stage II includes: IIA: (T2-3, N0, M0); IIB: (T4, N0, M0). T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N0: No regional lymph node metastasis detected on clinical and/or radiologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.) C136874 Neoplastic Process Clinical Stage II Cutaneous Merkel Cell Carcinoma AJCC v8 CL524732 Malignant Clinical Stage II Cutaneous Merkel Cell Carcinoma AJCC v8 Clinical Stage II Neuroendocrine Carcinoma of the Skin AJCC v8 Clinical Stage II Cutaneous Merkel Cell Carcinoma AJCC v8 Stage IIA includes: T2-3, N0, M0. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. N0: No regional lymph node metastasis detected on clinical and/or radiologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.) C136875 Neoplastic Process Clinical Stage IIA Cutaneous Merkel Cell Carcinoma AJCC v8 CL524733 Malignant Clinical Stage IIA Cutaneous Merkel Cell Carcinoma AJCC v8 Clinical Stage IIA Neuroendocrine Carcinoma of the Skin AJCC v8 Clinical Stage IIA Cutaneous Merkel Cell Carcinoma AJCC v8 Stage IIB includes: T4, N0, M0. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N0: No regional lymph node metastasis detected on clinical and/or radiologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.) C136876 Neoplastic Process Clinical Stage IIB Cutaneous Merkel Cell Carcinoma AJCC v8 CL524738 Malignant Clinical Stage IIB Cutaneous Merkel Cell Carcinoma AJCC v8 Clinical Stage IIB Neuroendocrine Carcinoma of the Skin AJCC v8 Clinical Stage IIB Cutaneous Merkel Cell Carcinoma AJCC v8 Stage III includes: T0-4, N1-3, M0. T0: No evidence of primary tumor. T1: Maximum clinical tumor diameter equal to or less than 2 cm. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N1: Metastasis in regional lymph node(s). N2: In-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) without lymph node metastasis. N3: In-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) with lymph node metastasis. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.) C136877 Neoplastic Process Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 CL524739 Malignant Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 Clinical Stage III Neuroendocrine Carcinoma of the Skin AJCC v8 Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 Stage IV includes: T0-4, Any N, M1. T0: No evidence of primary tumor. T1: Maximum clinical tumor diameter equal to or less than 2 cm. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. M1: Distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.) C136878 Neoplastic Process Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8 CL524736 Malignant Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8 Clinical Stage IV Neuroendocrine Carcinoma of the Skin AJCC v8 Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8 A term that refers to the pathologic staging of Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma), following the rules of the TNM AJCC v8 classification system. C136880 Neoplastic Process Cutaneous Merkel Cell Carcinoma by AJCC v8 Pathologic Stage CL524742 Malignant Cutaneous Merkel Cell Carcinoma by AJCC v8 Pathologic Stage Neuroendocrine Carcinoma of the Skin by AJCC v8 Pathologic Stage Cutaneous Merkel Cell Carcinoma by AJCC v8 Pathologic Stage Stage 0 includes: Tis, N0, M0. Tis: In situ primary tumor. N0: No regional lymph node metastasis detected on pathologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.) C136881 Neoplastic Process Pathologic Stage 0 Cutaneous Merkel Cell Carcinoma AJCC v8 CL524743 Malignant Pathologic Stage 0 Cutaneous Merkel Cell Carcinoma AJCC v8 Pathologic Stage 0 Neuroendocrine Carcinoma of the Skin AJCC v8 Pathologic Stage 0 Cutaneous Merkel Cell Carcinoma AJCC v8 Stage I includes: T1, N0, M0. T1: Maximum clinical tumor diameter equal to or less than 2 cm. N0: No regional lymph node metastasis detected on pathologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.) C136882 Neoplastic Process Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8 CL524740 Malignant Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8 Pathologic Stage I Neuroendocrine Carcinoma of the Skin AJCC v8 Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8 Stage II includes: IIA: (T2-3, N0, M0); IIB: (T4, N0, M0). T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N0: No regional lymph node metastasis detected on pathologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.) C136883 Neoplastic Process Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8 CL524741 Malignant Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8 Pathologic Stage II Neuroendocrine Carcinoma of the Skin AJCC v8 Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8 Stage IIA includes: T2-3, N0, M0. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. N0: No regional lymph node metastasis detected on pathologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.) C136884 Neoplastic Process Pathologic Stage IIA Cutaneous Merkel Cell Carcinoma AJCC v8 CL524714 Malignant Pathologic Stage IIA Cutaneous Merkel Cell Carcinoma AJCC v8 Pathologic Stage IIA Neuroendocrine Carcinoma of the Skin AJCC v8 Pathologic Stage IIA Cutaneous Merkel Cell Carcinoma AJCC v8 Stage IIB includes: T4, N0, M0. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N0: No regional lymph node metastasis detected on pathologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.) C136885 Neoplastic Process Pathologic Stage IIB Cutaneous Merkel Cell Carcinoma AJCC v8 CL524715 Malignant Pathologic Stage IIB Cutaneous Merkel Cell Carcinoma AJCC v8 Pathologic Stage IIB Neuroendocrine Carcinoma of the Skin AJCC v8 Pathologic Stage IIB Cutaneous Merkel Cell Carcinoma AJCC v8 Stage III includes: IIIA: (T1-4, N1a(sn) or N1a, M0); (T0, N1b, M0); IIIB: (T1-4, N1b-3, M0). T0: No evidence of primary tumor. T1: Maximum clinical tumor diameter equal to or less than 2 cm. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N1a(sn): Clinically occult regional lymph node metastasis identified only by sentinel lymph node biopsy. N1a: Clinically occult regional lymph node metastasis following lymph node dissection. N1b: Clinically and/or radiologically detected regional lymph node metastasis, microscopically confirmed. N2: In-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) without lymph node metastasis. N3: In-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) with lymph node metastasis. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.) C136886 Neoplastic Process Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 CL524712 Malignant Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 Pathologic Stage III Neuroendocrine Carcinoma of the Skin AJCC v8 Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 Stage IIIA includes: (T1-4, N1a(sn) or N1a, M0); (T0, N1b, M0). T0: No evidence of primary tumor. T1: Maximum clinical tumor diameter equal to or less than 2 cm. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N1a(sn): Clinically occult regional lymph node metastasis identified only by sentinel lymph node biopsy. N1a: Clinically occult regional lymph node metastasis following lymph node dissection. N1b: Clinically and/or radiologically detected regional lymph node metastasis, microscopically confirmed. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.) C136887 Neoplastic Process Pathologic Stage IIIA Cutaneous Merkel Cell Carcinoma AJCC v8 CL524713 Malignant Pathologic Stage IIIA Cutaneous Merkel Cell Carcinoma AJCC v8 Pathologic Stage IIIA Neuroendocrine Carcinoma of the Skin AJCC v8 Pathologic Stage IIIA Cutaneous Merkel Cell Carcinoma AJCC v8 Stage IIIB includes: T1-4, N1b-3, M0. T1: Maximum clinical tumor diameter equal to or less than 2 cm. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N1b: Clinically and/or radiologically detected regional lymph node metastasis, microscopically confirmed. N2: In-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) without lymph node metastasis. N3: In-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) with lymph node metastasis. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.) C136888 Neoplastic Process Pathologic Stage IIIB Cutaneous Merkel Cell Carcinoma AJCC v8 CL524718 Malignant Pathologic Stage IIIB Cutaneous Merkel Cell Carcinoma AJCC v8 Pathologic Stage IIIB Neuroendocrine Carcinoma of the Skin AJCC v8 Pathologic Stage IIIB Cutaneous Merkel Cell Carcinoma AJCC v8 Stage IV includes: T0-4, Any N, M1. T0: No evidence of primary tumor. T1: Maximum clinical tumor diameter equal to or less than 2 cm. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. M1: Distant metastasis microscopically confirmed. (AJCC 8th ed.) C136889 Neoplastic Process Pathologic Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8 CL524719 Malignant Pathologic Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8 Pathologic Stage IV Neuroendocrine Carcinoma of the Skin AJCC v8 Pathologic Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8 The reemergence of lymphocyte-rich classic Hodgkin lymphoma after a period of remission. C136971 Neoplastic Process Recurrent Lymphocyte-Rich Classical Hodgkin Lymphoma Recurrent Lymphocyte-Rich Classic Hodgkin Lymphoma CL524767 CTRP Malignant Recurrent Lymphocyte-Rich Classic Hodgkin Lymphoma Recurrent Lymphocyte-Rich Classical Hodgkin Lymphoma Recurrent Lymphocyte-Rich Classic Hodgkin Lymphoma An aggressive, castration-resistant, histologically distinct, metastatic carcinoma arising from the prostate gland. It is characterized by the presence of a pure population of cytologically bland malignant epithelial cells with moderate to abundant cytoplasm and rare mitotic figures. The prognosis is poor. C136972 Neoplastic Process Intermediate Atypical Prostate Carcinoma CL524764 Malignant IAC Intermediate Atypical Carcinoma Intermediate Atypical Metastatic Castration-Resistant Prostate Cancer Intermediate Atypical Metastatic Castration-Resistant Prostate Carcinoma Intermediate Atypical Prostate Carcinoma Intermediate Atypical mCRPC Intermediate Atypical Prostate Carcinoma A term that refers to the staging of cutaneous melanoma, following the rules of the TNM AJCC v8 classification system. This staging system does not apply to melanoma of the conjunctiva, melanoma of the uvea, mucosal melanoma arising in the head and neck, and mucosal melanoma of the urethra, vagina, rectum, and anus. (from AJCC 8th Ed.) C137645 Neoplastic Process Cutaneous Melanoma by AJCC v8 Stage CL524751 Malignant Cutaneous Melanoma by AJCC v8 Stage Melanoma of the Skin by AJCC v8 Stage Cutaneous Melanoma by AJCC v8 Stage A term that refers to the clinical staging of cutaneous melanoma, following the rules of the TNM AJCC v8 classification system. C137646 Neoplastic Process Cutaneous Melanoma by AJCC v8 Clinical Stage CL524748 Malignant Cutaneous Melanoma by AJCC v8 Clinical Stage Melanoma of the Skin by AJCC v8 Clinical Stage Cutaneous Melanoma by AJCC v8 Clinical Stage Stage 0 includes: Tis, N0, M0. Tis: Melanoma in situ. Thickness: Not applicable. Ulceration status: Not applicable. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137647 Neoplastic Process Clinical Stage 0 Cutaneous Melanoma AJCC v8 Clinical Stage 0 Cutaneous Melanoma AJCC v8 CL524749 CTRP Malignant Clinical Stage 0 Cutaneous Melanoma AJCC v8 Clinical Stage 0 Melanoma of the Skin AJCC v8 Stage 0 Cutaneous (Skin) Melanoma Clinical Stage 0 Cutaneous Melanoma AJCC v8 Stage I includes: IA: (T1a, N0, M0); IB: (T1b, N0, M0); (T2a, N0, M0). T1a: Tumor measuring less than 0.8 mm in thickness. Ulceration status: Without ulceration. T1b: Tumor measuring less than 0.8 mm in thickness with ulceration, or 0.8-1.0 mm with or without ulceration. T2a: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: Without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137648 Neoplastic Process Clinical Stage I Cutaneous Melanoma AJCC v8 Clinical Stage I Cutaneous Melanoma AJCC v8 CL524754 CTRP Malignant Clinical Stage I Cutaneous Melanoma AJCC v8 Clinical Stage I Melanoma of the Skin AJCC v8 Stage I Cutaneous (Skin) Melanoma Clinical Stage I Cutaneous Melanoma AJCC v8 Stage IA includes: T1a, N0, M0. T1a: Tumor measuring less than 0.8 mm in thickness. Ulceration status: Without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137649 Neoplastic Process Clinical Stage IA Cutaneous Melanoma AJCC v8 Clinical Stage IA Cutaneous Melanoma AJCC v8 CL524755 CTRP Malignant Clinical Stage IA Cutaneous Melanoma AJCC v8 Clinical Stage IA Melanoma of the Skin AJCC v8 Stage IA Cutaneous (Skin) Melanoma Clinical Stage IA Cutaneous Melanoma AJCC v8 Stage IB includes: (T1b, N0, M0); (T2a, N0, M0). T1b: Tumor measuring less than 0.8 mm in thickness with ulceration, or 0.8-1.0 mm with or without ulceration. T2a: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: Without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137650 Neoplastic Process Clinical Stage IB Cutaneous Melanoma AJCC v8 Clinical Stage IB Cutaneous Melanoma AJCC v8 CL524752 CTRP Malignant Clinical Stage IB Cutaneous Melanoma AJCC v8 Clinical Stage IB Melanoma of the Skin AJCC v8 Stage IB Cutaneous (Skin) Melanoma Clinical Stage IB Cutaneous Melanoma AJCC v8 Stage II includes: IIA: (T2b, N0, M0); (T3a, N0, M0); IIB: (T3b, N0, M0); (T4a, N0, M0); IIC: (T4b, N0, M0). T2b: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: With ulceration. T3a: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: Without ulceration. T3b: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: With ulceration. T4a: Tumor measuring more than 4.0 mm in thickness. Ulceration status: Without ulceration. T4b: Tumor measuring more than 4.0 mm in thickness. Ulceration status: With ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137651 Neoplastic Process Clinical Stage II Cutaneous Melanoma AJCC v8 Clinical Stage II Cutaneous Melanoma AJCC v8 CL524753 CTRP Malignant Clinical Stage II Cutaneous Melanoma AJCC v8 Clinical Stage II Melanoma of the Skin AJCC v8 Stage II Cutaneous (Skin) Melanoma Clinical Stage II Cutaneous Melanoma AJCC v8 Stage IIA includes: (T2b, N0, M0); (T3a, N0, M0). T2b: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: With ulceration. T3a: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: Without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137652 Neoplastic Process Clinical Stage IIA Cutaneous Melanoma AJCC v8 Clinical Stage IIA Cutaneous Melanoma AJCC v8 CL524758 CTRP Malignant Clinical Stage IIA Cutaneous Melanoma AJCC v8 Clinical Stage IIA Melanoma of the Skin AJCC v8 Stage IIA Cutaneous (Skin) Melanoma Clinical Stage IIA Cutaneous Melanoma AJCC v8 Stage IIB includes: (T3b, N0, M0); (T4a, N0, M0). T3b: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: With ulceration. T4a: Tumor measuring more than 4.0 mm in thickness. Ulceration status: Without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137653 Neoplastic Process Clinical Stage IIB Cutaneous Melanoma AJCC v8 Clinical Stage IIB Cutaneous Melanoma AJCC v8 CL524759 CTRP Malignant Clinical Stage IIB Cutaneous Melanoma AJCC v8 Clinical Stage IIB Melanoma of the Skin AJCC v8 Stage IIB Cutaneous (Skin) Melanoma Clinical Stage IIB Cutaneous Melanoma AJCC v8 Stage IIC includes: T4b, N0, M0. T4b: Tumor measuring more than 4.0 mm in thickness. Ulceration status: With ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137654 Neoplastic Process Clinical Stage IIC Cutaneous Melanoma AJCC v8 Clinical Stage IIC Cutaneous Melanoma AJCC v8 CL524756 CTRP Malignant Clinical Stage IIC Cutaneous Melanoma AJCC v8 Clinical Stage IIC Melanoma of the Skin AJCC v8 Stage IIC Cutaneous (Skin) Melanoma Clinical Stage IIC Cutaneous Melanoma AJCC v8 Stage III includes: Any T, Tis, N1 or More, M0. Tis: Melanoma in situ. Thickness: Not applicable. Ulceration status: Not applicable. N1: One tumor-involved node or in-transit, satellite, and/or microsatellite metastases with no tumor-involved nodes. N2: Two or three tumor-involved nodes or in-transit, satellite, and/or microsatellite metastases with one tumor-involved node. N3: Four or more tumor-involved nodes or in-transit, satellite, and/or microsatellite metastases with two or more tumor-involved nodes, or any number of matted nodes without or with in-transit, satellite, and/or microsatellite metastases. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137655 Neoplastic Process Clinical Stage III Cutaneous Melanoma AJCC v8 Clinical Stage III Cutaneous Melanoma AJCC v8 CL524757 CTRP Malignant Clinical Stage III Cutaneous Melanoma AJCC v8 Clinical Stage III Melanoma of the Skin AJCC v8 Stage III Cutaneous (Skin) Melanoma Clinical Stage III Cutaneous Melanoma AJCC v8 Stage IV includes: Any T, Any N, M1. M1: Evidence of distant metastasis. (AJCC 8th ed.) C137656 Neoplastic Process Clinical Stage IV Cutaneous Melanoma AJCC v8 Clinical Stage IV Cutaneous Melanoma AJCC v8 CL524841 CTRP Malignant Clinical Stage IV Cutaneous Melanoma AJCC v8 Clinical Stage IV Melanoma of the Skin AJCC v8 Stage IV Cutaneous (Skin) Melanoma Clinical Stage IV Cutaneous Melanoma AJCC v8 A term that refers to the pathologic staging of cutaneous melanoma, following the rules of the TNM AJCC v8 classification system. C137657 Neoplastic Process Cutaneous Melanoma by AJCC v8 Pathologic Stage CL524842 CPTAC Malignant Cutaneous Melanoma by AJCC v8 Pathologic Stage Melanoma of the Skin by AJCC v8 Pathologic Stage Tumor Stage (Pathological) Cutaneous Melanoma by AJCC v8 Pathologic Stage Stage 0 includes: Tis, N0, M0. Tis: Melanoma in situ. Thickness: Not applicable. Ulceration status: Not applicable. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137662 Neoplastic Process Pathologic Stage 0 Cutaneous Melanoma AJCC v8 Pathologic Stage 0 Cutaneous Melanoma AJCC v8 CL524843 CPTAC CTRP mCode Malignant Melanoma in situ, unspecified Pathologic Stage 0 Cutaneous Melanoma AJCC v8 Pathologic Stage 0 Melanoma of the Skin AJCC v8 Stage 0 Stage 0 Cutaneous (Skin) Melanoma Pathologic Stage 0 Cutaneous Melanoma AJCC v8 Stage I includes: IA: (T1a, N0, M0); (T1b, N0, M0); IB: (T2a, N0, M0). T1a: Tumor measuring less than 0.8 mm in thickness. Ulceration status: Without ulceration. T1b: Tumor measuring less than 0.8 mm in thickness with ulceration, or 0.8-1.0 mm with or without ulceration. T2a: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: Without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137663 Neoplastic Process Pathologic Stage I Cutaneous Melanoma AJCC v8 Pathologic Stage I Cutaneous Melanoma AJCC v8 CL524844 CTRP Malignant Pathologic Stage I Cutaneous Melanoma AJCC v8 Pathologic Stage I Melanoma of the Skin AJCC v8 Stage I Cutaneous (Skin) Melanoma Pathologic Stage I Cutaneous Melanoma AJCC v8 Stage IA includes: (T1a, N0, M0); (T1b, N0, M0). T1a: Tumor measuring less than 0.8 mm in thickness. Ulceration status: Without ulceration. T1b: Tumor measuring less than 0.8 mm in thickness with ulceration, or 0.8-1.0 mm with or without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137664 Neoplastic Process Pathologic Stage IA Cutaneous Melanoma AJCC v8 Pathologic Stage IA Cutaneous Melanoma AJCC v8 CL524849 CPTAC CTRP Malignant Pathologic Stage IA Cutaneous Melanoma AJCC v8 Pathologic Stage IA Melanoma of the Skin AJCC v8 Stage IA Stage IA Cutaneous (Skin) Melanoma Pathologic Stage IA Cutaneous Melanoma AJCC v8 Stage IB includes: T2a, N0, M0. T2a: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: Without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137665 Neoplastic Process Pathologic Stage IB Cutaneous Melanoma AJCC v8 Pathologic Stage IB Cutaneous Melanoma AJCC v8 CL524850 CPTAC CTRP Malignant Pathologic Stage IB Cutaneous Melanoma AJCC v8 Pathologic Stage IB Melanoma of the Skin AJCC v8 Stage IB Stage IB Cutaneous (Skin) Melanoma Pathologic Stage IB Cutaneous Melanoma AJCC v8 Stage II includes: IIA: (T2b, N0, M0); (T3a, N0, M0); IIB: (T3b, N0, M0); (T4a, N0, M0); IIC: (T4b, N0, M0). T2b: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: With ulceration. T3a: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: Without ulceration. T3b: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: With ulceration. T4a: Tumor measuring more than 4.0 mm in thickness. Ulceration status: Without ulceration. T4b: Tumor measuring more than 4.0 mm in thickness. Ulceration status: With ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137666 Neoplastic Process Pathologic Stage II Cutaneous Melanoma AJCC v8 Pathologic Stage II Cutaneous Melanoma AJCC v8 CL524847 CTRP Malignant Pathologic Stage II Cutaneous Melanoma AJCC v8 Pathologic Stage II Melanoma of the Skin AJCC v8 Stage II Cutaneous (Skin) Melanoma Pathologic Stage II Cutaneous Melanoma AJCC v8 Stage IIA includes: (T2b, N0, M0); (T3a, N0, M0). T2b: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: With ulceration. T3a: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: Without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137667 Neoplastic Process Pathologic Stage IIA Cutaneous Melanoma AJCC v8 Pathologic Stage IIA Cutaneous Melanoma AJCC v8 CL524848 CPTAC CTRP Malignant Pathologic Stage IIA Cutaneous Melanoma AJCC v8 Pathologic Stage IIA Melanoma of the Skin AJCC v8 Stage IIA Stage IIA Cutaneous (Skin) Melanoma Pathologic Stage IIA Cutaneous Melanoma AJCC v8 Stage IIB includes: (T3b, N0, M0); (T4a, N0, M0). T3b: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: With ulceration. T4a: Tumor measuring more than 4.0 mm in thickness. Ulceration status: Without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137668 Neoplastic Process Pathologic Stage IIB Cutaneous Melanoma AJCC v8 Pathologic Stage IIB Cutaneous Melanoma AJCC v8 CL524853 CPTAC CTRP Malignant Pathologic Stage IIB Cutaneous Melanoma AJCC v8 Pathologic Stage IIB Melanoma of the Skin AJCC v8 Stage IIB Stage IIB Cutaneous (Skin) Melanoma Pathologic Stage IIB Cutaneous Melanoma AJCC v8 Stage IIC includes: T4b, N0, M0. T4b: Tumor measuring more than 4.0 mm in thickness. Ulceration status: With ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137669 Neoplastic Process Pathologic Stage IIC Cutaneous Melanoma AJCC v8 Pathologic Stage IIC Cutaneous Melanoma AJCC v8 CL524854 CPTAC CTRP Malignant Pathologic Stage IIC Cutaneous Melanoma AJCC v8 Pathologic Stage IIC Melanoma of the Skin AJCC v8 Stage IIC Stage IIC Cutaneous (Skin) Melanoma Pathologic Stage IIC Cutaneous Melanoma AJCC v8 Stage III includes: IIIA: (T1a/b-T2a, N1a or N2a, M0); IIIB: (T0, N1b, N1c, M0); (T1a/b-T2a, N1b/c or N2b, M0); (T2b/T3a, N1a-N2b, M0); IIIC: (T0, N2b, N2c, N3b or N3c); (T1a-T3a, N2c or N3a/b/c, M0); (T3b/T4a, Any N greater than or equal to N1, M0); (T4b, N1a-N2c, M0); IIID: (T4b, N3a/b/c, M0). T1a: Tumor measuring less than 0.8 mm in thickness. Ulceration status: Without ulceration. T1b: Tumor measuring less than 0.8 mm in thickness with ulceration, or 0.8-1.0 mm with or without ulceration. T2a: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: Without ulceration. T0: No evidence of primary tumor (e.g., unknown primary or completely regressed melanoma). Thickness: Not applicable. Ulceration status: Not applicable. T2b: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: With ulceration. T3a: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: Without ulceration. T3b: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: With ulceration. T4a: Tumor measuring more than 4.0 mm in thickness. Ulceration status: Without ulceration. T4b: Tumor measuring more than 4.0 mm in thickness. Ulceration status: With ulceration. N1a: One clinically occult nodal metastasis (i.e., detected by sentinel lymph node biopsy). Presence of in-transit, satellite, and/or microsatellite metastases: No. N2a: Two or three clinically occult nodal metastases (i.e., detected by sentinel lymph node biopsy). Presence of in-transit, satellite, and/or microsatellite metastases: No. N1b: One clinically detected nodal metastasis. Presence of in-transit, satellite, and/or microsatellite metastases: No. N1c: No regional lymph node disease. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. N2b: Two or three nodal metastases at least one of which was clinically detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. N2c: One clinically occult nodal metastasis. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. N3b: Four or more nodal metastases, at least one of which was clinically detected, or presence of any number of matted nodes. Presence of in-transit, satellite, and/or microsatellite metastases: No. N3c: Two or more clinically occult nodal metastases. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. N3a: Four or more clinically occult nodal metastasis (i.e., detected by sentinel lymph node biopsy). Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137670 Neoplastic Process Pathologic Stage III Cutaneous Melanoma AJCC v8 Pathologic Stage III Cutaneous Melanoma AJCC v8 CL524851 CTRP Malignant Pathologic Stage III Cutaneous Melanoma AJCC v8 Pathologic Stage III Melanoma of the Skin AJCC v8 Stage III Cutaneous (Skin) Melanoma Pathologic Stage III Cutaneous Melanoma AJCC v8 Stage IIIA includes: T1a/b-T2a, N1a or N2a, M0. T1a: Tumor measuring less than 0.8 mm in thickness. Ulceration status: Without ulceration. T1b: Tumor measuring less than 0.8 mm in thickness with ulceration, or 0.8-1.0 mm with or without ulceration. T2a: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: Without ulceration. N1a: One clinically occult nodal metastasis (i.e., detected by sentinel lymph node biopsy). Presence of in-transit, satellite, and/or microsatellite metastases: No. N2a: Two or three clinically occult nodal metastases (i.e., detected by sentinel lymph node biopsy). Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137671 Neoplastic Process Pathologic Stage IIIA Cutaneous Melanoma AJCC v8 Pathologic Stage IIIA Cutaneous Melanoma AJCC v8 CL524852 CPTAC CTRP Malignant Pathologic Stage IIIA Cutaneous Melanoma AJCC v8 Pathologic Stage IIIA Melanoma of the Skin AJCC v8 Stage IIIA Stage IIIA Cutaneous (Skin) Melanoma Pathologic Stage IIIA Cutaneous Melanoma AJCC v8 Stage IIIB includes: (T0, N1b, N1c, M0); (T1a/b-T2a, N1b/c or N2b, M0); (T2b/T3a, N1a-N2b, M0). T0: No evidence of primary tumor (e.g., unknown primary or completely regressed melanoma). Thickness: Not applicable. Ulceration status: Not applicable. T1a: Tumor measuring less than 0.8 mm in thickness. Ulceration status: Without ulceration. T1b: Tumor measuring less than 0.8 mm in thickness with ulceration, or 0.8-1.0 mm with or without ulceration. T2a: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: Without ulceration. T2b: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: With ulceration. T3a: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: Without ulceration. N1b: One clinically detected nodal metastasis. Presence of in-transit, satellite, and/or microsatellite metastases: No. N1c: No regional lymph node disease. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. N2b: Two or three nodal metastases at least one of which was clinically detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. N1a: One clinically occult nodal metastasis (i.e., detected by sentinel lymph node biopsy). Presence of in-transit, satellite, and/or microsatellite metastases: No. N2a: Two or three clinically occult nodal metastases (i.e., detected by sentinel lymph node biopsy). Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137672 Neoplastic Process Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 CL524828 CPTAC CTRP Malignant Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 Pathologic Stage IIIB Melanoma of the Skin AJCC v8 Stage IIIB Stage IIIB Cutaneous (Skin) Melanoma Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 Stage IIIC includes: (T0, N2b, N2c, N3b or N3c); (T1a-T3a, N2c or N3a/b/c, M0); (T3b/T4a, Any N greater than or equal to N1, M0); (T4b, N1a-N2c, M0). T0: No evidence of primary tumor (e.g., unknown primary or completely regressed melanoma). Thickness: Not applicable. Ulceration status: Not applicable. T1a: Tumor measuring less than 0.8 mm in thickness. Ulceration status: Without ulceration. T1b: Tumor measuring less than 0.8 mm in thickness with ulceration, or 0.8-1.0 mm with or without ulceration. T2a: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: Without ulceration. T2b: Tumor measuring more than 1.0 and equal to or less than 2.0 mm in thickness. Ulceration status: With ulceration. T3a: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: Without ulceration. T3b: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: With ulceration. T4a: Tumor measuring more than 4.0 mm in thickness. Ulceration status: Without ulceration. T4b: Tumor measuring more than 4.0 mm in thickness. Ulceration status: With ulceration. N2b: Two or three nodal metastases at least one of which was clinically detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. N2c: One clinically occult nodal metastasis. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. N3b: Four or more nodal metastases, at least one of which was clinically detected, or presence of any number of matted nodes. Presence of in-transit, satellite, and/or microsatellite metastases: No. N3c: Two or more clinically occult nodal metastases. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. N3a: Four or more clinically occult nodal metastasis (i.e., detected by sentinel lymph node biopsy). Presence of in-transit, satellite, and/or microsatellite metastases: No. N1a: One clinically occult nodal metastasis (i.e., detected by sentinel lymph node biopsy). Presence of in-transit, satellite, and/or microsatellite metastases: No. N1b: One clinically detected nodal metastasis. Presence of in-transit, satellite, and/or microsatellite metastases: No. N1c: No regional lymph node disease. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. N2a: Two or three clinically occult nodal metastases (i.e., detected by sentinel lymph node biopsy). Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137673 Neoplastic Process Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 CL524829 CPTAC CTRP Malignant Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Pathologic Stage IIIC Melanoma of the Skin AJCC v8 Stage IIIC Stage IIIC Cutaneous (Skin) Melanoma Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Breast carcinoma presenting with isolated axillary lymphadenopathy, without clinical or mammographic evidence of breast tumor. C137674 Neoplastic Process Occult Breast Carcinoma CL524826 Malignant Occult Breast Carcinoma Occult Breast Carcinoma Stage IIID includes: T4b, N3a/b/c, M0. T4b: Tumor measuring more than 4.0 mm in thickness. Ulceration status: With ulceration. N3a: Four or more clinically occult nodal metastasis (i.e., detected by sentinel lymph node biopsy). Presence of in-transit, satellite, and/or microsatellite metastases: No. N3b: Four or more nodal metastases, at least one of which was clinically detected, or presence of any number of matted nodes. Presence of in-transit, satellite, and/or microsatellite metastases: No. N3c: Two or more clinically occult nodal metastases. Presence of in-transit, satellite, and/or microsatellite metastases: Yes. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.) C137675 Neoplastic Process Pathologic Stage IIID Cutaneous Melanoma AJCC v8 Pathologic Stage IIID Cutaneous Melanoma AJCC v8 CL524827 CTRP Malignant Pathologic Stage IIID Cutaneous Melanoma AJCC v8 Pathologic Stage IIID Melanoma of the Skin AJCC v8 Stage IIID Cutaneous (Skin) Melanoma Pathologic Stage IIID Cutaneous Melanoma AJCC v8 Stage IV includes: Any T, Tis, Any N, M1. Tis: Melanoma in situ. Thickness: Not applicable. Ulceration status: Not applicable. M1: Evidence of distant metastasis. (AJCC 8th ed.) C137677 Neoplastic Process Pathologic Stage IV Cutaneous Melanoma AJCC v8 Pathologic Stage IV Cutaneous Melanoma AJCC v8 CL524831 CPTAC CTRP Malignant Pathologic Stage IV Cutaneous Melanoma AJCC v8 Pathologic Stage IV Melanoma of the Skin AJCC v8 Stage IV Stage IV Cutaneous (Skin) Melanoma Pathologic Stage IV Cutaneous Melanoma AJCC v8 Any of the lymph nodes located within the breast parenchyma. C137678 Anatomical Structure Intramammary Lymph Node C2732830 GDC Lymph Node(s) Mammary Intramammary Lymph Node Intramammary Node Lymph Node(s) Mammary Intramammary Lymph Node An imaging procedure that combines F-18 sodium fluoride PET with a CT scan to overlay activity data onto detailed anatomic images. C137816 Diagnostic Procedure F-18 Sodium Fluoride Positron Emission Tomography and Computed Tomography Scan CL524888 NCCN F-18 Sodium Fluoride PET/CT F-18 Sodium Fluoride Positron Emission Tomography and Computed Tomography Scan F-18 Sodium Fluoride Positron Emission Tomography and Computed Tomography Scan An imaging procedure that combines FDG PET with a CT scan to overlay activity data onto detailed anatomic images. C137817 Diagnostic Procedure FDG-Positron Emission Tomography and Computed Tomography Scan CL524894 NCCN FDG PET/CT FDG-Positron Emission Tomography and Computed Tomography Scan FDG-Positron Emission Tomography and Computed Tomography Scan Breast lobular carcinoma in situ characterized by the presence of neoplastic large cells with marked nuclear pleomorphism. C137839 Neoplastic Process Breast Pleomorphic Lobular Carcinoma In Situ CL524883 GDC NCCN Malignant Lobular carcinoma in situ, pleomorphic Pleomorphic lobular carcinoma in situ Breast Pleomorphic Lobular Carcinoma In Situ Non-Invasive Pleomorphic Lobular Carcinoma of the Breast PLCIS Pleomorphic Lobular Breast Carcinoma In Situ Pleomorphic Lobular Carcinoma in Situ of the Breast pLCIS Breast Pleomorphic Lobular Carcinoma In Situ Anal carcinoma that does not respond to treatment. C137857 Neoplastic Process Refractory Anal Carcinoma Refractory Anal Carcinoma CL524870 CTRP Malignant Refractory Anal Cancer Refractory Anal Carcinoma Refractory Anal Carcinoma Pancreatic neuroendocrine carcinoma that does not respond to treatment. C137862 Neoplastic Process Refractory Pancreatic Neuroendocrine Carcinoma Refractory Pancreatic Neuroendocrine Carcinoma CL524942 CTRP Malignant Refractory Pancreatic Neuroendocrine Cancer Refractory Pancreatic Neuroendocrine Carcinoma Refractory Pancreatic Neuroendocrine Carcinoma Positron emission tomography combined with computed tomography of an anatomical area of interest with the use of the contrast agent fludeoxyglucose F 18 (18F-FDG) to enhance the image. C137868 Diagnostic Procedure FDG-Positron Emission Tomography/Computed Tomography of an Area of Interest CL524944 NCCN Area of Interest 18F FDG PET/CT Area of Interest FDG-PET/CT Area of Interest FDG-Positron Emission Tomography/Computed Tomography FDG PET/CT Area of Interest FDG-Positron Emission Tomography/Computed Tomography of an Area of Interest PET/CT, Area of Interest, FDG Positron Emission Tomography/Computed Tomography, Area of Interest, FDG FDG-Positron Emission Tomography/Computed Tomography of an Area of Interest Positron emission tomography combined with computed tomography of the region encompassing the skull base to the mid-thigh with the use of the contrast agent fludeoxyglucose F 18 (18F-FDG) to enhance the image. C137869 Diagnostic Procedure FDG-Positron Emission Tomography/Computed Tomography from the Skull Base to Mid-thigh CL524943 NCCN FDG PET/CT Skull Base to Mid-thigh FDG-Positron Emission Tomography/Computed Tomography from the Skull Base to Mid-thigh PET/CT, Skull Base to Mid-thigh, FDG Positron Emission Tomography/Computed Tomography, Skull Base to Mid-thigh, FDG Skull Base to Mid-thigh 18F FDG PET/CT Skull Base to Mid-thigh FDG-PET/CT Skull Base to Mid-thigh FDG-Positron Emission Tomography/Computed Tomography Skull Base to Mid-thigh PET/CT Scan with FDG FDG-Positron Emission Tomography/Computed Tomography from the Skull Base to Mid-thigh Magnetic resonance imaging of the pelvis without the use of a contrast agent. C137870 Diagnostic Procedure Magnetic Resonance Imaging of the Pelvis without Contrast Magnetic Resonance Imaging of the Pelvis without Contrast CL515656 CTRP NCCN MRI of the Pelvis without Contrast Magnetic Resonance Imaging of the Pelvis without Contrast Pelvic MRI without Contrast Pelvic Magnetic Resonance Imaging without Contrast Magnetic Resonance Imaging of the Pelvis without Contrast Magnetic resonance imaging of the entire body of a patient without the use of a contrast agent. C137871 Diagnostic Procedure Magnetic Resonance Imaging of the Whole Body without Contrast CL524945 NCCN Magnetic Resonance Imaging of the Whole Body without Contrast WB-MRI without Contrast Whole Body MRI without Contrast Whole Body Magnetic Resonance Imaging without Contrast Whole-body MRI without Contrast Magnetic Resonance Imaging of the Whole Body without Contrast Magnetic resonance imaging of the abdomen without the use of a contrast agent. C137872 Diagnostic Procedure Magnetic Resonance Imaging of the Abdomen without Contrast Magnetic Resonance Imaging of the Abdomen without Contrast CL527492 CTRP NCCN Abdominal MRI without Contrast MRI of the Abdomen without Contrast Magnetic Resonance Imaging of the Abdomen without Contrast Magnetic Resonance Imaging of the Abdomen without Contrast Magnetic resonance imaging of the abdomen and pelvis, without the use of a contrast agent. C137873 Diagnostic Procedure Magnetic Resonance Imaging of the Abdomen and Pelvis without Contrast CL515624 NCCN Abdominal/Pelvic MRI without Contrast MRI of the Abdomen and Pelvis without Contrast Magnetic Resonance Imaging of the Abdomen and Pelvis without Contrast Magnetic Resonance Imaging of the Abdomen and Pelvis without Contrast Magnetic resonance imaging of the brain without the use of a contrast agent. C137874 Diagnostic Procedure Magnetic Resonance Imaging of the Brain without Contrast CL515634 NCCN Brain MRI without Contrast Brain Magnetic Resonance Imaging without Contrast Head MRI without Contrast Magnetic Resonance Imaging of the Brain without Contrast Magnetic Resonance Imaging of the Brain without Contrast Magnetic resonance imaging of the breast without the use of a contrast agent. C137875 Diagnostic Procedure Magnetic Resonance Imaging of the Breast without Contrast Magnetic Resonance Imaging of the Breast without Contrast CL524948 CTRP NCCN Breast MRI without Contrast Breast Magnetic Resonance Imaging without Contrast Magnetic Resonance Imaging of the Breast without Contrast Magnetic Resonance Imaging of the Breast without Contrast Magnetic resonance imaging of the primary site without a contrast agent to enhance the image. C137902 Diagnostic Procedure Magnetic Resonance Imaging of a Primary Site with and without Contrast CL524924 NCCN MRI with and without Contrast of Primary Site Magnetic Resonance Imaging of a Primary Site with and without Contrast Magnetic Resonance Imaging with and without Contrast of Primary Site Magnetic Resonance Imaging of a Primary Site with and without Contrast Positron emission tomography combined with computed tomography of the region encompassing the skull base to the mid-thigh with the use of the contrast agent sodium fluoride F 18 (18F-NaF) to enhance the image. C137905 Diagnostic Procedure Sodium Fluoride Positron Emission Tomography/Computed Tomography from the Skull Base to Mid-thigh CL524927 NCCN 18F-NaF Skull Base to Mid-thigh PET/CT Scan PET/CT, Skull Base to Mid-thigh, Sodium Fluoride Positron Emission Tomography/Computed Tomography, Skull Base to Mid-thigh, Sodium Fluoride Skull Base to Mid-thigh 18F-NaF Positron Emission Tomography/Computed Tomography Skull Base to Mid-thigh PET/CT Scan with Sodium Fluoride Skull Base to Mid-thigh Sodium Fluoride Positron Emission Tomography/Computed Tomography Sodium Fluoride Positron Emission Tomography/Computed Tomography from the Skull Base to Mid-thigh Sodium Fluoride Positron Emission Tomography/Computed Tomography from the Skull Base to Mid-thigh Positron emission tomography combined with computed tomography of the whole body with the use of the contrast agent sodium fluoride F 18 (18F-NaF) to enhance the image. C137906 Diagnostic Procedure Sodium Fluoride Positron Emission Tomography/Computed Tomography of the Whole Body CL524926 NCCN 18F-NaF Whole-body PET/CT Scan NaF PET/CT WB PET/CT, Whole Body, Sodium Fluoride Sodium Fluoride Positron Emission Tomography/Computed Tomography of the Whole Body Sodium Fluoride WB PET-CT WB PET/CT Scan with Sodium Fluoride Whole Body 18F-NaF Positron Emission Tomography/Computed Tomography Whole Body Sodium Fluoride Positron Emission Tomography/Computed Tomography Sodium Fluoride Positron Emission Tomography/Computed Tomography of the Whole Body Positron emission tomography combined with computed tomography of the whole body, with the use of the contrast agent fludeoxyglucose F 18 (18F-FDG) to enhance the image. C137907 Diagnostic Procedure FDG-Positron Emission Tomography/Computed Tomography of the Whole Body FDG-Positron Emission Tomography/Computed Tomography of the Whole Body CL524929 CTRP NCCN EXPLORER Scanner FDG-Positron Emission Tomography/Computed Tomography of the Whole Body PET/CT, Whole Body, FDG Positron Emission Tomography/Computed Tomography, Whole Body, FDG Total-Body Positron Emission Tomography/Computed Tomography WB PET/CT Scan with FDG Whole Body FDG-PET/CT Whole Body FDG-Positron Emission Tomography/Computed Tomography Whole Body [18]F- Fludeoxyglucose Positron Emission Tomography/Computed Tomography Whole-body 18F FDG PET/CT Whole-body FDG-PET/CT [18]F-FDG PET/CT FDG-Positron Emission Tomography/Computed Tomography of the Whole Body Magnetic resonance imaging of the abdomen and pelvis, with and without the use of a contrast agent to enhance the image. C137911 Diagnostic Procedure Magnetic Resonance Imaging of the Abdomen and Pelvis with and without Contrast CL524914 NCCN Abdominal/Pelvic MRI with and without Contrast MRI of the Abdomen and Pelvis with and without Contrast Magnetic Resonance Imaging of the Abdomen and Pelvis with and without Contrast Magnetic Resonance Imaging of the Abdomen and Pelvis with and without Contrast Magnetic resonance imaging of bone. C137912 Diagnostic Procedure Magnetic Resonance Imaging of Bone C1960255 NCCN Bone MRI Magnetic Resonance Imaging of Bone Magnetic Resonance Imaging of Bone Magnetic resonance imaging of the brain with and without the use of a contrast agent to enhance the image. C137913 Diagnostic Procedure Magnetic Resonance Imaging of the Brain with and without Contrast Magnetic Resonance Imaging of the Brain with and without Contrast CL976401 ACC/AHA CTRP NCCN Documented findings from brain MRI Brain MRI Brain MRI with and without Contrast Brain Magnetic Resonance Imaging with and without Contrast Head MRI with and without Contrast Magnetic Resonance Imaging of the Brain with and without Contrast Magnetic Resonance Imaging of the Brain with and without Contrast Magnetic resonance imaging of the breast with and without the use of a contrast agent to enhance the image. C137914 Diagnostic Procedure Magnetic Resonance Imaging of the Breast with and without Contrast CL524912 NCCN Breast MRI with and without Contrast Breast Magnetic Resonance Imaging with and without Contrast Magnetic Resonance Imaging of the Breast with and without Contrast Magnetic Resonance Imaging of the Breast with and without Contrast Magnetic resonance imaging of the heart. C137915 Diagnostic Procedure Magnetic Resonance Imaging of the Heart Magnetic Resonance Imaging of the Heart C0412692 ACC/AHA CTRP NCCN A noninvasive medical imaging technology using magnetic field and radio waves to evaluate the heart's anatomy and function for detection and monitoring of cardiac diseases. Imaging that uses radiofrequency waves and a strong field rather than x-rays to provide amazingly clear and detailed pictures of cardiac structures. The technique is valuable for the diagnosis of many cardiovascular pathological conditions, including myocarditis, wall motion abnormalities, structural cardiac abnormalities, infiltrative diseases, intracardiac thrombus, and pericardial disease. Medical imaging with MRI technology for noninvasive assessment of the function and structure of the cardiovascular system using ECG gating and high temporal resolution protocols with an intent to assess myocarditis, cardiac function, and structures during or after COVID-19. Cardiac MRI Heart MRI Magnetic Resonance Imaging of the Heart Magnetic Resonance Imaging of the Heart Magnetic resonance imaging of the chest with and without the use of a contrast agent to enhance the image. C137916 Diagnostic Procedure Magnetic Resonance Imaging of the Chest with and without Contrast CL515639 NCCN Chest MRI with and without Contrast Chest Magnetic Resonance Imaging with and without Contrast Magnetic Resonance Imaging of the Chest with and without Contrast Magnetic Resonance Imaging of the Chest with and without Contrast Magnetic resonance imaging done from inside the rectum that usually utilizes a surface coil within a latex balloon to generate the magnetic field. C137917 Diagnostic Procedure Endorectal Magnetic Resonance Imaging CL524916 NCCN Endorectal MRI Endorectal Magnetic Resonance Imaging Endorectal Magnetic Resonance Imaging Magnetic resonance imaging of the head and neck with and without the use of a contrast agent to enhance the image. C137918 Diagnostic Procedure Magnetic Resonance Imaging of the Head and Neck with and without Contrast CL524915 NCCN Head and Neck Magnetic Resonance Imaging with and without Contrast Head/Neck MRI with and without Contrast Magnetic Resonance Imaging of the Head and Neck with and without Contrast Magnetic Resonance Imaging of the Head and Neck with and without Contrast Magnetic resonance imaging of an anatomical area of interest with and without a contrast agent to enhance the image. C137919 Diagnostic Procedure Magnetic Resonance Imaging of an Area of Interest with and without Contrast CL524919 NCCN MRI with and without Contrast of Area of Interest Magnetic Resonance Imaging of an Area of Interest with and without Contrast Magnetic Resonance Imaging with and without Contrast of Area of Interest Magnetic Resonance Imaging of an Area of Interest with and without Contrast Magnetic resonance imaging of the neck with and without a contrast agent to enhance the image. C137920 Diagnostic Procedure Magnetic Resonance Imaging of the Neck with and without Contrast CL524918 NCCN MRI of the Neck with and without Contrast Magnetic Resonance Imaging of the Neck with and without Contrast Neck Computed Tomography with and without Contrast Neck MRI with and without Contrast Magnetic Resonance Imaging of the Neck with and without Contrast Magnetic resonance imaging of the whole body with and without the use of a contrast agent to enhance the image. C137921 Diagnostic Procedure Magnetic Resonance Imaging of the Whole Body with and without Contrast CL524917 NCCN Magnetic Resonance Imaging of the Whole Body with and without Contrast WB-MRI with and without Contrast Whole Body MRI with and without Contrast Whole Body Magnetic Resonance Imaging with and without Contrast Whole-body MRI with and without Contrast Magnetic Resonance Imaging of the Whole Body with and without Contrast Ultrasound of one or more lymph nodes in the axillary area. C137924 Health Care Activity Axillary Lymph Node Ultrasound CL524922 NCCN Axillary Lymph Node Ultrasound Axillary Lymph Node Ultrasound An ultrasound of the neck. C137925 Health Care Activity Ultrasound of the Neck CL524921 NCCN Neck Ultrasound Ultrasound of the Neck Ultrasound of the Neck An ultrasound of one or more lymph nodes in an anatomical area of interest. C137926 Health Care Activity Regional Lymph Node Ultrasound CL524920 NCCN Regional Lymph Node Ultrasound Regional Lymph Node Ultrasound An X-ray of an anatomical area of interest. C137927 Diagnostic Procedure X-ray of an Area of Interest CL524979 NCCN Area of Interest X-ray X-ray Imaging of Area of Interest X-ray of an Area of Interest X-ray of an Area of Interest An X-ray of the primary site. C137928 Diagnostic Procedure X-ray of Primary Site CL524978 NCCN Primary Site X-ray X-ray Imaging of Primary Site X-ray of Primary Site X-ray of Primary Site Magnetic resonance imaging of the abdomen with and without the use of a contrast agent to enhance the image. C137929 Diagnostic Procedure Magnetic Resonance Imaging of the Abdomen with and without Contrast Magnetic Resonance Imaging of the Abdomen with and without Contrast CL524977 CTRP NCCN Abdominal MRI with and without Contrast MRI of the Abdomen with and without Contrast Magnetic Resonance Imaging of the Abdomen with and without Contrast Magnetic Resonance Imaging of the Abdomen with and without Contrast Multiphasic magnetic resonance imaging of the abdomen. C137930 Diagnostic Procedure Multiphasic Magnetic Resonance Imaging of the Abdomen CL524976 NCCN Abdominal MRI, Multiphasic Multiphasic MRI of the Abdomen Multiphasic Magnetic Resonance Imaging of the Abdomen Multiphasic Magnetic Resonance Imaging of the Abdomen Multiphasic magnetic resonance imaging of the abdomen and pelvis. C137931 Diagnostic Procedure Multiphasic Magnetic Resonance imaging of the Abdomen and Pelvis CL524982 NCCN Abdominal/Pelvic MRI, Multiphasic Multiphasic MRI of the Abdomen and Pelvis Multiphasic Magnetic Resonance imaging of the Abdomen and Pelvis Multiphasic Magnetic Resonance imaging of the Abdomen and Pelvis Magnetic resonance imaging of skeletal metastatic sites with the use of a contrast agent to enhance the image. C137932 Diagnostic Procedure Magnetic Resonance Imaging of Skeletal Metastatic Sites with Contrast CL524981 NCCN MRI of Skeletal Metastatic Sites with Contrast Magnetic Resonance Imaging of Skeletal Metastatic Sites with Contrast Magnetic Resonance Imaging of Skeletal Metastatic Sites with Contrast Magnetic resonance imaging of the pelvis with and without the use of a contrast agent to enhance the image. C137933 Diagnostic Procedure Magnetic Resonance Imaging of the Pelvis with and without Contrast CL524980 NCCN MRI of the Pelvis with and without Contrast Magnetic Resonance Imaging of the Pelvis with and without Contrast Pelvic MRI with and without Contrast Pelvic Magnetic Resonance Imaging with and without Contrast Magnetic Resonance Imaging of the Pelvis with and without Contrast Mammography of both breasts for the purpose of diagnosis of disease. C137937 Diagnostic Procedure Bilateral Diagnostic Mammogram CL524983 NCCN Bilateral Diagnostic Mammogram Bilateral Diagnostic Mammogram The reemergence of gray-zone lymphoma after a period of remission. C138013 Neoplastic Process Recurrent B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma Recurrent Gray-Zone Lymphoma CL525018 CTRP Malignant Recurrent B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma Recurrent B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma Recurrent Gray Zone Lymphoma Recurrent Gray-Zone Lymphoma Recurrent Gray-Zone Lymphoma Gray-zone lymphoma that is resistant to treatment. C138014 Neoplastic Process Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma Refractory Gray-Zone Lymphoma CL525017 CTRP Malignant Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma Refractory B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma Refractory Gray Zone Lymphoma Refractory Gray-Zone Lymphoma Refractory Gray-Zone Lymphoma The reemergence of extranodal diffuse large B-cell lymphoma after a period of remission. C138015 Neoplastic Process Recurrent Extranodal Diffuse Large B-Cell Lymphoma Recurrent Extranodal Diffuse Large B-cell Lymphoma CL525023 CTRP Malignant Recurrent Extranodal Diffuse Large B-Cell Lymphoma Recurrent Extranodal Diffuse Large B-cell Lymphoma Recurrent Extranodal Diffuse Large B-cell Lymphoma Extranodal diffuse large B-cell lymphoma that is resistant to treatment. C138018 Neoplastic Process Refractory Extranodal Diffuse Large B-Cell Lymphoma Refractory Extranodal Diffuse Large B-cell Lymphoma CL525021 CTRP Malignant Refractory Extranodal Diffuse Large B-Cell Lymphoma Refractory Extranodal Diffuse Large B-cell Lymphoma Refractory Extranodal Diffuse Large B-cell Lymphoma The reemergence of central nervous system lymphoma after a period of remission. C138019 Neoplastic Process Recurrent Central Nervous System Lymphoma Recurrent Central Nervous System Lymphoma CL525020 CTRP Malignant Recurrent Central Nervous System Lymphoma Recurrent Primary Central Nervous System Lymphoma Recurrent Central Nervous System Lymphoma Central nervous system lymphoma that is resistant to treatment. C138020 Neoplastic Process Refractory Central Nervous System Lymphoma Refractory Central Nervous System Lymphoma CL525027 CTRP Malignant Refractory Central Nervous System Lymphoma Refractory Primary Central Nervous System Lymphoma Refractory Central Nervous System Lymphoma The reemergence of testicular lymphoma after a period of remission. C138021 Neoplastic Process Recurrent Testicular Lymphoma Recurrent Testicular Lymphoma CL525026 CTRP Malignant Recurrent Testicular Lymphoma Recurrent Testicular Lymphoma Testicular lymphoma that is resistant to treatment. C138022 Neoplastic Process Refractory Testicular Lymphoma Refractory Testicular Lymphoma CL525025 CTRP Malignant Refractory Testicular Lymphoma Refractory Testicular Lymphoma The reemergence of breast lymphoma after a period of remission. C138023 Neoplastic Process Recurrent Breast Lymphoma Recurrent Breast Lymphoma CL525024 CTRP Malignant Recurrent Breast Lymphoma Recurrent Breast Lymphoma Breast lymphoma that is resistant to treatment. C138024 Neoplastic Process Refractory Breast Lymphoma Refractory Breast Lymphoma CL525005 CTRP Malignant Refractory Breast Lymphoma Refractory Breast Lymphoma The reemergence of intravascular large B-cell lymphoma after a period of remission. C138025 Neoplastic Process Recurrent Intravascular Large B-Cell Lymphoma Recurrent Intravascular Large B-Cell Lymphoma CL525004 CTRP Malignant Recurrent Intravascular B-Cell Lymphoma Recurrent Intravascular Large B-Cell Lymphoma Recurrent Intravascular Large B-Cell Lymphoma Intravascular large B-cell lymphoma that is resistant to treatment. C138026 Neoplastic Process Refractory Intravascular Large B-Cell Lymphoma Refractory Intravascular Large B-Cell Lymphoma CL525003 CTRP Malignant Refractory Intravascular B-Cell Lymphoma Refractory Intravascular Large B-Cell Lymphoma Refractory Intravascular Large B-Cell Lymphoma The reemergence of primary cutaneous diffuse large B-cell lymphoma, leg type after a period of remission. C138027 Neoplastic Process Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type CL525002 CTRP Malignant Recurrent Primary Cutaneous (Skin) Diffuse Large B-Cell Lymphoma, Leg Type Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type Primary cutaneous diffuse large B-cell lymphoma, leg type that is resistant to treatment. C138028 Neoplastic Process Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type CL525009 CTRP Malignant Refractory Primary Cutaneous (Skin) Diffuse Large B-Cell Lymphoma, Leg Type Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type A non-ionizing radiation imaging modality for quantitative assessment of disease burden and therapy response. WB-DWI uses the apparent diffusion coefficient (ADC) measurement to detect and quantify disease. ADC is influenced by tissue microarchitecture and may be altered in a disease state. C138131 Diagnostic Procedure Magnetic Resonance Whole-Body Diffusion-Weighted Imaging Magnetic Resonance Whole Body Diffusion-Weighted Imaging CL525106 CTRP Magnetic Resonance Whole Body Diffusion-Weighted Imaging Magnetic Resonance Whole-Body Diffusion-Weighted Imaging WB DW MRI WB-DWI Whole Body Magnetic Resonance Imaging Using Diffusion-Weighted Images Whole-Body Diffusion-Weighted MRI Magnetic Resonance Whole Body Diffusion-Weighted Imaging Indicates that a toxicity adverse effect has been experienced by a patient, but it is not severe enough for the patient to discontinue the treatment. C138161 Finding Therapy-Related Toxicity - Acceptable to Patient CL525676 NCCN Adverse Event is Acceptable to Patient Therapy-Related Toxicity - Acceptable to Patient Therapy-Related Toxicity is Acceptable to Patient Therapy-Related Toxicity - Acceptable to Patient Indicates that a toxicity adverse effect has been experienced by a patient, and it is severe enough for the patient to discontinue the treatment. C138162 Finding Therapy-Related Toxicity - Unacceptable to Patient CL525675 NCCN Adverse Event is Unacceptable to Patient Therapy-Related Toxicity - Unacceptable to Patient Therapy-Related Toxicity is Unacceptable to Patient Therapy-Related Toxicity - Unacceptable to Patient Indicates that a toxicity adverse effect has been experienced during endocrine drug treatment. C138163 Finding Endocrine Therapy Toxicity C1328362 NCCN PCDC Endocrine Therapy Toxicity Endocrine Toxicity Hormonal Therapy Toxicity Hormonal Treatment Toxicity Hormone Therapy Toxicity Endocrine Therapy Toxicity A header term that includes the following prostate carcinoma subtypes determined by gene expression profiling: luminal A prostate carcinoma, luminal B prostate carcinoma, and basal-like prostate carcinoma. C138167 Neoplastic Process Prostate Carcinoma by Gene Expression Profile CL525736 Malignant Prostate Cancer by Gene Expression Profile Prostate Carcinoma by Gene Expression Profile Prostate Carcinoma by Gene Expression Profile Prostate carcinoma associated with increased androgen receptor expression and signaling (androgen activity pathway), increased luminal markers, and a lower proliferation score than the luminal B and basal-like prostate carcinomas. C138168 Neoplastic Process Luminal A Prostate Carcinoma CL525735 Malignant Luminal A Prostate Cancer Luminal A Prostate Carcinoma Luminal A Prostate Carcinoma Prostate carcinoma associated with increased androgen receptor expression and signaling (androgen activity pathway), increased luminal markers, and a higher proliferation score than the luminal A prostate carcinoma. Patients with luminal B prostate carcinoma have the poorest prognosis but respond better to postoperative androgen deprivation therapy compared to patients with non-luminal B prostate carcinoma. C138169 Neoplastic Process Luminal B Prostate Carcinoma CL525734 Malignant Luminal B Prostate Cancer Luminal B Prostate Carcinoma Luminal B Prostate Carcinoma Prostate carcinoma in which the CD49f signature is increased, the luminal markers and androgen receptor expression and signaling (androgen activity pathway) are not increased, and the proliferation score is higher than the luminal A prostate carcinoma. C138170 Neoplastic Process Basal-Like Prostate Carcinoma CL525733 Malignant Basal-Like Prostate Cancer Basal-Like Prostate Carcinoma Basal-Like Prostate Carcinoma A follicular neoplasia confined to the germinal centers of the lymph nodes, without evidence of disseminated disease. It is characterized by the replacement of a germinal center by neoplastic centrocytes with uniformly intense positivity for BCL2. The surrounding mantle cuff and lymphoid architecture are intact. It has a low rate of progression to follicular lymphoma, but is often associated with prior or synchronous overt lymphoma. C138181 Neoplastic Process In Situ Follicular Neoplasia CL525716 Uncertain Malignant Potential In situ follicular neoplasia FLIS Follicular Lymphoma In Situ ISFN In Situ Follicular B-Cell Neoplasm In Situ Follicular Lymphoma In Situ Follicular Neoplasia In Situ Follicular Neoplasia The reemergence of an abdominal neuroendocrine neoplasm after a period of remission. C138183 Neoplastic Process Recurrent Abdominal Neuroendocrine Neoplasm Recurrent Abdominal Neuroendocrine Neoplasm CL525714 CTRP Undetermined Recurrent Abdominal Neuroendocrine Neoplasm Recurrent Abdominal Neuroendocrine Tumor Relapsed Abdominal Neuroendocrine Tumor Recurrent Abdominal Neuroendocrine Neoplasm An abdominal neuroendocrine neoplasm that does not respond to treatment. C138184 Neoplastic Process Refractory Abdominal Neuroendocrine Neoplasm Refractory Abdominal Neuroendocrine Neoplasm CL525721 CTRP Undetermined Refractory Abdominal Neuroendocrine Neoplasm Refractory Abdominal Neuroendocrine Tumor Refractory Abdominal Neuroendocrine Neoplasm A localized low-grade follicular lymphoma within the gastrointestinal tract, which is distinct from other gastrointestinal tract follicular lymphomas. It has features that overlap with in situ follicular neoplasia as well as some features resembling an extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue. The prognosis is excellent. C138185 Neoplastic Process Duodenal-Type Follicular Lymphoma Duodenal-Type Follicular Lymphoma CL525720 CTRP Malignant Duodenal-Type Follicular Lymphoma Duodenal-Type Follicular Lymphoma A predominantly diffuse, low-grade follicular lymphoma. It often presents as a large localized inguinal mass, lacks BCL2 rearrangement, and is associated with 1p36 deletion. C138186 Neoplastic Process Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion CL525719 Malignant Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion A neoplastic lymphoid process characterized by the presence of cyclin D1 positive lymphoid cells, typically in the inner mantle zones of lymphoid tissue follicles, in cases that do not suggest the diagnosis of a mantle cell lymphoma. It is often found incidentally and has a low rate of progression. C138191 Neoplastic Process In Situ Mantle Cell Neoplasia CL525722 Uncertain Malignant Potential In situ mantle cell neoplasia ISMCN In Situ Mantle Cell Lymphoma In Situ Mantle Cell Neoplasia In Situ Mantle Cell Neoplasm In Situ Mantle Cell Neoplasia Mantle cell lymphoma involving the peripheral blood, bone marrow, and often spleen. It usually has an indolent clinical course. C138192 Neoplastic Process Leukemic Nonnodal Mantle Cell Lymphoma CL525728 Malignant Leukemic Nonnodal Mantle Cell Lymphoma Leukemic Nonnodal Mantle Cell Lymphoma High-grade B-cell lymphoma characterized by the abnormal rearrangement of MYC gene, BCL2 gene, and/or BCL6 gene. Patients with this type of lymphoma usually respond poorly to standard treatments and have a poor prognosis. C138195 Neoplastic Process High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements CL519964 CTRP Malignant HGBL with MYC and BCL2 and/or BCL6 Rearrangements High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements A term that refers to high-grade B-cell lymphoma, not otherwise specified or high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements. C138211 Neoplastic Process High Grade B-Cell Lymphoma CL525710 Malignant HGBL High Grade B-Cell Lymphoma High-Grade B-Cell Lymphoma High Grade B-Cell Lymphoma A large B-cell lymphoma characterized by the presence of a diffuse proliferation of large, atypical HHV8-positive neoplastic lymphocytes. It usually arises in association with HHV8-positive multicentric Castleman disease. C138320 Neoplastic Process HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified CL525847 Malignant HHV8 positive diffuse large B-cell lymphoma HHV8-Positive DLBCL, NOS HHV8-Positive Diffuse Large B-Cell Lymphoma, NOS HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Human Herpesvirus 8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified KSHV/HHV8-Positive Diffuse Large B-Cell Lymphoma HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified A diffuse large B-cell lymphoma characterized by double expression of MYC and BCL2 proteins without MYC and BCL2 gene aberrations. These lymphomas may have a worse prognosis than other diffuse large B-cell lymphomas, not otherwise specified, but they are not as aggressive as the high-grade B-cell lymphomas, with rearrangements of MYC and BCL2 and/or BCL6 genes. C138899 Neoplastic Process Double-Expressor Lymphoma CL526418 GDC Malignant DEL Double Expressor Lymphoma Double-Expressing Lymphoma Double-Expressor Lymphoma double expressor lymphoma double_expressor_lymphoma Double-Expressor Lymphoma A soft tissue sarcoma that does not respond to treatment. C139001 Neoplastic Process Refractory Soft Tissue Sarcoma Refractory Soft Tissue Sarcoma CL526537 CTRP Malignant Refractory Soft Tissue Sarcoma Refractory Soft Tissue Sarcoma The reemergence of soft tissue sarcoma after a period of remission. C139002 Neoplastic Process Recurrent Soft Tissue Sarcoma Recurrent Soft Tissue Sarcoma CL526536 CTRP Malignant Recurrent Soft Tissue Sarcoma Recurrent Soft Tissue Sarcoma A group of node-based peripheral T-cell lymphomas with phenotypic features of T follicular helper (TFH) cells. This category includes the following: follicular helper T-cell lymphoma, angioimmunoblastic-type; follicular helper T-cell lymphoma, follicular-type; and follicular helper T-cell lymphoma, not otherwise specified. C139005 Neoplastic Process Follicular Helper T-Cell Lymphoma CL550759 CPTAC Malignant Peripheral T-cell lymphoma involving lymph nodes of inguinal region and lower limb Peripheral T-cell lymphoma involving lymph nodes of multiple sites Peripheral T-cell lymphoma, not classified, lymph nodes of multiple sites Follicular Helper T-Cell Lymphoma Nodal Follicular Helper T-Cell Lymphoma Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin Nodal Peripheral T-Cell Lymphoma of TFH Cell Origin TFH Lymphoma Follicular Helper T-Cell Lymphoma A header term that refers to the staging of multiple myeloma according to the Durie/Salmon staging system. C139008 Neoplastic Process Multiple Myeloma Myeloma by DS Stage CL526541 Malignant Multiple Myeloma Myeloma by DS Stage Plasma Cell Myeloma Myeloma by DS Stage Multiple Myeloma Myeloma by DS Stage A header term that refers to the staging of multiple myeloma according to the International Staging System. C139009 Neoplastic Process Multiple Myeloma by ISS Stage CL526540 Malignant Multiple Myeloma by ISS Stage Plasma Cell Myeloma by ISS Stage Multiple Myeloma by ISS Stage Follicular helper T-cell lymphoma that does not meet the criteria for any other specifically defined entity of follicular helper T-cell lymphoma. C139011 Neoplastic Process Follicular Helper T-Cell Lymphoma, Not Otherwise Specified CL526546 Malignant Follicular Helper T-Cell Lymphoma, NOS Follicular Helper T-Cell Lymphoma, Not Otherwise Specified Follicular Helper T-Cell Lymphoma, Not Otherwise Specified A rare anaplastic large cell lymphoma that develops in individuals with breast implants. It usually presents as an accumulation of seroma fluid between the implant and the surrounding fibrous capsule. The median interval from the time of the implant to the development of lymphoma is approximately 10 years. C139012 Neoplastic Process Breast Implant-Associated Anaplastic Large Cell Lymphoma CL526545 FDA GDC A non-Hodgkin lymphoma which is associated with breast implants, and consists of large anaplastic cells. The WHO diagnostic criteria for BIA-ALCL includes positive expression of CD30 (CD30+) and negativity for anaplastic lymphoma kinase (ALK-). Malignant Breast implant-associated anaplastic large cell lymphoma IMDRF:E180102 BIA-ALCL Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA ALCL) Breast Implant-Associated Anaplastic Large Cell Lymphoma Breast implant-associated anaplastic large cell lymphoma Breast Implant-Associated Anaplastic Large Cell Lymphoma A variant of lymphomatoid papulosis which mimics primary cutaneous aggressive epidermotropic CD8-positive cytotoxic T-cell lymphoma. C139014 Neoplastic Process Type D Lymphomatoid Papulosis CL526543 Uncertain Malignant Potential Type D LyP Type D Lymphomatoid Papulosis Type D Lymphomatoid Papulosis A variant of lymphomatoid papulosis characterized by the presence of atypical lymphocytes which exhibited distinct angioinvasion. C139015 Neoplastic Process Type E Lymphomatoid Papulosis CL526524 Uncertain Malignant Potential Angioinvasive Lymphomatoid Papulosis Type E Type E LyP Type E Lymphomatoid Papulosis Type E Lymphomatoid Papulosis A variant of lymphomatoid papulosis associated with chromosomal rearrangements involving the DUSP22-IRF4 locus at 6p25.3. C139017 Neoplastic Process Lymphomatoid Papulosis with DUSP22-IRF4 Gene Rearrangement CL526522 Uncertain Malignant Potential LyP with Chromosome 6p25 Rearrangement LyP with Chromosome 6p25.3 Rearrangement LyP with DUSP22-IRF4 Gene Rearrangement Lymphomatoid Papulosis with Chromosome 6p25.3 Rearrangement Lymphomatoid Papulosis with DUSP22 Locus Rearrangement Lymphomatoid Papulosis with DUSP22-IRF4 Gene Rearrangement Lymphomatoid Papulosis with DUSP22-IRF4 Gene Rearrangement A clonal T-cell lymphoproliferative disorder that can involve the mucosa in all sites of the gastrointestinal tract, but is most common in the small intestine and colon. The lymphoid cells infiltrate the lamina propria but usually do not show invasion of the epithelium. The clinical course is indolent, but most patients do not respond to conventional chemotherapy. A subset of cases progress to a higher-grade T-cell lymphoma with spread beyond the gastrointestinal tract. (WHO 2017) C139021 Neoplastic Process Indolent Clonal T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract CL526526 GDC Undetermined Indolent T-cell lymphoproliferative disorder of gastrointestinal tract ITLPD-GI Indolent Clonal T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract Indolent T-Cell Lymphoma of the Gastrointestinal Tract Indolent T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract Indolent T-cell lymphoproliferative disorder of gastrointestinal tract Indolent Clonal T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract A primary cutaneous T-cell lymphoproliferative disorder that presents as an acral (peripheral) lesion. It is composed of CD8-positive neoplastic T-lymphocytes. It is usually localized to a single site and has an indolent clinical course. Local or more extensive recurrences have been described in a minority of patients. C139023 Neoplastic Process Primary Cutaneous Acral CD8-Positive T-Cell Lymphoproliferative Disorder CL526531 Undetermined Primary Cutaneous Acral CD8-Positive T-Cell LPD Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma Primary Cutaneous Acral CD8-Positive T-Cell Lymphoproliferative Disorder Primary Cutaneous Acral CD8-Positive T-Cell Lymphoproliferative Disorder A parietal lymph node located along the inferior epigastric vessels. C139195 Anatomical Structure Epigastric Lymph Node C0229829 CDISC A parietal lymph node located along the inferior epigastric vessels. EPIGASTRIC LYMPH NODE Epigastric Lymph Node Epigastric Lymph Node Any lymph node located near the esophagus, including cervical, and upper, middle, and lower thoracic lymph nodes. C139196 Anatomical Structure Esophageal Lymph Node C0229760 CDISC Any lymph node located near the esophagus, including cervical, and upper, middle, and lower thoracic lymph nodes. ESOPHAGEAL LYMPH NODE Esophageal Lymph Node Esophageal Lymph Node An EBV-positive T-cell/NK-cell lymphoma that arises from the lymph nodes. It is characterized by a monomorphic pattern of infiltration and abscence of the angiodestruction and necrosis seen in extranodal NK/T-cell lymphomas. These lymphomas are more common in elderly patient, or in the setting of immune deficiency. (WHO 2017) C139288 Neoplastic Process Primary Nodal EBV-Positive T-Cell/NK-Cell Lymphoma CL526707 Provisional_Concept Malignant EBV-Positive Nodal T-and NK-Cell Lymphoma Node-Based EBV-Positive Peripheral T-Cell Lymphoma Node-Based Epstein-Barr Virus -Positive Peripheral T-Cell Lymphoma Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma Primary Nodal EBV-Positive T-Cell or NK-Cell Lymphoma Primary Nodal EBV-Positive T-Cell/NK-Cell Lymphoma Primary Nodal Epstein-Barr Virus-Positive T-Cell/NK-Cell Lymphoma Primary Nodal EBV-Positive T-Cell/NK-Cell Lymphoma A head and neck squamous cell carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C139291 Neoplastic Process Advanced Head and Neck Squamous Cell Carcinoma Advanced Head and Neck Squamous Cell Carcinoma CL526704 CTRP Malignant Advanced Head and Neck Squamous Cell Cancer Advanced Head and Neck Squamous Cell Carcinoma Advanced Head and Neck Squamous Cell Carcinoma A term that refers to the staging of breast cancer, following the rules of the TNM AJCC v8 classification system. It applies to invasive (infiltrating) carcinoma of the breast and ductal carcinoma in situ of the breast. It does not apply to breast sarcoma, phyllodes tumor, and breast lymphoma. (from AJCC 8th Ed.) C139532 Neoplastic Process Breast Cancer by AJCC v8 Stage CL526918 Malignant Breast Cancer by AJCC v8 Stage Breast Carcinoma by AJCC v8 Stage Breast Cancer by AJCC v8 Stage A term that refers to the staging of breast cancer, following the rules of the TNM AJCC v8 classification system. This staging system should only be used in global regions where biomarker tests are not routinely available. (from AJCC 8th Ed.) C139533 Neoplastic Process Breast Cancer by AJCC v8 Anatomic Stage CL526925 Malignant Breast Cancer by AJCC v8 Anatomic Stage Breast Carcinoma by AJCC v8 Anatomic Stage Breast Cancer by AJCC v8 Anatomic Stage Stage 0 includes: Tis, N0, M0. Tis: Ductal carcinoma in situ. Lobular carcinoma in situ is a benign entity and is removed from TNM staging in the AJCC Cancer Staging Manual, 8th Edition. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139534 Neoplastic Process Anatomic Stage 0 Breast Cancer AJCC v8 Anatomic Stage 0 Breast Cancer AJCC v8 CL526924 CTRP Malignant Anatomic Stage 0 Breast Cancer AJCC v8 Anatomic Stage 0 Breast Carcinoma AJCC v8 Stage 0 Breast Cancer Anatomic Stage 0 Breast Cancer AJCC v8 Stage I includes: IA: (T1, N0, M0); IB: (T0, N1mi, M0); (T1, N1mi, M0). T0: No evidence of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. N1mi: Tumor with micrometastases (approximately 200 cells, larger than 0.2 mm, but none larger than 2.0 mm). M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139535 Neoplastic Process Anatomic Stage I Breast Cancer AJCC v8 Anatomic Stage I Breast Cancer AJCC v8 CL526923 CTRP Malignant Anatomic Stage I Breast Cancer AJCC v8 Anatomic Stage I Breast Carcinoma AJCC v8 Stage I Breast Cancer Anatomic Stage I Breast Cancer AJCC v8 Stage IA includes: T1, N0, M0. T1: Tumor measuring 20 mm or less in greatest dimension. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139536 Neoplastic Process Anatomic Stage IA Breast Cancer AJCC v8 Anatomic Stage IA Breast Cancer AJCC v8 CL526922 CTRP Malignant Anatomic Stage IA Breast Cancer AJCC v8 Anatomic Stage IA Breast Carcinoma AJCC v8 Stage IA Breast Cancer Anatomic Stage IA Breast Cancer AJCC v8 Stage IB includes: (T0, N1mi, M0); (T1, N1mi, M0). T0: No evidence of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension. N1mi: Tumor with micrometastases (approximately 200 cells, larger than 0.2 mm, but none larger than 2.0 mm). M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139537 Neoplastic Process Anatomic Stage IB Breast Cancer AJCC v8 Anatomic Stage IB Breast Cancer AJCC v8 CL526929 CTRP Malignant Anatomic Stage IB Breast Cancer AJCC v8 Anatomic Stage IB Breast Carcinoma AJCC v8 Stage IB Breast Cancer Anatomic Stage IB Breast Cancer AJCC v8 Stage II includes: IIA: (T0, N1, M0); (T1, N1, M0); (T2, N0, M0); IIB: (T2, N1, M0); (T3, N0, M0). T0: No evidence of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension. T2: Tumor measuring more than 20 mm, but not more than 50 mm in greatest dimension. T3: Tumor measuring more than 50 mm in greatest dimension. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. N1: Tumor with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139538 Neoplastic Process Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage II Breast Cancer AJCC v8 CL526928 CTRP Malignant Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage II Breast Carcinoma AJCC v8 Stage II Breast Cancer Anatomic Stage II Breast Cancer AJCC v8 Stage IIA includes: (T0, N1, M0); (T1, N1, M0); (T2, N0, M0). T0: No evidence of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension. T2: Tumor measuring more than 20 mm, but not more than 50 mm in greatest dimension. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. N1: Tumor with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139539 Neoplastic Process Anatomic Stage IIA Breast Cancer AJCC v8 Anatomic Stage IIA Breast Cancer AJCC v8 CL526927 CTRP Malignant Anatomic Stage IIA Breast Cancer AJCC v8 Anatomic Stage IIA Breast Carcinoma AJCC v8 Stage IIA Breast Cancer Anatomic Stage IIA Breast Cancer AJCC v8 Stage IIB includes: (T2, N1, M0); (T3, N0, M0). T2: Tumor measuring more than 20 mm, but not more than 50 mm in greatest dimension. T3: Tumor measuring more than 50 mm in greatest dimension. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. N1: Tumor with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139540 Neoplastic Process Anatomic Stage IIB Breast Cancer AJCC v8 Anatomic Stage IIB Breast Cancer AJCC v8 CL526926 CTRP Malignant Anatomic Stage IIB Breast Cancer AJCC v8 Anatomic Stage IIB Breast Carcinoma AJCC v8 Stage IIB Breast Cancer Anatomic Stage IIB Breast Cancer AJCC v8 Stage III includes: IIIA: (T0, N2, M0); (T1, N2, M0); (T2, N2, M0); (T3, N1, M0); (T3, N2, M0); IIIB: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0); IIIC: (Any T, N3, M0). T0: No evidence of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension. T2: Tumor measuring more than 20 mm, but not more than 50 mm in greatest dimension. T3: Tumor measuring more than 50 mm in greatest dimension. T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or macroscopic nodules); invasion of the dermis alone does not qualify as T4. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. N1: Tumor with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy. N2: Tumor with metastases in 4-9 axillary lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the absence of axillary lymph node metastases. N3: Tumor with metastases in 10 or more axillary lymph nodes; or in infraclavicular (level III axillary) lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the presence of one or more positive level I, II axillary lymph nodes; or in more than three axillary lymph nodes and micrometastases or macrometastases by sentinel lymph node biopsy in clinically negative ipsilateral internal mammary lymph nodes; or in ipsilateral supraclavicular lymph nodes. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139541 Neoplastic Process Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage III Breast Cancer AJCC v8 CL526933 CTRP Malignant Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage III Breast Carcinoma AJCC v8 Stage III Breast Cancer Anatomic Stage III Breast Cancer AJCC v8 Stage IIIA includes: (T0, N2, M0); (T1, N2, M0); (T2, N2, M0); (T3, N1, M0); (T3, N2, M0). T0: No evidence of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension. T2: Tumor measuring more than 20 mm, but not more than 50 mm in greatest dimension. T3: Tumor measuring more than 50 mm in greatest dimension. N1: Tumor with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy. N2: Tumor with metastases in 4-9 axillary lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the absence of axillary lymph node metastases. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139542 Neoplastic Process Anatomic Stage IIIA Breast Cancer AJCC v8 Anatomic Stage IIIA Breast Cancer AJCC v8 CL526932 CTRP Malignant Anatomic Stage IIIA Breast Cancer AJCC v8 Anatomic Stage IIIA Breast Carcinoma AJCC v8 Stage IIIA Breast Cancer Anatomic Stage IIIA Breast Cancer AJCC v8 Stage IIIB includes: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0). T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or macroscopic nodules); invasion of the dermis alone does not qualify as T4. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. N1: Tumor with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy. N2: Tumor with metastases in 4-9 axillary lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the absence of axillary lymph node metastases. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139543 Neoplastic Process Anatomic Stage IIIB Breast Cancer AJCC v8 Anatomic Stage IIIB Breast Cancer AJCC v8 CL526931 CTRP Malignant Anatomic Stage IIIB Breast Cancer AJCC v8 Anatomic Stage IIIB Breast Carcinoma AJCC v8 Stage IIIB Breast Cancer Anatomic Stage IIIB Breast Cancer AJCC v8 Stage IIIC includes: Any T, N3, M0. N3: Tumor with metastases in 10 or more axillary lymph nodes; or in infraclavicular (level III axillary) lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the presence of one or more positive level I, II axillary lymph nodes; or in more than three axillary lymph nodes and micrometastases or macrometastases by sentinel lymph node biopsy in clinically negative ipsilateral internal mammary lymph nodes; or in ipsilateral supraclavicular lymph nodes. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139544 Neoplastic Process Anatomic Stage IIIC Breast Cancer AJCC v8 Anatomic Stage IIIC Breast Cancer AJCC v8 CL526930 CTRP Malignant Anatomic Stage IIIC Breast Cancer AJCC v8 Anatomic Stage IIIC Breast Carcinoma AJCC v8 Stage IIIC Breast Cancer Anatomic Stage IIIC Breast Cancer AJCC v8 Stage IV includes: Any T, Any N, M1. M1: Distant metastases detected by clinical and radiographic means and/or histologically proven metastases larger than 0.2 mm. (AJCC 8th ed.) C139545 Neoplastic Process Anatomic Stage IV Breast Cancer AJCC v8 Anatomic Stage IV Breast Cancer AJCC v8 CL526906 CTRP Malignant Anatomic Stage IV Breast Cancer AJCC v8 Anatomic Stage IV Breast Carcinoma AJCC v8 Stage IV Breast Cancer Anatomic Stage IV Breast Cancer AJCC v8 A benign epithelial-stromal neoplasm that arises from the anus and resembles the breast fibroadenoma. C139546 Neoplastic Process Anal Fibroadenoma CL526905 Benign Anal Ectopic Fibroadenoma Anal Fibroadenoma Anal Fibroadenoma A benign epithelial-stromal neoplasm that arises from the perineum and resembles the breast fibroadenoma. C139547 Neoplastic Process Fibroadenoma of Anogenital Mammary-Type Glands CL526904 Benign Fibroadenoma of Anogenital Mammary-Like Glands Fibroadenoma of Anogenital Mammary-Type Glands Perineal Ectopic Fibroadenoma Fibroadenoma of Anogenital Mammary-Type Glands A benign composite neoplasm that arises from the vulva and is characterized by mixed histopathologic features of hidradenoma papilliferum and fibroadenoma. C139548 Neoplastic Process Vulvar Composite Hidradenoma Papilliferum and Fibroadenoma CL526903 Benign Vulvar Composite Hidradenoma Papilliferum and Fibroadenoma Vulvar Composite Papillary Hidradenoma and Fibroadenoma Vulvar Composite Hidradenoma Papilliferum and Fibroadenoma A term that refers to the staging of breast cancer, following the rules of the TNM AJCC v8 classification system. This staging system should be used in countries where HER2, ER, and PR biomarker tests are routinely performed for patient care (U.S., Canada, etc.). (from AJCC 8th Ed.) C139554 Neoplastic Process Breast Cancer by AJCC v8 Prognostic Stage CL526912 Malignant Breast Cancer by AJCC v8 Prognostic Stage Breast Cancer by AJCC v8 Prognostic Stage Group Breast Carcinoma by AJCC v8 Prognostic Stage Breast Cancer by AJCC v8 Prognostic Stage Stage 0 includes: Tis, N0, M0, G1-3, HER2 Status: Any, ER Status: Any, PR Status: Any. Tis: Ductal carcinoma in situ. Lobular carcinoma in situ is a benign entity and is removed from TNM staging in the AJCC Cancer Staging Manual, 8th Edition. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. G1: Low combined histologic grade (favorable); SBR score of 3-5 points. G2: Intermediate combined histologic grade (moderately favorable); SBR score: 6-7 points. G3: High combined histologic grade (unfavorable); SBR score of 8-9 points. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139555 Neoplastic Process Prognostic Stage 0 Breast Cancer AJCC v8 Prognostic Stage 0 Breast Cancer AJCC v8 CL526911 CTRP Malignant Prognostic Stage 0 Breast Cancer AJCC v8 Prognostic Stage 0 Breast Carcinoma AJCC v8 Stage 0 Breast Cancer Prognostic Stage 0 Breast Cancer AJCC v8 Stage I includes: IA: (T1, N0, M0, G1, HER2 Status: Positive, ER Status: Any, PR Status: Any); (T1, N0, M0, G1-2, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T1, N0, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (T1, N0, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Any); (T0-1, N1mi, M0, G1, HER2 Status: Positive, ER Status: Any, PR Status: Any); (T0-1, N1mi, M0, G1-2, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T0-1, N1mi, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (T0-1, N1mi, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Any); (MultiGene Panel-Oncotype Dx Recurrence Score Less Than 11, T1-2, N0, M0, G1-3, HER2 Status: Negative, ER Status: Positive, PR Status: Any); IB: (T1, N0, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T1, N0, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T1, N0, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T1, N0, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T1, N0, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T1, N0, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T1, N0, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T0-1, N1mi, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-1, N1mi, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-1, N1mi, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T0-1, N1mi, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T0-1, N1mi, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-1, N1mi, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T0-1, N1mi, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T2, N0, M0, G1-3, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (T2, N0, M0, G1-2, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T1, N1, M0, G1-3, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (T1, N1, M0, G1-2, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T2, N1, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T2, N1, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (T0-2, N2, M0, G1-2, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (T3, N1-2, M0, G1, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (T3, N1-2, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Positive). T0: No evidence of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension. T2: Tumor measuring more than 20 mm, but not more than 50 mm in greatest dimension. T3: Tumor measuring more than 50 mm in greatest dimension. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. N1: Tumor with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy. N1mi: Micrometastases (approximately 200 cells, larger than 0.2 mm, but none larger than 2.0 mm). N2: Tumor with metastases in 4-9 axillary lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the absence of axillary lymph node metastases. G1: Low combined histologic grade (favorable); SBR score of 3-5 points. G2: Intermediate combined histologic grade (moderately favorable); SBR score: 6-7 points. G3: High combined histologic grade (unfavorable); SBR score of 8-9 points. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139556 Neoplastic Process Prognostic Stage I Breast Cancer AJCC v8 Prognostic Stage I Breast Cancer AJCC v8 CL526910 CTRP Malignant Prognostic Stage I Breast Cancer AJCC v8 Prognostic Stage I Breast Carcinoma AJCC v8 Stage I Breast Cancer Prognostic Stage I Breast Cancer AJCC v8 Stage IA includes: (T1, N0, M0, G1, HER2 Status: Positive, ER Status: Any, PR Status: Any); (T1, N0, M0, G1-2, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T1, N0, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (T1, N0, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Any); (T0-1, N1mi, M0, G1, HER2 Status: Positive, ER Status: Any, PR Status: Any); (T0-1, N1mi, M0, G1-2, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T0-1, N1mi, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (T0-1, N1mi, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Any); (MultiGene Panel-Oncotype Dx Recurrence Score Less Than 11, T1-2, N0, M0, G1-3, HER2 Status: Negative, ER Status: Positive, PR Status: Any). T0: No evidence of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension. T2: Tumor measuring more than 20 mm, but not more than 50 mm in greatest dimension. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. N1mi: Micrometastases (approximately 200 cells, larger than 0.2 mm, but none larger than 2.0 mm). G1: Low combined histologic grade (favorable); SBR score of 3-5 points. G2: Intermediate combined histologic grade (moderately favorable); SBR score: 6-7 points. G3: High combined histologic grade (unfavorable); SBR score of 8-9 points. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139557 Neoplastic Process Prognostic Stage IA Breast Cancer AJCC v8 Prognostic Stage IA Breast Cancer AJCC v8 CL526917 CTRP Malignant Prognostic Stage IA Breast Cancer AJCC v8 Prognostic Stage IA Breast Carcinoma AJCC v8 Stage IA Breast Cancer Prognostic Stage IA Breast Cancer AJCC v8 Stage IB includes: (T1, N0, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T1, N0, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T1, N0, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T1, N0, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T1, N0, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T1, N0, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T1, N0, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T0-1, N1mi, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-1, N1mi, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-1, N1mi, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T0-1, N1mi, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T0-1, N1mi, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-1, N1mi, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T0-1, N1mi, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T2, N0, M0, G1-3, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (T2, N0, M0, G1-2, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T1, N1, M0, G1-3, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (T1, N1, M0, G1-2, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T2, N1, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T2, N1, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (T0-2, N2, M0, G1-2, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (T3, N1-2, M0, G1, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (T3, N1-2, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Positive). T0: No evidence of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension. T2: Tumor measuring more than 20 mm, but not more than 50 mm in greatest dimension. T3: Tumor measuring more than 50 mm in greatest dimension. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. N1: Tumor with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy. N1mi: Micrometastases (approximately 200 cells, larger than 0.2 mm, but none larger than 2.0 mm). N2: Tumor with metastases in 4-9 axillary lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the absence of axillary lymph node metastases. G1: Low combined histologic grade (favorable); SBR score of 3-5 points. G2: Intermediate combined histologic grade (moderately favorable); SBR score: 6-7 points. G3: High combined histologic grade (unfavorable); SBR score of 8-9 points. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139558 Neoplastic Process Prognostic Stage IB Breast Cancer AJCC v8 Prognostic Stage IB Breast Cancer AJCC v8 CL526916 CTRP Malignant Prognostic Stage IB Breast Cancer AJCC v8 Prognostic Stage IB Breast Carcinoma AJCC v8 Stage IB Breast Cancer Prognostic Stage IB Breast Cancer AJCC v8 Stage II includes: IIA: (T1, N0, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T1, N0, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T1, N0, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T1, N0, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T1, N0, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T0-1, N1mi, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T0-1, N1mi, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T0-1, N1mi, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-1, N1mi, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-1, N1mi, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T0-1, N1, M0, G1, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T0-1, N1, M0, G1-2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T0-1, N1, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-1, N1, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-1, N1, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T2, N0, M0, G1, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T2, N0, M0, G1-2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T2, N0, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T2, N0, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T2, N0, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T0-2, N2, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T3, N1-2, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); IIB: (T0-1, N1, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T0-1, N1, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T0-1, N1, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-1, N1, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-1, N1, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T0-1, N1, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T2, N0, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T2, N0, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T2, N0, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T2, N0, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T2, N0, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T2, N0, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T2, N1, M0, G1, HER2 Status: Positive, ER Status: Any, PR Status: Any); (T2, N1, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-2, N2, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T0-2, N2, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (T3, N1-2, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T3, N1-2, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Positive). T0: No evidence of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension. T2: Tumor measuring more than 20 mm, but not more than 50 mm in greatest dimension. T3: Tumor measuring more than 50 mm in greatest dimension. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. N1: Tumor with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy. N1mi: Micrometastases (approximately 200 cells, larger than 0.2 mm, but none larger than 2.0 mm). N2: Tumor with metastases in 4-9 axillary lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the absence of axillary lymph node metastases. G1: Low combined histologic grade (favorable); SBR score of 3-5 points. G2: Intermediate combined histologic grade (moderately favorable); SBR score: 6-7 points. G3: High combined histologic grade (unfavorable); SBR score of 8-9 points. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139569 Neoplastic Process Prognostic Stage II Breast Cancer AJCC v8 Prognostic Stage II Breast Cancer AJCC v8 CL526894 CTRP Malignant Prognostic Stage II Breast Cancer AJCC v8 Prognostic Stage II Breast Carcinoma AJCC v8 Stage II Breast Cancer Prognostic Stage II Breast Cancer AJCC v8 Stage IIA includes: (T1, N0, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T1, N0, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T1, N0, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T1, N0, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T1, N0, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T0-1, N1mi, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T0-1, N1mi, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T0-1, N1mi, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-1, N1mi, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-1, N1mi, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T0-1, N1, M0, G1, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T0-1, N1, M0, G1-2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T0-1, N1, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-1, N1, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-1, N1, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T2, N0, M0, G1, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T2, N0, M0, G1-2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T2, N0, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T2, N0, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T2, N0, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T0-2, N2, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T3, N1-2, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Positive). T0: No evidence of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension. T2: Tumor measuring more than 20 mm, but not more than 50 mm in greatest dimension. T3: Tumor measuring more than 50 mm in greatest dimension. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. N1: Tumor with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy. N1mi: Micrometastases (approximately 200 cells, larger than 0.2 mm, but none larger than 2.0 mm). N2: Tumor with metastases in 4-9 axillary lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the absence of axillary lymph node metastases. G1: Low combined histologic grade (favorable); SBR score of 3-5 points. G2: Intermediate combined histologic grade (moderately favorable); SBR score: 6-7 points. G3: High combined histologic grade (unfavorable); SBR score of 8-9 points. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139571 Neoplastic Process Prognostic Stage IIA Breast Cancer AJCC v8 Prognostic Stage IIA Breast Cancer AJCC v8 CL526900 CTRP Malignant Prognostic Stage IIA Breast Cancer AJCC v8 Prognostic Stage IIA Breast Carcinoma AJCC v8 Stage IIA Breast Cancer Prognostic Stage IIA Breast Cancer AJCC v8 Stage IIB includes: (T0-1, N1, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T0-1, N1, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T0-1, N1, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-1, N1, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-1, N1, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T0-1, N1, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T2, N0, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T2, N0, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T2, N0, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T2, N0, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T2, N0, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T2, N0, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T2, N1, M0, G1, HER2 Status: Positive, ER Status: Any, PR Status: Any); (T2, N1, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-2, N2, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T0-2, N2, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (T3, N1-2, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T3, N1-2, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Positive). T0: No evidence of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension. T2: Tumor measuring more than 20 mm, but not more than 50 mm in greatest dimension. T3: Tumor measuring more than 50 mm in greatest dimension. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. N1: Tumor with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy. N2: Tumor with metastases in 4-9 axillary lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the absence of axillary lymph node metastases. G1: Low combined histologic grade (favorable); SBR score of 3-5 points. G2: Intermediate combined histologic grade (moderately favorable); SBR score: 6-7 points. G3: High combined histologic grade (unfavorable); SBR score of 8-9 points. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139572 Neoplastic Process Prognostic Stage IIB Breast Cancer AJCC v8 Prognostic Stage IIB Breast Cancer AJCC v8 CL526899 CTRP Malignant Prognostic Stage IIB Breast Cancer AJCC v8 Prognostic Stage IIB Breast Carcinoma AJCC v8 Stage IIB Breast Cancer Prognostic Stage IIB Breast Cancer AJCC v8 Stage III includes: IIIA: (T0-1, N1, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T0-1, N1, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-1, N1, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Any); (T2, N0, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T2, N0, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T2, N0, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Any); (T2, N1, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T2, N1, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Negative); (T2, N1, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T2, N1, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T2, N1, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Negative); (T3, N0, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T3, N0, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Negative); (T3, N0, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T3, N0, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T3, N0, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Negative); (T0-2, N2, M0, G1, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T0-2, N2, M0, G1, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T0-2, N2, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-2, N2, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-2, N2, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T0-2, N2, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T3, N1-2, M0, G1, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T3, N1-2, M0, G1, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T3, N1-2, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T3, N1-2, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T3, N1-2, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T3, N1-2, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T4, N0-2, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (Any T, N3, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); IIIB: (T2, N1, M0, G1-2, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T2, N1, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T3, N0, M0, G1-2, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T3, N0, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-2, N2, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-2, N2, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-2, N2, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T0-2, N2, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T0-2, N2, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T3, N1-2, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T3, N1-2, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T3, N1-2, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T3, N1-2, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T3, N1-2, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T4, N0-2, M0, G1, HER2 Status: Positive, ER Status: Any, PR Status: Any); (T4, N0-2, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (T4, N0-2, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T4, N0-2, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (Any T, N3, M0, G1, HER2 Status: Positive, ER Status: Any, PR Status: Any); (Any T, N3, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (Any T, N3, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (Any T, N3, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); IIIC: (T2, N1, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Any); (T3, N0, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Any ); (T0-2, N2, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T0-2, N2, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-2, N2, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Any); (T3, N1-2, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T3, N1-2, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T3, N1-2, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Any); (T4, N0-2, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T4, N0-2, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Any); (T4, N0-2, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T4, N0-2, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T4, N0-2, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T4, N0-2, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Any); (T4, N0-2, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T4, N0-2, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T4, N0-2, M0, G3, HER2 Status: Negative, ER Status: Any, PR Status: Any); (Any T, N3, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (Any T, N3, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Any); (Any T, N3, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (Any T, N3, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (Any T, N3, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (Any T, N3, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Any); (Any T, N3, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (Any T, N3, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (Any T, N3, M0, G3, HER2 Status: Negative, ER Status: Any, PR Status: Any). T0: No evidence of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension. T2: Tumor measuring more than 20 mm, but not more than 50 mm in greatest dimension. T3: Tumor measuring more than 50 mm in greatest dimension. T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or macroscopic nodules); invasion of the dermis alone does not qualify as T4. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. N1: Tumor with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy. N2: Tumor with metastases in 4-9 axillary lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the absence of axillary lymph node metastases. N3: Tumor with metastases in 10 or more axillary lymph nodes; or in infraclavicular (level III axillary) lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the presence of one or more positive level I, II axillary lymph nodes; or in more than three axillary lymph nodes and micrometastases or macrometastases by sentinel lymph node biopsy in clinically negative ipsilateral internal mammary lymph nodes; or in ipsilateral supraclavicular lymph nodes. G1: Low combined histologic grade (favorable); SBR score of 3-5 points. G2: Intermediate combined histologic grade (moderately favorable); SBR score: 6-7 points. G3: High combined histologic grade (unfavorable); SBR score of 8-9 points. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139582 Neoplastic Process Prognostic Stage III Breast Cancer AJCC v8 Prognostic Stage III Breast Cancer AJCC v8 CL526877 CTRP Malignant Prognostic Stage III Breast Cancer AJCC v8 Prognostic Stage III Breast Carcinoma AJCC v8 Stage III Breast Cancer Prognostic Stage III Breast Cancer AJCC v8 Stage IIIA includes: (T0-1, N1, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T0-1, N1, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-1, N1, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Any); (T2, N0, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T2, N0, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T2, N0, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Any); (T2, N1, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T2, N1, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Negative); (T2, N1, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T2, N1, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T2, N1, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Negative); (T3, N0, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T3, N0, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Negative); (T3, N0, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T3, N0, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T3, N0, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Negative); (T0-2, N2, M0, G1, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T0-2, N2, M0, G1, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T0-2, N2, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-2, N2, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-2, N2, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); ( T0-2, N2, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T3, N1-2, M0, G1, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T3, N1-2, M0, G1, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T3, N1-2, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T3, N1-2, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T3, N1-2, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T3, N1-2, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T4, N0-2, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (Any T, N3, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Positive). T0: No evidence of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension. T2: Tumor measuring more than 20 mm, but not more than 50 mm in greatest dimension. T3: Tumor measuring more than 50 mm in greatest dimension. T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or macroscopic nodules); invasion of the dermis alone does not qualify as T4. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. N1: Tumor with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy. N2: Tumor with metastases in 4-9 axillary lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the absence of axillary lymph node metastases. N3: Tumor with metastases in 10 or more axillary lymph nodes; or in infraclavicular (level III axillary) lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the presence of one or more positive level I, II axillary lymph nodes; or in more than three axillary lymph nodes and micrometastases or macrometastases by sentinel lymph node biopsy in clinically negative ipsilateral internal mammary lymph nodes; or in ipsilateral supraclavicular lymph nodes. G1: Low combined histologic grade (favorable); SBR score of 3-5 points. G2: Intermediate combined histologic grade (moderately favorable); SBR score: 6-7 points. G3: High combined histologic grade (unfavorable); SBR score of 8-9 points. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139583 Neoplastic Process Prognostic Stage IIIA Breast Cancer AJCC v8 Prognostic Stage IIIA Breast Cancer AJCC v8 CL526882 CTRP Malignant Prognostic Stage IIIA Breast Cancer AJCC v8 Prognostic Stage IIIA Breast Carcinoma AJCC v8 Stage IIIA Breast Cancer Prognostic Stage IIIA Breast Cancer AJCC v8 Stage IIIB includes: (T2, N1, M0, G1-2, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T2, N1, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T3, N0, M0, G1-2, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T3, N0, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-2, N2, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-2, N2, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-2, N2, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T0-2, N2, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T0-2, N2, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T3, N1-2, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T3, N1-2, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T3, N1-2, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T3, N1-2, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T3, N1-2, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T4, N0-2, M0, G1, HER2 Status: Positive, ER Status: Any, PR Status: Any); (T4, N0-2, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (T4, N0-2, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T4, N0-2, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (Any T, N3, M0, G1, HER2 Status: Positive, ER Status: Any, PR Status: Any); (Any T, N3, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (Any T, N3, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (Any T, N3, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Positive). T0: No evidence of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension. T2: Tumor measuring more than 20 mm, but not more than 50 mm in greatest dimension. T3: Tumor measuring more than 50 mm in greatest dimension. T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or macroscopic nodules); invasion of the dermis alone does not qualify as T4. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. N1: Tumor with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy. N2: Tumor with metastases in 4-9 axillary lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the absence of axillary lymph node metastases. N3: Tumor with metastases in 10 or more axillary lymph nodes; or in infraclavicular (level III axillary) lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the presence of one or more positive level I, II axillary lymph nodes; or in more than three axillary lymph nodes and micrometastases or macrometastases by sentinel lymph node biopsy in clinically negative ipsilateral internal mammary lymph nodes; or in ipsilateral supraclavicular lymph nodes. G1: Low combined histologic grade (favorable); SBR score of 3-5 points. G2: Intermediate combined histologic grade (moderately favorable); SBR score: 6-7 points. G3: High combined histologic grade (unfavorable); SBR score of 8-9 points. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139584 Neoplastic Process Prognostic Stage IIIB Breast Cancer AJCC v8 Prognostic Stage IIIB Breast Cancer AJCC v8 CL526881 CTRP Malignant Prognostic Stage IIIB Breast Cancer AJCC v8 Prognostic Stage IIIB Breast Carcinoma AJCC v8 Stage IIIB Breast Cancer Prognostic Stage IIIB Breast Cancer AJCC v8 Stage IIIC includes: (T2, N1, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Any); (T3, N0, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Any ); (T0-2, N2, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T0-2, N2, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-2, N2, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Any); (T3, N1-2, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T3, N1-2, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T3, N1-2, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Any); (T4, N0-2, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T4, N0-2, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Any); (T4, N0-2, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T4, N0-2, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T4, N0-2, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T4, N0-2, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Any); (T4, N0-2, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T4, N0-2, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T4, N0-2, M0, G3, HER2 Status: Negative, ER Status: Any, PR Status: Any); (Any T, N3, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (Any T, N3, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Any); (Any T, N3, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (Any T, N3, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (Any T, N3, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (Any T, N3, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Any); (Any T, N3, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (Any T, N3, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (Any T, N3, M0, G3, HER2 Status: Negative, ER Status: Any, PR Status: Any). T0: No evidence of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension. T2: Tumor measuring more than 20 mm, but not more than 50 mm in greatest dimension. T3: Tumor measuring more than 50 mm in greatest dimension. T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or macroscopic nodules); invasion of the dermis alone does not qualify as T4. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. N1: Tumor with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy. N2: Tumor with metastases in 4-9 axillary lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the absence of axillary lymph node metastases. N3: Tumor with metastases in 10 or more axillary lymph nodes; or in infraclavicular (level III axillary) lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the presence of one or more positive level I, II axillary lymph nodes; or in more than three axillary lymph nodes and micrometastases or macrometastases by sentinel lymph node biopsy in clinically negative ipsilateral internal mammary lymph nodes; or in ipsilateral supraclavicular lymph nodes. G1: Low combined histologic grade (favorable); SBR score of 3-5 points. G2: Intermediate combined histologic grade (moderately favorable); SBR score: 6-7 points. G3: High combined histologic grade (unfavorable); SBR score of 8-9 points. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.) C139585 Neoplastic Process Prognostic Stage IIIC Breast Cancer AJCC v8 Prognostic Stage IIIC Breast Cancer AJCC v8 CL526880 CTRP Malignant Prognostic Stage IIIC Breast Cancer AJCC v8 Prognostic Stage IIIC Breast Carcinoma AJCC v8 Stage IIIC Breast Cancer Prognostic Stage IIIC Breast Cancer AJCC v8 Stage IV includes: Any T, Any N, M1, G1-3, HER2 Status: Any, ER Status: Any, PR Status: Any. G1: Low combined histologic grade (favorable); SBR score of 3-5 points. G2: Intermediate combined histologic grade (moderately favorable); SBR score: 6-7 points. G3: High combined histologic grade (unfavorable); SBR score of 8-9 points. M1: Distant metastases detected by clinical and radiographic means and/or histologically proven metastases larger than 0.2 mm. (AJCC 8th ed.) C139587 Neoplastic Process Prognostic Stage IV Breast Cancer AJCC v8 Prognostic Stage IV Breast Cancer AJCC v8 CL526879 CTRP Malignant Prognostic Stage IV Breast Cancer AJCC v8 Prognostic Stage IV Breast Carcinoma AJCC v8 Stage IV Breast Cancer Prognostic Stage IV Breast Cancer AJCC v8 A term that refers to the staging of vulvar cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to all carcinomas of the vulva. Melanoma of the vulva is staged according to the classification for melanoma of the skin. (AJCC 8th Ed.) C139618 Neoplastic Process Vulvar Cancer by AJCC v8 Stage CL526941 Malignant Vulvar Cancer by AJCC v8 Stage Vulvar Carcinoma by AJCC v8 Stage Vulvar Cancer by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Tumor confined to the vulva and/or perineum. Multifocal lesions should be designated as such. The largest lesion or the lesion with the greatest depth of invasion will be the target lesion identified to address the highest pT stage. Depth of invasion is defined as the measurement of the tumor from the epithelial-stromal junction of the adjacent most superficial dermal papilla to the deepest point of invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139619 Neoplastic Process Stage I Vulvar Cancer AJCC v8 Stage I Vulvar Cancer AJCC v8 CL526940 CTRP Malignant Stage I Vulvar Cancer Stage I Vulvar Cancer AJCC v8 Stage I Vulvar Carcinoma AJCC v8 Stage I Vulvar Cancer AJCC v8 Stage IA includes: T1a, N0, M0. T1a: Lesion measuring 2 cm or less, confined to the vulva and/or perineum, and with stromal invasion of 1.0 mm or less. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139620 Neoplastic Process Stage IA Vulvar Cancer AJCC v8 Stage IA Vulvar Cancer AJCC v8 CL526947 CTRP Malignant Stage IA Vulvar Cancer Stage IA Vulvar Cancer AJCC v8 Stage IA Vulvar Carcinoma AJCC v8 Stage IA Vulvar Cancer AJCC v8 Stage IB includes: T1b, N0, M0. T1b: Lesion measuring more than 2 cm, or any size with stromal invasion of more than 1.0 mm, confined to the vulva and/or perineum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139621 Neoplastic Process Stage IB Vulvar Cancer AJCC v8 Stage IB Vulvar Cancer AJCC v8 CL526946 CTRP Malignant Stage IB Vulvar Cancer Stage IB Vulvar Cancer AJCC v8 Stage IB Vulvar Carcinoma AJCC v8 Stage IB Vulvar Cancer AJCC v8 Stage II includes: T2, N0, M0. T2: Tumor of any size with extension to adjacent perineal structures (lower/distal third of the urethra, lower/distal third of the vagina, anal involvement). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139622 Neoplastic Process Stage II Vulvar Cancer AJCC v8 Stage II Vulvar Cancer AJCC v8 CL526945 CTRP Malignant Stage II Vulvar Cancer Stage II Vulvar Cancer AJCC v8 Stage II Vulvar Carcinoma AJCC v8 Stage II Vulvar Cancer AJCC v8 Stage III includes: T1-T2, N1-N2c, M0. T1: Tumor confined to the vulva and/or perineum. Multifocal lesions should be designated as such. The largest lesion or the lesion with the greatest depth of invasion will be the target lesion identified to address the highest pT stage. Depth of invasion is defined as the measurement of the tumor from the epithelial-stromal junction of the adjacent most superficial dermal papilla to the deepest point of invasion. T2: Tumor of any size with extension to adjacent perineal structures (lower/distal third of the urethra, lower/distal third of the vagina, anal involvement). N1: Regional lymph node metastasis with one or two lymph node metastases each less than 5 mm, or one lymph node metastasis equal to 5 mm. N2a: Three or more lymph node metastases each less than 5 mm. It includes micrometastasis, N2mi. N2b: Two or more lymph node metastases equal to 5 mm. N2c: Lymph node(s) metastasis with extranodal extension. M0: No distant metastasis. (AJCC 8th Ed.) C139623 Neoplastic Process Stage III Vulvar Cancer AJCC v8 Stage III Vulvar Cancer AJCC v8 CL526944 CTRP Malignant Stage III Vulvar Cancer Stage III Vulvar Cancer AJCC v8 Stage III Vulvar Carcinoma AJCC v8 Stage III Vulvar Cancer AJCC v8 Stage IIIA includes: T1-T2, N1, M0. T1: Tumor confined to the vulva and/or perineum. Multifocal lesions should be designated as such. The largest lesion or the lesion with the greatest depth of invasion will be the target lesion identified to address the highest pT stage. Depth of invasion is defined as the measurement of the tumor from the epithelial-stromal junction of the adjacent most superficial dermal papilla to the deepest point of invasion. T2: Tumor of any size with extension to adjacent perineal structures (lower/distal third of the urethra, lower/distal third of the vagina, anal involvement). N1: Regional lymph node metastasis with one or two lymph node metastases each less than 5 mm, or one lymph node metastasis equal to 5 mm. M0: No distant metastasis. (AJCC 8th Ed.) C139624 Neoplastic Process Stage IIIA Vulvar Cancer AJCC v8 Stage IIIA Vulvar Cancer AJCC v8 CL526951 CTRP Malignant Stage IIIA Vulvar Cancer Stage IIIA Vulvar Cancer AJCC v8 Stage IIIA Vulvar Carcinoma AJCC v8 Stage IIIA Vulvar Cancer AJCC v8 Stage IIIB includes: T1-T2, N2a, N2b, M0. T1: Tumor confined to the vulva and/or perineum. Multifocal lesions should be designated as such. The largest lesion or the lesion with the greatest depth of invasion will be the target lesion identified to address the highest pT stage. Depth of invasion is defined as the measurement of the tumor from the epithelial-stromal junction of the adjacent most superficial dermal papilla to the deepest point of invasion. T2: Tumor of any size with extension to adjacent perineal structures (lower/distal third of the urethra, lower/distal third of the vagina, anal involvement). N2a: Three or more lymph node metastases each less than 5 mm. It includes micrometastasis, N2mi. N2b: Two or more lymph node metastases equal to 5 mm. M0: No distant metastasis. (AJCC 8th Ed.) C139625 Neoplastic Process Stage IIIB Vulvar Cancer AJCC v8 Stage IIIB Vulvar Cancer AJCC v8 CL526950 CTRP Malignant Stage IIIB Vulvar Cancer Stage IIIB Vulvar Cancer AJCC v8 Stage IIIB Vulvar Carcinoma AJCC v8 Stage IIIB Vulvar Cancer AJCC v8 Stage IIIC includes: T1-T2, N2c, M0. T1: Tumor confined to the vulva and/or perineum. Multifocal lesions should be designated as such. The largest lesion or the lesion with the greatest depth of invasion will be the target lesion identified to address the highest pT stage. Depth of invasion is defined as the measurement of the tumor from the epithelial-stromal junction of the adjacent most superficial dermal papilla to the deepest point of invasion. T2: Tumor of any size with extension to adjacent perineal structures (lower/distal third of the urethra, lower/distal third of the vagina, anal involvement). N2c: Lymph node(s) metastasis with extranodal extension. M0: No distant metastasis. (AJCC 8th Ed.) C139626 Neoplastic Process Stage IIIC Vulvar Cancer AJCC v8 Stage IIIC Vulvar Cancer AJCC v8 CL526949 CTRP Malignant Stage IIIC Vulvar Cancer Stage IIIC Vulvar Cancer AJCC v8 Stage IIIC Vulvar Carcinoma AJCC v8 Stage IIIC Vulvar Cancer AJCC v8 Stage IV includes: T1-T3, N3, M0-M1. T1: Tumor confined to the vulva and/or perineum. Multifocal lesions should be designated as such. The largest lesion or the lesion with the greatest depth of invasion will be the target lesion identified to address the highest pT stage. Depth of invasion is defined as the measurement of the tumor from the epithelial-stromal junction of the adjacent most superficial dermal papilla to the deepest point of invasion. T2: Tumor of any size with extension to adjacent perineal structures (lower/distal third of the urethra, lower/distal third of the vagina, anal involvement). T3: Tumor of any size with extension to any of the following: upper/proximal two-thirds of the urethra, upper/proximal two-thirds of the vagina, bladder mucosa, or rectal mucosa; or fixed to pelvic bone. N3: Fixed or ulcerated regional lymph node metastasis. M0: No distant metastasis. M1: Distant metastasis (including pelvic lymph node metastasis). (from AJCC 8th Ed.) C139627 Neoplastic Process Stage IV Vulvar Cancer AJCC v8 Stage IV Vulvar Cancer AJCC v8 CL526948 CTRP Malignant Stage IV Vulvar Cancer Stage IV Vulvar Cancer AJCC v8 Stage IV Vulvar Carcinoma AJCC v8 Stage IV Vulvar Cancer AJCC v8 Stage IVA includes: (T1-T2, N3, M0); (T3, Any N, M0). T1: Tumor confined to the vulva and/or perineum. Multifocal lesions should be designated as such. The largest lesion or the lesion with the greatest depth of invasion will be the target lesion identified to address the highest pT stage. Depth of invasion is defined as the measurement of the tumor from the epithelial-stromal junction of the adjacent most superficial dermal papilla to the deepest point of invasion. T2: Tumor of any size with extension to adjacent perineal structures (lower/distal third of the urethra, lower/distal third of the vagina, anal involvement). T3: Tumor of any size with extension to any of the following: upper/proximal two-thirds of the urethra, upper/proximal two-thirds of the vagina, bladder mucosa, or rectal mucosa; or fixed to pelvic bone. N3: Fixed or ulcerated regional lymph node metastasis. M0: No distant metastasis. (from AJCC 8th Ed.) C139628 Neoplastic Process Stage IVA Vulvar Cancer AJCC v8 Stage IVA Vulvar Cancer AJCC v8 CL526935 CTRP Malignant Stage IVA Vulvar Cancer Stage IVA Vulvar Cancer AJCC v8 Stage IVA Vulvar Carcinoma AJCC v8 Stage IVA Vulvar Cancer AJCC v8 Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis (including pelvic lymph node metastasis). (from AJCC 8th Ed.) C139630 Neoplastic Process Stage IVB Vulvar Cancer AJCC v8 Stage IVB Vulvar Cancer AJCC v8 CL526934 CTRP Malignant Stage IVB Vulvar Cancer Stage IVB Vulvar Cancer AJCC v8 Stage IVB Vulvar Carcinoma AJCC v8 Stage IVB Vulvar Cancer AJCC v8 A term that refers to the staging of vaginal cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to all carcinomas of the vagina. There is no AJCC staging system for mucosal melanoma of the vagina. (from AJCC 8th Ed.) C139657 Neoplastic Process Vaginal Cancer by AJCC v8 Stage CL537844 Malignant Vaginal Cancer by AJCC v8 Stage Vaginal Carcinoma by AJCC v8 Stage Vaginal Cancer by AJCC v8 Stage Stage I includes: IA: T1a, N0, M0; IB: T1b, N0, M0. T1a: Tumor confined to the vagina, measuring 2.0 cm or less. T1b: Tumor confined to the vagina, measuring more than 2.0 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139658 Neoplastic Process Stage I Vaginal Cancer AJCC v8 Stage I Vaginal Cancer AJCC v8 CL537843 CTRP Malignant Stage I Vaginal Cancer Stage I Vaginal Cancer AJCC v8 Stage I Vaginal Carcinoma AJCC v8 Stage I Vaginal Cancer AJCC v8 Stage IA includes: T1a, N0, M0. T1a: Tumor confined to the vagina, measuring 2.0 cm or less. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139659 Neoplastic Process Stage IA Vaginal Cancer AJCC v8 Stage IA Vaginal Cancer AJCC v8 CL537842 CTRP Malignant Stage IA Vaginal Cancer Stage IA Vaginal Cancer AJCC v8 Stage IA Vaginal Carcinoma AJCC v8 Stage IA Vaginal Cancer AJCC v8 Stage IB includes: T1b, N0, M0. T1b: Tumor confined to the vagina, measuring more than 2.0 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139660 Neoplastic Process Stage IB Vaginal Cancer AJCC v8 Stage IB Vaginal Cancer AJCC v8 CL537841 CTRP Malignant Stage IB Vaginal Cancer Stage IB Vaginal Cancer AJCC v8 Stage IB Vaginal Carcinoma AJCC v8 Stage IB Vaginal Cancer AJCC v8 Stage II includes: IIA: T2a, N0, M0; IIB: T2b, N0, M0. T2a: Tumor invading paravaginal tissues but not to pelvic wall, measuring 2.0 cm or less. T2b: Tumor invading paravaginal tissues but not to pelvic wall, measuring more than 2.0 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139661 Neoplastic Process Stage II Vaginal Cancer AJCC v8 Stage II Vaginal Cancer AJCC v8 CL537840 CTRP Malignant Stage II Vaginal Cancer Stage II Vaginal Cancer AJCC v8 Stage II Vaginal Carcinoma AJCC v8 Stage II Vaginal Cancer AJCC v8 Stage IIA includes: T2a, N0, M0. T2a: Tumor invading paravaginal tissues but not to pelvic wall, measuring 2.0 cm or less. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139662 Neoplastic Process Stage IIA Vaginal Cancer AJCC v8 Stage IIA Vaginal Cancer AJCC v8 CL537855 CTRP Malignant Stage IIA Vaginal Cancer Stage IIA Vaginal Cancer AJCC v8 Stage IIA Vaginal Carcinoma AJCC v8 Stage IIA Vaginal Cancer AJCC v8 Stage IIB includes: T2b, N0, M0. T2b: Tumor invading paravaginal tissues but not to pelvic wall, measuring more than 2.0 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139664 Neoplastic Process Stage IIB Vaginal Cancer AJCC v8 Stage IIB Vaginal Cancer AJCC v8 CL537853 CTRP Malignant Stage IIB Vaginal Cancer Stage IIB Vaginal Cancer AJCC v8 Stage IIB Vaginal Carcinoma AJCC v8 Stage IIB Vaginal Cancer AJCC v8 Stage III includes: (T1-T3, N1, M0); (T3, N0, M0). T1: Tumor confined to the vagina. T2: Tumor invading paravaginal tissues but not to pelvic sidewall. T3: Tumor extending to the pelvic sidewall and/or involving the lower third of the vagina and/or causing hydronephrosis or nonfunctioning kidney. N0: No regional lymph node metastasis. N1: Pelvic or inguinal lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139665 Neoplastic Process Stage III Vaginal Cancer AJCC v8 Stage III Vaginal Cancer AJCC v8 CL537852 CTRP Malignant Stage III Vaginal Cancer Stage III Vaginal Cancer AJCC v8 Stage III Vaginal Carcinoma AJCC v8 Stage III Vaginal Cancer AJCC v8 Stage IV includes: IVA: T4, Any N, M0; IVB: Any T, Any N, M1. T4: Tumor invading the mucosa of the bladder or rectum and/or extending beyond the true pelvis (bullous edema is not sufficient evidence to classify a tumor as T4). M0: No distant metastasis. M1: Distant metastasis. (from AJCC 8th Ed.) C139667 Neoplastic Process Stage IV Vaginal Cancer AJCC v8 Stage IV Vaginal Cancer AJCC v8 CL537850 CTRP Malignant Stage IV Vaginal Cancer Stage IV Vaginal Cancer AJCC v8 Stage IV Vaginal Carcinoma AJCC v8 Stage IV Vaginal Cancer AJCC v8 Stage IVA includes: T4, Any N, M0. T4: Tumor invading the mucosa of the bladder or rectum and/or extending beyond the true pelvis (bullous edema is not sufficient evidence to classify a tumor as T4). M0: No distant metastasis. (from AJCC 8th Ed.) C139669 Neoplastic Process Stage IVA Vaginal Cancer AJCC v8 Stage IVA Vaginal Cancer AJCC v8 CL537848 CTRP Malignant Stage IVA Vaginal Cancer Stage IVA Vaginal Cancer AJCC v8 Stage IVA Vaginal Carcinoma AJCC v8 Stage IVA Vaginal Cancer AJCC v8 Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 8th Ed.) C139670 Neoplastic Process Stage IVB Vaginal Cancer AJCC v8 Stage IVB Vaginal Cancer AJCC v8 CL537831 CTRP Malignant Stage IVB Vaginal Cancer Stage IVB Vaginal Cancer AJCC v8 Stage IVB Vaginal Carcinoma AJCC v8 Stage IVB Vaginal Cancer AJCC v8 Histologic transformation of a follicular lymphoma to an aggressive diffuse large B-cell lymphoma. C139681 Neoplastic Process Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma CL537837 CTRP Malignant Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma A term that refers to the staging of cervical cancer according to the American Joint Committee on Cancer, 8th edition. C139733 Neoplastic Process Cervical Cancer by AJCC v8 Stage CL537912 Malignant Cervical Cancer by AJCC v8 Stage Cervical Carcinoma by AJCC v8 Stage Cervical Cancer by AJCC v8 Stage Stage I includes: T1, Any N, M0. T1: Tumor confined to uterus (extension to corpus should be disregarded). M0: No distant metastasis. (AJCC 8th Ed.) C139734 Neoplastic Process Stage I Cervical Cancer AJCC v8 Stage I Cervical Cancer AJCC v8 CL537911 CPTAC CTRP Malignant I Stage I Cervical Cancer Stage I Cervical Cancer AJCC v8 Stage I Cervical Carcinoma AJCC v8 Stage I Cervical Cancer AJCC v8 Stage IA includes: T1a, Any N, M0. T1a: Tumor diagnosed only by microscopy. Stromal invasion with a maximum depth of 5.0 mm measured from the base of the epithelium and a horizontal spread of 7.0 mm or less. Vascular space involvement, venous or lymphatic, does not affect classification. M0: No distant metastasis. (AJCC 8th Ed.) C139735 Neoplastic Process Stage IA Cervical Cancer AJCC v8 Stage IA Cervical Cancer AJCC v8 CL537895 CPTAC CTRP Malignant IA Stage IA Cervical Cancer Stage IA Cervical Cancer AJCC v8 Stage IA Cervical Carcinoma AJCC v8 Stage IA Cervical Cancer AJCC v8 Stage IA1 includes: T1a1, Any N, M0. T1a1: Invasive cervical carcinoma with measured stromal invasion of 3.0 mm or less in depth and 7.0 mm or less in horizontal spread. M0: No distant metastasis. (AJCC 8th Ed.) C139736 Neoplastic Process Stage IA1 Cervical Cancer AJCC v8 Stage IA1 Cervical Cancer AJCC v8 CL537894 CPTAC CTRP Malignant IA1 Stage IA1 Cervical Cancer Stage IA1 Cervical Cancer AJCC v8 Stage IA1 Cervical Carcinoma AJCC v8 Stage IA1 Cervical Cancer AJCC v8 Stage IA2 includes: T1a2, Any N, M0. T1a2: Invasive cervical carcinoma with measured stromal invasion of more than 3.0 mm and not more than 5.0 mm, with a horizontal spread of 7.0 mm or less. M0: No distant metastasis. (AJCC 8th Ed.) C139737 Neoplastic Process Stage IA2 Cervical Cancer AJCC v8 Stage IA2 Cervical Cancer AJCC v8 CL537893 CPTAC CTRP Malignant IA2 Stage IA2 Cervical Cancer Stage IA2 Cervical Cancer AJCC v8 Stage IA2 Cervical Carcinoma AJCC v8 Stage IA2 Cervical Cancer AJCC v8 Stage IB includes: T1b, Any N, M0. T1b: Tumor with clinically visible lesion confined to the cervix or microscopic lesion greater than T1a/IA2. It includes all macroscopically visible lesions, even those with superficial invasion. M0: No distant metastasis. (AJCC 8th Ed.) C139738 Neoplastic Process Stage IB Cervical Cancer AJCC v8 Stage IB Cervical Cancer AJCC v8 CL537892 CPTAC CTRP Malignant IB Stage IB Cervical Cancer Stage IB Cervical Cancer AJCC v8 Stage IB Cervical Carcinoma AJCC v8 Stage IB Cervical Cancer AJCC v8 Stage IB1 includes: T1b1, Any N, M0. T1b1: Tumor with clinically visible lesion 4.0 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 8th Ed.) C139739 Neoplastic Process Stage IB1 Cervical Cancer AJCC v8 Stage IB1 Cervical Cancer AJCC v8 CL537891 CPTAC CTRP Malignant IB1 Stage IB1 Cervical Cancer Stage IB1 Cervical Cancer AJCC v8 Stage IB1 Cervical Carcinoma AJCC v8 Stage IB1 Cervical Cancer AJCC v8 Stage IB2 includes: T1b2, Any N, M0. T1b2: Tumor with clinically visible lesion more than 4.0 cm in greatest dimension. M0: No distant metastasis. (AJCC 8th Ed.) C139740 Neoplastic Process Stage IB2 Cervical Cancer AJCC v8 Stage IB2 Cervical Cancer AJCC v8 CL537890 CPTAC CTRP Malignant IB2 Stage IB2 Cervical Cancer Stage IB2 Cervical Cancer AJCC v8 Stage IB2 Cervical Carcinoma AJCC v8 Stage IB2 Cervical Cancer AJCC v8 Stage II includes: T2, Any N, M0. T2: Cervical carcinoma invading beyond the uterus but not to the pelvic wall or to lower third of vagina. M0: No distant metastasis. (AJCC 8th Ed.) C139743 Neoplastic Process Stage II Cervical Cancer AJCC v8 Stage II Cervical Cancer AJCC v8 CL537888 CPTAC CTRP Malignant II Stage II Cervical Cancer Stage II Cervical Cancer AJCC v8 Stage II Cervical Carcinoma AJCC v8 Stage II Cervical Cancer AJCC v8 Stage IIA includes: T2a, Any N, M0. T2a: Cervical carcinoma invading beyond the uterus but not to the pelvic wall or to lower third of vagina without parametrial invasion. M0: No distant metastasis. (AJCC 8th Ed.) C139744 Neoplastic Process Stage IIA Cervical Cancer AJCC v8 Stage IIA Cervical Cancer AJCC v8 CL537902 CPTAC CTRP Malignant IIA Stage IIA Cervical Cancer Stage IIA Cervical Cancer AJCC v8 Stage IIA Cervical Carcinoma AJCC v8 Stage IIA Cervical Cancer AJCC v8 Stage IIA1 includes: T2a1, Any N, M0. T2a1: Cervical carcinoma invading beyond the uterus but not to the pelvic wall or to lower third of vagina without parametrial invasion. Clinically visible lesion 4.0 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 8th Ed.) C139745 Neoplastic Process Stage IIA1 Cervical Cancer AJCC v8 Stage IIA1 Cervical Cancer AJCC v8 CL537901 CPTAC CTRP Malignant IIA1 Stage IIA1 Cervical Cancer Stage IIA1 Cervical Cancer AJCC v8 Stage IIA1 Cervical Carcinoma AJCC v8 Stage IIA1 Cervical Cancer AJCC v8 Stage IIA2 includes: T2a2, Any N, M0. T2a2: Cervical carcinoma invading beyond the uterus but not to the pelvic wall or to lower third of vagina without parametrial invasion. Clinically visible lesion more than 4.0 cm in greatest dimension. M0: No distant metastasis. (AJCC 8th Ed.) C139746 Neoplastic Process Stage IIA2 Cervical Cancer AJCC v8 Stage IIA2 Cervical Cancer AJCC v8 CL537900 CPTAC CTRP Malignant IIA2 Stage IIA2 Cervical Cancer Stage IIA2 Cervical Cancer AJCC v8 Stage IIA2 Cervical Carcinoma AJCC v8 Stage IIA2 Cervical Cancer AJCC v8 Stage IIB includes: T2b, Any N, M0. T2b: Cervical carcinoma invading beyond the uterus but not to the pelvic wall or to lower third of vagina with parametrial invasion. M0: No distant metastasis. (AJCC 8th Ed.) C139748 Neoplastic Process Stage IIB Cervical Cancer AJCC v8 Stage IIB Cervical Cancer AJCC v8 CL537898 CPTAC CTRP Malignant IIB Stage IIB Cervical Cancer Stage IIB Cervical Cancer AJCC v8 Stage IIB Cervical Carcinoma AJCC v8 Stage IIB Cervical Cancer AJCC v8 Stage III includes: T3, Any N, M0. T3: Tumor extending to pelvic sidewall and/or involving the lower third of vagina, and/or causing hydronephrosis or nonfunctioning kidney. M0: No distant metastasis. (AJCC 8th Ed.) C139749 Neoplastic Process Stage III Cervical Cancer AJCC v8 Stage III Cervical Cancer AJCC v8 CL537897 CPTAC CTRP Malignant III Stage III Cervical Cancer Stage III Cervical Cancer AJCC v8 Stage III Cervical Carcinoma AJCC v8 Stage III Cervical Cancer AJCC v8 Stage IIIA includes: T3a, Any N, M0. T3a: Tumor involving the lower third of vagina but not extending to pelvic wall. M0: No distant metastasis. (AJCC 8th Ed.) C139750 Neoplastic Process Stage IIIA Cervical Cancer AJCC v8 Stage IIIA Cervical Cancer AJCC v8 CL537896 CPTAC CTRP Malignant IIIA Stage IIIA Cervical Cancer Stage IIIA Cervical Cancer AJCC v8 Stage IIIA Cervical Carcinoma AJCC v8 Stage IIIA Cervical Cancer AJCC v8 Stage IIIB includes: T3b, Any N, M0. T3b: extending to pelvic wall and/or causing hydronephrosis or nonfunctioning kidney. M0: No distant metastasis. (AJCC 8th Ed.) C139752 Neoplastic Process Stage IIIB Cervical Cancer AJCC v8 Stage IIIB Cervical Cancer AJCC v8 CL537879 CPTAC CTRP Malignant IIIB Stage IIIB Cervical Cancer Stage IIIB Cervical Cancer AJCC v8 Stage IIIB Cervical Carcinoma AJCC v8 Stage IIIB Cervical Cancer AJCC v8 Stage IV includes: IVA: T4, Any N, M0; IVB: Any T, Any N, M1. T4: Tumor invading the mucosa of the bladder or rectum, and/or extending beyond the true pelvis (bullous edema is not sufficient to classify a tumor as T4). M0: No distant metastasis. M1: Distant metastasis (including peritoneal spread or involvement of the supraclavicular, mediastinal, or distant lymph nodes; lung; liver; or bone). (from AJCC 8th Ed.) C139753 Neoplastic Process Stage IV Cervical Cancer AJCC v8 Stage IV Cervical Cancer AJCC v8 CL537878 CPTAC CTRP Malignant IV Stage IV Cervical Cancer Stage IV Cervical Cancer AJCC v8 Stage IV Cervical Carcinoma AJCC v8 Stage IV Cervical Cancer AJCC v8 Stage IVA includes: T4, Any N, M0. T4: Tumor invading the mucosa of the bladder or rectum, and/or extending beyond the true pelvis (bullous edema is not sufficient to classify a tumor as T4). M0: No distant metastasis. (from AJCC 8th Ed.) C139754 Neoplastic Process Stage IVA Cervical Cancer AJCC v8 Stage IVA Cervical Cancer AJCC v8 CL537877 CPTAC CTRP Malignant IVA Stage IVA Cervical Cancer Stage IVA Cervical Cancer AJCC v8 Stage IVA Cervical Carcinoma AJCC v8 Stage IVA Cervical Cancer AJCC v8 Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis (including peritoneal spread or involvement of the supraclavicular, mediastinal, or distant lymph nodes; lung; liver; or bone). (from AJCC 8th Ed.) C139755 Neoplastic Process Stage IVB Cervical Cancer AJCC v8 Stage IVB Cervical Cancer AJCC v8 CL537876 CPTAC CTRP Malignant IVB Stage IVB Cervical Cancer Stage IVB Cervical Cancer AJCC v8 Stage IVB Cervical Carcinoma AJCC v8 Stage IVB Cervical Cancer AJCC v8 A term that refers to the staging of uterine corpus cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to carcinomas and carcinosarcomas. It does not apply to uterine corpus sarcomas: leiomyosarcomas, endometrial stromal sarcomas, and adenosarcomas. These sarcomas are staged according to the classification for uterine corpus sarcomas. (from AJCC 8th Ed.) C139801 Neoplastic Process Uterine Corpus Cancer by AJCC v8 Stage CL537958 CPTAC Malignant Tumor Stage (Pathological) Uterine Corpus Cancer by AJCC v8 Stage Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v8 Stage Uterine Corpus Cancer by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Uterine corpus carcinoma or carcinosarcoma with tumor confined to the corpus uteri, including endocervical glandular involvement. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139802 Neoplastic Process Stage I Uterine Corpus Cancer AJCC v8 Stage I Uterine Corpus Cancer AJCC v8 CL537957 CPTAC CTRP Malignant Stage I Stage I Uterine (including Endometrial) Cancer Stage I Uterine Corpus Cancer AJCC v8 Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Stage I Uterine Corpus Cancer AJCC v8 Stage IA includes: T1a, N0, M0. T1a: Uterine corpus carcinoma or carcinosarcoma with tumor limited to the endometrium or invading less than half the myometrium. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139803 Neoplastic Process Stage IA Uterine Corpus Cancer AJCC v8 Stage IA Uterine Corpus Cancer AJCC v8 CL537956 CTRP Malignant Stage IA Uterine (including Endometrial) Cancer Stage IA Uterine Corpus Cancer AJCC v8 Stage IA Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Stage IA Uterine Corpus Cancer AJCC v8 Stage IB includes: T1b, N0, M0. T1b: Uterine corpus carcinoma or carcinosarcoma with tumor invading one half or more of the myometrium. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139804 Neoplastic Process Stage IB Uterine Corpus Cancer AJCC v8 Stage IB Uterine Corpus Cancer AJCC v8 CL537955 CTRP Malignant Stage IB Uterine (including Endometrial) Cancer Stage IB Uterine Corpus Cancer AJCC v8 Stage IB Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Stage IB Uterine Corpus Cancer AJCC v8 Stage II includes: T2, N0, M0. T2: Uterine corpus carcinoma or carcinosarcoma with tumor invading the stromal connective tissue of the cervix but not extending beyond the uterus. Does not include endocervical glandular involvement. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139805 Neoplastic Process Stage II Uterine Corpus Cancer AJCC v8 Stage II Uterine Corpus Cancer AJCC v8 CL537954 CPTAC CTRP Malignant Stage II Stage II Uterine (including Endometrial) Cancer Stage II Uterine Corpus Cancer AJCC v8 Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Stage II Uterine Corpus Cancer AJCC v8 Stage III includes: T3, N0, M0. T3: Uterine corpus carcinoma or carcinosarcoma with tumor involving serosa, adnexa, vagina, or parametrium. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139806 Neoplastic Process Stage III Uterine Corpus Cancer AJCC v8 Stage III Uterine Corpus Cancer AJCC v8 CL537953 CPTAC CTRP Malignant Stage III Stage III Uterine (including Endometrial) Cancer Stage III Uterine Corpus Cancer AJCC v8 Stage III Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Stage III Uterine Corpus Cancer AJCC v8 Stage IIIA includes: T3a, N0, M0. T3a: Uterine corpus carcinoma or carcinosarcoma with tumor involving the serosa and/or adnexa (direct extension or metastasis). N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 8th Ed.) C139807 Neoplastic Process Stage IIIA Uterine Corpus Cancer AJCC v8 Stage IIIA Uterine Corpus Cancer AJCC v8 CL537952 CTRP Malignant Stage IIIA Uterine (including Endometrial) Cancer Stage IIIA Uterine Corpus Cancer AJCC v8 Stage IIIA Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Stage IIIA Uterine Corpus Cancer AJCC v8 Stage IIIB includes: T3b, N0, M0. T3b: Uterine corpus carcinoma or carcinosarcoma with vaginal involvement (direct extension or metastasis) or parametrial involvement. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 8th Ed.) C139808 Neoplastic Process Stage IIIB Uterine Corpus Cancer AJCC v8 Stage IIIB Uterine Corpus Cancer AJCC v8 CL537951 CTRP Malignant Stage IIIB Uterine (including Endometrial) Cancer Stage IIIB Uterine Corpus Cancer AJCC v8 Stage IIIB Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Stage IIIB Uterine Corpus Cancer AJCC v8 Stage IIIC includes: IIIC1: T1-T3, N1/N1mi/N1a, M0; IIIC2: T1-T3, N2/N2mi/N2a, M0. T1: Uterine corpus carcinoma or carcinosarcoma with tumor confined to the corpus uteri, including endocervical glandular involvement. T2: Uterine corpus carcinoma or carcinosarcoma with tumor invading the stromal connective tissue of the cervix but not extending beyond the uterus. Does not include endocervical glandular involvement. T3: Uterine corpus carcinoma or carcinosarcoma with tumor involving serosa, adnexa, vagina, or parametrium. N1: Regional lymph node metastasis to pelvic lymph nodes. N1mi: Regional lymph node metastasis (greater than 0.2 mm but nor greater than 2.0 mm in diameter) to pelvic lymph nodes. N1a: Regional lymph node metastasis (greater than 2.0 mm in diameter) to pelvic lymph nodes. N2: Regional lymph node metastasis to para-aortic lymph nodes, with or without positive pelvic lymph nodes. N2mi: Regional lymph node metastasis (greater than 0.2 mm but not greater than 2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes. N2a: Regional lymph node metastasis (greater than 2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes. M0: No distant metastasis. (from AJCC 8th Ed.) C139809 Neoplastic Process Stage IIIC Uterine Corpus Cancer AJCC v8 Stage IIIC Uterine Corpus Cancer AJCC v8 CL537966 CTRP Malignant Stage IIIC Uterine (including Endometrial) Cancer Stage IIIC Uterine Corpus Cancer AJCC v8 Stage IIIC Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Stage IIIC Uterine Corpus Cancer AJCC v8 Stage IIIC1 includes: T1-T3, N1/N1mi/N1a, M0. T1: Uterine corpus carcinoma or carcinosarcoma with tumor confined to the corpus uteri, including endocervical glandular involvement. T2: Uterine corpus carcinoma or carcinosarcoma with tumor invading the stromal connective tissue of the cervix but not extending beyond the uterus. Does not include endocervical glandular involvement. T3: Uterine corpus carcinoma or carcinosarcoma with tumor involving serosa, adnexa, vagina, or parametrium. N1: Regional lymph node metastasis to pelvic lymph nodes. N1mi: Regional lymph node metastasis (greater than 0.2 mm but nor greater than 2.0 mm in diameter) to pelvic lymph nodes. N1a: Regional lymph node metastasis (greater than 2.0 mm in diameter) to pelvic lymph nodes. M0: No distant metastasis. (from AJCC 8th Ed.) C139810 Neoplastic Process Stage IIIC1 Uterine Corpus Cancer AJCC v8 Stage IIIC1 Uterine Corpus Cancer AJCC v8 CL537965 CTRP Malignant Stage IIIC1 Uterine (including Endometrial) Cancer Stage IIIC1 Uterine Corpus Cancer AJCC v8 Stage IIIC1 Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Stage IIIC1 Uterine Corpus Cancer AJCC v8 Stage IIIC2 includes: T1-T3, N2/N2mi/N2a, M0. T1: Uterine corpus carcinoma or carcinosarcoma with tumor confined to the corpus uteri, including endocervical glandular involvement. T2: Uterine corpus carcinoma or carcinosarcoma with tumor invading the stromal connective tissue of the cervix but not extending beyond the uterus. Does not include endocervical glandular involvement. T3: Uterine corpus carcinoma or carcinosarcoma with tumor involving serosa, adnexa, vagina, or parametrium. N2: Regional lymph node metastasis to para-aortic lymph nodes, with or without positive pelvic lymph nodes. N2mi: Regional lymph node metastasis (greater than 0.2 mm but not greater than 2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes. N2a: Regional lymph node metastasis (greater than 2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes. M0: No distant metastasis. (from AJCC 8th Ed.) C139811 Neoplastic Process Stage IIIC2 Uterine Corpus Cancer AJCC v8 Stage IIIC2 Uterine Corpus Cancer AJCC v8 CL537964 CTRP Malignant Stage IIIC2 Uterine (including Endometrial) Cancer Stage IIIC2 Uterine Corpus Cancer AJCC v8 Stage IIIC2 Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Stage IIIC2 Uterine Corpus Cancer AJCC v8 Stage IV includes: IVA: T4, Any N, M0; IVB: Any T, Any N, M1. T4: Uterine corpus carcinoma or carcinosarcoma with tumor invading the bladder mucosa and/or bowel mucosa (bullous edema is not sufficient to classify a tumor as T4). M0: No distant metastasis. M1: Distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, lung, liver, or bone. It excludes metastasis to pelvic or para-aortic lymph nodes, vagina, uterine serosa, or adnexa). (from AJCC 8th Ed.) C139812 Neoplastic Process Stage IV Uterine Corpus Cancer AJCC v8 Stage IV Uterine Corpus Cancer AJCC v8 CL537963 CPTAC CTRP Malignant Stage IV Stage IV Uterine (including Endometrial) Cancer Stage IV Uterine Corpus Cancer AJCC v8 Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Stage IV Uterine Corpus Cancer AJCC v8 Stage IVA includes: T4, Any N, M0. T4: Uterine corpus carcinoma or carcinosarcoma with tumor invading the bladder mucosa and/or bowel mucosa (bullous edema is not sufficient to classify a tumor as T4). M0: No distant metastasis. (from AJCC 8th Ed.) C139813 Neoplastic Process Stage IVA Uterine Corpus Cancer AJCC v8 Stage IVA Uterine Corpus Cancer AJCC v8 CL537962 CTRP Malignant Stage IVA Uterine (including Endometrial) Cancer Stage IVA Uterine Corpus Cancer AJCC v8 Stage IVA Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Stage IVA Uterine Corpus Cancer AJCC v8 Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, lung, liver, or bone. It excludes metastasis to pelvic or para-aortic lymph nodes, vagina, uterine serosa, or adnexa). (from AJCC 8th Ed.) C139814 Neoplastic Process Stage IVB Uterine Corpus Cancer AJCC v8 Stage IVB Uterine Corpus Cancer AJCC v8 CL537961 CTRP Malignant Stage IVB Uterine (including Endometrial) Cancer Stage IVB Uterine Corpus Cancer AJCC v8 Stage IVB Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Stage IVB Uterine Corpus Cancer AJCC v8 A term that refers to the staging of uterine corpus sarcoma according to the American Joint Committee on Cancer, 8th edition. This staging system applies to leiomyosarcomas, endometrial stromal sarcomas, and adenosarcomas of the uterine corpus. It does not apply to carcinosarcomas which are staged according to the carcinomas and carcinosarcomas of the uterine corpus. (from AJCC 8th Ed.) C139869 Neoplastic Process Uterine Corpus Sarcoma by AJCC v8 Stage CL538016 Malignant Uterine Corpus Sarcoma by AJCC v8 Stage Uterine Corpus Sarcoma by AJCC v8 Stage A term that refers to the staging of uterine corpus leiomyosarcoma according to the American Joint Committee on Cancer, 8th edition. C139870 Neoplastic Process Uterine Corpus Leiomyosarcoma by AJCC v8 Stage CL538015 Malignant Uterine Corpus Leiomyosarcoma by AJCC v8 Stage Uterine Corpus Leiomyosarcoma by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Uterine corpus leiomyosarcoma with tumor limited to the uterus. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139871 Neoplastic Process Stage I Uterine Corpus Leiomyosarcoma AJCC v8 Stage I Uterine Corpus Leiomyosarcoma AJCC v8 CL538014 CTRP Malignant Stage I Uterine Corpus Leiomyosarcoma Stage I Uterine Corpus Leiomyosarcoma AJCC v8 Stage I Uterine Corpus Leiomyosarcoma AJCC v8 Stage IA includes: T1a, N0, M0. T1a: Uterine corpus leiomyosarcoma with tumor limited to the uterus, measuring 5 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139872 Neoplastic Process Stage IA Uterine Corpus Leiomyosarcoma AJCC v8 Stage IA Uterine Corpus Leiomyosarcoma AJCC v8 CL538013 CTRP Malignant Stage IA Uterine Corpus Leiomyosarcoma Stage IA Uterine Corpus Leiomyosarcoma AJCC v8 Stage IA Uterine Corpus Leiomyosarcoma AJCC v8 Stage IB includes: T1b, N0, M0. T1b: Uterine corpus leiomyosarcoma with tumor limited to the uterus, measuring more than 5 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139873 Neoplastic Process Stage IB Uterine Corpus Leiomyosarcoma AJCC v8 Stage IB Uterine Corpus Leiomyosarcoma AJCC v8 CL538028 CTRP Malignant Stage IB Uterine Corpus Leiomyosarcoma Stage IB Uterine Corpus Leiomyosarcoma AJCC v8 Stage IB Uterine Corpus Leiomyosarcoma AJCC v8 Stage II includes: T2, N0, M0. T2: Uterine corpus leiomyosarcoma with tumor extending beyond the uterus, within the pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139874 Neoplastic Process Stage II Uterine Corpus Leiomyosarcoma AJCC v8 Stage II Uterine Corpus Leiomyosarcoma AJCC v8 CL538027 CTRP Malignant Stage II Uterine Corpus Leiomyosarcoma Stage II Uterine Corpus Leiomyosarcoma AJCC v8 Stage II Uterine Corpus Leiomyosarcoma AJCC v8 Stage III includes: IIIA: T3a, N0, M0; IIIB: T3b, N0, M0; IIIC: T1-3, N1, M0. T1: Uterine corpus leiomyosarcoma with tumor limited to the uterus. T2: Uterine corpus leiomyosarcoma with tumor extending beyond the uterus, within the pelvis. T3: Uterine corpus leiomyosarcoma with tumor infiltrating abdominal tissues. T3a: Uterine corpus leiomyosarcoma with tumor infiltrating abdominal tissues at one site. T3b: Uterine corpus leiomyosarcoma with tumor infiltrating abdominal tissues at more than one site. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139875 Neoplastic Process Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Stage III Uterine Corpus Leiomyosarcoma AJCC v8 CL538026 CTRP Malignant Stage III Uterine Corpus Leiomyosarcoma Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Stage IIIA includes: T3a, N0, M0. T3a: Uterine corpus leiomyosarcoma with tumor infiltrating abdominal tissues at one site. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139876 Neoplastic Process Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8 Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8 CL538025 CTRP Malignant Stage IIIA Uterine Corpus Leiomyosarcoma Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8 Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8 Stage IIIB includes: T3b, N0, M0. T3b: Uterine corpus leiomyosarcoma with tumor infiltrating abdominal tissues at more than one site. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139877 Neoplastic Process Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8 Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8 CL538024 CTRP Malignant Stage IIIB Uterine Corpus Leiomyosarcoma Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8 Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8 Stage IIIC includes: T1-3, N1, M0. T1: Uterine corpus leiomyosarcoma with tumor limited to the uterus. T2: Uterine corpus leiomyosarcoma with tumor extending beyond the uterus, within the pelvis. T3: Uterine corpus leiomyosarcoma with tumor infiltrating abdominal tissues. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139878 Neoplastic Process Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8 Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8 CL538023 CTRP Malignant Stage IIIC Uterine Corpus Leiomyosarcoma Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8 Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8 Stage IV includes: IVA: T4, Any N, M0; IVB: Any T, Any N, M1. T4: Uterine corpus leiomyosarcoma with tumor invading bladder or rectum. M0: No distant metastasis. M1: Distant metastasis (excluding adnexa, pelvic, and abdominal tissues). (from AJCC 8th Ed.) C139879 Neoplastic Process Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 CL538022 CTRP Malignant Stage IV Uterine Corpus Leiomyosarcoma Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 Stage IVA includes: T4, Any N, M0. T4: Uterine corpus leiomyosarcoma with tumor invading bladder or rectum. M0: No distant metastasis. (from AJCC 8th Ed.) C139880 Neoplastic Process Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8 Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8 CL538021 CTRP Malignant Stage IVA Uterine Corpus Leiomyosarcoma Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8 Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8 Stage IVB includes: Any T, Any N, M1. M1: M1: Distant metastasis (excluding adnexa, pelvic, and abdominal tissues). (from AJCC 8th Ed.) C139881 Neoplastic Process Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8 Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8 CL538004 CTRP Malignant Stage IVB Uterine Corpus Leiomyosarcoma Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8 Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8 A term that refers to the staging of uterine corpus endometrial stroma sarcoma according to the American Joint Committee on Cancer, 8th edition. C139882 Neoplastic Process Uterine Corpus Endometrial Stromal Sarcoma by AJCC v8 Stage CL538003 Malignant Uterine Corpus Endometrial Stromal Sarcoma by AJCC v8 Stage Uterine Corpus Endometrial Stromal Sarcoma by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Uterine corpus endometrial stroma sarcoma with tumor limited to the uterus. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139883 Neoplastic Process Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 CL538002 CTRP Malignant Stage I Uterine Corpus Endometrial Stromal Sarcoma Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IA includes: T1a, N0, M0. T1a: Uterine corpus endometrial stroma sarcoma with tumor limited to the uterus, measuring 5 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139884 Neoplastic Process Stage IA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 CL538001 CTRP Malignant Stage IA Uterine Corpus Endometrial Stromal Sarcoma Stage IA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IB includes: T1b, N0, M0. T1b: Uterine corpus endometrial stroma sarcoma with tumor limited to the uterus, measuring more than 5 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139885 Neoplastic Process Stage IB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 CL538000 CTRP Malignant Stage IB Uterine Corpus Endometrial Stromal Sarcoma Stage IB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage II includes: T2, N0, M0. T2: Uterine corpus endometrial stroma sarcoma with tumor extending beyond the uterus, within the pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139886 Neoplastic Process Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 CL537999 CTRP Malignant Stage II Uterine Corpus Endometrial Stromal Sarcoma Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage III includes: IIIA: T3a, N0, M0; IIIB: T3b, N0, M0; IIIC: T1-3, N1, M0. T1: Uterine corpus endometrial stroma sarcoma with tumor limited to the uterus. T2: Uterine corpus endometrial stroma sarcoma with tumor extending beyond the uterus, within the pelvis. T3: Uterine corpus endometrial stroma sarcoma with tumor infiltrating abdominal tissues. T3a: Uterine corpus endometrial stroma sarcoma with tumor infiltrating abdominal tissues at one site. T3b: Uterine corpus endometrial stroma sarcoma with tumor infiltrating abdominal tissues at more than one site. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139887 Neoplastic Process Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 CL537998 CTRP Malignant Stage III Uterine Corpus Endometrial Stromal Sarcoma Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IIIA includes: T3a, N0, M0. T3a: Uterine corpus endometrial stroma sarcoma with tumor infiltrating abdominal tissues at one site. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139888 Neoplastic Process Stage IIIA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IIIA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 CL537997 CTRP Malignant Stage IIIA Uterine Corpus Endometrial Stromal Sarcoma Stage IIIA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IIIA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IIIB includes: T3b, N0, M0. T3b: Uterine corpus endometrial stroma sarcoma with tumor infiltrating abdominal tissues at more than one site. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139889 Neoplastic Process Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 CL538012 CTRP Malignant Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IIIB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IIIC includes: T1-3, N1, M0. T1: Uterine corpus endometrial stroma sarcoma with tumor limited to the uterus. T2: Uterine corpus endometrial stroma sarcoma with tumor extending beyond the uterus, within the pelvis. T3: Uterine corpus endometrial stroma sarcoma with tumor infiltrating abdominal tissues. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139890 Neoplastic Process Stage IIIC Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IIIC Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 CL538011 CTRP Malignant Stage IIIC Uterine Corpus Endometrial Stromal Sarcoma Stage IIIC Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IIIC Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IV includes: IVA: T4, Any N, M0; IVB: Any T, Any N, M1. T4: Uterine corpus endometrial stroma sarcoma with tumor invading bladder or rectum. M0: No distant metastasis. M1: Distant metastasis (excluding adnexa, pelvic, and abdominal tissues). (from AJCC 8th Ed.) C139891 Neoplastic Process Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 CL538010 CTRP Malignant Stage IV Uterine Corpus Endometrial Stromal Sarcoma Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IVA includes: T4, Any N, M0. T4: Uterine corpus endometrial stroma sarcoma with tumor invading bladder or rectum. M0: No distant metastasis. (from AJCC 8th Ed.) C139892 Neoplastic Process Stage IVA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IVA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 CL538009 CTRP Malignant Stage IVA Uterine Corpus Endometrial Stromal Sarcoma Stage IVA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IVA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IVB includes: Any T, Any N, M1. M1: M1: Distant metastasis (excluding adnexa, pelvic, and abdominal tissues). (from AJCC 8th Ed.) C139893 Neoplastic Process Stage IVB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IVB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 CL538008 CTRP Malignant Stage IVB Uterine Corpus Endometrial Stromal Sarcoma Stage IVB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 Stage IVB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8 A term that refers to the staging of uterine corpus adenosarcoma according to the American Joint Committee on Cancer, 8th edition. C139894 Neoplastic Process Uterine Corpus Adenosarcoma by AJCC v8 Stage CL538007 Malignant Uterine Corpus Adenosarcoma by AJCC v8 Stage Uterine Corpus Adenosarcoma by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Uterine corpus adenosarcoma with tumor limited to the uterus. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139895 Neoplastic Process Stage I Uterine Corpus Adenosarcoma AJCC v8 Stage I Uterine Corpus Adenosarcoma AJCC v8 CL538006 CTRP Malignant Stage I Uterine Corpus Adenosarcoma Stage I Uterine Corpus Adenosarcoma AJCC v8 Stage I Uterine Corpus Adenosarcoma AJCC v8 Stage IA includes: T1a, N0, M0. T1a: Uterine corpus adenosarcoma with tumor limited to the endometrium/endocervix. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139896 Neoplastic Process Stage IA Uterine Corpus Adenosarcoma AJCC v8 Stage IA Uterine Corpus Adenosarcoma AJCC v8 CL538005 CTRP Malignant Stage IA Uterine Corpus Adenosarcoma Stage IA Uterine Corpus Adenosarcoma AJCC v8 Stage IA Uterine Corpus Adenosarcoma AJCC v8 Stage IB includes: T1b, N0, M0. T1b: Uterine corpus adenosarcoma with tumor invading to less than half of the myometrium. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139897 Neoplastic Process Stage IB Uterine Corpus Adenosarcoma AJCC v8 Stage IB Uterine Corpus Adenosarcoma AJCC v8 CL537989 CTRP Malignant Stage IB Uterine Corpus Adenosarcoma Stage IB Uterine Corpus Adenosarcoma AJCC v8 Stage IB Uterine Corpus Adenosarcoma AJCC v8 Stage IC includes: T1c, N0, M0. T1c: Uterine corpus adenosarcoma with tumor invading more than half of the myometrium. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139898 Neoplastic Process Stage IC Uterine Corpus Adenosarcoma AJCC v8 Stage IC Uterine Corpus Adenosarcoma AJCC v8 CL537988 CTRP Malignant Stage IC Uterine Corpus Adenosarcoma Stage IC Uterine Corpus Adenosarcoma AJCC v8 Stage IC Uterine Corpus Adenosarcoma AJCC v8 Stage II includes: T2, N0, M0. T2: Uterine corpus adenosarcoma with tumor extending beyond the uterus, within the pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139899 Neoplastic Process Stage II Uterine Corpus Adenosarcoma AJCC v8 Stage II Uterine Corpus Adenosarcoma AJCC v8 CL537987 CTRP Malignant Stage II Uterine Corpus Adenosarcoma Stage II Uterine Corpus Adenosarcoma AJCC v8 Stage II Uterine Corpus Adenosarcoma AJCC v8 Stage III includes: IIIA: T3a, N0, M0; IIIB: T3b, N0, M0; IIIC: T1-3, N1, M0. T1: Uterine corpus adenosarcoma with tumor limited to the uterus. T2: Uterine corpus adenosarcoma with tumor extending beyond the uterus, within the pelvis. T3: Uterine corpus adenosarcoma with tumor infiltrating abdominal tissues. T3a: Uterine corpus adenosarcoma with tumor infiltrating abdominal tissues at one site. T3b: Uterine corpus adenosarcoma with tumor infiltrating abdominal tissues at more than one site. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139900 Neoplastic Process Stage III Uterine Corpus Adenosarcoma AJCC v8 Stage III Uterine Corpus Adenosarcoma AJCC v8 CL537986 CTRP Malignant Stage III Uterine Corpus Adenosarcoma Stage III Uterine Corpus Adenosarcoma AJCC v8 Stage III Uterine Corpus Adenosarcoma AJCC v8 Stage IIIA includes: T3a, N0, M0. T3a: Uterine corpus adenosarcoma with tumor infiltrating abdominal tissues at one site. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139901 Neoplastic Process Stage IIIA Uterine Corpus Adenosarcoma AJCC v8 Stage IIIA Uterine Corpus Adenosarcoma AJCC v8 CL537985 CTRP Malignant Stage IIIA Uterine Corpus Adenosarcoma Stage IIIA Uterine Corpus Adenosarcoma AJCC v8 Stage IIIA Uterine Corpus Adenosarcoma AJCC v8 Stage IIIB includes: T3b, N0, M0. T3b: Uterine corpus adenosarcoma with tumor infiltrating abdominal tissues at more than one site. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139902 Neoplastic Process Stage IIIB Uterine Corpus Adenosarcoma AJCC v8 Stage IIIB Uterine Corpus Adenosarcoma AJCC v8 CL537984 CTRP Malignant Stage IIIB Uterine Corpus Adenosarcoma Stage IIIB Uterine Corpus Adenosarcoma AJCC v8 Stage IIIB Uterine Corpus Adenosarcoma AJCC v8 Stage IIIC includes: T1-3, N1, M0. T1: Uterine corpus adenosarcoma with tumor limited to the uterus. T2: Uterine corpus adenosarcoma with tumor extending beyond the uterus, within the pelvis. T3: Uterine corpus adenosarcoma with tumor infiltrating abdominal tissues. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139903 Neoplastic Process Stage IIIC Uterine Corpus Adenosarcoma AJCC v8 Stage IIIC Uterine Corpus Adenosarcoma AJCC v8 CL537983 CTRP Malignant Stage IIIC Uterine Corpus Adenosarcoma Stage IIIC Uterine Corpus Adenosarcoma AJCC v8 Stage IIIC Uterine Corpus Adenosarcoma AJCC v8 Stage IV includes: IVA: T4, Any N, M0; IVB: Any T, Any N, M1. T4: Uterine corpus adenosarcoma with tumor invading bladder or rectum. M0: No distant metastasis. M1: Distant metastasis (excluding adnexa, pelvic, and abdominal tissues). (from AJCC 8th Ed.) C139904 Neoplastic Process Stage IV Uterine Corpus Adenosarcoma AJCC v8 Stage IV Uterine Corpus Adenosarcoma AJCC v8 CL537982 CTRP Malignant Stage IV Uterine Corpus Adenosarcoma Stage IV Uterine Corpus Adenosarcoma AJCC v8 Stage IV Uterine Corpus Adenosarcoma AJCC v8 Stage IVA includes: T4, Any N, M0. T4: Uterine corpus adenosarcoma with tumor invading bladder or rectum. M0: No distant metastasis. (from AJCC 8th Ed.) C139905 Neoplastic Process Stage IVA Uterine Corpus Adenosarcoma AJCC v8 Stage IVA Uterine Corpus Adenosarcoma AJCC v8 CL537996 CTRP Malignant Stage IVA Uterine Corpus Adenosarcoma Stage IVA Uterine Corpus Adenosarcoma AJCC v8 Stage IVA Uterine Corpus Adenosarcoma AJCC v8 Stage IVB includes: Any T, Any N, M1. M1: M1: Distant metastasis (excluding adnexa, pelvic, and abdominal tissues). (from AJCC 8th Ed.) C139906 Neoplastic Process Stage IVB Uterine Corpus Adenosarcoma AJCC v8 Stage IVB Uterine Corpus Adenosarcoma AJCC v8 CL537995 CTRP Malignant Stage IVB Uterine Corpus Adenosarcoma Stage IVB Uterine Corpus Adenosarcoma AJCC v8 Stage IVB Uterine Corpus Adenosarcoma AJCC v8 A term that refers to the staging of ovarian cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to ovarian carcinomas. Nonepithelial primary ovarian cancers may be staged using this classification but should be reported separately. (from AJCC 8th Ed.) C139963 Neoplastic Process Ovarian Cancer by AJCC v8 Stage CL538050 Malignant Ovarian Cancer by AJCC v8 Stage Ovarian Carcinoma by AJCC v8 Stage Ovarian Cancer by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Ovarian cancer with tumor limited to ovaries (one or both). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139964 Neoplastic Process Stage I Ovarian Cancer AJCC v8 Stage I Ovarian Cancer AJCC v8 CL538049 CTRP Malignant Stage I Ovarian Cancer Stage I Ovarian Cancer AJCC v8 Stage I Ovarian Carcinoma AJCC v8 Stage I Ovarian Cancer AJCC v8 Stage IA includes: T1a, N0, M0. T1a: Ovarian cancer with tumor limited to one ovary (capsule intact); no malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139965 Neoplastic Process Stage IA Ovarian Cancer AJCC v8 Stage IA Ovarian Cancer AJCC v8 CL538048 CTRP Malignant Stage IA Ovarian Cancer Stage IA Ovarian Cancer AJCC v8 Stage IA Ovarian Carcinoma AJCC v8 Stage IA Ovarian Cancer AJCC v8 Stage IB includes: T1b, N0, M0. T1b: Ovarian cancer with tumor limited to one or both ovaries (capsules intact); no tumor on ovarian surface; no malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139966 Neoplastic Process Stage IB Ovarian Cancer AJCC v8 Stage IB Ovarian Cancer AJCC v8 CL538047 CTRP Malignant Stage IB Ovarian Cancer Stage IB Ovarian Cancer AJCC v8 Stage IB Ovarian Carcinoma AJCC v8 Stage IB Ovarian Cancer AJCC v8 Stage IC includes: T1c, N0, M0. T1c: Ovarian cancer with tumor limited to one or both ovaries, with any of the following: surgical spill, capsule ruptured before surgery or tumor on ovarian surface, or malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139967 Neoplastic Process Stage IC Ovarian Cancer AJCC v8 Stage IC Ovarian Cancer AJCC v8 CL538046 CTRP Malignant Stage IC Ovarian Cancer Stage IC Ovarian Cancer AJCC v8 Stage IC Ovarian Carcinoma AJCC v8 Stage IC Ovarian Cancer AJCC v8 Stage II includes: T2, N0, M0. T2: Ovarian cancer with tumor involving one or both ovaries with pelvic extension below pelvic brim. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139968 Neoplastic Process Stage II Ovarian Cancer AJCC v8 Stage II Ovarian Cancer AJCC v8 CL538045 CTRP Malignant Stage II Ovarian Cancer Stage II Ovarian Cancer AJCC v8 Stage II Ovarian Carcinoma AJCC v8 Stage II Ovarian Cancer AJCC v8 Stage IIA includes: T2a, N0, M0. T2a: Ovarian cancer with tumor extension and/or implants on the uterus and/or fallopian tube(s) and/or ovaries. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139969 Neoplastic Process Stage IIA Ovarian Cancer AJCC v8 Stage IIA Ovarian Cancer AJCC v8 CL538060 CTRP Malignant Stage IIA Ovarian Cancer Stage IIA Ovarian Cancer AJCC v8 Stage IIA Ovarian Carcinoma AJCC v8 Stage IIA Ovarian Cancer AJCC v8 Stage IIB includes: T2b, N0, M0. T2b: Ovarian cancer with tumor extension to and/or implants on other pelvic tissues. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139970 Neoplastic Process Stage IIB Ovarian Cancer AJCC v8 Stage IIB Ovarian Cancer AJCC v8 CL538059 CTRP Malignant Stage IIB Ovarian Cancer Stage IIB Ovarian Cancer AJCC v8 Stage IIB Ovarian Carcinoma AJCC v8 Stage IIB Ovarian Cancer AJCC v8 Stage III includes: IIIA1: T1/2, N1, M0; IIIA2: T3a, N0/N1, M0; IIIB: T3b, N0/N1, M0; IIIC: T3c, N0/N1, M0. T1: Ovarian cancer with tumor limited to ovaries (one or both). T2: Ovarian cancer with tumor involving one or both ovaries with pelvic extension below pelvic brim. T3a: Ovarian cancer with microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes. T3b: Ovarian cancer with macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension with or without metastasis to the retroperitoneal lymph nodes. T3c: Ovarian cancer with macroscopic peritoneal metastasis beyond the pelvis more than 2 cm in greatest dimension with or without metastasis to the retroperitoneal lymph nodes (includes extension of tumor to capsule of liver and spleen without parenchymal involvement of either organ). N0: No regional lymph node metastasis. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No distant metastasis. (AJCC 8th Ed.) C139971 Neoplastic Process Stage III Ovarian Cancer AJCC v8 Stage III Ovarian Cancer AJCC v8 CL538058 CTRP Malignant Stage III Ovarian Cancer Stage III Ovarian Cancer AJCC v8 Stage III Ovarian Carcinoma AJCC v8 Stage III Ovarian Cancer AJCC v8 Stage IIIA includes: IIIA1: T1/2, N1, M0; IIIA2: T3a, N0/N1, M0. T1: Ovarian cancer with tumor limited to ovaries (one or both). T2: Ovarian cancer with tumor involving one or both ovaries with pelvic extension below pelvic brim. T3a: Ovarian cancer with microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes. N0: No regional lymph node metastasis. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No distant metastasis. (AJCC 8th Ed.) C139972 Neoplastic Process Stage IIIA Ovarian Cancer AJCC v8 Stage IIIA Ovarian Cancer AJCC v8 CL538057 CTRP Malignant Stage IIIA Ovarian Cancer Stage IIIA Ovarian Cancer AJCC v8 Stage IIIA Ovarian Carcinoma AJCC v8 Stage IIIA Ovarian Cancer AJCC v8 Stage IIIA1 includes: T1/2, N1, M0. T1: Ovarian cancer with tumor limited to ovaries (one or both). T2: Ovarian cancer with tumor involving one or both ovaries with pelvic extension below pelvic brim. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No distant metastasis. (AJCC 8th Ed.) C139973 Neoplastic Process Stage IIIA1 Ovarian Cancer AJCC v8 Stage IIIA1 Ovarian Cancer AJCC v8 CL538056 CTRP Malignant Stage IIIA1 Ovarian Cancer Stage IIIA1 Ovarian Cancer AJCC v8 Stage IIIA1 Ovarian Carcinoma AJCC v8 Stage IIIA1 Ovarian Cancer AJCC v8 Stage IIIA2 includes: T3a, N0/N1, M0. T3a: Ovarian cancer with microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes. N0: No regional lymph node metastasis. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No distant metastasis. (AJCC 8th Ed.) C139974 Neoplastic Process Stage IIIA2 Ovarian Cancer AJCC v8 Stage IIIA2 Ovarian Cancer AJCC v8 CL538055 CTRP Malignant Stage IIIA2 Ovarian Cancer Stage IIIA2 Ovarian Cancer AJCC v8 Stage IIIA2 Ovarian Carcinoma AJCC v8 Stage IIIA2 Ovarian Cancer AJCC v8 Stage IIIB includes: T3b, N0/N1, M0. T3b: Ovarian cancer with macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension with or without metastasis to the retroperitoneal lymph nodes. N0: No regional lymph node metastasis. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No distant metastasis. (AJCC 8th Ed.) C139975 Neoplastic Process Stage IIIB Ovarian Cancer AJCC v8 Stage IIIB Ovarian Cancer AJCC v8 CL538054 CTRP Malignant Stage IIIB Ovarian Cancer Stage IIIB Ovarian Cancer AJCC v8 Stage IIIB Ovarian Carcinoma AJCC v8 Stage IIIB Ovarian Cancer AJCC v8 Stage IIIC includes: T3c, N0/N1, M0. T3c: Ovarian cancer with macroscopic peritoneal metastasis beyond the pelvis more than 2 cm in greatest dimension with or without metastasis to the retroperitoneal lymph nodes (includes extension of tumor to capsule of liver and spleen without parenchymal involvement of either organ). N0: No regional lymph node metastasis. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No distant metastasis. (AJCC 8th Ed.) C139976 Neoplastic Process Stage IIIC Ovarian Cancer AJCC v8 Stage IIIC Ovarian Cancer AJCC v8 CL538053 CTRP Malignant Stage IIIC Ovarian Cancer Stage IIIC Ovarian Cancer AJCC v8 Stage IIIC Ovarian Carcinoma AJCC v8 Stage IIIC Ovarian Cancer AJCC v8 Stage IV includes: Any T, Any N, M1: M1: Distant metastasis, including pleural effusion with positive cytology; liver or splenic parenchymal metastasis; metastasis to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); and transmural involvement of intestine. (from AJCC 8th Ed.) C139977 Neoplastic Process Stage IV Ovarian Cancer AJCC v8 Stage IV Ovarian Cancer AJCC v8 CL538163 CTRP Malignant Stage IV Ovarian Cancer Stage IV Ovarian Cancer AJCC v8 Stage IV Ovarian Carcinoma AJCC v8 Stage IV Ovarian Cancer AJCC v8 Stage IVA includes: Any T, Any N, M1a. M1a: Ovarian cancer with pleural effusion with positive cytology. (from AJCC 8th Ed.) C139978 Neoplastic Process Stage IVA Ovarian Cancer AJCC v8 Stage IVA Ovarian Cancer AJCC v8 CL538162 CTRP Malignant Stage IVA Ovarian Cancer Stage IVA Ovarian Cancer AJCC v8 Stage IVA Ovarian Carcinoma AJCC v8 Stage IVA Ovarian Cancer AJCC v8 Stage IVB includes: Any T, Any N, M1b. M1b: Ovarian cancer with liver or splenic parenchymal metastases; metastases to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); transmural involvement of intestine. (from AJCC 8th Ed.) C139979 Neoplastic Process Stage IVB Ovarian Cancer AJCC v8 Stage IVB Ovarian Cancer AJCC v8 CL538161 CTRP Malignant Stage IVB Ovarian Cancer Stage IVB Ovarian Cancer AJCC v8 Stage IVB Ovarian Carcinoma AJCC v8 Stage IVB Ovarian Cancer AJCC v8 A term that refers to the staging of fallopian tube cancer according to the American Joint Committee on Cancer, 8th edition. C139983 Neoplastic Process Fallopian Tube Cancer by AJCC v8 Stage CL538158 Malignant Fallopian Tube Cancer by AJCC v8 Stage Fallopian Tube Carcinoma by AJCC v8 Stage Fallopian Tube Cancer by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Fallopian tube cancer with tumor limited to fallopian tube(s). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139984 Neoplastic Process Stage I Fallopian Tube Cancer AJCC v8 Stage I Fallopian Tube Cancer AJCC v8 CL538157 CTRP Malignant Stage I Fallopian Tube Cancer Stage I Fallopian Tube Cancer AJCC v8 Stage I Fallopian Tube Carcinoma AJCC v8 Stage I Fallopian Tube Cancer AJCC v8 Stage IA includes: T1a, N0, M0. T1a: Fallopian tube cancer with tumor limited to fallopian tube surface; no malignant cells in ascites or peritoneal washings N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139985 Neoplastic Process Stage IA Fallopian Tube Cancer AJCC v8 Stage IA Fallopian Tube Cancer AJCC v8 CL538171 CTRP Malignant Stage IA Fallopian Tube Cancer Stage IA Fallopian Tube Cancer AJCC v8 Stage IA Fallopian Tube Carcinoma AJCC v8 Stage IA Fallopian Tube Cancer AJCC v8 Stage IB includes: T1b, N0, M0. T1b: Fallopian tube cancer with tumor limited to fallopian tubes; no tumor on fallopian tube surface; no malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139986 Neoplastic Process Stage IB Fallopian Tube Cancer AJCC v8 Stage IB Fallopian Tube Cancer AJCC v8 CL538170 CTRP Malignant Stage IB Fallopian Tube Cancer Stage IB Fallopian Tube Cancer AJCC v8 Stage IB Fallopian Tube Carcinoma AJCC v8 Stage IB Fallopian Tube Cancer AJCC v8 Stage IC includes: T1c, N0, M0. T1c: Fallopian tube cancer with tumor limited to fallopian tubes, with any of the following: surgical spill, capsule ruptured before surgery or tumor on fallopian tube surface, or malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139987 Neoplastic Process Stage IC Fallopian Tube Cancer AJCC v8 Stage IC Fallopian Tube Cancer AJCC v8 CL538169 CTRP Malignant Stage IC Fallopian Tube Cancer Stage IC Fallopian Tube Cancer AJCC v8 Stage IC Fallopian Tube Carcinoma AJCC v8 Stage IC Fallopian Tube Cancer AJCC v8 Stage II includes: T2, N0, M0. T2: Fallopian tube cancer with tumor involving fallopian tubes with pelvic extension below pelvic brim. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139988 Neoplastic Process Stage II Fallopian Tube Cancer AJCC v8 Stage II Fallopian Tube Cancer AJCC v8 CL538168 CTRP Malignant Stage II Fallopian Tube Cancer Stage II Fallopian Tube Cancer AJCC v8 Stage II Fallopian Tube Carcinoma AJCC v8 Stage II Fallopian Tube Cancer AJCC v8 Stage IIA includes: T2a, N0, M0. T2a: Fallopian tube cancer with extension and/or implants on the uterus and/or fallopian tube(s) and/or ovaries. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139989 Neoplastic Process Stage IIA Fallopian Tube Cancer AJCC v8 Stage IIA Fallopian Tube Cancer AJCC v8 CL538167 CTRP Malignant Stage IIA Fallopian Tube Cancer Stage IIA Fallopian Tube Cancer AJCC v8 Stage IIA Fallopian Tube Carcinoma AJCC v8 Stage IIA Fallopian Tube Cancer AJCC v8 Stage IIB includes: T2b, N0, M0. T2b: Fallopian tube cancer with tumor extension to and/or implants on other pelvic tissues. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C139990 Neoplastic Process Stage IIB Fallopian Tube Cancer AJCC v8 Stage IIB Fallopian Tube Cancer AJCC v8 CL538166 CTRP Malignant Stage IIB Fallopian Tube Cancer Stage IIB Fallopian Tube Cancer AJCC v8 Stage IIB Fallopian Tube Carcinoma AJCC v8 Stage IIB Fallopian Tube Cancer AJCC v8 Stage III includes: IIIA1: T1/2, N1, M0; IIIA2: T3a, N0/N1, M0; IIIB: T3b, N0/N1, M0; IIIC: T3c, N0/N1, M0. T1: Fallopian tube cancer with tumor limited to fallopian tube(s). T2: Fallopian tube cancer with tumor involving fallopian tubes with pelvic extension below pelvic brim. T3a: Fallopian tube cancer with microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes. T3b: Fallopian tube cancer with macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension with or without metastasis to the retroperitoneal lymph nodes. T3c: Fallopian tube cancer with macroscopic peritoneal metastasis beyond the pelvis more than 2 cm in greatest dimension with or without metastasis to the retroperitoneal lymph nodes (includes extension of tumor to capsule of liver and spleen without parenchymal involvement of either organ). N0: No regional lymph node metastasis. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No distant metastasis. (AJCC 8th Ed.) C139991 Neoplastic Process Stage III Fallopian Tube Cancer AJCC v8 Stage III Fallopian Tube Cancer AJCC v8 CL538165 CTRP Malignant Stage III Fallopian Tube Cancer Stage III Fallopian Tube Cancer AJCC v8 Stage III Fallopian Tube Carcinoma AJCC v8 Stage III Fallopian Tube Cancer AJCC v8 Stage IIIA includes: IIIA1: T1/2, N1, M0; IIIA2: T3a, N0/N1, M0. T1: Fallopian tube cancer with tumor limited to fallopian tube(s). T2: Fallopian tube cancer with tumor involving fallopian tubes with pelvic extension below pelvic brim. T3a: Fallopian tube cancer with microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes. N0: No regional lymph node metastasis. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No distant metastasis. (AJCC 8th Ed.) C139992 Neoplastic Process Stage IIIA Fallopian Tube Cancer AJCC v8 Stage IIIA Fallopian Tube Cancer AJCC v8 CL538164 CTRP Malignant Stage IIIA Fallopian Tube Cancer Stage IIIA Fallopian Tube Cancer AJCC v8 Stage IIIA Fallopian Tube Carcinoma AJCC v8 Stage IIIA Fallopian Tube Cancer AJCC v8 Stage IIIA1 includes: T1/2, N1, M0. T1: T1: Fallopian tube cancer with tumor limited to fallopian tube(s). T2: Fallopian tube cancer with tumor involving fallopian tubes with pelvic extension below pelvic brim. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No distant metastasis. (AJCC 8th Ed.) C139993 Neoplastic Process Stage IIIA1 Fallopian Tube Cancer AJCC v8 Stage IIIA1 Fallopian Tube Cancer AJCC v8 CL538148 CTRP Malignant Stage IIIA1 Fallopian Tube Cancer Stage IIIA1 Fallopian Tube Cancer AJCC v8 Stage IIIA1 Fallopian Tube Carcinoma AJCC v8 Stage IIIA1 Fallopian Tube Cancer AJCC v8 Stage IIIA2 includes: T3a, N0/N1, M0. T3a: T3a: Fallopian tube cancer with microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes. N0: No regional lymph node metastasis. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No distant metastasis. (AJCC 8th Ed.) C139994 Neoplastic Process Stage IIIA2 Fallopian Tube Cancer AJCC v8 Stage IIIA2 Fallopian Tube Cancer AJCC v8 CL538147 CTRP Malignant Stage IIIA2 Fallopian Tube Cancer Stage IIIA2 Fallopian Tube Cancer AJCC v8 Stage IIIA2 Fallopian Tube Carcinoma AJCC v8 Stage IIIA2 Fallopian Tube Cancer AJCC v8 Stage IIIB includes: T3b, N0/N1, M0. T3b: Fallopian tube cancer with macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension with or without metastasis to the retroperitoneal lymph nodes. N0: No regional lymph node metastasis. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No distant metastasis. (AJCC 8th Ed.) C139995 Neoplastic Process Stage IIIB Fallopian Tube Cancer AJCC v8 Stage IIIB Fallopian Tube Cancer AJCC v8 CL538146 CTRP Malignant Stage IIIB Fallopian Tube Cancer Stage IIIB Fallopian Tube Cancer AJCC v8 Stage IIIB Fallopian Tube Carcinoma AJCC v8 Stage IIIB Fallopian Tube Cancer AJCC v8 Stage IIIC includes: T3c, N0/N1, M0. T3c: Fallopian tube cancer with macroscopic peritoneal metastasis beyond the pelvis more than 2 cm in greatest dimension with or without metastasis to the retroperitoneal lymph nodes (includes extension of tumor to capsule of liver and spleen without parenchymal involvement of either organ). N0: No regional lymph node metastasis. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No distant metastasis. (AJCC 8th Ed.) C139996 Neoplastic Process Stage IIIC Fallopian Tube Cancer AJCC v8 Stage IIIC Fallopian Tube Cancer AJCC v8 CL538145 CTRP Malignant Stage IIIC Fallopian Tube Cancer Stage IIIC Fallopian Tube Cancer AJCC v8 Stage IIIC Fallopian Tube Carcinoma AJCC v8 Stage IIIC Fallopian Tube Cancer AJCC v8 Stage IV includes: Any T, Any N, M1: M1: Distant metastasis, including pleural effusion with positive cytology; liver or splenic parenchymal metastasis; metastasis to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); and transmural involvement of intestine. (from AJCC 8th Ed.) C139997 Neoplastic Process Stage IV Fallopian Tube Cancer AJCC v8 Stage IV Fallopian Tube Cancer AJCC v8 CL538144 CTRP Malignant Stage IV Fallopian Tube Cancer Stage IV Fallopian Tube Cancer AJCC v8 Stage IV Fallopian Tube Carcinoma AJCC v8 Stage IV Fallopian Tube Cancer AJCC v8 Stage IVA includes: Any T, Any N, M1a. M1a: Fallopian tube cancer with pleural effusion with positive cytology. (from AJCC 8th Ed.) C139998 Neoplastic Process Stage IVA Fallopian Tube Cancer AJCC v8 Stage IVA Fallopian Tube Cancer AJCC v8 CL538143 CTRP Malignant Stage IVA Fallopian Tube Cancer Stage IVA Fallopian Tube Cancer AJCC v8 Stage IVA Fallopian Tube Carcinoma AJCC v8 Stage IVA Fallopian Tube Cancer AJCC v8 Stage IVB includes: Any T, Any N, M1b. M1b: Fallopian tube cancer with liver or splenic parenchymal metastases; metastases to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); transmural involvement of intestine. (from AJCC 8th Ed.) C139999 Neoplastic Process Stage IVB Fallopian Tube Cancer AJCC v8 Stage IVB Fallopian Tube Cancer AJCC v8 CL538142 CTRP Malignant Stage IVB Fallopian Tube Cancer Stage IVB Fallopian Tube Cancer AJCC v8 Stage IVB Fallopian Tube Carcinoma AJCC v8 Stage IVB Fallopian Tube Cancer AJCC v8 A term that refers to the staging of primary peritoneal cancer according to the American Joint Committee on Cancer, 7th edition. C140003 Neoplastic Process Primary Peritoneal Cancer by AJCC v7 Stage CL538154 Malignant Primary Peritoneal Cancer by AJCC v7 Stage Primary Peritoneal Carcinoma by AJCC v7 Stage Primary Peritoneal Cancer by AJCC v7 Stage A term that refers to the staging of primary peritoneal cancer according to the American Joint Committee on Cancer, 8th edition. C140004 Neoplastic Process Primary Peritoneal Cancer by AJCC v8 Stage CL538153 Malignant Primary Peritoneal Cancer by AJCC v8 Stage Primary Peritoneal Carcinoma by AJCC v8 Stage Primary Peritoneal Cancer by AJCC v8 Stage Stage II includes: T2, N0, M0. T2: Primary peritoneal cancer. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C140005 Neoplastic Process Stage II Primary Peritoneal Cancer AJCC v8 Stage II Primary Peritoneal Cancer AJCC v8 CL538152 CTRP Malignant Stage II Primary Peritoneal Cancer Stage II Primary Peritoneal Cancer AJCC v8 Stage II Primary Peritoneal Carcinoma AJCC v8 Stage II Primary Peritoneal Cancer AJCC v8 Stage IIA includes: T2a, N0, M0. T2a: Primary peritoneal cancer with extension and/or implants on the uterus and/or fallopian tube(s) and/or ovaries. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C140006 Neoplastic Process Stage IIA Primary Peritoneal Cancer AJCC v8 Stage IIA Primary Peritoneal Cancer AJCC v8 CL538151 CTRP Malignant Stage IIA Primary Peritoneal Cancer Stage IIA Primary Peritoneal Cancer AJCC v8 Stage IIA Primary Peritoneal Carcinoma AJCC v8 Stage IIA Primary Peritoneal Cancer AJCC v8 Stage IIB includes: T2b, N0, M0. T2b: Primary peritoneal cancer with tumor extension to and/or implants on other pelvic tissues. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.) C140007 Neoplastic Process Stage IIB Primary Peritoneal Cancer AJCC v8 Stage IIB Primary Peritoneal Cancer AJCC v8 CL538150 CTRP Malignant Stage IIB Primary Peritoneal Cancer Stage IIB Primary Peritoneal Cancer AJCC v8 Stage IIB Primary Peritoneal Carcinoma AJCC v8 Stage IIB Primary Peritoneal Cancer AJCC v8 Stage III includes: IIIA: T3a, N0/N1, M0; IIIB: T3b, N0/N1, M0; IIIC: T3c, N0/N1, M0. T3a: Primary peritoneal cancer with microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes. T3b: Primary peritoneal cancer with macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension with or without metastasis to the retroperitoneal lymph nodes. T3c: Primary peritoneal cancer with macroscopic peritoneal metastasis beyond the pelvis more than 2 cm in greatest dimension with or without metastasis to the retroperitoneal lymph nodes (includes extension of tumor to capsule of liver and spleen without parenchymal involvement of either organ). N0: No regional lymph node metastasis. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No distant metastasis. (AJCC 8th Ed.) C140008 Neoplastic Process Stage III Primary Peritoneal Cancer AJCC v8 Stage III Primary Peritoneal Cancer AJCC v8 CL538149 CTRP Malignant Stage III Primary Peritoneal Cancer Stage III Primary Peritoneal Cancer AJCC v8 Stage III Primary Peritoneal Carcinoma AJCC v8 Stage III Primary Peritoneal Cancer AJCC v8 Stage IIIA includes: T3a, N0/N1, M0. T3a: Primary peritoneal cancer with microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes. N0: No regional lymph node metastasis. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No distant metastasis. (AJCC 8th Ed.) C140009 Neoplastic Process Stage IIIA Primary Peritoneal Cancer AJCC v8 Stage IIIA Primary Peritoneal Cancer AJCC v8 CL538132 CTRP Malignant Stage IIIA Primary Peritoneal Cancer Stage IIIA Primary Peritoneal Cancer AJCC v8 Stage IIIA Primary Peritoneal Carcinoma AJCC v8 Stage IIIA Primary Peritoneal Cancer AJCC v8 Stage IIIB includes: T3b, N0/N1, M0. T3b: Primary peritoneal cancer with macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension with or without metastasis to the retroperitoneal lymph nodes. N0: No regional lymph node metastasis. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No distant metastasis. (AJCC 8th Ed.) C140010 Neoplastic Process Stage IIIB Primary Peritoneal Cancer AJCC v8 Stage IIIB Primary Peritoneal Cancer AJCC v8 CL538131 CTRP Malignant Stage IIIB Primary Peritoneal Cancer Stage IIIB Primary Peritoneal Cancer AJCC v8 Stage IIIB Primary Peritoneal Carcinoma AJCC v8 Stage IIIB Primary Peritoneal Cancer AJCC v8 Stage IIIC includes: T3c, N0/N1, M0. T3c: Primary peritoneal cancer with macroscopic peritoneal metastasis beyond the pelvis more than 2 cm in greatest dimension with or without metastasis to the retroperitoneal lymph nodes (includes extension of tumor to capsule of liver and spleen without parenchymal involvement of either organ). N0: No regional lymph node metastasis. N1: Positive retroperitoneal lymph nodes only (histologically confirmed). M0: No distant metastasis. (AJCC 8th Ed.) C140011 Neoplastic Process Stage IIIC Primary Peritoneal Cancer AJCC v8 Stage IIIC Primary Peritoneal Cancer AJCC v8 CL538130 CTRP Malignant Stage IIIC Primary Peritoneal Cancer Stage IIIC Primary Peritoneal Cancer AJCC v8 Stage IIIC Primary Peritoneal Carcinoma AJCC v8 Stage IIIC Primary Peritoneal Cancer AJCC v8 Stage IV includes: Any T, Any N, M1: M1: Distant metastasis, including pleural effusion with positive cytology; liver or splenic parenchymal metastasis; metastasis to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); and transmural involvement of intestine. (from AJCC 8th Ed.) C140012 Neoplastic Process Stage IV Primary Peritoneal Cancer AJCC v8 Stage IV Primary Peritoneal Cancer AJCC v8 CL538129 CTRP Malignant Stage IV Primary Peritoneal Cancer Stage IV Primary Peritoneal Cancer AJCC v8 Stage IV Primary Peritoneal Carcinoma AJCC v8 Stage IV Primary Peritoneal Cancer AJCC v8 Stage IVA includes: Any T, Any N, M1a. M1a: Primary peritoneal cancer with pleural effusion with positive cytology. (from AJCC 8th Ed.) C140013 Neoplastic Process Stage IVA Primary Peritoneal Cancer AJCC v8 Stage IVA Primary Peritoneal Cancer AJCC v8 CL538128 CTRP Malignant Stage IVA Primary Peritoneal Cancer Stage IVA Primary Peritoneal Cancer AJCC v8 Stage IVA Primary Peritoneal Carcinoma AJCC v8 Stage IVA Primary Peritoneal Cancer AJCC v8 Stage IVB includes: Any T, Any N, M1b. M1b: Primary peritoneal cancer with liver or splenic parenchymal metastases; metastases to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); transmural involvement of intestine. (from AJCC 8th Ed.) C140014 Neoplastic Process Stage IVB Primary Peritoneal Cancer AJCC v8 Stage IVB Primary Peritoneal Cancer AJCC v8 CL538127 CTRP Malignant Stage IVB Primary Peritoneal Cancer Stage IVB Primary Peritoneal Cancer AJCC v8 Stage IVB Primary Peritoneal Carcinoma AJCC v8 Stage IVB Primary Peritoneal Cancer AJCC v8 A term that refers to the staging of gestational trophoblastic tumor according to the American Joint Committee on Cancer, 7th edition. C140032 Neoplastic Process Gestational Trophoblastic Tumor by AJCC v7 Stage CL538109 Malignant Gestational Trophoblastic Tumor by AJCC v7 Stage Gestational Trophoblastic Tumor by AJCC v7 Stage A term that refers to the staging of penile cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to penile squamous cell carcinoma and associated histologic subtypes. It does not apply to urethral carcinomas, sarcomas, and melanomas. (from AJCC 8th Ed.) C140075 Neoplastic Process Penile Cancer by AJCC v8 Stage CL538192 Malignant Penile Cancer by AJCC v8 Stage Penile Squamous Cell Carcinoma by AJCC v8 Stage Squamous Cell Carcinoma of the Penis by AJCC v8 Stage Penile Cancer by AJCC v8 Stage Stage 0 includes: 0is: Tis, N0, M0; 0a: Ta, N0, M0. Tis: Penile cancer with a finding of carcinoma in situ (penile intraepithelial neoplasia [PeIN]). Ta: Penile cancer with a finding of noninvasive localized squamous cell carcinoma. N0: No lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140076 Neoplastic Process Stage 0 Penile Cancer AJCC v8 Stage 0 Penile Cancer AJCC v8 CL538191 CTRP Malignant Stage 0 Penile Cancer Stage 0 Penile Cancer AJCC v8 Stage 0 Penile Squamous Cell Carcinoma AJCC v8 Stage 0 Squamous Cell Carcinoma of the Penis AJCC v8 Stage 0 Penile Cancer AJCC v8 Stage 0is includes: Tis, N0, M0. Tis: Penile cancer with a finding of carcinoma in situ (penile intraepithelial neoplasia [PeIN]). N0: No lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140077 Neoplastic Process Stage 0is Penile Cancer AJCC v8 Stage 0is Penile Cancer AJCC v8 CL538190 CTRP Malignant Stage 0is Penile Cancer Stage 0is Penile Cancer AJCC v8 Stage 0is Penile Squamous Cell Carcinoma AJCC v8 Stage 0is Squamous Cell Carcinoma of the Penis AJCC v8 Stage 0is Penile Cancer AJCC v8 Stage 0a includes: Ta, N0, M0. Ta: Penile cancer with a finding of noninvasive localized squamous cell carcinoma. N0: No lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140078 Neoplastic Process Stage 0a Penile Cancer AJCC v8 Stage 0a Penile Cancer AJCC v8 CL538189 CTRP Malignant Stage 0a Penile Cancer Stage 0a Penile Cancer AJCC v8 Stage 0a Penile Squamous Cell Carcinoma AJCC v8 Stage 0a Squamous Cell Carcinoma of the Penis AJCC v8 Stage 0a Penile Cancer AJCC v8 Stage I includes: T1a, N0, M0. T1a: Penile cancer with tumor without lymphovascular invasion or perineural invasion and is not high grade (i.e., grade 3 or sarcomatoid). N0: No lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140079 Neoplastic Process Stage I Penile Cancer AJCC v8 Stage I Penile Cancer AJCC v8 CL538188 CTRP Malignant Stage I Penile Cancer Stage I Penile Cancer AJCC v8 Stage I Penile Squamous Cell Carcinoma AJCC v8 Stage I Squamous Cell Carcinoma of the Penis AJCC v8 Stage I Penile Cancer AJCC v8 Stage II includes: IIA: (T1b, N0, M0); (T2, N0, M0); IIB: (T3, N0, M0). T1b: Penile cancer with tumor exhibiting lymphovascular invasion and/or perineural invasion or is high grade (i.e., grade 3 or sarcomatoid). T2: Penile cancer with tumor invading into corpus spongiosum (either glans or ventral shaft) with or without urethral invasion. T3: Penile cancer with tumor invading into corpora cavernosum (including tunica albuginea) with or without urethral invasion. N0: No lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140080 Neoplastic Process Stage II Penile Cancer AJCC v8 Stage II Penile Cancer AJCC v8 CL538187 CTRP Malignant Stage II Penile Cancer Stage II Penile Cancer AJCC v8 Stage II Penile Squamous Cell Carcinoma AJCC v8 Stage II Squamous Cell Carcinoma of the Penis AJCC v8 Stage II Penile Cancer AJCC v8 Stage IIA includes: (T1b, N0, M0); (T2, N0, M0). T1b: Penile cancer with tumor exhibiting lymphovascular invasion and/or perineural invasion or is high grade (i.e., grade 3 or sarcomatoid). T2: Penile cancer with tumor invading into corpus spongiosum (either glans or ventral shaft) with or without urethral invasion. N0: No lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140081 Neoplastic Process Stage IIA Penile Cancer AJCC v8 Stage IIA Penile Cancer AJCC v8 CL538202 CTRP Malignant Stage IIA Penile Cancer Stage IIA Penile Cancer AJCC v8 Stage IIA Penile Squamous Cell Carcinoma AJCC v8 Stage IIA Squamous Cell Carcinoma of the Penis AJCC v8 Stage IIA Penile Cancer AJCC v8 Stage IIB includes: T3, N0, M0. T3: Penile cancer with tumor invading into corpora cavernosum (including tunica albuginea) with or without urethral invasion. N0: No lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140083 Neoplastic Process Stage IIB Penile Cancer AJCC v8 Stage IIB Penile Cancer AJCC v8 CL538201 CTRP Malignant Stage IIB Penile Cancer Stage IIB Penile Cancer AJCC v8 Stage IIB Penile Squamous Cell Carcinoma AJCC v8 Stage IIB Squamous Cell Carcinoma of the Penis AJCC v8 Stage IIB Penile Cancer AJCC v8 Stage III includes: IIIA: T1-3, N1, M0; IIIB: T1-3, N2, M0. T1: Glans: Penile cancer with tumor invading lamina propria. Foreskin: Penile cancer with tumor invading dermis, lamina propria, or dartos fascia. Shaft: Penile cancer with tumor invading connective tissue between epidermis and corpora regardless of location. All sites with or without lymphovascular invasion or perineural invasion and is or is not high grade. T2: Penile cancer with tumor invading into corpus spongiosum (either glans or ventral shaft) with or without urethral invasion. T3: Penile cancer with tumor invading into corpora cavernosum (including tunica albuginea) with or without urethral invasion. N1: Penile cancer with two or less unilateral inguinal metastases, no extranodal extension. N2: Penile cancer with three or more unilateral inguinal metastases or bilateral metastases. M0: No distant metastasis. (AJCC 8th ed.) C140084 Neoplastic Process Stage III Penile Cancer AJCC v8 Stage III Penile Cancer AJCC v8 CL538200 CTRP Malignant Stage III Penile Cancer Stage III Penile Cancer AJCC v8 Stage III Penile Squamous Cell Carcinoma AJCC v8 Stage III Squamous Cell Carcinoma of the Penis AJCC v8 Stage III Penile Cancer AJCC v8 Stage IIIA includes: T1-3, N1, M0. T1: Glans: Penile cancer with tumor invading lamina propria. Foreskin: Penile cancer with tumor invading dermis, lamina propria, or dartos fascia. Shaft: Penile cancer with tumor invading connective tissue between epidermis and corpora regardless of location. All sites with or without lymphovascular invasion or perineural invasion and is or is not high grade. T2: Penile cancer with tumor invading into corpus spongiosum (either glans or ventral shaft) with or without urethral invasion. T3: Penile cancer with tumor invading into corpora cavernosum (including tunica albuginea) with or without urethral invasion. N1: Penile cancer with two or less unilateral inguinal metastases, no extranodal extension. M0: No distant metastasis. (AJCC 8th ed.) C140085 Neoplastic Process Stage IIIA Penile Cancer AJCC v8 Stage IIIA Penile Cancer AJCC v8 CL538199 CTRP Malignant Stage IIIA Penile Cancer Stage IIIA Penile Cancer AJCC v8 Stage IIIA Penile Squamous Cell Carcinoma AJCC v8 Stage IIIA Squamous Cell Carcinoma of the Penis AJCC v8 Stage IIIA Penile Cancer AJCC v8 Stage IIIB includes: T1-3, N2, M0. T1: Glans: Penile cancer with tumor invading lamina propria. Foreskin: Penile cancer with tumor invading dermis, lamina propria, or dartos fascia. Shaft: Penile cancer with tumor invading connective tissue between epidermis and corpora regardless of location. All sites with or without lymphovascular invasion or perineural invasion and is or is not high grade. T2: Penile cancer with tumor invading into corpus spongiosum (either glans or ventral shaft) with or without urethral invasion. T3: Penile cancer with tumor invading into corpora cavernosum (including tunica albuginea) with or without urethral invasion. N2: Penile cancer with three or more unilateral inguinal metastases or bilateral metastases. M0: No distant metastasis. (AJCC 8th ed.) C140086 Neoplastic Process Stage IIIB Penile Cancer AJCC v8 Stage IIIB Penile Cancer AJCC v8 CL538198 CTRP Malignant Stage IIIB Penile Cancer Stage IIIB Penile Cancer AJCC v8 Stage IIIB Penile Squamous Cell Carcinoma AJCC v8 Stage IIIB Squamous Cell Carcinoma of the Penis AJCC v8 Stage IIIB Penile Cancer AJCC v8 Stage IV includes: (T4, Any N, M0); (Any T, N3, M0); (Any T, Any N, M1). T4: Penile cancer with tumor invading into adjacent structures (i.e., scrotum, prostate, pubic bone). N3: Penile cancer with extranodal extension of lymph node metastases or pelvic lymph node metastases. M1: Distant metastasis present. (AJCC 8th ed.) C140087 Neoplastic Process Stage IV Penile Cancer AJCC v8 Stage IV Penile Cancer AJCC v8 CL538197 CTRP Malignant Stage IV Penile Cancer Stage IV Penile Cancer AJCC v8 Stage IV Penile Squamous Cell Carcinoma AJCC v8 Stage IV Squamous Cell Carcinoma of the Penis AJCC v8 Stage IV Penile Cancer AJCC v8 An indolent non-Hodgkin lymphoma which has undergone histologic transformation to an aggressive non-Hodgkin lymphoma and has become resistant to treatment. C140091 Neoplastic Process Refractory Transformed Non-Hodgkin Lymphoma CL538177 Malignant Refractory Transformed Lymphoma Refractory Transformed Non-Hodgkin Lymphoma Refractory Transformed Non-Hodgkin Lymphoma A term that refers to the staging of prostate cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to adenocarcinomas and squamous cell carcinomas of the prostate gland. It does not apply to sarcomas, urothelial cell carcinomas, and urothelial carcinoma of bladder involving prostate. (from AJCC 8th Ed.) C140163 Neoplastic Process Prostate Cancer by AJCC v8 Stage CL538248 CPTAC Malignant Prostate Cancer by AJCC v8 Stage Prostate Carcinoma by AJCC v8 Stage Tumor Stage (Pathologic) Prostate Cancer by AJCC v8 Stage Stage I includes: (cT1a-c, cT2a, N0, M0, PSA less than 10, Grade Group 1); (pT2, N0, M0, PSA less than 10, Grade Group 1). cT1a: Prostate cancer in which the tumor is an incidental histologic finding in 5% or less of tissue resected. cT1b: Prostate cancer in which the tumor is an incidental histologic finding in more than 5% of tissue resected. cT1c: Prostate cancer in which the tumor is identified by needle biopsy found in one or both sides, but not palpable. cT2a: Prostate cancer in which the tumor involves one-half of one side or less. pT2: Prostate cancer which is organ confined. N0: Prostate cancer with no positive regional nodes. M0: Prostate cancer without evidence of distant metastasis. Grade Group 1: Gleason Score 6 or less, Gleason Pattern 3 or less+3. (AJCC 8th ed.) C140164 Neoplastic Process Stage I Prostate Cancer AJCC v8 Stage I Prostate Cancer AJCC v8 CL538247 CPTAC CTRP Malignant I Stage I Prostate Cancer Stage I Prostate Cancer AJCC v8 Stage I Prostate Carcinoma AJCC v8 Stage I Prostate Cancer AJCC v8 Stage II includes: IIA: (cT1a-c, cT2a, N0, M0, PSA equal or more than 10 and less than 20, Grade Group 1); (cT2b-c, N0, M0, PSA less than 20, Grade Group 1); IIB: T1-2, N0, M0, PSA less than 20, Grade Group 2; IIC: (T1-2, N0, M0, PSA less than 20, Grade Group 3); (T1-2, N0, M0, PSA less than 20, Grade Group 4). cT1a: Prostate cancer in which the tumor is an incidental histologic finding in 5% or less of tissue resected. cT1b: Prostate cancer in which the tumor is an incidental histologic finding in more than 5% of tissue resected. cT1c: Prostate cancer in which the tumor is identified by needle biopsy found in one or both sides, but not palpable. cT2a: Prostate cancer in which the tumor involves one-half of one side or less. cT2b: Prostate cancer in which the tumor involves more than one-half of one side but not both sides. cT2c: Prostate cancer in which the tumor involves both sides. T1: Prostate cancer with clinically inapparent tumor that is not palpable. T2: Prostate cancer in which the tumor is palpable and confined within the prostate. N0: Prostate cancer with no positive regional nodes. M0: Prostate cancer without evidence of distant metastasis. Grade Group 1: Gleason Score 6 or less, Gleason Pattern 3 or less+3. Grade Group 2: Gleason Score 7, Gleason Pattern 3+4. Grade Group 3: Gleason Score 7, Gleason Pattern 4+3. Grade Group 4: Gleason Score 8, Gleason Pattern 4+4. (AJCC 8th ed.) C140165 Neoplastic Process Stage II Prostate Cancer AJCC v8 Stage II Prostate Cancer AJCC v8 CL538246 CTRP Malignant Stage II Prostate Cancer Stage II Prostate Cancer AJCC v8 Stage II Prostate Carcinoma AJCC v8 Stage II Prostate Cancer AJCC v8 Stage IIA includes: (cT1a-c, cT2a, N0, M0, PSA equal or more than 10 and less than 20, Grade Group 1); (cT2b-c, N0, M0, PSA less than 20, Grade Group 1). cT1a: Prostate cancer in which the tumor is an incidental histologic finding in 5% or less of tissue resected. cT1b: Prostate cancer in which the tumor is an incidental histologic finding in more than 5% of tissue resected. cT1c: Prostate cancer in which the tumor is identified by needle biopsy found in one or both sides, but not palpable. cT2a: Prostate cancer in which the tumor involves one-half of one side or less. cT2b: Prostate cancer in which the tumor involves more than one-half of one side but not both sides. cT2c: Prostate cancer in which the tumor involves both sides. N0: Prostate cancer with no positive regional nodes. M0: Prostate cancer without evidence of distant metastasis. Grade Group 1: Gleason Score 6 or less, Gleason Pattern 3 or less+3. (AJCC 8th ed.) C140166 Neoplastic Process Stage IIA Prostate Cancer AJCC v8 Stage IIA Prostate Cancer AJCC v8 CL538245 CPTAC CTRP Malignant IIA Stage IIA Prostate Cancer Stage IIA Prostate Cancer AJCC v8 Stage IIA Prostate Carcinoma AJCC v8 Stage IIA Prostate Cancer AJCC v8 Stage IIB includes: T1-2, N0, M0, PSA less than 20, Grade Group 2. T1: Prostate cancer with clinically inapparent tumor that is not palpable. T2: Prostate cancer in which the tumor is palpable and confined within the prostate. N0: Prostate cancer with no positive regional nodes. M0: Prostate cancer without evidence of distant metastasis. Grade Group 2: Gleason Score 7, Gleason Pattern 3+4. (AJCC 8th ed.) C140167 Neoplastic Process Stage IIB Prostate Cancer AJCC v8 Stage IIB Prostate Cancer AJCC v8 CL538244 CPTAC CTRP Malignant IIB Stage IIB Prostate Cancer Stage IIB Prostate Cancer AJCC v8 Stage IIB Prostate Carcinoma AJCC v8 Stage IIB Prostate Cancer AJCC v8 Stage IIC includes: (T1-2, N0, M0, PSA less than 20, Grade Group 3); (T1-2, N0, M0, PSA less than 20, Grade Group 4). T1: Prostate cancer with clinically inapparent tumor that is not palpable. T2: Prostate cancer in which the tumor is palpable and confined within the prostate. N0: Prostate cancer with no positive regional nodes. M0: Prostate cancer without evidence of distant metastasis. Grade Group 3: Gleason Score 7, Gleason Pattern 4+3. Grade Group 4: Gleason Score 8, Gleason Pattern 4+4. (AJCC 8th ed.) C140168 Neoplastic Process Stage IIC Prostate Cancer AJCC v8 Stage IIC Prostate Cancer AJCC v8 CL538243 CPTAC CTRP Malignant IIC Stage IIC Prostate Cancer Stage IIC Prostate Cancer AJCC v8 Stage IIC Prostate Carcinoma AJCC v8 Stage IIC Prostate Cancer AJCC v8 Stage III includes: IIIA: T1-2, N0, M0, PSA 20 or more, Grade Group 1-4; IIIB: T3-4, N0, M0, PSA: Any, Grade Group 1-4; IIIC: Any T, N0, M0, PSA: Any, Grade Group 5. T1: Prostate cancer with clinically inapparent tumor that is not palpable. T2: Prostate cancer in which the tumor is palpable and confined within the prostate. T3: Prostate cancer with extraprostatic tumor that is not fixed or does not invade adjacent structures. T4: Prostate cancer in which the tumor is fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, and/or pelvic wall. N0: Prostate cancer with no positive regional nodes. M0: Prostate cancer without evidence of distant metastasis. Grade Group 1: Gleason Score 6 or less, Gleason Pattern 3 or less+3. Grade Group 2: Gleason Score 7, Gleason Pattern 3+4. Grade Group 3: Gleason Score 7, Gleason Pattern 4+3. Grade Group 4: Gleason Score 8, Gleason Pattern 4+4. Grade Group 5: Gleason Score 9 or 10, Gleason Pattern 4+5, or 5+4, or 5+5. (AJCC 8th ed.) C140169 Neoplastic Process Stage III Prostate Cancer AJCC v8 Stage III Prostate Cancer AJCC v8 CL538242 CTRP Malignant Stage III Prostate Cancer Stage III Prostate Cancer AJCC v8 Stage III Prostate Carcinoma AJCC v8 Stage III Prostate Cancer AJCC v8 Stage IIIA includes: T1-2, N0, M0, PSA 20 or more, Grade Group 1-4; T1: Prostate cancer with clinically inapparent tumor that is not palpable. T2: Prostate cancer in which the tumor is palpable and confined within the prostate. N0: Prostate cancer with no positive regional nodes. M0: Prostate cancer without evidence of distant metastasis. Grade Group 1: Gleason Score 6 or less, Gleason Pattern 3 or less+3. Grade Group 2: Gleason Score 7, Gleason Pattern 3+4. Grade Group 3: Gleason Score 7, Gleason Pattern 4+3. Grade Group 4: Gleason Score 8, Gleason Pattern 4+4. (AJCC 8th ed.) C140170 Neoplastic Process Stage IIIA Prostate Cancer AJCC v8 Stage IIIA Prostate Cancer AJCC v8 CL538350 CPTAC CTRP Malignant IIIA Stage IIIA Prostate Cancer Stage IIIA Prostate Cancer AJCC v8 Stage IIIA Prostate Carcinoma AJCC v8 Stage IIIA Prostate Cancer AJCC v8 Stage IIIB includes: T3-4, N0, M0, PSA: Any, Grade Group 1-4; T3: Prostate cancer with extraprostatic tumor that is not fixed or does not invade adjacent structures. T4: Prostate cancer in which the tumor is fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, and/or pelvic wall. N0: Prostate cancer with no positive regional nodes. M0: Prostate cancer without evidence of distant metastasis. Grade Group 1: Gleason Score 6 or less, Gleason Pattern 3 or less+3. Grade Group 2: Gleason Score 7, Gleason Pattern 3+4. Grade Group 3: Gleason Score 7, Gleason Pattern 4+3. Grade Group 4: Gleason Score 8, Gleason Pattern 4+4. (AJCC 8th ed.) C140171 Neoplastic Process Stage IIIB Prostate Cancer AJCC v8 Stage IIIB Prostate Cancer AJCC v8 CL538349 CPTAC CTRP Malignant IIIB Stage IIIB Prostate Cancer Stage IIIB Prostate Cancer AJCC v8 Stage IIIB Prostate Carcinoma AJCC v8 Stage IIIB Prostate Cancer AJCC v8 Stage IIIC includes: Any T, N0, M0, PSA: Any, Grade Group 5. N0: Prostate cancer with no positive regional nodes. M0: Prostate cancer without evidence of distant metastasis. Grade Group 5: Gleason Score 9 or 10, Gleason Pattern 4+5, or 5+4, or 5+5. (AJCC 8th ed.) C140172 Neoplastic Process Stage IIIC Prostate Cancer AJCC v8 Stage IIIC Prostate Cancer AJCC v8 CL538348 CPTAC CTRP Malignant IIIC Stage IIIC Prostate Cancer Stage IIIC Prostate Cancer AJCC v8 Stage IIIC Prostate Carcinoma AJCC v8 Stage IIIC Prostate Cancer AJCC v8 Stage IV includes: IVA: Any T, N1, M0, PSA: Any, Grade Group: Any; IVB: Any T, N0, M1, PSA: Any, Grade Group: Any. N0: Prostate cancer with no positive regional nodes. N1: Prostate cancer with metastases in regional node(s). M0: Prostate cancer without evidence of distant metastasis. M1: Prostate cancer with distant metastasis. (AJCC 8th ed.) C140173 Neoplastic Process Stage IV Prostate Cancer AJCC v8 Stage IV Prostate Cancer AJCC v8 CL538347 CTRP Malignant Stage IV Prostate Cancer Stage IV Prostate Cancer AJCC v8 Stage IV Prostate Carcinoma AJCC v8 Stage IV Prostate Cancer AJCC v8 Stage IVA includes: Any T, N1, M0, PSA: Any, Grade Group: Any. N1: Prostate cancer with metastases in regional node(s). M0: Prostate cancer without evidence of distant metastasis. (AJCC 8th ed.) C140174 Neoplastic Process Stage IVA Prostate Cancer AJCC v8 Stage IVA Prostate Cancer AJCC v8 CL538346 CPTAC CTRP Malignant IVA Stage IVA Prostate Cancer Stage IVA Prostate Cancer AJCC v8 Stage IVA Prostate Carcinoma AJCC v8 Stage IVA Prostate Cancer AJCC v8 Stage IVB includes: Any T, N0, M1, PSA: Any, Grade Group: Any. N0: Prostate cancer with no positive regional nodes. M1: Prostate cancer with distant metastasis. (AJCC 8th ed.) C140175 Neoplastic Process Stage IVB Prostate Cancer AJCC v8 Stage IVB Prostate Cancer AJCC v8 CL538345 CPTAC CTRP Malignant IVB Stage IVB Prostate Cancer Stage IVB Prostate Cancer AJCC v8 Stage IVB Prostate Carcinoma AJCC v8 Stage IVB Prostate Cancer AJCC v8 A term that refers to the staging of testicular cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to postpubertal germ cell tumors of the testis and malignant sex cord-stromal tumors of the testis. It does not apply to spermatocytic tumors (no AJCC staging system), nonmalignant sex cord-/gonadal -stromal tumors (no AJCC staging system), prepubertal germ cell tumors (no AJCC staging system), hematolymphoid tumors (hematologic malignancies staging system), and paratesticular neoplasms (no AJCC staging system). (from AJCC 8th Ed.) C140225 Neoplastic Process Testicular Cancer by AJCC v8 Stage CL538296 Malignant Testicular Cancer by AJCC v8 Stage Testicular Cancer by AJCC v8 Stage Stage 0 includes: pTis, N0, M0, S0. pTis: Testicular cancer with a finding of germ cell neoplasia in situ. N0: Testicular cancer with no regional lymph node metastasis. M0: Testicular cancer without evidence of distant metastasis. S0: Marker study levels within normal limits. (AJCC 8th ed.) C140226 Neoplastic Process Stage 0 Testicular Cancer AJCC v8 Stage 0 Testicular Cancer AJCC v8 CL538311 CTRP Malignant Stage 0 Testicular Cancer Stage 0 Testicular Cancer AJCC v8 Stage 0 Testicular Cancer AJCC v8 Stage I includes: pT1-T4, N0, M0, SX. pT1: Testicular cancer which is limited to testis (including rete testis invasion) without lymphovascular invasion. pT2: Testicular cancer which is limited to testis (including rete testis invasion) with lymphovascular invasion or invades hilar soft tissue or epididymis or penetrates visceral mesothelial layer covering the external surface of tunica albuginea with or without lymphovascular invasion. pT3: Testicular cancer in which the tumor invades spermatic cord with or without lymphovascular invasion. pT4: Testicular cancer in which the tumor invades scrotum with or without lymphovascular invasion. N0: Testicular cancer with no regional lymph node metastasis. M0: Testicular cancer without evidence of distant metastasis. SX: Marker studies not available or not performed. (AJCC 8th ed.) C140227 Neoplastic Process Stage I Testicular Cancer AJCC v8 Stage I Testicular Cancer AJCC v8 CL538310 CTRP Malignant Stage I Testicular Cancer Stage I Testicular Cancer AJCC v8 Stage I Testicular Cancer AJCC v8 Stage IA includes: pT1, N0, M0, S0. pT1: Testicular cancer which is limited to testis (including rete testis invasion) without lymphovascular invasion. N0: Testicular cancer with no regional lymph node metastasis. M0: Testicular cancer without evidence of distant metastasis. S0: Marker study levels within normal limits. (AJCC 8th ed.) C140228 Neoplastic Process Stage IA Testicular Cancer AJCC v8 Stage IA Testicular Cancer AJCC v8 CL538309 CTRP Malignant Stage IA Testicular Cancer Stage IA Testicular Cancer AJCC v8 Stage IA Testicular Cancer AJCC v8 Stage IB includes: (pT2, N0, M0, S0); (pT3, N0, M0, S0); (pT4, N0, M0, S0). pT2: Testicular cancer which is limited to testis (including rete testis invasion) with lymphovascular invasion or invades hilar soft tissue or epididymis or penetrates visceral mesothelial layer covering the external surface of tunica albuginea with or without lymphovascular invasion. pT3: Testicular cancer in which the tumor invades spermatic cord with or without lymphovascular invasion. pT4: Testicular cancer in which the tumor invades scrotum with or without lymphovascular invasion. N0: Testicular cancer with no regional lymph node metastasis. M0: Testicular cancer without evidence of distant metastasis. S0: Marker study levels within normal limits. (AJCC 8th ed.) C140229 Neoplastic Process Stage IB Testicular Cancer AJCC v8 Stage IB Testicular Cancer AJCC v8 CL538308 CTRP Malignant Stage IB Testicular Cancer Stage IB Testicular Cancer AJCC v8 Stage IB Testicular Cancer AJCC v8 Stage IS includes: Any pT/TX, N0, M0, S1-3. TX: Testicular cancer in which the primary tumor cannot be assessed. N0: Testicular cancer with no regional lymph node metastasis. M0: Testicular cancer without evidence of distant metastasis. S1: LDH less than 1.5 x N and hCG (mlU/mL) less than 5,000 and AFP (ng/mL) less than 1,000. S2: LDH 1.5-10 x N or hCG (mlU/mL) 5,000-50,000 or AFP (ng/mL) 1,000-10,000. S3: LDH more than 10 x N or hCG (mlU/mL) more than 50,000 or AFP (ng/mL) more than 10,000. N indicates the upper limit of normal for the LDH assay. (AJCC 8th ed.) C140232 Neoplastic Process Stage IS Testicular Cancer AJCC v8 Stage IS Testicular Cancer AJCC v8 CL538307 CTRP Malignant Stage IS Testicular Cancer Stage IS Testicular Cancer AJCC v8 Stage IS Testicular Cancer AJCC v8 Stage II includes: Any pT/TX, N1-3, M0, SX. TX: Testicular cancer in which the primary tumor cannot be assessed. N1: Testicular cancer with metastasis with a lymph node mass 2 cm or smaller in greatest dimension and less than or equal to five nodes positive, none larger than 2 cm in greatest dimension. N2: Testicular cancer with metastasis with a lymph node mass larger than 2 cm but not larger than 5 cm in greatest dimension; or more than five nodes positive, none larger than 5 cm; or evidence of extranodal extension of tumor. N3: Testicular cancer with metastasis with a lymph node mass larger than 5 cm in greatest dimension. M0: Testicular cancer without evidence of distant metastasis. SX: Marker studies not available or not performed. (AJCC 8th ed.) C140233 Neoplastic Process Stage II Testicular Cancer AJCC v8 Stage II Testicular Cancer AJCC v8 CL538306 CTRP Malignant Stage II Testicular Cancer Stage II Testicular Cancer AJCC v8 Stage II Testicular Cancer AJCC v8 Stage IIA includes: (Any pT/TX, N1, M0, S0); (Any pT/TX, N1, M0, S1). TX: Testicular cancer in which the primary tumor cannot be assessed. N1: Testicular cancer with metastasis with a lymph node mass 2 cm or smaller in greatest dimension and less than or equal to five nodes positive, none larger than 2 cm in greatest dimension. M0: Testicular cancer without evidence of distant metastasis. S0: Marker study levels within normal limits. S1: LDH less than 1.5 x N and hCG (mlU/mL) less than 5,000 and AFP (ng/mL) less than 1,000. N indicates the upper limit of normal for the LDH assay. (AJCC 8th ed.) C140234 Neoplastic Process Stage IIA Testicular Cancer AJCC v8 Stage IIA Testicular Cancer AJCC v8 CL538305 CTRP Malignant Stage IIA Testicular Cancer Stage IIA Testicular Cancer AJCC v8 Stage IIA Testicular Cancer AJCC v8 Stage IIB includes: (Any pT/TX, N2, M0, S0); (Any pT/TX, N2, M0, S1). TX: Testicular cancer in which the primary tumor cannot be assessed. N2: Testicular cancer with metastasis with a lymph node mass larger than 2 cm but not larger than 5 cm in greatest dimension; or more than five nodes positive, none larger than 5 cm; or evidence of extranodal extension of tumor. M0: Testicular cancer without evidence of distant metastasis. S0: Marker study levels within normal limits. S1: LDH less than 1.5 x N and hCG (mlU/mL) less than 5,000 and AFP (ng/mL) less than 1,000. N indicates the upper limit of normal for the LDH assay. (AJCC 8th ed.) C140235 Neoplastic Process Stage IIB Testicular Cancer AJCC v8 Stage IIB Testicular Cancer AJCC v8 CL538304 CTRP Malignant Stage IIB Testicular Cancer Stage IIB Testicular Cancer AJCC v8 Stage IIB Testicular Cancer AJCC v8 Stage IIC includes: (Any pT/TX, N3, M0, S0); (Any pT/TX, N3, M0, S1). TX: Testicular cancer in which the primary tumor cannot be assessed. N3: Testicular cancer with metastasis with a lymph node mass larger than 5 cm in greatest dimension. M0: Testicular cancer without evidence of distant metastasis. S0: Marker study levels within normal limits. S1: LDH less than 1.5 x N and hCG (mlU/mL) less than 5,000 and AFP (ng/mL) less than 1,000. N indicates the upper limit of normal for the LDH assay. (AJCC 8th ed.) C140236 Neoplastic Process Stage IIC Testicular Cancer AJCC v8 Stage IIC Testicular Cancer AJCC v8 CL538408 CTRP Malignant Stage IIC Testicular Cancer Stage IIC Testicular Cancer AJCC v8 Stage IIC Testicular Cancer AJCC v8 Stage III includes: Any pT/TX, Any N, M1, SX. TX: Testicular cancer in which the primary tumor cannot be assessed. M1: Testicular cancer with distant metastasis. SX: Marker studies not available or not performed. (AJCC 8th ed.) C140237 Neoplastic Process Stage III Testicular Cancer AJCC v8 Stage III Testicular Cancer AJCC v8 CL538407 CTRP Malignant Stage III Testicular Cancer Stage III Testicular Cancer AJCC v8 Stage III Testicular Cancer AJCC v8 Stage IIIA includes: (Any pT/TX, Any N, M1a, S0); (Any pT/TX, Any N, M1a, S1). TX: Testicular cancer in which the primary tumor cannot be assessed. M1a: Testicular cancer with non-retroperitoneal nodal or pulmonary metastases. S0: Marker study levels within normal limits. S1: LDH less than 1.5 x N and hCG (mlU/mL) less than 5,000 and AFP (ng/mL) less than 1,000. N indicates the upper limit of normal for the LDH assay. (AJCC 8th ed.) C140238 Neoplastic Process Stage IIIA Testicular Cancer AJCC v8 Stage IIIA Testicular Cancer AJCC v8 CL538406 CTRP Malignant Stage IIIA Testicular Cancer Stage IIIA Testicular Cancer AJCC v8 Stage IIIA Testicular Cancer AJCC v8 Stage IIIB includes: (Any pT/TX, N1-3, M0, S2); (Any pT/TX, Any N, M1a, S2). TX: Testicular cancer in which the primary tumor cannot be assessed. N1: Testicular cancer with metastasis with a lymph node mass 2 cm or smaller in greatest dimension and less than or equal to five nodes positive, none larger than 2 cm in greatest dimension. N2: Testicular cancer with metastasis with a lymph node mass larger than 2 cm but not larger than 5 cm in greatest dimension; or more than five nodes positive, none larger than 5 cm; or evidence of extranodal extension of tumor. N3: Testicular cancer with metastasis with a lymph node mass larger than 5 cm in greatest dimension. M0: Testicular cancer without evidence of distant metastasis. M1a: Testicular cancer with non-retroperitoneal nodal or pulmonary metastases. S2: LDH 1.5-10 x N or hCG (mlU/mL) 5,000-50,000 or AFP (ng/mL) 1,000-10,000. N indicates the upper limit of normal for the LDH assay. (AJCC 8th ed.) C140239 Neoplastic Process Stage IIIB Testicular Cancer AJCC v8 Stage IIIB Testicular Cancer AJCC v8 CL538405 CTRP Malignant Stage IIIB Testicular Cancer Stage IIIB Testicular Cancer AJCC v8 Stage IIIB Testicular Cancer AJCC v8 Stage IIIC includes: (Any pT/TX, N1-3, M0, S3); (Any pT/TX, Any N, M1a, S3); (Any pT/TX, Any N, M1b, Any S). TX: Testicular cancer in which the primary tumor cannot be assessed. N1: Testicular cancer with metastasis with a lymph node mass 2 cm or smaller in greatest dimension and less than or equal to five nodes positive, none larger than 2 cm in greatest dimension. N2: Testicular cancer with metastasis with a lymph node mass larger than 2 cm but not larger than 5 cm in greatest dimension; or more than five nodes positive, none larger than 5 cm; or evidence of extranodal extension of tumor. N3: Testicular cancer with metastasis with a lymph node mass larger than 5 cm in greatest dimension. M0: Testicular cancer without evidence of distant metastasis. M1a: Testicular cancer with non-retroperitoneal nodal or pulmonary metastases. M1b: Testicular cancer with non-pulmonary visceral metastases. S3: LDH more than 10 x N or hCG (mlU/mL) more than 50,000 or AFP (ng/mL) more than 10,000. N indicates the upper limit of normal for the LDH assay. (AJCC 8th ed.) C140240 Neoplastic Process Stage IIIC Testicular Cancer AJCC v8 Stage IIIC Testicular Cancer AJCC v8 CL538404 CTRP Malignant Stage IIIC Testicular Cancer Stage IIIC Testicular Cancer AJCC v8 Stage IIIC Testicular Cancer AJCC v8 A term that refers to the staging of testicular cancer according to the American Joint Committee on Cancer, 6th and 7th editions. C140241 Neoplastic Process Testicular Cancer by AJCC v6 and v7 Stage CL538403 Malignant Testicular Cancer by AJCC v6 and v7 Stage Testicular Cancer by AJCC v6 and v7 Stage A term that refers to the staging of kidney cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to carcinomas arising in the kidney. It does not apply to urothelial carcinomas (are staged according to the classification for renal pelvis and ureter), lymphomas (are staged according to the classification for Hodgkin and non-Hodgkin lymphoma), sarcomas (are staged according to the classification for soft tissue sarcoma of the abdomen and thoracic visceral organs), and Wilms tumor (no AJCC staging system). (from AJCC 8th Ed.) C140322 Neoplastic Process Renal Cell Cancer by AJCC v8 Stage CL538450 CPTAC Malignant Renal Cell Cancer by AJCC v8 Stage Renal Cell Carcinoma by AJCC v8 Stage Tumor Stage (Pathological) Renal Cell Cancer by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Tumor measuring 7 cm or less in greatest dimension, limited to the kidney. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140323 Neoplastic Process Stage I Renal Cell Cancer AJCC v8 Stage I Renal Cell Cancer AJCC v8 CL538449 CPTAC CTRP Malignant Stage I Stage I Renal Cell Cancer Stage I Renal Cell Cancer AJCC v8 Stage I Renal Cell Carcinoma AJCC v8 Stage I Renal Cell Cancer AJCC v8 Stage II includes: T2, N0, M0. T2: Tumor measuring more than 7 cm in greatest dimension, limited to the kidney. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140324 Neoplastic Process Stage II Renal Cell Cancer AJCC v8 Stage II Renal Cell Cancer AJCC v8 CL538448 CPTAC CTRP Malignant Stage II Stage II Renal Cell Cancer Stage II Renal Cell Cancer AJCC v8 Stage II Renal Cell Carcinoma AJCC v8 Stage II Renal Cell Cancer AJCC v8 Stage III includes: (T1, N1, M0); (T2, N1, M0); (T3, N0, M0); (T3, N1, M0). T1: Tumor measuring 7 cm or less in greatest dimension, limited to the kidney. T2: Tumor measuring more than 7 cm in greatest dimension, limited to the kidney. T3: Tumor extending into major veins or perinephric tissues, but not into the ipsilateral adrenal gland and not beyond Gerota's fascia. N0: No regional lymph node metastasis. N1: Metastasis in regional lymph node(s). M0: No distant metastasis. (AJCC 8th ed.) C140325 Neoplastic Process Stage III Renal Cell Cancer AJCC v8 Stage III Renal Cell Cancer AJCC v8 CL538462 CPTAC CTRP Malignant Stage III Stage III Renal Cell Cancer Stage III Renal Cell Cancer AJCC v8 Stage III Renal Cell Carcinoma AJCC v8 Stage III Renal Cell Cancer AJCC v8 Stage IV includes: (T4, Any N, M0); (Any T, Any N, M1). T4: Tumor invading beyond Gerota's fascia (including contiguous extension into the ipsilateral adrenal gland). M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C140326 Neoplastic Process Stage IV Renal Cell Cancer AJCC v8 Stage IV Renal Cell Cancer AJCC v8 CL538461 CPTAC CTRP Malignant Stage IV Stage IV Renal Cell Cancer Stage IV Renal Cell Cancer AJCC v8 Stage IV Renal Cell Carcinoma AJCC v8 Stage IV Renal Cell Cancer AJCC v8 A non-functioning neuroendocrine tumor that has spread extensively to other anatomic sites or is no longer responding to treatment. C140328 Neoplastic Process Advanced Non-Functioning Neuroendocrine Tumor CL538460 Malignant Advanced Non-Functioning Neuroendocrine Tumor Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm Advanced Nonfunctional Neuroendocrine Tumor Advanced Nonfunctional Well Differentiated Neuroendocrine Neoplasm Advanced Nonfunctioning Well Differentiated Neuroendocrine Neoplasm Advanced Non-Functioning Neuroendocrine Tumor A non-functioning, well-differentiated neuroendocrine neoplasm that has spread from the original site of growth to another anatomic site. C140329 Neoplastic Process Metastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm Metastatic Non-Functioning Neuroendocrine Tumor CL538459 CTRP Malignant Metastatic Non-Functioning Neuroendocrine Tumor Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm Metastatic Nonfunctional Neuroendocrine Tumor Metastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm Metastatic Nonfunctional Well Differentiated Neuroendocrine Tumor Metastatic Nonfunctioning Well Differentiated Neuroendocrine Neoplasm Metastatic Non-Functioning Neuroendocrine Tumor A term that refers to the staging of renal pelvis and ureter cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to renal pelvis and ureter urothelial (transitional cell) carcinoma, including histologic variants micropapillary and nested subtypes. It does not apply to renal cell carcinomas (are staged according to the classification for kidney), renal medullary carcinomas (are staged according to the classification for kidney), collecting duct carcinomas (are staged according to the classification for kidney), lymphomas (are staged according to the classification for Hodgkin and non-Hodgkin lymphoma), and mesenchymal tumors (are staged according to the classification for soft tissue sarcoma of the abdomen and thoracic visceral organs). (from AJCC 8th Ed.) C140355 Neoplastic Process Renal Pelvis and Ureter Cancer by AJCC v8 Stage CL538417 Malignant Renal Pelvis and Ureter Cancer by AJCC v8 Stage Renal Pelvis and Ureter Urothelial Carcinoma by AJCC v8 Stage Renal Pelvis and Ureter Cancer by AJCC v8 Stage A term that refers to the staging of renal pelvis cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to renal pelvis urothelial (transitional cell) carcinoma, including histologic variants micropapillary and nested subtypes. It does not apply to renal cell carcinomas (are staged according to the classification for kidney), renal medullary carcinomas (are staged according to the classification for kidney), collecting duct carcinomas (are staged according to the classification for kidney), lymphomas (are staged according to the classification for Hodgkin and non-Hodgkin lymphoma), and mesenchymal tumors (are staged according to the classification for soft tissue sarcoma of the abdomen and thoracic visceral organs). (from AJCC 8th Ed.) C140356 Neoplastic Process Renal Pelvis Cancer by AJCC v8 Stage CL538416 Malignant Renal Pelvis Cancer by AJCC v8 Stage Renal Pelvis Urothelial Carcinoma by AJCC v8 Stage Renal Pelvis Cancer by AJCC v8 Stage A term that refers to the staging of ureter cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to ureter urothelial (transitional cell) carcinoma, including histologic variants micropapillary and nested subtypes. (from AJCC 8th Ed.) C140357 Neoplastic Process Ureter Cancer by AJCC v8 Stage CL538431 Malignant Ureter Cancer by AJCC v8 Stage Ureter Urothelial Carcinoma by AJCC v8 Stage Ureter Cancer by AJCC v8 Stage Stage 0a includes: Ta, N0, M0. Ta: Papillary noninvasive carcinoma. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140358 Neoplastic Process Stage 0a Renal Pelvis and Ureter Cancer AJCC v8 Stage 0a Renal Pelvis and Ureter Cancer AJCC v8 CL538430 CTRP Malignant Stage 0a Renal Pelvis and Ureter Cancer Stage 0a Renal Pelvis and Ureter Cancer AJCC v8 Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma AJCC v8 Stage 0a Renal Pelvis and Ureter Cancer AJCC v8 Stage 0a includes: Ta, N0, M0. Ta: Papillary noninvasive carcinoma. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140359 Neoplastic Process Stage 0a Renal Pelvis Cancer AJCC v8 Stage 0a Renal Pelvis Cancer AJCC v8 CL538429 CTRP Malignant Stage 0a Renal Pelvis Cancer Stage 0a Renal Pelvis Cancer AJCC v8 Stage 0a Renal Pelvis Urothelial Carcinoma AJCC v8 Stage 0a Renal Pelvis Cancer AJCC v8 Stage 0a includes: Ta, N0, M0. Ta: Papillary noninvasive carcinoma. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140360 Neoplastic Process Stage 0a Ureter Cancer AJCC v8 Stage 0a Ureter Cancer AJCC v8 CL538428 CTRP Malignant Stage 0a Ureter Cancer Stage 0a Ureter Cancer AJCC v8 Stage 0a Ureter Urothelial Carcinoma AJCC v8 Stage 0a Ureter Cancer AJCC v8 Stage 0is includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140361 Neoplastic Process Stage 0is Renal Pelvis and Ureter Cancer AJCC v8 Stage 0is Renal Pelvis and Ureter Cancer AJCC v8 CL538427 CTRP Malignant Stage 0is Renal Pelvis and Ureter Cancer Stage 0is Renal Pelvis and Ureter Cancer AJCC v8 Stage 0is Renal Pelvis and Ureter Urothelial Carcinoma AJCC v8 Stage 0is Renal Pelvis and Ureter Cancer AJCC v8 Stage 0is includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140362 Neoplastic Process Stage 0is Renal Pelvis Cancer AJCC v8 Stage 0is Renal Pelvis Cancer AJCC v8 CL538426 CTRP Malignant Stage 0is Renal Pelvis Cancer Stage 0is Renal Pelvis Cancer AJCC v8 Stage 0is Renal Pelvis Urothelial Carcinoma AJCC v8 Stage 0is Renal Pelvis Cancer AJCC v8 Stage 0is includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140363 Neoplastic Process Stage 0is Ureter Cancer AJCC v8 Stage 0is Ureter Cancer AJCC v8 CL538425 CTRP Malignant Stage 0is Ureter Cancer Stage 0is Ureter Cancer AJCC v8 Stage 0is Ureter Urothelial Carcinoma AJCC v8 Stage 0is Ureter Cancer AJCC v8 Stage I includes: T1, N0, M0. T1: Tumor invades subepithelial connective tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140364 Neoplastic Process Stage I Renal Pelvis and Ureter Cancer AJCC v8 Stage I Renal Pelvis and Ureter Cancer AJCC v8 CL538424 CTRP Malignant Stage I Renal Pelvis and Ureter Cancer Stage I Renal Pelvis and Ureter Cancer AJCC v8 Stage I Renal Pelvis and Ureter Urothelial Carcinoma AJCC v8 Stage I Renal Pelvis and Ureter Cancer AJCC v8 Stage I includes: T1, N0, M0. T1: Tumor invades subepithelial connective tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140365 Neoplastic Process Stage I Renal Pelvis Cancer AJCC v8 Stage I Renal Pelvis Cancer AJCC v8 CL538534 CTRP Malignant Stage I Renal Pelvis Cancer Stage I Renal Pelvis Cancer AJCC v8 Stage I Renal Pelvis Urothelial Carcinoma AJCC v8 Stage I Renal Pelvis Cancer AJCC v8 Stage I includes: T1, N0, M0. T1: Tumor invades subepithelial connective tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140366 Neoplastic Process Stage I Ureter Cancer AJCC v8 Stage I Ureter Cancer AJCC v8 CL538533 CTRP Malignant Stage I Ureter Cancer Stage I Ureter Cancer AJCC v8 Stage I Ureter Urothelial Carcinoma AJCC v8 Stage I Ureter Cancer AJCC v8 Stage II includes: T2, N0, M0. T2: Tumor invades the muscularis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140367 Neoplastic Process Stage II Renal Pelvis and Ureter Cancer AJCC v8 Stage II Renal Pelvis and Ureter Cancer AJCC v8 CL538532 CTRP Malignant Stage II Renal Pelvis and Ureter Cancer Stage II Renal Pelvis and Ureter Cancer AJCC v8 Stage II Renal Pelvis and Ureter Urothelial Carcinoma AJCC v8 Stage II Renal Pelvis and Ureter Cancer AJCC v8 Stage II includes: T2, N0, M0. T2: Tumor invades the muscularis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140368 Neoplastic Process Stage II Renal Pelvis Cancer AJCC v8 Stage II Renal Pelvis Cancer AJCC v8 CL538531 CTRP Malignant Stage II Renal Pelvis Cancer Stage II Renal Pelvis Cancer AJCC v8 Stage II Renal Pelvis Urothelial Carcinoma AJCC v8 Stage II Renal Pelvis Cancer AJCC v8 Stage II includes: T2, N0, M0. T2: Tumor invades the muscularis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140369 Neoplastic Process Stage II Ureter Cancer AJCC v8 Stage II Ureter Cancer AJCC v8 CL538530 CTRP Malignant Stage II Ureter Cancer Stage II Ureter Cancer AJCC v8 Stage II Ureter Urothelial Carcinoma AJCC v8 Stage II Ureter Cancer AJCC v8 Stage III includes: T3, N0, M0. T3: For renal pelvis only: Tumor invades beyond muscularis into peripelvic fat or into the renal parenchyma. For ureter only: Tumor invades beyond muscularis into periureteric fat. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140370 Neoplastic Process Stage III Renal Pelvis and Ureter Cancer AJCC v8 Stage III Renal Pelvis and Ureter Cancer AJCC v8 CL538529 CTRP Malignant Stage III Renal Pelvis and Ureter Cancer Stage III Renal Pelvis and Ureter Cancer AJCC v8 Stage III Renal Pelvis and Ureter Urothelial Carcinoma AJCC v8 Stage III Renal Pelvis and Ureter Cancer AJCC v8 Stage III includes: T3, N0, M0. T3: Tumor invades beyond muscularis into peripelvic fat or into the renal parenchyma. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140371 Neoplastic Process Stage III Renal Pelvis Cancer AJCC v8 Stage III Renal Pelvis Cancer AJCC v8 CL538528 CTRP Malignant Stage III Renal Pelvis Cancer Stage III Renal Pelvis Cancer AJCC v8 Stage III Renal Pelvis Urothelial Carcinoma AJCC v8 Stage III Renal Pelvis Cancer AJCC v8 Stage III includes: T3, N0, M0. T3: Tumor invades beyond muscularis into periureteric fat. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140372 Neoplastic Process Stage III Ureter Cancer AJCC v8 Stage III Ureter Cancer AJCC v8 CL538527 CTRP Malignant Stage III Ureter Cancer Stage III Ureter Cancer AJCC v8 Stage III Ureter Urothelial Carcinoma AJCC v8 Stage III Ureter Cancer AJCC v8 Stage IV includes: (T4, N0, M0); (Any T, N1, M0); (Any T, N2, M0); (Any T, Any N, M1). T4: Tumor invades adjacent organs, or through the kidney into the perinephric fat. N0: No regional lymph node metastasis. N1: Metastasis in a single lymph node, 2 cm or less in greatest dimension. N2: Metastasis in a single lymph node, more than 2 cm in greatest dimension; or multiple lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C140373 Neoplastic Process Stage IV Renal Pelvis and Ureter Cancer AJCC v8 Stage IV Renal Pelvis and Ureter Cancer AJCC v8 CL538542 CTRP Malignant Stage IV Renal Pelvis and Ureter Cancer Stage IV Renal Pelvis and Ureter Cancer AJCC v8 Stage IV Renal Pelvis and Ureter Urothelial Carcinoma AJCC v8 Stage IV Renal Pelvis and Ureter Cancer AJCC v8 Stage IV includes: (T4, N0, M0); (Any T, N1, M0); (Any T, N2, M0); (Any T, Any N, M1). T4: Tumor invades adjacent organs, or through the kidney into the perinephric fat. N0: No regional lymph node metastasis. N1: Metastasis in a single lymph node, 2 cm or less in greatest dimension. N2: Metastasis in a single lymph node, more than 2 cm in greatest dimension; or multiple lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C140374 Neoplastic Process Stage IV Renal Pelvis Cancer AJCC v8 Stage IV Renal Pelvis Cancer AJCC v8 CL538541 CTRP Malignant Stage IV Renal Pelvis Cancer Stage IV Renal Pelvis Cancer AJCC v8 Stage IV Renal Pelvis Urothelial Carcinoma AJCC v8 Stage IV Renal Pelvis Cancer AJCC v8 Stage IV includes: (T4, N0, M0); (Any T, N1, M0); (Any T, N2, M0); (Any T, Any N, M1). T4: Tumor invades adjacent organs, or through the kidney into the perinephric fat. N0: No regional lymph node metastasis. N1: Metastasis in a single lymph node, 2 cm or less in greatest dimension. N2: Metastasis in a single lymph node, more than 2 cm in greatest dimension; or multiple lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C140375 Neoplastic Process Stage IV Ureter Cancer AJCC v8 Stage IV Ureter Cancer AJCC v8 CL538540 CTRP Malignant Stage IV Ureter Cancer Stage IV Ureter Cancer AJCC v8 Stage IV Ureter Urothelial Carcinoma AJCC v8 Stage IV Ureter Cancer AJCC v8 A term that refers to the staging of renal pelvis and ureter cancer according to the American Joint Committee on Cancer, 7th edition. C140376 Neoplastic Process Renal Pelvis and Ureter Cancer by AJCC v7 Stage CL538539 Malignant Renal Pelvis and Ureter Cancer by AJCC v7 Stage Renal Pelvis and Ureter Urothelial Carcinoma by AJCC v7 Stage Renal Pelvis and Ureter Cancer by AJCC v7 Stage A term that refers to the staging of renal pelvis cancer according to the American Joint Committee on Cancer, 7th edition. C140377 Neoplastic Process Renal Pelvis Cancer by AJCC v7 Stage CL538538 Malignant Renal Pelvis Cancer by AJCC v7 Stage Renal Pelvis Urothelial Carcinoma by AJCC v7 Stage Renal Pelvis Cancer by AJCC v7 Stage A term that refers to the staging of ureter cancer according to the American Joint Committee on Cancer, 7th edition. C140378 Neoplastic Process Ureter Cancer by AJCC v7 Stage CL538537 Malignant Ureter Cancer by AJCC v7 Stage Ureter Urothelial Carcinoma by AJCC v7 Stage Ureter Cancer by AJCC v7 Stage A term that refers to the staging of bladder cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to carcinomas arising in the bladder. The typical carcinoma of the bladder is urothelial carcinoma. These carcinomas may include other histologic elements, including adenocarcinoma, squamous cell carcinoma, and small cell neuroendocrine carcinoma, but should be classified as urothelial unless the cancer is composed entirely of the alternative histology. All histologic cell types that are derived primarily from the urinary bladder epithelium should follow this staging system. It does not apply to prostatic urothelial carcinomas (are staged according to the classification for urethra), lymphomas (are staged according to the classification for Hodgkin and non-Hodgkin lymphoma), and sarcomas (are staged according to the classification for soft tissue sarcoma of the abdomen and thoracic visceral organs). (from AJCC 8th Ed.) C140416 Neoplastic Process Bladder Cancer by AJCC v8 Stage CL538483 Malignant Bladder Cancer by AJCC v8 Stage Bladder Carcinoma by AJCC v8 Stage Bladder Cancer by AJCC v8 Stage Stage 0a includes: Ta, N0, M0. Ta: Non-invasive papillary carcinoma. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140417 Neoplastic Process Stage 0a Bladder Cancer AJCC v8 Stage 0a Bladder Cancer AJCC v8 CL538482 CPTAC CTRP Malignant 0a Stage 0a Bladder Cancer Stage 0a Bladder Cancer AJCC v8 Stage 0a Bladder Carcinoma AJCC v8 Stage 0a Bladder Cancer AJCC v8 Stage 0is includes: Tis, N0, M0. Tis: Urothelial carcinoma in situ: "flat tumor". N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140418 Neoplastic Process Stage 0is Bladder Cancer AJCC v8 Stage 0is Bladder Cancer AJCC v8 CL538481 CPTAC CTRP mCode Malignant 0is Carcinoma in situ of bladder Stage 0is Bladder Cancer Stage 0is Bladder Cancer AJCC v8 Stage 0is Bladder Carcinoma AJCC v8 Stage 0is Bladder Cancer AJCC v8 Stage I includes: T1, N0, M0. T1: Tumor invades lamina propria (subepithelial connective tissue). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140419 Neoplastic Process Stage I Bladder Cancer AJCC v8 Stage I Bladder Cancer AJCC v8 CL538480 CPTAC CTRP Malignant I Stage I Bladder Cancer Stage I Bladder Cancer AJCC v8 Stage I Bladder Carcinoma AJCC v8 Stage I Bladder Cancer AJCC v8 Stage II includes: (T2a, N0, M0); (T2b, N0, M0). T2a: Tumor invades superficial muscularis propria (inner half). T2b: Tumor invades deep muscularis propria (outer half). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140420 Neoplastic Process Stage II Bladder Cancer AJCC v8 Stage II Bladder Cancer AJCC v8 CL538479 CPTAC CTRP Malignant II Stage II Bladder Cancer Stage II Bladder Cancer AJCC v8 Stage II Bladder Carcinoma AJCC v8 Stage II Bladder Cancer AJCC v8 Stage III includes: IIIA: (T3a, T3b, T4a, N0, M0); (T1-T4a, N1, M0); IIIB: (T1-T4a, N2, N3, M0). T1: Tumor invades lamina propria (subepithelial connective tissue). T2: Tumor invades muscularis propria. T3: Tumor invades perivesical soft tissue. T3a: Tumor invades perivesical soft tissue, microscopically. T3b: Tumor invades perivesical soft tissue, macroscopically (extravesical mass). T4a: Extravesical tumor invades directly into prostatic stroma, uterus, vagina. N0: No regional lymph node metastasis. N1: Single regional lymph node metastasis in the true pelvis (perivesical, obturator, internal and external iliac, or sacral lymph node). N2: Multiple regional lymph node metastasis in the true pelvis (perivesical, obturator, internal and external iliac, or sacral lymph node metastasis). N3: Lymph node metastasis to the common iliac lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C140421 Neoplastic Process Stage III Bladder Cancer AJCC v8 Stage III Bladder Cancer AJCC v8 CL538494 CTRP Malignant Stage III Bladder Cancer Stage III Bladder Cancer AJCC v8 Stage III Bladder Carcinoma AJCC v8 Stage III Bladder Cancer AJCC v8 Stage IIIA includes: (T3a, T3b, T4a, N0, M0); (T1-T4a, N1, M0). T1: Tumor invades lamina propria (subepithelial connective tissue). T2: Tumor invades muscularis propria. T3: Tumor invades perivesical soft tissue. T3a: Tumor invades perivesical soft tissue, microscopically. T3b: Tumor invades perivesical soft tissue, macroscopically (extravesical mass). T4a: Extravesical tumor invades directly into prostatic stroma, uterus, vagina. N0: No regional lymph node metastasis. N1: Single regional lymph node metastasis in the true pelvis (perivesical, obturator, internal and external iliac, or sacral lymph node). M0: No distant metastasis. (AJCC 8th ed.) C140422 Neoplastic Process Stage IIIA Bladder Cancer AJCC v8 Stage IIIA Bladder Cancer AJCC v8 CL538493 CPTAC CTRP Malignant IIIA Stage IIIA Bladder Cancer Stage IIIA Bladder Cancer AJCC v8 Stage IIIA Bladder Carcinoma AJCC v8 Stage IIIA Bladder Cancer AJCC v8 Stage IIIB includes: T1-T4a, N2, N3, M0. T1: Tumor invades lamina propria (subepithelial connective tissue). T2: Tumor invades muscularis propria. T3: Tumor invades perivesical soft tissue. T4a: Extravesical tumor invades directly into prostatic stroma, uterus, vagina. N2: Multiple regional lymph node metastasis in the true pelvis (perivesical, obturator, internal and external iliac, or sacral lymph node metastasis). N3: Lymph node metastasis to the common iliac lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C140423 Neoplastic Process Stage IIIB Bladder Cancer AJCC v8 Stage IIIB Bladder Cancer AJCC v8 CL538492 CPTAC CTRP Malignant IIIB Stage IIIB Bladder Cancer Stage IIIB Bladder Cancer AJCC v8 Stage IIIB Bladder Carcinoma AJCC v8 Stage IIIB Bladder Cancer AJCC v8 Stage IV includes: IVA: (T4b, N0, M0); (Any T, Any N, M1a); IVB: (Any T, Any N, M1b). T4b: Extravesical tumor invades pelvic wall, abdominal wall. N0: No regional lymph node metastasis. M0: No distant metastasis. M1a: Distant metastasis limited to lymph nodes beyond the common iliacs. M1b: Non-lymph node distant metastases. (AJCC 8th ed.) C140424 Neoplastic Process Stage IV Bladder Cancer AJCC v8 Stage IV Bladder Cancer AJCC v8 CL538491 CTRP Malignant Stage IV Bladder Cancer Stage IV Bladder Cancer AJCC v8 Stage IV Bladder Carcinoma AJCC v8 Stage IV Bladder Cancer AJCC v8 Stage IVA includes: (T4b, N0, M0); (Any T, Any N, M1a). T4b: Extravesical tumor invades pelvic wall, abdominal wall. N0: No regional lymph node metastasis. M0: No distant metastasis. M1a: Distant metastasis limited to lymph nodes beyond the common iliacs. (AJCC 8th ed.) C140425 Neoplastic Process Stage IVA Bladder Cancer AJCC v8 Stage IVA Bladder Cancer AJCC v8 CL538490 CPTAC CTRP Malignant IVA Stage IVA Bladder Cancer Stage IVA Bladder Cancer AJCC v8 Stage IVA Bladder Carcinoma AJCC v8 Stage IVA Bladder Cancer AJCC v8 Stage IVB includes: Any T, Any N, M1b. M1b: Non-lymph node distant metastases. (AJCC 8th ed.) C140426 Neoplastic Process Stage IVB Bladder Cancer AJCC v8 Stage IVB Bladder Cancer AJCC v8 CL538489 CPTAC CTRP Malignant IVB Stage IVB Bladder Cancer Stage IVB Bladder Cancer AJCC v8 Stage IVB Bladder Carcinoma AJCC v8 Stage IVB Bladder Cancer AJCC v8 A term that refers to the staging of urethral cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to urothelial (transitional cell), squamous, and glandular carcinomas of the urethra and to urothelial (transitional cell) carcinomas of the prostate and prostatic urethra. It does not apply to squamous cell carcinomas of the penile foreskin (are staged according to the classification for penis), primary urothelial carcinomas of the bladder with transmural involvement of the prostate (are staged according to the classification for urinary bladder), prostatic adenocarcinomas (are staged according to the classification for prostate), mucosal melanomas of the urethra (no AJCC staging system), lymphomas (are staged according to the classification for Hodgkin and non-Hodgkin lymphoma), and sarcomas (are staged according to the classification for soft tissue sarcoma of the abdomen and thoracic visceral organs). (from AJCC 8th Ed.) C140457 Neoplastic Process Urethral Cancer by AJCC v8 Stage CL538584 Malignant Urethral Cancer by AJCC v8 Stage Urethral Carcinoma by AJCC v8 Stage Urethral Cancer by AJCC v8 Stage Stage 0a includes: Ta, N0, M0. Ta: For male penile urethra and female urethra: Non-invasive papillary carcinoma. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140458 Neoplastic Process Stage 0a Urethral Cancer AJCC v8 Stage 0a Urethral Cancer AJCC v8 CL538583 CTRP Malignant Stage 0a Urethral Cancer Stage 0a Urethral Cancer AJCC v8 Stage 0a Urethral Carcinoma AJCC v8 Stage 0a Urethral Cancer AJCC v8 Stage 0is includes: Tis, N0, M0. Tis: For male penile urethra and female urethra: Carcinoma in situ. For prostatic urethra: Carcinoma in situ involving the prostatic urethra or periurethral or prostatic ducts without stromal invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140459 Neoplastic Process Stage 0is Urethral Cancer AJCC v8 Stage 0is Urethral Cancer AJCC v8 CL538582 CTRP Malignant Stage 0is Urethral Cancer Stage 0is Urethral Cancer AJCC v8 Stage 0is Urethral Carcinoma AJCC v8 Stage 0is Urethral Cancer AJCC v8 Stage I includes: T1, N0, M0. T1: For male penile urethra and female urethra: Tumor invades subepithelial connective tissue. For prostatic urethra: Tumor invades urethral subepithelial connective tissue immediately underlying the urothelium. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140460 Neoplastic Process Stage I Urethral Cancer AJCC v8 Stage I Urethral Cancer AJCC v8 CL538581 CTRP Malignant Stage I Urethral Cancer Stage I Urethral Cancer AJCC v8 Stage I Urethral Carcinoma AJCC v8 Stage I Urethral Cancer AJCC v8 Stage II includes: T2, N0, M0. T2: For male penile urethra and female urethra: Tumor invades any of the following: corpus spongiosum, periurethral muscle. For prostatic urethra: Tumor invades the prostatic stroma surrounding ducts either by direct extension from the urothelial surface or by invasion from prostatic ducts. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140461 Neoplastic Process Stage II Urethral Cancer AJCC v8 Stage II Urethral Cancer AJCC v8 CL538564 CTRP Malignant Stage II Urethral Cancer Stage II Urethral Cancer AJCC v8 Stage II Urethral Carcinoma AJCC v8 Stage II Urethral Cancer AJCC v8 Stage III includes: (T1, N1, M0); (T2, N1, M0); (T3, N0, M0); (T3, N1, M0). T1: For male penile urethra and female urethra: Tumor invades subepithelial connective tissue. For prostatic urethra: Tumor invades urethral subepithelial connective tissue immediately underlying the urothelium. T2: For male penile urethra and female urethra: Tumor invades any of the following: corpus spongiosum, periurethral muscle. For prostatic urethra: Tumor invades the prostatic stroma surrounding ducts either by direct extension from the urothelial surface or by invasion from prostatic ducts. T3: For male penile urethra and female urethra: Tumor invades any of the following: corpus cavernosum, anterior vagina. For prostatic urethra: Tumor invades the periprostatic fat. N0: No regional lymph node metastasis. N1: Single regional lymph node metastasis in the inguinal region or true pelvis [perivesical, obturator, internal (hypogastric) and external iliac], or presacral lymph node. M0: No distant metastasis. (AJCC 8th ed.) C140462 Neoplastic Process Stage III Urethral Cancer AJCC v8 Stage III Urethral Cancer AJCC v8 CL538563 CTRP Malignant Stage III Urethral Cancer Stage III Urethral Cancer AJCC v8 Stage III Urethral Carcinoma AJCC v8 Stage III Urethral Cancer AJCC v8 Stage IV includes: (T4, N0, M0); (T4, N1, M0); (Any T, N2, M0); (Any T, Any N, M1). T4: For male penile urethra and female urethra: Tumor invades other adjacent organs (e.g., invasion of the bladder wall). For prostatic urethra: Tumor invades other adjacent organs (e.g., extraprostatic invasion of the bladder wall, rectal wall). N0: No regional lymph node metastasis. N1: Single regional lymph node metastasis in the inguinal region or true pelvis [perivesical, obturator, internal (hypogastric) and external iliac], or presacral lymph node. N2: Multiple regional lymph node metastasis in the inguinal region or true pelvis [perivesical, obturator, internal (hypogastric) and external iliac], or presacral lymph node. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.) C140463 Neoplastic Process Stage IV Urethral Cancer AJCC v8 Stage IV Urethral Cancer AJCC v8 CL538562 CTRP Malignant Stage IV Urethral Cancer Stage IV Urethral Cancer AJCC v8 Stage IV Urethral Carcinoma AJCC v8 Stage IV Urethral Cancer AJCC v8 A term that refers to the staging of urethral cancer according to the American Joint Committee on Cancer, 7th edition. C140464 Neoplastic Process Urethral Cancer by AJCC v7 Stage CL538561 Malignant Urethral Cancer by AJCC v7 Stage Urethral Carcinoma by AJCC v7 Stage Urethral Cancer by AJCC v7 Stage A term that refers to the staging of eyelid carcinoma according to the American Joint Committee on Cancer, 7th edition. C140511 Neoplastic Process Eyelid Carcinoma by AJCC v7 Stage CL538640 Malignant Eyelid Carcinoma by AJCC v7 Stage Eyelid Carcinoma by AJCC v7 Stage A term that refers to the staging of eyelid carcinoma according to the American Joint Committee on Cancer, 8th edition. This staging system applies to all primary carcinomas of the eyelid, including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), sebaceous carcinoma, and other rare carcinomas, such as all varieties of sweat gland carcinoma (e.g., eccrine carcinoma). It does not apply to carcinomas of the head and neck with direct extension to eyelid (are staged according to the cutaneous squamous cell carcinomas of the head and neck), Merkel cell carcinomas of the eyelid (are staged according to the classification for Merkel cell carcinomas), and melanomas of the eyelid (are staged according to the classification for melanomas of the skin). (from AJCC 8th Ed.) C140513 Neoplastic Process Eyelid Carcinoma by AJCC v8 Stage CL538639 Malignant Eyelid Carcinoma by AJCC v8 Stage Eyelid Carcinoma by AJCC v8 Stage Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No evidence of lymph node involvement. M0: No distant metastasis. (AJCC 8th ed.) C140515 Neoplastic Process Stage 0 Eyelid Carcinoma AJCC v8 CL538638 Malignant Stage 0 Eyelid Carcinoma AJCC v8 Stage 0 Eyelid Carcinoma AJCC v8 Stage I includes: IA: T1, N0, M0; IB: T2a, N0, M0. T1: Tumor measuring 10 mm or less in greatest dimension. T2a: Tumor measuring more than 10 mm but 20 mm or less in greatest dimension without invasion of the tarsal plate or eyelid margin. N0: No evidence of lymph node involvement. M0: No distant metastasis. (AJCC 8th ed.) C140516 Neoplastic Process Stage I Eyelid Carcinoma AJCC v8 CL538637 Malignant Stage I Eyelid Carcinoma AJCC v8 Stage I Eyelid Carcinoma AJCC v8 Stage IA includes: T1, N0, M0. T1: Tumor measuring 10 mm or less in greatest dimension. N0: No evidence of lymph node involvement. M0: No distant metastasis. (AJCC 8th ed.) C140517 Neoplastic Process Stage IA Eyelid Carcinoma AJCC v8 CL538636 Malignant Stage IA Eyelid Carcinoma AJCC v8 Stage IA Eyelid Carcinoma AJCC v8 Stage IB includes: T2a, N0, M0. T2a: Tumor measuring more than 10 mm but 20 mm or less in greatest dimension without invasion of the tarsal plate or eyelid margin. N0: No evidence of lymph node involvement. M0: No distant metastasis. (AJCC 8th ed.) C140518 Neoplastic Process Stage IB Eyelid Carcinoma AJCC v8 CL538650 Malignant Stage IB Eyelid Carcinoma AJCC v8 Stage IB Eyelid Carcinoma AJCC v8 Stage II includes: IIA: T2b-c, T3, N0, M0; IIB: T4, N0, M0. T2b: Tumor measuring more than 10 mm but 20 mm or less in greatest dimension with invasion of the tarsal plate or eyelid margin. T2c: Tumor measuring more than 10 mm but 20 mm or less in greatest dimension involving the full thickness of the eyelid. T3: Tumor measuring more than 20 mm but 30 mm or less in greatest dimension. T4: Any eyelid carcinoma invading adjacent ocular, orbital, or facial structures. N0: No evidence of lymph node involvement. M0: No distant metastasis. (AJCC 8th ed.) C140519 Neoplastic Process Stage II Eyelid Carcinoma AJCC v8 CL538649 Malignant Stage II Eyelid Carcinoma AJCC v8 Stage II Eyelid Carcinoma AJCC v8 Stage IIA includes: T2b-c, T3, N0, M0: T2b: Tumor measuring more than 10 mm but 20 mm or less in greatest dimension with invasion of the tarsal plate or eyelid margin. T2c: Tumor measuring more than 10 mm but 20 mm or less in greatest dimension involving the full thickness of the eyelid. T3: Tumor measuring more than 20 mm but 30 mm or less in greatest dimension. N0: No evidence of lymph node involvement. M0: No distant metastasis. (AJCC 8th ed.) C140520 Neoplastic Process Stage IIA Eyelid Carcinoma AJCC v8 CL538648 Malignant Stage IIA Eyelid Carcinoma AJCC v8 Stage IIA Eyelid Carcinoma AJCC v8 Stage IIB includes: T4, N0, M0. T4: Any eyelid carcinoma invading adjacent ocular, orbital, or facial structures. N0: No evidence of lymph node involvement. M0: No distant metastasis. (AJCC 8th ed.) C140521 Neoplastic Process Stage IIB Eyelid Carcinoma AJCC v8 CL538647 Malignant Stage IIB Eyelid Carcinoma AJCC v8 Stage IIB Eyelid Carcinoma AJCC v8 Stage III includes: IIIA: Any T, N1, M0; IIIB: Any T, N2, M0. N1: Metastasis in a single ipsilateral regional lymph node, measuring 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral regional lymph node, measuring more than 3 cm in greatest dimension, or in bilateral or contralateral lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C140522 Neoplastic Process Stage III Eyelid Carcinoma AJCC v8 CL538646 Malignant Stage III Eyelid Carcinoma AJCC v8 Stage III Eyelid Carcinoma AJCC v8 Stage IIIA includes: Any T, N1, M0. N1: Metastasis in a single ipsilateral regional lymph node, measuring 3 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 8th ed.) C140523 Neoplastic Process Stage IIIA Eyelid Carcinoma AJCC v8 CL538645 Malignant Stage IIIA Eyelid Carcinoma AJCC v8 Stage IIIA Eyelid Carcinoma AJCC v8 Stage IIIB includes: Any T, N2, M0. N2: Metastasis in a single ipsilateral regional lymph node, measuring more than 3 cm in greatest dimension, or in bilateral or contralateral lymph nodes. M0: No distant metastasis. (AJCC 8th ed.) C140524 Neoplastic Process Stage IIIB Eyelid Carcinoma AJCC v8 CL538644 Malignant Stage IIIB Eyelid Carcinoma AJCC v8 Stage IIIB Eyelid Carcinoma AJCC v8 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.) C140525 Neoplastic Process Stage IV Eyelid Carcinoma AJCC v8 CL538643 Malignant Stage IV Eyelid Carcinoma AJCC v8 Stage IV Eyelid Carcinoma AJCC v8 A term that refers to the staging of choroidal and ciliary body melanoma, following the rules of the TNM AJCC v8 classification system. C140659 Neoplastic Process Choroidal and Ciliary Body Melanoma by AJCC v8 Stage CL538750 Malignant Choroidal and Ciliary Body Melanoma by AJCC v8 Stage Posterior Uveal Melanoma by AJCC v8 Stage Choroidal and Ciliary Body Melanoma by AJCC v8 Stage Stage I includes: T1a, N0, M0. T1a: Tumor size category 1 without ciliary body involvement and extraocular extension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140660 Neoplastic Process Stage I Choroidal and Ciliary Body Melanoma AJCC v8 Stage I Choroidal and Ciliary Body Melanoma AJCC v8 CL538749 CTRP Malignant Stage I Choroidal and Ciliary Body Melanoma Stage I Choroidal and Ciliary Body Melanoma AJCC v8 Stage I Posterior Uveal Melanoma AJCC v8 Stage I Choroidal and Ciliary Body Melanoma AJCC v8 Stage II includes: IIA (T1b-d, N0, M0); (T2a, N0, M0); IIB (T2b, N0, M0); (T3a, N0, M0). T1b: Tumor size category 1 with ciliary body involvement. T1c: Tumor size category 1 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in largest diameter. T1d: Tumor size category 1 with ciliary body involvement and extraocular extension less than or equal to 5 mm in largest diameter. T2a: Tumor size category 2 without ciliary body involvement and extraocular extension. T2b: Tumor size category 2 with ciliary body involvement. T3a: Tumor size category 3 without ciliary body involvement and extraocular extension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140661 Neoplastic Process Stage II Choroidal and Ciliary Body Melanoma AJCC v8 Stage II Choroidal and Ciliary Body Melanoma AJCC v8 CL538748 CTRP Malignant Stage II Choroidal and Ciliary Body Melanoma Stage II Choroidal and Ciliary Body Melanoma AJCC v8 Stage II Posterior Uveal Melanoma AJCC v8 Stage II Choroidal and Ciliary Body Melanoma AJCC v8 Stage IIA includes: (T1b-d, N0, M0); (T2a, N0, M0). T1b: Tumor size category 1 with ciliary body involvement. T1c: Tumor size category 1 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in largest diameter. T1d: Tumor size category 1 with ciliary body involvement and extraocular extension less than or equal to 5 mm in largest diameter. T2a: Tumor size category 2 without ciliary body involvement and extraocular extension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140662 Neoplastic Process Stage IIA Choroidal and Ciliary Body Melanoma AJCC v8 Stage IIA Choroidal and Ciliary Body Melanoma AJCC v8 CL538747 CTRP Malignant Stage IIA Choroidal and Ciliary Body Melanoma Stage IIA Choroidal and Ciliary Body Melanoma AJCC v8 Stage IIA Posterior Uveal Melanoma AJCC v8 Stage IIA Choroidal and Ciliary Body Melanoma AJCC v8 Stage IIB includes: (T2b, N0, M0); (T3a, N0, M0). T2b: Tumor size category 2 with ciliary body involvement. T3a: Tumor size category 3 without ciliary body involvement and extraocular extension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140663 Neoplastic Process Stage IIB Choroidal and Ciliary Body Melanoma AJCC v8 Stage IIB Choroidal and Ciliary Body Melanoma AJCC v8 CL538762 CTRP Malignant Stage IIB Choroidal and Ciliary Body Melanoma Stage IIB Choroidal and Ciliary Body Melanoma AJCC v8 Stage IIB Posterior Uveal Melanoma AJCC v8 Stage IIB Choroidal and Ciliary Body Melanoma AJCC v8 Stage III includes: IIIA (T2c-d, N0, M0); (T3b-c, N0, M0); (T4a, N0, M0); IIIB (T3d, N0, M0); (T4b-c, N0, M0); IIIC: (T4d-e, N0, M0). T2c: Tumor size category 2 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in largest diameter. T2d: Tumor size category 2 with ciliary body involvement and extraocular extension less than or equal to 5 mm in largest diameter. T3b: Tumor size category 3 with ciliary body involvement. T3c: Tumor size category 3 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in largest diameter. T4a: Tumor size category 4 without ciliary body involvement and extraocular extension. T3d: Tumor size category 3 with ciliary body involvement and extraocular extension less than or equal to 5 mm in largest diameter. T4b: Tumor size category 4 with ciliary body involvement. T4c: Tumor size category 4 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in largest diameter. T4d: Tumor size category 4 with ciliary body involvement and extraocular extension less than or equal to 5 mm in largest diameter. T4e: Any tumor size category with extraocular extension more than 5 mm in largest diameter. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140664 Neoplastic Process Stage III Choroidal and Ciliary Body Melanoma AJCC v8 Stage III Choroidal and Ciliary Body Melanoma AJCC v8 CL538761 CTRP Malignant Stage III Choroidal and Ciliary Body Melanoma Stage III Choroidal and Ciliary Body Melanoma AJCC v8 Stage III Posterior Uveal Melanoma AJCC v8 Stage III Choroidal and Ciliary Body Melanoma AJCC v8 Stage IIIA includes: (T2c-d, N0, M0); (T3b-c, N0, M0); (T4a, N0, M0). T2c: Tumor size category 2 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in largest diameter. T2d: Tumor size category 2 with ciliary body involvement and extraocular extension less than or equal to 5 mm in largest diameter. T3b: Tumor size category 3 with ciliary body involvement. T3c: Tumor size category 3 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in largest diameter. T4a: Tumor size category 4 without ciliary body involvement and extraocular extension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140665 Neoplastic Process Stage IIIA Choroidal and Ciliary Body Melanoma AJCC v8 Stage IIIA Choroidal and Ciliary Body Melanoma AJCC v8 CL538760 CTRP Malignant Stage IIIA Choroidal and Ciliary Body Melanoma Stage IIIA Choroidal and Ciliary Body Melanoma AJCC v8 Stage IIIA Posterior Uveal Melanoma AJCC v8 Stage IIIA Choroidal and Ciliary Body Melanoma AJCC v8 Stage IIIB includes: (T3d, N0, M0); (T4b-c, N0, M0). T3d: Tumor size category 3 with ciliary body involvement and extraocular extension less than or equal to 5 mm in largest diameter. T4b: Tumor size category 4 with ciliary body involvement. T4c: Tumor size category 4 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in largest diameter. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140666 Neoplastic Process Stage IIIB Choroidal and Ciliary Body Melanoma AJCC v8 Stage IIIB Choroidal and Ciliary Body Melanoma AJCC v8 CL538759 CTRP Malignant Stage IIIB Choroidal and Ciliary Body Melanoma Stage IIIB Choroidal and Ciliary Body Melanoma AJCC v8 Stage IIIB Posterior Uveal Melanoma AJCC v8 Stage IIIB Choroidal and Ciliary Body Melanoma AJCC v8 Stage IIIC includes: T4d-e, N0, M0. T4d: Tumor size category 4 with ciliary body involvement and extraocular extension less than or equal to 5 mm in largest diameter. T4e: Any tumor size category with extraocular extension more than 5 mm in largest diameter. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.) C140667 Neoplastic Process Stage IIIC Choroidal and Ciliary Body Melanoma AJCC v8 Stage IIIC Choroidal and Ciliary Body Melanoma AJCC v8 CL538758 CTRP Malignant Stage IIIC Choroidal and Ciliary Body Melanoma Stage IIIC Choroidal and Ciliary Body Melanoma AJCC v8 Stage IIIC Posterior Uveal Melanoma AJCC v8 Stage IIIC Choroidal and Ciliary Body Melanoma AJCC v8 Stage IV includes: (Any T, N1, M0); (Any T, Any N, M1a-c). N1: Regional lymph node metastasis or discrete tumor deposits in the orbit. M0: No distant metastasis. M1a: Distant metastasis, with the largest diameter of the largest metastasis measuring 3 cm or less. M1b: Distant metastasis, with the largest diameter of the largest metastasis measuring 3.1-8.0 cm. M1c: Distant metastasis, with the largest diameter of the largest metastasis measuring 8.1 cm or more. (AJCC 8th ed.) C140668 Neoplastic Process Stage IV Choroidal and Ciliary Body Melanoma AJCC v8 Stage IV Choroidal and Ciliary Body Melanoma AJCC v8 CL538757 CTRP Malignant Stage IV Choroidal and Ciliary Body Melanoma Stage IV Choroidal and Ciliary Body Melanoma AJCC v8 Stage IV Posterior Uveal Melanoma AJCC v8 Stage IV Choroidal and Ciliary Body Melanoma AJCC v8 A term that refers to the staging of uveal melanoma, following the rules of the TNM AJCC v7 classification system. C140672 Neoplastic Process Uveal Melanoma by AJCC v7 Stage CL538737 CPTAC Malignant Tumor Stage (Pathologic) Uveal Melanoma by AJCC v7 Stage Uveal Melanoma by AJCC v7 Stage A term that refers to the staging of retinoblastoma according to the American Joint Committee on Cancer, 8th edition. This staging system does not apply to central nervous system component of "trilateral retinoblastoma" (is staged according to the classification for brain and spinal cord), retinoma (or retinocytoma) (no AJCC staging system), and medulloepithelioma (no AJCC staging system). (from AJCC 8th Ed.) C140750 Neoplastic Process Retinoblastoma by AJCC v8 Stage CL538804 Malignant Retinoblastoma by AJCC v8 Stage Retinoblastoma by AJCC v8 Stage A term that refers to the clinical staging of retinoblastoma according to the American Joint Committee on Cancer, 8th edition. C140751 Neoplastic Process Retinoblastoma by AJCC v8 Clinical Stage CL538803 Malignant Retinoblastoma by AJCC v8 Clinical Stage Retinoblastoma by AJCC v8 Clinical Stage Stage I includes: cT1, cT2, cT3, cN0, cM0, Any H. cT1: Intraretinal tumor(s) with subretinal fluid 5 mm or less from the base of any tumor. cT2: Intraocular tumor(s) with retinal detachment, vitreous seeding, or subretinal seeding. cT3: Advanced intraocular tumor(s). cN0: No regional lymph node involvement. cM0: No signs or symptoms of intracranial or distant metastasis. HX: Unknown or insufficient evidence of a constitutional RB1 gene mutation. H0: Normal RB1 alleles in blood tested with demonstrated high-sensitivity assays. H1: Bilateral retinoblastoma, retinoblastoma with an intracranial primitive neuroectodermal tumor (i.e., trilateral retinoblastoma), patient with family history of retinoblastoma, or molecular definition of a constitutional RB1 gene mutation. (AJCC 8th ed.) C140752 Neoplastic Process Clinical Stage I Retinoblastoma AJCC v8 CL538913 Malignant Clinical Stage I Retinoblastoma AJCC v8 Clinical Stage I Retinoblastoma AJCC v8 Stage II includes: cT4a, cN0, cM0, Any H. cT4a: Radiologic evidence of retrobulbar optic nerve involvement or thickening of optic nerve or involvement of orbital tissues. cN0: No regional lymph node involvement. cM0: No signs or symptoms of intracranial or distant metastasis. HX: Unknown or insufficient evidence of a constitutional RB1 gene mutation. H0: Normal RB1 alleles in blood tested with demonstrated high-sensitivity assays. H1: Bilateral retinoblastoma, retinoblastoma with an intracranial primitive neuroectodermal tumor (i.e., trilateral retinoblastoma), patient with family history of retinoblastoma, or molecular definition of a constitutional RB1 gene mutation. (AJCC 8th ed.) C140753 Neoplastic Process Clinical Stage II Retinoblastoma AJCC v8 CL538912 Malignant Clinical Stage II Retinoblastoma AJCC v8 Clinical Stage II Retinoblastoma AJCC v8 Stage III includes: (cT4b, cN0, cM0, Any H); (Any cT, cN1, cM0, Any H). cT4b: Extraocular tumor clinically evident with proptosis and/or an orbital mass. cN0: No regional lymph node involvement. cN1: Evidence of preauricular, submandibular, and cervical lymph node involvement. cM0: No signs or symptoms of intracranial or distant metastasis. HX: Unknown or insufficient evidence of a constitutional RB1 gene mutation. H0: Normal RB1 alleles in blood tested with demonstrated high-sensitivity assays. H1: Bilateral retinoblastoma, retinoblastoma with an intracranial primitive neuroectodermal tumor (i.e., trilateral retinoblastoma), patient with family history of retinoblastoma, or molecular definition of a constitutional RB1 gene mutation. (AJCC 8th ed.) C140754 Neoplastic Process Clinical Stage III Retinoblastoma AJCC v8 CL538911 Malignant Clinical Stage III Retinoblastoma AJCC v8 Clinical Stage III Retinoblastoma AJCC v8 Stage IV includes: Any cT, Any N, cM1 or pM1, Any H. cM1: Distant metastasis without microscopic confirmation. pM1: Distant metastasis with microscopic confirmation. HX: Unknown or insufficient evidence of a constitutional RB1 gene mutation. H0: Normal RB1 alleles in blood tested with demonstrated high-sensitivity assays. H1: Bilateral retinoblastoma, retinoblastoma with an intracranial primitive neuroectodermal tumor (i.e., trilateral retinoblastoma), patient with family history of retinoblastoma, or molecular definition of a constitutional RB1 gene mutation. (AJCC 8th ed.) C140755 Neoplastic Process Clinical Stage IV Retinoblastoma AJCC v8 CL538910 Malignant Clinical Stage IV Retinoblastoma AJCC v8 Clinical Stage IV Retinoblastoma AJCC v8 A term that refers to the pathologic staging of retinoblastoma according to the American Joint Committee on Cancer, 8th edition. C140756 Neoplastic Process Retinoblastoma by AJCC v8 Pathologic Stage CL538909 Malignant Retinoblastoma by AJCC v8 Pathologic Stage Retinoblastoma by AJCC v8 Pathologic Stage Stage I includes: pT1, pT2, pT3, pN0, cM0, Any H. pT1: Intraocular tumor(s) without any local invasion, focal choroidal invasion, or pre-or intralaminar involvement of the optic nerve head. pT2: Intraocular tumor(s) with local invasion. pT3: Intraocular tumor(s) with significant local invasion. pN0: No lymph node involvement. cM0: No signs or symptoms of intracranial or distant metastasis. HX: Unknown or insufficient evidence of a constitutional RB1 gene mutation. H0: Normal RB1 alleles in blood tested with demonstrated high-sensitivity assays. H1: Bilateral retinoblastoma, retinoblastoma with an intracranial primitive neuroectodermal tumor (i.e., trilateral retinoblastoma), patient with family history of retinoblastoma, or molecular definition of a constitutional RB1 gene mutation. (AJCC 8th ed.) C140757 Neoplastic Process Pathologic Stage I Retinoblastoma AJCC v8 CL538908 Malignant Pathologic Stage I Retinoblastoma AJCC v8 Pathologic Stage I Retinoblastoma AJCC v8 Stage II includes: pT4, pN0, cM0, Any H. pT4: Evidence of extraocular tumor: tumor at the transected end of the optic nerve, tumor in the meningeal spaces around the optic nerve, full-thickness invasion of the sclera with invasion of the episclera, adjacent adipose tissue, extraocular muscle, bone, conjunctiva, or eyelids. pN0: No lymph node involvement. cM0: No signs or symptoms of intracranial or distant metastasis. HX: Unknown or insufficient evidence of a constitutional RB1 gene mutation. H0: Normal RB1 alleles in blood tested with demonstrated high-sensitivity assays. H1: Bilateral retinoblastoma, retinoblastoma with an intracranial primitive neuroectodermal tumor (i.e., trilateral retinoblastoma), patient with family history of retinoblastoma, or molecular definition of a constitutional RB1 gene mutation. (AJCC 8th ed.) C140758 Neoplastic Process Pathologic Stage II Retinoblastoma AJCC v8 CL538907 Malignant Pathologic Stage II Retinoblastoma AJCC v8 Pathologic Stage II Retinoblastoma AJCC v8 Stage III includes: Any pT, pN1, cM0, Any H. pN1: Regional lymph node involvement. cM0: No signs or symptoms of intracranial or distant metastasis. HX: Unknown or insufficient evidence of a constitutional RB1 gene mutation. H0: Normal RB1 alleles in blood tested with demonstrated high-sensitivity assays. H1: Bilateral retinoblastoma, retinoblastoma with an intracranial primitive neuroectodermal tumor (i.e., trilateral retinoblastoma), patient with family history of retinoblastoma, or molecular definition of a constitutional RB1 gene mutation. (AJCC 8th ed.) C140759 Neoplastic Process Pathologic Stage III Retinoblastoma AJCC v8 CL538906 Malignant Pathologic Stage III Retinoblastoma AJCC v8 Pathologic Stage III Retinoblastoma AJCC v8 Stage IV includes: Any pT, Any N, cM1 or pM1, Any H. cM1: Distant metastasis without microscopic confirmation. pM1: Distant metastasis with microscopic confirmation. HX: Unknown or insufficient evidence of a constitutional RB1 gene mutation. H0: Normal RB1 alleles in blood tested with demonstrated high-sensitivity assays. H1: Bilateral retinoblastoma, retinoblastoma with an intracranial primitive neuroectodermal tumor (i.e., trilateral retinoblastoma), patient with family history of retinoblastoma, or molecular definition of a constitutional RB1 gene mutation. (AJCC 8th ed.) C140760 Neoplastic Process Pathologic Stage IV Retinoblastoma AJCC v8 CL538921 Malignant Pathologic Stage IV Retinoblastoma AJCC v8 Pathologic Stage IV Retinoblastoma AJCC v8 A term that refers to the staging of follicular thyroid gland carcinoma, following the rules of the TNM AJCC v7 classification system. C140958 Neoplastic Process Thyroid Gland Follicular Carcinoma by AJCC v7 Stage CL539107 Malignant Thyroid Gland Follicular Carcinoma by AJCC v7 Stage Thyroid Gland Follicular Carcinoma by AJCC v7 Stage A term that refers to the staging of differentiated thyroid gland carcinoma, following the rules of the TNM AJCC v7 classification system. C140959 Neoplastic Process Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage CL539106 Malignant Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage A term that refers to the staging of papillary thyroid gland carcinoma, following the rules of the TNM AJCC v7 classification system. C140960 Neoplastic Process Thyroid Gland Papillary Carcinoma by AJCC v7 Stage CL539105 Malignant Thyroid Gland Papillary Carcinoma by AJCC v7 Stage Thyroid Gland Papillary Carcinoma by AJCC v7 Stage A term that refers to the staging of differentiated thyroid gland carcinoma, following the rules of the TNM AJCC v8 classification system. C140965 Neoplastic Process Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage CL539085 Malignant Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage Stage I includes: Under 55 years: Any T, Any N, M0. 55 years and older: (T1, N0/NX, M0); (T2, N0/NX, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. N0: No evidence of locoregional lymph node metastasis. NX: Regional lymph nodes cannot be assessed. M0: No distant metastasis. (from AJCC 8th Ed.) C140966 Neoplastic Process Stage I Differentiated Thyroid Gland Carcinoma AJCC v8 Stage I Differentiated Thyroid Gland Carcinoma AJCC v8 CL539084 CTRP Malignant Stage I Differentiated Thyroid Gland Cancer Stage I Differentiated Thyroid Gland Carcinoma AJCC v8 Stage I Differentiated Thyroid Gland Carcinoma AJCC v8 Stage I includes: Any T, Any N, M0. M0: No distant metastasis. (from AJCC 8th Ed.) C140967 Neoplastic Process Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8 Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8 CL539083 CTRP Malignant Stage I Differentiated Thyroid Gland Cancer Under 55 Years Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8 Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8 Stage I includes: (T1, N0/NX, M0); (T2, N0/NX, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. N0: No evidence of locoregional lymph node metastasis. NX: Regional lymph nodes cannot be assessed. M0: No distant metastasis. (from AJCC 8th Ed.) C140968 Neoplastic Process Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8 Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8 CL539082 CTRP Malignant Stage I Differentiated Thyroid Gland Cancer 55 Years and Older Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8 Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8 Stage II includes: Under 55 years: Any T, Any N, M1; 55 years and older: (T1, N1, M0); (T2, N1, M0); (T3a/T3b, Any N, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. T3a: Tumor measuring more than 4 cm in greatest dimension limited to the thyroid. T3b: Gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid, or omohyoid muscles) from a tumor of any size. N1: Metastasis to regional nodes. M0: No distant metastasis. M1: Distant metastasis. (from AJCC 8th Ed.) C140969 Neoplastic Process Stage II Differentiated Thyroid Gland Carcinoma AJCC v8 Stage II Differentiated Thyroid Gland Carcinoma AJCC v8 CL539081 CTRP Malignant Stage II Differentiated Thyroid Gland Cancer Stage II Differentiated Thyroid Gland Carcinoma AJCC v8 Stage II Differentiated Thyroid Gland Carcinoma AJCC v8 Stage II includes: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 8th Ed.) C140970 Neoplastic Process Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8 Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8 CL539080 CTRP Malignant Stage II Differentiated Thyroid Gland Cancer Under 55 Years Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8 Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8 Stage II includes: (T1, N1, M0); (T2, N1, M0); (T3a/T3b, Any N, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. T3a: Tumor measuring more than 4 cm in greatest dimension limited to the thyroid. T3b: Gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid, or omohyoid muscles) from a tumor of any size. N1: Metastasis to regional nodes. M0: No distant metastasis. (from AJCC 8th Ed.) C140971 Neoplastic Process Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8 Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8 CL539079 CTRP Malignant Stage II Differentiated Thyroid Gland Cancer 55 Years and Older Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8 Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8 Stage III includes: 55 years and older: T4a, Any N, M0. T4a: Gross extrathyroidal extension invading subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve from a tumor of any size. M0: No distant metastasis. (from AJCC 8th Ed.) C140972 Neoplastic Process Stage III Differentiated Thyroid Gland Carcinoma AJCC v8 Stage III Differentiated Thyroid Gland Carcinoma AJCC v8 CL539094 CTRP Malignant Stage III Differentiated Thyroid Gland Cancer Stage III Differentiated Thyroid Gland Carcinoma AJCC v8 Stage III Differentiated Thyroid Gland Carcinoma AJCC v8 Stage IV includes: IVA: 55 years and older: T4b, Any N, M0; IVB: 55 years and older: Any T, Any N, M1. T4b: Gross extrathyroidal extension invading prevertebral fascia or encasing the carotid artery or mediastinal vessels from a tumor of any size. M0: No distant metastasis. M1: Distant metastasis. (from AJCC 8th Ed.) C140973 Neoplastic Process Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8 Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8 CL539093 CTRP Malignant Stage IV Differentiated Thyroid Gland Cancer Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8 Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8 Stage IVA includes: 55 years and older: T4b, Any N, M0. T4b: Gross extrathyroidal extension invading prevertebral fascia or encasing the carotid artery or mediastinal vessels from a tumor of any size. M0: No distant metastasis. (from AJCC 8th Ed.) C140974 Neoplastic Process Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8 Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8 CL539092 CTRP Malignant Stage IVA Differentiated Thyroid Gland Cancer Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8 Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8 Stage IVB includes: 55 years and older: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 8th Ed.) C140975 Neoplastic Process Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8 Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8 CL539091 CTRP Malignant Stage IVB Differentiated Thyroid Gland Cancer Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8 Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8 A term that refers to the staging of papillary thyroid gland carcinoma, following the rules of the TNM AJCC v8 classification system. C140976 Neoplastic Process Thyroid Gland Papillary Carcinoma by AJCC v8 Stage CL539090 CPTAC Malignant Thyroid Gland Papillary Carcinoma by AJCC v8 Stage Tumor Stage (Pathologic) Thyroid Gland Papillary Carcinoma by AJCC v8 Stage Stage I includes: Under 55 years: Any T, Any N, M0. 55 years and older: (T1, N0/NX, M0); (T2, N0/NX, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. N0: No evidence of locoregional lymph node metastasis. NX: Regional lymph nodes cannot be assessed. M0: No distant metastasis. (from AJCC 8th Ed.) C140977 Neoplastic Process Stage I Thyroid Gland Papillary Carcinoma AJCC v8 Stage I Thyroid Gland Papillary Carcinoma AJCC v8 CL539089 CPTAC CTRP Malignant I Stage I Thyroid Gland Papillary Cancer Stage I Thyroid Gland Papillary Carcinoma AJCC v8 Stage I Thyroid Gland Papillary Carcinoma AJCC v8 Stage I includes: Any T, Any N, M0. M0: No distant metastasis. (from AJCC 8th Ed.) C140978 Neoplastic Process Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8 Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8 CL539088 CPTAC CTRP Malignant I Under 55 Years Stage I Thyroid Gland Papillary Cancer Under 55 Years Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8 Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8 Stage I includes: (T1, N0/NX, M0); (T2, N0/NX, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. N0: No evidence of locoregional lymph node metastasis. NX: Regional lymph nodes cannot be assessed. M0: No distant metastasis. (from AJCC 8th Ed.) C140979 Neoplastic Process Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8 Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8 CL539087 CPTAC CTRP Malignant II 55 Years and Older Stage I Thyroid Gland Papillary Cancer 55 Years and Older Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8 Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8 Stage II includes: Under 55 years: Any T, Any N, M1; 55 years and older: (T1, N1, M0); (T2, N1, M0); (T3a/T3b, Any N, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. T3a: Tumor measuring more than 4 cm in greatest dimension limited to the thyroid. T3b: Gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid, or omohyoid muscles) from a tumor of any size. N1: Metastasis to regional nodes. M0: No distant metastasis. M1: Distant metastasis. (from AJCC 8th Ed.) C140980 Neoplastic Process Stage II Thyroid Gland Papillary Carcinoma AJCC v8 Stage II Thyroid Gland Papillary Carcinoma AJCC v8 CL539070 CPTAC CTRP Malignant II Stage II Thyroid Gland Papillary Cancer Stage II Thyroid Gland Papillary Carcinoma AJCC v8 Stage II Thyroid Gland Papillary Carcinoma AJCC v8 Stage II includes: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 8th Ed.) C140981 Neoplastic Process Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8 Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8 CL539069 CPTAC CTRP Malignant II Under Years Stage II Thyroid Gland Papillary Cancer Under 55 Years Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8 Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8 Stage II includes: (T1, N1, M0); (T2, N1, M0); (T3a/T3b, Any N, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. T3a: Tumor measuring more than 4 cm in greatest dimension limited to the thyroid. T3b: Gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid, or omohyoid muscles) from a tumor of any size. N1: Metastasis to regional nodes. M0: No distant metastasis. (from AJCC 8th Ed.) C140982 Neoplastic Process Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8 Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8 CL539068 CPTAC CTRP Malignant II 55 Years and Older Stage II Thyroid Gland Papillary Cancer 55 Years and Older Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8 Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8 Stage III includes: 55 years and older: T4a, Any N, M0. T4a: Gross extrathyroidal extension invading subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve from a tumor of any size. M0: No distant metastasis. (from AJCC 8th Ed.) C140983 Neoplastic Process Stage III Thyroid Gland Papillary Carcinoma AJCC v8 Stage III Thyroid Gland Papillary Carcinoma AJCC v8 CL539067 CPTAC CTRP Malignant III Stage III Thyroid Gland Papillary Cancer Stage III Thyroid Gland Papillary Carcinoma AJCC v8 Stage III Thyroid Gland Papillary Carcinoma AJCC v8 Stage IV includes: IVA: 55 years and older: T4b, Any N, M0; IVB: 55 years and older: Any T, Any N, M1. T4b: Gross extrathyroidal extension invading prevertebral fascia or encasing the carotid artery or mediastinal vessels from a tumor of any size. M0: No distant metastasis. M1: Distant metastasis. (from AJCC 8th Ed.) C140984 Neoplastic Process Stage IV Thyroid Gland Papillary Carcinoma AJCC v8 Stage IV Thyroid Gland Papillary Carcinoma AJCC v8 CL539066 CPTAC CTRP Malignant IV Stage IV Thyroid Gland Papillary Cancer Stage IV Thyroid Gland Papillary Carcinoma AJCC v8 Stage IV Thyroid Gland Papillary Carcinoma AJCC v8 Stage IVA includes: 55 years and older: T4b, Any N, M0. T4b: Gross extrathyroidal extension invading prevertebral fascia or encasing the carotid artery or mediastinal vessels from a tumor of any size. M0: No distant metastasis. (from AJCC 8th Ed.) C140985 Neoplastic Process Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8 Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8 CL539065 CPTAC CTRP Malignant IVA Stage IVA Thyroid Gland Papillary Cancer Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8 Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8 Stage IVB includes: 55 years and older: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 8th Ed.) C140986 Neoplastic Process Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8 Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8 CL539064 CPTAC CTRP Malignant IVB Stage IVB Thyroid Gland Papillary Cancer Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8 Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8 A term that refers to the staging of follicular thyroid gland carcinoma, following the rules of the TNM AJCC v8 classification system. C140987 Neoplastic Process Thyroid Gland Follicular Carcinoma by AJCC v8 Stage CL539063 Malignant Thyroid Gland Follicular Carcinoma by AJCC v8 Stage Thyroid Gland Follicular Carcinoma by AJCC v8 Stage Stage I includes: Under 55 years: Any T, Any N, M0. 55 years and older: (T1, N0/NX, M0); (T2, N0/NX, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. N0: No evidence of locoregional lymph node metastasis. NX: Regional lymph nodes cannot be assessed. M0: No distant metastasis. (from AJCC 8th Ed.) C140988 Neoplastic Process Stage I Thyroid Gland Follicular Carcinoma AJCC v8 Stage I Thyroid Gland Follicular Carcinoma AJCC v8 CL539078 CTRP Malignant Stage I Thyroid Gland Follicular Cancer Stage I Thyroid Gland Follicular Carcinoma AJCC v8 Stage I Thyroid Gland Follicular Carcinoma AJCC v8 Stage I includes: Any T, Any N, M0. M0: No distant metastasis. (from AJCC 8th Ed.) C140989 Neoplastic Process Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8 Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8 CL539077 CTRP Malignant Stage I Thyroid Gland Follicular Cancer Under 55 Years Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8 Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8 Stage I includes: (T1, N0/NX, M0); (T2, N0/NX, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. N0: No evidence of locoregional lymph node metastasis. NX: Regional lymph nodes cannot be assessed. M0: No distant metastasis. (from AJCC 8th Ed.) C140990 Neoplastic Process Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8 Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8 CL539076 CTRP Malignant Stage I Thyroid Gland Follicular Cancer 55 Years and Older Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8 Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8 Stage II includes: Under 55 years: Any T, Any N, M1; 55 years and older: (T1, N1, M0); (T2, N1, M0); (T3a/T3b, Any N, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. T3a: Tumor measuring more than 4 cm in greatest dimension limited to the thyroid. T3b: Gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid, or omohyoid muscles) from a tumor of any size. N1: Metastasis to regional nodes. M0: No distant metastasis. M1: Distant metastasis. (from AJCC 8th Ed.) C140991 Neoplastic Process Stage II Thyroid Gland Follicular Carcinoma AJCC v8 Stage II Thyroid Gland Follicular Carcinoma AJCC v8 CL539075 CTRP Malignant Stage II Thyroid Gland Follicular Cancer Stage II Thyroid Gland Follicular Carcinoma AJCC v8 Stage II Thyroid Gland Follicular Carcinoma AJCC v8 Stage II includes: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 8th Ed.) C140992 Neoplastic Process Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8 Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8 CL539074 CTRP Malignant Stage II Thyroid Gland Follicular Cancer Under 55 Years Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8 Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8 Stage II includes: (T1, N1, M0); (T2, N1, M0); (T3a/T3b, Any N, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. T3a: Tumor measuring more than 4 cm in greatest dimension limited to the thyroid. T3b: Gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid, or omohyoid muscles) from a tumor of any size. N1: Metastasis to regional nodes. M0: No distant metastasis. (from AJCC 8th Ed.) C140993 Neoplastic Process Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8 Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8 CL539073 CTRP Malignant Stage II Thyroid Gland Follicular Cancer 55 Years and Older Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8 Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8 Stage III includes: 55 years and older: T4a, Any N, M0. T4a: Gross extrathyroidal extension invading subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve from a tumor of any size. M0: No distant metastasis. (from AJCC 8th Ed.) C140995 Neoplastic Process Stage III Thyroid Gland Follicular Carcinoma AJCC v8 Stage III Thyroid Gland Follicular Carcinoma AJCC v8 CL539071 CTRP Malignant Stage III Thyroid Gland Follicular Cancer Stage III Thyroid Gland Follicular Carcinoma AJCC v8 Stage III Thyroid Gland Follicular Carcinoma AJCC v8 Stage IV includes: IVA: 55 years and older: T4b, Any N, M0; IVB: 55 years and older: Any T, Any N, M1. T4b: Gross extrathyroidal extension invading prevertebral fascia or encasing the carotid artery or mediastinal vessels from a tumor of any size. M0: No distant metastasis. M1: Distant metastasis. (from AJCC 8th Ed.) C140996 Neoplastic Process Stage IV Thyroid Gland Follicular Carcinoma AJCC v8 Stage IV Thyroid Gland Follicular Carcinoma AJCC v8 CL539054 CTRP Malignant Stage IV Thyroid Gland Follicular Cancer Stage IV Thyroid Gland Follicular Carcinoma AJCC v8 Stage IV Thyroid Gland Follicular Carcinoma AJCC v8 Stage IVA includes: 55 years and older: T4b, Any N, M0. T4b: Gross extrathyroidal extension invading prevertebral fascia or encasing the carotid artery or mediastinal vessels from a tumor of any size. M0: No distant metastasis. (from AJCC 8th Ed.) C140997 Neoplastic Process Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8 Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8 CL539053 CTRP Malignant Stage IVA Thyroid Gland Follicular Cancer Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8 Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8 Stage IVB includes: 55 years and older: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 8th Ed.) C140998 Neoplastic Process Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8 Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8 CL539052 CTRP Malignant Stage IVB Thyroid Gland Follicular Cancer Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8 Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8 A term that refers to the staging of thyroid gland anaplastic carcinoma, following the rules of the TNM AJCC v7 classification system. C140999 Neoplastic Process Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage CL539051 Malignant Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage Thyroid Gland Undifferentiated (Anaplastic) Carcinoma by AJCC v7 Stage Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage A term that refers to the staging of thyroid gland anaplastic carcinoma, following the rules of the TNM AJCC v8 classification system. C141000 Neoplastic Process Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage CL539050 Malignant Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage Thyroid Gland Undifferentiated (Anaplastic) Carcinoma by AJCC v8 Stage Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage Stage IVA includes: T1-T3a, N0/NX, M0. T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. T3a: Tumor measuring more than 4 cm in greatest dimension limited to the thyroid. N0: No evidence of locoregional lymph node metastasis. NX: Regional lymph nodes cannot be assessed. M0: No distant metastasis. (from AJCC 8th Ed.) C141001 Neoplastic Process Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8 Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v8 CL539049 CTRP Malignant Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v8 Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8 Undifferentiated (Anaplastic) Stage IVA Thyroid Gland Cancer Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v8 Stage IVB includes: (T1-T3a, N1, M0); (T3b, Any N, M0); (T4, Any N, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but 4 cm or less in greatest dimension limited to the thyroid. T3a: Tumor measuring more than 4 cm in greatest dimension limited to the thyroid. T3b: Gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid, or omohyoid muscles) from a tumor of any size. T4: Tumor of any size with gross extrathyroidal extension. N1: Metastasis to regional nodes. M0: No distant metastasis. (from AJCC 8th Ed.) C141003 Neoplastic Process Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8 Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8 CL539048 CTRP Malignant Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8 Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8 Undifferentiated (Anaplastic) Stage IVB Thyroid Gland Cancer Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 8th Ed.) C141004 Neoplastic Process Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8 Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v8 CL539047 CTRP Malignant Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v8 Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8 Undifferentiated (Anaplastic) Stage IVC Thyroid Gland Cancer Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v8 A term that refers to the staging of thyroid gland medullary carcinoma, following the rules of the TNM AJCC v7 classification system. C141041 Neoplastic Process Thyroid Gland Medullary Carcinoma by AJCC v7 Stage CL539152 Malignant Thyroid Gland Medullary Carcinoma by AJCC v7 Stage Thyroid Gland Medullary Carcinoma by AJCC v7 Stage A term that refers to the staging of thyroid gland medullary carcinoma, following the rules of the TNM AJCC v8 classification system. Differentiated and anaplastic thyroid gland carcinomas are staged according to the classification for thyroid-differentiated and anaplastic carcinoma. (from AJCC 8th Ed.) C141042 Neoplastic Process Thyroid Gland Medullary Carcinoma by AJCC v8 Stage CL539151 Malignant Thyroid Gland Medullary Carcinoma by AJCC v8 Stage Thyroid Gland Medullary Carcinoma by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. N0: No evidence of locoregional lymph node metastasis. M0: No distant metastasis. (from AJCC 8th Ed.) C141043 Neoplastic Process Stage I Thyroid Gland Medullary Carcinoma AJCC v8 Stage I Thyroid Gland Medullary Carcinoma AJCC v8 CL539150 CTRP Malignant Stage I Thyroid Gland Medullary Cancer Stage I Thyroid Gland Medullary Carcinoma AJCC v8 Stage I Thyroid Gland Medullary Carcinoma AJCC v8 Stage II includes: (T2, N0, M0); (T3, N0, M0). T2: Tumor measuring more than 2 cm but less than 4 cm in greatest dimension limited to the thyroid. T3: Tumor measuring 4 cm or more in greatest dimension or with extrathyroidal extension. N0: No evidence of locoregional lymph node metastasis. M0: No distant metastasis. (from AJCC 8th Ed.) C141044 Neoplastic Process Stage II Thyroid Gland Medullary Carcinoma AJCC v8 Stage II Thyroid Gland Medullary Carcinoma AJCC v8 CL539149 CTRP Malignant Stage II Thyroid Gland Medullary Cancer Stage II Thyroid Gland Medullary Carcinoma AJCC v8 Stage II Thyroid Gland Medullary Carcinoma AJCC v8 Stage III includes: T1-3, N1a, M0. T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but less than 4 cm in greatest dimension limited to the thyroid. T3: Tumor measuring 4 cm or more in greatest dimension or with extrathyroidal extension. N1a: Metastasis to level VI or VII (pretracheal, paratracheal, or prelaryngeal/Delphian, or upper mediastinal) lymph nodes. This can be unilateral or bilateral disease. M0: No distant metastasis. (from AJCC 8th Ed.) C141045 Neoplastic Process Stage III Thyroid Gland Medullary Carcinoma AJCC v8 Stage III Thyroid Gland Medullary Carcinoma AJCC v8 CL539132 CTRP Malignant Stage III Thyroid Gland Medullary Cancer Stage III Thyroid Gland Medullary Carcinoma AJCC v8 Stage III Thyroid Gland Medullary Carcinoma AJCC v8 Stage IV includes: IVA: (T4a, Any N, M0); (T1-3, N1b, M0); IVB: (T4b, Any N, M0); IVC: (Any T, Any N, M1). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but less than 4 cm in greatest dimension limited to the thyroid. T3: Tumor measuring 4 cm or more in greatest dimension or with extrathyroidal extension. T4a: Moderately advanced disease; tumor of any size with gross extrathyroidal extension into the nearby tissues of the neck, including subcutaneous soft tissue, larynx, trachea, esophagus, or recurrent laryngeal nerve. T4b: Very advanced disease; tumor of any size with extension towards the spine or into nearby large blood vessels, invading the prevertebral fascia, or encasing the carotid artery or mediastinal vessels. N1b: Metastasis to unilateral, bilateral, or contralateral lateral neck lymph nodes levels I, II, III, IV, or V or retropharyngeal lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (from AJCC 8th Ed.) C141046 Neoplastic Process Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 CL539131 CTRP Malignant Stage IV Thyroid Gland Medullary Cancer Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 Stage IVA includes: (T4a, Any N, M0); (T1-3, N1b, M0). T1: Tumor measuring 2 cm or less in greatest dimension limited to the thyroid. T2: Tumor measuring more than 2 cm but less than 4 cm in greatest dimension limited to the thyroid. T3: Tumor measuring 4 cm or more in greatest dimension or with extrathyroidal extension. T4a: Moderately advanced disease; tumor of any size with gross extrathyroidal extension into the nearby tissues of the neck, including subcutaneous soft tissue, larynx, trachea, esophagus, or recurrent laryngeal nerve. N1b: Metastasis to unilateral, bilateral, or contralateral lateral neck lymph nodes levels I, II, III, IV, or V or retropharyngeal lymph nodes. M0: No distant metastasis. (from AJCC 8th Ed.) C141047 Neoplastic Process Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8 Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8 CL539130 CTRP Malignant Stage IVA Thyroid Gland Medullary Cancer Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8 Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8 Stage IVB includes: T4b, Any N, M0. T4b: Very advanced disease; tumor of any size with extension towards the spine or into nearby large blood vessels, invading the prevertebral fascia, or encasing the carotid artery or mediastinal vessels. M0: No distant metastasis. (from AJCC 8th Ed.) C141048 Neoplastic Process Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8 Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8 CL539129 CTRP Malignant Stage IVB Thyroid Gland Medullary Cancer Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8 Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 8th Ed.) C141049 Neoplastic Process Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8 Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8 CL539128 CTRP Malignant Stage IVC Thyroid Gland Medullary Cancer Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8 Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8 Lung carcinoma that does not respond to treatment. C141076 Neoplastic Process Refractory Lung Carcinoma CL539119 Malignant Refractory Lung Carcinoma Refractory Lung Carcinoma Extensive stage small cell lung carcinoma that has reemerged after a period of remission. C141077 Neoplastic Process Recurrent Extensive Stage Lung Small Cell Carcinoma CL554791 Malignant Recurrent Extensive Stage Lung Small Cell Carcinoma Recurrent Extensive Stage Small Cell Lung Carcinoma Recurrent Extensive Stage Lung Small Cell Carcinoma Extensive stage small cell lung carcinoma that does not respond to treatment. C141078 Neoplastic Process Refractory Extensive Stage Lung Small Cell Carcinoma CL554792 Malignant Refractory Extensive Stage Lung Small Cell Carcinoma Refractory Extensive Stage Small Cell Lung Carcinoma Refractory Extensive Stage Lung Small Cell Carcinoma A term that refers to the staging of adrenal cortical carcinoma, following the rules of the TNM AJCC v7 classification system. C141098 Neoplastic Process Adrenal Cortical Carcinoma by AJCC v7 Stage CL539208 Malignant Adrenal Cortex Carcinoma by AJCC v7 Stage Adrenal Cortical Carcinoma by AJCC v7 Stage Adrenal Cortical Carcinoma by AJCC v7 Stage A term that refers to the staging of adrenal cortical carcinoma, following the rules of the TNM AJCC v8 classification system. Adrenal medullary pheochromocytoma is staged according to the classification for adrenal neuroendocrine tumors. There is no AJCC staging system for neuroblastic tumors of the adrenal gland. (from AJCC 8th Ed.) C141100 Neoplastic Process Adrenal Cortical Carcinoma by AJCC v8 Stage CL539206 Malignant Adrenal Cortex Carcinoma by AJCC v8 Stage Adrenal Cortical Carcinoma by AJCC v8 Stage Adrenal Cortical Carcinoma by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Tumor measuring 5 cm or less in greatest dimension, with no extra-adrenal invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 8th Ed.) C141101 Neoplastic Process Stage I Adrenal Cortex Carcinoma AJCC v8 Stage I Adrenal Cortical Carcinoma AJCC v8 CL539205 CTRP Malignant Stage I Adrenal Cortex Cancer Stage I Adrenal Cortex Carcinoma AJCC v8 Stage I Adrenal Cortical Carcinoma AJCC v8 Stage I Adrenal Cortical Carcinoma AJCC v8 Stage II includes: T2, N0, M0. T2: Tumor measuring more than 5 cm in greatest dimension, with no extra-adrenal invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 8th Ed.) C141102 Neoplastic Process Stage II Adrenal Cortex Carcinoma AJCC v8 Stage II Adrenal Cortical Carcinoma AJCC v8 CL539220 CTRP Malignant Stage II Adrenal Cortex Cancer Stage II Adrenal Cortex Carcinoma AJCC v8 Stage II Adrenal Cortical Carcinoma AJCC v8 Stage II Adrenal Cortical Carcinoma AJCC v8 Stage III includes: (T1, N1, M0); (T2, N1, M0); (T3, Any N, M0); (T4, Any N, M0). T1: Tumor measuring 5 cm or less in greatest dimension, with no extra-adrenal invasion. T2: Tumor measuring more than 5 cm in greatest dimension, with no extra-adrenal invasion. T3: Tumor of any size with local invasion but not invading adjacent organs. T4: Tumor of any size that invades adjacent organs (kidney, diaphragm, pancreas, spleen, or liver) or large blood vessels (renal vein or vena cava). N1: Metastasis in regional lymph node(s). M0: No distant metastasis. (from AJCC 8th Ed.) C141103 Neoplastic Process Stage III Adrenal Cortex Carcinoma AJCC v8 Stage III Adrenal Cortical Carcinoma AJCC v8 CL539219 CTRP Malignant Stage III Adrenal Cortex Cancer Stage III Adrenal Cortex Carcinoma AJCC v8 Stage III Adrenal Cortical Carcinoma AJCC v8 Stage III Adrenal Cortical Carcinoma AJCC v8 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 8th Ed.) C141104 Neoplastic Process Stage IV Adrenal Cortex Carcinoma AJCC v8 Stage IV Adrenal Cortical Carcinoma AJCC v8 CL539218 CTRP Malignant Stage IV Adrenal Cortex Cancer Stage IV Adrenal Cortex Carcinoma AJCC v8 Stage IV Adrenal Cortical Carcinoma AJCC v8 Stage IV Adrenal Cortical Carcinoma AJCC v8 A term that refers to the staging of adrenal gland pheochromocytoma and sympathetic paraganglioma, following the rules of the TNM AJCC v8 classification system. Parasympathetic paragangliomas are not staged because they are largely benign. This staging system does not apply to neuroendocrine tumors of the pancreas (are staged according to the classification for neuroendocrine tumors of the pancreas) and carotid body tumors (not staged). (from AJCC 8th Ed.) C141128 Neoplastic Process Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma by AJCC v8 Stage CL539178 Malignant Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma by AJCC v8 Stage Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma by AJCC v8 Stage Stage I includes: T1, N0, M0. T1: Pheochromocytoma measuring less than 5 cm in greatest dimension, with no extra-adrenal invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 8th Ed.) C141129 Neoplastic Process Stage I Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8 CL539177 Malignant Stage I Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8 Stage I Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8 Stage II includes: T2, N0, M0. T2: Pheochromocytoma measuring 5 cm or more in greatest dimension or paraganglioma-sympathetic of any size, with no extra-adrenal invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 8th Ed.) C141130 Neoplastic Process Stage II Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8 CL539176 Malignant Stage II Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8 Stage II Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8 Stage III includes: (T1, N1, M0); (T2, N1, M0); (T3, Any N, M0). T1: Pheochromocytoma measuring less than 5 cm in greatest dimension, with no extra-adrenal invasion. T2: Pheochromocytoma measuring 5 cm or more in greatest dimension or paraganglioma-sympathetic of any size, with no extra-adrenal invasion. T3: Tumor of any size with invasion into surrounding tissues (e.g., liver, pancreas, spleen, kidneys). N1: Regional lymph node metastasis. M0: No distant metastasis. (from AJCC 8th Ed.) C141131 Neoplastic Process Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8 CL539175 Malignant Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8 Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 8th Ed.) C141132 Neoplastic Process Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8 CL539174 Malignant Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8 Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8 An anatomic stage for Hodgkin and non-Hodgkin lymphomas based on the Ann Arbor classification criteria. C141139 Neoplastic Process Lymphoma by Ann Arbor Stage CL539183 Malignant Lymphoma by Ann Arbor Stage Lymphoma by Ann Arbor Stage An anatomic stage for non-Hodgkin lymphomas based on the Ann Arbor classification criteria. C141140 Neoplastic Process Non-Hodgkin Lymphoma by Ann Arbor Stage CL539182 Malignant Non-Hodgkin Lymphoma by Ann Arbor Stage Non-Hodgkin Lymphoma by Ann Arbor Stage An anatomic stage for Hodgkin lymphomas based on the Ann Arbor classification criteria. C141141 Neoplastic Process Hodgkin Lymphoma by Ann Arbor Stage CL539181 Malignant Hodgkin Lymphoma by Ann Arbor Stage Hodgkin Lymphoma by Ann Arbor Stage A term that refers to the staging of mycosis fungoides and Sezary syndrome, following the rules of the TNM AJCC v7 classification system. C141142 Neoplastic Process Mycosis Fungoides and Sezary Syndrome by AJCC v7 Stage CL539289 Malignant Mycosis Fungoides and Sezary Syndrome by AJCC v7 Stage Mycosis Fungoides and Sezary Syndrome by AJCC v7 Stage A term that refers to the staging of mycosis fungoides, following the rules of the TNM AJCC v7 classification system. C141143 Neoplastic Process Mycosis Fungoides by AJCC v7 Stage CL539288 Malignant Mycosis Fungoides by AJCC v7 Stage Mycosis Fungoides by AJCC v7 Stage A staging system for adult Hodgkin and adult non-Hodgkin lymphomas based on the Lugano classification criteria. This staging system does not apply to ocular adnexal lymphomas (are staged according to the classification for ocular adnexal lymphoma), pediatric lymphomas (are staged according to the classification for pediatric lymphoma), primary cutaneous lymphomas (are staged according to the classification for primary cutaneous lymphoma), and multiple myelomas (are staged according to the classification for plasma cell myeloma). (from AJCC 8th Ed.) C141148 Neoplastic Process Lugano Classification Adult Lymphoma by AJCC v8 Stage CL539283 Malignant Lugano Classification Adult Lymphoma by AJCC v8 Stage Lugano Classification Adult Lymphoma by AJCC v8 Stage Limited stage adult lymphoma based on the Lugano classification criteria. It includes stages I, IE, II, and IIE. (from AJCC 8th Ed.) C141149 Neoplastic Process Lugano Classification Limited Stage Adult Lymphoma AJCC v8 CL539282 Malignant Lugano Classification Limited Stage Adult Lymphoma AJCC v8 Lugano Classification Limited Stage Adult Lymphoma AJCC v8 Stage I: Involvement of a single lymphatic site (i.e., nodal region, Waldeyer's ring, thymus, or spleen). (from AJCC 8th Ed.) C141150 Neoplastic Process Lugano Classification Stage I Adult Lymphoma AJCC v8 CL539297 Malignant Lugano Classification Stage I Adult Lymphoma AJCC v8 Lugano Classification Stage I Adult Lymphoma AJCC v8 Stage IE: Single extralymphatic site in the absence of nodal involvement (rare in Hodgkin lymphoma). (from AJCC 8th Ed.) C141151 Neoplastic Process Lugano Classification Stage IE Adult Lymphoma AJCC v8 CL539296 Malignant Lugano Classification Stage IE Adult Lymphoma AJCC v8 Lugano Classification Stage IE Adult Lymphoma AJCC v8 Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm. (from AJCC 8th Ed.) C141152 Neoplastic Process Lugano Classification Stage II Adult Lymphoma AJCC v8 CL539295 Malignant Lugano Classification Stage II Adult Lymphoma AJCC v8 Lugano Classification Stage II Adult Lymphoma AJCC v8 Stage IIE: Contiguous extralymphatic extension from a nodal site with or without involvement of other lymph node regions on the same side of the diaphragm. (from AJCC 8th Ed.) C141153 Neoplastic Process Lugano Classification Stage IIE Adult Lymphoma AJCC v8 CL539294 Malignant Lugano Classification Stage IIE Adult Lymphoma AJCC v8 Lugano Classification Stage IIE Adult Lymphoma AJCC v8 Stage II Bulky: Stage II with disease bulk. (from AJCC 8th Ed.) C141154 Neoplastic Process Lugano Classification Stage II Bulky Adult Lymphoma AJCC v8 CL539293 Malignant Lugano Classification Stage II Bulky Adult Lymphoma AJCC v8 Lugano Classification Stage II Bulky Adult Lymphoma AJCC v8 Advanced stage adult lymphoma based on the Lugano classification criteria. It includes stages III and IV. (from AJCC 8th Ed.) C141155 Neoplastic Process Lugano Classification Advanced Stage Adult Lymphoma AJCC v8 CL539292 Malignant Lugano Classification Advanced Stage Adult Lymphoma AJCC v8 Lugano Classification Advanced Stage Adult Lymphoma AJCC v8 Stage III: Involvement of lymph node regions on both sides of the diaphragm; nodes above the diaphragm with spleen involvement. (from AJCC 8th Ed.) C141156 Neoplastic Process Lugano Classification Stage III Adult Lymphoma AJCC v8 CL539291 Malignant Lugano Classification Stage III Adult Lymphoma AJCC v8 Lugano Classification Stage III Adult Lymphoma AJCC v8 Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or noncontiguous extralymphatic organ involvement in conjunction with nodal stage II disease; or any extralymphatic organ involvement in nodal stage III disease. Stage IV includes any involvement of the CSF, bone marrow, liver, or lungs (other than by direct extension in stage IIE disease). (from AJCC 8th Ed.) C141157 Neoplastic Process Lugano Classification Stage IV Adult Lymphoma AJCC v8 CL539290 Malignant Lugano Classification Stage IV Adult Lymphoma AJCC v8 Lugano Classification Stage IV Adult Lymphoma AJCC v8 A staging system for adult non-Hodgkin lymphomas based on the Lugano classification criteria. This staging system does not apply to ocular adnexal lymphomas (are staged according to the classification for ocular adnexal lymphoma), pediatric non-Hodgkin lymphomas (are staged according to the St. Jude Children's Research Hospital staging system), primary cutaneous lymphomas (are staged according to the classification for primary cutaneous lymphoma), and multiple myelomas (are staged according to the classification for plasma cell myeloma). (from AJCC 8th Ed.) C141158 Neoplastic Process Lugano Classification Adult Non-Hodgkin Lymphoma by AJCC v8 Stage CL539273 Malignant Lugano Classification Adult Non-Hodgkin Lymphoma by AJCC v8 Stage Lugano Classification Adult Non-Hodgkin Lymphoma by AJCC v8 Stage Limited stage adult non-Hodgkin lymphoma based on the Lugano classification criteria. It includes stages I, IE, II, and IIE. (from AJCC 8th Ed.) C141159 Neoplastic Process Lugano Classification Limited Stage Adult Non-Hodgkin Lymphoma AJCC v8 Lugano Classification Limited Stage Adult Non-Hodgkin Lymphoma AJCC v8 CL539272 CTRP Malignant Lugano Classification Limited Stage Adult Non-Hodgkin Lymphoma AJCC v8 Lugano Classification Limited Stage Adult Non-Hodgkin Lymphoma AJCC v8 Stage I: Involvement of a single lymphatic site (i.e., nodal region, Waldeyer's ring, thymus, or spleen). (from AJCC 8th Ed.) C141160 Neoplastic Process Lugano Classification Stage I Adult Non-Hodgkin Lymphoma AJCC v8 CL539271 Malignant Lugano Classification Stage I Adult Non-Hodgkin Lymphoma AJCC v8 Lugano Classification Stage I Adult Non-Hodgkin Lymphoma AJCC v8 Stage IE: Single extralymphatic site in the absence of nodal involvement. (from AJCC 8th Ed.) C141161 Neoplastic Process Lugano Classification Stage IE Adult Non-Hodgkin Lymphoma AJCC v8 CL539270 Malignant Lugano Classification Stage IE Adult Non-Hodgkin Lymphoma AJCC v8 Lugano Classification Stage IE Adult Non-Hodgkin Lymphoma AJCC v8 Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm. (from AJCC 8th Ed.) C141162 Neoplastic Process Lugano Classification Stage II Adult Non-Hodgkin Lymphoma AJCC v8 CL539269 Malignant Lugano Classification Stage II Adult Non-Hodgkin Lymphoma AJCC v8 Lugano Classification Stage II Adult Non-Hodgkin Lymphoma AJCC v8 Stage IIE: Contiguous extralymphatic extension from a nodal site with or without involvement of other lymph node regions on the same side of the diaphragm. (from AJCC 8th Ed.) C141163 Neoplastic Process Lugano Classification Stage IIE Adult Non-Hodgkin Lymphoma AJCC v8 CL539268 Malignant Lugano Classification Stage IIE Adult Non-Hodgkin Lymphoma AJCC v8 Lugano Classification Stage IIE Adult Non-Hodgkin Lymphoma AJCC v8 Stage II Bulky: Stage II with disease bulk. (from AJCC 8th Ed.) C141164 Neoplastic Process Lugano Classification Stage II Bulky Adult Non-Hodgkin Lymphoma AJCC v8 CL539267 Malignant Lugano Classification Stage II Bulky Adult Non-Hodgkin Lymphoma AJCC v8 Lugano Classification Stage II Bulky Adult Non-Hodgkin Lymphoma AJCC v8 Advanced stage adult non-Hodgkin lymphoma based on the Lugano classification criteria. It includes stages III and IV. (from AJCC 8th Ed.) C141165 Neoplastic Process Lugano Classification Advanced Stage Adult Non-Hodgkin Lymphoma AJCC v8 CL539266 Malignant Lugano Classification Advanced Stage Adult Non-Hodgkin Lymphoma AJCC v8 Lugano Classification Advanced Stage Adult Non-Hodgkin Lymphoma AJCC v8 Stage III: Involvement of lymph node regions on both sides of the diaphragm; nodes above the diaphragm with spleen involvement. (from AJCC 8th Ed.) C141166 Neoplastic Process Lugano Classification Stage III Adult Non-Hodgkin Lymphoma AJCC v8 CL539281 Malignant Lugano Classification Stage III Adult Non-Hodgkin Lymphoma AJCC v8 Lugano Classification Stage III Adult Non-Hodgkin Lymphoma AJCC v8 Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or noncontiguous extralymphatic organ involvement in conjunction with nodal stage II disease; or any extralymphatic organ involvement in nodal stage III disease. Stage IV includes any involvement of the CSF, bone marrow, liver, or lungs (other than by direct extension in stage IIE disease). (from AJCC 8th Ed.) C141167 Neoplastic Process Lugano Classification Stage IV Adult Non-Hodgkin Lymphoma AJCC v8 CL539280 Malignant Lugano Classification Stage IV Adult Non-Hodgkin Lymphoma AJCC v8 Lugano Classification Stage IV Adult Non-Hodgkin Lymphoma AJCC v8 A staging system for Hodgkin lymphomas based on the Lugano classification criteria. Staging for childhood Hodgkin lymphoma is the same as for the adult counterpart. (from AJCC 8th Ed.) C141168 Neoplastic Process Lugano Classification Hodgkin Lymphoma by AJCC v8 Stage CL539279 Malignant Lugano Classification Hodgkin Lymphoma by AJCC v8 Stage Lugano Classification Hodgkin Lymphoma by AJCC v8 Stage Limited stage Hodgkin lymphoma based on the Lugano classification criteria. It includes stages I, IE, II, and IIE. (from AJCC 8th Ed.) C141169 Neoplastic Process Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 CL539278 CTRP Malignant Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Stage I: Involvement of a single lymphatic site (i.e., nodal region, Waldeyer's ring, thymus, or spleen). (from AJCC 8th Ed.) C141170 Neoplastic Process Lugano Classification Stage I Hodgkin Lymphoma AJCC v8 CL539277 Malignant Lugano Classification Stage I Hodgkin Lymphoma AJCC v8 Lugano Classification Stage I Hodgkin Lymphoma AJCC v8 Stage IE: Single extralymphatic site in the absence of nodal involvement (rare in Hodgkin lymphoma). (from AJCC 8th Ed.) C141171 Neoplastic Process Lugano Classification Stage IE Hodgkin Lymphoma AJCC v8 CL539276 Malignant Lugano Classification Stage IE Hodgkin Lymphoma AJCC v8 Lugano Classification Stage IE Hodgkin Lymphoma AJCC v8 Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm. (from AJCC 8th Ed.) C141172 Neoplastic Process Lugano Classification Stage II Hodgkin Lymphoma AJCC v8 CL539275 Malignant Lugano Classification Stage II Hodgkin Lymphoma AJCC v8 Lugano Classification Stage II Hodgkin Lymphoma AJCC v8 Stage IIE: Contiguous extralymphatic extension from a nodal site with or without involvement of other lymph node regions on the same side of the diaphragm. (from AJCC 8th Ed.) C141173 Neoplastic Process Lugano Classification Stage IIE Hodgkin Lymphoma AJCC v8 CL539274 Malignant Lugano Classification Stage IIE Hodgkin Lymphoma AJCC v8 Lugano Classification Stage IIE Hodgkin Lymphoma AJCC v8 Stage II Bulky: Stage II with disease bulk. (from AJCC 8th Ed.) C141174 Neoplastic Process Lugano Classification Stage II Bulky Hodgkin Lymphoma AJCC v8 CL539257 Malignant Lugano Classification Stage II Bulky Hodgkin Lymphoma AJCC v8 Lugano Classification Stage II Bulky Hodgkin Lymphoma AJCC v8 Advanced stage Hodgkin lymphoma based on the Lugano classification criteria. It includes stages III and IV. (from AJCC 8th Ed.) C141175 Neoplastic Process Lugano Classification Advanced Stage Hodgkin Lymphoma AJCC v8 CL539256 Malignant Lugano Classification Advanced Stage Hodgkin Lymphoma AJCC v8 Lugano Classification Advanced Stage Hodgkin Lymphoma AJCC v8 Stage III: Involvement of lymph node regions on both sides of the diaphragm; nodes above the diaphragm with spleen involvement. (from AJCC 8th Ed.) C141176 Neoplastic Process Lugano Classification Stage III Hodgkin Lymphoma AJCC v8 CL539255 Malignant Lugano Classification Stage III Hodgkin Lymphoma AJCC v8 Lugano Classification Stage III Hodgkin Lymphoma AJCC v8 Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or noncontiguous extralymphatic organ involvement in conjunction with nodal stage II disease; or any extralymphatic organ involvement in nodal stage III disease. Stage IV includes any involvement of the CSF, bone marrow, liver, or lungs (other than by direct extension in stage IIE disease). (from AJCC 8th Ed.) C141177 Neoplastic Process Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8 CL539254 Malignant Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8 Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8 A staging system for childhood Hodgkin lymphomas based on the Lugano classification criteria. Staging for childhood Hodgkin lymphoma is the same as for the adult counterpart. (from AJCC 8th Ed.) C141178 Neoplastic Process Lugano Classification Childhood Hodgkin Lymphoma by AJCC v8 Stage CL539253 Malignant Lugano Classification Childhood Hodgkin Lymphoma by AJCC v8 Stage Lugano Classification Childhood Hodgkin Lymphoma by AJCC v8 Stage Limited stage childhood Hodgkin lymphoma based on the Lugano classification criteria. It includes stages I, IE, II, and IIE. (from AJCC 8th Ed.) C141179 Neoplastic Process Lugano Classification Limited Stage Childhood Hodgkin Lymphoma AJCC v8 CL539252 Malignant Lugano Classification Limited Stage Childhood Hodgkin Lymphoma AJCC v8 Lugano Classification Limited Stage Childhood Hodgkin Lymphoma AJCC v8 Stage I: Involvement of a single lymphatic site (i.e., nodal region, Waldeyer's ring, thymus, or spleen). (from AJCC 8th Ed.) C141180 Neoplastic Process Lugano Classification Stage I Childhood Hodgkin Lymphoma AJCC v8 CL539251 Malignant Lugano Classification Stage I Childhood Hodgkin Lymphoma AJCC v8 Lugano Classification Stage I Childhood Hodgkin Lymphoma AJCC v8 Stage IE: Single extralymphatic site in the absence of nodal involvement (rare in Hodgkin lymphoma). (from AJCC 8th Ed.) C141181 Neoplastic Process Lugano Classification Stage IE Childhood Hodgkin Lymphoma AJCC v8 CL539250 Malignant Lugano Classification Stage IE Childhood Hodgkin Lymphoma AJCC v8 Lugano Classification Stage IE Childhood Hodgkin Lymphoma AJCC v8 Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm. (from AJCC 8th Ed.) C141182 Neoplastic Process Lugano Classification Stage II Childhood Hodgkin Lymphoma AJCC v8 CL539265 Malignant Lugano Classification Stage II Childhood Hodgkin Lymphoma AJCC v8 Lugano Classification Stage II Childhood Hodgkin Lymphoma AJCC v8 Stage IIE: Contiguous extralymphatic extension from a nodal site with or without involvement of other lymph node regions on the same side of the diaphragm. (from AJCC 8th Ed.) C141183 Neoplastic Process Lugano Classification Stage IIE Childhood Hodgkin Lymphoma AJCC v8 CL539264 Malignant Lugano Classification Stage IIE Childhood Hodgkin Lymphoma AJCC v8 Lugano Classification Stage IIE Childhood Hodgkin Lymphoma AJCC v8 Stage II Bulky: Stage II with disease bulk. (from AJCC 8th Ed.) C141184 Neoplastic Process Lugano Classification Stage II Bulky Childhood Hodgkin Lymphoma AJCC v8 CL539263 Malignant Lugano Classification Stage II Bulky Childhood Hodgkin Lymphoma AJCC v8 Lugano Classification Stage II Bulky Childhood Hodgkin Lymphoma AJCC v8 Advanced stage childhood Hodgkin lymphoma based on the Lugano classification criteria. It includes stages III and IV. (from AJCC 8th Ed.) C141185 Neoplastic Process Lugano Classification Advanced Stage Childhood Hodgkin Lymphoma AJCC v8 CL539262 Malignant Lugano Classification Advanced Stage Childhood Hodgkin Lymphoma AJCC v8 Lugano Classification Advanced Stage Childhood Hodgkin Lymphoma AJCC v8 Stage III: Involvement of lymph node regions on both sides of the diaphragm; nodes above the diaphragm with spleen involvement. (from AJCC 8th Ed.) C141186 Neoplastic Process Lugano Classification Stage III Childhood Hodgkin Lymphoma AJCC v8 CL539261 Malignant Lugano Classification Stage III Childhood Hodgkin Lymphoma AJCC v8 Lugano Classification Stage III Childhood Hodgkin Lymphoma AJCC v8 Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or noncontiguous extralymphatic organ involvement in conjunction with nodal stage II disease; or any extralymphatic organ involvement in nodal stage III disease. Stage IV includes any involvement of the bone marrow, liver, or lungs (other than by direct extension in stage IIE disease). (from AJCC 8th Ed.) C141187 Neoplastic Process Lugano Classification Stage IV Childhood Hodgkin Lymphoma AJCC v8 CL539260 Malignant Lugano Classification Stage IV Childhood Hodgkin Lymphoma AJCC v8 Lugano Classification Stage IV Childhood Hodgkin Lymphoma AJCC v8 A staging system for adult Hodgkin lymphomas based on the Lugano classification criteria. Staging for adult Hodgkin lymphoma is the same as for the childhood counterpart. (from AJCC 8th Ed.) C141189 Neoplastic Process Lugano Classification Adult Hodgkin Lymphoma by AJCC v8 Stage CL539258 Malignant Lugano Classification Adult Hodgkin Lymphoma by AJCC v8 Stage Lugano Classification Adult Hodgkin Lymphoma by AJCC v8 Stage Limited stage adult Hodgkin lymphoma based on the Lugano classification criteria. It includes stages I, IE, II, and IIE. (from AJCC 8th Ed.) C141190 Neoplastic Process Lugano Classification Limited Stage Adult Hodgkin Lymphoma AJCC v8 Lugano Classification Limited Stage Adult Hodgkin Lymphoma AJCC v8 CL539244 CTRP Malignant Lugano Classification Limited Stage Adult Hodgkin Lymphoma AJCC v8 Lugano Classification Limited Stage Adult Hodgkin Lymphoma AJCC v8 Stage I: Involvement of a single lymphatic site (i.e., nodal region, Waldeyer's ring, thymus, or spleen). (from AJCC 8th Ed.) C141191 Neoplastic Process Lugano Classification Stage I Adult Hodgkin Lymphoma AJCC v8 CL539243 Malignant Lugano Classification Stage I Adult Hodgkin Lymphoma AJCC v8 Lugano Classification Stage I Adult Hodgkin Lymphoma AJCC v8 Stage IE: Single extralymphatic site in the absence of nodal involvement (rare in Hodgkin lymphoma). (from AJCC 8th Ed.) C141192 Neoplastic Process Lugano Classification Stage IE Adult Hodgkin Lymphoma AJCC v8 CL539242 Malignant Lugano Classification Stage IE Adult Hodgkin Lymphoma AJCC v8 Lugano Classification Stage IE Adult Hodgkin Lymphoma AJCC v8 Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm. (from AJCC 8th Ed.) C141193 Neoplastic Process Lugano Classification Stage II Adult Hodgkin Lymphoma AJCC v8 CL539241 Malignant Lugano Classification Stage II Adult Hodgkin Lymphoma AJCC v8 Lugano Classification Stage II Adult Hodgkin Lymphoma AJCC v8 Stage IIE: Contiguous extralymphatic extension from a nodal site with or without involvement of other lymph node regions on the same side of the diaphragm. (from AJCC 8th Ed.) C141194 Neoplastic Process Lugano Classification Stage IIE Adult Hodgkin Lymphoma AJCC v8 CL539240 Malignant Lugano Classification Stage IIE Adult Hodgkin Lymphoma AJCC v8 Lugano Classification Stage IIE Adult Hodgkin Lymphoma AJCC v8 Stage II Bulky: Stage II with disease bulk. (from AJCC 8th Ed.) C141195 Neoplastic Process Lugano Classification Stage II Bulky Adult Hodgkin Lymphoma AJCC v8 CL539239 Malignant Lugano Classification Stage II Bulky Adult Hodgkin Lymphoma AJCC v8 Lugano Classification Stage II Bulky Adult Hodgkin Lymphoma AJCC v8 Advanced stage adult Hodgkin lymphoma based on the Lugano classification criteria. It includes stages III and IV. (from AJCC 8th Ed.) C141196 Neoplastic Process Lugano Classification Advanced Stage Adult Hodgkin Lymphoma AJCC v8 CL539238 Malignant Lugano Classification Advanced Stage Adult Hodgkin Lymphoma AJCC v8 Lugano Classification Advanced Stage Adult Hodgkin Lymphoma AJCC v8 Stage III: Involvement of lymph node regions on both sides of the diaphragm; nodes above the diaphragm with spleen involvement. (from AJCC 8th Ed.) C141197 Neoplastic Process Lugano Classification Stage III Adult Hodgkin Lymphoma AJCC v8 CL539237 Malignant Lugano Classification Stage III Adult Hodgkin Lymphoma AJCC v8 Lugano Classification Stage III Adult Hodgkin Lymphoma AJCC v8 Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or noncontiguous extralymphatic organ involvement in conjunction with nodal stage II disease; or any extralymphatic organ involvement in nodal stage III disease. Stage IV includes any involvement of the CSF, bone marrow, liver, or lungs (other than by direct extension in stage IIE disease). (from AJCC 8th Ed.) C141198 Neoplastic Process Lugano Classification Stage IV Adult Hodgkin Lymphoma AJCC v8 CL539249 Malignant Lugano Classification Stage IV Adult Hodgkin Lymphoma AJCC v8 Lugano Classification Stage IV Adult Hodgkin Lymphoma AJCC v8 Staging systems for Hodgkin and non-Hodgkin lymphomas of childhood. Different systems are used for Hodgkin lymphoma and non-Hodgkin lymphoma of childhood. Staging of childhood Hodgkin lymphoma is the same as for the adult counterpart and is based on the Lugano classification criteria. The Ann Arbor staging system has been found to be inappropriate for staging of the non-Hodgkin lymphomas of childhood. The St. Jude staging system has been widely accepted and remains the recommended staging system for non-Hodgkin lymphomas of childhood. (from AJCC 8th Ed.) C141202 Neoplastic Process Childhood Lymphoma by AJCC v8 Stage CL539248 Malignant Childhood Lymphoma by AJCC v8 Stage Childhood Lymphoma by AJCC v8 Stage A term that refers to the staging of Hodgkin lymphoma and non-Hodgkin lymphoma according to the AJCC v8 classification guidelines. C141205 Neoplastic Process Lymphoma by AJCC v8 Stage CL539245 Malignant Lymphoma by AJCC v8 Stage Lymphoma by AJCC v8 Stage A term that refers to the staging of chronic lymphocytic leukemia according to modified Rai staging system. This system is mainly used in North America. C141206 Neoplastic Process Chronic Lymphocytic Leukemia- Modified Rai Staging System CL539350 Malignant Chronic Lymphocytic Leukemia- Modified Rai Staging System Chronic Lymphocytic Leukemia- Modified Rai Staging System A term that refers to the staging of chronic lymphocytic leukemia according to Binet staging system. This system is in wide use outside the United States. C141208 Neoplastic Process Chronic Lymphocytic Leukemia- Binet Staging System CL539348 Malignant Chronic Lymphocytic Leukemia- Binet Staging System Chronic Lymphocytic Leukemia- Binet Staging System Findings: Lymphocytosis only; Survival (months): more than 120. (from AJCC 8th Ed.) C141209 Neoplastic Process Stage A Chronic Lymphocytic Leukemia CL539347 Malignant Stage A Chronic Lymphocytic Leukemia Stage A Chronic Lymphocytic Leukemia Findings: Lymphocytosis and adenopathy; Survival (months): 95. (from AJCC 8th Ed.) C141210 Neoplastic Process Stage B Chronic Lymphocytic Leukemia CL539346 Malignant Stage B Chronic Lymphocytic Leukemia Stage B Chronic Lymphocytic Leukemia Findings: Lymphocytosis, adenopathy, and enlarged spleen and/or liver; Survival (months): 72. (from AJCC 8th Ed.) C141211 Neoplastic Process Stage C Chronic Lymphocytic Leukemia CL539345 Malignant Stage C Chronic Lymphocytic Leukemia Stage C Chronic Lymphocytic Leukemia A staging system for childhood non-Hodgkin Lymphomas based on the St. Jude Children's Research Hospital staging system. The Ann Arbor staging system has been found to be inappropriate for staging of the non-Hodgkin lymphomas of childhood. The St. Jude staging system has been widely accepted for more than three decades and remains the recommended staging system for childhood non-Hodgkin lymphomas. (from AJCC 8th Ed.) C141217 Neoplastic Process St. Jude Childhood Non-Hodgkin Lymphoma by AJCC v8 Stage CL539355 Malignant St. Jude Childhood Non-Hodgkin Lymphoma by AJCC v8 Stage St. Jude Childhood Non-Hodgkin Lymphoma by AJCC v8 Stage Stage I: A single tumor (extranodal) or single anatomic area (nodal), with the exclusion of the mediastinum or abdomen. (from AJCC 8th Ed.) C141218 Neoplastic Process St. Jude Stage I Childhood Non-Hodgkin Lymphoma AJCC v8 St. Jude Stage I Childhood Non-Hodgkin Lymphoma AJCC v8 CL539354 CTRP Malignant St. Jude Stage I Childhood Non-Hodgkin Lymphoma AJCC v8 St. Jude Stage I Childhood Non-Hodgkin Lymphoma AJCC v8 Stage II: A single tumor (extranodal) with regional node involvement. Two or more nodal areas on the same side of the diaphragm. Two single (extranodal) tumors with or without regional node involvement on the same side of the diaphragm. A primary gastrointestinal tract tumor, usually in the ileocecal area, with or without involvement of associated mesenteric nodes only. (from AJCC 8th Ed.) C141219 Neoplastic Process St. Jude Stage II Childhood Non-Hodgkin Lymphoma AJCC v8 St. Jude Stage II Childhood Non-Hodgkin Lymphoma AJCC v8 CL539353 CTRP Malignant St. Jude Stage II Childhood Non-Hodgkin Lymphoma AJCC v8 St. Jude Stage II Childhood Non-Hodgkin Lymphoma AJCC v8 Stage III: Two single tumors (extranodal) on opposite sides of the diaphragm. Two or more nodal areas above and below the diaphragm. All the primary intrathoracic tumors (mediastinal, pleural, and thymic). All extensive primary intra-abdominal disease. All paraspinal or epidural tumors, regardless of other tumor site(s). (from AJCC 8th Ed.) C141220 Neoplastic Process St. Jude Stage III Childhood Non-Hodgkin Lymphoma AJCC v8 CL539352 Malignant St. Jude Stage III Childhood Non-Hodgkin Lymphoma AJCC v8 St. Jude Stage III Childhood Non-Hodgkin Lymphoma AJCC v8 Stage IV: Any tumor, with initial CNS and/or bone marrow involvement. (from AJCC 8th Ed.) C141221 Neoplastic Process St. Jude Stage IV Childhood Non-Hodgkin Lymphoma AJCC v8 CL539351 Malignant St. Jude Stage IV Childhood Non-Hodgkin Lymphoma AJCC v8 St. Jude Stage IV Childhood Non-Hodgkin Lymphoma AJCC v8 An anatomic stage for lymphocyte-depleted classic Hodgkin lymphoma based on the Ann Arbor classification criteria. C141222 Neoplastic Process Lymphocyte-Depleted Classic Hodgkin Lymphoma by Ann Arbor Stage CL539334 Malignant Lymphocyte-Depleted Classic Hodgkin Lymphoma by Ann Arbor Stage Lymphocyte-Depleted Classical Hodgkin Lymphoma by Ann Arbor Stage Lymphocyte-Depleted Classic Hodgkin Lymphoma by Ann Arbor Stage An anatomic stage for nodular sclerosis classic Hodgkin lymphoma based on the Ann Arbor classification criteria. C141223 Neoplastic Process Nodular Sclerosis Classic Hodgkin Lymphoma by Ann Arbor Stage CL539333 Malignant Nodular Sclerosis Classic Hodgkin Lymphoma by Ann Arbor Stage Nodular Sclerosis Classical Hodgkin Lymphoma by Ann Arbor Stage Nodular Sclerosis Classic Hodgkin Lymphoma by Ann Arbor Stage An anatomic stage for mixed cellularity classic Hodgkin lymphoma based on the Ann Arbor classification criteria. C141224 Neoplastic Process Mixed Cellularity Classic Hodgkin Lymphoma by Ann Arbor Stage CL539332 Malignant Mixed Cellularity Classic Hodgkin Lymphoma by Ann Arbor Stage Mixed Cellularity Classical Hodgkin Lymphoma by Ann Arbor Stage Mixed Cellularity Classic Hodgkin Lymphoma by Ann Arbor Stage An anatomic stage for nodular lymphocyte predominant B-cell lymphoma based on the Ann Arbor classification criteria. C141225 Neoplastic Process Nodular Lymphocyte Predominant B-Cell Lymphoma by Ann Arbor Stage CL539331 Malignant Nodular Lymphocyte Predominant B-Cell Lymphoma by Ann Arbor Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma by Ann Arbor Stage Nodular Lymphocyte Predominant B-Cell Lymphoma by Ann Arbor Stage An anatomic stage for adult Hodgkin lymphoma based on the Ann Arbor classification criteria. C141226 Neoplastic Process Adult Hodgkin Lymphoma by Ann Arbor Stage CL539330 Malignant Adult Hodgkin Lymphoma by Ann Arbor Stage Adult Hodgkin Lymphoma by Ann Arbor Stage An anatomic stage for childhood Hodgkin lymphoma based on the Ann Arbor classification criteria. C141227 Neoplastic Process Childhood Hodgkin Lymphoma by Ann Arbor Stage CL539329 Malignant Childhood Hodgkin Lymphoma by Ann Arbor Stage Childhood Hodgkin Lymphoma by Ann Arbor Stage An anatomic stage for adult non-Hodgkin lymphoma based on the Ann Arbor classification criteria. C141235 Neoplastic Process Adult Non-Hodgkin Lymphoma by Ann Arbor Stage CL539337 Malignant Adult Non-Hodgkin Lymphoma by Ann Arbor Stage Adult Non-Hodgkin Lymphoma by Ann Arbor Stage An anatomic stage for childhood non-Hodgkin lymphoma based on the Ann Arbor classification criteria. C141236 Neoplastic Process Childhood Non-Hodgkin Lymphoma by Ann Arbor Stage CL539336 Malignant Childhood Non-Hodgkin Lymphoma by Ann Arbor Stage Childhood Non-Hodgkin Lymphoma by Ann Arbor Stage An anatomic stage for B-cell non-Hodgkin lymphoma based on the Ann Arbor classification criteria. C141243 Neoplastic Process B-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage CL539314 Malignant B-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage B-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage An anatomic stage for T-cell non-Hodgkin lymphoma based on the Ann Arbor classification criteria. C141247 Neoplastic Process T-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage CL539325 Malignant T-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage T-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage An anatomic stage for B-lymphoblastic lymphoma based on the Ann Arbor classification criteria. C141250 Neoplastic Process B Lymphoblastic Lymphoma by Ann Arbor Stage CL539322 Malignant B Lymphoblastic Lymphoma by Ann Arbor Stage B-Lymphoblastic Lymphoma by Ann Arbor Stage B Lymphoblastic Lymphoma by Ann Arbor Stage An anatomic stage for Burkitt lymphoma based on the Ann Arbor classification criteria. C141253 Neoplastic Process Burkitt Lymphoma by Ann Arbor Stage CL539319 Malignant Burkitt Lymphoma by Ann Arbor Stage Burkitt Lymphoma by Ann Arbor Stage An anatomic stage for diffuse large B-cell lymphoma based on the Ann Arbor classification criteria. C141254 Neoplastic Process Diffuse Large B-Cell Lymphoma by Ann Arbor Stage CL539305 Malignant Diffuse Large B-Cell Lymphoma by Ann Arbor Stage Diffuse Large B-Cell Lymphoma by Ann Arbor Stage An anatomic stage for follicular lymphoma based on the Ann Arbor classification criteria. C141255 Neoplastic Process Follicular Lymphoma by Ann Arbor Stage CL539304 Malignant Follicular Lymphoma by Ann Arbor Stage Follicular Lymphoma by Ann Arbor Stage An anatomic stage for lymphoplasmacytic lymphoma based on the Ann Arbor classification criteria. C141256 Neoplastic Process Lymphoplasmacytic Lymphoma by Ann Arbor Stage CL539303 Malignant Lymphoplasmacytic Lymphoma by Ann Arbor Stage Lymphoplasmacytic Lymphoma by Ann Arbor Stage An anatomic stage for mantle cell lymphoma based on the Ann Arbor classification criteria. C141257 Neoplastic Process Mantle Cell Lymphoma by Ann Arbor Stage CL539302 Malignant Mantle Cell Lymphoma by Ann Arbor Stage Mantle Cell Lymphoma by Ann Arbor Stage An anatomic stage for marginal zone lymphoma based on the Ann Arbor classification criteria. C141258 Neoplastic Process Marginal Zone Lymphoma by Ann Arbor Stage CL539301 Malignant Marginal Zone Lymphoma by Ann Arbor Stage Marginal Zone Lymphoma by Ann Arbor Stage An anatomic stage for small lymphocytic lymphoma based on the Ann Arbor classification criteria. C141259 Neoplastic Process Small Lymphocytic Lymphoma by Ann Arbor Stage CL539300 Malignant Small Lymphocytic Lymphoma by Ann Arbor Stage Small Lymphocytic Lymphoma by Ann Arbor Stage An anatomic stage for extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue based on the Ann Arbor classification criteria. C141260 Neoplastic Process Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue by Ann Arbor Stage CL539299 Malignant Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue by Ann Arbor Stage Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue by Ann Arbor Stage An anatomic stage for nodal marginal zone lymphoma based on the Ann Arbor classification criteria. C141261 Neoplastic Process Nodal Marginal Zone Lymphoma by Ann Arbor Stage CL539298 Malignant Nodal Marginal Zone Lymphoma by Ann Arbor Stage Nodal Marginal Zone Lymphoma by Ann Arbor Stage An anatomic stage for primary mediastinal large B-cell lymphoma based on the Ann Arbor classification criteria. C141262 Neoplastic Process Primary Mediastinal Large B-Cell Lymphoma by Ann Arbor Stage CL550756 Malignant Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage Primary Mediastinal Large B-Cell Lymphoma by Ann Arbor Stage Primary Mediastinal Large B-Cell Lymphoma by Ann Arbor Stage An anatomic stage for centroblastic lymphoma based on the Ann Arbor classification criteria. C141263 Neoplastic Process Centroblastic Lymphoma by Ann Arbor Stage CL539312 Malignant Centroblastic Lymphoma by Ann Arbor Stage Centroblastic Lymphoma by Ann Arbor Stage An anatomic stage for mature T- and NK-cell non-Hodgkin lymphomas based on the Ann Arbor classification criteria. C141272 Neoplastic Process Mature T- and NK-Cell Lymphoma by Ann Arbor Stage CL539406 Malignant Mature T- and NK-Cell Lymphoma by Ann Arbor Stage Mature T- and NK-Cell Lymphoma by Ann Arbor Stage An anatomic stage for adult T-cell leukemia/lymphoma based on the Ann Arbor classification criteria. C141283 Neoplastic Process Adult T-Cell Leukemia/Lymphoma by Ann Arbor Stage CL539410 Malignant Adult T-Cell Leukemia/Lymphoma by Ann Arbor Stage Adult T-Cell Leukemia/Lymphoma by Ann Arbor Stage An anatomic stage for noncutaneous anaplastic large cell lymphoma based on the Ann Arbor classification criteria. C141284 Neoplastic Process Noncutaneous Anaplastic Large Cell Lymphoma by Ann Arbor Stage CL539409 Malignant Noncutaneous Anaplastic Large Cell Lymphoma by Ann Arbor Stage Noncutaneous Anaplastic Large Cell Lymphoma by Ann Arbor Stage An anatomic stage for noncutaneous childhood anaplastic large cell lymphoma based on the Ann Arbor classification criteria. C141292 Neoplastic Process Noncutaneous Childhood Anaplastic Large Cell Lymphoma by Ann Arbor Stage CL539391 Malignant Noncutaneous Childhood Anaplastic Large Cell Lymphoma by Ann Arbor Stage Noncutaneous Childhood Anaplastic Large Cell Lymphoma by Ann Arbor Stage An anatomic stage for follicular helper T-cell lymphoma, angioimmunoblastic-type based on the Ann Arbor classification criteria. C141294 Neoplastic Process Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type by Ann Arbor Stage CL539390 Malignant Angioimmunoblastic T-Cell Lymphoma by Ann Arbor Stage Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type by Ann Arbor Stage Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type by Ann Arbor Stage An anatomic stage for enteropathy-associated T-cell lymphoma based on the Ann Arbor classification criteria. C141295 Neoplastic Process Enteropathy-Associated T-Cell Lymphoma by Ann Arbor Stage CL539400 Malignant Enteropathy-Associated T-Cell Lymphoma by Ann Arbor Stage Enteropathy-Associated T-Cell Lymphoma by Ann Arbor Stage An anatomic stage for nasal type NK/T-cell lymphoma based on the Ann Arbor classification criteria. C141296 Neoplastic Process Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage CL539399 Malignant Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage A term that refers to the staging of mycosis fungoides and Sezary syndrome, following the rules of the TNM AJCC v8 classification system. This prognostic stage groups system is based on the ISCL/EORTC revision to the staging of mycosis fungoides and Sezary syndrome. There is no prognostic stage groups system for primary cutaneous B-cell/T-cell (non-mycosis fungoides/Sezary syndrome) lymphomas at this time. This staging system does not apply to eyelid skin lymphomas (are staged according to the classification for ocular adnexal lymphoma). (from AJCC 8th Ed.) C141346 Neoplastic Process Mycosis Fungoides and Sezary Syndrome by AJCC v8 Stage CL539474 Malignant Mycosis Fungoides and Sezary Syndrome by AJCC v8 Stage Mycosis Fungoides and Sezary Syndrome by AJCC v8 Stage Stage I includes: IA (T1, N0, M0, B0,1); IB (T2, N0, M0, B0,1). T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. T2: Patches, papules, or plaques covering 10% or more of the skin surface. N0: No clinically abnormal peripheral lymph nodes; biopsy not required. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 8th ed.) C141347 Neoplastic Process Stage I Mycosis Fungoides and Sezary Syndrome AJCC v8 CL539473 Malignant Stage I Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage I Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IA includes: T1, N0, M0, B0,1. T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. N0: No clinically abnormal peripheral lymph nodes; biopsy not required. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 8th ed.) C141348 Neoplastic Process Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v8 CL539472 Malignant Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IB includes: T2, N0, M0, B0,1. T2: Patches, papules, or plaques covering 10% or more of the skin surface. N0: No clinically abnormal peripheral lymph nodes; biopsy not required. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 8th ed.) C141349 Neoplastic Process Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8 CL539471 Malignant Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage II includes: IIA (T1,2, N1,2, M0, B0,1); IIB (T3, N0-2, M0, B0,1). T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. T2: Patches, papules, or plaques covering 10% or more of the skin surface. T3: One or more tumors (equal or greater than 1 cm in diameter). N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or National Cancer Institute (NCI) LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 8th ed.) C141350 Neoplastic Process Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8 CL539470 Malignant Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IIA includes: T1-2, N1,2, M0, B0,1. T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. T2: Patches, papules, or plaques covering 10% or more of the skin surface. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or National Cancer Institute (NCI) LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 8th ed.) C141351 Neoplastic Process Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8 CL539453 Malignant Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IIB includes: T3, N0-2, M0, B0,1. T3: One or more tumors (equal or greater than 1 cm in diameter). N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or National Cancer Institute (NCI) LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 8th ed.) C141352 Neoplastic Process Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8 CL539452 Malignant Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage III includes: (T4, N0-2, M0, B0,1); IIIA (T4, N0-2, M0, B0); IIIB (T4, N0-2, M0, B1). T4: Confluence of erythema covering 80% or more of body surface area. N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or National Cancer Institute (NCI) LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 8th ed.) C141353 Neoplastic Process Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8 CL539451 Malignant Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IIIA includes: T4, N0-2, M0, B0. T4: Confluence of erythema covering 80% or more of body surface area. N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or National Cancer Institute (NCI) LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). (AJCC 8th ed.) C141354 Neoplastic Process Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v8 CL539450 Malignant Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IIIB includes: T4, N0-2, M0, B1. T4: Confluence of erythema covering 80% or more of body surface area. N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or National Cancer Institute (NCI) LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. M0: No visceral organ involvement. B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 8th ed.) C141355 Neoplastic Process Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v8 CL539449 Malignant Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IV includes: IVA1 (T1-4, N0-2, M0, B2); IVA2 (T1-4, N3, M0, B0-2); IVB (T1-4, N0-3, M1, B0-2). T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. T2: Patches, papules, or plaques covering 10% or more of the skin surface. T3: One or more tumors (equal or greater than 1 cm in diameter). T4: Confluence of erythema covering 80% or more of body surface area. N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or National Cancer Institute (NCI) LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. N3: Clinically abnormal peripheral lymph nodes; histopathology Dutch grades 3-4 or NCI LN4; clone positive or negative. M0: No visceral organ involvement. M1: Visceral involvement (must have pathology confirmation and organ involved should be specified). B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. B2: High blood tumor burden: 1,000 per microliter or more Sezary cells with positive clone. (AJCC 8th ed.) C141356 Neoplastic Process Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8 CL539448 Malignant Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IVA1 includes: T1-4, N0-2, M0, B2. T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. T2: Patches, papules, or plaques covering 10% or more of the skin surface. T3: One or more tumors (equal or greater than 1 cm in diameter). T4: Confluence of erythema covering 80% or more of body surface area. N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or National Cancer Institute (NCI) LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. M0: No visceral organ involvement. B2: High blood tumor burden: 1,000 per microliter or more Sezary cells with positive clone. (AJCC 8th ed.) C141357 Neoplastic Process Stage IVA1 Mycosis Fungoides and Sezary Syndrome AJCC v8 CL539447 Malignant Stage IVA1 Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IVA1 Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IVA2 includes: T1-4, N3, M0, B0-2. T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. T2: Patches, papules, or plaques covering 10% or more of the skin surface. T3: One or more tumors (equal or greater than 1 cm in diameter). T4: Confluence of erythema covering 80% or more of body surface area. N3: Clinically abnormal peripheral lymph nodes; histopathology Dutch grades 3-4 or NCI LN4; clone positive or negative. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. B2: High blood tumor burden: 1,000 per microliter or more Sezary cells with positive clone. (AJCC 8th ed.) C141358 Neoplastic Process Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8 CL539446 Malignant Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IVB includes: T1-4, N0-3, M1, B0-2. T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. T2: Patches, papules, or plaques covering 10% or more of the skin surface. T3: One or more tumors (equal or greater than 1 cm in diameter). T4: Confluence of erythema covering 80% or more of body surface area. N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or National Cancer Institute (NCI) LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. N3: Clinically abnormal peripheral lymph nodes; histopathology Dutch grades 3-4 or NCI LN4; clone positive or negative. M1: Visceral involvement (must have pathology confirmation and organ involved should be specified). B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. B2: High blood tumor burden: 1,000 per microliter or more Sezary cells with positive clone. (AJCC 8th ed.) C141359 Neoplastic Process Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8 CL539461 Malignant Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8 A staging system for multiple myeloma based on the Revised International Staging System (RISS) criteria. This staging system does not apply to smoldering multiple myeloma (no AJCC staging system), monoclonal gammopathy of undetermined significance (no AJCC staging system), and Waldenstrom macroglobulinemia (no AJCC staging system). (from AJCC 8th Ed.) C141393 Neoplastic Process Multiple Myeloma by RISS Stage CL539430 Malignant Multiple Myeloma by RISS Stage Plasma Cell Myeloma by RISS Stage Plasma Cell Myeloma by Revised International Staging System Stage Multiple Myeloma by RISS Stage Serum beta-2-microglobulin less than 3.5 mg/L and serum albumin 3.5 g/dL or more and no high-risk cytogenetics and normal LDH. High risk cytogenetics consist of one or more of the following: del17p, t(4;14), or t(14;16). (from AJCC 8th Ed.) C141394 Neoplastic Process RISS Stage I Multiple Myeloma CL539429 Malignant RISS Stage I Multiple Myeloma RISS Stage I Plasma Cell Myeloma Revised International Staging System Stage I Plasma Cell Myeloma RISS Stage I Multiple Myeloma Not stage I or III. (from AJCC 8th Ed.) C141395 Neoplastic Process RISS Stage II Multiple Myeloma CL539428 Malignant RISS Stage II Multiple Myeloma RISS Stage II Plasma Cell Myeloma Revised International Staging System Stage II Plasma Cell Myeloma RISS Stage II Multiple Myeloma Serum beta-2-microglobulin 5.5 mg/L or more and high-risk cytogenetics and/or high LDH. High risk cytogenetics consist of one or more of the following: del17p, t(4;14), or t(14;16). (from AJCC 8th Ed.) C141396 Neoplastic Process RISS Stage III Multiple Myeloma CL539427 Malignant RISS Stage III Multiple Myeloma RISS Stage III Plasma Cell Myeloma Revised International Staging System Stage IIII Plasma Cell Myeloma RISS Stage III Multiple Myeloma The reemergence of acute biphenotypic leukemia after a period of remission. C141445 Neoplastic Process Recurrent Acute Biphenotypic Leukemia Recurrent Acute Biphenotypic Leukemia CL539502 CTRP Malignant Acute Biphenotypic Leukemia in Relapse Recurrent Acute Biphenotypic Leukemia Recurrent Acute Biphenotypic Leukemia The reemergence of acute undifferentiated leukemia after a period of remission. C141446 Neoplastic Process Recurrent Acute Undifferentiated Leukemia Recurrent Acute Undifferentiated Leukemia CL539501 CTRP Malignant Acute Undifferentiated Leukemia in Relapse Recurrent Acute Undifferentiated Leukemia Recurrent Acute Undifferentiated Leukemia A grouping of lymph nodes comprising neck lymph node boundary levels I-IV. C142146 Finding Neck Lymph Node Boundary Levels I-IV CL540188 Neck Lymph Node Boundary Levels I-IV Neck Lymph Node Levels I-IV Neck Lymph Node Boundary Levels I-IV A grouping of lymph nodes comprising neck lymph node boundary levels II-IV. C142147 Finding Neck Lymph Node Boundary Levels II-IV CL540187 Neck Lymph Node Boundary Levels II-IV Neck Lymph Node Levels II-IV Neck Lymph Node Boundary Levels II-IV Waldenstrom macroglobulinemia that does not respond to treatment. C142149 Neoplastic Process Refractory Waldenstrom Macroglobulinemia Refractory Waldenstrom Macroglobulinemia CL540185 CTRP Malignant Refractory Waldenstrom Macroglobulinemia Refractory Waldenstrom Macroglobulinemia Any lymph node located in the posterior of the neck, including the postauricular, superficial occipital, middle posterior cervical chain, and lower posterior cervical chain. C142301 Anatomical Structure Nuchal Lymph Node CL540273 CDISC Any lymph node located in the posterior of the neck, including the postauricular, superficial occipital, middle posterior cervical chain, and lower posterior cervical chain. NUCHAL LYMPH NODE Nuchal Lymph Node Nuchal Lymph Node Any lymph node located in the potential space of the neck, which is bounded superiorly by the base of the skull, inferiorly by the greater cornu of the hyoid bone, anteriorly by the investing fascia of the deep cervical fascia covering the medial pterygoid muscle, posteriorly by the prevertebral layer of the deep cervical fascia, medially by the middle (pretracheal) layer of the deep cervical fascia, and laterally by the investing fascia of the deep cervical fascia covering the deep lobe of the parotid. C142302 Anatomical Structure Parapharyngeal Lymph Node CL540272 CDISC Any lymph node located in the potential space of the neck, which is bounded superiorly by the base of the skull, inferiorly by the greater cornu of the hyoid bone, anteriorly by the investing fascia of the deep cervical fascia covering the medial pterygoid muscle, posteriorly by the prevertebral layer of the deep cervical fascia, medially by the middle (pretracheal) layer of the deep cervical fascia, and laterally by the investing fascia of the deep cervical fascia covering the deep lobe of the parotid. PARAPHARYNGEAL LYMPH NODE Parapharyngeal Lymph Node Parapharyngeal Lymph Node The lymph nodes located immediately posterior to the ear; also known as the mastoid lymph nodes or the posterior auricular lymph nodes. C142313 Anatomical Structure Retroauricular Lymph Node C0458296 CDISC The lymph nodes located immediately posterior to the ear. Mastoid Lymph Node Posterior Auricular Lymph Node RETROAURICULAR LYMPH NODE Retroauricular Lymph Node Retroauricular Lymph Node The integumentary covering located medial to the orbital ridges and superior to the nose. C142317 Anatomical Structure Skin Between the Eyebrows CL540363 CDISC The integument that covers the area located medial to the orbital ridges and superior to the nose. SKIN BETWEEN EYEBROWS Skin Between the Eyebrows Skin Between the Eyebrows The integumentary covering of the back. C142318 Anatomical Structure Skin Of The Back C0222155 CDISC The integument that covers the back. SKIN OF THE BACK Skin Of The Back Skin Of The Back The integumentary covering of the chin. C142319 Anatomical Structure Skin Of The Chin C0222106 CDISC The integument that covers the chin. SKIN OF THE CHIN Skin Of The Chin Skin Of The Chin Any lymph node located along the splenic artery that receives afferent drainage from the pancreas, spleen, and stomach, and which generally has their efferents join the celiac group of preaortic lymph nodes. C142320 Anatomical Structure Splenic Lymph Node CL540362 CDISC GDC UBERON Any lymph node located along the splenic artery that receives afferent drainage from the pancreas, spleen, and stomach, and which generally has their efferents join the celiac group of preaortic lymph nodes. The splenic lymph nodes (or pancreaticolienal) accompany the lienal (splenic) artery, and are situated in relation to the posterior surface and upper border of the pancreas; one or two members of this group are found in the gastrolienal ligament. Their afferents are derived from the stomach, spleen, and pancreas, their efferents join the celiac group of preaortic glands. Lymph Node(s) Splenic Splenic Splenic lymph nodes UBERON:0015469 Lymph Node(s) Splenic SPLENIC LYMPH NODE Splenic Lymph Node Splenic lymph nodes splenic lymph node Splenic Lymph Node The lymph nodes located between the anterior bellies of the digastric muscles. C142322 Anatomical Structure Submental Lymph Node C0229723 CDISC The lymph nodes located between the anterior bellies of the digastric muscles. (NCI) SUBMENTAL LYMPH NODE Submental Lymph Node Suprahyoid Lymph Node Suprahyoid Lymph Nodes Submental Lymph Node A form of PET/CT imaging in which radiopharmaceuticals is either ingested or injected intravenously in an attempt to enhance the collected images for diagnostic purposes. C142335 Diagnostic Procedure Contrast Enhanced PET-CT Scan CL540353 CDISC An imaging technique that utilizes positron emission tomography and computed tomography in a single machine, in which images are enhanced by the addition of contrast agents into the body. CONTRAST ENHANCED PET/CT SCAN Contrast Enhanced PET-CT Scan Contrast Enhanced PET-CT Scan A form of PET/CT imaging in which radiopharmaceuticals is not used. C142342 Diagnostic Procedure PET-CT Scan Without Contrast CL540360 CDISC An imaging technique that utilizes positron emission tomography and computed tomography in a single machine, in which the images are not enhanced by the addition of contrast agents into the body. PET-CT Scan Without Contrast PET/CT SCAN WITHOUT CONTRAST PET-CT Scan Without Contrast A highly aggressive, poorly differentiated carcinoma that arises from the thoracic structures. It is characterized by mutations and rearrangement of the NUT gene. It usually presents at an advanced stage with pleuritic chest pain and pleural effusion, non-productive cough, shortness of breath, and weigh loss. C142781 Neoplastic Process Thoracic NUT Carcinoma CL540737 Malignant Thoracic NMC Thoracic NUT Carcinoma Thoracic NUT Carcinoma A lung tumor that arises from perivascular epithelioid cells (PECs). C142783 Neoplastic Process Lung PEComa CL540736 Undetermined Lung PEComa Lung PEComatous Tumor Lung PEComa A benign lung tumor that arises from perivascular epithelioid cells (PECs). C142784 Neoplastic Process Benign Lung PEComa CL540735 Benign Benign Lung PEComa Benign Lung PEComa A malignant lung tumor that arises from perivascular epithelioid cells (PECs). C142785 Neoplastic Process Lung Malignant PEComa CL540734 Malignant Lung Malignant PEComa Malignant Lung PEComa Lung Malignant PEComa Pancreatic carcinoma that does not respond to treatment. C142808 Neoplastic Process Refractory Pancreatic Carcinoma CL540709 Malignant Refractory Pancreatic Carcinoma Refractory Pancreatic Carcinoma The reemergence of acute lymphoblastic leukemia after a period of remission. C142810 Neoplastic Process Recurrent Acute Lymphoblastic Leukemia C1504525 CPTAC mCode Malignant Acute lymphoblastic leukemia, in relapse Lymphoid leukemia, acute in relapse Acute lymphoblastic leukemia, in relapse Recurrent Acute Lymphoblastic Leukemia Recurrent Acute Lymphoblastic Leukemia The reemergence of B acute lymphoblastic leukemia after a period of remission. C142811 Neoplastic Process Recurrent B Acute Lymphoblastic Leukemia Recurrent B Acute Lymphoblastic Leukemia CL540707 CTRP Malignant Recurrent B Acute Lymphoblastic Leukemia Recurrent B-Cell Acute Lymphoblastic Leukemia Recurrent B Acute Lymphoblastic Leukemia B-acute lymphoblastic leukemia that does not respond to treatment. C142812 Neoplastic Process Refractory B Acute Lymphoblastic Leukemia Refractory B Acute Lymphoblastic Leukemia CL540706 CTRP Malignant Refractory B Acute Lymphoblastic Leukemia Refractory B-Cell Acute Lymphoblastic Leukemia Refractory B Acute Lymphoblastic Leukemia A rare lung neoplasm that occurs in the intrauterine and perinatal period. It is characterized by the proliferation of spindle cells in an interstitial, peribronchial pattern. Surgical resection of the involved lung parenchyma is the treatment of choice. C142823 Neoplastic Process Congenital Peribronchial Myofibroblastic Tumor C1266124 GDC Undetermined 8827/1 Congenital peribronchial myofibroblastic tumor Congenital Bronchopulmonary Leiomyosarcoma Congenital Fibrosarcoma Congenital Mesenchymal Malformation of Lung Congenital Peribronchial Myofibroblastic Tumor Congenital Pulmonary Myofibroblastic Tumor Congenital peribronchial myofibroblastic tumor Neonatal Pulmonary Hamartoma Congenital Peribronchial Myofibroblastic Tumor A sarcoma arising from the arterial intima of pulmonary arteries. C142825 Neoplastic Process Pulmonary Artery Intimal Sarcoma CL540697 Cellosaurus GDC Malignant Pulmonary artery intimal sarcoma Intimal Sarcoma of the Pulmonary Artery PAIS PAS PIS Pulmonary Artery Intimal Sarcoma Pulmonary Artery Sarcoma Pulmonary Intimal Sarcoma Pulmonary artery intimal sarcoma Pulmonary Artery Intimal Sarcoma A sarcoma that arises from the lung. It is related to a bronchus and is often predominantly endobronchial. It is characterized by the proliferation of round and spindle cells within a myxoid stroma. It is associated with the presence of an EWSR1::CREB1 fusion gene. C142827 Neoplastic Process Primary Pulmonary Myxoid Sarcoma with EWSR1-CREB1 Fusion CL536391 GDC Malignant Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation Low-Grade Malignant Myxoid Endobronchial Tumor PPMS Primary Pulmonary Myxoid Sarcoma Primary Pulmonary Myxoid Sarcoma with EWSR1-CREB1 Fusion Primary Pulmonary Myxoid Sarcoma with EWSR1::CREB1 Fusion Pulmonary Myxoid Sarcoma with EWSR1-CREB1 Translocation Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation Primary Pulmonary Myxoid Sarcoma with EWSR1-CREB1 Fusion A very rare, benign or malignant lung tumor with myoepithelial differentiation. C142828 Neoplastic Process Lung Myoepithelial Tumor CL540695 Undetermined Lung Myoepithelial Tumor Lung Myoepithelial Tumor A very rare benign lung tumor with myoepithelial differentiation. C142829 Neoplastic Process Lung Myoepithelioma CL540694 Benign Benign Lung Myoepithelioma Lung Myoepithelioma Lung Myoepithelioma A very rare malignant lung tumor with myoepithelial differentiation. C142830 Neoplastic Process Lung Myoepithelial Carcinoma CL545984 Malignant Lung Myoepithelial Carcinoma Lung Myoepithelial Carcinoma Langerhans cell histiocytosis affecting the lungs. It is characterized by an interstitial proliferation of Langerhans cells in the lung parenchyma. Most patients are current or former smokers. Steroids are the mainstay therapy for this condition. C142833 Neoplastic Process Pulmonary Langerhans Cell Histiocytosis C1562010 Undetermined PLCH Pulmonary Eosinophilic Granuloma Pulmonary Histiocytosis X Pulmonary Langerhans Cell Histiocytosis Pulmonary Langerhans Cell Histiocytosis The reemergence of malignant glioma after a period of remission. C142848 Neoplastic Process Recurrent Malignant Glioma Recurrent Malignant Glioma CL540771 CTRP Malignant Recurrent High Grade Glioma Recurrent High-Grade Glioma Recurrent Malignant Glioma Recurrent Malignant Glioma Peripheral primitive neuroectodermal tumor that does not respond to treatment. C142850 Neoplastic Process Refractory Peripheral Primitive Neuroectodermal Tumor Refractory Peripheral Primitive Neuroectodermal Tumor CL540769 CTRP Malignant Refractory Peripheral Primitive Neuroectodermal Tumor Refractory Peripheral Primitive Neuroectodermal Tumor Rhabdomyosarcoma that does not respond to treatment. C142851 Neoplastic Process Refractory Rhabdomyosarcoma Refractory Rhabdomyosarcoma CL540768 CTRP Malignant Refractory Rhabdomyosarcoma Refractory Rhabdomyosarcoma Ewing sarcoma that does not respond to treatment. C142853 Neoplastic Process Refractory Ewing Sarcoma Refractory Ewing Sarcoma CL540766 CTRP Malignant Refractory Ewing Sarcoma Refractory Ewing Sarcoma Hepatoblastoma that does not respond to treatment. C142854 Neoplastic Process Refractory Hepatoblastoma Refractory Hepatoblastoma CL540765 CTRP Malignant Refractory Hepatoblastoma Refractory Hepatoblastoma Malignant glioma that does not respond to treatment. C142855 Neoplastic Process Refractory Malignant Glioma Refractory Malignant Glioma CL540764 CTRP Malignant Refractory Malignant Glioma Refractory Malignant Glioma Medulloblastoma that does not respond to treatment. C142856 Neoplastic Process Refractory Medulloblastoma Refractory Medulloblastoma CL540747 CTRP Malignant Refractory Medulloblastoma Refractory Medulloblastoma Osteosarcoma that does not respond to treatment. C142857 Neoplastic Process Refractory Osteosarcoma Refractory Osteosarcoma CL540746 CTRP Malignant Refractory Osteosarcoma Refractory Osteosarcoma The reemergence of anaplastic oligoastrocytoma after a period of remission. C142861 Neoplastic Process Recurrent Anaplastic Oligoastrocytoma CL540743 Malignant Recurrent Anaplastic Oligoastrocytoma Recurrent Anaplastic Oligoastrocytoma The reemergence of anaplastic oligodendroglioma after a period of remission. C142862 Neoplastic Process Recurrent Anaplastic Oligodendroglioma CL540742 Malignant Recurrent Anaplastic Oligodendroglioma Recurrent Anaplastic Oligodendroglioma A microsatellite stable carcinoma that arises from the colon or rectum and has metastasized to other anatomic sites. C142867 Neoplastic Process Metastatic Microsatellite Stable Colorectal Carcinoma CL540752 Malignant Metastatic Microsatellite Stable Colorectal Cancer Metastatic Microsatellite Stable Colorectal Carcinoma Metastatic Microsatellite Stable Colorectal Carcinoma A microsatellite stable carcinoma that arises from the colon or rectum and has spread extensively to other anatomic sites or is no longer responding to treatment. C142868 Neoplastic Process Advanced Microsatellite Stable Colorectal Carcinoma CL540751 Malignant Advanced Microsatellite Stable Colorectal Cancer Advanced Microsatellite Stable Colorectal Carcinoma Advanced Microsatellite Stable Colorectal Carcinoma A carcinoma that arises from the intrahepatic or extrahepatic bile ducts and has metastasized to other anatomic sites. C142869 Neoplastic Process Metastatic Bile Duct Carcinoma CL540750 Malignant Metastatic Bile Duct Cancer Metastatic Bile Duct Carcinoma Metastatic Biliary Tract Cancer Metastatic Biliary Tract Carcinoma Metastatic Bile Duct Carcinoma A carcinoma that arises from the intrahepatic or extrahepatic bile ducts and has spread extensively to other anatomic sites or is no longer responding to treatment. C142870 Neoplastic Process Advanced Bile Duct Carcinoma CL540749 Malignant Advanced Bile Duct Cancer Advanced Bile Duct Carcinoma Advanced Biliary Tract Cancer Advanced Biliary Tract Carcinoma Advanced Bile Duct Carcinoma The reemergence of primary cutaneous lymphoma after a period of remission. C142876 Neoplastic Process Recurrent Primary Cutaneous Lymphoma Recurrent Primary Cutaneous Lymphoma CL541384 CTRP Malignant Recurrent Primary Cutaneous (Skin) Lymphoma Recurrent Primary Cutaneous Lymphoma Recurrent Primary Cutaneous Lymphoma Primary cutaneous lymphoma that does not respond to treatment. C142877 Neoplastic Process Refractory Primary Cutaneous Lymphoma Refractory Primary Cutaneous Lymphoma CL541385 CTRP Malignant Refractory Primary Cutaneous (Skin) Lymphoma Refractory Primary Cutaneous Lymphoma Refractory Primary Cutaneous Lymphoma Alveolar rhabdomyosarcoma that does not respond to treatment. C142880 Neoplastic Process Refractory Alveolar Rhabdomyosarcoma Refractory Alveolar Rhabdomyosarcoma CL541388 CTRP Malignant Refractory Alveolar Rhabdomyosarcoma Refractory Alveolar Rhabdomyosarcoma The reemergence of alveolar rhabdomyosarcoma after a period of remission. C142881 Neoplastic Process Recurrent Alveolar Rhabdomyosarcoma Recurrent Alveolar Rhabdomyosarcoma CL541389 CTRP Malignant Recurrent Alveolar Rhabdomyosarcoma Recurrent Alveolar Rhabdomyosarcoma The reemergence of hairy cell leukemia after a period of remission. C142882 Neoplastic Process Recurrent Hairy Cell Leukemia Recurrent Hairy Cell Leukemia C2854100 CTRP mCode Malignant Hairy cell leukemia, in relapse Recurrent Hairy Cell Leukemia Relapsed Hairy Cell Leukemia Recurrent Hairy Cell Leukemia Lymphocyte-rich classic Hodgkin lymphoma that does not respond to treatment. C142982 Neoplastic Process Refractory Lymphocyte-Rich Classical Hodgkin Lymphoma Refractory Lymphocyte-Rich Classic Hodgkin Lymphoma CL541414 CTRP Malignant Refractory Lymphocyte-Rich Classic Hodgkin Lymphoma Refractory Lymphocyte-Rich Classical Hodgkin Lymphoma Refractory Lymphocyte-Rich Classic Hodgkin Lymphoma Thyroid gland carcinoma that does not respond to treatment. C142983 Neoplastic Process Refractory Thyroid Gland Carcinoma Refractory Thyroid Gland Carcinoma CL541404 CTRP Malignant Refractory Thyroid Cancer Refractory Thyroid Gland Cancer Refractory Thyroid Gland Carcinoma Refractory Thyroid Gland Carcinoma The reemergence of squamous cell carcinoma of the skin after a period of remission. C143012 Neoplastic Process Recurrent Skin Squamous Cell Carcinoma CL541502 Malignant Recurrent Cutaneous Squamous Cell Carcinoma Recurrent Skin Squamous Cell Carcinoma Recurrent Skin Squamous Cell Carcinoma Squamous cell carcinoma of the skin which has spread to other anatomic sites. C143013 Neoplastic Process Metastatic Skin Squamous Cell Carcinoma C4087141 Malignant Metastatic Cutaneous Squamous Cell Carcinoma Metastatic Skin Squamous Cell Carcinoma Metastatic Skin Squamous Cell Carcinoma Marginal zone lymphoma which does not respond to treatment. C143085 Neoplastic Process Refractory Marginal Zone Lymphoma Refractory Marginal Zone Lymphoma C4087393 CTRP Malignant Refractory Marginal Zone Lymphoma Refractory Marginal Zone Lymphoma A diffusion-weighted MRI technique that utilizes data obtained from multiple b-values and diffusion directions to measure diffusion orientation and length scale; it has been used to identify distinct microscopic tissues based on water diffusion behavior. C143150 Diagnostic Procedure Restriction Spectrum Imaging Restriction Spectrum Imaging CL541615 CTRP RSI RSI-MRI Restriction Spectrum Imaging Restriction Spectrum MRI Restriction Spectrum Magnetic Resonance Imaging Restriction Spectrum Imaging A rare type A thymoma displaying atypical features (hypercellularity, increased mitotic activity, and focal necrosis). C146640 Neoplastic Process Atypical Type A Thymoma CL544670 Undetermined Atypical Type A Thymoma Atypical Type A Thymoma Variant Atypical Type A Thymoma A highly aggressive, poorly differentiated carcinoma that arises from the mediastinum/thymus. It is characterized by mutations and rearrangement of the NUT gene. C146706 Neoplastic Process Mediastinal/Thymic NUT Carcinoma CL544717 Malignant Mediastinal/Thymic NMC Mediastinal/Thymic NUT Carcinoma Mediastinal/Thymic NUT Carcinoma A very rare adenocarcinoma arising from the thymus. It is characterized by the presence of malignant polygonal cells resembling hepatocytes. C146717 Neoplastic Process Thymic Hepatoid Adenocarcinoma CL544711 Malignant Thymic Hepatoid Adenocarcinoma Thymic Hepatoid Carcinoma Thymic Hepatoid Adenocarcinoma A glioblastoma that is resistant to treatment. C146734 Neoplastic Process Refractory Glioblastoma Refractory Glioblastoma CL544697 CTRP Malignant Refractory Glioblastoma Refractory Glioblastoma A term that refers to the staging of mediastinal malignant germ cell tumors according to the Pediatric Study Group staging criteria. This staging system is not an official UICC TNM classification. (WHO Classification of Tumors of the Lung, Pleura, Thymus and Heart, 2015) C146848 Neoplastic Process Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group CL544830 Malignant Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group Malignant Thymic Germ Cell Tumor Stage Grouping of the Pediatric Study Group Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group Locoregional tumor, non-metastatic, complete resection. (WHO Classification of Tumors of the Lung, Pleura, Thymus and Heart, 2015) C146849 Neoplastic Process Stage I Malignant Mediastinal Germ Cell Tumor CL544831 Malignant Stage I Malignant Mediastinal Germ Cell Tumor Stage I Malignant Thymic Germ Cell Tumor Stage I Malignant Mediastinal Germ Cell Tumor Locoregional tumor, non-metastatic, macroscopic complete resection but microscopic residual tumor. (WHO Classification of Tumors of the Lung, Pleura, Thymus and Heart, 2015) C146850 Neoplastic Process Stage II Malignant Mediastinal Germ Cell Tumor CL544832 Malignant Stage II Malignant Mediastinal Germ Cell Tumor Stage II Malignant Thymic Germ Cell Tumor Stage II Malignant Mediastinal Germ Cell Tumor Locoregional tumor, regional lymph nodes negative or positive; no distant metastasis; biopsy only or gross residual tumor after primary resection. (WHO Classification of Tumors of the Lung, Pleura, Thymus and Heart, 2015) C146851 Neoplastic Process Stage III Malignant Mediastinal Germ Cell Tumor CL544833 Malignant Stage III Malignant Mediastinal Germ Cell Tumor Stage III Malignant Thymic Germ Cell Tumor Stage III Malignant Mediastinal Germ Cell Tumor Tumor with distant metastasis. (WHO Classification of Tumors of the Lung, Pleura, Thymus and Heart, 2015) C146852 Neoplastic Process Stage IV Malignant Mediastinal Germ Cell Tumor CL544834 Malignant Stage IV Malignant Mediastinal Germ Cell Tumor Stage IV Malignant Thymic Germ Cell Tumor Stage IV Malignant Mediastinal Germ Cell Tumor An angiosarcoma that has spread from its original site of growth to nearby tissues or lymph nodes. C146856 Neoplastic Process Locally Advanced Angiosarcoma Locally Advanced Angiosarcoma CL544822 CTRP Malignant Locally Advanced Angiosarcoma Locally Advanced Angiosarcoma A malignant germ cell tumor that arises from the mediastinum. It is characterized by the presence of at least two different germ cell tumor components. The different germ cell tumor components include choriocarcinoma, embryonal carcinoma, yolk sac tumor, teratoma, and seminoma. C146861 Neoplastic Process Mediastinal Mixed Germ Cell Tumor CL544826 Malignant Mediastinal Mixed Germ Cell Tumor Mediastinal Mixed Germ Cell Tumor A malignant tumor that arises from the mediastinum and is composed of myeloblasts, neutrophils and neutrophil precursors. It is the most common type of myeloid sarcoma affecting the mediastinum. C146883 Neoplastic Process Mediastinal Granulocytic Sarcoma CL544925 Malignant Mediastinal Granulocytic Sarcoma Mediastinal Granulocytic Sarcoma A carcinoma that arises from the genitourinary system and has metastasized to other anatomic sites. C146893 Neoplastic Process Metastatic Genitourinary System Carcinoma Metastatic Genitourinary System Carcinoma CL544920 CTRP Malignant Metastatic Genitourinary Cancer Metastatic Genitourinary Carcinoma Metastatic Genitourinary System Carcinoma Metastatic Urogenital Carcinoma Metastatic Genitourinary System Carcinoma A hemangioma that arises from the mediastinum. It can be of the capillary or the cavernous type. C146987 Neoplastic Process Mediastinal Hemangioma CL544943 Benign Mediastinal Hemangioma Mediastinal Hemangioma An epithelioid hemangioendothelioma that arises from the mediastinum. C146988 Neoplastic Process Mediastinal Epithelioid Hemangioendothelioma CL544944 Malignant Mediastinal Epithelioid Hemangioendothelioma Mediastinal Epithelioid Hemangioendothelioma A central nervous system non-Hodgkin lymphoma which does not respond to treatment. C146989 Neoplastic Process Refractory Central Nervous System Non-Hodgkin Lymphoma Refractory Central Nervous System Non-Hodgkin Lymphoma CL544945 CTRP Malignant Refractory Central Nervous System Non-Hodgkin Lymphoma Refractory Central Nervous System Non-Hodgkin Lymphoma The reemergence of central nervous system non-Hodgkin lymphoma after a period of remission. C146990 Neoplastic Process Recurrent Central Nervous System Non-Hodgkin Lymphoma Recurrent Central Nervous System Non-Hodgkin Lymphoma CL544946 CTRP Malignant Recurrent Central Nervous System Non-Hodgkin Lymphoma Recurrent Central Nervous System Non-Hodgkin Lymphoma Magnetic resonance imaging that uses a probe labeled with 19F. MR sensitivity of 19F is relatively high and no fluorine atoms exist in biological tissues, resulting in low endogenous background noise. C146991 Diagnostic Procedure Fluorine-19 Magnetic Resonance Imaging C3850007 19F-MRI Fluorine-19 MRI Fluorine-19 Magnetic Resonance Imaging Fluorine-19 Magnetic Resonance Imaging An extraskeletal osteosarcoma that arises from the heart. It produces osteoid and bone, and occasionally shows chondroblastic differentiation. C147003 Neoplastic Process Cardiac Extraskeletal Osteosarcoma CL544931 Malignant Cardiac Extraskeletal Osteosarcoma Cardiac Osteogenic Sarcoma Cardiac Osteosarcoma Heart Extraskeletal Osteosarcoma Cardiac Extraskeletal Osteosarcoma A low-grade sarcoma that arises from the heart. It is composed of spindle or rounded cells in a myxoid stroma. The most common location is the left atrium. C147004 Neoplastic Process Cardiac Myxofibrosarcoma CL544932 Malignant Cardiac Myxofibrosarcoma Cardiac Myxoid Malignant Fibrous Histiocytoma Heart Myxofibrosarcoma Heart Myxoid Malignant Fibrous Histiocytoma Cardiac Myxofibrosarcoma A germ cell tumor that arises within the myocardium or cardiac chambers. The reported cases have been teratomas and yolk sac tumors. C147005 Neoplastic Process Cardiac Germ Cell Tumor CL544933 Undetermined Cardiac Germ Cell Tumor Heart Germ Cell Tumor Cardiac Germ Cell Tumor A yolk sac tumor that arises within the myocardium or cardiac chambers. C147006 Neoplastic Process Cardiac Yolk Sac Tumor CL544934 Malignant Cardiac Yolk Sac Tumor Heart Yolk Sac Tumor Cardiac Yolk Sac Tumor A teratoma that arises within the myocardium or cardiac chambers. C147007 Neoplastic Process Cardiac Teratoma C1112387 Undetermined Cardiac Teratoma Heart Teratoma Cardiac Teratoma A neuroendocrine tumor that has spread from its original site of growth to another anatomic site. C147065 Neoplastic Process Metastatic Neuroendocrine Tumor CL545000 CPTAC mCode Malignant Metastatic_Carcinoid_Tumor Other secondary neuroendocrine tumors Secondary carcinoid tumors, unspecified site Secondary neuroendocrine tumor of other sites Secondary neuroendocrine tumor, unspecified site Secondary neuroendocrine tumors Metastatic Carcinoid Tumor Metastatic Neuroendocrine Tumor Metastatic Well Differentiated Neuroendocrine Neoplasm Secondary carcinoid tumors Secondary carcinoid tumors, unspecified site Secondary neuroendocrine tumors Metastatic Neuroendocrine Tumor An angiosarcoma that arises from the heart. It most often arises in the right atrium near the atrioventricular groove. The prognosis is poor. C147097 Neoplastic Process Cardiac Angiosarcoma CL545095 Malignant Cardiac Angiosarcoma Heart Angiosarcoma Cardiac Angiosarcoma A rare sarcoma that arises from the pericardium. The two most common types are angiosarcoma and synovial sarcoma. Patients present with symptoms related to pericardial effusion. C147098 Neoplastic Process Pericardial Sarcoma CL545096 Malignant Pericardial Sarcoma Pericardial Sarcoma A rare angiosarcoma that arises from the pericardium. Patients present with symptoms related to pericardial effusion. C147101 Neoplastic Process Pericardial Angiosarcoma CL545097 Malignant Pericardial Angiosarcoma Pericardial Angiosarcoma A rare synovial sarcoma that arises from the pericardium. Patients present with symptoms related to pericardial effusion. C147102 Neoplastic Process Pericardial Synovial Sarcoma CL545082 Malignant Pericardial Synovial Sarcoma Pericardial Synovial Sarcoma A teratoma that arises within the pericardium. C147103 Neoplastic Process Pericardial Teratoma CL545083 Undetermined Pericardial Teratoma Pericardial Teratoma A malignant germ cell tumor that arises within the pericardium. C147104 Neoplastic Process Malignant Pericardial Germ Cell Tumor CL545084 Malignant Malignant Pericardial Germ Cell Tumor Malignant Pericardial Germ Cell Tumor A yolk sac tumor that arises within the pericardium. C147105 Neoplastic Process Pericardial Yolk Sac Tumor CL545085 Malignant Pericardial Yolk Sac Tumor Pericardial Yolk Sac Tumor A germ cell tumor that arises from the pericardium. There is no evidence of atypia or metastases. C147106 Neoplastic Process Benign Pericardial Germ Cell Tumor CL545086 Benign Benign Pericardial Germ Cell Tumor Benign Pericardial Germ Cell Tumor Glioma that does not respond to treatment. C147107 Neoplastic Process Refractory Glioma CL545087 Undetermined Refractory Glioma Refractory Glioma Ependymoma that does not respond to treatment. C147108 Neoplastic Process Refractory Ependymoma CL545088 Undetermined Refractory Ependymoma Refractory Ependymoma The reemergence of SHH-activated medulloblastoma after a period of remission. C147109 Neoplastic Process Recurrent Medulloblastoma, SHH-Activated CL545089 Malignant Recurrent Medulloblastoma, SHH-Activated Recurrent Medulloblastoma, SHH-Activated SHH-activated medulloblastoma that does not respond to treatment. C147110 Neoplastic Process Refractory Medulloblastoma, SHH-Activated CL545074 Malignant Refractory Medulloblastoma, SHH-Activated Refractory Medulloblastoma, SHH-Activated A lymph node located adjacent to the larynx, in the parapharyngeal space. C147453 Body Part, Organ, or Organ Component Paralaryngeal Lymph Node CL545302 CDISC A lymph node located adjacent to the larynx, in the parapharyngeal space. PARALARYNGEAL LYMPH NODE Paralaryngeal Lymph Node Paralaryngeal Lymph Node A lymph node located anterior to the larynx. C147454 Body Part, Organ, or Organ Component Prelaryngeal Lymph Node C0229740 CDISC A lymph node located anterior to the larynx. PRELARYNGEAL LYMPH NODE Prelaryngeal Lymph Node Prelaryngeal Lymph Node A lymph node located anterior to the trachea, between the isthmus of the thyroid gland and the innominate vein. C147455 Body Part, Organ, or Organ Component Pretracheal Lymph Node C0229742 CDISC A lymph node located anterior to the trachea, between the isthmus of the thyroid gland and the innominate vein. PRETRACHEAL LYMPH NODE Pretracheal Lymph Node Pretracheal Lymph Node Ovarian carcinoma that progresses between one and six months of completing platinum therapy. C147561 Neoplastic Process Platinum-Resistant Ovarian Carcinoma Platinum-Resistant Ovarian Carcinoma CL545395 CTRP Malignant Platinum-Resistant Ovarian Cancer Platinum-Resistant Ovarian Carcinoma Platinum-Resistant Ovarian Carcinoma The reemergence of EBV-related lymphoma after a period of remission. C147863 Neoplastic Process Recurrent EBV-Related Lymphoma Recurrent EBV-Related Lymphoma CL545732 CTRP Malignant Recurrent EBV-Associated Lymphoma Recurrent EBV-Related Lymphoma Recurrent EBV-Related Lymphoma A brain glioblastoma that occurs during childhood. C147901 Neoplastic Process Childhood Brain Glioblastoma Childhood Brain Glioblastoma CL545693 CTRP Malignant Brain Glioblastoma Childhood Brain Glioblastoma Childhood Brain Glioblastoma An oropharyngeal squamous cell carcinoma which is negative for p16INK4a by immunohistochemistry. This negative immunohistochemistry result does not exclude human papillomavirus infection. C147906 Neoplastic Process p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma CL545695 CTRP Malignant Oropharyngeal Squamous Cell Carcinoma, p16INK4a Negative Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma p16INK4a Negative Oropharyngeal Squamous Cell Cancer p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma Non-squamous non-small cell lung carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C147924 Neoplastic Process Advanced Non-Squamous Non-Small Cell Lung Carcinoma Advanced Lung Non-Squamous Non-Small Cell Carcinoma CL554802 CTRP Malignant Advanced Lung Non-Squamous Non-Small Cell Carcinoma Advanced Non-Squamous Non-Small Cell Lung Cancer Advanced Non-Squamous Non-Small Cell Lung Carcinoma Advanced Lung Non-Squamous Non-Small Cell Carcinoma A B-cell non-Hodgkin lymphoma that arises from the brain, meninges, or spinal cord. C147948 Neoplastic Process Central Nervous System B-Cell Non-Hodgkin Lymphoma Central Nervous System B-Cell Non-Hodgkin Lymphoma CL545779 CTRP Malignant B-Cell Primary Central Nervous System Non-Hodgkin Lymphoma Central Nervous System B-Cell Non-Hodgkin Lymphoma Primary Central Nervous System B-Cell Non-Hodgkin's Lymphoma Central Nervous System B-Cell Non-Hodgkin Lymphoma Breast carcinoma that does not respond to treatment. C147965 Neoplastic Process Refractory Breast Carcinoma Refractory Breast Carcinoma CL545766 CTRP Malignant Refractory Breast Cancer Refractory Breast Carcinoma Refractory Breast Carcinoma Colorectal carcinoma that does not respond to treatment. C147982 Neoplastic Process Refractory Colorectal Carcinoma Refractory Colorectal Carcinoma CL545853 CTRP Malignant Refractory Colorectal Cancer Refractory Colorectal Carcinoma Refractory Colorectal Carcinoma Gastric carcinoma that does not respond to treatment. C147996 Neoplastic Process Refractory Gastric Carcinoma Refractory Gastric Carcinoma CL545850 CTRP Malignant Refractory Gastric (Stomach) Cancer Refractory Gastric Carcinoma Refractory Gastric Carcinoma Ovarian carcinoma caused by deleterious germline mutation in a gene of the BRCA family. C148024 Neoplastic Process BRCA-Associated Ovarian Carcinoma CL545816 Malignant BRCA-Associated Ovarian Carcinoma BRCA-Mutated Ovarian Carcinoma BRCA-Associated Ovarian Carcinoma The reemergence of BRCA-associated ovarian carcinoma after a period of remission. C148025 Neoplastic Process Recurrent BRCA-Mutated Ovarian Carcinoma Recurrent BRCA- Associated Ovarian Carcinoma CL545817 CTRP Malignant Recurrent BRCA- Associated Ovarian Carcinoma Recurrent BRCA-Mutated Ovarian Cancer Recurrent BRCA-Mutated Ovarian Carcinoma Recurrent BRCA- Associated Ovarian Carcinoma The reemergence of WHO grade 2 glioma after a period of remission. C148037 Neoplastic Process Recurrent WHO Grade II Glioma Recurrent WHO Grade 2 Glioma CL545812 CTRP Undetermined Recurrent Grade 2 Glioma Recurrent Grade II Glioma Recurrent WHO Grade 2 Glioma Recurrent WHO Grade II Glioma Recurrent WHO Grade 2 Glioma The reemergence of a WHO grade III glioma after a period of remission. C148038 Neoplastic Process Recurrent WHO Grade III Glioma Recurrent WHO Grade 3 Glioma CL545813 CTRP Malignant Recurrent Grade III Glioma Recurrent WHO Grade 3 Glioma Recurrent WHO Grade III Glioma Recurrent WHO Grade 3 Glioma A B-cell malignant neoplasm that has spread extensively to other anatomic sites or is no longer responding to treatment. C148065 Neoplastic Process Advanced B-Cell Neoplasm Advanced B-Cell Malignant Neoplasm CL545805 CTRP Malignant Advanced B-Cell Malignancy Advanced B-Cell Malignant Neoplasm Advanced B-Cell Neoplasm Advanced B-Cell Malignant Neoplasm A craniopharyngioma that is not amenable to surgical resection. C148076 Neoplastic Process Unresectable Craniopharyngioma Unresectable Craniopharyngioma CL545880 CTRP Benign Unresectable Craniopharyngioma Unresectable Craniopharyngioma The reemergence of a craniopharyngioma after a period of remission. C148077 Neoplastic Process Recurrent Craniopharyngioma Recurrent Craniopharyngioma CL545881 CTRP Benign Recurrent Craniopharyngioma Recurrent Craniopharyngioma An imaging procedure that combines F-18 sodium fluoride PET with an MRI scan to overlay activity data onto detailed anatomic images. C148079 Diagnostic Procedure F-18 Sodium Fluoride Positron Emission Tomography and Magnetic Resonance Imaging CL545883 NCCN F-18 Sodium Fluoride PET/MRI F-18 Sodium Fluoride PET/MRI Scan F-18 Sodium Fluoride Positron Emission Tomography and Magnetic Resonance Imaging F-18 Sodium Fluoride Positron Emission Tomography and Magnetic Resonance Imaging An imaging procedure that combines C-11 choline PET with an MRI scan to overlay activity data onto detailed anatomic images. C148080 Diagnostic Procedure C-11 Choline Positron Emission Tomography and Magnetic Resonance Imaging CL545884 C-11 Choline PET/MRI C-11 Choline PET/MRI Scan C-11 Choline Positron Emission Tomography and Magnetic Resonance Imaging C-11 Choline Positron Emission Tomography and Magnetic Resonance Imaging Malignant thymoma that does not respond to treatment. C148099 Neoplastic Process Refractory Malignant Thymoma Refractory Malignant Thymoma CL545873 CTRP Malignant Refractory Malignant Thymoma Refractory Malignant Thymoma A thymic carcinoma that is not amenable to surgical resection. C148125 Neoplastic Process Unresectable Thymic Carcinoma Unresectable Thymic Carcinoma CL550821 CTRP Malignant Unresectable Thymic Carcinoma Unresectable Thymic Carcinoma A thymic carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C148126 Neoplastic Process Locally Advanced Thymic Carcinoma Locally Advanced Thymic Carcinoma CL550818 CTRP Malignant Locally Advanced Thymic Carcinoma Locally Advanced Thymic Carcinoma Thymic carcinoma that has recurred after a period of remission. C148127 Neoplastic Process Recurrent Thymic Carcinoma Recurrent Thymic Carcinoma CL550817 CTRP Malignant Recurrent Thymic Carcinoma Recurrent Thymic Carcinoma A carcinoma that arises from the thymus and has spread from its original site of growth to another anatomic site. C148128 Neoplastic Process Metastatic Thymic Carcinoma Metastatic Thymic Carcinoma C4038952 CTRP Malignant Metastatic Thymic Carcinoma Metastatic Thymic Carcinoma Mycosis fungoides and Sezary syndrome that is resistant to treatment. C148129 Neoplastic Process Refractory Mycosis Fungoides and Sezary Syndrome Refractory Mycosis Fungoides and Sezary Syndrome C0862206 CTRP Malignant Refractory Mycosis Fungoides and Sezary Syndrome Refractory Mycosis Fungoides and Sezary Syndrome A head and neck squamous cell carcinoma that does not respond to treatment. C148152 Neoplastic Process Refractory Head and Neck Squamous Cell Carcinoma Refractory Head and Neck Squamous Cell Carcinoma CL550796 CTRP Malignant Refractory Head and Neck Squamous Cell Cancer Refractory Head and Neck Squamous Cell Carcinoma Refractory Squamous Cell Carcinoma of the Head and Neck Refractory Head and Neck Squamous Cell Carcinoma A head and neck squamous cell carcinoma which has spread from the original site of growth to another anatomic site. C148153 Neoplastic Process Metastatic Head and Neck Squamous Cell Carcinoma Metastatic Head and Neck Squamous Cell Carcinoma CL550795 CTRP Malignant Metastatic Head and Neck Squamous Cell Cancer Metastatic Head and Neck Squamous Cell Carcinoma Metastatic Head and Neck Squamous Cell Carcinoma Thymic carcinoma that does not respond to treatment. C148173 Neoplastic Process Refractory Thymic Carcinoma Refractory Thymic Carcinoma CL550775 CTRP Malignant Refractory Thymic Carcinoma Refractory Thymic Carcinoma Indolent adult non-Hodgkin lymphoma that is resistant to treatment. C148175 Neoplastic Process Refractory Indolent Adult Non-Hodgkin Lymphoma Refractory Indolent Adult Non-Hodgkin Lymphoma CL550769 CTRP Malignant Refractory Indolent Adult Non-Hodgkin Lymphoma Refractory Indolent Adult Non-Hodgkin Lymphoma An imaging procedure that combines fluciclovine F18 PET with an MRI scan to overlay activity data onto detailed anatomic images. C148191 Diagnostic Procedure F-18 Fluciclovine Positron Emission Tomography and Magnetic Resonance Imaging CL550876 NCCN F-18 Fluciclovine PET/MRI F-18 Fluciclovine PET/MRI Scan F-18 Fluciclovine Positron Emission Tomography and Magnetic Resonance Imaging F-18 Fluciclovine Positron Emission Tomography and Magnetic Resonance Imaging An imaging procedure that combines fluciclovine F18 PET with an computed tomography to overlay activity data onto detailed anatomic images. C148230 Diagnostic Procedure F-18 Fluciclovine Positron Emission Tomography and Computed Tomography F-18 Fluciclovine Positron Emission Tomography and Computed Tomography CL550843 CTRP NCCN OORO F-18 Fluciclovine PET/CT F-18 Fluciclovine PET/CT Scan F-18 Fluciclovine Positron Emission Tomography and Computed Tomography PET-CT (F-18 fluciclovine) F-18 Fluciclovine Positron Emission Tomography and Computed Tomography The reemergence of grade 3a follicular lymphoma after a period of remission. C148244 Neoplastic Process Recurrent Grade 3a Follicular Lymphoma Recurrent Grade 3a Follicular Lymphoma CL550827 CTRP Malignant Recurrent Grade 3a Follicular Lymphoma Recurrent Grade 3a Follicular Lymphoma A skin melanoma that is not amenable to surgical resection. C148245 Neoplastic Process Unresectable Cutaneous Melanoma Unresectable Cutaneous Melanoma CL550830 CTRP Malignant Unresectable Cutaneous (Skin) Melanoma Unresectable Cutaneous Melanoma Unresectable Melanoma of Skin Unresectable Skin Melanoma Unresectable Cutaneous Melanoma Ultrasound imaging following the administration of a microbubble contrast agent. C148281 Health Care Activity Contrast-Enhanced Ultrasound Contrast-Enhanced Ultrasound CL550907 CTRP CEUS Contrast-Enhanced Ultrasound Contrast-Enhanced Ultrasound Stage 0 bladder cancer defined according to the AJCC v6 and v7 criteria that is resistant to treatment. C148286 Neoplastic Process Refractory Stage 0 Bladder Cancer AJCC v6 and v7 Refractory Stage 0 Bladder Cancer AJCC v6 and v7 CL550906 CTRP Malignant Refractory Bladder Carcinoma In Situ AJCC v6 and v7 Refractory Stage 0 Bladder Cancer Refractory Stage 0 Bladder Cancer AJCC v6 and v7 Refractory Stage 0 Bladder Cancer AJCC v6 and v7 Leiomyosarcoma that does not respond to treatment. C148294 Neoplastic Process Refractory Leiomyosarcoma Refractory Leiomyosarcoma CL550900 CTRP Malignant Refractory Leiomyosarcoma Refractory Leiomyosarcoma Undifferentiated pleomorphic sarcoma that does not respond to treatment. C148295 Neoplastic Process Refractory Undifferentiated Pleomorphic Sarcoma Refractory Undifferentiated Pleomorphic Sarcoma CL550899 CTRP Malignant Refractory Undifferentiated Pleomorphic Sarcoma Refractory Undifferentiated Pleomorphic Sarcoma Synovial sarcoma that does not respond to treatment. C148296 Neoplastic Process Refractory Synovial Sarcoma Refractory Synovial Sarcoma CL550895 CTRP Malignant Refractory Synovial Sarcoma Refractory Synovial Sarcoma Myxoid liposarcoma that does not respond to treatment. C148297 Neoplastic Process Refractory Myxoid Liposarcoma Refractory Myxoid Liposarcoma CL550894 CTRP Malignant Refractory Myxoid Liposarcoma Refractory Myxoid/Round Cell Liposarcoma Refractory Myxoid Liposarcoma Myxoid liposarcoma that has spread to other anatomic sites. C148298 Neoplastic Process Metastatic Myxoid Liposarcoma Metastatic Myxoid Liposarcoma C4087469 CTRP Malignant Metastatic Myxoid Liposarcoma Metastatic Myxoid/Round Cell Liposarcoma Metastatic Myxoid Liposarcoma A sarcoma that does not respond to treatment. C148301 Neoplastic Process Refractory Sarcoma CL550890 CPTAC Malignant Refractory Sarcoma Refractory Sarcoma The reemergence of sarcoma after a period of remission. C148302 Neoplastic Process Recurrent Sarcoma CL550893 CPTAC Malignant Recurrent Sarcoma Recurrent Sarcoma A sarcoma which is not amenable to surgical resection. C148331 Neoplastic Process Unresectable Sarcoma CL550967 CPTAC Malignant Unresectable Sarcoma Unresectable Sarcoma Myelodysplastic syndrome that does not respond to treatment. C148362 Neoplastic Process Refractory Myelodysplastic Syndrome Refractory Myelodysplastic Syndrome CL550948 CTRP Malignant Refractory Myelodysplastic Syndrome Refractory Myelodysplastic Syndrome The reemergence of myelodysplastic syndrome after a period of remission. C148363 Neoplastic Process Recurrent Myelodysplastic Syndrome Recurrent Myelodysplastic Syndrome CL550947 CTRP Malignant Recurrent Myelodysplastic Syndrome Recurrent Myelodysplastic Syndrome Hypopharyngeal squamous cell carcinoma that does not respond to treatment. C148382 Neoplastic Process Refractory Hypopharyngeal Squamous Cell Carcinoma Refractory Hypopharyngeal Squamous Cell Carcinoma CL551031 CTRP Malignant Refractory Hypopharyngeal Squamous Cell Carcinoma Refractory Hypopharyngeal Throat Squamous Cell Cancer Refractory Hypopharyngeal Squamous Cell Carcinoma Laryngeal squamous cell carcinoma that does not respond to treatment. C148383 Neoplastic Process Refractory Laryngeal Squamous Cell Carcinoma Refractory Laryngeal Squamous Cell Carcinoma CL551030 CTRP Malignant Refractory Laryngeal Squamous Cell Carcinoma Refractory Laryngeal Throat Squamous Cell Cancer Refractory Laryngeal Squamous Cell Carcinoma Oral cavity squamous cell carcinoma that does not respond to treatment. C148384 Neoplastic Process Refractory Oral Cavity Squamous Cell Carcinoma Refractory Oral Cavity Squamous Cell Carcinoma CL551025 CTRP Malignant Refractory Oral Cavity Squamous Cell Cancer Refractory Oral Cavity Squamous Cell Carcinoma Refractory Oral Cavity Squamous Cell Carcinoma Oropharyngeal squamous cell carcinoma that does not respond to treatment. C148385 Neoplastic Process Refractory Oropharyngeal Squamous Cell Carcinoma Refractory Oropharyngeal Squamous Cell Carcinoma CL551024 CTRP Malignant Refractory Oropharyngeal Squamous Cell Carcinoma Refractory Oropharyngeal Throat Squamous Cell Cancer Refractory Oropharyngeal Squamous Cell Carcinoma Paranasal sinus squamous cell carcinoma that does not respond to treatment. C148386 Neoplastic Process Refractory Paranasal Sinus Squamous Cell Carcinoma Refractory Paranasal Sinus Squamous Cell Carcinoma CL551027 CTRP Malignant Refractory Paranasal Sinus Squamous Cell Cancer Refractory Paranasal Sinus Squamous Cell Carcinoma Refractory Paranasal Sinus Squamous Cell Carcinoma The reemergence of paranasal sinus squamous cell carcinoma after a period of remission. C148387 Neoplastic Process Recurrent Paranasal Sinus Squamous Cell Carcinoma Recurrent Paranasal Sinus Squamous Cell Carcinoma CL551026 CTRP Malignant Recurrent Paranasal Sinus Squamous Cell Cancer Recurrent Paranasal Sinus Squamous Cell Carcinoma Recurrent Paranasal Sinus Squamous Cell Carcinoma Molecular subtyping of diffuse large B-cell lymphomas (DLBCL) based on structural genomic abnormalities and gene expression data obtained from biopsy samples. The molecular analysis revealed four subtypes of DLBCL (MCD, BN2, N1, and EZB) which have distinct genotypic, epigenetic, and clinical characteristics. (NEJM 2018; 378: 1396-407) C148392 Neoplastic Process Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes CL551017 Malignant DLBCL, NOS Genetic Subtypes DLBCL, NOS Molecular Subtypes Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Genetic Subtypes Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes A diffuse large B-cell lymphoma molecular subtype characterized by the co-occurrence of MYD88 and CD79B gene mutations. Patients who belong in this subtype have an inferior outcome. (NEJM 2018; 378: 1396-407) C148394 Neoplastic Process MCD Diffuse Large B-Cell Lymphoma CL551019 Malignant MCD DLBCL MCD Diffuse Large B-Cell Lymphoma MCD Diffuse Large B-Cell Lymphoma A diffuse large B-cell lymphoma molecular subtype characterized by the presence of BCL6 gene fusions and NOTCH2 gene mutations. Patients who belong in this subtype have a favorable outcome. (NEJM 2018; 378: 1396-407) C148395 Neoplastic Process BN2 Diffuse Large B-Cell Lymphoma CL551018 Malignant BN2 DLBCL BN2 Diffuse Large B-Cell Lymphoma BN2 Diffuse Large B-Cell Lymphoma A diffuse large B-cell lymphoma molecular subtype characterized by the presence of NOTCH1 gene mutations. Patients who belong in this subtype have an inferior outcome. (NEJM 2018; 378: 1396-407) C148396 Neoplastic Process N1 Diffuse Large B-Cell Lymphoma CL551013 Malignant N1 DLBCL N1 Diffuse Large B-Cell Lymphoma N1 Diffuse Large B-Cell Lymphoma A diffuse large B-cell lymphoma molecular subtype characterized by the presence of EZH2 gene mutations and BCL2 gene translocations. Patients who belong in this subtype have a favorable outcome. (NEJM 2018; 378: 1396-407) C148398 Neoplastic Process EZB Diffuse Large B-Cell Lymphoma CL551015 Malignant EZB DLBCL EZB Diffuse Large B-Cell Lymphoma EZB Diffuse Large B-Cell Lymphoma Nasal cavity and paranasal sinus squamous cell carcinoma that does not respond to treatment. C148401 Neoplastic Process Refractory Sinonasal Squamous Cell Carcinoma CL551008 Malignant Refractory Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Refractory Sinonasal Squamous Cell Carcinoma Refractory Sinonasal Squamous Cell Carcinoma The reemergence of mixed phenotype acute leukemia after a period of remission. C148423 Neoplastic Process Recurrent Mixed Phenotype Acute Leukemia Recurrent Mixed Phenotype Acute Leukemia CL550993 CTRP Malignant Recurrent Mixed Phenotype Acute Leukemia Recurrent Mixed Phenotype Acute Leukemia The reemergence of leukemia after a period of remission. C148425 Neoplastic Process Recurrent Leukemia C0920028 CPTAC mCode Malignant Leukemia, unspecified, in relapse Recurrent Leukemia Recurrent Leukemia Leukemia that is resistant to treatment. C148426 Neoplastic Process Advanced Leukemia Refractory Leukemia CL550989 CPTAC CTRP Malignant Advanced Leukemia Refractory Leukemia Refractory Leukemia The reemergence of acute myeloid leukemia after a period of remission. C148427 Neoplastic Process Recurrent Acute Myeloid Leukemia Recurrent Acute Myeloid Leukemia C1142169 CPTAC CTRP mCode Malignant Acute myeloblastic leukemia, in relapse Myeloid leukemia, acute in relapse Acute myeloblastic leukemia, in relapse Recurrent Acute Myeloid Leukemia Recurrent Acute Myeloid Leukemia (AML) Recurrent Acute Myeloid Leukemia The reemergence of acute leukemia after a period of remission. C148429 Neoplastic Process Recurrent Acute Leukemia CL550990 CPTAC mCode Malignant Acute leukemia of unspecified cell type, in relapse Leukemia of unspecified cell type, acute in relapse Acute leukemia of unspecified cell type, in relapse Recurrent Acute Leukemia Recurrent Acute Leukemia Mixed phenotype acute leukemia that does not respond to treatment. C148430 Neoplastic Process Refractory Mixed Phenotype Acute Leukemia Refractory Mixed Phenotype Acute Leukemia CL550986 CTRP Malignant Refractory Mixed Phenotype Acute Leukemia Refractory Mixed Phenotype Acute Leukemia Acute leukemia that does not respond to treatment. C148431 Neoplastic Process Refractory Acute Leukemia CL550985 Malignant Refractory Acute Leukemia Refractory Acute Leukemia Intrahepatic cholangiocarcinoma that is not amenable to surgical removal. C148432 Neoplastic Process Unresectable Intrahepatic Cholangiocarcinoma Unresectable Intrahepatic Cholangiocarcinoma CL550988 CTRP Malignant Unresectable Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) Unresectable Intrahepatic Cholangiocarcinoma Unresectable Intrahepatic Cholangiocarcinoma Nasopharyngeal carcinoma that is resistant to treatment. C148434 Neoplastic Process Refractory Nasopharyngeal Carcinoma Refractory Nasopharyngeal Carcinoma CL550983 CTRP Malignant Refractory Nasopharyngeal Carcinoma Refractory Nasopharyngeal Throat Cancer Refractory Nasopharyngeal Carcinoma Urothelial carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C148493 Neoplastic Process Advanced Urothelial Carcinoma Advanced Urothelial Carcinoma CL551048 CTRP Malignant Advanced Urothelial Cancer Advanced Urothelial Carcinoma Advanced Urothelial Carcinoma Uveal melanoma that has spread from its primary site to another anatomic site. C148514 Neoplastic Process Metastatic Uveal Melanoma Metastatic Uveal Melanoma CL376191 CTRP Malignant Metastatic Uveal Melanoma Metastatic Uveal Melanoma Uveal melanoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C148515 Neoplastic Process Advanced Uveal Melanoma Advanced Uveal Melanoma CL551152 CTRP Malignant Advanced Uveal Melanoma Advanced Uveal Melanoma Advanced prostatic carcinoma which was not previously treated with androgen-deprivation therapy. C148536 Neoplastic Process Castration-Naive Prostate Carcinoma CL551133 NCCN Malignant CNPC Castration-Naive Prostate Cancer Castration-Naive Prostate Carcinoma Castration-Naive Prostate Carcinoma An adenocarcinoma that arises from the thoracic esophagus. C150027 Neoplastic Process Thoracic Esophagus Adenocarcinoma CL551783 Malignant Thoracic Esophagus Adenocarcinoma Thoracic Esophagus Adenocarcinoma A squamous cell carcinoma that arises from the thoracic esophagus. C150029 Neoplastic Process Thoracic Esophagus Squamous Cell Carcinoma CL551777 Malignant Thoracic Esophagus Squamous Cell Carcinoma Thoracic Esophagus Squamous Cell Carcinoma An adenocarcinoma that arises from the cervical esophagus. C150031 Neoplastic Process Cervical Esophagus Adenocarcinoma CL551776 Malignant Cervical Esophagus Adenocarcinoma Cervical Esophagus Adenocarcinoma A squamous cell carcinoma that arises from the cervical esophagus. C150032 Neoplastic Process Cervical Esophagus Squamous Cell Carcinoma CL551779 Malignant Cervical Esophagus Squamous Cell Carcinoma Cervical Esophagus Squamous Cell Carcinoma A squamous cell carcinoma that arises from the gastric cardia. C150034 Neoplastic Process Gastric Cardia Squamous Cell Carcinoma CL551778 Malignant Gastric Cardia Squamous Cell Carcinoma Gastric Cardia Squamous Cell Carcinoma A squamous cell carcinoma that arises from the distal esophagus. C150037 Neoplastic Process Distal Esophagus Squamous Cell Carcinoma Distal Esophagus Squamous Cell Carcinoma CL551890 CTRP Malignant Distal Esophagus Squamous Cell Carcinoma Squamous Cell Carcinoma of the Distal Esophagus Squamous Cell Carcinoma of the Lower Third of the Esophagus Distal Esophagus Squamous Cell Carcinoma The reemergence of chronic leukemia after a period of remission. C150043 Neoplastic Process Recurrent Chronic Leukemia CL551884 mCode Malignant Chronic leukemia of unspecified cell type, in relapse Recurrent Chronic Leukemia Recurrent Chronic Leukemia Chronic leukemia that is resistant to treatment. C150044 Neoplastic Process Refractory Chronic Leukemia CL551883 Malignant Refractory Chronic Leukemia Refractory Chronic Leukemia The reemergence of chronic myelomonocytic leukemia after a period of remission. C150048 Neoplastic Process Recurrent Chronic Myelomonocytic Leukemia Recurrent Chronic Myelomonocytic Leukemia CL551880 CTRP mCode Malignant Chronic myelomonocytic leukemia, in relapse Recurrent Chronic Myelomonocytic Leukemia Recurrent Chronic Myelomonocytic Leukemia Chronic myelomonocytic leukemia that is resistant to treatment. C150049 Neoplastic Process Refractory Chronic Myelomonocytic Leukemia Refractory Chronic Myelomonocytic Leukemia CL551882 CTRP Malignant Refractory Chronic Myelomonocytic Leukemia Refractory Chronic Myelomonocytic Leukemia (CMML) Refractory Chronic Myelomonocytic Leukemia Ovarian carcinoma that is resistant to treatment. C150091 Neoplastic Process Refractory Ovarian Carcinoma CL551838 Malignant Refractory Ovarian Carcinoma Refractory Ovarian Carcinoma Uterine corpus cancer that is resistant to treatment. C150092 Neoplastic Process Refractory Uterine Corpus Cancer CL551837 Malignant Refractory Uterine Corpus Cancer Refractory Uterine Corpus Cancer Endometrial carcinoma that is resistant to treatment C150093 Neoplastic Process Refractory Endometrial Carcinoma CL551840 Malignant Refractory Endometrial Carcinoma Refractory Endometrial Carcinoma The reemergence of endometrial carcinoma after a period of remission. C150094 Neoplastic Process Recurrent Endometrial Carcinoma CL551839 Malignant Recurrent Endometrial Carcinoma Recurrent Endometrial Carcinoma The reemergence of ovarian endometrioid adenocarcinoma after a period of remission. C150095 Neoplastic Process Recurrent Ovarian Endometrioid Adenocarcinoma CL551834 Malignant Recurrent Ovarian Endometrioid Adenocarcinoma Recurrent Ovarian Endometrioid Carcinoma Recurrent Ovarian Endometrioid Adenocarcinoma Ovarian endometrioid adenocarcinoma that is resistant to treatment. C150096 Neoplastic Process Refractory Ovarian Endometrioid Adenocarcinoma CL551833 Malignant Refractory Ovarian Endometrioid Adenocarcinoma Refractory Ovarian Endometrioid Adenocarcinoma The reemergence of endometrial endometrioid adenocarcinoma after a period of remission. C150097 Neoplastic Process Recurrent Endometrial Endometrioid Adenocarcinoma CL551836 Malignant Recurrent Endometrial Endometrioid Adenocarcinoma Recurrent Endometrial Endometrioid Adenocarcinoma Endometrial endometrioid adenocarcinoma that is resistant to treatment. C150098 Neoplastic Process Refractory Endometrial Endometrioid Adenocarcinoma CL551835 Malignant Refractory Endometrial Endometrioid Adenocarcinoma Refractory Endometrial Endometrioid Adenocarcinoma A melanoma that originates from melanocytes of the uveal tract and has spread to the liver. C150130 Neoplastic Process Uveal Melanoma Metastatic in the Liver Uveal Melanoma Metastatic in the Liver CL551922 CTRP Malignant Metastatic Uveal Melanoma in the Liver Uveal Melanoma Metastatic in the Liver Uveal Melanoma Metastatic in the Liver The reemergence of T-acute lymphoblastic leukemia after a period of remission. C150131 Neoplastic Process Recurrent T Acute Lymphoblastic Leukemia Recurrent T Acute Lymphoblastic Leukemia CL551918 CTRP Malignant Recurrent T Acute Lymphoblastic Leukemia Recurrent T-Acute Lymphoblastic Leukemia Recurrent T Acute Lymphoblastic Leukemia The reemergence of monomorphic epitheliotropic intestinal T-cell lymphoma after a period of remission. C150132 Neoplastic Process Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma CL551917 CTRP Malignant Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma The reemergence of T-cell prolymphocytic leukemia after a period of remission. C150133 Neoplastic Process Recurrent T-Cell Prolymphocytic Leukemia Recurrent T-Cell Prolymphocytic Leukemia CL551919 CTRP mCode Malignant Prolymphocytic leukemia of T-cell type, in relapse Recurrent T-Cell Prolymphocytic Leukemia Recurrent T-Cell Prolymphocytic Leukemia Protocols aimed at reducing the cost of breast MRI to improve access to it as a supplemental screening method. Shorter protocols and shorter acquisition times can be achieved with maintenance of diagnostic accuracy comparable to that obtained with conventional MRI protocols. Use of these abbreviated MRI protocols could result in lower cost and faster throughput, thus increasing availability. C150137 Diagnostic Procedure Abbreviated Breast MRI Protocol Abbreviated Breast MRI Protocol CL551916 CTRP AB-MRI Abbreviated Breast MRI Abbreviated Breast MRI Protocol Abbreviated Breast MRI Protocol A squamous cell carcinoma of the oropharynx that has spread extensively to other anatomic sites or is no longer responding to treatment. C150201 Neoplastic Process Advanced Squamous Cell Carcinoma of the Oropharynx Advanced Oropharyngeal Squamous Cell Carcinoma CL551966 CTRP Malignant Advanced Oropharyngeal Squamous Cell Carcinoma Advanced Oropharyngeal Throat Squamous Cell Cancer Advanced Squamous Cell Carcinoma of the Oropharynx Advanced Oropharyngeal Squamous Cell Carcinoma A squamous cell carcinoma of the oropharynx which has spread from the original site of growth to another anatomic site. C150202 Neoplastic Process Metastatic Squamous Cell Carcinoma of the Oropharynx Metastatic Oropharyngeal Squamous Cell Carcinoma CL551965 CTRP Malignant Metastatic Oropharyngeal Squamous Cell Carcinoma Metastatic Oropharyngeal Throat Squamous Cell Cancer Metastatic Squamous Cell Carcinoma of the Oropharynx Metastatic Oropharyngeal Squamous Cell Carcinoma A squamous cell carcinoma of the oral cavity that has spread extensively to other anatomic sites or is no longer responding to treatment. C150204 Neoplastic Process Advanced Squamous Cell Carcinoma of the Oral Cavity Advanced Oral Cavity Squamous Cell Carcinoma CL551967 CTRP Malignant Advanced Oral Cavity Squamous Cell Cancer Advanced Oral Cavity Squamous Cell Carcinoma Advanced Squamous Cell Carcinoma of the Oral Cavity Advanced Oral Cavity Squamous Cell Carcinoma A squamous cell carcinoma of the oral cavity which has spread from the original site of growth to another anatomic site. C150206 Neoplastic Process Metastatic Squamous Cell Carcinoma of the Oral Cavity Metastatic Oral Cavity Squamous Cell Carcinoma CL551961 CTRP Malignant Metastatic Oral Cavity Squamous Cell Cancer Metastatic Oral Cavity Squamous Cell Carcinoma Metastatic Squamous Cell Carcinoma of the Oral Cavity Metastatic Oral Cavity Squamous Cell Carcinoma A squamous cell carcinoma of the nasopharynx that has spread extensively to other anatomic sites or is no longer responding to treatment. C150207 Neoplastic Process Advanced Squamous Cell Carcinoma of the Nasopharynx Advanced Nasopharyngeal Squamous Cell Carcinoma CL551964 CTRP Malignant Advanced Nasopharyngeal Squamous Cell Carcinoma Advanced Nasopharyngeal Throat Squamous Cell Cancer Advanced Squamous Cell Carcinoma of the Nasopharynx Advanced Nasopharyngeal Squamous Cell Carcinoma A squamous cell carcinoma of the nasopharynx which has spread from the original site of growth to another anatomic site. C150209 Neoplastic Process Metastatic Squamous Cell Carcinoma of the Nasopharynx Metastatic Nasopharyngeal Squamous Cell Carcinoma CL551958 CTRP Malignant Metastatic Nasopharyngeal Squamous Cell Carcinoma Metastatic Nasopharyngeal Throat Squamous Cell Cancer Metastatic Squamous Cell Carcinoma of the Nasopharynx Metastatic Nasopharyngeal Squamous Cell Carcinoma A squamous cell carcinoma of the hypopharynx that has spread extensively to other anatomic sites or is no longer responding to treatment. C150210 Neoplastic Process Advanced Squamous Cell Carcinoma of the Hypopharynx Advanced Hypopharyngeal Squamous Cell Carcinoma CL551957 CTRP Malignant Advanced Hypopharyngeal Squamous Cell Carcinoma Advanced Hypopharyngeal Throat Squamous Cell Cancer Advanced Squamous Cell Carcinoma of the Hypopharynx Advanced Hypopharyngeal Squamous Cell Carcinoma A squamous cell carcinoma of the larynx that has spread extensively to other anatomic sites or is no longer responding to treatment. C150211 Neoplastic Process Advanced Squamous Cell Carcinoma of the Larynx Advanced Laryngeal Squamous Cell Carcinoma CL551960 CTRP Malignant Advanced Laryngeal Squamous Cell Carcinoma Advanced Laryngeal Throat Squamous Cell Cancer Advanced Squamous Cell Carcinoma of the Larynx Advanced Laryngeal Squamous Cell Carcinoma A squamous cell carcinoma of the hypopharynx that has spread from the original site of growth to another anatomic site. C150212 Neoplastic Process Metastatic Squamous Cell Carcinoma of the Hypopharynx Metastatic Hypopharyngeal Squamous Cell Carcinoma CL551959 CTRP Malignant Metastatic Hypopharyngeal Squamous Cell Carcinoma Metastatic Hypopharyngeal Throat Squamous Cell Cancer Metastatic Squamous Cell Carcinoma of the Hypopharynx Metastatic Hypopharyngeal Squamous Cell Carcinoma A squamous cell carcinoma of the larynx that has spread from the original site of growth to another anatomic site. C150213 Neoplastic Process Metastatic Squamous Cell Carcinoma of the Larynx Metastatic Laryngeal Squamous Cell Carcinoma CL551954 CTRP Malignant Metastatic Laryngeal Squamous Cell Carcinoma Metastatic Laryngeal Throat Squamous Cell Cancer Metastatic Squamous Cell Carcinoma of the Larynx Metastatic Laryngeal Squamous Cell Carcinoma Neuroblastoma usually presenting with metastatic disease and MYCN gene amplifications. C150281 Neoplastic Process High-Risk Neuroblastoma High Risk Neuroblastoma CL552015 CTRP Malignant High Risk Neuroblastoma High-Risk Neuroblastoma High Risk Neuroblastoma Bladder carcinoma that does not respond to treatment. C150316 Neoplastic Process Refractory Bladder Carcinoma Refractory Bladder Carcinoma CL552110 CTRP Malignant Refractory Bladder Cancer Refractory Bladder Carcinoma Refractory Bladder Carcinoma Non-hereditary renal cell carcinoma arising from a kidney and detected in the other kidney within six months of the first primary. The majority are clear cell renal cell carcinomas. C150359 Neoplastic Process Bilateral Synchronous Sporadic Renal Cell Carcinoma Bilateral Synchronous Sporadic Renal Cell Carcinoma CL552067 CTRP Malignant BSSRCC Bilateral Synchronous Sporadic Renal Cell Cancer Bilateral Synchronous Sporadic Renal Cell Carcinoma Bilateral Synchronous Sporadic Renal Cell Carcinoma Urothelial carcinoma that does not respond to treatment. C150364 Neoplastic Process Refractory Urothelial Carcinoma Refractory Urothelial Carcinoma CL552183 CTRP Malignant Refractory Urothelial Carcinoma Refractory Urothelial Carcinoma Urothelial carcinoma that is resistant to platinum therapy. C150365 Neoplastic Process Platinum-Resistant Urothelial Carcinoma CL552182 Malignant Platinum-Resistant Urothelial Carcinoma Platinum-Resistant Urothelial Carcinoma An unusual form of diffuse large B-cell lymphoma. It is not mass-forming and does not directly produce symptoms, but it is discovered incidentally on histological examination of surgical pathology specimens, excised for various pathologies other than lymphoma. The specimens typically contain fibrinous materials. Single and small aggregates of large lymphoma cells are found in only small foci within the fibrinous or amorphous material. EBV is positive, with type III latency. The clinical outcome is highly favorable, even with surgical excision alone. (WHO 2017) C150396 Neoplastic Process Fibrin-Associated Diffuse Large B-Cell Lymphoma Fibrin-Associated Diffuse Large B-Cell Lymphoma CL552155 CTRP Malignant FA-DLBCL Fibrin-Associated Diffuse Large B-Cell Lymphoma Fibrin-Associated EBV-Positive Large B-Cell Lymphoma Fibrin-Associated Diffuse Large B-Cell Lymphoma A rare HHV8-positive B-cell lymphoma indistinguishable from primary effusion lymphoma presenting as solid tumor mass. (WHO 2017) C150406 Neoplastic Process Extracavitary Primary Effusion Lymphoma Extracavitary Primary Effusion Lymphoma CL552149 CTRP Malignant Extracavitary PEL Extracavitary Primary Effusion Lymphoma Extracavitary Primary Effusion Lymphoma A large B-cell lymphoma presenting as a serous effusion without detectable tumor masses. It is universally associated with human herpes virus 8 (HHV8), also called Kaposi sarcoma-associated herpesvirus. It mostly occurs in the setting of immunodeficiency. The most common sites of involvement are the pleural, pericardial, and peritoneal cavities. (WHO 2017) C150407 Neoplastic Process Body Cavity Primary Effusion Lymphoma Body Cavity Primary Effusion Lymphoma CL552144 CTRP Malignant Body Cavity PEL Body Cavity Primary Effusion Lymphoma Body Cavity Primary Effusion Lymphoma A group of mature T-cell and NK-cell non-Hodgkin lymphomas that includes enteropathy-associated T-cell lymphoma, monomorphic epitheliotropic intestinal T-cell lymphoma, and intestinal T-cell lymphoma, not otherwise specified. Most of these lymphomas arise from the small intestine and a minority from the large intestine or stomach. C150495 Neoplastic Process Intestinal T-Cell Lymphoma Intestinal T-Cell Lymphoma CL552301 CTRP GDC Malignant 9717/3 Intestinal T-cell lymphoma Intestinal T-Cell Lymphoma Intestinal T-Cell Lymphoma A monomorphic epitheliotropic intestinal T-cell lymphoma arising from the small intestine. It is characterized by the presence of a monomorphic cellular infiltrate of small to medium-sized T-lymphocytes that are cytotoxic and express CD56. It is not associated with celiac disease. C150504 Neoplastic Process Small Intestinal Monomorphic Epitheliotropic T-Cell Lymphoma Small Intestinal Monomorphic Epitheliotropic T-Cell Lymphoma CL552289 CTRP Malignant Small Intestinal Monomorphic Epitheliotropic T-Cell Lymphoma Small Intestinal Monomorphic Epitheliotropic T-Cell Lymphoma A T-cell lymphoma arising in the intestines, or sometimes other sites in the gastrointestinal tract, that does not conform to either classic enteropathy-associated T-cell lymphoma or monomorphic epitheliotropic intestinal T-cell lymphoma. (WHO 2017) C150505 Neoplastic Process Intestinal T-Cell Lymphoma, Not Otherwise Specified Intestinal T-Cell Lymphoma, Not Otherwise Specified CL552288 CTRP Malignant Intestinal T-Cell Lymphoma, NOS Intestinal T-Cell Lymphoma, Not Otherwise Specified Intestinal T-Cell Lymphoma, Not Otherwise Specified T-acute lymphoblastic leukemia that does not respond to treatment. C150510 Neoplastic Process Refractory T Acute Lymphoblastic Leukemia Refractory T Acute Lymphoblastic Leukemia CL552284 CTRP Malignant Refractory T Acute Lymphoblastic Leukemia Refractory T-Acute Lymphoblastic Leukemia Refractory T Acute Lymphoblastic Leukemia A urethral urothelial carcinoma that has spread to another anatomical site. C150512 Neoplastic Process Metastatic Urethral Urothelial Carcinoma Metastatic Urethral Urothelial Carcinoma CL552286 CTRP Malignant Metastatic Urethral Urothelial Cancer Metastatic Urethral Urothelial Carcinoma Metastatic Urethral Urothelial Carcinoma Bladder urothelial carcinoma that has spread to another anatomical site. C150513 Neoplastic Process Metastatic Bladder Urothelial Carcinoma Metastatic Bladder Urothelial Carcinoma CL552283 CTRP Malignant Metastatic Bladder Urothelial Cancer Metastatic Bladder Urothelial Carcinoma Metastatic Bladder Urothelial Carcinoma Renal pelvis urothelial carcinoma that has spread to another anatomical site. C150514 Neoplastic Process Metastatic Renal Pelvis Urothelial Carcinoma Metastatic Renal Pelvis Urothelial Carcinoma CL552282 CTRP Malignant Metastatic Renal Pelvis Urothelial Cancer Metastatic Renal Pelvis Urothelial Carcinoma Metastatic Renal Pelvis Urothelial Carcinoma Ureter urothelial carcinoma that has spread to another anatomical site. C150515 Neoplastic Process Metastatic Ureter Urothelial Carcinoma Metastatic Ureter Urothelial Carcinoma C0862458 CTRP Malignant Metastatic Ureter Urothelial Cancer Metastatic Ureter Urothelial Carcinoma Metastatic Ureter Urothelial Carcinoma The reemergence of ureter urothelial carcinoma after a period of remission. C150516 Neoplastic Process Recurrent Ureter Urothelial Carcinoma Recurrent Ureter Urothelial Carcinoma C0862460 CTRP Malignant Recurrent Ureter Urothelial Cancer Recurrent Ureter Urothelial Carcinoma Recurrent Ureter Urothelial Carcinoma The reemergence of renal pelvis urothelial carcinoma after a period of remission. C150519 Neoplastic Process Recurrent Renal Pelvis Urothelial Carcinoma Recurrent Renal Pelvis Urothelial Carcinoma CL552281 CTRP Malignant Recurrent Renal Pelvis Urothelial Cancer Recurrent Renal Pelvis Urothelial Carcinoma Recurrent Renal Pelvis Urothelial Carcinoma Urothelial carcinoma that is not amenable to surgical resection. C150521 Neoplastic Process Unresectable Urothelial Carcinoma Unresectable Urothelial Carcinoma CL552276 CTRP Malignant Unresectable Urothelial Carcinoma Unresectable Urothelial Carcinoma Reemergence of a malignant bone neoplasm after a period of remission. C150524 Neoplastic Process Recurrent Malignant Bone Neoplasm Recurrent Malignant Bone Neoplasm CL552277 CTRP Malignant Recurrent Malignant Bone Neoplasm Recurrent Malignant Bone Neoplasm Malignant bone neoplasm that is resistant to treatment. C150525 Neoplastic Process Refractory Malignant Bone Neoplasm Refractory Malignant Bone Neoplasm CL552272 CTRP Malignant Refractory Malignant Bone Neoplasm Refractory Malignant Bone Neoplasm The reemergence of a malignant female reproductive system neoplasm after a period of remission. C150526 Neoplastic Process Recurrent Malignant Female Reproductive System Neoplasm Recurrent Malignant Female Reproductive System Neoplasm CL552271 CTRP Malignant Recurrent Malignant Female Reproductive System Neoplasm Recurrent Malignant Female Reproductive System Neoplasm Malignant female reproductive system neoplasm that is resistant to treatment. C150527 Neoplastic Process Refractory Malignant Female Reproductive System Neoplasm Refractory Malignant Female Reproductive System Neoplasm CL552274 CTRP Malignant Refractory Malignant Female Reproductive System Neoplasm Refractory Malignant Female Reproductive System Neoplasm Lip or oral cavity malignant neoplasm that is resistant to treatment. C150530 Neoplastic Process Refractory Malignant Oral Neoplasm Refractory Malignant Oral Neoplasm CL552267 CTRP Malignant Refractory Malignant Lip and Oral Cavity Neoplasm Refractory Malignant Oral Neoplasm Refractory Malignant Oral Neoplasm Reemergence of a malignant pharyngeal neoplasm after a period of remission. C150531 Neoplastic Process Recurrent Malignant Pharyngeal Neoplasm Recurrent Malignant Pharyngeal Neoplasm CL552270 CTRP Malignant Recurrent Malignant Pharyngeal Neoplasm Recurrent Malignant Pharyngeal Neoplasm Malignant pharyngeal neoplasm that is resistant to treatment. C150532 Neoplastic Process Refractory Malignant Pharyngeal Neoplasm Refractory Malignant Pharyngeal Neoplasm CL552269 CTRP Malignant Refractory Malignant Pharyngeal Neoplasm Refractory Malignant Pharyngeal Throat Neoplasm Refractory Malignant Pharyngeal Neoplasm The reemergence of a malignant male reproductive system neoplasm after a period of remission. C150533 Neoplastic Process Recurrent Malignant Male Reproductive System Neoplasm Recurrent Malignant Male Reproductive System Neoplasm CL552264 CTRP Malignant Recurrent Malignant Male Reproductive System Neoplasm Recurrent Malignant Male Reproductive System Neoplasm Malignant male reproductive system neoplasm that is resistant to treatment. C150534 Neoplastic Process Refractory Malignant Male Reproductive System Neoplasm Refractory Malignant Male Reproductive System Neoplasm CL552263 CTRP Malignant Refractory Malignant Male Reproductive System Neoplasm Refractory Malignant Male Reproductive System Neoplasm Reemergence of a malignant soft tissue neoplasm after a period of remission. C150536 Neoplastic Process Recurrent Malignant Soft Tissue Neoplasm Recurrent Malignant Soft Tissue Neoplasm CL552265 CTRP Malignant Recurrent Malignant Soft Tissue Neoplasm Recurrent Malignant Soft Tissue Neoplasm Malignant soft tissue neoplasm that is resistant to treatment. C150537 Neoplastic Process Refractory Malignant Soft Tissue Neoplasm Refractory Malignant Soft Tissue Neoplasm CL552260 CTRP Malignant Refractory Malignant Soft Tissue Neoplasm Refractory Malignant Soft Tissue Neoplasm The reemergence of malignant thyroid gland neoplasm after a period of remission. C150538 Neoplastic Process Recurrent Malignant Thyroid Gland Neoplasm Recurrent Malignant Thyroid Gland Neoplasm CL552259 CTRP Malignant Recurrent Malignant Thyroid Gland Neoplasm Recurrent Malignant Thyroid Gland Neoplasm Malignant thyroid gland neoplasm that is resistant to treatment. C150539 Neoplastic Process Refractory Malignant Thyroid Gland Neoplasm Refractory Malignant Thyroid Gland Neoplasm CL552262 CTRP Malignant Refractory Malignant Thyroid Gland Neoplasm Refractory Malignant Thyroid Gland Neoplasm Reemergence of a malignant endocrine neoplasm after a period of remission. C150540 Neoplastic Process Recurrent Malignant Endocrine Neoplasm Recurrent Malignant Endocrine Neoplasm CL552261 CTRP Malignant Recurrent Malignant Endocrine Neoplasm Recurrent Malignant Endocrine Neoplasm Malignant endocrine neoplasm that is resistant to treatment. C150541 Neoplastic Process Refractory Malignant Endocrine Neoplasm Refractory Malignant Endocrine Neoplasm CL552256 CTRP Malignant Refractory Malignant Endocrine Neoplasm Refractory Malignant Endocrine Neoplasm Reemergence of a malignant urinary system neoplasm after a period of remission. C150542 Neoplastic Process Recurrent Malignant Urinary System Neoplasm Recurrent Malignant Urinary System Neoplasm CL552255 CTRP Malignant Recurrent Malignant Urinary System Neoplasm Recurrent Malignant Urinary System Neoplasm Malignant urinary system neoplasm that is resistant to treatment. C150543 Neoplastic Process Refractory Malignant Urinary System Neoplasm Refractory Malignant Urinary System Neoplasm CL552258 CTRP Malignant Refractory Malignant Urinary System Neoplasm Refractory Malignant Urinary System Neoplasm Melanoma of the skin that is resistant to treatment. C150544 Neoplastic Process Refractory Melanoma of the Skin Refractory Cutaneous Melanoma CL554812 CTRP Malignant Refractory Cutaneous (Skin) Melanoma Refractory Cutaneous Melanoma Refractory Melanoma of the Skin Refractory Cutaneous Melanoma Reemergence of a malignant skin neoplasm after a period of remission. C150545 Neoplastic Process Recurrent Malignant Skin Neoplasm Recurrent Malignant Skin Neoplasm CL552252 CTRP Malignant Recurrent Malignant Skin Neoplasm Recurrent Malignant Skin Neoplasm Malignant skin neoplasm that is resistant to treatment. C150546 Neoplastic Process Refractory Malignant Skin Neoplasm Refractory Malignant Skin Neoplasm CL552251 CTRP Malignant Refractory Malignant Skin Neoplasm Refractory Malignant Skin Neoplasm A prostate adenocarcinoma characterized by the absence of focal or diffuse neuroendocrine differentiation. C150557 Neoplastic Process Prostate Adenocarcinoma Without Evidence of Neuroendocrine Differentiation Prostate Adenocarcinoma without Neuroendocrine Differentiation CL552360 CTRP Malignant Prostate Adenocarcinoma without Evidence of Neuroendocrine Differentiation Prostate Adenocarcinoma without Neuroendocrine Differentiation Prostate Adenocarcinoma without Neuroendocrine Differentiation Monoclonal gammopathy of undetermined significance defined by a serum IgM paraprotein concentration less than 30g/L; bone marrow lymphoplasmacytic infiltration of less than 10%; and no evidence of anemia, constitutional symptoms, hyperviscocity, lymphadenopathy, hepatosplenomegaly, or other end-organ damage that can be attributed to the underlying lymphoproliferative disorder. It is a precursor condition that may progress to lymphoplasmacytic lymphoma/ Waldenstrom macroglobulinemia, other B-cell neoplasms, or primary amyloidosis. Progression to plasma cell myeloma occurs rarely, if at all. (WHO 2017) C150566 Neoplastic Process IgM Monoclonal Gammopathy of Undetermined Significance IgM Monoclonal Gammopathy of Undetermined Significance CL552352 CTRP Undetermined IgM monoclonal gammopathy of undetermined significance IgM MGUS IgM Monoclonal Gammopathy of Undetermined Significance IgM Monoclonal Gammopathy of Undetermined Significance Endobronchial ultrasound that employs a flexible catheter housing a rotating ultrasound transducer to produces a 360 degree (radial) ultrasound image. C150569 Diagnostic Procedure Radial Probe Endobronchial Ultrasound Radial Probe Endobronchial Ultrasound CL552353 CTRP RP-EBUS Radial EBUS Radial Endobronchial Ultrasound Radial Probe EBUS Radial Probe Endobronchial Ultrasound Radial-Probe Endobronchial Ultrasound Radial Probe Endobronchial Ultrasound A carcinoma that arises from the bladder mucosa and invades the bladder wall. C150570 Neoplastic Process Infiltrating Bladder Carcinoma Invasive Bladder Carcinoma CL552348 CTRP Malignant Infiltrating Bladder Cancer Infiltrating Bladder Carcinoma Invasive Bladder Carcinoma Invasive Bladder Carcinoma A carcinoma that arises from the bladder mucosa and invades the muscle of the bladder wall. C150572 Neoplastic Process Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall Muscle Invasive Bladder Carcinoma CL552350 CTRP Malignant Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall Muscle Invasive Bladder Carcinoma Muscle-Invasive Bladder Carcinoma Muscle Invasive Bladder Carcinoma A cerebral neoplasm that is confined to a specific site without evidence of spread to other anatomic sites. C150573 Neoplastic Process Localized Cerebral Neoplasm CL552349 Undetermined Localized Cerebral Neoplasm Non-Metastatic Cerebral Neoplasm Localized Cerebral Neoplasm Any of various magnetic resonance (MR) imaging techniques with predictive power beyond that achievable with conventional contrast-enhanced MR, such as diffusion MRI, perfusion MRI, functional MRI, dynamic susceptibility contrast MRI, dynamic contrast enhancement MRI, higher order diffusion techniques such as diffusion tensor imaging, and MR spectroscopy. C150575 Diagnostic Procedure Advanced Magnetic Resonance Imaging Advanced Magnetic Resonance Imaging CL552343 CTRP AMRI Advanced Magnetic Resonance Imaging Advanced Magnetic Resonance Imaging Gastroesophageal junction adenocarcinoma which has spread from its original site of growth to another anatomic site. C150577 Neoplastic Process Metastatic Gastroesophageal Junction Adenocarcinoma Metastatic Gastroesophageal Junction Adenocarcinoma CL552345 CTRP Malignant Metastatic Gastroesophageal Junction Adenocarcinoma Metastatic Gastroesophageal Junction Adenocarcinoma Gastroesophageal junction adenocarcinoma that is not amenable to surgical resection. C150578 Neoplastic Process Unresectable Gastroesophageal Junction Adenocarcinoma CL552340 Malignant Unresectable Gastroesophageal Junction Adenocarcinoma Unresectable Gastroesophageal Junction Adenocarcinoma The reemergence of myxoid liposarcoma after a period of remission. C150579 Neoplastic Process Recurrent Myxoid Liposarcoma CL552339 Malignant Recurrent Myxoid Liposarcoma Recurrent Myxoid/Round Cell Liposarcoma Recurrent Myxoid Liposarcoma Adrenal cortical carcinoma that is not amenable to surgical resection. C150580 Neoplastic Process Unresectable Adrenal Cortical Carcinoma CL552342 Malignant Unresectable Adrenal Cortex Carcinoma Unresectable Adrenal Cortical Carcinoma Unresectable Adrenal Cortical Carcinoma Small cell lung carcinoma that does not respond to treatment. C150581 Neoplastic Process Refractory Lung Small Cell Carcinoma CL554813 Malignant Refractory Lung Small Cell Carcinoma Refractory Small Cell Lung Carcinoma Refractory Lung Small Cell Carcinoma Monoclonal gammopathy of undetermined significance defined by the presence in the serum of an IgG, IgA, or (rarely) IgD paraprotein at a concentration of less than 30g/L; clonal bone marrow plasma cells less than 10%; and absence of end-organ damage such as hypercalcemia, renal insufficiency, anemia, bone marrow lesions, and amyloidosis attributable to the plasma cell proliferative disorder. The risk of progression to plasma cell myeloma, light-chain amyloidosis, or a related disorder is 1% per year. (WHO 2017) C150588 Neoplastic Process Non-IgM Monoclonal Gammopathy of Undetermined Significance Non-IgM Monoclonal Gammopathy of Undetermined Significance CL552334 CTRP Undetermined Non-IgM MGUS Non-IgM Monoclonal Gammopathy of Undetermined Significance Non-IgM Monoclonal Gammopathy of Undetermined Significance A distinctive variant of follicular lymphoma arising from the testis. It has been reported with higher frequency in children, but is also seen rarely in adults. It differs biologically from nodal follicular lymphoma because it lacks evidence of the BCL2 translocation. It is usually of high cytological grade, usually grade 3A, but has a good prognosis, even without additional therapy beyond surgical excision. (WHO 2017) C150589 Neoplastic Process Testicular Follicular Lymphoma Testicular Follicular Lymphoma CL552333 CTRP Malignant PFLT Testicular Follicular Lymphoma Testicular Follicular Lymphoma The reemergence of dedifferentiated liposarcoma after a period of remission. C150592 Neoplastic Process Recurrent Dedifferentiated Liposarcoma Recurrent Dedifferentiated Liposarcoma CL552327 CTRP Malignant Recurrent Dedifferentiated Liposarcoma Recurrent Dedifferentiated Liposarcoma Dedifferentiated liposarcoma that does not respond to treatment. C150593 Neoplastic Process Refractory Dedifferentiated Liposarcoma Refractory Dedifferentiated Liposarcoma CL552330 CTRP Malignant Refractory Dedifferentiated Liposarcoma Refractory Dedifferentiated Liposarcoma Liposarcoma that does not respond to treatment. C150594 Neoplastic Process Refractory Liposarcoma Refractory Liposarcoma CL552329 CTRP Malignant Refractory Liposarcoma Refractory Liposarcoma Renal cell carcinoma that has spread from the kidney to other anatomic sites. C150595 Neoplastic Process Metastatic Renal Cell Carcinoma Metastatic Renal Cell Carcinoma CL552324 CTRP Malignant Metastatic Renal Cell Cancer Metastatic Renal Cell Carcinoma Metastatic Renal Cell Carcinoma Dedifferentiated liposarcoma that is not amenable to surgical resection. C150598 Neoplastic Process Unresectable Dedifferentiated Liposarcoma Unresectable Dedifferentiated Liposarcoma CL552325 CTRP Malignant Unresectable Dedifferentiated Liposarcoma Unresectable Dedifferentiated Liposarcoma Sarcoma that is amenable to surgical resection. C150605 Neoplastic Process Resectable Sarcoma Resectable Sarcoma CL552318 CTRP Malignant Resectable Sarcoma Resectable Sarcoma Liposarcoma that is amenable to surgical resection. C150606 Neoplastic Process Resectable Liposarcoma Resectable Liposarcoma CL552321 CTRP Malignant Resectable Liposarcoma Resectable Liposarcoma Dedifferentiated liposarcoma that is amenable to surgical resection. C150607 Neoplastic Process Resectable Dedifferentiated Liposarcoma Resectable Dedifferentiated Liposarcoma CL552320 CTRP Malignant Resectable Dedifferentiated Liposarcoma Resectable Dedifferentiated Liposarcoma Undifferentiated pleomorphic sarcoma that is not amenable to surgical resection. C150610 Neoplastic Process Unresectable Undifferentiated Pleomorphic Sarcoma Unresectable Undifferentiated Pleomorphic Sarcoma CL552317 CTRP Malignant Unresectable Undifferentiated Pleomorphic Sarcoma Unresectable Undifferentiated Pleomorphic Sarcoma Undifferentiated pleomorphic sarcoma that is amenable to surgical resection. C150611 Neoplastic Process Resectable Undifferentiated Pleomorphic Sarcoma Resectable Undifferentiated Pleomorphic Sarcoma CL552316 CTRP Malignant Resectable Undifferentiated Pleomorphic Sarcoma Resectable Undifferentiated Pleomorphic Sarcoma Neuroblastoma that is amenable to surgical resection. C150620 Neoplastic Process Resectable Neuroblastoma Resectable Neuroblastoma CL552304 CTRP Malignant Resectable Neuroblastoma Resectable Neuroblastoma Neuroblastoma which is not amenable to surgical resection. C150622 Neoplastic Process Unresectable Neuroblastoma Unresectable Neuroblastoma CL552306 CTRP Malignant Unresectable Neuroblastoma Unresectable Neuroblastoma A non-Hodgkin or Hodgkin lymphoma that develops in patients who are immunosuppressed with methotrexate. C150678 Neoplastic Process Methotrexate-Associated Lymphoma CL552569 CPTAC Malignant Methotrexate-Associated Lymphoma Methotrexate-Associated Lymphoma This category includes two main sub-groups, according to the degree of cytological atypia and clinical aggressiveness: Langerhans cell histiocytosis and Langerhans cell sarcoma. (WHO 2017) C150692 Neoplastic Process Tumors Derived from Langerhans Cells CL552494 Undetermined Tumors Derived from Langerhans Cells Tumors Derived from Langerhans Cells Langerhans cell histiocytosis presenting as a solitary lesion. C150701 Neoplastic Process Langerhans Cell Histiocytosis, Monostotic CL552503 GDC Undetermined Langerhans cell histiocytosis, mono-ostotic Langerhans cell histiocytosis, unifocal Langerhans Cell Histiocytosis, Monostotic Langerhans cell histiocytosis, mono-ostotic Langerhans Cell Histiocytosis, Monostotic Langerhans cell histiocytosis presenting with multiple sites of involvement. C150702 Neoplastic Process Langerhans Cell Histiocytosis, Polyostotic CL552504 GDC Undetermined Langerhans cell histiocytosis, multifocal Langerhans cell histiocytosis, poly-ostotic Langerhans Cell Histiocytosis, Polyostotic Langerhans cell histiocytosis, poly-ostotic Langerhans Cell Histiocytosis, Polyostotic Langerhans cell histiocytosis presenting with disseminated disease. C150703 Neoplastic Process Langerhans Cell Histiocytosis, Disseminated CL480899 GDC Undetermined Langerhans cell histiocytosis, disseminated Langerhans cell histiocytosis, generalized Langerhans Cell Histiocytosis, Disseminated Langerhans cell histiocytosis, disseminated Langerhans Cell Histiocytosis, Disseminated EBV-positive inflammatory follicular dendritic cell/fibroblastic reticular cell tumor that arises from the digestive system. C150704 Neoplastic Process EBV-Positive Inflammatory Follicular Dendritic Cell/Fibroblastic Reticular Cell Tumor of the Digestive System CL552505 Malignant EBV-Positive Inflammatory Follicular Dendritic Cell Sarcoma of the Digestive System EBV-Positive Inflammatory Follicular Dendritic Cell Tumor of the Digestive System EBV-Positive Inflammatory Follicular Dendritic Cell/Fibroblastic Reticular Cell Tumor of the Digestive System Epstein-Barr Virus Positive Inflammatory Follicular Dendritic Cell Sarcoma of the Digestive System Epstein-Barr Virus-Positive Inflammatory Follicular Dendritic Cell Sarcoma of the Digestive System Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma of the Digestive System EBV-Positive Inflammatory Follicular Dendritic Cell/Fibroblastic Reticular Cell Tumor of the Digestive System Gastrointestinal stromal tumor which has spread from its original site of growth to another anatomic site. C150738 Neoplastic Process Metastatic Gastrointestinal Stromal Tumor Metastatic Gastrointestinal Stromal Tumor CL552523 CTRP Malignant Metastatic Gastrointestinal Stromal Tumor Metastatic Gastrointestinal Stromal Tumor (GIST) Metastatic Gastrointestinal Stromal Tumor Gastrointestinal stromal tumor that has spread from its original site of growth to nearby tissues or lymph nodes. C150739 Neoplastic Process Locally Advanced Gastrointestinal Stromal Tumor Locally Advanced Gastrointestinal Stromal Tumor CL552524 CTRP Malignant Locally Advanced Gastrointestinal Stromal Tumor Locally Advanced Gastrointestinal Stromal Tumor (GIST) Locally Advanced Gastrointestinal Stromal Tumor Malignant gastrointestinal stromal tumor that is not amenable to surgical resection. C150741 Neoplastic Process Unresectable Gastrointestinal Stromal Tumor Unresectable Malignant Gastrointestinal Stromal Tumor CL552525 CTRP Malignant Unresectable Gastrointestinal Stromal Tumor Unresectable Gastrointestinal Stromal Tumor (GIST) Unresectable Malignant Gastrointestinal Stromal Tumor Unresectable Malignant Gastrointestinal Stromal Tumor The skin or integument covering the buttocks. C150855 Anatomical Structure Skin of the Buttock C0222165 CDISC The integument that covers the buttock. SKIN OF THE BUTTOCK Skin of the Buttock Skin of the Buttock A method of empirically measuring the velocity and attenuation of ultrasonic sound waves as they pass through tissue. C150873 Health Care Activity Quantitative Ultrasound CL552619 CDISC A type of ultrasound method in which the velocity and attenuation of ultrasonic sound waves are measured as they pass through tissue. QUANTITATIVE ULTRASOUND Quantitative Ultrasound Quantitative Ultrasound The lymph node or group of lymph nodes that drain a particular anatomic site or organ. C150905 Body Part, Organ, or Organ Component Draining Lymph Node CL552751 CDISC The lymph node or group of lymph nodes that drain a particular anatomic site or organ. Draining Lymph Node LYMPH NODE, DRAINING Draining Lymph Node Surgical removal of part or all of the adrenal gland. C15177 Therapeutic or Preventive Procedure Adrenalectomy Adrenalectomy C0001632 CTRP Surgery to remove one or both adrenal glands (a small organ on top of each kidney). Adrenalectomy Adrenal Gland Excision Adrenalectomy Excision of Adrenal Gland adrenalectomy Adrenalectomy Familial hematologic neoplasms associated with germline mutations without a preexisting disorder or organ dysfunction. C151897 Neoplastic Process Hematologic Neoplasm with Germline Predisposition without a Constitutional Disorder Affecting Multiple Organ Systems CL553241 Malignant Hematologic Neoplasm with Germline Predisposition without a Constitutional Disorder Affecting Multiple Organ Systems Hematologic Neoplasm with Germline Predisposition without a Preexisting Disorder or Organ Dysfunction Myeloid Neoplasm with Germline Predisposition without a Preexisting Disorder or Organ Dysfunction Hematologic Neoplasm with Germline Predisposition without a Constitutional Disorder Affecting Multiple Organ Systems Familial acute myeloid leukemia (AML) syndrome associated with biallelic CEBPA mutations. Patients typically present with AML as children or young adults. The familial form of AML with germline CEBPA mutation has morphological and immunophenotypic features similar to those of sporadic AML with CEBPA mutations. Overall, it has a favorable prognosis. (WHO 2017) C151898 Neoplastic Process Acute Myeloid Leukemia with Germline CEBPA Mutation C3711382 Malignant Acute Myeloid Leukemia with Germline Biallelic CEBPA Mutations Acute Myeloid Leukemia with Germline CEBPA Mutation Familial Acute Myeloid Leukemia with Mutated CEBPA Acute Myeloid Leukemia with Germline CEBPA Mutation An autosomal dominant familial myelodysplastic syndrome/acute myeloid leukemia syndrome characterized by inherited mutations in the gene on chromosome 5 encoding the DEAD box RNA helicase DDX41. Patients usually present with leukopenia, hypocellular bone marrow with prominent erythroid dysplasia and a normal karyotype, often leading to erythroleukemia. The prognosis is generally poor. (WHO 2017) C151901 Neoplastic Process Hematologic Neoplasm with Germline DDX41 Mutation CL553244 Malignant Hematologic Neoplasm with Germline DDX41 Mutation Hematologic Neoplasm with Germline DDX41 Mutation Hematologic neoplasms associated with germline mutations and familial platelet disorders. C151902 Neoplastic Process Hematologic Neoplasm with Germline Predisposition Associated with a Constitutional Platelet Disorder CL553245 Malignant Hematologic Neoplasm with Germline Predisposition Associated with a Constitutional Platelet Disorder Hematologic Neoplasm with Germline Predisposition and Preexisting Platelet Disorder Myeloid Neoplasm with Germline Predisposition and Preexisting Platelet Disorder Hematologic Neoplasm with Germline Predisposition Associated with a Constitutional Platelet Disorder An autosomal dominant syndrome characterized by abnormalities in platelet number and function and enhanced risk of developing myelodysplastic syndrome/acute myeloid leukemia at a young age. Patients have germline monoallelic mutations in RUNX1 gene. The clinical presentation is variable, even within the same family. Most affected individuals have a mild to moderate bleeding tendency. Platelet counts are normal or mildly reduced, with normal platelet morphology and variable degrees of platelet dysfunction. Distinct families with germline RUNX1 mutations exhibit varying risks of development of myeloid neoplasms with 11-100% (median: 44%) of family members affected. (WHO 2017) C151903 Neoplastic Process Hematologic Neoplasm with Germline RUNX1 Mutation CL553246 Malignant Hematologic Neoplasm with Germline RUNX1 Mutation Hematologic Neoplasm with Germline RUNX1 Mutation A digestive system carcinoma that has metastasized to another anatomic site and is resistant to treatment. C151904 Neoplastic Process Refractory Metastatic Digestive System Carcinoma Refractory Metastatic Digestive System Carcinoma CL553247 CTRP Malignant Refractory Metastatic Digestive System Carcinoma Refractory Metastatic Gastrointestinal System Carcinoma Refractory Metastatic Digestive System Carcinoma The reemergence of a metastatic digestive system carcinoma after a period of remission. C151905 Neoplastic Process Recurrent Metastatic Digestive System Carcinoma Recurrent Metastatic Digestive System Carcinoma CL553248 CTRP Malignant Recurrent Metastatic Digestive System Carcinoma Recurrent Metastatic Gastrointestinal System Carcinoma Recurrent Metastatic Digestive System Carcinoma A carcinoma hat arises from any part of the digestive system and is resistant to treatment. C151906 Neoplastic Process Refractory Digestive System Carcinoma Refractory Digestive System Carcinoma CL553249 CTRP Malignant Refractory Digestive System Carcinoma Refractory Gastrointestinal System Carcinoma Refractory Digestive System Carcinoma A head and neck carcinoma that does not respond to treatment. C151907 Neoplastic Process Refractory Head and Neck Carcinoma CL553250 Malignant Refractory Head and Neck Carcinoma Refractory Head and Neck Carcinoma An autosomal dominant disorder characterized by moderate thrombocytopenia and increased risk of developing myelodysplastic syndrome/acute myeloid leukemia. This disorder is characterized by germline mutations in ANKRD26, located on chromosome band 10p12.1. (WHO 2017) C151908 Neoplastic Process Hematologic Neoplasm with Germline ANKRD26 Mutation CL553251 Malignant Hematologic Neoplasm with Germline ANKRD26 Mutation Myeloid Neoplasm with Germline ANKRD26 Mutation Hematologic Neoplasm with Germline ANKRD26 Mutation Familial hematologic neoplasms associated with germline mutations and a preexisting disorder or organ dysfunction other than a platelet disorder. C151910 Neoplastic Process Hematologic Neoplasm with Germline Predisposition Associated with a Constitutional Disorder Affecting Multiple Organ Systems CL553253 Malignant Hematologic Neoplasm with Germline Predisposition Associated with Other Organ Dysfunction Hematologic Neoplasm with Germline Predisposition Associated with a Constitutional Disorder Affecting Multiple Organ Systems Myeloid Neoplasm with Germline Predisposition Associated with Other Organ Dysfunction Hematologic Neoplasm with Germline Predisposition Associated with a Constitutional Disorder Affecting Multiple Organ Systems Autosomal dominant familial thrombocytopenia associated with germline ETV6 mutation and hematologic malignancies. The hematologic malignancies reported are diverse, including myelodysplastic syndrome, acute myeloid leukemia, chronic myelomonocytic leukemia, B lymphoblastic leukemia, and plasma cell myeloma. Non-hematological neoplasms, including colorectal adenocarcinoma, have been also reported in affected families. (WHO 2017) C151911 Neoplastic Process Hematologic Neoplasm with Germline ETV6 Mutation CL553254 Malignant Hematologic Neoplasm with Germline ETV6 Mutation Hematologic Neoplasm with Germline ETV6 Mutation Myelodysplastic syndromes/acute myeloid leukemias associated with germline GATA2 mutation. C151912 Neoplastic Process Hematologic Neoplasm with Germline GATA2 Mutation CL553255 Malignant Hematologic Neoplasm with Germline GATA2 Mutation Myeloid Neoplasm with Germline GATA2 Mutation Hematologic Neoplasm with Germline GATA2 Mutation Familial myelodysplastic syndromes/ acute myeloid leukemias associated with telomerase biology disorders. C151921 Neoplastic Process Hematologic Neoplasm with Germline Predisposition Associated with Telomerase Biology Disorder CL553261 Malignant Hematologic Neoplasm with Germline Predisposition Associated with Telomerase Biology Disorder Myeloid Neoplasm with Germline Predisposition Associated with Telomerase Biology Disorder Hematologic Neoplasm with Germline Predisposition Associated with Telomerase Biology Disorder Familial myelodysplastic syndromes/ acute myeloid leukemias associated with inherited bone marrow failure syndromes. C151922 Neoplastic Process Hematologic Neoplasm with Germline Predisposition Associated with Inherited Bone Marrow Failure Syndrome CL553262 Malignant Hematologic Neoplasm Associated with Inherited Bone Marrow Failure Syndrome Hematologic Neoplasm with Germline Predisposition Associated with Inherited Bone Marrow Failure Syndrome Myeloid Neoplasm Associated with Inherited Bone Marrow Failure Syndrome Myeloid Neoplasm with Germline Predisposition Associated with Inherited Bone Marrow Failure Syndrome Hematologic Neoplasm with Germline Predisposition Associated with Inherited Bone Marrow Failure Syndrome Histologic transformation of a usually indolent non-Hodgkin lymphoma to an aggressive non-Hodgkin lymphoma. C151957 Neoplastic Process Transformed Non-Hodgkin Lymphoma Transformed Non-Hodgkin Lymphoma CL553185 CTRP Malignant Transformed Non-Hodgkin Lymphoma Transformed Non-Hodgkin Lymphoma A bile duct carcinoma that has spread to nearby tissues or lymph nodes. C151971 Neoplastic Process Locally Advanced Bile Duct Carcinoma Locally Advanced Bile Duct Carcinoma CL553193 CTRP Malignant Locally Advanced Bile Duct Cancer Locally Advanced Bile Duct Carcinoma Locally Advanced Bile Duct Carcinoma Acute leukemia of ambiguous lineage, expressing combinations of markers that do not allow for its classification as either acute undifferentiated leukemia or mixed phenotype acute leukemia, and definitive classification along a single lineage is difficult. (WHO 2017) C151975 Neoplastic Process Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified CL553197 Malignant Acute Leukemia of Ambiguous Lineage, NOS Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified The reemergence of Burkitt leukemia after a period of remission. C151976 Neoplastic Process Recurrent Burkitt Leukemia Recurrent Burkitt Leukemia CL553198 CTRP mCode Malignant Mature B-cell leukemia Burkitt-type, in relapse Recurrent Burkitt Leukemia Recurrent Burkitt Leukemia Burkitt leukemia resistant to treatment. C151977 Neoplastic Process Refractory Burkitt Leukemia Refractory Burkitt Leukemia CL553199 CTRP Malignant Refractory Burkitt Leukemia Refractory Burkitt Leukemia Lymphoblastic lymphoma that is resistant to treatment. C151978 Neoplastic Process Refractory Lymphoblastic Lymphoma Refractory Lymphoblastic Lymphoma CL553200 CTRP Malignant Refractory Lymphoblastic Lymphoma Refractory Lymphoblastic Lymphoma High-grade B-cell lymphoma with MYC and BCL2 or BCL6 rearrangements that is resistant to treatment. C151979 Neoplastic Process Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements CL553201 CTRP Malignant Refractory Double-Hit Lymphoma Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements Refractory High-Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements Surgical removal of the ovaries or testes. C15198 Therapeutic or Preventive Procedure Surgical Castration Surgical Castration C0007344 CTRP Surgical removal of the testicles (orchiectomy) or ovaries (oophorectomy) to stop the production of sex hormones. Decreasing the levels of hormones may stop the growth of certain cancers. Surgical_Castration Castration Surgical Castration castration surgical castration Surgical Castration The reemergence of high-grade B-cell lymphoma with MYC and BCL2 or BCL6 rearrangements after a period of remission. C151980 Neoplastic Process Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements CL553202 CTRP Malignant Recurrent Double-Hit Lymphoma Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements Recurrent High-Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements Rhabdomyosarcoma involving the organs and structures in the pelvis. C151981 Neoplastic Process Pelvic Rhabdomyosarcoma Pelvic Rhabdomyosarcoma CL553203 CTRP Malignant Pelvic Rhabdomyosarcoma Pelvic Rhabdomyosarcoma Rhabdomyosarcoma involving the organs and structures in the abdomen. C151982 Neoplastic Process Abdominal Rhabdomyosarcoma Abdominal Rhabdomyosarcoma CL553204 CTRP Malignant Abdominal Rhabdomyosarcoma Abdominal Rhabdomyosarcoma Rhabdomyosarcoma which is not amenable to surgical resection. C151983 Neoplastic Process Unresectable Rhabdomyosarcoma Unresectable Rhabdomyosarcoma CL553205 CTRP Malignant Unresectable Rhabdomyosarcoma Unresectable Rhabdomyosarcoma Undifferentiated high grade pleomorphic sarcoma involving the bones of the pelvis. C151984 Neoplastic Process Pelvic Undifferentiated Pleomorphic Sarcoma Pelvic Undifferentiated High Grade Pleomorphic Sarcoma CL553206 CTRP Malignant Pelvic Undifferentiated High Grade Pleomorphic Sarcoma Undifferentiated High Grade Pleomorphic Sarcoma of the Pelvis Undifferentiated Pelvic Pleomorphic Sarcoma Pelvic Undifferentiated High Grade Pleomorphic Sarcoma Undifferentiated pleomorphic sarcoma involving the organs and structures in the abdomen. C151985 Neoplastic Process Abdominal Undifferentiated Pleomorphic Sarcoma Abdominal Undifferentiated Pleomorphic Sarcoma CL553207 CTRP Malignant Abdominal Undifferentiated Pleomorphic Sarcoma Undifferentiated Abdominal Pleomorphic Sarcoma Abdominal Undifferentiated Pleomorphic Sarcoma A very rare mixed phenotype acute leukemia in which the blasts express combinations of B, T, myeloid, and megakaryocytic lineage markers but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. The prognosis is usually unfavorable. C151990 Neoplastic Process Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes Mixed Phenotype Acute Leukemia, Rare Types CL553211 CTRP Malignant Mixed Phenotype Acute Leukemia, NOS, Rare Subtypes Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes Mixed Phenotype Acute Leukemia, Rare Subtypes Mixed Phenotype Acute Leukemia, Rare Types Mixed Phenotype Acute Leukemia, Rare Types A very rare mixed phenotype acute leukemia in which the blasts show evidence of B-cell, T-cell, and myeloid lineage but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. C151991 Neoplastic Process Mixed Phenotype Acute Leukemia, B/T/Myeloid, Not Otherwise Specified Mixed Phenotype Acute Leukemia, B/T/Myeloid CL553212 CTRP Malignant MPAL-B/T/M Mixed Phenotype Acute Leukemia, B/T/Myeloid Mixed Phenotype Acute Leukemia, B/T/Myeloid, NOS Mixed Phenotype Acute Leukemia, B/T/Myeloid, Not Otherwise Specified Mixed Phenotype Acute Leukemia, B/T/Myeloid A very rare mixed phenotype acute leukemia in which the blasts show clear-cut evidence of both B-cell and T-cell lineage but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. C151992 Neoplastic Process Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified Mixed Phenotype Acute Leukemia, B/T CL553213 CTRP Malignant MPAL-B/T Mixed Phenotype Acute Leukemia, B/T Mixed Phenotype Acute Leukemia, B/T, NOS Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified Mixed Phenotype Acute Leukemia, B/T A pancreatic ductal adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C151993 Neoplastic Process Locally Advance Pancreatic Ductal Adenocarcinoma Locally Advanced Pancreatic Ductal Adenocarcinoma CL553214 CTRP Malignant Locally Advanced Pancreatic Ductal Adenocarcinoma Locally Advanced Pancreatic Ductal Adenocarcinoma Pancreatic ductal adenocarcinoma amenable to surgical resection. C151995 Neoplastic Process Resectable Pancreatic Ductal Adenocarcinoma Resectable Pancreatic Ductal Adenocarcinoma CL553216 CTRP Malignant Resectable Pancreatic Ductal Adenocarcinoma Resectable Pancreatic Ductal Adenocarcinoma An adenocarcinoma arising from the lower third of the esophagus. The vast majority of esophageal adenocarcinomas involve the lower third of the esophagus. C152036 Neoplastic Process Distal Esophagus Adenocarcinoma Distal Esophagus Adenocarcinoma CL553371 CTRP Malignant Adenocarcinoma of the Lower Third of the Esophagus Distal Esophagus Adenocarcinoma Distal Esophagus Adenocarcinoma Primary peritoneal carcinoma that is resistant to treatment. C152046 Neoplastic Process Refractory Primary Peritoneal Carcinoma Refractory Primary Peritoneal Carcinoma CL553381 CTRP Malignant Refractory Primary Peritoneal Cancer Refractory Primary Peritoneal Carcinoma Refractory Primary Peritoneal Carcinoma Fallopian tube carcinoma that is resistant to treatment. C152047 Neoplastic Process Refractory Fallopian Tube Carcinoma Refractory Fallopian Tube Carcinoma CL553382 CTRP Malignant Refractory Fallopian Tube Cancer Refractory Fallopian Tube Carcinoma Refractory Fallopian Tube Carcinoma Female reproductive system carcinoma that is resistant to treatment. C152048 Neoplastic Process Refractory Female Reproductive System Carcinoma CL553383 Malignant Refractory Female Reproductive System Cancer Refractory Female Reproductive System Carcinoma Refractory Female Reproductive System Carcinoma A metastatic sarcoma that is not amenable to surgical resection. C152074 Neoplastic Process Metastatic Unresectable Sarcoma Metastatic Unresectable Sarcoma CL553283 CTRP Malignant Metastatic Unresectable Sarcoma Metastatic Unresectable Sarcoma A sarcoma that has spread from its original site of growth to another anatomic site. C152076 Neoplastic Process Metastatic Sarcoma C0748505 CPTAC Malignant Metastatic Sarcoma Metastatic Sarcoma The reemergence of a malignant head and neck neoplasm after a period of remission. C152077 Neoplastic Process Recurrent Malignant Head and Neck Neoplasm CL553285 Malignant Recurrent Head and Neck Cancer Recurrent Malignant Head and Neck Neoplasm Recurrent Malignant Head and Neck Neoplasm A malignant head and neck neoplasm that is resistant to treatment. C152078 Neoplastic Process Refractory Malignant Head and Neck Neoplasm CL553286 Malignant Refractory Head and Neck Cancer Refractory Malignant Head and Neck Neoplasm Refractory Malignant Head and Neck Neoplasm The administration of estrogen, especially in postmenopausal women, to relieve menopausal symptoms and to protect against osteoporosis and heart disease. (Bartleby.com) C15231 Therapeutic or Preventive Procedure Estrogen Replacement Therapy C0014935 Hormones (estrogen, progesterone, or both) given to postmenopausal women or to women who have had their ovaries surgically removed. Hormones are given to replace the estrogen no longer produced by the ovaries. Estrogen_Replacement_Therapy ERT Estrogen Replacement Estrogen Replacement Therapy estrogen replacement therapy Estrogen Replacement Therapy C15251 Therapeutic or Preventive Procedure Postmenopausal Hormone Replacement Therapy C0019930 Postmenopausal_Hormone_Replacement_Therapy Postmenopausal Hormone Replacement Therapy Postmenopausal Hormone Replacement Therapy Surgical removal of part or all of the pituitary gland. C15255 Therapeutic or Preventive Procedure Hypophysectomy C0020632 Hypophysectomy Excision of the Hypophysis Excision of the Pituitary Gland Excision of the Pituitary Gland+B3297 Hypophysectomy Hypophysis Cerebri Excision Hypophysis Excision Pituitary Gland Excision Pituitectomy Hypophysectomy Surgical removal of one or both testicles. C15288 Therapeutic or Preventive Procedure Orchiectomy Orchiectomy C0029189 CTRP GDC OORO Surgery to remove one or both testicles. Orchiectomy Orchiectomy Testis Removed Castration Male Castration Male Gonadectomy Orchiectomy Testis Removed orchidectomy orchiectomy Orchiectomy Partial or complete removal of one or both of the ovaries. C15291 Therapeutic or Preventive Procedure Oophorectomy Oophorectomy C0029936 CPTAC CTRP GDC Surgery to remove one or both ovaries. Oophorectomy Oophorectomy Female Castration Oophorectomy Ovariectomy oophorectomy Oophorectomy Soft tissue sarcoma that has spread from its original site of growth to nearby tissues or lymph nodes. C153066 Neoplastic Process Locally Advanced Soft Tissue Sarcoma Locally Advanced Soft Tissue Sarcoma CL554213 CTRP Malignant Locally Advanced Soft Tissue Sarcoma Locally Advanced Soft Tissue Sarcoma Soft tissue sarcoma that is not amenable to surgical resection. C153068 Neoplastic Process Unresectable Soft Tissue Sarcoma Unresectable Soft Tissue Sarcoma CL554215 CTRP Malignant Unresectable Soft Tissue Sarcoma Unresectable Soft Tissue Sarcoma Soft tissue sarcoma that has spread from the original site of growth to another anatomic site. C153069 Neoplastic Process Metastatic Soft Tissue Sarcoma Metastatic Soft Tissue Sarcoma CL554216 CTRP Malignant Metastatic Soft Tissue Sarcoma Metastatic Soft Tissue Sarcoma Bone sarcoma that has spread from its original site of growth to nearby tissues or lymph nodes. C153070 Neoplastic Process Locally Advanced Bone Sarcoma Locally Advanced Bone Sarcoma CL554217 CTRP Malignant Locally Advanced Bone Sarcoma Locally Advanced Bone Sarcoma Sarcoma that has spread from its original site of growth to nearby tissues or lymph nodes. C153071 Neoplastic Process Locally Advanced Sarcoma CL554218 Malignant Locally Advanced Sarcoma Locally Advanced Sarcoma Bone sarcoma that is not amenable to surgical resection. C153072 Neoplastic Process Unresectable Bone Sarcoma Unresectable Bone Sarcoma CL554219 CTRP Malignant Unresectable Bone Sarcoma Unresectable Bone Sarcoma Bone sarcoma that has spread from the original site of growth to another anatomic site. C153073 Neoplastic Process Metastatic Bone Sarcoma Metastatic Bone Sarcoma CL554220 CTRP Malignant Metastatic Bone Sarcoma Metastatic Bone Sarcoma Synovial sarcoma that is not amenable to surgical resection. C153074 Neoplastic Process Unresectable Synovial Sarcoma Unresectable Synovial Sarcoma CL554221 CTRP Malignant Unresectable Synovial Sarcoma Unresectable Synovial Sarcoma Pancreatic neuroendocrine carcinoma that has spread from the original site of growth to another anatomic site. C153075 Neoplastic Process Metastatic Pancreatic Neuroendocrine Carcinoma Metastatic Pancreatic Neuroendocrine Carcinoma CL554222 CTRP Malignant Metastatic Pancreatic Neuroendocrine Cancer Metastatic Pancreatic Neuroendocrine Carcinoma Metastatic Pancreatic Neuroendocrine Carcinoma Pancreatic neuroendocrine carcinoma that is not amenable to surgical resection. C153079 Neoplastic Process Unresectable Pancreatic Neuroendocrine Carcinoma Unresectable Pancreatic Neuroendocrine Carcinoma CL554226 CTRP Malignant Unresectable Pancreatic Neuroendocrine Cancer Unresectable Pancreatic Neuroendocrine Carcinoma Unresectable Pancreatic Neuroendocrine Carcinoma Neuroendocrine tumor grade 1 that is not amenable to surgical resection. C153080 Neoplastic Process Unresectable Carcinoid Tumor Unresectable Neuroendocrine Tumor G1 CL554227 CTRP Malignant Unresectable Carcinoid Tumor Unresectable Neuroendocrine Tumor G1 Unresectable Neuroendocrine Tumor G1 Non-small cell lung carcinoma that does not respond to treatment. C153081 Neoplastic Process Refractory Non-Small Cell Lung Carcinoma Refractory Lung Non-Small Cell Carcinoma CL554814 CTRP Malignant Refractory Lung Non-Small Cell Carcinoma Refractory Non-Small Cell Lung Cancer Refractory Non-Small Cell Lung Carcinoma Refractory Lung Non-Small Cell Carcinoma Soft tissue sarcoma that is amenable to surgical resection. C153086 Neoplastic Process Resectable Soft Tissue Sarcoma CL554231 Malignant Resectable Soft Tissue Sarcoma Resectable Soft Tissue Sarcoma The reemergence of hepatosplenic T-cell lymphoma after a period of remission. C153160 Neoplastic Process Recurrent Hepatosplenic T-Cell Lymphoma CL554299 Malignant Recurrent Hepatosplenic T-Cell Lymphoma Recurrent Hepatosplenic T-Cell Lymphoma Hepatosplenic T-cell lymphoma that is resistant to treatment. C153161 Neoplastic Process Refractory Hepatosplenic T-Cell Lymphoma CL554300 Malignant Refractory Hepatosplenic T-Cell Lymphoma Refractory Hepatosplenic T-Cell Lymphoma Renal cell carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C153170 Neoplastic Process Advanced Renal Cell Carcinoma CL554305 Malignant Advanced Renal Cell Carcinoma Advanced Renal Cell Carcinoma Lymphoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C153172 Neoplastic Process Advanced Lymphoma Advanced Lymphoma CL554307 CPTAC CTRP Malignant Advanced Lymphoma Advanced Lymphoma The reemergence of a mediastinal lymphoma after a period of remission. C153175 Neoplastic Process Recurrent Mediastinal Lymphoma CL554309 Malignant Recurrent Mediastinal Lymphoma Recurrent Primary Mediastinal Lymphoma Recurrent Mediastinal Lymphoma Mediastinal lymphoma that is resistant to treatment. C153177 Neoplastic Process Refractory Mediastinal Lymphoma CL554311 Malignant Refractory Mediastinal Lymphoma Refractory Primary Mediastinal Lymphoma Refractory Mediastinal Lymphoma A mammography technique that incorporates the administration of an iodinated contrast agent to enhance lesions that are not visible on standard mammograms. CEM provides low-energy 2D mammographic images analogous to digital mammography and contrast-enhanced recombined images that allow assessment of neovascularity similar to that offered by MRI. C153181 Diagnostic Procedure Contrast-Enhanced Mammography Contrast-Enhanced Mammography CL554313 CTRP CEM Contrast-Enhanced Mammography Contrast-Enhanced Mammography A squamous cell carcinoma of the skin that has spread from its original site of growth to nearby tissues or lymph nodes. C153182 Neoplastic Process Locally Advanced Skin Squamous Cell Carcinoma CL554314 Malignant Locally Advanced Cutaneous Squamous Cell Carcinoma Locally Advanced Skin Squamous Cell Carcinoma Locally Advanced Skin Squamous Cell Carcinoma A synovial sarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C153184 Neoplastic Process Advanced Synovial Sarcoma CL554315 Malignant Advanced Synovial Sarcoma Advanced Synovial Sarcoma A sarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C153185 Neoplastic Process Advanced Sarcoma CL554316 Malignant Advanced Sarcoma Advanced Sarcoma Non-squamous non-small cell lung carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C153200 Neoplastic Process Locally Advanced Non-Squamous Non-Small Cell Lung Carcinoma Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma CL554815 CTRP Malignant Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma Locally Advanced Non-Squamous Non-Small Cell Lung Cancer Locally Advanced Non-Squamous Non-Small Cell Lung Carcinoma Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma Non-small cell squamous lung carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C153201 Neoplastic Process Advanced Non-Small Cell Squamous Lung Carcinoma Advanced Lung Non-Small Cell Squamous Carcinoma CL554816 CTRP Malignant Advanced Lung Non-Small Cell Squamous Carcinoma Advanced Non-Small Cell Squamous Lung Cancer Advanced Non-Small Cell Squamous Lung Carcinoma Advanced Squamous Non-Small Cell Lung Carcinoma Advanced Lung Non-Small Cell Squamous Carcinoma A carcinoma that arises from the lung and has metastasized to another anatomic site. C153202 Neoplastic Process Metastatic Lung Carcinoma CL554328 Malignant Metastatic Lung Carcinoma Metastatic Lung Carcinoma A lung carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C153203 Neoplastic Process Advanced Lung Carcinoma CL554329 Malignant Advanced Lung Carcinoma Advanced Lung Carcinoma A lung carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C153206 Neoplastic Process Locally Advanced Lung Carcinoma CL554331 Malignant Locally Advanced Lung Carcinoma Locally Advanced Lung Carcinoma A head and neck carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C153213 Neoplastic Process Locally Advanced Head and Neck Carcinoma CL554336 Malignant Locally Advanced Head and Neck Carcinoma Locally Advanced Head and Neck Carcinoma A carcinoma that originates from the wall of the colon or rectum and has spread to the lungs. C153224 Neoplastic Process Colorectal Carcinoma Metastatic in the Lung Colorectal Carcinoma Metastatic in the Lung CL554346 CTRP Malignant Colorectal Carcinoma Metastatic in the Lung Metastatic Colorectal Cancer in the Lung Colorectal Carcinoma Metastatic in the Lung A carcinoma that arises from the breast and has spread to the spine. C153226 Neoplastic Process Breast Carcinoma Metastatic in the Spine Breast Carcinoma Metastatic in the Spine CL554461 CTRP Malignant Breast Carcinoma Metastatic in the Spine Metastatic Breast Cancer in the Spine Breast Carcinoma Metastatic in the Spine A carcinoma that arises from the breast and has spread to the lymph nodes. C153227 Neoplastic Process Breast Carcinoma Metastatic in the Lymph Nodes Metastatic Breast Carcinoma in the Lymph Nodes CL554462 CTRP Malignant Breast Carcinoma Metastatic in Lymph Node Breast Carcinoma Metastatic in the Lymph Nodes Metastatic Breast Cancer in the Lymph Nodes Metastatic Breast Carcinoma in the Lymph Nodes Metastatic Breast Carcinoma in the Lymph Nodes A carcinoma that arises from the breast and has metastasized to another anatomic site. C153238 Neoplastic Process Metastatic Breast Carcinoma CL554471 Malignant Metastatic Breast Carcinoma Metastatic Breast Carcinoma A gastric adenocarcinoma that has spread from its original site of growth to another anatomic site and is not amenable to surgical resection. C153316 Neoplastic Process Metastatic Unresectable Gastric Adenocarcinoma Metastatic Unresectable Gastric Adenocarcinoma CL554429 CTRP Malignant Metastatic Unresectable Gastric (Stomach) Adenocarcinoma Metastatic Unresectable Gastric Adenocarcinoma Metastatic Unresectable Gastric Adenocarcinoma A gastric adenocarcinoma that has spread from its original site of growth to another anatomic site. C153319 Neoplastic Process Metastatic Gastric Adenocarcinoma C3160888 Malignant Metastatic Gastric Adenocarcinoma Metastatic Gastric Adenocarcinoma A gastric carcinoma that has spread from its original site of growth to another anatomic site. C153320 Neoplastic Process Metastatic Gastric Carcinoma CL554431 Malignant Metastatic Gastric Carcinoma Metastatic Gastric Carcinoma A chordoma that has spread from its original site of growth to other anatomic sites. C153323 Neoplastic Process Metastatic Chordoma Metastatic Chordoma CL554432 CTRP Malignant Metastatic Chordoma Metastatic Chordoma A chordoma that has spread from its original site of growth to nearby tissues. C153324 Neoplastic Process Locally Advanced Chordoma Locally Advanced Chordoma CL554433 CTRP Malignant Locally Advanced Chordoma Locally Advanced Chordoma A chordoma which is not amenable to surgical resection. C153325 Neoplastic Process Unresectable Chordoma Unresectable Chordoma CL554434 CTRP Malignant Unresectable Chordoma Unresectable Chordoma The reemergence of EBV-positive diffuse large B-cell lymphoma, not otherwise specified after a period of remission. C153331 Neoplastic Process Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified CL554437 CTRP Malignant Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, NOS Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified EBV-positive diffuse large B-cell lymphoma, not otherwise specified that is resistant to treatment. C153332 Neoplastic Process Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified CL554438 CTRP Malignant Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, NOS Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Metastatic prostatic carcinoma which is sensitive to androgen-deprivation therapy. C153336 Neoplastic Process Castration-Sensitive Prostate Carcinoma Castration-Sensitive Prostate Carcinoma CL554441 CTRP Malignant CSPC Castration-Sensitive Prostate Carcinoma Hormone-Sensitive Prostate Carcinoma Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) mHSPC Castration-Sensitive Prostate Carcinoma The reemergence of ovarian carcinosarcoma after a period of remission. C153347 Neoplastic Process Recurrent Ovarian Carcinosarcoma Recurrent Ovarian Carcinosarcoma CL554449 CTRP Malignant Recurrent Ovarian Carcinosarcoma Recurrent Ovarian Carcinosarcoma A triple-negative breast carcinoma that has spread from its original site of growth to another anatomic site. C153348 Neoplastic Process Metastatic Triple-Negative Breast Carcinoma Metastatic Triple-Negative Breast Carcinoma CL554450 CTRP Malignant Metastatic Triple-Negative Breast Carcinoma Metastatic Triple-Negative Breast Carcinoma Colon carcinoma that is resistant to treatment. C153351 Neoplastic Process Refractory Colon Carcinoma Refractory Colon Carcinoma CL554452 CTRP Malignant Refractory Colon Carcinoma Refractory Colon Carcinoma Liver carcinoma that is resistant to treatment. C153352 Neoplastic Process Refractory Liver Carcinoma Refractory Liver Carcinoma CL554453 CTRP Malignant Refractory Liver Carcinoma Refractory Liver Carcinoma Bile duct carcinoma that is resistant to treatment. C153355 Neoplastic Process Refractory Bile Duct Carcinoma Refractory Bile Duct Carcinoma CL554456 CTRP Malignant Refractory Bile Duct Carcinoma Refractory Bile Duct Carcinoma Small intestinal carcinoma that is resistant to treatment. C153356 Neoplastic Process Refractory Small Intestinal Carcinoma Refractory Small Intestinal Carcinoma CL554457 CTRP Malignant Refractory Small Intestinal Carcinoma Refractory Small Intestinal Carcinoma Small intestinal carcinoma that has spread to nearby tissues or lymph nodes. C153357 Neoplastic Process Locally Advanced Small Intestinal Carcinoma Locally Advanced Small Intestinal Carcinoma CL554458 CTRP Malignant Locally Advanced Small Intestinal Carcinoma Locally Advanced Small Intestinal Carcinoma Digestive system carcinoma that has spread to nearby tissues or lymph nodes. C153358 Neoplastic Process Locally Advanced Digestive System Carcinoma CL554459 Malignant Locally Advanced Digestive System Carcinoma Locally Advanced Digestive System Carcinoma The reemergence of gastroesophageal junction adenocarcinoma after a period of remission. C153359 Neoplastic Process Recurrent Gastroesophageal Junction Adenocarcinoma Recurrent Gastroesophageal Junction Adenocarcinoma CL554517 CTRP Malignant Recurrent Gastroesophageal Junction Adenocarcinoma Recurrent Gastroesophageal Junction Adenocarcinoma The reemergence of bile duct carcinoma after a period of remission. C153360 Neoplastic Process Recurrent Bile Duct Carcinoma Recurrent Bile Duct Carcinoma C0854791 CTRP Malignant Recurrent Bile Duct Carcinoma Recurrent Bile Duct Carcinoma A carcinoma of the cervix that has spread to another anatomic site. C153387 Neoplastic Process Metastatic Cervical Carcinoma CL554833 Malignant Metastatic Cervical Carcinoma Metastatic Cervical Carcinoma Cervical squamous cell carcinoma that has spread to another anatomic site. C153388 Neoplastic Process Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified Metastatic Cervical Squamous Cell Carcinoma CL554830 CTRP Malignant Metastatic Cervical Squamous Cell Carcinoma Metastatic Cervical Squamous Cell Carcinoma A cervical adenocarcinoma that has spread to another anatomic site. C153389 Neoplastic Process Metastatic Cervical Adenocarcinoma Metastatic Cervical Adenocarcinoma CL554831 CTRP Malignant Metastatic Cervical Adenocarcinoma Metastatic Cervical Adenocarcinoma A cervical adenosquamous carcinoma that has spread to another anatomic site. C153390 Neoplastic Process Metastatic Cervical Adenosquamous Carcinoma Metastatic Cervical Adenosquamous Carcinoma CL554836 CTRP Malignant Metastatic Cervical Adenosquamous Carcinoma Metastatic Cervical Adenosquamous Carcinoma A bone sarcoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C153475 Neoplastic Process Locally Advanced Unresectable Bone Sarcoma Locally Advanced Unresectable Bone Sarcoma CL554974 CTRP Malignant Locally Advanced Unresectable Bone Sarcoma Locally Advanced Unresectable Bone Sarcoma A soft tissue sarcoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C153476 Neoplastic Process Locally Advanced Unresectable Soft Tissue Sarcoma Locally Advanced Unresectable Soft Tissue Sarcoma CL554975 CTRP Malignant Locally Advanced Unresectable Soft Tissue Sarcoma Locally Advanced Unresectable Soft Tissue Sarcoma A sarcoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C153477 Neoplastic Process Locally Advanced Unresectable Sarcoma CL554972 Malignant Locally Advanced Unresectable Sarcoma Locally Advanced Unresectable Sarcoma Treatment with a radioactive substance that is linked to an antibody so that it will attach to a tumor when injected into the body. C15355 Therapeutic or Preventive Procedure Radioimmunotherapy Radioimmunotherapy C0085101 CTRP The use of radiolabeled monoclonal antibodies to treat diseases, including cancer. The radiolabeled monoclonal antibody locates and binds to substances in the body, including cancer cells. Radiation given off by the radioisotope may help kill the cancer cells. Radioimmunotherapy Immunoradiotherapy Immunotherapy, Cancer, Radioisotope Radioimmunotherapy radioimmunotherapeutics radioimmunotherapy Radioimmunotherapy The reemergence of acinic cell breast carcinoma after a period of remission. C153568 Neoplastic Process Recurrent Breast Acinic Cell Carcinoma CL555026 Malignant Recurrent Acinic Cell Breast Carcinoma Recurrent Breast Acinic Cell Carcinoma Recurrent Breast Acinic Cell Carcinoma The reemergence of pancreatic acinar cell carcinoma after a period of remission. C153569 Neoplastic Process Recurrent Pancreatic Acinar Cell Carcinoma CL555030 Malignant Recurrent Pancreatic Acinar Cell Carcinoma Recurrent Pancreatic Acinar Cell Carcinoma The reemergence of prostate acinar adenocarcinoma after a period of remission. C153570 Neoplastic Process Recurrent Prostate Acinar Adenocarcinoma CL555031 Malignant Recurrent Prostate Acinar Adenocarcinoma Recurrent Prostate Acinar Adenocarcinoma The reemergence of parotid gland acinic cell carcinoma after a period of remission. C153571 Neoplastic Process Recurrent Parotid Gland Acinic Cell Carcinoma CL555028 Malignant Recurrent Parotid Gland Acinic Cell Carcinoma Recurrent Parotid Gland Acinic Cell Carcinoma The reemergence of submandibular gland acinic cell carcinoma after a period of remission. C153572 Neoplastic Process Recurrent Submandibular Gland Acinic Cell Carcinoma CL555029 Malignant Recurrent Submandibular Gland Acinic Cell Carcinoma Recurrent Submandibular Gland Acinic Cell Carcinoma The reemergence of endocervical adenocarcinoma, usual-type after a period of remission. C153573 Neoplastic Process Recurrent Endocervical Adenocarcinoma, Usual-Type CL555034 Malignant Recurrent Cervical Adenocarcinoma, Usual Type Recurrent Cervical Adenocarcinoma, Usual-Type Recurrent Endocervical Adenocarcinoma, Usual Type Recurrent Endocervical Adenocarcinoma, Usual-Type Recurrent Endocervical Adenocarcinoma, Usual-Type The reemergence of ampulla of Vater adenocarcinoma after a period of remission. C153574 Neoplastic Process Recurrent Ampulla of Vater Adenocarcinoma CL555035 Malignant Recurrent Ampulla of Vater Adenocarcinoma Recurrent Ampulla of Vater Adenocarcinoma The reemergence of anal adenocarcinoma after a period of remission. C153575 Neoplastic Process Recurrent Anal Adenocarcinoma CL555032 Malignant Recurrent Anal Adenocarcinoma Recurrent Anal Adenocarcinoma The reemergence of anal mucinous adenocarcinoma after a period of remission. C153576 Neoplastic Process Recurrent Anal Mucinous Adenocarcinoma CL555033 Malignant Recurrent Anal Mucinous Adenocarcinoma Recurrent Anal Mucinous Adenocarcinoma The reemergence of Paget disease of the anal canal after a period of remission. C153577 Neoplastic Process Recurrent Paget Disease of the Anal Canal CL555038 Malignant Recurrent Paget Disease of the Anal Canal Recurrent Paget's Disease of the Anal Canal Recurrent Paget Disease of the Anal Canal The reemergence of appendix mucinous adenocarcinoma after a period of remission. C153579 Neoplastic Process Recurrent Appendix Mucinous Adenocarcinoma CL555036 Malignant Recurrent Appendix Mucinous Adenocarcinoma Recurrent Appendix Mucinous Adenocarcinoma A non-surgical procedure that was developed to deliver one or several maximum dose targeted radiation treatments for cancers in the brain or spine. C15358 Therapeutic or Preventive Procedure Stereotactic Radiosurgery Stereotactic Radiosurgery C0085203 CTRP GDC OORO A type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. It is used to treat brain tumors and other brain disorders that cannot be treated by regular surgery. It is also being studied in the treatment of other types of cancer. Stereotaxic_Radiosurgery Stereotactic Radiosurgery SRS Stereotactic External Beam Irradiation Stereotactic Radiation Therapy Stereotactic Radiosurgery Stereotactic Radiotherapy stereotactic external-beam radiation therapy stereotactic radiation therapy stereotactic radiosurgery stereotaxic radiation therapy stereotaxic radiosurgery Stereotactic Radiosurgery The reemergence of lobular breast carcinoma after a period of remission. C153584 Neoplastic Process Recurrent Lobular Breast Carcinoma CL555041 Malignant Recurrent Lobular Breast Carcinoma Recurrent Lobular Breast Carcinoma The reemergence of invasive breast carcinoma of no special type after a period of remission. C153587 Neoplastic Process Recurrent Invasive Breast Carcinoma of No Special Type CL555044 Malignant Recurrent Invasive Breast Carcinoma of No Special Type Recurrent Invasive Breast Ductal Carcinoma Recurrent Invasive Ductal Breast Carcinoma Recurrent Invasive Ductal Carcinoma of the Breast Recurrent Invasive Breast Carcinoma of No Special Type The reemergence of Paget disease of the breast after a period of remission. C153588 Neoplastic Process Recurrent Breast Paget Disease CL555045 Malignant Recurrent Breast Paget Disease Recurrent Paget Disease of the Breast Recurrent Paget's Disease of the Breast Recurrent Breast Paget Disease The reemergence of clear cell renal cell carcinoma after a period of remission. C153590 Neoplastic Process Recurrent Clear Cell Renal Cell Carcinoma CL555051 Malignant Recurrent Clear Cell Renal Cell Carcinoma Recurrent Clear Cell Renal Cell Carcinoma The reemergence of chromophobe renal cell carcinoma after a period of remission. C153595 Neoplastic Process Recurrent Chromophobe Renal Cell Carcinoma CL936838 Malignant Recurrent Chromophobe Renal Cell Carcinoma Recurrent Chromophobe Renal Cell Carcinoma The reemergence of salivary duct carcinoma after a period of remission. C153611 Neoplastic Process Recurrent Salivary Duct Carcinoma CL555066 Malignant Recurrent Salivary Duct Carcinoma Recurrent Salivary Duct Carcinoma The reemergence of minor salivary gland adenocarcinoma after a period of remission. C153612 Neoplastic Process Recurrent Minor Salivary Gland Adenocarcinoma CL555067 Malignant Recurrent Minor Salivary Gland Adenocarcinoma Recurrent Minor Salivary Gland Adenocarcinoma The reemergence of ovarian adenocarcinoma after a period of remission. C153614 Neoplastic Process Recurrent Ovarian Adenocarcinoma CL555072 Malignant Recurrent Ovarian Adenocarcinoma Recurrent Ovarian Adenocarcinoma The reemergence of ovarian serous adenocarcinoma after a period of remission. C153615 Neoplastic Process Recurrent Ovarian Serous Adenocarcinoma CL555069 Malignant Recurrent Ovarian Serous Adenocarcinoma Recurrent Ovarian Serous Adenocarcinoma The reemergence of ovarian mucinous adenocarcinoma after a period of remission. C153616 Neoplastic Process Recurrent Ovarian Mucinous Adenocarcinoma CL555070 Malignant Recurrent Ovarian Mucinous Adenocarcinoma Recurrent Ovarian Mucinous Adenocarcinoma The reemergence of ovarian cystadenocarcinoma after a period of remission. C153617 Neoplastic Process Recurrent Ovarian Cystadenocarcinoma CL555075 Malignant Recurrent Ovarian Cystadenocarcinoma Recurrent Ovarian Cystadenocarcinoma The reemergence of ovarian clear cell adenocarcinoma after a period of remission. C153618 Neoplastic Process Recurrent Ovarian Clear Cell Adenocarcinoma Recurrent Ovarian Clear Cell Adenocarcinoma CL555076 CTRP Malignant Recurrent Ovarian Clear Cell Adenocarcinoma Recurrent Ovarian Clear Cell Adenocarcinoma The reemergence of pancreatic ductal adenocarcinoma after a period of remission. C153619 Neoplastic Process Recurrent Pancreatic Ductal Adenocarcinoma CL555073 Malignant Recurrent Pancreatic Ductal Adenocarcinoma Recurrent Pancreatic Ductal Adenocarcinoma The reemergence of pancreatic cystadenocarcinoma after a period of remission. C153620 Neoplastic Process Recurrent Pancreatic Cystadenocarcinoma CL555074 Malignant Recurrent Pancreatic Cystadenocarcinoma Recurrent Pancreatic Cystadenocarcinoma The reemergence of thyroid gland papillary carcinoma after a period of remission. C153621 Neoplastic Process Recurrent Thyroid Gland Papillary Carcinoma CL555079 Malignant Recurrent Thyroid Gland Papillary Carcinoma Recurrent Thyroid Gland Papillary Carcinoma The reemergence of thyroid gland follicular carcinoma after a period of remission. C153622 Neoplastic Process Recurrent Thyroid Gland Follicular Carcinoma CL555080 Malignant Recurrent Thyroid Gland Follicular Carcinoma Recurrent Thyroid Gland Follicular Carcinoma The reemergence of thyroid gland medullary carcinoma after a period of remission. C153623 Neoplastic Process Recurrent Thyroid Gland Medullary Carcinoma CL555077 Malignant Recurrent Thyroid Gland Medullary Carcinoma Recurrent Thyroid Gland Medullary Carcinoma The reemergence of thyroid gland anaplastic carcinoma after a period of remission. C153624 Neoplastic Process Recurrent Thyroid Gland Anaplastic Carcinoma CL555078 Malignant Recurrent Thyroid Gland Anaplastic Carcinoma Recurrent Thyroid Gland Undifferentiated (Anaplastic) Carcinoma Recurrent Thyroid Gland Anaplastic Carcinoma The reemergence of skin angiosarcoma after a period of remission. C153626 Neoplastic Process Recurrent Skin Angiosarcoma CL554994 Malignant Recurrent Skin Angiosarcoma Recurrent Skin Angiosarcoma The use of exogenous steroids for the treatment of any disease or disorder. C15370 Therapeutic or Preventive Procedure Steroid Therapy Steroid Therapy C0149783 CTRP GDC Treatment with corticosteroid drugs to reduce swelling, pain, and other symptoms of inflammation. Steroid_Therapy Steroid Therapy Steroid Therapy steroid therapy Steroid Therapy The reemergence of parotid gland carcinoma after a period of remission. C153800 Neoplastic Process Recurrent Parotid Gland Carcinoma CL554997 Malignant Recurrent Parotid Gland Carcinoma Recurrent Parotid Gland Carcinoma The reemergence of submandibular gland carcinoma after a period of remission. C153801 Neoplastic Process Recurrent Submandibular Gland Carcinoma CL554998 Malignant Recurrent Submandibular Gland Carcinoma Recurrent Submandibular Gland Carcinoma The reemergence of appendix carcinoma after a period of remission. C153802 Neoplastic Process Recurrent Appendix Carcinoma CL554995 Malignant Recurrent Appendix Carcinoma Recurrent Appendix Carcinoma The reemergence of parotid gland adenoid cystic carcinoma after a period of remission. C153804 Neoplastic Process Recurrent Parotid Gland Adenoid Cystic Carcinoma CL554996 Malignant Recurrent Parotid Gland Adenoid Cystic Carcinoma Recurrent Parotid Gland Adenoid Cystic Carcinoma The reemergence of parotid gland carcinoma ex pleomorphic adenoma after a period of remission. C153805 Neoplastic Process Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma CL555001 Malignant Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma The reemergence of parotid gland mucoepidermoid carcinoma after a period of remission. C153806 Neoplastic Process Recurrent Parotid Gland Mucoepidermoid Carcinoma CL555002 Malignant Recurrent Parotid Gland Mucoepidermoid Carcinoma Recurrent Parotid Gland Mucoepidermoid Carcinoma The reemergence of submandibular gland mucoepidermoid carcinoma after a period of remission. C153807 Neoplastic Process Recurrent Submandibular Gland Mucoepidermoid Carcinoma CL554999 Malignant Recurrent Submandibular Gland Mucoepidermoid Carcinoma Recurrent Submandibular Gland Mucoepidermoid Carcinoma The reemergence of submandibular gland carcinoma ex pleomorphic adenoma after a period of remission. C153808 Neoplastic Process Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma CL555000 Malignant Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma The reemergence of submandibular gland adenoid cystic carcinoma after a period of remission. C153809 Neoplastic Process Recurrent Submandibular Gland Adenoid Cystic Carcinoma CL555005 Malignant Recurrent Submandibular Gland Adenoid Cystic Carcinoma Recurrent Submandibular Gland Adenoid Cystic Carcinoma The reemergence of parotid gland squamous cell carcinoma after a period of remission. C153810 Neoplastic Process Recurrent Parotid Gland Squamous Cell Carcinoma CL555006 Malignant Recurrent Parotid Gland Squamous Cell Carcinoma Recurrent Parotid Gland Squamous Cell Carcinoma The reemergence of submandibular gland squamous cell carcinoma after a period of remission. C153811 Neoplastic Process Recurrent Submandibular Gland Squamous Cell Carcinoma CL555003 Malignant Recurrent Submandibular Gland Squamous Cell Carcinoma Recurrent Submandibular Gland Squamous Cell Carcinoma The reemergence of submandibular gland undifferentiated carcinoma after a period of remission. C153812 Neoplastic Process Recurrent Submandibular Gland Undifferentiated Carcinoma CL555004 Malignant Recurrent Submandibular Gland Undifferentiated Carcinoma Recurrent Submandibular Gland Undifferentiated Carcinoma The reemergence of parotid gland undifferentiated carcinoma after a period of remission. C153813 Neoplastic Process Recurrent Parotid Gland Undifferentiated Carcinoma CL555009 Malignant Recurrent Parotid Gland Undifferentiated Carcinoma Recurrent Parotid Gland Undifferentiated Carcinoma The reemergence of malignant ovarian Brenner tumor after a period of remission. C153818 Neoplastic Process Recurrent Malignant Ovarian Brenner Tumor CL555008 Malignant Recurrent Malignant Ovarian Brenner Tumor Recurrent Malignant Ovarian Transitional Cell Tumor Recurrent Malignant Ovarian Brenner Tumor The reemergence of ovarian transitional cell carcinoma after a period of remission. C153819 Neoplastic Process Recurrent Ovarian Transitional Cell Carcinoma CL555010 Malignant Recurrent Ovarian Transitional Cell Carcinoma Recurrent Ovarian Transitional Cell Carcinoma C15382 Therapeutic or Preventive Procedure Gamma Knife C0086330 GDC A treatment using gamma rays, a type of high-energy radiation that can be tightly focused on small tumors or other lesions in the head or neck, so very little normal tissue receives radiation. The gamma rays are aimed at the tumor from many different angles at once, and deliver a large dose of radiation exactly to the tumor in one treatment session. This procedure is a type of stereotactic radiosurgery. Gamma Knife therapy is not a knife and is not surgery. Gamma Knife is a registered trademark of Elekta Instruments, Inc. Gamma_Knife Radiation, Stereotactic/Gamma Knife/SRS Gamma Knife Gamma Knife Radiosurgery Gamma Knife therapy Gamma Knife A proprietary method to determine liver iron concentration through an MRI-based imaging technology that uses R2-MRI relaxometry. C153820 Diagnostic Procedure FerriScan CL555011 FerriScan FerriScan R2-MRI FerriScan The reemergence of a primary malignant central nervous system neoplasm after a period of remission. C153823 Neoplastic Process Recurrent Malignant Central Nervous System Neoplasm Recurrent Primary Malignant Central Nervous System Neoplasm CL555012 CPTAC CTRP Malignant Recurrent Malignant Central Nervous System Neoplasm Recurrent Primary Malignant Central Nervous System Neoplasm Recurrent Primary Malignant Central Nervous System Neoplasm The reemergence of a malignant brain neoplasm after a period of remission. C153837 Neoplastic Process Recurrent Malignant Brain Neoplasm Recurrent Malignant Brain Neoplasm CL555015 CTRP Malignant Recurrent Malignant Brain Neoplasm Recurrent Malignant Brain Neoplasm A primary malignant central nervous system neoplasm that is resistant to treatment. C153842 Neoplastic Process Refractory Malignant Central Nervous System Neoplasm Refractory Primary Malignant Central Nervous System Neoplasm CL555017 CPTAC CTRP Malignant Refractory Malignant Central Nervous System Neoplasm Refractory Primary Malignant Central Nervous System Neoplasm Refractory Primary Malignant Central Nervous System Neoplasm A malignant brain neoplasm that is resistant to treatment. C153845 Neoplastic Process Refractory Malignant Brain Neoplasm Refractory Malignant Brain Neoplasm CL555019 CTRP Malignant Refractory Malignant Brain Neoplasm Refractory Malignant Brain Neoplasm A WHO grade 3 glioma that is resistant to treatment. C153865 Neoplastic Process Refractory WHO Grade III Glioma Refractory WHO Grade 3 Glioma CL555093 CTRP Malignant Refractory WHO Grade 3 Glioma Refractory WHO Grade III Glioma Refractory WHO Grade 3 Glioma A fibrolamellar carcinoma that has spread from the liver to another anatomic site. C154078 Neoplastic Process Metastatic Fibrolamellar Carcinoma Metastatic Fibrolamellar Carcinoma CL555114 CTRP Malignant Metastatic FLC Metastatic Fibrolamellar Carcinoma Metastatic Fibrolamellar Hepatocellular Carcinoma Metastatic Fibrolamellar Carcinoma The reemergence of fibrolamellar carcinoma after a period of remission. C154082 Neoplastic Process Recurrent Fibrolamellar Carcinoma Recurrent Fibrolamellar Carcinoma CL555115 CTRP Malignant Recurrent FLC Recurrent Fibrolamellar Carcinoma Recurrent Fibrolamellar Hepatocellular Carcinoma Relapsed FLC Relapsed Fibrolamellar Carcinoma Relapsed Fibrolamellar Hepatocellular Carcinoma Recurrent Fibrolamellar Carcinoma A carcinoma that arises from the liver and has spread to another anatomic site. C154088 Neoplastic Process Metastatic Liver Carcinoma C0856554 Malignant Metastatic Liver Carcinoma Metastatic Liver Carcinoma A hepatocellular carcinoma that has spread to another anatomic site. C154091 Neoplastic Process Metastatic Hepatocellular Carcinoma C0744869 Malignant Metastatic Hepatocellular Carcinoma Metastatic Hepatocellular Carcinoma A gastric adenocarcinoma that is not amenable to surgical resection. C154221 Neoplastic Process Unresectable Gastric Adenocarcinoma CL555165 Malignant Unresectable Gastric Adenocarcinoma Unresectable Gastric Adenocarcinoma A minimally invasive technique that uses endoscopic ultrasound to produce an image of the endobronchial passages. C154271 Diagnostic Procedure Endobronchial Ultrasound Bronchoscopy Endobronchial Ultrasound Bronchoscopy CL412798 CTRP EBUS Endobronchial Ultrasound Endobronchial Ultrasound Bronchoscopy Endobronchial Ultrasound Bronchoscopy An imaging procedure that combines gallium-68-labelled NeoBomb1 PET with an MRI scan to overlay activity data onto detailed anatomic images. C154293 Diagnostic Procedure Ga-68 NeoBOMB1 PET/MRI Positron Emission Tomography and Magnetic Resonance Imaging Ga-68 NeoBOMB1 PET/MRI Positron Emission Tomography and Magnetic Resonance Imaging CL555294 CTRP 68Ga NeoBOMB1 PET/MRI Ga-68 NeoBOMB1 PET/MRI Ga-68 NeoBOMB1 PET/MRI Positron Emission Tomography and Magnetic Resonance Imaging Gallium Ga 68-NeoB PET/MRI Gallium Ga-68 NeoBOMB1 PET/MRI Ga-68 NeoBOMB1 PET/MRI Positron Emission Tomography and Magnetic Resonance Imaging An imaging procedure that combines gallium-68-labelled PSMA-R2 with an MRI scan to overlay activity data onto detailed anatomic images. C154294 Diagnostic Procedure Ga-68 PSMA-R2 Positron Emission Tomography and Magnetic Resonance Imaging Ga-68 PSMA-R2 Positron Emission Tomography and Magnetic Resonance Imaging CL555291 CTRP 68Ga PSMA-R2 PET/MRI Ga-68 PSMA-R2 PET/MRI Ga-68 PSMA-R2 Positron Emission Tomography and Magnetic Resonance Imaging Gallium Ga-68 PMSA-R2 PET/MRI Ga-68 PSMA-R2 Positron Emission Tomography and Magnetic Resonance Imaging A squamous cell carcinoma that arises from the nasal cavity and/or paranasal sinuses and has spread from its original site of growth to nearby tissues or lymph nodes. C154322 Neoplastic Process Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Locally Advanced Sinonasal Squamous Cell Carcinoma CL555218 CTRP Malignant Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Locally Advanced Sinonasal Squamous Cell Carcinoma Locally Advanced Squamous Cell Carcinoma of the Nasal Cavity and Paranasal Sinus Locally Advanced Squamous Cell Carcinoma of the Nasal Cavity and/or Paranasal Sinuses Locally Advanced Sinonasal Squamous Cell Carcinoma A poorly differentiated carcinoma that arises from the nasal cavity and/or paranasal sinuses. C154324 Neoplastic Process Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma Sinonasal Poorly Differentiated Carcinoma CL555219 CTRP Malignant Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma Poorly Differentiated Carcinoma of the Nasal Cavity and/or Paranasal Sinuses Sinonasal Poorly Differentiated Carcinoma Sinonasal Poorly Differentiated Carcinoma The reemergence of peripheral T-cell lymphoma, not otherwise specified after a period of remission. C154333 Neoplastic Process Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified CL555223 CTRP Malignant Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified A glioblastoma characterized by the presence of DNA methylation in the promoter region of the MGMT gene. It is associated with improved survival. C154335 Neoplastic Process MGMT-Methylated Glioblastoma MGMT-Methylated Glioblastoma CL555227 CTRP Malignant MGMT-Methylated Glioblastoma Methylated MGMT Glioblastoma MGMT-Methylated Glioblastoma A corticotroph pituitary neuroendocrine tumor composed of basophilic PAS-positive cells that are diffusely and strongly positive for ACTH, consistent with the abundance of secretory granules seen at the ultrastructural level. (WHO) C154339 Neoplastic Process Densely Granulated Corticotroph Pituitary Neuroendocrine Tumor CL555230 Undetermined Densely Granulated Corticotroph PitNET/Adenoma Densely Granulated Corticotroph Pituitary Neuroendocrine Tumor Densely Granulated Corticotroph Pituitary Neuroendocrine Tumor/Adenoma Densely Granulated Corticotroph Pituitary Neuroendocrine Tumor A corticotroph pituitary neuroendocrine tumor composed of faintly basophilic or chromophobic PAS-positive cells with weak or patchy positivity for ACTH, consistent with the scant, small secretory granules seen ultrastructurally. (WHO) C154340 Neoplastic Process Sparsely Granulated Corticotroph Pituitary Neuroendocrine Tumor CL555231 Undetermined Sparsely Granulated Corticotroph PitNET/Adenoma Sparsely Granulated Corticotroph Pituitary Neuroendocrine Tumor Sparsely Granulated Corticotroph Pituitary Neuroendocrine Tumor/Adenoma Sparsely Granulated Corticotroph Pituitary Neuroendocrine Tumor A corticotroph pituitary tumor composed of cells with Crooke hyaline change. Ring-like cytokeratin expression is typical of these neoplasms. ACTH expression is dislocated to the cell periphery and juxtanuclear region. Ultrastructurally, intermediate filaments are arranged in a ring-like pattern. (WHO) C154342 Neoplastic Process Crooke Cell Tumor CL555229 Undetermined Crooke Cell Adenoma Crooke Cell Tumor Crooke Cell Tumor Use of techniques, biologically active substances, and procedures to enhance or restore the ability of the host immune system to fight cancer. Also used to lessen adverse effects that may be caused by some cancer treatments. C15438 Therapeutic or Preventive Procedure Cancer Immunotherapy C0278348 Cancer_Immunotherapy Cancer Immunotherapy Immuno-Chemotherapy Immunotherapy, Cancer, General immunotherapy for cancer Cancer Immunotherapy Corticotroph pituitary neuroendocrine tumor not associated with a hormonal syndrome. C154429 Neoplastic Process Non-Functioning Corticotroph Pituitary Neuroendocrine Tumor CL555247 Undetermined Non-Functioning Corticotroph Pituitary Neuroendocrine Tumor Nonfunctional Corticotroph Adenoma Nonfunctioning Corticotroph Adenoma Silent Corticotroph Adenoma Non-Functioning Corticotroph Pituitary Neuroendocrine Tumor A densely granulated corticotroph pituitary neuroendocrine tumor not associated with a hormonal syndrome. C154431 Neoplastic Process Non-Functioning Densely Granulated Corticotroph Pituitary Neuroendocrine Tumor CL555246 Undetermined Densely Granulated Nonfunctional Corticotroph Adenoma Densely Granulated Silent Corticotroph Adenoma Non-Functioning Densely Granulated Corticotroph Adenoma Non-Functioning Densely Granulated Corticotroph Pituitary Neuroendocrine Tumor Nonfunctional Corticotroph Adenoma Type 1 Silent Corticotroph Adenoma Type 1 Non-Functioning Densely Granulated Corticotroph Pituitary Neuroendocrine Tumor A sparsely granulated corticotroph pituitary neuroendocrine tumor not associated with a hormonal syndrome. C154432 Neoplastic Process Non-Functioning Sparsely Granulated Corticotroph Pituitary Neuroendocrine Tumor CL555249 Undetermined Non-Functioning Sparsely Granulated Corticotroph Adenoma Non-Functioning Sparsely Granulated Corticotroph Pituitary Neuroendocrine Tumor Nonfunctional Corticotroph Adenoma Type 2 Silent Corticotroph Adenoma Type 2 Sparsely Granulated Nonfunctional Corticotroph Adenoma Sparsely Granulated Silent Corticotroph Adenoma Non-Functioning Sparsely Granulated Corticotroph Pituitary Neuroendocrine Tumor Malignant mesothelioma of the pleura that is amenable to surgical resection. C154441 Neoplastic Process Resectable Malignant Pleural Mesothelioma Resectable Pleural Malignant Mesothelioma CL555366 CTRP Malignant Resectable Malignant Pleural Mesothelioma Resectable Pleural Malignant Mesothelioma Resectable Pleural Malignant Mesothelioma Malignant mesothelioma of the pleura that is not amenable to surgical resection. C154444 Neoplastic Process Unresectable Pleural Malignant Mesothelioma Unresectable Pleural Malignant Mesothelioma CL555369 CTRP Malignant Unresectable Pleural Malignant Mesothelioma Unresectable Pleural Malignant Mesothelioma Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level. C15445 Therapeutic or Preventive Procedure Hormone Therapy Hormone Therapy C0279025 CPTAC CTRP GDC OORO Cancer therapy, which incorporates hormonal manipulation (e.g., tamoxifen, androgen deprivation). Treatment that adds, blocks, or removes hormones. For certain conditions (such as diabetes or menopause), hormones are given to adjust low hormone levels. To slow or stop the growth of certain cancers (such as prostate and breast cancer), synthetic hormones or other drugs may be given to block the body's natural hormones. Sometimes surgery is needed to remove the gland that makes a certain hormone. Hormone_Therapy Hormone Therapy Hormones The concept covers but is not limited to: intermittent or permanent hormone suppression or ablation in treatment of hormone-dependent tumors, hormone replacement therapy of any kind, hormonal component of gender reassignment therapy, hormonal contraception, surgical and radiation castration. The treatment may include administration of hormones or hormone analogs to the patient, or decreasing the level of hormones in the body by using hormone antagonists, or hormone ablation therapy. Chemotherapy-Hormones/Steroids Endocrine Therapy Hormonal Hormonal Therapy Hormonal therapy Hormone Therapy Hormones endocrine therapy hormonal therapy hormone therapy hormone treatment Hormone Therapy Endocrine drug therapy that uses analogs of somatostatin to treat neuroendocrine tumors. C15449 Therapeutic or Preventive Procedure Somatostatin Analog Therapy Somatostatin Analog Therapy C0278907 CTRP Somatostatin_Analog_Therapy Somatostatin Analog Therapy Somatostatin Analogue Therapy Somatostatin Analog Therapy A renal cell carcinoma usually seen in children or young adults. It is characterized by papillary, alveolar and nested growth patterns with clear and eosinophilic cells. The carcinomas range from microscopic lesions to clinically symptomatic tumors. It is associated with translocations/gene fusions involving members of the MiT family of transcription factors. There are two subtypes: TFE3-rearranged renal cell carcinoma [Xp11 translocation renal cell carcinoma] and TFEB-rearranged renal cell carcinoma [t(6;11) renal cell carcinoma]. C154494 Neoplastic Process Renal Cell Carcinoma with MiT Translocations CL557969 GDC Malignant MiT family translocation renal cell carcinoma MiT Family Translocation-Associated Renal Cell Carcinoma MiT family translocation renal cell carcinoma Renal Cell Carcinoma with MiT Translocations Renal Cell Carcinoma with MiT Translocations A rare tumor, usually occurring in young adults (mean age 12 years) with slight female predominance. It is characterized by a proliferation of anaplastic spindle cells with bizarre, pleomorphic nuclei and atypical mitotic figures. Most cases show chondroid differentiation. C154496 Neoplastic Process Anaplastic Sarcoma of the Kidney CL555408 Malignant ASK Anaplastic Sarcoma of the Kidney Anaplastic Sarcoma of the Kidney A plurihormonal pituitary neuroendocrine tumor consisting of a single cell type producing two (or rarely more) hormones. (WHO) C154504 Neoplastic Process Monomorphous Plurihormonal Pituitary Neuroendocrine Tumor CL555415 Undetermined Monomorphous Plurihormonal Pituitary Neuroendocrine Tumor Monomorphous Plurihormonal Pituitary Neuroendocrine Tumor A plurihormonal pituitary neuroendocrine tumor consisting of two or more different cell lineages. (WHO) C154505 Neoplastic Process Plurimorphous Plurihormonal Pituitary Neuroendocrine Tumor CL555313 Undetermined Plurimorphous Plurihormonal Pituitary Neuroendocrine Tumor Plurimorphous Plurihormonal Pituitary Neuroendocrine Tumor Pituitary neuroendocrine tumors composed of adenohypopheseal cells of two lineages or a null cell tumor in combination with a lineage-specific pituitary neuroendocrine tumor in the same gland. C154519 Neoplastic Process Double Pituitary Neuroendocrine Tumors of Distinct Lineages CL555321 Undetermined Double PitNET/Adenomas of Distinct Lineages Double Pituitary Neuroendocrine Tumors of Distinct Lineages Double Pituitary Neuroendocrine Tumors/Adenomas of Distinct Lineages Pituitary Gland Double Adenomas Double Pituitary Neuroendocrine Tumors of Distinct Lineages Multiple pituitary neuroendocrine tumors composed of adenohypopheseal cells of two or more lineages or a null cell tumor in combination with a lineage-specific pituitary neuroendocrine tumor in the same gland. C154520 Neoplastic Process Multiple Synchronous Pituitary Neuroendocrine Tumors of Distinct Lineages CL555322 Undetermined Multiple Synchronous PitNET/Adenomas of Distinct Lineages Multiple Synchronous Pituitary Neuroendocrine Tumors of Distinct Lineages Multiple Synchronous Pituitary Neuroendocrine Tumors/Adenomas of Distinct Lineages Pituitary Gland Multiple Adenomas Multiple Synchronous Pituitary Neuroendocrine Tumors of Distinct Lineages An application of magnetic resonance imaging that uses spin refocusing and spin echo generation, resulting in shorter repetition times and faster imaging. C154542 Diagnostic Procedure Gradient Echo MRI Gradient Echo MRI CL555343 CTRP DIPG/DMG GRE GRE MRI Gradient Echo MRI Gradient Echo Magnetic Resonance Imaging Gradient Recalled Echo Imaging Gradient Echo MRI A renal cell carcinoma that is not amenable to surgical resection. C154545 Neoplastic Process Unresectable Renal Cell Carcinoma CL555346 Malignant Unresectable Renal Cell Carcinoma Unresectable Renal Cell Carcinoma Renal cell carcinoma that is amenable to surgical resection. C154547 Neoplastic Process Resectable Renal Cell Carcinoma CL555344 Malignant Resectable Renal Cell Carcinoma Resectable Renal Cell Carcinoma An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from any part of the gastrointestinal system. It is characterized by the presence of malignant large cells. C154617 Neoplastic Process Digestive System Large Cell Neuroendocrine Carcinoma CL555509 Malignant Digestive System Large Cell Neuroendocrine Carcinoma Gastrointestinal System Large Cell Neuroendocrine Carcinoma Digestive System Large Cell Neuroendocrine Carcinoma A neuroendocrine tumor that has spread extensively to other anatomic sites or is no longer responding to treatment. C154621 Neoplastic Process Advanced Carcinoid Tumor Advanced Well Differentiated Neuroendocrine Neoplasm Advanced Neuroendocrine Tumor CL555511 CTRP Malignant Advanced Carcinoid Tumor Advanced Neuroendocrine Tumor Advanced Well Differentiated Neuroendocrine Neoplasm Advanced Neuroendocrine Tumor The reemergence of gastric adenocarcinoma after a period of remission. C154622 Neoplastic Process Recurrent Gastric Adenocarcinoma Recurrent Gastric Adenocarcinoma C0863168 CTRP Malignant Recurrent Gastric Adenocarcinoma Recurrent Gastric Adenocarcinoma An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from any part of the gastrointestinal system. It is characterized by the presence of malignant small cells. C154641 Neoplastic Process Digestive System Small Cell Neuroendocrine Carcinoma CL555423 Malignant Digestive System Small Cell Carcinoma Digestive System Small Cell Neuroendocrine Carcinoma Gastrointestinal System Small Cell Neuroendocrine Carcinoma Digestive System Small Cell Neuroendocrine Carcinoma Destructive or removal of any part of the endocrine system by surgical means, including the use of lasers or electrical current. C15467 Therapeutic or Preventive Procedure Ablative Endocrine Surgery C0279028 Ablative_Endocrine_Surgery Ablative Endocrine Surgery Ablative Endocrine Surgery Any of the ducts that conveys pancreatic secretions from the pancreas to the duodenum. C154699 Body Part, Organ, or Organ Component Main Pancreatic and Accessory Ducts CL555468 CDISC Any of the ducts that conveys pancreatic secretions from the pancreas to the duodenum. DUCT, PANCREATIC Main Pancreatic and Accessory Ducts Main Pancreatic and Accessory Ducts Treatment to block production of adrenal hormones. C15472 Therapeutic or Preventive Procedure Adrenal Blockade C0279034 Adrenal_Blockade Adrenal Blockade Adrenal Blockade A lymph node that is located superficial to the buccinator muscle. C154770 Anatomical Structure Buccal Lymph Node C0229719 CDISC Lymph node(s) that are located superficial to the buccinator muscle. BUCCAL LYMPH NODE Buccal Lymph Node Buccinator Lymph Node Buccal Lymph Node A lymph node that is located between the two layers of the greater omentum, either superiorly along the cardiac half of the lesser curvature of the stomach or inferiorly along the pyloric half of the greater curvature of the stomach. C154773 Anatomical Structure Gastric Curvature Lymph Node CL555602 CDISC Lymph node(s) located between the two layers of the greater omentum, either superiorly along the cardiac half of the lesser curvature of the stomach or inferiorly along the pyloric half of the greater curvature of the stomach. GASTRIC CURVATURE LYMPH NODE Gastric Curvature Lymph Node Gastric Curvature Lymph Node A lymph node that is located in the connective tissue adjacent to the rectum. C154774 Anatomical Structure Perirectal Lymph Node C0229837 CDISC Lymph node(s) located in the connective tissue adjacent to the rectum. PERIRECTAL LYMPH NODE Perirectal Lymph Node Perirectal Lymph Node A lymph node that is located in the mesorectum, between the rectum and the sacrum. C154775 Body Part, Organ, or Organ Component Presacral Lymph Node CL555603 CDISC mCode Lymph node(s) located in the mesorectum, between the rectum and the sacrum. PRESACRAL LYMPH NODE Presacral Lymph Node Presacral lymph node group (body structure) Presacral Lymph Node An x-ray technique that incorporates the administration of an iodinated contrast agent to enhance lesions that are not visible on standard x-rays. C154783 Diagnostic Procedure Contrast Enhanced X-ray CL555521 CDISC A type of X-ray in which images are enhanced by the addition of contrast agents into the body. CONTRAST ENHANCED X-RAY Contrast Enhanced X-ray Contrast Enhanced X-ray An x-ray imaging technique that involves visualization of the pulmonary vasculature after fluoroscopy-guided catheter placement and injection of an iodinated contrast medium into the pulmonary circulation. C154789 Diagnostic Procedure Pulmonary Angiography C0202910 CDISC An x-ray imaging technique that involves visualization of the pulmonary vasculature after fluoroscopy-guided catheter placement and injection of an iodinated contrast medium into the pulmonary circulation. PULMONARY ANGIOGRAPHY Pulmonary Angiography Pulmonary Angiography A therapeutic regimen that utilizes pharmaceuticals to reduce serum levels of male sex hormones. C15481 Therapeutic or Preventive Procedure Antiandrogen Therapy Antiandrogen Therapy C0279492 CTRP GDC Treatment with drugs used to block production or interfere with the action of male sex hormones. Antiandrogen_Therapy Androgen Deprivation Therapy (ADT) ADT Androgen Deprivation Therapy Androgen Deprivation Therapy (ADT) Anti-androgen Therapy Anti-androgen Treatment Antiandrogen Therapy Antiandrogen Treatment Hormone Deprivation Therapy Hormone-Deprivation Therapy antiandrogen therapy Antiandrogen Therapy Administration of male hormones to produce a clinical effect. C15482 Therapeutic or Preventive Procedure Androgen Therapy C0279493 Androgen_Therapy Androgen Therapy Androgen Therapy The use of estrogen in the treatment of any disease or disorder. C15483 Therapeutic or Preventive Procedure Estrogen Therapy C0279494 Estrogen_Therapy Estrogen Therapy Estrogen Therapy The use of progestogens in the treatment of any disease or disorder. C15484 Therapeutic or Preventive Procedure Progestin Therapy C0279495 Progestin_Therapy Progestin Therapy Progestin Therapy The use of releasing hormone agonists to bind to specific receptors and ultimately downregulate the activity of its specific hormone. C15489 Therapeutic or Preventive Procedure Releasing Hormone Agonist Therapy Releasing Hormone Agonist Therapy C0279690 CTRP Releasing_Factor_Agonist_Therapy Releasing Factor Agonist Therapy Releasing Hormone Agonist Therapy Releasing Hormone Agonist Therapy C15503 Clinical Attribute Prior LHRH Agonist Therapy C0279804 Prior_LHRH_Agonist_Therapy Prior LHRH Agonist Therapy Prior LHRH Agonist Therapy Drug treatment to block the action of the female hormone progesterone. C15521 Therapeutic or Preventive Procedure Antiprogesterone Therapy C0280531 Antiprogestational_Therapy Antiprogestational Therapy Antiprogesterone Therapy Antiprogesterone Therapy Drug treatment to block the action of aromatases, thereby reducing estrogen biosynthesis. C15525 Therapeutic or Preventive Procedure Aromatase Inhibition Therapy Aromatase Inhibition Therapy C0280674 CTRP Aromatase_Inhibition Aromatase Inhibition Aromatase Inhibition Therapy Aromatase Inhibition Therapy Treatment with a 5a-reductase inhibitor with the goal of suppressing the conversion of testosterone to dihydrotestosterone. C15526 Therapeutic or Preventive Procedure 5a-Reductase Inhibition C0280703 _5a-Reductase_Inhibition 5a-Reductase Inhibition 5a-Reductase Inhibition A rare developmental early childhood neoplasm, arising within the fetal anterior pituitary. It is associated with DICER1 mutations. Patients present with features of Cushing disease, with elevated blood ACTH levels and hypercortisolism. Ophthalmoplegia is a frequent symptom. The overall prognosis is poor. (WHO) C155304 Neoplastic Process Pituitary Gland Blastoma Pituitary Gland Blastoma CL555935 CTRP Malignant Pituitary blastoma Pituitary Blastoma Pituitary Embryoma Pituitary Gland Blastoma Pituitary Gland Embryoma Pituitary Gland Blastoma A cutaneous melanoma that arises from the upper or lower extremity. C155305 Neoplastic Process Cutaneous Melanoma of the Extremity Cutaneous Melanoma of the Extremity CL555936 CTRP Malignant Cutaneous Melanoma of the Extremity Primary Cutaneous Melanoma of the Extremity Primary Extremity Melanoma Primary Melanoma of the Extremity Cutaneous Melanoma of the Extremity Cutaneous melanoma of the upper or lower extremity that has recurred after a period of remission. C155306 Neoplastic Process Recurrent Cutaneous Melanoma of the Extremity Recurrent Cutaneous Melanoma of the Extremity CL555941 CTRP Malignant Recurrent Cutaneous Melanoma of the Extremity Recurrent Extremity Melanoma Recurrent Melanoma of the Extremity Recurrent Cutaneous Melanoma of the Extremity Cutaneous melanoma of the upper or lower extremity that has spread extensively to other anatomic sites or is no longer responding to treatment. C155311 Neoplastic Process Advanced Cutaneous Melanoma of the Extremity Advanced Cutaneous Melanoma of the Extremity CL555943 CTRP Malignant Advanced Cutaneous Melanoma of the Extremity Advanced Extremity Melanoma Advanced Melanoma of the Extremity Advanced Cutaneous Melanoma of the Extremity Drug treatment to block the action of the female hormone prolactin. C15540 Therapeutic or Preventive Procedure Antiprolactin Therapy C0281149 Antiprolactin_Therapy Antiprolactin Therapy Antiprolactin Therapy A sarcoma that arises from the soft tissues or bones of the upper or lower extremity. C155647 Neoplastic Process Sarcoma of the Extremity Sarcoma of the Extremity CL556149 CPTAC CTRP Malignant Extremity Sarcoma Primary Extremity Sarcoma Primary Sarcoma of the Extremity Sarcoma of the Extremity Sarcoma of the Extremity A sarcoma of the soft tissues or bones of the upper or lower extremity that has recurred after a period of remission. C155648 Neoplastic Process Recurrent Sarcoma of the Extremity Recurrent Sarcoma of the Extremity CL556146 CTRP Malignant Recurrent Extremity Sarcoma Recurrent Sarcoma of the Extremity Recurrent Sarcoma of the Extremity A sarcoma of the soft tissues or bones of the upper or lower extremity that has spread extensively to other anatomic sites or is no longer responding to treatment. C155649 Neoplastic Process Advanced Sarcoma of the Extremity Advanced Sarcoma of the Extremity CL556147 CTRP Malignant Advanced Extremity Sarcoma Advanced Sarcoma of the Extremity Advanced Sarcoma of the Extremity A renal cell carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C155699 Neoplastic Process Locally Advanced Unresectable Renal Cell Carcinoma CL556302 Malignant Locally Advanced Unresectable Renal Cell Carcinoma Locally Advanced Unresectable Renal Cell Carcinoma The reemergence of pancreatic adenocarcinoma after a period of remission. C155742 Neoplastic Process Recurrent Pancreatic Adenocarcinoma Recurrent Pancreatic Adenocarcinoma C0861741 CTRP Malignant Recurrent Pancreatic Adenocarcinoma Recurrent Pancreatic Adenocarcinoma A pancreatic adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C155743 Neoplastic Process Locally Advanced Unresectable Pancreatic Adenocarcinoma Locally Advanced Unresectable Pancreatic Adenocarcinoma CL556228 CTRP Malignant Locally Advanced Unresectable Pancreatic Adenocarcinoma Locally Advanced Unresectable Pancreatic Adenocarcinoma A pituitary neoplasm composed of mature ganglionic cells admixed with pituitary neoplastic neuroendocrine cells. C155767 Neoplastic Process Mixed Gangliocytoma-Pituitary Neuroendocrine Tumor CL556243 Undetermined Mixed Gangliocytoma-PitNET Mixed Gangliocytoma-PitNET/Adenoma Mixed Gangliocytoma-Pituitary Neuroendocrine Tumor Mixed Gangliocytoma-Pituitary Neuroendocrine Tumor/Adenoma Pituitary Gland Adenoma with Gangliocytic Component Pituitary Gland Adenoma-Neuronal Choristoma Pituitary Gland Mixed Gangliocytoma-Adenoma Mixed Gangliocytoma-Pituitary Neuroendocrine Tumor A rare extraventricular neurocytoma (WHO grade 2) of the hypothalamic-pituitary area. (WHO 2017) C155768 Neoplastic Process Sellar Neurocytoma CL556248 Undetermined Extraventricular Neurocytoma of the Sellar Region Extraventricular Neurocytoma of the Sellar Region (WHO Grade 2) Extraventricular Neurocytoma of the Sellar Region (WHO Grade II) Sellar Neurocytoma Sellar Neurocytoma (WHO Grade 2) Sellar Neurocytoma (WHO Grade II) Sellar Neurocytoma An extremely rare paraganglioma arising from chief cells of the dispersed paraganglia of the sellar region. (WHO) C155769 Neoplastic Process Sellar Paraganglioma CL556249 Undetermined Sellar Paraganglioma Sellar Paraganglioma A rare neuroblastoma arising from the sella turcica. C155772 Neoplastic Process Sellar Neuroblastoma CL556247 Malignant Sellar Esthesioneuroblastoma Sellar Neuroblastoma Sellar Neuroblastoma A very rare, low-grade neoplasm that arises from the posterior pituitary. It is composed of epithelioid and oncocytic cells forming sheets and fascicles. It shows histopathological features reminiscent of ependymomas, including perivascular pseudorosettes and true rosettes. There is no evidence of necrosis or increased mitotic activity. Despite the presence of ependymal histopathological features, these neoplasms probably are not related to ependymomas. Their prognosis is unknown. C155774 Neoplastic Process Ependymal Pituicytoma CL556253 Undetermined Sellar ependymoma Ependymal Pituicytoma Sellar Ependymoma Ependymal Pituicytoma A rare meningioma that arises from the sellar region. C155776 Neoplastic Process Sellar Meningioma CL556251 Undetermined Sellar Meningioma Sellar Meningioma A rare meningioma arising from the intrasellar region. C155778 Neoplastic Process Intrasellar Meningioma CL556257 Undetermined Intrasellar Meningioma Intrasellar Meningioma An extremely rare schwannoma that arises from the sellar region. C155780 Neoplastic Process Sellar Schwannoma CL556255 Benign Sellar Neurilemmoma Sellar Neurinoma Sellar Schwannoma Sellar Schwannoma A chordoma that arises from the sellar region. C155781 Neoplastic Process Sellar Chordoma CL556260 Malignant Sellar Chordoma Sellar Chordoma A chondroid chordoma that arises from the sellar region. C155782 Neoplastic Process Sellar Chondroid Chordoma CL556261 Malignant Sellar Chondroid Chordoma Sellar Chondroid Chordoma A dedifferentiated chordoma that arises from the sellar region. C155783 Neoplastic Process Sellar Dedifferentiated Chordoma CL556258 Malignant Sellar Dedifferentiated Chordoma Sellar Dedifferentiated Chordoma An extremely rare meningeal solitary fibrous tumor that arises from the sellar region. C155784 Neoplastic Process Sellar Solitary Fibrous Tumor CL556259 Undetermined Sellar Hemangiopericytoma/ Solitary Fibrous Tumor Sellar Solitary Fibrous Tumor Sellar Solitary Fibrous Tumor/Hemangiopericytoma Sellar Solitary Fibrous Tumor A malignant neoplasm that has metastasized to the sellar region from another anatomic site. C155786 Neoplastic Process Metastatic Malignant Neoplasm in the Sellar Region CL556264 Malignant Metastatic Malignant Neoplasm in the Sellar Region Metastatic Malignant Neoplasm in the Sellar Region A primary or metastatic malignant neoplasm that affects the bones and structures of the skull. C155790 Neoplastic Process Malignant Skull Neoplasm CL556325 Malignant Malignant Skull Neoplasm Malignant Skull Neoplasm A primary or metastatic malignant neoplasm that affects the skull base. C155791 Neoplastic Process Malignant Skull Base Neoplasm CL556323 Malignant Malignant Skull Base Neoplasm Malignant Skull Base Neoplasm A neoplasm that arises from the bones and structures of skull and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C155792 Neoplastic Process Benign Skull Neoplasm CL556324 Benign Benign Skull Neoplasm Benign Skull Neoplasm A neoplasm that arises the skull base and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C155793 Neoplastic Process Benign Skull Base Neoplasm Benign Skull Base Neoplasm CL556328 CTRP Benign Benign Skull Base Neoplasm Benign Skull Base Neoplasm A rare non-Hodgkin lymphoma that arises from the pituitary gland. The majority are diffuse large B-cell lymphomas. C155796 Neoplastic Process Pituitary Gland Non-Hodgkin Lymphoma CL556327 Malignant Pituitary Gland Non-Hodgkin Lymphoma Primary Pituitary Gland Non-Hodgkin Lymphoma Pituitary Gland Non-Hodgkin Lymphoma A rare diffuse large B-cell lymphoma that arises from the pituitary gland. C155797 Neoplastic Process Pituitary Gland Diffuse Large B-Cell Lymphoma CL556332 Malignant Pituitary Gland Diffuse Large B-Cell Lymphoma Primary Pituitary Gland Diffuse Large B-Cell Lymphoma Pituitary Gland Diffuse Large B-Cell Lymphoma A germ cell tumor that arises from or adjacent to the sellar region. C155801 Neoplastic Process Sellar Germ Cell Tumor CL556335 Undetermined Germ Cell Tumor of the Sellar Region Sellar Germ Cell Tumor Sellar Germ Cell Tumor A germinoma that arises from or adjacent to the sellar region. C155802 Neoplastic Process Sellar Germinoma CL556336 Malignant Germinoma of the Sellar Region Sellar Germinoma Sellar Germinoma A germinoma that arises from the suprasellar region. C155803 Neoplastic Process Suprasellar Germinoma CL556333 Malignant Germinoma of the Suprasellar Region Suprasellar Germinoma Suprasellar Germinoma A yolk sac tumor that arises from or adjacent to the sellar region. C155804 Neoplastic Process Sellar Yolk Sac Tumor CL556334 Malignant Sellar Yolk Sac Tumor Yolk Sac Tumor of the Sellar Region Sellar Yolk Sac Tumor An embryonal carcinoma that arises from or adjacent to the sellar region. C155805 Neoplastic Process Sellar Embryonal Carcinoma CL556339 Malignant Embryonal Carcinoma of the Sellar Region Sellar Embryonal Carcinoma Sellar Embryonal Carcinoma A choriocarcinoma that arises from or adjacent to the sellar region. C155806 Neoplastic Process Sellar Choriocarcinoma CL556340 Malignant Choriocarcinoma of the Sellar Region Sellar Choriocarcinoma Sellar Choriocarcinoma A teratoma that arises from or adjacent to the sellar region. C155807 Neoplastic Process Sellar Teratoma CL556337 Undetermined Sellar Teratoma Teratoma of the Sellar Region Sellar Teratoma A mature teratoma that arises from or adjacent to the sellar region. C155808 Neoplastic Process Sellar Mature Teratoma CL556338 Benign Mature Teratoma of the Sellar Region Sellar Mature Teratoma Sellar Mature Teratoma An immature teratoma that arises from or adjacent to the sellar region. C155809 Neoplastic Process Sellar Immature Teratoma CL556343 Undetermined Immature Teratoma of the Sellar Region Sellar Immature Teratoma Sellar Immature Teratoma A teratoma with malignant transformation that arises from or adjacent to the sellar region. C155810 Neoplastic Process Sellar Teratoma with Malignant Transformation CL556344 Malignant Sellar Teratoma with Malignant Transformation Teratoma with Malignant Transformation of the Sellar Region Sellar Teratoma with Malignant Transformation A mixed germ cell tumor that arises from or adjacent to the sellar region. C155811 Neoplastic Process Sellar Mixed Germ Cell Tumor CL556341 Malignant Mixed Germ Cell Tumor of the Sellar Region Sellar Mixed Germ Cell Tumor Sellar Mixed Germ Cell Tumor The reemergence of endometrial clear cell adenocarcinoma after a period of remission. C155816 Neoplastic Process Recurrent Endometrial Clear Cell Adenocarcinoma Recurrent Endometrial Clear Cell Adenocarcinoma CL556345 CTRP Malignant Recurrent Endometrial Clear Cell Adenocarcinoma Recurrent Endometrial Clear Cell Adenocarcinoma The reemergence of endometrial undifferentiated carcinoma after a period of remission. C155817 Neoplastic Process Recurrent Endometrial Undifferentiated Carcinoma Recurrent Endometrial Undifferentiated Carcinoma CL556350 CTRP Malignant Recurrent Endometrial Undifferentiated Carcinoma Recurrent Endometrial Undifferentiated Carcinoma The reemergence of uterine corpus carcinosarcoma after a period of remission. C155818 Neoplastic Process Recurrent Uterine Corpus Carcinosarcoma Recurrent Uterine Corpus Carcinosarcoma CL556351 CTRP Malignant Recurrent Uterine Corpus Carcinosarcoma Recurrent Uterine Corpus Carcinosarcoma The reemergence of endometrial mixed cell adenocarcinoma after a period of remission. C155819 Neoplastic Process Recurrent Endometrial Mixed Epithelial Carcinoma Recurrent Endometrial Mixed Cell Adenocarcinoma CL556348 CTRP Malignant Recurrent Endometrial Mixed Cell Adenocarcinoma Recurrent Endometrial Mixed Epithelial Carcinoma Recurrent Endometrial Mixed Cell Adenocarcinoma Low grade glioma that is not amenable to surgical removal. C155829 Neoplastic Process Unresectable Low Grade Glioma CL556359 Undetermined Unresectable Low Grade Glioma Unresectable Low-Grade Glioma Unresectable Low Grade Glioma A malignant neoplasm that arises from the pancreas and has metastasized to another anatomic site. C155852 Neoplastic Process Metastatic Malignant Pancreatic Neoplasm CL562679 Malignant Metastatic Malignant Pancreatic Neoplasm Metastatic Malignant Pancreatic Neoplasm A neuroendocrine carcinoma that has spread from its original site of growth to another anatomic site. C155869 Neoplastic Process Metastatic Neuroendocrine Carcinoma Metastatic Neuroendocrine Carcinoma C3203639 CTRP Malignant Metastatic Neuroendocrine Carcinoma Metastatic Neuroendocrine Carcinoma A neuroendocrine carcinoma that has metastasized from its original site of growth to distal anatomic sites or is no longer responding to treatment. C155870 Neoplastic Process Advanced Neuroendocrine Carcinoma Advanced Neuroendocrine Carcinoma CL562685 CTRP Malignant Advanced Neuroendocrine Carcinoma Advanced Neuroendocrine Carcinoma A sarcoma that arises from the anatomic structures that surround the lungs and the pleura. C155873 Neoplastic Process Chest Wall Sarcoma Chest Wall Sarcoma CL562681 CPTAC CTRP Malignant Chest Wall Sarcoma Primary Thoracic Sarcoma Chest Wall Sarcoma A gastric adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C155874 Neoplastic Process Locally Advanced Unresectable Gastric Adenocarcinoma Locally Advanced Unresectable Gastric Adenocarcinoma CL562682 CTRP Malignant Locally Advanced Unresectable Gastric Adenocarcinoma Locally Advanced Unresectable Gastric Adenocarcinoma Desmoid fibromatosis that has recurred after a period of remission. C155875 Neoplastic Process Recurrent Desmoid-Type Fibromatosis Recurrent Desmoid Fibromatosis CL562683 CTRP Undetermined Recurrent Desmoid Fibromatosis Recurrent Desmoid Tumor Recurrent Desmoid-Type Fibromatosis Recurrent Desmoid Fibromatosis Desmoid fibromatosis that is not amenable to surgical resection. C155877 Neoplastic Process Unresectable Desmoid Fibromatosis CL562703 Undetermined Unresectable Desmoid Fibromatosis Unresectable Desmoid Tumor Unresectable Desmoid-Type Fibromatosis Unresectable Desmoid Fibromatosis Lung non-small cell carcinoma that is not amenable to surgical resection. C155901 Neoplastic Process Unresectable Lung Non-Small Cell Carcinoma Unresectable Lung Non-Small Cell Carcinoma CL562776 CTRP Malignant Unresectable Lung Non-Small Cell Carcinoma Unresectable Non-Small Cell Lung Carcinoma Unresectable Lung Non-Small Cell Carcinoma Lung carcinoma that is not amenable to surgical resection. C155902 Neoplastic Process Unresectable Lung Carcinoma Unresectable Lung Carcinoma CL562769 CTRP Malignant Unresectable Lung Carcinoma Unresectable Lung Carcinoma Digestive system carcinoma that is not amenable to surgical resection. C155903 Neoplastic Process Unresectable Digestive System Carcinoma CL562770 Malignant Unresectable Digestive System Carcinoma Unresectable Digestive System Carcinoma Lung adenocarcinoma that has spread from its original site of growth to another anatomic site. C155908 Neoplastic Process Metastatic Lung Adenocarcinoma Metastatic Lung Adenocarcinoma CL562767 CTRP Malignant Metastatic Lung Adenocarcinoma Metastatic Lung Adenocarcinoma Waldenstrom macroglobulinemia with serum IgM monoclonal protein equal or more than 3 g/dL and/or at least 10% bone marrow lymphoplasmacytic infiltration but no evidence of constitutional symptoms, symptomatic anemia, or hyperviscosity. (Blood 2008, 112:2709) C155910 Neoplastic Process Smoldering Waldenstrom Macroglobulinemia Smoldering Waldenstrom Macroglobulinemia CL562790 CTRP Malignant Asymptomatic Waldenstrom Macroglobulinemia Smoldering (Asymptomatic) Waldenstrom Macroglobulinemia Smoldering Waldenstrom Macroglobulinemia Smoldering Waldenstrom Macroglobulinemia A malignant neoplasm that has spread to the thoracic cavity from another anatomic site. C155919 Neoplastic Process Metastatic Malignant Neoplasm in the Thoracic Cavity Metastatic Malignant Neoplasm in the Thoracic Cavity CL562789 CTRP Malignant Metastatic Malignant Neoplasm in the Thoracic Cavity Metastatic Malignant Neoplasm in the Thorax Metastatic Malignant Neoplasm in the Thoracic Cavity A pancreatic neuroendocrine carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C155933 Neoplastic Process Locally Advanced Pancreatic Neuroendocrine Carcinoma Locally Advanced Pancreatic Neuroendocrine Carcinoma CL562800 CTRP Malignant Locally Advanced Pancreatic Neuroendocrine Carcinoma Locally Advanced Pancreatic Neuroendocrine Carcinoma A neuroendocrine carcinoma that arises from any part of the digestive system and has spread to nearby tissues or lymph nodes. C155934 Neoplastic Process Locally Advanced Digestive System Neuroendocrine Carcinoma Locally Advanced Digestive System Neuroendocrine Carcinoma CL562801 CTRP Malignant Locally Advanced Digestive System Neuroendocrine Carcinoma Locally Advanced Gastrointestinal System Neuroendocrine Carcinoma Locally Advanced Digestive System Neuroendocrine Carcinoma A neuroendocrine carcinoma that arises from any part of the digestive system and is not amenable to surgical resection. C155935 Neoplastic Process Unresectable Digestive System Neuroendocrine Carcinoma Unresectable Digestive System Neuroendocrine Carcinoma CL562802 CTRP Malignant Unresectable Digestive System Neuroendocrine Carcinoma Unresectable Gastrointestinal System Neuroendocrine Carcinoma Unresectable Digestive System Neuroendocrine Carcinoma A neuroendocrine carcinoma that arises from any part of the digestive system and has metastasized to another anatomic site. C155936 Neoplastic Process Metastatic Digestive System Neuroendocrine Carcinoma Metastatic Digestive System Neuroendocrine Carcinoma CL562796 CTRP Malignant Metastatic Digestive System Neuroendocrine Carcinoma Metastatic Gastrointestinal System Neuroendocrine Carcinoma Metastatic Digestive System Neuroendocrine Carcinoma A neuroendocrine carcinoma that arises from any part of the digestive system and does not respond to treatment. C155937 Neoplastic Process Refractory Digestive System Neuroendocrine Carcinoma Refractory Digestive System Neuroendocrine Carcinoma CL562797 CTRP Malignant Refractory Digestive System Neuroendocrine Carcinoma Refractory Gastrointestinal System Neuroendocrine Carcinoma Refractory Digestive System Neuroendocrine Carcinoma The reemergence of a neuroendocrine carcinoma in any part of the digestive system after a period of remission. C155938 Neoplastic Process Recurrent Digestive System Neuroendocrine Carcinoma CL562798 Malignant Recurrent Digestive System Neuroendocrine Carcinoma Recurrent Gastrointestinal System Neuroendocrine Carcinoma Recurrent Digestive System Neuroendocrine Carcinoma A hemangioblastoma that arises from the cerebrum. C155947 Neoplastic Process Cerebral Hemangioblastoma Cerebral Hemangioblastoma CL562820 CTRP Undetermined Cerebral Hemangioblastoma Cerebral Hemangioblastoma A hemangioblastoma that arises from the spinal cord. C155948 Neoplastic Process Spinal Hemangioblastoma Spinal Hemangioblastoma C4024223 CTRP Undetermined Spinal Hemangioblastoma Spinal Hemangioblastoma A hemangioblastoma that arises from the medulla oblongata. C155949 Neoplastic Process Medullary Hemangioblastoma Medullary Hemangioblastoma CL562814 CTRP Undetermined Medullary Hemangioblastoma Medullary Hemangioblastoma A malignant urinary system neoplasm that has developed in relatives of patients with a history of malignant urinary system neoplasm. C155950 Neoplastic Process Hereditary Malignant Urinary System Neoplasm Hereditary Malignant Urinary System Neoplasm CL562815 CTRP Malignant Hereditary Malignant Urinary System Neoplasm Hereditary Malignant Urinary System Neoplasm Chromophobe renal cell carcinoma that develops in a patient with Birt-Hogg-Dube syndrome. C155951 Neoplastic Process Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dube Syndrome Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dube Syndrome CL562816 CTRP Malignant Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dube Syndrome Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dube Syndrome A cystadenoma that arises from the broad or other uterine ligaments. It is characterized by the presence of small papillary projections in the inner surface of the cysts. It may be sporadic or associated with von Hippel-Lindau disease. C155952 Neoplastic Process Uterine Ligament Papillary Cystadenoma CL562811 Benign Uterine Ligament Papillary Cystadenoma Uterine Ligament Papillary Cystadenoma A cystadenoma that arises from the epididymis. It is characterized by the presence of small papillary projections in the inner surface of the cysts. It may be sporadic or associated with von Hippel-Lindau disease. C155953 Neoplastic Process Epididymal Papillary Cystadenoma Epididymal Papillary Cystadenoma CL562812 CTRP Benign Epididymal Papillary Cystadenoma Epididymal Papillary Cystadenoma A rare thyroid gland follicular adenoma composed predominantly of spindle cells. C155957 Neoplastic Process Thyroid Gland Spindle Cell Follicular Adenoma CL562807 Benign Thyroid Gland Spindle Cell Follicular Adenoma Thyroid Gland Spindle Cell Follicular Adenoma A thyroid gland follicular adenoma seen in patients treated with minocycline. The tumors have black discoloration visible on macroscopic examination and cytoplasmic accumulation of black pigment. (WHO 2017) C155958 Neoplastic Process Thyroid Gland Black Follicular Adenoma CL562808 Benign Thyroid Gland Black Follicular Adenoma Thyroid Gland Black Follicular Adenoma The reemergence of chordoma after a period of remission. C155973 Neoplastic Process Recurrent Chordoma Recurrent Chordoma CL562710 CTRP Malignant Recurrent Chordoma Recurrent Chordoma An encapsulated or well-circumscribed thyroid gland tumor composed of well-differentiated follicular cells with no nuclear features of papillary thyroid carcinoma and with questionable capsular or vascular invasion. This is a tumor indeterminate between follicular adenoma and follicular carcinoma. (WHO) C155978 Neoplastic Process Thyroid Gland Follicular Tumor of Uncertain Malignant Potential CL562736 Uncertain Malignant Potential Follicular tumor of uncertain malignant potential FT-UMP Thyroid Gland Follicular Neoplasm of Uncertain Malignant Potential Thyroid Gland Follicular Tumor of Uncertain Malignant Potential Thyroid Gland Follicular Tumor of Uncertain Malignant Potential The reemergence of visual pathway glioma after a period of remission. C155983 Neoplastic Process Recurrent Visual Pathway Glioma Recurrent Visual Pathway Glioma CL562733 CTRP Undetermined Recurrent Visual Pathway Glioma Recurrent Visual Pathway Glioma Visual pathway glioma that is resistant to treatment. C155984 Neoplastic Process Refractory Visual Pathway Glioma Refractory Visual Pathway Glioma CL562734 CTRP Undetermined Refractory Visual Pathway Glioma Refractory Visual Pathway Glioma Malignant peripheral nerve sheath tumor that is resistant to treatment. C155987 Neoplastic Process Refractory Malignant Peripheral Nerve Sheath Tumor Refractory Malignant Peripheral Nerve Sheath Tumor CL562730 CTRP Malignant Refractory Malignant Peripheral Nerve Sheath Tumor Refractory Malignant Peripheral Nerve Sheath Tumor Treatment with estrogens or estrogen/progesterone after menopause or ovariectomy to prevent pathological effects of decreased estrogen production. C15599 Therapeutic or Preventive Procedure Hormone Replacement Therapy C0282402 GDC Hormones (estrogen, progesterone, or both) given to women after menopause to replace the hormones no longer produced by the ovaries. Hormone_Replacement_Therapy In women, treatment with sex hormones is indicated for a number of reasons, including menopause, partial or full hysterectomy, or amenorrhea. NHLBI of NIH stopped early a major clinical trial of the risks and benefits of combined estrogen and progestin in healthy menopausal women due to an increased risk of invasive breast cancer and lack of overall benefit. Though with fewer cases of hip fractures and colon cancer, combined estrogen and progestin leads to an increased risk of invasive breast cancer, coronary heart disease, stroke, and pulmonary embolism in healthy menopausal women on estrogen plus progestin compared to those taking placebo pills. However, a separate study of estrogen alone in women who had a hysterectomy before receiving therapy continues unchanged because, at this point, the balance of risks and benefits of estrogen alone is still uncertain. (http://www.nhlbi.nih.gov/new/press/02-07-09.htm and NCI) HRT Hormone Replacement Rx Hormone Replacement Therapy hormone replacement therapy hormone replacement therapy type hormone_replacement_therapy_type menopausal hormone therapy Hormone Replacement Therapy The use of magnetic resonance imaging to evaluate the salivary glands and ducts. C155997 Diagnostic Procedure MR Sialography MR Sialography CL562751 CTRP MR Sialography MRI Sialography Magnetic Resonance Sialography MR Sialography A typical papillary thyroid gland carcinoma that is totally surrounded by a fibrous capsule, which may be intact or only focally infiltrated by tumor growth. It accounts for about 10% of all cases of papillary thyroid gland carcinoma and has an excellent prognosis. Regional nodal metastases may be present, but bloodborne metastases are rare. The survival rate is nearly 100%. (WHO 2017) C156034 Neoplastic Process Encapsulated Variant Thyroid Gland Papillary Carcinoma CL562888 GDC Malignant 8343/3 Encapsulated papillary carcinoma Papillary carcinoma, encapsulated Papillary carcinoma, encapsulated, of thyroid Encapsulated Variant Thyroid Gland Papillary Carcinoma Encapsulated Variant Thyroid Gland Papillary Carcinoma An anaplastic astrocytoma occurring in the frontal lobe. C156035 Neoplastic Process Frontal Lobe Anaplastic Astrocytoma CL562889 Malignant Frontal Lobe Anaplastic Astrocytoma Frontal Lobe Anaplastic Astrocytoma An anaplastic astrocytoma occurring in the temporal lobe. C156036 Neoplastic Process Temporal Lobe Anaplastic Astrocytoma CL562884 Malignant Temporal Lobe Anaplastic Astrocytoma Temporal Lobe Anaplastic Astrocytoma A pilocytic astrocytoma occurring in the third ventricle. C156037 Neoplastic Process Third Ventricle Pilocytic Astrocytoma CL562885 Undetermined Third Ventricle Pilocytic Astrocytoma Third Ventricle Pilocytic Astrocytoma A pilomyxoid astrocytoma occurring in the hypothalamic-chiasmatic region. C156038 Neoplastic Process Hypothalamic-Chiasmatic Pilomyxoid Astrocytoma CL562886 Undetermined Hypothalamic-Chiasmatic Pilomyxoid Astrocytoma Hypothalamic-Chiasmatic Pilomyxoid Astrocytoma A medulloblastoma occurring in the fourth ventricle. C156039 Neoplastic Process Fourth Ventricle Medulloblastoma CL562887 Malignant Fourth Ventricle Medulloblastoma Fourth Ventricle Medulloblastoma A germinoma that arises from the third ventricle. C156040 Neoplastic Process Third Ventricle Germinoma CL562880 Malignant Third Ventricle Germinoma Third Ventricle Germinoma A pleomorphic xanthoastrocytoma that arises from the supratentorial region of the brain. C156041 Neoplastic Process Supratentorial Pleomorphic Xanthoastrocytoma CL562881 Undetermined Supratentorial Pleomorphic Xanthoastrocytoma Supratentorial Pleomorphic Xanthoastrocytoma A pleomorphic xanthoastrocytoma that arises from the temporal lobe of the brain. C156042 Neoplastic Process Temporal Lobe Pleomorphic Xanthoastrocytoma CL562882 Undetermined Temporal Lobe Pleomorphic Xanthoastrocytoma Temporal Lobe Pleomorphic Xanthoastrocytoma Papillary carcinoma of the thyroid gland with focal areas of spindle cell metaplasia. C156045 Neoplastic Process Spindle Cell Variant Thyroid Gland Papillary Carcinoma CL562905 Malignant Spindle Cell Variant Thyroid Gland Papillary Carcinoma Spindle Cell Variant Thyroid Gland Papillary Carcinoma A rare variant of papillary thyroid gland carcinoma in which more than 30% of cells have hobnail features. (WHO) C156050 Neoplastic Process Hobnail Variant Thyroid Gland Papillary Carcinoma CL562902 Malignant Hobnail Variant Thyroid Gland Papillary Carcinoma Hobnail Variant Thyroid Gland Papillary Carcinoma A carcinoma that arises from the bladder and has metastasized to another anatomic site. C156062 Neoplastic Process Metastatic Bladder Carcinoma Metastatic Bladder Carcinoma CL562921 CTRP Malignant Metastatic Bladder Carcinoma Metastatic Bladder Carcinoma A carcinoma that arises from the fallopian tube and has metastasized to another anatomic site. C156063 Neoplastic Process Metastatic Fallopian Tube Carcinoma Metastatic Fallopian Tube Carcinoma CL562922 CTRP Malignant Metastatic Fallopian Tube Carcinoma Metastatic Fallopian Tube Carcinoma A carcinoma that arises from the ovary and has metastasized to another anatomic site. C156064 Neoplastic Process Metastatic Ovarian Carcinoma Metastatic Ovarian Carcinoma CL562923 CTRP Malignant Metastatic Ovarian Carcinoma Metastatic Ovarian Carcinoma A carcinoma that arises from the vagina and has metastasized to another anatomic site. C156065 Neoplastic Process Metastatic Vaginal Carcinoma Metastatic Vaginal Carcinoma CL562916 CTRP Malignant Metastatic Vaginal Carcinoma Metastatic Vaginal Carcinoma A carcinoma that arises from the vulva and has metastasized to another anatomic site. C156066 Neoplastic Process Metastatic Vulvar Carcinoma Metastatic Vulvar Carcinoma CL562917 CTRP Malignant Metastatic Vulvar Carcinoma Metastatic Vulvar Carcinoma A carcinoma that arises from the endometrium and has metastasized to another anatomic site. C156068 Neoplastic Process Metastatic Endometrial Carcinoma Metastatic Endometrial Carcinoma CL562919 CTRP Malignant Metastatic Endometrial Carcinoma Metastatic Endometrial Carcinoma A carcinoma that arises from the pancreas and has metastasized to another anatomic site. C156069 Neoplastic Process Metastatic Pancreatic Carcinoma CL562912 Malignant Metastatic Pancreatic Carcinoma Metastatic Pancreatic Carcinoma A carcinoma that arises from the adrenal cortex and has metastasized to another anatomic site. C156070 Neoplastic Process Metastatic Adrenal Cortical Carcinoma CL562913 Malignant Metastatic Adrenal Cortex Carcinoma Metastatic Adrenal Cortical Carcinoma Metastatic Adrenal Cortical Carcinoma A sarcoma that arises from the soft tissues during adulthood and has spread from the original site of growth to another anatomic site. C156071 Neoplastic Process Metastatic Adult Soft Tissue Sarcoma CL562914 Malignant Metastatic Adult Soft Tissue Sarcoma Metastatic Adult Soft Tissue Sarcoma A melanoma that arises from the skin and has metastasized to another anatomic site. C156072 Neoplastic Process Metastatic Cutaneous Melanoma CL562915 Malignant Metastatic Cutaneous Melanoma Metastatic Cutaneous Melanoma A carcinoma that arises from the esophagus and has metastasized to another anatomic site. C156073 Neoplastic Process Metastatic Esophageal Carcinoma Metastatic Esophageal Carcinoma CL562908 CTRP Malignant Metastatic Esophageal Carcinoma Metastatic Esophageal Carcinoma An adenocarcinoma that arises from the esophagus and has metastasized to another anatomic site. C156074 Neoplastic Process Metastatic Esophageal Adenocarcinoma CL562909 Malignant Metastatic Esophageal Adenocarcinoma Metastatic Esophageal Adenocarcinoma A squamous cell carcinoma that arises from the esophagus and has metastasized to another anatomic site. C156075 Neoplastic Process Metastatic Esophageal Squamous Cell Carcinoma CL562910 Malignant Metastatic Esophageal Squamous Cell Carcinoma Metastatic Esophageal Squamous Cell Carcinoma A keratinizing squamous cell carcinoma that arises from the nasopharynx and has metastasized to another anatomic site. C156077 Neoplastic Process Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma CL562936 Malignant Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma An undifferentiated carcinoma that arises from the nasopharynx and has metastasized to another anatomic site. C156078 Neoplastic Process Metastatic Nasopharyngeal Undifferentiated Carcinoma CL562937 Malignant Metastatic Nasopharyngeal Undifferentiated Carcinoma Metastatic Nasopharyngeal Undifferentiated Carcinoma A carcinoma that arises from the nasopharynx and has metastasized to another anatomic site. C156079 Neoplastic Process Metastatic Nasopharyngeal Carcinoma Metastatic Nasopharyngeal Carcinoma CL562938 CTRP Malignant Metastatic Nasopharyngeal Carcinoma Metastatic Nasopharyngeal Carcinoma A carcinoma that arises from the pharynx and has metastasized to another anatomic site. C156080 Neoplastic Process Metastatic Pharyngeal Carcinoma CL562939 Malignant Metastatic Pharyngeal Carcinoma Metastatic Pharyngeal Carcinoma A carcinoma that arises from the hypopharynx and has metastasized to another anatomic site. C156081 Neoplastic Process Metastatic Hypopharyngeal Carcinoma CL562932 Malignant Metastatic Hypopharyngeal Carcinoma Metastatic Hypopharyngeal Carcinoma A carcinoma that arises from the oropharynx and has metastasized to another anatomic site. C156082 Neoplastic Process Metastatic Oropharyngeal Carcinoma CL562933 Malignant Metastatic Oropharyngeal Carcinoma Metastatic Oropharyngeal Carcinoma A carcinoma that arises from the larynx and has metastasized to another anatomic site. C156085 Neoplastic Process Metastatic Laryngeal Carcinoma CL562928 Malignant Metastatic Laryngeal Carcinoma Metastatic Laryngeal Carcinoma A carcinoma that arises from the lip and/or oral cavity and has metastasized to another anatomic site. C156086 Neoplastic Process Metastatic Lip and Oral Cavity Carcinoma CL562929 Malignant Metastatic Lip and Oral Cavity Carcinoma Metastatic Lip and Oral Cavity Carcinoma A carcinoma that arises from the oral cavity and has metastasized to another anatomic site. C156087 Neoplastic Process Metastatic Oral Cavity Carcinoma CL562930 Malignant Metastatic Oral Cavity Carcinoma Metastatic Oral Cavity Carcinoma A carcinoma that arises from the lip and has metastasized to another anatomic site. C156088 Neoplastic Process Metastatic Lip Carcinoma CL562931 Malignant Metastatic Lip Carcinoma Metastatic Lip Carcinoma An adenoid cystic carcinoma that arises from the oral cavity and has metastasized to another anatomic site. C156089 Neoplastic Process Metastatic Oral Cavity Adenoid Cystic Carcinoma CL562924 Malignant Metastatic Oral Cavity Adenoid Cystic Carcinoma Metastatic Oral Cavity Adenoid Cystic Carcinoma A mucoepidermoid carcinoma that arises from the oral cavity and has metastasized to another anatomic site. C156090 Neoplastic Process Metastatic Oral Cavity Mucoepidermoid Carcinoma CL562925 Malignant Metastatic Oral Cavity Mucoepidermoid Carcinoma Metastatic Oral Cavity Mucoepidermoid Carcinoma A squamous cell carcinoma that arises from the lip and has metastasized to another anatomic site. C156091 Neoplastic Process Metastatic Lip Squamous Cell Carcinoma CL562926 Malignant Metastatic Lip Squamous Cell Carcinoma Metastatic Lip Squamous Cell Carcinoma A squamous cell carcinoma that arises from the lung and has metastasized to another anatomic site. C156092 Neoplastic Process Metastatic Lung Squamous Cell Carcinoma CL562927 Malignant Metastatic Lung Squamous Cell Carcinoma Metastatic Lung Squamous Cell Carcinoma An adenosquamous carcinoma that arises from the lung and has metastasized to another anatomic site. C156093 Neoplastic Process Metastatic Lung Adenosquamous Carcinoma Metastatic Lung Adenosquamous Carcinoma CL562832 CTRP Malignant Metastatic Lung Adenosquamous Carcinoma Metastatic Lung Adenosquamous Carcinoma A non-small cell carcinoma that arises from the lung and has metastasized to another anatomic site. C156094 Neoplastic Process Metastatic Lung Non-Small Cell Carcinoma Metastatic Lung Non-Small Cell Carcinoma CL562833 CTRP Malignant Metastatic Lung Non-Small Cell Carcinoma Metastatic Lung Non-Small Cell Carcinoma A small cell carcinoma that arises from the lung and has metastasized to another anatomic site. C156095 Neoplastic Process Metastatic Lung Small Cell Carcinoma Metastatic Lung Small Cell Carcinoma CL562834 CTRP Malignant Metastatic Lung Small Cell Carcinoma Metastatic Lung Small Cell Carcinoma A carcinoma that arises from the colon or rectum and has metastasized to another anatomic site. C156096 Neoplastic Process Metastatic Colorectal Carcinoma Metastatic Colorectal Carcinoma CL562835 CTRP Malignant Metastatic Colorectal Carcinoma Metastatic Colorectal Carcinoma A carcinoma that arises from the colon and has metastasized to another anatomic site. C156097 Neoplastic Process Metastatic Colon Carcinoma Metastatic Colon Carcinoma CL562828 CTRP Malignant Metastatic Colon Carcinoma Metastatic Colon Carcinoma A carcinoma that arises from the rectum and has metastasized to another anatomic site. C156098 Neoplastic Process Metastatic Rectal Carcinoma CL562829 Malignant Metastatic Rectal Carcinoma Metastatic Rectal Carcinoma A follicular carcinoma that arises from the thyroid gland and has metastasized to another anatomic site. C156099 Neoplastic Process Metastatic Thyroid Gland Follicular Carcinoma CL562830 Malignant Metastatic Thyroid Gland Follicular Carcinoma Metastatic Thyroid Gland Follicular Carcinoma A papillary carcinoma that arises from the thyroid gland and has metastasized to another anatomic site. C156100 Neoplastic Process Metastatic Thyroid Gland Papillary Carcinoma CL562831 Malignant Metastatic Papillary Thyroid Carcinoma Metastatic Thyroid Gland Papillary Carcinoma Metastatic Thyroid Gland Papillary Carcinoma A neuroblastoma that has metastasized from its original site of growth to another anatomic site. C156101 Neoplastic Process Metastatic Neuroblastoma CL493285 Malignant Metastatic Neuroblastoma Metastatic Neuroblastoma The reemergence of a blastic plasmacytoid dendritic cell neoplasm after a period of remission. C156103 Neoplastic Process Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm CL562825 CTRP Malignant Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm Blastic plasmacytoid dendritic cell neoplasm that is resistant to treatment. C156104 Neoplastic Process Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm CL562826 CTRP Malignant Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm An anaplastic oligodendroglioma occurring in the frontal lobe. C156120 Neoplastic Process Frontal Lobe Anaplastic Oligodendroglioma CL562842 Malignant Frontal Lobe Anaplastic Oligodendroglioma Frontal Lobe Anaplastic Oligodendroglioma An encapsulated follicular carcinoma of the thyroid gland which shows angioinvasion. C156122 Neoplastic Process Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive CL562836 GDC Malignant Follicular carcinoma, encapsulated, angioinvasive Follicular thyroid carcinoma (FTC), encapsulated angioinvasive FTC, Encapsulated Angioinvasive Follicular thyroid carcinoma (FTC), encapsulated angioinvasive Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive A follicular carcinoma of the thyroid gland with extension into surrounding thyroid or extrathyroid tissues. C156123 Neoplastic Process Thyroid Gland Follicular Carcinoma, Widely Invasive CL562837 Malignant FTC, Widely Invasive Thyroid Gland Follicular Carcinoma, Widely Invasive Thyroid Gland Follicular Carcinoma, Widely Invasive An adenocarcinoma that arises from the gastroesophageal junction and has not spread to other anatomic sites. C156166 Neoplastic Process Localized Gastroesophageal Junction Adenocarcinoma CL563003 Malignant Localized Gastroesophageal Junction Adenocarcinoma Localized Gastroesophageal Junction Adenocarcinoma A carcinoma that arises from the stomach and has not spread to other anatomic sites. C156167 Neoplastic Process Localized Gastric Carcinoma CL563004 Malignant Localized Gastric Carcinoma Localized Gastric Carcinoma An aggressive non-Hodgkin lymphoma that has recurred after a period of remission. C156232 Neoplastic Process Recurrent Aggressive Non-Hodgkin Lymphoma CL562944 Malignant Recurrent Aggressive Non-Hodgkin Lymphoma Recurrent Aggressive Non-Hodgkin Lymphoma An aggressive non-Hodgkin lymphoma that is resistant to treatment. C156233 Neoplastic Process Refractory Aggressive Non-Hodgkin Lymphoma CL562945 Malignant Refractory Aggressive Non-Hodgkin Lymphoma Refractory Aggressive Non-Hodgkin Lymphoma C15626 Therapeutic or Preventive Procedure Neuroendocrine Therapy C0338268 Neuroendocrine_Therapy Neuroendocrine Therapy Neuroendocrine Therapy A rare primary carcinoma of the thyroid gland characterized by the presence of clusters of malignant epithelial cells associated with abundant extracellular mucin deposition. C156267 Neoplastic Process Thyroid Gland Mucinous Carcinoma CL562970 Malignant Thyroid Gland Mucinous Carcinoma Thyroid Gland Mucinous Carcinoma A rare thymoma arising within or is attached to the thyroid gland. C156268 Neoplastic Process Intrathyroidal Thymoma CL562971 Undetermined Ectopic Thyroid Gland Thymoma Intrathyroidal Thymoma Intrathyroidal Thymoma A pancreatic adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C156269 Neoplastic Process Locally Advanced Pancreatic Adenocarcinoma Locally Advanced Pancreatic Adenocarcinoma CL562972 CTRP Malignant Locally Advanced Pancreatic Adenocarcinoma Locally Advanced Pancreatic Adenocarcinoma An alveolar soft part sarcoma involving the tongue. It usually occurs in children. C156273 Neoplastic Process Tongue Alveolar Soft Part Sarcoma' CL562998 Malignant Tongue Alveolar Soft Part Sarcoma' Tongue Alveolar Soft Part Sarcoma' A sarcoma that arises from the tongue. C156274 Neoplastic Process Tongue Sarcoma CL562992 Malignant Tongue Sarcoma Tongue Sarcoma An alveolar soft part sarcoma involving the orbit. It usually occurs in children. C156276 Neoplastic Process Orbital Alveolar Soft Part Sarcoma CL562993 Malignant Orbital Alveolar Soft Part Sarcoma Orbital Alveolar Soft Part Sarcoma An alveolar soft part sarcoma involving the bladder. C156277 Neoplastic Process Bladder Alveolar Soft Part Sarcoma CL562994 Malignant Bladder Alveolar Soft Part Sarcoma Bladder Alveolar Soft Part Sarcoma A nerve sheath myxoma with increased cellularity. C156278 Neoplastic Process Cellular Nerve Sheath Myxoma C1275959 Benign Cellular Nerve Sheath Myxoma Cellular Neurothekeoma Cellular Nerve Sheath Myxoma A liposarcoma that arises from the colon. C156279 Neoplastic Process Colon Liposarcoma CL562988 Malignant Colon Liposarcoma Colon Liposarcoma A sarcoma that arises from the parotid gland. C156280 Neoplastic Process Parotid Gland Sarcoma CL562989 Malignant Parotid Gland Sarcoma Parotid Gland Sarcoma A liposarcoma that arises from the parotid gland. C156281 Neoplastic Process Parotid Gland Liposarcoma CL562990 Malignant Parotid Gland Liposarcoma Parotid Gland Liposarcoma A liposarcoma involving the scrotum. C156282 Neoplastic Process Scrotal Liposarcoma CL562991 Malignant Scrotal Liposarcoma Scrotal Liposarcoma A sarcoma involving the scrotum. C156283 Neoplastic Process Scrotal Sarcoma CL562984 Malignant Scrotal Sarcoma Scrotal Sarcoma A prostatic carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C156284 Neoplastic Process Advanced Prostate Carcinoma CL562985 Malignant Advanced Prostate Carcinoma Advanced Prostate Carcinoma A prostatic carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C156285 Neoplastic Process Locally Advanced Prostate Carcinoma Locally Advanced Prostate Carcinoma CL562986 CTRP Malignant Locally Advanced Prostate Carcinoma Locally Advanced Prostate Carcinoma A prostatic adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C156286 Neoplastic Process Advanced Prostate Adenocarcinoma Advanced Prostate Adenocarcinoma CL562987 CTRP Malignant Advanced Prostate Adenocarcinoma Advanced Prostate Adenocarcinoma A prostatic adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C156287 Neoplastic Process Locally Advanced Prostate Adenocarcinoma CL563131 Malignant Locally Advanced Prostate Adenocarcinoma Locally Advanced Prostate Adenocarcinoma A prostatic carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C156288 Neoplastic Process Locally Advanced Unresectable Prostate Carcinoma CL563132 Malignant Locally Advanced Unresectable Prostate Carcinoma Locally Advanced Unresectable Prostate Carcinoma A prostatic adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C156289 Neoplastic Process Locally Advanced Unresectable Prostate Adenocarcinoma CL563133 Malignant Locally Advanced Unresectable Prostate Adenocarcinoma Locally Advanced Unresectable Prostate Adenocarcinoma A cervical carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C156294 Neoplastic Process Advanced Cervical Carcinoma Advanced Cervical Carcinoma CL563130 CTRP Malignant Advanced Cervical Carcinoma Advanced Cervical Carcinoma A cervical carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C156295 Neoplastic Process Locally Advanced Cervical Carcinoma Locally Advanced Cervical Carcinoma CL563123 CTRP Malignant Locally Advanced Cervical Carcinoma Locally Advanced Cervical Carcinoma A cervical adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C156297 Neoplastic Process Locally Advanced Cervical Adenocarcinoma CL563125 Malignant Locally Advanced Cervical Adenocarcinoma Locally Advanced Cervical Adenocarcinoma A cervical adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C156299 Neoplastic Process Locally Advanced Unresectable Cervical Adenocarcinoma CL563126 Malignant Locally Advanced Unresectable Cervical Adenocarcinoma Locally Advanced Unresectable Cervical Adenocarcinoma A cervical carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C156300 Neoplastic Process Locally Advanced Unresectable Cervical Carcinoma CL563119 Malignant Locally Advanced Unresectable Cervical Carcinoma Locally Advanced Unresectable Cervical Carcinoma A cervical adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C156304 Neoplastic Process Advanced Cervical Adenocarcinoma Advanced Cervical Adenocarcinoma CL563122 CTRP Malignant Advanced Cervical Adenocarcinoma Advanced Cervical Adenocarcinoma A rare schwannoma that arises from the thyroid gland. C156340 Neoplastic Process Thyroid Gland Schwannoma CL563150 Benign Thyroid Gland Schwannoma Thyroid Gland Schwannoma A rare malignant peripheral nerve sheath tumor that arises from the thyroid gland. C156341 Neoplastic Process Thyroid Gland Malignant Peripheral Nerve Sheath Tumor CL563146 Malignant Thyroid Gland Malignant Peripheral Nerve Sheath Tumor Thyroid Gland Malignant Peripheral Nerve Sheath Tumor A rare benign vascular neoplasm that arises from the thyroid gland. This category includes hemangiomas, cavernous hemangiomas, and lymphangiomas. C156342 Neoplastic Process Benign Thyroid Gland Vascular Neoplasm CL563147 Benign Benign Thyroid Gland Vascular Neoplasm Benign Thyroid Gland Vascular Neoplasm A rare hemangioma that arises from the thyroid gland. C156343 Neoplastic Process Thyroid Gland Hemangioma CL563148 Benign Thyroid Gland Hemangioma Thyroid Gland Hemangioma A rare cavernous hemangioma that arises from the thyroid gland. C156344 Neoplastic Process Thyroid Gland Cavernous Hemangioma CL563149 Benign Thyroid Gland Cavernous Hemangioma Thyroid Gland Cavernous Hemangioma An extremely rare lymphangioma that arises from the thyroid gland. C156345 Neoplastic Process Thyroid Gland Lymphangioma CL563143 Benign Thyroid Gland Lymphangioma Thyroid Gland Lymphangioma A leiomyoma that arises from the thyroid gland. C156346 Neoplastic Process Thyroid Gland Leiomyoma CL563144 Benign Thyroid Gland Leiomyoma Thyroid Gland Leiomyoma A leiomyosarcoma that arises from the thyroid gland. C156347 Neoplastic Process Thyroid Gland Leiomyosarcoma Thyroid Gland Leiomyosarcoma CL563145 CTRP Malignant Thyroid Gland Leiomyosarcoma Thyroid Gland Leiomyosarcoma A rare solitary fibrous tumor that arises from the thyroid gland. C156349 Neoplastic Process Thyroid Gland Solitary Fibrous Tumor CL563139 Undetermined Thyroid Gland Solitary Fibrous Tumor Thyroid Gland Solitary Fibrous Tumor A rare histiocytic and dendritic cell neoplasm that affects the thyroid gland. C156406 Neoplastic Process Thyroid Gland Histiocytic and Dendritic Cell Neoplasm CL563116 Undetermined Thyroid Gland Histiocytic and Dendritic Cell Neoplasm Thyroid Gland Histiocytic and Dendritic Cell Neoplasm Langerhans cell histiocytosis involving the thyroid gland focally or diffusely. It is exceedingly rare and usually occurs in patients with multifocal disease. C156407 Neoplastic Process Thyroid Gland Langerhans Cell Histiocytosis CL563117 Undetermined Thyroid Gland Langerhans Cell Histiocytosis Thyroid Gland Langerhans Cell Histiocytosis A rare follicular dendritic cell sarcoma involving the thyroid gland. It may be associated with chronic lymphocytic thyroiditis. C156408 Neoplastic Process Thyroid Gland Follicular Dendritic Cell Sarcoma CL563118 Malignant Thyroid Gland Follicular Dendritic Cell Sarcoma Thyroid Gland Follicular Dendritic Cell Sarcoma Rosai-Dorfman-Destombes disease affecting the thyroid gland. It is rare and is usually accompanied by involvement of cervical lymph nodes. C156409 Neoplastic Process Thyroid Gland Rosai-Dorfman-Destombes Disease CL563111 Undetermined Thyroid Gland Rosai-Dorfman Disease Thyroid Gland Rosai-Dorfman-Destombes Disease Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy Thyroid Gland Rosai-Dorfman-Destombes Disease A rare follicular lymphoma primarily involving the thyroid gland. C156410 Neoplastic Process Thyroid Gland Follicular Lymphoma CL563112 Malignant Thyroid Gland Follicular Lymphoma Thyroid Gland Follicular Lymphoma MRI imaging based on the observed T2 relaxation time of tissues. C156447 Diagnostic Procedure T2 (Observed)-Weighted Imaging CL563170 T2 (Observed)-Weighted Imaging T2*-Weighted Imaging T2*MRI T2*WI T2 (Observed)-Weighted Imaging The reemergence of primary peritoneal serous adenocarcinoma after a period of remission. C156453 Neoplastic Process Recurrent Primary Peritoneal Serous Adenocarcinoma Recurrent Primary Peritoneal Serous Adenocarcinoma CL563168 CTRP Malignant Recurrent Primary Peritoneal Serous Adenocarcinoma Recurrent Primary Peritoneal Serous Adenocarcinoma The reemergence of primary peritoneal low grade serous adenocarcinoma after a period of remission. C156454 Neoplastic Process Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma CL563169 CTRP Malignant Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma The reemergence of ovarian low-grade serous adenocarcinoma after a period of remission. C156455 Neoplastic Process Recurrent Low Grade Ovarian Serous Adenocarcinoma Recurrent Ovarian Low Grade Serous Adenocarcinoma CL563192 CTRP Malignant Recurrent Low Grade Ovarian Serous Adenocarcinoma Recurrent Ovarian Low Grade Serous Adenocarcinoma Recurrent Ovarian Low-Grade Serous Adenocarcinoma Recurrent Ovarian Low Grade Serous Adenocarcinoma A small cell neuroendocrine carcinoma that arises from an anatomic site other than the lung. C156457 Neoplastic Process Extrapulmonary Small Cell Carcinoma Extrapulmonary Small Cell Neuroendocrine Carcinoma Extrapulmonary Small Cell Neuroendocrine Carcinoma CL563194 CTEP CTRP Malignant ESCC Extrapulmonary SCC Extrapulmonary Small Cell Carcinoma Extrapulmonary Small Cell Neuroendocrine Carcinoma Small cell car. (extrapulmonary) Small cell carcinoma (extrapulmonary) Extrapulmonary Small Cell Neuroendocrine Carcinoma An ependymoma that arises from the brain. C156462 Neoplastic Process Brain Ependymoma Brain Ependymoma CL563190 CTRP Undetermined Brain Ependymoma Intracranial Ependymoma Brain Ependymoma A very rare renal cell carcinoma that usually affects young adults. It is characterized by mutations in one of the four subunits of the SDH complex (SDHA, SDHB, SDHC, or SDHD gene). Most frequently, the mutations occur in the SDHB subunit. It has a relatively good prognosis. C156464 Neoplastic Process Succinate Dehydrogenase-Deficient Renal Cell Carcinoma Succinate Dehydrogenase-Deficient Renal Cell Carcinoma CL563184 CTRP GDC Malignant Succinate Dehydrogenase-Deficient Renal Cell Carcinoma SDH Deficient Renal Cell Carcinoma SDH-Deficient Renal Cell Carcinoma SDH-RCC Succinate Dehydrogenase Renal Cell Carcinoma Succinate Dehydrogenase-Deficient Renal Cell Carcinoma Succinate Dehydrogenase-Deficient Renal Cell Carcinoma Kaposi sarcoma that is resistant to treatment. C156474 Neoplastic Process Refractory Kaposi Sarcoma Refractory Kaposi Sarcoma CL563202 CTRP Malignant Refractory Kaposi Sarcoma Refractory Kaposi Sarcoma Kaposi sarcoma that has spread from its original site of growth to another anatomic site. C156475 Neoplastic Process Metastatic Kaposi Sarcoma C1299260 Malignant Metastatic Kaposi Sarcoma Metastatic Kaposi Sarcoma Kaposi sarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C156476 Neoplastic Process Advanced Kaposi Sarcoma Advanced Kaposi Sarcoma CL563198 CTRP Malignant Advanced Kaposi Sarcoma Advanced Kaposi Sarcoma A benign or malignant neoplasm that affects the genitourinary system. C156482 Neoplastic Process Genitourinary System Neoplasm Genitourinary System Neoplasm CL935675 CTRP Undetermined Genitourinary System Neoplasm Genitourinary System Neoplasm A neoplasm that arises from the genitourinary system and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C156483 Neoplastic Process Benign Genitourinary System Neoplasm CL935676 Benign Benign Genitourinary System Neoplasm Benign Genitourinary System Neoplasm A primary or metastatic malignant neoplasm that affects the genitourinary system. C156484 Neoplastic Process Malignant Genitourinary System Neoplasm Malignant Genitourinary System Neoplasm C0751569 CPTAC CTRP Malignant Genitourinary Cancer Genitourinary System Cancer Malignant Genitourinary Neoplasm Malignant Genitourinary System Neoplasm Malignant Genitourinary System Neoplasm A neuroendocrine neoplasm that has spread from its original site of growth to another anatomic site. C156485 Neoplastic Process Metastatic Neuroendocrine Neoplasm Metastatic Neuroendocrine Neoplasm CL935670 CTRP Malignant Metastatic Neuroendocrine Neoplasm Metastatic Neuroendocrine Neoplasm A neuroendocrine neoplasm that has spread extensively to other anatomic sites or is no longer responding to treatment. C156486 Neoplastic Process Advanced Neuroendocrine Neoplasm Advanced Neuroendocrine Neoplasm CL935668 CTRP Malignant Advanced Neuroendocrine Neoplasm Advanced Neuroendocrine Neoplasm A neuroendocrine tumor that arises from the islet cells of the pancreas and has spread to another anatomic site. C156488 Neoplastic Process Metastatic Pancreatic Neuroendocrine Tumor Metastatic Pancreatic Neuroendocrine Tumor C2609093 CTRP Malignant Metastatic Pancreatic Islet Cell Tumor Metastatic Pancreatic Neuroendocrine Tumor Metastatic Pancreatic Neuroendocrine Tumor A pancreatic neuroendocrine tumor that has spread extensively to other anatomic sites or is no longer responding to treatment. C156489 Neoplastic Process Advanced Pancreatic Neuroendocrine Tumor Advanced Pancreatic Neuroendocrine Tumor CL935673 CTRP Malignant Advanced Pancreatic Islet Cell Tumor Advanced Pancreatic Neuroendocrine Tumor Advanced Pancreatic Neuroendocrine Tumor A neuroendocrine neoplasm that arises from any part of the digestive system and has metastasized to another anatomic site. C156492 Neoplastic Process Metastatic Digestive System Neuroendocrine Neoplasm Metastatic Digestive System Neuroendocrine Neoplasm CL935672 CTRP Malignant Metastatic Digestive System Neuroendocrine Neoplasm Metastatic Gastroenteropancreatic Neuroendocrine Neoplasm Metastatic Digestive System Neuroendocrine Neoplasm A neuroendocrine neoplasm that arises from the breast and has metastasized to another anatomic site. C156493 Neoplastic Process Metastatic Breast Neuroendocrine Neoplasm CL935662 Malignant Metastatic Breast Neuroendocrine Neoplasm Metastatic Breast Neuroendocrine Neoplasm A gastric neuroendocrine carcinoma that has spread from its original site of growth to another anatomic site. C156682 Neoplastic Process Metastatic Gastric Neuroendocrine Carcinoma CL935729 Malignant Metastatic Gastric Neuroendocrine Carcinoma Metastatic Gastric Neuroendocrine Carcinoma A gastric neuroendocrine carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C156683 Neoplastic Process Advanced Gastric Neuroendocrine Carcinoma CL935730 Malignant Advanced Gastric Neuroendocrine Carcinoma Advanced Gastric Neuroendocrine Carcinoma A gastric large cell neuroendocrine carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C156684 Neoplastic Process Advanced Gastric Large Cell Neuroendocrine Carcinoma CL935719 Malignant Advanced Gastric Large Cell Neuroendocrine Carcinoma Advanced Gastric Large Cell Neuroendocrine Carcinoma A gastric small cell neuroendocrine carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C156685 Neoplastic Process Advanced Gastric Small Cell Neuroendocrine Carcinoma CL935720 Malignant Advanced Gastric Small Cell Carcinoma Advanced Gastric Small Cell Neuroendocrine Carcinoma Advanced Gastric Small Cell Neuroendocrine Carcinoma A small intestinal neuroendocrine carcinoma that has spread from its original site of growth to another anatomic site. C156686 Neoplastic Process Metastatic Small Intestinal Neuroendocrine Carcinoma CL935717 Malignant Metastatic Small Intestinal Neuroendocrine Carcinoma Metastatic Small Intestinal Neuroendocrine Carcinoma A small intestinal neuroendocrine carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C156687 Neoplastic Process Advanced Small Intestinal Neuroendocrine Carcinoma CL935718 Malignant Advanced Small Intestinal Neuroendocrine Carcinoma Advanced Small Intestinal Neuroendocrine Carcinoma A small intestinal small cell neuroendocrine carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C156688 Neoplastic Process Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma CL935723 Malignant Advanced Small Intestinal Small Cell Carcinoma Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma A small intestinal large cell neuroendocrine carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C156689 Neoplastic Process Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma CL935724 Malignant Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma The reemergence of T-cell/histiocyte-rich large B-cell lymphoma after a period of remission. C156696 Neoplastic Process Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma CL935715 CTRP Malignant Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Histologic transformation of a marginal zone lymphoma to an aggressive diffuse large B-cell lymphoma. C156699 Neoplastic Process Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma CL935714 Malignant Diffuse Large B-Cell Lymphoma Transformed from Underlying Marginal Zone Lymphoma Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma A primary or metastatic malignant neoplasm that affects the peritoneum and/or retroperitoneum. C156711 Neoplastic Process Malignant Peritoneal and Retroperitoneal Neoplasm CL935862 CPTAC Malignant Malignant neoplasm of retroperitoneum and peritoneum Malignant Peritoneal and Retroperitoneal Neoplasm Malignant Peritoneal and Retroperitoneal Neoplasm A neoplasm that arises from the peritoneum and/or retroperitoneum and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C156713 Neoplastic Process Benign Peritoneal and Retroperitoneal Neoplasm CL935866 Benign Benign Peritoneal and Retroperitoneal Neoplasm Benign Peritoneal and Retroperitoneal Neoplasm The reemergence of acute myeloid leukemia not otherwise specified after a period of remission. C156716 Neoplastic Process Recurrent Acute Myeloid Leukemia Not Otherwise Specified CL935865 Malignant Recurrent Acute Myeloid Leukemia Not Otherwise Specified Recurrent Acute Myeloid Leukemia Not Otherwise Specified The reemergence of acute myelomonocytic leukemia after a period of remission. C156717 Neoplastic Process Recurrent Acute Myelomonocytic Leukemia C2861599 CPTAC mCode Malignant Acute myelomonocytic leukemia, in relapse Acute myelomonocytic leukemia, in relapse Recurrent Acute Myelomonocytic Leukemia Relapsed Acute Myelomonocytic Leukemia Recurrent Acute Myelomonocytic Leukemia The reemergence of acute myeloid leukemia with recurrent genetic abnormalities after a period of remission. C156718 Neoplastic Process Recurrent Acute Myeloid Leukemia with Recurrent Genetic Abnormalities CL935860 Malignant Recurrent Acute Myeloid Leukemia with Recurrent Genetic Abnormalities Recurrent Acute Myeloid Leukemia with Recurrent Genetic Abnormalities The reemergence of acute myeloid leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A after a period of remission. C156719 Neoplastic Process Recurrent Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A CL935859 CPTAC Malignant Acute myeloid leukemia with 11q23-abnormality in relapse Recurrent Acute Myeloid Leukemia with t(9;11)(p21.3; q23.3); MLLT3 (AF9)-KMT2A Recurrent Acute Myeloid Leukemia with t(9;11)(p21.3; q23.3); MLLT3-MLL Recurrent Acute Myeloid Leukemia with t(9;11)(p21.3; q23.3); MLLT3::MLL Recurrent Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A Recurrent Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A Fusion Recurrent Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3::KMT2A Recurrent Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3::KMT2A Fusion Relapsed Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A Recurrent Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A The reemergence of acute myeloid leukemia with multilineage dysplasia after a period of remission. C156720 Neoplastic Process Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia C2861610 CPTAC CTRP mCode Malignant Acute myeloid leukemia with multilineage dysplasia, in relapse Acute myeloid leukemia with multilineage dysplasia, in relapse Recurrent Acute Myeloid Leukemia (AML) with Multilineage Dysplasia Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia Relapsed Acute Myeloid Leukemia with Multilineage Dysplasia Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia The reemergence of acute monoblastic and monocytic leukemia after a period of remission. C156722 Neoplastic Process Recurrent Acute Monoblastic and Monocytic Leukemia Recurrent Acute Monoblastic and Monocytic Leukemia C2861618 CPTAC CTRP mCode Malignant Acute monoblastic/monocytic leukemia, in relapse Acute monoblastic/monocytic leukemia, in relapse Recurrent Acute Monoblastic and Monocytic Leukemia Relapsed Acute Monoblastic and Monocytic Leukemia Recurrent Acute Monoblastic and Monocytic Leukemia The reemergence of acute erythroid leukemia after a period of remission. C156723 Neoplastic Process Recurrent Acute Erythroid Leukemia C2861632 CPTAC mCode Malignant Acute erythroid leukemia, in relapse Acute erythroid leukemia, in relapse Recurrent Acute Erythroid Leukemia Relapsed Acute Erythroid Leukemia Recurrent Acute Erythroid Leukemia The reemergence of acute megakaryoblastic leukemia after a period of remission. C156731 Neoplastic Process Recurrent Acute Megakaryoblastic Leukemia C2367455 CPTAC mCode Malignant Acute megakaryoblastic leukemia, in relapse Acute megakaryoblastic leukemia, in relapse Recurrent Acute Megakaryoblastic Leukemia Relapsed Acute Megakaryoblastic Leukemia Recurrent Acute Megakaryoblastic Leukemia A microsatellite stable colorectal carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C156745 Neoplastic Process Locally Advanced Microsatellite Stable Colorectal Carcinoma Locally Advanced Microsatellite Stable Colorectal Carcinoma CL935892 CTRP Malignant Locally Advanced Microsatellite Stable Colorectal Carcinoma Locally Advanced Microsatellite Stable Colorectal Carcinoma Digestive system carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C156746 Neoplastic Process Advanced Digestive System Carcinoma Advanced Digestive System Carcinoma CL935897 CTRP Malignant Advanced Digestive System Carcinoma Advanced Digestive System Carcinoma A benign ovoid parathyroid gland neoplasm surrounded by a pseudocapsule. It is composed of chief cells, clear cells, oncocytic cells, or a mixture of cell types. It lacks the morphological characteristics of parathyroid gland carcinoma and there is no evidence of capsular invasion, vascular invasion, and perineural invasion. C156757 Neoplastic Process Parathyroid Gland Adenoma CL935888 CDISC Cellosaurus A benign neoplasm arising from the Chief cells of the parathyroid gland. Benign ADENOMA, PARATHYROID GLAND, BENIGN Parathyroid Gland Adenoma Parathyroid Gland Adenoma Blockage of the production of male hormones. C15676 Therapeutic or Preventive Procedure Androgen Suppression C1515985 OORO Treatment to suppress or block the production or action of male hormones. This is done by having the testicles removed, by taking female sex hormones, or by taking drugs called antiandrogens. Androgen_Suppression Androgen Ablation Androgen Deprivation Androgen Suppression Testosterone Suppression androgen ablation androgen deprivation androgen suppression Androgen Suppression Increasing prostate-specific antigen (PSA) following prostatectomy or radiation therapy in a patient with a history of localized prostate carcinoma. Signs of metastasis are absent using the currently available scanning technology. C156771 Neoplastic Process Biochemically Recurrent Prostate Carcinoma Biochemically Recurrent Prostate Carcinoma CL935822 CTRP Malignant BCR Prostate Carcinoma Biochemically Recurrent Prostate Carcinoma Micro-Metastatic Prostate Carcinoma PSA-Only (Biochemically) Recurrent Prostate Carcinoma PSA-Only Recurrent Prostate Carcinoma Biochemically Recurrent Prostate Carcinoma A carcinoma arising from the intrahepatic bile ducts, hepatic ducts, common bile duct, cystic duct, or gallbladder. C156781 Neoplastic Process Biliary Tract Carcinoma Biliary Tract Carcinoma CL935812 CTRP Malignant Biliary Tract Carcinoma Biliary Tract Carcinoma The reemergence of a carcinoma arising from any part of the biliary tract after a period of remission. C156782 Neoplastic Process Recurrent Biliary Tract Carcinoma Recurrent Biliary Tract Carcinoma CL935813 CTRP Malignant Recurrent Biliary Tract Carcinoma Recurrent Biliary Tract Carcinoma The history of when and what an individual smoke(s) or smoked. C156825 Clinical Attribute Smoking History CL935823 CPTAC Smoking History Smoking History Stereotactic radiation therapy that uses multiple doses of radiation spread over several treatment session. C156862 Therapeutic or Preventive Procedure Fractionated Stereotactic Radiation Therapy Fractionated Stereotactic Radiation Therapy CL935960 CTRP Fractionated Stereotactic Radiation Therapy Fractionated Stereotactic Radiotherapy Fractionated Stereotactic Radiation Therapy A malignant neoplasm that affects the bronchial tree. C156885 Neoplastic Process Malignant Bronchial Neoplasm Malignant Bronchial Neoplasm C1322284 CTRP mCode Malignant Malignant Bronchial Neoplasm Malignant Neoplasm of Bronchus Malignant neoplasm of unspecified main bronchus Malignant Bronchial Neoplasm Pancreatic adenocarcinoma that is amenable to surgical resection. C156906 Neoplastic Process Resectable Pancreatic Adenocarcinoma C0861748 Malignant Resectable Pancreatic Adenocarcinoma Resectable Pancreatic Adenocarcinoma Pancreatic acinar cell carcinoma that is amenable to surgical resection. C156907 Neoplastic Process Resectable Pancreatic Acinar Cell Carcinoma CL935918 Malignant Resectable Pancreatic Acinar Cell Carcinoma Resectable Pancreatic Acinar Cell Carcinoma Intrahepatic cholangiocarcinoma that is amenable to surgical resection. C156908 Neoplastic Process Resectable Intrahepatic Cholangiocarcinoma CL935919 Malignant Resectable Intrahepatic Cholangiocarcinoma Resectable Intrahepatic Cholangiocarcinoma Digestive system carcinoma that is amenable to surgical resection. C156909 Neoplastic Process Resectable Digestive System Carcinoma CL935923 Malignant Resectable Digestive System Carcinoma Resectable Digestive System Carcinoma Bile duct adenocarcinoma that is amenable to surgical resection. C156910 Neoplastic Process Resectable Bile Duct Adenocarcinoma C0862970 Malignant Resectable Bile Duct Adenocarcinoma Resectable Bile Duct Adenocarcinoma Extrahepatic bile duct adenocarcinoma that is amenable to surgical resection. C156911 Neoplastic Process Resectable Extrahepatic Bile Duct Adenocarcinoma CL935921 Malignant Resectable Extrahepatic Bile Duct Adenocarcinoma Resectable Extrahepatic Bile Duct Adenocarcinoma An extremely rare sex cord-stromal tumor that arises from the adrenal cortex. The reported cases were solitary and unilateral. C156943 Neoplastic Process Adrenal Cortical Sex Cord-Stromal Tumor CL935946 Undetermined Adrenal Cortex Sex Cord-Stromal Tumor Adrenal Cortical Sex Cord-Stromal Tumor Adrenal Cortical Sex Cord-Stromal Tumor A rare schwannoma that arises from the adrenal medulla. C156944 Neoplastic Process Adrenal Gland Schwannoma CL935943 Benign Adrenal Gland Schwannoma Adrenal Gland Schwannoma A rare lymphoma that arises from the adrenal gland. C156945 Neoplastic Process Adrenal Gland Lymphoma CL935944 Malignant Adrenal Gland Lymphoma Adrenal Gland Lymphoma A rare sarcoma that arises from the adrenal gland. C156956 Neoplastic Process Adrenal Gland Sarcoma Adrenal Gland Sarcoma CL935930 CTRP Malignant Adrenal Gland Sarcoma Adrenal Gland Sarcoma A surgical procedure to treat cancer cells that use high energy beams. C15696 Therapeutic or Preventive Procedure Radiosurgery Radiosurgery CL031853 CPTAC CTRP GDC A type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. It is used to treat brain tumors and other brain disorders that cannot be treated by regular surgery. It is also being studied in the treatment of other types of cancer. Radiation_Surgery Ablation, Radiosurgical Ablation, Radiosurgical Radiation Surgery Radiosurgery radiation surgery radiosurgery Radiosurgery C15700 Therapeutic or Preventive Procedure Total Estrogen Blockade C1519559 Therapy used to eliminate estrogen in the body. This may be done with surgery, radiation therapy, chemotherapy, or a combination of these procedures. Total_Estrogen_Blockade Total Estrogen Blockade total estrogen blockade Total Estrogen Blockade Breast adenocarcinoma that is positive for hormone receptors. C157056 Neoplastic Process Hormone Receptor Positive Breast Carcinoma Hormone Receptor-Positive Breast Carcinoma CL936020 CTRP Malignant Hormone Receptor Positive Breast Adenocarcinoma Hormone Receptor Positive Breast Carcinoma Hormone Receptor-Positive Breast Carcinoma Hormone Receptor-Positive Breast Carcinoma Hormone receptor-positive breast adenocarcinoma that does not respond to treatment. C157057 Neoplastic Process Refractory Hormone Receptor Positive Breast Carcinoma Refractory Hormone Receptor-Positive Breast Carcinoma CL936021 CTRP Malignant Refractory Hormone Receptor Positive Breast Adenocarcinoma Refractory Hormone Receptor Positive Breast Carcinoma Refractory Hormone Receptor-Positive Breast Carcinoma Refractory Hormone Receptor-Positive Breast Carcinoma An uncommon and potentially fatal intraocular non-Hodgkin lymphoma that involves the uvea, retina, vitreous body, and optic nerve. It is a subset of primary central nervous system non-Hodgkin lymphoma. The majority of cases are diffuse large B-cell lymphomas. C157065 Neoplastic Process Primary Vitreoretinal Non-Hodgkin Lymphoma CL936835 Malignant PVRL Primary Vitreoretinal Lymphoma Primary Vitreoretinal Non-Hodgkin Lymphoma Primary Vitreoretinal Non-Hodgkin Lymphoma An uncommon and potentially fatal diffuse large B-cell lymphoma that involves the uvea, retina, vitreous body, and optic nerve. It is a subset of primary central nervous system diffuse large B-cell lymphoma. C157067 Neoplastic Process Primary Vitreoretinal Diffuse Large B-Cell Lymphoma CL936837 Malignant PVR-LBCL PVRL DLBCL PVRL Diffuse Large B-Cell Lymphoma Primary Large B-Cell Lymphoma of the Vitreoretina Primary Vitreoretinal Diffuse Large B-Cell Lymphoma Primary Vitreoretinal Diffuse Large B-Cell Lymphoma The reemergence of primary vitreoretinal non-Hodgkin lymphoma after a period of remission. C157068 Neoplastic Process Recurrent Primary Vitreoretinal Lymphoma Recurrent Primary Vitreoretinal Non-Hodgkin Lymphoma CL936830 CTRP Malignant Recurrent PVRL Recurrent Primary Vitreoretinal Lymphoma Recurrent Primary Vitreoretinal Non-Hodgkin Lymphoma Recurrent Primary Vitreoretinal Non-Hodgkin Lymphoma Primary vitreoretinal non-Hodgkin lymphoma that does not respond to treatment. C157069 Neoplastic Process Refractory Primary Vitreoretinal Non-Hodgkin Lymphoma CL936831 Malignant Refractory PVRL Refractory Primary Vitreoretinal Lymphoma Refractory Primary Vitreoretinal Non-Hodgkin Lymphoma Refractory Primary Vitreoretinal Non-Hodgkin Lymphoma The reemergence of primary vitreoretinal diffuse large B-cell lymphoma after a period of remission. C157070 Neoplastic Process Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma CL936832 CTRP Malignant Recurrent PVRL DLBCL Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma Primary vitreoretinal diffuse large B-cell lymphoma that does not respond to treatment. C157071 Neoplastic Process Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma CL936833 Malignant Refractory PVRL DLBCL Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma The reemergence of primary diffuse large B-cell lymphoma of the central nervous system after a period of remission. C157073 Neoplastic Process Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System CL936796 Malignant Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Primary diffuse large B-cell lymphoma of the central nervous system that does not respond to treatment. C157074 Neoplastic Process Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System CL936797 Malignant Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System The reemergence of paraganglioma after a period of remission. C157125 Neoplastic Process Recurrent Paraganglioma Recurrent Paraganglioma CL936808 CTRP Undetermined Recurrent Paraganglioma Recurrent Paraganglioma Paraganglioma that is not amenable to surgical resection. C157126 Neoplastic Process Unresectable Paraganglioma Unresectable Paraganglioma CL936809 CTRP Undetermined Unresectable Paraganglioma Unresectable Paraganglioma Adrenal gland pheochromocytoma that is not amenable to surgical resection. C157128 Neoplastic Process Unresectable Adrenal Gland Pheochromocytoma Unresectable Adrenal Gland Pheochromocytoma CL936811 CTRP Undetermined Unresectable Adrenal Gland Pheochromocytoma Unresectable Adrenal Gland Pheochromocytoma Adrenal gland pheochromocytoma that has spread from its original site of growth to nearby tissues or lymph nodes. C157129 Neoplastic Process Locally Advanced Adrenal Gland Pheochromocytoma Locally Advanced Adrenal Gland Pheochromocytoma CL936804 CTRP Malignant Locally Advanced Adrenal Gland Pheochromocytoma Locally Advanced Adrenal Gland Pheochromocytoma The reemergence of a neuroendocrine neoplasm after a period of remission. C157130 Neoplastic Process Recurrent Neuroendocrine Neoplasm CL936805 Undetermined Recurrent Neuroendocrine Neoplasm Recurrent Neuroendocrine Neoplasm A neuroendocrine neoplasm that does not respond to treatment. C157131 Neoplastic Process Refractory Neuroendocrine Neoplasm CL936806 Undetermined Refractory Neuroendocrine Neoplasm Refractory Neuroendocrine Neoplasm A record of the individual's history of exposure to chemicals and/or occupational hazard. C157151 Clinical Attribute Chemical/Occupational Exposure History CL936905 CPTAC Chemical or Occupational Exposure History Chemical/Occupational Exposure History History of Chemical/Occupational Exposures Chemical/Occupational Exposure History A record of an individual's attribute, characteristic or exposure that increases the likelihood of developing a disease or injury. (WHO) C157153 Clinical Attribute Risk Factor History C0455624 CPTAC History of Risk Factors Risk Factor History Risk Factor History A rare variant of invasive lobular breast carcinoma characterized by the presence of histiocyte-like malignant cells with pale cytoplasm forming sheets or linear patterns. Apocrine differentiation may be present. It usually has an aggressive clinical course. C157235 Neoplastic Process Breast Histiocytoid Carcinoma CL936888 Malignant Breast Histiocytoid Carcinoma HBC Histiocytoid Breast Carcinoma Histiocytoid Lobular Breast Carcinoma Infiltrating Histiocytoid Breast Carcinoma Infiltrating Histiocytoid Lobular Breast Carcinoma Invasive Histiocytoid Breast Carcinoma Invasive Histiocytoid Lobular Breast Carcinoma Breast Histiocytoid Carcinoma Surgical removal of a testis through an inguinal approach. C15724 Therapeutic or Preventive Procedure Inguinal Orchiectomy C0747053 An operation in which the testicle is removed through an incision in the groin. Inguinal_Orchiectomy Inguinal Orchiectomy inguinal orchiectomy Inguinal Orchiectomy An intermixed ganglioneuroblastoma arising from the adrenal gland. C157243 Neoplastic Process Adrenal Gland Ganglioneuroblastoma, Intermixed CL936886 Malignant Adrenal Gland Ganglioneuroblastoma, Intermixed Adrenal Gland Ganglioneuroblastoma, Intermixed A nodular ganglioneuroblastoma arising from the adrenal gland. C157244 Neoplastic Process Adrenal Gland Ganglioneuroblastoma, Nodular CL936887 Malignant Adrenal Gland Ganglioneuroblastoma, Nodular Adrenal Gland Ganglioneuroblastoma, Nodular A ganglioneuroma arising from the adrenal gland. C157245 Neoplastic Process Adrenal Gland Ganglioneuroma CL936880 Benign Adrenal Gland Ganglioneuroma Adrenal Gland Ganglioneuroma (Schwannian Stroma-Dominant) Adrenal Gland Ganglioneuroma A neoplasm that combines morphologic characteristics of paraganglioma and neuroectodermal tumors such as neuroblastoma, ganglioneuroma, ganglioneuroblastoma, or peripheral nerve sheath tumor. C157246 Neoplastic Process Composite Paraganglioma CL936881 Undetermined Composite Paraganglioma Composite Pheochromocytoma and Paraganglioma Composite Pheochromocytoma/Paraganglioma Composite Paraganglioma A hereditary adrenal gland pheochromocytoma caused by mutations in SDHB, SDHC, and SDHD genes. C157248 Neoplastic Process Hereditary Adrenal Gland Pheochromocytoma CL936883 Undetermined Familial Adrenal Gland Pheochromocytoma Hereditary Adrenal Gland Pheochromocytoma Hereditary Adrenal Gland Pheochromocytoma Skin squamous cell carcinoma that is not amenable to surgical resection. C157320 Neoplastic Process Unresectable Skin Squamous Cell Carcinoma Unresectable Skin Squamous Cell Carcinoma CL937048 CTRP Malignant Unresectable Skin Squamous Cell Carcinoma Unresectable Skin Squamous Cell Carcinoma Skin carcinoma that is not amenable to surgical resection. C157324 Neoplastic Process Unresectable Skin Carcinoma CL937043 Malignant Unresectable Skin Carcinoma Unresectable Skin Carcinoma Basal cell carcinoma of the skin that is not amenable to surgical resection. C157331 Neoplastic Process Unresectable Skin Basal Cell Carcinoma CL937033 Malignant Unresectable Skin Basal Cell Carcinoma Unresectable Skin Basal Cell Carcinoma A condition caused by a B-cell or plasma cell clone resulting in the deposition of the secreted monoclonal immunoglobulin, without evidence for overt lymphoma or myeloma. This category includes a wide spectrum of renal pathology and include such lesions as immunoglobulin-associated amyloidosis, the monoclonal immunoglobulin deposition diseases (MIDDs; light chain deposition disease, heavy chain deposition disease, and light and heavy chain deposition disease), proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID), C3 glomerulopathy with monoclonal gammopathy, light chain proximal tubulopathy (Fanconi syndrome), and several others. C157343 Neoplastic Process Monoclonal Gammopathy of Renal Significance CL936968 Undetermined MGRS Monoclonal Gammopathy of Renal Significance Monoclonal Gammopathy of Renal Significance A pancreatic ductal adenocarcinoma term that refers to a continuum between resectable and locally advanced unresectable disease. C157350 Neoplastic Process Borderline Resectable Pancreatic Adenocarcinoma Borderline Resectable Pancreatic Ductal Adenocarcinoma CL936960 CTRP Malignant BR-PDAC BRPC Borderline Resectable Pancreatic Adenocarcinoma Borderline Resectable Pancreatic Cancer Borderline Resectable Pancreatic Carcinoma Borderline Resectable Pancreatic Ductal Adenocarcinoma Borderline Resectable Pancreatic Ductal Adenocarcinoma An adenocarcinoma that originates from the colorectal area and has spread to the liver. C157355 Neoplastic Process Colorectal Adenocarcinoma Metastatic in the Liver Colorectal Adenocarcinoma Metastatic in the Liver CL936958 CTRP Malignant Colorectal Adenocarcinoma Metastatic in the Liver Colorectal Adenocarcinoma Metastatic in the Liver A squamous non-small cell carcinoma that arises from the lung and has metastasized to another anatomic site. C157364 Neoplastic Process 'Metastatic Lung Non-Small Cell Squamous Carcinoma' Metastatic Lung Non-Small Cell Squamous Carcinoma CL936954 CTRP Malignant Metastatic Lung Non-Small Cell Squamous Carcinoma Metastatic Non-Small Cell Squamous Lung Carcinoma Metastatic Squamous Non-Small Cell Lung Carcinoma Metastatic Lung Non-Small Cell Squamous Carcinoma A non-small cell squamous carcinoma of the lung that has spread from its original site of growth to nearby tissues or lymph nodes. C157365 Neoplastic Process Locally Advanced Lung Non-Small Cell Squamous Carcinoma CL936947 Malignant Locally Advanced Lung Non-Small Cell Squamous Carcinoma Locally Advanced Squamous Non-Small Cell Lung Carcinoma Locally Advanced Lung Non-Small Cell Squamous Carcinoma A carcinoma that originates from the colorectal area and has spread to the liver. C157366 Neoplastic Process Colorectal Carcinoma Metastatic in the Liver Colorectal Carcinoma Metastatic in the Liver CL936948 CTRP Malignant Colorectal Carcinoma Metastatic in the Liver Colorectal Carcinoma Metastatic in the Liver C15743 Therapeutic or Preventive Procedure Medical Castration C1513054 Refers to the use of drugs to suppress the function of the ovaries or testicles. Medical_Castration Medical Castration medical castration Medical Castration Parents, siblings or children of an individual have a history of esophageal or gastric esophageal cancer. C157439 Group Attribute First Degree Family History of Esophageal or Gastric Esophageal Cancer First Degree Family History of Esophageal or Gastric Esophageal Cancer CL937171 CPTAC CTRP Family History of Esophageal or Gastric Esophageal Cancer in First Degree Relative First Degree Family History of Esophageal or Gastric Esophageal Cancer First Degree Family History of Esophageal or Gastric Esophageal Cancer An autosomal dominant tumor syndrome caused by germline CDKN1B mutations that result in a phenotype similar to that of multiple endocrine neoplasia type 1, characterized by endocrine neoplasms, particularly in the parathyroid glands, pituitary, and pancreas. (WHO 2017) C157449 Neoplastic Process Multiple Endocrine Neoplasia Type 4 C4274947 CCPS Undetermined MEN 4 Multiple Endocrine Neoplasia Type 1-Like Syndrome Multiple Endocrine Neoplasia Type 4 Multiple Endocrine Neoplasia Type 4 A squamous cell carcinoma that has spread from its original site of growth to the cervical lymph nodes. C157452 Neoplastic Process Metastatic Squamous Cell Carcinoma in Cervical Lymph Node Metastatic Squamous Cell Carcinoma in the Cervical Lymph Nodes CL937162 CTRP Malignant Metastatic Squamous Cell Carcinoma in Cervical Lymph Node Metastatic Squamous Cell Carcinoma in the Cervical Lymph Nodes Metastatic Squamous Cell Carcinoma in the Cervical Lymph Nodes The reemergence of monomorphic post-transplant lymphoproliferative disorder after a period of remission. C157474 Neoplastic Process Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder CL937090 CTRP Malignant Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder Relapsed Monomorphic Post-Transplant Lymphoproliferative Disorder Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder A monomorphic post-transplant lymphoproliferative disorder that does not respond to treatment. C157475 Neoplastic Process Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder CL937083 CTRP Malignant Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder The reemergence of polymorphic post-transplant lymphoproliferative disorder after a period of remission. C157476 Neoplastic Process Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder CL937084 CTRP Uncertain Malignant Potential Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder Relapsed Polymorphic Post-Transplant Lymphoproliferative Disorder Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder A polymorphic post-transplant lymphoproliferative disorder that does not respond to treatment. C157477 Neoplastic Process Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder CL937085 CTRP Uncertain Malignant Potential Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder Castration-resistant prostate carcinoma which is refractory to second-generation androgen receptor axis-targeted agents, namely abiraterone and enzalutamide. C157497 Neoplastic Process Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents CL937064 CTRP Malignant Castration-Resistant Prostate Carcinoma Refractory to Second-Generation ARAT Agents Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents Drug treatment to block the action of the female hormone estrogen. C15757 Therapeutic or Preventive Procedure Antiestrogen Therapy Antiestrogen Therapy C0854638 CTRP Antiestrogen_Therapy It is used in high-risk breast cancer patents and as a form of treatment in selected ovarian cancers. Antiestrogen Therapy Antiestrogen Therapy Anal canal or perianal skin intraepithelial neoplasia with mild dysplasia. C157573 Neoplastic Process Low Grade Anal Intraepithelial Neoplasia CL497895 Undetermined AIN1 Anal Intraepithelial Neoplasia 1 LG-AIN Low Grade Anal Intraepithelial Neoplasia Low Grade Anal Intraepithelial Neoplasia Anal canal or perianal skin intraepithelial neoplasia with moderate dysplasia. C157574 Neoplastic Process Anal Intraepithelial Neoplasia 2 Anal Intraepithelial Neoplasia 2 CL937282 CTRP Undetermined AIN2 Anal Intraepithelial Neoplasia 2 Anal Squamous Intraepithelial Neoplasia 2 Anal Intraepithelial Neoplasia 2 Anal canal or perianal skin intraepithelial neoplasia with severe dysplasia. C157575 Neoplastic Process Anal Intraepithelial Neoplasia 3 Anal Intraepithelial Neoplasia 3 CL937283 CTRP GDC Malignant 8077/2 AIN III Anal intraepithelial neoplasia, grade III AIN III AIN3 Anal Intraepithelial Neoplasia 3 Anal Squamous Intraepithelial Neoplasia 3 Anal intraepithelial neoplasia, grade III Anal Intraepithelial Neoplasia 3 The reemergence of giant cell glioblastoma after a period of remission. C157600 Neoplastic Process Recurrent Giant Cell Glioblastoma Recurrent Giant Cell Glioblastoma CL937260 CTRP Malignant Recurrent Giant Cell Glioblastoma Recurrent Giant Cell Glioblastoma The reemergence of ependymoma after a period of remission. C157601 Neoplastic Process Recurrent Ependymoma Recurrent Ependymoma CL937261 CTRP Undetermined Recurrent Ependymoma Recurrent Ependymoma A neuroendocrine neoplasm that arises from the lung and has spread to another anatomic site. C157602 Neoplastic Process Metastatic Lung Neuroendocrine Neoplasm Metastatic Lung Neuroendocrine Neoplasm CL937262 CTRP Malignant Metastatic Lung Neuroendocrine Neoplasm Metastatic Lung Neuroendocrine Neoplasm A clear cell renal cell carcinoma that is associated with a mutation in BAP1 gene. These tumors are typically high grade and associated with poor outcome. C157614 Neoplastic Process BAP1-Mutant Clear Cell Renal Cell Carcinoma CL937195 Malignant BAP1-Mutant Clear Cell Renal Cell Carcinoma BAP1-Mutant Clear Cell Renal Cell Carcinoma Fallopian tube carcinoma that progresses between one and six months of completing platinum therapy. C157621 Neoplastic Process Platinum-Resistant Fallopian Tube Cancer Platinum-Resistant Fallopian Tube Carcinoma CL937186 CTRP Malignant Platinum-Resistant Fallopian Tube Cancer Platinum-Resistant Fallopian Tube Carcinoma Platinum-Resistant Fallopian Tube Carcinoma Primary peritoneal carcinoma that progresses between one and six months of completing platinum therapy. C157622 Neoplastic Process Platinum-Resistant Primary Peritoneal Cancer Platinum-Resistant Primary Peritoneal Carcinoma CL937187 CTRP Malignant Platinum-Resistant Primary Peritoneal Cancer Platinum-Resistant Primary Peritoneal Carcinoma Platinum-Resistant Primary Peritoneal Carcinoma A cholangiocarcinoma that has metastasized to other anatomic sites. C157623 Neoplastic Process Metastatic Cholangiocarcinoma Metastatic Cholangiocarcinoma C4087471 CTRP Metastatic Cholangiocarcinoma Metastatic Cholangiocarcinoma Histologic transformation of an indolent chronic lymphocytic leukemia to an aggressive diffuse large B-cell lymphoma. C157624 Neoplastic Process Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma CL937181 CTRP Malignant Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma Histologic transformation of a small lymphocytic lymphoma to an aggressive diffuse large B-cell lymphoma. C157625 Neoplastic Process Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma CL937182 CTRP Malignant Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma The reemergence of urothelial carcinoma after a period of remission. C157631 Neoplastic Process Recurrent Urothelial Cancer Recurrent Urothelial Carcinoma C4049507 CTRP Malignant Recurrent Urothelial Cancer Recurrent Urothelial Carcinoma Relapsed Urothelial Cancer Relapsed Urothelial Carcinoma Recurrent Urothelial Carcinoma A urothelial carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C157636 Neoplastic Process Locally Advanced Urothelial Cancer Locally Advanced Urothelial Carcinoma CL937225 CTRP Malignant Locally Advanced Urothelial Cancer Locally Advanced Urothelial Carcinoma Locally Advanced Urothelial Carcinoma Sarcoma involving the organs and structures of the pelvis. C157652 Neoplastic Process Pelvic Sarcoma Pelvic Sarcoma C3164625 CTRP Malignant Pelvic Sarcoma Sarcoma of Pelvis Sarcoma of the Pelvis Pelvic Sarcoma Lymphoma that is not amenable to surgical resection. C157657 Neoplastic Process Unresectable Lymphoma Unresectable Lymphoma CL937213 CTRP Malignant Unresectable Lymphoma Unresectable Lymphoma T-cell/histiocyte-rich large B-cell lymphoma that is resistant to treatment. C157678 Neoplastic Process Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma CL937314 CTRP Malignant Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma The reemergence of primary effusion lymphoma after a period of remission. C157679 Neoplastic Process Recurrent Primary Effusion Lymphoma Recurrent Primary Effusion Lymphoma CL937315 CTRP Malignant Recurrent HHV8-Positive Primary Effusion Lymphoma Recurrent Primary Effusion Lymphoma Recurrent Primary Effusion Lymphoma Primary effusion lymphoma that is resistant to treatment. C157680 Neoplastic Process Refractory Primary Effusion Lymphoma Refractory Primary Effusion Lymphoma CL937316 CTRP Malignant Refractory HHV8-Positive Primary Effusion Lymphoma Refractory Primary Effusion Lymphoma Refractory Primary Effusion Lymphoma The reemergence of primary lymphoma of bone after a period of remission. C157681 Neoplastic Process Recurrent Primary Lymphoma of Bone Recurrent Primary Bone Lymphoma CL937317 CTRP Malignant Recurrent Primary Bone Lymphoma Recurrent Primary Lymphoma of Bone Recurrent Primary Bone Lymphoma Primary lymphoma of bone that is resistant to treatment. C157682 Neoplastic Process Refractory Primary Lymphoma of Bone Refractory Primary Bone Lymphoma CL937310 CTRP Malignant Refractory Primary Bone Lymphoma Refractory Primary Lymphoma of Bone Refractory Primary Bone Lymphoma The reemergence of plasmablastic lymphoma after a period of remission. C157683 Neoplastic Process Recurrent Plasmablastic Lymphoma Recurrent Plasmablastic Lymphoma CL937311 CTRP Malignant Recurrent Plasmablastic Lymphoma Recurrent Plasmablastic Lymphoma Plasmablastic lymphoma that is resistant to treatment. C157684 Neoplastic Process Refractory Plasmablastic Lymphoma Refractory Plasmablastic Lymphoma CL937312 CTRP Malignant Refractory Plasmablastic Lymphoma Refractory Plasmablastic Lymphoma The reemergence of NK-cell lymphoma, unclassifiable after a period of remission. C157689 Neoplastic Process Recurrent NK-Cell Lymphoma, Unclassifiable Recurrent NK-Cell Lymphoma, Unclassifiable CL937309 CTRP Malignant Recurrent NK-Cell Lymphoma, Unclassifiable Recurrent NK-Cell Lymphoma, Unclassifiable NK-cell lymphoma, unclassifiable that is resistant to treatment. C157690 Neoplastic Process Refractory NK-Cell Lymphoma, Unclassifiable Refractory NK-Cell Lymphoma, Unclassifiable CL937302 CTRP Malignant Refractory NK-Cell Lymphoma, Unclassifiable Refractory NK-Cell Lymphoma, Unclassifiable T-cell prolymphocytic leukemia that is resistant to treatment. C157691 Neoplastic Process Refractory T-Cell Prolymphocytic Leukemia Refractory T-Cell Prolymphocytic Leukemia CL937303 CTRP Malignant Refractory T-Cell Prolymphocytic Leukemia Refractory T-Cell Prolymphocytic Leukemia The reemergence of aggressive NK-cell leukemia after a period of remission. C157692 Neoplastic Process Recurrent Aggressive NK-Cell Leukemia Recurrent Aggressive NK-Cell Leukemia CL937304 CTRP Malignant Recurrent Aggressive NK-Cell Leukemia Recurrent Aggressive NK-Cell Leukemia/Lymphoma Recurrent Aggressive NK-Cell Leukemia Aggressive NK-cell leukemia that is resistant to treatment. C157693 Neoplastic Process Refractory Aggressive NK-Cell Leukemia Refractory Aggressive NK-Cell Leukemia CL937305 CTRP Malignant Refractory Aggressive NK-Cell Leukemia Refractory Aggressive NK-Cell Leukemia/Lymphoma Refractory Aggressive NK-Cell Leukemia Monomorphic epitheliotropic intestinal T-cell lymphoma that is resistant to treatment. C157694 Neoplastic Process Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma CL937298 CTRP Malignant Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma The reemergence of subcutaneous panniculitis-like T-cell lymphoma after a period of remission. C157695 Neoplastic Process Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma CL937299 CTRP Malignant Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma Subcutaneous panniculitis-like T-cell lymphoma that is resistant to treatment. C157696 Neoplastic Process Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma CL937300 CTRP Malignant Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma B-cell prolymphocytic leukemia that is resistant to treatment. C157697 Neoplastic Process Refractory B-Cell Prolymphocytic Leukemia Refractory B-Cell Prolymphocytic Leukemia CL937301 CTRP Malignant Refractory B-Cell Prolymphocytic Leukemia Refractory B-Cell Prolymphocytic Leukemia The most common renal cell carcinoma that develops in patients with end-stage renal disease and acquired cystic disease. C157718 Neoplastic Process Acquired Cystic Disease-Associated Renal Cell Carcinoma CL558162 GDC Malignant 8316/3 Acquired cystic disease-associated renal cell carcinoma (RCC) Cyst-associated renal cell carcinoma ACD-RCC Acquired Cystic Disease-Associated Renal Cell Carcinoma Acquired cystic disease-associated renal cell carcinoma (RCC) Cyst-associated renal cell carcinoma Acquired Cystic Disease-Associated Renal Cell Carcinoma Recurrent respiratory papillomatosis that affects the larynx. C157733 Neoplastic Process Laryngeal Papillomatosis C0396072 Undetermined Laryngeal Papillomatosis Recurrent Respiratory Papillomatosis of the Larynx Laryngeal Papillomatosis A synovial sarcoma arising from the kidney. C157737 Neoplastic Process Kidney Synovial Sarcoma CL937459 Malignant Kidney Synovial Sarcoma Renal Synovial Sarcoma Kidney Synovial Sarcoma An epithelial neoplasm with neuroendocrine differentiation that arises from the kidney. It includes neuroendocrine tumor, small cell neuroendocrine carcinoma, large cell neuroendocrine carcinoma, and paraganglioma. C157743 Neoplastic Process Kidney Neuroendocrine Neoplasm CL937404 Undetermined Kidney Neuroendocrine Neoplasm Kidney Neuroendocrine Neoplasm A cystic nephroma that occurs in very young children. C157745 Neoplastic Process Childhood Cystic Nephroma CL937405 Benign Childhood Cystic Nephroma Pediatric Cystic Nephroma Childhood Cystic Nephroma A neoplasm arising from the distal convoluted tubule and collecting duct areas of the kidney. C157748 Neoplastic Process Metanephric Tumor CL937401 Benign Uncertain Malignant Potential Metanephric Tumor Metanephric Tumor A rare benign renal neoplasm composed of moderately cellular spindle cells. It occurs mostly in infancy and childhood. C157749 Neoplastic Process Metanephric Stromal Tumor C1285519 Benign Metanephric Stromal Tumor Metanephric Stromal Tumor Bladder squamous cell carcinoma that has spread to another anatomical site. C157750 Neoplastic Process Metastatic Bladder Squamous Cell Carcinoma Metastatic Bladder Squamous Cell Carcinoma CL937399 CTRP Malignant Metastatic Bladder Squamous Cell Carcinoma Metastatic Bladder Squamous Cell Carcinoma Bladder plasmacytoid urothelial carcinoma that has spread to another anatomic site. C157751 Neoplastic Process Metastatic Bladder Plasmacytoid Urothelial Carcinoma CL937400 Malignant Metastatic Bladder Plasmacytoid Urothelial Carcinoma Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant Metastatic Invasive Bladder Urothelial Carcinoma, Plasmacytoid Variant Metastatic Plasmacytoid Urothelial Carcinoma of the Bladder Metastatic Bladder Plasmacytoid Urothelial Carcinoma Bladder lipid-rich urothelial carcinoma that has spread to another anatomic site. C157754 Neoplastic Process Metastatic Bladder Lipid-Rich Urothelial Carcinoma CL937398 Malignant Metastatic Bladder Lipid-Rich Urothelial Carcinoma Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Cell Variant Metastatic Invasive Bladder Urothelial Carcinoma, Lipid-Rich Variant Metastatic Lipid Rich Bladder Urothelial Carcinoma Metastatic Lipid-Cell Urothelial Carcinoma of the Bladder Metastatic Bladder Lipid-Rich Urothelial Carcinoma Kidney medullary carcinoma that has spread to another anatomical site. C157755 Neoplastic Process Metastatic Kidney Medullary Carcinoma Metastatic Kidney Medullary Carcinoma CL937395 CTRP Malignant Metastatic Kidney Medullary Carcinoma Metastatic Kidney Medullary Carcinoma Sarcomatoid renal cell carcinoma that has spread to another anatomical site. C157757 Neoplastic Process Metastatic Sarcomatoid Renal Cell Carcinoma Metastatic Sarcomatoid Renal Cell Carcinoma CL937393 CTRP Malignant Metastatic Sarcomatoid Renal Cell Carcinoma Metastatic Sarcomatoid Renal Cell Carcinoma A neuroendocrine neoplasm that arises from the bladder. C157758 Neoplastic Process Bladder Neuroendocrine Neoplasm CL937394 Undetermined Bladder Neuroendocrine Neoplasm Bladder Neuroendocrine Neoplasm A malignant, high grade neuroendocrine neoplasm that arises from the bladder. This category includes small cell and large cell neuroendocrine carcinoma. C157759 Neoplastic Process Bladder Neuroendocrine Carcinoma CL508346 Malignant Bladder Neuroendocrine Carcinoma Bladder Neuroendocrine Carcinoma An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the bladder. It is characterized by the presence of malignant large cells. C157760 Neoplastic Process Bladder Large Cell Neuroendocrine Carcinoma CL937392 Malignant Bladder Large Cell Neuroendocrine Carcinoma Bladder Large Cell Neuroendocrine Carcinoma Bladder large cell neuroendocrine carcinoma that has spread to another anatomical site. C157762 Neoplastic Process Metastatic Bladder Large Cell Neuroendocrine Carcinoma Metastatic Bladder Large Cell Neuroendocrine Carcinoma CL937390 CTRP Malignant Metastatic Bladder Large Cell Neuroendocrine Carcinoma Metastatic Bladder Large Cell Neuroendocrine Carcinoma Bladder small cell neuroendocrine carcinoma that has spread to another anatomic site. C157763 Neoplastic Process Metastatic Bladder Small Cell Neuroendocrine Carcinoma Metastatic Bladder Small Cell Neuroendocrine Carcinoma CL937391 CTRP Malignant Metastatic Bladder Small Cell Carcinoma Metastatic Bladder Small Cell Neuroendocrine Carcinoma Metastatic Bladder Small Cell Neuroendocrine Carcinoma Prostate small cell neuroendocrine carcinoma that has spread to another anatomic site. C157764 Neoplastic Process Metastatic Small Cell Neuroendocrine Prostate Cancer Metastatic Prostate Small Cell Neuroendocrine Carcinoma CL937389 CTRP Malignant Metastatic Prostate Small Cell Carcinoma Metastatic Prostate Small Cell Neuroendocrine Carcinoma Metastatic Small Cell Neuroendocrine Prostate Cancer Metastatic Small Cell Prostate Cancer Metastatic Prostate Small Cell Neuroendocrine Carcinoma Bladder sarcomatoid urothelial carcinoma that has spread to another anatomical site. C157766 Neoplastic Process Metastatic Bladder Sarcomatoid Urothelial Carcinoma CL937387 Malignant Metastatic Bladder Sarcomatoid Urothelial Carcinoma Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant Metastatic Invasive Bladder Urothelial Carcinoma, Sarcomatoid Variant Metastatic Sarcomatoid Bladder Urothelial Carcinoma Metastatic Sarcomatoid Urothelial Carcinoma of the Bladder Metastatic Bladder Sarcomatoid Urothelial Carcinoma Bladder micropapillary urothelial carcinoma that has spread to another anatomic site. C157767 Neoplastic Process Metastatic Bladder Micropapillary Urothelial Carcinoma CL937388 Malignant Metastatic Bladder Micropapillary Urothelial Carcinoma Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant Metastatic Invasive Bladder Urothelial Carcinoma, Micropapillary Variant Metastatic Micropapillary Bladder Urothelial Carcinoma Metastatic Micropapillary Urothelial Carcinoma of the Bladder Metastatic Bladder Micropapillary Urothelial Carcinoma Bladder clear cell (glycogen-rich) urothelial carcinoma that has spread to another anatomic site. C157768 Neoplastic Process Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma CL937385 Malignant Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma Metastatic Clear Cell Bladder Urothelial Carcinoma Metastatic Clear Cell Urothelial Carcinoma of the Bladder Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant Metastatic Invasive Bladder Urothelial Carcinoma, Clear Cell (Glycogen-Rich) Variant Metastatic Invasive Bladder Urothelial Carcinoma, Clear Cell Variant Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma Bladder giant cell urothelial carcinoma that has spread to another anatomic site. C157769 Neoplastic Process Metastatic Bladder Giant Cell Urothelial Carcinoma CL937386 Malignant Metastatic Bladder Giant Cell Urothelial Carcinoma Metastatic Giant Cell Bladder Urothelial Carcinoma Metastatic Giant Cell Urothelial Carcinoma of the Bladder Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells Metastatic Invasive Bladder Urothelial Carcinoma with Giant Cells Metastatic Bladder Giant Cell Urothelial Carcinoma Bladder nested urothelial carcinoma that has spread to another anatomic site. C157770 Neoplastic Process Metastatic Bladder Nested Urothelial Carcinoma CL937383 Malignant Metastatic Bladder Nested Urothelial Carcinoma Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant Metastatic Invasive Bladder Urothelial Carcinoma, Nested Variant Metastatic Nested Bladder Urothelial Carcinoma Metastatic Nested Urothelial Carcinoma of the Bladder Metastatic Bladder Nested Urothelial Carcinoma A malignant neoplasm that arises from the genitourinary system and has metastasized to other anatomic sites. C157774 Neoplastic Process Metastatic Genitourinary Tumor Metastatic Malignant Genitourinary System Neoplasm CL937379 CTRP Malignant Metastatic Genitourinary System Malignant Neoplasm Metastatic Genitourinary Tumor Metastatic Malignant Genitourinary System Neoplasm Metastatic Malignant Genitourinary System Neoplasm Therapy designed to use an individual's own immune system to recognize and destroy melanoma cancer cells. C157882 Therapeutic or Preventive Procedure Immunotherapy for Melanoma CL937481 CPTAC Immunotherapy for Melanoma Immunotherapy for Melanoma A diagnostic procedure during surgery in which dye is injected into the cystic duct to visualize the anatomy of the gallbladder and bile ducts. C157890 Diagnostic Procedure Intraoperative Cholangiogram C0203083 CPTAC Intraoperative Cholangiogram Intraoperative Cholangiogram A surgical procedure to treat disorders of the parathyroid gland. C157947 Therapeutic or Preventive Procedure Parathyroid Surgery CL937616 CPTAC Parathyroid Surgery Parathyroid Surgery A highly focused radiation therapy which delivers an intense dose of radiation to a tumor. C157991 Therapeutic or Preventive Procedure Stereotactic Ablative Radiotherapy Stereotactic Ablative Radiotherapy CL937631 CPTAC CTRP SABER SABR/SBRT Stereotactic Ablative Radiotherapy Stereotactic Ablative Radiotherapy An angiomyolipoma that arises from the kidney and is composed exclusively or predominantly of epithelioid cells. It is often associated with cytologic atypia and may recur or metastasize. C158032 Neoplastic Process Kidney Epithelioid Angiomyolipoma CL937602 Undetermined Epithelioid Angiomyolipoma/Epithelioid PEComa of the Kidney Kidney EAML Kidney Epithelioid Angiomyolipoma Kidney Epithelioid Type Angiomyolipoma Perivascular Epithelioid Cell Tumor of the Kidney Renal Epithelioid Angiomyolipoma Kidney Epithelioid Angiomyolipoma A family of tumors ranging from predominantly cystic tumors (adult cystic nephromas) to tumors that are variably solid (mixed epithelial and stromal tumors) and contain biphasic epithelial and stromal components with spindle stroma, glands, and cysts. Most of these tumors are benign. (WHO 2016). C158046 Neoplastic Process Kidney Mixed Epithelial and Stromal Tumor Family CL937591 Undetermined Kidney Mixed Epithelial and Stromal Tumor Family MEST Family Kidney Mixed Epithelial and Stromal Tumor Family The reemergence of a B-cell prolymphocytic leukemia after a period of remission. C158081 Neoplastic Process Recurrent B-Cell Prolymphocytic Leukemia Recurrent B-Cell Prolymphocytic Leukemia CL937698 CTRP mCode Malignant Prolymphocytic leukemia of B-cell type, in relapse Recurrent B-Cell Prolymphocytic Leukemia Recurrent B-Cell Prolymphocytic Leukemia A digestive system neuroendocrine neoplasm that is resistant to treatment. C158088 Neoplastic Process Refractory Digestive System Neuroendocrine Neoplasm Refractory Gastroenteropancreatic Neuroendocrine Tumor Refractory Digestive System Neuroendocrine Neoplasm CL937689 CTRP Undetermined Refractory Digestive System Neuroendocrine Neoplasm Refractory Gastroenteropancreatic Neuroendocrine Neoplasm Refractory Digestive System Neuroendocrine Neoplasm A digestive system neuroendocrine neoplasm that has spread extensively to other anatomic sites or is no longer responding to treatment. C158089 Neoplastic Process Advanced Gastroenteropancreatic Neuroendocrine Tumor Advanced Digestive System Neuroendocrine Neoplasm CL937690 CTRP Malignant Advanced Digestive System Neuroendocrine Neoplasm Advanced Gastroenteropancreatic Neuroendocrine Neoplasm Advanced Digestive System Neuroendocrine Neoplasm A digestive system neuroendocrine neoplasm that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C158090 Neoplastic Process Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumor Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm CL937687 CTRP Malignant Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Neoplasm Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm Cholangiocarcinoma that is resistant to treatment. C158101 Neoplastic Process Refractory Cholangiocarcinoma Refractory Cholangiocarcinoma CL937739 CTRP Malignant Refractory Cholangiocarcinoma Refractory Cholangiocarcinoma WHO grade 2 glioma that is resistant to treatment. C158104 Neoplastic Process Refractory WHO Grade II Glioma Refractory WHO Grade 2 Glioma CL937734 CTRP Undetermined Refractory WHO Grade 2 Glioma Refractory WHO Grade II Glioma Refractory WHO Grade 2 Glioma The reemergence of B-cell non-Hodgkin lymphoma transformed after a period of remission. C158149 Neoplastic Process Recurrent Transformed B-cell Non-Hodgkin Lymphoma Recurrent Transformed B-Cell Non-Hodgkin Lymphoma CL937656 CTRP Malignant Recurrent Transformed B-Cell Non-Hodgkin Lymphoma Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma Recurrent Transformed B-Cell Non-Hodgkin Lymphoma An indolent B-cell non-Hodgkin lymphoma which has undergone histologic transformation to an aggressive B-cell non-Hodgkin lymphoma and has become resistant to treatment. C158150 Neoplastic Process Refractory Transformed B-cell Non-Hodgkin Lymphoma Refractory Transformed B-Cell Non-Hodgkin Lymphoma CL937657 CTRP Malignant Refractory Transformed B-Cell Non-Hodgkin Lymphoma Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma Refractory Transformed B-Cell Non-Hodgkin Lymphoma The reemergence of chronic lymphocytic leukemia transformed to aggressive diffuse large B-cell lymphoma (Richter's transformation) after a period of remission. C158151 Neoplastic Process Recurrent Transformed Chronic Lymphocytic Leukemia Recurrent Transformed Chronic Lymphocytic Leukemia CL937654 CTRP Malignant Recurrent Richter Syndrome Recurrent Transformed Chronic Lymphocytic Leukemia Recurrent Transformed Chronic Lymphocytic Leukemia Chronic lymphocytic leukemia which has undergone histologic transformation to an aggressive diffuse large B-cell lymphoma (Richter's transformation) and has become resistant to treatment. C158152 Neoplastic Process Refractory Transformed Chronic Lymphocytic Leukemia Refractory Transformed Chronic Lymphocytic Leukemia CL937655 CTRP Malignant Refractory Richter Syndrome Refractory Transformed Chronic Lymphocytic Leukemia Refractory Transformed Chronic Lymphocytic Leukemia A non-invasive neoplasm that arises from the urothelial lining of the bladder. C158374 Neoplastic Process Bladder Non-Invasive Urothelial Neoplasm CL937936 Undetermined Bladder Non-Invasive Urothelial Neoplasm Bladder Non-Invasive Urothelial Neoplasm Endometrial serous adenocarcinoma that is resistant to treatment. C158378 Neoplastic Process Refractory Endometrial Serous Adenocarcinoma Refractory Endometrial Serous Adenocarcinoma CL937932 CTRP Malignant Refractory Endometrial Serous Adenocarcinoma Refractory Endometrial Serous Adenocarcinoma Endometrial mixed cell adenocarcinoma that is resistant to treatment. C158379 Neoplastic Process Refractory Endometrial Mixed Cell Adenocarcinoma Refractory Endometrial Mixed Cell Adenocarcinoma CL937929 CTRP Malignant Refractory Endometrial Mixed Cell Adenocarcinoma Refractory Endometrial Mixed Cell Adenocarcinoma Endometrial clear cell adenocarcinoma that is resistant to treatment. C158380 Neoplastic Process Refractory Endometrial Clear Cell Adenocarcinoma Refractory Endometrial Clear Cell Adenocarcinoma CL937930 CTRP Malignant Refractory Endometrial Clear Cell Adenocarcinoma Refractory Endometrial Clear Cell Adenocarcinoma Uterine Corpus Carcinosarcoma that is resistant to treatment. C158381 Neoplastic Process Refractory Endometrial Carcinosarcoma Refractory Uterine Corpus Carcinosarcoma CL937927 CTRP Malignant Refractory Endometrial Carcinosarcoma Refractory Uterine Corpus Carcinosarcoma Refractory Uterine Corpus Carcinosarcoma Papillary urothelial neoplastic proliferation in the bladder with some level of cytological and architectural disorder visible at low to intermediate magnification, with no invasion beyond the basement membrane (Ta). (WHO 2016) C158382 Neoplastic Process Bladder Non-Invasive Papillary Urothelial Carcinoma CL937928 Malignant Bladder Non-Invasive Papillary Urothelial Carcinoma Bladder Non-Invasive Papillary Urothelial Carcinoma Uterine corpus carcinosarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C158383 Neoplastic Process Advanced Endometrial Carcinosarcoma Advanced Uterine Corpus Carcinosarcoma CL937925 CTRP Malignant Advanced Endometrial Carcinosarcoma Advanced Uterine Corpus Carcinosarcoma Advanced Uterine Corpus Carcinosarcoma A paraganglioma that does not respond to treatment. C158401 Neoplastic Process Refractory Paraganglioma Refractory Paraganglioma CL937851 CTRP Undetermined Refractory Paraganglioma Refractory Paraganglioma A pheochromocytoma that does not respond to treatment. C158402 Neoplastic Process Refractory Adrenal Gland Pheochromocytoma Refractory Adrenal Gland Pheochromocytoma CL937852 CTRP Undetermined Refractory Adrenal Gland Pheochromocytoma Refractory Adrenal Gland Pheochromocytoma The reemergence of desmoplastic small round cell tumor after a period of remission. C158426 Neoplastic Process Recurrent Desmoplastic Small Round Cell Tumor Recurrent Desmoplastic Small Round Cell Tumor CL937892 CTRP Malignant Recurrent Desmoplastic Small Round Cell Tumor Recurrent Desmoplastic Small Round Cell Tumor Desmoplastic small round cell tumor that is resistant to treatment. C158427 Neoplastic Process Refractory Desmoplastic Small Round Cell Tumor Refractory Desmoplastic Small Round Cell Tumor CL937889 CTRP Malignant Refractory Desmoplastic Small Round Cell Tumor Refractory Desmoplastic Small Round Cell Tumor The reemergence of fibrosarcoma after a period of remission. C158428 Neoplastic Process Recurrent Fibrosarcoma Recurrent Fibrosarcoma CL937890 CTRP Malignant Recurrent Fibrosarcoma Recurrent Fibrosarcoma Fibrosarcoma that is resistant to treatment. C158429 Neoplastic Process Refractory Fibrosarcoma Refractory Fibrosarcoma CL937887 CTRP Malignant Refractory Fibrosarcoma Refractory Fibrosarcoma Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease. C15843 Therapeutic or Preventive Procedure Preventive Intervention Preventive Intervention CL000755 CDISC CDISC-GLOSS CTRP GDC OORO Any action or response to modify or stop the development of a disease. In medicine, action taken to decrease the chance of getting a disease or condition. For example, cancer prevention includes avoiding risk factors (such as smoking, obesity, lack of exercise, and radiation exposure) and increasing protective factors (such as getting regular physical activity, staying at a healthy weight, and having a healthy diet). Practices or interventions used to help people stay healthy and avoid disease. NOTE: Involves limiting the chances of illness, injuries, or reduced health status from occurring (primary prevention) and, when diseases occur, supporting people to manage them as effectively as possible in order to prevent progression or recurrence (secondary prevention). Prevention is achieved by applying vaccines, behavioral changes, life style changes, improved nutrition, etc. [After Prevention is better than cure, UK Department of Health and Social Care, Nov 5th 2018. After Primary, secondary and tertiary prevention, Institute for Work & Health, Toronto April 2015] Preventive_Intervention Prevention PREVENTATIVE PRYLX Prevention Prevention Measures Preventive Intervention Prophylactic Prophylaxis prevention prophylaxis Preventive Intervention The reemergence of spindle cell sarcoma after a period of remission. C158430 Neoplastic Process Recurrent Spindle Cell Sarcoma Recurrent Spindle Cell Sarcoma CL937888 CTRP Malignant Recurrent Spindle Cell Sarcoma Recurrent Spindle Cell Sarcoma Spindle cell sarcoma that is resistant to treatment. C158431 Neoplastic Process Refractory Spindle Cell Sarcoma Refractory Spindle Cell Sarcoma CL937885 CTRP Malignant Refractory Spindle Cell Sarcoma Refractory Spindle Cell Sarcoma The reemergence of endometrial adenocarcinoma after a period of remission. C158437 Neoplastic Process Recurrent Endometrial Adenocarcinoma Not Otherwise Specified Recurrent Endometrial Adenocarcinoma CL937879 CTRP Malignant Recurrent Endometrial Adenocarcinoma Recurrent Endometrial Adenocarcinoma, Not Otherwise Specified Recurrent Endometrial Adenocarcinoma A salivary gland carcinoma that has metastasized to another anatomic site. C158463 Neoplastic Process Metastatic Salivary Gland Carcinoma Metastatic Salivary Gland Carcinoma CL938031 CTRP Malignant Metastatic Salivary Gland Carcinoma Metastatic Salivary Gland Carcinoma A salivary gland carcinoma that has spread to nearby tissues or lymph nodes. C158464 Neoplastic Process Locally Advanced Salivary Gland Carcinoma Locally Advanced Salivary Gland Carcinoma CL938032 CTRP Malignant Locally Advanced Salivary Gland Carcinoma Locally Advanced Salivary Gland Carcinoma Lung small cell carcinoma that is resistant to platinum therapy. C158493 Neoplastic Process Platinum-Resistant Lung Small Cell Carcinoma Platinum-Resistant Lung Small Cell Carcinoma CL938062 CTRP Malignant Platinum-Resistant Lung Small Cell Carcinoma Platinum-Resistant Lung Small Cell Carcinoma Lung small cell carcinoma that is sensitive to platinum therapy. C158495 Neoplastic Process Platinum-Sensitive Lung Small Cell Carcinoma Platinum-Sensitive Lung Small Cell Carcinoma CL938060 CTRP Malignant Platinum-Sensitive Lung Small Cell Carcinoma Platinum-Sensitive Small Cell Lung Carcinoma Platinum-Sensitive Lung Small Cell Carcinoma Urethral urothelial carcinoma that is not amenable to surgical resection. C158585 Neoplastic Process Unresectable Urethral Urothelial Carcinoma Unresectable Urethral Urothelial Carcinoma CL938090 CTRP Malignant Unresectable Urethral Urothelial Carcinoma Unresectable Urethral Urothelial Carcinoma Bladder urothelial carcinoma that is not amenable to surgical resection. C158586 Neoplastic Process Unresectable Bladder Urothelial Carcinoma Unresectable Bladder Urothelial Carcinoma CL938091 CTRP Malignant Unresectable Bladder Urothelial Carcinoma Unresectable Bladder Urothelial Carcinoma Ureter urothelial carcinoma that is not amenable to surgical resection. C158587 Neoplastic Process Unresectable Ureter Urothelial Carcinoma Unresectable Ureter Urothelial Carcinoma CL938088 CTRP Malignant Unresectable Ureter Urothelial Carcinoma Unresectable Ureter Urothelial Carcinoma A renal pelvis urothelial carcinoma that is not amenable to surgical resection. C158588 Neoplastic Process Unresectable Renal Pelvis Urothelial Carcinoma Unresectable Renal Pelvis Urothelial Carcinoma CL938089 CTRP Malignant Unresectable Renal Pelvis Urothelial Carcinoma Unresectable Renal Pelvis Urothelial Carcinoma A low grade, non-invasive mixed epithelial proliferative neoplasm that arises from the ovary. In most cases is composed of serous and endocervical-type mucinous cells. C158616 Neoplastic Process Borderline Ovarian Mixed Epithelial Tumor/Atypical Proliferative Ovarian Mixed Epithelial Tumor CL950649 Uncertain Malignant Potential Borderline Ovarian Mixed Epithelial Tumor/Atypical Proliferative Ovarian Mixed Epithelial Tumor Borderline Ovarian Mixed Epithelial Tumor/Atypical Proliferative Ovarian Mixed Epithelial Tumor A neoplasm of low malignant potential arising from a site in the female reproductive system. Almost all cases have been reported in the ovary. It is characterized by the presence of cystic spaces which are lined by atypical serous epithelial cells. The surrounding ovarian stroma is fibrotic. There is no evidence of stromal invasion. C158622 Neoplastic Process Borderline Serous Cystadenofibroma CL950655 Uncertain Malignant Potential Borderline Serous Cystadenofibroma Borderline Serous Cystadenofibroma A mesenchymal neoplasm that arises from the bladder. C158636 Neoplastic Process Bladder Soft Tissue Neoplasm CL950616 Undetermined Bladder Soft Tissue Neoplasm Bladder Soft Tissue Neoplasm An exceptionally rare neuroendocrine carcinoma that arises from the prostate gland. It is characterized by the presence of malignant large cells. C158650 Neoplastic Process Prostate Large Cell Neuroendocrine Carcinoma CL950630 OORO Malignant Prostate Large Cell Neuroendocrine Carcinoma Prostate large cell neuroendocrine carcinoma Prostate Large Cell Neuroendocrine Carcinoma Acinar adenocarcinoma of the prostate gland characterized by the presence of scattered neuroendocrine cells by immunohistochemistry. C158656 Neoplastic Process Usual Prostate Adenocarcinoma with Neuroendocrine Differentiation CL950636 Malignant Usual Prostate Adenocarcinoma with Neuroendocrine Cells Usual Prostate Adenocarcinoma with Neuroendocrine Differentiation Usual Prostate Adenocarcinoma with Neuroendocrine Differentiation A prostate adenocarcinoma characterized by the presence of cells with eosinophilic cytoplasmic granules that are positive for neuroendocrine markers by immunohistochemistry. C158664 Neoplastic Process Prostate Adenocarcinoma with Paneth Cell-Like Neuroendocrine Differentiation CL950756 Malignant Prostate Adenocarcinoma with Paneth Cell-Like Neuroendocrine Differentiation Prostate Adenocarcinoma with Paneth Cell-Like Neuroendocrine Differentiation Inflammatory breast carcinoma that is not amenable to surgical resection. C158751 Neoplastic Process Unresectable Inflammatory Breast Carcinoma Unresectable Breast Inflammatory Carcinoma CL950717 CTRP Malignant Unresectable Breast Inflammatory Carcinoma Unresectable Inflammatory Breast Carcinoma Unresectable Breast Inflammatory Carcinoma Breast carcinoma that is not amenable to surgical resection. C158752 Neoplastic Process Unresectable Breast Carcinoma Unresectable Breast Carcinoma CL950718 CTRP Unresectable Breast Carcinoma Unresectable Breast Carcinoma A large cell neuroendocrine carcinoma that has metastasized from its original site of growth to another anatomic site. C158908 Neoplastic Process Metastatic Large Cell Neuroendocrine Carcinoma Metastatic Large Cell Neuroendocrine Carcinoma CL950799 CTRP Malignant Metastatic Large Cell Neuroendocrine Carcinoma Metastatic Large Cell Neuroendocrine Carcinoma A neuroendocrine carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C158909 Neoplastic Process Locally Advanced Neuroendocrine Carcinoma CL950800 Locally Advanced Neuroendocrine Carcinoma Locally Advanced Neuroendocrine Carcinoma A large cell neuroendocrine carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C158910 Neoplastic Process Locally Advanced Large Cell Neuroendocrine Carcinoma Locally Advanced Large Cell Neuroendocrine Carcinoma CL950801 CTRP Malignant Locally Advanced Large Cell Neuroendocrine Carcinoma Locally Advanced Large Cell Neuroendocrine Carcinoma A small cell neuroendocrine carcinoma that has metastasized from its original site of growth to another anatomic site. C158911 Neoplastic Process Metastatic Small Cell Neuroendocrine Carcinoma Metastatic Small Cell Neuroendocrine Carcinoma C0748861 CTRP Malignant Metastatic Small Cell Carcinoma Metastatic Small Cell Neuroendocrine Carcinoma Metastatic Small Cell Neuroendocrine Carcinoma An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the prostate gland. The mitotic count is more than 20 per 10 HPF. It is classified as either small or large cell neuroendocrine carcinoma based on the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm. C158912 Neoplastic Process Prostate Neuroendocrine Carcinoma CL950802 Malignant Prostate Neuroendocrine Carcinoma Prostate Neuroendocrine Carcinoma A neuroendocrine carcinoma that arises from the prostate gland and has spread to other anatomic sites. C158913 Neoplastic Process Metastatic Prostate Neuroendocrine Carcinoma Metastatic Prostate Neuroendocrine Carcinoma CL950803 CTRP Cellosaurus Malignant Metastatic Prostate Neuroendocrine Carcinoma Metastatic Prostate Neuroendocrine Carcinoma A prostate neuroendocrine carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C158914 Neoplastic Process Locally Advanced Prostate Neuroendocrine Carcinoma Locally Advanced Prostate Neuroendocrine Carcinoma CL950804 CTRP Malignant Locally Advanced Prostate Neuroendocrine Carcinoma Locally Advanced Prostate Neuroendocrine Carcinoma A small cell neuroendocrine carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C158915 Neoplastic Process Locally Advanced Small Cell Neuroendocrine Carcinoma Locally Advanced Small Cell Neuroendocrine Carcinoma CL950805 CTRP Malignant Locally Advanced Small Cell Carcinoma Locally Advanced Small Cell Neuroendocrine Carcinoma Locally Advanced Small Cell Neuroendocrine Carcinoma An adenocarcinoma that arises from the exocrine pancreatic ducts and has metastasized to other anatomic sites. C158960 Neoplastic Process Metastatic Pancreatic Ductal Adenocarcinoma Metastatic Pancreatic Ductal Adenocarcinoma CL950964 CTRP Malignant Metastatic Pancreatic Ductal Adenocarcinoma Metastatic Pancreatic Ductal Adenocarcinoma Pancreatic ductal adenocarcinoma that has not spread beyond the pancreas. C158961 Neoplastic Process Early Stage Pancreatic Ductal Adenocarcinoma Early Stage Pancreatic Ductal Adenocarcinoma CL950965 CTRP Malignant Early Stage Pancreatic Ductal Adenocarcinoma Early Stage Pancreatic Ductal Adenocarcinoma A rare type of amyloidosis characterized by the monoclonal deposition of immunoglobulin heavy chain fragments in organs and tissues. It is associated with plasma cell or B-cell lymphoproliferative disorders. C158962 Neoplastic Process AH Amyloidosis CL950966 Undetermined AH Amyloidosis AH Amyloidosis The most common type of amyloidosis. It is characterized by the monoclonal deposition of immunoglobulin light chain fragments in organs and tissues. It is associated with plasma cell or B-cell lymphoproliferative disorders. C158963 Neoplastic Process AL Amyloidosis C1304235 Cellosaurus Undetermined AL Amyloidosis Ig Light Chain Amyloidosis Immunoglobulin-Related Amyloidosis AL Amyloidosis An extremely rare type of amyloidosis characterized by the monoclonal deposition of immunoglobulin heavy chain and light chain fragments in organs and tissues. C158964 Neoplastic Process AHL Amyloidosis CL950968 Undetermined AHL Amyloidosis AHL Amyloidosis A subtype of monoclonal immunoglobulin deposition disease in which heavy and light chains deposition results in non-amyloid tissue deposits which may cause organ dysfunction. C158965 Neoplastic Process Light and Heavy Chain Deposition Disease CL950969 Undetermined LHCDD Light and Heavy Chain Deposition Disease Light and Heavy Chain Deposition Disease A rare angiosarcoma arising from the kidney. C159205 Neoplastic Process Kidney Angiosarcoma CL951257 Malignant Kidney Angiosarcoma Renal Angiosarcoma Kidney Angiosarcoma An extremely rare rhabdomyosarcoma arising from the kidney. Most cases are of embryonal type. C159206 Neoplastic Process Kidney Rhabdomyosarcoma CL951258 Malignant Kidney Rhabdomyosarcoma Renal Rhabdomyosarcoma Kidney Rhabdomyosarcoma A rare Ewing sarcoma arising from the kidney. C159208 Neoplastic Process Kidney Ewing Sarcoma CL951260 Malignant Kidney Ewing Sarcoma Renal Ewing Sarcoma Kidney Ewing Sarcoma A benign smooth muscle neoplasm arising from the kidney. C159209 Neoplastic Process Kidney Leiomyoma CL951261 Benign Kidney Leiomyoma Renal Leiomyoma Kidney Leiomyoma A rare hemangioma arising from the kidney. C159211 Neoplastic Process Kidney Hemangioma C2062513 Benign Kidney Hemangioma Renal Hemangioma Kidney Hemangioma A rare lymphangioma arising from the kidney. C159214 Neoplastic Process Kidney Lymphangioma CL951265 Benign Kidney Lymphangioma Renal Lymphangioma Kidney Lymphangioma A rare schwannoma arising from the kidney. C159221 Neoplastic Process Kidney Schwannoma CL951212 Benign Kidney Schwannoma Renal Schwannoma Kidney Schwannoma A rare solitary fibrous tumor arising from the kidney. C159222 Neoplastic Process Kidney Solitary Fibrous Tumor CL951213 Undetermined Kidney Solitary Fibrous Tumor Renal Solitary Fibrous Tumor Kidney Solitary Fibrous Tumor A well-differentiated neuroendocrine neoplasm arising from the kidney. It is characterized by the presence of uniform cells with stippled chromatin and inconspicuous nucleoli. Mitotic activity is low and tumor necrosis is absent. C159223 Neoplastic Process Kidney Neuroendocrine Tumor CL951214 Undetermined Kidney Neuroendocrine Tumor Kidney Well Differentiated Neuroendocrine Neoplasm Kidney Well-Differentiated Neuroendocrine Neoplasm Kidney Neuroendocrine Tumor An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the kidney. The mitotic count is more than 20 per 10 HPF. It is classified as either small or large cell neuroendocrine carcinoma based on the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm. C159224 Neoplastic Process Kidney Neuroendocrine Carcinoma CL951215 Malignant Kidney Neuroendocrine Carcinoma Kidney Neuroendocrine Carcinoma An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the kidney. It is characterized by the presence of malignant large cells. C159225 Neoplastic Process Kidney Large Cell Neuroendocrine Carcinoma CL951216 Malignant Kidney Large Cell Neuroendocrine Carcinoma Kidney Large Cell Neuroendocrine Carcinoma An extremely rare paraganglioma that arises from the renal hilum. Paragangliomas that arise from the perihilar sympathetic ganglia are not included in this category. C159226 Neoplastic Process Kidney Paraganglioma CL951217 Undetermined Kidney Paraganglioma Renal Paraganglioma Kidney Paraganglioma A rare benign or malignant germ cell tumor that arises from the kidney. C159227 Neoplastic Process Kidney Germ Cell Tumor CL951218 Undetermined Kidney Germ Cell Tumor Renal Germ Cell Tumor Kidney Germ Cell Tumor A squamous cell carcinoma that arises from the penis and is not caused by human papillomavirus infection. Morphologic variants include pseudohyperplastic, pseudoglandular, verrucous, papillary, and sarcomatoid carcinoma. C159244 Neoplastic Process Penile Human Papillomavirus-Independent Squamous Cell Carcinoma CL951232 Malignant Penile HPV-Independent Squamous Cell Carcinoma Penile Human Papillomavirus-Independent Squamous Cell Carcinoma Penile Human Papillomavirus-Independent Squamous Cell Carcinoma A multifocal, extremely differentiated squamous cell carcinoma of the penis. It typically occurs in older patients and is associated with lichen sclerosus. C159245 Neoplastic Process Penile Pseudohyperplastic Carcinoma CL951233 Malignant Penile Pseudohyperplastic Carcinoma Pseudohyperplastic Carcinoma of the Penis Penile Pseudohyperplastic Carcinoma A penile squamous cell carcinoma characterized by the formation of gland-like structures. C159246 Neoplastic Process Penile Pseudoglandular Carcinoma CL951234 Malignant Penile Pseudoglandular Carcinoma Pseudoglandular Carcinoma of the Penis Penile Pseudoglandular Carcinoma A variant of verrucous carcinoma of the penis. It is characterized by a labyrinthine growth pattern. C159247 Neoplastic Process Penile Carcinoma Cuniculatum CL951235 Malignant Carcinoma Cuniculatum of the Penis Penile Carcinoma Cuniculatum Penile Carcinoma Cuniculatum An extremely rare carcinoma that arises from the penis and is characterized by the presence of glandular and squamous components. C159248 Neoplastic Process Penile Adenosquamous Carcinoma CL951181 Malignant Adenosquamous Carcinoma of the Penis Penile Adenosquamous Carcinoma Penile Adenosquamous Carcinoma A variant of penile basaloid squamous cell carcinoma. It is characterized by a papillary exophytic or endophytic growth pattern. C159249 Neoplastic Process Penile Papillary-Basaloid Carcinoma CL951182 Malignant Papillary-Basaloid Carcinoma of the Penis Penile Papillary-Basaloid Carcinoma Penile Papillary-Basaloid Carcinoma A squamous cell carcinoma that arises from the penis. It is characterized by warty (condylomatous) and basaloid features. C159250 Neoplastic Process Penile Warty-Basaloid Carcinoma CL951183 Malignant Penile Warty-Basaloid Carcinoma Warty-Basaloid Carcinoma of the Penis Penile Warty-Basaloid Carcinoma A variant of penile squamous cell carcinoma characterized by the presence of malignant cells with clear cytoplasm. C159251 Neoplastic Process Penile Clear Cell Squamous Cell Carcinoma CL951184 Malignant Clear Cell Squamous Cell Carcinoma of the Penis Penile Clear Cell Squamous Cell Carcinoma Penile Clear Cell Squamous Cell Carcinoma A variant of penile squamous cell carcinoma characterized by the presence of islands of malignant cells with uniform vesicular nuclei and prominent nucleoli, and a dense lymphocytic infiltrate. C159252 Neoplastic Process Penile Lymphoepithelioma-Like Carcinoma CL951185 Malignant Lymphoepithelioma-Like Carcinoma of the Penis Penile Lymphoepithelioma-Like Carcinoma Penile Lymphoepithelioma-Like Carcinoma A low grade ovarian epithelial neoplasm characterized by the presence of neoplastic mucinous epithelial cells, atypia, and microinvasion of the ovarian stroma. C159311 Neoplastic Process Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor with Microinvasion CL951180 Malignant Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor with Microinvasion Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor with Microinvasion A low grade ovarian epithelial neoplasm characterized by the presence of neoplastic mucinous epithelial cells, atypia, and the presence of intraepithelial carcinoma. C159312 Neoplastic Process Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor with Intraepithelial Carcinoma CL951347 Uncertain Malignant Potential Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor with Intraepithelial Carcinoma Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor with Intraepithelial Carcinoma A low grade ovarian epithelial neoplasm characterized by the presence of atypical neoplastic serous and mucinous cells. Microinvasion of the ovarian stroma is present. C159313 Neoplastic Process Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor with Microinvasion CL951348 Uncertain Malignant Potential Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor with Microinvasion Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor with Microinvasion A low grade ovarian epithelial neoplasm characterized by the presence of glandular or cystic spaces which contain atypical glandular epithelial cells resembling endometrial cells. Microinvasion of the ovarian stroma is present. C159486 Neoplastic Process Borderline Ovarian Endometrioid Tumor/Atypical Proliferative Ovarian Endometrioid Tumor with Microinvasion CL951445 Malignant Uncertain Malignant Potential Borderline Ovarian Endometrioid Tumor/Atypical Proliferative Ovarian Endometrioid Tumor with Microinvasion Borderline Ovarian Endometrioid Tumor/Atypical Proliferative Ovarian Endometrioid Tumor with Microinvasion An extremely rare and highly aggressive malignant neoplasm arising from the peritoneum. Morphologically, it is a high grade tumor, composed of carcinomatous and sarcomatous elements. C159507 Neoplastic Process Primary Peritoneal Carcinosarcoma Primary Peritoneal Carcinosarcoma CL951410 CTRP Malignant Primary Peritoneal Carcinosarcoma Primary Peritoneal Malignant Mixed Mesodermal (Mullerian) Tumor Primary Peritoneal Carcinosarcoma A rare bladder adenocarcinoma with the histologic characteristics of endometrioid adenocarcinoma of the endometrium. C159542 Neoplastic Process Bladder Endometrioid Adenocarcinoma CL951380 Malignant Bladder Endometrioid Adenocarcinoma Bladder Endometrioid Carcinoma Bladder Endometrioid Adenocarcinoma Gastroesophageal junction adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C159548 Neoplastic Process Advanced Gastroesophageal Junction Adenocarcinoma Advanced Gastroesophageal Junction Adenocarcinoma CL951386 CTRP Malignant Advanced Gastroesophageal Junction Adenocarcinoma Advanced Gastroesophageal Junction Adenocarcinoma A clear cell renal cell carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C159562 Neoplastic Process Advanced Clear Cell Renal Cell Carcinoma Advanced Clear Cell Renal Cell Carcinoma CL951399 CTRP Malignant Advanced Clear Cell Renal Cell Carcinoma Advanced Clear Cell Renal Cell Carcinoma An indication that a history of chemical/occupational exposures exists. C159577 Clinical Attribute Chemical/Occupational Exposure Present CL951580 CPTAC Chemical/Occupational Exposure Present Yes Chemical/Occupational Exposure Present An indication that a history of chemical/occupational exposures does not exist. C159578 Clinical Attribute Chemical/Occupational Exposure Absent CL971155 CPTAC Chemical/Occupational Exposure Absent No Chemical/Occupational Exposure Absent The chemical/occupation exposure type is unknown. C159579 Clinical Attribute Chemical/Occupational Exposure Type Unknown CL971150 CPTAC Chemical/Occupational Exposure Type Unknown Unknown Chemical/Occupational Exposure Type Unknown A well-differentiated neuroendocrine neoplasm arising from the bladder. It is characterized by the presence of uniform cells with stippled chromatin and inconspicuous nucleoli. Mitotic activity is low and tumor necrosis is absent. C159582 Neoplastic Process Bladder Neuroendocrine Tumor CL951582 Undetermined Bladder Neuroendocrine Tumor Bladder Well Differentiated Neuroendocrine Neoplasm Bladder Well-Differentiated Neuroendocrine Neoplasm Bladder Neuroendocrine Tumor A rare melanoma that arises from the bladder mucosa. C159663 Neoplastic Process Bladder Melanoma CL951546 Malignant Bladder Melanoma Bladder Melanoma A rare melanoma that arises from the urethral mucosa. C159665 Neoplastic Process Urethral Melanoma CL951547 Malignant Urethral Melanoma Urethral Melanoma A malignant mesenchymal neoplasm with skeletal muscle differentiation arising from the bladder. C159667 Neoplastic Process Bladder Rhabdomyosarcoma C0349659 Malignant Bladder Rhabdomyosarcoma Bladder Rhabdomyosarcoma An embryonal rhabdomyosarcoma arising from the bladder. It is the most common type of rhabdomyosarcoma of the bladder affecting young children. C159668 Neoplastic Process Bladder Embryonal Rhabdomyosarcoma CL951493 Malignant Bladder Embryonal Rhabdomyosarcoma Bladder Embryonal Rhabdomyosarcoma An alveolar rhabdomyosarcoma arising from the bladder. It is the most common type of rhabdomyosarcoma of the bladder affecting older children and adolescents. C159669 Neoplastic Process Bladder Alveolar Rhabdomyosarcoma CL951494 Malignant Bladder Alveolar Rhabdomyosarcoma Bladder Alveolar Rhabdomyosarcoma A leiomyosarcoma that arises from the bladder. It is the most common type of bladder sarcoma in adults. C159670 Neoplastic Process Bladder Leiomyosarcoma CL951495 Malignant Bladder Leiomyosarcoma Bladder Leiomyosarcoma A very rare angiosarcoma that arises from the bladder. C159671 Neoplastic Process Bladder Angiosarcoma CL951496 Malignant Bladder Angiosarcoma Bladder Angiosarcoma The determination that an individual's risk factor history is negative. C159672 Clinical Attribute Risk Factor History Negative CL552484 CPTAC GDC None None Risk Factor History Negative Risk Factor History Negative A benign or malignant perivascular epithelioid cell tumor arising from the bladder. C159673 Neoplastic Process Bladder PEComa CL951497 Undetermined Bladder PEComa Bladder Perivascular Epithelioid Cell Tumor Bladder PEComa A benign perivascular epithelioid cell tumor arising from the bladder. C159674 Neoplastic Process Bladder Benign PEComa CL951498 Benign Bladder Benign PEComa Bladder Benign Perivascular Epithelioid Cell Tumor Bladder Benign PEComa Pleural malignant mesothelioma that is resistant to treatment. C159675 Neoplastic Process Refractory Pleural Malignant Mesothelioma Refractory Pleural Malignant Mesothelioma CL951499 CTRP Malignant Refractory Pleural Malignant Mesothelioma Refractory Pleural Malignant Mesothelioma An endometrial carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C159676 Neoplastic Process Advanced Endometrial Carcinoma Advanced Endometrial Carcinoma CL951500 CTRP Malignant Advanced Endometrial Carcinoma Advanced Endometrial Carcinoma A malignant perivascular epithelioid cell tumor arising from the bladder. C159677 Neoplastic Process Bladder Malignant PEComa CL951501 Malignant Bladder Malignant PEComa Bladder Malignant Perivascular Epithelioid Cell Tumor Bladder Malignant PEComa A fluoroscopic medical test done to evaluate the function of the diaphragm. The subject is asked to sniff quickly and the movement of the diaphragm is monitored with a fluoroscope. It is a quick and easy real-time assessment of diaphragmatic motor function. C159678 Diagnostic Procedure Diaphragm Fluoroscopy Diaphragm Fluoroscopy C0412038 CTRP Diaphragm Fluoroscopy Sniff Test Diaphragm Fluoroscopy A solitary fibrous tumor that arises from the bladder. Most of these tumors are benign. C159679 Neoplastic Process Bladder Solitary Fibrous Tumor CL951502 Undetermined Bladder Solitary Fibrous Tumor Bladder Solitary Fibrous Tumor A hemangioma that arises from the bladder. Most tumors occur in adults. C159680 Neoplastic Process Bladder Hemangioma CL951503 Benign Bladder Hemangioma Bladder Hemangioma A rare granular cell tumor arising from the bladder. Most tumors are benign. C159681 Neoplastic Process Bladder Granular Cell Tumor CL951504 Undetermined Bladder Granular Cell Tumor Bladder Granular Cell Tumor A plexiform or diffuse neurofibroma arising from the bladder. C159682 Neoplastic Process Bladder Neurofibroma CL951505 Benign Bladder Neurofibroma Bladder Neurofibroma Semisynthetic conjugates of various toxic molecules, including radioactive isotopes and bacterial or plant toxins, with specific immune substances such as immunoglobulins, monoclonal antibodies, and antigens. The antitumor or antiviral immune substance carries the toxin to the tumor or infected cell where the toxin exerts its poisonous effect. C15973 Therapeutic or Preventive Procedure Immunotoxin Cancer Immunotherapy C1512678 Immunotoxin_Cancer_Immunotherapy Immunotherapy, Cancer, Immunotoxin Immunotoxin Cancer Immunotherapy Immunotoxin Immunotherapy For Cancer Immunotoxin Cancer Immunotherapy The use of biological agents to enhance the host immune system in the treatment of cancer. C15974 Therapeutic or Preventive Procedure Biological Cancer Immunotherapy C1511142 Biological_Cancer_Immunotherapy Biological Cancer Immunotherapy Biological Immunotherapy for Cancer Immunotherapy, Cancer, Biological Biological Cancer Immunotherapy Chemical Cancer Immunotherapy is the use of chemical substances to alter the interaction between the host's immune defenses and cancer cells to boost, direct, or restore the body's ability to fight cancer. C15975 Therapeutic or Preventive Procedure Chemical Cancer Immunotherapy C1516447 Chemical_Cancer_Immunotherapy Chemical Cancer Immunotherapy Immunotherapy, Cancer, Chemical chemical immunotherapy for cancer Chemical Cancer Immunotherapy A gastric carcinoma that is not amenable to surgical resection. C159775 Neoplastic Process Unresectable Gastric Carcinoma Unresectable Gastric Carcinoma CL951628 CTRP Malignant Unresectable Gastric Carcinoma Unresectable Gastric Carcinoma The use of magnetic resonance to image the kidney and urinary system. C159884 Diagnostic Procedure MR Urography CL968965 MR Urography Magnetic Resonance Urography MR Urography The use of ultrasound to image the kidney. C159885 Health Care Activity Renal Ultrasound CL968964 Renal Ultrasound Renal Ultrasound Imaging Renal Ultrasound Ovarian carcinoma that has a documented response to platinum-based chemotherapy. C159902 Neoplastic Process Platinum Sensitive Ovarian Cancer Platinum-Sensitive Ovarian Carcinoma CL968921 CTRP Malignant Platinum Sensitive Ovarian Cancer Platinum-Sensitive Ovarian Cancer Platinum-Sensitive Ovarian Carcinoma Platinum-Sensitive Ovarian Carcinoma Thymic carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C159903 Neoplastic Process Advanced Thymic Carcinoma Advanced Thymic Carcinoma CL968920 CTRP Malignant Advanced Thymic Carcinoma Advanced Thymic Carcinoma A malignant thymoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C159904 Neoplastic Process Advanced Malignant Thymoma Advanced Malignant Thymoma CL968919 CTRP Malignant Advanced Malignant Thymoma Advanced Malignant Thymoma EBV-related lymphoma that is resistant to treatment. C160149 Neoplastic Process Refractory EBV-Related Lymphoma Refractory EBV-Related Lymphoma CL969114 CTRP Malignant Refractory EBV-Associated Lymphoma Refractory EBV-Related Lymphoma Refractory EBV-Related Lymphoma A carcinoma arising in a bladder diverticulum. Approximately one-third to half of the cases represent non-invasive, low-grade or high-grade urothelial carcinomas. Approximately half of the invasive carcinomas are urothelial. The rest include adenocarcinomas, squamous cell carcinomas, and small cell carcinomas. C160158 Neoplastic Process Carcinoma Arising in Bladder Diverticulum CL969119 Malignant Carcinoma Arising in Bladder Diverticulum Carcinoma Arising in Bladder Diverticulum The reemergence of high-grade B-cell lymphoma after a period of remission. C160229 Neoplastic Process Recurrent High-Grade B-Cell Lymphoma Recurrent High Grade B-Cell Lymphoma CL969313 CTRP Malignant Recurrent High Grade B-Cell Lymphoma Recurrent High-Grade B-Cell Lymphoma Recurrent High Grade B-Cell Lymphoma The reemergence of diffuse large B-cell lymphoma germinal center B-cell type after a period of remission. C160230 Neoplastic Process Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type CL969312 CTRP Malignant Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type The reemergence of diffuse large B-cell lymphoma activated B-cell type after a period of remission. C160231 Neoplastic Process Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type CL969311 CTRP Malignant Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type Recurrent Diffuse Large B-Cell Lymphoma Non-GC/ABC Recurrent Diffuse Large B-Cell Lymphoma Non-Germinal Center/Activated B-Cell Type Recurrent Non-GC/ABC DLBCL Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type The reemergence of transformed follicular lymphoma to diffuse large B-cell lymphoma after a period of remission. C160232 Neoplastic Process Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma CL969310 CTRP Malignant Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma High-grade B-cell lymphoma that is resistant to treatment. C160233 Neoplastic Process Refractory High-Grade B-Cell Lymphoma Refractory High Grade B-Cell Lymphoma CL969309 CTRP Malignant Refractory High Grade B-Cell Lymphoma Refractory High-Grade B-Cell Lymphoma Refractory High Grade B-Cell Lymphoma Diffuse large B-cell lymphoma germinal center B-cell type that is resistant to treatment. C160238 Neoplastic Process Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type CL969319 CTRP Malignant Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type Diffuse large B-cell lymphoma activated B-cell type that is resistant to treatment. C160239 Neoplastic Process Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type CL969318 CTRP Malignant Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type Refractory Diffuse Large B-Cell Lymphoma Non-GC/ABC Refractory Diffuse Large B-Cell Lymphoma Non-Germinal Center/Activated B-Cell Type Refractory Non-GC/ABC DLBCL Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type Transformed follicular lymphoma to diffuse large B-cell lymphoma that is resistant to treatment. C160240 Neoplastic Process Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma CL969317 CTRP Malignant Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma Lung small cell carcinoma that is not amenable to surgical resection. C160295 Neoplastic Process Unresectable Lung Small Cell Carcinoma Unresectable Lung Small Cell Carcinoma CL969252 CTRP Malignant Unresectable Lung Small Cell Carcinoma Unresectable Lung Small Cell Carcinoma Small cell lung carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C160296 Neoplastic Process Advanced Lung Small Cell Carcinoma Advanced Lung Small Cell Carcinoma CL969251 CTRP Malignant Advanced Lung Small Cell Carcinoma Advanced Lung Small Cell Carcinoma A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the jejunum. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3 to 20 percent. C160437 Neoplastic Process Jejunal Neuroendocrine Tumor G2 Jejunal Neuroendocrine Tumor G2 CL969374 CTRP mCode Undetermined Jejunal NET G2 Jejunal Neuroendocrine Tumor G2 Malignant carcinoid tumor of the jejunum Jejunal Neuroendocrine Tumor G2 A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the ileum. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3 to 20 percent. C160440 Neoplastic Process Ileal Neuroendocrine Tumor G2 Ileal Neuroendocrine Tumor G2 CL969573 CTRP mCode Undetermined Malignant carcinoid tumor of the ileum Ileal NET G2 Ileal Neuroendocrine Tumor G2 Malignant carcinoid tumor of the ileum Ileal Neuroendocrine Tumor G2 A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the duodenum. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3 to 20 percent. C160442 Neoplastic Process Duodenal Neuroendocrine Tumor G2 Duodenal Neuroendocrine Tumor G2 CL969571 CTRP mCode Undetermined Malignant carcinoid tumor of the duodenum Duodenal NET G2 Duodenal Neuroendocrine Tumor G2 Malignant carcinoid tumor of the duodenum Duodenal Neuroendocrine Tumor G2 A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the colon. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3 to 20 percent. C160443 Neoplastic Process Colon Neuroendocrine Tumor G2 Colon Neuroendocrine Tumor G2 CL969570 CTRP Undetermined Colon NET G2 Colon Neuroendocrine Tumor G2 Colon Neuroendocrine Tumor G2 A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the rectum. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3 to 20 percent. C160451 Neoplastic Process Rectal Neuroendocrine Tumor G2 Rectal Neuroendocrine Tumor G2 CL969579 CTRP mCode Undetermined Malignant carcinoid tumor of the rectum Malignant carcinoid tumor of the rectum Rectal NET G2 Rectal Neuroendocrine Tumor G2 Rectal Neuroendocrine Tumor G2 Esophageal carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C160599 Neoplastic Process Advanced Esophageal Carcinoma Advanced Esophageal Carcinoma CL969711 CTRP Malignant Advanced Esophageal Carcinoma Advanced Esophageal Carcinoma The reemergence of malignant ovarian granulosa cell tumor after a period of remission. C160619 Neoplastic Process Recurrent Malignant Ovarian Granulosa Cell Tumor Recurrent Malignant Ovarian Granulosa Cell Tumor CL969677 CTRP Malignant Recurrent Malignant Ovarian Granulosa Cell Tumor Recurrent Malignant Ovarian Granulosa Cell Tumor A squamous cell carcinoma that arises from the skin in a patient with a history of hematologic malignancy, usually non-Hodgkin lymphoma or chronic lymphocytic leukemia. C160666 Neoplastic Process Hematologic Malignancy-Associated Skin Squamous Cell Carcinoma Hematologic Malignancy-Associated Skin Squamous Cell Carcinoma CL969653 CTRP Malignant HMCSCC Hematologic Malignancy-Associated Cutaneous Squamous Cell Carcinoma Hematologic Malignancy-Associated Skin Squamous Cell Carcinoma Hematologic Malignancy-Associated Skin Squamous Cell Carcinoma An indication that a history of chemical/occupational exposures is unknown. C160678 Clinical Attribute Chemical/Occupational Exposure History Unknown CL969610 CPTAC Chemical/Occupational Exposure History Unknown Unknown Chemical/Occupational Exposure History Unknown The reemergence of oligodendroglioma after a period of remission. C160737 Neoplastic Process Recurrent Oligodendroglioma Recurrent Oligodendroglioma CL969776 CTRP Undetermined Recurrent Oligodendroglioma Recurrent Oligodendroglioma Ovarian serous adenocarcinoma that is not amenable to surgical resection. C160781 Neoplastic Process Unresectable Ovarian Serous Adenocarcinoma Unresectable Ovarian Serous Adenocarcinoma CL969764 CTRP Malignant Unresectable Ovarian Serous Adenocarcinoma Unresectable Ovarian Serous Adenocarcinoma Ovarian serous adenocarcinoma that has spread from its original site of growth to another anatomic site. C160782 Neoplastic Process Metastatic Ovarian Serous Adenocarcinoma Metastatic Ovarian Serous Adenocarcinoma CL969763 CTRP Malignant Metastatic Ovarian Serous Adenocarcinoma Metastatic Ovarian Serous Adenocarcinoma A non-small cell carcinoma of the lung that has spread from its original site of growth to nearby tissues or lymph nodes. C160783 Neoplastic Process Locally Advanced Lung Non-Small Cell Carcinoma Locally Advanced Lung Non-Small Cell Carcinoma CL969762 CTRP Malignant Locally Advanced Lung Non-Small Cell Carcinoma Locally Advanced Lung Non-Small Cell Carcinoma Acinar prostate adenocarcinoma characterized by the presence of microcystic foci in radical prostatectomy specimens. C160817 Neoplastic Process Prostate Acinar Microcystic Adenocarcinoma CL969734 Malignant Prostate Acinar Microcystic Adenocarcinoma Prostate Microcystic Adenocarcinoma Prostate Acinar Microcystic Adenocarcinoma An extremely rare prostate acinar adenocarcinoma characterized by the presence of giant, bizarre anaplastic cells with pleomorphic nuclei and lack of a spindle cell component. C160818 Neoplastic Process Prostate Acinar Pleomorphic Giant Cell Adenocarcinoma CL969733 Malignant Prostate Acinar Pleomorphic Giant Cell Adenocarcinoma Prostate Pleomorphic Giant Cell Adenocarcinoma Prostate Acinar Pleomorphic Giant Cell Adenocarcinoma An adenocarcinoma that arises from the colon and has metastasized to another anatomic site. C160819 Neoplastic Process Metastatic Colon Adenocarcinoma Metastatic Colon Adenocarcinoma CL519416 CTRP Malignant Metastatic Colon Adenocarcinoma Metastatic Colon Adenocarcinoma An adenocarcinoma that arises from the rectum and has metastasized to another anatomic site. C160820 Neoplastic Process Metastatic Rectal Adenocarcinoma Metastatic Rectal Adenocarcinoma CL969732 CTRP Malignant Metastatic Rectal Adenocarcinoma Metastatic Rectal Adenocarcinoma A paraganglioma that has spread extensively to other anatomic sites or is no longer responding to treatment. C160852 Neoplastic Process Advanced Paraganglioma Advanced Paraganglioma CL969926 CTRP Malignant Advanced Paraganglioma Advanced Paraganglioma An adrenal gland pheochromocytoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C160853 Neoplastic Process Advanced Adrenal Gland Pheochromocytoma Advanced Adrenal Gland Pheochromocytoma CL969925 CTRP Malignant Advanced Adrenal Gland Pheochromocytoma Advanced Adrenal Gland Pheochromocytoma Primary peritoneal carcinoma that has a documented response to platinum-based chemotherapy. C160872 Neoplastic Process Platinum-Sensitive Primary Peritoneal Carcinoma Platinum-Sensitive Primary Peritoneal Carcinoma CL969897 CTRP Malignant Platinum-Sensitive Peritoneal Cancer Platinum-Sensitive Peritoneal Carcinoma Platinum-Sensitive Primary Peritoneal Cancer Platinum-Sensitive Primary Peritoneal Carcinoma Platinum-Sensitive Primary Peritoneal Carcinoma Fallopian tube carcinoma that has a documented response to platinum-based chemotherapy. C160873 Neoplastic Process Platinum-Sensitive Fallopian Tube Carcinoma Platinum-Sensitive Fallopian Tube Carcinoma CL969896 CTRP Malignant Platinum-Sensitive Fallopian Tube Cancer Platinum-Sensitive Fallopian Tube Carcinoma Platinum-Sensitive Fallopian Tube Carcinoma The reemergence of anaplastic pleomorphic xanthoastrocytoma after a period of remission. C160904 Neoplastic Process Recurrent Anaplastic Pleomorphic Xanthoastrocytoma Recurrent Anaplastic Pleomorphic Xanthoastrocytoma CL969870 CTRP Malignant Recurrent Anaplastic Pleomorphic Xanthoastrocytoma Recurrent Anaplastic Pleomorphic Xanthoastrocytoma Anaplastic pleomorphic xanthoastrocytoma that is resistant to treatment. C160905 Neoplastic Process Refractory Anaplastic Pleomorphic Xanthoastrocytoma Refractory Anaplastic Pleomorphic Xanthoastrocytoma CL969869 CTRP Malignant Refractory Anaplastic Pleomorphic Xanthoastrocytoma Refractory Anaplastic Pleomorphic Xanthoastrocytoma The reemergence of anaplastic ependymoma after a period of remission. C160912 Neoplastic Process Recurrent Anaplastic Ependymoma Recurrent Anaplastic Ependymoma CL969878 CTRP Malignant Recurrent Anaplastic Ependymoma Recurrent Anaplastic Ependymoma Anaplastic ependymoma that is resistant to treatment. C160913 Neoplastic Process Refractory Anaplastic Ependymoma Refractory Anaplastic Ependymoma CL969877 CTRP Malignant Refractory Anaplastic Ependymoma Refractory Anaplastic Ependymoma The reemergence of anaplastic ganglioglioma after a period of remission. C160914 Neoplastic Process Recurrent Anaplastic Ganglioglioma Recurrent Anaplastic Ganglioglioma CL969876 CTRP Malignant Recurrent Anaplastic Ganglioglioma Recurrent Anaplastic Ganglioglioma Anaplastic ganglioglioma that is resistant to treatment. C160915 Neoplastic Process Refractory Anaplastic Ganglioglioma Refractory Anaplastic Ganglioglioma CL969875 CTRP Malignant Refractory Anaplastic Ganglioglioma Refractory Anaplastic Ganglioglioma A liposarcoma that has spread from its original site of growth to nearby tissues or lymph nodes. C160916 Neoplastic Process Locally Advanced Liposarcoma Locally Advanced Liposarcoma CL969874 CTRP Malignant Locally Advanced Liposarcoma Locally Advanced Liposarcoma A leiomyosarcoma that has spread from its original site of growth to nearby tissues or lymph nodes. C160917 Neoplastic Process Locally Advanced Leiomyosarcoma Locally Advanced Leiomyosarcoma CL969873 CTRP Malignant Locally Advanced Leiomyosarcoma Locally Advanced Leiomyosarcoma An undifferentiated pleomorphic sarcoma that has spread from its original site of growth to nearby tissues or lymph nodes. C160919 Neoplastic Process Locally Advanced Undifferentiated Pleomorphic Sarcoma Locally Advanced Undifferentiated Pleomorphic Sarcoma CL969872 CTRP Malignant Locally Advanced Undifferentiated Pleomorphic Sarcoma Locally Advanced Undifferentiated Pleomorphic Sarcoma A breast carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C160920 Neoplastic Process Locally Advanced Breast Carcinoma Locally Advanced Breast Carcinoma CL969886 CTRP Malignant Locally Advanced Breast Carcinoma Locally Advanced Breast Carcinoma C16093 Therapeutic or Preventive Procedure Exogenous Hormone Therapy C1516999 Exogenous_Hormone_Therapy Exogenous Hormone Therapy Exogenous Hormone Use Exogenous Hormone Therapy A minor salivary gland adenocarcinoma characterized by a cribriform pattern. It often metastasizes to the neck lymph nodes. C160974 Neoplastic Process Cribriform Adenocarcinoma of Minor Salivary Gland CL970007 Malignant CAMSG Cribriform Adenocarcinoma of Minor Salivary Gland Cribriform Adenocarcinoma of Minor Salivary Gland Adenocarcinomas that arises from the sinonasal tract. This category includes salivary-type and non-salivary type adenocarcinomas. The latter includes intestinal-type and non-intestinal-type adenocarcinomas. C160976 Neoplastic Process Sinonasal Adenocarcinoma CL970005 Malignant Nasal Cavity and Paranasal Sinus Adenocarcinoma Sinonasal Adenocarcinoma Sinonasal Adenocarcinoma An adenocarcinoma that arises from the sinonasal tract. It is characterized by the absence of features that resemble intestinal adenocarcinoma. C160977 Neoplastic Process Sinonasal Adenocarcinoma, Non-Intestinal-Type CL970004 Malignant Nasal Cavity and Paranasal Sinus Adenocarcinoma, Non-Intestinal-Type Sinonasal Adenocarcinoma, Non-Intestinal-Type Sinonasal Adenocarcinoma, Non-Intestinal-Type A sebaceous carcinoma that arises from the head and neck region. C160978 Neoplastic Process Head and Neck Sebaceous Carcinoma CL970003 Malignant Head and Neck Sebaceous Carcinoma Head and Neck Sebaceous Carcinoma A rare neuroendocrine carcinoma that arises from the head and neck. C160980 Neoplastic Process Head and Neck Neuroendocrine Carcinoma CL970001 Malignant Head and Neck Neuroendocrine Carcinoma Primary Head and Neck Neuroendocrine Carcinoma Head and Neck Neuroendocrine Carcinoma A small cell neuroendocrine carcinoma that arises from the head and neck. C160981 Neoplastic Process Head and Neck Small Cell Neuroendocrine Carcinoma CL970015 Malignant Head and Neck Small Cell Carcinoma Head and Neck Small Cell Neuroendocrine Carcinoma Head and Neck Small Cell Neuroendocrine Carcinoma A large cell neuroendocrine carcinoma that arises from the head and neck. C160982 Neoplastic Process Head and Neck Large Cell Neuroendocrine Carcinoma CL970014 Malignant Head and Neck Large Cell Neuroendocrine Carcinoma Head and Neck Large Cell Neuroendocrine Carcinoma An intestinal-type adenocarcinoma that arises from the sinonasal tract. It is characterized by the presence of a papillary growth pattern. C160984 Neoplastic Process Sinonasal Adenocarcinoma, Intestinal-Type with Papillary Pattern CL970012 Malignant Sinonasal Adenocarcinoma, Intestinal-Type with Papillary Pattern Sinonasal Adenocarcinoma, Intestinal-Type with Papillary Pattern An intestinal-type adenocarcinoma that arises from the sinonasal tract. It is characterized by the presence of a tubuloglandular growth pattern. C160986 Neoplastic Process Sinonasal Adenocarcinoma, Intestinal-Type with Colonic Pattern CL970010 Malignant Sinonasal Adenocarcinoma, Intestinal-Type with Colonic Pattern Sinonasal Adenocarcinoma, Intestinal-Type with Colonic Pattern An intestinal-type adenocarcinoma that arises from the sinonasal tract. It is characterized by the presence of a solid growth pattern. C160987 Neoplastic Process Sinonasal Adenocarcinoma, Intestinal-Type with Solid Pattern CL970009 Malignant Sinonasal Adenocarcinoma, Intestinal-Type with Solid Pattern Sinonasal Adenocarcinoma, Intestinal-Type with Solid Pattern An intestinal-type adenocarcinoma that arises from the sinonasal tract. It is characterized by the presence of malignant glandular cells with intracytoplasmic mucin. C160995 Neoplastic Process Sinonasal Adenocarcinoma, Intestinal-Type with Mucinous Pattern CL970017 Malignant Sinonasal Adenocarcinoma, Intestinal-Type with Mucinous Pattern Sinonasal Adenocarcinoma, Intestinal-Type with Mucinous Pattern An intestinal-type adenocarcinoma that arises from the sinonasal tract. It is characterized by the presence of a mixture of growth patterns. C161000 Neoplastic Process Sinonasal Adenocarcinoma, Intestinal-Type with Mixed Pattern CL969980 Malignant Sinonasal Adenocarcinoma, Intestinal-Type with Mixed Pattern Sinonasal Adenocarcinoma, Intestinal-Type with Mixed Pattern Adenocarcinomas that arise from the seromucinous glands and surface epithelium of the nasal cavity and paranasal sinuses. These adenocarcinomas morphologically resemble the adenocarcinomas that arise from the major and minor salivary glands. C161007 Neoplastic Process Sinonasal Adenocarcinoma, Salivary-Type CL969984 Malignant Nasal Cavity and Paranasal Sinus Adenocarcinoma, Salivary-Type Sinonasal Adenocarcinoma, Salivary-Type Sinonasal Adenocarcinoma, Salivary-Type Adenocarcinomas that arise from the nasal cavity and paranasal sinuses and do not resemble salivary gland adenocarcinomas. This category includes intestinal-type and non-intestinal type adenocarcinomas. C161008 Neoplastic Process Sinonasal Adenocarcinoma, Non-Salivary-Type CL969983 Malignant Nasal Cavity and Paranasal Sinus Adenocarcinoma, Non-Salivary-Type Sinonasal Adenocarcinoma, Non-Salivary-Type Surface Epithelial (Non-Salivary-Type) Sinonasal Adenocarcinoma Sinonasal Adenocarcinoma, Non-Salivary-Type An intra-acinar and/or intraductal neoplastic epithelial proliferation in the prostate gland that has some features of high-grade prostatic intraepithelial neoplasia but exhibits much greater architectural and/or cytological atypia, typically associated with high-grade, high-stage prostate carcinoma. (WHO 2016) C161022 Neoplastic Process Prostate Intraductal Carcinoma CL969986 OORO Malignant IDC-P Intraductal Carcinoma of the Prostate Intraductal Prostate Adenocarcinoma Intraductal Prostate Carcinoma Prostate Intraductal Carcinoma Prostate Intraductal carcinoma Prostate Intraductal Carcinoma A rare synovial sarcoma that arises from the prostate gland. C161034 Neoplastic Process Prostate Synovial Sarcoma CL969960 Malignant Prostate Synovial Sarcoma Prostate Synovial Sarcoma A rare osteosarcoma that arises from the prostate gland. C161035 Neoplastic Process Prostate Osteosarcoma CL969959 Malignant Prostate Osteosarcoma Prostate Osteosarcoma A rare undifferentiated pleomorphic sarcoma that arises from the prostate gland. C161038 Neoplastic Process Prostate Undifferentiated Pleomorphic Sarcoma CL969958 Malignant Prostate Undifferentiated Pleomorphic Sarcoma Prostate Undifferentiated Pleomorphic Sarcoma A rare inflammatory myofibroblastic tumor that arises from the prostate gland. C161042 Neoplastic Process Prostate Inflammatory Myofibroblastic Tumor CL969963 Undetermined Prostate Inflammatory Myofibroblastic Tumor Prostate Inflammatory Myofibroblastic Tumor A mesenchymal neoplasm that arises from the prostate gland. C161045 Neoplastic Process Prostate Soft Tissue Neoplasm CL969961 Undetermined Prostate Mesenchymal Neoplasm Prostate Soft Tissue Neoplasm Prostate Soft Tissue Neoplasm Colorectal adenocarcinoma that has spread from the original site of growth to other anatomic sites. C161048 Neoplastic Process Metastatic Colorectal Adenocarcinoma Metastatic Colorectal Adenocarcinoma CL969970 CTRP Malignant Metastatic Colorectal Adenocarcinoma Metastatic Colorectal Adenocarcinoma The integument that covers the forearm. C161378 Anatomical Structure Skin of the Forearm C0222215 CDISC The integument that covers the forearm. SKIN OF THE FOREARM Skin of the Forearm Skin of the Forearm The integument that covers the chest. C161379 Anatomical Structure Skin of the Chest C0222149 CDISC The integument that covers the chest. SKIN OF THE CHEST Skin of the Chest Skin of the Chest The integument that covers the inguinal region. C161380 Anatomical Structure Skin of the Inguinal Region C0222173 CDISC The integument that covers the inguinal region. SKIN OF THE INGUINAL REGION Skin of the Inguinal Region Skin of the Inguinal Region The integument that covers the region of the back, lateral to the vertebral region and below the scapula. C161391 Anatomical Structure Skin of the Infrascapular Region CL970115 CDISC The integument that covers the region of the back, lateral to the vertebral region and below the scapula. (NCI) SKIN OF THE INFRASCAPULAR REGION Skin of the Infrascapular Region Skin of the Infrascapular Region Radiation injury of the hematopoietic system. C161512 Finding Hematopoietic Radiation Injury C0022099 CDISC Hematopoietic injury resulting from radiation exposure. Bone Marrow Radiation Injury HEMATOPOIETIC RADIATION INJURY Hematopoietic Radiation Injury Hematopoietic Radiation Injury Radiation injury of the gastrointestinal system. C161513 Finding Gastrointestinal Radiation Injury CL970221 CDISC Gastrointestinal injury resulting from radiation exposure. GASTROINTESTINAL RADIATION INJURY Gastrointestinal Radiation Injury Gastrointestinal Radiation Injury Radiation injury of the pulmonary system. C161514 Finding Lung Radiation Injury CL970220 CDISC Lung injury resulting from radiation exposure. LUNG RADIATION INJURY Lung Radiation Injury Pulmonary Radiation Syndrome Lung Radiation Injury Radiation injury of the skin. C161515 Finding Cutaneous Radiation Injury CL970219 CDISC Skin injury resulting from radiation exposure. CUTANEOUS RADIATION INJURY Cutaneous Radiation Injury Cutaneous Radiation Injury Radiation injury of the kidney. C161516 Finding Renal Radiation Injury CL970218 CDISC Kidney injury resulting from radiation exposure. RENAL RADIATION INJURY Renal Radiation Injury Renal Radiation Injury Radiation injury of the cardiovascular system. C161517 Finding Cardiovascular Radiation Injury CL970217 CDISC Cardiovascular injury resulting from radiation exposure. CARDIOVASCULAR RADIATION INJURY Cardiovascular Radiation Injury Cardiovascular Radiation Injury Radiation injury of the central nervous system. C161518 Finding Central Nervous System Radiation Injury CL970216 CDISC Central nervous system injury resulting from radiation exposure. CENTRAL NERVOUS SYSTEM RADIATION INJURY Central Nervous System Radiation Injury Central Nervous System Radiation Injury Radiation injury of the liver. C161519 Finding Liver Radiation Injury CL970215 CDISC Liver injury resulting from radiation exposure. Hepatic Radiation Injury LIVER RADIATION INJURY Liver Radiation Injury Liver Radiation Injury A rare solitary fibrous tumor that arises from the prostate gland. C161579 Neoplastic Process Prostate Solitary Fibrous Tumor CL970174 Undetermined Prostate Solitary Fibrous Tumor Prostate Solitary Fibrous Tumor A rare malignant solitary fibrous tumor that arises from the prostate gland. C161580 Neoplastic Process Prostate Malignant Solitary Fibrous Tumor CL970173 Malignant Prostate Malignant Solitary Fibrous Tumor Prostate Malignant Solitary Fibrous Tumor A rare hemangioma that arises from the prostate gland. C161581 Neoplastic Process Prostate Hemangioma CL970172 Benign Prostate Hemangioma Prostate Hemangioma A rare granular cell tumor that arises from the prostate gland. C161582 Neoplastic Process Prostate Granular Cell Tumor CL970171 Undetermined Prostate Granular Cell Tumor Prostate Granular Cell Tumor A carcinoma that arises from the prostate gland and has spread to the pelvic cavity. C161584 Neoplastic Process Prostate Carcinoma Metastatic in the Pelvic Cavity Prostate Carcinoma Metastatic in the Pelvic Cavity CL970129 CTRP Malignant Prostate Carcinoma Metastatic in the Pelvic Cavity Prostate Carcinoma Metastatic in the Pelvic Cavity A clear cell sarcoma of soft tissue that has spread from the original site of growth to other anatomic sites. C161585 Neoplastic Process Metastatic Clear Cell Sarcoma of Soft Tissue Metastatic Clear Cell Sarcoma of Soft Tissue CL970128 CTRP Malignant Metastatic Clear Cell Sarcoma of Soft Tissue Metastatic Clear Cell Sarcoma of Soft Tissue A clear cell sarcoma of soft tissue that has spread extensively to other anatomic sites or is no longer responding to treatment. C161586 Neoplastic Process Advanced Clear Cell Sarcoma of Soft Tissue Advanced Clear Cell Sarcoma of Soft Tissue CL970127 CTRP Malignant Advanced Clear Cell Sarcoma of Soft Tissue Advanced Clear Cell Sarcoma of Soft Tissue A carcinoma that arises from the prostate gland and has spread to the lymph nodes. C161587 Neoplastic Process Prostate Carcinoma Metastatic in Lymph Node Prostate Carcinoma Metastatic in the Lymph Nodes CL970126 CTRP Malignant Prostate Carcinoma Metastatic in Lymph Node Prostate Carcinoma Metastatic in the Lymph Nodes Prostate Carcinoma Metastatic in the Lymph Nodes A rare diffuse large B-cell lymphoma that arises from the prostate gland. C161602 Neoplastic Process Prostate Diffuse Large B-Cell Lymphoma CL970142 Malignant Primary Prostate Diffuse Large B-Cell Lymphoma Prostate Diffuse Large B-Cell Lymphoma Prostate Diffuse Large B-Cell Lymphoma A rare follicular lymphoma that arises from the prostate gland. C161603 Neoplastic Process Prostate Follicular Lymphoma CL970141 Malignant Prostate Follicular Lymphoma Prostate Follicular Lymphoma A rare mantle cell lymphoma that arises from the prostate gland. C161604 Neoplastic Process Prostate Mantle Cell Lymphoma CL970140 Malignant Prostate Mantle Cell Lymphoma Prostate Mantle Cell Lymphoma A rare small lymphocytic lymphoma that arises from the prostate gland. C161605 Neoplastic Process Prostate Small Lymphocytic Lymphoma CL970139 Malignant Prostate Small Lymphocytic Lymphoma Prostate Small Lymphocytic Lymphoma A rare cystadenoma affecting the prostate gland. It is characterized by the presence of multilocular prostatic cysts. C161606 Neoplastic Process Prostate Cystadenoma CL970138 Benign Prostate Cystadenoma Prostate Cystadenoma A rare Wilms tumor affecting the prostate gland. C161607 Neoplastic Process Prostate Wilms Tumor CL970137 Malignant Prostate Nephroblastoma Prostate Wilms Tumor Prostate Wilms Tumor A rare extrarenal rhabdoid tumor affecting the prostate gland. C161608 Neoplastic Process Extrarenal Rhabdoid Tumor of the Prostate CL970150 Malignant Extrarenal Malignant Rhabdoid Tumor of the Prostate Extrarenal Rhabdoid Tumor of the Prostate Extrarenal Rhabdoid Tumor of the Prostate A metastatic, castration-resistant prostate carcinoma that is composed of fibroblast growth factor-driven malignant cells. C161609 Neoplastic Process Double-Negative Prostate Carcinoma Double-Negative Prostate Carcinoma CL970149 CTRP Malignant Double Negative Prostate Cancer Double-Negative Prostate Carcinoma Double-Negative Prostate Carcinoma A lymph node that has reduced mobility or is attached to adjacent structures. C161610 Body Part, Organ, or Organ Component Fixed Lymph Node C0240274 Fixed Lymph Node Fixed Lymph Node An exceptionally rare melanoma arising from the prostate gland. C161611 Neoplastic Process Prostate Melanoma CL970148 Malignant Prostate Melanoma Prostate Melanoma A paraganglioma that affects the prostate gland. C161612 Neoplastic Process Prostate Paraganglioma CL970147 Undetermined Prostate Paraganglioma Prostate Paraganglioma An extremely rare squamous cell carcinoma that arises from the seminal vesicle. Glandular formation and mucin secretion are absent. C161634 Neoplastic Process Seminal Vesicle Squamous Cell Carcinoma CL970338 Malignant Seminal Vesicle Squamous Cell Carcinoma Seminal Vesicle Squamous Cell Carcinoma A rare biphasic neoplasm that arises from the seminal vesicle. It is characterized by the presence of stromal and benign epithelial components. Rarely, the stromal component may display atypia and mitotic activity and the tumor may behave in a malignant clinical course. C161636 Neoplastic Process Seminal Vesicle Mixed Epithelial and Stromal Tumor CL970336 Undetermined Seminal Vesicle Mixed Epithelial and Stromal Tumor Seminal Vesicle Mixed Epithelial and Stromal Tumor A mesenchymal neoplasm that arises from the seminal vesicle. C161637 Neoplastic Process Seminal Vesicle Soft Tissue Neoplasm CL970335 Undetermined Seminal Vesicle Soft Tissue Neoplasm Seminal Vesicle Soft Tissue Neoplasm A leiomyoma that arises from the seminal vesicle. C161638 Neoplastic Process Seminal Vesicle Leiomyoma CL970334 Benign Seminal Vesicle Leiomyoma Seminal Vesicle Leiomyoma A schwannoma that affects the seminal vesicle. C161639 Neoplastic Process Seminal Vesicle Schwannoma CL970333 Benign Seminal Vesicle Schwannoma Seminal Vesicle Schwannoma An extramammary myofibroblastoma that affects the seminal vesicle. C161640 Neoplastic Process Seminal Vesicle Mammary-Type Myofibroblastoma CL970345 Benign Seminal Vesicle Mammary-Type Myofibroblastoma Seminal Vesicle Mammary-Type Myofibroblastoma A rare leiomyosarcoma that affects the seminal vesicle. C161641 Neoplastic Process Seminal Vesicle Leiomyosarcoma CL970344 Malignant Seminal Vesicle Leiomyosarcoma Seminal Vesicle Leiomyosarcoma An extremely rare angiosarcoma that affects the seminal vesicle. C161642 Neoplastic Process Seminal Vesicle Angiosarcoma CL970343 Malignant Seminal Vesicle Angiosarcoma Seminal Vesicle Angiosarcoma A neoplasm that arises from the seminal vesicle and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C161643 Neoplastic Process Benign Seminal Vesicle Neoplasm C0346217 Benign Benign Seminal Vesicle Neoplasm Benign Seminal Vesicle Neoplasm A primary or metastatic malignant neoplasm that affects the seminal vesicle. C161644 Neoplastic Process Malignant Seminal Vesicle Neoplasm C0346216 Malignant Malignant Seminal Vesicle Neoplasm Malignant Seminal Vesicle Neoplasm The spread of a malignant neoplasm to the seminal vesicle from an adjacent or distant anatomic site. C161649 Neoplastic Process Metastatic Malignant Neoplasm in the Seminal Vesicle CL970292 Malignant Metastatic Malignant Neoplasm in the Seminal Vesicle Metastatic Malignant Neoplasm in the Seminal Vesicle BRCA-associated breast carcinoma that has spread to another anatomic site. C161830 Neoplastic Process BRCA-Mutated Metastatic Breast Carcinoma Metastatic BRCA-Associated Breast Carcinoma CL970386 CTRP Malignant BRCA-Mutated Metastatic Breast Carcinoma Metastatic BRCA-Associated Breast Carcinoma Metastatic BRCA-Mutated Breast Carcinoma Metastatic BRCA-Associated Breast Carcinoma A rare childhood malignant liver neoplasm with overlapping features of hepatoblastoma and hepatocellular carcinoma. C161838 Neoplastic Process Hepatocellular Malignant Neoplasm, Not Otherwise Specified Hepatocellular Malignant Neoplasm, Not Otherwise Specified CL970394 Provisional_Concept CTRP Malignant HCN-NOS HEMNOS Hepatocellular Malignant Neoplasm, NOS Hepatocellular Malignant Neoplasm, Not Otherwise Specified Hepatocellular Malignant Neoplasm, Not Otherwise Specified Adenocarcinoma that arises from the esophagus and is confined entirely to the mucosa. C161906 Neoplastic Process Esophageal Intramucosal Adenocarcinoma Esophageal Intramucosal Adenocarcinoma CL970524 CTRP Malignant Esophageal Intramucosal Adenocarcinoma Esophageal Intramucosal Adenocarcinoma Short term endocrine therapy, prior to surgery, to "down-stage" primary breast cancer in order to increase the rate of breast-conserving surgery. (from JMCC 7:557-562, 2000 via Medscape) C16194 Therapeutic or Preventive Procedure Preoperative Endocrine Therapy C1514396 Preoperative_Endocrine_Therapy Preoperative Endocrine Therapy Preoperative Endocrine Therapy Pancreatic adenocarcinoma that is resistant to treatment. C162015 Neoplastic Process Refractory Pancreatic Adenocarcinoma Refractory Pancreatic Adenocarcinoma CL970673 CTRP Malignant Refractory Pancreatic Adenocarcinoma Refractory Pancreatic Adenocarcinoma Pancreatic adenocarcinoma that is not amenable to surgical resection. C162016 Neoplastic Process Unresectable Pancreatic Adenocarcinoma Unresectable Pancreatic Adenocarcinoma CL970672 CTRP Malignant Unresectable Pancreatic Adenocarcinoma Unresectable Pancreatic Adenocarcinoma Esophageal adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C162113 Neoplastic Process Locally Advanced Unresectable Esophageal Adenocarcinoma Locally Advanced Unresectable Esophageal Adenocarcinoma CL970582 CTRP Malignant Locally Advanced Unresectable Esophageal Adenocarcinoma Locally Advanced Unresectable Esophageal Adenocarcinoma Gastroesophageal junction adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C162114 Neoplastic Process Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma CL970581 CTRP Malignant Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma A colon adenocarcinoma that is not amenable to surgical resection. C162116 Neoplastic Process Unresectable Colon Adenocarcinoma CL970592 Malignant Unresectable Colon Adenocarcinoma Unresectable Colon Adenocarcinoma A rectal adenocarcinoma that is not amenable to surgical resection. C162117 Neoplastic Process Unresectable Rectal Adenocarcinoma CL970591 Malignant Unresectable Rectal Adenocarcinoma Unresectable Rectal Adenocarcinoma A testicular germ cell tumor that has undergone either partial or complete regression, resulting in the creation of a fibrotic nodule in the testis. C162139 Neoplastic Process Regressed Testicular Germ Cell Tumor C1275403 Undetermined Burnt-Out Germ Cell Tumor Regressed Germ Cell Tumor Regressed Testicular Germ Cell Tumor Regressed Testicular Germ Cell Tumor Colon adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C162152 Neoplastic Process Advanced Colon Adenocarcinoma Advanced Colon Adenocarcinoma CL970803 CTRP Malignant Advanced Colon Adenocarcinoma Advanced Colon Adenocarcinoma Pancreatic adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C162153 Neoplastic Process Advanced Pancreatic Adenocarcinoma Advanced Pancreatic Adenocarcinoma CL970802 CTRP Malignant Advanced Pancreatic Adenocarcinoma Advanced Pancreatic Adenocarcinoma Colorectal adenocarcinoma that is resistant to treatment. C162154 Neoplastic Process Refractory Colorectal Adenocarcinoma CL970801 Malignant Refractory Colorectal Adenocarcinoma Refractory Colorectal Adenocarcinoma Colon adenocarcinoma that is resistant to treatment. C162155 Neoplastic Process Refractory Colon Adenocarcinoma Refractory Colon Adenocarcinoma CL970800 CTRP Malignant Refractory Colon Adenocarcinoma Refractory Colon Adenocarcinoma Rectal carcinoma that is resistant to treatment. C162156 Neoplastic Process Refractory Rectal Carcinoma CL970815 Malignant Refractory Rectal Carcinoma Refractory Rectal Carcinoma Rectal adenocarcinoma that is resistant to treatment. C162157 Neoplastic Process Refractory Rectal Adenocarcinoma Refractory Rectal Adenocarcinoma CL970814 CTRP Malignant Refractory Rectal Adenocarcinoma Refractory Rectal Adenocarcinoma Lung non-small cell carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C162158 Neoplastic Process Advanced Lung Non-Small Cell Carcinoma CL970813 Malignant Advanced Lung Non-Small Cell Carcinoma Advanced Lung Non-Small Cell Carcinoma A breast carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C162182 Neoplastic Process Locally Advanced Unresectable Breast Carcinoma Locally Advanced Unresectable Breast Carcinoma CL970775 CTRP Malignant Locally Advanced Unresectable Breast Carcinoma Locally Advanced Unresectable Breast Carcinoma A sarcoma of soft tissue that has spread extensively to other anatomic sites or is no longer responding to treatment. C162194 Neoplastic Process Advanced Soft Tissue Sarcoma Advanced Soft Tissue Sarcoma CL970781 CTRP Malignant Advanced Soft Tissue Sarcoma Advanced Soft Tissue Sarcoma A term that refers to the staging of cervical cancer according to the International Federation of Gynecology and Obstetrics (FIGO) staging, 2018. C162225 Neoplastic Process Cervical Cancer by FIGO Stage 2018 CL970752 Malignant Cervical Cancer by FIGO Stage 2018 Cervical Carcinoma by FIGO Stage 2018 Cervical Cancer by FIGO Stage 2018 The carcinoma is strictly confined to the cervix (extension to the uterine corpus should be disregarded). (FIGO 2018) C162226 Neoplastic Process Stage I Cervical Cancer FIGO 2018 CL970751 Malignant Stage I Cervical Cancer FIGO 2018 Stage I Cervical Carcinoma FIGO 2018 Stage I Cervical Cancer FIGO 2018 Invasive cervical carcinoma that can be diagnosed only by microscopy, with maximum depth of invasion less than 5 mm. (FIGO 2018) C162227 Neoplastic Process Stage IA Cervical Cancer FIGO 2018 CL970750 Malignant Stage IA Cervical Cancer FIGO 2018 Stage IA Cervical Carcinoma FIGO 2018 Stage IA Cervical Cancer FIGO 2018 Cervical carcinoma with measured stromal invasion less than 3 mm in depth. (FIGO 2018) C162228 Neoplastic Process Stage IA1 Cervical Cancer FIGO 2018 CL970749 Malignant Stage IA1 Cervical Cancer FIGO 2018 Stage IA1 Cervical Carcinoma FIGO 2018 Stage IA1 Cervical Cancer FIGO 2018 Cervical carcinoma with measured stromal invasion equal or more than 3 mm and less than 5 mm in depth. (FIGO 2018) C162229 Neoplastic Process Stage IA2 Cervical Cancer FIGO 2018 CL970748 Malignant Stage IA2 Cervical Cancer FIGO 2018 Stage IA2 Cervical Carcinoma FIGO 2018 Stage IA2 Cervical Cancer FIGO 2018 Invasive cervical carcinoma with measured deepest invasion equal or more than 5 mm (greater than Stage IA), lesion limited to the cervix uteri. (FIGO 2018) C162230 Neoplastic Process Stage IB Cervical Cancer FIGO 2018 CL970747 Malignant Stage IB Cervical Cancer FIGO 2018 Stage IB Cervical Carcinoma FIGO 2018 Stage IB Cervical Cancer FIGO 2018 Invasive cervical carcinoma with equal or more than 5 mm depth of stromal invasion, and less than 2 cm in greatest dimension. (FIGO 2018) C162231 Neoplastic Process Stage IB1 Cervical Cancer FIGO 2018 CL970746 Malignant Stage IB1 Cervical Cancer FIGO 2018 Stage IB1 Cervical Carcinoma FIGO 2018 Stage IB1 Cervical Cancer FIGO 2018 Invasive cervical carcinoma equal or more than 2 cm and less than 4 cm in greatest dimension. (FIGO 2018) C162232 Neoplastic Process Stage IB2 Cervical Cancer FIGO 2018 CL970701 Malignant Stage IB2 Cervical Cancer FIGO 2018 Stage IB2 Cervical Carcinoma FIGO 2018 Stage IB2 Cervical Cancer FIGO 2018 Invasive cervical carcinoma equal or more than 4 cm in greatest dimension. (FIGO 2018) C162233 Neoplastic Process Stage IB3 Cervical Cancer FIGO 2018 CL970700 Malignant Stage IB3 Cervical Cancer FIGO 2018 Stage IB3 Cervical Carcinoma FIGO 2018 Stage IB3 Cervical Cancer FIGO 2018 The cervical carcinoma invades beyond the uterus, but has not extended onto the lower third of the vagina or to the pelvic wall. (FIGO 2018) C162234 Neoplastic Process Stage II Cervical Cancer FIGO 2018 CL970699 Malignant Stage II Cervical Cancer FIGO 2018 Stage II Cervical Carcinoma FIGO 2018 Stage II Cervical Cancer FIGO 2018 Cervical carcinoma limited to the upper two-thirds of the vagina without parametrial involvement. (FIGO 2018) C162235 Neoplastic Process Stage IIA Cervical Cancer FIGO 2018 CL970698 Malignant Stage IIA Cervical Cancer FIGO 2018 Stage IIA Cervical Carcinoma FIGO 2018 Stage IIA Cervical Cancer FIGO 2018 Cervical carcinoma limited to the upper two-thirds of the vagina without parametrial involvement, less than 4 cm in greatest dimension. (FIGO 2018) C162236 Neoplastic Process Stage IIA1 Cervical Cancer FIGO 2018 CL970697 Malignant Stage IIA1 Cervical Cancer FIGO 2018 Stage IIA1 Cervical Carcinoma FIGO 2018 Stage IIA1 Cervical Cancer FIGO 2018 Cervical carcinoma limited to the upper two-thirds of the vagina without parametrial involvement, equal or more than 4 cm in greatest dimension. (FIGO 2018) C162237 Neoplastic Process Stage IIA2 Cervical Cancer FIGO 2018 CL970696 Malignant Stage IIA2 Cervical Cancer FIGO 2018 Stage IIA2 Cervical Carcinoma FIGO 2018 Stage IIA2 Cervical Cancer FIGO 2018 Cervical carcinoma with parametrial involvement but not up to the pelvic wall. (FIGO 2018) C162238 Neoplastic Process Stage IIB Cervical Cancer FIGO 2018 CL970695 Malignant Stage IIB Cervical Cancer FIGO 2018 Stage IIB Cervical Carcinoma FIGO 2018 Stage IIB Cervical Cancer FIGO 2018 Cervical carcinoma that involves the lower third of the vagina and/or extends to the pelvic wall and/or causes hydronephrosis or nonfunctioning kidney and/or involves pelvic and/or para-aortic lymph nodes. (FIGO 2018) C162239 Neoplastic Process Stage III Cervical Cancer FIGO 2018 CL970694 Malignant Stage III Cervical Cancer FIGO 2018 Stage III Cervical Carcinoma FIGO 2018 Stage III Cervical Cancer FIGO 2018 Cervical carcinoma that involves the lower third of the vagina, with no extension to the pelvic wall. (FIGO 2018) C162240 Neoplastic Process Stage IIIA Cervical Cancer FIGO 2018 CL970709 Malignant Stage IIIA Cervical Cancer FIGO 2018 Stage IIIA Cervical Carcinoma FIGO 2018 Stage IIIA Cervical Cancer FIGO 2018 Cervical carcinoma with extension to the pelvic wall and/or hydronephrosis or nonfunctioning kidney (unless known to be due to another cause). (FIGO 2018) C162241 Neoplastic Process Stage IIIB Cervical Cancer FIGO 2018 CL970708 Malignant Stage IIIB Cervical Cancer FIGO 2018 Stage IIIB Cervical Carcinoma FIGO 2018 Stage IIIB Cervical Cancer FIGO 2018 Cervical carcinoma with involvement of pelvic and/or para-aortic lymph nodes, irrespective of tumor size and extent (with r and p notations). (FIGO 2018) C162242 Neoplastic Process Stage IIIC Cervical Cancer FIGO 2018 CL970707 Malignant Stage IIIC Cervical Cancer FIGO 2018 Stage IIIC Cervical Carcinoma FIGO 2018 Stage IIIC Cervical Cancer FIGO 2018 Cervical carcinoma with pelvic lymph node metastasis only. (FIGO 2018) C162243 Neoplastic Process Stage IIIC1 Cervical Cancer FIGO 2018 CL970706 Malignant Stage IIIC1 Cervical Cancer FIGO 2018 Stage IIIC1 Cervical Carcinoma FIGO 2018 Stage IIIC1 Cervical Cancer FIGO 2018 Cervical carcinoma with para-aortic lymph node metastasis. (FIGO 2018) C162244 Neoplastic Process Stage IIIC2 Cervical Cancer FIGO 2018 CL970705 Malignant Stage IIIC2 Cervical Cancer FIGO 2018 Stage IIIC2 Cervical Carcinoma FIGO 2018 Stage IIIC2 Cervical Cancer FIGO 2018 The cervical carcinoma has extended beyond the true pelvis or has involved (biopsy proven) the mucosa of the bladder or rectum. (A bullous edema, as such, does not permit a case to be allotted to Stage IV). (FIGO 2018) C162245 Neoplastic Process Stage IV Cervical Cancer FIGO 2018 CL970704 Malignant Stage IV Cervical Cancer FIGO 2018 Stage IV Cervical Carcinoma FIGO 2018 Stage IV Cervical Cancer FIGO 2018 The cervical carcinoma has spread to adjacent pelvic organs. (FIGO 2018) C162246 Neoplastic Process Stage IVA Cervical Cancer FIGO 2018 CL970703 Malignant Stage IVA Cervical Cancer FIGO 2018 Stage IVA Cervical Carcinoma FIGO 2018 Stage IVA Cervical Cancer FIGO 2018 The cervical carcinoma has spread to distant organs. (FIGO 2018) C162247 Neoplastic Process Stage IVB Cervical Cancer FIGO 2018 CL970702 Malignant Stage IVB Cervical Cancer FIGO 2018 Stage IVB Cervical Carcinoma FIGO 2018 Stage IVB Cervical Cancer FIGO 2018 A malignant neoplasm that arises in the female reproductive system and has spread from its original site of growth to other anatomic sites. C162254 Neoplastic Process Metastatic Malignant Female Reproductive System Neoplasm Metastatic Malignant Female Reproductive System Neoplasm CL970711 CTRP Malignant Metastatic Malignant Female Reproductive System Neoplasm Metastatic Malignant Female Reproductive System Neoplasm A malignant neoplasm that arises in the digestive system and has spread from its original site of growth to other anatomic sites. C162255 Neoplastic Process Metastatic Malignant Digestive System Neoplasm Metastatic Malignant Digestive System Neoplasm CL970710 CTRP Malignant Metastatic Malignant Digestive System Neoplasm Metastatic Malignant Digestive System Neoplasm A colorectal carcinoma characterized by a high mutational rate caused by DNA mismatch repair deficiency or POLE/POLD1 driver mutations. C162256 Neoplastic Process Hypermutated Colorectal Carcinoma Hypermutated Colorectal Carcinoma CL970724 CTRP Malignant Hypermutated Colorectal Cancer Hypermutated Colorectal Carcinoma Hypermutated Colorectal Carcinoma Colorectal carcinoma that is amenable to surgical resection. C162257 Neoplastic Process Resectable Colorectal Carcinoma Resectable Colorectal Carcinoma CL970723 CTRP Malignant Resectable Colorectal Carcinoma Resectable Colorectal Carcinoma A colorectal adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C162270 Neoplastic Process Locally Advanced Unresectable Colorectal Adenocarcinoma Locally Advanced Unresectable Colorectal Adenocarcinoma CL970894 CTRP Malignant Locally Advanced Unresectable Colorectal Adenocarcinoma Locally Advanced Unresectable Colorectal Adenocarcinoma A colon adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C162271 Neoplastic Process Locally Advanced Unresectable Colon Adenocarcinoma Locally Advanced Unresectable Colon Adenocarcinoma CL970893 CTRP Malignant Locally Advanced Unresectable Colon Adenocarcinoma Locally Advanced Unresectable Colon Adenocarcinoma A rectal adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C162272 Neoplastic Process Locally Advanced Unresectable Rectal Adenocarcinoma Locally Advanced Unresectable Rectal Adenocarcinoma CL970908 CTRP Malignant Locally Advanced Unresectable Rectal Adenocarcinoma Locally Advanced Unresectable Rectal Adenocarcinoma Colorectal mucinous adenocarcinoma that has spread from the original site of growth to other anatomic sites. C162273 Neoplastic Process Metastatic Colorectal Mucinous Adenocarcinoma Metastatic Colorectal Mucinous Adenocarcinoma CL970907 CTRP Malignant Metastatic Colorectal Mucinous Adenocarcinoma Metastatic Colorectal Mucinous Adenocarcinoma Mucinous adenocarcinoma of the appendix that has spread from the original site of growth to other anatomic sites. C162274 Neoplastic Process Metastatic Appendix Mucinous Adenocarcinoma Metastatic Appendix Mucinous Adenocarcinoma CL970906 CTRP Malignant Metastatic Appendix Mucinous Adenocarcinoma Metastatic Appendix Mucinous Adenocarcinoma Carcinoma of the appendix that has spread from the original site of growth to other anatomic sites. C162275 Neoplastic Process Metastatic Appendix Carcinoma CL970905 Malignant Metastatic Appendix Carcinoma Metastatic Appendix Carcinoma Gastric carcinoma that is caused by Epstein-Barr virus infection. C162304 Neoplastic Process EBV-Related Gastric Carcinoma EBV-Related Gastric Carcinoma C4274414 CTRP Malignant EBV-Associated Gastric Carcinoma EBV-Related Gastric Carcinoma EBVaGC Epstein-Barr Virus-Associated Gastric Carcinoma Epstein-Barr Virus-Related Gastric Carcinoma EBV-Related Gastric Carcinoma Sarcoma that is caused by Epstein-Barr virus infection. C162305 Neoplastic Process EBV-Related Sarcoma CL970876 Malignant EBV-Associated Sarcoma EBV-Related Sarcoma Epstein-Barr Virus-Associated Sarcoma Epstein-Barr Virus-Related Sarcoma EBV-Related Sarcoma Leiomyosarcoma that is caused by Epstein-Barr virus infection. C162306 Neoplastic Process EBV-Related Leiomyosarcoma EBV-Related Leiomyosarcoma CL970875 CTRP Malignant EBV LMS EBV-Associated Leiomyosarcoma EBV-Related Leiomyosarcoma Epstein-Barr Virus-Associated Leiomyosarcoma Epstein-Barr Virus-Related Leiomyosarcoma EBV-Related Leiomyosarcoma A form of magnetic resonance spectroscopic imaging that increases the selectivity of a spectroscopic measurement by increasing the number of quantum states in a quantum mechanical superposition state, allowing for studies of complex systems. C162316 Diagnostic Procedure Proton Multiple Quantum Coherence Magnetic Resonance Spectroscopic Imaging Proton Multiple Quantum Coherence Magnetic Resonance Spectroscopic Imaging CL970880 CTRP 1H MQC MRSI Proton Multiple Quantum Coherence Magnetic Resonance Spectroscopic Imaging Proton Multiple Quantum Coherence Magnetic Resonance Spectroscopic Imaging The reemergence of colorectal adenocarcinoma after a period of remission. C162441 Neoplastic Process Recurrent Colorectal Adenocarcinoma CL970994 Malignant Recurrent Colorectal Adenocarcinoma Recurrent Colorectal Adenocarcinoma The reemergence of colon adenocarcinoma after a period of remission. C162442 Neoplastic Process Recurrent Colon Adenocarcinoma Recurrent Colon Adenocarcinoma C0861429 CTRP Malignant Recurrent Colon Adenocarcinoma Recurrent Colon Adenocarcinoma The reemergence of rectal adenocarcinoma after a period of remission. C162443 Neoplastic Process Recurrent Rectal Adenocarcinoma Recurrent Rectal Adenocarcinoma C0861754 CTRP Malignant Recurrent Rectal Adenocarcinoma Recurrent Rectal Adenocarcinoma Hepatocellular carcinoma that is resistant to treatment. C162450 Neoplastic Process Refractory Hepatocellular Carcinoma Refractory Hepatocellular Carcinoma CL971002 CTRP Malignant Refractory Hepatocellular Carcinoma Refractory Hepatocellular Carcinoma The reemergence of high-grade B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements after a period of remission. C162451 Neoplastic Process Recurrent High-Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements CL971001 CTRP Malignant Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements Recurrent High-Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements High-grade B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements that is resistant to treatment. C162453 Neoplastic Process Refractory High-Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements CL970999 CTRP Malignant Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements Refractory High-Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements A carcinoid tumor or neuroendocrine carcinoma arising from the thymus gland. C162460 Neoplastic Process Thymic Neuroendocrine Neoplasm CL970958 Undetermined Thymic Neuroendocrine Neoplasm Thymic Neuroendocrine Neoplasm A thymic neuroendocrine neoplasm that has spread from its original site of growth to another anatomic site. C162461 Neoplastic Process Metastatic Thymic Neuroendocrine Neoplasm Metastatic Thymic Neuroendocrine Neoplasm CL970957 CTRP Malignant Metastatic Thymic Neuroendocrine Neoplasm Metastatic Thymic Neuroendocrine Neoplasm A clinically benign intratubular neoplastic proliferation of large Sertoli cells in the testis. It is associated with prominent basement membrane deposits. It occurs almost exclusively in patients with Peutz-Jeghers syndrome. C162466 Neoplastic Process Intratubular Large Cell Hyalinizing Sertoli Cell Neoplasia CL536345 Benign Intratubular large cell hyalinizing Sertoli cell neoplasia Intratubular Large Cell Hyalinizing Sertoli Cell Neoplasia Intratubular Large Cell Hyalinizing Sertoli Cell Neoplasia A diffuse large B-cell lymphoma that arises from the testis. It predominantly affects older men. Patients usually present with a unilateral hard painless mass. Bilateral masses have been described in a minority of patients. C162467 Neoplastic Process Testicular Diffuse Large B-Cell Lymphoma Testicular Diffuse Large B-Cell Lymphoma CL970966 CTRP Malignant Primary Diffuse Large B-Cell Lymphoma of the Testis Primary Large B-Cell Lymphoma of the Testis Primary Testicular Diffuse Large B-Cell Lymphoma Testicular Diffuse Large B-Cell Lymphoma Testicular Diffuse Large B-Cell Lymphoma A nasal type extranodal NK/T-cell lymphoma affecting the testis. Patients usually present with unilateral testicular enlargement. Bilateral involvement is rare. The prognosis is poor. C162468 Neoplastic Process Testicular Nasal Type Extranodal NK/T-Cell Lymphoma CL970965 Malignant Testicular Nasal Type Extranodal NK/T-Cell Lymphoma Testicular Nasal Type Extranodal NK/T-Cell Lymphoma A rare myeloid sarcoma that arises from the testis. At presentation the involvement is usually unilateral. C162469 Neoplastic Process Testicular Myeloid Sarcoma CL970964 Malignant Testicular Myeloid Sarcoma Testicular Myeloid Sarcoma A rare plasmacytoma that arises in the testis. At presentation the involvement is usually unilateral. C162470 Neoplastic Process Testicular Plasmacytoma CL970963 Malignant Testicular Plasmacytoma Testicular Plasmacytoma Colorectal carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C162475 Neoplastic Process Advanced Colorectal Carcinoma Advanced Colorectal Carcinoma CL970973 CTRP Malignant Advanced Colorectal Carcinoma Advanced Colorectal Carcinoma An adenomatoid tumor arising from the paratesticular structures. It is the most common tumor of the paratesticular region. The tail of the epididymis is the most common site of involvement. C162476 Neoplastic Process Paratesticular Adenomatoid Tumor CL970972 Benign Benign Paratesticular Mesothelioma Paratesticular Adenomatoid Tumor Paratesticular Adenomatoid Tumor A rare malignant mesothelioma that arises from the tunica vaginalis. C162477 Neoplastic Process Paratesticular Malignant Mesothelioma Paratesticular Malignant Mesothelioma C3494988 CTRP Malignant Paratesticular Malignant Mesothelioma Testicular Malignant Mesothelioma Tunica Vaginalis Malignant Mesothelioma Paratesticular Malignant Mesothelioma A benign cystadenoma that arises from the epididymis. C162483 Neoplastic Process Epididymal Cystadenoma CL970979 Benign Epididymal Cystadenoma Epididymal Cystadenoma A benign, borderline, or malignant neoplasm that affects the paratesticular structures. C162485 Neoplastic Process Paratesticular Neoplasm C0559487 Undetermined Neoplasm of Paratesticular Structures Neoplasm of the Testicular Adnexa Paratesticular Neoplasm Paratesticular Tumor Testicular Adnexa Neoplasm Testicular Adnexa Tumor Tumor of Paratesticular Structures Paratesticular Neoplasm An extremely rare squamous cell carcinoma that arises from the paratesticular structures. C162486 Neoplastic Process Paratesticular Squamous Cell Carcinoma CL970977 Malignant Paratesticular Squamous Cell Carcinoma Paratesticular Squamous Cell Carcinoma A rare neoplasm that arises from the epididymis and is characterized by the presence of a mixture of melanin-containing epithelial cells and smaller neuroblast-like cells. It usually occurs in infants and has a benign clinical course. C162488 Neoplastic Process Epididymal Melanotic Neuroectodermal Tumor CL970976 Benign Epididymal Melanotic Neuroectodermal Tumor Paratesticular Melanotic Neuroectodermal Tumor Epididymal Melanotic Neuroectodermal Tumor A rare Wilms tumor that arises from the paratesticular structures. C162489 Neoplastic Process Paratesticular Wilms Tumor CL970974 Malignant Paratesticular Nephroblastoma Paratesticular Wilms Tumor Paratesticular Wilms Tumor An extremely rare paraganglioma that arises from the paratesticular structures. C162490 Neoplastic Process Paratesticular Paraganglioma CL970931 Undetermined Paratesticular Paraganglioma Paratesticular Paraganglioma A mesenchymal neoplasm that arises from the paratesticular region. C162492 Neoplastic Process Paratesticular Soft Tissue Neoplasm CL970930 Undetermined Paratesticular Mesenchymal Neoplasm Paratesticular Soft Tissue Neoplasm Paratesticular Soft Tissue Neoplasm A liposarcoma that arises from the paratesticular region. C162493 Neoplastic Process Paratesticular Liposarcoma CL970929 Malignant Paratesticular Liposarcoma Paratesticular Liposarcoma A leiomyoma that arises from the paratesticular region. C162494 Neoplastic Process Paratesticular Leiomyoma CL970928 Benign Paratesticular Leiomyoma Paratesticular Leiomyoma A leiomyosarcoma that arises from the paratesticular region. C162495 Neoplastic Process Paratesticular Leiomyosarcoma CL970927 Malignant Paratesticular Leiomyosarcoma Paratesticular Leiomyosarcoma A rhabdomyoma that arises from the paratesticular region. C162496 Neoplastic Process Paratesticular Rhabdomyoma CL970926 Benign Paratesticular Rhabdomyoma Paratesticular Rhabdomyoma A rhabdomyosarcoma that arises from the paratesticular region. C162497 Neoplastic Process Paratesticular Rhabdomyosarcoma CL970925 Malignant Paratesticular Rhabdomyosarcoma Paratesticular Rhabdomyosarcoma A cellular angiofibroma that arises from the paratesticular region. C162498 Neoplastic Process Paratesticular Cellular Angiofibroma CL970939 Benign Paratesticular Cellular Angiofibroma Paratesticular Cellular Angiofibroma An extramammary myofibroblastoma that arises from the paratesticular region. C162500 Neoplastic Process Paratesticular Mammary-Type Myofibroblastoma CL970938 Benign Paratesticular Mammary-Type Myofibroblastoma Paratesticular Mammary-Type Myofibroblastoma A locally infiltrating, non-metastasizing angiomyxoma that arises from the paratesticular region. C162501 Neoplastic Process Paratesticular Deep (Aggressive) Angiomyxoma CL970937 Benign Paratesticular Deep "Aggressive" Angiomyxoma Paratesticular Deep (Aggressive) Angiomyxoma Paratesticular Deep (Aggressive) Angiomyxoma A schwannoma that arises from the paratesticular region. C162502 Neoplastic Process Paratesticular Schwannoma CL970936 Benign Paratesticular Schwannoma Paratesticular Schwannoma A capillary or cavernous hemangioma that arises from the paratesticular region. C162503 Neoplastic Process Paratesticular Hemangioma CL970935 Benign Paratesticular Hemangioma Paratesticular Hemangioma Gastroesophageal junction adenocarcinoma that does not respond to treatment. C162538 Neoplastic Process Refractory Gastroesophageal Junction Adenocarcinoma Refractory Gastroesophageal Junction Adenocarcinoma CL971110 CTRP Malignant Refractory Gastroesophageal Junction Adenocarcinoma Refractory Gastroesophageal Junction Adenocarcinoma Intraepithelial neoplasia of the penis that is not caused by human papillomavirus infection. It usually presents as a solitary white or pink macule or plaque that may be slightly elevated. A background of long-standing lichen sclerosus is often present. It is characterized by a thickened epithelium, subtle abnormal cellular maturation, and atypical basal layer cells. Parakeratosis is common. (WHO 2016) C162539 Neoplastic Process Differentiated Penile Intraepithelial Neoplasia, Human Papillomavirus-Independent CL971125 Undetermined Differentiated (Simplex) PeIN Differentiated (Simplex) Penile Intraepithelial Neoplasia Differentiated PeIN Differentiated Penile Intraepithelial Neoplasia Differentiated Penile Intraepithelial Neoplasia, HPV-Independent Differentiated Penile Intraepithelial Neoplasia, Human Papillomavirus-Independent Differentiated Penile Intraepithelial Neoplasia, Human Papillomavirus-Independent Intraepithelial neoplasia of the penis caused by human papillomavirus infection. C162541 Neoplastic Process Human Papillomavirus-Related Penile Intraepithelial Neoplasia CL971123 Undetermined HPV-Related PeIN Human Papillomavirus-Associated Penile Intraepithelial Neoplasia Human Papillomavirus-Related PeIN Human Papillomavirus-Related Penile Intraepithelial Neoplasia Penile Intraepithelial Neoplasia, HPV-Associated Penile Intraepithelial Neoplasia, HPV-Related Penile Intraepithelial Neoplasia, Human Papillomavirus- Related Penile Intraepithelial Neoplasia, Human Papillomavirus-Associated Human Papillomavirus-Related Penile Intraepithelial Neoplasia Intraepithelial neoplasia of the penis characterized by full-thickness replacement of the squamous epithelium by immature, small, monotonous, basophilic cells. The cells have round to oval nuclei, inconspicuous nucleoli, and scant cytoplasm. Apoptosis and mitotic figures are prominent. (WHO 2016) C162542 Neoplastic Process Basaloid (Undifferentiated) Penile Intraepithelial Neoplasia CL971122 Undetermined Basaloid (Undifferentiated) PeIN Basaloid (Undifferentiated) Penile Intraepithelial Neoplasia Basaloid PeIN Basaloid Penile Intraepithelial Neoplasia Basaloid (Undifferentiated) Penile Intraepithelial Neoplasia Intraepithelial neoplasia of the penis characterized by a slightly spiking papillomatous surface with atypical parakeratosis. There is prominent cellular pleomorphism, koilocytosis, and mitoses. Unlike in basaloid penile intraepithelial neoplasia, there is squamous maturation. (WHO 2016) C162543 Neoplastic Process Warty (Bowenoid) Penile Intraepithelial Neoplasia CL971121 Undetermined Warty (Bowenoid) PeIN Warty (Bowenoid) Penile Intraepithelial Neoplasia Warty PeIN Warty Penile Intraepithelial Neoplasia Warty (Bowenoid) Penile Intraepithelial Neoplasia Intraepithelial neoplasia of the penis characterized by the presence of a variable mixture of warty and basaloid cells. (WHO 2016) C162546 Neoplastic Process Warty-Basaloid Penile Intraepithelial Neoplasia CL971118 Undetermined Warty-Basaloid PeIN Warty-Basaloid Penile Intraepithelial Neoplasia Warty-Basaloid Penile Intraepithelial Neoplasia A melanoma that arises from the penis. It may be cutaneous or mucosal. The most common site of involvement is glans penis. C162547 Neoplastic Process Penile Melanoma CL971132 Malignant Melanoma of the Penis Penile Melanoma Penile Melanoma A lymphoma that arises from penile skin, subcutis, corpora cavernosa, and spongiosum. Diffuse large B-cell lymphoma is the most common primary penile lymphoma. (WHO 2016) C162548 Neoplastic Process Penile Lymphoma CL971131 Malignant Lymphoma of the Penis Penile Lymphoma Primary Penile Lymphoma Penile Lymphoma The spread of a malignant neoplasm to the penis from an adjacent or distant anatomic site. C162549 Neoplastic Process Metastatic Malignant Neoplasm in the Penis C0347002 Malignant Metastatic Malignant Neoplasm in the Penis Metastatic Malignant Neoplasm in the Penis A two-dimensional ultrasound imaging that displays the acoustic impedance of cross-section of tissue as bright dots representing the ultrasound echoes. The brightness of each dot is determined by the amplitude of the returned echo signal. This is the most common mode of ultrasound imaging. C162558 Health Care Activity B-Mode Ultrasound Imaging B-Mode Ultrasound Imaging C1302166 CTRP B-Mode Ultrasound B-Mode Ultrasound Imaging Brightness-mode Ultrasound B-Mode Ultrasound Imaging An ultrasound method for imaging blood vessels that uses dual-frequency ultrasound transducer technology to produce images with high resolution and a high contrast-to-tissue ratio and without significant contribution from background tissues. C162559 Health Care Activity Acoustic Angiography Acoustic Angiography CL971075 CTRP Acoustic Angiography Acoustic Angiography An extremely rare carcinoma arising from the peritoneum. It is characterized by the presence of a diffuse malignant infiltrate that is composed of epithelial cells without evidence of glandular or squamous differentiation. C162562 Neoplastic Process Primary Peritoneal Undifferentiated Carcinoma Primary Peritoneal Undifferentiated Carcinoma CL971074 CTRP Malignant Primary Peritoneal Undifferentiated Carcinoma Primary Peritoneal Undifferentiated Carcinoma An extremely rare transitional cell carcinoma that arises from the peritoneum. C162564 Neoplastic Process Primary Peritoneal Transitional Cell Carcinoma Primary Peritoneal Transitional Cell Carcinoma CL971072 CTRP Malignant Primary Peritoneal Transitional Cell Carcinoma Primary Peritoneal Transitional Cell Carcinoma An extremely rare adenocarcinoma arising from the peritoneum. It is composed of malignant glandular epithelium containing clear cells. C162566 Neoplastic Process Primary Peritoneal Clear Cell Carcinoma Primary Peritoneal Clear Cell Adenocarcinoma CL971085 CTRP Malignant Primary Peritoneal Clear Cell Adenocarcinoma Primary Peritoneal Clear Cell Carcinoma Primary Peritoneal Clear Cell Adenocarcinoma Head and neck carcinoma that is confined to the site in which it initially manifested without evidence of spread to other anatomic sites. C162569 Neoplastic Process Non-Metastatic Head and Neck Carcinoma Localized Head and Neck Carcinoma CL971082 CTRP Malignant Localized Head and Neck Carcinoma Non-Metastatic Head and Neck Carcinoma Localized Head and Neck Carcinoma Lung carcinoma that is confined to the site in which it initially manifested without evidence of spread to other anatomic sites. C162570 Neoplastic Process Non-Metastatic Lung Carcinoma Localized Lung Carcinoma CL971081 CTRP Malignant Localized Lung Carcinoma Non-Metastatic Lung Carcinoma Localized Lung Carcinoma A Merkel cell carcinoma that has spread from the original site of growth to another anatomic site. C162572 Neoplastic Process Metastatic Merkel Cell Carcinoma Metastatic Merkel Cell Carcinoma CL971080 CTRP mCode Malignant Metastatic Merkel Cell Carcinoma Secondary Merkel cell carcinoma Metastatic Merkel Cell Carcinoma A rare mesenchymal neoplasm that arises from the penis. C162574 Neoplastic Process Penile Soft Tissue Neoplasm CL971078 Undetermined Penile Mesenchymal Neoplasm Penile Soft Tissue Neoplasm Penile Soft Tissue Neoplasm A rare angiosarcoma that affects the penis. C162578 Neoplastic Process Penile Angiosarcoma CL971090 Malignant Penile Angiosarcoma Penile Angiosarcoma A hemangioma that occurs in the skin of the penis. C162579 Neoplastic Process Penile Hemangioma CL971089 Benign Penile Hemangioma Penile Hemangioma An epithelioid hemangioma that occurs in the skin of the penis. C162580 Neoplastic Process Penile Epithelioid Hemangioma CL971088 Benign Penile Epithelioid Hemangioma Penile Epithelioid Hemangioma An epithelioid hemangioendothelioma that occurs in the penis. C162581 Neoplastic Process Penile Epithelioid Hemangioendothelioma CL971087 Malignant Penile Epithelioid Hemangioendothelioma Penile Epithelioid Hemangioendothelioma A glomus tumor that occurs in the penis. C162582 Neoplastic Process Penile Glomus Tumor CL971086 Undetermined Penile Glomus Tumor Penile Glomus Tumor A leiomyoma that occurs in the penis. C162583 Neoplastic Process Penile Leiomyoma CL971101 Benign Penile Leiomyoma Penile Leiomyoma A rare malignant peripheral nerve sheath tumor that occurs in the penis. C162584 Neoplastic Process Penile Malignant Peripheral Nerve Sheath Tumor CL971100 Malignant Penile Malignant Peripheral Nerve Sheath Tumor Penile Malignant Peripheral Nerve Sheath Tumor A leiomyosarcoma that occurs in the penis. C162585 Neoplastic Process Penile Leiomyosarcoma CL971099 Malignant Penile Leiomyosarcoma Penile Leiomyosarcoma A schwannoma that occurs in the penis. C162586 Neoplastic Process Penile Schwannoma CL971098 Benign Penile Schwannoma Penile Schwannoma A neurofibroma that occurs in the penis. C162587 Neoplastic Process Penile Neurofibroma CL971097 Benign Penile Neurofibroma Penile Neurofibroma A rhabdomyosarcoma that occurs in the penis. It usually affects young children. Embryonal rhabdomyosarcoma is the most common type. C162588 Neoplastic Process Penile Rhabdomyosarcoma CL971096 Malignant Penile Rhabdomyosarcoma Penile Rhabdomyosarcoma A rare undifferentiated pleomorphic sarcoma that occurs in the penis. C162589 Neoplastic Process Penile Undifferentiated Pleomorphic Sarcoma CL971095 Malignant Penile Undifferentiated Pleomorphic Sarcoma Penile Undifferentiated Pleomorphic Sarcoma A rare benign mesenchymal neoplasm that occurs in the glans and corpora of the penis. It is characterized by the proliferation of spindle-shaped myofibroblasts in the intravascular spaces. C162590 Neoplastic Process Penile Myointimoma CL971094 Benign Myointimoma Myointimoma Penile Myointimoma Penile Myointimoma A lymphangioma that occurs in the skin of the penis. C162592 Neoplastic Process Penile Lymphangioma CL971050 Benign Penile Lymphangioma Penile Lymphangioma The spread of a malignant neoplasm to the head and neck. This may be from a primary head and neck malignant neoplasm, or from a malignant neoplasm at a distant site. C162594 Neoplastic Process Metastatic Malignant Neoplasm in the Head and Neck CL971049 Malignant Metastatic Malignant Neoplasm in the Head and Neck Metastatic Malignant Neoplasm to the Head and Neck Metastatic Malignant Neoplasm in the Head and Neck A carcinoma that has metastasized to the head and neck region from an unknown primary anatomic site. Metastatic squamous cell carcinoma in the neck lymph nodes accounts for the vast majority of these lesions. C162595 Neoplastic Process Head and Neck Carcinoma of Unknown Primary Head and Neck Carcinoma of Unknown Primary CL971048 CTRP Malignant Head and Neck CUP Head and Neck Carcinoma of Unknown Primary Head and Neck Carcinoma of Unknown Primary A colorectal carcinoma that is not amenable to surgical resection. C162600 Neoplastic Process Unresectable Colorectal Carcinoma Unresectable Colorectal Carcinoma CL971059 CTRP Malignant Unresectable Colorectal Carcinoma Unresectable Colorectal Carcinoma A fibrolamellar carcinoma that is not amenable to surgical resection. C162602 Neoplastic Process Unresectable Fibrolamellar Hepatocellular Carcinoma Unresectable Fibrolamellar Carcinoma CL971057 CTRP Malignant Unresectable Fibrolamellar Carcinoma Unresectable Fibrolamellar Hepatocellular Carcinoma Unresectable Fibrolamellar Carcinoma The reemergence of adamantinomatous craniopharyngioma after a period of remission. C162612 Neoplastic Process Recurrent Adamantinomatous Craniopharyngioma Recurrent Adamantinomatous Craniopharyngioma CL971062 CTRP Benign Recurrent Adamantinomatous Craniopharyngioma Recurrent Adamantinomatous Craniopharyngioma A ureter urothelial carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C162616 Neoplastic Process Locally Advanced Ureter Urothelial Carcinoma Locally Advanced Ureter Urothelial Carcinoma CL971070 CTRP Malignant Locally Advanced Ureter Urothelial Carcinoma Locally Advanced Ureter Urothelial Carcinoma A renal pelvis urothelial carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C162617 Neoplastic Process Locally Advanced Renal Pelvis Urothelial Carcinoma Locally Advanced Renal Pelvis Urothelial Carcinoma CL971069 CTRP Malignant Locally Advanced Renal Pelvis Urothelial Carcinoma Locally Advanced Renal Pelvis Urothelial Carcinoma A bladder urothelial carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C162618 Neoplastic Process Locally Advanced Bladder Urothelial Carcinoma Locally Advanced Bladder Urothelial Carcinoma CL971068 CTRP Malignant Locally Advanced Bladder Urothelial Carcinoma Locally Advanced Bladder Urothelial Carcinoma A urethral urothelial carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C162619 Neoplastic Process Locally Advanced Urethral Urothelial Carcinoma Locally Advanced Urethral Urothelial Carcinoma CL971067 CTRP Malignant Locally Advanced Urethral Urothelial Carcinoma Locally Advanced Urethral Urothelial Carcinoma Lung non-squamous non-small cell carcinoma that is not amenable to surgical resection. C162642 Neoplastic Process Unresectable Lung Non-Squamous Non-Small Cell Carcinoma Unresectable Lung Non-Squamous Non-Small Cell Carcinoma CL971034 CTRP Malignant Unresectable Lung Non-Squamous Non-Small Cell Carcinoma Unresectable Lung Non-Squamous Non-Small Cell Carcinoma A novel application of magnetic resonance imaging. Instead of using a repeated, serial acquisition of data for the characterization of individual parameters of interest, MRF uses a pseudorandomized acquisition that causes the signals from different materials or tissues to have a unique signal evolution or "fingerprint" that is simultaneously a function of the multiple material properties under investigation. The processing after acquisition involves a pattern recognition algorithm to match the fingerprints to a predefined dictionary of predicted signal evolutions. These can then be translated into quantitative maps of the MR parameters of interest. C162644 Diagnostic Procedure MR Fingerprinting MR Fingerprinting CL971033 CTRP MR Fingerprinting MRF MR Fingerprinting MRI that uses a magnet capable of producing a 7 tesla field strength. This increased magnet strength is can produce images with greater signal-to-noise ratio and increased spatial resolution, or faster imaging at standard resolution. C162646 Diagnostic Procedure 7 Tesla Magnetic Resonance Imaging 7 Tesla Magnetic Resonance Imaging CL971031 CTRP 7 T MRI 7 Tesla MRI 7 Tesla Magnetic Resonance Imaging 7 Tesla Magnetic Resonance Imaging Breast carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C162648 Neoplastic Process Advanced Breast Carcinoma Advanced Breast Carcinoma CL971030 CTRP Malignant Advanced Breast Carcinoma Advanced Breast Carcinoma Osteosarcoma that is amenable to surgical resection. C162661 Neoplastic Process Resectable Osteosarcoma Resectable Osteosarcoma CL973107 CTRP Malignant Resectable Osteosarcoma Resectable Osteosarcoma The reemergence of systemic anaplastic large cell lymphoma after a period of remission. C162688 Neoplastic Process Recurrent Systemic Anaplastic Large Cell Lymphoma Recurrent Systemic Anaplastic Large Cell Lymphoma CL973090 CTRP Malignant Recurrent Systemic Anaplastic Large Cell Lymphoma Recurrent Systemic Anaplastic Large Cell Lymphoma Systemic anaplastic large cell lymphoma that does not respond to treatment. C162689 Neoplastic Process Refractory Systemic Anaplastic Large Cell Lymphoma Refractory Systemic Anaplastic Large Cell Lymphoma CL973091 CTRP Malignant Refractory Systemic Anaplastic Large Cell Lymphoma Refractory Systemic Anaplastic Large Cell Lymphoma A thyroid gland medullary carcinoma that has spread from the original site of growth to another anatomic site. C162706 Neoplastic Process Metastatic Thyroid Gland Medullary Carcinoma Metastatic Thyroid Gland Medullary Carcinoma CL973095 CTRP Malignant Metastatic Thyroid Gland Medullary Carcinoma Metastatic Thyroid Gland Medullary Carcinoma Urinary system carcinoma that does not respond to treatment. C162719 Neoplastic Process Refractory Urinary System Carcinoma CL973228 Malignant Refractory Urinary System Carcinoma Refractory Urinary System Carcinoma A chordoma that does not respond to treatment. C162721 Neoplastic Process Refractory Chordoma CL973226 Malignant Refractory Chordoma Refractory Chordoma An epithelioid sarcoma that does not respond to treatment. C162722 Neoplastic Process Refractory Epithelioid Sarcoma Refractory Epithelioid Sarcoma CL973218 CTRP Malignant Refractory Epithelioid Sarcoma Refractory Epithelioid Sarcoma An atypical teratoid/rhabdoid tumor that does not respond to treatment. C162723 Neoplastic Process Refractory Atypical Teratoid/Rhabdoid Tumor Refractory Atypical Teratoid/Rhabdoid Tumor CL973219 CTRP Malignant Refractory Atypical Teratoid/Rhabdoid Tumor Refractory Atypical Teratoid/Rhabdoid Tumor The reemergence of an epithelioid malignant peripheral nerve sheath tumor after a period of remission. C162724 Neoplastic Process Recurrent Epithelioid Malignant Peripheral Nerve Sheath Tumor Recurrent Epithelioid Malignant Peripheral Nerve Sheath Tumor CL973216 CTRP Malignant Recurrent Epithelioid Malignant Peripheral Nerve Sheath Tumor Recurrent Epithelioid Malignant Peripheral Nerve Sheath Tumor An epithelioid malignant peripheral nerve sheath tumor that does not respond to treatment. C162725 Neoplastic Process Refractory Epithelioid Malignant Peripheral Nerve Sheath Tumor Refractory Epithelioid Malignant Peripheral Nerve Sheath Tumor CL973217 CTRP Malignant Refractory Epithelioid Malignant Peripheral Nerve Sheath Tumor Refractory Epithelioid Malignant Peripheral Nerve Sheath Tumor The reemergence of kidney medullary carcinoma after a period of remission. C162726 Neoplastic Process Recurrent Kidney Medullary Carcinoma Recurrent Kidney Medullary Carcinoma CL973222 CTRP Malignant Recurrent Kidney Medullary Carcinoma Recurrent Kidney Medullary Carcinoma A kidney medullary carcinoma that does not respond to treatment. C162727 Neoplastic Process Refractory Kidney Medullary Carcinoma Refractory Kidney Medullary Carcinoma CL973223 CTRP Malignant Refractory Kidney Medullary Carcinoma Refractory Kidney Medullary Carcinoma The reemergence of dedifferentiated chordoma after a period of remission. C162728 Neoplastic Process Recurrent Dedifferentiated Chordoma Recurrent Dedifferentiated Chordoma CL973220 CTRP Malignant Recurrent Dedifferentiated Chordoma Recurrent Dedifferentiated Chordoma A dedifferentiated chordoma that does not respond to treatment. C162729 Neoplastic Process Refractory Dedifferentiated Chordoma Refractory Dedifferentiated Chordoma CL973221 CTRP Malignant Refractory Dedifferentiated Chordoma Refractory Dedifferentiated Chordoma The reemergence of a rhabdoid tumor of the kidney after a period of remission. C162730 Neoplastic Process Recurrent Rhabdoid Tumor of the Kidney Recurrent Rhabdoid Tumor of the Kidney CL973238 CTRP Malignant Recurrent Rhabdoid Tumor of the Kidney Recurrent Rhabdoid Tumor of the Kidney A rhabdoid tumor of the kidney that does not respond to treatment. C162731 Neoplastic Process Refractory Rhabdoid Tumor of the Kidney Refractory Rhabdoid Tumor of the Kidney CL973239 CTRP Malignant Refractory Rhabdoid Tumor of the Kidney Refractory Rhabdoid Tumor of the Kidney The reemergence of a malignant myoepithelioma after a period of remission. C162732 Neoplastic Process Recurrent Malignant Myoepithelioma Recurrent Malignant Myoepithelioma CL973236 CTRP Malignant Recurrent Malignant Myoepithelioma Recurrent Malignant Myoepithelioma A malignant myoepithelioma that does not respond to treatment. C162733 Neoplastic Process Refractory Malignant Myoepithelioma Refractory Malignant Myoepithelioma CL973237 CTRP Malignant Refractory Malignant Myoepithelioma Refractory Malignant Myoepithelioma Biliary tract carcinoma that is resistant to treatment. C162750 Neoplastic Process Refractory Biliary Tract Carcinoma CL973195 Malignant Refractory Biliary Tract Carcinoma Refractory Biliary Tract Carcinoma A biliary tract carcinoma that has spread from the original site of growth to other anatomic sites. C162751 Neoplastic Process Metastatic Biliary Tract Carcinoma CL973200 Malignant Metastatic Biliary Tract Carcinoma Metastatic Biliary Tract Carcinoma A cholangiocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C162752 Neoplastic Process Advanced Cholangiocarcinoma Advanced Cholangiocarcinoma CL973201 CTRP Malignant Advanced Cholangiocarcinoma Advanced Cholangiocarcinoma Gallbladder carcinoma that is resistant to treatment. C162753 Neoplastic Process Refractory Gallbladder Carcinoma Refractory Gallbladder Carcinoma CL973198 CTRP Malignant Refractory Gallbladder Carcinoma Refractory Gallbladder Carcinoma A gallbladder carcinoma that has spread from the original site of growth to other anatomic sites. C162754 Neoplastic Process Metastatic Gallbladder Carcinoma Metastatic Gallbladder Carcinoma CL973199 CTRP Malignant Metastatic Gallbladder Carcinoma Metastatic Gallbladder Carcinoma Gallbladder carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C162755 Neoplastic Process Advanced Gallbladder Carcinoma Advanced Gallbladder Carcinoma CL973188 CTRP Malignant Advanced Gallbladder Carcinoma Advanced Gallbladder Carcinoma A head and neck squamous cell carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C162758 Neoplastic Process Locally Advanced Head and Neck Squamous Cell Carcinoma Locally Advanced Head and Neck Squamous Cell Carcinoma CL973187 CTRP Malignant Locally Advanced Head and Neck Squamous Cell Carcinoma Locally Advanced Head and Neck Squamous Cell Carcinoma Gastroesophageal junction adenocarcinoma that has spread to nearby tissues or lymph nodes. C162759 Neoplastic Process Locally Advanced Gastroesophageal Junction Adenocarcinoma Locally Advanced Gastroesophageal Junction Adenocarcinoma CL973192 CTRP Malignant Locally Advanced Gastroesophageal Junction Adenocarcinoma Locally Advanced Gastroesophageal Junction Adenocarcinoma A papillary renal cell carcinoma that has spread from the original site of growth to another anatomic site. C162760 Neoplastic Process Metastatic Papillary Renal Cell Carcinoma CL973193 Malignant Metastatic Papillary Renal Cell Carcinoma Metastatic Papillary Renal Cell Carcinoma A papillary renal cell carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C162761 Neoplastic Process Advanced Papillary Renal Cell Carcinoma CL973190 Malignant Advanced Papillary Renal Cell Carcinoma Advanced Papillary Renal Cell Carcinoma A bone sarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C162762 Neoplastic Process Advanced Bone Sarcoma CL973191 Malignant Advanced Bone Sarcoma Advanced Bone Sarcoma A myxoid liposarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C162763 Neoplastic Process Advanced Myxoid Liposarcoma CL973211 Malignant Advanced Myxoid Liposarcoma Advanced Myxoid/Round Cell Liposarcoma Advanced Myxoid Liposarcoma A colorectal carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C162766 Neoplastic Process Locally Advanced Colorectal Carcinoma CL973210 Malignant Locally Advanced Colorectal Carcinoma Locally Advanced Colorectal Carcinoma A gastric adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C162767 Neoplastic Process Locally Advanced Gastric Adenocarcinoma Locally Advanced Gastric Adenocarcinoma CL973215 CTRP Malignant Locally Advanced Gastric Adenocarcinoma Locally Advanced Gastric Adenocarcinoma A clear cell renal cell carcinoma that has spread from its original site of growth to other anatomic sites. C162768 Neoplastic Process Metastatic Clear Cell Renal Cell Carcinoma C2931852 Malignant Metastatic Clear Cell Renal Cell Carcinoma Metastatic Clear Cell Renal Cell Carcinoma A head and neck squamous cell carcinoma in which the malignant cells are positive for ASPH gene. C162770 Finding ASPH-Positive Head and Neck Squamous Cell Carcinoma ASPH-Positive Head and Neck Squamous Cell Carcinoma CL973214 CTRP Malignant ASPH-Positive Head and Neck Squamous Cell Carcinoma ASPH-Positive Head and Neck Squamous Cell Carcinoma A gastric carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C162772 Neoplastic Process Locally Advanced Gastric Carcinoma Locally Advanced Gastric Carcinoma CL973204 CTRP Malignant Locally Advanced Gastric Carcinoma Locally Advanced Gastric Carcinoma An acute myeloid leukemia with trisomy 8. Trisomy 8 is one of the most frequent occurring cytogenetic abnormalities in acute myeloid leukemia. It is grouped as intermediate risk in cytogenetic classifications of acute myeloid leukemia. C162775 Neoplastic Process Acute Myeloid Leukemia with Trisomy 8 Acute Myeloid Leukemia with Trisomy 8 CL973203 CTRP Malignant Acute Myeloid Leukemia with Trisomy 8 Acute Myeloid Leukemia with tri8 Acute Myeloid Leukemia with Trisomy 8 A B-cell acute lymphoblastic leukemia associated with t(4;11)(q21;23.3). This translocation leads to the generation of the fusion gene KMT2A-AFF1. C162776 Neoplastic Process B Acute Lymphoblastic Leukemia with t(4;11)(q21;23) B Acute Lymphoblastic Leukemia with t(4;11)(q21;23.3); KMT2A-AFF1 CL973207 CTRP Malignant Acute Lymphoblastic Leukemia with t(4;11)(q21;23) B Acute Lymphoblastic Leukemia with t(4;11)(q21;23.3) B Acute Lymphoblastic Leukemia with t(4;11)(q21;23.3); KMT2A-AFF1 B Acute Lymphoblastic Leukemia with t(4;11)(q21;23.3); KMT2A::AFF1 B-Cell Acute Lymphoblastic Leukemia with t(4;11)(q21;23.3) B Acute Lymphoblastic Leukemia with t(4;11)(q21;23.3); KMT2A-AFF1 A malignant neoplasm that arises in the colon or rectum that has spread from its original site of growth to other anatomic sites. C162780 Neoplastic Process Metastatic Malignant Colorectal Neoplasm Metastatic Malignant Colorectal Neoplasm CL973165 CTRP Malignant Metastatic Malignant Colorectal Neoplasm Metastatic Malignant Colorectal Neoplasm Breast carcinoma that is confined to the site in which it initially manifested without evidence of spread to other anatomic sites. C162782 Neoplastic Process Non-Metastatic Breast Carcinoma Localized Breast Carcinoma CL973163 CTRP Malignant Localized Breast Carcinoma Non-Metastatic Breast Carcinoma Localized Breast Carcinoma Merkel cell carcinoma that is not amenable to surgical resection. C162786 Neoplastic Process Unresectable Merkel Cell Carcinoma Unresectable Merkel Cell Carcinoma CL973169 CTRP Malignant Unresectable Merkel Cell Carcinoma Unresectable Merkel Cell Carcinoma Oropharyngeal squamous cell carcinoma that is amenable to surgical resection. C162787 Neoplastic Process Resectable Oropharyngeal Squamous Cell Carcinoma Resectable Oropharyngeal Squamous Cell Carcinoma CL973166 CTRP Malignant Resectable Oropharyngeal Squamous Cell Carcinoma Resectable Oropharyngeal Squamous Cell Carcinoma A benign or malignant neoplasm that affects the parapharyngeal space. C162820 Neoplastic Process Parapharyngeal Neoplasm CL973137 Undetermined Parapharyngeal Neoplasm Parapharyngeal Neoplasm A neoplasm that arises from the parapharyngeal space and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C162822 Neoplastic Process Benign Parapharyngeal Neoplasm Benign Parapharyngeal Neoplasm CL973127 CTRP Benign Benign Parapharyngeal Neoplasm Benign Parapharyngeal Neoplasm A primary or metastatic malignant neoplasm that affects the parapharyngeal space. C162823 Neoplastic Process Malignant Parapharyngeal Neoplasm Malignant Parapharyngeal Neoplasm CL973128 CTRP Malignant Malignant Parapharyngeal Neoplasm Malignant Parapharyngeal Neoplasm A benign or malignant neoplasm that affects the retropharyngeal space. C162825 Neoplastic Process Retropharyngeal Neoplasm CL973126 Undetermined Retropharyngeal Neoplasm Retropharyngeal Neoplasm A neoplasm that arises from the retropharyngeal space and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C162826 Neoplastic Process Benign Retropharyngeal Neoplasm Benign Retropharyngeal Neoplasm CL973131 CTRP Benign Benign Retropharyngeal Neoplasm Benign Retropharyngeal Neoplasm A primary or metastatic malignant neoplasm that affects the retropharyngeal space. C162828 Neoplastic Process Malignant Retropharyngeal Neoplasm Malignant Retropharyngeal Neoplasm CL973129 CTRP Malignant Malignant Retropharyngeal Neoplasm Malignant Retropharyngeal Neoplasm Oropharyngeal squamous cell carcinoma that is not amenable to surgical resection. C162833 Neoplastic Process Unresectable Oropharyngeal Squamous Cell Carcinoma Unresectable Oropharyngeal Squamous Cell Carcinoma CL973147 CTRP Malignant Unresectable Oropharyngeal Squamous Cell Carcinoma Unresectable Oropharyngeal Squamous Cell Carcinoma A malignant digestive system neoplasm that is not amenable to surgical resection. C162845 Neoplastic Process Unresectable Malignant Digestive System Neoplasm Unresectable Malignant Digestive System Neoplasm CL973144 CTRP Malignant Unresectable Malignant Digestive System Neoplasm Unresectable Malignant Digestive System Neoplasm Paranasal sinus squamous cell carcinoma that has spread from its original site of growth to another anatomic site. C162876 Neoplastic Process Metastatic Paranasal Sinus Squamous Cell Carcinoma Metastatic Paranasal Sinus Squamous Cell Carcinoma CL973361 CTRP Malignant Metastatic Paranasal Sinus Squamous Cell Carcinoma Metastatic Paranasal Sinus Squamous Cell Carcinoma An oropharyngeal squamous cell carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C162881 Neoplastic Process Locally Advanced Oropharyngeal Squamous Cell Carcinoma Locally Advanced Oropharyngeal Squamous Cell Carcinoma CL973315 CTRP Malignant Locally Advanced Oropharyngeal Squamous Cell Carcinoma Locally Advanced Oropharyngeal Squamous Cell Carcinoma Nasal cavity and/or paranasal sinus squamous cell carcinoma that has spread from its original site of growth to another anatomic site. C162882 Neoplastic Process Metastatic Sinonasal Squamous Cell Carcinoma CL973316 Malignant Metastatic Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Metastatic Sinonasal Squamous Cell Carcinoma Metastatic Sinonasal Squamous Cell Carcinoma Malignant mesothelioma that arises from the peritoneum. It is characterized by the presence of cells with epithelioid morphology. The epithelioid cells usually have eosinophilic cytoplasm, bland nuclei, and form tubulopapillary, microglandular, or sheet-like patterns. C162940 Neoplastic Process Peritoneal Epithelioid Mesothelioma Peritoneal Epithelioid Mesothelioma CL973298 CTRP Malignant Peritoneal Epithelioid Mesothelioma Peritoneal Epithelioid Mesothelioma The reemergence of cutaneous squamous cell carcinoma of the head and neck after a period of remission. C162942 Neoplastic Process Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck CL973296 CTRP Malignant Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck Cutaneous squamous cell carcinoma of the head and neck that is amenable to surgical resection. C162943 Neoplastic Process Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck CL973254 CTRP Malignant Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck An extremely rare tumor that arises from the testis. It is characterized by the proliferation of epithelioid cells with signet ring appearance separated by fibrous tissue into trabeculae and nests. The histologic features are bland and there is no mucin production. Mutations of CTNNB1 gene have been identified in the reported cases. It is considered a special type of sex cord-stromal tumor. All reported cases had a benign clinical course without metastases. C162966 Neoplastic Process Testicular Signet Ring Stromal Tumor CL973273 Benign PSRSTT Primary Signet Ring Stromal Tumor of the Testis Testicular Signet Ring Stromal Tumor Testicular Signet-Ring Stromal Tumor Testicular Signet Ring Stromal Tumor A grade 3 or 4 glioma that arises from the brain. This category includes anaplastic astrocytoma, anaplastic ependymoma, anaplastic oligoastrocytoma, anaplastic oligodendroglioma, anaplastic pleomorphic xanthoastrocytoma (all grade 3 gliomas), and glioblastoma (grade 4 glioma). C162993 Neoplastic Process Malignant Brain Glioma Malignant Brain Glioma C0349541 CTRP Malignant Brain High Grade Glioma Brain High-Grade Glioma Brain Malignant Glioma High Grade Brain Glioma High-Grade Brain Glioma Malignant Brain Glioma Malignant Brain Glioma A meningioma that is not amenable to surgical resection. C163006 Neoplastic Process Unresectable Meningioma Unresectable Meningioma CL973404 CTRP Undetermined Unresectable Meningioma Unresectable Meningioma The X-ray examination of the arterial blood vessels. C16308 Diagnostic Procedure Arteriography Arteriography C0003844 CTRP A procedure to x-ray arteries. The arteries can be seen because of an injection of a dye that outlines the vessels on an x-ray. Arteriography Arteriography arteriography Arteriography A technique used to locate radioactively labeled molecules, or fragments of molecules, by recording on a photographic or sensor plate the radiation emitted by radioactive material within a molecule. C16314 Research Activity Autoradiography Autoradiography C0004400 CTRP Autoradiography Autoradiography Autoradiography A type of positron emission tomography in which labeled monoclonal antibodies are tracked and quantitated after administration to the subject. C163547 Diagnostic Procedure Immuno-Positron Emission Tomography Scan CL976738 CDISC An imaging technique that utilizes positron emission tomography following administration of labeled antibody to confer specificity in the image. IMMUNO-PET SCAN Immuno-PET Scan Immuno-Positron Emission Tomography Scan Immuno-Positron Emission Tomography Scan Bladder urothelial carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C163954 Neoplastic Process Advanced Bladder Urothelial Carcinoma Advanced Bladder Urothelial Carcinoma CL977299 CTRP Malignant Advanced Bladder Urothelial Carcinoma Advanced Bladder Urothelial Carcinoma Ureter urothelial carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C163955 Neoplastic Process Advanced Ureter Urothelial Carcinoma Advanced Ureter Urothelial Carcinoma CL977298 CTRP Malignant Advanced Ureter Urothelial Carcinoma Advanced Ureter Urothelial Carcinoma Pituitary neuroendocrine tumor that has spread from its original site of growth to nearby tissues or lymph nodes. C163956 Neoplastic Process Locally Advanced Pituitary Gland Carcinoma Locally Advanced Pituitary Neuroendocrine Tumor CL977297 CTRP Malignant Locally Advanced PitNET Locally Advanced Pituitary Gland Carcinoma Locally Advanced Pituitary Neuroendocrine Tumor Locally Advanced Pituitary Neuroendocrine Tumor A parathyroid gland carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C163958 Neoplastic Process Locally Advanced Parathyroid Gland Carcinoma Locally Advanced Parathyroid Gland Carcinoma CL977295 CTRP Malignant Locally Advanced Parathyroid Gland Carcinoma Locally Advanced Parathyroid Gland Carcinoma Metastatic pituitary neuroendocrine tumor that is not amenable to surgical resection. C163959 Neoplastic Process Unresectable Pituitary Gland Carcinoma Metastatic Unresectable Pituitary Neuroendocrine Tumor CL977294 CTRP Malignant Metastatic Unresectable Pituitary Neuroendocrine Tumor Unresectable Metastatic PitNET Unresectable Metastatic Pituitary Neuroendocrine Tumor Unresectable Pituitary Gland Carcinoma Metastatic Unresectable Pituitary Neuroendocrine Tumor A small cell glioblastoma that is resistant to treatment. C163960 Neoplastic Process Refractory Small Cell Glioblastoma CL977293 Malignant Refractory Small Cell Glioblastoma Refractory Small Cell Glioblastoma The reemergence of small cell glioblastoma after a period of remission. C163961 Neoplastic Process Recurrent Small Cell Glioblastoma Recurrent Small Cell Glioblastoma CL977292 CTRP Malignant Recurrent Small Cell Glioblastoma Recurrent Small Cell Glioblastoma A gliosarcoma that is resistant to treatment. C163962 Neoplastic Process Refractory Gliosarcoma CL977291 Malignant Refractory Gliosarcoma Refractory Gliosarcoma A urethral urothelial carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C163963 Neoplastic Process Advanced Urethral Urothelial Carcinoma Advanced Urethral Urothelial Carcinoma CL977290 CTRP Malignant Advanced Urethral Urothelial Carcinoma Advanced Urethral Urothelial Carcinoma Thyroid gland medullary carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C163964 Neoplastic Process Advanced Thyroid Gland Medullary Carcinoma Advanced Thyroid Gland Medullary Carcinoma CL977289 CTRP Malignant Advanced Thyroid Gland Medullary Carcinoma Advanced Thyroid Gland Medullary Carcinoma Renal pelvis carcinoma that has spread from the original site of growth to other anatomic sites. C163965 Neoplastic Process Metastatic Renal Pelvis Carcinoma CL977288 Malignant Metastatic Renal Pelvis Carcinoma Metastatic Renal Pelvis Carcinoma Renal pelvis carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C163966 Neoplastic Process Advanced Renal Pelvis Carcinoma Advanced Renal Pelvis Carcinoma CL977287 CTRP Malignant Advanced Renal Pelvis Carcinoma Advanced Renal Pelvis Carcinoma Mixed adenoneuroendocrine carcinoma that arises from the digestive system and has metastasized to other anatomic sites. C163967 Neoplastic Process Metastatic Digestive System Mixed Adenoneuroendocrine Carcinoma Metastatic Digestive System Mixed Adenoneuroendocrine Carcinoma CL977286 CTRP Malignant Metastatic Digestive System Mixed Adenoneuroendocrine Carcinoma Metastatic Digestive System Mixed Adenoneuroendocrine Carcinoma Thyroid gland medullary carcinoma that is not amenable to surgical resection. C163974 Neoplastic Process Unresectable Thyroid Gland Medullary Carcinoma Unresectable Thyroid Gland Medullary Carcinoma CL977251 CTRP Malignant Unresectable Thyroid Gland Medullary Carcinoma Unresectable Thyroid Gland Medullary Carcinoma A neuroendocrine carcinoma that has metastasized from an unknown primary site. C163975 Neoplastic Process Neuroendocrine Carcinoma of Unknown Primary Neuroendocrine Carcinoma of Unknown Primary CL977250 CTRP Malignant Neuroendocrine Carcinoma of Unknown Primary Neuroendocrine Carcinoma of Unknown Primary The integumentary covering of the lower extremities. C164047 Anatomical Structure Skin of the Lower Extremity C1266887 CDISC GDC The integument that covers the lower limb. Skin, lower extremity, local Lower Extremity Skin SKIN OF THE LOWER LIMB Skin of the Lower Extremity Skin of the Lower Limb Skin, lower extremity, local Skin of the Lower Extremity The integumentary covering of the upper extremities. C164048 Anatomical Structure Skin of the Upper Extremity C0205032 CDISC GDC The integument that covers the upper limb. Skin, upper extremity, local SKIN OF THE UPPER LIMB Skin of the Upper Extremity Skin of the Upper Limb Skin, upper extremity, local Upper Extremity Skin Skin of the Upper Extremity Dedifferentiated liposarcoma that has spread from its original site of growth to another anatomic site. C164070 Neoplastic Process Metastatic Dedifferentiated Liposarcoma Metastatic Dedifferentiated Liposarcoma CL977396 CTRP Malignant Metastatic Dedifferentiated Liposarcoma Metastatic Dedifferentiated Liposarcoma Dedifferentiated liposarcoma that has spread from its original site of growth to nearby tissues or lymph nodes. C164071 Neoplastic Process Locally Advanced Dedifferentiated Liposarcoma Locally Advanced Dedifferentiated Liposarcoma CL977395 CTRP Malignant Locally Advanced Dedifferentiated Liposarcoma Locally Advanced Dedifferentiated Liposarcoma A malignant peripheral nerve sheath tumor that has spread from its original site of growth to nearby tissues or lymph nodes. C164074 Neoplastic Process Locally Advanced Malignant Peripheral Nerve Sheath Tumor Locally Advanced Malignant Peripheral Nerve Sheath Tumor CL977393 CTRP Malignant Locally Advanced Malignant Peripheral Nerve Sheath Tumor Locally Advanced Malignant Peripheral Nerve Sheath Tumor Alveolar soft part sarcoma that has spread from its original site of growth to nearby tissues or lymph nodes. C164076 Neoplastic Process Locally Advanced Alveolar Soft Part Sarcoma Locally Advanced Alveolar Soft Part Sarcoma CL977391 CTRP Malignant Locally Advanced Alveolar Soft Part Sarcoma Locally Advanced Alveolar Soft Part Sarcoma Alveolar soft part sarcoma that is not amenable to surgical resection. C164078 Neoplastic Process Unresectable Alveolar Soft Part Sarcoma Unresectable Alveolar Soft Part Sarcoma CL977389 CTRP Malignant Unresectable Alveolar Soft Part Sarcoma Unresectable Alveolar Soft Part Sarcoma Ewing sarcoma that has spread from its original site of growth to nearby tissues or lymph nodes. C164080 Neoplastic Process Locally Advanced Ewing Sarcoma Locally Advanced Ewing Sarcoma CL977388 CTRP Malignant Locally Advanced Ewing Sarcoma Locally Advanced Ewing Sarcoma A carcinoma arising from the genitourinary system. Representative examples include kidney carcinoma, bladder carcinoma, prostate carcinoma, endometrial carcinoma, cervical carcinoma, and ovarian carcinoma. C164141 Neoplastic Process Genitourinary System Carcinoma CL977335 Malignant Genitourinary System Carcinoma Genitourinary System Carcinoma A genitourinary system carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C164143 Neoplastic Process Advanced Genitourinary System Carcinoma CL977333 Malignant Advanced Genitourinary System Carcinoma Advanced Genitourinary System Carcinoma A rare, highly aggressive renal cell carcinoma caused by germline or (in a subset) somatic mutation of fumarate hydratase gene. It arises mostly in the setting of hereditary leiomyomatosis-renal cell carcinoma syndrome. C164156 Neoplastic Process Fumarate Hydratase-Deficient Renal Cell Carcinoma Fumarate Hydratase-Deficient Renal Cell Carcinoma CL977349 CTRP Malignant FH-Deficient RCC FH-Deficient Renal Cell Carcinoma Fumarate Hydratase-Deficient Renal Cell Carcinoma Fumarate Hydratase-Deficient Renal Cell Carcinoma Renal pelvis and ureter urothelial carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C164159 Neoplastic Process Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma CL977346 CTRP Malignant Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma Renal pelvis and ureter urothelial carcinoma that is not amenable to surgical resection. C164160 Neoplastic Process Unresectable Renal Pelvis and Ureter Urothelial Carcinoma Unresectable Renal Pelvis and Ureter Urothelial Carcinoma CL977345 CTRP Malignant Unresectable Renal Pelvis and Ureter Urothelial Carcinoma Unresectable Renal Pelvis and Ureter Urothelial Carcinoma Prostate adenocarcinoma that metastasizes quickly to other anatomic sites. It usually has a Gleason score between 8 and 10, a PSA level higher than 20 ng/ml, and is classified as T3b or T4. C164185 Neoplastic Process Aggressive Prostate Adenocarcinoma Aggressive Prostate Adenocarcinoma CL977325 CTRP Malignant Aggressive Prostate Adenocarcinoma Aggressive Prostate Adenocarcinoma A term that refers to the staging of prostate adenocarcinoma according to the American Joint Committee on Cancer, 7th edition. C164186 Neoplastic Process Prostate Adenocarcinoma by AJCC v7 Stage CL977324 Malignant Prostate Adenocarcinoma by AJCC v7 Stage Prostate Adenocarcinoma by AJCC v7 Stage A sarcoma that arises from the head and neck region. C164198 Neoplastic Process Head and Neck Sarcoma C1827431 Malignant Head and Neck Sarcoma Head and Neck Sarcoma A rare, slow-growing, low-grade soft tissue sarcoma arising from the sinonasal tract. It presents with non-specific obstructive nasal symptoms. Morphologically, it is an infiltrative, cellular spindle cell neoplasm. It is associated with rearrangement of the PAX3 gene. C164205 Neoplastic Process Biphenotypic Sinonasal Sarcoma CL977505 GDC Malignant 9045/3 Biphenotypic sinonasal sarcoma BSNS Biphenotypic Sinonasal Sarcoma Biphenotypic sinonasal sarcoma Low Grade Sinonasal Sarcoma with Neural and Myogenic Differentiation Low-Grade Sinonasal Sarcoma with Neural and Myogenic Differentiation Sinonasal Biphenotypic Sarcoma Biphenotypic Sinonasal Sarcoma Pancreatic ductal adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C164214 Neoplastic Process Advanced Pancreatic Ductal Adenocarcinoma Advanced Pancreatic Ductal Adenocarcinoma CL977523 CTRP Malignant Advanced Pancreatic Ductal Adenocarcinoma Advanced Pancreatic Ductal Adenocarcinoma Colon carcinoma that has developed in relatives of patients with a history of colon carcinoma. C164228 Neoplastic Process Hereditary Colon Carcinoma Hereditary Colon Carcinoma CL977485 CTRP Malignant Hereditary Colon Carcinoma Hereditary Colon Carcinoma Clear cell renal cell carcinoma that is resistant to treatment. C164236 Neoplastic Process Refractory Clear Cell Renal Cell Carcinoma Refractory Clear Cell Renal Cell Carcinoma CL977478 CTRP Malignant Refractory Clear Cell Renal Cell Carcinoma Refractory Clear Cell Renal Cell Carcinoma A malignant PEComa that has spread from its original site of growth to another anatomic site. C164245 Neoplastic Process Metastatic Malignant PEComa Metastatic Malignant PEComa CL977498 CTRP Malignant Metastatic Malignant PEComa Metastatic Malignant PEComa A malignant PEComa that has spread extensively to other anatomic sites or is no longer responding to treatment. C164246 Neoplastic Process Advanced Malignant PEComa Advanced Malignant PEComa CL977497 CTRP Malignant Advanced Malignant PEComa Advanced Malignant PEComa A malignant PEComa that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C164247 Neoplastic Process Locally Advanced Unresectable Malignant PEComa Locally Advanced Unresectable Malignant PEComa CL977496 CTEP CTRP Malignant Locally Advanced Unresectable Malignant PEComa Locally Advanced Unresectable Malignant PEComa A papilloma with an exophytic growth arising from the sinonasal track. C164251 Neoplastic Process Sinonasal Exophytic Papilloma CL977493 Benign Sinonasal papilloma, exophytic Sinonasal Exophytic Papilloma Sinonasal Exophytic Schneiderian Papilloma Sinonasal Papilloma, Exophytic Type Sinonasal Exophytic Papilloma An invasive urothelial carcinoma that exhibits spindle cell sarcomatoid features. C164252 Neoplastic Process Invasive Sarcomatoid Urothelial Carcinoma CL977492 Malignant Urothelial carcinoma, sarcomatoid Infiltrating Urothelial Carcinoma, Sarcomatoid Variant Invasive Sarcomatoid Urothelial Carcinoma Invasive Urothelial Carcinoma, Sarcomatoid Variant Invasive Sarcomatoid Urothelial Carcinoma An adenoma that arises from the glandular epithelium of the gastrointestinal tract and is associated with intestinal-type differentiation. C164253 Neoplastic Process Gastrointestinal Tract Adenoma, Intestinal-Type CL529495 Benign Adenoma, intestinal type Adenoma, Intestinal-Type Digestive System Adenoma, Intestinal-Type GI Adenoma, Intestinal-Type GI Tract Adenoma, Intestinal-Type Gastrointestinal Tract Adenoma, Intestinal-Type Gastrointestinal Tract Adenoma, Intestinal-Type A papilloma that arises from the ciliated respiratory mucosa that lines the nasal cavity. C164256 Neoplastic Process Nasal Cavity Papilloma CL977490 Benign Nasal Cavity Papilloma Nasal Cavity Schneiderian Papilloma Nasal Cavity Papilloma A malignant peripheral nerve sheath tumor that is not amenable to surgical resection. C164312 Neoplastic Process Unresectable Malignant Peripheral Nerve Sheath Tumor Unresectable Malignant Peripheral Nerve Sheath Tumor CL977441 CTRP Malignant Unresectable Malignant Peripheral Nerve Sheath Tumor Unresectable Malignant Peripheral Nerve Sheath Tumor A malignant peripheral nerve sheath tumor that is associated with NF1 gene inactivation and a history of neurofibromatosis type 1. C164313 Neoplastic Process NF1-Associated Malignant Peripheral Nerve Sheath Tumor CL977440 Malignant NF1-Associated Malignant Peripheral Nerve Sheath Tumor NF1-Associated Malignant Peripheral Nerve Sheath Tumor A malignant peripheral nerve sheath tumor that is not caused by inherited genetic mutations. C164314 Neoplastic Process Sporadic Malignant Peripheral Nerve Sheath Tumor Sporadic Malignant Peripheral Nerve Sheath Tumor CL977439 CTRP Malignant Sporadic Malignant Peripheral Nerve Sheath Tumor Sporadic Malignant Peripheral Nerve Sheath Tumor A malignant peripheral nerve sheath tumor that is the result of exposure to ionizing radiation. C164316 Neoplastic Process Radiation-Induced Malignant Peripheral Nerve Sheath Tumor CL977438 Malignant Radiation-Induced Malignant Peripheral Nerve Sheath Tumor Radiation-Induced Malignant Peripheral Nerve Sheath Tumor A type of diffusion-weighted magnetic resonance imaging that monitors the passage of contrast medium through a capillary bed. It is based on inhomogeneity of the magnetic field during the passage of a short bolus of contrast medium through the capillary bed. It can demonstrate the characteristics of the vascular physiology and hemodynamics of tumors and has been used to differentiate recurrence from radiation injury. C164660 Diagnostic Procedure Dynamic Susceptibility Contrast-Perfusion-Weighted Imaging Dynamic Susceptibility Contrast-Perfusion-Weighted Imaging CL977805 CTRP DIPG/DMG DSC DSC-PWI Dynamic Susceptibility Contrast Perfusion Weighted Imaging Dynamic Susceptibility Contrast Perfusion-Weighted MR Imaging Dynamic Susceptibility Contrast-Enhanced MR Perfusion Dynamic Susceptibility Contrast-Perfusion-Weighted Imaging Dynamic Susceptibility Contrast-Perfusion-Weighted Imaging Any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation. C16502 Diagnostic Procedure Diagnostic Imaging Diagnostic Imaging C0011923 CTRP GDC Diagnostic_Imaging Diagnostic Imaging Diagnostic Imaging Medical Imaging Diagnostic Imaging Liver carcinoma that is not amenable to surgical resection. C165171 Neoplastic Process Unresectable Liver and Intrahepatic Bile Duct Carcinoma Unresectable Liver Carcinoma CL978437 CTRP Malignant Unresectable Liver Carcinoma Unresectable Liver and Intrahepatic Bile Duct Carcinoma Unresectable Liver Carcinoma Carcinoma that arises from the ampulla of Vater and is not amenable to surgical resection. C165172 Neoplastic Process Unresectable Ampulla of Vater Carcinoma Unresectable Ampulla of Vater Carcinoma CL978438 CTRP Malignant Unresectable Ampulla of Vater Carcinoma Unresectable Ampulla of Vater Carcinoma Adenocarcinoma that arises from the periampullary region and is not amenable to surgical resection. C165173 Neoplastic Process Unresectable Periampullary Adenocarcinoma Unresectable Periampullary Adenocarcinoma CL978439 CTRP Malignant Unresectable Periampullary Adenocarcinoma Unresectable Periampullary Adenocarcinoma Carcinoma that arises from the head and neck region and is not amenable to surgical resection. C165174 Neoplastic Process Unresectable Head and Neck Carcinoma CL978440 Malignant Unresectable Head and Neck Carcinoma Unresectable Head and Neck Carcinoma Nasopharyngeal carcinoma that is not amenable to surgical resection. C165176 Neoplastic Process Unresectable Nasopharyngeal Carcinoma Unresectable Nasopharyngeal Carcinoma CL978441 CTRP Malignant Unresectable Nasopharyngeal Carcinoma Unresectable Nasopharyngeal Carcinoma A soft tissue sarcoma that arises from the trunk or the extremities. C165190 Neoplastic Process Soft Tissue Sarcoma of the Trunk and Extremities Soft Tissue Sarcoma of the Trunk and Extremities CL978431 CTRP Malignant Soft Tissue Sarcoma of the Trunk and Extremities Soft Tissue Sarcoma of the Trunk and Extremities The reemergence of diffuse large B-cell lymphoma, not otherwise specified after a period of remission. C165240 Neoplastic Process Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified CL978390 CTRP Malignant Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Diffuse large B-cell lymphoma, not otherwise specified that is resistant to treatment. C165241 Neoplastic Process Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified CL978391 CTRP Malignant Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified The reemergence of neuroendocrine carcinoma after a period of remission. C165253 Neoplastic Process Recurrent Neuroendocrine Carcinoma Recurrent Neuroendocrine Carcinoma CL978554 CTRP Malignant Recurrent Neuroendocrine Carcinoma Recurrent Neuroendocrine Carcinoma An exceedingly rare endometrioid adenocarcinoma arising from the peritoneum. C165260 Neoplastic Process Primary Peritoneal Endometrioid Adenocarcinoma CL978528 Malignant Primary Peritoneal Endometrioid Adenocarcinoma Primary Peritoneal Endometrioid Adenocarcinoma An exceedingly rare solid pseudopapillary neoplasm that occurs in ectopic pancreatic tissue in the ovary. C165261 Neoplastic Process Solid Pseudopapillary Neoplasm of the Ovary CL978529 Malignant Solid pseudopapillary tumor of ovary Primary Ovarian Solid Pseudopapillary Neoplasm Primary Ovarian Solid Pseudopapillary Tumor Solid Pseudopapillary Neoplasm of the Ovary Solid Pseudopapillary Tumor of the Ovary Solid Pseudopapillary Neoplasm of the Ovary The reemergence of ovarian high-grade serous adenocarcinoma after a period of remission. C165262 Neoplastic Process Recurrent High Grade Ovarian Serous Adenocarcinoma Recurrent Ovarian High Grade Serous Adenocarcinoma CL978530 CTRP Malignant Recurrent High Grade Ovarian Serous Adenocarcinoma Recurrent Ovarian High Grade Serous Adenocarcinoma Recurrent Ovarian High-Grade Serous Adenocarcinoma Recurrent Ovarian High Grade Serous Adenocarcinoma The reemergence of fallopian tube endometrioid adenocarcinoma after a period of remission. C165265 Neoplastic Process Recurrent Fallopian Tube Endometrioid Adenocarcinoma Recurrent Fallopian Tube Endometrioid Adenocarcinoma CL978532 CTRP Malignant Recurrent Fallopian Tube Endometrioid Adenocarcinoma Recurrent Fallopian Tube Endometrioid Adenocarcinoma The reemergence of fallopian tube high-grade serous adenocarcinoma after a period of remission. C165267 Neoplastic Process Recurrent High Grade Fallopian Tube Serous Adenocarcinoma Recurrent Fallopian Tube High Grade Serous Adenocarcinoma CL978534 CTRP Malignant Recurrent Fallopian Tube High Grade Serous Adenocarcinoma Recurrent Fallopian Tube High-Grade Serous Adenocarcinoma Recurrent High Grade Fallopian Tube Serous Adenocarcinoma Recurrent Fallopian Tube High Grade Serous Adenocarcinoma The reemergence of primary peritoneal high-grade serous adenocarcinoma after a period of remission. C165268 Neoplastic Process Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma CL978535 CTRP Malignant Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma The reemergence of primary peritoneal endometrioid adenocarcinoma after a period of remission. C165269 Neoplastic Process Recurrent Endometrioid Primary Peritoneal Carcinoma Recurrent Primary Peritoneal Endometrioid Adenocarcinoma CL978536 CTRP Malignant Recurrent Endometrioid Primary Peritoneal Carcinoma Recurrent Primary Peritoneal Endometrioid Adenocarcinoma Recurrent Primary Peritoneal Endometrioid Adenocarcinoma The reemergence of endometrial dedifferentiated carcinoma after a period of remission. C165282 Neoplastic Process Recurrent Endometrial Dedifferentiated Carcinoma Recurrent Endometrial Dedifferentiated Carcinoma CL978517 CTRP Malignant Recurrent Endometrial Dedifferentiated Carcinoma Recurrent Endometrial Dedifferentiated Carcinoma The reemergence of endometrial squamous cell carcinoma after a period of remission. C165283 Neoplastic Process Recurrent Endometrial Squamous Cell Carcinoma Recurrent Endometrial Squamous Cell Carcinoma CL978518 CTRP Malignant Recurrent Endometrial Squamous Cell Carcinoma Recurrent Endometrial Squamous Cell Carcinoma The reemergence of endometrial transitional cell carcinoma after a period of remission. C165284 Neoplastic Process Recurrent Endometrial Transitional Cell Carcinoma Recurrent Endometrial Transitional Cell Carcinoma CL978519 CTRP Malignant Recurrent Endometrial Transitional Cell Carcinoma Recurrent Endometrial Transitional Cell Carcinoma Endometrial dedifferentiated carcinoma that is resistant to treatment. C165286 Neoplastic Process Refractory Endometrial Dedifferentiated Carcinoma Refractory Endometrial Dedifferentiated Carcinoma CL978521 CTRP Malignant Refractory Endometrial Dedifferentiated Carcinoma Refractory Endometrial Dedifferentiated Carcinoma Endometrial transitional cell carcinoma that is resistant to treatment. C165287 Neoplastic Process Refractory Endometrial Squamous Cell Carcinoma Refractory Endometrial Squamous Cell Carcinoma CL978522 CTRP Malignant Refractory Endometrial Squamous Cell Carcinoma Refractory Endometrial Squamous Cell Carcinoma Endometrial transitional cell carcinoma that is resistant to treatment. C165288 Neoplastic Process Refractory Endometrial Transitional Cell Carcinoma Refractory Endometrial Transitional Cell Carcinoma CL978523 CTRP Malignant Refractory Endometrial Transitional Cell Carcinoma Refractory Endometrial Transitional Cell Carcinoma Endometrial adenocarcinoma that is resistant to treatment. C165289 Neoplastic Process Refractory Endometrial Adenocarcinoma, Not Otherwise Specified Refractory Endometrial Adenocarcinoma CL978524 CTRP Malignant Refractory Endometrial Adenocarcinoma Refractory Endometrial Adenocarcinoma, NOS Refractory Endometrial Adenocarcinoma, Not Otherwise Specified Refractory Endometrial Adenocarcinoma Endometrial mucinous adenocarcinoma that is resistant to treatment. C165290 Neoplastic Process Refractory Endometrial Mucinous Adenocarcinoma Refractory Endometrial Mucinous Adenocarcinoma CL978525 CTRP Malignant Refractory Endometrial Mucinous Adenocarcinoma Refractory Endometrial Mucinous Adenocarcinoma The reemergence of endometrial mucinous adenocarcinoma after a period of remission. C165291 Neoplastic Process Recurrent Endometrial Mucinous Adenocarcinoma Recurrent Endometrial Mucinous Adenocarcinoma CL978526 CTRP Malignant Recurrent Endometrial Mucinous Adenocarcinoma Recurrent Endometrial Mucinous Adenocarcinoma Liver carcinoma that is amenable to surgical resection. C165293 Neoplastic Process Resectable Liver and Intrahepatic Bile Duct Carcinoma Resectable Liver Carcinoma CL978499 CTRP Malignant Resectable Liver Carcinoma Resectable Liver and Intrahepatic Bile Duct Carcinoma Resectable Liver Carcinoma Endometrial undifferentiated carcinoma that is resistant to treatment. C165298 Neoplastic Process Refractory Endometrial Undifferentiated Carcinoma Refractory Endometrial Undifferentiated Carcinoma CL978504 CTRP Malignant Refractory Endometrial Undifferentiated Carcinoma Refractory Endometrial Undifferentiated Carcinoma Gastric carcinoma that has metastasized from its original site of growth to distal anatomic sites or is no longer responding to treatment. C165299 Neoplastic Process Advanced Gastric Carcinoma Advanced Gastric Carcinoma CL936754 CTRP Malignant Advanced Gastric Carcinoma Advanced Gastric Carcinoma A Merkel cell carcinoma that has metastasized from its original site of growth to distal anatomic sites or is no longer responding to treatment. C165300 Neoplastic Process Advanced Merkel Cell Carcinoma Advanced Merkel Cell Carcinoma CL978505 CTRP Malignant Advanced Merkel Cell Carcinoma Advanced Merkel Cell Carcinoma A lung neuroendocrine neoplasm that has spread extensively to other anatomic sites or is no longer responding to treatment. C165446 Neoplastic Process Advanced Lung Neuroendocrine Neoplasm Advanced Lung Neuroendocrine Neoplasm CL978599 CTRP Malignant Advanced Lung Neuroendocrine Neoplasm Advanced Lung Neuroendocrine Neoplasm A pancreatic neuroendocrine neoplasm that has spread from its original site of growth to another anatomic site. C165447 Neoplastic Process Metastatic Pancreatic Neuroendocrine Neoplasm Metastatic Pancreatic Neuroendocrine Neoplasm CL978600 CTRP Malignant Metastatic Pancreatic Neuroendocrine Neoplasm Metastatic Pancreatic Neuroendocrine Neoplasm A pancreatic neuroendocrine neoplasm that has spread extensively to other anatomic sites or is no longer responding to treatment. C165448 Neoplastic Process Advanced Pancreatic Neuroendocrine Neoplasm Advanced Pancreatic Neuroendocrine Neoplasm CL978601 CTRP Malignant Advanced Pancreatic Neuroendocrine Neoplasm Advanced Pancreatic Neuroendocrine Neoplasm A clear cell renal cell carcinoma that is not amenable to surgical resection. C165449 Neoplastic Process Unresectable Clear Cell Renal Cell Carcinoma Unresectable Clear Cell Renal Cell Carcinoma CL978602 CTRP Malignant Unresectable Clear Cell Renal Cell Carcinoma Unresectable Clear Cell Renal Cell Carcinoma Pancreatic ductal adenocarcinoma that is resistant to treatment. C165450 Neoplastic Process Refractory Pancreatic Ductal Adenocarcinoma Refractory Pancreatic Ductal Adenocarcinoma CL978603 CTRP Malignant Refractory Pancreatic Ductal Adenocarcinoma Refractory Pancreatic Ductal Adenocarcinoma Pancreatic carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C165452 Neoplastic Process Advanced Pancreatic Carcinoma Advanced Pancreatic Carcinoma CL978605 CTRP Malignant Advanced Pancreatic Carcinoma Advanced Pancreatic Carcinoma A neuroendocrine tumor that is not amenable to surgical resection. C165453 Neoplastic Process Unresectable Well Differentiated Neuroendocrine Neoplasm Unresectable Neuroendocrine Tumor CL978606 CTRP Malignant Unresectable Neuroendocrine Tumor Unresectable Well Differentiated Neuroendocrine Neoplasm Unresectable Neuroendocrine Tumor A lung neuroendocrine neoplasm that is not amenable to surgical resection. C165454 Neoplastic Process Unresectable Lung Neuroendocrine Neoplasm Unresectable Lung Neuroendocrine Neoplasm CL978607 CTRP Malignant Unresectable Lung Neuroendocrine Neoplasm Unresectable Lung Neuroendocrine Neoplasm A digestive system neuroendocrine neoplasm that is not amenable to surgical resection. C165455 Neoplastic Process Unresectable Digestive System Neuroendocrine Neoplasm Unresectable Digestive System Neuroendocrine Neoplasm CL978579 CTRP Malignant Unresectable Digestive System Neuroendocrine Neoplasm Unresectable Digestive System Neuroendocrine Neoplasm A pancreatic neuroendocrine neoplasm that is not amenable to surgical resection. C165456 Neoplastic Process Unresectable Pancreatic Neuroendocrine Neoplasm Unresectable Pancreatic Neuroendocrine Neoplasm CL978580 CTRP Malignant Unresectable Pancreatic Neuroendocrine Neoplasm Unresectable Pancreatic Neuroendocrine Neoplasm An ovarian carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C165458 Neoplastic Process Advanced Ovarian Carcinoma Advanced Ovarian Carcinoma CL978582 CTRP Malignant Advanced Ovarian Carcinoma Advanced Ovarian Carcinoma A verrucous carcinoma that arises from the skin. It usually affects the palms, soles, and distal digits. C165465 Neoplastic Process Skin Verrucous Carcinoma CL978589 Malignant Skin Verrucous Carcinoma Skin Verrucous Carcinoma A rare squamous cell carcinoma of the skin characterized by the presence of multinucleated non-neoplastic giant cells that resemble osteoclasts. C165466 Neoplastic Process Skin Squamous Cell Carcinoma with Osteoclast-Like Giant Cells CL978590 Malignant Skin Squamous Cell Carcinoma with Osteoclast-Like Giant Cells Skin Squamous Cell Carcinoma with Osteoclast-Like Giant Cells A rare, poorly differentiated squamous cell carcinoma of the skin. It is characterized by the presence of tumor cells islands surrounded and infiltrated by lymphocytes and plasma cells. C165467 Neoplastic Process Skin Lymphoepithelial Carcinoma C1276137 Malignant Skin Lymphoepithelial Carcinoma Skin Lymphoepithelioma-Like Carcinoma Skin Lymphoepithelial Carcinoma A rare carcinoma of the skin characterized by the presence of squamous cell carcinomatous and sarcomatous components. C165468 Neoplastic Process Skin Squamous Cell Carcinoma with Sarcomatoid Differentiation C1275281 Malignant Skin Carcinosarcoma Skin Metaplastic Carcinoma Skin Sarcomatoid Squamous Cell Carcinoma Skin Squamous Cell Carcinoma with Sarcomatoid Differentiation Skin Squamous Cell Carcinoma with Sarcomatoid Differentiation Oral cavity squamous cell carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C165472 Neoplastic Process Locally Advanced Oral Cavity Squamous Cell Carcinoma Locally Advanced Oral Cavity Squamous Cell Carcinoma CL978570 CTRP Malignant Locally Advanced Oral Cavity Squamous Cell Carcinoma Locally Advanced Oral Cavity Squamous Cell Carcinoma Laryngeal squamous cell carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C165473 Neoplastic Process Locally Advanced Laryngeal Squamous Cell Carcinoma Locally Advanced Laryngeal Squamous Cell Carcinoma CL978571 CTRP Malignant Locally Advanced Laryngeal Squamous Cell Carcinoma Locally Advanced Laryngeal Squamous Cell Carcinoma Positron emission tomography that uses a tracer other than fluoro-2-deoxy-D-glucose (FDG). C165483 Diagnostic Procedure Non-FDG-Positron Emission Tomography Non-FDG-Positron Emission Tomography CL978576 CTRP Non-FDG-PET Non-FDG-Positron Emission Tomography Non-Fluoro-2-deoxy-D-glucose- Positron Emission Tomography Non-FDG-Positron Emission Tomography A benign intraepidermal squamoproliferative neoplasm characterized by irregular acanthosis, hyperkeratosis, parakeratosis, and prominent chronic inflammation. C165485 Neoplastic Process Lichen Planus-Like Keratosis C1274594 Benign Lichen Planus-Like Keratosis Lichenoid Keratosis Lichen Planus-Like Keratosis Triple-negative breast carcinoma that is not amenable to surgical resection. C165491 Neoplastic Process Unresectable Triple-Negative Breast Carcinoma Unresectable Triple-Negative Breast Carcinoma CL978562 CTRP Malignant Unresectable Triple-Negative Breast Carcinoma Unresectable Triple-Negative Breast Carcinoma A cutaneous melanoma that is associated with genomic alterations observed in Spitz nevus and Spitz melanocytoma. It shares histopathological and clinical features with Spitz melanocytoma. C165497 Neoplastic Process Spitz Melanoma C3495721 Cellosaurus Malignant Malignant Spitz tumor MST Malignant Spitz Tumor Spitz Melanoma Spitzoid Melanoma Spitz Melanoma A rare cutaneous melanocytic neoplasm that presents as a slow growing pigmented nodule or papule. It is characterized by the proliferation of heavily pigmented epithelioid and dendritic cells, predominantly in the dermis. PRKAR1A gene inactivation is present in the majority of cases. It can spread to regional lymph nodes, but distant metastases are rare. C165498 Neoplastic Process Pigmented Epithelioid Melanocytoma CL978566 Undetermined Pigmented epithelioid melanocytoma Epithelioid Blue Nevus PEM Pigmented Epithelioid Melanocytoma Pigmented Epithelioid Melanocytoma A BAP1-inactivated melanocytoma that is combined with a smaller area of melanocytic proliferation in the basal layer of the epidermis. C165523 Neoplastic Process Combined BAP1-Inactivated Melanocytoma CL978688 Benign Combined BAP1-Inactivated Melanocytoma Combined BAP1-Inactivated Nevus Combined BAP1-Inactivated Melanocytoma A cutaneous melanocytoma caused by the inactivation of BAP1 tumor suppressor gene. It is characterized by the presence of a predominantly intradermal proliferation of large epithelioid melanocytes with a large amount of eosinophilic cytoplasm, and vesicular nuclei with prominent nucleoli. Progression to melanoma is infrequent. C165525 Neoplastic Process BAP1-Inactivated Melanocytoma CL978689 Benign BAP1-Deficient Tumor BAP1-Inactivated Cutaneous Melanocytic Neoplasm BAP1-Inactivated Cutaneous Melanocytic Tumor BAP1-Inactivated Cutaneous Melanocytoma BAP1-Inactivated Melanocytic Neoplasm BAP1-Inactivated Melanocytic Tumor BAP1-Inactivated Melanocytoma BAP1-Inactivated Nevus BAP1-Inactivated Skin Melanocytic Neoplasm BAP1-Inactivated Skin Melanocytic Tumor BAP1-Inactivated Spitzoid Nevus BAPoma BIM BIMT MBAIT Melanocytic BAP1-Mutated Atypical Intradermal Tumor Wiesner Nevus BAP1-Inactivated Melanocytoma A nevus that contains two or more melanocytic nevus components in the same lesion. The cellular components can be any combination of any nevus variants, but most frequently, a common nevus component is combined with a blue nevus, deep penetrating nevus, or Spitz nevus component. (WHO 2018) C165529 Neoplastic Process Combined Nevus CL978692 Benign Clonal Nevus Combined Nevus Inverted Type A Nevus Melanocytic Nevus with Phenotypic Heterogeneity Nevus with Atypical Dermal Nodules Nevus with Dermal Epithelioid Component Combined Nevus Acral lentiginous melanoma that is not amenable to surgical resection. C165535 Neoplastic Process Unresectable Acral Lentiginous Melanoma Unresectable Acral Lentiginous Melanoma CL978693 CTRP Malignant Unresectable Acral Lentiginous Melanoma Unresectable Acral Melanoma Unresectable Acral Lentiginous Melanoma Laryngeal carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C165560 Neoplastic Process Locally Advanced Laryngeal Carcinoma Locally Advanced Laryngeal Carcinoma CL978667 CTRP Malignant Locally Advanced Laryngeal Carcinoma Locally Advanced Laryngeal Carcinoma Pharyngeal carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C165561 Neoplastic Process Locally Advanced Pharyngeal Carcinoma Locally Advanced Pharyngeal Carcinoma CL978668 CTRP Malignant Locally Advanced Pharyngeal Carcinoma Locally Advanced Pharyngeal Carcinoma Lip and oral cavity carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C165562 Neoplastic Process Locally Advanced Lip and Oral Cavity Carcinoma Locally Advanced Lip and Oral Cavity Carcinoma CL978669 CTRP Malignant Locally Advanced Lip and Oral Cavity Carcinoma Locally Advanced Lip and Oral Cavity Carcinoma Paranasal sinus carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C165563 Neoplastic Process Locally Advanced Paranasal Sinus Carcinoma Locally Advanced Paranasal Sinus Carcinoma CL978670 CTRP Malignant Locally Advanced Paranasal Sinus Carcinoma Locally Advanced Paranasal Sinus Carcinoma A lymph node outside the abdominal cavity. C165584 Anatomical Structure Extra-Abdominal Lymph Node CL978820 CDISC A lymph node that is located outside of the abdominal wall. EXTRAABDOMINAL LYMPH NODE Extra-Abdominal Lymph Node Extraadominal Lymph Node Extra-Abdominal Lymph Node A diffusion MR framework for imaging and modeling of microstructure that uses time-varying gradients to probe a trajectory in q-space. C165594 Diagnostic Procedure Q-space Trajectory Imaging Q-space Trajectory Imaging CL978826 CTRP Q-space Trajectory Imaging QTI Q-space Trajectory Imaging Differentiated thyroid gland carcinoma that is resistant to treatment. C165607 Neoplastic Process Refractory Differentiated Thyroid Gland Carcinoma Refractory Differentiated Thyroid Gland Carcinoma CL978819 CTRP Malignant Refractory Differentiated Thyroid Gland Carcinoma Refractory Follicular/Papillary Thyroid Gland Carcinoma Refractory Differentiated Thyroid Gland Carcinoma Thyroid gland papillary carcinoma that is resistant to treatment. C165608 Neoplastic Process Refractory Thyroid Gland Papillary Carcinoma Refractory Thyroid Gland Papillary Carcinoma CL978812 CTRP Malignant Refractory Thyroid Gland Papillary Carcinoma Refractory Thyroid Gland Papillary Carcinoma Thyroid gland follicular carcinoma that is resistant to treatment. C165609 Neoplastic Process Refractory Thyroid Gland Follicular Carcinoma Refractory Thyroid Gland Follicular Carcinoma CL978813 CTRP Malignant Refractory Thyroid Gland Follicular Carcinoma Refractory Thyroid Gland Follicular Carcinoma Thyroid gland oncocytic carcinoma that is resistant to treatment. C165610 Neoplastic Process Refractory Thyroid Gland Hurthle Cell Carcinoma Refractory Thyroid Gland Oncocytic Carcinoma CL978814 CTRP Malignant Refractory Thyroid Gland Hurthle Cell Carcinoma Refractory Thyroid Gland Oncocytic (Hurthle Cell) Carcinoma Refractory Thyroid Gland Oncocytic Carcinoma Refractory Thyroid Gland Oncocytic Carcinoma The reemergence of differentiated thyroid gland carcinoma after a period of remission. C165611 Neoplastic Process Recurrent Differentiated Thyroid Gland Carcinoma CL978815 Malignant Recurrent Differentiated Thyroid Gland Carcinoma Recurrent Follicular/Papillary Thyroid Gland Carcinoma Recurrent Differentiated Thyroid Gland Carcinoma A gastric adenocarcinoma that arises from the proximal part of the stomach. C165628 Neoplastic Process Proximal Gastric Adenocarcinoma Proximal Gastric Adenocarcinoma CL978802 CTRP Malignant Proximal Gastric Adenocarcinoma Proximal Gastric Adenocarcinoma A proximal gastric adenocarcinoma that has spread from its original site of growth to another anatomic site. C165630 Neoplastic Process Metastatic Proximal Gastric Adenocarcinoma Metastatic Proximal Gastric Adenocarcinoma CL978782 CTRP Malignant Metastatic Proximal Gastric Adenocarcinoma Metastatic Proximal Gastric Adenocarcinoma A malignant neoplasm that arises from the pancreas and has not spread to other anatomic sites. C165631 Neoplastic Process Localized Malignant Pancreatic Neoplasm Localized Malignant Pancreatic Neoplasm CL978783 CTRP Malignant Localized Malignant Pancreatic Neoplasm Localized Malignant Pancreatic Neoplasm The use of high-dose, ablative radiation to target the celiac plexus nerve bundle to provide pain relief in the posterior abdomen. C165633 Therapeutic or Preventive Procedure Celiac Plexus Radiosurgery Celiac Plexus Radiosurgery CL978784 CTRP Celiac Plexus Radiosurgery Celiac Plexus Radiosurgery Immunotherapy that focuses on mobilizing the patient's own immune cells to recognize and eliminate cancer cells. C165652 Therapeutic or Preventive Procedure Immuno-oncology Therapy Immuno-oncology Therapy CL978948 CTRP IO Therapy Immuno-oncology Therapy Immunooncology Therapy Immuno-oncology Therapy A cutaneous melanoma that develops on sun-exposed sites with a high degree of cumulative sun damage (CSD). C165659 Neoplastic Process High-CSD Melanoma CL978954 Malignant Cutaneous Melanoma with a High Degree of Cumulative Sun Damage Cutaneous Melanoma with a High Degree of Cumulative Sun Damage (CSD) High-CSD Melanoma High-CSD Melanoma An acral nevus that arises from the nail matrix. C165662 Neoplastic Process Nail Matrix Nevus CL978937 Benign NMN Nail Matrix Nevus Nail Matrix Nevus An undifferentiated, high grade small round cell sarcoma affecting predominantly young adults. It is characterized by a recurrent translocation involving the CIC gene on chromosome 19 and DUX4 gene on chromosome 4. The translocation results in CIC-DUX4, t(4;19)(q35;q13) fusions. C165663 Neoplastic Process CIC-DUX4 Sarcoma CL978938 Cellosaurus Malignant CIC-DUX4 Sarcoma CIC::DUX4 Sarcoma CIC-DUX4 Sarcoma An undifferentiated, high grade small round cell sarcoma affecting predominantly young adults. It is characterized by a recurrent translocation involving the CIC gene on chromosome 19 and DUX4L gene on chromosome 10. The translocation results in CIC-DUX4L, t(10;19)(q26;q13) fusions. C165665 Neoplastic Process CIC-DUX4L Sarcoma CL978940 Malignant CIC-DUX4L Sarcoma CIC::DUX4L Sarcoma CIC-DUX4L Sarcoma A high-grade sarcoma characterized by the absence of EWSR1 rearrangement and the presence of small round malignant cells with a small amount of cytoplasm. C165671 Neoplastic Process EWSR1-Negative Small Round Cell Tumor CL978944 Malignant EWSR1-Negative Small Blue Round Cell Tumor EWSR1-Negative Small Cell Sarcoma EWSR1-Negative Small Round Cell Tumor EWSR1-Negative Small Round Cell Tumor An adenocarcinoma that arises from the breast and has metastasized to another anatomic site. C165698 Neoplastic Process Metastatic Breast Adenocarcinoma Metastatic Breast Adenocarcinoma C1697918 CTRP Malignant Metastatic Breast Adenocarcinoma Metastatic Breast Adenocarcinoma Breast adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C165699 Neoplastic Process Locally Advanced Breast Adenocarcinoma Locally Advanced Breast Adenocarcinoma CL978903 CTRP Malignant Locally Advanced Breast Adenocarcinoma Locally Advanced Breast Adenocarcinoma Breast adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C165700 Neoplastic Process Advanced Breast Adenocarcinoma Advanced Breast Adenocarcinoma CL978904 CTRP Malignant Advanced Breast Adenocarcinoma Advanced Breast Adenocarcinoma Hypopharyngeal squamous cell carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C165701 Neoplastic Process Locally Advanced Hypopharyngeal Squamous Cell Carcinoma Locally Advanced Hypopharyngeal Squamous Cell Carcinoma CL978905 CTRP Malignant Locally Advanced Hypopharyngeal Squamous Cell Carcinoma Locally Advanced Hypopharyngeal Squamous Cell Carcinoma Bladder urothelial carcinoma that does not respond to treatment. C165702 Neoplastic Process Refractory Bladder Urothelial Carcinoma Refractory Bladder Urothelial Carcinoma CL978906 CTRP Malignant Refractory Bladder Urothelial Carcinoma Refractory Bladder Urothelial Carcinoma Breast adenocarcinoma that does not respond to treatment. C165703 Neoplastic Process Refractory Breast Adenocarcinoma Refractory Breast Adenocarcinoma CL978914 CTRP Malignant Refractory Breast Adenocarcinoma Refractory Breast Adenocarcinoma An invasive bladder carcinoma characterized by the presence of more than one histologic pattern. C165716 Neoplastic Process Infiltrating Bladder Mixed Carcinoma Invasive Bladder Mixed Carcinoma CL978892 CTRP Malignant Infiltrating Bladder Mixed Carcinoma Invasive Bladder Mixed Carcinoma Invasive Bladder Mixed Carcinoma A technique for delivering heterogeneous doses of radiation to voluminous tumors not amenable to surgery. Built from a conventional two-dimensional grid, lattice radiation therapy utilizes three-dimensional radiation allowing the delivery of higher doses of radiation to small spheres, also called vertices, inside bulky tumors while limiting exposure to surrounding healthy tissue. C165722 Therapeutic or Preventive Procedure Lattice Stereotactic Body Radiation Therapy Lattice Stereotactic Body Radiation Therapy CL979276 CTRP LRT Lattice Radiotherapy Lattice Stereotactic Body Radiation Therapy Lattice-SBRT SBRT Delivered with Lattice Radiotherapy SBRT-LRT Lattice Stereotactic Body Radiation Therapy Skin squamous cell carcinoma that does not respond to treatment. C165735 Neoplastic Process Refractory Skin Squamous Cell Carcinoma Refractory Skin Squamous Cell Carcinoma CL978877 CTRP Malignant Refractory Skin Squamous Cell Carcinoma Refractory Skin Squamous Cell Carcinoma The reemergence of a metastatic skin squamous cell carcinoma after a period of remission. C165736 Neoplastic Process Recurrent Metastatic Skin Squamous Cell Carcinoma Recurrent Metastatic Skin Squamous Cell Carcinoma CL978878 CTRP Malignant Recurrent Metastatic Skin Squamous Cell Carcinoma Recurrent Metastatic Skin Squamous Cell Carcinoma The reemergence of skin squamous cell carcinoma after a period of remission, at or adjacent to the site of the original tumor. C165737 Neoplastic Process Locally Recurrent Skin Squamous Cell Carcinoma Locally Recurrent Skin Squamous Cell Carcinoma CL978887 CTRP Malignant Locally Recurrent Skin Squamous Cell Carcinoma Locally Recurrent Skin Squamous Cell Carcinoma A Merkel cell carcinoma that has spread to nearby tissues or lymph nodes. C165738 Neoplastic Process Locally Advanced Merkel Cell Carcinoma Locally Advanced Merkel Cell Carcinoma CL978888 CTRP Malignant Locally Advanced Merkel Cell Carcinoma Locally Advanced Merkel Cell Carcinoma The reemergence of a metastatic Merkel cell carcinoma after a period of remission. C165739 Neoplastic Process Recurrent Metastatic Merkel Cell Carcinoma Recurrent Metastatic Merkel Cell Carcinoma CL978889 CTRP Malignant Recurrent Metastatic Merkel Cell Carcinoma Recurrent Metastatic Merkel Cell Carcinoma The reemergence of Merkel cell carcinoma after a period of remission, at or adjacent to the site of the original tumor. C165740 Neoplastic Process Locally Recurrent Merkel Cell Carcinoma Locally Recurrent Merkel Cell Carcinoma CL978890 CTRP Malignant Locally Recurrent Merkel Cell Carcinoma Locally Recurrent Merkel Cell Carcinoma Merkel cell carcinoma that does not respond to treatment. C165741 Neoplastic Process Refractory Merkel Cell Carcinoma Refractory Merkel Cell Carcinoma CL978883 CTRP Malignant Refractory Merkel Cell Carcinoma Refractory Merkel Cell Carcinoma Neuroendocrine carcinoma that does not respond to treatment. C165742 Neoplastic Process Refractory Neuroendocrine Carcinoma CL978884 Malignant Refractory Neuroendocrine Carcinoma Refractory Neuroendocrine Carcinoma Breast adenocarcinoma that is negative for hormone receptors. C165743 Neoplastic Process Hormone Receptor Negative Breast Carcinoma Hormone Receptor-Negative Breast Carcinoma CL978885 CTRP Malignant ER and PR Negative Breast Carcinoma Estrogen Receptor and Progesterone Receptor Negative Breast Carcinoma Hormone Receptor Negative Breast Adenocarcinoma Hormone Receptor Negative Breast Carcinoma Hormone Receptor-Negative Breast Carcinoma Hormone Receptor-Negative Breast Carcinoma Renal cell carcinoma that does not respond to treatment. C165745 Neoplastic Process Refractory Renal Cell Carcinoma Refractory Renal Cell Carcinoma CL978863 CTRP Malignant Refractory Renal Cell Carcinoma Refractory Renal Cell Carcinoma Lung non-small cell carcinoma that is amenable to surgical resection. C165767 Neoplastic Process Resectable Lung Non-Small Cell Carcinoma Resectable Lung Non-Small Cell Carcinoma CL978846 CTRP Malignant Resectable Lung Non-Small Cell Carcinoma Resectable Lung Non-Small Cell Carcinoma A leiomyosarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C165780 Neoplastic Process Advanced Leiomyosarcoma Advanced Leiomyosarcoma CL979065 CTRP Malignant Advanced Leiomyosarcoma Advanced Leiomyosarcoma An undifferentiated pleomorphic sarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C165781 Neoplastic Process Advanced Undifferentiated Pleomorphic Sarcoma Advanced Undifferentiated Pleomorphic Sarcoma CL979066 CTRP Malignant Advanced Undifferentiated Pleomorphic Sarcoma Advanced Undifferentiated Pleomorphic Sarcoma Histologic transformation of mycosis fungoides to an aggressive non-Hodgkin lymphoma. C165783 Neoplastic Process Transformed Mycosis Fungoides CL979060 Malignant T-MF Transformed Mycosis Fungoides Transformed Mycosis Fungoides The reemergence of transformed mycosis fungoides after a period of remission. C165784 Neoplastic Process Recurrent Transformed Mycosis Fungoides Recurrent Transformed Mycosis Fungoides CL979061 CTRP Malignant Recurrent T-MF Recurrent Transformed Mycosis Fungoides Recurrent Transformed Mycosis Fungoides Transformed mycosis fungoides that is resistant to treatment. C165785 Neoplastic Process Refractory Transformed Mycosis Fungoides Refractory Transformed Mycosis Fungoides CL979062 CTRP Malignant Refractory T-MF Refractory Transformed Mycosis Fungoides Refractory Transformed Mycosis Fungoides The reemergence of T-cell non-Hodgkin lymphoma transformed after a period of remission. C165789 Neoplastic Process Recurrent Transformed T-cell Non-Hodgkin Lymphoma CL979067 Malignant Recurrent Transformed T-cell Non-Hodgkin Lymphoma Recurrent Transformed T-cell Non-Hodgkin Lymphoma An indolent T-cell non-Hodgkin lymphoma which has undergone histologic transformation to an aggressive T-cell non-Hodgkin lymphoma and has become resistant to treatment. C165791 Neoplastic Process Refractory Transformed T-cell Non-Hodgkin Lymphoma CL979068 Malignant Refractory Transformed T-cell Non-Hodgkin Lymphoma Refractory Transformed T-cell Non-Hodgkin Lymphoma The reemergence of mature B-cell non-Hodgkin lymphoma after a period of remission. C165799 Neoplastic Process Recurrent Mature B-Cell Non-Hodgkin Lymphoma CL979051 Malignant Recurrent Mature B-Cell Non-Hodgkin Lymphoma Recurrent Mature B-Cell Non-Hodgkin Lymphoma Examination of the tissues and deep structures of the body by x-ray, using the fluoroscope, a device that produces an image when x-rays strike a fluorescent screen. C16588 Diagnostic Procedure Fluoroscopy Fluoroscopy C0016356 CDISC CTRP OORO An imaging technique that produces real-time, moving images of tissues and deep structures of the body using the fluoroscope, a device that produces an image when X-rays strike a fluorescent screen. An x-ray procedure that makes it possible to see internal organs in motion. Fluoroscopy FLUOROSCOPY Fluoroscopy RF Radio Fluoroscopy Radiographic Fluoroscopy fluoroscopy Fluoroscopy Esophageal adenocarcinoma that has metastasized to a limited number of sites. C166120 Neoplastic Process Oligometastatic Esophageal Adenocarcinoma Oligometastatic Esophageal Adenocarcinoma CL979215 CTRP Malignant Oligometastatic Esophageal Adenocarcinoma Oligometastatic Esophageal Adenocarcinoma Gastric adenocarcinoma that has metastasized to a limited number of sites. C166121 Neoplastic Process Oligometastatic Gastric Adenocarcinoma Oligometastatic Gastric Adenocarcinoma CL979216 CTRP Malignant Oligometastatic Gastric Adenocarcinoma Oligometastatic Gastric Adenocarcinoma The reemergence of a myeloproliferative neoplasm after a period of remission. C166142 Neoplastic Process Recurrent Myeloproliferative Neoplasm Recurrent Myeloproliferative Neoplasm CL979197 CTRP Malignant Recurrent Myeloproliferative Neoplasm Recurrent Myeloproliferative Neoplasm The reemergence of a myelodysplastic/myeloproliferative neoplasm after a period of remission. C166143 Neoplastic Process Recurrent Myelodysplastic/Myeloproliferative Neoplasm Recurrent Myelodysplastic/Myeloproliferative Neoplasm CL979198 CTRP Malignant Recurrent Myelodysplastic/Myeloproliferative Neoplasm Recurrent Myelodysplastic/Myeloproliferative Neoplasm A glioblastoma that is amenable to surgical resection. C166156 Neoplastic Process Resectable Glioblastoma Resectable Glioblastoma CL979181 CTRP Malignant Resectable Glioblastoma Resectable Glioblastoma Esophageal carcinoma that is confined to the site in which it initially manifested without evidence of spread to other anatomic sites. C166171 Neoplastic Process Non-Metastatic Esophageal Carcinoma Localized Esophageal Carcinoma CL971433 CTRP Malignant Localized Esophageal Carcinoma Non-Metastatic Esophageal Carcinoma Localized Esophageal Carcinoma Anaplastic large cell lymphoma that is confined to a specific site without evidence of spread to other anatomic sites. C166179 Neoplastic Process Localized Anaplastic Large Cell Lymphoma Localized Anaplastic Large Cell Lymphoma CL971441 CTRP Malignant Localized Anaplastic Large Cell Lymphoma Localized Anaplastic Large Cell Lymphoma Anaplastic large cell lymphoma that has spread extensively to distant anatomic sites. C166180 Neoplastic Process Advanced Anaplastic Large Cell Lymphoma Advanced Anaplastic Large Cell Lymphoma CL971440 CTRP Malignant Advanced Anaplastic Large Cell Lymphoma Advanced Anaplastic Large Cell Lymphoma A malignant neoplasm that arises from the central nervous system and has spread from its original site of growth to other sites. C166181 Neoplastic Process Metastatic Primary Malignant Central Nervous System Neoplasm Metastatic Primary Malignant Central Nervous System Neoplasm CL971443 CTRP Malignant Metastatic Primary Malignant Central Nervous System Neoplasm Metastatic Primary Malignant Central Nervous System Neoplasm A malignant neoplasm that arises from the central nervous system and has spread from its original site of growth to nearby tissues or lymph nodes. C166182 Neoplastic Process Locally Advanced Primary Malignant Central Nervous System Neoplasm Locally Advanced Primary Malignant Central Nervous System Neoplasm CL971442 CTRP Malignant Locally Advanced Primary Malignant Central Nervous System Neoplasm Locally Advanced Primary Malignant Central Nervous System Neoplasm Gastric adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C166255 Neoplastic Process Advanced Gastric Adenocarcinoma Advanced Unresectable Gastric Adenocarcinoma Advanced Gastric Adenocarcinoma CL971298 CTRP Malignant Advanced Gastric Adenocarcinoma Advanced Unresectable Gastric Adenocarcinoma Unresectable Advanced Gastric (Stomach) Adenocarcinoma Advanced Gastric Adenocarcinoma Esophageal adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C166256 Neoplastic Process Advanced Esophageal Adenocarcinoma Advanced Esophageal Adenocarcinoma CL971301 CTRP Malignant Advanced Esophageal Adenocarcinoma Advanced Esophageal Adenocarcinoma Colorectal adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C166257 Neoplastic Process Advanced Colorectal Adenocarcinoma Advanced Colorectal Adenocarcinoma CL971300 CTRP Malignant Advanced Colorectal Adenocarcinoma Advanced Colorectal Adenocarcinoma A descriptive account of an individual's past medical procedures. C166353 Clinical Attribute Procedure History C1831566 Procedure History Procedure History A benign, intermediate, or malignant neoplasm that affects muscles and bones. C166354 Neoplastic Process Musculoskeletal Neoplasm Musculoskeletal Neoplasm C1285375 CTRP Undetermined Musculoskeletal Neoplasm Musculoskeletal System Neoplasm Musculoskeletal Neoplasm A mesenchymal neoplasm that arises from muscle or bone and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C166356 Neoplastic Process Benign Musculoskeletal Neoplasm CL971613 Benign Benign Musculoskeletal Neoplasm Benign Musculoskeletal Neoplasm A primary or metastatic malignant neoplasm that affects muscles and bones. C166357 Neoplastic Process Malignant Musculoskeletal Neoplasm Malignant Musculoskeletal Neoplasm C0036210 CTRP Malignant Malignant Musculoskeletal Neoplasm Malignant Musculoskeletal Neoplasm Melanoma that arises from the mucosal surface of the nasal cavity and paranasal sinus. C166399 Neoplastic Process Sinonasal Mucosal Melanoma CL971651 Malignant Nasal Cavity and Paranasal Sinus Melanoma Sinonasal Melanoma Sinonasal Mucosal Melanoma Sinonasal Mucosal Melanoma Rhabdomyosarcoma that has spread from its original site of growth to another anatomic site. C166414 Neoplastic Process Metastatic Rhabdomyosarcoma Metastatic Rhabdomyosarcoma CL971664 CTRP Malignant Metastatic Rhabdomyosarcoma Metastatic Rhabdomyosarcoma Rhabdomyosarcoma that has spread from its original site of growth to nearby tissues or lymph nodes. C166415 Neoplastic Process Locally Advanced Rhabdomyosarcoma Locally Advanced Rhabdomyosarcoma CL971666 CTRP Malignant Locally Advanced Rhabdomyosarcoma Locally Advanced Rhabdomyosarcoma A carcinoma that arises from the pancreas, bile ducts, gallbladder, or ampulla of Vater. C166418 Neoplastic Process Pancreatobiliary Carcinoma Pancreatobiliary Carcinoma CL971667 CTRP Malignant Pancreaticobiliary Cancer Pancreaticobiliary Carcinoma Pancreatobiliary Cancer Pancreatobiliary Carcinoma Pancreatobiliary Carcinoma A genitourinary system carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C167069 Neoplastic Process Locally Advanced Genitourinary System Carcinoma CL972059 Malignant Locally Advanced Genitourinary System Carcinoma Locally Advanced Genitourinary System Carcinoma A bladder carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C167071 Neoplastic Process Locally Advanced Bladder Carcinoma Locally Advanced Bladder Carcinoma CL972062 CTRP Malignant Locally Advanced Bladder Carcinoma Locally Advanced Bladder Carcinoma Ovarian carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C167072 Neoplastic Process Locally Advanced Ovarian Carcinoma Locally Advanced Ovarian Carcinoma CL972061 CTRP Malignant Locally Advanced Ovarian Carcinoma Locally Advanced Ovarian Carcinoma Ovarian carcinoma that is not amenable to surgical resection. C167073 Neoplastic Process Unresectable Ovarian Carcinoma Unresectable Ovarian Carcinoma CL972064 CTRP Malignant Unresectable Ovarian Carcinoma Unresectable Ovarian Carcinoma Gastric adenocarcinoma that is resistant to treatment. C167074 Neoplastic Process Refractory Gastric Adenocarcinoma Refractory Gastric Adenocarcinoma CL972063 CTRP Malignant Refractory Gastric Adenocarcinoma Refractory Gastric Adenocarcinoma Bladder carcinoma that is not amenable to surgical resection. C167075 Neoplastic Process Unresectable Bladder Carcinoma Unresectable Bladder Carcinoma CL972066 CTRP Malignant Unresectable Bladder Carcinoma Unresectable Bladder Carcinoma Triple-negative breast carcinoma that is resistant to treatment. C167076 Neoplastic Process Refractory Triple-Negative Breast Carcinoma Refractory Triple-Negative Breast Carcinoma CL972065 CTRP Malignant Refractory Triple Negative Breast Carcinoma Refractory Triple-Negative Breast Carcinoma Refractory Triple-Negative Breast Carcinoma The reemergence of diffuse astrocytoma after a period of remission. C167081 Neoplastic Process Recurrent Diffuse Astrocytoma Recurrent Diffuse Astrocytoma CL972072 CTRP Undetermined Recurrent Diffuse Astrocytoma Recurrent Diffuse Astrocytoma The reemergence of oligoastrocytoma after a period of remission. C167082 Neoplastic Process Recurrent Oligoastrocytoma CL972071 Undetermined Recurrent Oligoastrocytoma Recurrent Oligoastrocytoma A high risk pediatric acute myeloid leukemia with an extremely poor prognosis. The blasts show bright CD56 expression, dim-to-negative expression of CD45 and CD38, and lack of HLA-DR expression. This immunophenotype was named after one of the pediatric patient's initials (RAM), from Children's Oncology Group (COG) clinical trial AAML0531. C167089 Neoplastic Process Acute Myeloid Leukemia with RAM Immunophenotype CL972080 Malignant AML with RAM Immunophenotype Acute Myeloid Leukemia with RAM Immunophenotype Acute Myeloid Leukemia with RAM Immunophenotype Breast carcinoma caused by deleterious germline mutation in a gene of the BRCA family. C167189 Neoplastic Process BRCA-Associated Breast Carcinoma CL972417 Malignant BRCA-Associated Breast Carcinoma BRCA-Mutated Breast Carcinoma BRCA-Associated Breast Carcinoma Breast carcinoma caused by deleterious germline mutation in the PALB2 gene. C167193 Neoplastic Process PALB2-Associated Breast Carcinoma CL972420 Malignant PALB2-Associated Breast Carcinoma PALB2-Mutated Breast Carcinoma PALB2-Associated Breast Carcinoma Fallopian tube carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C167202 Neoplastic Process Locally Advanced Fallopian Tube Carcinoma Locally Advanced Fallopian Tube Carcinoma CL972427 CTRP Malignant Locally Advanced Fallopian Tube Carcinoma Locally Advanced Fallopian Tube Carcinoma A carcinoma that arises from the peritoneum and has metastasized to another anatomic site. C167203 Neoplastic Process Metastatic Primary Peritoneal Carcinoma Metastatic Primary Peritoneal Carcinoma CL972430 CTRP Malignant Metastatic Primary Peritoneal Carcinoma Metastatic Primary Peritoneal Carcinoma Primary peritoneal carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C167204 Neoplastic Process Locally Advanced Primary Peritoneal Carcinoma Locally Advanced Primary Peritoneal Carcinoma CL972429 CTRP Malignant Locally Advanced Primary Peritoneal Carcinoma Locally Advanced Primary Peritoneal Carcinoma Nasal cavity squamous cell carcinoma that has spread from its original site of growth to another anatomic site. C167236 Neoplastic Process Metastatic Nasal Cavity Squamous Cell Carcinoma Metastatic Nasal Cavity Squamous Cell Carcinoma CL972458 CTRP Malignant Metastatic Nasal Cavity Squamous Cell Carcinoma Metastatic Nasal Cavity Squamous Cell Carcinoma Colon carcinoma that is amenable to surgical resection. C167237 Neoplastic Process Resectable Colon Carcinoma Resectable Colon Carcinoma CL972461 CTRP Malignant Resectable Colon Carcinoma Resectable Colon Carcinoma Colon carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C167238 Neoplastic Process Advanced Colon Carcinoma Advanced Colon Carcinoma CL972460 CTRP Malignant Advanced Colon Carcinoma Advanced Colon Carcinoma Prostate carcinoma that is resistant to treatment. C167255 Neoplastic Process Refractory Prostate Carcinoma Refractory Prostate Carcinoma CL972243 CTRP Malignant Refractory Prostate Carcinoma Refractory Prostate Carcinoma Prostate adenocarcinoma that is resistant to treatment. C167256 Neoplastic Process Refractory Prostate Adenocarcinoma Refractory Prostate Adenocarcinoma CL972246 CTRP Malignant Refractory Prostate Adenocarcinoma Refractory Prostate Adenocarcinoma A malignant female reproductive system neoplasm that has spread extensively from its original site of growth to other anatomic sites or is no longer responding to treatment. C167260 Neoplastic Process Advanced Malignant Female Reproductive System Neoplasm Advanced Malignant Female Reproductive System Neoplasm CL972250 CTRP Malignant Advanced Malignant Female Reproductive System Neoplasm Advanced Malignant Female Reproductive System Neoplasm A squamous cell carcinoma that arises from the nasopharynx. C167265 Neoplastic Process Nasopharyngeal Squamous Cell Carcinoma Nasopharyngeal Squamous Cell Carcinoma CL972253 CTRP Malignant Nasopharyngeal Squamous Cell Carcinoma Nasopharyngeal Squamous Cell Carcinoma The reemergence of squamous cell carcinoma of the nasopharynx after a period of remission. C167266 Neoplastic Process Recurrent Nasopharyngeal Squamous Cell Carcinoma CL972252 Malignant Recurrent Nasopharyngeal Squamous Cell Carcinoma Recurrent Nasopharyngeal Squamous Cell Carcinoma A pancreatic neuroendocrine tumor that has spread from its original site of growth to nearby tissues or lymph nodes. C167324 Neoplastic Process Locally Advanced Pancreatic Neuroendocrine Tumor Locally Advanced Pancreatic Neuroendocrine Tumor CL972304 CTRP Malignant Locally Advanced Pancreatic Neuroendocrine Tumor Locally Advanced Pancreatic Neuroendocrine Tumor A neuroendocrine tumor that arises from the jejunum, ileum, proximal colon, or appendix. C167327 Neoplastic Process Midgut Neuroendocrine Tumor Midgut Neuroendocrine Tumor CL972306 CTRP Undetermined Midgut Neuroendocrine Tumor Midgut Neuroendocrine Tumor A neuroendocrine tumor grade 2 that arises from the jejunum, ileum, proximal colon, or appendix. C167328 Neoplastic Process Midgut Neuroendocrine Tumor G2 Midgut Neuroendocrine Tumor G2 CL972305 CTRP mCode Undetermined Malignant carcinoid tumor of the midgut, unspecified Midgut Neuroendocrine Tumor G2 Midgut Neuroendocrine Tumor G2 A midgut neuroendocrine tumor that has spread from its original site of growth to another anatomic site. C167329 Neoplastic Process Metastatic Midgut Neuroendocrine Tumor Metastatic Midgut Neuroendocrine Tumor CL972308 CTRP Malignant Metastatic Midgut Neuroendocrine Tumor Metastatic Midgut Neuroendocrine Tumor A midgut neuroendocrine tumor that has spread from its original site of growth to nearby tissues or lymph nodes. C167330 Neoplastic Process Locally Advanced Midgut Neuroendocrine Tumor Locally Advanced Midgut Neuroendocrine Tumor CL972307 CTRP Malignant Locally Advanced Midgut Neuroendocrine Tumor Locally Advanced Midgut Neuroendocrine Tumor A midgut neuroendocrine tumor that is not amenable to surgical resection. C167331 Neoplastic Process Unresectable Midgut Neuroendocrine Tumor Unresectable Midgut Neuroendocrine Tumor CL972310 CTRP Malignant Unresectable Midgut Neuroendocrine Tumor Unresectable Midgut Neuroendocrine Tumor A neuroendocrine neoplasm that has spread from its original site of growth to nearby tissues or lymph nodes. C167332 Neoplastic Process Locally Advanced Neuroendocrine Neoplasm CL972309 Malignant Locally Advanced Neuroendocrine Neoplasm Locally Advanced Neuroendocrine Neoplasm A neuroendocrine tumor that has spread from its original site of growth to nearby tissues or lymph nodes. C167333 Neoplastic Process Locally Advanced Neuroendocrine Tumor CL972312 Malignant Locally Advanced Carcinoid Tumor Locally Advanced Neuroendocrine Tumor Locally Advanced Well Differentiated Neuroendocrine Neoplasm Locally Advanced Neuroendocrine Tumor IDH-mutant astrocytoma characterized by the presence of necrosis and/or microvascular proliferation or homozygous deletion of CDKN2A and/or CDKN2B genes. The term glioblastoma no longer applies to central nervous system WHO grade 4 IDH-mutant astrocytomas. (WHO 2021) C167335 Neoplastic Process Astrocytoma, IDH-Mutant, Grade 4 CL972314 GDC Malignant 9445/3 Glioblastoma, IDH-mutant Astrocytoma, IDH-Mutant, Grade 4 Astrocytoma, IDH-Mutant, Grade IV Glioblastoma, IDH-Mutant Glioblastoma, IDH-mutant Astrocytoma, IDH-Mutant, Grade 4 Hepatocellular carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C167336 Neoplastic Process Advanced Hepatocellular Carcinoma Advanced Hepatocellular Carcinoma CL972313 CTRP Malignant Advanced Hepatocellular Carcinoma Advanced Hepatocellular Carcinoma A bladder carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C167338 Neoplastic Process Advanced Bladder Carcinoma Advanced Bladder Carcinoma CL972315 CTRP Malignant Advanced Bladder Carcinoma Advanced Bladder Carcinoma An adnexal carcinoma with ductal/glandular differentiation lacking specific histological features that would allow further classification. (WHO 2018) C167341 Neoplastic Process Adnexal Adenocarcinoma, Not Otherwise Specified CL972317 Malignant Adnexal adenocarcinoma, NOS Adnexal Adenocarcinoma, NOS Adnexal Adenocarcinoma, Not Otherwise Specified Adnexal Adenocarcinoma, Not Otherwise Specified A benign adnexal neoplasm with histological features of both spiradenoma and cylindroma in a single nodular lesion. C167342 Neoplastic Process Spiradenocylindroma CL972320 Benign Spiradenocylindroma Spiradenocylindroma A carcinoma that arises in a spiradenocylindroma. C167344 Neoplastic Process Spiradenocylindrocarcinoma CL972319 Malignant Carcinoma ex Spiradenocylindroma Malignant Spiradenocylindroma Spiradenocylindrocarcinoma Spiradenocylindrocarcinoma A rare malignant skin neoplasm that arises from a benign mixed tumor of the skin (chondroid syringoma). C167346 Neoplastic Process Malignant Mixed Tumor of the Skin C1321781 Malignant Cutaneous Malignant Mixed Tumor Malignant Chondroid Syringoma Malignant Mixed Tumor of the Skin Malignant Mixed Tumor of the Skin Nasopharyngeal squamous cell carcinoma that has spread to nearby tissues or lymph nodes. C167352 Neoplastic Process Locally Advanced Nasopharyngeal Squamous Cell Carcinoma Locally Advanced Nasopharyngeal Squamous Cell Carcinoma CL972327 CTRP Malignant Locally Advanced Nasopharyngeal Squamous Cell Carcinoma Locally Advanced Nasopharyngeal Squamous Cell Carcinoma Anal carcinoma with minimal stromal invasion. C167354 Neoplastic Process Microinvasive Anal Carcinoma Microinvasive Anal Carcinoma CL972329 CTRP Malignant Microinvasive Anal Carcinoma Microinvasive Anal Carcinoma A rare, low-grade sweat gland carcinoma with neuroendocrine differentiation. It usually arises on the eyelids and periorbital skin. It affects mostly older individuals. Women are affected more frequently than men. Morphologically, it is characterized by well-demarcated nodules with cystic, papillary, or cribriform architectural patterns. The neoplastic cells are small to intermediate polygonal to round cells. Small amounts of intracellular or extracellular mucin are present. In some cases, this carcinoma is a precursor of mucinous carcinoma. C167364 Neoplastic Process Endocrine Mucin-Producing Sweat Gland Carcinoma CL978748 Malignant Cutaneous Analogue of Papillary Solid Carcinoma of the Breast EMPSGC Endocrine Mucin-Producing Sweat Gland Carcinoma Endocrine Mucin-Producing Sweat Gland Carcinoma A sweat gland carcinoma usually arising from a pre-existing syringocystadenoma papilliferum. C167365 Neoplastic Process Syringocystadenocarcinoma Papilliferum CL972337 Malignant Syringocystadenocarcinoma Papilliferum Syringocystadenocarcinoma Papilliferum A rare indolent adnexal carcinoma with a cribriform pattern. C167366 Neoplastic Process Adnexal Cribriform Carcinoma CL972339 Malignant Adnexal Cribriform Carcinoma Adnexal Solid-Cribriform Carcinoma Primary Cutaneous Cribriform Carcinoma Adnexal Cribriform Carcinoma A rare adnexal carcinoma that is histopathologically identical to homologous lesions in the salivary gland and breast. (WHO 2018) C167368 Neoplastic Process Adnexal Secretory Carcinoma CL972340 Malignant Adnexal Secretory Carcinoma Mammary-Type Secretory Carcinoma of the Skin Primary Cutaneous Mammary Analogue Secretory Carcinoma Adnexal Secretory Carcinoma A rare aggressive adnexal carcinoma preferentially affecting the eyelid and histopathologically resembling a metastatic lobular carcinoma of the breast and/or some adenocarcinomas arising in the gastrointestinal tract. (WHO 2018) C167369 Neoplastic Process Signet Ring Cell/Histiocytoid Carcinoma CL978753 Malignant Signet Ring Cell/Histiocytoid Carcinoma Signet-Ring Cell/Histiocytoid Carcinoma Signet=Ring Cell/Histiocytoid Carcinoma Signet Ring Cell/Histiocytoid Carcinoma A benign skin neoplasm composed exclusively of myoepithelial cells. C167370 Neoplastic Process Skin Myoepithelioma CL972342 Benign Cutaneous Myoepithelioma Skin Myoepithelioma Skin Myoepithelioma Epithelioid sarcoma that has spread from its original site of growth to nearby tissues or lymph nodes. C167378 Neoplastic Process Locally Advanced Epithelioid Sarcoma Locally Advanced Epithelioid Sarcoma CL972348 CTRP Malignant Locally Advanced Epithelioid Sarcoma Locally Advanced Epithelioid Sarcoma Epithelioid sarcoma that is not amenable to surgical resection. C167379 Neoplastic Process Unresectable Epithelioid Sarcoma Unresectable Epithelioid Sarcoma CL972347 CTRP Malignant Unresectable Epithelioid Sarcoma Unresectable Epithelioid Sarcoma Epithelioid sarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C167380 Neoplastic Process Advanced Epithelioid Sarcoma Advanced Epithelioid Sarcoma CL972567 CTRP Malignant Advanced Epithelioid Sarcoma Advanced Epithelioid Sarcoma A rare biphasic malignant neoplasm with dual differentiation towards the specialized follicular stroma and germinative follicular cells, which can be strikingly atypical. (WHO 2018) C167381 Neoplastic Process Trichoblastic Carcinoma CL540823 Malignant Trichoblastic Carcinoma Trichoblastic Carcinoma A rare biphasic follicular neoplasm consisting of a malignant epithelial component resembling follicular germinative cells closely associated with a malignant stromal component differentiating towards specific follicular mesenchyme. (WHO 2018) C167382 Neoplastic Process Trichoblastic Carcinosarcoma CL972569 Malignant Trichoblastic Carcinosarcoma Trichoblastic Carcinosarcoma Fallopian tube carcinoma that has spread extensively from its original site of growth to other anatomic sites or is no longer responding to treatment. C167395 Neoplastic Process Advanced Fallopian Tube Carcinoma Advanced Fallopian Tube Carcinoma CL972580 CTRP Malignant Advanced Fallopian Tube Carcinoma Advanced Fallopian Tube Carcinoma Primary peritoneal carcinoma that has spread extensively from its original site of growth to other anatomic sites or is no longer responding to treatment. C167396 Neoplastic Process Advanced Primary Peritoneal Carcinoma Advanced Primary Peritoneal Carcinoma CL972579 CTRP Malignant Advanced Primary Peritoneal Carcinoma Advanced Primary Peritoneal Carcinoma C167448 Clinical Attribute Family Surgical History CL972606 Family Surgical History Family Surgical History A history of a first-degree relative with heart disease. C167449 Group Attribute Family History of Heart Disease CL982519 ACC/AHA The presence of heart disease in a first-degree family member. Family History of Heart Disease Family History of Heart Disease A history of a first-degree relative that was diagnosed with cardiomyopathy. C168016 Group Attribute Family History of Cardiomyopathy C1272241 ACC/AHA A disease of the heart muscle or myocardium proper. Cardiomyopathy Family History of Cardiomyopathy Family History of Cardiomyopathy A history of a first-degree relative with congenital heart disease. C168017 Group Attribute Family History of Congenital Heart Disease C0455683 ACC/AHA Having a first-degree or first- and second- degree relative with a history of CHD. Family History of CHD Family History of Congenital Heart Disease Family history of CHD Family History of Congenital Heart Disease A history of a first-degree relative that was diagnosed with prolongation of the heart rate corrected QT interval as calculated by the Bazett formula. C168018 Group Attribute Family History of Long QTc CL972618 ACC/AHA Disorder characterized by prolongation of the heart rate corrected QT interval that predisposes to ventricular arrhythmias and sudden death. As calculated by the Bazett formula. Family History of Long QTc Long QTc Family History of Long QTc A history of a first-degree relative whose death was attributed to sudden arrythmia death syndrome (SADS). C168019 Group Attribute Family History of Sudden Arrythmia Death Syndrome CL972949 ACC/AHA Unexpected sudden cardiac death secondary to a genetic condition that lowers the threshold for lethal arrhythmia. This includes Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, long QT syndrome, short QT syndrome, Timothy syndrome, and Wolff- Parkinson-White syndrome. Family History of SADS Family History of Sudden Arrhythmic Death Syndrome Family History of Sudden Arrythmia Death Syndrome SADS Family History of Sudden Arrythmia Death Syndrome A history of a first-degree relative that has had coronary artery bypass graft surgery. C168020 Clinical Attribute Family History of Coronary Artery Bypass Graft Surgery CL972619 ACC/AHA A procedure performed to bypass partially or completely occluded coronary arteries with veins and/or arteries harvested from elsewhere in the body, thereby improving the blood supply to the coronary circulation supplying the myocardium (heart muscle). CABG Family History of CABG Family History of Coronary Artery Bypass Graft Surgery Family History of Coronary Artery Bypass Graft Surgery A history of a first-degree relative that has had a percutaneous coronary intervention. C168021 Clinical Attribute Family History of Percutaneous Coronary Intervention CL972621 ACC/AHA PCI is the placement of an angioplasty guide wire, balloon, or other device (e.g., stent, atherectomy, brachytherapy, or thrombectomy catheter) into a native coronary artery or CABG for the purpose of mechanical coronary revascularization. The assessment of coronary lesion severity via intravascular ultrasound, coronary flow reserve, or fractional flow reserve is not considered to be a PCI procedure. Family History of PCI Family History of Percutaneous Coronary Intervention PCI Family History of Percutaneous Coronary Intervention Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders. C16809 Diagnostic Procedure Magnetic Resonance Imaging Magnetic Resonance Imaging C0024485 CDISC CTRP DIPG/DMG FDA GDC MRCT-Ctr OORO PCDC mCode A procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures of areas inside the body. These pictures can show the difference between normal and diseased tissue. NMRI makes better images of organs and soft tissue than other scanning techniques, such as computed tomography (CT) or x-ray. NMRI is especially useful for imaging the brain, the spine, the soft tissue of joints, and the inside of bones. A way to take pictures of the inside of a person’s body with a machine that uses strong magnets and radio waves. (https://mrctcenter.org/glossaryterm/magnetic-resonance-imaging-mri/) Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders. Magnetic_Resonance_Imaging MRI MR MR Imaging MRI MRI Scan MRIs Magnetic Resonance Magnetic Resonance Imaging Magnetic Resonance Imaging (MRI) Magnetic Resonance Imaging Scan Magnetic resonance imaging (procedure) Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance NMR Imaging NMRI Nuclear Magnetic Resonance Imaging Structural MRI magnetic resonance imaging nuclear magnetic resonance imaging sMRI Magnetic Resonance Imaging An indication that the patient does not consume caffeine on a regular basis. C168123 Finding Caffeine Not Routinely Consumed CL972965 ACC/AHA No routine caffeine, or infrequent caffeine, intake. Caffeine Not Routinely Consumed No Caffeine Not Routinely Consumed An indication that the patient consumes caffeine on a regular basis. C168124 Finding Caffeine Routinely Consumed C4062719 ACC/AHA Intake of caffeine routinely occurring as frequently as at least every other day. Caffeine Routinely Consumed Caffeine intake Caffeine Routinely Consumed A type of radiography used specifically to examine breast tissue. The procedure utilizes a low-dose of x-rays or radiation to generate an image. A mammography exam or mammogram, is used as a screening tool to detect early breast cancer in women experiencing no symptoms and to detect and diagnose breast disease. C16818 Diagnostic Procedure Mammography Mammography C0024671 CDISC CTRP A type of radiography used specifically to examine breast tissue. The procedure utilizes a low-dose of x-rays or radiation to generate an image. The use of film or a computer to create a picture of the breast. Mammography MAMMOGRAPHY MG Mammography mammography Mammography A history of a first-degree relative that has had an arrhythmia. C168194 Group Attribute Family History of Arrhythmia CL972727 ACC/AHA An electrocardiographic finding of an atypical cardiac rhythm resulting from a cardiac pathologic process. Arrhythmia Family History of Arrhythmia Family History of Arrhythmia A history of a first-degree relative that has had a chronic disease. C168195 Group Attribute Family History of Chronic Disease CL972730 ACC/AHA Family History of Chronic Disease Other chronic diseases Family History of Chronic Disease A history of a first-degree relative with Ehlers-Danlos syndrome. C168200 Group Attribute Family History of Ehlers-Danlos Syndrome CL972950 ACC/AHA A group of inherited connective tissue disorders characterized by loose and fragile skin and joint hypermobility. Ehlers-Danlos syndrome Family History of Ehlers-Danlos Syndrome Family History of Ehlers-Danlos Syndrome A history of a first-degree relative that has hyperlipidemia. C168202 Group Attribute Family History of Hyperlipidemia CL528345 ACC/AHA Elevated levels of lipids in the blood. Family History of Hyperlipidemia Hyperlipidemia Family History of Hyperlipidemia A history of a first-degree relative that has hypertension. C168203 Group Attribute Family History of Hypertension C0455405 ACC/AHA Pathological increase in blood pressure; a repeatedly elevated blood pressure exceeding 140/90 mm Hg. Family History of Hypertension Hypertension Family History of Hypertension A history of a first-degree relative with Marfan syndrome. C168205 Group Attribute Family History of Marfan Syndrome C4040152 ACC/AHA A genetic syndrome inherited as an autosomal dominant trait. It is caused by mutations in the FBN1 gene. It is characterized by tall stature, elongated extremities, mitral valve prolapse, aortic dilatation, aortic dissection, and subluxation of the lens. Diagnosis is made based on the 2010 Revised Ghent Nosology for Marfan syndrome Family History of Marfan Syndrome Marfan syndrome Family History of Marfan Syndrome A history of a first-degree relative that has had a myocardial infarction. C168206 Group Attribute Family History of Myocardial Infarction C0455406 ACC/AHA Clinical syndrome where there is evidence of myocardial necrosis in a clinical setting consistent with myocardial ischemia. Family History of MI Family History of Myocardial Infarction MI Family History of Myocardial Infarction A history of a first-degree relative that has had a stroke. C168208 Group Attribute Family History of Stroke CL972936 ACC/AHA An acute episode of focal or global neurological dysfunction caused by presumed brain, spinal cord, or retinal vascular injury as a result of hemorrhage or infarction but with insufficient information to allow categorization as ischemic or hemorrhagic. Family History of Stroke Stroke Family History of Stroke A history of a first-degree relative whose death was attributed to sudden infant death syndrome (SIDS). C168209 Group Attribute Family History of Sudden Infant Death Syndrome C0455454 ACC/AHA Unexpected death in infancy which remains unexplained following autopsy, review of the medical history, and investigation of the death circumstances and death scene. Family History of SIDS Family History of Sudden Infant Death Syndrome Sudden death/SIDS Family History of Sudden Infant Death Syndrome A history of a first-degree relative that has had syncope. C168210 Group Attribute Family History of Syncope C2315811 ACC/AHA Sudden loss of consciousness with spontaneous recovery. Family History of Syncope Syncope Family History of Syncope A history of any allergic reaction that the patient has had. C168250 Clinical Attribute History of Allergic Reaction CL972756 ACC/AHA A hypersensitivity reaction triggered by exposure to a previously encountered foreign substance to which the individual has formed antibodies. Allergic reaction History of Allergic Reaction History of Allergic Reaction An abnormality of cardiac structure or function was present at birth. C168251 Clinical Attribute History of Congenital Heart Disease CL972758 ACC/AHA Any abnormality of cardiac structure or function present at birth. History of CHD History of Congenital Heart Disease History of Congenital Heart Disease A history of the medication that the patient has taken. C168253 Clinical Attribute History of Medication CL972932 ACC/AHA A drug or substance used to treat a medical condition. History of Medication Medications History of Medication A history of a surgery not involving the heart. C168254 Clinical Attribute History of Non-Cardiac Surgery CL972759 ACC/AHA Surgeries or interventions performed in the patient that do not involve the heart, but are commonly seen in patients who have complex congenital heart disease. History of Non-Cardiac Surgery Noncardiac Surgical History History of Non-Cardiac Surgery An indication that the patient has a history of a non-cardiac surgery other than those listed. C168255 Finding History of Other Non-Cardiac Surgery CL972974 ACC/AHA History of Other Non-Cardiac Surgery Other History of Other Non-Cardiac Surgery A description of an individual's current and past use of illicit drugs. C168265 Clinical Attribute Illicit Drug Use History CL972979 ACC/AHA The nonmedical use of chemicals that are prohibited by international law. Illicit Drug Use Illicit Drug Use History Illicit Drug Use History The daily caloric intake is deficient. C168266 Finding Inadequate Daily Caloric Intake CL972766 ACC/AHA Deficient caloric intake per day. Inadequate Daily Caloric Intake Inadequate caloric intake Inadequate Daily Caloric Intake The daily fluid intake is deficient. C168267 Finding Inadequate Daily Fluid Intake CL972768 ACC/AHA Qualitative state of not being sufficient for a specific purpose. Inadequate Inadequate Daily Fluid Intake Inadequate Daily Fluid Intake The daily salt intake is deficient. C168268 Finding Inadequate Daily Salt Intake CL972767 ACC/AHA Qualitative state of not being sufficient for a specific purpose. Inadequate Inadequate Daily Salt Intake Inadequate Daily Salt Intake An indication that the patient has a family history of rheumatic fever or rheumatic heart disease. C168294 Finding Known Family History of Rheumatic Fever or Rheumatic Heart Disease CL972789 ACC/AHA The presence of a first-degree family member with a history of rheumatic fever or rheumatic heart disease. Family history of rheumatic fever/ rheumatic heart disease Known Family History of Rheumatic Fever or Rheumatic Heart Disease Known Family History of Rheumatic Fever or Rheumatic Heart Disease An indication that the patient has a history of alcohol use. C168296 Finding Known History of Alcohol Use CL972791 ACC/AHA Known History of Alcohol Use Yes Known History of Alcohol Use An indication that the patient has a history of an allergic reaction to fish. C168297 Finding Known History of Allergy to Fish CL973000 ACC/AHA Fish [allergy] Known History of Allergy to Fish Known History of Allergy to Fish An indication that the patient has a history of an allergic reaction to medication. C168298 Finding Known History of Allergy to Medication CL973020 ACC/AHA Known History of Allergy to Medication Medication [allergy] Known History of Allergy to Medication An indication that the patient has a history of congenital heart disease. C168299 Finding Known History of Congenital Heart Disease CL972794 ACC/AHA Known History of Congenital Heart Disease Yes Known History of Congenital Heart Disease An indication that the patient has a history of illicit drug use. C168301 Finding Known History of Illicit Drug Use CL972796 ACC/AHA Known History of Illicit Drug Use Yes Known History of Illicit Drug Use An indication that the patient has a history of an allergic reaction to an allergen other than those listed. C168304 Finding Known History of Other Allergy CL972985 ACC/AHA Known History of Other Allergy Others [allergy] Known History of Other Allergy An indication that the patient does not have a history of congenital heart disease. C168344 Finding No History of Congenital Heart Disease CL972658 ACC/AHA No No History of Congenital Heart Disease No History of Congenital Heart Disease An indication that the patient does not have a history of a surgery not involving the heart. C168349 Finding No History of Non-Cardiac Surgery CL972664 ACC/AHA No No History of Non-Cardiac Surgery No History of Non-Cardiac Surgery An indication that the patient does not have a history of alcohol use. C168352 Finding No Known History of Alcohol Use CL972665 ACC/AHA No No Known History of Alcohol Use No Known History of Alcohol Use An indication that the patient does not have a history of an allergic reaction. C168353 Finding No Known History of Allergy CL972668 ACC/AHA No Known History of Allergy None [allergy] No Known History of Allergy An indication that the patient does not have a history of illicit drug use. C168354 Finding No Known History of Illicit Drug Use CL972667 ACC/AHA No No Known History of Illicit Drug Use No Known History of Illicit Drug Use A history of a first-degree relative with diagnosed with a heart disease other than those listed. C168373 Finding Other Family History of Heart Disease CL972676 ACC/AHA Other Family History of Heart Disease Others Other Family History of Heart Disease An indication that the patient has a unknown family history of cardiovascular disease or cardiovascular disease risk factors. C168463 Finding Unknown Family History Cardiovascular Disease or Cardiovascular Disease Risk Factors CL972825 ACC/AHA Unknown Unknown Family History Cardiovascular Disease or Cardiovascular Disease Risk Factors Unknown Family History Cardiovascular Disease or Cardiovascular Disease Risk Factors An indication that it is unknown whether the patient has a history of alcohol use. C168464 Finding Unknown History of Alcohol Use CL972824 ACC/AHA Unknown Unknown History of Alcohol Use Unknown History of Alcohol Use An indication that it is unknown whether the patient has a history of an allergic reaction. C168465 Finding Unknown History of Allergy CL972827 ACC/AHA Unknown History of Allergy Unknown [allergy] Unknown History of Allergy An indication that it is unknown whether the patient has a history of congenital heart disease. C168466 Finding Unknown History of Congenital Heart Disease CL972826 ACC/AHA Unknown Unknown History of Congenital Heart Disease Unknown History of Congenital Heart Disease An indication that it is unknown whether the patient has a history of illicit drug use. C168468 Finding Unknown History of Illicit Drug Use CL972828 ACC/AHA Unknown Unknown History of Illicit Drug Use Unknown History of Illicit Drug Use An indication that it is unknown whether the patient has a history of a surgery not involving the heart. C168472 Finding Unknown History of Non-Cardiac Surgery CL972832 ACC/AHA Unknown Unknown History of Non-Cardiac Surgery Unknown History of Non-Cardiac Surgery A history of a first-degree relative with cardiovascular disease or cardiovascular disease risk factors. C168492 Clinical Attribute Family History of Cardiovascular Disease or Cardiovascular Disease Risk Factors CL972845 ACC/AHA Family History of Cardiovascular Disease or Cardiovascular Disease Risk Factors Family History of Cardiovascular Disease or Cardiovascular Disease Risk Factors A breast adenocarcinoma that is negative for the expression of the HER2 receptor. C168519 Neoplastic Process HER2 Negative Breast Carcinoma HER2-Negative Breast Carcinoma CL972848 CTRP Malignant HER2 Negative Breast Adenocarcinoma HER2 Negative Breast Carcinoma HER2-Negative Breast Carcinoma HER2-Negative Breast Carcinoma Skin squamous cell carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C168542 Neoplastic Process Advanced Skin Squamous Cell Carcinoma Advanced Skin Squamous Cell Carcinoma CL972871 CTRP Malignant Advanced Skin Squamous Cell Carcinoma Advanced Skin Squamous Cell Carcinoma Thyroid gland medullary carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C168543 Neoplastic Process Locally Advanced Thyroid Gland Medullary Carcinoma Locally Advanced Thyroid Gland Medullary Carcinoma CL972870 CTRP Malignant Locally Advanced Thyroid Gland Medullary Carcinoma Locally Advanced Thyroid Gland Medullary Carcinoma Pleural malignant mesothelioma that has spread from its original site of growth to another anatomic site. C168545 Neoplastic Process Metastatic Pleural Malignant Mesothelioma Metastatic Pleural Malignant Mesothelioma CL972872 CTRP Malignant Metastatic Pleural Malignant Mesothelioma Metastatic Pleural Malignant Mesothelioma Differentiated thyroid gland carcinoma that is not amenable to surgical resection. C168572 Neoplastic Process Unresectable Differentiated Thyroid Gland Carcinoma Unresectable Differentiated Thyroid Gland Carcinoma CL972897 CTRP Malignant Unresectable Differentiated Thyroid Gland Carcinoma Unresectable Differentiated Thyroid Gland Carcinoma A glioma that is amenable to surgical resection. C168573 Neoplastic Process Resectable Glioma Resectable Glioma CL972900 CTRP Undetermined Resectable Glioma Resectable Glioma Metastatic pancreatic adenocarcinoma that is resistant to treatment. C168583 Neoplastic Process Refractory Metastatic Pancreatic Adenocarcinoma Refractory Metastatic Pancreatic Adenocarcinoma CL972909 CTRP Malignant Refractory Metastatic Pancreatic Adenocarcinoma Refractory Metastatic Pancreatic Adenocarcinoma A rare benign pilar tumor with numerous intratumoral pigmented dendritic melanocytes. It typically affects elderly men. The most common location is the head and neck, followed by the trunk and the limbs. It manifests as a small, pigmented, purple or brownish-black papule or nodule. (WHO 2018) C168592 Neoplastic Process Melanocytic Matricoma CL978733 Benign Melanocytic Matricoma Melanocytic Matricoma Burkitt lymphoma that affects the skin. C168651 Neoplastic Process Cutaneous Burkitt Lymphoma CL1378745 Malignant Cutaneous Burkitt Lymphoma Cutaneous Burkitt Lymphoma Carcinoma that has spread diffusely to the gastrointestinal system. C168666 Neoplastic Process Gastrointestinal Carcinomatosis Gastrointestinal Carcinomatosis CL1378758 CTRP Malignant Gastrointestinal Carcinomatosis Gastrointestinal Carcinomatosis High-grade sarcoma that has spread from its original site of growth to another anatomic site. C168667 Neoplastic Process Metastatic High Grade Sarcoma Metastatic High Grade Sarcoma CL1378761 CTRP Malignant Metastatic High Grade Sarcoma Metastatic High-Grade Sarcoma Metastatic High Grade Sarcoma High-grade sarcoma that has spread from its original site of growth to nearby tissues or lymph nodes. C168668 Neoplastic Process Locally Advanced High Grade Sarcoma Locally Advanced High Grade Sarcoma CL1378760 CTRP Malignant Locally Advanced High Grade Sarcoma Locally Advanced High-Grade Sarcoma Locally Advanced High Grade Sarcoma A malignant neoplasm that has spread to the digestive system from another anatomic site. C168669 Neoplastic Process Metastatic Malignant Neoplasm in the Digestive System CL1378755 mCode Malignant Metastatic Malignant Neoplasm in the Digestive System Secondary malignant neoplasm of unspecified digestive organ Metastatic Malignant Neoplasm in the Digestive System Myxofibrosarcoma that has spread from its original site of growth to another anatomic site. C168670 Neoplastic Process Metastatic Myxofibrosarcoma Metastatic Myxofibrosarcoma CL1378754 CTRP Malignant Metastatic Myxofibrosarcoma Metastatic Myxofibrosarcoma Myxofibrosarcoma that has spread from its original site of growth to nearby tissues or lymph nodes. C168671 Neoplastic Process Locally Advanced Myxofibrosarcoma Locally Advanced Myxofibrosarcoma CL1378757 CTRP Malignant Locally Advanced Myxofibrosarcoma Locally Advanced Myxofibrosarcoma A benign or malignant neoplasm that affects the thoracic region of the spine. C168672 Neoplastic Process Thoracic Spine Neoplasm Thoracic Spine Neoplasm CL1378756 CTRP Undetermined Thoracic Spine Neoplasm Thoracic Spine Neoplasm A benign or malignant neoplasm that affects the lumbar region of the spine. C168673 Neoplastic Process Lumbar Spine Neoplasm Lumbar Spine Neoplasm CL1378767 CTRP Undetermined Lumbar Spine Neoplasm Lumbar Spine Neoplasm A benign or malignant neoplasm that affects the sacral region of the spine. C168674 Neoplastic Process Sacral Spine Neoplasm Sacral Spine Neoplasm CL1378766 CTRP Undetermined Sacral Spine Neoplasm Sacral Spine Neoplasm A benign or malignant neoplasm that affects the vertebrae, vertebral canal, and/or spinal cord. C168693 Neoplastic Process Spinal Neoplasm CL1378624 Undetermined Spinal Neoplasm Spinal Neoplasm A benign or malignant neoplasm that affects the lumbosacral region of the spine. C168694 Neoplastic Process Lumbosacral Spine Neoplasm CL1378623 Undetermined Lumbosacral Spine Neoplasm Lumbosacral Spine Neoplasm A benign or malignant neoplasm that affects the neck region of the spine. C168698 Neoplastic Process Cervical Spine Neoplasm CL1378631 Undetermined Cervical Spine Neoplasm Cervical Spine Neoplasm A liposarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C168701 Neoplastic Process Advanced Liposarcoma CL1378629 Malignant Advanced Liposarcoma Advanced Liposarcoma A malignant peripheral nerve sheath tumor that has spread extensively to other anatomic sites or is no longer responding to treatment. C168714 Neoplastic Process Advanced Malignant Peripheral Nerve Sheath Tumor Advanced Malignant Peripheral Nerve Sheath Tumor CL1378642 CTRP Malignant Advanced Malignant Peripheral Nerve Sheath Tumor Advanced Malignant Peripheral Nerve Sheath Tumor A dedifferentiated liposarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C168715 Neoplastic Process Advanced Dedifferentiated Liposarcoma Advanced Dedifferentiated Liposarcoma CL1378644 CTRP Malignant Advanced Dedifferentiated Liposarcoma Advanced Dedifferentiated Liposarcoma Fibrosarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C168716 Neoplastic Process Advanced Fibrosarcoma Advanced Fibrosarcoma CL1378643 CTRP Malignant Advanced Fibrosarcoma Advanced Fibrosarcoma A fibrosarcoma that is not amenable to surgical resection. C168717 Neoplastic Process Unresectable Fibrosarcoma Unresectable Fibrosarcoma CL1378639 CTRP Malignant Unresectable Fibrosarcoma Unresectable Fibrosarcoma An angiosarcoma that is not amenable to surgical resection. C168718 Neoplastic Process Unresectable Angiosarcoma Unresectable Angiosarcoma CL1378638 CTRP Malignant Unresectable Angiosarcoma Unresectable Angiosarcoma A myxoid liposarcoma that is not amenable to surgical resection. C168719 Neoplastic Process Unresectable Myxoid Liposarcoma Unresectable Myxoid Liposarcoma CL1378641 CTRP Malignant Unresectable Myxoid Liposarcoma Unresectable Myxoid Liposarcoma An angiosarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C168720 Neoplastic Process Advanced Angiosarcoma Advanced Angiosarcoma CL1378640 CTRP Malignant Advanced Angiosarcoma Advanced Angiosarcoma A soft tissue leiomyosarcoma that has spread from the original site of growth to another anatomic site. C168725 Neoplastic Process Metastatic Soft Tissue Leiomyosarcoma Metastatic Soft Tissue Leiomyosarcoma CL1378646 CTRP Malignant Metastatic Soft Tissue Leiomyosarcoma Metastatic Soft Tissue Leiomyosarcoma A soft tissue leiomyosarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C168727 Neoplastic Process Advanced Soft Tissue Leiomyosarcoma Advanced Soft Tissue Leiomyosarcoma CL1378645 CTRP Malignant Advanced Soft Tissue Leiomyosarcoma Advanced Soft Tissue Leiomyosarcoma A soft tissue leiomyosarcoma that is not amenable to surgical resection. C168728 Neoplastic Process Unresectable Soft Tissue Leiomyosarcoma Unresectable Soft Tissue Leiomyosarcoma CL1378647 CTRP Malignant Unresectable Soft Tissue Leiomyosarcoma Unresectable Soft Tissue Leiomyosarcoma Myelodysplastic syndrome caused by inherited damaging mutations in cancer susceptibility genes. C168742 Neoplastic Process Hereditary Myelodysplastic Syndrome CL1378661 Malignant Familial MDS Familial Myelodysplastic Syndrome Hereditary MDS Hereditary Myelodysplastic Syndrome Myelodysplastic Syndrome with Genetic Predisposition Hereditary Myelodysplastic Syndrome A familial myelodysplastic syndrome caused by inherited mutations in the SAMD9 gene. C168746 Neoplastic Process SAMD9-Associated Hereditary Myelodysplastic Syndrome CL1378658 Malignant SAMD9- Associated Familial MDS SAMD9-Associated Familial Myelodysplastic Syndrome SAMD9-Associated Hereditary Myelodysplastic Syndrome SAMD9-Associated Hereditary Myelodysplastic Syndrome A familial myelodysplastic syndrome caused by inherited mutations in the SAMD9L gene. C168747 Neoplastic Process SAMD9L-Associated Hereditary Myelodysplastic Syndrome CL1378657 Malignant SAMD9L-Associated Familial MDS SAMD9L-Associated Familial Myelodysplastic Syndrome SAMD9L-Associated Hereditary Myelodysplastic Syndrome SAMD9L-Associated Hereditary Myelodysplastic Syndrome A HER2-negative breast adenocarcinoma that has spread to another anatomic site. C168777 Neoplastic Process Metastatic HER2-Negative Breast Carcinoma CL1378678 Malignant Metastatic HER2 Negative Breast Adenocarcinoma Metastatic HER2 Negative Breast Carcinoma Metastatic HER2-Negative Breast Carcinoma Metastatic HER2-Negative Breast Carcinoma The reemergence of follicular helper T-cell lymphoma after a period of remission. C168778 Neoplastic Process Recurrent Nodal Peripheral T-Cell Lymphoma with TFH Phenotype Recurrent Follicular Helper T-Cell Lymphoma CL1378677 CTRP Malignant Recurrent Follicular Helper T-Cell Lymphoma Recurrent Nodal Peripheral T-Cell Lymphoma with TFH Phenotype Recurrent Follicular Helper T-Cell Lymphoma Follicular helper T-cell lymphoma that is resistant to treatment. C168779 Neoplastic Process Refractory Nodal Peripheral T-Cell Lymphoma with TFH Phenotype Refractory Follicular Helper T-Cell Lymphoma CL1378680 CTRP Malignant Refractory Follicular Helper T-Cell Lymphoma Refractory Nodal Peripheral T-Cell Lymphoma with TFH Phenotype Refractory Follicular Helper T-Cell Lymphoma The reemergence of follicular helper T-cell lymphoma, follicular-type after a period of remission. C168780 Neoplastic Process Recurrent Follicular T-Cell Lymphoma Recurrent Follicular Helper T-Cell Lymphoma, Follicular-Type CL1378679 CTRP Malignant Recurrent Follicular Helper T-Cell Lymphoma, Follicular-Type Recurrent Follicular T-Cell Lymphoma Recurrent Follicular Helper T-Cell Lymphoma, Follicular-Type Follicular helper T-cell lymphoma, follicular-type that is resistant to treatment. C168781 Neoplastic Process Refractory Follicular T-Cell Lymphoma Refractory Follicular Helper T-Cell Lymphoma, Follicular-Type CL1378690 CTRP Malignant Refractory Follicular Helper T-Cell Lymphoma, Follicular-Type Refractory Follicular T-Cell Lymphoma Refractory Follicular Helper T-Cell Lymphoma, Follicular-Type A HER2-negative breast adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C168782 Neoplastic Process Advanced HER2 Negative Breast Carcinoma Advanced HER2-Negative Breast Carcinoma CL1378689 CTRP Malignant Advanced HER2 Negative Breast Adenocarcinoma Advanced HER2 Negative Breast Carcinoma Advanced HER2-Negative Breast Carcinoma Advanced HER2-Negative Breast Carcinoma The reemergence of HER2-negative breast adenocarcinoma after a period of remission. C168783 Neoplastic Process Recurrent HER2 Negative Breast Carcinoma Recurrent HER2-Negative Breast Carcinoma CL1378692 CTRP Malignant Recurrent HER2 Negative Breast Adenocarcinoma Recurrent HER2 Negative Breast Carcinoma Recurrent HER2-Negative Breast Carcinoma Relapsed HER2 Negative Breast Carcinoma Recurrent HER2-Negative Breast Carcinoma A HER2-negative breast adenocarcinoma that is resistant to treatment. C168784 Neoplastic Process Refractory HER2 Negative Breast Carcinoma Refractory HER2-Negative Breast Carcinoma CL1378691 CTRP Malignant Refractory HER2 Negative Breast Adenocarcinoma Refractory HER2 Negative Breast Carcinoma Refractory HER2-Negative Breast Carcinoma Refractory HER2-Negative Breast Carcinoma Malignant mesothelioma that arises from the peritoneum. It is characterized by the presence of spindle cells. Anaplastic morphologic features and multinucleated malignant cells may also be seen. C168804 Neoplastic Process Peritoneal Sarcomatoid Mesothelioma Peritoneal Sarcomatoid Mesothelioma CL1378702 CTRP Malignant Peritoneal Sarcomatoid Mesothelioma Peritoneal Sarcomatoid Mesothelioma Malignant mesothelioma that arises from the peritoneum. It is characterized by the presence of epithelioid and sarcomatoid components, with each component representing at least 10% of the tumor. C168805 Neoplastic Process Peritoneal Biphasic Mesothelioma Peritoneal Biphasic Mesothelioma CL1378701 CTRP Malignant Peritoneal Biphasic Mesothelioma Peritoneal Biphasic Mesothelioma A neuroendocrine neoplasm that is not amenable to surgical resection. C168973 Neoplastic Process Unresectable Neuroendocrine Neoplasm Unresectable Neuroendocrine Neoplasm CL1378797 CTRP Malignant Unresectable Neuroendocrine Neoplasm Unresectable Neuroendocrine Neoplasm Esophageal carcinoma that has spread to nearby tissues or lymph nodes. C168976 Neoplastic Process Locally Advanced Esophageal Carcinoma Locally Advanced Esophageal Carcinoma CL1378798 CTRP Malignant Locally Advanced Esophageal Carcinoma Locally Advanced Esophageal Carcinoma Anal carcinoma that has spread to nearby tissues or lymph nodes. C168977 Neoplastic Process Locally Advanced Anal Carcinoma Locally Advanced Anal Carcinoma CL1378794 CTRP Malignant Locally Advanced Anal Carcinoma Locally Advanced Anal Carcinoma Hepatocellular carcinoma that has spread to nearby tissues or lymph nodes. C168979 Neoplastic Process Locally Advanced Hepatocellular Carcinoma Locally Advanced Hepatocellular Carcinoma CL1378796 CTRP Malignant Locally Advanced Hepatocellular Carcinoma Locally Advanced Hepatocellular Carcinoma A histiocytic and dendritic cell neoplasm that affects the skin. C168980 Neoplastic Process Cutaneous Histiocytic and Dendritic Cell Neoplasm CL1378795 Undetermined Cutaneous Histiocytic and Dendritic Cell Neoplasm Cutaneous Histiocytic and Dendritic Cell Neoplasm Carcinoma that arises from the intrahepatic, hilar, extrahepatic bile ducts, cystic duct, or gallbladder and has spread to nearby tissues or lymph nodes. C168981 Neoplastic Process Locally Advanced Biliary Tract Carcinoma Locally Advanced Biliary Tract Carcinoma CL1378801 CTRP Malignant Locally Advanced Biliary Tract Carcinoma Locally Advanced Biliary Tract Carcinoma Langerhans cell histiocytosis that affects the skin. It manifests with skin papules and plaques. C168983 Neoplastic Process Cutaneous Langerhans Cell Histiocytosis CL1378800 Undetermined Cutaneous Langerhans Cell Histiocytosis Cutaneous Langerhans Cell Histiocytosis A very rare dendritic cell tumor affecting the skin. It is composed of spindle to ovoid cells with a phenotype that is similar to the Langerhans cells. It manifests with cutaneous papules, nodules, and plaques. The clinical course is variable. C168984 Neoplastic Process Cutaneous Indeterminate Dendritic Cell Histiocytosis CL1378803 Undetermined Cutaneous Indeterminate Cell Histiocytosis Cutaneous Indeterminate Dendritic Cell Histiocytosis Cutaneous Indeterminate Dendritic Cell Tumor Cutaneous Indeterminate Dendritic Cell Histiocytosis A pancreatic carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C168985 Neoplastic Process Locally Advanced Pancreatic Carcinoma CL1378802 Malignant Locally Advanced Pancreatic Carcinoma Locally Advanced Pancreatic Carcinoma Rosai-Dorfman-Destombes disease affecting the skin. It manifests with multiple papules, nodules, or plaques. C168986 Neoplastic Process Cutaneous Rosai-Dorfman-Destombes Disease CL1378799 Undetermined Cutaneous Rosai-Dorfman Disease Cutaneous Rosai-Dorfman-Destombes Disease Cutaneous Sinus Histiocytosis With Massive Lymphadenopathy Cutaneous Rosai-Dorfman-Destombes Disease Erdheim-Chester disease that affects the skin. C168991 Neoplastic Process Cutaneous Erdheim-Chester Disease CL1378807 Undetermined Cutaneous Erdheim-Chester Disease Cutaneous Erdheim-Chester Disease Cholangiocarcinoma that has spread to nearby tissues or lymph nodes. C168994 Neoplastic Process Locally Advanced Cholangiocarcinoma Locally Advanced Cholangiocarcinoma CL1378805 CTRP Malignant Locally Advanced Cholangiocarcinoma Locally Advanced Cholangiocarcinoma Renal cell carcinoma that has spread to nearby tissues or lymph nodes. C168995 Neoplastic Process Locally Advanced Renal Cell Carcinoma Locally Advanced Renal Cell Carcinoma CL1378804 CTRP Malignant Locally Advanced Renal Cell Carcinoma Locally Advanced Renal Cell Carcinoma A malignant female reproductive system neoplasm that progresses between one and six months of completing platinum therapy. C169021 Neoplastic Process Platinum-Resistant Malignant Female Reproductive System Neoplasm Platinum-Resistant Malignant Female Reproductive System Neoplasm CL1378826 CTRP Malignant Platinum-Resistant Malignant Female Reproductive System Neoplasm Platinum-Resistant Malignant Female Reproductive System Neoplasm An adenocarcinoma that arises from the pancreas and has not spread to other anatomic sites. C169041 Neoplastic Process Localized Pancreatic Adenocarcinoma Localized Pancreatic Adenocarcinoma CL1378854 CTRP Malignant Localized Pancreatic Adenocarcinoma Localized Pancreatic Adenocarcinoma Bladder urachal urothelial carcinoma that has spread to another anatomic site. C169043 Neoplastic Process Metastatic Bladder Urachal Urothelial Carcinoma Metastatic Urachal Urothelial Carcinoma CL1378848 CTRP Malignant Metastatic Bladder Urachal Urothelial Carcinoma Metastatic Urachal Urothelial Carcinoma Metastatic Urachal Urothelial Carcinoma The reemergence of a soft tissue sarcoma of the trunk and extremities after a period of remission. C169050 Neoplastic Process Recurrent Soft Tissue Sarcoma of the Trunk and Extremities Recurrent Soft Tissue Sarcoma of the Trunk and Extremities CL1378861 CTRP Malignant Recurrent Soft Tissue Sarcoma of the Trunk and Extremities Recurrent Soft Tissue Sarcoma of the Trunk and Extremities An anaplastic oligodendroglioma that is resistant to treatment. C169074 Neoplastic Process Refractory Anaplastic Oligodendroglioma Refractory Anaplastic Oligodendroglioma CL1378884 CTRP Malignant Refractory Anaplastic Oligodendroglioma Refractory Anaplastic Oligodendroglioma An anaplastic astrocytoma that is resistant to treatment. C169075 Neoplastic Process Refractory Anaplastic Astrocytoma Refractory Anaplastic Astrocytoma CL1378880 CTRP Malignant Refractory Anaplastic Astrocytoma Refractory Anaplastic Astrocytoma Choroid melanoma that has spread from its primary site to another anatomic site. C169085 Neoplastic Process Metastatic Choroid Melanoma Metastatic Choroid Melanoma CL1379015 CTRP Malignant Metastatic Choroid Melanoma Metastatic Choroid Melanoma Clear cell renal cell carcinoma that has spread to nearby tissues or lymph nodes. C169099 Neoplastic Process Locally Advanced Clear Cell Renal Cell Carcinoma Locally Advanced Clear Cell Renal Cell Carcinoma CL1382245 CTRP Malignant Locally Advanced Clear Cell Renal Cell Carcinoma Locally Advanced Clear Cell Renal Cell Carcinoma A mesenchymal neoplasm that arises from the skin. C169100 Neoplastic Process Skin Soft Tissue Neoplasm CL1382240 Undetermined Skin Soft Tissue Neoplasm Skin Soft Tissue Neoplasm The reemergence of anal squamous cell carcinoma after a period of remission. C169102 Neoplastic Process Recurrent Anal Squamous Cell Carcinoma Recurrent Anal Squamous Cell Carcinoma CL1382239 CTRP Malignant Recurrent Anal Squamous Cell Carcinoma Recurrent Anal Squamous Cell Carcinoma Anal squamous cell carcinoma that has spread from its primary site to another anatomic site. C169103 Neoplastic Process Metastatic Anal Squamous Cell Carcinoma Metastatic Anal Squamous Cell Carcinoma CL541144 CTRP Malignant Metastatic Anal Squamous Cell Carcinoma Metastatic Anal Squamous Cell Carcinoma The reemergence of acute promyelocytic leukemia with t(15;17)(q24.1;q21.2); PML-RARA after a period of remission. C169107 Neoplastic Process Recurrent Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA CL1382243 mCode Malignant Acute promyelocytic leukemia, in relapse Recurrent Acute Promyelocytic Leukemia with PML-RARA Recurrent Acute Promyelocytic Leukemia with PML-RARA Fusion Recurrent Acute Promyelocytic Leukemia with PML::RARA Recurrent Acute Promyelocytic Leukemia with PML::RARA Fusion Recurrent Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA Recurrent Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA Fusion Recurrent Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML::RARA Recurrent Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML::RARA Fusion Recurrent Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA Periampullary adenocarcinoma that is amenable to surgical removal. C169108 Neoplastic Process Resectable Periampullary Adenocarcinoma Resectable Periampullary Adenocarcinoma CL1382256 CTRP Malignant Resectable Periampullary Adenocarcinoma Resectable Periampullary Adenocarcinoma A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered. C17007 Diagnostic Procedure Positron Emission Tomography Positron Emission Tomography C0032743 CDISC CTRP GDC OORO PCDC mCode A procedure in which a small amount of radioactive glucose (sugar) is injected into a vein, and a scanner is used to make detailed, computerized pictures of areas inside the body where the glucose is used. Because cancer cells often use more glucose than normal cells, the pictures can be used to find cancer cells in the body. An imaging technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance. A scanner reveals the tissue location of the metabolically-active substance administered. Positron_Emission_Tomography PET Medical Imaging, Positron Emission Tomography PET PET SCAN PET Scan PET scan PT Pet Scan Positron Emission Tomography Positron Emission Tomography Scan Positron emission tomography (procedure) Positron-Emission Tomography positron emission tomography scan proton magnetic resonance spectroscopic imaging Positron Emission Tomography A carcinoma that arises from the pancreas, bile ducts, gallbladder, or ampulla of Vater and has spread from its original site of growth to another anatomic site. C170458 Neoplastic Process Metastatic Pancreatobiliary Carcinoma Metastatic Pancreatobiliary Carcinoma CL1382913 CTRP Malignant Metastatic Pancreatobiliary Carcinoma Metastatic Pancreatobiliary Carcinoma A carcinoma that arises from the pancreas, bile ducts, gallbladder, or ampulla of Vater and has spread from its original site of growth to nearby tissues or lymph nodes. C170459 Neoplastic Process Locally Advanced Pancreatobiliary Carcinoma Locally Advanced Pancreatobiliary Carcinoma CL1382918 CTRP Malignant Locally Advanced Pancreatobiliary Carcinoma Locally Advanced Pancreatobiliary Carcinoma A malignant female reproductive system neoplasm that has spread from its original site of growth to nearby tissues or lymph nodes. C170460 Neoplastic Process Locally Advanced Malignant Female Reproductive System Neoplasm Locally Advanced Malignant Female Reproductive System Neoplasm CL1382919 CTRP Malignant Locally Advanced Malignant Female Reproductive System Neoplasm Locally Advanced Malignant Female Reproductive System Neoplasm Endometrial carcinoma that has spread to nearby tissues or lymph nodes. C170461 Neoplastic Process Locally Advanced Endometrial Carcinoma Locally Advanced Endometrial Carcinoma CL1382916 CTRP Malignant Locally Advanced Endometrial Carcinoma Locally Advanced Endometrial Carcinoma Gallbladder carcinoma that has spread to nearby tissues or lymph nodes. C170462 Neoplastic Process Locally Advanced Gallbladder Carcinoma Locally Advanced Gallbladder Carcinoma CL1382917 CTRP Malignant Locally Advanced Gallbladder Carcinoma Locally Advanced Gallbladder Carcinoma Skin squamous cell carcinoma that is amenable to surgical resection. C170464 Neoplastic Process Resectable Skin Squamous Cell Carcinoma Resectable Skin Squamous Cell Carcinoma CL1382907 CTRP Malignant Resectable Skin Squamous Cell Carcinoma Resectable Skin Squamous Cell Carcinoma Skin carcinoma that is amenable to surgical resection. C170465 Neoplastic Process Resectable Skin Carcinoma CL1382904 Malignant Resectable Skin Carcinoma Resectable Skin Carcinoma A malignant neoplasm that arises from the head and neck region and has spread to another anatomic site. C170467 Neoplastic Process Metastatic Malignant Head and Neck Neoplasm CL1382910 Malignant Metastatic Malignant Head and Neck Neoplasm Metastatic Malignant Head and Neck Neoplasm A malignant neoplasm that arises from the head and neck region and has spread extensively to other anatomic sites or is no longer responding to treatment. C170469 Neoplastic Process Advanced Malignant Head and Neck Neoplasm CL1382911 Malignant Advanced Malignant Head and Neck Neoplasm Advanced Malignant Head and Neck Neoplasm A malignant neoplasm that arises from the head and neck region and has spread from its original site of growth to nearby tissues or lymph nodes. C170470 Neoplastic Process Locally Advanced Malignant Head and Neck Neoplasm CL1382908 Malignant Locally Advanced Malignant Head and Neck Neoplasm Locally Advanced Malignant Head and Neck Neoplasm A rare atypical lipomatous tumor/well differentiated liposarcoma arising from the skin. C170472 Neoplastic Process Skin Atypical Lipomatous Tumor/Well Differentiated Liposarcoma CL1382930 Undetermined Skin ALT/WDLPS Skin Atypical Lipomatous Tumor Skin Atypical Lipomatous Tumor/Well Differentiated Liposarcoma Skin Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma Skin Atypical Lipomatous Tumor/Well Differentiated Liposarcoma A rare pleomorphic liposarcoma arising from the skin. C170473 Neoplastic Process Skin Pleomorphic Liposarcoma CL1382931 Malignant Skin Pleomorphic Liposarcoma Skin Pleomorphic Liposarcoma A spindle cell/pleomorphic lipoma arising from the skin. C170474 Neoplastic Process Skin Spindle Cell/Pleomorphic Lipoma CL1382928 Benign Skin Spindle Cell/Pleomorphic Lipoma Skin Spindle Cell/Pleomorphic Lipoma A spindle cell lipoma arising from the skin. C170475 Neoplastic Process Skin Spindle Cell Lipoma CL1382929 Benign Skin Spindle Cell Lipoma Skin Spindle Cell Lipoma A pleomorphic lipoma arising from the skin. C170476 Neoplastic Process Skin Pleomorphic Lipoma CL1382934 Benign Skin Pleomorphic Lipoma Skin Pleomorphic Lipoma An angiolipoma arising from the skin. C170478 Neoplastic Process Skin Angiolipoma CL1382932 Benign Skin Angiolipoma Skin Angiolipoma Cervical carcinoma that is resistant to treatment. C170513 Neoplastic Process Refractory Cervical Carcinoma Refractory Cervical Carcinoma CL1382939 CTRP Malignant Refractory Cervical Carcinoma Refractory Cervical Carcinoma Anal carcinoma that has spread from its primary site to another anatomic site. C170514 Neoplastic Process Metastatic Anal Carcinoma CL1382936 Malignant Metastatic Anal Carcinoma Metastatic Anal Carcinoma Anal carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C170515 Neoplastic Process Advanced Anal Carcinoma Advanced Anal Carcinoma CL1382937 CTRP Malignant Advanced Anal Carcinoma Advanced Anal Carcinoma Thyroid gland carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C170517 Neoplastic Process Advanced Thyroid Gland Carcinoma Advanced Thyroid Gland Carcinoma CL1382943 CTRP Malignant Advanced Thyroid Gland Carcinoma Advanced Thyroid Gland Carcinoma The skin surrounding the eye, including the skin of the eyelid. C170599 Anatomical Structure Skin Around the Eye CL1382789 CDISC The skin surrounding the eye, including the skin of the eyelid. SKIN AROUND THE EYE Skin Around the Eye Skin Around the Eye The skin surrounding the mouth, including the skin of the lip. C170600 Anatomical Structure Skin Around the Mouth CL1382808 CDISC The skin surrounding the mouth, including the skin of the lip. SKIN AROUND THE MOUTH Skin Around the Mouth Skin Around the Mouth A lymph node that is located above the mandibular margin of the submandibular triangle and is associated with the anterior facial vein and facial artery. C170601 Body Part, Organ, or Organ Component Perifacial Lymph Node CL1382809 CDISC A lymph node located above the mandibular margin of the submandibular triangle and is associated with the anterior facial vein and facial artery. PERIFACIAL LYMPH NODE Perifacial Lymph Node Perifacial Lymph Node Integument that folds in upon itself. C170602 Anatomical Structure Skinfold CL952057 CDISC An area of the integument that folds upon itself. SKIN FOLD Skinfold Skinfold The integument that covers the bending joints. C170603 Anatomical Structure Skin of the Bending Joint CL1382807 CDISC The integument that covers the bending joint. SKIN OF THE BENDING JOINT Skin of the Bending Joint Skin of the Bending Joint The integument that covers the palms. C170604 Anatomical Structure Skin of the Palm C0222226 CDISC The integument that covers the palm. SKIN OF THE PALM Skin of the Palm Skin of the Palm The integument that covers the underside of the foot. C170606 Anatomical Structure Skin of the Sole CL1382810 CDISC The integument that covers the sole. SKIN OF THE SOLE Skin of the Sole Skin of the Sole A neoplasm that arises from the periampullary region and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.. C170725 Neoplastic Process Benign Periampullary Neoplasm Benign Periampullary Neoplasm CL1383127 CTRP Benign Benign Periampullary Neoplasm Benign Periampullary Neoplasm The reemergence of a malignant breast neoplasm after a period of remission. C170726 Neoplastic Process Recurrent Malignant Breast Neoplasm Recurrent Malignant Breast Neoplasm CL1383125 CTRP Malignant Recurrent Malignant Breast Neoplasm Recurrent Malignant Breast Neoplasm The reemergence of breast sarcoma after a period of remission. C170727 Neoplastic Process Recurrent Breast Sarcoma C2363895 Malignant Recurrent Breast Sarcoma Recurrent Breast Sarcoma A malignant breast neoplasm that has metastasized to another anatomic site. C170728 Neoplastic Process Metastatic Malignant Breast Neoplasm CL1383142 Malignant Metastatic Malignant Breast Neoplasm Metastatic Malignant Breast Neoplasm A rare adenocarcinoma that arises from the lining of the peritoneum. C170733 Neoplastic Process Primary Peritoneal Adenocarcinoma Primary Peritoneal Adenocarcinoma CL1383147 CTRP Malignant Primary Peritoneal Adenocarcinoma Primary Peritoneal Adenocarcinoma An appendiceal neoplasm characterized by mucinous epithelial proliferation with extracellular mucin and pushing tumour margins. (WHO 2019) C170734 Neoplastic Process Appendix Mucinous Neoplasm Appendix Mucinous Neoplasm CL1383144 CTRP Malignant Appendix Mucinous Neoplasm Appendix Mucinous Tumor Appendix Mucinous Neoplasm A benign, often polypoid, fibroblastic neoplasm characterized by bizarre pleomorphic cells. (WHO 2018) C170736 Neoplastic Process Pleomorphic Fibroma CL449286 Benign Pleomorphic Fibroma Pleomorphic Fibroma The reemergence of platinum-resistant ovarian carcinoma after a period of remission. C170748 Neoplastic Process Recurrent Platinum-Resistant Ovarian Carcinoma Recurrent Platinum-Resistant Ovarian Carcinoma CL1383162 CTRP Malignant Recurrent Platinum-Resistant Ovarian Carcinoma Recurrent Platinum-Resistant Ovarian Carcinoma The reemergence of platinum-resistant fallopian tube carcinoma after a period of remission. C170750 Neoplastic Process Recurrent Platinum-Resistant Fallopian Tube Carcinoma Recurrent Platinum-Resistant Fallopian Tube Carcinoma CL1383160 CTRP Malignant Recurrent Platinum-Resistant Fallopian Tube Carcinoma Recurrent Platinum-Resistant Fallopian Tube Carcinoma The reemergence of platinum-resistant primary peritoneal carcinoma after a period of remission. C170751 Neoplastic Process Recurrent Platinum-Resistant Primary Peritoneal Carcinoma Recurrent Platinum-Resistant Primary Peritoneal Carcinoma CL1383161 CTRP Malignant Recurrent Platinum-Resistant Primary Peritoneal Carcinoma Recurrent Platinum-Resistant Primary Peritoneal Carcinoma The reemergence of ovarian undifferentiated carcinoma after a period of remission. C170754 Neoplastic Process Recurrent Ovarian Undifferentiated Carcinoma Recurrent Ovarian Undifferentiated Carcinoma CL1383148 CTRP Malignant Recurrent Ovarian Undifferentiated Carcinoma Recurrent Ovarian Undifferentiated Carcinoma The reemergence of fallopian tube undifferentiated carcinoma after a period of remission. C170755 Neoplastic Process Recurrent Fallopian Tube Undifferentiated Carcinoma Recurrent Fallopian Tube Undifferentiated Carcinoma CL1383149 CTRP Malignant Recurrent Fallopian Tube Undifferentiated Carcinoma Recurrent Fallopian Tube Undifferentiated Carcinoma The reemergence of primary peritoneal undifferentiated carcinoma after a period of remission. C170756 Neoplastic Process Recurrent Primary Peritoneal Undifferentiated Carcinoma Recurrent Primary Peritoneal Undifferentiated Carcinoma CL1383154 CTRP Malignant Recurrent Primary Peritoneal Undifferentiated Carcinoma Recurrent Primary Peritoneal Undifferentiated Carcinoma The reemergence of fallopian tube transitional cell carcinoma after a period of remission. C170757 Neoplastic Process Recurrent Fallopian Tube Transitional Cell Carcinoma Recurrent Fallopian Tube Transitional Cell Carcinoma CL1383155 CTRP Malignant Recurrent Fallopian Tube Transitional Cell Carcinoma Recurrent Fallopian Tube Transitional Cell Carcinoma The reemergence of primary peritoneal transitional cell carcinoma after a period of remission. C170759 Neoplastic Process Recurrent Primary Peritoneal Transitional Cell Carcinoma Recurrent Primary Peritoneal Transitional Cell Carcinoma CL1383153 CTRP Malignant Recurrent Primary Peritoneal Transitional Cell Carcinoma Recurrent Primary Peritoneal Transitional Cell Carcinoma The reemergence of fallopian tube clear cell adenocarcinoma after a period of remission. C170760 Neoplastic Process Recurrent Fallopian Tube Clear Cell Adenocarcinoma Recurrent Fallopian Tube Clear Cell Adenocarcinoma CL1383174 CTRP Malignant Recurrent Fallopian Tube Clear Cell Adenocarcinoma Recurrent Fallopian Tube Clear Cell Adenocarcinoma The reemergence of primary peritoneal clear cell adenocarcinoma after a period of remission. C170761 Neoplastic Process Recurrent Primary Peritoneal Clear Cell Adenocarcinoma Recurrent Primary Peritoneal Clear Cell Adenocarcinoma CL1383175 CTRP Malignant Recurrent Primary Peritoneal Clear Cell Adenocarcinoma Recurrent Primary Peritoneal Clear Cell Adenocarcinoma The reemergence of fallopian tube adenocarcinoma after a period of remission. C170766 Neoplastic Process Recurrent Fallopian Tube Adenocarcinoma CL1383176 Malignant Recurrent Fallopian Tube Adenocarcinoma Recurrent Fallopian Tube Adenocarcinoma The reemergence of primary peritoneal adenocarcinoma after a period of remission. C170767 Neoplastic Process Recurrent Primary Peritoneal Adenocarcinoma CL1383177 Malignant Recurrent Primary Peritoneal Adenocarcinoma Recurrent Primary Peritoneal Adenocarcinoma An infiltrating urothelial carcinoma of the bladder that has not invaded into the bladder muscularis propria. C170772 Neoplastic Process Superficial Bladder Urothelial Carcinoma Non-Muscle Invasive Bladder Urothelial Carcinoma CL1383165 CTRP Malignant Non-Muscle Invasive Bladder Transitional Cell Carcinoma Non-Muscle Invasive Bladder Urothelial Carcinoma Superficial Bladder Transitional Cell Carcinoma Superficial Bladder Urothelial Carcinoma Non-Muscle Invasive Bladder Urothelial Carcinoma The reemergence of non-muscle invasive bladder urothelial carcinoma after a period of remission. C170773 Neoplastic Process Recurrent Superficial Bladder Urothelial Carcinoma Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma CL1383170 CTRP Malignant Recurrent Non-Muscle Invasive Bladder Transitional Cell Carcinoma Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma Recurrent Superficial Bladder Transitional Cell Carcinoma Recurrent Superficial Bladder Urothelial Carcinoma Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma Squamous cell carcinoma arising from the upper or lower alveolar ridge. C170774 Neoplastic Process Alveolar Ridge Squamous Cell Carcinoma CL1383171 Cellosaurus Malignant Alveolar Ridge Squamous Cell Carcinoma Alveolar Ridge Squamous Cell Carcinoma Squamous cell carcinoma arising from the upper alveolar ridge. C170775 Neoplastic Process Upper Alveolar Ridge Squamous Cell Carcinoma Upper Alveolar Ridge Squamous Cell Carcinoma CL1383168 CTRP Malignant Upper Alveolar Ridge Squamous Cell Carcinoma Upper Alveolar Ridge Squamous Cell Carcinoma Squamous cell carcinoma arising from the lower alveolar ridge. C170776 Neoplastic Process Lower Alveolar Ridge Squamous Cell Carcinoma Lower Alveolar Ridge Squamous Cell Carcinoma CL1383169 CTRP Malignant Lower Alveolar Ridge Squamous Cell Carcinoma Lower Alveolar Ridge Squamous Cell Carcinoma Rectal carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C170777 Neoplastic Process Advanced Rectal Carcinoma CL1383190 Malignant Advanced Rectal Carcinoma Advanced Rectal Carcinoma Rectal carcinoma that has spread to nearby tissues or lymph nodes. C170778 Neoplastic Process Locally Advanced Rectal Carcinoma CL1383191 Malignant Locally Advanced Rectal Carcinoma Locally Advanced Rectal Carcinoma Rectal squamous cell carcinoma that has spread from the original site of growth to other anatomic sites. C170779 Neoplastic Process Metastatic Rectal Squamous Cell Carcinoma Metastatic Rectal Squamous Cell Carcinoma CL1383188 CTRP Malignant Metastatic Rectal Squamous Cell Carcinoma Metastatic Rectal Squamous Cell Carcinoma Rectal squamous cell carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C170780 Neoplastic Process Advanced Rectal Squamous Cell Carcinoma Advanced Rectal Squamous Cell Carcinoma CL1383189 CTRP Malignant Advanced Rectal Squamous Cell Carcinoma Advanced Rectal Squamous Cell Carcinoma Rectal squamous cell carcinoma that has spread to nearby tissues or lymph nodes. C170781 Neoplastic Process Locally Advanced Rectal Squamous Cell Carcinoma Locally Advanced Rectal Squamous Cell Carcinoma CL1383194 CTRP Malignant Locally Advanced Rectal Squamous Cell Carcinoma Locally Advanced Rectal Squamous Cell Carcinoma Oropharyngeal carcinoma that has spread to nearby tissues or lymph nodes. C170782 Neoplastic Process Locally Advanced Oropharyngeal Carcinoma Locally Advanced Oropharyngeal Carcinoma CL1383195 CTRP Malignant Locally Advanced Oropharyngeal Carcinoma Locally Advanced Oropharyngeal Carcinoma Oropharyngeal carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C170783 Neoplastic Process Advanced Oropharyngeal Carcinoma Advanced Oropharyngeal Carcinoma CL1383192 CTRP Malignant Advanced Oropharyngeal Carcinoma Advanced Oropharyngeal Carcinoma Pharyngeal carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C170784 Neoplastic Process Advanced Pharyngeal Carcinoma CL1383193 Malignant Advanced Pharyngeal Carcinoma Advanced Pharyngeal Carcinoma Vulvar carcinoma that has spread to nearby tissues or lymph nodes. C170785 Neoplastic Process Locally Advanced Vulvar Carcinoma Locally Advanced Vulvar Carcinoma CL1383182 CTRP Malignant Locally Advanced Vulvar Carcinoma Locally Advanced Vulvar Carcinoma Vulvar carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C170786 Neoplastic Process Advanced Vulvar Carcinoma Advanced Vulvar Carcinoma CL1383183 CTRP Malignant Advanced Vulvar Carcinoma Advanced Vulvar Carcinoma Vaginal carcinoma that has spread to nearby tissues or lymph nodes. C170787 Neoplastic Process Locally Advanced Vaginal Carcinoma Locally Advanced Vaginal Carcinoma CL1383180 CTRP Malignant Locally Advanced Vaginal Carcinoma Locally Advanced Vaginal Carcinoma Vaginal carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C170788 Neoplastic Process Advanced Vaginal Carcinoma Advanced Vaginal Carcinoma CL1383181 CTRP Malignant Advanced Vaginal Carcinoma Advanced Vaginal Carcinoma Penile carcinoma that has spread to nearby tissues or lymph nodes. C170789 Neoplastic Process Locally Advanced Penile Carcinoma Locally Advanced Penile Carcinoma CL1383186 CTRP Malignant Locally Advanced Penile Carcinoma Locally Advanced Penile Carcinoma Penile carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C170790 Neoplastic Process Advanced Penile Carcinoma Advanced Penile Carcinoma CL1383187 CTRP Malignant Advanced Penile Carcinoma Advanced Penile Carcinoma A history of a first-degree relative that has been diagnosed with a high-risk germline mutation. C170792 Group Attribute Family History of High-Risk Germline Mutations CL1383185 Family History of High-Risk Germline Mutations Family History of High-Risk Germline Mutations 3-dimensional, T1-weighted magnetic resonance imaging that uses gradient-echo acquisition with inversion recovery, in the absence of a contrast agent. C170793 Diagnostic Procedure Precontrast, 3-dimensional, Isotropic, IR-prepped T1-weighted Gradient Echo MRI CL1383205 3D Pre-Contrast T1-Weighted IR-GRE Precontrast, 3-dimensional, Isotropic, IR-prepped T1-weighted Gradient Echo MRI Precontrast, 3-dimensional, Isotropic, IR-prepped T1-weighted Gradient Echo MRI 2-dimensional magnetic resonance imaging that uses an inversion recovery set to null fluids. C170794 Diagnostic Procedure 2-dimensional Fluid-attenuated Inversion Recovery MRI CL1383206 2-dimensional Fluid-attenuated Inversion Recovery MRI 2D FLAIR 2-dimensional Fluid-attenuated Inversion Recovery MRI 2-dimension, T2-weighted magnetic resonance imaging that uses the diffusion of water molecules to generate contrast in MR images. Diffusion tensor imaging (DTI), a specific type of DWI, can be used to map white matter tractography in the brain. C170795 Diagnostic Procedure 2-dimensional, Diffusion-weighted Imaging/ Diffusion Tensor Imaging CL1383203 2-dimensional, Diffusion-weighted Imaging/ Diffusion Tensor Imaging 2D T2-Weighted 2-dimensional, Diffusion-weighted Imaging/ Diffusion Tensor Imaging 2-dimensional magnetic resonance imaging that highlights differences in the T2 relaxation time of tissues. C170796 Diagnostic Procedure 2-dimensional T2-weighted MRI CL1383204 2-dimensional T2-weighted MRI 2D T2-Weighted 2-dimensional T2-weighted MRI Magnetic resonance imaging in which the tissues with higher concentrations or densities of protons produce the strongest signals and appear the brightest on the image. C170797 Diagnostic Procedure Proton Density MRI CL1383209 Proton Density MRI Proton Density MRI 2-dimensional magnetic resonance imaging that uses proton density weighting and T2 weighting to suppress the signal from fatty tissues. C170798 Diagnostic Procedure 2-dimensional Proton Density, T2-weighted MRI CL1383210 2-dimensional Proton Density, T2-weighted MRI 2D PD/T2-Weighted MRI 2-dimensional Proton Density, T2-weighted MRI 3-dimensional, T1-weighted magnetic resonance imaging that uses gradient-echo acquisition with inversion recovery, done after injection of a contrast agent. C170799 Diagnostic Procedure Postcontrast, 3-dimensional, Isotropic, IR-prepped T1-weighted Gradient Echo MRI CL1383207 3D Post-Contrast T1-Weighted IR-GRE Postcontrast, 3-dimensional, Isotropic, IR-prepped T1-weighted Gradient Echo MRI Postcontrast, 3-dimensional, Isotropic, IR-prepped T1-weighted Gradient Echo MRI An endometrial serous adenocarcinoma that has spread to other anatomic sites. C170804 Neoplastic Process Metastatic Endometrial Serous Adenocarcinoma CL1383196 Malignant Metastatic Endometrial Serous Adenocarcinoma Metastatic Endometrial Serous Adenocarcinoma Endometrial adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C170805 Neoplastic Process Advanced Endometrial Adenocarcinoma, Not Otherwise Specified Advanced Endometrial Adenocarcinoma CL1383197 CTRP Malignant Advanced Endometrial Adenocarcinoma Advanced Endometrial Adenocarcinoma, Not Otherwise Specified Advanced Endometrial Adenocarcinoma An endometrial endometrioid adenocarcinoma that has spread to other anatomic sites. C170806 Neoplastic Process Metastatic Endometrial Endometrioid Adenocarcinoma CL1383201 Malignant Metastatic Endometrial Endometrioid Adenocarcinoma Metastatic Endometrial Endometrioid Adenocarcinoma Endometrial serous adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C170809 Neoplastic Process Advanced Endometrial Serous Adenocarcinoma Advanced Endometrial Serous Adenocarcinoma CL1383199 CTRP Malignant Advanced Endometrial Serous Adenocarcinoma Advanced Endometrial Serous Adenocarcinoma Endometrial endometrioid adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C170810 Neoplastic Process Advanced Endometrial Endometrioid Adenocarcinoma Advanced Endometrial Endometrioid Adenocarcinoma CL1383200 CTRP Malignant Advanced Endometrial Endometrioid Adenocarcinoma Advanced Endometrial Endometrioid Adenocarcinoma A malignant neoplasm of the skin that has spread to other anatomic sites. C170811 Neoplastic Process Metastatic Malignant Skin Neoplasm Metastatic Malignant Skin Neoplasm CL1382990 CTRP Malignant Metastatic Malignant Skin Neoplasm Metastatic Malignant Skin Neoplasm A malignant neoplasm of the skin that has spread extensively to other anatomic sites or is no longer responding to treatment. C170812 Neoplastic Process Advanced Malignant Skin Neoplasm Advanced Malignant Skin Neoplasm CL1382991 CTRP Malignant Advanced Malignant Skin Neoplasm Advanced Malignant Skin Neoplasm A neoplasm arising from the brain. C170814 Neoplastic Process Primary Brain Neoplasm Primary Brain Neoplasm C0750974 CTRP Undetermined Primary Brain Neoplasm Primary Brain Neoplasm Malignant mastocytosis that is resistant to treatment. C170816 Neoplastic Process Refractory Malignant Mastocytosis Refractory Malignant Mastocytosis CL1382995 CTRP Malignant Refractory Malignant Mastocytosis Refractory Malignant Mastocytosis The reemergence of malignant mastocytosis after a period of remission. C170817 Neoplastic Process Recurrent Malignant Mastocytosis Recurrent Malignant Mastocytosis CL1382992 CTRP Malignant Recurrent Malignant Mastocytosis Recurrent Malignant Mastocytosis A protocol for magnetic resonance imaging with the liver-specific contrast agent Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid (Gd-EOB-DTPA) that aims to achieve a more rapid throughput and a reduced cost while maintaining its predictive aspects. C170820 Diagnostic Procedure Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid, Abbreviated Magnetic Resonance Imaging Gadolinium Contrast-enhanced Abbreviated MRI CL1382984 CTRP Gadolinium Contrast-enhanced Abbreviated MRI Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid, Abbreviated Magnetic Resonance Imaging Gd-EOB-DTPA-AMRI Gadolinium Contrast-enhanced Abbreviated MRI A desmoplastic small round cell tumor that is not amenable to surgical resection. C170826 Neoplastic Process Unresectable Desmoplastic Small Round Cell Tumor Unresectable Desmoplastic Small Round Cell Tumor CL1382986 CTRP Malignant Unresectable Desmoplastic Small Round Cell Tumor Unresectable Desmoplastic Small Round Cell Tumor A desmoplastic small round cell tumor that has spread from the original site of growth to another anatomic site. C170827 Neoplastic Process Metastatic Desmoplastic Small Round Cell Tumor Metastatic Desmoplastic Small Round Cell Tumor CL1383002 CTRP Malignant Metastatic Desmoplastic Small Round Cell Tumor Metastatic Desmoplastic Small Round Cell Tumor Thyroid gland anaplastic carcinoma that has spread from the original site of growth to another anatomic site. C170831 Neoplastic Process Metastatic Thyroid Gland Anaplastic Carcinoma Metastatic Thyroid Gland Anaplastic Carcinoma CL1383005 CTRP Malignant Metastatic Thyroid Gland Anaplastic Carcinoma Metastatic Thyroid Gland Anaplastic Carcinoma Thyroid gland anaplastic carcinoma that does not respond to treatment. C170832 Neoplastic Process Refractory Thyroid Gland Anaplastic Carcinoma Refractory Thyroid Gland Anaplastic Carcinoma CL1383006 CTRP Malignant Refractory Thyroid Gland Anaplastic Carcinoma Refractory Thyroid Gland Anaplastic Carcinoma Thyroid gland anaplastic carcinoma that is not amenable to surgical resection. C170833 Neoplastic Process Unresectable Thyroid Gland Anaplastic Carcinoma Unresectable Thyroid Gland Anaplastic Carcinoma CL1383004 CTRP Malignant Unresectable Thyroid Gland Anaplastic Carcinoma Unresectable Thyroid Gland Anaplastic Carcinoma A rare benign cutaneous mesenchymal neoplasm of fibroblastic/myofibroblastic differentiation. (WHO 2018) C170888 Neoplastic Process Dermatomyofibroma C1275239 Benign Dermatomyofibroma Plaque-Like Dermal Fibromatosis Dermatomyofibroma A congenital or acquired benign dermal spindle cell neoplasm with histopathological features mimicking those of superficial dermal dermatofibrosarcoma protuberans. (WHO 2018) C170889 Neoplastic Process Plaque-Like CD34-Positive Dermal Fibroma CL978742 Benign Medallion-Like Dermal Dendrocyte Hamartoma Plaque-Like CD34-Positive Dermal Fibroma Plaque-Like CD34-Positive Dermal Fibroma Colon carcinoma that has spread to nearby tissues or lymph nodes. C170910 Neoplastic Process Locally Advanced Colon Carcinoma Locally Advanced Colon Carcinoma CL1383070 CTRP Malignant Locally Advanced Colon Carcinoma Locally Advanced Colon Carcinoma A myeloproliferative neoplasm that does not respond to treatment. C170911 Neoplastic Process Refractory Myeloproliferative Neoplasm Refractory Myeloproliferative Neoplasm CL1383071 CTRP Malignant Refractory Myeloproliferative Neoplasm Refractory Myeloproliferative Neoplasm A three-dimensional imaging technology that uses both a pulse ultrasound wave transmitted through each of the breast coronal sections and a wave scattered on the structure heterogeneities of these sections in numerous directions to obtain tomographic images of the breast. Acoustic attributes of each voxel, such as refractivity, frequency-dependent attenuation, and dispersion can be recorded and combined to yield automated lesion detection and differentiation. C170916 Diagnostic Procedure Multimodal Ultrasound Tomography Multimodal Ultrasound Tomography CL1383072 CTRP MUT Multi-Modal UltraSound Tomography Multimodal Ultrasound Computer-assisted Tomography Multimodal Ultrasound Tomography Multimodal Ultrasound Tomography A primary or metastatic malignant neoplasm that affects the jejunum. C170919 Neoplastic Process Malignant Jejunal Neoplasm CL1383062 mCode Malignant Malignant Jejunal Neoplasm Malignant neoplasm of jejunum Malignant Jejunal Neoplasm A malignant mixed mesodermal (Mullerian) tumor that has spread from its original site of growth to another anatomic site. C170929 Neoplastic Process Metastatic Malignant Mixed Mesodermal (Mullerian) Tumor CL1383081 Malignant Metastatic Malignant Mixed Mesodermal (Mullerian) Tumor Metastatic Malignant Mixed Mesodermal (Mullerian) Tumor A malignant mixed mesodermal (Mullerian) tumor that has spread extensively to other anatomic sites or is no longer responding to treatment. C170930 Neoplastic Process Advanced Malignant Mixed Mesodermal (Mullerian) Tumor CL1383082 Malignant Advanced Malignant Mixed Mesodermal (Mullerian) Tumor Advanced Malignant Mixed Mesodermal (Mullerian) Tumor Uterine corpus carcinosarcoma that has spread from its original site of growth to another anatomic site. C170931 Neoplastic Process Metastatic Uterine Corpus Carcinosarcoma Metastatic Uterine Corpus Carcinosarcoma CL1383087 CTRP Malignant Metastatic Uterine Corpus Carcinosarcoma Metastatic Uterine Corpus Carcinosarcoma Ovarian carcinosarcoma that has spread from its original site of growth to another anatomic site. C170933 Neoplastic Process Metastatic Ovarian Carcinosarcoma CL1383085 Malignant Metastatic Ovarian Carcinosarcoma Metastatic Ovarian Carcinosarcoma Ovarian carcinosarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C170934 Neoplastic Process Advanced Ovarian Carcinosarcoma Advanced Ovarian Carcinosarcoma CL1383086 CTRP Malignant Advanced Ovarian Carcinosarcoma Advanced Ovarian Carcinosarcoma Ovarian serous adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C170937 Neoplastic Process Advanced Ovarian Serous Adenocarcinoma Advanced Ovarian Serous Adenocarcinoma CL1383076 CTRP Malignant Advanced Ovarian Serous Adenocarcinoma Advanced Ovarian Serous Adenocarcinoma Ovarian endometrioid adenocarcinoma that has spread from its original site of growth to another anatomic site. C170938 Neoplastic Process Metastatic Ovarian Endometrioid Adenocarcinoma CL1383077 Malignant Metastatic Ovarian Endometrioid Adenocarcinoma Metastatic Ovarian Endometrioid Adenocarcinoma A primary or metastatic malignant neoplasm that affects the gastric fundus. C170940 Neoplastic Process Malignant Fundus Neoplasm C0864946 mCode Malignant Malignant Fundus Neoplasm Malignant neoplasm of fundus of stomach Malignant Fundus Neoplasm A primary or metastatic malignant neoplasm that affects the optic nerve. C170941 Neoplastic Process Malignant Optic Nerve Neoplasm C0346323 mCode Malignant Malignant Optic Nerve Neoplasm Malignant neoplasm of unspecified optic nerve Malignant Optic Nerve Neoplasm Ovarian endometrioid adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C170942 Neoplastic Process Advanced Ovarian Endometrioid Adenocarcinoma Advanced Ovarian Endometrioid Adenocarcinoma CL1383080 CTRP Malignant Advanced Ovarian Endometrioid Adenocarcinoma Advanced Ovarian Endometrioid Adenocarcinoma The spread of a malignant neoplasm to the urinary system from an adjacent or distant anatomic site. C170943 Neoplastic Process Metastatic Malignant Neoplasm in the Urinary System C0347007 mCode Malignant Metastatic Malignant Neoplasm in the Urinary System Secondary malignant neoplasm of bladder and other urinary organs Secondary malignant neoplasm of unspecified urinary organs Metastatic Malignant Neoplasm in the Urinary System Ovarian clear cell adenocarcinoma that has spread from its original site of growth to another anatomic site. C170944 Neoplastic Process Metastatic Ovarian Clear Cell Adenocarcinoma CL1383078 Malignant Metastatic Ovarian Clear Cell Adenocarcinoma Metastatic Ovarian Clear Cell Adenocarcinoma Ovarian clear cell adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C170945 Neoplastic Process Advanced Ovarian Clear Cell Adenocarcinoma Advanced Ovarian Clear Cell Adenocarcinoma CL1383079 CTRP Malignant Advanced Ovarian Clear Cell Adenocarcinoma Advanced Ovarian Clear Cell Adenocarcinoma Chondrosarcoma that has spread to nearby tissues or lymph nodes. C170953 Neoplastic Process Locally Advanced Chondrosarcoma Locally Advanced Chondrosarcoma CL1383224 CTRP Malignant Locally Advanced Chondrosarcoma Locally Advanced Chondrosarcoma A malignant female reproductive system neoplasm that is amenable to surgical resection. C170963 Neoplastic Process Resectable Malignant Female Reproductive System Neoplasm Resectable Malignant Female Reproductive System Neoplasm CL1383237 CTRP Malignant Resectable Malignant Female Reproductive System Neoplasm Resectable Malignant Female Reproductive System Neoplasm Thyroid gland carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C170965 Neoplastic Process Locally Advanced Thyroid Gland Carcinoma Locally Advanced Thyroid Gland Carcinoma CL1383235 CTRP Malignant Locally Advanced Thyroid Gland Carcinoma Locally Advanced Thyroid Gland Carcinoma A malignant neoplasm that arises from the central nervous system and has spread extensively to other anatomic sites or is no longer responding to treatment. C170966 Neoplastic Process Advanced Primary Malignant Central Nervous System Neoplasm CL1383240 Malignant Advanced Primary Malignant Central Nervous System Neoplasm Advanced Primary Malignant Central Nervous System Neoplasm Ovarian adenocarcinoma that is resistant to treatment. C170968 Neoplastic Process Refractory Ovarian Adenocarcinoma CL1383238 Malignant Refractory Ovarian Adenocarcinoma Refractory Ovarian Adenocarcinoma Fallopian tube carcinoma that is not amenable to surgical resection. C170969 Neoplastic Process Unresectable Fallopian Tube Carcinoma CL1383239 Malignant Unresectable Fallopian Tube Carcinoma Unresectable Fallopian Tube Carcinoma Fallopian tube adenocarcinoma that is not amenable to surgical resection. C170970 Neoplastic Process Unresectable Fallopian Tube Adenocarcinoma CL1383229 Malignant Unresectable Fallopian Tube Adenocarcinoma Unresectable Fallopian Tube Adenocarcinoma Fallopian tube adenocarcinoma that is resistant to treatment. C170971 Neoplastic Process Refractory Fallopian Tube Adenocarcinoma CL1383230 Malignant Refractory Fallopian Tube Adenocarcinoma Refractory Fallopian Tube Adenocarcinoma Primary peritoneal adenocarcinoma that has spread from its original site of growth to another anatomic site. C170972 Neoplastic Process Metastatic Primary Peritoneal Adenocarcinoma CL1383227 Malignant Metastatic Primary Peritoneal Adenocarcinoma Metastatic Primary Peritoneal Adenocarcinoma Primary peritoneal carcinoma that is not amenable to surgical resection. C170973 Neoplastic Process Unresectable Primary Peritoneal Carcinoma CL1383228 Malignant Unresectable Primary Peritoneal Carcinoma Unresectable Primary Peritoneal Carcinoma Primary peritoneal adenocarcinoma that is not amenable to surgical resection. C170974 Neoplastic Process Unresectable Primary Peritoneal Adenocarcinoma CL1383233 Malignant Unresectable Primary Peritoneal Adenocarcinoma Unresectable Primary Peritoneal Adenocarcinoma Primary peritoneal adenocarcinoma that is resistant to treatment. C170975 Neoplastic Process Refractory Primary Peritoneal Adenocarcinoma CL1383234 Malignant Refractory Primary Peritoneal Adenocarcinoma Refractory Primary Peritoneal Adenocarcinoma An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the colon. It is characterized by the presence of malignant large cells. C170977 Neoplastic Process Colon Large Cell Neuroendocrine Carcinoma CL1383232 Malignant Colon Large Cell Neuroendocrine Carcinoma Colon Large Cell Neuroendocrine Carcinoma Glioblastoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C170978 Neoplastic Process Advanced Glioblastoma Advanced Glioblastoma CL1383251 CTRP Malignant Advanced Glioblastoma Advanced Glioblastoma Glioblastoma that has spread from its original site of growth to another anatomic site. C170979 Neoplastic Process Metastatic Glioblastoma Metastatic Glioblastoma CL1383252 CTRP Malignant Metastatic Glioblastoma Metastatic Glioblastoma Glioblastoma that has spread from its original site of growth to nearby tissues. C170980 Neoplastic Process Locally Advanced Glioblastoma Locally Advanced Glioblastoma CL1383249 CTRP Malignant Locally Advanced Glioblastoma Locally Advanced Glioblastoma The reemergence of prostate adenocarcinoma after a period of remission. C171012 Neoplastic Process Recurrent Prostate Adenocarcinoma Recurrent Prostate Adenocarcinoma C0862638 CTRP Malignant Recurrent Prostate Adenocarcinoma Recurrent Prostate Adenocarcinoma A gliosarcoma arising from the supratentorial region. C171013 Neoplastic Process Supratentorial Gliosarcoma Supratentorial Gliosarcoma CL1383279 CTRP Malignant Supratentorial Gliosarcoma Supratentorial Gliosarcoma The reemergence of triple-negative breast carcinoma after a period of remission. C171014 Neoplastic Process Recurrent Triple-Negative Breast Carcinoma Recurrent Triple-Negative Breast Carcinoma CL1383284 CTRP Malignant Recurrent Triple Negative Breast Carcinoma Recurrent Triple-Negative Breast Carcinoma Recurrent Triple-Negative Breast Carcinoma Ovarian serous adenocarcinoma that is resistant to treatment. C171015 Neoplastic Process Refractory Ovarian Serous Adenocarcinoma Refractory Ovarian Serous Adenocarcinoma CL1383285 CTRP Malignant Refractory Ovarian Serous Adenocarcinoma Refractory Ovarian Serous Adenocarcinoma Fallopian tube high-grade serous adenocarcinoma that has spread from its original site of growth to other anatomic sites. C171016 Neoplastic Process Metastatic Fallopian Tube Serous Adenocarcinoma Metastatic Fallopian Tube High Grade Serous Adenocarcinoma CL1383282 CTRP Malignant Metastatic Fallopian Tube High Grade Serous Adenocarcinoma Metastatic Fallopian Tube High-Grade Serous Adenocarcinoma Metastatic Fallopian Tube Serous Adenocarcinoma Metastatic High Grade Fallopian Tube Serous Adenocarcinoma Metastatic High-Grade Fallopian Tube Serous Adenocarcinoma Metastatic Fallopian Tube High Grade Serous Adenocarcinoma Fallopian tube high-grade serous adenocarcinoma that is not amenable to surgical resection. C171017 Neoplastic Process Unresectable Fallopian Tube Serous Adenocarcinoma Unresectable Fallopian Tube High Grade Serous Adenocarcinoma CL1383283 CTRP Malignant Unresectable Fallopian Tube High Grade Serous Adenocarcinoma Unresectable Fallopian Tube High-Grade Serous Adenocarcinoma Unresectable Fallopian Tube Serous Adenocarcinoma Unresectable High Grade Fallopian Tube Serous Adenocarcinoma Unresectable High-Grade Fallopian Tube Serous Adenocarcinoma Unresectable Fallopian Tube High Grade Serous Adenocarcinoma Primary peritoneal serous adenocarcinoma that has spread from its original site of growth to another anatomic site. C171019 Neoplastic Process Metastatic Primary Peritoneal Serous Adenocarcinoma Metastatic Primary Peritoneal Serous Adenocarcinoma CL1383274 CTRP Malignant Metastatic Primary Peritoneal Serous Adenocarcinoma Metastatic Primary Peritoneal Serous Adenocarcinoma Primary peritoneal serous adenocarcinoma that is not amenable to surgical resection. C171020 Neoplastic Process Unresectable Primary Peritoneal Serous Adenocarcinoma Unresectable Primary Peritoneal Serous Adenocarcinoma CL1383271 CTRP Malignant Unresectable Primary Peritoneal Serous Adenocarcinoma Unresectable Primary Peritoneal Serous Adenocarcinoma Primary peritoneal serous adenocarcinoma that is resistant to treatment. C171021 Neoplastic Process Refractory Primary Peritoneal Serous Adenocarcinoma Refractory Primary Peritoneal Serous Adenocarcinoma CL1383272 CTRP Malignant Refractory Primary Peritoneal Serous Adenocarcinoma Refractory Primary Peritoneal Serous Adenocarcinoma A squamous cell carcinoma associated with human papilloma virus, arising from the mucosal sites of head and neck. C171023 Neoplastic Process Human Papillomavirus-Related Mucosal Head and Neck Squamous Cell Carcinoma Human Papillomavirus-Related Mucosal Head and Neck Squamous Cell Carcinoma CL1383278 CTRP Malignant HPV-Associated Mucosal Head and Neck Squamous Cell Carcinoma HPV-Related Mucosal Head and Neck Squamous Cell Carcinoma Human Papillomavirus-Associated Mucosal Head and Neck Squamous Cell Carcinoma Human Papillomavirus-Related Mucosal Head and Neck Squamous Cell Carcinoma Human Papillomavirus-Related Mucosal Head and Neck Squamous Cell Carcinoma A soft tissue angiosarcoma arising from the internal organs. C171026 Neoplastic Process Visceral Angiosarcoma CL1383291 Malignant Visceral Angiosarcoma Visceral Angiosarcoma An adenoid cystic carcinoma arising from the minor salivary glands in the tongue. C171028 Neoplastic Process Tongue Adenoid Cystic Carcinoma C0861625 Malignant Tongue Adenoid Cystic Carcinoma Tongue Adenoid Cystic Carcinoma A small or large cell neuroendocrine carcinoma arising from the thymus. C171031 Neoplastic Process Thymic Neuroendocrine Carcinoma C2210965 Malignant Thymic Neuroendocrine Carcinoma Thymic Neuroendocrine Carcinoma A small cell carcinoma, pulmonary-type or large cell neuroendocrine carcinoma arising from the ovary. C171032 Neoplastic Process Ovarian Neuroendocrine Carcinoma CL1383293 Malignant Ovarian Neuroendocrine Carcinoma Ovarian Neuroendocrine Carcinoma A small cell or large cell neuroendocrine carcinoma arising from the endometrium. C171033 Neoplastic Process Endometrial Neuroendocrine Carcinoma CL1383294 Malignant Endometrial Neuroendocrine Carcinoma Endometrial Neuroendocrine Carcinoma An anaplastic astrocytoma occurring in the parietal lobe. C171036 Neoplastic Process Parietal Lobe Anaplastic Astrocytoma CL1383286 Malignant Parietal Lobe Anaplastic Astrocytoma Parietal Lobe Anaplastic Astrocytoma Non-Hodgkin lymphoma arising from the mediastinum. C171037 Neoplastic Process Mediastinal Non-Hodgkin Lymphoma CL1383287 Malignant Mediastinal Non-Hodgkin Lymphoma Mediastinal Non-Hodgkin Lymphoma Hairy cell leukemia variant that is resistant to treatment. C171064 Neoplastic Process Refractory Hairy Cell Leukemia Variant Refractory Hairy Cell Leukemia Variant CL1405456 Provisional_Concept CTRP Malignant Refractory Hairy Cell Leukemia Variant Refractory Hairy Cell Leukemia Variant The reemergence of hairy cell leukemia variant after a period of remission. C171065 Neoplastic Process Recurrent Hairy Cell Leukemia Variant Recurrent Hairy Cell Leukemia Variant CL1405455 Provisional_Concept CTRP Malignant Recurrent Hairy Cell Leukemia Variant Recurrent Hairy Cell Leukemia Variant Primary central chondrosarcoma that is not amenable to surgical resection. C171070 Neoplastic Process Unresectable Primary Central Chondrosarcoma Unresectable Primary Central Chondrosarcoma CL1405450 CTRP Malignant Unresectable Primary Central Chondrosarcoma Unresectable Primary Central Chondrosarcoma Primary central chondrosarcoma that has spread from its original site of growth to other anatomic sites. C171072 Neoplastic Process Metastatic Primary Central Chondrosarcoma Metastatic Primary Central Chondrosarcoma CL1405448 CTRP Malignant Metastatic Primary Central Chondrosarcoma Metastatic Primary Central Chondrosarcoma A lymphoma involving the skin. C171101 Neoplastic Process Cutaneous Lymphoma C1302772 Malignant Cutaneous Lymphoma Skin Lymphoma Cutaneous Lymphoma Ann Arbor Stage II diffuse large B-cell lymphoma with a mass of nodes with one diameter more than 10cm or a mediastinal mass larger than one third of the transthoracic width. (Cotswolds modification) C171158 Neoplastic Process Ann Arbor Stage IIX (Bulky) Diffuse Large B-Cell Lymphoma CL1405374 Malignant Ann Arbor Stage IIX (Bulky) Diffuse Large B-Cell Lymphoma Ann Arbor Stage IIX (Bulky) Diffuse Large B-Cell Lymphoma Ann Arbor Stage II non-Hodgkin lymphoma with a mass of nodes with one diameter more than 10cm or a mediastinal mass larger than one third of the transthoracic width. (Cotswolds modification) C171159 Neoplastic Process Ann Arbor Stage IIX (Bulky) Non-Hodgkin Lymphoma CL1405373 Malignant Ann Arbor Stage IIX (Bulky) Non-Hodgkin Lymphoma Ann Arbor Stage IIX (Bulky) Non-Hodgkin Lymphoma Extraskeletal myxoid chondrosarcoma that does not respond to treatment. C171168 Neoplastic Process Refractory Extraskeletal Myxoid Chondrosarcoma Refractory Extraskeletal Myxoid Chondrosarcoma CL1405392 CTRP Malignant Refractory Extraskeletal Myxoid Chondrosarcoma Refractory Extraskeletal Myxoid Chondrosarcoma An extrarenal rhabdoid tumor affecting the ovary. C171169 Neoplastic Process Extrarenal Rhabdoid Tumor of the Ovary CL1405391 Malignant Extrarenal Rhabdoid Tumor of the Ovary Extrarenal Rhabdoid Tumor of the Ovary The reemergence of extrarenal rhabdoid tumor of the ovary after a period of remission. C171170 Neoplastic Process Recurrent Extrarenal Rhabdoid Tumor Of Ovary Recurrent Extrarenal Rhabdoid Tumor of the Ovary CL1405390 CTRP Malignant Recurrent Extrarenal Rhabdoid Tumor of the Ovary Recurrent Extrarenal Rhabdoid Tumor of the Ovary An extrarenal rhabdoid tumor of the ovary that is resistant to treatment. C171171 Neoplastic Process Refractory Extrarenal Rhabdoid Tumor of the Ovary Refractory Extrarenal Rhabdoid Tumor of the Ovary CL1405389 CTRP Malignant Refractory Extrarenal Rhabdoid Tumor of the Ovary Refractory Extrarenal Rhabdoid Tumor of the Ovary A history of a first-degree family member with ovarian cancer. C171218 Group Attribute Family History of Ovarian Cancer C0490017 Family History of Malignant Neoplasm of Ovary Family History of Ovarian Cancer Family History of Ovarian Cancer An individual history of cancer of the respiratory system. C171219 Clinical Attribute Personal History of Respiratory Tract Cancer C0260415 Personal History of Cancer of the Respiratory System Personal History of Malignant Neoplasm of Bronchus and Lung Personal History of Malignant Neoplasm of Respiratory Tract Personal History of Respiratory Tract Cancer Personal History of Respiratory Tract Cancer An individual history of melanoma of the skin. C171220 Clinical Attribute Personal History of Cutaneous Melanoma C0260448 Personal History of Cutaneous Melanoma Personal History of Malignant Melanoma of Skin Personal History of Cutaneous Melanoma An individual history of cancer of the stomach. C171229 Clinical Attribute Personal History of Gastric Cancer C0260409 Personal History of Gastric Cancer Personal History of Malignant Neoplasm of Stomach Personal History of Stomach Cancer Personal History of Gastric Cancer An individual history of cancer of the larynx. C171230 Clinical Attribute Personal History of Laryngeal Cancer C0260419 Personal History of Cancer of the Larynx Personal History of Laryngeal Cancer Personal History of Malignant Neoplasm of Larynx Personal History of Laryngeal Cancer An individual history of cancer of the prostate. C171231 Clinical Attribute Personal History of Prostate Cancer CL1406319 Personal History of Malignant Neoplasm of Prostate Personal History of Prostate Cancer Personal History of Prostatic Cancer Personal History of Prostate Cancer An individual history of leukemia. C171232 Clinical Attribute Personal History of Leukemia C0260437 Personal History of Leukemia Personal History of Leukemia An individual history of lymphoid leukemia. C171233 Clinical Attribute Personal History of Lymphoid Leukemia C0260439 Personal History of Lymphoid Leukemia Personal History of Lymphoid Leukemia An individual history of myeloid leukemia. C171234 Clinical Attribute Personal History of Myeloid Leukemia C0260440 Personal History of Myeloid Leukemia Personal History of Myeloid Leukemia An individual history of a neoplasm of the lymphatic and hematopoietic system. C171235 Clinical Attribute Personal History of Lymphatic and Hematopoietic Neoplasms CL1405558 Personal History of Lymphatic and Hematopoietic Neoplasms Personal History of Neoplasm of Lymphatic and Hematopoietic System Personal History of Lymphatic and Hematopoietic Neoplasms An individual history of cancer of the bone. C171236 Clinical Attribute Personal History of Bone Cancer C0260447 Personal History of Bone Cancer Personal History of Malignant Neoplasm of Bone Personal History of Bone Cancer A history of a first-degree family member with cancer of the gastrointestinal tract. C171237 Group Attribute Family History of Gastrointestinal Tract Cancer C0260506 Family History of Digestive System Cancer Family History of GI Tract Cancer Family History of Gastrointestinal Tract Cancer Family History of Malignant Neoplasm of Digestive System Family History of Malignant Neoplasm of Gastrointestinal Tract Family History of Gastrointestinal Tract Cancer A history of a first-degree family member with cancer of a respiratory or intrathoracic organ. C171238 Group Attribute Family History of Respiratory or Intrathoracic Cancer CL1405557 Family History of Malignant Neoplasm of Respiratory or Intrathoracic Organ Family History of Respiratory or Intrathoracic Cancer Family History of Respiratory or Intrathoracic Cancer A history of a first-degree family member with breast cancer. C171239 Group Attribute Family History of Breast Cancer C1261325 Family History of Breast Cancer Family History of Malignant Neoplasm of Breast Family History of Breast Cancer A history of a first-degree family member with cancer of the reproductive system. C171240 Group Attribute Family History of Reproductive System Cancer C0260510 Family History of Malignant Neoplasm of Genital Organ Family History of Malignant Neoplasm of the Reproductive System Family History of Reproductive System Cancer Family History of Reproductive System Cancer A history of a first-degree family member with prostate cancer. C171241 Group Attribute Family History of Prostate Cancer C1532320 Family History of Malignant Neoplasm of Prostate Family History of Prostate Cancer Family History of Prostatic Cancer Family History of Prostate Cancer A history of a first-degree family member with testicular cancer. C171242 Group Attribute Family History of Testicular Cancer C0490019 Family History of Malignant Neoplasm of Testis Family History of Testicular Cancer Family History of Testicular Cancer A history of a first-degree family member with kidney cancer. C171243 Group Attribute Family History of Kidney Cancer C0700102 Family History of Kidney Cancer Family History of Malignant Neoplasm of Kidney Family History of Kidney Cancer A history of a first-degree family member with cancer of the urinary system. C171244 Group Attribute Family History of Urinary System Cancer C0260511 Family History of Malignant Neoplasm of Urinary Organ Family History of Malignant Neoplasm of Urinary System Family History of Urinary System Cancer Family History of Urinary Tract Cancer Family History of Urinary System Cancer A history of a first-degree family member with leukemia. C171245 Group Attribute Family History of Leukemia C0260512 Family History of Leukemia Family History of Leukemia A history of a first-degree family member with a neoplasm of the lymphatic and hematopoietic system. C171246 Group Attribute Family History of Lymphatic and Hematopoietic Neoplasms CL1405566 Family History of Lymphatic and Hematopoietic Neoplasms Family History of Neoplasm of Lymphatic and Hematopoietic System Family History of Lymphatic and Hematopoietic Neoplasms A history of a first-degree family member with a specified cancer other than those listed. C171247 Group Attribute Family History of Other Specified Cancer C0260514 Family History of Other Specified Cancer Family History of Other Specified Malignant Neoplasm Family History of Other Specified Cancer A history of a first-degree family member with an unspecified cancer. C171248 Group Attribute Family History of Unspecified Cancer C1261378 Family History of Unspecified Cancer Family History of Unspecified Malignant Neoplasm Family History of Unspecified Cancer Diffuse large B-cell lymphoma that has spread extensively to distant anatomic sites or is no longer responding to treatment. C171264 Neoplastic Process Advanced Diffuse Large B-Cell Lymphoma Advanced Diffuse Large B-Cell Lymphoma CL1405571 CTRP Malignant Advanced Diffuse Large B-Cell Lymphoma Advanced Diffuse Large B-Cell Lymphoma Prostate carcinoma that has metastasized to a limited number of sites. C171265 Neoplastic Process Oligometastatic Prostate Carcinoma Oligometastatic Prostate Carcinoma CL1405570 CTRP Malignant Oligometastatic Prostate Carcinoma Oligometastatic Prostate Carcinoma Hypopharyngeal carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C171280 Neoplastic Process Locally Advanced Hypopharyngeal Carcinoma Locally Advanced Hypopharyngeal Carcinoma CL1405584 CTRP Malignant Locally Advanced Hypopharyngeal Carcinoma Locally Advanced Hypopharyngeal Carcinoma Oral cavity carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C171281 Neoplastic Process Locally Advanced Oral Cavity Carcinoma Locally Advanced Oral Cavity Carcinoma CL1405583 CTRP Malignant Locally Advanced Oral Cavity Carcinoma Locally Advanced Oral Cavity Carcinoma A malignant neoplasm of the skin that has spread from its original site of growth to nearby tissues or lymph nodes. C171284 Neoplastic Process Locally Advanced Malignant Skin Neoplasm CL1405580 Malignant Locally Advanced Malignant Skin Neoplasm Locally Advanced Malignant Skin Neoplasm Cutaneous melanoma that has spread from its original site of growth to nearby tissues or lymph nodes. C171285 Neoplastic Process Locally Advanced Cutaneous Melanoma Locally Advanced Cutaneous Melanoma CL1405579 CTRP Malignant Locally Advanced Cutaneous Melanoma Locally Advanced Cutaneous Melanoma The reemergence of lung squamous non-small cell carcinoma after a period of remission. C171286 Neoplastic Process Recurrent Lung Non-Small Cell Squamous Carcinoma Recurrent Lung Non-Small Cell Squamous Carcinoma CL1405578 CTRP Malignant Recurrent Lung Non-Small Cell Squamous Carcinoma Recurrent Lung Non-Small Cell Squamous Carcinoma The reemergence of ocular melanoma after a period of remission. C171294 Neoplastic Process Recurrent Ocular Melanoma Recurrent Ocular Melanoma CL1405599 CTRP Malignant Recurrent Ocular Melanoma Recurrent Ocular Melanoma Ocular melanoma that has spread from its original site of growth to another anatomic site. C171295 Neoplastic Process Metastatic Ocular Melanoma Metastatic Ocular Melanoma C2242657 CTRP Malignant Metastatic Ocular Melanoma Metastatic Ocular Melanoma Ocular melanoma that has spread from its original site of growth to nearby tissues. C171296 Neoplastic Process Locally Advanced Ocular Melanoma Locally Advanced Ocular Melanoma CL1405598 CTRP Malignant Locally Advanced Ocular Melanoma Locally Advanced Ocular Melanoma Liver carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C171298 Neoplastic Process Locally Advanced Liver Carcinoma Locally Advanced Liver Carcinoma CL1405596 CTRP Malignant Locally Advanced Liver Carcinoma Locally Advanced Liver Carcinoma A B-cell non-Hodgkin lymphoma with an indolent clinical course. Representative examples include grade 1 and grade 2 follicular lymphoma, marginal zone lymphoma, and lymphoplasmacytic lymphoma. C171299 Neoplastic Process Indolent B-Cell Non-Hodgkin Lymphoma Indolent B-Cell Non-Hodgkin Lymphoma CL1405595 CTRP Malignant Indolent B-Cell Non-Hodgkin Lymphoma Indolent B-Cell Non-Hodgkin Lymphoma A T-cell non-Hodgkin lymphoma with an indolent clinical course. C171300 Neoplastic Process Indolent T-Cell Non-Hodgkin Lymphoma CL1405594 Malignant Indolent T-Cell Non-Hodgkin Lymphoma Indolent T-Cell Non-Hodgkin Lymphoma Myxofibrosarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C171304 Neoplastic Process Advanced Myxofibrosarcoma Advanced Myxofibrosarcoma CL1405592 CTRP Malignant Advanced Myxofibrosarcoma Advanced Myxofibrosarcoma Fibrosarcoma that has spread from its original site of growth to nearby tissues or lymph nodes. C171317 Neoplastic Process Locally Advanced Fibrosarcoma CL1405604 Malignant Locally Advanced Fibrosarcoma Locally Advanced Fibrosarcoma Bile duct carcinoma that is not amenable to surgical resection. C171322 Neoplastic Process Unresectable Bile Duct Carcinoma Unresectable Bile Duct Carcinoma CL1405621 CTRP Malignant Unresectable Bile Duct Carcinoma Unresectable Bile Duct Carcinoma Carcinoma that arises from the ampulla of Vater and has spread to another anatomic site. C171326 Neoplastic Process Metastatic Ampulla of Vater Carcinoma Metastatic Ampulla of Vater Carcinoma CL1405618 CTRP Malignant Metastatic Ampulla of Vater Carcinoma Metastatic Ampulla of Vater Carcinoma Carcinoma that arises from the ampulla of Vater and has spread to nearby tissues or lymph nodes. C171327 Neoplastic Process Locally Advanced Ampulla of Vater Carcinoma Locally Advanced Ampulla of Vater Carcinoma CL1405617 CTRP Malignant Locally Advanced Ampulla of Vater Carcinoma Locally Advanced Ampulla of Vater Carcinoma Carcinoma that arises from the ampulla of Vater and has spread extensively to other anatomic sites or is no longer responding to treatment. C171329 Neoplastic Process Advanced Ampulla of Vater Carcinoma Advanced Ampulla of Vater Carcinoma CL1405616 CTRP Malignant Advanced Ampulla of Vater Carcinoma Advanced Ampulla of Vater Carcinoma A carcinoma that arises from the pancreas, bile ducts, gallbladder, or ampulla of Vater and has spread extensively to other anatomic sites or is no longer responding to treatment. C171330 Neoplastic Process Advanced Pancreatobiliary Carcinoma CL1405615 Malignant Advanced Pancreatobiliary Carcinoma Advanced Pancreatobiliary Carcinoma Carcinoma that arises from the intrahepatic, hilar, extrahepatic bile ducts, cystic duct, or gallbladder and has spread extensively to other anatomic sites or is no longer responding to treatment. C171331 Neoplastic Process Advanced Biliary Tract Carcinoma CL1405614 Malignant Advanced Biliary Tract Carcinoma Advanced Biliary Tract Carcinoma A myelodysplastic/myeloproliferative neoplasm that is resistant to treatment. C171339 Neoplastic Process Refractory Myelodysplastic/Myeloproliferative Neoplasm Refractory Myelodysplastic/Myeloproliferative Neoplasm CL1405465 CTRP Malignant Refractory Myelodysplastic/Myeloproliferative Neoplasm Refractory Myelodysplastic/Myeloproliferative Neoplasm Primary myelofibrosis that is resistant to treatment. C171340 Neoplastic Process Refractory Primary Myelofibrosis Refractory Primary Myelofibrosis CL1405464 CTRP Malignant Refractory Primary Myelofibrosis Refractory Primary Myelofibrosis Synovial sarcoma that has spread from its original site of growth to nearby tissues or lymph nodes. C171399 Neoplastic Process Locally Advanced Synovial Sarcoma Locally Advanced Synovial Sarcoma CL1405497 CTRP Malignant Locally Advanced Synovial Sarcoma Locally Advanced Synovial Sarcoma Stereotactic body radiation therapy that uses CT imaging to define and localize the area to be treated. C171423 Therapeutic or Preventive Procedure CT-guided Stereotactic Body Radiation Therapy CT-guided Stereotactic Body Radiation Therapy CL1405525 CTRP CT-guided SBRT CT-guided Stereotactic Body Radiation Therapy Computed Tomography-Guided Stereotactic Body Radiation Therapy CT-guided Stereotactic Body Radiation Therapy Stereotactic body radiation therapy that uses MR imaging to define and localize the area to be treated. C171424 Therapeutic or Preventive Procedure MRI-guided Stereotactic Body Radiation Therapy MRI-guided Stereotactic Body Radiation Therapy CL1405524 CTRP MR-guided SBRT MRI-guided SBRT MRI-guided Stereotactic Body Radiation Therapy Magnetic Resonance Imaging-guided Stereotactic Body Radiation Therapy MRI-guided Stereotactic Body Radiation Therapy Cutaneous melanoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C171572 Neoplastic Process Advanced Cutaneous Melanoma Advanced Cutaneous Melanoma CL1405795 CTRP Malignant Advanced Cutaneous Melanoma Advanced Cutaneous Melanoma Cutaneous squamous cell carcinoma of the head and neck that has spread from the original site of growth to another anatomic site. C171573 Neoplastic Process Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck CL1405794 CTRP Malignant Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck Cutaneous squamous cell carcinoma of the head and neck that has spread extensively to other anatomic sites or is no longer responding to treatment. C171574 Neoplastic Process Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck CL1405793 CTRP Malignant Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck Cutaneous squamous cell carcinoma of the head and neck that does not respond to treatment. C171575 Neoplastic Process Refractory Cutaneous Squamous Cell Carcinoma of the Head and Neck Refractory Cutaneous Squamous Cell Carcinoma of the Head and Neck CL1405792 CTRP Malignant Refractory Cutaneous Squamous Cell Carcinoma of the Head and Neck Refractory Cutaneous Squamous Cell Carcinoma of the Head and Neck A lethal form of advanced castration-resistant prostate carcinoma that emerges in the later stages of castration-resistant treatment. It is an adaptive response to androgen receptor pathway inhibition. The morphologic features vary, ranging from poorly differentiated carcinomas to mixed adenocarcinoma-small cell carcinomas to pure small cell carcinomas expressing neuroendocrine markers. Clinically, it manifests with rapidly progressive disease, visceral or lytic bone metastases and bulky tumor masses. Molecular studies have shown the loss of tumor suppressor genes TP53 and RB1. C171576 Neoplastic Process Aggressive Variant Prostate Carcinoma CL1405791 Malignant AVPCa Aggressive Variant Prostate Cancer Aggressive Variant Prostate Carcinoma Anaplastic Prostate Cancer Anaplastic Prostate Carcinoma Metastatic Aggressive Variant Prostate Cancer Metastatic Aggressive Variant Prostate Carcinoma Treatment-Related Anaplastic Prostate Cancer Treatment-Related Anaplastic Prostate Carcinoma Aggressive Variant Prostate Carcinoma Chromophobe renal cell carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C171579 Neoplastic Process Advanced Chromophobe Renal Cell Carcinoma Advanced Chromophobe Renal Cell Carcinoma CL1405817 CTRP Malignant Advanced Chromophobe Renal Cell Carcinoma Advanced Chromophobe Renal Cell Carcinoma Chromophobe renal cell carcinoma that has spread from the original site of growth to another anatomic site. C171580 Neoplastic Process Metastatic Chromophobe Renal Cell Carcinoma Metastatic Chromophobe Renal Cell Carcinoma CL1405816 CTRP Malignant Metastatic Chromophobe Renal Cell Carcinoma Metastatic Chromophobe Renal Cell Carcinoma Sarcomatoid renal cell carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C171581 Neoplastic Process Advanced Sarcomatoid Renal Cell Carcinoma Advanced Sarcomatoid Renal Cell Carcinoma CL1405815 CTRP Malignant Advanced Sarcomatoid Renal Cell Carcinoma Advanced Sarcomatoid Renal Cell Carcinoma A renal cell carcinoma, not otherwise specified, that has spread extensively to other anatomic sites or is no longer responding to treatment. C171582 Neoplastic Process Advanced Unclassified Renal Cell Carcinoma Advanced Renal Cell Carcinoma, Not Otherwise Specified CL1405814 CTRP Malignant Advanced Renal Cell Carcinoma, Not Otherwise Specified Advanced Unclassified Renal Cell Carcinoma Advanced Renal Cell Carcinoma, Not Otherwise Specified A renal cell carcinoma, not otherwise specified, that has spread from the original site of growth to another anatomic site. C171583 Neoplastic Process Metastatic Unclassified Renal Cell Carcinoma Metastatic Renal Cell Carcinoma, Not Otherwise Specified CL1405813 CTRP Malignant Metastatic Renal Cell Carcinoma, Not Otherwise Specified Metastatic Unclassified Renal Cell Carcinoma Metastatic Renal Cell Carcinoma, Not Otherwise Specified Colorectal adenocarcinoma that is not amenable to surgical resection. C171585 Neoplastic Process Unresectable Colorectal Adenocarcinoma Unresectable Colorectal Adenocarcinoma CL1405811 CTRP Malignant Unresectable Colorectal Adenocarcinoma Unresectable Colorectal Adenocarcinoma Esophageal carcinoma that is resistant to treatment. C171604 Neoplastic Process Refractory Esophageal Carcinoma CL1405824 Malignant Refractory Esophageal Carcinoma Refractory Esophageal Carcinoma Esophageal squamous cell carcinoma that is resistant to treatment. C171606 Neoplastic Process Refractory Esophageal Squamous Cell Carcinoma Refractory Esophageal Squamous Cell Carcinoma CL1405822 CTRP Malignant Refractory Esophageal Squamous Cell Carcinoma Refractory Esophageal Squamous Cell Carcinoma Esophageal squamous cell carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment C171607 Neoplastic Process Advanced Esophageal Squamous Cell Carcinoma Advanced Esophageal Squamous Cell Carcinoma CL1405821 CTRP Malignant Advanced Esophageal Squamous Cell Carcinoma Advanced Esophageal Squamous Cell Carcinoma Esophageal squamous cell carcinoma that is not amenable to surgical resection. C171608 Neoplastic Process Unresectable Esophageal Squamous Cell Carcinoma Unresectable Esophageal Squamous Cell Carcinoma CL1405820 CTRP Malignant Unresectable Esophageal Squamous Cell Carcinoma Unresectable Esophageal Squamous Cell Carcinoma Lung non-small cell squamous carcinoma that is resistant to treatment. C171609 Neoplastic Process Refractory Lung Non-Small Cell Squamous Carcinoma Refractory Lung Non-Small Cell Squamous Carcinoma CL1405819 CTRP Malignant Refractory Lung Non-Small Cell Squamous Carcinoma Refractory Lung Non-Small Cell Squamous Carcinoma Endometrial carcinoma that is not amenable to surgical resection. C171610 Neoplastic Process Unresectable Endometrial Carcinoma Unresectable Endometrial Carcinoma CL1405843 CTRP Malignant Unresectable Endometrial Carcinoma Unresectable Endometrial Carcinoma Prostate carcinoma that is not amenable to surgical resection. C171611 Neoplastic Process Unresectable Prostate Carcinoma Unresectable Prostate Carcinoma CL1405842 CTRP Malignant Unresectable Prostate Carcinoma Unresectable Prostate Carcinoma Lung non-small cell squamous carcinoma that is not amenable to surgical resection. C171612 Neoplastic Process Unresectable Lung Non-Small Cell Squamous Carcinoma Unresectable Lung Non-Small Cell Squamous Carcinoma CL1405841 CTRP Malignant Unresectable Lung Non-Small Cell Squamous Carcinoma Unresectable Lung Non-Small Cell Squamous Carcinoma A necessary but unplanned imaging procedure. C172046 Diagnostic Procedure Unexpected Imaging Required CL1405945 FDA Requirement for imaging that was not originally planned. IMDRF:F2203 Imaging Required Unexpected Imaging Required Unexpected Imaging Required A proprietary method for obtaining high-quality, high-resolution diffusion weighted (DWI) images even in body regions susceptible to artifacts. It is designed to be largely free of distortions and deliver sharp imaging at very higher spatial resolution. C172054 Diagnostic Procedure RESOLVE Diffuse Weighted Imaging RESOLVE Multishot Diffusion Weighted Echoplanar Imaging CL1406299 CTRP RESOLVE RESOLVE DWI RESOLVE Diffuse Weighted Imaging RESOLVE Multishot Diffusion Weighted Echoplanar Imaging RESOLVE Multishot Diffusion Weighted Echoplanar Scanning RESOLVE Multishot Diffusion Weighted Echoplanar Imaging An acute myeloid leukemia developing in patients with a prior history of myeloproliferative neoplasm. C172129 Neoplastic Process Acute Myeloid Leukemia Arising from Previous Myeloproliferative Neoplasm CL1406252 Malignant Acute Myeloid Leukemia Arising from Previous Myeloproliferative Neoplasm Acute Myeloid Leukemia Arising from Previous Myeloproliferative Neoplasm An acute myeloid leukemia developing in patients with a prior history of myelodysplastic/myeloproliferative neoplasm. C172130 Neoplastic Process Acute Myeloid Leukemia Arising from Previous Myelodysplastic/Myeloproliferative Neoplasm CL1406251 Malignant Acute Myeloid Leukemia Arising from Previous Myelodysplastic/Myeloproliferative Neoplasm Acute Myeloid Leukemia Arising from Previous Myelodysplastic/Myeloproliferative Neoplasm The reemergence of a myeloid neoplasm after a period of remission. C172132 Neoplastic Process Recurrent Myeloid Neoplasm CL1406250 Malignant Recurrent Myeloid Neoplasm Recurrent Myeloid Neoplasm The reemergence of a malignant lymphoid neoplasm after a period of remission. C172133 Neoplastic Process Recurrent Malignant Lymphoid Neoplasm CL1406249 Malignant Recurrent Malignant Lymphoid Neoplasm Recurrent Malignant Lymphoid Neoplasm A rare hemangioma occurring mainly in middle-aged adults. The most common location is in the trunk. The lesions are small, asymptomatic, and bluish. They are composed of irregular, dilated, congested thin-walled vascular channels with scant smooth muscle in a sinusoidal or sieve-like pattern. (WHO 2018) C172206 Neoplastic Process Sinusoidal Hemangioma CL477621 Benign Sinusoidal Hemangioma Sinusoidal Hemangioma Congenital hemangioma that regresses completely. C172207 Neoplastic Process Rapidly Involuting Congenital Hemangioma C1275421 Benign RICH Rapidly Involuting Congenital Hemangioma Rapidly Involuting Congenital Hemangioma Congenital hemangioma that does not regress. C172208 Neoplastic Process Non-Involuting Congenital Hemangioma C1275417 Benign NICH Non-Involuting Congenital Hemangioma Non-Involuting Congenital Hemangioma Congenital hemangioma that regresses incompletely. C172209 Neoplastic Process Partially Involuting Congenital Hemangioma CL507874 Benign PICH Partially Involuting Congenital Hemangioma Partially Involuting Congenital Hemangioma Papillary renal cell carcinoma that has spread to nearby tissues or lymph nodes. C172218 Neoplastic Process Locally Advanced Papillary Renal Cell Carcinoma Locally Advanced Papillary Renal Cell Carcinoma CL1406104 CTRP Malignant Locally Advanced Papillary Renal Cell Carcinoma Locally Advanced Papillary Renal Cell Carcinoma Sarcomatoid renal cell carcinoma that has spread to nearby tissues or lymph nodes. C172219 Neoplastic Process Locally Advanced Sarcomatoid Renal Cell Carcinoma Locally Advanced Sarcomatoid Renal Cell Carcinoma CL1406103 CTRP Malignant Locally Advanced Sarcomatoid Renal Cell Carcinoma Locally Advanced Sarcomatoid Renal Cell Carcinoma A renal cell carcinoma, not otherwise specified, that has spread to nearby tissues or lymph nodes. C172222 Neoplastic Process Locally Advanced Unclassified Renal Cell Carcinoma Locally Advanced Renal Cell Carcinoma, Not Otherwise Specified CL1406100 CTRP Malignant Locally Advanced Renal Cell Carcinoma, Not Otherwise Specified Locally Advanced Unclassified Renal Cell Carcinoma Locally Advanced Renal Cell Carcinoma, Not Otherwise Specified Esophageal adenocarcinoma that has spread to nearby tissues or lymph nodes. C172227 Neoplastic Process Locally Advanced Esophageal Adenocarcinoma Locally Advanced Esophageal Adenocarcinoma CL1406098 CTRP Malignant Locally Advanced Esophageal Adenocarcinoma Locally Advanced Esophageal Adenocarcinoma An indication that a variant in a BRCA family gene has been identified in a family member of a subject. C172230 Clinical Attribute Family History of BRCA Mutation CL1406124 GDC BRCA Family History BRCA Family History Family History of BRCA Mutation Family History of BRCA Mutation Ovarian undifferentiated carcinoma that has spread from its original site of growth to another anatomic site. C172234 Neoplastic Process Metastatic Ovarian Undifferentiated Carcinoma Metastatic Ovarian Undifferentiated Carcinoma CL1406121 CTRP Malignant Metastatic Ovarian Undifferentiated Carcinoma Metastatic Ovarian Undifferentiated Carcinoma Ovarian undifferentiated carcinoma that is not amenable to surgical resection. C172235 Neoplastic Process Unresectable Ovarian Undifferentiated Carcinoma Unresectable Ovarian Undifferentiated Carcinoma CL1406120 CTRP Malignant Unresectable Ovarian Undifferentiated Carcinoma Unresectable Ovarian Undifferentiated Carcinoma Distal bile duct adenocarcinoma that is not amenable to surgical resection. C172241 Neoplastic Process Unresectable Distal Bile Duct Adenocarcinoma Unresectable Distal Bile Duct Adenocarcinoma CL1406114 CTRP Malignant Unresectable Distal Bile Duct Adenocarcinoma Unresectable Distal Bile Duct Adenocarcinoma Distal bile duct adenocarcinoma that has spread from its original site of growth to another anatomic site. C172242 Neoplastic Process Metastatic Distal Bile Duct Adenocarcinoma Metastatic Distal Bile Duct Adenocarcinoma CL1406113 CTRP Malignant Metastatic Distal Bile Duct Adenocarcinoma Metastatic Extrahepatic Cholangiocarcinoma Metastatic Distal Bile Duct Adenocarcinoma Pancreatic ductal adenocarcinoma that is not amenable to surgical resection. C172245 Neoplastic Process Unresectable Pancreatic Ductal Adenocarcinoma Unresectable Pancreatic Ductal Adenocarcinoma CL1406110 CTRP Malignant Unresectable Pancreatic Ductal Adenocarcinoma Unresectable Pancreatic Ductal Adenocarcinoma Uveal melanoma that is not amenable to surgical resection. C172247 Neoplastic Process Unresectable Uveal Melanoma Unresectable Uveal Melanoma CL1406138 CTRP Malignant Unresectable Uveal Melanoma Unresectable Uveal Melanoma Distal esophagus adenocarcinoma that is not amenable to surgical resection. C172248 Neoplastic Process Unresectable Distal Esophagus Adenocarcinoma Unresectable Distal Esophagus Adenocarcinoma CL1406137 CTRP Malignant Unresectable Distal Esophagus Adenocarcinoma Unresectable Distal Esophagus Adenocarcinoma Distal esophagus adenocarcinoma that has spread from its original site of growth to another anatomic site. C172249 Neoplastic Process Metastatic Distal Esophagus Adenocarcinoma Metastatic Distal Esophagus Adenocarcinoma CL1406136 CTRP Malignant Metastatic Distal Esophagus Adenocarcinoma Metastatic Distal Esophagus Adenocarcinoma Intrahepatic cholangiocarcinoma that has spread from its original site of growth to another anatomic site. C172252 Neoplastic Process Metastatic Intrahepatic Cholangiocarcinoma Metastatic Intrahepatic Cholangiocarcinoma CL1406133 CTRP Malignant Metastatic Intrahepatic Cholangiocarcinoma Metastatic Intrahepatic Cholangiocarcinoma Renal pelvis and ureter urothelial carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C172276 Neoplastic Process Advanced Renal Pelvis and Ureter Urothelial Carcinoma CL1406141 Malignant Advanced Renal Pelvis and Ureter Urothelial Carcinoma Advanced Renal Pelvis and Ureter Urothelial Carcinoma Renal pelvis carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C172277 Neoplastic Process Locally Advanced Renal Pelvis Carcinoma CL1406140 Malignant Locally Advanced Renal Pelvis Carcinoma Locally Advanced Renal Pelvis Carcinoma Renal pelvis urothelial carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C172278 Neoplastic Process Advanced Renal Pelvis Urothelial Carcinoma Advanced Renal Pelvis Urothelial Carcinoma CL1406167 CTRP Malignant Advanced Renal Pelvis Urothelial Carcinoma Advanced Renal Pelvis Urothelial Carcinoma A malignant lymphoid neoplasm that does not respond to treatment. C172280 Neoplastic Process Refractory Malignant Lymphoid Neoplasm CL1406165 Malignant Refractory Malignant Lymphoid Neoplasm Refractory Malignant Lymphoid Neoplasm A myeloid neoplasm that does not respond to treatment. C172281 Neoplastic Process Refractory Myeloid Neoplasm CL1406164 Malignant Refractory Myeloid Neoplasm Refractory Myeloid Neoplasm Chronic lymphocytic leukemia/small lymphocytic lymphoma that does not respond to treatment. C172282 Neoplastic Process Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma CL1406163 CTRP Malignant Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma The reemergence of a plasma cell neoplasm after a period of remission. C172289 Neoplastic Process Recurrent Plasma Cell Neoplasm CL1406156 Malignant Recurrent Plasma Cell Neoplasm Recurrent Plasma Cell Neoplasm The use of high-frequency sound waves to generate images of the body. C17230 Health Care Activity Ultrasonography Ultrasound Imaging C0041618 CDISC CTRP GDC NICHD OORO A procedure in which high-energy sound waves are bounced off internal tissues or organs and make echoes. The echo patterns are shown on the screen of an ultrasound machine, forming a picture of body tissues called a sonogram. A technique in which high-frequency sound waves are bounced off internal organs and the echo pattern is converted into a 2 dimensional picture of the structures beneath the transducer. Ultrasound_Imaging Ultrasound 2-Dimensional Grayscale Ultrasound Imaging 2-Dimensional Ultrasound Imaging 2D-US ULTRASOUND US Ultrasonography Ultrasound Ultrasound Imaging Ultrasound Test Ultrasound, Medical ultrasonography ultrasound Ultrasound Imaging Grade 1 follicular lymphoma that is resistant to treatment. C172309 Neoplastic Process Refractory Grade 1 Follicular Lymphoma Refractory Grade 1 Follicular Lymphoma CL1406168 CTRP Malignant Refractory Grade 1 Follicular Lymphoma Refractory Grade 1 Follicular Lymphoma Grade 2 follicular lymphoma that is resistant to treatment. C172312 Neoplastic Process Refractory Grade 2 Follicular Lymphoma Refractory Grade 2 Follicular Lymphoma CL1406184 CTRP Malignant Refractory Grade 2 Follicular Lymphoma Refractory Grade 2 Follicular Lymphoma Grade 3 follicular lymphoma that is resistant to treatment. C172314 Neoplastic Process Refractory Grade 3 Follicular Lymphoma CL1406183 Malignant Refractory Grade 3 Follicular Lymphoma Refractory Grade 3 Follicular Lymphoma Grade 3a follicular lymphoma that is resistant to treatment. C172315 Neoplastic Process Refractory Grade 3a Follicular Lymphoma Refractory Grade 3a Follicular Lymphoma CL1406182 CTRP Malignant Refractory Grade 3a Follicular Lymphoma Refractory Grade 3a Follicular Lymphoma Grade 3b follicular lymphoma that is resistant to treatment. C172318 Neoplastic Process Refractory Grade 3b Follicular Lymphoma CL1406181 Malignant Refractory Follicular Large B-Cell Lymphoma Refractory Grade 3b Follicular Lymphoma Refractory Grade 3b Follicular Lymphoma The reemergence of grade 3b follicular lymphoma after a period of remission. C172323 Neoplastic Process Recurrent Grade 3b Follicular Lymphoma CL1406179 Malignant Recurrent Follicular Large B-Cell Lymphoma Recurrent Grade 3b Follicular Lymphoma Recurrent Grade 3b Follicular Lymphoma Esophageal squamous cell carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C172358 Neoplastic Process Locally Advanced Esophageal Squamous Cell Carcinoma Locally Advanced Esophageal Squamous Cell Carcinoma CL1406489 CTRP Malignant Locally Advanced Esophageal Squamous Cell Carcinoma Locally Advanced Esophageal Squamous Cell Carcinoma Follicular lymphoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C172359 Neoplastic Process Advanced Follicular Lymphoma Advanced Follicular Lymphoma CL1406519 CTRP Malignant Advanced Follicular Lymphoma Advanced Follicular Lymphoma Marginal zone lymphoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C172360 Neoplastic Process Advanced Marginal Zone Lymphoma Advanced Marginal Zone Lymphoma CL1406518 CTRP Malignant Advanced Marginal Zone Lymphoma Advanced Marginal Zone Lymphoma Transformed non-Hodgkin lymphoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C172361 Neoplastic Process Advanced Transformed Non-Hodgkin Lymphoma Advanced Transformed Non-Hodgkin Lymphoma CL1406521 CTRP Malignant Advanced Transformed Non-Hodgkin Lymphoma Advanced Transformed Non-Hodgkin Lymphoma Non-Hodgkin lymphoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C172371 Neoplastic Process Advanced Non-Hodgkin Lymphoma CL1406531 Malignant Advanced Non-Hodgkin Lymphoma Advanced Non-Hodgkin Lymphoma Hodgkin lymphoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C172373 Neoplastic Process Advanced Hodgkin Lymphoma CL1406533 Malignant Advanced Hodgkin Lymphoma Advanced Hodgkin Lymphoma Primary cutaneous T-cell non-Hodgkin lymphoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C172442 Neoplastic Process Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma CL1406363 CTRP Malignant Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Uterine corpus cancer that has spread extensively to other anatomic sites or is no longer responding to treatment. C172450 Neoplastic Process Advanced Uterine Corpus Cancer Advanced Uterine Corpus Cancer CL1406366 CTRP Malignant Advanced Uterine Corpus Cancer Advanced Uterine Corpus Cancer A type of positron emission tomography scan in which the images are not enhanced by the addition of contrast agents into the body. C172562 Diagnostic Procedure Contrast Enhanced PET Scan CL1406691 CDISC A type of PET scan in which images are enhanced by the addition of contrast agents into the body. CONTRAST ENHANCED PET SCAN Contrast Enhanced PET Scan PET Scan With Contrast Contrast Enhanced PET Scan Kidney carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C172617 Neoplastic Process Advanced Kidney Carcinoma CL1406704 Malignant Advanced Kidney Carcinoma Advanced Kidney Carcinoma Kidney carcinoma that has spread to nearby tissues or lymph nodes. C172618 Neoplastic Process Locally Advanced Kidney Carcinoma CL1406707 Malignant Locally Advanced Kidney Carcinoma Locally Advanced Kidney Carcinoma Kidney medullary carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C172620 Neoplastic Process Advanced Kidney Medullary Carcinoma Advanced Kidney Medullary Carcinoma CL1406737 CTRP Malignant Advanced Kidney Medullary Carcinoma Advanced Kidney Medullary Carcinoma A rare perineurioma arising from the skin. C172621 Neoplastic Process Cutaneous Perineurioma CL1406736 Benign Cutaneous Perineurioma Cutaneous Perineurioma The reemergence of kidney carcinoma after a period of remission. C172622 Neoplastic Process Recurrent Kidney Carcinoma CL1406739 Malignant Recurrent Kidney Carcinoma Recurrent Kidney Carcinoma Kidney carcinoma that is resistant to treatment. C172623 Neoplastic Process Refractory Kidney Carcinoma CL1406738 Malignant Refractory Kidney Carcinoma Refractory Kidney Carcinoma A malignant peripheral nerve sheath tumor that arises from the skin. C172624 Neoplastic Process Malignant Peripheral Nerve Sheath Tumor of the Skin CL1406741 Malignant Cutaneous Malignant Peripheral Nerve Sheath Tumor Dermal Malignant Peripheral Nerve Sheath Tumor Malignant Peripheral Nerve Sheath Tumor of the Skin Skin Malignant Peripheral Nerve Sheath Tumor Malignant Peripheral Nerve Sheath Tumor of the Skin An epithelioid malignant peripheral nerve sheath tumor that arises from the skin. C172625 Neoplastic Process Epithelioid Malignant Peripheral Nerve Sheath Tumor of the Skin CL1406740 Malignant Cutaneous Epithelioid Malignant Peripheral Nerve Sheath Tumor Dermal Epithelioid Malignant Peripheral Nerve Sheath Tumor Epithelioid Malignant Peripheral Nerve Sheath Tumor of the Skin Skin Epithelioid Malignant Peripheral Nerve Sheath Tumor Epithelioid Malignant Peripheral Nerve Sheath Tumor of the Skin The reemergence of acute leukemia of ambiguous lineage after a period of remission. C172626 Neoplastic Process Recurrent Acute Leukemia of Ambiguous Lineage Recurrent Acute Leukemia of Ambiguous Lineage CL1406743 CTRP Malignant Recurrent Acute Leukemia of Ambiguous Lineage Recurrent Acute Leukemia of Ambiguous Lineage Magnetic resonance imaging that uses T1ρ relaxation time as a contrast mechanism. It is useful in the study of low-frequency motional processes and chemical exchange in biological tissues. C172628 Diagnostic Procedure T1 Rho Magnetic Resonance Imaging T1 Rho Magnetic Resonance Imaging CL1406742 CTRP Spin Lock MRI T1 Rho MRI T1 Rho Magnetic Resonance Imaging T1rho MRI T1rho-weighted MR Imaging T1rho-weighted MRI T1ρ MRI T1 Rho Magnetic Resonance Imaging A printing process of electrostatic electrophotography that uses a photoconductive insulating medium in conjunction with X-rays or gamma rays to produce latent electrostatic-charge patterns for achieving an observable pattern. C17263 Diagnostic Procedure Xeroradiography C0043350 A type of x-ray in which a picture of the body is recorded on paper rather than on film. Xeroradiography Xeroradiography xeroradiography Xeroradiography Acute leukemia of ambiguous lineage that is resistant to treatment. C172630 Neoplastic Process Refractory Acute Leukemia of Ambiguous Lineage Refractory Acute Leukemia of Ambiguous Lineage CL1406744 CTRP Malignant Refractory Acute Leukemia of Ambiguous Lineage Refractory Acute Leukemia of Ambiguous Lineage Myxofibrosarcoma that arises from the dermis. C172632 Neoplastic Process Skin Myxofibrosarcoma C1275975 Malignant Dermal Myxofibrosarcoma Skin Myxofibrosarcoma Skin Myxofibrosarcoma A rare Ewing sarcoma that arises from the skin. C172634 Neoplastic Process Skin Ewing Sarcoma CL1406745 Malignant Cutaneous Ewing Sarcoma Skin Ewing Sarcoma Skin Ewing Sarcoma A rare, low-grade skin neoplasm of mesenchymal cells of unknown lineage with prominent cytoplasmic granularity. The lesions are most commonly non-ulcerated papules or nodules. Most cases are indolent, despite worrisome histopathologic features. Few cases with regional lymph node metastasis have been reported. (WHO 2018) C172637 Neoplastic Process Primitive Non-Neural Granular Cell Tumor CL978773 Uncertain Malignant Potential Dermal Non-Neural Granular Cell Tumor Non-Neural Granular Cell Tumor PNNGCT Primitive Non-Neural Granular Cell Tumor Primitive Polypoid Granular Cell Tumor Primitive Non-Neural Granular Cell Tumor Oral cavity squamous cell carcinoma that is not amenable to surgical resection. C172644 Neoplastic Process Unresectable Oral Cavity Squamous Cell Carcinoma Unresectable Oral Cavity Squamous Cell Carcinoma CL1406724 CTRP Malignant Unresectable Oral Cavity Squamous Cell Carcinoma Unresectable Oral Cavity Squamous Cell Carcinoma Laryngeal squamous cell carcinoma that is not amenable to surgical resection. C172645 Neoplastic Process Unresectable Laryngeal Squamous Cell Carcinoma Unresectable Laryngeal Squamous Cell Carcinoma CL1406727 CTRP Malignant Unresectable Laryngeal Squamous Cell Carcinoma Unresectable Laryngeal Squamous Cell Carcinoma Hypopharyngeal squamous cell carcinoma that is not amenable to surgical resection. C172646 Neoplastic Process Unresectable Hypopharyngeal Squamous Cell Carcinoma Unresectable Hypopharyngeal Squamous Cell Carcinoma CL1406726 CTRP Malignant Unresectable Hypopharyngeal Squamous Cell Carcinoma Unresectable Hypopharyngeal Squamous Cell Carcinoma Nasopharyngeal squamous cell carcinoma that is not amenable to surgical resection. C172647 Neoplastic Process Unresectable Nasopharyngeal Squamous Cell Carcinoma Unresectable Nasopharyngeal Squamous Cell Carcinoma CL1406729 CTRP Malignant Unresectable Nasopharyngeal Squamous Cell Carcinoma Unresectable Nasopharyngeal Squamous Cell Carcinoma Paranasal sinus squamous cell carcinoma that is not amenable to surgical resection. C172648 Neoplastic Process Unresectable Paranasal Sinus Squamous Cell Carcinoma Unresectable Paranasal Sinus Squamous Cell Carcinoma CL1406728 CTRP Malignant Unresectable Paranasal Sinus Squamous Cell Carcinoma Unresectable Paranasal Sinus Squamous Cell Carcinoma Salivary gland squamous cell carcinoma that has spread from the original site of growth to another anatomic site. C172649 Neoplastic Process Metastatic Salivary Gland Squamous Cell Carcinoma Metastatic Salivary Gland Squamous Cell Carcinoma CL1406731 CTRP Malignant Metastatic Salivary Gland Squamous Cell Carcinoma Metastatic Salivary Gland Squamous Cell Carcinoma The reemergence of salivary gland squamous cell carcinoma after a period of remission. C172650 Neoplastic Process Recurrent Salivary Gland Squamous Cell Carcinoma Recurrent Salivary Gland Squamous Cell Carcinoma CL1406730 CTRP Malignant Recurrent Salivary Gland Squamous Cell Carcinoma Recurrent Salivary Gland Squamous Cell Carcinoma Salivary gland squamous cell carcinoma that is not amenable to surgical resection. C172651 Neoplastic Process Unresectable Salivary Gland Squamous Cell Carcinoma Unresectable Salivary Gland Squamous Cell Carcinoma CL1406733 CTRP Malignant Unresectable Salivary Gland Squamous Cell Carcinoma Unresectable Salivary Gland Squamous Cell Carcinoma A benign epithelial neoplasm composed of columnar cells with differentiation to chief cells, parietal cells, or both, with a high rate of progression to adenocarcinoma (submucosal invasion). (WHO 2019) C172655 Neoplastic Process Oxyntic Gland Adenoma CL1406549 Benign OGA Oxyntic Gland Adenoma Oxyntic Gland Adenoma A very rare biphasic tumor arising in the gastric muscularis propria (usually of the antrum), generally in boys and young men. It is associated with MALAT1-GLI1 gene fusion. (WHO 2019) C172659 Neoplastic Process Gastroblastoma CL1406553 Malignant Gastroblastoma Gastroblastoma A well differentiated, high grade neoplasm with neuroendocrine differentiation that arises from the digestive system. The Ki-67 index is higher than 20%. C172660 Neoplastic Process Digestive System Neuroendocrine Tumor G3 CL1406552 Undetermined Digestive System Neuroendocrine Tumor G3 Digestive System Neuroendocrine Tumor G3 A well differentiated, high grade neoplasm with neuroendocrine differentiation that arises from the esophagus. The Ki-67 index is higher than 20%. C172661 Neoplastic Process Esophageal Neuroendocrine Tumor G3 CL1406555 Undetermined Esophageal Neuroendocrine Tumor G3 Esophageal Neuroendocrine Tumor G3 A well differentiated, high grade neoplasm with neuroendocrine differentiation that arises from the stomach. The Ki-67 index is higher than 20%. C172662 Neoplastic Process Gastric Neuroendocrine Tumor G3 CL1406554 mCode Undetermined Gastric Neuroendocrine Tumor G3 Malignant carcinoid tumor of the stomach Gastric Neuroendocrine Tumor G3 A well differentiated, high grade neoplasm with neuroendocrine differentiation that arises from the small intestine. The Ki-67 index is higher than 20%. C172664 Neoplastic Process Small Intestinal Neuroendocrine Tumor G3 CL1406557 Undetermined Small Intestinal Neuroendocrine Tumor G3 Small Intestinal Neuroendocrine Tumor G3 A rare appendix mucinous neoplasm characterized by the presence of neoplastic epithelial cells with high grade features. C172665 Neoplastic Process High Grade Appendix Mucinous Neoplasm CL1406556 Malignant HAMN High Grade Appendix Mucinous Adenocarcinoma High Grade Appendix Mucinous Neoplasm High-Grade Appendix Mucinous Neoplasm High Grade Appendix Mucinous Neoplasm A neuroendocrine tumor grade 3 that arises from the appendix. C172666 Neoplastic Process Appendix Neuroendocrine Tumor G3 CL1406559 Undetermined Appendix Neuroendocrine Tumor G3 Appendix Neuroendocrine Tumor G3 A neuroendocrine tumor grade 3 that arises from the ileum. C172667 Neoplastic Process Ileal Neuroendocrine Tumor G3 CL1406558 Undetermined Ileal Neuroendocrine Tumor G3 Ileal Neuroendocrine Tumor G3 A neuroendocrine tumor grade 3 that arises from the jejunum. C172668 Neoplastic Process Jejunal Neuroendocrine Tumor G3 CL1406561 Undetermined Jejunal Neuroendocrine Tumor G3 Jejunal Neuroendocrine Tumor G3 A neuroendocrine tumor grade 3 that arises from the jejunum, ileum, proximal colon, or appendix. C172669 Neoplastic Process Midgut Neuroendocrine Tumor G3 CL1406560 Undetermined Midgut Neuroendocrine Tumor G3 Midgut Neuroendocrine Tumor G3 A well differentiated, high grade neoplasm with neuroendocrine differentiation that arises from the small or large intestine. The Ki-67 index is higher than 20%. C172670 Neoplastic Process Intestinal Neuroendocrine Tumor G3 CL1406563 Undetermined Intestinal Neuroendocrine Tumor G3 Intestinal Neuroendocrine Tumor G3 A well differentiated, high grade neoplasm with neuroendocrine differentiation that arises from the duodenum. The Ki-67 index is higher than 20%. C172672 Neoplastic Process Duodenal Neuroendocrine Tumor G3 CL1406562 Undetermined Duodenal Neuroendocrine Tumor G3 Duodenal Neuroendocrine Tumor G3 A well differentiated, high grade neoplasm with neuroendocrine differentiation that arises from the ampulla of Vater and the periampullary region. The Ki-67 index is higher than 20%. C172673 Neoplastic Process Ampulla of Vater Neuroendocrine Tumor G3 CL1406535 Undetermined Ampulla of Vater Neuroendocrine Tumor G3 Ampulla of Vater Neuroendocrine Tumor G3 A benign, premalignant colorectal neoplasm composed of dysplastic epithelium. The descriptor "conventional" distinguishes this from lesions in the serrated pathway. (WHO 2019) C172680 Neoplastic Process Colorectal Conventional Adenoma CL1406540 Benign Colorectal Conventional Adenoma Conventional Colorectal Adenoma Colorectal Conventional Adenoma A benign, premalignant colon neoplasm composed of dysplastic epithelium. The descriptor "conventional" distinguishes this from lesions in the serrated pathway. (WHO 2019) C172682 Neoplastic Process Colon Conventional Adenoma CL1406542 Benign Colon Conventional Adenoma Colon Conventional Adenoma A benign, premalignant rectal neoplasm composed of dysplastic epithelium. The descriptor "conventional" distinguishes this from lesions in the serrated pathway. (WHO 2019) C172683 Neoplastic Process Rectal Conventional Adenoma CL1406544 Benign Rectal Conventional Adenoma Rectal Conventional Adenoma An adenocarcinoma that arises from the colorectal mucosa and is characterized by the presence of isolated malignant cells or malignant cells that form small aggregates. C172694 Neoplastic Process Colorectal Poorly Cohesive Adenocarcinoma CL1406585 Malignant Colorectal Poorly Cohesive Adenocarcinoma Colorectal Poorly Cohesive Adenocarcinoma A well differentiated colorectal adenocarcinoma with good prognosis. It resembles a villous adenoma on the surface. C172699 Neoplastic Process Colorectal Adenoma-Like Adenocarcinoma CL1406588 Malignant Colorectal Adenoma-Like Adenocarcinoma Colorectal Villous Adenocarcinoma Colorectal Adenoma-Like Adenocarcinoma A colorectal adenocarcinoma that develops in patients with a history of inflammatory bowel disease. C172700 Neoplastic Process Inflammatory Bowel Disease-Associated Colorectal Adenocarcinoma CL1406591 Malignant Inflammatory Bowel Disease-Associated Colorectal Adenocarcinoma Inflammatory Bowel Disease-Associated Colorectal Adenocarcinoma A well differentiated, high grade neoplasm with neuroendocrine differentiation that arises from the colon and rectum. The Ki-67 index is higher than 20%. C172701 Neoplastic Process Colorectal Neuroendocrine Tumor G3 CL1406590 Undetermined Colorectal Neuroendocrine Tumor G3 Colorectal Neuroendocrine Tumor G3 A well differentiated, high grade neoplasm with neuroendocrine differentiation that arises from the colon. The Ki-67 index is higher than 20%. C172702 Neoplastic Process Colon Neuroendocrine Tumor G3 CL1406593 Undetermined Colon Neuroendocrine Tumor G3 Colon Neuroendocrine Tumor G3 A well differentiated, high grade neoplasm with neuroendocrine differentiation that arises from the rectum. The Ki-67 index is higher than 20%. C172703 Neoplastic Process Rectal Neuroendocrine Tumor G3 CL1406592 Undetermined Rectal Neuroendocrine Tumor G3 Rectal Neuroendocrine Tumor G3 Anal canal or perianal skin intraepithelial neoplasia with moderate or severe dysplasia. C172706 Neoplastic Process High Grade Anal Intraepithelial Neoplasia High Grade Anal Intraepithelial Neoplasia CL1406565 CTRP Undetermined High Grade Anal Intraepithelial Neoplasia High Grade Anal Squamous Dysplasia High Grade Anal Squamous Intraepithelial Neoplasia High Grade Anal Intraepithelial Neoplasia Hepatocellular adenoma with features of both beta-catenin-activated hepatocellular adenoma and inflammatory hepatocellular adenoma. C172707 Neoplastic Process Beta-Catenin-Activated Inflammatory Hepatocellular Adenoma CL1406564 Benign Beta-Catenin-Activated Inflammatory Hepatocellular Adenoma b-IHCA Beta-Catenin-Activated Inflammatory Hepatocellular Adenoma Hepatocellular carcinoma characterized by the presence of steatohepatitis features, including macrovesicular steatosis, fibrosis, ballooning of malignant hepatocytes, Mallory bodies, and inflammation. C172709 Neoplastic Process Steatohepatitic Hepatocellular Carcinoma CL1406566 Malignant SH-HCC Steatohepatitic Hepatocellular Carcinoma Steatohepatitic Hepatocellular Carcinoma Hepatocellular carcinoma characterized by more than 50% growth of macrotrabecular pattern (equal to or more than 6 to 10 cells thick). It presents with higher grade and stage compared to conventional hepatocellular carcinoma. It has poor prognosis with early recurrence and poor overall survival. C172710 Neoplastic Process Macrotrabecular Massive Hepatocellular Carcinoma CL1406569 Malignant MTM-HCC Macrotrabecular Massive Hepatocellular Carcinoma Macrotrabecular Massive Hepatocellular Carcinoma Hepatocellular carcinoma characterized by the presence of malignant cells with smooth chromophobic cytoplasm, abrupt focal nuclear anaplasia, and scattered microscopic pseudocysts. C172712 Neoplastic Process Chromophobe Hepatocellular Carcinoma CL1406571 Malignant Chromophobe Hepatocellular Carcinoma Chromophobe Hepatocellular Carcinoma with Abrupt Anaplasia Chromophobe Hepatocellular Carcinoma Hepatocellular carcinoma characterized by the presence of diffuse neutrophil infiltrates within the tumor. C172713 Neoplastic Process Neutrophil-Rich Hepatocellular Carcinoma CL1406570 Malignant Neutrophil-Rich Hepatocellular Carcinoma Neutrophil-Rich Hepatocellular Carcinoma Hepatocellular carcinoma measuring equal to or less than 2 cm in diameter. It includes early hepatocellular carcinoma and small progressed hepatocellular carcinoma. C172714 Neoplastic Process Small Hepatocellular Carcinoma CL1406573 Malignant Small HCC Small Hepatocellular Carcinoma Small Hepatocellular Carcinoma A well to moderately differentiated small hepatocellular carcinoma. It is characterized by the presence of obvious stromal invasion and increase atypia compared with early hepatocellular carcinoma. C172716 Neoplastic Process Small Progressed Hepatocellular Carcinoma CL1406575 Malignant Small Progressed Hepatocellular Carcinoma Small pHCC Small Progressed Hepatocellular Carcinoma A carcinoma that arises from the liver and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component. At least 30 percent of either component should be present for the diagnosis to be made. C172718 Neoplastic Process Liver Mixed Adenoneuroendocrine Carcinoma CL1406574 Malignant Liver MANEC Liver Mixed Adenoneuroendocrine Carcinoma Liver Mixed Adenoneuroendocrine Carcinoma A well differentiated, low grade neoplasm with neuroendocrine differentiation that arises from the liver. The mitotic count is less than 2 per 10 HPF. C172719 Neoplastic Process Liver Neuroendocrine Tumor G1 CL1406577 Undetermined Hepatic Neuroendocrine Tumor G1 Liver Neuroendocrine Tumor G1 Liver Neuroendocrine Tumor G1 A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the liver. The mitotic count is 2-20 per 10 HPF. C172720 Neoplastic Process Liver Neuroendocrine Tumor G2 CL1406576 Undetermined Hepatic Neuroendocrine Tumor G2 Liver Neuroendocrine Tumor G2 Liver Neuroendocrine Tumor G2 A well differentiated, high grade neoplasm with neuroendocrine differentiation that arises from the liver. The Ki-67 index is higher than 20%. C172721 Neoplastic Process Liver Neuroendocrine Tumor G3 CL1406579 Undetermined Hepatic Neuroendocrine Tumor G3 Liver Neuroendocrine Tumor G3 Liver Neuroendocrine Tumor G3 An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the liver. It is characterized by the presence of malignant large cells. C172722 Neoplastic Process Liver Large Cell Neuroendocrine Carcinoma CL1406578 Malignant Hepatic Large Cell Neuroendocrine Carcinoma Liver Large Cell Neuroendocrine Carcinoma Liver Large Cell Neuroendocrine Carcinoma An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the liver. It is characterized by the presence of malignant small cells. C172725 Neoplastic Process Liver Small Cell Neuroendocrine Carcinoma CL1406609 Malignant Hepatic Small Cell Carcinoma Hepatic Small Cell Neuroendocrine Carcinoma Liver Small Cell Carcinoma Liver Small Cell Neuroendocrine Carcinoma Liver Small Cell Neuroendocrine Carcinoma A grossly visible non-invasive neoplasm of the gallbladder composed of uniform back-to-back mucinous glands arranged in a tubular configuration. (WHO 2019) C172731 Neoplastic Process Gallbladder Pyloric Gland Adenoma CL1406614 Benign Gallbladder Pyloric Gland Adenoma Gallbladder Tubulopapillary Adenoma Intracholecystic Papillary Tubular Neoplasm, Gastric Pyloric, Simple Mucinous Type Gallbladder Pyloric Gland Adenoma An adenoma that arises from the gallbladder and is associated with intestinal-type differentiation. C172735 Neoplastic Process Gallbladder Adenoma, Intestinal-Type CL1406615 Benign Gallbladder Adenoma, Intestinal-Type Gallbladder Adenoma, Intestinal-Type A well differentiated, high grade neoplasm with neuroendocrine differentiation that arises from the gallbladder. The Ki-67 index is higher than 20%. C172742 Neoplastic Process Gallbladder Neuroendocrine Tumor G3 CL1406595 Undetermined Gallbladder Neuroendocrine Tumor G3 Gallbladder Neuroendocrine Tumor G3 A well differentiated, high grade neoplasm with neuroendocrine differentiation that arises from the extrahepatic bile ducts. The Ki-67 index is higher than 20%. C172743 Neoplastic Process Extrahepatic Bile Duct Neuroendocrine Tumor G3 CL1406594 Undetermined Extrahepatic Bile Duct Neuroendocrine Tumor G3 Extrahepatic Bile Duct Neuroendocrine Tumor G3 Pancreatic intraepithelial neoplasia characterized by the presence of low grade epithelial dysplasia. C172803 Neoplastic Process Low Grade Pancreatic Intraepithelial Neoplasia CL1406863 Uncertain Malignant Potential Low Grade PanIN Low Grade Pancreatic Intraepithelial Neoplasia Low-Grade PanIN Low-Grade Pancreatic Intraepithelial Neoplasia Low Grade Pancreatic Intraepithelial Neoplasia Biliary intraepithelial neoplasia characterized by the presence of low grade epithelial dysplasia. C172804 Neoplastic Process Low Grade Biliary Intraepithelial Neoplasia CL497897 GDC Undetermined Biliary intraepithelial neoplasia, low grade Biliary intraepithelial neoplasia, low grade Low Grade BilIN Low Grade Biliary Intraepithelial Neoplasia Low-Grade BilIN Low-Grade Biliary Intraepithelial Neoplasia Low Grade Biliary Intraepithelial Neoplasia Neuroendocrine carcinoma that is not amenable to surgical resection. C172806 Neoplastic Process Unresectable Neuroendocrine Carcinoma Unresectable Neuroendocrine Carcinoma CL1406867 CTRP Malignant Unresectable Neuroendocrine Carcinoma Unresectable Neuroendocrine Carcinoma Digestive system mixed adenoneuroendocrine carcinoma that is not amenable to surgical resection. C172808 Neoplastic Process Unresectable Digestive System Mixed Adenoneuroendocrine Carcinoma Unresectable Digestive System Mixed Adenoneuroendocrine Carcinoma CL1406869 CTRP Malignant Unresectable Digestive System Mixed Adenoneuroendocrine Carcinoma Unresectable Digestive System Mixed Adenoneuroendocrine Carcinoma Large cell neuroendocrine carcinoma that is not amenable to surgical resection. C172810 Neoplastic Process Unresectable Large Cell Neuroendocrine Carcinoma Unresectable Large Cell Neuroendocrine Carcinoma CL1406845 CTRP Malignant Unresectable Large Cell Neuroendocrine Carcinoma Unresectable Large Cell Neuroendocrine Carcinoma An adenocarcinoma that arises from the pancreas and is characterized by the presence of isolated malignant cells or malignant cells that form small aggregates. C172811 Neoplastic Process Pancreatic Poorly Cohesive Adenocarcinoma CL1406844 Malignant Pancreatic Poorly Cohesive Adenocarcinoma Pancreatic Poorly Cohesive Adenocarcinoma An undifferentiated carcinoma that arises from the pancreas. It is characterized by the presence of rhabdoid cells. C172812 Neoplastic Process Pancreatic Undifferentiated Carcinoma with Rhabdoid Cells CL1406847 Malignant Pancreatic Undifferentiated Carcinoma with Rhabdoid Cells Pancreatic Undifferentiated Rhabdoid Carcinoma Pancreatic Undifferentiated Carcinoma with Rhabdoid Cells An invasive pancreatic ductal adenocarcinoma characterized by the presence of clusters of malignant cells located within artifactual clear stromal spaces. C172813 Neoplastic Process Invasive Pancreatic Micropapillary Adenocarcinoma CL1406846 Malignant Invasive Pancreatic Micropapillary Adenocarcinoma Pancreatic IMPC Pancreatic Invasive Micropapillary Adenocarcinoma Pancreatic Invasive Micropapillary Carcinoma Invasive Pancreatic Micropapillary Adenocarcinoma A well differentiated, high grade neoplasm with neuroendocrine differentiation that arises from the pancreas. The Ki-67 index is higher than 20%. C172814 Neoplastic Process Pancreatic Neuroendocrine Tumor G3 CL1406849 Cellosaurus Undetermined Pancreatic Neuroendocrine Tumor G3 Pancreatic Neuroendocrine Tumor G3 An extranodal low-grade B-cell non-Hodgkin lymphoma arising in mucosal or glandular tissues of the digestive system. It recapitulates the cytoarchitectural features of mucosa-associated lymphoid tissue (MALT). It is composed of small lymphoid cells, often including marginal zone cells. (WHO 2019) C172844 Neoplastic Process Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Involving the Digestive System Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Involving the Digestive System CL1406870 CTRP Malignant Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Involving the Digestive System Mucosa-Associated Lymphoid Tissue Lymphoma Involving the Digestive System Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Involving the Digestive System Follicular dendritic cell sarcoma that is not associated with Epstein-Barr virus. C172846 Neoplastic Process Conventional Follicular Dendritic Cell Sarcoma CL1406872 Malignant Conventional Follicular Dendritic Cell Sarcoma Conventional Follicular Dendritic Cell Sarcoma A rare, Epstein-Barr virus-associated variant of follicular dendritic cell sarcoma. It usually arises from the liver or spleen and has a favorable prognosis. The name of this entity has been changed from "sarcoma" to "tumor" because of its indolent nature. C172847 Neoplastic Process EBV-Positive Inflammatory Follicular Dendritic Cell/Fibroblastic Reticular Cell Tumor CL1406871 Malignant EBV-Positive Inflammatory Follicular Dendritic Cell Sarcoma EBV-Positive Inflammatory Follicular Dendritic Cell/Fibroblastic Reticular Cell Tumor Epstein-Barr Virus Positive Inflammatory Follicular Dendritic Cell Sarcoma Epstein-Barr Virus Positive Inflammatory Follicular Dendritic Cell/Fibroblastic Reticular Cell Tumor Epstein-Barr Virus-Positive Inflammatory Follicular Dendritic Cell Sarcoma Epstein-Barr Virus-Positive Inflammatory Follicular Dendritic Cell/Fibroblastic Reticular Cell Tumor IPT-Like FDCS Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma EBV-Positive Inflammatory Follicular Dendritic Cell/Fibroblastic Reticular Cell Tumor A sarcoma that arises from the digestive system. C172849 Neoplastic Process Digestive System Sarcoma CL1406874 Malignant Digestive System Sarcoma Digestive System Sarcoma A diffuse large B-cell lymphoma that arises from the digestive system. C172850 Neoplastic Process Digestive System Diffuse Large B-Cell Lymphoma CL1406873 Malignant Digestive System Diffuse Large B-Cell Lymphoma Primary Digestive System DLBCL Primary Digestive System Diffuse Large B-Cell Lymphoma Digestive System Diffuse Large B-Cell Lymphoma A multinodular intermediate fibroblastic neoplasm arising from the digestive system. It is characterized by the presence of spindle-shaped fibroblasts and myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes and plasma cells. C172851 Neoplastic Process Digestive System Inflammatory Myofibroblastic Tumor CL1406876 Undetermined Digestive System Inflammatory Myofibroblastic Tumor Digestive System Inflammatory Myofibroblastic Tumor A benign, intermediate, or malignant mesenchymal neoplasm that arises from the digestive system. C172852 Neoplastic Process Digestive System Soft Tissue Neoplasm CL1406875 Undetermined Digestive System Soft Tissue Neoplasm Digestive System Soft Tissue Neoplasm A benign, intermediate, or malignant mesenchymal neoplasm that arises from the esophagus. C172853 Neoplastic Process Esophageal Soft Tissue Neoplasm CL1406878 Undetermined Esophageal Soft Tissue Neoplasm Esophageal Soft Tissue Neoplasm A benign, intermediate, or malignant mesenchymal neoplasm that arises from the hepatobiliary system. C172854 Neoplastic Process Hepatobiliary Soft Tissue Neoplasm CL1406877 Undetermined Hepatobiliary Soft Tissue Neoplasm Hepatobiliary Soft Tissue Neoplasm A benign, intermediate, or malignant mesenchymal neoplasm that arises from the gallbladder. C172855 Neoplastic Process Gallbladder Soft Tissue Neoplasm CL1406880 Undetermined Gallbladder Soft Tissue Neoplasm Gallbladder Soft Tissue Neoplasm A benign, intermediate, or malignant mesenchymal neoplasm that arises from the liver and intrahepatic bile ducts. C172856 Neoplastic Process Liver Soft Tissue Neoplasm CL1406879 Undetermined Liver Soft Tissue Neoplasm Liver and Intrahepatic Bile Duct Soft Tissue Neoplasm Liver Soft Tissue Neoplasm A benign, intermediate, or malignant mesenchymal neoplasm that arises from the small or large intestine. C172857 Neoplastic Process Intestinal Soft Tissue Neoplasm CL1406882 Undetermined Intestinal Soft Tissue Neoplasm Intestinal Soft Tissue Neoplasm A solitary fibrous tumor arising from an anatomic site in the digestive system, including the esophagus, gallbladder, liver, pancreas, small bowel mesentery, and the serosal surfaces of the stomach and colon. C172940 Neoplastic Process Digestive System Solitary Fibrous Tumor CL1406769 Undetermined Digestive System Solitary Fibrous Tumor Digestive System Solitary Fibrous Tumor A benign, often polypoid, hypocellular fibroblastic neoplasm with a predilection for the stomach and ileum, containing a prominent inflammatory infiltrate, especially eosinophils. (WHO 2019) C172941 Neoplastic Process Inflammatory Fibroid Polyp C0334113 Benign Inflammatory Fibroid Polyp Inflammatory Fibroid Polyp A leiomyoma arising from an anatomic site in the digestive system. C172942 Neoplastic Process Digestive System Leiomyoma CL1406750 Benign Digestive System Leiomyoma Digestive System Leiomyoma A lipoma arising from an anatomic site in the digestive system. C172945 Neoplastic Process Digestive System Lipoma CL1406752 Benign Digestive System Lipoma Digestive System Lipoma A leiomyosarcoma arising from an anatomic site in the digestive system. C172951 Neoplastic Process Digestive System Leiomyosarcoma CL1406754 Malignant Digestive System Leiomyosarcoma Digestive System Leiomyosarcoma A rhabdomyosarcoma arising from an anatomic site in the digestive system. C172952 Neoplastic Process Digestive System Rhabdomyosarcoma CL1406753 Malignant Digestive System Rhabdomyosarcoma Digestive System Rhabdomyosarcoma Meningioma that is resistant to treatment. C172953 Neoplastic Process Refractory Meningioma Refractory Meningioma CL1406755 CTRP Undetermined Refractory Meningioma Refractory Meningioma A Kaposi sarcoma arising from the digestive system. C172955 Neoplastic Process Digestive System Kaposi Sarcoma CL1406756 mCode Malignant Digestive System Kaposi Sarcoma Kaposi's sarcoma of gastrointestinal sites Digestive System Kaposi Sarcoma A gastrointestinal tract sarcoma with neuroectodermal differentiation. It is characterized by the presence of neoplastic round cells with pale eosinophilic cytoplasm. Cytoplasmic clearing is seen only in a minority of cases. Half of the cases contain osteoclastic giant cells. It is associated with gene fusion translocations involving the EWSR1 gene, usually EWSR1-ATF1 fusion or EWSR1-CREB1 fusion. C172980 Neoplastic Process Gastrointestinal Clear Cell Sarcoma/Malignant Gastrointestinal Neuroectodermal Tumor CL1406771 Malignant CCS/ GNET Gastrointestinal Clear Cell Sarcoma/Malignant Gastrointestinal Neuroectodermal Tumor Gastrointestinal Clear Cell Sarcoma/Malignant Gastrointestinal Neuroectodermal Tumor Indolent non-Hodgkin lymphoma that is resistant to treatment. C173046 Neoplastic Process Refractory Indolent Non-Hodgkin Lymphoma Refractory Indolent Non-Hodgkin Lymphoma CL1406818 CTRP Malignant Refractory Indolent Non-Hodgkin Lymphoma Refractory Indolent Non-Hodgkin Lymphoma A squamous cell carcinoma that arises from the mucosal epithelium of the nasal cavity or the paranasal sinuses and is characterized by prominent production of keratin. C173077 Neoplastic Process Sinonasal Keratinizing Squamous Cell Carcinoma CL1406966 Malignant Nasal Cavity and Paranasal Sinus Keratinizing Squamous Cell Carcinoma Sinonasal Keratinizing Squamous Cell Carcinoma Sinonasal Keratinizing Squamous Cell Carcinoma A distinctive HPV-related non-keratinizing squamous cell carcinoma of the sinonasal tract arising most frequently from the maxillary sinus or nasal cavity. Most patients present with nasal obstruction and/or epistaxis. It is characterized by the presence of basaloid cell proliferations separated by collagenous fibrous bands. The basaloid cells align around microcystic spaces. C173078 Neoplastic Process Sinonasal Human Papillomavirus-Related Carcinoma with Adenoid Cystic-Like Features Sinonasal Human Papillomavirus-Related Multiphenotypic Carcinoma CL1406969 CTRP Malignant HPV-Associated Multiphenotypic Sinonasal Carcinoma HPV-Related Multiphenotypic Sinonasal Carcinoma Human Papillomavirus-Associated Multiphenotypic Sinonasal Carcinoma Human Papillomavirus-Related Multiphenotypic Sinonasal Carcinoma Sinonasal HPV-Associated Multiphenotypic Carcinoma Sinonasal HPV-Related Carcinoma with Adenoid Cystic-Like Features Sinonasal HPV-Related Multiphenotypic Carcinoma Sinonasal Human Papillomavirus-Associated Multiphenotypic Carcinoma Sinonasal Human Papillomavirus-Related Carcinoma with Adenoid Cystic-Like Features Sinonasal Human Papillomavirus-Related Multiphenotypic Carcinoma Sinonasal Human Papillomavirus-Related Multiphenotypic Carcinoma A poorly differentiated squamous cell carcinoma arising from the sinonasal tract. It is characterized by the presence of malignant cells with spindle cell features. C173079 Neoplastic Process Sinonasal Spindle Cell Squamous Carcinoma CL1406968 Malignant Nasal Cavity and Paranasal Sinus Spindle Cell (Sarcomatoid) Squamous Cell Carcinoma Nasal Cavity and Paranasal Sinus Spindle Cell Squamous Cell Carcinoma Sinonasal Spindle Cell (Sarcomatoid) Squamous Cell Carcinoma Sinonasal Spindle Cell Squamous Carcinoma Sinonasal Spindle Cell Squamous Cell Carcinoma Sinonasal Spindle Cell Squamous Carcinoma A nonkeratinizing squamous cell carcinoma arising from the sinonasal tract. It is characterized by the presence of large cells with vesicular nuclei and prominent nucleoli, a syncytial growth pattern, and a lymphoplasmacytic infiltrate. C173080 Neoplastic Process Sinonasal Lymphoepithelial Carcinoma CL1406971 Malignant Sinonasal Lymphoepithelial Carcinoma Sinonasal Lymphoepithelial Carcinoma A highly aggressive, poorly differentiated carcinoma that arises from the head and neck. Most cases are in the nasal cavity and paranasal sinuses. It is characterized by mutations and rearrangement of the NUT gene. C173087 Neoplastic Process Head and Neck NUT Carcinoma CL1406976 Malignant Head and Neck NUT Carcinoma Head and Neck NUT Carcinoma A highly aggressive, poorly differentiated carcinoma that arises from the nasal cavity and paranasal sinuses. It is characterized by mutations and rearrangement of the NUT gene. C173088 Neoplastic Process Sinonasal NUT Carcinoma CL1406979 Malignant Nasal Cavity and Paranasal Sinus NUT Carcinoma Sinonasal NUT Carcinoma Sinonasal NUT Carcinoma A neuroendocrine carcinoma that arises from the nasal cavity and paranasal sinuses. C173089 Neoplastic Process Sinonasal Neuroendocrine Carcinoma CL1406978 Malignant Nasal Cavity and Paranasal Sinus Neuroendocrine Carcinoma Sinonasal Neuroendocrine Carcinoma Sinonasal Neuroendocrine Carcinoma A large cell neuroendocrine carcinoma that arises from the nasal cavity and paranasal sinuses. C173091 Neoplastic Process Sinonasal Large Cell Neuroendocrine Carcinoma CL1407004 Malignant Nasal Cavity and Paranasal Sinus Large Cell Neuroendocrine Carcinoma Sinonasal Large Cell Neuroendocrine Carcinoma Sinonasal Large Cell Neuroendocrine Carcinoma A malignant sinonasal neoplasm with combined histological features of teratoma and carcinosarcoma, lacking malignant germ cell components. (WHO 2017) C173094 Neoplastic Process Sinonasal Teratocarcinosarcoma C2930987 Malignant Nasal Cavity and Paranasal Sinus Teratocarcinosarcoma Sinonasal Teratocarcinosarcoma Sinonasal Teratocarcinosarcoma A neoplasm that arises from the nasal cavity and paranasal sinuses and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C173095 Neoplastic Process Benign Sinonasal Neoplasm CL1407007 Benign Benign Nasal Cavity and Paranasal Sinus Neoplasm Benign Sinonasal Neoplasm Benign Sinonasal Neoplasm A primary or metastatic malignant neoplasm involving the nasal cavity and paranasal sinuses. C173097 Neoplastic Process Malignant Sinonasal Neoplasm C0220643 Malignant Malignant Nasal Cavity and Paranasal Sinus Neoplasm Malignant Sinonasal Neoplasm Malignant Sinonasal Neoplasm A pleomorphic adenoma that arises from the sinonasal tract. C173114 Neoplastic Process Sinonasal Pleomorphic Adenoma CL1406996 Benign Sinonasal Pleomorphic Adenoma Sinonasal Pleomorphic Adenoma A mesenchymal neoplasm that arises from the nasal cavity and paranasal sinuses. C173117 Neoplastic Process Sinonasal Soft Tissue Neoplasm CL1406998 Undetermined Sinonasal Soft Tissue Neoplasm Sinonasal Soft Tissue Neoplasm A sarcoma that arises from the nasal cavity and paranasal sinuses. C173118 Neoplastic Process Sinonasal Sarcoma CL1406997 Malignant Sinonasal Sarcoma Sinonasal Sarcoma A fibrosarcoma that arises from the nasal cavity and paranasal sinuses. C173120 Neoplastic Process Sinonasal Fibrosarcoma CL1406999 Malignant Sinonasal Fibrosarcoma Sinonasal Fibrosarcoma An undifferentiated pleomorphic sarcoma that arises from the nasal cavity and paranasal sinuses. C173121 Neoplastic Process Sinonasal Undifferentiated Pleomorphic Sarcoma CL1407001 Malignant Sinonasal Undifferentiated Pleomorphic Sarcoma Sinonasal Undifferentiated Pleomorphic Sarcoma A leiomyosarcoma that arises from the nasal cavity and paranasal sinuses. C173123 Neoplastic Process Sinonasal Leiomyosarcoma CL1407000 Malignant Sinonasal Leiomyosarcoma Sinonasal Leiomyosarcoma A rhabdomyosarcoma that arises from the nasal cavity and paranasal sinuses. C173124 Neoplastic Process Sinonasal Rhabdomyosarcoma CL1407003 Malignant Sinonasal Rhabdomyosarcoma Sinonasal Rhabdomyosarcoma An angiosarcoma that arises from the nasal cavity and paranasal sinuses. C173125 Neoplastic Process Sinonasal Angiosarcoma CL1407002 Malignant Sinonasal Angiosarcoma Sinonasal Angiosarcoma A malignant peripheral nerve sheath tumor that arises from the nasal cavity and paranasal sinuses. C173127 Neoplastic Process Sinonasal Malignant Peripheral Nerve Sheath Tumor CL1407025 Malignant Sinonasal Malignant Peripheral Nerve Sheath Tumor Sinonasal Malignant Peripheral Nerve Sheath Tumor A synovial sarcoma that arises from the nasal cavity and paranasal sinuses. C173128 Neoplastic Process Sinonasal Synovial Sarcoma CL1407026 Malignant Sinonasal Synovial Sarcoma Sinonasal Synovial Sarcoma A mesenchymal neoplasm that arises from the sinonasal tract and is characterized by an increased risk of local recurrence and/or a low risk of metastasis. C173132 Neoplastic Process Intermediate Sinonasal Soft Tissue Neoplasm CL1407029 Uncertain Malignant Potential Undetermined Intermediate Sinonasal Soft Tissue Neoplasm Sinonasal Intermediate Soft Tissue Neoplasm Intermediate Sinonasal Soft Tissue Neoplasm Desmoid fibromatosis that arises from the nasal cavity and paranasal sinuses. C173133 Neoplastic Process Sinonasal Desmoid Fibromatosis CL1407028 Undetermined Sinonasal Desmoid Fibromatosis Sinonasal Desmoid-Type Fibromatosis Sinonasal Desmoid Fibromatosis A sinonasal soft tissue neoplasm with hemangiopericytoma-like features. C173136 Neoplastic Process Sinonasal Glomangiopericytoma CL1407033 Undetermined Sinonasal Glomangiopericytoma Sinonasal Hemangiopericytoma-Like Tumor Sinonasal Glomangiopericytoma A solitary fibrous tumor that arises from the nasal cavity and paranasal sinuses. C173137 Neoplastic Process Sinonasal Solitary Fibrous Tumor CL1407032 Undetermined Sinonasal Solitary Fibrous Tumor Sinonasal Solitary Fibrous Tumor An epithelioid hemangioendothelioma that arises from the nasal cavity and paranasal sinuses. C173138 Neoplastic Process Sinonasal Epithelioid Hemangioendothelioma CL1407035 Malignant Sinonasal Epithelioid Hemangioendothelioma Sinonasal Epithelioid Hemangioendothelioma A mesenchymal neoplasm that arises from the nasal cavity and paranasal sinuses and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C173139 Neoplastic Process Benign Sinonasal Soft Tissue Neoplasm CL1407034 Benign Benign Sinonasal Soft Tissue Neoplasm Sinonasal Benign Soft Tissue Neoplasm Benign Sinonasal Soft Tissue Neoplasm A leiomyoma that arises from the nasal cavity and paranasal sinuses. C173140 Neoplastic Process Sinonasal Leiomyoma CL1407037 Benign Sinonasal Leiomyoma Sinonasal Leiomyoma A hemangioma that arises from the nasal cavity and paranasal sinuses. C173142 Neoplastic Process Sinonasal Hemangioma CL1407036 Benign Sinonasal Hemangioma Sinonasal Hemangioma A schwannoma that arises from the nasal cavity and paranasal sinuses. C173143 Neoplastic Process Sinonasal Schwannoma CL1407013 Benign Sinonasal Schwannoma Sinonasal Schwannoma A neurofibroma that arises from the nasal cavity and paranasal sinuses. C173144 Neoplastic Process Sinonasal Neurofibroma CL1407012 Benign Sinonasal Neurofibroma Sinonasal Neurofibroma The reemergence of an intracranial neoplasm after a period of remission. C173154 Neoplastic Process Recurrent Intracranial Neoplasm Recurrent Intracranial Neoplasm CL1407019 CTRP Undetermined Recurrent Intracranial Neoplasm Recurrent Intracranial Neoplasm An intracranial malignant neoplasm that has spread from its original site of growth to another anatomic site. C173155 Neoplastic Process Metastatic Intracranial Malignant Neoplasm Metastatic Intracranial Malignant Neoplasm CL1407022 CTRP Malignant Metastatic Intracranial Malignant Neoplasm Metastatic Intracranial Malignant Neoplasm Anal squamous cell carcinoma that is not amenable to surgical resection. C173156 Neoplastic Process Unresectable Anal Squamous Cell Carcinoma Unresectable Anal Squamous Cell Carcinoma CL1407021 CTRP Malignant Unresectable Anal Squamous Cell Carcinoma Unresectable Anal Squamous Cell Carcinoma Esophageal adenocarcinoma that is not amenable to surgical resection. C173162 Neoplastic Process Unresectable Esophageal Adenocarcinoma Unresectable Esophageal Adenocarcinoma CL1407042 CTRP Malignant Unresectable Esophageal Adenocarcinoma Unresectable Esophageal Adenocarcinoma A rare extracranial meningioma that arises from the sinonasal tract. C173163 Neoplastic Process Primary Sinonasal Meningioma CL1407041 Undetermined Primary Sinonasal Meningioma Primary Sinonasal Meningioma Deposits of borderline, malignant, and rarely benign tumors, usually from the ovary, on the peritoneal surface. C173164 Neoplastic Process Peritoneal Implant CL1407044 Undetermined Peritoneal Implant Peritoneal Implant A locally aggressive, primarily gnathic (jaw) tumor with a high propensity for recurrence. It originates wholly within the sinonasal tract, without connection to gnathic sites, arising from sinonasal epithelium and showing histological features identical to those of its counterpart originating in the jaw. (WHO 2017) C173166 Neoplastic Process Sinonasal Ameloblastoma CL1407046 Undetermined Sinonasal Ameloblastoma Sinonasal Ameloblastoma A plasmacytoma that arises from the sinonasal tract. C173169 Neoplastic Process Sinonasal Plasmacytoma CL1407047 Malignant Sinonasal Plasmacytoma Sinonasal Plasmacytoma A lymphoma that arises from the sinonasal tract. C173170 Neoplastic Process Sinonasal Lymphoma CL1407049 Malignant Sinonasal Lymphoma Sinonasal Lymphoma A non-Hodgkin lymphoma that arises from the sinonasal tract. C173171 Neoplastic Process Sinonasal Non-Hodgkin Lymphoma CL1407048 Malignant Sinonasal Non-Hodgkin Lymphoma Sinonasal Non-Hodgkin Lymphoma An extranodal NK/T-cell lymphoma that arises from the sinonasal tract. C173172 Neoplastic Process Sinonasal Extranodal NK/T-Cell Lymphoma Sinonasal Extranodal NK/T-Cell Lymphoma CL1407051 CTRP Malignant Sinonasal Extranodal NK/T-Cell Lymphoma Sinonasal Extranodal NK/T-Cell Lymphoma An extranodal NK/T-cell lymphoma that arises from the nasal cavity. C173173 Neoplastic Process Nasal Cavity Extranodal NK/T-Cell Lymphoma CL1407050 Malignant Nasal Cavity Extranodal NK/T-Cell Lymphoma Nasal Cavity Extranodal NK/T-Cell Lymphoma An olfactory neuroblastoma that arises from the sinonasal tract. C173174 Neoplastic Process Sinonasal Olfactory Neuroblastoma CL1407053 Malignant Sinonasal Olfactory Neuroblastoma Sinonasal Olfactory Neuroblastoma A Ewing sarcoma that arises from the nasal cavity and paranasal sinuses. C173175 Neoplastic Process Sinonasal Ewing Sarcoma CL1407052 Malignant Sinonasal Ewing Sarcoma Sinonasal Ewing Sarcoma A malignant mesenchymal neoplasm that arises from the nasal cavity and paranasal sinuses. C173176 Neoplastic Process Malignant Sinonasal Soft Tissue Neoplasm CL1407038 Malignant Malignant Sinonasal Soft Tissue Neoplasm Malignant Sinonasal Soft Tissue Neoplasm Colorectal carcinoma characterized by the absence of microsatellite instability. C173324 Neoplastic Process Microsatellite Stable Colorectal Carcinoma CL1407185 Malignant Microsatellite Stable Colorectal Carcinoma Microsatellite Stable Colorectal Carcinoma Ocular melanoma that is resistant to treatment. C173329 Neoplastic Process Refractory Ocular Melanoma CL1407161 Malignant Refractory Ocular Melanoma Refractory Ocular Melanoma Lung squamous cell carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C173330 Neoplastic Process Advanced Lung Squamous Cell Carcinoma Advanced Lung Squamous Cell Carcinoma CL1407162 CTRP Malignant Advanced Lung Squamous Cell Carcinoma Advanced Lung Squamous Cell Carcinoma Lung squamous cell carcinoma that is resistant to treatment. C173331 Neoplastic Process Refractory Lung Squamous Cell Carcinoma Refractory Lung Squamous Cell Carcinoma CL1407163 CTRP Malignant Refractory Lung Squamous Cell Carcinoma Refractory Lung Squamous Cell Carcinoma Microsatellite stable colorectal carcinoma that is resistant to treatment. C173332 Neoplastic Process Refractory Microsatellite Stable Colorectal Carcinoma Refractory Microsatellite Stable Colorectal Carcinoma CL1407164 CTRP Malignant Refractory Microsatellite Stable Colorectal Carcinoma Refractory Microsatellite Stable Colorectal Carcinoma A chordoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C173333 Neoplastic Process Advanced Chordoma Advanced Chordoma CL1407171 CTRP Malignant Advanced Chordoma Advanced Chordoma Anal canal squamous cell carcinoma that is resistant to treatment. C173334 Neoplastic Process Refractory Anal Canal Squamous Cell Carcinoma Refractory Anal Canal Squamous Cell Carcinoma CL1407172 CTRP Malignant Refractory Anal Canal Squamous Cell Carcinoma Refractory Anal Canal Squamous Cell Carcinoma Uveal melanoma that is resistant to treatment. C173335 Neoplastic Process Refractory Uveal Melanoma Refractory Uveal Melanoma CL1407173 CTRP Malignant Refractory Uveal Melanoma Refractory Uveal Melanoma Thyroid gland anaplastic carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C173336 Neoplastic Process Advanced Thyroid Gland Anaplastic Carcinoma Advanced Thyroid Gland Anaplastic Carcinoma CL1407174 CTRP Malignant Advanced Thyroid Gland Anaplastic Carcinoma Advanced Thyroid Gland Anaplastic Carcinoma Anal canal squamous cell carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C173338 Neoplastic Process Advanced Anal Canal Squamous Cell Carcinoma Advanced Anal Canal Squamous Cell Carcinoma CL1407167 CTRP Malignant Advanced Anal Canal Squamous Cell Carcinoma Advanced Anal Canal Squamous Cell Carcinoma An adenoid cystic carcinoma that arises from the nasopharynx. C173340 Neoplastic Process Nasopharyngeal Adenoid Cystic Carcinoma CL1407169 Malignant Nasopharyngeal Adenoid Cystic Carcinoma Nasopharyngeal Adenoid Cystic Carcinoma A pituitary neuroendocrine tumor that does not involve the sella turcica. C173345 Neoplastic Process Ectopic Pituitary Neuroendocrine Tumor CL1407212 Undetermined Ectopic PitNET/Adenoma Ectopic Pituitary Gland Adenoma Ectopic Pituitary Neuroendocrine Tumor Ectopic Pituitary Neuroendocrine Tumor/Adenoma Extrasellar Pituitary Gland Adenoma Ectopic Pituitary Neuroendocrine Tumor An ectopic pituitary neuroendocrine tumor that arises from the nasopharynx. C173352 Neoplastic Process Nasopharyngeal Pituitary Neuroendocrine Tumor CL1407219 Undetermined Nasopharyngeal PitNET/Adenoma Nasopharyngeal Pituitary Gland Adenoma Nasopharyngeal Pituitary Neuroendocrine Tumor Nasopharyngeal Pituitary Neuroendocrine Tumor/Adenoma Nasopharyngeal Pituitary Neuroendocrine Tumor A lymphoma that arises from the pharynx. C173354 Neoplastic Process Pharyngeal Lymphoma CL1407213 Malignant Pharyngeal Lymphoma Pharyngeal Lymphoma A non-Hodgkin lymphoma that arises from the pharynx. C173355 Neoplastic Process Pharyngeal Non-Hodgkin Lymphoma CL1407214 Malignant Pharyngeal Non-Hodgkin Lymphoma Pharyngeal Non-Hodgkin Lymphoma A Hodgkin lymphoma that arises from the pharynx. C173356 Neoplastic Process Pharyngeal Hodgkin Lymphoma CL1407215 Malignant Pharyngeal Hodgkin Lymphoma Pharyngeal Hodgkin Lymphoma A lymphoma that arises from the nasopharynx. C173357 Neoplastic Process Nasopharyngeal Lymphoma CL1407216 Malignant Nasopharyngeal Lymphoma Nasopharyngeal Lymphoma A non-Hodgkin lymphoma that arises from the nasopharynx. C173359 Neoplastic Process Nasopharyngeal Non-Hodgkin Lymphoma CL1407195 Malignant Nasopharyngeal Non-Hodgkin Lymphoma Nasopharyngeal Non-Hodgkin Lymphoma A Hodgkin lymphoma that arises from the nasopharynx. C173361 Neoplastic Process Nasopharyngeal Hodgkin Lymphoma CL1407196 Malignant Nasopharyngeal Hodgkin Lymphoma Nasopharyngeal Hodgkin Lymphoma A rare aggressive neuroendocrine carcinoma that arises from the skin and most often affects older individuals. It is usually located in the head, neck, and extremities. The tumor is composed of small round cells with scanty cytoplasm. Merkel cell polyomavirus is implicated in the majority of cases. C173385 Neoplastic Process Cutaneous Merkel Cell Carcinoma CL1407234 GDC A rare type of cancer that forms on or just beneath the skin, usually in parts of the body that have been exposed to the sun. It is most common in older people and in people with weakened immune systems. Malignant Primary cutaneous neuroendocrine carcinoma Cutaneous Merkel Cell Carcinoma Cutaneous Neuroendocrine Carcinoma Neuroendocrine Carcinoma of Skin Neuroendocrine Carcinoma of the Skin Skin Merkel Cell Carcinoma Skin Neuroendocrine Carcinoma Trabecular Skin Carcinoma neuroendocrine carcinoma of the skin trabecular cancer Cutaneous Merkel Cell Carcinoma A well-differentiated, low or intermediate grade neuroendocrine neoplasm that arises from the head and neck. C173387 Neoplastic Process Head and Neck Neuroendocrine Tumor CL1407236 Undetermined Head and Neck Neuroendocrine Tumor Head and Neck Well Differentiated Neuroendocrine Neoplasm Head and Neck Well-Differentiated Neuroendocrine Neoplasm Head and Neck Neuroendocrine Tumor A well-differentiated, intermediate grade neuroendocrine neoplasm that arises from the head and neck. C173388 Neoplastic Process Head and Neck Neuroendocrine Tumor G2 CL1407237 Undetermined Head and Neck Neuroendocrine Tumor G2 Head and Neck Neuroendocrine Tumor G2 A rare neuroendocrine carcinoma that arises from the larynx. C173390 Neoplastic Process Laryngeal Neuroendocrine Carcinoma CL1407247 Malignant Laryngeal Neuroendocrine Carcinoma Primary Laryngeal Neuroendocrine Carcinoma Laryngeal Neuroendocrine Carcinoma A well-differentiated, low or intermediate grade neuroendocrine neoplasm that arises from the larynx. C173391 Neoplastic Process Laryngeal Neuroendocrine Tumor CL1407248 Undetermined Laryngeal Neuroendocrine Tumor Laryngeal Well Differentiated Neuroendocrine Neoplasm Laryngeal Well-Differentiated Neuroendocrine Neoplasm Laryngeal Neuroendocrine Tumor A well-differentiated, intermediate grade neuroendocrine neoplasm that arises from the larynx. C173392 Neoplastic Process Laryngeal Neuroendocrine Tumor G2 CL1407249 Undetermined Laryngeal Neuroendocrine Tumor G2 Laryngeal Neuroendocrine Tumor G2 A large cell neuroendocrine carcinoma that arises from the larynx. C173395 Neoplastic Process Laryngeal Large Cell Neuroendocrine Carcinoma CL1407244 Malignant Laryngeal Large Cell Neuroendocrine Carcinoma Laryngeal Large Cell Neuroendocrine Carcinoma A mesenchymal neoplasm that arises from the larynx. C173397 Neoplastic Process Laryngeal Soft Tissue Neoplasm CL1407223 Undetermined Laryngeal Soft Tissue Neoplasm Laryngeal Soft Tissue Neoplasm A mesenchymal neoplasm that arises from the larynx and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C173399 Neoplastic Process Benign Laryngeal Soft Tissue Neoplasm CL1407225 Benign Benign Laryngeal Soft Tissue Neoplasm Benign Laryngeal Soft Tissue Neoplasm A malignant mesenchymal neoplasm that arises from the larynx. C173400 Neoplastic Process Malignant Laryngeal Soft Tissue Neoplasm CL1407226 Malignant Malignant Laryngeal Soft Tissue Neoplasm Malignant Laryngeal Soft Tissue Neoplasm An inflammatory myofibroblastic tumor that arises from the larynx. C173402 Neoplastic Process Laryngeal Inflammatory Myofibroblastic Tumor CL1407221 Undetermined Laryngeal Inflammatory Myofibroblastic Tumor Laryngeal Inflammatory Myofibroblastic Tumor A liposarcoma that arises from the tongue. C173404 Neoplastic Process Tongue Liposarcoma CL1407222 Malignant Tongue Liposarcoma Tongue Liposarcoma A granular cell tumor that arises from the larynx. C173405 Neoplastic Process Laryngeal Granular Cell Tumor CL1407231 Undetermined Laryngeal Granular Cell Tumor Laryngeal Granular Cell Tumor A benign neoplasm arising from hyaline cartilage of the larynx. It is characterized by the presence of chondrocytes, a lobulated growth pattern, and calcification. C173406 Neoplastic Process Laryngeal Chondroma CL1407232 Benign Laryngeal Chondroma Laryngeal Chondroma A chondrosarcoma that arises from hyaline cartilage of the larynx. C173407 Neoplastic Process Laryngeal Chondrosarcoma CL936659 Malignant Laryngeal Chondrosarcoma Laryngeal Chondrosarcoma A sarcoma that arises from soft tissue of the larynx. C173408 Neoplastic Process Laryngeal Soft Tissue Sarcoma CL1407233 Malignant Laryngeal Soft Tissue Sarcoma Laryngeal Soft Tissue Sarcoma The reemergence of mature T-cell and NK-cell neoplasm after a period of remission. C173409 Neoplastic Process Recurrent Mature T-Cell and NK-Cell Neoplasm Recurrent Mature T-Cell and NK-Cell Neoplasm CL1407227 CTRP Malignant Recurrent Mature T-Cell and NK-Cell Neoplasm Recurrent Mature T-Cell and NK-Cell Neoplasm Mature T-cell and NK-cell neoplasm that is resistant to treatment. C173411 Neoplastic Process Refractory Mature T-Cell and NK-Cell Neoplasm Refractory Mature T-Cell and NK-Cell Neoplasm CL1407228 CTRP Malignant Refractory Mature T-Cell and NK-Cell Neoplasm Refractory Mature T-Cell and NK-Cell Neoplasm A very rare pleomorphic adenoma that arises from the larynx. C173412 Neoplastic Process Laryngeal Pleomorphic Adenoma CL1407229 Benign Laryngeal Pleomorphic Adenoma Laryngeal Pleomorphic Adenoma A squamous cell carcinoma that arises from the oropharynx and lacks association with human papillomavirus type 16 infection. C173414 Neoplastic Process Oropharyngeal Human Papillomavirus-Independent Squamous Cell Carcinoma CL1407431 Malignant Oropharyngeal HPV Negative Squamous Cell Carcinoma Oropharyngeal HPV-Independent Squamous Cell Carcinoma Oropharyngeal HPV-Negative Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus Negative Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus-Independent Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus-Negative Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus-Independent Squamous Cell Carcinoma Verruca vulgaris in the lips and oral cavity. C173475 Neoplastic Process Oral Verruca Vulgaris CL1407452 Benign Oral Verruca Vulgaris Oral Verruca Vulgaris A benign, exophytic and polypoid growth that arises from the lips or oral cavity. It is covered by hyperplastic epithelium. Some cases are caused by human papillomavirus infection. C173476 Neoplastic Process Oral Squamous Papilloma CL1407453 Benign Oral Squamous Cell Papilloma Oral Squamous Papilloma Oral Squamous Papilloma Kaposi sarcoma arising from the oral cavity. C173477 Neoplastic Process Oral Cavity Kaposi Sarcoma CL1407446 Malignant Oral Cavity Kaposi Sarcoma Oral Cavity Kaposi Sarcoma A low-grade myofibroblastic sarcoma arising from the oral cavity. C173478 Neoplastic Process Oral Cavity Low Grade Myofibroblastic Sarcoma CL1407447 Malignant Oral Cavity Low Grade Myofibroblastic Sarcoma Oral Cavity Low-Grade Myofibroblastic Sarcoma Oral Cavity Myofibroblastic Sarcoma Oral Cavity Low Grade Myofibroblastic Sarcoma A mesenchymal neoplasm that arises from the oral cavity. C173479 Neoplastic Process Oral Cavity Soft Tissue Neoplasm CL1407448 Undetermined Oral Cavity Soft Tissue Neoplasm Oral Cavity Soft Tissue Neoplasm A mesenchymal neoplasm that arises from the oral cavity and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C173480 Neoplastic Process Benign Oral Cavity Soft Tissue Neoplasm CL1407449 Benign Benign Oral Cavity Soft Tissue Neoplasm Benign Oral Cavity Soft Tissue Neoplasm A soft tissue sarcoma that arises from the oral cavity. C173481 Neoplastic Process Oral Cavity Soft Tissue Sarcoma CL1407482 Malignant Oral Cavity Soft Tissue Sarcoma Oral Cavity Soft Tissue Sarcoma A histiocytic and dendritic cell neoplasm that affects the head and neck. C173485 Neoplastic Process Head and Neck Histiocytic and Dendritic Cell Neoplasm CL1407478 Undetermined Head and Neck Histiocytic and Dendritic Cell Neoplasm Head and Neck Histiocytic and Dendritic Cell Neoplasm Langerhans cell histiocytosis involving the head and neck. C173486 Neoplastic Process Head and Neck Langerhans Cell Histiocytosis CL1407479 Undetermined Head and Neck Langerhans Cell Histiocytosis Head and Neck Langerhans Cell Histiocytosis Langerhans cell histiocytosis involving the oral mucosa. C173487 Neoplastic Process Oral Mucosa Langerhans Cell Histiocytosis CL1407480 Undetermined Oral Cavity Langerhans Cell Histiocytosis Oral Mucosa Langerhans Cell Histiocytosis Oral Mucosa Langerhans Cell Histiocytosis A melanocytic neoplasm that arises from the skin or mucosal sites in the head and neck region. C173488 Neoplastic Process Head and Neck Melanocytic Neoplasm CL1407481 Undetermined Head and Neck Melanocytic Neoplasm Head and Neck Melanocytic Neoplasm An extramedullary myeloid tumor that arises from the oral cavity. It occurs de novo or can precede, coincide with, or follow the presentation of acute myeloid leukemia, or can constitute blastic transformation of a myelodysplastic syndrome or myeloproliferative neoplasm. (WHO 2017) C173489 Neoplastic Process Oral Cavity Myeloid Sarcoma CL1407487 Malignant Oral Cavity Myeloid Sarcoma Oral Cavity Myeloid Sarcoma A gastrointestinal stromal tumor that has spread extensively to other anatomic sites or is no longer responding to treatment. C173502 Neoplastic Process Advanced Gastrointestinal Stromal Tumor Advanced Gastrointestinal Stromal Tumor CL1407468 CTRP Malignant Advanced GIST Advanced Gastrointestinal Stromal Tumor Advanced Gastrointestinal Stromal Tumor Acute undifferentiated leukemia that does not respond to treatment. C173503 Neoplastic Process Refractory Acute Undifferentiated Leukemia Refractory Acute Undifferentiated Leukemia CL1407469 CTRP Malignant Refractory Acute Undifferentiated Leukemia Refractory Acute Undifferentiated Leukemia Ganglioneuroblastoma that does not respond to treatment. C173530 Neoplastic Process Refractory Ganglioneuroblastoma Refractory Ganglioneuroblastoma CL1407492 CTRP Malignant Refractory Ganglioneuroblastoma Refractory Ganglioneuroblastoma The reemergence of ganglioneuroblastoma after a period of remission. C173531 Neoplastic Process Recurrent Ganglioneuroblastoma Recurrent Ganglioneuroblastoma CL1407493 CTRP Malignant Recurrent Ganglioneuroblastoma Relapsed Ganglioneuroblastoma Recurrent Ganglioneuroblastoma Any magnetic resonance scanning technique that uses a high percentage of the scan time for data acquisition in order to achieve a short scan duration, resulting in higher image quality. C173553 Diagnostic Procedure Ultrafast MRI Ultrafast MRI CL1407322 CTRP Ultrafast MRI Ultrafast Magnetic Resonance Imaging Ultrafast MRI Primitive neuroectodermal tumor that does not respond to treatment. C173565 Neoplastic Process Refractory Primitive Neuroectodermal Tumor CL1407326 Malignant Refractory Primitive Neuroectodermal Tumor Refractory Primitive Neuroectodermal Tumor A pleomorphic adenoma that arises from the oropharynx. C173575 Neoplastic Process Oropharyngeal Pleomorphic Adenoma CL1407311 Benign Oropharyngeal Pleomorphic Adenoma Oropharyngeal Pleomorphic Adenoma A salivary gland polymorphous adenocarcinoma that arises from the oropharynx. C173576 Neoplastic Process Oropharyngeal Polymorphous Adenocarcinoma CL1407312 Malignant Oropharyngeal Polymorphous Adenocarcinoma Oropharyngeal Polymorphous Adenocarcinoma A lymphoma that arises from the oropharynx. C173577 Neoplastic Process Oropharyngeal Lymphoma CL1407313 Malignant Oropharyngeal Lymphoma Oropharyngeal Lymphoma A Hodgkin lymphoma that arises from the oropharynx. C173578 Neoplastic Process Oropharyngeal Hodgkin Lymphoma CL1407314 Malignant Oropharyngeal Hodgkin Lymphoma Oropharyngeal Hodgkin Lymphoma A non-Hodgkin lymphoma that arises from the oropharynx. C173579 Neoplastic Process Oropharyngeal Non-Hodgkin Lymphoma CL1407308 Malignant Oropharyngeal Non-Hodgkin Lymphoma Oropharyngeal Non-Hodgkin Lymphoma A follicular dendritic cell sarcoma that arises from the head and neck. The most frequently affected sites are the cervical lymph nodes, the Waldeyer ring, and the soft tissue of the neck. C173580 Neoplastic Process Head and Neck Follicular Dendritic Cell Sarcoma CL1407309 Malignant Head and Neck Follicular Dendritic Cell Sarcoma Head and Neck Follicular Dendritic Cell Sarcoma A rare Merkel cell carcinoma that arises from extracutaneous sites, including the oral cavity, salivary glands, breast, vulva, and vaginal wall. C173586 Neoplastic Process Extracutaneous Merkel Cell Carcinoma CL1407353 Malignant Extracutaneous Merkel Cell Carcinoma Extracutaneous Merkel Cell Carcinoma Merkel cell carcinoma that arises from the head and neck region. It usually arises from sun-exposed skin. Rare cases arising from the oral cavity and salivary glands have been reported. C173587 Neoplastic Process Head and Neck Merkel Cell Carcinoma Head and Neck Merkel Cell Carcinoma CL1407346 CTRP Malignant Head and Neck Lymph Nodes Merkel Cell Carcinoma Head and Neck Merkel Cell Carcinoma Head and Neck Merkel Cell Carcinoma of Unknown Primary Head and Neck Merkel Cell Carcinoma A head and neck carcinoma arising from heterotopic tissue elements (i.e. histologically normal tissue of a particular type that is present at an abnormal anatomical site). (WHO 2017) C173588 Neoplastic Process Head and Neck Heterotopia-Associated Carcinoma CL1407347 Malignant Head and Neck Accessory Tissue-Associated Carcinoma Head and Neck Heterotopia-Associated Carcinoma Head and Neck Heterotopia-Associated Carcinoma A rare malignant mesothelioma arising from the tunica vaginalis. It is characterized by the presence of cells with epithelioid morphology. The epithelioid cells usually have eosinophilic cytoplasm, bland nuclei, and form tubulopapillary, microglandular, or sheet-like patterns. C173605 Neoplastic Process Paratesticular Epithelioid Mesothelioma Paratesticular Epithelioid Mesothelioma CL1407332 CTRP Malignant Paratesticular Epithelioid Mesothelioma Testicular Epithelioid Mesothelioma Tunica Vaginalis Epithelioid Mesothelioma Paratesticular Epithelioid Mesothelioma A rare malignant mesothelioma arising from the tunica vaginalis. It is characterized by the presence of spindle cells. Anaplastic morphologic features and multinucleated malignant cells may also be seen. C173606 Neoplastic Process Paratesticular Sarcomatoid Mesothelioma Paratesticular Sarcomatoid Mesothelioma CL1407333 CTRP Malignant Paratesticular Sarcomatoid Mesothelioma Testicular Sarcomatoid Mesothelioma Tunica Vaginalis Sarcomatoid Mesothelioma Paratesticular Sarcomatoid Mesothelioma A rare malignant mesothelioma arising from the tunica vaginalis. It is characterized by the presence of epithelioid and sarcomatoid components, with each component representing at least 10% of the tumor. C173607 Neoplastic Process Paratesticular Biphasic Mesothelioma Paratesticular Biphasic Mesothelioma CL1407342 CTRP Malignant Paratesticular Biphasic Mesothelioma Testicular Biphasic Mesothelioma Tunica Vaginalis Biphasic Mesothelioma Paratesticular Biphasic Mesothelioma Paratesticular malignant mesothelioma that is not amenable to surgical resection. C173608 Neoplastic Process Unresectable Paratesticular Malignant Mesothelioma Unresectable Paratesticular Malignant Mesothelioma CL1407343 CTRP Malignant Unresectable Paratesticular Malignant Mesothelioma Unresectable Testicular Mesothelioma Unresectable Tunica Vaginalis Mesothelioma Unresectable Paratesticular Malignant Mesothelioma Paratesticular epithelioid mesothelioma that is not amenable to surgical resection. C173609 Neoplastic Process Unresectable Paratesticular Epithelioid Mesothelioma Unresectable Paratesticular Epithelioid Mesothelioma CL1407344 CTRP Malignant Unresectable Paratesticular Epithelioid Mesothelioma Unresectable Testicular Epithelioid Mesothelioma Unresectable Tunica Vaginalis Epithelioid Mesothelioma Unresectable Paratesticular Epithelioid Mesothelioma Paratesticular sarcomatoid mesothelioma that is not amenable to surgical resection. C173610 Neoplastic Process Unresectable Paratesticular Sarcomatoid Mesothelioma Unresectable Paratesticular Sarcomatoid Mesothelioma CL1407345 CTRP Malignant Unresectable Paratesticular Sarcomatoid Mesothelioma Unresectable Testicular Sarcomatoid Mesothelioma Unresectable Tunica Vaginalis Sarcomatoid Mesothelioma Unresectable Paratesticular Sarcomatoid Mesothelioma Paratesticular biphasic mesothelioma that is not amenable to surgical resection. C173611 Neoplastic Process Unresectable Paratesticular Biphasic Mesothelioma Unresectable Paratesticular Biphasic Mesothelioma CL1407338 CTRP Malignant Unresectable Paratesticular Biphasic Mesothelioma Unresectable Testicular Biphasic Mesothelioma Unresectable Tunica Vaginalis Biphasic Mesothelioma Unresectable Paratesticular Biphasic Mesothelioma Peritoneal malignant mesothelioma that is not amenable to surgical resection. C173612 Neoplastic Process Unresectable Peritoneal Malignant Mesothelioma Unresectable Peritoneal Malignant Mesothelioma CL1407339 CTRP Malignant Unresectable Peritoneal Malignant Mesothelioma Unresectable Peritoneal Malignant Mesothelioma Peritoneal epithelioid mesothelioma that is not amenable to surgical resection. C173613 Neoplastic Process Unresectable Peritoneal Epithelioid Mesothelioma Unresectable Peritoneal Epithelioid Mesothelioma CL1407340 CTRP Malignant Unresectable Peritoneal Epithelioid Mesothelioma Unresectable Peritoneal Epithelioid Mesothelioma Peritoneal sarcomatoid mesothelioma that is not amenable to surgical resection. C173614 Neoplastic Process Unresectable Peritoneal Sarcomatoid Mesothelioma Unresectable Peritoneal Sarcomatoid Mesothelioma CL1407341 CTRP Malignant Unresectable Peritoneal Sarcomatoid Mesothelioma Unresectable Peritoneal Sarcomatoid Mesothelioma Peritoneal biphasic mesothelioma that is not amenable to surgical resection. C173615 Neoplastic Process Unresectable Peritoneal Biphasic Mesothelioma Unresectable Peritoneal Biphasic Mesothelioma CL1407374 CTRP Malignant Unresectable Peritoneal Biphasic Mesothelioma Unresectable Peritoneal Biphasic Mesothelioma Pleural epithelioid mesothelioma that is not amenable to surgical resection. C173616 Neoplastic Process Unresectable Pleural Epithelioid Mesothelioma Unresectable Pleural Epithelioid Mesothelioma CL1407375 CTRP Malignant Unresectable Pleural Epithelioid Mesothelioma Unresectable Pleural Epithelioid Mesothelioma Pleural sarcomatoid mesothelioma that is not amenable to surgical resection. C173617 Neoplastic Process Unresectable Pleural Sarcomatoid Mesothelioma Unresectable Pleural Sarcomatoid Mesothelioma CL1407376 CTRP Malignant Unresectable Pleural Sarcomatoid Mesothelioma Unresectable Pleural Sarcomatoid Mesothelioma Pleural biphasic mesothelioma that is not amenable to surgical resection. C173618 Neoplastic Process Unresectable Pleural Biphasic Mesothelioma Unresectable Pleural Biphasic Mesothelioma CL1407377 CTRP Malignant Unresectable Pleural Biphasic Mesothelioma Unresectable Pleural Biphasic Mesothelioma Hereditary thyroid gland medullary carcinoma that is not amenable to surgical resection. C173637 Neoplastic Process Unresectable Hereditary Thyroid Gland Medullary Carcinoma Unresectable Hereditary Thyroid Gland Medullary Carcinoma CL1407362 CTRP Malignant Unresectable Hereditary Thyroid Gland Medullary Carcinoma Unresectable Hereditary Thyroid Gland Medullary Carcinoma The reemergence of hereditary thyroid gland medullary carcinoma after a period of remission. C173638 Neoplastic Process Recurrent Hereditary Thyroid Gland Medullary Carcinoma Recurrent Hereditary Thyroid Gland Medullary Carcinoma CL1407363 CTRP Malignant Recurrent Hereditary Thyroid Gland Medullary Carcinoma Recurrent Hereditary Thyroid Gland Medullary Carcinoma A rare sebaceous carcinoma that arises from the salivary glands. C173648 Neoplastic Process Salivary Gland Sebaceous Carcinoma CL1407400 Malignant Salivary Gland Sebaceous Adenocarcinoma Salivary Gland Sebaceous Carcinoma Salivary Gland Sebaceous Carcinoma A high-grade carcinoma that arises from the salivary glands. This category includes large and small cell types with or without neuroendocrine differentiation. C173649 Neoplastic Process Salivary Gland Poorly Differentiated Carcinoma CL1407401 Malignant Salivary Gland Poorly Differentiated Carcinoma Salivary Gland Poorly Differentiated Carcinoma A large cell carcinoma that arises from the salivary glands and exhibits neuroendocrine differentiation. C173650 Neoplastic Process Salivary Gland Large Cell Neuroendocrine Carcinoma CL1407402 Malignant Salivary Gland Large Cell Neuroendocrine Carcinoma Salivary Gland Large Cell Neuroendocrine Carcinoma An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the salivary glands. The mitotic count is more than 20 per 10 HPF. It is classified as either small or large cell neuroendocrine carcinoma based on the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm. C173653 Neoplastic Process Salivary Gland Neuroendocrine Carcinoma CL1407397 Malignant Salivary Gland Neuroendocrine Carcinoma Salivary Gland Neuroendocrine Carcinoma A rare benign salivary gland tumor that consists of a well-circumscribed biphasic proliferation of epithelial cells and reactive lymphoid tissue. Sebaceous and non-sebaceous forms can be distinguished. (WHO 2017) C173659 Neoplastic Process Salivary Gland Lymphadenoma CL1407403 Benign Salivary Gland Lymphadenoma Salivary Gland Lymphadenoma A hemangioma that arises from a salivary gland. It occurs almost exclusively in the parotid gland. C173680 Neoplastic Process Salivary Gland Hemangioma C3697841 Benign Salivary Gland Hemangioma Salivary Gland Hemangioma A lipoma that arises from a salivary gland. It usually occurs in the parotid gland. C173681 Neoplastic Process Salivary Gland Lipoma CL1407536 Benign Salivary Gland Lipoma Salivary Gland Lipoma A benign salivary gland neoplasm composed of mature adipose tissue and epithelial tissue. It usually occurs in the parotid gland. C173682 Neoplastic Process Sialolipoma CL1407537 Benign Sialolipoma Sialolipoma Acute biphenotypic leukemia that is resistant to treatment. C173683 Neoplastic Process Refractory Acute Biphenotypic Leukemia Refractory Acute Biphenotypic Leukemia CL1407531 CTRP Malignant Refractory Acute Biphenotypic Leukemia Refractory Acute Biphenotypic Leukemia A benign parotid gland neoplasm composed of mature adipose tissue and epithelial tissue. C173684 Neoplastic Process Parotid Gland Sialolipoma CL1407532 Benign Parotid Gland Sialolipoma Parotid Gland Sialolipoma Pharyngeal squamous cell carcinoma that has spread from the original site of growth to another anatomic site. C173685 Neoplastic Process Metastatic Pharyngeal Squamous Cell Carcinoma Metastatic Pharyngeal Squamous Cell Carcinoma CL1407533 CTRP Malignant Metastatic Pharyngeal Squamous Cell Carcinoma Metastatic Pharyngeal Squamous Cell Carcinoma A self-limiting, rapidly growing, non-encapsulated benign neoplasm that arises from the salivary glands. It is composed of fibroblastic/myofibroblastic cells. It usually occurs in the parotid gland. C173687 Neoplastic Process Salivary Gland Nodular Fasciitis CL1407542 Benign Salivary Gland Nodular Fasciitis Salivary Gland Nodular Fasciitis A self-limiting, rapidly growing, non-encapsulated benign neoplasm that arises from the parotid gland. It is composed of fibroblastic/myofibroblastic cells. C173688 Neoplastic Process Parotid Gland Nodular Fasciitis CL1407543 Benign Parotid Gland Nodular Fasciitis Parotid Gland Nodular Fasciitis The reemergence of pharyngeal squamous cell carcinoma after a period of remission. C173689 Neoplastic Process Recurrent Pharyngeal Squamous Cell Carcinoma Recurrent Pharyngeal Squamous Cell Carcinoma CL1407544 CTRP Malignant Recurrent Pharyngeal Squamous Cell Carcinoma Recurrent Pharyngeal Squamous Cell Carcinoma A lymphoma that manifests initially in a salivary gland. It usually occurs in the parotid gland. C173690 Neoplastic Process Salivary Gland Lymphoma CL1407545 Malignant Primary Salivary Gland Lymphoma Salivary Gland Lymphoma Salivary Gland Lymphoma A non-Hodgkin lymphoma that manifests initially in a salivary gland. It usually occurs in the parotid gland. Mucosa-associated lymphoid tissue lymphoma is the most common primary salivary gland non-Hodgkin lymphoma. C173691 Neoplastic Process Salivary Gland Non-Hodgkin Lymphoma CL1407538 Malignant Primary Salivary Gland Non-Hodgkin Lymphoma Salivary Gland Non-Hodgkin Lymphoma Salivary Gland Non-Hodgkin Lymphoma A very rare Hodgkin lymphoma that manifests initially in a salivary gland. C173692 Neoplastic Process Salivary Gland Hodgkin Lymphoma CL1407539 Malignant Primary Salivary Gland Hodgkin Lymphoma Salivary Gland Hodgkin Lymphoma Salivary Gland Hodgkin Lymphoma A low-grade extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue arising from a salivary gland. It usually occurs in the parotid gland and is often associated with Sjogren syndrome. The prognosis is favorable. C173693 Neoplastic Process Salivary Gland Mucosa-Associated Lymphoid Tissue Lymphoma CL1407540 Malignant Salivary Gland MALT Lymphoma Salivary Gland Mucosa-Associated Lymphoid Tissue Lymphoma Salivary Gland Mucosa-Associated Lymphoid Tissue Lymphoma Pharyngeal squamous cell carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C173694 Neoplastic Process Advanced Pharyngeal Squamous Cell Carcinoma Advanced Pharyngeal Squamous Cell Carcinoma CL1407541 CTRP Malignant Advanced Pharyngeal Squamous Cell Carcinoma Advanced Pharyngeal Squamous Cell Carcinoma A follicular lymphoma that manifests initially in a salivary gland. It usually occurs in the parotid gland. C173715 Neoplastic Process Salivary Gland Follicular Lymphoma CL1407567 Malignant Primary Salivary Gland Follicular Lymphoma Salivary Gland Follicular Lymphoma Salivary Gland Follicular Lymphoma A follicular lymphoma that manifests initially in the parotid gland. C173716 Neoplastic Process Parotid Gland Follicular Lymphoma CL1407560 Malignant Parotid Gland Follicular Lymphoma Primary Parotid Gland Follicular Lymphoma Parotid Gland Follicular Lymphoma A diffuse large B-cell lymphoma that manifests initially in a salivary gland. It usually occurs in the parotid gland. C173717 Neoplastic Process Salivary Gland Diffuse Large B-Cell Lymphoma CL1407561 Malignant Primary Salivary Gland Diffuse Large B-Cell Lymphoma Salivary Gland Diffuse Large B-Cell Lymphoma Salivary Gland Diffuse Large B-Cell Lymphoma A diffuse large B-cell lymphoma that manifests initially in the parotid gland. C173719 Neoplastic Process Parotid Gland Diffuse Large B-Cell Lymphoma CL1407563 Malignant Parotid Gland Diffuse Large B-Cell Lymphoma Primary Parotid Gland Diffuse Large B-Cell Lymphoma Parotid Gland Diffuse Large B-Cell Lymphoma A carcinoma that arises from tooth-forming tissues. C173720 Neoplastic Process Odontogenic Carcinoma CL1407572 GDC Malignant Odontogenic carcinoma Odontogenic Carcinoma Odontogenic carcinoma Odontogenic Carcinoma A rare, low-grade primary intraosseous carcinoma of the jaws, with bland cytology, markedly sclerotic stroma, and aggressive infiltration. It is characterized by single-file thin cords, nests, and strands of epithelium in a densely sclerotic stroma. Cytologically, individual epithelial cells are bland, with infrequent mitoses. Their cytoplasm may show vacuolation or partial clearing. There is no squamous differentiation. Despite the benign appearance, there is invasion of skeletal muscle, and perineural infiltration is characteristic. (WHO 2017) C173733 Neoplastic Process Sclerosing Odontogenic Carcinoma CL1407547 Malignant SOC Sclerosing Odontogenic Carcinoma Sclerosing Odontogenic Carcinoma An extremely rare malignant mixed odontogenic neoplasm in which both the epithelial and the mesenchymal components are cytologically malignant. (WHO 2017) C173735 Neoplastic Process Odontogenic Carcinosarcoma CL1407549 GDC Malignant 9342/3 Odontogenic Carcinosarcoma Odontogenic carcinosarcoma Ameloblastic Carcinosarcoma Malignant Odontogenic Mixed Tumor OCS Odontogenic Carcinosarcoma Odontogenic carcinosarcoma Odontogenic Carcinosarcoma A sarcoma that arises from tooth-forming tissues. C173738 Neoplastic Process Odontogenic Sarcoma C0542511 GDC Malignant Odontogenic sarcoma Odontogenic Sarcoma Odontogenic sarcoma Odontogenic Sarcoma An odontogenic sarcoma producing dentin/dentinoid. C173739 Neoplastic Process Ameloblastic Fibrodentinosarcoma C0334564 GDC Malignant Ameloblastic fibrodentinosarcoma Ameloblastic Fibrodentinosarcoma Ameloblastic fibrodentinosarcoma Ameloblastic Fibrodentinosarcoma An odontogenic sarcoma producing enamel/enameloid and dentin. C173740 Neoplastic Process Ameloblastic Fibro-Odontosarcoma CL1407559 GDC 9290/3 Malignant 9290/3 Ameloblastic fibro-odontosarcoma Ameloblastic odontosarcoma Odontogenic fibrosarcoma Ameloblastic Fibro-Odontosarcoma Ameloblastic Fibroodontosarcoma Ameloblastic fibro-odontosarcoma Ameloblastic odontosarcoma Odontogenic fibrosarcoma Ameloblastic Fibro-Odontosarcoma A rare adenosquamous carcinoma that arises from the tongue. C173807 Neoplastic Process Tongue Adenosquamous Carcinoma CL1407727 Cellosaurus Malignant Tongue Adenosquamous Carcinoma Tongue Adenosquamous Carcinoma A rare undifferentiated pleomorphic sarcoma that arises from the retroperitoneum. C173808 Neoplastic Process Retroperitoneal Undifferentiated Pleomorphic Sarcoma CL1407726 Malignant Retroperitoneal Undifferentiated Pleomorphic Sarcoma Retroperitoneal Undifferentiated Pleomorphic Sarcoma An exceptionally rare alveolar soft part sarcoma that arises from the lung. C173809 Neoplastic Process Lung Alveolar Soft Part Sarcoma CL1407625 Malignant Lung Alveolar Soft Part Sarcoma Primary Lung Alveolar Soft Part Sarcoma Lung Alveolar Soft Part Sarcoma A diffuse large B-cell lymphoma that arises from the bone, without lymph node or other extranodal involvement. C173811 Neoplastic Process Primary Bone Diffuse Large B-Cell Lymphoma CL1407624 Malignant Bone Diffuse Large B-Cell Lymphoma Primary Bone Diffuse Large B-Cell Lymphoma Primary Bone Diffuse Large B-Cell Lymphoma An exceedingly rare squamous cell carcinoma arising from the pancreas. C173813 Neoplastic Process Pancreatic Squamous Cell Carcinoma Pancreatic Squamous Cell Carcinoma C2675993 CTRP Malignant Pancreatic Squamous Cell Carcinoma Pancreatic Squamous Cell Carcinoma Intrahepatic cholangiocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C173814 Neoplastic Process Locally Advanced Intrahepatic Cholangiocarcinoma Locally Advanced Intrahepatic Cholangiocarcinoma CL1407621 CTRP Malignant Locally Advanced Intrahepatic Cholangiocarcinoma Locally Advanced Intrahepatic Cholangiocarcinoma The reemergence of ectomesenchymoma after a period of remission. C173815 Neoplastic Process Recurrent Ectomesenchymoma Recurrent Ectomesenchymoma CL1407620 CTRP Malignant Recurrent Ectomesenchymoma Recurrent Ectomesenchymoma A benign odontogenic tumor composed of variably cellular loose fibrous tissue with areas similar to the dental papilla, entirely surrounded by cuboidal to columnar epithelium resembling the internal epithelium of the enamel organ. It occurs intraosseously, with a marked preference for the mandible. (WHO 2017) C173819 Neoplastic Process Primordial Odontogenic Tumor CL1407623 Benign POT Primordial Odontogenic Tumor Primordial Odontogenic Tumor A benign fibro-osseous neoplasm affecting the jaws and the craniofacial skeleton. (WHO 2017) C173820 Neoplastic Process Ossifying Fibroma CL1407622 GDC Benign 9262/0 Fibro-osteoma Ossifying fibroma Ossifying Fibroma Ossifying Fibroma of the Jaws and Craniofacial Skeleton Ossifying fibroma Ossifying Fibroma A sarcoma that arises in a maxillofacial bone. C173841 Neoplastic Process Maxillofacial Sarcoma CL1407616 Malignant Maxillofacial Sarcoma Maxillofacial Sarcoma A chondrosarcoma that arises in a maxillofacial bone. C173842 Neoplastic Process Maxillofacial Chondrosarcoma CL1407615 Malignant Maxillofacial Chondrosarcoma Maxillofacial Chondrosarcoma A mesenchymal chondrosarcoma that arises in a maxillofacial bone. C173843 Neoplastic Process Maxillofacial Mesenchymal Chondrosarcoma CL1407618 Malignant Maxillofacial Mesenchymal Chondrosarcoma Maxillofacial Mesenchymal Chondrosarcoma An osteosarcoma that arises in a maxillofacial bone. C173844 Neoplastic Process Maxillofacial Osteosarcoma CL1407617 Malignant Maxillofacial Osteosarcoma Maxillofacial Osteosarcoma A neoplasm that arises in a maxillofacial bone. C173845 Neoplastic Process Maxillofacial Neoplasm CL1407650 Undetermined Maxillofacial Neoplasm Maxillofacial Neoplasm A glioma affecting both sides of the thalamus. C173846 Neoplastic Process Bilateral Thalamic Glioma Bilateral Thalamic Glioma CL1407649 CTRP Undetermined Bilateral Thalamic Glioma Bithalamic Glioma Bilateral Thalamic Glioma A neoplasm that arises from a maxillofacial bone and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C173892 Neoplastic Process Benign Maxillofacial Neoplasm CL1407684 Benign Benign Maxillofacial Neoplasm Benign Maxillofacial Neoplasm A benign neoplasm of hyaline cartilage that arises within the medullary cavity of a maxillofacial bone. It is characterized by the presence of chondrocytes, a lobulated growth pattern, and calcification. C173893 Neoplastic Process Maxillofacial Chondroma CL1407683 Benign Maxillofacial Chondroma Maxillofacial Chondroma A benign, well-circumscribed bone-forming neoplasm arising in a maxillofacial bone. C173894 Neoplastic Process Maxillofacial Osteoma CL1407686 Benign Maxillofacial Osteoma Maxillofacial Osteoma A benign chondroid-producing neoplasm arising in a maxillofacial bone. C173895 Neoplastic Process Maxillofacial Chondroblastoma CL1407685 Benign Maxillofacial Chondroblastoma Maxillofacial Chondroblastoma An uncommon benign cartilaginous neoplasm arising in a maxillofacial bone. It is characterized by the presence of spindle-shaped or stellate chondrocytes, a lobulated growth pattern, myxoid stroma formation, and sometimes multinucleated giant cells. C173897 Neoplastic Process Maxillofacial Chondromyxoid Fibroma CL1407664 Benign Maxillofacial Chondromyxoid Fibroma Maxillofacial Chondromyxoid Fibroma A benign bone-forming tumor that arises in a maxillofacial bone. It is characterized by limited growth potential. (WHO 2017) C173898 Neoplastic Process Maxillofacial Osteoid Osteoma CL1407667 Benign Maxillofacial Osteoid Osteoma Maxillofacial Osteoid Osteoma A benign bone-forming neoplasm with prominent osteoblastic rimming arising in a maxillofacial bone. C173899 Neoplastic Process Maxillofacial Osteoblastoma CL1407666 Benign Maxillofacial Osteoblastoma Maxillofacial Osteoblastoma A rare, benign, locally aggressive osteolytic neoplasm that arises in a maxillofacial bone. It is characterized by the presence of a rich collagenous stroma and spindle cells with minimal cellular atypia. C173900 Neoplastic Process Maxillofacial Desmoplastic Fibroma CL1407661 Benign Maxillofacial Desmoplastic Fibroma Maxillofacial Desmoplastic Fibroma The reemergence of a metastatic malignant neoplasm in the leptomeninges after a period of remission. C173916 Neoplastic Process Recurrent Metastatic Malignant Neoplasm in the Leptomeninges Recurrent Metastatic Malignant Neoplasm in the Leptomeninges CL1407706 CTRP Malignant Recurrent Metastatic Malignant Neoplasm in the Leptomeninges Recurrent Metastatic Malignant Neoplasm in the Leptomeninges Fibrous dysplasia affecting the craniofacial bones. C173926 Neoplastic Process Craniofacial Fibrous Dysplasia CL932243 Benign Craniofacial Fibrous Dysplasia Craniofacial Fibrous Dysplasia A neoplasm that arises from the head and neck and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C173932 Neoplastic Process Benign Head and Neck Neoplasm Benign Head and Neck Neoplasm CL1407692 CTRP Benign Benign Head and Neck Neoplasm Benign Head and Neck Neoplasm Differentiated thyroid gland carcinoma that has spread from its original site of growth to another anatomic site. C173979 Neoplastic Process Metastatic Differentiated Thyroid Gland Carcinoma Metastatic Differentiated Thyroid Gland Carcinoma CL1407896 CTRP Malignant Metastatic Differentiated Thyroid Gland Carcinoma Metastatic Differentiated Thyroid Gland Carcinoma Differentiated thyroid gland carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C173980 Neoplastic Process Advanced Differentiated Thyroid Gland Carcinoma Advanced Differentiated Thyroid Gland Carcinoma CL1407895 CTRP Malignant Advanced Differentiated Thyroid Gland Carcinoma Advanced Differentiated Thyroid Gland Carcinoma A locally invasive, papillary epithelial neoplasm arising in any area of the middle ear, including the mastoid process and air cells, and may fill the tympanic cavity. It is characterized by the presence of a papillary glandular pattern, with complex interdigitating papillae lying loosely or infiltrating fibrous connective tissue. (WHO 2017) C174022 Neoplastic Process Aggressive Papillary Tumor CL536959 Undetermined Aggressive papillary tumor Aggressive Papillary Tumor Middle Ear Aggressive Papillary Tumor Aggressive Papillary Tumor A neoplasm that arises from the inner ear and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include vestibular schwannoma and lipoma. C174023 Neoplastic Process Benign Inner Ear Neoplasm CL1407932 Benign Benign Inner Ear Neoplasm Benign Inner Ear Neoplasm Cervical carcinoma that is not amenable to surgical resection. C174024 Neoplastic Process Unresectable Cervical Carcinoma CL1407931 Malignant Unresectable Cervical Carcinoma Unresectable Cervical Carcinoma Cervical squamous cell carcinoma that is not amenable to surgical resection. C174025 Neoplastic Process Unresectable Cervical Squamous Cell Carcinoma, Not Otherwise Specified Unresectable Cervical Squamous Cell Carcinoma CL1407927 CTRP Malignant Unresectable Cervical Squamous Cell Carcinoma Unresectable Cervical Squamous Cell Carcinoma A malignant neoplasm that affects the inner ear. C174026 Neoplastic Process Malignant Inner Ear Neoplasm C2837942 Malignant Malignant Inner Ear Neoplasm Malignant Inner Ear Neoplasm Cervical adenosquamous carcinoma that is not amenable to surgical resection. C174027 Neoplastic Process Unresectable Cervical Adenosquamous Carcinoma Unresectable Cervical Adenosquamous Carcinoma CL1407929 CTRP Malignant Unresectable Cervical Adenosquamous Carcinoma Unresectable Cervical Adenosquamous Carcinoma Cervical adenocarcinoma that is not amenable to surgical resection. C174029 Neoplastic Process Unresectable Cervical Adenocarcinoma Unresectable Cervical Adenocarcinoma CL1407928 CTRP Malignant Unresectable Cervical Adenocarcinoma Unresectable Cervical Adenocarcinoma Cervical squamous cell carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C174030 Neoplastic Process Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified Advanced Cervical Squamous Cell Carcinoma CL1407909 CTRP Malignant Advanced Cervical Squamous Cell Carcinoma Advanced Cervical Squamous Cell Carcinoma Cervical adenosquamous carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C174032 Neoplastic Process Advanced Cervical Adenosquamous Carcinoma Advanced Cervical Adenosquamous Carcinoma CL1407911 CTRP Malignant Advanced Cervical Adenosquamous Carcinoma Advanced Cervical Adenosquamous Carcinoma A rare extracranial meningioma that arises from the middle ear. C174033 Neoplastic Process Primary Middle Ear Meningioma CL1407910 Undetermined Primary Ear Meningioma Primary Middle Ear Meningioma Primary Middle Ear Meningioma Salivary gland carcinoma that is not amenable to surgical resection. C174034 Neoplastic Process Unresectable Salivary Gland Carcinoma Unresectable Salivary Gland Carcinoma CL1407905 CTRP Malignant Unresectable Salivary Gland Carcinoma Unresectable Salivary Gland Carcinoma Endometrial adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C174043 Neoplastic Process Locally Advanced Endometrial Adenocarcinoma CL1407917 Malignant Locally Advanced Endometrial Adenocarcinoma Locally Advanced Endometrial Adenocarcinoma Endometrial endometrioid adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C174044 Neoplastic Process Locally Advanced Endometrial Endometrioid Adenocarcinoma Locally Advanced Endometrial Endometrioid Adenocarcinoma CL1407913 CTRP Malignant Locally Advanced Endometrial Endometrioid Adenocarcinoma Locally Advanced Endometrial Endometrioid Adenocarcinoma Poorly differentiated thyroid gland carcinoma that has spread from its original site of growth to another anatomic site. C174046 Neoplastic Process Metastatic Poorly Differentiated Thyroid Gland Carcinoma Metastatic Poorly Differentiated Thyroid Gland Carcinoma CL1407915 CTRP Malignant Metastatic Poorly Differentiated Thyroid Gland Carcinoma Metastatic Poorly Differentiated Thyroid Gland Carcinoma The reemergence of poorly differentiated thyroid gland carcinoma after a period of remission. C174047 Neoplastic Process Recurrent Poorly Differentiated Thyroid Gland Carcinoma Recurrent Poorly Differentiated Thyroid Gland Carcinoma CL1407914 CTRP Malignant Recurrent Poorly Differentiated Thyroid Gland Carcinoma Recurrent Poorly Differentiated Thyroid Gland Carcinoma The reemergence of AL amyloidosis after a period of remission. C174054 Neoplastic Process Recurrent AL Amyloidosis Recurrent AL Amyloidosis CL1407952 CTRP Malignant Recurrent AL Amyloidosis Recurrent AL Amyloidosis AL amyloidosis that does not respond to treatment. C174055 Neoplastic Process Refractory AL Amyloidosis Refractory AL Amyloidosis CL1407951 CTRP Malignant Refractory AL Amyloidosis Refractory AL Amyloidosis Rectal adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C174122 Neoplastic Process Locally Advanced Rectal Adenocarcinoma CL1407789 Malignant Locally Advanced Rectal Adenocarcinoma Locally Advanced Rectal Adenocarcinoma An acute myeloid leukemia characterized by rearrangement of the KMT2A gene. It affects infants, children and adults. It is usually associated with poor prognosis. C174129 Neoplastic Process Acute Myeloid Leukemia with MLL Rearrangement Acute Myeloid Leukemia with KMT2A Rearrangement CL1407773 CTRP GDC Malignant 9897/3 Acute myeloid leukaemia with 11q23-abnormality Acute myeloid leukemia with 11q23-abnormality not having achieved remission Acute myeloid leukemia, 11q23 abnormalities Acute myeloid leukemia, MLL Acute Myeloid Leukemia with 11q23 Abnormalities Acute Myeloid Leukemia with KMT2A Rearrangement Acute Myeloid Leukemia with KMT2A/MLL Rearrangement Acute Myeloid Leukemia with MLL Rearrangement Acute Myeloid Leukemia with MLLr Acute Myeloid Leukemia, MLL Acute myeloid leukemia, 11q23 abnormalities Acute myeloid leukemia, MLL Acute Myeloid Leukemia with KMT2A Rearrangement Vulvar carcinoma that is not amenable to surgical resection. C174198 Neoplastic Process Unresectable Vulvar Carcinoma CL1407828 Malignant Unresectable Vulvar Carcinoma Unresectable Vulvar Carcinoma Vulvar squamous cell carcinoma that is not amenable to surgical resection. C174199 Neoplastic Process Unresectable Vulvar Squamous Cell Carcinoma Unresectable Vulvar Squamous Cell Carcinoma CL1407823 CTRP Malignant Unresectable Vulvar Squamous Cell Carcinoma Unresectable Vulvar Squamous Cell Carcinoma The reemergence of vulvar squamous cell carcinoma after a period of remission. C174200 Neoplastic Process Recurrent Vulvar Squamous Cell Carcinoma Recurrent Vulvar Squamous Cell Carcinoma CL1407822 CTRP Malignant Recurrent Vulvar Squamous Cell Carcinoma Recurrent Vulvar Squamous Cell Carcinoma Vulvar squamous cell carcinoma that has spread from its original site of growth to another anatomic site. C174201 Neoplastic Process Metastatic Vulvar Squamous Cell Carcinoma Metastatic Vulvar Squamous Cell Carcinoma CL1407825 CTRP Malignant Metastatic Vulvar Squamous Cell Carcinoma Metastatic Vulvar Squamous Cell Carcinoma The reemergence of supratentorial glioblastoma after a period of remission. C174202 Neoplastic Process Recurrent Supratentorial Glioblastoma Recurrent Supratentorial Glioblastoma CL1407824 CTRP Malignant Recurrent Supratentorial Glioblastoma Recurrent Supratentorial Glioblastoma C174231 Diagnostic Procedure ECG Gated MRI CL1411799 CDISC A type of magnetic resonance imaging in which data is acquired during a specified portion of the cardiac cycle, allowing for the collection of stop motion imaging of the heart. ECG GATED MRI ECG Gated MRI ECG Gated MRI Intrahepatic cholangiocarcinoma that is resistant to treatment. C174247 Neoplastic Process Refractory Intrahepatic Cholangiocarcinoma Refractory Intrahepatic Cholangiocarcinoma CL1411794 CTRP Malignant Refractory Intrahepatic Cholangiocarcinoma Refractory Intrahepatic Cholangiocarcinoma A type of ECG gated MRI in which the images are enhanced by the addition of contrast agents into the body. C174358 Diagnostic Procedure Contrast Enhanced ECG Gated MRI CL1411770 CDISC A type of ECG gated MRI in which the images are enhanced by the addition of contrast agents into the body. CONTRAST ENHANCED ECG GATED MRI Contrast Enhanced ECG Gated MRI Contrast Enhanced ECG Gated MRI A type of ECG gated MRI in which the images are not enhanced by the addition of contrast agents into the body. C174359 Diagnostic Procedure ECG Gated MRI Without Contrast CL1411771 CDISC A type of ECG gated MRI in which the images are not enhanced by the addition of contrast agents into the body. ECG GATED MRI WITHOUT CONTRAST ECG Gated MRI Without Contrast ECG Gated MRI Without Contrast A benign epithelial neoplasm that arises from the conjunctiva. It is characterized by the presence of oncocytic cells with abundant eosinophilic and granular cytoplasm. C174388 Neoplastic Process Conjunctival Oncocytoma CL1411956 Benign Conjunctival Oncocytoma Conjunctival Oncocytoma A rapidly growing neoplasm that arises from the conjunctiva. It is characterized by a proliferation of squamous cells, acanthosis, keratinization, dysplasia, increased mitotic activity, and a central crater filled with keratinocytes. It is considered a variant of well-differentiated squamous cell carcinoma with distinct clinical behavior. C174390 Neoplastic Process Conjunctival Keratoacanthoma CL760934 Malignant Conjunctival Keratoacanthoma Conjunctival Keratoacanthoma A variant of conjunctival squamous cell carcinoma characterized by the presence of malignant spindle cells and/or pleomorphic cells. C174398 Neoplastic Process Conjunctival Spindle Cell Carcinoma CL1411954 Malignant Conjunctival Spindle Cell Carcinoma Conjunctival Spindle Cell Carcinoma A carcinoma that arises from the conjunctiva. It is characterized by the presence of a variable combination of squamous (epidermoid) cells and mucous cells, arranged in invasive sheets, cords, and ducts. (WHO 2018) C174402 Neoplastic Process Conjunctival Adenosquamous Carcinoma CL1411942 Malignant Conjunctival Adenosquamous Carcinoma Conjunctival Mucoepidermoid Carcinoma Conjunctival Adenosquamous Carcinoma A carcinoma that arises from the conjunctiva. C174403 Neoplastic Process Conjunctival Carcinoma CL1411943 Malignant Conjunctival Carcinoma Conjunctival Carcinoma A rare sebaceous carcinoma that arises from the conjunctiva. C174404 Neoplastic Process Conjunctival Sebaceous Carcinoma CL1411940 Malignant Conjunctival Sebaceous Carcinoma Conjunctival Sebaceous Carcinoma A junctional nevus that arises from the conjunctiva. It occurs almost exclusively in the juxtalimbal bulbar conjunctiva. It is characterized by an intraepithelial proliferation of type A nevus cells and/ or type B nevus cells. C174416 Neoplastic Process Conjunctival Junctional Nevus CL1411937 Benign Conjunctival Junctional Nevus Conjunctival Junctional Nevus A compound nevus that arises from the conjunctiva. It usually occurs in the bulbar conjunctiva, caruncle, and plica semilunaris. It is characterized by the presence of nevus cells within the epithelium and in the substantia propria. Type A nevus cells are present in the junctional nests and superficial substantia propria, and type B nevus cells are present in the deeper layers of the subepithelial compartment. C174418 Neoplastic Process Conjunctival Compound Nevus CL1411980 Benign Conjunctival Compound Nevus Conjunctival Compound Nevus A conjunctival nevus characterized by an intrastromal proliferation of predominantly type B nevus cells. C174426 Neoplastic Process Conjunctival Subepithelial (Stromal) Nevus CL1411972 Benign Conjunctival Stromal Nevus Conjunctival Subepithelial (Stromal) Nevus Conjunctival Subepithelial Nevus Conjunctival Subepithelial (Stromal) Nevus Adrenal cortical carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C174443 Neoplastic Process Locally Advanced Adrenal Cortex Carcinoma Locally Advanced Adrenal Cortical Carcinoma CL1411964 CTRP Malignant Locally Advanced Adrenal Cortex Carcinoma Locally Advanced Adrenal Cortical Carcinoma Locally Advanced Adrenal Cortical Carcinoma A compound nevus that arises from the conjunctiva in children and adolescents. It is characterized by the presence of chronic inflammatory features. C174448 Neoplastic Process Inflamed Juvenile Conjunctival Nevus CL1411967 Benign IJCN Inflamed Juvenile Conjunctival Nevus Inflamed Juvenile Conjunctival Nevus A benign melanocytic neoplasm that arises from the conjunctiva. It is characterized by the presence of dendritic and spindle-shaped melanocytes in the subepithelial connective tissue. It presents as a dark brown or black, slightly elevated conjunctival lesion. C174452 Neoplastic Process Conjunctival Blue Nevus CL1412009 Benign Conjunctival Blue Nevus Conjunctival Blue Nevus Ewing sarcoma characterized by the presence of large malignant cells with prominent nucleoli and irregular contours. C174456 Neoplastic Process Atypical Ewing Sarcoma C3698122 PCDC Malignant Atypical Ewing Sarcoma Large Cell Ewing Sarcoma Large Cell Ewing Tumor Atypical Ewing Sarcoma Acute myeloid leukemia not otherwise specified that does not respond to treatment. C174486 Neoplastic Process Refractory Acute Myeloid Leukemia Not Otherwise Specified CL1412036 Malignant Refractory Acute Myeloid Leukemia Not Otherwise Specified Refractory Acute Myeloid Leukemia Not Otherwise Specified A rare nevus that arises from the conjunctiva. It is characterized by the presence of large spindle-shaped or epithelioid melanocytes. C174493 Neoplastic Process Conjunctival Spitz Nevus CL1412038 Benign Conjunctival Spitz Nevus Conjunctival Spitz Nevus A malignant neoplasm that has spread to the conjunctiva from another anatomic site. C174496 Neoplastic Process Metastatic Malignant Neoplasm in the Conjunctiva C0686457 Malignant Metastatic Malignant Neoplasm in the Conjunctiva Metastatic Malignant Neoplasm in the Conjunctiva An iris melanoma characterized by the presence of malignant large epithelioid melanocytes. C174498 Neoplastic Process Iris Epithelioid Cell Melanoma CL1412029 Malignant Iris Epithelioid Cell Melanoma Iris Epithelioid Cell Melanoma A benign nevus that arises from the ciliary body. Only a small percentage of cases progress to ciliary body melanoma. C174500 Neoplastic Process Ciliary Body Nevus CL1412033 Benign Ciliary Body Nevus Ciliary Body Nevus A benign nevus that arises from the choroid. Only a small percentage of cases progress to choroid melanoma. C174501 Neoplastic Process Choroid Nevus C0346392 Benign Choroid Nevus Choroid Nevus A benign nevus derived from melanocytes of the uveal tract. Only a small percentage of cases progress to uveal melanoma. C174502 Neoplastic Process Uveal Nevus CL1412031 Benign Uveal Nevus Uveal Nevus A subtype of ciliary body, iris, and choroidal nevi. It is intensely pigmented and composed of large, plump, polyhedral cells. C174503 Neoplastic Process Uveal Melanocytoma CL1412022 Benign Magnocellular Nevus of the Uvea Uveal Melanocytoma Uveal Melanocytoma Cervical squamous cell carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C174505 Neoplastic Process Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified Locally Advanced Cervical Squamous Cell Carcinoma CL1412020 CTRP Malignant Locally Advanced Cervical Squamous Cell Carcinoma Locally Advanced Cervical Squamous Cell Carcinoma A melanoma arising from the iris. It is characterized by the presence of a mixture of spindle A melanoma cells, spindle B melanoma cells, and epithelioid melanoma cells. C174506 Neoplastic Process Iris Mixed Epithelioid and Spindle Cell Melanoma CL1412021 Malignant Iris Mixed Cell Melanoma Iris Mixed Epithelioid and Spindle Cell Melanoma Iris Mixed Epithelioid and Spindle Cell Melanoma A malignant neoplasm that has spread to the uvea from another anatomic site. C174507 Neoplastic Process Metastatic Malignant Neoplasm in the Uvea CL1412026 Malignant Metastatic Malignant Neoplasm in the Uvea Metastatic Malignant Neoplasm in the Uvea Vulvar carcinoma that does not respond to treatment. C174508 Neoplastic Process Refractory Vulvar Carcinoma Refractory Vulvar Carcinoma CL1412027 CTRP Malignant Refractory Vulvar Carcinoma Refractory Vulvar Carcinoma Vaginal carcinoma that does not respond to treatment. C174509 Neoplastic Process Refractory Vaginal Carcinoma Refractory Vaginal Carcinoma CL1412024 CTRP Malignant Refractory Vaginal Carcinoma Refractory Vaginal Carcinoma Lung adenocarcinoma that is not amenable to surgical resection. C174510 Neoplastic Process Unresectable Lung Adenocarcinoma Unresectable Lung Adenocarcinoma CL1412025 CTRP Malignant Unresectable Lung Adenocarcinoma Unresectable Lung Adenocarcinoma Acute monoblastic and monocytic leukemia that does not respond to treatment. C174511 Neoplastic Process Refractory Acute Monoblastic and Monocytic Leukemia Refractory Acute Monoblastic and Monocytic Leukemia CL1412014 CTRP Malignant Refractory Acute Monoblastic and Monocytic Leukemia Refractory Acute Monoblastic and Monocytic Leukemia Acute myelomonocytic leukemia that does not respond to treatment. C174512 Neoplastic Process Refractory Acute Myelomonocytic Leukemia Refractory Acute Myelomonocytic Leukemia CL1412015 CTRP Malignant Refractory Acute Myelomonocytic Leukemia Refractory Acute Myelomonocytic Leukemia An astrocytoma that arises from the retina. It is often found in association with the tuberous sclerosis complex. C174539 Neoplastic Process Retinal Astrocytoma C0339554 Undetermined Acquired Retinal Astrocytoma Intraocular Astrocytoma Intraocular Glioma Retinal Astrocytic Hamartoma Retinal Astrocytoma Retinal Astrocytoma A benign neoplasm that arises from the retinal pigment epithelium. It consists of cords and tubules of variably pigmented proliferating retinal pigment epithelium cells, separated by fibrous stroma. Malignant transformation is rare. (WHO 2018) C174550 Neoplastic Process Adenoma of the Retinal Pigment Epithelium CL1411816 Benign Adenoma of the Retinal Pigment Epithelium Adenoma of the Retinal Pigment Epithelium An adenocarcinoma that arises from the retinal pigment epithelium. The prognosis is good if the tumor has not extended extraocularly. C174551 Neoplastic Process Retinal Pigment Epithelium Adenocarcinoma CL1411867 Malignant Adenocarcinoma of the Retinal Pigment Epithelium Retinal Pigment Epithelium Adenocarcinoma Retinal Pigment Epithelium Adenocarcinoma A benign neoplasm of the pigmented ciliary epithelium (pigmented epithelial adenoma) and/ or the non-pigmented ciliary epithelium (non-pigmented epithelial adenoma). (WHO 2018) C174560 Neoplastic Process Ciliary Body Adenoma CL1411860 Benign Ciliary Body Adenoma Ciliary Body Adenoma An adenocarcinoma arising from the pigmented or non-pigmented ciliary epithelium. C174561 Neoplastic Process Ciliary Body Adenocarcinoma CL1411857 Malignant Ciliary Body Adenocarcinoma Ciliary Body Adenocarcinoma A kidney carcinoma that is not amenable to surgical resection. C174565 Neoplastic Process Unresectable Kidney Carcinoma CL1411861 Malignant Unresectable Kidney Carcinoma Unresectable Kidney Carcinoma Pancreatic adenosquamous carcinoma that is amenable to surgical resection. C174566 Neoplastic Process Resectable Pancreatic Adenosquamous Carcinoma Resectable Pancreatic Adenosquamous Carcinoma CL1411862 CTRP Malignant Resectable Pancreatic Adenosquamous Carcinoma Resectable Pancreatic Adenosquamous Carcinoma A kidney medullary carcinoma that is not amenable to surgical resection. C174567 Neoplastic Process Unresectable Kidney Medullary Carcinoma Unresectable Kidney Medullary Carcinoma CL1411851 CTRP Malignant Unresectable Kidney Medullary Carcinoma Unresectable Kidney Medullary Carcinoma Poorly differentiated thyroid gland carcinoma that is not amenable to surgical resection. C174569 Neoplastic Process Unresectable Poorly Differentiated Thyroid Gland Carcinoma Unresectable Poorly Differentiated Thyroid Gland Carcinoma CL1411849 CTRP Malignant Unresectable Poorly Differentiated Thyroid Gland Carcinoma Unresectable Poorly Differentiated Thyroid Gland Carcinoma Thyroid gland papillary carcinoma that is not amenable to surgical resection. C174570 Neoplastic Process Unresectable Thyroid Gland Papillary Carcinoma Unresectable Thyroid Gland Papillary Carcinoma CL1411850 CTRP Malignant Unresectable Thyroid Gland Papillary Carcinoma Unresectable Thyroid Gland Papillary Carcinoma Thyroid gland follicular carcinoma that is not amenable to surgical resection. C174571 Neoplastic Process Unresectable Thyroid Gland Follicular Carcinoma Unresectable Thyroid Gland Follicular Carcinoma CL1411855 CTRP Malignant Unresectable Thyroid Gland Follicular Carcinoma Unresectable Thyroid Gland Follicular Carcinoma Thyroid gland oncocytic carcinoma that is not amenable to surgical resection. C174572 Neoplastic Process Unresectable Thyroid Gland Hurthle Cell Carcinoma Unresectable Thyroid Gland Oncocytic Carcinoma CL1411856 CTRP Malignant Unresectable Thyroid Gland Hurthle Cell Carcinoma Unresectable Thyroid Gland Oncocytic (Hurthle Cell) Carcinoma Unresectable Thyroid Gland Oncocytic Carcinoma Unresectable Thyroid Gland Oncocytic Carcinoma The reemergence of thyroid gland oncocytic carcinoma after a period of remission. C174573 Neoplastic Process Recurrent Thyroid Gland Hurthle Cell Carcinoma Recurrent Thyroid Gland Oncocytic Carcinoma CL1411853 CTRP Malignant Recurrent Thyroid Gland Hurthle Cell Carcinoma Recurrent Thyroid Gland Oncocytic (Hurthle Cell) Carcinoma Recurrent Thyroid Gland Oncocytic Carcinoma Recurrent Thyroid Gland Oncocytic Carcinoma Thyroid gland oncocytic carcinoma that has spread from its original site of growth to another anatomic site. C174574 Neoplastic Process Metastatic Thyroid Gland Hurthle Cell Carcinoma Metastatic Thyroid Gland Oncocytic Carcinoma CL1411854 CTRP Malignant Metastatic Thyroid Gland Hurthle Cell Carcinoma Metastatic Thyroid Gland Oncocytic (Hurthle Cell) Carcinoma Metastatic Thyroid Gland Oncocytic Carcinoma Metastatic Thyroid Gland Oncocytic Carcinoma Stereotactic body radiation therapy (SBRT) that utilizes a proton beam. C175032 Therapeutic or Preventive Procedure Proton Stereotactic Body Radiation Therapy CL1412521 PCDC Proton SBRT Proton Stereotactic Body Radiation Therapy Proton Stereotactic Body Radiation Therapy Stereotactic body radiation therapy (SBRT) that utilizes a photon beam. C175033 Therapeutic or Preventive Procedure Photon Stereotactic Body Radiation Therapy CL1412321 PCDC Photon SBRT Photon Stereotactic Body Radiation Therapy Photon Stereotactic Body Radiation Therapy Gallbladder carcinoma that is discovered incidental to gallbladder surgery for another indication. C175214 Neoplastic Process Incidental Gallbladder Carcinoma CL1412587 Malignant IGBC Incidental Gallbladder Cancer Incidental Gallbladder Carcinoma Occult Gallbladder Cancer Occult Gallbladder Carcinoma Incidental Gallbladder Carcinoma The reemergence of diffuse large B-cell lymphoma that resulted from the transformation of marginal zone lymphoma, after a period of remission. C175216 Neoplastic Process Recurrent Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma Recurrent Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma CL1412592 CTRP Malignant Recurrent Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma Recurrent Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma Diffuse large B-cell lymphoma that resulted from the transformation of marginal zone lymphoma and is resistant to treatment. C175217 Neoplastic Process Refractory Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma Refractory Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma CL1412590 CTRP Malignant Refractory Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma Refractory Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma Lung adenosquamous carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C175218 Neoplastic Process Locally Advanced Lung Adenosquamous Carcinoma Locally Advanced Lung Adenosquamous Carcinoma CL1412591 CTRP Malignant Locally Advanced Lung Adenosquamous Carcinoma Locally Advanced Lung Adenosquamous Carcinoma Lung adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C175219 Neoplastic Process Locally Advanced Lung Adenocarcinoma Locally Advanced Lung Adenocarcinoma CL1412580 CTRP Malignant Locally Advanced Lung Adenocarcinoma Locally Advanced Lung Adenocarcinoma A malignant neoplasm that has spread to the visual pathway from another anatomic site. C175220 Neoplastic Process Metastatic Malignant Neoplasm in the Visual Pathway CL1412581 Malignant Metastatic Malignant Neoplasm in the Visual Pathway Metastatic Malignant Neoplasm in the Visual Pathway A primary or metastatic malignant neoplasm that affects the visual pathway. C175221 Neoplastic Process Malignant Visual Pathway Neoplasm CL1412578 Malignant Malignant Visual Pathway Neoplasm Malignant Visual Pathway Neoplasm The spread of a malignant neoplasm from its original site of growth to nearby lymph nodes. C175222 Neoplastic Process Metastatic Malignant Neoplasm in the Regional Lymph Nodes CL1412579 CPTAC Malignant Cancer_with_Regional_Lymph_Node_Involvement Metastatic Malignant Neoplasm in the Regional Lymph Nodes Regional lymph node (metastasis) Metastatic Malignant Neoplasm in the Regional Lymph Nodes A benign neoplastic melanocytic proliferation affecting the optic disk and optic nerve or the uvea. C175223 Neoplastic Process Eye Melanocytoma CL1412584 Benign Eye Melanocytoma Eye Melanocytoma A benign neoplastic melanocytic proliferation affecting the optic disk and optic nerve. C175224 Neoplastic Process Visual Pathway Melanocytoma CL1412585 Benign Visual Pathway Melanocytoma Visual Pathway Melanocytoma A very rare, benign or malignant embryonal neoplasm affecting the visual pathway during childhood. It arises from primitive medullary epithelium. C175225 Neoplastic Process Visual Pathway Medulloepithelioma CL1412582 Undetermined Visual Pathway Medulloepithelioma Visual Pathway Medulloepithelioma Triple-negative breast carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C175236 Neoplastic Process Advanced Triple-Negative Breast Carcinoma Advanced Triple-Negative Breast Carcinoma CL1412765 CTRP Malignant Advanced Triple-Negative Breast Carcinoma Advanced Triple-Negative Breast Carcinoma Triple-negative breast carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C175237 Neoplastic Process Locally Advanced Triple-Negative Breast Carcinoma Locally Advanced Triple-Negative Breast Carcinoma CL1412761 CTRP Malignant Locally Advanced Triple-Negative Breast Carcinoma Locally Advanced Triple-Negative Breast Carcinoma A benign or malignant neoplasm that affects the lacrimal duct. C175259 Neoplastic Process Nasolacrimal Duct Neoplasm C0349749 Undetermined Lacrimal Duct Neoplasm Nasolacrimal Duct Neoplasm Nasolacrimal Duct Neoplasm A benign epithelial neoplasm that arises from the lacrimal gland. It is characterized by the presence of oncocytic cells with abundant eosinophilic and granular cytoplasm. C175264 Neoplastic Process Lacrimal Gland Oncocytoma CL1412741 Benign Lacrimal Gland Oncocytoma Lacrimal Gland Oncocytoma An adenocarcinoma that arises from the lacrimal gland. It is characterized by the presence of large malignant epithelial cells with abundant granular eosinophilic cytoplasm. C175267 Neoplastic Process Lacrimal Gland Oncocytic Adenocarcinoma CL1412795 Malignant Lacrimal Gland Oncocytic Adenocarcinoma Lacrimal Gland Oncocytic Adenocarcinoma A benign neoplasm with myoepithelial differentiation arising from the lacrimal gland. It lacks an infiltrative growth pattern and does not metastasize. C175272 Neoplastic Process Lacrimal Gland Myoepithelioma CL1412794 Benign Lacrimal Gland Myoepithelioma Lacrimal Gland Myoepithelioma A carcinoma that arises from the lacrimal gland. It is characterized by the presence of a malignant cellular infiltrate exhibiting myoepithelial differentiation. C175274 Neoplastic Process Lacrimal Gland Myoepithelial Carcinoma CL1412788 Malignant Lacrimal Gland Myoepithelial Carcinoma Lacrimal Gland Myoepithelial Carcinoma An aggressive, high grade malignant neoplasm that arises from the lacrimal gland. It is characterized by the presence of a malignant epithelial and a sarcomatous component. C175279 Neoplastic Process Lacrimal Gland Carcinosarcoma CL1412783 Malignant Lacrimal Gland Carcinosarcoma Lacrimal Gland Carcinosarcoma A rare, slow-growing carcinoma that arises from the lacrimal gland. It is characterized by the presence of duct-like structures lined by two layers of cells, an inner layer composed of epithelial-type cells and an outer layer composed of clear, myoepithelial-type cells. C175288 Neoplastic Process Lacrimal Gland Epithelial-Myoepithelial Carcinoma CL1412778 Malignant Lacrimal Gland Epithelial-Myoepithelial Carcinoma Lacrimal Gland Epithelial-Myoepithelial Carcinoma An extremely rare, low-grade, salivary gland-type carcinoma that arises from the lacrimal gland. It exhibits acinar differentiation. C175290 Neoplastic Process Lacrimal Gland Acinic Cell Carcinoma CL1412772 Malignant Lacrimal Gland Acinic Cell Carcinoma Lacrimal Gland Acinic Cell Carcinoma A rare benign tumor that arises from the lacrimal gland. It is characterized by an oncocytic epithelial component and dense lymphoid stroma. C175291 Neoplastic Process Lacrimal Gland Warthin Tumor CL1412771 Benign Lacrimal Gland Warthin Tumor Lacrimal Gland Warthin Tumor A malignant gastric neoplasm that is not amenable to surgical resection. C175304 Neoplastic Process Unresectable Malignant Gastric Neoplasm Unresectable Malignant Gastric Neoplasm CL1412649 CTRP Malignant Unresectable Malignant Gastric Neoplasm Unresectable Malignant Gastric Neoplasm A neoplasm that arises from the lacrimal gland or lacrimal drainage system and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C175307 Neoplastic Process Benign Lacrimal System Neoplasm CL1412642 Benign Benign Lacrimal Apparatus Neoplasm Benign Lacrimal System Neoplasm Benign Lacrimal System Neoplasm A primary or metastatic malignant neoplasm affecting the lacrimal gland or the lacrimal drainage system. C175308 Neoplastic Process Malignant Lacrimal System Neoplasm CL1412645 mCode Malignant Malignant Lacrimal Apparatus Neoplasm Malignant Lacrimal System Neoplasm Malignant neoplasm of unspecified lacrimal gland and duct Malignant Lacrimal System Neoplasm A benign or malignant neoplasm that affects the lacrimal drainage system. C175316 Neoplastic Process Lacrimal Drainage System Neoplasm C1644176 Undetermined Lacrimal Drainage System Neoplasm Lacrimal Drainage System Neoplasm A neoplasm that arises from the lacrimal drainage system and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C175318 Neoplastic Process Benign Lacrimal Drainage System Neoplasm CL1412633 Benign Benign Lacrimal Drainage System Neoplasm Benign Lacrimal Drainage System Neoplasm A primary or metastatic malignant neoplasm that affects the lacrimal drainage system. C175319 Neoplastic Process Malignant Lacrimal Drainage System Neoplasm Malignant Lacrimal Drainage System Neoplasm CL1412632 CTRP Malignant Malignant Lacrimal Drainage System Neoplasm Malignant Lacrimal Drainage System Neoplasm A malignant neoplasm that has spread from its original site of growth to the lacrimal gland or lacrimal drainage system. C175327 Neoplastic Process Metastatic Malignant Neoplasm in the Lacrimal System CL1412625 Malignant Metastatic Malignant Neoplasm in the Lacrimal Apparatus Metastatic Malignant Neoplasm in the Lacrimal System Metastatic Malignant Neoplasm in the Lacrimal System A malignant neoplasm that has spread from its original site of growth to the lacrimal gland. C175329 Neoplastic Process Metastatic Malignant Neoplasm in the Lacrimal Gland C0686483 Malignant Metastatic Malignant Neoplasm in the Lacrimal Gland Metastatic Malignant Neoplasm in the Lacrimal Gland A malignant neoplasm that has spread from its original site of growth to the lacrimal drainage system. C175330 Neoplastic Process Metastatic Malignant Neoplasm in the Lacrimal Drainage System CL1412683 Malignant Metastatic Malignant Neoplasm in the Lacrimal Drainage System Metastatic Malignant Neoplasm in the Lacrimal Drainage System A benign exophytic papillary neoplasm that arises from the lacrimal drainage system. It consists of fibrovascular cores lined by epithelial cells. C175332 Neoplastic Process Lacrimal Drainage System Exophytic Papilloma CL1412685 Benign Exophytic Papilloma of the Lacrimal Drainage System Lacrimal Drainage System Exophytic Papilloma Lacrimal Drainage System Exophytic Papilloma A benign neoplasm of the lacrimal drainage system characterized by an inverted/endophytic or mixed growth pattern. It is the most common epithelial neoplasm of the lacrimal drainage system. (WHO 2018) C175334 Neoplastic Process Lacrimal Drainage System Inverted Papilloma CL1412679 Benign Inverted Papilloma of the Lacrimal Drainage System Lacrimal Drainage System Inverted Papilloma Lacrimal Drainage System Inverted Papilloma A squamous cell carcinoma of the lacrimal drainage system characterized by a plexiform or ribbon-like growth pattern, cytological atypia, and lack of histological evidence of keratinization. C175335 Neoplastic Process Lacrimal Drainage System Non-Keratinizing Squamous Cell Carcinoma CL1412678 Malignant Lacrimal Drainage System Non-Keratinizing Squamous Cell Carcinoma Lacrimal Drainage System Nonkeratinizing Squamous Cell Carcinoma Non-Keratinizing Squamous Cell Carcinoma of the Lacrimal Drainage System Lacrimal Drainage System Non-Keratinizing Squamous Cell Carcinoma An adenocarcinoma that arises from the lacrimal sac or nasolacrimal duct. C175336 Neoplastic Process Lacrimal Drainage System Adenocarcinoma CL1412681 Malignant Adenocarcinoma of the Lacrimal Drainage System Lacrimal Drainage System Adenocarcinoma Lacrimal Drainage System Adenocarcinoma A carcinoma that arises from the lacrimal sac, canaliculi, or nasolacrimal duct. C175337 Neoplastic Process Lacrimal Drainage System Carcinoma CL1412680 Malignant Carcinoma of the Lacrimal Drainage System Lacrimal Drainage System Carcinoma Lacrimal Drainage System Carcinoma A carcinoma that arises from the lacrimal sac. It is characterized by the presence of squamous cells, mucus producing cells, and cells of intermediate type. C175339 Neoplastic Process Lacrimal Drainage System Mucoepidermoid Carcinoma CL1412674 Malignant Lacrimal Drainage System Mucoepidermoid Carcinoma Mucoepidermoid Carcinoma of the Lacrimal Drainage System Lacrimal Drainage System Mucoepidermoid Carcinoma A carcinoma that arises from the lacrimal sac. It is characterized by the presence of malignant epithelial cells that form cribriform, tubular, and solid patterns. C175340 Neoplastic Process Lacrimal Drainage System Adenoid Cystic Carcinoma CL1412677 Malignant Adenoid Cystic Carcinoma of the Lacrimal Drainage System Lacrimal Drainage System Adenoid Cystic Carcinoma Lacrimal Drainage System Adenoid Cystic Carcinoma A rare nonkeratinizing squamous cell carcinoma that arises from the lacrimal sac or nasolacrimal duct. It is characterized by the presence of large cells with vesicular nuclei and prominent nucleoli, a syncytial growth pattern, and a lymphoplasmacytic infiltrate. C175344 Neoplastic Process Lacrimal Drainage System Lymphoepithelial Carcinoma CL1412673 Malignant Lacrimal Drainage System Lymphoepithelial Carcinoma Lacrimal Drainage System Lymphoepithelioma-Like Carcinoma Lymphoepithelial Carcinoma of the Lacrimal Drainage System Lymphoepithelioma-Like Carcinoma of the Lacrimal Drainage System Non-Keratinizing Undifferentiated Nasopharyngeal-Type Carcinoma of the Lacrimal Drainage System Nonkeratinizing Undifferentiated Nasopharyngeal-Type Carcinoma of the Lacrimal Drainage System Lacrimal Drainage System Lymphoepithelial Carcinoma An extremely rare melanoma that arises from the lacrimal drainage system. C175345 Neoplastic Process Lacrimal Drainage System Melanoma CL1412672 Malignant Lacrimal Drainage System Melanoma Melanoma of the Lacrimal Drainage System Lacrimal Drainage System Melanoma A carcinoma that arises from the lacrimal gland or the lacrimal drainage system. C175348 Neoplastic Process Lacrimal System Carcinoma CL1412669 Malignant Lacrimal Apparatus Carcinoma Lacrimal System Carcinoma Lacrimal System Carcinoma The reemergence of anal canal squamous cell carcinoma after a period of remission. C175360 Neoplastic Process Recurrent Anal Canal Squamous Cell Carcinoma Recurrent Anal Canal Squamous Cell Carcinoma CL1412657 CTRP Malignant Recurrent Anal Canal Squamous Cell Carcinoma Recurrent Anal Canal Squamous Cell Carcinoma Rectal adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C175363 Neoplastic Process Advanced Rectal Adenocarcinoma Advanced Rectal Adenocarcinoma CL1412706 CTRP Malignant Advanced Rectal Adenocarcinoma Advanced Rectal Adenocarcinoma The reemergence of anal canal squamous cell carcinoma after a period of remission, at or adjacent to the site of the original tumor. C175364 Neoplastic Process Locally Recurrent Anal Canal Squamous Cell Carcinoma Locally Recurrent Anal Canal Squamous Cell Carcinoma CL1412709 CTRP Malignant Locally Recurrent Anal Canal Squamous Cell Carcinoma Locally Recurrent Anal Canal Squamous Cell Carcinoma Anal canal squamous cell carcinoma that has spread from its original site of growth to another anatomic site. C175383 Neoplastic Process Metastatic Anal Canal Squamous Cell Carcinoma Metastatic Anal Canal Squamous Cell Carcinoma CL1412693 CTRP Malignant Metastatic Anal Canal Squamous Cell Carcinoma Metastatic Anal Canal Squamous Cell Carcinoma Anal canal squamous cell carcinoma that is not amenable to surgery. C175384 Neoplastic Process Unresectable Anal Canal Squamous Cell Carcinoma Unresectable Anal Canal Squamous Cell Carcinoma CL1412695 CTRP Malignant Unresectable Anal Canal Squamous Cell Carcinoma Unresectable Anal Canal Squamous Cell Carcinoma A follicular lymphoma that arises from the conjunctiva. C175430 Neoplastic Process Conjunctival Follicular Lymphoma CL1412824 Malignant Conjunctival Follicular Lymphoma Primary Conjunctival Follicular Lymphoma Conjunctival Follicular Lymphoma A mucosa-associated lymphoid tissue lymphoma affecting the conjunctiva. C175431 Neoplastic Process Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma CL1412823 CTRP Malignant Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma A non-Hodgkin lymphoma that arises from the conjunctiva. C175432 Neoplastic Process Conjunctival Non-Hodgkin Lymphoma CL1412826 Malignant Conjunctival Non-Hodgkin Lymphoma Primary Conjunctival Non-Hodgkin Lymphoma Conjunctival Non-Hodgkin Lymphoma A diffuse large B-cell lymphoma that arises from the conjunctiva. C175433 Neoplastic Process Conjunctival Diffuse Large B-Cell Lymphoma Conjunctival Diffuse Large B-Cell Lymphoma CL1412825 CTRP Malignant Conjunctival Diffuse Large B-Cell Lymphoma Primary Conjunctival Diffuse Large B-Cell Lymphoma Conjunctival Diffuse Large B-Cell Lymphoma Vaginal carcinoma that is not amenable to surgical resection. C175434 Neoplastic Process Unresectable Vaginal Carcinoma Unresectable Vaginal Carcinoma CL1412820 CTRP Malignant Unresectable Vaginal Carcinoma Unresectable Vaginal Carcinoma The reemergence of acral lentiginous melanoma after a period of remission. C175435 Neoplastic Process Recurrent Acral Lentiginous Melanoma Recurrent Acral Lentiginous Melanoma CL1412819 CTRP Malignant Recurrent Acral Lentiginous Melanoma Recurrent Acral Lentiginous Melanoma Ampulla of Vater carcinoma that is resistant to treatment. C175436 Neoplastic Process Refractory Ampulla of Vater Carcinoma Refractory Ampulla of Vater Carcinoma CL1412822 CTRP Malignant Refractory Ampulla of Vater Carcinoma Refractory Ampulla of Vater Carcinoma Extrahepatic bile duct carcinoma that is resistant to treatment. C175437 Neoplastic Process Refractory Extrahepatic Bile Duct Carcinoma Refractory Extrahepatic Bile Duct Carcinoma CL1412821 CTRP Malignant Refractory Extrahepatic Bile Duct Carcinoma Refractory Extrahepatic Bile Duct Carcinoma Distal bile duct adenocarcinoma that is resistant to treatment. C175438 Neoplastic Process Refractory Distal Bile Duct Adenocarcinoma Refractory Distal Bile Duct Adenocarcinoma CL1412816 CTRP Malignant Refractory Distal Bile Duct Adenocarcinoma Refractory Extrahepatic Cholangiocarcinoma Refractory Distal Bile Duct Adenocarcinoma An indolent, low-grade B-cell non-Hodgkin lymphoma that arises from the choroid, iris, or ciliary body. It is characterized by the presence of a diffuse infiltrate of small, round lymphocytes. Lymphoid follicles with germinal centers may be present. In the past these tumors were termed 'reactive lymphoid hyperplasia'. Now they are considered low-grade B-cell lymphomas, most commonly extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue. C175451 Neoplastic Process Primary Uveal Non-Hodgkin Lymphoma CL1412803 Malignant Primary Uveal Lymphoma Primary Uveal Non-Hodgkin Lymphoma Uveal Reactive Lymphoid Hyperplasia Primary Uveal Non-Hodgkin Lymphoma An indolent, low-grade B-cell non-Hodgkin lymphoma that arises from the choroid. It is characterized by the presence of a diffuse infiltrate of small, round lymphocytes. Lymphoid follicles with germinal centers may be present. In the past these tumors were termed 'reactive lymphoid hyperplasia'. Now they are considered low-grade B-cell lymphomas, most commonly extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue. C175464 Neoplastic Process Primary Choroidal Non-Hodgkin Lymphoma CL978760 Malignant Choroidal Reactive Lymphoid Hyperplasia Primary Choroidal Lymphoma Primary Choroidal Non-Hodgkin Lymphoma Primary Choroidal Non-Hodgkin Lymphoma An extremely rare low-grade B-cell non-Hodgkin lymphoma that arises from the ciliary body. It is characterized by the presence of a diffuse infiltrate of small, round lymphocytes. Most cases represent extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue. C175466 Neoplastic Process Primary Ciliary Body Non-Hodgkin Lymphoma CL1412851 Malignant Primary Ciliary Body Lymphoma Primary Ciliary Body Non-Hodgkin Lymphoma Primary Ciliary Body Non-Hodgkin Lymphoma An extremely rare low-grade B-cell non-Hodgkin lymphoma that arises from the iris. It is characterized by the presence of a diffuse infiltrate of small, round lymphocytes. Most cases represent extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue. C175467 Neoplastic Process Primary Iris Non-Hodgkin Lymphoma CL1412850 Malignant Primary Iris Lymphoma Primary Iris Non-Hodgkin Lymphoma Primary Iris Non-Hodgkin Lymphoma A non-Hodgkin lymphoma that has spread to the choroid following the initial presentation in another nodal or extranodal site. C175470 Neoplastic Process Secondary Choroidal Non-Hodgkin Lymphoma CL1412847 Malignant Secondary Choroidal Lymphoma Secondary Choroidal Non-Hodgkin Lymphoma Secondary Choroidal Non-Hodgkin Lymphoma A non-Hodgkin lymphoma that arises from the lacrimal gland or the lacrimal drainage system. The majority of cases are of B-cell type. The most common subtypes are mucosa-associated lymphoid tissue lymphoma, follicular lymphoma, and diffuse large B-cell lymphoma. C175479 Neoplastic Process Lacrimal System Non-Hodgkin Lymphoma CL1412839 Malignant Lacrimal System Lymphoma Lacrimal System Non-Hodgkin Lymphoma Primary Lacrimal System Lymphoma Primary Lacrimal System Non-Hodgkin Lymphoma Lacrimal System Non-Hodgkin Lymphoma A non-Hodgkin lymphoma that arises from the lacrimal gland. The majority of cases are of B-cell type. The most common subtypes are mucosa-associated lymphoid tissue lymphoma, follicular lymphoma, and diffuse large B-cell lymphoma. C175480 Neoplastic Process Lacrimal Gland Non-Hodgkin Lymphoma CL1412838 Malignant Lacrimal Gland Lymphoma Lacrimal Gland Non-Hodgkin Lymphoma Primary Lacrimal Gland Lymphoma Primary Lacrimal Gland Non-Hodgkin Lymphoma Lacrimal Gland Non-Hodgkin Lymphoma A non-Hodgkin lymphoma that arises from the lacrimal sac. The majority of cases are of B-cell type. The most common subtypes are mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma. C175481 Neoplastic Process Lacrimal Drainage System Non-Hodgkin Lymphoma CL1412841 Malignant Lacrimal Drainage System Lymphoma Lacrimal Drainage System Non-Hodgkin Lymphoma Lacrimal Sac Lymphoma Lacrimal Sac Non-Hodgkin Lymphoma Primary Lacrimal Drainage System Lymphoma Primary Lacrimal Drainage System Non-Hodgkin Lymphoma Primary Lacrimal Sac Lymphoma Primary Lacrimal Sac Non-Hodgkin Lymphoma Lacrimal Drainage System Non-Hodgkin Lymphoma A mucosa-associated lymphoid tissue lymphoma that arises from the lacrimal gland or the lacrimal drainage system. C175482 Neoplastic Process Lacrimal System Mucosa-Associated Lymphoid Tissue Lymphoma CL1412840 Malignant Lacrimal System Mucosa-Associated Lymphoid Tissue Lymphoma Lacrimal System Mucosa-Associated Lymphoid Tissue Lymphoma A mucosa-associated lymphoid tissue lymphoma that arises from the lacrimal gland. C175483 Neoplastic Process Lacrimal Gland Mucosa-Associated Lymphoid Tissue Lymphoma CL1412835 Malignant Lacrimal Gland Mucosa-Associated Lymphoid Tissue Lymphoma Lacrimal Gland Mucosa-Associated Lymphoid Tissue Lymphoma A mucosa-associated lymphoid tissue lymphoma that arises from the lacrimal sac. C175484 Neoplastic Process Lacrimal Drainage System Mucosa-Associated Lymphoid Tissue Lymphoma CL1412834 Malignant Lacrimal Drainage System Mucosa-Associated Lymphoid Tissue Lymphoma Lacrimal Sac Mucosa-Associated Lymphoid Tissue Lymphoma Lacrimal Drainage System Mucosa-Associated Lymphoid Tissue Lymphoma A diffuse large B-cell lymphoma that arises from the lacrimal gland or the lacrimal drainage system. C175485 Neoplastic Process Lacrimal System Diffuse Large B-Cell Lymphoma CL1412837 Malignant Lacrimal System Diffuse Large B-Cell Lymphoma Primary Lacrimal System Diffuse Large B-Cell Lymphoma Lacrimal System Diffuse Large B-Cell Lymphoma A diffuse large B-cell lymphoma that arises from the lacrimal gland. C175486 Neoplastic Process Lacrimal Gland Diffuse Large B-Cell Lymphoma CL1412836 Malignant Lacrimal Gland Diffuse Large B-Cell Lymphoma Primary Lacrimal Gland Diffuse Large B-Cell Lymphoma Lacrimal Gland Diffuse Large B-Cell Lymphoma A diffuse large B-cell lymphoma that arises from the lacrimal sac. C175487 Neoplastic Process Lacrimal Drainage System Diffuse Large B-Cell Lymphoma CL1412831 Malignant Lacrimal Drainage System Diffuse Large B-Cell Lymphoma Lacrimal Sac Diffuse Large B-Cell Lymphoma Primary Lacrimal Drainage System Diffuse Large B-Cell Lymphoma Primary Lacrimal Sac Diffuse Large B-Cell Lymphoma Lacrimal Drainage System Diffuse Large B-Cell Lymphoma A follicular lymphoma that arises from the lacrimal gland. C175488 Neoplastic Process Lacrimal Gland Follicular Lymphoma CL1412830 Malignant Lacrimal Gland Follicular Lymphoma Lacrimal Gland Follicular Lymphoma Nasopharyngeal carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C175491 Neoplastic Process Advanced Nasopharyngeal Carcinoma Advanced Nasopharyngeal Carcinoma CL1412886 CTRP Malignant Advanced Nasopharyngeal Carcinoma Advanced Nasopharyngeal Carcinoma A rare benign stromal tumor that arises from the bulbar conjunctiva. It is characterized by the presence of myxoid/collagenous stroma, spindle-shaped cells, pseudonuclear inclusions, and multinucleated cells. C175494 Neoplastic Process Conjunctival Stromal Tumor CL1412887 Benign Conjunctival Stromal Tumor Conjunctival Stromal Tumor A rare myxoma arising from the bulbar conjunctiva. C175495 Neoplastic Process Conjunctival Myxoma CL1412883 Benign Conjunctival Myxoma Conjunctival Myxoma A rare solitary fibrous tumor that arises from the optic nerve sheath. C175496 Neoplastic Process Optic Nerve Sheath Solitary Fibrous Tumor CL1412882 Undetermined Optic Nerve Sheath Solitary Fibrous Tumor Solitary Fibrous Tumor of the Optic Nerve Sheath Solitary Fibrous Tumor/Hemangiopericytoma of the Optic Nerve Sheath Optic Nerve Sheath Solitary Fibrous Tumor A hemangioma that arises from the conjunctiva. C175497 Neoplastic Process Conjunctival Hemangioma CL548564 Benign Conjunctival Hemangioma Conjunctival Hemangioma A lymphangioma that arises from the conjunctiva. C175498 Neoplastic Process Conjunctival Lymphangioma CL1412884 Benign Conjunctival Lymphangioma Conjunctival Lymphangioma An angiosarcoma that arises from the conjunctiva. C175499 Neoplastic Process Conjunctival Angiosarcoma CL1412879 Malignant Conjunctival Angiosarcoma Conjunctival Angiosarcoma A leiomyosarcoma that arises from the conjunctiva. C175500 Neoplastic Process Conjunctival Leiomyosarcoma CL1412878 Malignant Conjunctival Leiomyosarcoma Conjunctival Leiomyosarcoma A rhabdomyosarcoma that arises from the conjunctiva. C175501 Neoplastic Process Conjunctival Rhabdomyosarcoma CL1412881 Malignant Conjunctival Rhabdomyosarcoma Conjunctival Rhabdomyosarcoma A sarcoma that arises from the conjunctiva. C175502 Neoplastic Process Conjunctival Sarcoma CL1412880 Malignant Conjunctival Sarcoma Conjunctival Sarcoma A distal bile duct carcinoma that has spread from its original site of growth to other anatomic sites. C175503 Neoplastic Process Metastatic Distal Bile Duct Carcinoma CL1412875 Malignant Metastatic Distal Bile Duct Carcinoma Metastatic Distal Bile Duct Carcinoma Leiomyosarcoma that is amenable to surgical resection. C175505 Neoplastic Process Resectable Leiomyosarcoma Resectable Leiomyosarcoma CL1412877 CTRP Malignant Resectable Leiomyosarcoma Resectable Leiomyosarcoma Distal bile duct carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C175506 Neoplastic Process Locally Advanced Distal Bile Duct Carcinoma Locally Advanced Distal Bile Duct Carcinoma CL1412876 CTRP Malignant Locally Advanced Distal Bile Duct Carcinoma Locally Advanced Distal Bile Duct Carcinoma Thyroid gland oncocytic carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C175507 Neoplastic Process Locally Advanced Thyroid Gland Hurthle Cell Carcinoma Locally Advanced Thyroid Gland Oncocytic Carcinoma CL1412872 CTRP Malignant Locally Advanced Thyroid Gland Hurthle Cell Carcinoma Locally Advanced Thyroid Gland Oncocytic (Hurthle Cell) Carcinoma Locally Advanced Thyroid Gland Oncocytic Carcinoma Locally Advanced Thyroid Gland Oncocytic Carcinoma Small intestinal adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C175515 Neoplastic Process Locally Advanced Small Intestinal Adenocarcinoma Locally Advanced Small Intestinal Adenocarcinoma CL1412865 CTRP Malignant Locally Advanced Small Intestinal Adenocarcinoma Locally Advanced Small Intestinal Adenocarcinoma Small intestinal adenocarcinoma that is not amenable to surgical resection. C175516 Neoplastic Process Unresectable Small Intestinal Adenocarcinoma Unresectable Small Intestinal Adenocarcinoma CL1412864 CTRP Malignant Unresectable Small Intestinal Adenocarcinoma Unresectable Small Intestinal Adenocarcinoma Magnetic resonance imaging using standard protocols for high resolution structural and anatomic characterization, including T1 weighted, T2 weighted, fluid attenuated inversion recovery (FLAIR), and gadolinium-enhanced sequences. C175525 Diagnostic Procedure Conventional Magnetic Resonance Imaging Conventional Magnetic Resonance Imaging CL1412906 CTRP Conventional MRI Conventional Magnetic Resonance Imaging Conventional Magnetic Resonance Imaging A primary or metastatic malignant neoplasm that affects the hypothalamus. C175539 Neoplastic Process Malignant Hypothalamic Neoplasm Malignant Hypothalamic Neoplasm C0751238 CTRP Malignant Malignant Hypothalamic Neoplasm Malignant Hypothalamic Neoplasm A malignant digestive system neoplasm that has spread extensively to other anatomic sites or is no longer responding to treatment. C175547 Neoplastic Process Advanced Malignant Digestive System Neoplasm Advanced Malignant Digestive System Neoplasm CL1412997 CTRP Malignant Advanced Malignant Digestive System Neoplasm Advanced Malignant Digestive System Neoplasm A malignant neoplasm that arises from the brain and has spread extensively to other anatomic sites or is no longer responding to treatment. C175549 Neoplastic Process Advanced Primary Malignant Brain Neoplasm Advanced Primary Malignant Brain Neoplasm CL1413028 CTRP Malignant Advanced Primary Malignant Brain Neoplasm Advanced Primary Malignant Brain Neoplasm A malignant neoplasm that arises from the brain and has spread from its original site of growth to other sites. C175550 Neoplastic Process Metastatic Primary Malignant Brain Neoplasm Metastatic Primary Malignant Brain Neoplasm CL1413025 CTRP Malignant Metastatic Primary Malignant Brain Neoplasm Metastatic Primary Malignant Brain Neoplasm A magnetic resonance imaging (MRI)-based technique in which multiple lines of imaging data are acquired after each radiofrequency excitation. This allows images to be obtained in 20-100 ms rather than over several minutes, resulting in increased temporal resolution compared to other MRI methods. C17558 Diagnostic Procedure Echo-Planar Imaging Echo-Planar Imaging C0162734 CTRP Echo-Planar_Imaging EPI Echo-Planar Imaging Medical Imaging, Planar Echo-Planar Imaging A neuroendocrine carcinoma arising from the breast. It is classified as small cell or large cell neuroendocrine carcinoma. C175581 Neoplastic Process Breast Neuroendocrine Carcinoma CL1412946 Malignant Breast Neuroendocrine Carcinoma Breast Neuroendocrine Carcinoma An invasive breast carcinoma characterized by the presence of focal neuroendocrine differentiation. C175585 Neoplastic Process Breast Carcinoma with Neuroendocrine Differentiation CL1412942 Malignant Breast Adenocarcinoma with Neuroendocrine Differentiation Breast Carcinoma with Neuroendocrine Differentiation Breast Carcinoma with Neuroendocrine Differentiation The reemergence of breast adenocarcinoma after a period of remission. C175588 Neoplastic Process Recurrent Breast Adenocarcinoma Recurrent Breast Adenocarcinoma C0861355 CTRP Malignant Recurrent Breast Adenocarcinoma Recurrent Breast Adenocarcinoma Endometrial clear cell adenocarcinoma that has spread from its original site of growth to another anatomic site. C175596 Neoplastic Process Metastatic Endometrial Clear Cell Adenocarcinoma Metastatic Endometrial Clear Cell Adenocarcinoma CL1412934 CTRP Malignant Metastatic Endometrial Clear Cell Adenocarcinoma Metastatic Endometrial Clear Cell Adenocarcinoma Endometrial adenosquamous carcinoma that has spread from its original site of growth to another anatomic site. C175597 Neoplastic Process Metastatic Endometrial Adenosquamous Carcinoma Metastatic Endometrial Adenosquamous Carcinoma CL1412931 CTRP Malignant Metastatic Endometrial Adenosquamous Carcinoma Metastatic Endometrial Adenosquamous Carcinoma The reemergence of endometrial adenosquamous carcinoma after a period of remission. C175598 Neoplastic Process Recurrent Endometrial Adenosquamous Carcinoma Recurrent Endometrial Adenosquamous Carcinoma CL1412932 CTRP Malignant Recurrent Endometrial Adenosquamous Carcinoma Recurrent Endometrial Adenosquamous Carcinoma Endometrial mixed cell adenocarcinoma that has spread from its original site of growth to another anatomic site. C175599 Neoplastic Process Metastatic Endometrial Mixed Cell Adenocarcinoma Metastatic Endometrial Mixed Cell Adenocarcinoma CL1412929 CTRP Malignant Metastatic Endometrial Mixed Cell Adenocarcinoma Metastatic Endometrial Mixed Cell Adenocarcinoma A rare, low grade malignant epithelial neoplasm arising from the breast. It is characterized by the presence of uniform, small to medium size malignant epithelial cells and an infiltrating pattern. C175604 Neoplastic Process Breast Polymorphous Adenocarcinoma CL1412926 Malignant Breast PmA Breast Polymorphous Adenocarcinoma Breast Polymorphous Adenocarcinoma A rare subtype of invasive breast carcinoma characterized by tall columnar cells with reversed nuclear polarity, arranged in solid and solid papillary patterns, most commonly associated with IDH2 p.Arg172 hotspot mutations. (WHO 2019) C175607 Neoplastic Process Breast Tall Cell Carcinoma with Reversed Polarity CL1412922 Malignant Breast Tall Cell Carcinoma with Reversed Polarity TCCRP Breast Tall Cell Carcinoma with Reversed Polarity A well-differentiated neuroendocrine neoplasm that arises from the breast. It may be classified as G1 (low grade) or G2 (intermediate grade) neuroendocrine tumor. C175610 Neoplastic Process Breast Neuroendocrine Tumor Breast Neuroendocrine Tumor C3544078 CTRP Undetermined Breast Neuroendocrine Tumor Breast Neuroendocrine Tumor A well-differentiated, intermediate grade neuroendocrine neoplasm arising from the breast. C175611 Neoplastic Process Breast Neuroendocrine Tumor G2 CL1412920 Undetermined Breast Neuroendocrine Tumor G2 Breast Neuroendocrine Tumor G2 A malignant glomus tumor that is not amenable to surgical resection. C175661 Neoplastic Process Unresectable Malignant Glomus Tumor Unresectable Malignant Glomus Tumor CL1412969 CTRP Malignant Unresectable Malignant Glomus Tumor Unresectable Malignant Glomus Tumor A malignant glomus tumor that has spread from its original site of growth to another anatomic site. C175662 Neoplastic Process Metastatic Malignant Glomus Tumor Metastatic Malignant Glomus Tumor CL1412966 CTRP Malignant Metastatic Malignant Glomus Tumor Metastatic Malignant Glomus Tumor A malignant glomus tumor that has spread from its original site of growth to nearby tissues or lymph nodes. C175663 Neoplastic Process Locally Advanced Malignant Glomus Tumor Locally Advanced Malignant Glomus Tumor CL1412967 CTRP Malignant Locally Advanced Malignant Glomus Tumor Locally Advanced Malignant Glomus Tumor A malignant glomus tumor that is resistant to treatment. C175664 Neoplastic Process Refractory Malignant Glomus Tumor Refractory Malignant Glomus Tumor CL1412964 CTRP Malignant Refractory Malignant Glomus Tumor Refractory Malignant Glomus Tumor Osteosarcoma that has spread from its original site of growth to nearby tissues or lymph nodes. C175665 Neoplastic Process Locally Advanced Osteosarcoma Locally Advanced Osteosarcoma CL1412965 CTRP Malignant Locally Advanced Osteosarcoma Locally Advanced Osteosarcoma Desmoid-type fibromatosis that has invaded the surrounding tissues. C175667 Neoplastic Process Locally Invasive Desmoid-Type Fibromatosis Locally Invasive Desmoid-Type Fibromatosis CL1412963 CTRP Undetermined Locally Invasive Desmoid-Type Fibromatosis Locally Invasive Desmoid-Type Fibromatosis Desmoid fibromatosis that is resistant to treatment. C175670 Neoplastic Process Refractory Desmoid-Type Fibromatosis Refractory Desmoid Fibromatosis CL1412960 CTRP Undetermined Refractory Desmoid Fibromatosis Refractory Desmoid-Type Fibromatosis Refractory Desmoid Fibromatosis The spread of a malignant neoplasm from its original site of growth to supraclavicular lymph nodes. C175934 Neoplastic Process Metastatic Malignant Neoplasm in the Supraclavicular Lymph Nodes Metastatic Malignant Neoplasm in the Supraclavicular Lymph Nodes C0686637 CTRP Malignant Metastatic Malignant Neoplasm in the Supraclavicular Lymph Nodes Metastatic Malignant Neoplasm in the Supraclavicular Lymph Nodes Pleural malignant mesothelioma that has spread from its original site of growth to nearby tissues or lymph nodes. C175936 Neoplastic Process Locally Advanced Pleural Malignant Mesothelioma Locally Advanced Pleural Malignant Mesothelioma CL1413149 CTRP Malignant Locally Advanced Pleural Malignant Mesothelioma Locally Advanced Pleural Malignant Mesothelioma An abdominal neuroendocrine neoplasm that is not amenable to surgical resection. C175939 Neoplastic Process Unresectable Abdominal Neuroendocrine Neoplasm Unresectable Abdominal Neuroendocrine Neoplasm CL1413148 CTRP Malignant Unresectable Abdominal Neuroendocrine Neoplasm Unresectable Abdominal Neuroendocrine Neoplasm Breast lobular carcinoma in situ characterized by the presence of dyscohesive proliferations of type A and/or type B epithelial cells. Type A cells are small cells with uniform hyperchromatic nuclei, whereas type B cells have slightly larger vesicular nuclei, with mild variability in size and shape and with small nucleoli. The cell populations may be mixed in individual proliferations. (WHO 2019) C175949 Neoplastic Process Breast Classic Lobular Carcinoma In Situ CL1413138 Malignant Breast Classic LCIS Breast Classic Lobular Carcinoma In Situ Breast Classic Lobular Carcinoma In Situ Breast lobular carcinoma in situ characterized by the presence of neoplastic cells with cytological features identical to classic lobular carcinoma in situ, but with marked distention of terminal ductal lobular units or ducts. C175950 Neoplastic Process Breast Florid Lobular Carcinoma In Situ CL1413136 Malignant Breast Florid Lobular Carcinoma In Situ Breast Florid Lobular Carcinoma In Situ An adaptation of diffusion MRI that separates isotropic from anisotropic components in imaging voxels. It enables the measurement of axial and radial diffusivities within the anisotropic components of imaging voxels allowing visualization of inflammatory components within tissues. C175952 Diagnostic Procedure Diffusion Basis Spectrum Imaging Diffusion Basis Spectrum Imaging CL1413134 CTRP DBSI Diffusion Basis Spectrum Imaging Diffusion Basis Spectrum Imaging Breast ductal carcinoma in situ characterized by the presence of sheets of tumor cells with evidence of central necrosis and associated karyorrhectic/nuclear debris. C176005 Neoplastic Process Breast Ductal Carcinoma In Situ, Comedo Type C0334369 GDC Malignant 8501/2 Comedocarcinoma, noninfiltrating DCIS, comedo type Ductal carcinoma in situ, comedo type Breast Ductal Carcinoma In Situ, Comedo Type Breast Intraductal Comedo Adenocarcinoma Comedocarcinoma, noninfiltrating DCIS - Comedo comedo carcinoma Breast Ductal Carcinoma In Situ, Comedo Type Breast carcinoma characterized by the presence of fine fibrovascular stalks covered by neoplastic epithelial cells of low or intermediate nuclear grade, typically present within a cystic space and surrounded by a fibrous capsule. There are usually no myoepithelial cells along the papillae or at the periphery of the lesion. (WHO 2019) C176009 Neoplastic Process Encapsulated Breast Papillary Carcinoma CL1413439 Malignant Breast Intracystic Papillary Carcinoma Encapsulated Breast Papillary Carcinoma Encapsulated Breast Papillary Carcinoma Encapsulated breast papillary carcinoma characterized by the presence of neoplastic elements that permeate beyond the fibrous capsule with an irregular infiltrative appearance. (WHO 2019) C176010 Neoplastic Process Encapsulated Breast Papillary Carcinoma with Invasion CL1413438 Malignant Encapsulated Breast Papillary Carcinoma with Invasion Encapsulated Breast Papillary Carcinoma with Invasion Breast solid papillary carcinoma characterized by the presence of nodules with rounded, well-circumscribed contours and a distribution pattern consistent with an in situ process. (WHO 2019) C176011 Neoplastic Process Breast Solid Papillary Carcinoma In Situ CL517790 Malignant Breast Solid Papillary Carcinoma In Situ Breast Solid Papillary Carcinoma In Situ Breast solid papillary carcinoma associated with areas featuring strands or large clusters of tumor cells. (WHO 2019) C176012 Neoplastic Process Invasive Breast Solid Papillary Carcinoma CL1413436 Malignant Breast Solid Papillary Carcinoma with Invasion Invasive Breast Solid Papillary Carcinoma Invasive Breast Solid Papillary Carcinoma Biliary tract carcinoma that is not amenable to surgical resection. C176042 Neoplastic Process Unresectable Biliary Tract Carcinoma Unresectable Biliary Tract Carcinoma CL1413470 CTRP Malignant Unresectable Biliary Tract Carcinoma Unresectable Biliary Tract Carcinoma An umbrella term that comprises the spectrum of squamous neoplasms of the conjunctiva, ranging from low-grade squamous intraepithelial neoplasia to invasive conjunctival squamous cell carcinoma. C176043 Neoplastic Process Ocular Surface Squamous Neoplasia Ocular Surface Squamous Neoplasia CL936523 CTRP Undetermined Conjunctival Squamous Neoplasia OSSN Ocular Surface Squamous Neoplasia Ocular Surface Squamous Neoplasia A fibroadenoma characterized by the presence of a pericanalicular growth pattern, increased stromal cellularity, and less than 2 mitoses per 10 high-power fields. C176045 Neoplastic Process Breast Cellular Fibroadenoma CL1413469 Benign Breast Cellular Fibroadenoma Breast Cellular Fibroadenoma Any lymph node within the lower gastrointestinal tract. C176234 Anatomical Structure Lower Gastrointestinal Tract Lymph Node CL1642311 CDISC A lymph node located in the lower gastrointestinal tract. LOWER GASTROINTESTINAL TRACT LYMPH NODE Lower Gastrointestinal Tract Lymph Node Lower Gastrointestinal Tract Lymph Node An angiosarcoma that arises from the breast parenchyma and is not associated with radiation exposure. C176251 Neoplastic Process Primary Breast Angiosarcoma CL517775 Malignant Primary Angiosarcoma of the Breast Primary Breast Angiosarcoma Primary Breast Angiosarcoma A self-limiting, rapidly growing, non-encapsulated benign neoplasm that arises from the breast. It has been described in both the subcutis and parenchyma of the breast. It occurs most frequently in the upper-outer quadrant. It is composed of fibroblastic/myofibroblastic cells. C176253 Neoplastic Process Breast Nodular Fasciitis CL1642280 Benign Breast Nodular Fasciitis Breast Nodular Fasciitis An angiolipoma that arises from the breast. The majority are located in the subcutaneous tissue overlying the breast parenchyma, rather than in breast parenchyma. C176255 Neoplastic Process Breast Angiolipoma CL1642278 Benign Breast Angiolipoma Breast Angiolipoma Any lymph node within the colon. C176317 Anatomical Structure Colon Lymph Node CL1642320 CDISC A lymph node located in the colon. COLON LYMPH NODE Colon Lymph Node Colon Lymph Node Any lymph node within the ileum. C176318 Anatomical Structure Ileum Lymph Node CL1642321 CDISC A lymph node located in the ileum. ILEUM LYMPH NODE Ileum Lymph Node Ileum Lymph Node A magnetic resonance imaging technique that allows for the visualization of the entire small bowel by imaging the abdomen and pelvis during the enteric phase of digestion following oral administration of large volumes of enteric contrast material for bowel distention and intravenous contrast administration. C176331 Diagnostic Procedure Magnetic Resonance Enterography C4274338 CDISC A magnetic resonance imaging technique that allows for the visualization of the entire small bowel by imaging the abdomen and pelvis during the enteric phase of digestion following oral administration of large volumes of enteric contrast material for bowel distention, followed by intravenous administration of contrast agent. MAGNETIC RESONANCE ENTEROGRAPHY MRE Magnetic Resonance Enterography Magnetic Resonance Enterography An x-ray examination of the esophagus, stomach and first part of the small intestine following coating with barium solution via ingestion. C17639 Diagnostic Procedure Upper Gastrointestinal Series C0203057 A series of x-ray pictures of the esophagus, stomach, and duodenum (the first part of the small intestine). The x-ray pictures are taken after the patient drinks a liquid containing barium sulfate (a form of the silver-white metallic element barium). The barium sulfate coats and outlines the inner walls of the upper gastrointestinal tract so that they can be seen on the x-ray pictures. Upper_GI_Series Barium-Swallow X-ray Upper GI Upper GI Series Upper Gastrointestinal Series Upper Gastrointestinal Tract Radiography upper GI series upper gastrointestinal series Upper Gastrointestinal Series The evaluation of the liver and biliary tree using a contrast agent injected directly into the liver. C17641 Diagnostic Procedure Percutaneous Transhepatic Cholangiography C0203085 A procedure to x-ray the hepatic and common bile ducts. A contrasting agent is injected into the liver or bile duct, and the ducts are then x-rayed to find the point of obstruction. Percutaneous_Transhepatic_Cholangiography PTC Percutaneous Transhepatic Cholangiography percutaneous transhepatic cholangiography Percutaneous Transhepatic Cholangiography A schwannoma that arises from the breast. C176414 Neoplastic Process Breast Schwannoma CL1642532 Benign Breast Schwannoma Breast Schwannoma A neurofibroma that arises from the breast. C176415 Neoplastic Process Breast Neurofibroma CL1642530 Benign Breast Neurofibroma Breast Neurofibroma A technique in which sound waves are sent out by an ultrasound probe that has been inserted in the vagina and a computer uses the ultrasound echoes to create an image of the female genital tract. The test can be performed to evaluate women with infertility problems, abnormal bleeding, sources of unexplained pain, congenital malformations of the uterus and ovaries, and possible tumors and infection. C17644 Diagnostic Procedure Transvaginal Ultrasound Transvaginal Ultrasound C0203418 CDISC CTRP A procedure used to examine the vagina, uterus, fallopian tubes, and bladder. An instrument is inserted into the vagina, and sound waves bounce off organs inside the pelvic area. These sound waves create echoes, which a computer uses to create a picture called a sonogram. A technique in which sound waves are sent out by an ultrasound probe that has been inserted in the vagina and a computer uses the ultrasound echoes to create an image of the female reproductive organs. Transvaginal_Ultrasound TRANSVAGINAL ULTRASOUND TVS TVU Transvaginal Ultrasound transvaginal sonography transvaginal ultrasound Transvaginal Ultrasound The reemergence of a low grade astrocytoma after a period of remission. C176464 Neoplastic Process Recurrent Low Grade Astrocytic Tumor Recurrent Low Grade Astrocytoma CL1642519 CTRP Undetermined Recurrent Low Grade Astrocytic Tumor Recurrent Low Grade Astrocytoma Recurrent Low Grade Astrocytoma An extremely rare chondrosarcoma arising from the synovium either as a de novo neoplasm or secondary to synovial chondromatosis. C176467 Neoplastic Process Synovial Chondrosarcoma CL1642382 Malignant SCH Synovial Chondrosarcoma Synovial Chondrosarcoma A proliferation of atypical neoplastic epithelial cells confined to the mammary ducts of the male breast. It includes the entire spectrum of carcinoma in situ observed in the female breast. It usually develops in the retroareolar region. C176503 Neoplastic Process Male Breast Carcinoma In Situ C0686328 Malignant Male Breast Carcinoma In Situ Male Breast Carcinoma In Situ A rare invasive carcinoma that arises from the male breast. Morphologically, it is similar to the invasive carcinomas that arise from the female breast. It usually develops in the retroareolar region. C176504 Neoplastic Process Invasive Male Breast Carcinoma CL1642361 Malignant Invasive Male Breast Carcinoma Invasive Male Breast Carcinoma Sinonasal squamous cell carcinoma that is not amenable to surgical resection. C176513 Neoplastic Process Unresectable Sinonasal Squamous Cell Carcinoma CL1642366 Malignant Unresectable Sinonasal Squamous Cell Carcinoma Unresectable Sinonasal Squamous Cell Carcinoma Nasal cavity squamous cell carcinoma that is not amenable to surgical resection. C176514 Neoplastic Process Unresectable Nasal Cavity Squamous Cell Carcinoma Unresectable Nasal Cavity Squamous Cell Carcinoma CL1642364 CTRP Malignant Unresectable Nasal Cavity Squamous Cell Carcinoma Unresectable Nasal Cavity Squamous Cell Carcinoma A rare angiosarcoma that arises from the vulva. C176515 Neoplastic Process Vulvar Angiosarcoma CL1642365 Malignant Vulvar Angiosarcoma Vulvar Angiosarcoma A carcinoma that arises from the prostate and has not spread to other anatomic sites. C176517 Neoplastic Process Localized Prostate Carcinoma Non-Metastatic Prostate Carcinoma Localized Prostate Carcinoma CL1642372 CTRP Malignant Localized Prostate Carcinoma Localized Prostate Carcinoma An account of all reproductive events and problems a person has experienced. An important aggregate factor in epidemiological studies of women's health. The concept usually includes the number and timing of pregnancies and their outcomes, the incidence of breast feeding, and may include age of menarche and menopause, regularity of menstruation, fertility, gynecological or obstetric problems, or contraceptive usage. C17655 Clinical Attribute Reproductive History C0206076 Reproductive_History Reproductive Factors Reproductive History Reproductive Issues Reproductive History A sarcoma that is confined to a specific site without evidence of spread to other anatomic sites. C176558 Neoplastic Process Localized Sarcoma CL1642444 Malignant Localized Sarcoma Localized Sarcoma An invasive carcinoma that arises from the breast in females. C176579 Neoplastic Process Invasive Female Breast Carcinoma CL1642407 Malignant Invasive Female Breast Carcinoma Invasive Female Breast Carcinoma A proliferation of atypical neoplastic epithelial cells confined to the mammary ducts of the female breast. C176580 Neoplastic Process Female Breast Carcinoma In Situ C0686288 Malignant Female Breast Carcinoma In Situ Female Breast Carcinoma In Situ A malignant small intestinal neoplasm that has spread from its original site of growth to another anatomic site. C176678 Neoplastic Process Metastatic Malignant Small Intestinal Neoplasm C0861816 Malignant Metastatic Malignant Small Intestinal Neoplasm Metastatic Malignant Small Intestinal Neoplasm A malignant small intestinal neoplasm that has spread extensively to other anatomic sites or is no longer responding to treatment. C176679 Neoplastic Process Advanced Malignant Small Intestinal Neoplasm Advanced Malignant Small Intestinal Neoplasm CL1642718 CTRP Malignant Advanced Malignant Small Intestinal Neoplasm Advanced Malignant Small Intestinal Neoplasm The reemergence of breast implant-associated anaplastic large cell lymphoma after a period of remission. C176680 Neoplastic Process Recurrent Breast Implant-Associated Anaplastic Large Cell Lymphoma Recurrent Breast Implant-Associated Anaplastic Large Cell Lymphoma CL1642716 CTRP Malignant Recurrent Breast Implant-Associated Anaplastic Large Cell Lymphoma Recurrent Breast Implant-Associated Anaplastic Large Cell Lymphoma Breast implant-associated anaplastic large cell lymphoma that is resistant to treatment. C176681 Neoplastic Process Refractory Breast Implant-Associated Anaplastic Large Cell Lymphoma Refractory Breast Implant-Associated Anaplastic Large Cell Lymphoma CL1642717 CTRP Malignant Refractory Breast Implant-Associated Anaplastic Large Cell Lymphoma Refractory Breast Implant-Associated Anaplastic Large Cell Lymphoma The reemergence of head and neck squamous cell carcinoma after a period of remission, at or adjacent to the site of the original tumor. C176682 Neoplastic Process Locally Recurrent Head and Neck Squamous Cell Carcinoma Locally Recurrent Head and Neck Squamous Cell Carcinoma CL1642714 CTRP Malignant Locally Recurrent Head and Neck Squamous Cell Carcinoma Locally Recurrent Head and Neck Squamous Cell Carcinoma A rare, aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the rectum. It is characterized by the presence of malignant large cells. C176697 Neoplastic Process Rectal Large Cell Neuroendocrine Carcinoma CL1642676 Malignant Rectal Large Cell Neuroendocrine Carcinoma Rectal Large Cell Neuroendocrine Carcinoma A lung neuroendocrine tumor that is associated with carcinoid syndrome. C176705 Neoplastic Process Functioning Lung Neuroendocrine Tumor CL1642683 Undetermined Functioning Lung Carcinoid Tumor Functioning Lung Neuroendocrine Tumor Functioning Lung Neuroendocrine Tumor A lung neuroendocrine tumor that is not associated with carcinoid syndrome. C176706 Neoplastic Process Non-Functioning Lung Neuroendocrine Tumor CL1642681 Undetermined Non-Functioning Lung Carcinoid Tumor Non-Functioning Lung Neuroendocrine Tumor Non-Functioning Lung Neuroendocrine Tumor The reemergence of a lung neuroendocrine neoplasm after a period of remission. C176711 Neoplastic Process Recurrent Lung Neuroendocrine Neoplasm CL1642689 Undetermined Recurrent Lung Neuroendocrine Neoplasm Recurrent Lung Neuroendocrine Neoplasm A lung neuroendocrine neoplasm that has spread from its original site of growth to nearby tissues or lymph nodes. C176715 Neoplastic Process Locally Advanced Lung Neuroendocrine Neoplasm Locally Advanced Lung Neuroendocrine Neoplasm CL1642687 CTRP Malignant Locally Advanced Lung Neuroendocrine Neoplasm Locally Advanced Lung Neuroendocrine Neoplasm Lung adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C176727 Neoplastic Process Advanced Lung Adenocarcinoma Advanced Lung Adenocarcinoma CL1642569 CTRP Malignant Advanced Lung Adenocarcinoma Advanced Lung Adenocarcinoma A primary central chondrosarcoma that has spread from its original site of growth to nearby tissues and is not amenable to surgical resection. C176728 Neoplastic Process Locally Advanced Unresectable Primary Central Chondrosarcoma Locally Advanced Unresectable Primary Central Chondrosarcoma CL1642570 CTRP Malignant Locally Advanced Unresectable Primary Central Chondrosarcoma Locally Advanced Unresectable Primary Central Chondrosarcoma Lung small cell carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C176857 Neoplastic Process Locally Advanced Lung Small Cell Carcinoma Locally Advanced Lung Small Cell Carcinoma CL1642728 CTRP Malignant Locally Advanced Lung Small Cell Carcinoma Locally Advanced Lung Small Cell Carcinoma Non-squamous non-small cell lung carcinoma that is resistant to treatment. C176858 Neoplastic Process Refractory Lung Non-Squamous Non-Small Cell Carcinoma Refractory Lung Non-Squamous Non-Small Cell Carcinoma CL1642729 CTRP Malignant Refractory Lung Non-Squamous Non-Small Cell Carcinoma Refractory Lung Non-Squamous Non-Small Cell Carcinoma A malignant genitourinary neoplasm that has spread extensively to other anatomic sites or is no longer responding to treatment. C176859 Neoplastic Process Advanced Malignant Genitourinary System Neoplasm Advanced Malignant Genitourinary System Neoplasm CL1642877 CTRP Malignant Advanced Malignant Genitourinary System Neoplasm Advanced Malignant Genitourinary System Neoplasm A malignant thoracic neoplasm that has spread from its original site of growth to another anatomic site. C176862 Neoplastic Process Metastatic Malignant Thoracic Neoplasm CL1642880 Malignant Metastatic Malignant Thoracic Neoplasm Metastatic Malignant Thoracic Neoplasm A malignant thoracic neoplasm that has spread extensively to other anatomic sites or is no longer responding to treatment. C176863 Neoplastic Process Advanced Malignant Thoracic Neoplasm Advanced Malignant Thoracic Neoplasm CL1642881 CTRP Malignant Advanced Malignant Thoracic Neoplasm Advanced Malignant Thoracic Neoplasm Distal bile duct adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C176888 Neoplastic Process Advanced Distal Bile Duct Adenocarcinoma Advanced Distal Bile Duct Adenocarcinoma CL1642939 CTRP Malignant Advanced Distal Bile Duct Adenocarcinoma Advanced Extrahepatic Cholangiocarcinoma Advanced Distal Bile Duct Adenocarcinoma A glioma that is not amenable to surgical resection. C176889 Neoplastic Process Unresectable Glioma Unresectable Glioma CL1642940 CTRP Undetermined Unresectable Glioma Unresectable Glioma A glioblastoma that is not amenable to surgical resection. C176890 Neoplastic Process Unresectable Glioblastoma Unresectable Glioblastoma CL1642941 CTRP Malignant Unresectable Glioblastoma Unresectable Glioblastoma Intrahepatic cholangiocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C176891 Neoplastic Process Advanced Intrahepatic Cholangiocarcinoma Advanced Intrahepatic Cholangiocarcinoma CL1642942 CTRP Malignant Advanced Intrahepatic Cholangiocarcinoma Advanced Intrahepatic Cholangiocarcinoma Esophageal adenocarcinoma that is resistant to treatment. C176892 Neoplastic Process Refractory Esophageal Adenocarcinoma Refractory Esophageal Adenocarcinoma CL1642932 CTRP Malignant Refractory Esophageal Adenocarcinoma Refractory Esophageal Adenocarcinoma A rare inherited form of myofibromatosis caused by autosomal dominant mutation(s) in the PDGFRB gene, encoding platelet-derived growth factor receptor beta. The condition is characterized by the onset of solitary or multicentric benign tumors in the skin, striated muscles, bones, and viscera. The lesions may be present at birth or become apparent in early infancy or even occasionally in adult life. C176943 Neoplastic Process Infantile Myofibromatosis 1 C0432284 Benign IMF1 Infantile Myofibromatosis 1 Infantile Myofibromatosis 1 A rare inherited form of myofibromatosis caused by autosomal dominant mutation(s) in the NOTCH3 gene, encoding neurogenic locus notch homolog protein 3. The condition is characterized by the onset of solitary or multicentric benign tumors in the skin, striated muscles, bones, and viscera. Soft tissue lesions may regress spontaneously whereas visceral lesions are associated with high morbidity and mortality. C176944 Neoplastic Process Infantile Myofibromatosis 2 C4016659 Benign IMF2 Infantile Myofibromatosis 2 Infantile Myofibromatosis 2 An atypical lipomatous tumor/well differentiated liposarcoma composed of mature adipocytes in which, unlike in benign lipoma, substantial variation in cell size is appreciated alongside nuclear atypia in fat cells or stromal spindle cells. (WHO 2020) C176979 Neoplastic Process Lipoma-Like Atypical Lipomatous Tumor/Well Differentiated Liposarcoma CL1642762 GDC Undetermined Lipoma-like liposarcoma Lipoma-Like ALT/WDLPS Lipoma-Like Atypical Lipomatous Tumor/Well Differentiated Liposarcoma Lipoma-Like Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma Lipoma-Like Liposarcoma Lipoma-like liposarcoma Lipoma-Like Atypical Lipomatous Tumor/Well Differentiated Liposarcoma An atypical lipomatous tumor/well differentiated liposarcoma that occurs in a superficial body structure. C176980 Neoplastic Process Superficial Atypical Lipomatous Tumor/Well Differentiated Liposarcoma CL1642763 GDC Undetermined Superficial well differentiated liposarcoma Well differentiated liposarcoma of superficial soft tissue Superficial ALT/WDLPS Superficial Atypical Lipomatous Tumor Superficial Atypical Lipomatous Tumor/Well Differentiated Liposarcoma Superficial Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma Superficial Well Differentiated Liposarcoma Superficial Well-Differentiated Liposarcoma Superficial well differentiated liposarcoma Well differentiated liposarcoma of superficial soft tissue Superficial Atypical Lipomatous Tumor/Well Differentiated Liposarcoma An atypical lipomatous tumor/well differentiated liposarcoma that occurs in deep soft tissue. C176981 Neoplastic Process Atypical Lipomatous Tumor/Well Differentiated Liposarcoma of Deep Soft Tissue CL1642780 Undetermined ALT/WDLPS of Deep Soft Tissue Atypical Lipomatous Tumor/Well Differentiated Liposarcoma of Deep Soft Tissue Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma of Deep Soft Tissue Well Differentiated Liposarcoma of Deep Soft Tissue Well-Differentiated Liposarcoma of Deep Soft Tissue Atypical Lipomatous Tumor/Well Differentiated Liposarcoma of Deep Soft Tissue An exceptionally rare, aggressive adipocytic neoplasm, typically occurring in children and adolescents. Myxoid pleomorphic liposarcoma shows mixed histological features of conventional myxoid liposarcoma and pleomorphic liposarcoma and lacks the gene fusions and amplifications of myxoid liposarcoma, atypical lipomatous tumor, and dedifferentiated liposarcoma. (WHO 2020) C176989 Neoplastic Process Myxoid Pleomorphic Liposarcoma CL1642772 Malignant Myxoid Pleomorphic Liposarcoma Pleomorphic Myxoid Liposarcoma Myxoid Pleomorphic Liposarcoma Lymphoma that has spread from its original site of growth to nearby tissues or lymph nodes. C176994 Neoplastic Process Locally Advanced Lymphoma Locally Advanced Lymphoma CL1642777 CTRP Malignant Locally Advanced Lymphoma Locally Advanced Lymphoma Ureter urothelial carcinoma that is resistant to treatment. C176995 Neoplastic Process Refractory Ureter Urothelial Carcinoma Refractory Ureter Urothelial Carcinoma CL1642778 CTRP Malignant Refractory Ureter Urothelial Carcinoma Refractory Ureter Urothelial Carcinoma Urethral urothelial carcinoma that is resistant to treatment. C176996 Neoplastic Process Refractory Urethral Urothelial Carcinoma Refractory Urethral Urothelial Carcinoma CL1642779 CTRP Malignant Refractory Urethral Urothelial Carcinoma Refractory Urethral Urothelial Carcinoma Renal pelvis urothelial carcinoma that is resistant to treatment. C176997 Neoplastic Process Refractory Renal Pelvis Urothelial Carcinoma Refractory Renal Pelvis Urothelial Carcinoma CL1642843 CTRP Malignant Refractory Renal Pelvis Urothelial Carcinoma Refractory Renal Pelvis Urothelial Carcinoma Giant cell glioblastoma that is resistant to treatment. C176998 Neoplastic Process Refractory Giant Cell Glioblastoma Refractory Giant Cell Glioblastoma CL1642844 CTRP Malignant Refractory Giant Cell Glioblastoma Refractory Giant Cell Glioblastoma The reemergence of Sezary syndrome after a period of remission. C176999 Neoplastic Process Recurrent Sezary Syndrome Recurrent Sezary Syndrome C0862201 CTRP Malignant Recurrent Sezary Syndrome Recurrent Sezary Syndrome Sezary syndrome that is resistant to treatment. C177000 Neoplastic Process Refractory Sezary Syndrome Refractory Sezary Syndrome C0862207 CTRP Malignant Refractory Sezary Syndrome Refractory Sezary Syndrome Male reproductive system carcinoma that is resistant to treatment. C177149 Neoplastic Process Refractory Male Reproductive System Carcinoma CL1643096 Malignant Refractory Male Reproductive System Carcinoma Refractory Male Reproductive System Carcinoma Penile carcinoma that is resistant to treatment. C177150 Neoplastic Process Refractory Penile Carcinoma Refractory Penile Carcinoma CL1643099 CTRP Malignant Refractory Penile Carcinoma Refractory Penile Carcinoma Rectal squamous cell carcinoma that is resistant to treatment. C177151 Neoplastic Process Refractory Rectal Squamous Cell Carcinoma Refractory Rectal Squamous Cell Carcinoma CL1643098 CTRP Malignant Refractory Rectal Squamous Cell Carcinoma Refractory Rectal Squamous Cell Carcinoma Nasopharyngeal non-keratinizing carcinoma that has spread from its original site of growth to another anatomic site. C177153 Neoplastic Process Metastatic Nasopharyngeal Nonkeratinizing Carcinoma Metastatic Nasopharyngeal Non-Keratinizing Carcinoma CL1643100 CTRP Malignant Metastatic Nasopharyngeal Non-Keratinizing Carcinoma Metastatic Nasopharyngeal Nonkeratinizing Carcinoma Metastatic Nasopharyngeal Non-Keratinizing Carcinoma Lung neuroendocrine tumor that has spread from its original site of growth to another anatomic site. C177243 Neoplastic Process Metastatic Lung Carcinoid Tumor Metastatic Lung Neuroendocrine Tumor CL1643011 CTRP Malignant Metastatic Lung Carcinoid Tumor Metastatic Lung Neuroendocrine Tumor Metastatic Lung Neuroendocrine Tumor Lung neuroendocrine tumor that has spread extensively to other anatomic sites or is no longer responding to treatment. C177245 Neoplastic Process Advanced Lung Carcinoid Tumor Advanced Lung Neuroendocrine Tumor CL1643069 CTRP Malignant Advanced Lung Carcinoid Tumor Advanced Lung Neuroendocrine Tumor Advanced Lung Neuroendocrine Tumor Lung neuroendocrine tumor that is not amenable to surgical resection. C177246 Neoplastic Process Unresectable Lung Carcinoid Tumor Unresectable Lung Neuroendocrine Tumor CL1643071 CTRP Malignant Unresectable Lung Carcinoid Tumor Unresectable Lung Neuroendocrine Tumor Unresectable Lung Neuroendocrine Tumor A record of a patient's background regarding health and disease events of blood relatives. A patient's family medical history may be important in diagnosing existing conditions. C17726 Group Attribute Family Medical History C0241889 PCDC A record of the relationships among family members along with their medical histories. This includes current and past illnesses. A family history may show a pattern of certain diseases in a family. Family_Medical_History Other health problems within the family Epidemiology, Family Medical History FAMILY_HISTORY Family History Family History of Family Medical History family history family medical history Family Medical History A benign fibroblastic neoplasm characterized by a fusion of exon 7 of EWSR1 gene with exon 5 of SMAD3 gene. Patients usually present with a small painless superficial tumor in the hands and feet. Morphologically, there is zonation with acellular hyalinized center and peripheral proliferation of fibroblastic spindle cells without atypia. It may recur following incomplete excision. C177278 Neoplastic Process EWSR1-SMAD3-Positive Fibroblastic Tumor CL1643046 Provisional_Concept Benign EWSR1-SMAD3-Positive Fibroblastic Tumor EWSR1-SMAD3-Rearranged Fibroblastic Tumor EWSR1::SMAD3-Positive Fibroblastic Tumor EWSR1-SMAD3-Positive Fibroblastic Tumor A benign fibroblastic neoplasm composed of uniform spindle cells with abundant fibromyxoid stroma and a prominent network of innumerable branching, thin-walled blood vessels. It typically arises in the extremities, mainly the legs, frequently involving or adjacent to large joints such as the knee. Unusual anatomical locations include the back, abdominal wall, pelvic cavity, and breast. The tumors are often subcutaneous but may be intramuscular and deep. The lesion presents most often as a slow-growing painless mass. (WHO 2020) C177323 Neoplastic Process Angiofibroma of Soft Tissue CL1643268 Benign Angiofibroma of Soft Tissue Angiofibroma of Soft Tissue A low-grade neoplasm arising from the skin and subcutis. It is characterized by the presence of spindled cells with abundant, eosinophilic, granular to glassy cytoplasm, low mitotic activity, marked nuclear pleomorphism, diffuse CD34 expression, and frequent keratin immunoreactivity. The prognosis is excellent. C177324 Neoplastic Process Superficial CD34-Positive Fibroblastic Tumor CL1643287 Undetermined SCD34FT Superficial CD34-Positive Fibroblastic Tumor Superficial CD34-Positive Fibroblastic Tumor A rare variant of dermatofibrosarcoma protuberans characterized by plaque-like growth, resembling plaque-like CD34-positive dermal fibroma. C177325 Neoplastic Process Plaque-Like Dermatofibrosarcoma Protuberans CL1643286 Undetermined Plaque-Like Dermatofibrosarcoma Protuberans Plaque-Like Dermatofibrosarcoma Protuberans Toxicity that impairs or damages the lung(s). This condition is often caused by the administration of a pharmaceutical agent that causes damage to the lungs. C177374 Finding Pulmonary Toxicity C0919924 PCDC Pulmonary Toxicity Pulmonary Toxicity A rare subtype of myxofibrosarcoma composed predominantly of malignant epithelioid cells with abundant eosinophilic cytoplasm. C177414 Neoplastic Process Epithelioid Myxofibrosarcoma CL1643307 Malignant Epithelioid Myxofibrosarcoma Epithelioid Myxofibrosarcoma An in situ or invasive urothelial carcinoma that arises from the bladder wall and does not grow toward the hollow part of the bladder. C177531 Neoplastic Process Bladder Flat Urothelial Carcinoma CL1643231 Malignant Bladder Flat Urothelial Carcinoma Bladder Sessile Urothelial Carcinoma Bladder Flat Urothelial Carcinoma A carcinoma that arises from the sigmoid colon. C177680 Neoplastic Process Sigmoid Colon Carcinoma Sigmoid Colon Carcinoma C0751498 CTRP Malignant Sigmoid Colon Carcinoma Sigmoid Colon Carcinoma A malignant salivary gland neoplasm that is resistant to treatment. C177721 Neoplastic Process Refractory Malignant Salivary Gland Neoplasm CL1643369 Malignant Refractory Malignant Salivary Gland Neoplasm Refractory Malignant Salivary Gland Neoplasm Salivary gland carcinoma that is resistant to treatment. C177722 Neoplastic Process Refractory Salivary Gland Carcinoma Refractory Salivary Gland Carcinoma CL1643368 CTRP Malignant Refractory Salivary Gland Carcinoma Refractory Salivary Gland Carcinoma Salivary gland carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C177723 Neoplastic Process Advanced Salivary Gland Carcinoma Advanced Salivary Gland Carcinoma CL1643371 CTRP Malignant Advanced Salivary Gland Carcinoma Advanced Salivary Gland Carcinoma The reemergence of a malignant genitourinary system neoplasm after a period of remission. C177724 Neoplastic Process Recurrent Malignant Genitourinary System Neoplasm Recurrent Malignant Genitourinary System Neoplasm CL1643370 CTRP Malignant Recurrent Malignant Genitourinary System Neoplasm Recurrent Malignant Genitourinary System Neoplasm Medulloblastoma that has spread from its original site of growth to another anatomic site. C177725 Neoplastic Process Metastatic Medulloblastoma Metastatic Medulloblastoma CL1643372 CTRP Malignant Metastatic Medulloblastoma Metastatic Medulloblastoma A germ cell tumor that arises from the suprasellar region. C177769 Neoplastic Process Suprasellar Germ Cell Tumor Suprasellar Germ Cell Tumor C0349615 CTRP Undetermined Suprasellar Germ Cell Tumor Suprasellar Germ Cell Tumor An ovarian dermoid cyst associated with a distinct secondary component that resembles a somatic-type malignant neoplasm (e.g., carcinoma or sarcoma). C177774 Neoplastic Process Ovarian Dermoid Cyst with Somatic-Type Malignancy CL1647566 Cellosaurus Malignant Ovarian Dermoid Cyst with Somatic-Type Malignancy Ovarian Teratoma with Malignant Transformation Ovarian Dermoid Cyst with Somatic-Type Malignancy A chordoma that arises from the thoracic spine. C177775 Neoplastic Process Thoracic Chordoma CL1647564 Cellosaurus Malignant Thoracic Chordoma Thoracic Chordoma Rectal carcinoma characterized by the absence of microsatellite instability. C177776 Neoplastic Process Microsatellite Stable Rectal Carcinoma Microsatellite Stable Rectal Carcinoma CL1647565 CTRP Malignant Microsatellite Stable Rectal Carcinoma Microsatellite Stable Rectal Carcinoma Colon carcinoma characterized by the absence of microsatellite instability. C177777 Neoplastic Process Microsatellite Stable Colon Carcinoma Microsatellite Stable Colon Carcinoma CL1647562 CTRP Malignant Microsatellite Stable Colon Carcinoma Microsatellite Stable Colon Carcinoma Low grade glioma that is resistant to treatment. C177793 Neoplastic Process Refractory Low Grade Glioma Refractory Low Grade Glioma CL1647458 CTRP Undetermined Refractory Low Grade Glioma Refractory Low Grade Glioma The reemergence of low grade glioma after a period of remission. C177794 Neoplastic Process Recurrent Low Grade Glioma CL1647459 Undetermined Recurrent Low Grade Glioma Recurrent Low Grade Glioma Low grade astrocytoma that is resistant to treatment. C177795 Neoplastic Process Refractory Low Grade Astrocytoma Refractory Low Grade Astrocytoma CL1647456 CTRP Undetermined Refractory Low Grade Astrocytoma Refractory Low Grade Astrocytoma The reemergence of WHO grade 1 glioma after a period of remission. C177796 Neoplastic Process Recurrent WHO Grade 1 Glioma CL1647457 Undetermined Recurrent WHO Grade 1 Glioma Recurrent WHO Grade I Glioma Recurrent WHO Grade 1 Glioma A category of low grade gliomas that includes subependymal giant cell astrocytoma, pilocytic astrocytoma, angiocentric glioma, and subependymoma. C177797 Neoplastic Process WHO Grade 1 Glioma CL1647454 Undetermined WHO Grade 1 Glioma WHO Grade I Glioma WHO Grade 1 Glioma WHO grade 1 glioma that is resistant to treatment. C177798 Neoplastic Process Refractory WHO Grade I Glioma Refractory WHO Grade 1 Glioma CL1647455 CTRP Undetermined Refractory WHO Grade 1 Glioma Refractory WHO Grade I Glioma Refractory WHO Grade 1 Glioma Lung large cell neuroendocrine carcinoma that has spread from its original site of growth to another anatomic site. C177799 Neoplastic Process Metastatic Lung Large Cell Neuroendocrine Carcinoma Metastatic Lung Large Cell Neuroendocrine Carcinoma CL1647452 CTRP Malignant Metastatic Lung Large Cell Neuroendocrine Carcinoma Metastatic Lung Large Cell Neuroendocrine Carcinoma Lung large cell neuroendocrine carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C177801 Neoplastic Process Locally Advanced Lung Large Cell Neuroendocrine Carcinoma Locally Advanced Lung Large Cell Neuroendocrine Carcinoma CL1647450 CTRP Malignant Locally Advanced Lung Large Cell Neuroendocrine Carcinoma Locally Advanced Lung Large Cell Neuroendocrine Carcinoma Large cell neuroendocrine carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C177802 Neoplastic Process Advanced Large Cell Neuroendocrine Carcinoma CL1647451 Malignant Advanced Large Cell Neuroendocrine Carcinoma Advanced Large Cell Neuroendocrine Carcinoma The reemergence of B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 after a period of remission. C177895 Neoplastic Process Recurrent B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 Recurrent B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 CL1647484 CTRP Malignant Recurrent B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 Recurrent B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR::ABL1 Relapsed B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 Recurrent B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 A rare, aggressive type of chordoma characterized by loss of SMARCB1 expression. It affects children and occasionally young adults. Females are affected twice as frequently as males. It usually arises in the axial skeleton. It is composed of sheets or nests of malignant epithelioid cells with abundant eosinophilic cytoplasm. The prognosis is poor. C177898 Neoplastic Process Poorly Differentiated Chordoma CL1647483 Malignant Poorly Differentiated Chordoma Poorly Differentiated Chordoma A type of functional MRI that images dynamic changes in brain tissue while the subject performs a task or experiences a sensory stimulus designed to target specific cognitive processes. C178023 Diagnostic Procedure Task Functional Magnetic Resonance Imaging Task Functional Magnetic Resonance Imaging CL1647732 CDISC CTRP A type of functional magnetic resonance imaging that images dynamic changes in brain tissue while the subject performs a task or experiences a sensory stimulus designed to target specific cognitive processes. TASK FUNCTIONAL MRI Task Functional MRI Task Functional Magnetic Resonance Imaging Task fMRI Task Functional Magnetic Resonance Imaging A type of functional magnetic resonance imaging that is performed on an organ or brain tissue in the absence of a stimulus or task. C178024 Diagnostic Procedure Resting Functional Magnetic Resonance Imaging CL1647733 CDISC A type of functional magnetic resonance imaging that is performed on an organ in the absence of a stimulus or task. (NCI) RESTING FUNCTIONAL MRI Resting Functional MRI Resting Functional Magnetic Resonance Imaging Resting State Functional MRI Resting fMRI rs-fMRI Resting Functional Magnetic Resonance Imaging A rare smooth muscle neoplasm of uncertain biological potential. It is associated with Epstein-Barr virus infection and seen in patients with immunodeficiency, including primary immunodeficiency, HIV/AIDS infection, and post-transplant immunosuppression. C178217 Neoplastic Process EBV-Associated Smooth Muscle Tumor CL1647882 Undetermined EBV-Associated Smooth Muscle Neoplasm EBV-Associated Smooth Muscle Tumor EBV-SMT Epstein-Barr Virus-Associated Smooth Muscle Neoplasm Epstein-Barr Virus-Associated Smooth Muscle Tumor EBV-Associated Smooth Muscle Tumor A leiomyosarcoma characterized by the presence of poorly differentiated areas with pleomorphic appearance, in addition to areas with typical morphologic features. C178220 Neoplastic Process Pleomorphic Leiomyosarcoma CL936525 Malignant Pleomorphic Leiomyosarcoma Pleomorphic Leiomyosarcoma A pleomorphic leiomyosarcoma that lacks immunohistochemical staining for myogenic markers in the pleomorphic areas. C178222 Neoplastic Process Dedifferentiated Leiomyosarcoma CL1647880 Malignant Dedifferentiated Leiomyosarcoma Dedifferentiated Leiomyosarcoma Congenital/infantile spindle cell rhabdomyosarcoma characterized by the presence of gene fusions involving the VGLL2, SRF, TEAD1, NCOA2, and CITED2 genes. C178232 Neoplastic Process Congenital/Infantile Spindle Cell Rhabdomyosarcoma with VGLL2/NCOA2/CITED2 Rearrangements CL1647898 Malignant Congenital/Infantile Spindle Cell Rhabdomyosarcoma with VGLL2/NCOA2/CITED2 Rearrangements Congenital/Infantile Spindle Cell Rhabdomyosarcoma with VGLL2/NCOA2/CITED2 Rearrangements Spindle cell/sclerosing rhabdomyosarcoma characterized by the presence of MYOD1 p.Leu122Arg substitution mutation. This subtype includes most spindle cell/sclerosing rhabdomyosarcomas in adolescents and young adults, as well as some cases in older adults. It follows an aggressive clinical course. C178235 Neoplastic Process MYOD1-Mutant Spindle Cell/Sclerosing Rhabdomyosarcoma CL1647893 Malignant MYOD1-Mutant Spindle Cell/Sclerosing Rhabdomyosarcoma MYOD1-Mutant Spindle Cell/Sclerosing Rhabdomyosarcoma Intraosseous spindle cell rhabdomyosarcoma characterized by the fusion of the EWSR1 or FUS gene with the TFCP2 gene, or the MEIS1 gene with the NCOA2 gene. C178236 Neoplastic Process Intraosseous Spindle Cell Rhabdomyosarcoma with TFCP2/NCOA2 Rearrangements CL1647894 Malignant Intraosseous Spindle Cell Rhabdomyosarcoma with TFCP2/NCOA2 Rearrangements Intraosseous Spindle Cell Rhabdomyosarcoma with TFCP2/NCOA2 Rearrangements A schwannoma characterized by the presence of epithelioid cells with eosinophilic cytoplasm, within a myxoid and/or hyalinized stroma. C178245 Neoplastic Process Epithelioid Schwannoma CL1647884 Benign Epithelioid Schwannoma Epithelioid Schwannoma A premalignant neurofibromatous neoplasm characterized by the presence of at least two of the following features: cytologic atypia, hypercellularity, less than 3 mitotic figures per 10 HPFs, and loss of neurofibroma architecture. It is associated with an increased risk of progression to malignant peripheral nerve sheath tumor. C178255 Neoplastic Process Atypical Neurofibromatous Neoplasm of Uncertain Biologic Potential CL1647958 Uncertain Malignant Potential AN AN/ANUBP ANUBP Atypical Neurofibroma Atypical Neurofibromatous Neoplasm of Uncertain Biologic Potential Atypical Neurofibromatous Neoplasm with Uncertain Biologic Potential Atypical Neurofibromatous Neoplasm of Uncertain Biologic Potential Microsatellite stable colon carcinoma that has spread from its original site of growth to another anatomic site. C178268 Neoplastic Process Metastatic Microsatellite Stable Colon Carcinoma Metastatic Microsatellite Stable Colon Carcinoma CL1647973 CTRP Malignant Metastatic Microsatellite Stable Colon Carcinoma Metastatic Microsatellite Stable Colon Carcinoma Microsatellite stable colon carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C178269 Neoplastic Process Locally Advanced Microsatellite Stable Colon Carcinoma Locally Advanced Microsatellite Stable Colon Carcinoma CL1647974 CTRP Malignant Locally Advanced Microsatellite Stable Colon Carcinoma Locally Advanced Microsatellite Stable Colon Carcinoma A digestive system neuroendocrine neoplasm that has spread from its original site of growth to nearby tissues or lymph nodes. C178271 Neoplastic Process Locally Advanced Digestive System Neuroendocrine Neoplasm Locally Advanced Digestive System Neuroendocrine Neoplasm CL1647972 CTRP Malignant Locally Advanced Digestive System Neuroendocrine Neoplasm Locally Advanced Gastroenteropancreatic Neuroendocrine Neoplasm Locally Advanced Digestive System Neuroendocrine Neoplasm A magnetic resonance imaging technique that utilizes a combination of two-dimensional, three-dimensional, and diffusion imaging pulse sequences to enhance selective multiplanar visualization of spinal and peripheral nerve anatomy and pathology. C178279 Diagnostic Procedure Magnetic Resonance Neurography Magnetic Resonance Neurography C3805001 CTRP MR Imaging of Peripheral Nerves MR Neurography MRN Magnetic Resonance Neurography Magnetic Resonance Neurography Erythema, desquamation, and other cutaneous injury resulting from, and occurring within days or weeks of, radiation exposure. C178294 Finding Acute Radiation Skin Toxicity Acute Radiation Skin Toxicity CL1647922 CTRP Acute Radiation Skin Toxicity Acute Radiation Skin Toxicity Computed tomography that uses prostate specific membrane antigen labeled with gallium-68 that was been prepared by cyclotron. C178303 Diagnostic Procedure 68Ga-PSMA-cyclotron PET Scan 68Ga-PSMA-cyclotron PET Scan CL1647944 CTRP 68Ga-PSMA-cyclotron 68Ga-PSMA-cyclotron PET Scan 68Ga-PSMA-cyclotron PET Scan Computed tomography that uses prostate specific membrane antigen labeled with gallium-68 that was been prepared by a 68Ge/68Ga generator. C178304 Diagnostic Procedure 68Ga-PSMA-generator PET Scan 68Ga-PSMA-generator PET Scan CL1647941 CTRP 68Ga-PSMA-generator 68Ga-PSMA-generator PET Scan 68Ga-PSMA-generator PET Scan A HER2-negative breast adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C178348 Neoplastic Process Locally Advanced HER2 Negative Breast Adenocarcinoma Locally Advanced HER2-Negative Breast Carcinoma CL1647787 CTRP Malignant Locally Advanced HER2 Negative Breast Adenocarcinoma Locally Advanced HER2 Negative Breast Carcinoma Locally Advanced HER2-Negative Breast Carcinoma Locally Advanced HER2-Negative Breast Carcinoma A myxofibrosarcoma that is not amenable to surgical resection. C178372 Neoplastic Process Unresectable Myxofibrosarcoma Unresectable Myxofibrosarcoma CL1647799 CTRP Malignant Unresectable Myxofibrosarcoma Unresectable Myxofibrosarcoma Multiple myeloma that is resistant to three classes of therapeutic agents, including proteasome inhibitors, immunomodulatory agents, and monoclonal antibodies. C178375 Neoplastic Process Triple-Class Refractory Plasma Cell Myeloma Triple-Class Refractory Multiple Myeloma CL1647794 CTRP Malignant Triple-Class Refractory Multiple Myeloma Triple-Class Refractory Plasma Cell Myeloma Triple-Class Refractory Multiple Myeloma An emerging rare group of soft tissue tumors, usually characterized by a monomorphic spindle cell infiltrate, stromal hyalinization, and frequent coexpression of S100 and CD34 by immunohistochemistry. Most tumors harbor NTRK1 fusions with a variety of partners. Rare cases involving NTRK2 and NTRK3 fusions have also been reported. C178426 Neoplastic Process NTRK-Rearranged Spindle Cell Neoplasm CL1648150 Provisional_Concept Undetermined Lipofibromatosis-Like Neural Tumor NTRK-Positive Tumor Resembling Peripheral Nerve Sheath Tumor NTRK-Rearranged Mesenchymal Tumor NTRK-Rearranged Spindle Cell Neoplasm NTRK-Rearranged Spindle Cell Neoplasm A malignant melanocytic neoplasm that arises from a mucosal site of the female genital tract. C178437 Neoplastic Process Mucosal Melanoma of the Female Genital Tract CL1648139 Malignant Mucosal Melanoma of the Female Genital Tract Mucosal Melanoma of the Female Genital Tract A melanoma arising from the ovary. C178441 Neoplastic Process Ovarian Melanoma CL936328 Malignant Ovarian Melanoma Ovarian Melanoma A malignant melanocytic neoplasm that arises from a mucosal site of the genitourinary system. C178443 Neoplastic Process Mucosal Melanoma of the Genitourinary System CL1648144 Malignant Mucosal Melanoma of the Genitourinary System Mucosal Melanoma of the Genitourinary System A malignant melanocytic neoplasm that arises from a mucosal site of the urinary system. C178453 Neoplastic Process Mucosal Melanoma of the Urinary System CL1648124 Malignant Mucosal Melanoma of the Urinary System Mucosal Melanoma of the Urinary System A group of rare round and spindle cell sarcomas characterized by the presence of EWSR1 or FUS fusions involving partners unrelated to the ETS gene family. This category includes EWSR1-NFATC2, EWSR1-PATZ1, and FUS-NFATC2 sarcomas. C178459 Neoplastic Process Round Cell Sarcoma with EWSR1-non-ETS Fusion CL556470 Malignant Ewing-Like Sarcoma Round Cell Sarcoma with EWSR1-non-ETS Fusion Round Cell Sarcoma with EWSR1::non-ETS Fusion Round Cell Sarcoma with EWSR1-non-ETS Fusion A group of rare round and spindle cell sarcomas characterized by the presence of EWSR1-NFATC2 gene fusion. C178460 Neoplastic Process Round Cell Sarcoma with EWSR1-NFATC2 Gene Fusion CL1648130 Malignant EWSR1-NFATC2 Sarcoma EWSR1::NFATC2 Sarcoma Round Cell Sarcoma with EWSR1-NFATC2 Gene Fusion Round Cell Sarcoma with EWSR1::NFATC2 Gene Fusion Round Cell Sarcoma with EWSR1-NFATC2 Gene Fusion A group of rare round and spindle cell sarcomas characterized by the presence of EWSR1-PATZ1 gene fusion. C178461 Neoplastic Process Round Cell Sarcoma with EWSR1-PATZ1 Gene Fusion CL1648131 Malignant EWSR1-PATZ1 Sarcoma EWSR1::PATZ1 Sarcoma Round Cell Sarcoma with EWSR1-PATZ1 Gene Fusion Round Cell Sarcoma with EWSR1::PATZ1 Gene Fusion Round Cell Sarcoma with EWSR1-PATZ1 Gene Fusion A group of rare round and spindle cell sarcomas characterized by the presence of FUS-NFATC2 gene fusion. C178462 Neoplastic Process Round Cell Sarcoma with FUS-NFATC2 Gene Fusion CL1648132 Malignant FUS-NFATC2 Sarcoma FUS::NFATC2 Sarcoma Round Cell Sarcoma with FUS-NFATC2 Gene Fusion Round Cell Sarcoma with FUS::NFATC2 Gene Fusion Round Cell Sarcoma with FUS-NFATC2 Gene Fusion A group of rare primitive round cell sarcomas characterized by the presence of BCOR genetic alterations. This category includes sarcomas with BCOR-related gene fusions, most frequently BCOR-CCNB3, and sarcomas showing internal tandem duplication (BCOR-ITD). C178465 Neoplastic Process Sarcoma with BCOR Genetic Alterations CL1648105 Malignant Sarcoma with BCOR Genetic Alterations Sarcoma with BCOR Genetic Alterations A group of rare primitive round cell sarcomas characterized by the presence of BCOR-CCNB3 fusion gene. C178466 Neoplastic Process BCOR-CCNB3 Sarcoma CL1648106 Malignant BCOR-CCNB3 Fusion-Positive Sarcoma BCOR-CCNB3 Sarcoma BCOR-Rearranged Sarcoma BCOR::CCNB3 Fusion-Positive Sarcoma BCOR::CCNB3 Sarcoma BCOR-CCNB3 Sarcoma A group of rare primitive round cell sarcomas characterized by the presence of BCOR internal tandem duplication. This genetic alteration has been described in infantile undifferentiated round cell sarcomas and primitive myxoid mesenchymal tumors of infancy. C178468 Neoplastic Process BCOR ITD Sarcoma CL1648108 Malignant BCOR ITD Sarcoma BCOR-ITD Sarcoma Round Cell Sarcoma with BCOR Internal Tandem Duplication Sarcoma with BCOR Internal Tandem Duplication BCOR ITD Sarcoma A locally aggressive, low-grade chondrosarcoma arising in the medulla of bone. Tumors in the appendicular skeleton are called central atypical cartilaginous tumors and tumors in the axial skeleton are called central chondrosarcomas, grade 1. Tumors arising in the medulla of the bone without a benign precursor are called primary central atypical cartilaginous tumors/chondrosarcomas, grade 1. Tumors arising in the medulla of the bone in association with a pre-existing enchondroma are called secondary central atypical cartilaginous tumors/chondrosarcomas, grade 1. C178473 Neoplastic Process Central Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1 CL1648112 Malignant Central Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1 Low Grade Central Chondrosarcoma Low-Grade Central Chondrosarcoma Central Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1 Central atypical cartilaginous tumor/chondrosarcoma, grade 1 arising in the medulla of bone without a benign precursor. C178476 Neoplastic Process Primary Central Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1 CL1648114 Malignant Primary Central Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1 Primary Conventional Central Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1 Primary Central Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1 Central atypical cartilaginous tumor/chondrosarcoma, grade 1 arising in the medulla of bone in association with a pre-existing enchondroma. C178477 Neoplastic Process Secondary Central Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1 CL1648115 Malignant Secondary Central Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1 Secondary Conventional Central Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1 Secondary Central Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1 A locally aggressive, low-grade chondrosarcoma arising in the medulla of bone in the appendicular skeleton. C178478 Neoplastic Process Central Atypical Cartilaginous Tumor CL1648116 Malignant Central Atypical Cartilaginous Tumor Central Atypical Cartilaginous Tumor A locally aggressive, low-grade chondrosarcoma arising in the medulla of bone in the axial skeleton. C178479 Neoplastic Process Central Chondrosarcoma, Grade 1 CL1648117 Malignant Central Chondrosarcoma, Grade 1 Central Chondrosarcoma, Grade 1 A locally aggressive, low-grade chondrosarcoma arising within the cartilaginous cap of a pre-existing osteochondroma. Tumors in the appendicular skeleton are called peripheral atypical cartilaginous tumors and tumors in the axial skeleton are called peripheral chondrosarcomas, grade 1. C178480 Neoplastic Process Secondary Peripheral Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1 CL1648043 Malignant Low Grade Peripheral Chondrosarcoma Low-Grade Peripheral Chondrosarcoma Secondary Peripheral Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1 Secondary Peripheral Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1 A locally aggressive, low-grade chondrosarcoma arising within the cartilaginous cap of a pre-existing osteochondroma in the axial skeleton. C178481 Neoplastic Process Secondary Peripheral Chondrosarcoma, Grade 1 CL1648044 Malignant Peripheral Chondrosarcoma, Grade 1 Secondary Peripheral Chondrosarcoma, Grade 1 Secondary Peripheral Chondrosarcoma, Grade 1 A locally aggressive, low-grade chondrosarcoma arising within the cartilaginous cap of a pre-existing osteochondroma in the appendicular skeleton. C178482 Neoplastic Process Secondary Peripheral Atypical Cartilaginous Tumor CL1648045 Malignant Peripheral Atypical Cartilaginous Tumor Secondary Peripheral Atypical Cartilaginous Tumor Secondary Peripheral Atypical Cartilaginous Tumor A locally aggressive, low grade chondrosarcoma arising in the medulla of bone or within the cartilaginous cap of a pre-existing osteochondroma in the appendicular skeleton. C178483 Neoplastic Process Atypical Cartilaginous Tumor C3838825 Malignant Atypical cartilaginous tumor ACT Atypical Cartilaginous Tumor Atypical Cartilaginous Tumor A locally aggressive, low grade chondrosarcoma arising in the medulla of bone or within the cartilaginous cap of a pre-existing osteochondroma in the axial skeleton. C178484 Neoplastic Process Chondrosarcoma, Grade 1 CL1648046 Malignant Chondrosarcoma, Grade 1 Chondrosarcoma, Grade 1 An event in a personal medical history indicating that a myocardial infartion has occurred during the previous 6 months. C17849 Clinical Attribute History of Myocardial Infarction Within 6 Months C0278960 History_of_Myocardial_Infarction_Within_6_Months History of Myocardial Infarction Within 6 Months History of Myocardial Infarction Within 6 Months An intermediate-grade chondrosarcoma arising in the medulla of bone. C178491 Neoplastic Process Central Chondrosarcoma, Grade 2 CL1648053 Malignant Central Chondrosarcoma, Grade 2 Central Chondrosarcoma, Grade 2 An intermediate-grade chondrosarcoma arising within the cartilaginous cap of a pre-existing osteochondroma. C178492 Neoplastic Process Secondary Peripheral Chondrosarcoma, Grade 2 CL1648054 Malignant Secondary Peripheral Chondrosarcoma, Grade 2 Secondary Peripheral Chondrosarcoma, Grade 2 A high-grade chondrosarcoma arising in the medulla of bone. C178493 Neoplastic Process Central Chondrosarcoma, Grade 3 CL1648055 Malignant Central Chondrosarcoma, Grade 3 Central Chondrosarcoma, Grade 3 A high-grade chondrosarcoma arising within the cartilaginous cap of a pre-existing osteochondroma. C178494 Neoplastic Process Secondary Peripheral Chondrosarcoma, Grade 3 CL1648056 Malignant Secondary Peripheral Chondrosarcoma, Grade 3 Secondary Peripheral Chondrosarcoma, Grade 3 A group of SMARCB1/INI1 deficient tumors that arise from the central nervous system. It includes highly aggressive and slow-growing tumors. C178506 Neoplastic Process Central Nervous System SMARCB1/INI1-Deficient Tumor CL1648037 Undetermined Central Nervous System SMARCB1/INI1-Deficient Tumor Central Nervous System Tumor, SMARCB1-Mutant Central Nervous System SMARCB1/INI1-Deficient Tumor A SMARCB1-deficient tumor of the brain arising in the pineal region. It is characterized by the presence of spindled and epithelioid cells with low-grade morphology that are embedded in a desmoplastic stroma alternating with various extents of loose myxoid matrix. C178507 Neoplastic Process Desmoplastic Myxoid Tumor of the Pineal Region, SMARCB1-Mutant CL1648038 Undetermined Desmoplastic Myxoid Tumor of the Pineal Region, SMARCB1-Mutant Desmoplastic Myxoid Tumor, SMARCB1-Mutant Desmoplastic Myxoid Tumor of the Pineal Region, SMARCB1-Mutant A melanoma that arises from the mucosa of the penis. C178517 Neoplastic Process Penile Mucosal Melanoma CL1648019 Malignant Penile Mucosal Melanoma Penile Mucosal Melanoma A melanoma that arises from the skin of the penis. C178518 Neoplastic Process Penile Cutaneous Melanoma CL1648020 Malignant Penile Cutaneous Melanoma Penile Cutaneous Melanoma A melanoma that arises from mucosa of the stomach. C178519 Neoplastic Process Gastric Melanoma C1262241 Malignant Gastric Melanoma Gastric Mucosal Melanoma Gastric Melanoma A melanoma that arises from the mucosal surface of the pharynx. C178521 Neoplastic Process Pharyngeal Melanoma CL1648022 Malignant Pharyngeal Melanoma Pharyngeal Mucosal Melanoma Pharyngeal Melanoma A melanoma that arises from the mucosal surface of the nasopharynx. C178522 Neoplastic Process Nasopharyngeal Melanoma CL1648023 Malignant Nasopharyngeal Melanoma Nasopharyngeal Mucosal Melanoma Nasopharyngeal Melanoma A B-cell non-Hodgkin lymphoma with an aggressive clinical course. This category includes B lymphoblastic lymphoma, subtypes of diffuse large B-cell lymphoma, Burkitt lymphoma, grade 3 follicular lymphoma, and mantle cell lymphoma. C178541 Neoplastic Process Aggressive B-Cell Non-Hodgkin Lymphoma CL1648012 Malignant Aggressive B-Cell Non-Hodgkin Lymphoma Aggressive B-Cell Non-Hodgkin Lymphoma A T-cell non-Hodgkin lymphoma with an aggressive clinical course. This category includes T lymphoblastic lymphoma, anaplastic large cell lymphoma, ALK-negative, angioimmunoblastic T-cell lymphoma, hepatosplenic T-cell lymphoma, intestinal T-cell lymphoma, nasal type extranodal NK/T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified, and subtypes of primary cutaneous T-cell non-Hodgkin lymphoma. C178547 Neoplastic Process Aggressive T-Cell Non-Hodgkin Lymphoma CL1648088 Malignant Aggressive T-Cell Non-Hodgkin Lymphoma Aggressive T-Cell Non-Hodgkin Lymphoma The reemergence of an aggressive B-cell non-Hodgkin lymphoma after a period of remission. C178553 Neoplastic Process Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma CL1648094 CTRP Malignant Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma The reemergence of an aggressive T-cell non-Hodgkin lymphoma after a period of remission. C178554 Neoplastic Process Recurrent Aggressive T-Cell Non-Hodgkin Lymphoma CL1648095 Malignant Recurrent Aggressive T-Cell Non-Hodgkin Lymphoma Recurrent Aggressive T-Cell Non-Hodgkin Lymphoma An aggressive B-cell non-Hodgkin lymphoma that is resistant to treatment. C178555 Neoplastic Process Refractory Aggressive B-Cell Non-Hodgkin Lymphoma Refractory Aggressive B-Cell Non-Hodgkin Lymphoma CL1648096 CTRP Malignant Refractory Aggressive B-Cell Non-Hodgkin Lymphoma Refractory Aggressive B-Cell Non-Hodgkin Lymphoma An aggressive T-cell non-Hodgkin lymphoma that is resistant to treatment. C178556 Neoplastic Process Refractory Aggressive T-Cell Non-Hodgkin Lymphoma CL1648097 Malignant Refractory Aggressive T-Cell Non-Hodgkin Lymphoma Refractory Aggressive T-Cell Non-Hodgkin Lymphoma Low grade glioma that has spread from its primary site to another anatomic site. C178558 Neoplastic Process Metastatic Low Grade Glioma Metastatic Low Grade Glioma CL1648099 CTRP Malignant Metastatic Low Grade Glioma Metastatic Low Grade Glioma Low grade astrocytoma that has spread from its primary site to another anatomic site. C178559 Neoplastic Process Metastatic Low Grade Astrocytoma Metastatic Low Grade Astrocytoma CL1648100 CTRP Malignant Metastatic Low Grade Astrocytoma Metastatic Low Grade Astrocytoma A malignant bone tumor arising from the remnants of the fetal notochord. It is characterized by the presence of large epithelioid cells with clear to light eosinophilic cytoplasm. Some of the cells are large with bubbly, vacuolated cytoplasm (physaliphorous cells). The cells form cords and nests that are embedded within an extracellular myxoid matrix. C178563 Neoplastic Process Conventional Chordoma CL1648079 Malignant Conventional Chordoma Conventional Chordoma A very rare, locally aggressive neoplasm arising from the bones, usually from the metaphysis of long tubular bones. It is composed of spindle cells, hyaline cartilage nodules, and trabeculae of bone. It may recur locally, but no metastases have been reported. C178599 Neoplastic Process Fibrocartilaginous Mesenchymoma CL1648060 Undetermined Fibrocartilaginous Mesenchymoma Fibrocartilaginous Mesenchymoma A benign neoplasm that is composed of brown adipocytes and arises within or on the surface of bone. C178604 Neoplastic Process Bone Hibernoma CL1648063 Benign Bone Hibernoma Bone Hibernoma Langerhans cell histiocytosis affecting the bone. C178607 Neoplastic Process Bone Langerhans Cell Histiocytosis CL1648065 Undetermined Bone Langerhans Cell Histiocytosis Bone Langerhans Cell Histiocytosis Erdheim-Chester disease affecting the bone. C178609 Neoplastic Process Bone Erdheim-Chester Disease CL1648302 Undetermined Bone Erdheim-Chester Disease Bone Erdheim-Chester Disease Rosai-Dorfman-Destombes disease affecting the bone. C178613 Neoplastic Process Bone Rosai-Dorfman-Destombes Disease CL1648305 Undetermined Bone Rosai-Dorfman Disease Bone Rosai-Dorfman-Destombes Disease Bone Sinus Histiocytosis with Massive Lymphadenopathy Bone Rosai-Dorfman-Destombes Disease An MRI scan that images the entire body in one continuous session. C178628 Diagnostic Procedure Whole Body Magnetic Resonance Imaging Whole Body Magnetic Resonance Imaging C1142375 CTRP WB-MRI WBMRI Whole Body MRI Whole Body Magnetic Resonance Imaging Whole Body Magnetic Resonance Imaging The reemergence of fallopian tube mucinous adenocarcinoma after a period of remission. C178668 Neoplastic Process Recurrent Fallopian Tube Mucinous Adenocarcinoma Recurrent Fallopian Tube Mucinous Adenocarcinoma CL1648280 CTRP Malignant Recurrent Fallopian Tube Mucinous Adenocarcinoma Recurrent Fallopian Tube Mucinous Adenocarcinoma The reemergence of ovarian seromucinous carcinoma after a period of remission. C178669 Neoplastic Process Recurrent Ovarian Seromucinous Carcinoma Recurrent Ovarian Seromucinous Carcinoma CL1648281 CTRP Malignant Recurrent Ovarian Seromucinous Carcinoma Recurrent Ovarian Seromucinous Carcinoma Fallopian tube mucinous adenocarcinoma that is resistant to treatment. C178670 Neoplastic Process Refractory Fallopian Tube Mucinous Adenocarcinoma Refractory Fallopian Tube Mucinous Adenocarcinoma CL1648282 CTRP Malignant Refractory Fallopian Tube Mucinous Adenocarcinoma Refractory Fallopian Tube Mucinous Adenocarcinoma Ovarian seromucinous carcinoma that is resistant to treatment. C178671 Neoplastic Process Refractory Ovarian Seromucinous Carcinoma Refractory Ovarian Seromucinous Carcinoma CL1648283 CTRP Malignant Refractory Ovarian Seromucinous Carcinoma Refractory Ovarian Seromucinous Carcinoma Fallopian tube clear cell adenocarcinoma that is resistant to treatment. C178672 Neoplastic Process Refractory Fallopian Tube Clear Cell Adenocarcinoma Refractory Fallopian Tube Clear Cell Adenocarcinoma CL1648284 CTRP Malignant Refractory Fallopian Tube Clear Cell Adenocarcinoma Refractory Fallopian Tube Clear Cell Adenocarcinoma Fallopian tube endometrioid adenocarcinoma that is resistant to treatment. C178673 Neoplastic Process Refractory Fallopian Tube Endometrioid Adenocarcinoma Refractory Fallopian Tube Endometrioid Adenocarcinoma CL1648353 CTRP Malignant Refractory Fallopian Tube Endometrioid Adenocarcinoma Refractory Fallopian Tube Endometrioid Adenocarcinoma Fallopian tube transitional cell carcinoma that is resistant to treatment. C178674 Neoplastic Process Refractory Fallopian Tube Transitional Cell Carcinoma Refractory Fallopian Tube Transitional Cell Carcinoma CL1648354 CTRP Malignant Refractory Fallopian Tube Transitional Cell Carcinoma Refractory Fallopian Tube Transitional Cell Carcinoma Fallopian tube undifferentiated carcinoma that is resistant to treatment. C178675 Neoplastic Process Refractory Fallopian Tube Undifferentiated Carcinoma Refractory Fallopian Tube Undifferentiated Carcinoma CL1648355 CTRP Malignant Refractory Fallopian Tube Undifferentiated Carcinoma Refractory Fallopian Tube Undifferentiated Carcinoma Fallopian tube high-grade serous adenocarcinoma that is resistant to treatment. C178676 Neoplastic Process Refractory Fallopian Tube Serous Adenocarcinoma Refractory High Grade Fallopian Tube Serous Adenocarcinoma Refractory Fallopian Tube High Grade Serous Adenocarcinoma CL1648356 CTRP Malignant Refractory Fallopian Tube High Grade Serous Adenocarcinoma Refractory Fallopian Tube High-Grade Serous Adenocarcinoma Refractory Fallopian Tube Serous Adenocarcinoma Refractory High Grade Fallopian Tube Serous Adenocarcinoma Refractory Fallopian Tube High Grade Serous Adenocarcinoma Ovarian high-grade serous adenocarcinoma that is resistant to treatment. C178677 Neoplastic Process Refractory High Grade Ovarian Serous Adenocarcinoma Refractory Ovarian High Grade Serous Adenocarcinoma CL1648357 CTRP Malignant Refractory High Grade Ovarian Serous Adenocarcinoma Refractory Ovarian High Grade Serous Adenocarcinoma Refractory Ovarian High-Grade Serous Adenocarcinoma Refractory Ovarian High Grade Serous Adenocarcinoma Ovarian low-grade serous adenocarcinoma that is resistant to treatment. C178679 Neoplastic Process Refractory Low Grade Ovarian Serous Adenocarcinoma Refractory Ovarian Low Grade Serous Adenocarcinoma CL1648359 CTRP Malignant Refractory Low Grade Ovarian Serous Adenocarcinoma Refractory Ovarian Low Grade Serous Adenocarcinoma Refractory Ovarian-Low Grade Serous Adenocarcinoma Refractory Ovarian Low Grade Serous Adenocarcinoma Ovarian clear cell adenocarcinoma that is resistant to treatment. C178680 Neoplastic Process Refractory Ovarian Clear Cell Adenocarcinoma Refractory Ovarian Clear Cell Adenocarcinoma CL1648360 CTRP Malignant Refractory Ovarian Clear Cell Adenocarcinoma Refractory Ovarian Clear Cell Adenocarcinoma Ovarian mucinous adenocarcinoma that is resistant to treatment. C178681 Neoplastic Process Refractory Ovarian Mucinous Adenocarcinoma Refractory Ovarian Mucinous Adenocarcinoma CL1648361 CTRP Malignant Refractory Ovarian Mucinous Adenocarcinoma Refractory Ovarian Mucinous Adenocarcinoma Ovarian transitional cell carcinoma that is resistant to treatment. C178682 Neoplastic Process Refractory Ovarian Transitional Cell Carcinoma Refractory Ovarian Transitional Cell Carcinoma CL1648362 CTRP Malignant Refractory Ovarian Transitional Cell Carcinoma Refractory Ovarian Transitional Cell Carcinoma Ovarian undifferentiated carcinoma that is resistant to treatment. C178683 Neoplastic Process Refractory Ovarian Undifferentiated Carcinoma Refractory Ovarian Undifferentiated Carcinoma CL1648363 CTRP Malignant Refractory Ovarian Undifferentiated Carcinoma Refractory Ovarian Undifferentiated Carcinoma Primary peritoneal clear cell adenocarcinoma that is resistant to treatment. C178684 Neoplastic Process Refractory Primary Peritoneal Clear Cell Adenocarcinoma Refractory Primary Peritoneal Clear Cell Adenocarcinoma CL1648364 CTRP Malignant Refractory Primary Peritoneal Clear Cell Adenocarcinoma Refractory Primary Peritoneal Clear Cell Adenocarcinoma Primary peritoneal endometrioid adenocarcinoma that is resistant to treatment. C178685 Neoplastic Process Refractory Primary Peritoneal Endometrioid Adenocarcinoma Refractory Primary Peritoneal Endometrioid Adenocarcinoma CL1648365 CTRP Malignant Refractory Primary Peritoneal Endometrioid Adenocarcinoma Refractory Primary Peritoneal Endometrioid Adenocarcinoma Primary peritoneal high grade serous adenocarcinoma that is resistant to treatment. C178686 Neoplastic Process Refractory Primary Peritoneal High Grade Serous Adenocarcinoma Refractory Primary Peritoneal High Grade Serous Adenocarcinoma CL1648366 CTRP Malignant Refractory Primary Peritoneal High Grade Serous Adenocarcinoma Refractory Primary Peritoneal High Grade Serous Adenocarcinoma Primary peritoneal low grade serous adenocarcinoma that is resistant to treatment. C178687 Neoplastic Process Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma CL1648367 CTRP Malignant Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma Primary peritoneal transitional cell carcinoma that is resistant to treatment. C178688 Neoplastic Process Refractory Primary Peritoneal Transitional Cell Carcinoma Refractory Primary Peritoneal Transitional Cell Carcinoma CL1648368 CTRP Malignant Refractory Primary Peritoneal Transitional Cell Carcinoma Refractory Primary Peritoneal Transitional Cell Carcinoma Primary peritoneal undifferentiated carcinoma that is resistant to treatment. C178689 Neoplastic Process Refractory Primary Peritoneal Undifferentiated Carcinoma Refractory Primary Peritoneal Undifferentiated Carcinoma CL1648343 CTRP Malignant Refractory Primary Peritoneal Undifferentiated Carcinoma Refractory Primary Peritoneal Undifferentiated Carcinoma A malignant female reproductive system neoplasm that progresses during platinum therapy or within one month of completing platinum therapy. C178697 Neoplastic Process Platinum-Refractory Malignant Female Reproductive System Neoplasm CL1648347 Malignant Platinum-Refractory Malignant Female Reproductive System Neoplasm Platinum-Refractory Malignant Female Reproductive System Neoplasm Fallopian tube carcinoma that progresses during platinum therapy or within one month of completing platinum therapy. C178698 Neoplastic Process Platinum-Refractory Fallopian Tube Carcinoma CL1648348 Malignant Platinum-Refractory Fallopian Tube Carcinoma Platinum-Refractory Fallopian Tube Carcinoma Ovarian carcinoma that progresses during platinum therapy or within one month of completing platinum therapy. C178700 Neoplastic Process Platinum-Refractory Ovarian Carcinoma Platinum-Refractory Ovarian Carcinoma CL1648349 CTRP Malignant Platinum-Refractory Ovarian Carcinoma Platinum-Refractory Ovarian Carcinoma Primary peritoneal carcinoma that progresses during platinum therapy or within one month of completing platinum therapy. C178702 Neoplastic Process Platinum-Refractory Primary Peritoneal Carcinoma CL1648351 Malignant Platinum-Refractory Primary Peritoneal Carcinoma Platinum-Refractory Primary Peritoneal Carcinoma An application of diffusion weighted imaging where the measured signal is attenuated by random molecular motion of water molecules. C179061 Diagnostic Procedure Diffusion Weighted MRI with Background Subtraction CL1648529 DWIBS Diffusion Weighted Imaging with Background Subtraction Diffusion Weighted Imaging with Background Suppression Diffusion Weighted MRI with Background Subtraction Diffusion weighted with background subtraction (DWIBS) MRI Diffusion Weighted MRI with Background Subtraction Multiphasic magnetic resonance imaging performed prior to and after contrast administration. C179062 Diagnostic Procedure Multiphasic Contrast-enhanced MRI CL1648530 MCE-MRI Multiphase Contrast-enhanced MRI Multiphasic Contrast-enhanced MRI Multiphasic Contrast-enhanced MRI Multiphasic magnetic resonance imaging performed without contrast administration. C179063 Diagnostic Procedure Multiphasic Unenhanced MRI CL1648531 Multiphase Unenhanced MRI Multiphasic Unenhanced MRI Multiphasic Unenhanced MRI A magnetic resonance (MR) imaging technique used to enhance the capability of detecting anomalies by administering intravenous contrast then allowing for a delay of several minutes before imaging in order to maximize the contrast difference between normal and affected tissue. Imaging too early after contrast administration may lead to overestimation of affected tissue due to insufficient washout of contrast whereas imaging too late may lead to excessive washout and poor signal-to-noise ratio. C179064 Diagnostic Procedure Delayed-phase Contrast Enhancement Magnetic Resonance Imaging CL1648532 Delayed Phase Contrast Enhancement Magnetic Resonance Imaging Delayed-phase Contrast Enhancement Magnetic Resonance Imaging Late Phase Contrast Injection Late Phase Contrast Injection Magnetic Resonance Imaging Delayed-phase Contrast Enhancement Magnetic Resonance Imaging Head and neck carcinoma that is resistant to platinum therapy. C179151 Neoplastic Process Platinum-Resistant Head and Neck Carcinoma Platinum-Resistant Head and Neck Carcinoma CL1648468 CTRP Malignant Platinum-Resistant Head and Neck Carcinoma Platinum-Resistant Head and Neck Carcinoma Magnetic resonance imaging that captures lesion enhancement data during combinations of non-contrast or pre-contrast, arterial, venous, and delayed imaging sequential time ranges. C179164 Diagnostic Procedure Multiphasic Magnetic Resonance Imaging CL1648459 Multiphase MRI Multiphase Magnetic Resonance Imaging Multiphasic MRI Multiphasic Magnetic Resonance Imaging Multiphasic Magnetic Resonance Imaging MR imaging post-injection of a contrast agent when full enhancement of hepatic arteries is present, but antegrade enhancement of hepatic veins is absent. C179165 Diagnostic Procedure Arterial-phase Contrast Enhancement Magnetic Resonance Imaging CL382208 Arterial Phase Arterial Phase Contrast Enhancement Magnetic Resonance Imaging Arterial-phase Contrast Enhancement Magnetic Resonance Imaging Arterial-phase Contrast Enhancement Magnetic Resonance Imaging MR imaging post-injection of a contrast agent when antegrade enhancement of hepatic veins is present. C179166 Diagnostic Procedure Venous-phase Contrast Enhancement Magnetic Resonance Imaging CL1648587 Venous Phase Venous Phase Contrast Enhancement Magnetic Resonance Imaging Venous-phase Contrast Enhancement Magnetic Resonance Imaging Venous-phase Contrast Enhancement Magnetic Resonance Imaging The reemergence of appendix adenocarcinoma after a period of remission. C179174 Neoplastic Process Recurrent Appendix Adenocarcinoma Recurrent Appendix Adenocarcinoma CL1648443 CTRP Malignant Recurrent Appendix Adenocarcinoma Recurrent Appendix Adenocarcinoma Appendix carcinoma that is resistant to treatment. C179177 Neoplastic Process Refractory Appendix Carcinoma CL1648446 Malignant Refractory Appendix Carcinoma Refractory Appendix Carcinoma Appendix adenocarcinoma that is resistant to treatment. C179178 Neoplastic Process Refractory Appendix Adenocarcinoma Refractory Appendix Adenocarcinoma CL1648447 CTRP Malignant Refractory Appendix Adenocarcinoma Refractory Appendix Adenocarcinoma The reemergence of pseudomyxoma peritonei after a period of remission. C179179 Neoplastic Process Recurrent Pseudomyxoma Peritonei Recurrent Pseudomyxoma Peritonei CL1648448 CTRP Malignant Recurrent Mucinous Carcinoma Peritonei Recurrent Pseudomyxoma Peritonei Recurrent Pseudomyxoma Peritonei Pseudomyxoma peritonei that is resistant to treatment. C179180 Neoplastic Process Refractory Pseudomyxoma Peritonei Refractory Pseudomyxoma Peritonei CL1648449 CTRP Malignant Refractory Mucinous Carcinoma Peritonei Refractory Pseudomyxoma Peritonei Refractory Pseudomyxoma Peritonei A malignant digestive system neoplasm that has spread to nearby tissues or lymph nodes. C179181 Neoplastic Process Locally Advanced Malignant Digestive System Neoplasm Locally Advanced Malignant Digestive System Neoplasm CL1648450 CTRP Malignant Locally Advanced Malignant Digestive System Neoplasm Locally Advanced Malignant Digestive System Neoplasm The reemergence of uterine corpus leiomyosarcoma after a period of remission, at or adjacent to the site of the original tumor. C179182 Neoplastic Process Locally Recurrent Uterine Corpus Leiomyosarcoma Locally Recurrent Uterine Corpus Leiomyosarcoma CL1648451 CTRP Malignant Locally Recurrent Uterine Corpus Leiomyosarcoma Locally Recurrent Uterine Corpus Leiomyosarcoma The reemergence of primary myelofibrosis after a period of remission. C179203 Neoplastic Process Recurrent Primary Myelofibrosis Recurrent Primary Myelofibrosis CL1662074 CTRP Malignant Recurrent Primary Myelofibrosis Recurrent Primary Myelofibrosis The reemergence of acute bilineal leukemia after a period of remission. C179204 Neoplastic Process Recurrent Acute Bilineal Leukemia Recurrent Acute Bilineal Leukemia CL1662070 CTRP Malignant Recurrent Acute Bilineal Leukemia Recurrent Acute Bilineal Leukemia Acute bilineal leukemia that is resistant to treatment. C179205 Neoplastic Process Refractory Acute Bilineal Leukemia Refractory Acute Bilineal Leukemia CL1662069 CTRP Malignant Refractory Acute Bilineal Leukemia Refractory Acute Bilineal Leukemia A melanoma that has spread to the brain from its original site of growth, through the hematogenous route. C179206 Neoplastic Process Melanoma Metastatic in the Brain Metastatic Melanoma in the Brain CL1662072 CTRP Malignant Melanoma Metastatic in the Brain Metastatic Melanoma in the Brain Metastatic Melanoma in the Brain Ovarian squamous cell carcinoma that is resistant to treatment. C179207 Neoplastic Process Refractory Ovarian Squamous Cell Carcinoma Refractory Ovarian Squamous Cell Carcinoma CL1662071 CTRP Malignant Refractory Ovarian Squamous Cell Carcinoma Refractory Ovarian Squamous Cell Carcinoma An extremely rare adenocarcinoma that arises from the ovary. It is characterized by the presence of signet ring malignant epithelial cells. C179208 Neoplastic Process Ovarian Signet Ring Cell Carcinoma Ovarian Signet Ring Cell Carcinoma CL1662079 CTRP Malignant Ovarian Signet Ring Cell Carcinoma Ovarian Signet-Ring Cell Carcinoma Primary Ovarian Signet Ring Cell Carcinoma Ovarian Signet Ring Cell Carcinoma Lung adenocarcinoma that is resistant to treatment. C179209 Neoplastic Process Refractory Lung Adenocarcinoma Refractory Lung Adenocarcinoma CL1662078 CTRP Malignant Refractory Lung Adenocarcinoma Refractory Lung Adenocarcinoma Therapy designed to downregulate androgens by targeting of the androgen receptor and its signaling pathway. C179216 Therapeutic or Preventive Procedure Androgen Receptor-directed Therapy Androgen Receptor-directed Therapy CL1662059 CTRP ARDT Androgen Receptor Targeted Therapy Androgen Receptor-directed Therapy Androgen Receptor-directed Therapy A rare, low-grade malignant stromal tumor that arises from the breast. It is characterized by the proliferation of atypical stromal spindle cells that surround benign tubules and ducts in a pericanalicular pattern. Mitotic activity is present. The tumor has a multinodular and infiltrative growth pattern and lacks the leaf-like architecture of phyllodes tumor. Wide excision with negative margins is the treatment of choice. C179218 Neoplastic Process Breast Periductal Stromal Tumor CL1662060 Malignant Breast Periductal Stromal Tumor PDST Periductal Stromal Tumor Breast Periductal Stromal Tumor The reemergence of pilocytic astrocytoma after a period of remission. C179220 Neoplastic Process Recurrent Pilocytic Astrocytoma Recurrent Pilocytic Astrocytoma CL1662055 CTRP Undetermined Recurrent Pilocytic Astrocytoma Recurrent Pilocytic Astrocytoma The reemergence of gliomatosis cerebri after a period of remission. C179221 Neoplastic Process Recurrent Gliomatosis Cerebri Recurrent Gliomatosis Cerebri CL1662054 CTRP Malignant Recurrent Gliomatosis Cerebri Recurrent Gliomatosis Cerebri The reemergence of diffuse midline glioma, H3 K27M mutant, after a period of remission. C179222 Neoplastic Process Recurrent Diffuse Midline Glioma, H3 K27M-Mutant Recurrent Diffuse Midline Glioma, H3 K27M-Mutant CL1662057 CTRP Malignant Recurrent Diffuse Midline Glioma, H3 K27M-Mutant Recurrent Diffuse Midline Glioma, H3 K27M-Mutant The reemergence of anaplastic (malignant) meningioma after a period of remission. C179223 Neoplastic Process Recurrent Anaplastic (Malignant) Meningioma Recurrent Anaplastic (Malignant) Meningioma CL1662056 CTRP Malignant Recurrent Anaplastic (Malignant) Meningioma Recurrent Anaplastic (Malignant) Meningioma The reemergence of atypical meningioma after a period of remission. C179224 Neoplastic Process Recurrent Atypical Meningioma Recurrent Atypical Meningioma CL1662066 CTRP Undetermined Recurrent Atypical Meningioma Recurrent Atypical Meningioma The reemergence of a malignant choroid plexus neoplasm after a period of remission. C179226 Neoplastic Process Recurrent Malignant Choroid Plexus Neoplasm Recurrent Malignant Choroid Plexus Neoplasm CL1662068 CTRP Malignant Recurrent Malignant Choroid Plexus Neoplasm Recurrent Malignant Choroid Plexus Neoplasm The reemergence of pineal parenchymal cell neoplasm after a period of remission. C179227 Neoplastic Process Recurrent Pineal Parenchymal Cell Neoplasm Recurrent Pineal Parenchymal Cell Neoplasm CL1662067 CTRP Undetermined Recurrent Pineal Parenchymal Cell Neoplasm Recurrent Pineal Parenchymal Cell Neoplasm A rare, low-grade glioneuronal neoplasm characterized by a dinucleotide mutation at codon 385 of the PDGFR gene. It usually occurs in the septum pellucidum. It has also been described in the corpus callosum and periventricular white matter of the lateral ventricle. It has histologic features reminiscent of either dysembryoplastic neuroepithelial tumor or rosette-forming glioneuronal tumor. It is composed of oligodendrocyte-like cells in a prominent myxoid stroma. C179229 Neoplastic Process Myxoid Glioneuronal Tumor, PDGFRA p.K385-Mutant Myxoid Glioneuronal Tumor CL1662061 CTRP Undetermined Myxoid Glioneuronal Tumor Myxoid Glioneuronal Tumor, PDGFRA p.K385-Mutant Myxoid Glioneuronal Tumor A myxoid glioneuronal tumor that arises from the septum pellucidum. C179230 Neoplastic Process Myxoid Glioneuronal Tumor of the Septum Pellucidum CL1662064 Undetermined Myxoid Glioneuronal Tumor of the Septum Pellucidum Myxoid Glioneuronal Tumor, PDGFRA p.K385-Mutant of the Septum Pellucidum Myxoid Glioneuronal Tumor of the Septum Pellucidum A rare, low grade ovarian epithelial neoplasm characterized by the presence of glandular or cystic spaces which contain atypical glandular epithelial cells resembling endometrial cells. C179251 Neoplastic Process Borderline Ovarian Endometrioid Tumor CL1661924 Uncertain Malignant Potential Borderline Ovarian Endometrioid Tumor Borderline Ovarian Endometrioid Tumor A low grade ovarian epithelial neoplasm characterized by the presence of atypical neoplastic serous and mucinous cells. C179259 Neoplastic Process Borderline Ovarian Seromucinous Tumor CL1661931 Uncertain Malignant Potential Borderline Ovarian Seromucinous Tumor Borderline Ovarian Seromucinous Tumor MR imaging done at the time that a contrast agent would enhance hepatic arteries, but antegrade enhancement of hepatic veins would be absent. C179303 Diagnostic Procedure Arterial-phase Magnetic Resonance Imaging CL1661876 Arterial Phase Arterial Phase MRI Arterial Phase Magnetic Resonance Imaging Arterial-phase MRI Arterial-phase Magnetic Resonance Imaging Arterial-phase Magnetic Resonance Imaging MR imaging done at a time that a contrast agent would provide antegrade enhancement of hepatic veins. C179304 Diagnostic Procedure Venous-phase Magnetic Resonance Imaging CL1663171 Venous Phase Venous Phase MRI Venous Phase Magnetic Resonance Imaging Venous-phase MRI Venous-phase Magnetic Resonance Imaging Venous-phase Magnetic Resonance Imaging MR imaging done several minutes after the time that a contrast agent would normally be administered. C179306 Diagnostic Procedure Delayed-phase Magnetic Resonance Imaging CL1663170 Delayed-phase MRI Delayed-phase Magnetic Resonance Imaging Late Phase MRI Late Phase Magnetic Resonance Imaging Late-phase Late-phase MRI Late-phase Magnetic Resonance Imaging Delayed-phase Magnetic Resonance Imaging An exceedingly rare adenocarcinoma that arises from the uterine corpus and ovary and displays mesonephric differentiation. Some tumors are thought to derive from mesonephric duct (Wolffian duct) remnants. Others may have a Mullerian duct lineage. C179320 Neoplastic Process Mesonephric-Like Adenocarcinoma CL1661990 Malignant MLA Mesonephric-Like Adenocarcinoma Mesonephric-Like Adenocarcinoma An exceedingly rare adenocarcinoma that arises from the ovary and displays mesonephric differentiation. Some tumors are thought to derive from mesonephric duct (Wolffian duct) remnants. Others may have a Mullerian duct lineage. C179321 Neoplastic Process Ovarian Mesonephric-Like Adenocarcinoma CL1661989 Malignant Ovarian MLA Ovarian Mesonephric-Like Adenocarcinoma Ovarian Mesonephric-Like Adenocarcinoma An exceedingly rare adenocarcinoma that arises from the endometrium and displays mesonephric differentiation. Some tumors are thought to derive from mesonephric duct (Wolffian duct) remnants. Others may have a Mullerian duct lineage. C179322 Neoplastic Process Endometrial Mesonephric-Like Adenocarcinoma CL1661992 Malignant Endometrial MLA Endometrial Mesonephric-Like Adenocarcinoma Uterine Corpus MLA Uterine Corpus Mesonephric-Like Adenocarcinoma Endometrial Mesonephric-Like Adenocarcinoma An imaging technique that combines positron emission tomography with computed tomography to detect 68Ga-PSMA-11 bound to cancer cells and locate cancer lesions. C179332 Diagnostic Procedure PSMA PET-CT Scan PSMA PET-CT Scan CL1661965 CTRP OORO PET-CT (PSMA) PSMA PET-CT PSMA PET-CT Scan Prostate-specific Membrane Antigen PET-CT PSMA PET-CT Scan A positron emission tomography imaging technique that uses the PET-sensitive drug, 68Ga-PSMA-11, to bind to cancer cells and locate cancer lesions. C179333 Diagnostic Procedure PSMA PET Scan CL1661964 OORO PSMA PET PSMA PET Scan PSMA-Positron emission tomography Prostate-specific Membrane Antigen PET PSMA PET Scan An aggressive carcinoma arising from the ovary. Most patients present with advanced disease. Microscopically, it is characterized by the presence of an undifferentiated carcinomatous component and a second component of either endometrioid carcinoma or, rarely, serous carcinoma. C179334 Neoplastic Process Ovarian Dedifferentiated Carcinoma CL1661966 Malignant Ovarian Dedifferentiated Carcinoma Ovarian Dedifferentiated Carcinoma An adenocarcinoma that arises from the ovary and is characterized by the presence of two or more adenocarcinoma components, most often endometrioid and clear cell. C179339 Neoplastic Process Ovarian Mixed Cell Adenocarcinoma CL1661976 Malignant Ovarian Mixed Carcinoma Ovarian Mixed Cell Adenocarcinoma Ovarian Mixed Cell Adenocarcinoma A benign, intermediate, or malignant neoplasm that arises from the ovary and is composed of neoplastic cells with smooth muscle differentiation. C179359 Neoplastic Process Ovarian Smooth Muscle Neoplasm CL1661958 Undetermined Ovarian Smooth Muscle Neoplasm Ovarian Smooth Muscle Tumor Ovarian Smooth Muscle Neoplasm A benign smooth muscle neoplasm arising from the ovary. It is usually characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. Variants with increased cellularity, increased mitotic activity, myxoid changes, or epithelioid morphology have also been reported. C179360 Neoplastic Process Ovarian Leiomyoma CL1661938 Benign Ovarian Leiomyoma Ovarian Leiomyoma A smooth muscle neoplasm that arises from the ovary and cannot be reliably diagnosed as benign or malignant because of the presence of ambiguous morphologic findings. C179362 Neoplastic Process Ovarian Smooth Muscle Tumor of Uncertain Malignant Potential CL1661940 Uncertain Malignant Potential Ovarian STUMP Ovarian Smooth Muscle Neoplasm of Uncertain Malignant Potential Ovarian Smooth Muscle Tumor of Uncertain Malignant Potential Ovarian Smooth Muscle Tumor of Uncertain Malignant Potential An exceedingly rare, high-grade variant of conventional osteosarcoma characterized by the presence of numerous osteoclast-like giant cells and variable amount of tumor osteoid. C179410 Neoplastic Process Giant Cell-Rich Osteosarcoma CL1662218 PCDC Malignant GCRO Giant Cell Rich Osteosarcoma Giant Cell-Rich Osteosarcoma Giant Cell-Rich Osteosarcoma Digestive system neuroendocrine tumor G2 that has spread from its original site of growth to another anatomic site. C179415 Neoplastic Process Metastatic Digestive System Neuroendocrine Tumor G2 Metastatic Digestive System Neuroendocrine Tumor G2 CL1662213 CTRP Malignant Metastatic Digestive System Neuroendocrine Tumor G2 Metastatic Digestive System Neuroendocrine Tumor G2 Digestive system neuroendocrine tumor G1 that has spread extensively to other anatomic sites or is no longer responding to treatment. C179418 Neoplastic Process Advanced Digestive System Neuroendocrine Tumor G1 Advanced Digestive System Neuroendocrine Tumor G1 CL1662226 CTRP Malignant Advanced Digestive System NET G1 Advanced Digestive System Neuroendocrine Tumor G1 Advanced Digestive System Neuroendocrine Tumor G1 Digestive system neuroendocrine tumor G1 that is not amenable to surgical resection. C179419 Neoplastic Process Unresectable Digestive System Neuroendocrine Tumor G1 Unresectable Digestive System Neuroendocrine Tumor G1 CL1662225 CTRP Malignant Unresectable Digestive System Carcinoid Tumor Unresectable Digestive System Neuroendocrine Tumor G1 Unresectable Digestive System Neuroendocrine Tumor G1 A malignant thoracic neoplasm that is not amenable to surgical resection. C179420 Neoplastic Process Unresectable Malignant Thoracic Neoplasm Unresectable Malignant Thoracic Neoplasm CL1662220 CTRP Malignant Unresectable Malignant Thoracic Neoplasm Unresectable Malignant Thoracic Neoplasm Plexiform neurofibroma that is not amenable to surgical resection. C179423 Neoplastic Process Unresectable Plexiform Neurofibroma Unresectable Plexiform Neurofibroma CL1662221 CTRP Benign Unresectable Plexiform Neurofibroma Unresectable Plexiform Neurofibroma Acral lentiginous melanoma that has spread from its original site of growth to another anatomic site. C179427 Neoplastic Process Metastatic Acral Lentiginous Melanoma Metastatic Acral Lentiginous Melanoma CL1662201 CTRP Malignant Metastatic Acral Lentiginous Melanoma Metastatic Acral Lentiginous Melanoma B-acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 that is resistant to treatment. C179429 Neoplastic Process Refractory B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 Refractory B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 CL1662197 CTRP Malignant Refractory B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 Refractory B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR::ABL1 Refractory B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 The use of estrogen in postmenopausal women or to women who have had their ovaries surgically removed. C179434 Therapeutic or Preventive Procedure Estrogen Only Hormone Replacement Therapy CL1662210 GDC Estrogen only Estrogen Only Hormone Replacement Therapy Estrogen only Estrogen Only Hormone Replacement Therapy A combination of estrogen and progesterone given to postmenopausal women or to women who have had their ovaries surgically removed. C179452 Therapeutic or Preventive Procedure Estrogen/Progesterone Hormone Replacement Therapy CL1662310 GDC Progesterone and Estrogen Estrogen/Progesterone Hormone Replacement Therapy Progesterone and Estrogen Estrogen/Progesterone Hormone Replacement Therapy Progesterone given to postmenopausal women or to women who have had their ovaries surgically removed. C179453 Therapeutic or Preventive Procedure Progesterone Only Hormone Replacement Therapy CL1662305 GDC Progesterone only Progesterone Only Hormone Replacement Therapy Progesterone only Progesterone Only Hormone Replacement Therapy Platinum-resistant ovarian carcinoma that is not amenable to surgical resection. C179459 Neoplastic Process Unresectable Platinum-Resistant Ovarian Carcinoma Unresectable Platinum-Resistant Ovarian Carcinoma CL1662288 CTRP Malignant Unresectable Platinum-Resistant Ovarian Carcinoma Unresectable Platinum-Resistant Ovarian Carcinoma A platinum-resistant ovarian carcinoma that has spread from its original site of growth to another anatomic site. C179460 Neoplastic Process Metastatic Platinum-Resistant Ovarian Carcinoma Metastatic Platinum-Resistant Ovarian Carcinoma CL1662287 CTRP Malignant Metastatic Platinum-Resistant Ovarian Carcinoma Metastatic Platinum-Resistant Ovarian Carcinoma Castration-resistant prostate carcinoma that is not amenable to surgical resection. C179461 Neoplastic Process Unresectable Castration-Resistant Prostate Carcinoma Unresectable Castration-Resistant Prostate Carcinoma CL1662282 CTRP Malignant Unresectable Castration-Resistant Prostate Carcinoma Unresectable Castration-Resistant Prostate Carcinoma Peritoneal malignant mesothelioma that has spread from its original site of growth to another anatomic site. C179462 Neoplastic Process Metastatic Peritoneal Malignant Mesothelioma Metastatic Peritoneal Malignant Mesothelioma CL1662281 CTRP Malignant Metastatic Peritoneal Malignant Mesothelioma Metastatic Peritoneal Malignant Mesothelioma The reemergence of a malignant retroperitoneal neoplasm after a period of remission. C179463 Neoplastic Process Recurrent Malignant Retroperitoneal Neoplasm Recurrent Malignant Retroperitoneal Neoplasm CL1662284 CTRP Malignant Recurrent Malignant Retroperitoneal Neoplasm Recurrent Malignant Retroperitoneal Neoplasm The reemergence of a malignant scrotal neoplasm after a period of remission. C179464 Neoplastic Process Recurrent Malignant Scrotal Neoplasm Recurrent Malignant Scrotal Neoplasm CL1662283 CTRP Malignant Recurrent Malignant Scrotal Neoplasm Recurrent Malignant Scrotal Neoplasm The reemergence of a malignant spermatic cord neoplasm after a period of remission. C179466 Neoplastic Process Recurrent Malignant Spermatic Cord Neoplasm Recurrent Malignant Spermatic Cord Neoplasm CL1662293 CTRP Malignant Recurrent Malignant Spermatic Cord Neoplasm Recurrent Malignant Spermatic Cord Neoplasm A rare ovarian malignant tumor with neuroectodermal differentiation. It is characterized either by a small round cell proliferation or by neuronal or glial differentiation. C179474 Neoplastic Process Ovarian Neuroectodermal-Type Tumor CL1662269 Malignant Ovarian Neuroectodermal-Type Tumor Ovarian Neuroectodermal-Type Tumor An ovarian mixed germ cell-sex cord-stromal tumor in which the neoplastic cellular infiltrate does not have the distinctive appearance of a gonadoblastoma. C179475 Neoplastic Process Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified CL1662272 Undetermined Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified Breast carcinoma that has metastasized to a limited number of sites. C179515 Neoplastic Process Oligometastatic Breast Carcinoma Oligometastatic Breast Carcinoma CL1662127 CTRP Malignant Oligometastatic Breast Carcinoma Oligometastatic Breast Carcinoma An ultrasound imaging technique that uses enhanced vessel detection sensitivity to evaluate the structure and function of microvasculature. C179541 Health Care Activity Ultrasound Microvessel Imaging Ultrasound Microvessel Imaging CL1662119 CTRP 3D Ultrasound Microvessel Imaging UMI Ultrasound Microvessel Imaging Ultrasound Microvessel Imaging An epithelial neoplasm of Wolffian (mesonephric) origin arising from the broad ligament. Most tumors behave in a benign fashion. C179547 Neoplastic Process Broad Ligament Wolffian Tumor CL1662101 Undetermined Broad Ligament Wolffian Tumor Broad Ligament Wolffian Tumor An epithelial neoplasm of Wolffian (mesonephric) origin arising from the ovarian hilum. Most tumors behave in a benign fashion. C179548 Neoplastic Process Ovarian Wolffian Tumor CL1662100 Undetermined Ovarian Wolffian Tumor Wolffian Tumor of the Ovary Ovarian Wolffian Tumor A breast adenocarcinoma defined by low expression of HER2 (IHC1+ or IHC2+; FISH negative). C179553 Neoplastic Process HER2-Low Breast Carcinoma CL1662107 Malignant HER2 Low Breast Adenocarcinoma HER2 Low Breast Carcinoma HER2-Low Breast Adenocarcinoma HER2-Low Breast Carcinoma HER2-Low Breast Carcinoma A HER2-low breast adenocarcinoma that has spread from its original site of growth to another anatomic site. C179554 Neoplastic Process Metastatic HER2-Low Breast Carcinoma CL1662106 Malignant Metastatic HER2 Low Breast Adenocarcinoma Metastatic HER2 Low Breast Carcinoma Metastatic HER2-Low Breast Adenocarcinoma Metastatic HER2-Low Breast Carcinoma Metastatic HER2-Low Breast Carcinoma A HER2-low breast adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C179555 Neoplastic Process Advanced HER2 Low Breast Adenocarcinoma Advanced HER2-Low Breast Carcinoma CL1662109 CTRP Malignant Advanced HER2 Low Breast Adenocarcinoma Advanced HER2 Low Breast Carcinoma Advanced HER2-Low Breast Adenocarcinoma Advanced HER2-Low Breast Carcinoma Advanced HER2-Low Breast Carcinoma A benign well-circumscribed lesion arising from the mesentery. It is characterized by the presence of fibroblasts, lymphoplasmacytic infiltrates, collagenous stroma formation, psammoma bodies, and dystrophic calcifications. C179560 Neoplastic Process Peritoneal Calcifying Fibrous Tumor CL1662104 Benign Mesenteric Calcifying Fibrous Tumor Peritoneal Calcifying Fibrous Tumor Peritoneal Calcifying Fibrous Tumor A very rare sarcoma that arises from the peritoneum and is characterized by the presence of cells that resemble endometrial stromal cells. C179562 Neoplastic Process Peritoneal Low Grade Endometrioid Stromal Sarcoma CL1662085 Malignant Peritoneal Endometrioid Stromal Sarcoma Peritoneal Low Grade Endometrioid Stromal Sarcoma Peritoneal Low Grade Endometrioid Stromal Sarcoma The principle of functional MRI imaging is to take a series of images of an organ in quick succession and to statistically analyze the images for differences among them. Most commonly used in studies of brain function. C17958 Diagnostic Procedure Functional Magnetic Resonance Imaging Functional Magnetic Resonance Imaging C0376335 CDISC CTRP A noninvasive tool used to observe functioning in the brain or other organs by detecting changes in chemical composition, blood flow, or both. A type of MRI that takes a series of images of an organ in quick succession and statistically analyzes the differences between the images. Functional_Magnetic_Resonance_Imaging FUNCTIONAL MRI Functional MRI Functional Magnetic Resonance Imaging fMRI functional magnetic resonance imaging Functional Magnetic Resonance Imaging A carcinoma that has spread to the peritoneum from an adjacent or distal anatomic site. C179654 Neoplastic Process Metastatic Carcinoma in the Peritoneum CL1662425 Malignant Metastatic Carcinoma in the Peritoneum Metastatic Carcinoma in the Peritoneum A condition in which a sarcoma has spread extensively throughout the peritoneum. C179656 Neoplastic Process Peritoneal Sarcomatosis CL1662427 Malignant Peritoneal Sarcomatosis Peritoneal Sarcomatosis A sarcoma that has spread to the peritoneum from an adjacent or distal anatomic site. C179657 Neoplastic Process Metastatic Sarcoma in the Peritoneum CL1662426 Malignant Metastatic Sarcoma in the Peritoneum Metastatic Sarcoma in the Peritoneum Chromophobe renal cell carcinoma that has spread to nearby tissues or lymph nodes. C179677 Neoplastic Process Locally Advanced Chromophobe Renal Cell Carcinoma Locally Advanced Chromophobe Renal Cell Carcinoma CL1662397 CTRP Malignant Locally Advanced Chromophobe Renal Cell Carcinoma Locally Advanced Chromophobe Renal Cell Carcinoma A diffusion MRI-based imaging method capable of detecting and characterizing heterogeneous tumor composition and microvascularity simultaneously from a single clinical diffusion MRI scan. It uses a multiple diffusion compartment model to disentangle the confounding effects of anatomical complexities and neuropathologies of heterogeneous pathological components that are mixed in a single imaging voxel. It is primarily used to assess primary brain neoplasms. C179716 Diagnostic Procedure Heterogeneity Diffusion Imaging Heterogeneity Diffusion Imaging CL1662477 CTRP HDI Heterogeneity Diffusion Imaging Heterogeneity Diffusion Imaging Histologic transformation of an indolent B-cell non-Hodgkin lymphoma to an aggressive diffuse large B-cell lymphoma. C179717 Neoplastic Process Transformed Indolent Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma CL1662476 CTRP Malignant Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma Histologic transformation of a B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classic Hodgkin lymphoma to an aggressive diffuse large B-cell lymphoma. C179721 Neoplastic Process Transformed B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma Transformed B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma CL1662472 CTRP Malignant Transformed B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma Transformed B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma A non-invasive, precursor epithelial proliferation that arises from the fallopian tube, lacks severe atypia, and demonstrates serous differentiation. C179738 Neoplastic Process Serous Tubal Intraepithelial Lesion CL1662447 Precancerous STIL Serous Tubal Intraepithelial Lesion Serous Tubal Intraepithelial Lesion A benign or malignant neoplasm that affects the basal ganglia. C179882 Neoplastic Process Basal Ganglia Neoplasm Basal Ganglia Neoplasm CL1662364 CTRP Undetermined Basal Ganglia Neoplasm Basal Ganglia Neoplasm A benign or malignant neoplasm that affects the cerebellar peduncle. C179883 Neoplastic Process Cerebellar Peduncle Neoplasm Cerebellar Peduncle Neoplasm CL1662352 CTRP Undetermined Cerebellar Peduncle Neoplasm Cerebellar Peduncle Neoplasm A benign or malignant neoplasm that affects the corpus callosum. C179884 Neoplastic Process Corpus Callosum Neoplasm Corpus Callosum Neoplasm CL1662351 CTRP Undetermined Corpus Callosum Neoplasm Corpus Callosum Neoplasm A benign or malignant neoplasm that affects the optic tract. C179885 Neoplastic Process Optic Tract Neoplasm Optic Tract Neoplasm CL1662354 CTRP Undetermined Optic Tract Neoplasm Optic Tract Neoplasm A benign or malignant neoplasm that affects the optic chiasm. C179886 Neoplastic Process Optic Chiasm Neoplasm Optic Chiasm Neoplasm CL1662353 CTRP Undetermined Optic Chiasm Neoplasm Optic Chiasm Neoplasm An extremely rare, well-differentiated squamous cell carcinoma that arises from the esophagus. It is characterized by the presence of hyperkeratosis, acanthosis, dyskeratosis, keratin-filled cysts, koilocyte-like cells, intraepithelial neutrophils, and focal cytologic atypia. C179888 Neoplastic Process Esophageal Carcinoma Cuniculatum CL1662348 Malignant Esophageal Carcinoma Cuniculatum Esophageal Carcinoma Cuniculatum A variant of well-differentiated squamous cell carcinoma arising from the oral cavity. It is characterized by the presence of minimal cytological atypia, multiple keratin-filled crypts, and intraepithelial neutrophils. C179894 Neoplastic Process Oral Cavity Carcinoma Cuniculatum CL1662359 Malignant Oral Cavity Carcinoma Cuniculatum Oral Cavity Carcinoma Cuniculatum A cystadenoma that arises from the broad ligament. It is characterized by the presence of small papillary projections in the inner surface of the cysts. It may be sporadic or associated with von Hippel-Lindau disease. C179921 Neoplastic Process Broad Ligament Papillary Cystadenoma Broad Ligament Papillary Cystadenoma CL1662637 CTRP Benign Broad Ligament Papillary Cystadenoma Broad Ligament Papillary Cystadenoma A leiomyoma that arises from the broad or other uterine ligaments. C179923 Neoplastic Process Uterine Ligament Leiomyoma CL1662643 Benign Uterine Ligament Leiomyoma Uterine Ligament Leiomyoma A leiomyoma that arises from the broad ligament. C179924 Neoplastic Process Broad Ligament Leiomyoma CL1662642 Benign Broad Ligament Leiomyoma Broad Ligament Leiomyoma A benign neoplasm that arises from the broad or other uterine ligaments. It is characterized by the presence of a glandular and a mesenchymal component. C179925 Neoplastic Process Uterine Ligament Adenomyoma CL1662645 Benign Uterine Ligament Adenomyoma Uterine Ligament Adenomyoma A rare leiomyosarcoma that arises from the broad ligament. C179926 Neoplastic Process Broad Ligament Leiomyosarcoma CL1662644 Malignant Broad Ligament Leiomyosarcoma Broad Ligament Leiomyosarcoma An epithelial neoplasm of Wolffian (mesonephric) origin arising from a uterine ligament. Most tumors behave in a benign fashion. C179927 Neoplastic Process Uterine Ligament Wolffian Tumor CL1662640 Undetermined Uterine Ligament Wolffian Tumor Wolffian Tumor of the Uterine Ligament Uterine Ligament Wolffian Tumor A rare neoplasm that arises from the broad or other uterine ligaments and shows ependymal differentiation. C179928 Neoplastic Process Uterine Ligament Ependymoma CL1662639 Undetermined Uterine Ligament Ependymoma Uterine Ligament Ependymoma A rare neoplasm that arises from the broad ligament and shows ependymal differentiation. C179929 Neoplastic Process Broad Ligament Ependymoma CL1662641 Undetermined Broad Ligament Ependymoma Broad Ligament Ependymoma A benign, borderline, or malignant neoplasm that affects the broad ligament. C179931 Neoplastic Process Broad Ligament Neoplasm C1263787 Undetermined Broad Ligament Neoplasm Broad Ligament Neoplasm A gastrointestinal stromal tumor that through the process of dedifferentiation, results in an uncommon phenotype. Dedifferentiation in the context of GIST, may manifest as loss of CD117 expression and regression from specialized tissue to a more anaplastic/pleomorphic appearance, high nuclear atypia, high mitotic activity, and necrosis. C179932 Neoplastic Process Dedifferentiated Gastrointestinal Stromal Tumor CL1662626 Malignant Dedifferentiated Gastrointestinal Stromal Tumor Dedifferentiated Gastrointestinal Stromal Tumor A neoplasm that arises from the broad ligament and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C179933 Neoplastic Process Benign Broad Ligament Neoplasm C0347484 Benign Benign Broad Ligament Neoplasm Benign Broad Ligament Neoplasm A primary or metastatic malignant neoplasm that affects the broad ligament. C179934 Neoplastic Process Malignant Broad Ligament Neoplasm C0346866 mCode Malignant Malignant Broad Ligament Neoplasm Malignant neoplasm of unspecified broad ligament Malignant Broad Ligament Neoplasm A history of daily food intake. C17994 Clinical Attribute Dietary History C0425401 Dietary_History Dietary History Dietary History Acquisition or display of radiographic images using digital techniques. C18001 Diagnostic Procedure Digital Radiography C0442015 CDISC Any type of radiography that creates digitized images for analysis. Digital_X-Ray DIGITAL RADIOGRAPHY DX Digital Radiography Digital X-Ray Digital Radiography Ovarian carcinoma characterized by the absence of microsatellite instability. C180332 Neoplastic Process Microsatellite Stable Ovarian Carcinoma Microsatellite Stable Ovarian Carcinoma CL1662726 CTRP Malignant Microsatellite Stable Ovarian Carcinoma Microsatellite Stable Ovarian Carcinoma Microsatellite stable ovarian carcinoma that has spread from its original site of growth to another anatomic site. C180333 Neoplastic Process Metastatic Microsatellite Stable Ovarian Carcinoma Metastatic Microsatellite Stable Ovarian Carcinoma CL1662729 CTRP Malignant Metastatic Microsatellite Stable Ovarian Carcinoma Metastatic Microsatellite Stable Ovarian Carcinoma Microsatellite stable ovarian carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C180334 Neoplastic Process Advanced Microsatellite Stable Ovarian Carcinoma Advanced Microsatellite Stable Ovarian Carcinoma CL1662728 CTRP Malignant Advanced Microsatellite Stable Ovarian Carcinoma Advanced Microsatellite Stable Ovarian Carcinoma Endometrial carcinoma characterized by the absence of microsatellite instability. C180335 Neoplastic Process Microsatellite Stable Endometrial Carcinoma CL1662723 Malignant Microsatellite Stable Endometrial Carcinoma Microsatellite Stable Endometrial Carcinoma Microsatellite stable endometrial carcinoma that has spread from its original site of growth to another anatomic site. C180336 Neoplastic Process Metastatic Microsatellite Stable Endometrial Carcinoma Metastatic Microsatellite Stable Endometrial Carcinoma CL1662722 CTRP Malignant Metastatic Microsatellite Stable Endometrial Carcinoma Metastatic Microsatellite Stable Endometrial Carcinoma Microsatellite stable endometrial carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C180337 Neoplastic Process Advanced Microsatellite Stable Endometrial Carcinoma Advanced Microsatellite Stable Endometrial Carcinoma CL1662725 CTRP Malignant Advanced Microsatellite Stable Endometrial Carcinoma Advanced Microsatellite Stable Endometrial Carcinoma The reemergence of gangliocytoma after a period of remission. C180338 Neoplastic Process Recurrent Gangliocytoma Recurrent Gangliocytoma CL1662724 CTRP Undetermined Recurrent Gangliocytoma Recurrent Gangliocytoma Primary cutaneous T-cell non-Hodgkin lymphoma that has spread from its original site of growth to nearby tissues. C180374 Neoplastic Process Early Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Early Primary Cutaneous T-Cell Non-Hodgkin Lymphoma CL1662797 CTRP Malignant Early Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Early Primary Cutaneous T-Cell Non-Hodgkin Lymphoma A low-grade cerebral tumor associated with seizures and in many cases refractory epilepsy. It usually occurs in the second and third decades of life. It is characterized by the presence of oligodendroglioma-like components. It may also contain astrocytic components. MAPK pathway-activating genetic alterations play a role in the development of this tumor. Causative gene alterations include mutations resulting in the expression of BRAF p.V600E and gene fusions involving FGFR2 or FGFR3 genes. IDH gene mutations and 1p/19q codeletion are not present. C180378 Neoplastic Process Polymorphous Low-Grade Neuroepithelial Tumor of the Young Polymorphous Low Grade Neuroepithelial Tumor of the Young CL1662794 CTRP Undetermined Diffuse or Nonspecific Form of Dysembryoplastic Neuroepithelial Tumor Long-Term Epilepsy-Associated Tumor Massively Calcified Low Grade Glioma Massively Calcified Low-Grade Glioma PLNTY Polymorphous Low Grade Neuroepithelial Tumor of the Young Polymorphous Low-Grade Neuroepithelial Tumor of the Young Polymorphous Low Grade Neuroepithelial Tumor of the Young The use of magnetic resonance imaging to optimize stereotactic radiation therapy to specific anatomic and/or biological changes which may occur during the course of the treatment. C180379 Therapeutic or Preventive Procedure Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy CL1663143 CTRP SMART Stereotactic MR-guided Adaptive Radiation Therapy Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy The reemergence of myxoid glioneuronal tumor after a period of remission. C180397 Neoplastic Process Recurrent Myxoid Glioneuronal Tumor, PDGFRA p.K385-Mutant Recurrent Myxoid Glioneuronal Tumor CL1662763 CTRP Undetermined Recurrent Myxoid Glioneuronal Tumor Recurrent Myxoid Glioneuronal Tumor, PDGFRA p.K385-Mutant Recurrent Myxoid Glioneuronal Tumor The reemergence of multinodular and vacuolated neuronal tumor following a period of remission. C180398 Neoplastic Process Recurrent Multinodular and Vacuolated Tumor of the Cerebrum Recurrent Multinodular and Vacuolated Neuronal Tumor CL1662765 CTRP Undetermined Recurrent Multinodular and Vacuolated Neuronal Tumor Recurrent Multinodular and Vacuolated Tumor of the Cerebrum Recurrent Multinodular and Vacuolating Neuronal Tumor Recurrent Multinodular and Vacuolated Neuronal Tumor The reemergence of polymorphous low-grade neuroepithelial tumor of the young after a period of remission. C180400 Neoplastic Process Recurrent Polymorphous Low-Grade Neuroepithelial Tumor of the Youn Recurrent Polymorphous Low Grade Neuroepithelial Tumor of the Young CL1662761 CTRP Undetermined Recurrent Polymorphous Low Grade Neuroepithelial Tumor of the Young Recurrent Polymorphous Low-Grade Neuroepithelial Tumor of the Young Recurrent Polymorphous Low Grade Neuroepithelial Tumor of the Young Thyroid gland medullary carcinoma that is resistant to treatment. C180404 Neoplastic Process Refractory Thyroid Gland Medullary Carcinoma Refractory Thyroid Gland Medullary Carcinoma CL1662771 CTRP Malignant Refractory Thyroid Gland Medullary Carcinoma Refractory Thyroid Gland Medullary Carcinoma Colon carcinoma that is not amenable to surgical resection. C180406 Neoplastic Process Unresectable Colon Carcinoma Unresectable Colon Carcinoma CL1662773 CTRP Malignant Unresectable Colon Carcinoma Unresectable Colon Carcinoma A glioma that arises from the tectum mesenchephali. C180407 Neoplastic Process Tectal Glioma Tectal Glioma CL1662772 CTRP Undetermined Tectal Glioma Tectal Glioma The reemergence of tectal glioma after a period of remission. C180408 Neoplastic Process Recurrent Tectal Glioma Recurrent Tectal Glioma CL1662767 CTRP Undetermined Recurrent Tectal Glioma Recurrent Tectal Glioma Endometrial endometrioid adenocarcinoma exhibiting 50% or less solid non-glandular, non-squamous growth. C180510 Neoplastic Process Endometrial Low Grade Endometrioid Adenocarcinoma CL1663063 Malignant Endometrial Low Grade Endometrioid Adenocarcinoma Endometrial Low-Grade Endometrioid Adenocarcinoma Low Grade Endometrial Endometrioid Adenocarcinoma Low Grade Endometrial Endometrioid Carcinoma Low-Grade Endometrial Endometrioid Adenocarcinoma Low-Grade Endometrial Endometrioid Carcinoma Endometrial Low Grade Endometrioid Adenocarcinoma An endometrial endometrioid adenocarcinoma characterized by mutations in the exonuclease domain of the DNA polymerase epsilon (POLE) gene that result in an ultra-mutated tumor phenotype. C180512 Neoplastic Process POLE-Ultramutated Endometrial Endometrioid Adenocarcinoma CL1663057 Malignant POLE-Ultra-Mutated Endometrial Endometrioid Adenocarcinoma POLE-Ultra-Mutated Endometrial Endometrioid Carcinoma POLE-Ultramutated Endometrial Endometrioid Adenocarcinoma POLE-Ultramutated Endometrial Endometrioid Carcinoma POLE-Ultramutated Endometrial Endometrioid Adenocarcinoma An endometrial endometrioid adenocarcinoma characterized by mismatch repair (MMR) deficiency caused by inactivating methylation or less frequently mutation of an MMR gene (MLH1, PMS2, MSH2, or MSH6). C180514 Neoplastic Process Mismatch Repair-Deficient Endometrial Endometrioid Adenocarcinoma CL1663056 Malignant Mismatch Repair-Deficient Endometrial Endometrioid Adenocarcinoma Mismatch Repair-Deficient Endometrial Endometrioid Carcinoma Mismatch Repair-Deficient Endometrial Endometrioid Adenocarcinoma An endometrial endometrioid adenocarcinoma characterized by the presence of p53 gene mutations. C180515 Neoplastic Process p53-Mutant Endometrial Endometrioid Adenocarcinoma CL1663059 Malignant p53-Mutant Endometrial Endometrioid Adenocarcinoma p53-Mutant Endometrial Endometrioid Carcinoma p53-Mutant Endometrial Endometrioid Adenocarcinoma An endometrial endometrioid adenocarcinoma characterized by the absence of POLE gene mutations, mismatch repair (MMR) deficiency, and p53 gene mutations. C180516 Neoplastic Process No Specific Molecular Profile Endometrial Endometrioid Adenocarcinoma CL1663058 Malignant NSMP Endometrial Endometrioid Adenocarcinoma NSMP Endometrial Endometrioid Carcinoma No Specific Molecular Profile Endometrial Endometrioid Adenocarcinoma No Specific Molecular Profile Endometrial Endometrioid Carcinoma No Specific Molecular Profile Endometrial Endometrioid Adenocarcinoma Non-muscle invasive bladder urothelial carcinoma that is resistant to treatment. C180530 Neoplastic Process Refractory Non-Muscle Invasive Bladder Urothelial Carcinoma Refractory Non-Muscle Invasive Bladder Urothelial Carcinoma CL1663041 CTRP Malignant Refractory Non-Muscle Invasive Bladder Transitional Cell Carcinoma Refractory Non-Muscle Invasive Bladder Urothelial Carcinoma Refractory Superficial Bladder Transitional Cell Carcinoma Refractory Superficial Bladder Urothelial Carcinoma Refractory Non-Muscle Invasive Bladder Urothelial Carcinoma A very rare, low-grade midline brain neoplasm that affects the septum pellucidum. It is characterized by similar histological features to those found in dysembryoplastic neuroepithelial tumor, but does not display multinodularity. It usually manifests with symptoms related to increased intracranial pressure. Epilepsy has been reported in approximately one third of patients. PDGFRA gene mutations have been identified in the majority of patients. Alterations in FGFR1 and NF1 genes have also been reported. BRAF mutations which represent the most common molecular alteration found in cortical dysembryoplastic neuroepithelial tumor, were absent in this rare group of midline tumors. C180532 Neoplastic Process Dysembryoplastic Neuroepithelial-Like Tumor of the Septum Pellucidum Dysembryoplastic Neuroepithelial-Like Tumor of the Septum Pellucidum CL1663043 CTRP Undetermined DNET-Like Neoplasm of the Septum Pellucidum DNET-Like Tumor of the Septum Pellucidum Dysembryoplastic Neuroepithelial Neoplasm of the Septum Pellucidum Dysembryoplastic Neuroepithelial Tumor of the Septum Pellucidum Dysembryoplastic Neuroepithelial-Like Neoplasm of the Septum Pellucidum Dysembryoplastic Neuroepithelial-Like Tumor of the Septum Pellucidum Septal Dysembryoplastic Neuroepithelial Neoplasm Septal Dysembryoplastic Neuroepithelial Tumor sDNET Dysembryoplastic Neuroepithelial-Like Tumor of the Septum Pellucidum A rare mucinous adenocarcinoma arising from intestinal metaplasia of the endometrium. C180536 Neoplastic Process Endometrial Mucinous Adenocarcinoma, Intestinal-Type CL1663054 Malignant Endometrial Mucinous Adenocarcinoma, Intestinal-Type Endometrial Mucinous Adenocarcinoma, Intestinal-Type A rare mucinous adenocarcinoma arising from gastric metaplasia of the endometrium. C180537 Neoplastic Process Endometrial Mucinous Adenocarcinoma, Gastric-Type CL1663050 Malignant Endometrial Mucinous Adenocarcinoma, Gastric-Type Endometrial Mucinous Adenocarcinoma, Gastric-Type A smooth muscle tumor of uncertain malignant potential that arises from the uterine corpus and is composed of neoplastic spindle cells. C180540 Neoplastic Process Uterine Corpus Spindle Smooth Muscle Tumor of Uncertain Malignant Potential CL1663051 Uncertain Malignant Potential Uterine Corpus Spindle STUMP Uterine Corpus Spindle Smooth Muscle Tumor of Uncertain Malignant Potential Uterine Corpus Spindle Smooth Muscle Tumor of Uncertain Malignant Potential A smooth muscle tumor of uncertain malignant potential that arises from the uterine corpus and displays myxoid changes. C180541 Neoplastic Process Uterine Corpus Myxoid Smooth Muscle Tumor of Uncertain Malignant Potential CL1662967 Uncertain Malignant Potential Uterine Corpus Myxoid STUMP Uterine Corpus Myxoid Smooth Muscle Tumor of Uncertain Malignant Potential Uterine Corpus Myxoid Smooth Muscle Tumor of Uncertain Malignant Potential A smooth muscle tumor of uncertain malignant potential that arises from the uterine corpus and is composed of neoplastic epithelioid cells. C180542 Neoplastic Process Uterine Corpus Epithelioid Smooth Muscle Tumor of Uncertain Malignant Potential CL1662966 Uncertain Malignant Potential Uterine Corpus Epithelioid STUMP Uterine Corpus Epithelioid Smooth Muscle Tumor of Uncertain Malignant Potential Uterine Corpus Epithelioid Smooth Muscle Tumor of Uncertain Malignant Potential A rare inflammatory myofibroblastic tumor that arises from the uterine corpus. C180545 Neoplastic Process Uterine Corpus Inflammatory Myofibroblastic Tumor CL1662963 Undetermined Uterine Corpus Inflammatory Myofibroblastic Tumor Uterine Corpus Inflammatory Myofibroblastic Tumor A rare uterine corpus malignant small round cell tumor with neuroglial differentiation. The prognosis is poor. C180546 Neoplastic Process Uterine Corpus Central Primitive Neuroectodermal Tumor CL1662962 Malignant Uterine Corpus Central Primitive Neuroectodermal Tumor Uterine Corpus cPNET Uterine Corpus Central Primitive Neuroectodermal Tumor A bladder urothelial carcinoma invading into the bladder muscularis propria. C180604 Neoplastic Process Muscle Invasive Bladder Urothelial Carcinoma CL1662932 Malignant Muscle Invasive Bladder Urothelial Carcinoma Muscle Invasive Bladder Urothelial Carcinoma A bladder urothelial carcinoma that has focally invaded into the bladder muscularis propria. C180605 Neoplastic Process Localized Muscle Invasive Bladder Urothelial Carcinoma Localized Muscle Invasive Bladder Urothelial Carcinoma CL1662981 CTRP Malignant Localized Muscle Invasive Bladder Urothelial Carcinoma Localized Muscle Invasive Bladder Urothelial Carcinoma Urothelial carcinoma characterized by the presence of neoplastic epithelial cells with high grade features. C180606 Neoplastic Process High Grade Urothelial Carcinoma Urothelial Carcinoma, High Grade CL1662980 CTRP Malignant High Grade Urothelial Carcinoma High-Grade Urothelial Carcinoma Urothelial Carcinoma, High Grade Urothelial Carcinoma, High Grade Renal pelvis urothelial carcinoma characterized by the presence of neoplastic epithelial cells with high grade features. C180607 Neoplastic Process High Grade Renal Pelvis Urothelial Carcinoma Renal Pelvis Urothelial Carcinoma, High Grade CL1662983 CTRP Malignant High Grade Renal Pelvis Urothelial Carcinoma High-Grade Renal Pelvis Urothelial Carcinoma Renal Pelvis Urothelial Carcinoma, High Grade Renal Pelvis Urothelial Carcinoma, High-Grade Renal Pelvis Urothelial Carcinoma, High Grade Ureter urothelial carcinoma characterized by the presence of neoplastic epithelial cells with high grade features. C180608 Neoplastic Process High Grade Ureter Urothelial Carcinoma Ureter Urothelial Carcinoma, High Grade CL1662982 CTRP Malignant High Grade Ureter Urothelial Carcinoma High-Grade Ureter Urothelial Carcinoma Ureter Urothelial Carcinoma, High Grade Ureter Urothelial Carcinoma, High-Grade Ureter Urothelial Carcinoma, High Grade Bladder urothelial carcinoma characterized by the presence of neoplastic epithelial cells with high grade features. C180609 Neoplastic Process Bladder Urothelial Carcinoma, High Grade CL1662978 Malignant Bladder Urothelial Carcinoma, High Grade Bladder Urothelial Carcinoma, High-Grade High Grade Bladder Urothelial Carcinoma High-Grade Bladder Urothelial Carcinoma Bladder Urothelial Carcinoma, High Grade A gestational trophoblastic tumor characterized by the presence of two or three histological types of gestational trophoblastic tumor, including choriocarcinoma, placental site trophoblastic tumor, and epithelioid trophoblastic tumor. C180634 Neoplastic Process Mixed Trophoblastic Tumor CL1663434 Undetermined Mixed Trophoblastic Tumor Mixed Trophoblastic Tumor The spread of abnormal molar chorionic villi from an invasive hydatidiform mole in the uterine cavity to other anatomic sites, usually the vaginal wall and pelvis. C180635 Neoplastic Process Metastatic Hydatidiform Mole CL1663421 Malignant Metastatic Hydatidiform Mole Metastatic Hydatidiform Mole A rare sinonasal carcinoma characterized by the presence of a papillary architecture and bland morphological features similar to the Schneiderian papilloma, a pushing pattern of stromal invasion, and an increased risk of local recurrence. C180670 Neoplastic Process Low Grade Papillary Schneiderian Carcinoma CL1663392 Malignant LGPSC Low Grade Papillary Schneiderian Carcinoma Low Grade Papillary Sinonasal Carcinoma Low-Grade Papillary Schneiderian Carcinoma Low-Grade Papillary Sinonasal Carcinoma Low Grade Papillary Schneiderian Carcinoma A method of magnetic resonance imaging (MRI) that creates contrast between tissues based on differences in the longitudinal relaxation of a tissue's net magnetization vector; it measures the time taken for spinning protons to realign with the external magnetic field. This MRI sequence is produced by using short time to echo (TE) and repetition times (TR). C180727 Diagnostic Procedure T1-Weighted Magnetic Resonance Imaging CL1663294 Spin-lattice Relaxation MRI T1-Weighted MRI T1-Weighted Magnetic Resonance Imaging T1W MRI T1WI T1-Weighted Magnetic Resonance Imaging T1 weighted magnetic resonance imaging done with the addition of a contrast agent to enhance tissues. C180728 Diagnostic Procedure T1-Weighted Magnetic Resonance Imaging with Contrast CL1663295 Spin-lattice Relaxation MRI with Contrast T1-Weighted MRI with Contrast T1-Weighted Magnetic Resonance Imaging with Contrast T1W MRI with Contrast T1WI with Contrast T1-Weighted Magnetic Resonance Imaging with Contrast A method of magnetic resonance imaging (MRI) that creates contrast between tissues based on differences in the transverse relaxation of a tissue's net magnetization vector; it measures the time taken for spinning protons to lose phase coherence among the nuclei spinning perpendicular to the main field. This MRI sequence is produced by using a longer time to echo (TE) and repetition time (TR) than a T1-weighted sequence. C180729 Diagnostic Procedure T2-Weighted Magnetic Resonance Imaging CL1663296 T2-Weighted MRI T2-Weighted Magnetic Resonance Imaging T2W MRI T2-Weighted Magnetic Resonance Imaging Cervical squamous cell carcinoma in which information on the p16 immunohistochemistry or HPV testing status is not available. C180839 Neoplastic Process Cervical Squamous Cell Carcinoma, Not Otherwise Specified CL1663461 Cellosaurus Malignant Cervical Squamous Cell Carcinoma, NOS Cervical Squamous Cell Carcinoma, Not Otherwise Specified Cervical Squamous Cell Carcinoma, Not Otherwise Specified A cervical squamous cell carcinoma not associated with human papillomavirus infection. C180841 Neoplastic Process Human Papillomavirus-Independent Cervical Squamous Cell Carcinoma CL1663462 Cellosaurus Malignant HPV-Independent Cervical Squamous Cell Carcinoma Human Papillomavirus-Independent Cervical Squamous Cell Carcinoma Human Papillomavirus-Independent Cervical Squamous Cell Carcinoma Cervical adenocarcinoma in situ associated with human papillomavirus infection. C180845 Neoplastic Process Human Papillomavirus-Related Cervical Adenocarcinoma In Situ CL1663455 Malignant HPV-Associated Cervical Adenocarcinoma In Situ HPV-Related Cervical Adenocarcinoma In Situ HPVA Cervical Adenocarcinoma In Situ Human Papillomavirus-Associated Cervical Adenocarcinoma In Situ Human Papillomavirus-Related Cervical Adenocarcinoma In Situ Human Papillomavirus-Related Cervical Adenocarcinoma In Situ Cervical adenocarcinoma in situ not associated with human papillomavirus infection. C180846 Neoplastic Process Human Papillomavirus-Independent Cervical Adenocarcinoma In Situ CL1663456 Malignant HPV-Independent Cervical Adenocarcinoma In Situ Human Papillomavirus-Independent Cervical Adenocarcinoma In Situ Human Papillomavirus-Independent Cervical Adenocarcinoma In Situ Cervical adenocarcinoma not associated with human papillomavirus infection. C180848 Neoplastic Process Human Papillomavirus-Independent Cervical Adenocarcinoma CL1663458 Malignant HPV-Independent Cervical Adenocarcinoma Human Papillomavirus-Independent Cervical Adenocarcinoma NHPVA Cervical Adenocarcinoma Human Papillomavirus-Independent Cervical Adenocarcinoma A rare, human papillomavirus-associated premalignant glandular intraepithelial neoplasm that arises from the cervix. It is characterized by the presence of stratified, immature epithelial cells containing varying quantities of intracytoplasmic mucin. There is no evidence of stromal invasion. It is distinct from conventional cervical squamous or glandular intraepithelial neoplasias. C180860 Neoplastic Process Cervical Stratified Mucin-Producing Intraepithelial Lesion CL1663454 Undetermined Cervical Stratified Mucin-Producing Intraepithelial Lesion SMILE Stratified Mucin-Producing Intraepithelial Lesion Cervical Stratified Mucin-Producing Intraepithelial Lesion A rare, distinct form of invasive cervical mucinous adenocarcinoma associated with human papillomavirus infection. It is characterized by the presence of stratified, immature epithelial cells containing varying quantities of intracytoplasmic mucin. C180861 Neoplastic Process Cervical Invasive Stratified Mucinous Adenocarcinoma CL1663442 Malignant Cervical Invasive Stratified Mucinous Adenocarcinoma Cervical Invasive Stratified Mucinous Carcinoma ISMC Invasive Stratified Mucinous Adenocarcinoma Invasive Stratified Mucinous Carcinoma iSMILE Cervical Invasive Stratified Mucinous Adenocarcinoma A rare, invasive adenocarcinoma that arises from the cervix and is characterized by a micropapillary architecture. C180864 Neoplastic Process Cervical Micropapillary Adenocarcinoma CL1663445 Malignant Cervical Micropapillary Adenocarcinoma Invasive Cervical Micropapillary Adenocarcinoma Cervical Micropapillary Adenocarcinoma A cervical mucinous adenocarcinoma in which more than 50% of malignant cells contain intracytoplasmic mucin. There is no evidence of gastric, intestinal, or signet ring cell differentiation. C180869 Neoplastic Process Cervical Mucinous Adenocarcinoma, Not Otherwise Specified CL1663496 Malignant Cervical Mucinous Adenocarcinoma, NOS Cervical Mucinous Adenocarcinoma, Not Otherwise Specified Cervical Mucinous Adenocarcinoma, Not Otherwise Specified A cervical adenocarcinoma that cannot be classified by WHO criteria or International Endocervical Adenocarcinoma Criteria and Classification (IECC). C180870 Neoplastic Process Cervical Adenocarcinoma, Not Otherwise Specified CL1663497 Malignant Cervical Adenocarcinoma, NOS Cervical Adenocarcinoma, Not Otherwise Specified Invasive Cervical Adenocarcinoma, NOS Invasive Cervical Adenocarcinoma, Not Otherwise Specified Cervical Adenocarcinoma, Not Otherwise Specified A thymic neuroendocrine neoplasm that has spread extensively to other anatomic sites or is no longer responding to treatment. C180871 Neoplastic Process Advanced Thymic Neuroendocrine Neoplasm Advanced Thymic Neuroendocrine Neoplasm CL1663498 CTRP Malignant Advanced Thymic Neuroendocrine Neoplasm Advanced Thymic Neuroendocrine Neoplasm A thymic neuroendocrine neoplasm that is not amenable to surgical resection. C180872 Neoplastic Process Unresectable Thymic Neuroendocrine Neoplasm Unresectable Thymic Neuroendocrine Neoplasm CL1663499 CTRP Malignant Unresectable Thymic Neuroendocrine Neoplasm Unresectable Thymic Neuroendocrine Neoplasm A malignant neoplasm that arises from the brain that has spread from its original site of growth to nearby tissues or lymph nodes. C180874 Neoplastic Process Locally Advanced Primary Malignant Brain Neoplasm Locally Advanced Primary Malignant Brain Neoplasm CL1663501 CTRP Malignant Locally Advanced Primary Malignant Brain Neoplasm Locally Advanced Primary Malignant Brain Neoplasm Desmoplastic small round cell tumor that has spread from its original site of growth to nearby tissues or lymph nodes. C180875 Neoplastic Process Locally Advanced Desmoplastic Small Round Cell Tumor Locally Advanced Desmoplastic Small Round Cell Tumor CL1663502 CTRP Malignant Locally Advanced Desmoplastic Small Round Cell Tumor Locally Advanced Desmoplastic Small Round Cell Tumor Glioma that has spread from its original site of growth to nearby tissues or lymph nodes. C180876 Neoplastic Process Locally Advanced Glioma Locally Advanced Glioma CL1663503 CTRP Malignant Locally Advanced Glioma Locally Advanced Glioma Glioma that has spread from its original site of growth to another anatomic site. C180877 Neoplastic Process Metastatic Glioma C1328402 Malignant Metastatic Glioma Metastatic Glioma A rare carcinoma that arises from the cervix. It is characterized by the presence of squamous cells, mucus producing cells, and cells of intermediate type. C180878 Neoplastic Process Cervical Mucoepidermoid Carcinoma CL1663490 Malignant Cervical Mucoepidermoid Carcinoma Cervical Mucoepidermoid Carcinoma A rare germ cell tumor that arises from the cervix. Examples include mature cystic teratoma, yolk sac tumor, and choriocarcinoma. C180879 Neoplastic Process Cervical Germ Cell Tumor CL1663491 Undetermined Cervical Germ Cell Tumor Cervical Germ Cell Tumor A rare papillary neoplasm that grows within and is limited to the duct system of the minor salivary glands. This category includes papillary cystadenoma, ductal papilloma (including the intraductal and inverted variants), sialadenoma papilliferum, and intraductal papillary mucinous neoplasm. C180880 Neoplastic Process Minor Salivary Gland Intraductal Papillary Neoplasm CL1663492 Undetermined Minor Salivary Gland Intraductal Papillary Neoplasm Minor Salivary Gland Intraductal Papillary-Cystic Neoplasm Minor Salivary Gland Intraductal Papillary Neoplasm A rare, low-grade epithelial neoplasm with ductal differentiation that grows within and is limited to the duct system of the minor salivary glands. It is characterized by a proliferation of mucin-producing cells within the minor salivary gland ducts, intraductal accumulation of mucin, and a papillary growth pattern. Cytologic and architectural atypia and mitotic activity are present. AKT1 gene mutations have been identified in the majority of cases. Morphologically it resembles the intraductal papillary-mucinous neoplasms of the pancreas. C180881 Neoplastic Process Minor Salivary Gland Intraductal Papillary-Mucinous Neoplasm CL1663493 Undetermined Minor Salivary Gland IPMN Minor Salivary Gland Intraductal Papillary Mucinous Neoplasm Minor Salivary Gland Intraductal Papillary-Mucinous Neoplasm Minor Salivary Gland Intraductal Papillary-Mucinous Neoplasm A neuroendocrine carcinoma that arises from the gastroesophageal junction and is not amenable to surgical resection. C180885 Neoplastic Process Unresectable Gastroesophageal Junction Neuroendocrine Carcinoma Unresectable Gastroesophageal Junction Neuroendocrine Carcinoma CL1663489 CTRP Malignant Unresectable Gastroesophageal Junction Neuroendocrine Carcinoma Unresectable Gastroesophageal Junction Neuroendocrine Carcinoma A benign, localized, nodular and well-circumscribed neoplasm seen as a congenital neoplasm or in the first year of life. It is characterized by a biphasic growth pattern and is composed of small, undifferentiated mesenchymal cells associated with branching thin-walled vessels and more mature neoplastic spindle cells with abundant eosinophilic cytoplasm in a collagenous stroma. C180887 Neoplastic Process Infantile Myofibroma CL1663667 Benign Infantile Hemangiopericytoma Infantile Myofibroma Infantile Myofibroma A rare myofibroma that occurs in adults. C180888 Neoplastic Process Adult Myofibroma CL1663668 Benign Adult Myofibroma Adult Myofibroma Cutaneous squamous cell carcinoma of the head and neck that has spread from its original site of growth to nearby tissues or lymph nodes. C180891 Neoplastic Process Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck CL1663660 CTRP Malignant Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck Medulloblastoma, WNT-activated that is resistant to treatment. C180892 Neoplastic Process Refractory Medulloblastoma, WNT-Activated Refractory Medulloblastoma, WNT-Activated CL1663661 CTRP Malignant Refractory Medulloblastoma, WNT-Activated Refractory Medulloblastoma, WNT-Activated The reemergence of medulloblastoma, WNT-activated after a period of remission. C180893 Neoplastic Process Recurrent Medulloblastoma, WNT-Activated Recurrent Medulloblastoma, WNT-Activated CL1663662 CTRP Malignant Recurrent Medulloblastoma, WNT-Activated Recurrent Medulloblastoma, WNT-Activated Acute myeloid leukemia, myelodysplasia-related that is resistant to treatment. C180897 Neoplastic Process Refractory Acute Myeloid Leukemia with Myelodysplasia-Related Changes Refractory Acute Myeloid Leukemia, Myelodysplasia-Related CL1663651 CTRP Malignant Refractory Acute Myeloid Leukemia with Myelodysplasia-Related Changes Refractory Acute Myeloid Leukemia, Myelodysplasia-Related Refractory Acute Myeloid Leukemia, Myelodysplasia-Related A magnetic resonance (MR) imaging technique that allows assessment of the hemodynamic properties of a tissue, represented by regional blood volume (vascular density), flow, and vascular permeability (blood vessel leakiness). An intravenous contrast bolus is injected and rapidly repeated T1 imaging is obtained. Regional increased signal (T1 shortening) reflects both intravascular gadolinium (true perfusion), and accumulation of gadolinium in the extravascular space (permeability). C180898 Diagnostic Procedure Dynamic Contrast-enhanced MR Perfusion Dynamic Contrast-enhanced MR Perfusion CL1663652 CTRP DIPG/DMG DCE DCE MR Perfusion Dynamic Contrast-enhanced MR Perfusion Dynamic Contrast-enhanced MRI Perfusion Dynamic Contrast-enhanced Magnetic Resonance Imaging Perfusion Permeability MRI Dynamic Contrast-enhanced MR Perfusion A squamous cell carcinoma that arises from the vagina. It is classified as human papillomavirus-related or human papillomavirus-independent. When p16 immunohistochemistry or HPV testing is not available, the morphological diagnosis of squamous cell carcinoma, not otherwise specified is acceptable. C180915 Neoplastic Process Vaginal Squamous Cell Carcinoma CL1663640 Malignant Vaginal Squamous Cell Carcinoma Vaginal Squamous Cell Carcinoma A squamous cell carcinoma that arises from the vagina and is caused by human papillomavirus infection. C180917 Neoplastic Process Human Papillomavirus-Related Vaginal Squamous Cell Carcinoma CL1663641 Malignant Human Papillomavirus-Associated Vaginal Squamous Cell Carcinoma Human Papillomavirus-Related Vaginal Squamous Cell Carcinoma Human Papillomavirus-Related Vaginal Squamous Cell Carcinoma Vaginal squamous cell carcinoma not associated with human papillomavirus infection. C180919 Neoplastic Process Human Papillomavirus-Independent Vaginal Squamous Cell Carcinoma CL1663642 Malignant HPV-Independent Vaginal Squamous Cell Carcinoma Human Papillomavirus-Independent Vaginal Squamous Cell Carcinoma Human Papillomavirus-Independent Vaginal Squamous Cell Carcinoma Vaginal adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C180920 Neoplastic Process Advanced Vaginal Adenocarcinoma Advanced Vaginal Adenocarcinoma CL1663643 CTRP Malignant Advanced Vaginal Adenocarcinoma Advanced Vaginal Adenocarcinoma Vaginal squamous cell carcinoma, not otherwise specified that that has spread extensively to other anatomic sites or is no longer responding to treatment. C180921 Neoplastic Process Advanced Vaginal Squamous Cell Carcinoma, Not Otherwise Specified Advanced Vaginal Squamous Cell Carcinoma, Not Otherwise Specified CL1663633 CTRP Malignant Advanced Vaginal Squamous Cell Carcinoma, Not Otherwise Specified Advanced Vaginal Squamous Cell Carcinoma, Not Otherwise Specified Bronchogenic carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C180922 Neoplastic Process Advanced Bronchogenic Carcinoma Advanced Bronchogenic Carcinoma CL1663634 CTRP Malignant Advanced Bronchogenic Carcinoma Advanced Bronchogenic Carcinoma The reemergence of bronchogenic carcinoma after a period of remission. C180923 Neoplastic Process Recurrent Bronchogenic Carcinoma Recurrent Bronchogenic Carcinoma CL1663635 CTRP Malignant Recurrent Bronchogenic Carcinoma Recurrent Bronchogenic Carcinoma HER2-positive breast carcinoma that has spread from the original site of growth to another anatomic site. C180924 Neoplastic Process Metastatic HER2-Positive Breast Carcinoma CL1663636 Malignant Metastatic HER2 Positive Breast Carcinoma Metastatic HER2-Positive Breast Carcinoma Metastatic HER2-Positive Breast Carcinoma HER2-positive breast carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C180925 Neoplastic Process Advanced HER2 Positive Breast Carcinoma Advanced HER2-Positive Breast Carcinoma CL1663637 CTRP Malignant Advanced HER2 Positive Breast Carcinoma Advanced HER2-Positive Breast Carcinoma Advanced HER2-Positive Breast Carcinoma An adenocarcinoma that arises from the vagina and is caused by human papillomavirus infection. C180943 Neoplastic Process Human Papillomavirus-Related Vaginal Adenocarcinoma CL1663624 Malignant HPV-Associated Vaginal Adenocarcinoma HPV-Related Vaginal Adenocarcinoma Human Papillomavirus-Associated Vaginal Adenocarcinoma Human Papillomavirus-Related Vaginal Adenocarcinoma Human Papillomavirus-Related Vaginal Adenocarcinoma Vaginal mucinous adenocarcinoma characterized by the presence of gastric differentiation. C180945 Neoplastic Process Vaginal Mucinous Adenocarcinoma, Gastric-Type CL1663552 Malignant Vaginal Mucinous Adenocarcinoma, Gastric-Type Vaginal Mucinous Adenocarcinoma, Gastric-Type A vaginal mucinous adenocarcinoma that resembles a large intestinal adenocarcinoma. C180946 Neoplastic Process Vaginal Mucinous Adenocarcinoma, Intestinal-Type CL1663553 Malignant Vaginal Mucinous Adenocarcinoma, Intestinal-Type Vaginal Mucinous Adenocarcinoma, Intestinal-Type A rare vaginal adenocarcinoma arising from the Skene gland. It is characterized by morphological and immunohistochemical features similar to prostate adenocarcinoma. C180947 Neoplastic Process Vaginal Adenocarcinoma of Skene Gland Origin CL1663554 Malignant Vaginal Adenocarcinoma of Skene Gland Origin Vaginal Adenocarcinoma of Skene Gland Origin A rare urethral adenocarcinoma arising from the Skene gland. It is characterized by morphological and immunohistochemical features similar to prostate adenocarcinoma. C180948 Neoplastic Process Skene Gland Adenocarcinoma of the Urethra CL1663555 Malignant Skene Gland Adenocarcinoma of the Urethra Urethral Adenocarcinoma of Skene Gland Origin Skene Gland Adenocarcinoma of the Urethra Clear cell sarcoma of soft tissue that is resistant to treatment. C180979 Neoplastic Process Refractory Clear Cell Sarcoma of the Soft Tissue Refractory Clear Cell Sarcoma of Soft Tissue CL1663522 CTRP Malignant Refractory Clear Cell Sarcoma of Soft Tissue Refractory Clear Cell Sarcoma of Soft Tissue The reemergence of clear cell sarcoma of soft tissue after a period of remission. C180980 Neoplastic Process Recurrent Clear Cell Sarcoma of the Soft Tissue Recurrent Clear Cell Sarcoma of Soft Tissue CL1663523 CTRP Malignant Recurrent Clear Cell Sarcoma of Soft Tissue Recurrent Clear Cell Sarcoma of Soft Tissue The reemergence of T-cell large granular lymphocyte leukemia after a period of remission. C180985 Neoplastic Process Recurrent T-Cell Large Granular Lymphocyte Leukemia Recurrent T-Cell Large Granular Lymphocyte Leukemia CL1663513 CTRP Malignant Recurrent T-Cell Large Granular Lymphocyte Leukemia Recurrent T-Cell Large Granular Lymphocyte Leukemia T-cell large granular lymphocyte leukemia that is resistant to treatment. C180986 Neoplastic Process Refractory T-Cell Large Granular Lymphocyte Leukemia Refractory T-Cell Large Granular Lymphocyte Leukemia CL1663514 CTRP Malignant Refractory T-Cell Large Granular Lymphocyte Leukemia Refractory T-Cell Large Granular Lymphocyte Leukemia A positron emission tomography imaging technique that uses F-18 labelled DCFPyL to bind to prostate-specific membrane antigen-expressing tumor cells to locate cancer lesions. C180993 Diagnostic Procedure F-18 DCFPyL PSMA Positron Emission Tomography CL1663512 F-18 DCFPyL PSMA Positron Emission Tomography F-18 DCFPyL PSMA Positron Emission Tomography A magnetic resonance imaging method used to quantitate liver iron concentrations. Water ions moving near magnetic iron deposits destroy the homogeneity of the magnetic field causing the MRI image to darken at a rate proportional to the iron concentration. C181004 Diagnostic Procedure MRI Quantification of Liver Iron Concentration CL1663509 Liver Iron Concentration MRI Liver Iron Concentration MRI R2 Liver Iron Concentration MRI R2* Liver Iron Concentration R2 MRI Liver Iron Concentration R2* MRI Liver Iron Concentration by MRI MRI Quantification of Hepatic Iron Concentration MRI Quantification of Liver Iron Concentration MRI R2 MRI R2* R2 MRI R2* MRI MRI Quantification of Liver Iron Concentration Vaginal adenosquamous carcinoma that has spread from its original site of growth to another anatomic site. C181028 Neoplastic Process Metastatic Vaginal Adenosquamous Carcinoma CL1663601 Malignant Metastatic Vaginal Adenosquamous Carcinoma Metastatic Vaginal Adenosquamous Carcinoma Vaginal adenosquamous carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C181029 Neoplastic Process Advanced Vaginal Adenosquamous Carcinoma Advanced Vaginal Adenosquamous Carcinoma CL1663602 CTRP Malignant Advanced Vaginal Adenosquamous Carcinoma Advanced Vaginal Adenosquamous Carcinoma Vaginal squamous cell carcinoma that has spread from its original site of growth to another anatomic site. C181031 Neoplastic Process Metastatic Vaginal Squamous Cell Carcinoma CL1663604 Malignant Metastatic Vaginal Squamous Cell Carcinoma Metastatic Vaginal Squamous Cell Carcinoma Vaginal squamous cell carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C181032 Neoplastic Process Advanced Vaginal Squamous Cell Carcinoma Advanced Vaginal Squamous Cell Carcinoma CL1663605 CTRP Malignant Advanced Vaginal Squamous Cell Carcinoma Advanced Vaginal Squamous Cell Carcinoma Cervical squamous cell carcinoma that is resistant to treatment. C181034 Neoplastic Process Refractory Cervical Squamous Cell Carcinoma CL1663591 Malignant Refractory Cervical Squamous Cell Carcinoma Refractory Cervical Squamous Cell Carcinoma Cervical squamous cell carcinoma, not otherwise specified, that is resistant to treatment. C181035 Neoplastic Process Refractory Cervical Squamous Cell Carcinoma, Not Otherwise Specified Refractory Cervical Squamous Cell Carcinoma, Not Otherwise Specified CL1663592 CTRP Malignant Refractory Cervical Squamous Cell Carcinoma, Not Otherwise Specified Refractory Cervical Squamous Cell Carcinoma, Not Otherwise Specified Cervical adenocarcinoma that is resistant to treatment. C181036 Neoplastic Process Refractory Cervical Adenocarcinoma Refractory Cervical Adenocarcinoma CL1663593 CTRP Malignant Refractory Cervical Adenocarcinoma Refractory Cervical Adenocarcinoma The reemergence of primary cutaneous anaplastic large cell lymphoma after a period of remission. C181044 Neoplastic Process Recurrent Primary Cutaneous Anaplastic Large Cell Lymphoma Recurrent Primary Cutaneous Anaplastic Large Cell Lymphoma CL1663585 CTRP Malignant Recurrent Primary Cutaneous Anaplastic Large Cell Lymphoma Recurrent Primary Cutaneous Anaplastic Large Cell Lymphoma Primary cutaneous anaplastic large cell lymphoma that is resistant to treatment. C181045 Neoplastic Process Refractory Primary Cutaneous Anaplastic Large Cell Lymphoma Refractory Primary Cutaneous Anaplastic Large Cell Lymphoma CL1663586 CTRP Malignant Refractory Primary Cutaneous Anaplastic Large Cell Lymphoma Refractory Primary Cutaneous Anaplastic Large Cell Lymphoma The reemergence of systemic anaplastic large cell lymphoma, ALK-positive after a period of remission. C181047 Neoplastic Process Recurrent Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive Recurrent Systemic Anaplastic Large Cell Lymphoma, ALK-Positive CL1663588 CTRP Malignant Recurrent Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive Recurrent Systemic Anaplastic Large Cell Lymphoma, ALK-Positive Recurrent Systemic Anaplastic Large Cell Lymphoma, ALK-Positive Systemic anaplastic large cell lymphoma, ALK-positive that is resistant to treatment. C181048 Neoplastic Process Refractory Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive Refractory Systemic Anaplastic Large Cell Lymphoma, ALK-Positive CL1663589 CTRP Malignant Refractory Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive Refractory Systemic Anaplastic Large Cell Lymphoma, ALK-Positive Refractory Systemic Anaplastic Large Cell Lymphoma, ALK-Positive A rare neoplasm that arises from the salivary gland and consists of at least two histologically distinct types of tumor within the same topographic location. The tumor components can be either benign or malignant. C181078 Neoplastic Process Hybrid Salivary Gland Tumor Hybrid Salivary Gland Tumor CL1663702 CTRP Undetermined Hybrid Salivary Gland Neoplasm Hybrid Salivary Gland Tumor Hybrid Salivary Gland Tumor A rare carcinoma that arises from the salivary gland and consists of at least two histologically distinct types of carcinoma within the same topographic location. The carcinoma components usually are adenoid cystic carcinoma, epithelial-myoepithelial carcinoma, and/or salivary duct carcinoma. Adenoid cystic carcinoma is commonly the predominant component. C181079 Neoplastic Process Hybrid Salivary Gland Carcinoma CL1663703 Malignant Hybrid Salivary Gland Carcinoma Hybrid Salivary Gland Carcinoma Triple-negative breast carcinoma that has not spread beyond the breast or axillary lymph nodes. C181081 Neoplastic Process Early Stage Triple-Negative Breast Carcinoma Early Stage Triple-Negative Breast Carcinoma CL1663705 CTRP Malignant Early Stage Triple-Negative Breast Carcinoma Early-Stage Triple-Negative Breast Carcinoma Early Stage Triple-Negative Breast Carcinoma A carcinoma that arises from the jejunum. C181157 Neoplastic Process Jejunal Carcinoma CL1664396 Malignant Jejunal Carcinoma Jejunal Carcinoma An adenocarcinoma that arises from the jejunum. C181158 Neoplastic Process Jejunal Adenocarcinoma C4072935 Malignant Jejunal Adenocarcinoma Jejunal Adenocarcinoma A basal cell carcinoma that arises from the eyelid. C181159 Neoplastic Process Eyelid Basal Cell Carcinoma C0339114 Malignant Eyelid Basal Cell Carcinoma Ocular Basal Cell Carcinoma Eyelid Basal Cell Carcinoma A mucoepidermoid carcinoma that arises from the tongue. C181160 Neoplastic Process Tongue Mucoepidermoid Carcinoma C0861626 Malignant Tongue Mucoepidermoid Carcinoma Tongue Mucoepidermoid Carcinoma A squamous cell carcinoma that arises from the parotid or submandibular gland. C181161 Neoplastic Process Major Salivary Gland Squamous Cell Carcinoma CL1664387 Malignant Major Salivary Gland Squamous Cell Carcinoma Major Salivary Gland Squamous Cell Carcinoma A malignant neoplasm that arises from the epithelium of any part of the female reproductive system. Representative examples include ovarian carcinoma, cervical carcinoma, and endometrial carcinoma. C181162 Neoplastic Process Female Reproductive System Carcinoma CL1664388 Malignant Female Reproductive System Carcinoma Female Reproductive System Carcinoma A malignant neoplasm that arises from the epithelium of any part of the male reproductive system. Representative examples include prostate carcinoma and penile carcinoma. C181196 Neoplastic Process Male Reproductive System Carcinoma CL1664357 Malignant Male Reproductive System Carcinoma Male Reproductive System Carcinoma A malignant neoplasm that arises from the epithelium of any part of the urinary system. Representative examples include kidney carcinoma and bladder carcinoma. C181197 Neoplastic Process Urinary System Carcinoma CL1664361 Malignant Urinary System Carcinoma Urinary System Carcinoma A rare rhabdomyosarcoma that arises from the lung. C181201 Neoplastic Process Lung Rhabdomyosarcoma Lung Rhabdomyosarcoma CL1664351 CTRP Malignant Lung Rhabdomyosarcoma Pulmonary Rhabdomyosarcoma Lung Rhabdomyosarcoma A rare Hodgkin lymphoma that arises in and is confined to the lung at the time of diagnosis. C181205 Neoplastic Process Lung Hodgkin Lymphoma CL1664355 Malignant Lung Hodgkin Lymphoma Primary Lung Hodgkin Lymphoma Primary Pulmonary Hodgkin Lymphoma Pulmonary Hodgkin Lymphoma Lung Hodgkin Lymphoma An exceedingly rare Hodgkin lymphoma that arises from the bone, without lymph node or other extranodal involvement. C181207 Neoplastic Process Primary Bone Hodgkin Lymphoma CL1664353 Malignant Primary Bone Hodgkin Lymphoma Primary Bone Hodgkin Lymphoma An exceedingly rare Hodgkin lymphoma that arises from the thyroid gland. C181209 Neoplastic Process Thyroid Gland Hodgkin Lymphoma CL1664285 Malignant Primary Thyroid Gland Hodgkin Lymphoma Thyroid Gland Hodgkin Lymphoma Thyroid Gland Hodgkin Lymphoma A mantle cell lymphoma that manifests initially in the parotid gland. C181210 Neoplastic Process Parotid Gland Mantle Cell Lymphoma CL1664286 Malignant Parotid Gland Mantle Cell Lymphoma Parotid Gland Mantle Cell Lymphoma An exceedingly rare follicular lymphoma that arises in and is confined to the lung at the time of diagnosis. C181211 Neoplastic Process Lung Follicular Lymphoma CL1664283 Malignant Lung Follicular Lymphoma Primary Lung Follicular Lymphoma Lung Follicular Lymphoma A term that refers to the staging of cervical cancer according to the American Joint Committee on Cancer, 9th edition. This staging system applies to carcinomas and carcinosarcomas. It does not apply to sarcomas, lymphomas, and melanomas. Sarcomas are staged according to the corpus uteri classification for sarcomas. Lymphomas are staged according to Hodgkin and non-Hodgkin lymphoma classification. Melanomas are not staged. (from AJCC 9th Ed.) C181562 Neoplastic Process Cervical Cancer by AJCC v9 Stage CL1664492 Malignant Cervical Cancer by AJCC v9 Stage Cervical Carcinoma by AJCC v9 Stage Cervical Cancer by AJCC v9 Stage Stage I includes: T1, N0, M0. T1: Tumor strictly confined to the cervix (extension to corpus should be disregarded). N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 9th Ed.) C181564 Neoplastic Process Stage I Cervical Cancer AJCC v9 CL1664491 Malignant Stage I Cervical Cancer AJCC v9 Stage I Cervical Carcinoma AJCC v9 Stage I Cervical Cancer AJCC v9 Stage IA includes: T1a, N0, M0. T1a: Tumor that can be diagnosed only by microscopy with maximum depth of invasion equal or less than 5 mm. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 9th Ed.) C181565 Neoplastic Process Stage IA Cervical Cancer AJCC v9 CL1664495 Malignant Stage IA Cervical Cancer AJCC v9 Stage IA Cervical Carcinoma AJCC v9 Stage IA Cervical Cancer AJCC v9 Stage IA1 includes: T1a1, N0, M0. T1a1: Tumor with measured stromal invasion equal or less than 3 mm in depth. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 9th Ed.) C181567 Neoplastic Process Stage IA1 Cervical Cancer AJCC v9 CL1664493 Malignant Stage IA1 Cervical Cancer AJCC v9 Stage IA1 Cervical Carcinoma AJCC v9 Stage IA1 Cervical Cancer AJCC v9 Stage IA2 includes: T1a2, N0, M0. T1a2: Tumor with measured stromal invasion of more than 3.0 mm and equal or less than 5.0 mm in depth. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 9th Ed.) C181568 Neoplastic Process Stage IA2 Cervical Cancer AJCC v9 CL1664494 Malignant Stage IA2 Cervical Cancer AJCC v9 Stage IA2 Cervical Carcinoma AJCC v9 Stage IA2 Cervical Cancer AJCC v9 Stage IB includes: T1b, N0, M0. T1b: Tumor with measured deepest invasion more than 5 mm (greater than FIGO stage IA); lesion limited to the cervix uteri with size measured by maximum tumor diameter. Note: The involvement of vascular/lymphatic spaces should not change the staging. The lateral extent of the lesion is no longer considered. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 9th Ed.) C181570 Neoplastic Process Stage IB Cervical Cancer AJCC v9 CL1664485 Malignant Stage IB Cervical Cancer AJCC v9 Stage IB Cervical Carcinoma AJCC v9 Stage IB Cervical Cancer AJCC v9 Stage IB1 includes: T1b1, N0, M0. T1b1: Tumor measuring more than 5 mm in depth and equal or less than 2 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 9th Ed.) C181571 Neoplastic Process Stage IB1 Cervical Cancer AJCC v9 CL1664482 Malignant Stage IB1 Cervical Cancer AJCC v9 Stage IB1 Cervical Carcinoma AJCC v9 Stage IB1 Cervical Cancer AJCC v9 Stage IB2 includes: T1b2, N0, M0. T1b2: Tumor measuring more than 2 cm and equal or less than 4 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 9th Ed.) C181576 Neoplastic Process Stage IB2 Cervical Cancer AJCC v9 CL1664487 Malignant Stage IB2 Cervical Cancer AJCC v9 Stage IB2 Cervical Carcinoma AJCC v9 Stage IB2 Cervical Cancer AJCC v9 Stage IB3 includes: T1b3, N0, M0. T1b3: Tumor measuring more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 9th Ed.) C181579 Neoplastic Process Stage IB3 Cervical Cancer AJCC v9 CL1664475 Malignant Stage IB3 Cervical Cancer AJCC v9 Stage IB3 Cervical Carcinoma AJCC v9 Stage IB3 Cervical Cancer AJCC v9 Stage II includes: T2, N0, M0. T2: Tumor invading beyond the uterus but not to the pelvic wall or to lower third of vagina. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 9th Ed.) C181583 Neoplastic Process Stage II Cervical Cancer AJCC v9 CL1664479 Malignant Stage II Cervical Cancer AJCC v9 Stage II Cervical Carcinoma AJCC v9 Stage II Cervical Cancer AJCC v9 Stage IIA includes: T2a, N0, M0. T2a: Tumor with involvement limited to the upper two-thirds of the vagina without parametrial invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 9th Ed.) C181584 Neoplastic Process Stage IIA Cervical Cancer AJCC v9 CL1664480 Malignant Stage IIA Cervical Cancer AJCC v9 Stage IIA Cervical Carcinoma AJCC v9 Stage IIA Cervical Cancer AJCC v9 Stage IIA1 includes: T2a1, N0, M0. T2a1: Tumor with involvement limited to the upper two-thirds of the vagina without parametrial invasion measuring 4.0 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 9th Ed.) C181586 Neoplastic Process Stage IIA1 Cervical Cancer AJCC v9 CL1664470 Malignant Stage IIA1 Cervical Cancer AJCC v9 Stage IIA1 Cervical Carcinoma AJCC v9 Stage IIA1 Cervical Cancer AJCC v9 Stage IIA2 includes: T2a2, N0, M0. T2a2: Tumor with involvement limited to the upper two-thirds of the vagina without parametrial invasion measuring more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 9th Ed.) C181588 Neoplastic Process Stage IIA2 Cervical Cancer AJCC v9 CL1664468 Malignant Stage IIA2 Cervical Cancer AJCC v9 Stage IIA2 Cervical Carcinoma AJCC v9 Stage IIA2 Cervical Cancer AJCC v9 Stage IIB includes: T2b, N0, M0. T2b: Tumor with parametrial invasion but not up to the pelvic wall. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 9th Ed.) C181591 Neoplastic Process Stage IIB Cervical Cancer AJCC v9 CL1664474 Malignant Stage IIB Cervical Cancer AJCC v9 Stage IIB Cervical Carcinoma AJCC v9 Stage IIB Cervical Cancer AJCC v9 Stage III includes: T3, N0, M0. T3: Tumor extending to pelvic sidewall and/or involving the lower third of vagina, and/or causing hydronephrosis or nonfunctioning kidney. The pelvic sidewall is defined as the muscle, fascia, neurovascular structures, and skeletal portions of the bony pelvis. Cases with no cancer-free space between the tumor and pelvic wall by rectal examination are FIGO III. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 9th Ed.) C181592 Neoplastic Process Stage III Cervical Cancer AJCC v9 CL1664471 Malignant Stage III Cervical Cancer AJCC v9 Stage III Cervical Carcinoma AJCC v9 Stage III Cervical Cancer AJCC v9 Stage IIIA includes: T3a, N0, M0. T3a: Tumor involving the lower third of vagina but not extending to pelvic wall. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 9th Ed.) C181594 Neoplastic Process Stage IIIA Cervical Cancer AJCC v9 CL1664472 Malignant Stage IIIA Cervical Cancer AJCC v9 Stage IIIA Cervical Carcinoma AJCC v9 Stage IIIA Cervical Cancer AJCC v9 Stage IIIB includes: T3b, N0, M0. T3b: Tumor extending to pelvic wall and/or causing hydronephrosis or nonfunctioning kidney (unless known to be due to another cause). N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 9th Ed.) C181595 Neoplastic Process Stage IIIB Cervical Cancer AJCC v9 CL1664461 Malignant Stage IIIB Cervical Cancer AJCC v9 Stage IIIB Cervical Carcinoma AJCC v9 Stage IIIB Cervical Cancer AJCC v9 Stage IIIC includes: IIIC1: TX, T0, T1-3, N1, M0; IIIC2: TX, T0, T1-3, N2, M0. TX: Primary tumor cannot be assessed. T0: No evidence of primary tumor. T1: Tumor strictly confined to the cervix (extension to corpus should be disregarded). T2: Tumor invading beyond the uterus but not to the pelvic wall or to lower third of vagina. T3: Tumor extending to pelvic sidewall and/or involving the lower third of vagina, and/or causing hydronephrosis or nonfunctioning kidney. The pelvic sidewall is defined as the muscle, fascia, neurovascular structures, and skeletal portions of the bony pelvis. Cases with no cancer-free space between the tumor and pelvic wall by rectal examination are FIGO III. N1: Tumor with regional lymph node metastasis to pelvic lymph nodes only. N2: Tumor with regional lymph node metastasis to para-aortic lymph nodes with or without positive pelvic lymph nodes. M0: No distant metastasis. (from AJCC 9th Ed.) C181596 Neoplastic Process Stage IIIC Cervical Cancer AJCC v9 CL1664462 Malignant Stage IIIC Cervical Cancer AJCC v9 Stage IIIC Cervical Carcinoma AJCC v9 Stage IIIC Cervical Cancer AJCC v9 Stage IIIC1 includes: TX, T0, T1-3, N1, M0. TX: Primary tumor cannot be assessed. T0: No evidence of primary tumor. T1: Tumor strictly confined to the cervix (extension to corpus should be disregarded). T2: Tumor invading beyond the uterus but not to the pelvic wall or to lower third of vagina. T3: Tumor extending to pelvic sidewall and/or involving the lower third of vagina, and/or causing hydronephrosis or nonfunctioning kidney. The pelvic sidewall is defined as the muscle, fascia, neurovascular structures, and skeletal portions of the bony pelvis. Cases with no cancer-free space between the tumor and pelvic wall by rectal examination are FIGO III. N1: Tumor with regional lymph node metastasis to pelvic lymph nodes only. M0: No distant metastasis. (from AJCC 9th Ed.) C181597 Neoplastic Process Stage IIIC1 Cervical Cancer AJCC v9 CL1664459 Malignant Stage IIIC1 Cervical Cancer AJCC v9 Stage IIIC1 Cervical Carcinoma AJCC v9 Stage IIIC1 Cervical Cancer AJCC v9 Stage IIIC2 includes: TX, T0, T1-3, N2, M0. TX: Primary tumor cannot be assessed. T0: No evidence of primary tumor. T1: Tumor strictly confined to the cervix (extension to corpus should be disregarded). T2: Tumor invading beyond the uterus but not to the pelvic wall or to lower third of vagina. T3: Tumor extending to pelvic sidewall and/or involving the lower third of vagina, and/or causing hydronephrosis or nonfunctioning kidney. The pelvic sidewall is defined as the muscle, fascia, neurovascular structures, and skeletal portions of the bony pelvis. Cases with no cancer-free space between the tumor and pelvic wall by rectal examination are FIGO III. N2: Tumor with regional lymph node metastasis to para-aortic lymph nodes with or without positive pelvic lymph nodes. M0: No distant metastasis. (from AJCC 9th Ed.) C181598 Neoplastic Process Stage IIIC2 Cervical Cancer AJCC v9 CL1664460 Malignant Stage IIIC2 Cervical Cancer AJCC v9 Stage IIIC2 Cervical Carcinoma AJCC v9 Stage IIIC2 Cervical Cancer AJCC v9 Stage IV includes: IVA: T4, Any N, M0; IVB: Any T, Any N, M1. T4: Tumor has involved (biopsy-proven) the mucosa of the bladder or rectum, or has spread to adjacent organs. M0: No distant metastasis. M1: Distant metastasis including inguinal lymph nodes, lung, liver, bone, or intraperitoneal metastases. Metastases to pelvic or paraaortic lymph nodes, or vagina are excluded. (from AJCC 9th Ed.) C181599 Neoplastic Process Stage IV Cervical Cancer AJCC v9 CL1664465 Malignant Stage IV Cervical Cancer AJCC v9 Stage IV Cervical Carcinoma AJCC v9 Stage IV Cervical Cancer AJCC v9 Stage IVA includes: T4, Any N, M0. T4: Tumor has involved (biopsy-proven) the mucosa of the bladder or rectum, or has spread to adjacent organs. M0: No distant metastasis. (from AJCC 9th Ed.) C181601 Neoplastic Process Stage IVA Cervical Cancer AJCC v9 CL1664463 Malignant Stage IVA Cervical Cancer AJCC v9 Stage IVA Cervical Carcinoma AJCC v9 Stage IVA Cervical Cancer AJCC v9 Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis including inguinal lymph nodes, lung, liver, bone, or intraperitoneal metastases. Metastases to pelvic or paraaortic lymph nodes, or vagina are excluded. (from AJCC 9th Ed.) C181603 Neoplastic Process Stage IVB Cervical Cancer AJCC v9 CL1664764 Malignant Stage IVB Cervical Cancer AJCC v9 Stage IVB Cervical Carcinoma AJCC v9 Stage IVB Cervical Cancer AJCC v9 A squamous cell carcinoma of the larynx that arises from the epiglottis. C181714 Neoplastic Process Epiglottic Squamous Cell Carcinoma CL1664790 Malignant Epiglottic Squamous Cell Carcinoma Epiglottic Squamous Cell Carcinoma A description of an individual's current or previous use of tobacco. C181760 Finding History of Tobacco Use CL1664965 ACC/AHA OORO Current or previous use of any tobacco product including cigarettes, cigars, pipes, and chewing tobacco. (Captured as smoking status.) Is the patient a current or former user of tobacco products such as cigarettes, cigars, pipe, chewing tobacco Has tobacco use history History of Tobacco Use Tobacco Use Tobacco Use History History of Tobacco Use Agranulocytosis that occurs with chemotherapy. C181764 Finding Chemotherapy Related Agranulocytosis CL1664643 Chemotherapy Related Agranulocytosis Chemotherapy-Related Agranulocytosis Chemotherapy Related Agranulocytosis Inflammatory carcinoma of the breast that has spread from its original site of growth to another anatomic site. C181787 Neoplastic Process Metastatic Breast Inflammatory Carcinoma Metastatic Breast Inflammatory Carcinoma CL1664637 CTRP Malignant Metastatic Breast Inflammatory Carcinoma Metastatic Breast Inflammatory Carcinoma HER2-positive breast carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C181793 Neoplastic Process Locally Advanced HER2-Positive Breast Carcinoma Locally Advanced HER2-Positive Breast Carcinoma CL1664634 CTRP Malignant Locally Advanced HER2 Positive Breast Carcinoma Locally Advanced HER2-Positive Breast Carcinoma Locally Advanced HER2-Positive Breast Carcinoma The reemergence of indolent non-Hodgkin lymphoma after a period of remission. C181796 Neoplastic Process Recurrent Indolent Non-Hodgkin Lymphoma Recurrent Indolent Non-Hodgkin Lymphoma CL1664717 CTRP Malignant Recurrent Indolent Non-Hodgkin Lymphoma Recurrent Indolent Non-Hodgkin Lymphoma The reemergence of metastatic gastric carcinoma after a period of remission. C181856 Neoplastic Process Recurrent Metastatic Gastric Carcinoma Recurrent Metastatic Gastric Carcinoma CL1664675 CTRP Malignant Recurrent Metastatic Gastric Carcinoma Recurrent Metastatic Gastric Carcinoma Durie/Salmon stage I multiple myeloma associated with a relatively normal renal function (serum creatinine concentration < 2.0 mg/dL). C181859 Neoplastic Process DS Stage IA Multiple Myeloma CL1664674 Malignant DS Stage IA Multiple Myeloma DS Stage IA Plasma Cell Myeloma Durie/Salmon Stage IA Plasma Cell Myeloma DS Stage IA Multiple Myeloma Durie/Salmon stage I multiple myeloma associated with abnormal renal function (serum creatinine concentration greater than or equal to 2.0 mg/dL). C181860 Neoplastic Process DS Stage IB Multiple Myeloma CL1664893 Malignant DS Stage IB Multiple Myeloma DS Stage IB Plasma Cell Myeloma Durie/Salmon Stage IB Plasma Cell Myeloma DS Stage IB Multiple Myeloma Durie/Salmon stage II multiple myeloma associated with a relatively normal renal function (serum creatinine concentration < 2.0 mg/dL). C181862 Neoplastic Process DS Stage IIA Multiple Myeloma CL1664891 Malignant DS Stage IIA Multiple Myeloma DS Stage IIA Plasma Cell Myeloma Durie/Salmon Stage IIA Plasma Cell Myeloma DS Stage IIA Multiple Myeloma Durie/Salmon stage II multiple myeloma associated with abnormal renal function (serum creatinine concentration greater than or equal to 2.0 mg/dL). C181864 Neoplastic Process DS Stage IIB Multiple Myeloma CL1664897 Malignant DS Stage IIB Multiple Myeloma DS Stage IIB Plasma Cell Myeloma Durie/Salmon Stage IIB Plasma Cell Myeloma DS Stage IIB Multiple Myeloma Durie/Salmon stage III multiple myeloma associated with a relatively normal renal function (serum creatinine concentration < 2.0 mg/dL). C181865 Neoplastic Process DS Stage IIIA Multiple Myeloma CL1664898 Malignant DS Stage IIIA Multiple Myeloma DS Stage IIIA Plasma Cell Myeloma Durie/Salmon Stage IIIA Plasma Cell Myeloma DS Stage IIIA Multiple Myeloma Durie/Salmon stage III multiple myeloma associated with abnormal renal function (serum creatinine concentration greater than or equal to 2.0 mg/dL). C181866 Neoplastic Process DS Stage IIIB Multiple Myeloma CL1664895 Malignant DS Stage IIIB Multiple Myeloma DS Stage IIIB Plasma Cell Myeloma Durie/Salmon Stage IIIB Plasma Cell Myeloma DS Stage IIIB Multiple Myeloma Vulvar squamous cell carcinoma in which information on the p16 immunohistochemistry or HPV testing status is not available. C181902 Neoplastic Process Vulvar Squamous Cell Carcinoma, Not Otherwise Specified CL1664852 Malignant Vulvar Squamous Cell Carcinoma, NOS Vulvar Squamous Cell Carcinoma, Not Otherwise Specified Vulvar Squamous Cell Carcinoma, Not Otherwise Specified Vulvar squamous cell carcinoma not associated with human papillomavirus infection. C181903 Neoplastic Process Human Papillomavirus-Independent Vulvar Squamous Cell Carcinoma CL1664853 Malignant HPV-Independent Vulvar Squamous Cell Carcinoma Human Papillomavirus-Independent Vulvar Squamous Cell Carcinoma Human Papillomavirus-Independent Vulvar Squamous Cell Carcinoma A rare benign, borderline, or malignant phyllodes tumor arising from the vulva. C181905 Neoplastic Process Vulvar Phyllodes Tumor CL1664859 Undetermined Vulvar Phyllodes Tumor Vulvar Phyllodes Tumor A rare benign phyllodes tumor arising from the vulva. C181906 Neoplastic Process Benign Vulvar Phyllodes Tumor CL1664856 Benign Benign Vulvar Phyllodes Tumor Benign Vulvar Phyllodes Tumor A rare borderline phyllodes tumor arising from the vulva. C181907 Neoplastic Process Borderline Vulvar Phyllodes Tumor CL1664857 Uncertain Malignant Potential Borderline Vulvar Phyllodes Tumor Borderline Vulvar Phyllodes Tumor A rare extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue affecting the endometrium. C181910 Neoplastic Process Endometrial Mucosa-Associated Lymphoid Tissue Lymphoma CL1664844 Malignant Endometrial MALT Lymphoma Endometrial Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Endometrial Mucosa-Associated Lymphoid Tissue Lymphoma Endometrial Mucosa-Associated Lymphoid Tissue Lymphoma A benign, well-defined, lobulated, myxoid or gelatinous tumor that arises from the vulva. It shares morphological features with lipoblastoma, myxoid liposarcoma, and spindle cell lipoma. It is characterized by a lobulated growth and is composed of mature adipocytes, lipoblasts, and spindle cells without atypia in a myxoid matrix. DDIT3 and PLAG1 gene rearrangements seen in lipoblastoma and myxoid liposarcoma are not present in this tumor. It can recur infrequently and there are no reports of metastasis. C181925 Neoplastic Process Vulvar Lipoblastoma-Like Tumor CL1664943 Benign Vulvar Lipoblastoma-Like Neoplasm Vulvar Lipoblastoma-Like Tumor Vulvar Lipoblastoma-Like Tumor A rare, benign mesenchymal neoplasm that arises from the vulvar region, usually the labia majora of prepubertal girls. It presents as a slow-growing, unilateral painless mass. It is characterized by an infiltrative growth of bland spindle cells in a collagenous, edematous, or myxoid stroma. It may recur following incomplete excision. C181926 Neoplastic Process Vulvar Prepubertal Fibroma CL1664941 Benign Vulvar Prepubertal Fibroma Vulvar Prepubertal Fibroma A rare solitary fibrous tumor that arises from the vulva. C181935 Neoplastic Process Vulvar Solitary Fibrous Tumor CL1664933 Undetermined Vulvar Solitary Fibrous Tumor Vulvar Solitary Fibrous Tumor A rare solitary fibrous tumor that arises from the vagina. C181936 Neoplastic Process Vaginal Solitary Fibrous Tumor CL1664934 Undetermined Vaginal Solitary Fibrous Tumor Vaginal Solitary Fibrous Tumor A Kaposi sarcoma arising from the vulva. C181938 Neoplastic Process Vulvar Kaposi Sarcoma CL1664940 Malignant Vulvar Kaposi Sarcoma Vulvar Kaposi Sarcoma A smooth muscle neoplasm that arises from the vulva and cannot be reliably diagnosed as benign or malignant because of the presence of ambiguous morphologic findings. C181939 Neoplastic Process Vulvar Smooth Muscle Tumor of Uncertain Malignant Potential CL1664937 Uncertain Malignant Potential Vulvar STUMP Vulvar Smooth Muscle Neoplasm of Uncertain Malignant Potential Vulvar Smooth Muscle Tumor of Uncertain Malignant Potential Vulvar Smooth Muscle Tumor of Uncertain Malignant Potential A smooth muscle neoplasm that arises from the vagina and cannot be reliably diagnosed as benign or malignant because of the presence of ambiguous morphologic findings. C181940 Neoplastic Process Vaginal Smooth Muscle Tumor of Uncertain Malignant Potential CL1664938 Uncertain Malignant Potential Vaginal STUMP Vaginal Smooth Muscle Neoplasm of Uncertain Malignant Potential Vaginal Smooth Muscle Tumor of Uncertain Malignant Potential Vaginal Smooth Muscle Tumor of Uncertain Malignant Potential A smooth muscle neoplasm that arises from any part of the female reproductive system and cannot be reliably diagnosed as benign or malignant because of the presence of ambiguous morphologic findings. C181941 Neoplastic Process Female Reproductive System Smooth Muscle Tumor of Uncertain Malignant Potential CL1664927 Uncertain Malignant Potential Female Reproductive System STUMP Female Reproductive System Smooth Muscle Neoplasm of Uncertain Malignant Potential Female Reproductive System Smooth Muscle Tumor of Uncertain Malignant Potential Female Reproductive System Smooth Muscle Tumor of Uncertain Malignant Potential A rare benign polypoid skeletal muscle neoplasm arising from the vulva. It is characterized by the presence of round striated muscle cells and strap-like skeletal muscle cells, and vascular space formations within a fibrous and myxoid stroma. C181942 Neoplastic Process Vulvar Rhabdomyoma CL1664928 Benign Vulvar Rhabdomyoma Vulvar Rhabdomyoma A malignant mesenchymal neoplasm with skeletal muscle differentiation arising from the vulva. C181944 Neoplastic Process Vulvar Rhabdomyosarcoma CL1664926 Malignant Vulvar Rhabdomyosarcoma Vulvar Rhabdomyosarcoma The reemergence of distal bile duct adenocarcinoma after a period of remission. C181966 Neoplastic Process Recurrent Distal Bile Duct Adenocarcinoma Recurrent Distal Bile Duct Adenocarcinoma CL1664912 CTRP Malignant Recurrent Distal Bile Duct Adenocarcinoma Recurrent Extrahepatic Cholangiocarcinoma Recurrent Distal Bile Duct Adenocarcinoma Lung adenosquamous carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C181967 Neoplastic Process Advanced Lung Adenosquamous Carcinoma Advanced Lung Adenosquamous Carcinoma CL1664909 CTRP Malignant Advanced Lung Adenosquamous Carcinoma Advanced Lung Adenosquamous Carcinoma An epithelioid sarcoma that arises from the vulva. C181971 Neoplastic Process Vulvar Epithelioid Sarcoma CL1664913 Malignant Vulvar Epithelioid Sarcoma Vulvar Epithelioid Sarcoma A rare epithelioid sarcoma of the distal type that arises from the vulva. C181973 Neoplastic Process Vulvar Distal-Type Epithelioid Sarcoma CL1664907 Malignant Vulvar Distal-Type Epithelioid Sarcoma Vulvar Distal-Type Epithelioid Sarcoma Ewing sarcoma arising from the vulva. C181977 Neoplastic Process Vulvar Ewing Sarcoma CL1664906 Malignant Vulvar Ewing Sarcoma Vulvar Ewing Sarcoma The reemergence of astrocytoma, IDH-mutant, Grade 4, after a period of remission. C182018 Neoplastic Process Recurrent Glioblastoma, IDH-Mutant Recurrent Astrocytoma, IDH-Mutant, Grade 4 CL1770704 CTRP Malignant Recurrent Astrocytoma, IDH-Mutant, Grade 4 Recurrent Astrocytoma, IDH-Mutant, Grade IV Recurrent Glioblastoma, IDH-Mutant Recurrent Astrocytoma, IDH-Mutant, Grade 4 The reemergence of glioblastoma, IDH-wildtype after a period of remission. C182019 Neoplastic Process Recurrent Glioblastoma, IDH-Wildtype Recurrent Glioblastoma, IDH-Wildtype CL1770709 CTRP Malignant Recurrent Glioblastoma, IDH-Wildtype Recurrent Glioblastoma, IDH-Wildtype Pleomorphic liposarcoma that has spread from its original site of growth to another anatomic site. C182025 Neoplastic Process Metastatic Pleomorphic Liposarcoma Metastatic Pleomorphic Liposarcoma CL1770705 CTRP Malignant Metastatic Pleomorphic Liposarcoma Metastatic Pleomorphic Liposarcoma Pleomorphic liposarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C182026 Neoplastic Process Advanced Pleomorphic Liposarcoma Advanced Pleomorphic Liposarcoma CL1770706 CTRP Malignant Advanced Pleomorphic Liposarcoma Advanced Pleomorphic Liposarcoma Pleomorphic liposarcoma that is not amenable to surgical resection. C182028 Neoplastic Process Unresectable Pleomorphic Liposarcoma Unresectable Pleomorphic Liposarcoma CL1770647 CTRP Malignant Unresectable Pleomorphic Liposarcoma Unresectable Pleomorphic Liposarcoma The reemergence of schwannoma after a period of remission. C182029 Neoplastic Process Recurrent Schwannoma Recurrent Schwannoma CL1770644 CTRP Benign Recurrent Schwannoma Recurrent Schwannoma The reemergence of a nervous system neoplasm after a period of remission. C182030 Neoplastic Process Recurrent Nervous System Neoplasm CL1770645 Undetermined Recurrent Nervous System Neoplasm Recurrent Nervous System Neoplasm Immunoblastic lymphoma that is resistant to treatment. C182034 Neoplastic Process Refractory Immunoblastic Lymphoma Refractory Immunoblastic Lymphoma CL1770641 CTRP Malignant Refractory Immunoblastic Lymphoma Refractory Immunoblastic Lymphoma The reemergence of immunoblastic lymphoma after a period of remission. C182035 Neoplastic Process Recurrent Immunoblastic Lymphoma Recurrent Immunoblastic Lymphoma CL1770654 CTRP Malignant Recurrent Immunoblastic Lymphoma Recurrent Immunoblastic Lymphoma Appendix adenocarcinoma that has spread from its original site of growth to another anatomic site. C182104 Neoplastic Process Metastatic Appendix Adenocarcinoma CL1770602 Malignant Metastatic Appendix Adenocarcinoma Metastatic Appendix Adenocarcinoma Appendix adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C182105 Neoplastic Process Advanced Appendix Adenocarcinoma Advanced Appendix Adenocarcinoma CL1770599 CTRP Malignant Advanced Appendix Adenocarcinoma Advanced Appendix Adenocarcinoma The reemergence of HER2-positive breast carcinoma after a period of remission. C182108 Neoplastic Process Recurrent HER2-Positive Breast Carcinoma Recurrent HER2-Positive Breast Carcinoma CL1770612 CTRP Malignant Recurrent HER2 Positive Breast Carcinoma Recurrent HER2-Positive Breast Carcinoma Recurrent HER2-Positive Breast Carcinoma HER2-positive breast carcinoma that is resistant to treatment. C182110 Neoplastic Process Refractory HER2-Positive Breast Carcinoma Refractory HER2-Positive Breast Carcinoma CL1770610 CTRP Malignant Refractory HER2 Positive Breast Carcinoma Refractory HER2-Positive Breast Carcinoma Refractory HER2-Positive Breast Carcinoma Squamous cell carcinoma of the penis that has spread from its original site of growth to another anatomic site. C182111 Neoplastic Process Metastatic Squamous Cell Carcinoma of the Penis Metastatic Penile Squamous Cell Carcinoma C0862630 CTRP Malignant Metastatic Penile Squamous Cell Carcinoma Metastatic Squamous Cell Carcinoma of the Penis Metastatic Penile Squamous Cell Carcinoma Conjunctival melanoma that has spread from its original site of growth to another anatomic site. C182127 Neoplastic Process Metastatic Conjunctival Melanoma Metastatic Conjunctival Melanoma CL1770623 CTRP Malignant Metastatic Conjunctival Melanoma Metastatic Conjunctival Melanoma A diffuse glioma that arises from the midline structures of the central nervous system. The majority of these tumors are found in the brainstem. C182151 Neoplastic Process Diffuse Midline Glioma CL978762 Malignant Diffuse Midline Glioma Diffuse Midline Glioma A widely used spectroscopy technique that has a single image of focus that is relatively easy to acquire and interpret. This technique provides high signal-to-noise in a relatively short scan time and is most suitable for medium-sized homogenous lesions in large organs. C182232 Diagnostic Procedure Single Voxel Spectroscopy CL1770832 DIPG/DMG SV Single Voxel Spectroscopy Single Voxel Spectroscopy A spectroscopy technique that has multiple images of focus and a lower signal-to-noise and a slower imaging time. It is best for lesions in small organs or for inhomogeneous lesions in larger organs. C182278 Diagnostic Procedure Multi Voxel Spectroscopy CL1770878 DIPG/DMG MV Multi Voxel Spectroscopy Multi Voxel Spectroscopy A diffuse glioma that arises from the midline structures of the central nervous system, other than the pons. C182436 Neoplastic Process Diffuse Non-Pontine Midline Glioma CL1771122 DIPG/DMG Malignant Diffuse Non-Pontine Midline Glioma Non-Pontine-DMG Diffuse Non-Pontine Midline Glioma Intermittent therapeutic administration of high doses of steroids over short periods of time. C182447 Therapeutic or Preventive Procedure Pulse Steroids CL1771127 Corticosteroids - Pulse dose Pulse Steroid Therapy Pulse Steroids Pulse Steroids A rare, benign, circumscribed nodule arising from the bronchioles. It is usually seen in middle-aged to elderly patients. It is characterized by the presence a two-layer cellular structure composed of a basal and luminal layer. C183045 Neoplastic Process Bronchiolar Adenoma/Ciliated Muconodular Papillary Tumor CL1771510 Benign BA/CMPT Bronchiolar Adenoma/Ciliated Muconodular Papillary Tumor Lung Peripheral Papilloma Lung Solitary Peripheral Ciliated Glandular Papilloma Bronchiolar Adenoma/Ciliated Muconodular Papillary Tumor An invasive adenocarcinoma that arises from the lung. It is characterized by the absence of tall columnar cells and mucin production. This category includes lepidic adenocarcinoma, acinar adenocarcinoma, papillary adenocarcinoma, micropapillary adenocarcinoma, and solid adenocarcinoma. C183109 Neoplastic Process Invasive Lung Non-Mucinous Adenocarcinoma CL1771454 Malignant Invasive Lung Non-Mucinous Adenocarcinoma Invasive Lung Non-Mucinous Adenocarcinoma T1-weighted magnetic resonance imaging that uses multiple images to construct a 3-dimensional representation of an anatomic structure. C183113 Diagnostic Procedure 3-Dimensional T1-Weighted Magnetic Resonance Imaging 3-Dimensional T1-Weighted Magnetic Resonance Imaging CL1771463 CTRP 3-Dimensional T1-Weighted Magnetic Resonance Imaging 3-dimensional T1-Weighted MRI 3D T1-Weighted Anatomic Imaging 3D T1-Weighted MRI Three-Dimensional T1-Weighted MRI Three-Dimensional T1-Weighted Magnetic Resonance Imaging 3-Dimensional T1-Weighted Magnetic Resonance Imaging An aggressive, high-grade malignant neoplasm characterized by biallelic inactivation of SMARCA4 gene. It affects adults, usually heavy smokers, and involves the thorax (lung, pulmonary hilum, mediastinum, and/or pleura) with or without chest wall invasion. It is composed of sheets of malignant large round to epithelioid cells. Rhabdoid cells may be present. Increased number of mitoses and necrosis are frequently seen. The prognosis is poor. C183115 Neoplastic Process Thoracic SMARCA4-Deficient Undifferentiated Tumor CL1663952 Malignant SMARCA4-Deficient Thoracic Sarcoma SMARCA4-Deficient Thoracic Sarcomatoid Tumor SMARCA4-UT Thoracic SMARCA4-Deficient Undifferentiated Tumor Thoracic SMARCA4-Deficient Undifferentiated Tumor An extremely rare, low-grade carcinoma that arises endobronchially in the central airways. It is composed of small to medium-sized malignant epithelial cells with clear and eosinophilic cytoplasm forming nests, cords, and trabeculae in a hyalinized stroma. It is associated with the presence of EWSR1-ATF1 fusion gene. C183116 Neoplastic Process Lung Hyalinizing Clear Cell Carcinoma CL1771462 Malignant Lung Hyalinizing Clear Cell Carcinoma Lung Hyalinizing Clear Cell Carcinoma An aggressive extranodal B-cell non-Hodgkin lymphoma that affects the lung. It is characterized by the presence of large neoplastic lymphocytes exclusively in the lumina of small vessels, particularly capillaries. C183121 Neoplastic Process Lung Intravascular Large B-Cell Lymphoma CL1771361 Malignant IVLBCL Intravascular Large B-Cell Lymphoma of the Lung Lung Intravascular Large B-Cell Lymphoma Pulmonary Intravascular Large B-Cell Lymphoma Lung Intravascular Large B-Cell Lymphoma Malignant ovarian Brenner tumor that is resistant to treatment. C183126 Neoplastic Process Refractory Malignant Ovarian Brenner Tumor Refractory Malignant Ovarian Brenner Tumor CL1771358 CTRP Malignant Refractory Malignant Ovarian Brenner Tumor Refractory Malignant Ovarian Brenner Tumor The reemergence of small cell neuroendocrine carcinoma after a period of remission. C183127 Neoplastic Process Recurrent Small Cell Neuroendocrine Carcinoma Recurrent Small Cell Neuroendocrine Carcinoma CL1771355 CTRP Malignant Recurrent Small Cell Neuroendocrine Carcinoma Recurrent Small Cell Neuroendocrine Carcinoma The reemergence of extrapulmonary small cell neuroendocrine carcinoma after a period of remission. C183128 Neoplastic Process Recurrent Extrapulmonary Small Cell Neuroendocrine Carcinoma Recurrent Extrapulmonary Small Cell Neuroendocrine Carcinoma CL1771356 CTRP Malignant Recurrent Extrapulmonary Small Cell Neuroendocrine Carcinoma Recurrent Extrapulmonary Small Cell Neuroendocrine Carcinoma A non-invasive mesothelial neoplasm that arises from the pleura. It is characterized by the proliferation of a single-layer of flat or cuboidal neoplastic mesothelial cells. Cytological atypia is absent or minimal. Mitoses are absent. BAP1 gene inactivation and/or CDKN2A gene homozygous deletion are present. Patients present with non-resolving pleural effusion. It may progress to invasive epithelioid mesothelioma. C183134 Neoplastic Process Pleural Mesothelioma In Situ CL1771365 Uncertain Malignant Potential Pleural Mesothelioma In Situ Pleural Mesothelioma In Situ Primary effusion lymphoma that affects the pleural cavity. The majority of patients are HIV-positive men. C183135 Neoplastic Process Pleural Primary Effusion Lymphoma CL1771362 Malignant Pleural Primary Effusion Lymphoma Pleural Primary Effusion Lymphoma Primary effusion lymphoma that affects the pericardial cavity. The majority of patients are HIV-positive men. C183136 Neoplastic Process Pericardial Primary Effusion Lymphoma CL1771363 Malignant Pericardial Primary Effusion Lymphoma Pericardial Primary Effusion Lymphoma Primary effusion lymphoma that affects the peritoneal cavity. The majority of patients are HIV-positive men. C183137 Neoplastic Process Peritoneal Primary Effusion Lymphoma CL1771376 Malignant Peritoneal Primary Effusion Lymphoma Peritoneal Primary Effusion Lymphoma The reemergence of diffuse large B-cell lymphoma associated with chronic inflammation after a period of remission. C183140 Neoplastic Process Recurrent Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation Recurrent Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation CL1771375 CTRP Malignant Recurrent Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation Recurrent Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation A rare fibrin-associated diffuse large B-cell lymphoma that affects the heart. C183141 Neoplastic Process Cardiac Fibrin-Associated Diffuse Large B-Cell Lymphoma CL1771372 Malignant Cardiac FA-DLBCL Cardiac Fibrin-Associated Diffuse Large B-Cell Lymphoma Heart FA-DLBCL Heart Fibrin-Associated Diffuse Large B-Cell Lymphoma Cardiac Fibrin-Associated Diffuse Large B-Cell Lymphoma Diffuse large B-cell lymphoma associated with chronic inflammation that is resistant to treatment. C183142 Neoplastic Process Refractory Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation Refractory Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation CL1771373 CTRP Malignant Refractory Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation Refractory Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation A diffuse large B-cell lymphoma that arises from the heart. C183146 Neoplastic Process Cardiac Diffuse Large B-Cell Lymphoma CL1771383 Malignant Cardiac Diffuse Large B-Cell Lymphoma Heart Diffuse Large B-Cell Lymphoma Primary Cardiac Diffuse Large B-Cell Lymphoma Primary Heart Diffuse Large B-Cell Lymphoma Cardiac Diffuse Large B-Cell Lymphoma A procedure that uses sound waves to create a video image of the pelvic organs and tissues. A small, lubricated probe placed into the rectum releases sound waves, which create echoes as they enter a pelvic organ. The echoes that bounce back are sent to a computer that translates the pattern of echoes into a picture of the specific organ under examination. This procedure is most often used to evaluate the prostate gland. C18315 Diagnostic Procedure Transrectal Ultrasound Transrectal Ultrasound C2960324 CTRP A procedure in which a probe that sends out high-energy sound waves is inserted into the rectum. The sound waves are bounced off internal tissues or organs and make echoes. The echoes form a picture of body tissue called a sonogram. Transrectal ultrasound is used to look for abnormalities in the rectum and nearby structures, including the prostate. Transrectal_Ultrasound ERUS TRUS Transrectal Ultrasound endorectal ultrasound transrectal ultrasound Transrectal Ultrasound Malignant leptomeningeal neoplasm that is resistant to treatment. C183152 Neoplastic Process Refractory Malignant Leptomeningeal Neoplasm Refractory Malignant Leptomeningeal Neoplasm CL1771379 CTRP Malignant Refractory Malignant Leptomeningeal Neoplasm Refractory Malignant Leptomeningeal Neoplasm Ovarian mucinous adenocarcinoma that has spread from its original site of growth to another anatomic site. C183244 Neoplastic Process Metastatic Ovarian Mucinous Adenocarcinoma Metastatic Ovarian Mucinous Adenocarcinoma CL1771748 CTRP Malignant Metastatic Ovarian Mucinous Adenocarcinoma Metastatic Ovarian Mucinous Adenocarcinoma Ovarian mucinous adenocarcinoma that is not amenable to surgical resection. C183245 Neoplastic Process Unresectable Ovarian Mucinous Adenocarcinoma Unresectable Ovarian Mucinous Adenocarcinoma CL1771749 CTRP Malignant Unresectable Ovarian Mucinous Adenocarcinoma Unresectable Ovarian Mucinous Adenocarcinoma Embryonal rhabdomyosarcoma that has spread from its original site of growth to another anatomic site. C183250 Neoplastic Process Metastatic Embryonal Rhabdomyosarcoma Metastatic Embryonal Rhabdomyosarcoma C3873535 CTRP Malignant Metastatic Embryonal Rhabdomyosarcoma Metastatic Embryonal Rhabdomyosarcoma A sarcomatoid renal cell carcinoma that is not amenable to surgical resection. C183251 Neoplastic Process Unresectable Sarcomatoid Renal Cell Carcinoma Unresectable Sarcomatoid Renal Cell Carcinoma CL1771638 CTRP Malignant Unresectable Sarcomatoid Renal Cell Carcinoma Unresectable Sarcomatoid Renal Cell Carcinoma A rare, benign, well-circumscribed lesion arising from the pleura. It is characterized by the presence of fibroblasts, lymphoplasmacytic infiltrates, collagenous stroma formation, and dystrophic calcifications. Patients may present with chest pain, dyspnea, cough, or may be asymptomatic. C183277 Neoplastic Process Pleural Calcifying Fibrous Tumor CL1771660 Benign Pleural Calcifying Fibrous Tumor Pleural Calcifying Fibrous Tumor A very rare primary thymic carcinoma that resembles adenoid cystic carcinoma of the salivary gland. C183313 Neoplastic Process Thymic Carcinoma with Adenoid Cystic Carcinoma-Like Features CL528710 Malignant TCACC Thymic Carcinoma with Adenoid Cystic Carcinoma-Like Features Thymic Carcinoma with Adenoid Cystic Carcinoma-Like Features A primary thymic adenocarcinoma characterized by morphological and immunohistochemical features seen in colorectal adenocarcinoma. C183314 Neoplastic Process Thymic Enteric-Type Adenocarcinoma CL1771586 Malignant Thymic Enteric-Type Adenocarcinoma Thymic Intestinal-Type Adenocarcinoma Thymic Mucinous (Colloid) Adenocarcinoma Thymic Enteric-Type Adenocarcinoma A primary thymic adenocarcinoma that does not conform to either low-grade papillary adenocarcinoma or enteric-type adenocarcinoma. C183315 Neoplastic Process Thymic Adenocarcinoma, Not Otherwise Specified CL1771587 Malignant Thymic Adenocarcinoma, NOS Thymic Adenocarcinoma, Not Otherwise Specified Thymic Adenocarcinoma, Not Otherwise Specified A primary thymic carcinoma that cannot be defined as one of the thymic carcinomas with specific morphologic characteristics. C183316 Neoplastic Process Thymic Carcinoma, Not Otherwise Specified CL1771584 Malignant Thymic Carcinoma, NOS Thymic Carcinoma, Not Otherwise Specified Thymic Carcinoma, Not Otherwise Specified A rare follicular dendritic cell sarcoma that affects the structures of the mediastinum. C183374 Neoplastic Process Mediastinal Follicular Dendritic Cell Sarcoma CL1771628 Malignant Follicular Dendritic Cell Sarcoma of the Mediastinum Mediastinal Follicular Dendritic Cell Sarcoma Mediastinal Follicular Dendritic Cell Sarcoma The spread of a malignant neoplasm to the mediastinal lymph nodes from an adjacent or distant anatomic site. C183510 Neoplastic Process Metastatic Malignant Neoplasm in the Mediastinal Lymph Nodes C0686651 Malignant Metastatic Malignant Neoplasm in the Mediastinal Lymph Nodes Metastatic Malignant Neoplasm in the Mediastinal Lymph Nodes The reemergence of indolent B-cell non-Hodgkin lymphoma after a period of remission. C183512 Neoplastic Process Recurrent Indolent B-Cell Non-Hodgkin Lymphoma Recurrent Indolent B-Cell Non-Hodgkin Lymphoma CL1771882 CTRP Malignant Recurrent Indolent B-Cell Non-Hodgkin Lymphoma Recurrent Indolent B-Cell Non-Hodgkin Lymphoma The reemergence of indolent T-cell non-Hodgkin lymphoma after a period of remission. C183513 Neoplastic Process Recurrent Indolent T-Cell Non-Hodgkin Lymphoma Recurrent Indolent T-Cell Non-Hodgkin Lymphoma CL1771883 CTRP Malignant Recurrent Indolent T-Cell Non-Hodgkin Lymphoma Recurrent Indolent T-Cell Non-Hodgkin Lymphoma Indolent B-cell non-Hodgkin lymphoma that is resistant to treatment. C183514 Neoplastic Process Refractory Indolent B-Cell Non-Hodgkin Lymphoma Refractory Indolent B-Cell Non-Hodgkin Lymphoma CL1771880 CTRP Malignant Refractory Indolent B-Cell Non-Hodgkin Lymphoma Refractory Indolent B-Cell Non-Hodgkin Lymphoma Indolent T-cell non-Hodgkin lymphoma that is resistant to treatment. C183515 Neoplastic Process Refractory Indolent T-Cell Non-Hodgkin Lymphoma Refractory Indolent T-Cell Non-Hodgkin Lymphoma CL1771881 CTRP Malignant Refractory Indolent T-Cell Non-Hodgkin Lymphoma Refractory Indolent T-Cell Non-Hodgkin Lymphoma A benign adenoma that arises from the salivary gland. This group includes pleomorphic adenoma, canalicular adenoma, basal cell adenoma, and sebaceous adenoma. C184295 Neoplastic Process Salivary Gland Adenoma C0948102 Benign Salivary Gland Adenoma Salivary Gland Adenoma A type of ablative radiation therapy that uses a limited number of fairly large dose pulses while adjusting to specific anatomic and/or biological changes which may occur during the course of the treatment. C184323 Therapeutic or Preventive Procedure Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy CL1772623 CTRP PULSAR Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy Digital mammography assists in the early detection of breast cancer by incorporating modern electronics and computers into x-ray mammography methods. Instead of acquiring an image on film, it is collected electronically and can be stored directly into a computer. Digital mammography is quick and has the potential to reduce patient anxiety and inconvenience. Moreover, digital mammograms are easily archived and electronically transferable, making them ideal for teaching purposes and for evaluation during long-distance telemedicine consultations. C18467 Diagnostic Procedure Digital Mammography Digital Mammography C0860950 CTRP The use of a computer, rather than x-ray film, to create a picture of the breast. Digital_Mammography Digital Mammography digital mammography Digital Mammography An individual history of a cancer occurring in the central nervous system, other than those listed. C184750 Clinical Attribute Personal History of Other Central Nervous System Tumor CL1773067 GDC CNS, other History of Other Central Nervous System Tumor Other Central Nervous System Tumor Personal History of Other Central Nervous System Tumor Personal History of Other Central Nervous System Tumor An individual history of a rhabdoid tumor occurring in the central nervous system. C184751 Clinical Attribute Personal History of Central Nervous System Rhabdoid Tumor CL1773080 GDC CNS, rhabdoid tumor History of Central Nervous System Rhabdoid Tumor Personal History of Central Nervous System Rhabdoid Tumor Personal History of Central Nervous System Rhabdoid Tumor An individual history of acute myeloid leukemia and induction failure. C184765 Clinical Attribute Personal History of Acute Myeloid Leukemia with Induction Failure CL1773082 GDC Induction Failure AML (AML-IF) History of Acute Myeloid Leukemia with Induction Failure Personal History of Acute Myeloid Leukemia with Induction Failure Personal History of Acute Myeloid Leukemia with Induction Failure An individual history of a cancer, other than those listed, within 5 years of the current cancer diagnosis. C184782 Clinical Attribute Personal History of Other Cancer Within 5 Years CL1773099 GDC Other Cancer Within 5 Years History of Other Cancer Within 5 Years Personal History of Other Cancer Within 5 Years Personal History of Other Cancer Within 5 Years An individual history of leukemia, other than those listed. C184784 Clinical Attribute Personal History of Other Leukemia C0260442 GDC Other Leukemias Personal History of Other Leukemia Personal History of Other Leukemia The presence of more than one plasmacytoma arising in the bone, concurrently or sequentially, in the absence of bone marrow involvement by plasma cell myeloma. C185035 Neoplastic Process Multiple Solitary Plasmacytoma of Bone CL1773177 Malignant Multiple Solitary Plasmacytoma of Bone Multiple Solitary Plasmacytoma of Bone Multiple myeloma involving the central nervous system. It manifests with single or multiple intraparenchymal lesions and/or leptomeningeal involvement. Patients present with diffuse cerebral dysfunction and nerve paralysis. The prognosis is poor. C185037 Neoplastic Process Extramedullary Disease in Multiple Myeloma Involving the Central Nervous System CL1773175 Malignant Central Nervous System Myelomatosis Central Nervous System Plasma Cell Myeloma Extramedullary Disease in Multiple Myeloma Involving the Central Nervous System Extramedullary Disease in Plasma Cell Myeloma Involving the Central Nervous System Extramedullary Disease in Multiple Myeloma Involving the Central Nervous System A central nervous system multiple myeloma involving the leptomeninges. C185039 Neoplastic Process Extramedullary Disease in Multiple Myeloma Involving the Leptomeninges CL508321 Malignant Extramedullary Disease in Multiple Myeloma Involving the Leptomeninges Extramedullary Disease in Plasma Cell Myeloma Involving the Leptomeninges Leptomeningeal Myelomatosis Leptomeningeal Plasma Cell Myeloma Extramedullary Disease in Multiple Myeloma Involving the Leptomeninges A plasmacytoma that arises in the spleen. C185041 Neoplastic Process Splenic Plasmacytoma CL1773173 Malignant Plasmacytoma of Spleen Primary Extramedullary Plasmacytoma of Spleen Primary Extramedullary Splenic Plasmacytoma Primary Extraosseous Plasmacytoma of Spleen Primary Extraosseous Splenic Plasmacytoma Primary Plasmacytoma of Spleen Primary Splenic Plasmacytoma Splenic Plasmacytoma Splenic Plasmacytoma A plasmacytoma that arises in the liver. C185042 Neoplastic Process Liver Plasmacytoma CL1773182 Malignant Liver Plasmacytoma Plasmacytoma of Liver Primary Extramedullary Liver Plasmacytoma Primary Extraosseous Liver Plasmacytoma Primary Liver Plasmacytoma Liver Plasmacytoma A plasmacytoma that arises in the lung. C185043 Neoplastic Process Lung Plasmacytoma CL1773183 Malignant Lung Plasmacytoma Plasmacytoma of Lung Primary Extramedullary Lung Plasmacytoma Primary Extraosseous Lung Plasmacytoma Primary Lung Plasmacytoma Lung Plasmacytoma A plasmacytoma that arises in the skin. C185044 Neoplastic Process Cutaneous Plasmacytoma C1275323 Malignant Cutaneous Plasmacytoma Plasmacytoma of Skin Primary Cutaneous Plasmacytoma Primary Extramedullary Cutaneous Plasmacytoma Primary Extramedullary Plasmacytoma of Skin Primary Extramedullary Skin Plasmacytoma Primary Extraosseous Cutaneous Plasmacytoma Primary Extraosseous Plasmacytoma of Skin Primary Extraosseous Skin Plasmacytoma Skin Plasmacytoma Cutaneous Plasmacytoma Fibrolamellar carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C185067 Neoplastic Process Advanced Fibrolamellar Carcinoma Advanced Fibrolamellar Carcinoma CL1773124 CTRP Malignant Advanced Fibrolamellar Carcinoma Advanced Fibrolamellar Carcinoma Hilar cholangiocarcinoma that is not amenable to surgical resection. C185068 Neoplastic Process Unresectable Hilar Cholangiocarcinoma Unresectable Hilar Cholangiocarcinoma CL1773121 CTRP Malignant Unresectable Hilar Cholangiocarcinoma Unresectable Hilar Cholangiocarcinoma Hilar cholangiocarcinoma that has spread from its original site of growth to another anatomic site. C185069 Neoplastic Process Metastatic Hilar Cholangiocarcinoma Metastatic Hilar Cholangiocarcinoma CL1773122 CTRP Malignant Metastatic Hilar Cholangiocarcinoma Metastatic Hilar Cholangiocarcinoma Hilar cholangiocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C185070 Neoplastic Process Advanced Hilar Cholangiocarcinoma Advanced Hilar Cholangiocarcinoma CL1773119 CTRP Malignant Advanced Hilar Cholangiocarcinoma Advanced Hilar Cholangiocarcinoma Extrahepatic bile duct carcinoma that has spread from its original site of growth to another anatomic site. C185071 Neoplastic Process Metastatic Extrahepatic Bile Duct Carcinoma Metastatic Extrahepatic Bile Duct Carcinoma CL1773120 CTRP Malignant Metastatic Extrahepatic Bile Duct Carcinoma Metastatic Extrahepatic Bile Duct Carcinoma Extrahepatic bile duct carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C185072 Neoplastic Process Advanced Extrahepatic Bile Duct Carcinoma Advanced Extrahepatic Bile Duct Carcinoma CL1773117 CTRP Malignant Advanced Extrahepatic Bile Duct Carcinoma Advanced Extrahepatic Bile Duct Carcinoma The reemergence of chordoma after a period of remission, at or adjacent to the site of the original tumor. C185073 Neoplastic Process Locally Recurrent Chordoma Locally Recurrent Chordoma CL1773118 CTRP Malignant Locally Recurrent Chordoma Locally Recurrent Chordoma An individual history of pheochromocytoma or paraganglioma. C185075 Clinical Attribute Personal History of Pheochromocytoma or Paraganglioma CL1773130 GDC Phenochromocytoma or Paraganglioma History of Pheochromocytoma or Paraganglioma Personal History of Pheochromocytoma or Paraganglioma Personal History of Pheochromocytoma or Paraganglioma Histologic transformation of a lymphoplasmacytic lymphoma to an aggressive diffuse large B-cell lymphoma. C185134 Neoplastic Process Transformed Lymphoplasmacytic Lymphoma to Diffuse Large B-Cell Lymphoma Transformed Lymphoplasmacytic Lymphoma to Diffuse Large B-Cell Lymphoma CL1773467 CTRP Malignant Transformed Lymphoplasmacytic Lymphoma to Diffuse Large B-Cell Lymphoma Transformed Lymphoplasmacytic Lymphoma to Diffuse Large B-Cell Lymphoma Histologic transformation of Waldenstrom macroglobulinemia to an aggressive diffuse large B-cell lymphoma. C185135 Neoplastic Process Transformed Waldenstrom Macroglobulinemia to Diffuse Large B-Cell Lymphoma Transformed Waldenstrom Macroglobulinemia to Diffuse Large B-Cell Lymphoma CL1773466 CTRP Malignant Transformed Waldenstrom Macroglobulinemia to Diffuse Large B-Cell Lymphoma Transformed Waldenstrom Macroglobulinemia to Diffuse Large B-Cell Lymphoma Infiltration of organs and soft tissues by malignant (clonal) plasma cells in patients with history of multiple myeloma. Skin, liver, lymph nodes, pleura, and central nervous system are the most frequently affected sites. C185149 Neoplastic Process Extramedullary Disease in Multiple Myeloma CL1773481 Malignant EMD Extramedullary Disease Extramedullary Disease in Multiple Myeloma Extramedullary Disease in Plasma Cell Myeloma Extramedullary Manifestation in Multiple Myeloma Extramedullary Manifestation in Plasma Cell Myeloma Extramedullary Disease in Multiple Myeloma Infiltration of the spleen by malignant (clonal) plasma cells in patients with history of multiple myeloma C185151 Neoplastic Process Extramedullary Disease in Multiple Myeloma Involving the Spleen CL1773480 Malignant Extramedullary Disease in Multiple Myeloma Involving the Spleen Extramedullary Disease in Plasma Cell Myeloma Involving the Spleen Extramedullary Disease in Multiple Myeloma Involving the Spleen Infiltration of the hepatic sinusoids by malignant (clonal) plasma cells in patients with history of multiple myeloma. C185152 Neoplastic Process Extramedullary Disease in Multiple Myeloma Involving the Liver CL1773483 Malignant Extramedullary Disease in Multiple Myeloma Involving the Liver Extramedullary Disease in Plasma Cell Myeloma Involving the Liver Extramedullary Disease in Multiple Myeloma Involving the Liver Infiltration of the kidney by malignant (clonal) plasma cells in patients with history of multiple myeloma. C185153 Neoplastic Process ConcertAI Extramedullary Disease in Multiple Myeloma Involving the Kidney CL1773482 Malignant Extramedullary Disease in Multiple Myeloma Involving the Kidney Extramedullary Disease in Plasma Cell Myeloma Involving the Kidney Extramedullary Disease in Multiple Myeloma Involving the Kidney Infiltration of the skin by malignant (clonal) plasma cells in patients with history of multiple myeloma. C185155 Neoplastic Process Extramedullary Disease in Multiple Myeloma Involving the Skin CL1773500 Malignant Extramedullary Disease in Multiple Myeloma Involving the Skin Extramedullary Disease in Plasma Cell Myeloma Involving the Skin Extramedullary Disease in Multiple Myeloma Involving the Skin Bone infiltration by malignant plasma cells in patients with history of plasma cell myeloma. Bone involvement occurs in approximately eighty percent of newly diagnosed symptomatic plasma cell myeloma patients. The axial skeleton, particularly the spine, and the proximal long bones are the most commonly affected bone sites. It results in osteolytic bone lesions, widespread osteopenia, and compression fractures. C185156 Neoplastic Process Plasma Cell Myeloma-Induced Bone Disease CL1773503 Malignant MBD Multiple Myeloma-Induced Bone Disease Myeloma Bone Disease Plasma Cell Myeloma-Induced Bone Disease Plasma Cell Myeloma-Induced Bone Disease The reemergence of hormone receptor-positive breast adenocarcinoma after a period of remission. C185157 Neoplastic Process Recurrent Hormone Receptor-Positive Breast Carcinoma Recurrent Hormone Receptor-Positive Breast Carcinoma CL1773502 CTRP Malignant Recurrent Hormone Receptor Positive Breast Adenocarcinoma Recurrent Hormone Receptor Positive Breast Carcinoma Recurrent Hormone Receptor-Positive Breast Carcinoma Recurrent Hormone Receptor-Positive Breast Carcinoma Colorectal carcinoma that has metastasized to a limited number of sites. C185165 Neoplastic Process Oligometastatic Colorectal Carcinoma Oligometastatic Colorectal Carcinoma CL1773494 CTRP Malignant Oligometastatic Colorectal Cancer Oligometastatic Colorectal Carcinoma Oligometastatic Colorectal Carcinoma An astrocytoma associated with IDH1 or IDH2 gene mutations and absence of 1p/19q codeletion. It is classified as grade 2, 3, or 4. C185167 Neoplastic Process Astrocytoma, IDH-Mutant CL1773496 Undetermined Astrocytoma, IDH-Mutant Astrocytoma, IDH-Mutant A glioblastoma characterized by the presence of large numbers of neoplastic cells with granular, PAS-positive cytoplasm. It is associated with an aggressive clinical course. C185178 Neoplastic Process Granular Cell Glioblastoma CL1773399 Malignant Granular Cell Astrocytoma/Glioblastoma Granular Cell Glioblastoma Granular Cell Glioblastoma An astrocytoma characterized by the presence of large numbers of neoplastic cells with granular, PAS-positive cytoplasm. It is associated with an aggressive clinical course, even when the histologic features suggest a lower-grade astrocytoma. C185179 Neoplastic Process Granular Cell Astrocytoma CL1773398 Undetermined Granular Cell Astrocytoma Granular Cell Astrocytoma A rare glioblastoma characterized by the presence of a predominant population of neoplastic cells with foamy cytoplasm. C185180 Neoplastic Process Lipidized Glioblastoma CL1773401 Malignant Heavily Lipidized Glioblastoma Lipidized Glioblastoma Malignant Glioma with Heavily Lipidized (Foamy) Tumor Cells Lipidized Glioblastoma Astrocytoma lacking mutations in IDH1 or IDH2 genes. It includes diffuse astrocytoma, IDH-wildtype and anaplastic astrocytoma, IDH-wildtype. C185184 Neoplastic Process Astrocytoma, IDH-Wildtype CL1773405 Undetermined Astrocytoma, IDH-Wildtype Astrocytoma, IDH-Wildtype A central nervous system tumor with morphological features of astrocytoma in which there is insufficient information on the IDH genes status. C185185 Neoplastic Process Astrocytoma, Not Otherwise Specified CL1773404 Undetermined Astrocytoma, NOS Astrocytoma, Not Otherwise Specified Astrocytoma, Not Otherwise Specified A rare IDH-and H3-wildtype diffuse astrocytoma characterized by the presence of a monomorphic population of neoplastic cells that exhibit alteration in the MYB gene. This alteration is associated with fusion between MYB gene and a partner gene, usually PCDHGA1, MMP16, and MAML2 genes. C185195 Neoplastic Process Diffuse Astrocytoma, MYB-Altered CL1773413 Undetermined Diffuse Astrocytoma, MYB-Altered Isomorphic Astrocytoma Variant Isomorphic Diffuse Glioma Diffuse Astrocytoma, MYB-Altered A rare IDH-and H3-wildtype diffuse astrocytoma characterized by the presence of a monomorphic population of neoplastic cells that exhibit alteration in the MYBL1 gene. This alteration is associated with fusion between MYBL1 gene and a partner gene, usually PCDHGA1, MMP16, and MAML2 genes. C185196 Neoplastic Process Diffuse Astrocytoma, MYBL1-Altered CL1773414 Undetermined Diffuse Astrocytoma, MYBL1-Altered Isomorphic Astrocytoma Variant Isomorphic Diffuse Glioma Diffuse Astrocytoma, MYBL1-Altered A rare, low-grade diffuse glioma with morphological features of astrocytoma or oligodendroglioma, generally affecting children. It is characterized by a gene alteration that results in a MAPK pathway abnormality. The genetic abnormalities are typically a BRAF p.V600E substitution mutation, mutations or fusions involving the FGFR1 gene and internal tandem duplication (ITD) of the sequences of FGFR1 gene encoding the tyrosine kinase domain (TKD). The tumor is IDH-wildtype and does not have a homozygous deletion of CDKN2A gene. C185218 Neoplastic Process Diffuse Low Grade Glioma, MAPK Pathway-Altered CL1773448 Undetermined Diffuse Low Grade Glioma, MAPK Pathway-Altered Diffuse Low-Grade Glioma, MAPK Pathway-Altered Diffuse Low Grade Glioma, MAPK Pathway-Altered Diffuse low-grade glioma characterized by internal tandem duplications of the sequences in the FGFR1 gene encoding the tyrosine kinase domain. C185219 Neoplastic Process Diffuse Low Grade Glioma, FGFR1 Tyrosine Kinase Domain-Duplicated CL1773447 Undetermined Diffuse Low Grade Glioma, FGFR1 TKD-Duplicated Diffuse Low Grade Glioma, FGFR1 Tyrosine Kinase Domain-Duplicated Diffuse Low-Grade Glioma, FGFR1 TKD-Duplicated Diffuse Low-Grade Glioma, FGFR1 Tyrosine Kinase Domain-Duplicated Diffuse Low Grade Glioma, FGFR1 Tyrosine Kinase Domain-Duplicated Diffuse low-grade glioma characterized by FGFR1 gene mutations, an internal tandem duplication within the FGFR1 gene or the presence of an FGFR1 fusion gene. C185220 Neoplastic Process Diffuse Low Grade Glioma, FGFR1-Mutant CL1773450 Undetermined Diffuse Low Grade Glioma, FGFR1-Mutant Diffuse Low-Grade Glioma, FGFR1-Mutant Diffuse Low Grade Glioma, FGFR1-Mutant Diffuse low-grade glioma characterized by the presence of BRAF gene mutations encoding a p.V600E substitution mutation. C185221 Neoplastic Process Diffuse Low Grade Glioma, BRAF p.V600E-Mutant CL1773449 Undetermined Diffuse Low Grade Glioma, BRAF p.V600E-Mutant Diffuse Low-Grade Glioma, BRAF p.V600E Mutant Diffuse Low Grade Glioma, BRAF p.V600E-Mutant Myelodysplastic syndromes/acute myeloid leukemias associated with germline SAMD9 mutation. C185293 Neoplastic Process Hematologic Neoplasm with Germline SAMD9 Mutation CL1773387 Malignant Hematologic Neoplasm with Germline SAMD9 Mutation Myeloid Neoplasm with Germline SAMD9 Mutation Hematologic Neoplasm with Germline SAMD9 Mutation Myelodysplastic syndromes/acute myeloid leukemias associated with germline SAMD9L mutation. C185294 Neoplastic Process Hematologic Neoplasm with Germline SAMD9L Mutation CL1773386 Malignant Hematologic Neoplasm with Germline SAMD9L Mutation Myeloid Neoplasm with Germline SAMD9L Mutation Hematologic Neoplasm with Germline SAMD9L Mutation The reemergence of vaginal squamous cell carcinoma after a period of remission. C185302 Neoplastic Process Recurrent Vaginal Squamous Cell Carcinoma Recurrent Vaginal Squamous Cell Carcinoma CL1773568 CTRP Malignant Recurrent Vaginal Squamous Cell Carcinoma Recurrent Vaginal Squamous Cell Carcinoma Vaginal squamous cell carcinoma that is resistant to treatment. C185303 Neoplastic Process Refractory Vaginal Squamous Cell Carcinoma Refractory Vaginal Squamous Cell Carcinoma CL1773570 CTRP Malignant Refractory Vaginal Squamous Cell Carcinoma Refractory Vaginal Squamous Cell Carcinoma Vulvar squamous cell carcinoma that is resistant to treatment. C185304 Neoplastic Process Refractory Vulvar Squamous Cell Carcinoma Refractory Vulvar Squamous Cell Carcinoma CL1773569 CTRP Malignant Refractory Vulvar Squamous Cell Carcinoma Refractory Vulvar Squamous Cell Carcinoma Pancreatobiliary carcinoma that is resistant to treatment. C185305 Neoplastic Process Refractory Pancreatobiliary Carcinoma Refractory Pancreatobiliary Carcinoma CL1773572 CTRP Malignant Refractory Pancreatobiliary Carcinoma Refractory Pancreatobiliary Carcinoma Infiltration of the lung by malignant (clonal) plasma cells in patients with history of multiple myeloma. C185321 Neoplastic Process Extramedullary Disease in Multiple Myeloma Involving the Lung CL1773586 Malignant Extramedullary Disease in Multiple Myeloma Involving the Lung Extramedullary Disease in Plasma Cell Myeloma Involving the Lung Extramedullary Disease in Multiple Myeloma Involving the Lung Nasal cavity squamous cell carcinoma that has spread to nearby tissues or lymph nodes. C185350 Neoplastic Process Locally Advanced Nasal Cavity Squamous Cell Carcinoma Locally Advanced Nasal Cavity Squamous Cell Carcinoma CL1773839 CTRP Malignant Locally Advanced Nasal Cavity Squamous Cell Carcinoma Locally Advanced Nasal Cavity Squamous Cell Carcinoma Paranasal sinus squamous cell carcinoma that has spread to nearby tissues or lymph nodes. C185351 Neoplastic Process Locally Advanced Paranasal Sinus Squamous Cell Carcinoma Locally Advanced Paranasal Sinus Squamous Cell Carcinoma CL1773840 CTRP Malignant Locally Advanced Paranasal Sinus Squamous Cell Carcinoma Locally Advanced Paranasal Sinus Squamous Cell Carcinoma A diffuse midline glioma characterized by H3 K27 alteration and usually either a histone H3 K27M mutation, an EGFR mutation, or aberrant overexpression of EZHIP. The prognosis is poor. C185368 Neoplastic Process Diffuse Midline Glioma, H3 K27-Altered CL1773784 Malignant Diffuse Midline Glioma, H3 K27-Altered Diffuse Midline Glioma, H3 K27-Altered A diffuse midline glioma, H3 K27-altered, characterized by the presence of EGFR gene mutation. C185369 Neoplastic Process Diffuse Midline Glioma, EGFR-Mutant CL1773785 Malignant Diffuse Midline Glioma, EGFR-Mutant Diffuse Midline Glioma, EGFR-Mutant A diffuse midline glioma, H3 K27-altered, characterized by the presence of EZHIP overexpression. C185370 Neoplastic Process Diffuse Midline Glioma with EZHIP Overexpression CL1773802 Malignant Diffuse Midline Glioma with EZHIP Overexpression Diffuse Midline Glioma with EZHIP Overexpression A WHO grade 4 diffuse glioma arising in the cerebral hemispheres. It is characterized by the presence of missense mutation of the H3-3A gene. The prognosis is poor. C185371 Neoplastic Process Diffuse Hemispheric Glioma, H3 G34-Mutant CL1773803 Malignant Diffuse Hemispheric Glioma, H3 G34-Mutant Diffuse Hemispheric Glioma, H3 G34-Mutant Mesonephric adenocarcinoma that has spread from its original site of growth to another anatomic site. C185381 Neoplastic Process Metastatic Mesonephric Adenocarcinoma Metastatic Mesonephric Adenocarcinoma CL1773793 CTRP Malignant Metastatic Malignant Mesonephroma Metastatic Mesonephric Adenocarcinoma Metastatic Mesonephric Carcinoma Metastatic Mesonephric Adenocarcinoma An aggressive, WHO grade 4 diffuse brain glioma usually affecting children, adolescents, or young adults. It is characterized by the absence of histone H3, IDH1, and IDH2 mutations. It includes the following subtypes, based on DNA methylation profiles: diffuse pediatric-type high grade glioma RTK1, diffuse pediatric-type high grade glioma RTK2, and diffuse pediatric-type high grade glioma MYCN. C185467 Neoplastic Process Diffuse Pediatric-Type High Grade Glioma, H3-Wildtype and IDH-Wildtype CL1773755 GDC Malignant Diffuse Pediatric-type High Grade Glioma Diffuse High Grade Glioma in Childhood, H3-Wildtype Diffuse High-Grade Glioma in Childhood, H3-Wildtype Diffuse Pediatric-Type High Grade Glioma, H3-Wildtype and IDH-Wildtype Diffuse Pediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype Pediatric Glioblastoma, H3-Wildtype Pediatric-Type Glioblastoma, H3-Wildtype pHGG, H3-Wildtype Diffuse Pediatric-Type High Grade Glioma, H3-Wildtype and IDH-Wildtype An aggressive, WHO grade 4 diffuse glioma usually affecting children, adolescents, or young adults. It is characterized by receptor tyrosine kinase type 2 (RTK2) alterations. C185468 Neoplastic Process Diffuse Pediatric-Type High Grade Glioma RTK2 CL1773774 Malignant Diffuse Pediatric-Type High Grade Glioma RTK2 Diffuse Pediatric-Type High-Grade Glioma RTK2 pHGG RTK2 Diffuse Pediatric-Type High Grade Glioma RTK2 An aggressive, WHO grade 4 diffuse glioma usually affecting children, adolescents, or young adults. It is characterized by receptor tyrosine kinase type 1 (RTK1) alterations. C185469 Neoplastic Process Diffuse Pediatric-Type High Grade Glioma RTK1 CL1773775 Malignant Diffuse Pediatric-Type High Grade Glioma RTK1 Diffuse Pediatric-Type High-Grade Glioma RTK1 pHGG RTK1 Diffuse Pediatric-Type High Grade Glioma RTK1 An aggressive, WHO grade 4 diffuse glioma usually affecting children, adolescents, or young adults. It is characterized by the expression of MYCN molecular signature. C185470 Neoplastic Process Diffuse Pediatric-Type High Grade Glioma MYCN CL1773772 Malignant Diffuse Pediatric-Type High Grade Glioma MYCN Diffuse Pediatric-Type High-Grade Glioma MYCN pHGG MYCN Diffuse Pediatric-Type High Grade Glioma MYCN A high-grade cellular astrocytoma that arises in the cerebral hemisphere and occurs in early childhood. It is characterized by receptor tyrosine kinase fusions in the NTRK family, ROS1, ALK, or MET genes. It includes the following subtypes: infant-type hemispheric glioma, NTRK-altered, infant-type hemispheric glioma, ROS1-altered, infant-type hemispheric glioma, ALK-altered, and infant-type hemispheric glioma, MET-altered. C185471 Neoplastic Process Infant-Type Hemispheric Glioma CL1773773 Malignant Infant-Type Hemispheric Glioma Infant-Type Hemispheric Glioma A high-grade cellular astrocytoma that arises in the cerebral hemisphere and occurs in early childhood. It is characterized by receptor tyrosine kinase fusions in the NTRK family. C185472 Neoplastic Process Infant-Type Hemispheric Glioma, NTRK-Altered CL1773778 Malignant Infant-Type Hemispheric Glioma, NTRK-Altered Infant-Type Hemispheric Glioma, NTRK-Altered A high-grade cellular astrocytoma that arises in the cerebral hemisphere and occurs in early childhood. It is characterized by receptor tyrosine kinase fusions in the ROS1 gene. C185473 Neoplastic Process Infant-Type Hemispheric Glioma, ROS1-Altered CL1773779 Malignant Infant-Type Hemispheric Glioma, ROS1-Altered Infant-Type Hemispheric Glioma, ROS1-Altered A high-grade cellular astrocytoma that arises in the cerebral hemisphere and occurs in early childhood. It is characterized by receptor tyrosine kinase fusions in the ALK gene. C185474 Neoplastic Process Infant-Type Hemispheric Glioma, ALK-Altered CL1773776 Malignant Infant-Type Hemispheric Glioma, ALK-Altered Infant-Type Hemispheric Glioma, ALK-Altered A high-grade cellular astrocytoma that arises in the cerebral hemisphere and occurs in early childhood. It is characterized by receptor tyrosine kinase fusions in the MET gene. C185475 Neoplastic Process Infant-Type Hemispheric Glioma, MET-Altered CL1773777 Malignant Infant-Type Hemispheric Glioma, MET-Altered Infant-Type Hemispheric Glioma, MET-Altered A toxicity that impairs or damages the hematologic system. C185640 Finding Hematologic Toxicity CL1773881 PCDC Hematologic Toxicity Hematologic Toxicity A toxicity that impairs or damages other than the hematologic system. C185641 Finding Non-Hematologic Toxicity CL1773882 PCDC Non-Hematologic Toxicity Non-Hematologic Toxicity Toxicity that impairs or damages the liver. C185645 Finding Hepatic Toxicity CL1773897 PCDC Hepatic Toxicity Hepatic Toxicity Toxicity that impairs or damages the gastrointestinal system. C185646 Finding Gastrointestinal Toxicity CL1773960 PCDC GI Toxicity Gastrointestinal Toxicity Gastrointestinal Toxicity A toxicity that impairs or damages the musculoskeletal system. C185647 Finding Musculoskeletal Toxicity CL976393 PCDC Musculoskeletal Toxicity Musculoskeletal Toxicity Toxicity that develops due to the administration of psychiatric medications. C185648 Finding Toxicity due to Psychiatric Drugs CL1773899 PCDC Psychiatric Toxicity Toxicity due to Psychiatric Drugs Toxicity due to Psychiatric Drugs Toxicity related to an infusion. C185649 Finding Infusion Related Toxicity CL1773900 PCDC Infusion Related Toxicity TOXICITY_INFUSION Infusion Related Toxicity A non-Hodgkin or Hodgkin lymphoma that arises from an anatomic site other than a lymph node. C185752 Neoplastic Process Extranodal Lymphoma CL1778288 Malignant Extranodal Lymphoma Extranodal Lymphoma A non-Hodgkin lymphoma that arises from an anatomic site other than a lymph node. C185753 Neoplastic Process Extranodal Non-Hodgkin Lymphoma Extranodal Non-Hodgkin Lymphoma CL1778289 CTRP Malignant Extranodal Non-Hodgkin Lymphoma Extranodal Non-Hodgkin Lymphoma MRI that uses a magnet capable of producing a 1.5 tesla field strength. C185866 Diagnostic Procedure 1.5 Tesla Magnetic Resonance Imaging 1.5 Tesla Magnetic Resonance Imaging CL1778247 CTRP 1.5 T MRI 1.5 T Magnetic Resonance Imaging 1.5 Tesla MRI 1.5 Tesla Magnetic Resonance Imaging 1.5 Tesla Magnetic Resonance Imaging An astrocytoma characterized by high-grade piloid and/or glioblastoma-like histological features. It may occur anywhere in the central nervous system but most often arises in the posterior fossa. Alterations in the following three pathways are responsible for the pathogenesis of this tumor: MAPK pathway, retinoblastoma tumor suppressor protein cell-cycle pathway, and telomere maintenance pathway. C185879 Neoplastic Process High Grade Astrocytoma with Piloid Features CL1778487 Malignant Anaplastic Astrocytoma with Piloid Features Anaplastic Pilocytic Astrocytoma High Grade Astrocytoma with Piloid Features High-Grade Astrocytoma with Piloid Features High Grade Astrocytoma with Piloid Features Hormone receptor-positive breast carcinoma that has spread from its original site of growth to another anatomic site. C185880 Neoplastic Process Metastatic Hormone Receptor-Positive Breast Carcinoma Metastatic Hormone Receptor-Positive Breast Carcinoma CL1778488 CTRP Malignant Metastatic Hormone Receptor Positive Breast Adenocarcinoma Metastatic Hormone Receptor Positive Breast Carcinoma Metastatic Hormone Receptor-Positive Breast Carcinoma Metastatic Hormone Receptor-Positive Breast Carcinoma Hormone receptor-positive breast carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C185881 Neoplastic Process Advanced Hormone Receptor-Positive Breast Carcinoma Advanced Hormone Receptor-Positive Breast Carcinoma CL1778489 CTRP Malignant Advanced Hormone Receptor Positive Breast Adenocarcinoma Advanced Hormone Receptor Positive Breast Carcinoma Advanced Hormone Receptor-Positive Breast Carcinoma Advanced Hormone Receptor-Positive Breast Carcinoma Malignant gastrointestinal stromal tumor that is resistant to treatment. C185882 Neoplastic Process Refractory Malignant Gastrointestinal Stromal Tumor Refractory Malignant Gastrointestinal Stromal Tumor CL1778490 CTRP Malignant Refractory Gastrointestinal Stromal Tumor Refractory Malignant Gastrointestinal Stromal Tumor Refractory Malignant Gastrointestinal Stromal Tumor A provisional tumor entity described in the supratentorial brain and characterized by a distinct DNA methylation profile and monosomy of chromosome 14. It is composed of small to medium-sized cells showing perinuclear oligodendroglioma-like haloes, scattered multinucleated cells, and nuclear clusters composed of large pleomorphic nuclei. Most cases have been reported in pediatric patients. C185935 Neoplastic Process Diffuse Glioneuronal Tumor with Oligodendroglioma-Like Features and Nuclear Clusters CL1778510 Provisional_Concept Undetermined DGONC Diffuse Glioneuronal Tumor with Oligodendroglioma-Like Features and Nuclear Clusters Diffuse Glioneuronal Tumor with Oligodendroglioma-Like Features and Nuclear Clusters Triple-negative breast inflammatory carcinoma that has spread from its original site of growth to another anatomic site. C185954 Neoplastic Process Metastatic Triple-Negative Breast Inflammatory Carcinoma Metastatic Triple-Negative Breast Inflammatory Carcinoma CL1778437 CTRP Malignant Metastatic Triple-Negative Breast Inflammatory Carcinoma Metastatic Triple-Negative Breast Inflammatory Carcinoma A lymph node located adjacent to the trachea within the mediastinum, above the inferior margin of the left brachiocephalic vein crossing the trachea on the left and the superior border of the aortic arch on the right. C186130 Body Part, Organ, or Organ Component Upper Paratracheal Lymph Node C4248231 CDISC A lymph node located adjacent to the trachea within the mediastinum, above the inferior margin of the left brachiocephalic vein crossing the trachea on the left and the superior border of the aortic arch on the right. PARATRACHEAL LYMPH NODE, UPPER Upper Paratracheal Lymph Node Upper Paratracheal Lymph Node Ovarian high-grade serous adenocarcinoma that is not amenable to surgical resection. C186272 Neoplastic Process Unresectable High Grade Ovarian Serous Adenocarcinoma Unresectable Ovarian High Grade Serous Adenocarcinoma CL1778619 CTRP Malignant Unresectable High Grade Ovarian Serous Adenocarcinoma Unresectable High-Grade Ovarian Serous Adenocarcinoma Unresectable Ovarian High Grade Serous Adenocarcinoma Unresectable Ovarian High-Grade Serous Adenocarcinoma Unresectable Ovarian High Grade Serous Adenocarcinoma Ovarian endometrioid adenocarcinoma that is not amenable to surgical resection. C186273 Neoplastic Process Unresectable Ovarian Endometrioid Adenocarcinoma Unresectable Ovarian Endometrioid Adenocarcinoma CL1778620 CTRP Malignant Unresectable Ovarian Endometrioid Adenocarcinoma Unresectable Ovarian Endometrioid Adenocarcinoma Fallopian tube endometrioid adenocarcinoma that is not amenable to surgical resection. C186274 Neoplastic Process Unresectable Fallopian Tube Endometrioid Adenocarcinoma Unresectable Fallopian Tube Endometrioid Adenocarcinoma CL1778621 CTRP Malignant Unresectable Fallopian Tube Endometrioid Adenocarcinoma Unresectable Fallopian Tube Endometrioid Adenocarcinoma Primary peritoneal high-grade serous adenocarcinoma that is not amenable to surgical resection. C186275 Neoplastic Process Unresectable Primary Peritoneal High Grade Serous Adenocarcinoma Unresectable Primary Peritoneal High Grade Serous Adenocarcinoma CL1778622 CTRP Malignant Unresectable Primary Peritoneal High Grade Serous Adenocarcinoma Unresectable Primary Peritoneal High-Grade Serous Adenocarcinoma Unresectable Primary Peritoneal High Grade Serous Adenocarcinoma Primary peritoneal endometrioid adenocarcinoma that is not amenable to surgical resection. C186276 Neoplastic Process Unresectable Primary Peritoneal Endometrioid Adenocarcinoma Unresectable Primary Peritoneal Endometrioid Adenocarcinoma CL1778623 CTRP Malignant Unresectable Primary Peritoneal Endometrioid Adenocarcinoma Unresectable Primary Peritoneal Endometrioid Adenocarcinoma HER2-positive breast carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C186283 Neoplastic Process Locally Advanced Unresectable HER2-Positive Breast Carcinoma Locally Advanced Unresectable HER2-Positive Breast Carcinoma CL1778598 CTRP Malignant Locally Advanced Unresectable HER2-Positive Breast Carcinoma Locally Advanced Unresectable HER2-Positive Breast Carcinoma HER2-positive breast carcinoma that is not amenable to surgical resection. C186284 Neoplastic Process Unresectable HER2-Positive Breast Carcinoma Unresectable HER2-Positive Breast Carcinoma CL1778599 CTRP Malignant Unresectable HER2-Positive Breast Carcinoma Unresectable HER2-Positive Breast Carcinoma A circumscribed ependymoma that arises from the supratentorial region of the brain. The diagnosis of supratentorial ependymoma should be made either when genetic analysis did not reveal a fusion gene involving ZFTA or YAP1 genes (not elsewhere classified -NEC) or when the genetic analysis was unsuccessful or not reported (not otherwise specified-NOS). C186343 Neoplastic Process Supratentorial Ependymoma CL1778563 Undetermined Supratentorial Ependymoma Supratentorial Ependymoma A circumscribed ependymoma that arises from the supratentorial region of the brain, characterized by the absence of a fusion gene involving ZFTA or YAP1 genes. C186348 Neoplastic Process Supratentorial Ependymoma, Not Elsewhere Classified CL1778535 Undetermined Supratentorial Ependymoma, NEC Supratentorial Ependymoma, Not Elsewhere Classified Supratentorial Ependymoma, Not Elsewhere Classified A circumscribed ependymoma that arises from the supratentorial region of the brain in which the genetic analysis for fusion genes involving ZFTA or YAP1 genes was unsuccessful or not reported. C186349 Neoplastic Process Supratentorial Ependymoma, Not Otherwise Specified CL1778536 Undetermined Supratentorial Ependymoma, NOS Supratentorial Ependymoma, Not Otherwise Specified Supratentorial Ependymoma, Not Otherwise Specified A circumscribed ependymoma that arises from the supratentorial region of the brain. It is characterized by the presence of a fusion gene involving ZFTA gene. Available data indicate that it has the poorest prognosis of all supratentorial ependymomas. C186350 Neoplastic Process Supratentorial Ependymoma ZFTA Fusion-Positive CL1778537 Malignant Supratentorial Ependymoma ZFTA Fusion-Positive Supratentorial Ependymoma ZFTA Fusion-Positive An uncommon circumscribed ependymoma that arises from the supratentorial region of the brain. It affects young children and is characterized by the presence of a fusion gene involving YAP1 gene. Available data indicate that it has a favorable prognosis as compared to other supratentorial ependymomas. C186351 Neoplastic Process Supratentorial Ependymoma YAP1 Fusion-Positive CL1778538 Undetermined Childhood Supratentorial Ependymoma YAP1 Fusion-Positive Supratentorial Ependymoma YAP1 Fusion-Positive Supratentorial Ependymoma YAP1 Fusion-Positive A supratentorial ependymoma characterized by a gene fusion involving YAP1 and MAMLD1 genes. C186355 Neoplastic Process Supratentorial Ependymoma, YAP1-MAMLD1 Fusion-Positive CL1778542 Undetermined Supratentorial Ependymoma, YAP1-MAMLD1 Fusion-Positive Supratentorial Ependymoma, YAP1::MAMLD1 Fusion-Positive Supratentorial Ependymoma, YAP1-MAMLD1 Fusion-Positive Autoradiographic analysis performed by mounting the object for microscopy (e.g., on a glass slide) and bathing the object with a photographic emulsion that will record radioactive disintegrations occurring at close proximity. C18638 Research Activity Microscopic Autoradiography C1510990 Autoradiography_Microscopic Autoradiography, Microscopic Microscopic Autoradiography Microscopic Autoradiography Autoradiographic analysis performed in accordance with specified guidelines that will result in a defined correspondence between the intensity of the autoradiographic image and the amount of radioactivity present in the sample. This permits assignment of a value to the amount of radioactive material in the object under study. C18639 Research Activity Quantitative Autoradiography C1510991 Autoradiography_Quantitative Autoradiography, Quantitative Quantitative Autoradiography Quantitative Autoradiography A circumscribed ependymoma that arises in the posterior fossa. The diagnosis of posterior fossa ependymoma should be made either when molecular analysis for DNA methylation profiling cannot assign a molecular group (not elsewhere classified -NEC) or when the molecular analysis for DNA methylation profiling was unsuccessful or not reported (not otherwise specified-NOS). C186443 Neoplastic Process Posterior Fossa Ependymoma CL1778979 Undetermined Posterior Fossa Ependymoma Posterior Fossa Ependymoma A circumscribed ependymoma that arises in the posterior fossa in which molecular analysis for DNA methylation profiling cannot assign a molecular group. C186448 Neoplastic Process Posterior Fossa Ependymoma, Not Elsewhere Classified CL1778955 Undetermined Posterior Fossa Ependymoma, NEC Posterior Fossa Ependymoma, Not Elsewhere Classified Posterior Fossa Ependymoma, Not Elsewhere Classified A circumscribed ependymoma that arises in the posterior fossa in which molecular analysis for DNA methylation profiling was unsuccessful or not reported. C186449 Neoplastic Process Posterior Fossa Ependymoma, Not Otherwise Specified CL1778956 Undetermined Posterior Fossa Ependymoma, NOS Posterior Fossa Ependymoma, Not Otherwise Specified Posterior Fossa Ependymoma, Not Otherwise Specified A circumscribed ependymoma that arises in the posterior fossa with characteristic DNA methylation patterns, including CpG island hypermethylation, global DNA hypomethylation, reduction of nuclear H3 p.K28me3 (K27me3) expression, and EZHIP overexpression. It usually occurs in children younger than five years. PFA ependymomas have a worst prognosis compared to PFB ependymomas. C186450 Neoplastic Process Posterior Fossa Ependymoma, Group A (PFA) CL1778957 Malignant Group A Posterior Fossa Ependymoma Group A Posterior Fossa Ependymoma, Pediatric-Type Posterior Fossa Ependymoma, Group A (PFA) Posterior Fossa Group A (PFA) Ependymoma Posterior Fossa Group A (PFA) Ependymoma, Pediatric-Type Posterior Fossa Group A Ependymoma Posterior Fossa Ependymoma, Group A (PFA) A circumscribed ependymoma that arises in the posterior fossa with characteristic DNA methylation patterns including retention of nuclear H3 p.K28me3 (K27me3) expression, absence of CpG island hypermethylation, absence of global DNA hypomethylation, and absence of EZHIP overexpression. Widespread cytogenetic abnormalities are present. Frequent chromosomal aberrations include loss of 22q, monosomy 6, and trisomy 18. It occurs in children older than five years and adults and has a relatively good prognosis. C186451 Neoplastic Process Posterior Fossa Ependymoma, Group B (PFB) CL1778958 Undetermined Group B Posterior Fossa Ependymoma Group B Posterior Fossa Ependymoma, Adult-Type Posterior Fossa Ependymoma, Group B (PFB) Posterior Fossa Ependymoma, Group B (PFB), Adult-Type Posterior Fossa Group B (PFB) Ependymoma Posterior Fossa Group B (PFB) Ependymoma), Adult-Type Posterior Fossa Ependymoma, Group B (PFB) Primary peritoneal high-grade serous adenocarcinoma that has spread from its original site of growth to another anatomic site. C186453 Neoplastic Process Metastatic Primary Peritoneal High Grade Serous Adenocarcinoma Metastatic Primary Peritoneal High Grade Serous Adenocarcinoma CL1778960 CTRP Malignant Metastatic Primary Peritoneal High Grade Serous Adenocarcinoma Metastatic Primary Peritoneal High-Grade Serous Adenocarcinoma Metastatic Primary Peritoneal High Grade Serous Adenocarcinoma Ovarian high-grade serous adenocarcinoma that has spread from its original site of growth to another anatomic site. C186454 Neoplastic Process Metastatic Ovarian High Grade Serous Adenocarcinoma Metastatic Ovarian High Grade Serous Adenocarcinoma CL1778961 CTRP Malignant Metastatic Ovarian High Grade Serous Adenocarcinoma Metastatic Ovarian High-Grade Serous Adenocarcinoma Metastatic Ovarian High Grade Serous Adenocarcinoma Prostate adenocarcinoma with neuroendocrine differentiation that has spread from its original site of growth to another anatomic site. C186455 Neoplastic Process Metastatic Prostate Adenocarcinoma with Neuroendocrine Differentiation Metastatic Prostate Adenocarcinoma with Neuroendocrine Differentiation CL1778962 CTRP Malignant Metastatic Prostate Adenocarcinoma with Neuroendocrine Differentiation Metastatic Prostate Adenocarcinoma with Neuroendocrine Differentiation Prostate adenocarcinoma with neuroendocrine differentiation that has spread extensively to other anatomic sites or is no longer responding to treatment. C186456 Neoplastic Process Advanced Prostate Adenocarcinoma with Neuroendocrine Differentiation Advanced Prostate Adenocarcinoma with Neuroendocrine Differentiation CL1778963 CTRP Malignant Advanced Prostate Adenocarcinoma with Neuroendocrine Differentiation Advanced Prostate Adenocarcinoma with Neuroendocrine Differentiation The reemergence of diffuse large B-cell lymphoma that resulted from the transformation of indolent B-cell non-Hodgkin lymphoma, after a period of remission. C186483 Neoplastic Process Recurrent Transformed Indolent Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma CL1778870 CTRP Malignant Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma Diffuse large B-cell lymphoma that resulted from the transformation of indolent B-cell non-Hodgkin lymphoma and is resistant to treatment. C186484 Neoplastic Process Refractory Transformed Indolent Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma CL1778871 CTRP Malignant Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma Magnetic resonance imaging strategies that create a focused, tailored version of MRI. They aim to decrease acquisition and interpretation times, and improve patient throughput, while maintaining high sensitivity. C186493 Diagnostic Procedure Abbreviated Magnetic Resonance Imaging Abbreviated Magnetic Resonance Imaging CL1778877 CTRP ABMR AMRI Abbreviated MRI Abbreviated MRI Protocol Abbreviated Magnetic Resonance Imaging Abbreviated Magnetic Resonance Imaging Protocol Abbreviated Magnetic Resonance Imaging A rare, aggressive ependymoma that arises from the spinal cord. It displays microvascular proliferation, necrosis, and high mitotic rate. It is characterized by high-level MYCN amplification. Cytogenetic abnormalities include loss of chromosome 10 and focal losses on chromosome 11q. The prognosis is poor. C186494 Neoplastic Process Spinal Cord Ependymoma, MYCN Amplified CL1778904 Malignant Spinal Cord Ependymoma, MYCN Amplified Spinal Cord Ependymoma, MYCN-Amplified Spinal Ependymoma, MYCN Amplified Spinal Ependymoma, MYCN-Amplified Spinal Cord Ependymoma, MYCN Amplified An ependymoma of the spinal cord not associated with MYCN amplification and occurring in children. C186495 Neoplastic Process Childhood Spinal Cord Ependymoma CL1778905 Undetermined Childhood Spinal Cord Ependymoma Childhood Spinal Cord Ependymoma without MYCN Amplification Childhood Spinal Ependymoma Pediatric Spinal Cord Ependymoma Childhood Spinal Cord Ependymoma The reemergence of T-lymphoblastic lymphoma after a period of remission. C186511 Neoplastic Process Recurrent T Lymphoblastic Lymphoma Recurrent T Lymphoblastic Lymphoma CL1778889 CTRP Malignant Recurrent Precursor T-Lymphoblastic Lymphoma Recurrent T Lymphoblastic Lymphoma Recurrent T-Lymphoblastic Lymphoma Recurrent T Lymphoblastic Lymphoma No evidence of subarachnoid or hematogenous metastasis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.) C186521 Neoplastic Process Stage M0 Medulloblastoma CL1778897 Malignant M0 Medulloblastoma Stage M0 Medulloblastoma Stage M0 Medulloblastoma Microscopic tumor cells are detected in the cerebrospinal fluid. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.) C186522 Neoplastic Process Stage M1 Medulloblastoma CL1778898 Malignant M1 Medulloblastoma Stage M1 Medulloblastoma Stage M1 Medulloblastoma Gross nodular seeding is detected in the cerebellar/cerebral subarachnoid space or in the third or lateral ventricles. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.) C186523 Neoplastic Process Stage M2 Medulloblastoma CL1778899 Malignant M2 Medulloblastoma Stage M2 Medulloblastoma Stage M2 Medulloblastoma Gross nodular seeding is detected in the spinal subarachnoid space. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.) C186524 Neoplastic Process Stage M3 Medulloblastoma CL1778900 Malignant M3 Medulloblastoma Stage M3 Medulloblastoma Stage M3 Medulloblastoma Metastasis outside the cerebrospinal axis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.) C186525 Neoplastic Process Stage M4 Medulloblastoma CL1778901 Malignant M4 Medulloblastoma Stage M4 Medulloblastoma Stage M4 Medulloblastoma No evidence of subarachnoid or hematogenous metastasis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.) C186528 Neoplastic Process Stage M0 Atypical Teratoid/Rhabdoid Tumor CL1778823 Malignant M0 Atypical Teratoid/Rhabdoid Tumor Stage M0 Atypical Teratoid/Rhabdoid Tumor Stage M0 Atypical Teratoid/Rhabdoid Tumor Microscopic tumor cells are detected in the cerebrospinal fluid. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.) C186529 Neoplastic Process Stage M1 Atypical Teratoid/Rhabdoid Tumor CL1778824 Malignant M1 Atypical Teratoid/Rhabdoid Tumor Stage M1 Atypical Teratoid/Rhabdoid Tumor Stage M1 Atypical Teratoid/Rhabdoid Tumor Gross nodular seeding is detected in the cerebellar/cerebral subarachnoid space or in the third or lateral ventricles. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.) C186530 Neoplastic Process Stage M2 Atypical Teratoid/Rhabdoid Tumor CL1778825 Malignant M2 Atypical Teratoid/Rhabdoid Tumor Stage M2 Atypical Teratoid/Rhabdoid Tumor Stage M2 Atypical Teratoid/Rhabdoid Tumor Gross nodular seeding is detected in the spinal subarachnoid space. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.) C186531 Neoplastic Process Stage M3 Atypical Teratoid/Rhabdoid Tumor CL1778826 Malignant M3 Atypical Teratoid/Rhabdoid Tumor Stage M3 Atypical Teratoid/Rhabdoid Tumor Stage M3 Atypical Teratoid/Rhabdoid Tumor Metastasis outside the cerebrospinal axis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.) C186532 Neoplastic Process Stage M4 Atypical Teratoid/Rhabdoid Tumor CL1778827 Malignant M4 Atypical Teratoid/Rhabdoid Tumor Stage M4 Atypical Teratoid/Rhabdoid Tumor Stage M4 Atypical Teratoid/Rhabdoid Tumor A central nervous system embryonal tumor characterized by the presence of multilayered rosette formation and typically the presence of amplification of the C19MC region on chromosome 19 (19q13.42) or rarely a DICER1 mutation. C186534 Neoplastic Process Embryonal Tumor with Multilayered Rosettes CL1778829 GDC Malignant 9478/3 Embryonal tumor with multilayered rosettes, NOS ETMR Embryonal Tumor with Multilayered Rosettes Embryonal Tumor with Multilayered Rosettes, NOS Embryonal Tumor with Multilayered Rosettes An embryonal tumor with multilayered rosettes characterized by the presence of DICER1 mutation. Approximately half of embryonal tumors with multilayered rosettes that lack a C19MC alteration carry DICER1 mutations. C186535 Neoplastic Process Embryonal Tumor with Multilayered Rosettes, DICER1-Mutated CL1778830 Malignant Embryonal Tumor with Multilayered Rosettes, DICER1-Mutated Embryonal Tumor with Multilayered Rosettes, DICER1-Mutated No evidence of subarachnoid or hematogenous metastasis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.) C186537 Neoplastic Process Stage M0 Embryonal Tumor with Multilayered Rosettes CL1778832 Malignant M0 Embryonal Tumor with Multilayered Rosettes Stage M0 Embryonal Tumor with Multilayered Rosettes Stage M0 Embryonal Tumor with Multilayered Rosettes Microscopic tumor cells are detected in the cerebrospinal fluid. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.) C186538 Neoplastic Process Stage M1 Embryonal Tumor with Multilayered Rosettes CL1778833 Malignant M1 Embryonal Tumor with Multilayered Rosettes Stage M1 Embryonal Tumor with Multilayered Rosettes Stage M1 Embryonal Tumor with Multilayered Rosettes Gross nodular seeding is detected in the cerebellar/cerebral subarachnoid space or in the third or lateral ventricles. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.) C186539 Neoplastic Process Stage M2 Embryonal Tumor with Multilayered Rosettes CL1778834 Malignant M2 Embryonal Tumor with Multilayered Rosettes Stage M2 Embryonal Tumor with Multilayered Rosettes Stage M2 Embryonal Tumor with Multilayered Rosettes Gross nodular seeding is detected in the spinal subarachnoid space. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.) C186540 Neoplastic Process Stage M3 Embryonal Tumor with Multilayered Rosettes CL1778835 Malignant M3 Embryonal Tumor with Multilayered Rosettes Stage M3 Embryonal Tumor with Multilayered Rosettes Stage M3 Embryonal Tumor with Multilayered Rosettes Metastasis outside the cerebrospinal axis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.) C186541 Neoplastic Process Stage M4 Embryonal Tumor with Multilayered Rosettes CL1778836 Malignant M4 Embryonal Tumor with Multilayered Rosettes Stage M4 Embryonal Tumor with Multilayered Rosettes Stage M4 Embryonal Tumor with Multilayered Rosettes A central nervous system embryonal tumor lacking molecular abnormalities that would classify it as one of the molecularly defined central nervous system embryonal neoplasms. C186542 Neoplastic Process Central Nervous System Embryonal Tumor, Not Elsewhere Classified CL1778837 Malignant Central Nervous System Embryonal Tumor, NEC Central Nervous System Embryonal Tumor, Not Elsewhere Classified Central Nervous System Embryonal Tumor, Not Elsewhere Classified A rare central nervous system neoplasm with neuroblastic and/or neuronal differentiation. It is characterized by the presence of structural rearrangements of FOXR2 gene that result in the activation of the transcription factor FOXR2. C186547 Neoplastic Process Central Nervous System Neuroblastoma, FOXR2-Activated CL1778813 Malignant CNS Neuroblastoma, FOXR2-Activated Central Nervous System Neuroblastoma, FOXR2-Activated Central Nervous System Neuroblastoma, FOXR2-Activated A rare central nervous system embryonal tumor characterized by the presence of uniform oval or spindle-shaped cells with round or oval nuclei, pseudorosette formation, and heterozygous internal tandem duplication in exon 15 of the BCOR gene. C186556 Neoplastic Process Central Nervous System Tumor with BCOR Internal Tandem Duplication CL1778819 Malignant CNS Tumor with BCOR Internal Tandem Duplication Central Nervous System Tumor with BCOR Internal Tandem Duplication Central Nervous System Tumor with BCOR Internal Tandem Duplication No evidence of subarachnoid or hematogenous metastasis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.) C186568 Neoplastic Process Stage M0 Pineoblastoma CL1778857 Malignant M0 Pineoblastoma Stage M0 Pineoblastoma Stage M0 Pineoblastoma Microscopic tumor cells are detected in the cerebrospinal fluid. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.) C186569 Neoplastic Process Stage M1 Pineoblastoma CL1778858 Malignant M1 Pineoblastoma Stage M1 Pineoblastoma Stage M1 Pineoblastoma Gross nodular seeding is detected in the cerebellar/cerebral subarachnoid space or in the third or lateral ventricles. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.) C186570 Neoplastic Process Stage M2 Pineoblastoma CL1778859 Malignant M2 Pineoblastoma Stage M2 Pineoblastoma Stage M2 Pineoblastoma Gross nodular seeding is detected in the spinal subarachnoid space. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.) C186571 Neoplastic Process Stage M3 Pineoblastoma CL1778860 Malignant M3 Pineoblastoma Stage M3 Pineoblastoma Stage M3 Pineoblastoma Metastasis outside the cerebrospinal axis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.) C186572 Neoplastic Process Stage M4 Pineoblastoma CL1778861 Malignant M4 Pineoblastoma Stage M4 Pineoblastoma Stage M4 Pineoblastoma An SHH-activated, TP53-wildtype medulloblastoma caused by germline ELP1 gene variations and develops during childhood. C186591 Neoplastic Process ELP1-Associated Medulloblastoma CL1778852 Malignant ELP1-Associated Medulloblastoma ELP1-Associated Medulloblastoma, SHH-Activated, TP53-Wildtype ELP1-Associated Medulloblastoma A central nervous system solitary fibrous tumor characterized by the presence of areas of abrupt transition to high grade sarcoma. C186603 Neoplastic Process Central Nervous System Dedifferentiated Solitary Fibrous Tumor CL1778781 Malignant CNS Anaplastic Solitary Fibrous Tumor CNS Dedifferentiated Solitary Fibrous Tumor Central Nervous System Anaplastic Solitary Fibrous Tumor Central Nervous System Dedifferentiated Solitary Fibrous Tumor Central Nervous System Dedifferentiated Solitary Fibrous Tumor A rare, undifferentiated, high grade small round cell sarcoma that arises from the central nervous system. It is characterized by a recurrent translocation involving the CIC gene on chromosome 19 resulting in CIC gene fusion with different gene partners. C186607 Neoplastic Process Central Nervous System CIC-Rearranged Sarcoma CL1778783 Malignant CNS CIC-Rearranged Sarcoma Central Nervous System CIC-Rearranged Sarcoma Central Nervous System CIC-Rearranged Sarcoma A primary intracranial sarcoma composed of malignant pleomorphic or spindle neoplastic cells typically demonstrating myogenic and/or chondroid differentiation. Cytoplasmic eosinophilic globules and myxoid stroma formation are usually present. It is associated with mutations in the DICER1 gene. C186610 Neoplastic Process Primary Intracranial Sarcoma, DICER1-Mutant CL1778762 Malignant Primary Intracranial Sarcoma, DICER1-Mutant Primary Intracranial Sarcoma, DICER1-Mutant Ewing sarcoma that arises in the central nervous system. C186611 Neoplastic Process Central Nervous System Ewing Sarcoma CL1778763 Malignant CNS Ewing Sarcoma Central Nervous System Ewing Sarcoma Central Nervous System Ewing Sarcoma A provisional entity that refers to a group of neoplasms with a broad morphological spectrum, characterized by fusion of a FET family gene (usually EWSR1 and rarely FUS) with a member of the CREB family of transcription factors (CREB1, ATF1, or CREM). It includes entities previously termed intracranial angiomatoid fibrous histiocytoma or intracranial myxoid mesenchymal tumor. It is usually located in the supratentorial brain and mostly affects children and young adults. There is a spectrum of clinical behaviors ranging from slowly growing tumors to rapid recurrences, and rarely metastases. C186614 Neoplastic Process Intracranial Mesenchymal Tumor, FET-CREB Fusion-Positive CL1778766 Provisional_Concept Undetermined Intracranial Mesenchymal Tumor /Angiomatoid Fibrous Histiocytoma Intracranial Mesenchymal Tumor with FET-CREB Fusion Intracranial Mesenchymal Tumor, FET-CREB Fusion-Positive Intracranial Mesenchymal Tumor, FET::CREB Fusion-Positive Intracranial Mesenchymal Tumor, FET-CREB Fusion-Positive A term that refers to the staging of cervical cancer according to the International Federation of Gynecology and Obstetrics (FIGO) staging, 2009. C186619 Neoplastic Process Cervical Cancer by FIGO Stage 2009 CL1778770 Malignant Cervical Cancer by FIGO Stage 2009 Cervical Carcinoma by FIGO Stage 2009 Cervical Cancer by FIGO Stage 2009 The carcinoma is strictly confined to the cervix (extension to the uterine corpus should be disregarded). (FIGO 2009) C186620 Neoplastic Process Stage I Cervical Cancer FIGO 2009 CL1778771 Malignant Stage I Cervical Cancer FIGO 2009 Stage I Cervical Carcinoma FIGO 2009 Stage I Cervical Cancer FIGO 2009 Cervical carcinoma measuring equal or less than 5 mm in depth and equal or less than 7 mm in width. (FIGO 2009) C186621 Neoplastic Process Stage IA Cervical Cancer FIGO 2009 CL1778772 Malignant Stage IA Cervical Cancer FIGO 2009 Stage IA Cervical Carcinoma FIGO 2009 Stage IA Cervical Cancer FIGO 2009 Cervical carcinoma measuring equal or less than 3 mm in depth. (FIGO 2009) C186622 Neoplastic Process Stage IA1 Cervical Cancer FIGO 2009 CL1778773 Malignant Stage IA1 Cervical Cancer FIGO 2009 Stage IA1 Cervical Carcinoma FIGO 2009 Stage IA1 Cervical Cancer FIGO 2009 Cervical carcinoma measuring more than 3 mm and not more than 5 mm in depth. (FIGO 2009) C186623 Neoplastic Process Stage IA2 Cervical Cancer FIGO 2009 CL1778774 Malignant Stage IA2 Cervical Cancer FIGO 2009 Stage IA2 Cervical Carcinoma FIGO 2009 Stage IA2 Cervical Cancer FIGO 2009 Cervical carcinoma measuring more than 5 mm in depth. (FIGO 2009) C186624 Neoplastic Process Stage IB Cervical Cancer FIGO 2009 CL1778775 Malignant Stage IB Cervical Cancer FIGO 2009 Stage IB Cervical Carcinoma FIGO 2009 Stage IB Cervical Cancer FIGO 2009 Cervical carcinoma measuring more than 5 mm in depth and equal or less than 4 cm in maximum diameter. (FIGO 2009) C186625 Neoplastic Process Stage IB1 Cervical Cancer FIGO 2009 CL1778795 Malignant Stage IB1 Cervical Cancer FIGO 2009 Stage IB1 Cervical Carcinoma FIGO 2009 Stage IB1 Cervical Cancer FIGO 2009 Cervical carcinoma measuring more than 5 mm in depth and more than 4 cm in maximum diameter. (FIGO 2009) C186626 Neoplastic Process Stage IB2 Cervical Cancer FIGO 2009 CL1778796 Malignant Stage IB2 Cervical Cancer FIGO 2009 Stage IB2 Cervical Carcinoma FIGO 2009 Stage IB2 Cervical Cancer FIGO 2009 Cervical carcinoma invading beyond the uterus but not extending onto the lower third of the vagina or to the pelvic wall. (FIGO 2009) C186627 Neoplastic Process Stage II Cervical Cancer FIGO 2009 CL1778797 Malignant Stage II Cervical Cancer FIGO 2009 Stage II Cervical Carcinoma FIGO 2009 Stage II Cervical Cancer FIGO 2009 Cervical carcinoma limited to the upper two-thirds of the vagina. (FIGO 2009) C186628 Neoplastic Process Stage IIA Cervical Cancer FIGO 2009 CL1778798 Malignant Stage IIA Cervical Cancer FIGO 2009 Stage IIA Cervical Carcinoma FIGO 2009 Stage IIA Cervical Cancer FIGO 2009 Cervical carcinoma limited to the upper two-thirds of the vagina and is equal or less than 4 cm in diameter. (FIGO 2009) C186629 Neoplastic Process Stage IIA1 Cervical Cancer FIGO 2009 CL1778799 Malignant Stage IIA1 Cervical Cancer FIGO 2009 Stage IIA1 Cervical Carcinoma FIGO 2009 Stage IIA1 Cervical Cancer FIGO 2009 Cervical carcinoma limited to the upper two-thirds of the vagina and measuring more than 4 cm in diameter. (FIGO 2009) C186630 Neoplastic Process Stage IIA2 Cervical Cancer FIGO 2009 CL1778800 Malignant Stage IIA2 Cervical Cancer FIGO 2009 Stage IIA2 Cervical Carcinoma FIGO 2009 Stage IIA2 Cervical Cancer FIGO 2009 Cervical carcinoma with parametrial invasion. (FIGO 2009) C186631 Neoplastic Process Stage IIB Cervical Cancer FIGO 2009 CL1778801 Malignant Stage IIB Cervical Cancer FIGO 2009 Stage IIB Cervical Carcinoma FIGO 2009 Stage IIB Cervical Cancer FIGO 2009 Cervical carcinoma involving lower vagina, pelvic sidewall, and ureters. (FIGO 2009) C186632 Neoplastic Process Stage III Cervical Cancer FIGO 2009 CL1778802 Malignant Stage III Cervical Cancer FIGO 2009 Stage III Cervical Carcinoma FIGO 2009 Stage III Cervical Cancer FIGO 2009 Cervical carcinoma involving lower one-third of the vagina. (FIGO 2009) C186633 Neoplastic Process Stage IIIA Cervical Cancer FIGO 2009 CL1778803 Malignant Stage IIIA Cervical Cancer FIGO 2009 Stage IIIA Cervical Carcinoma FIGO 2009 Stage IIIA Cervical Cancer FIGO 2009 Cervical carcinoma involving the pelvic sidewall. (FIGO 2009) C186634 Neoplastic Process Stage IIIB Cervical Cancer FIGO 2009 CL1778804 Malignant Stage IIIB Cervical Cancer FIGO 2009 Stage IIIB Cervical Carcinoma FIGO 2009 Stage IIIB Cervical Cancer FIGO 2009 Cervical carcinoma involving adjacent and distant organs. (FIGO 2009) C186635 Neoplastic Process Stage IV Cervical Cancer FIGO 2009 CL1778805 Malignant Stage IV Cervical Cancer FIGO 2009 Stage IV Cervical Carcinoma FIGO 2009 Stage IV Cervical Cancer FIGO 2009 Cervical carcinoma with rectal or bladder involvement. (FIGO 2009) C186636 Neoplastic Process Stage IVA Cervical Cancer FIGO 2009 CL1778806 Malignant Stage IVA Cervical Cancer FIGO 2009 Stage IVA Cervical Carcinoma FIGO 2009 Stage IVA Cervical Cancer FIGO 2009 Cervical carcinoma involving distal organs outside the pelvis. (FIGO 2009) C186637 Neoplastic Process Stage IVB Cervical Cancer FIGO 2009 CL1778807 Malignant Stage IVB Cervical Cancer FIGO 2009 Stage IVB Cervical Carcinoma FIGO 2009 Stage IVB Cervical Cancer FIGO 2009 A circumscribed neoplasm that arises from leptomeningeal melanocytes. This category includes meningeal melanocytoma and meningeal melanoma. C186649 Neoplastic Process Circumscribed Meningeal Melanocytic Neoplasm CL1778787 Undetermined Circumscribed Meningeal Melanocytic Neoplasm Circumscribed Meningeal Melanocytic Tumor Circumscribed Meningeal Melanocytic Neoplasm A circumscribed meningeal melanocytic neoplasm with bland histological features and increased mitotic activity or invasion of the central nervous system. C186650 Neoplastic Process Meningeal Melanocytoma of Intermediate Grade CL1778788 Uncertain Malignant Potential Melanocytoma of Intermediate Grade Meningeal Melanocytoma of Intermediate Grade Meningeal Melanocytoma of Intermediate Grade A lymphoma that arises from the central nervous system in patients with acquired immunodeficiency conditions or rarely, hereditary immunodeficiency syndromes. C186658 Neoplastic Process Immunodeficiency-Related Central Nervous System Lymphoma CL1779159 Malignant Immunodeficiency-Associated Central Nervous System Lymphoma Immunodeficiency-Related Central Nervous System Lymphoma Immunodeficiency-Related Central Nervous System Lymphoma A diffuse large B-cell lymphoma that arises from the central nervous system in AIDS patients. C186660 Neoplastic Process AIDS-Related Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System CL1779161 Malignant AIDS-Associated Diffuse Large B-Cell Lymphoma of the Central Nervous System AIDS-Associated Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System AIDS-Related Diffuse Large B-Cell Lymphoma of the Central Nervous System AIDS-Related Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System AIDS-Related Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Lymphomatoid granulomatosis that affects the brain, spinal cord, and leptomeninges. C186662 Neoplastic Process Central Nervous System Lymphomatoid Granulomatosis CL1779163 Uncertain Malignant Potential Central Nervous System Lymphomatoid Granulomatosis Central Nervous System Lymphomatoid Granulomatosis Rosai-Dorfman-Destombes disease affecting the central nervous system. It presents with localized or multiple dural masses, parenchymal, and/or intrasellar lesions. C186663 Neoplastic Process Central Nervous System Rosai-Dorfman-Destombes Disease CL1779164 Undetermined Central Nervous System Rosai-Dorfman Disease Central Nervous System Rosai-Dorfman-Destombes Disease Central Nervous System Rosai-Dorfman-Destombes Disease Schwannomatosis caused by germline mutations in the SMARCB1 gene. C186703 Neoplastic Process SMARCB1 Schwannomatosis 1 CL1779198 Benign SMARCB1 Schwannomatosis 1 SMARCB1 Schwannomatosis 1 Schwannomatosis caused by germline mutations in the LZTR1 gene. C186704 Neoplastic Process LZTR1 Schwannomatosis 2 CL1779199 Benign LZTR1 Schwannomatosis 2 LZTR1 Schwannomatosis 2 A method for doppler ultrasound with increased ability to detect slow flow in small vessels. The technique operates on data acquired using multiple plane wave transmits at different transmit angles. For each Doppler sequence acquisition, a long ensemble of data is acquired that reduces the signal-to-noise ratio and improves target detection. C186712 Diagnostic Procedure Long Ensemble Angular-Coherence Doppler Ultrasound Long Ensemble Angular-Coherence Doppler Ultrasound CL1779181 CTRP Angular Coherence Doppler Ultrasound with Long Doppler Ensembles LEAD Long Ensemble Angular Coherence-based Doppler Long Ensemble Angular-Coherence Doppler Ultrasound Long Ensemble Angular-Coherence Doppler Ultrasound Acute myeloid leukemia not associated with cytogenetic abnormalities and arising as a result of the mutagenic effect of chemotherapy and/or ionizing radiation. C186730 Neoplastic Process Cytogenetically Normal Acute Myeloid Leukemia Post Cytotoxic Therapy CL1779123 Malignant Cytogenetically Normal Acute Myeloid Leukemia Post Cytotoxic Therapy Therapy-Related Cytogenetically Normal Acute Myeloid Leukemia Cytogenetically Normal Acute Myeloid Leukemia Post Cytotoxic Therapy A melanocytic nevus that arises from the lip and/or oral cavity. The majority are benign. Dysplastic nevi that can lead to the development of melanoma can rarely arise from the lip and/or oral cavity. C186731 Neoplastic Process Oral Melanocytic Nevus CL1643623 Undetermined Oral Melanocytic Nevus Oral Melanocytic Nevus Aggressive systemic mastocytosis associated with a germ cell tumor. C186732 Neoplastic Process Aggressive Systemic Mastocytosis with an Associated Germ Cell Tumor CL1779124 Malignant Aggressive Systemic Mastocytosis Associated with Germ Cell Tumor Aggressive Systemic Mastocytosis with an Associated Germ Cell Tumor Aggressive Systemic Mastocytosis with an Associated Germ Cell Tumor A disorder characterized by systemic infiltration of internal organs by aggregates of neoplastic mast cells and the presence of a co-occurring germ cell tumor. C186735 Neoplastic Process Systemic Mastocytosis with an Associated Germ Cell Tumor CL1779126 Undetermined Systemic Mastocytosis Associated with Germ Cell Tumor Systemic Mastocytosis with an Associated Germ Cell Tumor Systemic Mastocytosis with an Associated Germ Cell Tumor A method of ultrasonography for secondary breast cancer screening in asymptomatic women with dense breasts. It uses an ultrasound scanner and a transducer device which moves automatically in a scan box. The patient lies in a supine position and automated breast ultrasound is performed in anteroposterior, medial, and lateral views routinely, and in the superior or inferior view additionally in cases of large breasts. The image series is used for 3-dimensional image reconstruction and tumor detection. C186741 Diagnostic Procedure Automated Breast Ultrasound Automated Breast Ultrasound CL1779108 CTRP ABUS Automated Breast Ultrasound Automated Breast Ultrasound A squamous cell carcinoma that is associated with human papillomavirus infection and has metastasized to the neck lymph nodes from an unknown primary anatomic site. C187051 Neoplastic Process Human Papillomavirus-Related Head and Neck Squamous Cell Carcinoma of Unknown Primary Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary CL1792050 CTRP Malignant Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma of Unknown Primary Human Papillomavirus-Positive Neck Squamous Cell Carcinoma of Unknown Primary Human Papillomavirus-Related Head and Neck Squamous Cell Carcinoma of Unknown Primary Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary An acute leukemia that occurs during childhood. C187056 Neoplastic Process Childhood Acute Leukemia CL1792047 Malignant Childhood Acute Leukemia Pediatric Acute Leukemia Childhood Acute Leukemia A pituitary neuroendocrine tumor arising from PIT1-lineage adenohypophysial cells. C187086 Neoplastic Process Pituitary Neuroendocrine Tumor of PIT1-Lineage CL1791999 Undetermined PitNET of PIT1-Lineage PitNET of POU1F1-Lineage PitNET of Pituitary Specific Transcription Factor 1-Lineage PitNET/Adenoma of PIT1-Lineage PitNET/Adenoma of POU1F1-Lineage PitNET/Adenoma of Pituitary Specific Transcription Factor 1-Lineage Pituitary Neuroendocrine Tumor of PIT1-Lineage Pituitary Neuroendocrine Tumor of POU1F1-Lineage Pituitary Neuroendocrine Tumor of Pituitary Specific Transcription Factor 1-Lineage Pituitary Neuroendocrine Tumor/Adenoma of PIT1-Lineage Pituitary Neuroendocrine Tumor/Adenoma of POU1F1-Lineage Pituitary Neuroendocrine Tumor/Adenoma of Pituitary Specific Transcription Factor 1-Lineage Pituitary Neuroendocrine Tumor of PIT1-Lineage A pituitary neuroendocrine tumor arising from TPIT-lineage adenohypophysial cells. C187087 Neoplastic Process Pituitary Neuroendocrine Tumor of TPIT-Lineage CL1791996 Undetermined PitNET of TBX19-Lineage PitNET of TPIT-Lineage PitNET/Adenoma of TBX19-Lineage PitNET/Adenoma of TPIT-Lineage Pituitary Neuroendocrine Tumor of TBX19-Lineage Pituitary Neuroendocrine Tumor of TPIT-Lineage Pituitary Neuroendocrine Tumor/Adenoma of TBX19-Lineage Pituitary Neuroendocrine Tumor/Adenoma of TPIT-Lineage Pituitary Neuroendocrine Tumor of TPIT-Lineage A pituitary neuroendocrine tumor arising from SF1-lineage adenohypophysial cells. C187088 Neoplastic Process Pituitary Neuroendocrine Tumor of SF1-Lineage CL1791997 Undetermined PitNET of SF1-Lineage PitNET/Adenoma of SF1-Lineage Pituitary Neuroendocrine Tumor of SF1-Lineage Pituitary Neuroendocrine Tumor/Adenoma of SF1-Lineage Pituitary Neuroendocrine Tumor of SF1-Lineage A pituitary neuroendocrine tumor that belongs to more than one adenohypophysial cell lineage or does not show evidence of adenohypophysial hormonal immunoreactivity and specific adenohypophysial cell derivation. C187096 Neoplastic Process Pituitary Neuroendocrine Tumor without Distinct Lineage Differentiation CL1791979 Undetermined Pituitary Neuroendocrine Tumor without Distinct Lineage Differentiation Pituitary Neuroendocrine Tumor without Distinct Lineage Differentiation A well-differentiated pituitary neuroendocrine tumor composed of PIT1-lineage adenohypophyseal cells with acidophilic cytoplasm, extensive immunoreactivity for growth hormone and variable immunoreactivity for TSH, prolactin, and alpha-subunit. (WHO) C187098 Neoplastic Process Mature Plurihormonal PIT1 Lineage Pituitary Neuroendocrine Tumor CL1791989 Undetermined Mature Plurihormonal PIT1 Lineage PitNET/Adenoma Mature Plurihormonal PIT1 Lineage Pituitary Neuroendocrine Tumor Mature Plurihormonal PIT1 Lineage Pituitary Neuroendocrine Tumor/Adenoma Mature Plurihormonal PIT1 Lineage Pituitary Neuroendocrine Tumor An immature pituitary neuroendocrine tumor composed of PIT1-lineage adenohypophyseal cells with cytologic atypia and limited differentiation towards thyrotroph, somatotroph, and/or lactotroph cells. (WHO) C187099 Neoplastic Process Immature PIT1 Lineage Pituitary Neuroendocrine Tumor CL1791986 Undetermined Immature PIT1 Lineage PitNET/Adenoma Immature PIT1 Lineage Pituitary Neuroendocrine Tumor Immature PIT1 Lineage Pituitary Neuroendocrine Tumor/Adenoma Immature PIT1 Lineage Pituitary Neuroendocrine Tumor A pituitary neuroendocrine tumor in which further characterization regarding subtyping is not available. C187135 Neoplastic Process Pituitary Neuroendocrine Tumor, Not Otherwise Specified CL1792011 Undetermined PitNET, NOS PitNET, Not Otherwise Specified PitNET/Adenoma, NOS PitNET/Adenoma, Not Otherwise Specified Pituitary Neuroendocrine Tumor, NOS Pituitary Neuroendocrine Tumor, Not Otherwise Specified Pituitary Neuroendocrine Tumor/Adenoma, NOS Pituitary Neuroendocrine Tumor/Adenoma, Not Otherwise Specified Pituitary Neuroendocrine Tumor, Not Otherwise Specified Hormone receptor-positive breast carcinoma that is not amenable to surgical resection. C187160 Neoplastic Process Unresectable Hormone Receptor-Positive Breast Carcinoma Unresectable Hormone Receptor-Positive Breast Carcinoma CL1791915 CTRP Malignant Unresectable Hormone Receptor Positive Breast Adenocarcinoma Unresectable Hormone Receptor Positive Breast Carcinoma Unresectable Hormone Receptor-Positive Breast Carcinoma Unresectable Hormone Receptor-Positive Breast Carcinoma A HER2-negative breast adenocarcinoma that is not amenable to surgical resection. C187161 Neoplastic Process Unresectable HER2-Negative Breast Carcinoma Unresectable HER2-Negative Breast Carcinoma CL1791928 CTRP Malignant Unresectable HER2 Negative Breast Adenocarcinoma Unresectable HER2 Negative Breast Carcinoma Unresectable HER2-Negative Breast Carcinoma Unresectable HER2-Negative Breast Carcinoma Lung large cell neuroendocrine carcinoma that is not amenable to surgical resection. C187162 Neoplastic Process Unresectable Lung Large Cell Neuroendocrine Carcinoma Unresectable Lung Large Cell Neuroendocrine Carcinoma CL1791929 CTRP Malignant Unresectable Lung Large Cell Neuroendocrine Carcinoma Unresectable Lung Large Cell Neuroendocrine Carcinoma Lung large cell neuroendocrine carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C187163 Neoplastic Process Advanced Lung Large Cell Neuroendocrine Carcinoma Advanced Lung Large Cell Neuroendocrine Carcinoma CL1791926 CTRP Malignant Advanced Lung Large Cell Neuroendocrine Carcinoma Advanced Lung Large Cell Neuroendocrine Carcinoma The reemergence of childhood osteosarcoma after a period of remission. C187189 Neoplastic Process Recurrent Childhood Osteosarcoma Recurrent Childhood Osteosarcoma CL1791951 CTRP Malignant Recurrent Childhood Osteosarcoma Recurrent Childhood Osteosarcoma Childhood osteosarcoma that is resistant to treatment. C187192 Neoplastic Process Refractory Childhood Osteosarcoma Refractory Childhood Osteosarcoma CL1791946 CTRP Malignant Refractory Childhood Osteosarcoma Refractory Childhood Osteosarcoma Childhood rhabdomyosarcoma that is resistant to treatment. C187193 Neoplastic Process Refractory Childhood Rhabdomyosarcoma Refractory Childhood Rhabdomyosarcoma CL1791947 CTRP Malignant Refractory Childhood Rhabdomyosarcoma Refractory Childhood Rhabdomyosarcoma Childhood soft tissue sarcoma that is resistant to treatment. C187194 Neoplastic Process Refractory Childhood Soft Tissue Sarcoma Refractory Childhood Soft Tissue Sarcoma CL1791960 CTRP Malignant Refractory Childhood Soft Tissue Sarcoma Refractory Childhood Soft Tissue Sarcoma Lung carcinoma that has metastasized to a limited number of sites. C187195 Neoplastic Process Oligometastatic Lung Carcinoma Oligometastatic Lung Carcinoma CL1791961 CTRP Malignant Oligometastatic Lung Carcinoma Oligometastatic Lung Carcinoma The reemergence of a childhood Hodgkin or non-Hodgkin lymphoma after a period of remission. C187196 Neoplastic Process Recurrent Childhood Lymphoma Recurrent Childhood Lymphoma CL1791958 CTRP Malignant Recurrent Childhood Lymphoma Recurrent Childhood Lymphoma Childhood Hodgkin or non-Hodgkin lymphoma that is resistant to treatment. C187197 Neoplastic Process Refractory Childhood Lymphoma Refractory Childhood Lymphoma CL1791959 CTRP Malignant Refractory Childhood Lymphoma Refractory Childhood Lymphoma A primary or metastatic malignant neoplasm affecting the brain during childhood. C187207 Neoplastic Process Childhood Malignant Brain Neoplasm CL1792275 Malignant Childhood Malignant Brain Neoplasm Childhood Malignant Brain Neoplasm A childhood malignant neoplasm that has spread from its original site of growth to the brain. C187211 Neoplastic Process Metastatic Childhood Malignant Neoplasm in the Brain CL1792285 Malignant Metastatic Childhood Malignant Neoplasm in the Brain Metastatic Childhood Malignant Neoplasm in the Brain A childhood malignant neoplasm that arises from the brain and has spread from its original site of growth to other anatomic sites. C187212 Neoplastic Process Metastatic Childhood Primary Malignant Brain Neoplasm CL1792282 Malignant Metastatic Childhood Malignant Brain Neoplasm Metastatic Childhood Primary Malignant Brain Neoplasm Metastatic Childhood Primary Malignant Brain Neoplasm A childhood malignant neoplasm that arises from the brain and has spread extensively to other anatomic sites or is no longer responding to treatment. C187213 Neoplastic Process Advanced Childhood Malignant Brain Neoplasm Advanced Childhood Primary Malignant Brain Neoplasm CL1792283 CTRP Malignant Advanced Childhood Malignant Brain Neoplasm Advanced Childhood Primary Malignant Brain Neoplasm Advanced Childhood Primary Malignant Brain Neoplasm A central nervous system neoplasm in childhood that is resistant to treatment. C187214 Neoplastic Process Refractory Childhood Central Nervous System Neoplasm CL1792280 Undetermined Refractory Childhood Central Nervous System Neoplasm Refractory Childhood Central Nervous System Neoplasm A childhood brain neoplasm that is resistant to treatment. C187215 Neoplastic Process Refractory Childhood Brain Neoplasm Refractory Childhood Brain Neoplasm CL1792281 CTRP Undetermined Refractory Childhood Brain Neoplasm Refractory Childhood Brain Neoplasm Ovarian serous cystadenocarcinoma that has spread from the original site of growth to other anatomic sites. C187234 Neoplastic Process Metastatic Ovarian Serous Cystadenocarcinoma Metastatic Ovarian Serous Cystadenocarcinoma CL1792307 CTRP Malignant Metastatic Ovarian Serous Cystadenocarcinoma Metastatic Ovarian Serous Cystadenocarcinoma Ovarian serous cystadenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C187235 Neoplastic Process Advanced Ovarian Serous Cystadenocarcinoma Advanced Ovarian Serous Cystadenocarcinoma CL1792308 CTRP Malignant Advanced Ovarian Serous Cystadenocarcinoma Advanced Ovarian Serous Cystadenocarcinoma The reemergence of ovarian serous cystadenocarcinoma after a period of remission. C187241 Neoplastic Process Recurrent Ovarian Serous Cystadenocarcinoma Recurrent Ovarian Serous Cystadenocarcinoma CL1792302 CTRP Malignant Recurrent Ovarian Serous Cystadenocarcinoma Recurrent Ovarian Serous Cystadenocarcinoma Ovarian serous cystadenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C187242 Neoplastic Process Locally Advanced Ovarian Serous Cystadenocarcinoma Locally Advanced Ovarian Serous Cystadenocarcinoma CL1792315 CTRP Malignant Locally Advanced Ovarian Serous Cystadenocarcinoma Locally Advanced Ovarian Serous Cystadenocarcinoma Ovarian serous adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C187243 Neoplastic Process Locally Advanced Ovarian Serous Adenocarcinoma Locally Advanced Ovarian Serous Adenocarcinoma CL1792316 CTRP Malignant Locally Advanced Ovarian Serous Adenocarcinoma Locally Advanced Ovarian Serous Adenocarcinoma Extrahepatic bile duct carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C187244 Neoplastic Process Locally Advanced Extrahepatic Bile Duct Carcinoma Locally Advanced Extrahepatic Bile Duct Carcinoma CL1792313 CTRP Malignant Locally Advanced Extrahepatic Bile Duct Carcinoma Locally Advanced Extrahepatic Bile Duct Carcinoma A benign, encapsulated thyroid gland neoplasm characterized by the presence of large follicles with intrafollicular papillary architecture. The cells lining the papillae are usually columnar. It is usually a cystic neoplasm and lacks nuclear atypia and capsular invasion. Psammoma bodies are not present. Activating TSHR mutations have been described in the majority of cases. In a small number of cases GNAS mutations have been identified. C187261 Neoplastic Process Thyroid Gland Follicular Adenoma with Papillary Architecture CL1792299 Benign Thyroid Gland Follicular Adenoma with Papillary Architecture Thyroid Gland Follicular Adenoma with Papillary Architecture A thyroid gland neoplasm in which the incidence of metastatic spread is extremely low. This category includes thyroid gland noninvasive follicular neoplasm with papillary-like nuclear features, thyroid gland hyalinizing trabecular tumor, and thyroid gland tumors of uncertain malignant potential. C187273 Neoplastic Process Low Risk Thyroid Gland Neoplasm CL1792218 Undetermined Low Risk Thyroid Gland Neoplasm Low Risk Thyroid Gland Tumor Low-Risk Thyroid Gland Neoplasm Low-Risk Thyroid Gland Tumor Thyroid Gland Low Risk Neoplasm Thyroid Gland Low Risk Tumor Thyroid Gland Low-Risk Neoplasm Thyroid Gland Low-Risk Tumor Low Risk Thyroid Gland Neoplasm An encapsulated or well-circumscribed thyroid gland tumor composed of well-differentiated follicular cells, in which capsular or vascular invasion is indeterminate. C187284 Neoplastic Process Thyroid Gland Tumor of Uncertain Malignant Potential CL1792207 Uncertain Malignant Potential Thyroid Gland Neoplasm of Uncertain Malignant Potential Thyroid Gland Tumor of Uncertain Malignant Potential Thyroid Gland Tumor of Uncertain Malignant Potential A malignant testicular germ cell tumor that has spread extensively to other anatomic sites or is no longer responding to treatment. C187316 Neoplastic Process Advanced Malignant Testicular Germ Cell Tumor Advanced Malignant Testicular Germ Cell Tumor CL1792231 CTRP Malignant Advanced Malignant Testicular Germ Cell Tumor Advanced Malignant Testicular Germ Cell Tumor Digestive system neuroendocrine tumor G1 that has spread from its original site of growth to nearby tissues or lymph nodes. C187332 Neoplastic Process Locally Advanced Digestive System Neuroendocrine Tumor G1 Locally Advanced Digestive System Neuroendocrine Tumor G1 CL1792174 CTRP Malignant Locally Advanced Digestive System Carcinoid Tumor Locally Advanced Digestive System Neuroendocrine Tumor G1 Locally Advanced Digestive System Neuroendocrine Tumor G1 Digestive system neuroendocrine tumor G2 that has spread from its original site of growth to nearby tissues or lymph nodes. C187341 Neoplastic Process Locally Advanced Digestive System Neuroendocrine Tumor G2 Locally Advanced Digestive System Neuroendocrine Tumor G2 CL1792179 CTRP Malignant Locally Advanced Digestive System Neuroendocrine Tumor G2 Locally Advanced Digestive System Neuroendocrine Tumor G2 Digestive system neuroendocrine tumor G2 that is not amenable to surgical resection. C187345 Neoplastic Process Unresectable Digestive System Neuroendocrine Tumor G2 Unresectable Digestive System Neuroendocrine Tumor G2 CL1792175 CTRP Malignant Unresectable Digestive System Neuroendocrine Tumor G2 Unresectable Digestive System Neuroendocrine Tumor G2 An endometrial serous adenocarcinoma that has a documented response to platinum-based chemotherapy. C187374 Neoplastic Process Platinum-Sensitive Endometrial Serous Adenocarcinoma Platinum-Sensitive Endometrial Serous Adenocarcinoma CL1792203 CTRP Malignant Platinum Sensitive Endometrial Serous Adenocarcinoma Platinum-Sensitive Endometrial Serous Adenocarcinoma Platinum-Sensitive Endometrial Serous Adenocarcinoma Primary peritoneal carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C187389 Neoplastic Process Locally Advanced Unresectable Primary Peritoneal Carcinoma Locally Advanced Unresectable Primary Peritoneal Carcinoma CL1792191 CTRP Malignant Locally Advanced Unresectable Primary Peritoneal Carcinoma Locally Advanced Unresectable Primary Peritoneal Carcinoma An ovarian high-grade serous adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C187393 Neoplastic Process Locally Advanced Unresectable Ovarian High Grade Serous Adenocarcinoma Locally Advanced Unresectable Ovarian High Grade Serous Adenocarcinoma CL1792188 CTRP Malignant Locally Advanced Unresectable Ovarian High Grade Serous Adenocarcinoma Locally Advanced Unresectable Ovarian High-Grade Serous Adenocarcinoma Locally Advanced Unresectable Ovarian High Grade Serous Adenocarcinoma Fallopian tube carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C187394 Neoplastic Process Locally Advanced Unresectable Fallopian Tube Carcinoma Locally Advanced Unresectable Fallopian Tube Carcinoma CL1792189 CTRP Malignant Locally Advanced Unresectable Fallopian Tube Carcinoma Locally Advanced Unresectable Fallopian Tube Carcinoma A HER2-negative breast adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C187398 Neoplastic Process Locally Advanced Unresectable HER2-Negative Breast Carcinoma Locally Advanced Unresectable HER2-Negative Breast Carcinoma CL1792119 CTRP Malignant Locally Advanced Unresectable HER2 Negative Breast Carcinoma Locally Advanced Unresectable HER2-Negative Breast Carcinoma Locally Advanced Unresectable HER2-Negative Breast Carcinoma Hormone receptor-positive breast carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C187399 Neoplastic Process Locally Advanced Hormone Receptor-Positive Breast Carcinoma CL1792117 Malignant Locally Advanced Hormone Receptor Positive Breast Carcinoma Locally Advanced Hormone Receptor-Positive Breast Carcinoma Locally Advanced Hormone Receptor-Positive Breast Carcinoma Hormone receptor-positive breast carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C187400 Neoplastic Process Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma CL1792118 CTRP Malignant Locally Advanced Unresectable Hormone Receptor Positive Breast Adenocarcinoma Locally Advanced Unresectable Hormone Receptor Positive Breast Carcinoma Locally Advanced Unresectable Hormone Receptor-Positive Breast Adenocarcinoma Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma Triple-negative breast carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C187402 Neoplastic Process Locally Advanced Unresectable Triple-Negative Breast Carcinoma Locally Advanced Unresectable Triple-Negative Breast Carcinoma CL1792116 CTRP Malignant Locally Advanced Unresectable Triple Negative Breast Carcinoma Locally Advanced Unresectable Triple-Negative Breast Carcinoma Locally Advanced Unresectable Triple-Negative Breast Carcinoma A rare variant of invasive breast lobular carcinoma characterized by the presence of pools of extracellular mucin in which groups of floating lobular carcinoma cells are identified. C187405 Neoplastic Process Invasive Breast Lobular Carcinoma with Extracellular Mucin CL1792125 Malignant Invasive Breast Lobular Carcinoma with Extracellular Mucin Invasive Breast Lobular Carcinoma with Extracellular Mucin Production Invasive Breast Lobular Carcinoma with Extracellular Mucin Endometrial carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C187406 Neoplastic Process Locally Advanced Unresectable Endometrial Carcinoma Locally Advanced Unresectable Endometrial Carcinoma CL1792126 CTRP Malignant Locally Advanced Unresectable Endometrial Carcinoma Locally Advanced Unresectable Endometrial Carcinoma A non-small cell squamous carcinoma of the lung that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C187411 Neoplastic Process Locally Advanced Unresectable Lung Non-Small Cell Squamous Carcinoma Locally Advanced Unresectable Lung Non-Small Cell Squamous Carcinoma CL1792108 CTRP Malignant Locally Advanced Unresectable Lung Non-Small Cell Squamous Carcinoma Locally Advanced Unresectable Lung Non-Small Cell Squamous Carcinoma Cholangiocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C187412 Neoplastic Process Locally Advanced Unresectable Cholangiocarcinoma Locally Advanced Unresectable Cholangiocarcinoma CL1792109 CTRP Malignant Locally Advanced Unresectable Cholangiocarcinoma Locally Advanced Unresectable Cholangiocarcinoma Gallbladder carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C187413 Neoplastic Process Locally Advanced Unresectable Gallbladder Carcinoma Locally Advanced Unresectable Gallbladder Carcinoma CL1792107 CTRP Malignant Locally Advanced Unresectable Gallbladder Carcinoma Locally Advanced Unresectable Gallbladder Carcinoma A genetic subtype of diffuse large B-cell lymphoma characterized by SGK1 and TET2 gene mutations. C187445 Neoplastic Process ST2 Diffuse Large B-Cell Lymphoma CL1792135 Malignant ST2 Diffuse Large B-Cell Lymphoma ST2 Diffuse Large B-Cell Lymphoma A genetic subtype of diffuse large B-cell lymphoma characterized by TP53 gene mutations and deletions that is often accompanied by aneuploidy. C187447 Neoplastic Process A53 Diffuse Large B-Cell Lymphoma CL1792132 Malignant A53 Diffuse Large B-Cell Lymphoma A53 Diffuse Large B-Cell Lymphoma Malignant bone neoplasm that is amenable to surgical resection. C187448 Neoplastic Process Resectable Malignant Bone Neoplasm Resectable Malignant Bone Neoplasm CL1792133 CTRP Malignant Resectable Malignant Bone Neoplasm Resectable Malignant Bone Neoplasm Childhood acute myeloid leukemia that does not respond to treatment. C187449 Neoplastic Process Refractory Childhood Acute Myeloid Leukemia Refractory Childhood Acute Myeloid Leukemia CL1792130 CTRP Malignant Refractory Childhood Acute Myeloid Leukemia Refractory Childhood Acute Myeloid Leukemia Pancreatic ductal adenocarcinoma that has metastasized to a limited number of sites. C187450 Neoplastic Process Oligometastatic Pancreatic Ductal Adenocarcinoma Oligometastatic Pancreatic Ductal Adenocarcinoma CL1792131 CTRP Malignant Oligometastatic Pancreatic Ductal Adenocarcinoma Oligometastatic Pancreatic Ductal Adenocarcinoma Damage to DNA caused by ionizing radiation. Can cause base change mutations or strand breakage. C18754 Finding Radiation Induced DNA Damage C1514688 Radiation_Induced_DNA_Damage DNA Damage, Radiation Induced Genotoxicity, Radiation Induced Radiation Induced DNA Damage Radiation-Induced DNA Damage Radiation Induced DNA Damage A morphologic variant of follicular carcinoma of the thyroid gland characterized by the presence of malignant follicular cells with cytoplasmic vacuoles and eccentrically placed nuclei. C187643 Neoplastic Process Thyroid Gland Follicular Carcinoma, Signet Ring Cell Variant CL1792408 Malignant Thyroid Gland Follicular Carcinoma, Signet Ring Cell Variant Thyroid Gland Follicular Carcinoma, Signet Ring Cell Variant A thyroid gland papillary carcinoma characterized by the presence of thin cores of fibrovascular tissue lined by one or occasionally several layers of malignant cells with distinct nuclear features that include nuclear pseudoinclusions, nuclear grooves, and ground glass nuclear inclusions. C187644 Neoplastic Process Classic Thyroid Gland Papillary Carcinoma CL1792409 Malignant Classic (Conventional) Thyroid Gland Papillary Carcinoma Classic Thyroid Gland Papillary Carcinoma Conventional Thyroid Gland Papillary Carcinoma Classic Thyroid Gland Papillary Carcinoma A thyroid gland carcinoma that arises from follicular cells and is characterized by the presence of high mitotic activity and necrotic changes in the absence of anaplastic histological features. This category includes poorly differentiated thyroid gland carcinoma and differentiated high-grade thyroid gland carcinoma. C187645 Neoplastic Process High Grade Follicular Cell-Derived Non-Anaplastic Thyroid Gland Carcinoma CL1792422 Malignant Follicular-Derived Thyroid Gland Carcinoma, High Grade Follicular-Derived Thyroid Gland Carcinoma, High-Grade High Grade Follicular Cell-Derived Non-Anaplastic Thyroid Gland Carcinoma High-Grade Follicular Cell-Derived Non-Anaplastic Thyroid Gland Carcinoma High Grade Follicular Cell-Derived Non-Anaplastic Thyroid Gland Carcinoma A follicular-derived thyroid gland carcinoma that is histologically differentiated and has high-grade features. C187648 Neoplastic Process Differentiated High Grade Thyroid Gland Carcinoma CL1792421 Malignant DHGTC Differentiated High Grade Thyroid Gland Carcinoma Differentiated High-Grade Thyroid Gland Carcinoma Differentiated High Grade Thyroid Gland Carcinoma A record of a patient's background regarding health and the occurrence of disease events of the individual. In addition, personal medical history may be a variable in epidemiologic studies. C18772 Finding Personal Medical History C0262926 CPTAC NICHD PCDC A collection of information about a person's health. It may include information about allergies, illnesses and surgeries, and dates and results of physical exams, tests, screenings, and immunizations. It may also include information about medicines taken and about diet and exercise. Personal_Medical_History General Medical History History MEDICAL_HISTORY Medical History PMH Past Medical History Personal History Personal Medical History personal health record personal history personal medical history Personal Medical History A primary carcinoma of the thyroid gland containing a medullary carcinoma component that is immunohistochemically positive for calcitonin, and follicular carcinoma component that is immunohistochemically positive for thyroglobulin. C187992 Neoplastic Process Thyroid Gland Mixed Medullary and Follicular Carcinoma C1266055 GDC 8346/3 Malignant 8346/3 Mixed medullary-follicular carcinoma MMFTC Mixed Medullary and Follicular Thyroid Carcinoma Mixed medullary-follicular carcinoma Thyroid Gland Mixed Medullary and Follicular Carcinoma Thyroid Gland Mixed Medullary and Follicular Carcinoma A primary carcinoma of the thyroid gland containing a medullary carcinoma component that is immunohistochemically positive for calcitonin, and papillary carcinoma component that is immunohistochemically positive for thyroglobulin. C187993 Neoplastic Process Thyroid Gland Mixed Medullary and Papillary Carcinoma CL1792885 GDC 8347/3 Malignant 8347/3 Mixed medullary-papillary carcinoma MMPTC Mixed Medullary and Papillary Thyroid Carcinoma Mixed medullary-papillary carcinoma Thyroid Gland Mixed Medullary and Papillary Carcinoma Thyroid Gland Mixed Medullary and Papillary Carcinoma An invasive adenocarcinoma of the thyroid gland characterized by the presence of cells that secrete eosinophilic material. It is composed of cystic spaces, tubular structures, and solid areas. ETV6 translocations and ETV6-NTRK3 fusion are present. C187994 Neoplastic Process Thyroid Gland Secretory Carcinoma CL1792886 Malignant Mammary Analogue Secretory Carcinoma of Thyroid Gland Secretory Thyroid Carcinoma of Salivary Gland-Type Thyroid Gland Secretory Carcinoma Thyroid Gland Secretory Carcinoma A high-grade, rapidly growing malignant embryonal neoplasm that arises from the thyroid gland. It is characterized by the presence of primitive follicular-like structures surrounded by primitive small cells and primitive spindle cell mesenchymal stroma. It is associated with DICER1 gene mutations. The prognosis is poor. C187995 Neoplastic Process Thyroblastoma CL1792883 Malignant Thyroblastoma Thyroid Gland Carcinosarcoma Thyroid Gland Immature Teratoma Thyroid Gland Malignant Teratoid Tumor Thyroid Gland Malignant Teratoma Thyroid Gland Teratocarcinosarcoma Thyroblastoma An ovarian teratoma characterized by the presence of a neoplastic neuroendocrine component consistent with carcinoid tumor. C188015 Neoplastic Process Ovarian Teratoma with Carcinoid Tumor CL1792909 Undetermined Ovarian Teratoma with Carcinoid Tumor Ovarian Teratoma with Neuroendocrine Tumor Ovarian Teratoma with Carcinoid Tumor A clonal lymphoproliferative disorder composed of neoplastic B-cells. It includes B-cell non-Hodgkin lymphomas, B-cell leukemias, and plasma cell myeloma. C188021 Neoplastic Process B-Cell Malignant Neoplasm CL1792906 Malignant B-Cell Malignancy B-Cell Malignant Neoplasm B-Cell Malignant Neoplasm Mast cell leukemia associated with another clonal non-mast cell myeloid neoplasm (e.g., myelodysplastic syndrome, myeloproliferative neoplasm, and acute myeloid leukemia). C188031 Neoplastic Process Mast Cell Leukemia with an Associated Myeloid Neoplasm CL1792895 Malignant Mast Cell Leukemia Associated with Another Hematologic Neoplasm Mast Cell Leukemia with an Associated Myeloid Neoplasm Mast Cell Leukemia with an Associated Myeloid Neoplasm Bladder urothelial carcinoma that is amenable to surgical resection. C188032 Neoplastic Process Resectable Bladder Urothelial Carcinoma Resectable Bladder Urothelial Carcinoma CL1792896 CTRP Malignant Resectable Bladder Urothelial Carcinoma Resectable Bladder Urothelial Carcinoma Alveolar soft part sarcoma that is resistant to treatment. C188034 Neoplastic Process Refractory Alveolar Soft Part Sarcoma Refractory Alveolar Soft Part Sarcoma CL1792894 CTRP Malignant Refractory Alveolar Soft Part Sarcoma Refractory Alveolar Soft Part Sarcoma Breast carcinoma that is amenable to surgical resection. C188035 Neoplastic Process Resectable Breast Carcinoma Resectable Breast Carcinoma CL1792891 CTRP Malignant Resectable Breast Carcinoma Resectable Breast Carcinoma Adrenal cortical carcinoma that is resistant to treatment. C188036 Neoplastic Process Refractory Adrenal Cortex Carcinoma Refractory Adrenal Cortical Carcinoma CL1792892 CTRP Malignant Refractory Adrenal Cortex Carcinoma Refractory Adrenal Cortical Carcinoma Refractory Adrenal Cortical Carcinoma Smoldering systemic mastocytosis associated with the presence of a clonal non-mast cell myeloid neoplasm (e.g., myelodysplastic syndrome, myeloproliferative neoplasm, and acute myeloid leukemia). C188041 Neoplastic Process Smoldering Systemic Mastocytosis with an Associated Myeloid Neoplasm CL1792901 Malignant Smoldering Systemic Mastocytosis with an Associated Hematologic Neoplasm Smoldering Systemic Mastocytosis with an Associated Myeloid Neoplasm Smoldering Systemic Mastocytosis with an Associated Myeloid Neoplasm A well differentiated, low grade neuroendocrine neoplasm that arises from the sigmoid colon. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. C188043 Neoplastic Process Sigmoid Colon Neuroendocrine Tumor G1 Sigmoid Colon Neuroendocrine Tumor G1 CL1792899 CTRP Undetermined Sigmoid Colon Carcinoid Tumor Sigmoid Colon NET G1 Sigmoid Colon Neuroendocrine Tumor G1 Sigmoid Colon Neuroendocrine Tumor G1 A neoplasm that arises from the central nervous system and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C188049 Neoplastic Process Benign Central Nervous System Neoplasm Benign Central Nervous System Neoplasm C0347509 CTRP mCode Benign Benign Central Nervous System Neoplasm Benign neoplasm of brain and other parts of central nervous system Benign neoplasm of central nervous system, unspecified Benign Central Nervous System Neoplasm A primary or metastatic malignant neoplasm that affects the pylorus. C188051 Neoplastic Process Malignant Pylorus Neoplasm Malignant Pylorus Neoplasm C0153418 CTRP mCode Malignant Malignant Pylorus Neoplasm Malignant neoplasm of pylorus Malignant Pylorus Neoplasm A rare epithelioid sarcoma of the proximal type that arises from the pleura. C188055 Neoplastic Process Pleural Proximal-Type Epithelioid Sarcoma Pleural Proximal-Type Epithelioid Sarcoma CL1792825 CTRP Malignant Pleural Epithelioid Sarcoma Pleural Epithelioid Sarcoma of the Proximal Type Pleural Proximal-Type Epithelioid Sarcoma Pleural Proximal-Type Epithelioid Sarcoma A rare extraskeletal osteosarcoma that arises from the lung parenchyma. C188061 Neoplastic Process Lung Osteosarcoma Lung Osteosarcoma CL1792830 CTRP Malignant Lung Extraskeletal Osteosarcoma Lung Osteosarcoma Lung Osteosarcoma A rare leiomyosarcoma that arises from the pleural cavity. C188063 Neoplastic Process Pleural Leiomyosarcoma Pleural Leiomyosarcoma CL1792829 CTRP Malignant Pleural Leiomyosarcoma Primary Pleural Leiomyosarcoma Pleural Leiomyosarcoma An exceedingly rare malignant peripheral nerve sheath tumor that arises from the bone. C188064 Neoplastic Process Bone Malignant Peripheral Nerve Sheath Tumor Bone Malignant Peripheral Nerve Sheath Tumor CL1792814 CTRP Malignant Bone Malignant Peripheral Nerve Sheath Tumor Malignant Peripheral Nerve Sheath Tumor of Bone Bone Malignant Peripheral Nerve Sheath Tumor A rare leiomyosarcoma that arises from the pancreas. C188065 Neoplastic Process Pancreatic Leiomyosarcoma Pancreatic Leiomyosarcoma CL1792815 CTRP Malignant Pancreatic Leiomyosarcoma Primary Pancreatic Leiomyosarcoma Pancreatic Leiomyosarcoma A melanoma that arises from the jejunum. C188067 Neoplastic Process Jejunal Melanoma Jejunal Melanoma CL1792813 CTRP Malignant Jejunal Melanoma Primary Jejunal Melanoma Jejunal Melanoma A rare carcinoma that arises from the lung and has histopathological, immunohistochemical, and genetic features identical to those described in breast and salivary gland secretory carcinomas. C188068 Neoplastic Process Lung Secretory Carcinoma Lung Secretory Carcinoma CL1792810 CTRP Malignant Lung Secretory Carcinoma Mammary Analogue Secretory Carcinoma of Lung Lung Secretory Carcinoma A rare alveolar rhabdomyosarcoma arising from the prostate gland. C188070 Neoplastic Process Prostate Alveolar Rhabdomyosarcoma Prostate Alveolar Rhabdomyosarcoma CL1792808 CTRP Malignant Prostate Alveolar Rhabdomyosarcoma Prostate Alveolar Rhabdomyosarcoma A rhabdomyosarcoma arising from the retroperitoneum. C188071 Neoplastic Process Retroperitoneal Rhabdomyosarcoma Retroperitoneal Rhabdomyosarcoma CL1792809 CTRP Malignant Primary Retroperitoneal Rhabdomyosarcoma Retroperitoneal Rhabdomyosarcoma Retroperitoneal Rhabdomyosarcoma Diffuse large B-cell lymphoma that affects the tonsil and the bulk of the tumor is in this anatomic area. C188072 Neoplastic Process Tonsillar Diffuse Large B-Cell Lymphoma Tonsillar Diffuse Large B-Cell Lymphoma CL1792822 CTRP Malignant Primary Tonsillar Diffuse Large B-Cell Lymphoma Tonsillar Diffuse Large B-Cell Lymphoma Tonsillar Diffuse Large B-Cell Lymphoma Malignant peripheral nerve sheath tumor that arises in the retroperitoneum. C188073 Neoplastic Process Retroperitoneal Malignant Peripheral Nerve Sheath Tumor Retroperitoneal Malignant Peripheral Nerve Sheath Tumor CL1792823 CTRP Malignant Primary Retroperitoneal Malignant Peripheral Nerve Sheath Tumor Retroperitoneal Malignant Peripheral Nerve Sheath Tumor Retroperitoneal Malignant Peripheral Nerve Sheath Tumor Infiltration of the uterine corpus by malignant (clonal) plasma cells in patients with history of multiple myeloma. C188074 Neoplastic Process Extramedullary Disease in Plasma Cell Myeloma Involving the Uterine Corpus Extramedullary Disease in Multiple Myeloma Involving the Uterine Corpus CL1792820 CTRP Malignant Extramedullary Disease in Multiple Myeloma Involving the Uterine Corpus Extramedullary Disease in Plasma Cell Myeloma Involving the Uterine Corpus Extramedullary Disease in Multiple Myeloma Involving the Uterine Corpus A rare Burkitt lymphoma arising from the kidney. C188075 Neoplastic Process Kidney Burkitt Lymphoma Kidney Burkitt Lymphoma CL1792821 CTRP Malignant Kidney Burkitt Lymphoma Primary Kidney Burkitt Lymphoma Primary Renal Burkitt Lymphoma Renal Burkitt Lymphoma Kidney Burkitt Lymphoma A carcinoma that has spread to the rectum from another anatomic site. C188076 Neoplastic Process Metastatic Carcinoma in the Rectum Metastatic Carcinoma in the Rectum CL1792818 CTRP Malignant Metastatic Carcinoma in the Rectum Metastatic Carcinoma in the Rectum A carcinoma that has spread to the pancreas from another anatomic site. C188077 Neoplastic Process Metastatic Carcinoma in the Pancreas Metastatic Carcinoma in the Pancreas CL1792819 CTRP Malignant Metastatic Carcinoma in the Pancreas Metastatic Carcinoma in the Pancreas An epithelioid cell melanoma arising from the rectum. C188079 Neoplastic Process Rectal Epithelioid Cell Melanoma Rectal Epithelioid Cell Melanoma CL1792816 CTRP Malignant Rectal Epithelioid Cell Melanoma Rectal Epithelioid Cell Melanoma A rare mantle cell lymphoma that affects the tonsil and the bulk of the tumor is in this anatomic area. C188080 Neoplastic Process Tonsillar Mantle Cell Lymphoma Tonsillar Mantle Cell Lymphoma CL1792817 CTRP Malignant Primary Tonsillar Mantle Cell Lymphoma Tonsillar Mantle Cell Lymphoma Tonsillar Mantle Cell Lymphoma A non-Hodgkin lymphoma that arises from the nasal cavity and is characterized by the presence of a diffuse malignant infiltrate composed of large B-lymphocytes. C188081 Neoplastic Process Nasal Cavity Diffuse Large B-Cell Lymphoma Nasal Cavity Diffuse Large B-Cell Lymphoma CL1792856 CTRP Malignant Nasal Cavity Diffuse Large B-Cell Lymphoma Primary Nasal Cavity Diffuse Large B-Cell Lymphoma Nasal Cavity Diffuse Large B-Cell Lymphoma A rare anaplastic large cell lymphoma that arises in the lung parenchyma. C188082 Neoplastic Process Lung Anaplastic Large Cell Lymphoma Lung Anaplastic Large Cell Lymphoma CL1792857 CTRP Malignant Lung Anaplastic Large Cell Lymphoma Primary Lung Anaplastic Large Cell Lymphoma Primary Pulmonary Anaplastic Large Cell Lymphoma Pulmonary Anaplastic Large Cell Lymphoma Lung Anaplastic Large Cell Lymphoma A squamous cell carcinoma that has spread to the breast from another anatomic site. C188112 Neoplastic Process Metastatic Squamous Cell Carcinoma in the Breast Metastatic Squamous Cell Carcinoma in the Breast CL1792843 CTRP Malignant Metastatic Squamous Cell Carcinoma in the Breast Metastatic Squamous Cell Carcinoma in the Breast A squamous cell carcinoma that has spread to the skin from another anatomic site. C188113 Neoplastic Process Metastatic Squamous Cell Carcinoma in the Skin Metastatic Squamous Cell Carcinoma in the Skin CL1792770 CTRP Malignant Metastatic Squamous Cell Carcinoma in the Skin Metastatic Squamous Cell Carcinoma in the Skin A B-or T-cell non-Hodgkin lymphoma arising in the skin. C188114 Neoplastic Process Primary Cutaneous Non-Hodgkin Lymphoma Primary Cutaneous Non-Hodgkin Lymphoma CL1792771 CTRP Malignant Primary Cutaneous Non-Hodgkin Lymphoma Primary Cutaneous Non-Hodgkin Lymphoma A rare embryonal rhabdomyosarcoma that arises in the middle ear. C188115 Neoplastic Process Middle Ear Embryonal Rhabdomyosarcoma Middle Ear Embryonal Rhabdomyosarcoma CL1792768 CTRP Malignant Middle Ear Embryonal Rhabdomyosarcoma Middle Ear Embryonal Rhabdomyosarcoma The reemergence of oligodendroglioma, IDH-mutant and 1p/19q-codeleted after a period of remission. C188126 Neoplastic Process Recurrent Oligodendroglioma, IDH-Mutant Recurrent Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted CL1792774 CTRP Undetermined Recurrent Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted Recurrent Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted The reemergence of IDH-mutant astrocytoma after a period of remission. C188127 Neoplastic Process Recurrent Astrocytoma, IDH-Mutant Recurrent Astrocytoma, IDH-Mutant CL1792772 CTRP Undetermined Recurrent Astrocytoma, IDH-Mutant Recurrent Astrocytoma, IDH-Mutant Thyroid gland anaplastic carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C188128 Neoplastic Process Locally Advanced Thyroid Gland Anaplastic Carcinoma Locally Advanced Thyroid Gland Anaplastic Carcinoma CL1792773 CTRP Malignant Locally Advanced Thyroid Gland Anaplastic Carcinoma Locally Advanced Thyroid Gland Anaplastic Carcinoma Neoplastic post-transplant lymphoproliferative disorder that is resistant to treatment. C188179 Disease or Syndrome Refractory Neoplastic Post-Transplant Lymphoproliferative Disorder Refractory Neoplastic Post-Transplant Lymphoproliferative Disorder CL1792745 CTRP Undetermined Refractory Neoplastic Post-Transplant Lymphoproliferative Disorder Refractory Neoplastic Post-Transplant Lymphoproliferative Disorder The reemergence of neoplastic post-transplant lymphoproliferative disorder after a period of remission. C188180 Disease or Syndrome Recurrent Neoplastic Post-Transplant Lymphoproliferative Disorder Recurrent Neoplastic Post-Transplant Lymphoproliferative Disorder CL1792746 CTRP Undetermined Recurrent Neoplastic Post-Transplant Lymphoproliferative Disorder Relapsed Neoplastic Post-Transplant Lymphoproliferative Disorder Recurrent Neoplastic Post-Transplant Lymphoproliferative Disorder A carcinoma that arises from the adrenal cortex and is composed of oncocytic cells that constitute more than 90% of malignant cells. C188181 Neoplastic Process Adrenal Cortical Oncocytic Carcinoma CL1792743 Malignant Adrenal Cortex Oncocytic Carcinoma Adrenal Cortical Oncocytic Carcinoma Adrenocortical Carcinoma- Oncocytic Type Adrenal Cortical Oncocytic Carcinoma A carcinoma that arises from the adrenal cortex and is characterized by the presence of abundant extracellular connective tissue mucin. C188182 Neoplastic Process Adrenal Cortical Myxoid Carcinoma CL1792744 Malignant Adrenal Cortex Myxoid Carcinoma Adrenal Cortical Myxoid Carcinoma Adrenocortical Carcinoma- Myxoid Type Adrenal Cortical Myxoid Carcinoma A carcinoma that arises from the adrenal cortex and is characterized by the presence of more than twenty mitoses per ten square millimeters. C188183 Neoplastic Process Adrenal Cortical High Grade Carcinoma CL1792742 Malignant Adrenal Cortex High Grade Carcinoma Adrenal Cortex High-Grade Carcinoma Adrenal Cortical High Grade Carcinoma Adrenal Cortical High-Grade Carcinoma Adrenal Cortical High Grade Carcinoma A rare melanoma that arises within the adrenal cortex. C188185 Neoplastic Process Adrenal Cortical Melanoma CL1792752 Malignant Adrenal Cortex Melanoma Adrenal Cortical Melanoma Adrenal Melanoma Adrenal Cortical Melanoma Alveolar soft part sarcoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C188198 Neoplastic Process Advanced Alveolar Soft Part Sarcoma Advanced Alveolar Soft Part Sarcoma CL1793118 CTRP Malignant Advanced Alveolar Soft Part Sarcoma Advanced Alveolar Soft Part Sarcoma Soft tissue leiomyosarcoma that has spread to nearby tissues or lymph nodes. C188205 Neoplastic Process Locally Advanced Soft Tissue Leiomyosarcoma CL1793123 Malignant Locally Advanced Soft Tissue Leiomyosarcoma Locally Advanced Soft Tissue Leiomyosarcoma Uterine corpus leiomyosarcoma that has spread from its original site of growth to another anatomic site. C188207 Neoplastic Process Metastatic Uterine Corpus Leiomyosarcoma Metastatic Uterine Corpus Leiomyosarcoma CL1793110 CTRP Malignant Metastatic Uterine Corpus Leiomyosarcoma Metastatic Uterine Corpus Leiomyosarcoma Uterine corpus leiomyosarcoma that has spread to nearby tissues or lymph nodes. C188208 Neoplastic Process Locally Advanced Uterine Corpus Leiomyosarcoma Locally Advanced Uterine Corpus Leiomyosarcoma CL1793109 CTRP Malignant Locally Advanced Uterine Corpus Leiomyosarcoma Locally Advanced Uterine Corpus Leiomyosarcoma Uterine corpus leiomyosarcoma that is not amenable to surgical resection. C188209 Neoplastic Process Unresectable Uterine Corpus Leiomyosarcoma Unresectable Uterine Corpus Leiomyosarcoma CL1793112 CTRP Malignant Unresectable Uterine Corpus Leiomyosarcoma Unresectable Uterine Corpus Leiomyosarcoma A benign, usually encapsulated slow growing tumor composed of Schwann cells affecting the seventh cranial nerve. C188213 Neoplastic Process Schwannoma of the Seventh Cranial Nerve CL1793116 Cellosaurus Benign Facial Nerve Neurilemmoma Facial Nerve Schwannoma Neurilemmoma of the Seventh Cranial Nerve Schwannoma of the Facial Nerve Schwannoma of the Seventh Cranial Nerve Schwannoma of the Seventh Cranial Nerve A rare mixed neuroendocrine non-neuroendocrine neoplasm that arises from the pancreas and is composed of ductal adenocarcinoma and a neuroendocrine neoplastic component. The latter is usually a poorly differentiated neuroendocrine carcinoma and rarely a well differentiated neuroendocrine tumor. C188217 Neoplastic Process Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Neoplasm CL1793080 Malignant Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Neoplasm Pancreatic Mixed Ductal-Neuroendocrine Neoplasm Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Neoplasm A well-differentiated neuroendocrine neoplasm of low, intermediate, or high grade. C188218 Neoplastic Process Carcinoid Tumor Neuroendocrine Tumor C0003650 CPTAC CTEP CTRP GDC A slow-growing type of tumor usually found in the gastrointestinal system (most often in the appendix), and sometimes in the lungs or other sites. Carcinoid tumors may spread to the liver or other sites in the body, and they may secrete substances such as serotonin or prostaglandins, causing carcinoid syndrome. 8240/3 8241/3 8248/1 Undetermined Carcinoid_Tumor Neoplasm_of_the_Diffuse_Neuroendocrine_System 8240/3 8241/3 8248/1 Apudoma Carcinoid tumor, NOS Carcinoid, NOS Enterochromaffin cell carcinoid APUDoma Apudoma Carcinoid Tumor Carcinoid tumor Enterochromaffin Cell Carcinoid Enterochromaffin cell carcinoid Neuroendocrine Tumor Well Differentiated Neuroendocrine Neoplasm Well-Differentiated Neuroendocrine Neoplasm carcinoid Neuroendocrine Tumor A well-differentiated neuroendocrine neoplasm that arises from the cervix. It may be classified as G1 (low grade) or G2 (intermediate grade) neuroendocrine tumor. C188221 Neoplastic Process Cervical Neuroendocrine Tumor CL1793081 Undetermined Cervical Neuroendocrine Tumor Cervical Neuroendocrine Tumor A neoplasm with neuroendocrine differentiation that arises from the head and neck. This category includes neuroendocrine tumors, neuroendocrine carcinomas, and paragangliomas. C188222 Neoplastic Process Head and Neck Neuroendocrine Neoplasm CL1793084 Undetermined Head and Neck Neuroendocrine Neoplasm Head and Neck Neuroendocrine Neoplasm A well-differentiated, low grade neuroendocrine neoplasm that arises from the larynx. C188223 Neoplastic Process Laryngeal Neuroendocrine Tumor G1 CL1793083 Undetermined Laryngeal Neuroendocrine Tumor G1 Laryngeal Neuroendocrine Tumor G1 A well-differentiated, low grade neuroendocrine neoplasm that arises from the head and neck. C188224 Neoplastic Process Head and Neck Neuroendocrine Tumor G1 CL1793074 Undetermined Head and Neck Neuroendocrine Tumor G1 Head and Neck Neuroendocrine Tumor G1 The reemergence of a digestive system neuroendocrine neoplasm after a period of remission. C188228 Neoplastic Process Recurrent Digestive System Neuroendocrine Neoplasm Recurrent Digestive System Neuroendocrine Neoplasm CL1793077 CTRP Undetermined Recurrent Digestive System Neuroendocrine Neoplasm Recurrent Digestive System Neuroendocrine Neoplasm A usually indolent neuroendocrine neoplasm that almost exclusively arises in the second part of the duodenum. Rare sites of involvement include jejunum, pylorus, appendix, thymus, and lung. It is a triphasic tumor consisting of a mixture of epithelioid neuroendocrine cells, Schwann-like cells, and ganglion cell-like elements. C188229 Neoplastic Process Composite Gangliocytoma/Neuroma and Neuroendocrine Tumor CL1793076 GDC Undetermined 8683/0 Gangliocytic paraganglioma CoGNET Composite Gangliocytoma/Neuroma and Neuroendocrine Tumor Gangliocytic NET Gangliocytic Neuroendocrine Tumor Gangliocytic Paraganglioma MiGNeN Mixed Ganglioneuroma-Neuroendocrine Neoplasm Composite Gangliocytoma/Neuroma and Neuroendocrine Tumor Microsatellite stable endometrial carcinoma that is resistant to treatment. C188230 Neoplastic Process Refractory Microsatellite Stable Endometrial Carcinoma Refractory Microsatellite Stable Endometrial Carcinoma CL1793079 CTRP Malignant Refractory Microsatellite Stable Endometrial Carcinoma Refractory Microsatellite Stable Endometrial Carcinoma A rare lipoma that arises from the adrenal gland. C188250 Neoplastic Process Adrenal Gland Lipoma CL1793105 Benign Adrenal Gland Lipoma Adrenal Gland Lipoma A rare hemangioma that arises from the adrenal gland. C188251 Neoplastic Process Adrenal Gland Hemangioma CL1793104 Benign Adrenal Gland Hemangioma Adrenal Gland Hemangioma A rare lymphangioma that arises from the adrenal gland. C188252 Neoplastic Process Adrenal Gland Lymphangioma CL1793106 Benign Adrenal Gland Lymphangioma Adrenal Gland Lymphangioma A rare leiomyoma that arises from the adrenal gland. C188253 Neoplastic Process Adrenal Gland Leiomyoma CL1639726 Benign Adrenal Gland Leiomyoma Adrenal Gland Leiomyoma A rare leiomyosarcoma that arises from the adrenal gland. C188254 Neoplastic Process Adrenal Gland Leiomyosarcoma CL1793108 Malignant Adrenal Gland Leiomyosarcoma Adrenal Gland Leiomyosarcoma An inherited neoplastic syndrome caused by mutations in the MYC-associated factor X (MAX) gene. It is associated with the development of paragangliomas/pheochromocytomas, pituitary neuroendocrine tumors, and parathyroid adenomas. Renal cell carcinomas, squamous cell carcinomas, breast carcinomas, lung carcinomas, and endometrial carcinomas have also been reported. C188257 Neoplastic Process Multiple Endocrine Neoplasia Type 5 CL1793094 Undetermined MAX-Associated Tumor MEN Type 5 MEN5 Multiple Endocrine Neoplasia Type 5 Multiple Endocrine Neoplasia Type 5 An individual history of cancer of the uterus. C188284 Clinical Attribute Personal History of Uterine Cancer Personal History of Uterine Cancer CL1793039 CTRP Personal History of Uterine Cancer Personal History of Uterine Cancer Ultrasound imaging that uses frequencies above 10 megahertz (MHz). This yields improved spatial resolution, but at the expense of a shallower depth of penetration. It is useful when visualizing a superficial organ like the skin. C188307 Diagnostic Procedure High Frequency Ultrasound Imaging High Frequency Ultrasound Imaging CL1793133 CTRP HFUS High Frequency Ultrasound Imaging High Frequency Ultrasound Imaging Primary myelofibrosis characterized by the presence of less than 10% blasts in the peripheral blood or bone marrow. C188314 Neoplastic Process Chronic Phase Primary Myelofibrosis CL1793031 GDC Malignant Chronic idiopathic myelofibrosis Chronic Idiopathic Myelofibrosis Chronic Phase Primary Myelofibrosis Chronic idiopathic myelofibrosis Chronic Phase Primary Myelofibrosis Rapid progression of a myeloproliferative neoplasm, characterized by the presence of myeloblasts accounting for 10-19% of the peripheral blood white cells or the nucleated cells in the bone marrow. C188315 Neoplastic Process Accelerated Phase Myeloproliferative Neoplasm CL1793030 Malignant Accelerated Phase Myeloproliferative Neoplasm MPN-AP Accelerated Phase Myeloproliferative Neoplasm Transformation of a myeloproliferative neoplasm into acute myeloid leukemia, typically via accelerated phase myeloproliferative neoplasm. Myeloblasts account for 20% or more of the peripheral blood white cells or the nucleated cells in the bone marrow. C188316 Neoplastic Process Blast Phase Myeloproliferative Neoplasm CL1793052 Malignant Blast Phase Myeloproliferative Neoplasm Leukemic Transformation of Myeloproliferative Neoplasm MPN-BP Blast Phase Myeloproliferative Neoplasm Rapid progression of primary myelofibrosis, characterized by the presence of myeloblasts accounting for 10-19% of the peripheral blood white cells or the nucleated cells in the bone marrow. C188317 Neoplastic Process Accelerated Phase Primary Myelofibrosis Accelerated Phase Primary Myelofibrosis CL1793051 CTRP Malignant Accelerated Phase Primary Myelofibrosis Accelerated Phase Primary Myelofibrosis Transformation of primary myelofibrosis into acute myeloid leukemia, typically via accelerated phase primary myelofibrosis. Myeloblasts account for 20% or more of the peripheral blood white cells or the nucleated cells in the bone marrow. C188318 Neoplastic Process Blast Phase Primary Myelofibrosis Blast Phase Primary Myelofibrosis CL1793054 CTRP Malignant Blast Phase Primary Myelofibrosis Leukemic Transformation of Primary Myelofibrosis Blast Phase Primary Myelofibrosis Breast adenocarcinoma that is positive for estrogen receptors. C188366 Neoplastic Process Estrogen Receptor-Positive Breast Carcinoma Estrogen Receptor-Positive Breast Carcinoma CL1793606 CTRP Malignant ER+ Breast Carcinoma Estrogen Receptor Positive Breast Adenocarcinoma Estrogen Receptor Positive Breast Carcinoma Estrogen Receptor-Positive Breast Adenocarcinoma Estrogen Receptor-Positive Breast Carcinoma Estrogen Receptor-Positive Breast Carcinoma The reemergence of platinum-sensitive ovarian carcinoma after a period of remission. C188391 Neoplastic Process Recurrent Platinum-Sensitive Ovarian Carcinoma Recurrent Platinum-Sensitive Ovarian Carcinoma CL1793631 CTRP Malignant Recurrent Platinum Sensitive Ovarian Carcinoma Recurrent Platinum-Sensitive Ovarian Carcinoma Recurrent Platinum-Sensitive Ovarian Carcinoma Myelodysplastic syndrome with excess blasts that occurs during childhood. C188449 Neoplastic Process Childhood Myelodysplastic Syndrome with Excess Blasts CL1793584 Malignant Childhood Myelodysplastic Neoplasm with Increased Blasts Childhood Myelodysplastic Syndrome with Excess Blasts Childhood Myelodysplastic Syndrome with Increased Blasts cMDS-EB cMDS-IB Childhood Myelodysplastic Syndrome with Excess Blasts An acute myeloid leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1 occurring in children. C188450 Neoplastic Process Childhood Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1 CL1793583 Malignant Childhood Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1::RUNX1T1 Childhood Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Childhood Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Fusion Childhood Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1::RUNX1T1 Fusion Childhood Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1 An acute myeloid leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A occurring in children. C188451 Neoplastic Process Childhood Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A CL1793582 Malignant Childhood Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A Childhood Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A Fusion Childhood Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL Childhood Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3::KMT2A Childhood Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3::KMT2A Fusion Childhood Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A B lymphoblastic leukemia/lymphoma that occurs during childhood. C188453 Neoplastic Process Childhood B Lymphoblastic Leukemia/Lymphoma CL1793588 Malignant Childhood B Lymphoblastic Leukemia/Lymphoma Childhood B-Cell Lymphoblastic Leukemia/Lymphoma Childhood B Lymphoblastic Leukemia/Lymphoma Primary mediastinal large B-cell lymphoma that occurs during childhood. C188455 Neoplastic Process Childhood Primary Mediastinal Large B-Cell Lymphoma CL1793586 Malignant Childhood Primary Mediastinal (Thymic) Large B-Cell Lymphoma Childhood Primary Mediastinal Large B-Cell Lymphoma Childhood Primary Mediastinal Large B-Cell Lymphoma An EBV-positive diffuse large B-cell lymphoma, not otherwise specified, that occurs during childhood. It was originally described in patients older than 50 years, but it has been increasingly recognized in younger patients. C188456 Neoplastic Process Childhood EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified CL1793577 Malignant Childhood EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Childhood EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified An EBV-positive diffuse large B-cell lymphoma, not otherwise specified, that occurs in adults. It was originally described in patients older than 50 years, but it has been increasingly recognized in younger patients. C188457 Neoplastic Process Adult EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified CL1793576 Malignant Adult EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Adult EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified A large B-cell lymphoma with IRF4 rearrangement that occurs during childhood. C188458 Neoplastic Process Childhood Large B-Cell Lymphoma with IRF4 Rearrangement CL1793575 Malignant Childhood Large B-Cell Lymphoma with IRF4 Rearrangement Childhood Large B-Cell Lymphoma with IRF4 Rearrangement Peripheral T-cell lymphoma, not otherwise specified, that occurs during childhood. C188459 Neoplastic Process Childhood Peripheral T-Cell Lymphoma, Not Otherwise Specified CL1793574 Malignant Childhood Peripheral T-Cell Lymphoma, Not Otherwise Specified Childhood Peripheral T-Cell Lymphoma, Not Otherwise Specified An anaplastic large cell lymphoma, ALK-positive that occurs during childhood. C188460 Neoplastic Process Childhood Anaplastic Large Cell Lymphoma, ALK-Positive CL1793581 Malignant Childhood Anaplastic Large Cell Lymphoma, ALK-Positive Childhood Anaplastic Large Cell Lymphoma, ALK-Positive An astrocytoma that is amenable to surgical resection. C188469 Neoplastic Process Resectable Astrocytoma Resectable Astrocytoma CL1793519 CTRP Undetermined Resectable Astrocytoma Resectable Astrocytoma An oligodendroglioma that is amenable to surgical resection. C188470 Neoplastic Process Resectable Oligodendroglioma Resectable Oligodendroglioma CL1793518 CTRP Undetermined Resectable Oligodendroglioma Resectable Oligodendroglioma A record of a patient's medical background regarding the occurrence of cancer and cancer-related problems. C18849 Clinical Attribute Individual Cancer History C0455471 CPTAC GDC Individual_Cancer_History Personal history of Hodgkin lymphoma Personal history of in-situ neoplasm of breast Personal history of leukaemia Personal history of lymphoid leukemia Personal history of malignant melanoma of skin Personal history of malignant neoplasm of bone Personal history of malignant neoplasm of brain Personal history of malignant neoplasm of breast Personal history of malignant neoplasm of bronchus and lung Personal history of malignant neoplasm of liver Personal history of malignant neoplasm of other organs and systems Personal history of malignant neoplasm of ovary Personal history of malignant neoplasm of pancreas Personal history of malignant neoplasm of prostate Personal history of malignant neoplasm of soft tissue Personal history of malignant neoplasm of stomach Personal history of malignant neoplasm of trachea, bronchus and lung Personal history of myeloid leukemia Personal history of non-Hodgkin lymphomas Personal history of other lymphatic and hematopoietic neoplasms Personal history of other malignant neoplasm of kidney Personal history of other malignant neoplasm of large intestine Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues Personal history of unspecified leukemia Cancer History Individual Cancer History history of tumor history_of_tumor prior malignancy prior_malignancy Individual Cancer History An imaging procedure that combines fluoro-furanyl-norprogesterone F18 PET with computed tomography to quantitate progesterone receptor (PgR) status in PgR-positive breast cancers. C188679 Diagnostic Procedure Fluorine F 18 Fluoro Furanyl Norprogesterone Positron Emission Tomography and Computed Tomography Fluorine F 18 Fluoro Furanyl Norprogesterone Positron Emission Tomography and Computed Tomography CL1793724 CTRP FFNP PET-CT FFNP PET-CT Scan FFNP-PET/CT Fluorine F 18 Fluoro Furanyl Norprogesterone Positron Emission Tomography and Computed Tomography Fluorine F 18 Fluoro Furanyl Norprogesterone Positron Emission Tomography and Computed Tomography The reemergence of anaplastic astrocytoma, IDH-wildtype after a period of remission. C188691 Neoplastic Process Recurrent Anaplastic Astrocytoma, IDH-Wildtype Recurrent Anaplastic Astrocytoma, IDH-Wildtype CL1793768 CTRP Malignant Recurrent Anaplastic Astrocytoma, IDH-Wildtype Recurrent Anaplastic Astrocytoma, IDH-Wildtype A header term that refers to the classification of lung small cell carcinoma based on the expression pattern of different neuroendocrine markers such as chromogranin A, synaptophysin, neural cell adhesion molecule 1, and gastrin-releasing peptide. C188753 Neoplastic Process Lung Small Cell Carcinoma Neuroendocrine Subtype CL1793707 Malignant Lung Small Cell Carcinoma Neuroendocrine Subtype SCLC Neuroendocrine Subtype Lung Small Cell Carcinoma Neuroendocrine Subtype Lung small cell carcinoma characterized by high expression pattern of different neuroendocrine markers such as chromogranin A, synaptophysin, neural cell adhesion molecule 1, and gastrin-releasing peptide. It is associated with low numbers of infiltrating immune cells (immune desert phenotype). C188754 Neoplastic Process Lung Small Cell Carcinoma, Neuroendocrine-High Subtype CL1793706 Malignant Lung Small Cell Carcinoma, NE-High Subtype Lung Small Cell Carcinoma, Neuroendocrine-High Subtype SCLC, NE-High Subtype Lung Small Cell Carcinoma, Neuroendocrine-High Subtype Lung small cell carcinoma characterized by low expression pattern of different neuroendocrine markers such as chromogranin A, synaptophysin, neural cell adhesion molecule 1, and gastrin-releasing peptide. It is associated with increased numbers of infiltrating immune cells (immune oasis phenotype). C188755 Neoplastic Process Lung Small Cell Carcinoma, Neuroendocrine-Low Subtype CL1793705 Malignant Lung Small Cell Carcinoma, NE-Low Subtype Lung Small Cell Carcinoma, Neuroendocrine-Low Subtype SCLC, NE-Low Subtype Lung Small Cell Carcinoma, Neuroendocrine-Low Subtype A header term that refers to the molecular classification of lung small cell carcinoma according to the relative expression of four transcription factors: achaete-scute homolog 1 (ASCL1), neurogenic differentiation factor 1 (NEUROD1), yes-associated protein 1 (YAP1), and POU class 2 homeobox 3 (POU2F3). C188756 Neoplastic Process Lung Small Cell Carcinoma Molecular Subtypes CL1793704 Malignant Lung Small Cell Carcinoma Molecular Subtypes Lung Small Cell Carcinoma by Molecular Profile Molecular Subtypes of Lung Small Cell Carcinoma SCLC Molecular Subtypes SCLC by Molecular Profile Lung Small Cell Carcinoma Molecular Subtypes A molecular subtype of lung small cell carcinoma characterized by the overexpression of achaete-scute homolog 1 (ASCL1) transcription factor. It is associated with high expression of neuroendocrine markers and classic morphology. C188761 Neoplastic Process Lung Small Cell Carcinoma, A Subtype CL1793699 Malignant Lung Small Cell Carcinoma, A Subtype SCLC-A Lung Small Cell Carcinoma, A Subtype A molecular subtype of lung small cell carcinoma characterized by the overexpression of neurogenic differentiation factor 1 (NEUROD1). It is associated with low expression of neuroendocrine markers and variant morphology. C188762 Neoplastic Process Lung Small Cell Carcinoma, N Subtype CL1793698 Malignant Lung Small Cell Carcinoma, N Subtype SCLC-N Lung Small Cell Carcinoma, N Subtype A molecular subtype of lung small cell carcinoma characterized by the overexpression of POU class 2 homeobox 3 (POU2F3) transcription factor. C188763 Neoplastic Process Lung Small Cell Carcinoma, P Subtype CL1793697 Malignant Lung Small Cell Carcinoma, P Subtype SCLC-P Lung Small Cell Carcinoma, P Subtype A molecular subtype of lung small cell carcinoma characterized by the low expression of achaete-scute homolog 1 (ASCL1), neurogenic differentiation factor 1 (NEUROD1), and POU class 2 homeobox 3 (POU2F3) transcription factor signatures and elevated inflammatory gene signature expression. C188765 Neoplastic Process Lung Small Cell Carcinoma, I Subtype CL1793703 Malignant Lung Small Cell Carcinoma, I Subtype Lung Small Cell Carcinoma, Inflamed Subtype SCLC-I Lung Small Cell Carcinoma, I Subtype A molecular subtype of lung small cell carcinoma characterized by the overexpression of yes-associated protein 1 (YAP1) transcription factor. C188766 Neoplastic Process Lung Small Cell Carcinoma, Y Subtype CL1793702 Malignant Lung Small Cell Carcinoma, Y Subtype SCLC-Y Lung Small Cell Carcinoma, Y Subtype The reemergence of high-grade B-cell lymphoma, not otherwise specified, after a period of remission. C188788 Neoplastic Process Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified CL1794076 CTRP Malignant Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified Recurrent High-Grade B-Cell Lymphoma, Not Otherwise Specified Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified High-grade B-cell lymphoma, not otherwise specified, that is resistant to treatment. C188789 Neoplastic Process Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified CL1794083 CTRP Malignant Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified Refractory High-Grade B-Cell Lymphoma, Not Otherwise Specified Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified The reemergence of ALK-positive large B-cell lymphoma after a period of remission. C188790 Neoplastic Process Recurrent ALK Positive Large B-Cell Lymphoma Recurrent ALK-Positive Large B-Cell Lymphoma CL1794082 CTRP Malignant Recurrent ALK-Positive Large B-Cell Lymphoma Recurrent ALK-Positive Large B-Cell Lymphoma ALK-positive large B-cell lymphoma that is resistant to treatment. C188791 Neoplastic Process Refractory ALK Positive Large B-Cell Lymphoma Refractory ALK-Positive Large B-Cell Lymphoma CL1794081 CTRP Malignant Refractory ALK-Positive Large B-Cell Lymphoma Refractory ALK-Positive Large B-Cell Lymphoma The reemergence of extrarenal rhabdoid tumor after a period of remission. C188881 Neoplastic Process Recurrent Extrarenal Rhabdoid Tumor Recurrent Extrarenal Rhabdoid Tumor CL1794015 CTRP Malignant Recurrent Extrarenal Rhabdoid Tumor Recurrent Extrarenal Rhabdoid Tumor Extrarenal rhabdoid tumor that is resistant to treatment. C188884 Neoplastic Process Refractory Extrarenal Rhabdoid Tumor Refractory Extrarenal Rhabdoid Tumor CL1794051 CTRP Malignant Refractory Extrarenal Rhabdoid Tumor Refractory Extrarenal Rhabdoid Tumor Extrarenal rhabdoid tumor that is not amenable to surgical resection. C188886 Neoplastic Process Unresectable Extrarenal Rhabdoid Tumor Unresectable Extrarenal Rhabdoid Tumor CL1794050 CTRP Malignant Unresectable Extrarenal Rhabdoid Tumor Unresectable Extrarenal Rhabdoid Tumor Fibrolamellar carcinoma that is resistant to treatment. C188887 Neoplastic Process Refractory Fibrolamellar Carcinoma Refractory Fibrolamellar Carcinoma CL1794056 CTRP Malignant Refractory Fibrolamellar Carcinoma Refractory Fibrolamellar Carcinoma Rhabdoid tumor of the kidney that is not amenable to surgical resection. C188888 Neoplastic Process Unresectable Rhabdoid Tumor of the Kidney Unresectable Rhabdoid Tumor of the Kidney CL1794055 CTRP Malignant Unresectable Rhabdoid Tumor of the Kidney Unresectable Rhabdoid Tumor of the Kidney A rare diffuse astrocytoma, MYBL1-altered that occurs during childhood. C188920 Neoplastic Process Childhood Diffuse Astrocytoma, MYBL1-Altered CL1793983 Undetermined Childhood Diffuse Astrocytoma, MYBL1-Altered Childhood Diffuse Astrocytoma, MYBL1-Altered A rare diffuse astrocytoma, MYB-altered that occurs during childhood. C188921 Neoplastic Process Childhood Diffuse Astrocytoma, MYB-Altered CL1793982 Undetermined Childhood Diffuse Astrocytoma, MYB-Altered Childhood Diffuse Astrocytoma, MYB-Altered A diffuse midline glioma, H3 K27-altered that occurs during childhood. C188922 Neoplastic Process Childhood Diffuse Midline Glioma, H3 K27-Altered CL1793981 Malignant Childhood Diffuse Midline Glioma, H3 K27-Altered Childhood Diffuse Midline Glioma, H3 K27-Altered A rare diffuse midline glioma, H3 K27-altered that occurs during adulthood. C188923 Neoplastic Process Adult Diffuse Midline Glioma, H3 K27-Altered CL1793972 Malignant Adult Diffuse Midline Glioma, H3 K27-Altered Adult Diffuse Midline Glioma, H3 K27-Altered A diffuse intrinsic pontine glioma that occurs during childhood. C188924 Neoplastic Process Childhood Diffuse Intrinsic Pontine Glioma CL1793971 Malignant Childhood Diffuse Intrinsic Pontine Glioma Childhood Diffuse Intrinsic Pontine Glioma A diffuse intrinsic pontine glioma that occurs during adulthood. C188925 Neoplastic Process Adult Diffuse Intrinsic Pontine Glioma CL1793970 Malignant Adult Diffuse Intrinsic Pontine Glioma Adult Diffuse Intrinsic Pontine Glioma A diffuse hemispheric glioma, H3 G34-mutant that occurs during childhood. C188926 Neoplastic Process Childhood Diffuse Hemispheric Glioma, H3 G34-Mutant CL1793969 Malignant Childhood Diffuse Hemispheric Glioma, H3 G34-Mutant Childhood Diffuse Hemispheric Glioma, H3 G34-Mutant A diffuse hemispheric glioma, H3 G34-mutant that occurs in young adults. C188927 Neoplastic Process Adult Diffuse Hemispheric Glioma, H3 G34-Mutant CL1793976 Malignant Adult Diffuse Hemispheric Glioma, H3 G34-Mutant Adult Diffuse Hemispheric Glioma, H3 G34-Mutant An astroblastoma, MN1-altered that occurs during childhood. C188929 Neoplastic Process Childhood Astroblastoma, MN1-Altered CL1793974 Undetermined Childhood Astroblastoma, MN1-Altered Childhood Astroblastoma, MN1-Altered An astroblastoma, MN1-altered that occurs during adulthood. C188930 Neoplastic Process Adult Astroblastoma, MN1-Altered CL1793973 Undetermined Adult Astroblastoma, MN1-Altered Adult Astroblastoma, MN1-Altered A dysembryoplastic neuroepithelial tumor that occurs during childhood. C188931 Neoplastic Process Childhood Dysembryoplastic Neuroepithelial Tumor CL1793966 Undetermined Childhood Dysembryoplastic Neuroepithelial Tumor Childhood Dysembryoplastic Neuroepithelial Tumor A dysembryoplastic neuroepithelial tumor that occurs during adulthood. C188932 Neoplastic Process Adult Dysembryoplastic Neuroepithelial Tumor CL1793965 Undetermined Adult Dysembryoplastic Neuroepithelial Tumor Adult Dysembryoplastic Neuroepithelial Tumor A multinodular and vacuolated neuronal tumor that occurs during childhood. C188933 Neoplastic Process Childhood Multinodular and Vacuolated Neuronal Tumor CL1793964 Undetermined Childhood Multinodular and Vacuolated Neuronal Tumor Childhood Multinodular and Vacuolated Neuronal Tumor A multinodular and vacuolated neuronal tumor that occurs in adults. C188934 Neoplastic Process Adult Multinodular and Vacuolated Neuronal Tumor CL1793963 Undetermined Adult Multinodular and Vacuolated Neuronal Tumor Adult Multinodular and Vacuolated Neuronal Tumor A supratentorial ependymoma ZFTA fusion-positive that occurs during childhood. C188935 Neoplastic Process Childhood Supratentorial Ependymoma ZFTA Fusion-Positive CL1793968 Malignant Childhood Supratentorial Ependymoma ZFTA Fusion-Positive Childhood Supratentorial Ependymoma ZFTA Fusion-Positive A supratentorial ependymoma ZFTA fusion-positive that occurs in adults. C188938 Neoplastic Process Adult Supratentorial Ependymoma ZFTA Fusion-Positive CL1793967 Malignant Adult Supratentorial Ependymoma ZFTA Fusion-Positive Adult Supratentorial Ependymoma ZFTA Fusion-Positive A posterior fossa ependymoma that occurs during childhood. C188943 Neoplastic Process Childhood Posterior Fossa Ependymoma CL1793962 Undetermined Childhood Posterior Fossa Ependymoma Childhood Posterior Fossa Ependymoma A posterior fossa ependymoma that occurs in adults. C188945 Neoplastic Process Adult Posterior Fossa Ependymoma CL1793960 Undetermined Adult Posterior Fossa Ependymoma Adult Posterior Fossa Ependymoma A ganglioneuroma that occurs during childhood. C188946 Neoplastic Process Childhood Ganglioneuroma CL1793959 Benign Childhood Ganglioneuroma Childhood Ganglioneuroma A ganglioneuroma that occurs in adults. C188947 Neoplastic Process Adult Ganglioneuroma CL1794010 Benign Adult Ganglioneuroma Adult Ganglioneuroma An adamantinomatous craniopharyngioma that occurs during childhood. C188948 Neoplastic Process Childhood Adamantinomatous Craniopharyngioma CL1794009 Benign Childhood Adamantinomatous Craniopharyngioma Childhood Adamantinomatous Craniopharyngioma An adamantinomatous craniopharyngioma that occurs in adults. C188949 Neoplastic Process Adult Adamantinomatous Craniopharyngioma CL1794008 Benign Adult Adamantinomatous Craniopharyngioma Adult Adamantinomatous Craniopharyngioma A neoplasm that affects the nervous system during childhood. C188950 Neoplastic Process Childhood Nervous System Neoplasm CL1794007 Undetermined Childhood Nervous System Neoplasm Childhood Nervous System Neoplasm A neoplasm that affects the peripheral nervous system during childhood. C188951 Neoplastic Process Childhood Peripheral Nervous System Neoplasm CL1794013 Undetermined Childhood Peripheral Nervous System Neoplasm Childhood Peripheral Nervous System Neoplasm A rare ganglioneuroma that arises from the choroid. C188956 Neoplastic Process Choroidal Ganglioneuroma CL1794001 Benign Choroidal Ganglioneuroma Choroidal Ganglioneuroma A soft tissue or bone neoplasm that occurs during childhood. C188963 Neoplastic Process Childhood Connective and Soft Tissue Neoplasm CL1794003 Undetermined Childhood Connective and Soft Tissue Neoplasm Pediatric Connective and Soft Tissue Neoplasm Childhood Connective and Soft Tissue Neoplasm An NTRK-rearranged spindle cell neoplasm that occurs during childhood. C188964 Neoplastic Process Childhood NTRK-Rearranged Spindle Cell Neoplasm CL1793994 Provisional_Concept Undetermined Childhood NTRK-Rearranged Spindle Cell Neoplasm Pediatric NTRK-Rearranged Spindle Cell Neoplasm Childhood NTRK-Rearranged Spindle Cell Neoplasm An EWSR1-SMAD3-positive fibroblastic tumor that occurs during childhood. C188965 Neoplastic Process Childhood EWSR1-SMAD3-Positive Fibroblastic Tumor CL1793993 Provisional_Concept Benign Childhood EWSR1-SMAD3-Positive Fibroblastic Tumor Childhood EWSR1::SMAD3-Positive Fibroblastic Tumor Pediatric EWSR1-SMAD3-Positive Fibroblastic Tumor Pediatric EWSR1::SMAD3-Positive Fibroblastic Tumor Childhood EWSR1-SMAD3-Positive Fibroblastic Tumor A low-grade fibromyxoid sarcoma that occurs during childhood. C188970 Neoplastic Process Childhood Low Grade Fibromyxoid Sarcoma CL1793996 Malignant Childhood Low Grade Fibromyxoid Sarcoma Childhood Low-Grade Fibromyxoid Sarcoma Pediatric Low Grade Fibromyxoid Sarcoma Pediatric Low-Grade Fibromyxoid Sarcoma Childhood Low Grade Fibromyxoid Sarcoma A sclerosing epithelioid fibrosarcoma that occurs during childhood. C188971 Neoplastic Process Childhood Sclerosing Epithelioid Fibrosarcoma CL1793995 Malignant Childhood Sclerosing Epithelioid Fibrosarcoma Pediatric Sclerosing Epithelioid Fibrosarcoma Childhood Sclerosing Epithelioid Fibrosarcoma An inflammatory myofibroblastic tumor that occurs during childhood. C188972 Neoplastic Process Childhood Inflammatory Myofibroblastic Tumor CL1793987 Undetermined Childhood Inflammatory Myofibroblastic Tumor Pediatric Inflammatory Myofibroblastic Tumor Childhood Inflammatory Myofibroblastic Tumor A low-grade myofibroblastic sarcoma that occurs during childhood. C188973 Neoplastic Process Childhood Low Grade Myofibroblastic Sarcoma CL1793986 Malignant Childhood Low Grade Myofibroblastic Sarcoma Childhood Low-Grade Myofibroblastic Sarcoma Pediatric Low Grade Myofibroblastic Sarcoma Pediatric Low-Grade Myofibroblastic Sarcoma Childhood Low Grade Myofibroblastic Sarcoma A fibrous histiocytoma that occurs during childhood. C188974 Neoplastic Process Childhood Fibrous Histiocytoma CL1793985 Benign Childhood Fibrous Histiocytoma Pediatric Fibrous Histiocytoma Childhood Fibrous Histiocytoma A plexiform fibrohistiocytic tumor that occurs during childhood. C188975 Neoplastic Process Childhood Plexiform Fibrohistiocytic Tumor CL1793984 Undetermined Childhood Plexiform Fibrohistiocytic Tumor Pediatric Plexiform Fibrohistiocytic Tumor Childhood Plexiform Fibrohistiocytic Tumor A tenosynovial giant cell tumor that occurs during childhood. C188976 Neoplastic Process Childhood Tenosynovial Giant Cell Tumor CL1793990 Undetermined Childhood Tenosynovial Giant Cell Tumor Pediatric Tenosynovial Giant Cell Tumor Childhood Tenosynovial Giant Cell Tumor A kaposiform hemangioendothelioma that occurs during childhood. C188977 Neoplastic Process Childhood Kaposiform Hemangioendothelioma CL1793989 Undetermined Childhood Kaposiform Hemangioendothelioma Pediatric Kaposiform Hemangioendothelioma Childhood Kaposiform Hemangioendothelioma A papillary intralymphatic angioendothelioma that occurs during childhood. C188978 Neoplastic Process Childhood Papillary Intralymphatic Angioendothelioma CL507882 Undetermined Childhood Papillary Intralymphatic Angioendothelioma Pediatric Papillary Intralymphatic Angioendothelioma Childhood Papillary Intralymphatic Angioendothelioma A pseudomyogenic hemangioendothelioma that occurs during childhood. C188979 Neoplastic Process Childhood Pseudomyogenic Hemangioendothelioma CL1793988 Undetermined Childhood Pseudomyogenic Hemangioendothelioma Pediatric Pseudomyogenic Hemangioendothelioma Childhood Pseudomyogenic Hemangioendothelioma Kaposi sarcoma that occurs during childhood. C188980 Neoplastic Process Childhood Kaposi Sarcoma CL1793921 Malignant Childhood Kaposi Sarcoma Pediatric Kaposi Sarcoma Childhood Kaposi Sarcoma A sarcoma that occurs during childhood. C188981 Neoplastic Process Childhood Sarcoma CL1793920 Malignant Childhood Sarcoma Pediatric Sarcoma Childhood Sarcoma An EBV-associated smooth muscle tumor that occurs during childhood. C188982 Neoplastic Process Childhood EBV-Associated Smooth Muscle Tumor CL1793919 Undetermined Childhood EBV-Associated Smooth Muscle Tumor Pediatric EBV-Associated Smooth Muscle Tumor Childhood EBV-Associated Smooth Muscle Tumor A rhabdomyoma that occurs during childhood. C188983 Neoplastic Process Childhood Rhabdomyoma CL1793918 Benign Childhood Rhabdomyoma Pediatric Rhabdomyoma Childhood Rhabdomyoma An ectomesenchymoma that occurs during childhood. C188984 Neoplastic Process Childhood Ectomesenchymoma CL1793925 Malignant Childhood Ectomesenchymoma Pediatric Ectomesenchymoma Childhood Ectomesenchymoma A schwannoma that occurs during childhood. C188992 Neoplastic Process Childhood Schwannoma CL1793917 Benign Childhood Schwannoma Pediatric Schwannoma Childhood Schwannoma A neurofibroma that occurs during childhood. C188995 Neoplastic Process Childhood Neurofibroma CL1793916 Benign Childhood Neurofibroma Pediatric Neurofibroma Childhood Neurofibroma A perineurioma that occurs during childhood. C188997 Neoplastic Process Childhood Perineurioma CL1793909 Benign Childhood Perineurioma Pediatric Perineurioma Childhood Perineurioma A granular cell tumor that occurs during childhood. C188998 Neoplastic Process Childhood Granular Cell Tumor CL1793908 Undetermined Childhood Granular Cell Tumor Pediatric Granular Cell Tumor Childhood Granular Cell Tumor An angiomatoid fibrous histiocytoma that occurs during childhood. C188999 Neoplastic Process Childhood Angiomatoid Fibrous Histiocytoma CL1793907 Undetermined Childhood Angiomatoid Fibrous Histiocytoma Pediatric Angiomatoid Fibrous Histiocytoma Childhood Angiomatoid Fibrous Histiocytoma A PEComa that occurs during childhood. C189000 Neoplastic Process Childhood PEComa CL1793913 Undetermined Childhood PEComa Pediatric PEComa Childhood PEComa A myoepithelial tumor that occurs during childhood. C189001 Neoplastic Process Childhood Myoepithelial Tumor CL1793912 Undetermined Childhood Myoepithelial Tumor Childhood Myoepithelial Tumor of Soft Tissue Pediatric Myoepithelial Tumor Pediatric Myoepithelial Tumor of Soft Tissue Childhood Myoepithelial Tumor A Ewing sarcoma that occurs during childhood. C189002 Neoplastic Process Childhood Ewing Sarcoma CL1793911 Malignant Childhood Ewing Sarcoma Pediatric Ewing Sarcoma Childhood Ewing Sarcoma A round cell sarcoma with EWSR1-non-ETS fusion that occurs during childhood. C189003 Neoplastic Process Childhood Round Cell Sarcoma with EWSR1-non-ETS Fusion CL1793910 Malignant Childhood Round Cell Sarcoma with EWSR1-non-ETS Fusion Childhood Round Cell Sarcoma with EWSR1::non-ETS Fusion Pediatric Round Cell Sarcoma with EWSR1-non-ETS Fusion Pediatric Round Cell Sarcoma with EWSR1::non-ETS Fusion Childhood Round Cell Sarcoma with EWSR1-non-ETS Fusion A CIC-rearranged sarcoma that occurs during childhood. C189006 Neoplastic Process Childhood CIC-Rearranged Sarcoma CL1793904 Malignant Childhood CIC-Rearranged Sarcoma Pediatric CIC-Rearranged Sarcoma Childhood CIC-Rearranged Sarcoma A sarcoma with BCOR genetic alterations that occurs during childhood. C189007 Neoplastic Process Childhood Sarcoma with BCOR Genetic Alterations CL1793903 Malignant Childhood Sarcoma with BCOR Genetic Alterations Pediatric Sarcoma with BCOR Genetic Alterations Childhood Sarcoma with BCOR Genetic Alterations A pancreatic ductal adenocarcinoma that has not spread to other anatomic sites. C189009 Neoplastic Process Localized Pancreatic Ductal Adenocarcinoma Localized Pancreatic Ductal Adenocarcinoma CL1793905 CTRP Malignant Localized Pancreatic Ductal Adenocarcinoma Localized Pancreatic Ductal Adenocarcinoma A bone neoplasm that occurs during childhood. C189015 Neoplastic Process Childhood Bone Neoplasm CL1793950 Undetermined Childhood Bone Neoplasm Pediatric Bone Neoplasm Childhood Bone Neoplasm A sarcoma that arises from the bone and occurs during childhood. C189017 Neoplastic Process Childhood Bone Sarcoma CL1793955 Malignant Childhood Bone Sarcoma Pediatric Bone Sarcoma Childhood Bone Sarcoma Subungual exostosis that occurs during childhood. C189019 Neoplastic Process Childhood Subungual Exostosis CL1793953 Benign Childhood Subungual Exostosis Pediatric Subungual Exostosis Childhood Subungual Exostosis An osteoblastoma that occurs during childhood. C189020 Neoplastic Process Childhood Osteoblastoma CL1793945 Benign Childhood Osteoblastoma Pediatric Osteoblastoma Childhood Osteoblastoma An osteoid osteoma that occurs during childhood. C189021 Neoplastic Process Childhood Osteoid Osteoma CL1793944 Benign Childhood Osteoid Osteoma Pediatric Osteoid Osteoma Childhood Osteoid Osteoma An osteosarcoma that arises from the bone and occurs during childhood. C189022 Neoplastic Process Childhood Bone Osteosarcoma CL1793943 Malignant Childhood Bone Osteosarcoma Pediatric Bone Osteosarcoma Childhood Bone Osteosarcoma A chondroblastoma that occurs during childhood. C189023 Neoplastic Process Childhood Chondroblastoma CL1793942 Benign Childhood Chondroblastoma Pediatric Chondroblastoma Childhood Chondroblastoma An osteochondroma that occurs during childhood. C189024 Neoplastic Process Childhood Osteochondroma CL1793949 Benign Childhood Osteochondroma Pediatric Osteochondroma Childhood Osteochondroma A chondromyxoid fibroma that occurs during childhood. C189025 Neoplastic Process Childhood Chondromyxoid Fibroma CL1793948 Benign Childhood Chondromyxoid Fibroma Pediatric Chondromyxoid Fibroma Childhood Chondromyxoid Fibroma A rare primary central chondrosarcoma that occurs during childhood. C189026 Neoplastic Process Childhood Primary Central Chondrosarcoma CL1793947 Malignant Childhood Primary Central Chondrosarcoma Pediatric Primary Central Chondrosarcoma Childhood Primary Central Chondrosarcoma A rare chondrosarcoma that occurs during childhood. C189027 Neoplastic Process Childhood Chondrosarcoma CL1793946 Malignant Childhood Chondrosarcoma Pediatric Chondrosarcoma Childhood Chondrosarcoma A bone hemangioma that occurs during childhood. C189028 Neoplastic Process Childhood Bone Hemangioma CL1793937 Benign Childhood Bone Hemangioma Pediatric Bone Hemangioma Childhood Bone Hemangioma An aneurysmal bone cyst that occurs during childhood. C189029 Neoplastic Process Childhood Aneurysmal Bone Cyst CL1793936 Benign Childhood Aneurysmal Bone Cyst Pediatric Aneurysmal Bone Cyst Childhood Aneurysmal Bone Cyst A giant cell tumor of bone that occurs during childhood. C189030 Neoplastic Process Childhood Giant Cell Tumor of Bone CL1793935 Undetermined Childhood Giant Cell Tumor of Bone Pediatric Giant Cell Tumor of Bone Childhood Giant Cell Tumor of Bone A non-ossifying fibroma that occurs during childhood. C189031 Neoplastic Process Childhood Non-Ossifying Fibroma CL1793934 Benign Childhood Non-Ossifying Fibroma Pediatric Non-Ossifying Fibroma Childhood Non-Ossifying Fibroma A rare chordoma that occurs during childhood. C189032 Neoplastic Process Childhood Chordoma CL1793941 Malignant Childhood Chordoma Pediatric Chordoma Childhood Chordoma Fibrous dysplasia that occurs during childhood. C189033 Neoplastic Process Childhood Fibrous Dysplasia CL1793940 Benign Childhood Fibrous Dysplasia Pediatric Fibrous Dysplasia Childhood Fibrous Dysplasia The reemergence of B acute lymphoblastic leukemia, Philadelphia chromosome negative, after a period of remission. C189042 Neoplastic Process Recurrent B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Recurrent B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative CL1793931 CTRP Malignant Recurrent B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Recurrent B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative B acute lymphoblastic leukemia, Philadelphia chromosome negative, that does not respond to treatment. C189043 Neoplastic Process Refractory B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Refractory B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative CL1793930 CTRP Malignant Refractory B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Refractory B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative A testicular teratoma associated with germ cell neoplasia in situ and chromosome 12p amplification. C189057 Neoplastic Process Testicular Teratoma, Postpubertal-Type CL536200 Malignant Postpubertal-Type Teratoma Teratoma, Postpubertal-Type Testicular Postpubertal Type Teratoma Testicular Postpubertal-Type Teratoma Testicular Teratoma, Postpubertal Type Testicular Teratoma, Postpubertal-Type Testicular Teratoma, Postpubertal-Type Adenocarcinoma that arises from the gallbladder and is not amenable to surgical resection. C189064 Neoplastic Process Unresectable Gallbladder Adenocarcinoma Unresectable Gallbladder Adenocarcinoma CL1794265 CTRP Malignant Unresectable Gallbladder Adenocarcinoma Unresectable Gallbladder Adenocarcinoma Adenocarcinoma that arises from the ampulla of Vater and is not amenable to surgical resection. C189065 Neoplastic Process Unresectable Ampulla of Vater Adenocarcinoma Unresectable Ampulla of Vater Adenocarcinoma CL1794264 CTRP Malignant Unresectable Ampulla of Vater Adenocarcinoma Unresectable Ampulla of Vater Adenocarcinoma A soft tissue sarcoma that is confined to a specific site without evidence of spread to other anatomic sites. C189240 Neoplastic Process Localized Soft Tissue Sarcoma Localized Soft Tissue Sarcoma CL1794134 CTRP Malignant Localized Soft Tissue Sarcoma Localized Soft Tissue Sarcoma A term that refers to the classification of kidney carcinomas according to their molecular characteristics. C189241 Neoplastic Process Kidney Carcinoma Molecular Subtypes CL1794140 Malignant Kidney Carcinoma Molecular Subtypes Kidney Carcinoma, Molecularly Defined Molecular Subtypes of Kidney Carcinoma Renal Carcinoma Molecular Subtypes Renal Carcinoma, Molecularly Defined Kidney Carcinoma Molecular Subtypes A TFE3 or TFEB-rearranged renal cell carcinoma that occurs during childhood. C189242 Neoplastic Process Childhood Renal Cell Carcinoma with MiT Translocations CL1794139 Malignant Childhood Renal Cell Carcinoma with MiT Translocations Childhood Renal Cell Carcinoma with MiT Translocations A kidney carcinoma that occurs during childhood. C189244 Neoplastic Process Childhood Kidney Carcinoma CL1794138 Malignant Childhood Kidney Carcinoma Childhood Kidney Carcinoma A high-grade carcinoma that arises from the renal medulla and is characterized by inactivation of the SMARCB1 gene. It affects children and adults and occurs mainly in patients with sickle cell trait. The majority of the cases occur in the right kidney. C189247 Neoplastic Process SMARCB1-Deficient Kidney Medullary Carcinoma CL1794128 Malignant SMARCB1-Deficient Kidney Medullary Carcinoma SMARCB1-Deficient Renal Medullary Carcinoma SMARCB1-Deficient Kidney Medullary Carcinoma A SMARCB1-deficient kidney medullary carcinoma that occurs during childhood. C189248 Neoplastic Process Childhood SMARCB1-Deficient Kidney Medullary Carcinoma CL1794127 Malignant Childhood SMARCB1-Deficient Kidney Medullary Carcinoma Childhood SMARCB1-Deficient Renal Medullary Carcinoma Childhood SMARCB1-Deficient Kidney Medullary Carcinoma An extremely rare renal cell carcinoma characterized by the presence of chromosomal translocations involving the chromosome 2p23 breakpoint that result in gene fusions between the anaplastic lymphoma kinase gene (ALK) and various gene partners. C189249 Neoplastic Process ALK-Rearranged Renal Cell Carcinoma CL1794133 Malignant ALK-RCC ALK-Rearranged Renal Cell Carcinoma Anaplastic Lymphoma Kinase Rearrangement-Associated Renal Cell Carcinoma ALK-Rearranged Renal Cell Carcinoma An ALK-rearranged renal cell carcinoma that occurs during childhood. C189250 Neoplastic Process Childhood ALK-Rearranged Renal Cell Carcinoma CL1794132 Malignant Childhood ALK-RCC Childhood ALK-Rearranged Renal Cell Carcinoma Childhood Anaplastic Lymphoma Kinase Rearrangement-Associated Renal Cell Carcinoma Childhood ALK-Rearranged Renal Cell Carcinoma A renal cell carcinoma associated with biallelic somatic mutations in the TSC1 or TSC2 genes and characterized by the presence of neoplastic polygonal cells with abundant eosinophilic cytoplasm and cystic changes. C189254 Neoplastic Process Eosinophilic Solid and Cystic Renal Cell Carcinoma CL1794123 Malignant ESC RCC ESC-RCC Eosinophilic Solid and Cystic Renal Cell Carcinoma Eosinophilic Solid and Cystic Renal Cell Carcinoma An eosinophilic solid and cystic renal cell carcinoma that occurs during childhood. C189255 Neoplastic Process Childhood Eosinophilic Solid and Cystic Renal Cell Carcinoma CL1794122 Malignant Childhood ESC RCC Childhood ESC-RCC Childhood Eosinophilic Solid and Cystic Renal Cell Carcinoma Childhood Eosinophilic Solid and Cystic Renal Cell Carcinoma A neoplasm that affects the genitourinary system during childhood. C189258 Neoplastic Process Childhood Genitourinary System Neoplasm CL1794126 Undetermined Childhood Genitourinary System Neoplasm Pediatric Genitourinary System Neoplasm Childhood Genitourinary System Neoplasm An anaplastic sarcoma of the kidney that occurs during childhood. C189260 Neoplastic Process Childhood Anaplastic Sarcoma of the Kidney CL1794125 Malignant Childhood Anaplastic Sarcoma of the Kidney Pediatric Anaplastic Sarcoma of the Kidney Childhood Anaplastic Sarcoma of the Kidney An extremely rare Ewing sarcoma that arises from the kidney during childhood. C189261 Neoplastic Process Childhood Kidney Ewing Sarcoma CL1794124 Malignant Childhood Kidney Ewing Sarcoma Childhood Renal Ewing Sarcoma Pediatric Kidney Ewing Sarcoma Pediatric Renal Ewing Sarcoma Childhood Kidney Ewing Sarcoma A malignant neoplasm that affects the genitourinary system during childhood. C189269 Neoplastic Process Childhood Malignant Genitourinary System Neoplasm CL1794117 Malignant Childhood Malignant Genitourinary System Neoplasm Pediatric Malignant Genitourinary System Neoplasm Childhood Malignant Genitourinary System Neoplasm An autosomal dominant condition caused by mutation(s) in the OSMR gene, encoding oncostatin-M-specific receptor subunit beta. It is characterized by localized cutaneous amyloidosis. C189282 Neoplastic Process Familial Primary Localized Cutaneous Amyloidosis-1 CL1794161 Cellosaurus Undetermined Familial Primary Localized Cutaneous Amyloidosis-1 PLCA1 Familial Primary Localized Cutaneous Amyloidosis-1 A neoplasm that affects the ovary during childhood. C189286 Neoplastic Process Childhood Ovarian Neoplasm CL1794152 Undetermined Childhood Ovarian Neoplasm Pediatric Ovarian Neoplasm Childhood Ovarian Neoplasm A fibroma that arises from the ovary during childhood. C189288 Neoplastic Process Childhood Ovarian Fibroma CL1794150 Benign Childhood Ovarian Fibroma Childhood Ovarian Fibroma A sclerosing stromal tumor that arises from the ovary during childhood. C189289 Neoplastic Process Childhood Ovarian Sclerosing Stromal Tumor CL1794149 Benign Childhood Ovarian Sclerosing Stromal Tumor Childhood Ovarian Sclerosing Stromal Tumor An ovarian Sertoli-Leydig cell tumor that occurs during childhood. C189292 Neoplastic Process Childhood Ovarian Sertoli-Leydig Cell Tumor CL1794154 Undetermined Childhood Ovarian Sertoli-Leydig Cell Tumor Childhood Ovarian Sertoli-Leydig Cell Tumor A term that refers to the classification of ovarian Sertoli-Leydig cell tumors according to their molecular characteristics. C189319 Neoplastic Process Ovarian Sertoli-Leydig Cell Tumor Molecular Subtypes CL1794486 Undetermined Molecular Subtypes of Ovarian Sertoli-Leydig Cell Tumor Molecular Subtypes of Sertoli-Leydig Cell Tumor Ovarian Sertoli-Leydig Cell Tumor Molecular Subtypes Ovarian Sertoli-Leydig Cell Tumor, Molecularly Defined Sertoli-Leydig Cell Tumor Molecular Subtypes Sertoli-Leydig Cell Tumor, Molecularly Defined Ovarian Sertoli-Leydig Cell Tumor Molecular Subtypes Ovarian Sertoli-Leydig cell tumor characterized by the presence of DICER1 gene mutation. It is associated with moderately and poorly differentiated histological features, presence of retiform or heterologous elements, and younger age. C189328 Neoplastic Process DICER1-Mutant Ovarian Sertoli-Leydig Cell Tumor CL1794489 Undetermined DICER1-Mutant Ovarian Sertoli-Leydig Cell Tumor DICER1-Mutant Sertoli-Leydig Cell Tumor DICER1-Mutant Ovarian Sertoli-Leydig Cell Tumor Ovarian Sertoli-Leydig cell tumor characterized by mutation at position 402 of the coding sequence of the FOXL2 gene where cytosine has been replaced by guanine. It is associated with moderately and poorly differentiated histological features and absence of retiform or heterologous elements. It is described in postmenopausal patients. C189329 Neoplastic Process FOXL2 c.402C>G (p.Cys134Trp)-Mutant Ovarian Sertoli-Leydig Cell Tumor CL1794488 Undetermined FOXL2 c.402C>G (p.Cys134Trp)-Mutant Ovarian Sertoli-Leydig Cell Tumor FOXL2 c.402C>G (p.Cys134Trp)-Mutant Sertoli-Leydig Cell Tumor FOXL2 c.402C>G (p.Cys134Trp)-Mutant Ovarian Sertoli-Leydig Cell Tumor Ovarian Sertoli-Leydig cell tumor characterized by the absence of DICER1 and FOXL2 gene mutations. It is associated with well-differentiated histological features, absence of retiform or heterologous elements, and intermediate age. C189331 Neoplastic Process DICER1/FOXL2-Wildtype Ovarian Sertoli-Leydig Cell Tumor CL1794478 Undetermined DICER1/FOXL2-Wildtype Ovarian Sertoli-Leydig Cell Tumor DICER1/FOXL2-Wildtype Sertoli-Leydig Cell Tumor DICER1/FOXL2-Wildtype Ovarian Sertoli-Leydig Cell Tumor An ovarian gynandroblastoma that occurs during childhood. C189333 Neoplastic Process Childhood Ovarian Gynandroblastoma CL1794477 Undetermined Childhood Gynandroblastoma Childhood Ovarian Gynandroblastoma Childhood Ovarian Gynandroblastoma A rare ovarian small cell carcinoma, hypercalcemic type that occurs during childhood. C189334 Neoplastic Process Childhood Ovarian Small Cell Carcinoma, Hypercalcemic Type CL1794476 Malignant Childhood Ovarian Small Cell Carcinoma, Hypercalcemic Type Childhood Ovarian Small Cell Carcinoma, Hypercalcemic Type Mullerian papilloma that occurs during childhood. C189337 Neoplastic Process Childhood Mullerian Papilloma CL1794481 Benign Childhood Mullerian Papilloma Childhood Mullerian Papilloma A neoplasm that affects the breast and occurs during childhood. C189338 Neoplastic Process Childhood Breast Neoplasm CL1794480 Undetermined Childhood Breast Neoplasm Pediatric Breast Neoplasm Childhood Breast Neoplasm A fibroadenoma that arises from the breast and occurs during childhood. C189339 Neoplastic Process Childhood Breast Fibroadenoma CL1794531 Benign Childhood Breast Fibroadenoma Childhood Breast Fibroadenoma A phyllodes tumor that arises from the breast and occurs during childhood. C189340 Neoplastic Process Childhood Breast Phyllodes Tumor CL1794530 Undetermined Childhood Breast Phyllodes Tumor Childhood Breast Phyllodes Tumor Medulloblastoma, SHH-activated, characterized by SUFU gene mutations and chromosome 2 gain. It affects mostly infants. C189841 Neoplastic Process Medulloblastoma, SHH-1 CL1798609 Provisional_Concept Malignant Medulloblastoma, SHH-1 SHH-1 Medulloblastoma Medulloblastoma, SHH-1 Medulloblastoma, SHH-activated, characterized by chromosome 9q loss and nodular morphology. It affects mostly infants. C189844 Neoplastic Process Medulloblastoma, SHH-2 Medulloblastoma, SHH-2 CL1798614 Provisional_Concept CTRP Malignant Medulloblastoma, SHH-2 Medulloblastoma, SHH-Gamma SHH-2 Medulloblastoma SHH-II Medulloblastoma Medulloblastoma, SHH-2 Medulloblastoma, SHH-activated, characterized by mutations of TP53 and ELP1 genes. It affects older individuals. C189845 Neoplastic Process Medulloblastoma, SHH-3 Medulloblastoma, SHH-3 CL1798613 Provisional_Concept CTRP Malignant Medulloblastoma, SHH-3 Medulloblastoma, SHH-Alpha SHH-3 Medulloblastoma Medulloblastoma, SHH-3 Medulloblastoma, SHH-activated, characterized by mutations of U1-snRNA and TERT genes. Mutations of PTCH1 or SMO genes are usually also present. It affects mostly adults. C189846 Neoplastic Process Medulloblastoma, SHH-4 Medulloblastoma, SHH-4 CL1798616 Provisional_Concept CTRP Malignant Medulloblastoma, SHH-4 SHH-4 Medulloblastoma Medulloblastoma, SHH-4 A neoplasm that affects any part of the digestive system and occurs during childhood. C189869 Neoplastic Process Childhood Digestive System Neoplasm CL1798576 Malignant Childhood Digestive System Neoplasm Childhood Gastrointestinal System Neoplasm Pediatric Digestive System Neoplasm Pediatric Gastrointestinal System Neoplasm Childhood Digestive System Neoplasm A malignant neoplasm that affects any part of the digestive system and occurs during childhood. C189870 Neoplastic Process Childhood Malignant Digestive System Neoplasm CL1798575 Malignant Childhood Malignant Digestive System Neoplasm Childhood Malignant Gastrointestinal System Neoplasm Pediatric Malignant Digestive System Neoplasm Pediatric Malignant Gastrointestinal System Neoplasm Childhood Malignant Digestive System Neoplasm A subtype of hepatoblastoma characterized by the presence of an epithelial component and absence of mesenchymal elements. It includes hepatoblastoma with pure fetal epithelial differentiation, hepatoblastoma with combined fetal and embryonal epithelial differentiation, macrotrabecular hepatoblastoma, and small cell undifferentiated hepatoblastoma (small cell undifferentiated hepatoblastoma with loss of INI1 nuclear staining should be classified as rhabdoid tumor). C189923 Neoplastic Process Epithelial Hepatoblastoma CL1798561 Malignant Epithelial Hepatoblastoma Epithelial Hepatoblastoma Epithelial hepatoblastoma characterized by the presence of fetal or embryonal cells showing nuclear pleomorphism. Malignant giant cells may be present. C189924 Neoplastic Process Epithelial Hepatoblastoma with Pleomorphic Pattern CL1798564 Malignant Epithelial Hepatoblastoma with Pleomorphic Pattern Poorly Differentiated Hepatoblastoma Epithelial Hepatoblastoma with Pleomorphic Pattern A mixed epithelial and mesenchymal hepatoblastoma characterized by the absence of heterologous elements, muscle, cartilage or osteoid. C189926 Neoplastic Process Non-Teratoid Hepatoblastoma CL1798516 Malignant Hepatoblastoma without Teratoid Features Non-Teratoid Hepatoblastoma Nonteratoid Hepatoblastoma Non-Teratoid Hepatoblastoma A term that refers to the staging of hepatoblastoma, following the rules of the PRETEXT (pre-treatment extent of tumor) system. C189927 Neoplastic Process Hepatoblastoma by PRETEXT Stage CL1798515 Malignant Hepatoblastoma by PRETEXT Stage Hepatoblastoma by PRETEXT Stage A term that refers to the staging of hepatoblastoma according to post-operative findings. C189929 Neoplastic Process Hepatoblastoma by Postsurgical Stage CL1798517 Malignant Hepatoblastoma by Postsurgical Stage Hepatoblastoma by Postsurgical Stage A fibrolamellar variant of hepatocellular carcinoma that occurs during childhood. C189932 Neoplastic Process Childhood Fibrolamellar Carcinoma CL1798522 Malignant Childhood Fibrolamellar Carcinoma Pediatric Fibrolamellar Carcinoma Childhood Fibrolamellar Carcinoma An embryonal sarcoma of the liver that occurs during childhood. C189934 Neoplastic Process Childhood Liver Embryonal Sarcoma CL1798524 Malignant Childhood Embryonal Sarcoma of the Liver Childhood Liver Embryonal Sarcoma Childhood Undifferentiated (Embryonal) Sarcoma Childhood Undifferentiated (Embryonal) Sarcoma of the Liver Pediatric Embryonal Sarcoma of the Liver Pediatric Liver Embryonal Sarcoma Pediatric Undifferentiated (Embryonal) Sarcoma Pediatric Undifferentiated (Embryonal) Sarcoma of the Liver Childhood Liver Embryonal Sarcoma An embryonal sarcoma of the liver that occurs during adulthood. C189935 Neoplastic Process Adult Liver Embryonal Sarcoma CL1798523 Malignant Adult Embryonal Sarcoma of the Liver Adult Liver Embryonal Sarcoma Adult Undifferentiated (Embryonal) Sarcoma Adult Undifferentiated (Embryonal) Sarcoma of the Liver Adult Liver Embryonal Sarcoma A type of magnetic resonance imaging that uses field strengths below 0.1 Tesla. C189946 Diagnostic Procedure Ultra-Low-Field MRI Ultra-Low-Field MRI CL1798529 CTRP ULF-MRI Ultra Low Field MRI Ultra-Low Field MRI Ultra-Low Field Strength MRI Ultra-Low Field Strength Magnetic Resonance Imaging Ultra-Low-Field MRI Ultra-Low-Field Magnetic Resonance Imaging Ultra-Low-Field MRI Platinum-resistant ovarian carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C189977 Neoplastic Process Advanced Platinum-Resistant Ovarian Carcinoma Advanced Platinum-Resistant Ovarian Carcinoma CL1798508 CTRP Malignant Advanced Platinum-Resistant Ovarian Carcinoma Advanced Platinum-Resistant Ovarian Carcinoma Platinum-resistant ovarian carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C189978 Neoplastic Process Locally Advanced Platinum-Resistant Ovarian Carcinoma Locally Advanced Platinum-Resistant Ovarian Carcinoma CL1798507 CTRP Malignant Locally Advanced Platinum-Resistant Ovarian Carcinoma Locally Advanced Platinum-Resistant Ovarian Carcinoma Uterine corpus sarcoma that has spread from its original site of growth to another anatomic site. C190009 Neoplastic Process Metastatic Uterine Corpus Sarcoma Metastatic Uterine Corpus Sarcoma CL1798488 CTRP Malignant Metastatic Uterine Corpus Sarcoma Metastatic Uterine Corpus Sarcoma Uterine corpus sarcoma that is not amenable to surgical resection. C190016 Neoplastic Process Unresectable Uterine Corpus Sarcoma Unresectable Uterine Corpus Sarcoma CL1798492 CTRP Malignant Unresectable Uterine Corpus Sarcoma Unresectable Uterine Corpus Sarcoma A hemangioma that arises from the liver and is present at birth. The majority involute in infancy. C190019 Neoplastic Process Liver Congenital Hemangioma CL1798851 Benign HCH Hepatic Congenital Hemangioma Liver Congenital Hemangioma Liver Congenital Hemangioma An angiosarcoma that arises from the liver during childhood. Most cases arise within preexisting liver infantile hemangiomas. C190020 Neoplastic Process Childhood Liver Angiosarcoma CL1798854 Malignant Childhood Hepatic Angiosarcoma Childhood Liver Angiosarcoma Pediatric Hepatic Angiosarcoma Pediatric Liver Angiosarcoma Childhood Liver Angiosarcoma A pancreatoblastoma that occurs during childhood. It is the most common malignant pancreatic neoplasm in children younger than ten years of age. C190023 Neoplastic Process Childhood Pancreatoblastoma CL1798853 Malignant Childhood Pancreatoblastoma Pediatric Pancreatoblastoma Childhood Pancreatoblastoma An acinar cell carcinoma that arises from the pancreas during childhood. C190024 Neoplastic Process Childhood Pancreatic Acinar Cell Carcinoma CL1798857 Malignant Childhood Pancreatic Acinar Cell Carcinoma Pediatric Pancreatic Acinar Cell Carcinoma Childhood Pancreatic Acinar Cell Carcinoma An acinar cell cystadenocarcinoma that arises from the pancreas during childhood. C190026 Neoplastic Process Childhood Pancreatic Acinar Cell Cystadenocarcinoma CL1798855 Malignant Childhood Pancreatic Acinar Cell Cystadenocarcinoma Pediatric Pancreatic Acinar Cell Cystadenocarcinoma Childhood Pancreatic Acinar Cell Cystadenocarcinoma A solid pseudopapillary neoplasm of the pancreas occurring during childhood. It is the most frequent pediatric pancreatic tumor. It usually affects adolescent females. C190027 Neoplastic Process Childhood Solid Pseudopapillary Neoplasm of the Pancreas CL1798856 Malignant Childhood Solid Pseudopapillary Neoplasm of the Pancreas Pediatric Solid Pseudopapillary Neoplasm of the Pancreas Childhood Solid Pseudopapillary Neoplasm of the Pancreas A gastroblastoma that occurs during childhood. C190028 Neoplastic Process Childhood Gastroblastoma CL1798861 Malignant Childhood Gastroblastoma Pediatric Gastroblastoma Childhood Gastroblastoma A neuroendocrine tumor that arises from the appendix during childhood. It is usually located in the tip of the appendix. The vast majority of cases are grade 1 neuroendocrine tumors. C190029 Neoplastic Process Childhood Appendix Neuroendocrine Tumor CL1798862 Undetermined Childhood Appendix Neuroendocrine Tumor Pediatric Appendix Neuroendocrine Tumor Childhood Appendix Neuroendocrine Tumor A benign or malignant neoplasm arising from the epithelial cells of an endocrine organ during childhood. C190056 Neoplastic Process Childhood Endocrine Neoplasm CL1798835 Undetermined Childhood Endocrine Neoplasm Pediatric Endocrine Neoplasm Childhood Endocrine Neoplasm A follicular adenoma of the thyroid gland that occurs during childhood. C190060 Neoplastic Process Childhood Thyroid Gland Follicular Adenoma CL1798837 Benign Childhood Thyroid Gland Follicular Adenoma Pediatric Thyroid Gland Follicular Adenoma Childhood Thyroid Gland Follicular Adenoma A spindle epithelial tumor with thymus-like elements that arises from the thyroid gland and occurs during childhood. C190064 Neoplastic Process Childhood Thyroid Gland Spindle Epithelial Tumor with Thymus-Like Elements CL1798840 Malignant Childhood Thyroid Gland Spindle Epithelial Tumor with Thymus-Like Elements Pediatric Thyroid Gland Spindle Epithelial Tumor with Thymus-Like Elements Childhood Thyroid Gland Spindle Epithelial Tumor with Thymus-Like Elements An adenoma of the parathyroid gland that occurs during childhood. C190066 Neoplastic Process Childhood Parathyroid Gland Adenoma CL1798838 Benign Childhood Parathyroid Gland Adenoma Pediatric Parathyroid Gland Adenoma Childhood Parathyroid Gland Adenoma An adenoma of the adrenal cortex that occurs during childhood. C190068 Neoplastic Process Childhood Adrenal Cortical Adenoma CL1798844 Benign Childhood Adrenal Cortical Adenoma Pediatric Adrenal Cortical Adenoma Childhood Adrenal Cortical Adenoma A carcinoma that arises from the adrenal cortex and occurs during childhood. C190069 Neoplastic Process Childhood Adrenal Cortical Carcinoma CL1798845 Malignant Childhood Adrenal Cortical Carcinoma Pediatric Adrenal Cortical Carcinoma Childhood Adrenal Cortical Carcinoma A malignant neoplasm arising from the epithelial cells of an endocrine organ during childhood. C190070 Neoplastic Process Childhood Malignant Endocrine Neoplasm CL1798842 Malignant Childhood Malignant Endocrine Neoplasm Pediatric Malignant Endocrine Neoplasm Childhood Malignant Endocrine Neoplasm A sympathetic paraganglioma that occurs during childhood. C190071 Neoplastic Process Childhood Sympathetic Paraganglioma CL1798843 Undetermined Childhood Sympathetic Paraganglioma Pediatric Sympathetic Paraganglioma Childhood Sympathetic Paraganglioma A parasympathetic paraganglioma that occurs during childhood. C190072 Neoplastic Process Childhood Parasympathetic Paraganglioma CL1798848 Undetermined Childhood Parasympathetic Paraganglioma Pediatric Parasympathetic Paraganglioma Childhood Parasympathetic Paraganglioma A composite paraganglioma that occurs during childhood. C190073 Neoplastic Process Childhood Composite Paraganglioma CL1798849 Undetermined Childhood Composite Paraganglioma Childhood Composite Pheochromocytoma and Paraganglioma Childhood Composite Pheochromocytoma/Paraganglioma Pediatric Composite Paraganglioma Pediatric Composite Pheochromocytoma and Paraganglioma Pediatric Composite Pheochromocytoma/Paraganglioma Childhood Composite Paraganglioma A paraganglioma that occurs during childhood. C190074 Neoplastic Process Childhood Paraganglioma CL1798846 Undetermined Childhood Paraganglioma Pediatric Paraganglioma Childhood Paraganglioma A neuroendocrine neoplasm that occurs during childhood. C190075 Neoplastic Process Childhood Neuroendocrine Neoplasm CL1798847 Undetermined Childhood Neuroendocrine Neoplasm Pediatric Neuroendocrine Neoplasm Childhood Neuroendocrine Neoplasm A neuroendocrine tumor that arises from the digestive system and occurs during childhood. C190076 Neoplastic Process Childhood Digestive System Neuroendocrine Tumor CL1798801 Undetermined Childhood Digestive System NET Childhood Digestive System Neuroendocrine Tumor Childhood GEP-NET Childhood Gastroenteropancreatic Neuroendocrine Tumor Pediatric Digestive System NET Pediatric Digestive System Neuroendocrine Tumor Pediatric GEP-NET Pediatric Gastroenteropancreatic Neuroendocrine Tumor Childhood Digestive System Neuroendocrine Tumor A neuroendocrine tumor that occurs during childhood. C190077 Neoplastic Process Childhood Neuroendocrine Tumor CL1798802 Undetermined Childhood Neuroendocrine Tumor Pediatric Neuroendocrine Tumor Childhood Neuroendocrine Tumor A neuroendocrine tumor grade 2 that occurs during childhood. C190078 Neoplastic Process Childhood Neuroendocrine Tumor G2 CL1798800 Undetermined Childhood Neuroendocrine Tumor G2 Pediatric Neuroendocrine Tumor G2 Childhood Neuroendocrine Tumor G2 A benign or malignant neoplasm that involves the tissues of the thorax during childhood. C190090 Neoplastic Process Childhood Thoracic Neoplasm CL1798810 Undetermined Childhood Thoracic Neoplasm Pediatric Thoracic Neoplasm Childhood Thoracic Neoplasm A benign or malignant neoplasm that involves the lungs during childhood. C190095 Neoplastic Process Childhood Lung Neoplasm CL1798811 Undetermined Childhood Lung Neoplasm Pediatric Lung Neoplasm Childhood Lung Neoplasm A malignant neoplasm that involves the tissues of the thorax during childhood. C190098 Neoplastic Process Childhood Malignant Thoracic Neoplasm CL1798817 Malignant Childhood Malignant Thoracic Neoplasm Pediatric Malignant Thoracic Neoplasm Childhood Malignant Thoracic Neoplasm A malignant neoplasm that involves the lungs during childhood. C190100 Neoplastic Process Childhood Malignant Lung Neoplasm CL1798815 Malignant Childhood Malignant Lung Neoplasm Pediatric Malignant Lung Neoplasm Childhood Malignant Lung Neoplasm A benign tumor that arises from striated cardiac myocytes during childhood. It is the most common heart tumor in the pediatric population. C190104 Neoplastic Process Childhood Cardiac Rhabdomyoma CL1798819 Benign Childhood Cardiac Rhabdomyoma Pediatric Cardiac Rhabdomyoma Childhood Cardiac Rhabdomyoma A congenital benign tumor of lung interstitial mesenchymal cells that presents with respiratory symptoms in neonates. Images reveal a well-circumscribed solid or partially cystic lung mass. Microscopical examination reveals widened alveolar septa that contain bland, uniform mesenchymal cells. Some cases show ALK rearrangement and A2M-ALK gene fusion. C190105 Neoplastic Process Fetal Lung Interstitial Tumor CL1798823 Benign FLIT Fetal Lung Interstitial Tumor Fetal Lung Interstitial Tumor A benign or malignant neoplasm that affects the anatomic structures of the head and neck region and occurs during childhood. C190119 Neoplastic Process Childhood Head and Neck Neoplasm CL1798783 Undetermined Childhood Head and Neck Neoplasm Childhood Head and Neck Tumor Pediatric Head and Neck Neoplasm Pediatric Head and Neck Tumor Childhood Head and Neck Neoplasm A malignant neoplasm that affects the anatomic structures of the head and neck region and occurs during childhood. C190121 Neoplastic Process Childhood Malignant Head and Neck Neoplasm CL1798781 Malignant Childhood Malignant Head and Neck Neoplasm Childhood Malignant Head and Neck Tumor Pediatric Malignant Head and Neck Neoplasm Pediatric Malignant Head and Neck Tumor Childhood Malignant Head and Neck Neoplasm A benign, intermediate, or malignant neoplasm that affects the skin and occurs during childhood. C190123 Neoplastic Process Childhood Skin Neoplasm CL1798787 Undetermined Childhood Skin Neoplasm Childhood Skin Tumor Pediatric Skin Neoplasm Pediatric Skin Tumor Childhood Skin Neoplasm A malignant neoplasm that affects the skin and occurs during childhood. C190125 Neoplastic Process Childhood Malignant Skin Neoplasm CL1798785 Malignant Childhood Malignant Skin Neoplasm Childhood Malignant Skin Tumor Pediatric Malignant Skin Neoplasm Pediatric Malignant Skin Tumor Childhood Malignant Skin Neoplasm Ocular melanoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C190137 Neoplastic Process Advanced Ocular Melanoma CL1798793 Malignant Advanced Ocular Melanoma Advanced Ocular Melanoma Uveal melanoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C190138 Neoplastic Process Locally Advanced Unresectable Uveal Melanoma Locally Advanced Unresectable Uveal Melanoma CL1798794 CTRP Malignant Locally Advanced Unresectable Uveal Melanoma Locally Advanced Unresectable Uveal Melanoma A squamous cell carcinoma that is not associated with human papillomavirus infection and has metastasized to the neck lymph nodes from an unknown primary anatomic site. C190149 Neoplastic Process Human Papillomavirus-Negative Head and Neck Squamous Cell Carcinoma of Unknown Primary Human Papillomavirus-Negative Neck Squamous Cell Carcinoma of Unknown Primary CL1798746 CTRP Malignant Human Papillomavirus Negative Head and Neck Squamous Cell Carcinoma of Unknown Primary Human Papillomavirus Negative Neck Squamous Cell Carcinoma of Unknown Primary Human Papillomavirus-Negative Head and Neck Squamous Cell Carcinoma of Unknown Primary Human Papillomavirus-Negative Neck Squamous Cell Carcinoma of Unknown Primary Human Papillomavirus-Negative Neck Squamous Cell Carcinoma of Unknown Primary A squamous papilloma of the larynx that occurs during childhood. C190150 Neoplastic Process Childhood Laryngeal Squamous Papilloma CL1798747 Benign Childhood Laryngeal Squamous Cell Papilloma Childhood Laryngeal Squamous Papilloma Pediatric Laryngeal Squamous Cell Papilloma Childhood Laryngeal Squamous Papilloma A benign or malignant neoplasm that arises from tooth-forming tissues and occurs during childhood. C190152 Neoplastic Process Childhood Odontogenic Neoplasm CL1798752 Undetermined Childhood Odontogenic Neoplasm Childhood Odontogenic Tumor Pediatric Odontogenic Neoplasm Pediatric Odontogenic Tumor Childhood Odontogenic Neoplasm An ameloblastoma that occurs during childhood. C190154 Neoplastic Process Childhood Ameloblastoma CL1798750 Undetermined Childhood Ameloblastoma Pediatric Ameloblastoma Childhood Ameloblastoma An ameloblastic fibroma that occurs during childhood. C190155 Neoplastic Process Childhood Ameloblastic Fibroma CL1798755 Benign Childhood Ameloblastic Fibroma Pediatric Ameloblastic Fibroma Childhood Ameloblastic Fibroma An adenomatoid odontogenic tumor that occurs during childhood. C190156 Neoplastic Process Childhood Adenomatoid Odontogenic Tumor CL1798756 Benign Childhood Adenomatoid Odontogenic Tumor Pediatric Adenomatoid Odontogenic Tumor Childhood Adenomatoid Odontogenic Tumor An odontogenic myxoma that occurs during childhood. C190157 Neoplastic Process Childhood Odontogenic Myxoma CL1798753 Benign Childhood Odontogenic Myxoma Pediatric Odontogenic Myxoma Childhood Odontogenic Myxoma An ossifying fibroma that occurs during childhood. C190158 Neoplastic Process Childhood Ossifying Fibroma CL1798754 Benign Childhood Ossifying Fibroma Pediatric Ossifying Fibroma Childhood Ossifying Fibroma A rare, benign, non-odontogenic tumor that arises from the sinonasal tract and occurs almost exclusively in children younger than three years old. It is a hypocellular tumor composed of spindle, stellate, or round cells in a myxoid stroma. C190160 Neoplastic Process Sinonasal Tract Myxoma CL1798760 Benign Sinonasal Tract Myxoma Sinonasal Tract Myxoma A salivary gland pleomorphic adenoma that occurs during childhood. C190161 Neoplastic Process Childhood Salivary Gland Pleomorphic Adenoma CL1798757 Benign Childhood Salivary Gland Pleomorphic Adenoma Pediatric Salivary Gland Pleomorphic Adenoma Childhood Salivary Gland Pleomorphic Adenoma The reemergence of lung non-small cell carcinoma after a period of remission, at or adjacent to the site of the original tumor. C190195 Neoplastic Process Locally Recurrent Lung Non-Small Cell Carcinoma Locally Recurrent Lung Non-Small Cell Carcinoma CL1798734 CTRP Malignant Locally Recurrent Lung Non-Small Cell Carcinoma Locally Recurrent Lung Non-Small Cell Carcinoma The reemergence of breast carcinoma after a period of remission, at or adjacent to the site of the original tumor. C190196 Neoplastic Process Locally Recurrent Breast Carcinoma Locally Recurrent Breast Carcinoma CL1798735 CTRP Malignant Locally Recurrent Breast Carcinoma Locally Recurrent Breast Carcinoma The reemergence of clear cell renal cell carcinoma after a period of remission, at or adjacent to the site of the original tumor. C190197 Neoplastic Process Locally Recurrent Clear Cell Renal Cell Carcinoma Locally Recurrent Clear Cell Renal Cell Carcinoma CL1798732 CTRP Malignant Locally Recurrent Clear Cell Renal Cell Carcinoma Locally Recurrent Clear Cell Renal Cell Carcinoma The reemergence of gastric carcinoma after a period of remission, at or adjacent to the site of the original tumor. C190198 Neoplastic Process Locally Recurrent Gastric Carcinoma Locally Recurrent Gastric Carcinoma CL1798733 CTRP Malignant Locally Recurrent Gastric Carcinoma Locally Recurrent Gastric Carcinoma The reemergence of colorectal carcinoma after a period of remission, at or adjacent to the site of the original tumor. C190199 Neoplastic Process Locally Recurrent Colorectal Carcinoma Locally Recurrent Colorectal Carcinoma CL1798738 CTRP Malignant Locally Recurrent Colorectal Carcinoma Locally Recurrent Colorectal Carcinoma The reemergence of endometrial carcinoma after a period of remission, at or adjacent to the site of the original tumor. C190200 Neoplastic Process Locally Recurrent Endometrial Carcinoma Locally Recurrent Endometrial Carcinoma CL1798739 CTRP Malignant Locally Recurrent Endometrial Carcinoma Locally Recurrent Endometrial Carcinoma The reemergence of ovarian carcinoma after a period of remission, at or adjacent to the site of the original tumor. C190201 Neoplastic Process Locally Recurrent Ovarian Carcinoma Locally Recurrent Ovarian Carcinoma CL1798736 CTRP Malignant Locally Recurrent Ovarian Carcinoma Locally Recurrent Ovarian Carcinoma A HER2-negative breast adenocarcinoma that has not spread beyond the breast and the axillary lymph nodes. C190215 Neoplastic Process Early Stage HER2-Negative Breast Carcinoma Early Stage HER2-Negative Breast Carcinoma CL1799059 CTRP Malignant Early Stage HER2 Negative Breast Adenocarcinoma Early Stage HER2 Negative Breast Carcinoma Early Stage HER2-Negative Breast Adenocarcinoma Early Stage HER2-Negative Breast Carcinoma Early Stage HER2-Negative Breast Carcinoma Cutaneous melanoma that is amenable to surgical resection. C190240 Neoplastic Process Resectable Cutaneous Melanoma Resectable Cutaneous Melanoma CL1799036 CTRP Malignant Resectable Cutaneous Melanoma Resectable Cutaneous Melanoma A mucoepidermoid carcinoma that occurs during childhood. C190272 Neoplastic Process Childhood Mucoepidermoid Carcinoma CL1799050 Malignant Childhood Mucoepidermoid Carcinoma Pediatric Mucoepidermoid Carcinoma Childhood Mucoepidermoid Carcinoma A mucoepidermoid carcinoma of the salivary gland that occurs during childhood. C190273 Neoplastic Process Childhood Salivary Gland Mucoepidermoid Carcinoma CL1799013 Malignant Childhood Salivary Gland Mucoepidermoid Carcinoma Pediatric Salivary Gland Mucoepidermoid Carcinoma Childhood Salivary Gland Mucoepidermoid Carcinoma An acinic cell carcinoma of the salivary gland that occurs during childhood. C190274 Neoplastic Process Childhood Salivary Gland Acinic Cell Carcinoma CL1799014 Malignant Childhood Salivary Gland Acinic Cell Carcinoma Pediatric Salivary Gland Acinic Cell Carcinoma Childhood Salivary Gland Acinic Cell Carcinoma A nasopharyngeal carcinoma that occurs during childhood. C190276 Neoplastic Process Childhood Nasopharyngeal Carcinoma CL1799012 Malignant Childhood Nasopharyngeal Carcinoma Pediatric Nasopharyngeal Carcinoma Childhood Nasopharyngeal Carcinoma A NUT carcinoma that arises from the head and neck and occurs during childhood. C190278 Neoplastic Process Childhood Head and Neck NUT Carcinoma CL1799018 Malignant Childhood Head and Neck NUT Carcinoma Childhood Head and Neck NUT Midline Carcinoma Pediatric Head and Neck NUT Carcinoma Pediatric Head and Neck NUT Midline Carcinoma Childhood Head and Neck NUT Carcinoma A pilomatricoma that occurs during childhood. C190279 Neoplastic Process Childhood Pilomatricoma CL1799015 Benign Childhood Pilomatricoma Pediatric Pilomatricoma Childhood Pilomatricoma A rare melanoma of the skin that occurs during childhood. C190280 Neoplastic Process Childhood Cutaneous Melanoma CL1799016 Malignant Childhood Cutaneous Melanoma Pediatric Cutaneous Melanoma Childhood Cutaneous Melanoma A pigmented spindle cell nevus that occurs during childhood. C190281 Neoplastic Process Childhood Pigmented Spindle Cell Nevus CL1799021 Benign Childhood Pigmented Spindle Cell Nevus Pediatric Pigmented Spindle Cell Nevus Childhood Pigmented Spindle Cell Nevus A Spitz nevus that occurs during childhood. C190282 Neoplastic Process Childhood Spitz Nevus CL1799022 Benign Childhood Spitz Nevus Pediatric Spitz Nevus Childhood Spitz Nevus A blue nevus that occurs during childhood. C190283 Neoplastic Process Childhood Blue Nevus CL1799019 Benign Childhood Blue Nevus Pediatric Blue Nevus Childhood Blue Nevus A circumscribed proliferation of melanocytes in the skin that occurs during childhood. It is characterized by the absence of atypical or malignant cytological features, and absence of invasive features or metastatic potential. C190284 Neoplastic Process Childhood Benign Skin Melanocytic Nevus CL1799020 Benign Childhood Benign Skin Melanocytic Nevus Pediatric Benign Skin Melanocytic Nevus Childhood Benign Skin Melanocytic Nevus A junctional nevus that occurs during childhood. C190285 Neoplastic Process Childhood Junctional Nevus CL1799024 Benign Childhood Junctional Nevus Pediatric Junctional Nevus Childhood Junctional Nevus A compound nevus that occurs during childhood. C190286 Neoplastic Process Childhood Compound Nevus CL1799025 Benign Childhood Compound Nevus Pediatric Compound Nevus Childhood Compound Nevus A dermal nevus that occurs during childhood. C190287 Neoplastic Process Childhood Dermal Nevus CL1799023 Benign Childhood Dermal Nevus Pediatric Dermal Nevus Childhood Dermal Nevus The reemergence of T-cell and NK-cell neoplasm after a period of remission. C190400 Neoplastic Process Recurrent T-Cell and NK-Cell Neoplasm CL1798950 Undetermined Recurrent T-Cell and NK-Cell Neoplasm Recurrent T-Cell and NK-Cell Neoplasm T-cell and NK-cell neoplasm that is resistant to treatment. C190401 Neoplastic Process Refractory T-Cell and NK-Cell Neoplasm CL1798905 Undetermined Refractory T-Cell and NK-Cell Neoplasm Refractory T-Cell and NK-Cell Neoplasm Colorectal adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C190413 Neoplastic Process Locally Advanced Colorectal Adenocarcinoma CL1798910 Malignant Locally Advanced Colorectal Adenocarcinoma Locally Advanced Colorectal Adenocarcinoma Colon adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C190415 Neoplastic Process Locally Advanced Colon Adenocarcinoma Locally Advanced Colon Adenocarcinoma CL1798909 CTRP Malignant Locally Advanced Colon Adenocarcinoma Locally Advanced Colon Adenocarcinoma A papillary renal cell carcinoma that is not amenable to surgical resection. C190505 Neoplastic Process Unresectable Papillary Renal Cell Carcinoma Unresectable Papillary Renal Cell Carcinoma CL1799188 CTRP Malignant Unresectable Papillary Renal Cell Carcinoma Unresectable Papillary Renal Cell Carcinoma A renal cell carcinoma, not otherwise specified, that is not amenable to surgical resection. C190508 Neoplastic Process Unresectable Unclassified Renal Cell Carcinoma Unresectable Renal Cell Carcinoma, Not Otherwise Specified CL1799193 CTRP Malignant Unresectable Renal Cell Carcinoma, Not Otherwise Specified Unresectable Unclassified Renal Cell Carcinoma Unresectable Renal Cell Carcinoma, Not Otherwise Specified The use of pulsed ultrasound to visualize blood flow through blood vessels. Flow direction and speed are shown in differing colors. C190518 Diagnostic Procedure Color Flow Doppler Ultrasound Imaging C0474781 CD CDI CFD Color Doppler Color Doppler Imaging Color Flow Doppler Color Flow Doppler Ultrasound Color Flow Doppler Ultrasound Imaging Color Flow Doppler Ultrasound Imaging The continuous recording of fluoroscopy images as a movie. C190520 Diagnostic Procedure Cinefluorography C0008797 CF Cinefluorography Cinefluorography X-ray imaging that replaces film with a phosphor imaging plate to create a digital image. C190521 Diagnostic Procedure Computed Radiography CL382908 CR Computed Radiography Computed Radiography An ultrasound technique that uses a B-mode transducer to visualize blood flow and a Doppler probe to assess velocity and direction of the blood flow. C190534 Diagnostic Procedure Duplex Ultrasound Duplex Ultrasound C0242845 CTRP DD Duplex Doppler Duplex Doppler Ultrasound Duplex Ultrasound Duplex Ultrasound Fluoroscopy that includes an image digitization and recording device. C190535 Diagnostic Procedure Digital Fluoroscopy CL1799257 DF Digital Fluoroscopy Digital Fluoroscopy Radiography done within the oral cavity. C190548 Diagnostic Procedure Intraoral Radiography CL1799259 IO Intra-Oral Radiography Intraoral Radiography Intraoral Radiography A childhood neoplasm that arises from the breast and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C190574 Neoplastic Process Childhood Benign Breast Neoplasm CL1799155 Benign Childhood Benign Breast Neoplasm Pediatric Benign Breast Neoplasm Childhood Benign Breast Neoplasm A malignant neoplasm that affects the breast and occurs during childhood. C190575 Neoplastic Process Childhood Malignant Breast Neoplasm CL1799159 Malignant Childhood Malignant Breast Neoplasm Pediatric Malignant Breast Neoplasm Childhood Malignant Breast Neoplasm A childhood neoplasm that arises from connective and soft tissue and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C190576 Neoplastic Process Childhood Benign Connective and Soft Tissue Neoplasm CL1799160 Benign Childhood Benign Connective and Soft Tissue Neoplasm Pediatric Benign Connective and Soft Tissue Neoplasm Childhood Benign Connective and Soft Tissue Neoplasm A childhood neoplasm that arises from bone and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C190577 Neoplastic Process Childhood Benign Bone Neoplasm CL1799157 Benign Childhood Benign Bone Neoplasm Pediatric Benign Bone Neoplasm Childhood Benign Bone Neoplasm A malignant neoplasm that affects the bone or articular cartilage and occurs during childhood. C190578 Neoplastic Process Childhood Malignant Bone Neoplasm CL1799158 Malignant Childhood Malignant Bone Neoplasm Pediatric Malignant Bone Neoplasm Childhood Malignant Bone Neoplasm A childhood neoplasm that arises from the digestive system and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C190580 Neoplastic Process Childhood Benign Digestive System Neoplasm CL1799162 Benign Childhood Benign Digestive System Neoplasm Childhood Benign Gastrointestinal System Neoplasm Pediatric Benign Digestive System Neoplasm Pediatric Benign Gastrointestinal System Neoplasm Childhood Benign Digestive System Neoplasm A childhood neoplasm that arises from the liver and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C190581 Neoplastic Process Childhood Benign Liver Neoplasm CL1799163 Benign Childhood Benign Liver Neoplasm Childhood Benign Liver and Intrahepatic Bile Duct Neoplasm Pediatric Benign Liver Neoplasm Pediatric Benign Liver and Intrahepatic Bile Duct Neoplasm Childhood Benign Liver Neoplasm A neoplasm that arises from the liver and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C190592 Neoplastic Process Benign Liver Neoplasm C0496870 Benign Benign Liver Neoplasm Benign Liver and Intrahepatic Bile Duct Neoplasm Benign Liver Neoplasm A primary or metastatic malignant neoplasm that affects the liver. C190593 Neoplastic Process Malignant Liver Neoplasm C0345904 mCode Malignant Malignant Liver Neoplasm Malignant neoplasm of liver, not specified as primary or secondary Malignant Liver Neoplasm A childhood epithelial neoplasm that arises from an endocrine organ and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C190600 Neoplastic Process Childhood Benign Endocrine Neoplasm CL1799132 Benign Childhood Benign Endocrine Neoplasm Pediatric Benign Endocrine Neoplasm Childhood Benign Endocrine Neoplasm A childhood neoplasm that arises from any part of the genitourinary system and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C190602 Neoplastic Process Childhood Benign Genitourinary System Neoplasm CL1799130 Benign Childhood Benign Genitourinary System Neoplasm Pediatric Benign Genitourinary System Neoplasm Childhood Benign Genitourinary System Neoplasm A childhood neoplasm that arises from the kidney and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C190608 Neoplastic Process Childhood Benign Kidney Neoplasm CL1799137 Benign Childhood Benign Kidney Neoplasm Pediatric Benign Kidney Neoplasm Childhood Benign Kidney Neoplasm A childhood neoplasm that arises from the head and neck and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C190613 Neoplastic Process Childhood Benign Head and Neck Neoplasm CL1799139 Benign Childhood Benign Head and Neck Neoplasm Pediatric Benign Head and Neck Neoplasm Childhood Benign Head and Neck Neoplasm The continuous recording of fluoroscopy images as a video film. C190617 Diagnostic Procedure Videofluorography CL1799241 VF Videofluorography Videofluorography A childhood neoplasm that arises from the skin and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C190618 Neoplastic Process Childhood Benign Skin Neoplasm CL1799140 Benign Childhood Benign Skin Neoplasm Pediatric Benign Skin Neoplasm Childhood Benign Skin Neoplasm A childhood neoplasm that arises from the tissues of thorax and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C190620 Neoplastic Process Childhood Benign Thoracic Neoplasm CL1799144 Benign Childhood Benign Thoracic Neoplasm Pediatric Benign Thoracic Neoplasm Childhood Benign Thoracic Neoplasm A childhood neoplasm that arises from the lung and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C190621 Neoplastic Process Childhood Benign Lung Neoplasm CL1799145 Benign Childhood Benign Lung Neoplasm Pediatric Benign Lung Neoplasm Childhood Benign Lung Neoplasm A childhood neoplasm that arises from the nervous system and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C190622 Neoplastic Process Childhood Benign Nervous System Neoplasm CL1799142 Benign Childhood Benign Nervous System Neoplasm Pediatric Benign Nervous System Neoplasm Childhood Benign Nervous System Neoplasm A primary or metastatic malignant neoplasm that affects the nervous system and occurs during childhood. C190623 Neoplastic Process Childhood Malignant Nervous System Neoplasm CL1799143 Malignant Childhood Malignant Nervous System Neoplasm Pediatric Malignant Nervous System Neoplasm Childhood Malignant Nervous System Neoplasm Oropharyngeal undifferentiated carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C190631 Neoplastic Process Locally Advanced Oropharyngeal Undifferentiated Carcinoma Locally Advanced Oropharyngeal Undifferentiated Carcinoma CL1799108 CTRP Malignant Locally Advanced Oropharyngeal Undifferentiated Carcinoma Locally Advanced Oropharyngeal Undifferentiated Carcinoma Oropharyngeal undifferentiated carcinoma that is not amenable to surgical resection. C190632 Neoplastic Process Unresectable Oropharyngeal Undifferentiated Carcinoma Unresectable Oropharyngeal Undifferentiated Carcinoma CL1799111 CTRP Malignant Unresectable Oropharyngeal Undifferentiated Carcinoma Unresectable Oropharyngeal Undifferentiated Carcinoma An ovarian high-grade serous adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C190633 Neoplastic Process Advanced Ovarian High Grade Serous Adenocarcinoma Advanced Ovarian High Grade Serous Adenocarcinoma CL1799112 CTRP Malignant Advanced Ovarian High Grade Serous Adenocarcinoma Advanced Ovarian High-Grade Serous Adenocarcinoma Advanced Ovarian High Grade Serous Adenocarcinoma A childhood neoplasm that arises from the ovary and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C190658 Neoplastic Process Childhood Benign Ovarian Neoplasm CL1799124 Benign Childhood Benign Ovarian Neoplasm Pediatric Benign Ovarian Neoplasm Childhood Benign Ovarian Neoplasm A malignant neoplasm that affects the ovary and occurs during childhood. C190659 Neoplastic Process Childhood Malignant Ovarian Neoplasm CL1799125 Malignant Childhood Malignant Ovarian Neoplasm Pediatric Malignant Ovarian Neoplasm Childhood Malignant Ovarian Neoplasm Hormone receptor-negative breast carcinoma that is not amenable to surgical resection. C190676 Neoplastic Process Unresectable Hormone Receptor-Negative Breast Carcinoma Unresectable Hormone Receptor-Negative Breast Carcinoma CL1799089 CTRP Malignant Unresectable Hormone Receptor Negative Breast Carcinoma Unresectable Hormone Receptor-Negative Breast Carcinoma Unresectable Hormone Receptor-Negative Breast Carcinoma Hormone receptor-negative breast carcinoma that has spread from its original site of growth to another anatomic site. C190677 Neoplastic Process Metastatic Hormone Receptor-Negative Breast Carcinoma Metastatic Hormone Receptor-Negative Breast Carcinoma CL1799093 CTRP Malignant Metastatic Hormone Receptor Negative Breast Carcinoma Metastatic Hormone Receptor-Negative Breast Carcinoma Metastatic Hormone Receptor-Negative Breast Carcinoma Hormone receptor-negative breast carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C190678 Neoplastic Process Advanced Hormone Receptor-Negative Breast Carcinoma Advanced Hormone Receptor-Negative Breast Carcinoma CL1799094 CTRP Malignant Advanced Hormone Receptor Negative Breast Carcinoma Advanced Hormone Receptor-Negative Breast Carcinoma Advanced Hormone Receptor-Negative Breast Carcinoma The reemergence of microsatellite stable colorectal carcinoma after a period of remission. C190679 Neoplastic Process Recurrent Microsatellite Stable Colorectal Carcinoma Recurrent Microsatellite Stable Colorectal Carcinoma CL1799091 CTRP Malignant Recurrent Microsatellite Stable Colorectal Carcinoma Recurrent Microsatellite Stable Colorectal Carcinoma A group of aggressive endometrial carcinomas with high-grade histological features. It includes high grade endometrial endometrioid adenocarcinoma, endometrial clear cell adenocarcinoma, endometrial serous adenocarcinoma, and endometrial undifferentiated carcinoma. C190680 Neoplastic Process High Grade Endometrial Carcinoma High Grade Endometrial Carcinoma CL1799092 CTRP Malignant High Grade Endometrial Carcinoma High-Grade Endometrial Carcinoma High Grade Endometrial Carcinoma Digestive system neuroendocrine tumor G2 that has spread extensively to other anatomic sites or is no longer responding to treatment. C190711 Neoplastic Process Advanced Digestive System Neuroendocrine Tumor G2 Advanced Digestive System Neuroendocrine Tumor G2 CL1799401 CTRP Malignant Advanced Digestive System NET G2 Advanced Digestive System Neuroendocrine Tumor G2 Advanced Digestive System Neuroendocrine Tumor G2 Pancreatic neuroendocrine tumor G1 that has spread from its original site of growth to another anatomic site. C190712 Neoplastic Process Metastatic Pancreatic Neuroendocrine Tumor G1 CL1799395 Malignant Metastatic Pancreatic Neuroendocrine Tumor G1 Metastatic Pancreatic Neuroendocrine Tumor G1 Pancreatic neuroendocrine tumor G1 that has spread extensively to other anatomic sites or is no longer responding to treatment. C190713 Neoplastic Process Advanced Pancreatic Neuroendocrine Tumor G1 Advanced Pancreatic Neuroendocrine Tumor G1 CL1799396 CTRP Malignant Advanced Pancreatic Neuroendocrine Tumor G1 Advanced Pancreatic Neuroendocrine Tumor G1 Pancreatic neuroendocrine tumor G2 that has spread from its original site of growth to another anatomic site. C190714 Neoplastic Process Metastatic Pancreatic Neuroendocrine Tumor G2 CL1799397 Malignant Metastatic Pancreatic Neuroendocrine Tumor G2 Metastatic Pancreatic Neuroendocrine Tumor G2 Pancreatic neuroendocrine tumor G2 that has spread extensively to other anatomic sites or is no longer responding to treatment. C190715 Neoplastic Process Advanced Pancreatic Neuroendocrine Tumor G2 Advanced Pancreatic Neuroendocrine Tumor G2 CL1799398 CTRP Malignant Advanced Pancreatic Neuroendocrine Tumor G2 Advanced Pancreatic Neuroendocrine Tumor G2 Melanoma that affects both the iris and ciliary body. C190746 Neoplastic Process Iridociliary Melanoma CL1799384 Malignant Iridociliary Melanoma Iridociliary Melanoma Oropharyngeal undifferentiated carcinoma that is amenable to surgical resection. C190769 Neoplastic Process Resectable Oropharyngeal Undifferentiated Carcinoma Resectable Oropharyngeal Undifferentiated Carcinoma CL1799346 CTRP Malignant Resectable Oropharyngeal Undifferentiated Carcinoma Resectable Oropharyngeal Undifferentiated Carcinoma Pancreatic adenosquamous carcinoma that has spread from its original site of growth to another anatomic site. C190770 Neoplastic Process Metastatic Pancreatic Adenosquamous Carcinoma Metastatic Pancreatic Adenosquamous Carcinoma CL1799347 CTRP Malignant Metastatic Pancreatic Adenosquamous Carcinoma Metastatic Pancreatic Adenosquamous Carcinoma Pancreatic squamous cell carcinoma that has spread from its original site of growth to another anatomic site. C190771 Neoplastic Process Metastatic Pancreatic Squamous Cell Carcinoma Metastatic Pancreatic Squamous Cell Carcinoma CL1799348 CTRP Malignant Metastatic Pancreatic Squamous Cell Carcinoma Metastatic Pancreatic Squamous Cell Carcinoma Non-muscle invasive bladder carcinoma that has spread from its original site of growth to another anatomic site. C190772 Neoplastic Process Metastatic Non-Muscle Invasive Bladder Carcinoma Metastatic Non-Muscle Invasive Bladder Carcinoma CL1799356 CTRP Malignant Metastatic Non-Muscle Invasive Bladder Carcinoma Metastatic Non-Muscle Invasive Bladder Carcinoma Non-muscle invasive bladder carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C190773 Neoplastic Process Locally Advanced Non-Muscle Invasive Bladder Carcinoma Locally Advanced Non-Muscle Invasive Bladder Carcinoma CL1799357 CTRP Malignant Locally Advanced Non-Muscle Invasive Bladder Carcinoma Locally Advanced Non-Muscle Invasive Bladder Carcinoma The reemergence of non-muscle invasive bladder carcinoma after a period of remission. C190774 Neoplastic Process Recurrent Non-Muscle Invasive Bladder Carcinoma Recurrent Non-Muscle Invasive Bladder Carcinoma CL1799358 CTRP Malignant Recurrent Non-Muscle Invasive Bladder Carcinoma Recurrent Non-Muscle Invasive Bladder Carcinoma The reemergence of MGMT-methylated glioblastoma after a period of remission. C190775 Neoplastic Process Recurrent MGMT-Methylated Glioblastoma Recurrent MGMT-Methylated Glioblastoma CL1799359 CTRP Malignant Recurrent MGMT-Methylated Glioblastoma Recurrent MGMT-Methylated Glioblastoma Pancreatic neuroendocrine tumor that is not amenable to surgical resection. C190782 Neoplastic Process Unresectable Pancreatic Neuroendocrine Tumor Unresectable Pancreatic Neuroendocrine Tumor CL1799314 CTRP Malignant Unresectable Pancreatic Neuroendocrine Tumor Unresectable Pancreatic Neuroendocrine Tumor Genitourinary system carcinoma that is not amenable to surgical resection. C190783 Neoplastic Process Unresectable Genitourinary System Carcinoma Unresectable Genitourinary System Carcinoma CL1799315 CTRP Malignant Unresectable Genitourinary System Carcinoma Unresectable Genitourinary System Carcinoma The reemergence of accelerated phase chronic myeloid leukemia, BCR-ABL1 positive after a period of remission. C190786 Neoplastic Process Recurrent Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Recurrent Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive CL1799310 CTRP Malignant Recurrent Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Recurrent Accelerated Phase Chronic Myelogenous Leukemia, BCR::ABL1 Positive Recurrent Accelerated Phase Chronic Myeloid Leukemia Recurrent Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive Recurrent Accelerated Phase Chronic Myeloid Leukemia, BCR::ABL1 Positive Recurrent Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive Accelerated phase chronic myeloid leukemia, BCR-ABL1 positive that is resistant to treatment. C190787 Neoplastic Process Refractory Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Refractory Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive CL1799311 CTRP Malignant Refractory Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Refractory Accelerated Phase Chronic Myelogenous Leukemia, BCR::ABL1 Positive Refractory Accelerated Phase Chronic Myeloid Leukemia Refractory Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive Refractory Accelerated Phase Chronic Myeloid Leukemia, BCR::ABL1 Positive Refractory Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive Magnetic resonance imaging that combines morphologic T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI). It is used to detect, localize, and guide prostatic targeted biopsy. C190834 Diagnostic Procedure Biparametric Magnetic Resonance Imaging Biparametric Magnetic Resonance Imaging CL1799300 CTRP Biparametric MRI Biparametric Magnetic Resonance Imaging bpMRI Biparametric Magnetic Resonance Imaging A B-acute lymphoblastic leukemia that occurs in patients with Down syndrome. It usually affects young children, but it can occur in adults as well. It has an unfavorable clinical outcome. Cases of T-acute lymphoblastic leukemia in patients with Down syndrome have not been reported. C190847 Neoplastic Process B Acute Lymphoblastic Leukemia Associated with Down Syndrome B Acute Lymphoblastic Leukemia Associated with Down Syndrome CL1799271 CTRP Malignant Acute Lymphoblastic Leukemia Associated with Down Syndrome B Acute Lymphoblastic Leukemia Associated with Down Syndrome DS-ALL B Acute Lymphoblastic Leukemia Associated with Down Syndrome Breast carcinoma that is positive for androgen receptors. C190851 Neoplastic Process Androgen Receptor-Positive Breast Carcinoma CL1799267 Malignant Androgen Receptor Positive Breast Adenocarcinoma Androgen Receptor Positive Breast Carcinoma Androgen Receptor-Positive Breast Adenocarcinoma Androgen Receptor-Positive Breast Carcinoma Androgen Receptor-Positive Breast Carcinoma Androgen receptor-positive breast carcinoma that has spread from its original site of growth to another anatomic site. C190852 Neoplastic Process Metastatic Androgen Receptor-Positive Breast Carcinoma Metastatic Androgen Receptor-Positive Breast Carcinoma CL1799268 CTRP Malignant Metastatic Androgen Receptor Positive Breast Adenocarcinoma Metastatic Androgen Receptor Positive Breast Carcinoma Metastatic Androgen Receptor-Positive Breast Adenocarcinoma Metastatic Androgen Receptor-Positive Breast Carcinoma Metastatic Androgen Receptor-Positive Breast Carcinoma Estrogen receptor-positive breast carcinoma that has spread from its original site of growth to another anatomic site. C190856 Neoplastic Process Metastatic Estrogen Receptor-Positive Breast Carcinoma Metastatic Estrogen Receptor-Positive Breast Carcinoma CL1799278 CTRP Malignant Metastatic Estrogen Receptor Positive Breast Adenocarcinoma Metastatic Estrogen Receptor Positive Breast Carcinoma Metastatic Estrogen Receptor-Positive Breast Adenocarcinoma Metastatic Estrogen Receptor-Positive Breast Carcinoma Metastatic Estrogen Receptor-Positive Breast Carcinoma Lung carcinoma that is amenable to surgical resection. C190952 Neoplastic Process Resectable Lung Carcinoma CL1799555 Malignant Resectable Lung Carcinoma Resectable Lung Carcinoma Lung squamous cell carcinoma that is amenable to surgical resection. C190953 Neoplastic Process Resectable Lung Squamous Cell Carcinoma Resectable Lung Squamous Cell Carcinoma CL1799556 CTRP Malignant Resectable Lung Squamous Cell Carcinoma Resectable Lung Squamous Cell Carcinoma Lung adenocarcinoma that is amenable to surgical resection. C190954 Neoplastic Process Resectable Lung Adenocarcinoma Resectable Lung Adenocarcinoma CL1799549 CTRP Malignant Resectable Lung Adenocarcinoma Resectable Lung Adenocarcinoma B lymphoblastic leukemia/lymphoma characterized by a gene-expression profile similar to that of ETV6-RUNX1-positive B lymphoblastic leukemia/lymphoma, absence of the pathognomonic ETV6-RUNX1 rearrangement, and rearrangements or deletions of ETV6 and IKZF1 genes. C190956 Neoplastic Process B Lymphoblastic Leukemia/Lymphoma with ETV6-RUNX1-Like Features CL1799551 Malignant B Lymphoblastic Leukemia/Lymphoma with ETV6-RUNX1-Like Features B Lymphoblastic Leukemia/Lymphoma with ETV6::RUNX1-Like Features B-Lymphoblastic Leukemia/Lymphoma with ETV6-RUNX1-Like Features B-Lymphoblastic Leukemia/Lymphoma with ETV6::RUNX1-Like Features B Lymphoblastic Leukemia/Lymphoma with ETV6-RUNX1-Like Features B acute lymphoblastic leukemia characterized by a gene-expression profile similar to that of ETV6-RUNX1-positive B acute lymphoblastic leukemia, absence of the pathognomonic ETV6-RUNX1 rearrangement, and rearrangements or deletions of ETV6 and IKZF1 genes. C190957 Neoplastic Process B Acute Lymphoblastic Leukemia with ETV6-RUNX1-Like Features CL1799552 Malignant B Acute Lymphoblastic Leukemia with ETV6-RUNX1-Like Features B Acute Lymphoblastic Leukemia with ETV6::RUNX1-Like Features B-Acute Lymphoblastic Leukemia with ETV6-RUNX1-Like Features B-Acute Lymphoblastic Leukemia with ETV6::RUNX1-Like Features ETV6::RUNX1-like features B Acute Lymphoblastic Leukemia with ETV6-RUNX1-Like Features The reemergence of astrocytoma, IDH-mutant, grade 3 after a period of remission. C191197 Neoplastic Process Recurrent Astrocytoma, IDH-Mutant, Grade 3 Recurrent Astrocytoma, IDH-Mutant, Grade 3 CL1799657 CTRP Malignant Recurrent Astrocytoma, IDH-Mutant, Grade 3 Recurrent Astrocytoma, IDH-Mutant, Grade 3 The reemergence of brain glioblastoma after a period of remission. C191198 Neoplastic Process Recurrent Brain Glioblastoma Recurrent Brain Glioblastoma CL1799628 CTRP Malignant Recurrent Brain Glioblastoma Recurrent Brain Glioblastoma A positron emission tomography and computed tomography scan that uses a gallium-68 labeled marker. C191199 Diagnostic Procedure Ga-68 PET/CT Scan Ga-68 PET/CT Scan CL1799629 CTRP Ga-68 PET/CT Scan Gallium-68 PET/CT Scan Gallium-68 Positron Emission Tomography and Computed Tomography Scan Ga-68 PET/CT Scan A lymph node that is found within the parenchyma of the lung. C191304 Body Part, Organ, or Organ Component Pulmonary Lymph Node C0229749 CDISC mCode A lymph node that is found within the parenchyma of the lung. (NCI) PULMONARY LYMPH NODE Pulmonary Lymph Node Structure of intrapulmonary lymph node (body structure) Pulmonary Lymph Node A type of X-ray in which the images are not enhanced by the addition of contrast agents into the body. C191329 Diagnostic Procedure X-Ray Without Contrast CL1904784 CDISC A type of X-ray in which the images are not enhanced by the addition of contrast agents into the body. X-RAY WITHOUT CONTRAST X-Ray Without Contrast X-Ray Without Contrast A type of PET scan in which the images are not enhanced by the addition of contrast agents into the body. C191330 Diagnostic Procedure PET SCAN Without Contrast CL1904783 CDISC A type of PET scan in which the images are not enhanced by the addition of contrast agents into the body. PET SCAN WITHOUT CONTRAST PET SCAN Without Contrast PET SCAN Without Contrast A renal cell carcinoma that cannot be classified into one of the established subtypes of renal cell carcinoma. C191370 Neoplastic Process Unclassified Renal Cell Carcinoma Renal Cell Carcinoma, Not Otherwise Specified CL1904778 CTRP GDC Malignant Unclassified_Renal_Cell_Carcinoma 8312/3 Renal cell carcinoma, NOS Renal cell carcinoma, unclassified RCC-NEC RCC-NOS Renal Cell Carcinoma, NOS Renal Cell Carcinoma, Not Elsewhere Classified Renal Cell Carcinoma, Not Otherwise Specified Renal Cell Carcinoma, Unclassified Renal cell carcinoma, NOS Renal cell carcinoma, unclassified Unclassified Renal Cell Cancer Unclassified Renal Cell Carcinoma Renal Cell Carcinoma, Not Otherwise Specified A renal cell carcinoma characterized by the presence of mutations in the ELOC (TCEB1) gene at 8q21.11. C191375 Neoplastic Process ELOC-Mutated Renal Cell Carcinoma CL1904775 Malignant ELOC (Formerly TCEB1)-Mutated RCC ELOC (Formerly TCEB1)-Mutated Renal Cell Carcinoma ELOC-Mutated RCC ELOC-Mutated Renal Cell Carcinoma TCEB1-Mutated RCC TCEB1-Mutated Renal Cell Carcinoma ELOC-Mutated Renal Cell Carcinoma A benign mesenchymal tumor that arises from the kidney and is composed of mature adipose tissue, thick-walled blood vessels, and epithelioid and spindle smooth muscle cells. C191391 Neoplastic Process Kidney Classic Angiomyolipoma CL1905086 Benign Classic Angiomyolipoma/PEComa of the Kidney Kidney Classic Angiomyolipoma Kidney Classic Angiomyolipoma/PEComa Kidney Classic Angiomyolipoma A rare angiomyolipoma of the kidney characterized by the presence of polygonal cells with eosinophilic cytoplasm. C191392 Neoplastic Process Kidney Oncocytoma-Like Angiomyolipoma CL1905085 Benign Kidney Oncocytoma-Like Angiomyolipoma Kidney Oncocytoma-Like Angiomyolipoma A rare angiomyolipoma of the kidney characterized by the presence of solid and cystic architectural patterns. The cysts are lined by hobnail epithelial cells. C191393 Neoplastic Process Kidney Angiomyolipoma with Epithelial Cysts CL1905084 Benign Kidney AMLEC Kidney Angiomyolipoma with Epithelial Cysts Kidney Angiomyolipoma with Epithelial Cysts A rare hemangioblastoma that arises from the kidney. C191394 Neoplastic Process Kidney Hemangioblastoma C1860392 Undetermined Kidney Hemangioblastoma Renal Hemangioblastoma Kidney Hemangioblastoma The reemergence of platinum-sensitive fallopian tube carcinoma after a period of remission. C191395 Neoplastic Process Recurrent Platinum-Sensitive Fallopian Tube Carcinoma Recurrent Platinum-Sensitive Fallopian Tube Carcinoma CL1905090 CTRP Malignant Recurrent Platinum-Sensitive Fallopian Tube Carcinoma Recurrent Platinum-Sensitive Fallopian Tube Carcinoma The reemergence of platinum-sensitive primary peritoneal carcinoma after a period of remission. C191407 Neoplastic Process Recurrent Platinum-Sensitive Primary Peritoneal Carcinoma Recurrent Platinum-Sensitive Primary Peritoneal Carcinoma CL1905099 CTRP Malignant Recurrent Platinum-Sensitive Primary Peritoneal Carcinoma Recurrent Platinum-Sensitive Primary Peritoneal Carcinoma Transformation of plasma cell myeloma to plasma cell leukemia. C191432 Neoplastic Process Secondary Plasma Cell Leukemia CL1905078 Malignant Multiple Myeloma Transformation to Plasma Cell Leukemia Plasma Cell Leukemia Secondary to Multiple Myeloma Plasma Cell Leukemia Secondary to Plasma Cell Myeloma Plasma Cell Myeloma Transformation to Plasma Cell Leukemia Secondary Plasma Cell Leukemia Secondary Plasma Cell Leukemia Ultrasound examination of the blood flow through the vasculature of the lower extremities. C191543 Diagnostic Procedure Lower Extremity Doppler Ultrasonography CL1904991 ACC/AHA Documented findings from the ultrasound examination Doppler Ultrasound of Leg Lower Extremity Doppler Ultrasonography Lower extremity ultrasound Lower Extremity Doppler Ultrasonography A papillary neoplasm of the urothelium. The papillary structures exhibit minimal architectural distortion and minimal atypia. Mitoses are infrequent. It usually occurs in the urinary bladder, but it can arise from other sites in the urinary tract. Patients are at an increased risk of developing new papillary lesions. Occasionally, the new lesions are urothelial carcinomas. C191672 Neoplastic Process Papillary Urothelial Neoplasm of Low Malignant Potential CL1905256 GDC Undetermined 8130/1 Papillary transitional cell neoplasm of low malignant potential Papillary urothelial neoplasm of low malignant potential PUNLMP Papillary Urothelial Neoplasm of Low Malignant Potential Papillary urothelial neoplasm of low malignant potential Papillary Urothelial Neoplasm of Low Malignant Potential A non-invasive papillary urothelial carcinoma characterized by minimal cytologic atypia and infrequent mitotic figures (usually limited to the lower half of the tumor). It usually occurs in the urinary bladder, but it can arise from other sites in the urinary tract. This type of carcinoma recurs frequently, may invade the urinary tract wall, and has a low risk of progression. C191673 Neoplastic Process Non-Invasive Papillary Urothelial Carcinoma, Low Grade CL1411089 Malignant Non-Invasive Papillary Urothelial Carcinoma, Low Grade Non-Invasive Papillary Urothelial Carcinoma, Low-Grade Non-Invasive Papillary Urothelial Carcinoma, Low Grade A non-invasive papillary urothelial carcinoma characterized by marked architectural and cytologic abnormalities and frequent mitotic figures (at all levels of the urothelium). It usually occurs in the urinary bladder, but it can arise from other sites in the urinary tract. C191675 Neoplastic Process Non-Invasive Papillary Urothelial Carcinoma, High Grade CL1646731 Malignant Non-Invasive Papillary Urothelial Carcinoma, High Grade Non-Invasive Papillary Urothelial Carcinoma, High-Grade Non-Invasive Papillary Urothelial Carcinoma, High Grade Invasive urothelial carcinoma with lymphoepithelioma-like features. C191678 Neoplastic Process Invasive Lymphoepithelioma-Like Urothelial Carcinoma CL1905271 Malignant Invasive Lymphoepithelioma-Like Urothelial Carcinoma Lymphoepithelioma-Like Urothelial Carcinoma Invasive Lymphoepithelioma-Like Urothelial Carcinoma An invasive urothelial carcinoma characterized by the presence of giant cells. C191679 Neoplastic Process Invasive Giant Cell Urothelial Carcinoma CL1905270 Malignant Giant Cell Urothelial Carcinoma Invasive Giant Cell Urothelial Carcinoma Invasive Giant Cell Urothelial Carcinoma An invasive urothelial carcinoma that exhibits glandular differentiation. C191680 Neoplastic Process Invasive Urothelial Carcinoma with Glandular Differentiation CL1905275 Malignant Invasive Urothelial Carcinoma with Glandular Differentiation Urothelial Carcinoma with Glandular Differentiation Invasive Urothelial Carcinoma with Glandular Differentiation An invasive urothelial carcinoma that exhibits squamous differentiation. C191681 Neoplastic Process Invasive Urothelial Carcinoma with Squamous Differentiation CL1905274 GDC Malignant Urothelial carcinoma with squamous differentiation Invasive Urothelial Carcinoma with Squamous Differentiation Urothelial Carcinoma with Squamous Differentiation Urothelial carcinoma with squamous differentiation Invasive Urothelial Carcinoma with Squamous Differentiation An invasive urothelial carcinoma characterized by the presence of trophoblastic differentiation. C191682 Neoplastic Process Invasive Urothelial Carcinoma with Trophoblastic Differentiation CL1905273 GDC Malignant Urothelial carcinoma with trophoblastic differentiation Invasive Urothelial Carcinoma with Trophoblastic Differentiation Urothelial Carcinoma with Trophoblastic Differentiation Urothelial carcinoma with trophoblastic differentiation Invasive Urothelial Carcinoma with Trophoblastic Differentiation An invasive urothelial carcinoma characterized by the presence of clear (glycogen-rich) cells. C191683 Neoplastic Process Invasive Clear Cell (Glycogen-Rich) Urothelial Carcinoma CL1797870 GDC Malignant Clear cell (glycogen-rich) urothelial carcinoma Clear Cell (Glycogen-Rich) Urothelial Carcinoma Clear Cell Urothelial Carcinoma Clear cell (glycogen-rich) urothelial carcinoma Invasive Clear Cell (Glycogen-Rich) Urothelial Carcinoma Invasive Clear Cell Urothelial Carcinoma Invasive Clear Cell (Glycogen-Rich) Urothelial Carcinoma Invasive urothelial carcinoma characterized by the presence of lipid laden tumor cells. C191684 Neoplastic Process Invasive Lipid-Rich Urothelial Carcinoma CL1905265 GDC Malignant Lipid-rich urothelial carcinoma Invasive Lipid-Rich Urothelial Carcinoma Lipid-Rich Urothelial Carcinoma Lipid-rich urothelial carcinoma Invasive Lipid-Rich Urothelial Carcinoma Invasive urothelial carcinoma characterized by microcysts formation. C191685 Neoplastic Process Invasive Microcystic Urothelial Carcinoma CL1905264 GDC Malignant Microcystic urothelial carcinoma Invasive Microcystic Urothelial Carcinoma Microcystic Urothelial Carcinoma Microcystic urothelial carcinoma Invasive Microcystic Urothelial Carcinoma Invasive urothelial carcinoma exhibiting micropapillary growth pattern. C191686 Neoplastic Process Invasive Micropapillary Urothelial Carcinoma CL1905263 CPTAC Malignant Invasive Micropapillary Urothelial Carcinoma Micropapillary Urothelial Carcinoma Invasive Micropapillary Urothelial Carcinoma Invasive urothelial carcinoma characterized by a nested growth pattern. C191687 Neoplastic Process Invasive Nested Urothelial Carcinoma CL1905262 GDC Malignant Nested urothelial carcinoma Invasive Nested Urothelial Carcinoma Nested Urothelial Carcinoma Nested urothelial carcinoma Invasive Nested Urothelial Carcinoma Invasive urothelial carcinoma characterized by the presence of malignant cells with plasmacytoid features. C191688 Neoplastic Process Invasive Plasmacytoid Urothelial Carcinoma CL1905269 Malignant Invasive Lymphoma-Like/Plasmacytoid Urothelial Carcinoma Invasive Plasmacytoid Urothelial Carcinoma Lymphoma-Like/Plasmacytoid Urothelial Carcinoma Plasmacytoid Urothelial Carcinoma Invasive Plasmacytoid Urothelial Carcinoma Clear cell (glycogen-rich) urothelial carcinoma that has spread to another anatomic site. C191692 Neoplastic Process Metastatic Clear Cell (Glycogen-Rich) Urothelial Carcinoma Metastatic Clear Cell (Glycogen-Rich) Urothelial Carcinoma CL1905266 CTRP Malignant Metastatic Clear Cell (Glycogen-Rich) Urothelial Carcinoma Metastatic Clear Cell Urothelial Carcinoma Metastatic Clear Cell (Glycogen-Rich) Urothelial Carcinoma Giant cell urothelial carcinoma that has spread to another anatomic site. C191693 Neoplastic Process Metastatic Giant Cell Urothelial Carcinoma Metastatic Giant Cell Urothelial Carcinoma CL1905233 CTRP Malignant Metastatic Giant Cell Urothelial Carcinoma Metastatic Giant Cell Urothelial Carcinoma Lipid-rich urothelial carcinoma that has spread to another anatomic site. C191694 Neoplastic Process Metastatic Lipid-Rich Urothelial Carcinoma Metastatic Lipid-Rich Urothelial Carcinoma CL1905232 CTRP Malignant Metastatic Lipid Rich Urothelial Carcinoma Metastatic Lipid-Rich Urothelial Carcinoma Metastatic Lipid-Rich Urothelial Carcinoma Micropapillary urothelial carcinoma that has spread to another anatomic site. C191695 Neoplastic Process Metastatic Micropapillary Urothelial Carcinoma Metastatic Micropapillary Urothelial Carcinoma CL1905231 CTRP Malignant Metastatic Micropapillary Urothelial Carcinoma Metastatic Micropapillary Urothelial Carcinoma Nested urothelial carcinoma that has spread to another anatomic site. C191696 Neoplastic Process Metastatic Nested Urothelial Carcinoma Metastatic Nested Urothelial Carcinoma CL1905230 CTRP Malignant Metastatic Nested Urothelial Carcinoma Metastatic Nested Urothelial Carcinoma Plasmacytoid urothelial carcinoma that has spread to another anatomic site. C191697 Neoplastic Process Metastatic Plasmacytoid Urothelial Carcinoma Metastatic Plasmacytoid Urothelial Carcinoma CL1905237 CTRP Malignant Metastatic Plasmacytoid Urothelial Carcinoma Metastatic Plasmacytoid Urothelial Carcinoma A rare invasive urothelial carcinoma characterized by the presence of medium to large nests of malignant cells. C191725 Neoplastic Process Invasive Large Nested Urothelial Carcinoma CL1905202 Malignant Invasive Large Nested Urothelial Carcinoma Large Nested Urothelial Carcinoma Invasive Large Nested Urothelial Carcinoma A rare invasive bladder urothelial carcinoma characterized the presence of medium to large nests of malignant cells. C191726 Neoplastic Process Invasive Bladder Large Nested Urothelial Carcinoma CL1905201 Malignant Bladder Large Nested Urothelial Carcinoma Invasive Bladder Large Nested Urothelial Carcinoma Invasive Bladder Large Nested Urothelial Carcinoma Invasive urothelial carcinoma characterized by the presence of a tubular growth pattern. C191728 Neoplastic Process Invasive Tubular Urothelial Carcinoma CL1905199 Malignant Invasive Tubular Urothelial Carcinoma Tubular Urothelial Carcinoma Invasive Tubular Urothelial Carcinoma Invasive bladder urothelial carcinoma characterized the presence of a tubular growth pattern. C191729 Neoplastic Process Invasive Bladder Tubular Urothelial Carcinoma CL1905206 Malignant Bladder Tubular Urothelial Carcinoma Invasive Bladder Tubular Urothelial Carcinoma Invasive Bladder Tubular Urothelial Carcinoma Invasive urothelial carcinoma that lacks the morphological features indicating urothelial origin. Immunohistochemical studies are required to demonstrate the urothelial lineage in these tumors. C191730 Neoplastic Process Invasive Poorly Differentiated Urothelial Carcinoma CL1905205 Malignant Invasive Poorly Differentiated Urothelial Carcinoma Poorly Differentiated Urothelial Carcinoma Invasive Poorly Differentiated Urothelial Carcinoma Invasive bladder urothelial carcinoma that lacks the morphological features indicating urothelial origin. Immunohistochemical studies are required to demonstrate the urothelial lineage in these tumors. C191731 Neoplastic Process Invasive Bladder Poorly Differentiated Urothelial Carcinoma CL1905204 Malignant Bladder Poorly Differentiated Urothelial Carcinoma Invasive Bladder Poorly Differentiated Urothelial Carcinoma Invasive Bladder Poorly Differentiated Urothelial Carcinoma Invasive urothelial carcinoma characterized by the presence of malignant cells forming trabeculae, cords, sheets, and nests. Individual malignant cells are also present. C191734 Neoplastic Process Invasive Conventional Urothelial Carcinoma CL1905193 CPTAC Malignant Conventional Urothelial Carcinoma Invasive Conventional Urothelial Carcinoma Invasive Conventional Urothelial Carcinoma Invasive bladder urothelial carcinoma characterized by the presence of malignant cells forming trabeculae, cords, sheets, and nests. Individual malignant cells are also present. C191735 Neoplastic Process Invasive Bladder Conventional Urothelial Carcinoma CL1905192 Malignant Bladder Conventional Urothelial Carcinoma Invasive Bladder Conventional Urothelial Carcinoma Invasive Bladder Conventional Urothelial Carcinoma Sarcomatoid urothelial carcinoma that has spread to another anatomical site. C191736 Neoplastic Process Metastatic Sarcomatoid Urothelial Carcinoma Metastatic Sarcomatoid Urothelial Carcinoma CL1905191 CTRP Malignant Metastatic Sarcomatoid Urothelial Carcinoma Metastatic Sarcomatoid Urothelial Carcinoma A rare papillary neoplastic growth that arises from the urothelial mucosa. It is characterized by the presence of fibrovascular cores lined by benign keratinizing squamous epithelium. There is no evidence of architectural or cytologic atypia. It usually occurs in elderly people and is found in the bladder and urethra. C191740 Neoplastic Process Squamous Papilloma of the Urinary Tract CL1905195 Benign Squamous Papilloma of the Urinary Tract Squamous Papilloma of the Urothelial Tract Urinary Tract Squamous Papilloma Squamous Papilloma of the Urinary Tract A rare squamous cell carcinoma that arises from the urinary tract. Almost all cases have been reported in the bladder. Causes include urinary stasis, recurrent chronic inflammation, and smoking. In regions where schistosomiasis is endemic, it is the major etiologic factor of bladder squamous cell carcinoma. C191749 Neoplastic Process Squamous Cell Carcinoma of the Urinary Tract CL1905210 Malignant Pure Squamous Cell Carcinoma of the Urinary Tract Pure Squamous Cell Carcinoma of the Urothelium Squamous Cell Carcinoma of the Urinary Tract Squamous Cell Carcinoma of the Urothelium Squamous Cell Carcinoma of the Urinary Tract An exophytic glandular neoplasm of the urinary tract, morphologically similar to its intestinal counterpart. It usually arises from the bladder and urachus. It often coexists with in situ or infiltrating bladder adenocarcinoma. C191750 Neoplastic Process Villous Adenoma of the Urinary Tract CL1905209 Benign Villous Adenoma of the Urinary Tract Villous Adenoma of the Urinary Tract A rare carcinoma with pure glandular differentiation arising anywhere in the urinary tract. This group does not include clear cell and endometrioid adenocarcinomas. C191751 Neoplastic Process Adenocarcinoma of the Urinary Tract CL1905208 Malignant Adenocarcinoma of the Urinary Tract Adenocarcinoma of the Urinary Tract, NOS Adenocarcinoma of the Urinary Tract, Not Otherwise Specified Adenocarcinoma of the Urinary Tract A carcinoma that arises from a diverticulum in the urinary tract. Most histological subtypes of urinary tract carcinomas have been reported in urinary tract diverticula. C191753 Neoplastic Process Diverticular Carcinoma of the Urinary Tract CL1905214 Malignant Diverticular Carcinoma of the Urinary Tract Diverticular Carcinoma of the Urinary Tract An adenocarcinoma that arises from the urinary tract and is characterized by the presence of malignant cells with clear and eosinophilic cytoplasm arranged in tubulo-cystic, papillary, or solid growth patterns. It usually arises from the urethra but can also occur in the bladder. It predominantly affects females and usually has an aggressive clinical course. C191768 Neoplastic Process Clear Cell Adenocarcinoma of the Urinary Tract CL1905167 Malignant Clear Cell Adenocarcinoma of the Urinary Tract Clear Cell Adenocarcinoma of the Urinary Tract An exceptionally rare endometrioid adenocarcinoma that arises from the urinary tract. It occurs in middle-aged and elderly females. It is associated with genitourinary endometriosis and has been described in the bladder and ureter. C191769 Neoplastic Process Endometrioid Adenocarcinoma of the Urinary Tract CL1905172 Malignant Endometrioid Adenocarcinoma of the Urinary Tract Endometrioid Adenocarcinoma of the Urinary Tract An application of 3-dimensional magnetic resonance imaging (MRI) that transforms the MR T1-weighted signal, voxel by voxel, to a quantitative entropy enhancement value (qEEV) based on Shannon entropy to assess changes over time. The data is used to create a color heat map with larger MR signal changes seen as greater change along the color scale. C191778 Diagnostic Procedure Three-Dimensional Dynamic Intensity Entropy Transformation Magnetic Resonance Imaging Three-Dimensional Dynamic Intensity Entropy Transformation Magnetic Resonance Imaging CL1905189 CTRP 3D- Dynamic Intensity Entropy Transformation Magnetic Resonance Imaging 3D-Dynamic Intensity Entropy Transformation MRI DIET-MRI Three-Dimensional Dynamic Intensity Entropy Transformation MRI Three-Dimensional Dynamic Intensity Entropy Transformation Magnetic Resonance Imaging Three-Dimensional Dynamic Intensity Entropy Transformation Magnetic Resonance Imaging The reemergence of primary cutaneous gamma-delta T-cell lymphoma after a period of remission C191818 Neoplastic Process Recurrent Primary Cutaneous Gamma-Delta T-Cell Lymphoma Recurrent Primary Cutaneous Gamma-Delta T-Cell Lymphoma CL1905161 CTRP Malignant Recurrent Primary Cutaneous Gamma-Delta T-Cell Lymphoma Recurrent Primary Cutaneous Gamma-Delta T-Cell Lymphoma Primary cutaneous gamma-delta T-cell lymphoma that is resistant to treatment. C191820 Neoplastic Process Refractory Primary Cutaneous Gamma-Delta T-Cell Lymphoma Refractory Primary Cutaneous Gamma-Delta T-Cell Lymphoma CL1905160 CTRP Malignant Refractory Primary Cutaneous Gamma-Delta T-Cell Lymphoma Refractory Primary Cutaneous Gamma-Delta T-Cell Lymphoma The reemergence of primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma after a period of remission. C191823 Neoplastic Process Recurrent Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma Recurrent Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma CL1905140 CTRP Malignant Recurrent Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma Recurrent Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma that is resistant to treatment. C191824 Neoplastic Process Refractory Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma Refractory Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma CL1905139 CTRP Malignant Refractory Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma Refractory Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma Extrapulmonary small cell neuroendocrine carcinoma that has spread to another anatomic site. C191852 Neoplastic Process Metastatic Extrapulmonary Small Cell Neuroendocrine Carcinoma Metastatic Extrapulmonary Small Cell Neuroendocrine Carcinoma CL1905145 CTRP Malignant Metastatic Extrapulmonary Small Cell Neuroendocrine Carcinoma Metastatic Extrapulmonary Small Cell Neuroendocrine Carcinoma Small cell neuroendocrine carcinoma that is resistant to treatment. C191853 Neoplastic Process Refractory Small Cell Neuroendocrine Carcinoma CL1905119 Malignant Refractory Small Cell Neuroendocrine Carcinoma Refractory Small Cell Neuroendocrine Carcinoma Extrapulmonary small cell neuroendocrine carcinoma that is resistant to treatment. C191854 Neoplastic Process Refractory Extrapulmonary Small Cell Neuroendocrine Carcinoma CL1905118 Malignant Refractory Extrapulmonary Small Cell Neuroendocrine Carcinoma Refractory Extrapulmonary Small Cell Neuroendocrine Carcinoma Extrapulmonary small cell neuroendocrine carcinoma that is not amenable to surgical resection. C191855 Neoplastic Process Unresectable Extrapulmonary Small Cell Neuroendocrine Carcinoma Unresectable Extrapulmonary Small Cell Neuroendocrine Carcinoma CL1905117 CTRP Malignant Unresectable Extrapulmonary Small Cell Neuroendocrine Carcinoma Unresectable Extrapulmonary Small Cell Neuroendocrine Carcinoma Prostate small cell neuroendocrine carcinoma that is not amenable to surgical resection. C191856 Neoplastic Process Unresectable Prostate Small Cell Neuroendocrine Carcinoma Unresectable Prostate Small Cell Neuroendocrine Carcinoma CL1905116 CTRP Malignant Unresectable Prostate Small Cell Neuroendocrine Carcinoma Unresectable Prostate Small Cell Neuroendocrine Carcinoma Bladder small cell neuroendocrine carcinoma that is not amenable to surgical resection. C191857 Neoplastic Process Unresectable Bladder Small Cell Neuroendocrine Carcinoma Unresectable Bladder Small Cell Neuroendocrine Carcinoma CL1905123 CTRP Malignant Unresectable Bladder Small Cell Neuroendocrine Carcinoma Unresectable Bladder Small Cell Neuroendocrine Carcinoma The reemergence of prostate small cell neuroendocrine carcinoma after a period of remission. C191859 Neoplastic Process Recurrent Prostate Small Cell Neuroendocrine Carcinoma Recurrent Prostate Small Cell Neuroendocrine Carcinoma CL1905121 CTRP Malignant Recurrent Prostate Small Cell Neuroendocrine Carcinoma Recurrent Prostate Small Cell Neuroendocrine Carcinoma The reemergence of bladder small cell neuroendocrine carcinoma after a period of remission. C191860 Neoplastic Process Recurrent Bladder Small Cell Neuroendocrine Carcinoma Recurrent Bladder Small Cell Neuroendocrine Carcinoma CL1905120 CTRP Malignant Recurrent Bladder Small Cell Neuroendocrine Carcinoma Recurrent Bladder Small Cell Neuroendocrine Carcinoma Bladder small cell neuroendocrine carcinoma that is resistant to treatment. C191861 Neoplastic Process Refractory Bladder Small Cell Neuroendocrine Carcinoma Refractory Bladder Small Cell Neuroendocrine Carcinoma CL1905113 CTRP Malignant Refractory Bladder Small Cell Neuroendocrine Carcinoma Refractory Bladder Small Cell Neuroendocrine Carcinoma Prostate small cell neuroendocrine carcinoma that is resistant to treatment. C191862 Neoplastic Process Refractory Prostate Small Cell Neuroendocrine Carcinoma Refractory Prostate Small Cell Neuroendocrine Carcinoma CL1905112 CTRP Malignant Refractory Prostate Small Cell Neuroendocrine Carcinoma Refractory Prostate Small Cell Neuroendocrine Carcinoma Adrenal cortical carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C191863 Neoplastic Process Advanced Adrenal Cortical Carcinoma Advanced Adrenal Cortical Carcinoma CL1905111 CTRP Malignant Advanced Adrenal Cortical Carcinoma Advanced Adrenal Cortical Carcinoma A rare subtype of prostate acinar adenocarcinoma that morphologically resembles high-grade prostatic intraepithelial neoplasia. It is characterized by the presence of large malignant glands lined with pseudostratified epithelium. It is graded as Gleason score 3+3=6. C191961 Neoplastic Process Prostatic Intraepithelial Neoplasia-Like Adenocarcinoma CL1905417 Malignant PIN-Like Adenocarcinoma Prostatic Intraepithelial Neoplasia-Like Adenocarcinoma Prostatic Intraepithelial Neoplasia-Like Adenocarcinoma A prostate carcinoma with partial or complete neuroendocrine differentiation that results from the transformation of castration-resistant prostate adenocarcinoma following potent androgen-deprivation therapy. The prognosis is poor. C191963 Neoplastic Process Treatment-Related Prostate Neuroendocrine Carcinoma CL1905413 Malignant Treatment-Related Neuroendocrine Prostate Carcinoma Treatment-Related Neuroendocrine Prostatic Carcinoma Treatment-Related Prostate Neuroendocrine Carcinoma Treatment-Related Prostatic Neuroendocrine Carcinoma t-NEPC Treatment-Related Prostate Neuroendocrine Carcinoma A small or large cell neuroendocrine carcinoma that arises from an anatomic site other than the lung. C191977 Neoplastic Process Extrapulmonary Neuroendocrine Carcinoma Extrapulmonary Neuroendocrine Carcinoma CL1905433 CTRP Malignant EP-PD-NEC Extrapulmonary Neuroendocrine Carcinoma Extrapulmonary Poorly Differentiated Neuroendocrine Carcinoma Extrapulmonary Neuroendocrine Carcinoma The reemergence of extrapulmonary neuroendocrine carcinoma after a period of remission. C191978 Neoplastic Process Recurrent Extrapulmonary Neuroendocrine Carcinoma Recurrent Extrapulmonary Neuroendocrine Carcinoma CL1905434 CTRP Malignant Recurrent Extrapulmonary Neuroendocrine Carcinoma Recurrent Extrapulmonary Neuroendocrine Carcinoma Extrapulmonary neuroendocrine carcinoma that is resistant to treatment. C191979 Neoplastic Process Refractory Extrapulmonary Neuroendocrine Carcinoma CL1905427 Malignant Refractory Extrapulmonary Neuroendocrine Carcinoma Refractory Extrapulmonary Neuroendocrine Carcinoma Extrapulmonary neuroendocrine carcinoma that is not amenable to surgical resection. C191980 Neoplastic Process Unresectable Extrapulmonary Neuroendocrine Carcinoma Unresectable Extrapulmonary Neuroendocrine Carcinoma CL1905428 CTRP Malignant Unresectable Extrapulmonary Neuroendocrine Carcinoma Unresectable Extrapulmonary Neuroendocrine Carcinoma Extrapulmonary neuroendocrine carcinoma that has spread to another anatomic site. C191981 Neoplastic Process Metastatic Extrapulmonary Neuroendocrine Carcinoma Metastatic Extrapulmonary Neuroendocrine Carcinoma CL1905429 CTRP Malignant Metastatic Extrapulmonary Neuroendocrine Carcinoma Metastatic Extrapulmonary Neuroendocrine Carcinoma Extrapulmonary neuroendocrine carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C191982 Neoplastic Process Advanced Extrapulmonary Neuroendocrine Carcinoma Advanced Extrapulmonary Neuroendocrine Carcinoma CL1905430 CTRP Malignant Advanced Extrapulmonary Neuroendocrine Carcinoma Advanced Extrapulmonary Neuroendocrine Carcinoma Extrapulmonary neuroendocrine carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C191983 Neoplastic Process Locally Advanced Extrapulmonary Neuroendocrine Carcinoma CL1905401 Malignant Locally Advanced Extrapulmonary Neuroendocrine Carcinoma Locally Advanced Extrapulmonary Neuroendocrine Carcinoma A large cell neuroendocrine carcinoma that arises from an anatomic site other than the lung. C191984 Neoplastic Process Extrapulmonary Large Cell Neuroendocrine Carcinoma CL1905402 Malignant Extrapulmonary Large Cell Neuroendocrine Carcinoma Extrapulmonary Large Cell Neuroendocrine Carcinoma The reemergence of extrapulmonary large cell neuroendocrine carcinoma after a period of remission. C191985 Neoplastic Process Recurrent Extrapulmonary Large Cell Neuroendocrine Carcinoma CL1905403 Malignant Recurrent Extrapulmonary Large Cell Neuroendocrine Carcinoma Recurrent Extrapulmonary Large Cell Neuroendocrine Carcinoma Extrapulmonary large cell neuroendocrine carcinoma that is resistant to treatment. C191986 Neoplastic Process Refractory Extrapulmonary Large Cell Neuroendocrine Carcinoma CL1905404 Malignant Refractory Extrapulmonary Large Cell Neuroendocrine Carcinoma Refractory Extrapulmonary Large Cell Neuroendocrine Carcinoma Extrapulmonary large cell neuroendocrine carcinoma that is not amenable to surgical resection. C191987 Neoplastic Process Unresectable Extrapulmonary Large Cell Neuroendocrine Carcinoma CL1905397 Malignant Unresectable Extrapulmonary Large Cell Neuroendocrine Carcinoma Unresectable Extrapulmonary Large Cell Neuroendocrine Carcinoma Extrapulmonary large cell neuroendocrine carcinoma that has spread to another anatomic site. C191988 Neoplastic Process Metastatic Extrapulmonary Large Cell Neuroendocrine Carcinoma CL1905398 Malignant Metastatic Extrapulmonary Large Cell Neuroendocrine Carcinoma Metastatic Extrapulmonary Large Cell Neuroendocrine Carcinoma Extrapulmonary large cell neuroendocrine carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C191990 Neoplastic Process Advanced Extrapulmonary Large Cell Neuroendocrine Carcinoma CL1905400 Malignant Advanced Extrapulmonary Large Cell Neuroendocrine Carcinoma Advanced Extrapulmonary Large Cell Neuroendocrine Carcinoma Extrapulmonary large cell neuroendocrine carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C191991 Neoplastic Process Locally Advanced Extrapulmonary Large Cell Neuroendocrine Carcinoma CL1905394 Malignant Locally Advanced Extrapulmonary Large Cell Neuroendocrine Carcinoma Locally Advanced Extrapulmonary Large Cell Neuroendocrine Carcinoma Extrapulmonary small cell neuroendocrine carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C191992 Neoplastic Process Locally Advanced Extrapulmonary Small Cell Neuroendocrine Carcinoma CL1905395 Malignant Locally Advanced Extrapulmonary Small Cell Neuroendocrine Carcinoma Locally Advanced Extrapulmonary Small Cell Neuroendocrine Carcinoma Extrapulmonary small cell neuroendocrine carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C191993 Neoplastic Process Advanced Extrapulmonary Small Cell Neuroendocrine Carcinoma CL1905396 Malignant Advanced Extrapulmonary Small Cell Neuroendocrine Carcinoma Advanced Extrapulmonary Small Cell Neuroendocrine Carcinoma Large cell neuroendocrine carcinoma that is resistant to treatment. C191997 Neoplastic Process Refractory Large Cell Neuroendocrine Carcinoma CL1905393 Malignant Refractory Large Cell Neuroendocrine Carcinoma Refractory Large Cell Neuroendocrine Carcinoma Small cell neuroendocrine carcinoma that is not amenable to surgical resection. C192014 Neoplastic Process Unresectable Small Cell Neuroendocrine Carcinoma CL1905407 Malignant Unresectable Small Cell Neuroendocrine Carcinoma Unresectable Small Cell Neuroendocrine Carcinoma Lung neuroendocrine carcinoma that is not amenable to surgical resection. C192018 Neoplastic Process Unresectable Lung Neuroendocrine Carcinoma CL1905374 Malignant Unresectable Lung Neuroendocrine Carcinoma Unresectable Lung Neuroendocrine Carcinoma The reemergence of large cell neuroendocrine carcinoma after a period of remission. C192023 Neoplastic Process Recurrent Large Cell Neuroendocrine Carcinoma CL1905366 Malignant Recurrent Large Cell Neuroendocrine Carcinoma Recurrent Large Cell Neuroendocrine Carcinoma Intratubular germ cell neoplasia characterized by the filling of the seminiferous tubules by embryonal carcinoma cells. Central necrosis and calcifications are often present. C192096 Neoplastic Process Stage 0 Testicular Embryonal Carcinoma AJCC v6 and v7 Intratubular Embryonal Carcinoma CL1905617 CTRP Malignant Intratubular Embryonal Carcinoma Stage 0 Testicular Embryonal Carcinoma Stage 0 Testicular Embryonal Carcinoma AJCC v6, v7, and v8 Intratubular Embryonal Carcinoma Testicular yolk sac tumor that is associated with germ cell neoplasia in situ and usually occurs as a component of mixed germ cell tumor. Pure postpubertal-type testicular yolk sac tumor is exceedingly rare. C192099 Neoplastic Process Testicular Yolk Sac Tumor, Postpubertal-Type CL1905613 Malignant Postpubertal Type Testicular Yolk Sac Tumor Postpubertal-Type Testicular Yolk Sac Tumor Testicular Yolk Sac Tumor, Postpubertal Type Testicular Yolk Sac Tumor, Postpubertal-Type Testicular Yolk Sac Tumor, Postpubertal-Type Testicular yolk sac tumor that almost always occurs in pure form and is not associated with germ cell neoplasia in situ. It affects young children and is the most frequently seen testicular neoplasm in prepubertal children. C192100 Neoplastic Process Testicular Yolk Sac Tumor, Prepubertal-Type CL1905614 Malignant Prepubertal Type Testicular Yolk Sac Tumor Prepubertal-Type Testicular Yolk Sac Tumor Testicular Yolk Sac Tumor, Prepubertal Type Testicular Yolk Sac Tumor, Prepubertal-Type Testicular Yolk Sac Tumor, Prepubertal-Type An application of magnetic resonance imaging design for imaging the heart and the aorta. It provides a volumetric, isotropic, time-resolved sequence that enables three-directional velocity encoding, allowing clinicians to visualize blood flow through the cardiovascular system. C192104 Diagnostic Procedure 4-Dimensional Magnetic Resonance Imaging 4-Dimensional Magnetic Resonance Imaging CL1905632 CTRP 4-Dimensional Magnetic Resonance Imaging 4D MRI 4D Magnetic Resonance Imaging; 4D Flow MRI Four-dimensional Flow MRI In-plane Phase-contrast Imaging 4-Dimensional Magnetic Resonance Imaging A rare trophoblastic neoplasm that arises in metastatic sites of testicular mixed germ cell tumors following chemotherapy, or is part of treated or untreated testicular mixed germ cell tumors, or is secondary to either chemotherapy-induced or spontaneous regression of testicular choriocarcinoma. It is characterized by the presence of cysts lined by squamoid trophoblastic cells. The cysts are often compressed surrounded by other germ cell components. C192106 Neoplastic Process Testicular Cystic Trophoblastic Tumor CL1905628 Undetermined Testicular CTT Testicular Choriocarcinoma-Like Lesion Testicular Cystic Trophoblastic Tumor Testicular Cystic Trophoblastic Tumor A testicular teratoma that is not associated with germ cell neoplasia in situ or chromosome 12p amplification. C192107 Neoplastic Process Testicular Teratoma, Prepubertal-Type CL978768 Benign Prepubertal-Type Teratoma Teratoma, Prepubertal-Type Testicular Prepubertal Type Teratoma Testicular Prepubertal-Type Teratoma Testicular Teratoma, Prepubertal Type Testicular Teratoma, Prepubertal-Type Testicular Teratoma, Prepubertal-Type A very rare testicular germ cell tumor that combines teratoma and yolk sac tumor. It usually affects young children. It is not associated with chromosome 12p amplification or germ cell neoplasia in situ. C192115 Neoplastic Process Testicular Mixed Teratoma and Yolk Sac Tumor, Prepubertal-Type CL1905624 Malignant Testicular Mixed Teratoma and Yolk Sac Tumor, Prepubertal Type Testicular Mixed Teratoma and Yolk Sac Tumor, Prepubertal-Type Testicular Mixed Teratoma and Yolk Sac Tumor, Prepubertal-Type A rare, benign, well-circumscribed tumor that arises from the testis. It is characterized by the presence of fascicles of spindle cells showing muscle cell differentiation. It lacks sex cord differentiation. C192116 Neoplastic Process Gonadal Myoid Stromal Tumor CL1905625 Benign Gonadal Myoid Stromal Tumor Myoid Gonadal Stromal Tumor Gonadal Myoid Stromal Tumor An exceedingly rare carcinoma with squamous differentiation arising from the epididymis. C192119 Neoplastic Process Epididymal Squamous Cell Carcinoma CL1905596 Malignant Epididymal Squamous Cell Carcinoma Epididymal Squamous Cell Carcinoma A rare carcinoma that arises from the epididymis. C192120 Neoplastic Process Epididymal Carcinoma CL1905597 Malignant Epididymal Carcinoma Epididymal Carcinoma A rare, indolent, usually solitary mesothelial neoplasm that arises from the tunica vaginalis. It is characterized by the presence of a papillary architecture in which the papillae are lined by cuboidal mesothelial cells. Mitotic figures are usually absent. Stromal invasion is absent or minimal. It usually manifests with a hydrocele and less frequently scrotal mass. C192121 Neoplastic Process Paratesticular Well Differentiated Papillary Mesothelial Tumor CL1905598 Undetermined Paratesticular Well Differentiated Papillary Mesothelial Tumor Paratesticular Well-Differentiated Papillary Mesothelial Tumor Testicular Adnexa Well Differentiated Papillary Mesothelial Tumor Testicular Adnexa Well-Differentiated Papillary Mesothelial Tumor Paratesticular Well Differentiated Papillary Mesothelial Tumor A benign, borderline, or malignant epithelial neoplasm that arises from the paratesticular structures. C192122 Neoplastic Process Paratesticular Epithelial Neoplasm CL1905591 Undetermined Paratesticular Epithelial Neoplasm Testicular Adnexa Epithelial Neoplasm Paratesticular Epithelial Neoplasm A rare serous cystadenoma that arises from the paratesticular structures. C192123 Neoplastic Process Paratesticular Serous Cystadenoma CL1905592 Benign Paratesticular Serous Cystadenoma Testicular Adnexa Serous Cystadenoma Paratesticular Serous Cystadenoma A rare, non-invasive, serous cystic tumor that arises from the paratesticular structures. It is characterized by the presence of irregular papillary formations with irregular branching. The papillae are lined by atypical columnar epithelial cells with eosinophilic cytoplasm. Mitoses are rare. Metastases have not been reported. C192124 Neoplastic Process Borderline Paratesticular Serous Tumor CL1905593 Uncertain Malignant Potential Borderline Paratesticular Serous Tumor Borderline Testicular Adnexa Serous Tumor Paratesticular Serous Tumor of Borderline Malignancy Testicular Adnexa Serous Tumor of Borderline Malignancy Borderline Paratesticular Serous Tumor A rare serous cystadenocarcinoma that arises from the paratesticular structures. C192125 Neoplastic Process Paratesticular Serous Cystadenocarcinoma CL1905594 Malignant Paratesticular Serous Cystadenocarcinoma Testicular Adnexa Serous Cystadenocarcinoma Paratesticular Serous Cystadenocarcinoma A rare mucinous cystadenoma that arises from the paratesticular structures. C192126 Neoplastic Process Paratesticular Mucinous Cystadenoma CL1905587 Benign Paratesticular Mucinous Cystadenoma Testicular Adnexa Mucinous Cystadenoma Paratesticular Mucinous Cystadenoma A rare, non-invasive, mucinous cystic tumor that arises from the paratesticular structures. It is characterized by the presence of irregular papillary formations with irregular branching. The papillae are lined by atypical mucinous epithelial cells. Metastases have not been reported. C192127 Neoplastic Process Borderline Paratesticular Mucinous Tumor CL1905588 Uncertain Malignant Potential Borderline Paratesticular Mucinous Tumor Borderline Testicular Adnexa Mucinous Tumor Paratesticular Mucinous Tumor of Borderline Malignancy Testicular Adnexa Mucinous Tumor of Borderline Malignancy Borderline Paratesticular Mucinous Tumor A rare mucinous cystadenocarcinoma that arises from the paratesticular structures. C192128 Neoplastic Process Paratesticular Mucinous Cystadenocarcinoma CL1905589 Malignant Paratesticular Mucinous Cystadenocarcinoma Testicular Adnexa Mucinous Cystadenocarcinoma Paratesticular Mucinous Cystadenocarcinoma A carcinoma that arises from the paratesticular structures. C192129 Neoplastic Process Paratesticular Carcinoma CL1905590 Malignant Paratesticular Carcinoma Testicular Adnexa Carcinoma Paratesticular Carcinoma A carcinoma that arises from the seminal vesicle. C192130 Neoplastic Process Seminal Versicle Carcinoma CL1905583 Malignant Seminal Versicle Carcinoma Seminal Versicle Carcinoma A primary or metastatic malignant neoplasm that affects the paratesticular structures. C192139 Neoplastic Process Malignant Paratesticular Neoplasm C3696981 Malignant Malignant Paratesticular Neoplasm Malignant Testicular Adnexa Neoplasm Malignant Paratesticular Neoplasm A neoplasm that arises from the paratesticular structures and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C192140 Neoplastic Process Benign Paratesticular Neoplasm CL1905608 Benign Benign Paratesticular Neoplasm Benign Testicular Adnexa Neoplasm Benign Paratesticular Neoplasm A group of very rare tumors with endometrioid epithelial differentiation arising from the paratesticular structures. It includes benign tumors, borderline tumors (tumors with atypical epithelial proliferation), and malignant tumors (endometrioid adenocarcinomas). C192141 Neoplastic Process Paratesticular Endometrioid Tumor CL1905609 Undetermined Paratesticular Endometrioid Tumor Testicular Adnexa Endometrioid Tumor Paratesticular Endometrioid Tumor An exceedingly rare adenocarcinoma that arises from the paratesticular structures. It is characterized by the presence of columnar, hobnail, and polygonal cells with clear cytoplasm. C192142 Neoplastic Process Paratesticular Clear Cell Adenocarcinoma CL1905603 Malignant Paratesticular Clear Cell Adenocarcinoma Testicular Adnexa Clear Cell Adenocarcinoma Paratesticular Clear Cell Adenocarcinoma A mesothelial neoplasm that arises from the paratesticular structures. It includes adenomatoid tumor, well differentiated papillary mesothelial tumor, and malignant mesothelioma. C192144 Neoplastic Process Paratesticular Mesothelial Neoplasm CL1905605 Undetermined Paratesticular Mesothelial Neoplasm Paratesticular Mesothelial Tumor Testicular Adnexa Mesothelial Neoplasm Testicular Adnexa Mesothelial Tumor Paratesticular Mesothelial Neoplasm Gastric adenocarcinoma that is amenable to surgical resection. C192203 Neoplastic Process Resectable Gastric Adenocarcinoma Resectable Gastric Adenocarcinoma CL1905555 CTRP Malignant Resectable Gastric Adenocarcinoma Resectable Gastric Adenocarcinoma Gastroesophageal junction adenocarcinoma that is amenable to surgical resection. C192204 Neoplastic Process Resectable Gastroesophageal Junction Adenocarcinoma Resectable Gastroesophageal Junction Adenocarcinoma CL1905550 CTRP Malignant Resectable Gastroesophageal Junction Adenocarcinoma Resectable Gastroesophageal Junction Adenocarcinoma Estrogen receptor-positive breast carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C192211 Neoplastic Process Advanced Estrogen Receptor-Positive Breast Carcinoma Advanced Estrogen Receptor-Positive Breast Carcinoma CL1905548 CTRP Malignant Advanced Estrogen Receptor Positive Breast Adenocarcinoma Advanced Estrogen Receptor Positive Breast Carcinoma Advanced Estrogen Receptor-Positive Breast Adenocarcinoma Advanced Estrogen Receptor-Positive Breast Carcinoma Advanced Estrogen Receptor-Positive Breast Carcinoma Estrogen receptor-positive breast carcinoma that is not amenable to surgical resection. C192212 Neoplastic Process Unresectable Estrogen Receptor-Positive Breast Carcinoma Unresectable Estrogen Receptor-Positive Breast Carcinoma CL1905549 CTRP Malignant Unresectable Estrogen Receptor Positive Breast Adenocarcinoma Unresectable Estrogen Receptor Positive Breast Carcinoma Unresectable Estrogen Receptor-Positive Breast Adenocarcinoma Unresectable Estrogen Receptor-Positive Breast Carcinoma Unresectable Estrogen Receptor-Positive Breast Carcinoma Estrogen receptor-positive breast carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C192213 Neoplastic Process Locally Advanced Estrogen Receptor-Positive Breast Carcinoma Locally Advanced Estrogen Receptor-Positive Breast Carcinoma CL1905545 CTRP Malignant Locally Advanced Estrogen Receptor Positive Breast Adenocarcinoma Locally Advanced Estrogen Receptor Positive Breast Carcinoma Locally Advanced Estrogen Receptor-Positive Breast Adenocarcinoma Locally Advanced Estrogen Receptor-Positive Breast Carcinoma Locally Advanced Estrogen Receptor-Positive Breast Carcinoma Hepatoblastoma that has spread from its original site of growth to another anatomic site. C192216 Neoplastic Process Metastatic Hepatoblastoma Metastatic Hepatoblastoma CL1912561 CTRP Malignant Metastatic Hepatoblastoma Metastatic Hepatoblastoma A human papillomavirus-related benign neoplasm affecting the penis. Most often it arises from the glans penis in young men. It usually presents with a nodular wart. Morphologically, it is characterized by an exophytic papillary proliferation of squamous cells and acanthosis. Most cases either resolve spontaneously or do not recur following removal. C192221 Neoplastic Process Penile Condyloma Acuminatum CL1912564 Benign Condyloma Acuminatum of the Penis Penile Condyloma Acuminatum Penile Condyloma Acuminatum A penile squamous cell carcinoma characterized by the absence of special morphologic features and lack of information on p16 immunohistochemistry and human papilloma virus testing status. C192222 Neoplastic Process Penile Squamous Cell Carcinoma, Not Otherwise Specified CL1912563 Malignant Penile SCC-NOS Penile Squamous Cell Carcinoma, NOS Penile Squamous Cell Carcinoma, Not Otherwise Specified Penile Squamous Cell Carcinoma, Not Otherwise Specified An extremely rare carcinoma that arises from the penis and is characterized by the presence of mucinous and squamous components. C192223 Neoplastic Process Penile Mucoepidermoid Carcinoma CL1912562 Malignant Penile Mucoepidermoid Carcinoma Penile Mucoepidermoid Carcinoma A technique that uses X-ray film to visualize gross anatomical structures that have been radioactively labeled. C19231 Diagnostic Procedure Autoradiography, Gross C1510989 Autoradiography_Gross Autoradiography, Gross Gross Autoradiography Autoradiography, Gross A positron emission tomography imaging technique that uses C-11 choline to bind to cancer cells and locate cancer lesions. C192560 Diagnostic Procedure Carbon-11 Choline Positron Emission Tomography CL1912650 OORO Carbon-11 Choline Positron Emission Tomography Choline Positron emission tomography Carbon-11 Choline Positron Emission Tomography A positron emission tomography imaging technique that uses F-18 fluciclovine to bind to cancer cells and locate cancer lesions. C192561 Diagnostic Procedure F-18 Fluciclovine Positron Emission Tomography CL1912649 OORO F-18 Fluciclovine Positron Emission Tomography Fluciclovine - Positron emission tomography F-18 Fluciclovine Positron Emission Tomography A magnetic resonance imaging sequence acquired to capture motion. Reconstructions of repeatedly imaged areas of interest over a certain amount of time (and typically within a single anatomic slice) can then be viewed as a movie. C192578 Diagnostic Procedure Cine Magnetic Resonance Imaging Cine Magnetic Resonance Imaging C0282596 CTRP OORO Cine Magnetic Resonance Imaging Cine-MRI Cine Magnetic Resonance Imaging A derived CT-like image generated from a series of MR sequences that can be used for radiation dose calculation. C192579 Diagnostic Procedure MRI-based Synthetic Computed Tomography CL1912635 OORO MRI-based Synthetic Computed Tomography Synthetic Computed Tomography MRI-based Synthetic Computed Tomography Fluoroscopy that includes kilovoltage images. C192597 Diagnostic Procedure Kilovoltage Fluoroscopy CL1912623 OORO Kilovoltage Fluoroscopy kV - fluorography Kilovoltage Fluoroscopy The reemergence of muscle invasive bladder urothelial carcinoma after a period of remission. C192630 Neoplastic Process Recurrent Muscle Invasive Bladder Urothelial Carcinoma Recurrent Muscle Invasive Bladder Urothelial Carcinoma CL1912603 CTRP Malignant Recurrent Muscle Invasive Bladder Urothelial Carcinoma Recurrent Muscle Invasive Bladder Urothelial Carcinoma A bladder urothelial carcinoma that is confined to the site in which it initially manifested without evidence of spread to other anatomic sites, and has not invaded the bladder muscularis propria. C192631 Neoplastic Process Localized Non-Muscle Invasive Bladder Urothelial Carcinoma Localized Non-Muscle Invasive Bladder Urothelial Carcinoma CL1912602 CTRP Malignant Localized Non-Muscle Invasive Bladder Urothelial Carcinoma Localized Non-Muscle Invasive Bladder Urothelial Carcinoma The spread of a malignant neoplasm to the genitourinary system from an adjacent or distant anatomic site. C192662 Neoplastic Process Metastatic Malignant Neoplasm in the Genitourinary System CL1912574 Malignant Metastatic Malignant Neoplasm in the Genitourinary System Metastatic Malignant Neoplasm in the Genitourinary System The spread of a malignant neoplasm to the male or female reproductive system from an adjacent or distant anatomic site. C192663 Neoplastic Process Metastatic Malignant Neoplasm in the Reproductive System C0153693 mCode Malignant Metastatic Malignant Neoplasm in the Reproductive System Secondary malignant neoplasm of genital organs Metastatic Malignant Neoplasm in the Reproductive System The spread of a malignant neoplasm to the male reproductive system from an adjacent or distant anatomic site. C192664 Neoplastic Process Metastatic Malignant Neoplasm in the Male Reproductive System CL1912573 Malignant Metastatic Malignant Neoplasm in the Male Reproductive System Metastatic Malignant Neoplasm in the Male Reproductive System The spread of a malignant neoplasm to the female reproductive system from an adjacent or distant anatomic site. C192665 Neoplastic Process Metastatic Malignant Neoplasm in the Female Reproductive System CL1912579 Malignant Metastatic Malignant Neoplasm in the Female Reproductive System Metastatic Malignant Neoplasm in the Female Reproductive System A benign or malignant, primary or metastatic neoplasm involving the urinary tract (renal pelvis, ureter, bladder, and urethra). C192666 Neoplastic Process Urinary Tract Neoplasm CL1912578 Undetermined Urinary Tract Neoplasm Urinary Tract Neoplasm A neoplasm that arises from the organs that comprise the urinary tract and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C192667 Neoplastic Process Benign Urinary Tract Neoplasm CL1912577 Benign Benign Urinary Tract Neoplasm Benign Urinary Tract Tumor Benign Urinary Tract Neoplasm A primary or metastatic malignant neoplasm involving the urinary tract. C192668 Neoplastic Process Malignant Urinary Tract Neoplasm CL1912576 Malignant Malignant Urinary Tract Neoplasm Malignant Urinary Tract Tumor Malignant Urinary Tract Neoplasm A carcinoma that arises from the organs that comprise the urinary tract. This category includes renal pelvis carcinoma, ureter carcinoma, bladder carcinoma, urethral carcinoma, urothelial carcinoma, adenocarcinoma of the urinary tract, clear cell adenocarcinoma of the urinary tract, diverticular carcinoma of the urinary tract, endometrioid adenocarcinoma of the urinary tract, and squamous cell carcinoma of the urinary tract. C192669 Neoplastic Process Urinary Tract Carcinoma CL1912582 Malignant Urinary Tract Carcinoma Urinary Tract Carcinoma The spread of a malignant neoplasm to the urinary tract from an adjacent or distant anatomic site. C192670 Neoplastic Process Metastatic Malignant Neoplasm in the Urinary Tract CL1774064 Malignant Metastatic Malignant Neoplasm in the Urinary Tract Metastatic Malignant Neoplasm in the Urinary Tract A carcinoma that arises from the base of the skull. C192732 Neoplastic Process Skull Base Carcinoma Skull Base Carcinoma CL1912902 CTRP Malignant Skull Base Carcinoma Skull Base Carcinoma The reemergence of skull base carcinoma after a period of remission. C192733 Neoplastic Process Recurrent Skull Base Carcinoma Recurrent Skull Base Carcinoma CL1912908 CTRP Malignant Recurrent Skull Base Carcinoma Recurrent Skull Base Carcinoma An imaging procedure that combines radiohybrid prostate specific membrane antigen (rhPSMA) ligand, rhPSMA-7.3 F18 PET with computed tomography to overlay activity data onto detailed anatomic images. C192750 Diagnostic Procedure 18F-RhPSMA 7.3 PET/CT Scan 18F-rhPSMA 7.3 PET/CT Scan CL1912899 CTRP 18F-rhPSMA 7.3 PET/CT 18F-rhPSMA 7.3 PET/CT Scan Flotufolastat F-18 PET/CT Scan 18F-rhPSMA 7.3 PET/CT Scan Digestive system neuroendocrine tumor G3 that has spread from its original site of growth to another anatomic site. C192769 Neoplastic Process Metastatic Digestive System Neuroendocrine Tumor G3 CL1912894 Malignant Metastatic Digestive System Neuroendocrine Tumor G3 Metastatic Digestive System Neuroendocrine Tumor G3 Digestive system neuroendocrine tumor G3 that has spread from its original site of growth to nearby tissues or lymph nodes. C192773 Neoplastic Process Locally Advanced Digestive System Neuroendocrine Tumor G3 Locally Advanced Digestive System Neuroendocrine Tumor G3 CL1912870 CTRP Malignant Locally Advanced Digestive System Neuroendocrine Tumor G3 Locally Advanced Digestive System Neuroendocrine Tumor G3 Pancreatic neuroendocrine tumor G3 that has spread from its original site of growth to nearby tissues or lymph nodes. C192787 Neoplastic Process Locally Advanced Pancreatic Neuroendocrine Tumor G3 Locally Advanced Pancreatic Neuroendocrine Tumor G3 CL1912881 CTRP Malignant Locally Advanced Pancreatic Neuroendocrine Tumor G3 Locally Advanced Pancreatic Neuroendocrine Tumor G3 Panreatic neuroendocrine tumor G3 that has spread from its original site of growth to another anatomic site. C192791 Neoplastic Process Metastatic Pancreatic Neuroendocrine Tumor G3 CL1912854 Malignant Metastatic Pancreatic Neuroendocrine Tumor G3 Metastatic Pancreatic Neuroendocrine Tumor G3 Digestive system neuroendocrine tumor G3 that is not amenable to surgical resection. C192794 Neoplastic Process Unresectable Digestive System Neuroendocrine Tumor G3 Unresectable Digestive System Neuroendocrine Tumor G3 CL1912859 CTRP Malignant Unresectable Digestive System Neuroendocrine Tumor G3 Unresectable Digestive System Neuroendocrine Tumor G3 Pancreatic neuroendocrine tumor G3 that is not amenable to surgical resection. C192795 Neoplastic Process Unresectable Pancreatic Neuroendocrine Tumor G3 Unresectable Pancreatic Neuroendocrine Tumor G3 CL1912858 CTRP Malignant Unresectable Pancreatic Neuroendocrine Tumor G3 Unresectable Pancreatic Neuroendocrine Tumor G3 Lung neuroendocrine carcinoma that has spread from its original site of growth to another anatomic site. C192797 Neoplastic Process Metastatic Lung Neuroendocrine Carcinoma Metastatic Lung Neuroendocrine Carcinoma CL1912856 CTRP Malignant Metastatic Lung Neuroendocrine Carcinoma Metastatic Lung Neuroendocrine Carcinoma Lung neuroendocrine carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C192798 Neoplastic Process Advanced Lung Neuroendocrine Carcinoma CL1912863 Malignant Advanced Lung Neuroendocrine Carcinoma Advanced Lung Neuroendocrine Carcinoma Lung neuroendocrine carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C192799 Neoplastic Process Locally Advanced Lung Neuroendocrine Carcinoma Locally Advanced Lung Neuroendocrine Carcinoma CL1912862 CTRP Malignant Locally Advanced Lung Neuroendocrine Carcinoma Locally Advanced Lung Neuroendocrine Carcinoma The reemergence of hormone receptor-negative breast carcinoma after a period of remission. C192837 Neoplastic Process Recurrent Hormone Receptor-Negative Breast Carcinoma Recurrent Hormone Receptor-Negative Breast Carcinoma CL1912833 CTRP Malignant Recurrent Hormone Receptor Negative Breast Adenocarcinoma Recurrent Hormone Receptor Negative Breast Carcinoma Recurrent Hormone Receptor-Negative Breast Adenocarcinoma Recurrent Hormone Receptor-Negative Breast Carcinoma Recurrent Hormone Receptor-Negative Breast Carcinoma Hormone receptor-negative breast carcinoma that is resistant to treatment. C192838 Neoplastic Process Refractory Hormone Receptor-Negative Breast Carcinoma Refractory Hormone Receptor-Negative Breast Carcinoma CL1912832 CTRP Malignant Refractory Hormone Receptor Negative Breast Adenocarcinoma Refractory Hormone Receptor Negative Breast Carcinoma Refractory Hormone Receptor-Negative Breast Adenocarcinoma Refractory Hormone Receptor-Negative Breast Carcinoma Refractory Hormone Receptor-Negative Breast Carcinoma Microsatellite stable colorectal carcinoma that is not amenable to surgical resection. C192839 Neoplastic Process Unresectable Microsatellite Stable Colorectal Carcinoma Unresectable Microsatellite Stable Colorectal Carcinoma CL1912808 CTRP Malignant Unresectable Microsatellite Stable Colorectal Carcinoma Unresectable Microsatellite Stable Colorectal Carcinoma Use of ultrasound for imaging for diagnostic purposes. C19337 Diagnostic Procedure Diagnostic Ultrasound CL415372 OORO PCDC mCode Diagnostic_Ultrasound Diagnosis (US) Diagnosis, Ultrasound Diagnostic Ultrasound Diagnostic ultrasonography (procedure) Ultrasound Diagnostic Ultrasound This imaging technique returns information about the mechanical properties (feel) of tissues by combining MRI with ultrasound. A properly equipped MRI machine captures a cross sectional image of the sound waves, produced by ultrasound techniques, which are then processed by computer to produce an image showing the hardness or elasticity of tissues within the cross section. C19338 Diagnostic Procedure Magnetic Resonance Elastography Magnetic Resonance Elastography C1518156 CDISC CTRP An imaging technique that combines MRI with ultrasound to assess the mechanical properties of tissues. An MRI machine captures a cross sectional image of the sound waves, produced by ultrasound techniques, which are then processed by computer to produce an image showing the hardness or elasticity of tissues within the cross section. Magnetic_Resonance_Elastography MAGNETIC RESONANCE ELASTOGRAPHY MRE Magnetic Resonance Elastography Magnetic Resonance Elastography The reemergence of acute myeloid leukemia with KMT2A rearrangement after a period of remission. C193407 Neoplastic Process Recurrent Acute Myeloid Leukemia with KMT2A Rearrangement C2861604 mCode Malignant Acute myeloid leukemia with 11q23 abnormality in relapse Recurrent Acute Myeloid Leukemia with KMT2A Rearrangement Recurrent Acute Myeloid Leukemia with MLL Rearrangement Recurrent Acute Myeloid Leukemia with KMT2A Rearrangement The reemergence of acute panmyelosis with myelofibrosis after a period of remission. C193410 Neoplastic Process Recurrent Acute Panmyelosis with Myelofibrosis C2861640 mCode Malignant Acute panmyelosis with myelofibrosis, in relapse Recurrent Acute Panmyelosis with Myelofibrosis Recurrent Acute Panmyelosis with Myelofibrosis The reemergence of atypical chronic myeloid leukemia after a period of remission. C193414 Neoplastic Process Recurrent Atypical Chronic Myeloid Leukemia C2861588 mCode Malignant Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse Recurrent Atypical Chronic Myeloid Leukemia Recurrent Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Recurrent Atypical Chronic Myeloid Leukemia, BCR::ABL1 Negative Recurrent aCML Recurrent Atypical Chronic Myeloid Leukemia A neoplasm that arises from a cranial nerve and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C193416 Neoplastic Process Benign Cranial Nerve Neoplasm C0004992 mCode Benign Benign Cranial Nerve Neoplasm Benign neoplasm of cranial nerves Benign Cranial Nerve Neoplasm A grade I, slowly growing meningioma that arises from the spinal meninges. C193417 Neoplastic Process Benign Spinal Meningioma C0154035 mCode Benign Benign Spinal Meningioma Benign neoplasm of spinal meninges Benign Spinal Meningioma The reemergence of extraosseous plasmacytoma after a period of remission. C193418 Neoplastic Process Recurrent Extraosseous Plasmacytoma C2854080 mCode Malignant Extramedullary plasmacytoma in relapse Recurrent Extraosseous Plasmacytoma Recurrent Extraosseous Plasmacytoma Gastrointestinal stromal tumor that arises from the rectum. C193420 Neoplastic Process Rectal Gastrointestinal Stromal Tumor C4267835 mCode Undetermined Gastrointestinal stromal tumor of rectum Rectal Gastrointestinal Stromal Tumor Rectal Gastrointestinal Stromal Tumor The reemergence of juvenile myelomonocytic leukemia after a period of remission. C193422 Neoplastic Process Recurrent Juvenile Myelomonocytic Leukemia C2861624 mCode Malignant Juvenile myelomonocytic leukemia, in relapse Recurrent Juvenile Myelomonocytic Leukemia Recurrent Juvenile Myelomonocytic Leukemia The reemergence of lymphoid leukemia after a period of remission. C193424 Neoplastic Process Recurrent Lymphoid Leukemia C2349274 mCode Malignant Lymphoid leukemia, unspecified, in relapse Recurrent Lymphoid Leukemia Recurrent Lymphoid Leukemia A primary or metastatic malignant neoplasm involving the ileum. C193425 Neoplastic Process Malignant Ileal Neoplasm C0153428 mCode Malignant Malignant Ileal Neoplasm Malignant neoplasm of ileum Malignant Ileal Neoplasm The reemergence of mast cell leukemia after a period of remission. C193426 Neoplastic Process Recurrent Mast Cell Leukemia C2367254 mCode Malignant Mast cell leukemia, in relapse Recurrent Mast Cell Leukemia Recurrent Mast Cell Leukemia The reemergence of acute monocytic leukemia after a period of remission. C193429 Neoplastic Process Recurrent Acute Monocytic Leukemia C2349295 mCode Malignant Monocytic leukemia, unspecified in relapse Recurrent Acute Monocytic Leukemia Recurrent Acute Monocytic Leukemia The reemergence of myeloid leukemia after a period of remission. C193431 Neoplastic Process Recurrent Myeloid Leukemia C2349285 mCode Malignant Myeloid leukemia, unspecified in relapse Recurrent Myeloid Leukemia Recurrent Myeloid Leukemia The reemergence of myeloid sarcoma after a period of remission. C193432 Neoplastic Process Recurrent Myeloid Sarcoma C2349281 mCode Malignant Myeloid sarcoma, in relapse Recurrent Myeloid Sarcoma Recurrent Myeloid Sarcoma The reemergence of plasma cell leukemia after a period of remission. C193433 Neoplastic Process Recurrent Plasma Cell Leukemia C2349263 mCode Malignant Plasma cell leukemia in relapse Recurrent Plasma Cell Leukemia Recurrent Plasma Cell Leukemia The reemergence of solitary plasmacytoma after a period of remission. C193436 Neoplastic Process Recurrent Solitary Plasmacytoma C2854085 mCode Malignant Recurrent Solitary Plasmacytoma Solitary plasmacytoma in relapse Recurrent Solitary Plasmacytoma Merkel cell carcinoma that is amenable to surgical resection. C193450 Neoplastic Process Resectable Merkel Cell Carcinoma Resectable Merkel Cell Carcinoma CL1913100 CTRP Malignant Resectable Merkel Cell Carcinoma Resectable Merkel Cell Carcinoma Angiosarcoma that is resistant to treatment. C193455 Neoplastic Process Refractory Angiosarcoma Refractory Angiosarcoma CL1913108 CTRP Malignant Refractory Angiosarcoma Refractory Angiosarcoma Solitary fibrous tumor that is resistant to treatment. C193456 Neoplastic Process Refractory Solitary Fibrous Tumor Refractory Solitary Fibrous Tumor CL1913109 CTRP Undetermined Refractory Hemangiopericytoma Refractory Solitary Fibrous Tumor Refractory Solitary Fibrous Tumor PEComa that is resistant to treatment. C193458 Neoplastic Process Refractory PEComa Refractory PEComa CL1913107 CTRP Undetermined Refractory PEComa Refractory PEComa Pleomorphic liposarcoma that is resistant to treatment. C193459 Neoplastic Process Refractory Pleomorphic Liposarcoma Refractory Pleomorphic Liposarcoma CL1913104 CTRP Malignant Refractory Pleomorphic Liposarcoma Refractory Pleomorphic Liposarcoma Various NMR methods that can be used to determine 3D structures of macromolecules. C19577 Research Activity Multidimensional NMR Techniques C1513736 Multidimensional_NMR_Techniques Multidimensional NMR Techniques Multidimensional NMR Techniques An aggressive osteosarcoma with high-grade morphological features. This category includes high-grade surface osteosarcoma and conventional osteosarcoma. C197813 Neoplastic Process High Grade Osteosarcoma CL1913682 Malignant High Grade Osteosarcoma High-Grade Osteosarcoma High Grade Osteosarcoma An osteosarcoma with intermediate-grade morphological features. A representative example is periosteal osteosarcoma. C197814 Neoplastic Process Intermediate Grade Osteosarcoma CL1913679 Malignant Intermediate Grade Osteosarcoma Intermediate-Grade Osteosarcoma Intermediate Grade Osteosarcoma An osteosarcoma with low-grade morphological features. This category includes parosteal osteosarcoma and low-grade central osteosarcoma. C197815 Neoplastic Process Low Grade Osteosarcoma CL1913680 Malignant Low Grade Osteosarcoma Low-Grade Osteosarcoma Low Grade Osteosarcoma Lung squamous cell carcinoma that has spread to nearly tissues or lymph nodes. C197986 Neoplastic Process Locally Advanced Squamous Cell Lung Carcinoma Locally Advanced Lung Squamous Cell Carcinoma CL1913843 CTRP Malignant Locally Advanced Lung Squamous Cell Carcinoma Locally Advanced Lung Squamous Cell Carcinoma PRETEX I hepatoblastoma confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198011 Neoplastic Process Localized PRETEX I Hepatoblastoma CL1913824 Malignant Hepatoblastoma Localized PRETEXT I Localized PRETEX I Hepatoblastoma Localized PRETEX I Hepatoblastoma PRETEX II hepatoblastoma confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198012 Neoplastic Process Localized PRETEX II Hepatoblastoma CL1913825 Malignant Hepatoblastoma Localized PRETEXT II Localized PRETEX II Hepatoblastoma Localized PRETEX II Hepatoblastoma PRETEX III hepatoblastoma confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198013 Neoplastic Process Localized PRETEX III Hepatoblastoma CL1913822 Malignant Hepatoblastoma Localized PRETEXT III Localized PRETEX III Hepatoblastoma Localized PRETEX III Hepatoblastoma PRETEX IV hepatoblastoma confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198014 Neoplastic Process Localized PRETEX IV Hepatoblastoma CL1913823 Malignant Hepatoblastoma Localized PRETEXT IV Localized PRETEX IV Hepatoblastoma Localized PRETEX IV Hepatoblastoma PRETEX I hepatoblastoma with distant metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198015 Neoplastic Process Metastatic PRETEX I Hepatoblastoma CL1913820 Malignant Hepatoblastoma Metastatic PRETEXT I Metastatic PRETEX I Hepatoblastoma Metastatic PRETEX I Hepatoblastoma PRETEX II hepatoblastoma with distant metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198016 Neoplastic Process Metastatic PRETEX II Hepatoblastoma CL1913821 Malignant Hepatoblastoma Metastatic PRETEXT II Metastatic PRETEX II Hepatoblastoma Metastatic PRETEX II Hepatoblastoma PRETEX III hepatoblastoma with distant metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198017 Neoplastic Process Metastatic PRETEX III Hepatoblastoma CL1913818 Malignant Hepatoblastoma Metastatic PRETEXT III Metastatic PRETEX III Hepatoblastoma Metastatic PRETEX III Hepatoblastoma PRETEX IV hepatoblastoma with distant metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198018 Neoplastic Process Metastatic PRETEX IV Hepatoblastoma CL1913819 Malignant Hepatoblastoma Metastatic PRETEXT IV Metastatic PRETEX IV Hepatoblastoma Metastatic PRETEX IV Hepatoblastoma A term that refers to the staging of childhood acute lymphoblastic Leukemia according to the Toronto childhood cancer staging guidelines v2. C198030 Neoplastic Process Childhood Acute Lymphoblastic Leukemia by Toronto Guidelines v2 CL1913807 Malignant Childhood Acute Lymphoblastic Leukemia by Toronto Guidelines v2 Pediatric Acute Lymphoblastic Leukemia by Toronto Guidelines v2 Childhood Acute Lymphoblastic Leukemia by Toronto Guidelines v2 A term that refers to the staging of childhood acute lymphoblastic leukemia according to the tier 1 Toronto childhood cancer staging guidelines v2. C198031 Neoplastic Process Childhood Acute Lymphoblastic Leukemia Toronto Guidelines v2, Tier 1 CL1913804 Malignant Childhood Acute Lymphoblastic Leukemia Toronto Guidelines v2, Tier 1 Pediatric Acute Lymphoblastic Leukemia Toronto Guidelines v2, Tier 1 Childhood Acute Lymphoblastic Leukemia Toronto Guidelines v2, Tier 1 No clinical signs of CNS involvement and no blasts in CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198032 Neoplastic Process Childhood Acute Lymphoblastic Leukemia CNS-Negative Toronto Guidelines v2 CL1913805 Malignant Childhood Acute Lymphoblastic Leukemia CNS-Negative Toronto Guidelines v2 Childhood Acute Lymphoblastic Leukemia Central Nervous System-Negative Toronto Guidelines v2 Pediatric Acute Lymphoblastic Leukemia CNS-Negative Toronto Guidelines v2 Pediatric Acute Lymphoblastic Leukemia Central Nervous System-Negative Toronto Guidelines v2 Childhood Acute Lymphoblastic Leukemia CNS-Negative Toronto Guidelines v2 Clinical signs of CNS involvement or blasts in CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198034 Neoplastic Process Childhood Acute Lymphoblastic Leukemia CNS-Positive Toronto Guidelines v2 CL1913803 Malignant Childhood Acute Lymphoblastic Leukemia CNS-Positive Toronto Guidelines v2 Childhood Acute Lymphoblastic Leukemia Central Nervous System-Positive Toronto Guidelines v2 Pediatric Acute Lymphoblastic Leukemia CNS-Positive Toronto Guidelines v2 Pediatric Acute Lymphoblastic Leukemia Central Nervous System-Positive Toronto Guidelines v2 Childhood Acute Lymphoblastic Leukemia CNS-Positive Toronto Guidelines v2 A term that refers to the staging of childhood acute lymphoblastic leukemia according to the tier 2 Toronto childhood cancer staging guidelines v2. C198035 Neoplastic Process Childhood Acute Lymphoblastic Leukemia Toronto Guidelines v2, Tier 2 CL1913785 Malignant Childhood Acute Lymphoblastic Leukemia Toronto Guidelines v2, Tier 2 Pediatric Acute Lymphoblastic Leukemia Toronto Guidelines v2, Tier 2 Childhood Acute Lymphoblastic Leukemia Toronto Guidelines v2, Tier 2 No clinical signs of CNS involvement and no blasts in CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198036 Neoplastic Process Childhood Acute Lymphoblastic Leukemia CNS 1 Toronto Guidelines v2 CL1913786 Malignant Acute lymphoblastic leukemia CNS1 Childhood Acute Lymphoblastic Leukemia CNS 1 Toronto Guidelines v2 Childhood Acute Lymphoblastic Leukemia Central Nervous System 1 Toronto Guidelines v2 Pediatric Acute Lymphoblastic Leukemia CNS 1 Toronto Guidelines v2 Pediatric Acute Lymphoblastic Leukemia Central Nervous System 1 Toronto Guidelines v2 Childhood Acute Lymphoblastic Leukemia CNS 1 Toronto Guidelines v2 No clinical signs of CNS involvement and blasts in CSF and either: WBC < 5/μL CSF or WBC > or = 5/uL CSF and RBC > or = 10/uL CSF and WBC/RBC in CSF < or = 2x WBC/RBC in blood. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198039 Neoplastic Process Childhood Acute Lymphoblastic Leukemia CNS 2 Toronto Guidelines v2 CL1913781 Malignant Acute lymphoblastic leukemia CNS2 Childhood Acute Lymphoblastic Leukemia CNS 2 Toronto Guidelines v2 Childhood Acute Lymphoblastic Leukemia Central Nervous System 2 Toronto Guidelines v2 Pediatric Acute Lymphoblastic Leukemia CNS 2 Toronto Guidelines v2 Pediatric Acute Lymphoblastic Leukemia Central Nervous System 2 Toronto Guidelines v2 Childhood Acute Lymphoblastic Leukemia CNS 2 Toronto Guidelines v2 Clinical signs of CNS involvement or blasts in CSF and WBC > or = 5/uL CSF and either: RBC < 10/uL CSF or RBC > or = 10/uL CSF and WBC/RBC in CSF > 2x WBC/RBC in blood. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198040 Neoplastic Process Childhood Acute Lymphoblastic Leukemia CNS 3 Toronto Guidelines v2 CL1913782 Malignant Acute lymphoblastic leukemia CNS3 Childhood Acute Lymphoblastic Leukemia CNS 3 Toronto Guidelines v2 Childhood Acute Lymphoblastic Leukemia Central Nervous System 3 Toronto Guidelines v2 Pediatric Acute Lymphoblastic Leukemia CNS 3 Toronto Guidelines v2 Pediatric Acute Lymphoblastic Leukemia Central Nervous System 3 Toronto Guidelines v2 Childhood Acute Lymphoblastic Leukemia CNS 3 Toronto Guidelines v2 A term that refers to the staging of childhood Hodgkin lymphoma according to the Toronto childhood cancer staging guidelines v2. Staging is the same for both tiers (tier 1 and 2). C198041 Neoplastic Process Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Stage CL1913779 Malignant Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Stage Pediatric Hodgkin Lymphoma by Toronto Guidelines v2 Stage Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Stage Involvement of a single lymph node region or involvement of a single extra-lymphatic organ or site, without lymph node involvement. This definition applies to both tiers (tier 1 and 2). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198042 Neoplastic Process Stage I Childhood Hodgkin Lymphoma by Toronto Guidelines v2 CL1913780 Malignant Hodgkin lymphoma Stage I Stage I Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Stage I Pediatric Hodgkin Lymphoma by Toronto Guidelines v2 Stage I Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Involvement of a single lymph node region or involvement of a single extra-lymphatic organ or site, without lymph node involvement. No constitutional symptoms are recorded. This definition applies to both tiers (tier 1 and 2). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198043 Neoplastic Process Stage IA Childhood Hodgkin Lymphoma by Toronto Guidelines v2 CL1913793 Malignant Stage IA Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Stage IA Pediatric Hodgkin Lymphoma by Toronto Guidelines v2 Stage IA Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Involvement of a single lymph node region or involvement of a single extra-lymphatic organ or site, without lymph node involvement. The medical record states there are constitutional symptoms. This definition applies to both tiers (tier 1 and 2). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198044 Neoplastic Process Stage IB Childhood Hodgkin Lymphoma by Toronto Guidelines v2 CL1913794 Malignant Stage IB Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Stage IB Pediatric Hodgkin Lymphoma by Toronto Guidelines v2 Stage IB Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Involvement of two or more lymph node regions on the same side (either above or below) of the diaphragm or localized involvement of a single extra-lymphatic organ or site in association with regional lymph node involvement (i.e., local extension from a lymph node area into a nearby organ), with or without involvement of other contiguous lymph node regions on the same side (either above or below) of the diaphragm. This definition applies to both tiers (tier 1 and 2). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198045 Neoplastic Process Stage II Childhood Hodgkin Lymphoma by Toronto Guidelines v2 CL1913791 Malignant Hodgkin lymphoma Stage II Stage II Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Stage II Pediatric Hodgkin Lymphoma by Toronto Guidelines v2 Stage II Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Involvement of two or more lymph node regions on the same side (either above or below) of the diaphragm or localized involvement of a single extra-lymphatic organ or site in association with regional lymph node involvement (i.e., local extension from a lymph node area into a nearby organ), with or without involvement of other contiguous lymph node regions on the same side (either above or below) of the diaphragm. No constitutional symptoms are recorded. This definition applies to both tiers (tier 1 and 2). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198046 Neoplastic Process Stage IIA Childhood Hodgkin Lymphoma by Toronto Guidelines v2 CL1913792 Malignant Stage IIA Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Stage IIA Pediatric Hodgkin Lymphoma by Toronto Guidelines v2 Stage IIA Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Involvement of two or more lymph node regions on the same side (either above or below) of the diaphragm or localized involvement of a single extra-lymphatic organ or site in association with regional lymph node involvement (i.e., local extension from a lymph node area into a nearby organ), with or without involvement of other contiguous lymph node regions on the same side (either above or below) of the diaphragm. The medical record states there are constitutional symptoms. This definition applies to both tiers (tier 1 and 2). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198047 Neoplastic Process Stage IIB Childhood Hodgkin Lymphoma by Toronto Guidelines v2 CL1913789 Malignant Stage IIB Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Stage IIB Pediatric Hodgkin Lymphoma by Toronto Guidelines v2 Stage IIB Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Involvement of lymph node regions on both sides (above and below) of the diaphragm. This may be accompanied by extra-lymphatic extension in association with adjacent lymph node involvement (i.e., local extension from a lymph node area into a nearby organ) and/or involvement of spleen. This definition applies to both tiers (tier 1 and 2). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198048 Neoplastic Process Stage III Childhood Hodgkin Lymphoma by Toronto Guidelines v2 CL1913790 Malignant Hodgkin lymphoma Stage III Stage III Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Stage III Pediatric Hodgkin Lymphoma by Toronto Guidelines v2 Stage III Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Involvement of lymph node regions on both sides (above and below) of the diaphragm. This may be accompanied by extra-lymphatic extension in association with adjacent lymph node involvement (i.e., local extension from a lymph node area into a nearby organ) and/or involvement of spleen. No constitutional symptoms are recorded. This definition applies to both tiers (tier 1 and 2). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198049 Neoplastic Process Stage IIIA Childhood Hodgkin Lymphoma by Toronto Guidelines v2 CL1913787 Malignant Stage IIIA Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Stage IIIA Pediatric Hodgkin Lymphoma by Toronto Guidelines v2 Stage IIIA Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Involvement of lymph node regions on both sides (above and below) of the diaphragm. This may be accompanied by extra-lymphatic extension in association with adjacent lymph node involvement (i.e., local extension from a lymph node area into a nearby organ) and/or involvement of spleen. The medical record states there are constitutional symptoms. This definition applies to both tiers (tier 1 and 2). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198050 Neoplastic Process Stage IIIB Childhood Hodgkin Lymphoma by Toronto Guidelines v2 CL1913788 Malignant Stage IIIB Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Stage IIIB Pediatric Hodgkin Lymphoma by Toronto Guidelines v2 Stage IIIB Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Diffuse or disseminated (multifocal) involvement of one or more extra-lymphatic organs with or without associated lymph node involvement or isolated (non-contiguous) extra-lymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s) or any involvement of liver, bone marrow, lungs (except by direct extension from another site) or CSF. This definition applies to both tiers (tier 1 and 2). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198051 Neoplastic Process Stage IV Childhood Hodgkin Lymphoma by Toronto Guidelines v2 CL1913769 Malignant Hodgkin lymphoma Stage IV Stage IV Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Stage IV Pediatric Hodgkin Lymphoma by Toronto Guidelines v2 Stage IV Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Diffuse or disseminated (multifocal) involvement of one or more extra-lymphatic organs with or without associated lymph node involvement or isolated (non-contiguous) extra-lymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s) or any involvement of liver, bone marrow, lungs (except by direct extension from another site) or CSF. No constitutional symptoms are recorded. This definition applies to both tiers (tier 1 and 2). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198052 Neoplastic Process Stage IVA Childhood Hodgkin Lymphoma by Toronto Guidelines v2 CL1913770 Malignant Stage IVA Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Stage IVA Pediatric Hodgkin Lymphoma by Toronto Guidelines v2 Stage IVA Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Diffuse or disseminated (multifocal) involvement of one or more extra-lymphatic organs with or without associated lymph node involvement or isolated (non-contiguous) extra-lymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s) or any involvement of liver, bone marrow, lungs (except by direct extension from another site) or CSF. The medical record states there are constitutional symptoms. This definition applies to both tiers (tier 1 and 2). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198053 Neoplastic Process Stage IVB Childhood Hodgkin Lymphoma by Toronto Guidelines v2 CL1913767 Malignant Stage IVB Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Stage IVB Pediatric Hodgkin Lymphoma by Toronto Guidelines v2 Stage IVB Childhood Hodgkin Lymphoma by Toronto Guidelines v2 A term that refers to the staging of childhood non-Hodgkin lymphoma according to the Toronto childhood cancer staging guidelines v2. C198054 Neoplastic Process Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage CL1913768 Malignant Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage Pediatric Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage A term that refers to the staging of childhood non-Hodgkin lymphoma according to the tier 1 Toronto childhood cancer staging guidelines v2. C198055 Neoplastic Process Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage, Tier 1 CL1913765 Malignant Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage, Tier 1 Pediatric Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage, Tier 1 Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage, Tier 1 No involvement of CNS and no involvement of bone marrow. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198056 Neoplastic Process Limited Stage Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 CL1913766 Malignant Limited Stage Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Limited Stage Pediatric Non-Hodgkin Lymphoma by Toronto Guidelines v2 Limited Stage Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Involvement of CNS and/or bone marrow. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198057 Neoplastic Process Advanced Stage Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 CL1913763 Malignant Advanced Stage Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Advanced Stage Pediatric Non-Hodgkin Lymphoma by Toronto Guidelines v2 Advanced Stage Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 A term that refers to the staging of childhood non-Hodgkin lymphoma according to the tier 2 Toronto childhood cancer staging guidelines v2. C198058 Neoplastic Process Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage, Tier 2 CL1913764 Malignant Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage, Tier 2 Pediatric Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage, Tier 2 Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage, Tier 2 Involvement of a single tumor mass or nodal area, excluding the abdomen and mediastinum. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198059 Neoplastic Process Stage I Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 CL1913777 Malignant Non-Hodgkin lymphoma Stage I Stage I Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage I Pediatric Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage I Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 A single tumor (extranodal) with regional node involvement or two or more nodal areas on the same side (either above or below) of the diaphragm or two or more single (extranodal) tumors, with or without regional node involvement, on the same side (either above or below) of the diaphragm or a completely resected primary gastrointestinal tract tumor with or without involvement of associated mesenteric nodes only. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198060 Neoplastic Process Stage II Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 CL1913778 Malignant Non-Hodgkin lymphoma Stage II Stage II Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage II Pediatric Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage II Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Tumors (extranodal) or nodal areas on both sides (above and below) of the diaphragm or any primary intrathoracic tumors (mediastinal, hilar, pulmonary, pleural, or thymic) or extensive (unresectable) primary intra-abdominal disease or any paraspinal or epidural tumors regardless of other tumor sites. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198061 Neoplastic Process Stage III Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 CL1913775 Malignant Non-Hodgkin lymphoma Stage III Stage III Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage III Pediatric Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage III Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Initial CNS and/or bone marrow involvement. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198062 Neoplastic Process Stage IV Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 CL1913776 Malignant Non-Hodgkin lymphoma Stage IV Stage IV Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage IV Pediatric Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage IV Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 A term that refers to the staging of childhood neuroblastoma according to the Toronto childhood cancer staging guidelines v2. C198063 Neoplastic Process Childhood Neuroblastoma by Toronto Guidelines v2 Stage CL1913773 Malignant Childhood Neuroblastoma by Toronto Guidelines v2 Stage Pediatric Neuroblastoma by Toronto Guidelines v2 Stage Childhood Neuroblastoma by Toronto Guidelines v2 Stage A term that refers to the staging of childhood neuroblastoma according to the tier 1 Toronto childhood cancer staging guidelines v2. C198064 Neoplastic Process Childhood Neuroblastoma by Toronto Guidelines v2 Stage, Tier 1 CL1913774 Malignant Childhood Neuroblastoma by Toronto Guidelines v2 Stage, Tier 1 Pediatric Neuroblastoma by Toronto Guidelines v2 Stage, Tier 1 Childhood Neuroblastoma by Toronto Guidelines v2 Stage, Tier 1 Localized tumor not involving vital structures and confined to one body compartment. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198065 Neoplastic Process Localized Childhood Neuroblastoma by Toronto Guidelines v2 CL1913771 Malignant Localized Childhood Neuroblastoma by Toronto Guidelines v2 Localized Pediatric Neuroblastoma by Toronto Guidelines v2 Localized Childhood Neuroblastoma by Toronto Guidelines v2 Locoregional tumor with spread. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198066 Neoplastic Process Locoregional Childhood Neuroblastoma by Toronto Guidelines v2 CL1913772 Malignant Locoregional Childhood Neuroblastoma by Toronto Guidelines v2 Locoregional Pediatric Neuroblastoma by Toronto Guidelines v2 Locoregional Childhood Neuroblastoma by Toronto Guidelines v2 Distant metastatic disease (except stage MS). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198067 Neoplastic Process Metastatic Childhood Neuroblastoma by Toronto Guidelines v2 CL1913753 Malignant Metastatic Childhood Neuroblastoma by Toronto Guidelines v2 Metastatic Childhood Neuroblastoma by Toronto Guidelines v2, Tier 1 Metastatic Pediatric Neuroblastoma by Toronto Guidelines v2 Metastatic Pediatric Neuroblastoma by Toronto Guidelines v2, Tier 1 Metastatic Childhood Neuroblastoma by Toronto Guidelines v2 Metastatic disease confined to skin, liver, and/or bone marrow in a patient less than 18 months (547 days). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198069 Neoplastic Process MS Childhood Neuroblastoma by Toronto Guidelines v2 CL1913754 Malignant MS Childhood Neuroblastoma by Toronto Guidelines v2 MS Childhood Neuroblastoma by Toronto Guidelines v2, Tier 1 MS Pediatric Neuroblastoma by Toronto Guidelines v2 MS Pediatric Neuroblastoma by Toronto Guidelines v2, Tier 1 MS Childhood Neuroblastoma by Toronto Guidelines v2 A term that refers to the staging of childhood neuroblastoma according to the tier 2 Toronto childhood cancer staging guidelines v2. C198071 Neoplastic Process Childhood Neuroblastoma by Toronto Guidelines v2 Stage, Tier 2 CL1913752 Malignant Childhood Neuroblastoma by Toronto Guidelines v2 Stage, Tier 2 Pediatric Neuroblastoma by Toronto Guidelines v2 Stage, Tier 2 Childhood Neuroblastoma by Toronto Guidelines v2 Stage, Tier 2 Localized tumor that does not involve any vital structures as defined by the list of IDRFs (i.e., there are no IDRFs) and the tumor must be confined within one body compartment, neck, chest, abdomen, or pelvis. An intraspinal tumor extension that does not fulfill the criteria for an IDRF is consistent with stage L1. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198072 Neoplastic Process Stage L1 Childhood Neuroblastoma by Toronto Guidelines v2 CL1913749 Malignant Neuroblastoma Stage L1 Stage L1 Childhood Neuroblastoma by Toronto Guidelines v2 Stage L1 Pediatric Neuroblastoma by Toronto Guidelines v2 Stage L1 Childhood Neuroblastoma by Toronto Guidelines v2 Locoregional tumor with one or more IDRFs. The tumor may be ipsilateral contiguous within body compartments (i.e., a left-sided abdominal tumor with left-sided lung, bone or pleura involvement should be considered stage L2). However, a clearly left-sided abdominal tumor with right-sided lung, bone or pleura (or vice-versa) involvement is defined as metastatic disease. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198073 Neoplastic Process Stage L2 Childhood Neuroblastoma by Toronto Guidelines v2 CL1913750 Malignant Neuroblastoma Stage L2 Stage L2 Childhood Neuroblastoma by Toronto Guidelines v2 Stage L2 Pediatric Neuroblastoma by Toronto Guidelines v2 Stage L2 Childhood Neuroblastoma by Toronto Guidelines v2 Distant metastatic disease (i.e., not contiguous with the primary tumor) except as defined for stage MS. Nonregional (distant) lymph node involvement is metastatic disease. However, an upper abdominal tumor with enlarged lower mediastinal nodes or a pelvic tumor with inguinal lymph node involvement is considered locoregional disease. Ascites and/or a pleural effusion, even with malignant cells, do not constitute metastatic disease unless they are remote from the body compartment of the primary tumor. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198074 Neoplastic Process Stage M Childhood Neuroblastoma by Toronto Guidelines v2 CL1913747 Malignant Neuroblastoma Stage M Stage M Childhood Neuroblastoma by Toronto Guidelines v2 Stage M Childhood Neuroblastoma by Toronto Guidelines v2, Tier 2 Stage M Pediatric Neuroblastoma by Toronto Guidelines v2 Stage M Pediatric Neuroblastoma by Toronto Guidelines v2, Tier 2 Stage M Childhood Neuroblastoma by Toronto Guidelines v2 Metastatic disease confined to skin, liver, and/or bone marrow, in a patient less than 18 months (547 days). MIBG scintigraphy must be negative in bone and bone marrow. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198075 Neoplastic Process Stage MS Childhood Neuroblastoma by Toronto Guidelines v2 CL1913748 Malignant Neuroblastoma Stage MS Stage MS Childhood Neuroblastoma by Toronto Guidelines v2 Stage MS Childhood Neuroblastoma by Toronto Guidelines v2, Tier 2 Stage MS Pediatric Neuroblastoma by Toronto Guidelines v2 Stage MS Pediatric Neuroblastoma by Toronto Guidelines v2, Tier 2 Stage MS Childhood Neuroblastoma by Toronto Guidelines v2 A term that refers to the staging of childhood malignant kidney neoplasms excluding renal cell carcinoma, according to the Toronto childhood cancer staging guidelines v2, International Society of Pediatric Oncology (SIOP) protocol. It is based on findings at surgery for patients who have received chemotherapy prior to surgery. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198076 Neoplastic Process Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, International Society of Pediatric Oncology (SIOP) Protocol CL1913761 Malignant Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, International Society of Pediatric Oncology (SIOP) Protocol Pediatric Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, International Society of Pediatric Oncology (SIOP) Protocol Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, International Society of Pediatric Oncology (SIOP) Protocol A term that refers to the staging of childhood malignant kidney neoplasms excluding renal cell carcinoma, according to the tier 1 Toronto childhood cancer staging guidelines v2, International Society of Pediatric Oncology (SIOP) protocol. C198077 Neoplastic Process Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Tier 1, International Society of Pediatric Oncology (SIOP) Protocol CL1913762 Malignant Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Tier 1, International Society of Pediatric Oncology (SIOP) Protocol Pediatric Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Tier 1, International Society of Pediatric Oncology (SIOP) Protocol Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Tier 1, International Society of Pediatric Oncology (SIOP) Protocol Tumor confined to area of origin including abdominal lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198078 Neoplastic Process Localized Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol CL1913759 Malignant Localized Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol Localized Pediatric Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol Localized Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol Distant metastases present at diagnosis. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198079 Neoplastic Process Metastatic Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol CL1913760 Malignant Metastatic Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol Metastatic Pediatric Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol Metastatic Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol A term that refers to the staging of childhood malignant kidney neoplasms excluding renal cell carcinoma, according to the tier 2 Toronto childhood cancer staging guidelines v2, International Society of Pediatric Oncology (SIOP) protocol. C198080 Neoplastic Process Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Tier 2, International Society of Pediatric Oncology (SIOP) Protocol CL1913757 Malignant Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Tier 2, International Society of Pediatric Oncology (SIOP) Protocol Pediatric Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Tier 2, International Society of Pediatric Oncology (SIOP) Protocol Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Tier 2, International Society of Pediatric Oncology (SIOP) Protocol Tumor limited to kidney and completely resected. Renal capsule may be infiltrated by tumor, but tumor does not reach the outer surface. Tumor may protrude or bulge into the pelvic system or ureter but does not infiltrate. Vessel of renal sinus not involved. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198081 Neoplastic Process Stage y-I Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol CL1913758 Malignant Renal tumor (excluding renal cell carcinomas) Stage y-I Stage y-I Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol Stage y-I Pediatric Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol Stage y-I Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol Tumor extends beyond kidney but completely resected. Tumor penetrates renal capsule into perirenal fat. Tumor infiltrates the renal sinus and/or invades blood and lymphatic vessels outside renal parenchyma but is completely resected. Tumor infiltrates adjacent organs or vena cava but is completely resected. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198082 Neoplastic Process Stage y-II Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol CL1913755 Malignant Renal tumor (excluding renal cell carcinomas) Stage y-II Stage y-II Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol Stage y-II Pediatric Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol Stage y-II Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol Incomplete excision of the tumor (gross or microscopic extension beyond the resection margins). Involved abdominal lymph nodes, including necrotic tumor or chemotherapy-induced changes. Tumor rupture before or intraoperatively. Tumor has penetrated the peritoneal surface. Tumor thrombi present at resection margins. Surgical biopsy prior to resection (does not include needle biopsy). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198083 Neoplastic Process Stage y-III Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol CL1913756 Malignant Renal tumor (excluding renal cell carcinomas) Stage y-III Stage y-III Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol Stage y-III Pediatric Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol Stage y-III Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol Hematogenous metastases or spread beyond abdomen at diagnosis. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198084 Neoplastic Process Stage IV Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol CL1913737 Malignant Renal tumor (excluding renal cell carcinomas) Stage IV Stage IV Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol Stage IV Pediatric Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol Stage IV Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol A term that refers to the staging of childhood malignant kidney neoplasms excluding renal cell carcinoma, according to the Toronto childhood cancer staging guidelines v2, Children's Oncology Group (COG) protocol. It is based on findings at surgery for patients who have not received chemotherapy prior to surgery. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198085 Neoplastic Process Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Children's Oncology Group (COG) Protocol CL1913738 Malignant Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Children's Oncology Group (COG) Protocol Pediatric Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Children's Oncology Group (COG) Protocol Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Children's Oncology Group (COG) Protocol A term that refers to the staging of childhood malignant kidney neoplasms excluding renal cell carcinoma, according to the tier 1 Toronto childhood cancer staging guidelines v2, Children's Oncology Group (COG) protocol. C198086 Neoplastic Process Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Tier 1, Children's Oncology Group (COG) Protocol CL1913735 Malignant Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Tier 1, Children's Oncology Group (COG) Protocol Pediatric Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Tier 1, Children's Oncology Group (COG) Protocol Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Tier 1, Children's Oncology Group (COG) Protocol Tumor confined to area of origin including abdominal lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198087 Neoplastic Process Localized Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol CL1913736 Malignant Localized Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol Localized Pediatric Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol Localized Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol Distant metastases present at diagnosis. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198088 Neoplastic Process Metastatic Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol CL1913733 Malignant Metastatic Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol Metastatic Pediatric Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol Metastatic Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol A term that refers to the staging of childhood malignant kidney neoplasms excluding renal cell carcinoma, according to the tier 2 Toronto childhood cancer staging guidelines v2, Children's Oncology Group (COG) protocol. C198089 Neoplastic Process Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Tier 2, Children's Oncology Group (COG) Protocol CL1913734 Malignant Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Tier 2, Children's Oncology Group (COG) Protocol Pediatric Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Tier 2, Children's Oncology Group (COG) Protocol Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Tier 2, Children's Oncology Group (COG) Protocol Tumor is limited to the kidney and completely excised. Renal capsule intact, not penetrated by tumor. No tumor invasion of veins or lymphatics of renal sinus. No nodal or hematogenous metastases. No prior biopsy. Negative margins. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198096 Neoplastic Process Stage I Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol CL1913741 Malignant Renal tumor (excluding renal cell carcinomas) Stage I Stage I Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol Stage I Pediatric Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol Stage I Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol Tumor extends beyond kidney but completely resected. Tumor penetrates renal capsule. Tumor in lymphatics or veins of renal sinus. Tumor in renal vein with margin not involved. No nodal or hematogenous metastases. Negative margins. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198097 Neoplastic Process Stage II Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol CL1913742 Malignant Renal tumor (excluding renal cell carcinomas) Stage II Stage II Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol Stage II Pediatric Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol Stage II Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol Residual tumor or nonhematogenous metastases confined to abdomen. Involved abdominal nodes. Peritoneal contamination or tumor implant. Tumor spillage of any degree occurring before or during surgery. Gross residual tumor in abdomen. Biopsy of tumor (including fine-needle aspiration) prior to removal of kidney. Resection margins involved by tumor. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198098 Neoplastic Process Stage III Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol CL1913739 Malignant Renal tumor (excluding renal cell carcinomas) Stage III Stage III Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol Stage III Pediatric Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol Stage III Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol Hematogenous metastases or spread beyond abdomen at diagnosis. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198100 Neoplastic Process Stage IV Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol CL1913721 Malignant Renal tumor (excluding renal cell carcinomas) Stage IV Stage IV Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol Stage IV Pediatric Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol Stage IV Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol A term that refers to the staging of childhood malignant kidney neoplasms excluding renal cell carcinoma, according to the Toronto childhood cancer staging guidelines v2. C198104 Neoplastic Process Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage CL1913720 Malignant Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage Pediatric Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage The reemergence of oral cavity squamous cell carcinoma after a period of remission, at or adjacent to the site of the original tumor. C198147 Neoplastic Process Locally Recurrent Oral Cavity Squamous Cell Carcinoma Locally Recurrent Oral Cavity Squamous Cell Carcinoma CL1914067 CTRP Malignant Locally Recurrent Oral Cavity Squamous Cell Carcinoma Locally Recurrent Oral Cavity Squamous Cell Carcinoma The reemergence of oropharyngeal squamous cell carcinoma after a period of remission, at or adjacent to the site of the original tumor. C198148 Neoplastic Process Locally Recurrent Oropharyngeal Squamous Cell Carcinoma Locally Recurrent Oropharyngeal Squamous Cell Carcinoma CL1914064 CTRP Malignant Locally Recurrent Oropharyngeal Squamous Cell Carcinoma Locally Recurrent Oropharyngeal Squamous Cell Carcinoma A term that refers to the staging of childhood rhabdomyosarcoma according to the Toronto childhood cancer staging guidelines v2. C198149 Neoplastic Process Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Stage CL1914065 Malignant Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Stage Pediatric Rhabdomyosarcoma by Toronto Guidelines v2 Stage Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Stage A term that refers to the staging of childhood rhabdomyosarcoma according to the tier 1 Toronto childhood cancer staging guidelines v2. C198150 Neoplastic Process Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Stage, Tier 1 CL1914046 Malignant Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Stage, Tier 1 Pediatric Rhabdomyosarcoma by Toronto Guidelines v2 Stage, Tier 1 Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Stage, Tier 1 The reemergence of laryngeal squamous cell carcinoma after a period of remission, at or adjacent to the site of the original tumor. C198151 Neoplastic Process Locally Recurrent Laryngeal Squamous Cell Carcinoma Locally Recurrent Laryngeal Squamous Cell Carcinoma CL1914047 Malignant Locally Recurrent Laryngeal Squamous Cell Carcinoma Locally Recurrent Laryngeal Squamous Cell Carcinoma Tumor confined to the area of origin including the regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198152 Neoplastic Process Localized Childhood Rhabdomyosarcoma by Toronto Guidelines v2 CL1914044 Malignant Localized Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Localized Pediatric Rhabdomyosarcoma by Toronto Guidelines v2 Localized Childhood Rhabdomyosarcoma by Toronto Guidelines v2 The reemergence of hypopharyngeal squamous cell carcinoma after a period of remission, at or adjacent to the site of the original tumor. C198153 Neoplastic Process Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma CL1914045 CTRP Malignant Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma Distant metastases present. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198154 Neoplastic Process Metastatic Childhood Rhabdomyosarcoma by Toronto Guidelines v2 CL1914042 Malignant Metastatic Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Metastatic Pediatric Rhabdomyosarcoma by Toronto Guidelines v2 Metastatic Childhood Rhabdomyosarcoma by Toronto Guidelines v2 A term that refers to the staging of childhood rhabdomyosarcoma according to the tier 2 Toronto childhood cancer staging guidelines v2. C198155 Neoplastic Process Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Stage, Tier 2 CL1914043 Malignant Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Stage, Tier 2 Pediatric Rhabdomyosarcoma by Toronto Guidelines v2 Stage, Tier 2 Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Stage, Tier 2 Favorable site and any T, any N, M0. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198156 Neoplastic Process Stage I Childhood Rhabdomyosarcoma by Toronto Guidelines v2 CL1914040 Malignant Rhabdomyosarcoma Stage I Stage I Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Stage I Pediatric Rhabdomyosarcoma by Toronto Guidelines v2 Stage I Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Unfavorable site and T1a, T2a, N0, M0. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198157 Neoplastic Process Stage II Childhood Rhabdomyosarcoma by Toronto Guidelines v2 CL1914041 Malignant Rhabdomyosarcoma Stage II Stage II Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Stage II Pediatric Rhabdomyosarcoma by Toronto Guidelines v2 Stage II Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Unfavorable site and (T1a, T2a, N1, M0); (T1b, T2b, Any N, M0). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198158 Neoplastic Process Stage III Childhood Rhabdomyosarcoma by Toronto Guidelines v2 CL1914054 Malignant Rhabdomyosarcoma Stage III Stage III Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Stage III Pediatric Rhabdomyosarcoma by Toronto Guidelines v2 Stage III Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Any site and any T, any N, M1. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198159 Neoplastic Process Stage IV Childhood Rhabdomyosarcoma by Toronto Guidelines v2 CL1914055 Malignant Rhabdomyosarcoma Stage IV Stage IV Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Stage IV Pediatric Rhabdomyosarcoma by Toronto Guidelines v2 Stage IV Childhood Rhabdomyosarcoma by Toronto Guidelines v2 A term that refers to the staging of childhood non-rhabdomyosarcoma soft tissue sarcoma according to the Toronto childhood cancer staging guidelines v2. C198160 Neoplastic Process Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage CL1914052 Malignant Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage A term that refers to the staging of childhood non-rhabdomyosarcoma soft tissue sarcoma according to the tier 1 Toronto childhood cancer staging guidelines v2. C198161 Neoplastic Process Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage, Tier 1 CL1914053 Malignant Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage, Tier 1 Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage, Tier 1 Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage, Tier 1 Tumor confined to the area of origin including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198162 Neoplastic Process Localized Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 CL1914050 Malignant Localized Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Localized Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Localized Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Distant metastases present. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198163 Neoplastic Process Metastatic Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 CL1914051 Malignant Metastatic Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Metastatic Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Metastatic Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 A term that refers to the staging of childhood non-rhabdomyosarcoma soft tissue sarcoma according to the tier 2 Toronto childhood cancer staging guidelines v2. C198164 Neoplastic Process Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage, Tier 2 CL1914048 Malignant Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage, Tier 2 Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage, Tier 2 Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage, Tier 2 Any T, N0, M0, G1 or GX. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198165 Neoplastic Process Stage I Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 CL1914049 Malignant Non-rhabdomyosarcoma soft tissue sarcoma Stage I Stage I Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage I Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage I Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 T1, N0, M0, G2 or G3. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198166 Neoplastic Process Stage II Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 CL1914030 Malignant Non-rhabdomyosarcoma soft tissue sarcoma Stage II Stage II Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage II Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage II Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 T2 or T3 or T4, N0, M0, G2 or G3 or Any T, N1, M0, Any G (G1, G2, G3 or GX). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198167 Neoplastic Process Stage III Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 CL1914031 Malignant Non-rhabdomyosarcoma soft tissue sarcoma Stage III Stage III Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage III Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage III Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Any T, Any N, M1, Any G (G1, G2, G3, GX). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198168 Neoplastic Process Stage IV Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 CL1914028 Malignant Non-rhabdomyosarcoma soft tissue sarcoma Stage IV Stage IV Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage IV Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage IV Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 A term that refers to the staging of childhood malignant bone neoplasm according to the Toronto childhood cancer staging guidelines v2. Staging is the same for both tiers (tier 1 and 2). C198170 Neoplastic Process Childhood Malignant Bone Neoplasm by Toronto Guidelines v2 Stage CL1914026 Malignant Childhood Malignant Bone Neoplasm by Toronto Guidelines v2 Stage Pediatric Malignant Bone Neoplasm by Toronto Guidelines v2 Stage Childhood Malignant Bone Neoplasm by Toronto Guidelines v2 Stage Tumor confined to the area of origin including the regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198172 Neoplastic Process Localized Childhood Malignant Bone Neoplasm by Toronto Guidelines v2 CL1914024 Malignant Localized Childhood Malignant Bone Neoplasm by Toronto Guidelines v2 Localized Malignant Bone Tumor Localized Pediatric Malignant Bone Neoplasm by Toronto Guidelines v2 Malignant bone tumor Localized Localized Childhood Malignant Bone Neoplasm by Toronto Guidelines v2 Distant metastases present. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198173 Neoplastic Process Metastatic Childhood Malignant Bone Neoplasm by Toronto Guidelines v2 CL1914025 Malignant Malignant bone tumor Metastatic Metastatic Childhood Malignant Bone Neoplasm by Toronto Guidelines v2 Metastatic Pediatric Malignant Bone Neoplasm by Toronto Guidelines v2 Metastatic malignant bone tumor Metastatic Childhood Malignant Bone Neoplasm by Toronto Guidelines v2 A term that refers to the staging of childhood retinoblastoma according to the Toronto childhood cancer staging guidelines v2. C198174 Neoplastic Process Childhood Retinoblastoma by Toronto Guidelines v2 Stage CL1914038 Malignant Childhood Retinoblastoma by Toronto Guidelines v2 Stage Pediatric Retinoblastoma by Toronto Guidelines v2 Stage Childhood Retinoblastoma by Toronto Guidelines v2 Stage A term that refers to the staging of childhood retinoblastoma according to the tier 1 Toronto childhood cancer staging guidelines v2. C198175 Neoplastic Process Childhood Retinoblastoma by Toronto Guidelines v2 Stage, Tier 1 CL1914039 Malignant Childhood Retinoblastoma by Toronto Guidelines v2 Stage, Tier 1 Pediatric Retinoblastoma by Toronto Guidelines v2 Stage, Tier 1 Childhood Retinoblastoma by Toronto Guidelines v2 Stage, Tier 1 Intraocular tumor. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198176 Neoplastic Process Localized Childhood Retinoblastoma by Toronto Guidelines v2 CL1914036 Malignant Localized Childhood Retinoblastoma by Toronto Guidelines v2 Localized Pediatric Retinoblastoma by Toronto Guidelines v2 Localized Childhood Retinoblastoma by Toronto Guidelines v2 Orbital extension or regional lymph nodes involvement. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198177 Neoplastic Process Regional Childhood Retinoblastoma by Toronto Guidelines v2 CL1914037 Malignant Regional Childhood Retinoblastoma by Toronto Guidelines v2 Regional Pediatric Retinoblastoma by Toronto Guidelines v2 Regional Childhood Retinoblastoma by Toronto Guidelines v2 Distant metastases present. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198178 Neoplastic Process Metastatic Childhood Retinoblastoma by Toronto Guidelines v2 CL1914034 Malignant Metastatic Childhood Retinoblastoma by Toronto Guidelines v2 Metastatic Pediatric Retinoblastoma by Toronto Guidelines v2 Metastatic Childhood Retinoblastoma by Toronto Guidelines v2 A term that refers to the staging of childhood retinoblastoma according to the tier 2 Toronto childhood cancer staging guidelines v2. C198179 Neoplastic Process Childhood Retinoblastoma by Toronto Guidelines v2 Stage, Tier 2 CL1914035 Malignant Childhood Retinoblastoma by Toronto Guidelines v2 Stage, Tier 2 Pediatric Retinoblastoma by Toronto Guidelines v2 Stage, Tier 2 Childhood Retinoblastoma by Toronto Guidelines v2 Stage, Tier 2 The tumor is confined to the globe. Enucleation has not been performed. (The patient is treated "conservatively" with either focal therapies or chemotherapy.) (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198180 Neoplastic Process Stage 0 Childhood Retinoblastoma by Toronto Guidelines v2 CL1914032 Malignant Retinoblastoma Stage 0 Stage 0 Childhood Retinoblastoma by Toronto Guidelines v2 Stage 0 Pediatric Retinoblastoma by Toronto Guidelines v2 Stage 0 Retinoblastoma Stage 0 Childhood Retinoblastoma by Toronto Guidelines v2 Enucleation with negative margins. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198181 Neoplastic Process Stage I Childhood Retinoblastoma by Toronto Guidelines v2 CL1914033 Malignant Retinoblastoma Stage I Stage I Childhood Retinoblastoma by Toronto Guidelines v2 Stage I Pediatric Retinoblastoma by Toronto Guidelines v2 Stage I Retinoblastoma Stage I Childhood Retinoblastoma by Toronto Guidelines v2 Enucleation with microscopic residual disease. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198182 Neoplastic Process Stage II Childhood Retinoblastoma by Toronto Guidelines v2 CL1914014 Malignant Retinoblastoma Stage II Stage II Childhood Retinoblastoma by Toronto Guidelines v2 Stage II Pediatric Retinoblastoma by Toronto Guidelines v2 Stage II Retinoblastoma Stage II Childhood Retinoblastoma by Toronto Guidelines v2 Regional extension: involvement of the orbit and/or preauricular or cervical lymph node extension. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198183 Neoplastic Process Stage III Childhood Retinoblastoma by Toronto Guidelines v2 CL1914015 Malignant Retinoblastoma Stage III Stage III Childhood Retinoblastoma by Toronto Guidelines v2 Stage III Pediatric Retinoblastoma by Toronto Guidelines v2 Stage III Retinoblastoma Stage III Childhood Retinoblastoma by Toronto Guidelines v2 Distant metastatic disease. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198185 Neoplastic Process Stage IV Childhood Retinoblastoma by Toronto Guidelines v2 CL1914012 Malignant Retinoblastoma Stage IV Stage IV Childhood Retinoblastoma by Toronto Guidelines v2 Stage IV Pediatric Retinoblastoma by Toronto Guidelines v2 Stage IV Retinoblastoma Stage IV Childhood Retinoblastoma by Toronto Guidelines v2 A term that refers to the staging of childhood hepatoblastoma according to the Toronto childhood cancer staging guidelines v2. C198186 Neoplastic Process Childhood Hepatoblastoma by Toronto Guidelines v2 Stage CL1914013 Malignant Childhood Hepatoblastoma by Toronto Guidelines v2 Stage Pediatric Hepatoblastoma by Toronto Guidelines v2 Stage Childhood Hepatoblastoma by Toronto Guidelines v2 Stage A term that refers to the staging of childhood hepatoblastoma according to the tier 1 Toronto childhood cancer staging guidelines v2. C198187 Neoplastic Process Childhood Hepatoblastoma by Toronto Guidelines v2 Stage, Tier 1 CL1914010 Malignant Childhood Hepatoblastoma by Toronto Guidelines v2 Stage, Tier 1 Pediatric Hepatoblastoma by Toronto Guidelines v2 Stage, Tier 1 Childhood Hepatoblastoma by Toronto Guidelines v2 Stage, Tier 1 Tumor confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198188 Neoplastic Process Localized Childhood Hepatoblastoma by Toronto Guidelines v2, Tier1 CL1914011 Malignant Localized Childhood Hepatoblastoma by Toronto Guidelines v2, Tier1 Localized Pediatric Hepatoblastoma by Toronto Guidelines v2, Tier1 Localized Childhood Hepatoblastoma by Toronto Guidelines v2, Tier1 Distant metastases present. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198189 Neoplastic Process Metastatic Childhood Hepatoblastoma by Toronto Guidelines v2, Tier 1 CL1914008 Malignant Metastatic Childhood Hepatoblastoma by Toronto Guidelines v2, Tier 1 Metastatic Pediatric Hepatoblastoma by Toronto Guidelines v2, Tier 1 Metastatic Childhood Hepatoblastoma by Toronto Guidelines v2, Tier 1 A term that refers to the staging of childhood hepatoblastoma according to the tier 2 Toronto childhood cancer staging guidelines v2. It includes localized tumors, metastatic tumors, and the PRETEXT system. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198190 Neoplastic Process Childhood Hepatoblastoma by Toronto Guidelines v2 Stage, Tier 2 CL1914009 Malignant Childhood Hepatoblastoma by Toronto Guidelines v2 Stage, Tier 2 Pediatric Hepatoblastoma by Toronto Guidelines v2 Stage, Tier 2 Childhood Hepatoblastoma by Toronto Guidelines v2 Stage, Tier 2 Tumor confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198191 Neoplastic Process Localized Childhood Hepatoblastoma by Toronto Guidelines v2, Tier 2 CL1914022 Malignant Localized Childhood Hepatoblastoma by Toronto Guidelines v2, Tier 2 Localized Pediatric Hepatoblastoma by Toronto Guidelines v2, Tier 2 Localized Childhood Hepatoblastoma by Toronto Guidelines v2, Tier 2 Distant metastases present. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198192 Neoplastic Process Metastatic Childhood Hepatoblastoma by Toronto Guidelines v2, Tier 2 CL1914023 Malignant Metastatic Childhood Hepatoblastoma by Toronto Guidelines v2, Tier 2 Metastatic Pediatric Hepatoblastoma by Toronto Guidelines v2, Tier 2 Metastatic Childhood Hepatoblastoma by Toronto Guidelines v2, Tier 2 The integument that covers the area above the eyebrow. C198298 Anatomical Structure Skin Above the Eyebrow CL1913919 CDISC The integument that covers the area above the eyebrow. SKIN ABOVE THE EYEBROW Skin Above the Eyebrow Skin Above the Eyebrow The integument that covers the outer corner of the eye were the upper and lower eyelids meet. C198299 Anatomical Structure Skin of the Outer Canthus of the Eye CL1913920 CDISC The integument that covers the outer corner of the eye were the upper and lower eyelids meet. SKIN OF THE OUTER CANTHUS OF THE EYE Skin of the Outer Canthus of the Eye Skin of the Outer Canthus of the Eye The integument that covers the area directly below the eye. C198300 Anatomical Structure Skin Under the Eye CL1913918 CDISC The integument that covers the area directly below the eye. SKIN UNDER THE EYE Skin Under the Eye Skin of the Tear Trough Skin Under the Eye A term that refers to the staging of childhood testicular germ cell tumor according to the Toronto childhood cancer staging guidelines v2. C198413 Neoplastic Process Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage CL1914179 Malignant Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage Pediatric Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage A term that refers to the staging of childhood testicular germ cell tumor according to the tier 1 Toronto childhood cancer staging guidelines v2. C198414 Neoplastic Process Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage, Tier 1 CL1914176 Malignant Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage, Tier 1 Pediatric Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage, Tier 1 Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage, Tier 1 Tumor confined to the testes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198415 Neoplastic Process Localized Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 CL1914177 Malignant Localized Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Localized Pediatric Testicular Germ Cell Tumor by Toronto Guidelines v2 Localized Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Tumor extension to regional lymph nodes: interaortocaval, para-aortic (periaortic), paracaval, preaortic, precaval, retroaortic, retrocaval, and along spermatic cord. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198416 Neoplastic Process Regional Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 CL1914174 Malignant Regional Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Regional Pediatric Testicular Germ Cell Tumor by Toronto Guidelines v2 Regional Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Distant metastases present. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198417 Neoplastic Process Metastatic Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 CL1914175 Malignant Metastatic Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Metastatic Pediatric Testicular Germ Cell Tumor by Toronto Guidelines v2 Metastatic Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 A term that refers to the staging of childhood testicular germ cell tumor according to the tier 2 Toronto childhood cancer staging guidelines v2. C198418 Neoplastic Process Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage, Tier 2 CL1914188 Malignant Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage, Tier 2 Pediatric Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage, Tier 2 Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage, Tier 2 pT1-4, N0, M0, SX. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198419 Neoplastic Process Stage I Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 CL1914189 Malignant Stage I Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage I Pediatric Testicular Germ Cell Tumor by Toronto Guidelines v2 Testicular germ cell tumor Stage I Stage I Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 pT1, N0, M0, S0. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198420 Neoplastic Process Stage IA Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 CL1914186 Malignant Stage IA Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage IA Pediatric Testicular Germ Cell Tumor by Toronto Guidelines v2 Testicular germ cell tumor Stage IA Stage IA Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 pT2-4, N0, M0, S0. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198421 Neoplastic Process Stage IB Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 CL1914187 Malignant Stage IB Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage IB Pediatric Testicular Germ Cell Tumor by Toronto Guidelines v2 Testicular germ cell tumor Stage IB Stage IB Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Any pT, N0, M0, S1-3. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198423 Neoplastic Process Stage IS Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 CL1914184 Malignant Stage IS Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage IS Pediatric Testicular Germ Cell Tumor by Toronto Guidelines v2 Testicular germ cell tumor Stage IS Stage IS Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Any pT, N1-3, M0, SX. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198424 Neoplastic Process Stage II Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 CL1914185 Malignant Stage II Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage II Pediatric Testicular Germ Cell Tumor by Toronto Guidelines v2 Testicular germ cell tumor Stage II Stage II Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Any pT, N1, M0, S0, S1. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198425 Neoplastic Process Stage IIA Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 CL1914182 Malignant Stage IIA Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage IIA Pediatric Testicular Germ Cell Tumor by Toronto Guidelines v2 Testicular germ cell tumor Stage IIA Stage IIA Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Any pT, N2, M0, S0, S1. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198426 Neoplastic Process Stage IIB Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 CL1914183 Malignant Stage IIB Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage IIB Pediatric Testicular Germ Cell Tumor by Toronto Guidelines v2 Testicular germ cell tumor Stage IIB Stage IIB Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Any pT, N3, M0, S0, S1. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198427 Neoplastic Process Stage IIC Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 CL1914164 Malignant Stage IIC Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage IIC Pediatric Testicular Germ Cell Tumor by Toronto Guidelines v2 Testicular germ cell tumor Stage IIC Stage IIC Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Any pT, Any N, M1, SX. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198428 Neoplastic Process Stage III Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 CL1914165 Malignant Stage III Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage III Pediatric Testicular Germ Cell Tumor by Toronto Guidelines v2 Testicular germ cell tumor Stage III Stage III Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Any pT, Any N, M1, S0, S1. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198429 Neoplastic Process Stage IIIA Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 CL1914162 Malignant Stage IIIA Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage IIIA Pediatric Testicular Germ Cell Tumor by Toronto Guidelines v2 Testicular germ cell tumor Stage IIIA Stage IIIA Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Any pT, N1-N3, M0, S2 or Any pT, Any N, M1, S2. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198430 Neoplastic Process Stage IIIB Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 CL1914163 Malignant Stage IIIB Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage IIIB Pediatric Testicular Germ Cell Tumor by Toronto Guidelines v2 Testicular germ cell tumor Stage IIIB Stage IIIB Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Any pT, N1-N3, M0, S3 or Any pT, Any N, M1, S3. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198432 Neoplastic Process Stage IIIC Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 CL1914161 Malignant Stage IIIC Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage IIIC Pediatric Testicular Germ Cell Tumor by Toronto Guidelines v2 Testicular germ cell tumor Stage IIIC Stage IIIC Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 A term that refers to the staging of childhood ovarian germ cell tumor according to the Toronto childhood cancer staging guidelines v2. C198434 Neoplastic Process Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage CL1914159 Malignant Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage Pediatric Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage A term that refers to the staging of childhood ovarian germ cell tumor according to the tier 1 Toronto childhood cancer staging guidelines v2. C198436 Neoplastic Process Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage, Tier 1 CL1914173 Malignant Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage, Tier 1 Pediatric Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage, Tier 1 Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage, Tier 1 Tumor confined to ovaries. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198437 Neoplastic Process Localized Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 CL1914170 Malignant Localized Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Localized Pediatric Ovarian Germ Cell Tumor by Toronto Guidelines v2 Localized Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Tumor involves one or both ovaries with pelvic extension and/or spread to the peritoneum outside the pelvis and/or retroperitoneal lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198439 Neoplastic Process Regional Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 CL1914168 Malignant Regional Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Regional Pediatric Ovarian Germ Cell Tumor by Toronto Guidelines v2 Regional Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Distant metastatic disease excluding peritoneal metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198441 Neoplastic Process Metastatic Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 CL1914166 Malignant Metastatic Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Metastatic Pediatric Ovarian Germ Cell Tumor by Toronto Guidelines v2 Metastatic Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 A malignant germ cell tumor that arises from the ovary and has spread to another anatomic site. C198444 Neoplastic Process Metastatic Malignant Ovarian Germ Cell Tumor CL1914149 Malignant Metastatic Malignant Ovarian Germ Cell Tumor Metastatic Malignant Ovarian Germ Cell Tumor A term that refers to the staging of childhood ovarian germ cell tumor according to the tier 2 Toronto childhood cancer staging guidelines v2. C198445 Neoplastic Process Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage, Tier 2 CL1914146 Malignant Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage, Tier 2 Pediatric Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage, Tier 2 Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage, Tier 2 Tumor confined to ovaries (one or both). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198446 Neoplastic Process Stage I Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 CL1914147 Malignant Ovarian germ cell tumor Stage I Stage I Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage I Pediatric Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage I Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Tumor involves one or both ovaries with pelvic extension (below the pelvic brim). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198447 Neoplastic Process Stage II Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 CL1914144 Malignant Ovarian germ cell tumor Stage II Stage II Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage II Pediatric Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage II Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Tumor involves one or both ovaries with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198448 Neoplastic Process Stage III Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 CL1914145 Malignant Ovarian germ cell tumor Stage III Stage III Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage III Pediatric Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage III Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Distant metastasis (excludes peritoneal metastases). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198449 Neoplastic Process Stage IV Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 CL1914142 Malignant Ovarian germ cell tumor Stage IV Stage IV Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage IV Pediatric Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage IV Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 A term that refers to the staging of childhood astrocytoma according to the Toronto childhood cancer staging guidelines v2. This staging system is the same for both tiers (tier 1 and 2). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198450 Neoplastic Process Childhood Astrocytoma by Toronto Guidelines v2 Stage CL1914143 Malignant Childhood Astrocytoma by Toronto Guidelines v2 Stage Pediatric Astrocytoma by Toronto Guidelines v2 Stage Childhood Astrocytoma by Toronto Guidelines v2 Stage Localized disease. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198451 Neoplastic Process Localized Childhood Astrocytoma by Toronto Guidelines v2 CL1914156 Malignant Astrocytomas Localized Localized Childhood Astrocytoma by Toronto Guidelines v2 Localized Pediatric Astrocytoma by Toronto Guidelines v2 Localized Childhood Astrocytoma by Toronto Guidelines v2 Distant metastases present. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198452 Neoplastic Process Metastatic Childhood Astrocytoma by Toronto Guidelines v2 CL1914157 Malignant Astrocytomas Metastatic Metastatic Childhood Astrocytoma by Toronto Guidelines v2 Metastatic Pediatric Astrocytoma by Toronto Guidelines v2 Metastatic Childhood Astrocytoma by Toronto Guidelines v2 A term that refers to the staging of childhood central nervous system embryonal tumor according to the Toronto childhood cancer staging guidelines v2. C198453 Neoplastic Process Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage CL1914154 Malignant Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage Pediatric Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage A term that refers to the staging of childhood central nervous system embryonal tumor according to the tier 1 Toronto childhood cancer staging guidelines v2. C198455 Neoplastic Process Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage, Tier 1 CL1914155 Malignant Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage, Tier 1 Pediatric Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage, Tier 1 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage, Tier 1 Localized disease. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198457 Neoplastic Process Localized Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 CL1914153 Malignant Localized Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Localized Pediatric Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Localized Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Disease beyond local site (e.g., other lesions in brain or spine or tumor cells in CSF or distant metastases). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198459 Neoplastic Process Metastatic Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 CL1914151 Malignant Metastatic Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Metastatic Pediatric Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Metastatic Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 A term that refers to the staging of childhood central nervous system embryonal tumor according to the tier 2 Toronto childhood cancer staging guidelines v2. C198460 Neoplastic Process Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage, Tier 2 CL1914133 Malignant Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage, Tier 2 Pediatric Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage, Tier 2 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage, Tier 2 No visible disease on imaging (MRI brain and spine) beyond primary site of disease and no tumor cells in the CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198461 Neoplastic Process Stage M0 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 CL1914134 Malignant M0 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 M0 Pediatric Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage M0 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage M0 Pediatric Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage M0 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Tumor cells in the CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198462 Neoplastic Process Stage M1 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 CL1914131 Malignant M1 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 M1 Pediatric Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage M1 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage M1 Pediatric Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage M1 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Visible metastasis in brain. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198471 Neoplastic Process Stage M2 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 CL1914140 Malignant M2 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 M2 Pediatric Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage M2 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage M2 Pediatric Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage M2 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Visible metastasis in spine or visible metastasis in cervicomedullary junction. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198472 Neoplastic Process Stage M3 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 CL1914137 Malignant M3 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 M3 Pediatric Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage M3 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage M3 Pediatric Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage M3 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Metastasis outside of the central nervous system. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198473 Neoplastic Process Stage M4 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 CL1914138 Malignant M4 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 M4 Pediatric Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage M4 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage M4 Pediatric Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage M4 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 A term that refers to the staging of childhood medulloblastoma according to the Toronto childhood cancer staging guidelines v2. C198474 Neoplastic Process Childhood Medulloblastoma by Toronto Guidelines v2 Stage CL1914135 Malignant Childhood Medulloblastoma by Toronto Guidelines v2 Stage Pediatric Medulloblastoma by Toronto Guidelines v2 Stage Childhood Medulloblastoma by Toronto Guidelines v2 Stage A term that refers to the staging of childhood medulloblastoma according to the tier 1 Toronto childhood cancer staging guidelines v2. C198475 Neoplastic Process Childhood Medulloblastoma by Toronto Guidelines v2 Stage, Tier 1 CL1914136 Malignant Childhood Medulloblastoma by Toronto Guidelines v2 Stage, Tier 1 Pediatric Medulloblastoma by Toronto Guidelines v2 Stage, Tier 1 Childhood Medulloblastoma by Toronto Guidelines v2 Stage, Tier 1 Localized disease. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198476 Neoplastic Process Localized Childhood Medulloblastoma by Toronto Guidelines v2 CL1914117 Malignant Localized Childhood Medulloblastoma by Toronto Guidelines v2 Localized Pediatric Medulloblastoma by Toronto Guidelines v2 Localized Childhood Medulloblastoma by Toronto Guidelines v2 Disease beyond local site (e.g., other lesions in brain or spine or tumor cells in CSF or distant metastases). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198477 Neoplastic Process Metastatic Childhood Medulloblastoma by Toronto Guidelines v2 CL1914118 Malignant Metastatic Childhood Medulloblastoma by Toronto Guidelines v2 Metastatic Pediatric Medulloblastoma by Toronto Guidelines v2 Metastatic Childhood Medulloblastoma by Toronto Guidelines v2 A term that refers to the staging of childhood medulloblastoma according to the tier 2 Toronto childhood cancer staging guidelines v2. C198478 Neoplastic Process Childhood Medulloblastoma by Toronto Guidelines v2 Stage, Tier 2 CL1914115 Malignant Childhood Medulloblastoma by Toronto Guidelines v2 Stage, Tier 2 Pediatric Medulloblastoma by Toronto Guidelines v2 Stage, Tier 2 Childhood Medulloblastoma by Toronto Guidelines v2 Stage, Tier 2 No visible disease on imaging (MRI brain and spine) beyond primary site of disease and no tumor cells in the CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198479 Neoplastic Process Stage M0 Childhood Medulloblastoma by Toronto Guidelines v2 CL1914116 Malignant M0 Childhood Medulloblastoma by Toronto Guidelines v2 M0 Pediatric Medulloblastoma by Toronto Guidelines v2 Medulloblastoma M0 Stage M0 Childhood Medulloblastoma by Toronto Guidelines v2 Stage M0 Pediatric Medulloblastoma by Toronto Guidelines v2 Stage M0 Childhood Medulloblastoma by Toronto Guidelines v2 Tumor cells in the CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198480 Neoplastic Process Stage M1 Childhood Medulloblastoma by Toronto Guidelines v2 CL1914113 Malignant M1 Childhood Medulloblastoma by Toronto Guidelines v2 M1 Pediatric Medulloblastoma by Toronto Guidelines v2 Medulloblastoma M1 Stage M1 Childhood Medulloblastoma by Toronto Guidelines v2 Stage M1 Pediatric Medulloblastoma by Toronto Guidelines v2 Stage M1 Childhood Medulloblastoma by Toronto Guidelines v2 Visible metastasis in brain. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198481 Neoplastic Process Stage M2 Childhood Medulloblastoma by Toronto Guidelines v2 CL1914114 Malignant M2 Childhood Medulloblastoma by Toronto Guidelines v2 M2 Pediatric Medulloblastoma by Toronto Guidelines v2 Medulloblastoma M2 Stage M2 Childhood Medulloblastoma by Toronto Guidelines v2 Stage M2 Pediatric Medulloblastoma by Toronto Guidelines v2 Stage M2 Childhood Medulloblastoma by Toronto Guidelines v2 Visible metastasis in spine or visible metastasis in cervicomedullary junction. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198482 Neoplastic Process Stage M3 Childhood Medulloblastoma by Toronto Guidelines v2 CL1914111 Malignant M3 Childhood Medulloblastoma by Toronto Guidelines v2 M3 Pediatric Medulloblastoma by Toronto Guidelines v2 Medulloblastoma M3 Stage M3 Childhood Medulloblastoma by Toronto Guidelines v2 Stage M3 Pediatric Medulloblastoma by Toronto Guidelines v2 Stage M3 Childhood Medulloblastoma by Toronto Guidelines v2 Metastasis outside of the central nervous system. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198483 Neoplastic Process Stage M4 Childhood Medulloblastoma by Toronto Guidelines v2 CL1914112 Malignant M4 Childhood Medulloblastoma by Toronto Guidelines v2 M4 Pediatric Medulloblastoma by Toronto Guidelines v2 Medulloblastoma M4 Stage M4 Childhood Medulloblastoma by Toronto Guidelines v2 Stage M4 Pediatric Medulloblastoma by Toronto Guidelines v2 Stage M4 Childhood Medulloblastoma by Toronto Guidelines v2 A term that refers to the staging of childhood ependymoma according to the Toronto childhood cancer staging guidelines v2. C198484 Neoplastic Process Childhood Ependymoma by Toronto Guidelines v2 Stage CL1914125 Malignant Childhood Ependymoma by Toronto Guidelines v2 Stage Pediatric Ependymoma by Toronto Guidelines v2 Stage Childhood Ependymoma by Toronto Guidelines v2 Stage A term that refers to the staging of childhood ependymoma according to the tier 1 Toronto childhood cancer staging guidelines v2. C198485 Neoplastic Process Childhood Ependymoma by Toronto Guidelines v2 Stage, Tier 1 CL1914126 Malignant Childhood Ependymoma by Toronto Guidelines v2 Stage, Tier 1 Pediatric Ependymoma by Toronto Guidelines v2 Stage, Tier 1 Childhood Ependymoma by Toronto Guidelines v2 Stage, Tier 1 Localized disease. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198486 Neoplastic Process Localized Childhood Ependymoma by Toronto Guidelines v2 CL1914123 Malignant Localized Childhood Ependymoma by Toronto Guidelines v2 Localized Pediatric Ependymoma by Toronto Guidelines v2 Localized Childhood Ependymoma by Toronto Guidelines v2 Disease beyond local site (e.g., other lesions in brain or spine or tumor cells in CSF or distant metastases). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198487 Neoplastic Process Metastatic Childhood Ependymoma by Toronto Guidelines v2 CL1914124 Malignant Metastatic Childhood Ependymoma by Toronto Guidelines v2 Metastatic Pediatric Ependymoma by Toronto Guidelines v2 Metastatic Childhood Ependymoma by Toronto Guidelines v2 A term that refers to the staging of childhood ependymoma according to the tier 2 Toronto childhood cancer staging guidelines v2. C198488 Neoplastic Process Childhood Ependymoma by Toronto Guidelines v2 Stage, Tier 2 CL1914121 Malignant Childhood Ependymoma by Toronto Guidelines v2 Stage, Tier 2 Pediatric Ependymoma by Toronto Guidelines v2 Stage, Tier 2 Childhood Ependymoma by Toronto Guidelines v2 Stage, Tier 2 No visible disease on imaging (MRI brain and spine) beyond primary site of disease and no tumor cells in the CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198489 Neoplastic Process Stage M0 Childhood Ependymoma by Toronto Guidelines v2 CL1914122 Malignant Ependymoma M0 M0 Childhood Ependymoma by Toronto Guidelines v2 M0 Pediatric Ependymoma by Toronto Guidelines v2 Stage M0 Childhood Ependymoma by Toronto Guidelines v2 Stage M0 Pediatric Ependymoma by Toronto Guidelines v2 Stage M0 Childhood Ependymoma by Toronto Guidelines v2 Tumor cells in the CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198490 Neoplastic Process Stage M1 Childhood Ependymoma by Toronto Guidelines v2 CL1914119 Malignant Ependymoma M1 M1 Childhood Ependymoma by Toronto Guidelines v2 M1 Pediatric Ependymoma by Toronto Guidelines v2 Stage M1 Childhood Ependymoma by Toronto Guidelines v2 Stage M1 Pediatric Ependymoma by Toronto Guidelines v2 Stage M1 Childhood Ependymoma by Toronto Guidelines v2 Visible metastasis in brain. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198491 Neoplastic Process Stage M2 Childhood Ependymoma by Toronto Guidelines v2 CL1914120 Malignant Ependymoma M2 M2 Childhood Ependymoma by Toronto Guidelines v2 M2 Pediatric Ependymoma by Toronto Guidelines v2 Stage M2 Childhood Ependymoma by Toronto Guidelines v2 Stage M2 Pediatric Ependymoma by Toronto Guidelines v2 Stage M2 Childhood Ependymoma by Toronto Guidelines v2 Visible metastasis in spine or visible metastasis in cervicomedullary junction. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198492 Neoplastic Process Stage M3 Childhood Ependymoma by Toronto Guidelines v2 CL1914101 Malignant Ependymoma M3 M3 Childhood Ependymoma by Toronto Guidelines v2 M3 Pediatric Ependymoma by Toronto Guidelines v2 Stage M3 Childhood Ependymoma by Toronto Guidelines v2 Stage M3 Pediatric Ependymoma by Toronto Guidelines v2 Stage M3 Childhood Ependymoma by Toronto Guidelines v2 Metastasis outside of the central nervous system. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.) C198493 Neoplastic Process Stage M4 Childhood Ependymoma by Toronto Guidelines v2 CL1914102 Malignant Ependymoma M4 M4 Childhood Ependymoma by Toronto Guidelines v2 M4 Pediatric Ependymoma by Toronto Guidelines v2 Stage M4 Childhood Ependymoma by Toronto Guidelines v2 Stage M4 Pediatric Ependymoma by Toronto Guidelines v2 Stage M4 Childhood Ependymoma by Toronto Guidelines v2 A neuroblastoma that arises from the brain during childhood. C198500 Neoplastic Process Childhood Brain Neuroblastoma CL1914109 Malignant Childhood Brain Neuroblastoma Childhood Brain Neuroblastoma A ganglioneuroblastoma that arises from the brain and occurs during childhood. C198501 Neoplastic Process Childhood Brain Ganglioneuroblastoma CL1914110 Malignant Childhood Brain Ganglioneuroblastoma Childhood Brain Ganglioneuroblastoma A myeloproliferative neoplasm characterized by the absence of Philadelphia chromosome and BCR-ABL1 fusion gene expression. This group includes polycythemia vera, essential thrombocythemia, and primary myelofibrosis. C198555 Neoplastic Process Myeloproliferative Neoplasm, BCR-ABL1 Negative CL1905747 Malignant BCR-ABL1 Negative Myeloproliferative Neoplasm BCR::ABL1 Negative Myeloproliferative Neoplasm Myeloproliferative Neoplasm, BCR-ABL1 Negative Myeloproliferative Neoplasm, BCR::ABL1 Negative Myeloproliferative Neoplasm, BCR-ABL1 Negative Hematologic neoplasms characterized by the rearrangement of the FLT3 gene, most often resulting in the formation of t(12;13)(p13.2;q12.2)/ETV6-FLT3 fusion transcripts. Patients usually present with T-ALL or myeloid sarcoma. C198559 Neoplastic Process Myeloid/Lymphoid Neoplasms with FLT3 Rearrangement CL1905748 Malignant M/LN-eo with FLT3 Rearrangement Myeloid/Lymphoid Neoplasm with FLT3 Rearrangement Myeloid/Lymphoid Neoplasms with FLT3 Rearrangement Myeloid/Lymphoid Neoplasms with FLT3 Rearrangement Hematologic neoplasms characterized by t(9;12)(q34.1;p13.2) that results in ETV6-ABL1 gene fusion. They have clinicopathological features of chronic myeloid leukemia with frequent eosinophilia. C198565 Neoplastic Process Myeloid/Lymphoid Neoplasms with ETV6-ABL1 CL1905754 Malignant M/LN-eo with t(9;12)(q34.1;p13.2)/ETV6-ABL1 M/LN-eo with t(9;12)(q34.1;p13.2)/ETV6::ABL1 Myeloid/Lymphoid Neoplasm with ETV6-ABL1 Myeloid/Lymphoid Neoplasm with ETV6::ABL1 Myeloid/Lymphoid Neoplasms with (9;12)(q34.1;p13.2)/ETV6-ABL1 Myeloid/Lymphoid Neoplasms with (9;12)(q34.1;p13.2)/ETV6::ABL1 Myeloid/Lymphoid Neoplasms with ETV6-ABL1 Myeloid/Lymphoid Neoplasms with ETV6::ABL1 Myeloid/Lymphoid Neoplasms with ETV6-ABL1 A variant of indolent systemic mastocytosis that affects predominantly older males. It is characterized by a limited degree of bone marrow infiltration by clonal mast cells and an absence of skin involvement. The serum tryptase levels are normal or slightly elevated. C198573 Neoplastic Process Bone Marrow Mastocytosis CL1908723 Undetermined BMM Bone Marrow Mastocytosis Bone Marrow Mastocytosis A myelodysplastic/myeloproliferative neoplasm characterized by the presence of persistent monocytosis, presence of at least one myeloid neoplasm-associated mutation, absence of significant dysplasia or increased blasts in the bone marrow, absence of morphologic findings suggestive of chronic myelomonocytic leukemia in the bone marrow, and absence of history of a reactive condition that would explain the persistent monocytosis. C198580 Neoplastic Process Clonal Monocytosis of Undetermined Significance CL1905758 Malignant CMUS Clonal Monocytosis of Undetermined Significance Clonal Monocytosis of Undetermined Significance A myelodysplastic/myeloproliferative neoplasm characterized by thrombocytosis, anemia, blasts less than 5% in bone marrow and less than 1% in peripheral blood, presence of SF3B1 gene mutation, absence of BCR/ABL fusion, absence of genetic abnormalities associated with myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions, and no history of other myelodysplastic/myeloproliferative neoplasms or myeloproliferative neoplasms and myelodysplastic syndromes. C198581 Neoplastic Process Myelodysplastic/Myeloproliferative Neoplasm with SF3B1 Mutation and Thrombocytosis CL1905764 Malignant MDS/MPN-T-SF3B1 Myelodysplastic/Myeloproliferative Neoplasm with SF3B1 Mutation and Thrombocytosis Myelodysplastic/Myeloproliferative Neoplasm with SF3B1 Mutation and Thrombocytosis A myelodysplastic/myeloproliferative neoplasm that fulfills the diagnostic criteria of clonal monocytosis of undetermined significance and is associated with cytopenia. C198582 Neoplastic Process Clonal Cytopenia with Monocytosis of Undetermined Significance CL1905763 Malignant CCMUS Clonal Cytopenia with Monocytosis of Undetermined Significance Clonal Cytopenia with Monocytosis of Undetermined Significance A new provisional entity under the umbrella of myelodysplastic/myeloproliferative neoplasms, not otherwise specified. It is characterized by the presence of isochromosome 17q. The clinical course is aggressive. C198583 Neoplastic Process Myelodysplastic/Myeloproliferative Neoplasm with Isolated Isochromosome 17q CL1905766 Provisional_Concept Malignant MDS/MPN with i(17q) Myelodysplastic/Myeloproliferative Neoplasm with Isolated Isochromosome 17q Myelodysplastic/Myeloproliferative Neoplasm with i(17q) Myelodysplastic/Myeloproliferative Neoplasm with Isolated Isochromosome 17q Myelodysplastic syndrome characterized by mutation of SF3B1 gene. There is bone marrow dysplasia typically in one or more hematopoietic cell lineages. There are less than 5% blasts in bone marrow and less than 2% blasts in peripheral blood. C198587 Neoplastic Process Myelodysplastic Syndrome with Mutated SF3B1 CL1907914 Malignant MDS-SF3B1 Myelodysplastic Neoplasm with Low Blasts and SF3B1 Mutation Myelodysplastic Syndrome with Mutated SF3B1 Myelodysplastic Syndrome with Ringed Sideroblasts Myelodysplastic Syndrome with Mutated SF3B1 Myelodysplastic syndrome with low blasts characterized by the absence of defining genetic abnormalities. C198589 Neoplastic Process Myelodysplastic Syndrome, Not Otherwise Specified CL1905772 GDC mCode 9989/3 Malignant 9989/3 Myelodysplastic syndrome, NOS MDS, NOS Myelodysplastic Syndrome with Low Blasts, Not Otherwise Specified Myelodysplastic Syndrome with Ringed Sideroblasts Myelodysplastic Syndrome, NOS Myelodysplastic Syndrome, Not Otherwise Specified Myelodysplastic syndrome, NOS Myelodysplastic syndrome, unspecified Myelodysplastic Syndrome, Not Otherwise Specified Myeloid neoplasm characterized by the presence of TP53 gene mutations. This category includes myelodysplastic syndrome, myelodysplastic syndrome/acute myeloid leukemia, and acute myeloid leukemia with mutated TP53. C198593 Neoplastic Process Myeloid Neoplasm with Mutated TP53 CL1905768 Malignant Myeloid Neoplasm with Mutated TP53 Myeloid Neoplasm with Mutated TP53 Myelodysplastic syndrome characterized by the presence of TP53 gene mutations. C198594 Neoplastic Process Myelodysplastic Syndrome with Mutated TP53 CL1905767 Malignant MDS with Mutated TP53 Myelodysplastic Syndrome with Mutated TP53 Myelodysplastic Syndrome with Mutated TP53 Myelodysplastic syndrome/acute myeloid leukemia characterized by the presence of TP53 gene mutations. There are 10%-19% blasts in bone marrow or peripheral blood. C198595 Neoplastic Process Myelodysplastic Syndrome/Acute Myeloid Leukemia with Mutated TP53 CL1905770 Malignant MDS/AML with Mutated TP53 Myelodysplastic Syndrome/Acute Myeloid Leukemia with Mutated TP53 Myelodysplastic Syndrome/Acute Myeloid Leukemia with Mutated TP53 Acute myeloid leukemia characterized by the presence of TP53 gene mutations. There are 20% or more blasts in bone marrow or peripheral blood. C198596 Neoplastic Process Acute Myeloid Leukemia with Mutated TP53 CL1905769 Malignant AML with Mutated TP53 Acute Myeloid Leukemia with Mutated TP53 Acute Myeloid Leukemia with Mutated TP53 Myelodysplastic syndrome/acute myeloid leukemia in which there is no information on myelodysplasia-related gene mutations and cytogenetic abnormalities. C198597 Neoplastic Process Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified CL932343 Malignant MDS/AML, NOS MDS/AML, Not Otherwise Specified Myelodysplastic Syndrome/Acute Myeloid Leukemia, NOS Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified Esophageal adenocarcinoma that is amenable to surgical resection. C198615 Neoplastic Process Resectable Esophageal Adenocarcinoma Resectable Esophageal Adenocarcinoma CL1905785 CTRP Malignant Resectable Esophageal Adenocarcinoma Resectable Esophageal Adenocarcinoma Ampulla of Vater adenocarcinoma that is amenable to surgical resection. C198616 Neoplastic Process Resectable Ampulla of Vater Adenocarcinoma Resectable Ampulla of Vater Adenocarcinoma CL1905784 CTRP Malignant Resectable Ampulla of Vater Adenocarcinoma Resectable Ampulla of Vater Adenocarcinoma Gallbladder adenocarcinoma that is amenable to surgical resection. C198617 Neoplastic Process Resectable Gallbladder Adenocarcinoma Resectable Gallbladder Adenocarcinoma CL1905780 CTRP Malignant Resectable Gallbladder Adenocarcinoma Resectable Gallbladder Adenocarcinoma A myeloid neoplasm that resembles juvenile myelomonocytic leukemia by clinical and hematologic criteria but lacks mutations of the RAS pathway. Secondary mutations may be present. C198661 Neoplastic Process Juvenile Myelomonocytic Leukemia-Like Neoplasm CL1905813 Malignant JMML-Like Neoplasm Juvenile Myelomonocytic Leukemia-Like Neoplasm Juvenile Myelomonocytic Leukemia-Like Neoplasm A transient myeloproliferative disorder that is associated with Noonan syndrome and occurs in the first year of life. It is associated with germline mutations in PTPN11, KRAS, NRAS, or RIT1 genes. C198662 Neoplastic Process Noonan Syndrome-Associated Myeloproliferative Disorder CL1905824 Undetermined Noonan Syndrome-Associated Myeloproliferative Disorder Noonan Syndrome-Associated Myeloproliferative Disorder A group of myeloid disorders that occur in childhood and/or are associated with germline gene mutations. It includes juvenile myelomonocytic leukemia, juvenile myelomonocytic leukemia-like neoplasm, refractory cytopenia of childhood, Noonan syndrome-associated myeloproliferative disorder, and myeloid neoplasm with germline predisposition. C198663 Neoplastic Process Pediatric and/or Germline Mutation-Associated Myeloid Disorders CL1905823 Undetermined Pediatric and/or Germline Mutation-Associated Myeloid Disorders Pediatric and/or Germline Mutation-Associated Myeloid Disorders A method of using ultrasound for obtaining images of the posterior segment of the eye. C198675 Health Care Activity B-Scan Ocular Ultrasonography CL1905826 B-Scan Ocular USG B-Scan Ocular Ultrasonography B-Scan Ocular Ultrasound B-Scan Ultrasonography Bright Scan Ocular Ultrasonography B-Scan Ocular Ultrasonography The reemergence of mesonephric adenocarcinoma after a period of remission. C198678 Neoplastic Process Recurrent Mesonephric Adenocarcinoma Recurrent Mesonephric Adenocarcinoma CL1905838 CTRP Malignant Recurrent Mesonephric Adenocarcinoma Recurrent Mesonephric Carcinoma Recurrent Mesonephric Adenocarcinoma Juvenile myelomonocytic leukemia that is associated with neurofibromatosis type 1 (NF1). C198680 Neoplastic Process Juvenile Myelomonocytic Leukemia Associated with Neurofibromatosis CL1905840 Malignant JMML Associated with Neurofibromatosis Juvenile Myelomonocytic Leukemia Associated with Neurofibromatosis Juvenile Myelomonocytic Leukemia Associated with Neurofibromatosis Juvenile myelomonocytic leukemia that is associated with a genetic disorder caused by germline mutations in the CBL gene and phenotypically resembles Noonan syndrome (Noonan syndrome-like disorder). C198682 Neoplastic Process Juvenile Myelomonocytic Leukemia Associated with Noonan Syndrome-Like Disorder CL1905835 Malignant JMML Associated with CBL Syndrome JMML Associated with Noonan Syndrome-Like Disorder Juvenile Myelomonocytic Leukemia Associated with CBL Syndrome Juvenile Myelomonocytic Leukemia Associated with Noonan Syndrome-Like Disorder Juvenile Myelomonocytic Leukemia Associated with Noonan Syndrome-Like Disorder B-acute lymphoblastic leukemia that results from germline gene mutations. This category includes B-acute lymphoblastic leukemia with germline PAX5 mutation and B-acute lymphoblastic leukemia with germline IKZF1 mutation. C198683 Neoplastic Process B Acute Lymphoblastic Leukemia with Germline Predisposition CL1905834 Malignant B ALL with Germline Predisposition B Acute Lymphoblastic Leukemia with Germline Predisposition B-ALL with Germline Predisposition B-Acute Lymphoblastic Leukemia with Germline Predisposition B Acute Lymphoblastic Leukemia with Germline Predisposition B-acute lymphoblastic leukemia that results from germline mutation of the PAX5 gene. C198684 Neoplastic Process B Acute Lymphoblastic Leukemia with Germline PAX5 Mutation CL1905837 Malignant B Acute Lymphoblastic Leukemia with Germline PAX5 Mutation B-ALL with Germline PAX5 Mutation B-Acute Lymphoblastic Leukemia with Germline PAX5 Mutation B Acute Lymphoblastic Leukemia with Germline PAX5 Mutation B-acute lymphoblastic leukemia that results from germline mutation of the IKZF1 gene. C198685 Neoplastic Process B Acute Lymphoblastic Leukemia with Germline IKZF1 Mutation CL1905836 Malignant B Acute Lymphoblastic Leukemia with Germline IKZF1 Mutation B-ALL with Germline IKZF1 Mutation B-Acute Lymphoblastic Leukemia with Germline IKZF1 Mutation B Acute Lymphoblastic Leukemia with Germline IKZF1 Mutation Endometrial undifferentiated carcinoma that has spread from its original site of growth to another anatomic site. C198705 Neoplastic Process Metastatic Endometrial Undifferentiated Carcinoma CL1905862 Malignant Metastatic Endometrial Undifferentiated Carcinoma Metastatic Endometrial Undifferentiated Carcinoma Endometrial undifferentiated carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C198706 Neoplastic Process Advanced Endometrial Undifferentiated Carcinoma Advanced Endometrial Undifferentiated Carcinoma CL1905858 CTRP Malignant Advanced Endometrial Undifferentiated Carcinoma Advanced Endometrial Undifferentiated Carcinoma Acute myeloid leukemia with variant RARA rearrangement and expression of STAT3-RARA fusion protein. C198827 Neoplastic Process Acute Myeloid Leukemia with STAT3-RARA CL1906266 Malignant Acute Myeloid Leukemia with STAT3-RARA Acute Myeloid Leukemia with STAT3-RARA Expression Acute Myeloid Leukemia with STAT3-RARA Fusion Acute Myeloid Leukemia with STAT3::RARA Acute Myeloid Leukemia with STAT3::RARA Expression Acute Myeloid Leukemia with STAT3::RARA Fusion Acute Myeloid Leukemia with STAT3-RARA Acute myeloid leukemia with variant RARA rearrangement associated with t(1;17)(q42.3;q21.2) resulting in IRF2BP2-RARA fusion protein expression. C198831 Neoplastic Process Acute Myeloid Leukemia with t(1;17)(q42.3;q21.2); IRF2BP2-RARA CL1906277 Malignant Acute Myeloid Leukemia with t(1;17)(q42.3;q21.2); IRF2BP2-RARA Acute Myeloid Leukemia with t(1;17)(q42.3;q21.2); IRF2BP2-RARA Fusion Acute Myeloid Leukemia with t(1;17)(q42.3;q21.2); IRF2BP2::RARA Acute Myeloid Leukemia with t(1;17)(q42.3;q21.2); IRF2BP2::RARA Fusion Acute Myeloid Leukemia with t(1;17)(q42.3;q21.2); IRF2BP2-RARA Acute myeloid leukemia with variant RARA rearrangement and expression of TBL1XR1-RARA fusion protein. C198834 Neoplastic Process Acute Myeloid Leukemia with TBL1XR1-RARA CL1906275 Malignant Acute Myeloid Leukemia with TBL1XR1-RARA Acute Myeloid Leukemia with TBL1XR1-RARA Expression Acute Myeloid Leukemia with TBL1XR1-RARA Fusion Acute Myeloid Leukemia with TBL1XR1::RARA Acute Myeloid Leukemia with TBL1XR1::RARA Expression Acute Myeloid Leukemia with TBL1XR1::RARA Fusion Acute Myeloid Leukemia with TBL1XR1-RARA Acute myeloid leukemia with variant RARA rearrangement and expression of FIP1L1-RARA fusion protein. C198839 Neoplastic Process Acute Myeloid Leukemia with FIP1L1-RARA CL1906284 Malignant Acute Myeloid Leukemia with FIP1L1-RARA Acute Myeloid Leukemia with FIP1L1-RARA Expression Acute Myeloid Leukemia with FIP1L1-RARA Fusion Acute Myeloid Leukemia with FIP1L1::RARA Acute Myeloid Leukemia with FIP1L1::RARA Expression Acute Myeloid Leukemia with FIP1L1::RARA Fusion Acute Myeloid Leukemia with FIP1L1-RARA Acute myeloid leukemia with variant RARA rearrangement and expression of BCOR-RARA fusion protein. C198841 Neoplastic Process Acute Myeloid Leukemia with BCOR-RARA CL1906286 Malignant Acute Myeloid Leukemia with BCOR-RARA Acute Myeloid Leukemia with BCOR-RARA Expression Acute Myeloid Leukemia with BCOR-RARA Fusion Acute Myeloid Leukemia with BCOR::RARA Acute Myeloid Leukemia with BCOR::RARA Expression Acute Myeloid Leukemia with BCOR::RARA Fusion Acute Myeloid Leukemia with BCOR-RARA A term referring to acute myeloid leukemias with rearrangement of the MECOM gene with various genes other than the GATA2 gene. C198846 Neoplastic Process Acute Myeloid Leukemia with a Variant MECOM Rearrangement CL1906293 Malignant AML with Other MECOM Rearrangements AML with a Variant MECOM Rearrangement Acute Myeloid Leukemia with Other MECOM Rearrangements Acute Myeloid Leukemia with a Variant MECOM Rearrangement Acute Myeloid Leukemia with a Variant MECOM Rearrangement An acute myeloid leukemia associated with t(3;8)(q26.2;q24) resulting in MYC and MECOM rearrangement. C198847 Neoplastic Process Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM CL1906292 Malignant AML with t(3;8)(q26.2;q24); MYC, MECOM Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM An acute myeloid leukemia associated with t(3;12)(q26.2;p13.2) resulting in the expression of ETV6-MECOM fusion gene. C198849 Neoplastic Process Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM CL1906294 Malignant AML with t(3;12)(q26.2;p13.2); ETV6-MECOM AML with t(3;12)(q26.2;p13.2); ETV6::MECOM Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM Fusion Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6::MECOM Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6::MECOM Fusion Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM An acute myeloid leukemia associated with t(3;21)(q26.2;q22.1) resulting in the expression of MECOM-RUNX1 fusion gene. C198850 Neoplastic Process Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1 CL1906289 Malignant AML with t(3;21)(q26.2;q22.1); MECOM-RUNX1 AML with t(3;21)(q26.2;q22.1); MECOM::RUNX1 Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1 Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1 Fusion Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM::RUNX1 Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM::RUNX1 Fusion Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1 An acute myeloid leukemia associated with t(4;11)(q21.3;q23.3) resulting in AFF1-KMT2A gene fusion. C198861 Neoplastic Process Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A CL1906298 Malignant AML with t(4;11)(q21.3;q23.3); AFF1-KMT2A AML with t(4;11)(q21.3;q23.3); AFF1-MLL AML with t(4;11)(q21.3;q23.3); AFF1::KMT2A AML with t(4;11)(q21.3;q23.3); AFF1::MLL Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A Fusion Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-MLL Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1::KMT2A Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1::KMT2A Fusion Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1::MLL Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A An acute myeloid leukemia associated with t(10;11)(q21.3;q23.3) resulting in TET1-KMT2A gene fusion. C198869 Neoplastic Process Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A CL1906306 Malignant AML with t(10;11)(q21.3;q23.3); TET1-KMT2A AML with t(10;11)(q21.3;q23.3); TET1-MLL AML with t(10;11)(q21.3;q23.3); TET1::KMT2A AML with t(10;11)(q21.3;q23.3); TET1::MLL Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A Fusion Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-MLL Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1::KMT2A Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1::KMT2A Fusion Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1::MLL Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A An acute myeloid leukemia associated with t(11;19)(q23.3;p13.1) resulting in KMT2A-ELL gene fusion. C198870 Neoplastic Process Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL CL1906317 Malignant AML with t(11;19)(q23.3;p13.1); KMT2A-ELL AML with t(11;19)(q23.3;p13.1); KMT2A::ELL AML with t(11;19)(q23.3;p13.1); MLL-ELL AML with t(11;19)(q23.3;p13.1); MLL::ELL Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL Fusion Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A::ELL Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A::ELL Fusion Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); MLL-ELL Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); MLL::ELL Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL An acute myeloid leukemia associated with t(11;19)(q23.3;p13.3) resulting in KMT2A-MLLT1 gene fusion. It usually affects infants and children. C198874 Neoplastic Process Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1 CL1906313 Malignant AML with t(11;19)(q23.3;p13.3); KMT2A-MLLT1 AML with t(11;19)(q23.3;p13.3); KMT2A::MLLT1 AML with t(11;19)(q23.3;p13.3); MLL-MLLT1 AML with t(11;19)(q23.3;p13.3); MLL::MLLT1 Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1 Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1 Fusion Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A::MLLT1 Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A::MLLT1 Fusion Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); MLL-MLLT1 Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); MLL::MLLT1 Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1 An acute myeloid leukemia associated with ASXL1 gene mutation. C198883 Neoplastic Process Acute Myeloid Leukemia with ASXL1 Mutation CL1906320 Malignant AML with ASXL1 Gene Mutation AML with ASXL1 Mutation Acute Myeloid Leukemia with ASXL1 Gene Mutation Acute Myeloid Leukemia with ASXL1 Mutation Acute Myeloid Leukemia with ASXL1 Mutation An acute myeloid leukemia associated with BCOR gene mutation. C198884 Neoplastic Process Acute Myeloid Leukemia with BCOR Mutation CL1906323 Malignant AML with BCOR Gene Mutation AML with BCOR Mutation Acute Myeloid Leukemia with BCOR Gene Mutation Acute Myeloid Leukemia with BCOR Mutation Acute Myeloid Leukemia with BCOR Mutation An acute myeloid leukemia associated with EZH2 gene mutation. C198885 Neoplastic Process Acute Myeloid Leukemia with EZH2 Mutation CL1906322 Malignant AML with EZH2 Gene Mutation AML with EZH2 Mutation Acute Myeloid Leukemia with EZH2 Gene Mutation Acute Myeloid Leukemia with EZH2 Mutation Acute Myeloid Leukemia with EZH2 Mutation An acute myeloid leukemia associated with SF3B1 gene mutation. C198886 Neoplastic Process Acute Myeloid Leukemia with SF3B1 Mutation CL1906333 Malignant AML with SF3B1 Gene Mutation AML with SF3B1 Mutation Acute Myeloid Leukemia with SF3B1 Gene Mutation Acute Myeloid Leukemia with SF3B1 Mutation Acute Myeloid Leukemia with SF3B1 Mutation An acute myeloid leukemia associated with SRSF2 gene mutation. C198887 Neoplastic Process Acute Myeloid Leukemia with SRSF2 Mutation CL1906332 Malignant AML with SRSF2 Gene Mutation AML with SRSF2 Mutation Acute Myeloid Leukemia with SRSF2 Gene Mutation Acute Myeloid Leukemia with SRSF2 Mutation Acute Myeloid Leukemia with SRSF2 Mutation An acute myeloid leukemia associated with STAG2 gene mutation. C198888 Neoplastic Process Acute Myeloid Leukemia with STAG2 Mutation CL1906335 Malignant AML with STAG2 Gene Mutation AML with STAG2 Mutation Acute Myeloid Leukemia with STAG2 Gene Mutation Acute Myeloid Leukemia with STAG2 Mutation Acute Myeloid Leukemia with STAG2 Mutation An acute myeloid leukemia associated with U2AF1 gene mutation. C198889 Neoplastic Process Acute Myeloid Leukemia with U2AF1 Mutation CL1906334 Malignant AML with U2AF1 Gene Mutation AML with U2AF1 Mutation Acute Myeloid Leukemia with U2AF1 Gene Mutation Acute Myeloid Leukemia with U2AF1 Mutation Acute Myeloid Leukemia with U2AF1 Mutation An acute myeloid leukemia associated with ZRSR2 gene mutation. C198890 Neoplastic Process Acute Myeloid Leukemia with ZRSR2 Mutation CL1906329 Malignant AML with ZRSR2 Gene Mutation AML with ZRSR2 Mutation Acute Myeloid Leukemia with ZRSR2 Gene Mutation Acute Myeloid Leukemia with ZRSR2 Mutation Acute Myeloid Leukemia with ZRSR2 Mutation An acute myeloid leukemia characterized by the presence of CEBPA bZIP domain mutation. It is associated with a favorable clinical outcome. C198891 Neoplastic Process Acute Myeloid Leukemia with In-Frame bZIP CEBPA Mutation CL1906328 Malignant AML with In-Frame bZIP CEBPA Mutation Acute Myeloid Leukemia with In-Frame bZIP CEBPA Mutation Acute Myeloid Leukemia with In-Frame bZIP CEBPA Mutation An adenocarcinoma that arises from the stomach and has not spread to other anatomic sites. C198918 Neoplastic Process Localized Gastric Adenocarcinoma Localized Gastric Adenocarcinoma CL1906363 CTRP Malignant Localized Gastric Adenocarcinoma Localized Gastric Adenocarcinoma A malignant supratentorial neoplasm that is confined to a specific site without evidence of spread to other anatomic sites. C198950 Neoplastic Process Localized Malignant Supratentorial Neoplasm Localized Malignant Supratentorial Neoplasm CL1906377 CTRP Malignant Localized Malignant Supratentorial Neoplasm Localized Malignant Supratentorial Neoplasm The reemergence of a malignant supratentorial neoplasm after a period of remission. C198951 Neoplastic Process Recurrent Malignant Supratentorial Neoplasm Recurrent Malignant Supratentorial Neoplasm CL1906387 CTRP Malignant Recurrent Malignant Supratentorial Neoplasm Recurrent Malignant Supratentorial Neoplasm A group of acute myeloid leukemias classified based on specific karyotype findings. C198957 Neoplastic Process Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities CL1906386 Malignant AML with MDS-Related Cytogenetic Abnormalities AML with Myelodysplasia-Related Cytogenetic Abnormalities Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities Acute myeloid leukemia associated with deletion of the long arm of chromosome 5 [del(5q)]. C198959 Neoplastic Process Acute Myeloid Leukemia with del(5q) CL1906394 Malignant AML with del(5q) Acute Myeloid Leukemia with del(5q) Acute Myeloid Leukemia with del(5q) Acute myeloid leukemia associated with deletion of the long arm of chromosome 7 [del(7q)]. C198960 Neoplastic Process Acute Myeloid Leukemia with del(7q) CL1906393 Malignant AML with del(7q) Acute Myeloid Leukemia with del(7q) Acute Myeloid Leukemia with del(7q) Acute myeloid leukemia associated with deletion of the short arm of chromosome 12 [del(12p)]. C198961 Neoplastic Process Acute Myeloid Leukemia with del(12p) CL1906396 Malignant AML with del(12p) Acute Myeloid Leukemia with del(12p) Acute Myeloid Leukemia with del(12p) Acute myeloid leukemia associated with isochromosome 17q [i(17q)]. C198962 Neoplastic Process Acute Myeloid Leukemia with i(17q) CL1906395 Malignant AML with i(17q) Acute Myeloid Leukemia with i(17q) Acute Myeloid Leukemia with i(17q) Acute myeloid leukemia associated with deletion of the short arm of chromosome 17 [del(17p)]. C198963 Neoplastic Process Acute Myeloid Leukemia with del(17p) CL1906390 Malignant AML with del(17p) Acute Myeloid Leukemia with del(17p) Acute Myeloid Leukemia with del(17p) Acute myeloid leukemia associated with deletion of the long arm of chromosome 20 [del(20q)]. C198964 Neoplastic Process Acute Myeloid Leukemia with del(20q) CL1906389 Malignant AML with del(20q) Acute Myeloid Leukemia with del(20q) Acute Myeloid Leukemia with del(20q) Acute myeloid leukemia associated with at least 3 unrelated clonal chromosomal abnormalities. C198965 Neoplastic Process Acute Myeloid Leukemia with Complex Karyotype CL1906392 Malignant AML with Complex Karyotype Acute Myeloid Leukemia with Complex Karyotype Acute Myeloid Leukemia with Complex Karyotype Acute myeloid leukemia associated with isodicentric chromosome Xq13 [idic(X)(q13)]. C198966 Neoplastic Process Acute Myeloid Leukemia with idic(X)(q13) CL1906391 Malignant AML with idic(X)(q13) Acute Myeloid Leukemia with idic(X)(q13) Acute Myeloid Leukemia with idic(X)(q13) An individual history of colorectal cancer. C198972 Clinical Attribute Personal History of Colorectal Cancer CL1797588 GDC Colorectal Cancer History of Colorectal Cancer Personal History of Colorectal Cancer Personal History of Colorectal Cancer An individual history of low grade glioma. C198973 Clinical Attribute Personal History of Low Grade Glioma CL1906399 GDC Lower Grade Glioma History of Low Grade Glioma Personal History of Low Grade Glioma Personal History of Low Grade Glioma The reemergence of endometrial low-grade endometrioid adenocarcinoma after a period of remission. C199153 Neoplastic Process Recurrent Low Grade Endometrial Endometrioid Adenocarcinoma Recurrent Endometrial Low Grade Endometrioid Adenocarcinoma CL1906103 CTRP Malignant Recurrent Endometrial Low Grade Endometrioid Adenocarcinoma Recurrent Endometrial Low-Grade Endometrioid Adenocarcinoma Recurrent Low Grade Endometrial Endometrioid Adenocarcinoma Recurrent Low-Grade Endometrial Endometrioid Adenocarcinoma Recurrent Endometrial Low Grade Endometrioid Adenocarcinoma The reemergence of endometrial high-grade endometrioid adenocarcinoma after a period of remission. C199156 Neoplastic Process Recurrent Endometrial High Grade Endometrioid Adenocarcinoma CL1906098 Malignant Recurrent Endometrial High Grade Endometrioid Adenocarcinoma Recurrent Endometrial High-Grade Endometrioid Adenocarcinoma Recurrent High Grade Endometrial Endometrioid Adenocarcinoma Recurrent High-Grade Endometrial Endometrioid Adenocarcinoma Recurrent Endometrial High Grade Endometrioid Adenocarcinoma Ovarian endometrioid adenocarcinoma exhibiting 50% or less solid non-glandular, non-squamous growth. C199159 Neoplastic Process Ovarian Low Grade Endometrioid Adenocarcinoma CL1906109 Malignant Low Grade Ovarian Endometrioid Adenocarcinoma Low-Grade Ovarian Endometrioid Adenocarcinoma Ovarian Low Grade Endometrioid Adenocarcinoma Ovarian Low-Grade Endometrioid Adenocarcinoma Ovarian Low Grade Endometrioid Adenocarcinoma Ovarian endometrioid adenocarcinoma exhibiting 5% or less solid non-glandular, non-squamous growth. C199160 Neoplastic Process FIGO Grade 1 Ovarian Endometrioid Adenocarcinoma CL1906108 Malignant FIGO Grade 1 Ovarian Endometrioid Adenocarcinoma FIGO Grade 1 Ovarian Endometrioid Adenocarcinoma Ovarian endometrioid adenocarcinoma exhibiting 6-50% solid non-glandular, non-squamous growth. C199162 Neoplastic Process FIGO Grade 2 Ovarian Endometrioid Adenocarcinoma CL1906110 Malignant FIGO Grade 2 Ovarian Endometrioid Adenocarcinoma FIGO Grade 2 Ovarian Endometrioid Adenocarcinoma Ovarian endometrioid adenocarcinoma exhibiting more than 50% solid non-glandular, non-squamous growth. C199166 Neoplastic Process Ovarian High Grade Endometrioid Adenocarcinoma CL1906106 Malignant FIGO Grade 3 Ovarian Endometrioid Adenocarcinoma High Grade Ovarian Endometrioid Adenocarcinoma High-Grade Ovarian Endometrioid Adenocarcinoma Ovarian High Grade Endometrioid Adenocarcinoma Ovarian High-Grade Endometrioid Adenocarcinoma Ovarian High Grade Endometrioid Adenocarcinoma The reemergence of ovarian low-grade endometrioid adenocarcinoma after a period of remission. C199167 Neoplastic Process Recurrent Low Grade Ovarian Endometrioid Adenocarcinoma Recurrent Ovarian Low Grade Endometrioid Adenocarcinoma CL1906117 CTRP Malignant Recurrent Low Grade Ovarian Endometrioid Adenocarcinoma Recurrent Low-Grade Ovarian Endometrioid Adenocarcinoma Recurrent Ovarian Low Grade Endometrioid Adenocarcinoma Recurrent Ovarian Low-Grade Endometrioid Adenocarcinoma Recurrent Ovarian Low Grade Endometrioid Adenocarcinoma The reemergence of ovarian high-grade endometrioid adenocarcinoma after a period of remission. C199168 Neoplastic Process Recurrent Ovarian High Grade Endometrioid Adenocarcinoma CL1906116 Malignant Recurrent High Grade Ovarian Endometrioid Adenocarcinoma Recurrent High-Grade Ovarian Endometrioid Adenocarcinoma Recurrent Ovarian High Grade Endometrioid Adenocarcinoma Recurrent Ovarian High-Grade Endometrioid Adenocarcinoma Recurrent Ovarian High Grade Endometrioid Adenocarcinoma T lymphoblastic leukemia/lymphoma in which the blasts have unique immunophenotypic and genetic characteristics suggesting only limited early T-cell differentiation. C199170 Neoplastic Process Early T Precursor Lymphoblastic Leukemia/Lymphoma CL1906118 Malignant ETP Lymphoblastic Leukemia/Lymphoma Early T Precursor Lymphoblastic Leukemia/Lymphoma Early T-Cell Precursor Lymphoblastic Leukemia/Lymphoma Early T-Precursor Lymphoblastic Leukemia/Lymphoma Early T Precursor Lymphoblastic Leukemia/Lymphoma An early T precursor acute lymphoblastic leukemia associated with the presence of BCL11B gene rearrangement. C199171 Neoplastic Process Early T Precursor Acute Lymphoblastic Leukemia with BCL11B Rearrangement CL1906113 Malignant ETP ALL with BCL11B Rearrangement Early T Cell Precursor ALL with BCL11B Rearrangement Early T Cell Precursor Acute Lymphoblastic Leukemia with BCL11B Rearrangement Early T Precursor ALL with BCL11B Rearrangement Early T Precursor Acute Lymphoblastic Leukemia with BCL11B Rearrangement Early T-Cell Precursor ALL with BCL11B Rearrangement Early T-Cell Precursor Acute Lymphoblastic Leukemia with BCL11B Rearrangement Early T-Precursor Acute Lymphoblastic Leukemia with BCL11B Rearrangement Early T Precursor Acute Lymphoblastic Leukemia with BCL11B Rearrangement Early T precursor acute lymphoblastic leukemia in which further genetic/molecular characterization is not available. C199172 Neoplastic Process Early T Precursor Acute Lymphoblastic Leukemia, Not Otherwise Specified CL1906112 Malignant ETP ALL, NOS ETP-ALL, NOS Early T Cell Precursor ALL, NOS Early T Cell Precursor Acute Lymphoblastic Leukemia, NOS Early T Cell Precursor Acute Lymphoblastic Leukemia, Not Otherwise Specified Early T Precursor ALL, NOS Early T Precursor ALL, Not Otherwise Specified Early T Precursor Acute Lymphoblastic Leukemia, Not Otherwise Specified Early T-Cell Precursor ALL, NOS Early T-Cell Precursor ALL, Not Otherwise Specified Early T-Cell Precursor Acute Lymphoblastic Leukemia, Not Otherwise Specified Early T-Precursor Acute Lymphoblastic Leukemia, Not Otherwise Specified Early T Precursor Acute Lymphoblastic Leukemia, Not Otherwise Specified T-lymphoblastic leukemia/lymphoma in which further genetic/molecular characterization is not available. C199173 Neoplastic Process T Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified CL1906115 Malignant T Lymphoblastic Leukemia/Lymphoma, NOS T Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified T-Cell Lymphoblastic Leukemia/Lymphoma, NOS T-Cell Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified T-Lymphoblastic Leukemia/Lymphoma, NOS T-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified T Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified T acute lymphoblastic leukemia in which further genetic/molecular characterization is not available. C199174 Neoplastic Process T Acute Lymphoblastic Leukemia, Not Otherwise Specified CL1906114 Malignant T Acute Lymphoblastic Leukemia, NOS T Acute Lymphoblastic Leukemia, Not Otherwise Specified T-ALL, NOS T-Cell Acute Lymphoblastic Leukemia, NOS T-Cell Acute Lymphoblastic Leukemia, Not Otherwise Specified T Acute Lymphoblastic Leukemia, Not Otherwise Specified B-acute lymphoblastic leukemias characterized by the presence of recurring cytogenetic and/or molecular abnormalities. C199202 Neoplastic Process B Acute Lymphoblastic Leukemia with Recurrent Genetic Abnormalities CL1906147 Malignant B Acute Lymphoblastic Leukemia with Recurrent Genetic Abnormalities B-ALL with Recurrent Genetic Abnormalities B-Acute Lymphoblastic Leukemia with Recurrent Genetic Abnormalities B Acute Lymphoblastic Leukemia with Recurrent Genetic Abnormalities B-acute lymphoblastic leukemias characterized by the absence of recurrent genetic abnormalities. C199204 Neoplastic Process B Acute Lymphoblastic Leukemia, Not Otherwise Specified C0349636 Malignant B Acute Lymphoblastic Leukemia, NOS B Acute Lymphoblastic Leukemia, Not Otherwise Specified B-ALL, NOS B-ALL, Not Otherwise Specified B-Acute Lymphoblastic Leukemia, NOS B-Acute Lymphoblastic Leukemia, Not Otherwise Specified B Acute Lymphoblastic Leukemia, Not Otherwise Specified B-acute lymphoblastic leukemia associated with t(9;22)(q34.1;q11.2); BCR-ABL1 and characterized by lymphoblastic proliferation without differentiating myeloid cell proliferation. C199210 Neoplastic Process B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 with Lymphoid Only Involvement CL1906154 Malignant B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 with Lymphoid Only Involvement B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR::ABL1 with Lymphoid Only Involvement B-ALL with t(9;22)(q34.1;q11.2); BCR-ABL1 with Lymphoid Only Involvement B-ALL with t(9;22)(q34.1;q11.2); BCR::ABL1 with Lymphoid Only Involvement B-Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 with Lymphoid Only Involvement B-Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR::ABL1 with Lymphoid Only Involvement de novo B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 de novo B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR::ABL1 B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 with Lymphoid Only Involvement B-acute lymphoblastic leukemia associated with t(9;22)(q34.1;q11.2); BCR-ABL1 and characterized by both lymphoblastic and differentiating myeloid cell proliferation. C199211 Neoplastic Process B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 with Multilineage Involvement CL1906150 Malignant B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 with Multilineage Involvement B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR::ABL1 with Multilineage Involvement B Lymphoid Blast Phase of Chronic Myeloid Leukemia, BCR-ABL1 Positive B Lymphoid Blast Phase of Chronic Myeloid Leukemia, BCR::ABL1 Positive B-ALL with t(9;22)(q34.1;q11.2); BCR-ABL1 with Multilineage Involvement B-ALL with t(9;22)(q34.1;q11.2); BCR::ABL1 with Multilineage Involvement B-Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 with Multilineage Involvement B-Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR::ABL1 with Multilineage Involvement B-Lymphoid Blast Phase of Chronic Myeloid Leukemia, BCR-ABL1 Positive B-Lymphoid Blast Phase of Chronic Myeloid Leukemia, BCR::ABL1 Positive B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 with Multilineage Involvement B-acute lymphoblastic leukemia associated with a low hypodiploid karyotype. C199213 Cell or Molecular Dysfunction Low-Hypodiploid B Acute Lymphoblastic Leukemia CL1906152 Malignant B Acute Lymphoblastic Leukemia, Low Hypodiploid B-ALL, Low Hypodiploid B-Acute Lymphoblastic Leukemia, Low Hypodiploid Low Hypodiploid B Acute Lymphoblastic Leukemia Low Hypodiploid B-Acute Lymphoblastic Leukemia Low-Hypodiploid B Acute Lymphoblastic Leukemia Low-Hypodiploid B-Acute Lymphoblastic Leukemia Low-Hypodiploid B Acute Lymphoblastic Leukemia B-acute lymphoblastic leukemia associated with a near haploid karyotype. C199215 Neoplastic Process Near-Haploid B Acute Lymphoblastic Leukemia CL1906160 Malignant B Acute Lymphoblastic Leukemia, Near Haploid B-ALL, Near Haploid B-Acute Lymphoblastic Leukemia, Near Haploid Near Haploid B Acute Lymphoblastic Leukemia Near Haploid B-Acute Lymphoblastic Leukemia Near-Haploid B Acute Lymphoblastic Leukemia Near-Haploid B-Acute Lymphoblastic Leukemia Near-Haploid B Acute Lymphoblastic Leukemia B-acute lymphoblastic leukemia, BCR-ABL1-like in which further genetic/molecular characterization is not available. C199223 Neoplastic Process B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Not Otherwise Specified CL1906168 Malignant B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, NOS B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Not Otherwise Specified B Acute Lymphoblastic Leukemia, BCR::ABL1-Like, NOS B Acute Lymphoblastic Leukemia, BCR::ABL1-Like, Not Otherwise Specified B-ALL, BCR-ABL1-Like, NOS B-ALL, BCR::ABL1-Like, NOS B-Acute Lymphoblastic Leukemia, BCR-ABL1-Like, NOS B-Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Not Otherwise Specified B-Acute Lymphoblastic Leukemia, BCR::ABL1-Like, NOS B-Acute Lymphoblastic Leukemia, BCR::ABL1-Like, Not Otherwise Specified B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Not Otherwise Specified B-acute lymphoblastic leukemia, BCR-ABL1-like associated with aberrant activation of the JAK-STAT signaling pathway. C199224 Neoplastic Process B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, JAK-STAT Activated CL1906167 Malignant B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, JAK-STAT Activated B Acute Lymphoblastic Leukemia, BCR::ABL1-Like, JAK-STAT Activated B-ALL, BCR-ABL1-Like, JAK-STAT Activated B-ALL, BCR::ABL1-Like, JAK-STAT Activated B-Acute Lymphoblastic Leukemia, BCR-ABL1-Like, JAK-STAT Activated B-Acute Lymphoblastic Leukemia, BCR::ABL1-Like, JAK-STAT Activated B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, JAK-STAT Activated B-acute lymphoblastic leukemia, BCR-ABL1-like associated with rearrangement of an ABL class gene (e.g., ABL1, ABL2, CSF1R, PDGFRA, and PDGFRB). C199228 Neoplastic Process B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, ABL Class Rearranged CL1906163 Malignant B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, ABL Class Rearranged B Acute Lymphoblastic Leukemia, BCR::ABL1-Like, ABL Class Rearranged B-ALL, BCR-ABL1-Like, ABL Class Rearranged B-ALL, BCR::ABL1-Like, ABL Class Rearranged B-Acute Lymphoblastic Leukemia, BCR-ABL1-Like, ABL Class Rearranged B-Acute Lymphoblastic Leukemia, BCR::ABL1-Like, ABL Class Rearranged B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, ABL Class Rearranged B-acute lymphoblastic leukemia, BCR-ABL1-like associated with ABL1 gene rearrangement. C199229 Neoplastic Process B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, ABL1 Rearranged CL1906166 Malignant B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, ABL1 Rearranged B Acute Lymphoblastic Leukemia, BCR::ABL1-Like, ABL1 Rearranged B-ALL, BCR-ABL1-Like, ABL1 Rearranged B-ALL, BCR::ABL1-Like, ABL1 Rearranged B-Acute Lymphoblastic Leukemia, BCR-ABL1-Like, ABL1 Rearranged B-Acute Lymphoblastic Leukemia, BCR::ABL1-Like, ABL1 Rearranged B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, ABL1 Rearranged B-acute lymphoblastic leukemia associated with MYC gene rearrangement. The prognosis is poor. C199230 Neoplastic Process B Acute Lymphoblastic Leukemia with MYC Rearrangement CL1906165 Malignant B Acute Lymphoblastic Leukemia with MYC Rearrangement B-ALL with MYC Rearrangement B-Acute Lymphoblastic Leukemia with MYC Rearrangement B Acute Lymphoblastic Leukemia with MYC Rearrangement B-lymphoblastic leukemia/lymphoma associated with MYC gene rearrangement. The prognosis is poor. C199231 Neoplastic Process B Lymphoblastic Leukemia/Lymphoma with MYC Rearrangement CL1906176 Malignant B Lymphoblastic Leukemia/Lymphoma with MYC Rearrangement B-Lymphoblastic Leukemia/Lymphoma with MYC Rearrangement B Lymphoblastic Leukemia/Lymphoma with MYC Rearrangement B-acute lymphoblastic leukemia associated with DUX4 gene rearrangement. The prognosis is good. C199232 Neoplastic Process B Acute Lymphoblastic Leukemia with DUX4 Rearrangement CL1906175 Malignant B Acute Lymphoblastic Leukemia with DUX4 Rearrangement B-ALL with DUX4 Rearrangement B-Acute Lymphoblastic Leukemia with DUX4 Rearrangement B Acute Lymphoblastic Leukemia with DUX4 Rearrangement B-acute lymphoblastic leukemia associated with MEF2D gene rearrangement. The prognosis is poor. C199233 Neoplastic Process B Acute Lymphoblastic Leukemia with MEF2D Rearrangement CL1906178 Malignant B Acute Lymphoblastic Leukemia with MEF2D Rearrangement B-ALL with MEF2D Rearrangement B-Acute Lymphoblastic Leukemia with MEF2D Rearrangement B Acute Lymphoblastic Leukemia with MEF2D Rearrangement B-acute lymphoblastic leukemia associated with ZNF384 gene rearrangement. The prognosis is variable. C199234 Neoplastic Process B Acute Lymphoblastic Leukemia with ZNF384 Rearrangement CL1906177 Malignant B Acute Lymphoblastic Leukemia with ZNF384 Rearrangement B-ALL with ZNF384 Rearrangement B-Acute Lymphoblastic Leukemia with ZNF384 Rearrangement B Acute Lymphoblastic Leukemia with ZNF384 Rearrangement B-acute lymphoblastic leukemia associated with ZNF362 gene rearrangement. The prognosis is variable. C199237 Neoplastic Process B Acute Lymphoblastic Leukemia with ZNF362 Rearrangement CL1906174 Malignant B Acute Lymphoblastic Leukemia with ZNF362 Rearrangement B-ALL with ZNF362 Rearrangement B-Acute Lymphoblastic Leukemia with ZNF362 Rearrangement B Acute Lymphoblastic Leukemia with ZNF362 Rearrangement B-acute lymphoblastic leukemia associated with NUTM1 gene rearrangement. The prognosis is good. C199239 Neoplastic Process B Acute Lymphoblastic Leukemia with NUTM1 Rearrangement CL1906183 Malignant B Acute Lymphoblastic Leukemia with NUTM1 Rearrangement B-ALL with NUTM1 Rearrangement B-Acute Lymphoblastic Leukemia with NUTM1 Rearrangement B Acute Lymphoblastic Leukemia with NUTM1 Rearrangement An exceptionally rare childhood B-acute lymphoblastic leukemia associated with HLF gene rearrangement. The prognosis is poor. C199240 Neoplastic Process B Acute Lymphoblastic Leukemia with HLF Rearrangement CL1906182 Malignant B Acute Lymphoblastic Leukemia with HLF Rearrangement B-ALL with HLF Rearrangement B-Acute Lymphoblastic Leukemia with HLF Rearrangement B Acute Lymphoblastic Leukemia with HLF Rearrangement An exceptionally rare childhood B-acute lymphoblastic leukemia associated with TCF3-HLF gene rearrangement resulting in the formation of TCF3-HLF chimeric transcription factor. The prognosis is poor. C199241 Neoplastic Process B Acute Lymphoblastic Leukemia with TCF3-HLF Rearrangement CL1906185 Malignant B Acute Lymphoblastic Leukemia with TCF3-HLF Fusion B Acute Lymphoblastic Leukemia with TCF3-HLF Rearrangement B Acute Lymphoblastic Leukemia with TCF3::HLF Fusion B Acute Lymphoblastic Leukemia with TCF3::HLF Rearrangement B-ALL with TCF3-HLF Rearrangement B-ALL with TCF3::HLF Rearrangement B-Acute Lymphoblastic Leukemia with TCF3-HLF Fusion B-Acute Lymphoblastic Leukemia with TCF3-HLF Rearrangement B-Acute Lymphoblastic Leukemia with TCF3::HLF Fusion B-Acute Lymphoblastic Leukemia with TCF3::HLF Rearrangement B Acute Lymphoblastic Leukemia with TCF3-HLF Rearrangement An exceptionally rare childhood B-acute lymphoblastic leukemia associated with TCF4-HLF gene rearrangement resulting in the formation of TCF4-HLF chimeric transcription factor. The prognosis is poor. C199242 Neoplastic Process B Acute Lymphoblastic Leukemia with TCF4-HLF Rearrangement CL1906184 Malignant B Acute Lymphoblastic Leukemia with TCF4-HLF Rearrangement B Acute Lymphoblastic Leukemia with TCF4::HLF Rearrangement B-ALL with TCF4-HLF Rearrangement B-ALL with TCF4::HLF Rearrangement B-Acute Lymphoblastic Leukemia with TCF4-HLF Rearrangement B-Acute Lymphoblastic Leukemia with TCF4::HLF Rearrangement B Acute Lymphoblastic Leukemia with TCF4-HLF Rearrangement B-acute lymphoblastic leukemia associated with concomitant CDX2 deregulation and expression of the chimeric UBTF-ATXN7L3 fusion oncoprotein. It usually affects female adolescents and young adults. The prognosis is poor following treatment with conventional chemotherapy. C199258 Neoplastic Process B Acute Lymphoblastic Leukemia with UBTF-ATXN7L3/PAN3, CDX2 ("CDX2/UBTF") CL1906198 Malignant B Acute Lymphoblastic Leukemia with UBTF-ATXN7L3/PAN3, CDX2 ("CDX2/UBTF") B Acute Lymphoblastic Leukemia, CDX2-Deregulated, UBTF-ATXN7L3 Rearranged B Acute Lymphoblastic Leukemia, CDX2-Deregulated, UBTF::ATXN7L3 Rearranged B Acute Lymphoblastic Leukemia, CDX2/UBTF-Deregulated B-ALL with UBTF-ATXN7L3/PAN3, CDX2 ("CDX2/UBTF") B-ALL with UBTF::ATXN7L3/PAN3, CDX2 ("CDX2/UBTF") B-ALL, CDX2-Deregulated, UBTF-ATXN7L3 Rearranged B-ALL, CDX2-Deregulated, UBTF::ATXN7L3 Rearranged B-ALL, CDX2/UBTF-Deregulated B-Acute Lymphoblastic Leukemia with UBTF-ATXN7L3/PAN3, CDX2 ("CDX2/UBTF") B-Acute Lymphoblastic Leukemia, CDX2-Deregulated, UBTF-ATXN7L3 Rearranged B-Acute Lymphoblastic Leukemia, CDX2-Deregulated, UBTF::ATXN7L3 Rearranged B-Acute Lymphoblastic Leukemia, CDX2/UBTF-Deregulated B Acute Lymphoblastic Leukemia with UBTF-ATXN7L3/PAN3, CDX2 ("CDX2/UBTF") B-acute lymphoblastic leukemia associated with IKZF1 missense mutation p.Asn159Tyr (N159Y). C199259 Neoplastic Process B Acute Lymphoblastic Leukemia with IKZF1 N159Y Mutation CL1906193 Malignant B Acute Lymphoblastic Leukemia with IKZF1 N159Y Mutation B-ALL with IKZF1 N159Y Mutation B-Acute Lymphoblastic Leukemia with IKZF1 N159Y Mutation B Acute Lymphoblastic Leukemia with IKZF1 N159Y Mutation B-acute lymphoblastic leukemia associated with PAX5 P80R mutation. C199260 Neoplastic Process B Acute Lymphoblastic Leukemia with PAX5 P80R Mutation CL1906192 Malignant B Acute Lymphoblastic Leukemia with PAX5 P80R Mutation B-ALL with PAX5 P80R Mutation B-Acute Lymphoblastic Leukemia with PAX5 P80R Mutation B Acute Lymphoblastic Leukemia with PAX5 P80R Mutation B-acute lymphoblastic leukemia associated with mutations in the ZEB2 gene that encode a histidine to arginine amino acid substitution at codon 1038. This variation appears to phenocopy the IGH-CEBPE gene fusion. This is a provisional entity. C199262 Neoplastic Process B Acute Lymphoblastic Leukemia with Mutated ZEB2 (p.H1038R) CL1906194 Provisional_Concept Malignant B Acute Lymphoblastic Leukemia with Mutated ZEB2 (p.H1038R) B Acute Lymphoblastic Leukemia with Mutated ZEB2 (p.H1038R)/IGH-CEBPE B Acute Lymphoblastic Leukemia with Mutated ZEB2 (p.H1038R)/IGH::CEBPE B-ALL with Mutated ZEB2 (p.H1038R) B-ALL with Mutated ZEB2 (p.H1038R)/IGH-CEBPE B-ALL with Mutated ZEB2 (p.H1038R)/IGH::CEBPE B-Acute Lymphoblastic Leukemia with Mutated ZEB2 (p.H1038R) B-Acute Lymphoblastic Leukemia with Mutated ZEB2 (p.H1038R)/IGH-CEBPE B-Acute Lymphoblastic Leukemia with Mutated ZEB2 (p.H1038R)/IGH::CEBPE B Acute Lymphoblastic Leukemia with Mutated ZEB2 (p.H1038R) B-acute lymphoblastic leukemia associated with PAX5 gene alteration, including rearrangements, point mutations, and intragenic lesions. This is a provisional entity. C199264 Neoplastic Process B Acute Lymphoblastic Leukemia with PAX5 Alteration CL1906204 Provisional_Concept Malignant B Acute Lymphoblastic Leukemia with PAX5 Alteration B-ALL with PAX5 Alteration B-Acute Lymphoblastic Leukemia with PAX5 Alteration B Acute Lymphoblastic Leukemia with PAX5 Alteration Therapy-related toxicity leading to multiple treatment dose reductions or delays, early treatment stoppage, unplanned hospital admission, or death. C199267 Finding Unacceptable Toxicity CL1906201 Unacceptable Toxicity Unacceptable Toxicity Monoclonal B-cell lymphocytosis characterized by the presence of more than 5 x 10^9/L abnormal B-lymphocytes in peripheral blood and presence of the characteristic immunophenotype of chronic lymphocytic leukemia. This type of monoclonal B-cell lymphocytosis evolves to chronic lymphocytic leukemia at a rate of 1-2% per year. C199373 Neoplastic Process Monoclonal B-Cell Lymphocytosis, Chronic Lymphocytic Leukemia Type CL975382 Precancerous High Count Monoclonal B-Cell Lymphocytosis Monoclonal B-Cell Lymphocytosis, Chronic Lymphocytic Leukemia Type Monoclonal B-Cell Lymphocytosis, Chronic Lymphocytic Leukemia Type Monoclonal B-cell lymphocytosis characterized by the presence of fewer than 5 x 10^9/L abnormal B-lymphocytes in peripheral blood and absence of the characteristic immunophenotype of chronic lymphocytic leukemia. This type of monoclonal B-cell lymphocytosis does not progress to chronic lymphocytic leukemia. C199374 Neoplastic Process Monoclonal B-Cell Lymphocytosis, Non-Chronic Lymphocytic Leukemia Type CL973810 Undetermined Low Count Monoclonal B-Cell Lymphocytosis Monoclonal B-Cell Lymphocytosis, Non-Chronic Lymphocytic Leukemia Type Monoclonal B-Cell Lymphocytosis, Non-Chronic Lymphocytic Leukemia Type A subtype of IgM monoclonal gammopathy of undetermined significance characterized by the presence of clonal plasma cells, absence of clonal B-lymphocytes, and absence of MYD88 gene mutation. The t(11;14)(q13;q32) is present in some cases. This subtype is considered a precursor of multiple myeloma. C199382 Neoplastic Process IgM Monoclonal Gammopathy of Undetermined Significance, Plasma Cell Type CL1906757 Precancerous IgM MGUS, Plasma Cell Type IgM Monoclonal Gammopathy of Undetermined Significance, Plasma Cell Type IgM Monoclonal Gammopathy of Undetermined Significance, Plasma Cell Type A subtype of IgM monoclonal gammopathy of undetermined significance that includes cases associated with MYD88 mutation and cases associated with the presence of monoclonal B-lymphocytes without the presence of abnormal lymphoplasmacytic aggregates that are diagnostic of lymphoplasmacytic lymphoma or other small B-lymphocytic neoplasms. C199384 Neoplastic Process IgM Monoclonal Gammopathy of Undetermined Significance, Not Otherwise Specified CL1906766 Undetermined IgM MGUS, NOS IgM MGUS, Not Otherwise Specified IgM Monoclonal Gammopathy of Undetermined Significance, NOS IgM Monoclonal Gammopathy of Undetermined Significance, Not Otherwise Specified IgM Monoclonal Gammopathy of Undetermined Significance, Not Otherwise Specified A clonal B-cell lymphoproliferative disease of the bone marrow that results in autoimmune hemolytic anemia. It is distinct from lymphoplasmacytic lymphoma and IgM monoclonal gammopathy of undetermined significance. It lacks MYD88 gene mutation and is associated with trisomies of chromosomes 3, 12, and 18, and mutations in KMT2D and CARD11 genes. C199387 Neoplastic Process Primary Cold Agglutinin Disease CL1906763 Undetermined Primary CAD Primary Cold Agglutinin Disease Primary Cold Agglutinin-Associated Lymphoproliferative Disease Primary Cold Agglutinin-Associated Lymphoproliferative Disorder Primary Cold Agglutinin Disease Amyloidosis that arises and remains localized in the skin. There are three main forms of primary cutaneous amyloidosis: lichen amyloidosis presenting with multiple itchy, raised, scaly red/brown spots; macular amyloidosis presenting with itchy, flat, brown or grey spots that form patches of darkened skin; and nodular amyloidosis presenting with brown or red nodules. C199391 Neoplastic Process Primary Cutaneous Amyloidosis C0268397 Undetermined Primary Cutaneous Amyloidosis Primary Localized Cutaneous Amyloidosis Primary Cutaneous Amyloidosis Multiple myelomas characterized by the presence of recurring cytogenetic abnormalities. C199392 Neoplastic Process Multiple Myeloma with Recurrent Genetic Abnormalities CL1906773 Malignant Multiple Myeloma with Recurrent Genetic Abnormalities Plasma Cell Myeloma with Recurrent Genetic Abnormalities Multiple Myeloma with Recurrent Genetic Abnormalities Multiple myeloma characterized by the presence of a translocation involving a CCND family gene. C199405 Neoplastic Process Multiple Myeloma with CCND Family Translocation CL1906779 Malignant Multiple Myeloma with CCND Family Translocation Plasma Cell Myeloma with CCND Family Translocation Multiple Myeloma with CCND Family Translocation Multiple myeloma characterized by the presence of a translocation involving a MAF family gene. C199406 Neoplastic Process Multiple Myeloma with MAF Family Translocation CL1906778 Malignant Multiple Myeloma with MAF Family Translocation Plasma Cell Myeloma with MAF Family Translocation Multiple Myeloma with MAF Family Translocation Multiple myeloma characterized by the presence of a translocation involving the NSD2 gene. C199407 Neoplastic Process Multiple Myeloma with NSD2 Translocation CL1906788 Malignant Multiple Myeloma with NSD2 Translocation Plasma Cell Myeloma with NSD2 Translocation Multiple Myeloma with NSD2 Translocation Multiple myeloma characterized by the presence of plasma cells in which the chromosomal number is greater than the normal diploid number. C199409 Neoplastic Process Multiple Myeloma with Hyperdiploidy CL1906789 Malignant Multiple Myeloma with Hyperdiploidy Plasma Cell Myeloma with Hyperdiploidy Multiple Myeloma with Hyperdiploidy Multiple myeloma characterized by the presence of t(11;14)(q13;q32). It is the most common immunoglobulin heavy chain translocation found in multiple myeloma and results in CCND1 overexpression. C199413 Neoplastic Process Multiple Myeloma with t(11;14)(q13;q32) CL1906787 Malignant Multiple Myeloma with t(11;14)(q13;q32) Plasma Cell Myeloma with t(11;14)(q13;q32) Multiple Myeloma with t(11;14)(q13;q32) Multiple myelomas characterized by the absence of recurrent genetic abnormalities. C199418 Neoplastic Process Multiple Myeloma, Not Otherwise Specified CL1906795 Malignant Multiple Myeloma, NOS Multiple Myeloma, Not Otherwise Specified Plasma Cell Myeloma, NOS Plasma Cell Myeloma, Not Otherwise Specified Multiple Myeloma, Not Otherwise Specified The reemergence of estrogen receptor-positive breast carcinoma after a period of remission. C199427 Neoplastic Process Recurrent Estrogen Receptor-Positive Breast Carcinoma Recurrent Estrogen Receptor-Positive Breast Carcinoma CL1906797 CTRP Malignant Recurrent Estrogen Receptor Positive Breast Adenocarcinoma Recurrent Estrogen Receptor Positive Breast Carcinoma Recurrent Estrogen Receptor-Positive Breast Adenocarcinoma Recurrent Estrogen Receptor-Positive Breast Carcinoma Recurrent Estrogen Receptor-Positive Breast Carcinoma A primary cutaneous marginal zone lymphoproliferative disorder characterized by class-switched immunoglobulin heavy chain expression. The majority of cases are IgG-positive. C199457 Neoplastic Process Heavy Chain Class-Switched Primary Cutaneous Marginal Zone Lymphoproliferative Disorder CL1906828 Undetermined Heavy Chain Class-Switched Primary Cutaneous Marginal Zone Lymphoproliferative Disorder Heavy Chain Class-Switched Primary Cutaneous Marginal Zone Lymphoproliferative Disorder A primary cutaneous marginal zone lymphoproliferative disorder characterized by the presence of class-switched immunoglobulin heavy chain expressing IgG. C199458 Neoplastic Process IgG-Positive Primary Cutaneous Marginal Zone Lymphoproliferative Disorder CL1906827 Undetermined IgG Positive Primary Cutaneous Marginal Zone Lymphoproliferative Disorder IgG-Positive Primary Cutaneous Marginal Zone Lymphoproliferative Disorder IgG-Positive Primary Cutaneous Marginal Zone Lymphoproliferative Disorder A primary cutaneous marginal zone lymphoproliferative disorder characterized by the presence of class-switched immunoglobulin heavy chain expressing IgG4. C199459 Neoplastic Process IgG4-Positive Primary Cutaneous Marginal Zone Lymphoproliferative Disorder CL1906824 Undetermined IgG4 Positive Primary Cutaneous Marginal Zone Lymphoproliferative Disorder IgG4-Positive Primary Cutaneous Marginal Zone Lymphoproliferative Disorder IgG4-Positive Primary Cutaneous Marginal Zone Lymphoproliferative Disorder A primary cutaneous marginal zone lymphoproliferative disorder characterized by expression of IgM and absence of class-switched immunoglobulin heavy chain expression. C199460 Neoplastic Process IgM-Positive Primary Cutaneous Marginal Zone Lymphoproliferative Disorder CL1906823 Undetermined IgM Positive Primary Cutaneous Marginal Zone Lymphoproliferative Disorder IgM-Positive Primary Cutaneous Marginal Zone Lymphoproliferative Disorder IgM-Positive Primary Cutaneous Marginal Zone Lymphoproliferative Disorder The reemergence of fallopian tube carcinosarcoma after a period of remission. C199462 Neoplastic Process Recurrent Fallopian Tube Carcinosarcoma Recurrent Fallopian Tube Carcinosarcoma CL1906825 CTRP Malignant Recurrent Fallopian Tube Carcinosarcoma Recurrent Fallopian Tube Carcinosarcoma The reemergence of primary peritoneal carcinosarcoma after a period of remission. C199463 Neoplastic Process Recurrent Primary Peritoneal Carcinosarcoma Recurrent Primary Peritoneal Carcinosarcoma CL1906834 CTRP Malignant Recurrent Primary Peritoneal Carcinosarcoma Recurrent Primary Peritoneal Carcinosarcoma Follicular lymphoma characterized by the absence of BCL2 rearrangement and the presence of CD23-positive neoplastic cells. It is associated with STAT6 mutations. It presents with low-stage disease, typically in the inguinal region, and often has a predominant diffuse growth pattern. C199467 Neoplastic Process BCL2-R-Negative, CD23-Positive Follicle Center Lymphoma CL1906830 Provisional_Concept Malignant BCL2-R Negative, CD23 Positive Follicle Center Lymphoma BCL2-R-Negative, CD23-Positive Follicle Center Lymphoma BCL2-R-Negative, CD23-Positive Follicle Center Lymphoma A molecular subtype of mantle cell lymphoma characterized by the presence of cyclin D1 expression and/or CCND1 rearrangement.. C199481 Neoplastic Process Cyclin D1-Positive Mantle Cell Lymphoma CL1906844 Malignant Cyclin D1-Positive MCL Cyclin D1-Positive Mantle Cell Lymphoma Mantle Cell Lymphoma with CCND1 Rearrangement Mantle Cell Lymphoma with CCND1 Translocation Cyclin D1-Positive Mantle Cell Lymphoma Mantle cell lymphoma characterized by the presence of CCND2 gene rearrangement. A small number of cases express this gene rearrangement and not CCND1 gene rearrangement. C199482 Neoplastic Process Mantle Cell Lymphoma with CCND2 Rearrangement CL1906847 Malignant Mantle Cell Lymphoma with CCND2 Rearrangement Mantle Cell Lymphoma with CCND2 Translocation Mantle Cell Lymphoma with CCND2 Rearrangement Mantle cell lymphoma characterized by the presence of CCND3 gene rearrangement. A small number of cases express this gene rearrangement and not CCND1 gene rearrangement. C199483 Neoplastic Process Mantle Cell Lymphoma with CCND3 Rearrangement CL1906846 Malignant Mantle Cell Lymphoma with CCND3 Rearrangement Mantle Cell Lymphoma with CCND3 Translocation Mantle Cell Lymphoma with CCND3 Rearrangement Ovarian high-grade serous adenocarcinoma that progresses between one and six months of completing platinum therapy. C199567 Neoplastic Process Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma CL1906920 Malignant Platinum Resistant Ovarian High Grade Serous Adenocarcinoma Platinum Resistant Ovarian High-Grade Serous Adenocarcinoma Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma Platinum-Resistant Ovarian High-Grade Serous Adenocarcinoma Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma An HHV-8 and EBV-negative primary effusion-based lymphoma that affects elderly, HIV-negative patients with history of medical conditions that result in fluid overload. The majority of cases have been reported in Japan. Most tumors exhibit centroblastic or immunoblastic morphology. The prognosis is good. C199576 Neoplastic Process HHV-8 and EBV-Negative Primary Effusion-Based Lymphoma CL1906927 Provisional_Concept Malignant Fluid Overload-Associated Large B-Cell Lymphoma HHV-8 and EBV-Negative Primary Effusion-Based Lymphoma HHV-8 and Epstein-Barr Virus-Negative Primary Effusion-Based Lymphoma Human Herpesvirus-8 and Epstein-Barr Virus-Negative Primary Effusion-Based Lymphoma KSVH/HHV8-Negative Effusion-Based Lymphoma HHV-8 and EBV-Negative Primary Effusion-Based Lymphoma An EBV-positive B-cell lymphoproliferative disorder characterized by altered tissue architecture and a polymorphic infiltrate that does not fulfill the criteria for the diagnosis of lymphoma and cannot be precisely categorized. C199580 Neoplastic Process EBV-Positive Polymorphic B-Cell Lymphoproliferative Disorder, Not Otherwise Specified CL1906939 Undetermined EBV-Positive Polymorphic B-Cell Lymphoproliferative Disorder, NOS EBV-Positive Polymorphic B-Cell Lymphoproliferative Disorder, Not Otherwise Specified Epstein-Barr Virus-Positive Polymorphic B-Cell Lymphoproliferative Disorder, NOS Epstein-Barr Virus-Positive Polymorphic B-Cell Lymphoproliferative Disorder, Not Otherwise Specified EBV-Positive Polymorphic B-Cell Lymphoproliferative Disorder, Not Otherwise Specified High-grade B-cell lymphoma characterized by the abnormal rearrangement of MYC and BCL2 genes. C199617 Neoplastic Process High Grade B-Cell Lymphoma with MYC and BCL2 Rearrangements CL1906525 Malignant HGBCL-DH-BCL2 High Grade B-Cell Lymphoma with MYC and BCL2 Rearrangements High-Grade B-Cell Lymphoma with MYC and BCL2 Rearrangements High Grade B-Cell Lymphoma with MYC and BCL2 Rearrangements High-grade B-cell lymphoma characterized by the abnormal rearrangement of MYC and BCL6 genes. C199618 Neoplastic Process High Grade B-Cell Lymphoma with MYC and BCL6 Rearrangements CL1906524 Provisional_Concept Malignant HGBCL-DH-BCL6 High Grade B-Cell Lymphoma with MYC and BCL6 Rearrangements High-Grade B-Cell Lymphoma with MYC and BCL6 Rearrangements High Grade B-Cell Lymphoma with MYC and BCL6 Rearrangements Sebaceous carcinoma that is resistant to treatment. C199636 Neoplastic Process Refractory Sebaceous Carcinoma Refractory Sebaceous Carcinoma CL1906540 CTRP Malignant Refractory Sebaceous Carcinoma Refractory Sebaceous Carcinoma Adnexal carcinoma that is resistant to treatment. C199637 Neoplastic Process Refractory Adnexal Carcinoma Refractory Adnexal Carcinoma CL1906535 CTRP Malignant Refractory Adnexal Carcinoma Refractory Adnexal Carcinoma Salivary duct carcinoma that has spread from its original site of growth to another anatomic site. C199662 Neoplastic Process Metastatic Salivary Duct Carcinoma Metastatic Salivary Duct Carcinoma CL1906562 CTRP Malignant Metastatic Salivary Duct Carcinoma Metastatic Salivary Duct Carcinoma The reemergence of salivary gland adenocarcinoma, not otherwise specified after a period of remission. C199663 Neoplastic Process Recurrent Salivary Gland Adenocarcinoma, Not Otherwise Specified Recurrent Salivary Gland Adenocarcinoma, Not Otherwise Specified CL1906557 CTRP Malignant Recurrent Salivary Gland Adenocarcinoma, Not Otherwise Specified Recurrent Salivary Gland Adenocarcinoma, Not Otherwise Specified Salivary gland adenocarcinoma, not otherwise specified that has spread from its original site of growth to another anatomic site. C199664 Neoplastic Process Metastatic Salivary Gland Adenocarcinoma, Not Otherwise Specified Metastatic Salivary Gland Adenocarcinoma, Not Otherwise Specified CL1906556 CTRP Malignant Metastatic Salivary Gland Adenocarcinoma, Not Otherwise Specified Metastatic Salivary Gland Adenocarcinoma, Not Otherwise Specified Salivary gland adenocarcinoma that has spread from its original site of growth to another anatomic site. C199665 Neoplastic Process Metastatic Salivary Gland Adenocarcinoma CL1906559 Malignant Metastatic Salivary Gland Adenocarcinoma Metastatic Salivary Gland Adenocarcinoma The reemergence of salivary gland adenocarcinoma after a period of remission. C199666 Neoplastic Process Recurrent Salivary Gland Adenocarcinoma CL1906558 Malignant Recurrent Salivary Gland Adenocarcinoma Recurrent Salivary Gland Adenocarcinoma Hydroa vacciniforme lymphoproliferative disorder characterized by the presence of self-limited papulovesicular skin lesions in sun-exposed areas. There is no involvement of internal organs. It has an indolent course and usually affects White individuals. C199676 Neoplastic Process Classic Hydroa Vacciniforme Lymphoproliferative Disorder CL1906575 Benign Classic HV LPD Classic HV-LPD Classic Hydroa Vacciniforme Lymphoproliferative Disorder Classic Hydroa Vacciniforme Lymphoproliferative Disorder Hydroa vacciniforme lymphoproliferative disorder characterized by severe clinical course and associated with fever, lymph node involvement, and involvement of internal organs by EBV-positive T-cells and NK-cells. It usually affects Asian and Latin American individuals. C199677 Neoplastic Process Systemic Hydroa Vacciniforme Lymphoproliferative Disorder CL1906577 Undetermined Systemic HV LPD Systemic HV-LPD Systemic Hydroa Vacciniforme Lymphoproliferative Disorder Systemic Hydroa Vacciniforme Lymphoproliferative Disorder An indolent lymphoproliferative disorder that affects the gastrointestinal tract. The neoplastic lymphocytes have the typical phenotype of NK-cells, are of medium to large size, show mild pleomorphism, and are EBV infection negative. Features that characterize extranodal NK/T-cell lymphomas (e.g., angioinvasion and angiodestruction) are not present. C200037 Disease or Syndrome Indolent NK-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract CL527328 Undetermined Indolent NK-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract Lymphomatoid Gastropathy NK-Cell Enteropathy NKCE Indolent NK-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract A genetic subtype of systemic anaplastic large cell lymphoma, ALK-negative characterized by rearrangement of DUSP22 gene. It tends to have a favorable prognosis. C200050 Neoplastic Process DUSP22-R Anaplastic Large Cell Lymphoma, ALK-Negative CL1907327 Malignant DUSP22 Rearranged ALCL, ALK-Negative DUSP22 Rearranged Anaplastic Large Cell Lymphoma, ALK-Negative DUSP22-R ALCL, ALK-Negative DUSP22-R Anaplastic Large Cell Lymphoma, ALK-Negative DUSP22-R Anaplastic Large Cell Lymphoma, ALK-Negative Sebaceous carcinoma that has spread from the original site of growth to other anatomic sites. C200060 Neoplastic Process Metastatic Sebaceous Carcinoma Metastatic Sebaceous Carcinoma CL1907345 CTRP Malignant Metastatic Sebaceous Carcinoma Metastatic Sebaceous Carcinoma Adnexal carcinoma that has spread from the original site of growth to other anatomic sites. C200062 Neoplastic Process Metastatic Adnexal Carcinoma Metastatic Adnexal Carcinoma CL1907344 CTRP Malignant Metastatic Adnexal Carcinoma Metastatic Adnexal Carcinoma Adnexal carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C200063 Neoplastic Process Advanced Adnexal Carcinoma Advanced Adnexal Carcinoma CL1907347 CTRP Malignant Advanced Adnexal Carcinoma Advanced Adnexal Carcinoma Sebaceous carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C200064 Neoplastic Process Advanced Sebaceous Carcinoma Advanced Sebaceous Carcinoma CL1907346 CTRP Malignant Advanced Sebaceous Carcinoma Advanced Sebaceous Carcinoma The reemergence of adnexal carcinoma after a period of remission. C200065 Neoplastic Process Recurrent Adnexal Carcinoma Recurrent Adnexal Carcinoma CL1907341 CTRP Malignant Recurrent Adnexal Carcinoma Recurrent Adnexal Carcinoma The reemergence of sebaceous carcinoma after a period of remission. C200066 Neoplastic Process Recurrent Sebaceous Carcinoma Recurrent Sebaceous Carcinoma CL1907340 CTRP Malignant Recurrent Sebaceous Carcinoma Recurrent Sebaceous Carcinoma A molecular subtype of peripheral T-cell lymphoma, not otherwise specified, characterized by high expression of GATA3. It is composed of a monomorphic lymphocytic infiltrate with minimal inflammation and is associated with a poor prognosis. C200073 Neoplastic Process Peripheral T-Cell Lymphoma-GATA3 CL1907349 Malignant PTCL-GATA3 Peripheral T-Cell Lymphoma-GATA3 Peripheral T-Cell Lymphoma-GATA3 A molecular subtype of peripheral T-cell lymphoma, not otherwise specified, characterized by high expression of T-box 21 (TBX21). It is composed of a polymorphic lymphocytic infiltrate admixed with abundant inflammatory cells and is associated with a better prognosis compared to peripheral T-cell lymphoma-GATA3. C200074 Neoplastic Process Peripheral T-Cell Lymphoma-TBX21 CL1907348 Malignant PTCL-TBX21 Peripheral T-Cell Lymphoma-TBX21 Peripheral T-Cell Lymphoma-TBX21 Differentiated thyroid gland carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C200083 Neoplastic Process Locally Advanced Differentiated Thyroid Gland Carcinoma Locally Advanced Differentiated Thyroid Gland Carcinoma CL1907356 CTRP Malignant Locally Advanced Differentiated Thyroid Gland Carcinoma Locally Advanced Differentiated Thyroid Gland Carcinoma Diagnosis of more than one distinct tumor focus in the same breast, within two months. C200087 Neoplastic Process Synchronous Ipsilateral Breast Carcinoma CL1907367 Synchronous Ipsilateral Breast Carcinoma Synchronous Ipsilateral Breast Carcinoma Cutaneous squamous cell carcinoma of the head and neck that is not amenable to surgical resection. C200088 Neoplastic Process Unresectable Cutaneous Squamous Cell Carcinoma of the Head and Neck Unresectable Cutaneous Squamous Cell Carcinoma of the Head and Neck CL1907370 CTRP Malignant Unresectable Cutaneous Squamous Cell Carcinoma of the Head and Neck Unresectable Cutaneous Squamous Cell Carcinoma of the Head and Neck A rare histiocytic neoplasm associated with ALK gene rearrangement leading to activation of signaling pathways. The neoplastic cells have a mature histiocytic phenotype, and usually have a foamy cytoplasm. It is characterized by frequent neurologic involvement and responds to ALK inhibition treatments. C200105 Neoplastic Process ALK-Positive Histiocytosis CL1906947 Undetermined ALK-Positive Histiocytosis ALK-Positive Histiocytosis Information about an individual's personal medical history that is reported by a healthcare professional, consumer, or patient through an organized data collection system. C200145 Finding Solicited Medical History CL1906987 Solicited Medical History Solicited Medical History An intestinal-type adenoma that arises from the vulva. It is characterized by the presence of a tubulovillous architectural pattern. C200207 Neoplastic Process Vulvar Tubulovillous Adenoma CL1907049 Benign Vulvar Tubulovillous Adenoma Vulvar Tubulovillous Adenoma A benign, borderline, or malignant cystic neoplasm that arises from the exocrine pancreas. This category includes pancreatic mucinous-cystic neoplasms, pancreatic cystadenomas, and pancreatic cystadenocarcinomas. C200227 Neoplastic Process Pancreatic Cystic Neoplasm Pancreatic Cystic Neoplasm CL381202 CTRP Undetermined Pancreatic Cystic Neoplasm Pancreatic Cystic Neoplasm A rare benign salivary gland adenoma that arises from ducts that resemble normal striated ducts. C200313 Neoplastic Process Salivary Gland Striated Duct Adenoma CL1907127 Benign SDA Salivary Gland Striated Duct Adenoma Striated Duct Adenoma Salivary Gland Striated Duct Adenoma Myelodysplastic syndrome characterized by the presence of biallelic TP53 inactivating alterations. They include biallelic TP53 gene mutations or one TP53 gene mutation and concurrent copy loss of TP53. There are less than 20% blasts in bone marrow and peripheral blood. It is associated with a poor prognosis. C200376 Neoplastic Process Myelodysplastic Syndrome with Biallelic TP53 Inactivation CL1907395 Malignant MDS-biTP53 Myelodysplastic Neoplasm with Biallelic Multi-Hit TP53 Alteration Myelodysplastic Neoplasm with Biallelic TP53 Alteration Myelodysplastic Neoplasm with Biallelic TP53 Inactivation Myelodysplastic Syndrome with Biallelic TP53 Alteration Myelodysplastic Syndrome with Biallelic TP53 Inactivation Myelodysplastic Syndrome with Biallelic TP53 Inactivation Myelodysplastic syndrome characterized by the presence of TP53 gene inactivating alterations. They include monoallelic or biallelic TP53 gene mutations or one TP53 gene mutation and concurrent copy loss of TP53. C200377 Neoplastic Process Myelodysplastic Syndrome with TP53 Inactivation CL1907397 Malignant Myelodysplastic Neoplasm with TP53 Alteration Myelodysplastic Neoplasm with TP53 Inactivation Myelodysplastic Syndrome with TP53 Alteration Myelodysplastic Syndrome with TP53 Inactivation Myelodysplastic Syndrome with TP53 Inactivation Myelodysplastic syndrome characterized by the presence of monoallelic TP53 gene mutation. C200379 Neoplastic Process Myelodysplastic Syndrome with Monoallelic TP53 Mutation CL1907393 Malignant Myelodysplastic Neoplasm with Monoallelic TP53 Mutation Myelodysplastic Syndrome with Monoallelic TP53 Mutation Myelodysplastic Syndrome with Monoallelic TP53 Mutation Myelodysplastic syndrome characterized by the presence of biallelic TP53 gene mutations. It is associated with a poor prognosis. C200381 Neoplastic Process Myelodysplastic Syndrome with Biallelic TP53 Mutation CL1907394 Malignant Myelodysplastic Neoplasm with Biallelic TP53 Mutation Myelodysplastic Syndrome with Biallelic TP53 Mutation Myelodysplastic Syndrome with Biallelic TP53 Mutation Myelodysplastic syndrome characterized by the presence of less than 5% blasts in bone marrow and less than 2% blasts in peripheral blood. C200389 Neoplastic Process Myelodysplastic Syndrome with Low Blasts CL1907401 Malignant MDS-LB Myelodysplastic Neoplasm with Low Blasts Myelodysplastic Syndrome with Low Blasts Myelodysplastic Syndrome with Low Blasts Myelodysplastic syndrome characterized by the presence of defining genetic abnormalities. C200390 Neoplastic Process Myelodysplastic Syndrome with Genetic Abnormalities CL1907400 Malignant Myelodysplastic Neoplasm with Genetic Abnormalities Myelodysplastic Syndrome with Genetic Abnormalities Myelodysplastic Syndrome with Genetic Abnormalities Myelodysplastic syndrome that occurs in childhood and is characterized by cytopenia and the presence of less than 5% blasts in bone marrow and less than 2% blasts in peripheral blood. C200396 Neoplastic Process Childhood Myelodysplastic Syndrome with Low Blasts CL1907406 Malignant Childhood MDS with Low Blasts Childhood Myelodysplastic Syndrome with Low Blasts cMDS-LB Childhood Myelodysplastic Syndrome with Low Blasts Childhood myelodysplastic syndrome with low blasts that is characterized by bone marrow hypocellularity. C200397 Neoplastic Process Childhood Myelodysplastic Syndrome with Low Blasts, Hypocellular CL1907405 Malignant Childhood MDS with Low Blasts, Hypocellular Childhood Myelodysplastic Syndrome with Low Blasts, Hypocellular cMDS-LB, Hypocellular Childhood Myelodysplastic Syndrome with Low Blasts, Hypocellular Childhood myelodysplastic syndrome with low blasts in which further characterization is not available. C200398 Neoplastic Process Childhood Myelodysplastic Syndrome with Low Blasts, Not Otherwise Specified CL1907407 Malignant Childhood Myelodysplastic Syndrome with Low Blasts, NOS Childhood Myelodysplastic Syndrome with Low Blasts, Not Otherwise Specified cMDS-LB, NOS Childhood Myelodysplastic Syndrome with Low Blasts, Not Otherwise Specified Myelodysplastic syndromes/acute myeloid leukemias characterized by the presence of gene mutations that are associated with myelodysplasia. C200400 Neoplastic Process Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations CL1907416 Malignant MDS/AML with Myelodysplasia-Related Gene Mutations Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations Myelodysplastic syndromes/acute myeloid leukemias classified based on specific karyotype findings. C200402 Neoplastic Process Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities CL1907417 Malignant MDS/AML with Myelodysplasia-Related Cytogenetic Abnormalities Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities Acute myeloid leukemia characterized by rearrangement of the MECOM gene with various genes. C200407 Neoplastic Process Acute Myeloid Leukemia with MECOM Rearrangement CL1907413 Malignant Acute Myeloid Leukemia with MECOM Rearrangement Acute Myeloid Leukemia with MECOM Rearrangement Acute myeloid leukemia characterized by rearrangement of the NUP98 gene with various genes. C200411 Neoplastic Process Acute Myeloid Leukemia with NUP98 Rearrangement CL1907422 Malignant Acute Myeloid Leukemia with NUP98 Rearrangement Acute Myeloid Leukemia with NUP98 Rearrangement Acute myeloid leukemia associated with FUS-ERG gene fusion. The prognosis is poor. C200419 Neoplastic Process Acute Myeloid Leukemia with FUS-ERG CL1907428 Malignant AML with FUS-ERG AML with FUS-ERG Fusion AML with FUS::ERG AML with FUS::ERG Fusion Acute Myeloid Leukemia with FUS-ERG Acute Myeloid Leukemia with FUS-ERG Fusion Acute Myeloid Leukemia with FUS::ERG Acute Myeloid Leukemia with FUS::ERG Fusion Acute Myeloid Leukemia with FUS-ERG Acute myeloid leukemia associated with NPM1-MLF1 gene fusion. C200420 Neoplastic Process Acute Myeloid Leukemia with NPM1-MLF1 CL1907424 Malignant AML with NPM1-MLF1 AML with NPM1-MLF1 Fusion AML with NPM1::MLF1 AML with NPM1::MLF1 Fusion Acute Myeloid Leukemia with NPM1-MLF1 Acute Myeloid Leukemia with NPM1-MLF1 Fusion Acute Myeloid Leukemia with NPM1::MLF1 Acute Myeloid Leukemia with NPM1::MLF1 Fusion Acute Myeloid Leukemia with NPM1-MLF1 Acute myeloid leukemia associated with KAT6A-CREBBP gene fusion. C200421 Neoplastic Process Acute Myeloid Leukemia with KAT6A-CREBBP CL1907423 Malignant AML with KAT6A-CREBBP AML with KAT6A-CREBBP Fusion AML with KAT6A::CREBBP AML with KAT6A::CREBBP Fusion Acute Myeloid Leukemia with KAT6A-CREBBP Acute Myeloid Leukemia with KAT6A-CREBBP Fusion Acute Myeloid Leukemia with KAT6A::CREBBP Acute Myeloid Leukemia with KAT6A::CREBBP Fusion Acute Myeloid Leukemia with KAT6A-CREBBP The historical fact that a family member was a smoker. C200469 Group Attribute Family History of Smoking C2733371 GDC Family History of Smoking relative smoker relative_smoker Family History of Smoking Acute leukemia of ambiguous lineage characterized by the presence of defined genetic alterations. C200494 Neoplastic Process Acute Leukemia of Ambiguous Lineage with Defining Genetic Abnormalities CL1907493 Malignant Acute Leukemia of Ambiguous Lineage with Defining Genetic Abnormalities Acute Leukemia of Ambiguous Lineage with Defining Genetic Abnormalities A midgut neuroendocrine tumor G1 that has spread from its original site of growth to another anatomic site. C200495 Neoplastic Process Metastatic Midgut Neuroendocrine Tumor G1 Metastatic Midgut Neuroendocrine Tumor G1 CL1907492 CTRP Malignant Metastatic Midgut NET G1 Metastatic Midgut Neuroendocrine Tumor G1 Metastatic Midgut Neuroendocrine Tumor G1 A midgut neuroendocrine tumor G2 that has spread from its original site of growth to another anatomic site. C200496 Neoplastic Process Metastatic Midgut Neuroendocrine Tumor G2 Metastatic Midgut Neuroendocrine Tumor G2 CL1907502 CTRP Malignant Metastatic Midgut NET G2 Metastatic Midgut Neuroendocrine Tumor G2 Metastatic Midgut Neuroendocrine Tumor G2 A midgut neuroendocrine tumor G3 that has spread from its original site of growth to another anatomic site. C200497 Neoplastic Process Metastatic Midgut Neuroendocrine Tumor G3 CL1907501 Malignant Metastatic Midgut NET G3 Metastatic Midgut Neuroendocrine Tumor G3 Metastatic Midgut Neuroendocrine Tumor G3 A very rare mixed phenotype acute leukemia in which the blasts show evidence of T-cell and megakaryocytic lineage but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. C200502 Neoplastic Process Mixed Phenotype Acute Leukemia, T/Megakaryocytic CL1907500 Malignant MPAL-T/Mk Mixed Phenotype Acute Leukemia, T/Megakaryocytic Mixed Phenotype Acute Leukemia, T/Megakaryocytic A clonal proliferation of plasmacytoid dendritic cells in patients with defined myeloid neoplasms. It is characterized by neoplastic proliferations of mature cells with plasmacytoid morphology in the skin, bone marrow, and very rarely, lymph nodes. Patients are predominantly older males. C200513 Neoplastic Process Mature Plasmacytoid Dendritic Cell Proliferation Associated with Myeloid Neoplasm CL1907517 Malignant MPDCP Mature Plasmacytoid Dendritic Cell Proliferation Mature Plasmacytoid Dendritic Cell Proliferation Associated with Myeloid Neoplasm Mature Plasmacytoid Dendritic Cell Proliferation Associated with Myeloid Neoplasm A group of mesenchymal neoplasms that arise from the lymph node and spleen. C200520 Neoplastic Process Stroma-Derived Neoplasm of Lymphoid Tissues CL1907514 Undetermined Stroma-Derived Neoplasm of Lymphoid Tissues Stroma-Derived Neoplasm of Lymphoid Tissues A very rare benign vascular neoplasm that is unique to the spleen and is characterized by vascular proliferations with a hybrid endothelial-histiocytic phenotype. Most patients are asymptomatic, and the tumor is discovered incidentally on imaging studies performed for other reasons. C200524 Neoplastic Process Littoral Cell Angioma C1627365 Benign LCA Littoral Cell Angioma Littoral Cell Angioma A benign, circumscribed lesion that arises from the spleen and is composed of multiple angiomatoid nodules in a fibrosclerotic stroma. It most often affects middle-aged females. It is usually asymptomatic, and most cases are detected incidentally on imaging studies. C200533 Neoplastic Process Sclerosing Angiomatoid Nodular Transformation of Spleen CL1667133 Benign SANT Sclerosing Angiomatoid Nodular Transformation Sclerosing Angiomatoid Nodular Transformation of Spleen Sclerosing Angiomatoid Nodular Transformation of Spleen A T2-weighted gradient-echo MRI sequence that is mainly used in the assessment of the central nervous system. It has short acquisition times, high signal-to-noise ratio, and better contrast-to-noise ratio. It is useful in the assessment of the cranial nerves, and can also be used when studying cysts, cystic masses, and neurocysticercosis and in hydrocephalus cases. C200534 Diagnostic Procedure Constructive Interference In Steady State CL1907585 CISS Constructive Interference In Steady State Constructive Interference In Steady State An acquisition sequence that provides images of fluid filled structures with very short acquisition times. It uses the T2 steady state contrast mechanism to provide high signal-to-noise-ratio images with strong signal from fluid tissues while suppressing background tissue for contrast and anatomic detail of small structures. C200536 Diagnostic Procedure Fast Imaging Employing Steady-State Acquisition CL1907526 Balanced Steady-State Gradient Echo FIESTA Fast Imaging Employing Steady-State Acquisition Fast Imaging Employing Steady-State Acquisition Intrahepatic cholangiocarcinoma that has metastasized to a limited number of sites. C200569 Neoplastic Process Oligometastatic Intrahepatic Cholangiocarcinoma Oligometastatic Intrahepatic Cholangiocarcinoma CL1907566 CTRP Malignant Oligometastatic Intrahepatic Cholangiocarcinoma Oligometastatic Intrahepatic Cholangiocarcinoma Breast adenocarcinoma that is positive for progesterone receptors. C200570 Neoplastic Process Progesterone Receptor-Positive Breast Carcinoma Progesterone Receptor-Positive Breast Carcinoma CL1907565 CTRP Malignant PR+ Breast Carcinoma Progesterone Receptor Positive Breast Adenoarcinoma Progesterone Receptor Positive Breast Carcinoma Progesterone Receptor-Positive Breast Adenoarcinoma Progesterone Receptor-Positive Breast Carcinoma Progesterone Receptor-Positive Breast Carcinoma Progesterone receptor-positive breast carcinoma that has spread from its original site of growth to another anatomic site. C200572 Neoplastic Process Metastatic Progesterone Receptor-Positive Breast Carcinoma Metastatic Progesterone Receptor-Positive Breast Carcinoma CL1907567 CTRP Malignant Metastatic Progesterone Receptor Positive Breast Adenocarcinoma Metastatic Progesterone Receptor Positive Breast Carcinoma Metastatic Progesterone Receptor-Positive Breast Adenocarcinoma Metastatic Progesterone Receptor-Positive Breast Carcinoma Metastatic Progesterone Receptor-Positive Breast Carcinoma Progesterone receptor-positive breast carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C200573 Neoplastic Process Advanced Progesterone Receptor-Positive Breast Carcinoma Advanced Progesterone Receptor-Positive Breast Carcinoma CL1907563 CTRP Malignant Advanced Progesterone Receptor Positive Breast Adenocarcinoma Advanced Progesterone Receptor Positive Breast Carcinoma Advanced Progesterone Receptor-Positive Breast Adenocarcinoma Advanced Progesterone Receptor-Positive Breast Carcinoma Advanced Progesterone Receptor-Positive Breast Carcinoma The reemergence of progesterone receptor-positive breast carcinoma after a period of remission. C200574 Neoplastic Process Recurrent Progesterone Receptor-Positive Breast Carcinoma Recurrent Progesterone Receptor-Positive Breast Carcinoma CL1907562 CTRP Malignant Recurrent Progesterone Receptor Positive Breast Adenocarcinoma Recurrent Progesterone Receptor Positive Breast Carcinoma Recurrent Progesterone Receptor-Positive Breast Adenocarcinoma Recurrent Progesterone Receptor-Positive Breast Carcinoma Recurrent Progesterone Receptor-Positive Breast Carcinoma Appendix carcinoma that is amenable to surgical resection. C200577 Neoplastic Process Resectable Appendix Carcinoma Resectable Appendix Carcinoma CL1907572 CTRP Malignant Resectable Appendix Carcinoma Resectable Appendix Carcinoma The reemergence of tonsillar squamous cell carcinoma after a period of remission. C200582 Neoplastic Process Recurrent Tonsillar Squamous Cell Carcinoma Recurrent Tonsillar Squamous Cell Carcinoma CL1907569 CTRP Malignant Recurrent Tonsillar SCC Recurrent Tonsillar Squamous Cell Carcinoma Recurrent Tonsillar Squamous Cell Carcinoma Tonsillar squamous cell carcinoma that has spread from its original site of growth to another anatomic site. C200583 Neoplastic Process Metastatic Tonsillar Squamous Cell Carcinoma Metastatic Tonsillar Squamous Cell Carcinoma CL1907571 CTRP Malignant Metastatic Tonsillar SCC Metastatic Tonsillar Squamous Cell Carcinoma Metastatic Tonsillar Squamous Cell Carcinoma Sinonasal carcinoma that has spread from its original site of growth to another anatomic site. C200584 Neoplastic Process Metastatic Sinonasal Carcinoma Metastatic Sinonasal Carcinoma CL1907570 CTRP Malignant Metastatic Sinonasal Carcinoma Metastatic Sinonasal Carcinoma An exceptionally rare childhood B-lymphoblastic leukemia/lymphoma associated with TCF3-HLF gene rearrangement resulting in the formation of TCF3-HLF chimeric transcription factor. The prognosis is poor. C200587 Neoplastic Process B Lymphoblastic Leukemia/Lymphoma with TCF3-HLF Rearrangement CL1907574 Malignant B Lymphoblastic Leukemia/Lymphoma with TCF3-HLF Fusion B Lymphoblastic Leukemia/Lymphoma with TCF3-HLF Rearrangement B Lymphoblastic Leukemia/Lymphoma with TCF3::HLF Fusion B Lymphoblastic Leukemia/Lymphoma with TCF3::HLF Rearrangement B-Lymphoblastic Leukemia/Lymphoma with TCF3-HLF Fusion B-Lymphoblastic Leukemia/Lymphoma with TCF3-HLF Rearrangement B-Lymphoblastic Leukemia/Lymphoma with TCF3::HLF Fusion B-Lymphoblastic Leukemia/Lymphoma with TCF3::HLF Rearrangement B Lymphoblastic Leukemia/Lymphoma with TCF3-HLF Rearrangement A term that refers to the classification of atypical teratoid/rhabdoid tumors according to their molecular characteristics. C200597 Neoplastic Process Atypical Teratoid/Rhabdoid Tumor Molecular Subtypes CL1915307 Malignant AT/RT Molecular Subtypes ATRT Molecular Subtypes Atypical Teratoid/Rhabdoid Tumor Molecular Subtypes Atypical Teratoid/Rhabdoid Tumor Molecular Subtypes Atypical teratoid/rhabdoid tumor characterized by overexpression of genes in the sonic hedgehog (SHH) pathway (GLI2, BOC, PTCHD2, and MYCN). C200598 Neoplastic Process Atypical Teratoid/Rhabdoid Tumor-SHH CL1915293 Malignant AT/RT-SHH ATRT-SHH Atypical Teratoid/Rhabdoid Tumor-SHH Atypical Teratoid/Rhabdoid Tumor-SHH Atypical teratoid/rhabdoid tumor characterized by overexpression of MYC gene. C200599 Neoplastic Process Atypical Teratoid/Rhabdoid Tumor-MYC CL1915294 Malignant AT/RT-MYC ATRT-MYC Atypical Teratoid/Rhabdoid Tumor-MYC Atypical Teratoid/Rhabdoid Tumor-MYC Atypical teratoid/rhabdoid tumor characterized by overexpression of melanosomal genes (TYR, TYRP, MITF, and OTX2). C200600 Neoplastic Process Atypical Teratoid/Rhabdoid Tumor-TYR CL1915295 Malignant AT/RT-TYR ATRT-TYR Atypical Teratoid/Rhabdoid Tumor-TYR Atypical Teratoid/Rhabdoid Tumor-TYR Polycythemia vera, post-polycythemic myelofibrosis phase that is resistant to treatment. C200605 Neoplastic Process Refractory Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase Refractory Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase CL1915299 CTRP Malignant Refractory Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase Refractory Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase Post-essential thrombocythemia myelofibrosis that is resistant to treatment. C200606 Neoplastic Process Refractory Post-Essential Thrombocythemia Myelofibrosis Refractory Post-Essential Thrombocythemia Myelofibrosis CL1915312 CTRP Malignant Refractory Post-Essential Thrombocythemia Myelofibrosis Refractory Post-Essential Thrombocythemia Myelofibrosis A term that refers to follicular lymphoma grade 1, 2, and 3A. C200669 Neoplastic Process Classic Follicular Lymphoma CL1915335 Malignant Classic FL Classic Follicular Lymphoma cFL Classic Follicular Lymphoma An uncommon morphologic variant of follicular lymphoma characterized by the presence of predominantly medium-sized neoplastic lymphocytes with blastoid features or large neoplastic lymphocytes with cleaved nuclei. C200684 Neoplastic Process Follicular Lymphoma with Unusual Cytological Features CL1915347 Malignant Follicular Lymphoma with Unusual Cytological Features uFL Follicular Lymphoma with Unusual Cytological Features A molecular subtype of mantle cell lymphoma characterized by the absence of cyclin D1 expression and CCND1 rearrangement. C200685 Neoplastic Process Cyclin D1-Negative Mantle Cell Lymphoma CL1915348 Malignant Cyclin D1-Negative MCL Cyclin D1-Negative Mantle Cell Lymphoma Cyclin D1-Negative Mantle Cell Lymphoma A term that refers to diffuse large B-cell lymphomas that arise as primary tumors in the central nervous system, vitreoretina, and testis in immunocompetent patients. C200687 Neoplastic Process Primary Large B-Cell Lymphoma of Immune-Privileged Site CL1915366 Malignant IP-LBCL Primary Diffuse Large B-Cell Lymphoma of Immune-Privileged Site Primary Diffuse Large B-Cell Lymphomas of Immune-Privileged Sites Primary Large B-Cell Lymphoma of Immune-Privileged Site Primary Large B-Cell Lymphomas of Immune-Privileged Sites Primary Large B-Cell Lymphoma of Immune-Privileged Site Burkitt lymphoma that is not associated with Epstein-Barr virus infection. C200688 Neoplastic Process EBV-Negative Burkitt Lymphoma CL1915367 Malignant EBV-Negative Burkitt Lymphoma EBV-Negative Burkitt Lymphoma The reemergence of platinum-resistant ovarian high-grade serous adenocarcinoma after a period of remission. C200719 Neoplastic Process Recurrent Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma CL1915393 Malignant Recurrent Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma Recurrent Platinum-Resistant Ovarian High-Grade Serous Adenocarcinoma Recurrent Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma A term that refers to rare paraneoplastic syndromes associated with plasma cell neoplasms. This category includes the following: POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes); TEMPI syndrome (telangiectasia, elevated erythropoietin and erythrocytosis, monoclonal gammopathy, perinephric fluid collection, and intrapulmonary shunting); and AESOP syndrome (adenopathy and extensive skin patch overlying a plasmacytoma). C200738 Neoplastic Process Plasma Cell Neoplasm with Associated Paraneoplastic Syndrome CL1915409 Malignant Plasma Cell Neoplasm with Associated Paraneoplastic Syndrome Plasma Cell Neoplasm with Associated Paraneoplastic Syndrome An exceedingly rare syndrome characterized by adenopathy and a red-to-brown skin patch overlying a plasmacytoma. C200742 Neoplastic Process AESOP Syndrome CL1915411 Malignant AESOP Syndrome Adenopathy and Extensive Skin Patch Overlying Plasmacytoma AESOP Syndrome A group of malignant gliomas that includes the following: glioblastoma; diffuse midline glioma; diffuse hemispheric glioma, H3 G34-mutant; astrocytoma, IDH-mutant, grade 4; and diffuse pediatric-type high grade glioma, H3-wildtype and IDH-wildtype. C200758 Neoplastic Process WHO Grade 4 Glioma CL1915423 Malignant WHO Grade 4 Glioma WHO Grade 4 Glioma The reemergence of WHO grade 4 glioma after a period of remission. C200759 Neoplastic Process Recurrent WHO Grade 4 Glioma Recurrent WHO Grade 4 Glioma CL1915424 CTRP Malignant Recurrent WHO Grade 4 Glioma Recurrent WHO Grade 4 Glioma Any nuclear medicine study that utilizes a radioactive tracer to image blood vessels or characterize blood flow. C20080 Diagnostic Procedure Angiography Radioangiography X-ray Angiography CL378222 CDISC CTRP A procedure to x-ray blood vessels. The blood vessels can be seen because of an injection of a dye that shows up in the x-ray. The X-ray examination of blood vessels or chambers of the heart after introduction of a radiopaque substance. Angiography ANGIOGRAPHY Angiography Radioangiography X-ray Angiography angiography X-ray Angiography An exceedingly rare peripheral T-cell lymphoma that arises from the skin and does not meet the criteria that define the other well characterized primary cutaneous peripheral T-cell lymphomas, i.e., it is a diagnosis of exclusion. C201080 Neoplastic Process Primary Cutaneous Peripheral T-Cell Lymphoma, Not Otherwise Specified CL1915470 Malignant Primary Cutaneous Peripheral T-Cell Lymphoma, NOS Primary Cutaneous Peripheral T-Cell Lymphoma, Not Otherwise Specified Primary Cutaneous Peripheral T-Cell Lymphoma, Unspecified pcPTCL-NOS Primary Cutaneous Peripheral T-Cell Lymphoma, Not Otherwise Specified Myeloid leukemia presenting with leukemic infiltration of tissues and normal or decreased leukocyte count in the peripheral blood. C201127 Neoplastic Process Aleukemic Myeloid leukemia C0221291 Malignant Aleukemic Granulocytic Leukemia Aleukemic Myelogenous Leukemia Aleukemic Myeloid leukemia Aleukemic Myeloid leukemia An angiofibroma that arises from the nose. It is found in adults as a solitary, dome-shaped papule on the nose. C201129 Neoplastic Process Angiofibroma of Nose C0334428 Benign Angiofibroma of Nose Fibrous Papule of Nose Angiofibroma of Nose MRI method that measure the diffusion of water in the tissue, rather than the content of water as measured in conventional MRI. C20117 Diagnostic Procedure Diffusion MRI Diffusion MRI C1136216 CTRP Diffusion_MRI Diffusion MRI Diffusion MRI Pancreatic acinar cell carcinoma that has spread from its original site of growth to another anatomic site. C201196 Neoplastic Process Metastatic Pancreatic Acinar Cell Carcinoma Metastatic Pancreatic Acinar Cell Carcinoma CL1920525 CTRP Malignant Metastatic Pancreatic Acinar Cell Carcinoma Metastatic Pancreatic Acinar Cell Carcinoma A highly aggressive, poorly to undifferentiated carcinoma that arises from the sinonasal tract. It is characterized by loss of one SWI/SNF complex subunit (either SMARCB1 or SMARCA4) and lacks histological features to allow classification into another specific entity. Most patients present with locally advanced disease. C201634 Neoplastic Process SWI/SNF Complex-Deficient Sinonasal Carcinoma CL1920826 Malignant SWI/SNF Complex-Deficient Sinonasal Carcinoma SWI/SNF-Deficient Sinonasal Carcinoma Sinonasal SWI/SNF Complex-Deficient Carcinoma Sinonasal SWI/SNF-Deficient Carcinoma SWI/SNF Complex-Deficient Sinonasal Carcinoma An SWI/SNF-deficient sinonasal carcinoma characterized by biallelic deletion or inactivating mutation of SMARCB1 gene. It usually affects the paranasal sinuses, especially ethmoid. It is composed of a monomorphic malignant epithelial cellular population with a predominantly basaloid or plasmacytoid/rhabdoid morphology. C201635 Neoplastic Process SMARCB1-Deficient Sinonasal Carcinoma CL1920827 Malignant SMARCB1-Deficient Sinonasal Carcinoma Sinonasal SMARCB1-Deficient Carcinoma SMARCB1-Deficient Sinonasal Carcinoma An SWI/SNF-deficient sinonasal carcinoma characterized by inactivating mutation of SMARCB1 gene. It usually affects the nasal sinuses. It is composed of malignant epithelial cells with a predominantly oncocytoid/plasmacytoid morphology and prominent glandular formations. C201636 Neoplastic Process SMARCB1-Deficient Sinonasal Adenocarcinoma CL1920824 Malignant SMARCB1-Deficient Sinonasal Adenocarcinoma Sinonasal SMARCB1-Deficient Adenocarcinoma SMARCB1-Deficient Sinonasal Adenocarcinoma An SWI/SNF-deficient sinonasal carcinoma characterized by inactivating mutation of SMARCA4 gene. It usually affects the nasal sinuses. It is composed of malignant large epithelioid anaplastic cells. C201637 Neoplastic Process SMARCA4 -Deficient Sinonasal Carcinoma CL1920825 Malignant SMARCA4 -Deficient Sinonasal Carcinoma Sinonasal SMARCA4 -Deficient Carcinoma SMARCA4 -Deficient Sinonasal Carcinoma An exophytic, warty, well differentiated, slow growing and non-metastasizing squamous cell carcinoma arising from the trachea. C201742 Neoplastic Process Tracheal Verrucous Carcinoma CL1920896 Malignant Tracheal Verrucous Carcinoma Tracheal Verrucous Carcinoma An exophytic, warty, well differentiated, slow growing and non-metastasizing squamous cell carcinoma arising from the hypopharynx. C201743 Neoplastic Process Hypopharyngeal Verrucous Carcinoma CL1920897 Malignant Hypopharyngeal Verrucous Carcinoma Hypopharyngeal Verrucous Carcinoma A high-grade, aggressive variant of squamous cell carcinoma that arises from the hypopharynx. It is characterized by the presence of small malignant cells with hyperchromatic nuclei and scant amount of cytoplasm forming lobules with peripheral palisading. C201746 Neoplastic Process Hypopharyngeal Basaloid Squamous Cell Carcinoma CL1920893 Malignant Hypopharyngeal Basaloid Carcinoma Hypopharyngeal Basaloid Squamous Cell Carcinoma Hypopharyngeal Basaloid Squamous Cell Carcinoma A high-grade, aggressive variant of squamous cell carcinoma that arises from the trachea. It is characterized by the presence of small malignant cells with hyperchromatic nuclei and scant amount of cytoplasm forming lobules with peripheral palisading. C201747 Neoplastic Process Tracheal Basaloid Squamous Cell Carcinoma CL1920894 Malignant Tracheal Basaloid Carcinoma Tracheal Basaloid Squamous Cell Carcinoma Tracheal Basaloid Squamous Cell Carcinoma A variant of squamous cell carcinoma that arises from the hypopharynx. It is characterized by exophytic and papillary growth. The papillae are covered by a malignant stratified squamous epithelium. C201748 Neoplastic Process Hypopharyngeal Papillary Squamous Cell Carcinoma CL1920891 Malignant Hypopharyngeal Papillary Squamous Cell Carcinoma Hypopharyngeal Papillary Squamous Cell Carcinoma A squamous cell carcinoma that arises from the hypopharynx. It is characterized by the presence of a malignant spindle cell cellular component. In some cases, there is a biphasic morphology due to the presence of a well-differentiated squamous cell carcinoma component. The latter is either in situ or invasive squamous cell carcinoma. C201749 Neoplastic Process Hypopharyngeal Spindle Cell Squamous Carcinoma CL1920892 Malignant Hypopharyngeal Spindle Cell Carcinoma Hypopharyngeal Spindle Cell Squamous Carcinoma Hypopharyngeal Spindle Cell Squamous Carcinoma The radiographic examination of the spinal cord and nerve roots following the injection of a contrast medium into the spinal subarachnoid space. The X-rays taken may highlight conditions such as spinal tumors, spinal cord swelling and herniated discs. C20175 Diagnostic Procedure Myelography C0026995 Myelography Myelography Myelography Tomographic examination of the kidney. C20176 Diagnostic Procedure Nephrotomography C0203103 Nephrotomography Nephrotomography Nephrotomography A benign, well-circumscribed or encapsulated neoplasm that arises from the salivary glands, usually the parotid. It is characterized by nodular and less often multinodular proliferation of cuboidal ductal cells and attenuated myoepithelial cells, resembling bi-layered intercalated ducts. Most lesions are incidental findings, usually measuring less than 5 mm. C201764 Neoplastic Process Salivary Gland Intercalated Duct Adenoma CL1920654 Benign Intercalated Duct Adenoma Salivary Gland Intercalated Duct Adenoma Salivary Gland Intercalated Duct Adenoma The creation of an image of the kidneys and urinary system using an intravenously administered contrast medium. By taking several X-rays over a short period of time, it is possible to check for the proper functioning of both kidneys and the urinary system. C20177 Diagnostic Procedure Intravenous Pyelography CL378230 CDISC A procedure in which x-ray images of the kidneys, ureters, and bladder are taken at regular times after a substance that shows up on x-rays is injected into a blood vessel. The substance outlines the kidneys, ureters, and bladder as it flows through the system and collects in the urine. IVP is usually done to look for a block in the flow of urine. An imaging technique in which X-ray images of the renal pelvis and urinary tract are obtained after intravenous injection of a radiopaque substance. Intravenous_Pyelography INTRAVENOUS PYELOGRAPHY IVP Intravenous Pyelography Intravenous Urography intravenous pyelography Intravenous Pyelography A benign neoplasm that arises from the parotid gland. It is characterized by the presence of multicystic formations, lined by neoplastic stratified squamous epithelium and containing keratotic lamellae. The neoplastic squamous epithelial cells have bland nuclei and abundant eosinophilic cytoplasm. Focally, solid islands of squamous cells surrounded by collagenous stroma are present. C201770 Neoplastic Process Parotid Gland Keratocystoma CL1920653 Benign Keratocystoma Parotid Gland Keratocystoma Parotid Gland Keratocystoma A rare, low-grade adenocarcinoma that arises from the salivary gland. Almost all cases have been described in the oral cavity. It is characterized by a microcystic growth pattern, uniform intercalated duct-like tumor cells, basophilic luminal secretions, and fibromyxoid stroma formation. It is associated with MEF2C-SS18 fusion gene expression. C201772 Neoplastic Process Salivary Gland Microsecretory Adenocarcinoma CL1920672 Malignant Salivary Gland Microsecretory Adenocarcinoma Salivary Gland Microsecretory Adenocarcinoma A salivary gland polymorphous adenocarcinoma characterized by the presence of uniform malignant cells with scant cytoplasm forming trabecular, tubular, microcystic, solid, and papillary-cystic patterns. The tumor stroma can be mucinous, myxoid, or hyalinized. Perineural involvement is often seen. C201781 Neoplastic Process Salivary Gland Polymorphous Adenocarcinoma, Conventional Subtype CL1920665 Malignant Salivary Gland Polymorphous Adenocarcinoma, Conventional Subtype Salivary Gland Polymorphous Adenocarcinoma, Conventional Subtype A salivary gland polymorphous adenocarcinoma characterized by the presence of malignant cells forming cribriform and multinodular patterns. C201786 Neoplastic Process Salivary Gland Polymorphous Adenocarcinoma, Cribriform Subtype CL1920662 Malignant CASG Cribriform Adenocarcinoma of the Salivary Glands Salivary Gland Polymorphous Adenocarcinoma, Cribriform Subtype Salivary Gland Polymorphous Adenocarcinoma, Cribriform Subtype A rare, slow-growing carcinoma that arises from the salivary glands, usually the minor salivary glands of the oral cavity. It is composed of malignant clear and eosinophilic cells in a hyalinized stroma. Most cases are associated with translocation of EWSR1 and ATF1, resulting in the formation of EWSR1-ATF1 fusion gene. The prognosis is good. C201823 Neoplastic Process Salivary Gland Hyalinizing Clear Cell Carcinoma CL1920703 Malignant Salivary Gland Hyalinizing Clear Cell Carcinoma Salivary Gland Hyalinizing Clear Cell Carcinoma A low-grade adenocarcinoma that arises from the minor salivary glands, usually in the oral cavity. It is characterized by the presence of a biphasic population of ductal and myoepithelial cells in a collagenous stroma. The prognosis is good. C201832 Neoplastic Process Minor Salivary Gland Sclerosing Microcystic Adenocarcinoma CL1920697 Malignant Minor Salivary Gland Sclerosing Microcystic Adenocarcinoma SMA Salivary Gland Sclerosing Microcystic Adenocarcinoma Sclerosing Microcystic Adenocarcinoma Minor Salivary Gland Sclerosing Microcystic Adenocarcinoma Penile carcinoma that is not amenable to surgical resection. C201837 Neoplastic Process Unresectable Penile Carcinoma CL1920713 Malignant Unresectable Penile Carcinoma Unresectable Penile Carcinoma Penile squamous cell carcinoma that is not amenable to surgical resection. C201838 Neoplastic Process Unresectable Penile Squamous Cell Carcinoma Unresectable Penile Squamous Cell Carcinoma CL1920714 CTRP Malignant Unresectable Penile Squamous Cell Carcinoma Unresectable Penile Squamous Cell Carcinoma A rare variant of chromophobe renal cell carcinoma that exhibits oncocytoma-like features. C201839 Neoplastic Process Oncocytic Variant of Chromophobe Renal Cell Carcinoma Oncocytic Variant of Chromophobe Renal Cell Carcinoma CL1920712 CTRP Malignant Oncocytic Renal Cell Carcinoma Oncocytic Variant of Chromophobe Renal Cell Carcinoma Oncocytic Variant of Chromophobe Renal Cell Carcinoma An adenocarcinoma that arises from the prostate and has not spread to other anatomic sites. C201849 Neoplastic Process Localized Prostate Adenocarcinoma Localized Prostate Adenocarcinoma CL1920706 CTRP Malignant Localized Prostate Adenocarcinoma Localized Prostate Adenocarcinoma A well differentiated squamous cell carcinoma arising from the tongue. It is an exophytic, warty, slow growing tumor, usually affecting older males. It is associated with the chronic use of smokeless tobacco. C201878 Neoplastic Process Tongue Verrucous Carcinoma CL1920729 Malignant Tongue Verrucous Carcinoma Tongue Verrucous Carcinoma Ectomesenchymal chondromyxoid tumor that arises from the tongue, usually the anterior dorsal aspect. C201880 Neoplastic Process Tongue Ectomesenchymal Chondromyxoid Tumor CL1920727 Benign Tongue Ectomesenchymal Chondromyxoid Tumor Tongue Ectomesenchymal Chondromyxoid Tumor An oropharyngeal squamous cell carcinoma characterized by the presence of keratinization and intercellular bridges. C201904 Neoplastic Process Oropharyngeal Keratinizing Squamous Cell Carcinoma CL1920756 Malignant Oropharyngeal Keratinizing Squamous Cell Carcinoma Oropharyngeal Keratinizing Squamous Cell Carcinoma An oropharyngeal human papillomavirus-independent squamous cell carcinoma characterized by the presence of keratinization and intercellular bridges. C201905 Neoplastic Process Oropharyngeal Human Papillomavirus-Independent Keratinizing Squamous Cell Carcinoma CL1920757 Malignant Oropharyngeal HPV-Independent Keratinizing Squamous Cell Carcinoma Oropharyngeal HPV-Negative Keratinizing Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus-Independent Keratinizing Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus-Negative Keratinizing Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus-Independent Keratinizing Squamous Cell Carcinoma An oropharyngeal human papillomavirus-related squamous cell carcinoma characterized by the presence of keratinization and intercellular bridges. C201906 Neoplastic Process Oropharyngeal Human Papillomavirus-Related Keratinizing Squamous Cell Carcinoma CL1920754 Malignant Oropharyngeal HPV-Associated Keratinizing Squamous Cell Carcinoma Oropharyngeal HPV-Positive Keratinizing Squamous Cell Carcinoma Oropharyngeal HPV-Related Keratinizing Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus-Associated Keratinizing Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus-Positive Keratinizing Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus-Related Keratinizing Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus-Related Keratinizing Squamous Cell Carcinoma An oropharyngeal human papillomavirus-related squamous cell carcinoma characterized by the absence of keratinization and intercellular bridges. C201907 Neoplastic Process Oropharyngeal Human Papillomavirus-Related Non-Keratinizing Squamous Cell Carcinoma CL1920755 Malignant Oropharyngeal HPV-Associated Non-Keratinizing Squamous Cell Carcinoma Oropharyngeal HPV-Positive Non-Keratinizing Squamous Cell Carcinoma Oropharyngeal HPV-Related Non-Keratinizing Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus-Associated Non-Keratinizing Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus-Positive Non-Keratinizing Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus-Related Non-Keratinizing Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus-Related Non-Keratinizing Squamous Cell Carcinoma Extraskeletal myxoid chondrosarcoma that has spread to nearby tissues or lymph nodes. C201951 Neoplastic Process Locally Advanced Extraskeletal Myxoid Chondrosarcoma Locally Advanced Extraskeletal Myxoid Chondrosarcoma CL1921399 CTRP Malignant Locally Advanced Extraskeletal Myxoid Chondrosarcoma Locally Advanced Extraskeletal Myxoid Chondrosarcoma Soft tissue sarcoma of the trunk and extremities that is amenable to surgical resection. C201952 Neoplastic Process Resectable Soft Tissue Sarcoma of the Trunk and Extremities Resectable Soft Tissue Sarcoma of the Trunk and Extremities CL1921400 CTRP Malignant Resectable Soft Tissue Sarcoma of the Trunk and Extremities Resectable Soft Tissue Sarcoma of the Trunk and Extremities A chromophobe renal cell carcinoma that is not amenable to surgical resection. C201953 Neoplastic Process Unresectable Chromophobe Renal Cell Carcinoma Unresectable Chromophobe Renal Cell Carcinoma CL1921421 CTRP Malignant Unresectable Chromophobe Renal Cell Carcinoma Unresectable Chromophobe Renal Cell Carcinoma Histologic transformation of chronic lymphocytic leukemia to Hodgkin lymphoma. C201960 Neoplastic Process Transformed Chronic Lymphocytic Leukemia to Hodgkin Lymphoma Transformed Chronic Lymphocytic Leukemia to Hodgkin Lymphoma CL1921419 CTRP Malignant Transformed Chronic Lymphocytic Leukemia to Hodgkin Lymphoma Transformed Chronic Lymphocytic Leukemia to Hodgkin Lymphoma Histologic transformation of small lymphocytic lymphoma to Hodgkin lymphoma. C201961 Neoplastic Process Transformed Small Lymphocytic Lymphoma to Hodgkin Lymphoma Transformed Small Lymphocytic Lymphoma to Hodgkin Lymphoma CL1921428 CTRP Malignant Transformed Small Lymphocytic Lymphoma to Hodgkin Lymphoma Transformed Small Lymphocytic Lymphoma to Hodgkin Lymphoma A term that refers to the classification of pineoblastomas according to their molecular characteristics. C201966 Neoplastic Process Pineoblastoma Molecular Subtypes CL1921425 Malignant Pineoblastoma Molecular Subtypes Pineoblastoma Molecular Subtypes Pineoblastoma characterized by alterations in genes involved in miRNA biogenesis (DICER1, DROSHA, and DGCR8). It may manifest as a sporadic tumor or part of DICER1 syndrome. It affects children. C201967 Neoplastic Process Pineoblastoma miRNA Processing Altered 1 CL1921423 Malignant PB-miRNA1 Pineoblastioma-miRNA1 Pineoblastoma miRNA Processing Altered 1 Pineoblastoma miRNA Processing Altered Group 1 Pineoblastoma miRNA Processing Altered 1 Pineoblastoma characterized by alterations in genes involved in miRNA biogenesis (DICER1, DROSHA, and DGCR8). It may manifest as a sporadic tumor or part of DICER1 syndrome. It affects older children and follows a more favorable course. C201968 Neoplastic Process Pineoblastoma miRNA Processing Altered 2 CL1921424 Malignant PB-miRNA2 Pineoblastioma-miRNA2 Pineoblastoma miRNA Processing Altered 2 Pineoblastoma miRNA Processing Altered Group 2 Pineoblastoma miRNA Processing Altered 2 Pineoblastoma characterized by alterations in RB1 gene. It may develop in the setting of congenital retinoblastoma, also known as trilateral retinoblastoma. It affects young children and is associated with a dismal prognosis. C201969 Neoplastic Process Pineoblastoma, RB1-Altered CL1921409 Malignant PB, RB1-Altered PB-RB1 Pineoblastoma, RB1-Altered Pineoblastoma-RB1 Pineoblastoma, RB1-Altered Pineoblastoma characterized by MYC activation, chromosome 16 losses, and overexpression of FOXR2. It affects young children and is associated with a dismal prognosis. C201973 Neoplastic Process Pineoblastoma, MYC/FOXR2-Activated CL1921407 Malignant PB, MYC-Altered PB, MYC/FOXR2-Activated PB, MYC/FOXR2-Altered PB-MYC PB-MYC/FOXR2 Pineoblastoma, MYC-Altered Pineoblastoma, MYC/FOXR2-Activated Pineoblastoma, MYC/FOXR2-Altered Pineoblastoma-MYC Pineoblastoma-MYC/FOXR2 Pineoblastoma, MYC/FOXR2-Activated Pilocytic astrocytoma that arises from the brain. C201975 Neoplastic Process Brain Pilocytic Astrocytoma CL1921405 Undetermined Brain Pilocytic Astrocytoma Brain Pilocytic Astrocytoma Pilocytic astrocytoma that arises from the spinal cord. C201976 Neoplastic Process Spinal Cord Pilocytic Astrocytoma CL1921406 Undetermined Spinal Cord Pilocytic Astrocytoma Spinal Cord Pilocytic Astrocytoma A low-grade glioma that arises from the brain. C201977 Neoplastic Process Brain Low Grade Glioma C1997581 Undetermined Brain Low Grade Glioma Brain Low-Grade Glioma Brain Low Grade Glioma A very rare, non-invasive epithelial neoplasm that arises from the lung. It is composed of multilocular cysts filled with mucus. The cysts are lined with columnar mucinous epithelium. Focal cellular atypia is present. C201978 Neoplastic Process Pulmonary Mucinous Cystic Tumor of Borderline Malignancy C0334365 GDC Uncertain Malignant Potential 8472/1 Mucinous cystic tumor of borderline malignancy Lung Mucinous Cystic Tumor of Borderline Malignancy Lung Mucinous Cystic Tumor of Low or Borderline Malignancy Mucinous cystic tumor of borderline malignancy Pulmonary Mucinous Cystic Tumor of Borderline Malignancy Pulmonary Mucinous Cystic Tumor of Low or Borderline Malignancy Pulmonary Mucinous Cystic Tumor of Borderline Malignancy A description of an individual's current or previous caffeine consumption. C201990 Clinical Attribute Caffeine Use History CL1921444 Caffeine History Caffeine Use Caffeine Use History Caffeine Use History An embryonal tumor with multilayered rosettes that arises from the fourth ventricle. C202010 Neoplastic Process Embryonal Tumor with Multilayered Rosettes of the Fourth Ventricle CL1921430 Malignant Embryonal Tumor with Multilayered Rosettes of the Fourth Ventricle Fourth Ventricle Embryonal Tumor with Multilayered Rosettes Embryonal Tumor with Multilayered Rosettes of the Fourth Ventricle A calcifying epithelial odontogenic tumor that contains a variable proportion of clear cells containing diastase-labile PAS-positive material that is consistent with glycogen. C202057 Neoplastic Process Clear Cell Calcifying Epithelial Odontogenic Tumor CL1921482 Benign Clear Cell Calcifying Epithelial Odontogenic Tumor Clear Cell Calcifying Epithelial Odontogenic Tumor A calcifying epithelial odontogenic tumor characterized by cystic/microcystic changes. C202058 Neoplastic Process Cystic/Microcystic Calcifying Epithelial Odontogenic Tumor CL1921479 Benign Cystic/Microcystic Calcifying Epithelial Odontogenic Tumor Cystic/Microcystic Calcifying Epithelial Odontogenic Tumor A calcifying epithelial odontogenic tumor that contains significant numbers of Langerhans cells. C202059 Neoplastic Process Non-Calcifying/Langerhans Cell-Rich Calcifying Epithelial Odontogenic Tumor CL1921480 Benign Non-Calcifying/Langerhans Cell-Rich Calcifying Epithelial Odontogenic Tumor Non-Calcifying/Langerhans Cell-Rich Calcifying Epithelial Odontogenic Tumor A rare ameloblastoma characterized by the presence of cribriform architecture and the formation of duct-like structures. Dentinoid is usually present. C202061 Neoplastic Process Adenoid Ameloblastoma CL976502 Undetermined Adenoid Ameloblastoma Adenoid Ameloblastoma with Dentinoid Adenoid Ameloblastoma An odontogenic fibroma that arises from tooth-forming tissues in the mandible and maxilla. C202077 Neoplastic Process Central Odontogenic Fibroma CL1921478 GDC Benign 9321/0 Central odontogenic fibroma Central Odontogenic Fibroma Central odontogenic fibroma Central Odontogenic Fibroma A central odontogenic fibroma characterized by the presence of amyloid deposits. Langerhans cells are often present in the odontogenic epithelium. C202078 Neoplastic Process Odontogenic Fibroma, Amyloid Subtype CL1921476 Benign Odontogenic Fibroma, Amyloid Subtype Odontogenic Fibroma, Amyloid Subtype A central odontogenic fibroma composed of granular cells admixed with odontogenic epithelium. C202079 Neoplastic Process Odontogenic Fibroma, Granular Cell Subtype CL1921477 Benign Odontogenic Fibroma, Granular Cell Subtype Odontogenic Fibroma, Granular Cell Subtype A central odontogenic fibroma characterized by the presence of odontogenic fibroma components admixed with ossifying fibroma-like tissue. C202080 Neoplastic Process Odontogenic Fibroma, Ossifying Subtype CL1921474 Benign Odontogenic Fibroma, Ossifying Subtype Odontogenic Fibroma, Ossifying Subtype A central odontogenic fibroma characterized by the presence of combined histological features of giant cell granuloma and odontogenic fibroma. C202081 Neoplastic Process Hybrid Odontogenic Fibroma with Central Giant Cell Granuloma CL1921475 Benign Hybrid Odontogenic Fibroma with Central Giant Cell Granuloma Hybrid Odontogenic Fibroma with Central Giant Cell Granuloma Histologic transformation of EGFR mutation-positive lung adenocarcinoma to squamous cell carcinoma, following treatment with tyrosine kinase inhibitors. C202128 Neoplastic Process Transformed EGFR-Positive Lung Adenocarcinoma to Squamous Cell Carcinoma CL1921175 Cellosaurus Malignant Transformed EGFR-Positive Lung Adenocarcinoma to Lung Squamous Cell Carcinoma Transformed EGFR-Positive Lung Adenocarcinoma to Squamous Cell Carcinoma Transformed EGFR-Positive Lung Adenocarcinoma to Squamous Cell Carcinoma Lung adenocarcinoma that is associated with EGFR gene mutation. C202130 Neoplastic Process EGFR-Positive Lung Adenocarcinoma CL1921173 Malignant EGFR-Positive Lung Adenocarcinoma EGFR-Positive Lung Adenocarcinoma Lung non-small cell carcinoma that is associated with EGFR gene mutation. C202131 Neoplastic Process EGFR-Positive Lung Non-Small Cell Carcinoma CL1921171 Malignant EGFR-Positive Lung Non-Small Cell Carcinoma EGFR-Positive Lung Non-Small Cell Carcinoma Histologic transformation of EGFR mutation-positive lung non-small cell carcinoma to small cell carcinoma, following treatment with tyrosine kinase inhibitors. C202132 Neoplastic Process Transformed EGFR-Positive Lung Non-Small Cell Carcinoma to Small Cell Carcinoma CL1921172 Malignant Transformed EGFR-Positive Lung Non-Small Cell Carcinoma to Lung Small Cell Carcinoma Transformed EGFR-Positive Lung Non-Small Cell Carcinoma to Small Cell Carcinoma Transformed EGFR-Positive Lung Non-Small Cell Carcinoma to Small Cell Carcinoma Histologic transformation of EGFR mutation-positive lung adenocarcinoma to small cell carcinoma, following treatment with tyrosine kinase inhibitors. C202133 Neoplastic Process Transformed EGFR-Positive Lung Adenocarcinoma to Small Cell Carcinoma CL1921156 Cellosaurus Malignant Transformed EGFR-Positive Lung Adenocarcinoma to Lung Small Cell Carcinoma Transformed EGFR-Positive Lung Adenocarcinoma to Small Cell Carcinoma Transformed EGFR-Positive Lung Adenocarcinoma to Small Cell Carcinoma A rare, benign fibro-osseous neoplasm that usually affects the jaws and predominantly arises in children and adolescents. It is characterized by prominent osteoid formation rimmed by osteoblasts in a fibrotic stroma. Patients usually present with painless jaw expansion that is associated with rapid growth and tooth displacement. Amplifications of MDM2 and RASAL1 genes have been detected in some cases. Recurrences have been reported in a minority of cases. C202205 Neoplastic Process Juvenile Trabecular Ossifying Fibroma C3697892 Benign JTOF Juvenile Trabecular Ossifying Fibroma Trabecular Juvenile Ossifying Fibroma Trabecular Ossifying Fibroma Juvenile Trabecular Ossifying Fibroma A rare, benign fibro-osseous neoplasm that arises from the craniofacial skeleton. It is characterized by the presence of multiple ossicles resembling psammoma bodies in a hypercellular stroma. It usually affects individuals in their second to fourth decades. Recurrences following surgical excision have been reported in a minority of cases. C202209 Neoplastic Process Psammomatoid Ossifying Fibroma C3697525 Benign Juvenile Psammomatoid Ossifying Fibroma PsOF Psammomatoid Ossifying Fibroma Psammomatoid Ossifying Fibroma An osteoma that arises from the surface of the bone. C202252 Neoplastic Process Surface Osteoma C3697813 Benign Ivory Exostosis Periosteal Osteoma Surface Osteoma Surface Osteoma An osteoma that arises from the endosteum. C202253 Neoplastic Process Central Osteoma C0265512 Benign Central Osteoma Endosteal Osteoma Enostosis Central Osteoma An osteoma that arises from the jaw. It affects the mandible more often than the maxilla. C202254 Neoplastic Process Jaw Osteoma CL1921212 Benign Jaw Osteoma Jaw Osteoma An osteoblastoma that arises from the jaw. It affects the mandible more often than the maxilla. C202256 Neoplastic Process Jaw Osteoblastoma CL1921253 Benign Jaw Osteoblastoma Jaw Osteoblastoma A chondromyxoid fibroma that arises from the jaw. C202257 Neoplastic Process Jaw Chondromyxoid Fibroma CL1921254 Benign Jaw Chondromyxoid Fibroma Jaw Chondromyxoid Fibroma A desmoplastic fibroma that arises from the jaw. It affects the mandible more often than the maxilla. C202258 Neoplastic Process Jaw Desmoplastic Fibroma CL1921251 Benign Jaw Desmoplastic Fibroma Jaw Desmoplastic Fibroma A rare osteochondroma that arises from a maxillofacial bone. C202260 Neoplastic Process Maxillofacial Osteochondroma CL1921249 Benign Maxillofacial Osteochondroma Maxillofacial Osteochondroma An osteosarcoma that arises from the jaw. It affects the mandible more often than the maxilla. C202261 Neoplastic Process Jaw Osteosarcoma CL1921250 Malignant Jaw Osteosarcoma Jaw Osteosarcoma A primary or metastatic malignant neoplasm that affects a maxillofacial bone. C202262 Neoplastic Process Malignant Maxillofacial Neoplasm CL1921247 Malignant Malignant Maxillofacial Neoplasm Malignant Maxillofacial Neoplasm An aggressive, high-grade rhabdomyosarcoma characterized by TFCP2 rearrangement that results either in TFCP2-FUS or TFCP2-EWSR1 fusion gene formation. It affects young adults and arises from bone and less frequently soft tissue. It predominantly affects the craniofacial bones. Histologically, it usually shows a biphasic pattern with spindle and epithelioid cell areas. It is associated with poor prognosis. C202263 Neoplastic Process Rhabdomyosarcoma with TFCP2 Rearrangement CL1921248 Malignant Epithelioid/Spindle Cell Rhabdomyosarcoma Epithelioid/Spindle Cell Rhabdomyosarcoma with TFCP2 Rearrangement Rhabdomyosarcoma with TFCP2 Rearrangement TFCP2-RMS Rhabdomyosarcoma with TFCP2 Rearrangement A rhabdomyosarcoma with TFCP2 rearrangement that arises from a maxillofacial bone. C202264 Neoplastic Process Maxillofacial Rhabdomyosarcoma with TFCP2 Rearrangement CL1921261 Malignant Maxillofacial Epithelioid/Spindle Cell Rhabdomyosarcoma Maxillofacial Epithelioid/Spindle Cell Rhabdomyosarcoma with TFCP2 Rearrangement Maxillofacial Rhabdomyosarcoma with TFCP2 Rearrangement Maxillofacial TFCP2-RMS Maxillofacial Rhabdomyosarcoma with TFCP2 Rearrangement A rhabdomyosarcoma with TFCP2 rearrangement that arises from the jaw. It affects the mandible more often than the maxilla. C202265 Neoplastic Process Jaw Rhabdomyosarcoma with TFCP2 Rearrangement CL1921262 Malignant Jaw Epithelioid/Spindle Cell Rhabdomyosarcoma Jaw Epithelioid/Spindle Cell Rhabdomyosarcoma with TFCP2 Rearrangement Jaw Rhabdomyosarcoma with TFCP2 Rearrangement Jaw TFCP2-RMS Jaw Rhabdomyosarcoma with TFCP2 Rearrangement A malignant glioma that occurs during childhood. C202298 Neoplastic Process Childhood Malignant Glioma CL1921284 Malignant Childhood High Grade Glioma Childhood High-Grade Glioma Childhood Malignant Glioma Pediatric High Grade Glioma Pediatric High-Grade Glioma Pediatric Malignant Glioma Childhood Malignant Glioma A low-grade glioma that occurs during childhood. C202299 Neoplastic Process Childhood Low Grade Glioma CL1921285 Undetermined Childhood Low Grade Glioma Childhood Low-Grade Glioma Pediatric Low Grade Glioma Pediatric Low-Grade Glioma Childhood Low Grade Glioma A group of renal cell carcinomas characterized by the absence of lipid-containing clear adenocarcinoma cells. This category includes the following morphological subtypes: papillary renal cell carcinoma; sarcomatoid renal cell carcinoma; chromophobe renal cell carcinoma; tubulocystic renal cell carcinoma; and eosinophilic solid and cystic renal cell carcinoma. C202497 Neoplastic Process Non-Clear Cell Renal Cell Carcinoma CL1921818 Malignant Non Clear Cell Renal Cell Carcinoma Non-Clear Cell Renal Cell Carcinoma nccRCC Non-Clear Cell Renal Cell Carcinoma Digestive system adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C202500 Neoplastic Process Locally Advanced Unresectable Digestive System Adenocarcinoma Locally Advanced Unresectable Digestive System Adenocarcinoma CL1921802 CTRP Malignant Locally Advanced Unresectable Digestive System Adenocarcinoma Locally Advanced Unresectable Digestive System Adenocarcinoma An osteoma that arises from the bony cortex of the external auditory canal and, rarely, the middle ear. C202574 Neoplastic Process Ear Osteoma C0155411 Benign Ear Exostosis Ear Osteoma Ear Osteoma A rare papilloma that arises from the middle ear and resembles a sinonasal papilloma. Approximately half of the patients have concurrent sinonasal or nasopharyngeal papillomas. C202582 Neoplastic Process Middle Ear Papilloma CL1921886 Benign Middle Ear Papilloma Middle Ear Sinonasal-Type Papilloma Middle Ear Papilloma An inverted papilloma that arises from the middle ear and resembles a sinonasal inverted papilloma. C202583 Neoplastic Process Middle Ear Inverted Sinonasal-Type Papilloma CL1921883 Benign Middle Ear Inverted Sinonasal-Type Papilloma Middle Ear Inverted Sinonasal-Type Papilloma An exophytic papilloma that arises from the middle ear and resembles an exophytic sinonasal papilloma. C202584 Neoplastic Process Middle Ear Exophytic Sinonasal-Type Papilloma CL1921884 Benign Middle Ear Exophytic Sinonasal-Type Papilloma Middle Ear Exophytic Sinonasal-Type Papilloma An oncocytic papilloma that arises from the middle ear and resembles an oncocytic sinonasal papilloma. C202585 Neoplastic Process Middle Ear Oncocytic Sinonasal-Type Papilloma CL1921881 Benign Middle Ear Oncocytic Sinonasal-Type Papilloma Middle Ear Oncocytic Sinonasal-Type Papilloma A squamous cell carcinoma that arises from the keratinizing squamous epithelium that lines the external auditory canal. C202594 Neoplastic Process External Auditory Canal Squamous Cell Carcinoma C1828185 Cellosaurus Malignant EACSCC External Auditory Canal Squamous Cell Carcinoma Squamous Cell Carcinoma of the External Auditory Canal External Auditory Canal Squamous Cell Carcinoma A benign adipose tissue neoplasm that arises from the buccal mucosa. C202609 Neoplastic Process Buccal Mucosa Lipoma CL1921879 Benign Buccal Mucosa Lipoma Buccal Mucosa Lipoma A liposarcoma that arises from the head and neck. The majority affect the subcutaneous connective tissue of the face, neck, and scalp. C202611 Neoplastic Process Head and Neck Liposarcoma CL1921907 Malignant Head and Neck Liposarcoma Head and Neck Liposarcoma Nodular fasciitis that arises from the head and neck. It usually affects the face, oral cavity, orbit, ear, parotid gland, and neck. C202613 Neoplastic Process Head and Neck Nodular Fasciitis CL1921906 Benign Head and Neck Nodular Fasciitis Head and Neck Nodular Fasciitis A solitary fibrous tumor that arises from the orbit. Most of these tumors are benign. C202620 Neoplastic Process Orbit Solitary Fibrous Tumor CL1921913 Undetermined Orbit Solitary Fibrous Tumor Orbit Solitary Fibrous Tumor A low-grade myofibroblastic sarcoma arising from the tongue. C202621 Neoplastic Process Tongue Low Grade Myofibroblastic Sarcoma CL1921911 Malignant Tongue Low Grade Myofibroblastic Sarcoma Tongue Low-Grade Myofibroblastic Sarcoma Tongue Low Grade Myofibroblastic Sarcoma A low-grade myofibroblastic sarcoma arising from the gingiva. C202622 Neoplastic Process Gingival Low Grade Myofibroblastic Sarcoma CL1921912 Malignant Gingival Low Grade Myofibroblastic Sarcoma Gingival Low-Grade Myofibroblastic Sarcoma Gingival Low Grade Myofibroblastic Sarcoma A mesenchymal neoplasm that arises from the soft tissue of the head and neck. C202623 Neoplastic Process Head and Neck Soft Tissue Neoplasm CL1921909 Undetermined Head and Neck Soft Tissue Neoplasm Head and Neck Soft Tissue Neoplasm A non-metastasizing mesenchymal neoplasm that lacks cytological/morphological atypical features and arises from the soft tissue of the head and neck. C202624 Neoplastic Process Benign Head and Neck Soft Tissue Neoplasm CL1921910 Benign Benign Head and Neck Soft Tissue Neoplasm Benign Head and Neck Soft Tissue Neoplasm A mesenchymal neoplasm with cytological/morphological malignant features and metastatic potential that arises from the soft tissue of the head and neck. C202625 Neoplastic Process Malignant Head and Neck Soft Tissue Neoplasm CL1921908 Malignant Malignant Head and Neck Soft Tissue Neoplasm Malignant Head and Neck Soft Tissue Neoplasm A colon carcinoma that arises from cecum, ascending colon, or hepatic flexure. C202633 Neoplastic Process Proximal Colon Carcinoma CL1921894 Malignant Proximal Colon Cancer Proximal Colon Carcinoma Proximal Colon Carcinoma A colon carcinoma that arises from the splenic flexure, descending colon, or sigmoid colon. C202634 Neoplastic Process Distal Colon Carcinoma CL1921895 Malignant Distal Colon Cancer Distal Colon Carcinoma Distal Colon Carcinoma An inflammatory myofibroblastic tumor that arises from the head and neck. The most frequently affected sites are the larynx, sinonasal tract, and oral cavity. C202635 Neoplastic Process Head and Neck Inflammatory Myofibroblastic Tumor CL1921903 Undetermined Head and Neck Inflammatory Myofibroblastic Tumor Head and Neck Inflammatory Myofibroblastic Tumor A benign adipose tissue neoplasm that arises from the head and neck. The most frequently affected sites are the lower lip, buccal mucosa, and tongue. C202646 Neoplastic Process Head and Neck Lipoma C0578545 Benign Head and Neck Lipoma Head and Neck Lipoma A hemangioma that arises from the head and neck. The most frequently affected sites are the oral cavity and sinonasal tract mucosa. C202647 Neoplastic Process Head and Neck Hemangioma CL1921505 Benign Head and Neck Hemangioma Head and Neck Hemangioma An epithelioid hemangioma that arises from the head and neck. The most frequently affected sites are the forehead, preauricular region, and scalp. C202652 Neoplastic Process Head and Neck Epithelioid Hemangioma CL1921514 Benign Head and Neck Epithelioid Hemangioma Head and Neck Epithelioid Hemangioma A lymphangioma that arises from the head and neck. It usually affects the skin and soft tissue of the head and neck region. C202654 Neoplastic Process Head and Neck Lymphangioma CL1921512 Benign Head and Neck Lymphangioma Head and Neck Lymphangioma A rare epithelioid hemangioendothelioma that arises from the head and neck. The most frequently affected sites are the oral cavity, soft tissue of the neck, and salivary glands. C202655 Neoplastic Process Head and Neck Epithelioid Hemangioendothelioma CL1921509 Malignant Head and Neck Epithelioid Hemangioendothelioma Head and Neck Epithelioid Hemangioendothelioma An angiosarcoma that arises from the head and neck. The most frequently affected sites are the oral cavity, nasal cavity, and maxillary sinus. C202656 Neoplastic Process Head and Neck Angiosarcoma CL1921510 Malignant Head and Neck Angiosarcoma Head and Neck Angiosarcoma A benign neoplasm with smooth muscle differentiation that arises from the head and neck. The most frequently affected site is the oral cavity. C202711 Neoplastic Process Head and Neck Leiomyoma CL1921560 Benign Head and Neck Leiomyoma Head and Neck Leiomyoma A rare neoplasm of uncertain biological potential that arises from the head and neck. It is associated with EBV infection, exhibits smooth muscle differentiation, and occurs in immunocompromised patients. The most frequent sites of involvement are the larynx, oropharynx, and eye/orbit. C202849 Neoplastic Process Head and Neck EBV-Associated Smooth Muscle Tumor CL1921686 Undetermined Head and Neck EBV-Associated Smooth Muscle Tumor Head and Neck Epstein-Barr Virus-Associated Smooth Muscle Neoplasm Head and Neck Epstein-Barr Virus-Associated Smooth Muscle Tumor Head and Neck EBV-Associated Smooth Muscle Tumor A neoplasm with smooth muscle differentiation that cannot be reliably diagnosed as benign or malignant because of the presence of ambiguous morphologic findings. The vast majority of cases arise from the female reproductive system. Malignant behavior has been reported in a minority of cases. C202851 Neoplastic Process Smooth Muscle Tumor of Uncertain Malignant Potential CL018077 Uncertain Malignant Potential STUMP Smooth Muscle Tumor of Uncertain Malignant Potential Smooth Muscle Tumor of Uncertain Malignant Potential A rare smooth muscle tumor of uncertain malignant potential that arises from the sinonasal tract. C202852 Neoplastic Process Sinonasal Smooth Muscle Tumor of Uncertain Malignant Potential CL1921682 Uncertain Malignant Potential Sinonasal STUMP Sinonasal Smooth Muscle Tumor of Uncertain Malignant Potential Sinonasal Tract STUMP Sinonasal Tract Smooth Muscle Tumor of Uncertain Malignant Potential Sinonasal Smooth Muscle Tumor of Uncertain Malignant Potential A malignant neoplasm with smooth muscle differentiation that arises from the head and neck. The most frequently affected sites are the subcutaneous and deep neck soft tissues. C202853 Neoplastic Process Head and Neck Leiomyosarcoma CL1921683 Malignant Head and Neck Leiomyosarcoma Head and Neck Leiomyosarcoma A benign neoplasm with skeletal muscle differentiation that arises from the head and neck. It usually affects the mouth, parapharyngeal space, larynx, salivary glands, and soft tissue of the neck. C202858 Neoplastic Process Head and Neck Rhabdomyoma CL1921670 Benign Head and Neck Rhabdomyoma Head and Neck Rhabdomyoma A malignant neoplasm with skeletal muscle differentiation that arises from the head and neck. It usually affects the orbit, eyelid, ear, sinonasal tract, and nasopharynx. C202859 Neoplastic Process Head and Neck Rhabdomyosarcoma CL1921667 Malignant Head and Neck Rhabdomyosarcoma Head and Neck Rhabdomyosarcoma A neurofibroma that arises from the oral cavity. The tongue is the most frequently affected site. C202860 Neoplastic Process Oral Cavity Neurofibroma CL1921668 Benign Oral Cavity Neurofibroma Oral Cavity Neurofibroma A neurofibroma that arises from the tongue. C202861 Neoplastic Process Tongue Neurofibroma C5826646 Benign Tongue Neurofibroma Tongue Neurofibroma A schwannoma that arises from the oral cavity. C202876 Neoplastic Process Oral Cavity Schwannoma CL1921707 Benign Oral Cavity Schwannoma Oral Cavity Schwannoma A schwannoma that arises from the tongue. C202877 Neoplastic Process Tongue Schwannoma CL1921705 Benign Tongue Schwannoma Tongue Schwannoma A malignant peripheral nerve sheath tumor that arises from the head and neck. It usually affects the soft tissue of the neck. The head and neck region is the most frequently involved site for malignant peripheral nerve sheath tumors, following the trunk and extremities. C202878 Neoplastic Process Head and Neck Malignant Peripheral Nerve Sheath Tumor CL1921706 Malignant Head and Neck Malignant Peripheral Nerve Sheath Tumor Head and Neck Malignant Peripheral Nerve Sheath Tumor A phosphaturic mesenchymal tumor that arises from the head and neck. It usually affects the paranasal sinuses. The head and neck region is the most frequently involved site for phosphaturic mesenchymal tumors, following the appendicular skeleton. C202879 Neoplastic Process Head and Neck Phosphaturic Mesenchymal Tumor CL1921703 Undetermined Head and Neck PMT Head and Neck Phosphaturic Mesenchymal Tumor Head and Neck Phosphaturic Mesenchymal Tumor A phosphaturic mesenchymal tumor that arises from the appendicular skeleton. The appendicular skeleton is the most frequently involved site for phosphaturic mesenchymal tumors. C202880 Neoplastic Process Appendicular Skeleton Phosphaturic Mesenchymal Tumor CL1921704 Undetermined Appendicular Skeleton PMT Appendicular Skeleton Phosphaturic Mesenchymal Tumor Appendicular Skeleton Phosphaturic Mesenchymal Tumor An extraskeletal myxoid chondrosarcoma that arises from the head and neck. The orbit is the most frequently affected site. C202881 Neoplastic Process Head and Neck Extraskeletal Myxoid Chondrosarcoma CL1921715 Malignant Head and Neck Extraskeletal Myxoid Chondrosarcoma Head and Neck NR4A3-Rearranged Myxoid Sarcoma Head and Neck Extraskeletal Myxoid Chondrosarcoma An extraskeletal myxoid chondrosarcoma that arises from the orbit. The orbit is the most frequently affected site for extraskeletal myxoid chondrosarcomas in the head and neck region. C202882 Neoplastic Process Orbit Extraskeletal Myxoid Chondrosarcoma CL1921716 Malignant Orbit Extraskeletal Myxoid Chondrosarcoma Orbit NR4A3-Rearranged Myxoid Sarcoma Orbit Extraskeletal Myxoid Chondrosarcoma A synovial sarcoma characterized by the presence of poorly differentiated morphological features and absence of spindle cells. C202883 Neoplastic Process Poorly Differentiated Synovial Sarcoma CL1921713 Malignant Poorly Differentiated Synovial Sarcoma Poorly Differentiated Synovial Sarcoma A synovial sarcoma that arises from the head and neck region. C202884 Neoplastic Process Head and Neck Synovial Sarcoma CL1921714 Malignant Head and Neck Synovial Sarcoma Head and Neck Synovial Sarcoma Neck lymph node boundary level II contains the upper jugular nodal group. It is divided by the accessory nerve into sublevels IIA and IIB. The following anatomical structures define sublevel IIA: Superior: skull base; inferior: horizontal plane defined by the inferior border of the hyoid bone; anterior (medial): stylohyoid muscle; posterior (lateral): vertical plane defined by the spinal accessory nerve. The following anatomical structures define sublevel IIB: Superior: skull base; inferior: horizontal plane defined by the inferior body of the hyoid bone; anterior (medial): vertical plane defined by the spinal accessory nerve; posterior (lateral): lateral border of the sternocleidomastoid muscle. (partially adapted from AJCC 8th ed.) C202889 Finding Neck Lymph Node Boundary Level II CL1921693 Neck Lymph Node Boundary Level II Neck Lymph Node Boundary Level II Neck lymph node boundary level V contains the posterior triangle lymph node group. It includes the lymph nodes located along the lower half of the spinal accessory nerve and the transverse cervical artery. The supraclavicular nodes are also included in this group. It is divided into sublevels VA and VB. The following anatomical structures define sublevel VA: Superior: apex of the convergence of the sternocleidomastoid and trapezius muscles; inferior: horizontal plane defined by the lower border of the cricoid cartilage; anterior (medial): posterior border of the sternocleidomastoid muscle or sensory branches of the cervical plexus; posterior (lateral): anterior border of the trapezius muscle. The following anatomical structures define sublevel VB: Superior: horizontal plane defined by the lower border of the cricoid cartilage; inferior: clavicle; anterior (medial): posterior border of the sternocleidomastoid muscle; posterior (lateral): anterior border of the trapezius muscle. (partially adapted from AJCC 8th ed.) C202890 Finding Neck Lymph Node Boundary Level V CL1921694 Neck Lymph Node Boundary Level V Neck Lymph Node Boundary Level V Prostate small cell neuroendocrine carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C202894 Neoplastic Process Advanced Prostate Small Cell Neuroendocrine Carcinoma Advanced Prostate Small Cell Neuroendocrine Carcinoma CL1921690 CTRP Malignant Advanced Prostate Small Cell Neuroendocrine Carcinoma Advanced Prostate Small Cell Neuroendocrine Carcinoma A rare mesenchymal neoplasm of uncertain histogenesis that arises from soft tissue and viscera. It is characterized by the presence of nests and sheets of neoplastic epithelioid cells separated by a rich delicate arborizing vascular network, and GLI1 gene rearrangement. It presents as a slow-growing painless mass. The majority of cases have an indolent clinical course following complete excision. Distant metastases have been reported in a minority of cases. C202896 Neoplastic Process GLI1-Altered Soft Tissue Tumor CL1921688 Undetermined Epithelioid Neoplasm with GLI1 Rearrangement GAESTT GLI1-Altered Epithelioid Soft Tissue Tumor GLI1-Altered Soft Tissue Tumor Pericytoma with t(7;12) GLI1-Altered Soft Tissue Tumor A GLI1-altered soft tissue tumor that arises from the head and neck. The majority of cases arise from the tongue. Less frequently involved sites include the submandibular gland and soft tissue of neck. C202897 Neoplastic Process Head and Neck GLI1-Altered Soft Tissue Tumor CL1921701 Undetermined Head and Neck Epithelioid Neoplasm with GLI1 Rearrangement Head and Neck GAESTT Head and Neck GLI1-Altered Epithelioid Soft Tissue Tumor Head and Neck GLI1-Altered Soft Tissue Tumor Head and Neck GLI1-Altered Soft Tissue Tumor A GLI1-altered soft tissue tumor that arises from the tongue. C202898 Neoplastic Process Tongue GLI1-Altered Soft Tissue Tumor CL1921702 Undetermined Tongue Epithelioid Neoplasm with GLI1 Rearrangement Tongue GAESTT Tongue GLI1-Altered Epithelioid Soft Tissue Tumor Tongue GLI1-Altered Soft Tissue Tumor Tongue GLI1-Altered Soft Tissue Tumor Non-muscle invasive bladder carcinoma that is resistant to treatment. C202899 Neoplastic Process Refractory Non-Muscle Invasive Bladder Carcinoma Refractory Non-Muscle Invasive Bladder Carcinoma CL1921699 CTRP Malignant Refractory Non-Muscle Invasive Bladder Carcinoma Refractory Non-Muscle Invasive Bladder Carcinoma An undifferentiated pleomorphic sarcoma that arises from the head and neck region. C202901 Neoplastic Process Head and Neck Undifferentiated Pleomorphic Sarcoma CL1921697 Malignant Head and Neck Undifferentiated Pleomorphic Sarcoma Head and Neck Undifferentiated Pleomorphic Sarcoma A Ewing sarcoma that arises from the head and neck region. The most frequent sites of involvement are the skull and facial bones, head and neck soft tissue, and mandible. C202904 Neoplastic Process Head and Neck Ewing Sarcoma CL1921696 Malignant Head and Neck Ewing Sarcoma Head and Neck Ewing Sarcoma A rare myeloid sarcoma that arises from the head and neck region. The oral cavity is the most frequently affected site. C202914 Neoplastic Process Head and Neck Myeloid Sarcoma CL1922094 Malignant Head and Neck Extramedullary Myeloid Sarcoma Head and Neck Myeloid Sarcoma Head and Neck Myeloid Sarcoma A Hodgkin or non-Hodgkin lymphoma that arises from the head and neck region. Hodgkin lymphomas are usually located in the lymph nodes of the neck. Non-Hodgkin lymphomas usually arise from the ocular adnexa, salivary glands, larynx, and thyroid gland. C202921 Neoplastic Process Head and Neck Lymphoma CL1922076 Malignant Head and Neck Lymphoma Head and Neck Lymphoma A Hodgkin lymphoma that affects the head and neck region. It is usually located in the lymph nodes of the neck. C202922 Neoplastic Process Head and Neck Hodgkin Lymphoma CL1922077 Malignant Head and Neck Hodgkin Lymphoma Head and Neck Hodgkin Lymphoma A non-Hodgkin lymphoma that affects the head and neck region. It usually arises from the ocular adnexa, salivary glands, larynx, and thyroid gland. C202923 Neoplastic Process Head and Neck Non-Hodgkin Lymphoma CL1922074 Malignant Head and Neck Non-Hodgkin Lymphoma Head and Neck Non-Hodgkin Lymphoma An extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue that affects the head and neck region. It usually arises from the ocular adnexa and salivary glands. C202924 Neoplastic Process Head and Neck Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue CL1922075 Malignant Head and Neck Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Head and Neck MALT Head and Neck Mucosa-Associated Lymphoid Tissue Lymphoma Head and Neck Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue A mantle cell lymphoma that affects the head and neck region. The most common site of involvement is the Waldeyer ring, usually the tonsils. Other sites of involvement include the orbit, salivary glands, and nasopharynx. C202925 Neoplastic Process Head and Neck Mantle Cell Lymphoma CL1922072 Malignant Head and Neck Mantle Cell Lymphoma Head and Neck Mantle Cell Lymphoma A follicular lymphoma that arises from the head and neck region. It usually affects older individuals, and the most common sites of involvement are the cervical lymph nodes and Waldeyer ring. C202926 Neoplastic Process Head and Neck Follicular Lymphoma CL1922073 Malignant Head and Neck Follicular Lymphoma Head and Neck Follicular Lymphoma A pediatric-type follicular lymphoma that affects the head and neck region. C202927 Neoplastic Process Head and Neck Pediatric-Type Follicular Lymphoma CL1922070 Malignant Head and Neck Pediatric-Type Follicular Lymphoma Head and Neck Pediatric-Type Follicular Lymphoma A large B-cell lymphoma with IRF4 rearrangement that arises from the head and neck region, usually the Waldeyer ring and/or cervical lymph nodes. C202929 Neoplastic Process Head and Neck Large B-Cell Lymphoma with IRF4 Rearrangement CL1922084 Malignant Head and Neck Large B-Cell Lymphoma with IRF4 Rearrangement Head and Neck Large B-Cell Lymphoma with IRF4 Rearrangement A diffuse large B-cell lymphoma that arises from the head and neck region. It affects both lymph nodes and extranodal sites. The most frequently affected extranodal site is the Waldeyer ring, particularly the palatine tonsil. C202930 Neoplastic Process Head and Neck Diffuse Large B-Cell Lymphoma CL1922085 Malignant Head and Neck DLBCL Head and Neck Diffuse Large B-Cell Lymphoma Primary Head and Neck DLBCL Primary Head and Neck Diffuse Large B-Cell Lymphoma Head and Neck Diffuse Large B-Cell Lymphoma A Burkitt lymphoma that arises from the head and neck region. In patients with endemic Burkitt lymphoma, the jaws and other facial bones are usually affected. In patients with sporadic Burkitt lymphoma, the gingiva, orbit, and Waldeyer ring are usually affected. In patients with immunodeficiency-related Burkitt lymphoma, the lymph nodes are usually affected. C202935 Neoplastic Process Head and Neck Burkitt Lymphoma CL1922078 Malignant Head and Neck Burkitt Lymphoma Head and Neck Burkitt Lymphoma A plasmablastic lymphoma that arises from the head and neck region. The most frequently affected site is the oral cavity. C202936 Neoplastic Process Head and Neck Plasmablastic Lymphoma CL1922079 Malignant Head and Neck Plasmablastic Lymphoma Head and Neck Plasmablastic Lymphoma A spectrum of T-cell lymphoproliferative disorders that arise from skin, subcutaneous tissue, and head and neck mucosal sites. They are characterized by the presence of CD30-positive neoplastic lymphocytes. Cells that resemble the hallmark cells of anaplastic large cell lymphoma are often seen. C202952 Disease or Syndrome Primary CD30-Positive T-Cell Lymphoproliferative Disorder CL1922114 Undetermined Primary CD30-Positive T-Cell Lymphoproliferative Disorder Primary CD30-Positive T-Cell Lymphoproliferative Disorder A spectrum of T-cell lymphoproliferative disorders that arise from the mucosal sites of the head and neck. They are characterized by the presence of CD30-positive neoplastic lymphoid cells with pleomorphic nuclei and abundant cytoplasm. Cells that resemble the hallmark cells of anaplastic large cell lymphoma are often seen. The lesions usually arise from the oral cavity and, less frequently, the conjunctiva, orbit, and nasopharynx. In most cases complete remission is achieved, following excision, with or without radiotherapy, and with or without systemic chemotherapy. C202953 Disease or Syndrome Primary Head and Neck Mucosal CD30-Positive T-Cell Lymphoproliferative Disorder CL1922099 Undetermined Primary Head and Neck Mucosal CD30-Positive T-Cell Lymphoproliferative Disorder Primary Mucosal CD30-Positive T-Cell Lymphoproliferative Disorder Primary Head and Neck Mucosal CD30-Positive T-Cell Lymphoproliferative Disorder A neoplasm of hematopoietic and lymphoid cell origin that affects the head and neck region. C202954 Neoplastic Process Head and Neck Hematopoietic and Lymphoid Cell Neoplasm CL1922100 Undetermined Head and Neck Hematopoietic and Lymphoid Cell Neoplasm Head and Neck Hematopoietic and Lymphoid Cell Neoplasm A spectrum of T-cell lymphoproliferative disorders that arise from the oral mucosa and are characterized by the presence of CD30-positive neoplastic lymphoid cells with pleomorphic nuclei and abundant cytoplasm. Cells that resemble the hallmark cells of anaplastic large cell lymphoma are often seen. The lesions arise from the gingiva, buccal mucosa, tongue, and palate. Patients usually present with a mass that is often ulcerated. In most cases complete remission is achieved, following excision, with or without radiotherapy, and with or without systemic chemotherapy. C202955 Disease or Syndrome Primary Oral Cavity CD30-Positive T-Cell Lymphoproliferative Disorder CL1922097 Undetermined Primary Oral Cavity CD30-Positive T-Cell Lymphoproliferative Disorder Primary Oral Mucosa CD30-Positive T-Cell Lymphoproliferative Disorder Primary Oral Cavity CD30-Positive T-Cell Lymphoproliferative Disorder A benign histiocytic tumor that arises from the skin and occurs during childhood; it is distinct from Langerhans cell histiocytosis. It is characterized by the presence of lipid-laden, foamy histiocytes and Touton-type giant cells in the dermis. The lesions usually develop during infancy. They consist of cutaneous papules and nodules (most often in the head and neck). C202966 Neoplastic Process Cutaneous Juvenile Xanthogranuloma CL1922102 Benign Cutaneous Juvenile Xanthogranuloma Cutaneous Juvenile Xanthogranuloma A benign histiocytic tumor that usually arises from the skin of the head and neck and occurs during childhood. It is distinct from Langerhans cell histiocytosis. Rarely, it can arise from extracutaneous head and neck sites, including the eye, ocular adnexa, oral cavity, paranasal sinuses, and ear. It is characterized by the presence of lipid-laden, foamy histiocytes and Touton-type giant cells. C202967 Neoplastic Process Head and Neck Juvenile Xanthogranuloma CL1922103 Benign Head and Neck Juvenile Xanthogranuloma Head and Neck Juvenile Xanthogranuloma Rosai-Dorfman-Destombes disease that affects the head and neck region. It usually affects the cervical lymph nodes. Extranodal head and neck sites of involvement include the orbit, oral cavity, nasal cavity, and paranasal sinuses. C202971 Neoplastic Process Head and Neck Rosai-Dorfman-Destombes Disease CL1922138 Undetermined Head and Neck Rosai-Dorfman Disease Head and Neck Rosai-Dorfman-Destombes Disease Head and Neck Rosai-Dorfman-Destombes Disease Erdheim-Chester disease that affects the head and neck region. Patients present with xanthelasma-like lesions in the face, neck, and around the eyes. C202972 Neoplastic Process Head and Neck Erdheim-Chester Disease CL1922136 Undetermined Head and Neck Erdheim-Chester Disease Head and Neck Erdheim-Chester Disease A plasmacytoma that arises from the head and neck region. C202973 Neoplastic Process Head and Neck Plasmacytoma CL1922137 Malignant Head and Neck Plasmacytoma Head and Neck Plasmacytoma A dermoid cyst that arises from the head and neck region. It usually affects the orbit, periorbital tissue, dorsum of the nose, floor of the mouth, and ear. C202975 Neoplastic Process Head and Neck Dermoid Cyst CL1922135 Benign Head and Neck Dermoid Cyst Head and Neck Dermoid Cyst An exceptionally rare benign or malignant germ cell tumor that arises from the head and neck region. It usually affects the sinonasal tract and nasopharynx. C202977 Neoplastic Process Head and Neck Germ Cell Tumor CL1922134 Undetermined Head and Neck Germ Cell Tumor Head and Neck Germ Cell Tumor An exceptionally rare benign or malignant germ cell tumor that arises from the nasal cavity or paranasal sinuses. C202978 Neoplastic Process Sinonasal Germ Cell Tumor CL1922144 Undetermined Sinonasal Germ Cell Tumor Sinonasal Germ Cell Tumor An exceptionally rare benign or malignant germ cell tumor that arises from the nasopharynx. C202979 Neoplastic Process Nasopharyngeal Germ Cell Tumor CL1922145 Undetermined Nasopharyngeal Germ Cell Tumor Nasopharyngeal Germ Cell Tumor An exceptionally rare mature or immature teratoma that arises from the head and neck region. C202980 Neoplastic Process Head and Neck Teratoma CL1922142 Undetermined Head and Neck Teratoma Head and Neck Teratoma An exceptionally rare mature or immature teratoma that arises from the nasal cavity or paranasal sinuses. C202981 Neoplastic Process Sinonasal Teratoma CL1922143 Undetermined Sinonasal Teratoma Sinonasal Teratoma An exceptionally rare mature or immature teratoma that arises from the nasopharynx. C202982 Neoplastic Process Nasopharyngeal Teratoma CL781026 Undetermined Nasopharyngeal Teratoma Nasopharyngeal Teratoma An exceptionally rare malignant germ cell tumor that arises from the head and neck region. It usually affects the sinonasal tract and nasopharynx. C202983 Neoplastic Process Malignant Head and Neck Germ Cell Tumor CL1922141 Malignant Malignant Head and Neck Germ Cell Tumor Malignant Head and Neck Germ Cell Tumor An exceptionally rare malignant germ cell tumor that arises from the nasal cavity or paranasal sinuses. C202984 Neoplastic Process Malignant Sinonasal Germ Cell Tumor CL1922139 Malignant Malignant Sinonasal Germ Cell Tumor Malignant Sinonasal Germ Cell Tumor An exceptionally rare malignant germ cell tumor that arises from the nasopharynx. C202985 Neoplastic Process Malignant Nasopharyngeal Germ Cell Tumor CL1922140 Malignant Malignant Nasopharyngeal Germ Cell Tumor Malignant Nasopharyngeal Germ Cell Tumor The reemergence of HHV8-positive diffuse large B-cell lymphoma, not otherwise specified, after a period of remission. C202986 Neoplastic Process Recurrent HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Recurrent HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified CL1922123 CTRP Malignant Recurrent HHV8-Positive DLBCL, NOS Recurrent HHV8-Positive Diffuse Large B-Cell Lymphoma, NOS Recurrent HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Recurrent HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified HHV8-positive diffuse large B-cell lymphoma, not otherwise specified that is resistant to treatment. C202987 Neoplastic Process Refractory HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Refractory HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified CL1922124 CTRP Malignant Refractory HHV8-Positive DLBCL, NOS Refractory HHV8-Positive Diffuse Large B-Cell Lymphoma, NOS Refractory HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Refractory HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Lymphomatoid granulomatosis that is resistant to treatment. C202989 Neoplastic Process Refractory Lymphomatoid Granulomatosis Refractory Lymphomatoid Granulomatosis CL1922122 CTRP Uncertain Malignant Potential Refractory Angiocentric Immunoproliferative Lesion Refractory LYG Refractory Lymphomatoid Granulomatosis Refractory Lymphomatoid Granulomatosis A neuroendocrine neoplasm that arises from the sinonasal tract. C202990 Neoplastic Process Sinonasal Neuroendocrine Neoplasm CL1922119 Undetermined Sinonasal Neuroendocrine Neoplasm Sinonasal Neuroendocrine Neoplasm A well-differentiated, low or intermediate grade neuroendocrine neoplasm that arises from the sinonasal tract. C202991 Neoplastic Process Sinonasal Neuroendocrine Tumor CL1922120 Undetermined Sinonasal Neuroendocrine Tumor Sinonasal Well Differentiated Neuroendocrine Neoplasm Sinonasal Well-Differentiated Neuroendocrine Neoplasm Sinonasal Neuroendocrine Tumor A neuroendocrine neoplasm that arises from the nasal cavity. C202992 Neoplastic Process Nasal Cavity Neuroendocrine Neoplasm CL1922117 Undetermined Nasal Cavity Neuroendocrine Neoplasm Nasal Cavity Neuroendocrine Neoplasm A neuroendocrine neoplasm that arises from the paranasal sinuses. C202993 Neoplastic Process Paranasal Sinus Neuroendocrine Neoplasm CL1922118 Undetermined Paranasal Sinus Neuroendocrine Neoplasm Paranasal Sinus Neuroendocrine Neoplasm A well-differentiated, low or intermediate grade neuroendocrine neoplasm that arises from the nasal cavity. C202994 Neoplastic Process Nasal Cavity Neuroendocrine Tumor CL1922131 Undetermined Nasal Cavity Neuroendocrine Tumor Nasal Cavity Well Differentiated Neuroendocrine Neoplasm Nasal Cavity Well-Differentiated Neuroendocrine Neoplasm Nasal Cavity Neuroendocrine Tumor A well-differentiated, low or intermediate grade neuroendocrine neoplasm that arises from the paranasal sinuses. C202995 Neoplastic Process Paranasal Sinus Neuroendocrine Tumor CL1922132 Undetermined Paranasal Sinus Neuroendocrine Tumor Paranasal Sinus Well Differentiated Neuroendocrine Neoplasm Paranasal Sinus Well-Differentiated Neuroendocrine Neoplasm Paranasal Sinus Neuroendocrine Tumor A neuroendocrine carcinoma that arises from the nasal cavity. C202996 Neoplastic Process Nasal Cavity Neuroendocrine Carcinoma CL1922129 Malignant Nasal Cavity Neuroendocrine Carcinoma Nasal Cavity Neuroendocrine Carcinoma A neuroendocrine carcinoma that arises from the paranasal sinuses. C202997 Neoplastic Process Paranasal Sinus Neuroendocrine Carcinoma CL1922130 Malignant Paranasal Sinus Neuroendocrine Carcinoma Paranasal Sinus Neuroendocrine Carcinoma A small cell neuroendocrine carcinoma that arises from the nasal cavity. C203002 Neoplastic Process Nasal Cavity Small Cell Neuroendocrine Carcinoma CL1922126 Malignant Nasal Cavity Small Cell Neuroendocrine Carcinoma Nasal Cavity Small Cell Neuroendocrine Carcinoma A small cell neuroendocrine carcinoma that arises from the paranasal sinuses. C203004 Neoplastic Process Paranasal Sinus Small Cell Neuroendocrine Carcinoma CL1922169 Malignant Paranasal Sinus Small Cell Neuroendocrine Carcinoma Paranasal Sinus Small Cell Neuroendocrine Carcinoma A large cell neuroendocrine carcinoma that arises from the nasal cavity. C203005 Neoplastic Process Nasal Cavity Large Cell Neuroendocrine Carcinoma CL1922166 Malignant Nasal Cavity Large Cell Neuroendocrine Carcinoma Nasal Cavity Large Cell Neuroendocrine Carcinoma A large cell neuroendocrine carcinoma that arises from the paranasal sinuses. C203006 Neoplastic Process Paranasal Sinus Large Cell Neuroendocrine Carcinoma CL1922167 Malignant Paranasal Sinus Large Cell Neuroendocrine Carcinoma Paranasal Sinus Large Cell Neuroendocrine Carcinoma A well-differentiated, low grade neuroendocrine neoplasm that arises from the nasal cavity or paranasal sinuses. C203007 Neoplastic Process Sinonasal Neuroendocrine Tumor G1 CL1922164 Undetermined Sinonasal Neuroendocrine Tumor G1 Sinonasal Neuroendocrine Tumor G1 A well-differentiated, low grade neuroendocrine neoplasm that arises from the nasal cavity. C203008 Neoplastic Process Nasal Cavity Neuroendocrine Tumor G1 CL1922165 Undetermined Nasal Cavity Neuroendocrine Tumor G1 Nasal Cavity Neuroendocrine Tumor G1 A well-differentiated, low grade neuroendocrine neoplasm that arises from the paranasal sinuses. C203009 Neoplastic Process Paranasal Sinus Neuroendocrine Tumor G1 CL1922162 Undetermined Paranasal Sinus Neuroendocrine Tumor G1 Paranasal Sinus Neuroendocrine Tumor G1 A well-differentiated, intermediate grade neuroendocrine neoplasm that arises from the nasal cavity or paranasal sinuses. C203010 Neoplastic Process Sinonasal Neuroendocrine Tumor G2 CL1922163 Undetermined Sinonasal Neuroendocrine Tumor G2 Sinonasal Neuroendocrine Tumor G2 A well-differentiated, intermediate grade neuroendocrine neoplasm that arises from the nasal cavity. C203011 Neoplastic Process Nasal Cavity Neuroendocrine Tumor G2 CL1922176 Undetermined Nasal Cavity Neuroendocrine Tumor G2 Nasal Cavity Neuroendocrine Tumor G2 A well-differentiated, intermediate grade neuroendocrine neoplasm that arises from the paranasal sinuses. C203012 Neoplastic Process Paranasal Sinus Neuroendocrine Tumor G2 CL1922177 Undetermined Paranasal Sinus Neuroendocrine Tumor G2 Paranasal Sinus Neuroendocrine Tumor G2 An extremely rare neuroendocrine carcinoma that arises from the nasopharynx. C203013 Neoplastic Process Nasopharyngeal Neuroendocrine Carcinoma CL1922174 Malignant Nasopharyngeal Neuroendocrine Carcinoma Nasopharyngeal Neuroendocrine Carcinoma An extremely rare small cell neuroendocrine carcinoma that arises from the nasopharynx. C203014 Neoplastic Process Nasopharyngeal Small Cell Neuroendocrine Carcinoma CL1922175 Malignant Nasopharyngeal Small Cell Neuroendocrine Carcinoma Nasopharyngeal Small Cell Neuroendocrine Carcinoma An extremely rare large cell neuroendocrine carcinoma that arises from the nasopharynx. C203015 Neoplastic Process Nasopharyngeal Large Cell Neuroendocrine Carcinoma CL1922172 Malignant Nasopharyngeal Large Cell Neuroendocrine Carcinoma Nasopharyngeal Large Cell Neuroendocrine Carcinoma An extremely rare neuroendocrine carcinoma that arises from the oropharynx. C203016 Neoplastic Process Oropharyngeal Neuroendocrine Carcinoma CL1922173 Malignant Oropharyngeal Neuroendocrine Carcinoma Oropharyngeal Neuroendocrine Carcinoma An extremely rare small cell neuroendocrine carcinoma that arises from the oropharynx. C203017 Neoplastic Process Oropharyngeal Small Cell Neuroendocrine Carcinoma CL1922170 Malignant Oropharyngeal Small Cell Neuroendocrine Carcinoma Oropharyngeal Small Cell Neuroendocrine Carcinoma An extremely rare large cell neuroendocrine carcinoma that arises from the oropharynx. C203018 Neoplastic Process Oropharyngeal Large Cell Neuroendocrine Carcinoma CL1922171 Malignant Oropharyngeal Large Cell Neuroendocrine Carcinoma Oropharyngeal Large Cell Neuroendocrine Carcinoma A well-differentiated, low-grade epithelial neoplasm with neuroendocrine differentiation. It arises from multiple sites, including the digestive system, lung, and head and neck. C203250 Neoplastic Process Neuroendocrine Tumor G1 CL1921979 Undetermined Benign carcinoid tumor of unknown primary site Benign carcinoid tumor of unspecified site Other benign neuroendocrine tumors NET G1 Neuroendocrine Tumor G1 Neuroendocrine Tumor Grade 1 Neuroendocrine Tumor G1 A well-differentiated, high-grade epithelial neoplasm with neuroendocrine differentiation. It usually arises from the digestive system. C203251 Neoplastic Process Neuroendocrine Tumor G3 CL1921992 Undetermined NET G3 Neuroendocrine Tumor G3 Neuroendocrine Tumor Grade 3 Neuroendocrine Tumor G3 Digestive system neuroendocrine tumor G3 that has spread extensively to other anatomic sites or is no longer responding to treatment. C203252 Neoplastic Process Advanced Digestive System Neuroendocrine Tumor G3 CL1921993 Malignant Advanced Digestive System NET G3 Advanced Digestive System Neuroendocrine Tumor G3 Advanced Digestive System Neuroendocrine Tumor G3 A neuroendocrine carcinoma that arises from any part of the digestive system and has spread extensively to other anatomic sites or is no longer responding to treatment. C203253 Neoplastic Process Advanced Digestive System Neuroendocrine Carcinoma CL1921990 Malignant Advanced Digestive System Neuroendocrine Carcinoma Advanced Gastrointestinal System Neuroendocrine Carcinoma Advanced Digestive System Neuroendocrine Carcinoma A neuroendocrine tumor grade 1 that arises from the esophagus, stomach, or duodenum. C203258 Neoplastic Process Foregut Neuroendocrine Tumor G1 CL1921987 Undetermined Foregut NET G1 Foregut Neuroendocrine Tumor G1 Foregut Neuroendocrine Tumor G1 A neuroendocrine tumor grade 2 that arises from the esophagus, stomach, or duodenum. C203259 Neoplastic Process Foregut Neuroendocrine Tumor G2 CL1922025 mCode Undetermined Foregut NET G2 Foregut Neuroendocrine Tumor G2 Malignant carcinoid tumor of the foregut, unspecified Foregut Neuroendocrine Tumor G2 A neuroendocrine tumor grade 3 that arises from the esophagus, stomach, or duodenum. C203260 Neoplastic Process Foregut Neuroendocrine Tumor G3 CL1922026 Undetermined Foregut NET G3 Foregut Neuroendocrine Tumor G3 Foregut Neuroendocrine Tumor G3 A neuroendocrine tumor grade 1 that arises from the sigmoid colon, descending colon, or rectum. C203262 Neoplastic Process Hindgut Neuroendocrine Tumor G1 CL1922024 Undetermined Hindgut NET G1 Hindgut Neuroendocrine Tumor G1 Hindgut Neuroendocrine Tumor G1 Diffuse midline glioma that is not amenable to surgical resection. C203263 Neoplastic Process Unresectable Diffuse Midline Glioma Unresectable Diffuse Midline Glioma CL1922021 CTRP Malignant Unresectable Diffuse Midline Glioma Unresectable Diffuse Midline Glioma A neuroendocrine tumor grade 2 that arises from the sigmoid colon, descending colon, or rectum. C203265 Neoplastic Process Hindgut Neuroendocrine Tumor G2 CL1922019 mCode Undetermined Hindgut NET G2 Hindgut Neuroendocrine Tumor G2 Malignant carcinoid tumor of the hindgut, unspecified Hindgut Neuroendocrine Tumor G2 A neuroendocrine tumor grade 3 that arises from the sigmoid colon, descending colon, or rectum. C203266 Neoplastic Process Hindgut Neuroendocrine Tumor G3 CL1922020 Undetermined Hindgut NET G3 Hindgut Neuroendocrine Tumor G3 Hindgut Neuroendocrine Tumor G3 The reemergence of diffuse midline glioma after a period of remission. C203267 Neoplastic Process Recurrent Diffuse Midline Glioma Recurrent Diffuse Midline Glioma CL1922033 CTRP Malignant Recurrent Diffuse Midline Glioma Recurrent Diffuse Midline Glioma Astrocytoma, IDH-mutant that is not amenable to surgical resection. C203269 Neoplastic Process Unresectable Astrocytoma, IDH-Mutant Unresectable Astrocytoma, IDH-Mutant CL1922031 CTRP Undetermined Unresectable Astrocytoma, IDH-Mutant Unresectable Astrocytoma, IDH-Mutant Oligodendroglioma, IDH-mutant and 1p/19q-codeleted that is not amenable to surgical resection. C203270 Neoplastic Process Unresectable Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted Unresectable Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted CL1922032 CTRP Undetermined Unresectable Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted Unresectable Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted Diffuse midline glioma, H3 K27M-mutant that is not amenable to surgical resection. C203271 Neoplastic Process Unresectable Diffuse Midline Glioma, H3 K27M-Mutant Unresectable Diffuse Midline Glioma, H3 K27M-Mutant CL1922029 CTRP Malignant Unresectable Diffuse Midline Glioma, H3 K27M-Mutant Unresectable Diffuse Midline Glioma, H3 K27M-Mutant Diffuse hemispheric glioma, H3 G34-mutant that is not amenable to surgical resection. C203272 Neoplastic Process Unresectable Diffuse Hemispheric Glioma, H3 G34-Mutant Unresectable Diffuse Hemispheric Glioma, H3 G34-Mutant CL1922030 CTRP Malignant Unresectable Diffuse Hemispheric Glioma, H3 G34-Mutant Unresectable Diffuse Hemispheric Glioma, H3 G34-Mutant The reemergence of diffuse hemispheric glioma, H3 G34-mutant after a period of remission. C203273 Neoplastic Process Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant CL1922027 CTRP Malignant Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant The reemergence of an astrocytic tumor after a period of remission. C203274 Neoplastic Process Recurrent Astrocytic Tumor Recurrent Astrocytic Tumor CL1922028 CTRP Undetermined Recurrent Astrocytic Tumor Recurrent Astrocytic Tumor An astrocytic tumor that is not amenable to surgical resection. C203282 Neoplastic Process Unresectable Astrocytic Tumor Unresectable Astrocytic Tumor CL1922010 CTRP Undetermined Unresectable Astrocytic Tumor Unresectable Astrocytic Tumor A pilocytic astrocytoma that is not amenable to surgical resection. C203283 Neoplastic Process Unresectable Pilocytic Astrocytoma Unresectable Pilocytic Astrocytoma CL1922017 CTRP Undetermined Unresectable Pilocytic Astrocytoma Unresectable Pilocytic Astrocytoma An oligodendroglioma that is not amenable to surgical resection. C203284 Neoplastic Process Unresectable Oligodendroglioma Unresectable Oligodendroglioma CL1922018 CTRP Undetermined Unresectable Oligodendroglioma Unresectable Oligodendroglioma The reemergence of a diffuse glioma after a period of remission. C203285 Neoplastic Process Recurrent Diffuse Glioma Recurrent Diffuse Glioma CL1922015 CTRP Undetermined Recurrent Diffuse Glioma Recurrent Diffuse Glioma A diffuse glioma that is not amenable to surgical resection. C203286 Neoplastic Process Unresectable Diffuse Glioma Unresectable Diffuse Glioma CL1922016 CTRP Undetermined Unresectable Diffuse Glioma Unresectable Diffuse Glioma The reemergence of glioneuronal and neuronal tumors after a period of remission. C203302 Neoplastic Process Recurrent Glioneuronal and Neuronal Tumors Recurrent Glioneuronal and Neuronal Tumors CL1922057 CTRP Undetermined Recurrent Glioneuronal and Neuronal Tumors Recurrent Glioneuronal and Neuronal Tumors Glioneuronal and neuronal tumors that are not amenable to surgical resection. C203308 Neoplastic Process Unresectable Glioneuronal and Neuronal Tumors Unresectable Glioneuronal and Neuronal Tumors CL1922041 CTRP Undetermined Unresectable Glioneuronal and Neuronal Tumors Unresectable Glioneuronal and Neuronal Tumors A primary central nervous system neoplasm that is not amenable to surgical resection. C203309 Neoplastic Process Unresectable Primary Central Nervous System Neoplasm Unresectable Primary Central Nervous System Neoplasm CL1922042 CTRP Undetermined Unresectable Primary Central Nervous System Neoplasm Unresectable Primary Central Nervous System Neoplasm A primary malignant central nervous system neoplasm that is not amenable to surgical resection. C203310 Neoplastic Process Unresectable Primary Malignant Central Nervous System Neoplasm CL1922039 Malignant Unresectable Primary Malignant Central Nervous System Neoplasm Unresectable Primary Malignant Central Nervous System Neoplasm A fallopian tube high-grade serous adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C203311 Neoplastic Process Advanced Fallopian Tube High Grade Serous Adenocarcinoma Advanced Fallopian Tube High Grade Serous Adenocarcinoma CL1922040 CTRP Malignant Advanced Fallopian Tube High Grade Serous Adenocarcinoma Advanced Fallopian Tube High-Grade Serous Adenocarcinoma Advanced Fallopian Tube High Grade Serous Adenocarcinoma A primary peritoneal high-grade serous adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C203312 Neoplastic Process Advanced Primary Peritoneal High Grade Serous Adenocarcinoma Advanced Primary Peritoneal High Grade Serous Adenocarcinoma CL1922037 CTRP Malignant Advanced Primary Peritoneal High Grade Serous Adenocarcinoma Advanced Primary Peritoneal High-Grade Serous Adenocarcinoma Advanced Primary Peritoneal High Grade Serous Adenocarcinoma A platinum-resistant fallopian tube carcinoma that has spread from its original site of growth to another anatomic site. C203313 Neoplastic Process Metastatic Platinum-Resistant Fallopian Tube Carcinoma Metastatic Platinum-Resistant Fallopian Tube Carcinoma CL1922038 CTRP Malignant Metastatic Platinum-Resistant Fallopian Tube Carcinoma Metastatic Platinum-Resistant Fallopian Tube Carcinoma A platinum-resistant primary peritoneal carcinoma that has spread from its original site of growth to another anatomic site. C203314 Neoplastic Process Metastatic Platinum-Resistant Primary Peritoneal Carcinoma Metastatic Platinum-Resistant Primary Peritoneal Carcinoma CL1922035 CTRP Malignant Metastatic Platinum-Resistant Primary Peritoneal Carcinoma Metastatic Platinum-Resistant Primary Peritoneal Carcinoma A platinum-resistant fallopian tube carcinoma that is not amenable to surgical resection. C203315 Neoplastic Process Unresectable Platinum-Resistant Fallopian Tube Carcinoma Unresectable Platinum-Resistant Fallopian Tube Carcinoma CL1922036 CTRP Malignant Unresectable Platinum-Resistant Fallopian Tube Carcinoma Unresectable Platinum-Resistant Fallopian Tube Carcinoma A platinum-resistant primary peritoneal carcinoma that is not amenable to surgical resection. C203316 Neoplastic Process Unresectable Platinum-Resistant Primary Peritoneal Carcinoma Unresectable Platinum-Resistant Primary Peritoneal Carcinoma CL1922047 CTRP Malignant Unresectable Platinum-Resistant Primary Peritoneal Carcinoma Unresectable Platinum-Resistant Primary Peritoneal Carcinoma A breast adenocarcinoma that is not amenable to surgical resection. C203331 Neoplastic Process Unresectable Breast Adenocarcinoma Unresectable Breast Adenocarcinoma CL1922059 CTRP Malignant Unresectable Breast Adenocarcinoma Unresectable Breast Adenocarcinoma The reemergence of breast ductal carcinoma in situ after a period of remission. C203339 Neoplastic Process Recurrent Breast Ductal Carcinoma In Situ Recurrent Breast Ductal Carcinoma In Situ CTRP Malignant Recurrent Breast Ductal Carcinoma In Situ Recurrent DCIS Recurrent Non-Infiltrating Ductal Carcinoma of the Breast Recurrent Non-Invasive Ductal Carcinoma of the Breast Recurrent Breast Ductal Carcinoma In Situ The reemergence of breast medullary carcinoma after a period of remission. C203341 Neoplastic Process Recurrent Breast Medullary Carcinoma Recurrent Breast Medullary Carcinoma CTRP Malignant Recurrent Breast Medullary Carcinoma Recurrent Infiltrating Medullary Carcinoma of the Breast Recurrent Invasive Medullary Carcinoma of the Breast Recurrent Breast Medullary Carcinoma The reemergence of breast mucinous carcinoma after a period of remission. C203342 Neoplastic Process Recurrent Breast Mucinous Carcinoma Recurrent Breast Mucinous Carcinoma CTRP Malignant Recurrent Breast Mucinous Carcinoma Recurrent Infiltrating Mucinous Carcinoma of the Breast Recurrent Invasive Mucinous Carcinoma of the Breast Recurrent Breast Mucinous Carcinoma The reemergence of breast papillary carcinoma after a period of remission. C203344 Neoplastic Process Recurrent Breast Papillary Carcinoma Recurrent Breast Papillary Carcinoma CTRP Malignant Recurrent Breast Papillary Carcinoma Recurrent Breast Papillary Carcinoma The reemergence of breast tubular carcinoma after a period of remission. C203362 Neoplastic Process Recurrent Breast Tubular Carcinoma Recurrent Breast Tubular Carcinoma CTRP Malignant Recurrent Breast Tubular Carcinoma Recurrent Infiltrating Tubular Carcinoma of the Breast Recurrent Invasive Tubular Carcinoma of the Breast Recurrent Breast Tubular Carcinoma A WHO grade 4 glioma that is resistant to treatment. C203369 Neoplastic Process Refractory WHO Grade 4 Glioma Refractory WHO Grade 4 Glioma CTRP Malignant Refractory WHO Grade 4 Glioma Refractory WHO Grade IV Glioma Refractory WHO Grade 4 Glioma A salivary gland adenocarcinoma, not otherwise specified, characterized by the presence of high-grade morphological features. C203370 Neoplastic Process Salivary Gland High Grade Adenocarcinoma, Not Otherwise Specified Salivary Gland High Grade Adenocarcinoma, Not Otherwise Specified CTRP Malignant Salivary Gland High Grade Adenocarcinoma, Not Otherwise Specified Salivary Gland High-Grade Adenocarcinoma, Not Otherwise Specified Salivary Gland High Grade Adenocarcinoma, Not Otherwise Specified A salivary gland adenocarcinoma, not otherwise specified, characterized by the presence of low-grade morphological features. C203374 Neoplastic Process Salivary Gland Low Grade Adenocarcinoma, Not Otherwise Specified Malignant Salivary Gland Low Grade Adenocarcinoma, Not Otherwise Specified Salivary Gland Low-Grade Adenocarcinoma, Not Otherwise Specified Salivary Gland Low Grade Adenocarcinoma, Not Otherwise Specified A salivary gland adenocarcinoma, not otherwise specified, characterized by the presence of intermediate-grade morphological features. C203375 Neoplastic Process Salivary Gland Intermediate Grade Adenocarcinoma, Not Otherwise Specified Salivary Gland Intermediate Grade Adenocarcinoma, Not Otherwise Specified CTRP Malignant Salivary Gland Intermediate Grade Adenocarcinoma, Not Otherwise Specified Salivary Gland Intermediate-Grade Adenocarcinoma, Not Otherwise Specified Salivary Gland Intermediate Grade Adenocarcinoma, Not Otherwise Specified An invasive adenocarcinoma that arises from the salivary gland. Morphologically, it is characterized by the presence of intestinal-type malignant epithelial cells. C203376 Neoplastic Process Salivary Gland Intestinal-Type Adenocarcinoma Malignant Salivary Gland Intestinal-Type Adenocarcinoma Salivary Gland Intestinal-Type Adenocarcinoma A salivary gland secretory carcinoma that has spread from its original site of growth to other anatomic sites. C203380 Neoplastic Process Metastatic Salivary Gland Secretory Carcinoma Metastatic Salivary Gland Secretory Carcinoma CTRP Malignant Metastatic Salivary Gland Secretory Carcinoma Metastatic Salivary Gland Secretory Carcinoma The reemergence of salivary gland mucoepidermoid carcinoma after a period of remission. C203381 Neoplastic Process Recurrent Salivary Gland Mucoepidermoid Carcinoma Recurrent Salivary Gland Mucoepidermoid Carcinoma CTRP Malignant Recurrent Salivary Gland Mucoepidermoid Carcinoma Recurrent Salivary Gland Mucoepidermoid Carcinoma An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the colon. The mitotic count is more than 20 per 10 HPF. It is classified as either small or large cell neuroendocrine carcinoma based on the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm. C203384 Neoplastic Process Colon Neuroendocrine Carcinoma Malignant Colon Neuroendocrine Carcinoma Colon Neuroendocrine Carcinoma An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the rectum. The mitotic count is more than 20 per 10 HPF. It is classified as either small or large cell neuroendocrine carcinoma based on the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm. C203385 Neoplastic Process Rectal Neuroendocrine Carcinoma Malignant Rectal Neuroendocrine Carcinoma Rectal Neuroendocrine Carcinoma A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the cecum. C203386 Neoplastic Process Cecum Neuroendocrine Tumor Undetermined Cecum Neuroendocrine Tumor Cecum Neuroendocrine Tumor A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the ascending colon. C203387 Neoplastic Process Ascending Colon Neuroendocrine Tumor Undetermined Ascending Colon Neuroendocrine Tumor Ascending Colon Neuroendocrine Tumor A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the descending colon. C203388 Neoplastic Process Descending Colon Neuroendocrine Tumor Undetermined Descending Colon Neuroendocrine Tumor Descending Colon Neuroendocrine Tumor A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the sigmoid colon. C203389 Neoplastic Process Sigmoid Colon Neuroendocrine Tumor Undetermined Sigmoid Colon Neuroendocrine Tumor Sigmoid Colon Neuroendocrine Tumor A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the transverse colon. C203390 Neoplastic Process Transverse Colon Neuroendocrine Tumor Undetermined Transverse Colon Neuroendocrine Tumor Transverse Colon Neuroendocrine Tumor A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the ascending colon. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3 to 20 percent. C203391 Neoplastic Process Ascending Colon Neuroendocrine Tumor G2 mCode Undetermined Malignant carcinoid tumor of the ascending colon Ascending Colon NET G2 Ascending Colon Neuroendocrine Tumor G2 Malignant carcinoid tumor of the ascending colon Ascending Colon Neuroendocrine Tumor G2 A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the cecum. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3 to 20 percent. C203392 Neoplastic Process Cecum Neuroendocrine Tumor G2 mCode Undetermined Cecum NET G2 Cecum Neuroendocrine Tumor G2 Malignant carcinoid tumor of the cecum Cecum Neuroendocrine Tumor G2 A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the descending colon. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3 to 20 percent. C203393 Neoplastic Process Descending Colon Neuroendocrine Tumor G2 mCode Undetermined Descending Colon NET G2 Descending Colon Neuroendocrine Tumor G2 Malignant carcinoid tumor of the descending colon Descending Colon Neuroendocrine Tumor G2 A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the sigmoid colon. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3 to 20 percent. C203394 Neoplastic Process Sigmoid Colon Neuroendocrine Tumor G2 Sigmoid Colon Neuroendocrine Tumor G2 CTRP mCode Undetermined Malignant carcinoid tumor of the sigmoid colon Malignant carcinoid tumor of the sigmoid colon Sigmoid Colon NET G2 Sigmoid Colon Neuroendocrine Tumor G2 Sigmoid Colon Neuroendocrine Tumor G2 A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the transverse colon. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3 to 20 percent. C203395 Neoplastic Process Transverse Colon Neuroendocrine Tumor G2 mCode Undetermined Malignant carcinoid tumor of the transverse colon Transverse Colon NET G2 Transverse Colon Neuroendocrine Tumor G2 Transverse Colon Neuroendocrine Tumor G2 Bladder adenocarcinoma that has spread from its original site of growth to other anatomic sites. C203406 Neoplastic Process Metastatic Bladder Adenocarcinoma Metastatic Bladder Adenocarcinoma CTRP Malignant Metastatic Bladder Adenocarcinoma Metastatic Bladder Adenocarcinoma Bladder adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C203407 Neoplastic Process Locally Advanced Bladder Adenocarcinoma Locally Advanced Bladder Adenocarcinoma CTRP Malignant Locally Advanced Bladder Adenocarcinoma Locally Advanced Bladder Adenocarcinoma Bladder adenocarcinoma that is not amenable to surgical resection. C203409 Neoplastic Process Unresectable Bladder Adenocarcinoma Unresectable Bladder Adenocarcinoma CTRP Malignant Unresectable Bladder Adenocarcinoma Unresectable Bladder Adenocarcinoma Bladder squamous cell carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C203410 Neoplastic Process Locally Advanced Bladder Squamous Cell Carcinoma Locally Advanced Bladder Squamous Cell Carcinoma CTRP Malignant Locally Advanced Bladder Squamous Cell Carcinoma Locally Advanced Bladder Squamous Cell Carcinoma Bladder squamous cell carcinoma that is not amenable to surgical resection. C203411 Neoplastic Process Unresectable Bladder Squamous Cell Carcinoma Unresectable Bladder Squamous Cell Carcinoma CTRP Malignant Unresectable Bladder Squamous Cell Carcinoma Unresectable Bladder Squamous Cell Carcinoma Kidney medullary carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C203412 Neoplastic Process Locally Advanced Kidney Medullary Carcinoma Locally Advanced Kidney Medullary Carcinoma CTRP Malignant Locally Advanced Kidney Medullary Carcinoma Locally Advanced Kidney Medullary Carcinoma Penile squamous cell carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C203413 Neoplastic Process Locally Advanced Penile Squamous Cell Carcinoma Locally Advanced Penile Squamous Cell Carcinoma CTRP Malignant Locally Advanced Penile Squamous Cell Carcinoma Locally Advanced Penile Squamous Cell Carcinoma A bladder small cell neuroendocrine carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C203415 Neoplastic Process Locally Advanced Bladder Small Cell Neuroendocrine Carcinoma Malignant Locally Advanced Bladder Small Cell Neuroendocrine Carcinoma Locally Advanced Bladder Small Cell Neuroendocrine Carcinoma T acute lymphoblastic leukemia characterized by an ectopic activation of the HOXA genes. C203426 Neoplastic Process T Acute Lymphoblastic Leukemia, HOXA Dysregulated Malignant T Acute Lymphoblastic Leukemia, HOXA Dysregulated T-Acute Lymphoblastic Leukemia, HOXA Dysregulated T Acute Lymphoblastic Leukemia, HOXA Dysregulated T acute lymphoblastic leukemia characterized by the presence of SPI1 gene rearrangement. It has a poor prognosis. C203428 Neoplastic Process T Acute Lymphoblastic Leukemia with SPI1 Rearrangement Malignant T Acute Lymphoblastic Leukemia with SPI1 Rearrangement T Acute Lymphoblastic Leukemia with SPI1 Rearrangement T acute lymphoblastic leukemia characterized by the presence of TLX1 gene rearrangement. C203431 Neoplastic Process T Acute Lymphoblastic Leukemia with TLX1 Rearrangement Malignant T Acute Lymphoblastic Leukemia with TLX1 Rearrangement T Acute Lymphoblastic Leukemia with TLX1 Rearrangement T acute lymphoblastic leukemia characterized by the presence of TLX3 gene rearrangement. C203432 Neoplastic Process T Acute Lymphoblastic Leukemia with TLX3 Rearrangement Malignant T Acute Lymphoblastic Leukemia with TLX3 Rearrangement T Acute Lymphoblastic Leukemia with TLX3 Rearrangement T acute lymphoblastic leukemia characterized by the presence of TAL1 gene rearrangement. C203433 Neoplastic Process T Acute Lymphoblastic Leukemia with TAL1 Rearrangement Malignant T Acute Lymphoblastic Leukemia with TAL1 Rearrangement T Acute Lymphoblastic Leukemia with TAL1 Rearrangement T acute lymphoblastic leukemia characterized by the presence of LMO1 gene rearrangement. C203434 Neoplastic Process T Acute Lymphoblastic Leukemia with LMO1 Rearrangement Malignant T Acute Lymphoblastic Leukemia with LMO1 Rearrangement T Acute Lymphoblastic Leukemia with LMO1 Rearrangement T acute lymphoblastic leukemia characterized by the presence of LMO2 gene rearrangement. C203435 Neoplastic Process T Acute Lymphoblastic Leukemia with LMO2 Rearrangement Malignant T Acute Lymphoblastic Leukemia with LMO2 Rearrangement T Acute Lymphoblastic Leukemia with LMO2 Rearrangement A rare acute leukemia of ambiguous lineage characterized by the presence of BCL11B gene rearrangement. C203437 Neoplastic Process Acute Leukemia of Ambiguous Lineage with BCL11B Rearrangement Malignant Acute Leukemia of Ambiguous Lineage with BCL11B Rearrangement Acute Leukemia of Ambiguous Lineage with BCL11B Rearrangement Chronic myelomonocytic leukemia characterized by the absence of a markedly elevated white blood cell count in the peripheral blood. C203443 Neoplastic Process Myelodysplastic Chronic Myelomonocytic Leukemia Malignant MD-CMML Myelodysplastic Chronic Myelomonocytic Leukemia Myelodysplastic Chronic Myelomonocytic Leukemia Chronic myelomonocytic leukemia characterized by the presence of a markedly elevated white blood cell count in the peripheral blood. C203444 Neoplastic Process Myeloproliferative Chronic Myelomonocytic Leukemia Malignant MP-CMML Myeloproliferative Chronic Myelomonocytic Leukemia Myeloproliferative Chronic Myelomonocytic Leukemia T-acute lymphoblastic leukemias characterized by the presence of recurring cytogenetic and/or molecular abnormalities. C203469 Neoplastic Process T Acute Lymphoblastic Leukemia with Recurrent Genetic Abnormalities Malignant T Acute Lymphoblastic Leukemia with Recurrent Genetic Abnormalities T Acute Lymphoblastic Leukemia with Recurrent Genetic Abnormalities Olfactory neuroblastoma that has spread from its original site of growth to other anatomic sites. C203511 Neoplastic Process Metastatic Olfactory Neuroblastoma Metastatic Olfactory Neuroblastoma CTRP Malignant Metastatic Olfactory Neuroblastoma Metastatic Olfactory Neuroblastoma Olfactory neuroblastoma that has spread from its original site of growth to nearby tissues or lymph nodes. C203513 Neoplastic Process Locally Advanced Olfactory Neuroblastoma Locally Advanced Olfactory Neuroblastoma CTRP Malignant Locally Advanced Olfactory Neuroblastoma Locally Advanced Olfactory Neuroblastoma Sinonasal carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C203515 Neoplastic Process Locally Advanced Sinonasal Carcinoma Locally Advanced Sinonasal Carcinoma CTRP Malignant Locally Advanced Sinonasal Carcinoma Locally Advanced Sinonasal Carcinoma Juvenile myelomonocytic leukemia that is resistant to treatment. C203523 Neoplastic Process Refractory Juvenile Myelomonocytic Leukemia Refractory Juvenile Myelomonocytic Leukemia CTRP Malignant Refractory Juvenile Myelomonocytic Leukemia Refractory Juvenile Myelomonocytic Leukemia A neuroblastoma that has spread from its original site of growth to nearby tissues or lymph nodes. C203526 Neoplastic Process Locally Advanced Neuroblastoma Malignant Locally Advanced Neuroblastoma Locally Advanced Neuroblastoma A sarcoma in which the grade cannot be evaluated. C203583 Neoplastic Process Sarcoma GX Malignant AJCC Sarcoma GX AJCC Sarcoma Grade X FNCLCC Sarcoma GX FNCLCC Sarcoma Grade X Sarcoma GX Sarcoma Grade X Sarcoma GX Appendix adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C203618 Neoplastic Process Locally Advanced Appendix Adenocarcinoma Locally Advanced Appendix Adenocarcinoma CTRP Malignant Locally Advanced Appendix Adenocarcinoma Locally Advanced Appendix Adenocarcinoma Appendix adenocarcinoma that is not amenable to surgical resection. C203619 Neoplastic Process Unresectable Appendix Adenocarcinoma Unresectable Appendix Adenocarcinoma CTRP Malignant Unresectable Appendix Adenocarcinoma Unresectable Appendix Adenocarcinoma The reemergence of primary cutaneous diffuse large B-cell lymphoma after a period of remission. C203667 Neoplastic Process Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma CTRP Malignant Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma Primary cutaneous diffuse large B-cell lymphoma that is resistant to treatment. C203669 Neoplastic Process Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma CTRP Malignant Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma A carcinoma that arises from the esophagus or gastroesophageal junction. C203673 Neoplastic Process Esophageal and Gastroesophageal Junction Carcinoma Malignant Cancer of Esophagus and Gastroesophageal Junction Carcinoma of Esophagus and Gastroesophageal Junction Esophageal and Gastroesophageal Junction Cancer Esophageal and Gastroesophageal Junction Carcinoma Esophagus and Gastroesophageal Junction Cancer Esophageal and Gastroesophageal Junction Carcinoma A carcinoma that arises from the gastroesophageal junction. The vast majority of cases are adenocarcinomas. Rare cases are neuroendocrine carcinomas. C203675 Neoplastic Process Gastroesophageal Junction Carcinoma Malignant Gastroesophageal Junction Carcinoma Gastroesophageal Junction Carcinoma A HER2-low breast adenocarcinoma that is not amenable to surgical resection. C203700 Neoplastic Process Unresectable HER2-Low Breast Carcinoma Unresectable HER2-Low Breast Carcinoma CTRP Malignant Unresectable HER2 Low Breast Adenocarcinoma Unresectable HER2 Low Breast Carcinoma Unresectable HER2-Low Breast Adenocarcinoma Unresectable HER2-Low Breast Carcinoma Unresectable HER2-Low Breast Carcinoma A very rare mixed neuroendocrine non-neuroendocrine neoplasm that arises from the pancreas and is composed of ductal adenocarcinoma and a neuroendocrine tumor component. C203795 Neoplastic Process Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Tumor Malignant Pancreatic Mixed Ductal Adenocarcinoma-NET Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Tumor Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Tumor The reemergence of bladder non-invasive papillary urothelial carcinoma, low grade, after a period of remission. C203815 Neoplastic Process Recurrent Non-Invasive Bladder Papillary Urothelial Carcinoma, Low Grade Recurrent Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade CTRP Malignant Recurrent Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade Recurrent Non-Invasive Bladder Papillary Urothelial Carcinoma, Low Grade Recurrent Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade A phase of chronic myeloid leukemia, Philadelphia chromosome positive, BCR-ABL1 positive in which the peripheral blood smear shows leukocytosis with neutrophils in different stages of maturation, less than 2% blasts, and normal or increased platelet count. Most patients have mild anemia. The bone marrow is hypercellular due to increased numbers of neutrophils and their precursors, and blasts usually account for fewer than 5% of the marrow cells. Megakaryocytes are smaller than normal and have hypolobated nuclei. The spleen is enlarged due to infiltration of the cords of the red pulp by granulocytes. C203904 Neoplastic Process Chronic Phase Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Phase Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive CTRP Malignant Chronic Phase Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Phase Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive A low-grade mucinous adenocarcinoma that has spread to the peritoneum. C203946 Neoplastic Process Low Grade Mucinous Carcinoma Peritonei Malignant LGMCP Low Grade Mucinous Carcinoma Peritonei Low Grade Peritoneal Mucinous Carcinomatosis Low-Grade Mucinous Carcinoma Peritonei Low-Grade Peritoneal Mucinous Carcinomatosis Low Grade Mucinous Carcinoma Peritonei A high-grade mucinous adenocarcinoma that has spread to the peritoneum. C203948 Neoplastic Process High Grade Mucinous Carcinoma Peritonei Malignant HGMCP High Grade Mucinous Carcinoma Peritonei High Grade Peritoneal Mucinous Carcinomatosis High-Grade Mucinous Carcinoma Peritonei High-Grade Peritoneal Mucinous Carcinomatosis High Grade Mucinous Carcinoma Peritonei A high-grade mucinous adenocarcinoma that has spread to the peritoneum and is characterized by the presence of signet ring malignant cells. C203949 Neoplastic Process High Grade Mucinous Carcinoma Peritonei with Signet Ring Cells Cellosaurus Malignant HGMCP-S High Grade Mucinous Carcinoma Peritonei with Signet Ring Cells High Grade Peritoneal Mucinous Carcinomatosis with Signet Ring Cells High-Grade Mucinous Carcinoma Peritonei with Signet Ring Cells High-Grade Peritoneal Mucinous Carcinomatosis with Signet Ring Cells High Grade Mucinous Carcinoma Peritonei with Signet Ring Cells A wart on the palmar surface of the hand. It is caused by human papillomavirus. C203968 Neoplastic Process Verruca Palmaris Benign Verruca Palmaris Verruca Palmaris A wart characterized by the presence of flat-topped cutaneous papules. It is caused by human papillomavirus. It most commonly affects children and usually arises on the face, hands, and shins. C203969 Neoplastic Process Verruca Plana Benign Flat Wart Plane Wart Verruca Plana Verruca Plana Pancreatic adenosquamous carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C204035 Neoplastic Process Advanced Pancreatic Adenosquamous Carcinoma Advanced Pancreatic Adenosquamous Carcinoma CTRP Malignant Advanced Pancreatic Adenosquamous Carcinoma Advanced Pancreatic Adenosquamous Carcinoma A digestive system neuroendocrine tumor that has spread extensively to other anatomic sites or is no longer responding to treatment. C204036 Neoplastic Process Advanced Digestive System Neuroendocrine Tumor Advanced Digestive System Neuroendocrine Tumor CTRP Malignant Advanced Digestive System Neuroendocrine Tumor Advanced Digestive System Neuroendocrine Tumor A digestive system neuroendocrine tumor that has spread from its original site of growth to another anatomic site. C204037 Neoplastic Process Metastatic Digestive System Neuroendocrine Tumor Malignant Metastatic Digestive System Neuroendocrine Tumor Metastatic Digestive System Neuroendocrine Tumor A digestive system neuroendocrine tumor that has spread from its original site of growth to nearby tissues or lymph nodes. C204038 Neoplastic Process Locally Advanced Digestive System Neuroendocrine Tumor Malignant Locally Advanced Digestive System Neuroendocrine Tumor Locally Advanced Digestive System Neuroendocrine Tumor The reemergence of a B-cell malignant neoplasm after a period of remission. C204124 Neoplastic Process Recurrent B-Cell Malignant Neoplasm Recurrent B-Cell Malignant Neoplasm CTRP Malignant Recurrent B-Cell Malignant Neoplasm Recurrent B-Cell Malignant Neoplasm A B-cell malignant neoplasm that is resistant to treatment. C204126 Neoplastic Process Refractory B-Cell Malignant Neoplasm Refractory B-Cell Malignant Neoplasm CTRP Malignant Refractory B-Cell Malignant Neoplasm Refractory B-Cell Malignant Neoplasm A nodular basal cell carcinoma composed of solid and cystic areas. C204355 Neoplastic Process Skin Nodulocystic Basal Cell Carcinoma Malignant Nodulocystic Basal Cell Carcinoma Skin Nodulocystic Basal Cell Carcinoma Skin Nodulocystic Basal Cell Carcinoma A Merkel cell carcinoma that is associated with Merkel cell polyoma virus infection. C204383 Neoplastic Process Merkel Cell Polyoma Virus-Positive Merkel Cell Carcinoma Malignant MCPyV-Positive MCC MCPyV-Positive Merkel Cell Carcinoma Merkel Cell Polyoma Virus-Positive Merkel Cell Carcinoma Merkel Cell Polyoma Virus-Positive Merkel Cell Carcinoma A Merkel cell carcinoma that is not associated with Merkel cell polyoma virus infection. C204385 Neoplastic Process Merkel Cell Polyoma Virus-Negative Merkel Cell Carcinoma Malignant MCPyV-Negative MCC MCPyV-Negative Merkel Cell Carcinoma Merkel Cell Polyoma Virus-Negative Merkel Cell Carcinoma Merkel Cell Polyoma Virus-Negative Merkel Cell Carcinoma A HER2-low breast adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C204437 Neoplastic Process Locally Advanced HER2-Low Breast Carcinoma Locally Advanced HER2-Low Breast Carcinoma CTRP Malignant Locally Advanced HER2 Low Breast Adenocarcinoma Locally Advanced HER2 Low Breast Carcinoma Locally Advanced HER2-Low Breast Adenocarcinoma Locally Advanced HER2-Low Breast Carcinoma Locally Advanced HER2-Low Breast Carcinoma A nevus characterized by an intraepidermal proliferation of nested melanocytes along the basal epidermis. C204482 Neoplastic Process Lentiginous Melanocytic Nevus Benign Lentiginous Melanocytic Nevus Lentiginous Melanocytic Nevus A pigmented epithelioid melanocytoma that is associated with PRKAR1A gene inactivation. C204574 Neoplastic Process PRKAR1A-Inactivated Pigmented Epithelioid Melanocytoma Undetermined PRKAR1A-Inactivated PEM PRKAR1A-Inactivated Pigmented Epithelioid Melanocytoma PRKAR1A-Inactivated Pigmented Epithelioid Melanocytoma A cutaneous neoplasm associated with MITF gene rearrangement and either ACTIN-MITF translocation or MITF-CREM translocation. It is composed of large cells with clear cytoplasm that exhibit melanocytic differentiation and proliferate in the dermis. It presents as a single non-pigmented cutaneous nodule. C204739 Neoplastic Process MITF Pathway-Activated Melanocytic Tumor Undetermined MITF Pathway-Activated Melanocytic Neoplasm MITF Pathway-Activated Melanocytic Tumor MITF Pathway-Activated Melanocytic Tumor A MITF pathway-activated melanocytic tumor characterized by a cytogenetic translocation between ACTIN and MITF genes that results in ACTIN-MITF gene fusion. It presents as a single non-pigmented cutaneous nodule in the distal extremities or trunk. It is composed of large cells with clear cytoplasm that exhibit melanocytic differentiation and proliferate in the dermis without an intraepidermal component. Extension in the subcutaneous tissue is frequently seen. Atypical nuclear features may be present. It has an indolent clinical course. C204740 Neoplastic Process Clear Cell Tumor with Melanocytic Differentiation and ACTIN-MITF Translocation Undetermined CCTMAM Clear Cell Neoplasm with Melanocytic Differentiation and ACTIN-MITF Translocation Clear Cell Neoplasm with Melanocytic Differentiation and ACTIN::MITF Translocation Clear Cell Tumor with Melanocytic Differentiation and ACTIN-MITF Translocation Clear Cell Tumor with Melanocytic Differentiation and ACTIN::MITF Translocation Clear Cell Tumor with Melanocytic Differentiation and ACTIN-MITF Translocation A MITF pathway-activated melanocytic tumor characterized by a cytogenetic translocation between MITF and CREM genes that results in MITF-CREM gene fusion. It presents as a single non-pigmented cutaneous nodule in the distal extremities. It is composed of large cells with clear cytoplasm that exhibit melanocytic differentiation and proliferate in the dermis without an intraepidermal component. Extension in the subcutaneous tissue is frequently seen. The neoplastic cells exhibit atypical features, including nuclear enlargement and hyperchromasia, irregular nuclear borders, and enlarged nucleolus. Mitotic activity is prominent. The biologic potential of this tumor is unknown. C204741 Neoplastic Process Clear Cell Tumor with Melanocytic Differentiation and MITF-CREM Translocation Undetermined CCTMMC Clear Cell Neoplasm with Melanocytic Differentiation and MITF-CREM Translocation Clear Cell Neoplasm with Melanocytic Differentiation and MITF::CREM Translocation Clear Cell Tumor with Melanocytic Differentiation and MITF-CREM Translocation Clear Cell Tumor with Melanocytic Differentiation and MITF::CREM Translocation Clear Cell Tumor with Melanocytic Differentiation and MITF-CREM Translocation A clear cell tumor with melanocytic differentiation characterized by a cytogenetic translocation between ACTB and MITF genes that results in ACTB-MITF gene fusion. C204755 Neoplastic Process Clear Cell Tumor with Melanocytic Differentiation and ACTB-MITF Translocation Undetermined Clear Cell Neoplasm with Melanocytic Differentiation and ACTB-MITF Translocation Clear Cell Neoplasm with Melanocytic Differentiation and ACTB::MITF Translocation Clear Cell Tumor with Melanocytic Differentiation and ACTB-MITF Translocation Clear Cell Tumor with Melanocytic Differentiation and ACTB::MITF Translocation Clear Cell Tumor with Melanocytic Differentiation and ACTB-MITF Translocation A clear cell tumor with melanocytic differentiation characterized by a cytogenetic translocation between ACTG1 and MITF genes that results in ACTG1-MITF gene fusion. C204756 Neoplastic Process Clear Cell Tumor with Melanocytic Differentiation and ACTG1-MITF Translocation Undetermined Clear Cell Neoplasm with Melanocytic Differentiation and ACTG1-MITF Translocation Clear Cell Neoplasm with Melanocytic Differentiation and ACTG1::MITF Translocation Clear Cell Tumor with Melanocytic Differentiation and ACTG1-MITF Translocation Clear Cell Tumor with Melanocytic Differentiation and ACTG1::MITF Translocation Clear Cell Tumor with Melanocytic Differentiation and ACTG1-MITF Translocation A Spitz nevus characterized by the presence of both junctional and dermal melanocytic components. C204787 Neoplastic Process Compound Spitz Nevus Benign Compound Spitz Nevus Compound Spitz Nevus A Spitz nevus characterized by the presence of a junctional melanocytic component without involvement of the dermis. C204788 Neoplastic Process Junctional Spitz Nevus Benign Junctional Spitz Nevus Junctional Spitz Nevus A Spitz nevus characterized by the presence of an intradermal melanocytic component without junctional melanocytic activity. C204789 Neoplastic Process Dermal Spitz Nevus Benign Dermal Spitz Nevus Intradermal Spitz Nevus Dermal Spitz Nevus A term that refers to a group of melanocytic neoplasms that are composed of epithelioid and/or spindle cells and extend from the epidermis into the reticular dermis, often in a wedge-shaped configuration. They are usually associated with oncogenic mutations that activate the MAP-kinase pathway. This category includes Spitz nevus, Spitz melanocytoma, and Spitz melanoma. C204790 Neoplastic Process Spitz Tumor Undetermined Spitz Neoplasm Spitz Tumor Spitz Tumor A melanoma that arises from the skin in the absence of severe actinic keratosis. It can arise from a pre-existing nevus or de novo. C204840 Neoplastic Process Melanoma in Intermittently Sun-Exposed Skin Malignant Melanoma in Intermittently Sun-Exposed Skin Melanoma in Intermittently Sun-Exposed Skin A cutaneous melanoma that develops on sun exposed sites with low cumulative sun damage (CSD). It is characterized by a prominent junctional and intraepidermal component with intraepidermal proliferation of individual atypical melanocytes and formation of nests of atypical melanocytes along the dermal-epidermal junction. The dermal component is composed of atypical melanocytes that fail to mature. The atypical melanocytes have large nuclei, prominent nucleoli, and eosinophilic or lightly pigmented cytoplasm. It is the most common melanoma subtype in the Western world. C204843 Neoplastic Process Superficial Spreading Melanoma Low-CSD Melanoma, Superficial Spreading Melanoma Subtype CTRP GDC Malignant 8743/3 Low cumulative sun damage melanoma Superficial spreading melanoma Cutaneous Superficial Spreading Melanoma Low-CSD Melanoma, SSM Subtype Low-CSD Melanoma, Superficial Spreading Melanoma Low-CSD Melanoma, Superficial Spreading Melanoma (SSM) Low-CSD Melanoma, Superficial Spreading Melanoma Subtype Low-CSD Melanoma/SSM Low-CSD Melanoma/Superficial Spreading Melanoma Pagetoid Melanoma SSM Superficial Spreading Cutaneous (Skin) Melanoma Superficial Spreading Melanoma Superficial Spreading Melanoma of the Skin Superficial spreading melanoma Low-CSD Melanoma, Superficial Spreading Melanoma Subtype A melanoma that arises from a chronically sun-exposed skin area. It is associated with severe actinic keratosis. C204864 Neoplastic Process Melanoma in Chronically Sun-Exposed Skin Malignant Melanoma in Chronically Sun-Exposed Skin Melanoma in Chronically Sun-Exposed Skin Platinum-refractory ovarian carcinoma that has spread from its original site of growth to another anatomic site. C204865 Neoplastic Process Metastatic Platinum-Refractory Ovarian Carcinoma Metastatic Platinum-Refractory Ovarian Carcinoma CTRP Malignant Metastatic Platinum-Refractory Ovarian Carcinoma Metastatic Platinum-Refractory Ovarian Carcinoma Platinum-refractory ovarian carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C204866 Neoplastic Process Advanced Platinum-Refractory Ovarian Carcinoma Advanced Platinum-Refractory Ovarian Carcinoma CTRP Malignant Advanced Platinum-Refractory Ovarian Carcinoma Advanced Platinum-Refractory Ovarian Carcinoma Platinum-refractory ovarian carcinoma that is not amenable to surgical resection. C204867 Neoplastic Process Unresectable Platinum-Refractory Ovarian Carcinoma Unresectable Platinum-Refractory Ovarian Carcinoma CTRP Malignant Unresectable Platinum-Refractory Ovarian Carcinoma Unresectable Platinum-Refractory Ovarian Carcinoma Platinum-refractory ovarian carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C204868 Neoplastic Process Locally Advanced Platinum-Refractory Ovarian Carcinoma Locally Advanced Platinum-Refractory Ovarian Carcinoma CTRP Malignant Locally Advanced Platinum-Refractory Ovarian Carcinoma Locally Advanced Platinum-Refractory Ovarian Carcinoma A cutaneous melanoma that arises from the palms, soles, and nails. C204883 Neoplastic Process Acral Melanoma Malignant Acral Melanoma Acral Melanoma A melanoma that arises from the area underneath a fingernail or toenail. It affects the fingernails more often than the toenails. C204887 Neoplastic Process Subungual Melanoma Malignant Subungual Melanoma Subungual Melanoma A melanoma that arises from the palmar surface of hands and plantar surface of feet. C204888 Neoplastic Process Volar Melanoma Malignant Volar Melanoma Volar Melanoma A melanoma that arises from the nail plate. C204889 Neoplastic Process Nail Apparatus Melanoma Malignant NAM Nail Apparatus Melanoma Nail Melanoma Nail Plate Melanoma Nail Apparatus Melanoma A blue nevus characterized by the proliferation of dendritic melanocytes in sclerotic stromal collagen. C204910 Neoplastic Process Dendritic Blue Nevus Benign DBN Dendritic Blue Nevus Dendritic Blue Nevus A dendritic blue nevus characterized by the presence of prominent sclerotic stromal collagen. C204911 Neoplastic Process Sclerosing Blue Nevus Benign Sclerosing Blue Nevus Sclerosing Blue Nevus A congenital melanocytic nevus measuring 15-200 mm. It is typically amenable to surgical resection. C204976 Congenital Abnormality Intermediate Congenital Melanocytic Nevus Benign Intermediate Congenital Melanocytic Nevus Intermediate Congenital Nevus Intermediate Congenital Melanocytic Nevus A melanocytic neoplasm that arises from the conjunctiva. This category includes conjunctival nevus, conjunctival melanocytic intraepithelial lesions, and conjunctival melanoma. C204977 Neoplastic Process Conjunctival Melanocytic Neoplasm Undetermined Conjunctival Melanocytic Neoplasm Conjunctival Melanocytic Tumor Conjunctival Melanocytic Neoplasm A balloon cell nevus that arises from the conjunctiva. C204978 Neoplastic Process Conjunctival Balloon Cell Nevus Benign Conjunctival Balloon Cell Nevus Conjunctival Balloon Cell Nevus Conjunctival melanocytic intraepithelial lesion characterized by the presence of mild atypia. C204979 Neoplastic Process Low Grade Conjunctival Melanocytic Intraepithelial Lesion Undetermined Low Grade C-MIL Low Grade Conjunctival Melanocytic Intraepithelial Lesion Low-Grade C-MIL Low-Grade Conjunctival Melanocytic Intraepithelial Lesion PAM with Mild Atypia Primary Acquired Melanosis with Mild Atypia Low Grade Conjunctival Melanocytic Intraepithelial Lesion Conjunctival melanocytic intraepithelial lesion characterized by the presence of moderate to severe atypia. C204980 Neoplastic Process High Grade Conjunctival Melanocytic Intraepithelial Lesion Undetermined High Grade C-MIL High Grade Conjunctival Melanocytic Intraepithelial Lesion High-Grade C-MIL High-Grade Conjunctival Melanocytic Intraepithelial Lesion PAM with Moderate to Severe Atypia Primary Acquired Melanosis with Moderate to Severe Atypia High Grade Conjunctival Melanocytic Intraepithelial Lesion A term that refers to conjunctival melanocytic intraepithelial lesions with severe atypia involving close to full thickness of the epithelium or lesions with histologic characteristics of melanoma that lack documented evidence of subepithelial invasion. C204981 Neoplastic Process Conjunctival Melanoma In Situ Malignant Conjunctival Melanoma In Situ Conjunctival Melanoma In Situ Fallopian tube high-grade serous adenocarcinoma that progresses between one and six months of completing platinum therapy. C204982 Neoplastic Process Platinum-Resistant Fallopian Tube High Grade Serous Adenocarcinoma Malignant Platinum-Resistant Fallopian Tube High Grade Serous Adenocarcinoma Platinum-Resistant Fallopian Tube-High Grade Serous Adenocarcinoma Platinum-Resistant Fallopian Tube High Grade Serous Adenocarcinoma The reemergence of platinum-resistant fallopian tube high-grade serous adenocarcinoma after a period of remission. C204984 Neoplastic Process Recurrent Platinum-Resistant Fallopian Tube High Grade Serous Adenocarcinoma Recurrent Platinum-Resistant Fallopian Tube High Grade Serous Adenocarcinoma CTRP Malignant Recurrent Platinum-Resistant Fallopian Tube High Grade Serous Adenocarcinoma Recurrent Platinum-Resistant Fallopian Tube High-Grade Serous Adenocarcinoma Recurrent Platinum-Resistant Fallopian Tube High Grade Serous Adenocarcinoma Primary peritoneal high-grade serous adenocarcinoma that progresses between one and six months of completing platinum therapy. C204985 Neoplastic Process Platinum-Resistant Primary Peritoneal High Grade Serous Adenocarcinoma Malignant Platinum-Resistant Primary Peritoneal High Grade Serous Adenocarcinoma Platinum-Resistant Primary Peritoneal High-Grade Serous Adenocarcinoma Platinum-Resistant Primary Peritoneal High Grade Serous Adenocarcinoma The reemergence of platinum-resistant primary peritoneal high-grade serous adenocarcinoma after a period of remission. C204986 Neoplastic Process Recurrent Platinum-Resistant Primary Peritoneal High Grade Serous Adenocarcinoma Recurrent Platinum-Resistant Primary Peritoneal High Grade Serous Adenocarcinoma CTRP Malignant Recurrent Platinum-Resistant Primary Peritoneal High Grade Serous Adenocarcinoma Recurrent Platinum-Resistant Primary Peritoneal High-Grade Serous Adenocarcinoma Recurrent Platinum-Resistant Primary Peritoneal High Grade Serous Adenocarcinoma Ovarian high-grade serous adenocarcinoma that progresses during platinum therapy or within one month of completing platinum therapy. C204987 Neoplastic Process Platinum-Refractory Ovarian High Grade Serous Adenocarcinoma Platinum-Refractory Ovarian High Grade Serous Adenocarcinoma CTRP Malignant Platinum-Refractory Ovarian High Grade Serous Adenocarcinoma Platinum-Refractory Ovarian High-Grade Serous Adenocarcinoma Platinum-Refractory Ovarian High Grade Serous Adenocarcinoma Fallopian tube high-grade serous adenocarcinoma that progresses during platinum therapy or within one month of completing platinum therapy. C204988 Neoplastic Process Platinum-Refractory Fallopian Tube High Grade Serous Adenocarcinoma CTRP Malignant Platinum-Refractory Fallopian Tube High Grade Serous Adenocarcinoma Platinum-Refractory Fallopian Tube High-Grade Serous Adenocarcinoma Platinum-Refractory Fallopian Tube High Grade Serous Adenocarcinoma Primary peritoneal high-grade serous adenocarcinoma that progresses during platinum therapy or within one month of completing platinum therapy. C204991 Neoplastic Process Platinum-Refractory Primary Peritoneal High Grade Serous Adenocarcinoma Platinum-Refractory Primary Peritoneal High Grade Serous Adenocarcinoma CTRP Malignant Platinum-Refractory Primary Peritoneal High Grade Serous Adenocarcinoma Platinum-Refractory Primary Peritoneal High-Grade Serous Adenocarcinoma Platinum-Refractory Primary Peritoneal High Grade Serous Adenocarcinoma A melanocytic neoplasm that arises from the iris, ciliary body, and choroid. This category includes nevus and its subtype melanocytoma, and melanoma. C205057 Neoplastic Process Uveal Melanocytic Neoplasm Undetermined Uveal Melanocytic Neoplasm Uveal Melanocytic Tumor Uveal Melanocytic Neoplasm A diffuse proliferation of melanocytes that affects the leptomeninges. This category includes melanocytosis and melanomatosis. C205069 Neoplastic Process Diffuse Meningeal Melanocytic Neoplasm Malignant Diffuse Meningeal Melanocytic Neoplasm Diffuse Meningeal Melanocytic Neoplasm A melanoma that is confined to the dermis and subcutaneous tissue without involvement of the epidermis. C205129 Neoplastic Process Dermal Melanoma Malignant Dermal Melanoma Dermal Melanoma A melanoma that has spread to the skin from a cutaneous or extracutaneous primary site. C205130 Neoplastic Process Metastatic Melanoma in the Skin Malignant Metastatic Melanoma in the Skin Metastatic Melanoma in the Skin A melanoma that has spread to the lymph nodes from a cutaneous or extracutaneous primary site. C205131 Neoplastic Process Metastatic Melanoma in the Lymph Nodes Malignant Metastatic Melanoma in the Lymph Nodes Metastatic Melanoma in the Lymph Nodes An endometrial carcinoma that has a documented response to platinum-based chemotherapy. C205187 Neoplastic Process Platinum-Sensitive Endometrial Carcinoma Malignant Platinum-Sensitive Endometrial Carcinoma Platinum-Sensitive Endometrial Carcinoma The reemergence of platinum-sensitive endometrial carcinoma after a period of remission. C205188 Neoplastic Process Recurrent Platinum-Sensitive Endometrial Carcinoma Recurrent Platinum-Sensitive Endometrial Carcinoma CTRP Malignant Recurrent Platinum-Sensitive Endometrial Carcinoma Recurrent Platinum-Sensitive Endometrial Carcinoma Radiographic visualization of the aorta and its branches following injection of contrast media. C205189 Diagnostic Procedure Aortography Aortography Aortography A pancreatic ductal adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection. C205226 Neoplastic Process Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma CTRP Malignant Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma The reemergence of hormone-sensitive prostate carcinoma in an anatomic site other than the prostate gland, after a period of remission. C205238 Neoplastic Process Recurrent Castration-Sensitive Prostate Carcinoma Recurrent Castration-Sensitive Prostate Carcinoma CTRP Malignant Recurrent Castration-Sensitive Prostate Carcinoma Recurrent Hormone-Sensitive Prostate Carcinoma Recurrent Castration-Sensitive Prostate Carcinoma Bladder urothelial carcinoma confined to the lining of the bladder. C205286 Neoplastic Process Early Stage Bladder Urothelial Carcinoma Early Stage Bladder Urothelial Carcinoma CTRP Malignant Early Stage Bladder Urothelial Carcinoma Early Stage Bladder Urothelial Carcinoma A stage term that refers to cervical carcinoma stages IA, IB, and IIA. C205287 Neoplastic Process Early Stage Cervical Carcinoma Early Stage Cervical Carcinoma CTRP Malignant Early Stage Cervical Carcinoma Early Stage Cervical Carcinoma A stage term referring to clear cell renal cell carcinoma that presents as a small tumor and is confined to the kidney. C205289 Neoplastic Process Early Stage Clear Cell Renal Cell Carcinoma Early Stage Clear Cell Renal Cell Carcinoma CTRP Malignant Early Stage Clear Cell Renal Cell Carcinoma Early Stage Clear Cell Renal Cell Carcinoma A stage term referring to colorectal carcinoma that is limited to the colon/rectum or local lymph nodes, without metastasis to distant anatomic sites. C205290 Neoplastic Process Early Stage Colorectal Carcinoma Early Stage Colorectal Carcinoma CTRP Malignant Early Stage Colorectal Carcinoma Early Stage Colorectal Carcinoma A stage term referring to endometrial carcinoma that is confined to the uterus. C205295 Neoplastic Process Early Stage Endometrial Carcinoma Early Stage Endometrial Carcinoma CTRP Malignant Early Stage Endometrial Carcinoma Early Stage Endometrial Carcinoma A stage term referring to esophageal carcinoma that is confined to the esophageal mucosa or submucosa. C205298 Neoplastic Process Early Stage Esophageal Carcinoma Early Stage Esophageal Carcinoma CTRP Malignant Early Stage Esophageal Carcinoma Early Stage Esophageal Carcinoma A stage term referring to hepatocellular carcinoma that presents as a single tumor with the largest diameter measuring 2 cm or less. The liver function is well-preserved and there is no vascular invasion or metastasis. (Barcelona Liver Cancer Classification). C205301 Neoplastic Process Early Stage Hepatocellular Carcinoma Early Stage Hepatocellular Carcinoma CTRP Malignant Early Stage Hepatocellular Carcinoma Very Early Stage Hepatocellular Carcinoma Early Stage Hepatocellular Carcinoma A stage term that refers to lung non-small cell carcinoma stages I, II, and IIIA. C205303 Neoplastic Process Early Stage Lung Non-Small Cell Carcinoma Early Stage Lung Non-Small Cell Carcinoma CTRP Malignant Early Stage Lung Non-Small Cell Carcinoma Early Stage Lung Non-Small Cell Carcinoma A stage term that refers to a malignant tumor confined to a limited area of the skin without lymph node or distant metastases. C205307 Neoplastic Process Early Stage Malignant Skin Neoplasm Early Stage Malignant Skin Neoplasm CTRP Malignant Early Stage Malignant Skin Neoplasm Early Stage Malignant Skin Neoplasm Cervical carcinoma that is amenable to surgical resection. C205308 Neoplastic Process Resectable Cervical Carcinoma Resectable Cervical Carcinoma CTRP Malignant Resectable Cervical Carcinoma Resectable Cervical Carcinoma Clear cell renal cell carcinoma that is amenable to surgical resection. C205309 Neoplastic Process Resectable Clear Cell Renal Cell Carcinoma Resectable Clear Cell Renal Cell Carcinoma CTRP Malignant Resectable Clear Cell Renal Cell Carcinoma Resectable Clear Cell Renal Cell Carcinoma Endometrial carcinoma that is amenable to surgical resection. C205310 Neoplastic Process Resectable Endometrial Carcinoma Resectable Endometrial Carcinoma CTRP Malignant Resectable Endometrial Carcinoma Resectable Endometrial Carcinoma Esophageal carcinoma that is amenable to surgical resection. C205311 Neoplastic Process Resectable Esophageal Carcinoma Resectable Esophageal Carcinoma CTRP Malignant Resectable Esophageal Carcinoma Resectable Esophageal Carcinoma Triple-negative breast carcinoma that is amenable to surgical resection. C205314 Neoplastic Process Resectable Triple-Negative Breast Carcinoma CTRP Malignant Resectable Triple-Negative Breast Carcinoma Resectable Triple-Negative Breast Carcinoma A very rare carcinoma that arises from adnexal structures in the skin. It is characterized by mutations and rearrangement of the NUT gene. It presents as a papular or nodular lesion and has been described in the hand, shoulder, trunk, and lower limb. Histologically, there is a proliferation of malignant epithelial cells in the dermis and/or subcutaneous tissue. The tumor cells display round nuclei with prominent single nucleoli. Features include the presence of small round ducts and foci of abrupt keratinization. C205357 Neoplastic Process Primary Cutaneous NUT Adnexal Carcinoma Provisional_Concept Malignant NUT Adnexal Carcinoma Primary Cutaneous NUT Adnexal Carcinoma Primary Cutaneous NUT Adnexal Carcinoma A renal cell carcinoma that is mainly confined to the kidney with or without involvement of perinephric tissues and without evidence of spread to other organs. C205361 Neoplastic Process Localized Renal Cell Carcinoma Localized Renal Cell Carcinoma CTRP Malignant Localized Renal Cell Carcinoma Localized Renal Cell Carcinoma A rare subtype of trichoblastoma characterized by the presence of lobules of basaloid cells. The lobules are separated by fibrous stroma. It is associated with the expression of recurrent FOXK1/GRHL and GPS2/GRHL gene fusions. C205371 Neoplastic Process Trichogerminoma Benign Trichogerminoma Trichogerminoma Adaptive proton radiation therapy that shortens the cycle between image capture and radiation therapy plan, occurring while the patient is on the treatment table. C205386 Therapeutic or Preventive Procedure Online Adaptive Proton Stereotactic Body Radiation Therapy Online Adaptive Proton Stereotactic Body Radiation Therapy CTRP Online Adaptive Proton SBRT Online Adaptive Proton Stereotactic Body Radiation Therapy Online Adaptive Proton Stereotactic Body Radiation Therapy A rare, benign cystic neoplasm that arises from the apocrine gland. It is characterized by the presence of papillary-like epithelial projections and more complex architectural patterns compared to apocrine hidrocystoma. C205459 Neoplastic Process Apocrine Cystadenoma Benign Apocrine Cystadenoma Apocrine Gland Cystadenoma Apocrine Cystadenoma A poroma with eccrine differentiation. C205462 Neoplastic Process Eccrine Poroma GDC Benign Eccrine poroma Eccrine Poroma Eccrine poroma Eccrine Poroma A poroma with apocrine differentiation. C205463 Neoplastic Process Apocrine Poroma Benign Apocrine Poroma Apocrine Poroma A poroma characterized by the presence of aggregates of basaloid cells confined to the epidermis. C205475 Neoplastic Process Hidroacanthoma Simplex Benign HS Hidroacanthoma Simplex Hidroacanthoma Simplex A poroma characterized by the presence of a single or several nodules of neoplastic cells forming solid and cystic areas in the dermis. C205476 Neoplastic Process Poroid Hidradenoma Benign PH Poroid Hidradenoma Poroid Hidradenoma A hidradenoma characterized by the presence of solid lobular neoplastic cell proliferations and cystic spaces filled with homogeneous eosinophilic material. C205539 Neoplastic Process Solid Cystic Hidradenoma Benign SCH Solid Cystic Hidradenoma Solid and Cystic Hidradenoma Solid Cystic Hidradenoma A skin myoepithelioma characterized by a solid syncytial growth of ovoid, spindled, or histiocytoid cells. The majority of cases are associated with EWSR1/PBX3 gene fusion. C205551 Neoplastic Process Skin Syncytial Myoepithelioma Benign CSM Cutaneous Syncytial Myoepithelioma Skin Syncytial Myoepithelioma Syncytial Myoepithelioma of Skin Syncytial Myoepithelioma of the Skin Skin Syncytial Myoepithelioma An acute myeloid leukemia arising from prior myelodysplastic syndrome, myeloproliferative neoplasm, or myelodysplastic/myeloproliferative neoplasm, or as a result of previous exposure to alkylating agents or topoisomerase II inhibitors. C25765 Neoplastic Process Secondary Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia C0280449 CTRP Cellosaurus PCDC Malignant Secondary_Acute_Myeloid_Leukemia SECONDARY_AML Secondary AGL Secondary AML Secondary Acute Granulocytic Leukemia Secondary Acute Myeloblastic Leukemia Secondary Acute Myelogenous Leukemia Secondary Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia (AML) Secondary Acute Myeloid Leukemia A malignant germ cell tumor that arises from the testis and has spread to another anatomic site. C25771 Neoplastic Process Metastatic Malignant Testicular Germ Cell Tumor Metastatic Malignant Testicular Germ Cell Tumor C1096715 CTRP Malignant Metastatic_Malignant_Testicular_Germ_Cell_Tumor Metastatic Malignant Testicular Germ Cell Tumor Metastatic Testicular Cancer Metastatic Malignant Testicular Germ Cell Tumor An often clinically aggressive neuroendocrine tumor located in the pancreas or small intestine. It is composed of cells containing vasoactive intestinal peptide. It may cause intractable diarrhea and metabolic disturbances. C26749 Neoplastic Process VIP-Producing Neuroendocrine Tumor C0011993 Cellosaurus GDC 8155/1 Undetermined Vasoactive_Intestinal_Peptide_Producing_Neoplasm 8155/1 Vipoma Vipoma, NOS VIP Producing Neoplasm VIP- Secreting Neoplasm VIP- Secreting Tumor VIP-Producing NET VIP-Producing Neuroendocrine Tumor VIPoma Vasoactive Intestinal Peptide Producing Neoplasm Vasoactive Intestinal Peptide Producing Tumor Vasoactive Intestinal Peptide Secreting Neoplasm Vipoma, NOS VIP-Producing Neuroendocrine Tumor Leukemia that is caused by radiation. C26814 Neoplastic Process Radiation-Related Leukemia C0023488 CPTAC Malignant Radiation-Related_Leukemia Radiation-Induced Leukemia Radiation-Related Leukemia Radiation-Related Leukemia A wart on the plantar surface of the foot. It is caused by human papillomavirus. C26913 Neoplastic Process Verruca Plantaris C0042548 NICHD A common wart on the plantar surface of the foot. Benign Verruca_Plantaris Plantar Wart Verruca Plantaris Verruca Plantaris A malignant mesenchymal neoplasm composed of spindle-shaped cells. This is a morphologic term which can be applied to a wide range of sarcomas. C27005 Neoplastic Process Spindle Cell Sarcoma Spindle Cell Sarcoma C0205945 CPTAC CTRP Cellosaurus GDC A type of connective tissue cancer in which the cells are spindle-shaped when examined under a microscope. 8801/3 Malignant Spindle_Cell_Sarcoma 8801/3 Spindle cell sarcoma Spindle Cell Sarcoma Spindle cell sarcoma spindle cell sarcoma Spindle Cell Sarcoma An acquired or congenital benign skin melanocytic neoplasm. It can occur on any area of the body, but most commonly occurs on the face of children and the thighs of young females. It is characterized by a proliferation of large spindle, oval, or large epithelioid melanocytes in the dermal-epidermal junction. The melanocytic proliferation subsequently extends into the dermis. C27007 Neoplastic Process Spitz Nevus C0206739 GDC 8770/0 Benign Spitz_Spindle_Cell_Nevus 8770/0 Epithelioid and spindle cell nevus Juvenile melanoma Juvenile nevus Spindle cell nevus, NOS Spitz nevus Benign Juvenile Melanoma Epithelioid and spindle cell nevus Juvenile Nevus Juvenile nevus Spindle and/ or Epithelioid Cell Nevus Spindle cell nevus, NOS Spitz Nevus Spitz nevus Spitz Nevus A hemangioma that is not present at birth but develops later in life. C27018 Neoplastic Process Acquired Hemangioma C0856897 Benign Acquired_Hemangioma Acquired Hemangioma Acquired Hemangioma A neoplasm with neuroendocrine differentiation that arises from the pancreas. It includes neuroendocrine tumors and neuroendocrine carcinomas. C27031 Neoplastic Process Pancreatic Neuroendocrine Neoplasm CL973078 GDC 8150/1 Undetermined Pancreatic_Endocrine_Neoplasm 8150/1 Islet cell tumor, NOS Pancreatic endocrine tumor, NOS PanNEN Pancreatic Endocrine Neoplasm Pancreatic Neuroendocrine Neoplasm Pancreatic Neuroendocrine Neoplasm A pilocytic astrocytoma that occurs during adolescence. C27081 Neoplastic Process Juvenile Pilocytic Astrocytoma C0280783 NICHD A pilocytic astrocytoma that occurs during adolescence. A slow-growing type of central nervous system tumor that forms from glial (supportive) tissue of the brain and spinal cord. Juvenile pilocytic astrocytoma usually occurs in children and young adults. It forms in the brain more often than the spinal cord. Undetermined Juvenile_Pilocytic_Astrocytoma Juvenile Pilocytic Astrocytoma juvenile pilocytic astrocytoma Juvenile Pilocytic Astrocytoma A benign squamoproliferative skin lesion caused by human papillomavirus. It is characterized by hyperkeratosis, acanthosis, papillomatosis, parakeratosis, and prominent rete ridges. It usually affects the hands and fingers. Other sites of involvement include the elbows, knees, face, and genitalia. C27087 Neoplastic Process Verruca Vulgaris C0043037 NICHD A wart on the skin. Benign Verruca_Vulgaris Common Viral Wart Common Wart Verruca Vulgaris Verruca Vulgaris A benign sweat gland neoplasm usually occurring in the scalp or the face. It may present as solitary or multiple papular or nodular lesions. It may be a sporadic lesion or part of Brooke-Spiegler syndrome. It arises from the dermis and has a multinodular, circumscribed appearance. The nodules contain basaloid cells with small, dark nuclei. Complete excision is usually curative. C27094 Neoplastic Process Cylindroma C1305968 GDC 8200/0 Benign Cylindroma 8200/0 Cylindroma of skin Eccrine dermal cylindroma Cylindroma Cylindroma of Skin Cylindroma of skin Cylindroma of the Skin Dermal Cylindroma Cylindroma A benign nevus characterized by the absence of melanin pigment in the melanocytes. C27095 Neoplastic Process Nonpigmented Nevus C0334432 GDC 8730/0 Benign Nonpigmented_Nevus 8730/0 Achromic nevus Nonpigmented nevus Nonpigmented Nevus Nonpigmented nevus Nonpigmented Nevus An aggressive malignant mesenchymal neoplasm that arises from the liver and usually occurs in older children. It is composed of immature spindle, stellate, polymorphous, and giant cells. C27096 Neoplastic Process Liver Embryonal Sarcoma Liver Embryonal Sarcoma C0855073 CPTAC CTRP GDC 8805/3 8991/3 Malignant Undifferentiated_Embryonal_Sarcoma 8991/3 Embryonal sarcoma ESL Embryonal Sarcoma Embryonal Sarcoma (Undifferentiated Sarcoma) Embryonal Sarcoma of the Liver Embryonal sarcoma Liver Embryonal Sarcoma UES Undifferentiated (Embryonal) Sarcoma Undifferentiated (Embryonal) Sarcoma of the Liver Undifferentiated Sarcoma Undifferentiated sarcoma Liver Embryonal Sarcoma A clinical variant of Burkitt lymphoma that occurs in equatorial Africa. The Epstein-Barr virus has been detected in all patients. It is the most common malignancy of childhood in this area. C27122 Neoplastic Process Endemic Burkitt Lymphoma C0343640 GDC Malignant Endemic_Burkitt_s_Lymphoma Endemic African Burkitt Lymphoma African Burkitt's Lymphoma Endemic Endemic Burkitt Lymphoma Endemic Burkitt's Lymphoma Endemic Burkitt Lymphoma A neoplasm with tricholemmal differentiation. It affects women more frequently than men. It usually presents on the scalp as a solitary, multilobular, large, exophytic mass. Morphologically, it may display benign cytological features and appear as a circumscribed solid-cystic neoplasm or it may display malignant characteristics and invasive features. Cases without malignant characteristics usually have an indolent course. Complete surgical excision is recommended in such cases to avoid recurrences and to allow complete examination of the specimen. Cases with malignant characteristics may have a locally aggressive clinical course, recur, or metastasize. C27125 Neoplastic Process Proliferating Trichilemmal Tumor C0086809 GDC 8103/0 8103/1 Undetermined Pilar_Tumor 8103/0 Pilar tumor Proliferating trichilemmal cyst Proliferating trichilemmal tumor Pilar Cyst Pilar Tumor Pilar tumor Proliferating Pilar Tumor Proliferating Trichilemmal Cyst Proliferating Trichilemmal Tumor Proliferating Tricholemmal Tumor Proliferating trichilemmal cyst Proliferating trichilemmal tumor Proliferating Trichilemmal Tumor A vascular neoplasm that arises from the skin and is characterized by the absence of atypical or malignant cytological features, and absence of invasive features or metastatic potential. C27127 Neoplastic Process Benign Skin Vascular Neoplasm C0347396 Benign Benign_Cutaneous_Vascular_Neoplasm Benign Cutaneous Vascular Neoplasm Benign Cutaneous Vascular Tumor Benign Skin Vascular Neoplasm Benign Skin Vascular Tumor Benign Skin Vascular Neoplasm An invasive adenocarcinoma confined to the mucosa or mucosa and submucosa of the gastric wall. The regional lymph nodes may or may not be involved. It usually occurs in the lesser curvature. The 5-year survival rate following resection is between 80 percent and 95 percent, and remains high even when lymph node metastases are present. C27131 Neoplastic Process Early Gastric Cancer C0349530 Malignant Early_Gastric_Cancer EGC Early Gastric Cancer Microinvasive Gastric Cancer Superficial Gastric Cancer Superficial Spreading Gastric Cancer Surface Gastric Cancer Early Gastric Cancer A benign hair follicle neoplasm with trichoblastic differentiation. It usually presents as a solitary papular lesion It most often presents on the head and neck area, but it may develop in any anatomic site containing hair follicles. Because of its benign nature, treatment usually is not required, provided that the diagnosis has been established with certainty. C27132 Neoplastic Process Trichoblastoma C0349658 CDISC GDC A benign hair follicle neoplasm with trichoblastic differentiation. 8100/0 Benign Trichogenic_Trichoblastoma 8100/0 Brooke tumor Epithelioma adenoides cysticum Trichoepithelioma Brooke tumor Brooke's Tumor TRICHOEPITHELIOMA, BENIGN Trichoblastic Fibroma Trichoblastoma Trichoepithelioma Trichogenic Adnexal Tumor Trichogenic Trichoblastoma Trichoblastoma A neoplasm that arises from hematopoietic and lymphoid cells. Representative examples include myeloproliferative neoplasms, myelodysplastic syndromes, leukemias, Hodgkin lymphomas, and non-Hodgkin lymphomas. C27134 Neoplastic Process Hematopoietic and Lymphoid Cell Neoplasm Hematopoietic and Lymphoid Cell Neoplasm C0376545 CDISC CPTAC CTEP CTRP GDC mCode A cancer of the blood or bone marrow, such as leukemia or lymphoma. A malignant neoplasm composed of hemolymphoreticular cells. Undetermined Hematopoietic_Cell_Neoplasm Hematologic Cancer Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified Neoplasm of uncertain behavior of other lymphatic and hematopoietic tissues Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue Other lymphatic and hematopoietic tissues Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue HEMOLYMPHORETICULAR TUMOR, MALIGNANT Hematologic Cancer Hematologic Neoplasm Hematological Neoplasm Hematopoietic Neoplasm Hematopoietic Neoplasms Including Lymphomas Hematopoietic and Lymphoid Cell Neoplasm Hematopoietic and Lymphoid Neoplasm Hematopoietic malignancy, NOS Malignant Hematologic Neoplasm Malignant Hematopoietic Neoplasm Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified hematologic cancer Hematopoietic and Lymphoid Cell Neoplasm A histologic variant of basal cell carcinoma of the skin characterized by the presence of strands and nests of malignant cells that are embedded in a dense fibrotic stroma. C27182 Neoplastic Process Skin Sclerosing/Morphoeic Basal Cell Carcinoma C0555191 GDC Malignant Morphea-Type_Sclerosing_Basal_Cell_Carcinoma 8092/3 Infiltrating basal cell carcinoma, sclerosing Basal Cell Carcinoma Sclerosing Type Morphea-Type (Sclerosing) Basal Cell Carcinoma Morphea-Type Basal Cell Carcinoma Morpheaform Basal Cell Carcinoma Sclerosing Type Basal Cell Carcinoma Skin Morphea-Type (Sclerosing) Basal Cell Carcinoma Skin Sclerosing/Morphoeic Basal Cell Carcinoma Skin Sclerosing/Morphoeic Basal Cell Carcinoma A rare glioblastoma that arises from the spinal cord and occurs in adults. C27183 Neoplastic Process Adult Spinal Cord Glioblastoma C0559185 Malignant Adult_Spinal_Cord_Glioblastoma Adult Spinal Cord Glioblastoma Adult Spinal Cord Glioblastoma Multiforme Adult Spinal Cord Glioblastoma C27188 Finding Radiation-Induced Mosaicism C0599547 Radiation-Induced_Mosaicism Radiation-Induced Mosaicism Radiation-Induced Mosaicism An aggressive malignant smooth muscle neoplasm, arising from the stomach. It is characterized by a proliferation of neoplastic spindle cells. C27200 Neoplastic Process Gastric Leiomyosarcoma C0744295 Cellosaurus Malignant Gastric_Leiomyosarcoma Gastric Leiomyosarcoma Gastric Leiomyosarcoma An invasive bladder urothelial carcinoma exhibiting micropapillary growth pattern. C27202 Neoplastic Process Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant Invasive Bladder Micropapillary Urothelial Carcinoma C1517579 CTRP Malignant Invasive_Papillary_Urothelial_Carcinoma Bladder Micropapillary Urothelial Carcinoma Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant Invasive Bladder Micropapillary Urothelial Carcinoma Invasive Bladder Urothelial Carcinoma, Micropapillary Variant Invasive Bladder Micropapillary Urothelial Carcinoma An extranodal non-Hodgkin lymphoma that arises from the stomach with the bulk of the mass located in the stomach. The vast majority of cases are diffuse large B-cell lymphomas and B-cell lymphomas of the mucosa-associated lymphoid tissue. C27235 Neoplastic Process Gastric Non-Hodgkin Lymphoma C1333784 Malignant Gastric_Non-Hodgkin_s_Lymphoma Gastric Non-Hodgkin Lymphoma Gastric Non-Hodgkin's Lymphoma Non-Hodgkin's Lymphoma of Stomach Non-Hodgkin's Lymphoma of the Stomach Primary Gastric Non-Hodgkin Lymphoma Primary Gastric Non-Hodgkin's Lymphoma Gastric Non-Hodgkin Lymphoma A medulloblastoma developing in patients with familiar adenomatous polyposis syndrome. It is observed in patients with Turcot syndrome, type 2. C27237 Neoplastic Process Familial Adenomatous Polyposis Associated Medulloblastoma C1333598 Malignant Familial_Adenomatous_Polyposis_Associated_Medulloblastomas FAP Associated Medulloblastoma Familial Adenomatous Polyposis Associated Medulloblastoma Familial Adenomatous Polyposis Associated Medulloblastoma Intraepithelial neoplasia involving the anal canal. The epithelial cells exhibit mild dysplasia (grade I intraepithelial neoplasia). C27238 Neoplastic Process Low Grade Anal Canal Intraepithelial Neoplasia C1334412 8077/0 Undetermined Low-Grade_Anal_Canal_Intraepithelial_Neoplasia ASIN-L Low Grade Anal Canal Dysplasia Low Grade Anal Canal Intraepithelial Neoplasia Low Grade Anal Canal Squamous Dysplasia Low Grade Anal Canal Squamous Intraepithelial Neoplasia Low Grade Anal Squamous Intraepithelial Neoplasia Low-Grade Intraepithelial Neoplasia of Anal Canal Low-Grade Intraepithelial Neoplasia of the Anal Canal Low Grade Anal Canal Intraepithelial Neoplasia An aggressive malignant tumor arising from trophoblastic cells in the uterus during pregnancy. Approximately half of the cases develop from a complete hydatidiform mole. There is often marked elevation of human chorionic gonadotropin (hCG) in the blood. Choriocarcinomas disseminate rapidly through the hematogenous route; the lungs are most frequently affected. C27246 Neoplastic Process Uterine Corpus Choriocarcinoma Uterine Corpus Choriocarcinoma C0279677 CTRP Malignant Uterine_Corpus_Choriocarcinoma Gestational Uterine Corpus Choriocarcinoma Uterine Corpus Choriocarcinoma Uterine Corpus Gestational Choriocarcinoma Uterine Corpus Choriocarcinoma Stage IVB includes: Any T, Any N, M1. M1: distant metastasis (including pelvic lymph node metastasis). (AJCC 6th and 7th eds.) C27247 Neoplastic Process Stage IVB Vulvar Cancer AJCC v6 and v7 Stage IVB Vulvar Cancer AJCC v6 and v7 C0852667 CTRP Malignant Stage_IVB_Vulvar_Cancer Stage IVB Carcinoma of Vulva Stage IVB Carcinoma of the Vulva Stage IVB Vulva Carcinoma Stage IVB Vulval Cancer Stage IVB Vulval Carcinoma Stage IVB Vulvar Cancer Stage IVB Vulvar Cancer AJCC v6 Stage IVB Vulvar Cancer AJCC v6 and v7 Stage IVB Vulvar Cancer AJCC v7 Stage IVB Vulvar Carcinoma Stage IVB Vulvar Cancer AJCC v6 and v7 A rare, self-limiting, rapidly growing, non-encapsulated benign osteolytic neoplasm that arises from the cranium. It is characterized by the presence of plump spindle-shaped fibroblasts, multinucleated osteoclast-like giant cells, chronic inflammatory infiltrate, red blood cell extravasation, and high mitotic activity. C27248 Neoplastic Process Cranial Nodular Fasciitis C1333162 Benign Cranial_Nodular_Fasciitis Cranial Nodular Fasciitis Cranial Pseudosarcomatous Fasciitis Cranial Nodular Fasciitis A benign mesothelial neoplasm that arises from the uterine body. It is characterized by the presence of gland-like structures. C27250 Neoplastic Process Uterine Corpus Adenomatoid Tumor C1336902 Benign Uterine_Corpus_Adenomatoid_Tumor Benign Uterine Corpus Mesothelioma Uterine Corpus Adenomatoid Tumor Uterine Corpus Localized Epithelial Mesothelioma Uterine Corpus Adenomatoid Tumor A well differentiated, low grade neuroendocrine neoplasm (carcinoid tumor) arising from the gastrointestinal tract. It is characterized by the presence of enterochromaffin-like type granules in the neoplastic cells. C27252 Neoplastic Process Enterochromaffin-Like Cell Neuroendocrine Tumor G1 C1266030 GDC 8242/1 8242/3 Undetermined Enterochromaffin-Like_Cell_Carcinoid_Tumor 8242/1 8242/3 ECL cell carcinoid, NOS ECL cell carcinoid, malignant Enterochromaffin-like cell carcinoid, NOS Enterochromaffin-like cell tumor Enterochromaffin-like cell tumor, malignant ECL Cell NET G1 Enterochromaffin-Like Cell Carcinoid Tumor Enterochromaffin-Like Cell NET G1 Enterochromaffin-Like Cell Neuroendocrine Tumor Enterochromaffin-Like Cell Neuroendocrine Tumor G1 Enterochromaffin-Like Cell Neuroendocrine Tumor G1 A benign, well-circumscribed renal cortical neoplasm affecting females more often than males. Polycythemia has been reported in twelve-percent of patients. C27253 Neoplastic Process Metanephric Adenoma C1266045 GDC 8191/0 8325/0 Benign Metanephric_Adenoma 8191/0 Embryonal adenoma Metanephric adenoma Embryonal adenoma Kidney Embryonal Adenoma Metanephric Adenoma Metanephric adenoma Metanephric Adenoma A carcinoma of the eccrine glands. It consists of dilated ducts with papillary projections. C27254 Neoplastic Process Papillary Eccrine Carcinoma C1367789 GDC Malignant Eccrine_Papillary_Adenocarcinoma 8408/3 Eccrine papillary adenocarcinoma Syringocystadenocarcinoma papilliferum Papillary Eccrine Carcinoma Papillary Eccrine Carcinoma An adenocarcinoma with eccrine differentiation arising from the sweat glands. It includes the following subtypes: ductal eccrine adenocarcinoma, papillary eccrine carcinoma, and eccrine porocarcinoma. C27255 Neoplastic Process Eccrine Carcinoma Eccrine Carcinoma C1302864 CDISC CTRP GDC A malignant carcinoma with eccrine differentiation arising from the sweat glands. 8413/3 Malignant Eccrine_Adenocarcinoma 8413/3 Eccrine adenocarcinoma CARCINOMA, ECCRINE GLAND, MALIGNANT Eccrine Carcinoma Eccrine adenocarcinoma Eccrine Carcinoma A morphologic variant of angiofibroma characterized by the presence of multinucleated giant cells, collagenous or myxoid stroma, focal sclerotic areas, and angiectoid spaces. C27256 Neoplastic Process Giant Cell Angiofibroma C1367539 GDC Benign Giant_Cell_Angiofibroma 9160/0 Giant cell angiofibroma Giant Cell Angiofibroma Giant cell angiofibroma Giant Cell Angiofibroma A benign mesenchymal neoplasm that usually arises in the superficial soft tissues of the vulva or inguinal and scrotal regions. It is characterized by the presence of a cellular fibroblastic proliferation in an edematous to fibrous stroma containing numerous vessels. C27257 Neoplastic Process Cellular Angiofibroma C1367534 GDC Benign Cellular_Angiofibroma 9160/0 Cellular angiofibroma Cellular Angiofibroma Cellular angiofibroma Cellular Angiofibroma A category of clonal hematopoietic disorders that have both myelodysplastic and myeloproliferative features at the time of initial presentation. C27262 Neoplastic Process Myelodysplastic/Myeloproliferative Disease Myelodysplastic/Myeloproliferative Neoplasm C1301355 CPTAC CTRP 9975/3 Malignant Myelodysplastic_Myeloproliferative_Disease MDS-MPD MDS/MPD MDS/MPN MPD-MDS MPD/MDS Myelodysplastic/Myeloproliferative Disease Myelodysplastic/Myeloproliferative Diseases Myelodysplastic/Myeloproliferative Disorder Myelodysplastic/Myeloproliferative Disorders Myelodysplastic/Myeloproliferative Neoplasm Myeloproliferative/Myelodysplastic Disorders Myeloproliferative/Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasm C27268 Neoplastic Process Lymphoma by Stage C1272836 Header_Concept Malignant Lymphoma_by_Stage Lymphoma by Stage Lymphoma by Stage A benign, well circumscribed adnexal neoplasm arising from the intraepidermal portion of the sweat gland duct. It usually presents as a solitary, dome-shaped papule, nodule, or plaque on acral sites. It is characterized by a proliferation of uniform basaloid cells in the dermis and is associated with the presence of focal ductal and cystic structures. Complete excision is curative. C27273 Neoplastic Process Poroma C1533161 GDC 8409/0 Benign Poroma_Acrospiroma 8409/0 Poroma, NOS Poroid Tumor Poroma Poroma Intraepithelial neoplasia involving the anal canal. The epithelial cells exhibit moderate dysplasia (grade II intraepithelial neoplasia) or severe dysplasia (grade III intraepithelial neoplasia or carcinoma in situ). C27275 Neoplastic Process High Grade Anal Canal Intraepithelial Neoplasia C1334009 Undetermined High_Grade_Anal_Canal_Intraepithelial_Neoplasia ASIN-H High Grade Anal Canal Dysplasia High Grade Anal Canal Intraepithelial Neoplasia High Grade Anal Canal Squamous Dysplasia High Grade Anal Canal Squamous Intraepithelial Neoplasia High Grade Anal Squamous Intraepithelial Neoplasia High Grade Anal Canal Intraepithelial Neoplasia A myelodysplastic syndrome resulting from chemotherapy or radiation therapy for cancer or exposure to certain chemicals. C27280 Neoplastic Process Secondary Myelodysplastic Syndrome Secondary Myelodysplastic Syndrome C0280745 CTRP Malignant Secondary_Myelodysplastic_Syndrome Secondary MDS Secondary Myelodysplastic Syndrome Secondary Myelodysplastic Syndrome Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C27282 Neoplastic Process Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7 Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7 C0854743 CTRP Malignant Stage_0_AIDS-Related_Anal_Canal_Cancer Stage 0 AIDS-Related Anal Canal Cancer Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7 Stage 0 AIDS-Related Anal Canal Cancer AJCC v7 Stage 0 AIDS-Related Anal Canal Carcinoma AJCC v6 and v7 Stage 0 AIDS-Related Anal Carcinoma AJCC v6 and v7 Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7 Stage I includes: T1, N0, M0. T1: Tumor 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C27283 Neoplastic Process Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7 Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7 C0854744 CTRP Malignant Stage_I_AIDS-Related_Anal_Canal_Cancer Stage I AIDS-Related Anal Canal Cancer Stage I AIDS-Related Anal Canal Cancer AJCC v6 Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7 Stage I AIDS-Related Anal Canal Cancer AJCC v7 Stage I AIDS-Related Anal Canal Carcinoma AJCC v6 and v7 Stage I AIDS-Related Anal Carcinoma AJCC v6 and v7 Stage I AIDS-Related Anal Canal Cancer AJCC v6 and v7 Stage II includes: (T2, N0, M0); (T3,N0, M0). T2: Tumor more than 2 cm but not more than 5 cm in greatest dimension. T3: Tumor more than 5 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C27284 Neoplastic Process Stage II AIDS-Related Anal Canal Cancer AJCC v6 and v7 Stage II AIDS-Related Anal Canal Cancer AJCC v6 and v7 C0854745 CTRP Malignant Stage_II_AIDS-Related_Anal_Canal_Cancer Stage II AIDS-Related Anal Canal Cancer Stage II AIDS-Related Anal Canal Cancer AJCC v6 Stage II AIDS-Related Anal Canal Cancer AJCC v6 and v7 Stage II AIDS-Related Anal Canal Cancer AJCC v7 Stage II AIDS-Related Anal Canal Carcinoma AJCC v6 and v7 Stage II AIDS-Related Anal Carcinoma AJCC v6 and v7 Stage II AIDS-Related Anal Canal Cancer AJCC v6 and v7 Stage III includes: IIIA (T1, N1, M0); (T2, N1, M0); (T3, N1, M0); (T4, N0, M0); IIIB (T4, N1, M0); (Any T, N2, M0); (Any T, N3, M0). T1: Tumor 2 cm or less in greatest dimension. T2: tumor more than 2 cm but not more than 5 cm in greatest dimension. T3: Tumor more than 5 cm in greatest dimension. T4: Tumor of any size that invades adjacent organ(s). N1: Metastasis in perirectal lymph node(s). N0: No regional lymph node metastasis. N2: Metastasis in unilateral internal iliac and/or inguinal lymph node(s). N3: Metastasis in perirectal and inguinal lymph nodes and/or bilateral internal iliac and/or inguinal lymph nodes. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C27285 Neoplastic Process Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7 Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7 C0854746 CTRP Malignant Stage_III_AIDS-Related_Anal_Canal_Cancer Stage III AIDS-Related Anal Canal Cancer Stage III AIDS-Related Anal Canal Cancer AJCC v6 Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7 Stage III AIDS-Related Anal Canal Cancer AJCC v7 Stage III AIDS-Related Anal Canal Carcinoma AJCC v6 and v7 Stage III AIDS-Related Anal Carcinoma AJCC v6 and v7 Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7 Stage IV includes: (Any T, Any N, M1). M1: Distant metastasis. (AJCC 6th and 7th Eds.) C27286 Neoplastic Process Stage IV AIDS-Related Anal Canal Cancer AJCC v6 and v7 Stage IV AIDS-Related Anal Canal Cancer AJCC v6 and v7 C0854747 CTRP Malignant Stage_IV_AIDS-Related_Anal_Canal_Cancer Stage IV AIDS-Related Anal Canal Cancer Stage IV AIDS-Related Anal Canal Cancer AJCC v6 Stage IV AIDS-Related Anal Canal Cancer AJCC v6 and v7 Stage IV AIDS-Related Anal Canal Cancer AJCC v7 Stage IV AIDS-Related Anal Canal Carcinoma AJCC v6 and v7 Stage IV AIDS-Related Anal Carcinoma AJCC v6 and v7 Stage IV AIDS-Related Anal Canal Cancer AJCC v6 and v7 A benign neoplasm of the ovary characterized by the presence of glandular structures with endometrial-type well-differentiated cells in a fibrotic stroma. C27287 Neoplastic Process Ovarian Endometrioid Adenofibroma C0334337 GDC 8380/0 8381/0 Benign Ovarian_Endometrioid_Adenofibroma 8380/0 8381/0 Endometrioid adenofibroma, NOS Endometrioid adenoma, NOS Endometrioid adenoma, NOS Ovarian Endometrioid Adenofibroma Ovarian Endometrioid Adenofibroma A benign neoplasm of the ovary characterized by the presence of cystic structures lined by endometrial-type well-differentiated cells in a fibrotic stroma. C27288 Neoplastic Process Ovarian Endometrioid Cystadenofibroma C1335158 GDC Benign Ovarian_Endometrioid_Cystadenofibroma 8381/0 Endometrioid cystadenofibroma, NOS Ovarian Endometrioid Cystadenofibroma Ovarian Endometrioid Cystadenofibroma An epithelial neoplasm that arises from the ovary characterized by the presence of cystic spaces which are lined by atypical glandular epithelial cells resembling endometrial cells. The surrounding ovarian stroma is fibrotic. There is no evidence of stromal invasion. C27289 Neoplastic Process Borderline Ovarian Endometrioid Cystadenofibroma C1332595 Uncertain Malignant Potential Borderline_Ovarian_Endometrioid_Cystadenofibroma Borderline Malignancy Ovarian Endometrioid Cystadenofibroma Borderline Ovarian Endometrioid Cystadenofibroma Low Malignant Potential Ovarian Endometrioid Cystadenofibroma Borderline Ovarian Endometrioid Cystadenofibroma A spectrum of malignant tumors arising from the soft tissues, characterized morphologically by the presence of small round cells. Ewing sarcoma and peripheral primitive neuroectodermal tumor represent the ends of a spectrum, with Ewing sarcoma lacking evidence of neural differentiation and the markers that characterize the peripheral primitive neuroectodermal tumor. Ewing sarcoma and peripheral primitive neuroectodermal tumor may share cytogenetic abnormalities, proto-oncogene expression, cell culture and immunohistochemical abnormalities. Pain and the presence of a mass are the most common clinical symptoms. C27293 Neoplastic Process Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor C1333514 CTRP Malignant Extraosseous_Ewing_s_Sarcoma_Peripheral_Primitive_Neuroectodermal_Tumor Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Extraosseous Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor A primitive neuroectodermal tumor that is confined to a specific site without evidence of spread to other anatomic sites. C27294 Neoplastic Process Localized Primitive Neuroectodermal Tumor C1334410 Malignant Localized_Primitive_Neuroectodermal_Tumor Localized Primitive Neuroectodermal Tumor Localized Primitive Neuroectodermal Tumor The reemergence of a primitive neuroectodermal tumor of the central or the peripheral nervous system after a period of remission. C27295 Neoplastic Process Recurrent Primitive Neuroectodermal Tumor C1335720 Malignant Recurrent_Primitive_Neuroectodermal_Tumor Recurrent Primitive Neuroectodermal Tumor Recurrent Primitive Neuroectodermal Tumor An anaplastic meningioma that arises within the cranial cavity. C27307 Neoplastic Process Anaplastic (Malignant) Intracranial Meningioma C0854909 Malignant Anaplastic_Malignant_Intracranial_Meningioma Anaplastic (Malignant) Intracranial Meningioma Anaplastic (Malignant) Intracranial Meningioma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C27308 Neoplastic Process Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma C0855091 CTRP Malignant Stage_I_B-Cell_Non-Hodgkin_s_Lymphoma Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma Stage I B-Cell Lymphoma Stage I B-Cell Non-Hodgkin Lymphoma Stage I B-Cell Non-Hodgkin's Lymphoma Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma An adenocarcinoma that arises from the periampullary region. C27322 Neoplastic Process Periampullary Adenocarcinoma Periampullary Adenocarcinoma C1335377 CTRP Cellosaurus A cancer that forms near the ampulla of Vater (an enlargement of the ducts from the liver and pancreas where they join and enter the small intestine). Malignant Periampullary_Adenocarcinoma Periampullary Adenocarcinoma periampullary cancer Periampullary Adenocarcinoma Carcinoma of the duodenum amendable to surgical removal. C27323 Neoplastic Process Resectable Duodenal Carcinoma C0861843 Malignant Resectable_Duodenal_Carcinoma Resectable Duodenal Carcinoma Resectable Duodenal Carcinoma Cholangiocarcinoma that is not amenable to surgical resection. C27324 Neoplastic Process Unresectable Cholangiocarcinoma C0862953 Malignant Non-Resectable_Cholangiocarcinoma Non-Resectable Cholangiocarcinoma Non-Resectable Cholangiocellular Carcinoma Unresectable Cholangiocarcinoma Unresectable Cholangiocarcinoma The reemergence of cholangiocarcinoma after a period of remission. C27325 Neoplastic Process Recurrent Cholangiocarcinoma C0862967 Malignant Recurrent_Cholangiocarcinoma Recurrent Cholangiocarcinoma Recurrent Cholangiocellular Carcinoma Recurrent Cholangiocarcinoma Cholangiocarcinoma that is amenable to surgical resection. C27326 Neoplastic Process Resectable Cholangiocarcinoma C0862981 Malignant Resectable_Cholangiocarcinoma Resectable Cholangiocarcinoma Resectable Cholangiocellular Carcinoma Resectable Cholangiocarcinoma A hepatocellular carcinoma that is not amenable to surgical resection. C27345 Neoplastic Process Unresectable Hepatocellular Carcinoma Unresectable Hepatocellular Carcinoma C1112459 CTRP Malignant Non-Resectable_Hepatocellular_Carcinoma Non-Resectable Hepatocellular Carcinoma Unresectable Hepatocellular Cancer Unresectable Hepatocellular Carcinoma Unresectable Hepatocellular Carcinoma An aggressive malignant neoplasm with a poor response to therapy, usually presenting as stage III/IV disease. It is characterized by the presence of neoplastic cells with morphologic and immunophenotypic characteristics similar to those seen in mature histiocytes. C27349 Neoplastic Process Histiocytic Sarcoma Histiocytic Sarcoma C0334663 CDISC CPTAC CTRP Cellosaurus GDC mCode A malignant neoplasm composed of cells resembling histiocytes. 9755/3 Malignant Histiocytic_Sarcoma 9755/3 Histiocytic sarcoma Malignant histiocytosis Histiocytic Sarcoma Histiocytic sarcoma SARCOMA, HISTIOCYTIC, MALIGNANT Histiocytic Sarcoma This subgroup of myeloproliferative neoplasms includes cases which do not meet the morphologic criteria of any of the defined myeloproliferative neoplasms, or which have characteristics that overlap at least two of the myeloproliferative neoplasms. C27350 Neoplastic Process Myeloproliferative Neoplasm, Unclassifiable Myeloproliferative Neoplasm, Not Otherwise Specified C1333046 CTRP GDC 9975/3 Malignant Chronic_Myeloproliferative_Disease_Unclassifiable 9960/3 9975/3 Chronic myeloproliferative disease, NOS Myeloproliferative disease, NOS Myeloproliferative neoplasm, NOS Myeloproliferative neoplasm, unclassifiable CMPD, U CMPD-U Chronic Myeloproliferative Disease, Unclassifiable Chronic Myeloproliferative Disorder, Unclassifiable Chronic myeloproliferative disease, NOS MPN, U MPN-NOS MPN-U Myeloproliferative Neoplasm, NOS Myeloproliferative Neoplasm, Not Otherwise Specified Myeloproliferative Neoplasm, Unclassifiable Myeloproliferative disease, NOS Myeloproliferative neoplasm, NOS Unclassifiable Chronic Myeloproliferative Disease Unclassifiable Chronic Myeloproliferative Disorder Myeloproliferative Neoplasm, Not Otherwise Specified A small round cell tumor with neural differentiation that is confined to a specific area of the bone and has not spread to other anatomic sites. C27353 Neoplastic Process Localized Peripheral Primitive Neuroectodermal Tumor of Bone C0855007 Malignant Localized_Peripheral_Primitive_Neuroectodermal_Tumor_of_Bone Localized Neuroepithelioma of Bone Localized PNET of Bone Localized Peripheral Primitive Neuroectodermal Tumor of Bone Localized Peripheral Primitive Neuroectodermal Tumor of Bone The reemergence of peripheral primitive neuroectodermal tumor of the bone after a period of remission. C27354 Neoplastic Process Recurrent Peripheral Primitive Neuroectodermal Tumor of Bone C0855010 Malignant Recurrent_Peripheral_Primitive_Neuroectodermal_Tumor_of_Bone Recurrent Neuroepithelioma of Bone Recurrent PNET of Bone Recurrent Peripheral Primitive Neuroectodermal Tumor of Bone Recurrent Peripheral Primitive Neuroectodermal Tumor of Bone A hematologic malignancy that is resistant to treatment. C27357 Neoplastic Process Refractory Hematologic Malignancy C1335724 Malignant Refractory_Hematologic_Malignancy Refractory Hematologic Cancer Refractory Hematologic Malignancy Refractory Hematologic Malignancy The reemergence of a hematologic malignancy after a period of remission. C27358 Neoplastic Process Recurrent Hematopoietic and Lymphoid Cell Neoplasm Recurrent Hematologic Malignancy C1335737 CTRP Malignant Relapsed_Hematologic_Malignancy Recurrent Hematologic Cancer Recurrent Hematologic Malignancy Recurrent Hematopoietic and Lymphoid Cell Neoplasm Relapsed Hematologic Cancer Relapsed Hematologic Malignancy Recurrent Hematologic Malignancy A ganglioglioma that arises from the central nervous system and occurs during childhood. C27362 Neoplastic Process Childhood Ganglioglioma Childhood Ganglioglioma C1332969 CTRP NICHD A ganglioglioma that occurs during childhood. Undetermined Childhood_Ganglioglioma Childhood Ganglioglioma Ganglioglioma Childhood Ganglioglioma C27363 Neoplastic Process Adult Ganglioglioma C1332202 Undetermined Adult_Ganglioglioma Adult Ganglioglioma Adult Ganglioglioma Primary cutaneous anaplastic large cell lymphoma that occurs in adults. C27365 Neoplastic Process Adult Primary Cutaneous Anaplastic Large Cell Lymphoma Adult Primary Cutaneous Anaplastic Large Cell Lymphoma C1332214 CTRP Malignant Adult_Primary_Cutaneous_Anaplastic_Large_Cell_Lymphoma Adult Primary Cutaneous Anaplastic Large Cell Lymphoma Adult Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma Adult Primary Cutaneous K-1+ Anaplastic Large Cell Lymphoma Primary Cutaneous Anaplastic Large Cell Lymphoma Adult Primary Cutaneous Anaplastic Large Cell Lymphoma An anaplastic large cell lymphoma affecting multiple anatomic sites and occurring in adults. C27366 Neoplastic Process Adult Systemic Anaplastic Large Cell Lymphoma Adult Systemic Anaplastic Large Cell Lymphoma C1332216 CTRP Malignant Adult_Systemic_Anaplastic_Large_Cell_Lymphoma Adult Systemic Anaplastic Large Cell Lymphoma Adult Systemic CD30+ Anaplastic Large Cell Lymphoma Adult Systemic K-1+ Anaplastic Large Cell Lymphoma Systemic Anaplastic Large Cell Lymphoma Adult Systemic Anaplastic Large Cell Lymphoma An anaplastic large cell lymphoma occurring in adults. C27367 Neoplastic Process Adult Anaplastic Large Cell Lymphoma Adult Anaplastic Large Cell Lymphoma C1332182 CTRP Malignant Adult_Anaplastic_Large_Cell_Lymphoma Adult Anaplastic Large Cell Lymphoma Adult CD30+ Anaplastic Large Cell Lymphoma Adult K-1+ Anaplastic Large Cell Lymphoma Anaplastic Large Cell Lymphoma Adult Anaplastic Large Cell Lymphoma A benign or malignant neoplasm that affects the liver and occurs during childhood. C27368 Neoplastic Process Childhood Liver Neoplasm C1332971 Undetermined Childhood_Hepatic_Neoplasm Childhood Liver Neoplasm Childhood Liver and Intrahepatic Bile Duct Neoplasm Pediatric Liver Neoplasm Childhood Liver Neoplasm An aggressive rhabdomyosarcoma occurring in adults. The neoplasm is characterized by the presence of bizarre round, spindle, and polygonal cells. Clinical presentation includes a rapidly enlarging painful mass usually in the lower extremities. C27369 Neoplastic Process Adult Pleomorphic Rhabdomyosarcoma C1332211 GDC 8901/3 Malignant Adult_Pleomorphic_Rhabdomyosarcoma 8901/3 Pleomorphic rhabdomyosarcoma, adult type Adult Pleomorphic Rhabdomyosarcoma Pleomorphic rhabdomyosarcoma, adult type Adult Pleomorphic Rhabdomyosarcoma A clear cell sarcoma of soft tissue occurring during adulthood. C27370 Neoplastic Process Adult Clear Cell Sarcoma of Soft Parts Adult Clear Cell Sarcoma of Soft Tissue C1332198 CTRP Malignant Adult_Clear_Cell_Sarcoma_of_Soft_Parts Adult Clear Cell Sarcoma of Soft Parts Adult Clear Cell Sarcoma of Soft Tissue Clear Cell Sarcoma of Soft Tissue Adult Clear Cell Sarcoma of Soft Tissue A clear cell sarcoma of soft tissue occurring in children. C27371 Neoplastic Process Childhood Clear Cell Sarcoma of Soft Parts Childhood Clear Cell Sarcoma of Soft Tissue C1332964 CTRP NICHD A clear cell sarcoma of soft tissue occurring in children. Malignant Childhood_Clear_Cell_Sarcoma_of_Soft_Parts Childhood Clear Cell Sarcoma of Soft Parts Childhood Clear Cell Sarcoma of Soft Tissue Clear Cell Sarcoma of Soft Tissue Pediatric Clear Cell Sarcoma of Soft Parts Childhood Clear Cell Sarcoma of Soft Tissue A desmoplastic small round cell tumor occurring in children. C27372 Neoplastic Process Childhood Desmoplastic Small Round Cell Tumor Childhood Desmoplastic Small Round Cell Tumor C1332966 CTRP Cellosaurus NICHD A desmoplastic small round cell tumor occurring in children. Malignant Childhood_Desmoplastic_Small_Round_Cell_Tumor Childhood Desmoplastic Small Round Cell Tumor Desmoplastic Small Round Cell Tumor Pediatric Desmoplastic Small Round Cell Tumor Childhood Desmoplastic Small Round Cell Tumor A desmoplastic small round cell tumor occurring in adults. C27373 Neoplastic Process Adult Desmoplastic Small Round Cell Tumor Adult Desmoplastic Small Round Cell Tumor C1332199 CTRP Cellosaurus Malignant Adult_Desmoplastic_Small_Round_Cell_Tumor Adult Desmoplastic Small Round Cell Tumor Desmoplastic Small Round Cell Tumor Adult Desmoplastic Small Round Cell Tumor A rare mesenchymal chondrosarcoma that occurs during childhood. C27374 Neoplastic Process Childhood Mesenchymal Chondrosarcoma Childhood Mesenchymal Chondrosarcoma C1332982 CTRP NICHD A rare mesenchymal chondrosarcoma that occurs during childhood. Malignant Childhood_Mesenchymal_Chondrosarcoma Childhood Mesenchymal Chondrosarcoma Mesenchymal Chondrosarcoma Pediatric Mesenchymal Chondrosarcoma Childhood Mesenchymal Chondrosarcoma A mesenchymal chondrosarcoma occurring in adults. C27375 Neoplastic Process Adult Mesenchymal Chondrosarcoma C1332207 Malignant Adult_Mesenchymal_Chondrosarcoma Adult Mesenchymal Chondrosarcoma Adult Mesenchymal Chondrosarcoma An osteosarcoma that arises from the soft tissue and occurs during childhood. C27376 Neoplastic Process Childhood Extraskeletal Osteosarcoma C1332968 NICHD An osteosarcoma that arises from the soft tissue and occurs during childhood. Malignant Childhood_Extraskeletal_Osteosarcoma Childhood Extraosseous Osteosarcoma Childhood Extraskeletal Osteosarcoma Pediatric Extraosseous Osteosarcoma Pediatric Extraskeletal Osteosarcoma Childhood Extraskeletal Osteosarcoma A myxoid chondrosarcoma occurring in children. C27377 Neoplastic Process Childhood Extraskeletal Myxoid Chondrosarcoma C1332984 NICHD An extraskeletal myxoid chondrosarcoma occurring during childhood. Malignant Childhood_Myxoid_Chondrosarcoma Childhood Extraskeletal Myxoid Chondrosarcoma Childhood Myxoid Chondrosarcoma Pediatric Myxoid Chondrosarcoma Childhood Extraskeletal Myxoid Chondrosarcoma An adenocarcinoma arising from the follicular cells of the thyroid gland. C27380 Neoplastic Process Thyroid Gland Adenocarcinoma Thyroid Gland Adenocarcinoma C1704228 CTRP Malignant Thyroid_Adenocarcinoma Thyroid Adenocarcinoma Thyroid Gland Adenocarcinoma Thyroid Gland Adenocarcinoma A carcinoma that has spread to the adrenal cortex from an adjacent or distal anatomic site. C27381 Neoplastic Process Metastatic Carcinoma in the Adrenal Cortex C1334716 Malignant Metastatic_Carcinoma_to_Adrenal_Cortex Metastatic Carcinoma in the Adrenal Cortex Metastatic Carcinoma to the Adrenal Cortex Metastatic Carcinoma in the Adrenal Cortex A condition in which a carcinoma has spread extensively throughout the peritoneum. C27382 Neoplastic Process Peritoneal Carcinomatosis Peritoneal Carcinomatosis C0346990 CTRP Malignant Abdominal_Carcinomatosis Abdominal Carcinomatosis Carcinomatosis of the Peritoneum Peritoneal Carcinomatosis Peritoneal Carcinomatosis Diffuse spread of cancer to the meninges. C27383 Neoplastic Process Meningeal Carcinomatosis C0220654 A serious problem that may occur in cancer in which cancer cells spread from the original (primary) tumor to the meninges (thin layers of tissue that cover and protect the brain and spinal cord). It can happen in many types of cancer, but is the most common in melanoma, breast, lung, and gastrointestinal cancer. The cancer may cause the meninges to be inflamed. Malignant Meningeal_Carcinomatosis Carcinomatosis of the Meninges Meningeal Carcinomatosis meningeal carcinomatosis Meningeal Carcinomatosis Carcinoma that has spread diffusely to the pleura. C27384 Neoplastic Process Pleural Carcinomatosis C1335433 Malignant Pleural_Carcinomatosis Carcinomatosis of the Pleura Pleural Carcinomatosis Pleural Carcinomatosis Carcinoma that has spread diffusely to the pericardium. C27385 Neoplastic Process Pericardial Carcinomatosis C1335378 Malignant Pericardial_Carcinomatosis Carcinomatosis of the Pericardium Pericardial Carcinomatosis Pericardial Carcinomatosis An uncommon type of hepatocelluar carcinoma, morphologically characterized by significant fibrosis around the sinusoid-like spaces and atrophy of the tumor trabeculae. C27388 Neoplastic Process Scirrhous Hepatocellular Carcinoma Scirrhous Hepatocellular Carcinoma C1266018 CTRP GDC 8172/3 Malignant Sclerosing_Hepatocellular_Carcinoma 8172/3 Hepatocellular carcinoma, scirrhous Sclerosing hepatic carcinoma Hepatocellular carcinoma, scirrhous Scirrhous Hepatocellular Cancer Scirrhous Hepatocellular Carcinoma Sclerosing Hepatic Carcinoma Sclerosing Hepatocellular Carcinoma Sclerosing hepatic carcinoma Scirrhous Hepatocellular Carcinoma A rare squamous cell carcinoma that either arises from or is associated with the presence of inverted papilloma in the nose. C27389 Neoplastic Process Carcinoma Arising in Nasal Papillomatosis C1332840 Malignant Carcinoma_Arising_in_Nasal_Papillomatosis Carcinoma Arising in Nasal Papillomatosis Carcinoma Arising in Nasal Papillomatosis A carcinoma that arises from the ovary and is characterized by the presence of small malignant cells. It includes small cell carcinoma, hypercalcemic type and small cell carcinoma, pulmonary type. C27390 Neoplastic Process Ovarian Small Cell Carcinoma Ovarian Small Cell Carcinoma C2212006 CTRP Cellosaurus Malignant Ovarian_Small_Cell_Carcinoma Ovarian Small Cell Cancer Ovarian Small Cell Carcinoma Ovarian Small Cell Carcinoma A primary small cell carcinoma of the ovary that is associated with hypercalcemia and has metastasized to other anatomic sites. C27391 Neoplastic Process Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type C1334736 Malignant Metastatic_Ovarian_Small_Cell_Carcinoma_with_Hypercalcemia Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type A parathyroid gland adenoma composed predominantly or entirely of neoplastic cells with abundant granular eosinophilic cytoplasm. C27393 Neoplastic Process Parathyroid Gland Oncocytic Adenoma C1335351 Benign Parathyroid_Oncocytic_Adenoma Parathyroid Gland Oncocytic Adenoma Parathyroid Gland Oxyphilic Adenoma Parathyroid Oncocytic Adenoma Parathyroid Gland Oncocytic Adenoma A primary malignant neoplasm of the vagina composed of malignant melanocytes. C27394 Neoplastic Process Vaginal Melanoma C2004576 Cellosaurus Malignant Vaginal_Melanoma Melanoma of Vagina Melanoma of the Vagina Vaginal Melanoma Vaginal Melanoma An ameloblastoma that arises from the soft tissues in the gingiva or alveolar mucosa. It presents as a painless exophytic mass. C27396 Neoplastic Process Extraosseous/Peripheral Ameloblastoma C1333513 Undetermined Extraosseous_Ameloblastoma Ameloblastoma, Extraosseous/Peripheral Type Extraosseous Ameloblastoma Extraosseous/Peripheral Ameloblastoma Extraosseous/Peripheral Ameloblastoma A histologic variant of conventional ameloblastoma characterized by the presence of odontogenic epithelial islands in a fibrotic stroma. C27397 Neoplastic Process Follicular Ameloblastoma C0457530 Undetermined Follicular_Ameloblastoma Follicular Ameloblastoma Follicular Ameloblastoma A conventional ameloblastoma with follicular pattern in which the odontogenic epithelial islands contain granular cells. C27398 Neoplastic Process Granular Cell Ameloblastoma C0457532 Undetermined Granular_Cell_Ameloblastoma Granular Cell Ameloblastoma Granular Cell Ameloblastoma An ependymoma of the spinal cord not associated with MYCN amplification and occurring in adults. C27399 Neoplastic Process Adult Spinal Cord Ependymoma Adult Spinal Cord Ependymoma C1332215 CTRP Undetermined Adult_Spinal_Cord_Ependymoma Adult Spinal Cord Ependymoma Adult Spinal Cord Ependymoma without MYCN Amplification Adult Spinal Ependymoma Spinal Cord Ependymoma Adult Spinal Cord Ependymoma A mature teratoma that arises from the central nervous system in adults. C27400 Neoplastic Process Adult Central Nervous System Mature Teratoma C1332194 Benign Adult_Central_Nervous_System_Mature_Teratoma Adult Central Nervous System Mature Teratoma Adult Central Nervous System Mature Teratoma C27401 Neoplastic Process Adult Central Nervous System Immature Teratoma C1332193 Undetermined Adult_Central_Nervous_System_Immature_Teratoma Adult Central Nervous System Immature Teratoma Adult Central Nervous System Immature Teratoma C27402 Neoplastic Process Adult Central Nervous System Mixed Germ Cell Tumor Adult Central Nervous System Mixed Germ Cell Tumor C1332195 CTRP Malignant Adult_Central_Nervous_System_Mixed_Germ_Cell_Neoplasm Adult Central Nervous System Mixed Germ Cell Tumor Central Nervous System Mixed Germ Cell Tumor Adult Central Nervous System Mixed Germ Cell Tumor A mixed germ cell tumor that arises from the central nervous system and occurs during childhood. C27403 Neoplastic Process Childhood Central Nervous System Mixed Germ Cell Tumor Childhood Central Nervous System Mixed Germ Cell Tumor C1332956 CTRP NICHD A mixed germ cell tumor that arises from the central nervous system during childhood. Malignant Childhood_Central_Nervous_System_Mixed_Germ_Cell_Neoplasm Central Nervous System Mixed Germ Cell Tumor Childhood Central Nervous System Mixed Germ Cell Tumor Childhood Central Nervous System Mixed Germ Cell Tumor A mature teratoma that arises from the central nervous system during childhood. C27404 Neoplastic Process Childhood Central Nervous System Mature Teratoma C1332955 NICHD A mature teratoma that arises from the central nervous system during childhood. Benign Childhood_Central_Nervous_System_Mature_Teratoma Childhood Central Nervous System Mature Teratoma Childhood Central Nervous System Mature Teratoma An immature teratoma that arises from the central nervous system and occurs during childhood. C27405 Neoplastic Process Childhood Central Nervous System Immature Teratoma C1332954 NICHD An immature teratoma that arises from the central nervous system during childhood. Undetermined Childhood_Central_Nervous_System_Immature_Teratoma Childhood Central Nervous System Immature Teratoma Childhood Central Nervous System Immature Teratoma A germinoma arising from the central nervous system during childhood. C27406 Neoplastic Process Childhood Central Nervous System Germinoma Childhood Central Nervous System Germinoma C1332953 CTRP NICHD A germinoma that arises from the central nervous system during childhood. Malignant Childhood_Central_Nervous_System_Germinoma Central Nervous System Germinoma Childhood Central Nervous System Germinoma Childhood Central Nervous System Germinoma A somatostatin-producing neuroendocrine tumor that arises from the duodenum. C27407 Neoplastic Process Duodenal Somatostatin-Producing Neuroendocrine Tumor C1333320 Undetermined Duodenal_Delta_Cell_Somatostatin_Producing_Neoplasm Duodenal Somatostatin Producing Tumor Duodenal Somatostatin-Producing NET Duodenal Somatostatin-Producing Neuroendocrine Tumor Duodenal Somatostatinoma Duodenal Somatostatin-Producing Neuroendocrine Tumor The spread of a carcinoma to the lung. This may be from a primary lung carcinoma, or from a carcinoma at a distant anatomic site. C27408 Neoplastic Process Metastatic Carcinoma in the Lung Metastatic Carcinoma in the Lung C0238254 CTRP Malignant Metastatic_Carcinoma_to_the_Lung Metastatic Carcinoma in the Lung Metastatic Carcinoma to the Lung Secondary Lung Cancer Secondary Lung Carcinoma Metastatic Carcinoma in the Lung A Burkitt lymphoma that arises from the small intestine. C27409 Neoplastic Process Small Intestinal Burkitt Lymphoma C1335991 Malignant Small_Intestinal_Burkitt_s_Lymphoma Primary Small Intestinal Burkitt's Lymphoma Small Intestinal Burkitt Lymphoma Small Intestinal Burkitt's Lymphoma Small Intestine Burkitt Lymphoma Small Intestine Burkitt's Lymphoma Small Intestinal Burkitt Lymphoma A morphologic variant of Burkitt lymphoma that arises from the small intestine. It is characterized by marked nuclear pleomorphism, abundant apoptotic debris, and the presence of tangible body macrophages. C27410 Neoplastic Process Small Intestinal Atypical Burkitt/Burkitt-Like Lymphoma C1335990 Malignant Small_Intestinal_Atypical_Burkitt_s_Burkitt_s-Like_Lymphoma Primary Small Intestinal Atypical Burkitt's/Burkitt's-Like Lymphoma Small Intestinal Atypical Burkitt/Burkitt-Like Lymphoma Small Intestine Atypical Burkitt's/Burkitt's-like Lymphoma Small Intestinal Atypical Burkitt/Burkitt-Like Lymphoma A mantle cell lymphoma that arises from the colon. It often presents as a polypoid lesion. C27411 Neoplastic Process Colon Mantle Cell Lymphoma C1333095 Malignant Colon_Mantle_Cell_Lymphoma Colon Mantle Cell Lymphoma Colon Mantle Cell Lymphoma An intestinal-type adenoma arising from the ampulla of Vater. It is characterized by the presence of tubular and villous epithelial structures and it is associated with dysplasia. C27412 Neoplastic Process Ampulla of Vater Tubulovillous Adenoma C1332253 Benign Ampulla_of_Vater_Tubulovillous_Adenoma Ampulla of Vater Tubulovillous Adenoma Ampulla of Vater Tubulovillous Adenoma An intramucosal malignant glandular epithelial infiltrate in a colonic adenoma. There is no evidence of submucosal invasion. C27413 Neoplastic Process Adenoma of the Colon with Intramucosal Adenocarcinoma C1332168 Malignant Adenoma_of_the_Colon_with_Intramucosal_Adenocarcinoma Adenoma of Colon with Intramucosal Adenocarcinoma Adenoma of the Colon with Intramucosal Adenocarcinoma Colonic Adenoma with Intramucosal Adenocarcinoma Adenoma of the Colon with Intramucosal Adenocarcinoma A carcinoma with glandular differentiation arising from the ampulla of Vater. Morphologically, it is characterized by the presence of glycogen-rich cells with hyperchromatic nuclei. C27414 Neoplastic Process Ampulla of Vater Clear Cell Adenocarcinoma C1332246 Malignant Ampulla_of_Vater_Clear_Cell_Adenocarcinoma Ampulla of Vater Clear Cell Adenocarcinoma Ampulla of Vater Clear Cell Adenocarcinoma An invasive adenocarcinoma arising from the ampulla of Vater. Morphologically, it is characterized by the presence of intestinal-type malignant epithelial cells. C27415 Neoplastic Process Ampulla of Vater Intestinal-Type Adenocarcinoma Ampulla of Vater Intestinal-Type Adenocarcinoma C1332247 CTRP Malignant Ampulla_of_Vater_Intestinal_Type_Adenocarcinoma Ampulla of Vater Intestinal-Type Adenocarcinoma Ampulla of Vater Invasive Intestinal Type Adenocarcinoma Ampulla of Vater Intestinal-Type Adenocarcinoma A carcinoma with glandular differentiation arising from the ampulla of Vater. Morphologically, it is characterized by the presence of mucoid stroma formation. C27416 Neoplastic Process Ampulla of Vater Mucinous Adenocarcinoma C1332248 Malignant Ampulla_of_Vater_Mucinous_Adenocarcinoma Ampulla of Vater Mucinous Adenocarcinoma Ampulla of Vater Mucinous Adenocarcinoma A carcinoma with squamous differentiation arising from the ampulla of Vater. Signs and symptoms include jaundice, abdominal pain, anorexia, nausea, vomiting, and weight loss. C27417 Neoplastic Process Ampulla of Vater Squamous Cell Carcinoma C1332251 Malignant Ampulla_of_Vater_Squamous_Cell_Carcinoma Ampulla of Vater Squamous Cell Carcinoma Ampulla of Vater Squamous Cell Carcinoma A carcinoma with glandular and squamous differentiation arising from the ampulla of Vater. Signs and symptoms include jaundice, abdominal pain, anorexia, nausea, vomiting, and weight loss. C27418 Neoplastic Process Ampulla of Vater Adenosquamous Carcinoma C1332245 Cellosaurus Malignant Ampulla_of_Vater_Adenosquamous_Carcinoma Ampulla of Vater Adenosquamous Carcinoma Ampulla of Vater Adenosquamous Carcinoma An aggressive carcinoma arising from the ampulla of Vater. Morphologically, it is characterized by the presence of malignant epithelial cells without evidence of glandular or squamous differentiation. Signs and symptoms include jaundice, abdominal pain, anorexia, nausea, vomiting, and weight loss. C27419 Neoplastic Process Ampulla of Vater Undifferentiated Carcinoma C1332254 Malignant Ampulla_of_Vater_Undifferentiated_Carcinoma Ampulla of Vater Undifferentiated Carcinoma Ampulla of Vater Undifferentiated Carcinoma A rare variant of esophageal squamous cell carcinoma. It is an exophytic, cauliflower-like or papillary mass that can arise in any part of the esophagus. This variant of squamous cell carcinoma grows slowly and invades locally, with a very low metastasizing potential. (WHO) C27420 Neoplastic Process Esophageal Verrucous Carcinoma Esophageal Verrucous Carcinoma C1333470 CTRP Malignant Esophageal_Verrucous_Carcinoma Esophageal Verrucous Cancer Esophageal Verrucous Carcinoma Verrucous Carcinoma of Esophagus Verrucous Carcinoma of the Esophagus Esophageal Verrucous Carcinoma An esophageal carcinoma characterized by the presence of distinguishable squamous and glandular carcinomatous components. C27421 Neoplastic Process Esophageal Adenosquamous Carcinoma Esophageal Adenosquamous Carcinoma C2063886 CTRP Malignant Esophageal_Adenosquamous_Carcinoma Esophageal Adenosquamous Cancer Esophageal Adenosquamous Carcinoma Esophageal Adenosquamous Carcinoma An esophageal carcinoma characterized by the absence of microscopic features of squamous differentiation. C27422 Neoplastic Process Esophageal Undifferentiated Carcinoma Esophageal Undifferentiated Carcinoma C2188058 CTRP Malignant Esophageal_Undifferentiated_Carcinoma Esophageal Undifferentiated Carcinoma Undifferentiated Esophageal Cancer Esophageal Undifferentiated Carcinoma A lesion in which the architectural and cytologic abnormalities involve either the lower or both the lower and the upper half of the esophageal squamous epithelium. C27423 Neoplastic Process Esophageal Squamous Intraepithelial Neoplasia C1333468 Undetermined Esophageal_Squamous_Intraepithelial_Neoplasia Esophageal Squamous Dysplasia Esophageal Squamous Intraepithelial Neoplasia Esophageal Squamous Intraepithelial Neoplasia A lesion in which the architectural and cytologic abnormalities involve either the lower or both the lower and the upper half of the esophageal glandular epithelium. C27424 Neoplastic Process Esophageal Glandular Intraepithelial Neoplasia C1333447 Undetermined Esophageal_Glandular_Intraepithelial_Neoplasia Esophageal Glandular Dysplasia Esophageal Glandular Intraepithelial Neoplasia Esophageal Glandular Intraepithelial Neoplasia A lesion in which the architectural and cytologic abnormalities involve both the lower and the upper half of the esophageal mucosa. It includes lesions termed moderate dysplasia, and carcinoma in situ (severe dysplasia). (WHO, 2000) C27425 Neoplastic Process Esophageal High Grade Intraepithelial Neoplasia C1333450 GDC 8148/2 Undetermined Esophageal_High-Grade_Intraepithelial_Neoplasia 8148/2 Esophageal intraepithelial neoplasia, high grade Esophageal High Grade Intraepithelial Neoplasia Esophageal High-Grade Dysplasia Esophageal High-Grade Intraepithelial Neoplasia Esophageal intraepithelial neoplasia, high grade Esophageal High Grade Intraepithelial Neoplasia A lesion in which the architectural and cytologic abnormalities involve both the lower and the upper half of the esophageal squamous epithelium. C27426 Neoplastic Process High Grade Esophageal Squamous Intraepithelial Neoplasia C1333451 GDC 8077/2 Undetermined Esophageal_High-Grade_Squamous_Intraepithelial_Neoplasia Esophageal squamous intraepithelial neoplasia (dysplasia), high grade Esophageal High-Grade Squamous Intraepithelial Neoplasia High Grade Esophageal Squamous Intraepithelial Neoplasia High-Grade Esophageal Squamous Dysplasia High-Grade Esophageal Squamous Intraepithelial Neoplasia High Grade Esophageal Squamous Intraepithelial Neoplasia A lesion in which the architectural and cytologic abnormalities are confined to the lower half of the esophageal squamous epithelium. C27427 Neoplastic Process Low Grade Esophageal Squamous Intraepithelial Neoplasia C1333458 GDC 8077/0 Undetermined Esophageal_Low-Grade_Squamous_Intraepithelial_Neoplasia 8077/0 Esophageal squamous intraepithelial neoplasia (dysplasia), low grade Esophageal Low Grade Squamous Intraepithelial Neoplasia Esophageal squamous intraepithelial neoplasia (dysplasia), low grade Low Grade Esophageal Squamous Dysplasia Low Grade Esophageal Squamous Intraepithelial Neoplasia Low Grade Esophageal Squamous Intraepithelial Neoplasia A lesion in which the architectural and cytologic abnormalities are confined to the lower half of the esophageal glandular epithelium. C27428 Neoplastic Process Low Grade Esophageal Glandular Intraepithelial Neoplasia C1333457 GDC 8148/0 Undetermined Esophageal_Low-Grade_Glandular_Intraepithelial_Neoplasia 8148/0 Esophageal glandular dysplasia (intraepithelial neoplasia), low grade Esophageal Low Grade Glandular Intraepithelial Neoplasia Esophageal glandular dysplasia (intraepithelial neoplasia), low grade Low Grade Esophageal Glandular Dysplasia Low Grade Esophageal Glandular Intraepithelial Neoplasia Low Grade Esophageal Glandular Intraepithelial Neoplasia A lesion in which the architectural and cytologic abnormalities involve both the lower and the upper half of the esophageal glandular epithelium. C27429 Neoplastic Process High Grade Esophageal Glandular Intraepithelial Neoplasia C1333449 GDC 8148/2 Undetermined Esophageal_High-Grade_Glandular_Intraepithelial_Neoplasia 8148/2 Esophageal glandular dysplasia (intraepithelial neoplasia), high grade Esophageal High-Grade Glandular Intraepithelial Neoplasia Esophageal glandular dysplasia (intraepithelial neoplasia), high grade High Grade Esophageal Glandular Intraepithelial Neoplasia High-Grade Esophageal Glandular Dysplasia High-Grade Esophageal Glandular Intraepithelial Neoplasia High Grade Esophageal Glandular Intraepithelial Neoplasia A gastrointestinal stromal tumor that arises from the esophagus. The majority are spindle cell tumors that exhibit high mitotic activity and affect the distal esophagus. C27430 Neoplastic Process Esophageal Gastrointestinal Stromal Tumor Esophageal Gastrointestinal Stromal Tumor C1333446 CTRP mCode Undetermined Esophageal_Gastrointestinal_Stromal_Tumor Esophageal GIST Esophageal Gastrointestinal Stromal Tumor Esophageal Gastrointestinal Stromal Tumor (GIST) Gastrointestinal stromal tumor of esophagus Esophageal Gastrointestinal Stromal Tumor A gastric intraepithelial lesion characterized by the presence of neoplastic cells with mild cytologic atypia, mild architectural changes, and low number of mitotic figures. C27436 Neoplastic Process Low Grade Gastric Intraepithelial Neoplasia C1334415 Undetermined Low-Grade_Gastric_Intraepithelial_Neoplasia Gastric Mild Intraepithelial Neoplasia (Dysplasia) Low Grade Gastric Intraepithelial Neoplasia Low Grade Gastric Intraepithelial Neoplasia (Dysplasia) Low-Grade Gastric Glandular Intraepithelial Neoplasia Low Grade Gastric Intraepithelial Neoplasia A gastric intraepithelial lesion characterized by the presence of neoplastic cells that are cuboidal with a high nucleus to cytoplasmic ratio, prominent nucleoli, significant architectural changes, and increased number of mitotic figures. C27437 Neoplastic Process High Grade Gastric Intraepithelial Neoplasia C1334004 Undetermined High-Grade_Gastric_Intraepithelial_Neoplasia High Grade Gastric Intraepithelial Neoplasia High-Grade Gastric Glandular Intraepithelial Neoplasia High-Grade Gastric Glandular Intraepithelial Neoplasia (Dysplasia) High-Grade Gastric Intraepithelial Neoplasia (Dysplasia) High Grade Gastric Intraepithelial Neoplasia A mesenchymal neoplasm that arises from the stomach and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include leiomyoma, lipoma, and hemangioma. C27438 Neoplastic Process Benign Gastric Soft Tissue Neoplasm C1332504 Benign Benign_Gastric_Mesenchymal_Neoplasm Benign Gastric Soft Tissue Neoplasm Benign Soft Tissue Neoplasm of Stomach Benign Soft Tissue Neoplasm of the Stomach Benign Gastric Soft Tissue Neoplasm A sarcoma that arises from the stomach. Representative examples include Kaposi sarcoma, leiomyosarcoma, and liposarcoma. C27439 Neoplastic Process Gastric Sarcoma C1334586 Malignant Malignant_Gastric_Mesenchymal_Neoplasm Gastric Sarcoma Malignant Gastric Soft Tissue Neoplasm Malignant Soft Tissue Neoplasm of Stomach Malignant Soft Tissue Neoplasm of the Stomach Gastric Sarcoma A mantle cell lymphoma that affects the stomach. It may arise as a solitary mass or it may be a component of multifocal lymphomatous polyposis of the gastrointestinal tract. It usually has an aggressive clinical course. C27440 Neoplastic Process Gastric Mantle Cell Lymphoma C1333780 Malignant Gastric_Mantle_Cell_Lymphoma Gastric Mantle Cell Lymphoma Mantle Cell Lymphoma of Stomach Mantle Cell Lymphoma of the Stomach Gastric Mantle Cell Lymphoma A mantle cell lymphoma that arises from the small intestine. It may present as an isolated mass in the small intestine or as a part of the multiple lymphomatous polyposis. C27441 Neoplastic Process Small Intestinal Mantle Cell Lymphoma C1336003 Malignant Small_Intestinal_Mantle_Cell_Lymphoma Mantle Cell Lymphoma of Small Intestine Mantle Cell Lymphoma of the Small Intestine Small Intestinal Mantle Cell Lymphoma Small Intestinal Mantle Cell Lymphoma A well differentiated neuroendocrine tumor that arises from the stomach. It produces serotonin and it may occasionally be found in association with a carcinoid syndrome. C27443 Neoplastic Process Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor C3274137 Undetermined Gastric_EC-Cell_Serotonin_Producing_Carcinoid_Tumor Gastric EC Cell Serotonin-Producing NET Gastric EC-Cell Serotonin-Producing Neuroendocrine Tumor Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor A well differentiated neuroendocrine tumor that arises from the stomach. It produces gastrin and it may be associated with Zollinger-Ellison syndrome. C27444 Neoplastic Process Gastric Gastrin-Producing Neuroendocrine Tumor C1333767 Undetermined Gastric_G-Cell_Gastrin_Producing_Neoplasm Gastric Gastrin Producing Tumor Gastric Gastrin-Producing NET Gastric Gastrin-Producing Neuroendocrine Tumor Gastric Gastrinoma Gastrin Producing Neuroendocrine Tumor of the Stomach Gastrin Producing Tumor of the Stomach Gastrin-Producing Neuroendocrine Tumor of the Stomach Gastric Gastrin-Producing Neuroendocrine Tumor A neuroendocrine tumor arising from the wall of the appendix, producing glucagon-like peptides. Morphologically, it is characterized by the presence of neoplastic cells forming tubular or trabecular patterns. C27445 Neoplastic Process Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor C3274138 Undetermined Appendiceal_L-Cell_Glucagon-Like_Peptide_Producing_Neoplasm Appendiceal L-Cell Glucagon-Like Peptide-Producing NET Appendiceal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor Appendix L-Cell Glucagon-Like Peptide-Producing NET Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor Appendix L-Cell NET Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor A well differentiated neuroendocrine tumor that arises from the colon and produces serotonin. C27446 Neoplastic Process Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor C1333102 Undetermined Colonic_EC-Cell_Serotonin_Producing_Tumor Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor Colonic EC-Cell Serotonin Producing Tumor Colonic EC-Cell Serotonin-Producing Tumor Colonic Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor Colonic Enterochromaffin Cell Serotonin-Producing Tumor Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor A neuroendocrine tumor that arises from the colon and produces glucagon-like peptides. Morphologically, it is characterized by the presence of neoplastic cells forming tubular or trabecular patterns. C27447 Neoplastic Process Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor C3274139 Undetermined Colonic_L-Cell_Glucagon-Like_Peptide_Producing_Neoplasm Colon L-Cell Glucagon-Like Peptide-Producing NET Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor Colonic L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor A neuroendocrine tumor that arises from the gastrointestinal tract and produces glucagon-like peptides. Morphologically, it is characterized by the presence of neoplastic cells forming tubular or trabecular patterns. C27448 Neoplastic Process L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor C3274140 8152/1 Undetermined L-Cell_Glucagon-Like_Peptide_Producing_Neoplasm Glucagon-Like Peptide-Producing Tumor L-Cell Glucagon-Like Peptide-Producing NET L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the small intestine. It is characterized by the presence of malignant small cells. C27449 Neoplastic Process Small Intestinal Small Cell Neuroendocrine Carcinoma C1336008 Malignant Small_Intestinal_Small_Cell_Carcinoma Small Intestinal Small Cell Carcinoma Small Intestinal Small Cell Neuroendocrine Carcinoma Small Intestinal Small Cell Neuroendocrine Carcinoma A gastrin-producing neuroendocrine tumor that arises from the small intestine. It is characterized by the presence of uniform cells that form pseudorosettes. The neoplastic cells have uniform nuclei and small amount of eosinophilic cytoplasm. C27450 Neoplastic Process Small Intestinal Gastrin-Producing Neuroendocrine Tumor C3274141 Undetermined Small_Intestinal_G-Cell_Gastrin_Producing_Neoplasm Small Intestinal G Cell NET Small Intestinal Gastrin-Producing NET Small Intestinal Gastrin-Producing Neuroendocrine Tumor Small Intestinal Gastrinoma Small Intestinal Gastrin-Producing Neuroendocrine Tumor A well differentiated neuroendocrine tumor that arises from the small intestine and produces serotonin. C27451 Neoplastic Process Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor C3274142 Undetermined Small_Intestinal_EC-Cell_Serotonin_Producing_Tumor Small Intestinal EC-Cell Serotonin-Producing NET Small Intestinal EC-Cell Serotonin-Producing Neuroendocrine Tumor Small Intestinal Enterochromaffin Cell (EC-Cell), Serotonin-Producing Neuroendocrine Tumor Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor Small Intestinal Enterochromaffin Cell, Serotonin-Producing Neuroendocrine Tumor Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor A neuroendocrine tumor that arises from the small intestine and produces glucagon-like peptides. Morphologically, it is characterized by the presence of neoplastic cells forming tubular or trabecular patterns. C27452 Neoplastic Process Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor C3274143 Undetermined Small_Intestinal_L-Cell_Glucagon-Like_Peptide_Producing_Neoplasm Small Intestinal L-Cell Glucagon-Like Peptide-Producing NET Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor Small Intestinal L-Cell, Glucagon-Like Peptide-Producing Neuroendocrine Tumor Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor A somatostatin-producing neuroendocrine tumor that arises from the small intestine. C27453 Neoplastic Process Small Intestinal Somatostatin-Producing Neuroendocrine Tumor C1335992 Undetermined Small_Intestinal_Delta_Cell_Somatostatin_Producing_Neoplasm Small Intestinal Somatostatin Producing Tumor Small Intestinal Somatostatin-Producing NET Small Intestinal Somatostatin-Producing Neuroendocrine Tumor Small Intestinal Somatostatin-Producing Neuroendocrine Tumor A usually malignant pancreatic neuroendocrine tumor producing vasoactive intestinal peptide (VIP). It may or may not be associated with inappropriate secretion of VIP and an associated clinical syndrome. C27454 Neoplastic Process Pancreatic VIP-Producing Neuroendocrine Tumor CL448472 Undetermined Pancreatic_Vasoactive_Intestinal_Peptide_Producing_Neoplasm Pancreatic VIP Producing NET Pancreatic VIP Producing Neoplasm Pancreatic VIP Producing Tumor Pancreatic VIP-Producing Neuroendocrine Tumor Pancreatic Vasoactive Intestinal Peptide Producing Neoplasm Pancreatic Vasoactive Intestinal Peptide Producing Tumor Pancreatic VIP-Producing Neuroendocrine Tumor A neuroendocrine tumor that arises from the small intestine and produces vasoactive intestinal peptide. C27455 Neoplastic Process Small Intestinal VIP-Producing Neuroendocrine Tumor C1336009 Undetermined Small_Intestinal_Vasoactive_Intestinal_Peptide_Producing_Neoplasm Small Intestinal VIP-Producing NET Small Intestinal VIP-Producing Neuroendocrine Tumor Small Intestinal VIPoma Small Intestinal Vasoactive Intestinal Peptide Producing Tumor Small Intestinal VIP-Producing Neuroendocrine Tumor A usually polypoid neoplasm that arises from the glandular epithelium of the colonic and rectal mucosa. It is characterized by a tubular architectural pattern. The neoplastic glandular cells have dysplastic features. C27456 Neoplastic Process Colorectal Tubular Adenoma C1333117 Benign Colorectal_Tubular_Adenoma Colorectal Tubular Adenoma Colorectal Tubular Adenoma An adenoma that arises from the colon or rectum. It is characterized by the presence of moderate epithelial dysplasia. C27457 Neoplastic Process Colorectal Adenoma with Moderate Dysplasia C1333107 Benign Colorectal_Adenoma_with_Moderate_Dysplasia Colorectal Adenoma with Moderate Dysplasia Colorectal Adenoma with Moderate Dysplasia An adenoma that arises from the colon or rectum. It is characterized by the presence of mild epithelial dysplasia. C27458 Neoplastic Process Colorectal Adenoma with Mild Dysplasia C1333106 Benign Colorectal_Adenoma_with_Mild_Dysplasia Colorectal Adenoma with Mild Dysplasia Colorectal Adenoma with Mild Dysplasia A precancerous neoplastic process that affects the colon or rectum. It is characterized by low or high grade dysplasia of the mucosal epithelium. There is no evidence of invasion. C27459 Neoplastic Process Colorectal Intraepithelial Neoplasia C1333112 Undetermined Colorectal_Intraepithelial_Neoplasia Colorectal Dysplasia Colorectal Intraepithelial Neoplasia Large Intestinal Dysplasia Large Intestinal Intraepithelial Neoplasia Colorectal Intraepithelial Neoplasia A precancerous neoplastic process that affects the colon or rectum. It is characterized by mild epithelial dysplasia and mild architectural alterations of the mucosal epithelium. There is no evidence of invasion. C27460 Neoplastic Process Colorectal Low Grade Intraepithelial Neoplasia C1333115 Undetermined Colorectal_Low-Grade_Intraepithelial_Neoplasia Colorectal Low Grade Intraepithelial Neoplasia Colorectal Low-Grade Dysplasia Large Intestinal Low Grade Dysplasia Large Intestinal Low Grade Intraepithelial Neoplasia Colorectal Low Grade Intraepithelial Neoplasia A precancerous neoplastic process that affects the colon or rectum. It is characterized by moderate or severe epithelial dysplasia and complex architectural alterations of the mucosal epithelium. There is no evidence of invasion. C27461 Neoplastic Process Colorectal High Grade Intraepithelial Neoplasia C1333110 Undetermined Colorectal_High-Grade_Intraepithelial_Neoplasia Colorectal High Grade Intraepithelial Neoplasia Colorectal High-Grade Dysplasia Colorectal High-Grade Intraepithelial Neoplasia Large Intestinal High Grade Dysplasia Large Intestinal High Grade Intraepithelial Neoplasia Colorectal High Grade Intraepithelial Neoplasia A precancerous neoplastic process that affects the small intestine. It is characterized by low or high grade dysplasia of the mucosal epithelium. There is no evidence of invasion. C27462 Neoplastic Process Small Intestinal Intraepithelial Neoplasia C1335999 Undetermined Small_Intestinal_Intraepithelial_Neoplasia Small Intestinal Dysplasia Small Intestinal Intraepithelial Neoplasia Small Intestinal Intraepithelial Neoplasia A precancerous neoplastic process that affects the small intestine. It is characterized by mild epithelial dysplasia and mild architectural alterations of the mucosal epithelium. There is no evidence of invasion. C27463 Neoplastic Process Small Intestinal Low Grade Intraepithelial Neoplasia C1336002 Undetermined Small_Intestinal_Low-Grade_Intraepithelial_Neoplasia Small Intestinal Low Grade Intraepithelial Neoplasia Small Intestinal Low-Grade Dysplasia Small Intestinal Low Grade Intraepithelial Neoplasia A precancerous neoplastic process that affects the small intestine. It is characterized by moderate or severe epithelial dysplasia and complex architectural alterations of the mucosal epithelium. There is no evidence of invasion. C27464 Neoplastic Process Small Intestinal High Grade Intraepithelial Neoplasia C1335997 Undetermined Small_Intestinal_High-Grade_Intraepithelial_Neoplasia Small Intestinal High Grade Intraepithelial Neoplasia Small Intestinal High-Grade Dysplasia Small Intestinal High Grade Intraepithelial Neoplasia A rare Burkitt lymphoma that arises from the colon. C27465 Neoplastic Process Colon Burkitt Lymphoma C1333083 Malignant Colon_Burkitt_s_Lymphoma Colon Burkitt Lymphoma Colon Burkitt's Lymphoma Primary Colon Burkitt's Lymphoma Colon Burkitt Lymphoma An ectopic ACTH producing pancreatic neuroendocrine tumor. It may be associated with Cushing syndrome. Most patients present with metastases at the time of diagnosis and the prognosis is usually poor. C27466 Neoplastic Process Pancreatic ACTH-Producing Neuroendocrine Tumor C1335300 8158/1 Undetermined Pancreatic_Adrenocorticotropic_Hormone_Producing_Neoplasm ACTH-producing tumor Ectopic ACTH-Producing Pancreatic Neuroendocrine Tumor Pancreatic ACTH Producing NET Pancreatic ACTH Producing Neuroendocrine Tumor Pancreatic ACTH Producing Tumor Pancreatic ACTH-Producing Neuroendocrine Tumor Pancreatic ACTH-Producing Neuroendocrine Tumor With Cushing Syndrome Pancreatic Adrenocorticotropic Hormone Producing Tumor Pancreatic ACTH-Producing Neuroendocrine Tumor Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C27467 Neoplastic Process Stage 0 Lung Cancer AJCC v6 and v7 Stage 0 Lung Cancer AJCC v6 and v7 C0685053 CPTAC CTRP Malignant Stage_0_Lung_Cancer Carcinoma in situ of bronchus and lung Carcinoma in situ of unspecified bronchus and lung Carcinoma in situ: Bronchus and lung Bronchial Carcinoma in situ Stage 0 Lung Cancer Stage 0 Lung Cancer AJCC v6 Stage 0 Lung Cancer AJCC v6 and v7 Stage 0 Lung Cancer AJCC v7 Stage 0 Lung Carcinoma Stage 0 Lung Cancer AJCC v6 and v7 A small round cell tumor with neural differentiation arising from the soft tissues. C27471 Neoplastic Process Peripheral Primitive Neuroectodermal Tumor of Soft Tissues C1112437 Malignant Peripheral_Neuroectodermal_Tumor_of_Soft_Tissues Peripheral Neuroectodermal Tumor of Soft Tissues Peripheral Neuroectodermal Tumor of the Soft Tissues Peripheral Neuroepithelioma of Soft Tissues Peripheral Neuroepithelioma of the Soft Tissues Peripheral Primitive Neuroectodermal Tumor of Soft Tissues Peripheral Primitive Neuroectodermal Tumor of Soft Tissues An epithelioid sarcoma predominantly involving the pelvis, perineum, and genital organs. It tends to have a more aggressive clinical course as compared to the more frequently seen distal-type epithelioid sarcoma. C27472 Neoplastic Process Proximal-Type Epithelioid Sarcoma C1335563 Malignant Proximal-Type_Epithelioid_Sarcoma Central Epithelioid Sarcoma Large Cell Epithelioid Sarcoma Proximal-Type Epithelioid Sarcoma Proximal-Type Epithelioid Sarcoma An epithelioid sarcoma involving the extremities. It usually presents as nodular masses in the dermis and subcutaneous tissues or in the tendons and fascia. It frequently recurs and metastasizes to other anatomic sites. The most common sites of metastasis are the lungs, lymph nodes, bones, and brain. C27473 Neoplastic Process Distal-Type Epithelioid Sarcoma C1333306 Malignant Distal-Type_Epithelioid_Sarcoma Classic Epithelioid Sarcoma Conventional Epithelioid Sarcoma Distal-Type Epithelioid Sarcoma Peripheral Epithelioid Sarcoma Distal-Type Epithelioid Sarcoma An infiltrating carcinoma of the bladder that has not invaded into the bladder muscularis propria. C27474 Neoplastic Process Superficial Bladder Carcinoma Non-Muscle Invasive Bladder Carcinoma C1336527 CTRP Malignant Superficial_Bladder_Cancer NMIBC Non-Muscle Invasive Bladder Cancer Non-Muscle Invasive Bladder Carcinoma Superficial Bladder Cancer Superficial Bladder Carcinoma Superficial Urinary Bladder Cancer Superficial Urinary Bladder Carcinoma Non-Muscle Invasive Bladder Carcinoma A benign neoplasm which is composed of adipocytes and arises from the surface of the bone or the medullary cavity. C27475 Neoplastic Process Bone Lipoma C1332580 Benign Bone_Lipoma Bone Lipoma Lipoma of Bone Lipoma of the Bone Bone Lipoma A very rare schwannoma of the bone. It is often located in the mandible and is well circumscribed. C27476 Neoplastic Process Bone Schwannoma C1332476 Benign Benign_Bone_Schwannoma Benign Bone Neurilemmoma Benign Bone Schwannoma Benign Neurilemmoma of Bone Benign Neurilemmoma of the Bone Benign Schwannoma of Bone Benign Schwannoma of the Bone Bone Schwannoma Bone Schwannoma A giant cell tumor that arises from the bone and is characterized by the absence of local aggression and lack of metastatic potential. C27477 Neoplastic Process Benign Osteoclastic Giant Cell-Rich Tumor of Bone C0855006 Benign Benign_Giant_Cell_Tumor_of_Bone Benign Osteoclastic Giant Cell-Rich Tumor of Bone Benign Osteoclastic Giant Cell-Rich Tumor of the Bone Benign Osteoclastic Giant Cell-Rich Tumor of Bone A benign neoplasm arising from the fibrous soft tissues of the gingiva. It is characterized by the presence of spindle-shaped fibroblasts and numerous dilated vascular channels. C27478 Neoplastic Process Gingival Angiofibroma C1333818 Benign Gingival_Angiofibroma Gingival Angiofibroma Gingival Angiofibroma A morphologic variant of fibroma with numerous dilated vascular channels that arises from the posterolateral wall of the roof of the nasal cavity or lateral nasopharynx. It is associated with somatic mutations in CTNNB1 gene in the majority of cases. C27479 Neoplastic Process Sinonasal Tract Angiofibroma C1367536 Benign Nasopharyngeal_Angiofibroma Nasopharyngeal Angiofibroma Nasopharyngeal Juvenile Angiofibroma Sinonasal Angiofibroma Sinonasal Tract Angiofibroma Sinonasal Tract Angiofibroma A morphologic variant of fetal rhabdomyoma characterized by the presence of a prominent myxoid stroma and primitive skeletal spindle cells. C27480 Neoplastic Process Classic Rhabdomyoma C1334856 Benign Myxoid_Rhabdomyoma Classic Rhabdomyoma Myxoid Rhabdomyoma Classic Rhabdomyoma A chondrosarcoma that arises either in a pre-existing enchondroma or within the cartilaginous cap of a pre-existing osteochondroma. C27482 Neoplastic Process Secondary Chondrosarcoma C1335938 Cellosaurus Malignant Secondary_Chondrosarcoma Secondary Chondrosarcoma Secondary Chondrosarcoma A lipoma usually occurring in the extremities of young children (usually boys). It is characterized by lobules of adipose tissue, separated by fibrous septa. The adipose tissue is composed of mature adipocytes and lipoblasts. The lipoblasts may be scarce, depending on the age of the patient. C27483 Neoplastic Process Lipoblastoma C1260965 GDC Benign Lipoblastoma 8881/0 Fetal lipoma, NOS Lipoblastoma Embryonic Lipoma Fetal Lipoma Infantile Lipoma Lipoblastoma Lipoblastoma An angiomyolipoma arising from the liver. C27485 Neoplastic Process Liver Angiomyolipoma C1333962 Undetermined Hepatic_Angiomyolipoma Hepatic Angiomyolipoma Liver Angiomyolipoma Liver PEComa Liver Angiomyolipoma A neoplastic process characterized by a diffuse poorly circumscribed overgrowth of adipose tissue in the pelvic region. Clinical presentation includes complaints of back and abdominal pain, urinary frequency, perineal pain and constipation. It predominately affects black males. C27486 Neoplastic Process Pelvic Lipomatosis C0406608 Benign Pelvic_Lipomatosis Pelvic Lipomatosis Pelvic Lipomatosis A neoplastic process characterized by a diffuse poorly circumscribed overgrowth of adipose tissue in the face, upper middle back, and sternal region. It is associated with adrenocortical steroid therapy or an increase in endogenous adrenocortical hormone. C27487 Neoplastic Process Steroid Lipomatosis C1336506 Benign Steroid_Lipomatosis Steroid Lipomatosis Steroid Lipomatosis A neoplastic process characterized by a diffuse poorly circumscribed overgrowth of adipose tissue in the mediastinum. C27488 Neoplastic Process Mediastinal Lipomatosis C1334662 Benign Mediastinal_Lipomatosis Mediastinal Lipomatosis Mediastinal Lipomatosis A benign adipocytic neoplasm, characterized by ill-defined tumor margins and the presence of variable proportions of mild to moderately atypical spindle cells, adipocytes, lipoblasts, pleomorphic cells, multinucleated giant cells, and a myxoid or collagenous extracellular matrix. It has a low tendency for local recurrence if incompletely excised. Unlike conventional atypical lipomatous tumors, there is no risk for dedifferentiation. (WHO 2020) C27489 Neoplastic Process Atypical Spindle Cell/Pleomorphic Lipomatous Tumor C1275275 Benign Spindle_Cell_Liposarcoma Atypical Spindle Cell Lipoma Atypical Spindle Cell/Pleomorphic Lipomatous Tumor Fibrosarcoma-Like Lipomatous Neoplasm Spindle Cell Liposarcoma Atypical Spindle Cell/Pleomorphic Lipomatous Tumor An alveolar rhabdomyosarcoma characterized by the presence of large striated muscle cells with clear cytoplasm, giant cells with myoblastic differentiation, and fibrovascular septa. C27492 Neoplastic Process Conventional Alveolar Rhabdomyosarcoma C1333154 Malignant Conventional_Alveolar_Rhabdomyosarcoma Conventional Alveolar Rhabdomyosarcoma Typical Alveolar Rhabdomyosarcoma Conventional Alveolar Rhabdomyosarcoma A morphologic variant of alveolar rhabdomyosarcoma. It is characterized by the presence of a solid growth pattern and the absence of fibrovascular stroma. C27493 Neoplastic Process Solid Alveolar Rhabdomyosarcoma C1336025 Malignant Solid_Alveolar_Rhabdomyosarcoma Solid Alveolar Rhabdomyosarcoma Solid Alveolar Rhabdomyosarcoma An aggressive malignant smooth muscle neoplasm. It is characterized by the presence of malignant smooth muscle cells with granular cytoplasmic changes. C27494 Neoplastic Process Granular Cell Leiomyosarcoma C1333871 Malignant Granular_Cell_Leiomyosarcoma Granular Cell Leiomyosarcoma Granular Cell Leiomyosarcoma A morphologic variant of leiomyosarcoma characterized by the presence of an inflammatory infiltrate admixed with malignant spindle cells. C27495 Neoplastic Process Inflammatory Leiomyosarcoma C1334179 Malignant Inflammatory_Leiomyosarcoma Inflammatory Leiomyosarcoma Inflammatory Leiomyosarcoma A benign multifocal proliferation of glomus cells forming clusters around dilated vascular spaces. C27496 Neoplastic Process Glomangiomatosis C1333824 Benign Glomangiomatosis Glomangiomatosis Glomangiomatosis Glomangiomatosis A glomus tumor that shows atypical characteristics and has borderline malignant potential. C27497 Neoplastic Process Glomus Tumor of Uncertain Malignant Potential C1333826 Uncertain Malignant Potential Glomus_Tumor_of_Uncertain_Malignant_Potential Glomus Tumor of Uncertain Malignant Potential Glomus Tumor of Uncertain Malignant Potential A Kaposi sarcoma affecting the lymph nodes. C27500 Neoplastic Process Lymphadenopathic Kaposi Sarcoma C1334457 CPTAC mCode Malignant Lymphadenopathic_Kaposi_s_Sarcoma Kaposi's sarcoma, lymph nodes Kaposi's sarcoma of lymph nodes Lymphadenopathic Kaposi Sarcoma Lymphadenopathic Kaposi's Sarcoma Lymphadenopathic Kaposi Sarcoma A well differentiated extraskeletal myxoid chondrosarcoma. C27501 Neoplastic Process Conventional Extraskeletal Myxoid Chondrosarcoma C1337010 Malignant Well-Differentiated_Extraskeletal_Chondrosarcoma Conventional Extraskeletal Myxoid Chondrosarcoma Extraskeletal Well Differentiated Myxoid Chondrosarcoma Well Differentiated Extraosseous Myxoid Chondrosarcoma Well Differentiated Extraskeletal Myxoid Chondrosarcoma Conventional Extraskeletal Myxoid Chondrosarcoma A rare malignant soft tissue neoplasm of uncertain differentiation, characterized by the presence of chondroblast-like cells in a myxoid stroma and a multinodular growth pattern. The most common sites of involvement are the deep soft tissues of the extremities, particularly the thigh. It usually presents as an enlarging soft tissue mass. Patients may have long survivals, but local recurrences and metastases occur in approximately half of the cases. The most common site of metastasis is the lungs. C27502 Neoplastic Process Extraskeletal Myxoid Chondrosarcoma C0334551 Cellosaurus GDC 9231/3 Malignant Myxoid_Extraskeletal_Chondrosarcoma 9231/3 Myxoid chondrosarcoma EMC Extraosseous Chondrosarcoma Extraskeletal Chondrosarcoma Extraskeletal Myxoid Chondrosarcoma Myxoid Chondrosarcoma Myxoid Extraosseous Chondrosarcoma Myxoid Extraskeletal Chondrosarcoma Myxoid chondrosarcoma NR4A3-Rearranged Myxoid Sarcoma Extraskeletal Myxoid Chondrosarcoma A benign diffuse vascular proliferation usually occurring in young adults. It is characterized by the formation of capillary-sized and cavernous vascular spaces. Patients present with diffuse persistent swelling. C27503 Neoplastic Process Angiomatosis C0002992 NICHD Benign Angiomatosis Angiomatosis Diffuse Angiomatosis Diffuse Hemangioma Multiple Hemangiomas Angiomatosis A hemangioma associated with Castleman disease and POEMS syndrome. The lesions affect the trunk and extremities and present as erythematous papules. (WHO 2018) C27505 Neoplastic Process Glomeruloid Hemangioma C1304511 Benign Glomeruloid_Hemangioma Glomeruloid Hemangioma Glomeruloid Hemangioma A hemangioma characterized by the presence of hobnail endothelial cells. C27506 Neoplastic Process Hobnail Hemangioma C0346076 Benign Hobnail_Hemangioma Hobnail Hemangioma Targetoid Hemosiderotic Hemangioma Hobnail Hemangioma A hemangioma arising from the peripheral nerves. C27507 Neoplastic Process Hemangioma of Peripheral Nerve C1333956 Benign Hemangioma_of_Peripheral_Nerve Hemangioma of Peripheral Nerve Hemangioma of Peripheral Nerve A lymphangioma arising from the organs of the abdominal cavity. C27508 Neoplastic Process Intra-Abdominal Lymphangioma C1334234 Benign Intra-Abdominal_Lymphangioma Intra-Abdominal Lymphangioma Intra-Abdominal Lymphangioma A lymphangioma arising from the skin. C27509 Neoplastic Process Skin Lymphangioma C1333176 Benign Cutaneous_Lymphangioma Cutaneous Lymphangioma Skin Lymphangioma Skin Lymphangioma An intermediate, locally aggressive blood vessel neoplasm characterized by the presence of spindle endothelial cells, and formation of capillary-sized and slit-like vascular channels. It is often associated with hemorrhage and hemosiderin deposition. C27510 Neoplastic Process Kaposiform Hemangioendothelioma C1367420 GDC Undetermined Kaposiform_Hemangioendothelioma 9130/1 Kaposiform hemangioendothelioma KHE Kaposiform Hemangioendothelioma Kaposiform hemangioendothelioma Kaposiform Hemangioendothelioma An intermediate, locally aggressive and rarely metastasizing blood vessel neoplasm. It is characterized by the presence of hobnail endothelial cells and formation of arborizing vascular channels. C27511 Neoplastic Process Retiform Hemangioendothelioma C1304512 Undetermined Hobnail_Hemangioendothelioma Hobnail Hemangioendothelioma Retiform Hemangioendothelioma Retiform Hemangioendothelioma An angiosarcoma that develops in association with long standing lymphedema. C27512 Neoplastic Process Angiosarcoma Associated with Lymphedema C1332297 Malignant Angiosarcoma_Associated_with_Lymphedema Angiosarcoma Associated with Lymphedema Angiosarcoma Associated with Lymphedema A malignant vascular neoplasm arising in an anatomic site exposed to radiation therapy. C27513 Neoplastic Process Radiation-Related Angiosarcoma C1335661 Malignant Radiation-Related_Angiosarcoma Radiation-Induced Angiosarcoma Radiation-Related Angiosarcoma Radiation-Related Angiosarcoma A benign histiocytic tumor that arises from the skin and occurs during adulthood. It is distinct from Langerhans cell histiocytosis. It is characterized by the presence of lipid-laden, foamy histiocytes and Touton-type giant cells in the dermis. The lesions appear as cutaneous papules and nodules. C27514 Neoplastic Process Cutaneous Adult Xanthogranuloma C1332220 Benign Adult_Xanthogranuloma Adult Xanthogranuloma Cutaneous Adult Xanthogranuloma Cutaneous Adult Xanthogranuloma A rare benign soft tissue neoplasm characterized by the presence of an abundant collagenous or myxocollagenous matrix, spindle-shaped, and stellate-shaped fibroblasts. It usually presents as an asymptomatic, slowly growing subcutaneous mass. The most common sites of involvement are the upper arm, shoulder, and lower limb. C27515 Neoplastic Process Desmoplastic Fibroblastoma C1300346 Benign Sclerotic_Fibroma Sclerotic fibroma Collagenous Fibroma Desmoplastic Fibroblastoma Desmoplastic Fibroblastoma A benign epithelial verrucous lesion of the skin. Morphologically, it is characterized by the presence of epidermolytic hyperkeratosis and papillomatosis. C27516 Neoplastic Process Epidermolytic Acanthoma C1333414 Benign Epidermolytic_Acanthoma Epidermolytic Acanthoma Epidermolytic Acanthoma A benign epithelial neoplasm of the skin. It presents as a papular or nodular lesion. Morphologically, it is characterized by the presence of hyperkeratosis, acanthosis, papillomatosis, and prominent acantholysis. C27517 Neoplastic Process Acantholytic Acanthoma C1301270 Benign Acantholytic_Acanthoma Acantholytic Acanthoma Acantholytic Acanthoma A benign, well-circumscribed skin squamous lesion characterized by the presence of enlarged keratinocytes with nuclei twice the normal size. (WHO 2018) C27518 Neoplastic Process Large Cell Acanthoma C1334362 Benign Large_Cell_Acanthoma Large cell acanthoma Large Cell Acanthoma Large Cell Acanthoma A neoplasm that arises from the hair follicle and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C27520 Neoplastic Process Benign Hair Follicle Neoplasm C0853031 CDISC A benign neoplasm that arises from the hair follicle. Benign Benign_Hair_Follicle_Neoplasm Benign Follicular Neoplasm Benign Follicular Tumor Benign Hair Follicle Neoplasm Benign Hair Follicle Tumor HAIR FOLLICLE NEOPLASM, BENIGN Benign Hair Follicle Neoplasm Trichilemmoma in which there is no evidence of sclerotic stroma formation. C27521 Neoplastic Process Classic Type Trichilemmoma C1333060 Benign Classic_Type_Trichilemmoma Classic Type Trichilemmoma Classic Type Tricholemmoma Classic Type Trichilemmoma A variant of tricholemmoma that is characterized by extensive sclerotic stroma formation. C27522 Neoplastic Process Desmoplastic Trichilemmoma C1275206 Benign Desmoplastic_Trichilemmoma Desmoplastic Trichilemmoma Desmoplastic Tricholemmoma Desmoplastic Trichilemmoma A benign adnexal tumor occurring in the face of young female subjects. It is characterized by the presence of epithelial neoplastic cells and keratinous cysts in a desmoplastic stroma. C27524 Neoplastic Process Columnar Trichoblastoma C0432526 Benign Desmoplastic_Trichoepithelioma Columnar Trichoblastoma Desmoplastic Trichoepithelioma Sclerosing Epithelial Hamartoma Columnar Trichoblastoma A cutaneous myxoma arising from the hair follicle. C27526 Neoplastic Process Follicular Myxoma C1336823 Benign Trichogenic_Myxoma Follicular Myxoma Trichogenic Myxoma Follicular Myxoma A benign dermal adnexal neoplasm with apocrine differentiation. It usually occurs in the scalp and has a female predilection. It presents as an asymptomatic solitary nodule. It is characterized by a lobular architecture. The lobules are composed by tubular structures lined by epithelial cells. There is no cytologic atypia or mitotic figures present. C27527 Neoplastic Process Tubular Apocrine Adenoma C0334350 CL448474 Obsolete_Concept GDC 8408/0 Benign Tubular_Apocrine_Adenoma 8408/0 Eccrine papillary adenoma Tubular Apocrine Adenoma Tubular Papillary Adenoma Tubular Apocrine Adenoma A malignant vascular neoplasm arising from blood vessels and lymphatics of the skin. C27529 Neoplastic Process Malignant Skin Vascular Neoplasm C1304404 Malignant Malignant_Cutaneous_Vascular_Neoplasm Malignant Cutaneous Vascular Neoplasm Malignant Cutaneous Vascular Tumor Malignant Skin Vascular Neoplasm Malignant Skin Vascular Tumor Malignant Skin Vascular Neoplasm A benign well-circumscribed tumor, composed of lobules of mature adipocytes, that arises within subcutaneous tissue, deep soft tissues or on the surface of bones. C27530 Neoplastic Process Conventional Lipoma C1333059 Benign Classic_Type_Lipoma Classic Type Lipoma Conventional Lipoma Conventional Lipoma A rare low-grade carcinoma of the sweat glands. The most common sites are eyelids, scalp, axilla, face and trunk. It is histologically characterized by proliferating ducts until the overproduction of mucin creates islands of tumor cells, essentially floating in mucinous pools (Rosai J. Ackerman's Surgical Pathology). C27533 Neoplastic Process Primary Cutaneous Mucinous Carcinoma C1879641 Malignant Adnexal_Mucinous_Adenocarcinoma Adnexal Mucinous Adenocarcinoma Adnexal Mucinous Carcinoma Primary Cutaneous Mucinous Carcinoma Sweat Gland Mucinous Carcinoma Primary Cutaneous Mucinous Carcinoma An adenocarcinoma arising from the sweat glands. Most cases present as nodular lesions on the digits, usually in the hands. It is characterized by the presence of epithelial cells in the dermis forming nodules. Cystic structures containing papillary projections are also present. It may recur and metastasize, most commonly to the lungs. C27534 Neoplastic Process Digital Papillary Adenocarcinoma Digital Papillary Adenocarcinoma C1266064 CL053818 CTRP GDC 8408/1 8408/3 Malignant Aggressive_Digital_Papillary_Adenocarcinoma 8408/1 8408/3 Aggressive digital papillary adenoma Digital papillary adenocarcinoma Eccrine papillary adenocarcinoma Aggressive Digital Papillary Adenocarcinoma Aggressive Digital Papillary Adenoma Aggressive digital papillary adenoma Digital Papillary Adenocarcinoma Digital Papillary Adenoma Digital Papillary Carcinoma Digital Papillary Eccrine Carcinoma Digital papillary adenocarcinoma Papillary Digital Eccrine Carcinoma Digital Papillary Adenocarcinoma A variant of basal cell carcinoma morphologically characterized by the presence of thin strands of basaloid cells forming a reticulate pattern. C27535 Neoplastic Process Skin Adenoid Basal Cell Carcinoma C1266007 GDC 8098/3 Malignant Adenoid_Basal_Cell_Carcinoma 8098/3 Adenoid basal carcinoma Adenoid Basal Cell Carcinoma Skin Adenoid Basal Cell Carcinoma Skin Adenoid Basal Cell Carcinoma A morphologic variant of basal cell carcinoma characterized by the presence of clear cells. C27536 Neoplastic Process Skin Clear Cell Basal Cell Carcinoma C1516599 Malignant Clear_Cell_Basal_Cell_Carcinoma Clear Cell Basal Cell Carcinoma Skin Clear Cell Basal Cell Carcinoma Skin Clear Cell Basal Cell Carcinoma A basal cell carcinoma of the skin that is characterized by cyst formation. C27537 Neoplastic Process Skin Cystic Basal Cell Carcinoma C1275193 Malignant Cystic_Basal_Cell_Carcinoma Cystic Basal Cell Carcinoma Skin Cystic Basal Cell Carcinoma Skin Cystic Basal Cell Carcinoma A basal cell carcinoma of the skin that is characterized by follicular differentiation. C27538 Neoplastic Process Skin Follicular Basal Cell Carcinoma C1883723 Malignant Follicular_Pilar_Basal_Cell_Carcinoma Follicular Basal Cell Carcinoma Skin Basal Cell Carcinoma with Matrical Differentiation Skin Follicular Basal Cell Carcinoma Skin Follicular Basal Cell Carcinoma A variant of basal cell carcinoma presenting as a pale, indurated plaque, usually in the upper trunk or face. Morphologically, it is characterized by the presence of strands, cords, and columns of basaloid cells infiltrating the dermis. Perineural invasion may be present and the basaloid cell infiltrate may extend into deeper tissues. C27539 Neoplastic Process Skin Infiltrating Basal Cell Carcinoma C0334257 GDC 8092/3 Malignant Infiltrating_Basal_Cell_Carcinoma 8092/3 Basal cell carcinoma, desmoplastic type Basal cell carcinoma, morpheic Infiltrating basal cell carcinoma, NOS Infiltrating basal cell carcinoma, non-sclerosing Infiltrating Basal Cell Carcinoma Infiltrating basal cell carcinoma, NOS Skin Infiltrating Basal Cell Carcinoma Skin Infiltrating Basal Cell Carcinoma A rare type of basal cell carcinoma. It is characterized by multiple tiny cysts lined by infundibular epithelium. C27540 Neoplastic Process Skin Infundibulocystic Basal Cell Carcinoma C1304297 Malignant Infundibulocystic_Basal_Cell_Carcinoma Infundibulocystic Basal Cell Carcinoma Skin Infundibulocystic Basal Cell Carcinoma Skin Infundibulocystic Basal Cell Carcinoma A basal cell carcinoma of the skin characterized by the presence of small nodules that permeate the dermis. It presents as an elevated or flat infiltrating tumor, usually in the back. C27541 Neoplastic Process Skin Micronodular Basal Cell Carcinoma CL331352 GDC Malignant Micronodular_Basal_Cell_Carcinoma 8097/3 Basal cell carcinoma, micronodular Basal cell carcinoma, micronodular Micronodular Basal Cell Carcinoma Skin Micronodular Basal Cell Carcinoma Skin Micronodular Basal Cell Carcinoma A squamous cell carcinoma of the skin histologically resembling a vascular tumor due to extreme acantholysis. C27542 Neoplastic Process Skin Pseudovascular Squamous Cell Carcinoma C1335974 Malignant Skin_Pseudovascular_Squamous_Cell_Carcinoma Pseudovascular Skin Squamous Cell Carcinoma Skin Pseudovascular Squamous Cell Carcinoma Skin Pseudovascular Squamous Cell Carcinoma An aggressive variant of skin squamous cell carcinoma. It is characterized by the presence of nests of malignant basaloid squamous cells with scant amount of cytoplasm. C27543 Neoplastic Process Skin Basaloid Squamous Cell Carcinoma C1335973 Malignant Skin_Basaloid_Squamous_Cell_Carcinoma Basaloid Skin Squamous Cell Carcinoma Skin Basaloid Carcinoma Skin Basaloid Squamous Cell Carcinoma Skin Basaloid Squamous Cell Carcinoma A morphologic variant of atypical fibroxanthoma characterized by the presence of atypical mitotic figures, high mitotic activity, and pleomorphic cells. C27545 Neoplastic Process Classic Type Atypical Fibroxanthoma C1333058 Undetermined Classic_Type_Atypical_Fibroxanthoma Classic Type Atypical Fibroxanthoma Classic Type Atypical Fibroxanthoma A morphologic variant of atypical fibroxanthoma characterized by the presence of spindle-shaped fibrohistiocytic cells and a storiform growth pattern. C27546 Neoplastic Process Spindle Cell Type Atypical Fibroxanthoma C1275252 Undetermined Spindle_Cell_Type_Atypical_Fibroxanthoma Spindle Cell Type Atypical Fibroxanthoma Spindle Cell Type Atypical Fibroxanthoma A morphologic variant of dermatofibrosarcoma protuberans characterized by the presence of a fibrosarcomatous component. C27547 Neoplastic Process Fibrosarcomatous Dermatofibrosarcoma Protuberans C3665732 GDC Undetermined Fibrosarcomatous_Dermatofibrosarcoma_Protuberans Dermatofibrosarcoma protuberans, fibrosarcomatous Fibrosarcomatous dermatofibrosarcoma protuberans Fibrosarcomatous Dermatofibrosarcoma Protuberans Fibrosarcomatous dermatofibrosarcoma protuberans Fibrosarcomatous Dermatofibrosarcoma Protuberans A benign, darkly pigmented skin lesion characterized by proliferation of keratinocytes and melanocytes. C27548 Neoplastic Process Melanoacanthoma C1321683 Benign Melanoacanthoma Melanoacanthoma Melanoacanthoma A lobular hemangioma present in multiple anatomic sites. C27552 Neoplastic Process Multiple Lobular Capillary Hemangiomas C1334826 Benign Multiple_Lobular_Capillary_Hemangiomas Multiple Lobular Capillary Hemangiomas Multiple Pyogenic Granulomas Multiple Lobular Capillary Hemangiomas A bladder urothelial carcinoma that arises in a patient with a history of organ transplantation. C27634 Neoplastic Process Transplant-Related Bladder Urothelial Carcinoma C1336817 Malignant Transplant-Related_Urothelial_Transitional_Cell_Carcinoma Transplant-Related Bladder Transitional Cell Carcinoma Transplant-Related Bladder Urothelial Carcinoma Transplant-Related Bladder Urothelial Carcinoma A hepatocellular carcinoma that arises in a patient with a history of organ transplantation. C27635 Neoplastic Process Transplant-Related Hepatocellular Carcinoma Transplant-Related Hepatocellular Carcinoma C1336811 CTRP Malignant Transplant-Related_Hepatocellular_Carcinoma Transplant-Related Hepatocellular Cancer Transplant-Related Hepatocellular Carcinoma Transplant-Related Hepatocellular Carcinoma A squamous cell carcinoma that arises from the skin in a patient with a history of organ transplantation. C27636 Neoplastic Process Transplant-Related Skin Squamous Cell Carcinoma Transplant-Related Skin Squamous Cell Carcinoma C1336816 CTRP Malignant Transplant-Related_Skin_Squamous_Cell_Carcinoma TCSSC Transplant-Related Skin Squamous Cell Carcinoma Transplant-Related Skin Squamous Cell Carcinoma A lung carcinoma that arises in a patient with a history of organ transplantation. C27637 Neoplastic Process Transplant-Related Lung Carcinoma Transplant-Related Lung Carcinoma C1336813 CTRP Malignant Transplant-Related_Lung_Carcinoma Transplant-Related Lung Cancer Transplant-Related Lung Carcinoma Transplant-Related Lung Carcinoma A renal cell carcinoma that arises in a patient with a history of organ transplantation. C27638 Neoplastic Process Transplant-Related Renal Cell Carcinoma Transplant-Related Renal Cell Carcinoma C1336815 CTRP Malignant Transplant-Related_Renal_Cell_Carcinoma Transplant-Related Renal Cell Cancer Transplant-Related Renal Cell Carcinoma Transplant-Related Renal Cell Carcinoma A hematologic malignancy that arises in a patient with a history of organ transplantation. C27639 Neoplastic Process Transplant-Related Hematologic Malignancy C1336810 Malignant Transplant-Related_Hematologic_Malignancy Transplant-Related Hematologic Malignancy Transplant-Related Hematologic Malignancy A Kaposi sarcoma that arises in a patient with a history of organ transplantation. C27640 Neoplastic Process Transplant-Related Kaposi Sarcoma C1336812 Malignant Transplant-Related_Kaposi_s_Sarcoma Transplant-Related Kaposi Sarcoma Transplant-Related Kaposi's Sarcoma Transplant-Related Kaposi Sarcoma A carcinoma that arises from the cervix and is caused by human papillomavirus infection. C27675 Neoplastic Process Human Papillomavirus-Related Cervical Carcinoma Human Papillomavirus-Related Cervical Carcinoma C1334051 CTRP Malignant Human_Papilloma_Virus-Related_Cervical_Carcinoma HPV-Associated Cervical Carcinoma HPV-Related Cervical Carcinoma HPVA Cervical Carcinoma Human Papilloma Virus Related Cervical Carcinoma Human Papilloma Virus-Related Cervical Carcinoma Human Papillomavirus (HPV)-Related Cervical Cancer Human Papillomavirus-Associated Cervical Carcinoma Human Papillomavirus-Related Cervical Carcinoma Human Papillomavirus-Related Cervical Carcinoma A cervical squamous cell carcinoma associated with human papillomavirus infection. C27676 Neoplastic Process Human Papillomavirus-Related Cervical Squamous Cell Carcinoma C1334052 Cellosaurus Malignant Human_Papilloma_Virus-Related_Cervical_Squamous_Cell_Carcinoma HPV-Associated Cervical Squamous Cell Carcinoma HPV-Related Cervical Squamous Cell Carcinoma HPVA Cervical Squamous Cell Carcinoma Human Papilloma Virus Related Cervical Squamous Cell Carcinoma Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma Human Papillomavirus-Associated Cervical Squamous Cell Carcinoma Human Papillomavirus-Related Cervical Squamous Cell Carcinoma Human Papillomavirus-Related Cervical Squamous Cell Carcinoma A cervical adenocarcinoma associated with the presence of human papillomavirus infection. C27677 Neoplastic Process Human Papillomavirus-Related Cervical Adenocarcinoma C1334053 Cellosaurus Malignant Human_Papilloma_Virus-Related_Endocervical_Adenocarcinoma HPV-Related Endocervical Adenocarcinoma HPVA Cervical Adenocarcinoma Human Papilloma Virus Related Endocervical Adenocarcinoma Human Papilloma Virus-Related Endocervical Adenocarcinoma Human Papillomavirus- Associated Endocervical Adenocarcinoma Human Papillomavirus-Associated Cervical Adenocarcinoma Human Papillomavirus-Related Cervical Adenocarcinoma Human Papillomavirus-Related Endocervical Adenocarcinoma Human Papillomavirus-Related Cervical Adenocarcinoma A squamous cell carcinoma that arises from the vulva and is caused by human papillomavirus infection. C27679 Neoplastic Process Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma C1334059 Malignant Human_Papilloma_Virus-Related_Vulvar_Squamous_Cell_Carcinoma HPV-Related Vulvar Squamous Cell Carcinoma Human Papilloma Virus Related Vulvar Squamous Cell Carcinoma Human Papilloma Virus-Related Vulvar Squamous Cell Carcinoma Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma An esophageal squamous cell carcinoma that arises from squamous epithelial cells infected with human papillomavirus. C27680 Neoplastic Process Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma C1334054 CTRP Malignant Human_Papilloma_Virus-Related_Esophageal_Squamous_Cell_Carcinoma HPV-Related Esophageal Squamous Cell Carcinoma Human Papilloma Virus Related Esophageal Squamous Cell Carcinoma Human Papilloma Virus-Related Esophageal Squamous Cell Carcinoma Human Papillomavirus (HPV)-Related Esophageal Squamous Cell Cancer Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma An anal squamous cell carcinoma related to infection with sexually transmittable human papillomavirus. C27681 Neoplastic Process Human Papillomavirus-Related Anal Squamous Cell Carcinoma C1334049 Malignant Human_Papilloma_Virus-Related_Anal_Squamous_Cell_Carcinoma HPV-Related Anal Squamous Cell Carcinoma Human Papilloma Virus Related Anal Squamous Cell Carcinoma Human Papilloma Virus-Related Anal Squamous Cell Carcinoma Human Papillomavirus-Related Anal Squamous Cell Carcinoma Human Papillomavirus-Related Anal Squamous Cell Carcinoma A squamous cell carcinoma that arises from the penis and is caused by human papillomavirus infection. C27682 Neoplastic Process Penile Human Papillomavirus-Related Squamous Cell Carcinoma C1334056 Malignant Human_Papilloma_Virus-Related_Penile_Squamous_Cell_Carcinoma HPV-Related Penile Squamous Cell Carcinoma Human Papilloma Virus Related Penile Squamous Cell Carcinoma Human Papilloma Virus-Related Penile Squamous Cell Carcinoma Human Papillomavirus-Related Penile Squamous Cell Carcinoma Human Papillomavirus-Related Squamous Cell Carcinoma of the Penis Penile HPV-Associated Squamous Cell Carcinoma Penile Human Papillomavirus-Associated Squamous Cell Carcinoma Penile Human Papillomavirus-Related Squamous Cell Carcinoma Penile Human Papillomavirus-Related Squamous Cell Carcinoma A hepatocellular carcinoma that develops following hepatitis virus exposure and injury of the liver parenchyma. C27686 Neoplastic Process Hepatitis Virus-Related Hepatocellular Carcinoma Hepatitis Virus-Related Hepatocellular Carcinoma C1333979 CTRP Malignant Hepatitis_Virus-Related_Hepatocellular_Carcinoma Hepatitis Virus Related Hepatocellular Carcinoma Hepatitis Virus-Related Hepatocellular Cancer Hepatitis Virus-Related Hepatocellular Carcinoma Hepatitis Virus-Related Hepatocellular Carcinoma A hepatocellular carcinoma that develops following hepatitis B virus exposure and injury of the liver parenchyma. C27687 Neoplastic Process Hepatitis B Virus-Related Hepatocellular Carcinoma C1333977 CPTAC Malignant Hepatitis_B_Virus-Related_Hepatocellular_Carcinoma Hepatitis B Virus Related Hepatocellular Carcinoma Hepatitis B Virus-Related Hepatocellular Carcinoma Liver Cancer Secondary to Hepatitis B Hepatitis B Virus-Related Hepatocellular Carcinoma A hepatocellular carcinoma that develops following hepatitis C virus exposure and injury of the liver parenchyma. C27688 Neoplastic Process Hepatitis C Virus-Related Hepatocellular Carcinoma C1333978 CPTAC Malignant Hepatitis_C_Virus-Related_Hepatocellular_Carcinoma Hepatitis C Virus Related Hepatocellular Carcinoma Hepatitis C Virus-Related Hepatocellular Carcinoma Liver Cancer Secondary to Hepatitis C Hepatitis C Virus-Related Hepatocellular Carcinoma Lymphoma that is caused by Epstein-Barr virus infection. C27691 Neoplastic Process EBV-Related Lymphoma C1333431 Malignant Epstein-Barr_Virus-Related_Lymphoma EBV Related Lymphoma EBV-Associated Lymphoma EBV-Related Lymphoma Epstein-Barr Virus Related Lymphoma Epstein-Barr Virus-Related Lymphoma EBV-Related Lymphoma Hodgkin lymphoma that is caused by Epstein-Barr virus infection. C27692 Neoplastic Process EBV-Related Hodgkin Lymphoma C1333430 Malignant Epstein-Barr_Virus-Related_Hodgkin_s_Lymphoma EBV Related Hodgkin's Lymphoma EBV-Related Hodgkin Lymphoma EBV-Related Hodgkin's Lymphoma Epstein-Barr Virus Related Hodgkin's Lymphoma Epstein-Barr Virus-Related Hodgkin Lymphoma Epstein-Barr Virus-Related Hodgkin's Lymphoma EBV-Related Hodgkin Lymphoma Non-Hodgkin lymphoma that is caused by Epstein-Barr virus infection. C27693 Neoplastic Process EBV-Related Non-Hodgkin Lymphoma C1333433 Malignant Epstein-Barr_Virus-Related_Non-Hodgkin_s_Lymphoma EBV Related Non-Hodgkin's Lymphoma EBV-Related Non-Hodgkin Lymphoma EBV-Related Non-Hodgkin's Lymphoma Epstein-Barr Virus Related Non-Hodgkin's Lymphoma Epstein-Barr Virus-Related Non-Hodgkin Lymphoma Epstein-Barr Virus-Related Non-Hodgkin's Lymphoma EBV-Related Non-Hodgkin Lymphoma Burkitt lymphoma that is caused by Epstein-Barr virus infection. C27694 Neoplastic Process EBV-Related Burkitt Lymphoma C1333427 Cellosaurus Malignant Epstein-Barr_Virus-Related_Burkitt_s_Lymphoma EBV Related Burkitt's Lymphoma EBV-Associated Burkitt Lymphoma EBV-Related Burkitt Lymphoma EBV-Related Burkitt's Lymphoma Epstein-Barr Virus-Related Burkitt Lymphoma Epstein-Barr Virus-Related Burkitt's Lymphoma EBV-Related Burkitt Lymphoma A clonal lymphoproliferative disorder that develops following organ transplantation and is associated with Epstein-Barr virus infection. C27695 Neoplastic Process EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder C1333429 Malignant Epstein-Barr_Virus-Related_Clonal_Post-Transplant_Lymphoproliferative_Disorder EBV Related Clonal PTLD EBV-Associated Clonal Post-Transplant Lymphoproliferative Disorder EBV-Related Clonal PTLD EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder Epstein-Barr Virus-Associated Clonal Post-Transplant Lymphoproliferative Disorder Epstein-Barr Virus-Related Clonal Post-Transplant Lymphoproliferative Disorder EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder Lymphoma that is caused by a virus infection. C27699 Neoplastic Process Virus-Related Lymphoma C1336968 CPTAC Malignant Virus-Related_Lymphoma Virus Related Lymphoma Virus-Related Lymphoma Virus-Related Lymphoma A sarcoma that is caused by a virus. C27707 Neoplastic Process Virus-Related Sarcoma C1336969 Malignant Virus-Related_Sarcoma Virus-Related Sarcoma Virus-Related Sarcoma A neoplasm originating from the apical lung. Most superior sulcus neoplasms are bronchogenic carcinomas. This tumor may be associated with Pancoast syndrome. It is also known as Pancoast tumor. C27710 Neoplastic Process Pulmonary Sulcus Neoplasm C1335574 A type of lung cancer that begins in the upper part of a lung and spreads to nearby tissues such as the ribs and vertebrae. Most pulmonary sulcus tumors are non-small cell cancers. Undetermined Pulmonary_Sulcus_Neoplasm Pulmonary Sulcus Neoplasm Pulmonary Sulcus Tumor pulmonary sulcus tumor Pulmonary Sulcus Neoplasm A rare gastrointestinal stromal tumor that presents as a solitary mass outside the gastrointestinal tract. C27716 Neoplastic Process Extragastrointestinal Gastrointestinal Stromal Tumor C1333500 Undetermined Extragastrointestinal_Gastrointestinal_Stromal_Tumor EGIST Extragastrointestinal Gastrointestinal Stromal Tumor Extragastrointestinal Stromal Tumor Extragastrointestinal Gastrointestinal Stromal Tumor A malignant vascular neoplasm arising from an area of skin exposed to radiation therapy. C27719 Neoplastic Process Skin Radiation-Related Angiosarcoma C1333179 Malignant Cutaneous_Radiation-Related_Angiosarcoma Cutaneous Radiation-Induced Angiosarcoma Cutaneous Radiation-Related Angiosarcoma Skin Radiation-Related Angiosarcoma Skin Radiation-Related Angiosarcoma A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the pancreas. According to the presence or absence of clinical syndromes that result from hormone hypersecretion, pancreatic neuroendocrine tumors are classified either as functional or nonfunctional. C27720 Neoplastic Process Pancreatic Neuroendocrine Tumor Pancreatic Neuroendocrine Tumor CL480914 CPTAC CTEP CTRP Cellosaurus GDC A mass of abnormal cells that forms in the endocrine (hormone-producing) tissues of the pancreas. Islet cell tumors may be benign (not cancer) or malignant (cancer). 8150/1 Undetermined Well-Differentiated_Pancreatic_Endocrine_Neoplasm 8150/0 Benign neoplasm: Endocrine pancreas Pancreatic endocrine tumor, benign Islet Cell Tumor Islet cell tumors - pancreas Islet cell tumors of the pancreas PanNET Pancreatic NET Pancreatic Neuroendocrine Tumor Pancreatic Well Differentiated Neuroendocrine Neoplasm Pancreatic Well-Differentiated Neuroendocrine Neoplasm Well Differentiated Pancreatic Endocrine Neoplasm Well Differentiated Pancreatic Neuroendocrine Neoplasm Well-Differentiated Pancreatic Endocrine Neoplasm Well-Differentiated Pancreatic Neuroendocrine Neoplasm islet cell tumor Pancreatic Neuroendocrine Tumor A neoplasm with neuroendocrine differentiation arising from the digestive system. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms). C27721 Neoplastic Process Digestive System Neuroendocrine Neoplasm C1333799 Undetermined Gastrointestinal_Neuroendocrine_Neoplasm Digestive System Neuroendocrine Neoplasm Gastroenteropancreatic Neuroendocrine Neoplasm Gastrointestinal Neuroendocrine Neoplasm Gastrointestinal System Neuroendocrine Neoplasm Digestive System Neuroendocrine Neoplasm A myelodysplastic syndrome resulting from chemotherapy or radiation therapy for cancer. C27722 Neoplastic Process Myelodysplastic Syndrome Post Cytotoxic Therapy C1292780 GDC 9987/3 Malignant Therapy-Related_Myelodysplastic_Syndrome 9987/3 Therapy-related myelodysplastic syndrome, NOS MDS Post Cytotoxic Therapy MDS-pCT Myelodysplastic Syndrome Post Cytotoxic Therapy Therapy Related Myelodysplastic Syndrome Therapy-Related MDS Therapy-Related Myelodysplastic Syndrome t-MDS Myelodysplastic Syndrome Post Cytotoxic Therapy An encapsulated or well-circumscribed thyroid gland tumor composed of well-differentiated follicular cells with well-developed or partially developed nuclear features of papillary thyroid carcinoma and with questionable capsular or vascular invasion. This is a tumor indeterminate between follicular adenoma and follicular carcinoma. Tumors in which vascular invasion has been excluded by all means are called non-invasive follicular thyroid neoplasms with papillary-like nuclear features. (WHO) C27729 Neoplastic Process Thyroid Gland Well-Differentiated Tumor of Uncertain Malignant Potential C1266046 GDC 8330/1 Uncertain Malignant Potential Atypical_Follicular_Adenoma 8330/1 Atypical follicular adenoma Well differentiated tumor of uncertain malignant potential Atypical Follicular Adenoma Atypical follicular adenoma Thyroid Gland Atypical Follicular Adenoma Thyroid Gland Well-Differentiated Neoplasm of Uncertain Malignant Potential Thyroid Gland Well-Differentiated Tumor of Uncertain Malignant Potential WDT-UMP Thyroid Gland Well-Differentiated Tumor of Uncertain Malignant Potential A Wilms tumor of the kidney which occurs in children. C27730 Neoplastic Process Childhood Kidney Wilms Tumor Childhood Kidney Wilms Tumor C1333015 CTRP NICHD A Wilms tumor that occurs in children. Malignant Childhood_Wilms_Tumor Childhood Kidney Nephroblastoma Childhood Kidney Wilms Tumor Childhood Renal Wilms Tumor Childhood Renal Wilms' Tumor Childhood Wilms Tumor Wilms Tumor Childhood Kidney Wilms Tumor Gastrointestinal stromal tumor that arises from the colon or rectum. The majority of cases have spindle cell morphology. C27735 Neoplastic Process Colorectal Gastrointestinal Stromal Tumor Colorectal Gastrointestinal Stromal Tumor C1333109 CTRP mCode Undetermined Colorectal_Gastrointestinal_Stromal_Tumor Colorectal (Colon or Rectal) Gastrointestinal Stromal Tumor (GIST) Colorectal GIST Colorectal Gastrointestinal Stromal Tumor Gastrointestinal stromal tumor of large intestine Colorectal Gastrointestinal Stromal Tumor Stage IIB includes: (T3b, N0, M0); (T4a, N0, M0). T3b: Cutaneous melanoma with a tumor measuring 2.01-4.0 mm in thickness, with ulceration. T4a: Cutaneous melanoma with a tumor measuring more than 4.0 mm in thickness, without ulceration. N0: No regional lymph node metastases. M0: No detectable evidence of distant metastases. (from AJCC 6th and 7th Eds.) C27742 Neoplastic Process Stage IIB Cutaneous Melanoma AJCC v6 and v7 Stage IIB Cutaneous Melanoma AJCC v6 and v7 C1336187 CTRP Malignant Stage_IIB_Melanoma_of_the_Skin Stage IIB Cutaneous (Skin) Melanoma Stage IIB Cutaneous Melanoma AJCC v6 and v7 Stage IIB Melanoma Stage IIB Melanoma of Skin Stage IIB Melanoma of the Skin Stage IIB Skin Melanoma AJCC v6 Stage IIB Skin Melanoma AJCC v7 Stage IIB Cutaneous Melanoma AJCC v6 and v7 Acute myeloid leukemias that do not fulfill the criteria for inclusion in the group of acute myeloid leukemias which have recurrent genetic abnormalities or myelodysplastic changes, or are therapy-related. This category includes entities classified according to the French-American-British classification scheme. C27753 Neoplastic Process Acute Myeloid Leukemia, Not Otherwise Specified CL054841 CPTAC CTEP GDC PCDC Malignant Acute_Myeloid_Leukemia_not_Otherwise_Categorized 9861/3 Acute myeloid leukemia, NOS Not Classified AML not otherwise specified AML, NOS AML, Not Otherwise Specified Acute Myeloid Leukemia NOS Acute Myeloid Leukemia Not Otherwise Categorized Acute Myeloid Leukemia Not Otherwise Specified Acute Myeloid Leukemia, NOS Acute Myeloid Leukemia, Not Otherwise Specified Acute myeloid leukemia, NOS Acute Myeloid Leukemia, Not Otherwise Specified Acute myeloid leukemia occurring as late complication of prior therapy with alkylating agents. C27754 Neoplastic Process Alkylating Agent-Related Acute Myeloid Leukemia Alkylating Agent-Related Acute Myeloid Leukemia C1321724 CTRP GDC Malignant Alkylating_Agent-Related_Acute_Myeloid_Leukemia 9920/3 Therapy-related acute myeloid leukemia, alkylating agent related Therapy-related acute myeloid leukemia, epipodophyllotoxin-related Alkylating Agent Related Acute Myeloid Leukemia Alkylating Agent-Related AML Alkylating Agent-Related Acute Myeloid Leukemia Therapy-related acute myeloid leukemia, alkylating agent related Alkylating Agent-Related Acute Myeloid Leukemia Acute myeloid leukemias arising as a result of the mutagenic effect of therapeutic agents targeting DNA-topoisomerase II. The vast majority of patients present without a preceding myelodysplastic phase. The acute myeloid leukemias are usually of the monoblastic or myelomonocytic type. Clonal cytogenetic abnormalities are frequently present and usually involve chromosome 11q23 (MLL gene). C27755 Neoplastic Process Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia C1336769 Malignant Topoisomerase_II_Inhibitor-Related_Acute_Myeloid_Leukemia Topoisomerase II Inhibitor Related Acute Myeloid Leukemia Topoisomerase II Inhibitor-Related AML Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia Acute Promyelocytic leukemia characterized by the presence of hypergranular promyelocytes and characteristic cells that contain bundles of Auer rods. C27756 Neoplastic Process Typical Acute Promyelocytic Leukemia C1336843 Malignant Typical_Acute_Promyelocytic_Leukemia Hypergranular Acute Promyelocytic Leukemia Typical Acute Promyelocytic Leukemia Typical Acute Promyelocytic Leukemia Acute promyelocytic leukemia in which the promyelocytes in the peripheral blood have paucity or absence of cytoplasmic granules and characteristic bilobed nuclei. C27757 Neoplastic Process Microgranular Acute Promyelocytic Leukemia Microgranular Acute Promyelocytic Leukemia C0563634 CPTAC CTRP PCDC Malignant Microgranular_Acute_Promyelocytic_Leukemia Hypogranular Acute Promyelocytic Leukemia M3 Variant M3v Microgranular Acute Promyelocytic Leukemia Microgranular Acute Promyelocytic Leukemia Non-Hodgkin lymphoma that is caused by Helicobacter Pylori. C27762 Neoplastic Process Helicobacter Pylori-Related Non-Hodgkin Lymphoma C1333954 Malignant Helicobacter_Pylori-Related_Non-Hodgkin_s_Lymphoma Helicobacter Pylori-Related Non-Hodgkin Lymphoma Helicobacter Pylori-Related Non-Hodgkin's Lymphoma Helicobacter Pylori-Related Non-Hodgkin Lymphoma A low grade, indolent B-cell lymphoma that is associated with Helicobacter pylori infection. C27763 Neoplastic Process Helicobacter Pylori-Associated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma C1333952 Malignant Helicobacter_Pylori-Related_Gastric_Mucosa-Associated_Lymphoid_Tissue_Lymphoma Helicobacter Pylori-Associated Gastric MALT Helicobacter Pylori-Associated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Helicobacter Pylori-Associated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma An adenocarcinoma that arises from the gastric mucosa and is caused by persistent infection with Helicobacter pylori. C27765 Neoplastic Process Helicobacter Pylori-Related Gastric Adenocarcinoma C1333951 Malignant Helicobacter_Pylori-Related_Gastric_Adenocarcinoma Helicobacter Pylori-Related Gastric Adenocarcinoma Helicobacter Pylori-Related Gastric Adenocarcinoma A squamous cell carcinoma of the bladder that is caused by Schistosoma hematobium. C27768 Neoplastic Process Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma C1335926 Malignant Schistosoma_Hematobium-Related_Bladder_Squamous_Cell_Carcinoma Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma A cholangiocarcinoma that has developed following infection with Opisthorchis viverrini. C27769 Neoplastic Process Opisthorchis Viverrini-Related Cholangiocarcinoma C1335113 Cellosaurus Malignant Opisthorchis_Viverrini-Related_Cholangiocarcinoma Liver Fluke-Related Cholangiocarcinoma Opisthorchis Viverrini-Related Cholangiocarcinoma Opisthorchis Viverrini-Related Cholangiocellular Carcinoma Opisthorchis Viverrini-Related Cholangiocarcinoma A cavernous hemangioma characterized by the presence of hylanized vascular channels and is often associated with the presence of calcifications, fibrosis, and hemorrhage. C27777 Neoplastic Process Giant Hemangioma C1333817 Benign Giant_Hemangioma Giant Hemangioma Giant Hemangioma A myelodysplastic/myeloproliferative neoplasm that does not meet the criteria of other myelodysplastic/myeloproliferative neoplasms, myelodysplastic syndromes, and myeloproliferative neoplasms. It is associated with cytopenia, blasts less than 20% in bone marrow and peripheral blood, thrombocytosis, and absence of genetic abnormalities associated with myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions. C27780 Neoplastic Process Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified C1328061 CTRP GDC Malignant Myelodysplastic_Myeloproliferative_Disease_Unclassifiable Myelodysplastic and myeloproliferative disease, not elsewhere classified Myelodysplastic/myeloproliferative neoplasm, unclassifiable MDS/MPN, NOS MDS/MPN, U MDS/MPN-U Myelodysplastic/Myeloproliferative Neoplasm, NOS Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Myelodysplastic/myeloproliferative neoplasm, unclassifiable Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified A liposarcoma characterized by the presence of round non-lipogenic primitive mesenchymal cells and small signet ring lipoblasts within a myxoid stoma with a branching vascular pattern. This category includes hypercellular lesions with round cell morphology, formerly known as round cell liposarcoma. C27781 Neoplastic Process Myxoid Liposarcoma C0206634 Cellosaurus GDC 8852/3 Malignant Myxoid_Round_Cell_Liposarcoma 8852/3 Myxoid liposarcoma Myxoliposarcoma MLPS Myxoid Liposarcoma Myxoid liposarcoma Myxoid/Round Cell Liposarcoma Myxoliposarcoma Myxoid Liposarcoma Carcinoma of the penis that has spread from its original site of growth to another anatomic site. C27784 Neoplastic Process Metastatic Penile Carcinoma CL448416 Malignant Metastatic_Penile_Cancer Metastatic Carcinoma of Penis Metastatic Carcinoma of the Penis Metastatic Penile Cancer Metastatic Penile Carcinoma Metastatic Penis Cancer Metastatic Penis Carcinoma Metastatic Penile Carcinoma Stage I includes: pT1-4, N0, M0, SX. pT1: Tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade into the tunica albuginea but not the tunica vaginalis. pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis. pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion. pT4: Tumor invades the scrotum with or without vascular/lymphatic invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C27785 Neoplastic Process Stage I Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7 Stage I Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7 C1336489 CTRP Malignant Stage_I_Testicular_Non-Seminomatous_Germ_Cell_Tumor Stage I Testicular Non-Seminomatous Germ Cell Tumor Stage I Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 Stage I Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7 Stage I Testicular Non-Seminomatous Germ Cell Tumor AJCC v7 Stage I Testicular Nonseminomatous Germ Cell Tumor Stage I Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7 Stage II includes: Any pT/TX, N1-3, M0, SX. pTX: Primary tumor cannot be assessed. N1: Metastasis with a lymph node mass 2 cm or less in greatest dimension; or multiple lymph nodes, none more than 2cm in greatest dimension. N2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, any one mass greater than 2 cm but not more than 5 cm in greatest dimension. N3: Metastasis with a lymph node mass more than 5 cm in greatest dimension. M0: No distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C27786 Neoplastic Process Stage II Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7 Stage II Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7 C1336325 CTRP Malignant Stage_II_Testicular_Non-Seminomatous_Germ_Cell_Tumor Stage II Testicular Non-Seminomatous Germ Cell Tumor Stage II Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 Stage II Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7 Stage II Testicular Non-Seminomatous Germ Cell Tumor AJCC v7 Stage II Testicular Nonseminomatous Germ Cell Tumor Stage II Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7 Stage III includes: Any pT/TX, Any N, M1, SX. M1: Distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C27787 Neoplastic Process Stage III Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7 Stage III Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7 C1336272 CTRP Malignant Stage_III_Testicular_Non-Seminomatous_Germ_Cell_Tumor Stage III Testicular Non-Seminomatous Germ Cell Tumor Stage III Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 Stage III Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7 Stage III Testicular Non-Seminomatous Germ Cell Tumor AJCC v7 Stage III Testicular Nonseminomatous Germ Cell Tumor Stage III Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7 A neoplastic clonal expansion of endometrial glands characterized by cytologic changes of the epithelium and the presence of an increased number of endometrial glands. The glands form crowded aggregates with tubular or branching patterns which are cytologically distinct from the background architectural and cytological pattern. It is associated with molecular changes seen in endometrioid endometrial carcinoma, including microsatellite instability, PAX2 inactivation, and PTEN, KRAS, and CTNNB1 gene mutations. C27789 Neoplastic Process Atypical Endometrial Hyperplasia Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia C0349579 CPTAC CTRP GDC Undetermined Atypical_Endometrial_Hyperplasia Endometrial_Intraepithelial_Neoplasia 8380/2 Atypical hyperplasia/Endometrial intraepithelial neoplasia (EIN) Atypical hyperplasia/Endometrioid intraepithelial neoplasm Endometrioid intraepithelial neoplasia Atypical Endometrial Hyperplasia Atypical Hyperplasia of Endometrium Atypical Hyperplasia of the Endometrium Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasm Atypical hyperplasia/Endometrial intraepithelial neoplasia (EIN) EAH/EIN EIN EmGD Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia Endometrial Glandular Dysplasia Endometrial Hyperplasia with Atypia Endometrial Intraepithelial Neoplasia Endometrial intraepithelial neoplasia (EIN) Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. cN0: No palpable or visibly enlarged inguinal lymph nodes. pN0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C27790 Neoplastic Process Penile Carcinoma In Situ C0154089 GDC mCode Abnormal cells are found on the surface of the skin of the penis. These abnormal cells may become cancer and spread into nearby normal tissue. 8080/2 Malignant Penile_Carcinoma_in_situ 8080/2 Queyrat erythroplasia Bowen Disease of the Penis Bowen's Disease of Penis Bowen's Disease of the Penis Carcinoma in situ of Penis Carcinoma in situ of penis Carcinoma in situ of the Penis Erythroplasia of Queyrat Grade III Penile Intraepithelial Neoplasia Grade III Squamous Intraepithelial Lesion of Penis Grade III Squamous Intraepithelial Lesion of the Penis Penile Carcinoma In Situ Penile Carcinoma In Situ AJCC v7 Queyrat Erythroplasia Queyrat erythroplasia Queyrat's Erythroplasia stage 0 penile carcinoma in situ Penile Carcinoma In Situ A gastrointestinal stromal tumor composed of neoplastic spindle cells. C27792 Neoplastic Process Spindle Cell Type Gastrointestinal Stromal Tumor C1336056 Undetermined Spindle_Cell_Type_Gastrointestinal_Stromal_Tumor Spindle Cell Type GIST Spindle Cell Type Gastrointestinal Stromal Tumor Spindle Cell Type Gastrointestinal Stromal Tumor A gastrointestinal stromal tumor composed of a mixture of neoplastic epithelioid and spindle cells. C27793 Neoplastic Process Mixed Cell Type Gastrointestinal Stromal Tumor C1334781 Undetermined Mixed_Cell_Type_Gastrointestinal_Stromal_Tumor Mixed Cell Type GIST Mixed Cell Type Gastrointestinal Stromal Tumor Mixed Cell Type Gastrointestinal Stromal Tumor A carcinoma that arises from the kidney and has metastasized to another anatomic site. C27806 Neoplastic Process Metastatic Kidney Carcinoma Metastatic Kidney Carcinoma C0278678 CTRP Malignant Metastatic_Renal_Cell_Cancer Metastatic Kidney Carcinoma Metastatic Kidney Carcinoma C27807 Neoplastic Process Nodular Sclerosis Classic Hodgkin Lymphoma, Syncytial Variant CL054962 GDC Malignant Hodgkin_s_Disease_Nodular_Sclerosis_Syncytial_Variant 9667/3 Hodgkin disease, nodular sclerosis, syncytial variant Hodgkin disease, nodular sclerosis, syncytial variant Hodgkin's Disease, Nodular Sclerosis, Syncytial Variant Nodular Sclerosis Classic Hodgkin Lymphoma, Syncytial Variant Nodular Sclerosis Classical Hodgkin Lymphoma, Syncytial Variant Nodular Sclerosis Hodgkin Lymphoma, Syncytial Variant Nodular Sclerosis Classic Hodgkin Lymphoma, Syncytial Variant An adenocarcinoma arising from the intrahepatic or extrahepatic bile ducts. C27813 Neoplastic Process Bile Duct Adenocarcinoma C1370800 CPTAC Cellosaurus GDC Malignant Bile_Duct_Adenocarcinoma 8160/3 Bile duct adenocarcinoma Adenocarcinoma Bile Duct Adenocarcinoma Bile duct adenocarcinoma Bile Duct Adenocarcinoma A carcinoma arising from the intrahepatic or extrahepatic bile ducts. C27814 Neoplastic Process Bile Duct Carcinoma Bile Duct Carcinoma C0740277 CPTAC CTRP GDC Cancer that forms in a bile duct. A bile duct is a tube that carries bile (fluid made by the liver that helps digest fat) between the liver and gallbladder and the intestine. Bile ducts include the common hepatic, cystic, and common bile ducts. Bile duct cancer may be found inside the liver (intrahepatic) or outside the liver (extrahepatic). Malignant Bile_Duct_Carcinoma 8160/3 Bile Duct Cancer Bile duct carcinoma Bile Duct Cancer Bile Duct Cancer (including Cholangiocarcinoma) Bile Duct Carcinoma Bile duct carcinoma bile duct cancer Bile Duct Carcinoma Primary or metastatic malignant neoplasm involving the endometrium (mucous membrane that lines the endometrial cavity). C27815 Neoplastic Process Malignant Endometrial Neoplasm C0007103 mCode Malignant Malignant_Endometrial_Neoplasm Malignant neoplasm: Endometrium Malignant Endometrial Neoplasm Malignant neoplasm of endometrium Malignant Endometrial Neoplasm A nevus characterised by the presence of excessive pigment. C27816 Neoplastic Process Pigmented Nevus C3553699 GDC 8720/0 Benign Pigmented_Nevus 8720/0 Pigmented nevus, NOS Pigmented Nevus Pigmented nevus, NOS Pigmented Nevus A rare, slow-growing, usually non-invasive intraepithelial adenocarcinoma affecting the penile skin or mucosal surface. The malignant cells are large with abundant pale cytoplasm and vesicular nuclei with prominent nucleoli. (WHO 2016) C27817 Neoplastic Process Paget Disease of the Penis Penile Paget Disease C0221286 CTEP CTRP Malignant Paget_s_Disease_of_Penis Paget Disease of the Penis Paget's Disease of Penis Paget's Disease of the Penis Penile Paget Disease Penile adenocarcinoma Penile Paget Disease Ureter carcinoma that has spread to another anatomical site. C27818 Neoplastic Process Metastatic Ureter Carcinoma CL552364 Malignant Metastatic_Neoplasm_of_the_Ureter Metastatic Carcinoma of Ureter Metastatic Carcinoma of the Ureter Metastatic Ureter Carcinoma Metastatic Ureter Carcinoma A urethral carcinoma that has spread to another anatomical site. C27819 Neoplastic Process Metastatic Urethral Carcinoma CL552365 Malignant Metastatic_Neoplasm_of_the_Urethra Metastatic Carcinoma of Urethra Metastatic Carcinoma of the Urethra Metastatic Urethral Carcinoma Metastatic Urethral Carcinoma Stage IIIC Breast Cancer was added in the 6th Edition AJCC Staging Manual, on the basis of metastasis to the infraclavicular lymph nodes (N3) plus any T, M0. C27828 Neoplastic Process Stage IIIC Breast Cancer AJCC v6 Stage IIIC Breast Cancer AJCC v6 C2216700 CTRP Malignant Stage_IIIC_Breast_Cancer Stage IIIC Breast Cancer Stage IIIC Breast Cancer AJCC v6 Stage IIIC Breast Carcinoma AJCC v6 Stage IIIC Breast Cancer AJCC v6 C27829 Neoplastic Process Invasive Breast Carcinoma by Histologic Grade C1334273 Header_Concept Malignant Invasive_Breast_Carcinoma_by_Histologic_Grade Infiltrating Breast Carcinoma by Histologic Grade Infiltrating Breast Carcinoma by Nottingham Combined Histologic Grade Invasive Breast Carcinoma by Histologic Grade Invasive Breast Carcinoma by Nottingham Combined Histologic Grade Invasive Breast Carcinoma by Histologic Grade A well differentiated invasive breast carcinoma. C27830 Neoplastic Process Grade 1 Invasive Breast Carcinoma C1333832 Malignant Grade_1_Invasive_Breast_Carcinoma Favorable Infiltrating Breast Carcinoma Grade 1 Infiltrating Breast Carcinoma Grade 1 Invasive Breast Carcinoma Low Combined Histologic Grade Infiltrating Breast Carcinoma Well Differentiated Infiltrating Breast Carcinoma Well Differentiated Invasive Breast Carcinoma Grade 1 Invasive Breast Carcinoma A moderately differentiated invasive breast carcinoma. C27831 Neoplastic Process Grade 2 Invasive Breast Carcinoma C1333838 Malignant Grade_2_Invasive_Breast_Carcinoma Grade 2 Infiltrating Breast Carcinoma Grade 2 Invasive Breast Carcinoma Intermediate Combined Histologic Grade Infiltrating Breast Carcinoma Moderately Differentiated Infiltrating Breast Carcinoma Moderately Differentiated Invasive Breast Carcinoma Moderately Favorable Infiltrating Breast Carcinoma Grade 2 Invasive Breast Carcinoma A poorly differentiated invasive breast carcinoma. C27832 Neoplastic Process Grade 3 Invasive Breast Carcinoma C1333843 Malignant Grade_3_Invasive_Breast_Carcinoma Grade 3 Infiltrating Breast Carcinoma Grade 3 Invasive Breast Carcinoma High Combined Histologic Grade Infiltrating Breast Carcinoma Poorly Differentiated Infiltrating Breast Carcinoma Poorly Differentiated Invasive Breast Carcinoma Unfavorable Infiltrating Breast Carcinoma Grade 3 Invasive Breast Carcinoma A high-grade, aggressive adenocarcinoma arising from the endometrium. It is characterized by the presence of complex papillary patterns with cellular budding. Atypical mitoses, necrosis, and psammoma bodies may be present. It is classified as type II endometrial carcinoma and it is not associated with endometrial hyperplasia. It tends to invade deeply into the myometrium and spreads into the lymphatic vessels. Patients frequently present with spread of the tumor beyond the uterus at the time of diagnosis. The prognosis is usually poor. C27838 Neoplastic Process Endometrial Serous Adenocarcinoma Endometrial Serous Adenocarcinoma C0854924 CTEP CTRP Cellosaurus Malignant Uterine_Serous_Carcinoma Endometrial Serous Adenocarcinoma Serous endometrial adenocarcinoma Uterine Corpus Serous Adenocarcinoma Uterine Papillary Serous Carcinoma Uterine Serous Adenocarcinoma Uterine Serous Carcinoma Uterine Serous Papillary Adenocarcinoma Endometrial Serous Adenocarcinoma An endometrioid adenocarcinoma arising from the endometrium. Morphologically it is characterized by the presence of malignant glandular cells containing glycogen vacuoles which are usually subnuclear and reminiscent of early secretory endometrium. C27839 Neoplastic Process Endometrial Endometrioid Adenocarcinoma, Secretory Variant Endometrial Endometrioid Adenocarcinoma, Secretory Variant C1266057 CTRP GDC 8382/3 Malignant Uterine_Corpus_Endometrioid_Adenocarcinoma_Secretory_Variant 8382/3 Endometrioid adenocarcinoma, secretory variant Endometrial Endometrioid Adenocarcinoma, Secretory Variant Endometrioid adenocarcinoma, secretory variant Secretory Uterine Corpus Endometrioid Adenocarcinoma Endometrial Endometrioid Adenocarcinoma, Secretory Variant A morphologic variant of endometrioid adenocarcinoma characterized by the presence of large multinucleated clear cells. C27843 Neoplastic Process Endometrial Endometrioid Adenocarcinoma with Clear Cell Change C1336908 Malignant Uterine_Corpus_Endometrioid_Adenocarcinoma_with_Clear_Cell_Change Endometrial Endometrioid Adenocarcinoma with Clear Cell Change Endometrial Endometrioid Adenocarcinoma with Clear Cell Change A primary endometrioid adenocarcinoma of the endometrium characterized by the presence of a component with poorly differentiated carcinoma cells. C27844 Neoplastic Process Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component C1336915 Malignant Uterine_Corpus_Endometrioid_Adenocarcinoma_with_a_Poorly_Differentiated_Carcinomatous_Component Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component A primary endometrioid adenocarcinoma of the endometrium characterized by the presence of a component with undifferentiated malignant cells. C27845 Neoplastic Process Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component C1336916 Malignant Uterine_Corpus_Endometrioid_Adenocarcinoma_with_an_Undifferentiated_Carcinomatous_Component Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component A primary endometrioid adenocarcinoma of the endometrium characterized by the presence of numerous finger-like villi lined by neoplastic columnar cells. C27846 Neoplastic Process Villoglandular Endometrial Endometrioid Adenocarcinoma C1336962 GDC Malignant Villoglandular_Uterine_Corpus_Endometrioid_Adenocarcinoma Endometrioid adenocarcinoma, villoglandular Endometrioid adenocarcinoma, villoglandular Villoglandular Endometrial Endometrioid Adenocarcinoma Villoglandular Endometrial Endometrioid Adenocarcinoma An endometrioid adenocarcinoma arising from the endometrium, in which ciliated cells line the majority of the malignant glands. C27848 Neoplastic Process Endometrial Endometrioid Adenocarcinoma, Ciliated Variant C1266058 GDC 8383/3 Malignant Uterine_Corpus_Endometrioid_Adenocarcinoma_Ciliated_Variant 8383/3 Endometrioid adenocarcinoma, ciliated cell variant Ciliated Uterine Corpus Endometrioid Adenocarcinoma Endometrial Endometrioid Adenocarcinoma, Ciliated Variant Endometrioid adenocarcinoma, ciliated cell variant Endometrial Endometrioid Adenocarcinoma, Ciliated Variant A primary endometrioid adenocarcinoma of the endometrium characterized by the presence of eosinophilic malignant glandular epithelial cells. C27849 Neoplastic Process Oxyphilic Endometrial Endometrioid Adenocarcinoma C1518768 Malignant Oxyphilic_Uterine_Corpus_Endometrioid_Adenocarcinoma Oxyphilic Endometrial Endometrioid Adenocarcinoma Oxyphilic Endometrial Endometrioid Adenocarcinoma A primary endometrioid adenocarcinoma of the endometrium characterized by the presence of spindled malignant epithelial cells. C27850 Neoplastic Process Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells C1336913 Malignant Uterine_Corpus_Endometrioid_Adenocarcinoma_with_Spindled_Epithelial_Cells Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells Sarcomatoid Uterine Corpus Endometrioid Adenocarcinoma Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells A Burkitt lymphoma with plasmacytoid differentiation occurring in HIV-positive patients. C27857 Neoplastic Process AIDS-Related Burkitt Lymphoma with Plasmacytoid Differentiation C1336922 Malignant V-ABL_Gene AIDS-Related Burkitt Lymphoma with Plasmacytoid Differentiation AIDS-Related Burkitt's Lymphoma with Plasmacytoid Differentiation AIDS-Related Burkitt Lymphoma with Plasmacytoid Differentiation A plasmablastic lymphoma in a patient with acquired immunodeficiency syndrome. C27859 Neoplastic Process AIDS-Related Plasmablastic Lymphoma C1332055 Malignant AIDS-Related_Plasmablastic_Lymphoma AIDS-Related Plasmablastic Lymphoma AIDS-Related Plasmablastic Lymphoma Bladder non-invasive papillary urothelial carcinoma characterized by minimal cytologic atypia and infrequent mitotic figures (usually limited to the lower half of the tumor). This type of carcinoma recurs frequently, may invade the bladder wall, and has a low risk of progression. C27875 Neoplastic Process Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade C1518006 CPTAC CTRP Malignant Low-Grade_Papillary_Urothelial_Carcinoma Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade Non-Invasive Bladder Papillary Urothelial Carcinoma, Low Grade Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade Bladder non-invasive papillary urothelial carcinoma characterized by marked architectural and cytologic abnormalities and frequent mitotic figures (at all levels of the urothelium). C27876 Neoplastic Process Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade C1512434 CPTAC Malignant High-Grade_Papillary_Urothelial_Carcinoma Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade Non-Invasive Bladder Papillary Urothelial Carcinoma, High Grade Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade Marked thickening of the bladder urothelium with minimal or absent cytologic atypia and absence of true papillary formations. It is found most commonly on routine follow-up cystoscopy in patients with a history of papillary urothelial neoplasms. (WHO 2016) C27880 Neoplastic Process Bladder Urothelial Proliferation of Uncertain Malignant Potential CL938072 Uncertain Malignant Potential Intraurothelial_Neoplasia Bladder Urothelial Proliferation of Uncertain Malignant Potential Bladder Urothelial Proliferation of Uncertain Malignant Potential Intraurothelial neoplasia characterized by dysplastic changes which are not severe enough to warrant the diagnosis of bladder carcinoma in situ. C27882 Neoplastic Process Bladder Urothelial Dysplasia C1521918 Undetermined Low-Grade_Intraurothelial_Neoplasia Bladder Low Grade Intraurothelial Neoplasia Bladder Urothelial Dysplasia Low-Grade Bladder Intraurothelial Neoplasia Bladder Urothelial Dysplasia A benign or malignant neoplasm that arises from the urothelial lining of the urinary tract and is characterized by papillary formations. C27883 Neoplastic Process Papillary Urothelial Neoplasm C1335329 Undetermined Papillary_Urothelial_Neoplasm Papillary Transitional Cell Neoplasm of the Urinary Tract Papillary Urothelial Neoplasm Urinary Tract Papillary Transitional Cell Neoplasm Papillary Urothelial Neoplasm A papillary urothelial neoplasm that arises from the urinary bladder. The papillary structures exhibit minimal architectural distortion and minimal atypia. Mitoses are infrequent. Patients are at an increased risk of developing new papillary lesions. Occasionally, the new lesions are urothelial carcinomas. C27884 Neoplastic Process Bladder Papillary Urothelial Neoplasm of Low Malignant Potential C1266010 8130/1 Undetermined Papillary_Urothelial_Neoplasm_of_Low_Malignant_Potential Bladder PUNLMP Bladder Papillary Neoplasm of Low Malignant Potential Bladder Papillary Transitional Cell Neoplasm of Low Malignant Potential Bladder Papillary Urothelial Neoplasm of Low Malignant Potential Bladder Papillary Urothelial Neoplasm of Low Malignant Potential An invasive urothelial carcinoma that arises from the urinary bladder urothelium. C27885 Neoplastic Process Infiltrating Bladder Urothelial Carcinoma Invasive Bladder Urothelial Carcinoma C1334281 CTRP Malignant Invasive_Urothelial_Transitional_Cell_Carcinoma Infiltrating Bladder Urothelial Carcinoma Infiltrating Transitional Cell Carcinoma of the Urinary Bladder Invasive Bladder Transitional Cell Carcinoma Invasive Bladder Urothelial Carcinoma Invasive Transitional Cell Carcinoma of the Urinary Bladder Invasive Bladder Urothelial Carcinoma A papillary renal cell carcinoma characterized by the presence of papillae covered by small cells with scant amount of cytoplasm. The cells are arranged in a single layer on the basement membrane of the papillae. C27886 Neoplastic Process Type 1 Papillary Renal Cell Carcinoma Type 1 Papillary Renal Cell Carcinoma C1336839 CTRP GDC Malignant Type_1_Papillary_Renal_Cell_Carcinoma Type 1 Type 1 Papillary Renal Cell Cancer Type 1 Papillary Renal Cell Carcinoma Type 1 Papillary Renal Cell Carcinoma A papillary renal cell carcinoma characterized by the presence of papillae covered by cells of a higher nuclear grade as compared to type 1 papillary renal cell carcinoma. The cells have eosinophilic cytoplasm and pseudostratified nuclei. C27887 Neoplastic Process Type 2 Papillary Renal Cell Carcinoma Type 2 Papillary Renal Cell Carcinoma C1336840 CTRP GDC Malignant Type_2_Papillary_Renal_Cell_Carcinoma Type 2 Type 2 Papillary Renal Cell Cancer Type 2 Papillary Renal Cell Carcinoma Type 2 Papillary Renal Cell Carcinoma A variant of chromophobe renal cell carcinoma. It is characterized by the presence of large pale cells with thickened cell membranes. C27888 Neoplastic Process Classic Variant of Chromophobe Renal Cell Carcinoma C1333062 Malignant Classic_Variant_of_Chromophobe_Renal_Cell_Carcinoma Classic Variant of Chromophobe Renal Cell Carcinoma Classic Variant of Chromophobe Renal Cell Carcinoma A variant of chromophobe renal cell carcinoma in which more than 80% of the malignant cells have granular, eosinophilic cytoplasm. C27889 Neoplastic Process Eosinophilic Variant of Chromophobe Renal Cell Carcinoma C1333405 Malignant Eosinophilic_Variant_of_Chromophobe_Renal_Cell_Carcinoma Eosinophilic Variant of Chromophobe Renal Cell Carcinoma Eosinophilic Variant of Chromophobe Renal Cell Carcinoma A papillary renal cell carcinoma that occurs in a patient who does not have a family history of papillary renal cell carcinoma nor is a carrier of an inherited DNA change that would increase the risk of developing this carcinoma. C27890 Neoplastic Process Sporadic Papillary Renal Cell Carcinoma C1336078 Malignant Sporadic_Papillary_Renal_Cell_Carcinoma Sporadic Papillary Renal Cell Carcinoma Sporadic Papillary Renal Cell Carcinoma A group of renal cell carcinomas characterized by the presence of different translocations involving the chromosome Xp11.2. These translocations result in the creation of gene fusions involving the TFE3 gene. Patients are usually children and young adults. Morphologically, the malignant epithelial cells form papillary patterns. C27891 Neoplastic Process Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions TFE3-Rearranged Renal Cell Carcinoma C1337036 CTRP Cellosaurus 0000/0 Malignant Xp11_Translocation-Related_Renal_Cell_Carcinoma Renal Cell Cancer Associated with Xp11.2 Translocations/TFE3 Gene Fusions Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions TFE3-Rearranged Renal Cell Carcinoma Xp11 Translocation Renal Cell Carcinoma Xp11.2 Translocation-Related Renal Cell Carcinoma tRCC TFE3-Rearranged Renal Cell Carcinoma A high grade carcinoma of the kidney. It is not a distinct clinicopathological entity and includes a diverse group of renal cell carcinomas which have been transformed from a lower to a higher grade. C27893 Neoplastic Process Sarcomatoid Renal Cell Carcinoma Sarcomatoid Renal Cell Carcinoma C1266043 CTEP CTRP Cellosaurus GDC 8318/3 Malignant Sarcomatoid_Renal_Cell_Carcinoma 8318/3 Renal cell carcinoma, sarcomatoid Renal cell carcinoma, spindle cell RCC w/ sarcomatoid features Renal Cell Carcinoma, Sarcomatoid Renal cell carcinoma with sarcomatoid features Renal cell carcinoma, sarcomatoid Sarcomatoid Renal Cell Cancer Sarcomatoid Renal Cell Carcinoma Sarcomatoid Renal Cell Carcinoma A T-cell lymphoproliferative disorder with uncertain malignant potential. A representative example is lymphomatoid papulosis. C27897 Neoplastic Process T-Cell Proliferation of Uncertain Malignant Potential C1336550 Uncertain Malignant Potential T-Cell_Proliferation_of_Uncertain_Malignant_Potential T-Cell Proliferation of Uncertain Malignant Potential T-Cell Proliferation of Uncertain Malignant Potential The reemergence of a small round cell tumor with neural differentiation after a period of remission. C27899 Neoplastic Process Recurrent Peripheral Primitive Neuroectodermal Tumor Recurrent Peripheral Primitive Neuroectodermal Tumor C1335719 CTRP Malignant Recurrent_Peripheral_Primitive_Neuroectodermal_Tumor Recurrent Peripheral Primitive Neuroectodermal Tumor Recurrent Peripheral Primitive Neuroectodermal Tumor The reemergence of Askin tumor after a period of remission. C27900 Neoplastic Process Recurrent Askin Tumor CL448482 Malignant Recurrent_Askin_s_Tumor Recurrent Askin Tumor Recurrent Askin's Tumor Recurrent Askin Tumor A small round cell tumor confined to a specific area of the thoracic cavity without evidence of spread to other anatomic sites. C27902 Neoplastic Process Localized Askin Tumor C1321778 Malignant Localized_Askin_s_Tumor Localized Askin Tumor Localized Askin's Tumor Localized Askin Tumor A small round cell tumor with neural differentiation, confined to a specific site without evidence of spread to other anatomic sites. C27903 Neoplastic Process Localized Peripheral Primitive Neuroectodermal Tumor C1334408 Malignant Localized_Peripheral_Primitive_Neuroectodermal_Tumor Localized Peripheral Primitive Neuroectodermal Tumor Localized Peripheral Primitive Neuroectodermal Tumor An aggressive malignant smooth muscle neoplasm, arising from the retroperitoneum. It is characterized by a proliferation of neoplastic spindle cells. C27904 Neoplastic Process Retroperitoneal Leiomyosarcoma C2187547 Cellosaurus Malignant Retroperitoneal_Leiomyosarcoma Retroperitoneal Leiomyosarcoma Retroperitoneal Leiomyosarcoma An invasive prostate adenocarcinoma characterized by the presence of well differentiated malignant glandular epithelial components. C27905 Neoplastic Process Well Differentiated Prostate Adenocarcinoma C1337020 Malignant Well_Differentiated_Prostate_Adenocarcinoma Well Differentiated Prostate Adenocarcinoma Well Differentiated Prostate Adenocarcinoma An invasive prostate adenocarcinoma characterized by the presence of malignant cells exhibiting moderate differentiation. C27906 Neoplastic Process Moderately Differentiated Prostate Adenocarcinoma C1334792 Malignant Moderately_Differentiated_Prostate_Adenocarcinoma Moderately Differentiated Prostate Adenocarcinoma Moderately Differentiated Prostate Adenocarcinoma A lymphoproliferative disorder composed of neoplastic B-cells. It includes B-cell non-Hodgkin lymphomas, B-cell leukemias, plasma cell neoplasms, and B-cell proliferations of uncertain malignant potential. C27907 Neoplastic Process B-Cell Neoplasm C1332362 CPTAC Cellosaurus Undetermined B-Cell_Lymphocytic_Neoplasm B-Cell Neoplasm B-Cell Neoplasm A group of neoplasms composed of T-lymphocytes and/or NK-cells. C27908 Neoplastic Process T-Cell and NK-Cell Neoplasm C1336554 Undetermined T-Cell_and_NK-Cell_Neoplasm T-Cell Neoplasm T-Cell and NK-Cell Neoplasm T-Cell and NK-Cell Neoplasm A group of neoplasms composed of T-lymphocytes with a mature (peripheral/post-thymic) immunophenotypic profile and/or NK-cells. C27909 Neoplastic Process Mature T-Cell and NK-Cell Neoplasm Mature T-Cell and NK-Cell Neoplasm C1334640 CTRP Undetermined Mature_T-Cell_and_NK-Cell_Neoplasm Mature T-Cell Neoplasm Mature T-Cell and NK-Cell Neoplasm Mature T-Cell and NK-Cell Neoplasm A neoplasm that arises from mature B-lymphocytes or plasma cells. Representative examples include mature B-cell non-Hodgkin lymphomas, chronic lymphocytic leukemia, hairy cell leukemia, plasma cell neoplasms, and B-cell proliferations of uncertain malignant potential. C27910 Neoplastic Process Mature B-Cell Neoplasm C1334633 Undetermined Mature_B-Cell_Lymphocytic_Neoplasm Mature B-Cell Lymphocytic Neoplasm Mature B-Cell Neoplasm Mature B-Cell Neoplasm An indolent, mature B-cell neoplasm composed of small, round B-lymphocytes. When the bone marrow and peripheral blood are involved, the term chronic lymphocytic leukemia is used. The term small lymphocytic lymphoma is restricted to cases which do not show leukemic involvement of the bone marrow and peripheral blood. C27911 Neoplastic Process Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma C1302547 GDC An indolent (slow-growing) cancer in which immature lymphocytes (white blood cells) are found in the blood and bone marrow and/or in the lymph nodes. Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are the same disease, but in CLL cancer cells are found mostly in the blood and bone marrow. In SLL cancer cells are found mostly in the lymph nodes. Chronic lymphocytic leukemia/small lymphocytic lymphoma is a type of non-Hodgkin lymphoma. 9823/3 Malignant Chronic_Lymphocytic_Leukemia_Small_Lymphocytic_Lymphoma 9823/3 B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma B-cell lymphocytic leukemia/small lymphocytic lymphoma B-cell lymphocytic leukemia/small lymphocytic lymphoma CLL/SLL Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma chronic lymphocytic leukemia/small lymphocytic lymphoma Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Acute myeloid leukemias, myelodysplastic syndromes, and myelodysplastic/myeloproliferative neoplasms arising as a result of the mutagenic effect of chemotherapy agents and/or radiation that are used for the treatment of neoplastic or non-neoplastic disorders. C27912 Neoplastic Process Myeloid Neoplasm Post Cytotoxic Therapy C1292776 GDC NICHD PCDC Acute myeloid leukemias, myelodysplastic syndromes, and myelodysplastic/myeloproliferative neoplasms arising as a result of the mutagenic effect of chemotherapy agents and/or radiation that are used for the treatment of neoplastic or non-neoplastic disorders. 9920/3 Malignant Therapy-Related_Acute_Myeloid_Leukemia_and_Myelodysplastic_Syndrome 9920/3 Therapy related myeloid neoplasm Therapy-related myeloid neoplasm Acute Myeloid Leukaemias and Myelodysplastic Syndromes, Therapy-Related Myeloid Neoplasm Post Cytotoxic Therapy Therapy related myeloid neoplasm Therapy-Related AML and MDS Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome Therapy-Related Myeloid Neoplasm Therapy-related Myeloid Neoplasms Myeloid Neoplasm Post Cytotoxic Therapy Acute myeloid leukemias and myelodysplastic syndromes arising as a result of the mutagenic effect of alkylating agents that are used for the treatment of malignant tumors. Patients usually develop a myelodysplastic syndrome which may evolve to a higher grade myelodysplastic syndrome or acute myeloid leukemia. A minority of patients present with an acute myeloid leukemia. Clonal cytogenetic abnormalities are frequently present and usually are unbalanced translocations or deletions of chromosomes 5 and 7. Patients with acute myeloid leukemia usually do not respond to treatment and have an unfavorable clinical outcome. C27913 Neoplastic Process Alkylating Agent-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome C1332234 Malignant Alkylating_Agent-Related_Acute_Myeloid_Leukemia_and_Myelodysplastic_Syndrome Alkylating Agent Related Acute Myeloid Leukemia and Myelodysplastic Syndrome Alkylating Agent-Related AML and MDS Alkylating Agent-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome Alkylating Agent-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome A clinical variant of Burkitt lymphoma that occurs throughout the world. It affects both children and adults and is more frequently seen in males. C27914 Neoplastic Process Sporadic Burkitt Lymphoma C1336077 GDC Malignant Sporadic_Burkitt_s_Lymphoma Sporadic, adult Sporadic, pediatric Sporadic Burkitt Lymphoma Sporadic Burkitt's Lymphoma Sporadic Burkitt Lymphoma Burkitt lymphoma in a patient with immunodeficiency. C27915 Neoplastic Process Immunodeficiency-Related Burkitt Lymphoma C1334158 GDC Malignant Immunodeficiency-Related_Burkitt_s_Lymphoma Immunodeficiency-associated, adult Immunodeficiency-associated, pediatric Immunodeficiency Associated Burkitt Lymphoma Immunodeficiency Associated Burkitt's Lymphoma Immunodeficiency Related Burkitt Lymphoma Immunodeficiency Related Burkitt's Lymphoma Immunodeficiency-Associated Burkitt Lymphoma Immunodeficiency-Associated Burkitt's Lymphoma Immunodeficiency-Related Burkitt Lymphoma Immunodeficiency-Related Burkitt's Lymphoma Immunodeficiency-Related Burkitt Lymphoma An invasive prostate adenocarcinoma characterized by the presence of poorly differentiated malignant cells. C27916 Neoplastic Process Poorly Differentiated Prostate Adenocarcinoma C1335446 Malignant Poorly_Differentiated_Prostate_Adenocarcinoma Poorly Differentiated Prostate Adenocarcinoma Poorly Differentiated Prostate Adenocarcinoma A squamous cell carcinoma of the skin that arises from burn scars. It usually manifests between 20 and 40 years after the original burn. C27918 Neoplastic Process Old Burn Scar-Related Skin Squamous Cell Carcinoma C1335106 Malignant Old_Burn_Scar-Related_Skin_Squamous_Cell_Carcinoma Old Burn Scar-Related Skin Squamous Cell Carcinoma Old Burn Scar-Related Squamous Cell Carcinoma of Skin Old Burn Scar-Related Squamous Cell Carcinoma of the Skin Old Burn Scar-Related Skin Squamous Cell Carcinoma A cutaneous melanoma that arises in an old burn scar tissue. C27919 Neoplastic Process Old Burn Scar-Related Skin Melanoma Old Burn Scar-Related Cutaneous Melanoma C1335104 CTRP Malignant Old_Burn_Scar-Related_Melanoma_of_the_Skin Old Burn Scar-Related Cutaneous (Skin) Melanoma Old Burn Scar-Related Cutaneous Melanoma Old Burn Scar-Related Melanoma of Skin Old Burn Scar-Related Melanoma of the Skin Old Burn Scar-Related Skin Melanoma Old Burn Scar-Related Cutaneous Melanoma Cutaneous melanoma that arises following exposure to solar radiation. C27920 Neoplastic Process Solar Radiation-Related Skin Melanoma Solar Radiation-Related Cutaneous Melanoma C1336023 CTRP Malignant Solar_Radiation-Related_Melanoma_of_the_Skin Solar Radiation-Related Cutaneous (Skin) Melanoma Solar Radiation-Related Cutaneous Melanoma Solar Radiation-Related Melanoma of Skin Solar Radiation-Related Melanoma of the Skin Solar Radiation-Related Skin Melanoma Solar Radiation-Related Cutaneous Melanoma A squamous cell carcinoma arising in a skin site exposed to solar radiation. C27921 Neoplastic Process Solar Radiation-Related Skin Squamous Cell Carcinoma C1336024 Malignant Solar_Radiation-Related_Skin_Squamous_Cell_Carcinoma Solar Radiation-Related Skin Squamous Cell Carcinoma Solar Radiation-Related Skin Squamous Cell Carcinoma A hepatocellular carcinoma that develops following exposure to aflatoxin. C27922 Neoplastic Process Aflatoxins-Related Hepatocellular Carcinoma Aflatoxins-Related Hepatocellular Carcinoma C1332222 CTRP Malignant Aflatoxins-Related_Hepatocellular_Carcinoma Aflatoxins-Related Hepatocellular Cancer Aflatoxins-Related Hepatocellular Carcinoma Aflatoxins-Related Hepatocellular Carcinoma A hepatocellular carcinoma that develops following alcohol-induced injury of the liver parenchyma. C27924 Neoplastic Process Alcohol-Related Hepatocellular Carcinoma Alcohol-Related Hepatocellular Carcinoma C1332228 CPTAC CTRP Malignant Alcohol-Related_Hepatocellular_Carcinoma Alcohol-Related Hepatocellular Cancer Alcohol-Related Hepatocellular Carcinoma Liver Cancer Secondary to Alcohol Use Alcohol-Related Hepatocellular Carcinoma A carcinoma arising in the lung due to exposure to asbestos. C27925 Neoplastic Process Asbestos-Related Lung Carcinoma Asbestos-Related Lung Carcinoma C1332337 CTRP Malignant Asbestos-Related_Lung_Carcinoma Asbestos-Related Lung Cancer Asbestos-Related Lung Carcinoma Asbestos-Related Lung Carcinoma An esophageal carcinoma that results from alcohol consumption. The alcohol-related esophageal carcinomas are always of squamous cell type. There is no association between alcohol consumption and esophageal adenocarcinomas. C27928 Neoplastic Process Alcohol-Related Esophageal Squamous Cell Carcinoma Alcohol-Related Esophageal Squamous Cell Carcinoma C1332227 CTRP Malignant Alcohol-Related_Esophageal_Carcinoma Alcohol-Related Esophageal Carcinoma Alcohol-Related Esophageal Squamous Cell Cancer Alcohol-Related Esophageal Squamous Cell Carcinoma Alcohol-Related Esophageal Squamous Cell Carcinoma A carcinoma that arises from the larynx and is caused by alcohol abuse. C27929 Neoplastic Process Alcohol-Related Laryngeal Carcinoma Alcohol-Related Laryngeal Carcinoma C1332229 CTRP Malignant Alcohol-Related_Laryngeal_Carcinoma Alcohol-Related Laryngeal Carcinoma Alcohol-Related Laryngeal Throat Cancer Alcohol-Related Laryngeal Carcinoma Acute myeloid leukemia caused by benzene. C27931 Neoplastic Process Benzene-Related Acute Myeloid Leukemia C1332544 Malignant Benzene-Related_Acute_Myeloid_Leukemia Benzene-Related Acute Myeloid Leukemia Benzene-Related Acute Myeloid Leukemia A rare low-grade primary thymic adenocarcinoma characterized by a papillary growth pattern. C27937 Neoplastic Process Thymic Low Grade Papillary Adenocarcinoma C1335327 Malignant Papillary_Thymic_Carcinoma Papillary Carcinoma of Thymus Papillary Carcinoma of the Thymus Thymic Low Grade Papillary Adenocarcinoma Thymic Low-Grade Papillary Adenocarcinoma Thymic Papillary Adenocarcinoma Thymic Papillary Carcinoma Thymus Papillary Carcinoma Thymic Low Grade Papillary Adenocarcinoma A spectrum of non-invasive neoplastic lesions that arise from the terminal ductal lobular units of the breast. There is atypical small epithelial cell proliferation. Pagetoid involvement of the terminal ducts may or may not be present. In the minority of cases, there is a risk for subsequent development of invasive ductal or invasive lobular carcinoma. C27939 Neoplastic Process Lobular Neoplasia Breast Lobular Neoplasia C0861352 CTRP Undetermined Lobular_Neoplasia Breast LN Breast Lobular Neoplasia LIN LN Lobular Intraepithelial Neoplasia Lobular Neoplasia Breast Lobular Neoplasia A variant of gastrointestinal stromal tumor with ultrastructural features of neural differentiation. It is composed of spindle or epithelioid neoplastic cells. C27940 Neoplastic Process Gastrointestinal Autonomic Nerve Tumor C2931518 GDC Undetermined Gastrointestinal_Autonomic_Nerve_Tumor 8936/1 GANT Gastrointestinal autonomic nerve tumor GANT Gastrointestinal Autonomic Nerve Tumor Gastrointestinal Stromal Tumor with Neurogenic Differentiation Gastrointestinal autonomic nerve tumor Plexosarcoma Gastrointestinal Autonomic Nerve Tumor A neoplastic ductal proliferative lesion of the breast characterized by the formation of secondary lumens and prominent intraductal proliferation of a heterogeneous cellular population that may include epithelial cells, myoepithelial cells, or metaplastic apocrine cells. C27941 Neoplastic Process Breast Usual Ductal Hyperplasia C3532429 Undetermined Usual_Ductal_Breast_Hyperplasia Breast Hyperplasia without Atypia Breast Usual Ductal Hyperplasia Ductal Breast Hyperplasia of Usual Type Ordinary Intraductal Breast Hyperplasia UDH Usual Ductal Breast Hyperplasia Breast Usual Ductal Hyperplasia A group of non-invasive epithelial proliferations that occur in the ductal system of the breast. The vast majority of cases arise in the terminal ductal lobular units. This category includes atypical ductal hyperplasia, usual ductal hyperplasia, flat epithelial atypia, and ductal carcinoma in situ. There is an increased risk for subsequent development of invasive breast carcinoma. C27942 Neoplastic Process Breast Intraductal Proliferative Lesion C1334631 Undetermined Mammary_Intraepithelial_Neoplasia_Ductal_Type Breast Intraductal Proliferative Lesion DIN Ductal Intraepithelial Neoplasia Intraductal Proliferative Lesion Intraductal Proliferative Lesion of the Breast Mammary Intraepithelial Neoplasia, Ductal Type Breast Intraductal Proliferative Lesion A breast papilloma characterized by the presence of predominant sclerosing architectural features. C27944 Neoplastic Process Breast Sclerosing Papilloma C1335932 Benign Sclerosing_Breast_Papilloma Breast Sclerosing Papilloma Complex Sclerosing Papillary Lesion Complex Sclerosing Papillary Lesion of the Breast Sclerosing Breast Papilloma Breast Sclerosing Papilloma An adverse effect of a drug used therapeutically or diagnostically. C27955 Finding Drug Toxicity Drug Toxicity C0013221 CTRP Drug_Toxicity Drug Toxicity toxicity, drug Drug Toxicity C27962 Finding Radiation Toxicity Radiation Toxicity C0281224 CTRP Cellosaurus Radiation_Toxicity Radiation Toxicity toxicity, radiation Radiation Toxicity The adverse effect of some iatrogenic therapies. It is an accepted side effect in radiation therapy where the desired effect is to kill rapidly growing tumor cells. In the killing of tumor cells, other cells that are rapidly growing e.g hair, mucous membranes are also killed. C27988 Finding Cytotoxicity C0596402 Cytotoxicity Cytotoxicity Lytotoxicity Cytotoxicity The finding of bodily harm due to the poisonous effects of something. C27990 Finding Toxicity C0600688 Patient Code (Appendix B) FDA GDC The extent to which something is poisonous or harmful. Toxicity Toxicity TOX Toxicity toxicity Toxicity C27995 Sign or Symptom Urinary Tract Toxicity Urinary Tract Toxicity C0280953 CTRP Urinary_Tract_Toxicity Urinary Tract Toxicity toxicity, urinary tract Urinary Tract Toxicity C28008 Finding Irreversible Toxicity C0879537 Side effects that are caused by toxic substances or something harmful to the body and do not go away. Irreversible_Toxicity Irreversible Toxicity irreversible toxicity Irreversible Toxicity An intraepidermal squamous cell carcinoma involving the area of the nipple. C28292 Neoplastic Process Squamous Cell Carcinoma In Situ of the Nipple C1336080 Malignant Squamous_Cell_Carcinoma_In_Situ_of_the_Nipple Intraepidermal Squamous Carcinoma of Nipple Intraepidermal Squamous Carcinoma of the Nipple Nipple Intraepidermal Squamous Carcinoma Squamous Cell Carcinoma In Situ of Nipple Squamous Cell Carcinoma In Situ of the Nipple Squamous Cell Carcinoma In Situ of the Nipple A hepatocellular carcinoma that occurs during adulthood and has spread extensively to other anatomic sites or is no longer responding to treatment. C28302 Neoplastic Process Advanced Adult Hepatocellular Carcinoma Advanced Adult Hepatocellular Carcinoma C1706732 CTRP Malignant Advanced_Adult_Primary_Hepatocellular_Carcinoma Advanced Adult Hepatocellular Carcinoma Advanced Adult Hepatoma Advanced Hepatocellular Cancer Advanced Adult Hepatocellular Carcinoma A carcinoma that arises from the breast and has metastasized to the skin. C28311 Neoplastic Process Breast Carcinoma Metastatic in the Skin Metastatic Breast Carcinoma in the Skin C0935909 CTRP Cancer that has spread from the breast to the skin. Malignant Breast_Carcinoma_Metastatic_to_the_Skin Breast Carcinoma Metastatic in the Skin Breast Carcinoma Metastatic to the Skin Cutaneous Breast Cancer Metastatic Breast Cancer in the Skin Metastatic Breast Carcinoma in the Skin cutaneous breast cancer Metastatic Breast Carcinoma in the Skin A neuroendocrine tumor arising from the delta cells of the pancreas. It is characterized by the absence of a hormone-related clinical syndrome. C28333 Neoplastic Process Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor C1335311 Undetermined Pancreatic_Non-Functioning_Delta_Cell_Neoplasm Non-Functional Pancreatic Delta Cell NET Non-Functional Pancreatic Delta Cell Neuroendocrine Tumor Non-Functioning Pancreatic Delta Cell Neoplasm Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor Non-Functioning Pancreatic Delta Cell Tumor Nonfunctional Pancreatic Delta Cell Neuroendocrine Tumor Nonfunctioning Pancreatic Delta Cell Neuroendocrine Tumor Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor A usually malignant neuroendocrine tumor arising from the delta cells of the pancreas. It may be associated with inappropriate secretion of somatostatin and an associated clinical syndrome, or it may be hormonally inactive (non-functioning). C28396 Neoplastic Process Pancreatic Delta Cell Neuroendocrine Tumor C1335301 Undetermined Pancreatic_Delta_Cell_Neoplasm Pancreatic Delta Cell NET Pancreatic Delta Cell Neoplasm Pancreatic Delta Cell Neuroendocrine Tumor Pancreatic Delta Cell Tumor Pancreatic Delta Cell Neuroendocrine Tumor A carcinoma that arises in the area of the nipple. Representative examples include Paget disease and skin squamous cell carcinoma. C28432 Neoplastic Process Nipple Carcinoma Nipple Carcinoma C1334966 CTRP Malignant Nipple_Carcinoma Nipple Cancer Nipple Carcinoma Nipple Carcinoma A benign or malignant (primary or metastatic) neoplasm affecting the adrenal cortex. C2858 Neoplastic Process Adrenal Cortical Neoplasm C0001618 GDC Undetermined Adrenal_Cortex_Neoplasm 8370/0 Adrenal cortical tumor, NOS Adrenal Cortex Neoplasm Adrenal Cortex Tumor Adrenal Cortical Neoplasm Adrenocortical Neoplasm Adrenocortical Tumor Adrenal Cortical Neoplasm A benign or malignant (primary or metastatic) neoplasm affecting the adrenal glands. C2859 Neoplastic Process Adrenal Gland Neoplasm C0001624 Undetermined Adrenal_Gland_Neoplasm Adrenal Gland Neoplasm Adrenal Gland Tumor Adrenal Neoplasm Adrenal Neoplasms Adrenal Tumor Neoplasm of Adrenal Gland Neoplasm of the Adrenal Gland Tumor of Adrenal Gland Tumor of the Adrenal Gland Adrenal Gland Neoplasm A benign, testicular or ovarian tumor, derived from adrenal embryonic rest cells. It is composed of hyperplastic adrenal cortical tissue, and it is associated with congenital adrenal hyperplasia. C2860 Neoplastic Process Adrenal Rest Tumor C0001630 GDC 8671/0 Undetermined Adrenal_Rest_Neoplasm 8671/0 Adrenal rest tumor Adrenal Rest Neoplasm Adrenal Rest Tumor Adrenal rest tumor Adrenal Rest Tumor A chronic myeloproliferative neoplasm characterized by bone marrow fibrosis, proliferation of atypical megakaryocytes and granulocytes in the bone marrow, anemia, splenomegaly, and extramedullary hematopoiesis. (WHO, 2001) C2862 Neoplastic Process Primary Myelofibrosis Primary Myelofibrosis C0001815 CPTAC CTEP CTRP Cellosaurus GDC A progressive, chronic disease in which the bone marrow is replaced by fibrous tissue and blood is made in organs such as the liver and the spleen, instead of in the bone marrow. This disease is marked by an enlarged spleen and progressive anemia. 9961/3 Malignant Chronic_Idiopathic_Myelofibrosis 9961/3 Agnogenic myeloid metaplasia Megakaryocytic myelosclerosis Myelofibrosis with myeloid metaplasia Myelosclerosis with myeloid metaplasia Primary myelofibrosis AMM Agnogenic Myeloid Metaplasia Agnogenic myeloid metaplasia Idiopathic Bone Marrow Fibrosis Idiopathic Myelofibrosis Myelosclerosis with Myeloid Metaplasia Myelosclerosis with myeloid metaplasia PMF Primary Myelofibrosis Primary myelofibrosis agnogenic myeloid metaplasia idiopathic myelofibrosis myelosclerosis with myeloid metaplasia Primary Myelofibrosis A myelodysplastic syndrome characterized mainly by dysplasia of the erythroid series. Refractory anemia is uncommon. It is primarily a disease of older adults. The median survival exceeds 5 years. (WHO, 2001) C2872 Neoplastic Process Refractory Anemia Refractory Anemia C0002893 CPTAC CTRP Cellosaurus GDC mCode 9980/3 Malignant Refractory_Anemia 9980/3 Refractory anaemia, unspecified Refractory anemia Aregenerative Anemia RA Refractory Anemia Refractory anemia Refractory anemia, unspecified Refractory Anemia The lymph nodes around the subsegmental bronchi. C28745 Tissue Subsegmental Lymph Node C1515031 Subsegmental_Lymph_Node Subsegmental Lymph Node Subsegmental Lymph Node Station Subsegmental Lymph Node A benign or malignant neoplasm that affects the anal canal or anal margin. Representative examples of benign neoplasms include squamous papilloma and papillary hidradenoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and melanoma. C2877 Neoplastic Process Anal Neoplasm Anal Neoplasm C0003463 CTRP Undetermined Anal_Neoplasm Anal Neoplasm Anal Neoplasms, Benign and Malignant Anal Tumor Anal Tumors Anus Neoplasm Neoplasm of Anus Neoplasm of the Anus Tumor of Anus Tumor of the Anus Anal Neoplasm A benign or malignant sex cord-stromal tumor arising from the ovary. It is characterized by the presence of neoplastic Leydig cells. Signs and symptoms include hirsutism, menorrhagia and metrorrhagia. It may be associated with trisomy 8. C2880 Neoplastic Process Ovarian Sertoli-Leydig Cell Tumor C0003810 GDC NICHD A benign or malignant sex cord-stromal tumor arising from the ovary. It is characterized by the presence of neoplastic Leydig cells. It may be associated with trisomy 8. A rare type of ovarian tumor in which the tumor cells secrete a male sex hormone. This may cause virilization (the appearance of male physical characteristics in females). Undetermined Androblastoma 8631/1 Androblastoma, NOS Sertoli-Leydig cell tumor, NOS Androblastoma Arrhenoblastoma Ovarian Sertoli-Leydig Cell Neoplasm Ovarian Sertoli-Leydig Cell Tumor Sertoli-Leydig Cell Tumor Sertoli-Leydig Cell Tumor of Ovary Sertoli-Leydig Cell Tumor of the Ovary Sertoli-Leydig Neoplasm of Ovary Sertoli-Leydig Neoplasm of the Ovary Sertoli-Leydig cell tumor of the ovary androblastoma arrhenoblastoma Ovarian Sertoli-Leydig Cell Tumor A neoplasm that arises from the colon and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C2894 Neoplastic Process Benign Colon Neoplasm C0004991 CPTAC Benign Benign_Colon_Neoplasm Benign neoplasm of colon Benign Colon Neoplasm Benign Colon Tumor Benign Colonic Neoplasm Benign Colonic Tumor Benign Neoplasm of Colon Benign Neoplasm of the Colon Benign Tumor of Colon Benign Tumor of the Colon Benign Colon Neoplasm A neoplasm that arises from the ovary and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include serous cystadenoma, mucinous cystadenoma, clear cell adenofibroma, benign Brenner tumor, thecoma, and fibroma. C2895 Neoplastic Process Benign Ovarian Neoplasm C0004997 CPTAC Benign Benign_Ovarian_Neoplasm Benign neoplasm of ovary Benign neoplasm of unspecified ovary Benign Neoplasm of Ovary Benign Neoplasm of the Ovary Benign Ovarian Neoplasm Benign Ovarian Tumor Benign Tumor of Ovary Benign Tumor of the Ovary Benign Ovarian Neoplasm A neoplasm that arises from the skin and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C2896 Neoplastic Process Benign Skin Neoplasm Benign Skin Neoplasm C0004998 CPTAC CTRP Benign Benign_Skin_Neoplasm Benign neoplasm of skin, site unspecified Benign Cutaneous Neoplasm Benign Cutaneous Tumor Benign Neoplasm of Skin Benign Neoplasm of the Skin Benign Skin Neoplasm Benign Skin Tumor Benign Tumor of Skin Benign Tumor of the Skin Skin Neoplasms, Benign Benign Skin Neoplasm A benign or malignant neoplasm that affects the intrahepatic or extrahepatic bile ducts. Representative examples of benign neoplasms include bile duct adenoma and extrahepatic bile duct lipoma. Representative examples of malignant neoplasms include intrahepatic and extrahepatic cholangiocarcinoma. C2898 Neoplastic Process Bile Duct Neoplasm Bile Duct Neoplasm C0005396 CTRP Undetermined Bile_Duct_Neoplasm Bile Duct Neoplasm Bile Duct Tumor Intrahepatic and Extrahepatic Bile Duct Neoplasm Intrahepatic and Extrahepatic Bile Duct Tumor Bile Duct Neoplasm A benign or malignant, primary or metastatic neoplasm of the bladder. C2901 Neoplastic Process Bladder Neoplasm Bladder Neoplasm C0005695 CPTAC CTRP Undetermined Bladder_Neoplasm Neoplasm of uncertain behavior of bladder Neoplasm of unspecified nature of bladder Bladder Neoplasm Bladder Tumor Bladder Tumors Neoplasm of Bladder Neoplasm of Urinary Bladder Neoplasm of the Bladder Neoplasm of the Urinary Bladder Tumor of Bladder Tumor of Urinary Bladder Tumor of the Bladder Tumor of the Urinary Bladder Urinary Bladder Neoplasm Urinary Bladder Neoplasms Urinary Bladder Tumor Urinary Bladder Tumors Bladder Neoplasm Intraepidermal squamous cell carcinoma, confined to the epidermis. There is no evidence of invasion. C2906 Neoplastic Process Skin Squamous Cell Carcinoma In Situ Skin Squamous Cell Carcinoma In Situ C2314897 CTRP Malignant Skin_Squamous_Cell_Carcinoma_in_situ Intraepidermal Squamous Cell Carcinoma Skin Squamous Cell Cancer In Situ Skin Squamous Cell Carcinoma In Situ Squamous Cell Carcinoma in situ of Skin Squamous Cell Carcinoma in situ of the Skin Skin Squamous Cell Carcinoma In Situ A benign or malignant neoplasm that arises from or metastasizes to the brain. C2907 Neoplastic Process Brain Neoplasm Brain Tumor Brain Neoplasm C0006118 CPTAC CTRP Cellosaurus MedDRA NICHD mCode An abnormal intracranial solid mass or growth. The growth of abnormal cells in the tissues of the brain. Brain tumors can be benign (not cancer) or malignant (cancer). Undetermined Brain_Neoplasm Brain tumor Neoplasm of uncertain or unknown behaviour: Brain, unspecified Neoplasm of unspecified behavior of brain Neoplasm of unspecified nature of brain Brain Neoplasm Brain Neoplasms Brain Tumor Neoplasm of Brain Neoplasm of the Brain Neoplasm of unspecified behavior of brain Tumor of Brain Tumor of the Brain brain tumor Brain Neoplasm A benign or malignant neoplasm of the breast parenchyma. It can originate from the ducts, lobules or the breast adipose tissue. Breast neoplasms are much more common in females than males. C2910 Neoplastic Process Breast Neoplasm Breast Neoplasm C1458155 Patient Code (Appendix B) CPTAC CTRP FDA Undetermined Breast_Neoplasm Neoplasm of uncertain behavior of breast Neoplasm of unspecified nature of breast Breast Neoplasm Breast Tumor Neoplasm of Breast Neoplasm of the Breast Tumor of Breast Tumor of the Breast Breast Neoplasm A highly aggressive lymphoma composed of monomorphic medium-sized B-cells with basophilic cytoplasm and numerous mitotic figures. It is often associated with the presence of Epstein-Barr virus (EBV) and is commonly seen in AIDS patients. Three morphologic variants are recognized: classical Burkitt lymphoma, Burkitt lymphoma with plasmacytoid differentiation, and atypical Burkitt/Burkitt-like lymphoma. All cases express the MYC translocation [t(8;14)]. (WHO, 2001) C2912 Neoplastic Process Burkitt Lymphoma Burkitt Lymphoma C0006413 CPTAC CTRP Cellosaurus GDC mCode An aggressive (fast-growing) type of B-cell non-Hodgkin lymphoma that occurs most often in children and young adults. The disease may affect the jaw, central nervous system, bowel, kidneys, ovaries, or other organs. There are three main types of Burkitt lymphoma (sporadic, endemic, and immunodeficiency related). Sporadic Burkitt lymphoma occurs throughout the world, and endemic Burkitt lymphoma occurs in Africa. Immunodeficiency-related Burkitt lymphoma is most often seen in AIDS patients. 9687/3 Malignant Burkitt_s_Lymphoma 9687/3 Burkitt lymphoma Burkitt lymphoma, NOS Burkitt lymphoma, NOS (Includes all variants) Burkitt lymphoma, extranodal and solid organ sites Burkitt lymphoma, intra-abdominal lymph nodes Burkitt lymphoma, lymph nodes of head, face, and neck Burkitt lymphoma, lymph nodes of multiple sites Burkitt lymphoma, unspecified site Burkitt tumor Burkitt's tumor or lymphoma Burkitt's tumor or lymphoma involving intra-abdominal lymph nodes Burkitt's tumor or lymphoma involving lymph nodes of axilla and upper limb Burkitt's tumor or lymphoma involving lymph nodes of head, face, and neck Malignant lymphoma, small noncleaved, Burkitt type Malignant lymphoma, undifferentiated, Burkitt type NHL, Burkitt lymphoma (BL) Burkitt Lymphoma Burkitt lymphoma, unspecified site Burkitt's Lymphoma Burkitt's lymphoma NHL, Burkitt lymphoma (BL) Small Non-Cleaved Cell Lymphoma, Burkitt's Type Burkitt Lymphoma A carcinoma that arises from the breast in females. It is the most common malignant tumor that affects females. C2918 Neoplastic Process Female Breast Carcinoma Female Breast Carcinoma C0007104 CTRP Malignant Female_Breast_Carcinoma Breast Carcinoma, Female Carcinoma of Female Breast Carcinoma of the Female Breast Female Breast Cancer Female Breast Carcinoma Mammary Carcinoma of Female Breast Mammary Carcinoma of the Female Breast Female Breast Carcinoma An adenocarcinoma arising from the prostate gland. It is one of the most common malignant tumors afflicting men. The majority of adenocarcinomas arise in the peripheral zone and a minority occurs in the central or the transitional zone of the prostate gland. Grading of prostatic adenocarcinoma predicts disease progression and correlates with survival. Several grading systems have been proposed, of which the Gleason system is the most commonly used. Gleason sums of 2 to 4 represent well-differentiated disease, 5 to 7 moderately differentiated disease and 8 to 10 poorly differentiated disease. Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic adenocarcinoma. Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy. Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease. C2919 Neoplastic Process Prostate Adenocarcinoma Prostate Adenocarcinoma C0007112 CTRP OORO Malignant Prostate_Adenocarcinoma Adenocarcinoma of Prostate Adenocarcinoma of the Prostate PRAD Prostate Adenocarcinoma Prostate Adenocarcinoma A primary or metastatic malignant neoplasm involving the skin. Primary malignant skin neoplasms most often are carcinomas (either basal cell or squamous cell carcinomas) or melanomas. Metastatic malignant neoplasms to the skin include carcinomas and lymphomas. C2920 Neoplastic Process Malignant Skin Neoplasm Malignant Skin Neoplasm C0007114 CPTAC CTEP CTRP GDC mCode Cancer that forms in the tissues of the skin. There are several types of skin cancer. Skin cancer that forms in melanocytes (skin cells that make pigment) is called melanoma. Skin cancer that forms in the lower part of the epidermis (the outer layer of the skin) is called basal cell carcinoma. Skin cancer that forms in squamous cells (flat cells that form the surface of the skin) is called squamous cell carcinoma. Skin cancer that forms in neuroendocrine cells (cells that release hormones in response to signals from the nervous system) is called neuroendocrine carcinoma of the skin. Most skin cancers form in older people on parts of the body exposed to the sun or in people who have weakened immune systems. Malignant Malignant_Skin_Neoplasm Malignant neoplasm: Malignant neoplasm of skin, unspecified Malignant neoplasm: Skin of ear and external auricular canal Malignant neoplasm: Skin of eyelid, including canthus Malignant neoplasm: Skin of lower limb, including hip Malignant neoplasm: Skin of other and unspecified parts of face Malignant neoplasm: Skin of scalp and neck Malignant neoplasm: Skin of trunk Malignant neoplasm: Skin of upper limb, including shoulder Other and unspecified malignant neoplasm of scalp and skin of neck Other and unspecified malignant neoplasm of skin Other and unspecified malignant neoplasm of skin of lower limb, including hip Other and unspecified malignant neoplasm of skin of other and unspecified parts of face Other and unspecified malignant neoplasm of skin of trunk, except scrotum Other and unspecified malignant neoplasm of skin of upper limb, including shoulder Other and unspecified malignant neoplasm of skin, site unspecified Other malignant neoplasms of skin Other specified malignant neoplasm of overlapping sites of skin Other specified malignant neoplasm of scalp and skin of neck Other specified malignant neoplasm of skin, unspecified Skin Cancer Unspecified malignant neoplasm of scalp and skin of neck Unspecified malignant neoplasm of skin of unspecified part of face Unspecified malignant neoplasm of skin, site unspecified Unspecified malignant neoplasm of skin, unspecified Malignant Neoplasm of Skin Malignant Neoplasm of the Skin Malignant Skin Neoplasm Malignant Skin Tumor Malignant Tumor of Skin Malignant Tumor of the Skin Melanoma and Non-Melanoma Skin Cancer Skin Cancer Skin Cancer, Including Melanoma Skin Neoplasm, Malignant Skin cancer, NOS Unspecified malignant neoplasm of skin, unspecified skin cancer Malignant Skin Neoplasm The most frequently seen skin cancer. It arises from basal cells of the epidermis and pilosebaceous units. Clinically it is divided into the following types: nodular, ulcerative, superficial, multicentric, erythematous, and sclerosing or morphea-like. More than 95% of these carcinomas occur in patients over 40. They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck and the remaining 15% on the trunk and extremities. Basal cell carcinoma usually grows in a slow and indolent fashion. However, if untreated, the tumor may invade the subcutaneous fat, skeletal muscle and bone. Distant metastases are rare. Excision, curettage and irradiation cure most basal cell carcinomas. C2921 Neoplastic Process Skin Basal Cell Cancer Skin Basal Cell Carcinoma C0007117 CPTAC CTEP CTRP Cellosaurus GDC Cancer that begins in the lower part of the epidermis (the outer layer of the skin). It may appear as a small white or flesh-colored bump that grows slowly and may bleed. Basal cell cancers are usually found on areas of the body exposed to the sun. Basal cell cancers rarely metastasize (spread) to other parts of the body. They are the most common form of skin cancer. 8090/3 Malignant Basal_Cell_Carcinoma 8090/3 Basal Cell Cancer Basal Cell Carcinoma Basal cell carcinoma of skin of left eyelid, including canthus Basal cell carcinoma of skin of other and unspecified parts of face Basal cell carcinoma of skin of other part of trunk Basal cell carcinoma of skin of other parts of face Basal cell carcinoma of skin of right eyelid, including canthus Basal cell carcinoma of skin of trunk, except scrotum Basal cell carcinoma of skin of unspecified eyelid, including canthus Basal cell carcinoma of skin of unspecified parts of face Basal cell carcinoma of skin, site unspecified Basal cell carcinoma of skin, unspecified Basal cell carcinoma, NOS Basal cell epithelioma BCC Basal Cell Cancer Basal Cell Carcinoma Basal Cell Carcinoma of Skin Basal Cell Carcinoma of the Skin Basal Cell Epithelioma Basal Cell Skin Carcinoma Basal cell carcinoma Basal cell epithelioma Skin Basal Cell Cancer Skin Basal Cell Carcinoma basal cell cancer basal cell carcinoma Skin Basal Cell Carcinoma A basal cell carcinoma which displays squamous differentiation. The neoplastic cells have more abundant cytoplasm with more marked keratinization than typical basal cell carcinomas. It usually has a more aggressive clinical course compared to typical basal cell carcinoma, and it may produce regional or widespread metastases. C2922 Neoplastic Process Skin Basosquamous Cell Carcinoma C0007118 CDISC GDC A basal cell carcinoma (skin neoplasm) which displays squamous differentiation. 8094/3 8095/3 Malignant Basosquamous_Cell_Carcinoma 8094/3 8095/3 Basosquamous carcinoma Metatypical carcinoma Mixed basal-squamous cell carcinoma BASOSQUAMOUS TUMOR, MALIGNANT Basosquamous Carcinoma Basosquamous Cell Carcinoma Basosquamous carcinoma Skin Basosquamous Cell Carcinoma Skin Metatypical Basal Cell Carcinoma Skin Metatypical Carcinoma Skin Mixed Basal and Squamous Cell Carcinoma Skin Basosquamous Cell Carcinoma A solitary adenocarcinoma arising from the lung and measuring 3 cm or less in size. It is characterized by a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. It is usually a non-mucinous adenocarcinoma, but rarely may be mucinous. C2923 Neoplastic Process Minimally Invasive Lung Adenocarcinoma Minimally Invasive Lung Adenocarcinoma C2750265 CDISC CTEP CTRP Cellosaurus GDC A malignant lung neoplasm originating from the alveolar/bronchiolar epithelium. 8250/3 8251/3 Malignant Bronchiolo-Alveolar_Lung_Carcinoma 8250/3 8251/3 Alveolar adenocarcinoma Alveolar carcinoma Alveolar cell carcinoma Bronchiolar adenocarcinoma Bronchiolar carcinoma Bronchiolo-alveolar adenocarcinoma, NOS Bronchiolo-alveolar carcinoma, NOS Minimally invasive adenocarcinoma, NOS BAC Bronchioalveolar Adenocarcinoma of Lung Bronchioalveolar Adenocarcinoma of the Lung Bronchioalveolar Lung Carcinoma Bronchiolo-Alveolar Carcinoma of Lung Bronchiolo-Alveolar Carcinoma of the Lung Bronchiolo-Alveolar Lung Carcinoma Bronchioloalveolar Adenocarcinoma of Lung Bronchioloalveolar Adenocarcinoma of the Lung Bronchioloalveolar Carcinoma Bronchioloalveolar Lung Adenocarcinoma Bronchioloalveolar carcinoma CARCINOMA, BRONCHIOLOALVEOLAR, MALIGNANT Minimally Invasive Lung Adenocarcinoma Minimally Invasive Lung Adenocarcinoma A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS. C2924 Neoplastic Process Breast Ductal Carcinoma In Situ Ductal Breast Carcinoma In Situ Breast Ductal Carcinoma In Situ C0007124 CPTAC CTEP CTRP GDC mCode A noninvasive condition in which abnormal cells are found in the lining of a breast duct. The abnormal cells have not spread outside the duct to other tissues in the breast. In some cases, ductal carcinoma in situ may become invasive cancer and spread to other tissues, although it is not known at this time how to predict which lesions will become invasive. 8500/2 Malignant Ductal_Carcinoma_in_situ_of_the_Breast 8500/2 DCIS, NOS Ductal carcinoma in situ, NOS Intraductal adenocarcinoma, noninfiltrating, NOS Intraductal carcinoma in situ of left breast Intraductal carcinoma in situ of right breast Intraductal carcinoma in situ of unspecified breast Intraductal carcinoma, NOS Intraductal carcinoma, noninfiltrating, NOS Breast Ductal Carcinoma In Situ Breast Ductal Carcinoma In Situ, NOS DCIS DCIS, NOS Ductal Breast Carcinoma In Situ Ductal Carcinoma In Situ Ductal Carcinoma In Situ (DCIS) Ductal Carcinoma In Situ of Breast Ductal Carcinoma In Situ of the Breast Ductal carcinoma in situ Intraductal Breast Carcinoma Intraductal Carcinoma Intraductal Carcinoma of Breast Intraductal Carcinoma of the Breast Intraductal carcinoma in situ of breast Intraductal carcinoma in situ of unspecified breast Non-Infiltrating Ductal Adenocarcinoma of Breast Non-Infiltrating Ductal Adenocarcinoma of the Breast Non-Infiltrating Ductal Breast Adenocarcinoma Non-Infiltrating Ductal Breast Carcinoma Non-Infiltrating Ductal Carcinoma of Breast Non-Infiltrating Ductal Carcinoma of the Breast Non-Infiltrating Intraductal Adenocarcinoma Non-Infiltrating Intraductal Adenocarcinoma of Breast Non-Infiltrating Intraductal Adenocarcinoma of the Breast Non-Infiltrating Intraductal Breast Adenocarcinoma Non-Infiltrating Intraductal Carcinoma Non-Invasive Ductal Adenocarcinoma of Breast Non-Invasive Ductal Adenocarcinoma of the Breast Non-Invasive Ductal Breast Adenocarcinoma Non-Invasive Ductal Breast Carcinoma Non-Invasive Ductal Carcinoma of Breast Non-Invasive Ductal Carcinoma of the Breast Non-Invasive Intraductal Adenocarcinoma of Breast Non-Invasive Intraductal Adenocarcinoma of the Breast Non-Invasive Intraductal Breast Adenocarcinoma ductal carcinoma in situ intraductal carcinoma Breast Ductal Carcinoma In Situ A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy. C2926 Neoplastic Process Non-Small Cell Lung Carcinoma Lung Non-Small Cell Carcinoma C0007131 CPTAC CTEP CTRP Cellosaurus A group of lung cancers that are named for the kinds of cells found in the cancer and how the cells look under a microscope. The three main types of non-small cell lung cancer are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma. Non-small cell lung cancer is the most common kind of lung cancer. Malignant Non-Small_Cell_Lung_Carcinoma Lung Non-Small Cell Carcinoma NSCLC NSCLC - Non-Small Cell Lung Cancer Non Small Cell Lung Cancer NOS Non-Small Cell Cancer of Lung Non-Small Cell Cancer of the Lung Non-Small Cell Carcinoma of Lung Non-Small Cell Carcinoma of the Lung Non-Small Cell Lung Cancer Non-Small Cell Lung Carcinoma Non-small cell lung cancer, NOS non-small cell lung cancer Lung Non-Small Cell Carcinoma A parasympathetic paraganglioma arising from paraganglia adjacent to or in the bifurcation of the common carotid artery. Most patients present with a slow growing, painless mass in the neck. C2932 Neoplastic Process Carotid Body Paraganglioma Carotid Body Paraganglioma C1866553 CTRP GDC 8692/1 Undetermined Carotid_Body_Paraganglioma 8693/1 Carotid body paraganglioma Carotid body tumor Chemodectoma Carotid Body Chemodectoma Carotid Body Paraganglioma Carotid Body Tumor Carotid body paraganglioma Carotid body tumor Chemodectoma Paraganglioma of Carotid Body Paraganglioma of the Carotid Body Tumor of Carotid Body Tumor of the Carotid Body Carotid Body Paraganglioma A benign or malignant (primary or metastatic) tumor involving the cerebellum. C2935 Neoplastic Process Cerebellar Neoplasm C0007762 Undetermined Cerebellar_Neoplasm Cerebellar Neoplasm Cerebellar Tumor Neoplasm of Cerebellum Neoplasm of the Cerebellum Tumor of Cerebellum Tumor of the Cerebellum Cerebellar Neoplasm A neoplasm that involves a brain ventricle. It may be a primary neoplasm arising from a brain ventricle, a metastasis from a distant anatomic site, or an extension of an invasive neoplasm from an adjacent brain structure. C2937 Neoplastic Process Intraventricular Brain Neoplasm C0007798 Undetermined Intraventricular_Brain_Neoplasm Brain Neoplasms, Intraventricular Intraventricular Brain Neoplasm Intraventricular Brain Neoplasms Intraventricular Brain Tumor Intraventricular Neoplasm of Brain Intraventricular Neoplasm of the Brain Intraventricular Neoplasms Intraventricular Tumor of Brain Intraventricular Tumor of the Brain Intraventricular Brain Neoplasm A benign, malignant, or precancerous neoplasm that affects the cervix. C2940 Neoplastic Process Cervical Neoplasm Cervical Neoplasm C0007873 CTRP Undetermined Cervical_Neoplasm Cervical Neoplasm Cervical Tumor Cervix Neoplasm Cervix Tumor Cervix Uteri Neoplasm Cervix Uteri Tumor Neoplasm of Cervix Neoplasm of Cervix Uteri Neoplasm of Uterine Cervix Neoplasm of the Cervix Neoplasm of the Cervix Uteri Neoplasm of the Uterine Cervix Tumor of Cervix Tumor of Cervix Uteri Tumor of Uterine Cervix Tumor of the Cervix Tumor of the Cervix Uteri Tumor of the Uterine Cervix Uterine Cervix Neoplasm Uterine Cervix Tumor Cervical Neoplasm A benign, well-demarcated polypoid neoplasm arising from the bile duct epithelium. According to the growth pattern, it is classified as tubular, papillary, or tubulopapillary. Adenomas arising from the extrahepatic bile ducts usually produce symptoms related to biliary obstruction. C2942 Neoplastic Process Bile Duct Adenoma C0008309 CDISC GDC A benign neoplasm arising from/comprising cells resembling those of bile ducts. 8160/0 Benign Bile_Duct_Adenoma 8160/0 Bile duct adenoma Cholangioma Adenoma of Bile Duct Adenoma of the Bile Duct BDA Bile Duct Adenoma Bile duct adenoma CHOLANGIOMA, BENIGN Cholangioadenoma Cholangioma Hepatocholangiocellular Adenoma Hepatocholangioma Bile Duct Adenoma A benign, chondroid-producing, well-circumscribed, lytic neoplasm usually arising from the epiphysis of long bones. It is characterized by the presence of chondroblasts, osteoclast-like giant cells, chondroid formation, calcification, and mitotic activity. In aggressive cases, there is rearrangement of the 8q21 chromosome band. It occurs most frequently in children and young adults and rarely metastasizes. C2945 Neoplastic Process Chondroblastoma C0008441 GDC 9230/0 Benign Chondroblastoma 9230/0 Chondroblastoma, NOS Chondromatous giant cell tumor Codman tumor Chondroblastoma Chondroblastoma, NOS Chondroblastoma, Not Otherwise Specified Chondroblastoma A malignant cartilaginous matrix-producing mesenchymal neoplasm arising from the bone and soft tissue. It usually affects middle-aged to elderly adults. The pelvic bones, ribs, shoulder girdle, and long bones are the most common sites of involvement. Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion. C2946 Neoplastic Process Chondrosarcoma Chondrosarcoma C0008479 CDISC CPTAC CTEP CTRP Cellosaurus GDC A malignant mesenchymal neoplasm arising from cartilage-forming tissues. A type of cancer that forms in bone cartilage. It usually starts in the pelvis (between the hip bones), the shoulder, the ribs, or at the ends of the long bones of the arms and legs. A rare type of chondrosarcoma called extraskeletal chondrosarcoma does not form in bone cartilage. Instead, it forms in the soft tissues of the upper part of the arms and legs. Chondrosarcoma can occur at any age but is more common in people older than 40 years. It is a type of bone cancer. 9220/3 Malignant Chondrosarcoma 9220/3 Chondrosarcoma Chondrosarcoma, NOS Fibrochondrosarcoma CHONDROSARCOMA, MALIGNANT Chondrosarcoma Chondrosarcoma, NOS chondrosarcoma Chondrosarcoma A malignant bone tumor arising from the remnants of the fetal notochord. Although it can occur at all ages, it is more frequently seen in middle-aged adults. The most frequent sites of involvement are the sacrococcygeal area, spheno-occipital area, and cervico-thoraco-lumbar spine. Chordomas tend to recur and may metastasize. The most common sites of metastasis are lung, bone, lymph nodes, and subcutaneous tissue. C2947 Neoplastic Process Chordoma Chordoma C0008487 CDISC CPTAC CTRP GDC A malignant bone neoplasm arising from the remnants of the fetal notochord. A type of bone cancer that usually starts in the lower spinal column or at the base of the skull. 9370/3 Malignant Chordoma 9370/3 Chordoma, NOS CHORDOMA, MALIGNANT Chordoma Chordoma, NOS chordoma Chordoma A benign or malignant neoplasm that affects the choroid. C2949 Neoplastic Process Choroid Neoplasm C0008523 Undetermined Choroid_Neoplasm Choroid Neoplasm Choroid Tumor Choroidal Neoplasm Choroidal Tumor Neoplasm of Choroid Neoplasm of the Choroid Tumor of Choroid Tumor of the Choroid Choroid Neoplasm A benign or malignant neoplasm that affects the colon. Representative examples of benign neoplasms include lipoma and leiomyoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma. Colonic adenomas always exhibit epithelial dysplasia and are considered premalignant neoplasms. C2953 Neoplastic Process Colon Neoplasm C0009375 Undetermined Colon_Neoplasm Colon Neoplasm Colon Tumor Colonic Neoplasm Colonic Tumor Neoplasm of Colon Neoplasm of the Colon Tumor of Colon Tumor of the Colon Colon Neoplasm A malignant epithelial neoplasm that arises from the colon or rectum and invades through the muscularis mucosa into the submucosa. The vast majority are adenocarcinomas. C2955 Neoplastic Process Colorectal Carcinoma Colorectal Carcinoma C0009402 CPTAC CTEP CTRP Cellosaurus GDC Cancer that develops in the colon (the longest part of the large intestine) and/or the rectum (the last several inches of the large intestine before the anus). Malignant Colorectal_Carcinoma Colorectal Cancer CRC Cancer of Large Bowel Cancer of Large Intestine Cancer of the Large Bowel Cancer of the Large Intestine Carcinoma of Large Bowel Carcinoma of Large Intestine Carcinoma of the Large Bowel Carcinoma of the Large Intestine Colorectal (Colon or Rectal) Cancer Colorectal Cancer Colorectal Carcinoma Colorectal cancer, NOS Large Bowel Cancer Large Bowel Carcinoma Large Intestine Cancer Large Intestine Carcinoma colorectal cancer Colorectal Carcinoma A benign or malignant neoplasm that affects the colon or rectum. Representative examples of benign neoplasms include lipoma and leiomyoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma. Colorectal adenomas always exhibit epithelial dysplasia and are considered premalignant neoplasms. C2956 Neoplastic Process Colorectal Neoplasm Colorectal Neoplasm C0009404 CTRP Undetermined Colorectal_Neoplasm Colorectal Neoplasm Colorectal Tumor Large Bowel Neoplasm Large Bowel Tumor Large Intestinal Neoplasm Large Intestine Neoplasm Large Intestine Tumor Neoplasm of Large Bowel Neoplasm of the Large Bowel Tumor of Large Bowel Tumor of the Large Bowel Colorectal Neoplasm A benign or malignant neoplasm that affects the conjunctiva. Representative examples include papilloma, squamous cell carcinoma, and melanoma. C2961 Neoplastic Process Conjunctival Neoplasm C0009761 Undetermined Conjunctival_Neoplasm Conjunctiva Neoplasm Conjunctiva Tumor Conjunctival Neoplasm Conjunctival Neoplasms Conjunctival Tumor Neoplasm of Conjunctiva Neoplasm of the Conjunctiva Tumor of Conjunctiva Tumor of the Conjunctiva Conjunctival Neoplasm Abnormal growth of the cells that comprise the cranial nerves. C2963 Neoplastic Process Cranial Nerve Neoplasm Cranial Nerve Neoplasm C0010267 CPTAC CTRP mCode Undetermined Cranial_Nerve_Neoplasm Benign neoplasm of cranial nerves Benign neoplasm: Cranial nerves Cranial Nerve Neoplasm Cranial Nerve Neoplasms Cranial Nerve Tumor Neoplasm of Cranial Nerve Neoplasm of the Cranial Nerve Neoplasm of uncertain behavior of cranial nerves Tumor of Cranial Nerve Tumor of the Cranial Nerve Cranial Nerve Neoplasm A benign, partly cystic, epithelial tumor of the sellar region, presumably derived from Rathke pouch epithelium. It affects mainly children and young adults. There are two clinicopathological forms: adamantinomatous craniopharyngioma and papillary craniopharyngioma. The most significant factor associated with recurrence is the extent of surgical resection, with lesions greater than 5 cm in diameter carrying a markedly worse prognosis. (Adapted from WHO) C2964 Congenital Abnormality Neoplastic Process Craniopharyngioma C0010276 CDISC CPTAC CTEP GDC NICHD mCode A benign brain tumor that may be considered malignant because it can damage the hypothalamus, the area of the brain that controls body temperature, hunger, and thirst. A benign epithelial neoplasm of the sellar region, presumably derived from Rathke pouch epithelium. A histologically benign, but locally destructive, partly cystic, epithelial tumor of the sellar region, derived from Rathke pouch epithelium. 9350/1 Benign Craniopharyngioma 9350/1 Craniopharyngioma Craniopharyngioma, NOS Neoplasm of uncertain or unknown behaviour: Craniopharyngeal duct Rathke pouch tumor Benign neoplasm of craniopharyngeal duct CRANIOPHARYNGIOMA, BENIGN Craniopharyngeal Tumor Craniopharyngioma Craniopharyngioma (WHO Grade 1) Craniopharyngioma (WHO Grade I) Cystoma Neoplasm of Rathke's Pouch Rathke Pouch Neoplasm Rathke Pouch Tumor Rathke pouch tumor Rathke's Pouch Neoplasm Rathke's Pouch Tumor Tumor of Rathke's Pouch craniopharyngioma Craniopharyngioma A record of an individual's background in regard to smoking tobacco. This would include such factors as start date, end date (if applicable), number of cigarette smoked, attempts to quit, and others. C29719 Clinical Attribute Tobacco Smoking History C1519384 CPTAC NICHD Smoking_History Smoking History Tobacco Smoking History Tobacco Smoking History A record of a patient's medical background regarding the cancer and cancer-related problems of blood relatives. C29878 Group Attribute Family Cancer History C0260515 GDC OORO Relationship and Type for first and second degree relatives, e.g. Father - Prostate, Mother - Breast, List all pairings. Family_Cancer_History Family history of leukemia Family history of malignant neoplasm Family history of malignant neoplasm of breast Family history of malignant neoplasm of gastrointestinal tract Family history of malignant neoplasm of kidney Family history of malignant neoplasm of other genital organ Family history of malignant neoplasm of other respiratory and intrathoracic organs Family history of malignant neoplasm of other urinary organs Family history of malignant neoplasm of ovary Family history of malignant neoplasm of prostate Family history of malignant neoplasm of testis Family history of malignant neoplasm of unspecified genital organ Family history of other lymphatic and hematopoietic neoplasms Family history of unspecified malignant neoplasm Family Cancer History Family History of Cancer relative with cancer history relative_with_cancer_history Family Cancer History Surgery to remove one ovary. C29892 Therapeutic or Preventive Procedure Unilateral Oophorectomy C0041687 Unilateral_Oophorectomy Unilateral Oophorectomy Unilateral Ovariectomy ovariectomy - unilateral Unilateral Oophorectomy Surgery that does not remove the entire ovary. This can be by design or by error. C29893 Therapeutic or Preventive Procedure Incomplete Oophorectomy C0195490 Surgery to remove part of one ovary or part of both ovaries. Incomplete_Oophorectomy Incomplete Oophorectomy Incomplete Ovariectomy Ovariectomy, Incomplete partial oophorectomy Incomplete Oophorectomy Magnetic resonance spectroscopy is a noninvasive imaging technique that acts as a complement to conventional imaging of brain tumors in order to improve the sensitivity and specificity of the diagnostic process. This technique operates by exciting and recording signals from a range of magnetic resonance frequencies, allowing the identification and quantification of several biologically significant molecules containing proton groups that resonate in the appropriate frequency range. The technique facilitates observation of the spatial distribution of metabolic patterns over a region of interest and surrounding tissue at a high spatial resolution. C29934 Diagnostic Procedure Magnetic Resonance Spectroscopic Imaging Magnetic Resonance Spectroscopic Imaging C1522706 CDISC CTRP A noninvasive imaging method that provides information about cellular activity (metabolic information). It is used along with magnetic resonance imaging (MRI) which provides information about the shape and size of the tumor (spatial information). Magnetic resonance spectroscopy is a noninvasive imaging technique that operates by exciting and recording signals from a range of magnetic resonance frequencies, allowing the identification and quantification of several biologically significant molecules containing proton groups that resonate in the appropriate frequency range. The technique facilitates observation of the spatial distribution of metabolic patterns over a region of interest and surrounding tissue at a high spatial resolution. (NCI) Magnetic_Resonance_Spectroscopic_Imaging 1H- Nuclear Magnetic Resonance Spectroscopic Imaging 1H-nuclear magnetic resonance spectroscopic imaging MRS MRS Imaging MRSI MS Magnetic Resonance Spectroscopic Imaging Magnetic Resonance Spectroscopy Proton Magnetic Resonance Spectroscopic Imaging magnetic resonance spectroscopic imaging proton magnetic resonance spectroscopic imaging Magnetic Resonance Spectroscopic Imaging A benign or malignant neoplasm that affects the wall of the duodenum. Representative examples include adenoma, carcinoma, and lymphoma. C2995 Neoplastic Process Duodenal Neoplasm C0013291 Undetermined Duodenal_Neoplasm Duodenal Neoplasm Duodenal Tumor Neoplasm of Duodenum Neoplasm of the Duodenum Tumor of Duodenum Tumor of the Duodenum Duodenal Neoplasm A benign or malignant neoplasm that affects the external, middle, or internal ear. Representative examples include ceruminous adenoma, polyp, and carcinoma. C3000 Neoplastic Process Ear Neoplasm C0013449 Undetermined Ear_Neoplasm Ear Neoplasm Ear Neoplasms Ear Tumor Neoplasm of Ear Neoplasm of the Ear Tumor of Ear Tumor of the Ear Ear Neoplasm A common benign hyaline cartilage neoplasm arising in the intramedullary bone. It is characterized by the presence of chondrocytes, low mitotic activity, and in some cases, a nodular pattern and calcification. The small bones of the hands and feet are the most frequently affected sites. C3007 Neoplastic Process Enchondroma C1704356 GDC A benign (noncancerous) growth of cartilage in bones or in other areas where cartilage is not normally found. Benign Enchondroma 9220/0 Enchondroma Central Chondroma Enchondroma enchondroma Enchondroma A rare benign disorder characterized by lack of normal endochondral ossification, and the growth of multiple enchondromas. It primarily affects the bones of the hand, in children and young adults. Extent of the disease varies; in some cases, neoplastic involvement may be widespread causing considerable deformity. C3008 Disease or Syndrome Neoplastic Process Enchondromatosis C0014084 Cellosaurus PCDC Benign Enchondromatosis Dyschondroplasia Enchondromatosis Ollier Disease Ollier's Disease Enchondromatosis A benign or malignant neoplasm arising from the epithelial cells of an endocrine organ. Representative examples include pituitary gland adenoma, pituitary gland carcinoma, thyroid gland carcinoma, carcinoid tumor, and neuroendocrine carcinoma. C3010 Neoplastic Process Endocrine Neoplasm Endocrine Neoplasm C0014132 CPTAC CTRP NICHD Undetermined Endocrine_Neoplasm Neoplasm of uncertain behavior of endocrine glands and nervous system Endocrine Neoplasm Endocrine System Neoplasm Endocrine System Tumor Endocrine Tumor Endocrine Neoplasm A benign, borderline, or malignant neoplasm that affects the endometrium. C3012 Neoplastic Process Endometrial Neoplasm C0014170 Undetermined Endometrial_Neoplasm Endometrial Neoplasm Endometrial Tumor Endometrium Neoplasm Endometrium Tumor Neoplasm of Endometrium Neoplasm of the Endometrium Tumor of Endometrium Tumor of the Endometrium Endometrial Neoplasm An account of all experiences related to the receipt of blood, WBC, platelets, and/or other blood components. C30142 Clinical Attribute Transfusion History C1519604 Transfusion_History Transfusion History Transfusion History A clinical variant of Langerhans cell histiocytosis characterized by unifocal involvement of a bone (most often), skin, or lung. Patients are usually older children or adults usually presenting with a lytic bone lesion. The etiology is unknown. Morphologically, eosinophilic granuloma is characterized by the presence of Langerhans cells in a characteristic milieu which includes histiocytes, eosinophils, neutrophils, and small, mature lymphocytes. C3016 Neoplastic Process Eosinophilic Granuloma C0014461 Cellosaurus GDC NICHD mCode A clinical variant of Langerhans cell histiocytosis that is characterized by unifocal involvement of a bone (most often), skin, or lung. Patients are usually older children or adults, often presenting with a lytic bone lesion of an unknown etiology. Morphologically, eosinophilic granuloma is characterized by the presence of Langerhans cells in a characteristic milieu that includes histiocytes, eosinophils, neutrophils, and small, mature lymphocytes. 9752/1 Undetermined Eosinophilic_Granuloma 9751/3 Eosinophilic granuloma Langerhans cell granulomatosis, unifocal Chronic Unifocal Langerhans Cell Histiocytosis Eosinophilic Granuloma Eosinophilic Xanthomatous Granuloma Eosinophilic granuloma Monostotic Langerhans Cell Histiocytosis Unifocal Langerhans Cell Histiocytosis Unifocal Langerhans-cell histiocytosis Eosinophilic Granuloma A WHO grade 2, slow growing tumor of children and young adults, usually located intraventricularly. It is the most common ependymal neoplasm. It often causes clinical symptoms by blocking cerebrospinal fluid pathways. Key histological features include perivascular pseudorosettes and ependymal rosettes. (WHO) C3017 Neoplastic Process Ependymoma Ependymoma C0014474 CPTAC CTEP Cellosaurus DIPG/DMG GDC MedDRA NICHD A malignant neoplasm arising from ependymal cells that line the ventricles of the brain and the central canal of the spinal cord. A type of brain tumor that begins in cells lining the spinal cord central canal (fluid-filled space down the center) or the ventricles (fluid-filled spaces of the brain). Ependymomas may also form in the choroid plexus (tissue in the ventricles that makes cerebrospinal fluid). 9391/3 Undetermined Ependymoma 9391/3 CNS, ependymoma Ependymoma Ependymoma, NOS Epithelial ependymoma CNS, ependymoma Ependymoma Ependymoma, NOS WHO Grade 2 Ependymal Neoplasm WHO Grade 2 Ependymal Tumor WHO Grade II Ependymal Neoplasm WHO Grade II Ependymal Tumor ependymoma Ependymoma A primary or metastatic neoplasm that involves the space between the vertebral periosteum and dura mater that surrounds the spinal cord. C3019 Neoplastic Process Epidural Spinal Canal Neoplasm C0014536 Undetermined Epidural_Spinal_Canal_Neoplasm Epidural Neoplasm Epidural Spinal Canal Neoplasm Epidural Spinal Canal Tumor Epidural Spinal Canal Tumors Epidural Spinal Neoplasms Epidural Spinal Tumors Epidural Tumor Extradural Neoplasm Extradural Spinal Canal Neoplasm Extradural Spinal Canal Neoplasms Extradural Spinal Canal Tumor Extradural Spinal Neoplasms Extradural Spinal Tumors Extradural Tumor Neoplasm of Epidural Spinal Canal Neoplasm of Extradural Spinal Canal Neoplasm of the Epidural Spinal Canal Neoplasm of the Extradural Spinal Canal Tumor of Epidural Spinal Canal Tumor of Extradural Spinal Canal Tumor of the Epidural Spinal Canal Tumor of the Extradural Spinal Canal Epidural Spinal Canal Neoplasm A benign or malignant neoplasm involving the esophagus. C3028 Neoplastic Process Esophageal Neoplasm Esophageal Neoplasm C0014859 CTRP Undetermined Esophageal_Neoplasm Esophageal Neoplasm Esophageal Neoplasms, Benign and Malignant Esophageal Tumor Esophageal Tumors Esophagus Neoplasm Esophagus Tumor Neoplasm of Esophagus Neoplasm of the Esophagus Tumor of Esophagus Tumor of the Esophagus Esophageal Neoplasm A benign or malignant neoplasm affecting the structures of the eye. C3030 Neoplastic Process Eye Neoplasm C0015414 Undetermined Eye_Neoplasm Eye Neoplasm Eye Tumor Neoplasm of Eye Neoplasm of the Eye Ocular Neoplasm Ocular Tumor Tumor of Eye Tumor of the Eye Eye Neoplasm A benign or malignant neoplasm that affects the eyelid. Representative examples include hemangioma, nevus, and carcinoma. C3031 Neoplastic Process Eyelid Neoplasm C0015424 Undetermined Eyelid_Neoplasm Eyelid Neoplasm Eyelid Tumor Neoplasm of Eyelid Neoplasm of the Eyelid Tumor of Eyelid Tumor of the Eyelid Eyelid Neoplasm A benign or malignant neoplasm affecting the fallopian tube. Representative examples of benign neoplasms include papilloma, adenofibroma, and leiomyoma. Representative examples of malignant neoplasms include carcinoma, carcinosarcoma, and adenosarcoma. C3032 Neoplastic Process Fallopian Tube Neoplasm C0015558 Undetermined Fallopian_Tube_Neoplasm Fallopian Tube Neoplasm Fallopian Tube Tumor Neoplasm of Fallopian Tube Neoplasm of the Fallopian Tube Tumor of Fallopian Tube Tumor of the Fallopian Tube Fallopian Tube Neoplasm A non-metastasizing neoplasm arising from the fibrous tissue. It is characterized by the presence of spindle-shaped fibroblasts. C3041 Neoplastic Process Fibroma C0016045 CDISC GDC A benign neoplasm arising from fibrous tissue. 8810/0 Benign Fibroma 8810/0 Fibroma, NOS FIBROMA, BENIGN Fibroma Fibroma, NOS Fibroma A poorly circumscribed neoplasm arising from the soft tissues. It is characterized by the presence of spindle-shaped fibroblasts and an infiltrative growth pattern. C3042 Neoplastic Process Fibromatosis C0016048 A condition in which multiple fibromas develop. Fibromas are tumors (usually benign) that affect connective tissue. Undetermined Fibromatosis Fibromatosis fibromatosis Fibromatosis A malignant mesenchymal fibroblastic neoplasm affecting the soft tissue and bone. C3043 Neoplastic Process Fibrosarcoma C0016057 CDISC CPTAC CTEP Cellosaurus GDC NICHD A malignant mesenchymal neoplasm of the soft tissue and bone. 8810/3 Malignant Fibrosarcoma 8810/3 Fibrosarcoma, NOS FIBROSARCOMA, MALIGNANT Fibrosarcoma Fibrosarcoma, NOS Malignant Fibromatous Neoplasm fibrosarcoma Fibrosarcoma A benign or malignant neoplasm affecting the gallbladder. Representative examples of benign neoplasms include lipoma, leiomyoma, and neurofibroma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma. C3048 Neoplastic Process Gallbladder Neoplasm C0016978 Undetermined Gallbladder_Neoplasm Gallbladder Neoplasm Gallbladder Tumor Neoplasm of Gallbladder Neoplasm of the Gallbladder Tumor of Gallbladder Tumor of the Gallbladder Gallbladder Neoplasm A benign neuroblastic tumor of the sympathetic nervous system that occurs in childhood. Ganglioneuroma typically arises from the sympathetic trunk in the mediastinum. Histologic features include spindle cell proliferation (resembling a neurofibroma) and the presence of large ganglion cells. Common presenting features include a palpable abdominal mass, hepatomegaly, and a thoracic mass detected on routine chest X-ray. C3049 Neoplastic Process Ganglioneuroma Ganglioneuroma C0017075 CDISC CTRP GDC A benign neoplasm characterized by the presence of ganglion cells and spindle cell proliferation, located primarily in the brain, ganglia, or adrenal medulla. 9490/0 Benign Ganglioneuroma 9490/0 Ganglioneuroma GANGLIONEUROMA, BENIGN Ganglioneuroma Ganglioneuroma (Schwannian Stroma-Dominant) Neural Crest Tumor, Benign Ganglioneuroma A gastrin-producing neuroendocrine tumor. It is usually located in the pancreas but it is also found at other anatomic sites, including the stomach and small intestine. C3050 Neoplastic Process Gastrin-Producing Neuroendocrine Tumor Gastrin-Producing Neuroendocrine Tumor C0017150 CTRP GDC A tumor that causes overproduction of gastric acid. It usually begins in the duodenum (first part of the small intestine that connects to the stomach) or the islet cells of the pancreas. Rarely, it may also begin in other organs, including the stomach, liver, jejunum (the middle part of the small intestine), biliary tract (organs and ducts that make and store bile), mesentery, or heart. It is a type of neuroendocrine tumor, and it may metastasize (spread) to the liver and the lymph nodes. 8153/1 Undetermined G-Cell_Gastrin_Producing_Neoplasm 8153/1 G cell tumor, NOS Gastrin cell tumor Gastrinoma Gastrinoma, NOS G Cell Tumor G-Cell Gastrin Producing Tumor G-Cell Tumor Gastrin Secreting Tumor Gastrin-Producing NET Gastrin-Producing Neuroendocrine Tumor Gastrinoma gastrinoma Gastrin-Producing Neuroendocrine Tumor A benign or malignant neoplasm involving any part of the digestive system. C3052 Neoplastic Process Digestive System Neoplasm Digestive System Neoplasm C0017185 CPTAC CTRP Cellosaurus Undetermined Gastrointestinal_Neoplasm Neoplasm of uncertain behavior of other specified digestive organs Neoplasm of uncertain behavior of stomach, intestines, and rectum Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified Neoplasm of unspecified behavior of digestive system Neoplasm of unspecified nature of digestive system Digestive Neoplasm Digestive System Neoplasm Digestive System Tumor Digestive Tumor GI Neoplasm GI System Neoplasm GI System Tumor GI Tumor Gastrointestinal Neoplasm Gastrointestinal System Neoplasm Gastrointestinal System Tumor Gastrointestinal Tumor Neoplasm of Digestive System Neoplasm of GI System Neoplasm of Gastrointestinal System Neoplasm of the Digestive System Neoplasm of the GI System Neoplasm of the Gastrointestinal System Tumor of Digestive System Tumor of GI System Tumor of Gastrointestinal System Tumor of the Digestive System Tumor of the GI System Tumor of the Gastrointestinal System Digestive System Neoplasm A benign, precancerous, or malignant neoplasm that affects the female reproductive system. Representative examples include uterine corpus leiomyoma, endocervical polyp, ovarian carcinoma, cervical carcinoma, and endometrial carcinoma. C3053 Neoplastic Process Female Reproductive System Neoplasm Female Reproductive System Neoplasm C0017416 CTRP Undetermined Female_Reproductive_System_Neoplasm Female Reproductive System Neoplasm Female Reproductive System Tumor Gynecologic Neoplasm Gynecologic Tumor Neoplasm of Female Reproductive System Neoplasm of the Female Reproductive System Tumor of Female Reproductive System Tumor of the Female Reproductive System Female Reproductive System Neoplasm A benign, borderline, or malignant neoplasm that affects the male reproductive system. Representative examples include benign prostate phyllodes tumor, benign testicular Sertoli cell tumor, prostatic intraepithelial neoplasia, prostate carcinoma, testicular seminoma, and testicular embryonal carcinoma. C3054 Neoplastic Process Male Reproductive System Neoplasm Male Reproductive System Neoplasm C0017417 CTRP Undetermined Male_Reproductive_System_Neoplasm Male Reproductive System Neoplasm Male Reproductive System Tumor Neoplasm of Male Reproductive System Neoplasm of the Male Reproductive System Tumor of Male Reproductive System Tumor of the Male Reproductive System Male Reproductive System Neoplasm A benign, intermediate, or malignant tumor that arises from the bone or soft tissue. It is characterized by the presence of multinucleated osteoclast-like giant cells. C3055 Neoplastic Process Giant Cell Tumor C0017525 GDC Undetermined Giant_Cell_Tumor Giant Cell Tumors Giant Cell Tumor Giant Cell Tumor A benign or malignant neoplasm that affects the upper or lower gingiva. C3057 Neoplastic Process Gingival Neoplasm C0017570 Undetermined Gingival_Neoplasm Gingival Neoplasm Gingival Tumor Gum Neoplasm Gum Tumor Neoplasm of Gingiva Neoplasm of Gum Neoplasm of the Gingiva Neoplasm of the Gum Tumor of Gingiva Tumor of Gum Tumor of the Gingiva Tumor of the Gum Gingival Neoplasm The most malignant astrocytic tumor (WHO grade 4). It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO) C3058 Neoplastic Process Glioblastoma C0017636 CPTAC CTEP Cellosaurus GDC A fast-growing type of central nervous system tumor that forms from glial (supportive) tissue of the brain and spinal cord and has cells that look very different from normal cells. GBM usually occurs in adults and affects the brain more often than the spinal cord. 9440/3 Malignant Glioblastoma 01 02 03 04 10 20 62 9440/3 CNS, glioblastoma (GBM) Glioblastoma Glioblastoma multiforme Glioblastoma, NOS Spongioblastoma multiforme Glioblastoma is not an astrocytoma. It is an astrocytic tumor. The latter includes astrocytomas and glioblastomas. However, when an anaplastic astrocytoma progresses to grade IV tumor, it is called a glioblastoma. CNS, glioblastoma (GBM) GBM GBM (Glioblastoma) Glioblastoma Glioblastoma Multiforme Glioblastoma multiforme Spongioblastoma Multiforme Spongioblastoma multiforme glioblastoma glioblastoma multiforme Glioblastoma A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells). Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas. Tumors that arise from oligodendrocytes are called oligodendroglial tumors. Tumors that arise from ependymal cells are called ependymomas. C3059 Neoplastic Process Glioma Glioma C0017638 CPTAC CTRP GDC NICHD A general term for tumors of the central nervous system, including astrocytomas, ependymal tumors, glioblastoma multiforme, and primitive neuroectodermal tumors. Undetermined Neuroglial_Tumor 9380/3 Glioma, NOS Gliomas Glial Neoplasm Glial Tumor Glioma Glioma, NOS Neoplasm of Neuroglia Neoplasm of the Neuroglia Neuroglial Neoplasm Neuroglial Tumor Tumor of Neuroglia Tumor of the Neuroglia glial tumor glioma Glioma A rare benign or malignant mesenchymal neoplasm arising from cells that resemble the modified smooth muscle cells of the glomus body. The majority of glomus tumors occur in the distal extremities. C3060 Neoplastic Process Glomus Tumor C0017653 Cellosaurus GDC 8711/0 Undetermined Glomus_Tumor 8711/0 Glomus tumor, NOS Glomus Neoplasm Glomus Tumor Glomus Tumor An extra-adrenal parasympathetic paraganglioma arising from paraganglia in the base of the skull and middle ear. C3061 Neoplastic Process Jugulotympanic Paraganglioma C0017671 GDC 8690/1 Undetermined Jugulotympanic_Paraganglioma 8690/1 Glomus jugulare tumor, NOS Jugular paraganglioma Jugulotympanic paraganglioma Glomus Jugulare Neoplasm Glomus Jugulare Tumor Jugular Paraganglioma Jugular paraganglioma Jugulotympanic Paraganglioma Jugulotympanic paraganglioma Neoplasm of Glomus Jugulare Neoplasm of the Glomus Jugulare Tumor of Glomus Jugulare Tumor of the Glomus Jugulare Jugulotympanic Paraganglioma A usually malignant, glucagon-producing neuroendocrine tumor arising from the pancreatic alpha cells. It may or may not be associated with inappropriate secretion of glucagon and an associated clinical syndrome. C3062 Neoplastic Process Pancreatic Glucagon-Producing Neuroendocrine Tumor CL495919 8152/1 Undetermined Pancreatic_Alpha_Cell_Glucagon_Producing_Neoplasm Alpha Cell Tumor Alpha Cell Tumor of Pancreas Alpha Cell Tumor of the Pancreas Glucagon-Producing Islet Cell Tumor Glucagon-Producing Tumor of Islet Cells Glucagon-Producing Tumor of the Islet Cells Pancreatic Alpha Cell Tumor Pancreatic Glucagon Producing NET Pancreatic Glucagon Producing Neuroendocrine Tumor Pancreatic Glucagon Producing Tumor Pancreatic Glucagon-Producing Neuroendocrine Tumor Pancreatic Glucagon-Producing Neuroendocrine Tumor A slow-growing sex cord-stromal tumor characterized by the presence of granulosa-like cells and Call-Exner bodies. It is almost always found in the ovary and rarely in the testis. There are two types of granulosa cell tumors: the adult and the juvenile. C3070 Neoplastic Process Granulosa Cell Tumor C0018206 GDC NICHD A slow-growing, malignant tumor that is characterized by the presence of granulosa-like cells, and which is almost always found in the ovary. In rare cases, it has also been found in the testicle. A type of slow-growing, malignant tumor that usually affects the ovary. Undetermined Granulosa_Cell_Tumor 8620/1 Granulosa cell tumor, NOS Granulosa Cell Neoplasm Granulosa Cell Tumor granulosa cell tumor Granulosa Cell Tumor A rare neoplasm arising from the ovary. Although it may occur at any age, it is more often seen in young females. Morphologically, it is characterized by a mixture of two cellular populations: well differentiated Sertoli cells and granulosa cells, with the latter constituting at least ten percent of the neoplasm. The vast majority of cases are stage I lesions at presentation and produce either estrogenic or androgenic manifestations. Although it may present as a massive ovarian tumor, it usually follows a benign clinical course. Very rare case reports of testicular lesions morphologically resembling gynandroblastomas are in fact variants of juvenile granulose cell tumor, or Sertoli cell tumor, or a combination of both. C3072 Neoplastic Process Ovarian Gynandroblastoma C0018413 GDC 8632/1 Undetermined Gynandroblastoma 8632/1 Gynandroblastoma Gynandroblastoma Gynandroblastoma of Ovary Gynandroblastoma of the Ovary Ovarian Gynandroblastoma Ovarian Gynandroblastoma A benign or malignant neoplasm that affects the anatomic structures of the head and neck region. Representative examples of benign neoplasms include salivary gland pleomorphic adenoma and nasal cavity papilloma. Representative examples of malignant neoplasms include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma. C3077 Neoplastic Process Head and Neck Neoplasm Head and Neck Neoplasm C0018671 CPTAC CTRP Undetermined Head_and_Neck_Neoplasm Neoplasm of uncertain behavior of lip, oral cavity, and pharynx Head and Neck Neoplasm Head and Neck Neoplasm (Excluding Central Nervous System) Head and Neck Tumor Neoplasm of Head and Neck Neoplasm of the Head and Neck Tumor of Head and Neck Tumor of the Head and Neck Head and Neck Neoplasm A benign or malignant neoplasm that affects the heart and/or the pericardium. Representative examples include atrial myxoma, cardiac myeloid sarcoma, and pericardial malignant mesothelioma. C3081 Neoplastic Process Heart Neoplasm C0018809 NICHD Undetermined Cardiac_Neoplasm Cardiac Neoplasm Cardiac Neoplasms Cardiac Tumor Heart Neoplasm Heart Tumor Neoplasm of Heart Neoplasm of the Heart Tumor of Heart Tumor of the Heart Heart Neoplasm A group of rare clonal disorders of immunoglobulin synthesis associated with B-cell proliferative disorders. C3082 Neoplastic Process Heavy Chain Disease C0018852 GDC mCode 9762/3 Malignant Heavy_Chain_Disease 9762/3 Heavy chain disease, NOS HCD Heavy Chain Disease Heavy chain disease Heavy Chain Disease A clonal disorder characterized by the secretion of a truncated gamma chain. In most cases, it is associated with morphologic changes also seen in lymphoplasmacytic lymphomas, but the clinical course is typically more aggressive than in lymphoplasmacytic lymphoma. C3083 Neoplastic Process Gamma Heavy Chain Disease C0018854 GDC Malignant Gamma_Heavy_Chain_Disease 9762/3 Franklin disease Gamma heavy chain disease Franklin Disease Franklin disease Franklin's Disease Gamma Heavy Chain Disease Gamma heavy chain disease Gamma Heavy Chain Disease A benign vascular lesion characterized by the formation of capillary-sized or cavernous vascular channels. C3085 Neoplastic Process Hemangioma Hemangioma C0018916 CDISC CPTAC CTRP Cellosaurus GDC MedDRA NICHD A benign vascular neoplasm characterized by the formation of capillary-sized or cavernous vascular channels. A benign, vascular neoplasm characterized by the formation of capillary-sized vascular channels. 9120/0 Benign Hemangioma 9120/0 Angioma, NOS Hemangioma Hemangioma unspecified site Hemangioma, NOS Angioma Benign Angioma Benign Hemangioma HEMANGIOMA, BENIGN Hemangioma Hemangioma, NOS Hemangioma A hemangioma characterized by the presence of cavernous vascular spaces. C3086 Neoplastic Process Cavernous Hemangioma C0018920 GDC 9121/0 Benign Cavernous_Hemangioma 9121/0 Cavernous hemangioma Cavernoma Cavernous Angioma Cavernous Hemangioma Cavernous hemangioma Cavernous Hemangioma A malignant tumor arising from the endothelial cells of the blood vessels. Microscopically, it is characterized by frequently open vascular anastomosing and branching channels. The malignant cells that line the vascular channels are spindle or epithelioid and often display hyperchromatic nuclei. Angiosarcomas most frequently occur in the skin and breast. Patients with long-standing lymphedema are at increased risk of developing angiosarcoma. C3088 Neoplastic Process Angiosarcoma Angiosarcoma C0018923 CDISC CPTAC CTRP Cellosaurus GDC A malignant vascular neoplasm arising from endothelial cells. A type of cancer that begins in the cells that line blood vessels. 9120/3 Malignant Angiosarcoma 9130/3 Angiosarcoma Haemangiosarcoma Hemangioendothelial sarcoma Hemangioendothelioma, malignant Hemangiosarcoma Angiosarcoma HEMANGIOSARCOMA, MALIGNANT Hemangiosarcoma Malignant Angioendothelioma Malignant Hemangioendothelioma angiosarcoma hemangiosarcoma Angiosarcoma A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation. C3099 Neoplastic Process Hepatocellular Carcinoma Hepatocellular Carcinoma C0019204 CDISC CPTAC CTEP CTRP Cellosaurus GDC mCode A malignant neoplasm arising from hepatocytes. A type of adenocarcinoma and the most common type of liver tumor. 8170/3 Malignant Hepatocellular_Carcinoma 8170/3 Hepatocarcinoma Hepatocellular carcinoma, NOS Hepatoma, NOS Hepatoma, malignant Liver cell carcinoma Malignant neoplasm: Liver cell carcinoma CARCINOMA, HEPATOCELLULAR, MALIGNANT Carcinoma of Liver Cells Carcinoma of the Liver Cells HCC Hepatocellular Cancer Hepatocellular Carcinoma Hepatocellular carcinoma Hepatoma LIHC Liver Cell Cancer (Hepatocellular Carcinoma) Liver Cell Carcinoma Liver cell carcinoma Primary Carcinoma of Liver Cells Primary Carcinoma of the Liver Cells hepatocellular carcinoma hepatoma Hepatocellular Carcinoma A neoplastic proliferation of Langerhans cells which contain Birbeck granules by ultrastructural examination. Three major overlapping syndromes are recognized: eosinophilic granuloma, Letterer-Siwe disease, and Hand-Schuller-Christian disease. The clinical course is generally related to the number of organs affected at presentation. (WHO, 2001) C3107 Neoplastic Process Langerhans Cell Histiocytosis Langerhans Cell Histiocytosis C0019621 CTEP CTRP Cellosaurus GDC NICHD A group of rare disorders in which too many Langerhans cells (a type of white blood cell) grow in certain tissues and organs including the bones, skin, and lungs, and damage them. Langerhans cell histiocytosis may also affect the pituitary gland (which makes hormones that control other glands and many body functions, especially growth). Langerhans cell histiocytosis is most common in children and young adults. Tissue infiltration by Langerhans cells (histiocytes). When infiltration involves the pituitary stalk or gland, presentation includes diabetes insipidus, which is sometimes accompanied by other pituitary dysfunction. 9751/1 9751/3 9752/1 9753/1 9754/3 Undetermined Langerhans_Cell_Histiocytosis 9751/1 9751/3 Histiocytosis X, NOS Langerhans cell granulomatosis Langerhans cell histiocytosis, NOS Histiocytosis X LCH Langerhans Cell Granulomatosis Langerhans Cell Histiocytosis Langerhans cell granulomatosis Langerhans cell histiocytosis Langerhans cell histiocytosis, NOS Langerhans Cell Histiocytosis A benign or malignant neoplasm that affects the hypopharynx. C3127 Neoplastic Process Hypopharyngeal Neoplasm C0020627 Undetermined Hypopharyngeal_Neoplasm Hypopharyngeal Neoplasm Hypopharyngeal Neoplasms Hypopharyngeal Tumor Neoplasm of Hypopharynx Neoplasm of the Hypopharynx Tumor of Hypopharynx Tumor of the Hypopharynx Hypopharyngeal Neoplasm A primary or metastatic neoplasm that affects the hypothalamus. C3129 Neoplastic Process Hypothalamic Neoplasm C0020659 Undetermined Hypothalamic_Neoplasm Hypothalamic Neoplasm Hypothalamic Neoplasms Hypothalamic Tumor Neoplasm of Hypothalamus Neoplasm of the Hypothalamus Tumor of Hypothalamus Tumor of the Hypothalamus Hypothalamic Neoplasm A benign or malignant neoplasm that affects the wall of the ileum. Representative examples include adenoma, carcinoma, and lymphoma. C3130 Neoplastic Process Ileal Neoplasm C0020876 Undetermined Ileal_Neoplasm Ileal Neoplasm Ileal Tumor Neoplasm of Ileum Neoplasm of the Ileum Tumor of Ileum Tumor of the Ileum Ileal Neoplasm A clonal disorder, also known as immunoproliferative small intestinal disease or Mediterranean lymphoma, characterized by the secretion of a defective alpha heavy chain. It predominantly affects young people in the Mediterranean region. It involves the small intestine, and patients usually present with malabsorption syndrome, abdominal pain, weight loss, and fever. There is extensive villous atrophy of the small intestinal mucosa, which is heavily infiltrated by small lymphocytes and plasma cells. The small intestinal morphologic changes are consistent with a mucosa-associated lymphoid tissue lymphoma (MALT lymphoma). C3132 Neoplastic Process Alpha Heavy Chain Disease C0021071 GDC mCode 9760/3 9764/3 Malignant Alpha_Heavy_Chain_Disease 9760/3 9762/3 9764/3 Alpha heavy chain disease Immunoproliferative disease, NOS Immunoproliferative small intestinal disease Mediterranean lymphoma Alpha Heavy Chain Disease Alpha heavy chain disease IPSID Immunoproliferative Small Intestinal Disease Immunoproliferative disease, NOS Immunoproliferative small intestinal disease Immunoproliferative small intestinal diseases Mediterranean Abdominal Lymphoma Mediterranean Lymphoma Mediterranean lymphoma Alpha Heavy Chain Disease A benign or malignant neoplasm that occurs in brain parenchymal tissue below the tentorium cerebelli. C3139 Neoplastic Process Infratentorial Neoplasm C0021432 CPTAC mCode Undetermined Infratentorial_Neoplasm Neoplasm of uncertain or unknown behaviour: Brain, infratentorial Brain Neoplasms, Infratentorial Infratentorial Neoplasm Infratentorial Neoplasms Infratentorial Tumor Infratentorial Tumors Neoplasm of uncertain behavior of brain, infratentorial Neoplasms, Infratentorial Infratentorial Neoplasm An insulin-producing neuroendocrine tumor arising from the beta cells of the pancreas. It may or may not be associated with inappropriate secretion of insulin and an associated clinical syndrome. C3140 Neoplastic Process Pancreatic Insulin-Producing Neuroendocrine Tumor Pancreatic Insulin-Producing Neuroendocrine Tumor CL480898 CTRP An abnormal mass that grows in the beta cells of the pancreas that make insulin. Beta cell neoplasms are usually benign (not cancer). They secrete insulin and are the most common cause of low blood sugar caused by having too much insulin in the body. 8151/0 8151/1 Undetermined Pancreatic_Beta_Cell_Insulin_Producing_Neoplasm Beta Cell Tumor Beta Cell Tumor of Pancreas Beta Cell Tumor of the Pancreas Insulin-Producing Islet Cell Tumor Insulin-Producing Tumor of Islet Cells Insulin-Producing Tumor of the Islet Cells Pancreatic Beta Cell Tumor Pancreatic Insulin Producing NET Pancreatic Insulin Producing Neoplasm Pancreatic Insulin Producing Tumor Pancreatic Insulin-Producing Neuroendocrine Tumor beta cell neoplasm beta cell tumor of the pancreas pancreatic insulin-producing tumor Pancreatic Insulin-Producing Neuroendocrine Tumor A benign or malignant neoplasm involving the small or large intestine. C3141 Neoplastic Process Intestinal Neoplasm C0021841 Undetermined Intestinal_Neoplasm Intestinal Neoplasm Intestinal Neoplasms Intestinal Tumor Intestinal Tumors Neoplasm of Intestines Neoplasm of the Intestines Tumor of Intestines Tumor of the Intestines Intestinal Neoplasm A neoplasm that affects the iris. This category includes nevus and melanoma. C3142 Neoplastic Process Iris Neoplasm C0022079 Undetermined Iris_Neoplasm Iris Neoplasm Iris Tumor Neoplasm of Iris Neoplasm of the Iris Tumor of Iris Tumor of the Iris Iris Neoplasm A dome-shaped, rapidly growing skin lesion composed of well differentiated squamous cells. It usually occurs on sun-exposed areas of the body, most often the head, neck, and limbs. It is considered a variant of well-differentiated squamous cell carcinoma with distinct clinical behavior. Keratoacanthomas affect males more frequently than females and the majority tend to regress spontaneously. C3146 Neoplastic Process Keratoacanthoma C0022572 Cellosaurus A rapidly growing, dome-shaped skin tumor that usually occurs on sun-exposed areas of the body, especially around the head and neck. Keratoacanthoma occurs more often in males. Although in most patients it goes away on its own, in a few patients it comes back. Rarely, it may spread to other parts of the body. 8071/1 Malignant Keratoacanthoma Cutaneous Keratoacanthoma Keratoacanthoma Skin Keratoacanthoma keratoacanthoma Keratoacanthoma A benign or malignant neoplasm affecting the kidney. Representative examples of benign renal neoplasms include fibroma, lipoma, oncocytoma, and juxtaglomerular cell tumor. Representative examples of malignant renal neoplasms include renal cell carcinoma, renal pelvis carcinoma, Wilms tumor, rhabdoid tumor, sarcoma, and lymphoma. C3150 Neoplastic Process Kidney Neoplasm Kidney Neoplasm C3149267 CTRP Cellosaurus NICHD Neoplasia located in the kidney. Undetermined Renal_Neoplasm Kidney Neoplasm Kidney Tumor Neoplasm of Kidney Neoplasm of the Kidney Renal Neoplasm Renal Tumor Renal Tumors Tumor of Kidney Tumor of the Kidney Kidney Neoplasm Metastatic signet-ring cell carcinoma in the ovary. The primary site is the gastrointestinal tract or breast. C3153 Neoplastic Process Krukenberg Tumor C0022790 Cellosaurus GDC A tumor in the ovary caused by the spread of stomach cancer. Malignant Krukenberg_Tumor 8490/6 Krukenberg tumor Krukenberg Neoplasm Krukenberg Tumor Krukenberg tumor Krukenberg Tumor A benign or malignant neoplasm involving the larynx. C3156 Neoplastic Process Laryngeal Neoplasm C0023055 Undetermined Laryngeal_Neoplasm Laryngeal Neoplasm Larynx Neoplasm Neoplasm of Larynx Neoplasm of the Larynx Laryngeal Neoplasm A well-circumscribed benign smooth muscle neoplasm characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C3157 Neoplastic Process Leiomyoma Leiomyoma C1302742 CDISC CTRP Cellosaurus GDC A benign neoplasm, originating from smooth muscle cells. A benign smooth muscle tumor, usually in the uterus or gastrointestinal tract. 8890/0 Benign Leiomyoma 8890/0 Leiomyoma Leiomyoma, NOS Fibroid Fibroid Neoplasm Fibroid Tumor LEIOMYOMA, BENIGN Leiomyoma Leiomyoma, NOS Leiomyomatous Neoplasm Leiomyomatous Tumor fibroid leiomyoma Leiomyoma An uncommon, aggressive malignant smooth muscle neoplasm, usually occurring in post-menopausal women. It is characterized by a proliferation of neoplastic spindle cells. Morphologic variants include epithelioid, granular cell, inflammatory and myxoid leimyosarcomas. C3158 Neoplastic Process Leiomyosarcoma Leiomyosarcoma C0023269 CDISC CPTAC CTEP CTRP Cellosaurus FDA GDC A malignant (cancer) tumor of smooth muscle cells that can arise almost anywhere in the body, but is most common in the uterus, abdomen, or pelvis. A malignant neoplasm, originating from smooth muscle cells. A malignant tumor of smooth muscle cells that can arise almost anywhere in the body but is most common in the uterus, abdomen, or pelvis. 8890/3 Malignant Leiomyosarcoma 8890/3 Leiomyosarcoma, NOS IMDRF:E180103 LEIOMYOSARCOMA, MALIGNANT Leiomyosarcoma Leiomyosarcoma (excluding uterine leiomyosarcoma) Leiomyosarcoma - not uterine Leiomyosarcoma, NOS Leiomyosarcomas leiomyosarcoma Leiomyosarcoma A multifocal, multisystem form of Langerhans-cell histiocytosis. There is involvement of multiple organ systems including the bones, skin, liver, spleen, and lymph nodes. Patients are usually infants presenting with fever, hepatosplenomegaly, lymphadenopathy, bone and skin lesions, and pancytopenia. C3160 Neoplastic Process Letterer-Siwe Disease Letterer-Siwe Disease C0023381 CPTAC CTRP Cellosaurus GDC NICHD mCode A multifocal, multisystem form of Langerhans-cell histiocytosis. There is involvement of multiple organ systems that may include the bones, skin, liver, spleen, and lymph nodes. Patients are usually infants presenting with fever, hepatosplenomegaly, lymphadenopathy, bone and skin lesions, and pancytopenia. 9754/3 Malignant Letterer-Siwe_Disease 9751/3 Letterer-Siwe disease Acute Disseminated Langerhans Cell Histiocytosis Letterer-Siwe Disease Letterer-Siwe disease Multifocal Multisystem Langerhans Cell Histiocytosis Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis Letterer-Siwe Disease A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years. C3161 Neoplastic Process Leukemia Leukemia C0023418 CDISC CPTAC CTEP CTRP GDC MedDRA NICHD A cancer of the blood or bone marrow that is characterized by increased production of abnormal blood cells. A progressive, proliferative disease of blood cells, originating from myeloid or lymphoid stem cells. Cancer that starts in blood-forming tissue such as the bone marrow and causes large numbers of blood cells to be produced and enter the bloodstream. 9800/3 Malignant Leukemia 9800/3 Leukaemia of unspecified cell type Leukaemia, unspecified Leukemia Leukemia of unspecified cell type Leukemia, NOS Leukemia, unspecified not having achieved remission Leukemias, NOS Other leukaemias of specified cell type Other leukemia of unspecified cell type Other leukemia of unspecified cell type without mention of having achieved remission Other specified leukaemias Other specified leukemia Other specified leukemias Other specified leukemias not having achieved remission Unspecified leukemia Unspecified leukemia without mention of having achieved remission Blood (Leukemia) LEUKEMIA, MALIGNANT Leukemia Leukemia NOS Leukemia, Disease Leukemia, NOS Leukemias Leukemias, General leukemia Leukemia The most common type of chronic lymphoid leukemia. It comprises 90% of chronic lymphoid leukemias in the United States. Morphologically, the neoplastic cells are small, round B-lymphocytes. This type of leukemia is not considered to be curable with available therapy. (WHO, 2001) C3163 Neoplastic Process Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia C0023434 CPTAC CTEP CTRP Cellosaurus GDC An indolent (slow-growing) cancer in which too many immature lymphocytes (white blood cells) are found mostly in the blood and bone marrow. Sometimes, in later stages of the disease, cancer cells are found in the lymph nodes and the disease is called small lymphocytic lymphoma. Malignant Chronic_Lymphocytic_Leukemia 9823/3 B-cell lymphocytic leukemia/small lymphocytic lymphoma Chronic lymphatic leukemia Chronic lymphocytic leukaemia of B-cell type Chronic lymphocytic leukemia Chronic lymphocytic leukemia of B-cell type not having achieved remission Chronic lymphocytic leukemia, B-cell type (includes all variants of BCLL) Chronic lymphoid leukemia Chronic lymphoid leukemia without mention of having achieved remission Lymphoid leukemia, chronic B Cell CLL B Cell Chronic Lymphocytic Leukemia B Cell Lymphocytic Leukemia B-Cell CLL B-Cell Chronic Lymphocytic Leukemia B-Cell Chronic Lymphoid Leukemia B-Cell Lymphocytic Leukemia BCLL CLL Chronic B-Cell Lymphocytic Leukemia Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia (CLL) Chronic lymphatic leukemia Chronic lymphocytic leukemia Chronic lymphocytic leukemia, NOS Hematopoeitic - Chronic Lymphocytic Leukemia (CLL) chronic lymphocytic leukemia Chronic Lymphocytic Leukemia A rare acute myeloid leukemia in which the immature cells differentiate towards basophils. C3164 Neoplastic Process Acute Basophilic Leukemia C0023437 CPTAC GDC NICHD PCDC A rare acute myeloid leukemia in which the immature cells differentiate towards basophils. 9870/3 Malignant Acute_Basophilic_Leukemia 9870/3 Acute basophilic leukaemia Acute basophilic leukemia Acute Basophilic Leukemia Acute basophilic leukaemia Acute basophilic leukemia Basophilic Leukemia Leukemia Basophilic Acute Basophilic Leukemia Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia. C3167 Neoplastic Process Acute Lymphoblastic Leukemia (ALL) Acute Lymphoblastic Leukemia C3550748 CDISC CPTAC CTEP CTRP Cellosaurus GDC MedDRA NICHD PCDC A progressive, proliferative disease of blood cells, originating from immature lymphoid cells. A rapidly progressive cancer of the blood and bone marrow consisting of the proliferation of lymphoblasts, which are immature, dysfunctional white blood cells. An aggressive (fast-growing) type of leukemia (blood cancer) in which too many lymphoblasts (immature white blood cells) are found in the blood and bone marrow. 9835/3 Malignant Acute_Lymphoblastic_Leukemia 9835/3 Acute lymphatic leukemia Acute lymphoblastic leukaemia [ALL] Acute lymphoblastic leukemia Acute lymphoblastic leukemia (ALL) Acute lymphoblastic leukemia not having achieved remission Acute lymphoblastic leukemia, NOS Acute lymphoblastic leukemia, precursor cell type Acute lymphoblastic leukemia-lymphoma, NOS Acute lymphocytic leukemia Acute lymphoid leukemia Acute lymphoid leukemia without mention of having achieved remission Lymphoblastic leukemia, NOS Lymphoid leukemia, acute Precursor cell lymphoblastic leukemia, NOS Precursor cell lymphoblastic leukemia, not phenotyped ALL ALL - Acute Lymphocytic Leukemia ALL_TYPE Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia (ALL) Acute Lymphocytic Leukaemia Acute Lymphocytic Leukemia Acute Lymphocytic Leukemias Acute Lymphogenous Leukemia Acute Lymphoid Leukemia Acute lymphatic leukemia Acute lymphoblastic leukemia Acute lymphoblastic leukemia (ALL) Acute lymphoblastic leukemia, NOS Acute lymphoblastic leukemia, precursor cell type Acute lymphocytic leukemia Acute lymphoid leukemia LEUKEMIA, LYMPHOBLASTIC, MALIGNANT Lymphoblastic Leukemia Lymphoblastic leukemia, NOS Precursor Cell Lymphoblastic Leukemia Precursor Lymphoblasic Leukemia Precursor Lymphoblastic Leukemia Precursor cell lymphoblastic leukemia, NOS acute lymphoblastic leukemia acute lymphocytic leukemia Acute Lymphoblastic Leukemia An acute lymphoblastic leukemia occurring during childhood. The majority of cases are B-acute lymphoblastic leukemias. Approximately 15% of the cases are T-acute lymphoblastic leukemias. C3168 Neoplastic Process Childhood Acute Lymphoblastic Leukemia Childhood Acute Lymphoblastic Leukemia C0023452 CTRP Cellosaurus NICHD An acute lymphoblastic leukemia occurring during childhood. The majority of cases are B-acute lymphoblastic leukemias. Approximately 15% of the cases are T-acute lymphoblastic leukemias. Malignant Childhood_Acute_Lymphoblastic_Leukemia Acute Lymphoblastic Leukemia (ALL) Childhood ALL Childhood Acute Lymphoblastic Leukemia Childhood Acute Lymphocytic Leukemia Childhood Acute Lymphogenous Leukemia Childhood Acute Lymphoid Leukemia Childhood Precursor Lymphoblastic Leukemia Pediatric ALL Pediatric Acute Lymphoblastic Leukemia Pediatric Acute Lymphocytic Leukemia Pediatric Acute Lymphocytic Leukemia (ALL) Pediatric Acute Lymphogenous Leukemia Pediatric Acute Lymphoid Leukemia Childhood Acute Lymphoblastic Leukemia A variant of systemic mastocytosis with involvement of the bone marrow (20% or more mast cells) and the peripheral blood (mast cells account for 10% or more of peripheral blood white cells). (WHO, 2001) C3169 Neoplastic Process Mast Cell Leukemia Mast Cell Leukemia C0023461 CDISC CPTAC CTRP Cellosaurus GDC A progressive, proliferative disease of blood cells, originating from mast cells. 9742/3 Malignant Mast_Cell_Leukemia 9742/3 Mast cell leukaemia Mast cell leukemia LEUKEMIA, MAST CELL, MALIGNANT Mast Cell Leukemia Mast cell leukaemia Mast Cell Leukemia An acute myeloid leukemia in which at least 50% of the blasts are of megakaryocytic lineage. (WHO, 2001) C3170 Neoplastic Process Acute Megakaryoblastic Leukemia Acute Megakaryoblastic Leukemia C0023462 CDISC CPTAC CTRP Cellosaurus GDC NICHD PCDC A progressive, proliferative disease of blood cells, originating from immature megakaryocytes. An acute myeloid leukemia in which at least 50% of the blasts are of megakaryocytic lineage. (WHO, 2001) 9910/3 Malignant Acute_Megakaryoblastic_Leukemia 9910/3 Acute megakaryoblastic leukaemia Acute megakaryoblastic leukemia Acute megakaryoblastic leukemia not having achieved remission FAB M7 M7 Megakaryocytic leukemia AMKL Acute M7 Myeloid Leukemia Acute Megakaryoblastic Leukemia Acute Megakaryoblastic Leukemia (FAB Type M7) Acute Megakaryoblastic Leukemia (Fab Type M7) Acute Megakaryocytic Leukemia Acute megakaryoblastic leukaemia FAB M7 Fab M7 LEUKEMIA, MEGAKARYOCYTIC, MALIGNANT M7 M7 OR Acute Megakaryoblastic Leukemia Acute Megakaryoblastic Leukemia A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities; 2) AML with multilineage dysplasia; 3) Therapy-related AML; 4) AML not otherwise specified. The required bone marrow or peripheral blood blast percentage for the diagnosis of AML is 20% (WHO classification). C3171 Neoplastic Process Acute Myeloid Leukemia (AML) Acute Myeloid Leukemia C4015937 CPTAC CTEP CTRP Cellosaurus GDC MedDRA NICHD A rapidly progressive cancer of the blood and bone marrow consisting of the proliferation of abnormal myeloblasts, which are immature, dysfunctional white blood cells. An aggressive (fast-growing) disease in which too many myeloblasts (immature white blood cells that are not lymphoblasts) are found in the bone marrow and blood. 9861/3 Malignant Acute_Myeloid_Leukemia 9861/3 9872/3 Acute granulocytic leukemia Acute myeloblastic leukaemia [AML] Acute myeloblastic leukemia Acute myeloblastic leukemia, not having achieved remission Acute myelocytic leukemia Acute myelogenous leukemia Acute myeloid leukemia Acute myeloid leukemia (AML) Acute myeloid leukemia without mention of having achieved remission Acute non-lymphocytic leukemia Myeloid leukemia, acute AML AML - Acute Myeloid Leukemia ANLL Acute Granulocytic Leukemia Acute Myeloblastic Leukemia Acute Myelocytic Leukemia Acute Myelogenous Leukemia Acute Myelogenous Leukemias Acute Myeloid Leukemia Acute Myeloid Leukemia (AML) Acute Nonlymphocytic Leukemia Acute granulocytic leukemia Acute myeloblastic leukemia Acute myelocytic leukemia Acute myelogenous leukemia Acute myeloid leukemia Acute myeloid leukemia (AML) Hematopoeitic - Acute Myleogenous Leukemia (AML) acute myeloblastic leukemia acute myelogenous leukemia acute myeloid leukemia acute nonlymphocytic leukemia Acute Myeloid Leukemia A clonal proliferation of myeloid cells and their precursors in the bone marrow, peripheral blood, and spleen. When the proliferating cells are immature myeloid cells and myeloblasts, it is called acute myeloid leukemia. When the proliferating myeloid cells are neutrophils, it is called chronic myelogenous leukemia. C3172 Neoplastic Process Myeloid Leukemia Myeloid Leukemia C0023470 CDISC CPTAC CTRP GDC A progressive, proliferative disease of blood cells, originating from immature granulocytes. 9860/3 Malignant Myeloid_Leukemia 9860/3 Granulocytic leukemia, NOS Myelocytic leukemia, NOS Myelogenous leukemia, NOS Myeloid Leukemias Myeloid leukaemia Myeloid leukaemia, unspecified Myeloid leukemia Myeloid leukemia, NOS Myeloid leukemia, subacute Non-lymphocytic leukemia, NOS Other myeloid leukaemia Other myeloid leukemia Other myeloid leukemia without mention of having achieved remission Subacute myeloid leukemia without mention of having achieved remission Unspecified myeloid leukemia Unspecified myeloid leukemia without mention of having achieved remission LEUKEMIA, GRANULOCYTIC, MALIGNANT Leukemia Granulocytic Leukemia Myeloid Myelocytic Leukemia Myelogenous Leukemia Myeloid Leukemia Myeloid leukemia, NOS Non-Lymphoblastic Leukemia Non-Lymphocytic Leukemia Non-lymphoblastic Leukemia Non-lymphocytic Leukemia Myeloid Leukemia A phase of chronic myeloid leukemia characterized by one or more of the following: 1) Myeloblasts accounting for 10-19% of the peripheral blood white cells or of the nucleated cells in the bone marrow, 2) peripheral blood basophils at least 20%, 3) persistent thrombocytopenia that is unrelated to therapy, 4) persistent thrombocytosis despite adequate therapy, 5) increasing white blood cell count and increasing spleen size unresponsive to therapy, and/or evidence of clonal evolution. (WHO, 2001) C3173 Neoplastic Process Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive C0023472 A phase of chronic myelogenous leukemia in which the disease is progressing. In this phase, 10% to 19% of the cells in the blood and bone marrow are blast cells (immature blood cells). Malignant Accelerated_Phase_Chronic_Myelogenous_Leukemia Accelerated Phase CML Accelerated Phase Chronic Granulocytic Leukemia Accelerated Phase Chronic Myelocytic Leukemia Accelerated Phase Chronic Myelogenous Leukemia Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Accelerated Phase Chronic Myelogenous Leukemia, BCR::ABL1 Positive Accelerated Phase Chronic Myeloid Leukemia Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive Accelerated Phase Chronic Myeloid Leukemia, BCR::ABL1 Positive Aggressive-Phase CML Aggressive-Phase Chronic Myelocytic Leukemia Aggressive-Phase Chronic Myelogenous Leukemia Aggressive-Phase Chronic Myeloid Leukemia accelerated phase chronic myelogenous leukemia Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive A chronic myeloproliferative neoplasm characterized by the expression of the BCR-ABL1 fusion gene. It presents with neutrophilic leukocytosis. It can appear at any age, but it mostly affects middle aged and older individuals. Patients usually present with fatigue, weight loss, anemia, night sweats, and splenomegaly. If untreated, it follows a biphasic or triphasic natural course; an initial indolent chronic phase which is followed by an accelerated phase, a blast phase, or both. Allogeneic stem cell transplantation and tyrosine kinase inhibitors delay disease progression and prolong overall survival. C3174 Neoplastic Process Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Myeloid Leukemia, BCR-ABL1 Positive C0023473 CPTAC CTRP Cellosaurus GDC A slowly progressing disease in which too many white blood cells are made in the bone marrow. 9863/3 9875/3 Malignant Chronic_Myelogenous_Leukemia 9863/3 9875/3 Chronic granulocytic leukemia, NOS Chronic myelocytic leukemia, NOS Chronic myelogenous leukemia, BCR-ABL positive Chronic myelogenous leukemia, BCR/ABL positive Chronic myeloid leukaemia [CML], BCR/ABL-positive Chronic myeloid leukemia without mention of having achieved remission Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission Chronic myeloid leukemia, NOS Myeloid leukemia, chronic BCR-ABL Positive Chronic Myelogenous Leukemia CML CML - Chronic Myelogenous Leukemia Chronic Granulocytic Leukemia Chronic Myelocytic Leukemia Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia (CML) Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Myelogenous Leukemia, BCR::ABL1 Positive Chronic Myelogenous Leukemias Chronic Myeloid Leukemia Chronic Myeloid Leukemia, BCR-ABL1 Positive Chronic Myeloid Leukemia, BCR::ABL1 Positive Chronic myelogenous leukemia, BCR-ABL positive Hematopoeitic - Chronic Myelocytic Leukemia (CML) chronic granulocytic leukemia chronic myelogenous leukemia chronic myeloid leukemia Chronic Myeloid Leukemia, BCR-ABL1 Positive A phase of chronic myeloid leukemia, BCR-ABL1 positive in which the peripheral blood smear shows leukocytosis with neutrophils in different stages of maturation, less than 2% blasts, and normal or increased platelet count. Most patients have mild anemia. The bone marrow is hypercellular due to increased numbers of neutrophils and their precursors, and blasts usually account for fewer than 5% of the marrow cells. Megakaryocytes are smaller than normal and have hypolobated nuclei. The spleen is enlarged due to infiltration of the cords of the red pulp by granulocytes. C3175 Neoplastic Process Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive C0023474 A phase of chronic myelogenous leukemia in which fewer than 10% of the cells in the blood and bone marrow are blast cells (immature blood cells). This phase may last from several months to several years, and there may be no symptoms of leukemia. Malignant Chronic_Phase_Chronic_Myelogenous_Leukemia Chronic Phase CML Chronic Phase Chronic Granulocytic Leukemia Chronic Phase Chronic Myelocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase Chronic Myelogenous Leukemia, BCR::ABL1 Positive Chronic Phase Chronic Myeloid Leukemia Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive Chronic Phase Chronic Myeloid Leukemia, BCR::ABL1 Positive chronic phase chronic myelogenous leukemia Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive Myeloid leukemia characterized by the absence of Philadelphia chromosome. C3176 Neoplastic Process Myeloid Leukemia, Philadelphia-Negative C1292772 Malignant Philadelphia-Negative_Myelogenous_Leukemia Myeloid Leukemia, Philadelphia-Negative Philadelphia-Negative Myelogenous Leukemia Philadelphia-Negative Myeloid Leukemia Myeloid Leukemia, Philadelphia-Negative Myeloid leukemia characterized by the presence of Philadelphia chromosome. C3177 Neoplastic Process Myeloid Leukemia, Philadelphia-Positive C0023476 Malignant Philadelphia-Positive_Myelogenous_Leukemia Myeloid Leukemia, Philadelphia-Positive Ph1-Positive Granulocytic Leukemia Ph1-Positive Myelocytic Leukemia Ph1-Positive Myelogenous Leukemia Ph1-Positive Myeloid Leukemia Philadelphia-Positive Granulocytic Leukemia Philadelphia-Positive Myelocytic Leukemia Philadelphia-Positive Myelogenous Leukemia Philadelphia-Positive Myeloid Leukemia Myeloid Leukemia, Philadelphia-Positive A myelodysplastic/myeloproliferative neoplasm which is characterized by persistent monocytosis, absence of a Philadelphia chromosome and BCR/ABL fusion gene, fewer than 20 percent blasts in the bone marrow and blood, myelodysplasia, and absence of PDGFRA or PDGFRB rearrangement. C3178 Neoplastic Process Chronic Myelomonocytic Leukemia Chronic Myelomonocytic Leukemia C0023480 CPTAC CTEP CTRP Cellosaurus GDC A slowly progressing type of myelodysplastic/myeloproliferative disease in which too many myelomonocytes (a type of white blood cell) are in the bone marrow, crowding out other normal blood cells, such as other white blood cells, red blood cells, and platelets. 9945/3 Malignant Chronic_Myelomonocytic_Leukemia 9945/3 Chronic monocytic leukemia without mention of having achieved remission Chronic myelomonocytic leukaemia Chronic myelomonocytic leukemia in transformation Chronic myelomonocytic leukemia not having achieved remission Chronic myelomonocytic leukemia, NOS Monocytic leukemia, chronic CMML Chronic Myelomonocytic Leukemia Chronic Myelomonocytic Leukemia (CMML) Chronic myelomonocytic leukemia chronic myelomonocytic leukemia Chronic Myelomonocytic Leukemia A rare chronic myeloproliferative neoplasm characterized by neutrophilic leukocytosis. There is no detectable Philadelphia chromosome or BCR/ABL fusion gene. C3179 Neoplastic Process Chronic Neutrophilic Leukemia Chronic Neutrophilic Leukemia C0023481 CTRP Cellosaurus GDC A disease in which too many neutrophils (a type of white blood cell) are found in the blood. The extra neutrophils may cause the spleen and liver to become enlarged. Chronic neutrophilic leukemia may stay the same for many years or it may progress quickly to acute leukemia. 9963/3 Malignant Chronic_Neutrophilic_Leukemia 9963/3 Chronic neutrophilic leukemia Chronic Neutrophilic Leukemia Chronic neutrophilic leukemia Neutrophilic Leukemia chronic neutrophilic leukemia Chronic Neutrophilic Leukemia An aggressive plasma cell neoplasm characterized by the presence of neoplastic plasma cells in the peripheral blood. It is characterized by the presence of a circulating clonal plasma cell count that exceeds 2x10^9/L or is 20% of the leukocyte differential count. C3180 Neoplastic Process Plasma Cell Leukemia Plasma Cell Leukemia C0023484 CPTAC CTRP GDC 9733/3 Malignant Plasma_Cell_Leukemia 9733/3 Plasma cell leukemia Plasmacytic leukemia Leukemia Plasmacytic Plasma Cell Leukemia Plasma cell leukemia Plasmacytic Leukemia Plasmacytic leukemia Plasma Cell Leukemia A mature B- or T- cell leukemia with progressive clinical course. It is characterized by the presence of medium-sized lymphocytes with visible nucleoli (prolymphocytes) in the peripheral blood, bone marrow, and spleen. C3181 Neoplastic Process Prolymphocytic Leukemia Prolymphocytic Leukemia C0023486 CTEP CTRP GDC A type of chronic lymphocytic leukemia (CLL) in which too many immature white blood cells (prolymphocytes) are found in the blood and bone marrow. PLL usually progresses more rapidly than classic CLL. 9832/3 Malignant Prolymphocytic_Leukemia 9832/3 Prolymphocytic leukemia, NOS PLL Prolymphocytic Leukemia Prolymphocytic leukemia (B or T) Prolymphocytic leukemia (B or T-cell) prolymphocytic leukemia Prolymphocytic Leukemia An acute myeloid leukemia (AML) in which abnormal promyelocytes predominate. It is characterized by the PML-RARA fusion. There are two variants: the typical and microgranular variant. This AML is particularly sensitive to treatment with all trans-retinoic acid and has a favorable prognosis. (WHO) C3182 Neoplastic Process Acute Promyelocytic Leukemia with PML-RARA Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA C0023487 CPTAC CTEP CTRP Cellosaurus GDC NICHD PCDC Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia (AML), and it is treated differently than other types of AML because of its marked sensitivity to differentiating effects of all trans-retinoic acid. APL is characterized by a severe coagulopathy which may be present at diagnosis. APL occurs in 7 % of children with AML. An aggressive (fast-growing) type of acute myeloid leukemia in which there are too many immature blood-forming cells in the blood and bone marrow. It is usually marked by an exchange of parts of chromosomes 15 and 17. 9866/3 Malignant Acute_Promyelocytic_Leukemia 9866/3 Acute myeloid leukemia, PML/RAR-alpha Acute promyelocytic leukaemia [PML] Acute promyelocytic leukaemia, PML-RAR-alpha Acute promyelocytic leukaemia, t(15;17)(q22;q11-12) Acute promyelocytic leukemia, NOS Acute promyelocytic leukemia, t(15;17)(q22;q11-12) FAB M3 (includes all variants) M3 AML with t(15;17)(q24.1;q21.2) APL APML APML - Acute promyelocytic leukemia Acute Promyelocytic Leukemia Acute Promyelocytic Leukemia with PML-RARA Acute Promyelocytic Leukemia with PML::RARA Acute Promyelocytic Leukemia with t(15;17)(q22;q12); PML-RARA Acute Promyelocytic Leukemia with t(15;17)(q22;q12); PML/RARA Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA Fusion Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML::RARA Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML::RARA Fusion Acute promyelocytic leukaemia, PML-RAR-alpha Acute promyelocytic leukaemia, t(15;17)(q22;q11-12) Acute promyelocytic leukemia FAB M3 M3 M3 OR Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA Promyelocytic Leukemia acute promyelocytic leukemia promyelocytic leukemia Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA Acute lymphoblastic leukemia of T-cell origin. It comprises about 15% of childhood cases and 25% of adult cases. It is more common in males than females. (WHO, 2001) C3183 Neoplastic Process T cell acute lymphoblastic leukemia T Acute Lymphoblastic Leukemia C1961099 CTEP CTRP Cellosaurus GDC NICHD PCDC An acute lymphoblastic leukemia of T-lineage origin. An aggressive (fast-growing) type of leukemia (blood cancer) in which too many T-cell lymphoblasts (immature white blood cells) are found in the bone marrow and blood. 9837/3 Malignant Precursor_T_Lymphoblastic_Leukemia 9837/3 Precursor T-cell lymphoblastic leukemia Acute T Cell Leukemia Acute T Cell Lymphoblastic Leukemia Acute T Cell Lymphocytic Leukemia Acute T-Cell Leukemia Acute T-Cell Lymphoblastic Leukemia Acute T-Cell Lymphocytic Leukemia Precursor T-Cell Lymphoblastic Leukemia Precursor T-Lymphoblastic Leukemia Precursor T-lymphoblastic leukemia (T-cell ALL) T Acute Lymphoblastic Leukemia T cell acute lymphoblastic leukemia T-ALL T-Acute Lymphoblastic Leukemia T-Cell Acute Lymphoblastic Leukemia T-Cell Type Acute Leukemia T-cell ALL T-cell acute lymphoblastic leukemia T-cell acute lymphocytic leukemia precursor T-lymphoblastic leukemia T Acute Lymphoblastic Leukemia A peripheral (mature) T-cell neoplasm linked to the human T-cell leukemia virus type 1 (HTLV-1). Adult T-cell leukemia/lymphoma is endemic in several regions of the world, in particular Japan, the Caribbean, and parts of Central Africa. C3184 Neoplastic Process Adult T-Cell Leukemia/Lymphoma Adult T-Cell Leukemia/Lymphoma C0023493 CTEP CTRP Cellosaurus GDC An aggressive (fast-growing) type of T-cell non-Hodgkin lymphoma caused by the human T-cell leukemia virus type 1 (HTLV-1). It is marked by bone and skin lesions, high calcium levels, and enlarged lymph nodes, spleen, and liver. 9827/3 Malignant Adult_T-Cell_Lymphoma_Leukemia 9827/3 Adult T-cell leukemia Adult T-cell leukemia/lymphoma (HTLV-1 positive) Adult T-cell leukemia/lymphoma (HTLV-1 positive) (includes all variants) Adult T-cell lymphoma Adult T-cell lymphoma/leukemia ATLL Adult T Cell Lymphoma/Leukemia Adult T-Cell Leukemia/Lymphoma Adult T-Cell Lymphoma/Leukemia Adult T-cell leukemia/lymphoma Adult T-cell lymphoma/leukemia HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia HTLV-I Associated Adult T-Cell Leukemia/Lymphoma adult T-cell leukemia/lymphoma Adult T-Cell Leukemia/Lymphoma A sex cord-stromal tumor occurring in the testis and rarely in the ovary. It is predominantly or completely composed of Leydig cells which may contain crystals of Reinke. In males it usually presents as a painless testicular enlargement and it may be associated with gynecomastia and decreased libido. The majority of the cases have a benign clinical course. Approximately 10% of the cases have a malignant clinical course and metastasize. In females it may be associated with androgenic manifestations and it follows a benign clinical course. C3188 Neoplastic Process Leydig Cell Tumor Leydig Cell Tumor C0023601 CTRP GDC NICHD A sex cord-stromal tumor, comprising Leydig cells, either predominantly or completely, occurring in the testis and rarely in the ovary. 8650/1 Undetermined Leydig_Cell_Tumor 8650/1 Interstitial cell tumor, NOS Leydig cell tumor, NOS Interstitial Cell Neoplasm Interstitial Cell Tumor Leydig Cell Neoplasm Leydig Cell Tumor Leydig Cell Tumor A benign or malignant neoplasm involving the lip. C3191 Neoplastic Process Lip Neoplasm C0023761 Undetermined Lip_Neoplasm Lip Neoplasm Lip Neoplasms Lip Tumor Neoplasm of Lip Neoplasm of the Lip Tumor of Lip Tumor of the Lip Lip Neoplasm A benign, usually painless, well-circumscribed lipomatous tumor composed of adipose tissue. C3192 Neoplastic Process Lipoma C0023798 CDISC CPTAC Cellosaurus GDC NICHD A benign (not cancer) tumor made of fat cells. A benign neoplasm composed of adipose tissue. 8850/0 Benign Lipoma 8850/0 Lipoma of other specified sites Lipoma, NOS LIPOMA, BENIGN Lipoma Lipoma, NOS lipoma Lipoma A neoplastic process characterized by diffuse overgrowth of mature adipose tissue. C3193 Neoplastic Process Lipomatosis C2931642 Benign Lipomatosis Launois-Bensaude Syndrome Lipomatosis Madelung Disease Madelung's Disease Lipomatosis A usually painless malignant tumor that arises from adipose tissue. Microscopically, it may contain a spectrum of neoplastic adipocytes ranging from lipoblasts to pleomorphic malignant adipocytes. Morphologic variants include: well differentiated, dedifferentiated, pleomorphic, and myxoid liposarcoma. The metastatic potential is higher in less differentiated tumors. C3194 Neoplastic Process Liposarcoma Liposarcoma C0346117 CDISC CPTAC CTEP CTRP Cellosaurus GDC A malignant neoplasm composed of adipose tissue. 8850/3 Malignant Liposarcoma Malignant_Lipomatous_Neoplasm 8850/3 Fibroliposarcoma Liposarcoma, NOS LIPOSARCOMA, MALIGNANT Liposarcoma Liposarcoma, NOS Malignant Lipomatous Neoplasm liposarcoma Liposarcoma A benign or malignant, primary or metastatic neoplasm involving the lungs. Representative examples of benign neoplasms include adenoma, papilloma, chondroma, and endobronchial lipoma. Representative examples of malignant neoplasms include carcinoma, carcinoid tumor, sarcoma, and lymphoma. C3200 Neoplastic Process Lung Neoplasm Lung Neoplasm C0024121 CTRP Undetermined Lung_Neoplasm Lung Neoplasm Lung Neoplasms Lung Tumor Neoplasm of Lung Neoplasm of the Lung Tumor of Lung Tumor of the Lung Lung Neoplasm A benign ovarian stromal tumor in which more than 90% of the tumor cells resemble steroid hormone-secreting cells. Crystals of Reinke are not present. It occurs in post-menopausal women and it is usually associated with estrogenic effects. C3202 Neoplastic Process Ovarian Stromal Luteoma C0024167 CDISC GDC A benign neoplasm of the ovary, composed of leuteinized granulosa-theca cells. 8610/0 Benign Luteoma 8610/0 Luteinoma Luteoma, NOS LUTEOMA, BENIGN Luteal Cell Neoplasm Luteal Cell Tumor Luteinoma Luteoma Ovarian Stroma Luteoma Ovarian Stromal Luteoma Ovarian Stromal Luteoma A lymphangioma characterized by the presence of collagen bundle formation. It has an indolent clinical course and may be associated with skin plaques. C3203 Neoplastic Process Acquired Progressive Lymphangioma C0024217 GDC Benign Lymphangioendothelioma 9170/0 Lymphangioendothelioma, NOS Acquired Progressive Lymphangioma Lymphangioendothelioma Acquired Progressive Lymphangioma A neoplasm with perivascular epithelioid cell differentiation, often associated with tuberous sclerosis. It is characterized by the presence of smooth muscle and epithelioid cells and by the proliferation of lymphatic vessels. Sites of involvement include the lymph nodes, lung, mediastinum, and retroperitoneum. C3204 Neoplastic Process Lymphangioleiomyoma C0024223 GDC 9174/0 Undetermined Lymphangiomyoma 9174/0 Lymphangiomyoma Lymphangioleiomyoma Lymphangiomyoma Lymphangioleiomyoma The respiratory passage distal to the respiratory bronchiole. Alveolar sacs and alveoli arise from the alveolar duct. C32056 Tissue Alveolar Duct C0391892 Alveolar_Duct Alveolar Duct Alveolar Duct Paired glands located on either side of the anus of most carnivores that secrete a noxious-smelling liquid, thus allowing members of the same species to identify one another. C32068 Anatomical Structure Anal Gland C0162322 Anal_Gland Anal Gland Anal Gland A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas. C3208 Neoplastic Process Lymphoma Lymphoma C4227552 CDISC CPTAC CTEP CTRP Cellosaurus FDA GDC MedDRA NICHD A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas. A malignant neoplasm composed of lymphocytes of B- or T/NK-cell phenotype. A malignant neoplasm of the lymphatic system that is comprised of abnormal lymphocytes. Cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer. 9590/3 Malignant Lymphoma 9590/3 Lymphoma Lymphoma, NOS Malignant Lymphomas, NOS or Diffuse Malignant lymphoma, NOS Other malignant lymphomas Other malignant lymphomas involving intra-abdominal lymph nodes Other malignant lymphomas involving intrathoracic lymph nodes Other malignant lymphomas involving lymph nodes of head, face, and neck Other malignant lymphomas involving lymph nodes of inguinal region and lower limb Other malignant lymphomas involving lymph nodes of multiple sites Other malignant lymphomas, unspecified site, extranodal and solid organ sites IMDRF:E180104 LYMPHOMA, MALIGNANT Lymphoma Lymphoma (Hodgkin and Non-Hodgkin) Lymphoma (Hodgkin's and Non-Hodgkin's) Lymphoma, NOS Lymphomatous Malignant Lymphoma lymphoma Lymphoma A neoplasm of follicle centre B cells which has at least a partial follicular pattern. Follicular lymphomas comprise about 35% of adult non-Hodgkin lymphomas in the U.S. and 22% worldwide. Most patients have widespread disease at diagnosis. Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present. The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)]. Histological grade correlates with prognosis. Grades 1 and 2 follicular lymphomas are indolent and grade 3 is more aggressive (adapted from WHO, 2001). C3209 Neoplastic Process Follicular Lymphoma Follicular Lymphoma C0024301 CDISC CPTAC CTEP CTRP Cellosaurus GDC mCode A neoplasm of lymphoid cells which has at least a partial follicular pattern. A type of B-cell non-Hodgkin lymphoma (cancer of the immune system) that is usually indolent (slow-growing). The tumor cells grow as groups to form nodules. There are several subtypes of follicular lymphoma. 9690/3 Malignant Follicular_Lymphoma 9690/3 Follicular lymphoma Follicular lymphoma, NOS Follicular lymphoma, unspecified Follicular lymphoma, unspecified, unspecified site Malignant lymphoma, centroblasticcentrocytic, follicular Malignant lymphoma, follicle center, NOS Malignant lymphoma, follicle center, follicular Malignant lymphoma, follicular, NOS Malignant lymphoma, lymphocytic, nodular, NOS Malignant lymphoma, nodular, NOS Nodular lymphoma Nodular lymphoma involving intra-abdominal lymph nodes Nodular lymphoma involving lymph nodes of head, face, and neck Nodular lymphoma involving lymph nodes of multiple sites Nodular lymphoma, unspecified site, extranodal and solid organ sites Other types of follicular lymphoma, unspecified site Follicle Center Lymphoma Follicular Centre Cell Lymphoma Follicular Lymphoma Follicular Non-Hodgkin Lymphoma Follicular Non-Hodgkin's Lymphoma Follicular lymphoma Follicular lymphoma, unspecified, unspecified site LYMPHOMA, FOLLICULAR, MALIGNANT Lymphoma, Follicular Centre Cell follicular lymphoma Follicular Lymphoma A lymph node located in the anterior part of the mediastinum. C32097 Anatomical Structure Anterior Mediastinal Lymph Node C0229758 CDISC A lymph node located in the anterior part of the mediastinum. Anterior_Mediastinal_Lymph_Node ANTERIOR MEDIASTINAL LYMPH NODE Anterior Mediastinal Lymph Node Prevascular Lymph Node Anterior Mediastinal Lymph Node Distinct from Hodgkin lymphoma both morphologically and biologically, non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss. The clinical course varies according to the morphologic type. NHL is clinically classified as indolent, aggressive, or having a variable clinical course. NHL can be of B-or T-/NK-cell lineage. C3211 Neoplastic Process Non-Hodgkin Lymphoma Non-Hodgkin Lymphoma C0024305 CPTAC CTEP CTRP Cellosaurus GDC MedDRA NICHD mCode A malignant neoplasm of the lymphatic system that is comprised of abnormal lymphocytes in the absence of Reed-Sternberg cells. Any of a large group of cancers of lymphocytes (white blood cells). NHLs can occur at any age and are often marked by lymph nodes that are larger than normal, fever, and weight loss. There are many different types of NHL. These types can be divided into aggressive (fast-growing) and indolent (slow-growing) types, and they can be formed from either B-cells or T-cells. B-cell NHLs include Burkitt lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), diffuse large B-cell lymphoma, follicular lymphoma, immunoblastic large cell lymphoma, precursor B-lymphoblastic lymphoma, and mantle cell lymphoma. T-cell NHLs include mycosis fungoides, anaplastic large cell lymphoma, and precursor T-lymphoblastic lymphoma. Lymphomas that occur after bone marrow or stem cell transplantation are usually B-cell NHLs. Prognosis and treatment depend on the stage and type of disease. 9591/3 Malignant Non-Hodgkin_s_Lymphoma 9591/3 Large cell lymphoma Large cell lymphoma involving intra-abdominal lymph nodes Large cell lymphoma involving intrathoracic lymph nodes Large cell lymphoma involving lymph nodes of inguinal region and lower limb Large cell lymphoma involving lymph nodes of multiple sites Large cell lymphoma, unspecified site, extranodal and solid organ sites Lymphosarcoma Lymphosarcoma and reticulosarcoma and other specified malignant tumors of lymphatic tissue Lymphosarcoma involving intrathoracic lymph nodes Lymphosarcoma involving lymph nodes of multiple sites Lymphosarcoma, unspecified site, extranodal and solid organ sites Malignant lymphoma, non-Hodgkin, NOS Non-Hodgkin lymphoma, NOS Non-Hodgkin lymphoma, unspecified Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck Non-Hodgkin lymphoma, unspecified, unspecified site Non-Hodgkin's lymphoma Other and unspecified types of non-Hodgkin lymphoma Other named variants of lymphosarcoma and reticulosarcoma Other named variants of lymphosarcoma and reticulosarcoma, unspecified site Other specified types of non-Hodgkin lymphoma Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites Other specified types of non-Hodgkin lymphoma, intra-abdominal lymph nodes Other specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes Other specified types of non-Hodgkin lymphoma, lymph nodes of head, face, and neck Other specified types of non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites Other specified types of non-Hodgkin lymphoma, unspecified site Reticulosarcoma Reticulosarcoma involving intra-abdominal lymph nodes Reticulosarcoma involving intrathoracic lymph nodes Reticulosarcoma involving lymph nodes of axilla and upper limb Reticulosarcoma involving lymph nodes of head, face, and neck Reticulosarcoma involving lymph nodes of inguinal region and lower limb Reticulosarcoma involving lymph nodes of multiple sites Reticulosarcoma, unspecified site, extranodal and solid organ sites NHL NHL, NOS Non-Hodgkin Lymphoma Non-Hodgkin lymphoma, NOS Non-Hodgkin lymphoma, unspecified site Non-Hodgkin's Lymphoma Non-Hodgkin's Lymphoma (NHL) non-Hodgkin lymphoma Non-Hodgkin Lymphoma A clonal neoplasm of small B-lymphocytes, lymphoplasmacytoid cells, and plasma cells involving the bone marrow, lymph nodes, and the spleen. The majority of patients have a serum IgM paraprotein. C3212 Neoplastic Process Lymphoplasmacytic Lymphoma Lymphoplasmacytic Lymphoma C0334633 CDISC CTEP CTRP GDC A malignant neoplasm composed of lymphocytes (B-cells), lymphoplasmacytoid cells, and plasma cells. 9671/3 9761/3 Malignant Lymphoplasmacytic_Lymphoma_Waldenstrom_s_Macroglobulinemia 9671/3 Lymphoplasmacytic lymphoma Malignant lymphoma, lymphoplasmacytic Malignant lymphoma, lymphoplasmacytoid Malignant lymphoma, plasmacytoid Plasmacytic lymphoma Immunocytoma, Lymphoplasmacytic Type LYMPHOMA, LYMPHOPLASMACYTIC, MALIGNANT Lymphoma, Plasmacytic Lymphoplasmacytic Lymphoma Lymphoplasmacytic lymphoma Lymphoplasmacytic lymphoma (Waldenstrom macroglobulinemia) Lymphoplasmacytoid Lymphoma lymphoplasmacytic lymphoma Lymphoplasmacytic Lymphoma A type of large, coiled, tubular, sometimes branched, specialized sweat gland that empties into the upper portion of a hair follicle instead of directly onto the skin surface. It has no secretory innervation but is sensitive to epinephrine in the bloodstream. C32132 Body Part, Organ, or Organ Component Apocrine Sweat Gland C0930083 Apocrine_Sweat_Gland Apocrine Sweat Gland Apocrine Sweat Gland A primary or metastatic malignant neoplasm that affects the retina. C3216 Neoplastic Process Malignant Retinal Neoplasm Malignant Retinal Neoplasm C0024622 CPTAC CTRP mCode Malignant Malignant_Retinal_Neoplasm Malignant neoplasm of left retina Malignant neoplasm of retina Malignant neoplasm of right retina Malignant neoplasm of unspecified retina Malignant neoplasm: Retina Malignant Neoplasm of Retina Malignant Neoplasm of the Retina Malignant Retina Neoplasm Malignant Retina Tumor Malignant Retinal Neoplasm Malignant Retinal Tumor Malignant Tumor of Retina Malignant Tumor of the Retina Malignant neoplasm of unspecified retina Malignant Retinal Neoplasm A neoplasm that arises from mast cells and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3217 Neoplastic Process Benign Mastocytoma C2242987 CDISC A benign neoplasm composed of mast cells. Benign Benign_Mastocytoma Benign Mastocytoma MAST CELL TUMOR, BENIGN Benign Mastocytoma A variant of cutaneous mastocytosis which is seen almost exclusively in children. (WHO, 2001) C3218 Neoplastic Process Diffuse Cutaneous Mastocytosis C0024901 GDC 9740/1 Undetermined Diffuse_Cutaneous_Mastocytosis 9740/1 Diffuse cutaneous mastocytosis Diffuse Cutaneous Mastocytosis Diffuse cutaneous mastocytosis Diffuse Cutaneous Mastocytosis A benign or malignant neoplasm that affects the maxillary sinus. Representative examples of benign neoplasms include Schneiderian papilloma and salivary gland-type adenoma. Representative examples of malignant neoplasms include carcinoma and lymphoma. C3219 Neoplastic Process Maxillary Sinus Neoplasm C0024958 Undetermined Maxillary_Sinus_Neoplasm Maxillary Sinus Neoplasm Maxillary Sinus Tumor Neoplasm of Maxillary Sinus Neoplasm of the Maxillary Sinus Tumor of Maxillary Sinus Tumor of the Maxillary Sinus Maxillary Sinus Neoplasm A benign or malignant neoplasm that affects the structures of the mediastinum. Representative examples include mediastinal lipoma, mediastinal schwannoma, thymoma, mediastinal germ cell tumor, and mediastinal lymphoma. C3221 Neoplastic Process Mediastinal Neoplasm C0025063 Undetermined Mediastinal_Neoplasm Mediastinal Neoplasm Mediastinal Neoplasm NOS Mediastinal Tumor Neoplasm of Mediastinum Neoplasm of the Mediastinum Tumor of Mediastinum Tumor of the Mediastinum Mediastinal Neoplasm A malignant, invasive embryonal neoplasm arising from the cerebellum or posterior fossa. It occurs predominantly in children and has the tendency to metastasize via the cerebrospinal fluid pathways. Signs and symptoms include truncal ataxia, disturbed gait, lethargy, headache, and vomiting. There are four histologic variants: classic medulloblastoma, large cell/anaplastic medulloblastoma, desmoplastic/nodular medulloblastoma, and medulloblastoma with extensive nodularity. C3222 Neoplastic Process Medulloblastoma C0025149 CDISC CTEP Cellosaurus GDC MedDRA NICHD A malignant brain tumor that begins in the lower part of the brain and that can spread to the spine or to other parts of the body. Medulloblastomas are a type of primitive neuroectodermal tumor (PNET). A malignant, invasive embryonal neoplasm arising from the cerebellum. A rapidly progressive cancer of the brain that originates in the cerebellum. 9470/3 Malignant Medulloblastoma CNS, medulloblastoma Medulloblastoma CNS, medulloblastoma MEDULLOBLASTOMA, MALIGNANT Medulloblastoma Medulloblastomas medulloblastoma Medulloblastoma Lymph node located in the bronchi. C32232 Anatomical Structure Bronchial Lymph Node C1305372 CDISC Lymph node(s) adjacent to the bronchi. Bronchial_Lymph_Node Bronchial Lymph Node LYMPH NODE, BRONCHIAL Bronchial Lymph Node The left and right bronchi considered together with their branches. C32233 Body Part, Organ, or Organ Component Bronchial Tree C1442216 Bronchial_Tree Bronchial Tree Bronchial Tree A type of minor salivary gland located in the mucous membrane of the cheek. C32237 Body Part, Organ, or Organ Component Buccal Salivary Gland C0226918 Buccal_Salivary_Gland Buccal Salivary Gland Buccal Salivary Gland Multiple endocrine neoplasia caused by inactivation of the tumor suppressor gene MEN-1. Patients may develop hyperparathyroidism and parathyroid gland adenomas, pituitary gland adenomas, pancreatic islet cell neoplasms, and carcinoid tumors. C3225 Neoplastic Process Multiple Endocrine Neoplasia Type 1 Multiple Endocrine Neoplasia Type 1 C0025267 CCPS CTRP Cellosaurus NICHD mCode A rare, inherited disorder that affects the endocrine glands and can cause tumors in the parathyroid and pituitary glands and the pancreas. These tumors are usually benign (not cancer). They cause the glands to secrete high levels of hormones, which can lead to other medical problems, such as kidney stones, fertility problems, and severe ulcers. In some cases, tumors inside the pancreas can become malignant (cancer). Multiple endocrine neoplasia caused by inactivating mutation(s) of the tumor suppressor gene MEN1, encoding the menin protein, a component of the histone methyltransferase complex. The condition is characterized by hyperfunctioning adenomas of the parathyroid glands, adrenal glands, pituitary gland, and pancreatic endocrine cells (most commonly gastrinomas and insulinomas); thymic and bronchial carcinoid tumors also may develop. Undetermined Multiple_Endocrine_Neoplasia_Type_I MEA Type 1 MEA Type I MEN 1 MEN Type 1 MEN Type I MEN1 syndrome Multiple Endocrine Adenomatosis Multiple Endocrine Adenomatosis Type 1 Multiple Endocrine Adenomatosis Type I Multiple Endocrine Adenomatosis, Type I Multiple Endocrine Neoplasia Type 1 Multiple Endocrine Neoplasia Type I Multiple Endocrine Neoplasia, Type I Multiple endocrine neoplasia [MEN] type I Wermer Syndrome Wermer syndrome Wermer's Syndrome multiple endocrine neoplasia type 1 syndrome Multiple Endocrine Neoplasia Type 1 Multiple endocrine neoplasia caused by mutation of the RET gene. Patients develop medullary thyroid carcinomas, and may also develop pheochromocytomas and parathyroid gland hyperplasia. C3226 Neoplastic Process Multiple Endocrine Neoplasia Type 2A Multiple Endocrine Neoplasia Type 2A C0025268 CTRP Cellosaurus NICHD mCode Multiple endocrine neoplasia caused by activating mutation(s) of the RET protooncogene, encoding proto-oncogene tyrosine-protein kinase receptor Ret. This condition is characterized by medullary thyroid carcinoma, accompanied in some cases by pheochromocytoma and parathyroid gland hyperplasia or adenoma. Undetermined Multiple_Endocrine_Neoplasia_Type_II MEA Type 2a MEA Type II MEN 2A MEN Type 2a MEN Type II Multiple Endocrine Adenomatosis Type 2A Multiple Endocrine Adenomatosis Type 2a Multiple Endocrine Adenomatosis Type II Multiple Endocrine Adenomatosis, Type II Multiple Endocrine Neoplasia Type 2A Multiple Endocrine Neoplasia Type 2a Multiple Endocrine Neoplasia Type II Multiple Endocrine Neoplasia, Type II Multiple endocrine neoplasia [MEN] type IIA Multiple Endocrine Neoplasia Type 2A Simple tubular or compound racemose type glands located in the region where the esophagus attaches to the stomach which secrete mucus. C32261 Anatomical Structure Cardia Gland C1516289 Cardia_Gland Cardia Gland Cardia Gland Multiple endocrine neoplasia caused by mutation of the RET gene. Patients develop medullary thyroid carcinomas and numerous neural defects including neuromas. C3227 Neoplastic Process Multiple Endocrine Neoplasia Type 2B C0025269 Cellosaurus NICHD mCode Multiple endocrine neoplasia caused by activating mutation(s) of the RET protooncogene, encoding proto-oncogene tyrosine-protein kinase receptor Ret (most commonly the M918T mutation). This condition is characterized by an aggressive form of medullary thyroid carcinoma, accompanied by pheochromocytoma, mucosal neuromas, thickened corneal nerves, and Marfanoid habitus in most affected individuals. Undetermined Multiple_Endocrine_Neoplasia_Type_III MEN 2B MEN IIB MEN Type 2B MEN Type IIB Multiple Endocrine Adenomatosis Type IIB Multiple Endocrine Neoplasia Type 2B Multiple Endocrine Neoplasia Type 2b Multiple Endocrine Neoplasia Type 3 Multiple Endocrine Neoplasia Type IIB Multiple Endocrine Neoplasia Type III Multiple Endocrine Neoplasia, Type III Multiple endocrine neoplasia [MEN] type IIB Multiple Endocrine Neoplasia Type 2B A benign or malignant neoplasm that affects the meninges. The majority of the neoplasms arise from meningothelial cells and are called meningiomas. Non-meningothelial cell neoplasms include mesenchymal, non-meningothelial tumors, hemangiopericytomas, and melanocytic lesions. C3229 Neoplastic Process Meningeal Neoplasm Meningeal Neoplasm C0025284 CPTAC CTRP mCode Undetermined Meningeal_Neoplasm Neoplasm of uncertain behavior of meninges Meningeal Neoplasm Meningeal Neoplasms Meningeal Tumor Meninges Neoplasm Meninges Tumor Neoplasm of Meninges Neoplasm of the Meninges Neoplasm of uncertain behavior of meninges, unspecified Tumor of Meninges Tumor of the Meninges Meningeal Neoplasm A gland situated in the external auditory canal that produces a waxy secretion. C32294 Body Part, Organ, or Organ Component Ceruminous Gland C0229352 Ceruminous_Gland Ceruminous Gland Ceruminous Gland The mucous secreting glands in the cervix. C32296 Body Part, Organ, or Organ Component Cervical Gland C2724437 Cervical_Gland Cervical Gland Cervical Gland Any of the lymph nodes located in the neck. C32298 Body Part, Organ, or Organ Component Cervical Lymph Node C0588054 CDISC CPTAC GDC PCDC mCode Lymph node(s) in the cervical region, or neck. Cervical_Lymph_Node Cervical lymph nodes Cervical, NOS Lymph Node(s) Cervical CERVICAL LYMPH NODE Cervical Lymph Node Cervical Nodes Cervical lymph node structure (body structure) Cervical lymph nodes LYMPH NODE, CERVICAL Lymph Node(s) Cervical Cervical Lymph Node A generally slow growing tumor attached to the dura mater. It is composed of neoplastic meningothelial (arachnoidal) cells. It typically occurs in adults, often women and it has a wide range of histopathological appearances. Of the various subtypes, meningothelial, fibrous and transitional meningiomas are the most common. Most meningiomas are WHO grade 1 tumors, and some are WHO grade 2 or 3 tumors. Most subtypes share a common clinical behavior, although some subtypes are more likely to recur and follow a more aggressive clinical course. (Adapted from WHO) C3230 Neoplastic Process Meningioma Meningioma C4012135 CPTAC CTEP CTRP Cellosaurus GDC MedDRA NICHD A type of slow-growing tumor that forms in the meninges (thin layers of tissue that cover and protect the brain and spinal cord). Meningiomas usually occur in adults. A usually benign tumor that develops in the meninges. 9530/0 Undetermined Meningioma 9530/0 Meningioma Meningioma, NOS Meningiomas Meningioma Meningioma, NOS Meningiomas meningioma Meningioma A membranous tube containing endolymph within the cochlea between the scala vestibuli and the scala tympani. C32335 Anatomical Structure Cochlear Duct C1323110 Cochlear_Duct Cochlear Duct Cochlear Duct A component of the biliary duct system created by the convergence of the left and right hepatic ducts. C32356 Anatomical Structure Common Hepatic Duct C0019149 CDISC A duct that conveys bile from the convergence of the left and right hepatic ducts to the common bile duct. A tube that carries bile from the liver. It starts where the right and left hepatic (liver) ducts join outside the liver. It ends where the cystic duct from the gall bladder joins it to form the common bile duct. It is part of the biliary duct system. Common_Hepatic_Duct Common Hepatic Duct DUCT, COMMON HEPATIC common hepatic duct Common Hepatic Duct Paired exocrine glands located at the base of the penis, positioned posterior and lateral to the urethra, that produce and secrete a clear viscous liquid that lubricates the urethra in preparation for the passage of sperm. C32395 Body Part, Organ, or Organ Component Cowper Gland C0006366 CDISC The exocrine glands of the male reproductive system located at the base of the penis. Cowper_s_Gland Bulbourethral Gland Cowper Gland Cowper's Gland GLAND, BULBOURETHRAL Cowper Gland A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia. Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001) C3242 Neoplastic Process Multiple Myeloma Plasma Cell Myeloma Multiple Myeloma C0026764 CDISC CPTAC CTEP CTRP Cellosaurus GDC A malignant neoplasm of the bone marrow composed of plasma cells. A type of cancer that begins in plasma cells (white blood cells that produce antibodies). 9732/3 Malignant Plasma_Cell_Myeloma 9732/3 Multiple Myeloma Multiple myeloma Multiple myeloma and immunoproliferative neoplasms Multiple myeloma not having achieved remission Multiple myeloma without mention of having achieved remission Myeloma, NOS Myelomatosis Plasma cell myeloma Kahler disease MYELOMA, PLASMA CELL, MALIGNANT Multiple Myeloma Multiple Myeloma/Plasma Cell Myeloma Multiple myeloma Myeloma Myeloma, NOS Myelomatosis Plasma Cell Myeloma Plasma Cell Myeloma/Multiple Myeloma Plasma cell myeloma multiple myeloma myeloma myelomatosis plasma cell myeloma Multiple Myeloma A short duct attached to the gallbladder through which the bile from the gallbladder is secreted in the common bile duct. C32421 Anatomical Structure Cystic Duct C0010672 CDISC A duct that conveys bile from the gallbladder to the common bile duct. A tube that carries bile from the gall bladder. It joins the common hepatic duct to form the common bile duct. It is part of the biliary duct system. Cystic_Duct Cystic Duct DUCT, CYSTIC cystic duct Cystic Duct Lymph nodes located deep to the sternocleidomastoid muscle, which surround the internal jugular vein, and serve as the main pathway of lymphatic drainage for the head and neck. C32431 Body Part, Organ, or Organ Component Deep Cervical Lymph Node C0458298 Deep_Cervical_Lymph_Node Deep Cervical Lymph Node Deep Cervical Lymph Node A peripheral (mature) T-cell lymphoma presenting in the skin with patches/plaques. It is characterized by epidermal and dermal infiltration of small to medium-sized T-cells with cerebriform nuclei. Patients with limited disease generally have an excellent prognosis. In the more advanced stages, the prognosis is poor. (WHO, 2001) C3246 Neoplastic Process Mycosis Fungoides Mycosis Fungoides C0026948 CPTAC CTEP CTRP Cellosaurus GDC mCode A type of non-Hodgkin's lymphoma that first appears on the skin and can spread to the lymph nodes or other organs such as the spleen, liver, or lungs. 9700/3 Malignant Mycosis_Fungoides 9700/3 Mycosis fungoides Mycosis fungoides involving lymph nodes of multiple sites Mycosis fungoides, unspecified site Mycosis fungoides, unspecified site, extranodal and solid organ sites CTCL/ Mycosis fungoides Cutaneous T-cell lymphoma/Mycosis fungoides MF Mycosis Fungoides Mycosis fungoides Mycosis fungoides, unspecified site mycosis fungoides Mycosis Fungoides A clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20%, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukemia. It may occur de novo or as a result of exposure to alkylating agents and/or radiotherapy. (WHO, 2001) C3247 Neoplastic Process Myelodysplastic Syndrome Myelodysplastic Syndrome C3463824 CPTAC CTEP CTRP Cellosaurus GDC MedDRA NICHD A disorder characterized by insufficiently healthy hematapoietic cell production by the bone marrow. A group of diseases in which the bone marrow does not make enough healthy blood cells. A pre-malignant disorder characterized by blood cytopenias and abnormalities in bone marrow morphology. 9989/3 Malignant Myelodysplastic_Syndrome High grade myelodysplastic syndrome lesions Low grade myelodysplastic syndrome lesions Myelodysplastic Syndrome Myelodysplastic Syndromes Myelodysplastic syndrome Myelodysplastic syndrome, unspecified Myelodysplastic syndromes Other myelodysplastic syndromes Preleukemia Preleukemic syndrome Dysmyelopoietic Syndrome MDN MDS Myelodysplasia Myelodysplastic Neoplasm Myelodysplastic Syndrome Myelodysplastic Syndrome/Neoplasm Myelodysplastic Syndromes Myelodysplastic syndrome Oligoblastic Leukemia Preleukemia Smoldering Leukemia myelodysplasia myelodysplastic syndromes preleukemia smoldering leukemia Myelodysplastic Syndrome A convoluted tube connecting the efferent ductules of the testicle to the vas deferens. C32484 Anatomical Structure Duct of the Epididymis C0458632 Duct_of_the_Epididymis Duct of the Epididymis Duct of the Epididymis An embryonic remnant of the mesonephric duct in females that runs parallel to the uterus, cervix and vagina. C32485 Anatomical Structure Duct of Gartner C0086336 Duct_of_the_Gartner Duct of Gartner Duct of Gartner An accessory pancreatic duct with two branches, one of which opens directly to the duodenum at the minor duodenal papilla while the other connects to the pancreatic duct. C32487 Anatomical Structure Ductus Santorini C0227573 Ductus_Santorini Accessory Pancreatic Duct Ductus Pancreaticus Accessorius Ductus Santorini Ductus Santorini An acute myeloid leukemia (AML) characterized by blasts without evidence of maturation to more mature neutrophils. (WHO, 2001) C3249 Neoplastic Process Acute Myeloid Leukemia without Maturation C0026998 CPTAC GDC NICHD PCDC An acute myeloid leukemia (AML) characterized by blasts without evidence of significant maturation in the neutrophilic lineage. 9873/3 Malignant Acute_Myeloid_Leukemia_without_Maturation 9873/3 Acute myeloid leukemia without maturation FAB M1 M1 AML without Maturation Acute M1 Myeloid Leukemia Acute Myeloblastic Leukemia without Maturation Acute Myelogenous Leukemia without Maturation Acute Myeloid Leukemia without Maturation Acute Myeloid Leukemia without Maturation (FAB M1) Acute myeloid leukemia without maturation FAB M1 M1 M1 Acute Myeloblastic Leukemia M1 Acute Myeloblastic Leukemia without Maturation M1 Acute Myelogenous Leukemia M1 Acute Myelogenous Leukemia without Maturation M1 Acute Myeloid Leukemia M1 Acute Myeloid Leukemia without Maturation Acute Myeloid Leukemia without Maturation An unbranched, coiled, tubular gland not associated with the hair follicle that promotes cooling by evaporation of its secretion. It is innervated by cholinergic nerve fibers. C32490 Body Part, Organ, or Organ Component Eccrine Sweat Gland C0013492 A type of simple sweat gland that is found in almost all regions of the skin. These glands produce sweat that reaches the surface of the skin by way of coiled ducts (tubes). The body is cooled as sweat evaporates from the skin. Eccrine_Sweat_Gland Eccrine Sweat Gland eccrine gland Eccrine Sweat Gland One of 12 to 14 small seminal ducts leading from the testis to the head of the epididymis. C32492 Body Part, Organ, or Organ Component Efferent Duct C0228013 CDISC A duct or ducts that convey spermatozoa from the rete testis to the head of the epididymis. Efferent_Ductule DUCT, EFFERENT Efferent Duct Efferent Ductule Efferent Duct Bilateral tubes formed by the joining of the vas deferens and the excretory duct of the seminal vesicle which merge into the urethra after passing through the prostate. C32493 Anatomical Structure Ejaculatory Duct C0013747 Ejaculatory_Duct Ejaculatory Duct Ejaculatory Duct An acute myeloid leukemia (AML) characterized by blasts with evidence of maturation to more mature neutrophils. (WHO, 2001) C3250 Neoplastic Process Acute Myeloid Leukemia with Maturation C1879321 CPTAC GDC NICHD PCDC An acute myeloid leukemia (AML) characterized by blasts with evidence of significant maturation in the neutrophilic lineage. 9874/3 Malignant Acute_Myeloid_Leukemia_with_Maturation 9874/3 Acute myeloid leukemia with maturation FAB M2, NOS M2 AML with Maturation Acute M2 Myeloid Leukemia Acute Myeloblastic Leukemia with Maturation Acute Myelocytic Leukemia with Maturation Acute Myelogenous Leukemia with Maturation Acute Myeloid Leukemia (AML-M2) Acute Myeloid Leukemia with Maturation Acute myeloid leukemia with maturation FAB M2 M2 M2 Acute Granulocytic Leukemia M2 Acute Myeloblastic Leukemia M2 Acute Myeloblastic Leukemia with Maturation M2 Acute Myelocytic Leukemia with Maturation M2 Acute Myelogenous Leukemia M2 Acute Myelogenous Leukemia with Maturation M2 Acute Myeloid Leukemia M2 Acute Myeloid Leukemia with Maturation Acute Myeloid Leukemia with Maturation The part of the ovary that produces hormones, mainly estrogen and progesterone, though small amounts of androgens and other protein hormones are also produced. C32508 Body Part, Organ, or Organ Component Endocrine Ovary C1266874 Endocrine_Ovary Endocrine Ovary Endocrine Ovary The tissue responsible for generating and secreting hormones involved in reproduction. In males, testosterone is produced and secreted from the testes while the female ovaries produce and secrete estrogens and progestrones. C32510 Anatomical Structure Endocrine Sex Organ C1516846 Endocrine_Sex_Organ Endocrine Sex Organ Endocrine Sex Organ The part of the testis that produces testosterone. C32511 Body Part, Organ, or Organ Component Endocrine Testis C1268152 Endocrine_Testis Endocrine Testis Endocrine Testis A granular cell tumor characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3252 Neoplastic Process Benign Granular Cell Tumor C0027043 CDISC A benign neoplasm, comprised of large cells with cytoplasmatic granules, occurring in various organs/tissues. Benign Benign_Granular_Cell_Tumor Benign Granular Cell Myoblastoma Benign Granular Cell Neoplasm Benign Granular Cell Tumor GRANULAR CELL TUMOR, BENIGN Myoblastoma Benign Granular Cell Tumor A self-limited benign neoplasm characterized by a zonal architecture. It is composed of spindle cells oriented randomly or in short intersecting fascicles. Peripherally, the spindle cells merge with osteoblasts that rim and populate ill-defined trabeculae and sheets of unmineralized woven bone, which is surrounded by well-formed trabecular and cortical-type bone that remodels into lamellar bone. Treatment is usually simple excision. Prognosis is excellent; recurrence is uncommon. (WHO 2020) C3253 Neoplastic Process Myositis Ossificans C0027122 Benign Myositis_Ossificans Myositis Ossificans Myositis Ossificans The small, compound, unbranched exocrine glands varying in number that are located within the submucosa of the esophagus. C32536 Anatomical Structure Esophageal Gland C0227178 Esophageal_Gland Esophageal Gland Esophageal Gland A benign soft tissue neoplasm characterized by the presence of neoplastic spindle and stellate cells, and vascular proliferation in a myxoid stroma. C3254 Neoplastic Process Angiomyxoma CL329980 GDC 8841/0 8841/1 Benign Angiomyxoma 8841/1 Angiomyxoma Angiomyxoma, NOS Angiomyxoma Angiomyxoma An enzyme producing region of the pancreatic tissue containing the pancreatic acini and exocrine intralobular ducts which collectively secrete the digestive enzymes into the main pancreatic duct to drain into the duodenal part of the small intestine. C32546 Anatomical Structure Exocrine Pancreas C0553695 CDISC An enzyme producing region of the pancreatic tissue containing the pancreatic acini and exocrine intralobular ducts which collectively secrete the digestive enzymes into the main pancreatic duct to drain into the duodenal part of the small intestine. (NCI) Exocrine_Pancreas Exocrine Pancreas PANCREAS, EXOCRINE Exocrine Pancreas An infiltrating malignant soft tissue neoplasm characterized by the presence of immature undifferentiated cells and abundant myxoid stroma formation. C3255 Neoplastic Process Myxosarcoma C0027155 CDISC GDC A malignant soft tissue neoplasm with a myxoid stroma formation. 8840/3 Malignant Myxosarcoma 8840/3 Myxosarcoma MYXOSARCOMA, MALIGNANT Myxosarcoma Myxosarcoma A benign or malignant neoplasm affecting the nasopharynx. Representative examples of benign neoplasms include angiofibroma and squamous papilloma. Representative examples of malignant neoplasms include keratinizing squamous cell carcinoma and nonkeratinizing carcinoma. C3257 Neoplastic Process Nasopharyngeal Neoplasm C0027439 Undetermined Nasopharyngeal_Neoplasm Nasopharyngeal Neoplasm Nasopharyngeal Neoplasms Nasopharyngeal Tumor Neoplasm of Nasopharynx Neoplasm of the Nasopharynx Tumor of Nasopharynx Tumor of the Nasopharynx Nasopharyngeal Neoplasm The portion of the biliary tract outside the liver; the common hepatic duct joins the cystic duct to form the common bile duct. C32573 Anatomical Structure Extrahepatic Bile Duct C0206187 CDISC GDC The part of the common hepatic bile duct (tube that collects bile from the liver) that is outside the liver. This duct joins a duct from the gallbladder to form the common bile duct, which carries bile into the small intestine when food is being digested. The portion of the biliary tract outside the liver; the common hepatic duct joins the cystic duct to form the common bile duct. (NCI) Extrahepatic_Bile_Duct Extrahepatic bile duct EXTRAHEPATIC BILE DUCT Extrahepatic Bile Duct Extrahepatic bile duct extrahepatic bile duct Extrahepatic Bile Duct A fold of skin covering the tip of the clitoris. C32590 Anatomical Structure Female Prepuce C0227771 Female_Prepuce Female Prepuce Preputium Clitoridis Female Prepuce The 1.5 inch long tube carrying urine from the bladder to the outside of the body exiting between the clitoris and vagina. C32591 Anatomical Structure Female Urethra C0458485 Female_Urethra Female Urethra Female Urethra A benign or malignant neoplasm that affects the neck region. C3260 Neoplastic Process Neck Neoplasm C0027533 Undetermined Neck_Neoplasm Neck Neoplasm Neck Neoplasms (Including All Pharyngeal Related Neoplasms) Neck Tumor Neoplasm of Neck Neoplasm of the Neck Tumor of Neck Tumor of the Neck Neck Neoplasm The tubular glands in the mucosa of the gastric fundus that can secrete mucous, hydrochloric acid, pepsinogen, or any of the digestive hormones. C32643 Body Part, Organ, or Organ Component Fundic Gland C0017130 Fundic_Gland Fundic Gland Fundus Gland Gastric Gland Fundic Gland The small accessory lacrimal glands on the upper and lower eyelids that secrete tears. There are approximately 42 glands on the upper lid and 6-8 glands on the lower lid. C32678 Body Part, Organ, or Organ Component Gland of Krause C1306642 Gland_of_Krause Accessory Lacrimal Gland Gland of Krause Gland of Krause A gland in the margins of the eyelids that opens into the follicles of the eyelashes and produces secretions that lubricate the eyeball. C32679 Body Part, Organ, or Organ Component Gland of Moll C0229267 Gland_of_Moll Ciliary Gland Gland of Moll Gland of Moll A benign or malignant, primary or metastatic neoplasm involving the central or peripheral nervous system. C3268 Neoplastic Process Nervous System Neoplasm Nervous System Neoplasm C0027766 CPTAC CTRP NICHD Undetermined Nervous_System_Neoplasm Neoplasm of Nervous System Neoplasm of the Nervous System Nervous System Neoplasm Nervous System Neoplasms Nervous System Tumor Nervous System Tumour Tumor of Nervous System Tumor of the Nervous System Nervous System Neoplasm The larger accessory lacrimal glands on the upper and lower eyelids that secrete tears. There are approximately 2-5 glands on the upper lid and 1-3 glands on the lower lid. C32680 Body Part, Organ, or Organ Component Gland of Wolfring CL449022 Gland_of_Wolfring Gland of Wolfring Gland of Wolfring A benign, usually encapsulated slow growing tumor composed of Schwann cells. It affects peripheral and cranial nerves. It recurs infrequently and only rare cases associated with malignant transformation have been reported. C3269 Neoplastic Process Schwannoma C0027809 CDISC Cellosaurus GDC A benign neoplasm of the peripheral nervous system composed of well-differentiated Schwann cells. A tumor of the peripheral nervous system that arises in the nerve sheath (protective covering). It is almost always benign, but rare malignant schwannomas have been reported. 9560/0 Benign Schwannoma 9560/0 Neurilemoma, NOS Neurinoma Psammomatous schwannoma Schwannoma, NOS Benign Neurilemmoma Benign Schwannoma Neurilemmoma Neurinoma SCHWANNOMA, BENIGN Schwannoma Schwannoma (WHO Grade I) Schwannoma (Who Grade I) Schwannoma, NOS schwannoma Schwannoma A malignant neuroblastic tumor characterized by the presence of neuroblastic cells, the absence of ganglion cells, and the absence of a prominent Schwannian stroma formation. C3270 Neoplastic Process Neuroblastoma Neuroblastoma C2751421 CDISC CPTAC CTEP CTRP Cellosaurus GDC MedDRA NICHD A malignant neoplasm composed of neuroblastic cells. A malignant neoplasm comprised of neuroblasts that commonly arises in or near the adrenal glands. Cancer that arises in immature nerve cells and affects mostly infants and children. 9500/3 Malignant Neuroblastoma 9500/3 Central neuroblastoma Neuroblastoma Neuroblastoma (NBL) Neuroblastoma, NOS NEUROBLASTOMA, MALIGNANT Neural Crest Tumor, Malignant Neuroblastoma Neuroblastoma (NBL) Neuroblastoma (Schwannian Stroma-Poor) Neuroblastoma (Schwannian Stroma-poor) Neuroblastoma, NOS neuroblastoma Neuroblastoma An intraneural or extraneural neoplasm arising from nerve tissues and neural sheaths. It is composed of perineurial-like fibroblasts and Schwann cells. It usually presents as a localized cutaneous lesion and less often as a circumscribed peripheral nerve mass. Patients with neurofibromatosis type 1 present with multiple masses. Neurofibromas which arise from major nerves and plexiform neurofibromas are precursor lesions to malignant peripheral nerve sheath tumors. C3272 Neoplastic Process Neurofibroma C0027830 CDISC Cellosaurus GDC A benign tumor that develops from the cells and tissues that cover nerves. An intraneural or extraneural neoplasm arising from nerve tissues and neural sheaths, composed of perineurial-like fibroblasts and Schwann cells. 9540/0 Benign Neurofibroma 9540/0 Neurofibroma, NOS NEUROFIBROMA, BENIGN Neurofibroma Neurofibroma (WHO Grade I) Neurofibroma, NOS neurofibroma Neurofibroma Any of the three ducts associated with the liver including the right hepatic duct, left hepatic duct and common hepatic duct. C32730 Anatomical Structure Hepatic Duct C0917710 GDC UBERON Any portion of the ducts that carry bile from the liver to the common bile duct. This may include both intrahepatic components (parts of left and right hepatic ducts) and extrahepatic components (common hepatic duct, plus hilar portion). Hepatic_Duct Hepatic Duct UBERON:0005171 Hepatic Duct hepatic duct Hepatic Duct A benign peripheral nerve sheath neoplasm that arises from the vestibular division of the vestibulocochlear nerve (eight cranial nerve) in the auditory canal or within the labyrinth. It is composed almost entirely of differentiated neoplastic Schwann cells. C3276 Neoplastic Process Acoustic Schwannoma Vestibular Schwannoma C3549435 CTRP Cellosaurus GDC Benign Acoustic_Schwannoma 9560/0 Acoustic neuroma Acoustic Neurilemmoma Acoustic Neuroma Acoustic Schwannoma Acoustic neuroma Neurilemoma, Acoustic Neuroma, Acoustic Vestibular Neurilemmoma Vestibular Schwannoma Vestibular Schwannoma One of the three lymph nodes of the pelvis: the superior gluteal, interior gluteal or sacral. C32761 Body Part, Organ, or Organ Component Iliac Lymph Node C0229807 CDISC GDC mCode Lymph node(s) adjacent to the iliac vessels in the iliosacral region and cranial to the iliofemoral lymph node. Iliac_Lymph_Node Iliac, NOS ILIAC LYMPH NODE Iliac Lymph Node LYMPH NODE, ILIAC Structure of iliac lymph node (body structure) Iliac Lymph Node Either of two paired parathyroid glands distal to the head. C32787 Body Part, Organ, or Organ Component Inferior Parathyroid Gland C0447650 Inferior_Parathyroid_Gland Inferior Parathyroid Gland Inferior Parathyroid Gland A superficial or deep lymph node located in the inguinal area. C32801 Anatomical Structure Inguinal Lymph Node C0729596 CDISC GDC PCDC Lymph node(s) in the inguinal region. Inguinal_Lymph_Node Inguinal Lymph Node(s) Inguinal Lymph Node, Inguinal INGUINAL LYMPH NODE Inguinal Inguinal Lymph Node LYMPH NODE, INGUINAL Lymph Node(s) Inguinal Lymph Node, Inguinal Inguinal Lymph Node One of two types of intercalated ducts located in either the pancreas or salivary gland. C32820 Anatomical Structure Intercalated Duct C1512817 Intercalated_Duct Intercalated Duct Intercalated Duct Small channels in the liver situated between the interlobar ducts and the lobules, which carry bile from the canaliculi and Canals of Hering to the intrahepatic bile ducts. C32827 Body Part, Organ, or Organ Component Interlobular Bile Duct C0227515 Interlobular_Bile_Duct Interlobular Bile Duct Interlobular Bile Duct A gland duct that drains secretions from more than one lobe of an organ. C32828 Anatomical Structure Interlobular Duct C1512857 Interlobular_Duct Interlobular Duct Interlobular Duct Any of the lymph nodes of the breast located under the ribcage, near the sternum. C32853 Body Part, Organ, or Organ Component Internal Mammary Lymph Node C0444440 CDISC GDC UBERON mCode Any of the lymph nodes of the breast located under the ribcage, near the sternum. Lymph node(s) in or adjacent to the mammary gland. Internal_Mammary_Lymph_Node Lymph Node(s) Internal Mammary UBERON:0035219 INTERNAL MAMMARY LYMPH NODE Internal Mammary Lymph Node Internal mammary lymph node group (body structure) LYMPH NODE, MAMMARY GLAND Lymph Node(s) Internal Mammary Structure of parasternal lymph node (body structure) internal mammary lymph node nodus parasternale parasternal lymph node parasternal node Internal Mammary Lymph Node A benign or malignant neoplasm arising from tooth-forming tissues. It occurs in the maxillofacial skeleton or the gingiva. Benign neoplasms are slow growing and are not associated with specific clinical symptoms. Pain is absent or slight. Malignant neoplasms are usually associated with rapid swelling and pain. C3286 Neoplastic Process Odontogenic Neoplasm Odontogenic Neoplasm C0028880 CTRP GDC 9270/1 Undetermined Odontogenic_Neoplasm 9270/1 Odontogenic Tumors Odontogenic tumor, NOS Odontogenic Neoplasm Odontogenic Tumor Odontogenic Tumors Odontogenic tumor, NOS Odontogenic Neoplasm A well-differentiated (WHO grade 2), diffusely infiltrating neuroglial tumor, typically located in the cerebral hemispheres. It is composed predominantly of cells which morphologically resemble oligodendroglia. The neoplastic cells have rounded homogeneous nuclei and, on paraffin sections, a swollen, clear cytoplasm ('honeycomb' appearance). (Adapted from WHO) C3288 Neoplastic Process Oligodendroglioma Oligodendroglioma C0751396 CTEP Cellosaurus DIPG/DMG A rare, slow-growing tumor that begins in oligodendrocytes (cells that cover and protect nerve cells in the brain and spinal cord). 9450/3 Undetermined Oligodendroglioma Oligodendroglioma Oligodendroglioma, NOS WHO Grade 2 Oligodendroglial Neoplasm WHO Grade 2 Oligodendroglial Tumor WHO Grade II Oligodendroglial Neoplasm WHO Grade II Oligodendroglial Tumor Well Differentiated Oligodendroglial Tumor Well Differentiated Oligodendroglioma oligodendroglioma Oligodendroglioma A benign or malignant neoplasm that affects the orbit. C3290 Neoplastic Process Orbit Neoplasm C0029185 Undetermined Orbit_Neoplasm Neoplasm of Orbit Neoplasm of the Orbit Orbit Neoplasm Orbit Tumor Orbital Neoplasm Orbital Neoplasms Orbital Tumor Tumor of Orbit Tumor of the Orbit Orbit Neoplasm A round gland located between the mucous membrane and orbicularis oris muscle of the mouth. C32904 Anatomical Structure Labial Salivary Gland C0226928 Labial_Salivary_Gland Labial Salivary Gland Labial Salivary Gland A benign or malignant neoplasm that affects the oropharynx. C3291 Neoplastic Process Oropharyngeal Neoplasm C0029295 Undetermined Oropharyngeal_Neoplasm Neoplasm of Oropharynx Neoplasm of the Oropharynx Oropharyngeal Neoplasm Oropharyngeal Neoplasms Oropharyngeal Tumor Tumor of Oropharynx Tumor of the Oropharynx Oropharyngeal Neoplasm A channel conveying the milk secreted by the lobes of the breast to and through the nipple. C32910 Body Part, Organ, or Organ Component Lactiferous Duct C0222613 Lactiferous_Duct Lactiferous Duct Lactiferous Duct A rare benign bone-forming neoplasm usually arising from the spine. It is a well-circumscribed lytic tumor that varies in size. The tumor is composed of woven bone trabeculae and shares similar histologic characteristics with the osteoid osteoma. Surgical curettage is the treatment of choice. The prognosis is excellent. C3294 Neoplastic Process Osteoblastoma C0029417 CDISC Cellosaurus GDC A benign neoplasm of bone, characterized by the formation of osteoid tissue and large osteoblast-like cells. 9200/0 Benign Osteoblastoma 9200/0 Giant osteoid osteoma Osteoblastoma, NOS Giant Osteoid Osteoma Giant osteoid osteoma OSTEOBLASTOMA, BENIGN Ossifying Giant Cell Tumor Osteoblastoma Osteoblastoma, NOS Osteoblastoma A common, benign cartiliginous neoplasm arising from the metaphysis of bone. The tumor grows on the surface of the bone; it may be pedunculated or sessile. It is characterized by the presence of chondrocytes, a cartilage cap, and a fibrous perichondrium that extends to the periosteum of the bone. In some cases, there is deletion of 8q24.1 chromosome locus. C3295 Neoplastic Process Osteochondroma C0029423 CDISC GDC A benign cartiliginous neoplasm arising from the metaphysis of bone. 9210/0 Benign Osteochondroma 9210/0 Cartilaginous exostosis Ecchondroma Osteocartilaginous exostosis Osteochondroma OSTEOCHONDROMA, BENIGN Osteocartilaginous Exostosis Osteocartilaginous exostosis Osteochondroma Osteochondroma The fallopian tube that extends from the uterus to the ovary in the left side of the pelvic cavity. C32959 Anatomical Structure Left Fallopian Tube C0227902 GDC Left_Fallopian_Tube Fallopian Tube, Left Fallopian Tube, Left Left Fallopian Tube Left Fallopian Tube A benign, well-circumscribed, bone-forming neoplasm predominantly composed of lamellar bone. It usually arises from the calvarial, facial, or jaw bones. It is usually asymptomatic but it may cause local swelling or obstruction of the paranasal sinuses. Asymptomatic cases have an indolent clinical course. C3296 Neoplastic Process Osteoma C0029440 CDISC GDC A benign well-differentiated neoplasm of bone. 9180/0 Benign Osteoma 9180/0 Osteoma, NOS OSTEOMA, BENIGN Osteoma Osteoma, NOS Osteoma The duct that drains bile from the left lobe of the liver into the common hepatic duct. C32960 Anatomical Structure Left Hepatic Duct C0227560 Left_Hepatic_Duct Left Hepatic Duct Left Hepatic Duct The 2-lobed lung located on the left side of the body. C32967 Anatomical Structure Left Lung C0225730 CDISC The 2-lobed lung located on the left side of the body. (NCI) Left_Lung LUNG, LEFT Left Lung Left Lung The ovary that is located in the left side of the pelvis. C32969 Anatomical Structure Left Ovary C0227874 GDC Left_Ovary Ovary, Left Left Ovary Ovary, Left Left Ovary A small, benign, bone-forming neoplasm that can arise from any bone but more frequently affects the long bones. The central portion of the neoplasm (nidus) contains differentiated osteoblasts which produce osteoid and sometimes bone. The lesion is usually surrounded by hypervascular sclerotic bone and has limited growth potential. Clinical signs and symptoms include pain and localized tenderness, at the site of the lesion. The pain may be intense but in the majority of cases it is completely alleviated by non-steroidal anti-inflammatory drugs. Prognosis is excellent and recurrences are rare. C3297 Neoplastic Process Osteoid Osteoma C0029441 Cellosaurus GDC 9191/0 Benign Osteoid_Osteoma 9191/0 Osteoid osteoma, NOS Osteoid Osteoma Osteoid osteoma, NOS Osteoid Osteoma A type of minor salivary gland located on the tongue. C32987 Anatomical Structure Lingual Salivary Gland C0930558 Lingual_Salivary_Gland Lingual Salivary Gland Lingual Salivary Gland The lymphoid follicles on the dorsal surface in the posterior region of the tongue. C32988 Anatomical Structure Lingual Tonsil C0229871 CDISC GDC A tonsil in the mucosa at the root of the tongue. Lingual_Tonsil Lingual tonsil Lingual Tonsil Lingual tonsil TONSIL, LINGUAL Lingual Tonsil A malignant epithelial cellular proliferation characterized by the presence of atypical cells with large nuclei and abundant pale cytoplasm within the squamous epithelium of the nipple. In almost all cases there is an underlying intraductal breast carcinoma or intraductal and invasive carcinoma. The skin changes range from redness to eczematous appearance. C3301 Neoplastic Process Nipple Paget Disease C1704323 A form of breast cancer in which the tumor grows from ducts beneath the nipple onto the surface of the nipple. Symptoms commonly include itching and burning and an eczema-like condition around the nipple, sometimes accompanied by oozing or bleeding. Malignant Paget_s_Disease_of_the_Nipple Nipple Paget Disease Nipple Paget's Disease Paget Disease of the Nipple Paget's Disease of Nipple Paget's Disease of the Nipple Paget's disease of the nipple Nipple Paget Disease A lymph node named according to its location in the body. C33027 Anatomical Structure Lymph Node by Anatomic Site C1518053 GDC Lymph_Node_by_Anatomic_Site Lymph Node Station Lymph Node by Anatomic Site Nodal Station lymph node involved site lymph_node_involved_site Lymph Node by Anatomic Site One of the two, usually rudimentary, mammary glands in the male. C33048 Anatomical Structure Male Breast C0222604 Male_Breast Male Breast Male Breast A fold of skin covering the tip of the penis. C33049 Anatomical Structure Male Prepuce C0227952 CDISC GDC UBERON A fold of skin covering the tip of the penis. A retractable double-layered fold of skin and mucous membrane that covers the glans penis and protects the urinary meatus when the penis is not erect. The loose skin that covers the head of the penis. Male_Prepuce Foreskin Prepuce UBERON:0001332 FORESKIN Foreskin Male Prepuce Preputium Penis foreskin penile prepuce prepuce of male prepuce of penis preputium penis Male Prepuce A benign or malignant neoplasm involving the pancreas. C3305 Neoplastic Process Pancreatic Neoplasm Pancreatic Neoplasm C0030297 CTRP Undetermined Pancreatic_Neoplasm Neoplasm of Pancreas Neoplasm of the Pancreas Pancreas Neoplasm Pancreas Tumor Pancreatic Neoplasm Pancreatic Tumor Tumor of Pancreas Tumor of the Pancreas Pancreatic Neoplasm The 8 inch long tube carrying urine from the bladder to the outside of the body exiting at the end of the penis. C33050 Anatomical Structure Male Urethra C0458452 Male_Urethra Male Urethra Male Urethra A lymph node located in the mediastinum. Mediastinal lymph nodes are arranged in three groups, one on the lateral, another on the medial, and a third on the anterior aspect of the vessels; the third group is, however, sometimes absent. C33073 Body Part, Organ, or Organ Component Mediastinal Lymph Node C0588055 CDISC GDC UBERON mCode A lymph node that is part of a mediastinum. Each consists of several lymph node groups, especially along the trachea (5 groups), along the esophagus and between the lung and the diaphragm. In the mediastinal lymph nodes arises lymphatic ducts, which drains the lymph to the left subclavian vein (to the venous angle in the confluence of the subclavian and deep jugular veins). The mediastinal lymph nodes along the esophagus are in tight connection with the abdominal lymph nodes along the esophagus and the stomach. That fact facilitates spreading of tumors cells through these lymphatics in cases of cancers of the stomach and particularly of the esophagus. Through the mediastinum, the main lymphatic drainage from the abdominal organs goes via the thoracic duct (ductus thoracicus), which drains majority of the lymph from the abdomen to the above mentioned left venous angle. Lymph node(s) in the mediastinal region. Mediastinal_Lymph_Node Lymph Node(s) Mediastinal Lymph Nodes(s) Mediastinal Mediastinal Mediastinal lymph nodes UBERON:0002524 LYMPH NODE, MEDIASTINAL Lymph Node(s) Mediastinal Lymph Nodes(s) Mediastinal MEDIASTINAL LYMPH NODE Mediastinal Lymph Node Mediastinal lymph node structure (body structure) Mediastinal lymph nodes mediastinal lymph node mediastinal node Mediastinal Lymph Node A sebaceous gland in the eyelid that produces a specific type of sebum. C33075 Anatomical Structure Meibomian Gland C0025181 CDISC A sebaceous gland in the eyelid that produces meibum. Meibomian_Gland GLAND, MEIBOMIAN Meibomian Gland Meibomian Gland A neoplasm arising from paraganglia located along the sympathetic or parasympathetic nerves. Infrequently, it may arise outside the usual distribution of the sympathetic and parasympathetic paraganglia. Tumors arising from the adrenal gland medulla are called pheochromocytomas. Morphologically, paragangliomas usually display a nesting (Zellballen) growth pattern. There are no reliable morphologic criteria to distinguish between benign and malignant paragangliomas. The only definitive indicator of malignancy is the presence of regional or distant metastases. C3308 Neoplastic Process Paraganglioma Paraganglioma C0030421 CTRP GDC A rare, usually benign tumor that develops from cells of the paraganglia. Paraganglia are a collection of cells that came from embryonic nervous tissue, and are found near the adrenal glands and some blood vessels and nerves. Paragangliomas that develop in the adrenal gland are called pheochromocytomas. Those that develop outside of the adrenal glands near blood vessels or nerves are called glomus tumors or chemodectomas. 8680/1 Undetermined Paraganglionic_Neoplasm 8680/1 Paraganglioma, NOS Neoplasm of Paraganglion Neoplasm of the Paraganglion Paraganglioma Paraganglioma, NOS Paraganglion Neoplasm Paraganglion Tumor Paraganglionic Neoplasm Paraganglionic Tumor Tumor of Paraganglion Tumor of the Paraganglion paraganglioma Paraganglioma A paraganglioma arising from sympathetic or parasympathetic paraganglia outside the adrenal gland. C3309 Neoplastic Process Extra-Adrenal Paraganglioma Extra-Adrenal Paraganglioma CL497918 CTRP GDC 8693/1 Undetermined Extra-Adrenal_Paraganglioma 8693/1 Extra-adrenal paraganglioma, NOS Extra-Adrenal Paraganglioma Extra-Adrenal Paraganglionic Neoplasm Extra-adrenal paraganglioma, NOS Extraadrenal Paraganglioma Extra-Adrenal Paraganglioma A small salivary gland located within the aerodigestive tract. C33129 Anatomical Structure Minor Salivary Gland C0036099 Minor_Salivary_Gland Minor Salivary Gland Minor Salivary Gland A benign or malignant neoplasm affecting the parathyroid glands. C3313 Neoplastic Process Parathyroid Gland Neoplasm C0030521 Undetermined Parathyroid_Neoplasm Neoplasm of Parathyroid Neoplasm of Parathyroid Gland Neoplasm of the Parathyroid Neoplasm of the Parathyroid Gland Parathyroid Gland Neoplasm Parathyroid Gland Tumor Parathyroid Neoplasm Parathyroid Tumor Tumor of Parathyroid Tumor of Parathyroid Gland Tumor of the Parathyroid Tumor of the Parathyroid Gland Parathyroid Gland Neoplasm A benign or malignant neoplasm that affects the parotid gland. Representative examples of benign neoplasms include Warthin tumor, monomorphic adenoma, and pleomorphic adenoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma. C3314 Neoplastic Process Parotid Gland Neoplasm C0030581 Undetermined Parotid_Gland_Neoplasm Neoplasm of Parotid Neoplasm of Parotid Gland Neoplasm of the Parotid Neoplasm of the Parotid Gland Parotid Gland Neoplasm Parotid Gland Tumor Parotid Neoplasm Parotid Tumor Tumor of Parotid Tumor of Parotid Gland Tumor of the Parotid Tumor of the Parotid Gland Parotid Gland Neoplasm Salivary glands that produce and secrete a saliva made up exclusively of mucous. C33141 Anatomical Structure Mucous Salivary Gland C0227440 CDISC Salivary glands that produce and secrete a saliva made up exclusively of mucous. (NCI) Mucous_Salivary_Gland GLAND, SALIVARY, MUCOUS Mucous Salivary Gland Mucous Salivary Gland Fibromatosis arising from the soft tissues of the penis. It is characterized by the presence of spindle-shaped fibroblasts, and an infiltrative growth pattern. It causes the penis to bend when it becomes erect. C3316 Neoplastic Process Penile Fibromatosis C0030848 Undetermined Penile_Fibromatosis Penile Fibromatosis Penile Induration Peyronie's Disease Peyronie's Fibromatosis Penile Fibromatosis A tube-like structure that conveys tears from the lacrimal sac to the nasal cavity. C33161 Anatomical Structure Nasolacrimal Duct C0027437 CDISC A duct that conveys tears from the eye to the nasal cavity. Nasolacrimal_Duct DUCT, NASOLACRIMAL Nasolacrimal Duct Nasolacrimal Duct A benign, borderline, or malignant neoplasm that affects the penis. Representative examples include penile hemangioma, penile intraepithelial neoplasia, and penile carcinoma. C3317 Neoplastic Process Penile Neoplasm C0030849 Undetermined Penile_Neoplasm Neoplasm of Penis Neoplasm of the Penis Penile Neoplasm Penile Neoplasms Penile Tumor Tumor of Penis Tumor of the Penis Penile Neoplasm A benign or malignant neoplasm arising from a peripheral nerve or the perineural sheaths. C3321 Neoplastic Process Peripheral Nervous System Neoplasm Peripheral Nervous System Neoplasm C0031118 CTEP CTRP Undetermined Peripheral_Nervous_System_Neoplasm CNS-excluded nervous sys. cancer CNS-excluded nervous system cancer, NOS Neoplasm of PNS Neoplasm of Peripheral Nerve Neoplasm of Peripheral Nervous System Neoplasm of the PNS Neoplasm of the Peripheral Nerve Neoplasm of the Peripheral Nervous System Neoplasms, PNS Neoplasms, Peripheral Nervous System PNS Neoplasm PNS Neoplasms PNS Tumor Peripheral Nerve Neoplasm Peripheral Nerve Tumor Peripheral Nervous System Neoplasm Peripheral Nervous System Tumor Tumor of PNS Tumor of Peripheral Nerve Tumor of Peripheral Nervous System Tumor of the PNS Tumor of the Peripheral Nerve Tumor of the Peripheral Nervous System Peripheral Nervous System Neoplasm A benign or malignant neoplasm that affects the peritoneum. Representative examples of benign neoplasms include adenomatoid tumor and disseminated peritoneal leiomyomatosis. Representative examples of malignant neoplasms include primary peritoneal carcinoma, metastatic carcinoma to the peritoneum, and malignant mesothelioma. C3322 Neoplastic Process Peritoneal Neoplasm C0031149 Undetermined Peritoneal_Neoplasm Peritoneal Neoplasm Peritoneal Neoplasm Anatomic structures in the head responsible for special sensations rather than general sensations. This category includes the eyes, ears, nose, and tongue. C33224 Anatomical Structure Organ of Special Sense C0935626 Organ_of_the_Special_Sense Organ of Special Sense Special Sense Organ Organ of Special Sense One of the many racemose mucous glands within the back half of the hard palate submucosa. C33249 Anatomical Structure Palatine Salivary Gland C0930557 Palatine_Salivary_Gland Palatine Salivary Gland Palatine Salivary Gland A benign or malignant neoplasm that affects the nasopharynx, oropharynx, or hypopharynx. C3325 Neoplastic Process Pharyngeal Neoplasm C0031347 Undetermined Pharyngeal_Neoplasm Neoplasm of Pharynx Neoplasm of the Pharynx Pharyngeal Neoplasm Pharyngeal Neoplasms Pharyngeal Tumor Pharynx Neoplasm Pharynx Tumor Tumor of Pharynx Tumor of the Pharynx Pharyngeal Neoplasm Two masses of lymphatic tissue located one on either side of the oropharynx in the oropharyngeal isthmus. C33250 Anatomical Structure Palatine Tonsil C0040421 CDISC GDC A tonsil in the mucosa of the glossopalatine arch of the oropharynx. Palatine_Tonsil Tonsil, NOS Palatine Tonsil TONSIL, PALATINE Palatine Tonsil A neuroendocrine neoplasm of the sympathetic nervous system that arises from the chromaffin cells of the adrenal medulla and secretes catecholamines. Clinical presentation includes headaches, palpitations, chest and abdominal pain, hypertension, fever, and tremor. Microscopically, a characteristic nesting (zellballen) growth pattern is usually seen. Other growth patterns including trabecular pattern may also be present. C3326 Neoplastic Process Adrenal Gland Pheochromocytoma Adrenal Gland Pheochromocytoma C1861851 CTEP CTRP Cellosaurus GDC Tumor that forms in the center of the adrenal gland (gland located above the kidney) that causes it to make too much adrenaline. Pheochromocytomas are usually benign (not cancer) but can cause high blood pressure, pounding headaches, heart palpitations, flushing of the face, nausea, and vomiting. 8700/0 Undetermined Pheochromocytoma 8700/0 Adrenal medullary paraganglioma Chromaffin paraganglioma Pheochromocytoma, NOS Adrenal Gland Chromaffin Paraganglioma Adrenal Gland Chromaffinoma Adrenal Gland Paraganglioma Adrenal Gland Pheochromocytoma Adrenal Medullary Paraganglioma Adrenal Medullary Pheochromocytoma Adrenal Pheochromocytoma Adrenal medullary paraganglioma Chromaffin Paraganglioma of the Adrenal Gland Intraadrenal Paraganglioma PCC Pheochromocytoma Pheochromocytoma (adrenal) pheochromocytoma Adrenal Gland Pheochromocytoma A small, tubular passageway carrying saliva from the parotid gland to the oropharynx. C33277 Anatomical Structure Parotid Duct C0227458 Parotid_Duct Parotid Duct Stensen's Duct Parotid Duct A lymph node located close to, on, or within the parotid gland. C33278 Anatomical Structure Parotid Gland Lymph Node C0229715 CDISC GDC UBERON mCode A lymph node found near the parotid gland. Lymph node(s) in or adjacent to the parotid gland. Parotid_Gland_Lymph_Node Lymph Node(s) Parotid Parotid UBERON:0015857 LYMPH NODE, PAROTID Lymph Node(s) Parotid Lymph node level VIII (qualifier value) PAROTID GLAND LYMPH NODE Parotid Gland Lymph Node parotid lymph node parotid node Parotid Gland Lymph Node A benign or malignant neoplasm that affects the pineal region. C3328 Neoplastic Process Pineal Region Neoplasm Pineal Region Neoplasm C1412004 CTRP GDC NICHD mCode A tumor arising in the pineal region, the majority of which are malignant germ cell tumors. A minority of pinealomas are benign, and comprise neoplastic cells that resemble normal pineocytes. A type of brain tumor that occurs in or around the pineal gland, a tiny organ near the center of the brain. Undetermined Pineal_Region_Neoplasm 9360/1 Pinealoma Neoplasm of Pineal Area Neoplasm of Pineal Region Neoplasm of the Pineal Area Neoplasm of the Pineal Region Neoplasm of uncertain behavior of pineal gland Pineal Area Neoplasm Pineal Area Tumor Pineal Body Neoplasm Pineal Body Tumor Pineal Neoplasm Pineal Region Neoplasm Pineal Region Tumor Pineal Tumor Pinealoma Tumor of Pineal Area Tumor of Pineal Region Tumor of the Pineal Area Tumor of the Pineal Region pineal region tumor Pineal Region Neoplasm A well-differentiated neuroendocrine neoplasm that arises from the adenohypophysial cells of the anterior lobe of the pituitary gland. The tumor can be hormonally functioning or not. It has a low frequency of metastatic spread. When metastatic, the term metastatic pituitary neuroendocrine tumor is endorsed instead of pituitary carcinoma. (WHO) C3329 Neoplastic Process Pituitary Neuroendocrine Tumor Pituitary Neuroendocrine Tumor C0032000 CDISC CTRP Cellosaurus GDC NICHD A benign neoplasm of the anterior lobe of the pituitary gland. A non-metastasizing tumor that arises from the adenohypophysial cells of the anterior lobe of the pituitary gland. 8272/0 Undetermined Pituitary_Gland_Adenoma 8272/0 Pituitary adenoma, NOS ADENOMA, ANTERIOR LOBE PITUITARY GLAND, BENIGN Adenoma of Pituitary Adenoma of Pituitary Gland Adenoma of the Pituitary Adenoma of the Pituitary Gland PitNET PitNET/Adenoma Pituitary Adenoma Pituitary Gland Adenoma Pituitary Neuroendocrine Tumor Pituitary Neuroendocrine Tumor (Formerly Pituitary Adenoma) Pituitary Neuroendocrine Tumor/Adenoma Pituitary adenoma, NOS Pituitary Neuroendocrine Tumor A benign or malignant neoplasm affecting the pituitary gland. The vast majority are pituitary neuroendocrine tumors (formerly pituitary adenomas). C3330 Neoplastic Process Pituitary Gland Neoplasm Pituitary Gland Neoplasm C0032019 CPTAC CTRP NICHD mCode A neoplasm in the pituitary gland. A tumor that forms in the pituitary gland. The pituitary is a pea-sized organ in the center of the brain above the back of the nose. It makes hormones that affect other glands and many body functions, especially growth. Most pituitary tumors are benign (not cancer). Undetermined Pituitary_Gland_Neoplasm Neoplasm of uncertain or unknown behaviour: Pituitary gland Neoplasm of Pituitary Neoplasm of Pituitary Gland Neoplasm of the Pituitary Neoplasm of the Pituitary Gland Neoplasm of uncertain behavior of pituitary gland Pituitary Gland Neoplasm Pituitary Gland Tumor Pituitary Neoplasm Pituitary Tumor Tumor of Pituitary Tumor of Pituitary Gland Tumor of the Pituitary Tumor of the Pituitary Gland pituitary tumor Pituitary Gland Neoplasm A fold of lymphatic tissue covered by ciliated epithelium at the very back of the nose, in the roof of the nasopharynx. C33318 Anatomical Structure Pharyngeal Tonsil C0001428 CDISC GDC UBERON A tonsil in the mucosa of the nasopharynx. The lymph tissue in the roof and posterior wall of the nasopharynx. Pharyngeal_Tonsil Adenoid Tonsil (Pharyngeal) UBERON:0001732 Adenoid PHARYNGEAL TONSIL Pharyngeal Tonsil TONSIL, PHARYNGEAL Tonsil (Pharyngeal) adenoid nasopharyngeal tonsil pharyngeal tonsil tonsil of Luschka tonsilla pharyngealis Pharyngeal Tonsil A benign or malignant neoplasm that involves the serous membrane that lines the lungs and thoracic cavity. Most pleural neoplasms are metastatic. Diffuse malignant mesothelioma is the most common primary malignant neoplasm of the pleura. C3332 Neoplastic Process Pleural Neoplasm C0032229 CPTAC Undetermined Pleural_Neoplasm Neoplasm of uncertain or unknown behaviour: Pleura Neoplasm of Pleura Neoplasm of the Pleura Pleural Neoplasm Pleural Tumor Tumor of Pleura Tumor of the Pleura Pleural Neoplasm A chronic myeloproliferative neoplasm characterized by an increased red blood cell production. The bone marrow is hypercellular due to a panmyelotic proliferation typically characterized by pleomorphic megakaryocytes. The major symptoms are related to hypertension, splenomegaly or to episodes of thrombosis and/or hemorrhage. C3336 Neoplastic Process Polycythemia Vera Polycythemia Vera C0032463 CPTAC CTEP CTRP Cellosaurus GDC NICHD mCode A disease in which there are too many red blood cells in the bone marrow and blood, causing the blood to thicken. The number of white blood cells and platelets may also increase. The extra blood cells may collect in the spleen and cause it to become enlarged. They may also cause bleeding problems and make clots form in blood vessels. 9950/3 Malignant Polycythemia_Vera 9950/3 Polycythemia rubra vera Polycythemia vera Proliferative polycythemia Chronic Erythremia Polycythemia Rubra Vera Polycythemia Vera Polycythemia rubra vera Polycythemia vera Polycythemmia vera polycythemia vera Polycythemia Vera A pituitary neuroendocrine tumor that produces prolactin. C3342 Neoplastic Process Prolactin-Producing Pituitary Gland Tumor Lactotroph Pituitary Neuroendocrine Tumor C0033375 CTRP GDC NICHD A pituitary neuroendocrine tumor that produces prolactin. 8271/0 Undetermined Prolactin_Secreting_Pituitary_Gland_Adenoma 8271/0 Lactotroph adenoma Prolactinoma Lactotrope Adenoma Lactotroph Cell Adenoma Lactotroph PitNET/Adenoma Lactotroph Pituitary Neuroendocrine Tumor Lactotroph Pituitary Neuroendocrine Tumor/Adenoma PRL Producing Pituitary Gland Adenoma Pituitary Gland Prolactinoma Pituitary Prolactinoma Prolactin Producing Adenoma of Pituitary Prolactin Producing Adenoma of Pituitary Gland Prolactin Producing Adenoma of the Pituitary Prolactin Producing Adenoma of the Pituitary Gland Prolactin Producing Pituitary Adenoma Prolactin Producing Pituitary Gland Adenoma Prolactin Secreting Adenoma Prolactin Secreting Adenoma of Pituitary Prolactin Secreting Adenoma of Pituitary Gland Prolactin Secreting Adenoma of the Pituitary Prolactin Secreting Adenoma of the Pituitary Gland Prolactin Secreting Pituitary Adenoma Prolactin Secreting Pituitary Gland Adenoma Prolactin-Producing Pituitary Gland Adenoma Prolactin-Producing Pituitary Gland Tumor Prolactinoma Prolactinoma of Pituitary Prolactinoma of Pituitary Gland Prolactinoma of the Pituitary Prolactinoma of the Pituitary Gland Lactotroph Pituitary Neuroendocrine Tumor A benign, borderline, or malignant neoplasm that affects the prostate gland. Representative examples include benign prostate phyllodes tumor, prostatic intraepithelial neoplasia, prostate carcinoma, and prostate sarcoma. C3343 Neoplastic Process Prostate Neoplasm Prostate Neoplasm C0033578 CPTAC CTRP Undetermined Prostate_Neoplasm Neoplasm of uncertain behavior of prostate Neoplasm of Prostate Neoplasm of the Prostate Prostate Neoplasm Prostate Tumor Tumor of Prostate Tumor of the Prostate Prostate Neoplasm The coiled tubular glands that produce mucous and gastrin located around the pylorus in the stomach. C33431 Anatomical Structure Pyloric Gland C0227239 Pyloric_Gland Pyloric Gland Pyloric Gland A usually well differentiated mucinous adenocarcinoma of the peritoneum. The majority of cases represent tumor spread from a primary low grade mucinous neoplasm of the appendix. Cases of pseudomyxoma peritonei associated with mucinous adenocarcinomas of the gallbladder, stomach, colon, rectum, pancreas, lung, breast, and fallopian tubes have also been reported. In the past, the ovary has been considered as a common primary site associated with pseudomyxoma peritonei. However, there is recent evidence based on immunohistochemistry and molecular genetic analysis suggesting that most cases of pseudomyxoma peritonei probably represent metastasis from an appendiceal and not ovarian primary. C3345 Neoplastic Process Pseudomyxoma Peritonei Pseudomyxoma Peritonei C0033822 CTRP Cellosaurus GDC A build-up of mucus in the peritoneal cavity. The mucus may come from ruptured ovarian cysts, from the appendix, or from other abdominal tissues. Mucus-secreting cells may attach to the peritoneal lining and continue to secrete mucus. 8480/6 Malignant Pseudomyxoma_Peritonei 8480/6 Pseudomyxoma peritonei Pseudomyxoma peritonei with unknown primary site Gelatinous Ascites Mucinous Ascites Mucinous Carcinoma Peritonei Myxoma Peritonei Peritoneal Cavity Pseudomyxoma Peritonei Pseudomyxoma Peritonei Pseudomyxoma peritonei pseudomyxoma peritonei Pseudomyxoma Peritonei The fallopian tube that extends from the uterus to the ovary in the right side of the pelvic cavity. C33475 Anatomical Structure Right Fallopian Tube C0227900 GDC Right_Fallopian_Tube Fallopian Tube, Right Fallopian Tube, Right Right Fallopian Tube Right Fallopian Tube The duct that drains bile from the right lobe of the liver into the common hepatic duct. C33476 Anatomical Structure Right Hepatic Duct C0227557 Right_Hepatic_Duct Right Hepatic Duct Right Hepatic Duct The 3-lobed lung located on the right side of the body. C33483 Anatomical Structure Right Lung C0225706 CDISC The 3-lobed lung located on the right side of the body. (NCI) Right_Lung LUNG, RIGHT Right Lung Right Lung A lymphatic vessel that drains lymph from the right side of the head and neck, the right arm, and the right thoracic cavity. C33484 Anatomical Structure Right Lymphatic Duct C0229907 Right_Lymphatic_Duct Right Lymphatic Duct Right Lymphatic Duct The ovary that is located in the right side of the pelvis. C33487 Anatomical Structure Right Ovary C0227873 GDC Right_Ovary Ovary, Right Ovary, Right Right Ovary Right Ovary A benign or malignant neoplasm that affects the rectum. Representative examples of benign neoplasms include lipoma and leiomyoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma. Rectal adenomas always exhibit epithelial dysplasia and are considered premalignant neoplasms. C3350 Neoplastic Process Rectal Neoplasm C0034885 Undetermined Rectal_Neoplasm Neoplasm of Rectum Neoplasm of the Rectum Rectal Neoplasm Rectal Tumor Tumor of Rectum Tumor of the Rectum Rectal Neoplasm Small glands located within the epidermis, and associated with the hair follicle, that produce and secrete an oily substance that lubricates the skin and hair. C33519 Anatomical Structure Sebaceous Gland C0036505 CDISC Small glands located within the skin that are usually associated with the hair follicle. Sebaceous_Gland GLAND, SEBACEOUS SEBACEOUS GLAND Sebaceous Gland Sebaceous Gland The small tube that carries sebum from the sebaceous gland to the hair follicle or skin. C33520 Anatomical Structure Sebaceous Gland Duct C1182773 Sebaceous_Gland_Duct Sebaceous Gland Duct Sebaceous Gland Duct The small glands located within the epidermis of the eyelid that produce and secrete an oily substance that lubricates the eyelashes. C33521 Anatomical Structure Sebaceous Gland of the Eyelash C0229272 CDISC A sebaceous gland in the eyelid that produces an oily substance that lubricates the eyelashes. Sebaceous_Gland_of_the_Eyelash GLAND, ZEIS Gland of Zeis Sebaceous Gland of Eyelash Sebaceous Gland of the Eyelash Sebaceous Gland of the Eyelash The membranous tube that is located within the osseous semicircular canal. C33528 Anatomical Structure Semicircular Duct C1323109 Semicircular_Duct Semicircular Duct Semicircular Duct A gland of the mouth that produces both serous fluid and mucous. C33537 Anatomical Structure Seromucous Salivary Gland C0227442 Seromucous_Salivary_Gland Seromucous Salivary Gland Seromucous Salivary Gland Salivary glands that produce and secrete a saliva made up exclusively of a pale-yellow transparent fluid containing amylase. C33539 Anatomical Structure Serous Salivary Gland C0227441 CDISC Salivary glands that produce and secrete a saliva made up exclusively of a pale-yellow transparent fluid containing amylase. (NCI) Serous_Salivary_Gland GLAND, SALIVARY, SEROUS Serous Salivary Gland Serous Salivary Gland A benign or malignant, primary or metastatic neoplasm involving the respiratory system. C3355 Neoplastic Process Respiratory System Neoplasm C0035244 CPTAC Undetermined Respiratory_Tract_Neoplasm Neoplasm of uncertain behavior of trachea, bronchus, and lung Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung Neoplasm of unspecified behavior of respiratory system Neoplasm of unspecified nature of respiratory system Respiratory System Neoplasm Respiratory Tract Neoplasm Respiratory System Neoplasm The integumentary covering of the face. C33561 Anatomical Structure Skin of the Face C0222084 CDISC GDC The skin or integument that covers the face. Skin_of_the_Face Skin of other and unspecified parts of face SKIN OF THE FACE Skin of the Face Skin of the Face A benign or malignant neoplasm that affects the retroperitoneum. C3357 Neoplastic Process Retroperitoneal Neoplasm C0035358 Undetermined Retroperitoneal_Neoplasm Retroperitoneal Neoplasm Retroperitoneal Neoplasm A benign mesenchymal tumor arising from skeletal or cardiac muscle. C3358 Neoplastic Process Rhabdomyoma C0035411 CDISC GDC NICHD A benign neoplasm arising from skeletal or cardiac muscle, characterized by the presence of rhabdomyoblasts. 8900/0 Benign Rhabdomyoma 8900/0 Rhabdomyoma, NOS RHABDOMYOMA, BENIGN Rhabdomyoma Rhabdomyoma, NOS Rhabdomyomatous Neoplasm Rhabdomyoma A rare aggressive malignant mesenchymal neoplasm arising from skeletal muscle. It usually occurs in children and young adults. Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomic sites. C3359 Neoplastic Process Rhabdomyosarcoma Rhabdomyosarcoma C1276181 CDISC CPTAC CTEP Cellosaurus GDC MedDRA NICHD PCDC A malignant mesenchymal neoplasm arising from skeletal muscle. A malignant neoplasm arising from skeletal myocytes. Cancer that forms in the soft tissues in a type of muscle called striated muscle. Rhabdomyosarcoma can occur anywhere in the body. 8900/3 Malignant Rhabdomyosarcoma 8900/3 Rhabdomyosarcoma Rhabdomyosarcoma, NOS Rhabdosarcoma RHABDOMYOSARCOMA, MALIGNANT Rhabdomyosarcoma Rhabdomyosarcoma, NOS rhabdomyosarcoma Rhabdomyosarcoma A lymph node located in the hilar region of the spleen. C33600 Anatomical Structure Splenic Hilar Lymph Node C0229782 CDISC PCDC A lymph node located in the hilar region of the spleen. (NCI) Splenic_Hilar_Lymph_Node SPLENIC HILAR LYMPH NODE Splenic Hilar Lymph Node Splenic Hilar Nodes Splenic Lymph Node Splenic Hilar Lymph Node A benign or malignant neoplasm that affects the major or minor salivary glands. Representative examples of benign neoplasms include Warthin tumor, monomorphic adenoma, and pleomorphic adenoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma. C3361 Neoplastic Process Salivary Gland Neoplasm C0036095 Undetermined Salivary_Gland_Neoplasm Neoplasm of Salivary Gland Neoplasm of the Salivary Gland Salivary Gland Neoplasm Salivary Gland Tumor Tumor of Salivary Gland Tumor of the Salivary Gland Salivary Gland Neoplasm A benign or malignant neoplasm that arises from the sebaceous glands. Representative examples include sebaceous adenoma and sebaceous carcinoma. C3363 Neoplastic Process Sebaceous Gland Neoplasm C0036503 Undetermined Sebaceous_Neoplasm Sebaceous Gland Neoplasm Sebaceous Gland Tumor Sebaceous Neoplasm Sebaceous Tumor Sebaceous Gland Neoplasm A type of intralobular duct, which is found in some salivary glands, and which is lined by low columnar epithelial cells that have characteristic basal striations, which are formed by regions of basal membrane invaginations with mitochondrial accumulation. C33635 Anatomical Structure Striated Duct C1514993 Striated_Duct Striated Duct Striated Duct A small, tubular passageway that transports saliva from the submandibular gland into the floor of the mouth, exiting adjacent to the lingual frenulum. C33649 Anatomical Structure Submandibular Duct C0227472 Submandibular_Duct Submandibular Duct Wharton's Duct Submandibular Duct Any of the lymph nodes extending from the chin to the occiput, including submental, submandibular, buccal, mandibular, preauricular, and occipital nodes. C33659 Anatomical Structure Superficial Cervical Lymph Node C0458297 CDISC Lymph node(s) in the side of the neck, cranial to the scapula and lateral to the deep cervical lymph node. Superficial_Cervical_Lymph_Node LYMPH NODE, CERVICAL, SUPERFICIAL Superficial Cervical Lymph Node Superficial Cervical Lymph Node A generalized peripheral (mature) T-cell neoplasm characterized by the presence of erythroderma, lymphadenopathy, and neoplastic, cerebriform T-lymphocytes in the blood. Sezary syndrome is an aggressive disease. (WHO, 2001) C3366 Neoplastic Process Sezary Syndrome Sezary Syndrome C0036920 CPTAC CTEP CTRP Cellosaurus GDC mCode A form of cutaneous T-cell lymphoma, a cancerous disease that affects the skin. 9701/3 Malignant Sezary_Syndrome 9701/3 Sezary disease Sezary disease, unspecified site Sezary syndrome CTCL / Sezary syndrome Cutaneous T-cell lymphoma/Sezary syndrome Sezary Syndrome Sezary disease Sezary disease, unspecified site Sezary syndrome Sezary's Disease Sézary Syndrome Sezary Syndrome Either of two paired parathyroid glands closest to the head. C33691 Anatomical Structure Superior Parathyroid Gland C0447651 Superior_Parathyroid_Gland Superior Parathyroid Gland Superior Parathyroid Gland The small coiled tubes in the skin that produce and secrete sweat. C33712 Anatomical Structure Sweat Gland C0038989 CDISC The small coiled tubular glands in the skin that produce and secrete sweat. Sweat_Gland SUDORIFEROUS GLAND Sweat Gland Sweat Gland The small tube that drains sweat from the sweat gland to the skin. C33713 Anatomical Structure Sweat Gland Duct C0221955 Sweat_Gland_Duct Sweat Gland Duct Sweat Gland Duct A benign, intermediate, or malignant neoplasm involving the skin. C3372 Neoplastic Process Skin Neoplasm Skin Neoplasm C0037286 CPTAC CTRP Undetermined Skin_Neoplasm Neoplasm of uncertain behavior of skin Neoplasm of uncertain or unknown behaviour: Skin Neoplasm of Skin Neoplasm of the Skin Skin Neoplasm Skin Neoplasms Skin Tumor Tumor of Skin Tumor of the Skin Skin Neoplasm A benign or malignant neoplasm that affects the bones and structures of the skull. C3375 Neoplastic Process Skull Neoplasm C0037305 Undetermined Skull_Neoplasm Neoplasm of Skull Neoplasm of the Skull Skull Neoplasm Skull Tumor Tumor of Skull Tumor of the Skull Skull Neoplasm The largest lymphatic vessel in the body, originating at the cisternal chyli and emptying into the junction of the left internal jugular and subclavian veins. It receives lymph from the entire body, with the exception of the right upper limb, the right side of the head and neck, and the right upper thorax. C33768 Body Part, Organ, or Organ Component Thoracic Duct C0039979 mCode Thoracic_Duct Thoracic Duct Thoracic duct structure (body structure) Thoracic Duct Lymph node located in the thoracic cavity. C33769 Anatomical Structure Thoracic Lymph Node C0229745 CDISC Lymph node located in the thoracic cavity. (NCI) Thoracic_Lymph_Node THORACIC LYMPH NODE Thoracic Lymph Node Thoracic Lymph Node A benign, intermediate, or malignant neoplasm that arises from the soft tissue. The most common types are lipomatous (fatty), vascular, smooth muscle, fibrous, and fibrohistiocytic neoplasms. C3377 Neoplastic Process Soft Tissue Neoplasm Soft Tissue Neoplasm C0037579 CPTAC CTEP CTRP Undetermined Soft_Tissue_Neoplasm Neoplasm of uncertain behavior of connective and other soft tissue Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue Neoplasm of Soft Tissue Neoplasm of the Soft Tissue Soft Tissue Neoplasm Soft Tissue Tumor Soft Tissue Tumors Soft tissue neoplasm, NOS Tumor of Soft Tissue Tumor of the Soft Tissue Soft Tissue Neoplasm A rare, usually malignant neuroendocrine tumor arizing from delta cells. This neoplasm produces large amounts of somatostatin, which may result in a syndrome characterized by diarrhea, steatorrhea, weight loss, and gastric hyposecretion. Sixty percent are found in the pancreas and 40% in the duodenum or jejunum. The peak incidence occurs between 40 and 60 years of age; women are affected more than men by 2:1. C3379 Neoplastic Process Somatostatin-Producing Neuroendocrine Tumor Somatostatin-Producing Neuroendocrine Tumor C0037661 CTRP GDC 8156/1 Undetermined Delta_Cell_Somatostatin_Producing_Neoplasm 8156/1 Somatostatin cell tumor, NOS Somatostatinoma Somatostatinoma, NOS Delta Cell Tumor Somatostatin Cell Tumor Somatostatin Producing Tumor Somatostatin cell tumor, NOS Somatostatin-Producing NET Somatostatin-Producing Neuroendocrine Tumor Somatostatin-Producing Tumor Somatostatinoma Somatostatinoma, NOS Tumor of Delta Cells Tumor of the Delta Cells Somatostatin-Producing Neuroendocrine Tumor A primary or metastatic neoplasm affecting the spinal cord. C3381 Neoplastic Process Spinal Cord Neoplasm Spinal Cord Neoplasm C0037930 CTRP MedDRA NICHD mCode A neoplasm arising within the spinal cord. Undetermined Spinal_Cord_Neoplasm Spinal cord neoplasm Neoplasm of Spinal Cord Neoplasm of the Spinal Cord Neoplasm of uncertain behavior of spinal cord Spinal Cord Neoplasm Spinal Cord Tumor Tumor of Spinal Cord Tumor of the Spinal Cord Spinal Cord Neoplasm A neoplasm that occurs within the spinal canal including the spinal cord and surrounding paraspinal spaces. C3382 Neoplastic Process Intraspinal Neoplasm C0037939 Undetermined Intraspinal_Neoplasm Intraspinal Neoplasm Intraspinal Neoplasms Intraspinal Tumor Neoplasm of Spinal Canal and Spinal Cord Neoplasm of the Spinal Canal and Spinal Cord Neoplasms of Spinal Canal and Spinal Cord Neoplasms of the Spinal Canal and Spinal Cord Spinal Canal Tumors Spinal Canal and Spinal Cord Neoplasm Spinal Canal and Spinal Cord Tumor Spinal Neoplasms Spinal Tumors Tumor of Spinal Canal and Spinal Cord Tumor of the Spinal Canal and Spinal Cord Intraspinal Neoplasm A benign or malignant neoplasm that affects the spleen. Representative examples include hemangioma, lymphoma, splenic involvement by leukemia, and angiosarcoma. C3383 Neoplastic Process Splenic Neoplasm Splenic Neoplasm C0037999 CTRP Undetermined Splenic_Neoplasm Splenic Neoplasm Splenic Neoplasm A channel located in the membranous labyrinth of the inner ear that connects the saccule to both the utricle and to the endolymphatic duct. C33845 Anatomical Structure Utriculosaccular Duct C0229450 Utriculosaccular_Duct Utriculosaccular Duct Utriculosaccular Duct A benign or malignant neoplasm involving the stomach. C3387 Neoplastic Process Gastric Neoplasm Gastric Neoplasm C0038356 CTRP Undetermined Gastric_Neoplasm Gastric Neoplasm Gastric Tumor Neoplasm of Stomach Neoplasm of the Stomach Stomach Neoplasm Stomach Tumor Tumor of Stomach Tumor of the Stomach Gastric Neoplasm A benign or malignant neoplasm that affects the sublingual gland. C3392 Neoplastic Process Sublingual Gland Neoplasm C0038554 Undetermined Sublingual_Gland_Neoplasm Neoplasm of Sublingual Gland Neoplasm of the Sublingual Gland Sublingual Gland Neoplasm Sublingual Gland Tumor Tumor of Sublingual Gland Tumor of the Sublingual Gland Sublingual Gland Neoplasm A benign or malignant neoplasm that affects the submandibular gland. C3393 Neoplastic Process Submandibular Gland Neoplasm C0038558 Undetermined Submandibular_Gland_Neoplasm Neoplasm of Submandibular Gland Neoplasm of the Submandibular Gland Submandibular Gland Neoplasm Submandibular Gland Tumor Tumor of Submandibular Gland Tumor of the Submandibular Gland Submandibular Gland Neoplasm A benign or malignant neoplasm that occurs within the intracranial cavity above the tentorium cerebelli. C3397 Neoplastic Process Supratentorial Neoplasm C0038874 CPTAC mCode Undetermined Supratentorial_Neoplasm Neoplasm of uncertain or unknown behaviour: Brain, supratentorial Brain Neoplasms, Supratentorial Neoplasm of uncertain behavior of brain, supratentorial Supratentorial Neoplasm Supratentorial Neoplasms Supratentorial Tumor Supratentorial Tumors Supratentorial Neoplasm A benign or malignant neoplasm arising from the sweat glands. C3398 Neoplastic Process Sweat Gland Neoplasm C0038987 GDC 8400/1 Undetermined Sweat_Gland_Neoplasm 8400/1 Sweat gland tumor, NOS Neoplasm of Sweat Gland Neoplasm of the Sweat Gland Sweat Gland Neoplasm Sweat Gland Neoplasms Sweat Gland Tumor Sweat gland tumor, NOS Tumor of Sweat Gland Tumor of the Sweat Gland Sweat Gland Neoplasm A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11). It can occur at any age, but mainly affects young adults, more commonly males. Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee. Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components). Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes. C3400 Neoplastic Process Synovial Sarcoma Synovial Sarcoma C0039101 CDISC CPTAC CTEP CTRP Cellosaurus GDC A malignant neoplasm that usually arises in the synovial membranes of the joints and the synovial cells of the tendons and bursae. A malignant tumor that develops in the synovial membrane of the joints. 9040/3 Malignant Synovial_Sarcoma 9040/3 Synovial sarcoma, NOS Synovioma, NOS Synovioma, malignant SARCOMA, SYNOVIAL, MALIGNANT SS Synovial Sarcoma Synovial sarcoma Synovial sarcoma, NOS Synovioma, NOS synovial sarcoma Synovial Sarcoma A bean-shaped retroperitoneal organ situated below the diaphragm and posterior to the liver. C34005 Body Part, Organ, or Organ Component Right Kidney C0227613 Right_Kidney Right Kidney Right Kidney A bean-shaped retroperitoneal organ situated below the diaphragm and posterior to the spleen. C34006 Body Part, Organ, or Organ Component Left Kidney C0227614 Left_Kidney Left Kidney Left Kidney A locally aggressive, diffusely infiltrating tumor, arising in the tendon sheath. It is composed of synovial-like mononuclear cells, hemosiderin-laden macrophages, foam cells, and inflammatory cells. Multinucleated osteoclast-like giant cells are usually present, although in a minority of cases they may be absent or rare. It predominantly affects young adults. Symptoms include joint swelling, pain, and joint effusion. C3401 Neoplastic Process Tenosynovial Giant Cell Tumor, Diffuse Type C0039106 9251/0 Undetermined Diffuse_Giant_Cell_Tumor_of_Tendon_Sheath Tenosynovial giant cell tumor, diffuse Diffuse Giant Cell Neoplasm of Tendon Sheath Diffuse Giant Cell Neoplasm of Tenosynovium Diffuse Giant Cell Neoplasm of the Tenosynovium Diffuse Giant Cell Tumor of Tendon Sheath Diffuse Giant Cell Tumor of Tenosynovium Diffuse Giant Cell Tumor of the Tenosynovium Diffuse Tenosynovial Giant Cell Neoplasm Diffuse Tenosynovial Giant Cell Tumor Pigmented Villonodular Synovitis Tenosynovial Giant Cell Tumor, Diffuse Type Tenosynovial Giant Cell Tumor, Diffuse Type A tumor usually arising in the synovium of joints, bursa or tendon sheath. It is characterized by the presence of mononuclear cells, multinucleated osteoclast-like giant cells, hemosiderin-laden macrophages, foam cells, and an inflammatory infiltrate. According to the growth pattern, it is classified as localized or diffuse. C3402 Neoplastic Process Tenosynovial Giant Cell Tumor C1318543 GDC 9252/0 Undetermined Giant_Cell_Tumor_of_Tendon_Sheath 9252/0 Fibrous histiocytoma of tendon sheath Giant cell tumor of tendon sheath Tenosynovial giant cell tumor Tenosynovial giant cell tumor, NOS Fibrous Histiocytoma of Tendon Sheath Fibrous histiocytoma of tendon sheath Giant Cell Neoplasm of Tendon Sheath Giant Cell Neoplasm of Tenosynovium Giant Cell Neoplasm of the Tenosynovium Giant Cell Tumor of Tendon Sheath Giant Cell Tumor of Tenosynovium Giant Cell Tumor of the Tenosynovium Giant cell tumor of tendon sheath Tendon Sheath Giant Cell Neoplasm Tendon Sheath Giant Cell Tumor Tenosynovial Giant Cell Neoplasm Tenosynovial Giant Cell Tumor Tenosynovial giant cell tumor Tenosynovial Giant Cell Tumor A benign or malignant neoplasm that affects the testis. Representative examples include fibroma, thecoma, benign Sertoli cell tumor, seminoma, embryonal carcinoma, sarcoma, leukemia, and lymphoma. C3404 Neoplastic Process Testicular Neoplasm Testicular Neoplasm C0039590 CTRP Cellosaurus Undetermined Testicular_Neoplasm Neoplasm of Testis Neoplasm of the Testis Testicular Neoplasm Testicular Tumor Tumor of Testis Tumor of the Testis Testicular Neoplasm An ovarian or testicular stromal tumor characterized by the presence of lipid-rich neoplastic spindle cells. In females, uterine bleeding is the most common symptom. A minority of post-menopausal women with thecoma have an associated endometrial adenocarcinoma or rarely a malignant mixed mullerian tumor or endometrial stromal sarcoma. Rare cases with nuclear atypia and mitotic activity may metastasize. In males, thecomas are rare and they usually present as slow growing, sometimes painful masses. Metastases have not been reported. C3405 Neoplastic Process Thecoma C0039747 GDC 8600/0 Undetermined Thecoma 8600/0 Theca cell tumor Thecoma, NOS Thecoma Thecoma, NOS Thecoma A benign or malignant, primary or metastatic neoplasm involving the tissues of the thorax. C3406 Neoplastic Process Thoracic Neoplasm C0039981 CPTAC Undetermined Thoracic_Neoplasm Neoplasm of uncertain behavior of pleura, thymus, and mediastinum Neoplasm of Thorax Neoplasm of the Thorax Thoracic Neoplasm Thoracic Tumor Tumor of Thorax Tumor of the Thorax Thoracic Neoplasm A chronic myeloproliferative neoplasm that involves primarily the megakaryocytic lineage. It is characterized by sustained thrombocytosis in the blood, increased numbers of large, mature megakaryocytes in the bone marrow, and episodes of thrombosis and/or hemorrhage. (WHO, 2008) C3407 Neoplastic Process Essential Thrombocythemia Essential Thrombocythemia C0040028 CPTAC CTEP CTRP Cellosaurus GDC NICHD mCode A chronic condition that involves primarily the megakaryocytic lineage. It is characterized by sustained thrombocytosis in the blood, increased numbers of large, mature megakaryocytes in the bone marrow, and elevated risk for thrombosis and/or hemorrhage. An increased number of thrombocytes (platelets) in the blood, without a known cause. 9962/3 Malignant Essential_Thrombocythemia 9962/3 Essential (haemorrhagic) thrombocythaemia Essential hemorrhagic thrombocythaemia Essential thrombocythemia Idiopathic hemorrhagic thrombocythaemia Idiopathic thrombocythemia ET Essential (hemorrhagic) thrombocythemia Essential Thrombocytemia Essential Thrombocythemia Essential Thrombocytosis Essential thrombocythemia Idiopathic Thrombocythemia Idiopathic thrombocythemia Primary Thrombocythemia Primary Thrombocytosis essential thrombocythemia essential thrombocytosis Essential Thrombocythemia A neoplasm arising from the epithelial cells of the thymus. Although thymomas are usually encapsulated tumors, they may invade the capsule and infiltrate the surrounding tissues or even metastasize to distant anatomic sites. The following morphologic subtypes are currently recognized: type A, type B, type AB, metaplastic, micronodular, microscopic, and sclerosing thymoma. Thymomas type B are further subdivided into types B1, B2, and B3. Thymoma type B3 usually has the most aggressive clinical course. C3411 Neoplastic Process Thymoma Thymoma C0040100 CPTAC CTEP CTRP Cellosaurus GDC A tumor of the thymus, an organ that is part of the lymphatic system and is located in the chest, behind the breastbone. 8580/1 Undetermined Thymoma 8580/1 Thymic Epithelial Neoplasms Thymoma, NOS Thymoma Thymoma, NOS thymoma Thymoma A neoplasm that affects the thymus. Representative examples include thymoma and carcinoma. C3412 Neoplastic Process Thymus Neoplasm C3714644 Cellosaurus Undetermined Thymic_Neoplasm Neoplasm of Thymus Neoplasm of the Thymus Thymic Neoplasm Thymic Tumor Thymus Neoplasm Thymus Tumor Tumor of Thymus Tumor of the Thymus Thymus Neoplasm A benign or malignant neoplasm affecting the thyroid gland. C3414 Neoplastic Process Thyroid Gland Neoplasm C0040136 CPTAC NICHD A neoplasm of the thyroid gland. Undetermined Thyroid_Neoplasm Neoplasm of uncertain or unknown behaviour: Thyroid gland Neoplasm of Thyroid Neoplasm of Thyroid Gland Neoplasm of the Thyroid Neoplasm of the Thyroid Gland Thyroid Gland Neoplasm Thyroid Gland Tumor Thyroid Neoplasm Thyroid Neoplasms Thyroid Tumor Tumor of Thyroid Tumor of Thyroid Gland Tumor of the Thyroid Tumor of the Thyroid Gland Thyroid Gland Neoplasm A benign or malignant neoplasm involving the tongue. C3416 Neoplastic Process Tongue Neoplasm C0040411 Undetermined Tongue_Neoplasm Neoplasm of Tongue Neoplasm of the Tongue Tongue Neoplasm Tongue Tumor Tumor of Tongue Tumor of the Tongue Tongue Neoplasm A benign or malignant neoplasm that affects the tonsil. C3417 Neoplastic Process Tonsillar Neoplasm C0040422 Cellosaurus Undetermined Tonsillar_Neoplasm Neoplasm of Tonsil Neoplasm of the Tonsil Tonsil Neoplasm Tonsil Tumor Tonsillar Neoplasm Tonsillar Neoplasms Tonsillar Tumor Tumor of Tonsil Tumor of the Tonsil Tonsillar Neoplasm A benign or malignant neoplasm that affects the trachea. Representative examples include tracheal leiomyoma and tracheal carcinoma. C3419 Neoplastic Process Tracheal Neoplasm C0040582 Undetermined Tracheal_Neoplasm Neoplasm of Trachea Neoplasm of the Trachea Trachea Neoplasm Trachea Tumor Tracheal Neoplasm Tracheal Tumor Tumor of Trachea Tumor of the Trachea Tracheal Neoplasm A benign or malignant neoplasm that affects the ureter. C3427 Neoplastic Process Ureter Neoplasm C0041955 Undetermined Ureter_Neoplasm Neoplasm of Ureter Neoplasm of the Ureter Neoplasms of Ureter Neoplasms of the Ureter Tumor of Ureter Tumor of the Ureter Ureter Neoplasm Ureter Tumor Ureteral Neoplasm Ureteral Tumor Ureter Neoplasm A benign or malignant neoplasm that affects the urethra. Urethral carcinoma is a representative example. C3428 Neoplastic Process Urethra Neoplasm C0041971 Undetermined Urethra_Neoplasm Neoplasm of Urethra Neoplasm of the Urethra Tumor of Urethra Tumor of the Urethra Urethra Neoplasm Urethra Tumor Urethral Neoplasm Urethral Tumor Urethra Neoplasm A benign or malignant, primary or metastatic neoplasm involving the urinary system (kidney, ureter, bladder, and urethra). C3431 Neoplastic Process Urinary System Neoplasm Urinary System Neoplasm C0042076 CTRP Undetermined Urinary_Tract_Neoplasm Neoplasm of Urinary System Neoplasm of the Urinary System Tumor of Urinary System Tumor of the Urinary System Urinary System Neoplasm Urinary System Tumor Urinary System Neoplasm The most frequent form of cutaneous mastocytosis. In children, the lesions tend to be papular, and are characterized by aggregates of elongated or spindle-shaped mast cells which fill the papillary dermis and extend into the reticular dermis. In adults, the lesions tend to have fewer mast cells compared to those in children. The lesions are located most commonly on the trunk, but they can be seen on the extremities, head and neck. (WHO, 2001) C3433 Neoplastic Process Urticaria Pigmentosa/Maculopapular Cutaneous Mastocytosis Urticaria Pigmentosa/Maculopapular Cutaneous Mastocytosis C0042111 CTRP GDC 9740/1 Undetermined Urticaria_Pigmentosa_Maculopapular_Cutaneous_Mastocytosis 9740/1 Urticaria pigmentosa UP/MPCM Urticaria Pigmentosa Urticaria Pigmentosa/Maculopapular Cutaneous Mastocytosis Urticaria pigmentosa Urticaria Pigmentosa/Maculopapular Cutaneous Mastocytosis A benign smooth muscle neoplasm arising from the body of the uterus. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C3434 Neoplastic Process Uterine Corpus Leiomyoma Uterine Corpus Leiomyoma C0042133 CPTAC CTRP Cellosaurus GDC Benign Uterine_Corpus_Leiomyoma 8890/0 Fibroid uterus Fibromyoma Leiomyofibroma Leiomyoma of uterus, unspecified Submucous leiomyoma of uterus Body of Uterus Fibroid Body of Uterus Leiomyoma Corpus Uteri Fibroid Corpus Uteri Leiomyoma Fibroid of Body of Uterus Fibroid of Corpus Uteri Fibroid of Uterine Body Fibroid of Uterine Corpus Fibroid of the Body of Uterus Fibroid of the Corpus Uteri Fibroid of the Uterine Body Fibroid of the Uterine Corpus Fibroid uterus Fibromyoma Leiomyofibroma Leiomyoma of Body of Uterus Leiomyoma of Corpus Uteri Leiomyoma of Uterine Body Leiomyoma of Uterine Corpus Leiomyoma of the Body of Uterus Leiomyoma of the Corpus Uteri Leiomyoma of the Uterine Body Leiomyoma of the Uterine Corpus Uterine Body Fibroid Uterine Body Leiomyoma Uterine Corpus Fibroid Uterine Corpus Leiomyoma Uterine Corpus Leiomyomata Uterine Fibroid Uterine Fibroids Uterine Corpus Leiomyoma A benign or malignant neoplasm that affects the uterine corpus or the cervix. Representative examples of benign neoplasms include leiomyoma, adenomyoma, and endocervical polyp. Representative examples of malignant neoplasms include endometrial carcinoma, carcinosarcoma, and cervical carcinoma. C3435 Neoplastic Process Uterine Neoplasm C0042138 CPTAC Undetermined Uterine_Neoplasm Neoplasm of uncertain behavior of uterus Neoplasm of Uterus Neoplasm of the Uterus Tumor of Uterus Tumor of the Uterus Uterine Neoplasm Uterine Neoplasms Uterine Tumor Uterine Neoplasm A neoplasm that affects the uvea. Uveal melanoma is a representative example. C3436 Neoplastic Process Uveal Neoplasm C0042162 Undetermined Uveal_Neoplasm Neoplasm of Uvea Neoplasm of the Uvea Tumor of Uvea Tumor of the Uvea Uvea Neoplasm Uvea Tumor Uveal Neoplasm Uveal Tract Neoplasm Uveal Tumor Uveal Neoplasm A benign or malignant neoplasm affecting the vagina. Representative examples of benign neoplasms include squamous papilloma and melanocytic nevus. Representative examples of malignant neoplasms include carcinoma, melanoma, and sarcoma. C3437 Neoplastic Process Vaginal Neoplasm C0042258 Undetermined Vaginal_Neoplasm Neoplasm of Vagina Neoplasm of the Vagina Tumor of Vagina Tumor of the Vagina Vagina Neoplasm Vagina Tumor Vaginal Neoplasm Vaginal Tumor Vaginal Neoplasm A non-metastasizing neoplasm that arises from the mandible. C34417 Neoplastic Process Benign Neoplasm of Mandible C0004994 CPTAC Benign Benign_Neoplasm_of_Lower_Jaw_Bone Benign neoplasm of lower jaw bone Benign Neoplasm of Lower Jaw Bone Benign Neoplasm of Mandible Benign Neoplasm of Mandible A benign, precancerous, or malignant neoplasm that affects the vulva. Representative examples include Bartholin gland adenoma, vulvar nodular hidradenoma, vulvar intraepithelial neoplasia, vulvar carcinoma, and vulvar melanoma. C3443 Neoplastic Process Vulvar Neoplasm C0042995 Undetermined Vulvar_Neoplasm Neoplasm of Vulva Neoplasm of the Vulva Tumor of Vulva Tumor of the Vulva Vulva Neoplasm Vulva Tumor Vulvar Neoplasm Vulvar Tumor Vulvar Neoplasm A squamous cell carcinoma that arises from any of the following anatomic sites: lip and oral cavity, nasal cavity, paranasal sinuses, pharynx, larynx, and salivary glands. C34447 Neoplastic Process Head and Neck Squamous Cell Carcinoma C1168401 CTEP Cellosaurus Cancer of the head and neck that begins in squamous cells (thin, flat cells that form the surface of the skin, eyes, various internal organs, and the lining of hollow organs and ducts of some glands). Squamous cell carcinoma of the head and neck includes cancers of the nasal cavity, sinuses, lips, mouth, salivary glands, throat, and larynx (voice box). Most head and neck cancers are squamous cell carcinomas. Malignant Head_and_Neck_Squamous_Cell_Carcinoma HNSCC Head and Neck Squamous Cell Carcinoma Head and neck squamous cell carcinoma, NOS SCCHN Squamous Cell Carcinoma of Head and Neck Squamous Cell Carcinoma of the Head and Neck squamous cell carcinoma of the head and neck Head and Neck Squamous Cell Carcinoma An uncommon, benign cartilaginous neoplasm usually occurring in adults. The nodular tumor arises from the synovial membranes of joints. It is characterized by the presence of chondrocytes, nuclear pleomorphism, and hyaline cartilage differentiation. Clinical presentation may include joint pain, swelling, and limited range of motion. C34467 Neoplastic Process Synovial Chondromatosis C0008476 Benign Synovial_Chondromatosis Henderson-Jones Syndrome Reichel Syndrome Reichel's Syndrome Synovial Chondromatosis Synovial Chondromatosis A benign histiocytic tumor that usually arises from the skin and occurs during childhood; it is distinct from Langerhans cell histiocytosis. It is characterized by the presence of lipid-laden, foamy histiocytes and Touton-type giant cells in the dermis. The lesions usually develop during infancy. While the majority of cases arise from the skin, it can rarely also arise from extracutaneous sites including the eye, ocular adnexa, oral cavity, paranasal sinuses, and ear. It is sometimes associated with deep soft tissues nodules. C3451 Neoplastic Process Juvenile Xanthogranuloma C0043324 NICHD A macrophage disorder that occurs during childhood; it is distinct from Langerhans cell histiocytosis, and is characterized by cutaneous papules and nodules (most often in the head and neck). Benign Juvenile_Xanthogranuloma JXG Juvenile Solitary Xanthogranuloma Juvenile Xanthogranuloma Juvenile Xanthogranuloma Acute CNS, visual, GI, and cardiac disturbances caused by an overdose of, or intolerance to, the cardiac glycoside, digitalis. C34539 Finding Digitalis Toxicity C0012254 Digitalis_Toxicity Digitalis Toxicity Digitalis Toxicity A rare benign neoplasm arising from the soft tissues of the digits, in young children. It is characterized by the presence of fibroblastic spindle cells, and intracytoplasmic eosinophilic spherical inclusions. C3456 Neoplastic Process Inclusion Body Fibromatosis C1318562 Benign Infantile_Digital_Fibromatosis Digital Fibrous Tumor of Reye Inclusion Body Fibromatosis Infantile Digital Fibroma/Fibromatosis Infantile Digital Fibromatosis Reye Tumor Reye's Tumor Inclusion Body Fibromatosis The most common type of non-Hodgkin lymphoma. It includes the most frequently seen morphologic variants which are: diffuse large B-cell lymphoma, follicular lymphoma, small lymphocytic lymphoma and marginal zone B-cell lymphoma. C3457 Neoplastic Process B-Cell Non-Hodgkin Lymphoma B-Cell Non-Hodgkin Lymphoma CL448793 CPTAC CTRP Cellosaurus mCode A type of cancer that forms in B cells (a type of immune system cell). B-cell lymphomas usually occur in adults and may be either indolent (slow-growing) or aggressive (fast-growing). There are many different types of B-cell lymphomas, and prognosis and treatment depend on the type and stage of cancer. Malignant B-Cell_Non-Hodgkin_s_Lymphoma Unspecified B-cell lymphoma, extranodal and solid organ sites Unspecified B-cell lymphoma, intrapelvic lymph nodes Unspecified B-cell lymphoma, lymph nodes of multiple sites Unspecified B-cell lymphoma, spleen Unspecified B-cell lymphoma, unspecified site B-Cell Non Hodgkin's Lymphoma B-Cell Non-Hodgkin Lymphoma B-Cell Non-Hodgkin's Lymphoma B-cell lymphoma Lymphomas Non-Hodgkin's B-Cell Non-Hodgkin's B-Cell Lymphoma Non-Hodgkin's Lymphoma B-Cell Unspecified B-cell lymphoma, unspecified site B-Cell Non-Hodgkin Lymphoma A polyp that arises from the endocervix. It is characterized by the presence of endocervical glands and a fibrovascular stroma. C34584 Neoplastic Process Endocervical Polyp C0014126 GDC Benign Endocervical_Polyp Benign endocervical polyp Benign endocervical polyp Endocervical Polyp Endocervical Polyp A follicular lymphoma which contains more than 15 centroblasts per 40X high-power microscopic field. C3460 Neoplastic Process Grade 3 Follicular Lymphoma Grade 3 Follicular Lymphoma C0079745 CPTAC CTRP GDC mCode A type of non-Hodgkin lymphoma marked by large cells and enlarged lymph nodes. Grade 3 follicular lymphoma is less common, and more aggressive than grades 1 or 2 follicular lymphoma. 9698/3 Malignant Grade_3_Follicular_Lymphoma 9698/3 Follicular lymphoma grade III, unspecified Follicular lymphoma, grade 3 Malignant lymphoma, histiocytic, nodular Malignant lymphoma, large cell, follicular, NOS Malignant lymphoma, large cell, noncleaved, follicular Malignant lymphoma, large cleaved cell, follicular Follicular Large Cell Lymphoma Follicular Lymphoma Grade 3 Follicular Lymphoma, Predominantly Large Cell Follicular lymphoma grade III, unspecified, unspecified site Follicular lymphoma, grade 3 Grade 3 Grade 3 Follicular Lymphoma Grade III Follicular Large Cell Lymphoma Grade III Follicular Lymphoma Nodular Histiocytic Lymphoma WHO Follicular Lymphoma Histologic Grade 3 follicular large cell lymphoma grade 3 follicular lymphoma Grade 3 Follicular Lymphoma A benign medullary neoplasm characterized by the presence of poorly organized and inadequately mineralized bone and intervening fibrous tissue, in varying proportions. It can be monostotic or polyostotic. The skull, femur, tibia, and humerus are the most frequently affected bones. It manifests with pain, deformities, and fractures. GNAS activating mutations are detected in the majority of cases. C34609 Neoplastic Process Fibrous Dysplasia C4012071 Cellosaurus Benign Fibrous_Dysplasia_of_Bone Fibrous dysplasia Fibrous Dysplasia Fibrous Dysplasia of Bone Fibrous Dysplasia A diffuse large B-cell lymphoma characterized by the presence of immunoblasts with uniformly round-to-oval nuclei, a prominent nucleolus, and abundant cytoplasm. C3461 Neoplastic Process Immunoblastic Lymphoma Immunoblastic Lymphoma C0079746 CDISC CTRP GDC A malignant neoplasm composed of immunoblasts (large B cells). 9684/3 Malignant Immunoblastic_Lymphoma 9684/3 Immunoblastic sarcoma Malignant lymphoma, immunoblastic, NOS Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS Malignant lymphoma, large cell, immunoblastic Immunoblastic Lymphoma LYMPHOMA, IMMUNOBLASTIC, MALIGNANT Immunoblastic Lymphoma Fibrous dysplasia affecting more than one bone. When it is associated with café-au-lait skin pigmentation and endocrine disorders, it is known as McCune-Albright syndrome. C34610 Neoplastic Process Polyostotic Fibrous Dysplasia C0016065 NICHD Benign Polyostotic_Fibrous_Dysplasia_of_Bone Polyostotic Fibrous Dysplasia Polyostotic Fibrous Dysplasia of Bone Polyostotic Fibrous Dysplasia A follicular lymphoma which contains up to 5 centroblasts per 40X high-power microscopic field. C3465 Neoplastic Process Grade 1 Follicular Lymphoma Grade 1 Follicular Lymphoma C0079765 CPTAC CTRP Cellosaurus GDC mCode An indolent (slow-growing) type of non-Hodgkin lymphoma marked by enlarged lymph nodes and small cells that have cleaved (u-shaped) nuclei. 9695/3 Malignant Grade_1_Follicular_Lymphoma 9695/3 Follicular lymphoma grade I, unspecified site Follicular lymphoma, grade 1 Follicular lymphoma, small cleaved cell Malignant lymphoma, lymphocytic, poorly differentiated, nodular Malignant lymphoma, small cleaved cell, follicular Follicular Lymphoma Grade 1 Follicular Small Cleaved Cell Lymphoma Follicular lymphoma grade I, unspecified site Follicular lymphoma, grade 1 Follicular lymphoma, small cleaved cell Grade 1 Grade 1 Follicular Lymphoma Grade I Follicular Lymphoma Grade I Follicular Small Cleaved Cell Lymphoma Poorly Differentiated Nodular Lymphocytic Lymphoma WHO Follicular Lymphoma Histologic Grade 1 grade 1 follicular lymphoma Grade 1 Follicular Lymphoma A non-Hodgkin lymphoma of T-cell lineage. It includes the T lymphoblastic lymphoma and the mature T- and NK-cell lymphomas. C3466 Neoplastic Process T-Cell Non-Hodgkin Lymphoma T-Cell Non-Hodgkin Lymphoma C0079772 CTRP Cellosaurus GDC A disease in which certain cells of the lymph system (called T lymphocytes) become cancer. Malignant T-Cell_Non-Hodgkin_s_Lymphoma 9702/3 T-cell lymphoma, NOS Non-Hodgkin's T-Cell Lymphoma T Cell Lymphoma T-Cell Lymphoma T-Cell Non-Hodgkin Lymphoma T-Cell Non-Hodgkin's Lymphoma T-Cell and NK-Cell Non-Hodgkin Lymphoma T-Cell and NK-Cell Non-Hodgkin's Lymphoma T-cell lymphoma T-Cell Non-Hodgkin Lymphoma A T-cell non-Hodgkin lymphoma arising from the skin. Representative examples include mycosis fungoides and primary cutaneous anaplastic large cell lymphoma. C3467 Neoplastic Process Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Primary Cutaneous T-Cell Non-Hodgkin Lymphoma C0079773 CPTAC CTRP Cellosaurus GDC mCode Any of a group of T-cell non-Hodgkin lymphomas that begins in the skin as an itchy, red rash that can thicken or form a tumor. The most common types are mycosis fungoides and Sezary syndrome. 9709/3 Malignant Cutaneous_T-Cell_Lymphoma 9709/3 Cutaneous T-cell lymphoma, NOS Cutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes CTCL Cutaneous T Cell Lymphoma Cutaneous T-Cell Non-Hodgkin Lymphoma Cutaneous T-Cell Non-Hodgkin's Lymphoma Cutaneous T-cell lymphoma, unspecified, unspecified site PCTCL Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Primary Cutaneous T-Cell Non-Hodgkin's Lymphoma Skin T-Cell Non-Hodgkin's Lymphoma T-Cell Non-Hodgkin's Lymphoma of Skin T-Cell Non-Hodgkin's Lymphoma of the Skin cutaneous T-cell lymphoma Primary Cutaneous T-Cell Non-Hodgkin Lymphoma This type of lymphoma is not frequently seen in the western hemisphere. Clinically, with the exception of anaplastic large cell lymphoma, mature T- and NK-cell lymphomas are among the most aggressive of all hematopoietic neoplasms. Representative disease entities include mycosis fungoides, angioimmunoblastic T-cell lymphoma, hepatosplenic T-cell lymphoma, and anaplastic large cell lymphoma. C3468 Neoplastic Process Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma C0079774 CPTAC CTRP GDC mCode One of a group of aggressive (fast-growing) non-Hodgkin lymphomas that begins in mature T lymphocytes (T cells that have matured in the thymus gland and goes to other lymphatic sites in the body, including lymph nodes, bone marrow, and spleen.) 9702/3 Malignant Mature_T-Cell_and_NK-Cell_Non-Hodgkin_s_Lymphoma Mature T- and NK-Cell Lymphomas Mature T/NK-cell lymphoma, unspecified Mature T/NK-cell lymphomas Mature T- and NK-Cell Lymphomas Mature T-Cell Non-Hodgkin's Lymphoma Mature T-Cell and NK-Cell Lymphoma Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma Mature T-and NK-Cell Lymphoma Mature T/NK-cell lymphomas, unspecified, unspecified site PTCL Peripheral T-Cell Lymphoma mature T-cell lymphoma peripheral T-cell lymphoma Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma A superficial fibromatosis arising from the soft tissue of the palm. It is characterized by the presence of spindle-shaped fibroblasts, and an infiltrative growth pattern. It predominantly affects adult males. C3469 Neoplastic Process Palmar Fibromatosis C3549781 Undetermined Palmar_Fibromatosis Palmar/plantar type fibromatosis Dupuytren Contracture Dupuytren's Contracture Palmar Fibromatosis Palmar Fibromatosis An aggressive lymphoma that develops in HIV-positive patients. There is a significant increase in the incidence of lymphomas associated with the AIDS epidemic. These lymphomas are usually extranodal, most often express a B-cell phenotype and morphologically are classified as Burkitt, diffuse large B-cell, and Hodgkin lymphomas. The prognosis is closely related to the severity of immunodeficiency. C3471 Neoplastic Process AIDS-Related Lymphoma AIDS-Related Lymphoma C0085090 CTRP Malignant AIDS-Related_Lymphoma AIDS Lymphoma AIDS Related Lymphoma AIDS-Related Lymphoma HIV Associated Lymphoma Lymphoma AIDS Related Lymphoma, AIDS-Related AIDS-Related Lymphoma An intraventricular neoplasm that originates from the choroid plexus. The vast majority of choroid plexus neoplasms originate from the epithelial layer and include the choroid plexus papilloma, atypical choroid plexus papilloma, and choroid plexus carcinoma. C3473 Neoplastic Process Choroid Plexus Neoplasm C0085138 A rare type of cancer that occurs in the ventricles of the brain. It usually occurs in children younger than 2 years. Undetermined Choroid_Plexus_Neoplasm Choroid Plexus Neoplasm Choroid Plexus Tumor Neoplasm of Choroid Plexus Neoplasm of the Choroid Plexus Tumor of Choroid Plexus Tumor of the Choroid Plexus choroid plexus tumor Choroid Plexus Neoplasm An unusual benign or malignant neoplasm characterized by the presence of neoplastic large polygonal cells with granular, eosinophilic cytoplasm which contains abundant lysosomes. It was originally thought to be a tumor originating from muscle cells and was named granular cell myoblastoma. Subsequent studies have suggested a derivation from Schwann cells. It affects females more often than males and it usually presents as a solitary mass. A minority of patients have multiple tumors. It can arise from many anatomic sites including the posterior pituitary gland, skin, oral cavity, esophagus, stomach, heart, mediastinum, and breast. C3474 Neoplastic Process Granular Cell Tumor C0085167 GDC 9580/0 Undetermined Granular_Cell_Tumor 9580/0 Granular cell myoblastoma, NOS Granular cell tumor, NOS Abrikossoff Tumor Abrikossoff's Tumor Granular Cell Myoblastoma Granular Cell Nerve Sheath Tumor Granular Cell Schwannoma Granular Cell Tumor Granular cell tumor, NOS Granular Cell Tumor A friable, benign vascular neoplasm with lobular capillary architecture that presents as a raised red skin growth. C3480 Neoplastic Process Lobular Capillary Hemangioma C0263218 MedDRA NICHD A friable, benign vascular neoplasm with lobular capillary architecture that presents as a raised red skin growth. Benign Lobular_Capillary_Hemangioma Pyogenic granuloma Granulation Tissue-Type Hemangioma Granuloma Pyogenicum Granuloma Telangiecticum Granulomata Pyogenicum Hemangiomatous Granulation Tissue Lobular Capillary Hemangioma Lobular Hemangioma Pyogenic Granuloma Lobular Capillary Hemangioma An epithelial or non-epithelial malignant neoplasm that arises from the liver. Representative examples include hepatocellular carcinoma, intrahepatic cholangiocarcinoma, lymphoma, and sarcoma. C34803 Neoplastic Process Primary Malignant Liver Neoplasm Primary Malignant Liver Neoplasm C0024620 CPTAC CTRP NICHD mCode Malignant Primary_Malignant_Neoplasm_of_Liver Malignant neoplasm of liver, primary Malignant neoplasm of liver, primary, unspecified as to type Malignant neoplasm: Liver, unspecified Malignant neoplasm of liver, primary, unspecified as to type Primary Malignant Liver Neoplasm Primary Malignant Neoplasm of Liver Primary Malignant Liver Neoplasm A slowly progressing leukemia characterized by a clonal (malignant) proliferation of maturing and mature myeloid cells or mature lymphocytes. When the clonal cellular population is composed of myeloid cells, the process is called chronic myelogenous leukemia. When the clonal cellular population is composed of lymphocytes, it is classified as chronic lymphocytic leukemia, hairy cell leukemia, or T-cell large granular lymphocyte leukemia. C3483 Neoplastic Process Chronic Leukemia Chronic Leukemia C1279296 CPTAC CTRP GDC A slowly progressing cancer that starts in blood-forming tissues such as the bone marrow, and causes large numbers of white blood cells to be produced and enter the blood stream. Malignant Chronic_Leukemia 9800/3 Chronic leukemia of unspecified cell type not having achieved remission Chronic leukemia of unspecified cell type without mention of having achieved remission Chronic leukemia, NOS Leukemia of unspecified cell type, chronic Chronic Leukemia Chronic leukemia, NOS chronic leukemia Chronic Leukemia A benign or malignant gastrointestinal stromal tumor with epithelioid morphology. C3486 Neoplastic Process Epithelioid Cell Type Gastrointestinal Stromal Tumor C0086533 GDC 8891/0 Undetermined Epithelioid_Cell_Type_Gastrointestinal_Stromal_Tumor Epithelioid leiomyoma Leiomyoblastoma Epithelioid Cell Type GIST Epithelioid Cell Type Gastrointestinal Stromal Tumor Leiomyoblastoma Stout's Leiomyoblastoma Epithelioid Cell Type Gastrointestinal Stromal Tumor A neoplasm that arises from the penis and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3489 Neoplastic Process Benign Penile Neoplasm C0149627 Benign Benign_Penile_Neoplasm Benign Neoplasm of Penis Benign Neoplasm of the Penis Benign Penile Neoplasm Benign Penile Tumor Benign Tumor of Penis Benign Tumor of the Penis Benign Penile Neoplasm A malignant epithelial neoplasm arising from the lips. C3490 Neoplastic Process Lip Carcinoma Lip Carcinoma C0149637 CPTAC CTRP Malignant Lip_Carcinoma Carcinoma of Lip Carcinoma of the Lip Lip Cancer Lip Carcinoma Lip Carcinoma A malignant epithelial neoplasm that arises from the cecum and invades through the muscularis mucosa into the submucosa. The vast majority are adenocarcinomas. C3491 Neoplastic Process Cecum Carcinoma Cecum Carcinoma C0149640 CTRP Malignant Cecum_Carcinoma Carcinoma of Cecum Carcinoma of the Cecum Cecal Cancer Cecal Carcinoma Cecum Cancer Cecum Carcinoma Cecum Carcinoma A carcinoma arising from squamous bronchial epithelial cells. It may be keratinizing or non-keratinizing. Keratinizing squamous cell carcinoma is characterized by the presence of keratinization, pearl formation, and/or intercellular bridges. Non-keratinizing squamous cell carcinoma is characterized by the absence of keratinization, pearl formation, and intercellular bridges. Cigarette smoking and arsenic exposure are strongly associated with squamous cell lung carcinoma. C3493 Neoplastic Process Lung Squamous Cell Carcinoma Squamous Cell Lung Carcinoma Lung Squamous Cell Carcinoma C0149782 CTEP CTRP Cellosaurus GDC Malignant Squamous_Cell_Lung_Carcinoma 60 Epidermoid Cell Carcinoma of Lung Epidermoid Cell Carcinoma of the Lung Epidermoid Cell Lung Carcinoma LSCC LUSC Lung Squamous Cell Carcinoma Squamous Cell Carcinoma of Lung Squamous Cell Carcinoma of the Lung Squamous Cell Lung Cancer Squamous Cell Lung Carcinoma Squamous cell lung carcinoma Lung Squamous Cell Carcinoma A benign lung neoplasm characterized by the presence of a fibrovascular stroma lined by cuboidal to columnar cells. Patients are usually asymptomatic and it is incidentally discovered as a pulmonary nodule during chest X-ray examination. Surgical excision is curative. C3494 Neoplastic Process Lung Papillary Adenoma C0149845 CDISC GDC A benign neoplasia of the lung, arising from bronchial epithelium. Cancer that forms in tissues of the bronchi (large air passages in the lungs including those that lead to the lungs from the windpipe). 8260/0 Benign Bronchial_Adenoma 8140/1 Bronchial adenoma, NOS ADENOMA, BRONCHIAL, BENIGN Adenoma of Bronchus Adenoma of the Bronchus Bronchial Adenoma Lung Papillary Adenoma Papillary Adenoma of Type II Pneumocytes Peripheral Papillary Tumor of Type II Pneumocytes Type II Pneumocyte Adenoma bronchial adenoma Lung Papillary Adenoma A neoplasm that arises from the glandular epithelium of the colonic mucosa. It is characterized by a villous architectural pattern. The neoplastic glandular cells have dysplastic features. C3495 Neoplastic Process Colon Villous Adenoma C0149862 Benign Colon_Villous_Adenoma Colon Villous Adenoma Colonic Villous Adenoma Villous Adenoma of Colon Villous Adenoma of the Colon Colon Villous Adenoma A lobular hemangioma arising from the skin and attached subcutaneous tissues. C34967 Neoplastic Process Lobular Capillary Hemangioma of Skin and Subcutaneous Tissue C0034214 Benign Lobular_Capillary_Hemangioma_of_Skin_and_Subcutaneous_Tissue Lobular Capillary Hemangioma of Skin and Subcutaneous Tissue Pyogenic Granuloma of Skin and Subcutaneous Tissue Lobular Capillary Hemangioma of Skin and Subcutaneous Tissue A benign neoplasm that arises from the lung. It is characterized by the presence of mesenchymal tissues admixed with entrapped respiratory epithelium. The majority of cases are peripheral and asymptomatic. A minority of cases arise endobronchially and present with signs and symptoms of bronchial obstruction. Wedge resection or bronchoplastic resection is usually curative. Recurrence is very rare. C3497 Neoplastic Process Pulmonary Hamartoma C0149927 Benign Lung_Hamartoma Pulmonary hamartoma Hamartoma of Lung Hamartoma of the Lung Lung Chondroid Hamartoma Lung Hamartoma Pulmonary Hamartoma Pulmonary Hamartoma A benign neoplasm arising from soft tissue of the ovary. It is characterized by the presence of spindle-shaped fibroblasts. C3498 Neoplastic Process Ovarian Fibroma C0149951 Benign Ovarian_Fibroma Fibroma of Ovary Fibroma of the Ovary Ovarian Fibroma Ovarian Fibroma A cardiac myxoma arising from the atrium. C3499 Neoplastic Process Atrial Myxoma C0151241 Benign Atrial_Myxoma Atrial Myxoma Myxoma of Atrium Myxoma of the Atrium Atrial Myxoma A benign, encapsulated neoplasm arising from the follicular cells of the thyroid gland. It may be associated with thyroid hormone secretion but it does not have malignant characteristics. C3502 Neoplastic Process Thyroid Gland Follicular Adenoma C0151468 CDISC Cellosaurus GDC NICHD A benign neoplasm arising from follicular cells of the thyroid gland. A non-malignant neoplasm of the thyroid gland arising from epithelial cells. 8330/0 Benign Thyroid_Adenoma 8330/0 Follicular Adenoma Follicular adenoma Follicular adenoma, NOS ADENOMA, FOLLICULAR CELL, BENIGN Adenoma of Thyroid Adenoma of Thyroid Gland Adenoma of the Thyroid Adenoma of the Thyroid Gland Follicular Adenoma Follicular Adenoma of Thyroid Follicular Adenoma of Thyroid Gland Follicular Adenoma of the Thyroid Follicular Adenoma of the Thyroid Gland Follicular adenoma Thyroid Adenoma Thyroid Follicular Adenoma Thyroid Gland Adenoma Thyroid Gland Follicular Adenoma Thyroid Gland Follicular Adenoma A primary melanoma arising from atypical melanocytes in the skin. Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi. Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma. C3510 Neoplastic Process Cutaneous Melanoma Cutaneous Melanoma C0151779 CPTAC CTRP Cellosaurus mCode Malignant Cutaneous_Melanoma Malignant melanoma of left lower limb, including hip Malignant melanoma of nose Malignant melanoma of other part of trunk Malignant melanoma of other parts of face Malignant melanoma of other specified sites of skin Malignant melanoma of right lower limb, including hip Malignant melanoma of right upper limb, including shoulder Malignant melanoma of skin Malignant melanoma of skin of breast Malignant melanoma of skin of ear and external auditory canal Malignant melanoma of skin of lip Malignant melanoma of skin of lower limb, including hip Malignant melanoma of skin of other and unspecified parts of face Malignant melanoma of skin of scalp and neck Malignant melanoma of skin of trunk, except scrotum Malignant melanoma of skin of upper limb, including shoulder Malignant melanoma of unspecified lower limb, including hip Malignant melanoma of unspecified part of face Malignant melanoma of unspecified upper limb, including shoulder Malignant neoplasm: Malignant melanoma of lip Malignant neoplasm: Malignant melanoma of scalp and neck Malignant neoplasm: Malignant melanoma of skin, unspecified Malignant neoplasm: Malignant melanoma of trunk Malignant neoplasm: Malignant melanoma of upper limb, including shoulder Malignant neoplasm: Overlapping malignant melanoma of skin Melanoma of skin, site unspecified CM Cutaneous (Skin) Melanoma Cutaneous Melanoma Malignant Cutaneous Melanoma Malignant Melanoma (of Skin), Stage Unspecified Malignant Melanoma of Skin Malignant Melanoma of Skin Stage Unspecified Malignant melanoma of skin, unspecified Melanoma of Skin Melanoma of the Skin Skin Melanoma Skin, Melanoma Cutaneous Melanoma A morphologic variant of uterine corpus leiomyoma characterized by the presence of hyalinized or myxoid stroma, edema, cystic changes, hemorrhage, and calcifications. C3511 Neoplastic Process Uterine Corpus Degenerated Leiomyoma C0151995 Benign Degenerated_Uterine_Corpus_Leiomyoma Degenerated Uterine Fibroid Uterine Corpus Degenerated Leiomyoma Uterine Fibroid Degenerated Uterine Leiomyoma Degenerated Uterine Corpus Degenerated Leiomyoma A carcinoma that arises from the lung and is characterized by the presence of malignant glandular epithelial cells. There is a male predilection with a male to female ratio of 2:1. Usually lung adenocarcinoma is asymptomatic and is identified through screening studies or as an incidental radiologic finding. If clinical symptoms are present they include shortness of breath, cough, hemoptysis, chest pain, and fever. Tobacco smoke is a known risk factor. C3512 Neoplastic Process Lung Adenocarcinoma Lung Adenocarcinoma C0152013 CPTAC CTEP CTRP Cellosaurus GDC Malignant Lung_Adenocarcinoma 52 Adenocarcinoma Adenocarcinoma of Lung Adenocarcinoma of the Lung LUAD Lung Adenocarcinoma Lung adenocarcinoma Lung Adenocarcinoma A malignant epithelial tumor arising from the esophageal mucosa. Two major histologic types of esophageal carcinoma have been described: squamous cell carcinoma and adenocarcinoma. This type of cancer is associated with excessive ethanol and cigarette usage. C3513 Neoplastic Process Esophageal Carcinoma Esophageal Carcinoma C0152018 CPTAC CTEP CTRP Cellosaurus GDC Cancer that forms in tissues lining the esophagus (the muscular tube through which food passes from the throat to the stomach). Two types of esophageal cancer are squamous cell carcinoma (cancer that begins in flat cells lining the esophagus) and adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids). Malignant Esophageal_Carcinoma Esophageal Cancer Cancer of Esophagus Cancer of the Esophagus Carcinoma of Esophagus Carcinoma of the Esophagus ESCA Esophageal Cancer Esophageal Carcinoma Esophageal cancer, NOS Esophagus Carcinoma esophageal cancer Esophageal Carcinoma A locally aggressive and destructive benign cystic neoplasm of the bone. It is characterized by the formation of multiloculated hemorrhagic cystic spaces which are separated by fibrous septa. It can arise from any bone, but usually affects the metaphysis of long bones. It manifests with pain and swelling and may recur following curettage. C3516 Neoplastic Process Aneurysmal Bone Cyst C0152244 Benign Aneurysmal_Bone_Cyst Aneurysmal bone cyst ABC Aneurysmal Bone Cyst Aneurysmal Cyst of Bone Aneurysmal Cyst of the Bone Aneurysmal Bone Cyst A subtype of classic Hodgkin lymphoma with scattered Reed-Sternberg and Hodgkin cells in a diffuse or vaguely nodular mixed inflammatory background without nodular sclerosing fibrosis. (WHO, 2008) C3517 Neoplastic Process Mixed Cellularity Classic Hodgkin Lymphoma Mixed Cellularity Classic Hodgkin Lymphoma C0152266 CPTAC CTRP GDC PCDC mCode 9652/3 Malignant Mixed_Cellularity_Hodgkin_s_Lymphoma 9652/3 Classical Hodgkin lymphoma, mixed cellularity, NOS Hodgkin lymphoma, mixed cellularity, NOS Hodgkin's disease, mixed cellularity Hodgkin's disease, mixed cellularity, involving lymph nodes of head, face, and neck Hodgkin's disease, mixed cellularity, involving lymph nodes of multiple sites Mixed cellularity classical Hodgkin lymphoma Mixed cellularity classical Hodgkin lymphoma, extranodal and solid organ sites Mixed cellularity classical Hodgkin lymphoma, lymph nodes of head, face, and neck Mixed cellularity classical Hodgkin lymphoma, lymph nodes of multiple sites Mixed cellularity classical Hodgkin lymphoma, unspecified site Hodgkin Lymphoma, Mixed Cellularity, NOS Hodgkin's Disease Mixed Cellularity Hodgkin's Lymphoma Mixed Cellularity MCCHL MCHL Mixed Cellularity Classic Hodgkin Lymphoma Mixed Cellularity Classical Hodgkin Lymphoma Mixed Cellularity Hodgkin Lymphoma Mixed Cellularity Hodgkin's Disease Mixed Cellularity Hodgkin's Lymphoma Mixed cellularity classical Hodgkin lymphoma, unspecified site Mixed Cellularity Classic Hodgkin Lymphoma A primary or metastatic malignant neoplasm that affects the uvula. C35177 Neoplastic Process Malignant Uvula Neoplasm C0153377 CPTAC mCode Malignant Malignant_Uvula_Neoplasm Malignant neoplasm of uvula Malignant neoplasm: Uvula Malignant Uvula Neoplasm Malignant Uvula Tumor Malignant Uvula Tumour Malignant Uvular Neoplasm Malignant Uvular Tumor Malignant Uvular Tumour Malignant neoplasm of uvula Malignant Uvula Neoplasm A primary or metastatic malignant neoplasm that affects the mandible. C35178 Neoplastic Process Malignant Neoplasm of Mandible C0153511 CPTAC mCode Malignant Malignant_Neoplasm_of_Lower_Jaw_Bone Malignant neoplasm of mandible Malignant neoplasm: Mandible Malignant Neoplasm of Lower Jaw Bone Malignant Neoplasm of Mandible Malignant neoplasm of mandible Malignant Neoplasm of Mandible A subtype of classic Hodgkin lymphoma characterized by collagen bands that surround at least one nodule, and Hodgkin and Reed-Sternberg cells with lacunar type morphology. (WHO, 2008) C3518 Neoplastic Process Nodular Sclerosis Classic Hodgkin Lymphoma Nodular Sclerosis Classic Hodgkin Lymphoma C0152268 CPTAC CTRP GDC PCDC mCode 9663/3 Malignant Nodular_Sclerosis_Hodgkin_s_Lymphoma 9663/3 Classical Hodgkin lymphoma, nodular sclerosis, NOS Hodgkin disease, nodular sclerosis, NOS Hodgkin lymphoma, nodular sclerosis, NOS Hodgkin's disease, nodular sclerosis Hodgkin's disease, nodular sclerosis, involving intrathoracic lymph nodes Hodgkin's disease, nodular sclerosis, involving lymph nodes of axilla and upper limb Hodgkin's disease, nodular sclerosis, involving lymph nodes of head, face, and neck Hodgkin's disease, nodular sclerosis, involving lymph nodes of inguinal region and lower limb Hodgkin's disease, nodular sclerosis, involving lymph nodes of multiple sites Hodgkin's disease, nodular sclerosis, unspecified site, extranodal and solid organ sites Nodular sclerosis classical Hodgkin lymphoma Nodular sclerosis classical Hodgkin lymphoma, intrathoracic lymph nodes Nodular sclerosis classical Hodgkin lymphoma, lymph nodes of head, face, and neck Nodular sclerosis classical Hodgkin lymphoma, lymph nodes of inguinal region and lower limb Nodular sclerosis classical Hodgkin lymphoma, lymph nodes of multiple sites Nodular sclerosis classical Hodgkin lymphoma, unspecified site Classical Hodgkin lymphoma, nodular sclerosis, NOS Hodgkin Lymphoma, Nodular Sclerosis, NOS Hodgkin disease, nodular sclerosis, NOS Hodgkin's Nodular Sclerosis NSCHL NSHD NSHL Nodular Sclerosis Classic Hodgkin Lymphoma Nodular Sclerosis Classical Hodgkin Lymphoma Nodular Sclerosis Hodgkin Lymphoma Nodular Sclerosis Hodgkin's Disease Nodular Sclerosis Hodgkin's Lymphoma Nodular sclerosis classical Hodgkin lymphoma, unspecified site Nodular Sclerosis Classic Hodgkin Lymphoma An intraepithelial carcinoma arising from any part of the digestive system without evidence of invasion. C35180 Neoplastic Process Digestive System Carcinoma In Situ Digestive System Carcinoma In Situ C0154057 CPTAC CTRP mCode Malignant Gastrointestinal_Carcinoma_in_situ Carcinoma in situ of digestive organs Carcinoma in situ of other and unspecified digestive organs Carcinoma in situ of unspecified part of intestine Carcinoma in situ of digestive organ, unspecified Digestive System Carcinoma In Situ Gastrointestinal System Carcinoma In Situ Digestive System Carcinoma In Situ A myelodysplastic/myeloproliferative neoplasm characterized by the presence of leukocytosis with increased numbers of neutrophils, promyelocytes, myelocytes, and metamyelocytes; blasts less than 20% in bone marrow and peripheral blood; dysgranulopoiesis; minimal or absent monocytosis; absence of eosinophilia; and presence of bone marrow hypercellularity with granulocytic proliferation and granulocytic dysplasia. Dysplasia in the erythroid and megakaryocytic lineages may be present or absent. No evidence of BCR/ABL fusion is present. C3519 Neoplastic Process Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Atypical Chronic Myeloid Leukemia CL1779346 CTRP Cellosaurus GDC 9876/3 Malignant Atypical_Chronic_Myeloid_Leukemia 9860/3 9876/3 Atypical chronic myeloid leukemia, BCR/ABL negative Atypical chronic myeloid leukemia, Philadelphia chromosome (Ph1) negative Subacute granulocytic leukemia Subacute myelogenous leukemia Subacute myeloid leukemia Atypical CML Atypical Chronic Myeloid Leukemia Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Atypical Chronic Myeloid Leukemia, BCR::ABL1 Negative MDS/MPN-N Myelodysplastic/Myeloproliferative Neoplasm with Neutrophilia Subacute Granulocytic Leukemia Subacute Myelogenous Leukemia Subacute Myeloid Leukemia Subacute granulocytic leukemia Subacute myelogenous leukemia Subacute myeloid leukemia aCML Atypical Chronic Myeloid Leukemia A tumor mass composed of myeloblasts or immature myeloid cells. It occurs in extramedullary sites or the bone. (WHO, 2001) C3520 Neoplastic Process Myeloid Sarcoma Myeloid Sarcoma CL414320 CDISC CPTAC CTRP GDC NICHD PCDC A malignant neoplasm composed of myeloblasts or immature myeloid cells. It occurs in extramedullary sites or the bone. A malignant, green-colored tumor of myeloid cells (a type of immature white blood cell). This tumor is usually associated with myelogenous leukemia. A tumor mass composed of myeloblasts or immature myeloid cells. It occurs in extramedullary sites or the bone. (WHO, 2001) 9930/3 Malignant Myeloid_Sarcoma 9930/3 Chloroma Myeloid sarcoma Myeloid sarcoma without mention of having achieved remission Myeloid sarcoma, not having achieved remission Chloroma Extramedullary Myeloid Sarcoma Extramedullary Myeloid Tumor MYELOID_SARCOMA Myeloid Sarcoma Myeloid sarcoma SARCOMA, MYELOID, MALIGNANT chloroma Myeloid Sarcoma A polyp in the uterine cavity that is formed by placenta remnants. C3521 Neoplastic Process Placental Polyp C0152437 Benign Placental_Polyp Placenta Polyp Placental Polyp Polyp of Placenta Polyp of the Placenta Placental Polyp A primary or metastatic malignant neoplasm that affects the base of the tongue. C3524 Neoplastic Process Malignant Posterior Tongue Neoplasm Malignant Posterior Tongue Neoplasm C0153350 CPTAC CTRP mCode Malignant Malignant_Posterior_Tongue_Neoplasm Malignant neoplasm of base of tongue Malignant neoplasm of junctional zone of tongue Malignant Base of Tongue Neoplasm Malignant Base of Tongue Tumor Malignant Base of the Tongue Neoplasm Malignant Base of the Tongue Tumor Malignant Neoplasm of Base of Tongue Malignant Neoplasm of Posterior Tongue Malignant Neoplasm of the Base of the Tongue Malignant Neoplasm of the Posterior Tongue Malignant Posterior Tongue Neoplasm Malignant Posterior Tongue Tumor Malignant Tumor of Base of Tongue Malignant Tumor of Posterior Tongue Malignant Tumor of the Base of the Tongue Malignant Tumor of the Posterior Tongue Malignant neoplasm of base of tongue Malignant Posterior Tongue Neoplasm A primary or metastatic malignant neoplasm involving the parotid gland. Representative examples include carcinoma, malignant mixed tumor, and non-Hodgkin lymphoma. C3525 Neoplastic Process Malignant Parotid Gland Neoplasm Malignant Parotid Gland Neoplasm C0747273 CPTAC CTRP mCode Cancer that forms in a parotid gland, the largest of the salivary glands, which make saliva and release it into the mouth. There are 2 parotid glands, one in front of and just below each ear. Most salivary gland tumors begin in parotid glands. Malignant Malignant_Parotid_Gland_Neoplasm Malignant neoplasm of parotid gland Cancer of Parotid Cancer of Parotid Gland Cancer of the Parotid Cancer of the Parotid Gland Malignant Neoplasm of Parotid Malignant Neoplasm of Parotid Gland Malignant Neoplasm of the Parotid Malignant Neoplasm of the Parotid Gland Malignant Parotid Gland Neoplasm Malignant Parotid Gland Tumor Malignant Parotid Neoplasm Malignant Parotid Tumor Malignant Tumor of Parotid Malignant Tumor of Parotid Gland Malignant Tumor of the Parotid Malignant Tumor of the Parotid Gland Malignant neoplasm of parotid gland Parotid Gland Cancer parotid gland cancer Malignant Parotid Gland Neoplasm A multifocal benign neoplasm arising from bone or soft tissue. It is characterized by the presence of chondrocytes and is composed of hyaline cartilage. C35259 Neoplastic Process Chondromatosis C0206636 GDC 9220/1 Benign Chondromatosis 9220/1 Chondromatosis, NOS Chondromatosis Chondromatosis, NOS Chondromatosis A malignant neoplasm that arises from the submandibular gland. The majority are carcinomas. C3526 Neoplastic Process Malignant Submandibular Gland Neoplasm C0153360 CPTAC mCode Malignant Malignant_Submandibular_Gland_Neoplasm Malignant neoplasm of submandibular gland Malignant neoplasm: Submandibular gland Malignant Neoplasm of Submandibular Gland Malignant Neoplasm of the Submandibular Gland Malignant Submandibular Gland Neoplasm Malignant Submandibular Gland Tumor Malignant Tumor of Submandibular Gland Malignant Tumor of the Submandibular Gland Malignant neoplasm of submandibular gland Malignant Submandibular Gland Neoplasm A rare malignant neoplasm that arises from the sublingual gland. The majority are carcinomas. C3527 Neoplastic Process Malignant Sublingual Gland Neoplasm C0153361 CPTAC mCode Malignant Malignant_Sublingual_Gland_Neoplasm Malignant neoplasm of sublingual gland Malignant Neoplasm of Sublingual Gland Malignant Neoplasm of the Sublingual Gland Malignant Sublingual Gland Neoplasm Malignant Sublingual Gland Tumor Malignant Tumor of Sublingual Gland Malignant Tumor of the Sublingual Gland Malignant neoplasm of sublingual gland Malignant Sublingual Gland Neoplasm C35278 Finding Chemically Induced Neurotoxicity C1516456 Chemically_Induced_Neurotoxicity Chemically Induced Neurotoxicity Chemically Induced Neurotoxicity A primary or metastatic malignant neoplasm that affects the hard palate. C3528 Neoplastic Process Malignant Hard Palate Neoplasm C0153375 CPTAC mCode Malignant Malignant_Hard_Palate_Neoplasm Malignant neoplasm of hard palate Malignant neoplasm: Hard palate Malignant Hard Palate Neoplasm Malignant Hard Palate Tumor Malignant Neoplasm of Hard Palate Malignant Neoplasm of the Hard Palate Malignant Tumor of Hard Palate Malignant Tumor of the Hard Palate Malignant neoplasm of hard palate Malignant Hard Palate Neoplasm A primary or metastatic malignant neoplasm that affects the soft palate. C3529 Neoplastic Process Malignant Soft Palate Neoplasm C0153376 CPTAC mCode Malignant Malignant_Soft_Palate_Neoplasm Malignant neoplasm of soft palate Malignant neoplasm: Soft palate Malignant Neoplasm of Soft Palate Malignant Neoplasm of the Soft Palate Malignant Soft Palate Neoplasm Malignant Soft Palate Tumor Malignant Tumor of Soft Palate Malignant Tumor of the Soft Palate Malignant neoplasm of soft palate Malignant Soft Palate Neoplasm A primary or metastatic malignant neoplasm that affects the hard palate, soft palate, or uvula. C3530 Neoplastic Process Malignant Palate Neoplasm Malignant Palate Neoplasm C0153378 CPTAC CTRP mCode Malignant Malignant_Palate_Neoplasm Malignant neoplasm of palate, unspecified Cancer of Palate Cancer of the Palate Malignant Neoplasm of Palate Malignant Neoplasm of the Palate Malignant Palate Neoplasm Malignant Palate Tumor Malignant Tumor of Palate Malignant Tumor of the Palate Malignant neoplasm of palate, unspecified Palate Cancer Malignant Palate Neoplasm A primary or metastatic malignant neoplasm that affects the pyriform sinus. C3531 Neoplastic Process Malignant Pyriform Fossa Neoplasm C0153400 CPTAC mCode Malignant Malignant_Pyriform_Fossa_Neoplasm Malignant neoplasm of piriform sinus Malignant neoplasm of pyriform sinus Malignant Neoplasm of Pyriform Fossa Malignant Neoplasm of Pyriform Sinus Malignant Neoplasm of the Pyriform Fossa Malignant Neoplasm of the Pyriform Sinus Malignant Pyriform Fossa Neoplasm Malignant Pyriform Fossa Tumor Malignant Pyriform Sinus Neoplasm Malignant Pyriform Sinus Tumor Malignant Tumor of Pyriform Fossa Malignant Tumor of Pyriform Sinus Malignant Tumor of the Pyriform Fossa Malignant Tumor of the Pyriform Sinus Malignant neoplasm of pyriform sinus Malignant Pyriform Fossa Neoplasm A primary or metastatic malignant neoplasm involving the thoracic region of the esophagus. C3532 Neoplastic Process Malignant Neoplasm of the Thoracic Esophagus C0153411 CPTAC Malignant Malignant_Neoplasm_of_the_Thoracic_Esophagus Malignant neoplasm of thoracic esophagus Malignant Neoplasm of Thoracic Esophagus Malignant Neoplasm of the Thoracic Esophagus Malignant Neoplasm of the Thoracic Esophagus A primary or metastatic malignant neoplasm involving the upper third segment of the esophagus. C3533 Neoplastic Process Malignant Neoplasm of the Upper Third of the Esophagus C0153413 CPTAC mCode Malignant Malignant_Neoplasm_of_the_Upper_Third_of_the_Esophagus Malignant neoplasm of upper third of esophagus Malignant neoplasm: Upper third of oesophagus Malignant Neoplasm of Proximal Third of Esophagus Malignant Neoplasm of Upper Third of Esophagus Malignant Neoplasm of the Proximal Third of the Esophagus Malignant Neoplasm of the Upper Third of the Esophagus Malignant Tumor of Proximal Third of Esophagus Malignant Tumor of Upper Third of Esophagus Malignant Tumor of the Proximal Third of the Esophagus Malignant Tumor of the Upper Third of the Esophagus Malignant neoplasm of upper third of esophagus Malignant Neoplasm of the Upper Third of the Esophagus A primary or metastatic malignant neoplasm involving the middle third segment of the esophagus. C3534 Neoplastic Process Malignant Neoplasm of the Middle Third of the Esophagus C0153414 CPTAC mCode Malignant Malignant_Neoplasm_of_the_Middle_Third_of_the_Esophagus Malignant neoplasm of middle third of esophagus Malignant neoplasm: Middle third of oesophagus Malignant Middle Third of Esophagus Neoplasm Malignant Middle Third of Esophagus Tumor Malignant Middle Third of the Esophagus Neoplasm Malignant Middle Third of the Esophagus Tumor Malignant Neoplasm of Middle Third of Esophagus Malignant Neoplasm of the Middle Third of the Esophagus Malignant Tumor of Middle Third of Esophagus Malignant Tumor of the Middle Third of the Esophagus Malignant neoplasm of middle third of esophagus Malignant Neoplasm of the Middle Third of the Esophagus A primary or metastatic malignant neoplasm involving the lower third segment of the esophagus. C3535 Neoplastic Process Malignant Neoplasm of the Lower Third of the Esophagus C0153415 CPTAC mCode Malignant Malignant_Neoplasm_of_the_Lower_Third_of_the_Esophagus Malignant neoplasm of lower third of esophagus Malignant neoplasm: Lower third of oesophagus Malignant Lower Third of Esophagus Neoplasm Malignant Lower Third of Esophagus Tumor Malignant Lower Third of the Esophagus Neoplasm Malignant Lower Third of the Esophagus Tumor Malignant Neoplasm of Distal Third of Esophagus Malignant Neoplasm of Lower Third of Esophagus Malignant Neoplasm of the Distal Third of the Esophagus Malignant Neoplasm of the Lower Third of the Esophagus Malignant Tumor of Distal Third of Esophagus Malignant Tumor of Lower Third of Esophagus Malignant Tumor of the Distal Third of the Esophagus Malignant Tumor of the Lower Third of the Esophagus Malignant neoplasm of lower third of esophagus Malignant Neoplasm of the Lower Third of the Esophagus A primary or metastatic malignant neoplasm involving the ampulla of Vater. C3536 Neoplastic Process Malignant Ampulla of Vater Neoplasm C0153454 CPTAC mCode Malignant Malignant_Ampulla_of_Vater_Neoplasm Malignant neoplasm of ampulla of Vater Malignant neoplasm: Ampulla of Vater Malignant Ampulla of Vater Neoplasm Malignant Ampulla of Vater Tumor Malignant Neoplasm of Ampulla of Vater Malignant Neoplasm of the Ampulla of Vater Malignant Tumor of Ampulla of Vater Malignant Tumor of the Ampulla of Vater Malignant neoplasm of ampulla of Vater Malignant Ampulla of Vater Neoplasm A primary or metastatic malignant neoplasm involving the retroperitoneum. The vast majority of cases are carcinomas, lymphomas, or sarcomas. C3537 Neoplastic Process Malignant Retroperitoneal Neoplasm C0153465 CPTAC mCode Malignant Malignant_Retroperitoneal_Neoplasm Malignant neoplasm of retroperitoneum Malignant neoplasm: Retroperitoneum Malignant Retroperitoneal Neoplasm Malignant neoplasm of retroperitoneum Malignant Retroperitoneal Neoplasm A neoplasm that affects the bone marrow. It may arise in the bone marrow (e.g., myeloid leukemia) or may involve the bone marrow as a secondary, metastatic tumor (e.g., metastatic carcinoma to the bone marrow). C35370 Neoplastic Process Bone Marrow Neoplasm C0282609 NICHD Undetermined Bone_Marrow_Neoplasm Bone Marrow Neoplasm Bone Marrow Tumor Neoplasm of Bone Marrow Bone Marrow Neoplasm A primary or metastatic malignant neoplasm involving the peritoneum. Representative examples include carcinoma and malignant mesothelioma. C3538 Neoplastic Process Malignant Peritoneal Neoplasm C0153467 CPTAC mCode Cancer of the tissue that lines the abdominal wall and covers organs in the abdomen. Malignant Malignant_Peritoneal_Neoplasm Malignant neoplasm of peritoneum, unspecified Malignant neoplasm of specified parts of peritoneum Malignant neoplasm: Peritoneum, unspecified Malignant neoplasm: Specified parts of peritoneum Cancer of Peritoneum Cancer of the Peritoneum Malignant Peritoneal Neoplasm Malignant neoplasm of peritoneum, unspecified Peritoneal Cancer Peritoneal Cavity Cancer peritoneal cancer Malignant Peritoneal Neoplasm A malignant neoplasm affecting the spleen. Representative examples include leukemias, lymphomas, and sarcomas. C3539 Neoplastic Process Malignant Splenic Neoplasm C0153470 CPTAC Cellosaurus GDC mCode Malignant Malignant_Splenic_Neoplasm Malignant neoplasm: Spleen Spleen Cancer Cancer of the Spleen Malignant Neoplasm of Spleen Malignant Neoplasm of the Spleen Malignant Splenic Neoplasm Malignant Splenic Tumor Malignant Tumor of Spleen Malignant Tumor of the Spleen Malignant neoplasm of spleen Spleen Cancer Splenic Cancer Malignant Splenic Neoplasm A primary or metastatic malignant neoplasm involving the maxillary sinus. C3540 Neoplastic Process Malignant Maxillary Sinus Neoplasm C0153476 CPTAC mCode Malignant Malignant_Maxillary_Sinus_Neoplasm Malignant neoplasm of maxillary sinus Malignant neoplasm: Maxillary sinus Malignant Maxillary Sinus Neoplasm Malignant Maxillary Sinus Tumor Malignant Neoplasm of Maxillary Sinus Malignant Neoplasm of the Maxillary Sinus Malignant Tumor of Maxillary Sinus Malignant Tumor of the Maxillary Sinus Malignant neoplasm of maxillary sinus Malignant Maxillary Sinus Neoplasm A primary or metastatic malignant neoplasm involving the ethmoid sinus. C3541 Neoplastic Process Malignant Ethmoid Sinus Neoplasm C0153477 CPTAC mCode Malignant Malignant_Ethmoid_Sinus_Neoplasm Malignant neoplasm of ethmoidal sinus Malignant neoplasm: Ethmoidal sinus Malignant Ethmoid Sinus Neoplasm Malignant Ethmoid Sinus Tumor Malignant Ethmoidal Sinus Neoplasm Malignant Ethmoidal Sinus Tumor Malignant Neoplasm of Ethmoid Sinus Malignant Neoplasm of Ethmoidal Sinus Malignant Neoplasm of the Ethmoid Sinus Malignant Neoplasm of the Ethmoidal Sinus Malignant Tumor of Ethmoid Sinus Malignant Tumor of Ethmoidal Sinus Malignant Tumor of the Ethmoid Sinus Malignant Tumor of the Ethmoidal Sinus Malignant neoplasm of ethmoidal sinus Malignant Ethmoid Sinus Neoplasm A benign or malignant neoplasm that arises from the parotid gland. It is characterized by the presence of epithelial and mesenchymal elements. This category includes pleomorphic adenoma, carcinoma ex pleomorphic adenoma, and carcinosarcoma. C35416 Neoplastic Process Mixed Tumor of the Parotid Gland C0345604 Benign Mixed_Tumor_of_the_Parotid_Gland Mixed Tumor of Parotid Gland Mixed Tumor of the Parotid Gland Mixed Tumor of the Parotid Gland A carcinoma that arises from the intrahepatic bile duct epithelium in any site of the intrahepatic biliary tree. Grossly, the malignant lesions are solid, nodular, and grayish. Morphologically, the vast majority of cases are adenocarcinomas. Signs and symptoms include malaise, weight loss, right upper quadrant abdominal pain, and night sweats. Early detection is difficult and the prognosis is generally poor. C35417 Neoplastic Process Intrahepatic Cholangiocarcinoma Intrahepatic Cholangiocarcinoma C0345905 CDISC CPTAC CTRP Cellosaurus mCode A malignant neoplasm of the liver arising from/comprising cells resembling those of bile ducts. Malignant Intrahepatic_Cholangiocarcinoma Malignant neoplasm: Intrahepatic bile duct carcinoma CHOLANGIOCARCINOMA, INTRAHEPATIC, MALIGNANT ICC ICCA Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) Intrahepatic Bile Duct Carcinoma Intrahepatic Carcinoma of Bile Duct Intrahepatic Carcinoma of the Bile Duct Intrahepatic Cholangiocarcinoma Intrahepatic Cholangiocellular Carcinoma Intrahepatic bile duct carcinoma iCC iCCA Intrahepatic Cholangiocarcinoma A benign adipose tissue neoplasm of the axilla. C35419 Neoplastic Process Axillary Lipoma C0347429 Benign Lipoma_of_Axilla Axillary Lipoma Lipoma of Axilla Axillary Lipoma A primary or metastatic malignant neoplasm involving the frontal sinus. C3542 Neoplastic Process Malignant Frontal Sinus Neoplasm C0153478 mCode Malignant Malignant_Frontal_Sinus_Neoplasm Malignant Frontal Sinus Neoplasm Malignant Frontal Sinus Tumor Malignant Neoplasm of Frontal Sinus Malignant Neoplasm of the Frontal Sinus Malignant Tumor of Frontal Sinus Malignant Tumor of the Frontal Sinus Malignant neoplasm of frontal sinus Malignant Frontal Sinus Neoplasm A primary or metastatic malignant neoplasm involving the sphenoid sinus. C3543 Neoplastic Process Malignant Sphenoid Sinus Neoplasm Malignant Sphenoid Sinus Neoplasm C0153479 CPTAC CTRP mCode Malignant Malignant_Sphenoid_Sinus_Neoplasm Malignant neoplasm of sphenoidal sinus Malignant Neoplasm of Sphenoid Sinus Malignant Neoplasm of Sphenoidal Sinus Malignant Neoplasm of the Sphenoid Sinus Malignant Neoplasm of the Sphenoidal Sinus Malignant Sphenoid Sinus Neoplasm Malignant Sphenoid Sinus Tumor Malignant Sphenoidal Sinus Neoplasm Malignant Sphenoidal Sinus Tumor Malignant Tumor of Sphenoid Sinus Malignant Tumor of Sphenoidal Sinus Malignant Tumor of the Sphenoid Sinus Malignant Tumor of the Sphenoidal Sinus Malignant neoplasm of sphenoid sinus Malignant Sphenoid Sinus Neoplasm A malignant neoplasm that affects the glottic area of the larynx. The vast majority of cases represent squamous cell carcinomas. C3544 Neoplastic Process Malignant Glottis Neoplasm C0153483 CPTAC mCode Malignant Malignant_Glottis_Neoplasm Malignant neoplasm of glottis Malignant neoplasm: Glottis Malignant Glottis Neoplasm Malignant Glottis Tumor Malignant Neoplasm of Glottis Malignant Neoplasm of the Glottis Malignant Tumor of Glottis Malignant Tumor of the Glottis Malignant neoplasm of glottis Malignant Glottis Neoplasm A malignant neoplasm that affects the supraglottic area of the larynx. The vast majority of cases are squamous cell carcinomas. C3545 Neoplastic Process Malignant Supraglottis Neoplasm C0153484 CPTAC mCode Malignant Malignant_Supraglottis_Neoplasm Malignant neoplasm of supraglottis Malignant neoplasm: Supraglottis Malignant Neoplasm of Supraglottis Malignant Neoplasm of the Supraglottis Malignant Supraglottic Neoplasm Malignant Supraglottic Tumor Malignant Supraglottis Neoplasm Malignant Supraglottis Tumor Malignant Tumor of Supraglottis Malignant Tumor of the Supraglottis Malignant neoplasm of supraglottis Malignant Supraglottis Neoplasm A malignant neoplasm that affects the subglottic area of the larynx. The vast majority of cases are squamous cell carcinomas. C3546 Neoplastic Process Malignant Subglottis Neoplasm C0153485 CPTAC mCode Malignant Malignant_Subglottis_Neoplasm Malignant neoplasm of subglottis Malignant neoplasm: Subglottis Malignant Neoplasm of Subglottis Malignant Neoplasm of the Subglottis Malignant Subglottic Neoplasm Malignant Subglottic Tumor Malignant Subglottis Neoplasm Malignant Subglottis Tumor Malignant Tumor of Subglottis Malignant Tumor of the Subglottis Malignant neoplasm of subglottis Malignant Subglottis Neoplasm A rare variant of mycosis fungoides, characterized by the development of folds of lax skin in the axillae or groins. It has been reported in association with Hodgkin lymphoma. Morphologically, there is a dense granulomatous dermal atypical lymphocytic infiltrate, often associated with multinucleated giant cells. Destruction of elastic tissue is present. Most cases have an indolent clinical course. C35464 Neoplastic Process Granulomatous Slack Skin Disease C0376407 Malignant Granulomatous_Slack_Skin_Disease Granulomatous Slack Skin Disease Granulomatous Slack Skin Disease A primary or metastatic malignant neoplasm affecting the pleura. A representative example of primary malignant pleural neoplasm is the malignant pleural mesothelioma. A representative example of metastatic malignant neoplasm to the pleura is metastatic carcinoma that has spread to the pleura from another anatomic site. C3547 Neoplastic Process Malignant Pleural Neoplasm Malignant Pleural Neoplasm C0153494 CPTAC CTRP mCode Malignant Malignant_Pleural_Neoplasm Malignant neoplasm of other specified sites of pleura Malignant neoplasm of pleura Malignant neoplasm of pleura, unspecified Malignant neoplasm of visceral pleura Malignant neoplasm: Pleura Cancer of Pleura Cancer of the Pleura Malignant Neoplasm of Pleura Malignant Neoplasm of the Pleura Malignant Pleural Neoplasm Malignant Pleural Tumor Malignant Tumor of Pleura Malignant Tumor of the Pleura Malignant neoplasm of pleura Pleural Cancer Malignant Pleural Neoplasm A primary or metastatic malignant neoplasm involving the heart. C3548 Neoplastic Process Malignant Cardiac Neoplasm C0153500 CPTAC mCode A rare cancer that develops in tissues of the heart. Malignant Malignant_Cardiac_Neoplasm Malignant neoplasm of heart Malignant neoplasm: Heart Cardiac Neoplasm, Malignant Heart Cancer Malignant Cardiac Neoplasm Malignant Cardiac Tumor Malignant Heart Neoplasm Malignant Heart Tumor Malignant Neoplasm of Heart Malignant Neoplasm of the Heart Malignant Tumor of Heart Malignant Tumor of the Heart Malignant neoplasm of heart heart cancer Malignant Cardiac Neoplasm A primary or metastatic malignant neoplasm affecting the mediastinum. Representative examples of primary malignant mediastinal neoplasms include malignant germ cell tumors, malignant mesenchymal tumors, lymphomas, and malignant peripheral nerve sheath tumors. A representative example of metastatic malignant neoplasm to the mediastinum is the metastatic carcinoma to the mediastinum from another anatomic site. C3549 Neoplastic Process Malignant Mediastinal Neoplasm Malignant Mediastinal Neoplasm C0153504 CPTAC CTRP mCode Malignant Malignant_Mediastinal_Neoplasm Malignant neoplasm of anterior mediastinum Malignant neoplasm of mediastinum, part unspecified Malignant neoplasm: Anterior mediastinum Malignant neoplasm: Mediastinum, part unspecified Malignant neoplasm: Posterior mediastinum Cancer of Mediastinum Cancer of the Mediastinum Malignant Mediastinal Neoplasm Malignant Mediastinal Neoplasm NOS Malignant Mediastinal Tumor Malignant Neoplasm of Mediastinum Malignant Neoplasm of the Mediastinum Malignant Tumor of Mediastinum Malignant Tumor of the Mediastinum Malignant neoplasm of mediastinum, part unspecified Mediastinal Cancer Malignant Mediastinal Neoplasm The adverse effect of some iatrogenic therapies. It is an accepted side effect in radiation therapy where the desired effect is to kill rapidly growing tumor cells. In the killing of tumor cells, other cells that are rapidly growing e.g hair, mucous membranes are also killed. C35496 Finding Chemically Induced Cytotoxicity C1516454 Chemically_Induced_Cytotoxicity Chemically Induced Cytotoxicity Chemically Induced Cytotoxicity A benign or malignant (primary or metastatic) neoplasm that affects the lymph nodes. C35497 Neoplastic Process Lymph Node Neoplasm C0596869 Undetermined Lymph_Node_Neoplasm Lymph Node Neoplasm Lymph Node Neoplasm A Kaposi sarcoma arising from the skin. It presents with patches, plaques, or nodules. C3550 Neoplastic Process Skin Kaposi Sarcoma Skin Kaposi Sarcoma C0153560 CPTAC CTRP mCode Malignant Skin_Kaposi_s_Sarcoma Kaposi's sarcoma, skin Cutaneous (Skin) Kaposi Sarcoma Cutaneous Kaposi Sarcoma Cutaneous Kaposi's Sarcoma Kaposi's Sarcoma of Skin Kaposi's Sarcoma of the Skin Kaposi's sarcoma of skin Skin Kaposi Sarcoma Skin Kaposi's Sarcoma Skin Kaposi Sarcoma C35500 Finding Chemically Induced Toxicity C1516457 Chemically_Induced_Toxicity Chemically Induced Toxicity Chemically Induced Toxicity Malignant neoplasms that either originate from the bone marrow (e.g. myeloid leukemias) or involve the bone marrow as secondary-metastatic tumors (e.g. metastatic carcinomas to the bone marrow). C35501 Neoplastic Process Malignant Bone Marrow Neoplasm C2703042 CPTAC Cancer that forms in the blood-forming stem cells of the bone marrow (soft sponge-like tissue in the center of most bones). Bone marrow cancer includes leukemias and multiple myeloma. Malignant Malignant_Bone_Marrow_Neoplasm Malignant Bone Marrow Neoplasm Malignant Bone Marrow Tumor bone marrow cancer Malignant Bone Marrow Neoplasm Carcinoma, predominantly squamous cell, arising from epithelial cells of the larynx or pharynx. C35506 Neoplastic Process Throat Carcinoma C0740339 GDC Cancer that forms in tissues of the pharynx (the hollow tube inside the neck that starts behind the nose and ends at the top of the windpipe and esophagus). Throat cancer includes cancer of the nasopharynx (the upper part of the throat behind the nose), the oropharynx (the middle part of the pharynx), and the hypopharynx (the bottom part of the pharynx). Cancer of the larynx (voice box) may also be included as a type of throat cancer. Most throat cancers are squamous cell carcinomas (cancer that begins in thin, flat cells that look like fish scales). Malignant Throat_Cancer Throat Cancer Throat Cancer Throat Carcinoma throat cancer Throat Carcinoma A Kaposi sarcoma arising from the lung. C3551 Neoplastic Process Lung Kaposi Sarcoma C0153564 CPTAC mCode Malignant Lung_Kaposi_s_Sarcoma Kaposi's sarcoma, lung Kaposi's Sarcoma of Lung Kaposi's Sarcoma of the Lung Kaposi's sarcoma of unspecified lung Lung Kaposi Sarcoma Lung Kaposi's Sarcoma Pulmonary Kaposi's Sarcoma Lung Kaposi Sarcoma Primary or metastatic malignant neoplasm involving the uterine corpus and/or the cervix. C3552 Neoplastic Process Malignant Uterine Neoplasm Malignant Uterine Neoplasm C0153567 CPTAC CTEP CTRP GDC mCode Cancer that forms in tissues of the uterus (the small, hollow, pear-shaped organ in a woman's pelvis in which a fetus develops). Two types of uterine cancer are endometrial cancer (cancer that begins in cells lining the uterus) and uterine sarcoma (a rare cancer that begins in muscle or other tissues in the uterus). Malignant Malignant_Uterine_Neoplasm Malignant neoplasm of isthmus Malignant neoplasm of uterus, part unspecified Uterine Cancer Cancer of Uterus Cancer of the Uterus Malignant Neoplasm of Uterus Malignant Neoplasm of the Uterus Malignant Tumor of Uterus Malignant Tumor of the Uterus Malignant Uterine Neoplasm Malignant Uterine Tumor Malignant neoplasm of uterus, part unspecified Uterine Cancer Uterine cancer, NOS uterine cancer Malignant Uterine Neoplasm A malignant neoplasm that affects the endocervix. C3553 Neoplastic Process Malignant Endocervical Neoplasm Malignant Endocervical Neoplasm C0153569 CPTAC CTRP mCode Malignant Malignant_Endocervical_Neoplasm Malignant neoplasm of endocervix Malignant neoplasm: Endocervix Malignant Endocervical Neoplasm Malignant Endocervical Tumor Malignant Endocervix Neoplasm Malignant Endocervix Tumor Malignant Neoplasm of Endocervix Malignant Neoplasm of Uterine Endocervix Malignant Neoplasm of the Endocervix Malignant Neoplasm of the Uterine Endocervix Malignant Tumor of Endocervix Malignant Tumor of Uterine Endocervix Malignant Tumor of the Endocervix Malignant Tumor of the Uterine Endocervix Malignant Uterine Endocervix Neoplasm Malignant Uterine Endocervix Tumor Malignant neoplasm of endocervix Malignant Endocervical Neoplasm A malignant neoplasm that affects the exocervix. C3554 Neoplastic Process Malignant Exocervical Neoplasm C0153570 CPTAC mCode Malignant Malignant_Exocervical_Neoplasm Malignant neoplasm of exocervix Malignant neoplasm: Exocervix Malignant Exocervical Neoplasm Malignant Exocervical Tumor Malignant Exocervix Neoplasm Malignant Exocervix Tumor Malignant Neoplasm of Exocervix Malignant Neoplasm of Uterine Exocervix Malignant Neoplasm of the Exocervix Malignant Neoplasm of the Uterine Exocervix Malignant Tumor of Exocervix Malignant Tumor of Uterine Exocervix Malignant Tumor of the Exocervix Malignant Tumor of the Uterine Exocervix Malignant Uterine Exocervix Neoplasm Malignant Uterine Exocervix Tumor Malignant neoplasm of exocervix Malignant Exocervical Neoplasm A primary or metastatic neoplasm that affects the placenta. C3555 Neoplastic Process Malignant Placental Neoplasm C0153572 CDISC CPTAC mCode A malignant neoplasm arising from decidua (placental) cells. Malignant Malignant_Placental_Neoplasm Malignant neoplasm of placenta DECIDUOMA, MALIGNANT Malignant Neoplasm of Placenta Malignant Neoplasm of the Placenta Malignant Placenta Neoplasm Malignant Placenta Tumor Malignant Placental Neoplasm Malignant Placental Tumor Malignant Tumor of Placenta Malignant Tumor of the Placenta Malignant neoplasm of placenta Malignant Placental Neoplasm A rare, benign epithelial neoplasm composed of irregular proliferating nests and islands of epithelium, including solid and gland-like sebaceous elements, surrounded by lymphoid stroma. Most occur in the parotid gland. Symptoms include a progressively enlarging, painless mass. Sebaceous lymphadenocarcinoma is the malignant counterpart. C35555 Neoplastic Process Salivary Gland Sebaceous Lymphadenoma C1335909 Benign Salivary_Gland_Sebaceous_Lymphadenoma Lymphadenoma Salivary Gland Sebaceous Lymphadenoma Sebaceous Lymphadenoma of Salivary Gland Sebaceous Lymphadenoma of the Salivary Gland Salivary Gland Sebaceous Lymphadenoma A morphologic variant of embryonal rhabdomyosarcoma occurring in female children. The neoplasm arises from the vagina. It is characterized by the formation of a cambium layer in the affected tissue and polypoid nodules with an abundant myxoid stroma. C35556 Neoplastic Process Childhood Vaginal Botryoid-Type Embryonal Rhabdomyosarcoma C1332945 Malignant Childhood_Botryoid-Type_Embryonal_Rhabdomyosarcoma_of_the_Vagina Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina Childhood Sarcoma Botryoides of the Vagina Childhood Vaginal Botryoid-Type Embryonal Rhabdomyosarcoma Childhood Vaginal Embryonal Rhabdomyosarcoma Vaginal Childhood Botryoid-Type Embryonal Rhabdomyosarcoma Vaginal Childhood Sarcoma Botryoides Childhood Vaginal Botryoid-Type Embryonal Rhabdomyosarcoma A morphologic variant of papillary carcinoma of the thyroid gland characterized by the presence of tall malignant follicular cells, arranged in papillary and trabecular patterns. Necrotic changes and high mitotic activity are present. C35558 Neoplastic Process Tall Cell Variant Thyroid Gland Papillary Carcinoma C1336695 GDC Malignant Tall_Cell_Variant_Papillary_Carcinoma 8344/3 Papillary carcinoma, tall cell Tall Cell Variant Papillary Carcinoma Tall Cell Variant Thyroid Gland Papillary Carcinoma Tall Cell Variant Thyroid Gland Papillary Carcinoma A malignant neoplasm that affects the uterine corpus. Representative examples include endometrial carcinoma, carcinosarcoma, leiomyosarcoma, and adenosarcoma. C3556 Neoplastic Process Malignant Uterine Corpus Neoplasm C0153574 CPTAC mCode Malignant Malignant_Uterine_Corpus_Neoplasm Malignant neoplasm of body of uterus Malignant neoplasm of corpus uteri Malignant neoplasm of corpus uteri, except isthmus Malignant neoplasm of other specified sites of body of uterus Malignant neoplasm: Corpus uteri, unspecified Malignant Corpus Uteri Neoplasm Malignant Corpus Uteri Tumor Malignant Neoplasm of Uterine Body Malignant Neoplasm of the Uterine Body Malignant Tumor of Uterine Body Malignant Tumor of the Uterine Body Malignant Uterine Body Neoplasm Malignant Uterine Body Tumor Malignant Uterine Corpus Neoplasm Malignant Uterine Corpus Tumor Malignant neoplasm of corpus uteri, unspecified Malignant Uterine Corpus Neoplasm A morphologic category that includes neoplasms arising from cells that form and support the nervous system. Such neoplasms include neuroepithelial cell neoplasms and neoplasms that arise from the perineural sheaths (perineurial cell neoplasms and Schwann cell neoplasms). C35562 Neoplastic Process Neuroepithelial, Perineurial, and Schwann Cell Neoplasm C1334956 Undetermined Neuroepithelial_Perineurial_and_Schwann_Cell_Neoplasm Neural Neoplasm Neural Tumor Neuroepithelial, Perineurial, and Schwann Cell Neoplasm Neuroepithelial, Perineurial, and Schwann Cell Neoplasm Damage or injury to the heart caused by a chemical agent. C35569 Finding Chemically Induced Cardiotoxicity Chemically Induced Cardiotoxicity C1516453 CTRP Chemically_Induced_Cardiotoxicity Chemically Induced Cardiac Toxicity Chemically Induced Cardiotoxicity Toxicity, Chemically Induced Cardiac Chemically Induced Cardiotoxicity A malignant neoplasm that affects the clitoris. C3557 Neoplastic Process Malignant Clitoral Neoplasm C0153589 CPTAC mCode Malignant Malignant_Clitoral_Neoplasm Malignant neoplasm: Clitoris Malignant Clitoral Neoplasm Malignant Clitoral Tumor Malignant Clitoris Neoplasm Malignant Clitoris Tumor Malignant Neoplasm of Clitoris Malignant Neoplasm of the Clitoris Malignant Tumor of Clitoris Malignant Tumor of the Clitoris Malignant neoplasm of clitoris Malignant Clitoral Neoplasm C35570 Finding Chemically Induced Urinary Tract Toxicity C1516458 Chemically_Induced_Urinary_Tract_Toxicity Chemically Induced Urinary Tract Toxicity Toxicity, Chemically Induced Urinary Tract Chemically Induced Urinary Tract Toxicity A morphologic variant of embryonal rhabdomyosarcoma occurring in children. The tumor arises from organs with a mucosal epithelial surface. It is characterized by the formation of a cambium layer in the affected tissue and polypoid nodules within an abundant myxoid stroma. C35574 Neoplastic Process Childhood Botryoid-Type Embryonal Rhabdomyosarcoma Childhood Botryoid-Type Embryonal Rhabdomyosarcoma C0279616 CTRP NICHD A histologic subtype of embryonal rhabdomyosarcoma that arises under the morphologic surface of body orifices such as the vagina, bladder, nasopharynx, and biliary tract. Malignant Childhood_Botryoid-Type_Embryonal_Rhabdomyosarcoma Botryoid-Type Embryonal Rhabdomyosarcoma Childhood Botryoid Rhabdomyosarcoma Childhood Botryoid-Type Embryonal Rhabdomyosarcoma Childhood Sarcoma Botryoides Childhood Botryoid-Type Embryonal Rhabdomyosarcoma C35575 Finding Chemically Induced Irreversible Toxicity C1516455 Chemically_Induced_Irreversible_Toxicity Chemically Induced Irreversible Toxicity Chemically Induced Irreversible Toxicity A primary or metastatic malignant neoplasm that affects the epididymis. Representative examples include primary epididymal adenocarcinoma and metastatic carcinoma to the epididymis arising from another anatomic site. C3558 Neoplastic Process Malignant Epididymal Neoplasm C0153602 mCode Malignant Malignant_Epididymal_Neoplasm Malignant Epididymal Neoplasm Malignant Epididymal Tumor Malignant Neoplasm of Epididymis Malignant Neoplasm of the Epididymis Malignant Tumor of Epididymis Malignant Tumor of the Epididymis Malignant neoplasm of unspecified epididymis Malignant Epididymal Neoplasm A primary or metastatic malignant neoplasm that affects the spermatic cord. C3559 Neoplastic Process Malignant Spermatic Cord Neoplasm Malignant Spermatic Cord Neoplasm C0153603 CPTAC CTRP mCode Malignant Malignant_Spermatic_Cord_Neoplasm Malignant neoplasm of spermatic cord Malignant neoplasm of unspecified spermatic cord Malignant Neoplasm of Spermatic Cord Malignant Neoplasm of the Spermatic Cord Malignant Spermatic Cord Neoplasm Malignant Spermatic Cord Tumor Malignant Tumor of Spermatic Cord Malignant Tumor of the Spermatic Cord Malignant neoplasm of unspecified spermatic cord Malignant Spermatic Cord Neoplasm A primary or metastatic malignant neoplasm affecting the scrotum. C3560 Neoplastic Process Malignant Scrotal Neoplasm C0153604 CPTAC mCode Malignant Malignant_Scrotal_Neoplasm Malignant neoplasm of scrotum Malignant Neoplasm of Scrotum Malignant Neoplasm of the Scrotum Malignant Scrotal Neoplasm Malignant Scrotal Tumor Malignant Tumor of Scrotum Malignant Tumor of the Scrotum Malignant neoplasm of scrotum Malignant Scrotal Neoplasm A malignant neoplasm involving the accessory urethral glands. C3561 Neoplastic Process Malignant Accessory Urethral Gland Neoplasm C1708901 mCode Malignant Malignant_Paraurethral_Gland_Neoplasm Malignant Accessory Urethral Gland Neoplasm Malignant neoplasm of paraurethral glands Malignant Accessory Urethral Gland Neoplasm A primary or metastatic malignant neoplasm involving the orbit. C3562 Neoplastic Process Malignant Orbit Neoplasm C0153626 CPTAC mCode Malignant Malignant_Orbit_Neoplasm Malignant neoplasm of left orbit Malignant neoplasm of orbit Malignant neoplasm of right orbit Malignant neoplasm of unspecified orbit Malignant neoplasm: Orbit Malignant Neoplasm of Orbit Malignant Neoplasm of the Orbit Malignant Orbit Neoplasm Malignant Orbit Tumor Malignant Orbital Neoplasm Malignant Orbital Tumor Malignant Tumor of Orbit Malignant Tumor of the Orbit Malignant neoplasm of unspecified orbit Malignant Orbit Neoplasm A primary or metastatic malignant neoplasm affecting the lacrimal gland. C3563 Neoplastic Process Malignant Lacrimal Gland Neoplasm C0153627 Malignant Malignant_Lacrimal_Gland_Neoplasm Malignant Lacrimal Gland Neoplasm Malignant Lacrimal Gland Tumor Malignant Neoplasm of Lacrimal Gland Malignant Neoplasm of the Lacrimal Gland Malignant Tumor of Lacrimal Gland Malignant Tumor of the Lacrimal Gland Malignant Lacrimal Gland Neoplasm A primary or metastatic malignant neoplasm that affects the conjunctiva. C3564 Neoplastic Process Malignant Conjunctival Neoplasm Malignant Conjunctival Neoplasm C0153628 CTRP mCode Malignant Malignant_Conjunctival_Neoplasm Malignant Conjunctiva Neoplasm Malignant Conjunctiva Tumor Malignant Conjunctival Neoplasm Malignant Conjunctival Tumor Malignant Neoplasm of Conjunctiva Malignant Neoplasm of the Conjunctiva Malignant Tumor of Conjunctiva Malignant Tumor of the Conjunctiva Malignant neoplasm of unspecified conjunctiva Malignant Conjunctival Neoplasm A malignant liver neoplasm that is not amenable to surgical resection. C35648 Neoplastic Process Unresectable Malignant Liver Neoplasm C0854793 Malignant Non-Resectable_Primary_Hepatic_Malignant_Neoplasm Non-Resectable Hepatic Malignant Neoplasm Non-Resectable Malignant Liver Neoplasm Non-Resectable Malignant Neoplasm of Liver Unresectable Malignant Liver Neoplasm Unresectable Malignant Liver Neoplasm A primary or metastatic malignant neoplasm that affects the cornea. C3565 Neoplastic Process Malignant Corneal Neoplasm C0153629 CPTAC mCode Malignant Malignant_Corneal_Neoplasm Malignant neoplasm of cornea Malignant Cornea Neoplasm Malignant Cornea Tumor Malignant Corneal Neoplasm Malignant Corneal Tumor Malignant Neoplasm of Cornea Malignant Neoplasm of the Cornea Malignant Tumor of Cornea Malignant Tumor of the Cornea Malignant neoplasm of unspecified cornea Malignant Corneal Neoplasm A primary or metastatic malignant neoplasm that affects the choroid. C3566 Neoplastic Process Malignant Choroid Neoplasm C0153630 CPTAC mCode Malignant Malignant_Choroid_Neoplasm Malignant neoplasm of choroid Malignant neoplasm of unspecified choroid Malignant Choroid Neoplasm Malignant Choroid Tumor Malignant Neoplasm of Choroid Malignant Neoplasm of the Choroid Malignant Tumor of Choroid Malignant Tumor of the Choroid Malignant neoplasm of unspecified choroid Malignant Choroid Neoplasm A primary or metastatic malignant neoplasm affecting the lacrimal duct. C3567 Neoplastic Process Malignant Nasolacrimal Duct Neoplasm C0153631 Malignant Malignant_Lacrimal_Duct_Neoplasm Malignant neoplasm of lacrimal duct Malignant Lacrimal Duct Neoplasm Malignant Lacrimal Duct Tumor Malignant Nasolacrimal Duct Neoplasm Malignant Neoplasm of Lacrimal Duct Malignant Neoplasm of the Lacrimal Duct Malignant Tumor of Lacrimal Duct Malignant Tumor of the Lacrimal Duct Malignant Nasolacrimal Duct Neoplasm The reemergence of a malignant salivary gland neoplasm after a period of remission. C35675 Neoplastic Process Recurrent Malignant Salivary Gland Neoplasm C1370879 Malignant Recurrent_Malignant_Neoplasm_of_Salivary_Gland Recurrent Malignant Neoplasm of Salivary Gland Recurrent Malignant Salivary Gland Neoplasm Recurrent Malignant Salivary Gland Neoplasm A malignant neoplasm that arises from the gallbladder and it has not spread to other anatomic sites. C35676 Neoplastic Process Localized Malignant Gallbladder Neoplasm C0278806 Malignant Localized_Malignant_Gallbladder_Neoplasm Localized Malignant Gallbladder Neoplasm Malignant Neoplasm of Gallbladder Localized Localized Malignant Gallbladder Neoplasm A primary or metastatic malignant neoplasm affecting the brain. C3568 Neoplastic Process Malignant Brain Neoplasm Malignant Brain Neoplasm C0153633 CPTAC CTRP GDC MedDRA NICHD mCode An abnormal solid mass arising within the brain with histologic features suggesting the potential to metastasize. Malignant Malignant_Brain_Neoplasm Brain Cancer Malignant neoplasm of brain Malignant neoplasm of brain, unspecified Malignant neoplasm of other parts of brain Malignant neoplasm: Brain, unspecified Malignant neoplasm: Cerebral ventricle Malignant neoplasm: Overlapping lesion of brain Brain Cancer Brain Neoplasms, Malignant Cancer of Brain Cancer of the Brain Malignant Brain Neoplasm Malignant Brain Tumor Malignant Neoplasm of Brain Malignant Neoplasm of the Brain Malignant Tumor of Brain Malignant Tumor of the Brain Malignant neoplasm of brain, unspecified Malignant Brain Neoplasm A rare variant of mycosis fungoides, characterized by cerebriform lymphocytic infiltration of the hair follicles of the head and neck. Most cases show mucinous degeneration of the hair follicles, and are designated as mycosis fungoides-associated follicular mucinosis. Cases without mucinous degeneration have been reported as pilotropic mycosis fungoides. There is no difference in clinical presentation or outcome between mycosis fungoides-associated follicular mucinosis and pilotropic mycosis fungoides. In the recent WHO-EORTC classification, folliculotropic mycosis fungoides is the preferred term for all cases. C35685 Neoplastic Process Folliculotropic Mycosis Fungoides C1627767 Malignant Mycosis_Fungoides-Associated_Follicular_Mucinosis Follicular Mycosis Fungoides Folliculotropic Mycosis Fungoides Mycosis Fungoides-Associated Follicular Mucinosis Folliculotropic Mycosis Fungoides A low-grade extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue arising from the parotid gland. It is the most common type of non-Hodgkin lymphoma in the parotid gland and is often associated with Sjogren syndrome. The prognosis is favorable. C35687 Neoplastic Process Parotid Gland Mucosa-Associated Lymphoid Tissue Lymphoma C1335364 Malignant Parotid_Gland_Mucosa-Associated_Lymphoid_Tissue_Lymphoma Parotid Gland MALT Lymphoma Parotid Gland Mucosa-Associated Lymphoid Tissue Lymphoma Parotid Gland Mucosa-Associated Lymphoid Tissue Lymphoma An extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue that arises from the breast as a primary tumor. C35688 Neoplastic Process Breast Mucosa-Associated Lymphoid Tissue Lymphoma C1332633 Malignant Breast_Mucosa-Associated_Lymphoid_Tissue_Lymphoma Breast Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Breast MALT lymphoma Breast Mucosa-Associated Lymphoid Tissue Lymphoma Breast Mucosa-Associated Lymphoid Tissue Lymphoma An extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue that arises from the ocular adnexa. It is the most common type of primary ocular adnexal lymphoma. C35689 Neoplastic Process Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma C1335103 Malignant Ocular_Adnexae_Mucosa-Associated_Lymphoid_Tissue_Lymphoma Ocular Adnexal MALT lymphoma Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma Primary and secondary (metastatic) malignant tumors that occur in the cerebellum. Histologic types include medulloblastomas, high grade (WHO Stage III or IV) cerebellar astrocytomas, lymphomas, gangliogliomas, gliosarcomas, and several other subtypes. The most frequent malignant cerebellar neoplasm of childhood is medulloblastoma. In adults, metastases from other sites are relatively common. Clinical features include ataxia, headache, nausea, dizziness, nystagmus, diplopia, papilledema, etc. C3569 Neoplastic Process Malignant Cerebellar Neoplasm C0153640 CPTAC mCode Malignant Malignant_Cerebellar_Neoplasm Malignant neoplasm of cerebellum NOS Malignant neoplasm: Cerebellum Cancer of Cerebellum Cancer of the Cerebellum Cerebellar Cancer Cerebellar Neoplasm, Malignant Cerebellar Tumor, Malignant Malignant Cerebellar Neoplasm Malignant Cerebellar Neoplasms Malignant Cerebellar Tumor Malignant Neoplasm of Cerebellum Malignant Neoplasm of the Cerebellum Malignant Tumor of Cerebellum Malignant Tumor of the Cerebellum Malignant neoplasm of cerebellum Malignant Cerebellar Neoplasm A lymphoma that arises from the eye. C35690 Neoplastic Process Eye Lymphoma C1333519 Malignant Eye_Lymphoma Eye Lymphoma Ocular Lymphoma Primary Eye Lymphoma Primary Ocular Lymphoma Eye Lymphoma A benign or malignant neoplasm that arises from the salivary glands. It is characterized by the presence of epithelial and mesenchymal elements. This category includes pleomorphic adenoma, carcinoma ex pleomorphic adenoma, and carcinosarcoma. C35691 Neoplastic Process Mixed Tumor of the Salivary Gland CL448484 Benign Mixed_Tumor_of_the_Salivary_Gland Mixed Tumor of Salivary Gland Mixed Tumor of the Salivary Gland Mixed Tumor of the Salivary Gland A carcinoma that arises from the posterior wall of the pharynx. C35692 Neoplastic Process Posterior Pharyngeal Wall Carcinoma Posterior Pharyngeal Wall Carcinoma C1335450 CTRP Malignant Posterior_Pharyngeal_Wall_Carcinoma Posterior Pharyngeal Wall Carcinoma Posterior Pharyngeal Wall Throat Cancer Posterior Pharyngeal Wall Carcinoma A squamous cell carcinoma that arises from the posterior wall of the pharynx. C35693 Neoplastic Process Posterior Pharyngeal Wall Squamous Cell Carcinoma C1335451 Malignant Posterior_Pharyngeal_Wall_Squamous_Cell_Carcinoma Posterior Pharyngeal Wall Squamous Cell Carcinoma Posterior Pharyngeal Wall Squamous Cell Carcinoma Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a: Moderately advanced disease. Tumor invades skin, mandible, ear canal, and/or facial nerve. T1: Tumor measuring 2 cm or less in greatest dimension without extraparenchymal extension. Extraparenchymal extension is clinical or macroscopic evidence of invasion of soft tissues. Microscopic evidence alone does not constitute extraparenchymal extension for classification purposes. T2: Tumor measuring more than 2 cm, but not more than 4 cm in greatest dimension without extraparenchymal extension. T3: Tumor measuring more than 4 cm in greatest dimension, and/or tumor having extraparenchymal extension. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C35694 Neoplastic Process Stage IVA Major Salivary Gland Cancer AJCC v7 Stage IVA Major Salivary Gland Cancer AJCC v7 C1336347 CTRP Malignant Stage_IVA_Major_Salivary_Gland_Carcinoma Stage IVA Major Salivary Gland Cancer Stage IVA Major Salivary Gland Cancer AJCC v7 Stage IVA Major Salivary Gland Carcinoma Stage IVA Major Salivary Gland Carcinoma AJCC v7 Stage IVA Salivary Gland Cancer Stage IVA Major Salivary Gland Cancer AJCC v7 Stage IVB includes: (T4b, Any N, M0); (Any T, N3, M0). T4b: Very advanced disease. Tumor invades skull base and/or pterygoid plates and/or encases carotid artery. N3: Metastasis in a lymph node, more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C35695 Neoplastic Process Stage IVB Major Salivary Gland Cancer AJCC v7 Stage IVB Major Salivary Gland Cancer AJCC v7 C1336378 CTRP Malignant Stage_IVB_Major_Salivary_Gland_Carcinoma Stage IVB Major Salivary Gland Cancer Stage IVB Major Salivary Gland Cancer AJCC v7 Stage IVB Major Salivary Gland Carcinoma Stage IVB Major Salivary Gland Carcinoma AJCC v7 Stage IVB Salivary Gland Cancer Stage IVB Major Salivary Gland Cancer AJCC v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C35696 Neoplastic Process Stage IVC Major Salivary Gland Cancer AJCC v7 Stage IVC Major Salivary Gland Cancer AJCC v7 C1336398 CTRP Malignant Stage_IVC_Major_Salivary_Gland_Carcinoma Stage IVC Major Salivary Gland Cancer Stage IVC Major Salivary Gland Cancer AJCC v7 Stage IVC Major Salivary Gland Carcinoma Stage IVC Major Salivary Gland Carcinoma AJCC v7 Stage IVC Salivary Gland Cancer Stage IVC Major Salivary Gland Cancer AJCC v7 A carcinoma of the larynx that arises from the epiglottis. C35697 Neoplastic Process Epiglottic Carcinoma Epiglottic Carcinoma C1112382 CTRP Malignant Epiglottic_Carcinoma Epiglottic Cancer Epiglottic Carcinoma Epiglottic Throat Cancer Epiglottic Carcinoma A non-metastasizing neoplasm that arises from the uvula. C35698 Neoplastic Process Benign Uvula Neoplasm C0345562 Benign Benign_Uvula_Neoplasm Benign Uvula Neoplasm Benign Uvula Tumor Benign Uvula Tumour Benign Uvular Neoplasm Benign Uvular Tumor Benign Uvula Neoplasm A primary or metastatic malignant neoplasm that affects the brain stem. C3570 Neoplastic Process Malignant Brain Stem Neoplasm C0153641 CPTAC mCode Malignant Malignant_Brain_Stem_Neoplasm Malignant neoplasm of brain stem Malignant neoplasm: Brain stem Malignant Brain Stem Neoplasm Malignant Brain Stem Tumor Malignant Brainstem Neoplasm Malignant Brainstem Tumor Malignant Neoplasm of Brain Stem Malignant Neoplasm of Brainstem Malignant Neoplasm of the Brain Stem Malignant Neoplasm of the Brainstem Malignant Tumor of Brain Stem Malignant Tumor of Brainstem Malignant Tumor of the Brain Stem Malignant Tumor of the Brainstem Malignant neoplasm of brain stem Malignant Brain Stem Neoplasm A locally aggressive carcinoma that arises from the salivary glands, predominantly the parotid gland. It is characterized by the presence of a malignant cellular infiltrate exhibiting myoepithelial differentiation. Patients usually present with a painless mass. C35700 Neoplastic Process Salivary Gland Myoepithelial Carcinoma C1335904 Malignant Salivary_Gland_Myoepithelial_Carcinoma Salivary Gland Myoepithelial Carcinoma Salivary Gland Myoepithelial Carcinoma A carcinoma that arises from the salivary glands, most often the parotid gland. It presents as a slow growing and painless mass. It is characterized by the presence of duct-like structures lined by two layers of cells, an inner layer composed of epithelial-type cells and an outer layer composed of clear, myoepithelial-type cells. C35701 Neoplastic Process Salivary Gland Epithelial-Myoepithelial Carcinoma C1335900 Cellosaurus Malignant Salivary_Gland_Epithelial_Myoepithelial_Carcinoma Salivary Gland Epithelial Myoepithelial Carcinoma Salivary Gland Epithelial-Myoepithelial Carcinoma Salivary Gland Epithelial-Myoepithelial Carcinoma A low grade malignant epithelial neoplasm arising from the salivary gland. It usually arises from the oral cavity, with approximately 60% of the cases involving the palate. The most common presenting sign is a painless mass in the palate. It is characterized by the presence of uniform, small to medium size malignant epithelial cells and an infiltrating pattern. There is a variety of morphologic patterns which may be present within an individual tumor, including lobular, papillary, papillary-cystic, cribriform, and trabecular pattern. It usually has a favorable clinical outcome and a low metastatic potential. C35702 Neoplastic Process Salivary Gland Polymorphous Adenocarcinoma C1335907 GDC 8525/3 Malignant Salivary_Gland_Polymorphous_Low-Grade_Adenocarcinoma 8525/3 Polymorphous adenocarcinoma Polymorphous low grade adenocarcinoma Polymorphous adenocarcinoma, classic Polymorphous low grade adenocarcinoma Salivary Gland PmA Salivary Gland Polymorphous Adenocarcinoma Salivary Gland Polymorphous Adenocarcinoma, Classical Variant Salivary Gland Polymorphous Low Grade Adenocarcinoma Salivary Gland Terminal Duct Adenocarcinoma Salivary Gland Polymorphous Adenocarcinoma An infrequent small cell carcinoma that arises from the salivary glands. It is characterized by the presence of neuroendocrine differentiation and a high number of mitotic figures. C35703 Neoplastic Process Salivary Gland Small Cell Neuroendocrine Carcinoma C1335982 Malignant Salivary_Gland_Anaplastic_Small_Cell_Carcinoma Salivary Gland Small Cell Neuroendocrine Carcinoma Salivary Gland Small Cell Neuroendocrine Carcinoma A primary or metastatic malignant neoplasm that affects a cranial nerve. C3571 Neoplastic Process Malignant Cranial Nerve Neoplasm C0153644 CPTAC mCode Malignant Malignant_Cranial_Nerve_Neoplasm Malignant neoplasm of left optic nerve Malignant neoplasm of other cranial nerves Malignant neoplasm of unspecified optic nerve Malignant neoplasm: Optic nerve Cranial Nerve Neoplasm, Malignant Malignant Cranial Nerve Neoplasm Malignant Cranial Nerve Tumor Malignant Neoplasm of Cranial Nerve Malignant Neoplasm of the Cranial Nerve Malignant Tumor of Cranial Nerve Malignant Tumor of the Cranial Nerve Malignant neoplasm of unspecified cranial nerve Malignant Cranial Nerve Neoplasm A testicular teratoma associated with a distinct secondary component that resembles a somatic-type malignant neoplasm (e.g., carcinoma or sarcoma). C35711 Neoplastic Process Testicular Teratoma with Somatic-Type Malignancy C1336729 Malignant Testicular_Teratoma_with_Somatic-Type_Malignancy Testicular Teratoma with Non-Germ Cell Malignancy Testicular Teratoma with Somatic-Type Malignancy Testicular Teratoma with Somatic-Type Malignancy A rare primary thymic carcinoma, characterized by an undifferentiated solid tumor growth, without associated sarcomatoid features. C35718 Neoplastic Process Thymic Undifferentiated Carcinoma C1336865 Cellosaurus Malignant Undifferentiated_Thymic_Carcinoma Thymic Undifferentiated Carcinoma Thymic Undifferentiated Carcinoma A primary or metastatic malignant neoplasm affecting the spinal cord. Representative examples include lymphoma, melanoma, and sarcoma. C3572 Neoplastic Process Malignant Spinal Cord Neoplasm C0153646 CPTAC mCode Cancer that begins in the spinal column (backbone) or spinal cord. The spinal column is made up of linked bones, called vertebrae. The spinal cord is a column of nerve tissue that runs from the base of the skull down the back. It is surrounded by three protective membranes, and is enclosed within the vertebrae. Many different types of cancer may form in the bones, tissues, fluid, or nerves of the spine. Malignant Malignant_Spinal_Cord_Neoplasm Malignant neoplasm of spinal cord Malignant neoplasm: Spinal cord Malignant Neoplasm of Spinal Cord Malignant Neoplasm of the Spinal Cord Malignant Spinal Cord Neoplasm Malignant Spinal Cord Tumor Malignant Tumor of Spinal Cord Malignant Tumor of the Spinal Cord Malignant neoplasm of spinal cord spine cancer Malignant Spinal Cord Neoplasm A malignant neoplasm that affects the pineal region. C3573 Neoplastic Process Malignant Pineal Region Neoplasm C0153655 CPTAC mCode Malignant Malignant_Pineal_Region_Neoplasm Malignant neoplasm of pineal gland Malignant neoplasm: Pineal gland Malignant Neoplasm of Pineal Gland Malignant Neoplasm of the Pineal Gland Malignant Pineal Area Neoplasm Malignant Pineal Area Tumor Malignant Pineal Gland Neoplasm Malignant Pineal Gland Tumor Malignant Pineal Region Neoplasm Malignant Pineal Region Tumor Malignant Tumor of Pineal Gland Malignant Tumor of the Pineal Gland Malignant neoplasm of pineal gland Malignant Pineal Region Neoplasm A rare, highly aggressive carcinoma that arises from the salivary gland, predominantly the parotid gland. It is characterized by the presence of large pleomorphic malignant cells with or without neuroendocrine differentiation. Patients usually present with a rapidly growing mass. C35735 Neoplastic Process Salivary Gland Large Cell Carcinoma C2111671 Malignant Large_Cell_Undifferentiated_Salivary_Gland_Carcinoma Large Cell Salivary Gland Carcinoma Large Cell Undifferentiated Salivary Gland Carcinoma Salivary Gland Large Cell Carcinoma Salivary Gland Large Cell Carcinoma A rare carcinoma that arises from the salivary glands, most often the parotid gland. It is characterized by the presence of an undifferentiated carcinomatous component associated with a prominent reactive lymphoplasmacytic infiltrate. C35736 Neoplastic Process Salivary Gland Lymphoepithelial Carcinoma C1334461 Malignant Lymphoepithelial_Salivary_Gland_Carcinoma Lymphoepithelial Salivary Gland Carcinoma Salivary Gland Lymphoepithelial Carcinoma Salivary Gland Lymphoepithelial Carcinoma A rare, aggressive carcinoma that arises from the salivary glands. It is characterized by the presence of a squamous and a glandular epithelial component. C35737 Neoplastic Process Salivary Gland Adenosquamous Carcinoma C1335894 Malignant Salivary_Gland_Adenosquamous_Carcinoma Salivary Gland Adenosquamous Carcinoma Salivary Gland Adenosquamous Carcinoma A rare, benign, encapsulated epithelial tumor composed of cells that form solid, variably shaped islands and cysts, both showing focal sebaceous differentiation. The mean age of patients is reported to be 58 years, and most tumors occur in the parotid gland. There is a male predominance. Most patients are asymptomatic. C35738 Neoplastic Process Salivary Gland Sebaceous Adenoma C1335908 Benign Salivary_Gland_Sebaceous_Adenoma Salivary Gland Sebaceous Adenoma Salivary Gland Sebaceous Adenoma A carotid body paraganglioma that metastasizes to other anatomic sites. C3574 Neoplastic Process Metastatic Carotid Body Paraganglioma C0153656 CDISC mCode A malignant neoplasm of the chemoreceptor system (e.g. carotid body, glomus jugulare, glomus vagale). Malignant Malignant_Carotid_Body_Paraganglioma CHEMODECTOMA, MALIGNANT Malignant Carotid Body Neoplasm Malignant Carotid Body Paraganglioma Malignant Carotid Body Tumor Malignant Neoplasm of Carotid Body Malignant Neoplasm of the Carotid Body Malignant Tumor of Carotid Body Malignant Tumor of the Carotid Body Malignant neoplasm of carotid body Metastatic Carotid Body Paraganglioma Metastatic Carotid Body Paraganglioma A malignant neoplasm that has spread to the structures of the axilla from another anatomic site. C35748 Neoplastic Process Metastatic Malignant Neoplasm in the Axilla C0684830 Malignant Metastatic_Malignant_Neoplasm_to_the_Axilla Axillary Metastases Axillary Metastasis Metastatic Malignant Neoplasm in the Axilla Metastatic Malignant Neoplasm to the Axilla Metastatic Malignant Tumor to the Axilla Metastatic Malignant Neoplasm in the Axilla A benign or malignant neoplasm that affects the structures of the axilla. Representative examples include axillary lipoma, axillary lymph node lymphoma, and metastatic carcinoma to the axillary lymph nodes. C35749 Neoplastic Process Axillary Neoplasm C1290308 Undetermined Axillary_Neoplasm Axillary Neoplasm Axillary Neoplasm A malignant neoplasm affecting the endocrine glands. Representative examples include thyroid gland carcinoma, parathyroid gland carcinoma, pituitary gland carcinoma, and adrenal cortex carcinoma. C3575 Neoplastic Process Malignant Endocrine Neoplasm Malignant Endocrine Neoplasm C0153658 CPTAC CTEP CTRP mCode Cancer that occurs in endocrine tissue, the tissue in the body that secretes hormones. Malignant Malignant_Endocrine_Neoplasm Malignant neoplasm of endocrine gland, site unspecified Malignant neoplasm of other endocrine glands and related structures Endocrine Neoplasm, Malignant Endocrine cancer, NOS Malignant Endocrine Gland Neoplasm Malignant Endocrine Gland Tumor Malignant Endocrine Neoplasm Malignant Endocrine Tumor Malignant Neoplasm of Endocrine Gland Malignant Neoplasm of the Endocrine Gland Malignant Tumor of Endocrine Gland Malignant Tumor of the Endocrine Gland Malignant neoplasm of endocrine gland, unspecified endocrine cancer Malignant Endocrine Neoplasm A neoplasm that arises from the axilla and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C35750 Neoplastic Process Benign Axillary Neoplasm C0684828 Benign Benign_Axillary_Neoplasm Benign Axillary Neoplasm Benign Axillary Neoplasm Stage IIIB small cell lung carcinoma that has spread to the pleural fluid. C35756 Neoplastic Process Stage IIIB Small Cell Lung Carcinoma with Pleural Effusion AJCC v7 Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7 C1336231 CTRP Malignant Stage_IIIB_Small_Cell_Lung_Carcinoma_with_Pleural_Effusion Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7 Stage IIIB Small Cell Cancer of Lung with Pleural Effusion Stage IIIB Small Cell Cancer of the Lung with Pleural Effusion Stage IIIB Small Cell Carcinoma of Lung with Pleural Effusion Stage IIIB Small Cell Carcinoma of the Lung with Pleural Effusion Stage IIIB Small Cell Lung Cancer with Pleural Effusion Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7 Stage IIIB small cell lung carcinoma that has not spread to the pleural fluid. C35757 Neoplastic Process Stage IIIB Small Cell Lung Carcinoma without Pleural Effusion AJCC v7 Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7 C1336232 CTRP Malignant Stage_IIIB_Small_Cell_Lung_Carcinoma_without_Pleural_Effusion Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7 Stage IIIB Small Cell Cancer of Lung without Pleural Effusion Stage IIIB Small Cell Cancer of the Lung without Pleural Effusion Stage IIIB Small Cell Carcinoma of Lung without Pleural Effusion Stage IIIB Small Cell Carcinoma of the Lung without Pleural Effusion Stage IIIB Small Cell Lung Cancer without Pleural Effusion Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C35758 Neoplastic Process Stage 0 Large Cell Lung Carcinoma AJCC v6 and v7 Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7 C0854978 CTRP Malignant Stage_0_Large_Cell_Lung_Carcinoma Stage 0 Large Cell Carcinoma of Lung Stage 0 Large Cell Carcinoma of the Lung Stage 0 Large Cell Lung Cancer Stage 0 Large Cell Lung Carcinoma AJCC v6 Stage 0 Large Cell Lung Carcinoma AJCC v7 Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7 Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7 A very rare pleomorphic adenoma of the salivary glands that metastasizes inexplicably, despite the benign histopathologic features. The most common sites of metastasis are bone, lung, and head and neck. C35759 Neoplastic Process Metastasizing Pleomorphic Adenoma of the Salivary Gland C1334711 Benign Metastasizing_Mixed_Tumor_of_the_Salivary_Gland Metastasizing Mixed Tumor of Salivary Gland Metastasizing Mixed Tumor of the Salivary Gland Metastasizing Pleomorphic Adenoma of the Salivary Gland Metastasizing Pleomorphic Adenoma of the Salivary Gland A primary or metastatic malignant neoplasm affecting the tissues of the thorax. C3576 Neoplastic Process Malignant Thoracic Neoplasm Malignant Thoracic Neoplasm C0153661 CPTAC CTRP mCode Malignant Malignant_Thoracic_Neoplasm Malignant neoplasm of heart, mediastinum and pleura Malignant neoplasm of other and ill-defined sites within the respiratory system and intrathoracic organs Malignant neoplasm of other and ill-defined sites: Thorax Malignant neoplasm of other sites within the respiratory system and intrathoracic organs Malignant neoplasm of thorax Malignant neoplasm of thymus, heart, and mediastinum Malignant Neoplasm of Thorax Malignant Neoplasm of the Thorax Malignant Thoracic Neoplasm Malignant Thoracic Tumor Malignant Tumor of Thorax Malignant Tumor of the Thorax Malignant neoplasm of thorax Malignant Thoracic Neoplasm A mesenchymal tumor composed of fibroblastic and histiocytic cells. C35765 Neoplastic Process Histiocytoma C1509147 Cellosaurus GDC 8831/0 Benign Histiocytoma 8831/0 Histiocytoma, NOS Histiocytoma Histiocytoma, NOS Histiocytoma The spread of a malignant neoplasm to the lung. This may be from a primary lung malignant neoplasm, or from a malignant neoplasm at a distant site. C3577 Neoplastic Process Metastatic Malignant Neoplasm to the Lung Metastatic Malignant Neoplasm in the Lung C0153676 CPTAC CTEP CTRP mCode Cancer that has spread from the original (primary) tumor to the lung. Malignant Metastatic_Neoplasm_to_the_Lung Secondary malignant neoplasm of left lung Secondary malignant neoplasm of lung Secondary malignant neoplasm of right lung Secondary malignant neoplasm of unspecified lung Lung Metastases Metastases to Lung Metastases to lung, NOS Metastasis to Lung Metastasis to the Lung Metastatic Malignant Neoplasm in the Lung Metastatic Malignant Neoplasm to the Lung Metastatic Neoplasm to the Lung Metastatic Tumor to the Lung Pulmonary Metastasis Secondary malignant neoplasm of lung Secondary malignant neoplasm of unspecified lung lung metastasis Metastatic Malignant Neoplasm in the Lung A stromal tumor that originates from the interstitial cells of Cajal. It may involve any part of the gastrointestinal tract. The majority of cases occur in the stomach. Morphologic variants include the epithelioid cell type, spindle cell type, and mixed cell type. Most cases contain KIT- or PDGFRA-activating mutations. Lesions with a diameter greater than 10cm and more than 5 mitotic figures per 50HPF tend to have a more aggressive clinical course. Until recently, surgery has been the only effective therapy for this tumor. However, many patients still experience recurrence. A KIT tyrosine kinase inhibitor, imatinib mesylate (also known as STI-571 or Gleevec), is now effective in the treatment of relapsed and unresectable cases. C35778 Neoplastic Process Gastrointestinal Stromal Tumor of the Gastrointestinal Tract Gastrointestinal Stromal Tumor of the Gastrointestinal Tract C1333802 CTRP Undetermined Gastrointestinal_Stromal_Tumor_of_the_Gastrointestinal_Tract Digestive Stromal Neoplasm Digestive Stromal Tumor Digestive Tract Stromal Neoplasm Digestive Tract Stromal Tumor Gastrointestinal Stromal Tumor (GIST) of the Gastrointestinal Tract Gastrointestinal Stromal Tumor of Gastrointestinal Tract Gastrointestinal Stromal Tumor of the Gastrointestinal Tract Gastrointestinal Tract Stromal Neoplasm Gastrointestinal Tract Stromal Tumor Stromal Neoplasm of Digestive Tract Stromal Neoplasm of Gastrointestinal Tract Stromal Neoplasm of the Digestive Tract Stromal Neoplasm of the Gastrointestinal Tract Stromal Tumor of Digestive Tract Stromal Tumor of Gastrointestinal Tract Stromal Tumor of the Digestive Tract Stromal Tumor of the Gastrointestinal Tract Gastrointestinal Stromal Tumor of the Gastrointestinal Tract The spread of a malignant neoplasm to the mediastinum from an adjacent or distant anatomic site. C3578 Neoplastic Process Metastatic Malignant Neoplasm in the Mediastinum C0153677 CPTAC mCode Malignant Metastatic_Neoplasm_to_the_Mediastinum Secondary malignant neoplasm of mediastinum Metastases to Mediastinum Metastases to the Mediastinum Metastasis to the Mediastinum Metastatic Malignant Neoplasm in the Mediastinum Metastatic Malignant Neoplasm to the Mediastinum Metastatic Neoplasm to the Mediastinum Metastatic Tumor to the Mediastinum Secondary malignant neoplasm of mediastinum Metastatic Malignant Neoplasm in the Mediastinum A uveal melanoma characterized by the presence of malignant large epithelioid melanocytes. C35780 Neoplastic Process Epithelioid Cell Uveal Melanoma Uveal Epithelioid Cell Melanoma C0279692 CTRP Malignant Epitheliod_Cell_Uveal_Melanoma Epithelioid Cell Uveal Melanoma Uveal Epithelioid Cell Melanoma Uveal Epithelioid Cell Melanoma A melanoma arising from the choroid, ciliary body, or the iris. It is characterized by the presence of a mixture of spindle A melanoma cells, spindle B melanoma cells, and epithelioid melanoma cells. C35781 Neoplastic Process Mixed Cell Uveal Melanoma Uveal Mixed Epithelioid and Spindle Cell Melanoma C1334782 CTRP Malignant Mixed_Cell_Uveal_Melanoma Mixed Cell Uveal Melanoma Uveal Mixed Cell Melanoma Uveal Mixed Epithelioid and Spindle Cell Melanoma Uveal Mixed Epithelioid and Spindle Cell Melanoma A melanoma arising from the choroid. It is characterized by the presence of a mixture of spindle A melanoma cells, spindle B melanoma cells, and epithelioid melanoma cells. C35782 Neoplastic Process Choroid Mixed Epithelioid and Spindle Cell Melanoma C1333025 Malignant Choroid_Mixed_Cell_Melanoma Choroid Mixed Cell Melanoma Choroid Mixed Epithelioid and Spindle Cell Melanoma Choroid Mixed Epithelioid and Spindle Cell Melanoma A melanoma arising from the ciliary body. It is characterized by the presence of a mixture of spindle A melanoma cells, spindle B melanoma cells, and epithelioid melanoma cells. C35783 Neoplastic Process Ciliary Body Mixed Epithelioid and Spindle Cell Melanoma C1333051 Malignant Ciliary_Body_Mixed_Cell_Melanoma Ciliary Body Mixed Cell Melanoma Ciliary Body Mixed Epithelioid and Spindle Cell Melanoma Ciliary Body Mixed Epithelioid and Spindle Cell Melanoma The spread of a malignant neoplasm to the pleura from an adjacent or distant anatomic site. C3579 Neoplastic Process Metastatic Malignant Neoplasm in the Pleura C0153678 mCode Malignant Metastatic_Neoplasm_to_the_Pleura Metastases to Pleura Metastasis to the Pleura Metastatic Malignant Neoplasm in the Pleura Metastatic Malignant Neoplasm to the Pleura Metastatic Neoplasm to the Pleura Metastatic Tumor to the Pleura Secondary malignant neoplasm of pleura Metastatic Malignant Neoplasm in the Pleura A variant of mycosis fungoides, characterized by an exclusively intraepidermal atypical (cerebriform) lymphocytic infiltrate. Patients present with a localized psoriasiform or hyperkeratotic patch or plaque, usually in the extremities. Extracutaneous dissemination of the disease has never been reported. C35794 Neoplastic Process Pagetoid Reticulosis C1367970 GDC Malignant Pagetoid_Reticulosis 9700/3 Pagetoid reticulosis Pagetoid Reticulosis Pagetoid reticulosis Pagetoid Reticulosis The spread of a malignant neoplasm from a primary site to the skeletal system. The majority of metastatic neoplasms to the bone are carcinomas. C3580 Neoplastic Process Metastatic Malignant Neoplasm to the Bone Metastatic Malignant Neoplasm in the Bone C0153690 CPTAC CTEP CTRP mCode Cancer that has spread from the original (primary) tumor to the bone. Malignant Metastatic_Neoplasm_to_the_Bone Secondary malignant neoplasm of bone Secondary malignant neoplasm of bone and bone marrow Bone Metastases Bone Metastasis Metastases to bone, NOS Metastatic Cancer to the Bone Metastatic Malignant Neoplasm in the Bone Metastatic Malignant Neoplasm to the Bone Metastatic Neoplasm to the Bone Metastatic Tumor to the Bone Secondary malignant neoplasm of bone bone metastasis Metastatic Malignant Neoplasm in the Bone Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C3581 Neoplastic Process Ann Arbor Stage III Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Stage III Nodular Sclerosis Classic Hodgkin Lymphoma C0153767 CTRP Malignant Stage_III_Nodular_Sclerosis_Hodgkin_s_Lymphoma Ann Arbor Stage III Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Stage III Nodular Sclerosis Classical Hodgkin Lymphoma Nodular Sclerosis Hodgkin's Disease Stage III Nodular Sclerosis Hodgkin's Lymphoma Stage III Stage III Nodular Sclerosis Classical Hodgkin Lymphoma Stage III Nodular Sclerosis Hodgkin Lymphoma Stage III Nodular Sclerosis Hodgkin's Disease Stage III Nodular Sclerosis Hodgkin's Lymphoma Ann Arbor Stage III Nodular Sclerosis Classic Hodgkin Lymphoma A primary or metastatic malignant tumor involving the lymph node. Lymphomas and metastatic carcinomas are representative examples. C35812 Neoplastic Process Malignant Lymph Node Neoplasm C0948627 CPTAC GDC Malignant Malignant_Lymph_Node_Neoplasm Lymph Node Cancer Lymph Node Cancer Malignant Lymph Node Neoplasm Malignant Lymph Node Neoplasm A benign or malignant (primary or metastatic) neoplasm that affects the hematopoietic and lymphatic system. C35813 Neoplastic Process Hematopoietic and Lymphoid System Neoplasm Hematopoietic and Lymphatic System Neoplasm C1512393 CTRP mCode Undetermined Hematopoietic_System_Neoplasm Hematopoietic and Lymphatic System Neoplasm Hematopoietic and Lymphoid System Neoplasm Hematopoietic and Lymphoid System Tumor Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified Hematopoietic and Lymphatic System Neoplasm A tumor mass composed of myeloblasts, neutrophils and neutrophil precursors. Granulocytic sarcoma is the most common type of myeloid sarcoma. (WHO, 2001) C35815 Neoplastic Process Granulocytic Sarcoma C0152276 CDISC Cellosaurus GDC A malignant neoplasm composed of myeloblasts, neutrophils and neutrophil precursors. A malignant, green-colored tumor of myeloid cells (a type of immature white blood cell). This tumor is usually associated with myelogenous leukemia. Malignant Granulocytic_Sarcoma 9930/3 Granulocytic sarcoma Granulocytic Sarcoma Granulocytic sarcoma SARCOMA, GRANULOCYTIC, MALIGNANT granulocytic sarcoma Granulocytic Sarcoma A less common form of myeloid sarcoma composed of monoblasts. Monoblastic sarcoma may precede or occur simultaneously with acute monoblastic leukemia. (WHO 2001) C35816 Neoplastic Process Monoblastic Sarcoma C1334793 Malignant Monoblastic_Sarcoma Monoblastic Sarcoma Monoblastic Sarcoma A granulocytic sarcoma composed primarily of myeloblasts (WHO 2001). C35817 Neoplastic Process Blastic Granulocytic Sarcoma Blastic Granulocytic Sarcoma C0919896 CTRP Malignant Blastic_Granulocytic_Sarcoma Blastic Granulocytic Sarcoma Myeloblastoma Blastic Granulocytic Sarcoma A granulocytic sarcoma composed of myeloblasts and promyelocytes (WHO 2001). C35818 Neoplastic Process Immature Granulocytic Sarcoma C1334153 Malignant Immature_Granulocytic_Sarcoma Immature Granulocytic Sarcoma Immature Granulocytic Sarcoma A granulocytic sarcoma composed of promyelocytes and more mature neutrophils (WHO 2001). C35819 Neoplastic Process Differentiated Granulocytic Sarcoma C1333287 Malignant Differentiated_Granulocytic_Sarcoma Differentiated Granulocytic Sarcoma Differentiated Granulocytic Sarcoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C3582 Neoplastic Process Ann Arbor Stage III Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Stage III Mixed Cellularity Classic Hodgkin Lymphoma C0153775 CTRP Malignant Stage_III_Mixed_Cellularity_Hodgkin_s_Lymphoma Ann Arbor Stage III Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Stage III Mixed Cellularity Classical Hodgkin Lymphoma Mixed Cellularity Hodgkin's Disease Stage III Mixed Cellularity Hodgkin's Lymphoma Stage III Stage III Mixed Cellularity Classical Hodgkin Lymphoma Stage III Mixed Cellularity Hodgkin Lymphoma Stage III Mixed Cellularity Hodgkin's Disease Stage III Mixed Cellularity Hodgkin's Lymphoma Ann Arbor Stage III Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C3583 Neoplastic Process Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma C0153783 CTRP Malignant Stage_III_Lymphocyte_Depleted_Hodgkin_s_Lymphoma Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma Ann Arbor Stage III Lymphocyte-Depleted Classical Hodgkin Lymphoma Stage III Hodgkin's Disease Lymphocyte Depletion Type Stage III Hodgkin's Lymphoma Lymphocyte Depleted Stage III Hodgkin's Lymphoma Lymphocyte Depletion Type Stage III Lymphocyte Depleted Classical Hodgkin Lymphoma Stage III Lymphocyte Depleted Hodgkin Lymphoma Stage III Lymphocyte Depleted Hodgkin's Lymphoma Stage III Lymphocyte-Depleted Classical Hodgkin Lymphoma Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma A morphologic variant of papillary carcinoma of the thyroid gland characterized by the presence of pseudostratified malignant follicular cells. C35830 Neoplastic Process Columnar Cell Variant Thyroid Gland Papillary Carcinoma C1266054 CPTAC GDC 8344/3 Malignant Columnar_Cell_Variant_Papillary_Carcinoma 8344/3 Papillary carcinoma, columnar cell Columnar Cell Variant Papillary Carcinoma Columnar Cell Variant Papillary Thyroid Gland Carcinoma Columnar Cell Variant Thyroid Gland Papillary Carcinoma Papillary Thyroid Carcinoma, Columnar Variant Columnar Cell Variant Thyroid Gland Papillary Carcinoma An aggressive, high grade malignant tumor that arises from the salivary gland. It is characterized by the presence of a malignant epithelial and a sarcomatous component. C35831 Neoplastic Process Salivary Gland Carcinosarcoma C1332842 Malignant Carcinosarcoma_of_the_Salivary_Gland Carcinosarcoma of Salivary Gland Carcinosarcoma of the Salivary Gland Salivary Gland Carcinosarcoma True Malignant Mixed Tumor of the Salivary Gland Salivary Gland Carcinosarcoma An aggressive, high grade malignant tumor that arises from the parotid gland. It is characterized by the presence of a malignant epithelial and a sarcomatous component. C35832 Neoplastic Process Parotid Gland Carcinosarcoma C1335357 Malignant Parotid_Gland_Carcinosarcoma Parotid Gland Carcinosarcoma Parotid Gland Carcinosarcoma An uncommon benign epithelial tumor, characterized by predominantly unicystic or multicystic growth; there is focal intraluminal papillary proliferation of the lining epithelium. Nearly half occur in the parotid gland. In the minor salivary glands, women are affected more than men. In the major salivary glands, cystadenomas present as slowly enlarging, asymptomatic masses that may be slightly compressible. Cystadenocarcinoma is the malignant counterpart. C35833 Neoplastic Process Salivary Gland Cystadenoma C1335898 Benign Salivary_Gland_Cystadenoma Salivary Gland Cystadenoma Salivary Gland Cystadenoma An intraluminal papillary proliferation that causes unicystic dilatation of the duct and may have features in common with papillary cystadenoma. It is quite rare, and involves almost exclusively the excretory ducts of intraoral minor salivary glands. It presents as an asymptomatic submucosal swelling. C35834 Neoplastic Process Salivary Gland Intraductal Papilloma C1335901 Benign Salivary_Gland_Intraductal_Papilloma Salivary Gland Intraductal Papilloma Salivary Gland Intraductal Papilloma A very rare benign tumor of the minor salivary glands, characterized by a luminal papillary proliferation that arises at the junction of the salivary gland duct and the oral mucosal surface epithelium and expands as a nodular mass into the lamina propria. It presents as an asymptomatic mucosal swelling. C35835 Neoplastic Process Salivary Gland Inverted Ductal Papilloma C1335902 Benign Salivary_Gland_Inverted_Ductal_Papilloma Salivary Gland Inverted Ductal Papilloma Salivary Gland Inverted Ductal Papilloma An uncommon exophytic papillary proliferation that involves mucosal surface epithelium and salivary duct epithelium. It is exceptional among salivary gland neoplasms because it manifests as an exophytic papillary excrescence of the mucosa, rather than as a submucosal or intraglandular mass. It most often affects the hard or soft palate. It is generally asymptomatic. C35836 Neoplastic Process Salivary Gland Sialadenoma Papilliferum C1335910 Benign Salivary_Gland_Sialadenoma_Papilliferum Salivary Gland Sialadenoma Papilliferum Salivary Gland Sialadenoma Papilliferum A rare, malignant primitive neoplasm that occurs in the salivary glands. Most tumors arise from the parotid gland, followed by the submandibular gland, and rarely the minor salivary glands. It is usually diagnosed during the neonatal period and presents with painless face swelling. C35837 Neoplastic Process Sialoblastoma C1266145 GDC 8974/1 Malignant Salivary_Gland_Sialoblastoma 8974/1 Sialoblastoma Salivary Gland Sialoblastoma Sialoblastoma Sialoblastoma A benign papillary neoplasm that arises from the salivary glands. This category includes intraductal papilloma, inverted ductal papilloma, and sialadenoma papilliferum. C35839 Neoplastic Process Salivary Gland Ductal Papilloma C1335899 Benign Salivary_Gland_Ductal_Papilloma Salivary Gland Ductal Papilloma Salivary Gland Ductal Papilloma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C3584 Neoplastic Process Ann Arbor Stage III Hodgkin Lymphoma Ann Arbor Stage III Hodgkin Lymphoma C0153792 CTRP Malignant Stage_III_Hodgkin_s_Lymphoma Ann Arbor Stage III Hodgkin Lymphoma Hodgkin's Disease Stage III Hodgkin's Lymphoma Stage III Stage III Hodgkin Lymphoma Stage III Hodgkin's Disease Stage III Hodgkin's Lymphoma Ann Arbor Stage III Hodgkin Lymphoma A carcinoma that arises from the head and neck region. Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma. C35850 Neoplastic Process Head and Neck Carcinoma Head and Neck Carcinoma C3887461 CPTAC CTRP Malignant Head_and_Neck_Carcinoma Carcinoma of Head and Neck Carcinoma of the Head and Neck Head and Neck Carcinoma Head and Neck Carcinoma A clear cell renal cell carcinoma characterized by absent or inconspicuous and basophilic nucleoli at x 400 magnification. (WHO 1982 /ISUP 2014) C35851 Neoplastic Process Grade 1 Clear Cell Renal Cell Carcinoma C1333829 CPTAC Malignant Grade_1_Conventional_Clear_Cell_Renal_Cell_Carcinoma G1 Nuclei round, uniform, approximately 10 um; nucleoli inconspicuous or absent Grade 1 Clear Cell Renal Cell Carcinoma Grade 1 Conventional (Clear Cell) Renal Cell Carcinoma Grade 1 Clear Cell Renal Cell Carcinoma A clear cell renal cell carcinoma characterized by nucleoli conspicuous and eosinophilic at x 400 magnification, and visible but not prominent at x 100 magnification. (WHO 1982 /ISUP 2014) C35852 Neoplastic Process Grade 2 Clear Cell Renal Cell Carcinoma C1333835 CPTAC Malignant Grade_2_Conventional_Clear_Cell_Renal_Cell_Carcinoma G2 Nuclei slightly irregular, approximately 15 um; nucleoli evident Grade 2 Clear Cell Renal Cell Carcinoma Grade 2 Conventional (Clear Cell) Renal Cell Carcinoma Grade 2 Clear Cell Renal Cell Carcinoma A clear cell renal cell carcinoma characterized by nucleoli conspicuous and eosinophilic at x 100 magnification. (WHO 1982 /ISUP 2014) C35853 Neoplastic Process Grade 3 Clear Cell Renal Cell Carcinoma C1333841 CPTAC Malignant Grade_3_Conventional_Clear_Cell_Renal_Cell_Carcinoma G3 Nuclei very irregular, approximately 20 um; nucleoli large and prominent Grade 3 Clear Cell Renal Cell Carcinoma Grade 3 Conventional (Clear Cell) Renal Cell Carcinoma Grade 3 Clear Cell Renal Cell Carcinoma A clear cell renal cell carcinoma characterized by extreme nuclear pleomorphism and/or sarcomatoid and/or rhabdoid differentiation and/or tumor giant cells. (WHO, 1982 /ISUP 2014) C35854 Neoplastic Process Grade 4 Clear Cell Renal Cell Carcinoma C1333852 CPTAC Malignant Grade_4_Conventional_Clear_Cell_Renal_Cell_Carcinoma G4 Nuclei bizarre and multilobated, 20 um or greater, nucleoli prominent, chromatin clumped Grade 4 Clear Cell Renal Cell Carcinoma Grade 4 Conventional (Clear Cell) Renal Cell Carcinoma Grade 4 Clear Cell Renal Cell Carcinoma A high grade malignant bone-forming mesenchymal neoplasm producing osteoid. The tumor arises from the medullary portion of the bone. It affects the long bones and most commonly, the distal femur, proximal tibia, and proximal humerus. Pain with or without a palpable mass is the most common clinical presentation. It usually has an aggressive growth and may metastasize through the hematogenous route. The lung is the most frequent site of metastasis. C35870 Neoplastic Process Conventional Osteosarcoma Conventional Osteosarcoma C1266166 CTRP GDC PCDC 9186/3 9195/3 Malignant Conventional_Osteosarcoma 9186/3 9195/3 Central osteosarcoma Central osteosarcoma, NOS Conventional central osteosarcoma Intracortical osteosarcoma Medullary osteosarcoma COS Central Central Osteosarcoma Central osteosarcoma Conventional Central Osteosarcoma Conventional Osteosarcoma Conventional central osteosarcoma Intracortical Osteogenic Sarcoma Intracortical Osteosarcoma Intracortical osteosarcoma Medullary Osteosarcoma Medullary osteosarcoma Conventional Osteosarcoma A spectrum of malignant tumors arising from the bone and characterized morphologically by the presence of small round cells. Ewing sarcoma and peripheral primitive neuroectodermal tumor represent the ends of a spectrum, with Ewing sarcoma lacking evidence of neural differentiation and the markers that characterize the peripheral primitive neuroectodermal tumor. Ewing sarcoma and peripheral primitive neuroectodermal tumor may share cytogenetic abnormalities, proto-oncogene expression, cell culture and immunohistochemical abnormalities. Pain and the presence of a mass are the most common clinical symptoms. C35871 Neoplastic Process Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone C1333481 Cellosaurus Malignant Ewing_s_Sarcoma_Peripheral_Primitive_Neuroectodermal_Tumor_of_Bone Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone A Kaposi sarcoma that develops after organ transplantation or immunosuppressive treatment. C35873 Neoplastic Process Iatrogenic Kaposi Sarcoma C1334149 Malignant Iatrogenic_Kaposi_s_Sarcoma Iatrogenic Kaposi Sarcoma Iatrogenic Kaposi's Sarcoma Iatrogenic Kaposi Sarcoma A Kaposi sarcoma that occurs in adults and children in Equatorial Africa. C35874 Neoplastic Process Endemic African Kaposi Sarcoma C1275231 Cellosaurus Malignant Endemic_African_Kaposi_s_Sarcoma Endemic African Kaposi Sarcoma Endemic African Kaposi's Sarcoma Endemic African Kaposi Sarcoma A lung carcinoma arising from the bronchial epithelium. C35875 Neoplastic Process Bronchogenic Carcinoma Bronchogenic Carcinoma C2750266 CDISC CPTAC CTRP Cellosaurus A malignant neoplasia of the lung, arising from bronchial epithelium. Cancer that begins in the tissue that lines or covers the airways of the lungs, including small cell and non-small cell lung cancer. Malignant Bronchogenic_Carcinoma Bronchial Carcinoma Bronchiogenic Carcinoma Bronchogenic Carcinoma Bronchogenic Lung Cancer Bronchogenic Lung Carcinoma Bronchus Cancer CARCINOMA, BRONCHIAL, MALIGNANT bronchogenic carcinoma Bronchogenic Carcinoma A neoplasm that arises within the skull and occurs during childhood. C35876 Neoplastic Process Childhood Intracranial Neoplasm C1332975 NICHD A primary neoplasm that arises within the skull, and which occurs during childhood. Undetermined Childhood_Intracranial_Neoplasm Childhood Intracranial Neoplasm Childhood Intracranial Neoplasm A neoplasm that arises from the lip and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3591 Neoplastic Process Benign Lip Neoplasm C0153932 Benign Benign_Lip_Neoplasm Benign Lip Neoplasm Benign Lip Tumor Benign Neoplasm of Lip Benign Neoplasm of the Lip Benign Tumor of Lip Benign Tumor of the Lip Lip Neoplasm, Benign Benign Lip Neoplasm A neoplasm that arises from the tongue and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3592 Neoplastic Process Benign Tongue Neoplasm C0153933 CPTAC Benign Benign_Tongue_Neoplasm Benign neoplasm of tongue Benign Neoplasm of Tongue Benign Neoplasm of the Tongue Benign Tongue Neoplasm Benign Tongue Tumor Benign Tumor of Tongue Benign Tumor of the Tongue Tongue Neoplasm, Benign Benign Tongue Neoplasm A neoplasm that arises from the floor of the mouth and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3593 Neoplastic Process Benign Floor of the Mouth Neoplasm C0153934 Benign Benign_Floor_of_the_Mouth_Neoplasm Benign Floor of Mouth Neoplasm Benign Floor of Mouth Tumor Benign Floor of the Mouth Neoplasm Benign Floor of the Mouth Tumor Benign Neoplasm of Floor of Mouth Benign Neoplasm of the Floor of the Mouth Benign Tumor of Floor of Mouth Benign Tumor of the Floor of the Mouth Benign Floor of the Mouth Neoplasm A neoplasm that arises from the tonsil and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3594 Neoplastic Process Benign Tonsillar Neoplasm C0153936 Benign Benign_Tonsillar_Neoplasm Benign Neoplasm of Tonsil Benign Neoplasm of the Tonsil Benign Tonsil Neoplasm Benign Tonsil Tumor Benign Tonsillar Neoplasm Benign Tonsillar Tumor Benign Tumor of Tonsil Benign Tumor of the Tonsil Tonsillar Neoplasm, Benign Benign Tonsillar Neoplasm A neoplasm that arises from the nasopharynx and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Nasopharyngeal angiofibroma is a representative example. C3595 Neoplastic Process Benign Nasopharyngeal Neoplasm C0153938 Benign Benign_Nasopharyngeal_Neoplasm Benign Nasopharyngeal Neoplasm Benign Nasopharyngeal Tumor Benign Neoplasm of Nasopharynx Benign Neoplasm of the Nasopharynx Benign Tumor of Nasopharynx Benign Tumor of the Nasopharynx Nasopharyngeal Neoplasm, Benign Benign Nasopharyngeal Neoplasm A neoplasm that arises from the hypopharynx and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3596 Neoplastic Process Benign Hypopharyngeal Neoplasm C0153939 Benign Benign_Hypopharyngeal_Neoplasm Benign Hypopharyngeal Neoplasm Benign Hypopharyngeal Tumor Benign Neoplasm of Hypopharynx Benign Neoplasm of the Hypopharynx Benign Tumor of Hypopharynx Benign Tumor of the Hypopharynx Hypopharyngeal Neoplasm, Benign Benign Hypopharyngeal Neoplasm A neoplasm that arises from the pharynx and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3597 Neoplastic Process Benign Pharyngeal Neoplasm C0153940 CPTAC Benign Benign_Pharyngeal_Neoplasm Benign neoplasm of pharynx, unspecified Benign Neoplasm of Pharynx Benign Neoplasm of the Pharynx Benign Pharyngeal Neoplasm Benign Pharyngeal Tumor Benign Pharynx Neoplasm Benign Pharynx Tumor Benign Tumor of Pharynx Benign Tumor of the Pharynx Pharyngeal Neoplasm Benign Benign Pharyngeal Neoplasm A neoplasm that arises from the esophageal wall and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3598 Neoplastic Process Benign Esophageal Neoplasm C0153942 Benign Benign_Esophageal_Neoplasm Benign Esophageal Neoplasm Benign Esophageal Tumor Benign Esophagus Neoplasm Benign Esophagus Tumor Benign Neoplasm of Esophagus Benign Neoplasm of the Esophagus Benign Tumor of Esophagus Benign Tumor of the Esophagus Benign Esophageal Neoplasm A neoplasm that arises from the stomach and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3599 Neoplastic Process Benign Gastric Neoplasm C0153943 Benign Benign_Gastric_Neoplasm Benign Gastric Neoplasm Benign Gastric Tumor Benign Gastric Tumors Benign Neoplasm of Stomach Benign Neoplasm of the Stomach Benign Stomach Neoplasms Benign Stomach Tumors Benign Tumor of Stomach Benign Tumor of the Stomach Benign Tumors of Stomach Benign Tumors of the Stomach Gastric Neoplasms, Benign Gastric Tumors, Benign Stomach Neoplasms, Benign Stomach Tumors, Benign Benign Gastric Neoplasm A neoplasm that arises from the small intestine and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3600 Neoplastic Process Benign Small Intestinal Neoplasm C0153944 CPTAC Benign Benign_Small_Intestinal_Neoplasm Benign neoplasm of duodenum, jejunum, and ileum Benign Neoplasm of Small Intestine Benign Neoplasm of the Small Intestine Benign Small Intestinal Neoplasm Benign Small Intestinal Neoplasm NOS Benign Small Intestinal Tumor Benign Small Intestine Neoplasm Benign Small Intestine Tumor Benign Tumor of Small Intestine Benign Tumor of the Small Intestine Benign Small Intestinal Neoplasm A neoplasm that arises from the larynx and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3601 Neoplastic Process Benign Laryngeal Neoplasm C0153952 CPTAC Benign Benign_Laryngeal_Neoplasm Benign neoplasm of larynx Benign Laryngeal Neoplasm Benign Laryngeal Tumor Benign Larynx Neoplasm Benign Larynx Tumor Benign Neoplasm of Larynx Benign Neoplasm of the Larynx Benign Tumor of Larynx Benign Tumor of the Larynx Laryngeal Neoplasm, Benign Benign Laryngeal Neoplasm A neoplasm that arises from the trachea and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3602 Neoplastic Process Benign Tracheal Neoplasm C0153953 Benign Benign_Tracheal_Neoplasm Benign Neoplasm of Trachea Benign Neoplasm of the Trachea Benign Trachea Neoplasm Benign Trachea Tumor Benign Tracheal Neoplasm Benign Tracheal Tumor Benign Tumor of Trachea Benign Tumor of the Trachea Benign Tracheal Neoplasm A neoplasm that arises from the pleura and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3603 Neoplastic Process Benign Pleural Neoplasm C0153955 Benign Benign_Pleural_Neoplasm Benign Neoplasm of Pleura Benign Neoplasm of the Pleura Benign Pleural Neoplasm Benign Pleural Tumor Benign Tumor of Pleura Benign Tumor of the Pleura Benign Pleural Neoplasm A neoplasm that arises from the mediastinum and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include lipoma, leiomyoma, and schwannoma. C3604 Neoplastic Process Benign Mediastinal Neoplasm C0153956 Benign Benign_Mediastinal_Neoplasm Benign Mediastinal Neoplasm Benign Mediastinal Neoplasms NOS Benign Mediastinal Tumor Benign Neoplasm of Mediastinum Benign Neoplasm of the Mediastinum Benign Tumor of Mediastinum Benign Tumor of the Mediastinum Benign Mediastinal Neoplasm A neoplasm that arises from the heart and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include atrial myxoma, cardiac lipoma, and cardiac fibroma. C3605 Neoplastic Process Benign Cardiac Neoplasm C0153957 Benign Benign_Cardiac_Neoplasm Benign Cardiac Neoplasm Benign Cardiac Tumor Benign Heart Neoplasm Benign Heart Tumor Benign Neoplasm of Heart Benign Neoplasm of the Heart Benign Tumor of Heart Benign Tumor of the Heart Benign Cardiac Neoplasm A term referring to acute myeloid leukemias which show variant translocations involving the RARA gene. The variant fusion partners include NUMA1, ZBTB16, STAT5B, and NPM1. These leukemias often have the morphologic features of acute promyelocytic leukemia. C36055 Neoplastic Process Acute Myeloid Leukemia with a Variant RARA Rearrangement C2825128 NICHD A term referring to acute myeloid leukemias which show variant translocations involving the RARA gene. The variant fusion partners include NUMA1, ZBTB16 (PLZF), STAT5B, and NPM1. These leukemias often have the morphologic features of acute promyelocytic leukemia. Malignant Acute_Promyelocytic_Leukemia_with_Variant_Translocations AML with Variant RARA Translocation Acute Myeloid Leukemia with a Variant RARA Rearrangement Acute Myeloid Leukemia with a Variant RARA Translocation Acute Promyelocytic Leukemia with Other RARA Rearrangements Acute Myeloid Leukemia with a Variant RARA Rearrangement Acute myeloid leukemia with the variant RARA t(11;17)(q23;q21) and the expression of ZBTB16-RARA fusion protein. It lacks differentiation response to retinoids treatment. C36056 Neoplastic Process Acute Myeloid Leukemia with t(11;17)(q23;q21); ZBTB16-RARA C2825129 NICHD Acute myeloid leukemia with the variant RARA t(11;17)(q23;q21) and the expression of PLZF-RARA fusion protein. It does not respond to retinoid treatment. Malignant Acute_Promyelocytic_Leukemia_with_t_11_17_q23_q21 APL with t(11;17)(q23;q21); PLZF-RARA APL with t(11;17)(q23;q21); ZBTB16-RARA Acute Myeloid Leukemia with t(11;17)(q23;q21) Acute Myeloid Leukemia with t(11;17)(q23;q21); ZBTB16-RARA Acute Myeloid Leukemia with t(11;17)(q23;q21); ZBTB16-RARA Fusion Acute Myeloid Leukemia with t(11;17)(q23;q21); ZBTB16::RARA Acute Myeloid Leukemia with t(11;17)(q23;q21); ZBTB16::RARA Fusion Acute Promyelocytic Leukemia with t(11;17)(q23;q21); PLZF-RARA Acute Promyelocytic Leukemia with t(11;17)(q23;q21); ZBTB16-RARA Acute Promyelocytic Leukemia with t(11;17)(q23;q21); ZBTB16::RARA Acute Myeloid Leukemia with t(11;17)(q23;q21); ZBTB16-RARA Acute myeloid leukemia with the variant RARA t(5;17)(q35;q21) and the expression of NPM1-RARA fusion protein. C36057 Neoplastic Process Acute Myeloid Leukemia with t(5;17)(q35;q21); NPM1-RARA C4055494 NICHD An acute myeloid leukemia associated with t(5;17)(q35;q21) and NPM1-RARA fusion protein expression. This type of leukemia often has the morphologic features of acute promyelocytic leukemia. There have been rare cases in children reported in the literature. Malignant Acute_Promyelocytic_Leukemia_with_t_5_17_q32_q12 AML with t(5;17)(q35;q21) AML with t(5;17)(q35;q21);NPM1-RARA Acute Myeloid Leukemia with t(5;17)(q35;q21) Acute Myeloid Leukemia with t(5;17)(q35;q21); NPM1-RARA Acute Myeloid Leukemia with t(5;17)(q35;q21); NPM1-RARA Fusion Acute Myeloid Leukemia with t(5;17)(q35;q21); NPM1::RARA Acute Myeloid Leukemia with t(5;17)(q35;q21); NPM1::RARA Fusion Acute Myeloid Leukemia with t(5;17)(q35;q21);NPM1-RARA Acute Myeloid Leukemia with t(5;17)(q35;q21); NPM1-RARA Acute myeloid leukemia with the variant RARA t(11;17)(q13;q21) and the expression of NUMA1-RARA fusion protein. C36058 Neoplastic Process Acute Myeloid Leukemia with t(11;17)(q13;q21); NUMA1-RARA C2825131 NICHD Acute myeloid leukemia with the variant RARA t(11;17)(q13;q21) and the expression of NUMA1-RARA fusion protein. Malignant Acute_Promyelocytic_Leukemia_with_t_11_17_q13_q21 APL with t(11;17)(q13;q21); NUMA1-RARA Acute Myeloid Leukemia with t(11;17)(q13;q21) Acute Myeloid Leukemia with t(11;17)(q13;q21); NUMA1-RARA Acute Myeloid Leukemia with t(11;17)(q13;q21); NUMA1-RARA Fusion Acute Myeloid Leukemia with t(11;17)(q13;q21); NUMA1::RARA Fusion Acute Promyelocytic Leukemia with t(11;17)(q13;q21); NUMA1-RARA Acute Promyelocytic Leukemia with t(11;17)(q13;q21); NUMA1::RARA Acute Promyelocytic Leukemia with t(11;17)(q13;q21); NUMA1::RARA Fusion Acute Myeloid Leukemia with t(11;17)(q13;q21); NUMA1-RARA A lipoma that arises from the spermatic cord. C3606 Neoplastic Process Spermatic Cord Lipoma C0153972 Benign Spermatic_Cord_Lipoma Lipoma of Spermatic Cord Lipoma of the Spermatic Cord Spermatic Cord Lipoma Spermatic Cord Lipoma A chronic myelomonocytic leukemia characterized by a peripheral blood eosinophil count of equal or greater than 1.5x10E9/L, and absence of PDGFRA or PDGFRB gene abnormalities. C36060 Neoplastic Process Chronic Myelomonocytic Leukemia with Eosinophilia C1333045 Malignant Chronic_Myelomonocytic_Leukemia_with_Eosinophilia CMML with Eosinophilia Chronic Myelomonocytic Leukemia with Eosinophilia Chronic Myelomonocytic Leukemia with Eosinophilia A chronic myelomonocytic leukemia characterized by the presence of less than 10 percent blasts in the bone marrow and less than 5 percent blasts in the peripheral blood. C36061 Neoplastic Process Chronic Myelomonocytic Leukemia-1 C1333043 Malignant Chronic_Myelomonocytic_Leukemia-1 CMML-1 Chronic Myelomonocytic Leukemia-1 Chronic Myelomonocytic Leukemia-1 A chronic myelomonocytic leukemia characterized by the presence of 10-19 percent blasts in the bone marrow and 5-19 percent blasts in the peripheral blood or by the presence of Auer rods regardless of the blasts count. C36062 Neoplastic Process Chronic Myelomonocytic Leukemia-2 C1333044 Malignant Chronic_Myelomonocytic_Leukemia-2 CMML-2 Chronic Myelomonocytic Leukemia-2 Chronic Myelomonocytic Leukemia-2 A neoplasm that arises from the cervix and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include squamous papilloma, endocervical polyp, and rhabdomyoma. C3607 Neoplastic Process Benign Cervical Neoplasm C0153997 Benign Benign_Cervical_Neoplasm Benign Cervical Neoplasm Benign Cervix Uteri Neoplasm Benign Cervix Uteri Neoplasm NOS Benign Cervix Uteri Tumor Benign Neoplasm of Cervix Uteri Benign Neoplasm of Uterine Cervix Benign Neoplasm of the Cervix Uteri Benign Neoplasm of the Uterine Cervix Benign Tumor of Cervix Uteri Benign Tumor of Uterine Cervix Benign Tumor of the Cervix Uteri Benign Tumor of the Uterine Cervix Benign Uterine Cervix Neoplasm Benign Uterine Cervix Tumor Benign Cervical Neoplasm A small round cell tumor of the bone with neural differentiation that has spread from its original site of growth to another anatomic site. C36074 Neoplastic Process Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone C0855008 Malignant Metastatic_Peripheral_Primitive_Neuroectodermal_Tumor_of_Bone Metastatic Peripheral Neuroepithelioma of Bone Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone A rare histiocytic disorder of unknown etiology, characterized by distention of the lymph node sinuses and sinusoidal histiocytic infiltration. The histiocytes characteristically contain ingested lymphocytes and are S100 and CD68 positive, and CD1a negative. Patients present with cervical lymphadenopathy, fever, leukocytosis, and hypergammaglobulinemia. It can affect extranodal sites, including skin, bones, and the respiratory tract. It occurs in isolation or may be associated with autoimmune disorders or malignancies. Mutations in NRAS, KRAS, MAP2K1, and ARAF genes have been identified in affected tissues, suggesting a clonal origin in some cases. It is a self-limited disorder, although some patients may have a poor prognosis. C36075 Neoplastic Process Rosai-Dorfman-Destombes Disease C0019625 Undetermined Rosai-Dorfman_Disease Destombes-Rosai-Dorfman Disease RDD Rosai-Dorfman Disease Rosai-Dorfman-Destombes Disease SHML Sinus Histiocytosis with Massive Lymphadenopathy Rosai-Dorfman-Destombes Disease A primary or metastatic malignant neoplasm that affects the male or female reproductive system. Representative examples include prostate carcinoma, penile carcinoma, testicular seminoma, testicular embryonal carcinoma, endometrial carcinoma, cervical carcinoma, ovarian carcinoma, and uterine corpus leiomyosarcoma. C36076 Neoplastic Process Malignant Reproductive System Neoplasm C1334618 Malignant Malignant_Reproductive_System_Neoplasm Malignant Reproductive System Neoplasm Malignant Reproductive System Neoplasm A carcinoma that arises from the junction, or adjacent to the junction, of the right and left hepatic ducts. C36077 Neoplastic Process Hilar Cholangiocarcinoma Hilar Cholangiocarcinoma C0206702 CTRP Cellosaurus GDC Cancer that develops in cells that line the bile ducts in the liver, where the right and left ducts meet. It is a type of cholangiocarcinoma. Malignant Hilar_Cholangiocarcinoma 8162/3 Klatskin tumor Perihilar cholangiocarcinoma Hilar CC Hilar Cholangiocarcinoma Klatskin Tumor Klatskin tumor Perihilar Cholangiocarcinoma Hilar Cholangiocarcinoma A glomus tumor arising in the finger and usually associated with pain. C36079 Neoplastic Process Subungual Glomus Tumor C1304510 Undetermined Subungual_Glomus_Tumor Subungual Glomus Tumor Subungual Glomus Tumor A neoplasm that arises from the uterine corpus and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include leiomyoma, adenomyoma, endometrial stromal nodule, and endometrial polyp. C3608 Neoplastic Process Benign Uterine Corpus Neoplasm C0153998 Benign Benign_Uterine_Corpus_Neoplasm Benign Corpus Uteri Neoplasm Benign Corpus Uteri Tumor Benign Neoplasm of Body of Uterus Benign Neoplasm of Corpus Uteri Benign Neoplasm of Uterine Body Benign Neoplasm of Uterine Corpus Benign Neoplasm of the Body of Uterus Benign Neoplasm of the Corpus Uteri Benign Neoplasm of the Uterine Body Benign Neoplasm of the Uterine Corpus Benign Tumor of Body of Uterus Benign Tumor of Corpus Uteri Benign Tumor of Uterine Body Benign Tumor of Uterine Corpus Benign Tumor of the Body of Uterus Benign Tumor of the Corpus Uteri Benign Tumor of the Uterine Body Benign Tumor of the Uterine Corpus Benign Uterine Body Neoplasm Benign Uterine Body Tumor Benign Uterine Corpus Neoplasm Benign Uterine Corpus Tumor Benign Uterine Corpus Neoplasm A biologic subset of diffuse large B-cell lymphomas with a unique molecular signature or expression profile. It represents approximately 50% of diffuse large B-cell lymphomas, and is characterized by the expression of CD10, BCL-6, A-myb, and LMO2 genes, BCL-2 translocation, and c-REL amplification. Morphologically, the vast majority of these lymphomas are centroblastic and a small minority are immunoblastic (ratio20:1). Patients with this type of diffuse large B-cell lymphoma have a more favorable outcome, with a 5-year survival rate of 60% and a median survival of 10 years. C36080 Neoplastic Process Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type C1333295 Cellosaurus Malignant Diffuse_Large_B-Cell_Lymphoma_with_a_Germinal_Center_B-Cell_Expression_Profile DLBCL Germinal Center B-Cell Type Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type Diffuse Large B-Cell Lymphoma with a Germinal Center B-Cell Expression Profile GCB-DLBCL Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type A biologic subset of diffuse large B-cell lymphomas with a unique molecular signature or expression profile. It represents approximately 30% of diffuse large B-cell lymphomas, and is characterized by the expression of CD44, PKCbeta1, Cyclin D2, BCL-2, and IRF4/MUM1 genes. Morphologically, these lymphomas are either centroblastic or immunoblastic (ratio 2:1). Patients with this type of diffuse large B-cell lymphoma are reported to have a less favorable outcome compared to those with a germinal center B-cell expression profile, with a 5-year survival rate of 35% and a median survival of 2 years. C36081 Neoplastic Process Diffuse Large B-Cell Lymphoma Activated B-Cell Type Diffuse Large B-Cell Lymphoma Activated B-Cell Type C1333296 CTRP Cellosaurus Malignant Diffuse_Large_B-Cell_Lymphoma_with_an_Activated_B-Cell_Expression_Profile ABC DLBCL ABC-DLBCL Activated B-Cell-Like Diffuse Large B-Cell Lymphoma DLBCL Activated B-Cell Type Diffuse Large B-Cell Lymphoma Activated B-Cell Type Diffuse Large B-Cell Lymphoma Non-GC/ABC Diffuse Large B-Cell Lymphoma Non-Germinal Center/Activated B-Cell Type Diffuse Large B-Cell Lymphoma with an Activated B-Cell Expression Profile Non-GC/ABC DLBCL Diffuse Large B-Cell Lymphoma Activated B-Cell Type A carcinoma that has spread to the bone from another, primary anatomic site. Bone is one of the most frequent sites of metastatic carcinoma. Common sites of origin include lung, breast, and prostate. C36082 Neoplastic Process Metastatic Carcinoma in the Bone CL414683 Malignant Metastatic_Carcinoma_to_the_Bone Metastatic Carcinoma in the Bone Metastatic Carcinoma to the Bone Metastatic Carcinoma in the Bone A benign or malignant epithelial neoplasm that arises anywhere in the ductal system of the breast. This category includes intraductal papilloma, intraductal papillary carcinoma, ductal hyperplasia with or without atypia, and ductal carcinoma in situ. C36083 Neoplastic Process Breast Intraductal Neoplasm C0948967 Undetermined Intraductal_Breast_Neoplasm Breast Intraductal Neoplasm Intraductal Breast Neoplasm Breast Intraductal Neoplasm An invasive breast carcinoma characterized by the presence of clusters of malignant cells located within artifactual clear stromal spaces that resemble vascular spaces. C36084 Neoplastic Process Invasive Breast Micropapillary Carcinoma C3838947 Cellosaurus GDC Malignant Invasive_Micropapillary_Breast_Carcinoma 8507/3 Invasive micropapillary carcinoma Invasive micropapillary carcinoma of breast Infiltrating Micropapillary Breast Carcinoma Invasive Breast Micropapillary Carcinoma Invasive Micropapillary Breast Carcinoma Invasive Breast Micropapillary Carcinoma An invasive breast carcinoma characterized by the presence of papillary structures. C36085 Neoplastic Process Invasive Breast Papillary Carcinoma C1334280 8507/3 Malignant Invasive_Papillary_Breast_Carcinoma Infiltrating Papillary Breast Carcinoma Invasive Breast Papillary Carcinoma Invasive Papillary Breast Carcinoma Invasive Breast Papillary Carcinoma A breast lesion characterized by the presence of dilated terminal ductal lobular units in which the epithelial lining has been replaced by a single layer of mildly atypical cells, or there is atypical, monotonous epithelial hyperplasia of three to five layers. This lesion relates to columnar cell change with atypia and columnar cell hyperplasia with atypia. C36086 Neoplastic Process Breast Flat Ductal Epithelial Atypia C1333620 Undetermined Flat_Ductal_Epithelial_Atypia_of_the_Breast Breast Flat Ductal Epithelial Atypia Clinging Carcinoma Clinging Carcinoma In Situ DIN 1A Ductal Intraepithelial Neoplasia, Grade 1A FEA Flat Ductal Epithelial Atypia Flat Ductal Epithelial Atypia of the Breast Flat Epithelial Atypia Flat Epithelial Atypia of the Breast Breast Flat Ductal Epithelial Atypia A benign papillary neoplasm that arises in a large duct of the breast. It is characterized by the presence of a fibrovascular core that is lined by benign epithelial and myoepithelial proliferations. Patients usually present with nipple discharge. C36087 Neoplastic Process Breast Central Papilloma C1332896 Benign Central_Papilloma Breast Central Papilloma Central Breast Papilloma Large Duct Breast Papilloma Solitary Intraductal Breast Papilloma Breast Central Papilloma A benign papillary neoplasm that arises in a terminal ductal lobular unit. It is characterized by the presence of a fibrovascular core that is lined by benign epithelial and myoepithelial proliferations. Peripheral breast papillomas are often multiple and are usually found microscopically. Patients are often asymptomatic. C36088 Neoplastic Process Breast Peripheral Papilloma C1335390 Benign Peripheral_Papilloma Breast Peripheral Papilloma Microscopic Breast Papilloma Peripheral Breast Papilloma Breast Peripheral Papilloma An intraductal papilloma of the breast characterized by the presence of focal epithelial atypia. C36089 Neoplastic Process Atypical Breast Papilloma Breast Atypical Papilloma C1332346 CTRP Benign Atypical_Breast_Papilloma Atypical Breast Papilloma Breast Atypical Papilloma Intraductal Breast Papilloma with Atypia Breast Atypical Papilloma A neoplasm that arises from the uterine corpus or cervix and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include leiomyoma, adenomyoma, and endocervical polyp. C3609 Neoplastic Process Benign Uterine Neoplasm C0153999 Benign Benign_Uterine_Neoplasm Benign Neoplasm of Uterus Benign Neoplasm of the Uterus Benign Tumor of Uterus Benign Tumor of the Uterus Benign Uterine Neoplasm Benign Uterine Neoplasm NOS Benign Uterine Neoplasms Benign Uterine Tumor Benign Uterine Tumors Benign Uterus Neoplasm Benign Uterus Neoplasms Benign Uterus Tumor Benign Uterus Tumors Uterine Neoplasms, Benign Uterine Tumors, Benign Uterous Neoplasms, Benign Uterous Tumors, Benign Benign Uterine Neoplasm A benign or malignant papillary neoplasm that arises anywhere in the ductal system of the breast. It is characterized by the presence of fibrovascular structures lined by epithelial proliferations. This category includes intraductal papilloma and papillary ductal carcinoma in situ. C36090 Neoplastic Process Breast Intraductal Papillary Neoplasm C1334252 Undetermined Intraductal_Papillary_Breast_Neoplasm Breast Intraductal Papillary Neoplasm Intraductal Papillary Breast Neoplasm Breast Intraductal Papillary Neoplasm A mature teratoma that arises from the testis and is characterized by the presence of one or more cysts. The cysts are lined by squamous epithelium and contain skin appendages. Other teratomatous components may or may not be present. C36092 Neoplastic Process Testicular Dermoid Cyst C1336706 Benign Testicular_Dermoid_Cyst Testicular Dermoid Cyst Testicular Dermoid Cyst A cervical squamous cell carcinoma with minimal stromal invasion. The risk of lymph node metastasis is low. C36094 Neoplastic Process Early Invasive Cervical Squamous Cell Carcinoma C1333370 Malignant Early_Invasive_Cervical_Squamous_Cell_Carcinoma Early Invasive Cervical Squamous Cell Carcinoma Microinvasive Cervical Squamous Cell Carcinoma Early Invasive Cervical Squamous Cell Carcinoma A mucinous adenocarcinoma arising from the endocervical glandular epithelium. It is characterized by the presence of malignant glandular cells that contain significant amount of intracytoplasmic mucin. Histologic variants include intestinal-type, signet ring-type, gastric-type, cervical invasive stratified mucinous adenocarcinoma, and mucinous adenocarcinoma, not otherwise specified. All histologic variants except gastric-type adenocarcinoma are associated with human papillomavirus infection. C36095 Neoplastic Process Cervical Mucinous Adenocarcinoma C1332919 Malignant Cervical_Mucinous_Adenocarcinoma Cervical Mucinous Adenocarcinoma Cervical Mucinous Adenocarcinoma A cervical adenocarcinoma with minimal stromal invasion. The risk of local lymph node metastasis is insignificant and the prognosis is excellent. C36096 Neoplastic Process Early Invasive Cervical Adenocarcinoma C1333369 Malignant Early_Invasive_Cervical_Adenocarcinoma Cervical Microinvasive Adenocarcinoma Early Invasive Cervical Adenocarcinoma Early Invasive Cervical Adenocarcinoma An aggressive malignant mixed epithelial and mesenchymal neoplasm that arises from the cervix. It is characterized by the presence of malignant epithelial elements and malignant mesenchymal elements. C36097 Neoplastic Process Cervical Carcinosarcoma C1332917 Malignant Cervical_Malignant_Mixed_Mesodermal_Mullerian_Tumor Cervical Carcinosarcoma Cervical Malignant Mixed Mesodermal (Mullerian) Tumor Cervical Malignant Mixed Mesodermal (Müllerian) Tumor Cervical Carcinosarcoma A morphologic variant of embryonal rhabdomyosarcoma occurring in female children. The neoplasm arises from the vulva. It is characterized by the formation of a cambium layer in the affected tissue and polypoid nodules with an abundant myxoid stroma. C36098 Neoplastic Process Childhood Vulvar Botryoid-Type Embryonal Rhabdomyosarcoma C1332946 Malignant Childhood_Botryoid-Type_Embryonal_Rhabdomyosarcoma_of_the_Vulva Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva Childhood Sarcoma Botryoides of the Vulva Childhood Vulvar Botryoid-Type Embryonal Rhabdomyosarcoma Childhood Vulvar Embryonal Rhabdomyosarcoma Vulvar Childhood Botryoid-Type Embryonal Rhabdomyosarcoma Childhood Vulvar Botryoid-Type Embryonal Rhabdomyosarcoma A morphologic variant of embryonal rhabdomyosarcoma occurring in adults. The neoplasm arises from organs containing a mucosal epithelial surface. It is characterized by the formation of a cambium layer in the affected tissue and polypoid nodules with an abundant myxoid stroma. C36099 Neoplastic Process Adult Botryoid-Type Embryonal Rhabdomyosarcoma C1332185 Malignant Adult_Botryoid-Type_Embryonal_Rhabdomyosarcoma Adult Botryoid Sarcoma Adult Botryoid-Type Embryonal Rhabdomyosarcoma Adult Botryoid-Type Embryonal Rhabdomyosarcoma A neoplasm that arises from the vagina and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3610 Neoplastic Process Benign Vaginal Neoplasm C0154002 Benign Benign_Vaginal_Neoplasm Benign Neoplasm of Vagina Benign Neoplasm of the Vagina Benign Tumor of Vagina Benign Tumor of the Vagina Benign Vaginal Neoplasm Benign Vaginal Neoplasms Benign Vaginal Tumor Benign Vaginal Neoplasm Ovarian carcinoma that has developed in relatives of patients that have a history of ovarian carcinoma. C36102 Neoplastic Process Hereditary Ovarian Carcinoma Hereditary Ovarian Carcinoma C1333992 CTRP GDC Malignant Hereditary_Ovarian_Carcinoma Hereditary Ovarian Cancer Familial Ovarian Carcinoma Hereditary Ovarian Cancer Hereditary Ovarian Carcinoma Hereditary Ovarian Carcinoma Breast carcinoma that has developed in male relatives of patients with history of breast carcinoma. C36106 Neoplastic Process Hereditary Male Breast Carcinoma C1333988 Malignant Hereditary_Male_Breast_Carcinoma Familial Male Breast Carcinoma Hereditary Male Breast Carcinoma Hereditary Male Breast Carcinoma Breast carcinoma that has developed in female relatives of patients with history of breast carcinoma. C36107 Neoplastic Process Hereditary Female Breast Carcinoma C1333986 Cellosaurus Malignant Hereditary_Female_Breast_Carcinoma Familial Female Breast Carcinoma Hereditary Female Breast Carcinoma Hereditary Female Breast Carcinoma A neoplasm that arises from the vulva and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include cellular angiofibroma, melanocytic nevus, nodular hidradenoma, and Bartholin gland adenoma. C3611 Neoplastic Process Benign Vulvar Neoplasm C0154003 Benign Benign_Vulvar_Neoplasm Benign Neoplasm of Vulva Benign Neoplasm of the Vulva Benign Tumor of Vulva Benign Tumor of the Vulva Benign Vulva Neoplasm Benign Vulva Tumor Benign Vulval Neoplasm Benign Vulvar Neoplasm Benign Vulvar Tumor Benign Vulvar Neoplasm A neoplasm that arises from the testis and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3612 Neoplastic Process Benign Testicular Neoplasm C0154007 Benign Benign_Testicular_Neoplasm Benign Neoplasm of Testis Benign Neoplasm of the Testis Benign Testicular Neoplasm Benign Testicular Tumor Benign Tumor of Testis Benign Tumor of the Testis Benign Testicular Neoplasm A neoplasm that arises from the prostate and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include benign phyllodes tumor, leiomyoma, and fibroma. C3613 Neoplastic Process Benign Prostate Neoplasm C0154009 Benign Benign_Prostate_Neoplasm Benign Neoplasm of Prostate Benign Neoplasm of the Prostate Benign Prostate Neoplasm Benign Prostate Tumor Benign Prostatic Neoplasm Benign Tumor of Prostate Benign Tumor of the Prostate Benign Prostate Neoplasm A neoplasm that arises from the epididymis and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include adenomatoid tumor and leiomyoma. C3614 Neoplastic Process Benign Epididymal Neoplasm C0154010 Benign Benign_Epididymal_Neoplasm Benign Epididymal Neoplasm Benign Epididymal Tumor Benign Neoplasm of Epididymis Benign Neoplasm of the Epididymis Benign Tumor of Epididymis Benign Tumor of the Epididymis Benign Epididymal Neoplasm A neoplasm that arises from the scrotum and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3615 Neoplastic Process Benign Scrotal Neoplasm C0154011 Benign Benign_Scrotal_Neoplasm Benign Neoplasm of Scrotum Benign Neoplasm of the Scrotum Benign Scrotal Neoplasm Benign Scrotal Tumor Benign Tumor of Scrotum Benign Tumor of the Scrotum Benign Scrotal Neoplasm A neoplasm that arises from the renal pelvis and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3616 Neoplastic Process Benign Renal Pelvis Neoplasm C0154015 Benign Benign_Renal_Pelvis_Neoplasm Benign Kidney Pelvis Neoplasm Benign Neoplasm of Renal Pelvis Benign Neoplasm of the Renal Pelvis Benign Renal Pelvis Neoplasm Benign Renal Pelvis Tumor Benign Tumor of Renal Pelvis Benign Tumor of the Renal Pelvis Benign Renal Pelvis Neoplasm A neoplasm that arises from the ureter and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3617 Neoplastic Process Benign Ureter Neoplasm C0154016 Benign Benign_Ureter_Neoplasm Benign Neoplasm of Ureter Benign Neoplasm of the Ureter Benign Tumor of Ureter Benign Tumor of the Ureter Benign Ureter Neoplasm Benign Ureter Tumor Benign Ureteral Neoplasm Benign Ureteral Tumor Benign Ureteric Neoplasm Benign Ureteric Neoplasm NOS Benign Ureter Neoplasm A neoplasm that arises from the bladder and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3618 Neoplastic Process Benign Bladder Neoplasm C0154017 CPTAC Benign Benign_Bladder_Neoplasm Benign neoplasm of bladder Benign Bladder Neoplasm Benign Bladder Tumor Benign Neoplasm of Bladder Benign Neoplasm of Urinary Bladder Benign Neoplasm of the Bladder Benign Neoplasm of the Urinary Bladder Benign Tumor of Bladder Benign Tumor of Urinary Bladder Benign Tumor of the Bladder Benign Tumor of the Urinary Bladder Benign Urinary Bladder Neoplasm Benign Urinary Bladder Tumor Benign Bladder Neoplasm A neoplasm that arises from the urethra and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3619 Neoplastic Process Benign Urethral Neoplasm C0154019 Benign Benign_Urethral_Neoplasm Benign Neoplasm of Urethra Benign Neoplasm of the Urethra Benign Tumor of Urethra Benign Tumor of the Urethra Benign Urethra Neoplasm Benign Urethra Tumor Benign Urethral Neoplasm Benign Urethral Neoplasm NOS Benign Urethral Tumor Benign Urethral Neoplasm A neoplasm that arises from the orbit and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3620 Neoplastic Process Benign Orbit Neoplasm C0154023 CPTAC Benign Benign_Orbit_Neoplasm Benign neoplasm of unspecified site of unspecified orbit Benign Neoplasm of Orbit Benign Neoplasm of the Orbit Benign Orbit Neoplasm Benign Orbit Tumor Benign Orbital Neoplasm Benign Orbital Tumor Benign Tumor of Orbit Benign Tumor of the Orbit Benign Orbit Neoplasm A sporadic or less frequently familial neoplasm that arises from the glandular epithelium of the gastrointestinal tract and liver. In the gastrointestinal tract, it manifests as a polypoid or flat circumscribed lesion. Morphologically, it is characterized by a proliferation of neoplastic glandular cells and is associated with dysplasia. Based on the growth pattern, it may be classified as tubular, villous, or tubulovillous. The dysplasia is classified as mild, moderate, or severe. The frequency of malignant transformation depends on the size of the lesion and the degree of dysplasia. Larger gastrointestinal tract adenomas with severe dysplastic changes carry a higher risk of progression to invasive adenocarcinoma. Gastrointestinal adenomas may present as solitary or multifocal lesions. In the liver, it arises from the hepatocytes. Grossly, it appears as a soft, round mass. Morphologically, the neoplastic cells resemble normal hepatocytes. C36207 Neoplastic Process Digestive System Adenoma C0948101 Benign Gastrointestinal_Adenoma Digestive System Adenoma GI System Adenoma Gastrointestinal System Adenoma Digestive System Adenoma A neoplasm that arises from the lacrimal gland and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3621 Neoplastic Process Benign Lacrimal Gland Neoplasm C0154024 Benign Benign_Lacrimal_Gland_Neoplasm Benign Lacrimal Gland Neoplasm Benign Lacrimal Gland Tumor Benign Neoplasm of Lacrimal Gland Benign Neoplasm of the Lacrimal Gland Benign Tumor of Lacrimal Gland Benign Tumor of the Lacrimal Gland Benign Lacrimal Gland Neoplasm A neoplasm that arises from the conjunctiva and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3622 Neoplastic Process Benign Conjunctival Neoplasm C0154025 Benign Benign_Conjunctival_Neoplasm Benign Conjunctiva Neoplasm Benign Conjunctiva Tumor Benign Conjunctival Neoplasm Benign Conjunctival Tumor Benign Neoplasm of Conjunctiva Benign Neoplasm of the Conjunctiva Benign Tumor of Conjunctiva Benign Tumor of the Conjunctiva Benign Conjunctival Neoplasm A neoplasm that arises from the cornea and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3623 Neoplastic Process Benign Corneal Neoplasm C0154026 Benign Benign_Corneal_Neoplasm Benign Cornea Neoplasm Benign Cornea Tumor Benign Corneal Neoplasm Benign Corneal Tumor Benign Neoplasm of Cornea Benign Neoplasm of the Cornea Benign Tumor of Cornea Benign Tumor of the Cornea Benign Corneal Neoplasm A neoplasm that arises from the retina and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3624 Neoplastic Process Benign Retinal Neoplasm C0154027 Benign Benign_Retinal_Neoplasm Benign Neoplasm of Retina Benign Neoplasm of the Retina Benign Retina Neoplasm Benign Retina Tumor Benign Retinal Neoplasm Benign Retinal Tumor Benign Tumor of Retina Benign Tumor of the Retina Benign Retinal Neoplasm A neoplasm that arises from the choroid and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3625 Neoplastic Process Benign Choroid Neoplasm C0154028 Benign Benign_Choroid_Neoplasm Benign Choroid Neoplasm Benign Choroid Tumor Benign Neoplasm of Choroid Benign Neoplasm of the Choroid Benign Tumor of Choroid Benign Tumor of the Choroid Benign Choroid Neoplasm A neoplasm that arises from the lacrimal duct and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3626 Neoplastic Process Benign Nasolacrimal Duct Neoplasm C0154029 Benign Benign_Lacrimal_Duct_Neoplasm Benign Lacrimal Duct Neoplasm Benign Lacrimal Duct Tumor Benign Nasolacrimal Duct Neoplasm Benign Neoplasm of Lacrimal Duct Benign Neoplasm of the Lacrimal Duct Benign Tumor of Lacrimal Duct Benign Tumor of the Lacrimal Duct Benign Nasolacrimal Duct Neoplasm Hereditary clear cell renal cell carcinoma associated with biallelic loss/inactivation of the von Hippel-Lindau tumor suppressor gene. C36260 Neoplastic Process Hereditary Clear Cell Renal Cell Carcinoma Hereditary Clear Cell Renal Cell Carcinoma C1333985 CTRP Malignant Hereditary_Conventional_Clear_Cell_Renal_Cell_Carcinoma Hereditary Clear Cell Renal Cell Cancer Hereditary Clear Cell Renal Cell Carcinoma Hereditary Conventional (Clear Cell) Renal Cell Carcinoma Von Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma Hereditary Clear Cell Renal Cell Carcinoma The most common type of renal cell carcinoma, characterized by a loss of genetic material of the short arm of chromosome 3. The most common symptom at the time of diagnosis is hematuria. The tumor has a golden-yellow color because of the abundance of intracytoplasmic lipid. This is a clinically aggressive type of renal cell carcinoma. The tumor usually metastasizes to unusual sites and late metastasis is common. C36261 Neoplastic Process Non-Hereditary Clear Cell Renal Cell Carcinoma C1334978 Malignant Non-Hereditary_Conventional_Clear_Cell_Renal_Cell_Carcinoma Non-Hereditary Clear Cell Renal Cell Carcinoma Non-Hereditary Conventional (Clear Cell) Renal Cell Carcinoma Sporadic Clear Cell Renal Cell Carcinoma Sporadic Conventional (Clear Cell) Renal Cell Carcinoma Non-Hereditary Clear Cell Renal Cell Carcinoma The most common variant of adult T-cell leukemia/lymphoma. It is characterized by systemic disease with a leukemic phase, generalized lymphadenopathy, and skin lesions. Hypercalcemia is commonly seen. C36265 Neoplastic Process Acute Adult T-Cell Leukemia/Lymphoma Acute Adult T-Cell Leukemia/Lymphoma C1332146 CTRP Malignant Acute_Adult_T-Cell_Lymphoma_Leukemia Acute Adult T-Cell Leukemia/Lymphoma Acute Adult T-Cell Lymphoma/Leukemia Acute Adult T-Cell Leukemia/Lymphoma An adult T-cell leukemia/lymphoma characterized by generalized lymphadenopathy without peripheral blood involvement. Most patients have advanced disease, however hypercalcemia is not frequently present. C36266 Neoplastic Process Lymphomatous Adult T-Cell Leukemia/Lymphoma Lymphomatous Adult T-Cell Leukemia/Lymphoma C1334466 CTRP Malignant Lymphomatous_Adult_T-Cell_Lymphoma_Leukemia Lymphomatous Adult T-Cell Leukemia/Lymphoma Lymphomatous Adult T-Cell Lymphoma/Leukemia Lymphomatous Adult T-Cell Leukemia/Lymphoma A rare morphologic variant of adult T-cell leukemia/lymphoma characterized by the presence of Hodgkin-like and Reed-Sternberg-like cells. C36268 Neoplastic Process Hodgkin-Like Adult T-Cell Leukemia/Lymphoma C1334035 Malignant Hodgkin_s-Like_Adult_T-Cell_Lymphoma_Leukemia Hodgkin's-Like Adult T-Cell Lymphoma/Leukemia Hodgkin-Like Adult T-Cell Leukemia/Lymphoma Hodgkin-Like Adult T-Cell Lymphoma/Leukemia Hodgkin-Like Adult T-Cell Leukemia/Lymphoma A neoplasm that arises from the spinal cord and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3627 Neoplastic Process Benign Spinal Cord Neoplasm C0154034 mCode Benign Benign_Spinal_Cord_Neoplasm Benign Neoplasm of Spinal Cord Benign Neoplasm of the Spinal Cord Benign Spinal Cord Neoplasm Benign Spinal Cord Tumor Benign Tumor of Spinal Cord Benign Tumor of the Spinal Cord Benign neoplasm of spinal cord Spinal Cord Neoplasm, Benign Benign Spinal Cord Neoplasm A T-cell prolymphocytic leukemia characterized by the presence of small neoplastic prolymphocytes often with invisible nucleolus by light microscopy. C36270 Neoplastic Process T-Cell Prolymphocytic Leukemia, Small Cell Variant C1336552 Malignant T-Cell_Prolymphocytic_Leukemia_Small_Cell_Variant T-Cell Prolymphocytic Leukemia, Small Cell Variant T-Cell Prolymphocytic Leukemia, Small Cell Variant A T-cell prolymphocytic leukemia characterized by the presence of neoplastic prolymphocytes with irregular or cerebriform nuclear outline. C36271 Neoplastic Process T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant C1336551 Malignant T-Cell_Prolymphocytic_Leukemia_Cerebriform_Cell_Variant T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant T-Cell Prolymphocytic Leukemia, Sezary Cell-like Variant T-Cell Prolymphocytic Leukemia, Sézary Cell-like Variant T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant A chronic lymphocytic leukemia characterized by the presence of neoplastic lymphocytes with plasmacytoid morphology. C36272 Neoplastic Process Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation C1333040 Malignant Chronic_Lymphocytic_Leukemia_with_Plasmacytoid_Differentiation Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation A small lymphocytic lymphoma characterized by the presence of neoplastic lymphocytes with plasmacytoid morphology. C36273 Neoplastic Process Small Lymphocytic Lymphoma with Plasmacytoid Differentiation C1336012 Malignant Small_Lymphocytic_Lymphoma_with_Plasmacytoid_Differentiation Small Lymphocytic Lymphoma with Plasmacytoid Differentiation Small Lymphocytic Lymphoma with Plasmacytoid Differentiation A neoplasm that arises from the thyroid gland and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3628 Neoplastic Process Benign Thyroid Gland Neoplasm C0154038 CPTAC Benign Benign_Thyroid_Neoplasm Benign neoplasm of thyroid glands Benign Neoplasm of Thyroid Benign Neoplasm of Thyroid Gland Benign Neoplasm of Thyroid Glands Benign Neoplasm of the Thyroid Benign Neoplasm of the Thyroid Gland Benign Thyroid Gland Neoplasm Benign Thyroid Gland Tumor Benign Thyroid Neoplasm Benign Thyroid Neoplasm NOS Benign Thyroid Tumor Benign Tumor of Thyroid Benign Tumor of Thyroid Gland Benign Tumor of the Thyroid Benign Tumor of the Thyroid Gland Thyroid Neoplasm, Benign Benign Thyroid Gland Neoplasm A neoplasm that arises from the adrenal gland and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3629 Neoplastic Process Benign Adrenal Gland Neoplasm Benign Adrenal Gland Neoplasm C0154040 CPTAC CTRP Benign Benign_Adrenal_Gland_Neoplasm Benign neoplasm of left adrenal gland Benign neoplasm of unspecified adrenal gland Benign Adrenal Gland Neoplasm Benign Adrenal Gland Tumor Benign Adrenal Neoplasm Benign Adrenal Tumor Benign Neoplasm of Adrenal Gland Benign Neoplasm of the Adrenal Gland Benign Tumor of Adrenal Gland Benign Tumor of the Adrenal Gland Benign Adrenal Gland Neoplasm A neoplasm that arises from the parathyroid glands and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3630 Neoplastic Process Benign Parathyroid Gland Neoplasm C0154041 Cellosaurus Benign Benign_Parathyroid_Neoplasm Benign Neoplasm of Parathyroid Benign Neoplasm of Parathyroid Gland Benign Neoplasm of the Parathyroid Benign Neoplasm of the Parathyroid Gland Benign Parathyroid Gland Neoplasm Benign Parathyroid Gland Tumor Benign Parathyroid Neoplasm Benign Parathyroid Tumor Benign Tumor of Parathyroid Benign Tumor of Parathyroid Gland Benign Tumor of the Parathyroid Benign Tumor of the Parathyroid Gland Parathyroid Tumor Benign Benign Parathyroid Gland Neoplasm A carcinoma that arises from the breast and has metastasized to the lung. C36300 Neoplastic Process Breast Carcinoma Metastatic in the Lung Metastatic Breast Carcinoma in the Lung C1332626 CTRP Malignant Breast_Carcinoma_Metastatic_to_the_Lung Breast Carcinoma Metastatic in the Lung Breast Carcinoma Metastatic to the Lung Metastatic Breast Cancer in the Lung Metastatic Breast Carcinoma in the Lung Metastatic Breast Carcinoma in the Lung A carcinoma that has spread to the brain from its original site in the breast, through the hematogenous route. C36301 Neoplastic Process Breast Carcinoma Metastatic in the Brain Metastatic Breast Carcinoma in the Brain C1332624 CTRP Malignant Breast_Carcinoma_Metastatic_to_the_Brain Breast Carcinoma Metastatic in the Brain Breast Carcinoma Metastatic to the Brain Metastatic Breast Cancer in the Brain Metastatic Breast Carcinoma in the Brain Metastatic Breast Carcinoma in the Brain A carcinoma that originates from the breast and has spread to the liver. C36302 Neoplastic Process Breast Carcinoma Metastatic in the Liver Metastatic Breast Carcinoma in the Liver C1332625 CTRP Malignant Breast_Carcinoma_Metastatic_to_the_Liver Breast Carcinoma Metastatic in the Liver Breast Carcinoma Metastatic to the Liver Metastatic Breast Cancer in the Liver Metastatic Breast Carcinoma in the Liver Metastatic Breast Carcinoma in the Liver A carcinoma that arises from the breast and has metastasized to the bone. C36303 Neoplastic Process Breast Carcinoma Metastatic in the Bone Metastatic Breast Carcinoma in the Bone C1332623 CTRP Malignant Breast_Carcinoma_Metastatic_to_the_Bone Breast Carcinoma Metastatic in the Bone Breast Carcinoma Metastatic to the Bone Metastatic Breast Cancer in the Bone Metastatic Breast Carcinoma in the Bone Metastatic Breast Carcinoma in the Bone A carcinoma that has spread to the brain from its original site in the lung, through the hematogenous route. C36304 Neoplastic Process Metastatic Lung Carcinoma in the Brain C1334441 Malignant Lung_Carcinoma_Metastatic_to_the_Brain Lung Carcinoma Metastatic in the Brain Lung Carcinoma Metastatic to the Brain Metastatic Lung Carcinoma in the Brain Metastatic Lung Carcinoma in the Brain A carcinoma that arises from the lung and has metastasized to the bone. C36305 Neoplastic Process Metastatic Lung Carcinoma in the Bone C1334440 Malignant Lung_Carcinoma_Metastatic_to_the_Bone Lung Carcinoma Metastatic in the Bone Lung Carcinoma Metastatic to the Bone Metastatic Lung Carcinoma in the Bone Metastatic Lung Carcinoma in the Bone A carcinoma that originates from the lung and has spread to the liver. C36306 Neoplastic Process Metastatic Lung Carcinoma in the Liver C1334442 Malignant Lung_Carcinoma_Metastatic_to_the_Liver Lung Carcinoma Metastatic in the Liver Lung Carcinoma Metastatic to the Liver Metastatic Lung Carcinoma in the Liver Metastatic Lung Carcinoma in the Liver A carcinoma that arises from the prostate gland and has spread to the lungs. C36307 Neoplastic Process Prostate Carcinoma Metastatic in the Lung C1335506 Malignant Prostate_Carcinoma_Metastatic_to_the_Lung Prostate Carcinoma Metastatic in the Lung Prostate Carcinoma Metastatic to the Lung Prostate Carcinoma Metastatic in the Lung A carcinoma that arises from the prostate gland and has spread to the bone. C36308 Neoplastic Process Prostate Carcinoma Metastatic in the Bone C1335505 Malignant Prostate_Carcinoma_Metastatic_to_the_Bone Prostate Carcinoma Metastatic in the Bone Prostate Carcinoma Metastatic to the Bone Prostate Carcinoma Metastatic in the Bone A carcinoma that originates from the colonic wall and has spread to the liver. C36309 Neoplastic Process Colon Carcinoma Metastatic in the Liver C1333085 Malignant Colon_Carcinoma_Metastatic_to_the_Liver Colon Carcinoma Metastatic in the Liver Colon Carcinoma Metastatic to the Liver Colon Carcinoma Metastatic in the Liver A neoplasm that arises from the pineal region and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3631 Neoplastic Process Benign Pineal Region Neoplasm Benign Pineal Region Neoplasm C0154043 CTRP Benign Benign_Pineal_Region_Neoplasm Benign Neoplasm of Pineal Parenchyma Benign Neoplasm of the Pineal Parenchyma Benign Pineal Area Neoplasm Benign Pineal Area Tumor Benign Pineal Parenchymal Neoplasm Benign Pineal Parenchymal Tumor Benign Pineal Region Neoplasm Benign Pineal Region Tumor Benign Tumor of Pineal Parenchyma Benign Tumor of the Pineal Parenchyma Pineal Parenchymal Neoplasms, Benign Benign Pineal Region Neoplasm A B-cell acute leukemia characterized by the presence of lymphoblasts that carry a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome. C36312 Neoplastic Process B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 C0023453 CTRP Cellosaurus Malignant Philadelphia_Positive_Acute_Lymphoblastic_Leukemia Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive B Acute Lymphoblastic Leukemia with BCR-ABL1 Fusion B Acute Lymphoblastic Leukemia with BCR::ABL1 Fusion B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR::ABL1 B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1 B-Acute Lymphoblastic Leukemia with BCR-ABL1 Fusion B-Acute Lymphoblastic Leukemia with BCR::ABL1 Fusion B-Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 B-Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR::ABL1 B-Cell Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1 Philadelphia Positive Acute Lymphoblastic Leukemia Philadelphia Positive Precursor Lymphoblastic Leukemia B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 A hemangioma arising from the brain and meninges. C3633 Neoplastic Process Intracranial Hemangioma Intracranial Hemangioma C0154050 CTRP mCode Benign Intracranial_Hemangioma Angioma of Intracranial Structure Angioma of the Intracranial Structure Hemangioma of Intracranial Structure Hemangioma of intracranial structures Hemangioma of the Intracranial Structure Intracranial Angioma Intracranial Hemangioma Intracranial Hemangioma A hemangioma arising from organs within the abdominal cavity. C3635 Neoplastic Process Intra-Abdominal Hemangioma C0154052 NICHD Benign Intra-Abdominal_Hemangioma Hemangioma of Intra-Abdominal Structure Hemangioma, Intra-Abdominal Intra-Abdominal Hemangioma Intra-Abdominal Hemangioma A neoplasm that arises from the lymph nodes and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3636 Neoplastic Process Benign Lymph Node Neoplasm C0154054 Benign Benign_Lymph_Node_Neoplasm Benign Lymph Node Neoplasm Benign Lymph Node Neoplasm NOS Benign Lymph Node Tumor Benign Neoplasm of Lymph Node Benign Neoplasm of the Lymph Node Benign Tumor of Lymph Node Benign Tumor of the Lymph Node Benign Lymph Node Neoplasm Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C3637 Neoplastic Process Stage 0 Esophageal Cancer AJCC v6 Stage 0 Esophageal Cancer AJCC v6 C2981160 CTRP Malignant Stage_0_Esophageal_Cancer Carcinoma in situ of Esophagus AJCC v6 Carcinoma in situ of the Esophagus AJCC v6 Esophageal Cancer Stage 0 AJCC v6 Esophageal Carcinoma Stage 0 AJCC v6 Esophageal Carcinoma in situ AJCC v6 Esophagus Carcinoma in situ AJCC v6 Oesophageal Carcinoma NOS Stage 0 AJCC v6 Severe Esophageal Dysplasia AJCC v6 Stage 0 Carcinoma of Esophagus AJCC v6 Stage 0 Carcinoma of the Esophagus AJCC v6 Stage 0 Esophageal Cancer Stage 0 Esophageal Cancer AJCC v6 Stage 0 Esophageal Carcinoma AJCC v6 Stage 0 Esophagus Carcinoma AJCC v6 Stage 0 Esophageal Cancer AJCC v6 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial or invasion of lamina propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C3638 Neoplastic Process Stage 0 Colon Cancer AJCC v6 and v7 Stage 0 Colon Cancer AJCC v6 and v7 C0154061 CPTAC CTRP mCode Malignant Stage_0_Colon_Cancer Carcinoma in situ of colon Carcinoma in situ: Colon Carcinoma in situ of Colon Carcinoma in situ of colon Carcinoma in situ of the Colon Colon Cancer Stage 0 Colon Carcinoma in situ Colonic Carcinoma in situ Stage 0 Carcinoma of Colon Stage 0 Carcinoma of the Colon Stage 0 Colon Cancer Stage 0 Colon Cancer AJCC v6 Stage 0 Colon Cancer AJCC v6 and v7 Stage 0 Colon Cancer AJCC v7 Stage 0 Colon Carcinoma Stage 0 Colonic Carcinoma Stage 0 Colon Cancer AJCC v6 and v7 A carcinoma that arises from the tracheal mucosa and is confined to the epithelial layer without evidence of further tissue invasion. C3639 Neoplastic Process Tracheal Carcinoma In Situ C0154070 CPTAC mCode Malignant Tracheal_Carcinoma_in_situ Carcinoma in situ of trachea Carcinoma in situ of Trachea Carcinoma in situ of the Trachea Carcinoma in situ of trachea Severe Epithelial Dysplasia of Trachea Trachea Carcinoma in situ Tracheal Carcinoma In Situ Tracheal Carcinoma In Situ Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. (AJCC 6th and 7th eds.) C3640 Neoplastic Process Stage 0 Skin Cancer Stage 0 Skin Cancer C0154073 CPTAC CTRP mCode Abnormal cells are found in the lower part of the epidermis (the outer layer of the skin). These abnormal cells may become cancer and spread into nearby normal tissue. Malignant Stage_0_Skin_Cancer Carcinoma in situ of skin of other and unspecified parts of face Carcinoma in situ of skin, site unspecified Carcinoma in situ of Skin Carcinoma in situ of skin, unspecified Carcinoma in situ of the Skin Carcinoma of Skin Stage 0 Carcinoma of the Skin Stage 0 Cutaneous Carcinoma in situ Skin Cancer Stage 0 Skin Carcinoma Stage 0 Skin Carcinoma in situ Stage 0 Skin Cancer Stage 0 Skin Cancer AJCC v6 Stage 0 Skin Cancer AJCC v7 Stage 0 Skin Carcinoma nonmelanoma carcinoma in situ stage 0 nonmelanoma skin carcinoma in situ Stage 0 Skin Cancer Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C3641 Neoplastic Process Stage 0 Breast Cancer AJCC v6 and v7 Stage 0 Breast Cancer AJCC v6 and v7 C0154084 CPTAC CTRP mCode There are 2 types of stage 0 breast carcinoma in situ: ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS). DCIS is a noninvasive condition in which abnormal cells are found in the lining of a breast duct (a tube that carries milk to the nipple). The abnormal cells have not spread outside the duct to other tissues in the breast. In some cases, DCIS may become invasive cancer and spread to other tissues, although it is not known how to predict which lesions will become invasive cancer. LCIS is a condition in which abnormal cells are found in the lobules (small sections of tissue involved with making milk) of the breast. This condition seldom becomes invasive cancer; however, having LCIS in one breast increases the risk of developing breast cancer in either breast. Malignant Stage_0_Breast_Cancer Carcinoma in situ of breast Carcinoma in situ of breast and genitourinary system Carcinoma in situ of breast, unspecified Other specified type of carcinoma in situ of breast Breast Cancer Stage 0 Breast Cancer in situ Breast Carcinoma in situ Carcinoma in situ of Breast Carcinoma in situ of breast Carcinoma in situ of the Breast In situ Breast Cancer Non-Infiltrating Breast Carcinoma Non-Infiltrating Carcinoma of Breast Non-Infiltrating Carcinoma of the Breast Non-Invasive Breast Carcinoma Non-Invasive Carcinoma of Breast Non-Invasive Carcinoma of the Breast Stage 0 Breast Cancer Stage 0 Breast Cancer AJCC v6 Stage 0 Breast Cancer AJCC v6 and v7 Stage 0 Breast Cancer AJCC v7 Stage 0 Breast Carcinoma Stage 0 Carcinoma of Breast Stage 0 Carcinoma of the Breast Unspecified type of carcinoma in situ of breast Unspecified type of carcinoma in situ of unspecified breast breast cancer in situ stage 0 breast carcinoma in situ Stage 0 Breast Cancer AJCC v6 and v7 High grade prostatic intraepithelial neoplasia characterized by the presence of severe architectural and cytologic abnormalities. C3642 Neoplastic Process Grade III Prostatic Intraepithelial Neoplasia C0154088 CPTAC GDC mCode Malignant Grade_III_Prostatic_Intraepithelial_Neoplasia 8148/2 Carcinoma in situ of prostate Carcinoma in situ: Prostate PIN III Prostatic intraepithelial neoplasia, grade III Adenocarcinoma in situ of Prostate Adenocarcinoma in situ of the Prostate Carcinoma in situ of prostate Grade 3 PIN Grade 3 Prostatic Intraepithelial Neoplasia Grade III PIN Grade III Prostatic Intraepithelial Neoplasia PIN III Prostate Adenocarcinoma in situ Prostatic intraepithelial neoplasia, grade III Grade III Prostatic Intraepithelial Neoplasia Stage 0 includes: (Tis, N0, M0) and (Ta, N0, M0). Tis: Carcinoma in situ. Ta: Non-invasive verrucous carcinoma. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C3643 Neoplastic Process Stage 0 Penile Cancer AJCC v6 Stage 0 Penile Cancer AJCC v6 CL449077 CTRP Malignant Stage_0_Penile_Cancer Stage 0 Carcinoma of Penis AJCC v6 Stage 0 Carcinoma of the Penis AJCC v6 Stage 0 Penile Cancer Stage 0 Penile Cancer AJCC v6 Stage 0 Penile Carcinoma AJCC v6 Stage 0 Penile Cancer AJCC v6 Stage 0is includes: Tis, N0, M0. Tis: Carcinoma in situ: "flat tumor". N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C3644 Neoplastic Process Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7 Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7 C0154091 CTRP Malignant Stage_0is_Bladder_Cancer Bladder Flat CIS Bladder Flat Carcinoma in Situ Carcinoma in situ of Urinary Bladder Carcinoma in situ of the Urinary Bladder Flat CIS of the Bladder Flat CIS of the Urinary Bladder Flat Carcinoma in Situ of the Bladder Flat Carcinoma in Situ of the Urinary Bladder High Grade Bladder Intraurothelial Neoplasia Stage 0is Bladder Cancer Stage 0is Bladder Carcinoma Stage 0is Bladder Urothelial Cancer Stage 0is Bladder Urothelial Carcinoma Stage 0is Bladder Urothelial Carcinoma AJCC v6 Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7 Stage 0is Bladder Urothelial Carcinoma AJCC v7 Stage 0is Carcinoma of Bladder Stage 0is Carcinoma of Urinary Bladder Stage 0is Carcinoma of the Bladder Stage 0is Carcinoma of the Urinary Bladder Stage 0is Urinary Bladder Carcinoma Urinary Bladder Flat CIS Urinary Bladder Flat Carcinoma in Situ Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7 Late radiation injury (LRI) is the damage to the soft tissue and bone following radiation therapy that occurs weeks and years after the radiation exposure. Pathogenesis of LRI stems from ischemia, interruption of the blood supply and direct cell damage. LRIs include but not limited to the skin atrophy, ulceration and non-healing wounds; cystitis, proctosigmoiditis, resulting to fistulas, abscesses, fibrosis and scaring; laryngitis, osteoradionecrosis; central nervous system injury, optic neuropathy. C3665 Finding Late Radiation Injury C0160814 Late_Radiation_Injury Late Radiation Injury Late Radiation Injury A benign or malignant, primary or metastatic neoplasm affecting the male and female reproductive system. C3674 Neoplastic Process Reproductive System Neoplasm C0178830 CPTAC Undetermined Reproductive_System_Neoplasm Neoplasm of unspecified nature of other genitourinary organs Neoplasm of Reproductive System Neoplasm of the Reproductive System Reproductive Neoplasm Reproductive System Neoplasm Reproductive System Tumor Reproductive Tumor Tumor of Reproductive System Tumor of the Reproductive System Reproductive System Neoplasm A rare adenocarcinoma of the major and minor salivary glands, originating from basaloid, myoepithelial and ductal cells. While morphologically resembling basal cell carcinomas, it is a distinct entity. The tumor is not encapsulated, may invade locally, and less frequently may metastasize. It usually occurs in older patients. C3678 Neoplastic Process Salivary Gland Basal Cell Adenocarcinoma C0205641 GDC 8147/3 Malignant Salivary_Gland_Basal_Cell_Adenocarcinoma 8147/3 Basal cell adenocarcinoma Basal Cell Adenocarcinoma Basal Cell Adenocarcinoma of Salivary Gland Basal Cell Adenocarcinoma of the Salivary Gland Basal cell adenocarcinoma Salivary Gland Basal Cell Adenocarcinoma Salivary Gland Basal Cell Adenocarcinoma An aggressive adenocarcinoma that arises from the sweat glands. It usually presents as a firm, erythematous nodular lesion in the axilla. Morphologically, it is characterized by the presence of tubular structures and apocrine differentiation. C3682 Neoplastic Process Sweat Gland Tubular Carcinoma C1883403 Malignant Tubular_Adenocarcinoma Sweat Gland Tubular Adenocarcinoma Sweat Gland Tubular Carcinoma Sweat Gland Tubular Carcinoma A benign epithelial neoplasm arising from the salivary glands. It is characterized by the presence of a monomorphic cellular infiltrate. C3686 Neoplastic Process Salivary Gland Monomorphic Adenoma C0205649 GDC 8146/0 Benign Salivary_Gland_Monomorphic_Adenoma 8146/0 Monomorphic adenoma Salivary Gland Monomorphic Adenoma Salivary Gland Monomorphic Adenoma A low grade, unencapsulated neoplasm with papillary, tubular, or tubulopapillary architecture, less than 15 mm in size. C3687 Neoplastic Process Renal Papillary Adenoma C1518879 Benign Papillary_Adenoma Chromophil Adenoma of the Kidney Papillary Adenoma of the Kidney Renal Papillary Adenoma Renal Papillary Adenoma An invasive mixed adenoneuroendocrine carcinoma of the appendix characterized by a submucosal growth and the presence of neoplastic signet-ring cells resembling goblet cells of the intestine. C3689 Neoplastic Process Appendix Goblet Cell Adenocarcinoma CL512511 8243/3 Malignant Goblet_Cell_Carcinoid_Tumor Appendix Adenocarcinoid Tumor Appendix Goblet Cell Adenocarcinoma Appendix Goblet Cell Carcinoid Appendix Goblet Cell Carcinoid Tumor Appendix Mixed Carcinoid-Adenocarcinoma Appendix Mucinous Carcinoid Tumor Appendix Goblet Cell Adenocarcinoma Solitary or multiple, slightly raised pigmented melanocytic lesions with irregular borders, usually measuring more than 0.6cm in greatest dimension. Morphologically, there is melanocytic atypia and the differential diagnosis from melanoma may be difficult. Patients are at an increased risk for the development of melanoma. C3694 Neoplastic Process Dysplastic Nevus Dysplastic Nevus C0205748 CTRP GDC A type of nevus (mole) that looks different from a common mole. A dysplastic nevus is often larger with borders that are not easy to see. Its color is usually uneven and can range from pink to dark brown. Parts of the mole may be raised above the skin surface. A dysplastic nevus may develop into malignant melanoma (a type of skin cancer). 8727/0 Undetermined Dysplastic_Nevus 8727/0 Dysplastic nevus Atypical Nevus Clark Nevus Clark's Nevus Dysplastic Nevus Dysplastic nevus NAD Nevus with Architectural Disorder Nevus with Architectural Disorder and Cytologic Atypia of Melanocytes dysplastic nevi dysplastic nevus Dysplastic Nevus A rare benign neoplasm of the endocardium. The vast majority of cases arise in the heart valves. Histopathologic examination reveals a papilloma lined by endothelial cells with a central avascular core which contains fibroblasts and elastic fibers. Patients may be asymptomatic or present with ischemic or embolic events. C3695 Neoplastic Process Papillary Fibroelastoma C1947920 Benign Papillary_Fibroelastoma Fibroelastic Papilloma Giant Lambl Excrescence Papillary Fibroelastoma Papillary Fibroelastoma A benign, slowly growing tumor (WHO grade I) typically arising in the wall of the lateral ventricles and composed of large ganglioid astrocytes. It is the most common CNS neoplasm in patients with tuberous sclerosis complex and typically occurs during the first two decades of life. (WHO) C3696 Neoplastic Process Subependymal Giant Cell Astrocytoma Subependymal Giant Cell Astrocytoma C0205768 CTRP GDC 9384/1 Undetermined Subependymal_Giant_Cell_Astrocytoma 9384/1 Subependymal giant cell astrocytoma SEGA Subependymal Giant Cell Astrocytic Neoplasm Subependymal Giant Cell Astrocytic Tumor Subependymal Giant Cell Astrocytoma Subependymal giant cell astrocytoma Subependymal Giant Cell Astrocytoma A slow growing, WHO grade I glioma which generally occurs in young adults. It arises almost exclusively in the conus medullaris, cauda equina, and filum terminale of the spinal cord. It generally has a favorable prognosis and is characterized histologically by tumor cells arranged in a papillary manner around vascularized mucoid stromal cores. (Adapted from WHO). C3697 Neoplastic Process Myxopapillary Ependymoma C0205769 CDISC GDC A benign neoplasm of ependymal origin. 9394/1 Undetermined Myxopapillary_Ependymoma 9394/1 Myxopapillary ependymoma EPENDYMOMA, BENIGN Myxopapillary Ependymoma Myxopapillary ependymoma Myxopapillary Ependymoma A benign, slow growing tumor which may cause symptoms by blocking cerebrospinal fluid pathways. It is characterized by the presence of delicate fibrovascular connective tissue fronds covered by a single layer of epithelial cells. Mitotic activity is extremely low. Surgical resection is usually curative. (Adapted from WHO) C3698 Neoplastic Process Choroid Plexus Papilloma C4012134 CDISC Cellosaurus GDC A benign neoplasm of the choroid plexus of the central nervous system. 9390/0 Benign Choroid_Plexus_Papilloma 9390/0 Choroid plexus papilloma, NOS Choroid Plexus Papilloma Choroid plexus papilloma, NOS PAPILLOMA, CHOROID PLEXUS, BENIGN Papilloma of Choroid Plexus Papilloma of the Choroid Plexus Choroid Plexus Papilloma A hemangioma arising from skeletal muscle. C3699 Neoplastic Process Intramuscular Hemangioma C0205789 GDC 9132/0 Benign Intramuscular_Hemangioma 9132/0 Intramuscular hemangioma Intramuscular Angioma Intramuscular Hemangioma Intramuscular hemangioma Intramuscular Hemangioma A morphologic variant of leiomyosarcoma characterized by the presence of epithelioid round cells with eosinophilic to clear cytoplasm. C3700 Neoplastic Process Epithelioid Leiomyosarcoma Epithelioid Leiomyosarcoma C0205815 CTRP GDC 8891/3 Malignant Epithelioid_Leiomyosarcoma 8891/3 Epithelioid leiomyosarcoma Epithelioid Leiomyosarcoma Epithelioid leiomyosarcoma Epithelioid Leiomyosarcoma A morphologic variant of leiomyosarcoma characterized by the presence of cellular pleomorphism, malignant cells with large nuclei, and a myxoid stroma. C3701 Neoplastic Process Myxoid Leiomyosarcoma C0205816 GDC 8896/3 Malignant Myxoid_Leiomyosarcoma 8896/3 Myxoid leiomyosarcoma Myxoid Leiomyosarcoma Myxoid leiomyosarcoma Myxoid Leiomyosarcoma A rare benign slow growing adipose tissue tumor, characterized by the presence of polygonal brown fat cells with multivacuolated and/or granular cytoplasm. The tumor is usually painless and is most often seen in young adults. C3702 Neoplastic Process Hibernoma C0205822 CDISC Cellosaurus GDC A benign neoplasm of the brown adipose tissue. 8880/0 Benign Hibernoma 8880/0 Brown fat tumor Fetal fat cell lipoma Hibernoma Brown Fat Neoplasm Brown Fat Tumor Brown fat tumor Fetal Fat Cell Lipoma Fetal fat cell lipoma HIBERNOMA, BENIGN Hibernoma Hibernoma A benign circumscribed tumor characterized by small spindle cells, rounded hyperchromatic cells and multinucleated giant cells with radially arranged nuclei. C3703 Neoplastic Process Pleomorphic Lipoma C0205823 GDC 8854/0 Benign Pleomorphic_Lipoma 8854/0 Pleomorphic lipoma PL Pleomorphic Lipoma Pleomorphic lipoma Pleomorphic Lipoma An atypical lipomatous tumor/well differentiated liposarcoma that shows progression to a usually non-lipomatous, high grade sarcoma. The non-lipomatous sarcoma component may be present in the primary lesion or at the site of recurrence. C3704 Neoplastic Process Dedifferentiated Liposarcoma Dedifferentiated Liposarcoma C0205824 CTRP Cellosaurus GDC 8858/3 Malignant Dedifferentiated_Liposarcoma 8858/3 Dedifferentiated liposarcoma DDLPS Dedifferentiated Liposarcoma Dedifferentiated liposarcoma Dedifferentiated Liposarcoma A rare, aggressive liposarcoma characterized by the presence of varying proportions of pleomorphic lipoblasts in a background that resembles undifferentiated pleomorphic sarcoma. C3705 Neoplastic Process Pleomorphic Liposarcoma Pleomorphic Liposarcoma C0205825 CTRP Cellosaurus GDC 8854/3 Malignant Pleomorphic_Liposarcoma 8854/3 Pleomorphic liposarcoma Pleomorphic Liposarcoma Pleomorphic liposarcoma Pleomorphic Liposarcoma A rare malignant embryonal neoplasm arising from the cerebellum. It is characterized by the morphologic features of a medulloblastoma and the presence of a striated muscle component. Its clinical behavior is similar to medulloblastoma. C3706 Neoplastic Process Medullomyoblastoma C0205833 GDC 9472/3 Malignant Medullomyoblastoma 9472/3 Medullomyoblastoma Medullomyoblastoma Medullomyoblastoma with Myogenic Differentiation Medullomyoblastoma The presence of multiple meningiomas in the leptomeninges. C3707 Neoplastic Process Meningiomatosis C0205834 GDC 9530/1 Undetermined Meningiomatosis 9530/1 Diffuse meningiomatosis Meningiomatosis, NOS Multiple meningiomas Meningiomas, Multiple Meningiomatosis Meningiomatosis, NOS Multiple meningiomas Meningiomatosis A rare benign neoplasm arising from tooth-forming tissues. It is characterized by the presence of a fibromyxoid stroma, epithelial component, dentin, and enamel. Recurrences are rare. C3710 Neoplastic Process Ameloblastic Fibro-Odontoma C0205865 CDISC GDC A benign neoplasm arising from tooth-forming tissues with-enamel organ differentiation (but without enamel formation). 9290/0 Benign Ameloblastic_Fibro-Odontoma 9290/0 Ameloblastic fibro-odontoma Fibroameloblastic odontoma Ameloblastic Fibro-Odontoma Ameloblastic Fibroodontoma Ameloblastic fibro-odontoma Fibroameloblastic Odontoma Fibroameloblastic odontoma ODONTOMA, AMELOBLASTIC, BENIGN Ameloblastic Fibro-Odontoma An aggressive malignant neoplasm of uncertain differentiation, characterized by the presence of epithelioid cells forming nodular patterns. The nodules often undergo central necrosis, resulting in a pseudogranulomatous growth pattern. It usually occurs in young adults. The most common sites of involvement are the extremities (distal-type epithelioid sarcoma), and less frequently the pelvis, perineum, and genital organs (proximal-type epithelioid sarcoma). C3714 Neoplastic Process Epithelioid Sarcoma Epithelioid Sarcoma C0205944 CPTAC CTRP Cellosaurus GDC 8804/3 Malignant Epithelioid_Sarcoma 8804/3 Epithelioid cell sarcoma Epithelioid sarcoma Epithelioid sarcoma, NOS ES Epithelioid Cell Sarcoma Epithelioid Sarcoma Epithelioid cell sarcoma Epithelioid sarcoma Epithelioid Sarcoma A malignant neoplasm that originates in the neuroectoderm. The neuroectoderm constitutes the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems and includes some glial cell precursors. C3716 Neoplastic Process Primitive Neuroectodermal Tumor Primitive Neuroectodermal Tumor C0206663 CPTAC CTRP Cellosaurus GDC PCDC One of a group of cancers that develop from the same type of early cells, and share certain biochemical and genetic features. Some PNETs develop in the brain and central nervous system (CNS-PNET), and others develop in sites outside of the brain such as the limbs, pelvis, and chest wall (peripheral PNET). 9473/3 9503/3 Malignant Neuroectodermal_Tumor 9364/3 9473/3 9503/3 Neuroectodermal tumor, NOS Neuroepithelioma, NOS PNET, NOS Primitive neuroectodermal tumor, NOS Neuroectodermal Neoplasm Neuroectodermal Tumor Neuroepithelioma PNET PNET, NOS Primitive Neuroectodermal Neoplasm Primitive Neuroectodermal Tumor Primitive Neuroectodermal Tumor (PNET) Primitive neuroectodermal tumor, NOS neuroectodermal tumor primitive neuroectodermal tumor Primitive Neuroectodermal Tumor A T-cell peripheral lymphoma composed of usually large, pleomorphic, CD30 positive T-lymphocytes with abundant cytoplasm. It is characterized by the presence of a translocation involving the ALK gene and expression of ALK fusion protein. Most patients present with peripheral and/or abdominal lymphadenopathy, and often have advanced disease and extranodal involvement. C37193 Neoplastic Process Anaplastic Large Cell Lymphoma, ALK-Positive C1332079 CPTAC Cellosaurus GDC mCode 9714/3 Malignant ALK-Positive_Anaplastic_Large_Cell_Lymphoma 9714/3 Anaplastic large cell lymphoma, ALK positive Anaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites Anaplastic large cell lymphoma, ALK-positive, lymph nodes of axilla and upper limb Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck Anaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites Anaplastic large cell lymphoma, ALK-positive, unspecified site ALCL, ALK+ ALK-Positive Anaplastic Large Cell Lymphoma ALKoma Anaplastic Large Cell Lymphoma, ALK-Positive Anaplastic large cell lymphoma, ALK positive Anaplastic large cell lymphoma, ALK-positive, unspecified site Anaplastic Large Cell Lymphoma, ALK-Positive A T-cell peripheral lymphoma morphologically indistinguishable from anaplastic large cell lymphoma, ALK-positive. It is characterized by the absence of the translocation involving the ALK gene and lacks expression of ALK fusion protein. C37194 Neoplastic Process Anaplastic Large Cell Lymphoma, ALK-Negative C1332078 CPTAC Cellosaurus GDC 9702/3 Malignant ALK-Negative_Anaplastic_Large_Cell_Lymphoma 9702/3 Anaplastic large cell lymphoma, ALK negative Anaplastic large cell lymphoma, ALK-negative Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes ALCL, ALK- ALK-Negative Anaplastic Large Cell Lymphoma Anaplastic Large Cell Lymphoma, ALK-Negative Anaplastic large cell lymphoma, ALK negative Anaplastic Large Cell Lymphoma, ALK-Negative A T-cell peripheral lymphoma affecting multiple anatomic sites. It is composed of usually large, pleomorphic, CD30 positive T-lymphocytes with abundant cytoplasm. It is characterized by the presence of a translocation involving the ALK gene and expression of ALK fusion protein. C37195 Neoplastic Process Systemic Anaplastic Large Cell Lymphoma, ALK-Positive C1335492 Malignant Primary_Systemic_ALK-Positive_Anaplastic_Large_Cell_Lymphoma Primary Systemic ALK-Positive ALCL Primary Systemic ALK-Positive Anaplastic Large Cell Lymphoma Primary Systemic ALKoma Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive Systemic Anaplastic Large Cell Lymphoma, ALK-Positive Systemic Anaplastic Large Cell Lymphoma, ALK-Positive Anaplastic large cell lymphoma, ALK-negative affecting multiple anatomic sites. C37196 Neoplastic Process Systemic Anaplastic Large Cell Lymphoma, ALK-Negative C1335491 Malignant Primary_Systemic_ALK-Negative_Anaplastic_Large_Cell_Lymphoma Primary Systemic ALK-Negative Anaplastic Large Cell Lymphoma Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative Systemic Anaplastic Large Cell Lymphoma, ALK-Negative Systemic Anaplastic Large Cell Lymphoma, ALK-Negative A peripheral (mature) T-cell lymphoma, consisting of usually large anaplastic, CD30 positive cells. The majority of cases are positive for the anaplastic large cell lymphoma (ALK) protein. The most frequently seen genetic alteration is a t(2;5) translocation. Majority of patients present with advanced disease. The most important prognostic indicator is ALK positivity, which has been associated with a favorable prognosis. (WHO, 2001) C3720 Neoplastic Process Anaplastic Large Cell Lymphoma Anaplastic Large Cell Lymphoma C0206180 CPTAC CTRP Cellosaurus FDA GDC An aggressive (fast-growing) type of non-Hodgkin lymphoma that is usually of the T-cell type. The cancer cells express a marker called CD30 or Ki-1 on the surface, and may appear in the lymph nodes, skin, bones, soft tissues, lungs, or liver. 9714/3 Malignant Anaplastic_Large_Cell_Lymphoma 9714/3 Anaplastic large cell lymphoma Anaplastic large cell lymphoma involving lymph nodes of head, face, and neck Anaplastic large cell lymphoma involving lymph nodes of multiple sites Anaplastic large cell lymphoma, CD30+ Anaplastic large cell lymphoma, NOS Anaplastic large cell lymphoma, T cell and Null cell type Anaplastic large cell lymphoma, T-cell and Null-cell type Anaplastic large cell lymphoma, unspecified site, extranodal and solid organ sites Large cell (Ki-1+) lymphoma NHL, anaplastic large cell lymphoma ALCL Anaplastic Large Cell Lymphoma Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type Anaplastic large cell lymphoma, CD30+ Anaplastic large cell lymphoma, NOS CD30 Positive Anaplastic Large Cell Lymphoma Ki-1 Lymphoma Ki-1+ ALCL Ki-1+ Anaplastic Large Cell Lymphoma NHL, anaplastic large cell lymphoma anaplastic large cell lymphoma Anaplastic Large Cell Lymphoma A recently recognized variant of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) expressing somatic hypermutations of the Immunoglobulin heavy chain (IGH) genes. The recognition of this variant alters the belief that CLL/SLL is always derived from a naive, pregerminal center B-cell. The presence of somatic hypermutations of IGH genes occurs in approximately 50% of CLL/SLL cases and implies a postgerminal center, memory origin. Patients with this variant of CLL/SLL have a favorable prognosis, with a reported median survival of more than 24 years. C37201 Neoplastic Process Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation C1333037 Malignant Chronic_Lymphocytic_Leukemia_Small_Lymphocytic_Lymphoma_with_Immunoglobulin_Heavy_Chain_Variable-Region_Gene_Somatic_Hypermutation CLL/SLL with IGVH SHM Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation Postgerminal Center Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation Chronic lymphocytic leukemia characterized by the presence of somatic hypermutation within the immunoglobulin heavy chain gene variable region of neoplastic clones. Patients have a better prognosis as compared to those with unmutated immunoglobulin heavy chain gene variable region rearrangements. C37202 Neoplastic Process Chronic Lymphocytic Leukemia with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation C1333039 Malignant Chronic_Lymphocytic_Leukemia_with_Immunoglobulin_Heavy_Chain_Variable-Region_Gene_Somatic_Hypermutation CLL with IGVH SHM Chronic Lymphocytic Leukemia with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation Postgerminal Center Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation Small lymphocytic lymphoma characterized by the presence of somatic hypermutation within the immunoglobulin heavy chain gene variable region of neoplastic clones. Patients have a better prognosis as compared to those with unmutated immunoglobulin heavy chain gene variable region rearrangements. C37203 Neoplastic Process Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation C1336011 Malignant Small_Lymphocytic_Lymphoma_with_Immunoglobulin_Heavy_Chain_Variable-Region_Gene_Somatic_Hypermutation Postgerminal Center Small Lymphocytic Lymphoma SLL with IGVH SH Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation A recently recognized variant of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) that lacks somatic hypermutations of the Immunoglobulin heavy chain (IGH) genes, implying pregerminal center B-cell origin. Microarray gene expression profiling studies have demonstrated the expression of ZAP-70 gene (Syk family tyrosine kinase) in this subset of CLL/CLL. Patients with this variant of CLL/SLL have an unfavorable prognosis compared to those with somatic hypermutations of the IGH genes, with a median survival of approximately 6-8 years. C37204 Neoplastic Process Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene C1333038 Malignant Chronic_Lymphocytic_Leukemia_Small_Lymphocytic_Lymphoma_with_Unmutated_Immunoglobulin_Heavy_Chain-Region_Gene CLL/SLL with Unmutated IGVH Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene Pregerminal Center Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene Chronic lymphocytic leukemia characterized by the absence of somatic hypermutation within the immunoglobulin heavy chain gene variable region of neoplastic clones. Patients have a significantly worse prognosis as compared to those with mutated immunoglobulin heavy chain gene variable region rearrangements. C37205 Neoplastic Process Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene C1333041 Malignant Chronic_Lymphocytic_Leukemia_with_Unmutated_Immunoglobulin_Heavy_Chain-Region_Gene CLL with Unmutated IGVH Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene Pregerminal Center Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene Small lymphocytic lymphoma characterized by the absence of somatic hypermutation within the immunoglobulin heavy chain gene variable region of neoplastic clones. Patients have a significantly worse prognosis as compared to those with mutated immunoglobulin heavy chain gene variable region rearrangements. C37206 Neoplastic Process Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene C1336013 Malignant Small_Lymphocytic_Lymphoma_with_Unmutated_Immunoglobulin_Heavy_Chain-Region_Gene Pregerminal Center Small Lymphocytic Lymphoma SLL with Unmutated IGVH Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene A high-grade B-cell lymphoma characterized by the presence of medium-size neoplastic lymphocytes with a scant amount of cytoplasm and inconspicuous nucleoli, resembling lymphoblasts. C37209 Neoplastic Process High Grade B-Cell Lymphoma with Blastoid Morphologic Features C1332568 Malignant Blastoid_Follicular_Lymphoma Blastoid HGBL Diffuse Blastoid B-Cell Lymphoma High Grade B-Cell Lymphoma with Blastoid Morphologic Features High-Grade B-Cell Lymphoma with Blastoid Morphologic Features High Grade B-Cell Lymphoma with Blastoid Morphologic Features A chronic, recurrent cutaneous disorder characterized by the presence of spontaneously regressing papules. The papules are composed of an atypical lymphocytic infiltrate that contains anaplastic CD30-positive T-cells, which are found in type A and diffuse large cell type (type C) lymphomatoid papulosis. In a small number of cases, of type B, the lymphocytic infiltrate is composed of small, cerebriform-like lymphocytes that are often negative for CD30. The majority of cases follow a benign clinical course, but some cases are clonal and may progress to lymphoma. Treatment options include low dose methotrexate and psoralen/UVA (PUVA). C3721 Neoplastic Process Lymphomatoid Papulosis C0206182 GDC 9718/1 Uncertain Malignant Potential Lymphomatoid_Papulosis 9718/3 Lymphomatoid Papulosis Lymphomatoid papulosis LyP Lymphomatoid Papulosis Lymphomatoid papulosis Lymphomatoid Papulosis A rare renal cell carcinoma affecting young patients. It is characterized by the presence of the chromosomal translocation t(6;11) which fuses the TFEB transcription factor gene, located on chromosome 6, with the MALAT1 gene, located on chromosome 11. C37210 Neoplastic Process TFEB-Rearranged Renal Cell Carcinoma C1335746 Malignant Renal_Neoplasm_with_t_6_11_p21_q12 Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1::TFEB TFEB-Altered Renal Cell Carcinoma TFEB-Rearranged Renal Cell Carcinoma t(6;11) Renal Cell Carcinoma t(6;11);(p21;q12) Renal Cell Carcinoma TFEB-Rearranged Renal Cell Carcinoma A low-grade malignant neoplasm that arises from the exocrine pancreas. It is characterized by the presence of uniform cells that form solid and pseudopapillary patterns, cystic changes, and hemorrhage. Perineural invasion, vascular invasion, and invasion into surrounding tissues may be present. It usually presents as an encapsulated, solitary, and lobulated pancreatic mass. It is usually found incidentally during physical examination or it may present with abdominal discomfort and pain. It occurs predominantly in young women. Complete removal of the tumor is curative in the majority of cases. C37212 Neoplastic Process Solid Pseudopapillary Neoplasm of the Pancreas C1336030 GDC Malignant Solid_Pseudopapillary_Tumor_of_the_Pancreas 8452/3 Solid pseudopapillary neoplasm of pancreas Solid Pseudopapillary Neoplasm of the Pancreas Solid Pseudopapillary Tumor of the Pancreas Solid Pseudopapillary Neoplasm of the Pancreas An infiltrating pancreatic ductal adenocarcinoma, characterized by the presence of malignant cells floating in pools of mucin. It has a more favorable prognosis than the conventional infiltrating ductal adenocarcinoma. It often arises in association with intraductal pancreatic mucinous neoplasms and in some cases it may result in the development of pseudomyxoma peritonei. C37214 Neoplastic Process Pancreatic Colloid Carcinoma C1333081 CPTAC Malignant Colloid_Carcinoma_of_the_Pancreas Colloid Carcinoma of the Pancreas Colloid carcinoma (Mucinous noncystic carcinoma) Mucinous Noncystic Carcinoma Pancreatic Colloid Carcinoma Pancreatic Mucinous Noncystic Carcinoma Pancreatic Colloid Carcinoma A benign lymphatic neoplasm usually arising from the neck and characterized by cystic dilation of the lymphatic vessels. C3724 Neoplastic Process Cystic Hygroma C0206620 GDC NICHD 9173/0 Benign Cystic_Lymphangioma 9173/0 Cystic hygroma Cystic lymphangioma Hygroma, NOS Cystic Hygroma Cystic Lymphangioma Cystic hygroma Cystic lymphangioma Hygroma Hygroma, NOS Cystic Hygroma A multifocal neoplasm with perivascular epithelioid cell differentiation affecting almost exclusively females of child-bearing age. It is characterized by the presence of smooth muscle and epithelioid cells and by the proliferation of lymphatic vessels. Sites of involvement include the lungs, mediastinum, and the retroperitoneum. It usually presents with chylous pleural effusion or ascites. C3725 Neoplastic Process Lymphangioleiomyomatosis Lymphangioleiomyomatosis C0751674 CTRP Cellosaurus GDC 9174/1 Undetermined Lymphangiomyomatosis 9174/1 Lymphangioleiomyomatosis Lymphangiomyomatosis LAM Lymphangioleiomyomatosis Lymphangiomyomatosis Lymphangioleiomyomatosis A pancreatic ductal adenocarcinoma characterized by the presence of adenocarcinoma cells with foamy cytoplasm. C37256 Neoplastic Process Pancreatic Foamy Gland Adenocarcinoma C1335303 Malignant Pancreatic_Foamy_Gland_Adenocarcinoma Pancreatic Foamy Gland Adenocarcinoma Pancreatic Foamy Gland Adenocarcinoma A melanoma of the skin characterized by a proliferation of atypical spindled melanocytes in the dermis, in a background of abundant collagen. It usually presents as an amelanotic raised nodular lesion. C37257 Neoplastic Process Desmoplastic Melanoma Desmoplastic Melanoma C0334439 CTRP GDC A rare form of malignant melanoma marked by nonpigmented lesions on sun-exposed areas of the body, most commonly on the head and neck. 8745/3 Malignant Desmoplastic_Melanoma 8745/3 Desmoplastic melanoma, NOS Desmoplastic melanoma, amelanotic Desmoplastic melanoma, malignant Desmoplastic Cutaneous (Skin) Melanoma Desmoplastic Melanoma desmoplastic melanoma Desmoplastic Melanoma A benign primary melanocytic tumor of the skin that presents as a dermal nodule. Morphologically, it is characterized by the presence of paraganglioma-like features that include a nested growth pattern of the tumor cells. The nests are composed of epithelioid cells and are separated by delicate fibrous strands. Cytoplasmic melanin is not present; however immunohistochemical studies have confirmed the melanocytic lineage of the tumor cells. C37258 Neoplastic Process Paraganglioma-Like Dermal Melanocytic Tumor C1335334 Benign Paraganglioma-Like_Dermal_Melanocytic_Tumor Dermal Melanocytic Tumor Resembling Paraganglioma PDMT Paraganglioma-Like Dermal Melanocytic Tumor Paraganglioma-Like Dermal Melanocytic Tumor A benign neoplasm characterized by the presence of a glandular and a mesenchymal (fibromyomatous) component. It occurs in the uterine corpus, cervix, and uterine ligaments. A variant of adenomyoma associated with glandular architectural complexity is called atypical polypoid adenomyoma. Simple polypectomy is usually curative. Atypical polypoid adenomyoma may recur following polypectomy. C3726 Neoplastic Process Adenomyoma C0206622 CDISC GDC A benign neoplasm characterized by the presence of a glandular and a mesenchymal component. 8932/0 Benign Adenomyoma 8932/0 Adenomyoma Adenomyoma, NOS ADENOMYOMA, BENIGN Adenomyoma Adenomyoma A rare, usually benign tumor that arises from the kidney. It belongs to the spectrum of mixed epithelial and stromal tumor family. It usually affects females. It is characterized by the presence of a biphasic pattern with tubular and cystic structures in a spindle cell stroma. Patients usually present with flank pain and hematuria. C37263 Neoplastic Process Kidney Mixed Epithelial and Stromal Tumor CL448522 Undetermined Mixed_Epithelial_Stromal_Tumor_of_the_Kidney Kidney Mixed Epithelial and Stromal Tumor MEST Mixed Epithelial Stromal Tumor of the Kidney Renal Epithelial Stromal Tumor Kidney Mixed Epithelial and Stromal Tumor A rare, benign neoplasm that most often manifests as a multiloculated cystic renal mass. It is characterized by the presence of solid and cystic components. The solid components contain a mixture of epithelial and stromal elements. C37264 Neoplastic Process Benign Kidney Mixed Epithelial and Stromal Tumor C1272677 Benign Benign_Mixed_Epithelial_Stromal_Tumor_of_the_Kidney Benign Kidney Mixed Epithelial and Stromal Tumor Benign MEST Benign Mixed Epithelial Stromal Tumor of the Kidney Benign Kidney Mixed Epithelial and Stromal Tumor A mixed epithelial stromal tumor of the kidney with malignant stromal features. C37265 Neoplastic Process Malignant Mixed Epithelial and Stromal Tumor of the Kidney C1334602 Malignant Malignant_Mixed_Epithelial_Stromal_Tumor_of_the_Kidney Kidney Malignant Mixed Epithelial and Stromal Tumor Malignant Kidney Mixed Epithelial and Stromal Tumor Malignant MEST Malignant Mixed Epithelial Stromal Tumor of the Kidney Malignant Mixed Epithelial and Stromal Tumor of the Kidney Malignant Mixed Epithelial and Stromal Tumor of the Kidney A flat urothelial lesion of variable thickness in the bladder, devoid of papillary structures containing cytologically malignant cells. (WHO 2016) C37266 Neoplastic Process Bladder Urothelial Carcinoma In Situ C1332559 CPTAC Malignant Bladder_Flat_Intraepithelial_Lesion Urothelial carcinoma in situ Bladder Flat Intraepithelial Lesion Bladder Urothelial Carcinoma In Situ Flat Intraepithelial Lesion of the Bladder Flat Intraepithelial Lesion of the Urinary Bladder Urinary Bladder Flat Intraepithelial Lesion Urothelial Carcinoma In Situ Bladder Urothelial Carcinoma In Situ Focal proliferation of small acinar glandular cells in the prostate gland with cytologic changes ranging from atypia to highly suggestive of malignancy. C37268 Neoplastic Process Atypical Small Acinar Proliferation of the Prostate Gland Atypical Small Acinar Proliferation of the Prostate Gland C1332353 CTRP Undetermined Atypical_Small_Acinar_Proliferation_of_the_Prostate_Gland ASAP Atypical Small Acinar Proliferation of the Prostate Gland Prostatic Atypical Small Acinar Proliferation Atypical Small Acinar Proliferation of the Prostate Gland HPV-negative vulvar squamous intraepithelial proliferation characterized by atypia of the basal and parabasal keratinocytes in an otherwise well-differentiated epithelium. Despite its subtle appearance, it has a high risk of malignant transformation. (WHO 2020) C37272 Neoplastic Process Vulvar Intraepithelial Neoplasia, HPV-Independent C1335968 GDC Undetermined Simplex_Differentiated_Type_of_Vulvar_Intraepithelial_Neoplasia Differentiated-type vulvar intraepithelial neoplasia Differentiated Vulvar Intraepithelial Neoplasia Differentiated-type vulvar intraepithelial neoplasia Simplex (Differentiated) Vulvar Intraepithelial Neoplasia SxVIN Vulvar Carcinoma In Situ of Simplex Type Vulvar Intraepithelial Neoplasia, Differentiated Vulvar Intraepithelial Neoplasia, Differentiated (Simplex) Vulvar Intraepithelial Neoplasia, Differentiated (Simplex) Type Vulvar Intraepithelial Neoplasia, Differentiated Type Vulvar Intraepithelial Neoplasia, HPV-Independent Vulvar Intraepithelial Neoplasia, Simplex d-VIN dVIN Vulvar Intraepithelial Neoplasia, HPV-Independent A malignant embryonal neoplasm that arises from the liver. It occurs almost exclusively in infants, although isolated cases in older children and adults have been reported. Microscopically, it consists of either epithelial or epithelial and mesenchymal components. C3728 Neoplastic Process Hepatoblastoma Hepatoblastoma C0206624 CDISC CPTAC CTEP CTRP Cellosaurus GDC MedDRA NICHD mCode A malignant liver neoplasm composed of immature hepatocytic elements. A malignant liver tumor that arises from precursors of hepatocytes. It occurs almost exclusively in infants. The lungs are the most common site of metastasis. A type of liver tumor that occurs in infants and children. 8970/3 Malignant Hepatoblastoma 8970/3 Embryonal hepatoma Hepatoblastoma Hepatoblastoma, NOS Malignant neoplasm: Hepatoblastoma HBL HEPATOBLASTOMA, MALIGNANT Hepatoblastoma Pediatric Embryonal Hepatoma Pediatric Hepatoblastoma hepatoblastoma Hepatoblastoma A high-grade, aggressive variant of squamous cell carcinoma that arises from the head and neck region. The most common sites of origin are pyriform sinus, epiglottis, and base of tongue. It is characterized by the presence of small malignant cells with hyperchromatic nuclei and scant amount of cytoplasm forming lobules with peripheral palisading. Comedonecrosis may be present. C37290 Neoplastic Process Head and Neck Basaloid Squamous Cell Carcinoma C1333940 Cellosaurus Malignant Head_and_Neck_Basaloid_Squamous_Cell_Carcinoma Basaloid Squamous Cell Carcinoma of Head and Neck Basaloid Squamous Cell Carcinoma of the Head and Neck Head and Neck Basaloid Carcinoma Head and Neck Basaloid Squamous Cell Carcinoma Head and Neck Basaloid Squamous Cell Carcinoma A group of tumors affecting the female reproductive system, characterized by the presence of epithelial and stromal elements. It includes the following clinicopathological entities: adenofibroma, adenomyoma, Mullerian adenosarcoma, and malignant mixed mesodermal (Mullerian) tumor. C3730 Neoplastic Process Mixed Mesodermal (Mullerian) Tumor C0206627 GDC A rare cancer of the uterus, ovary, or fallopian tubes. 8950/3 8951/3 Undetermined Mixed_Mesodermal_Mullerian_Tumor 8950/3 8951/3 Mesodermal mixed tumor Mullerian mixed tumor Mesodermal Mixed Tumor Mesodermal mixed tumor Mixed Mesodermal (Mullerian) Neoplasm Mixed Mesodermal (Mullerian) Tumor Mixed Mesodermal (Müllerian) Neoplasm Mixed Mesodermal (Müllerian) Tumor Mixed Mullerian Tumor Mixed Müllerian Tumor Mullerian mixed tumor Mullerian tumor Mixed Mesodermal (Mullerian) Tumor A papillary carcinoma arising in the thyroid gland from multiple foci. C37304 Neoplastic Process Multicentric Thyroid Gland Papillary Carcinoma C1334817 Malignant Multicentric_Papillary_Thyroid_Carcinoma Multicentric Papillary Thyroid Carcinoma Multicentric Papillary Thyroid Gland Carcinoma Multicentric Thyroid Gland Papillary Carcinoma Multicentric Thyroid Gland Papillary Carcinoma A biphasic tumor that consists of fetal adenocarcinoma (typically low-grade) and primitive mesenchymal stroma. Foci of specific mesenchymal differentiation (osteosarcoma, chondrosarcoma, or rhabdomyosarcoma) may also be present, but are not required for the diagnosis. Most patients are smokers. The prognosis is very poor. (WHO 2015) C3732 Neoplastic Process Pulmonary Blastoma C0206629 Cellosaurus GDC 8972/3 Malignant Pulmonary_Blastoma 8972/3 Pneumoblastoma Pulmonary blastoma Blastoma of Lung Blastoma of the Lung Lung Blastoma Pneumoblastoma Pulmonary Blastoma Pulmonary blastoma Pulmonary Blastoma A lipoma with prominent vascularity. The vascular tissue is more abundant at the periphery of the tumor and contains fibrin thrombi. It occurs more frequently in younger individuals as a painful subcutaneous nodule, often on the arms. C3733 Neoplastic Process Angiolipoma C0206632 CDISC GDC A lipoma characterized by prominent vascularization. 8861/0 Benign Angiolipoma 8861/0 Angiolipoma, NOS ANGIOLIPOMA, BENIGN Angiolipoma Angiolipoma, NOS Angiolipoma A neoplasm with perivascular epithelioid cell differentiation often associated with tuberous sclerosis. It is characterized by a mixture of epithelioid cells, smooth muscle, vessels, and mature adipose tissue. The kidney is the most common site of involvement. Other sites of involvement include the liver, lung, lymph nodes, and retroperitoneum. The vast majority of cases follow a benign clinical course. However, cases of metastatic angiomyolipomas with sarcomatoid features have been described. C3734 Neoplastic Process Angiomyolipoma Angiomyolipoma C0206633 CTRP GDC A benign (noncancer) tumor of fat and muscle tissue that usually is found in the kidney. Angiomyolipomas rarely cause symptoms, but may bleed or grow large enough to be painful or cause kidney failure. They are common in patients with tuberous sclerosis (a genetic disorder in which benign tumors grow in the kidneys, brain, eyes, heart, lungs, and skin, causing seizures, mental problems, and skin lesions). 8860/0 Undetermined Angiomyolipoma 8860/0 Angiomyolipoma Angiomyolipoma angiomyolipoma Angiomyolipoma A morphologic variant of chondrosarcoma arising from bone and soft tissue. It is characterized by the presence of malignant small round cells, biphasic growth pattern, and well differentiated hyaline cartilage. Clinical presentation includes pain and swelling. The clinical course is aggressive, with local recurrences and distant metastases. C3737 Neoplastic Process Mesenchymal Chondrosarcoma C0206637 GDC 9240/3 Malignant Mesenchymal_Chondrosarcoma 9240/3 Mesenchymal chondrosarcoma Mesenchymal Chondrosarcoma Mesenchymal chondrosarcoma Mesenchymal Chondrosarcoma A benign, intermediate, or malignant bone tumor characterized by the presence of osteoclast-like giant cells. Clinical presentation includes pain, edema, and decreased range of motion in the affected joint. C3738 Neoplastic Process Osteoclastic Giant Cell-Rich Tumor of Bone C4048303 9250/1 Undetermined Giant_Cell_Tumor_of_Bone Osteoclastic Giant Cell-Rich Tumor of Bone Osteoclastic Giant Cell-Rich Tumor of the Bone Osteoclastic Giant Cell-Rich Tumor of Bone A benign neoplasm composed of fibroblastic spindle cells in a whorled storiform pattern. It is characterized by the presence of foam cells, inflammatory cells, hemosiderin deposition and stromal hemorrhage. C3739 Neoplastic Process Fibrous Histiocytoma C0206644 CDISC Cellosaurus GDC A benign neoplasm composed of a fibroblastic and a histiocytic component. 8830/0 Benign Benign_Fibrous_Histiocytoma 8830/0 Benign fibrous histiocytoma Benign fibrous histiocytoma, NOS Fibrous histiocytoma, NOS Fibroxanthoma, NOS Xanthofibroma Benign Fibrous Histiocytoma Benign fibrous histiocytoma Fibrous Histiocytoma Fibrous histiocytoma, NOS Fibroxanthoma, NOS HISTIOCYTOMA, FIBROUS, BENIGN Fibrous Histiocytoma A rare, benign, locally aggressive osteolytic neoplasm. It is characterized by the presence of a rich collagenous stroma and spindle cells with minimal cellular atypia. C3740 Neoplastic Process Desmoplastic Fibroma C0206645 CDISC GDC A benign neoplasm characterized by osteolysis and the presence of a rich collagenous stroma and spindle cells. 8823/0 Benign Bone_Desmoplastic_Fibroma 8823/0 Desmoplastic fibroma Bone Desmoplastic Fibroma Desmoid Tumor of Bone Desmoplastic Fibroma Desmoplastic Fibroma of Bone Desmoplastic Fibroma of the Bone Desmoplastic fibroma OSTEOFIBROMA, BENIGN Osseous Desmoplastic Fibroma Desmoplastic Fibroma An insidious poorly circumscribed neoplasm arising from the deep soft tissues of the abdomen. It is characterized by the presence of elongated spindle-shaped fibroblasts, collagenous stroma formation, and an infiltrative growth pattern. C3741 Neoplastic Process Abdominal (Mesenteric) Fibromatosis C0206646 Cellosaurus GDC 8822/1 Undetermined Abdominal_Fibromatosis 8822/1 Abdominal desmoid Abdominal fibromatosis Mesenteric fibromatosis Retroperitoneal fibromatosis Abdominal (Mesenteric) Fibromatosis Abdominal Desmoid Abdominal Desmoid Tumor Abdominal Fibromatosis Abdominal desmoid Abdominal fibromatosis Intraabdominal Desmoid Intraabdominal Desmoid Tumor Intraabdominal Fibromatosis Mesenteric Desmoid Mesenteric Desmoid Tumor Mesenteric Fibromatosis Mesenteric fibromatosis Peritoneal Desmoid Fibromatosis Abdominal (Mesenteric) Fibromatosis A benign, multifocal, nodular and well-circumscribed neoplasm usually seen as a congenital neoplasm or in the first year of life. It is characterized by a biphasic growth pattern and is composed of small, undifferentiated mesenchymal cells associated with branching thin-walled vessels and more mature neoplastic spindle cells with abundant eosinophilic cytoplasm in a collagenous stroma. C3742 Neoplastic Process Myofibromatosis C0206648 GDC 8824/1 Benign Myofibromatosis 8824/1 Infantile myofibromatosis Myofibromatosis Infantile Hemangiopericytoma Infantile Myofibromatosis Infantile myofibromatosis Multicentric Myofibromatosis Myofibromatosis Myofibromatosis A benign tumor of the breast characterized by the presence of stromal and epithelial elements. It presents as a painless, solitary, slow growing, firm, and mobile mass. It is the most common benign breast lesion. It usually occurs in women of childbearing age. The majority of fibroadenomas do not recur after complete excision. A slightly increased risk of developing cancer within fibroadenomas or in the breast tissue of patients previously treated for fibroadenomas has been reported. C3744 Neoplastic Process Breast Fibroadenoma C0206650 CDISC GDC A benign (not cancer) tumor that usually forms in the breast from both fibrous and glandular tissue. Fibroadenomas are the most common benign breast tumors. A benign neoplasm originating from glandular cells with a fibrous or fibroblastic component. 9010/0 Benign Fibroadenoma 9010/0 Fibroadenoma, NOS Breast Fibroadenoma FIBROADENOMA, BENIGN Fibroadenoma Fibroadenoma of Breast Fibroadenoma of the Breast fibroadenoma Breast Fibroadenoma A rare malignant neoplasm with melanocytic differentiation characterized by the presence of polygonal or spindle shaped clear cells. This sarcoma usually affects the tendons and aponeuroses and is associated with a poor prognosis due to recurrences and metastases. C3745 Neoplastic Process Clear Cell Sarcoma of Soft Tissue Clear Cell Sarcoma of Soft Tissue C0206651 CPTAC CTEP CTRP Cellosaurus GDC A soft tissue tumor that begins in a tendon (tough, fibrous, cord-like tissue that connects muscle to bone or to another structure). Clear cell sarcoma of soft tissue has certain markers that are also found on malignant melanoma (a type of skin cancer). It usually occurs in the leg or arm. 9044/3 Malignant Clear_Cell_Sarcoma_of_Soft_Parts 9044/3 Clear cell sarcoma, NOS Melanoma, malignant, of soft parts Clear Cell Sarcoma of Soft Parts Clear Cell Sarcoma of Soft Tissue Clear Cell Sarcoma of Tendons and Aponeuroses Clear cell sarcoma - not kidney Clear cell sarcoma of soft tissue Clear cell sarcoma/Malignant melanoma of soft parts (excluding Clear cell sarcoma of the kidney) Melanoma of Soft Parts Melanoma of the Soft Parts Melanoma, malignant, of soft parts clear cell sarcoma of soft tissue malignant melanoma of soft parts Clear Cell Sarcoma of Soft Tissue A sarcoma characterized by the presence of small round or elongated malignant cells with a small amount of cytoplasm. C3746 Neoplastic Process Small Cell Sarcoma C0206652 CPTAC GDC 8803/3 Malignant Small_Cell_Sarcoma 8803/3 Small cell sarcoma Small Cell Sarcoma Small Cell Sarcomas Small cell sarcoma Small Cell Sarcoma A benign, slow-growing neoplasm that arises from the dermis or subcutaneous tissue. It is characterized by the presence of well-differentiated smooth muscle cells which are arranged around numerous vessels. C3747 Neoplastic Process Angioleiomyoma C0206653 GDC 8894/0 Benign Angiomyoma 8894/0 Angioleiomyoma Angiomyoma Vascular leiomyoma Angioleiomyoma Angiomyoma Vascular Leiomyoma Vascular leiomyoma Angioleiomyoma A condition characterized by the presence of numerous small benign smooth muscle neoplasms located throughout the body. C3748 Neoplastic Process Leiomyomatosis C0206654 GDC 8890/1 Benign Leiomyomatosis 8890/1 Leiomyomatosis, NOS Leiomyomatosis Leiomyomatosis, NOS Leiomyomatosis A rapidly growing malignant mesenchymal neoplasm. It is characterized by the presence of round cells with myoblastic differentiation and a fibrovascular stroma resembling an alveolar growth pattern. The tumor usually presents in the extremities. C3749 Neoplastic Process Alveolar Rhabdomyosarcoma Alveolar Rhabdomyosarcoma C0206655 CTEP CTRP Cellosaurus GDC A soft tissue tumor that is most common in older children and teenagers. It begins in embryonic muscle cells (cells that develop into muscles in the body). It can occur at many places in the body, but usually occurs in the trunk, arms, or legs. 8920/3 Malignant Alveolar_Rhabdomyosarcoma 8920/3 Alveolar rhabdomyosarcoma ARMS Alveolar Rhabdomyosarcoma Alveolar rhabdomyosarcoma Monomorphous Round Cell Rhabdomyosarcoma alveolar rhabdomyosarcoma Alveolar Rhabdomyosarcoma A rare malignant neoplasm characterized by the presence of large epithelioid cells with abundant cytoplasm forming nests and pseudoalveolar structures. The groups of the epithelioid cells are separated by thin-walled sinusoidal spaces. It occurs most often in adolescents and young adults. In adults the most common sites of involvement are the extremities, and in infants and children, the head and neck. It usually presents as a slowly growing mass and it frequently metastasizes to other anatomic sites. The most common sites of metastasis are the lungs, bone, and brain. C3750 Neoplastic Process Alveolar Soft Part Sarcoma Alveolar Soft Part Sarcoma C0206657 CPTAC CTEP CTRP Cellosaurus GDC A soft tissue tumor that is most common in older children and teenagers. It begins in the soft supporting tissue that connects and surrounds the organs and other tissues. Alveolar soft part sarcoma usually occurs in the legs, but can also occur in the arms, hands, head, or neck. It can cause the growth of new blood vessels that help the tumor grow and spread. 9581/3 Malignant Alveolar_Soft_Part_Sarcoma 9581/3 Alveolar soft part sarcoma ASPS Alveolar Soft Part Sarcoma Alveolar soft part sarcoma Alveolar soft-part sarcoma alveolar soft part sarcoma Alveolar Soft Part Sarcoma A benign or malignant myomatous neoplasm arising from smooth muscle. C3751 Neoplastic Process Smooth Muscle Neoplasm C0206658 GDC Undetermined Smooth_Muscle_Neoplasm Smooth muscle tumor, NOS Neoplasm of Smooth Muscle Neoplasm of the Smooth Muscle Smooth Muscle Neoplasm Smooth Muscle Tumor Smooth muscle tumor, NOS Tumor of Smooth Muscle Tumor of the Smooth Muscle Smooth Muscle Neoplasm A mixed germ cell/sex cord-stromal tumor characterized by the presence of large germ cells which resemble seminoma cells and small cells which resemble Sertoli or granulosa cells. It occurs in the testis and the ovary and is identified in children and adults. It is often associated with gonadal dysgenesis and abnormal karyotype. C3754 Neoplastic Process Gonadoblastoma C0206661 GDC NICHD PCDC A mixed germ cell/sex cord-stromal tumor characterized by the presence of large germ cells that resemble seminoma cells and small cells that resemble Sertoli or granulosa cells. It occurs in the testis and the ovary, and is identified in children and adults. It is often associated with gonadal dysgenesis and abnormal karyotype. 9073/1 Undetermined Gonadoblastoma 9073/1 Gonadoblastoma Gonocytoma Gonadoblastoma Gonadoblastoma A rare gestational trophoblastic tumor characterized by the presence of a diffuse cellular infiltrate composed of intermediate trophoblasts and cytotrophoblasts and by the absense of a significant population of syncytiotrophoblasts. C3757 Neoplastic Process Placental Site Trophoblastic Tumor C0206666 GDC 9104/1 Undetermined Placental-Site_Gestational_Trophoblastic_Tumor 9104/1 Placental site trophoblastic tumor PSTT Placental Site Gestational Trophoblastic Tumor Placental Site Trophoblastic Tumor Placental-Site GTT Placental-Site Gestational Trophoblastic Neoplasm Placental-Site Gestational Trophoblastic Tumor Placental Site Trophoblastic Tumor A benign epithelial neoplasm arising from the hepatocytes. Grossly, it appears as a soft, round mass which often contains areas of hemorrhage and necrosis. Morphologically, the neoplastic cells resemble normal hepatocytes and form plates separated by sinusoids. Most patients have a history of contraceptive or anabolic steroids use. C3758 Neoplastic Process Hepatocellular Adenoma C0206669 CDISC GDC A benign epithelial neoplasm arising from hepatocytes. 8170/0 Benign Hepatocellular_Adenoma 8170/0 Hepatocellular adenoma Hepatoma, benign Liver cell adenoma ADENOMA, HEPATOCELLULAR, BENIGN Adenoma of Liver Cells Adenoma of the Liver Cells HCA Hepatocellular Adenoma Hepatocellular adenoma Liver Cell Adenoma Liver cell adenoma Hepatocellular Adenoma A benign cystic proliferation of the sweat glands with apocrine or eccrine differentiation. It usually presents as a dome-shaped, cystic papular or nodular lesion usually in the face and neck. It is a unilocular or mutlilocular lesion lined by an inner and an outer layer of epithelium. Complete excision is usually curative. C3760 Neoplastic Process Hidrocystoma C0206672 GDC 8404/0 Benign Hidrocystoma 8404/0 Hidrocystoma Hidrocystoma Hydrocystoma Hidrocystoma A benign sweat gland neoplasm usually affecting the lower eyelids and upper cheeks. The lesions are papular and are usually numerous. Morphologically, there are nests, cords, and tubules of epithelial cells present, surrounded by a dense stroma in the reticular dermis. C3761 Neoplastic Process Syringoma C0206673 GDC 8407/0 Benign Syringoma 8407/0 Syringoma, NOS Eccrine Syringoma Syringoma Syringoma, NOS Syringoma A polypoid neoplasm arising from the glandular epithelium of the gastrointestinal tract. There is proliferation of glandular cells which may display dysplastic cytologic features. Representative examples include the adenomatous polyps of the colon and rectum.. C3764 Neoplastic Process Adenomatous Polyp Adenomatous Polyp C0206677 CTRP GDC 8210/0 Benign Adenomatous_Polyp 8210/0 Adenomatous polyp, NOS Polypoid adenoma Adenomatous Polyp Adenomatous polyp, NOS GI Tract Adenomatous Polyp Gastrointestinal Tract Adenomatous Polyp Polypoid Adenoma Polypoid adenoma Adenomatous Polyp An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the pancreas. The mitotic count is more than 20 per 10 HPF. It is classified as either small or large cell neuroendocrine carcinoma based on the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm. C3770 Neoplastic Process Pancreatic Neuroendocrine Carcinoma Pancreatic Neuroendocrine Carcinoma C1328479 CDISC CPTAC CTRP GDC A malignant endocrine neoplasm arising from islets of Langerhans of the pancreas. Cancer arising from cells in the islets of Langerhans, which are found in the pancreas. 8150/3 Malignant Pancreatic_Endocrine_Carcinoma 8150/3 Islet cell adenocarcinoma Islet cell carcinoma Malignant neoplasm of islets of Langerhans Malignant neoplasm: Endocrine pancreas Pancreatic endocrine tumor, malignant CARCINOMA, ISLET CELL, MALIGNANT High Grade Pancreatic Neuroendocrine Carcinoma High-Grade Pancreatic Neuroendocrine Carcinoma Islet Cell Cancer Islet Cell Carcinoma Islet cell carcinoma Malignant Islet Cell Tumor Malignant Pancreatic Endocrine Tumor PanNEC Pancreatic Endocrine Carcinoma Pancreatic NEC Pancreatic Neuroendocrine Cancer Pancreatic Neuroendocrine Carcinoma Poorly Differentiated Neuroendocrine Neoplasm Poorly Differentiated Pancreatic Endocrine Carcinoma islet cell cancer pancreatic endocrine cancer Pancreatic Neuroendocrine Carcinoma An adenocarcinoma of the breast arising from the lobules. This is a relatively uncommon carcinoma, represents approximately 10% of the breast adenocarcinomas and is often bilateral or multifocal. C3771 Neoplastic Process Lobular Breast Carcinoma Breast Lobular Carcinoma C0206692 CTRP GDC Cancer that begins in the lobules (the glands that make milk) of the breast. Lobular carcinoma in situ (LCIS) is a condition in which abnormal cells are found only in the lobules. When cancer has spread from the lobules to surrounding tissues, it is invasive lobular carcinoma. LCIS does not become invasive lobular carcinoma very often, but having LCIS in one breast increases the risk of developing invasive cancer in either breast. 8520/3 Malignant Lobular_Breast_Carcinoma 8520/3 Lobular adenocarcinoma Lobular carcinoma, NOS Breast Lobular Carcinoma Lobular Adenocarcinoma Lobular Breast Carcinoma Lobular Carcinoma Lobular Carcinoma of Breast Lobular Carcinoma of the Breast Lobular adenocarcinoma lobular carcinoma Breast Lobular Carcinoma A usually aggressive carcinoma composed of malignant cells exhibiting neuroendocrine differentiation. C3773 Neoplastic Process Neuroendocrine Carcinoma Neuroendocrine Carcinoma C0206695 CPTAC CTEP CTRP GDC mCode 8246/3 Malignant Neuroendocrine_Carcinoma 8246/3 Malignant neuroendocrine tumors Malignant poorly differentiated neuroendocrine carcinoma, any site Malignant poorly differentiated neuroendocrine tumors Neuroendocrine carcinoma, NOS Other malignant neuroendocrine tumors High-Grade Neuroendocrine Carcinoma Malignant poorly differentiated neuroendocrine tumors NEC Neuroendocrine Cancer Neuroendocrine Carcinoma Neuroendocrine cancer, NOS Neuroendocrine carcinoma, NOS Neuroendocrine Carcinoma A carcinoma arising from the sebaceous glands, sweat glands, or the hair follicles. Representative examples include sebaceous carcinoma, apocrine carcinoma, eccrine carcinoma, and pilomatrical carcinoma. C3775 Neoplastic Process Adnexal Carcinoma C0206697 CDISC GDC A malignant epithelial neoplasm arising from sebaceous or sweat glands or from hair follicles. 8390/3 Malignant Adnexal_Carcinoma 8390/3 Adnexal carcinoma Skin appendage carcinoma Adnexal Carcinoma Adnexal carcinoma CARCINOMA, ADNEXAL, MALIGNANT Carcinoma of Adnexa Carcinoma of Skin Appendage Skin Appendage Carcinoma Skin appendage carcinoma Adnexal Carcinoma Squamous or glandular intraepithelial neoplasia that affects the cervical mucosal epithelium. There is no evidence of stromal invasion. According to the degree of cellular atypia and the associated architectural changes, it is classified as low or high grade. C3782 Neoplastic Process Cervical Intraepithelial Neoplasia Cervical Intraepithelial Neoplasia C0206708 CTEP CTRP Cellosaurus NICHD Growth of abnormal cells on the surface of the cervix. Numbers from 1 to 3 may be used to describe how abnormal the cells are and how much of the cervical tissue is involved. Undetermined Cervical_Intraepithelial_Neoplasia CIN Cervical Dysplasia Cervical Intraepithelial Neoplasia Cervical intraepith. neoplasia Cervical intraepithelial neoplasia (CIN) Cervix Intraepithelial Neoplasia Cervix Uteri Intraepithelial Neoplasia Intraepithelial Neoplasia of Cervix Intraepithelial Neoplasia of Cervix Uteri Intraepithelial Neoplasia of Uterine Cervix Intraepithelial Neoplasia of the Cervix Intraepithelial Neoplasia of the Cervix Uteri Intraepithelial Neoplasia of the Uterine Cervix Uterine Cervix Intraepithelial Neoplasia cervical intraepithelial neoplasia Cervical Intraepithelial Neoplasia A group of lymphomas displaying molecular, morphologic, immunophenotypic, and clinical overlap between classic Hodgkin lymphoma and diffuse large B-cell lymphoma. This term particularly applies to mediastinal lymphomas with overlapping features of mediastinal (thymic) large B-cell lymphoma and classic Hodgkin lymphoma. C37869 Neoplastic Process B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma Gray-Zone Lymphoma C1333878 CPTAC CTRP GDC 9596/3 Malignant Gray_Zone_Lymphoma 9596/3 B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma Gray Zone Lymphoma Gray-Zone Lymphoma Hodgkin-Like Anaplastic Large Cell Lymphoma Large B-Cell Lymphoma with Hodgkin Features Gray-Zone Lymphoma A neoplasm of the nervous system that arises from the neuroepithelial tissues. Representative examples include astrocytic tumors, oligodendroglial tumors, ependymal tumors, and primitive neuroectodermal tumors. C3787 Neoplastic Process Neuroepithelial Neoplasm C0206715 GDC Undetermined Neuroepithelial_Neoplasm Neuroepitheliomatous Neoplasms Neoplasm of Neuroepithelial Tissue Neoplasm of Neuroepithelium Neoplasm of the Neuroepithelium Neuroepithelial Neoplasm Neuroepithelial Neoplasms Neuroepithelial Tissue Neoplasm Neuroepithelial Tissue Tumor Neuroepithelial Tumor Neuroepithelial Tumors Neuroepitheliomatous Neoplasms Tumor of Neuroepithelial Tissue Tumor of Neuroepithelium Tumor of the Neuroepithelium Neuroepithelial Neoplasm A mediastinal lymphoma with molecular, morphologic, immunophenotypic, and clinical features of both mediastinal (thymic) large B-cell lymphoma and classic Hodgkin lymphoma. The identification of this group of lymphomas, along with recent gene expression profiling results (PDL2 gene expression in both mediastinal (thymic) large B-cell lymphoma tissues and Hodgkin lymphoma cell lines), further supports the hypothesis that mediastinal (thymic) large B-cell lymphomas and classic Hodgkin lymphomas are related entities. C37870 Neoplastic Process Mediastinal Gray-Zone Lymphoma C1334657 Malignant Mediastinal_Gray_Zone_Lymphoma Mediastinal B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma Mediastinal B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma Mediastinal Gray Zone Lymphoma Mediastinal Gray-Zone Lymphoma Mediastinal Grey Zone Lymphoma Mediastinal Grey-Zone Lymphoma Mediastinal Gray-Zone Lymphoma A renal cell carcinoma with papillary architecture comprised of clear cells. It is characterized by the t(X;1)(p11.2;q21) resulting in fusion of the PRCC and TFE3 genes. C37872 Neoplastic Process Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21) C1514839 Malignant Renal_Cell_Carcinoma_with_t_X_1_p11_q21 Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21) Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21) A renal cell carcinoma with papillary architecture comprised of clear cells. It is characterized by the t(X;1)(p11.2;p34) resulting in fusion of the PSF and TFE3 genes. C37874 Neoplastic Process Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34) C1514838 Malignant Renal_Cell_Carcinoma_with_t_X_1_p11_p34 Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34) Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34) A renal cell carcinoma with papillary architecture comprised of clear cells. It is characterized by the t(X;1)(p11.2;q25) resulting in fusion of the ASPL and TFE3 genes. C37876 Neoplastic Process Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25) C1514837 Malignant Renal_Cell_Carcinoma_with_t_X_17_p11_q25 Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25) Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25) A well differentiated, slow growing neuroepithelial neoplasm composed of neoplastic, mature ganglion cells and neoplastic glial cells. Some gangliogliomas show anaplastic features in their glial component and are considered to be WHO grade III. Rare cases of newly diagnosed gangliogliomas with grade IV (glioblastoma) changes in the glial component have also been reported. (Adapted from WHO) C3788 Neoplastic Process Ganglioglioma C0206716 Cellosaurus GDC 9505/1 Undetermined Ganglioglioma 9505/1 Ganglioglioma, NOS Glioneuroma Neuroastrocytoma Ganglioglioma Ganglioglioma, NOS Ganglioglioma A rare neuroectodermal tumor originating from olfactory receptor cells in the nasal cavity or paranasal sinuses. Microscopically, it is characterized by neuroblastic differentiation with occasional formation of rosettes. If the tumor is not resected at an early stage, the prognosis is usually poor. C3789 Neoplastic Process Olfactory Neuroblastoma Olfactory Neuroblastoma C0206717 CTRP Cellosaurus GDC 9522/3 9523/3 Malignant Olfactory_Neuroblastoma 9522/3 9523/3 Esthesioneuroblastoma Esthesioneuroepithelioma Olfactory neuroblastoma Olfactory neuroepithelioma Esthesioneuroblastoma Esthesioneuroepithelioma Olfactory Esthesioneuroblastoma Olfactory Neuroblastoma Olfactory Neuroepithelioma Olfactory neuroblastoma Olfactory neuroepithelioma Olfactory Neuroblastoma A malignant neuroblastic tumor characterized by the presence of neuroblastic cells, ganglion cells, and a stroma with Schwannian differentiation constituting more than fifty-percent of the tumor volume. There are two histologic subtypes identified: ganglioneuroblastoma, intermixed and ganglioneuroblastoma, nodular. C3790 Neoplastic Process Ganglioneuroblastoma Ganglioneuroblastoma C0206718 CDISC CPTAC CTRP Cellosaurus GDC A malignant neoplasm characterized by the presence of neuroblastic and ganglion cells and a stroma with Schwannian differentiation. 9490/3 Malignant Ganglioneuroblastoma 9490/3 Ganglioneuroblastoma GANGLIONEUROBLASTOMA, MALIGNANT Ganglioneuroblastoma Ganglioneuroblastoma An intraventricular neuronal neoplasm composed of uniform round cells with neuronal differentiation. It is typically located in the lateral ventricles in the region of the foramen of Monro. It generally affects young adults and has a favorable prognosis. (Adapted from WHO) C3791 Neoplastic Process Central Neurocytoma C0206719 GDC 9506/1 Undetermined Neurocytoma 9506/1 Central neurocytoma Neurocytoma Central Neurocytoma Central Neurocytoma (WHO Grade 2) Central Neurocytoma (WHO Grade II) Central neurocytoma Central Neurocytoma A neoplasm arising in the ovary or testis. It is composed of granulosa cells, Leydig cells, Sertoli cells, and fibroblasts. Each of these cell types may constitute the only cellular component that is present in the neoplasm or it may be mixed with other cell types in various combinations. The prognosis can not always be predicted on histologic grounds alone. Approximately, 10% of these tumors may metastasize. Representative examples include granulosa cell tumor, Leydig cell tumor, Sertoli cell tumor, and tumors of the thecoma-fibroma group. C3794 Neoplastic Process Sex Cord-Stromal Tumor C0206724 GDC NICHD A rare type of cancer that forms in the tissues that support the ovaries or testes. These tumors may release sex hormones. Sex cord-gonadal stromal tumors include granulosa cell, Sertoli cell, and Leydig cell tumors. A tumor arising in the ovary or testis. It is composed of one or more of the following: granulosa cells, Leydig cells, Sertoli cells, and/or fibroblasts. 8590/1 Undetermined Sex_Cord-Stromal_Tumor 8590/1 Gonadal stromal tumor, NOS Sex cord tumor, NOS Sex cord-gonadal stromal tumor, NOS Gonadal stromal tumor, NOS Sex Cord-Stromal Neoplasm Sex Cord-Stromal Tumor sex cord tumor sex cord-gonadal stromal tumor sex cord-stromal tumor Sex Cord-Stromal Tumor A benign, slow growing neoplasm which is typically attached to a ventricular wall. It is composed of glial tumor cell clusters embedded in an abundant fibrillary matrix with frequent microcystic change. Some lesions have the histological features of both subependymoma and ependymoma. It is often detected incidentally and has a very favorable prognosis. (Adapted from WHO.) C3795 Neoplastic Process Subependymoma C0206725 CDISC GDC A benign neoplasm of the brain localized in the vicinity of a ventricular wall and is composed of glial tumor cell clusters embedded in an abundant fibrillary matrix with frequent microcystic changes. 9383/1 Undetermined Subependymoma 9383/1 Mixed subependymoma-ependymoma Subependymal glioma Subependymoma SUBEPENDYMOMA, BENIGN Subependymal Astrocytoma Subependymal Glioma Subependymal glioma Subependymoma WHO Grade 1 Ependymal Neoplasm WHO Grade 1 Ependymal Tumor WHO Grade I Ependymal Neoplasm WHO Grade I Ependymal Tumor Who Grade I Ependymal Neoplasm Who Grade I Ependymal Tumor Subependymoma A rare histological variant of glioblastoma (WHO grade IV) characterized by a biphasic tissue pattern with alternating areas displaying glial and mesenchymal differentiation (WHO). C3796 Neoplastic Process Gliosarcoma C0206726 Cellosaurus GDC A type of glioma (cancer of the brain that comes from glial, or supportive, cells). 9442/3 Malignant Gliosarcoma 9442/3 Glioblastoma with sarcomatous component Gliosarcoma Glioblastoma with a Sarcomatous Component Gliosarcoma gliosarcoma Gliosarcoma An elongated and multinodular neurofibroma, formed when the tumor involves either multiple trunks of a plexus or multiple fascicles of a large nerve, such as the sciatic. Some plexiform neurofibromas resemble a bag of worms, others produce a massive ropy enlargement of the nerve. (Adapted from WHO) C3797 Neoplastic Process Plexiform Neurofibroma Plexiform Neurofibroma C3279070 CTEP CTRP GDC A nerve that has become thick and misshapen due to the abnormal growth of cells and tissues that cover the nerve. 9550/0 Benign Plexiform_Neurofibroma 9550/0 Plexiform neurofibroma Plexiform neuroma Plexiform Neurofibroma Plexiform neurofibroma plexiform neurofibroma Plexiform Neurofibroma An uncommon, highly aggressive malignant tumor, arising from the peripheral nerves and affecting mostly adults in their third to sixth decades of life. It usually occurs in medium-sized and large nerves of the buttock, thigh, upper arm, or the paraspinal region. It may be associated with neurofibromatosis 1 (NF1). C3798 Neoplastic Process Malignant Peripheral Nerve Sheath Tumor Malignant Peripheral Nerve Sheath Tumor C3279060 CDISC CPTAC CTEP CTRP Cellosaurus GDC A malignant neoplasm, originating from the sheaths of the peripheral nerve. A type of soft tissue sarcoma that develops in cells that form a protective sheath (covering) around peripheral nerves, which are nerves that are outside of the central nervous system (brain and spinal cord). 9540/3 9560/3 Malignant Malignant_Peripheral_Nerve_Sheath_Tumor 9540/3 9560/3 MPNST, NOS Malignant peripheral nerve sheath tumor Malignant peripheral nerve sheath tumor, NOS Malignant schwannoma, NOS Neurilemoma, malignant Neurilemosarcoma Neurofibrosarcoma Neurogenic sarcoma Neurosarcoma MPNST MPNST, NOS Malig. periph. nerve sheath tum. Malignant Neurilemmoma Malignant Peripheral Nerve Sheath Neoplasm Malignant Peripheral Nerve Sheath Tumor Malignant Peripheral Nerve Sheath Tumour Malignant Schwannoma Malignant peripheral nerve sheath tumor Neurilemoma, malignant Neurofibrosarcoma Neurofibrosarcoma, Malignant Neurogenic sarcoma SCHWANNOMA, MALIGNANT malignant peripheral nerve sheath tumor Malignant Peripheral Nerve Sheath Tumor A morphologic variant of fibroma characterized by the presence of numerous dilated vascular channels. C3799 Neoplastic Process Angiofibroma C0206731 CDISC GDC A benign, morphologic variant of fibroma characterized by the presence of numerous dilated vascular channels. 9160/0 Benign Angiofibroma 9160/0 Angiofibroma, NOS Juvenile angiofibroma ANGIOFIBROMA, BENIGN Angiofibroma Angiofibroma, NOS Angiofibromatous Hyperplasia Fibroangioma, Benign Fibrous Papule Telangiectatic Fibroma Angiofibroma An intradermal nevus characterized by the presence of benign pigmented dendritic spindle-shaped melanocytes. It most frequently occurs in the skin of the distal upper extremities, followed by the lower extremities, scalp, face, and buttocks. It usually presents as a single blue or blue-black papular lesion less than 1cm in diameter. Simple excision is usually curative. C3803 Neoplastic Process Blue Nevus C0206736 GDC 8780/0 Benign Blue_Nevus 8780/0 Blue nevus, NOS Jadassohn blue nevus Blue Nevus Blue Nevus of Skin Blue Nevus of the Skin Blue Skin Nevus Blue nevus, NOS Blue Nevus A nevus characterized by the proliferation of nevus cells in the dermis without involvement of the dermal-epidermal junction. C3804 Neoplastic Process Dermal Nevus C0206737 GDC 8750/0 Benign Intradermal_Nevus 8750/0 Dermal nevus Intradermal nevus Dermal Nevus Dermal nevus Intradermal Nevus Intradermal nevus Dermal Nevus The radiographic examination of the tracheobronchial tree following the injection of a radiopaque material. C38040 Diagnostic Procedure Bronchography C0006282 Bronchography Bronchography Bronchography A radiographic procedure to obtain an image of the urinary bladder by filling the bladder with contrast medium. C38049 Diagnostic Procedure Cystography C0203126 Cystography Cystography Cystography A procedure, also known as sonohysterography or saline infusion sonography, using a minimally invasive ultrasound technique to view the inside of the uterus. Sterile saline is injected into the endometrial cavity thereby distending the endometrial cavity, providing good visualization of the anatomic structures within. C38066 Diagnostic Procedure Hysterosonography Hysterosonography C1512577 CTRP Hysterosonography Hysterosonography Saline Infusion Sonography Sonohysterography Hysterosonography The examination of the lymph nodes and lymphatic vessels following the injection of a radiopaque substance. C38069 Diagnostic Procedure Lymphangiography Lymphangiography C0024219 CDISC CTRP A type of angiographic procedure that allows for the examination of the lymph nodes and lymphatic vessels following the injection of a radiopaque substance. An x-ray study of the lymphatic system. A dye is injected into a lymphatic vessel and travels throughout the lymphatic system. The dye outlines the lymphatic vessels and organs on the x-ray. Lymphangiography LYMPHANGIOGRAPHY Lymphangiography Lymphography lymphangiography lymphography Lymphangiography A nuclear imaging method that evaluates bilateral renal function including glomerular filtration, renal excretion and renal tubular cell uptake markers by using radionuclides. C38086 Diagnostic Procedure Renography C0205917 Renography Renography Renography An epithelial neoplasm with neuroendocrine differentiation. This category includes neuroendocrine tumors, neuroendocrine carcinomas, and paragangliomas. C3809 Neoplastic Process Neuroendocrine Tumor Neuroendocrine Neoplasm C0206754 CPTAC CTRP GDC NICHD A tumor that forms from cells that release hormones in response to a signal from the nervous system. Some examples of neuroendocrine tumors are carcinoid tumors, islet cell tumors, medullary thyroid carcinomas, pheochromocytomas, and neuroendocrine carcinomas of the skin (Merkel cell cancer). These tumors may secrete higher-than-normal amounts of hormones, which can cause many different symptoms. Undetermined Neuroendocrine_Neoplasm Neuroendocrine Tumor Neuroendocrine tumors NEN Neuroendocrine Neoplasm Neuroendocrine Tumor neuroendocrine tumor Neuroendocrine Neoplasm A procedure used to detect fractures, tumors, or degenerative conditions of the bone. C38092 Diagnostic Procedure Skeletal Survey X-Ray C0202616 Skeletal_Survey_X-Ray Skeletal Survey Skeletal Survey X-Ray Skeletal Survey X-Ray A procedure that examines motility and mucosal pattern of the small intestine and involves the patient drinking barium as well as having X-rays of the abdomen taken at intermittent intervals. C38094 Diagnostic Procedure Small Bowel Follow Through Procedure C1519363 Small_Bowel_Follow_Through_Procedure Small Bowel Follow Through Procedure Small Bowel Follow Through Procedure A radiographic examination of the vagina using the intravaginal injection of contrast medium. C38096 Diagnostic Procedure Vaginography C0203051 Vaginography Vaginography Vaginography A type of X-ray in which contrast medium is injected into a vein to show the details of the structure of the vena cava and any associated abnormalities. C38098 Diagnostic Procedure Venacavography C1519963 Venacavography Venacavography Venacavography A type of X-ray in which contrast medium is injected into a vein to show the details of its structure and any associated abnormalities. C38099 Diagnostic Procedure Venography C0031545 A procedure in which an x-ray of the veins is taken after a special dye is injected into the bone marrow or veins. Venography Venography venography Venography A benign, intermediate, or malignant neoplasm that affects the connective and soft tissue. C3810 Neoplastic Process Connective and Soft Tissue Neoplasm Connective and Soft Tissue Neoplasm C0206765 CTRP Undetermined Connective_and_Soft_Tissue_Neoplasm Connective and Soft Tissue Neoplasm Connective and Soft Tissue Tumor Musculoskeletal and Soft Tissue Neoplasm Musculoskeletal and Soft Tissue Tumor Neoplasm of Skeletal and Soft Tissue Neoplasm of Soft Tissue and Bone Neoplasm of Soft Tissue and Skeleton Skeletal and Soft Tissue Neoplasm Skeletal and Soft Tissue Tumor Soft Tissue and Bone Neoplasm Soft Tissue and Bone Tumor Tumor of Skeletal and Soft Tissue Tumor of Soft Tissue and Bone Tumor of Soft Tissue and Skeleton Connective and Soft Tissue Neoplasm A radiographic procedure using the emission of x-rays to form an image of the structure penetrated by the radiation. C38101 Diagnostic Procedure Radiography X-Ray Imaging C0043299 CDISC CTRP MRCT-Ctr OORO PCDC mCode A radiographic procedure using the emission of x-rays, a type of penetrating energy wave. A way of taking pictures of the inside of a person's body using X-ray radiation. (https://mrctcenter.org/glossaryterm/x-ray/) Radiography Conventional X-Ray Diagnostic Radiology Medical Imaging, X-Ray Plain film radiographs RG Radiographic Imaging Radiographic imaging procedure (procedure) Radiography Static X-Ray X-RAY X-Ray X-Ray Imaging X-ray X-Ray Imaging A radiographic procedure to form an image of the abdomen. C38102 Diagnostic Procedure Abdominal Radiography C0034573 An x-ray of the organs inside the abdomen. An x-ray is a type of radiation that can pass through the body and onto film, making pictures of areas inside the body. X-rays may be used to help diagnose disease. Abdominal_Radiography Abdominal Radiography Abdominal X-Ray abdominal x-ray Abdominal Radiography An x-ray examination of the chest. C38103 Diagnostic Procedure Chest Radiography Chest Radiography C0039985 ACC/AHA CTRP An x-ray of the structures inside the chest. An x-ray is a type of high-energy radiation that can go through the body and onto film, making pictures of areas inside the chest, which can be used to diagnose disease. Documented findings from the radiological examination of the chest (chest x-ray) Chest_Radiography Chest Radiography Chest X-ray Chest radiography chest x-ray Chest Radiography A morphologic variant of dermatofibrosarcoma protuberans characterized by the presence of areas of myofibroblastic differentiation. C38105 Neoplastic Process Dermatofibrosarcoma Protuberans with Myoid Differentiation C1275249 Undetermined Myoid_Dermatofibrosarcoma_Protuberans Dermatofibrosarcoma Protuberans with Myoid Differentiation Myoid Dermatofibrosarcoma Protuberans Dermatofibrosarcoma Protuberans with Myoid Differentiation A morphologic variant of dermatofibrosarcoma protuberans characterized by the presence of extensive myxoid stroma formation and a storiform growth pattern. C38106 Neoplastic Process Myxoid Dermatofibrosarcoma Protuberans CL448745 Undetermined Myxoid_Dermatofibrosarcoma_Protuberans Myxoid Dermatofibrosarcoma Protuberans Myxoid Dermatofibrosarcoma Protuberans A morphologic variant of dermatofibrosarcoma protuberans characterized by the presence of poorly differentiated sarcomatous components. C38107 Neoplastic Process Dedifferentiated Dermatofibrosarcoma Protuberans C1333264 Undetermined Dedifferentiated_Dermatofibrosarcoma_Protuberans Dedifferentiated Dermatofibrosarcoma Protuberans Dedifferentiated Dermatofibrosarcoma Protuberans A morphologic variant of dermatofibrosarcoma protuberans characterized by areas of fibroblastoma like-differentiation, and the presence of giant cells. C38108 Neoplastic Process Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation C1333277 Undetermined Dermatofibrosarcoma_Protuberans_with_Giant_Cell_Fibroblastoma-Like_Differentiation Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation A basal cell carcinoma of the skin that is characterized by adnexal differentiation. C38109 Neoplastic Process Skin Basal Cell Carcinoma with Adnexal Differentiation C1879790 Malignant Basosebaceous_Basal_Cell_Carcinoma Skin Basal Cell Carcinoma with Adnexal Differentiation Skin Basal Cell Carcinoma with Adnexal Differentiation A primary or metastatic malignant neoplasm that affects the major or minor salivary glands. Representative examples include carcinoma, lymphoma, and sarcoma. C3811 Neoplastic Process Malignant Salivary Gland Neoplasm Malignant Salivary Gland Neoplasm C0220636 CPTAC CTEP CTRP A rare cancer that forms in tissues of a salivary gland (gland in the mouth that makes saliva). Most salivary gland cancers occur in older people. Malignant Malignant_Salivary_Gland_Neoplasm Malignant neoplasm of salivary gland, unspecified Cancer of Salivary Gland Cancer of the Salivary Gland Malignant Neoplasm of Salivary Gland Malignant Neoplasm of the Salivary Gland Malignant Salivary Gland Neoplasm Malignant Salivary Gland Tumor Malignant Tumor of Salivary Gland Malignant Tumor of the Salivary Gland Salivary Gland Cancer Salivary gland cancer salivary gland cancer Malignant Salivary Gland Neoplasm A rare type of basal cell carcinoma. It is characterized by the presence of mucin containing signet ring cells. C38110 Neoplastic Process Skin Signet Ring Cell Basal Cell Carcinoma C1519320 Malignant Signet_Ring_Cell_Basal_Cell_Carcinoma Signet Ring Cell Basal Cell Carcinoma Skin Signet Ring Cell Basal Cell Carcinoma Skin Signet-Ring Cell Basal Cell Carcinoma Skin Signet Ring Cell Basal Cell Carcinoma A basal cell carcinoma of the skin characterized by the presence of sarcomatoid features. C38111 Neoplastic Process Skin Basal Cell Carcinoma with Sarcomatoid Differentiation C1519182 Malignant Sarcomatoid_Basal_Cell_Carcinoma Skin Basal Cell Carcinoma with Sarcomatoid Differentiation Skin Sarcomatoid Basal Cell Carcinoma Skin Basal Cell Carcinoma with Sarcomatoid Differentiation The process of obtaining contrast esophagrams. C38112 Diagnostic Procedure Esophagography C0203065 Esophagography Barium Swallow Contrast Esophagraphy Esophagography barium swallow Esophagography A malignant neoplasm that has spread to the brain from another anatomic site or system. The majority are carcinomas (usually lung or breast carcinomas). C3813 Neoplastic Process Metastatic Malignant Neoplasm to the Brain Metastatic Malignant Neoplasm in the Brain C0220650 CPTAC CTEP CTRP mCode Cancer that has spread from the original (primary) tumor to the brain. Malignant Metastatic_Neoplasm_to_the_Brain Secondary malignant neoplasm of brain Brain Metastases Brain Metastasis Metast. to brain parenchyma, NOS Metastases to brain parenchyma, NOS Metastatic Malignant Neoplasm in the Brain Metastatic Malignant Neoplasm to the Brain Metastatic Neoplasm to the Brain Metastatic Tumor to the Brain Secondary malignant neoplasm of brain brain metastasis Metastatic Malignant Neoplasm in the Brain A malignant neoplasm that has spread from its original site of growth to the leptomeninges. C3814 Neoplastic Process Metastatic Malignant Neoplasm to the Leptomeninges Metastatic Malignant Neoplasm in the Leptomeninges CL411846 CTEP CTRP A serious problem that may occur in cancer in which cancer cells spread from the original (primary) tumor to the meninges (thin layers of tissue that cover and protect the brain and spinal cord). It can happen in many types of cancer, but is the most common in melanoma, breast, lung, and gastrointestinal cancer. The cancer may cause the meninges to be inflamed. Malignant Metastasis_to_the_Leptomeninges Leptomeningeal Metastases Leptomeningeal Metastasis Leptomeningeal metastases, NOS Meningeal Metastasis Metastasis to the Leptomeninges Metastatic Malignant Neoplasm in the Leptomeninges Metastatic Malignant Neoplasm in the Meninges Metastatic Malignant Neoplasm to the Leptomeninges Metastatic Neoplasm to the Leptomeninges Metastatic Neoplasm to the Meninges Metastatic Tumor to the Leptomeninges carcinomatous meningitis leptomeningeal carcinoma leptomeningeal metastasis meningeal metastasis neoplastic meningitis Metastatic Malignant Neoplasm in the Leptomeninges A soft tissue mesenchymal tumor with perivascular epithelioid cell differentiation. Representative examples include angiomyolipoma, clear cell-sugar-tumor of the lung, and lymphangioleiomyomatosis. C38150 Neoplastic Process PEComa C1300127 Undetermined Neoplasm_with_Perivascular_Epithelioid_Cell_Differentiation Neoplasm with Perivascular Epithelioid Cell Differentiation PEComa Tumor with Perivascular Epithelioid Cell Differentiation PEComa An angiomyolipoma composed exclusively or predominantly of epithelioid cells. It is often associated with cytologic atypia and may recur or metastasize. C38151 Neoplastic Process Epithelioid Angiomyolipoma C1333426 Undetermined Epithelioid_Type_Angiomyolipoma Angiomyolipoma, epithelioid EAML Epithelioid Angiomyolipoma Epithelioid Type Angiomyolipoma Epithelioid Angiomyolipoma A rare benign lung tumor with perivascular epithelioid cell differentiation. It is composed of round or oval cells with abundant clear or eosinophilic cytoplasm and distinct cell borders. The vast majority of patients are asymptomatic and the tumors are discovered incidentally. Excision is curative. C38152 Neoplastic Process Lung Clear Cell Tumor C1333065 Benign Clear_Cell-Sugar-Tumor_of_the_Lung CCSTL Clear Cell-Sugar-Tumor of Lung Clear Cell-Sugar-Tumor of the Lung Lung Clear Cell Tumor Sugar Tumor Lung Clear Cell Tumor Lymphangiomyomatosis involving the lungs and local lymph nodes. Patients usually present with chylous pleural effusion. The clinical course is variable. Patients with resectable lesions usually have a favorable clinical outcome. Patients with diffuse lesions usually have a progressive clinical course. C38153 Neoplastic Process Lung Lymphangioleiomyomatosis C0349649 Cellosaurus Undetermined Lung_Lymphangioleiomyomatosis Lung Lymphangioleiomyomatosis Lung Lymphangiomyomatosis Lung Lymphangioleiomyomatosis A very rare, usually benign neoplasm with perivascular epithelioid cell differentiation characterized by the presence of clear spindle cells arranged in fascicles and nests that usually affects young girls. Patients usually present with a painful abdominal mass. C38154 Neoplastic Process Clear Cell Myomelanocytic Tumor of the Falciform Ligament/Ligamentum Teres C1333068 Undetermined Clear_Cell_Myomelanocytic_Tumor_of_the_Falciform_Ligament_Ligamentum_Teres CCMMT Clear Cell Myomelanocytic Tumor of the Falciform Ligament/Ligamentum Teres Clear Cell Myomelanocytic Tumor of the Falciform Ligament/Ligamentum Teres A bone osteosarcoma that has metastasized to skeletal or extraskeletal sites. C38157 Neoplastic Process Metachronous Osteosarcoma C1334704 Malignant Metachronous_Osteosarcoma Metachronous Osteosarcoma Metachronous Osteosarcoma of the Bone Metachronous Osteosarcoma Wilms tumor arising in the remaining kidney following treatment of the original Wilms tumor. C38158 Neoplastic Process Metachronous Kidney Wilms Tumor C1334705 Malignant Metachronous_Wilms_Tumor Metachronous Kidney Nephroblastoma Metachronous Kidney Wilms Tumor Metachronous Wilms Tumor Metachronous Wilms Tumor of the Kidney Metachronous Kidney Wilms Tumor A plasmablastic lymphoma that arises from a mucosal site. C38159 Neoplastic Process Plasmablastic Lymphoma of Mucosa Site C1335427 Malignant Plasmablastic_Lymphoma_of_Mucosa_Site Plasmablastic Lymphoma of Mucosa Site Plasmablastic Lymphoma of Mucosa Site A plasmablastic mucosal site lymphoma in a patient with acquired immunodeficiency syndrome. C38160 Neoplastic Process AIDS-Related Plasmablastic Lymphoma of Mucosa Site C1332056 Malignant AIDS-Related_Plasmablastic_Lymphoma_of_Mucosa_Site AIDS-Related Plasmablastic Lymphoma of Mucosa Site AIDS-Related Plasmablastic Lymphoma of Mucosa Site A non-Hodgkin lymphoma that arises from any part of the digestive system, with the bulk of the disease localized to that site. C38161 Neoplastic Process Digestive System Non-Hodgkin Lymphoma C1333800 Malignant Gastrointestinal_Non-Hodgkin_s_Lymphoma Digestive System Non-Hodgkin Lymphoma Gastrointestinal Non-Hodgkin Lymphoma Gastrointestinal Non-Hodgkin's Lymphoma Primary Digestive System Non-Hodgkin Lymphoma Primary Gastrointestinal Non-Hodgkin's Lymphoma Digestive System Non-Hodgkin Lymphoma A non-Hodgkin or Hodgkin lymphoma that arises from any part of the digestive system, with the bulk of the disease localized to that site. C38162 Neoplastic Process Digestive System Lymphoma C0740372 Malignant Gastrointestinal_Lymphoma Digestive System Lymphoma Gastrointestinal Lymphoma Primary Digestive System Lymphoma Primary Gastrointestinal Lymphoma Digestive System Lymphoma A Hodgkin lymphoma that arises from any part of the digestive system, with the bulk of the disease localized to that site. C38163 Neoplastic Process Digestive System Hodgkin Lymphoma C1333797 Malignant Gastrointestinal_Hodgkin_s_Lymphoma Digestive System Hodgkin Lymphoma Gastrointestinal Hodgkin Lymphoma Gastrointestinal Hodgkin's Lymphoma Primary Digestive System Hodgkin Lymphoma Primary Gastrointestinal Hodgkin's Lymphoma Digestive System Hodgkin Lymphoma A premalignant pathologic process arising from an organ of the male reproductive system. It is characterized by cellular atypia and/or dysplasia but does not show morphologic evidence of stromal invasion at the time of diagnosis. Representative examples include prostatic intraepithelial neoplasia, giant condyloma acuminatum of the penis, and penile intraepithelial neoplasia. C38164 Neoplastic Process Male Reproductive System Precancerous Condition C1334555 Header_Concept Undetermined Male_Reproductive_System_Precancerous_Condition Male Reproductive System Precancerous Condition Male Reproductive System Precancerous Condition A plasma cell neoplasm that secretes an abnormal immunoglobulin, which deposits in tissues and forms a beta-pleated sheet structure that binds Congo red dye with characteristic birefringence. (WHO, 2001) C3819 Neoplastic Process Primary Amyloidosis C0268381 GDC Undetermined Primary_Amyloidosis 9769/1 Primary amyloidosis Primary Amyloidosis Primary amyloidosis Primary Amyloidosis A cavernous angiomatosis associated with the destruction of platelets, resulting in thrombocytopenia. C3821 Neoplastic Process Hemangiomatosis with Thrombocytopenia C0221025 Benign Hemangiomatosis_with_Thrombocytopenia Hemangioma-Hemorrhage Syndrome Hemangiomatosis with Thrombocytopenia Kasabach-Merritt Syndrome Thrombocytopenia-Hemangioma Syndrome Thrombopenia-Hemangioma Syndrome Hemangiomatosis with Thrombocytopenia A self-limiting, rapidly growing, non-encapsulated benign neoplasm that arises from the soft tissues. It is characterized by the presence of plump spindle-shaped fibroblasts, multinucleated osteoclast-like giant cells, chronic inflammatory infiltrate, red blood cell extravasation, and high mitotic activity. C3827 Neoplastic Process Nodular Fasciitis C0410005 Benign Nodular_Fasciitis Nodular fasciitis Nodular Fasciitis Pseudosarcomatous Fasciitis Nodular Fasciitis A rare tumor containing unequivocal elements of both hepatocellular and cholangiocarcinoma that are intimately admixed. This tumor should be distinguished from separate hepatocellular carcinoma and cholangiocarcinoma arising in the same liver. The prognosis of this tumor is poor. C3828 Neoplastic Process Combined Hepatocellular Carcinoma and Cholangiocarcinoma Combined Hepatocellular Carcinoma and Cholangiocarcinoma C0221287 CTRP Cellosaurus GDC 8180/3 Malignant Combined_Hepatocellular_Carcinoma_and_Cholangiocarcinoma 8180/3 Combined hepatocellular carcinoma and cholangiocarcinoma Hepatocholangiocarcinoma Mixed hepatocellular and bile duct carcinoma Carcinoma of Liver and Intrahepatic Biliary Tract Carcinoma of the Liver and Intrahepatic Biliary Tract Cholangiohepatoma Combined Hepatocellular Cancer and Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) Combined Hepatocellular Carcinoma and Cholangiocarcinoma Combined hepatocellular carcinoma and cholangiocarcinoma Hepatocholangiocarcinoma Liver and Intrahepatic Biliary Tract Carcinoma Mixed Hepatocellular Cholangiocarcinoma cHCC-CCA Combined Hepatocellular Carcinoma and Cholangiocarcinoma A benign neoplasm arising from the synovial membrane. Examples include the diffuse giant cell tumor of tendon sheath and localized giant cell tumor of tendon sheath. C3829 Neoplastic Process Benign Synovial Neoplasm C0221289 CDISC Cellosaurus GDC A benign neoplasm arising from the synovial membrane. 9040/0 Benign Benign_Synovial_Neoplasm 9040/0 Synovioma, benign Benign Neoplasm of Synovium Benign Neoplasm of the Synovium Benign Synovial Neoplasm Benign Synovial Tumor Benign Synovioma Benign Tumor of Synovium Benign Tumor of the Synovium SYNOVIOMA, BENIGN Synovioma, benign Benign Synovial Neoplasm An uncommon benign cartilaginous neoplasm arising from the bone. It is characterized by the presence of spindle-shaped or stellate chondrocytes, a lobulated growth pattern, myxoid stroma formation, and sometimes multinucleated giant cells. It has been associated with chromosomal rearrangement of 6q13 and 6q25 bands. The most common clinical symptom is mild, localized pain. C3830 Neoplastic Process Chondromyxoid Fibroma C0221290 GDC 9241/0 Benign Chondromyxoid_Fibroma 9241/0 Chondromyxoid fibroma Chondromyxoid Fibroma Chondromyxoid fibroma Chondromyxoid Fibroma A usually slow-growing epithelial neoplasm with ductal differentiation that arises from the exocrine pancreas and grows mostly within the pancreatic ducts. Grossly, it is characterized by the presence of intraductal masses. Morphologically, there is proliferation of mucin-producing cells within the pancreatic ducts, intraductal accumulation of mucin, and a papillary growth pattern. It may be associated with the presence of an invasive carcinoma. It usually occurs in older patients. Signs and symptoms include epigastric pain, weight loss, jaundice, chronic pancreatitis, and diabetes mellitus. C38342 Neoplastic Process Pancreatic Intraductal Papillary-Mucinous Neoplasm Pancreatic Intraductal Papillary-Mucinous Neoplasm C1266071 CTRP Cellosaurus GDC Undetermined Pancreatic_Intraductal_Papillary-Mucinous_Neoplasm Intraductal Papillary Mucinous Neoplasm Pancreatic IPMN Pancreatic Intraductal Papillary-Mucinous Neoplasm Pancreatic Intraductal Papillary-Mucinous Tumor Pancreatic Intraductal Papillary-Mucinous Neoplasm Acute myeloid leukemia with variant RARA rearrangement and expression of STAT5B-RARA fusion protein. C38377 Neoplastic Process Acute Myeloid Leukemia with STAT5B-RARA C4055496 NICHD Acute myeloid leukemia with the variant RARA t(17;17)(q21;q21) and the expression of STAT5B-RARA fusion protein. Malignant Acute_Promyelocytic_Leukemia_with_t_17_17_q11_q11 APL with t(17;17)(q21;q21); STAT5B-RARA Acute Myeloid Leukemia with STAT5B-RARA Acute Myeloid Leukemia with STAT5B-RARA Expression Acute Myeloid Leukemia with STAT5B-RARA Fusion Acute Myeloid Leukemia with STAT5B::RARA Acute Myeloid Leukemia with STAT5B::RARA Expression Acute Myeloid Leukemia with STAT5B::RARA Fusion Acute Myeloid Leukemia with t(17;17)(q21;q21) Acute Promyelocytic Leukemia with t(17;17)(q21;q21); STAT5B-RARA Acute Myeloid Leukemia with STAT5B-RARA A hemangioma present at birth. C3841 Congenital Abnormality Neoplastic Process Congenital Hemangioma C0235753 Benign Congenital_Hemangioma Congenital Angioma Congenital Hemangioma Congenital Non-Progressive Hemangioma Congenital Hemangioma A rare benign neoplasm that arises from the urinary tract and is characterized by the presence of a papillary growth with a central fibrovascular core. The latter is lined by normal urothelium. C3842 Neoplastic Process Urothelial Papilloma C0235754 GDC 8120/1 Benign Urothelial_Papilloma 8120/1 Papilloma of bladder Urothelial papilloma, NOS Papilloma of bladder Urothelial Papilloma Urothelial papilloma, NOS Urothelial Papilloma A malignant tumor arising from the epithelium of the gallbladder. It is usually associated with the presence of gallstones. Clinical symptoms are not specific and usually present late in the course. Morphologically, most gallbladder carcinomas are adenocarcinomas; squamous cell carcinomas, adenosquamous carcinomas, signet ring carcinomas, and undifferentiated carcinomas can also occur. C3844 Neoplastic Process Gallbladder Carcinoma Gallbladder Carcinoma C0235782 CPTAC CTEP CTRP Cellosaurus GDC Cancer that forms in tissues of the gallbladder. The gallbladder is a pear-shaped organ below the liver that collects and stores bile (a fluid made by the liver to digest fat). Gallbladder cancer begins in the innermost layer of tissue and spreads through the outer layers as it grows. Malignant Gallbladder_Carcinoma Gallbladder Cancer Cancer of Gallbladder Cancer of the Gallbladder Carcinoma of Gallbladder Carcinoma of the Gallbladder Gall bladder carcinoma (adeno) Gall bladder carcinoma (adenocarcinoma) Gallbladder Cancer Gallbladder Carcinoma gallbladder cancer Gallbladder Carcinoma Leukemia that occurs during the neonatal period. C3845 Neoplastic Process Neonatal Leukemia C0235813 Malignant Neonatal_Leukemia Neonatal Leukemia Neonatal Leukemia An adenoma that arises from the large intestine and the appendix. It is characterized by prominent serration of the glands. C38458 Neoplastic Process Traditional Serrated Adenoma C1266025 GDC 8213/0 Benign Serrated_Adenoma 8213/0 Mixed adenomatous and hyperplastic polyp Serrated adenoma Serrated adenoma, NOS Traditional serrated adenoma Serrated Adenoma Serrated Adenoma Type II Serrated adenoma TSA Traditional Serrated Adenoma Traditional serrated adenoma Traditional Serrated Adenoma A neoplasm that arises from the breast in females and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C3848 Neoplastic Process Benign Female Breast Neoplasm C0235922 Benign Benign_Female_Breast_Neoplasm Benign Female Breast Neoplasm Benign Female Breast Tumor Benign Neoplasm of Female Breast Benign Neoplasm of the Female Breast Benign Tumor of Female Breast Benign Tumor of the Female Breast Benign Female Breast Neoplasm A carcinoma arising from the exocrine pancreas. The overwhelming majority of pancreatic carcinomas are adenocarcinomas. C3850 Neoplastic Process Pancreatic Carcinoma Pancreatic Carcinoma C0235974 CPTAC CTEP CTRP Cellosaurus GDC A disease in which malignant (cancer) cells are found in the tissues of the pancreas. Malignant Pancreatic_Carcinoma Pancreas Cancer Cancer of Pancreas Cancer of the Pancreas Carcinoma of Pancreas Carcinoma of the Pancreas Exocrine Pancreas Carcinoma Pancreas Cancer Pancreas Carcinoma Pancreatic Cancer Pancreatic Carcinoma Pancreatic cancer (excluding Islets), NOS Pancreatic cancer (not Islets) exocrine cancer pancreatic cancer Pancreatic Carcinoma A cystic teratoma that arises from the ovary. It presents as a cystic mass that contains sebaceous material admixed with hairs. In a minority of cases it is bilateral. C3856 Neoplastic Process Ovarian Dermoid Cyst C0237020 Cellosaurus Benign Ovarian_Dermoid_Cyst Dermoid Cyst of Ovary Dermoid Cyst of the Ovary Ovarian Dermoid Cyst Ovarian Dermoid Cyst A carcinoma that arises from the extrahepatic bile ducts. The majority are adenocarcinomas. C3860 Neoplastic Process Extrahepatic Bile Duct Carcinoma Extrahepatic Bile Duct Carcinoma C0238019 CTRP A rare cancer that forms in the part of the bile duct that is outside the liver. The bile duct is the tube that collects bile from the liver and joins a duct from the gallbladder to form the common bile duct, which carries bile into the small intestine when food is being digested. Malignant Extrahepatic_Bile_Duct_Carcinoma Carcinoma of Extrahepatic Bile Duct Carcinoma of the Extrahepatic Bile Duct Extrahepatic Bile Duct Cancer Extrahepatic Bile Duct Carcinoma extrahepatic bile duct cancer Extrahepatic Bile Duct Carcinoma A rare malignant tumor of the breast, affecting mostly older men. It accounts for less than 1% of all malignancies in men. The most common histologic type is invasive ductal carcinoma. Most patients are treated with mastectomy. C3862 Neoplastic Process Male Breast Carcinoma Male Breast Carcinoma C0238033 CTRP Cancer that forms in tissues of the breast in men. Most male breast cancer begins in cells lining the ducts. It is very rare and usually affects older men. Malignant Male_Breast_Carcinoma Carcinoma of Male Breast Carcinoma of the Male Breast Male Breast Cancer Male Breast Carcinoma male breast cancer Male Breast Carcinoma A benign papillary neoplasm that arises anywhere in the ductal system of the breast. It is characterized by the presence of fibrovascular structures lined by benign epithelial and myoepithelial proliferations. Intraductal breast papillomas are classified as central, when they arise in large ducts, or peripheral, when they arise in the terminal ductal lobular units. C3863 Neoplastic Process Breast Intraductal Papilloma C0238034 GDC A benign (not cancer), wart-like growth in a milk duct of the breast. It is usually found close to the nipple and may cause a discharge from the nipple. It may also cause pain and a lump in the breast that can be felt. It usually affects women aged 35-55 years. Having a single papilloma does not increase the risk of breast cancer. When there are multiple intraductal breast papillomas, they are usually found farther from the nipple. There may not be a nipple discharge and the papillomas may not be felt. Having multiple intraductal breast papillomas may increase the risk of breast cancer. 8504/0 Benign Intracystic_Papilloma Intraductal_Breast_Papilloma 8504/0 Intracystic papillary adenoma Intracystic papilloma Breast Intracystic Papilloma Breast Intraductal Papilloma Breast Papilloma Duct Papilloma of Breast Duct Papilloma of the Breast Ductal Breast Papilloma Intracystic Papilloma Intracystic papillary adenoma Intracystic papilloma Intraductal Breast Papilloma Intraductal Papilloma of Breast Intraductal Papilloma of the Breast Papilloma of Breast Papilloma of the Breast intraductal breast papilloma Breast Intraductal Papilloma An adenoma that arises from the colon. The group of colonic adenomas includes tubular, villous, and tubulovillous adenomas, traditional serrated adenomas, sessile serrated adenomas/polyps, and familial adenomatous polyposis. C3864 Neoplastic Process Colon Adenoma C0850572 Benign Colonic_Adenoma Adenoma of Colon Adenoma of the Colon Colon Adenoma Colonic Adenoma Colon Adenoma A benign smooth muscle neoplasm arising from the lower part of the esophagus. It is the most common mesenchymal neoplasm of the esophagus. Dysphagia is a frequent clinical symptom. C3866 Neoplastic Process Esophageal Leiomyoma C0238114 Benign Esophageal_Leiomyoma Esophageal Leiomyoma Esophagus Leiomyoma Leiomyoma of Esophagus Leiomyoma of the Esophagus Esophageal Leiomyoma Coexistence of Hodgkin and non-Hodgkin lymphoma in the same anatomic site. C38661 Neoplastic Process Composite Lymphoma Composite Lymphoma C0545080 CPTAC CTRP GDC A rare form of lymphoma (cancer that begins in cells of the immune system) in which different types of lymphoma cells occur at the same time. The different lymphoma cells may form in the same tissue or organ or in many different tissues or organs. The composite lymphoma may contain different types of non-Hodgkin lymphoma cells or both Hodgkin and non-Hodgkin lymphoma cells. 9596/3 Malignant Composite_Lymphoma 9596/3 Composite Hodgkin and non-Hodgkin lymphoma Composite Lymphoma composite lymphoma Composite Lymphoma The section of the left hepatic duct located in the liver. C38668 Anatomical Structure Intrahepatic Portion of the Left Hepatic Duct C1512950 Intrahepatic_Portion_of_the_Left_Hepatic_Duct Intrahepatic Portion of the Left Hepatic Duct Intrahepatic Portion of the Left Hepatic Duct The section of the right hepatic duct located in the liver. C38669 Anatomical Structure Intrahepatic Portion of the Right Hepatic Duct C1512951 Intrahepatic_Portion_of_the_Right_Hepatic_Duct Intrahepatic Portion of the Right Hepatic Duct Intrahepatic Portion of the Right Hepatic Duct A carcinoma arising from the fallopian tube. Most patients are postmenopausal, and postmenopausal bleeding is the most frequently seen symptom. Morphologically, the majority of fallopian tube carcinomas are serous or endometrioid adenocarcinomas. C3867 Neoplastic Process Fallopian Tube Carcinoma Fallopian Tube Carcinoma C0238122 CPTAC CTEP CTRP Cellosaurus Malignant Fallopian_Tube_Carcinoma Cancer of Fallopian Tube Cancer of the Fallopian Tube Carcinoma of Fallopian Tube Carcinoma of the Fallopian Tube Fallopian Tube Cancer Fallopian Tube Carcinoma Fallopian tube carcinoma Fallopian Tube Carcinoma The segment of the left hepatic duct located in the hilum of the liver. C38670 Anatomical Structure Hilar Portion of the Left Hepatic Duct C1512461 Hilar_Portion_of_the_Left_Hepatic_Duct Hilar Portion of the Left Hepatic Duct Hilar Portion of the Left Hepatic Duct The segment of the right hepatic duct located in the hilum of the liver. C38671 Anatomical Structure Hilar Portion of the Right Hepatic Duct C1512462 Hilar_Portion_of_the_Right_Hepatic_Duct Hilar Portion of the Right Hepatic Duct Hilar Portion of the Right Hepatic Duct A stromal tumor most commonly seen in the gastrointestinal tract. Rare cases of solitary masses in the omentum or the mesentery have also been reported (extragastrointestinal gastrointestinal stromal tumor). It is a tumor that differentiates along the lines of interstitial cells of Cajal. Most cases contain KIT- or PDGFRA-activating mutations. Until recently, surgery has been the only effective therapy for this tumor. However, many patients still experience recurrence. Conventional chemotherapy and radiation therapy have been of limited value. A KIT tyrosine kinase inhibitor, imatinib mesylate (also known as STI-571 or Gleevec), is now effective in the treatment of relapsed and unresectable cases. C3868 Neoplastic Process Gastrointestinal Stromal Tumor Gastrointestinal Stromal Tumor C3149028 CPTAC CTEP CTRP Cellosaurus GDC mCode A type of tumor that usually begins in cells in the wall of the gastrointestinal tract. It can be benign or malignant. 8936/1 Undetermined Gastrointestinal_Stromal_Tumor 8936/1 GIST, NOS Gastrointestinal stromal tumor, NOS GIST GIST, NOS GISTs Gastrointestinal Stromal Neoplasm Gastrointestinal Stromal Tumor Gastrointestinal Stromal Tumor (GIST) Gastrointestinal stromal tumor Gastrointestinal stromal tumor, NOS Gastrointestinal stromal tumor, unspecified site gastrointestinal stromal tumor Gastrointestinal Stromal Tumor A hemangioma arising from the liver. C3869 Neoplastic Process Liver Hemangioma C0238246 Benign Hepatic_Hemangioma Angioma of Liver Angioma of the Liver Hemangioma of Liver Hemangioma of the Liver Hepatic Angioma Hepatic Hemangioma Liver Angioma Liver Hemangioma Liver Hemangioma A carcinoma arising from the nasopharyngeal epithelium. It includes the following types: keratinizing squamous cell carcinoma, nonkeratinizing carcinoma (differentiated and undifferentiated), basaloid squamous cell carcinoma, and papillary adenocarcinoma. C3871 Neoplastic Process Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma C2931822 CPTAC CTEP CTRP Cellosaurus Cancer that forms in tissues of the nasopharynx (upper part of the throat behind the nose). Most nasopharyngeal cancers are squamous cell carcinomas (cancer that begins in flat cells lining the nasopharynx). Malignant Nasopharyngeal_Carcinoma Cancer of Nasopharynx Cancer of the Nasopharynx Carcinoma of Nasopharynx Carcinoma of the Nasopharynx NPC Nasopharyngeal Cancer Nasopharyngeal Carcinoma Nasopharyngeal Throat Cancer Nasopharyngeal carcinoma Nasopharynx Cancer nasopharyngeal cancer Nasopharyngeal Carcinoma A neoplasm that arises from the ovary and is composed of nests of neoplastic urothelial-type cells in a fibrotic stroma. It includes benign Brenner tumor, borderline Brenner tumor, and malignant Brenner tumor. C3872 Neoplastic Process Ovarian Brenner Tumor Ovarian Brenner Tumor C0006160 CTRP Undetermined Brenner_Tumor_of_the_Ovary Ovarian_Transitional_Cell_Neoplasm Brenner Neoplasm of Ovary Brenner Neoplasm of the Ovary Brenner Tumor of Ovary Brenner Tumor of the Ovary Ovarian Brenner Neoplasm Ovarian Brenner Tumor Ovarian Transitional Cell Neoplasm Ovarian Transitional Cell Tumor Ovarian Brenner Tumor A neoplasm that arises from the ovary and originates from germ cells. Representative examples include teratoma, embryonal carcinoma, yolk sac tumor, and dysgerminoma. C3873 Neoplastic Process Ovarian Germ Cell Tumor Ovarian Germ Cell Tumor C0238324 CTRP MedDRA NICHD A neoplasm arising from gonadal tissue within the ovary. An abnormal mass of tissue that forms in germ (egg) cells in the ovary (female reproductive gland in which the eggs are formed). These tumors usually occur in teenage girls or young women, usually affect just one ovary, and can be benign (not cancer) or malignant (cancer). The most common ovarian germ cell tumor is called dysgerminoma. Undetermined Ovarian_Germ_Cell_Tumor Ovarian germ cell tumor Germ Cell Neoplasm of Ovary Germ Cell Neoplasm of the Ovary Germ Cell Tumor of Ovary Germ Cell Tumor of the Ovary Ovarian Germ Cell Neoplasm Ovarian Germ Cell Tumor ovarian germ cell tumor Ovarian Germ Cell Tumor A cystic adenocarcinoma that arises from the pancreas. It includes the acinar cell and serous cystadenocarcinoma subtypes. C3874 Neoplastic Process Pancreatic Cystadenocarcinoma C0238337 CTEP Malignant Pancreatic_Cystadenocarcinoma Cystadenocarcinoma - pancreas Cystadenocarcinoma of Pancreas Cystadenocarcinoma of the Pancreas Cystadenocarcinoma of the pancreas Pancreatic Cystadenocarcinoma Pancreatic Cystadenocarcinoma An ependymoma that arises from the spinal cord. It is characterized by the absence of MYCN gene amplification and frequent loss of chromosome 22q and mutations of NF2. C3875 Neoplastic Process Spinal Cord Ependymoma C0238432 Undetermined Spinal_Cord_Ependymoma Ependymoma of Spinal Cord Ependymoma of the Spinal Cord Spinal Cord Ependymoma Spinal Cord Ependymoma without MYCN Amplification Spinal Ependymoma Spinal Cord Ependymoma A rare benign smooth muscle neoplasm arising from the wall of the stomach. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. Unlike gastrointestinal stromal tumors, gastric leiomyomas are by definition negative for CD34 and CD117 (C-KIT). C3876 Neoplastic Process Gastric Leiomyoma C0238440 Benign Gastric_Leiomyoma Gastric Leiomyoma Leiomyoma of Stomach Leiomyoma of the Stomach Gastric Leiomyoma An adenocarcinoma of the colon that has invaded into the submucosa. C38760 Neoplastic Process Submucosal Invasive Colon Adenocarcinoma C1515024 Malignant Submucosal_Invasive_Colon_Adenocarcinoma Submucosal Invasive Colon Adenocarcinoma Submucosal Invasive Colon Adenocarcinoma A primary, low grade carcinoma of the thyroid gland composed of groups of squamoid and mucous cells, surrounded by fibrous tissue. Prominent cystic structures may be present. The clinical course is usually indolent. C38762 Neoplastic Process Thyroid Gland Mucoepidermoid Carcinoma C1513721 Malignant Mucoepidermoid_Thyroid_Carcinoma Mucoepidermoid Thyroid Carcinoma Mucoepidermoid Thyroid Gland Carcinoma Thyroid Gland Mucoepidermoid Carcinoma Thyroid Gland Mucoepidermoid Carcinoma A rare type of mucoepidermoid carcinoma of the thyroid gland, usually associated with chronic lymphocytic thyroiditis. It exhibits a unique morphologic appearance consisting of a squamoid, nested growth pattern, dense fibrosis, and mucinous differentiation. The histogenesis of this unusual carcinoma has been debated, and it is unclear if it arises from remnants of the ultimobranchial body or from the follicular epithelial cells. C38763 Neoplastic Process Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia C1519204 Malignant Sclerosing_Mucoepidermoid_Thyroid_Carcinoma_with_Eosinophilia SMECE Sclerosing Mucoepidermoid Thyroid Carcinoma with Eosinophilia Sclerosing Mucoepidermoid Thyroid Gland Carcinoma with Eosinophilia Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia A non-seminomatous germ cell tumor arising from the testis. It is characterized by the presence of various tissues which correspond to the different germinal layers (endoderm, mesoderm, and ectoderm). Testicular teratomas in children follow a benign clinical course whereas in postpubertal patients may metastasize to other anatomic sites. C3877 Neoplastic Process Testicular Teratoma Testicular Teratoma C0238451 CTRP Cellosaurus Undetermined Testicular_Teratoma Teratoma of Testis Teratoma of the Testis Testicular Teratoma Testicular Teratoma A primary carcinoma of the thyroid gland composed of undifferentiated cells. The malignant cells demonstrate evidence of epithelial differentiation, either by immunohistochemistry or electron microscopic studies. Microscopically, in the majority of cases there is a mixture of spindle, epithelioid, and giant cells. The vast majority of the patients present with a rapidly enlarging neck mass. The clinical course is usually aggressive. C3878 Neoplastic Process Thyroid Gland Undifferentiated (Anaplastic) Carcinoma Thyroid Gland Anaplastic Carcinoma C0238461 CTEP CTRP Cellosaurus NICHD A rare, aggressive type of thyroid cancer in which the malignant (cancer) cells look very different from normal thyroid cells. An aggressive carcinoma of the thyroid gland composed of undifferentiated cells. Malignant Anaplastic_Thyroid_Carcinoma ATC Anaplastic Carcinoma of Thyroid Anaplastic Carcinoma of Thyroid Gland Anaplastic Carcinoma of the Thyroid Anaplastic Carcinoma of the Thyroid Gland Anaplastic Follicular Cell Derived Thyroid Carcinoma Anaplastic Follicular Cell Derived Thyroid Gland Carcinoma Anaplastic Thyroid Cancer Anaplastic Thyroid Carcinoma Anaplastic Thyroid Gland Carcinoma Anaplastic thyroid carcinoma Dedifferentiated Thyroid Gland Carcinoma Metaplastic Thyroid Gland Carcinoma Pleomorphic Thyroid Gland Carcinoma Sarcomatoid Thyroid Gland Carcinoma Thyroid Gland Anaplastic Carcinoma Thyroid Gland Carcinosarcoma Thyroid Gland Giant Cell Carcinoma Thyroid Gland Metaplastic Carcinoma Thyroid Gland Pleomorphic Carcinoma Thyroid Gland Sarcomatoid Carcinoma Thyroid Gland Spindle Cell Carcinoma Thyroid Gland Undifferentiated (Anaplastic) Carcinoma Undifferentiated (Anaplastic) Thyroid Gland Cancer Undifferentiated (Anaplastic) Thyroid Gland Carcinoma Undifferentiated Carcinoma of Thyroid Undifferentiated Carcinoma of Thyroid Gland Undifferentiated Carcinoma of the Thyroid Undifferentiated Carcinoma of the Thyroid Gland Undifferentiated Thyroid Carcinoma Undifferentiated Thyroid Gland Carcinoma Undifferentiated Thyroid Tumor anaplastic thyroid cancer Thyroid Gland Anaplastic Carcinoma A neuroendocrine carcinoma arising from the C-cells of the thyroid gland. It is closely associated with multiple endocrine neoplasia syndromes. Approximately 10% to 20% of medullary thyroid carcinomas are familial. Patients usually present with a thyroid nodule that is painless and firm. In the majority of cases nodal involvement is present at diagnosis. Surgery is the preferred treatment for both primary lesions and recurrences. This carcinoma is generally not very sensitive to radiation and almost unresponsive to chemotherapy. C3879 Neoplastic Process Thyroid Gland Medullary Carcinoma Thyroid Gland Medullary Carcinoma C0238462 CDISC CTEP CTRP Cellosaurus GDC NICHD A neuroendocrine malignant epithelial neoplasm arising from C-cells of the thyroid gland. Cancer that develops in C cells of the thyroid. The C cells make a hormone (calcitonin) that helps maintain a healthy level of calcium in the blood. Carcinoma arising from the C-cells of the thyroid gland. Malignant Medullary_Thyroid_Carcinoma 8345/3 C cell carcinoma Medullary thyroid carcinoma Parafollicular cell carcinoma C Cell Carcinoma C cell carcinoma C-Cell Carcinoma CARCINOMA, C-CELL, MALIGNANT MTC Medullary Carcinoma Medullary Carcinoma of Thyroid Medullary Carcinoma of Thyroid Gland Medullary Carcinoma of the Thyroid Medullary Carcinoma of the Thyroid Gland Medullary Thyroid Cancer Medullary Thyroid Carcinoma Medullary Thyroid Gland Carcinoma Medullary thyroid carcinoma Parafollicular Cell Carcinoma Parafollicular cell carcinoma Thyroid Gland Medullary Cancer Thyroid Gland Medullary Carcinoma Thyroid Gland Neuroendocrine Carcinoma Thyroid Medullary Carcinoma medullary thyroid cancer Thyroid Gland Medullary Carcinoma A benign nevus occurring in the eyelid. C3880 Neoplastic Process Eyelid Nevus C0239460 Benign Eyelid_Nevus Eyelid Nevus Nevus of Eyelid Nevus of the Eyelid Eyelid Nevus An angiomyolipoma arising from the kidney. C3888 Neoplastic Process Kidney Angiomyolipoma C0241961 Cellosaurus Undetermined Renal_Angiomyolipoma Angiomyolipoma of Kidney Angiomyolipoma of the Kidney Kidney Angiomyolipoma Renal Angiomyolipoma Kidney Angiomyolipoma A clonal disorder characterized by the secretion of a mu heavy chain that lacks a variable region. Most patients present with slowly progressive chronic lymphocytic leukemia (CLL). In contrast to most cases of CLL, Mu heavy chain disease is associated with hepatosplenomegaly and absence of lymphadenopathy. C3892 Neoplastic Process Mu Heavy Chain Disease C0242310 GDC Malignant Mu_Heavy_Chain_Disease 9762/3 Mu heavy chain disease Mu Heavy Chain Disease Mu heavy chain disease Mu Heavy Chain Disease A benign meningioma which may recur in approximately 7-20% of the cases. This category includes the angiomatous meningioma, fibrous meningioma, lymphoplasmacyte-rich meningioma, meningothelial meningioma, metaplastic meningioma, microcystic meningioma, psammomatous meningioma, secretory meningioma, and transitional meningioma. C38936 Neoplastic Process Grade I Meningioma Grade 1 Meningioma C1512260 CTRP Undetermined Grade_I_Meningioma Grade 1 Meningioma Grade I Meningioma WHO Grade 1 Meningioma WHO Grade I Meningioma Grade 1 Meningioma An atypical meningioma which may recur in approximately 29-40% of the cases. This category includes the atypical meningioma, chordoid meningioma, and clear cell meningioma. C38937 Neoplastic Process Grade II Meningioma Grade 2 Meningioma C1512259 CTRP Undetermined Grade_II_Meningioma Grade 2 Meningioma Grade II Meningioma WHO Grade 2 Meningioma WHO Grade II Meningioma Grade 2 Meningioma A malignant meningioma with aggressive clinical course. It recurs in approximately 50-78% of the cases. This category includes the anaplastic (malignant) meningioma, papillary meningioma, and rhabdoid meningioma. C38938 Neoplastic Process Grade III Meningioma Grade 3 Meningioma CL411899 CDISC CPTAC CTRP A malignant neoplasm of the meninges. Malignant Grade_III_Meningioma Grade 3 Meningioma Grade III Meningioma MENINGIOMA, MALIGNANT WHO Grade 3 Meningioma WHO Grade III Meningioma Who Grade III Meningioma Grade 3 Meningioma An indolent, extranodal type of non-Hodgkin lymphoma composed of small B-lymphocytes (centrocyte-like cells). The gastrointestinal tract is the most common site of involvement. Other common sites of involvement include lung, head and neck, ocular adnexae, skin, thyroid, and breast. Gastric involvement is associated with the presence of H. pylori infection. (WHO, 2001) C3898 Neoplastic Process Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue C0242647 CPTAC CTEP CTRP Cellosaurus GDC mCode A type of cancer that arises in cells in mucosal tissue that are involved in antibody production. 9699/3 Malignant Extranodal_Marginal_Zone_B-Cell_Lymphoma_of_Mucosa-Associated_Lymphoid_Tissue 9671/3 9699/3 Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue Immunocytoma MALT lymphoma Marginal zone lymphoma, unspecified site, extranodal and solid organ sites Mucosal-associated lymphoid tissue lymphoma Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT-lymphoma) Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue Immunocytoma MALT Lymphoma MALT lymphoma MALT-lymphoma MALToma Mucosa-Associated Lymphoid Tissue Lymphoma Mucosal-associated lymphoid tissue lymphoma mucosa-associated lymphoid tissue lymphoma Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue An osteosarcoma usually arising from the metaphysis of long bones. It is characterized by the presence of a cystic architecture with blood-filled spaces. The prognosis is similar to that of conventional osteosarcoma. C3902 Neoplastic Process Telangiectatic Osteosarcoma Telangiectatic Osteosarcoma C0259782 CTRP Cellosaurus GDC PCDC 9183/3 Malignant Telangiectatic_Osteosarcoma 9183/3 Telangiectatic osteosarcoma Malignant Bone Aneurysm Telangiectatic Osteogenic Sarcoma Telangiectatic Osteosarcoma Telangiectatic osteosarcoma Telangiectatic Osteosarcoma A tumor composed of two or more glial cell types (astrocytes, ependymal cells, and oligodendrocytes). C3903 Neoplastic Process Mixed Glioma Mixed Glioma C0259783 CDISC CTRP GDC A brain tumor that forms from more than one type of brain cell, usually astrocytes and oligodendrocytes. A malignant neoplasm comprising two or more glial cell types (e.g., astrocytes, ependymal cells, oligodendrocytes). 9382/3 Undetermined Mixed_Glioma 9382/3 Mixed glioma GLIOMA, MIXED, MALIGNANT Glioma, Mixed Mixed Glial Neoplasm Mixed Glial Tumor Mixed Glioma Mixed Neuroglial Neoplasm Mixed Neuroglial Tumor Mixed glioma mixed glioma Mixed Glioma A WHO grade III meningioma characterized by the predominance of a perivascular pseudopapillary pattern. C3904 Neoplastic Process Papillary Meningioma C3163622 GDC 9538/3 Malignant Papillary_Meningioma 9538/3 Papillary meningioma Papillary Meningioma Papillary meningioma Papillary Meningioma A carcinoma arising from the ampulla of Vater. The vast majority of cases are adenocarcinomas. Signs and symptoms include jaundice, abdominal pain, anorexia, nausea, vomiting, and weight loss. C3908 Neoplastic Process Ampulla of Vater Carcinoma Ampulla of Vater Carcinoma C0262401 CPTAC CTRP Cancer that forms in the ampulla of Vater (an enlargement of the ducts from the liver and pancreas where they join and enter the small intestine). Symptoms include jaundice, abdominal pain, nausea, vomiting, and weight loss. Malignant Ampulla_of_Vater_Carcinoma Ampulla of Vater Cancer Ampulla of Vater Carcinoma Ampullary Carcinoma ampulla of Vater cancer ampullary cancer Ampulla of Vater Carcinoma An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant small cells. C3915 Neoplastic Process Small Cell Carcinoma Small Cell Neuroendocrine Carcinoma C0262584 CPTAC CTRP GDC 8041/3 8042/3 Malignant Small_Cell_Carcinoma 8041/3 8042/3 Oat cell carcinoma Reserve cell carcinoma Round cell carcinoma Small cell carcinoma, NOS Small cell neuroendocrine carcinoma Oat Cell Cancer Oat Cell Carcinoma Oat cell carcinoma SCNEC Small Cell Cancer Small Cell Carcinoma Small Cell NEC Small Cell Neuroendocrine Carcinoma Small cell carcinoma, NOS Small cell neuroendocrine carcinoma oat cell cancer Small Cell Neuroendocrine Carcinoma A carcinoma arising from the vaginal epithelium. The majority of vaginal carcinomas are squamous cell carcinomas. C3917 Neoplastic Process Vaginal Carcinoma Vaginal Carcinoma C0262659 CPTAC CTEP CTRP Cancer that forms in the tissues of the vagina (birth canal). The vagina leads from the cervix (the opening of the uterus) to the outside of the body. The most common type of vaginal cancer is squamous cell carcinoma, which starts in the thin, flat cells lining the vagina. Another type of vaginal cancer is adenocarcinoma, cancer that begins in glandular cells in the lining of the vagina. Malignant Vaginal_Carcinoma Cancer of Vagina Cancer of the Vagina Carcinoma of Vagina Carcinoma of the Vagina Vagina Cancer Vagina Carcinoma Vaginal Cancer Vaginal Carcinoma Vaginal cancer, NOS vaginal cancer Vaginal Carcinoma A hemangioma arising from the skin, presenting as a red dot. C3926 Neoplastic Process Angioma Serpiginosum C0263637 Benign Angioma_Serpiginosum Angioma Serpiginosum Angioma Serpiginosum A poorly circumscribed neoplasm arising from the soft tissues in infants. It is characterized by the presence of bland fibroblastic spindle cells, collagenous stroma formation, primitive mesenchymal round cells, and mature fat cells. These components combined form a distinct organoid pattern. C3942 Neoplastic Process Fibrous Hamartoma of Infancy C0265979 Benign Fibrous_Hamartoma_of_Infancy Fibrous Hamartoma Fibrous Hamartoma of Infancy Infantile Fibrous Hamartoma Fibrous Hamartoma of Infancy A melanocytic nevus that is present at birth. It may present as a small macular, papular, or plaque-like lesion or as a large brown to black hairy skin lesion. C3944 Congenital Abnormality Disease or Syndrome Congenital Melanocytic Nevus C1318558 Cellosaurus GDC NICHD Benign Congenital_Melanocytic_Skin_Nevus 8761/0 Congenital melanocytic nevus, NOS CMN Congenital Melanocytic Nevi Congenital Melanocytic Nevus Congenital Melanocytic Nevus of Skin Congenital Melanocytic Nevus of the Skin Congenital Nevus of Skin Congenital Nevus of the Skin Congenital Pigmented Melanocytic Nevus Congenital Pigmented Nevus of Skin Congenital Pigmented Nevus of the Skin Congenital Pigmented Skin Nevus Congenital Skin Nevus Congenital Melanocytic Nevus A lobular hemangioma arising from the oral mucosa. C3950 Neoplastic Process Oral Mucosa Lobular Capillary Hemangioma C0267019 Benign Oral_Mucosa_Lobular_Capillary_Hemangioma Oral Mucosa Lobular Capillary Hemangioma Oral Mucosa Pyogenic Granuloma Pyogenic Granuloma of Oral Mucosa Pyogenic Granuloma of the Oral Mucosa Oral Mucosa Lobular Capillary Hemangioma A intraepithelial neoplasia (dysplasia) that arises in either the native gastric mucosa or in metaplastic gastric epithelium. It has a flat, polypoid or slightly depressed growth pattern. It is graded as low grade (mild dysplasia) or high grade (moderate dysplasia and carcinoma in situ). (WHO, 2000) C3955 Neoplastic Process Gastric Intraepithelial Neoplasia CL448525 Undetermined Gastric_Intraepithelial_Neoplasia Gastric Glandular Intraepithelial Dysplasia Gastric Glandular Intraepithelial Neoplasia Gastric Intraepithelial Neoplasia Gastric Intraepithelial Neoplasia (Dysplasia) Intraepithelial Neoplasia (Dysplasia) of Stomach Intraepithelial Neoplasia (Dysplasia) of the Stomach Stomach Intraepithelial Neoplasia (Dysplasia) Gastric Intraepithelial Neoplasia A lymphoma that arises in the context of autoimmune lymphoproliferative syndrome. C39578 Neoplastic Process Autoimmune Lymphoproliferative Syndrome-Related Lymphoma C1510972 CPTAC Malignant Autoimmune_Lymphoproliferative_Syndrome-Associated_Lymphoma ALPS-Related Lymphoma Autoimmune Lymphoproliferative Syndrome-Associated Lymphoma Autoimmune Lymphoproliferative Syndrome-Related Lymphoma Autoimmune Lymphoproliferative Syndrome-Related Lymphoma A rare, benign process that affects the peritoneal cavity and is characterized by the formation of multiple small nodules that are composed of well differentiated smooth muscle. It usually affects adults in their late reproductive years. Most patients are asymptomatic. The tumor nodules may regress spontaneously. C3958 Neoplastic Process Disseminated Peritoneal Leiomyomatosis Disseminated Peritoneal Leiomyomatosis C0267785 CTRP Benign Leiomyomatosis_Peritonealis_Disseminata Diffuse Peritoneal Leiomyomatosis Disseminated Peritoneal Leiomyomatosis Leiomyomatosis Peritonealis Disseminata Disseminated Peritoneal Leiomyomatosis T-cell large granular lymphocyte leukemia defined by the presence of CD3-positive, CD8-positive, and T-cell receptor alpha-beta-positive cytotoxic T-cells. C39584 Neoplastic Process T-Cell Large Granular Lymphocyte Leukemia, Common Variant C1515128 Malignant T-Cell_Large_Granular_Lymphocyte_Leukemia_Common_Varianr T-Cell Large Granular Lymphocyte Leukemia, Common Variant T-Cell Large Granular Lymphocyte Leukemia, Common Variant An uncommon variant of T-cell large granular lymphocyte leukemia expressing the gamma-delta T-cell receptor. Approximately 60% of these cases are CD8-positive and the remainder are CD4/CD8-negative. C39586 Neoplastic Process T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta C1515129 Malignant T-Cell_Large_Granular_Lymphocyte_Leukemia_Expressing_the_T-Cell_Receptor_Gamma-Delta T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta T-Cell Large Granular Lymphocyte Leukemia Expressing the TCR Gamma-Delta T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta An Epstein-Barr virus negative disorder with a chronic clinical course affecting predominantly adults and characterized by the proliferation of large granular lymphocytes with natural killer cell immunophenotype. The T-cell receptor genes are not rearranged. C39591 Neoplastic Process Chronic Lymphoproliferative Disorder of NK-Cells Chronic Lymphoproliferative Disorder of NK-Cells C1512709 Provisional_Concept CTRP Cellosaurus GDC A type of leukemia in which large natural killer (NK) cells (a type of white blood cell) that contain granules (small particles) are found in the blood. It is a chronic disease that may last for a long time and get worse. 9831/3 Benign Indolent_NK-Cell_Lymphoproliferative_Disorder 9831/3 Chronic lymphoproliferative disorder of NK cells CLPD-NK Chronic Lymphoproliferative Disorder of NK-Cells Chronic NK-Cell Lymphocytosis Chronic NK-LGL Lymphoproliferative Disorder Chronic NK-Large Granular Lymphocyte Lymphoproliferative Disorder Chronic lymphoproliferative disorder of NK cells Indolent Large Granular NK-Cell Lymphoproliferative Disorder Indolent NK-Cell Lymphoproliferative Disorder NK Large Granular Lymphocytic Leukemia NK-Cell Large Granular Lymphocyte Lymphocytosis NK-LGL leukemia NK-LGLL NK-Large Granular Lymphocytic Leukemia NK-Type Lymphoproliferative Disorder of Granular Lymphocytes natural killer-cell large granular lymphocyte leukemia Chronic Lymphoproliferative Disorder of NK-Cells An enteropathy-associated T-cell lymphoma arising from the small intestine, most commonly the jejunum or ileum. Patients usually present with abdominal pain, often associated with intestinal perforation. It is associated with celiac disease. The lymphoma cells are usually medium-sized to large and form an ulcerating mucosal lesion with invasion of the small intestinal wall. Villous atrophy is present in the adjacent small intestinal mucosa. In a minority of cases the lymphoma cells are medium-sized and form a monomorphic infiltrate. C39610 Neoplastic Process Small Intestinal Enteropathy-Associated T-Cell Lymphoma C1519371 Malignant Small_Intestinal_Enteropathy-Type_T-Cell_Lymphoma Small Intestinal EATL Small Intestinal Enteropathy-Associated T-Cell Lymphoma Small Intestinal Enteropathy-Type T-Cell Lymphoma Small Intestinal Enteropathy-Associated T-Cell Lymphoma A header term that includes the rare following variants of mycosis fungoides: folliculotropic mycosis fungoides, granulomatous slack skin disease, and pagetoid reticulosis. C39644 Neoplastic Process Mycosis Fungoides Variant C1513782 Malignant Mycosis_Fungoides_Variant Mycosis Fungoides Variant Mycosis Fungoides Variant An anaplastic large cell lymphoma characterized by the presence of numerous giant cells. C39674 Neoplastic Process Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype C1519368 Malignant Small_Cell_Variant_Anaplastic_Large_Cell_Lymphoma_Giant_Cell_Rich_Subtype Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype A are variant of anaplastic large cell lymphoma. It is characterized by presence of large spindle shaped cells resembling a soft tissue sarcoma. C39675 Neoplastic Process Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype C1519369 Malignant Small_Cell_Variant_Anaplastic_Large_Cell_Lymphoma_Sarcomatoid_Subtype Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype An anaplastic large cell lymphoma, characterized by lymphoid cells with signet ring nuclei. C39676 Neoplastic Process Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype C1519370 Malignant Small_Cell_Variant_Anaplastic_Large_Cell_Lymphoma_Signet_Ring_like_Subtype Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype A benign neoplasm arising from soft tissue of the prostate. It is characterized by the presence of spindle-shaped fibroblasts. C3972 Neoplastic Process Prostate Fibroma C0268885 Benign Prostate_Fibroma Fibroma of Prostate Fibroma of the Prostate Prostate Fibroma Prostate Fibroma An intermediate fibroblastic neoplasm arising from the lung. It is characterized by the presence of spindle-shaped fibroblasts and myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes and plasma cells. C39740 Neoplastic Process Lung Inflammatory Myofibroblastic Tumor C1518038 GDC 8827/1 Undetermined Lung_Inflammatory_Myofibroblastic_Tumor 8827/1 Myofibroblastic tumor, peribronchial Lung Inflammatory Myofibroblastic Tumor Myofibroblastic Tumor, Peribronchial Myofibroblastic tumor, peribronchial Lung Inflammatory Myofibroblastic Tumor A multinodular intermediate fibroblastic neoplasm arising from the retroperitoneum. It is characterized by the presence of spindle-shaped fibroblasts and myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes and plasma cells. C39741 Neoplastic Process Retroperitoneal Inflammatory Myofibroblastic Tumor C1514921 Undetermined Retroperitoneal_Inflammatory_Myofibroblastic_Tumor Retroperitoneal Inflammatory Myofibroblastic Tumor Retroperitoneal Inflammatory Myofibroblastic Tumor An aggressive mantle cell lymphoma characterized by the presence of pleomorphic neoplastic B-lymphocytes. C39747 Neoplastic Process Pleomorphic Variant Mantle Cell Lymphoma C2698836 Malignant Pleomorphic_Blastoid_Variant_Mantle_Cell_Lymphoma Pleomorphic Variant Mantle Cell Lymphoma Pleomorphic Variant Mantle Cell Lymphoma A classification of primary endometrial adenocarcinomas that refers to clear cell adenocarcinoma, serous adenocarcinoma, and serous endometrial intraepithelial carcinoma. C39749 Neoplastic Process Type II Endometrial Adenocarcinoma Type II Endometrial Adenocarcinoma C1519714 CTRP Malignant Type_II_Endometrial_Adenocarcinoma Type II Endometrial Adenocarcinoma Type II Endometrial Adenocarcinoma A glioblastoma that arises de novo. It is more commonly seen in older patients. Mutations in IDH1 or IDH2 genes are not present. C39750 Neoplastic Process Glioblastoma, IDH-Wildtype C1514422 GDC Malignant Primary_Glioblastoma Glioblastoma, IDH wildtype Glioblastoma, IDH Wildtype Glioblastoma, IDH-Wildtype Primary Glioblastoma Primary Glioblastoma Multiforme Primary Glioblastoma, IDH-Wildtype Glioblastoma, IDH-Wildtype A glioblastoma arising from a lower grade astrocytoma. C39751 Neoplastic Process Secondary Glioblastoma C1519214 Malignant Secondary_Glioblastoma Secondary Glioblastoma Secondary Glioblastoma Multiforme Secondary Glioblastoma A histologic variant of conventional ameloblastoma characterized by the presence of basal cells forming anastomosing strands and cords in a delicate stroma. C39753 Neoplastic Process Plexiform Ameloblastoma C0457529 Undetermined Plexiform_Ameloblastoma Plexiform Ameloblastoma Plexiform Ameloblastoma A conventional ameloblastoma with follicular pattern in which the central cells in the odontogenic epithelial islands show squamous differentiation. C39754 Neoplastic Process Acanthomatous Ameloblastoma C0457531 Undetermined Acanthomatous_Ameloblastoma Acanthomatous Ameloblastoma Acanthomatous Ameloblastoma An intraosseous ameloblastoma that arises from the jaw, usually the mandible. It grows slowly, invades locally, and recurs frequently. It presents with swelling of the jaw. C39755 Neoplastic Process Conventional Ameloblastoma C1513734 Undetermined Multicystic_Ameloblastoma Conventional Ameloblastoma Intraosseous Ameloblastoma Solid/Multicystic Ameloblastoma Conventional Ameloblastoma An ameloblastoma that presents as a unilocular cyst. It usually arises from the mandible. C39756 Neoplastic Process Unicystic Ameloblastoma C0457521 Undetermined Unicystic_Ameloblastoma Ameloblastoma, Unicystic Type UAM Unicystic Ameloblastoma Unicystic Ameloblastoma A conventional ameloblastoma with follicular pattern in which the odontogenic epithelial islands are composed of uniform basaloid cells. C39757 Neoplastic Process Basal Cell Ameloblastoma C1511055 Undetermined Basal_Cell_Ameloblastoma Basal Cell Ameloblastoma Basal Cell Ameloblastoma A conventional ameloblastoma characterized by the presence of prominent desmoplastic stroma resulting in compression of the neoplastic epithelial islands. C39758 Neoplastic Process Desmoplastic Ameloblastoma C0457533 Undetermined Desmoplastic_Ameloblastoma Desmoplastic Ameloblastoma Desmoplastic Ameloblastoma A hemangioblastoma that arises from the retina. It can occur sporadically or as part of von Hippel- Lindau syndrome. C39783 Neoplastic Process Retinal Hemangioblastoma C1514915 Undetermined Retinal_Capillary_Hemangioma Retinal_Hemangioblastoma Retinal Capillary Hemangioma Retinal Hemangioblastoma Retinal Hemangioblastoma A rare neoplasm that affects the inner ear. C39784 Neoplastic Process Inner Ear Neoplasm C1512779 Undetermined Inner_Ear_Neoplasm Inner Ear Neoplasm Internal Ear Neoplasm Inner Ear Neoplasm Renal cell carcinoma that has developed in relatives of patients with history of renal cell carcinoma. C39789 Neoplastic Process Hereditary Renal Cell Carcinoma Hereditary Renal Cell Carcinoma CL412456 CTRP GDC Malignant Hereditary_Renal_Cell_Carcinoma Hereditary Renal Cell Carcinoma Familial Renal Cancer Hereditary Renal Cell Cancer Hereditary Renal Cell Carcinoma Hereditary Renal Cell Carcinoma A renal cell carcinoma with constitutional chromosome 3 translocations. C39790 Neoplastic Process Renal Cell Carcinoma with Constitutional Chromosome 3 Translocations C1514835 Malignant Renal_Cell_Carcinoma_with_Constitutional_Chromosome_3_Translocations Renal Cell Carcinoma with Constitutional Chromosome 3 Translocations Renal Cell Carcinoma with Constitutional Chromosome 3 Translocations A renal cell carcinoma with papillary architecture comprised of clear cells. It is characterized by the inv(X)(p11;q12) resulting in fusion of the NONO (p54nrb) and TFE3 genes. C39802 Neoplastic Process Renal Cell Carcinoma Associated with inv(X)(p11;q12) C1514836 Malignant Renal_Cell_Carcinoma_with_inv_X_p11_q12 Renal Cell Carcinoma Associated with inv(X)(p11;q12) Renal Cell Carcinoma Associated with inv(X)(p11;q12) A low grade carcinoma of the kidney characterized by the presence of tubules which are separated by mucinous stroma. Often the tubular structures have a spindle cell appearance. Patients are usually asymptomatic and occasionally they may present with hematuria or flank pain. C39807 Neoplastic Process Mucinous Tubular and Spindle Cell Carcinoma of the Kidney C1513719 GDC 0000/0 Malignant Mucinous_Tubular_and_Spindle_Renal_Cell_Carcinoma Mucinous tubular and spindle cell carcinoma Mucinous Tubular and Spindle Cell Carcinoma of the Kidney Mucinous Tubular and Spindle Cell Carcinoma of the Kidney A benign, solitary, and partially cystic neoplasm arising from the kidney. It occurs in children and adults. Presenting symptoms include hematuria and polycythemia. It is characterized by the presence of epithelial nodules embedded in a stroma containing spindle cells. C39812 Neoplastic Process Metanephric Adenofibroma C1266141 GDC 8965/0 Benign Metanephric_Adenofibroma 8965/0 Nephrogenic adenofibroma Metanephric Adenofibroma Nephrogenic Adenofibroma Nephrogenic adenofibroma Metanephric Adenofibroma A congenital mesoblastic nephroma characterized by the presence of interlacing fascicles of fibroblastic cells, low mitotic activity, and collagen formation. C39814 Neoplastic Process Classic Congenital Mesoblastic Nephroma C1516475 NICHD A congenital, mesoblastic nephroma that is characterized by the presence of interlacing fascicles of fibroblastic cells, low mitotic activity, and collagen formation. It is often diagnosed by prenatal ultrasound or within 3 months of birth, and closely resembles infantile fibromatosis. Malignant Childhood_Classic_Congenital_Mesoblastic_Nephroma Classic Congenital Mesoblastic Nephroma Classic Mesoblastic Nephroma Classic Congenital Mesoblastic Nephroma A congenital mesoblastic nephroma characterized by increased cellularity, sheet-like proliferation of fibroblastic cells, and increased mitotic activity. Necrotic changes are commonly present. C39815 Neoplastic Process Cellular Congenital Mesoblastic Nephroma C1516474 NICHD A congenital mesoblastic nephroma that is characterized by increased cellularity, sheet-like proliferation of fibroblastic cells, and increased mitotic activity. There is a suggested linkage with infantile fibrosarcoma that is based on both containing the same t(12;15)(p13;q25) translocation, resulting in the ETV6/NTRK3 fusion. This type is associated with risk of recurrence. Malignant Childhood_Cellular_Congenital_Mesoblastic_Nephroma Cellular Congenital Mesoblastic Nephroma Cellular Mesoblastic Nephroma Infantile Renal Fibrosarcoma Cellular Congenital Mesoblastic Nephroma An invasive urothelial carcinoma of the bladder that exhibits squamous differentiation. C39816 Neoplastic Process Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation Invasive Bladder Urothelial Carcinoma with Squamous Differentiation C1512748 CTRP Malignant Infiltrating_Bladder_Urothelial_Carcinoma_with_Squamous_Differentiation Bladder Urothelial Carcinoma with Squamous Differentiation Infiltrating Bladder Urothelial Carcinoma with Squamous Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation Invasive Bladder Urothelial Carcinoma with Squamous Differentiation Invasive Bladder Urothelial Carcinoma with Squamous Differentiation An invasive urothelial carcinoma of the bladder that exhibits glandular differentiation. C39817 Neoplastic Process Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation Invasive Bladder Urothelial Carcinoma with Glandular Differentiation C1512747 CTRP Malignant Infiltrating_Bladder_Urothelial_Carcinoma_with_Glandular_Differentiation Bladder Urothelial Carcinoma with Glandular Differentiation Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation Invasive Bladder Urothelial Carcinoma with Glandular Differentiation Invasive Bladder Urothelial Carcinoma with Glandular Differentiation An invasive bladder urothelial carcinoma characterized by the presence of trophoblastic differentiation. C39818 Neoplastic Process Invasive Bladder Urothelial Carcinoma with Trophoblastic Differentiation C1512749 Malignant Infiltrating_Bladder_Urothelial_Carcinoma_with_Trophoblastic_Differentiation Bladder Urothelial Carcinoma with Trophoblastic Differentiation Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation Invasive Bladder Urothelial Carcinoma with Trophoblastic Differentiation Invasive Bladder Urothelial Carcinoma with Trophoblastic Differentiation Invasive bladder urothelial carcinoma characterized by a nested growth pattern. C39819 Neoplastic Process Invasive Bladder Nested Urothelial Carcinoma C1512741 Malignant Infiltrating_Bladder_Urothelial_Carcinoma_Nested_Variant Bladder Nested Urothelial Carcinoma Infiltrating Bladder Urothelial Carcinoma, Nested Variant Invasive Bladder Nested Urothelial Carcinoma Invasive Bladder Urothelial Carcinoma, Nested Variant Invasive Bladder Nested Urothelial Carcinoma Invasive bladder urothelial carcinoma characterized by microcysts formation. C39820 Neoplastic Process Invasive Bladder Microcystic Urothelial Carcinoma C1512740 Malignant Infiltrating_Bladder_Urothelial_Carcinoma_Microcystic_Variant Bladder Microcystic Urothelial Carcinoma Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant Invasive Bladder Microcystic Urothelial Carcinoma Invasive Bladder Urothelial Carcinoma, Microcystic Variant Invasive Bladder Microcystic Urothelial Carcinoma Invasive bladder urothelial carcinoma with lymphoepithelioma-like features. C39821 Neoplastic Process Invasive Bladder Lymphoepithelioma-Like Carcinoma C1512736 Malignant Infiltrating_Bladder_Lymphoepithelioma-like_Carcinoma Bladder Lymphoepithelioma-Like Carcinoma Infiltrating Bladder Lymphoepithelioma-Like Carcinoma Invasive Bladder Lymphoepithelioma-Like Carcinoma Invasive Bladder Lymphoepithelioma-Like Carcinoma Invasive bladder urothelial carcinoma characterized by the presence of malignant cells with plasmacytoid features. C39823 Neoplastic Process Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant Invasive Bladder Plasmacytoid Urothelial Carcinoma C1512739 CTRP Malignant Infiltrating_Bladder_Urothelial_Carcinoma_Lymphoma-like_Variant Infiltrating_Bladder_Urothelial_Carcinoma_Plasmacytoid_Variant Bladder Plasmacytoid Urothelial Carcinoma Infiltrating Bladder Urothelial Carcinoma, Lymphoma-Like/Plasmacytoid Variant Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant Invasive Bladder Lymphoma-Like/Plasmacytoid Urothelial Carcinoma Invasive Bladder Plasmacytoid Urothelial Carcinoma Invasive Bladder Urothelial Carcinoma, Lymphoma-Like/Plasmacytoid Variant Invasive Bladder Urothelial Carcinoma, Plasmacytoid Variant Invasive Bladder Plasmacytoid Urothelial Carcinoma An invasive urothelial carcinoma of the bladder that exhibits spindle cell sarcomatoid features. C39824 Neoplastic Process Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant Invasive Bladder Sarcomatoid Urothelial Carcinoma C1512743 CTRP Cellosaurus Malignant Infiltrating_Bladder_Urothelial_Carcinoma_Sarcomatoid_Variant Bladder Carcinosarcoma Bladder Sarcomatoid Urothelial Carcinoma Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant Invasive Bladder Sarcomatoid Urothelial Carcinoma Invasive Bladder Urothelial Carcinoma, Sarcomatoid Variant Invasive Bladder Sarcomatoid Urothelial Carcinoma Invasive bladder sarcomatoid urothelial carcinoma characterized by the presence of heterologous elements. C39825 Neoplastic Process Invasive Bladder Sarcomatoid Urothelial Carcinoma with Heterologous Elements C1512744 Malignant Infiltrating_Bladder_Urothelial_Carcinoma_Sarcomatoid_Variant_with_Heterologous_Elements Bladder Sarcomatoid Urothelial Carcinoma with Heterologous Elements Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements Invasive Bladder Sarcomatoid Urothelial Carcinoma with Heterologous Elements Invasive Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements Invasive Bladder Sarcomatoid Urothelial Carcinoma with Heterologous Elements Invasive bladder sarcomatoid urothelial carcinoma characterized by the absence of heterologous elements. C39826 Neoplastic Process Invasive Bladder Sarcomatoid Urothelial Carcinoma without Heterologous Elements C1512745 Malignant Infiltrating_Bladder_Urothelial_Carcinoma_Sarcomatoid_Variant_without_Heterologous_Elements Bladder Sarcomatoid Urothelial Carcinoma without Heterologous Elements Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements Invasive Bladder Sarcomatoid Urothelial Carcinoma without Heterologous Elements Invasive Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements Invasive Bladder Sarcomatoid Urothelial Carcinoma without Heterologous Elements An invasive urothelial carcinoma of the bladder characterized by the presence of clear (glycogen-rich) cells. C39827 Neoplastic Process Invasive Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma C1512737 Malignant Infiltrating_Bladder_Urothelial_Carcinoma_Clear_Cell_Variant Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma Bladder Clear Cell Urothelial Carcinoma Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant Invasive Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma Invasive Bladder Urothelial Carcinoma, Clear Cell (Glycogen-Rich) Variant Invasive Bladder Urothelial Carcinoma, Clear Cell Variant Invasive Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma Invasive bladder urothelial carcinoma characterized by the presence of lipid laden tumor cells. C39828 Neoplastic Process Invasive Bladder Lipid-Rich Urothelial Carcinoma C1512738 Malignant Infiltrating_Bladder_Urothelial_Carcinoma_Lipid_Cell_Variant Bladder Lipid-Rich Urothelial Carcinoma Infiltrating Bladder Urothelial Carcinoma, Lipid-Cell Variant Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant Invasive Bladder Lipid-Rich Urothelial Carcinoma Invasive Bladder Urothelial Carcinoma, Lipid-Rich Variant Invasive Bladder Lipid-Rich Urothelial Carcinoma An invasive urothelial carcinoma of the bladder with giant cells. C39829 Neoplastic Process Invasive Bladder Giant Cell Urothelial Carcinoma C1512746 Malignant Infiltrating_Bladder_Urothelial_Carcinoma_with_Giant_Cells Bladder Giant Cell Urothelial Carcinoma Infiltrating Bladder Urothelial Carcinoma with Giant Cells Invasive Bladder Giant Cell Urothelial Carcinoma Invasive Bladder Urothelial Carcinoma with Giant Cells Invasive Bladder Giant Cell Urothelial Carcinoma A non-invasive papillary neoplasm of the bladder urothelium. C39831 Neoplastic Process Bladder Non-Invasive Papillary Urothelial Neoplasm C1518358 Undetermined Non-Invasive_Bladder_Papillary_Urothelial_Neoplasm Bladder Non-Invasive Papillary Urothelial Neoplasm Non-Invasive Bladder Papillary Urothelial Neoplasm Bladder Non-Invasive Papillary Urothelial Neoplasm A rare variant of well differentiated squamous cell carcinoma, usually associated with bladder schistosomiasis. C39832 Neoplastic Process Bladder Verrucous Carcinoma C1511208 Malignant Bladder_Verrucous_Squamous_Cell_Carcinoma Bladder Verrucous Carcinoma Bladder Verrucous Squamous Cell Carcinoma Bladder Verrucous Carcinoma A verrucous squamous cell carcinoma of the bladder that is caused by Schistosoma hematobium. C39833 Neoplastic Process Schistosoma Hematobium-Related Bladder Verrucous Carcinoma C1519195 Malignant Schistosoma_Hematobium-Related_Bladder_Verrucous_Squamous_Cell_Carcinoma Schistosoma Hematobium-Related Bladder Verrucous Carcinoma Schistosoma Hematobium-Related Bladder Verrucous Squamous Cell Carcinoma Schistosoma Hematobium-Related Bladder Verrucous Carcinoma A rare, benign neoplasm of bladder that is composed of papillary cores with overlying histologically benign squamous epithelium. C39834 Neoplastic Process Bladder Squamous Papilloma C1511199 Benign Bladder_Squamous_Cell_Papilloma Bladder Keratotic Papilloma Bladder Squamous Cell Papilloma Bladder Squamous Papilloma Bladder Squamous Papilloma A rare adenocarcinoma that arises in the bladder. It is characterized by intestinal type glands and resembles colonic adenocarcinoma. C39835 Neoplastic Process Bladder Enteric Type Adenocarcinoma C1511188 Malignant Bladder_Enteric_Type_Adenocarcinoma Bladder Colonic Type Adenocarcinoma Bladder Enteric Type Adenocarcinoma Bladder Enteric Type Adenocarcinoma An adenocarcinoma, not otherwise specified, arising from the bladder. C39836 Neoplastic Process Bladder Adenocarcinoma, Not Otherwise Specified CL448661 Malignant Bladder_Adenocarcinoma_not_Otherwise_Specified Bladder Adenocarcinoma NOS Bladder Adenocarcinoma, NOS Bladder Adenocarcinoma, Not Otherwise Specified Bladder Adenocarcinoma, Not Otherwise Specified A rare primary adenocarcinoma of the bladder. Histologically it is characterized by malignant cells floating in pools of mucin. C39837 Neoplastic Process Bladder Mucinous Adenocarcinoma C1511193 Malignant Bladder_Mucinous_Adenocarcinoma Bladder Colloid Adenocarcinoma Bladder Mucinous Adenocarcinoma Bladder Mucinous Adenocarcinoma A rare variant of bladder adenocarcinoma. It is characterized by the presence of a mixture of polygonal hepatoid cells and glandular adenocarcinoma cells. C39838 Neoplastic Process Bladder Hepatoid Adenocarcinoma C1511189 Malignant Bladder_Hepatoid_Adenocarcinoma Bladder Hepatoid Adenocarcinoma Bladder Hepatoid Adenocarcinoma A variant of bladder adenocarcinoma that histologically consists of more than one growth pattern such as enteric, mucinous or signet ring types. C39839 Neoplastic Process Bladder Mixed Adenocarcinoma C1511192 Malignant Bladder_Mixed_Adenocarcinoma Bladder Mixed Adenocarcinoma Bladder Mixed Adenocarcinoma A rare variant of carcinoma of the urachal remnant of bladder. C39842 Neoplastic Process Bladder Urachal Carcinoma Urachal Carcinoma C1511205 CPTAC CTRP GDC Malignant Bladder_Urachal_Carcinoma Malignant neoplasm of urachus Urachal carcinoma Bladder Urachal Cancer Bladder Urachal Carcinoma Urachal Carcinoma Urachal carcinoma Urachal Carcinoma A rare bladder adenocarcinoma that develops from the urachal remnant. C39843 Neoplastic Process Urachal Adenocarcinoma C1511204 Malignant Bladder_Urachal_Adenocarcinoma Bladder Urachal Adenocarcinoma Urachal Adenocarcinoma Urachal Adenocarcinoma A urothelial carcinoma of the urinary bladder that arises from the urachal epithelium. C39844 Neoplastic Process Urachal Urothelial Carcinoma C1511207 Malignant Bladder_Urachal_Urothelial_Carcinoma Bladder Urachal Urothelial Carcinoma Urachal Urothelial Carcinoma Urachal Urothelial Carcinoma A rare variant of bladder urachal carcinoma with squamous cell features. C39845 Neoplastic Process Urachal Squamous Cell Carcinoma C1511206 Malignant Bladder_Urachal_Squamous_Cell_Carcinoma Bladder Urachal Squamous Cell Carcinoma Urachal Squamous Cell Carcinoma Urachal Squamous Cell Carcinoma A rare morphologic variant of bladder carcinoma characterized by the presence of malignant glandular epithelial cells and clear cells forming a tubulo-cystic pattern. C39847 Neoplastic Process Bladder Tubulo-Cystic Clear Cell Adenocarcinoma C1511203 Malignant Bladder_Tubulo-Cystic_Clear_Cell_Adenocarcinoma Bladder Tubulo-Cystic Clear Cell Adenocarcinoma Bladder Tubulo-Cystic Clear Cell Adenocarcinoma A rare morphologic variant of bladder adenocarcinoma characterized by the presence of malignant glandular epithelial cells and clear cells forming a papillary pattern. C39848 Neoplastic Process Bladder Papillary Clear Cell Adenocarcinoma Bladder Papillary Clear Cell Adenocarcinoma C1511196 CTRP Malignant Bladder_Papillary_Clear_Cell_Adenocarcinoma Bladder Papillary Clear Cell Adenocarcinoma Bladder Papillary Clear Cell Adenocarcinoma A rare morphologic variant of bladder adenocarcinoma characterized by the presence of malignant glandular epithelial cells and clear cells forming a diffuse pattern. C39849 Neoplastic Process Bladder Diffuse Clear Cell Adenocarcinoma C1511187 Malignant Bladder_Diffuse_Clear_Cell_Adenocarcinoma Bladder Diffuse Clear Cell Adenocarcinoma Bladder Diffuse Clear Cell Adenocarcinoma Stage 0 includes: 0a (Ta, N0, M0); 0is (Tis, N0, M0). Ta: Papillary noninvasive carcinoma. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C39850 Neoplastic Process Stage 0 Renal Pelvis and Ureter Cancer AJCC v7 Stage 0 Renal Pelvis and Ureter Cancer AJCC v7 C1519503 CTRP Abnormal cells are found in tissue lining the inside of the renal pelvis or ureter. These abnormal cells may become cancer and spread into nearby normal tissue. Stage 0 is divided into stages 0a (papillary carcinoma) and 0is (carcinoma in situ), depending on the type of tumor. Stage 0a may look like tiny mushrooms growing from the lining of the renal pelvis or ureter. Stage 0is is a flat tumor on the tissue lining the inside of the renal pelvis or ureter. Malignant Stage_0_Renal_Pelvis_and_Ureter_Carcinoma Stage 0 Renal Pelvis and Ureter Cancer Stage 0 Renal Pelvis and Ureter Cancer AJCC v7 Stage 0 Renal Pelvis and Ureter Transitional Cell Carcinoma Stage 0 Renal Pelvis and Ureter Urothelial Carcinoma Stage 0 Renal Pelvis and Ureter Urothelial Carcinoma AJCC v7 stage 0 transitional cell carcinoma in situ of the renal pelvis and ureter Stage 0 Renal Pelvis and Ureter Cancer AJCC v7 A carcinoma that arises from the urothelial lining of the bladder. It is the most common morphologic type of urinary bladder carcinoma. It usually affects males in their sixth and seventh decades of life. Hematuria is the most common symptom at presentation. Pathologic stage is the strongest predictor of survival. C39851 Neoplastic Process Bladder Urothelial Carcinoma Bladder Urothelial Carcinoma C0279680 CTRP Cellosaurus Malignant Bladder_Urothelial_Carcinoma Bladder Transitional Cell Carcinoma Bladder Urothelial Cancer Bladder Urothelial Carcinoma Transitional Cell Carcinoma of the Urinary Bladder Urinary Bladder Transitional Cell Carcinoma Urinary Bladder Urothelial Carcinoma Urothelial Carcinoma of the Urinary Bladder Bladder Urothelial Carcinoma A benign or malignant neoplasm that arises from the urothelial lining of the urinary tract (bladder, renal pelvis, ureter, or urethra). C39852 Neoplastic Process Urothelial Neoplasm C1519840 Benign Urothelial_Neoplasm Transitional Cell Neoplasm of the Urinary Tract Urothelial Neoplasm Urothelial Neoplasm Urothelial carcinoma that invades into surrounding tissue. C39853 Neoplastic Process Invasive Urothelial Carcinoma C1512751 Malignant Infiltrating_Urothelial_Carcinoma Infiltrating Transitional Cell Carcinoma of the Urinary Tract Infiltrating Urothelial Carcinoma Invasive Urothelial Carcinoma Invasive Urothelial Carcinoma A non-invasive neoplasm affecting the urothelium. C39854 Neoplastic Process Non-Invasive Urothelial Neoplasm C1518361 Undetermined Non-Invasive_Urothelial_Neoplasm Non-Invasive Transitional Cell Neoplasm of the Urinary Tract Non-Invasive Urothelial Neoplasm Non-Invasive Urothelial Neoplasm A neoplasm with papillary architectural pattern arising from the bladder urothelial cells. C39857 Neoplastic Process Bladder Papillary Urothelial Neoplasm C1511197 Undetermined Bladder_Papillary_Urothelial_Neoplasm Bladder Papillary Transitional Cell Neoplasm Bladder Papillary Urothelial Neoplasm Urinary Bladder Papillary Transitional Cell Neoplasm Urinary Bladder Papillary Urothelial Neoplasm Bladder Papillary Urothelial Neoplasm A rare benign neoplasm that arises from the bladder and is characterized by the presence of a papillary growth with a central fibrovascular core. The latter is lined by normal urothelium. C39858 Neoplastic Process Bladder Urothelial Papilloma C1384678 Benign Bladder_Urothelial_Papilloma Bladder Transitional Cell Papilloma Bladder Urothelial Papilloma Urinary Bladder Transitional Cell Papilloma Urinary Bladder Urothelial Papilloma Bladder Urothelial Papilloma An endophytic urothelial neoplasm arising from the bladder. It shares several morphologic features with urothelial papilloma. C39859 Neoplastic Process Bladder Inverted Papilloma C1511190 Benign Bladder_Inverted_Papilloma Bladder Inverted Papilloma Urinary Bladder Inverted Papilloma Bladder Inverted Papilloma A rare urethral squamous cell carcinoma that is related to human papilloma virus (HPV) infection of the urinary tract. C39862 Neoplastic Process Human Papillomavirus-Related Urethral Squamous Cell Carcinoma C1512510 Malignant Human_Papilloma_Virus-Related_Urethral_Squamous_Cell_Carcinoma Human Papilloma Virus-Related Urethral Squamous Cell Carcinoma Human Papillomavirus-Related Urethral Squamous Cell Carcinoma Human Papillomavirus-Related Urethral Squamous Cell Carcinoma An adenocarcinoma that arises from the Cowper glands. C39864 Neoplastic Process Cowper Gland Adenocarcinoma of the Urethra C1516284 Malignant Carcinoma_of_Cowper_Glands Adenocarcinoma of Cowper Glands Cowper Gland Adenocarcinoma of the Urethra Cowper Gland Adenocarcinoma of the Urethra An adenocarcinoma that arises from the Littre glands. C39865 Neoplastic Process Littre Gland Adenocarcinoma of the Urethra C1516285 Malignant Carcinoma_of_Littre_Glands Adenocarcinoma of Littre Glands Littre Gland Adenocarcinoma of the Urethra Littre Gland Adenocarcinoma of the Urethra A primary or metastatic malignant neoplasm that affects the female urethra. C39866 Neoplastic Process Female Urethral Malignant Neoplasm C1517154 Malignant Female_Urethral_Malignant_Neoplasm Female Urethral Malignant Neoplasm Female Urethral Malignant Neoplasm A primary or metastatic malignant neoplasm that affects the male urethra. C39867 Neoplastic Process Male Urethral Malignant Neoplasm C1518164 Malignant Male_Urethral_Malignant_Neoplasm Male Urethral Malignant Neoplasm Male Urethral Malignant Neoplasm A primary or metastatic malignant neoplasm that affects the penile urethra. C39868 Neoplastic Process Penile Urethral Malignant Neoplasm C1518950 Malignant Penile_Urethral_Malignant_Neoplasm Penile Urethral Malignant Neoplasm Penile Urethral Malignant Neoplasm A malignant neoplasm that affects the bulbomembranous part of the urethra. C39869 Neoplastic Process Bulbomembranous Urethral Malignant Neoplasm C1511339 Malignant Bulbomembranous_Urethral_Malignant_Neoplasm Bulbomembranous Urethral Malignant Neoplasm Bulbomembranous Urethral Malignant Neoplasm A primary or metastatic malignant neoplasm that affects the prostatic urethra. C39870 Neoplastic Process Prostatic Urethral Malignant Neoplasm C1514523 Malignant Prostatic_Urethral_Malignant_Neoplasm Prostatic Urethral Malignant Neoplasm Prostatic Urethral Malignant Neoplasm An epithelial neoplasm of the urethra, which is morphologically characterized by the presence of a villous architectural pattern. C39872 Neoplastic Process Urethral Villous Adenoma C1519828 Benign Urethral_Villous_Adenoma Urethral Villous Adenoma Urethral Villous Adenoma A verrucous carcinoma arising from the urethra. C39874 Neoplastic Process Urethral Verrucous Carcinoma C1519827 Malignant Urethral_Verrucous_Carcinoma Urethral Verrucous Carcinoma Urethral Verrucous Carcinoma A rare mucosa-associated lymphoid tissue lymphoma affecting the bladder. C39878 Neoplastic Process Bladder Mucosa-Associated Lymphoid Tissue Lymphoma Bladder Mucosa-Associated Lymphoid Tissue Lymphoma C1511194 CTRP Malignant Bladder_Mucosa-Associated_Lymphoid_Tissue_Lymphoma Bladder MALT Lymphoma Bladder Mucosa-Associated Lymphoid Tissue Lymphoma Bladder Mucosa-Associated Lymphoid Tissue Lymphoma Invasive urothelial carcinoma that affects the renal pelvis and ureter. C39879 Neoplastic Process Invasive Renal Pelvis and Ureter Urothelial Carcinoma C1512750 Malignant Infiltrating_Renal_Pelvis_and_Ureter_Urothelial_Carcinoma Infiltrating Renal Pelvis and Ureter Transitional Cell Carcinoma Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma Invasive Renal Pelvis and Ureter Urothelial Carcinoma Upper Urinary Tract Infiltrating Urothelial Carcinoma Invasive Renal Pelvis and Ureter Urothelial Carcinoma An unusual variant of acinar prostate adenocarcinoma characterized by the presence of neoplastic small atrophic glands that contain malignant cells with scant cytoplasm. C39880 Neoplastic Process Prostate Acinar Adenocarcinoma, Atrophic Pattern C1515862 Malignant Acinar_Prostate_Adenocarcinoma_Atrophic_Variant Prostate Acinar Adenocarcinoma, Atrophic Pattern Prostate Acinar Atrophic Adenocarcinoma Prostate Adenocarcinoma, Atrophic Pattern Prostate Atrophic Adenocarcinoma Prostate Acinar Adenocarcinoma, Atrophic Pattern Acinar prostate adenocarcinoma characterized by the presence of neoplastic large glands that resemble the benign, non-neoplastic prostate glands. C39881 Neoplastic Process Prostate Acinar Pseudohyperplastic Adenocarcinoma C1515866 Malignant Acinar_Prostate_Adenocarcinoma_Pseudohyperplastic_Variant Prostate Acinar Pseudohyperplastic Adenocarcinoma Prostate Pseudohyperplastic Adenocarcinoma Prostate Acinar Pseudohyperplastic Adenocarcinoma Acinar prostate adenocarcinoma characterized by the presence of malignant cells with abundant xanthomatous appearing cytoplasm. C39882 Neoplastic Process Prostate Acinar Foamy Gland Adenocarcinoma C1515863 Malignant Acinar_Prostate_Adenocarcinoma_Foamy_Gland_Variant Prostate Acinar Foamy Gland Adenocarcinoma Prostate Foamy Gland Adenocarcinoma Prostate Acinar Foamy Gland Adenocarcinoma An exceptionally rare acinar prostate adenocarcinoma characterized by the presence of malignant large cells with granular eosinophilic cytoplasm. C39884 Neoplastic Process Prostate Acinar Oncocytic Adenocarcinoma C1515865 Malignant Acinar_Prostate_Adenocarcinoma_Oncocytic_Variant Prostate Acinar Oncocytic Adenocarcinoma Prostate Oncocytic Adenocarcinoma Prostate Acinar Oncocytic Adenocarcinoma Acinar prostate adenocarcinoma characterized by the presence of malignant cells forming syncytial patterns and dense lymphocytic infiltrates. C39885 Neoplastic Process Prostate Acinar Lymphoepithelioma-Like Adenocarcinoma C1515864 Malignant Acinar_Prostate_Adenocarcinoma_Lymphoepithelioma-like_Variant Prostate Acinar Lymphoepithelioma-Like Adenocarcinoma Prostate Lymphoepithelioma-Like Adenocarcinoma Prostate Acinar Lymphoepithelioma-Like Adenocarcinoma High grade prostatic intraepithelial neoplasia characterized by the presence of signet ring cells in the affected glands. C39887 Neoplastic Process High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant C1512438 Undetermined High-Grade_Prostatic_Intraepithelial_Neoplasia_Signet_Ring_Variant High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant High Grade Prostatic Intraepithelial Neoplasia, Signet-Ring Variant High-Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant High-Grade Prostatic Intraepithelial Neoplasia, Signet-Ring Variant High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant High grade prostatic intraepithelial neoplasia characterized by the presence of masses of mucin within the affected distended glands. C39888 Neoplastic Process High Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant C1512437 Undetermined High-Grade_Prostatic_Intraepithelial_Neoplasia_Mucinous_Variant High Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant High-Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant High Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant High grade prostatic intraepithelial neoplasia characterized by the presence of large glands with papillary infoldings that contain cells with xanthomatous cytoplasm. C39889 Neoplastic Process High Grade Prostatic Intraepithelial Neoplasia, Foamy Variant C1512435 Undetermined High-Grade_Prostatic_Intraepithelial_Neoplasia_Foamy_Variant High Grade Prostatic Intraepithelial Neoplasia, Foamy Variant High-Grade Prostatic Intraepithelial Neoplasia, Foamy Variant High Grade Prostatic Intraepithelial Neoplasia, Foamy Variant High grade prostatic intraepithelial neoplasia characterized by the presence of secretory cells with their nuclei polarized towards the lumen of the glands. C39890 Neoplastic Process High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant C1512436 Undetermined High-Grade_Prostatic_Intraepithelial_Neoplasia_Inverted_Variant High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant High-Grade Prostatic Intraepithelial Neoplasia, Inverted Variant High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant High grade prostatic intraepithelial neoplasia characterized by the presence of small neuroendocrine cells in the affected glands. C39891 Neoplastic Process High Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant C1512439 Undetermined High-Grade_Prostatic_Intraepithelial_Neoplasia_Small_Cell_Neuroendocrine_Variant High Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant High-Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant High Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant A prostate ductal adenocarcinoma characterized by the presence of neoplastic large back-to-back glands with slit-like lumens. C39895 Neoplastic Process Prostate Ductal Adenocarcinoma, Cribriform Pattern C1514511 Malignant Prostate_Ductal_Adenocarcinoma_Cribriform_Pattern Prostate Ductal Adenocarcinoma, Cribriform Pattern Prostate Ductal Adenocarcinoma, Cribriform Pattern A prostate ductal adenocarcinoma characterized by the presence of a papillary growth pattern. C39896 Neoplastic Process Prostate Ductal Adenocarcinoma, Papillary Pattern C1514512 OORO Malignant Prostate_Ductal_Adenocarcinoma_Papillary_Pattern Prostate Ductal Adenocarcinoma, Papillary Pattern Prostate Papillary Ductal Adenocarcinoma Prostate Ductal Adenocarcinoma, Papillary Pattern A prostate ductal adenocarcinoma characterized by the presence of cribriform and/or papillary patterns and areas of solid nests of malignant cells. C39897 Neoplastic Process Prostate Ductal Adenocarcinoma, Solid Pattern C1514513 OORO Malignant Prostate_Ductal_Adenocarcinoma_Solid_Pattern Prostate Ductal Adenocarcinoma, Solid Pattern Prostate Solid Ductal Adenocarcinoma Prostate Ductal Adenocarcinoma, Solid Pattern An urothelial carcinoma that arises from the urothelial lining of the prostatic ducts or the prostatic urethra. C39898 Neoplastic Process Primary Prostate Urothelial Carcinoma Primary Prostate Urothelial Carcinoma C1514430 CTRP Cellosaurus OORO Malignant Primary_Prostate_Urothelial_Carcinoma Primary Prostate Urothelial Cancer Primary Prostate Urothelial Carcinoma Prostate Transitional Cell Carcinoma Prostate Urothelial Carcinoma Transitional Cell Carcinoma of Prostate Transitional Cell Carcinoma of the Prostate Primary Prostate Urothelial Carcinoma A transitional cell carcinoma that has spread to the prostate gland directly from the bladder. C39899 Neoplastic Process Secondary Prostate Urothelial Carcinoma C1519218 Malignant Secondary_Prostate_Urothelial_Carcinoma Secondary Prostate Urothelial Carcinoma Secondary Prostate Urothelial Carcinoma An urothelial carcinoma that arises from the urothelial lining of the prostatic urethra. C39900 Neoplastic Process Prostatic Urethra Urothelial Carcinoma C1514522 Malignant Prostatic_Urethra_Urothelial_Carcinoma Prostatic Urethra Urothelial Carcinoma Prostatic Urethra Urothelial Carcinoma An urothelial carcinoma that arises from the urothelial lining of the prostatic ducts. C39901 Neoplastic Process Prostatic Duct Urothelial Carcinoma C1514519 Malignant Prostatic_Duct_Urothelial_Carcinoma Prostatic Duct Urothelial Carcinoma Prostatic Duct Urothelial Carcinoma An invasive prostate carcinoma composed of prostatic basal cells. C39902 Neoplastic Process Prostate Basal Cell Carcinoma C1514507 OORO Malignant Prostate_Basal_Cell_Carcinoma Basal Cell Carcinoma of the Prostate Prostate Basal Cell Carcinoma Prostate Basal cell carcinoma Prostate Basal Cell Carcinoma An invasive prostate adenocarcinoma characterized by the presence of malignant cells that exhibit neuroendocrine differentiation. C39903 Neoplastic Process Prostate Adenocarcinoma with Neuroendocrine Differentiation C1514506 Cellosaurus OORO Malignant Prostate_Adenocarcinoma_with_Focal_Neuroendocrine_Differentiation Prostate Adenocarcinoma with Neuroendocrine Differentiation Prostate Adenocarcinoma with neuroendocrine features Prostate Adenocarcinoma with Neuroendocrine Differentiation A rare neoplasm arising from specialized prostatic stroma. This category includes prostatic stromal proliferations of uncertain malignant potential and prostatic stromal sarcomas. C39904 Neoplastic Process Tumor of Specialized Prostatic Stroma C1519695 Undetermined Tumor_of_Specialized_Prostatic_Stroma Tumor of Specialized Prostatic Stroma Tumor of Specialized Prostatic Stroma A neoplastic lesion that arises from the prostate gland stroma. Morphologic characteristics include hypercellular stroma with scattered atypical cells, prominent overgrowth of the prostatic stroma, or changes resembling benign phyllodes tumor. The majority of cases do not have an aggressive clinical course. A minority of cases however, may progress to stromal sarcoma. C39905 Neoplastic Process Prostate Stromal Tumor of Uncertain Malignant Potential C1514517 Uncertain Malignant Potential Prostate_Stromal_Proliferation_of_Uncertain_Malignant_Potential Prostate Stromal Proliferation of Uncertain Malignant Potential Prostate Stromal Tumor of Uncertain Malignant Potential Prostatic Stromal Tumor of Uncertain Malignant Potential STUMP Prostate Stromal Tumor of Uncertain Malignant Potential An extremely rare adenocarcinoma that arises from the seminal vesicle. C39906 Neoplastic Process Seminal Vesicle Adenocarcinoma C1519233 Malignant Seminal_Vesicle_Adenocarcinoma Seminal Vesicle Adenocarcinoma Seminal Vesicle Adenocarcinoma A rare benign cystadenoma that arises from the seminal vesicle. C39907 Neoplastic Process Seminal Vesicle Cystadenoma C1519234 Benign Seminal_Vesicle_Cystadenoma Seminal Vesicle Cystadenoma Seminal Vesicle Cystadenoma A benign or malignant neoplasm that affects the seminal vesicle. Representative examples include cystadenoma and adenocarcinoma. C39908 Neoplastic Process Seminal Vesicle Neoplasm C0341767 Undetermined Seminal_Vesicle_Neoplasm Seminal Vesicle Neoplasm Seminal Vesicle Neoplasm A testicular mixed germ cell-sex cord-stromal tumor. It is usually associated with mixed gonadal dysgenesis and ambiguous genitalia. It is characterized by the presence of nests of large neoplastic germ cells and immature cells that resemble Sertoli cells. C39911 Neoplastic Process Testicular Gonadoblastoma C1515283 NICHD A gonadoblastoma that occurs in the testis. Undetermined Testicular_Gonadoblastoma Testicular Gonadoblastoma Testicular Gonadoblastoma A testicular mixed germ cell-sex cord-stromal tumor in which the neoplastic germ cells and the neoplastic sex cord-stromal cells do not form nests and are instead arranged in a diffuse pattern. C39912 Neoplastic Process Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified CL448662 GDC Undetermined Testicular_Mixed_Germ_Cell-Sex_Cord-Stromal_Tumor_Unclassified Mixed germ cell sex cord-stromal tumor, unclassified Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified A germ cell tumor that arises from the testis and is characterized by the presence of one histologic component. This category includes seminoma, teratoma, embryonal carcinoma, yolk sac tumor, and choriocarcinoma. C39915 Neoplastic Process Testicular Pure Germ Cell Tumor C1514608 Undetermined Pure_Testicular_Germ_Cell_Tumor Testicular Pure Germ Cell Tumor Testicular Pure Germ Cell Tumor A testicular seminoma characterized by the presence of syncytiotrophoblastic giant cells. C39919 Neoplastic Process Testicular Seminoma with Syncytiotrophoblastic Cells C1515295 Malignant Testicular_Seminoma_with_Syncytiotrophoblastic_Cells Testicular Seminoma with Syncytiotrophoblastic Cells Testicular Seminoma with Syncytiotrophoblastic Cells The most aggressive form of Kaposi sarcoma. It presents in patients who are infected with the human immunodeficiency virus. It can affect the skin and internal organs. C3992 Neoplastic Process AIDS-Related Kaposi Sarcoma AIDS-Related Kaposi Sarcoma C0276535 CTEP CTRP Cellosaurus Malignant AIDS-Related_Kaposi_s_Sarcoma AIDS Related Kaposi's Sarcoma AIDS, Kaposi's Sarcoma AIDS-Related Kaposi Sarcoma AIDS-Related Kaposi's Sarcoma AIDS-related Kaposi sarcoma Autoimmune Deficiency Syndrome-Related Kaposi Sarcoma Epidemic Kaposi's Sarcoma Kaposi's Sarcoma AIDS Related Kaposi's Sarcoma Epidemic Type AIDS-Related Kaposi Sarcoma A seminoma of the testis characterized by increased cellular pleomorphism, high mitotic activity, and a non-prominent stromal lymphocytic infiltrate. C39920 Neoplastic Process Testicular Seminoma with High Mitotic Index C0334516 GDC 9062/3 Malignant Testicular_Seminoma_with_High_Mitotic_Index 9062/3 Seminoma with high mitotic index Seminoma, anaplastic Anaplastic Seminoma Atypical Seminoma Seminoma with high mitotic index Seminoma, anaplastic Testicular Seminoma with High Mitotic Index Testicular Seminoma with High Mitotic Index A testicular germ cell tumor derived from postpubertal-type germ cells. It is characterized by the presence of three cell types: round cells with eosinophilic cytoplasm, small cells with dark nucleus and a small amount of cytoplasm, and mono-or multinucleated giant cells. The neoplastic cells are not cohesive. There is an edematous stroma present; lymphocytic infiltrates are rarely seen. Most patients are older males. C39921 Neoplastic Process Testicular Spermatocytic Tumor C0334517 GDC 9063/3 Malignant Testicular_Spermatocytic_Seminoma 9063/3 Spermatocytic seminoma Spermatocytoma Spermatocytic Seminoma Spermatocytic Tumor Spermatocytic seminoma Testicular Spermatocytic Seminoma Testicular Spermatocytic Tumor Testicular Spermatocytic Tumor A malignant germ cell tumor that arises from the testis and is characterized by the presence of a spermatocytic tumor component that is contiguous with an undifferentiated or differentiated sarcomatous component. It usually presents as a slowly growing mass that enlarges very rapidly soon after the initial diagnosis. C39922 Neoplastic Process Testicular Spermatocytic Tumor with Sarcoma C1515298 Malignant Testicular_Spermatocytic_Seminoma_with_Sarcoma Spermatocytic Tumor with Sarcoma Testicular Spermatocytic Seminoma with Sarcoma Testicular Spermatocytic Tumor with Sarcoma Testicular Spermatocytic Tumor with Sarcoma A yolk sac tumor that arises from the testis and is characterized by the presence of a meshwork of small vacuolated cells resulting in a honeycomb appearance. C39923 Neoplastic Process Testicular Yolk Sac Tumor, Microcystic Pattern C1515308 Malignant Testicular_Yolk_Sac_Tumor_Microcystic_Pattern Testicular Yolk Sac Tumor, Microcystic Pattern Testicular Yolk Sac Tumor, Reticular Pattern Testicular Yolk Sac Tumor, Microcystic Pattern A yolk sac tumor that arises from the testis and is characterized by the presence of collections of thin-walled spaces. C39924 Neoplastic Process Testicular Yolk Sac Tumor, Macrocystic Pattern C1515307 Malignant Testicular_Yolk_Sac_Tumor_Macrocystic_Pattern Testicular Yolk Sac Tumor, Macrocystic Pattern Testicular Yolk Sac Tumor, Macrocystic Pattern A yolk sac tumor that arises from the testis and is characterized by the presence of aggregates of polygonal malignant cells with clear cytoplasm and prominent nucleoli. C39925 Neoplastic Process Testicular Yolk Sac Tumor, Solid Pattern C1515312 Malignant Testicular_Yolk_Sac_Tumor_Solid_Pattern Testicular Yolk Sac Tumor, Solid Pattern Testicular Yolk Sac Tumor, Solid Pattern A yolk sac tumor that arises from the testis and is characterized by the presence of gland-like spaces, irregular alveoli, and tubular structures. C39926 Neoplastic Process Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern C1515305 Malignant Testicular_Yolk_Sac_Tumor_Glandular-Alveolar_Pattern Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern Testicular Yolk Sac Tumor, Glandular-Alveolar Pattern A yolk sac tumor that arises from the testis and is characterized by the presence of connective tissue stalks that contain a blood vessel and are lined by cells with clear cytoplasm and prominent nucleoli. C39927 Neoplastic Process Testicular Yolk Sac Tumor, Endodermal Sinus/Perivascular Pattern C1515303 Malignant Testicular_Yolk_Sac_Tumor_Endodermal_Sinus_Pattern Testicular Yolk Sac Tumor, Endodermal Sinus Pattern Testicular Yolk Sac Tumor, Endodermal Sinus/Perivascular Pattern Testicular Yolk Sac Tumor, Endodermal Sinus/Perivascular Pattern A yolk sac tumor that arises from the testis and is characterized by the presence of numerous papillary structures that are lined by cells with prominent nucleoli. C39928 Neoplastic Process Testicular Yolk Sac Tumor, Papillary Pattern C1515310 Malignant Testicular_Yolk_Sac_Tumor_Papillary_Pattern Testicular Yolk Sac Tumor, Papillary Pattern Testicular Yolk Sac Tumor, Papillary Pattern A yolk sac tumor that arises from the testis and is characterized by the presence of myxomatous tissue that contains collections of malignant cells with prominent nucleoli. C39929 Neoplastic Process Testicular Yolk Sac Tumor, Myxomatous Pattern C1515309 Malignant Testicular_Yolk_Sac_Tumor_Myxomatous_Pattern Testicular Yolk Sac Tumor, Myxomatous Pattern Testicular Yolk Sac Tumor, Myxomatous Pattern Stage II includes: IIA (T3, N0, M0); IIB (T4, N0, M0). T3: Tumor invades through the muscularis propria or into non-peritonealized pericolic or perirectal tissues. T4: Tumor directly invades other organs or structures, and/or perforates visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C3993 Neoplastic Process Stage II Colon Cancer AJCC v6 Stage II Colon Cancer AJCC v6 C0278479 CTRP Malignant Stage_II_Colon_Cancer AJCC Stage II Colon Cancer v6 Colon Cancer Stage II AJCC v6 Dukes B Carcinoma of Colon Dukes B Carcinoma of the Colon Dukes B Colon Carcinoma Dukes B Colonic Carcinoma Stage II Cancer of Colon AJCC v6 Stage II Cancer of the Colon AJCC v6 Stage II Carcinoma of Colon AJCC v6 Stage II Carcinoma of the Colon AJCC v6 Stage II Colon Cancer Stage II Colon Cancer AJCC v6 Stage II Colon Carcinoma AJCC v6 Stage II Colonic Carcinoma AJCC v6 Stage II Colon Cancer AJCC v6 A yolk sac tumor that arises from the testis and is characterized by the presence of collections of vesicles that are surrounded by connective tissue. C39930 Neoplastic Process Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern C1515311 Malignant Testicular_Yolk_Sac_Tumor_Polyvesicular_Vitelline_Pattern Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern A yolk sac tumor that arises from the testis and is characterized by the presence of hepatoid cells collections. C39931 Neoplastic Process Testicular Yolk Sac Tumor, Hepatoid Pattern C1515306 Malignant Testicular_Yolk_Sac_Tumor_Hepatoid_Pattern Testicular Yolk Sac Tumor, Hepatoid Pattern Testicular Yolk Sac Tumor, Hepatoid Pattern A yolk sac tumor that arises from the testis and is characterized by the presence of immature glands. C39932 Neoplastic Process Testicular Yolk Sac Tumor, Enteric Pattern C1515304 Malignant Testicular_Yolk_Sac_Tumor_Enteric_Pattern Testicular Yolk Sac Tumor, Enteric Pattern Testicular Yolk Sac Tumor, Enteric Pattern A tumor that arises from the testis and is composed of neoplastic trophoblastic cells. The vast majority of cases are choriocarcinomas. C39934 Neoplastic Process Testicular Trophoblastic Tumor C1515301 Undetermined Testicular_Trophoblastic_Neoplasm Testicular Trophoblastic Tumor Testicular Trophoblastic Tumor A choriocarcinoma that arises from the testis and is characterized by the predominance of cytotrophoblastic and intermediate trophoblastic cells. Syncytiotrophoblastic cells are absent or not prominent. C39935 Neoplastic Process Testicular Monophasic Choriocarcinoma C1515290 Malignant Testicular_Monomorphic_Choriocarcinoma Testicular Monophasic Choriocarcinoma Testicular Monophasic Choriocarcinoma A teratoma that arises from the testis. It is composed exclusively of one of the following tissue types: endoderm, ectoderm, or mesoderm. C39936 Neoplastic Process Monodermal Testicular Teratoma C1513470 Undetermined Monodermal_Testicular_Teratoma Monodermal Testicular Teratoma Monodermal Testicular Teratoma Stage IV includes: (Any T, Any N, M1). M1: Distant metastasis. (AJCC 6th ed.) C3994 Neoplastic Process Stage IV Colon Cancer AJCC v6 Stage IV Colon Cancer AJCC v6 C0861461 CTRP Malignant Stage_IV_Colon_Cancer AJCC Stage IV Colon Cancer v6 Astler-Coller D Colon Carcinoma Colon Cancer Stage IV AJCC v6 Colon Cancer, Stage IV AJCC v6 Dukes D Carcinoma of Colon Dukes D Carcinoma of the Colon Dukes D Colon Carcinoma Dukes D Colonic Carcinoma Stage IV Carcinoma of Colon AJCC v6 Stage IV Carcinoma of the Colon AJCC v6 Stage IV Colon Cancer Stage IV Colon Cancer AJCC v6 Stage IV Colon Carcinoma AJCC v6 Stage IV Colonic Carcinoma AJCC v6 Stage IV Colon Cancer AJCC v6 A Leydig cell tumor characterized by a large size, cellular atypia, high mitotic activity, vascular invasion and necrotic changes. The prognosis is usually poor. C39942 Neoplastic Process Malignant Testicular Leydig Cell Tumor C1515288 Malignant Testicular_Malignant_Leydig_Cell_Tumor Malignant Testicular Leydig Cell Tumor Malignant Testicular Leydig Cell Tumor A testicular Sertoli cell tumor in which the neoplastic cells have clear and vacuolated cytoplasm due to accumulation of intracytoplasmic lipids. C39943 Neoplastic Process Testicular Sertoli Cell Tumor, Lipid Rich Variant C1515296 8641/0 Benign Testicular_Sertoli_Cell_Tumor_Lipid_Rich_Variant Testicular Sertoli Cell Tumor, Lipid Rich Variant Testicular Sertoli Cell Tumor, Lipid Rich Variant A testicular Sertoli cell tumor characterized by the presence of large polygonal cells with eosinophilic cytoplasm in a myxoid and hyalinized stroma. Calcifications may be present in the stroma. Malignant behavior is uncommon. C39944 Neoplastic Process Testicular Large Cell Calcifying Sertoli Cell Tumor C1266109 GDC 8642/1 Undetermined Testicular_Large_Cell_Calcifying_Sertoli_Cell_Tumor 8642/1 Large cell calcifying Sertoli cell tumor LCCSCT Large cell calcifying Sertoli cell tumor Testicular Large Cell Calcifying Sertoli Cell Tumor Testicular Large Cell Calcifying Sertoli Cell Tumor A rare testicular Sertoli cell tumor characterized by the presence of neoplastic tubules that are surrounded by a dense fibrotic stroma. C39945 Neoplastic Process Testicular Sclerosing Sertoli Cell Tumor C1515291 Benign Testicular_Sclerosing_Sertoli_Cell_Tumor Testicular Sclerosing Sertoli Cell Tumor Testicular Sclerosing Sertoli Cell Tumor A rare, low-grade malignant sex cord-stromal tumor that arises from the testis in adults. It is composed of granulosa cells in an often fibrothecomatous stroma. Several morphologic patterns have been identified and include insular, gyriform, trabecular, pseudosarcomatous, and solid. Gynecomastia is present in approximately a quarter of the patients. Metastases have been reported in a minority of patients. C39946 Neoplastic Process Adult Testicular Granulosa Cell Tumor C1515284 Malignant Testicular_Granulosa_Cell_Tumor_Adult_Type Adult granulosa cell tumor of testis Adult Testicular Granulosa Cell Tumor Adult Type Testicular Granulosa Cell Tumor Adult Testicular Granulosa Cell Tumor A rare, benign sex cord-stromal tumor that arises from the testis. It is the most frequent congenital testicular neoplasm and is usually diagnosed during the perinatal period. It usually presents as an asymptomatic scrotal or abdominal mass. Morphologically, it is characterized by the presence of cysts that are lined by cells resembling granulosa and theca cells. C39947 Neoplastic Process Juvenile Testicular Granulosa Cell Tumor C1515285 NICHD A rare sex cord-stromal tumor that arises from the testis. Benign Testicular_Granulosa_Cell_Tumor_Juvenile_Type Granulosa cell tumor of testis, juvenile Juvenile Testicular Granulosa Cell Tumor Juvenile Type Testicular Granulosa Cell Tumor Juvenile Testicular Granulosa Cell Tumor A malignant sex cord-gonadal stromal tumor that arises from the testis. It is characterized by cellular pleomorphism, anaplastic features, increased mitotic activity, and vascular invasion. C39948 Neoplastic Process Malignant Testicular Sex Cord-Stromal Tumor C1515289 Malignant Testicular_Malignant_Sex_Cord-Stromal_Tumor Malignant Testicular Sex Cord-Stromal Tumor Malignant Testicular Sex Cord-Stromal Tumor A group of rare, slow-growing stromal tumors that arise from the testis. This category includes thecoma and fibroma. C39949 Neoplastic Process Testicular Tumor of the Thecoma/Fibroma Group C1515302 Undetermined Testicular_Tumor_of_the_Thecoma_Fibroma_Group Testicular Tumor of the Thecoma/Fibroma Group Testicular Tumor of the Thecoma/Fibroma Group Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 6th and 7th Eds.) C3995 Neoplastic Process Stage IV Breast Cancer AJCC v6 and v7 Stage IV Breast Cancer AJCC v6 and v7 C0278488 CTRP Cancer has spread to other organs of the body, most often the bones, lungs, liver, or brain. Malignant Stage_IV_Breast_Cancer Breast Cancer Stage IV Breast Carcinoma Stage IV Stage IV Breast Cancer Stage IV Breast Cancer AJCC v6 Stage IV Breast Cancer AJCC v6 and v7 Stage IV Breast Cancer AJCC v7 Stage IV Breast Carcinoma stage IV breast cancer Stage IV Breast Cancer AJCC v6 and v7 A sex cord-stromal tumor that arises from the ovary or the testis. Representative examples include fibroma, fibrosarcoma, and thecoma. C39950 Neoplastic Process Tumor of the Thecoma/Fibroma Group C1519696 Undetermined Tumor_of_the_Thecoma_Fibroma_Group Tumor of the Thecoma/Fibroma Group Tumor of the Thecoma/Fibroma Group A benign neoplasm that arises from the testis and is characterized by the presence of fusiform cells and collagenization. C39951 Neoplastic Process Testicular Fibroma C1515282 Benign Testicular_Fibroma Testicular Fibroma Testicular Fibroma A rare benign tumor that arises from the testis and is characterized by the presence of lipid-rich neoplastic spindle cells. C39952 Neoplastic Process Testicular Thecoma C1515299 Benign Testicular_Thecoma Testicular Thecoma Testicular Thecoma A very rare, usually benign neoplasm that arises from the paratesticular structures. It is characterized by the presence of solid and cystic nests of neoplastic urothelial-type cells in a fibrotic stroma. C39953 Neoplastic Process Paratesticular Brenner Tumor C1515281 Undetermined Testicular_Brenner_Tumor Paratesticular Brenner Tumor Testicular Adnexa Brenner Tumor Testicular Brenner Tumor Paratesticular Brenner Tumor A benign or malignant neoplasm that affects the rete testis. Representative examples include adenoma and adenocarcinoma. C39955 Neoplastic Process Rete Testis Neoplasm C1514912 Undetermined Rete_Testis_Neoplasm Rete Testis Neoplasm Rete Testis Neoplasm A benign, circumscribed, cystic or mixed cystic and solid epithelial neoplasm arising from the rete testis. C39956 Neoplastic Process Rete Testis Adenoma C1514910 CDISC A benign epithelial neoplasm arising from the rete testis. Benign Rete_Testis_Adenoma ADENOMA, RETE TESTIS, BENIGN Rete Testis Adenoma Rete Testis Adenoma A rare adenocarcinoma that arises from the epididymis. It usually presents as a scrotal mass and may be associated with testicular pain. C39957 Neoplastic Process Epididymal Adenocarcinoma C1510784 Malignant Adenocarcinoma_of_the_Epididymis Adenocarcinoma of the Epididymis Epididymal Adenocarcinoma Epididymal Adenocarcinoma A benign or malignant neoplasm that affects the epididymis. Representative examples include epididymal adenomatoid tumor and epididymal adenocarcinoma. C39958 Neoplastic Process Epididymal Neoplasm C0346239 Undetermined Epididymal_Neoplasm Epididymal Neoplasm Epididymal Neoplasm A squamous cell carcinoma that arises from the penis and is characterized by a mixture of morphologic patterns (e.g., high grade squamous cell carcinoma and verrucous carcinoma or warty-basaloid carcinoma). C39959 Neoplastic Process Penile Mixed Squamous Cell Carcinoma C1513369 Malignant Mixed_Squamous_Cell_Carcinoma_of_the_Penis Mixed Squamous Cell Carcinoma of the Penis Penile Mixed Squamous Cell Carcinoma Penile Mixed Squamous Cell Carcinoma A condition in which an abnormal amount of a single immunoglobulin is present in the serum. This category includes IgM monoclonal gammopathy of undetermined significance and non-IgM monoclonal gammopathy of undetermined significance. Up to 25% of cases of monoclonal gammopathy of undetermined significance progress to a B-cell malignancy or myeloma. C3996 Neoplastic Process Monoclonal Gammopathy of Undetermined Significance Monoclonal Gammopathy of Undetermined Significance C0026470 CTEP CTRP Cellosaurus GDC A benign condition in which there is a higher-than-normal level of a protein called M protein in the blood. Patients with MGUS are at an increased risk of developing cancer. 9765/1 Undetermined Monoclonal_Gammopathy_of_Undetermined_Significance 9765/1 MGUS Monoclonal gammopathy of undetermined significance Monoclonal gammopathy of undetermined significance, NOS Monoclonal gammopathy, NOS MGUS Monoclonal Gammopathy of Undetermined Significance Monoclonal Gammopathy of Undetermined Significance (MGUS) Monoclonal gammopathy of undetermined significance Monoclonal gammopathy of undetermined significance (MGUS) monoclonal gammopathy of undetermined significance Monoclonal Gammopathy of Undetermined Significance A basal cell carcinoma of the penis with an indolent clinical course. It is usually superficial and arises from the shaft and rarely the glans. C39961 Neoplastic Process Penile Basal Cell Carcinoma Penile Basal Cell Carcinoma C1518949 CTRP Malignant Penile_Basal_Cell_Carcinoma Basal Cell Carcinoma of the Penis Penile Basal Cell Cancer Penile Basal Cell Carcinoma Penile Basal Cell Carcinoma A cutaneous, usually multifocal lesion in the penis characterized by the presence of verrucous papules. It is caused by human papillomavirus infection. Morphologically there is bowenoid dysplasia present. Progression to invasive carcinoma is infrequent. C39963 Neoplastic Process Penile Bowenoid Papulosis C1536526 Precancerous Penile_Bowenoid_Papulosis Penile Bowenoid Papulosis Penile Bowenoid Papulosis An ovarian thecoma characterized by the presence of cells with uniform nuclei and abundant vacuolated cytoplasm. Mitoses are not present or, when present, are rare. C39964 Neoplastic Process Typical Ovarian Thecoma C1519721 Benign Typical_Ovarian_Thecoma Typical Ovarian Thecoma Typical Ovarian Thecoma A rare, benign sex cord-stromal tumor that arises from the ovary. It is characterized by the presence of round cells with a single cytoplasmic vacuole and an eccentric nucleus resembling signet ring cells. Mucin stains are negative. C39965 Neoplastic Process Ovarian Signet Ring Stromal Tumor C1518735 Benign Ovarian_Signet_Ring_Stromal_Tumor Ovarian Signet Ring Stromal Tumor Ovarian Signet-Ring Stromal Tumor Ovarian Signet Ring Stromal Tumor A sex cord-stromal tumor that arises from the ovary and is composed entirely of, or in various combinations of, Sertoli cells, Leydig cells, and fibroblast-like cells. C39966 Neoplastic Process Ovarian Sertoli-Stromal Cell Tumor C1518732 NICHD A sex cord-stromal tumor, comprising in its entirety or in various combinations, Sertoli cells, Leydig cells, and fibroblast-like cells, that arises from the ovary. Undetermined Ovarian_Sertoli-Stromal_Cell_Tumor Ovarian Sertoli-Stromal Cell Tumor Ovarian Sertoli-Stromal Tumor Ovarian Sertoli-Stromal Cell Tumor A Sertoli-Leydig cell tumor of the ovary characterized by the presence of spindle-shaped gonadal stromal cells and Sertoli cells, some of which are atypical. Leydig cells are also present forming clusters at the periphery of the cellular aggregates. Metastases have been reported in a minority of patients. C39968 Neoplastic Process Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor C1318541 GDC 8631/1 Undetermined Intermediate_Differentiated_Ovarian_Sertoli-Leydig_Cell_Tumor 8631/1 Sertoli-Leydig cell tumor of intermediate differentiation Sertoli-Leydig cell tumor of intermediate differentiation, NOS Intermediate Differentiated Ovarian Sertoli-Leydig Cell Tumor Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor Sertoli-Leydig cell tumor of intermediate differentiation Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor A medulloblastoma occurring in children. C3997 Neoplastic Process Childhood Medulloblastoma Childhood Medulloblastoma C0278510 CTRP NICHD A medulloblastoma occurring in children. Malignant Childhood_Medulloblastoma Childhood Medulloblastoma Medulloblastoma Pediatric Medulloblastoma Childhood Medulloblastoma A Sertoli-Leydig cell tumor that arises from the ovary. It is characterized by the presence of epithelial and/or mesenchymal components and neoplasms that arise from these components. C39970 Neoplastic Process Ovarian Sertoli-Leydig Cell Tumor with Heterologous Elements C1518730 Undetermined Ovarian_Sertoli-Leydig_Cell_Tumor_with_Heterologous_Elements Ovarian Sertoli-Leydig Cell Tumor with Heterologous Elements Ovarian Sertoli-Leydig Cell Tumor with Heterologous Elements A Sertoli-Leydig cell tumor of the ovary in which anastomosing, slit-like spaces resembling rete testis constitute at least 90% of the tumor elements. It may present with estrogenic and less often androgenic manifestations. It usually follows a benign clinical course. C39971 Neoplastic Process Ovarian Retiform Sertoli-Leydig Cell Tumor C1518728 8633/1 Undetermined Ovarian_Retiform_Sertoli-Leydig_Cell_Tumor Ovarian Retiform Sertoli-Leydig Cell Tumor Ovarian Retiform Sertoli-Leydig Cell Tumor An ovarian Sertoli-Leydig cell tumor of intermediate differentiation, characterized by the presence of a heterologous component, usually consisting of cartilage, skeletal muscle, or rhabdomyosarcoma. C39972 Neoplastic Process Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements C1266107 GDC 8634/1 Undetermined Intermediate_Differentiated_Ovarian_Sertoli-Leydig_Cell_Tumor_Variant_with_Heterologous_Elements 8634/1 Sertoli-Leydig cell tumor, intermediate differentiation, with heterologous elements Intermediate Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements Sertoli-Leydig cell tumor, intermediate differentiation, with heterologous elements Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements An ovarian poorly differentiated Sertoli-Leydig cell tumor. It is characterized by the presence of a heterologous component, usually consisting of cartilage, skeletal muscle, or rhabdomyosarcoma. C39973 Neoplastic Process Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements C1266108 GDC 8634/3 Malignant Poorly_Differentiated_Ovarian_Sertoli-Leydig_Cell_Tumor_Variant_with_Heterologous_Elements 8634/3 Sertoli-Leydig cell tumor, poorly differentiated, with heterologous elements Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements Sertoli-Leydig cell tumor, poorly differentiated, with heterologous elements Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements A Sertoli-Leydig cell tumor characterized by the presence of spaces that resemble rete testis (retiform elements). These spaces form anastomosing patterns and comprise at least ten percent but less than ninety percent of the tumor. When the retiform elements comprise ninety percent or more of the tumor, the term retiform Sertoli-Leydig cell tumor is used. A minority of patients may have an aggressive clinical course. C39974 Neoplastic Process Ovarian Sertoli-Leydig Cell Tumor with Retiform Elements C1266106 GDC Undetermined Ovarian_Sertoli-Leydig_Cell_Tumor_with_Retiform_Elements 8633/1 Sertoli-Leydig cell tumor, retiform Ovarian Sertoli-Leydig Cell Tumor with Retiform Elements Sertoli-Leydig cell tumor, retiform Ovarian Sertoli-Leydig Cell Tumor with Retiform Elements A sex cord-stromal tumor of the testis or the ovary. It is characterized by the presence of Sertoli cells forming tubules. Leydig cells are rare or absent. It may be associated with Peutz-Jeghers syndrome. In males, the presenting symptom is a slow growing testicular mass. Most cases follow a benign clinical course. In females it may present with estrogenic or androgenic manifestations. The vast majority of cases have a benign clinical course. C39976 Neoplastic Process Sertoli Cell Tumor C0036769 GDC NICHD A sex cord-stromal tumor of the testis or the ovary. It is characterized by the presence of Sertoli cells forming tubules. Leydig cells are rare or absent. It may be associated with Peutz-Jeghers syndrome. 8630/1 8640/1 Undetermined Sertoli_Cell_Tumor 8640/1 Androblastoma, NOS Arrhenoblastoma, NOS Pick tubular adenoma Sertoli cell adenoma Sertoli cell tumor, NOS Testicular adenoma Tubular androblastoma, NOS Sertoli Cell Tumor Sertoli cell adenoma Sertoli cell tumor, NOS Sertoli Cell Tumor A rare, benign and well circumscribed stromal tumor of the ovary. It is characterized by the presence of a fibrotic stroma with clusters of Leydig cells. The Leydig cells contain crystals of Reinke. Patients may present with virilization. C39977 Neoplastic Process Ovarian Stromal-Leydig Cell Tumor C1518741 NICHD A rare, benign, well circumscribed stromal tumor of the ovary. It is characterized by the presence of a fibrotic stroma with clusters of Leydig cells. Benign Ovarian_Stromal-Leydig_Cell_Tumor Ovarian Stromal-Leydig Cell Tumor Ovarian Stromal-Leydig Tumor Ovarian Stromal-Leydig Cell Tumor A sex cord-stromal tumor that arises from the ovary and lacks the morphologic features that belong to the categories of granulosa-stromal tumors, Sertoli-stromal tumors, or steroid cell tumors. C39978 Neoplastic Process Ovarian Sex Cord-Stromal Tumor, Not Otherwise Specified C1518734 Undetermined Ovarian_Sex_Cord-Stromal_Tumor_of_Mixed_or_Unclassified_Cell_Types Ovarian Sex Cord-Stromal Tumor, NOS Ovarian Sex Cord-Stromal Tumor, Not Otherwise Specified Ovarian Sex Cord-Stromal Tumor, Not Otherwise Specified A steroid cell tumor that arises from the ovary and is defined by morphologic features that do not fit into the categories of Leydig cell tumor and stromal luteoma. These features include solid proliferations of polygonal neoplastic cells with eosinophilic and granular cytoplasm. Grossly, these tumors usually present as large and well circumscribed masses and are usually associated with androgenic manifestations. Approximately one third of the cases have a malignant clinical course. C39979 Neoplastic Process Ovarian Steroid Cell Tumor, Not Otherwise Specified C1518740 Undetermined Ovarian_Steroid_Cell_Tumor_Not_Otherwise_Specified Ovarian Steroid Cell Tumor, NOS Ovarian Steroid Cell Tumor, Not Otherwise Specified Ovarian Steroid Cell Tumor, Not Otherwise Specified The reemergence of colon carcinoma after a period of remission. C3998 Neoplastic Process Recurrent Colon Carcinoma Recurrent Colon Carcinoma C0278553 CTRP Malignant Recurrent_Colon_Cancer Recurrent Cancer of Colon Recurrent Cancer of the Colon Recurrent Colon Cancer Recurrent Colon Carcinoma Recurrent Colon Carcinoma An ovarian steroid cell tumor not otherwise specified, and characterized by the absence of nuclear atypia, mitotic figures, necrosis, and hemorrhage. C39980 Neoplastic Process Well Differentiated Ovarian Steroid Cell Tumor C1520133 Undetermined Well_Differentiated_Ovarian_Steroid_Cell_Tumor Well Differentiated Ovarian Steroid Cell Tumor Well Differentiated Ovarian Steroid Cell Tumor A steroid tumor of the ovary which has an aggressive clinical course and metastasizes to other anatomic sites. It is usually of large size and is characterized by nuclear atypia, increased mitotic activity, hemorrhage, and necrosis. Sometimes, patients have abdominal metastases at presentation. C39981 Neoplastic Process Malignant Ovarian Steroid Cell Tumor C1266110 GDC 8670/3 Malignant Malignant_Ovarian_Steroid_Cell_Tumor 8670/3 Steroid cell tumor, malignant Malignant Ovarian Steroid Cell Tumor Steroid cell tumor, malignant Malignant Ovarian Steroid Cell Tumor A Leydig cell tumor that arises from the ovarian stroma. C39983 Neoplastic Process Ovarian Leydig Cell Tumor, Non-Hilar Type C1518719 Benign Ovarian_Leydig_Cell_Tumor_Non-Hilar_Type Ovarian Leydig Cell Tumor, Non-Hilar Type Ovarian Leydig Cell Tumor, Non-Hilar Type An ovarian Leydig cell tumor for which the site of origin (ovarian hilus or ovarian stroma) cannot be determined. C39984 Neoplastic Process Ovarian Leydig Cell Tumor, Not Otherwise Specified CL448663 Benign Ovarian_Leydig_Cell_Tumor_Not_Otherwise_Specified Ovarian Leydig Cell Tumor, Not Otherwise Specified Ovarian Leydig Cell Tumor, Not Otherwise Specified A neoplasm that arises from the ovary and is composed of tissues that resemble dysgerminoma or seminoma and are admixed with sex cord tissues. It is found in children or young adults and usually is associated with secondary sex organs abnormalities. The majority of patients present as phenotypic females with virilization. The minority of patients present as phenotypic males with feminization. It typically affects both gonads. If a malignant germ cell component is present, it may metastasize to other anatomic sites. C39985 Neoplastic Process Ovarian Gonadoblastoma C1518716 NICHD A gonadoblastoma that occurs in the ovary. Undetermined Ovarian_Gonadoblastoma Ovarian Gonadoblastoma Ovarian Gonadoblastoma A malignant tumor that arises from the ovary and is characterized by the presence of malignant germ cell components but lacks a teratoma component. C39986 Neoplastic Process Ovarian Primitive Germ Cell Tumor C1518727 Malignant Ovarian_Primitive_Germ_Cell_Tumor Ovarian Primitive Germ Cell Tumor Ovarian Primitive Germ Cell Tumor A yolk sac tumor that arises from the ovary and is characterized by the presence of multiple dilated spaces lined by cells that resemble mesothelial cells. The dilated spaces coexist with columnar epithelial tissues. C39987 Neoplastic Process Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern C1518749 Malignant Ovarian_Yolk_Sac_Tumor_Polyvesicular_Vitelline_Pattern Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern A yolk sac tumor that arises from the ovary and is characterized by the presence of extensive differentiation into endodermal type glandular structures. C39988 Neoplastic Process Ovarian Yolk Sac Tumor, Glandular Pattern C1518747 Malignant Ovarian_Yolk_Sac_Tumor_Glandular_Pattern Ovarian Yolk Sac Tumor, Glandular Pattern Ovarian Yolk Sac Tumor, Glandular Pattern A yolk sac tumor that arises from the ovary and is characterized by the presence of extensive differentiation into hepatic tissue. C39989 Neoplastic Process Ovarian Yolk Sac Tumor, Hepatoid Pattern C1518748 Malignant Ovarian_Yolk_Sac_Tumor_Hepatoid_Pattern Ovarian Yolk Sac Tumor, Hepatoid Pattern Ovarian Yolk Sac Tumor, Hepatoid Pattern An esophageal carcinoma which has reappeared after a period of remission or after presumed treatment. C3999 Neoplastic Process Recurrent Esophageal Carcinoma Recurrent Esophageal Carcinoma C0854761 CTRP Malignant Recurrent_Esophageal_Cancer Esophageal Carcinoma, Recurrent Oesophageal Carcinoma Recurrent Recurrent Cancer of Esophagus Recurrent Cancer of the Esophagus Recurrent Carcinoma of Esophagus Recurrent Carcinoma of the Esophagus Recurrent Esophageal Cancer Recurrent Esophageal Carcinoma Recurrent Esophagus Cancer Relapsed Cancer of Esophagus Relapsed Cancer of the Esophagus Relapsed Carcinoma of Esophagus Relapsed Carcinoma of the Esophagus Relapsed Esophageal Cancer Relapsed Esophagus Carcinoma Recurrent Esophageal Carcinoma A rare, malignant germ cell tumor arising from the ovary. It is characterized by the presence of embryoid bodies which resemble early embryos. C39990 Neoplastic Process Ovarian Polyembryoma Ovarian Polyembryoma C1514199 CTRP Malignant Polyembryoma_of_the_Ovary Ovarian Polyembryoma Polyembryoma of the Ovary Ovarian Polyembryoma A malignant germ cell tumor that arises from the ovary and is composed of cytotrophoblasts, syncytiotrophoblasts, and extravillous trophoblasts. The prognosis is less favorable than gestational choriocarcinoma. C39991 Neoplastic Process Non-Gestational Ovarian Choriocarcinoma C1518355 Cellosaurus Malignant Non-Gestational_Ovarian_Choriocarcinoma Non-Gestational Ovarian Choriocarcinoma Non-Gestational Ovarian Choriocarcinoma A germ cell tumor that arises from the ovary and is composed of tissues that originate from two or three of the following germ layers, endoderm, ectoderm, or mesoderm. C39992 Neoplastic Process Ovarian Biphasic or Triphasic Teratoma C1518691 Undetermined Ovarian_Biphasic_or_Triphasic_Teratoma Ovarian Biphasic or Triphasic Teratoma Ovarian Biphasic or Triphasic Teratoma A teratoma that arises from the ovary. It contains mature tissue elements and a limited amount of immature tissue elements. C39993 Neoplastic Process Grade 1 Ovarian Teratoma CL563196 Benign Grade_1_Immature_Ovarian_Teratoma Grade 1 Ovarian Teratoma Grade 1 Ovarian Teratoma A teratoma that arises from the ovary. It is composed exclusively of immature tissue elements. C39995 Neoplastic Process Malignant Ovarian Teratoma CL563197 Cellosaurus Malignant Grade_3_Immature_Ovarian_Teratoma Grade 3 Ovarian Teratoma Malignant Ovarian Teratoma Malignant Ovarian Teratoma A rare type of teratoma that arises from the ovary and resembles a malformed fetus. C39996 Neoplastic Process Ovarian Fetiform Teratoma C1518715 Benign Ovarian_Fetiform_Teratoma Homunculus Ovarian Fetiform Teratoma Ovarian Fetiform Teratoma A secondary carcinoma that has developed in an ovarian dermoid cyst. In the majority of cases, the secondary carcinoma is a squamous cell carcinoma. C39997 Neoplastic Process Ovarian Dermoid Cyst with Secondary Carcinoma C1518705 Malignant Ovarian_Dermoid_Cyst_with_Secondary_Carcinoma Ovarian Dermoid Cyst with Secondary Carcinoma Ovarian Dermoid Cyst with Secondary Carcinoma A secondary squamous cell carcinoma that has developed in an ovarian dermoid cyst. C39998 Neoplastic Process Ovarian Dermoid Cyst with Squamous Cell Carcinoma C1518710 Malignant Ovarian_Dermoid_Cyst_with_Squamous_Cell_Carcinoma Ovarian Dermoid Cyst with Squamous Cell Carcinoma Ovarian Dermoid Cyst with Squamous Cell Carcinoma A secondary adenocarcinoma that has developed in an ovarian dermoid cyst. C39999 Neoplastic Process Ovarian Dermoid Cyst with Adenocarcinoma C1518696 Malignant Ovarian_Dermoid_Cyst_with_Adenocarcinoma Ovarian Dermoid Cyst with Adenocarcinoma Ovarian Dermoid Cyst with Adenocarcinoma Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C4000 Neoplastic Process Stage 0 Cervical Cancer AJCC v6 Stage 0 Cervical Cancer AJCC v6 C0851140 CTRP GDC Malignant Stage_0_Cervical_Cancer 8077/2 CIN III with severe dysplasia Cervical intraepithelial neoplasia, grade III Cin III, NOS CIN 3 AJCC v6 CIN Grade 3 AJCC v6 Carcinoma in situ of Cervix AJCC v6 Carcinoma in situ of Cervix Uteri AJCC v6 Carcinoma in situ of Uterine Cervix AJCC v6 Carcinoma in situ of the Cervix AJCC v6 Carcinoma in situ of the Cervix Uteri AJCC v6 Carcinoma in situ of the Uterine Cervix AJCC v6 Cervical Carcinoma in situ AJCC v6 Cervical Intraepithelial Neoplasia Grade 3 AJCC v6 Cervical Severe Dysplasia AJCC v6 Cervical cancer stage 0 AJCC v6 Cervix Carcinoma in situ AJCC v6 Cervix Intraepithelial Neoplasia Grade 3 AJCC v6 Cervix Severe Dysplasia AJCC v6 Cervix Uteri Carcinoma in situ AJCC v6 Cervix Uteri Intraepithelial Neoplasia Grade 3 AJCC v6 Cervix Uteri Severe Dysplasia AJCC v6 FIGO Stage 0 Carcinoma of Cervix FIGO Stage 0 Carcinoma of Cervix Uteri FIGO Stage 0 Carcinoma of Uterine Cervix FIGO Stage 0 Carcinoma of the Cervix FIGO Stage 0 Carcinoma of the Cervix Uteri FIGO Stage 0 Carcinoma of the Uterine Cervix FIGO Stage 0 Cervical Carcinoma FIGO Stage 0 Cervix Carcinoma FIGO Stage 0 Cervix Uteri Carcinoma FIGO Stage 0 Uterine Cervix Carcinoma Grade 3 Cervical Intraepithelial Neoplasia AJCC v6 Intraepithelial Neoplasia of Cervix Grade 3 AJCC v6 Intraepithelial Neoplasia of Cervix Uteri Grade 3 AJCC v6 Intraepithelial Neoplasia of Uterine Cervix Grade 3 AJCC v6 Intraepithelial Neoplasia of the Cervix Grade 3 AJCC v6 Intraepithelial Neoplasia of the Cervix Uteri Grade 3 AJCC v6 Intraepithelial Neoplasia of the Uterine Cervix Grade 3 AJCC v6 Severe Cervical Dysplasia AJCC v6 Severe Dysplasia of Cervix AJCC v6 Severe Dysplasia of Cervix Uteri AJCC v6 Severe Dysplasia of Uterine Cervix AJCC v6 Severe Dysplasia of the Cervix AJCC v6 Severe Dysplasia of the Cervix Uteri AJCC v6 Severe Dysplasia of the Uterine Cervix AJCC v6 Stage 0 Cervical Cancer Stage 0 Cervical Cancer AJCC v6 Uterine Cervix Carcinoma in situ AJCC v6 Uterine Cervix Intraepithelial Neoplasia Grade 3 AJCC v6 Uterine Cervix Severe Dysplasia AJCC v6 Stage 0 Cervical Cancer AJCC v6 A secondary melanoma or melanocytic nevus that has developed in an ovarian dermoid cyst. C40000 Neoplastic Process Ovarian Dermoid Cyst with Secondary Melanocytic Lesion C1518706 Undetermined Ovarian_Dermoid_Cyst_with_Secondary_Melanocytic_Lesion Ovarian Dermoid Cyst with Secondary Melanocytic Lesion Ovarian Dermoid Cyst with Secondary Melanocytic Lesion A secondary melanoma that has developed in an ovarian dermoid cyst. C40001 Neoplastic Process Ovarian Dermoid Cyst with Melanoma C1518701 Malignant Ovarian_Dermoid_Cyst_with_Melanoma Ovarian Dermoid Cyst with Melanoma Ovarian Dermoid Cyst with Melanoma A secondary melanocytic nevus that has developed in an ovarian dermoid cyst. C40002 Neoplastic Process Ovarian Dermoid Cyst with Melanocytic Nevus C1518700 Benign Ovarian_Dermoid_Cyst_with_Melanocytic_Nevus Ovarian Dermoid Cyst with Melanocytic Nevus Ovarian Dermoid Cyst with Melanocytic Nevus A secondary sebaceous adenoma or sebaceous carcinoma that has developed in an ovarian dermoid cyst. C40003 Neoplastic Process Ovarian Dermoid Cyst with Secondary Sebaceous Tumor C1518709 Undetermined Ovarian_Dermoid_Cyst_with_Secondary_Sebaceous_Tumor Ovarian Dermoid Cyst with Secondary Sebaceous Tumor Ovarian Dermoid Cyst with Secondary Sebaceous Tumor A secondary sebaceous carcinoma that has developed in an ovarian dermoid cyst. C40004 Neoplastic Process Ovarian Dermoid Cyst with Sebaceous Carcinoma C1518704 Malignant Ovarian_Dermoid_Cyst_with_Sebaceous_Carcinoma Ovarian Dermoid Cyst with Sebaceous Carcinoma Ovarian Dermoid Cyst with Sebaceous Carcinoma A secondary sebaceous adenoma that has developed in an ovarian dermoid cyst. C40005 Neoplastic Process Ovarian Dermoid Cyst with Sebaceous Adenoma C1518703 Benign Ovarian_Dermoid_Cyst_with_Sebaceous_Adenoma Ovarian Dermoid Cyst with Sebaceous Adenoma Ovarian Dermoid Cyst with Sebaceous Adenoma A secondary corticotropin secreting adenoma or prolactin secreting adenoma that has developed in an ovarian dermoid cyst. The clinical course is benign. C40006 Neoplastic Process Ovarian Dermoid Cyst with Secondary Pituitary-Type Tumor C1518707 Undetermined Ovarian_Dermoid_Cyst_with_Secondary_Pituitary-Type_Tumor Ovarian Dermoid Cyst with Secondary Pituitary-Type Tumor Ovarian Dermoid Cyst with Secondary Pituitary-Type Tumor A corticotropin secreting adenoma that has developed in an ovarian dermoid cyst. It may present with Cushing syndrome. The clinical course is benign. C40007 Neoplastic Process Ovarian Dermoid Cyst with Corticotropin Secreting Adenoma C1518698 Benign Ovarian_Dermoid_Cyst_with_Corticotropin_Secreting_Adenoma Ovarian Dermoid Cyst with Corticotropin Secreting Adenoma Ovarian Dermoid Cyst with Corticotropin Secreting Adenoma A prolactin secreting adenoma that has developed in an ovarian dermoid cyst. It may present with hyperprolactinemia and amenorrhea. The clinical course is benign. C40008 Neoplastic Process Ovarian Dermoid Cyst with Prolactin Secreting Adenoma C1518702 Benign Ovarian_Dermoid_Cyst_with_Prolactin_Secreting_Adenoma Ovarian Dermoid Cyst with Prolactin Secreting Adenoma Ovarian Dermoid Cyst with Prolactin Secreting Adenoma A secondary sarcoma that has developed in an ovarian dermoid cyst. Representative examples of secondary sarcomas include leiomyosarcoma, fibrosarcoma, and angiosarcoma. C40009 Neoplastic Process Ovarian Dermoid Cyst with Secondary Sarcoma C1518708 Malignant Ovarian_Dermoid_Cyst_with_Secondary_Sarcoma Ovarian Dermoid Cyst with Secondary Sarcoma Ovarian Dermoid Cyst with Secondary Sarcoma An advanced, invasive breast adenocarcinoma characterized by the presence of distinct changes in the overlying skin. These changes include diffuse erythema, edema, peau d'orange (skin of an orange) appearance, tenderness, induration, warmth, enlargement, and in some cases a palpable mass. The skin changes are the consequence of lymphatic obstruction from the underlying invasive breast adenocarcinoma. Microscopically, the dermal lymphatics show prominent infiltration by malignant cells. The invasive breast adenocarcinoma is usually of ductal, NOS type. There is not significant inflammatory cell infiltrate present, despite the name of this carcinoma. C4001 Neoplastic Process Inflammatory Breast Carcinoma Breast Inflammatory Carcinoma C0278601 CTEP CTRP Cellosaurus GDC A type of breast cancer in which the breast looks red and swollen and feels warm. The skin of the breast may also show the pitted appearance called peau d'orange (like the skin of an orange). The redness and warmth occur because the cancer cells block the lymph vessels in the skin. 8530/3 Malignant Inflammatory_Breast_Carcinoma 8530/3 Inflammatory carcinoma Breast Inflammatory Carcinoma Inflammatory Breast Cancer Inflammatory Breast Carcinoma Inflammatory Carcinoma of Breast Inflammatory Carcinoma of the Breast Inflammatory breast carcinoma Inflammatory carcinoma Mastitis Carcinomatosa inflammatory breast cancer Breast Inflammatory Carcinoma A secondary leiomyosarcoma that has developed in an ovarian dermoid cyst. C40010 Neoplastic Process Ovarian Dermoid Cyst with Leiomyosarcoma C1518699 Malignant Ovarian_Dermoid_Cyst_with_Leiomyosarcoma Ovarian Dermoid Cyst with Leiomyosarcoma Ovarian Dermoid Cyst with Leiomyosarcoma A secondary angiosarcoma that has developed in an ovarian dermoid cyst. C40011 Neoplastic Process Ovarian Dermoid Cyst with Angiosarcoma C1518697 Malignant Ovarian_Dermoid_Cyst_with_Angiosarcoma Ovarian Dermoid Cyst with Angiosarcoma Ovarian Dermoid Cyst with Angiosarcoma A carcinoid tumor that arises from the ovary and is characterized by the presence of round cells with abundant eosinophilic cytoplasm forming cribriform patterns. Clinical manifestations of carcinoid syndrome occur in approximately thirty percent of patients. The prognosis is favorable. C40013 Neoplastic Process Ovarian Insular Carcinoid Tumor C1518718 Undetermined Ovarian_Insular_Carcinoid_Tumor Ovarian Insular Carcinoid Tumor Ovarian Insular Carcinoid Tumor A carcinoid tumor that arises from the ovary and is characterized by the presence of columnar cells with abundant cytoplasm forming ribbons. The prognosis is excellent. C40014 Neoplastic Process Ovarian Trabecular Carcinoid Tumor C1518745 Undetermined Ovarian_Trabeculal_Carcinoid_Tumor Ovarian Trabecular Carcinoid Tumor Ovarian Trabecular Carcinoid Tumor A rare carcinoid tumor that arises from the ovary and is characterized by the presence of glands that are lined by cells that contain intracytoplasmic mucin or resemble goblet cells. Pools of mucin, containing glands, may also be present. It may have an aggressive clinical course and it can metastasize to other anatomic sites. C40015 Neoplastic Process Ovarian Mucinous Carcinoid Tumor C1518724 Undetermined Ovarian_Mucinous_Carcinoid_Tumor Ovarian Mucinous Carcinoid Tumor Ovarian Mucinous Carcinoid Tumor A benign or malignant neoplasm that arises from the rete ovarii which is located in the ovarian hilus. It includes adenoma, cystadenoma, cystadenofibroma, and adenocarcinoma. C40016 Neoplastic Process Rete Ovarii Neoplasm C1514909 Undetermined Rete_Ovarii_Neoplasm Rete Ovarii Neoplasm Rete Ovarii Neoplasm An exceptionally rare adenocarcinoma that arises from the rete ovarii. C40017 Neoplastic Process Rete Ovarii Adenocarcinoma C3840223 GDC Malignant Rete_Ovarii_Adenocarcinoma 9110/3 Adenocarcinoma of rete ovarii Adenocarcinoma of rete ovarii Rete Ovarii Adenocarcinoma Rete Ovarii Adenocarcinoma An adenoma that arises from the rete ovarii. It is composed of elongated tubules. The clinical course is benign. C40018 Neoplastic Process Rete Ovarii Adenoma C1514905 CDISC A benign adenoma arising from the rete ovarii, generally composed of intratubular mass(es) that distend the tubule. Benign Rete_Ovarii_Adenoma Adenoma of rete ovarii ADENOMA, RETE OVARII, BENIGN Rete Ovarii Adenoma Rete Ovarii Adenoma An exceptionally rare cystadenoma that arises from the rete ovarii. C40019 Neoplastic Process Rete Ovarii Cystadenoma C1514907 Benign Rete_Ovarii_Cystadenoma Rete Ovarii Cystadenoma Rete Ovarii Cystadenoma A localized malignant neoplasm arising in an extraosseous site. It is composed of clonal (malignant) plasma cells forming a tumor mass. It most frequently involves the oropharynx, nasopharynx, sinuses, and larynx. C4002 Neoplastic Process Extraosseous Plasmacytoma Extraosseous Plasmacytoma C0278619 CTRP GDC 9734/3 Malignant Extramedullary_Plasmacytoma 9734/3 Extraosseous plasmacytoma Plasmacytoma, extramedullary Extramedullary Plasmacytoma Extraosseous Plasmacytoma Extraosseous plasmacytoma Plasmacytoma, extramedullary Extraosseous Plasmacytoma An exceptionally rare cystadenofibroma that arises from the rete ovarii. C40020 Neoplastic Process Rete Ovarii Cystadenofibroma C1514906 Benign Rete_Ovarii_Cystadenofibroma Rete Ovarii Cystadenofibroma Rete Ovarii Cystadenofibroma A lymphoma that affects the ovary. Lymphomatous involvement of the ovary is rare and in approximately half of the cases both ovaries are affected. C40021 Neoplastic Process Ovarian Lymphoma C1518720 Malignant Ovarian_Lymphoma Ovarian Lymphoma Primary Ovarian Lymphoma Ovarian Lymphoma A rare carcinoma that arises from the peritoneum and resembles the malignant surface epithelial-stromal tumors that arise from the ovary. Serous adenocarcinoma is the most common histologic variant. It affects women almost exclusively. The diagnosis of primary peritoneal carcinoma can be made only if both ovaries are not involved by tumor, or, if the ovaries are involved, the tumor is confined to the ovarian surface without invasion of the ovarian stroma and the peritoneal involvement is greater than the ovarian surface involvement. C40022 Neoplastic Process Primary Peritoneal Carcinoma Primary Peritoneal Carcinoma C1514428 CPTAC CTEP CTRP Cellosaurus Malignant Primary_Peritoneal_Carcinoma PPC Primary Peritoneal Cancer Primary Peritoneal Carcinoma Primary peritoneal carcinoma Primary Peritoneal Carcinoma A rare, serous adenocarcinoma that arises from the lining of the peritoneum. It affects females. The clinical behavior and pathologic characteristics are similar to the serous adenocarcinoma that arises from the ovary. C40023 Neoplastic Process Primary Peritoneal Serous Adenocarcinoma Primary Peritoneal Serous Adenocarcinoma C1514429 CTRP Malignant Primary_Peritoneal_Serous_Adenocarcinoma Primary Peritoneal Serous Adenocarcinoma Primary Peritoneal Serous Adenocarcinoma A serous epithelial tumor that arises from the peritoneum and histologically resembles the serous borderline tumors that arise from the ovary. C40024 Neoplastic Process Borderline Peritoneal Serous Tumor C1514418 Uncertain Malignant Potential Primary_Borderline_Peritoneal_Epithelial_Neoplasm Borderline Peritoneal Serous Tumor Peritoneal SBT Peritoneal Serous Borderline Tumor Primary Borderline Peritoneal Epithelial Neoplasm Primary Borderline Peritoneal Epithelial Tumor Primary Peritoneal Borderline Epithelial Neoplasm Primary Peritoneal Borderline Epithelial Tumor Primary Peritoneal Serous Borderline Tumor Primary Peritoneal Serous Borderline Tumor/ Primary Peritoneal Atypical Proliferative Serous Tumor Borderline Peritoneal Serous Tumor An invasive malignant neoplasm that arises from the ovary and is characterized by the presence of malignant epithelial cells that, in well differentiated tumors, resemble the epithelium of the fallopian tube or, in poorly differentiated tumors, show anaplastic features and marked nuclear atypia. It includes serous adenocarcinoma and serous adenocarcinofibroma. C40025 Neoplastic Process Malignant Ovarian Serous Tumor C1518234 Malignant Malignant_Ovarian_Serous_Tumor Malignant Ovarian Serous Tumor Malignant Ovarian Serous Tumor An invasive malignant tumor that originates from the surface epithelium of the ovary. It is composed of malignant epithelial cells and stroma. Representative examples include serous adenocarcinoma, mucinous adenocarcinoma, endometrioid adenocarcinoma, clear cell adenocarcinoma, and malignant Brenner tumor. C40026 Neoplastic Process Malignant Ovarian Epithelial Tumor Malignant Ovarian Epithelial Tumor C1518236 CTEP CTRP Malignant Malignant_Ovarian_Surface_Epithelial_Stromal_Tumor Malignant Ovarian Epithelial Tumor Malignant Ovarian Surface Epithelial-Stromal Neoplasm Malignant Ovarian Surface Epithelial-Stromal Tumor Ovarian stromal cancer Malignant Ovarian Epithelial Tumor A low grade ovarian epithelial neoplasm characterized by the presence of neoplastic serous epithelial cells, atypia, and microinvasion of the ovarian stroma. C40027 Neoplastic Process Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor with Microinvasion C1511270 Malignant Borderline_Ovarian_Serous_Tumor_with_Microinvasion Borderline Ovarian Serous Neoplasm with Microinvasion Borderline Ovarian Serous Tumor with Microinvasion Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor with Microinvasion Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor with Microinvasion A low malignant potential adenofibroma arising from the ovary. It is characterized by an atypical epithelial hyperplasia. The epithelial cells are of serous type. There is no evidence of stromal destructive invasion. C40028 Neoplastic Process Borderline Ovarian Serous Adenofibroma C1266152 GDC 9014/1 Uncertain Malignant Potential Borderline_Ovarian_Serous_Adenofibroma 9014/1 Serous adenofibroma of borderline malignancy Borderline Ovarian Serous Adenofibroma Serous adenofibroma of borderline malignancy Borderline Ovarian Serous Adenofibroma A neoplasm of low malignant potential arising from the ovary. It is characterized by the presence of cystic spaces which are lined by atypical serous epithelial cells. The surrounding ovarian stroma is fibrotic. There is no evidence of stromal invasion. C40029 Neoplastic Process Borderline Ovarian Serous Cystadenofibroma C1511267 Uncertain Malignant Potential Borderline_Ovarian_Serous_Cystadenofibroma Borderline Ovarian Serous Cystadenofibroma Borderline Ovarian Serous Cystadenofibroma Stage IV includes: (T4, N0, M0); (T4, N1, M0); (Any T, N2, M0); (Any T, Any N, M1). T4: Tumor invades beyond Gerota's fascia. N0: No regional lymph node metastases. N1: Metastasis in a single regional lymph node. N2: Metastasis in more than one regional lymph node. M0: No distant metastasis. M1: Distant metastasis. (AJCC 6th ed.) C4003 Neoplastic Process Stage IV Renal Cell Cancer AJCC v6 Stage IV Renal Cell Cancer AJCC v6 C0862448 CTRP Cancer has spread (1) beyond the layer of fatty tissue around the kidney and may be found in the adrenal gland above the kidney with cancer, or in nearby lymph nodes; or (2) to other organs, such as the lungs, liver, bones, or brain, and may have spread to lymph nodes. Malignant Stage_IV_Renal_Cell_Cancer Renal Cell Cancer Stage IV AJCC v6 Renal Cell Carcinoma, Stage IV AJCC v6 Stage IV Renal Cell Cancer Stage IV Renal Cell Cancer AJCC v6 Stage IV Renal Cell Carcinoma AJCC v6 stage IV kidney cancer stage IV renal cell cancer Stage IV Renal Cell Cancer AJCC v6 A benign neoplasm of the ovary characterized by the presence of glands with serous epithelial cells in a fibrotic stroma. C40031 Neoplastic Process Ovarian Serous Adenofibroma C1518729 Benign Ovarian_Serous_Adenofibroma Ovarian Serous Adenofibroma Ovarian Serous Adenofibroma A benign neoplasm of the ovary characterized by the presence of cystic structures lined by serous epithelial cells in a fibrotic stroma. C40032 Neoplastic Process Ovarian Serous Cystadenofibroma C0877572 Cellosaurus Benign Ovarian_Serous_Cystadenofibroma Ovarian Serous Cystadenofibroma Ovarian Serous Cystadenofibroma An invasive malignant neoplasm that arises from the ovary and is characterized by the presence of malignant epithelial cells that contain intracytoplasmic mucin and may resemble the epithelial cells of the endocervix or gastrointestinal tract. It includes mucinous adenocarcinoma and mucinous adenocarcinofibroma. C40033 Neoplastic Process Malignant Ovarian Mucinous Tumor C1518233 Malignant Malignant_Ovarian_Mucinous_Tumor Malignant Ovarian Mucinous Neoplasm Malignant Ovarian Mucinous Tumor Malignant Ovarian Mucinous Tumor A malignant neoplasm of the ovary with an invasive epithelial component and a fibrotic stroma. The epithelial component is characterized by the presence of malignant epithelial cells with intracytoplasmic mucin. Cystic spaces are also present which contain mucoid material. C40034 Neoplastic Process Ovarian Mucinous Adenocarcinofibroma C1266155 GDC 9015/3 Malignant Ovarian_Mucinous_Adenocarcinofibroma 9015/3 Mucinous adenocarcinofibroma Mucinous adenocarcinofibroma Ovarian Mucinous Adenocarcinofibroma Ovarian Mucinous Malignant Adenofibroma Ovarian Mucinous Adenocarcinofibroma A malignant neoplasm of the ovary with an invasive epithelial component and a fibrotic stroma. Histologic variants include clear cell, serous, and mucinous adenocarcinofibroma. C40035 Neoplastic Process Adenocarcinofibroma C1510778 Malignant Adenocarcinofibroma Adenocarcinofibroma Malignant Adenofibroma Adenocarcinofibroma A low grade mucinous epithelial neoplasm arising from the ovary. It is characterized by an atypical proliferation of mucinous-type epithelial cells without evidence of stromal invasion. The mucinous epithelial cells may be of intestinal or endocervical type. C40036 Neoplastic Process Borderline Ovarian Mucinous Tumor Borderline Ovarian Mucinous Tumor C0279664 CTRP Uncertain Malignant Potential Borderline_Ovarian_Mucinous_Tumor Borderline Ovarian Mucinous Neoplasm Borderline Ovarian Mucinous Tumor Borderline Ovarian Mucinous Tumor A neoplasm of low malignant potential arising from the ovary. It is characterized by the proliferation of neoplastic mucinous epithelial cells that resemble intestinal epithelial cells. There is no evidence of stromal invasion. C40037 Neoplastic Process Borderline Ovarian Mucinous Tumor, Intestinal Type C1511265 Uncertain Malignant Potential Borderline_Ovarian_Mucinous_Tumor_Intestinal_Type Borderline Ovarian Mucinous Tumor, Intestinal Type Borderline Ovarian Mucinous Tumor, Intestinal Type A neoplasm of low malignant potential arising from the ovary. It is characterized by the proliferation of neoplastic epithelial cells that resemble endocervical epithelial cells. There is no evidence of stromal invasion. C40038 Neoplastic Process Borderline Ovarian Mucinous Tumor, Endocervical-Like C1511264 Uncertain Malignant Potential Borderline_Ovarian_Mucinous_Tumor_Endocervical-like Borderline Ovarian Mucinous Tumor, Endocervical-Like Borderline Ovarian Mucinous Tumor, Endocervical-Like A non-metastasizing neoplasm that arises from the ovary and is characterized by the presence of neoplastic epithelium that resembles the epithelium of the endocervix or gastrointestinal tract. There is no evidence of atypia. It includes mucinous adenofibroma, mucinous cystadenofibroma, and mucinous cystadenoma. C40039 Neoplastic Process Benign Ovarian Mucinous Tumor C1511100 Benign Benign_Ovarian_Mucinous_Tumor Benign Ovarian Mucinous Neoplasm Benign Ovarian Mucinous Tumor Benign Ovarian Mucinous Tumor An adenocarcinoma arising from the stomach glandular epithelium. Gastric adenocarcinoma is primarily a disease of older individuals. It most commonly develops after a long period of atrophic gastritis and is strongly associated with Helicobacter pylori infection. The lack of early symptoms often delays the diagnosis of gastric cancer. The majority of patients present with advanced tumors which have poor rates of curability. Microscopically, two important histologic types of gastric adenocarcinoma are recognized: the intestinal and diffuse type. The overall prognosis of gastric adenocarcinomas is poor, even in patients who receive a "curative" resection (adapted from Sternberg's Surgical Pathology, 3rd ed., 1999). C4004 Neoplastic Process Gastric Adenocarcinoma Gastric Adenocarcinoma C0278701 CPTAC CTEP CTRP Cellosaurus Malignant Gastric_Adenocarcinoma Adenocarcinoma Adenocarcinoma - stomach Adenocarcinoma of Stomach Adenocarcinoma of the Stomach Adenocarcinoma of the stomach Gastric (Stomach) Adenocarcinoma Gastric Adenocarcinoma Gastric Adenocarcinoma, NOS STAD Stomach Adenocarcinoma Gastric Adenocarcinoma A benign neoplasm of the ovary characterized by the presence of glands with mucinous columnar epithelial cells in a fibrotic stroma. C40040 Neoplastic Process Ovarian Mucinous Adenofibroma C1518723 Benign Ovarian_Mucinous_Adenofibroma Ovarian Mucinous Adenofibroma Ovarian Mucinous Adenofibroma A benign neoplasm of the ovary characterized by the presence of cystic structures lined by mucinous columnar epithelial cells in a fibrotic stroma. C40041 Neoplastic Process Ovarian Mucinous Cystadenofibroma C1518725 Benign Ovarian_Mucinous_Cystadenofibroma Ovarian Mucinous Cystadenofibroma Ovarian Mucinous Cystadenofibroma A mucinous cystic tumor of the ovary characterized by the presence of one or more well circumscribed solid nodules in the wall of the cysts (mural nodules) that protrude into the lumen. The mural nodules may be benign (sarcoma-like) or malignant. The malignant mural nodules histologically are anaplastic carcinomas, carcinosarcomas, or sarcomas. The clinical course depends on the histology of the mural nodules. The prognosis of mucinous cystic tumors with benign mural nodules is the same as the corresponding types of mucinous cystic tumors without the mural nodules. Mucinous cystic tumors with malignant mural nodules may follow a malignant clinical course. C40042 Neoplastic Process Ovarian Mucinous Cystic Tumor with Mural Nodules C1513716 Undetermined Mucinous_Cystic_Tumor_with_Mural_Nodules Ovarian Mucinous Cystic Tumor with Mural Nodules Ovarian Mucinous Cystic Tumor with Mural Nodules The presence of abundant mucoid or gelatinous, cellular or acellular material in the pelvis and abdominal cavity (pseudomyxoma peritonei) that is associated with the presence of an ovarian mucinous cystic tumor. In the vast majority of cases, the presence of pseudomyxoma peritonei is the result of metastasis from a primary appendiceal or gastrointestinal tumor site, and the ovarian mucinous tumor is metastatic rather than primary. C40043 Neoplastic Process Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei C1518726 Malignant Ovarian_Mucinous_Cystic_Tumor_Associated_with_Pseudomyxoma_Peritonei Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei An invasive malignant neoplasm that arises from the ovary characterized by the presence of malignant, endometrial-type cells. It includes endometrioid adenocarcinoma and carcinosarcoma. C40051 Neoplastic Process Malignant Ovarian Endometrioid Tumor C1518231 Malignant Malignant_Ovarian_Endometrioid_Tumor Malignant Ovarian Endometrioid Tumor Malignant Ovarian Endometrioid Tumor Stage IV includes: IVA: (T4, Any N, M0); IVB: (Any T, Any N, M1). T4: Tumor invades bladder mucosa and/or bowel mucosa (bullous edema is not sufficient to classify a tumor as T4). M1: Distant metastasis (includes metastasis to abdominal lymph nodes other than para-aortic, and/or inguinal lymph nodes: excludes metastasis to vagina, pelvic serosa, or adnexa). (AJCC 6th ed.) C4006 Neoplastic Process Stage IV Uterine Corpus Cancer AJCC v6 Stage IV Uterine Corpus Cancer AJCC v6 C0278801 CTRP Cancer cells have spread to the lining of the bladder or rectum or to distant parts of the body. Malignant Stage_IV_Endometrial_Cancer Stage IV Cancer of Uterine Corpus AJCC v6 Stage IV Cancer of the Corpus Uteri AJCC v6 Stage IV Cancer of the Uterine Corpus AJCC v6 Stage IV Endometrial Cancer AJCC v6 Stage IV Uterine (including Endometrial) Cancer Stage IV Uterine Corpus Cancer AJCC v6 stage IV cancer of the uterus stage IV endometrial cancer Stage IV Uterine Corpus Cancer AJCC v6 An endometrioid adenocarcinoma that arises from the ovary and exhibits squamous differentiation. The squamous cell component often has a cytologically benign appearance. C40061 Neoplastic Process Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation C2212017 Malignant Ovarian_Endometrioid_Adenocarcinoma_with_Squamous_Differentiation Ovarian Adenoacanthoma Ovarian Adenosquamous Carcinoma Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation A rare invasive mesenchymal tumor that arises from the ovary. It is characterized by the absence of marked pleomorphism and nuclear atypia in the neoplastic mesenchymal cells. It may have a favorable clinical outcome. C40063 Neoplastic Process Ovarian Low Grade Endometrioid Stromal Sarcoma C1518022 Malignant Low_Grade_Ovarian_Endometrioid_Stromal_Sarcoma Endometrioid Stromal Sarcoma of the Ovary Low Grade Endometrioid Stromal Sarcoma of the Ovary Ovarian Endometrioid Stromal Sarcoma Ovarian Low Grade Endometrioid Stromal Sarcoma Ovarian Low Grade Endometrioid Stromal Sarcoma A category of rare neoplasms that arise from the ovary. It includes low grade endometrioid stromal sarcoma and undifferentiated sarcoma. C40065 Neoplastic Process Ovarian Endometrioid Stromal and Related Neoplasms Ovarian Endometrioid Stromal and Related Neoplasms C1518714 CTRP Malignant Ovarian_Endometrioid_Stromal_Sarcoma Ovarian Endometrioid Stromal and Related Neoplasms Ovarian Endometrioid Stromal and Related Neoplasms An aggressive high grade sarcoma that arises from the ovary. It is characterized by the presence of marked pleomorphism and nuclear atypia in the neoplastic mesenchymal cells. The prognosis is poor. C40066 Neoplastic Process Ovarian Undifferentiated Sarcoma C2188139 Malignant Undifferentiated_Ovarian_Sarcoma Ovarian Undifferentiated Sarcoma Undifferentiated Ovarian Sarcoma Ovarian Undifferentiated Sarcoma An epithelial neoplasm that arises from the ovary characterized by the presence of glandular or cystic spaces which contain atypical glandular epithelial cells resembling endometrial cells. The surrounding ovarian stroma is fibrotic. There is no evidence of stromal invasion. C40069 Neoplastic Process Borderline Ovarian Endometrioid Adenofibroma C1511262 GDC Uncertain Malignant Potential Borderline_Ovarian_Endometrioid_Adenofibroma 8381/1 Endometrioid adenofibroma, borderline malignancy Endometrioid cystadenofibroma, borderline malignancy Borderline Ovarian Endometrioid Adenofibroma Borderline Ovarian Endometrioid Adenofibroma A non-Hodgkin or Hodgkin lymphoma that arises from the small intestine. C4007 Neoplastic Process Small Intestinal Lymphoma Small Intestinal Lymphoma C0278805 CTRP Malignant Small_Intestinal_Lymphoma Lymphoma of Small Bowel Lymphoma of Small Intestine Lymphoma of the Small Bowel Lymphoma of the Small Intestine Primary Small Intestinal Lymphoma Small Bowel Lymphoma Small Intestinal Lymphoma Small Intestine Lymphoma Small Intestinal Lymphoma A non-metastasizing neoplasm that arises from the ovary and is characterized by the presence of glands or cysts lined by benign endometrial-type cells. It includes endometrioid adenofibroma, endometrioid cystadenofibroma, and endometrioid cystadenoma. C40072 Neoplastic Process Benign Ovarian Endometrioid Tumor C2063099 Benign Benign_Ovarian_Endometrioid_Tumor Benign Ovarian Endometrioid Tumor Benign Ovarian Endometrioid Tumor A benign neoplasm of the ovary characterized by the presence of cystic structures lined by endometrial-type well-differentiated cells. C40075 Neoplastic Process Ovarian Endometrioid Cystadenoma C1518713 Benign Ovarian_Endometrioid_Cystadenoma Ovarian Endometrioid Cystadenoma Ovarian Endometrioid Cystadenoma A benign, borderline, or malignant epithelial tumor of the ovary that is characterized by a predominance of clear and hobnail cells. C40076 Neoplastic Process Ovarian Clear Cell Tumor C0346164 Undetermined Ovarian_Clear_Cell_Tumor Ovarian Clear Cell Neoplasm Ovarian Clear Cell Tumor Ovarian Clear Cell Tumor An invasive malignant neoplasm that arises from the ovary and is characterized by a predominance of clear and hobnail malignant epithelial cells. C40077 Neoplastic Process Malignant Ovarian Clear Cell Tumor C1265995 GDC Malignant Malignant_Ovarian_Clear_Cell_Tumor 8005/3 Malignant tumor, clear cell type Malignant Ovarian Clear Cell Neoplasm Malignant Ovarian Clear Cell Tumor Malignant tumor, clear cell type Malignant Ovarian Clear Cell Tumor A malignant glandular epithelial neoplasm characterized by the presence of clear and hobnail cells. It is highly associated with ovarian endometriosis, pelvic endometriosis and paraendocrine hypercalcemia. C40078 Neoplastic Process Ovarian Clear Cell Adenocarcinoma Ovarian Clear Cell Adenocarcinoma C1518693 CTRP Cellosaurus Malignant Ovarian_Clear_Cell_Adenocarcinoma Ovarian Clear Cell Adenocarcinoma Ovarian Clear Cell Adenocarcinoma A malignant neoplasm of the ovary with an invasive epithelial component and a fibrotic stroma. The epithelial component is characterized by the presence of malignant epithelial cells with clear cytoplasm. C40079 Neoplastic Process Ovarian Clear Cell Adenocarcinofibroma C1266040 GDC 8313/3 Malignant Ovarian_Clear_Cell_Adenocarcinofibroma 8313/3 Clear cell adenocarcinofibroma Clear cell adenocarcinofibroma Ovarian Clear Cell Adenocarcinofibroma Ovarian Clear Cell Malignant Adenofibroma Ovarian Clear Cell Adenocarcinofibroma The reemergence of gallbladder carcinoma after a period of remission. C4008 Neoplastic Process Recurrent Gallbladder Carcinoma Recurrent Gallbladder Carcinoma C0278809 CTRP Malignant Recurrent_Gallbladder_Carcinoma Gallbladder Cancer, Recurrent Recurrent Cancer of Gallbladder Recurrent Cancer of the Gallbladder Recurrent Gallbladder Cancer Recurrent Gallbladder Carcinoma Relapsed Cancer of Gallbladder Relapsed Cancer of the Gallbladder Relapsed Gallbladder Cancer Recurrent Gallbladder Carcinoma An epithelial neoplasm with low malignant potential affecting the ovary. It is characterized by the presence of clear or hobnail cells. In some cases, the cells may display nuclear atypia and prominent nucleoli. When such cells are present, they remain confined to the glands. There is no evidence of stromal invasion. C40080 Neoplastic Process Borderline Ovarian Clear Cell Tumor Borderline Ovarian Clear Cell Tumor C0279676 CTRP GDC Uncertain Malignant Potential Borderline_Ovarian_Clear_Cell_Tumor 8313/1 8444/1 Clear cell borderline tumor Clear cell cystic tumor of borderline malignancy Borderline Ovarian Clear Cell Neoplasm Borderline Ovarian Clear Cell Tumor Clear cell cystic tumor of borderline malignancy Borderline Ovarian Clear Cell Tumor An epithelial neoplasm with low malignant potential affecting the ovary. It is characterized by the presence of atypical glands and/or cystic spaces lined with clear or hobnail cells. C40081 Neoplastic Process Borderline Ovarian Clear Cell Adenofibroma C1266039 GDC 8313/1 Uncertain Malignant Potential Borderline_Ovarian_Clear_Cell_Adenofibroma 8313/1 Clear cell adenofibroma of borderline malignancy Borderline Ovarian Clear Cell Adenofibroma Clear cell adenofibroma of borderline malignancy Borderline Ovarian Clear Cell Adenofibroma A non-invasive clear cell adenofibromatous neoplasm that arises from the ovary. It is characterized by the presence of atypical neoplastic clear or hobnail epithelial cells and intraepithelial carcinoma. C40082 Neoplastic Process Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor with Intraepithelial Carcinoma C1511259 Uncertain Malignant Potential Borderline_Ovarian_Clear_Cell_Adenofibroma_with_Intraepithelial_Carcinoma Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor with Intraepithelial Carcinoma Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor with Intraepithelial Carcinoma An epithelial neoplasm with low malignant potential affecting the ovary. It is characterized by the presence of prominent cystic spaces lined with atypical clear or hobnail cells. There is no evidence of stromal invasion. C40083 Neoplastic Process Borderline Ovarian Clear Cell Cystadenofibroma C1511260 8444/1 Uncertain Malignant Potential Borderline_Ovarian_Clear_Cell_Cystadenofibroma Borderline Ovarian Clear Cell Cystadenofibroma Borderline Ovarian Clear Cell Cystadenofibroma A non-metastasizing neoplasm that arises from the ovary. It is characterized by a predominance of clear and hobnail benign epithelial cells. C40084 Neoplastic Process Benign Ovarian Clear Cell Tumor C1511098 Benign Benign_Ovarian_Clear_Cell_Tumor Benign Ovarian Clear Cell Neoplasm Benign Ovarian Clear Cell Tumor Benign Ovarian Clear Cell Tumor An uncommon benign neoplasm of glandular epithelium characterized by the presence of clear or hobnail cells within a dense fibrous stroma. C40085 Neoplastic Process Ovarian Clear Cell Adenofibroma C1518694 Benign Ovarian_Clear_Cell_Adenofibroma Ovarian Clear Cell Adenofibroma Ovarian Clear Cell Adenofibroma A benign neoplasm of glandular epithelium characterized by the presence of clear or hobnail cells within a dense fibrous stroma and cystic structures. C40086 Neoplastic Process Ovarian Clear Cell Cystadenofibroma C1518695 Benign Ovarian_Clear_Cell_Cystadenofibroma Ovarian Clear Cell Cystadenofibroma Ovarian Clear Cell Cystadenofibroma A malignant mixed epithelial neoplasm that arises from the ovary and is composed predominantly of serous and endocervical-type mucinous cells. C40090 Neoplastic Process Ovarian Seromucinous Carcinoma Ovarian Seromucinous Carcinoma C0279392 CTRP GDC Malignant Malignant_Ovarian_Mixed_Epithelial_Tumor Seromucinous carcinoma Ovarian Seromucinous Carcinoma Ovarian Seromucinous Carcinoma A usually high grade squamous cell carcinoma that arises from the ovary and is not associated with a germ cell tumor. The prognosis is poor. C40093 Neoplastic Process Ovarian Squamous Cell Carcinoma Ovarian Squamous Cell Carcinoma C2019443 CTRP Cellosaurus Malignant Ovarian_Squamous_Cell_Carcinoma Ovarian_Squamous_Cell_Tumor Ovarian Squamous Cell Cancer Ovarian Squamous Cell Carcinoma Ovarian Squamous Cell Carcinoma A serous adenocarcinoma that arises from the fallopian tube. It is usually a high grade invasive adenocarcinoma. C40099 Neoplastic Process Fallopian Tube Serous Adenocarcinoma Fallopian Tube Serous Adenocarcinoma C1517124 CTRP Malignant Fallopian_Tube_Serous_Adenocarcinoma Fallopian Tube Serous Adenocarcinoma Fallopian Tube Serous Adenocarcinoma A craniopharyngioma that occurs during adulthood. It can be either adamantinomatous or papillary. The papillary histologic variant occurs virtually exclusively in adults. Clinical signs and symptoms include visual disturbances and endocrine deficiencies. C4010 Neoplastic Process Adult Craniopharyngioma Adult Craniopharyngioma C0278875 CTRP Benign Adult_Craniopharyngioma Adult Craniopharyngioma Adult Neoplasm of Rathke's Pouch Adult Rathke Pouch Tumor Adult Rathke's Pouch Neoplasm Adult Rathke's Pouch Tumor Adult Tumor of Rathke's Pouch Craniopharyngioma Adult Craniopharyngioma A benign, borderline, or malignant epithelial tumor of the fallopian tube characterized by the presence of neoplastic serous epithelial cells. C40102 Neoplastic Process Fallopian Tube Serous Neoplasm C1517125 Undetermined Fallopian_Tube_Serous_Neoplasm Fallopian Tube Serous Neoplasm Fallopian Tube Serous Tumor Fallopian Tube Serous Neoplasm An extremely rare adenocarcinoma that arises from the fallopian tube. It is characterized by the presence of neoplastic epithelial cells that contain intracytoplasmic mucin. The cases that have been reported are predominantly in situ mucinous adenocarcinomas. C40103 Neoplastic Process Fallopian Tube Mucinous Adenocarcinoma Fallopian Tube Mucinous Adenocarcinoma C1517119 CTRP Malignant Fallopian_Tube_Mucinous_Adenocarcinoma Fallopian Tube Mucinous Adenocarcinoma Fallopian Tube Mucinous Adenocarcinoma A rare transitional cell carcinoma that arises from the fallopian tube. C40104 Neoplastic Process Fallopian Tube Transitional Cell Carcinoma Fallopian Tube Transitional Cell Carcinoma C1517128 CTRP Malignant Fallopian_Tube_Transitional_Cell_Carcinoma Fallopian Tube Transitional Cell Cancer Fallopian Tube Transitional Cell Carcinoma Fallopian Tube Transitional Cell Carcinoma Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ (limited to tubal mucosa). N0: No regional lymph node metastasis. M0: No distant metastasis. FIGO no longer includes stage 0. (AJCC 7th ed.) C40105 Neoplastic Process Stage 0 Fallopian Tube Cancer AJCC v7 Stage 0 Fallopian Tube Cancer AJCC v7 C0347176 CTRP Malignant Stage_0_Fallopian_Tube_Cancer Fallopian Tube Carcinoma in Situ Stage 0 Fallopian Tube Cancer Stage 0 Fallopian Tube Cancer AJCC v7 Tubal Intraepithelial Carcinoma Stage 0 Fallopian Tube Cancer AJCC v7 A rare epithelial tumor arising from the fallopian tube without definitive morphologic characteristics of malignancy. This category includes borderline mucinous and serous neoplasms and borderline endometrioid tumor. C40106 Neoplastic Process Borderline Fallopian Tube Neoplasm C1511256 Uncertain Malignant Potential Borderline_Fallopian_Tube_Neoplasm Borderline Fallopian Tube Neoplasm Borderline Fallopian Tube Tumor Fallopian Tube Neoplasm of Low Malignant Potential Borderline Fallopian Tube Neoplasm A neoplasm of low malignant potential arising from the fallopian tube. It is characterized by an atypical proliferation of serous-type epithelial cells without evidence of stromal invasion. C40107 Neoplastic Process Borderline Fallopian Tube Serous Tumor C1511257 Uncertain Malignant Potential Borderline_Fallopian_Tube_Serous_Neoplasm Borderline Fallopian Tube Serous Neoplasm Borderline Fallopian Tube Serous Tumor Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor Borderline Fallopian Tube Serous Tumor A neoplasm of low malignant potential arising from the fallopian tube. It is characterized by an atypical proliferation of mucinous-type epithelial cells without evidence of stromal invasion. C40108 Neoplastic Process Borderline Fallopian Tube Mucinous Tumor C1511255 Uncertain Malignant Potential Borderline_Fallopian_Tube_Mucinous_Neoplasm Borderline Fallopian Tube Mucinous Neoplasm Borderline Fallopian Tube Mucinous Tumor Borderline Fallopian Tube Mucinous Tumor A rare borderline or malignant epithelial tumor of the fallopian tube characterized by the presence of neoplastic epithelial cells that contain intracytoplasmic mucin and may resemble the epithelial cells of the endocervix or gastrointestinal tract. C40109 Neoplastic Process Fallopian Tube Mucinous Neoplasm C1517120 Undetermined Fallopian_Tube_Mucinous_Neoplasm Fallopian Tube Mucinous Neoplasm Fallopian Tube Mucinous Tumor Fallopian Tube Mucinous Neoplasm A medulloblastoma occurring in adults. C4011 Neoplastic Process Adult Medulloblastoma Adult Medulloblastoma C0278876 CTRP Malignant Adult_Medulloblastoma Adult Brain Medulloblastoma Adult Medulloblastoma Medulloblastoma Adult Medulloblastoma A neoplasm of low malignant potential arising from the fallopian tube. It is characterized by the presence of glandular or cystic spaces which contain atypical glandular epithelial cells resembling endometrial cells. There is no evidence of stromal invasion. C40110 Neoplastic Process Borderline Fallopian Tube Endometrioid Tumor C1511254 Uncertain Malignant Potential Borderline_Fallopian_Tube_Endometrioid_Neoplasm Borderline Fallopian Tube Endometrioid Neoplasm Borderline Fallopian Tube Endometrioid Tumor Borderline Fallopian Tube Endometrioid Tumor A benign, borderline, or malignant epithelial tumor of the fallopian tube that is characterized by the presence of glands and/or cysts lined by neoplastic cells that resemble endometrial cells. C40111 Neoplastic Process Fallopian Tube Endometrioid Tumor C1517113 Undetermined Fallopian_Tube_Endometrioid_Tumor Fallopian Tube Endometrioid Neoplasm Fallopian Tube Endometrioid Tumor Fallopian Tube Endometrioid Tumor A benign epithelial neoplasm that arises from the fallopian tube. It is characterized by the presence of fibrovascular stalks lined by serous epithelial cells. C40112 Neoplastic Process Fallopian Tube Serous Papilloma C1517123 Benign Fallopian_Tube_Papilloma Fallopian Tube Papilloma Fallopian Tube Serous Papilloma Fallopian Tube Serous Papilloma A rare, benign, asymptomatic neoplasm that arises from the fallopian tube. The majority of cases are incidental findings during operation for an unrelated gynecologic disorder. The tumors are round and solitary and contain connective tissue and papillary or tubular structures lined by serous-type epithelium. C40113 Neoplastic Process Fallopian Tube Serous Adenofibroma C1517109 Benign Fallopian_Tube_Adenofibroma Fallopian Tube Adenofibroma Fallopian Tube Serous Adenofibroma Fallopian Tube Serous Adenofibroma A rare, benign, asymptomatic neoplasm that arises from the fallopian tube. The tumors are round and solitary and contain connective tissue and cystic structures lined by serous-type epithelium. The majority of cases are incidental findings during operation for an unrelated gynecologic disorder. C40114 Neoplastic Process Fallopian Tube Serous Cystadenofibroma C1517111 Benign Fallopian_Tube_Cystadenofibroma Fallopian Tube Cystadenofibroma Fallopian Tube Serous Cystadenofibroma Fallopian Tube Serous Cystadenofibroma An adenomatous polyp that arises from the interstitial portion of the fallopian tube and is characterized by the presence of endometrial epithelium. It may obstruct the lumen of the fallopian tube and result in infertility or tubal pregnancy. C40115 Neoplastic Process Fallopian Tube Endometrioid Polyp C1517112 Benign Fallopian_Tube_Endometrioid_Polyp Fallopian Tube Endometrioid Adenomatous Polyp Fallopian Tube Endometrioid Polyp Fallopian Tube Endometrioid Polyp A rare metaplastic lesion that arises from the fallopian tube. It is characterized by the presence of an intraluminal papillary proliferation composed of atypical epithelial cells with abundant eosinophilic cytoplasm. In the vast majority of cases, it is an incidental finding during microscopic examination of a fallopian tube in the postpartum period. C40116 Neoplastic Process Fallopian Tube Metaplastic Papillary Tumor C1517118 Undetermined Fallopian_Tube_Metaplastic_Papillary_Tumor Fallopian Tube Metaplastic Papillary Tumor Fallopian Tube Metaplastic Papillary Tumor Stage IV includes: (Any T, Any N, M1a); (Any T, Any N, M1b). M1a: Lung cancer with separate tumor nodule(s) in a contralateral lobe; tumor with pleural nodules or malignant pleural (or pericardial) effusion. M1b: Distant metastasis. (AJCC 7th ed.) C4012 Neoplastic Process Stage IV Non-Small Cell Lung Cancer AJCC v7 Stage IV Lung Non-Small Cell Cancer AJCC v7 C0278987 CTRP The tumor may be any size and cancer may have spread to lymph nodes. One or more of the following is true: (1) there are one or more tumors in both lungs; (2) cancer is found in fluid around the lungs or the heart; and/or (3) cancer has spread to other parts of the body, such as the brain, liver, adrenal glands, kidneys, or bone. Malignant Stage_IV_Non-Small_Cell_Lung_Cancer Stage IV Lung Non-Small Cell Cancer AJCC v7 Stage IV NSCLC Stage IV Non-Oat Cell Carcinoma of Lung Stage IV Non-Oat Cell Carcinoma of the Lung Stage IV Non-Oat Cell Lung Carcinoma Stage IV Non-Small Cell Carcinoma of Lung Stage IV Non-Small Cell Carcinoma of the Lung Stage IV Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer AJCC v7 Stage IV Non-Small Cell Lung Carcinoma stage IV non-small cell lung cancer Stage IV Lung Non-Small Cell Cancer AJCC v7 A carcinosarcoma that arises from the fallopian tube. It usually affects postmenopausal women and presents with abdominal pain, abdominal distension or genital bleeding. The prognosis is usually poor. C40124 Neoplastic Process Fallopian Tube Carcinosarcoma Fallopian Tube Carcinosarcoma C1517117 CTRP Malignant Fallopian_Tube_Malignant_Mixed_Mesodermal_Mullerian_Tumor Fallopian Tube Carcinosarcoma Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor Fallopian Tube Malignant Mixed Mesodermal (Müllerian) Tumor Fallopian Tube Carcinosarcoma An extremely rare malignant neoplasm that arises from the fallopian tube and is characterized by the presence of a benign epithelial component and a sarcomatous component. C40125 Neoplastic Process Fallopian Tube Adenosarcoma Fallopian Tube Adenosarcoma C1517121 CTRP Malignant Fallopian_Tube_Mullerian_Adenosarcoma Fallopian Tube Adenosarcoma Fallopian Tube Mullerian Adenosarcoma Fallopian Tube Müllerian Adenosarcoma Fallopian Tube Adenosarcoma A benign or malignant mesenchymal neoplasm of the fallopian tube. Representative examples include leiomyoma and leiomyosarcoma. C40126 Neoplastic Process Fallopian Tube Soft Tissue Neoplasm C1517126 Undetermined Fallopian_Tube_Soft_Tissue_Neoplasm Fallopian Tube Soft Tissue Neoplasm Fallopian Tube Soft Tissue Neoplasm A benign smooth muscle neoplasm arising from the fallopian tube. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C40127 Neoplastic Process Fallopian Tube Leiomyoma CL525249 Benign Fallopian_Tube_Leiomyoma Fallopian Tube Leiomyoma Fallopian Tube Leiomyoma An aggressive malignant smooth muscle neoplasm, arising from the fallopian tube. It is characterized by a proliferation of neoplastic spindle cells. C40128 Neoplastic Process Fallopian Tube Leiomyosarcoma Fallopian Tube Leiomyosarcoma C1517116 CTRP Malignant Fallopian_Tube_Leiomyosarcoma Fallopian Tube Leiomyosarcoma Fallopian Tube Leiomyosarcoma A benign neoplasm that arises from the fallopian tube and originates from mesothelial cells. It is characterized by the presence of gland-like structures that are lined by flat or cuboidal cells. It is usually discovered as an incidental finding. C40129 Neoplastic Process Fallopian Tube Adenomatoid Tumor C1517110 Benign Fallopian_Tube_Adenomatoid_Tumor Benign Fallopian Tube Mesothelioma Fallopian Tube Adenomatoid Tumor Fallopian Tube Adenomatoid Tumor A primary or metastatic malignant neoplasm affecting the head and neck. Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma. C4013 Neoplastic Process Malignant Head and Neck Neoplasm Malignant Head and Neck Neoplasm C0278996 CPTAC CTEP CTRP GDC mCode Cancer that arises in the head or neck region (in the nasal cavity, sinuses, lip, mouth, salivary glands, throat, or larynx [voice box]). Malignant Malignant_Head_and_Neck_Neoplasm Head and Neck Cancer Malignant neoplasm of head, face, and neck Malignant neoplasm of nasal cavities, middle ear, and accessory sinuses Malignant neoplasm of nasal cavity and middle ear Malignant neoplasm of other and ill-defined sites: Head, face and neck Cancer of Head and Neck Cancer of the Head and Neck Head and Neck Cancer Head and neck cancer, NOS Malignant Head and Neck Neoplasm Malignant Head and Neck Tumor Malignant Neoplasm of Head and Neck Malignant Neoplasm of the Head and Neck Malignant Tumor of Head and Neck Malignant Tumor of the Head and Neck Malignant neoplasm of head, face and neck head and neck cancer Malignant Head and Neck Neoplasm A rare germ cell tumor that affects the fallopian tube. The vast majority of cases are teratomas. C40130 Neoplastic Process Fallopian Tube Germ Cell Tumor C1517114 Undetermined Fallopian_Tube_Germ_Cell_Tumor Fallopian Tube Germ Cell Neoplasm Fallopian Tube Germ Cell Tumor Fallopian Tube Germ Cell Tumor A teratoma that arises from the fallopian tube. It is a rare tumor, often found incidentally. C40131 Neoplastic Process Fallopian Tube Teratoma C1517127 Undetermined Fallopian_Tube_Teratoma Fallopian Tube Teratoma Fallopian Tube Teratoma A benign, borderline, or malignant neoplasm that affects the broad or other uterine ligaments. C40133 Neoplastic Process Uterine Ligament Neoplasm C1519870 Undetermined Uterine_Ligament_Neoplasm Neoplasm of the Uterine Ligament Tumor of the Uterine Ligament Uterine Ligament Neoplasm Uterine Ligament Tumor Uterine Ligament Neoplasm A rare adenocarcinoma that arises from the broad ligament. C40135 Neoplastic Process Broad Ligament Adenocarcinoma C1519866 Malignant Uterine_Ligament_Adenocarcinoma Broad Ligament Adenocarcinoma Broad Ligament Adenocarcinoma A rare mucinous adenocarcinoma that arises from the broad ligament. C40137 Neoplastic Process Broad Ligament Mucinous Adenocarcinoma C1519869 Malignant Uterine_Ligament_Mucinous_Adenocarcinoma Broad Ligament Mucinous Adenocarcinoma Broad Ligament Mucinous Adenocarcinoma A rare endometrioid adenocarcinoma that arises from the broad ligament. Some of the reported cases were associated with endometriosis. C40138 Neoplastic Process Broad Ligament Endometrioid Adenocarcinoma C1519868 Malignant Uterine_Ligament_Endometrioid_Adenocarcinoma Broad Ligament Endometrioid Adenocarcinoma Broad Ligament Endometrioid Adenocarcinoma A rare clear cell adenocarcinoma that arises from the broad ligament. C40139 Neoplastic Process Broad Ligament Clear Cell Adenocarcinoma C1519867 Malignant Uterine_Ligament_Clear_Cell_Adenocarcinoma Broad Ligament Clear Cell Adenocarcinoma Broad Ligament Clear Cell Adenocarcinoma An oligodendroglioma occurring during adulthood. C4014 Neoplastic Process Adult Oligodendroglioma Adult Oligodendroglioma C0279070 CTRP Undetermined Adult_Oligodendroglioma Adult Oligodendroglioma Grade 2 Adult Oligodendroglial Tumor Grade II Adult Oligodendroglial Tumor Oligodendroglioma Adult Oligodendroglioma An adnexal epithelial neoplasm of Wolffian (mesonephric) origin. It predominantly affects the broad ligament and presents as a unilateral adnexal mass. Most tumors behave in a benign fashion. C40141 Neoplastic Process Wolffian Tumor C1520159 GDC 9110/0 9110/1 Benign Undetermined Wolffian_Adnexal_Tumor 9110/0 9110/1 Mesonephric adenoma Mesonephric tumor, NOS Mesonephroma, NOS Mesonephroma, benign Mesonephromas Wolffian duct adenoma Wolffian duct tumor Wolffian tumor FATWO Female Adnexal Tumor of Probable Wolffian Origin Mesonephric Adenoma Mesonephric adenoma Mesonephroma Mesonephroma, NOS Mesonephroma, benign Mesonephromas Retiform Wolffian Adenoma WAT Wolffian Adenoma Wolffian Adnexal Neoplasm Wolffian Adnexal Tumor Wolffian Duct Adenoma Wolffian Duct Neoplasm Wolffian Duct Tumor Wolffian Tumor Wolffian duct adenoma Wolffian duct tumor mesonephroma Wolffian Tumor A benign mesonephric neoplasm that arises from the broad or other uterine ligaments and occurs in women with von Hippel-Lindau disease. It is a cystic lesion characterized by the presence of multiple papillary excrescences. C40142 Neoplastic Process Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease C3642324 Benign Uterine_Ligament_Papillary_Cystadenoma Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease A primary, usually low grade adenocarcinoma of the endometrium in which the majority of the malignant epithelial cells contain abundant intracytoplasmic mucin. C40144 Neoplastic Process Endometrial Mucinous Adenocarcinoma C0854923 Malignant Uterine_Corpus_Mucinous_Adenocarcinoma Endometrial Mucinous Adenocarcinoma Uterine Corpus Mucinous Adenocarcinoma Endometrial Mucinous Adenocarcinoma A classification of primary endometrial adenocarcinomas that refers to endometrioid adenocarcinoma and mucinous adenocarcinoma. C40145 Neoplastic Process Type I Endometrial Adenocarcinoma Type I Endometrial Adenocarcinoma C1519719 CTRP Malignant Type_I_Endometrial_Adenocarcinoma Type I Endometrial Adenocarcinoma Type I Endometrial Adenocarcinoma Endometrial endometrioid adenocarcinoma exhibiting 5% or less solid non-glandular, non-squamous growth. C40146 Neoplastic Process FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma C1512249 Malignant Grade_1_Endometrial_Endometrioid_Adenocarcinoma FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma Grade 1 Endometrial Endometrioid Adenocarcinoma Grade 1 Endometrial Endometrioid Carcinoma FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma Endometrial endometrioid adenocarcinoma exhibiting 6-50% solid non-glandular, non-squamous growth. C40147 Neoplastic Process FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma C1512252 Malignant Grade_2_Endometrial_Endometrioid_Adenocarcinoma FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma Grade 2 Endometrial Endometrioid Adenocarcinoma Grade 2 Endometrial Endometrioid Carcinoma FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma Endometrial endometrioid adenocarcinoma exhibiting more than 50% solid non-glandular, non-squamous growth. C40148 Neoplastic Process Grade 3 Endometrial Endometrioid Adenocarcinoma Endometrial High Grade Endometrioid Adenocarcinoma C1512255 CTRP Malignant Grade_3_Endometrial_Endometrioid_Adenocarcinoma Endometrial High Grade Endometrioid Adenocarcinoma Endometrial High-Grade Endometrioid Adenocarcinoma FIGO Grade 3 Endometrial Endometrioid Adenocarcinoma Grade 3 Endometrial Endometrioid Adenocarcinoma High Grade Endometrial Endometrioid Adenocarcinoma High Grade Endometrial Endometrioid Carcinoma High-Grade Endometrial Endometrioid Adenocarcinoma High-Grade Endometrial Endometrioid Carcinoma Endometrial High Grade Endometrioid Adenocarcinoma A primary mucinous adenocarcinoma of the endometrium that contains equal to or less than 5% non-squamous solid areas. C40149 Neoplastic Process FIGO Grade 1 Endometrial Mucinous Adenocarcinoma C1512250 Malignant Grade_1_Endometrial_Mucinous_Adenocarcinoma FIGO Grade 1 Endometrial Mucinous Adenocarcinoma FIGO Grade 1 Endometrial Mucinous Adenocarcinoma A malignant neoplasm that has spread to the central nervous system from another anatomic site or system. The majority are carcinomas (usually lung or breast carcinomas). C4015 Neoplastic Process Metastatic Malignant Neoplasm to the Central Nervous System Metastatic Malignant Neoplasm in the Central Nervous System C0686377 CPTAC CTRP Cancer that has spread from the original (primary) tumor to the central nervous system (CNS). Malignant Metastatic_Neoplasm_to_the_Central_Nervous_System Secondary malignant neoplasm of brain and cerebral meninges Secondary malignant neoplasm of brain and spinal cord CNS Metastases CNS Metastasis CNS metastasis Central Nervous System Metastases Central Nervous System Metastasis Metastatic Malignant Neoplasm in the Central Nervous System Metastatic Malignant Neoplasm to the Central Nervous System Metastatic Neoplasm to the CNS Metastatic Neoplasm to the Central Nervous System Metastatic Tumor to the CNS Metastatic Tumor to the Central Nervous System central nervous system metastasis Metastatic Malignant Neoplasm in the Central Nervous System A primary mucinous adenocarcinoma of the endometrium that contains 6-50% non-squamous solid areas. C40150 Neoplastic Process FIGO Grade 2 Endometrial Mucinous Adenocarcinoma C1512253 Malignant Grade_2_Endometrial_Mucinous_Adenocarcinoma FIGO Grade 2 Endometrial Mucinous Adenocarcinoma FIGO Grade 2 Endometrial Mucinous Adenocarcinoma A primary mucinous adenocarcinoma of the endometrium that contains more than 50% non-squamous solid areas. C40151 Neoplastic Process FIGO Grade 3 Endometrial Mucinous Adenocarcinoma C1512256 Malignant Grade_3_Endometrial_Mucinous_Adenocarcinoma FIGO Grade 3 Endometrial Mucinous Adenocarcinoma FIGO Grade 3 Endometrial Mucinous Adenocarcinoma A precursor of endometrial serous adenocarcinoma characterized by the replacement of the normal endometrial cells by malignant glandular cells that resemble the malignant cells of invasive serous adenocarcinoma. The endometrial neoplastic process is non-invasive. It may coexist with invasive endometrial adenocarcinoma or can be associated with metastases outside the uterus, in the absence of invasive endometrial carcinoma. C40152 Neoplastic Process Serous Endometrial Intraepithelial Carcinoma C1516857 GDC mCode Malignant Endometrial_Serous_Intraepithelial_Carcinoma Serous endometrial intraepithelial carcinoma Serous intraepithelial carcinoma Carcinoma in situ of endometrium EIC Endometrial Intraepithelial Carcinoma Endometrial Serous Carcinoma in Situ Endometrial Serous Intraepithelial Carcinoma Endometrial Surface Serous Carcinoma SEIC Serous Endometrial Intraepithelial Carcinoma Serous endometrial intraepithelial carcinoma Serous Endometrial Intraepithelial Carcinoma An adenocarcinoma that arises from the endometrium and is characterized by the presence of both type I and type II endometrial adenocarcinoma components. The minor component constitutes at least 5% of the entire tumor. C40153 Neoplastic Process Endometrial Mixed Cell Adenocarcinoma CL556361 CPTAC Malignant Endometrial_Mixed_Adenocarcinoma Endometrial Mixed Carcinoma Endometrial Mixed Cell Adenocarcinoma Mixed cell adenocarcinoma Endometrial Mixed Cell Adenocarcinoma A rare primary carcinoma of the endometrium characterized by the presence of malignant epithelial cells resembling urothelial transitional cells. The malignant transitional cells constitute at least 90% of the tumor cells. C40154 Neoplastic Process Endometrial Transitional Cell Carcinoma C1516864 Malignant Endometrial_Transitional_Cell_Carcinoma Endometrial Transitional Cell Carcinoma Endometrial Transitional Cell Carcinoma An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the endometrium. It is characterized by the presence of small malignant cells, necrotic changes, and an increased mitotic rate. C40155 Neoplastic Process Endometrial Small Cell Neuroendocrine Carcinoma C1516858 Malignant Endometrial_Small_Cell_Carcinoma Endometrial Small Cell Carcinoma Endometrial Small Cell Neuroendocrine Carcinoma Endometrial Small Cell Neuroendocrine Carcinoma A primary carcinoma of the endometrium characterized by the presence of malignant cells that lack evidence of differentiation. C40156 Neoplastic Process Endometrial Undifferentiated Carcinoma C1516865 Cellosaurus Malignant Endometrial_Undifferentiated_Carcinoma Endometrial Undifferentiated Carcinoma Undifferentiated Endometrial Carcinoma Endometrial Undifferentiated Carcinoma A primary or metastatic malignant neoplasm affecting the bone or articular cartilage. C4016 Neoplastic Process Malignant Bone Neoplasm Malignant Bone Neoplasm C0279530 CPTAC CTEP CTRP GDC MedDRA NICHD A solid malignant neoplasm that develops or arises in the bone. Primary bone cancer is cancer that forms in cells of the bone. Some types of primary bone cancer are osteosarcoma, Ewing sarcoma, malignant fibrous histiocytoma, and chondrosarcoma. Secondary bone cancer is cancer that spreads to the bone from another part of the body (such as the prostate, breast, or lung). Malignant Malignant_Bone_Neoplasm Bone Cancer Bone cancer Malignant neoplasm of bone and articular cartilage Malignant neoplasm of bone and articular cartilage of limbs Malignant neoplasm of bone and articular cartilage of other and unspecified sites Malignant neoplasm of bone and articular cartilage, site unspecified Malignant neoplasm of bones of skull and face, except mandible Malignant neoplasm of long bones of left lower limb Malignant neoplasm of long bones of lower limb Malignant neoplasm of long bones of right lower limb Malignant neoplasm of long bones of unspecified lower limb Malignant neoplasm of pelvic bones, sacrum, and coccyx Malignant neoplasm of scapula and long bones of left upper limb Malignant neoplasm of scapula and long bones of right upper limb Malignant neoplasm of scapula and long bones of unspecified upper limb Malignant neoplasm of scapula and long bones of upper limb Malignant neoplasm of short bones of lower limb Malignant neoplasm of short bones of unspecified upper limb Malignant neoplasm of short bones of upper limb Malignant neoplasm of unspecified bones and articular cartilage of right limb Malignant neoplasm of unspecified bones and articular cartilage of unspecified limb Malignant neoplasm of vertebral column, excluding sacrum and coccyx Malignant neoplasm: Bone and articular cartilage, unspecified Malignant neoplasm: Bones of skull and face Malignant neoplasm: Long bones of lower limb Malignant neoplasm: Pelvic bones, sacrum and coccyx Malignant neoplasm: Scapula and long bones of upper limb Malignant neoplasm: Short bones of lower limb Malignant neoplasm: Short bones of upper limb Malignant neoplasm: Vertebral column Bone Cancer Bone cancer, NOS Cancer of Bone Cancer of the Bone Malignant Bone Neoplasm Malignant Bone Tumor Malignant Neoplasm of Bone Malignant Neoplasm of the Bone Malignant Osseous Neoplasm Malignant Osseous Tumor Malignant Tumor of Bone Malignant Tumor of the Bone Osseous Cancer bone cancer Malignant Bone Neoplasm A morphologic variant of uterine corpus leiomyoma characterized by an increased number of mitoses (up to 19 mitoses per 10 high-powered fields). C40162 Neoplastic Process Uterine Corpus Leiomyoma, Mitotically Active Variant C1519854 Benign Uterine_Corpus_Leiomyoma_Mitotically_Active_Variant Uterine Corpus Leiomyoma, Mitotically Active Variant Uterine Corpus Leiomyoma, Mitotically Active Variant A morphologic variant of leiomyoma arising from the uterine corpus. It is characterized by a dense cellular infiltrate composed of spindle or round cells with scant cytoplasm and a less obvious interlacing fascicle pattern. C40163 Neoplastic Process Uterine Corpus Cellular Leiomyoma C1519845 Benign Uterine_Corpus_Cellular_Leiomyoma Uterine Corpus Cellular Leiomyoma Uterine Corpus Cellular Leiomyoma A morphologic variant of uterine corpus leiomyoma characterized by the presence of round or polygonal epithelioid smooth muscle cells forming clusters. C40164 Neoplastic Process Uterine Corpus Epithelioid Leiomyoma C1519850 GDC Benign Uterine_Corpus_Epithelioid_Leiomyoma 8891/0 Epithelioid leiomyoma Uterine Corpus Epithelioid Leiomyoma Uterine Corpus Epithelioid Leiomyoma A morphologic variant of uterine corpus leiomyoma characterized by zones of hemorrhagic infarction surrounded by hypercellular areas. It usually develops in women of childbearing years, particularly those that are pregnant, post-partum, or taking oral contraceptives. C40165 Neoplastic Process Uterine Corpus Apoplectic Leiomyoma C1519852 Benign Uterine_Corpus_Hemorrhagic_Cellular_Leiomyoma Uterine Corpus Apoplectic Leiomyoma Uterine Corpus Hemorrhagic Cellular Leiomyoma Uterine Corpus Leiomyoma with Apoplectic Change Uterine Corpus Apoplectic Leiomyoma A morphologic variant of uterine corpus leiomyoma characterized by extensive myxoid degeneration of the neoplasm connective tissue stroma. C40166 Neoplastic Process Uterine Corpus Myxoid Leiomyoma C1519860 Benign Uterine_Corpus_Myxoid_Leiomyoma Uterine Corpus Myxoid Leiomyoma Uterine Corpus Myxoid Leiomyoma A morphologic variant of uterine corpus leiomyoma characterized by significant cytologic atypia. The atypical cells are large with pleomophic hyperchromatic nuclei. C40167 Neoplastic Process Uterine Corpus Bizarre Leiomyoma C1519853 Benign Uterine_Corpus_Leiomyoma_Atypical_Variant Uterine Corpus Bizarre Leiomyoma Uterine Corpus Leiomyoma with Bizarre Nuclei Uterine Corpus Leiomyoma, Atypical Variant Uterine Corpus Symplastic Leiomyoma Uterine Corpus Bizarre Leiomyoma A rare morphologic variant of uterine corpus leiomyoma characterized by the presence of scattered islands of mature adipocytes within the smooth muscle neoplasm. C40168 Neoplastic Process Uterine Corpus Lipoleiomyoma CL018075 Benign Uterine_Corpus_Lipoleiomyoma Uterine Corpus Lipoleiomyoma Uterine Corpus Lipomatous Leiomyoma Uterine Corpus Lipoleiomyoma A breast carcinoma arising from the ducts. While ductal carcinomas can arise at other sites, this term is universally used to refer to carcinomas of the breast. Ductal carcinomas account for about two thirds of all breast cancers. Two types of ductal carcinomas have been described: ductal carcinoma in situ (DCIS) and invasive breast carcinoma of no special type. The latter often spreads to the axillary lymph nodes and other anatomic sites. The two forms of ductal carcinoma often coexist. C4017 Neoplastic Process Ductal Breast Carcinoma Breast Ductal Carcinoma C1527349 CPTAC CTRP Cellosaurus GDC The most common type of breast cancer. It begins in the cells that line the milk ducts in the breast. Malignant Ductal_Breast_Carcinoma 8500/3 Duct adenocarcinoma, NOS Duct carcinoma, NOS Duct cell carcinoma Ductal carcinoma, NOS Breast Ductal Carcinoma Duct Adenocarcinoma Duct Carcinoma Ductal Adenocarcinoma Ductal Breast Carcinoma Ductal Carcinoma Ductal Carcinoma of Breast Ductal Carcinoma of the Breast Ductal adenocarcinoma ductal carcinoma Breast Ductal Carcinoma An unusual condition characterized by the presence of numerous small benign smooth muscle neoplasms located throughout the body of the uterus. C40170 Neoplastic Process Uterine Corpus Diffuse Leiomyomatosis C1519855 Benign Uterine_Corpus_Leiomyomatosis Uterine Corpus Diffuse Leiomyomatosis Uterine Corpus Diffuse Leiomyomatosis A rare morphologic variant of uterine corpus leiomyoma. Macroscopically, it is characterized by large, fungating, and multinodular neoplasm masses arising from the uterine corpus, and extending into the broad ligament or the peritoneal cavity. Microscopically, it shows neoplastic smooth muscle cells infiltrating the myometrium. The neoplastic cells are arranged in a micronodular pattern. Hydropic changes and increased vascularity are also present. C40172 Neoplastic Process Uterine Corpus Dissecting Leiomyoma C1519847 Benign Uterine_Corpus_Dissecting_Leiomyoma Cotyledonoid Dissecting Leiomyoma Sternberg Tumor Uterine Corpus Dissecting Leiomyoma Uterine Corpus Dissecting Leiomyoma A cytologically benign smooth muscle neoplasm that arises from the uterine corpus and has metastasized to the lungs, abdomen, or lymph nodes. It usually presents in women with a history of benign uterine leiomyomas that have been surgically removed years before the extrauterine neoplasm spread. C40173 Neoplastic Process Uterine Corpus Metastasizing Leiomyoma C1511090 GDC 8898/1 Benign Benign_Metastasizing_Leiomyoma 8898/1 Metastasizing leiomyoma Benign Metastasizing Leiomyoma of the Uterine Corpus Uterine Corpus Metastasizing Leiomyoma Uterine Corpus Metastasizing Leiomyoma A morphologic variant of leiomyosarcoma arising from the uterine corpus. It is characterized by the presence of epithelioid round cells with eosinophilic to clear cytoplasm. C40174 Neoplastic Process Uterine Corpus Epithelioid Leiomyosarcoma C1519851 Malignant Uterine_Corpus_Epithelioid_Leiomyosarcoma Uterine Corpus Epithelioid Leiomyosarcoma Uterine Corpus Epithelioid Leiomyosarcoma A morphologic variant of leiomyosarcoma arising from the uterus corpus. It is characterized by the presence of cellular pleomorphism, malignant cells with large nuclei, and a myxoid stroma. C40175 Neoplastic Process Uterine Corpus Myxoid Leiomyosarcoma C1519861 Malignant Uterine_Corpus_Myxoid_Leiomyosarcoma Uterine Corpus Myxoid Leiomyosarcoma Uterine Corpus Myxoid Leiomyosarcoma A benign, intermediate, or malignant neoplasm that arises from the uterine corpus and is composed of neoplastic cells with smooth muscle differentiation. C40176 Neoplastic Process Uterine Corpus Smooth Muscle Neoplasm C1519863 Undetermined Uterine_Corpus_Smooth_Muscle_Neoplasm Uterine Corpus Smooth Muscle Neoplasm Uterine Corpus Smooth Muscle Neoplasm A smooth muscle neoplasm that arises from the uterine corpus and cannot be reliably diagnosed as benign or malignant because of the presence of ambiguous morphologic findings. C40177 Neoplastic Process Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential C1519864 CTRP GDC 8897/1 Uncertain Malignant Potential Uterine_Corpus_Smooth_Muscle_Neoplasm_of_Uncertain_Malignant_Potential 8897/1 Smooth muscle tumor of uncertain malignant potential Borderline Uterine Corpus Smooth Muscle Neoplasm Uterine Corpus STUMP Uterine Corpus Smooth Muscle Neoplasm of Uncertain Malignant Potential Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential A rare primary neoplasm of the uterine corpus characterized by the presence of endometrial stromal and smooth muscle components. C40178 Neoplastic Process Mixed Endometrial Stromal and Smooth Muscle Neoplasm C1513364 Undetermined Mixed_Endometrial_Stromal_and_Smooth_Muscle_Neoplasm Mixed Endometrial Stromal and Smooth Muscle Neoplasm Mixed Endometrial Stromal and Smooth Muscle Tumor Stromomyoma Mixed Endometrial Stromal and Smooth Muscle Neoplasm A benign or malignant mesenchymal neoplasm of the uterine corpus. Representative examples include leiomyoma, leiomyosarcoma, and endometrial stromal sarcoma. C40179 Neoplastic Process Uterine Corpus Soft Tissue Neoplasm C1519865 Undetermined Uterine_Corpus_Soft_Tissue_Neoplasm Uterine Corpus Soft Tissue Neoplasm Uterine Corpus Soft Tissue Neoplasm A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina. The overall lobular architecture is preserved. It is frequently multifocal (90% in some series) and bilateral. It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma. C4018 Neoplastic Process Breast Lobular Carcinoma In Situ Lobular Breast Carcinoma In Situ Breast Lobular Carcinoma In Situ C0279563 CTEP CTRP GDC mCode A condition in which abnormal cells are found in the lobules of the breast. Lobular carcinoma in situ seldom becomes invasive cancer; however, having it in one breast increases the risk of developing breast cancer in either breast. 8520/2 Malignant Lobular_Carcinoma_in_situ_of_the_Breast 8520/2 LCIS, NOS Lobular carcinoma in situ, NOS Lobular carcinoma, noninfiltrating Breast Lobular Carcinoma In Situ LCIS LCIS, NOS Lobular Breast Carcinoma In Situ Lobular Ca in situ of Breast Lobular Ca in situ of the Breast Lobular Carcinoma In Situ (LCIS) Lobular Carcinoma In Situ of the Breast Lobular Carcinoma In Situ of the Breast (LCIS) Lobular Carcinoma in situ Lobular Carcinoma in situ of Breast Lobular carcinoma in situ Lobular carcinoma in situ of breast Lobular carcinoma in situ of unspecified breast Lobular carcinoma in situ, NOS Non-Infiltrating Lobular Breast Carcinoma Non-Infiltrating Lobular Carcinoma Non-Infiltrating Lobular Carcinoma of Breast Non-Infiltrating Lobular Carcinoma of the Breast Non-Invasive Lobular Breast Carcinoma Non-Invasive Lobular Carcinoma of Breast Non-Invasive Lobular Carcinoma of the Breast lobular carcinoma in situ Breast Lobular Carcinoma In Situ A neoplasm with perivascular epithelioid cell differentiation arising from the uterine corpus wall. C40180 Neoplastic Process Uterine Corpus PEComa C1519862 Undetermined Uterine_Corpus_Perivascular_Epithelioid_Cell_Tumor Uterine Corpus PEComa Uterine Corpus Perivascular Epithelioid Cell Tumor Uterine Corpus PEComa A primary, benign or malignant neoplasm of the uterine corpus characterized by the presence of an epithelial and a mesenchymal component. Representative examples include adenomyoma, adenosarcoma, and carcinosarcoma. C40181 Neoplastic Process Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm C1519858 Undetermined Uterine_Corpus_Mixed_Epithelial_and_Mesenchymal_Neoplasm Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm Uterine Corpus Mixed Epithelial and Mesenchymal Tumor Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm An uncommon malignant neoplasm arising from the uterine corpus. It is characterized by the presence of a malignant epithelial component and a benign mesenchymal (usually fibrous) component. C40182 Neoplastic Process Uterine Corpus Carcinofibroma C1883485 GDC 8934/3 Malignant Uterine_Corpus_Adenocarcinofibroma 8934/3 Carcinofibroma Uterine Corpus Carcinofibroma Uterine Corpus Carcinofibroma A variant of cervical squamous cell carcinoma characterized by the presence of keratin pearls. Intercellular bridges and cytoplasmic keratinization are usually present. C40187 Neoplastic Process Cervical Keratinizing Squamous Cell Carcinoma Cervical Keratinizing Squamous Cell Carcinoma C1517658 CPTAC CTRP Cellosaurus Malignant Keratinizing_Cervical_Squamous_Cell_Carcinoma Cervical Keratinizing Squamous Cell Carcinoma Squamous Cell Carcinoma, Keratinizing Cervical Keratinizing Squamous Cell Carcinoma A variant of cervical squamous cell carcinoma characterized by the presence of polygonal squamous cells. Intercellular bridges and cytoplasmic keratinization may be present, but keratin pearls are absent. C40188 Neoplastic Process Cervical Non-Keratinizing Squamous Cell Carcinoma C1518366 CPTAC Malignant Non-Keratinizing_Cervical_Squamous_Cell_Carcinoma Cervical Non-Keratinizing Squamous Cell Carcinoma Cervical Nonkeratinizing Squamous Cell Carcinoma Squamous Cell Carcinoma, Non-Keratinizing Cervical Non-Keratinizing Squamous Cell Carcinoma An aggressive variant of cervical squamous cell carcinoma characterized by the presence of nests of malignant basaloid squamous cells with scant amount of cytoplasm. C40189 Neoplastic Process Cervical Basaloid Squamous Cell Carcinoma C1511063 Malignant Basaloid_Cervical_Squamous_Cell_Carcinoma Cervical Basaloid Carcinoma Cervical Basaloid Squamous Cell Carcinoma Cervical Basaloid Squamous Cell Carcinoma Paget disease of the breast associated with the presence of a usually high grade ductal carcinoma in situ in the lactiferous glands. C4019 Neoplastic Process Paget Disease and Intraductal Carcinoma of the Breast Breast Paget Disease and Intraductal Carcinoma C0279566 CTRP GDC 8543/3 Malignant Paget_s_Disease_and_Intraductal_Carcinoma_of_the_Breast 8543/3 Paget disease and intraductal carcinoma of breast Breast Paget Disease and Intraductal Carcinoma Paget Disease and Intraductal Carcinoma of the Breast Paget disease and intraductal carcinoma of breast Paget's Disease and Intraductal Carcinoma of Breast Paget's Disease and Intraductal Carcinoma of the Breast Paget's Disease of Breast with Intraductal Carcinoma Paget's Disease of the Breast with Intraductal Carcinoma Breast Paget Disease and Intraductal Carcinoma A highly differentiated variant of cervical squamous cell carcinoma characterized by the presence of a warty surface and stromal invasion with pushing borders. The malignant cells have abundant cytoplasm and minimal nuclear atypia. Koilocytosis is not present. C40190 Neoplastic Process Cervical Verrucous Carcinoma C1516435 Malignant Cervical_Verrucous_Carcinoma Cervical Verrucous Carcinoma Cervical Verrucous Carcinoma A human papillomavirus-related cervical squamous cell carcinoma characterized by the presence of a warty surface and koilocytotic atypia. C40191 Neoplastic Process Cervical Warty Carcinoma C1516436 Malignant Cervical_Warty_Carcinoma Cervical Condylomatous Squamous Cell Carcinoma Cervical Warty Carcinoma Cervical Warty Squamous Cell Carcinoma Cervical Warty Carcinoma A human papillomavirus-related cervical squamous cell carcinoma characterized by the presence of papillary structures covered with epithelial cells which show features of cervical intraepithelial neoplasia. The malignant cellular component below the papillary structures is a squamous cell carcinoma. C40192 Neoplastic Process Cervical Papillary Squamous Cell Carcinoma C1516429 Malignant Cervical_Papillary_Squamous_Cell_Carcinoma Cervical Papillary Squamous Cell Carcinoma Cervical Papillary Squamous Cell Carcinoma A variant of cervical squamous cell carcinoma characterized by the presence of islands of cells with uniform, vesicular nuclei and prominent nucleoli and a dense lymphocytic infiltrate. C40193 Neoplastic Process Cervical Lymphoepithelioma-Like Carcinoma C1516418 Malignant Cervical_Lymphoepithelioma-like_Carcinoma Cervical Lymphoepithelioma-Like Carcinoma Cervical Lymphoepithelioma-Like Carcinoma A human papillomavirus-related cervical squamous cell carcinoma characterized by the presence of papillary structures with fibrovascular cores. It is covered with multiple layers of atypical cells that resemble cervical intraepithelial neoplasia 3. C40194 Neoplastic Process Cervical Squamotransitional Carcinoma C1516433 GDC Malignant Cervical_Squamotransitional_Carcinoma Squamotransitional cell carcinoma Cervical Squamotransitional Carcinoma Cervical Squamotransitional Carcinoma A benign, precancerous, or malignant neoplasm that arises from the squamous epithelium of the cervix. Representative examples include condyloma acuminatum, cervical intraepithelial neoplasia, and squamous cell carcinoma. C40195 Neoplastic Process Cervical Squamous Neoplasm C1516434 Undetermined Cervical_Squamous_Neoplasm Cervical Squamous Neoplasm Cervical Squamous Tumor Cervical Squamous Neoplasm A precancerous neoplastic process that affects the cervical squamous epithelium without evidence of invasion. It is usually associated with human papillomavirus infection. It is characterized by the presence of mild atypia in the superficial epithelial layer that may be associated with koilocytosis. Maturation is present in the upper two thirds of the epithelium. Mitotic figures are not numerous and are present in the basal third of the epithelium. C40196 Neoplastic Process Low Grade Cervical Squamous Intraepithelial Neoplasia Low Grade Cervical Squamous Intraepithelial Neoplasia C1518005 CTRP Undetermined Low-Grade_Cervical_Squamous_Intraepithelial_Neoplasia Cervical Squamous Intraepithelial Neoplasia 1 Low Grade Cervical Squamous Intraepithelial Lesion Low Grade Cervical Squamous Intraepithelial Neoplasia Low-Grade CIN Low-Grade Cervical SIL Low-Grade Cervical Squamous Intraepithelial Lesion Mild Squamous Dysplasia of the Cervix Low Grade Cervical Squamous Intraepithelial Neoplasia A precancerous neoplastic process that affects the cervical squamous epithelium. It is usually associated with human papillomavirus infection. It is classified as cervical squamous intraepithelial neoplasia 2 when there is nuclear atypia in both the upper and lower epithelial layers, mitotic figures are confined to the basal two-thirds of the epithelium, and maturation is present in the upper half of the epithelium. It is classified as cervical squamous intraepithelial neoplasia 3 when there is nuclear atypia and mitotic figures throughout the entire thickness of the epithelium, and maturation is absent or confined to the upper third of the epithelium. C40197 Neoplastic Process High Grade Cervical Squamous Intraepithelial Neoplasia C1512433 Undetermined High-Grade_Cervical_Squamous_Intraepithelial_Neoplasia HSIL of Cervix High Grade Cervical Squamous Intraepithelial Lesion High Grade Cervical Squamous Intraepithelial Neoplasia High-Grade CIN High-Grade Cervical SIL High-Grade Cervical Squamous Intraepithelial Lesion High Grade Cervical Squamous Intraepithelial Neoplasia Cervical squamous intraepithelial neoplasia characterized by the presence of maturation in the upper half of the squamous epithelium and conspicuous nuclear atypia which is present in all epithelial layers. Mitotic figures are present in the basal two thirds of the epithelium. C40198 Neoplastic Process Cervical Squamous Intraepithelial Neoplasia 2 Cervical Squamous Intraepithelial Neoplasia 2 C0349459 CTRP A condition in which moderately abnormal cells grow on the thin layer of tissue that covers the cervix. These abnormal cells are not malignant (cancer) but may become cancer. Undetermined Cervical_Squamous_Intraepithelial_Neoplasia_2 CIN 2 Cervical Squamous Intraepithelial Neoplasia 2 Moderate Squamous Dysplasia of the Cervix cervical squamous intraepithelial neoplasia 2 Cervical Squamous Intraepithelial Neoplasia 2 Cervical squamous intraepithelial neoplasia characterized by the presence of maturation in the upper two-thirds of the squamous epithelium and mild nuclear atypia which is present in all epithelial layers. Mitotic figures are present in the basal third of the epithelium. C40199 Neoplastic Process Cervical Squamous Intraepithelial Neoplasia 1 C1527424 A condition in which slightly abnormal cells grow on the thin layer of tissue that covers the cervix. These abnormal cells are not malignant (cancer) but may become cancer. Undetermined Cervical_Squamous_Intraepithelial_Neoplasia_1 CIN 1 Cervical Squamous Intraepithelial Neoplasia 1 cervical squamous intraepithelial neoplasia 1 Cervical Squamous Intraepithelial Neoplasia 1 A conventional osteosarcoma characterized by the presence of spindle shaped cells. C4020 Neoplastic Process Fibroblastic Osteosarcoma Fibroblastic Osteosarcoma C0279602 CDISC CTRP GDC PCDC A malignant fibrosarcoma characterized by pleomorphic cells intermixed with variable amounts of collagenous matrix. 9182/3 Malignant Fibroblastic_Osteosarcoma 9182/3 Fibroblastic osteosarcoma Osteofibrosarcoma FIBROSARCOMA, OSTEOGENIC, MALIGNANT Fibroblastic Osteogenic Sarcoma Fibroblastic Osteosarcoma Fibroblastic osteosarcoma Fibrosarcomatous Osteogenic Sarcoma Fibrosarcomatous Osteosarcoma Osteogenic Fibrosarcoma Fibroblastic Osteosarcoma A rare adenocarcinoma that arises from the cervix. It is characterized by the presence of papillary patterns and cellular budding. Psammoma bodies are often seen. C40201 Neoplastic Process Cervical Serous Adenocarcinoma C1516431 Malignant Cervical_Serous_Adenocarcinoma Cervical Serous Adenocarcinoma Cervical Serous Adenocarcinoma A cervical mucinous adenocarcinoma that resembles a large intestinal adenocarcinoma. C40203 Neoplastic Process Cervical Mucinous Adenocarcinoma, Intestinal-Type C1516422 GDC Malignant Cervical_Mucinous_Adenocarcinoma_Intestinal_Variant Mucinous carcinoma, intestinal type Cervical Mucinous Adenocarcinoma, Intestinal Type Cervical Mucinous Adenocarcinoma, Intestinal Variant Cervical Mucinous Adenocarcinoma, Intestinal-Type Cervical Mucinous Adenocarcinoma, Intestinal-Type A rare cervical mucinous adenocarcinoma characterized by the presence of signet ring cells. C40205 Neoplastic Process Cervical Mucinous Adenocarcinoma, Signet Ring Cell-Type C1516424 Malignant Cervical_Mucinous_Adenocarcinoma_Signet_Ring_Cell_Variant Cervical Mucinous Adenocarcinoma, Signet Ring Cell Type Cervical Mucinous Adenocarcinoma, Signet Ring Cell Variant Cervical Mucinous Adenocarcinoma, Signet Ring Cell-Type Cervical Mucinous Adenocarcinoma, Signet-Ring Cell Type Cervical Mucinous Adenocarcinoma, Signet Ring Cell-Type Cervical adenocarcinoma characterized by the presence of gastric differentiation. It is not associated with human papillomavirus infection. C40206 Neoplastic Process Human Papillomavirus-Independent Cervical Adenocarcinoma, Gastric-Type C1516423 Cellosaurus GDC Malignant Cervical_Mucinous_Adenocarcinoma_Minimal_Deviation_Variant 8483/3 Mucinous carcinoma, gastric type Cervical Adenoma Malignum Cervical Mucinous Adenocarcinoma, Gastric Type Cervical Mucinous Adenocarcinoma, Minimal Deviation Type Cervical Mucinous Adenocarcinoma, Minimal Deviation Variant HPV-Independent Cervical Adenocarcinoma, Gastric-Type Human Papillomavirus-Independent Cervical Adenocarcinoma, Gastric Type Human Papillomavirus-Independent Cervical Adenocarcinoma, Gastric-Type Human Papillomavirus-Independent Cervical Adenocarcinoma, Gastric-Type A cervical adenocarcinoma characterized by the presence of a prominent villoglandular pattern. C40208 Neoplastic Process Cervical Villoglandular Adenocarcinoma C1516425 GDC Malignant Cervical_Mucinous_Adenocarcinoma_Villoglandular_Variant Villoglandular carcinoma Cervical Adenocarcinoma, Villoglandular Variant Cervical Villoglandular Adenocarcinoma Cervical Villoglandular Carcinoma Cervical Villoglandular Adenocarcinoma An osteosarcoma characterised by the presence of atypical cartilage of variable cellularity. It may or may not be associated with the presence of myxoid areas or focal bone formation. C4021 Neoplastic Process Chondroblastic Osteosarcoma Chondroblastic Osteosarcoma C0279603 CTRP Cellosaurus GDC PCDC 9181/3 Malignant Chondrosarcomatous_Osteosarcoma 9180/3 9181/3 Chondroblastic osteosarcoma Osteochondrosarcoma Chondroblastic Osteogenic Sarcoma Chondroblastic Osteosarcoma Chondroblastic osteosarcoma Chondroblastic Osteosarcoma A benign, malignant, or precancerous neoplasm that arises from the glandular epithelium of the cervix. Representative examples include endocervical polyp, cervical adenocarcinoma, and cervical glandular intraepithelial neoplasia. C40210 Neoplastic Process Cervical Glandular Neoplasm C1516416 Undetermined Cervical_Glandular_Neoplasm Cervical Glandular Neoplasm Cervical Glandular Tumor Cervical Glandular Neoplasm A poorly differentiated variant of adenosquamous carcinoma that arises from the cervix. It is characterized by the presence of large malignant cells with ground glass cytoplasm and stromal eosinophilic infiltrates. C40212 Neoplastic Process Cervical Poorly Differentiated Adenosquamous Carcinoma C1516407 Cellosaurus Malignant Cervical_Adenosquamous_Carcinoma_Glassy_Cell_Variant Cervical Adenosquamous Carcinoma, Glassy Cell Variant Cervical Poorly Differentiated Adenosquamous Carcinoma Cervical Poorly Differentiated Adenosquamous Carcinoma A rare low grade carcinoma that arises from the cervix. It is characterized by the presence of nests of basaloid cells with focal glandular formations. C40213 Neoplastic Process Cervical Adenoid Basal Carcinoma Cervical Adenoid Basal Carcinoma C1516403 CTRP Malignant Cervical_Adenoid_Basal_Carcinoma Cervical Adenoid Basal Cancer Cervical Adenoid Basal Carcinoma Cervical Adenoid Basal Carcinoma A rare, aggressive neuroendocrine carcinoma that arises from the cervix and is characterized by the presence of malignant cells with abundant cytoplasm, large nuclei, and prominent nucleoli. C40214 Neoplastic Process Cervical Large Cell Neuroendocrine Carcinoma C1516417 Malignant Cervical_Large_Cell_Neuroendocrine_Carcinoma Cervical Large Cell Neuroendocrine Carcinoma Cervical Large Cell Neuroendocrine Carcinoma A rare, benign, papillary neoplasm that arises from the cervix. It is characterized by the presence of a fibrovascular core covered by mucinous epithelial cells. C40215 Neoplastic Process Cervical Mullerian Papilloma C1516427 Benign Cervical_Mullerian_Papilloma Cervical Mullerian Papilloma Cervical Müllerian Papilloma Cervical Mullerian Papilloma A benign or malignant mesenchymal neoplasm of the cervix. Representative examples include rhabdomyoma, alveolar soft part sarcoma, and AIDS-related Kaposi sarcoma. C40216 Neoplastic Process Cervical Soft Tissue Neoplasm C1516432 Undetermined Cervical_Soft_Tissue_Neoplasm Cervical Soft Tissue Neoplasm Cervical Soft Tissue Tumor Cervical Soft Tissue Neoplasm A category of benign or malignant mesenchymal neoplasms that arises from the uterine corpus. This category includes the endometrial stromal nodule which is benign and non-invasive, the endometrial stromal sarcoma, and the undifferentiated uterine sarcoma. The endometrial stromal sarcoma is an invasive malignant neoplasm, further subdivided into low grade and high grade endometrial stromal sarcoma. Undifferentiated uterine sarcoma was previously also known as high grade endometrial stromal sarcoma. In 2014, high grade endometrial stromal sarcoma was reclassified and is currently considered a distinct and rare neoplasm. It appears to have a prognosis that falls between low grade endometrial stromal sarcoma and undifferentiated sarcoma. C40217 Neoplastic Process Uterine Corpus Endometrial Stromal and Related Neoplasms C1519848 Undetermined Uterine_Corpus_Endometrial_Stromal_Neoplasm Uterine Corpus Endometrial Stromal and Related Neoplasms Uterine Corpus Endometrial Stromal and Related Tumors Uterine Corpus Endometrial Stromal and Related Neoplasms A category of rare neoplasms that arise from the cervix. It includes low grade endometrioid stromal sarcoma and undifferentiated endocervical sarcoma. C40218 Neoplastic Process Cervical Endometrioid Stromal and Related Neoplasms C3642325 Undetermined Endometrial_Stromal_Neoplasm_of_the_Cervix Cervical Endometrioid Stromal and Related Neoplasms Cervical Endometrioid Stromal and Related Tumors Endometrioid Stromal and Related Neoplasms of the Cervix Endometrioid Stromal and Related Tumors of the Cervix Cervical Endometrioid Stromal and Related Neoplasms A uterine corpus sarcoma originating from the endometrial stroma. It is further subdivided into low grade and high grade endometrial stromal sarcoma. C40219 Neoplastic Process Uterine Corpus Endometrial Stromal Sarcoma C1519849 Malignant Uterine_Corpus_Endometrial_Stromal_Sarcoma Uterine Corpus ESS Uterine Corpus Endometrial Stromal Sarcoma Uterine Corpus Endometrial Stromal Sarcoma A form of melanoma occurring most often on the plantar, palmar, subungual, and periungual skin. It presents as a pigmented macular lesion with irregular borders. Morphologically, it consists of atypical spindled and dendritic melanocytes. The epidermis is often hyperplastic and there is pagetoid infiltration of the epidermis by anaplastic cells. C4022 Neoplastic Process Acral Lentiginous Melanoma Acral Lentiginous Melanoma C0346037 CTRP Cellosaurus GDC 8744/3 Malignant Acral_Lentiginous_Malignant_Melanoma 8744/3 Acral lentiginous melanoma, malignant Acral melanoma Acral Lentiginous Malignant Melanoma Acral Lentiginous Melanoma Acral Melanoma Acral lentiginous melanoma, malignant Acral Lentiginous Melanoma A very rare sarcoma that arises from the cervix and is characterized by the presence of cells that resemble endometrial stromal cells. C40222 Neoplastic Process Cervical Low Grade Endometrioid Stromal Sarcoma C3642327 Malignant Low_Grade_Endometrial_Stromal_Sarcoma_of_the_Cervix Cervical Endometrioid Stromal Sarcoma Cervical Low Grade Endometrioid Stromal Sarcoma Endometrioid Stromal Sarcoma of the Cervix Low Grade Endometrioid Stromal Sarcoma of the Cervix Cervical Low Grade Endometrioid Stromal Sarcoma A rare, indolent, invasive mesenchymal tumor that arises from the endometrial stroma. It is characterized by the presence of a plexiform vasculature, infrequent mitoses, and insignificant cytologic atypia. Late recurrences may occur. C40223 Neoplastic Process Uterine Corpus Low Grade Endometrial Stromal Sarcoma C1519857 GDC Malignant Uterine_Corpus_Low_Grade_Endometrial_Stromal_Sarcoma 8931/3 Endometrial stromal sarcoma, low grade JAZF1-SUZ12 ESS JAZF1-SUZ12 Endometrial Stromal Sarcoma JAZF1::SUZ12 Endometrial Stromal Sarcoma Uterine Corpus Low Grade ESS Uterine Corpus Low Grade Endometrial Stromal Sarcoma Uterine Corpus Low Grade Endometrial Stromal Sarcoma A high grade undifferentiated sarcoma that arises from the endocervix. C40224 Neoplastic Process Endocervical Undifferentiated Sarcoma C1519782 Malignant Undifferentiated_Endocervical_Sarcoma Endocervical Undifferentiated Sarcoma Undifferentiated Endocervical Sarcoma Undifferentiated Sarcoma of the Endocervix Endocervical Undifferentiated Sarcoma An alveolar soft part sarcoma arising from the cervix. C40225 Neoplastic Process Cervical Alveolar Soft Part Sarcoma C1516408 Malignant Cervical_Alveolar_Soft_Part_Sarcoma Cervical Alveolar Soft Part Sarcoma Cervical Alveolar Soft Part Sarcoma A benign or malignant neoplasm that arises from the cervix and is characterized by the presence of epithelial and mesenchymal elements. This category includes adenofibroma, adenomyoma, adenosarcoma, and carcinosarcoma. C40226 Neoplastic Process Cervical Mixed Epithelial and Mesenchymal Neoplasm C1516420 Undetermined Cervical_Mixed_Epithelial_and_Mesenchymal_Neoplasm Cervical Mixed Epithelial and Mesenchymal Neoplasm Cervical Mixed Epithelial and Mesenchymal Neoplasm A neoplasm that arises from the cervix and is characterized by the presence of benign epithelial and benign mesenchymal elements. This category includes adenofibroma and adenomyoma. C40227 Neoplastic Process Benign Cervical Mixed Epithelial and Mesenchymal Neoplasm C1511086 Benign Benign_Cervical_Mixed_Epithelial_and_Mesenchymal_Neoplasm Benign Cervical Mixed Epithelial and Mesenchymal Neoplasm Benign Cervical Mixed Epithelial and Mesenchymal Neoplasm A mixed epithelial and mesenchymal neoplasm that arises from the cervix. It is characterized by the presence of malignant mesenchymal elements and benign or malignant epithelial elements. This category includes adenosarcoma and carcinosarcoma. C40228 Neoplastic Process Malignant Mixed Epithelial and Mesenchymal Neoplasm of the Cervix C1518168 Malignant Malignant_Cervical_Mixed_Epithelial_and_Mesenchymal_Neoplasm Malignant Cervical Mixed Epithelial and Mesenchymal Neoplasm Malignant Mixed Epithelial and Mesenchymal Neoplasm of the Cervix Malignant Mixed Epithelial and Mesenchymal Neoplasm of the Cervix A rare malignant mixed epithelial and mesenchymal neoplasm that arises from the cervix. It is characterized by the presence of malignant mesenchymal elements and benign epithelial elements. C40229 Neoplastic Process Cervical Adenosarcoma C1516426 Malignant Cervical_Mullerian_Adenosarcoma Cervical Adenosarcoma Cervical Mullerian Adenosarcoma Cervical Müllerian Adenosarcoma Cervical Adenosarcoma An osteosarcoma usually arising from the metaphysis of long bones. It is characterized by the presence of small cells and osteoid production. The prognosis is usually unfavorable. C4023 Neoplastic Process Small Cell Osteosarcoma C0279622 Cellosaurus GDC PCDC 9185/3 Malignant Small_Cell_Osteosarcoma 9185/3 Round cell osteosarcoma Small cell osteosarcoma Small Cell Osteogenic Sarcoma Small Cell Osteosarcoma Small cell osteosarcoma Small Cell Osteosarcoma A rare, benign, polypoid neoplasm that arises from the cervix. It is characterized by the presence of epithelial and mesenchymal elements. C40230 Neoplastic Process Cervical Adenofibroma C1516402 Benign Cervical_Adenofibroma Cervical Adenofibroma Cervical Adenofibroma A rare, benign, usually polypoid neoplasm that arises from the cervix. It is characterized by the presence of a glandular component and a smooth muscle cell component. Variants include the endocervical-type, mesonephric-type, and atypical polypoid adenomyoma. C40231 Neoplastic Process Cervical Adenomyoma C1516404 Benign Cervical_Adenomyoma Cervical Adenomyoma Cervical Adenomyoma An adenomyoma that arises from the cervix and is characterized by the presence of endocervical mucinous glands and a smooth muscle cell component. There is no atypia or significant mitotic activity present. C40232 Neoplastic Process Cervical Adenomyoma, Endocervical-Type C1516405 Benign Cervical_Adenomyoma_Endocervical_Type Cervical Adenomyoma, Endocervical Type Cervical Adenomyoma, Endocervical-Type Cervical Adenomyoma, Endocervical-Type An adenomyoma that arises from the cervix and is characterized by the presence of glands showing mesonephric differentiation and a smooth muscle cell component. There is no atypia or significant mitotic activity present. C40233 Neoplastic Process Cervical Adenomyoma, Mesonephric-Type C1516406 Benign Cervical_Adenomyoma_Endometrial_Type Cervical Adenomyoma, Mesonephric Type Cervical Adenomyoma, Mesonephric-Type Cervical Adenomyoma, Mesonephric-Type An adenomyoma that arises from the cervix and is characterized by the presence of a glandular component exhibiting architectural complexity. C40234 Neoplastic Process Cervical Atypical Polypoid Adenomyoma C1516409 Benign Cervical_Atypical_Polypoid_Adenomyoma Cervical Atypical Polypoid Adenomyoma Cervical Atypical Polypoid Adenomyoma An adenomyoma that arises from the uterine corpus and is characterized by the presence of marked glandular architectural complexity. It may recur following excision. C40235 Neoplastic Process Uterine Corpus Atypical Polypoid Adenomyoma C1519844 Benign Uterine_Corpus_Atypical_Polypoid_Adenomyoma Uterine Corpus Atypical Polypoid Adenomyoma Uterine Corpus Atypical Polypoid Adenomyoma An embryonal neoplasm arising from the cervix with morphologic features resembling Wilms tumor of the kidney. C40236 Neoplastic Process Cervical Wilms Tumor C1516437 Malignant Cervical_Wilms_Tumor Cervical Nephroblastoma Cervical Wilms Tumor Cervical Wilms Tumor An aggressive malignant tumor of melanocytic origin that arises from the cervix. C40239 Neoplastic Process Cervical Melanoma C0877611 Cellosaurus Malignant Cervical_Melanoma Cervical Melanoma Melanoma of the Cervix Cervical Melanoma A squamous cell carcinoma arising from the esophagus. It is associated with a long history of tobacco and alcohol abuse and is exceedingly rare before the age of 30. The median age is around 65 in both males and females. It is located mostly in the middle and lower third of the esophagus. Grossly, polypoid, ulcerated, plaque-like and occult lesions have been described. The microscopic features are the same as in other squamous cell carcinomas. Any degree of differentiation may occur, and variation within a single tumor is common. The prognosis is poor. C4024 Neoplastic Process Esophageal Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma C0279626 CTEP CTRP Cellosaurus Malignant Esophageal_Squamous_Cell_Carcinoma ESCC Esophageal Epidermoid Carcinoma Esophageal SCC Esophageal Squamous Cell Cancer Esophageal Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma, NOS Esophageal Squamous Cell Carcinoma, Not Otherwise Specified Esophagus SCC Esophagus Squamous Cell Carcinoma SCC of Esophagus SCC of the Esophagus Squamous Cell Carcinoma of Esophagus Squamous Cell Carcinoma of the Esophagus Squamous cell car. - esophagus Squamous cell carcinoma of the esophagus Esophageal Squamous Cell Carcinoma A nevus that arises from the cervix. It is characterized by the presence of benign, heavily pigmented dendritic melanocytes. C40240 Neoplastic Process Cervical Blue Nevus C1516410 Benign Cervical_Blue_Nevus Blue Nevus of the Cervix Cervical Blue Nevus Cervical Blue Nevus A benign, precancerous, or malignant neoplasm that arises from the squamous epithelium of the vagina. C40242 Neoplastic Process Vaginal Squamous Neoplasm C1519931 Undetermined Vaginal_Squamous_Neoplasm Vaginal Squamous Neoplasm Vaginal Squamous Tumor Vaginal Squamous Neoplasm A squamous cell carcinoma that arises from the vagina and is characterized by the presence of keratin pearls. Intercellular bridges and cytoplasmic keratinization are usually present. C40243 Neoplastic Process Vaginal Keratinizing Squamous Cell Carcinoma C1519922 Malignant Vaginal_Keratinizing_Squamous_Cell_Carcinoma Vaginal Keratinizing Squamous Cell Carcinoma Vaginal Keratinizing Squamous Cell Carcinoma A squamous cell carcinoma that arises from the vagina and is characterized by the presence of polygonal squamous cells. Intercellular bridges and cytoplasmic keratinization may be present, but keratin pearls are absent. C40244 Neoplastic Process Vaginal Non-Keratinizing Squamous Cell Carcinoma C1519927 Malignant Vaginal_Non-Keratinizing_Squamous_Cell_Carcinoma Vaginal Non-Keratinizing Squamous Cell Carcinoma Vaginal Non-Keratinizing Squamous Cell Carcinoma A squamous cell carcinoma that arises from the vagina and is characterized by the presence of nests of malignant basaloid squamous cells with scant amounts of cytoplasm. C40245 Neoplastic Process Vaginal Basaloid Squamous Cell Carcinoma C1519916 Malignant Vaginal_Basaloid_Carcinoma Vaginal Basaloid Carcinoma Vaginal Basaloid Squamous Cell Carcinoma Vaginal Basaloid Squamous Cell Carcinoma A squamous cell carcinoma that arises from the vagina and is characterized by a papillary growth pattern, hyperkeratosis, and koilocytosis. C40248 Neoplastic Process Vaginal Warty Carcinoma C1519937 Malignant Vaginal_Warty_Carcinoma Vaginal Warty Carcinoma Vaginal Warty Carcinoma A malignant tumor with glandular differentiation arising predominantly from Barrett mucosa in the lower third of the esophagus. Rare examples of esophageal adenocarcinoma deriving from ectopic gastric mucosa in the upper esophagus have also been reported. Grossly, esophageal adenocarcinomas are similar to esophageal squamous cell carcinomas. Microscopically, adenocarcinomas arising in the setting of Barrett esophagus are typically papillary and/or tubular. The prognosis is poor. C4025 Neoplastic Process Esophageal Adenocarcinoma Esophageal Adenocarcinoma C0279628 CPTAC CTEP CTRP Cellosaurus Malignant Esophageal_Adenocarcinoma Adenocarcinoma Adenocarcinoma - esophagus Adenocarcinoma of Esophagus Adenocarcinoma of the Esophagus Adenocarcinoma of the esophagus Esophageal Adenocarcinoma Esophagus Adenocarcinoma Esophageal Adenocarcinoma A benign or malignant neoplasm that arises from the vagina and is characterized by the presence of neoplastic glandular epithelial cells. Representative examples include adenoma, endometrioid adenocarcinoma, and clear cell adenocarcinoma. C40250 Neoplastic Process Vaginal Glandular Neoplasm C1519921 Undetermined Vaginal_Glandular_Neoplasm Vaginal Glandular Neoplasm Vaginal Glandular Tumor Vaginal Glandular Neoplasm A rare adenocarcinoma that arises from the vagina with histologic features resembling the endometrioid adenocarcinoma of the endometrium. C40251 Neoplastic Process Vaginal Endometrioid Adenocarcinoma C1519920 Malignant Vaginal_Endometrioid_Adenocarcinoma Vaginal Endometrioid Adenocarcinoma Vaginal Endometrioid Adenocarcinoma A rare adenocarcinoma that arises from the vagina with histologic features resembling cervical mucinous adenocarcinoma. C40252 Neoplastic Process Vaginal Mucinous Adenocarcinoma C1519925 Malignant Vaginal_Mucinous_Adenocarcinoma Vaginal Mucinous Adenocarcinoma Vaginal Mucinous Adenocarcinoma Vaginal adenocarcinoma that derives from Wolffian duct remnants and shows mesonephric differentiation. C40253 Neoplastic Process Vaginal Mesonephric Adenocarcinoma C1519923 Malignant Vaginal_Mesonephric_Adenocarcinoma Gartner Duct Adenocarcinoma Vaginal Mesonephric Adenocarcinoma Vaginal Mesonephric Adenocarcinoma Cervical adenocarcinoma that derives from Wolffian duct remnants and shows mesonephric differentiation. It is not associated with human papillomavirus infection. C40254 Neoplastic Process Cervical Mesonephric Adenocarcinoma C1516419 Malignant Cervical_Mesonephric_Adenocarcinoma Cervical Mesonephric Adenocarcinoma HPV- Independent Cervical Adenocarcinoma, Mesonephric Type HPV- Independent Cervical Adenocarcinoma, Mesonephric-Type Human Papillomavirus-Independent Cervical Adenocarcinoma, Mesonephric Type Human Papillomavirus-Independent Cervical Adenocarcinoma, Mesonephric-Type Cervical Mesonephric Adenocarcinoma A benign papilloma that arises from the vagina in infants and young women. C40255 Neoplastic Process Vaginal Mullerian Papilloma C1519926 Benign Vaginal_Mullerian_Papilloma Vaginal Mullerian Papilloma Vaginal Müllerian Papilloma Vaginal Mullerian Papilloma A glandular epithelial neoplasm that arises from the vagina and shows intestinal differentiation. C40256 Neoplastic Process Vaginal Adenoma C1519913 Benign Vaginal_Adenoma Vaginal Adenoma Vaginal Adenomatous Polyp Vaginal Intestinal-Type Adenoma Vaginal Adenoma An adenoma that arises from the vagina and is characterized by a tubulovillous architectural pattern. C40258 Neoplastic Process Vaginal Tubulovillous Adenoma C1519933 Benign Vaginal_Tubular_Adenoma Vaginal_Tubulovillous_Adenoma Vaginal Tubulovillous Adenoma Vaginal Tubulovillous Adenoma An adenoma that arises from the vagina and is characterized by a villous architectural pattern. C40259 Neoplastic Process Vaginal Villous Adenoma C1519936 Benign Vaginal_Villous_Adenoma Vaginal Villous Adenoma Vaginal Villous Adenoma An invasive cystic adenocarcinoma arising from the ovary. It is characterized by the presence of malignant glandular epithelial cells which contain intracytoplasmic mucin. The malignant cells invade the ovarian stroma and the cystic spaces contain mucoid material. In a minority of cases both ovaries are involved by the tumor. The prognosis for stage I tumors is excellent. Patients with metastases usually have a poor prognosis. C4026 Neoplastic Process Ovarian Mucinous Cystadenocarcinoma Ovarian Mucinous Cystadenocarcinoma C0279665 CTRP Cellosaurus Malignant Ovarian_Mucinous_Cystadenocarcinoma Mucinous Cystadenocarcinoma of Ovary Mucinous Cystadenocarcinoma of the Ovary Ovarian Mucinous Cystadenocarcinoma Ovarian Mucinous Cystadenocarcinoma A carcinoma that arises from the vagina and is characterized by the presence of malignant glandular and malignant squamous epithelial components. C40260 Neoplastic Process Vaginal Adenosquamous Carcinoma Vaginal Adenosquamous Carcinoma C1519915 CTRP Malignant Vaginal_Adenosquamous_Carcinoma Vaginal Adenosquamous Cancer Vaginal Adenosquamous Carcinoma Vaginal Adenosquamous Carcinoma An adenoid cystic carcinoma that arises from the vagina. Myoepithelial cells are usually not present. C40261 Neoplastic Process Vaginal Adenoid Cystic Carcinoma Vaginal Adenoid Cystic Carcinoma C1519912 CTRP Malignant Vaginal_Adenoid_Cystic_Carcinoma Vaginal Adenoid Cystic Cancer Vaginal Adenoid Cystic Carcinoma Vaginal Adenoid Cystic Carcinoma A carcinoma that arises from the vagina and is characterized by the presence of nests of basaloid cells with focal glandular formations. C40262 Neoplastic Process Vaginal Adenoid Basal Carcinoma Vaginal Adenoid Basal Carcinoma C1519911 CTRP Malignant Vaginal_Adenoid_Basal_Carcinoma Vaginal Adenoid Basal Cancer Vaginal Adenoid Basal Carcinoma Vaginal Adenoid Basal Carcinoma A rare small cell neuroendocrine carcinoma that arises from the vagina. C40263 Neoplastic Process Vaginal Small Cell Neuroendocrine Carcinoma C1519929 Malignant Vaginal_Small_Cell_Carcinoma Vaginal Small Cell Carcinoma Vaginal Small Cell Neuroendocrine Carcinoma Vaginal Small Cell Neuroendocrine Carcinoma A carcinoma that arises from the vagina and is characterized by the lack of specific cellular differentiation. C40264 Neoplastic Process Vaginal Undifferentiated Carcinoma Vaginal Undifferentiated Carcinoma C1519934 CTRP Malignant Vaginal_Undifferentiated_Carcinoma Undifferentiated Vaginal Cancer Vaginal Undifferentiated Carcinoma Vaginal Undifferentiated Carcinoma A benign or malignant mesenchymal neoplasm that arises from the vagina. Representative examples include leiomyoma, rhabdomyoma, leiomyosarcoma, endometrioid stromal sarcoma, and botryoid-type embryonal rhabdomyosarcoma. C40265 Neoplastic Process Vaginal Soft Tissue Neoplasm C1519930 Undetermined Vaginal_Soft_Tissue_Neoplasm Vaginal Soft Tissue Neoplasm Vaginal Soft Tissue Tumor Vaginal Soft Tissue Neoplasm A rare benign skeletal muscle neoplasm arising from the cervix. It is characterized by the presence of small nucleated rhabdomyoblasts within a fibrous and myxoid stroma. C40266 Neoplastic Process Cervical Rhabdomyoma C1516430 Benign Cervical_Rhabdomyoma Cervical Rhabdomyoma Cervical Rhabdomyoma A morphologic variant of embryonal rhabdomyosarcoma arising from the vagina. It is characterized by the formation of a cambium layer in the affected tissue and polypoid nodules with an abundant myxoid stroma. It occurs in female adults. C40267 Neoplastic Process Adult Vaginal Botryoid-Type Embryonal Rhabdomyosarcoma C1515893 Malignant Adult_Botryoid-Type_Embryonal_Rhabdomyosarcoma_of_the_Vagina Adult Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina Adult Sarcoma Botryoides of the Vagina Adult Vaginal Botryoid-Type Embryonal Rhabdomyosarcoma Adult Vaginal Embryonal Rhabdomyosarcoma Adult Vaginal Botryoid-Type Embryonal Rhabdomyosarcoma A morphologic variant of embryonal rhabdomyosarcoma arising from the vagina. It is characterized by the formation of a cambium layer in the affected tissue and polypoid nodules within an abundant myxoid stroma. C40268 Neoplastic Process Vaginal Botryoid-Type Embryonal Rhabdomyosarcoma C1511275 Malignant Botryoid-Type_Embryonal_Rhabdomyosarcoma_of_the_Vagina Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina Sarcoma Botryoides of the Vagina Vaginal Botryoid-Type Embryonal Rhabdomyosarcoma Vaginal Embryonal Rhabdomyosarcoma Vaginal Botryoid-Type Embryonal Rhabdomyosarcoma A category of rare neoplasms that arise from the vagina. It includes low grade endometrioid stromal sarcoma and undifferentiated sarcoma. C40269 Neoplastic Process Vaginal Endometrioid Stromal and Related Neoplasms C3642328 Undetermined Endometrial_Stromal_Neoplasm_of_the_Vagina Endometrioid Stromal and Related Neoplasms of the Vagina Endometrioid Stromal and Related Tumors of the Vagina Vaginal Endometrioid Stromal and Related Neoplasms Vaginal Endometrioid Stromal and Related Tumors Vaginal Endometrioid Stromal and Related Neoplasms An uncommon intraepithelial malignant neoplasm of eccrine or apocrine origin, arising from the vulva. It usually affects post-menopausal women. In approximately 10-20% of the cases there is an associated anorectal, or urothelial carcinoma or a skin appendage adenocarcinoma identified. It presents as a red, eczematous lesion. Microscopically, it is characterized by the presence of the typical Paget cells which are large, round cells with abundant cytoplasm and prominent nuclei. C4027 Neoplastic Process Paget Disease of the Vulva Vulvar Paget Disease C1275217 CTRP Malignant Vulvar_Paget_s_Disease Paget Disease of the Vulva Paget's Disease of Vulva Paget's Disease of the Vulva Vulva Paget's Disease Vulvar Paget Disease Vulvar Paget's Disease Vulvar Paget Disease An infiltrating sarcoma that arises from the vagina. It is characterized by the presence of cells that resemble endometrial stromal cells. C40271 Neoplastic Process Vaginal Low Grade Endometrioid Stromal Sarcoma C3642330 Malignant Low_Grade_Endometrial_Stromal_Sarcoma_of_the_Vagina Endometrioid Stromal Sarcoma of the Vagina Low Grade Endometrioid Stromal Sarcoma of the Vagina Vaginal Endometrioid Stromal Sarcoma Vaginal Low Grade Endometrioid Stromal Sarcoma Vaginal Low Grade Endometrioid Stromal Sarcoma A high grade infiltrating sarcoma that arises from the vagina. It is characterized by the presence of malignant small spindle cells with scant cytoplasm. C40272 Neoplastic Process Vaginal Undifferentiated Sarcoma C1519935 Malignant Vaginal_Undifferentiated_Sarcoma Vaginal Undifferentiated Sarcoma Vaginal Undifferentiated Sarcoma A locally infiltrating, non-metastasizing vaginal angiomyxoma. It may recur following resection. C40273 Neoplastic Process Vaginal Deep (Aggressive) Angiomyxoma C1519919 Benign Vaginal_Deep_Angiomyxoma Vaginal Aggressive Angiomyxoma Vaginal Deep "Aggressive" Angiomyxoma Vaginal Deep (Aggressive) Angiomyxoma Vaginal Deep Angiomyxoma Vaginal Deep (Aggressive) Angiomyxoma A benign or malignant neoplasm that arises from the vagina and is characterized by the presence of epithelial and mesenchymal elements. This category includes benign mixed tumor, adenosarcoma, carcinosarcoma, and malignant mixed tumor resembling synovial sarcoma. C40274 Neoplastic Process Vaginal Mixed Epithelial and Mesenchymal Neoplasm C1519924 Undetermined Vaginal_Mixed_Epithelial_and_Mesenchymal_Neoplasm Vaginal Mixed Epithelial and Mesenchymal Neoplasm Vaginal Mixed Epithelial and Mesenchymal Tumor Vaginal Mixed Epithelial and Mesenchymal Neoplasm A non-metastasizing neoplasm that arises from the vagina and is characterized by the presence of benign epithelial and benign mesenchymal elements. C40275 Neoplastic Process Benign Vaginal Mixed Epithelial and Mesenchymal Neoplasm C1511106 Benign Benign_Vaginal_Mixed_Epithelial_and_Mesenchymal_Neoplasm Benign Vaginal Mixed Epithelial and Mesenchymal Neoplasm Benign Vaginal Mixed Epithelial and Mesenchymal Tumor Benign Vaginal Mixed Epithelial and Mesenchymal Neoplasm A malignant neoplasm that arises from the vagina and is characterized by the presence of an epithelial and a mesenchymal component. This category includes adenosarcoma, carcinosarcoma, and malignant mixed tumor resembling synovial sarcoma. C40276 Neoplastic Process Malignant Vaginal Mixed Epithelial and Mesenchymal Neoplasm C1512974 Malignant Malignant_Vaginal_Mixed_Epithelial_and_Mesenchymal_Neoplasm Malignant Vaginal Mixed Epithelial and Mesenchymal Neoplasm Malignant Vaginal Mixed Epithelial and Mesenchymal Tumor Malignant Vaginal Mixed Epithelial and Mesenchymal Neoplasm A malignant mixed epithelial and mesenchymal neoplasm that arises from the vagina and is characterized by the presence of a malignant mesenchymal component and a benign or atypical mullerian-type epithelial component. C40277 Neoplastic Process Vaginal Adenosarcoma C1519914 Malignant Vaginal_Adenosarcoma Vaginal Adenosarcoma Vaginal Mullerian Adenosarcoma Vaginal Müllerian Adenosarcoma Vaginal Adenosarcoma An aggressive mixed epithelial and mesenchymal neoplasm that arises from the vagina and is characterized by the presence of a malignant epithelial component and a malignant mesenchymal component. C40278 Neoplastic Process Vaginal Carcinosarcoma C1519918 Malignant Vaginal_Carcinosarcoma Vaginal Carcinosarcoma Vaginal Malignant Mixed Mesodermal (Mullerian) Tumor Vaginal Malignant Mixed Mesodermal (Müllerian) Tumor Vaginal Carcinosarcoma A very rare malignant mixed epithelial and mesenchymal neoplasm that arises from the vagina and resembles synovial sarcoma. It is characterized by a biphasic pattern and is composed of gland-like structures that are lined by epithelial cells and a cellular mesenchymal component. C40279 Neoplastic Process Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma C1512975 Malignant Malignant_Vaginal_Mixed_Tumor_Resembling_Synovial_Sarcoma Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma A squamous cell carcinoma arising from the cervical epithelium. It usually evolves from a precancerous cervical lesion. Increased numbers of sexual partners and human papillomavirus (HPV) infection are risk factors for cervical squamous cell carcinoma. Survival is most closely related to the stage of disease at the time of diagnosis. C4028 Neoplastic Process Cervical Squamous Cell Carcinoma, Not Otherwise Specified Cervical Squamous Cell Carcinoma C0279671 CTEP CTRP Malignant Cervical_Squamous_Cell_Carcinoma Cervical Squamous Cell Cancer Cervical Squamous Cell Carcinoma Cervix Squamous Cell Carcinoma Cervix Uteri Squamous Cell Carcinoma Squamous Cell Carcinoma of Cervix Squamous Cell Carcinoma of Cervix Uteri Squamous Cell Carcinoma of Uterine Cervix Squamous Cell Carcinoma of the Cervix Squamous Cell Carcinoma of the Cervix Uteri Squamous Cell Carcinoma of the Uterine Cervix Squamous cervical cancer Uterine Cervix Squamous Cell Carcinoma Cervical Squamous Cell Carcinoma A non-metastasizing, well circumscribed neoplasm that arises from the vagina and is characterized by the presence of a predominant benign mesenchymal component and benign glandular or squamous epithelial cells. C40280 Neoplastic Process Benign Vaginal Mixed Tumor C1511107 Benign Benign_Vaginal_Mixed_Tumor Benign Vaginal Mixed Tumor Vaginal Spindle Cell Epithelioma Benign Vaginal Mixed Tumor A neoplasm that arises from the vagina and is characterized by the proliferation of nests of benign melanocytes. C40281 Neoplastic Process Benign Vaginal Melanocytic Nevus C1511105 Benign Benign_Vaginal_Melanocytic_Nevus Benign Vaginal Melanocytic Nevus Benign Vaginal Melanocytic Nevus A neoplasm that arises from the vagina and is characterized by the proliferation of subepithelial benign dendritic melanocytes. C40282 Neoplastic Process Vaginal Blue Nevus C1519917 Benign Vaginal_Blue_Nevus Vaginal Blue Nevus Vaginal Blue Nevus A benign, precancerous, or malignant neoplasm that arises from the squamous epithelium of the vulva. Representative examples include vestibular papilloma, intraepithelial neoplasia, and squamous cell carcinoma. C40283 Neoplastic Process Vulvar Squamous Neoplasm C1520097 Undetermined Vulvar_Squamous_Neoplasm Vulvar Squamous Neoplasm Vulvar Squamous Tumor Vulvar Squamous Neoplasm A squamous cell carcinoma that arises from the vulva and is characterized by the presence of keratin pearls. C40284 Neoplastic Process Vulvar Keratinizing Squamous Cell Carcinoma C2109334 Malignant Vulvar_Keratinizing_Squamous_Cell_Carcinoma Vulvar Keratinizing Squamous Cell Carcinoma Vulvar Keratinizing Squamous Cell Carcinoma A squamous cell carcinoma that arises from the vulva and is characterized by the absence of keratin pearls. C40285 Neoplastic Process Vulvar Non-Keratinizing Squamous Cell Carcinoma C1520092 Malignant Vulvar_Non-Keratinizing_Squamous_Cell_Carcinoma Vulvar Non-Keratinizing Squamous Cell Carcinoma Vulvar Non-Keratinizing Squamous Cell Carcinoma A squamous cell carcinoma that arises from the vulva and is characterized by the presence of nests of malignant basaloid cells with a scant amount of cytoplasm. C40286 Neoplastic Process Vulvar Basaloid Squamous Cell Carcinoma C2211850 Malignant Vulvar_Basaloid_Carcinoma Vulvar Basaloid Carcinoma Vulvar Basaloid Squamous Cell Carcinoma Vulvar Basaloid Squamous Cell Carcinoma A squamous cell carcinoma that arises from the vulva and is characterized by the presence of a warty surface and cellular changes that are caused by human papillomavirus infection. C40287 Neoplastic Process Vulvar Warty Carcinoma C1520102 Malignant Vulvar_Warty_Carcinoma Vulvar Condylomatous Carcinoma Vulvar Warty Carcinoma Vulvar Warty Carcinoma An aggressive squamous cell carcinoma that arises from the vulva and is characterized by the prominence of malignant giant cells. C40289 Neoplastic Process Vulvar Squamous Cell Carcinoma with Tumor Giant Cells C1520096 Malignant Vulvar_Squamous_Cell_Carcinoma_with_Tumor_Giant_Cells Vulvar Squamous Cell Carcinoma with Tumor Giant Cells Vulvar Squamous Cell Carcinoma with Tumor Giant Cells An adenocarcinoma arising from the endocervical glandular epithelium. It is classified as either human papillomavirus-related or human papillomavirus-independent adenocarcinoma. Histologic variants include usual-type, mucinous, mesonephric, serous, clear cell, and endometrioid adenocarcinoma. C4029 Neoplastic Process Cervical Adenocarcinoma Endocervical Carcinoma Cervical Adenocarcinoma C0279672 CPTAC CTEP CTRP Cellosaurus Malignant Cervical_Adenocarcinoma Endocervical_Carcinoma Adenocarcinoma Adenocarcinoma - cervix Adenocarcinoma of Cervix Adenocarcinoma of Cervix Uteri Adenocarcinoma of Uterine Cervix Adenocarcinoma of the Cervix Adenocarcinoma of the Cervix Uteri Adenocarcinoma of the Uterine Cervix Adenocarcinoma of the cervix Carcinoma of Endocervix Carcinoma of the Endocervix Cervical Adenocarcinoma Cervix Adenocarcinoma Cervix Uteri Adenocarcinoma Endocervical Adenocarcinoma Endocervical Cancer Endocervical Carcinoma Uterine Cervix Adenocarcinoma Cervical Adenocarcinoma A benign neoplastic process characterized by the presence of multiple vestibular papillomas in the vulva. C40290 Neoplastic Process Vulvar Squamous Papillomatosis C1519982 Benign Vestibular_Micropapillomatosis Micropapillomatosis Labialis Vestibular Micropapillomatosis Vulvar Squamous Cell Papillomatosis Vulvar Squamous Papillomatosis Vulvar Squamous Papillomatosis Seborrheic keratosis that arises from follicular structures in the vulva. It is characterized by the presence of prominent squamous eddies. C40291 Neoplastic Process Vulvar Inverted Follicular Keratosis C1520084 Benign Vulvar_Inverted_Follicular_Keratosis Vulvar Inverted Follicular Keratosis Vulvar Inverted Follicular Keratosis A benign or malignant neoplasm that arises from the vulva and is composed of glandular epithelial cells. Representative examples include adenoma of the minor vestibular glands, Bartholin gland adenoma, and Bartholin gland adenocarcinoma. C40292 Neoplastic Process Vulvar Glandular Neoplasm C1520082 Undetermined Vulvar_Glandular_Neoplasm Vulvar Glandular Neoplasm Vulvar Glandular Tumor Vulvar Glandular Neoplasm A carcinoma that arises from the Bartholin gland and is characterized by the presence of malignant squamous epithelial cells. C40293 Neoplastic Process Bartholin Gland Squamous Cell Carcinoma C1511052 Malignant Bartholin_s_Gland_Squamous_Cell_Carcinoma Bartholin Gland Squamous Cell Carcinoma Bartholin's Gland Squamous Cell Carcinoma Bartholin Gland Squamous Cell Carcinoma A carcinoma that arises from the Bartholin gland and is characterized by the presence of islands of uniform malignant cells forming cribriform patterns. C40295 Neoplastic Process Bartholin Gland Adenoid Cystic Carcinoma C1511047 Malignant Bartholin_s_Gland_Adenoid_Cystic_Carcinoma Bartholin Gland Adenoid Cystic Carcinoma Bartholin's Gland Adenoid Cystic Carcinoma Bartholin Gland Adenoid Cystic Carcinoma A carcinoma that arises from the Bartholin gland and is characterized by the presence of malignant glandular epithelial cells and malignant squamous epithelial cells. C40296 Neoplastic Process Bartholin Gland Adenosquamous Carcinoma C1511050 Malignant Bartholin_s_Gland_Adenosquamous_Carcinoma Bartholin Gland Adenosquamous Carcinoma Bartholin's Gland Adenosquamous Carcinoma Bartholin Gland Adenosquamous Carcinoma A rare carcinoma that arises from the Bartholin gland and is characterized by the presence of malignant urothelial-type epithelial cells. C40297 Neoplastic Process Bartholin Gland Transitional Cell Carcinoma C1511053 Malignant Bartholin_s_Gland_Transitional_Cell_Carcinoma Bartholin Gland Transitional Cell Carcinoma Bartholin's Gland Transitional Cell Carcinoma Bartholin Gland Transitional Cell Carcinoma A rare small cell neuroendocrine carcinoma that arises from the Bartholin gland. C40298 Neoplastic Process Bartholin Gland Small Cell Neuroendocrine Carcinoma C1511051 Malignant Bartholin_s_Gland_Small_Cell_Carcinoma Bartholin Gland Small Cell Carcinoma Bartholin Gland Small Cell Neuroendocrine Carcinoma Bartholin's Gland Small Cell Carcinoma Bartholin Gland Small Cell Neuroendocrine Carcinoma A rare, benign neoplasm that arises from the Bartholin gland and is characterized by the presence of clustered glands and tubules lined by mucin-secreting epithelial cells. C40299 Neoplastic Process Bartholin Gland Adenoma C1511048 Benign Bartholin_s_Gland_Adenoma Bartholin Gland Adenoma Bartholin's Gland Adenoma Bartholin Gland Adenoma A carcinoma arising from the urothelial lining of the urinary tract (bladder, renal pelvis, ureter, or urethra). C4030 Neoplastic Process Urothelial Carcinoma C2145472 CTEP GDC Malignant Urothelial_Transitional_Cell_Carcinoma 8120/3 Urothelial carcinoma, NOS Transitional Cell Carcinoma of the Urinary Tract Transitional cell car. -uroth. Transitional cell carcinoma of the urothelial tract Uroepithelial Carcinoma Urothelial Carcinoma Urothelial carcinoma, NOS Urothelial tract/bladder cancer, NOS Urothelial/bladder cancer, NOS Urothelial Carcinoma A rare, benign neoplasm that arises from the Bartholin gland and is characterized by the presence of a fibromuscular stroma and glands lined by mucin-secreting epithelial cells, arranged in a lobular architecture. C40300 Neoplastic Process Bartholin Gland Adenomyoma C1511049 Benign Bartholin_s_Gland_Adenomyoma Bartholin Gland Adenomyoma Bartholin's Gland Adenomyoma Bartholin Gland Adenomyoma A rare, benign neoplasm that arises from the vulva It is characterized by the presence of clusters of small glands lined by mucinous epithelial cells. Bartholin duct structures are not present. C40301 Neoplastic Process Adenoma of Minor Vestibular Glands C1510791 Benign Adenoma_of_Minor_Vestibular_Glands Adenoma of Minor Vestibular Glands Adenoma of Minor Vestibular Glands A benign neoplasm that arises from the vulva and is characterized by the presence of epithelial cells forming nests and tubules in a fibrotic stroma. It may recur locally and complete excision is recommended. C40302 Neoplastic Process Benign Mixed Tumor of the Vulva C1511091 Benign Benign_Mixed_Tumor_of_the_Vulva Benign Mixed Tumor of the Vulva Chondroid Syringoma of the Vulva Vulvar Chondroid Syringoma Benign Mixed Tumor of the Vulva A benign or malignant vulvar neoplasm with differentiating characteristics towards sweat or sebaceous glands or hair follicles. Representative examples include trichoepithelioma, syringoma, and eccrine adenocarcinoma. C40303 Neoplastic Process Vulvar Neoplasm of Skin Appendage Origin C1520101 Undetermined Vulvar_Tumor_of_Skin_Appendage_Origin Vulvar Neoplasm of Skin Appendage Origin Vulvar Tumor of Skin Appendage Origin Vulvar Neoplasm of Skin Appendage Origin A malignant neoplasm that arises from sweat glands in the vulva. Representative examples include eccrine adenocarcinoma, apocrine adenocarcinoma, and Paget disease. C40304 Neoplastic Process Malignant Vulvar Sweat Gland Neoplasm C1512976 Malignant Malignant_Vulvar_Sweat_Gland_Neoplasm Malignant Vulvar Sweat Gland Neoplasm Malignant Vulvar Sweat Gland Neoplasm An eccrine adenocarcinoma that arises from the sweat glands in the vulva. C40305 Neoplastic Process Vulvar Eccrine Adenocarcinoma C2202743 Malignant Vulvar_Eccrine_Adenocarcinoma Vulvar Eccrine Adenocarcinoma Vulvar Eccrine Adenocarcinoma A porocarcinoma that arises from the sweat glands in the vulva. C40306 Neoplastic Process Vulvar Porocarcinoma C1520081 Malignant Vulvar_Eccrine_Porocarcinoma Vulvar Eccrine Porocarcinoma Vulvar Porocarcinoma Vulvar Porocarcinoma A vulvar sweat gland carcinoma characterized by the presence of clear cells. C40307 Neoplastic Process Vulvar Clear Cell Hidradenocarcinoma C1520076 Malignant Vulvar_Clear_Cell_Hidradenocarcinoma Vulvar Clear Cell Hidradenocarcinoma Vulvar Clear Cell Hidradenocarcinoma An apocrine adenocarcinoma that arises from the sweat glands in the vulva. C40308 Neoplastic Process Vulvar Apocrine Adenocarcinoma C2202741 Malignant Vulvar_Apocrine_Adenocarcinoma Vulvar Apocrine Adenocarcinoma Vulvar Apocrine Adenocarcinoma A carcinoma that arises from the vulva. It is characterized by the presence of malignant basaloid glandular epithelial cells that resemble sebaceous epithelium and are arranged in cords and nests. C40309 Neoplastic Process Vulvar Sebaceous Carcinoma C1520094 Malignant Vulvar_Sebaceous_Carcinoma Vulvar Sebaceous Carcinoma Vulvar Sebaceous Carcinoma A squamous cell carcinoma of the bladder arising from metaplastic epithelium. It represents less than 10% of bladder carcinomas. The exception is the Middle East along the Nile Valley, where it represents the most common form of carcinoma because of the endemic nature of schistosomiasis. Bladder squamous cell carcinoma is often associated with long-standing chronic inflammation of the bladder and usually has a poor prognosis. The diagnosis of squamous cell carcinoma of the bladder should be reserved for those tumors that are predominantly keratin forming. C4031 Neoplastic Process Bladder Squamous Cell Carcinoma Bladder Squamous Cell Carcinoma C0279681 CTRP Cellosaurus Malignant Bladder_Squamous_Cell_Carcinoma Bladder Epidermoid Carcinoma Bladder Squamous Cell Cancer Bladder Squamous Cell Carcinoma Epidermoid Carcinoma of Bladder Epidermoid Carcinoma of Urinary Bladder Epidermoid Carcinoma of the Bladder Epidermoid Carcinoma of the Urinary Bladder Squamous Cell Carcinoma of Bladder Squamous Cell Carcinoma of Urinary Bladder Squamous Cell Carcinoma of the Bladder Squamous Cell Carcinoma of the Urinary Bladder Urinary Bladder Epidermoid Carcinoma Urinary Bladder Squamous Cell Carcinoma Bladder Squamous Cell Carcinoma An adenocarcinoma with sebaceous differentiation. It presents as a painless mass and it may be multifocal. It grows in the ocular adnexae and in the skin of head and neck, trunk, genitals, and extremities. It is characterized by the presence of malignant cells with multivesicular and clear cytoplasm. It may recur and metastasize. C40310 Neoplastic Process Sebaceous Carcinoma Sebaceous Carcinoma C0206684 CDISC CTRP GDC A malignant adenocarcinoma with sebaceous differentiation. 8410/3 Malignant Sebaceous_Carcinoma 8410/3 Sebaceous adenocarcinoma Sebaceous carcinoma ADENOCARCINOMA, SEBACEOUS, MALIGNANT Carcinoma of Sebaceous Gland Carcinoma of the Sebaceous Gland Carcinoma, Sebaceous Cell Sebaceous Adenocarcinoma Sebaceous Cancer Sebaceous Carcinoma Sebaceous Gland Carcinoma Sebaceous carcinoma Sebaceous Carcinoma A benign neoplasm that arises from eccrine ducts in the vulva and is characterized by the presence of tubules and cysts which are lined by epithelial cells in the densely fibrotic dermis. C40311 Neoplastic Process Vulvar Syringoma C1520099 Benign Vulvar_Syringoma Vulvar Syringoma Vulvar Syringoma A nodular hidradenoma that arises from the vulva. C40312 Neoplastic Process Vulvar Nodular Hidradenoma C1520091 Benign Vulvar_Nodular_Hidradenoma Vulvar Nodular Hidradenoma Vulvar Nodular Hidradenoma A benign neoplasm that arises from the vulva and is characterized by the presence of nests of monomorphic basaloid cells forming small cysts that contain keratin. C40314 Neoplastic Process Vulvar Trichoblastoma C1520100 Benign Vulvar_Trichoepithelioma Vulvar Trichoblastoma Vulvar Trichoepithelioma Vulvar Trichoblastoma An astrocytic tumor of uncertain relation to pilocytic astrocytoma. It occurs predominantly in infants and young children. It is characterized by a monomorphic architectural pattern, usually associated with the absence of Rosenthal fibers and eosinophilic granular bodies. The clinical course is usually aggressive. C40315 Neoplastic Process Pilomyxoid Astrocytoma C1519086 GDC 9425/3 Undetermined Pilomyxoid_Astrocytoma 9425/3 Pilomyxoid astrocytoma Pilomyxoid Astrocytoma Pilomyxoid astrocytoma Pilomyxoid Astrocytoma A benign or malignant mesenchymal neoplasm of the vulva. Representative examples include leiomyoma, cellular angiofibroma, angiomyxoma, leiomyosarcoma, liposarcoma, and childhood botryoid-type embryonal rhabdomyosarcoma. C40316 Neoplastic Process Vulvar Soft Tissue Neoplasm C1520095 Undetermined Vulvar_Soft_Tissue_Neoplasm Vulvar Soft Tissue Neoplasm Vulvar Soft Tissue Tumor Vulvar Soft Tissue Neoplasm A malignant mesenchymal neoplasm that arises from the vulva. Representative examples include childhood botryoid-type embryonal rhabdomyosarcoma, alveolar soft part sarcoma, and leiomyosarcoma. C40317 Neoplastic Process Vulvar Sarcoma C0238525 Malignant Vulvar_Sarcoma Vulvar Sarcoma Vulvar Sarcoma An aggressive malignant smooth muscle neoplasm, arising from the vulva. It is characterized by a proliferation of neoplastic spindle cells. C40318 Neoplastic Process Vulvar Leiomyosarcoma C2168304 Cellosaurus Malignant Vulvar_Leiomyosarcoma Vulvar Leiomyosarcoma Vulvar Leiomyosarcoma An epithelioid sarcoma of the proximal type that arises from the vulva. C40319 Neoplastic Process Vulvar Proximal-Type Epithelioid Sarcoma C1520093 Malignant Vulvar_Proximal-Type_Epithelioid_Sarcoma Vulvar Proximal-Type Epithelioid Sarcoma Vulvar Proximal-Type Epithelioid Sarcoma A rare adenocarcinoma arising from metaplastic bladder epithelium. It is frequently associated with long-standing local irritation. The majority of cases originate from the trigone and the posterior wall of the bladder. This group does not include clear cell and endometrioid adenocarcinomas. C4032 Neoplastic Process Bladder Adenocarcinoma Bladder Adenocarcinoma C0279682 CTRP Malignant Bladder_Adenocarcinoma Adenocarcinoma of Bladder Adenocarcinoma of Urinary Bladder Adenocarcinoma of the Bladder Adenocarcinoma of the Urinary Bladder Bladder Adenocarcinoma Bladder Adenocarcinoma Excluding Clear Cell Adenocarcinoma and Endometrioid Adenocarcinoma Urinary Bladder Adenocarcinoma Bladder Adenocarcinoma An alveolar soft part sarcoma arising from the vulva. C40320 Neoplastic Process Vulvar Alveolar Soft Part Sarcoma C1520069 Malignant Vulvar_Alveolar_Soft_Part_Sarcoma Vulvar Alveolar Soft Part Sarcoma Vulvar Alveolar Soft Part Sarcoma A rare liposarcoma that arises from the vulva. C40321 Neoplastic Process Vulvar Liposarcoma C2184082 Malignant Vulvar_Liposarcoma Vulvar Liposarcoma Vulvar Liposarcoma A locally infiltrating, non-metastasizing vulvar angiomyxoma. It may recur following resection. C40322 Neoplastic Process Vulvar Deep (Aggressive) Angiomyxoma C1520078 Benign Vulvar_Deep_Angiomyxoma Vulvar Aggressive Angiomyxoma Vulvar Deep "Aggressive" Angiomyxoma Vulvar Deep (Aggressive) Angiomyxoma Vulvar Deep Angiomyxoma Vulvar Deep (Aggressive) Angiomyxoma An angiomyxoma arising from the dermis or subcutaneous tissues. It may recur following resection. C40323 Neoplastic Process Superficial Angiomyxoma C1275280 Benign Superficial_Angiomyxoma Superficial Angiomyxoma Superficial Angiomyxoma A vulvar angiomyxoma arising from the dermis or subcutaneous tissues. It may recur following resection. C40324 Neoplastic Process Vulvar Superficial Angiomyxoma C1520098 Benign Vulvar_Superficial_Angiomyxoma Vulvar Superficial Angiomyxoma Vulvar Superficial Angiomyxoma A deep or superficial angiomyxoma of the vulva. It may recur following resection. C40325 Neoplastic Process Vulvar Angiomyxoma C1520070 Benign Vulvar_Angiomyxoma Vulvar Angiomyxoma Vulvar Angiomyxoma A benign smooth muscle neoplasm arising from the vulva. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C40326 Neoplastic Process Vulvar Leiomyoma C1520087 Benign Vulvar_Leiomyoma Vulvar Leiomyoma Vulvar Leiomyoma A benign neoplasm arising from the fibrous tissue of the vulva. It is characterized by the presence of spindle-shaped fibroblasts, numerous dilated vascular channels, and increased cellularity. C40327 Neoplastic Process Vulvar Cellular Angiofibroma C1520075 Benign Vulvar_Cellular_Angiofibroma Vulvar Cellular Angiofibroma Vulvar Cellular Angiofibroma A usually benign granular cell tumor that arises from the vulva. C40328 Neoplastic Process Vulvar Granular Cell Tumor C1520083 Undetermined Vulvar_Granular_Cell_Tumor Vulvar Granular Cell Tumor Vulvar Granular Cell Tumor A usually pigmented, nodular or polypoid malignant neoplasm that originates from melanocytes and arises from the vulva. It presents with bleeding and dysuria. C40329 Neoplastic Process Vulvar Melanoma C0241989 Cellosaurus Malignant Vulvar_Melanoma Vulvar Melanoma Vulvar Melanoma A malignant epithelial neoplasm of the kidney characterized by the presence of lipid-containing clear cells within a vascular network. The tumor may metastasize to unusual sites and late metastasis is common. C4033 Neoplastic Process Clear Cell Renal Cell Carcinoma Clear Cell Renal Cell Carcinoma C4225533 CPTAC CTEP CTRP Cellosaurus GDC The most common type of kidney cancer. It begins in the lining of the renal tubules in the kidney. The renal tubules filter the blood and produce urine. Malignant Conventional_Clear_Cell_Renal_Cell_Carcinoma 50 63 64 65 70 8311/1 8312/3 Grawitz tumor Hypernephroid tumor Hypernephroma CCRCC Clear Cell Adenocarcinoma of Kidney Clear Cell Adenocarcinoma of the Kidney Clear Cell Adenocarcinoma, Kidney Clear Cell Carcinoma of Kidney Clear Cell Carcinoma of the Kidney Clear Cell RCC Clear Cell Renal Cell Cancer Clear Cell Renal Cell Carcinoma Conventional (Clear Cell) Renal Cell Adenocarcinoma Conventional (Clear Cell) Renal Cell Carcinoma Conventional Renal Cell Carcinoma Grawitz Tumor Grawitz tumor Hypernephroid tumor Hypernephroma Kidney Clear Cell Adenocarcinoma Kidney Clear Cell Carcinoma RCC, clear cell adenocarcinoma Renal Clear Cell Adenocarcinoma Renal Clear Cell Carcinoma Renal cell carcinoma, clear cell adenocarcinoma hypernephroma Clear Cell Renal Cell Carcinoma A benign nevus that arises from the vulva and is present at birth. C40330 Neoplastic Process Vulvar Congenital Melanocytic Nevus C1520077 Benign Vulvar_Congenital_Melanocytic_Nevus Vulvar Congenital Melanocytic Nevus Vulvar Congenital Nevus Vulvar Congenital Melanocytic Nevus A benign nevus that arises from the vulva during childhood and grows with increasing age. C40331 Neoplastic Process Vulvar Acquired Melanocytic Nevus C1520068 Benign Vulvar_Acquired_Melanocytic_Nevus Vulvar Acquired Melanocytic Nevus Vulvar Acquired Melanocytic Nevus A benign nevus that arises from the vulva and is characterized by the presence of heavily pigmented dendritic melanocytes exclusively in the dermis. C40332 Neoplastic Process Vulvar Blue Nevus C1520074 Benign Vulvar_Blue_Nevus Vulvar Blue Nevus Vulvar Blue Nevus A small, well circumscribed melanocytic neoplasm that arises from the vulva and affects women in their reproductive years. It is characterized by the presence of junctional nests of melanocytes. Some of the superficial melanocytes show atypia. During pregnancy the atypical melanocytic changes may appear more prominent. This neoplasm is not associated with the presence of dysplastic nevi in other anatomic areas. C40333 Neoplastic Process Atypical Melanocytic Nevus of Genital Type C1520072 Undetermined Vulvar_Atypical_Melanocytic_Nevus_of_the_Genital_Type AMNGT Atypical Melanocytic Nevus of Genital Type Atypical Melanocytic Nevus of the Genital Type Atypical Melanocytic Nevus, Genital Type Atypical Vulvar Nevus Atypical Melanocytic Nevus of Genital Type A rare, elevated and pigmented, compound or junctional nevus that arises from the vulva. It affects women in their reproductive years and may be associated with the presence of dysplastic nevi in other anatomic areas. It is characterized by the presence of epithelioid or spindle-shaped melanocytes exhibiting nuclear pleomorphism and prominent nucleoli. C40334 Neoplastic Process Vulvar Dysplastic Melanocytic Nevus C1520079 Undetermined Vulvar_Dysplastic_Melanocytic_Nevus Vulvar Dysplastic Melanocytic Nevus Vulvar Dysplastic Melanocytic Nevus A neoplasm that originates from melanocytes and arises from the vulva. This category includes congenital and acquired melanocytic nevus, blue nevus, dysplastic melanocytic nevus, atypical melanocytic nevus of genital type, and melanoma. C40335 Neoplastic Process Vulvar Melanocytic Neoplasm C1520090 Undetermined Vulvar_Melanocytic_Neoplasm Vulvar Melanocytic Neoplasm Vulvar Melanocytic Neoplasm A gastrointestinal stromal tumor that arises from the retroperitoneum. This is an extragastrointestinal tumor, meaning that it does not arise directly from the gastrointestinal tract. C40337 Neoplastic Process Retroperitoneal Gastrointestinal Stromal Tumor C1514920 Undetermined Retroperitoneal_Gastrointestinal_Stromal_Tumor Retroperitoneal EGIST Retroperitoneal Extragastrointestinal Stromal Tumor Retroperitoneal Gastrointestinal Stromal Tumor Retroperitoneal Gastrointestinal Stromal Tumor A gastrointestinal stromal tumor that arises from the peritoneum. This is an extragastrointestinal tumor, meaning that it does not arise directly from the gastrointestinal tract. C40338 Neoplastic Process Peritoneal Gastrointestinal Stromal Tumor Peritoneal Gastrointestinal Stromal Tumor C1519009 CTRP Undetermined Peritoneal_Gastrointestinal_Stromal_Tumor Peritoneal EGIST Peritoneal Extragastrointestinal Stromal Tumor Peritoneal Gastrointestinal Stromal Tumor Peritoneal Gastrointestinal Stromal Tumor (GIST) Peritoneal Gastrointestinal Stromal Tumor A gastrointestinal stromal tumor that arises from the mesentery. This is an extragastrointestinal tumor, meaning that it does not arise directly from the gastrointestinal tract. C40339 Neoplastic Process Mesenteric Gastrointestinal Stromal Tumor Mesenteric Gastrointestinal Stromal Tumor C1513146 CTRP Undetermined Mesenteric_Gastrointestinal_Stromal_Tumor Mesenteric EGIST Mesenteric Extragastrointestinal Stromal Tumor Mesenteric Gastrointestinal Stromal Tumor Mesenteric Gastrointestinal Stromal Tumor (GIST) Mesenteric Gastrointestinal Stromal Tumor The reemergence of laryngeal carcinoma after a period of remission. C4034 Neoplastic Process Recurrent Laryngeal Carcinoma Recurrent Laryngeal Carcinoma C0279818 CTRP Malignant Recurrent_Laryngeal_Carcinoma Recurrent Carcinoma of Larynx Recurrent Carcinoma of the Larynx Recurrent Laryngeal Cancer Recurrent Laryngeal Carcinoma Recurrent Laryngeal Throat Cancer Recurrent Larynx Cancer Recurrent Larynx Carcinoma Relapsed Carcinoma of Larynx Relapsed Carcinoma of the Larynx Relapsed Laryngeal Carcinoma Relapsed Larynx Carcinoma Recurrent Laryngeal Carcinoma A gastrointestinal stromal tumor that arises from the omentum. This is an extragastrointestinal tumor, meaning that it does not arise directly from the gastrointestinal tract. C40340 Neoplastic Process Omentum Gastrointestinal Stromal Tumor Omentum Gastrointestinal Stromal Tumor C1518571 CTRP Undetermined Omentum_Gastrointestinal_Stromal_Tumor Omentum EGIST Omentum Extragastrointestinal Stromal Tumor Omentum Gastrointestinal Stromal Tumor Omentum Gastrointestinal Stromal Tumor (GIST) Omentum Gastrointestinal Stromal Tumor A non-invasive lesion of the testis, characterized by the presence of malignant large germ cells with abundant cytoplasm in the seminiferous tubules. It may be associated with undescended or atrophic testis and infertility. The vast majority of cases progress to invasive germ cell tumors. C40345 Neoplastic Process Testicular Intratubular Germ Cell Neoplasia, Unclassified Testicular Germ Cell Neoplasia In Situ C1515286 CTRP GDC 9064/2 Malignant Testicular_Intratubular_Germ_Cell_Neoplasia_Unclassified 9064/2 Intratubular malignant germ cells GCNIS Gonocytoma In Situ IGCNU Intratubular malignant germ cells Testicular Germ Cell Neoplasia In Situ Testicular Intraepithelial Neoplasia Testicular Intratubular Germ Cell Neoplasia Testicular Intratubular Germ Cell Neoplasia of Unclassified Type Testicular Intratubular Germ Cell Neoplasia of the Unclassified Type Testicular Intratubular Germ Cell Neoplasia, Unclassified Testicular Germ Cell Neoplasia In Situ An invasive breast carcinoma characterized by the presence of more than one malignant epithelial histologic pattern. C40347 Neoplastic Process Breast Mixed Carcinoma C1517577 8523/3 8524/3 Malignant Invasive_Mixed_Breast_Carcinoma Breast Mixed Carcinoma Infiltrating Mixed Breast Carcinoma Invasive Breast Mixed Carcinoma Invasive Mixed Breast Carcinoma Breast Mixed Carcinoma An invasive breast adenocarcinoma characterised by the presence of non-neoplastic stromal osteoclastic giant cells. The carcinomatous component is usually an invasive ductal carcinoma, although all other breast adenocarcinoma subtypes have also been described. The prognosis depends on the characteristics of the adenocarcinomatous component, and is not related to the presence of the giant cells. C40349 Neoplastic Process Breast Carcinoma with Osteoclast-Like Stromal Giant Cells C1511304 Malignant Breast_Carcinoma_with_Osteoclastic_Giant_Cells Breast Carcinoma with Osteoclast-Like Stromal Giant Cells Breast Carcinoma with Osteoclastic Giant Cells Breast Carcinoma with Osteoclast-Like Stromal Giant Cells A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland. Radiation exposure is a risk factor and it is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries. Diagnostic procedures include thyroid ultrasound and fine needle biopsy. Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei. The nuclei also display clearing or have a ground glass appearance. C4035 Neoplastic Process Thyroid Gland Papillary Carcinoma Thyroid Gland Papillary Carcinoma C3149311 CPTAC CTEP CTRP Cellosaurus GDC NICHD A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland. The diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei. The nuclei also display clearing or have a ground glass appearance. Cancer that forms in follicular cells in the thyroid and grows in small finger-like shapes. It grows slowly, is more common in women than in men, and often occurs before age 45. It is the most common type of thyroid cancer. Malignant Papillary_Thyroid_Carcinoma 8260/3 Papillary carcinoma of thyroid PTC Papillary Cancer of Thyroid Papillary Cancer of Thyroid Gland Papillary Cancer of the Thyroid Papillary Cancer of the Thyroid Gland Papillary Carcinoma of Thyroid Papillary Carcinoma of Thyroid Gland Papillary Carcinoma of the Thyroid Papillary Carcinoma of the Thyroid Gland Papillary Thyroid Cancer Papillary Thyroid Carcinoma Papillary Thyroid Carcinoma, NOS Papillary Thyroid Gland Carcinoma Papillary carcinoma of thyroid Papillary thyroid carcinoma Thyroid Gland Papillary Cancer Thyroid Gland Papillary Carcinoma Thyroid Papillary Carcinoma papillary thyroid cancer Thyroid Gland Papillary Carcinoma An invasive ductal breast carcinoma, not otherwise specified, characterized by increased levels of human beta-chorionic gonadotropin in the serum. Morphologic evidence of choriocarcinomatous differentiation is rare. C40350 Neoplastic Process Breast Carcinoma with Choriocarcinomatous Features C1511302 Malignant Breast_Carcinoma_with_Choriocarcinomatous_Features Breast Carcinoma with Choriocarcinomatous Features Breast Carcinoma with Choriocarcinomatous Features A very rare primary malignant tumor of the breast, characterized by an invasive breast carcinoma that co-exists with a melanoma component. The vast majority of melanotic tumors that affect the breast are metastatic melanomas that originate in extra-mammary sites. C40351 Neoplastic Process Breast Carcinoma with Melanotic Features C1511303 Malignant Breast_Carcinoma_with_Melanotic_Features Breast Carcinoma with Melanotic Features Breast Carcinoma with Melanotic Features An invasive breast adenocarcinoma characterized by the presence of tall columnar neoplastic cells that contain intracytoplasmic mucin. Grossly, cystic changes are identified. C40354 Neoplastic Process Breast Mucinous Cystadenocarcinoma C1511318 Malignant Breast_Mucinous_Cystadenocarcinoma Breast Mucinous Cystadenocarcinoma Breast Mucinous Cystadenocarcinoma An invasive breast adenocarcinoma characterized by the presence of tall columnar neoplastic cells that contain intracytoplasmic mucin. Grossly, cystic changes are not identified. C40355 Neoplastic Process Breast Columnar Cell Mucinous Carcinoma C1511305 Malignant Breast_Columnar_Cell_Mucinous_Carcinoma Breast Columnar Cell Mucinous Adenocarcinoma Breast Columnar Cell Mucinous Carcinoma Breast Columnar Cell Mucinous Carcinoma A poorly differentiated neuroendocrine carcinoma that arises from the breast. It is characterized by the presence of large neuroendocrine cells and high mitotic activity. C40356 Neoplastic Process Breast Large Cell Neuroendocrine Carcinoma Breast Large Cell Neuroendocrine Carcinoma C1511316 CTRP Malignant Breast_Large_Cell_Neuroendocrine_Carcinoma Breast Large Cell Neuroendocrine Carcinoma Breast Large Cell Neuroendocrine Carcinoma A squamous cell carcinoma that arises from the breast parenchyma and is characterized by the presence of large malignant cells that exhibit keratinization. C40357 Neoplastic Process Breast Squamous Cell Carcinoma, Large Cell Keratinizing Variant C1519486 Malignant Squamous_Cell_Breast_Carcinoma_Large_Cell_Keratinizing_Variant Breast Squamous Cell Carcinoma, Large Cell Keratinizing Variant Squamous Cell Breast Carcinoma, Large Cell Keratinizing Variant Breast Squamous Cell Carcinoma, Large Cell Keratinizing Variant A squamous cell carcinoma that arises from the breast parenchyma and is characterized by the presence of spindle-shaped malignant cells. C40358 Neoplastic Process Breast Squamous Cell Carcinoma, Spindle Cell Variant C1519487 Malignant Squamous_Cell_Breast_Carcinoma_Spindle_Cell_Variant Breast Squamous Cell Carcinoma, Spindle Cell Variant Squamous Cell Breast Carcinoma, Spindle Cell Variant Breast Squamous Cell Carcinoma, Spindle Cell Variant A squamous cell carcinoma that arises from the breast parenchyma and is characterized by cellular discohesion resulting in a pseudoangiosarcomatous pattern. C40359 Neoplastic Process Breast Squamous Cell Carcinoma, Acantholytic Variant C1519485 Cellosaurus Malignant Squamous_Cell_Breast_Carcinoma_Acantholytic_Variant Breast Squamous Cell Carcinoma, Acantholytic Variant Squamous Cell Breast Carcinoma, Acantholytic Variant Breast Squamous Cell Carcinoma, Acantholytic Variant An invasive adenocarcinoma of the breast usually affecting post-menopausal women, characterized by extensive spindle cell metaplasia of the neoplastic glandular cells. C40360 Neoplastic Process Breast Adenocarcinoma with Spindle Cell Metaplasia C1511281 Malignant Breast_Adenocarcinoma_with_Spindle_Cell_Metaplasia Breast Adenocarcinoma with Spindle Cell Metaplasia Breast Adenocarcinoma with Spindle Cell Metaplasia An invasive breast carcinoma characterized by the presence of tubular and glandular neoplastic cell structures, admixed with islands of neoplastic cells showing squamous differentiation. C40361 Neoplastic Process Breast Adenosquamous Carcinoma C1510796 Malignant Adenosquamous_Breast_Carcinoma Adenosquamous Breast Carcinoma Breast Adenosquamous Carcinoma Breast Adenosquamous Carcinoma A low grade metaplastic carcinoma of the breast with morphologic features similar to the adenosquamous carcinoma of the skin. In the majority of cases the prognosis is excellent. C40362 Neoplastic Process Low Grade Breast Adenosquamous Carcinoma C1518013 GDC Malignant Low_Grade_Adenosquamous_Breast_Carcinoma Low grade adenosquamous carcinoma Infiltrating Breast Syringomatous Adenoma Low Grade Adenosquamous Breast Carcinoma Low Grade Breast Adenosquamous Carcinoma Low Grade Breast Adenosquamous Carcinoma An invasive, non-metastasizing neoplasm with sweat duct differentiation that arises in the area of the nipple. Local recurrences have been reported. C40363 Neoplastic Process Nipple Syringomatous Tumor C3839745 Benign Nipple_Syringomatous_Adenoma Infiltrating Nipple Syringomatous Adenoma Nipple Syringomatous Adenoma Nipple Syringomatous Tumor Syringomatous Tumor of the Nipple Nipple Syringomatous Tumor An invasive breast carcinoma characterized by the presence of a mesenchymal cellular component. The mesenchymal cellular component ranges from cartilaginous and osseous, to purely sarcomatous. C40364 Neoplastic Process Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma C1513365 Malignant Mixed_Epithelial_Mesenchymal_Metaplastic_Breast_Carcinoma Breast Carcinosarcoma Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma An invasive breast carcinoma characterized by the presence of cytoplasmic neutral lipids in the vast majority of the malignant cells. C40365 Neoplastic Process Breast Lipid-Rich Carcinoma C1517894 Malignant Lipid-Rich_Breast_Carcinoma Breast Lipid-Rich Carcinoma Lipid Secreting Breast Carcinoma Lipid-Rich Breast Carcinoma Breast Lipid-Rich Carcinoma A rare breast adenocarcinoma characterized by the presence of malignant oncocytic cells. The oncocytic cells comprise more than 70 percent of the malignant cellular population. C40366 Neoplastic Process Breast Oncocytic Carcinoma C1518574 Malignant Oncocytic_Breast_Carcinoma Breast Oncocytic Carcinoma Oncocytic Breast Carcinoma Breast Oncocytic Carcinoma A breast adenocarcinoma characterized by the presence of serous (acinic cell) differentiation. C40367 Neoplastic Process Breast Acinic Cell Carcinoma C1515868 Malignant Acinic_Cell_Breast_Carcinoma Acinic Cell Breast Carcinoma Breast Acinic Cell Carcinoma Breast Acinic Cell Carcinoma An uncommon, usually aggressive adenocarcinoma of the breast characterized by the presence of clear cells that contain glycogen. C40368 Neoplastic Process Glycogen-Rich, Clear Cell Breast Carcinoma C1512224 Malignant Glycogen-Rich_Clear_Cell_Breast_Carcinoma Breast Glycogen-Rich Carcinoma Breast Glycogen-Rich, Clear Cell Carcinoma Glycogen-Rich, Clear Cell Breast Carcinoma Glycogen-Rich, Clear Cell Breast Carcinoma A very rare breast adenocarcinoma with sebaceous differentiation. C40369 Neoplastic Process Breast Sebaceous Carcinoma C1519207 Malignant Sebaceous_Breast_Carcinoma Breast Sebaceous Carcinoma Breast Sebaceous Carcinoma An acute myeloid leukemia developing in patients with a prior history of myelodysplastic syndrome. C4037 Neoplastic Process Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome C1321721 CTRP GDC Malignant Acute_Myeloid_Leukemia_with_Multilineage_Dysplasia_following_Myelodysplastic_Syndrome 9895/3 Acute myeloid leukemia with prior myelodysplastic syndrome Acute myeloid leukemia without prior myelodysplastic syndrome AML/MDS Acute Myeloid Leukemia (AML) Arising from Previous Myelodysplastic Syndrome Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome Acute Myeloid Leukemia with Multilineage Dysplasia following Myelodysplastic Syndrome Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome Carcinoma that is detected in one breast within two months from the diagnosis of carcinoma in the other breast. C40370 Neoplastic Process Synchronous Bilateral Breast Carcinoma C1515107 Malignant Synchronous_Bilateral_Breast_Carcinoma Synchronous Bilateral Breast Cancer Synchronous Bilateral Breast Carcinoma Synchronous Contralateral Breast Carcinoma Synchronous Bilateral Breast Carcinoma Invasive breast carcinoma measuring 1 mm or less in size. C40374 Neoplastic Process Microinvasive Breast Carcinoma Microinvasive Breast Carcinoma C2732473 CTRP Malignant Microinvasive_Breast_Carcinoma DCISM Ductal Carcinoma In Situ with Microinvasion MIC Microinvasive Breast Carcinoma Microinvasive Breast Carcinoma A diffuse large B-cell lymphoma that arises from the breast. It is the most common type of primary breast lymphoma. C40375 Neoplastic Process Breast Diffuse Large B-Cell Lymphoma C1511306 Malignant Breast_Diffuse_Large_B-Cell_Lymphoma Breast DLBCL Breast Diffuse Large B-Cell Lymphoma Primary Breast DLBCL Primary Breast Diffuse Large B-Cell Lymphoma Breast Diffuse Large B-Cell Lymphoma A Burkitt lymphoma that arises from the breast. It usually affects pregnant or lactating women and presents with bilateral breast involvement and breast swelling. C40376 Neoplastic Process Breast Burkitt Lymphoma C1511286 Malignant Breast_Burkitt_s_Lymphoma Breast Burkitt Lymphoma Breast Burkitt's Lymphoma Breast Burkitt Lymphoma A follicular lymphoma that arises from the breast as a primary tumor. C40377 Neoplastic Process Breast Follicular Lymphoma C1511311 Malignant Breast_Follicular_Lymphoma Breast Follicular Lymphoma Breast Follicular Lymphoma A malignant vascular neoplasm arising from the skin of the breast secondary to radiation treatment for breast cancer. C40378 Neoplastic Process Postradiation Breast Angiosarcoma C1514246 Malignant Post-Radiotherapy_Breast_Angiosarcoma Post-Radiotherapy Breast Angiosarcoma Postradiation Angiosarcoma of the Breast Postradiation Breast Angiosarcoma Postradiation Breast Angiosarcoma An angiosarcoma arising from the skin of the arm following radical mastectomy and resulting lymphedema. C40379 Neoplastic Process Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema C1510888 Malignant Angiosarcoma_of_the_Skin_of_the_Arm_after_Radical_Mastectomy_followed_by_Lymphedema Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema S-T Syndrome Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema A well-differentiated neuroendocrine neoplasm that arises from the lung. It is characterized by the presence of uniform polygonal cells with small or moderate amount of cytoplasm and inconspicuous nucleoli. The cells are usually arranged in organoid and trabecular patterns. It is classified as grade 1 (G1-typical carcinoid tumor) or grade 2 (G2-atypical carcinoid tumor) based on the number of mitotic figures and the absence or presence of necrosis. Grade 2 neuroendocrine tumors have a worse prognosis. C4038 Neoplastic Process Lung Carcinoid Tumor Lung Neuroendocrine Tumor C0280089 CPTAC CTRP Cellosaurus Undetermined Lung_Carcinoid_Tumor Benign carcinoid tumor of the bronchus and lung Carcinoid Tumor of Lung Carcinoid Tumor of the Lung Lung Carcinoid Tumor Lung NET Lung Neuroendocrine Tumor Pulmonary Carcinoid Tumor Lung Neuroendocrine Tumor A benign diffuse vascular proliferation in the breast. It is characterized by the formation of capillary-sized and cavernous vascular spaces. C40381 Neoplastic Process Breast Angiomatosis C1511284 Benign Breast_Angiomatosis Breast Angiomatosis Breast Angiomatosis A benign, well circumscribed neoplasm that arises from the breast. Representative examples include tubular adenoma and ductal adenoma. C40382 Neoplastic Process Breast Adenoma C1328385 Benign Breast_Adenoma Breast Adenoma Breast Adenoma A rare, benign and well circumscribed neoplasm that arises from the breast. It is characterized by the proliferation of epithelial cells with extensive apocrine metaplasia. C40383 Neoplastic Process Breast Apocrine Adenoma C1388299 Benign Breast_Apocrine_Adenoma Breast Apocrine Adenoma Breast Apocrine Adenoma A benign, well circumscribed neoplasm that is located within the lumen of a duct in the breast parenchyma. It is characterized by the presence of glandular structures at the periphery and fibrous tissue at the center of the tumor. C40384 Neoplastic Process Breast Ductal Adenoma C1511307 Benign Breast_Ductal_Adenoma Breast Ductal Adenoma Ductal Adenoma Breast Ductal Adenoma A multifocal neoplastic process characterized by the proliferation of spindle to cuboidal myoepithelial cells within and/or around small breast ducts. C40385 Neoplastic Process Breast Myoepitheliosis C1513799 Undetermined Myoepitheliosis Breast Myoepitheliosis Breast Myoepitheliosis A neoplastic process characterized by the proliferation of spindle to cuboidal myoepithelial cells in and around small breast ducts exhibiting cytologic atypia and mitotic activity. C40386 Neoplastic Process Breast Atypical Myoepitheliosis C1511285 Undetermined Breast_Atypical_Myoepitheliosis Atypical Breast Myoepitheliosis Breast Atypical Myoepitheliosis Breast Atypical Myoepitheliosis A neoplastic process characterized by the proliferation of spindle to cuboidal myoepithelial cells within small breast ducts. C40387 Neoplastic Process Breast Intraductal Myoepitheliosis C1512935 Undetermined Intraductal_Breast_Myoepitheliosis Breast Intraductal Myoepitheliosis Intraductal Breast Myoepitheliosis Breast Intraductal Myoepitheliosis A neoplastic process characterized by the proliferation of spindle to cuboidal myoepithelial cells around small breast ducts. C40388 Neoplastic Process Breast Periductal Myoepitheliosis C1518974 Undetermined Periductal_Breast_Myoepitheliosis Breast Periductal Myoepitheliosis Periductal Breast Myoepitheliosis Breast Periductal Myoepitheliosis A benign or malignant tumor that arises from the breast and originates from or is composed of myoepithelial cells. Representative examples include adenomyoepithelioma, myoepitheliosis, and malignant myoepithelioma. C40389 Neoplastic Process Breast Myoepithelial Tumor C1511319 Undetermined Breast_Myoepithelial_Neoplasm Breast Myoepithelial Neoplasm Breast Myoepithelial Tumor Breast Myoepithelial Tumor A benign or malignant tumor characterized by the presence of cells that show myoepithelial differentiation. Based on its morphologic features, it is classified as benign or malignant. A representative example of benign myoepithelioma is benign salivary gland myoepithelioma. Representative examples of malignant myoepithelioma or myoepithelial carcinoma are malignant breast myoepithelioma and salivary gland myoepithelial carcinoma. C40392 Neoplastic Process Myoepithelial Tumor C0027070 GDC 8982/0 8982/1 Undetermined Myoepithelial_Neoplasm 8982/0 Myoepithelial tumor Myoepithelioma Myoepithelioma, NOS Myoepithelial Neoplasm Myoepithelial Tumor Myoepithelial Tumor of Soft Tissue Myoepithelial tumor Myoepithelioma Myoepithelial Tumor A benign or malignant tumor that arises from the salivary glands. It is characterized by the presence of neoplastic cells with myoepithelial differentiation. This category includes benign myoepithelioma and myoepithelial carcinoma. C40393 Neoplastic Process Salivary Gland Myoepithelial Tumor C1519175 Undetermined Salivary_Gland_Myoepithelial_Neoplasm Salivary Gland Myoepithelial Neoplasm Salivary Gland Myoepithelial Tumor Salivary Gland Myoepithelial Tumor An invasive malignant tumor that arises from the breast. It is characterized by the presence of spindle-shaped myoepithelial cells. Mitoses are present. Rarely, local recurrences and distant metastases have been reported. C40395 Neoplastic Process Breast Malignant Myoepithelioma C1518167 Cellosaurus Malignant Malignant_Breast_Myoepithelioma Breast Malignant Myoepithelioma Breast Myoepithelial Carcinoma Malignant Breast Myoepithelioma Breast Malignant Myoepithelioma A myofibroblastoma occurring in the breast of both women and men. It presents as a slowly growing mass. C40397 Neoplastic Process Breast Myofibroblastoma C1511320 Benign Breast_Myofibroblastoma Breast Myofibroblastoma Breast Myofibroblastoma A multinodular intermediate fibroblastic neoplasm arising from the breast. It is characterized by the presence of spindle-shaped fibroblasts and myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes, and plasma cells. C40398 Neoplastic Process Breast Inflammatory Myofibroblastic Tumor C1511315 Undetermined Breast_Inflammatory_Myofibroblastic_Tumor Breast Inflammatory Myofibroblastic Tumor Breast Inflammatory Myofibroblastic Tumor A well-circumscribed benign smooth muscle neoplasm arising from the breast. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C40399 Neoplastic Process Breast Leiomyoma C1511317 Benign Breast_Leiomyoma Breast Leiomyoma Breast Leiomyoma A squamous cell carcinoma of the oral cavity that arises from the buccal mucosa. C4040 Neoplastic Process Buccal Mucosa Squamous Cell Carcinoma C0280299 Cellosaurus Malignant Buccal_Mucosa_Squamous_Cell_Carcinoma Buccal Mucosa Squamous Cell Carcinoma SCC of Buccal Mucosa SCC of the Buccal Mucosa Squamous Cell Carcinoma of Buccal Mucosa Squamous Cell Carcinoma of the Buccal Mucosa Buccal Mucosa Squamous Cell Carcinoma A usually benign neoplasm that arises from the breast. It presents as a single, firm, and painless mass. It is characterized by the presence of neoplastic cells with eosinophilic granular cytoplasm. C40400 Neoplastic Process Breast Granular Cell Tumor C1511312 Undetermined Breast_Granular_Cell_Tumor Breast Granular Cell Tumor Breast Granular Cell Tumor A benign, malignant, or borderline biphasic neoplasm that arises from the breast parenchyma. It is characterized by the presence of an epithelial and a mesenchymal (stromal) component. The typical examples are fibroadenoma and phyllodes tumor. C40405 Neoplastic Process Breast Fibroepithelial Neoplasm C1511309 Undetermined Breast_Fibroepithelial_Neoplasm Breast Fibroepithelial Neoplasm Breast Fibroepithelial Tumor Breast Fibroepithelial Neoplasm A benign, intermediate, or malignant mesenchymal neoplasm that arises from the breast. C40406 Neoplastic Process Breast Soft Tissue Neoplasm C1511323 Undetermined Breast_Soft_Tissue_Neoplasm Breast Soft Tissue Neoplasm Breast Soft Tissue Tumor Breast Soft Tissue Neoplasm An embryonal pediatric tumor of the kidney which may also be seen rarely in adults. The peak incidence of Wilms tumor is between the second and fifth year of life. Microscopically, it is composed of a mixture of cellular elements (blastemal, stromal, and epithelial). The most common sites of metastasis include the regional lymph nodes, lungs, and liver. C40407 Neoplastic Process Kidney Wilms Tumor C0027708 CDISC Cellosaurus GDC NICHD A disease in which malignant (cancer) cells are found in the kidney, and may spread to the lungs, liver, or nearby lymph nodes. Wilms tumor usually occurs in children younger than 5 years old. A malignant embryonal neoplasm of the kidney. 8960/3 Malignant Renal_Wilms_Tumor 8960/3 Nephroblastoma, NOS Nephroma, NOS Embryonal Nephroma Kidney Nephroblastoma Kidney Wilms Tumor NEPHROBLASTOMA, MALIGNANT Nephroblastoma Renal Wilms Tumor Renal Wilms' Tumor Wilms Tumor of the Kidney Wilms' Tumor of the Kidney Wilms' tumor Kidney Wilms Tumor A rare, benign and well circumscribed neoplasm that arises from the breast. It is characterized by the proliferation of epithelial and myoepithelial cells surrounded by chondroid stroma. C40408 Neoplastic Process Breast Pleomorphic Adenoma C1511322 Benign Breast_Pleomorphic_Adenoma Breast Pleomorphic Adenoma Pleomorphic Adenoma of the Breast Breast Pleomorphic Adenoma A benign, slow-growing tumor composed of cells that demonstrate both epithelial and mesenchymal differentiation. It is the most common neoplasm of salivary gland origin, and mostly occurs in the parotid gland. The average age of patients has been reported to be 43 years; women are more often affected than men. The malignant change rate has been estimated to be 6%. The malignant counterpart is carcinoma ex pleomorphic adenoma. C40409 Neoplastic Process Salivary Gland Pleomorphic Adenoma C1519176 Cellosaurus Benign Salivary_Gland_Pleomorphic_Adenoma Benign Mixed Salivary Gland Neoplasm Benign Mixed Salivary Gland Tumor Benign Mixed Salivary Neoplasm Benign Mixed Salivary Tumor Salivary Gland Pleomorphic Adenoma Salivary Gland Pleomorphic Adenoma A squamous cell carcinoma of the oral cavity that arises from the floor of the mouth. C4041 Neoplastic Process Floor of Mouth Squamous Cell Carcinoma C0280300 Cellosaurus Malignant Floor_of_Mouth_Squamous_Cell_Carcinoma Floor of Mouth SCC Floor of Mouth Squamous Cell Carcinoma SCC of Floor of Mouth SCC of the Floor of Mouth Squamous Cell Carcinoma of Floor of Mouth Squamous Cell Carcinoma of the Floor of Mouth Floor of Mouth Squamous Cell Carcinoma A carcinoma that arises from a pleomorphic adenoma in the salivary glands. It usually originates in the parotid gland. Patients usually present with a history of a long-standing tumor mass which grew rapidly in the past few months. Patients with non-invasive or minimally invasive carcinoma have an excellent prognosis. In cases where there is invasion of the surrounding tissues, the clinical course is aggressive. C40410 Neoplastic Process Salivary Gland Carcinoma ex Pleomorphic Adenoma C1519172 Cellosaurus Malignant Salivary_Gland_Carcinoma_Ex_Pleomorphic_Adenoma Salivary Gland Carcinoma ex Pleomorphic Adenoma Salivary Gland Carcinoma ex Pleomorphic Adenoma A squamous cell carcinoma that arises from the lip. It affects males more often than females and it usually involves the lower lip. Risk factors include UV exposure, alcohol consumption, smoking, and immunosuppression. C4042 Neoplastic Process Lip Squamous Cell Carcinoma C0280302 CPTAC Cellosaurus Malignant Lip_Squamous_Cell_Carcinoma Squamous cell carcinoma of skin of lip Lip SCC Lip Squamous Cell Carcinoma SCC of Lip SCC of the Lip Squamous Cell Carcinoma of Lip Squamous Cell Carcinoma of the Lip Lip Squamous Cell Carcinoma A squamous cell carcinoma arising from the hypopharynx. Signs and symptoms include dysphagia, hemoptysis, and the presence of a neck mass. C4043 Neoplastic Process Hypopharyngeal Squamous Cell Carcinoma Hypopharyngeal Squamous Cell Carcinoma C0280321 CTRP Cellosaurus Malignant Hypopharyngeal_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Hypopharynx Epidermoid Carcinoma of the Hypopharynx Hypopharyngeal Conventional Squamous Cell Carcinoma Hypopharyngeal Epidermoid Carcinoma Hypopharyngeal Squamous Cell Carcinoma Hypopharyngeal Throat Squamous Cell Cancer Squamous Cell Carcinoma of Hypopharynx Squamous Cell Carcinoma of the Hypopharynx Hypopharyngeal Squamous Cell Carcinoma A juvenile granulosa cell tumor that involves both ovaries. C40434 Neoplastic Process Juvenile Bilateral Ovarian Granulosa Cell Tumor C1517627 Uncertain Malignant Potential Juvenile_Type_Bilateral_Ovarian_Granulosa_Cell_Tumor Juvenile Bilateral Ovarian Granulosa Cell Tumor Juvenile Type Bilateral Ovarian Granulosa Cell Tumor Juvenile Bilateral Ovarian Granulosa Cell Tumor A sex cord-stromal tumor that arises from the ovary in a patient diagnosed with Peutz-Jeghers syndrome. C40436 Neoplastic Process Ovarian Sex Cord-Stromal Tumor Associated with Peutz-Jeghers Syndrome C1518733 Undetermined Ovarian_Sex_Cord-Stromal_Tumor_Associated_with_Peutz-Jeghers_Syndrome Ovarian Sex Cord-Stromal Tumor Associated with Peutz-Jeghers Syndrome Ovarian Sex Cord-Stromal Tumor Associated with Peutz-Jeghers Syndrome An undifferentiated small cell carcinoma that arises from the ovary and is associated with hypercalcemia. Electron microscopic studies show neurosecretory granules are either absent or, when present, are in small numbers. C40439 Neoplastic Process Ovarian Small Cell Carcinoma, Hypercalcemic Type C1518736 Cellosaurus GDC Malignant Ovarian_Small_Cell_Carcinoma_Hypercalcemic_Type Small cell carcinoma, hypercalcemic type Ovarian Small Cell Carcinoma, Hypercalcemic Type SCCOHT Ovarian Small Cell Carcinoma, Hypercalcemic Type A squamous cell carcinoma that arises from the larynx. It is the most common histologic type of laryngeal carcinoma. It can arise from the glottis, supraglottic area, or it can be transglottic. Glottic squamous cell carcinoma is the most frequent laryngeal carcinoma in the United States. The symptoms, clinical behavior and the prognosis depend on the site of origin within the larynx. C4044 Neoplastic Process Laryngeal Squamous Cell Carcinoma Laryngeal Squamous Cell Carcinoma C0280324 CTEP CTRP Cellosaurus Malignant Laryngeal_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Larynx Epidermoid Carcinoma of the Larynx Laryngeal Conventional Squamous Cell Carcinoma Laryngeal Epidermoid Carcinoma Laryngeal Squamous Cell Carcinoma Laryngeal Throat Squamous Cell Cancer Laryngeal squamous cell carcinoma Larynx Epidermoid Carcinoma Larynx Squamous Cell Carcinoma Squamous Cell Carcinoma of Larynx Squamous Cell Carcinoma of the Larynx Laryngeal Squamous Cell Carcinoma An aggressive small cell neuroendocrine carcinoma that arises from the ovary. Morphologically, it resembles the small cell carcinoma that arises from the lung. C40440 Neoplastic Process Ovarian Small Cell Carcinoma, Pulmonary-Type C1518737 GDC Malignant Ovarian_Small_Cell_Carcinoma_Pulmonary_Type Small cell carcinoma pulmonary type Ovarian Small Cell Carcinoma, Pulmonary-Type Ovarian Small Cell NEC Ovarian Small Cell Neuroendocrine Carcinoma Ovarian Small Cell Carcinoma, Pulmonary-Type A rare malignant trophoblastic tumor that arises from the ovary as a result of ectopic ovarian pregnancy. There is no germ cell component present. C40442 Neoplastic Process Ovarian Gestational Choriocarcinoma C1517538 Malignant Gestational_Ovarian_Choriocarcinoma Gestational Ovarian Choriocarcinoma Ovarian Gestational Choriocarcinoma Ovarian Gestational Choriocarcinoma An embryonal neoplasm arising from the ovary with morphologic features resembling Wilms tumor of the kidney. It occurs during the reproductive age and may present as a rapidly growing adnexal mass. C40443 Neoplastic Process Ovarian Wilms Tumor C1518746 Malignant Ovarian_Wilms_Tumor Ovarian Nephroblastoma Ovarian Wilms Tumor Ovarian Wilms Tumor A rare malignant mesothelial neoplasm that usually involves both the ovarian surface and the ovarian stroma. In most cases there is bilateral ovarian involvement. C40444 Neoplastic Process Ovarian Malignant Mesothelioma C1518721 Malignant Ovarian_Malignant_Mesothelioma Ovarian Malignant Mesothelioma Ovarian Malignant Mesothelioma An oligodendroglioma that arises from the central nervous system and occurs during childhood. C4045 Neoplastic Process Childhood Oligodendroglioma Childhood Oligodendroglioma C0280475 CTRP NICHD An oligodendroglioma that occurs during childhood. Undetermined Childhood_Oligodendroglioma Childhood Oligodendroglioma Oligodendroglioma Pediatric Oligodendroglioma Childhood Oligodendroglioma Fallopian tube carcinoma that has developed in relatives of patients that have a history of fallopian tube carcinoma. C40455 Neoplastic Process Hereditary Fallopian Tube Carcinoma Hereditary Fallopian Tube Carcinoma C1512418 CTRP Malignant Hereditary_Fallopian_Tube_Carcinoma Familial Fallopian Tube Carcinoma Hereditary Fallopian Tube Cancer Hereditary Fallopian Tube Carcinoma Hereditary Fallopian Tube Carcinoma A WHO grade 1, relatively circumscribed, slowly growing, often cystic astrocytoma occurring in children and young adults. Histologically it is characterized by a biphasic pattern with compacted bipolar cells associated with Rosenthal fibers and multipolar cells associated with microcysts and eosinophilic bodies/hyaline droplets. (WHO) C4047 Neoplastic Process Pilocytic Astrocytoma C0334583 CTEP Cellosaurus DIPG/DMG GDC 9421/1 Undetermined Pilocytic_Astrocytoma 9421/1 Pilocytic astrocytoma Piloid astrocytoma Grade 1 Astrocytic Neoplasm Grade 1 Astrocytic Tumor Grade 1 Astrocytoma Grade I Astrocytic Neoplasm Grade I Astrocytic Tumor Grade I Astrocytoma Pilocytic Astrocytoma Pilocytic astrocytoma Pilocytic Astrocytoma A pilocytic astrocytoma that occurs during childhood. C4048 Neoplastic Process Childhood Pilocytic Astrocytoma Childhood Pilocytic Astrocytoma C1332995 CTRP NICHD A pilocytic astrocytoma that occurs during childhood. Undetermined Childhood_Pilocytic_Astrocytoma Childhood Pilocytic Astrocytoma Pediatric Pilocytic Astrocytoma Pilocytic Astrocytoma Pilocytic Astrocytoma of Childhood Childhood Pilocytic Astrocytoma A WHO grade 3 malignant glioma of ependymal origin with accelerated growth and an unfavorable clinical outcome, particularly in children. It is characterized by high mitotic activity, often accompanied by microvascular proliferation and pseudo-palisading necrosis. (Adapted from WHO) C4049 Neoplastic Process Anaplastic Ependymoma C0280788 CPTAC GDC 9392/3 Malignant Anaplastic_Ependymoma 9392/3 Ependymoma, anaplastic Anaplastic Ependymal Neoplasm Anaplastic Ependymal Tumor Anaplastic Ependymoma Ependymoma with Anaplasia Ependymoma, anaplastic Malignant Ependymoma Undifferentiated Ependymal Neoplasm Undifferentiated Ependymal Tumor Undifferentiated Ependymoma WHO Grade 3 Ependymal Neoplasm WHO Grade 3 Ependymal Tumor WHO Grade III Ependymal Neoplasm WHO Grade III Ependymal Tumor Anaplastic Ependymoma A WHO grade 2 tumor composed of a conspicuous mixture of two distinct neoplastic cell types morphologically resembling the tumor cells in oligodendroglioma and diffuse astrocytoma. (WHO) C4050 Neoplastic Process Oligoastrocytoma Oligoastrocytoma C0280793 CDISC CTRP Cellosaurus GDC A benign neoplasm of the central nervous system with an astrocytic and oligodendrocytic component. A brain tumor that forms from both oligodendrocytes and astrocytes, which are types of glial cells (cells that cover and protect nerve cells in the brain and spinal cord and help them work the way they should). An oligoastrocytoma is a type of mixed glioma. Undetermined Mixed_Astrocytoma-Oligodendroglioma 9382/3 Oligoastrocytoma Oligoastrocytoma, NOS GLIOMA, MIXED, BENIGN Mixed Astrocytic-Oligodendroglial Neoplasm Mixed Astrocytic-Oligodendroglial Tumor Mixed Astrocytoma-Oligodendroglioma Mixed Oligo-Astrocytoma Oligoastrocytoma WHO Grade 2 Mixed Glioma WHO Grade II Mixed Glioma oligoastrocytoma Oligoastrocytoma A WHO grade III meningioma characterized by the presence of malignant morphologic features, including malignant cytology and a very high mitotic index (20 or more mitoses per ten high power fields). C4051 Neoplastic Process Anaplastic (Malignant) Meningioma Anaplastic (Malignant) Meningioma C0259785 CTRP GDC A rare, fast-growing tumor that forms in one of the inner layers of the meninges (thin layers of tissue that cover and protect the brain and spinal cord). Malignant meningioma often spreads to other areas of the body. 9530/3 Malignant Anaplastic_Malignant_Meningioma 9530/3 Meningioma, anaplastic Meningioma, malignant Anaplastic (Malignant) Meningioma Anaplastic Meningioma Malignant Meningioma Meningioma, Malignant Meningioma, anaplastic Meningioma, malignant malignant meningioma Anaplastic (Malignant) Meningioma A squamous cell carcinoma that arises from the vulva. It is classified as human papillomavirus-related or human papillomavirus-independent. When p16 immunohistochemistry or HPV testing is not available, the morphological diagnosis of squamous cell carcinoma, not otherwise specified is acceptable. C4052 Neoplastic Process Vulvar Squamous Cell Carcinoma Vulvar Squamous Cell Carcinoma C0280856 CTRP Cellosaurus Malignant Vulvar_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Vulva Epidermoid Carcinoma of the Vulva Epidermoid Cell Carcinoma of Vulva Epidermoid Cell Carcinoma of the Vulva Squamous Cell Carcinoma of Vulva Squamous Cell Carcinoma of the Vulva Vulva Epidermoid Carcinoma Vulva Epidermoid Cell Carcinoma Vulva Squamous Cell Carcinoma Vulvar Epidermoid Carcinoma Vulvar Epidermoid Cell Carcinoma Vulvar Squamous Cell Cancer Vulvar Squamous Cell Carcinoma Vulvar Squamous Cell Carcinoma A human papillomavirus-related neoplasm arising from the anus. Morphologically, it is characterized by an exophytic papillary proliferation of squamous cells and acanthosis. C4054 Neoplastic Process Anal Condyloma Acuminatum C0281779 Benign Anal_Condyloma_Acuminatum Anal Condyloma Anal Condyloma Acuminatum Condylomata of Anus Condylomata of the Anus Anal Condyloma Acuminatum A grade I, slowly growing meningioma. Only a minority of tumors recur following complete resection. C4055 Neoplastic Process Benign Meningioma C0281784 CDISC A benign neoplasm of the meninges. Benign Benign_Meningioma Benign Meningioma Benign Meningioma (WHO Grade 1) Benign Meningioma (WHO Grade I) MENINGIOMA, BENIGN Meningioma, Benign Benign Meningioma A benign intraluminal polypoid neoplasm of the esophagus. It includes the squamous papilloma and the giant fibrovascular polyp. C4057 Disease or Syndrome Esophageal Polyp C0281838 Esophageal_Polyp Esophageal Polyp Esophageal Polyp A benign ovarian surface epithelial-stromal tumor characterized by the presence of cystic structures lined by serous epithelial cells, mucinous columnar epithelial cells, or endometrial-type well-differentiated cells. C4060 Neoplastic Process Ovarian Cystadenoma C0346169 Benign Ovarian_Cystadenoma Benign Cystadenoma of Ovary Benign Cystadenoma of the Ovary Benign Ovarian Cystadenoma Cystadenoma of Ovary Cystadenoma of the Ovary Cystoma Serosum Simplex Ovarian Cystadenoma Simple Cystoma of Ovary Simple Cystoma of the Ovary Simple Ovarian Cystoma Ovarian Cystadenoma A papillomatous lesion that arises from the eyelid. C4061 Neoplastic Process Eyelid Papilloma C1142491 Benign Eyelid_Papilloma Eyelid Papilloma Papilloma of Eyelid Papilloma of the Eyelid Eyelid Papilloma A benign or malignant mesenchymal neoplasm arising from smooth, skeletal, or cardiac muscle. C4063 Neoplastic Process Myomatous Neoplasm C0282606 GDC Undetermined Myomatous_Neoplasm Myomatous Neoplasms Muscle Neoplasm Muscle Tumor Myomatous Neoplasm Myomatous Neoplasms Myomatous Tumor Neoplasm of Muscle Neoplasm of the Muscle Tumor of Muscle Tumor of the Muscle Myomatous Neoplasm A neoplastic proliferation of the epithelial cells that line the acini and the ducts of the prostate gland. The neoplastic epithelial cells are confined within the acini and the ducts and they do not invade the surrounding prostatic stroma. Morphologically, it is classified as low or high grade. C4064 Neoplastic Process Prostatic Intraepithelial Neoplasia C0282612 CTEP Noncancerous growth of cells lining the internal and external surfaces of the prostate gland. Having high-grade PIN may increase the risk of developing prostate cancer. Undetermined Prostatic_Intraepithelial_Neoplasia PIN PIN - Prostatic Intraepithelial Neoplasia Prostate intraepithelial neopl. Prostate intraepithelial neoplasia (PIN) Prostatic Intraepithelial Neoplasia prostatic intraepithelial neoplasia Prostatic Intraepithelial Neoplasia An adenocarcinoma of the cervix or the vagina that derives from Wolffian duct remnants and shows mesonephric differentiation. C4072 Neoplastic Process Mesonephric Adenocarcinoma C0025490 GDC 9110/3 Malignant Mesonephric_Adenocarcinoma 9110/3 Mesonephric adenocarcinoma Mesonephroma, malignant Wolffian duct carcinoma MNAC Malignant Mesonephroma Mesonephric Adenocarcinoma Mesonephric Carcinoma Mesonephric adenocarcinoma Mesonephroma, malignant Mesonephric Adenocarcinoma A rare sarcoma arising from the meninges. C4073 Neoplastic Process Meningeal Sarcoma C0302327 GDC Malignant Meningeal_Sarcoma 9530/3 Meningeal sarcoma Meningothelial sarcoma Meningeal Sarcoma Meningeal sarcoma Meninges Sarcoma Sarcoma of Meninges Sarcoma of the Meninges Meningeal Sarcoma A B-cell non-Hodgkin lymphoma composed of large noncleaved cells. This is a subtype of diffuse large B-cell non-Hodgkin lymphoma. C4074 Neoplastic Process Centroblastic Lymphoma Centroblastic Lymphoma C0302329 CTRP GDC Malignant Centroblastic_Lymphoma 9680/3 Malignant lymphoma, centroblastic, NOS Malignant lymphoma, centroblastic, diffuse Malignant lymphoma, large B-cell, diffuse, centroblastic, NOS Centroblastic Lymphoma Diffuse Centroblastic Lymphoma Centroblastic Lymphoma A rare, usually solitary, benign epithelial tumor of the skin that appears to arise from a hair follicle. It usually develops in the head and neck region as a nodular lesion with a central keratotic plug. C4087 Disease or Syndrome Warty Dyskeratoma C0334063 Benign Isolated_Follicular_Keratosis Warty dyskeratoma Follicular Dyskeratoma Isolated Follicular Keratosis Warty Dyskeratoma Warty Dyskeratoma A morphologic variant of testicular seminoma characterized by the presence of seminoma cells arranged in cribriform patterns and few lymphocytes. C40957 Neoplastic Process Testicular Seminoma, Cribriform Variant C1515292 Malignant Testicular_Seminoma_Cribriform_Variant Testicular Seminoma, Cribriform Variant Testicular Seminoma, Cribriform Variant A morphologic variant of testicular seminoma characterized by the presence of seminoma cells arranged in pseudoglandular patterns and few lymphocytes. C40958 Neoplastic Process Testicular Seminoma, Pseudoglandular Variant C1515293 Malignant Testicular_Seminoma_Pseudoglandular_Variant Testicular Seminoma, Pseudoglandular Variant Testicular Seminoma, Pseudoglandular Variant A morphologic variant of testicular seminoma characterized by the presence of seminoma cells arranged in tubular patterns and few lymphocytes. C40959 Neoplastic Process Testicular Seminoma, Tubular Variant C1515294 Malignant Testicular_Seminoma_Tubular_Variant Testicular Seminoma, Tubular Variant Testicular Seminoma, Tubular Variant A rare malignant germ cell tumor that arises from the testis and is characterized by the presence of embryoid bodies. C40962 Neoplastic Process Testicular Polyembryoma Testicular Polyembryoma C1514200 CTRP Malignant Polyembryoma_of_the_Testis Polyembryoma of Testis Polyembryoma of the Testis Testicular Polyembryoma Testicular Polyembryoma A neoplastic lymphoproliferative process characterized by an angiocentric arrangement of tumor cells and associated angiodestruction. It includes lymphomatoid granulomatosis which is a lymphoproliferative lesion derived from mature B-lymphocytes and cases of extranodal NK/T-cell lymphomas of nasal type. C40970 Neoplastic Process Angiocentric Immunoproliferative Lesion CL331771 GDC 9766/1 Undetermined Angiocentric_Immunoproliferative_Lesion 9766/1 Angiocentric immunoproliferative lesion AIL Angiocentric Immunoproliferative Lesion Angiocentric immunoproliferative lesion Angiocentric Immunoproliferative Lesion A superficial basal cell carcinoma of the skin characterized by the presence of lobules of basaloid cells which are separated by large distances and represent multifocal discrete tumors. C4108 Neoplastic Process Superficial Multifocal Basal Cell Carcinoma C0334256 GDC 8091/3 Malignant Superficial_Multifocal_Basal_Cell_Carcinoma 8091/3 Multicentric basal cell carcinoma Multifocal superficial basal cell carcinoma Multicentric Basal Cell Carcinoma Multicentric basal cell carcinoma Multifocal superficial basal cell carcinoma Superficial Multifocal Basal Cell Carcinoma Superficial Multifocal Basal Cell Carcinoma A variant of basal cell carcinoma presenting as an elevated or erythematous nodular lesion usually in the back. Morphologically, it is characterized by the presence of cords of basaloid cells extending from the epidermis into the dermis, creating a fenestrating pattern. It follows an indolent course. C4109 Neoplastic Process Skin Fibroepithelial Basal Cell Carcinoma C0346013 GDC 8093/3 Malignant Fibroepithelioma_of_Pinkus 8093/3 Basal cell carcinoma, fibroepithelial Fibroepithelial basal cell carcinoma, Pinkus type Fibroepithelioma of Pinkus type Fibroepithelioma, NOS Pinkus tumor Basal cell carcinoma, fibroepithelial Fibroepithelial Basal Cell Carcinoma Fibroepithelioma of Pinkus Fibroepithelioma of Pinkus type Pinkus Tumor Pinkus tumor Skin Fibroepithelial Basal Cell Carcinoma Skin Fibroepithelial Basal Cell Carcinoma A skin appendage neoplasm with follicular differentiation. It usually occurs in the head and neck region, particularly the face. It presents as a solitary dome-shaped small lesion. The clinical course is benign. C4112 Neoplastic Process Trichofolliculoma C0334262 GDC 8101/0 Benign Trichofolliculoma 8101/0 Trichofolliculoma Trichofolliculoma Trichofolliculoma A benign neoplasm arising from the outer hair sheath and infundibulum. It occurs in the head and neck, usually on the face. It usually presents as an exophytic wart-like lesion or a dome-shaped lesion with a smooth surface. Morphologically, it is characterized by the proliferation of cuboidal cells with clear or eosinophilic cytoplasm in the dermis with connection to the epidermis/hair follicle. There is peripheral cellular palisading, and the lesion is surrounded by a hyaline band. C4113 Neoplastic Process Trichilemmoma C0334263 CDISC Cellosaurus GDC A benign hair follicle neoplasm in the outer hair sheath and infundibulum, characterized by central cells showing highly eosinophilic amorphous keratin. 8102/0 8102/2 Benign Trichilemmoma 8102/0 Trichilemmoma TRICHOLEMMOMA, BENIGN Trichilemmoma Tricholemmoma Trichilemmoma A very rare, locally aggressive, malignant neoplasm of the hair follicle. The majority of the cases arise de novo, however malignant transformation from a pre-existing pilomatricoma has been reported. It usually presents as a solitary nodule in the head and neck, upper extremities, or buttocks. Morphologically, it is characterized by the presence of aggregates of basaloid cells infiltrating the dermis. Masses of ghost cells are present in the cellular aggregates. Complete surgical excision is the treatment of choice. If it is not completely removed, it usually recurs, but it rarely metastasizes to distant anatomic sites. C4114 Neoplastic Process Pilomatrical Carcinoma C0585475 GDC 8110/3 Malignant Pilomatrix_Carcinoma 8110/3 Matrical carcinoma Pilomatrical carcinoma Pilomatricoma, malignant Pilomatrix carcinoma Pilomatrixoma, malignant Invasive Pilomatrixoma Matrical Carcinoma Matrical carcinoma Pilomatrical Carcinoma Pilomatrix Carcinoma Pilomatrix Carcinoma of Skin Pilomatrix Carcinoma of the Skin Pilomatrix Skin Carcinoma Pilomatrix carcinoma Pilomatrical Carcinoma A benign neoplasm that arises from the ciliated respiratory mucosa that lines the nasal cavity and paranasal sinuses. It is classified as inverted papilloma, oncocytic papilloma, and exophytic papilloma. Clinical manifestations include nasal obstruction, epistaxis, and anosmia. C4117 Neoplastic Process Sinonasal Papilloma C0334268 GDC 8121/0 Benign Schneiderian_Papilloma 8121/0 Schneiderian papilloma, NOS Sinonasal papilloma Sinonasal papilloma, NOS Sinonasal papilloma, exophytic Sinonasal papilloma, fungiform Schneiderian Papilloma Schneiderian papilloma, NOS Sinonasal Papilloma Sinonasal Schneiderian Papilloma Sinonasal papilloma Sinonasal Papilloma Polycythemia vera characterized by the proliferation of the erythroid, granulocytic, and megakaryocytic lineages. The peripheral blood shows excess of red blood cells, neutrophilia, and thrombocytosis. The bone marrow is hypercellular for the patient's age. C41232 Neoplastic Process Polycythemia Vera, Polycythemic Phase C1514197 Malignant Polycythemia_Vera_Polycythemic_Stage Polycythemia Vera, Polycythemic Phase Polycythemia Vera, Polycythemic Stage Polycythemia Vera, Polycythemic Phase Progression of polycythemia vera characterized by decreased erythropoiesis and granulopoiesis, reticulin and collagen fibrosis of the bone marrow, leucoerythroblastic reaction in the peripheral blood, poikilocytosis, tear-drop shaped red blood cells, and splenomegaly. C41233 Neoplastic Process Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase C3805232 CTRP Malignant Polycythemia_Vera_Post-Polycythemic_Myelofibrosis_and_Myeloid_Metaplasia_Phase Polycythemia Vera, "Spent" Phase Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase Polycythemia Vera, Post-Polycythemic Myelofibrosis and Myeloid Metaplasia Stage Post-PV MF Post-polycythemia Vera Myelofibrosis Spent Phase and Post-Polycythemic Myelofibrosis Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase Primary myelofibrosis characterized by bone marrow hypercellularity and the presence of atypical megakaryocytes. There is no increase in the percentage of myeloblasts and no significant increase in reticulin or collagen fibrosis in the bone marrow. C41237 Neoplastic Process Early/Prefibrotic Primary Myelofibrosis C1516553 Malignant Chronic_Idiopathic_Myelofibrosis_Prefibrotic_Stage Early/Prefibrotic Primary Myelofibrosis Early/Prefibrotic Stage PMF Early/Prefibrotic Stage Primary Myelofibrosis Pre-PMF Prefibrotic/Early Primary Myelofibrosis Primary Myelofibrosis, Prefibrotic Stage Primary Myelofibrosis, Prefibrotic/Early Stage Early/Prefibrotic Primary Myelofibrosis Primary myelofibrosis characterized by reticulin or collagen fibrosis in the bone marrow. The bone marrow is usually normocellular or hypocellular. Myeloblasts account for less than 10% of the bone marrow cells. Atypical megakaryocytes are present. C41238 Neoplastic Process Overt Primary Myelofibrosis C1516552 Malignant Chronic_Idiopathic_Myelofibrosis_Fibrotic_Stage Chronic Idiopathic Myelofibrosis, Fibrotic Stage Overt Primary Myelofibrosis Primary Myelofibrosis, Fibrotic Stage Primary Myelofibrosis, Overt Fibrotic Stage Overt Primary Myelofibrosis A cystic epithelial neoplasm characterized by the presence of columnar mucin-producing epithelial cells, ovarian-type stroma formation, and a focal or extensive invasive carcinomatous component. C41246 Neoplastic Process Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma C1518870 8470/3 Malignant Pancreatic_Invasive_Mucinous_Cystadenocarcinoma Pancreatic Invasive Mucinous Cystadenocarcinoma Pancreatic Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma A non-invasive or invasive cystic epithelial neoplasm that affects almost exclusively females. It is characterized by the presence of columnar mucin-producing epithelial cells and ovarian-type stroma formation. C41247 Neoplastic Process Pancreatic Mucinous-Cystic Neoplasm Pancreatic Mucinous-Cystic Neoplasm C1518872 CTRP Cellosaurus Undetermined Pancreatic_Mucinous_Cystic_Neoplasm Pancreatic Mucinous Cystic Neoplasm Pancreatic Mucinous-Cystic Neoplasm Pancreatic Mucinous-Cystic Neoplasm A benign or malignant epithelial neoplasm that is usually cystic and arises from the exocrine pancreas. It is characterized by the presence of neoplastic epithelial cells that produce fluid similar to serum. Representative examples include serous cystadenoma and serous cystadenocarcinoma. C41248 Neoplastic Process Pancreatic Serous Neoplasm C1518875 Undetermined Pancreatic_Serous_Cystic_Neoplasm Pancreatic Serous Cystic Neoplasm Pancreatic Serous Neoplasm Pancreatic Serous Neoplasm A non-invasive pancreatic intraductal papillary mucinous neoplasm characterized by the presence of neoplastic epithelial cells that form a single layer and are well polarized. The neoplastic cells exhibit small and uniform nuclei, mild pleomorphism, and rare mitotic figures. C41249 Neoplastic Process Pancreatic Intraductal Papillary-Mucinous Neoplasm, Low Grade CL497939 8453/0 Uncertain Malignant Potential Pancreatic_Intraductal_Papillary-Mucinous_Adenoma Pancreatic Intraductal Papillary Mucinous Neoplasm with Low Grade Dysplasia Pancreatic Intraductal Papillary-Mucinous Adenoma Pancreatic Intraductal Papillary-Mucinous Neoplasm with Low Grade Dysplasia Pancreatic Intraductal Papillary-Mucinous Neoplasm, Low Grade Pancreatic Intraductal Papillary-Mucinous Neoplasm, Low-Grade Pancreatic Intraductal Papillary-Mucinous Neoplasm, Low Grade A non-invasive pancreatic intraductal papillary mucinous neoplasm characterized by the presence of neoplastic epithelial cells that exhibit loss of polarity, nuclear stratification, hyperchromasia, and pleomorphism. There is severe architectural atypia and frequent mitotic figures present. C41251 Neoplastic Process Pancreatic Intraductal Papillary-Mucinous Neoplasm, High Grade C3532881 GDC 8453/2 Uncertain Malignant Potential Pancreatic_Non-Invasive_Intraductal_Papillary-Mucinous_Carcinoma 8453/2 Intraductal papillary mucinous neoplasm with high grade dysplasia Intraductal papillary-mucinous carcinoma, non-invasive Pancreatic Intraductal Papillary Mucinous Neoplasm with High Grade Dysplasia Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia Pancreatic Intraductal Papillary-Mucinous Neoplasm, High Grade Pancreatic Intraductal Papillary-Mucinous Neoplasm, High-Grade Pancreatic Non-Invasive Intraductal Papillary-Mucinous Carcinoma Pancreatic Intraductal Papillary-Mucinous Neoplasm, High Grade An epithelial, usually multiloculated neoplasm arising from the intrahepatic or extrahepatic bile ducts. It occurs predominantly in females. Signs and symptoms include abdominal mass, abdominal pain, and jaundice. Morphologically, the cystic spaces are lined by columnar epithelium and contain mucinous or serous fluid. C4129 Neoplastic Process Bile Duct Mucinous Cystic Neoplasm C0334285 GDC 8161/0 Benign Undetermined Bile_Duct_Cystadenoma 8161/0 Bile duct cystadenoma Bile Duct Cystadenoma Bile Duct MCN Bile Duct Mucinous Cystic Neoplasm Bile duct cystadenoma Cystadenoma of Bile Duct Cystadenoma of the Bile Duct Bile Duct Mucinous Cystic Neoplasm A mucinous cystic neoplasm that arises from the intrahepatic or extrahepatic bile ducts and it is associated with an invasive carcinomatous component. C4130 Neoplastic Process Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma C0334286 GDC 8161/3 Malignant Biliary_Cystadenocarcinoma 8161/3 Bile duct cystadenocarcinoma Bile Duct Cystadenocarcinoma Bile Duct MCN with an Associated Invasive Carcinoma Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma Bile duct cystadenocarcinoma Biliary Cystadenocarcinoma Cystadenocarcinoma of Bile Duct Cystadenocarcinoma of the Bile Duct Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma A distinctive type of liver cell carcinoma that arises in non-cirrhotic livers and is seen predominantly in young patients. The tumor cells are polygonal and deeply eosinophilic, and are embedded in a fibrous stroma. The prognosis is similar to classical hepatocellular carcinoma that arises in non-cirrhotic livers, and better than hepatocellular carcinoma that arises in cirrhotic livers. C4131 Neoplastic Process Fibrolamellar Carcinoma Fibrolamellar Carcinoma C0334287 CPTAC CTRP GDC 8171/3 Malignant Fibrolamellar_Hepatocellular_Carcinoma 8171/3 Hepatocellular carcinoma, fibrolamellar FLC Fibrolamellar Cancer Fibrolamellar Carcinoma Fibrolamellar Carcinoma of Liver Cells Fibrolamellar Carcinoma of the Liver Cells Fibrolamellar Hepatocellular Carcinoma Hepatocellular Fibrolamellar Carcinoma Hepatocellular carcinoma, fibrolamellar Liver Cell Fibrolamellar Carcinoma Oncocytic Hepatocellular Tumor Polygonal Cell Type Hepatocellular Carcinoma with Fibrous Stroma Fibrolamellar Carcinoma An adenoma arising from the glandular epithelium of the gastrointestinal tract. It is characterized by the presence of a tubular architectural pattern. Most often it occurs in the large intestine, small intestine, and the stomach. The neoplastic epithelial cells show dysplastic features. C4133 Neoplastic Process Tubular Adenoma C0334292 CDISC GDC A benign neoplasm arising from glandular epithelium, characterized by a tubular architectural pattern. 8211/0 Benign Tubular_Adenoma 8211/0 Tubular adenoma, NOS ADENOMA, TUBULAR CELL, BENIGN GI Tract Tubular Adenoma Gastrointestinal Tract Tubular Adenoma Tubular Adenoma Tubular adenoma, NOS Tubular Adenoma A condition in which multiple adenomas develop in the gastrointestinal tract. C4135 Neoplastic Process Multiple Adenomatous Polyps C0334294 GDC 8221/0 Undetermined Multiple_Adenomatous_Polyps 8221/0 Multiple adenomatous polyps GI Tract Multiple Adenomatous Polyps Gastrointestinal Tract Multiple Adenomatous Polyps Multiple Adenomatous Polyps Multiple adenomatous polyps Multiple Adenomatous Polyps A well differentiated, low grade neoplasm with neuroendocrine differentiation that arises from the appendix. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. C4138 Neoplastic Process Appendix Neuroendocrine Tumor G1 C0334298 CPTAC 8240/1 Undetermined Appendix_Carcinoid_Tumor Appendix Carcinoid Tumor Appendix NET G1 Appendix Neuroendocrine Tumor G1 Appendix Neuroendocrine Tumor G1 A benign, well circumscribed lung neoplasm morphologically characterized by the presence of cystic spaces resembling alveoli, lined by a simple cuboidal epithelium. The cystic spaces are surrounded by a spindle cell stroma which may show myxoid changes. It is a solitary, usually peripheral lung lesion. Patients are usually asymptomatic and its discovery is an incidental finding during chest X-ray examination. Surgical excision is curative. C4140 Neoplastic Process Alveolar Adenoma C0334303 CDISC GDC A benign lung neoplasm arising from the alveolar/bronchiolar epithelium. 8251/0 Benign Alveolar_Adenoma 8251/0 Alveolar adenoma ADENOMA, BRONCHIOLOALVEOLAR, BENIGN Adenoma of Alveoli Adenoma of the Alveoli Alveolar Adenoma Alveolar adenoma Alveolar Adenoma A neurofibroma characterized by the presence of scattered atypical or bizarre nuclei and smudgy chromatin in the absence of other worrisome features. (WHO 2020) C41426 Neoplastic Process Neurofibroma with Atypia C1510961 Benign Atypical_Neurofibroma Ancient Neurofibroma Neurofibroma with Atypia Neurofibroma with Atypia A neurofibroma characterized by the presence of areas with increased cellularity. C41427 Neoplastic Process Cellular Neurofibroma C1516371 Benign Cellular_Neurofibroma Cellular Neurofibroma Cellular Neurofibroma An adenoma arising from the glandular epithelium of the gastrointestinal tract. It is characterized by the presence of a tubular and a villous architectural pattern. Most often it occurs in the large intestine, small intestine, and the stomach. The neoplastic epithelial cells show dysplastic features. C4143 Neoplastic Process Tubulovillous Adenoma C0334307 GDC A neoplasm that grows in the colon and other places in the gastrointestinal tract and sometimes in other parts of the body. These adenomas may become malignant (cancerous). 8263/0 Benign Tubulovillous_Adenoma 8263/0 Papillotubular adenoma Tubulo-papillary adenoma Tubulovillous adenoma, NOS Villoglandular adenoma GI Tract Tubulovillous Adenoma Gastrointestinal Tract Tubulovillous Adenoma Tubulovillous Adenoma Tubulovillous adenoma, NOS tubulovillous adenoma Tubulovillous Adenoma A benign, usually encapsulated slow growing tumor of the peripheral nervous system composed of Schwann cells. It recurs infrequently and only rare cases associated with malignant transformation have been reported. C41430 Neoplastic Process Peripheral Nerve Schwannoma C1519001 Benign Peripheral_Nerve_Schwannoma Peripheral Nerve Schwannoma Peripheral Nerve Schwannoma A type of carcinoma that comprises a minority of renal cell carcinomas. It is characterized by loss of chromosomes 1 and Y. Based on the cytoplasmic characteristics of the neoplastic cells, this type of carcinoma is classified as classic (typical), eosinophilic, or oncocytic. It has a much better prognosis than other renal cell carcinomas. C4146 Neoplastic Process Chromophobe Renal Cell Carcinoma Chromophobe Renal Cell Carcinoma C1266042 CTRP Cellosaurus GDC 8270/3 8317/3 Malignant Chromophobe_Renal_Cell_Carcinoma 8270/3 8317/3 Chromophobe adenocarcinoma Chromophobe carcinoma Chromophobe cell renal carcinoma Renal cell carcinoma, chromophobe type Chromophobe Adenocarcinoma Chromophobe Carcinoma Chromophobe Carcinoma of Kidney Chromophobe Carcinoma of the Kidney Chromophobe Cell Carcinoma of Kidney Chromophobe Cell Carcinoma of the Kidney Chromophobe RCC Chromophobe Renal Cell Cancer Chromophobe Renal Cell Carcinoma Chromophobe adenocarcinoma Chromophobe carcinoma Chromophobe cell renal carcinoma Renal Cell Carcinoma, Chromophobe Type Renal cell carcinoma, chromophobe type Chromophobe Renal Cell Carcinoma Any therapeutic procedure that administers dihydrotestosterone, often transdermally, as androgen replacement therapy. Dihydrotestosterone therapy is intended to activate various biochemical processes that are dependent on the steroid. C41474 Therapeutic or Preventive Procedure Dihydrotestosterone Therapy C1511963 Dihydrotestosterone_Secretion_Induction Dihydrotestosterone Secretion Dihydrotestosterone Secretion Induction Dihydrotestosterone Therapy Dihydrotestosterone Therapy Any therapeutic procedure that employs an inhibitor of 3-oxo-5-alpha-steroid 4-dehydrogenases, and results in reduced production of dihydrotestosterone from testosterone. Dihydrotestosterone suppression is used to treat the symptoms of benign prostatic hypertrophy. C41497 Therapeutic or Preventive Procedure Dihydrotestosterone Suppression C1511964 Dihydrotestosterone_Secretion_Inhibition Dihydrotestosterone Secretion Inhibition Dihydrotestosterone Suppression Dihydrotestosterone Suppression A parathyroid gland adenoma composed predominantly of neoplastic chief cells. These cells have either slightly eosinophilic or vacuolated cytoplasm, and round nuclei. C4154 Neoplastic Process Parathyroid Gland Chief Cell Adenoma Parathyroid Gland Chief Cell Adenoma C0334320 CTRP GDC 8321/0 Benign Parathyroid_Chief_Cell_Adenoma 8321/0 Chief cell adenoma Chief Cell Adenoma Chief Cell Adenoma of Parathyroid Chief Cell Adenoma of Parathyroid Gland Chief Cell Adenoma of the Parathyroid Chief Cell Adenoma of the Parathyroid Gland Chief cell adenoma Parathyroid Chief Cell Adenoma Parathyroid Gland Chief Cell Adenoma Parathyroid Gland Chief Cell Adenoma A rare parathyroid gland adenoma composed of neoplastic cells with abundant cytoplasm. The cytoplasm of the neoplastic cells is usually not entirely clear, and is often variably vacuolated, foamy, and granular. C4155 Neoplastic Process Parathyroid Gland Water-Clear Cell Adenoma C0334321 GDC 8322/0 Benign Water-Clear_Cell_Adenoma 8322/0 Water-clear cell adenoma Parathyroid Gland Water-Clear Cell Adenoma Water-Clear Cell Adenoma Water-clear cell adenoma Parathyroid Gland Water-Clear Cell Adenoma A thyroid gland adenoma composed of microfollicular structures. C4160 Neoplastic Process Thyroid Gland Microfollicular Adenoma C0334328 GDC 8333/0 Benign Microfollicular_Adenoma 8333/0 Fetal adenoma Microfollicular adenoma, NOS Fetal Adenoma Fetal adenoma Microfollicular Adenoma Thyroid Gland Fetal Adenoma Thyroid Gland Microfollicular Adenoma Thyroid Gland Microfollicular Adenoma A thyroid gland adenoma composed of large size follicles. C4161 Neoplastic Process Thyroid Gland Macrofollicular Adenoma C0334329 Cellosaurus GDC 8334/0 Benign Macrofollicular_Adenoma 8334/0 Colloid adenoma Macrofollicular adenoma Colloid Adenoma Colloid adenoma Macrofollicular Adenoma Macrofollicular adenoma Thyroid Gland Macrofollicular Adenoma Thyroid Gland Macrofollicular Adenoma An intrahepatic cholangiocarcinoma that arises from the canals of Hering. C41617 Neoplastic Process Cholangiolocellular Carcinoma C1516490 Malignant Cholangiolocellular_Carcinoma CLC Cholangiolocellular Carcinoma Cholangiolocellular Carcinoma An intrahepatic cholangiocarcinoma that produces abundant mucin. C41618 Neoplastic Process Mucin-Producing Intrahepatic Cholangiocarcinoma C1513718 Malignant Mucinous_Intrahepatic_Cholangiocarcinoma Mucin-Producing Intrahepatic Cholangiocarcinoma Mucinous Intrahepatic Cholangiocarcinoma Mucin-Producing Intrahepatic Cholangiocarcinoma An intrahepatic cholangiocarcinoma characterized by the presence of signet ring adenocarcinoma cells. C41619 Neoplastic Process Signet Ring Cell Intrahepatic Cholangiocarcinoma C1519321 Malignant Signet_Ring_Cell_Intrahepatic_Cholangiocarcinoma Signet Ring Cell Intrahepatic Cholangiocarcinoma Signet-Ring Cell Intrahepatic Cholangiocarcinoma Signet Ring Cell Intrahepatic Cholangiocarcinoma A benign, well circumscribed neoplasm arising from the cortex of the kidney. It secrets renin and the patients usually present with severe hypertension and marked hypokalemia. Morphologically, it is characterized by the presence of sheets of polygonal or spindle-shaped neoplastic cells forming a hemangiopericytic pattern. C4162 Neoplastic Process Juxtaglomerular Cell Tumor C0334331 Cellosaurus GDC 8361/0 Benign Juxtaglomerular_Cell_Tumor 8361/0 Juxtaglomerular tumor Reninoma Juxtaglomerular Cell Tumor Juxtaglomerular Neoplasm Juxtaglomerular Tumor Juxtaglomerular tumor Reninoma Juxtaglomerular Cell Tumor A rare, aggressive variant of intrahepatic cholangiocarcinoma. It is characterized by the presence of adenocarcinoma cells that are intermingled with malignant pleomorphic spindle cells. C41620 Neoplastic Process Sarcomatoid Intrahepatic Cholangiocarcinoma C1519184 Malignant Sarcomatous_Intrahepatic_Cholangiocarcinoma Intrahepatic Cholangiocarcinoma with Extensive Sarcomatous Changes Sarcomatoid Intrahepatic Cholangiocarcinoma Sarcomatous Intrahepatic Cholangiocarcinoma Sarcomatoid Intrahepatic Cholangiocarcinoma An adenoma of the adrenal cortex composed of neoplastic compact cells with eosinophilic cytoplasm. C4163 Neoplastic Process Adrenal Cortical Compact Cell Adenoma C0334332 GDC 8371/0 Benign Compact_Cell_Adrenal_Cortical_Adenoma 8371/0 Adrenal cortical adenoma, compact cell Adrenal Cortex Compact Cell Adenoma Adrenal Cortical Compact Cell Adenoma Adrenal Gland Compact Cell Adenoma Adrenal cortical adenoma, compact cell Compact Cell Adrenal Cortex Adenoma Compact Cell Adrenal Cortical Adenoma Compact Cell Adrenocortical Adenoma Adrenal Cortical Compact Cell Adenoma A usually functioning adenoma of the adrenal cortex. Grossly, it has a dark brown appearance and is characterized by the presence of neoplastic cells containing abundant intracytoplasmic lipofuscin. It may be associated with Cushing syndrome. C4164 Neoplastic Process Pigmented Adrenal Cortical Adenoma C0334333 GDC 8372/0 Benign Heavily_Pigmented_Adrenal_Cortical_Adenoma 8372/0 Adrenal cortical adenoma, pigmented Black adenoma Pigmented adenoma Adrenal cortical adenoma, pigmented Black Adenoma Black adenoma Heavily Pigmented Adrenal Cortex Adenoma Heavily Pigmented Adrenal Cortical Adenoma Heavily Pigmented Adrenocortical Adenoma Pigmented Adrenal Cortex Adenoma Pigmented Adrenal Cortical Adenoma Pigmented Adrenal Gland Adenoma Pigmented adenoma Pigmented Adrenal Cortical Adenoma An adenoma of the adrenal cortex composed of neoplastic clear cells containing intracytoplasmic lipid droplets. C4165 Neoplastic Process Adrenal Cortical Clear Cell Adenoma C0334334 GDC 8373/0 Benign Clear_Cell_Adrenal_Cortical_Adenoma 8373/0 Adrenal cortical adenoma, clear cell Adrenal Cortex Clear Cell Adenoma Adrenal Cortical Clear Cell Adenoma Adrenal Gland Clear Cell Adenoma Adrenal cortical adenoma, clear cell Clear Cell Adrenal Cortex Adenoma Clear Cell Adrenal Cortical Adenoma Clear Cell Adrenocortical Adenoma Adrenal Cortical Clear Cell Adenoma An adenoma of the adrenal cortex composed of neoplastic cells with cytologic features of glomerulosa cells. C4166 Neoplastic Process Adrenal Cortical Glomerulosa Cell Adenoma C0334335 GDC 8374/0 Benign Glomerulosa_Cell_Adrenal_Cortical_Adenoma 8374/0 Adrenal cortical adenoma, glomerulosa cell Adrenal Cortex Glomerulosa Cell Adenoma Adrenal Cortical Glomerulosa Cell Adenoma Adrenal Gland Glomerulosa Cell Adenoma Adrenal cortical adenoma, glomerulosa cell Glomerulosa Cell Adrenal Cortex Adenoma Glomerulosa Cell Adrenal Cortical Adenoma Glomerulosa Cell Adrenocortical Adenoma Adrenal Cortical Glomerulosa Cell Adenoma An adenoma of the adrenal cortex composed of a mixed neoplastic cellular population, including varying numbers of neoplastic clear and compact cells. C4167 Neoplastic Process Adrenal Cortical Mixed Cell Adenoma C0334336 GDC 8375/0 Benign Mixed_Cell_Adrenal_Cortical_Adenoma 8375/0 Adrenal cortical adenoma, mixed cell Adrenal Cortex Mixed Cell Adenoma Adrenal Cortical Mixed Cell Adenoma Adrenal Gland Mixed Cell Adenoma Adrenal cortical adenoma, mixed cell Mixed Cell Adrenal Cortex Adenoma Mixed Cell Adrenal Cortical Adenoma Mixed Cell Adrenocortical Adenoma Adrenal Cortical Mixed Cell Adenoma A benign epithelial neoplasm arising from the apocrine sweat glands. Representative examples include tubular apocrine adenoma and external auditory canal ceruminous adenoma. C4168 Neoplastic Process Apocrine Adenoma C0334345 GDC 8401/0 Benign Apocrine_Adenoma 8401/0 Apocrine adenoma Apocrine Adenoma Apocrine adenoma Apocrine Adenoma A carcinoma with apocrine differentiation arising from the sweat glands. It presents as single or multiple nodular lesions which may be ulcerated or hemorrhagic and is usually in the axilla and less often in the anogenital region. It grows in the dermis and infiltrates subcutaneous tissues. It is characterized by the presence of large cells with abundant eosinophilic cytoplasm and large often vesicular nuclei. Most cases are slow growing tumors and have a prolonged course. C4169 Neoplastic Process Apocrine Carcinoma C1706827 GDC 8401/3 Malignant Apocrine_Carcinoma 8401/3 Apocrine adenocarcinoma Apocrine Adenocarcinoma Apocrine Carcinoma Apocrine Gland Carcinoma Apocrine adenocarcinoma Carcinoma of Apocrine Gland Apocrine Carcinoma A benign epithelial neoplasm with eccrine or apocrine differentiation, arising from the sweat glands. It usually presents as a solitary, well circumscribed, firm nodule in the face and upper trunk. It is characterized by the presence of basaloid cells forming nodules in the dermis. Cases of carcinoma arising from long standing spiradenomas have been reported. C4170 Neoplastic Process Spiradenoma C0334347 GDC 8403/0 Benign Eccrine_Spiradenoma 8403/0 Eccrine spiradenoma Spiradenoma, NOS Benign Eccrine Spiradenoma Eccrine Spiradenoma Eccrine spiradenoma Spiradenoma Spiradenoma, NOS Spiradenoma A benign neoplasm arising from the sweat glands. It presents as a slow growing cystic nodular lesion most often in the skin of the vulva and the perianal region. It is characterized by the presence of cystic and large papillary structures. The papillary structures contain connective tissue and are covered by two layers of epithelium. Complete excision is curative. C4171 Neoplastic Process Hidradenoma Papilliferum C0334348 GDC 8405/0 Benign Papillary_Hidradenoma_Hidradenoma_Papilliferum 8405/0 Hidradenoma papilliferum Papillary hidradenoma Hidradenoma Papilliferum Hidradenoma papilliferum Papillary Hidradenoma Papillary hidradenoma Hidradenoma Papilliferum A benign adnexal neoplasm occurring during childhood or adolescence. It usually presents as a papular lesion or a plaque on the head and neck. It may arise in an organoid nevus such as sebaceous. It is characterized by an endophytic invagination of the epithelium into the dermis. There are dermal cystic spaces present, containing villous projections. Complete excision is curative. C4172 Neoplastic Process Syringocystadenoma Papilliferum C0406803 GDC 8406/0 Benign Papillary_Syringadenoma_Syringocystadenoma_Papilliferum 8406/0 Papillary syringadenoma Papillary syringocystadenoma Syringocystadenoma papilliferum Papillary Syringadenoma Papillary Syringocystadenoma Papillary syringocystadenoma SCAP Syringadenoma Syringocystadenoma Papilliferum Syringocystadenoma papilliferum Syringocystadenoma Papilliferum A benign, well circumscribed neoplasm arising from the sebaceous glands. It usually presents as a small yellowish tumor in the sun exposed skin of head and neck. It is characterized by the presence of sebaceous cells aggregates with a peripheral rim of basaloid cells. C4174 Neoplastic Process Sebaceous Adenoma C1368816 CDISC GDC A benign adenoma neoplasm with sebaceous differentiation. 8410/0 Benign Sebaceous_Adenoma 8410/0 Sebaceous adenoma ADENOMA, SEBACEOUS, BENIGN Adenoma of Sebaceous Gland Adenoma of the Sebaceous Gland Adenoma, Sebaceous Cell Sebaceous Adenoma Sebaceous Gland Adenoma Sebaceous adenoma Skin Appendage Sebaceous Adenoma Sebaceous Adenoma An infiltrating adenocarcinoma derived from ceruminous glands in the external auditory canal. C4176 Neoplastic Process Ceruminous Adenocarcinoma C0334353 CDISC GDC A malignant neoplasm derived from ceruminous glands in the external auditory canal. 8420/3 Malignant Ceruminous_Adenocarcinoma 8420/3 Ceruminous adenocarcinoma Ceruminous carcinoma CARCINOMA, CERUMINOUS GLAND, MALIGNANT Ceruminous Adenocarcinoma Ceruminous Adenocarcinoma of the External Auditory Canal Ceruminous adenocarcinoma External Auditory Canal Ceruminous Adenocarcinoma Ceruminous Adenocarcinoma A classic form of gliomatosis cerebri. It is characterized by diffuse growth of neoplastic glial tissue without any focal mass. C41842 Neoplastic Process Gliomatosis Cerebri Type I C1517555 Malignant Gliomatosis_Cerebri_Type_I Gliomatosis Cerebri Type I Gliomatosis Cerebri Type I A classic form of gliomatosis cerebri. It is characterized by diffuse growth of neoplastic glial tissue without any focal mass. C41843 Neoplastic Process Gliomatosis Cerebri Type II C1512194 Malignant Gliomatosis_Cerebri_Type_II Gliomatosis Cerebri Type II Gliomatosis Cerebri Type II A rare, low grade invasive adenocarcinoma of the breast characterized by the presence of cells that secrete milk-like material. Morphologically, it usually appears as a circumscribed lesion, composed of cystic spaces, tubular structures, and solid areas. C4189 Neoplastic Process Breast Secretory Carcinoma C0334371 GDC 8502/3 8508/3 Malignant Secretory_Breast_Carcinoma 8508/3 Cystic hypersecretory carcinoma Juvenile carcinoma of breast Secretory carcinoma Secretory carcinoma of breast Breast Secretory Carcinoma Cystic Hypersecretory Breast Carcinoma Cystic Hypersecretory Carcinoma of Breast Cystic Hypersecretory Carcinoma of the Breast Cystic hypersecretory carcinoma Infiltrating Cystic Hypersecretory Duct Breast Carcinoma Invasive Cystic Hypersecretory Duct Breast Carcinoma Juvenile Breast Carcinoma Juvenile Carcinoma of Breast Juvenile Carcinoma of the Breast Juvenile Secretory Breast Carcinoma Juvenile Secretory Carcinoma of Breast Juvenile Secretory Carcinoma of the Breast Juvenile carcinoma of breast Secretory Breast Carcinoma Secretory Carcinoma Secretory Carcinoma of Breast Secretory Carcinoma of the Breast Secretory carcinoma of breast Breast Secretory Carcinoma Breast ductal carcinoma in situ characterized by the presence of filiform arborizing fibrovascular cores lined by neoplastic ductal epithelium. (WHO 2019) C4190 Neoplastic Process Breast Papillary Ductal Carcinoma In Situ C0334372 GDC 8503/2 Malignant Intraductal_Papillary_Breast_Carcinoma 8503/2 DCIS, papillary Ductal carcinoma in situ, papillary Intraductal papillary adenocarcinoma, NOS Intraductal papillary carcinoma Noninfiltrating intraductal papillary adenocarcinoma Noninfiltrating intraductal papillary carcinoma Breast Intracystic Papillary Carcinoma Breast Intraductal Papillary Carcinoma Breast Papillary DCIS Breast Papillary Ductal Carcinoma In Situ Intraductal Papillary Adenocarcinoma Intraductal Papillary Breast Adenocarcinoma Intraductal Papillary Breast Carcinoma Intraductal Papillary Carcinoma Intraductal papillary carcinoma Non-Infiltrating Intraductal Papillary Adenocarcinoma Non-Infiltrating Intraductal Papillary Carcinoma Non-Infiltrating Papillary Breast Adenocarcinoma Non-Infiltrating Papillary Breast Carcinoma Non-Invasive Intraductal Papillary Adenocarcinoma Non-Invasive Intraductal Papillary Carcinoma Non-Invasive Papillary Breast Adenocarcinoma Non-Invasive Papillary Breast Carcinoma Papillary DCIS Papillary Ductal Carcinoma In Situ Breast Papillary Ductal Carcinoma In Situ A benign epithelial neoplasm arising from the nipple. Signs and symptoms include serous or sanguineous nipple discharge and nipple erosion. It is characterized by the presence of aggregates of small tubules replacing the nipple stroma. The tubules are lined by epithelial and myoepithelial cells. C4192 Neoplastic Process Nipple Adenoma C0334378 GDC 8506/0 Benign Nipple_Adenoma 8506/0 Adenoma of nipple Subareolar duct papillomatosis Adenoma of Nipple Adenoma of nipple Adenoma of the Nipple Erosive Nipple Adenomatosis Nipple Adenoma Subareolar Duct Papillomatosis Subareolar duct papillomatosis Nipple Adenoma A medullary thyroid gland carcinoma characterized by the presence of amyloid stroma. The majority of medullary carcinomas of the thyroid gland are associated with amyloid deposits. The latter are highlighted with Congo red staining method. C4193 Neoplastic Process Thyroid Gland Medullary Carcinoma with Amyloid Stroma C0334379 GDC 8345/3 Malignant Medullary_Carcinoma_with_Amyloid_Stroma 8345/3 Medullary carcinoma with amyloid stroma C Cell Adenocarcinoma with Amyloid Stroma C Cell Carcinoma with Amyloid Stroma Medullary Adenocarcinoma with Amyloid Stroma Medullary Carcinoma with Amyloid Stroma Medullary Thyroid Gland Carcinoma with Amyloid Stroma Medullary carcinoma with amyloid stroma Parafollicular Cell Adenocarcinoma with Amyloid Stroma Parafollicular Cell Carcinoma with Amyloid Stroma Thyroid Gland Medullary Carcinoma with Amyloid Stroma Thyroid Gland Medullary Carcinoma with Amyloid Stroma A term that refers to a large and heterogeneous group of invasive breast carcinomas that cannot be classified morphologically as any of the special histological types. (WHO 2019) C4194 Neoplastic Process Invasive Ductal Carcinoma, Not Otherwise Specified Invasive Breast Carcinoma of No Special Type C1134719 CTRP Cellosaurus GDC The most common type of invasive breast cancer. It starts in the cells that line the milk ducts in the breast, grows outside the ducts, and often spreads to the lymph nodes. 8500/3 8521/3 Malignant Invasive_Ductal_Carcinoma_not_Otherwise_Specified 8500/3 Infiltrating duct adenocarcinoma Infiltrating duct carcinoma, NOS Infiltrating ductular carcinoma IBC NST Infiltrating Ductal Adenocarcinoma Infiltrating Ductal Breast Carcinoma Infiltrating Ductal Carcinoma Infiltrating Ductal Carcinoma of Breast Infiltrating Ductal Carcinoma of the Breast Invasive Breast Carcinoma of No Special Type Invasive Ductal Adenocarcinoma Invasive Ductal Breast Carcinoma Invasive Ductal Carcinoma Invasive Ductal Carcinoma of Breast Invasive Ductal Carcinoma of the Breast Invasive Ductal Carcinoma, NOS Invasive Ductal Carcinoma, NST Invasive Ductal Carcinoma, No Specific Type Invasive Ductal Carcinoma, Not Otherwise Specified infiltrating ductal carcinoma Invasive Breast Carcinoma of No Special Type The co-existence of ductal and lobular carcinoma in situ in the breast, without evidence of stromal invasion. C4195 Neoplastic Process Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ C0334383 GDC 8522/2 Malignant Ductal_Carcinoma_in_situ_and_Lobular_Carcinoma_in_situ 8522/2 Intraductal carcinoma and lobular carcinoma in situ Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ DCIS and LCIS of Breast DCIS and LCIS of the Breast Ductal Breast Carcinoma In Situ and Lobular Carcinoma In Situ Ductal Carcinoma in situ with Lobular Carcinoma in situ of Breast Ductal Carcinoma in situ with Lobular Carcinoma in situ of the Breast Ductal and Lobular Breast Carcinoma in situ Ductal and Lobular Carcinoma in situ of Breast Ductal and Lobular Carcinoma in situ of the Breast Intraductal Carcinoma and Lobular Carcinoma in situ Intraductal and Lobular Breast Carcinoma in situ Intraductal and Lobular Carcinoma in situ of Breast Intraductal and Lobular Carcinoma in situ of the Breast Intraductal carcinoma and lobular carcinoma in situ Non-Infiltrating Ductal and Non-Infiltrating Lobular Breast Carcinoma Non-Infiltrating Ductal with Non-Infiltrating Lobular Carcinoma of Breast Non-Infiltrating Ductal with Non-Infiltrating Lobular Carcinoma of the Breast Non-Invasive Ductal Breast Carcinoma with Non-Invasive Lobular Breast Carcinoma Non-Invasive Ductal Carcinoma with Non-Invasive Lobular Carcinoma of Breast Non-Invasive Ductal Carcinoma with Non-Invasive Lobular Carcinoma of the Breast Non-Invasive Ductal and Non-Invasive Lobular Breast Carcinoma Non-Invasive Ductal and Non-Invasive Lobular Carcinoma Non-Invasive Ductal with Non-Invasive Lobular Breast Carcinoma Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ A variant of ovarian thecoma characterized by the presence of lutein cells. It is associated with a lower frequency of estrogenic manifestations compared to typical thecomas. In a minority of cases androgenic manifestations are present. C4203 Neoplastic Process Ovarian Luteinized Thecoma C0334399 GDC 8601/0 Undetermined Luteinized_Thecoma 8601/0 Thecoma, luteinized Luteinized Ovarian Thecoma Luteinized Thecoma of Ovary Luteinized Thecoma of the Ovary Ovarian Luteinized Thecoma Thecoma, luteinized Ovarian Luteinized Thecoma A benign ovarian stromal tumor characterized by the presence of cellular areas which contain fibroblasts and round cells. The cellular areas are separated by sclerotic or edematous hypocellular tissue. Symptoms include abdominal discomfort and menstrual abnormalities. C4204 Neoplastic Process Ovarian Sclerosing Stromal Tumor C0334400 GDC 8602/0 Benign Ovarian_Sclerosing_Stromal_Tumor 8602/0 Sclerosing stromal tumor Ovarian Sclerosing Stromal Neoplasm Ovarian Sclerosing Stromal Tumor Sclerosing Stromal Neoplasm of Ovary Sclerosing Stromal Neoplasm of the Ovary Sclerosing Stromal Tumor Sclerosing Stromal Tumor of Ovary Sclerosing Stromal Tumor of the Ovary Ovarian Sclerosing Stromal Tumor A neuroblastoma characterized by the absence of differentiating neuroblasts. C42046 Neoplastic Process Undifferentiated Neuroblastoma Undifferentiated Neuroblastoma C1519787 CTRP GDC Malignant Undifferentiated_Neuroblastoma Undifferentiated Undifferentiated or Poorly Differentiated Undifferentiated Undifferentiated Neuroblastoma Undifferentiated Neuroblastoma A neuroblastoma in which the differentiating neuroblasts constitute less than five-percent of the tumor cells. C42047 Neoplastic Process Poorly Differentiated Neuroblastoma Poorly Differentiated Neuroblastoma C1514225 CTRP GDC Malignant Poorly_Differentiated_Neuroblastoma Poorly Differentiated Undifferentiated or Poorly Differentiated Poorly Differentiated Poorly Differentiated Neuroblastoma Poorly Differentiated Neuroblastoma A neuroblastoma in which the differentiating neuroblasts constitute more than five-percent of the tumor cells. C42048 Neoplastic Process Differentiating Neuroblastoma Differentiating Neuroblastoma C1511934 CTRP GDC Malignant Differentiating_Neuroblastoma Differentiating Differentiating Differentiating Neuroblastoma Differentiating Neuroblastoma A granulosa cell tumor which has an aggressive clinical course and metastasizes to other anatomic sites. C4205 Neoplastic Process Malignant Granulosa Cell Tumor C0334401 CDISC GDC A malignant neoplasm of the ovary, originating from granulosa cells. 8620/3 Malignant Malignant_Granulosa_Cell_Tumor 8620/3 Granulosa cell carcinoma Granulosa cell tumor, malignant GRANULOSA CELL TUMOR, MALIGNANT Granulosa cell carcinoma Granulosa cell tumor, malignant Malignant Granulosa Cell Neoplasm Malignant Granulosa Cell Tumor Malignant Granulosa Cell Tumor A ganglioneuroblastoma characterized by the presence of neuroblastic cells in a Schwannian stroma, without the presence of hemorrhagic neuroblastic nodules. C42057 Neoplastic Process Ganglioneuroblastoma, Intermixed C1517444 Malignant Ganglioneuroblastoma_Intermixed GNB-i Ganglioneuroblastoma, Intermixed Ganglioneuroblastoma, Intermixed (Schwannian Stroma-Rich) Ganglioneuroblastoma, Intermixed A ganglioneuroblastoma characterized by the presence of neuroblastic cells in a Schwannian stroma, and the formation of hemorrhagic neuroblastic nodules. C42058 Neoplastic Process Ganglioneuroblastoma, Nodular C1517445 Malignant Ganglioneuroblastoma_Nodular GNBn Ganglioneuroblastoma, Nodular Ganglioneuroblastoma, Nodular A neuroblastic tumor characterized by the presence of a ganglioneuroblastoma component and the formation of Schwannian stroma which constitutes more than fifty-percent of the tumor volume. C42059 Neoplastic Process Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor C1516760 Malignant Composite_Ganglioneuroblastoma_Schwannian_Stroma_Rich_and_Stroma_Poor Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor A neuroblastic tumor characterized by the presence of a ganglioneuroblastoma component and the formation of Schwannian stroma which is the predominant component of the tumor volume. C42060 Neoplastic Process Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor C1516761 Malignant Composite_Ganglioneuroblastoma_Stroma_Dominant_and_Stroma_Poor Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor A ganglioneuroma characterized by the presence of differentiating neuroblasts, maturing and mature ganglion cells. C42064 Neoplastic Process Maturing Ganglioneuroma C1513034 Benign Maturing_Ganglioneuroma Maturing Ganglioneuroma Maturing Ganglioneuroma A ganglioneuroma characterized by the presence of mature ganglion cells and a mature Schwannian stroma. C42065 Neoplastic Process Mature Ganglioneuroma C1513025 Benign Mature_Ganglioneuroma Mature Ganglioneuroma Mature Ganglioneuroma A sex cord-stromal tumor occurring in the ovary and testis. In females it occurs predominantly in the first three decades of life and presents unilaterally as stage I disease in the vast majority of cases. It is characterized by the presence of granulosa cells forming macrofollicular structures. The majority of cases have a good prognosis. In males it represents the most frequent congenital testicular neoplasm, and the vast majority of cases occur in the perinatal period. It presents as a scrotal or abdominal mass, and it more often affects the left testis. Approximately 20% of the patients have ambiguous external genitalia. It is characterized by the presence of cystic spaces lined by granulosa cells and cells resembling theca cells. Metastases have not been reported. C4207 Neoplastic Process Juvenile Granulosa Cell Tumor C0334403 GDC NICHD A rare type of tumor derived from the granulosa cells in the ovary or testis. Ninety percent of girls with the tumor will have low stage disease, which is curable with surgery alone. In males, it usually presents in infancy (median age, 6 days), which is treated with surgery alone. 8622/1 Undetermined Juvenile_Granulosa_Cell_Tumor 8622/1 Granulosa cell tumor, juvenile Granulosa cell tumor, juvenile Juvenile Granulosa Cell Tumor Juvenile Type Granulosa Cell Neoplasm Juvenile Type Granulosa Cell Tumor Juvenile Granulosa Cell Tumor An ovarian sex cord-stromal tumor characterized by the presence of Sertoli cells forming annular tubules. It may be associated with Peutz-Jeghers syndrome. Cases associated with Peutz-Jeghers syndrome have followed a benign clinical course. Cases which are not associated with Peutz-Jeghers syndrome have been reported having a clinically malignant course. C4208 Neoplastic Process Ovarian Sex Cord Tumor with Annular Tubules C1519276 GDC 8623/1 Undetermined Sex_Cord_Tumor_with_Annular_Tubules 8623/1 Sex cord tumor with annular tubules Ovarian Sertoli Cell Tumor, Annular Tubular Variant Ovarian Sex Cord Neoplasm with Annular Tubules Ovarian Sex Cord Tumor with Annular Tubules Sex cord tumor with annular tubules Ovarian Sex Cord Tumor with Annular Tubules A neoplasm that arises from the choroid plexus in the brain and occurs during childhood. C42080 Neoplastic Process Childhood Choroid Plexus Neoplasm Childhood Choroid Plexus Neoplasm CL448678 CTRP NICHD A neoplasm that arises from the choroid plexus during childhood. Undetermined Childhood_Choroid_Plexus_Neoplasm Childhood Choroid Plexus Neoplasm Choroid Plexus Neoplasm Childhood Choroid Plexus Neoplasm A Sertoli-Leydig tumor of the ovary characterized by the presence of Sertoli cells in tubules without evidence of significant nuclear atypia or mitotic activity. Primitive gonadal stromal cells are not present. It usually follows a benign clinical course. C4209 Neoplastic Process Well Differentiated Ovarian Sertoli-Leydig Cell Tumor C1314745 GDC 8631/0 Benign Benign_Androblastoma 8631/0 Sertoli-Leydig cell tumor, well differentiated Sertoli-Leydig cell tumor, well differentiated Well Differentiated Ovarian Sertoli-Leydig Cell Tumor Well Differentiated Ovarian Sertoli-Leydig Cell Tumor A Sertoli-Leydig tumor of the ovary characterized by the presence of a sarcomatoid stroma which contains primitive gonadal stromal cells. It may behave in a malignant fashion and metastasize to other anatomic sites. C4210 Neoplastic Process Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor C1266105 GDC 8631/3 Malignant Malignant_Androblastoma 8631/3 Sertoli-Leydig cell tumor, poorly differentiated Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor Sertoli-Leydig cell tumor, poorly differentiated Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor A Sertoli cell tumor that arises from the ovary and is characterized by the presence of cells that are distended by the presence of intracytoplasmic lipid. C4211 Neoplastic Process Ovarian Sertoli Cell Tumor with Lipid Storage C0334408 GDC Benign Tubular_Androblastoma_with_Lipid_Storage 8641/0 Sertoli cell tumor with lipid storage Ovarian Sertoli Cell Tumor with Lipid Storage Sertoli cell tumor with lipid storage Ovarian Sertoli Cell Tumor with Lipid Storage A Leydig cell tumor which does not recur or metastasize. Morphologically, there is no evidence of cellular atypia, increased mitotic activity, necrosis, or vascular invasion. C4212 Neoplastic Process Benign Leydig Cell Tumor C0334409 CDISC GDC A benign neoplasm of the testis originating from interstitial (Leydig) cells. 8650/0 Benign Benign_Leydig_Cell_Tumor 8650/0 Interstitial cell tumor, benign Leydig cell tumor, benign Adenoma, Interstitial Adenoma, Leydig Cell Benign Interstitial Cell Neoplasm Benign Interstitial Cell Tumor Benign Leydig Cell Neoplasm Benign Leydig Cell Tumor Interstitial cell tumor, benign LEYDIG CELL TUMOR, BENIGN Leydig cell tumor, benign Benign Leydig Cell Tumor A Leydig cell tumor characterized by large tumor size, the presence of cytologic atypia, increased mitotic activity, necrosis, and vascular invasion. Approximately 10% of the testicular Leydig cell tumors show malignant characteristics and metastasize. Leydig cell tumors of the ovary follow a benign clinical course. C4213 Neoplastic Process Malignant Leydig Cell Tumor C0334410 CDISC GDC A malignant neoplasm of the testis originating from interstitial (Leydig) cells. 8650/3 Malignant Malignant_Leydig_Cell_Tumor 8650/3 Interstitial cell tumor, malignant Leydig cell tumor, malignant Carcinoma, Leydig Cell Interstitial cell tumor, malignant LEYDIG CELL TUMOR, MALIGNANT Leydig cell tumor, malignant Malignant Interstitial Cell Neoplasm Malignant Interstitial Cell Tumor Malignant Leydig Cell Neoplasm Malignant Leydig Cell Tumor Malignant Leydig Cell Tumor A benign Leydig cell tumor which arises in the hilar area of the ovary. C4214 Neoplastic Process Ovarian Hilus Cell Tumor C0346179 GDC 8660/0 Benign Hilar_Cell_Tumor 8660/0 Hilar cell tumor Hilus cell tumor Hilar Cell Neoplasm Hilar Cell Tumor of Ovary Hilar Cell Tumor of the Ovary Hilar cell tumor Hilus Cell Neoplasm Hilus Cell Tumor Hilus cell tumor Ovarian Hilar Cell Tumor Ovarian Hilus Cell Tumor Ovarian Hilus Cell Tumor An ovarian tumor in which the vast majority of the cells (more than 90% of the tumor cells) resemble steroid hormone-secreting cells. It usually presents with androgenic manifestations. Approximately one-third of the cases follow a malignant clinical course. C4215 Neoplastic Process Ovarian Steroid Cell Tumor C0334412 GDC 8670/0 Undetermined Steroid_Cell_Tumor_of_the_Ovary 8670/0 Lipid cell tumor of ovary Lipoid cell tumor of ovary Masculinovoblastoma Steroid cell tumor, NOS Lipid Cell Neoplasm of Ovary Lipid Cell Neoplasm of the Ovary Lipid Cell Tumor of Ovary Lipid Cell Tumor of the Ovary Lipid cell tumor of ovary Ovarian Lipid Cell Neoplasm Ovarian Lipid Cell Tumor Ovarian Lipoid Cell Neoplasm Ovarian Steroid Cell Neoplasm Ovarian Steroid Cell Tumor Steroid Cell Tumor of Ovary Steroid Cell Tumor of the Ovary Ovarian Steroid Cell Tumor A paraganglioma arising from the chromaffin cells of the paraganglia that are located along the sympathetic nerves. It includes extra-adrenal paragangliomas and paragangliomas that arise from the adrenal medulla. The latter are commonly referred to as pheochromocytomas. Representative examples of extra-adrenal sympathetic paragangliomas include the bladder, and superior and inferior paraaortic paragangliomas. Clinical signs are related to the secretion of catecholamines resulting in hypertension. C4216 Neoplastic Process Sympathetic Paraganglioma C0334415 GDC 8681/1 Undetermined Sympathetic_Paraganglioma 8700/0 Chromaffin tumor Chromaffinoma Sympathetic paraganglioma Chromaffin Neoplasm Chromaffin Tumor Chromaffin tumor Chromaffinoma Sympathetic Paraganglioma Sympathetic Paraganglionic Neoplasm Sympathetic paraganglioma Sympathetic Paraganglioma An extra-adrenal paraganglioma that arises from paraganglia located along the parasympathetic nerves. Representative examples include aorticopulmonary, carotid body, jugulotympanic, and mediastinal paragangliomas. C4217 Neoplastic Process Parasympathetic Paraganglioma C0334416 GDC 8682/1 Undetermined Parasympathetic_Paraganglioma 8682/1 Parasympathetic paraganglioma Parasympathetic Extra-Adrenal Paraganglioma Parasympathetic Paraganglioma Parasympathetic Paraganglionic Neoplasm Parasympathetic paraganglioma Parasympathetic Paraganglioma An extra-adrenal parasympathetic paraganglioma that arises from paraganglia adjacent to the base of the heart and great vessels. C4218 Neoplastic Process Aorticopulmonary Paraganglioma C0334417 GDC 8691/1 Undetermined Aortic_Body_Paraganglioma 8691/1 Aortic body paraganglioma Aortic body tumor Aorticopulmonary paraganglioma Aortic Body Neoplasm Aortic Body Paraganglioma Aortic Body Tumor Aortic body paraganglioma Aortic body tumor Aorticopulmonary Paraganglioma Aorticopulmonary paraganglioma Neoplasm of Aortic Body Neoplasm of the Aortic Body Paraganglioma of Aortic Body Paraganglioma of the Aortic Body Tumor of Aortic Body Tumor of the Aortic Body Aorticopulmonary Paraganglioma An extra-adrenal paraganglioma that metastasizes to regional or distant anatomic sites. Common sites of metastasis include the lymph nodes, lungs, bones, and liver. C4219 Neoplastic Process Metastatic Extra-Adrenal Paraganglioma C0334418 GDC 8693/3 Malignant Malignant_Extra-Adrenal_Paraganglioma 8693/3 Extra-adrenal paraganglioma, malignant Nonchromaffin paraganglioma, malignant Extra-adrenal paraganglioma, malignant Malignant Extra-Adrenal Paraganglioma Metastatic Extra-Adrenal Paraganglioma Nonchromaffin paraganglioma, malignant Metastatic Extra-Adrenal Paraganglioma A pheochromocytoma that metastasizes to other anatomic sites. Common sites of metastasis include lymph nodes, bones, liver, and lung. Morphologic features associated with malignant pheochromocytomas include: atypical mitotic figures, capsular and vascular invasion, tumor cell necrosis, and high mitotic activity. C4220 Neoplastic Process Metastatic Adrenal Gland Pheochromocytoma Metastatic Adrenal Gland Pheochromocytoma C1708998 CDISC CTRP GDC A malignant neoplasm of the adrenal gland medulla. 8700/3 Malignant Malignant_Pheochromocytoma Metastatic_Pheochromocytoma 8700/3 Adrenal medullary paraganglioma, malignant Pheochromoblastoma Pheochromocytoma, malignant Adrenal medullary paraganglioma, malignant Malignant Adrenal Gland Chromaffin Neoplasm Malignant Adrenal Gland Chromaffin Paraganglioma Malignant Adrenal Gland Chromaffin Tumor Malignant Adrenal Gland Chromaffinoma Malignant Adrenal Gland Paraganglioma Malignant Adrenal Gland Pheochromocytoma Malignant Adrenal Medullary Paraganglioma Malignant Adrenal Medullary Pheochromocytoma Malignant Adrenal Pheochromocytoma Malignant Pheochromocytoma Metastatic Adrenal Gland Pheochromocytoma Metastatic Pheochromocytoma PHEOCHROMOCYTOMA, MALIGNANT Pheochromoblastoma Pheochromocytoma, malignant Metastatic Adrenal Gland Pheochromocytoma A very rare morphologic variant of glomus tumor with a size greater than 2 cm. The tumor arises in subfascial or visceral tissues. It is characterized by the presence of atypical mitotic figures, or marked nuclear atypia, or the combination of both. It has an aggressive clinical course. C4221 Neoplastic Process Malignant Glomus Tumor C1266111 GDC 8710/3 8711/3 Malignant Malignant_Glomus_Tumor 8710/3 8711/3 Glomangiosarcoma Glomoid sarcoma Glomus tumor, malignant Glomangiosarcoma Glomus tumor, malignant Malignant Glomus Neoplasm Malignant Glomus Tumor Malignant Glomus Tumor A morphologic variant of the glomus tumor characterized by the presence of dilated veins, surrounded by small clusters of glomus cells. Glomangiomas are most often present in patients with multiple lesions. C4222 Neoplastic Process Glomangioma C0334421 GDC 8712/0 Benign Glomangioma 8712/0 Glomangioma Glomangioma Glomuvenous Malformation Glomangioma A morphologic variant of the glomus tumor with architectural features similar to solid glomus tumor. It is characterized by the presence of elongated glomus cells which resemble mature smooth muscle. C4223 Neoplastic Process Glomangiomyoma C0334422 GDC 8713/0 Benign Glomangiomyoma 8713/0 Glomangiomyoma Glomangiomyoma Glomangiomyoma Nodular melanoma that arises from the skin. It may or may not arise from a pre-existing nevus. C4225 Neoplastic Process Cutaneous Nodular Melanoma Cutaneous Nodular Melanoma C0334424 CTRP 8721/3 Malignant Nodular_Melanoma Cutaneous Nodular Melanoma Nodular Cutaneous (Skin) Melanoma Nodular Malignant Melanoma of Skin Nodular Malignant Melanoma of the Skin Nodular Malignant Skin Melanoma Cutaneous Nodular Melanoma An uncommon variant of melanocytic nevus. It presents as a small pigmented skin lesion. It is characterized by the presence of large melanocytes with clear, foamy or finely vacuolated cytoplasm. It may recur if it is not completely excised. C4226 Neoplastic Process Balloon Cell Nevus C0334425 GDC 8722/0 Benign Balloon_Cell_Nevus 8722/0 Balloon cell nevus Balloon Cell Nevus Balloon cell nevus Balloon Cell Nevus A rare variant of melanoma with a vertical growth phase. It presents as a nodular or polypoid skin lesion. It is characterized by the presence of nodules which contain large melanoma cells with clear, foamy or finely vacuolated cytoplasm. The prognosis is similar to that of other melanomas matched for depth of invasion. C4227 Neoplastic Process Balloon Cell Melanoma Balloon Cell Melanoma C0334426 CTRP GDC 8722/3 Malignant Balloon_Cell_Malignant_Skin_Melanoma 8722/3 Balloon cell melanoma Balloon Cell Cutaneous (Skin) Melanoma Balloon Cell Malignant Melanoma Balloon Cell Malignant Melanoma of Skin Balloon Cell Malignant Melanoma of the Skin Balloon Cell Malignant Skin Melanoma Balloon Cell Melanoma Balloon Cell Skin Melanoma Balloon cell melanoma Balloon Cell Melanoma An intradermal nevus characterized by the presence of nests of atrophic nevus cells which are hyalinized and resemble nerve bundles. C4229 Neoplastic Process Neuronevus C0334430 GDC 8725/0 Benign Neuronevus 8725/0 Neuronevus Neural Nevus Neuronevus Neuronevus A benign neoplastic melanocytic proliferation within or adjacent to the optic disk. It presents as a pigmented, intraocular tumor. C4230 Neoplastic Process Optic Disc Melanocytoma C2004458 GDC 8726/0 Benign Melanocytoma_of_the_Eyeball Melanocytoma, eyeball Melanocytoma of Eyeball Melanocytoma of the Eyeball Melanocytoma, eyeball Optic Disc Melanocytoma Optic Disc Melanocytoma A melanoma arising from a melanocytic nevus which involves the dermal-epidermal junction of the skin. C4232 Neoplastic Process Melanoma in Junctional Nevus Melanoma in Junctional Nevus C0334434 CTRP GDC 8740/3 Malignant Melanoma_in_Junctional_Nevus 8740/3 Malignant melanoma in junctional nevus Cutaneous (Skin) Melanoma in Junctional Nevus Malignant Melanoma in Junctional Nevus Malignant Melanoma of Skin in Junctional Nevus Malignant Melanoma of the Skin in Junctional Nevus Malignant Skin Melanoma in Junctional Nevus Malignant melanoma in junctional nevus Melanoma in Junctional Nevus Melanoma in Junctional Nevus A congenital melanocytic nevus that measures more than 200 mm or is unresectable. It usually presents as a dark brown to black hairy lesion. Morphologically, it is characterized by the presence of a compound or intradermal nevus. There is an increased risk of malignant transformation to melanoma, rhabdomyosarcoma, and poorly differentiated malignant tumors. C4234 Neoplastic Process Giant Congenital Melanocytic Nevus C1842036 Cellosaurus GDC 8761/1 Benign Giant_Pigmented_Nevus 8761/1 Giant pigmented nevus, NOS Bathing Trunk Nevus GCN Giant Congenital Melanocytic Nevus Giant Congenital Nevus Giant Pigmented Nevus of Skin Giant Pigmented Nevus of the Skin Giant pigmented nevus, NOS Giant Congenital Melanocytic Nevus A melanoma arising in a giant congenital melanocytic nevus. The risk of developing a melanoma in a giant congenital melanocytic nevus has been reported to be between 5% and 50%. The incidence of developing melanoma is higher before the age of 10 and in adult life. C4235 Neoplastic Process Melanoma Arising in Giant Congenital Nevus C0334441 GDC 8761/3 Malignant Skin_Melanoma_in_Giant_Pigmented_Nevus 8761/3 Malignant melanoma arising in giant congenital nevus Malignant melanoma in congenital melanocytic nevus Malignant melanoma in giant pigmented nevus Malignant melanoma in congenital melanocytic nevus Malignant melanoma in giant pigmented nevus Melanoma Arising in Giant Congenital Nevus Melanoma Arising in Giant Congenital Nevus A rare melanoma which develops in a pre-existing blue nevus. It occurs more frequently on the scalp, face, orbit, back, buttocks, extremities, hands, and feet. C4240 Neoplastic Process Melanoma Arising from Blue Nevus Melanoma Arising in Blue Nevus C0334447 CTRP GDC 8780/3 Malignant Blue_Nevus-Like_Melanoma 8780/3 Blue nevus, malignant Blue Nevus-Like Melanoma Cutaneous (Skin) Melanoma Arising from Blue Nevus MBN Malignant Blue Nevus Malignant Blue Nevus of Skin Malignant Blue Nevus of the Skin Malignant Cutaneous Blue Nevus Malignant Skin Blue Nevus Melanoma Arising from Blue Nevus Melanoma Arising in Blue Nevus Melanoma Arising in Blue Nevus A blue nevus characterized by a multinodular cellular infiltrate with a dumb-bell architecture occupying the reticular dermis. The cellular infiltrate often extends into the subcutaneous tissue. The cellular infiltrate is composed of spindle-shaped melanocytes with pale cytoplasm alternating with bundles of pigmented spindle-shaped melanocytes. In occasional cases an increased mitotic activity, focal necrosis, and nuclear pleomorphism may be seen. Such cases with atypical features may have an uncertain malignant potential. C4241 Neoplastic Process Cellular Blue Nevus C0334448 GDC 8790/0 Benign Cellular_Blue_Nevus 8790/0 Cellular blue nevus CBN Cellular Blue Nevus Cellular Blue Nevus of Skin Cellular Blue Nevus of the Skin Cellular blue nevus Cellular Blue Nevus A neoplasm that arises from soft tissue and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4242 Neoplastic Process Benign Soft Tissue Neoplasm C0334450 GDC 8800/0 Benign Benign_Soft_Tissue_Neoplasm 8800/0 Soft tissue tumor, benign Benign Neoplasm of Soft Tissue Benign Neoplasm of the Soft Tissue Benign Soft Tissue Neoplasm Benign Soft Tissue Tumor Benign Tumor of Soft Tissue Benign Tumor of the Soft Tissue Soft tissue tumor, benign Benign Soft Tissue Neoplasm The occurrence of several sarcomas in different anatomic locations. C4243 Neoplastic Process Sarcomatosis C0334451 GDC 8800/9 Malignant Sarcomatosis 8800/9 Sarcomatosis, NOS Sarcomatosis Sarcomatosis, NOS Sarcomatosis A fibrosarcoma that occurs in infants. It shares identical morphologic features with adult fibrosarcoma but carries the t(12;15)(p13;q25) translocation that results in ETV6-NTRK3 gene fusion. It usually affects the superficial and deep soft tissues of the extremities. The prognosis is generally much more favorable than for adult fibrosarcoma, and it rarely metastasizes. C4244 Neoplastic Process Infantile Fibrosarcoma C0334459 CTEP GDC NICHD A fibrosarcoma typically congenital, and occurring most commonly within the first three months of life, sharing identical morphologic features with adult fibrosarcoma but rarely metastatic. It usually affects the superficial and deep soft tissues of the extremities. The majority of infantile fibrosarcomas carry the t(12;15)(p13;q25) translocation. 8814/3 Malignant Infantile_Fibrosarcoma 8814/3 Congenital fibrosarcoma Infantile fibrosarcoma Congenital Fibrosarcoma Congenital fibrosarcoma IFS Infantile Fibrosarcoma Infantile fibrosarcoma Infantile fibrosarcoma (congenital fibrosarcoma) Infantile Fibrosarcoma A benign, slow-growing tumor arising from the soft tissues usually in the mid-thoracic region of the elderly. It is characterized by the presence of paucicellular collagenous tissue, adipocytes and a predominance of large coarse elastic fibers arranged in globules. C4245 Neoplastic Process Elastofibroma C0334460 GDC 8820/0 Benign Elastofibroma 8820/0 Elastofibroma Elastofibroma Elastofibroma Dorsi Elastofibroma An intermediate cutaneous mesenchymal neoplasm of uncertain differentiation, usually affecting the actinic-damaged skin of the elderly. The tumor presents as a single cutaneous nodule which is often ulcerated. Microscopically, it is characterized by the presence of highly atypical cytologic features, pleomorphism and abundant mitotic figures. The vast majority of patients have an excellent prognosis following conservative therapy. Recurrences are infrequent, and metastasis is rare. C4246 Neoplastic Process Atypical Fibroxanthoma C0346053 GDC 8830/1 Undetermined Atypical_Fibroxanthoma 8830/1 Atypical fibrous histiocytoma Atypical fibroxanthoma AFX Atypical Cutaneous Fibroxanthoma Atypical Fibrous Histiocytoma Atypical Fibroxanthoma Atypical Fibroxanthoma of Skin Atypical Fibroxanthoma of the Skin Atypical Skin Fibroxanthoma Atypical fibrous histiocytoma Atypical fibroxanthoma Superficial Malignant Fibrous Histiocytoma Atypical Fibroxanthoma An undifferentiated soft tissue sarcoma characterized by the presence of a pleomorphic malignant cellular infiltrate. It is also known as malignant fibrous histiocytoma. C4247 Neoplastic Process Undifferentiated Pleomorphic Sarcoma Undifferentiated Pleomorphic Sarcoma C3549501 CDISC CTEP CTRP Cellosaurus GDC A malignant neoplasm composed of a fibroblastic and a histiocytic component. A soft tissue sarcoma that usually occurs in the limbs, most commonly the legs, and may also occur in the abdomen. 8830/3 Malignant Malignant_Fibrous_Histiocytoma 8830/3 Fibroxanthoma, malignant Malignant fibrous histiocytoma Undifferentiated pleomorphic sarcoma FIBROSARCOMA, PLEOMORPHIC, MALIGNANT Fibroxanthosarcoma Histiocytoma, Fibrous, Malignant MFH Malignant Fibrous Histiocytoma Malignant Fibrous Histiocytoma of Soft Tissue and Bone Malignant Fibrous Histiocytoma of the Soft Tissue and Bone Malignant Fibroxanthoma Malignant fibrous histiocytoma Storiform-Pleomorphic Fibrous Histiocytoma Storiform-Pleomorphic MFH Storiform-Pleomorphic Malignant Fibrous Histiocytoma UPS Unclassified Pleomorphic Sarcoma Unclassified Pleomorphic Sarcoma (Formerly "MFH") Unclassified Pleomorphic Sarcoma (Formerly "Malignant Fibrous Histiocytoma") Undifferentiated Pleomorphic Sarcoma Undifferentiated Pleomorphic Soft Tissue Sarcoma Undifferentiated pleomorphic sarcoma malignant fibrous cytoma malignant fibrous histiocytoma Undifferentiated Pleomorphic Sarcoma A benign, intermediate, or malignant mesenchymal neoplasm composed of adipose (fatty) tissue. C4248 Neoplastic Process Lipomatous Neoplasm C0206631 GDC Undetermined Lipomatous_Neoplasm Lipomatous Neoplasms Adipose Tissue Neoplasm Adipose Tissue Tumor Lipomatous Neoplasm Lipomatous Neoplasms Lipomatous Tumor Neoplasm of Adipose Tissue Neoplasm of the Adipose Tissue Tumor of Adipose Tissue Tumor of the Adipose Tissue Lipomatous Neoplasm A benign well-circumscribed tumor composed of mature adipocytes, characterized by areas of abundant fibrous tissue. C4249 Neoplastic Process Fibrolipoma C0334467 CDISC GDC A benign neoplasm comprising mature adipocytes, characterized by areas of abundant fibrous tissue. 8851/0 Benign Fibrolipoma 8851/0 Fibrolipoma FIBROLIPOMA, BENIGN Fibrolipoma Fibrolipoma A benign well-circumscribed tumor composed of mature adipocytes, characterized by areas of abundant fibrous tissue and extensive myxoid change. C4251 Neoplastic Process Fibromyxolipoma C0334470 GDC 8852/0 Benign Fibromyxolipoma 8852/0 Fibromyxolipoma Myxolipoma Fibromyxolipoma Myxolipoma Fibromyxolipoma A malignant neoplasm characterized by the presence of a combination of liposarcomatous morphologic subtypes: myxoid/round cell and well differentiated/dedifferentiated liposarcoma or myxoid/round cell and pleomorphic liposarcoma. C4253 Neoplastic Process Mixed Liposarcoma C0334472 GDC 8855/3 Malignant Mixed_Liposarcoma 8855/3 Mixed liposarcoma Mixed Liposarcoma Mixed liposarcoma Mixed Liposarcoma A benign circumscribed tumor composed of spindled cells, adipocytes, and collagen bundles. There is no evidence of nuclear hyperchromasia or mitotic activity. C4254 Neoplastic Process Spindle Cell Lipoma C0334474 GDC 8857/0 Benign Spindle_Cell_Lipoma 8857/0 Spindle cell lipoma SCL Spindle Cell Lipoma Spindle cell lipoma Spindle Cell Lipoma A neoplastic process characterized by the presence of multiple lipoblastomas. C4255 Neoplastic Process Lipoblastomatosis C0334475 GDC 8881/0 Benign Lipoblastomatosis 8881/0 Fetal lipomatosis Lipoblastomatosis Fetal Lipomatosis Fetal lipomatosis Lipoblastomatosis Lipoblastomatosis A morphologic variant of classic leiomyoma characterized by a dense cellular infiltrate composed of spindle or round cells with scant cytoplasm and a less obvious interlacing fascicle pattern. C4256 Neoplastic Process Cellular Leiomyoma C0334477 GDC 8892/0 Benign Cellular_Leiomyoma 8892/0 Cellular leiomyoma Cellular Leiomyoma Cellular leiomyoma Cellular Leiomyoma A morphologic variant of leiomyoma characterized by the presence of pleomorphic muscle cells with bizarre hyperchromatic nuclei and eosinophilic cytoplasm. C4257 Neoplastic Process Bizarre Leiomyoma C0334478 GDC 8893/0 Benign Bizarre_Leiomyoma 8893/0 Atypical leiomyoma Bizarre leiomyoma Pleomorphic leiomyoma Symplastic leiomyoma Atypical Leiomyoma Atypical leiomyoma Bizarre Leiomyoma Bizarre leiomyoma Pleomorphic Leiomyoma Pleomorphic leiomyoma Bizarre Leiomyoma An aggressive malignant mesenchymal neoplasm with skeletal muscle differentiation, occurring in adults and rarely in children. The tumor is characterized by the presence of bizarre round, spindle, and polygonal cells. Clinical presentation includes a rapidly enlarging painful mass usually of the lower extremities. C4258 Neoplastic Process Pleomorphic Rhabdomyosarcoma C0334480 Cellosaurus GDC Malignant Pleomorphic_Rhabdomyosarcoma 8901/3 Pleomorphic rhabdomyosarcoma, NOS Pleomorphic Rhabdomyosarcoma Pleomorphic rhabdomyosarcoma, NOS Pleomorphic Rhabdomyosarcoma A rhabdomyosarcoma composed of embryonic and alveolar components. It is characterized by the presence of spindle cells with myoblastic differentiation, a myxoid stroma, and fibrous septa. These tumors were previously considered variants of alveolar rhabdomyosarcoma. The lack of PAX3-FOXO1 fusions in most of these tumors suggests that are biologically and clinically related to embryonal rhabdomyosarcoma. C4259 Neoplastic Process Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features C1709053 GDC 8902/3 Malignant Mixed_Type_Rhabdomyosarcoma 8902/3 Mixed type rhabdomyosarcoma Mixed Alveolar Rhabdomyosarcoma Mixed Type Alveolar Rhabdomyosarcoma Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features A retinoblastoma that occurs in a patient without a family history of the disease. C42596 Neoplastic Process Sporadic Retinoblastoma C0751484 Cellosaurus Malignant Sporadic_Retinoblastoma Sporadic Retinoblastoma Sporadic Retinoblastoma A well differentiated mucinous neoplasm that arises from the appendix. It is characterized by slow growth and it is associated with the development of pseudomyxoma peritonei. C42598 Neoplastic Process Low Grade Appendix Mucinous Neoplasm C1708747 GDC 8480/1 Malignant Low_Grade_Appendix_Mucinous_Neoplasm 8480/1 Low grade appendiceal mucinous neoplasm Appendix Well Differentiated Mucinous Adenocarcinoma LAMN Low Grade Appendiceal Mucinous Neoplasm Low Grade Appendix Mucinous Neoplasm Low grade appendiceal mucinous neoplasm Low-Grade Appendiceal Mucinous Neoplasm Low-Grade Appendix Mucinous Neoplasm Low Grade Appendix Mucinous Neoplasm A rare benign mesenchymal neoplasm arising from skeletal muscle. It is characterized by the presence of immature spindle and polygonal cells within a scant myxoid stroma. It usually develops in the head and neck region of young children. C4260 Neoplastic Process Fetal Rhabdomyoma C0334482 GDC 8903/0 Benign Fetal_Rhabdomyoma 8903/0 Fetal rhabdomyoma Fetal Rhabdomyoma Fetal rhabdomyoma Fetal Rhabdomyoma C42606 Finding Chemotherapeutic Agent Toxicity Chemotherapeutic Agent Toxicity C1707372 CTRP Chemotherapeutic_Agent_Toxicity Chemotherapeutic Agent Toxicity Chemotherapeutic Agent Toxicity The finding of bodily harm due to the poisonous effects associated with the action or administration of therapeutic agents. C42607 Finding Therapy-Related Toxicity Therapy-Related Toxicity C1710382 CTRP Therapy-Related_Toxicity Therapy-Related Toxicity Therapy-Related Toxicity A benign mesenchymal neoplasm arising from skeletal muscle and occurring in adults. C4261 Neoplastic Process Adult Extracardiac Rhabdomyoma C4055487 GDC 8904/0 Benign Adult_Rhabdomyoma 8904/0 Adult rhabdomyoma Adult Extracardiac Rhabdomyoma Adult Extracardiac Rhabdomyomatous Hamartoma Adult Extracardiac Rhabdomyoma A non-infiltrating, benign mesenchymal neoplasm arising from the uterine corpus. It is characterized by the presence of neoplastic cells that resemble the cells of the proliferative phase of endometrial stroma and numerous thin-walled small vessels. It usually presents with abnormal uterine bleeding and menorrhagia. C4262 Neoplastic Process Endometrial Stromal Nodule C0334485 GDC 8930/0 Benign Endometrial_Stromal_Nodule 8930/0 Endometrial stromal nodule Endometrial Stromal Nodule Endometrial stromal nodule Endometrial Stromal Nodule An infiltrating mesenchymal tumor arising from the uterine corpus, cervix, vagina, and the ovary. It is characterized by the presence of oval to spindle-shape cells that resemble the cells of the endometrial stroma, without evidence of significant atypia and pleomorphism. Numerous small vessels are also present. It is usually characterized by indolent growth and late recurrences. C4263 Neoplastic Process Low Grade Endometrioid Stromal Sarcoma C0334486 GDC 8931/3 Malignant Low_Grade_Endometrial_Stromal_Sarcoma 8931/3 Endolymphatic stromal myosis Endometrial stromatosis Stromal endometriosis Stromal myosis, NOS Endolymphatic Stromal Myosis Endolymphatic stromal myosis Low Grade Endometrioid Stromal Sarcoma Low Grade Endometrioid Stromal Sarcoma A rare pediatric sarcoma affecting the kidney. It is characterized by the presence of epithelioid or spindle cells forming cords or nests, separated by fibrovascular septa. It metastasizes to lung, bone, brain and soft tissue. C4264 Neoplastic Process Clear Cell Sarcoma of the Kidney Clear Cell Sarcoma of the Kidney C0334488 CTEP CTRP GDC NICHD A rare primary renal tumor characterized by nests or cords of cells that are separated by regularly spaced fibrovascular septa, and which are known to metastasize to lung, bone, brain and soft tissue. It is associated with internal tandem duplications in the BCOR gene. A rare type of kidney cancer, in which the inside of the cells look clear when viewed under a microscope. Clear cell sarcoma can spread from the kidney to other organs, most commonly the bone, but also including the lungs, brain, and soft tissues of the body. 8964/3 Malignant Clear_Cell_Sarcoma_of_the_Kidney 8964/3 Clear cell sarcoma of kidney Clear cell sarcoma of the kidney (CCSK) CCSK Childhood Clear Cell Sarcoma of the Kidney Childhood Kidney Clear Cell Sarcoma Childhood Renal Clear Cell Sarcoma Clear Cell Sarcoma of Kidney Clear Cell Sarcoma of the Kidney Clear cell sarcoma - kidney Clear cell sarcoma of kidney Clear cell sarcoma of the kidney Clear cell sarcoma of the kidney (CCSK) Kidney Clear Cell Sarcoma Pediatric Kidney Clear Cell Sarcoma Pediatric Renal Clear Cell Sarcoma Renal Clear Cell Sarcoma clear cell sarcoma of the kidney Clear Cell Sarcoma of the Kidney A rare malignant epithelial neoplasm arising from the pancreas. The vast majority of cases occur during childhood. It is characterized by acinar differentiation, the formation of squamoid corpuscles, and the formation of stromal bands. Patients may present with an abdominal mass. Symptoms include pain, weight loss, and diarrhea. It may metastasize to lymph nodes, liver, and distant anatomic sites. Children who do not have metastatic disease at the time of diagnosis usually have a favorable clinical outcome when treated with a combination of surgery and chemotherapy. However, children with metastatic disease at presentation or adult patients usually have a poor prognosis. C4265 Neoplastic Process Pancreatoblastoma C0334489 Cellosaurus GDC 8971/3 Malignant Pancreatoblastoma 8971/3 Pancreatoblastoma Pancreatoblastoma Pancreatoblastoma A squamous cell carcinoma arising from the lip or the oral cavity. The oral cavity squamous cell carcinoma usually arises from the buccal mucosa, tongue, or gums. It occurs predominantly in adults who use tobacco and alcohol and has a tendency to metastasize early to lymph nodes. C42690 Neoplastic Process Lip and Oral Cavity Squamous Cell Carcinoma Lip and Oral Cavity Squamous Cell Carcinoma C0280297 CTEP CTRP Malignant Lip_and_Oral_Cavity_Squamous_Cell_Carcinoma Lip and Oral Cavity Squamous Cell Cancer Lip and Oral Cavity Squamous Cell Carcinoma Lip and oral cavity squamous cell carcinoma Lip/oral cavity squam. cell car. Lip and Oral Cavity Squamous Cell Carcinoma A malignant neoplasm that arises from the ovary. It is characterized by the presence of an invasive malignant urothelial-type cellular component and nests of benign urothelial-type cells in a fibrotic stroma. When the neoplasm is confined to the ovary, the prognosis is good. C4270 Neoplastic Process Malignant Ovarian Brenner Tumor Malignant Ovarian Brenner Tumor C1518237 CTRP Cellosaurus GDC 9000/3 Malignant Malignant_Brenner_Tumor 9000/3 Brenner tumor, malignant Brenner tumor, malignant Malignant Brenner Tumor of Ovary Malignant Brenner Tumor of the Ovary Malignant Ovarian Brenner Tumor Malignant Ovarian Transitional Cell Neoplasm Malignant Ovarian Transitional Cell Tumor Malignant Ovarian Brenner Tumor A usually aggressive malignant neoplasm arising from the uterine corpus and less often the cervix. It is characterized by the presence of two components: a malignant epithelial component and a sarcomatous component. In the uterine corpus the epithelial component is usually glandular whereas in the cervix is usually non-glandular. Carcinosarcoma of the cervix, although it is aggressive, it may have a better prognosis compared to the uterine corpus carcinosarcoma. C42700 Neoplastic Process Uterine Carcinosarcoma Uterine Carcinosarcoma C0280630 CTEP CTRP Cellosaurus Malignant Uterine_Carcinosarcoma Carcinosarcoma of the Uterus Carcinosarcoma of the uterus Malignant Mixed Mesodermal (Mullerian) Tumor of the Uterus Malignant Mixed Mesodermal (Müllerian) Tumor of the Uterus Uterine Carcinosarcoma Uterine Malignant Mixed Mesodermal (Mullerian) Tumor Uterine Malignant Mixed Mesodermal (Müllerian) Tumor Uterine Carcinosarcoma A morphologic variant of breast fibroadenoma without clinical significance. It is characterized by distortion and compression of the ducts by proliferating stromal cells. C4271 Neoplastic Process Breast Intracanalicular Fibroadenoma C0334496 GDC 9011/0 Benign Intracanalicular_Fibroadenoma 9011/0 Intracanalicular fibroadenoma Breast Intracanalicular Fibroadenoma Intracanalicular Breast Fibroadenoma Intracanalicular Fibroadenoma Intracanalicular Fibroadenoma of Breast Intracanalicular Fibroadenoma of the Breast Intracanalicular fibroadenoma Breast Intracanalicular Fibroadenoma A morphologic variant of breast fibroadenoma without clinical significance. It is characterized by circumferential proliferation of stromal cells around the ducts. This results in the formation of rounded ductal-epithelial structures. C4272 Neoplastic Process Breast Pericanalicular Fibroadenoma C0334497 GDC 9012/0 Benign Pericanalicular_Fibroadenoma 9012/0 Pericanalicular fibroadenoma Breast Pericanalicular Fibroadenoma Pericanalicular Breast Fibroadenoma Pericanalicular Fibroadenoma Pericanalicular Fibroadenoma of Breast Pericanalicular Fibroadenoma of the Breast Pericanalicular fibroadenoma Breast Pericanalicular Fibroadenoma A breast fibroadenoma characterized by a very large size. This term has also been used as a synonym for juvenile fibroadenoma by some authors. The latter is characterized by epithelial hyperplasia and an increased stromal cellularity. C4273 Neoplastic Process Breast Giant Fibroadenoma C0334500 GDC 9016/0 Benign Giant_Fibroadenoma 9016/0 Giant fibroadenoma Breast Giant Fibroadenoma Giant Breast Fibroadenoma Giant Fibroadenoma Giant Fibroadenoma of Breast Giant Fibroadenoma of the Breast Giant fibroadenoma Breast Giant Fibroadenoma A breast fibroadenoma that usually occurs in young women. It is characterized by epithelial hyperplasia and an increased stromal cellularity. C4276 Neoplastic Process Juvenile Breast Fibroadenoma C0346158 GDC 9030/0 Benign Juvenile_Fibroadenoma 9030/0 Juvenile fibroadenoma Breast Juvenile Fibroadenoma Juvenile Breast Fibroadenoma Juvenile Fibroadenoma Juvenile Fibroadenoma of Breast Juvenile Fibroadenoma of the Breast Juvenile fibroadenoma Juvenile Breast Fibroadenoma A synovial sarcoma characterized by the presence of a spindle cell component only. C4277 Neoplastic Process Spindle Cell Synovial Sarcoma C0334505 Cellosaurus GDC 9041/3 Malignant Synovial_Sarcoma_with_Spindle_Cell_Components 9041/3 Synovial sarcoma, monophasic fibrous Synovial sarcoma, spindle cell Spindle Cell Synovial Sarcoma Synovial Sarcoma with Spindle Cell Components Synovial sarcoma, spindle cell Spindle Cell Synovial Sarcoma Acute myelomonocytic leukemia without an abnormal eosinophilic component in the bone marrow. C42779 Neoplastic Process Acute Myelomonocytic Leukemia without Abnormal Eosinophils C1706708 Malignant Acute_Myelomonocytic_Leukemia_without_Abnormal_Eosinophils Acute Myelomonocytic Leukemia without Abnormal Eosinophils Acute Myelomonocytic Leukemia without Abnormal Eosinophils A synovial sarcoma characterized by the presence of an epithelial cell component only. The epithelial cells are arranged in glandular or papillary structures. C4278 Neoplastic Process Epithelial Synovial Sarcoma C0334506 GDC 9042/3 Malignant Epithelioid_Synovial_Sarcoma 9042/3 Synovial sarcoma, epithelioid cell Epithelial Sarcoma of Synovium Epithelial Sarcoma of the Synovium Epithelial Synovial Sarcoma Epithelioid Cell Sarcoma of Synovium Epithelioid Cell Sarcoma of the Synovium Epithelioid Cell Synovial Sarcoma Epithelioid Synovial Sarcoma Synovial sarcoma, epithelioid cell Epithelial Synovial Sarcoma A synovial sarcoma characterized by the presence of both an epithelial and a spindle cell component. C4279 Neoplastic Process Biphasic Synovial Sarcoma C0334507 Cellosaurus GDC 9043/3 Malignant Biphasic_Synovial_Sarcoma 9043/3 Synovial sarcoma, biphasic Biphasic Sarcoma of Synovium Biphasic Sarcoma of the Synovium Biphasic Synovial Sarcoma Biphasic Synovial Sarcoma A localized neoplasm of probable fibroblastic derivation, that arises from the pericardium. It is characterized by the presence of round to spindle-shaped cells, hylanized stroma formation, thin-walled branching blood vessels, and thin bands of collagen. C4281 Neoplastic Process Pericardial Solitary Fibrous Tumor C1708716 Undetermined Localized_Benign_Fibrous_Mesothelioma Benign Pericardial Mesothelial Neoplasm Pericardial Benign Mesothelioma Pericardial Fibroma Pericardial Fibrous Mesothelioma Pericardial Solitary Fibrous Tumor Pericardial Submesothelial Fibroma Pericardial Solitary Fibrous Tumor A carcinoma with histological features identical to thyroid carcinoma, arising in ovarian mature teratoma with aberrant thyroid tissue (struma ovarii). C4291 Neoplastic Process Thyroid Carcinoma Arising in Struma Ovarii C0334525 GDC 9090/3 Malignant Malignant_Struma_Ovarii 9090/3 Struma ovarii, malignant Malignant Struma Ovarii Struma ovarii, malignant Thyroid Carcinoma Arising in Struma Ovarii Thyroid Carcinoma Arising in Struma Ovarii An ovarian neoplasm characterized by the presence of aberrant thyroid tissue and a carcinoid tumor. A minority of patients develop symptoms of functioning thyroid tissue. The neuroendocrine carcinoid cells infiltrate the aberrant thyroid tissue and progressively replace the follicular lining cells. C4292 Neoplastic Process Strumal Carcinoid C0334526 GDC 9091/1 Undetermined Strumal_Carcinoid_Neoplasm 9091/1 Struma ovarii and carcinoid Strumal carcinoid Struma Ovarii and Carcinoid Struma ovarii and carcinoid Strumal Carcinoid Strumal carcinoid Strumal Carcinoid A hemangioma composed of veins. C4296 Neoplastic Process Venous Hemangioma C0334532 GDC 9122/0 Benign Venous_Hemangioma 9122/0 Venous hemangioma Venous Angioma Venous Hemangioma Venous Malformation Venous hemangioma Venous Hemangioma A hemangioma characterized by the presence of epithelioid endothelial cells. C4298 Neoplastic Process Epithelioid Hemangioma C1368797 GDC 9125/0 Benign Epithelioid_Hemangioma 9125/0 Epithelioid hemangioma Histiocytoid hemangioma Angiolymphoid Hyperplasia with Eosinophilia Epithelioid Hemangioma Epithelioid hemangioma Histiocytoid Hemangioma Histiocytoid hemangioma Epithelioid Hemangioma A skin hemangioma characterized by the presence of epidermal hyperplasia. C4299 Neoplastic Process Verrucous Hemangioma C0334540 GDC 9142/0 Benign Verrucous_Keratotic_Hemangioma 9142/0 Verrucous keratotic hemangioma Verrucous Hemangioma Verrucous Keratotic Hemangioma Verrucous Venous Malformation Verrucous keratotic hemangioma Verrucous Hemangioma A benign neoplasm of bone surface composed of hyaline cartilage. It arises beneath the periosteum and is characterized by the presence of chondrocytes, a lobulated growth pattern, and calcification. C4302 Neoplastic Process Periosteal Chondroma C4076530 GDC 9221/0 Benign Periosteal_Chondroma 9221/0 Juxtacortical chondroma Periosteal chondroma Juxtacortical Chondroma Juxtacortical chondroma Periosteal Chondroma Periosteal chondroma Periosteal Chondroma A malignant tumor that arises from the bone. It is characterized by the presence of an area of high grade sarcoma in an otherwise typical giant cell tumor (primary malignancy in giant cell tumor), or the presence of sarcoma in which the pre-existing giant cell tumor may or may not be apparent (secondary malignancy in giant cell tumor). C4304 Neoplastic Process Malignancy in Giant Cell Tumor of Bone Malignancy in Giant Cell Tumor of Bone C0334552 CDISC CTRP Cellosaurus GDC A malignant neoplasm of bone comprised of osteoclast-like giant cells and mononuclear cells. 9250/3 Malignant Malignant_Giant_Cell_Tumor_of_Bone 9250/3 Giant cell sarcoma of bone Giant cell tumor of bone, malignant Dedifferentiated Giant Cell Tumor Giant Cell Bone Sarcoma Giant Cell Sarcoma of Bone Giant Cell Sarcoma of the Bone Giant cell sarcoma of bone Giant cell tumor of bone, malignant Malignancy in Giant Cell Tumor of Bone Malignancy in Giant Cell Tumor of the Bone Malignant Giant Cell Tumor of Bone OSTEOCLASTOMA, MALIGNANT Malignancy in Giant Cell Tumor of Bone A benign, slow growing neoplasm arising from tooth-forming tissues. It occurs in the maxillofacial skeleton or the gingiva. Representative examples include adenomatoid odontogenic tumor, calcifying cystic odontogenic tumor, and squamous odontogenic tumor. C4306 Neoplastic Process Benign Odontogenic Neoplasm Benign Odontogenic Neoplasm C0334557 CDISC CTRP GDC A benign neoplasm arising from tooth-forming tissues. 9270/0 Benign Benign_Odontogenic_Neoplasm 9270/0 Odontogenic tumor, benign Benign Odontogenic Neoplasm Benign Odontogenic Tumor ODONTOGENIC TUMOR, BENIGN Odontogenic tumor, benign Benign Odontogenic Neoplasm A rare benign bone-forming neoplasm usually arising from the jaw. It is a well-circumscribed lytic tumor that varies in size. The cell of origin is the cementoblast. C4308 Neoplastic Process Cementoblastoma C0007659 GDC 9273/0 Benign Benign_Cementoblastoma 9273/0 Cementoblastoma, benign Benign Cementoblastoma Cementoblastoma Cementoblastoma, benign Cementoblastoma A benign, slow growing neoplasm arising from tooth-forming tissues. The vast majority of cases are intraosseous and most often grow in the maxilla. It is characterized by the presence of odontogenic epithelium which is embedded in a connective tissue stroma. Local excision is curative and recurrences are very rare. C4310 Neoplastic Process Adenomatoid Odontogenic Tumor C0334565 GDC 9300/0 Benign Adenomatoid_Odontogenic_Tumor 9300/0 Adenoameloblastoma Adenomatoid odontogenic tumor AOT Adenomatoid Odontogenic Neoplasm Adenomatoid Odontogenic Tumor Adenomatoid odontogenic tumor Adenomatoid Odontogenic Tumor A carcinoma usually arising from the maxilla and less often the mandible. Symptoms include swelling and paresthesia. It is characterized by the presence of rounded islands of malignant epithelial cells in a fibrous stroma and the benign features of calcifying cystic odontogenic tumor. The clinical course varies from slow growing and locally invasive to rapidly growing and highly aggressive with metastases. C4311 Neoplastic Process Ghost Cell Odontogenic Carcinoma C0334566 GDC 9302/3 Malignant Odontogenic_Ghost_Cell_Neoplasm 9302/3 Ghost cell odontogenic carcinoma GCOC Ghost Cell Odontogenic Carcinoma Ghost cell odontogenic carcinoma Odontogenic Ghost Cell Neoplasm Ghost Cell Odontogenic Carcinoma The most common odontogenic tumor, arising from the epithelial component of the embryonic tooth and usually affecting the molar-ramus region of the mandible or maxilla. Although most ameloblastomas are morphologically and clinically benign, they may cause extensive local destruction, recur, or metastasize. C4313 Neoplastic Process Ameloblastoma Ameloblastoma C0002448 CTRP Cellosaurus GDC 9310/0 Undetermined Ameloblastoma 9310/0 Ameloblastoma, NOS Ameloblastoma Ameloblastoma, NOS Ameloblastoma A rare, benign neoplasm arising from tooth-forming tissues in the mandible and maxilla (central odontogenic fibroma); and rarely from extraosseous tissues, usually in the gingiva (peripheral odontogenic fibroma). It is characterized by the presence of odontogenic epithelium that is embedded in a fibrous stroma. Local enucleation of the tumor is curative. C4314 Neoplastic Process Odontogenic Fibroma C1260966 CDISC GDC A benign intraosseous neoplasm arising from tooth-forming tissues in the mandible and maxilla, characterized by the presence of islands of odontogenic epithelium. 9321/0 Benign Odontogenic_Fibroma 9321/0 Odontogenic fibroma, NOS FIBROMA, ODONTOGENIC, BENIGN OdF Odontogenic Fibroma Odontogenic Fibroma A rare, benign, extraosseous neoplasm arising from tooth-forming tissues. It usually presents as a slow growing exophytic mass in the gingiva. It is characterized by the presence of odontogenic epithelium that is embedded in a fibrous stroma. C4315 Neoplastic Process Peripheral Odontogenic Fibroma C0334571 GDC 9322/0 Benign Peripheral_Odontogenic_Fibroma 9322/0 Peripheral odontogenic fibroma Peripheral Odontogenic Fibroma Peripheral odontogenic fibroma Peripheral Odontogenic Fibroma A rare neoplasm arising from tooth-forming tissues. It usually arises from the posterior mandible. It is characterized by the presence of an epithelial component and fibromyxoid stroma. It may recur and rarely shows malignant transformation to ameloblastic fibrosarcoma. It is treated with enucleation and curettage. C4316 Neoplastic Process Ameloblastic Fibroma C0334572 GDC 9330/0 Benign Ameloblastic_Fibroma 9330/0 Ameloblastic fibroma Ameloblastic Fibroma Ameloblastic fibroma Fibrodentinoma Ameloblastic Fibroma A locally aggressive malignant neoplasm arising from odontogenic tissue. It occurs in the mandible and less often in the maxilla. It is characterized by the presence of a malignant connective tissue component and a benign epithelial component. The frequency of distal metastases is low. C4317 Neoplastic Process Ameloblastic Fibrosarcoma C0334573 GDC 9330/3 Malignant Ameloblastic_Fibrosarcoma 9330/3 Ameloblastic fibrosarcoma Ameloblastic sarcoma AFS Ameloblastic Fibrosarcoma Ameloblastic fibrosarcoma Ameloblastic sarcoma Ameloblastic Fibrosarcoma A diffuse glial tumor which infiltrates the brain extensively, involving more than two lobes. It is frequently bilateral and often extends to the infratentorial structures, even to the spinal cord. It is probably of astrocytic origin, although GFAP expression may be scant or absent. (Adapted from WHO.) C4318 Neoplastic Process Gliomatosis Cerebri C0334576 GDC 9381/3 Malignant Gliomatosis_Cerebri 9381/3 Gliomatosis cerebri Astrocytosis cerebri Gliomatosis Gliomatosis Cerebri Gliomatosis cerebri Gliomatosis Cerebri A rare variant of ependymoma characterized by well formed papillae. Tumor cell processes abutting capillaries are usually GFAP-positive. Differential diagnoses include choroid plexus papilloma, papillary meningioma and metastatic papillary carcinoma. (Adapted from WHO) C4319 Neoplastic Process Papillary Ependymoma C0334578 GDC 9393/3 Undetermined Papillary_Ependymoma 9393/3 Papillary ependymoma Papillary Ependymoma Papillary ependymoma Papillary Ependymoma A rare variant of diffuse astrocytoma. It is predominantly composed of neoplastic astrocytes showing a small cell body with few, flaccid processes with a low content of glial filaments and scant GFAP expression. This lesion is not well defined and is considered by some authors as an occasional histopathological feature rather than a reproducibly identifiable variant. When occurring in children, this neoplasm may be difficult to separate from pilocytic juvenile astrocytoma. (Adapted from WHO) C4320 Neoplastic Process Protoplasmic Astrocytoma C0334580 GDC 9410/3 Undetermined Protoplasmic_Astrocytoma 9410/3 Protoplasmic astrocytoma Protoplasmic Astrocytoma Protoplasmic astrocytoma Protoplasmic Astrocytoma A rare variant of diffuse astrocytoma. It is characterized by the presence of a conspicuous, though variable, fraction of gemistocytic neoplastic astrocytes. Gemistocytes are round to oval astrocytes with abundant, glassy, non-fibrillary cytoplasm which appears to displace the dark, angulated nucleus to the periphery of the cell. To make the diagnosis of gemistocytic astrocytoma, gemistocytes should amount to more than approximately 20% of all tumor cells. (Adapted from WHO) C4321 Neoplastic Process Gemistocytic Astrocytoma C0334581 GDC 9411/3 Undetermined Gemistocytic_Astrocytoma 9411/3 Gemistocytic astrocytoma Gemistocytic astrocytoma, NOS Gemistocytoma Gemistocytic Astrocytoma Gemistocytic astrocytoma Gemistocytoma Gemistocytic Astrocytoma The most frequent histological variant of diffuse astrocytoma. It is predominantly composed of fibrillary neoplastic astrocytes. Nuclear atypia is a diagnostic criterion but mitotic activity, necrosis and microvascular proliferation are absent. The occasional or regional occurrence of gemistocytic neoplastic cells is compatible with the diagnosis of fibrillary astrocytoma. (WHO) C4322 Neoplastic Process Fibrillary Astrocytoma C0334582 CTEP Cellosaurus GDC 9420/3 Undetermined Fibrillary_Astrocytoma 9420/3 Fibrillary astrocytoma Fibrous astrocytoma Fibrillary Astrocytoma Fibrillary astrocytoma Fibrous astrocytoma Fibrillary Astrocytoma Acute myeloid leukemia or myelodysplastic syndrome occurring in children with Down syndrome. The acute myeloid leukemia is usually an acute megakaryoblastic leukemia, and is associated with GATA1 gene mutation. C43223 Neoplastic Process Myeloid Leukemia Associated with Down Syndrome C2825149 Cellosaurus GDC NICHD PCDC Acute myeloid leukemia occurring in children with Down syndrome. During the first 3 years of life, it is usually the megakaryoblastic subtype, and is associated with GATA1 gene mutation. After age 4 this is no longer the case. 9898/3 Malignant Acute_Myeloid_Leukemia_Transient_Myeloproliferative_Disorder_in_Down_Syndrome 9898/3 Myeloid leukemia associated with Down Syndrome Myeloid leukemia associated with Down syndrome AML Occurring in Children with Down Syndrome Acute Myeloid Leukemia Occurring in Children with Down syndrome Acute Myeloid Leukemia with GATA1 Mutations MLDS Myeloid Leukemia Associated with Down Syndrome Myeloid leukemia associated with Down Syndrome Myeloid Leukemia Associated with Down Syndrome A WHO grade 2 astrocytic tumor with a relatively favorable prognosis. It is characterized by pleomorphic and lipidized cells expressing GFAP often surrounded by a reticulin network and eosinophilic granular bodies. It presents in the superficial cerebral hemispheres and involves the meninges. It typically affects children and young adults. C4323 Neoplastic Process Pleomorphic Xanthoastrocytoma C0334586 GDC 9424/3 Undetermined Pleomorphic_Xanthoastrocytoma 9424/3 Pleomorphic xanthoastrocytoma Pleomorphic xanthoastrocytoma, NOS PXA Pleomorphic Xantho-Astrocytoma Pleomorphic Xanthoastrocytoma Pleomorphic xanthoastrocytoma Pleomorphic Xanthoastrocytoma A rare glial neoplasm characterized by structural rearrangements of the MN1 gene at chromosome band 22q12.1. It is usually found in the cerebral hemispheres of young adults and children and predominantly affects females. Morphologically, it consists of elongated glial cells with abundant eosinophilic cytoplasm and GFAP-positive processes, arranged perivascularly. C4324 Neoplastic Process Astroblastoma, MN1-Altered C0334587 GDC 9430/3 Undetermined Astroblastoma 9430/3 Astroblastoma Astroblastoma Astroblastoma, MN1-Altered Astroblastoma, MN1-Altered A rare histological variant of glioblastoma with a predominance of bizarre, multinucleated giant cells, an occasionally abundant stromal reticulin network, and a high frequency of TP53 mutations. (WHO) C4325 Neoplastic Process Giant Cell Glioblastoma C0334588 Cellosaurus GDC 9441/3 Malignant Giant_Cell_Glioblastoma 9441/3 Giant cell glioblastoma Giant Cell Glioblastoma Giant cell glioblastoma Giant Cell Glioblastoma A WHO grade 3 oligodendroglioma with focal or diffuse malignant morphologic features (prominent nuclear pleomorphism, mitoses, and increased cellularity). C4326 Neoplastic Process Anaplastic Oligodendroglioma C0334590 CTEP Cellosaurus GDC 9451/3 Malignant Anaplastic_Oligodendroglioma 9451/3 Oligodendroglioma, anaplastic Oligodendroglioma, anaplastic, NOS Anaplastic Oligodendroglioma Anaplastic oligodendroglioma Malignant Oligodendroglioma Oligodendroglioma, Malignant Oligodendroglioma, anaplastic Undifferentiated Oligodendroglioma WHO Grade 3 Oligodendroglial Neoplasm WHO Grade 3 Oligodendroglial Tumor WHO Grade III Oligodendroglial Neoplasm WHO Grade III Oligodendroglial Tumor Anaplastic Oligodendroglioma A rare, usually aggressive malignant embryonal neoplasm of the central nervous system occurring in children. It is characterized by the presence of neuroepithelial cells which form papillary, trabecular, or tubular structures and absence of C19MC amplification. Symptoms include headache, nausea, and vomiting. C4327 Neoplastic Process Medulloepithelioma Central Nervous System Medulloepithelioma C0334596 CTRP GDC NICHD A rare malignant embryonal neoplasm of the central nervous system, occurring in children. It is characterized by the presence of neuroepithelial cells that form papillary, trabecular, or tubular structures. Malignant Medulloepithelioma 9501/3 Diktyoma, malignant Central Nervous System Medulloepithelioma Medulloepithelioma Medulloepithelioma, Central Nervous System Central Nervous System Medulloepithelioma Mastocytosis that manifests with pure cutaneous involvement. C43277 Neoplastic Process Pure Cutaneous Mastocytosis C1709775 Undetermined Pure_Cutaneous_Mastocytosis Pure Cutaneous Mastocytosis Pure Cutaneous Mastocytosis A neurofibroma characterized by the presence of structures which resemble Vater-Pacini corpuscles. C4328 Neoplastic Process Pacinian Neurofibroma C0334599 GDC 9507/0 Benign Pacinian_Neurofibroma 9507/0 Pacinian tumor Pacinian Neurofibroma Pacinian tumor Pacinian Neurofibroma A WHO grade I meningioma characterized by the presence of tumor cells that form lobules. The tumor cells are generally uniform. Whorls and psammoma bodies are usually not present. C4329 Neoplastic Process Meningothelial Meningioma C0334605 Cellosaurus GDC 9531/0 Undetermined Meningothelial_Meningioma 9531/0 Endotheliomatous meningioma Meningothelial meningioma Syncytial meningioma Meningothelial Meningioma Meningothelial meningioma Meningotheliomatous Meningioma Meningothelial Meningioma An autosomal dominant inherited adenocarcinoma that arises from the gastric mucosa and is characterized by the presence of poorly cohesive malignant cells and absence of glandular formations. C43295 Neoplastic Process Hereditary Gastric Diffuse Adenocarcinoma CL1793011 Cellosaurus Malignant Hereditary_Diffuse_Gastric_Adenocarcinoma Hereditary Diffuse Gastric Adenocarcinoma Hereditary Diffuse Gastric Cancer Hereditary Gastric Diffuse Adenocarcinoma Hereditary Gastric Diffuse Adenocarcinoma A carcinoma that arises from the pancreas in a patient with a family history of pancreatic cancer. In the minority of cases, patients have recognized genetic syndromes (e.g., FAMMM syndrome, BRCA2 syndrome, Peutz-Jeghers syndrome) however, in the majority of cases the genetic cause has not been identified. C43298 Neoplastic Process Hereditary Pancreatic Carcinoma Hereditary Pancreatic Carcinoma C2931038 CPTAC CTRP Cellosaurus Malignant Hereditary_Pancreatic_Carcinoma Familial Pancreatic Cancer Familial Pancreatic Carcinoma Familial pancreatic cancer syndrome Hereditary Pancreatic Cancer Hereditary Pancreatic Carcinoma Hereditary Pancreatic Carcinoma A WHO grade I meningioma characterized by the presence of spindle cells that form bundles in a collagen matrix. C4330 Neoplastic Process Fibrous Meningioma C0334606 GDC 9532/0 Undetermined Fibrous_Meningioma 9532/0 Fibroblastic meningioma Fibrous meningioma Fibroblastic Meningioma Fibroblastic meningioma Fibrous Meningioma Fibrous meningioma Fibrous Meningioma A WHO grade I meningioma characterized by the presence of psammoma bodies that predominate over the meningeal cells. C4331 Neoplastic Process Psammomatous Meningioma C0334607 GDC 9533/0 Undetermined Psammomatous_Meningioma 9533/0 Psammomatous meningioma Psammomatous Meningioma Psammomatous meningioma Psammomatous Meningioma A neoplasm that arises from the hair follicle and metastasizes to other anatomic sites. C43310 Neoplastic Process Malignant Hair Follicle Neoplasm C1708881 CDISC A malignant neoplasm that arises from the hair follicle. Malignant Malignant_Hair_Follicle_Neoplasm HAIR FOLLICLE NEOPLASM, MALIGNANT Malignant Hair Follicle Neoplasm Malignant Hair Follicle Tumor Malignant Hair Follicle Neoplasm A neoplasm involving the germinative follicular epithelium. C43311 Neoplastic Process Germinative Follicular Epithelium Neoplasm C1708240 Undetermined Germinative_Follicular_Epithelium_Neoplasm Germinative Follicular Epithelium Neoplasm Germinative Follicular Epithelium Tumor Germinative Follicular Epithelium Neoplasm A trichoblastoma characterized by the presence of neoplastic epithelial cell forming nodules. There are palisaded basaloid cells present at the periphery and pale larger cells with vesicular nuclei, prominent nucleoli, and abundant cytoplasm present at the center of the nodules. The epithelial cells are admixed with numerous small lymphocytes and occasional large multinucleated cells that resemble Reed-Sternberg cells. C43312 Neoplastic Process Adamantinoid Trichoblastoma Benign Mixed_Epithelial_and_Mesenchymal_Hair_Follicle_Neoplasm Adamantinoid Trichoblastoma Adamantinoid Trichoblastoma A mesenchymal neoplasm arising from the pilar sheath of the hair follicle. C43313 Neoplastic Process Pilar-Associated Mesenchyme Neoplasm C1709539 Undetermined Pilar-Associated_Mesenchyme_Neoplasm Pilar-Associated Mesenchyme Neoplasm Pilar-Associated Mesenchyme Tumor Pilar-Associated Mesenchyme Neoplasm A neoplasm that arises from the outer hair sheath and infundibulum. It is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C43315 Neoplastic Process Benign Outer Hair Sheath and Infundibulum Neoplasm C1706924 Benign Benign_Outer_Hair_Sheath_and_Infundibulum_Neoplasm Benign Outer Hair Sheath and Infundibulum Neoplasm Benign Outer Hair Sheath and Infundibulum Tumor Benign Outer Hair Sheath and Infundibulum Neoplasm A malignant neoplasm that arises from the outer hair sheath and infundibulum. C43316 Neoplastic Process Malignant Outer Hair Sheath and Infundibulum Neoplasm C1708896 Malignant Malignant_Outer_Hair_Sheath_and_Infundibulum_Neoplasm Malignant Outer Hair Sheath and Infundibulum Neoplasm Malignant Outer Hair Sheath and Infundibulum Tumor Malignant Outer Hair Sheath and Infundibulum Neoplasm A neoplasm that arises from the germinative follicular epithelium and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C43319 Neoplastic Process Benign Germinative Follicular Epithelium Neoplasm C1706922 Benign Benign_Germinative_Epithelium_Neoplasm Benign Germinative Follicular Epithelium Neoplasm Benign Germinative Follicular Epithelium Tumor Benign Germinative Follicular Epithelium Neoplasm A WHO grade I meningioma characterized by the presence of small and medium sized vessels that predominate over the meningioma cells. C4332 Neoplastic Process Angiomatous Meningioma C0334608 GDC 9534/0 Undetermined Angiomatous_Meningioma 9534/0 Angiomatous meningioma Angiomatous Meningioma Angiomatous meningioma Angiomatous Meningioma A malignant neoplasm that arises from germinative follicular epithelial cells. C43321 Neoplastic Process Malignant Germinative Follicular Epithelium Neoplasm C1708879 Malignant Malignant_Germinative_Follicular_Epithelium_Neoplasm Malignant Germinative Follicular Epithelium Neoplasm Malignant Germinative Follicular Epithelium Tumor Malignant Germinative Follicular Epithelium Neoplasm A trichoblastoma characterized by the presence of neoplastic epithelial cells forming cribriform patterns. C43322 Neoplastic Process Cribriform Trichoblastoma Benign Benign_Mixed_Epithelial_and_Mesenchymal_Hair_Follicle_Neoplasm Conventional Trichoepithelioma Cribriform Trichoblastoma Cribriform Trichoblastoma A mesenchymal neoplasm arising from the pilar sheath of the hair follicle. It is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include fibrofolliculoma, perifollicular fibroma, pilar leiomyoma, and trichogenic myxoma. C43323 Neoplastic Process Benign Pilar-Associated Mesenchyme Neoplasm C1706925 Benign Benign_Pilar-Associated_Mesenchyme_Neoplasm Benign Pilar-Associated Mesenchyme Neoplasm Benign Pilar-Associated Mesenchyme Tumor Benign Pilar-Associated Mesenchyme Neoplasm A neoplasm involving the outer hair sheath and infundibulum. C43324 Neoplastic Process Outer Hair Sheath and Infundibulum Neoplasm C1709361 Undetermined Outer_Hair_Sheath_and_Infundibulum_Neoplasm Neoplasm of the Outer Hair Sheath and Infundibulum Outer Hair Sheath and Infundibulum Neoplasm Outer Hair Sheath and Infundibulum Tumor Tumor of the Outer Hair Sheath and Infundibulum Outer Hair Sheath and Infundibulum Neoplasm A rare, benign, slowly growing tumor of the hair follicle occurring usually in the face or buttocks. Morphologically, it is a well-defined dermal tumor that contains numerous cysts and epithelial islands. The cysts are lined by infundibulum-like squamous epithelial cells. C43325 Neoplastic Process Trichoadenoma C0346007 Benign Trichoadenoma Trichoadenoma Trichoadenoma of Nikolowski Trichoadenoma A rare malignant tumor arising from the outer hair sheath and infundibulum on the face. It is considered the malignant counterpart of tricholemmoma. Complete surgical excision is required. C43326 Neoplastic Process Trichilemmal Carcinoma C1266009 GDC 8102/3 Malignant Trichilemmal_Carcinoma 8102/3 Trichilemmal carcinoma Trichilemmocarcinoma Trichoblastic carcinoma Trichilemmal Carcinoma Trichilemmal carcinoma Trichilemmocarcinoma Trichilemmal Carcinoma A rare malignant neoplasm that arises from the outer root sheath of the hair follicle. It usually occurs in the scalp, face and trunk. Histopathology shows cords of malignant squamous cells infiltrating into the dermis. C43327 Neoplastic Process Malignant Proliferating Pilar Tumor CL1407132 mCode Malignant Malignant_Proliferating_Pilar_Tumor Malignant Pilar Tumor Malignant Proliferating Pilar Tumor Malignant Proliferating Trichilemmal Cyst Malignant Proliferating Trichilemmal Tumor Malignant neoplasm with pilar differentiation (morphologic abnormality) Malignant Proliferating Pilar Tumor A WHO grade I meningioma characterized by the coexistence of meningothelial cells and fibrous architectural patterns. C4333 Neoplastic Process Transitional Meningioma C0334611 GDC 9537/0 Undetermined Transitional_Meningioma 9537/0 Mixed meningioma Transitional meningioma Mixed Meningioma Mixed meningioma Transitional (Mixed) Meningioma Transitional Meningioma Transitional meningioma Transitional Meningioma A rare, pilar-associated mesenchyme neoplasm with follicular differentiation. It usually occurs in the face, neck, and chest. It presents as a dome-shaped papular lesion. It is composed of epithelial and mesenchymal cells. Patients with Birt-Hogg-Dube syndrome may develop follicular fibromas. C43331 Neoplastic Process Fibrofolliculoma C0346011 GDC 8391/0 Benign Fibrofolliculoma 8391/0 Fibrofolliculoma Follicular fibroma Fibrofolliculoma Follicular fibroma Fibrofolliculoma A cutaneous leiomyoma arising from the arrector pili muscle. C43332 Neoplastic Process Pilar Leiomyoma C1709540 Benign Pilar_Leiomyoma Pilar Leiomyoma Piloleiomyoma Pilar Leiomyoma A benign tumor usually arising in the face, trunk or thighs. C43333 Neoplastic Process Spindle-Cell Predominant Trichodiscoma C1704237 GDC Benign Trichodiscoma 8391/0 Trichodiscoma Neurofollicular Hamartoma Spindle-Cell Predominant Trichodiscoma Trichodiscoma Spindle-Cell Predominant Trichodiscoma A benign epithelial neoplasm occurring in the head, neck or back region. It is characterized by proliferation of basaloid cells in the upper dermis with broad attachments to the epidermis. C43334 Neoplastic Process Superficial Epithelioma with Sebaceous Differentiation C1710249 Undetermined Superficial_Epithelioma_with_Sebaceous_Differentiation Superficial Epithelioma with Sebaceous Differentiation Superficial Epithelioma with Sebaceous Differentiation A benign neoplasm characterized by sebaceous cell differentiation. It arises from the dermis and typically affects the face and neck. C43336 Neoplastic Process Sebaceoma C1275210 Benign Sebaceoma Sebaceoma Infundibular Adenoma Poroma-Like Adnexal Neoplasm Sebaceoma Sebaceous Epithelioma Sebocrine Adenoma Sebomatricoma Sebaceoma A rare condition characterized by diffuse spread of sarcoma cells throughout the meninges. The neoplastic cells are derived from meningeal connective tissue. Clinically, this disorder may present as a fulminant pachymeningitis and/or encephalitis. C4334 Neoplastic Process Meningeal Sarcomatosis C0334612 GDC 9539/3 Malignant Meningeal_Sarcomatosis 9539/3 Meningeal sarcomatosis Meningeal Sarcomatosis Meningeal sarcomatosis Meninges Sarcomatosis Sarcomatosis of Meninges Sarcomatosis of the Meninges Meningeal Sarcomatosis A carcinoma that arises from the sebaceous glands of the ocular adnexa and sebaceous glands of the eyelid and caruncle. C43340 Neoplastic Process Eye Sebaceous Carcinoma C1709308 Cellosaurus Malignant Ocular_Sebaceous_Carcinoma Eye Sebaceous Carcinoma Ocular Sebaceous Carcinoma Eye Sebaceous Carcinoma A rare variant of sebaceous carcinoma that does not affect the ocular region. C43341 Neoplastic Process Extraocular Cutaneous Sebaceous Carcinoma C1707986 Malignant Extraocular_Cutaneous_Sebaceous_Carcinoma Extraocular Cutaneous Sebaceous Carcinoma Extraocular Cutaneous Sebaceous Carcinoma A slow-growing, usually solitary, dome-shaped benign sweat gland adenoma, most frequently located on the eyelid. It is characterized by a cystic proliferation of apocrine glands. Surgical excision is curative. C43342 Neoplastic Process Apocrine Hidrocystoma C1704335 GDC Benign Apocrine_Hydrocystoma 8401/0 Apocrine cystadenoma Apocrine Hidrocystoma Apocrine Hydrocystoma Apocrine Hidrocystoma A carcinoma that arises in a cylindroma. C43344 Neoplastic Process Cylindrocarcinoma C1707290 Malignant Carcinoma_ex_Eccrine_Spiradenoma Carcinoma ex Cylindroma Cylindrocarcinoma Malignant Cylindroma Cylindrocarcinoma A very rare eccrine adenocarcinoma characterized by the presence of prominent ductal differentiation. C43345 Neoplastic Process Ductal Eccrine Adenocarcinoma C1260964 Malignant Ductal_Eccrine_Carcinoma DEA Ductal Eccrine Adenocarcinoma Ductal Eccrine Carcinoma Ductal Eccrine Adenocarcinoma A variant of ductal eccrine carcinoma with spindled cell appearance. C43346 Neoplastic Process Ductal Eccrine Carcinoma with Spindle Cell Elements C1707828 Malignant Ductal_Eccrine_Carcinoma_with_Spindle_Cell_Elements Ductal Eccrine Carcinoma with Spindle Cell Elements Ductal Eccrine Carcinoma with Spindle Cell Elements A variant of ductal eccrine carcinoma with squamoid metaplasia. C43347 Neoplastic Process Squamoid Eccrine Ductal Carcinoma C1707829 Malignant Ductal_Eccrine_Carcinoma_with_Squamous_Metaplasia Ductal Eccrine Carcinoma with Squamous Metaplasia Squamoid Ductal Eccrine Carcinoma Squamoid Eccrine Ductal Carcinoma Squamoid Eccrine Ductal Carcinoma A variant of ductal eccrine carcinoma with abundant fibromyxoid stroma. C43349 Neoplastic Process Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma C1707827 Malignant Ductal_Eccrine_Carcinoma_with_Abundant_Fibromyxoid_Stroma Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma A malignant peripheral nerve sheath tumor which shows rhabdomyosarcomatous differentiation. More than half of the patients have neurofibromatosis type 1. The prognosis is usually poor. C4335 Neoplastic Process Malignant Triton Tumor C0334616 GDC 9561/3 Malignant Malignant_Triton_Tumor 9561/3 MPNST with rhabdomyoblastic differentiation Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation Malignant schwannoma with rhabdomyoblastic differentiation Triton tumor, malignant MPNST with Rhabdomyosarcoma Malignant Neoplasm of Peripheral Nerve Sheath with Rhabdomyosarcoma Malignant Neoplasm of the Peripheral Nerve Sheath with Rhabdomyosarcoma Malignant Peripheral Nerve Sheath Neoplasm with Rhabdomyosarcoma Malignant Peripheral Nerve Sheath Tumor with Rhabdomyosarcoma Malignant Triton Tumor Malignant Tumor of Peripheral Nerve Sheath with Rhabdomyosarcoma Malignant Tumor of the Peripheral Nerve Sheath with Rhabdomyosarcoma Triton tumor, malignant Malignant Triton Tumor A cylindroma occurring as a solitary sporadic lesion. C43351 Neoplastic Process Sporadic Cylindroma C1710164 Benign Sporadic_Cylindroma Sporadic Cylindroma Sporadic Cylindroma A poroma characterized by the presence of cords and aggregates of neoplastic cells in the superficial dermis in connection with the epidermis. C43353 Neoplastic Process Classic Poroma C1707401 Benign Classical_Eccrine_Poroma Classic Poroma Classical Poroma Classic Poroma A rare intraepidermal neoplasia that arises from the acrosyringial portion of the eccrine duct. C43354 Neoplastic Process Porocarcinoma In Situ C1275212 Benign Hidroacanthoma_Simplex Porocarcinoma in situ Hidroacanthoma Simplex Porocarcinoma In Situ Porocarcinoma In Situ A rare benign eccrine lesion usually arising on acral areas as a solitary papule or nodule. Multiple lesions are referred as syringofibroadenomatosis. It is characterized by the presence of epithelial cuboidal cells forming anastomosing cords in a fibrovascular stroma. C43356 Neoplastic Process Syringofibroadenoma C1266060 GDC 8392/0 Benign Eccrine_Syringofibroadenoma 8392/0 Syringofibroadenoma Acrosyringeal Adenomatosis Acrosyringeal Nevus ESFA Eccrine Poromatosis Eccrine Syringofibroadenoma Eccrine Syringofibroadenoma of Mascaro Eccrine Syringofibroadenomatous Hyperplasia Linear Eccrine Poroma SFA Syringofibroadenoma Syringofibroadenoma An uncommon granular cell tumor which may metastasize to other anatomic sites. Morphologic characteristics include the presence of spindling neoplastic cells, necrosis, extensive pleomorphism, prominent nucleoli, and increased mitiotic activity. C4336 Neoplastic Process Malignant Granular Cell Tumor C0334618 CDISC GDC A malignant neoplasm, comprised of large cells with cytoplasmatic granules, occurring in various organs/tissues. 9580/3 Malignant Malignant_Granular_Cell_Tumor 9580/3 Granular cell myoblastoma, malignant Granular cell tumor, malignant GRANULAR CELL TUMOR, MALIGNANT Granular cell myoblastoma, malignant Granular cell tumor, malignant Malignant Granular Cell Myoblastoma Malignant Granular Cell Neoplasm Malignant Granular Cell Tumor Myoblastoma, Malignant Malignant Granular Cell Tumor A non-Hodgkin lymphoma composed of small to medium sized B-lymphocytes (centrocytes). Most patients present with advanced stage disease with lymphadenopathy, hepatosplenomegaly, and bone marrow involvement. The gastrointestinal tract is the most commonly affected extranodal site by this type of non-Hodgkin lymphoma. The vast majority of cases express the t(11;14)(q13;q32) resulting in the rearrangement of the BCL-1 gene and the overexpression of cyclin D1 mRNA. C4337 Neoplastic Process Mantle Cell Lymphoma Mantle Cell Lymphoma C0334634 CPTAC CTEP CTRP Cellosaurus GDC mCode An aggressive (fast-growing) type of B-cell non-Hodgkin lymphoma that usually occurs in middle-aged or older adults. It is marked by small- to medium-size cancer cells that may be in the lymph nodes, spleen, bone marrow, blood, and gastrointestinal system. 9673/3 Malignant Mantle_Cell_Lymphoma 9673/3 Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse Mantle cell lymphoma Mantle cell lymphoma (Includes all variants blastic, pleomorphic, small cell) Mantle cell lymphoma, extranodal and solid organ sites Mantle cell lymphoma, lymph nodes of multiple sites Mantle cell lymphoma, unspecified site Mantle cell lymphoma, unspecified site, extranodal and solid organ sites Mantle zone lymphoma Classical Mantle Cell Lymphoma MCL Mantle Cell Lymphoma Mantle Zone Lymphoma Mantle cell lymphoma Mantle cell lymphoma, unspecified site Mantle zone lymphoma mantle cell lymphoma Mantle Cell Lymphoma An atypical proliferation of atypical melanocytes in the dermal-epidermal junction, without infiltration of the papillary or reticular dermis. The melanocytic proliferation is associated with actinic damage and epidermal atrophy. It usually occurs in the sun-exposed skin of elderly people. It is a form of melanoma in situ. C43372 Neoplastic Process Lentigo Maligna C0149722 GDC 8742/2 Malignant Lentigo_Maligna 8742/2 Hutchinson melanotic freckle, NOS Lentigo maligna Hutchinson Melanotic Freckle Hutchinson melanotic freckle, NOS Hutchinson's Melanotic Freckle LMM In Situ Lentigo Maligna Lentigo Maligna Melanoma In Situ Lentigo maligna Lentigo Maligna A clinico-pathological entity reflecting the multiple polyps throughout the gastrointestinal tract created as a result of involvement by a non-Hodgkin lymphoma. Typically, mantle cell lymphomas involving the gastrointestinal tract give rise to multifocal lymphomatous polyposis. Importantly, other histologic subtypes of non-Hodgkin lymphoma can also produce this clinico-pathological entity. (WHO, 2000) C4339 Neoplastic Process Multifocal Lymphomatous Polyposis C0334638 GDC Malignant Multifocal_Lymphomatous_Polyposis 9673/3 Malignant lymphomatous polyposis Multifocal Lymphomatous Polyposis Multiple Lymphomatous Polyposis Multifocal Lymphomatous Polyposis A group of peripheral T-cell lymphomas that do not meet the criteria for any other category of specifically defined entities of peripheral T-cell lymphoma. C4340 Neoplastic Process Peripheral T-Cell Lymphoma, Not Otherwise Specified Peripheral T-Cell Lymphoma, Unclassifiable Peripheral T-Cell Lymphoma, Not Otherwise Specified C2853959 CPTAC CTEP CTRP GDC mCode Malignant Unspecified_Peripheral_T-Cell_Lymphoma 9702/3 Mature T-cell lymphoma, NOS Peripheral T-cell lymphoma Peripheral T-cell lymphoma, NOS Peripheral T-cell lymphoma, not classified Peripheral T-cell lymphoma, not classified, extranodal and solid organ sites Peripheral T-cell lymphoma, not classified, unspecified site Peripheral T-cell lymphoma, unspecified site, extranodal and solid organ sites Mature T-Cell Lymphoma, NOS PTCL, NOS PTCL-NOS Peripheral T-Cell Lymphoma, NOS Peripheral T-Cell Lymphoma, Not Otherwise Specified Peripheral T-Cell Lymphoma, Unclassifiable Peripheral T-cell lymphoma, NOS Peripheral T-cell lymphoma, not classified, unspecified site Peripheral T-Cell Lymphoma, Not Otherwise Specified A usually indolent mature B-cell lymphoma, arising from the marginal zone of lymphoid tissues. It is characterized by the presence of small to medium sized atypical lymphocytes. It comprises three entities, according to the anatomic sites involved: extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue, which affects extranodal sites (most often stomach, lung, skin, and ocular adnexa); nodal marginal zone B-cell lymphoma, which affects lymph nodes without evidence of extranodal disease; and splenic marginal zone B-cell lymphoma, which affects the spleen and splenic hilar lymph nodes, bone marrow, and often the peripheral blood. C4341 Neoplastic Process Marginal Zone Lymphoma Marginal Zone Lymphoma C1367654 CPTAC CTRP GDC An indolent (slow-growing) type of B-cell non-Hodgkin lymphoma that begins forming in certain areas (the marginal zones) of lymph tissue. There are three types based on whether it forms in the spleen, lymph nodes, or other lymphoid tissue that contains a lot of B cells (a type of white blood cell). 9699/3 Malignant Marginal_Zone_B-Cell_Lymphoma 9699/3 Marginal zone B-cell lymphoma, NOS Marginal zone lymphoma Marginal zone lymphoma involving lymph nodes of inguinal region and lower limb Marginal zone lymphoma, NOS MZBCL MZL Marginal Zone B-Cell Lymphoma Marginal Zone Lymphoma Marginal zone lymphoma, NOS marginal zone B-cell lymphoma marginal zone lymphoma Marginal Zone Lymphoma A rare extranodal B-cell non-Hodgkin lymphoma, characterized by the presence of lymphoma cells exclusively in the lumina of small vessels, particularly capillaries. This is an extremely aggressive lymphoma which responds poorly to chemotherapy. (WHO, 2001) C4342 Neoplastic Process Intravascular Large B-Cell Lymphoma Intravascular Large B-Cell Lymphoma C0334660 CTRP GDC 9712/3 Malignant Intravascular_Large_B-Cell_Lymphoma 9680/3 9712/3 Angioendotheliomatosis Angiotropic lymphoma Intravascular B-cell lymphoma Intravascular large B-cell lymphoma Angiotropic Large Cell Lymphoma Angiotropic Lymphoma Angiotropic lymphoma IVLBCL Intravascular B-Cell Lymphoma Intravascular B-cell lymphoma Intravascular Large B-Cell Lymphoma Intravascular large B-cell lymphoma Malignant Angioendotheliomatosis Intravascular Large B-Cell Lymphoma C4343 Neoplastic Process Aleukemic Lymphoid Leukemia C0334667 GDC Malignant Aleukemic_Lymphoid_Leukemia 9820/3 Aleukemic lymphatic leukemia Aleukemic lymphoid leukemia Aleukemic Lymphatic Leukemia Aleukemic Lymphogenous Leukemia Aleukemic Lymphoid Leukemia Aleukemic lymphatic leukemia Aleukemic lymphoid leukemia Aleukemic Lymphoid Leukemia An acute myeloid leukemia characterized by bone marrow fibrosis without preexisting primary myelofibrosis. C4344 Neoplastic Process Acute Panmyelosis with Myelofibrosis Acute Panmyelosis with Myelofibrosis C0334674 CPTAC CTRP GDC PCDC 9931/3 Malignant Acute_Panmyelosis_with_Myelofibrosis 9931/3 Acute myelofibrosis Acute myelosclerosis, NOS Acute panmyelosis with myelofibrosis Acute panmyelosis, NOS APMF Acute (Malignant) Myelofibrosis Acute (Malignant) Myelosclerosis Acute Myelofibrosis Acute Myelosclerosis Acute Panmyelosis Acute Panmyelosis with Myelofibrosis Acute myelofibrosis Acute panmyelosis with myelofibrosis Acute Panmyelosis with Myelofibrosis A group of myeloid neoplasms that includes the following: chronic myeloid leukemia, BCR-ABL1 positive; polycythemia vera; essential thrombocythemia; primary myelofibrosis; chronic neutrophilic leukemia; chronic eosinophilic leukemia, not otherwise specified; and myeloproliferative neoplasm, unclassifiable. C4345 Neoplastic Process Myeloproliferative Neoplasm Myeloproliferative Neoplasm C1292778 CPTAC CTRP Cellosaurus GDC mCode A group of slow growing blood cancers, including chronic myelogenous leukemia, in which large numbers of abnormal red blood cells, white blood cells, or platelets grow and spread in the bone marrow and the peripheral blood. 9960/3 9975/1 Malignant Chronic_Myeloproliferative_Disorder Chronic Myeloproliferative Disorders Chronic myeloproliferative disease Chronic myeloproliferative disorder CMPD Chronic Myeloproliferative Disease Chronic Myeloproliferative Disorder Chronic Myeloproliferative Disorders Chronic Myeloproliferative Neoplasm Chronic myeloproliferative disease Chronic myeloproliferative disorder MPD MPN Myeloproliferative Disease Myeloproliferative Disorder Myeloproliferative Neoplasm Myeloproliferative Tumor myeloproliferative disorder Myeloproliferative Neoplasm A basal cell carcinoma of the skin that is characterized by sebaceous differentiation. C4346 Neoplastic Process Skin Basal Cell Carcinoma with Sebaceous Differentiation C0334683 GDC Malignant Sebaceous_Epithelioma 8410/0 Sebaceous epithelioma Basal Cell Carcinoma with Sebaceous Differentiation Basal Cell Epithelioma with Sebaceous Differentiation Basosebaceous Epithelioma Sebaceous Epithelioma Sebaceous epithelioma Skin Basal Cell Carcinoma with Sebaceous Differentiation Skin Basal Cell Carcinoma with Sebaceous Differentiation An astrocytoma, without designation of benign or malignant, that is found in the supratentorial region. The infratentorial location is more common in children. C4347 Neoplastic Process Childhood Cerebral Astrocytoma Childhood Cerebral Astrocytoma C0338070 CTRP Undetermined Childhood_Cerebral_Astrocytoma Cerebral Astrocytoma Childhood Astrocytoma of Cerebrum Childhood Astrocytoma of the Cerebrum Childhood Cerebral Astrocytoma Pediatric Astrocytoma of Cerebrum Pediatric Astrocytoma of the Cerebrum Pediatric Cerebral Astrocytoma Childhood Cerebral Astrocytoma A hormone producing or non-producing pituitary neuroendocrine tumor not associated with a hormonal syndrome. C4348 Neoplastic Process Non-Functioning Pituitary Gland Tumor Non-Functioning Pituitary Neuroendocrine Tumor C0338078 CTRP NICHD Undetermined Non-Functioning_Pituitary_Gland_Adenoma Functionless Adenoma of Pituitary Functionless Adenoma of Pituitary Gland Functionless Adenoma of the Pituitary Functionless Adenoma of the Pituitary Gland Functionless Pituitary Adenoma Functionless Pituitary Gland Adenoma Non-Functioning Adenoma of Pituitary Non-Functioning Adenoma of Pituitary Gland Non-Functioning Adenoma of the Pituitary Non-Functioning Adenoma of the Pituitary Gland Non-Functioning PitNET/Adenoma Non-Functioning Pituitary Adenoma Non-Functioning Pituitary Gland Adenoma Non-Functioning Pituitary Gland Tumor Non-Functioning Pituitary Neuroendocrine Tumor Non-Functioning Pituitary Neuroendocrine Tumor/Adenoma Non-Secretory Adenoma of Pituitary Non-Secretory Adenoma of Pituitary Gland Non-Secretory Adenoma of the Pituitary Non-Secretory Adenoma of the Pituitary Gland Non-Secretory Pituitary Adenoma Non-Secretory Pituitary Gland Adenoma Nonfunctional Pituitary Gland Adenoma Nonfunctioning Pituitary Gland Adenoma Silent Pituitary Gland Adenoma Non-Functioning Pituitary Neuroendocrine Tumor An adenocarcinoma arising from the colon. It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease. Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits. According to the degree of cellular differentiation, colonic adenocarcinomas are divided into well, moderately, and poorly differentiated. Histologic variants include mucinous adenocarcinoma, signet ring cell carcinoma, medullary carcinoma, serrated adenocarcinoma, cribriform comedo-type adenocarcinoma, and micropapillary adenocarcinoma. C4349 Neoplastic Process Colon Adenocarcinoma Colon Adenocarcinoma C0338106 CTEP CTRP Cellosaurus GDC Malignant Colon_Adenocarcinoma 30 41 Adenocarcinoma - colon Adenocarcinoma of Colon Adenocarcinoma of the Colon Adenocarcinoma of the colon Colon Adenocarcinoma Colonic Adenocarcinoma Colon Adenocarcinoma A rare neoplastic polyp that arises from the stomach. It is characterized by the presence of gastric epithelial differentiation and pyloric gland-type tubular structures, which are closely packed. C43526 Neoplastic Process Gastric Pyloric Gland Adenoma C1709780 Benign Pyloric_Gland_Adenoma Gastric Pyloric Gland Adenoma Gastric Pyloric Gland Adenoma A primary adenocarcinoma of the stomach in a patient with no family history of gastric cancer or inherited high risk mutations. C43527 Neoplastic Process Sporadic Gastric Adenocarcinoma C1711192 Malignant Sporadic_Gastric_Carcinoma Sporadic Gastric Adenocarcinoma Sporadic Gastric Adenocarcinoma A sporadic adenocarcinoma that arises from the gastric mucosa and is characterized by the presence of poorly cohesive malignant cells and absence of glandular formations. C43529 Neoplastic Process Sporadic Gastric Diffuse Adenocarcinoma C1710165 Malignant Sporadic_Diffuse_Gastric_Adenocarcinoma Sporadic Diffuse Gastric Adenocarcinoma Sporadic Gastric Diffuse Adenocarcinoma Sporadic Gastric Diffuse Adenocarcinoma A carcinoma that arises from the small intestine. It is composed of malignant squamous cells. C43534 Neoplastic Process Small Intestinal Squamous Cell Carcinoma Small Intestinal Squamous Cell Carcinoma C1710111 CTRP Malignant Small_Intestinal_Squamous_Cell_Carcinoma Small Intestinal Squamous Cell Cancer Small Intestinal Squamous Cell Carcinoma Small Intestinal Squamous Cell Carcinoma A carcinoma that arises from the small intestine. It is composed of malignant glandular cells and malignant squamous cells. C43535 Neoplastic Process Small Intestinal Adenosquamous Carcinoma Small Intestinal Adenosquamous Carcinoma C1711182 CTRP Malignant Small_Intestinal_Adenosquamous_Carcinoma Small Intestinal Adenosquamous Cancer Small Intestinal Adenosquamous Carcinoma Small Intestinal Adenosquamous Carcinoma An invasive adenocarcinoma that arises from the small intestine. It is composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. C43536 Neoplastic Process Small Intestinal Mucinous Adenocarcinoma C1710109 Malignant Small_Intestinal_Mucinous_Adenocarcinoma Small Intestinal Mucinous Adenocarcinoma Small Intestinal Mucinous Adenocarcinoma A carcinoma that arises from the small intestine. It is characterized by the presence of malignant epithelial cells with vesicular nucleus, distinct nucleolus, and abundant pink cytoplasm. C43537 Neoplastic Process Small Intestinal Medullary Carcinoma Small Intestinal Medullary Carcinoma C1711326 CTRP Malignant Small_Intestinal_Medullary_Carcinoma Small Intestinal Medullary Cancer Small Intestinal Medullary Carcinoma Small Intestinal Medullary Carcinoma A carcinoma that arises from the small intestine. It is composed of malignant epithelial cells which do not display evidence of glandular, squamous, or transitional cell differentiation. C43538 Neoplastic Process Small Intestinal Undifferentiated Carcinoma Small Intestinal Undifferentiated Carcinoma C1710114 CTRP Malignant Small_Intestinal_Undifferentiated_Carcinoma Small Intestinal Undifferentiated Carcinoma Undifferentiated Small Intestinal Cancer Small Intestinal Undifferentiated Carcinoma A neoplasm that arises from the upper or lower eyelid and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4354 Neoplastic Process Benign Eyelid Neoplasm C0339107 CPTAC Benign Benign_Eyelid_Neoplasm Benign neoplasm of eyelid, including canthus Benign Eyelid Neoplasm Benign Eyelid Tumor Benign Neoplasm of Eyelid Benign Neoplasm of the Eyelid Benign Tumor of Eyelid Benign Tumor of the Eyelid Benign Eyelid Neoplasm A pituitary neuroendocrine tumor with a diameter equal or less than 10 mm. C43541 Neoplastic Process Pituitary Neuroendocrine Tumor/Microadenoma C1709552 Undetermined Pituitary_Gland_Microadenoma PitNET/Microadenoma Pituitary Gland Microadenoma Pituitary Neuroendocrine Tumor/Microadenoma Pituitary Neuroendocrine Tumor/Microadenoma A pituitary neuroendocrine tumor with a diameter greater than 10 mm. Clinical manifestations include headache, visual field disturbances, pituitary insufficiency, and mild hyperprolactinemia. C43542 Neoplastic Process Pituitary Neuroendocrine Tumor/Macroadenoma C0346308 Undetermined Pituitary_Gland_Macroadenoma PitNET/Macroadenoma Pituitary Gland Macroadenoma Pituitary Neuroendocrine Tumor/Macroadenoma Pituitary Neuroendocrine Tumor/Macroadenoma An invasive adenocarcinoma that arises from the small intestine. It is characterized by the presence of malignant glandular cells in which the nucleus is pressed to one side by the presence of intracytoplasmic mucus. C43543 Neoplastic Process Small Intestinal Signet Ring Cell Carcinoma C1710110 Malignant Small_Intestinal_Signet_Ring_Cell_Carcinoma Small Intestinal Signet Ring Cell Carcinoma Small Intestinal Signet-Ring Cell Carcinoma Small Intestinal Signet Ring Cell Carcinoma An adenoma arising from the appendix. It is characterized by the presence of tubular epithelial structures and it is associated with dysplasia. C43546 Neoplastic Process Appendix Tubular Adenoma C1706834 Benign Appendix_Tubular_Adenoma Appendix Tubular Adenoma Appendix Tubular Adenoma An adenoma arising from the appendix. It is characterized by the presence of tubular and villous epithelial structures and it is associated with dysplasia. C43547 Neoplastic Process Appendix Tubulovillous Adenoma C1706836 Benign Appendix_Tubulovillous_Adenoma Appendix Tubulovillous Adenoma Appendix Tubulovillous Adenoma An adenoma that arises from the appendix. It is characterized by prominent serration of the glands. C43549 Neoplastic Process Appendix Traditional Serrated Adenoma C1711169 Benign Appendix_Serrated_Adenoma Appendix Serrated Adenoma Appendix Serrated Adenoma Type II Appendix TSA Appendix Traditional Serrated Adenoma Appendix Traditional Serrated Adenoma A papilloma that arises from the eyelid. It is composed of squamous cells and is characterized by the presence of an acanthotic epithelium with hyperkeratosis and papillary projections with an inner fibrovascular core. It is the most common benign epithelial tumor of eyelid. It usually affects middle-aged or older adults. C4355 Neoplastic Process Eyelid Squamous Papilloma C0339108 Benign Eyelid_Squamous_Cell_Papilloma Epidermoid Papilloma of Eyelid Epidermoid Papilloma of the Eyelid Eyelid Epidermoid Papilloma Eyelid Squamous Cell Papilloma Eyelid Squamous Papilloma Squamous Cell Papilloma of Eyelid Squamous Cell Papilloma of the Eyelid Eyelid Squamous Papilloma A circumscribed neoplasm arising from the glandular epithelium of the appendix. Morphologically, it is characterized by a proliferation of neoplastic glandular cells and it is associated with dysplasia. According to the growth pattern, it may be classified as tubular, villous, or tubulovillous. The dysplasia is classified as mild, moderate, or severe. C43550 Neoplastic Process Appendix Adenoma C1706829 Benign Appendix_Adenoma Appendix Adenoma Appendix Adenoma A neoplasm that arises from the glandular epithelium of the small intestine. It is characterized by a villous architectural pattern. The neoplastic glandular cells have dysplastic features. C43551 Neoplastic Process Small Intestinal Villous Adenoma C1710115 Benign Small_Intestinal_Villous_Adenoma Small Intestinal Villous Adenoma Small Intestinal Villous Adenoma A usually polypoid neoplasm that arises from the glandular epithelium of the small intestine. It is characterized by a tubular architectural pattern. The neoplastic glandular cells have dysplastic features. C43552 Neoplastic Process Small Intestinal Tubular Adenoma C1710112 Benign Small_Intestinal_Tubular_Adenoma Small Intestinal Tubular Adenoma Small Intestinal Tubular Adenoma A neoplasm that arises from the glandular epithelium of the small intestine. It is characterized by tubular and villous architectural patterns. The neoplastic glandular cells have dysplastic features. C43553 Neoplastic Process Small Intestinal Tubulovillous Adenoma C1710113 Benign Small_Intestinal_Tubulovillous_Adenoma Small Intestinal Tubulovillous Adenoma Small Intestinal Tubulovillous Adenoma An adenocarcinoma arising from the appendix, characterized by the presence of signet-ring, mucin-producing malignant cells. The signet-ring cells constitute more than fifty-percent of the malignant cells. C43554 Neoplastic Process Appendix Signet Ring Cell Carcinoma C1711320 Malignant Appendix_Signet_Ring_Cell_Carcinoma Appendix Signet Ring Cell Carcinoma Appendix Signet-Ring Cell Carcinoma Appendix Signet Ring Cell Carcinoma An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the wall of the appendix. It is characterized by the presence of malignant small cells. C43555 Neoplastic Process Appendix Small Cell Neuroendocrine Carcinoma C1706833 Malignant Appendix_Small_Cell_Carcinoma Appendix Small Cell Carcinoma Appendix Small Cell Neuroendocrine Carcinoma Appendix Small Cell Neuroendocrine Carcinoma A high grade carcinoma arising from the appendix, characterized by the absence of glandular or squamous differentiation. C43556 Neoplastic Process Appendix Undifferentiated Carcinoma C1706837 Malignant Appendix_Undifferentiated_Carcinoma Appendix Undifferentiated Carcinoma Appendix Undifferentiated Carcinoma An adenocarcinoma arising from the appendix, characterized by the presence of mucinous stroma formation. C43558 Neoplastic Process Appendix Mucinous Adenocarcinoma C1706832 Malignant Appendix_Mucinous_Adenocarcinoma Appendix Mucinous Adenocarcinoma Appendix Mucinous Adenocarcinoma A benign skin neoplasm that arises from the eyelid. It is characterized by the intraepidermal proliferation of basaloid keratinocytes, acanthosis, hyperkeratosis, and cysts formation. C4356 Neoplastic Process Eyelid Seborrheic Keratosis C0339109 Benign Eyelid_Seborrheic_Keratosis Basal Cell Papilloma of Eyelid Basal Cell Papilloma of the Eyelid Eyelid Basal Cell Papilloma Eyelid Seborrheic Keratosis Seborrheic Keratosis of Eyelid Seborrheic Keratosis of the Eyelid Eyelid Seborrheic Keratosis A carcinoma that arises from the appendix. It is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component. At least 30 percent of either component should be present for the diagnosis to be made. C43564 Neoplastic Process Appendix Mixed Adenoneuroendocrine Carcinoma C1706831 Undetermined Appendix_Mixed_Endocrine-Exocrine_Neoplasm Appendix MANEC Appendix Mixed Adenoneuroendocrine Carcinoma Appendix Mixed Endocrine-Exocrine Neoplasm Appendix Mixed Adenoneuroendocrine Carcinoma A neuroendocrine tumor that arises from the appendix. It does not show the morphologic characteristics of typical carcinoid tumors (neoplastic cells forming solid nests). In contrast, the tumor cells form small discrete tubules. C43565 Neoplastic Process Appendix Tubular Carcinoid C1266031 GDC 8245/1 Malignant Appendix_Tubular_Carcinoid 8245/1 Tubular carcinoid Appendix Tubular Carcinoid Appendix Tubular Carcinoid Tumor Tubular carcinoid Appendix Tubular Carcinoid A capillary hemangioma arising from the eyelid. C4357 Neoplastic Process Eyelid Capillary Hemangioma C0339110 Benign Eyelid_Capillary_Hemangioma Capillary Angioma of Eyelid Capillary Angioma of Lid Capillary Angioma of the Eyelid Capillary Angioma of the Lid Capillary Hemangioma of Eyelid Capillary Hemangioma of Lid Capillary Hemangioma of the Eyelid Capillary Hemangioma of the Lid Eyelid Capillary Angioma Eyelid Capillary Hemangioma Eyelid Capillary Hemangioma A benign adipose tissue neoplasm involving the wall of the appendix. C43576 Neoplastic Process Appendix Lipoma C1706830 Benign Appendix_Lipoma Appendix Lipoma Appendix Lipoma An adenoma that arises from the colon. It is characterized by prominent serration of the glands. C43577 Neoplastic Process Colon Traditional Serrated Adenoma C1707435 Benign Colon_Serrated_Adenoma Colon Serrated Adenoma Colon Serrated Adenoma Type II Colon TSA Colon Traditional Serrated Adenoma Colon Traditional Serrated Adenoma A melanoma that arises from the upper or lower eyelid. C4358 Neoplastic Process Eyelid Melanoma C0339116 CPTAC Malignant Eyelid_Melanoma Malignant melanoma of left eyelid, including canthus Malignant melanoma of skin of eyelid, including canthus Malignant neoplasm: Malignant melanoma of eyelid, including canthus Eyelid Melanoma Malignant Eyelid Melanoma Malignant Melanoma of Eyelid Malignant Melanoma of the Eyelid Melanoma of Eyelid Melanoma of the Eyelid Eyelid Melanoma An adenocarcinoma arising from the rectosigmoid area. It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease. Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits. According to the degree of cellular differentiation, rectosigmoid adenocarcinomas are divided into well, moderately, and poorly differentiated. Histologic variants include mucinous adenocarcinoma, signet ring cell carcinoma, medullary carcinoma, serrated adenocarcinoma, cribriform comedo-type adenocarcinoma, and micropapillary adenocarcinoma. C43584 Neoplastic Process Rectosigmoid Adenocarcinoma Rectosigmoid Adenocarcinoma C1711390 CTRP Cellosaurus Malignant Rectosigmoid_Adenocarcinoma Rectosigmoid Adenocarcinoma Rectosigmoid Adenocarcinoma An invasive colorectal adenocarcinoma characterized by the presence of extracellular mucin pools that contain malignant glandular epithelial structures. The extracellular mucin pools occupy more than 50% of the malignant lesion. C43585 Neoplastic Process Colorectal Mucinous Adenocarcinoma C1707439 Cellosaurus Malignant Colorectal_Mucinous_Adenocarcinoma Colorectal Mucinous Adenocarcinoma Colorectal Mucinous Adenocarcinoma An invasive colorectal adenocarcinoma characterized by the presence of malignant glandular epithelial cells with prominent intracytoplasmic mucin resulting in the displacement of the nuclei. The malignant glandular cells with intracytoplasmic mucin constitute more than 50% of the malignant cellular infiltrate. C43586 Neoplastic Process Colorectal Signet Ring Cell Carcinoma C1707440 Malignant Colorectal_Signet_Ring_Cell_Carcinoma Colorectal Signet Ring Cell Carcinoma Colorectal Signet-Ring Cell Carcinoma Colorectal Signet Ring Cell Carcinoma An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the colon or rectum. It is characterized by the presence of malignant small cells. C43587 Neoplastic Process Colorectal Small Cell Neuroendocrine Carcinoma C1707441 Malignant Colorectal_Small_Cell_Carcinoma Colorectal Small Cell Carcinoma Colorectal Small Cell Neuroendocrine Carcinoma Large Intestinal Small Cell Neuroendocrine Carcinoma Colorectal Small Cell Neuroendocrine Carcinoma A very rare colorectal carcinoma characterized by the presence of a malignant squamous cell infiltrate. C43588 Neoplastic Process Colorectal Squamous Cell Carcinoma Colorectal Squamous Cell Carcinoma C1707442 CTRP Malignant Colorectal_Squamous_Cell_Carcinoma Colorectal (Colon or Rectal) Squamous Cell Cancer Colorectal Squamous Cell Carcinoma Colorectal Squamous Cell Carcinoma An unusual colorectal carcinoma characterized by the presence of glandular and squamous carcinomatous components. The two carcinomatous components may be admixed within the tumor, or the two may appear separately in different areas. C43589 Neoplastic Process Colorectal Adenosquamous Carcinoma Colorectal Adenosquamous Carcinoma C1707437 CTRP Malignant Colorectal_Adenosquamous_Carcinoma Colorectal (Colon or Rectal) Adenosquamous Cancer Colorectal Adenosquamous Carcinoma Colorectal Adenosquamous Carcinoma A rare, invasive colorectal adenocarcinoma characterized by the presence of sheets of malignant epithelial cells with vesicular nuclei, prominent nucleoli, and abundant eosinophilic cytoplasm. It usually has a favorable prognosis. C43590 Neoplastic Process Colorectal Medullary Carcinoma C1707438 Malignant Colorectal_Medullary_Carcinoma Colorectal Medullary Carcinoma Colorectal Medullary Carcinoma An invasive malignant epithelial tumor that arises from the colon or rectum. There is no morphologic, immunophenotypic, or molecular biological evidence of glandular or squamous differentiation. C43591 Neoplastic Process Colorectal Undifferentiated Carcinoma Colorectal Undifferentiated Carcinoma C1707443 CTRP Malignant Colorectal_Undifferentiated_Carcinoma Colorectal Undifferentiated Carcinoma Undifferentiated Colorectal (Colon or Rectal) Cancer Colorectal Undifferentiated Carcinoma An invasive adenocarcinoma of the rectosigmoid area characterized by the presence of pools of extracellular mucin. Malignant glandular epithelial cells are present in the mucin collections. Mucin constitutes more than 50% of the lesion. C43592 Neoplastic Process Rectosigmoid Mucinous Adenocarcinoma C1709867 Malignant Rectosigmoid_Mucinous_Adenocarcinoma Rectosigmoid Mucinous Adenocarcinoma Rectosigmoid Mucinous Adenocarcinoma An infiltrating adenocarcinoma arising from the rectosigmoid area. It is characterized by the presence of malignant glandular cells with prominent intracytoplasmic mucin. These cells constitute more than 50% of the malignant cellular population. C43593 Neoplastic Process Rectosigmoid Signet Ring Cell Carcinoma C1709869 Malignant Rectosigmoid_Signet_Ring_Cell_Carcinoma Rectosigmoid Signet Ring Cell Carcinoma Rectosigmoid Signet-Ring Cell Carcinoma Rectosigmoid Signet Ring Cell Carcinoma An unusual rectal carcinoma characterized by the presence of glandular and squamous carcinomatous components. The two carcinomatous components may be admixed within the tumor, or the two may appear separately in different areas. C43594 Neoplastic Process Rectal Adenosquamous Carcinoma Rectal Adenosquamous Carcinoma C1709865 CTRP Malignant Rectal_Adenosquamous_Carcinoma Rectal Adenosquamous Cancer Rectal Adenosquamous Carcinoma Rectal Adenosquamous Carcinoma A precancerous neoplastic intraepithelial process involving the squamous epithelium of the perianal skin. Clinically, it usually presents as a white or red area in the perianal skin. Morphologically, it is characterized by full thickness dysplasia of the squamous epithelium and sometimes of the pilosebaceous epithelium. Human papillomavirus DNA sometimes may be identified in the dysplastic epithelium. It may recur after treatment, however only a small percentage of cases progress to squamous cell carcinoma. C43598 Neoplastic Process Perianal Intraepithelial Neoplasia C1332271 Undetermined Anal_Margin_Intraepithelial_Neoplasia Anal Margin Bowen Disease Anal Margin Bowen's Disease Anal Margin Intraepithelial Neoplasia Anal Margin Squamous Dysplasia Bowen Disease PSIN Perianal Intraepithelial Neoplasia Perianal Skin Bowen Disease Perianal Skin Bowen's Disease Perianal Squamous Dysplasia Perianal Squamous Intraepithelial Neoplasia Perianal Intraepithelial Neoplasia A benign or malignant neoplasm that affects the lacrimal gland. C4360 Neoplastic Process Lacrimal Gland Neoplasm C0339124 Undetermined Lacrimal_Gland_Neoplasm Lacrimal Gland Neoplasm Neoplasm of Lacrimal Gland Neoplasm of the Lacrimal Gland Lacrimal Gland Neoplasm An adenocarcinoma that arises from the gallbladder. It is characterized by the presence of neoplastic tubular glands lined by columnar cells or neoplastic glands lined by goblet cells. C43604 Neoplastic Process Gallbladder Adenocarcinoma, Intestinal-Type C1708171 Malignant Gallbladder_Adenocarcinoma_Intestinal_Type Gallbladder Adenocarcinoma, Intestinal-Type Gallbladder Adenocarcinoma, Intestinal-Type A rare morphologic variant of gallbladder adenocarcinoma composed of malignant glandular epithelium with a predominance of glycogen rich clear cells. The cells display hyperchromic nuclei and well-defined cytoplasmic borders. C43605 Neoplastic Process Gallbladder Clear Cell Adenocarcinoma C1708172 Malignant Gallbladder_Clear_Cell_Adenocarcinoma Gallbladder Clear Cell Adenocarcinoma Gallbladder Clear Cell Adenocarcinoma A neoplastic, non-invasive lesion that affects the gallbladder epithelium. It is characterized by the presence of atypical epithelial cells with an increased nuclear/cytoplasmic ratio, nuclear hyperchromasia, and loss of nuclear polarity. C43606 Neoplastic Process Gallbladder Biliary Intraepithelial Neoplasia C1708174 Undetermined Gallbladder_Intraepithelial_Neoplasia Gallbladder BilIN Gallbladder Biliary Intraepithelial Neoplasia Gallbladder Dysplasia Gallbladder Intraepithelial Neoplasia Intracystic BilIN Intracystic Biliary Intraepithelial Neoplasia Gallbladder Biliary Intraepithelial Neoplasia Biliary intraepithelial neoplasia that affects the gallbladder epithelium. It is characterized by the absence of intraluminal micropapillary projections. C43607 Neoplastic Process Gallbladder Flat Biliary Intraepithelial Neoplasia C1708173 Undetermined Gallbladder_Flat_Intraepithelial_Neoplasia Gallbladder Flat BilIN Gallbladder Flat Biliary Intraepithelial Neoplasia Gallbladder Flat Intraepithelial Neoplasia Gallbladder Flat Biliary Intraepithelial Neoplasia Biliary intraepithelial neoplasia that affects the gallbladder epithelium. It is characterized by the presence of intraluminal micropapillary projections. C43609 Neoplastic Process Gallbladder Papillary Biliary Intraepithelial Neoplasia C1708177 Undetermined Gallbladder_Papillary_Intraepithelial_Neoplasia Gallbladder Papillary BilIN Gallbladder Papillary Biliary Intraepithelial Neoplasia Gallbladder Papillary Intraepithelial Neoplasia Gallbladder Papillary Biliary Intraepithelial Neoplasia A benign or malignant neoplasm that affects the cornea. C4361 Neoplastic Process Corneal Neoplasm C0339304 Undetermined Corneal_Neoplasm Cornea Neoplasm Cornea Tumor Corneal Neoplasm Corneal Tumor Neoplasm of Cornea Neoplasm of the Cornea Tumor of Cornea Tumor of the Cornea Corneal Neoplasm A morphologic variant of hepatocellular carcinoma, characterized by the presence of malignant cells which show marked variation in their size and shape. Bizarre mononuclear or multinucleated giant cells are often present. C43625 Neoplastic Process Pleomorphic Hepatocellular Carcinoma Pleomorphic Hepatocellular Carcinoma C1709568 CTRP GDC 8175/3 Malignant Pleomorphic_Hepatocellular_Carcinoma 8175/3 Hepatocellular carcinoma, pleomorphic type Hepatocellular carcinoma, pleomorphic type Pleomorphic Hepatocellular Cancer Pleomorphic Hepatocellular Carcinoma Pleomorphic Hepatocellular Carcinoma A morphologic variant of hepatocellular carcinoma characterized by the presence of malignant spindle cells or atypical giant cells. C43627 Neoplastic Process Sarcomatoid Hepatocellular Carcinoma Sarcomatoid Hepatocellular Carcinoma C1710014 CTRP Cellosaurus GDC 8173/3 Malignant Sarcomatous_Hepatocellular_Carcinoma 8173/3 Hepatocellular carcinoma, sarcomatoid Hepatocellular carcinoma, spindle cell variant Hepatocellular carcinoma, sarcomatoid Hepatocellular carcinoma, spindle cell variant Sarcomatoid Hepatocellular Cancer Sarcomatoid Hepatocellular Carcinoma Sarcomatous Hepatocellular Carcinoma Sarcomatoid Hepatocellular Carcinoma The segment of either hepatic duct located in the hilum of the liver. C43630 Anatomical Structure Hilar Portion of the Hepatic Duct C1711262 Hilar_Portion_of_the_Hepatic_Duct Hilar Portion of the Hepatic Duct Hilar Portion of the Hepatic Duct A benign or malignant neoplasm that affects the ciliary body. C4364 Neoplastic Process Ciliary Body Neoplasm C0339349 Undetermined Ciliary_Body_Neoplasm Ciliary Body Neoplasm Ciliary Body Tumor Neoplasm of Ciliary Body Neoplasm of the Ciliary Body Tumor of Ciliary Body Tumor of the Ciliary Body Ciliary Body Neoplasm A non-Hodgkin lymphoma arising from the retina. C4365 Neoplastic Process Primary Retinal Non-Hodgkin Lymphoma C0339556 Malignant Retinal_Lymphoma Lymphoma of Retina Lymphoma of the Retina Primary Retinal Lymphoma Primary Retinal Non-Hodgkin Lymphoma Retinal Lymphoma Primary Retinal Non-Hodgkin Lymphoma A benign exophytic squamous cell neoplasm with papillary growth that arises from the nasal vestibule. C4369 Neoplastic Process Nasal Vestibule Squamous Papilloma C0339826 Benign Nasal_Vestibule_Squamous_Papilloma Nasal Vestibule Papilloma Nasal Vestibule Squamous Cell Papilloma Nasal Vestibule Squamous Papilloma Papilloma of Nasal Vestibule Papilloma of the Nasal Vestibule Squamous Papilloma of Nasal Vestibule Squamous Papilloma of the Nasal Vestibule Nasal Vestibule Squamous Papilloma Lymphangiomyomatosis involving the dermis. C4370 Neoplastic Process Skin Lymphangioleiomyomatosis C0340116 Undetermined Skin_Lymphangioleiomyomatosis Lymphangioleiomyomatosis of Skin Lymphangioleiomyomatosis of the Skin Skin Lymphangioleiomyomatosis Skin Lymphangioleiomyomatosis A capillary hemangioma arising from the lip and presenting as a papular lesion. C4372 Neoplastic Process Cherry Hemangioma of Lip C0341011 Benign Cherry_Hemangioma_of_Lip Cherry Hemangioma of Lip Senile Hemangioma of Lip Cherry Hemangioma of Lip A non-metastasizing cystic epithelial neoplasm arising from the exocrine pancreas. C4374 Neoplastic Process Pancreatic Cystadenoma C0341486 Benign Pancreatic_Cystadenoma Cystadenoma of Pancreas Cystadenoma of the Pancreas Pancreatic Cystadenoma Pancreatic Cystadenoma A benign or malignant, primary or metastatic neoplasm affecting the accessory urethral gland. C4378 Neoplastic Process Accessory Urethral Gland Neoplasm C1709469 Undetermined Paraurethral_Gland_Neoplasm Accessory Urethral Gland Neoplasm Accessory Urethral Gland Neoplasm A benign or malignant neoplasm that affects the scrotum. C4380 Neoplastic Process Scrotal Neoplasm C0341790 Undetermined Scrotal_Neoplasm Neoplasm of Scrotum Neoplasm of the Scrotum Scrotal Neoplasm Scrotal Tumor Tumor of Scrotum Tumor of the Scrotum Scrotal Neoplasm A benign, borderline, or malignant tumor that originates from the surface epithelium of the ovary. It is composed of epithelial cells and stroma. Representative examples of benign tumors include serous cystadenoma, mucinous cystadenoma, and benign Brenner tumor. Representative examples of borderline tumors include serous surface papillary tumor, mucinous adenofibroma, and borderline Brenner tumor. Representative examples of malignant tumors include serous adenocarcinoma, mucinous adenocarcinoma, endometrioid adenocarcinoma, and malignant Brenner tumor. C4381 Neoplastic Process Ovarian Epithelial Tumor C0341823 Undetermined Ovarian_Epithelial_Neoplasm Epithelial Neoplasm of Ovary Epithelial Neoplasm of the Ovary Epithelial Tumor of Ovary Epithelial Tumor of the Ovary Ovarian Epithelial Tumor Ovarian Surface Epithelial-Stromal Tumor Ovarian Surface-Epithelial Stromal Neoplasm Ovarian Epithelial Tumor A benign human papillomavirus-related neoplasm that arises from the vulva. It is characterized by the presence of papillary structures with fibrovascular cores covered by stratified squamous epithelium showing koilocytotic changes. C4382 Neoplastic Process Vulvar Condyloma Acuminatum C0341851 Benign Vulvar_Condyloma_Acuminatum Condylomata Acuminata of Vulva Condylomata Acuminata of the Vulva Vulvar Condyloma Vulvar Condyloma Acuminatum Vulvar Condyloma Acuminatum A morphologic variant of intrahepatic cholangiocarcinoma composed of malignant glandular epithelium, an abundant fibrous stroma, and the presence of clear cells. Clinical symptoms include abdominal pain, weight loss and malaise. C43848 Neoplastic Process Clear Cell Intrahepatic Cholangiocarcinoma C1707406 Malignant Clear_Cell_Intrahepatic_Cholangiocarcinoma Clear Cell Intrahepatic Cholangiocarcinoma Clear Cell Intrahepatic Cholangiocarcinoma A capillary hemangioma of the skin, presenting as a red papular lesion. C4390 Neoplastic Process Cherry Hemangioma C0343082 Benign Cherry_Hemangioma Campbell de Morgan Spot Cherry Angioma Cherry Hemangioma Senile Angioma Senile Hemangioma Cherry Hemangioma A neoplastic process characterized by a symmetric poorly circumscribed overgrowth of adipose tissue in the neck. It predominantly affects middle age men of Mediterranean origin. C4392 Neoplastic Process Cervical Symmetrical Lipomatosis C0024445 Cellosaurus Benign Cervical_Symmetrical_Lipomatosis Cervical Symmetrical Lipomatosis Multiple Symmetrical Lipomatosis Cervical Symmetrical Lipomatosis A primary or metastatic malignant neoplasm affecting the adrenal medulla. C4396 Neoplastic Process Malignant Adrenal Medulla Neoplasm C0344456 CPTAC mCode Malignant Malignant_Adrenal_Medulla_Neoplasm Malignant neoplasm of medulla of right adrenal gland Malignant Adrenal Medulla Neoplasm Malignant Adrenal Medulla Tumor Malignant Neoplasm of Adrenal Medulla Malignant Neoplasm of the Adrenal Medulla Malignant Tumor of Adrenal Medulla Malignant Tumor of the Adrenal Medulla Malignant neoplasm of medulla of unspecified adrenal gland Malignant Adrenal Medulla Neoplasm A benign or malignant neoplasm that affects the base of the tongue. C4400 Neoplastic Process Posterior Tongue Neoplasm C0345522 Undetermined Posterior_Tongue_Neoplasm Base of Tongue Neoplasm Base of Tongue Tumor Base of the Tongue Neoplasm Base of the Tongue Tumor Neoplasm of Base of Tongue Neoplasm of Posterior Tongue Neoplasm of the Base of the Tongue Neoplasm of the Posterior Tongue Posterior Tongue Neoplasm Posterior Tongue Tumor Tumor of Base of Tongue Tumor of Posterior Tongue Tumor of the Base of the Tongue Tumor of the Posterior Tongue Posterior Tongue Neoplasm A benign or malignant neoplasm that affects the floor of the mouth. C4401 Neoplastic Process Floor of the Mouth Neoplasm C0345538 Undetermined Floor_of_the_Mouth_Neoplasm Floor of Mouth Neoplasm Floor of Mouth Tumor Floor of the Mouth Neoplasm Floor of the Mouth Tumor Neoplasm of Floor of Mouth Neoplasm of the Floor of the Mouth Tumor of Floor of Mouth Tumor of the Floor of the Mouth Floor of the Mouth Neoplasm A benign or malignant neoplasm that affects the hard palate, soft palate, or uvula. C4402 Neoplastic Process Palate Neoplasm C0030215 Undetermined Palate_Neoplasm Neoplasm of Palate Neoplasm of the Palate Palate Neoplasm Palate Tumor Tumor of Palate Tumor of the Palate Palate Neoplasm A neoplasm that arises from the hard palate and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4403 Neoplastic Process Benign Hard Palate Neoplasm C0345552 Benign Benign_Hard_Palate_Neoplasm Benign Hard Palate Neoplasm Benign Hard Palate Tumor Benign Neoplasm of Hard Palate Benign Neoplasm of the Hard Palate Benign Tumor of Hard Palate Benign Tumor of the Hard Palate Benign Hard Palate Neoplasm A non-metastasizing neoplasm that arises from the soft palate or uvula. C4404 Neoplastic Process Benign Soft Palate Neoplasm C0345557 Benign Benign_Soft_Palate_Neoplasm Benign Neoplasm of Soft Palate Benign Neoplasm of the Soft Palate Benign Soft Palate Neoplasm Benign Soft Palate Tumor Benign Tumor of Soft Palate Benign Tumor of the Soft Palate Benign Soft Palate Neoplasm A benign or malignant neoplasm that affects the buccal mucosa. C4405 Neoplastic Process Buccal Mucosa Neoplasm C0345563 Undetermined Buccal_Mucosa_Neoplasm Buccal Mucosa Neoplasm Buccal Mucosa Tumor Neoplasm of Buccal Mucosa Neoplasm of the Buccal Mucosa Tumor of Buccal Mucosa Tumor of the Buccal Mucosa Buccal Mucosa Neoplasm A neoplasm that arises from the buccal mucosa and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4406 Neoplastic Process Benign Buccal Mucosa Neoplasm C0345566 Benign Benign_Buccal_Mucosa_Neoplasm Benign Buccal Mucosa Neoplasm Benign Buccal Mucosa Tumor Benign Neoplasm of Buccal Mucosa Benign Neoplasm of the Buccal Mucosa Benign Tumor of Buccal Mucosa Benign Tumor of the Buccal Mucosa Benign Buccal Mucosa Neoplasm A benign or malignant neoplasm that affects the major salivary glands. Representative examples of benign neoplasms include Warthin tumor, monomorphic adenoma, and pleomorphic adenoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma. C4407 Neoplastic Process Major Salivary Gland Neoplasm C0345599 Undetermined Major_Salivary_Gland_Neoplasm Major Salivary Gland Neoplasm Major Salivary Gland Tumor Neoplasm of Major Salivary Gland Neoplasm of the Major Salivary Gland Tumor of Major Salivary Gland Tumor of the Major Salivary Gland Major Salivary Gland Neoplasm A neoplasm that arises from the base of tongue and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4408 Neoplastic Process Benign Posterior Tongue Neoplasm C0345612 Benign Benign_Posterior_Tongue_Neoplasm Benign Base of Tongue Neoplasm Benign Base of Tongue Tumor Benign Base of the Tongue Neoplasm Benign Base of the Tongue Tumor Benign Neoplasm of Base of Tongue Benign Neoplasm of Posterior Tongue Benign Neoplasm of the Base of the Tongue Benign Neoplasm of the Posterior Tongue Benign Posterior Tongue Neoplasm Benign Posterior Tongue Tumor Benign Tumor of Base of Tongue Benign Tumor of Posterior Tongue Benign Tumor of the Base of the Tongue Benign Tumor of the Posterior Tongue Benign Posterior Tongue Neoplasm A benign or malignant neoplasm that affects the minor salivary glands. C4409 Neoplastic Process Minor Salivary Gland Neoplasm C0345613 Undetermined Minor_Salivary_Gland_Neoplasm Minor Salivary Gland Neoplasm Minor Salivary Gland Tumor Neoplasm of Minor Salivary Gland Neoplasm of the Minor Salivary Gland Tumor of Minor Salivary Gland Tumor of the Minor Salivary Gland Minor Salivary Gland Neoplasm A primary or metastatic malignant neoplasm that affects the minor salivary glands. Representative examples include carcinoma and malignant mixed tumor. C4410 Neoplastic Process Malignant Minor Salivary Gland Neoplasm C0345614 Malignant Malignant_Minor_Salivary_Gland_Neoplasm Malignant Minor Salivary Gland Neoplasm Malignant Minor Salivary Gland Tumor Malignant Neoplasm of Minor Salivary Gland Malignant Neoplasm of the Minor Salivary Gland Malignant Tumor of Minor Salivary Gland Malignant Tumor of the Minor Salivary Gland Malignant Minor Salivary Gland Neoplasm A neoplasm that arises from the minor salivary glands and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4411 Neoplastic Process Benign Minor Salivary Gland Neoplasm C0345615 Benign Benign_Minor_Salivary_Gland_Neoplasm Benign Minor Salivary Gland Neoplasm Benign Minor Salivary Gland Tumor Benign Neoplasm of Minor Salivary Gland Benign Neoplasm of the Minor Salivary Gland Benign Tumor of Minor Salivary Gland Benign Tumor of the Minor Salivary Gland Benign Minor Salivary Gland Neoplasm A benign or malignant neoplasm that affects the middle ear. Representative examples include adenoma, paraganglioma, and carcinoma. C4412 Neoplastic Process Middle Ear Neoplasm C0345617 Undetermined Middle_Ear_Neoplasm Middle Ear Neoplasm Middle Ear Tumor Neoplasm of Middle Ear Neoplasm of the Middle Ear Tumor of Middle Ear Tumor of the Middle Ear Middle Ear Neoplasm A benign or malignant neoplasm that affects the nasal cavity. Representative examples of benign neoplasms include Schneiderian papilloma and salivary gland-type adenoma. Representative examples of malignant neoplasms include carcinoma and lymphoma. C4413 Neoplastic Process Nasal Cavity Neoplasm C0345630 Undetermined Nasal_Cavity_Neoplasm Nasal Cavity Neoplasm Nasal Cavity Tumor Neoplasm of Nasal Cavity Neoplasm of the Nasal Cavity Tumor of Nasal Cavity Tumor of the Nasal Cavity Nasal Cavity Neoplasm A neoplasm that arises from the maxillary sinus and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4414 Neoplastic Process Benign Maxillary Sinus Neoplasm C0345666 Benign Benign_Maxillary_Sinus_Neoplasm Benign Maxillary Sinus Neoplasm Benign Maxillary Sinus Tumor Benign Neoplasm of Maxillary Sinus Benign Neoplasm of the Maxillary Sinus Benign Tumor of Maxillary Sinus Benign Tumor of the Maxillary Sinus Benign Maxillary Sinus Neoplasm A benign or malignant neoplasm that affects the ethmoid sinus. Representative examples of benign neoplasms include Schneiderian papilloma and salivary gland-type adenoma. Representative examples of malignant neoplasms include carcinoma and lymphoma. C4416 Neoplastic Process Ethmoid Sinus Neoplasm C0345668 Undetermined Ethmoid_Sinus_Neoplasm Ethmoid Sinus Neoplasm Ethmoid Sinus Tumor Ethmoidal Sinus Neoplasm Ethmoidal Sinus Tumor Neoplasm of Ethmoid Sinus Neoplasm of Ethmoidal Sinus Neoplasm of the Ethmoid Sinus Neoplasm of the Ethmoidal Sinus Tumor of Ethmoid Sinus Tumor of Ethmoidal Sinus Tumor of the Ethmoid Sinus Tumor of the Ethmoidal Sinus Ethmoid Sinus Neoplasm A neoplasm that arises from the ethmoid sinus and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4417 Neoplastic Process Benign Ethmoid Sinus Neoplasm C0345670 Benign Benign_Ethmoid_Sinus_Neoplasm Benign Ethmoid Sinus Neoplasm Benign Ethmoid Sinus Tumor Benign Ethmoidal Sinus Neoplasm Benign Ethmoidal Sinus Tumor Benign Neoplasm of Ethmoid Sinus Benign Neoplasm of Ethmoidal Sinus Benign Neoplasm of the Ethmoid Sinus Benign Neoplasm of the Ethmoidal Sinus Benign Tumor of Ethmoid Sinus Benign Tumor of Ethmoidal Sinus Benign Tumor of the Ethmoid Sinus Benign Tumor of the Ethmoidal Sinus Benign Ethmoid Sinus Neoplasm A benign or malignant neoplasm that affects the frontal sinus. Representative examples of benign neoplasms include Schneiderian papilloma and salivary gland-type adenoma. Representative examples of malignant neoplasms include carcinoma and lymphoma. C4419 Neoplastic Process Frontal Sinus Neoplasm C0345672 Undetermined Frontal_Sinus_Neoplasm Frontal Sinus Neoplasm Frontal Sinus Tumor Neoplasm of Frontal Sinus Neoplasm of the Frontal Sinus Tumor of Frontal Sinus Tumor of the Frontal Sinus Frontal Sinus Neoplasm A neoplasm that arises from the frontal sinus and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4420 Neoplastic Process Benign Frontal Sinus Neoplasm C0345674 Benign Benign_Frontal_Sinus_Neoplasm Benign Frontal Sinus Neoplasm Benign Frontal Sinus Tumor Benign Neoplasm of Frontal Sinus Benign Neoplasm of the Frontal Sinus Benign Tumor of Frontal Sinus Benign Tumor of the Frontal Sinus Benign Frontal Sinus Neoplasm A neoplasm that arises from the sphenoid sinus and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4422 Neoplastic Process Benign Sphenoid Sinus Neoplasm C0345678 Benign Benign_Sphenoid_Sinus_Neoplasm Benign Neoplasm of Sphenoid Sinus Benign Neoplasm of Sphenoidal Sinus Benign Neoplasm of the Sphenoid Sinus Benign Neoplasm of the Sphenoidal Sinus Benign Sphenoid Sinus Neoplasm Benign Sphenoid Sinus Tumor Benign Sphenoidal Sinus Neoplasm Benign Sphenoidal Sinus Tumor Benign Tumor of Sphenoid Sinus Benign Tumor of Sphenoidal Sinus Benign Tumor of the Sphenoid Sinus Benign Tumor of the Sphenoidal Sinus Benign Sphenoid Sinus Neoplasm A benign or malignant neoplasm that affects the pyriform sinus. C4424 Neoplastic Process Pyriform Fossa Neoplasm C0345704 Undetermined Pyriform_Fossa_Neoplasm Neoplasm of Pyriform Fossa Neoplasm of Pyriform Sinus Neoplasm of the Pyriform Fossa Neoplasm of the Pyriform Sinus Pyriform Fossa Neoplasm Pyriform Fossa Tumor Pyriform Sinus Neoplasm Pyriform Sinus Tumor Tumor of Pyriform Fossa Tumor of Pyriform Sinus Tumor of the Pyriform Fossa Tumor of the Pyriform Sinus Pyriform Fossa Neoplasm A benign or malignant neoplasm that affects the glottic area of the larynx. C4425 Neoplastic Process Glottis Neoplasm C0345713 Undetermined Glottis_Neoplasm Glottis Neoplasm Glottis Tumor Neoplasm of Glottis Neoplasm of the Glottis Tumor of Glottis Tumor of the Glottis Glottis Neoplasm A benign or malignant neoplasm that affects the subglottic area of the larynx. C4426 Neoplastic Process Subglottis Neoplasm C0345746 Undetermined Subglottis_Neoplasm Neoplasm of Subglottis Neoplasm of the Subglottis Subglottic Neoplasm Subglottic Tumor Subglottis Neoplasm Subglottis Tumor Tumor of Subglottis Tumor of the Subglottis Subglottis Neoplasm A neoplasm that arises from the subglottis and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4427 Neoplastic Process Benign Subglottis Neoplasm C0345749 Benign Benign_Subglottis_Neoplasm Benign Neoplasm of Subglottis Benign Neoplasm of the Subglottis Benign Subglottic Neoplasm Benign Subglottic Tumor Benign Subglottis Neoplasm Benign Subglottis Tumor Benign Tumor of Subglottis Benign Tumor of the Subglottis Benign Subglottis Neoplasm Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C4428 Neoplastic Process Gastric Cardia Carcinoma In Situ AJCC v6 and v7 C0345795 Malignant Gastric_Cardia_Carcinoma_in_situ Carcinoma in situ of Cardia of Stomach Carcinoma in situ of Gastric Cardia Carcinoma in situ of the Cardia of the Stomach Carcinoma in situ of the Gastric Cardia Gastric Cardia Carcinoma In Situ Gastric Cardia Carcinoma In Situ AJCC v6 and v7 Stage 0 Gastric Cardia Carcinoma Gastric Cardia Carcinoma In Situ AJCC v6 and v7 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C4429 Neoplastic Process Gastric Fundus Carcinoma In Situ AJCC v6 and v7 C0345800 Malignant Gastric_Fundus_Carcinoma_in_situ Carcinoma in situ of Fundus of Stomach Carcinoma in situ of Gastric Fundus Carcinoma in situ of the Fundus of the Stomach Carcinoma in situ of the Gastric Fundus Gastric Fundus Carcinoma In Situ Gastric Fundus Carcinoma In Situ AJCC v6 and v7 Stage 0 Gastric Fundus Carcinoma Gastric Fundus Carcinoma In Situ AJCC v6 and v7 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C4430 Neoplastic Process Gastric Body Carcinoma In Situ AJCC v6 and v7 C0345805 Malignant Gastric_Body_Carcinoma_in_situ Carcinoma in situ of Body of Stomach Carcinoma in situ of Gastric Body Carcinoma in situ of the Body of the Stomach Carcinoma in situ of the Gastric Body Gastric Body Carcinoma In Situ Gastric Body Carcinoma In Situ AJCC v6 and v7 Stage 0 Gastric Body Carcinoma Gastric Body Carcinoma In Situ AJCC v6 and v7 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C4431 Neoplastic Process Gastric Pylorus Carcinoma In Situ AJCC v6 and v7 C0345815 Malignant Gastric_Pylorus_Carcinoma_in_situ Carcinoma in situ of Gastric Pylorus Carcinoma in situ of Pylorus of Stomach Carcinoma in situ of the Gastric Pylorus Carcinoma in situ of the Pylorus of the Stomach Gastric Pylorus Carcinoma In Situ Gastric Pylorus Carcinoma In Situ AJCC v6 and v7 Stage 0 Gastric Pylorus Carcinoma Gastric Pylorus Carcinoma In Situ AJCC v6 and v7 A benign or malignant neoplasm that affects the small intestine. Representative examples of benign neoplasms include lipoma and leiomyoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma. C4432 Neoplastic Process Small Intestinal Neoplasm C0345832 Undetermined Small_Intestinal_Neoplasm Neoplasm of Small Bowel Neoplasm of Small Intestine Neoplasm of the Small Bowel Neoplasm of the Small Intestine Small Bowel Neoplasm Small Bowel Tumor Small Intestinal Neoplasm Small Intestine Neoplasm Small Intestine Tumor Tumor of Small Bowel Tumor of Small Intestine Tumor of the Small Bowel Tumor of the Small Intestine Small Intestinal Neoplasm A benign or malignant neoplasm that affects the cecum. Representative examples of benign neoplasms include lipoma and leiomyoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma. Cecal adenomas always exhibit epithelial dysplasia and are considered premalignant neoplasms. C4433 Neoplastic Process Cecum Neoplasm C0007528 Undetermined Cecum_Neoplasm Cecum Neoplasm Cecum Tumor Neoplasm of Cecum Neoplasm of the Cecum Tumor of Cecum Tumor of the Cecum Cecum Neoplasm A benign or malignant neoplasm involving the appendix. C4434 Neoplastic Process Appendix Neoplasm C0003614 Undetermined Appendix_Neoplasm Appendix Neoplasm Appendix Tumor Neoplasm of Appendix Neoplasm of the Appendix Tumor of Appendix Tumor of the Appendix Appendix Neoplasm A carcinoma that arises from the intrahepatic bile ducts, the hepatic ducts, or the common bile duct distal to the insertion of the cystic duct. The vast majority of tumors are adenocarcinomas. C4436 Neoplastic Process Cholangiocarcinoma Cholangiocarcinoma C0206698 CDISC CPTAC CTEP CTRP Cellosaurus GDC A malignant neoplasm arising from/comprising cells resembling those of bile ducts. A rare type of cancer that develops in cells that line the bile ducts in the liver. Cancer that forms where the right and left ducts meet is called Klatskin tumor. 8160/3 Malignant Cholangiocarcinoma 8160/3 Cholangiocarcinoma CC CHOLANGIOCARCINOMA, MALIGNANT Cholangiocar.- intra/extrahepatic Cholangiocarcinoma Cholangiocarcinoma, intrahepatic and extrahepatic bile ducts (adenocarcinoma) Cholangiocellular Carcinoma Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) cholangiocarcinoma cholangiosarcoma Cholangiocarcinoma A malignant soft tissue neoplasm that arises from the liver. Representative examples include angiosarcoma, undifferentiated (embryonal) sarcoma, rhabdomyosarcoma, and leiomyosarcoma. C4437 Neoplastic Process Liver Sarcoma C0345906 Malignant Hepatic_Sarcoma Malignant neoplasm: Other sarcomas of liver Hepatic Sarcoma Liver Sarcoma Sarcoma of Liver Sarcoma of the Liver Liver Sarcoma A malignant vascular neoplasm arising from the liver. C4438 Neoplastic Process Liver Angiosarcoma C0345907 CPTAC Cellosaurus GDC mCode 9124/3 Malignant Hepatic_Angiosarcoma 9124/3 Kupffer cell sarcoma Malignant neoplasm: Angiosarcoma of liver Angiosarcoma of Liver Angiosarcoma of liver Angiosarcoma of the Liver Hemangiosarcoma of Liver Hemangiosarcoma of the Liver Hepatic Angiosarcoma Hepatic Hemangiosarcoma Kupffer cell sarcoma Liver Angiosarcoma Liver Hemangiosarcoma Primary Angiosarcoma of Liver Primary Angiosarcoma of the Liver Liver Angiosarcoma Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C4439 Neoplastic Process Stage 0 Gallbladder Cancer AJCC v6 and v7 Stage 0 Gallbladder Cancer AJCC v6 and v7 C0345911 CTRP Abnormal cells are found in the innermost (mucosal) layer of the gallbladder. These abnormal cells may become cancer and spread into nearby normal tissue. Malignant Stage_0_Gallbladder_Cancer Carcinoma in situ of Gallbladder Carcinoma in situ of the Gallbladder Gallbladder Cancer Stage 0 Gallbladder Carcinoma in situ Stage 0 Carcinoma of Gallbladder Stage 0 Carcinoma of the Gallbladder Stage 0 Gallbladder Cancer Stage 0 Gallbladder Cancer AJCC v6 Stage 0 Gallbladder Cancer AJCC v6 and v7 Stage 0 Gallbladder Cancer AJCC v7 Stage 0 Gallbladder Carcinoma stage 0 gallbladder carcinoma in situ Stage 0 Gallbladder Cancer AJCC v6 and v7 A neoplasm that arises from the gallbladder and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4440 Neoplastic Process Gallbladder Benign Neoplasm C0345912 Benign Benign_Gallbladder_Neoplasm Benign Gallbladder Neoplasm Benign Gallbladder Tumor Benign Neoplasm of Gallbladder Benign Neoplasm of the Gallbladder Benign Tumor of Gallbladder Benign Tumor of the Gallbladder Gallbladder Benign Neoplasm Gallbladder Benign Tumor Gallbladder Benign Neoplasm A benign or malignant neoplasm that affects the extrahepatic bile ducts. Representative examples include adenoma and adenocarcinoma. C4441 Neoplastic Process Extrahepatic Bile Duct Neoplasm C0345913 Undetermined Extrahepatic_Bile_Duct_Neoplasm Extrahepatic Bile Duct Neoplasm Extrahepatic Bile Duct Tumor Neoplasm of Extrahepatic Bile Duct Neoplasm of the Extrahepatic Bile Duct Tumor of Extrahepatic Bile Duct Tumor of the Extrahepatic Bile Duct Extrahepatic Bile Duct Neoplasm A benign or malignant neoplasm involving the ampulla of Vater. C4443 Neoplastic Process Ampulla of Vater Neoplasm C0345916 Undetermined Ampulla_of_Vater_Neoplasm Ampulla of Vater Neoplasm Ampulla of Vater Tumor Neoplasm of Ampulla of Vater Neoplasm of the Ampulla of Vater Tumor of Ampulla of Vater Tumor of the Ampulla of Vater Ampulla of Vater Neoplasm Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C4444 Neoplastic Process Stage 0 Ampulla of Vater Cancer AJCC v7 Stage 0 Ampulla of Vater Cancer AJCC v7 C0345918 CTRP Malignant Stage_0_Ampulla_of_Vater_Cancer Ampulla of Vater Cancer Stage 0 Ampulla of Vater Carcinoma in situ Ampullary Carcinoma in Situ Stage 0 Ampulla of Vater Cancer Stage 0 Ampulla of Vater Cancer AJCC v7 Stage 0 Ampulla of Vater Carcinoma Stage 0 Ampullary Carcinoma Stage 0 Ampulla of Vater Cancer AJCC v7 A benign or malignant neoplasm that arises from the epithelial cells of the exocrine pancreatic tissue. C4445 Neoplastic Process Pancreatic Exocrine Neoplasm C0345920 Undetermined Exocrine_Pancreas_Neoplasm Exocrine Pancreas Neoplasm Exocrine Pancreas Tumor Neoplasm of Exocrine Pancreas Neoplasm of the Exocrine Pancreas Pancreatic Exocrine Neoplasm Pancreatic Exocrine Tumor Tumor of Exocrine Pancreas Tumor of the Exocrine Pancreas Pancreatic Exocrine Neoplasm A pancreatic neuroendocrine tumor that secretes serotonin. When it metastasizes to the liver or retroperitoneum, it produces the carcinoid syndrome. Most cases are graded G1 or G2. C4446 Neoplastic Process Pancreatic Serotonin-Producing Neuroendocrine Tumor C0345933 Cellosaurus Undetermined Pancreatic_Carcinoid_Tumor Carcinoid Tumor of Pancreas Carcinoid Tumor of the Pancreas EC Cell, Serotonin Producing Pancreatic NET EC Cell, Serotonin Producing Pancreatic Neuroendocrine Tumor Enterochromaffin Cell Serotonin-Producing Pancreatic Neuroendocrine Tumor Pancreatic Carcinoid Tumor Pancreatic Serotonin Producing Neoplasm Pancreatic Serotonin Producing Tumor Pancreatic Serotonin-Producing Neuroendocrine Tumor Serotonin-Producing Pancreatic Neuroendocrine Tumor Serotonin-Producing Tumor of Pancreas Serotonin-Producing Tumor of the Pancreas Pancreatic Serotonin-Producing Neuroendocrine Tumor A neoplasm that arises from the retroperitoneum and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4447 Neoplastic Process Benign Retroperitoneal Neoplasm C0496873 CPTAC Benign Benign_Retroperitoneal_Neoplasm Benign neoplasm: Retroperitoneum Benign Retroperitoneal Neoplasm Benign Retroperitoneal Neoplasm A rare squamous cell carcinoma that arises from the mucosal lining of the trachea. It usually grows as an intraluminal mass and later invades extraluminal structures. The majority of patients present with hemoptysis, coughing, dyspnea, or stridor. C4448 Neoplastic Process Tracheal Squamous Cell Carcinoma C0345946 Malignant Tracheal_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Trachea Epidermoid Carcinoma of the Trachea Squamous Cell Carcinoma of Trachea Squamous Cell Carcinoma of the Trachea Trachea Epidermoid Carcinoma Trachea Squamous Cell Carcinoma Tracheal Epidermoid Carcinoma Tracheal Squamous Cell Carcinoma Tracheal Squamous Cell Carcinoma An undifferentiated non-small cell lung carcinoma composed of large polygonal cells without evidence of glandular, squamous, or neuroendocrine differentiation. C4450 Neoplastic Process Large Cell Lung Carcinoma Lung Large Cell Carcinoma C0345958 CTRP Cellosaurus Malignant Large_Cell_Lung_Carcinoma Anaplastic Lung Carcinoma Large Cell Carcinoma of Lung Large Cell Carcinoma of the Lung Large Cell Lung Cancer Large Cell Lung Carcinoma Large Cell Undifferentiated Lung Carcinoma Lung Large Cell Carcinoma Lung Large Cell Carcinoma A large cell lung carcinoma characterized by a predominance of clear cells that may or may not contain glycogen. C4451 Neoplastic Process Lung Large Cell Carcinoma, Clear Cell Variant C1707407 Malignant Clear_Cell_Lung_Carcinoma Clear Cell Carcinoma of Lung, Large Cell Type Clear Cell Carcinoma of the Lung, Large Cell Type Clear Cell Lung Carcinoma, Large Cell Type Large Cell Lung Carcinoma, Clear Cell Variant Lung Large Cell Carcinoma, Clear Cell Variant Lung Large Cell Carcinoma, Clear Cell Variant A morphologic variant of lung sarcomatoid carcinoma characterized by the presence of mononuclear and multinucleated pleomorphic neoplastic giant cells that lack cohesion. C4452 Neoplastic Process Lung Giant Cell Carcinoma C0345960 Cellosaurus Malignant Giant_Cell_Lung_Carcinoma Giant Cell Carcinoma of Lung Giant Cell Carcinoma of the Lung Lung Giant Cell Carcinoma Lung Giant Cell Carcinoma A low-grade malignant blood vessel neoplasm arising from the lung. It is characterized by the presence of epithelioid endothelial cells. The neoplastic cells are arranged in cords and nests, which are embedded in a myxoid to hyalinized stroma. C4453 Neoplastic Process Lung Epithelioid Hemangioendothelioma C0345961 Malignant Lung_Epithelioid_Hemangioendothelioma Epithelioid Angioendothelioma of Lung Epithelioid Angioendothelioma of the Lung Epithelioid Hemangioendothelioma of Lung Epithelioid Hemangioendothelioma of the Lung Intravascular Bronchioloalveolar Tumor Lung Epithelioid Angioendothelioma Lung Epithelioid Hemangioendothelioma Pulmonary Epithelioid Angioendothelioma Pulmonary Epithelioid Hemangioendothelioma Lung Epithelioid Hemangioendothelioma A neoplasm that arises from the lung and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4454 Neoplastic Process Benign Lung Neoplasm C0345963 Benign Benign_Lung_Neoplasm Benign Lung Neoplasm Benign Lung Tumor Benign Neoplasm of Lung Benign Neoplasm of the Lung Benign Tumor of Lung Benign Tumor of the Lung Benign Lung Neoplasm A benign, well circumscribed epithelial neoplasm that arises from the bronchus or the lung parenchyma. Representative examples include alveolar adenoma, papillary adenoma, and mucus gland adenoma. C4455 Neoplastic Process Lung Adenoma C0345964 Benign Lung_Adenoma Adenoma of Lung Adenoma of the Lung Lung Adenoma Pulmonary Adenoma Lung Adenoma A localized neoplasm of probable fibroblastic derivation, that arises from the pleura. It is characterized by the presence of round to spindle-shaped cells, hylanized stroma formation, thin-walled branching blood vessels, and thin bands of collagen. C4457 Neoplastic Process Pleural Solitary Fibrous Tumor C0334511 Cellosaurus GDC Undetermined Pleural_Fibroma 9051/0 Fibrous mesothelioma, benign Fibroma of Pleura Fibroma of the Pleura Localized Fibrous Mesothelioma of Pleura Localized Fibrous Mesothelioma of the Pleura Pleural Fibroma Pleural Solitary Fibrous Tumor Pleural Submesothelial Fibroma Solitary Fibrous Tumor of Pleura Solitary Fibrous Tumor of the Pleura Pleural Solitary Fibrous Tumor A non-metastasizing neoplasm that arises from the thymus. C4458 Neoplastic Process Benign Thymus Neoplasm C0345975 CPTAC Benign Benign_Thymus_Neoplasm Benign neoplasm of thymus Benign neoplasm: Thymus Benign Neoplasm of Thymus Benign Neoplasm of the Thymus Benign Thymic Neoplasm Benign Thymic Tumor Benign Thymus Neoplasm Benign Thymus Tumor Benign Tumor of Thymus Benign Tumor of the Thymus Benign Thymus Neoplasm A squamous cell carcinoma of the skin with a prominent clear cell component. C4459 Neoplastic Process Skin Clear Cell Squamous Cell Carcinoma C0345978 Malignant Clear_Cell_Squamous_Cell_Skin_Carcinoma Clear Cell Squamous Cell Carcinoma of Skin Clear Cell Squamous Cell Carcinoma of the Skin Clear Cell Squamous Cell Skin Carcinoma Skin Clear Cell Squamous Cell Carcinoma Skin Clear Cell Squamous Cell Carcinoma A histologic variant of squamous cell carcinoma that arises from the skin. It is characterized by loosening of the intercellular bridges between the malignant cells which results in acantholysis. C4460 Neoplastic Process Skin Acantholytic Squamous Cell Carcinoma C0345979 CPTAC Malignant Acantholytic_Squamous_Cell_Skin_Carcinoma Acantholytic Squamous Cell Carcinoma of Skin Acantholytic Squamous Cell Carcinoma of the Skin Acantholytic Squamous Cell Skin Carcinoma Acantholytic squamous cell carcinoma Skin Acantholytic Squamous Cell Carcinoma Skin Adenoid Squamous Cell Carcinoma Skin Pseudoglandular Squamous Cell Carcinoma Skin Acantholytic Squamous Cell Carcinoma A benign or malignant neoplasm that arises from the hair follicles, sebaceous glands, or sweat glands. C4463 Neoplastic Process Skin Appendage Neoplasm C0345988 GDC Undetermined Skin_Appendage_Neoplasm Adnexal and Skin Appendage Neoplasms Adnexal Neoplasm of Skin Adnexal Neoplasm of the Skin Adnexal Tumor of Skin Adnexal Tumor of the Skin Appendageal Neoplasm Appendageal Tumor Cutaneous Adnexal Neoplasm Skin Appendage Neoplasm Skin Appendage Tumor Skin Appendageal Neoplasm Skin Appendageal Tumor Skin Appendage Neoplasm A benign, small, papular or nodular skin neoplasm that usually arises above the upper lip. It is characterized by an epithelial proliferation with a central cavity. The cavity wall is lined with keratinocytes. C4468 Neoplastic Process Pilar Sheath Acanthoma C0346005 Benign Pilar_Sheath_Acanthoma Pilar sheath acanthoma Acanthoma of Pilar Sheath Acanthoma of the Pilar Sheath Infundibuloisthmicoma Pilar Sheath Acanthoma Pilar Sheath Acanthoma A tumor involving the follicular infundibulum. C4469 Neoplastic Process Tumor of the Follicular Infundibulum C0346006 Benign Follicular_Infundibulum_Neoplasm Basal Cell Hamartoma with Follicular Differentiation Follicular Infundibulum Neoplasm Follicular Infundibulum Tumor Neoplasm of the Follicular Infundibulum Tumor of the Follicular Infundibulum Tumor of the Follicular Infundibulum A benign neoplasm characterized by the presence of spindle-shaped fibroblasts surrounding the hair follicle. C4470 Neoplastic Process Perifollicular Fibroma C1704236 GDC Benign Perifollicular_Fibroma 8391/0 Perifollicular fibroma Perifollicular Fibroma Perifollicular fibroma Trichoblastic Fibroma Perifollicular Fibroma A rare adenoid cystic carcinoma that arises from the skin. It is very aggressive in nature with a high risk of local recurrence. C4471 Neoplastic Process Adenoid Cystic Skin Carcinoma C0346017 Malignant Adenoid_Cystic_Skin_Carcinoma Adenoid Cystic Carcinoma of Skin Adenoid Cystic Carcinoma of the Skin Adenoid Cystic Cutaneous Carcinoma Adenoid Cystic Skin Carcinoma Primary Adenoid Cystic Carcinoma (PACC) of the Skin Primary Cutaneous Adenocystic Carcinoma Adenoid Cystic Skin Carcinoma A rare carcinoma of the skin. It is characterized by epidermoid cells interspersed with glandular cells. C4472 Neoplastic Process Skin Mucoepidermoid Carcinoma C0346019 Malignant Mucoepidermoid_Skin_Carcinoma Mucoepidermoid Carcinoma of Skin Mucoepidermoid Carcinoma of the Skin Skin Mucoepidermoid Carcinoma Skin Mucoepidermoid Carcinoma A poroma characterized by the presence of small nodules of neoplastic cells in the superficial dermis without connection to the epidermis. C4473 Neoplastic Process Dermal Duct Tumor C0346024 Benign Eccrine_Dermal_Duct_Neoplasm DDT Dermal Duct Neoplasm Dermal Duct Tumor Dermal Duct Tumor A rare, benign, slow-growing and painless neoplasm of sweat glands. It usually arises in the head and neck. It is characterized by the presence of a mesenchymal chondroid stroma, fibrosis, and epithelial structures. C4474 Neoplastic Process Benign Mixed Tumor of the Skin C0346026 GDC Benign Benign_Mixed_Tumor_of_the_Skin_Chondroid_Syringoma 8940/0 Chondroid syringoma Benign Mixed Tumor of Skin Benign Mixed Tumor of Skin (Chondroid Syringoma) Benign Mixed Tumor of the Skin Benign Mixed Tumor of the Skin (Chondroid Syringoma) Chondroid Syringoma Chondroid syringoma Mixed Tumor of the Skin (Chondroid Syringoma) Benign Mixed Tumor of the Skin A benign, intermediate, or malignant neoplasm that arises from the dermis. C4475 Neoplastic Process Dermal Neoplasm C0346041 Undetermined Dermal_Neoplasm Dermal Neoplasm Dermal Tumor Neoplasm of Dermis Neoplasm of the Dermis Tumor of Dermis Tumor of the Dermis Dermal Neoplasm A peripheral nervous system neoplasm that arises from the dermis. C4479 Neoplastic Process Cutaneous Neural Neoplasm C0346055 Undetermined Cutaneous_Neural_Neoplasm Cutaneous Neural Neoplasm Neural Neoplasm of Skin Neural Neoplasm of the Skin Neural Tumor of Skin Neural Tumor of the Skin Skin Neoplasm of Neural Origin Skin Neural Neoplasm Skin Neural Tumor Skin Tumor of Neural Origin Cutaneous Neural Neoplasm A smooth muscle neoplasm occurring in the skin. C4480 Neoplastic Process Skin Smooth Muscle Neoplasm C0346062 Undetermined Cutaneous_Smooth_Muscle_Neoplasm Cutaneous Neoplasm of Smooth Muscle Origin Cutaneous Smooth Muscle Neoplasm Cutaneous Tumor of Smooth Muscle Origin Skin Neoplasm of Smooth Muscle Origin Skin Smooth Muscle Neoplasm Skin Tumor of Smooth Muscle Origin Smooth Muscle Skin Neoplasm Skin Smooth Muscle Neoplasm A ganglioneuroma arising from the skin. C4481 Neoplastic Process Cutaneous Ganglioneuroma C0346063 Benign Cutaneous_Ganglioneuroma Cutaneous Ganglioneuroma Ganglioneuroma of Skin Ganglioneuroma of the Skin Skin Ganglioneuroma Cutaneous Ganglioneuroma A benign smooth muscle neoplasm arising from the arrector pili muscle, tunica media of blood vessels, and dartos muscle of the genitalia. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C4482 Neoplastic Process Cutaneous Leiomyoma Skin Leiomyoma C0346064 CTRP Benign Cutaneous_Leiomyoma Cutaneous (Skin) Leiomyoma Cutaneous Leiomyoma Leiomyoma Cutis Leiomyoma of Skin Leiomyoma of the Skin Skin Leiomyoma Skin Leiomyoma A cutaneous leiomyoma arising from the dartos muscle of the scrotum or labia majora. C4483 Neoplastic Process Dartoic Leiomyoma C0346066 Benign Dartoic_Leiomyoma Dartoic Leiomyoma Dartoic Myoma Dartoic Leiomyoma A rare, mitotically active spindle cell neoplasm arising from the smooth muscle in the dermis. It has an excellent prognosis, as compared to the deep soft tissue leiomyosarcomas. C4484 Neoplastic Process Atypical Intradermal Smooth Muscle Neoplasm C3549861 Undetermined Cutaneous_Leiomyosarcoma AISMN Atypical Intradermal Smooth Muscle Neoplasm Atypical Intradermal Smooth Muscle Tumor Cutaneous Leiomyosarcoma Leiomyosarcoma of Skin Leiomyosarcoma of the Skin Skin Leiomyosarcoma Atypical Intradermal Smooth Muscle Neoplasm A hemangioma present at birth. It is characterized by the presence of rubbery skin lesions. C4486 Neoplastic Process Blue Rubber Bleb Nevus C0346072 Benign Blue_Rubber_Bleb_Nevus Bean Syndrome Blue Rubber Bleb Nevus Blue Rubber Bleb Nevus A capillary hemangioma of the skin usually presenting with patches or plaques. C4487 Neoplastic Process Tufted Angioma C0346073 GDC 9161/0 Benign Tufted_Hemangioma 9161/0 Acquired tufted hemangioma Acquired tufted hemangioma Angioblastoma of Nakagawa TA Tufted Angioma Tufted Angioma of Skin Tufted Angioma of the Skin Tufted Hemangioma Tufted Hemangioma of Skin Tufted Hemangioma of the Skin Tufted Skin Angioma Tufted Angioma A malignant vascular neoplasm arising from the skin. C4489 Neoplastic Process Cutaneous Angiosarcoma Skin Angiosarcoma C0346081 CTRP Cellosaurus Malignant Skin_Angiosarcoma Angiosarcoma of Skin Angiosarcoma of the Skin Cutaneous Angiosarcoma Hemangiosarcoma of Skin Hemangiosarcoma of the Skin Skin Angiosarcoma Skin Hemangiosarcoma Skin Angiosarcoma A malignant vascular neoplasm of the skin arising from the lymphatic vessels. C4490 Neoplastic Process Skin Lymphangiosarcoma C0346082 Malignant Skin_Lymphangiosarcoma Lymphangiosarcoma of Skin Lymphangiosarcoma of Stewart and Treves Lymphangiosarcoma of the Skin Skin Lymphangiosarcoma Skin Lymphangiosarcoma A glomus tumor arising from the skin. It usually presents as a small red-blue nodule and it often associated with pain at the site. C4491 Neoplastic Process Skin Glomus Tumor C0346083 Undetermined Glomus_Tumor_of_the_Skin Glomus Neoplasm of Skin Glomus Neoplasm of the Skin Glomus Skin Neoplasm Glomus Skin Tumor Glomus Tumor of Skin Glomus Tumor of the Skin Skin Glomus Neoplasm Skin Glomus Tumor Skin Glomus Tumor A vascular proliferation arising from the skin. It is characterized by the presence of prominent endothelial cells and formation of vascular channels. C4494 Neoplastic Process Skin Hemangioendothelioma C0346086 Undetermined Skin_Hemangioendothelioma Angioendothelioma of Skin Angioendothelioma of the Skin Hemangioendothelioma of Skin Hemangioendothelioma of the Skin Skin Angioendothelioma Skin Hemangioendothelioma Skin Hemangioendothelioma A rare speckled nevus with concentric pattern of pigmentation and central papule surrounded by clear zone. C4495 Neoplastic Process Cockade Nevus C0346091 Benign Cockade_Nevus Cockade Nevus Cockade Nevus A blue nevus that is not associated with increased cellularity. C4496 Neoplastic Process Common Blue Nevus C0346094 Benign Common_Blue_Nevus Common Blue Nevus Common Blue Nevus of Skin Common Blue Nevus of the Skin Common Blue Nevus Mucosa-associated lymphoid tissue lymphoma that arises from the ocular adnexa and caused by stimulation of lymphoid tissue due to Chlamydia psittaci bacterial infection. C44960 Neoplastic Process Chlamydia Psittaci-Associated Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma Chlamydia Psittaci-Associated Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma C1707385 CTRP Malignant Chlamydia_Psittaci-Related_Ocular_Adnexal_Mucosa-Associated_Lymphoid_Tissue_Lymphoma Chlamydia Psittaci-Associated Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma Chlamydia psittaci-Associated Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma Chlamydophila Psittaci-Associated Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma Chlamydia Psittaci-Associated Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma A benign melanocytic nevus characterized by the presence of desmoplastic stroma. C4497 Neoplastic Process Desmoplastic Nevus C0346098 Benign Desmoplastic_Nevus Desmoplastic Nevus Desmoplastic Nevus A melanocytic nevus that contains a variable number of darkly pigmented macules and papules. C4498 Neoplastic Process Nevus Spilus C0346099 Benign Nevus_Spilus Lentiginous melanocytic nevus Nevus Spilus Speckled Lentiginous Nevus Nevus Spilus A rare benign neoplasm that arises from the mesothelial cells of the pleura. It is characterized by a proliferation of epithelioid cells forming glandular and tubular patterns in a fibrous stroma. C4499 Neoplastic Process Pleural Adenomatoid Tumor C0346112 Benign Benign_Pleural_Mesothelioma Benign Pleural Mesothelioma Pleural Adenomatoid Tumor Pleural Adenomatoid Tumor A mesenchymal neoplasm composed of adipose (fatty) tissue. There is no evidence of atypical or malignant cytological and architectural features, invasive features, or metastases. C4502 Neoplastic Process Benign Lipomatous Neoplasm C0346118 CPTAC Benign Benign_Lipomatous_Neoplasm Benign lipomatous neoplasm, unspecified Benign Adipose Tissue Neoplasm Benign Adipose Tissue Tumor Benign Lipomatous Neoplasm Benign Lipomatous Tumor Benign Neoplasm of Adipose Tissue Benign Neoplasm of the Adipose Tissue Benign Tumor of Adipose Tissue Benign Tumor of the Adipose Tissue Benign Lipomatous Neoplasm Breast carcinoma that has developed in relatives of patients with history of breast carcinoma. C4503 Neoplastic Process Hereditary Breast Carcinoma Hereditary Breast Carcinoma C0346153 CTRP GDC Malignant Hereditary_Breast_Carcinoma Hereditary Breast Cancer Familial Breast Carcinoma Familial Cancer of Breast Familial Cancer of the Breast Hereditary Breast Cancer Hereditary Breast Carcinoma Hereditary Breast Carcinoma A phyllodes tumor of the breast characterized by infiltrative margins and a sarcomatous stromal component. The sarcomatous stroma usually displays features of fibrosarcoma. Liposarcomatous, osteosarcomatous, or rhabdomyosarcomatous elements may also be present. C4504 Neoplastic Process Malignant Breast Phyllodes Tumor C0346154 Cellosaurus Malignant Malignant_Phyllodes_Breast_Tumor Malignant Breast Phyllodes Neoplasm Malignant Breast Phyllodes Tumor Malignant Mammary Phyllodes Neoplasm Malignant Mammary Phyllodes Tumor Malignant Phyllodes Breast Neoplasm Malignant Phyllodes Neoplasm of Breast Malignant Phyllodes Neoplasm of the Breast Malignant Phyllodes Tumor of Breast Malignant Phyllodes Tumor of the Breast Malignant Breast Phyllodes Tumor A neoplasm that arises from the breast and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4505 Neoplastic Process Benign Breast Neoplasm C0346156 CPTAC Benign Benign_Breast_Neoplasm Benign neoplasm of breast Benign Breast Neoplasm Benign Breast Tumor Benign Neoplasm of Breast Benign Neoplasm of the Breast Benign Tumor of Breast Benign Tumor of the Breast Benign Breast Neoplasm A benign, borderline, or malignant mixed epithelial tumor of the ovary. It is characterized by the presence of more than one epithelial cell type, most often serous and endocervical-type mucinous. C4508 Neoplastic Process Ovarian Seromucinous Tumor C0346166 Undetermined Ovarian_Mixed_Epithelial_Neoplasm Ovarian Seromucinous Tumor Ovarian Seromucinous Tumor An aggressive carcinoma arising from the ovary. Most patients present with advanced disease. Microscopically, it is characterized by significant cytologic atypia, increased mitotic activity, and necrosis. The prognosis is usually poor. C4509 Neoplastic Process Ovarian Undifferentiated Carcinoma Ovarian Undifferentiated Carcinoma C0346167 CTRP Cellosaurus Malignant Undifferentiated_Ovarian_Carcinoma Anaplastic Carcinoma of Ovary Anaplastic Carcinoma of the Ovary Anaplastic Ovarian Carcinoma Ovarian Undifferentiated Carcinoma Undifferentiated Carcinoma of Ovary Undifferentiated Carcinoma of the Ovary Undifferentiated Ovarian Cancer Undifferentiated Ovarian Carcinoma Ovarian Undifferentiated Carcinoma A neoplasm that arises from the surface epithelium of the ovary and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include serous cystadenoma, mucinous cystadenoma, clear cell adenofibroma, and benign Brenner tumor. C4510 Neoplastic Process Benign Ovarian Epithelial Tumor C0346168 Benign Benign_Ovarian_Epithelial_Neoplasm Benign Epithelial Neoplasm of Ovary Benign Epithelial Neoplasm of the Ovary Benign Epithelial Tumor of Ovary Benign Epithelial Tumor of the Ovary Benign Ovarian Epithelial Neoplasm Benign Ovarian Epithelial Tumor Benign Ovarian Surface Epithelial Neoplasm Benign Ovarian Surface Epithelial Tumor Benign Ovarian Surface Epithelial-Stromal Tumor Benign Surface Epithelial Neoplasm of Ovary Benign Surface Epithelial Neoplasm of the Ovary Benign Surface Epithelial Tumor of Ovary Benign Surface Epithelial Tumor of the Ovary Benign Ovarian Epithelial Tumor A benign, usually bilateral neoplasm of the ovary characterized by the presence of cystic structures that contain watery fluid and are lined by serous epithelial cells. Signs and symptoms include abdominal enlargement, pain, and vaginal bleeding. C4511 Neoplastic Process Ovarian Serous Cystadenoma C0346170 Cellosaurus Benign Ovarian_Serous_Cystadenoma Benign Ovarian Serous Cystadenoma Benign Serous Cystadenoma of Ovary Benign Serous Cystadenoma of the Ovary Ovarian Serous Cystadenoma Serous Cystadenoma of Ovary Serous Cystadenoma of the Ovary Ovarian Serous Cystadenoma A benign neoplasm of the ovary characterized by the presence of cystic structures lined by mucinous columnar epithelial cells. C4512 Neoplastic Process Ovarian Mucinous Cystadenoma C0346172 Cellosaurus Benign Ovarian_Mucinous_Cystadenoma Benign Mucinous Cystadenoma of Ovary Benign Mucinous Cystadenoma of the Ovary Benign Ovarian Mucinous Cystadenoma Mucinous Cystadenoma of Ovary Mucinous Cystadenoma of the Ovary Ovarian Mucinous Cystadenoma Ovarian Mucinous Cystadenoma An invasive malignant neoplasm that arises from the ovary and originates from primordial germ cells. Representative examples include embryonal carcinoma, yolk sac tumor, dysgerminoma, and non-gestational choriocarcinoma. C4514 Neoplastic Process Malignant Ovarian Germ Cell Tumor C0346180 Malignant Malignant_Ovarian_Germ_Cell_Tumor Malignant Germ Cell Neoplasm of Ovary Malignant Germ Cell Neoplasm of the Ovary Malignant Germ Cell Tumor of Ovary Malignant Germ Cell Tumor of the Ovary Malignant Ovarian Germ Cell Neoplasm Malignant Ovarian Germ Cell Tumor Ovarian Germ Cell Cancer Malignant Ovarian Germ Cell Tumor A choriocarcinoma arising from the ovary. When it appears before puberty is of germ cell origin. In children and young adults signs and symptoms include precocious pseudopuberty and vaginal bleeding. Serum human chorionic gonadotropin is elevated. Germ cell derived ovarian choriocarcinoma should be differentiated from primary or metastatic gestational choriocarcinoma affecting the ovary. The prognosis of germ cell derived choriocarcinoma is less favorable and requires more aggressive chemotherapy treatment regimens compared to gestational choriocarcinoma. C4515 Neoplastic Process Ovarian Choriocarcinoma Ovarian Choriocarcinoma C0346181 CTRP Malignant Ovarian_Choriocarcinoma Choriocarcinoma of Ovary Choriocarcinoma of the Ovary Germ Cell Choriocarcinoma of Ovary Germ Cell Choriocarcinoma of the Ovary Ovarian Choriocarcinoma Ovarian Germ Cell Choriocarcinoma Ovarian Choriocarcinoma A germ cell tumor that arises from the ovary. There is no evidence of atypia or metastases. The vast majority of cases are benign dermoid cysts. C4516 Neoplastic Process Benign Ovarian Germ Cell Tumor C0346184 Benign Benign_Ovarian_Germ_Cell_Neoplasm Benign Germ Cell Neoplasm of Ovary Benign Germ Cell Neoplasm of the Ovary Benign Germ Cell Tumor of Ovary Benign Germ Cell Tumor of the Ovary Benign Ovarian Germ Cell Neoplasm Benign Ovarian Germ Cell Neoplasms Benign Ovarian Germ Cell Tumor Benign Ovarian Germ Cell Tumors Germ Cell Neoplasms, Ovarian, Benign Germ Cell Tumors, Ovarian, Benign Ovarian Germ Cell Neoplasms, Benign Ovarian Germ Cell Tumors, Benign Benign Ovarian Germ Cell Tumor Primary cutaneous marginal zone lymphoproliferative disorder that arises from chronically stimulated lymphoid tissue in the skin in response to Borrelia burgdoferi infection. C45163 Neoplastic Process Borrelia Burgdoferi-Associated Primary Cutaneous Marginal Zone Lymphoproliferative Disorder C1706987 Undetermined Borrelia_Burgdoferi-Related_Cutaneous_Marginal_Zone_B-Cell_Lymphoma_of_Mucosa-Associated_Lymphoid_Tissue Borrelia Burgdoferi-Associated Cutaneous Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Borrelia Burgdoferi-Associated Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Borrelia Burgdoferi-Associated Primary Cutaneous Marginal Zone Lymphoproliferative Disorder Borrelia Burgdoferi-Associated Primary Cutaneous Marginal Zone Lymphoproliferative Disorder A mucosa-associated lymphoid tissue lymphoma that arises from the small intestine and it is associated with Campylobacter jejuni infection. C45166 Neoplastic Process Campylobacter Jejuni-Associated Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma C1707245 Malignant Campylobacter_Jejuni-Related_Small_Intestinal_Mucosa-Associated_Lymphoid_Tissue_Lymphoma Campylobacter Jejuni-Associated Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma Campylobacter Jejuni-Associated Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma A neoplasm that arises from the fallopian tube and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include papilloma, adenofibroma, and leiomyoma. C4517 Neoplastic Process Benign Fallopian Tube Neoplasm C0346190 Benign Benign_Fallopian_Tube_Neoplasm Benign Fallopian Tube Neoplasm Benign Fallopian Tube Tumor Benign Neoplasm of Fallopian Tube Benign Neoplasm of the Fallopian Tube Benign Tumor of Fallopian Tube Benign Tumor of the Fallopian Tube Fallopian Tube Neoplasm, Benign Fallopian Tube Tumor, Benign Benign Fallopian Tube Neoplasm A rare benign neoplasm characterized by the presence of smooth muscle cells growing within veins. C4518 Neoplastic Process Intravenous Leiomyomatosis C0346200 Benign Intravenous_Leiomyomatosis Intravenous Leiomyomatosis Intravenous Leiomyomatosis An uncommon carcinoma arising from the cervix. It is composed of malignant glandular epithelial cells and malignant squamous epithelial cells. C4519 Neoplastic Process Cervical Adenosquamous Carcinoma Cervical Adenosquamous Carcinoma C0346202 CPTAC CTRP Cellosaurus Malignant Cervical_Adenosquamous_Carcinoma Adenosquamous Carcinoma Adenosquamous Cell Carcinoma of Cervix Adenosquamous Cell Carcinoma of Cervix Uteri Adenosquamous Cell Carcinoma of Uterine Cervix Adenosquamous Cell Carcinoma of the Cervix Adenosquamous Cell Carcinoma of the Cervix Uteri Adenosquamous Cell Carcinoma of the Uterine Cervix Cervical Adenosquamous Cancer Cervical Adenosquamous Carcinoma Cervical Adenosquamous Cell Carcinoma Cervix Adenosquamous Cell Carcinoma Cervix Uteri Adenosquamous Cell Carcinoma Uterine Cervix Adenosquamous Cell Carcinoma Cervical Adenosquamous Carcinoma A diffuse large B-cell lymphoma that arises from the skin. This category includes primary cutaneous diffuse large B-cell lymphoma, leg type, and primary cutaneous diffuse large B-cell lymphoma, other, which includes primary cutaneous intravascular large B-cell lymphoma and primary cutaneous T-cell/histiocyte-rich large B-cell lymphoma. C45193 Neoplastic Process Primary Cutaneous Diffuse Large B-Cell Lymphoma C1709655 Malignant Primary_Cutaneous_Diffuse_Large_B-Cell_Lymphoma Primary Cutaneous Diffuse Large B-Cell Lymphoma Primary Cutaneous Diffuse Large B-Cell Lymphoma An aggressive primary cutaneous B-cell lymphoma, usually involving the lower leg. It is composed of a generally monotonous proliferation of immunoblasts, or less frequently centroblasts, with few admixed reactive cells. This type of lymphoma occurs most often in elderly women who present with rapidly growing tumors, usually on one or both legs. Dissemination to extracutaneous sites is frequent. Treatment with combination chemotherapy is usually required. C45194 Neoplastic Process Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type C1709656 GDC 9680/3 Malignant Primary_Cutaneous_Diffuse_Large_B-Cell_Lymphoma_Leg_Type Primary cutaneous DLBCL, leg type Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type Primary cutaneous DLBCL, leg type Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. FIGO no longer includes stage 0. (AJCC 7th ed.) C4520 Neoplastic Process Cervical Adenocarcinoma In Situ C0346203 Malignant Cervical_Adenocarcinoma_in_situ Adenocarcinoma in situ of Cervix Adenocarcinoma in situ of Cervix Uteri Adenocarcinoma in situ of Uterine Cervix Adenocarcinoma in situ of the Cervix Adenocarcinoma in situ of the Cervix Uteri Adenocarcinoma in situ of the Uterine Cervix Cervical Adenocarcinoma In Situ Cervix Adenocarcinoma in situ Cervix Uteri Adenocarcinoma in situ Uterine Cervix Adenocarcinoma in situ Cervical Adenocarcinoma In Situ A low-grade, late-metastasizing variant of fibrosarcoma characterized by alternating fibrous and myxoid areas and a whorling growth pattern. The neoplastic cells have a spindle morphology, and lack hyperchromasia or significant nuclear atypia. Approximately 40% of cases show the focal presence of collagen rosettes. A t(7;16)(q33;p11) translocation has been identified in the majority of cases, associated with the presence of FUS-CREB3L2 fusion protein. Rare cases carry the t(11;16)(p11;p11) translocation which is associated with the presence of the FUS-CREB3L1 fusion protein. C45202 Neoplastic Process Low Grade Fibromyxoid Sarcoma C1275282 Cellosaurus GDC Malignant Low_Grade_Fibromyxoid_Sarcoma Low-grade fibromyxoid sarcoma Low Grade Fibromyxoid Sarcoma Low-grade fibromyxoid sarcoma Low Grade Fibromyxoid Sarcoma A low grade fibromyxoid sarcoma characterized by the presence of prominent collagen rosettes. C45203 Neoplastic Process Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes C1708749 Malignant Low_Grade_Fibromyxoid_Sarcoma_with_Giant_Collagen_Rosettes Hyalinizing Spindle Cell Tumor with Giant Rosettes Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes A superficial neoplastic process involving exclusively the vaginal squamous epithelium without extension to underlying tissue. It is classified as low- or high-grade intraepithelial neoplasia. C4521 Neoplastic Process Vaginal Intraepithelial Neoplasia C0346208 CTEP Undetermined Vaginal_Intraepithelial_Neoplasia Intraepithelial Neoplasia of Vagina Intraepithelial Neoplasia of the Vagina Intraepithelial Neoplasm of Vagina Intraepithelial Neoplasm of the Vagina Intraepithelial Tumor of Vagina Intraepithelial Tumor of the Vagina VAIN Vaginal Intraepithelial Neoplasia Vaginal Intraepithelial Neoplasm Vaginal Intraepithelial Tumor Vaginal SIL Vaginal Squamous Intraepithelial Lesion Vaginal intraepithelial neoplasia Vaginal Intraepithelial Neoplasia A low grade fibromyxoid sarcoma that may have poorly formed collagen rosettes, but lacks prominent, well formed collagen rosettes. C45210 Neoplastic Process Classical Low Grade Fibromyxoid Sarcoma C1707402 Malignant Classical_Low_Grade_Fibromyxoid_Sarcoma Classical Low Grade Fibromyxoid Sarcoma Classical Low Grade Fibromyxoid Sarcoma Intravascular large B-cell lymphoma that arises from the skin. C45214 Neoplastic Process Primary Cutaneous Intravascular Large B-Cell Lymphoma C1709658 Malignant Primary_Cutaneous_Intravascular_Large_B-Cell_Lymphoma Primary Cutaneous Intravascular Large B-Cell Lymphoma Primary Cutaneous Intravascular Large B-Cell Lymphoma T-Cell/histiocyte-rich large B-cell lymphoma that arises from the skin. C45215 Neoplastic Process Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma C1709660 Malignant Primary_Cutaneous_T-Cell_Histiocyte_Rich_Lymphoma Primary Cutaneous T-Cell/Histiocyte Rich Lymphoma Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Plasmablastic lymphoma that arises from the skin. C45216 Neoplastic Process Primary Cutaneous Plasmablastic Lymphoma C1709659 Malignant Primary_Cutaneous_Plasmablastic_Lymphoma Primary Cutaneous Plasmablastic Lymphoma Primary Cutaneous Plasmablastic Lymphoma A header term that includes the following diffuse large B-cell lymphoma subtypes by gene expression profiling: activated B-cell-like diffuse large B-cell lymphoma, germinal center B-cell-like diffuse large B-cell lymphoma, and type 3 diffuse large B-cell lymphoma. C45219 Neoplastic Process Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile C1707742 Malignant Diffuse_Large_B-Cell_Lymphoma_by_Gene_Expression_Profile Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ (preinvasive carcinoma. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C4522 Neoplastic Process Stage 0 Vulvar Cancer AJCC v6 Stage 0 Vulvar Cancer AJCC v6 C0278729 CTRP GDC Malignant Stage_0_Vulvar_Cancer 8077/2 VIN III Vulvar intraepithelial neoplasia, grade III AJCC Stage 0 Vulvar Cancer v6 Carcinoma in situ of Vulva AJCC v6 Carcinoma in situ of the Vulva AJCC v6 FIGO Stage 0 Carcinoma of Vulva AJCC v6 FIGO Stage 0 Carcinoma of the Vulva AJCC v6 FIGO Stage 0 Vulva Carcinoma FIGO Stage 0 Vulvar Carcinoma AJCC v6 Stage 0 Vulval Cancer AJCC v6 Stage 0 Vulval Carcinoma AJCC v6 Stage 0 Vulvar Cancer Stage 0 Vulvar Cancer AJCC v6 Stage 0 Vulvar Carcinoma AJCC v6 Vulva Carcinoma in situ AJCC v6 Vulvar Cancer Stage 0 AJCC v6 Vulvar Carcinoma in situ AJCC v6 Stage 0 Vulvar Cancer AJCC v6 Stage 0 includes: pTis, N0, M0, S0. pTis: Intratubular germ cell neoplasia (carcinoma in situ). N0: regional lymph node metastasis. M0: No distant metastasis. S0: Marker study levels within normal limits. (AJCC 6th and 7th eds.) C4523 Neoplastic Process Stage 0 Testicular Cancer AJCC v6 and v7 Stage 0 Testicular Cancer AJCC v6 and v7 C0346237 CTRP PCDC Abnormal cells are found in the tiny tubules where the sperm cells begin to develop. These abnormal cells may become cancer and spread into nearby normal tissue. All tumor marker levels are normal. Malignant Stage_0_Testicular_Cancer Stage 0 Stage 0 Cancer of Testis Stage 0 Cancer of the Testis Stage 0 Testicular Cancer Stage 0 Testicular Cancer AJCC v6 Stage 0 Testicular Cancer AJCC v6 and v7 Stage 0 Testicular Cancer AJCC v7 stage 0 testicular carcinoma in situ Stage 0 Testicular Cancer AJCC v6 and v7 A biologic subset of diffuse large B-cell lymphomas (DLBCL) that do not overexpress the genes whose overexpression characterizes the germinal center B-cell-like and activated B-cell-like DLBCL. Morphologically, these lymphomas are either immunoblastic or centroblastic. Patients with this type of diffuse large B-cell lymphoma are reported to have a less favorable outcome, similar to those with an activated B-cell-like gene expression profile. C45231 Neoplastic Process Diffuse Large B-Cell Lymphoma Unclassifiable Diffuse Large B-Cell Lymphoma Unclassifiable C1710498 CTRP Malignant Type_3_Diffuse_Large_B-Cell_Lymphoma DLBCL Unclassifiable Diffuse Large B-Cell Lymphoma Indeterminate Diffuse Large B-Cell Lymphoma Unclassifiable Type 3 DLBCL Type 3 Diffuse Large B-Cell Lymphoma Diffuse Large B-Cell Lymphoma Unclassifiable A precursor lymphoid neoplasm that affects the skin. C45238 Neoplastic Process Cutaneous Precursor Lymphoid Neoplasm C1707590 Malignant Cutaneous_Precursor_Lymphoblastic_Leukemia_Lymphoma Cutaneous Precursor Lymphoblastic Lymphoma/Leukemia Cutaneous Precursor Lymphoid Neoplasm Cutaneous Precursor Lymphoid Neoplasm A rare kidney neoplasm of low malignant potential. It is a well-circumscribed multicystic mass without solid areas. The inner lining of the cystic structures is composed of clear cells. It usually presents as a unilateral solitary mass. C4524 Neoplastic Process Multilocular Cystic Renal Cell Carcinoma Multilocular Cystic Renal Neoplasm of Low Malignant Potential C0346249 CTRP Cellosaurus 8316/3 Uncertain Malignant Potential Multilocular_Cystic_Renal_Cell_Carcinoma Multilocular cystic renal neoplasm of low malignant potential Multilocular Clear Cell Renal Cell Carcinoma Multilocular Cystic Renal Cell Cancer Multilocular Cystic Renal Neoplasm of Low Malignant Potential Renal Cystadenocarcinoma Multilocular Cystic Renal Neoplasm of Low Malignant Potential A neoplasm of hematopoietic and lymphoid cell origin that affects the skin. C45240 Neoplastic Process Cutaneous Hematopoietic and Lymphoid Cell Neoplasm C1707548 Undetermined Cutaneous_Hematopoietic_and_Lymphoid_Cell_Neoplasm Cutaneous Hematopoietic and Lymphoid Cell Neoplasm Cutaneous Hematopoietic and Lymphoid Cell Neoplasm B-lymphoblastic leukemia/lymphoma that affects the skin. C45241 Neoplastic Process Cutaneous B Lymphoblastic Leukemia/Lymphoma C1707589 Malignant Cutaneous_Precursor_B-Lymphoblastic_Leukemia_Lymphoma Cutaneous B Lymphoblastic Leukemia/Lymphoma Cutaneous B-Lymphoblastic Leukemia/Lymphoma Cutaneous Precursor B-Lymphoblastic Lymphoma/Leukemia Cutaneous B Lymphoblastic Leukemia/Lymphoma T-lymphoblastic leukemia/lymphoma that affects the skin. C45242 Neoplastic Process Cutaneous T Lymphoblastic Leukemia/Lymphoma C1707591 Malignant Cutaneous_Precursor_T-Lymphoblastic_Leukemia_Lymphoma Cutaneous Precursor T-Lymphoblastic Lymphoma/Leukemia Cutaneous T Lymphoblastic Leukemia/Lymphoma Cutaneous T-Lymphoblastic Leukemia/Lymphoma Cutaneous T Lymphoblastic Leukemia/Lymphoma A mature B-cell neoplasm that affects the skin. C45249 Neoplastic Process Cutaneous Mature B-Cell Neoplasm C1707551 Undetermined Cutaneous_Mature_B-Cell_Neoplasm Cutaneous Mature B-Cell Lymphocytic Neoplasm Cutaneous Mature B-Cell Neoplasm Cutaneous Mature B-Cell Neoplasm A sarcoma that arises from the kidney. C4525 Neoplastic Process Kidney Sarcoma C0346251 CDISC A malignant neoplasm of the kidney parenchyma. Malignant Renal_Sarcoma Kidney Sarcoma Renal Sarcoma SARCOMA, RENAL, MALIGNANT Sarcoma of Kidney Sarcoma of the Kidney Kidney Sarcoma A group of neoplasms composed of T-lymphocytes with a mature (peripheral/post-thymic) immunophenotypic profile and/or NK-cells affecting the skin. C45250 Neoplastic Process Cutaneous Mature T-Cell and NK-Cell Neoplasm C1707552 Undetermined Cutaneous_Mature_T-Cell_and_NK-Cell_Neoplasm Cutaneous Mature T-Cell and NK-Cell Neoplasm Cutaneous Mature T-Cell and NK-Cell Neoplasm A benign tumor of the kidney, characterized by the presence of large cells with abundant eosinophilic granular cytoplasm. The majority of these tumors are discovered incidentally, during work-up of other conditions. C4526 Neoplastic Process Kidney Oncocytoma C0346255 Benign Renal_Oncocytoma Kidney Oncocytoma Oncocytoma of Kidney Oncocytoma of the Kidney Renal Epithelial Oncocytic Neoplasm Renal Epithelial Oncocytic Tumor Renal Oncocytoma Kidney Oncocytoma A chronic lymphocytic leukemia that affects the skin. C45264 Neoplastic Process Cutaneous Chronic Lymphocytic Leukemia C1707542 Malignant Cutaneous_Chronic_Lymphocytic_Leukemia Cutaneous Chronic Lymphocytic Leukemia Cutaneous Chronic Lymphocytic Leukemia Mantle cell lymphoma that affects the skin. C45266 Neoplastic Process Cutaneous Mantle Cell Lymphoma C1707550 Malignant Cutaneous_Mantle_Cell_Lymphoma Cutaneous Mantle Cell Lymphoma Cutaneous Mantle Cell Lymphoma Lymphomatoid granulomatosis that affects the skin. C45267 Neoplastic Process Cutaneous Lymphomatoid Granulomatosis C1707549 Uncertain Malignant Potential Cutaneous_Lymphomatoid_Granulomatosis Cutaneous Lymphomatoid Granulomatosis Cutaneous Lymphomatoid Granulomatosis Nasal type extranodal NK/T-cell lymphoma affecting the skin. C45268 Neoplastic Process Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma C1707588 Malignant Cutaneous_Nasal_Type_Extranodal_NK_T-Cell_Lymphoma Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma Follicular helper T-cell lymphoma, angioimmunoblastic-type affecting the skin. C45271 Neoplastic Process Cutaneous Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type C1707541 Malignant Cutaneous_Angioimmunoblastic_T-Cell_Lymphoma Cutaneous Angioimmunoblastic T-Cell Lymphoma Cutaneous Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type Cutaneous Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type Adult T-cell leukemia/lymphoma affecting the skin. C45272 Neoplastic Process Cutaneous Adult T-Cell Leukemia/Lymphoma C1707540 Malignant Cutaneous_Adult_T-Cell_Lymphoma_Leukemia Cutaneous Adult T-Cell Leukemia/Lymphoma Cutaneous Adult T-Cell Lymphoma/Leukemia Cutaneous Adult T-Cell Leukemia/Lymphoma A rare benign neoplasm that arises from the renal pelvis and is characterized by the presence of a papillary growth with a central fibrovascular core. The latter is lined by normal urothelium. C4528 Neoplastic Process Renal Pelvis Urothelial Papilloma C1514844 Benign Renal_Pelvis_Papilloma Renal Pelvis Urothelial Papilloma Renal Pelvis Urothelial Papilloma Stage 0is includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C4529 Neoplastic Process Stage 0is Ureter Cancer AJCC v7 Stage 0is Ureter Cancer AJCC v7 C0346267 CTRP Malignant Stage_0is_Ureter_Cancer Carcinoma in situ of Ureter Carcinoma in situ of the Ureter Stage 0is Carcinoma of Ureter Stage 0is Carcinoma of the Ureter Stage 0is Ureter Cancer Stage 0is Ureter Cancer AJCC v7 Stage 0is Ureter Carcinoma Stage 0is Ureter Urothelial Carcinoma Stage 0is Ureter Urothelial Carcinoma AJCC v7 Stage 0is Ureteral Carcinoma Ureter Cancer Stage 0is Ureter Carcinoma in situ Ureteral Carcinoma in situ Stage 0is Ureter Cancer AJCC v7 An exophytic and polypoid lesion attached to the ureter by a broad base or a thin stalk. C4530 Neoplastic Process Ureter Polyp C0346269 Benign Ureter_Polyp Polyp of Ureter Polyp of the Ureter Ureter Polyp Ureteral Polyp Ureter Polyp Stage 0is includes: (Tis, N0, M0); (Tis pu, N0, M0); (Tis pd, N0, M0). Tis: Carcinoma in situ. Tis pu: Carcinoma in situ, involvement of the prostatic urethra. Tis pd: Carcinoma in situ, involvement of the prostatic ducts. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C4531 Neoplastic Process Stage 0is Urethral Cancer AJCC v7 Stage 0is Urethral Cancer AJCC v7 C0346280 CTRP Malignant Stage_0is_Urethral_Cancer Carcinoma in situ of Urethra Carcinoma in situ of the Urethra Stage 0is Carcinoma of Urethra Stage 0is Carcinoma of the Urethra Stage 0is Urethra Carcinoma Stage 0is Urethral Cancer Stage 0is Urethral Cancer AJCC v7 Stage 0is Urethral Carcinoma Urethra Carcinoma in situ Urethral Carcinoma in situ Stage 0is Urethral Cancer AJCC v7 A neoplasm that arises from the accessory urethral glands and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4532 Neoplastic Process Benign Accessory Urethral Gland Neoplasm C1711308 Benign Benign_Paraurethral_Gland_Neoplasm Benign Accessory Urethral Gland Neoplasm Benign Accessory Urethral Gland Neoplasm A rare, EBV-positive cutaneous T-cell lymphoproliferative disorder, composed of CD8 positive cytotoxic T-lymphocytes. It affects children, almost exclusively in Latin America and Asia. Patients present with papulovesicular skin lesions, clinically resembling hydroa vacciniforme, in areas of sun-exposed skin. C45327 Neoplastic Process Hydroa Vacciniforme Lymphoproliferative Disorder C1708397 GDC NICHD In contrast to hydroa vacciniforme (HV), HV-like lymphoma is not induced by sun exposure and the lesions can occur in both sun-exposed and covered body areas. It affects children, almost exclusively in Latin America and Asia. 9725/3 Undetermined Hydroa_Vacciniforme-Like_Cutaneous_T-Cell_Lymphoma 9725/3 Hydroa vacciniforme-like lymphoma Hydroa vacciniforme-like lymphoproliferative disorder HV LPD HV-LPD HV-Like LPD HV-Like Lymphoma Hydroa Vacciniforme Lymphoproliferative Disorder Hydroa Vacciniforme-Like Cutaneous T-Cell Lymphoma Hydroa Vacciniforme-Like Lymphoma Hydroa Vacciniforme-Like Lymphoproliferative Disorder Hydroa vacciniforme-like lymphoma Hydroa Vacciniforme Lymphoproliferative Disorder A malignant neoplasm that arises from the choroid plexus. The vast majority are carcinomas. C4533 Neoplastic Process Malignant Choroid Plexus Neoplasm C0346289 Malignant Malignant_Choroid_Plexus_Neoplasm Malignant Choroid Plexus Neoplasm Malignant Choroid Plexus Neoplasms Malignant Choroid Plexus Tumor Malignant Choroid Plexus Tumors Malignant Neoplasm of Choroid Plexus Malignant Neoplasm of the Choroid Plexus Malignant Tumor of Choroid Plexus Malignant Tumor of the Choroid Plexus Malignant Choroid Plexus Neoplasm An aggressive, epidermotropic primary cutaneous T-cell lymphoma. It is characterized by the presence of eruptive papules and nodules, or tumors, which may be localized or disseminated. Morphologically, it is composed of small to medium-sized, or medium-sized to large, CD8-positive T-lymphocytes with pleomorphic or blastic nuclei. Epidermotropism is often pronounced. Angiocentricity and angioinvasion may be present. C45339 Neoplastic Process Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma C1709653 GDC 9709/3 Malignant Primary_Cutaneous_Aggressive_Epidermotropic_CD8-Positive_T-Cell_Lymphoma Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma Primary Cutaneous Aggressive Epidermotropic CD8-Positive T-Cell Lymphoma Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma Primary Cutaneous CD8-Positive Aggressive Epidermotropic T-Cell Lymphoma Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma A neoplasm that arises from glial cells in the spinal cord. Representative examples include astrocytoma, oligodendroglioma, and ependymoma. C4534 Neoplastic Process Spinal Cord Glioma C0346294 Cellosaurus Undetermined Spinal_Cord_Glial_Neoplasm Glial Neoplasm Spinal Cord Glial Tumor of Spinal Cord Spinal Cord Glial Neoplasm Spinal Cord Glial Tumor Spinal Cord Glioma Spinal Cord Glioma An aggressive cutaneous lymphoma of mature, activated gamma/delta T-lymphocytes. It usually presents with disseminated plaques and nodules. Involvement of mucosal sites is frequent. However, involvement of lymph nodes, spleen, or bone marrow is uncommon. Morphologically, there are three patterns of cutaneous involvement: epidermotropic, dermal, and subcutaneous. Often, more than one pattern may co-exist in a single biopsy specimen, or may be present in different biopsy specimens from the same patient. The lymphocytic infiltrate is composed of medium- to large-sized lymphocytes expressing CD56. Most cases lack both CD4 and CD8, although CD8 may be present in some cases. This group of lymphomas includes cases previously known as subcutaneous panniculitis-like T-cell lymphoma with a gamma/delta phenotype. C45340 Neoplastic Process Primary Cutaneous Gamma-Delta T-Cell Lymphoma Primary Cutaneous Gamma-Delta T-Cell Lymphoma C1707547 CTRP GDC 9726/3 Malignant Cutaneous_Gamma_Delta_T-Cell_Lymphoma 9726/3 Primary cutaneous gamma-delta T-cell lymphoma Cutaneous Gamma/Delta T-Cell Lymphoma Peripheral Gamma-Delta T-Cell Lymphoma Primary Cutaneous Gamma-Delta T-Cell Lymphoma Primary cutaneous gamma-delta T-cell lymphoma Primary Cutaneous Gamma-Delta T-Cell Lymphoma C4535 Neoplastic Process Spinal Cord Oligodendroglioma C0346295 Undetermined Spinal_Cord_Oligodendroglioma Oligodendroglioma of Spinal Cord Spinal Cord Oligodendroglioma Well Differentiated Spinal Cord Oligodendroglial Tumor Well Differentiated Spinal Cord Oligodendroglioma Spinal Cord Oligodendroglioma Pituitary neuroendocrine tumor that has spread from its original site of growth to another anatomic site. C4536 Neoplastic Process Metastatic Pituitary Gland Carcinoma Pituitary Gland Carcinoma Metastatic Pituitary Neuroendocrine Tumor C0346300 CPTAC CTEP CTRP Cellosaurus GDC 8272/3 Malignant Pituitary_Gland_Carcinoma 8272/3 Pituitary carcinoma, NOS Cancer of Pituitary Cancer of Pituitary Gland Cancer of the Pituitary Cancer of the Pituitary Gland Carcinoma of Pituitary Carcinoma of Pituitary Gland Carcinoma of the Pituitary Carcinoma of the Pituitary Gland Metastatic PitNET Metastatic Pituitary Gland Carcinoma Metastatic Pituitary Neuroendocrine Tumor Pituitary Carcinoma Pituitary Gland Adenocarcinoma Pituitary Gland Cancer Pituitary Gland Carcinoma Pituitary carcinoma, NOS Pituitary gland cancer, NOS Metastatic Pituitary Neuroendocrine Tumor A primary cutaneous T-cell lymphoproliferative disorder. It usually presents with a solitary plaque or tumor on the face, neck, or upper trunk. Morphologically, it is composed of small to medium-sized CD4-positive, CD8-negative, and CD30-negative pleomorphic T-lymphocytes. A small number of large pleomorphic T-lymphocytes may also be present. The lymphocytic infiltrate is dermal. Focal epidermotropism and subcutaneous involvement may be present. The clinical behavior is almost always indolent and most patients present with localized disease. C45366 Neoplastic Process Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder CL524855 GDC 9709/3 Uncertain Malignant Potential Primary_Cutaneous_CD4-Positive_Small_Medium-Sized_Pleomorphic_T-Cell_Lymphoma 9709/3 Primary cutaneous CD4 positive small/medium T-cell lymphoproliferative disorder Primary cutaneous CD4-positive small/medium T-cell lymphoma Primary Cutaneous CD4-Positive Small or Medium T-Cell Lymphoproliferative Disorder Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder Primary Cutaneous CD4-Positive Small/Medium-Sized Pleomorphic T-Cell Lymphoproliferative Disorder Primary Cutaneous CD4-Positive Small/Medium-Sized T-Cell Lymphoproliferative Disorder Primary cutaneous CD4-positive small/medium T-cell lymphoma Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder A glioma that affects the optic nerve. This condition can be seen in association with neurofibromatosis 1. It is most commonly seen in the pediatric age group. C4537 Neoplastic Process Optic Nerve Glioma Optic Nerve Glioma C3279059 CTRP Undetermined Optic_Nerve_Glioma Glioma of Optic Nerve Glioma of the Optic Nerve Optic Nerve Glioma Optic Nerve Glioma A meningioma that arises from the sheath of the optic nerve. C4538 Neoplastic Process Optic Nerve Sheath Meningioma C0346328 Undetermined Optic_Nerve_Sheath_Meningioma Meningioma of Optic Nerve Sheath Meningioma of the Optic Nerve Sheath Optic Nerve Sheath Meningioma Optic Nerve Sheath Meningioma A low-grade extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue that affects the thymus. It is characterized by the presence of centrocyte-like or monocytoid lymphocytes that surround reactive lymphoid follicles. There is infiltration of the thymic epithelium by lymphocytes and formation of lymphoepithelial lesions. It is associated with the presence of autoimmune disease, most frequently Sjogren syndrome. Patients are usually asymptomatic and the tumor is detected incidentally as a mediastinal mass on chest x-ray. A minority of patients present with dyspnea, hemoptysis, and chest pain. The prognosis is excellent. C45380 Neoplastic Process Thymic Mucosa-Associated Lymphoid Tissue Lymphoma C1710402 Malignant Thymic_Mucosa-Associated_Lymphoid_Tissue_Lymphoma MALT Lymphoma of the Mediastinum Mediastinal Mucosa-Associated Lymphoid Tissue Lymphoma Primary Thymic Extranodal Marginal Zone Lymphoma Thymic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Thymic Mucosa-Associated Lymphoid Tissue Lymphoma Thymic Mucosa-Associated Lymphoid Tissue Lymphoma A primary or metastatic malignant neoplasm affecting the eighth cranial nerve, also referred to as the vestibulocochlear nerve. C4539 Neoplastic Process Malignant Vestibulocochlear Nerve Neoplasm C0346331 mCode Malignant Malignant_Vestibulocochlear_Nerve_Neoplasm Cancer of Vestibulocochlear Nerve Cancer of the Vestibulocochlear Nerve Malignant Acoustic Nerve Neoplasm Malignant Acoustic Nerve Tumor Malignant Eighth Cranial Nerve Neoplasm Malignant Eighth Cranial Nerve Tumor Malignant Neoplasm of Acoustic Nerve Malignant Neoplasm of Eighth Cranial Nerve Malignant Neoplasm of Vestibulocochlear Nerve Malignant Neoplasm of the Acoustic Nerve Malignant Neoplasm of the Eighth Cranial Nerve Malignant Neoplasm of the Vestibulocochlear Nerve Malignant Tumor of Acoustic Nerve Malignant Tumor of Eighth Cranial Nerve Malignant Tumor of Vestibulocochlear Nerve Malignant Tumor of the Acoustic Nerve Malignant Tumor of the Eighth Cranial Nerve Malignant Tumor of the Vestibulocochlear Nerve Malignant Vestibulocochlear Nerve Neoplasm Malignant Vestibulocochlear Nerve Tumor Malignant neoplasm of unspecified acoustic nerve Malignant Vestibulocochlear Nerve Neoplasm A carcinoma that arises from the lacrimal gland. It is characterized by the presence of malignant epithelial cells that form cribriform, tubular, and solid patterns. C4540 Neoplastic Process Lacrimal Gland Adenoid Cystic Carcinoma C0346340 Cellosaurus Malignant Lacrimal_Gland_Adenoid_Cystic_Carcinoma Adenoid Cystic Carcinoma of Lacrimal Gland Adenoid Cystic Carcinoma of the Lacrimal Gland Lacrimal Gland Adenoid Cystic Carcinoma Lacrimal Gland Adenoid Cystic Carcinoma An adenocarcinoma that arises from the lacrimal gland. C4541 Neoplastic Process Lacrimal Gland Adenocarcinoma C0346341 Malignant Lacrimal_Gland_Adenocarcinoma Adenocarcinoma of Lacrimal Gland Adenocarcinoma of the Lacrimal Gland Lacrimal Gland Adenocarcinoma Lacrimal Gland Adenocarcinoma A benign, usually encapsulated neoplasm of the lacrimal gland composed of epithelial and mesenchymal cells. Pleomorphic adenomas are neoplasms that develop in the salivary glands or heterotopic salivary gland tissues. It has been suggested that myoepithelial cells play a major role in the histogenesis of these tumors. In the lacrimal gland, pleomorphic adenomas presumably develop from metaplastic myoepithelial cells. C4542 Neoplastic Process Lacrimal Gland Pleomorphic Adenoma C0346345 Benign Lacrimal_Gland_Pleomorphic_Adenoma Benign Mixed Tumor of Lacrimal Gland Benign Mixed Tumor of the Lacrimal Gland Lacrimal Gland Benign Mixed Tumor Lacrimal Gland Pleomorphic Adenoma Pleomorphic Adenoma of Lacrimal Gland Pleomorphic Adenoma of the Lacrimal Gland Lacrimal Gland Pleomorphic Adenoma An adenocarcinoma that arises from the colonic glandular epithelium and invades the lamina propria or muscularis mucosa but not the submucosa. C45429 Neoplastic Process Colon Intramucosal Adenocarcinoma C1707434 Malignant Colon_Intramucosal_Adenocarcinoma Colon Intramucosal Adenocarcinoma Colon Intramucosal Neoplasia Colon Intramucosal Adenocarcinoma A malignant mesenchymal neoplasm with skeletal muscle differentiation that arises from the orbit. C4543 Neoplastic Process Orbit Rhabdomyosarcoma C0346347 Malignant Orbit_Rhabdomyosarcoma Orbit Rhabdomyosarcoma Rhabdomyosarcoma of Orbit Rhabdomyosarcoma of the Orbit Orbit Rhabdomyosarcoma An angiomyofibroblastoma arising from the vagina. C45445 Neoplastic Process Vaginal Angiomyofibroblastoma C1710609 Benign Vaginal_Angiomyofibroblastoma Vaginal Angiomyofibroblastoma Vaginal Angiomyofibroblastoma An angiomyofibroblastoma arising from the vulva. C45446 Neoplastic Process Vulvar Angiomyofibroblastoma C1710641 Benign Vulvar_Angiomyofibroblastoma Vulvar Angiomyofibroblastoma Vulvar Angiomyofibroblastoma A capillary hemangioma arising from the orbit. C4545 Neoplastic Process Orbit Capillary Hemangioma C0346351 Benign Orbit_Capillary_Hemangioma Capillary Angioma of Orbit Capillary Angioma of the Orbit Capillary Hemangioma of Orbit Capillary Hemangioma of the Orbit Orbit Capillary Angioma Orbit Capillary Hemangioma Orbit Capillary Hemangioma A cavernous hemangioma arising from the orbit. C4546 Neoplastic Process Orbit Cavernous Hemangioma C0346352 Benign Orbit_Cavernous_Hemangioma Cavernous Angioma of Orbit Cavernous Angioma of the Orbit Cavernous Hemangioma of Orbit Cavernous Hemangioma of the Orbit Orbit Cavernous Angioma Orbit Cavernous Hemangioma Orbit Cavernous Hemangioma A borderline blood vessel neoplasm that has locally aggressive behavior. C45473 Neoplastic Process Intermediate (Locally Aggressive) Blood Vessel Neoplasm C1708537 Undetermined Intermediate_Locally_Aggressive_Blood_Vessel_Neoplasm Intermediate (Locally Aggressive) Blood Vessel Neoplasm Intermediate (Locally Aggressive) Blood Vessel Neoplasm A borderline blood vessel neoplasm that may metastasize on rare occasions. C45474 Neoplastic Process Intermediate (Rarely Metastasizing) Blood Vessel Neoplasm C1708539 Undetermined Intermediate_Rarely_Metastasizing_Blood_Vessel_Neoplasm Intermediate (Rarely Metastasizing) Blood Vessel Neoplasm Intermediate (Rarely Metastasizing) Blood Vessel Neoplasm An intermediate, locally aggressive and rarely metastasizing blood vessel neoplasm. It is characterized by the presence of spindle, plump, and epithelioid endothelial cells and cellular atypia. C45475 Neoplastic Process Composite Hemangioendothelioma C1304513 Undetermined Composite_Hemangioendothelioma CHE Composite Hemangioendothelioma Composite Hemangioendothelioma An intermediate, rarely metastasizing blood vessel neoplasm. It is characterized by the presence of a polymorphic cellular infiltrate. C45476 Neoplastic Process Polymorphus Hemangioendothelioma C1709592 Undetermined Polymorphus_Hemangioendothelioma Polymorphus Hemangioendothelioma Polymorphus Hemangioendothelioma A benign congenital tumor that affects the orbit. It is one of the most common orbital tumors. It is characterized by the presence of a cystic structure that is lined by keratinizing epithelium and contains adnexal structures. Complete surgical excision is curative. C4548 Neoplastic Process Orbit Dermoid Cyst C0346356 Benign Orbit_Dermoid_Cyst Dermoid Cyst of Orbit Dermoid Cyst of the Orbit Orbit Dermoid Cyst Orbit Dermoid Cyst A localized lymphangioma characterized by microcystic changes. C45485 Neoplastic Process Lymphangioma Circumscriptum C0343089 9171/0 Benign Lymphangioma_Circumscriptum Lymphangioma Circumscriptum Lymphangioma Circumscriptum A low-grade squamous cell carcinoma that arises from the conjunctiva. It is the most common primary malignant tumor that arises from the conjunctiva. It usually affects older white males. Excessive exposure to sunlight is a risk factor. Patients may present with a mass, red eye, or pain. C4549 Neoplastic Process Conjunctival Squamous Cell Carcinoma Conjunctival Squamous Cell Carcinoma C0346359 CTRP Cellosaurus Malignant Conjunctival_Squamous_Cell_Carcinoma Conjunctiva Epidermoid Carcinoma Conjunctiva Squamous Cell Carcinoma Conjunctival Epidermoid Carcinoma Conjunctival Squamous Cell Cancer Conjunctival Squamous Cell Carcinoma Epidermoid Carcinoma of Conjunctiva Epidermoid Carcinoma of the Conjunctiva Squamous Cell Carcinoma of Conjunctiva Squamous Cell Carcinoma of the Conjunctiva Conjunctival Squamous Cell Carcinoma A melanoma that arises from the conjunctiva. C4550 Neoplastic Process Conjunctival Melanoma Conjunctival Melanoma C0346360 CPTAC CTRP Cellosaurus Malignant Conjunctival_Melanoma Conjunctiva Melanoma Conjunctival Melanoma Malignant Conjunctiva Melanoma Malignant Conjunctival Melanoma Malignant Melanoma of Conjunctiva Malignant Melanoma of the Conjunctiva Melanoma of Conjunctiva Melanoma of the Conjunctiva Conjunctival Melanoma A morphologic variant of squamous cell lung carcinoma characterized by the presence of papillary structures. C45502 Neoplastic Process Lung Squamous Cell Carcinoma, Papillary Variant C1710175 Malignant Squamous_Cell_Lung_Carcinoma_Papillary_Variant Lung Squamous Cell Carcinoma, Papillary Variant Squamous Cell Lung Carcinoma, Papillary Variant Lung Squamous Cell Carcinoma, Papillary Variant A morphologic variant of squamous cell lung carcinoma characterized by the presence of clear cells. C45503 Neoplastic Process Lung Squamous Cell Carcinoma, Clear Cell Variant C1710174 Malignant Squamous_Cell_Lung_Carcinoma_Clear_Cell_Variant Lung Squamous Cell Carcinoma, Clear Cell Variant Squamous Cell Lung Carcinoma, Clear Cell Variant Lung Squamous Cell Carcinoma, Clear Cell Variant A poorly differentiated morphologic variant of squamous cell lung carcinoma characterized by the presence of small tumor cells with focal squamous differentiation. C45504 Neoplastic Process Lung Squamous Cell Carcinoma, Small Cell Variant C1710176 Malignant Squamous_Cell_Lung_Carcinoma_Small_Cell_Variant Lung Squamous Cell Carcinoma, Small Cell Variant Squamous Cell Lung Carcinoma, Small Cell Variant Lung Squamous Cell Carcinoma, Small Cell Variant A morphologic variant of squamous cell lung carcinoma characterized by nuclear palisading. C45507 Neoplastic Process Lung Basaloid Squamous Cell Carcinoma Lung Basaloid Squamous Cell Carcinoma C1710173 CTRP Malignant Squamous_Cell_Lung_Carcinoma_Basaloid_Variant Basaloid Squamous Cell Lung Carcinoma Lung Basaloid Squamous Cell Carcinoma Squamous Cell Lung Carcinoma, Basaloid Variant Lung Basaloid Squamous Cell Carcinoma A rare morphologic variant of lung adenocarcinoma characterized by the presence of glandular structures containing glycogen-rich cells forming tubules that resemble fetal lung tubules. C45509 Neoplastic Process Lung Fetal Adenocarcinoma C1708045 CPTAC GDC 8333/3 Malignant Fetal_Lung_Adenocarcinoma 8333/3 Fetal adenocarcinoma Fetal Adenocarcinoma Fetal Lung Adenocarcinoma Fetal adenocarcinoma Lung Fetal Adenocarcinoma Pulmonary Adenocarcinoma of Fetal Type Pulmonary Endodermal Tumor Resembling Fetal Lung Well-Differentiated Fetal Lung Adenocarcinoma Lung Fetal Adenocarcinoma A benign melanocytic nevus that arises from the conjunctiva. C4551 Neoplastic Process Conjunctival Nevus C0346363 Benign Conjunctival_Nevus Conjunctival Nevus Nevus of Conjunctiva Nevus of the Conjunctiva Conjunctival Nevus A morphologic variant of lung adenocarcinoma characterized by the presence of mucin pools containing islands of well differentiated adenocarcinoma cells. C45512 Neoplastic Process Lung Colloid Adenocarcinoma C1708776 Malignant Lung_Mucinous_Adenocarcinoma Lung_Mucinous_Cystadenocarcinoma Lung Colloid Adenocarcinoma Lung Mucinous Cystadenocarcinoma Lung Colloid Adenocarcinoma A rare and distinctive type of lung carcinoma characterized by the presence of a syncytial growth pattern, large vesicular nuclei with eosinophilic nucleoli, and dense lymphoplasmacytic infiltration. C45519 Neoplastic Process Lung Lymphoepithelial Carcinoma C1708792 Malignant Lymphoepithelioma-Like_Lung_Carcinoma Lung Lymphoepithelial Carcinoma Lung Lymphoepithelioma-Like Carcinoma Lymphoepithelioma-Like Lung Carcinoma Lung Lymphoepithelial Carcinoma A rare squamous cell carcinoma that arises from the cornea. C4552 Neoplastic Process Corneal Squamous Cell Carcinoma C0346366 Malignant Corneal_Squamous_Cell_Carcinoma Cornea Epidermoid Carcinoma Cornea Squamous Cell Carcinoma Corneal Epidermoid Carcinoma Corneal Squamous Cell Carcinoma Epidermoid Carcinoma of Cornea Epidermoid Carcinoma of the Cornea Squamous Cell Carcinoma of Cornea Squamous Cell Carcinoma of the Cornea Corneal Squamous Cell Carcinoma A melanoma that arises from the cornea. C4553 Neoplastic Process Corneal Melanoma C0346367 CPTAC Malignant Corneal_Melanoma Cornea Melanoma Corneal Melanoma Malignant Cornea Melanoma Malignant Corneal Melanoma Malignant Melanoma of Cornea Malignant Melanoma of the Cornea Melanoma of Cornea Melanoma of the Cornea Corneal Melanoma A malignant neoplasm that affects the iris. This category includes primary iris melanoma and metastatic malignant neoplasms in the iris. C4554 Neoplastic Process Malignant Iris Neoplasm C0346372 Malignant Malignant_Iris_Neoplasm Malignant Iris Neoplasm Malignant Iris Tumor Malignant Neoplasm of Iris Malignant Neoplasm of the Iris Malignant Tumor of Iris Malignant Tumor of the Iris Malignant Iris Neoplasm A rare, aggressive, poorly differentiated, non-small cell lung carcinoma characterized by the presence of a sarcomatoid component often associated with giant cell differentiation. There is a male to female ratio of 4:1. Clinical symptoms include cough, hemoptysis, chest pain, progressive dyspnea and fever secondary to recurrent pneumonia. Cigarette smoking is a major risk factor. C45540 Neoplastic Process Lung Sarcomatoid Carcinoma C1708781 Cellosaurus Malignant Lung_Sarcomatoid_Carcinoma Lung Sarcomatoid Carcinoma Lung Sarcomatoid Carcinoma A morphologic variant of sarcomatoid carcinoma characterized by the presence of malignant spindle cells and focal lymphoplasmacytic infiltrates. Adenocarcinoma cells, malignant squamous cells, and giant cells are not present. C45541 Neoplastic Process Lung Spindle Cell Carcinoma Lung Spindle Cell Carcinoma C1708784 CTRP Malignant Lung_Spindle_Cell_Carcinoma Lung Spindle Cell Carcinoma Lung Spindle Cell Carcinoma A morphologic variant of sarcomatoid carcinoma characterized by the presence of malignant glandular or squamous cells associated with malignant giant and spindle cells. C45542 Neoplastic Process Lung Pleomorphic Carcinoma C1711397 Cellosaurus Malignant Lung_Pleomorphic_Carcinoma Lung Pleomorphic Carcinoma Lung Pleomorphic Carcinoma A morphologic variant of lung sarcomatoid carcinoma composed of a mixture of non-small cell lung carcinoma and a sarcomatous component. C45543 Neoplastic Process Lung Carcinosarcoma C1711276 Cellosaurus Malignant Lung_Carcinosarcoma Lung Carcinosarcoma Pulmonary Carcinosarcoma Lung Carcinosarcoma A lung carcinoma characterized by the presence of malignant non-keratinizing squamoid cells, mucin-producing cells and intermediate type cells. C45544 Neoplastic Process Lung Mucoepidermoid Carcinoma Lung Mucoepidermoid Carcinoma C1708778 CTRP Cellosaurus Malignant Lung_Mucoepidermoid_Carcinoma Lung Mucoepidermoid Cancer Lung Mucoepidermoid Carcinoma Lung Mucoepidermoid Carcinoma A lung carcinoma arising within the bronchi or bronchial tubes. It is characterized by the presence of myoepithelial cells, spindle cells, clear cells, and duct-forming epithelial cells. Surgical resection may be curative. C45545 Neoplastic Process Lung Epithelial-Myoepithelial Carcinoma Lung Epithelial-Myoepithelial Carcinoma C1708770 CTRP Malignant Lung_Epithelial-Myoepithelial_Carcinoma Lung Epithelial-Myoepithelial Cancer Lung Epithelial-Myoepithelial Carcinoma Lung Epithelial-Myoepithelial Carcinoma A neoplasm that arises from the iris and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4555 Neoplastic Process Benign Iris Neoplasm C0346374 Benign Benign_Iris_Neoplasm Benign Iris Neoplasm Benign Iris Tumor Benign Neoplasm of Iris Benign Neoplasm of the Iris Benign Tumor of Iris Benign Tumor of the Iris Benign Iris Neoplasm A neuroendocrine tumor of the lung characterized by the absence of necrosis and the presence of less than 2 mitoses per 10 high power fields. C45550 Neoplastic Process Lung Neuroendocrine Tumor G1 C1708788 Cellosaurus Undetermined Lung_Typical_Carcinoid_Tumor Lung NET G1 Lung NET Grade 1 Lung NET, Grade 1 Lung Neuroendocrine Tumor G1 Lung Neuroendocrine Tumor Grade 1 Lung Neuroendocrine Tumor, Grade 1 Lung Typical Carcinoid Tumor Lung Neuroendocrine Tumor G1 A neuroendocrine tumor of the lung showing focal necrotic changes or a number of mitotic figures between 2 and 10/10 high power fields. C45551 Neoplastic Process Lung Neuroendocrine Tumor G2 C1708766 CPTAC mCode 8249/3 Undetermined Lung_Atypical_Carcinoid_Tumor Malignant carcinoid tumor of the bronchus and lung Lung Atypical Carcinoid Tumor Lung NET G2 Lung NET Grade 2 Lung NET, Grade 2 Lung Neuroendocrine Tumor G2 Lung Neuroendocrine Tumor Grade 2 Lung Neuroendocrine Tumor, Grade 2 Malignant carcinoid tumor of the bronchus and lung Lung Neuroendocrine Tumor G2 A benign nevus that arises from the iris. Only a small percentage of cases progress to iris melanoma. C4556 Neoplastic Process Iris Nevus C0346376 Benign Iris_Nevus Iris Nevus Nevus of Iris Nevus of the Iris Iris Nevus A high grade malignant neoplasm that arises from the lung and is characterized by the presence of malignant neuroendocrine cells. This category includes small cell lung carcinoma, large cell lung neuroendocrine carcinoma, and combined lung carcinoma. C45569 Neoplastic Process Lung Neuroendocrine Carcinoma C1708364 Malignant High_Grade_Lung_Neuroendocrine_Neoplasm High Grade Lung Neuroendocrine Neoplasm Lung Neuroendocrine Carcinoma Lung Neuroendocrine Carcinoma A rare, unilateral, malignant embryonal neoplasm typically presenting as a ciliary body mass during childhood. It arises from primitive medullary epithelium. C4557 Neoplastic Process Malignant Ciliary Body Medulloepithelioma Ciliary Body Malignant Medulloepithelioma C0346378 CTRP Malignant Ciliary_Body_Medulloepithelioma Ciliary Body Malignant Medulloepithelioma Malignant Ciliary Body Medulloepithelioma Malignant Medulloepithelioma of Ciliary Body Malignant Medulloepithelioma of the Ciliary Body Ciliary Body Malignant Medulloepithelioma A papillary neoplasm that arises endobronchially. It is characterized by the presence of a delicate fibrovascular core lined by stratified squamous epithelium. Squamous cell papillomas can be solitary or multiple. Patients usually present with signs and symptoms of bronchial obstruction. Because of the possibility of recurrence and reported cases of squamous cell carcinomas arising at the excision site of squamous cell papillomas, complete excision is indicated. C45573 Neoplastic Process Lung Squamous Papilloma C1708785 Benign Lung_Squamous_Papilloma Bronchial Squamous Cell Papilloma Lung Squamous Cell Papilloma Lung Squamous Papilloma Lung Squamous Papilloma A rare uveal melanoma that arises from the ciliary body. Patients may present with blurred vision, visual field loss, floaters, and ocular pain. The prognosis is usually poor. C4558 Neoplastic Process Ciliary Body Melanoma C0346379 Malignant Ciliary_Body_Melanoma Ciliary Body Malignant Melanoma Ciliary Body Melanoma Malignant Melanoma of Ciliary Body Malignant Melanoma of the Ciliary Body Melanoma of Ciliary Body Melanoma of the Ciliary Body Ciliary Body Melanoma A well-circumscribed benign smooth muscle neoplasm arising from the ciliary body of the eye. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C4560 Neoplastic Process Ciliary Body Leiomyoma C0346386 Benign Ciliary_Body_Leiomyoma Ciliary Body Leiomyoma Leiomyoma of Ciliary Body Leiomyoma of the Ciliary Body Ciliary Body Leiomyoma A benign papillary neoplasm that arises endobronchially. It is characterized by the presence of fibrovascular cores lined by columnar, cuboidal, and goblet cells. Patients usually present with signs and symptoms of bronchial obstruction. Complete resection is curative. C45601 Neoplastic Process Bronchial Glandular Papilloma C1708772 Benign Lung_Glandular_Papilloma Bronchial Glandular Papilloma Lung Glandular Papilloma Bronchial Glandular Papilloma An exceedingly rare benign endobronchial neoplasm characterized by the presence of fibrovascular cores which are lined by both squamous and glandular epithelium. Patients present with obstructive symptoms. Complete resection is curative. C45602 Neoplastic Process Bronchial Mixed Squamous Cell and Glandular Papilloma C1314684 GDC 8560/0 Benign Lung_Mixed_Squamous_and_Glandular_Papilloma 8560/0 Mixed squamous cell and glandular papilloma Bronchial Mixed Squamous Cell and Glandular Papilloma Lung Mixed Squamous Cell and Glandular Papilloma Lung Mixed Squamous and Glandular Papilloma Mixed squamous cell and glandular papilloma Bronchial Mixed Squamous Cell and Glandular Papilloma A very rare, well circumscribed, benign epithelial neoplasm that arises from the bronchus. It is characterized by the presence of epithelial cells, myoepithelial cells, and fibromyxoid stroma. C45603 Neoplastic Process Lung Pleomorphic Adenoma C1708780 Benign Lung_Pleomorphic_Adenoma Lung Pleomorphic Adenoma Lung Pleomorphic Adenoma A very rare, well circumscribed, benign cystic neoplasm that arises from the lung. It is characterized by the presence of cysts which are lined by tall mucinous epithelium and filled with mucin. C45604 Neoplastic Process Lung Mucinous Cystadenoma C1708777 Benign Lung_Mucinous_Cystadenoma Lung Mucinous Cystadenoma Lung Mucinous Cystadenoma A diffuse large B-cell lymphoma that is localized to the lungs at the time of presentation. Signs and symptoms include cough, dyspnea, and hemoptysis. C45605 Neoplastic Process Lung Diffuse Large B-Cell Lymphoma C1709666 Malignant Primary_Pulmonary_Diffuse_Large_B-Cell_Lymphoma High Grade MALT Lymphoma of the Lung Lung Diffuse Large B-Cell Lymphoma Primary Lung Diffuse Large B-Cell Lymphoma Primary Pulmonary Diffuse Large B-Cell Lymphoma Pulmonary Diffuse Large B-Cell Lymphoma Lung Diffuse Large B-Cell Lymphoma A rare lymphoproliferative disorder that affects the lungs. It is characterized by the presence of an angiocentric and angiodestructive polymorphic cellular infiltrate composed of EBV-positive neoplastic B-lymphocytes and reactive T-lymphocytes. The majority of patients present with bilateral nodular lesions in the lungs. The prognosis depends on the histologic grade of the lesions. One third of patients with grade 1 lesions and two thirds of patients with grade 2 lesions progress to non-Hodgkin lymphoma. Grade 3 lesions, by definition, are classified as non-Hodgkin lymphomas. C45607 Neoplastic Process Pulmonary Lymphomatoid Granulomatosis C1260886 Uncertain Malignant Potential Pulmonary_Lymphomatoid_Granulomatosis Lung Lymphomatoid Granulomatosis Pulmonary Lymphomatoid Granulomatosis Pulmonary Lymphomatoid Granulomatosis A uveal melanoma that arises from the choroid. It is the most common primary malignant intraocular tumor. It usually affects Caucasians of northern European descent. It usually remains asymptomatic for a long period. When signs and symptoms occur, they include blurred vision, visual field loss, floaters, and ocular pain. Tumor size is the most important factor that relates to prognosis. C4561 Neoplastic Process Choroid Melanoma C0346388 Malignant Choroid_Melanoma Choroid Malignant Melanoma Choroid Melanoma Choroidal Melanoma Malignant Melanoma of Choroid Malignant Melanoma of the Choroid Melanoma of Choroid Melanoma of the Choroid Choroid Melanoma A benign, intermediate, or malignant mesenchymal neoplasm that arises from the lung. C45612 Neoplastic Process Lung Soft Tissue Neoplasm C1708783 Undetermined Lung_Soft_Tissue_Neoplasm Lung Soft Tissue Neoplasm Lung Soft Tissue Neoplasm A hemangioma arising from the choroid. C4562 Neoplastic Process Choroid Hemangioma C0346390 Benign Choroid_Hemangioma Angioma of Choroid Angioma of the Choroid Benign Angioma of Choroid Benign Angioma of the Choroid Benign Choroid Angioma Benign Choroid Hemangioma Benign Hemangioma of Choroid Benign Hemangioma of the Choroid Choroid Angioma Choroid Hemangioma Hemangioma of Choroid Hemangioma of the Choroid Hemangioma, Choroid, Benign Choroid Hemangioma A primary or metastatic malignant neoplasm that affects the lung and pleura. C45625 Neoplastic Process Malignant Lung and Pleural Neoplasm C1708889 Malignant Malignant_Lung_and_Pleural_Neoplasm Malignant Lung and Pleural Neoplasm Malignant Lung and Pleural Neoplasm A pleuropulmonary blastoma composed of malignant small cells. Sarcomatous features are absent. C45626 Neoplastic Process Type I Pleuropulmonary Blastoma CL497419 NICHD A pleuropulmonary blastoma comprising malignant small cells in a cystic pattern. Malignant Type_I_Pleuropulmonary_Blastoma Type I Pleuropulmonary Blastoma Type I Pleuropulmonary Blastoma A pleuropulmonary blastoma composed of malignant small cells and characterized by the presence of a sarcomatous component. It usually follows an aggressive clinical course. C45627 Neoplastic Process Type II Pleuropulmonary Blastoma CL497418 NICHD A pleuropulmonary blastoma comprising malignant small cells in a cystic and solid pattern. Malignant Type_II_Pleuropulmonary_Blastoma Type II Pleuropulmonary Blastoma Type II Pleuropulmonary Blastoma A pleuropulmonary blastoma characterized by a solid pattern and sarcomatous features. It usually follows an aggressive clinical course. C45628 Neoplastic Process Type III Pleuropulmonary Blastoma CL497417 NICHD A pleuropulmonary blastoma comprising malignant small cells in a solid pattern. Malignant Type_III_Pleuropulmonary_Blastoma Type III Pleuropulmonary Blastoma Type III Pleuropulmonary Blastoma A benign neoplasm composed of hyaline cartilage arising from the lung. It is characterized by the presence of chondrocytes, a lobulated growth pattern, and calcification. C45629 Neoplastic Process Lung Chondroma C3203483 Benign Lung_Chondroma Lung Chondroma Pulmonary Chondroma Lung Chondroma A rare myeloproliferative neoplasm characterized by a clonal proliferation of eosinophilic precursors resulting in persistently increased numbers of eosinophils in the blood, marrow and peripheral tissues. Since acute eosinophilic leukemia is at best exceedingly rare, the term eosinophilic leukemia is normally used as a synonym for chronic eosinophilic leukemia. In cases in which it is impossible to prove clonality and there is no increase in blast cells, the diagnosis of "idiopathic hypereosinophilic syndrome" is preferred. (WHO, 2001) C4563 Neoplastic Process Chronic Eosinophilic Leukemia Chronic Eosinophilic Leukemia, Not Otherwise Specified C0346421 CTEP CTRP Cellosaurus GDC A disease in which too many eosinophils (a type of white blood cell) are found in the bone marrow, blood, and other tissues. Chronic eosinophilic leukemia may stay the same for many years, or it may progress quickly to acute leukemia. 9964/3 Malignant Chronic_Eosinophilic_Leukemia 9860/3 9964/3 Chronic eosinophilic leukemia Chronic eosinophilic leukemia, NOS Eosinophilic leukemia CEL CEL, NOS CEL/Hypereosinophilic syndrome Chronic Eosinophilic Leukemia Chronic Eosinophilic Leukemia, NOS Chronic Eosinophilic Leukemia, Not Otherwise Specified Chronic eosinophilic leukemia, NOS Chronic eosinophilic leukemia/hypereosinophilic syndrome Eosinophilic Leukemia Eosinophilic leukemia chronic eosinophilic leukemia Chronic Eosinophilic Leukemia, Not Otherwise Specified Lymphangiomatosis diffusely involving the lung parenchyma. C45630 Neoplastic Process Diffuse Pulmonary Lymphangiomatosis C1707744 Undetermined Diffuse_Pulmonary_Lymphangiomatosis Diffuse Pulmonary Lymphangiomatosis Diffuse Pulmonary Lymphangiomatosis A synovial sarcoma arising from the lungs. C45631 Neoplastic Process Lung Synovial Sarcoma C1708786 Malignant Lung_Synovial_Sarcoma Lung Synovial Sarcoma Lung Synovial Sarcoma A biphasic synovial sarcoma arising from the lungs. C45632 Neoplastic Process Lung Biphasic Synovial Sarcoma C1708767 Malignant Lung_Biphasic_Synovial_Sarcoma Lung Biphasic Synovial Sarcoma Lung Biphasic Synovial Sarcoma A monophasic synovial sarcoma arising from the lungs. C45633 Neoplastic Process Lung Monophasic Synovial Sarcoma C1708775 Malignant Lung_Monophasic_Synovial_Sarcoma Lung Monophasic Synovial Sarcoma Lung Monophasic Synovial Sarcoma A germ cell tumor that arises from the lung. C45636 Neoplastic Process Lung Germ Cell Tumor C1708771 Undetermined Lung_Germ_Cell_Neoplasm Lung Germ Cell Neoplasm Lung Germ Cell Tumor Lung Germ Cell Tumor A teratoma that arises from the lung. C45637 Neoplastic Process Lung Teratoma C0345965 Undetermined Lung_Teratoma Lung Teratoma Lung Teratoma An epithelial neoplasm that arises from ectopic thymic tissue in the lung. Histologically it is identical to the thymomas that arise from the mediastinum. Signs and symptoms include cough, dyspnea, fever, and weight loss. Surgical excision is the recommended treatment. C45638 Neoplastic Process Intrapulmonary Thymoma C1708557 Undetermined Intrapulmonary_Thymoma Intrapulmonary Thymoma Intrapulmonary Thymoma An invasive or non-invasive thymoma that arises from the mediastinum. Thymomas are the most common anterior mediastinal tumors. C45639 Neoplastic Process Mediastinal Thymoma C1708961 Undetermined Mediastinal_Thymoma Mediastinal Thymoma Mediastinal Thymoma A malignant vascular neoplasm arising from the spleen. C4564 Neoplastic Process Splenic Angiosarcoma C0346424 Malignant Splenic_Angiosarcoma Angiosarcoma of Spleen Angiosarcoma of the Spleen Hemangiosarcoma of Spleen Hemangiosarcoma of the Spleen Splenic Angiosarcoma Splenic Hemangiosarcoma Splenic Angiosarcoma A neoplasm that arises from any of the organs in the thoracic cavity and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4565 Neoplastic Process Benign Thoracic Neoplasm C0346440 Benign Benign_Thoracic_Neoplasm Benign Neoplasm of Thorax Benign Neoplasm of the Thorax Benign Thoracic Neoplasm Benign Thoracic Tumor Benign Tumor of Thorax Benign Tumor of the Thorax Benign Thoracic Neoplasm A rare malignant neoplasm that derives from melanocytes and arises from the lung in a patient with no history of previous melanoma and no evidence of melanoma in another site at the time of diagnosis. It usually presents as a solitary lesion and the prognosis is poor. C45652 Neoplastic Process Lung Melanoma C1708773 Malignant Lung_Melanoma Lung Melanoma Lung Melanoma A malignant neoplasm that arises from the hilar region of the lung. C4566 Neoplastic Process Malignant Lung Hilum Neoplasm C2607931 Malignant Malignant_Lung_Hilum_Neoplasm Malignant Hilar Lung Neoplasm Malignant Hilar Lung Tumor Malignant Lung Hilum Neoplasm Malignant Lung Hilum Tumor Malignant Neoplasm of Lung Hilum Malignant Neoplasm of the Lung Hilum Malignant Tumor of Lung Hilum Malignant Tumor of the Lung Hilum Malignant Lung Hilum Neoplasm A rare, non-invasive, localized or multifocal mesothelial neoplasm that arises from the pleura. It is characterized by the presence of papillae with myxoid fibrovascular cores, lined by a single layer of mesothelial cells. The clinical course is usually indolent. C45660 Neoplastic Process Pleural Well Differentiated Papillary Mesothelial Tumor C1709580 Undetermined Pleural_Well_Differentiated_Papillary_Mesothelioma Well differentiated papillary mesothelioma of pleura Pleural WDPM Pleural WDPMT Pleural Well Differentiated Papillary Mesothelial Tumor Pleural Well-Differentiated Papillary Mesothelial Tumor Pleural Well Differentiated Papillary Mesothelial Tumor A localized or multifocal mesothelial neoplasm arising from the peritoneum. It predominantly occurs in women. It is characterized by the formation of papillae, covered by a single layer of blunt mesothelial cells. Mitotic figures are not present. There is no evidence of severe cytologic atypia. It has a relatively favorable clinical outcome, compared to diffuse malignant mesothelioma. C45661 Neoplastic Process Peritoneal Well Differentiated Papillary Mesothelial Tumor C1709507 Undetermined Peritoneal_Well_Differentiated_Papillary_Mesothelioma Peritoneal WDPM Peritoneal WDPMT Peritoneal Well Differentiated Papillary Mesothelial Tumor Peritoneal Well-Differentiated Papillary Mesothelial Tumor Peritoneal Well Differentiated Papillary Mesothelial Tumor Malignant mesothelioma that arises from the pleura. It is characterized by the presence of cells with epithelioid morphology. The epithelioid cells usually have eosinophilic cytoplasm, bland nuclei, and form tubulopapillary, microglandular, or sheet-like patterns. C45662 Neoplastic Process Pleural Epithelioid Mesothelioma Pleural Epithelioid Mesothelioma C1709574 CTRP Cellosaurus Malignant Pleural_Epithelioid_Mesothelioma Pleural Epithelioid Mesothelioma Pleural Epithelioid Mesothelioma Malignant mesothelioma that arises from the pleura. It is characterized by the presence of spindle cells. Anaplastic morphologic features and multinucleated malignant cells may also be seen. C45663 Neoplastic Process Pleural Sarcomatoid Mesothelioma Pleural Sarcomatoid Mesothelioma C1709578 CTRP Cellosaurus Malignant Pleural_Sarcomatoid_Mesothelioma Pleural Sarcomatoid Mesothelioma Pleural Sarcomatoid Mesothelioma Malignant mesothelioma that arises from the pleura. It is characterized by the presence of dense collagenized stroma occupying at least 50% of the tumor. The malignant cells are arranged in a vague storiform pattern. C45664 Neoplastic Process Pleural Desmoplastic Mesothelioma C1709572 Cellosaurus Malignant Pleural_Desmoplastic_Mesothelioma Pleural Desmoplastic Mesothelioma Pleural Desmoplastic Mesothelioma Malignant mesothelioma that arises from the pleura. It is characterized by the presence of epithelioid and sarcomatoid components, with each component representing at least 10% of the tumor. C45665 Neoplastic Process Pleural Biphasic Mesothelioma Pleural Biphasic Mesothelioma C1709570 CTRP Cellosaurus Malignant Pleural_Biphasic_Mesothelioma Pleural Biphasic Mesothelioma Pleural Biphasic Mesothelioma A mesothelioma that arises from the pleura with the gross appearance of a circumscribed lesion and the microscopic appearance of diffuse malignant mesothelioma, without evidence of diffuse spread. C45666 Neoplastic Process Localized Pleural Malignant Mesothelioma C0854890 Malignant Localized_Pleural_Malignant_Mesothelioma Localized Pleural Malignant Mesothelioma Localized Pleural Malignant Mesothelioma A primary or metastatic malignant neoplasm that affects the pericardium. C4567 Neoplastic Process Malignant Pericardial Neoplasm C0346609 Malignant Malignant_Pericardial_Neoplasm Malignant Neoplasm of Pericardium Malignant Neoplasm of the Pericardium Malignant Pericardial Neoplasm Malignant Pericardial Tumor Malignant Tumor of Pericardium Malignant Tumor of the Pericardium Malignant Pericardial Neoplasm A malignant neoplasm that affects the inner layer of the pericardium. C4568 Neoplastic Process Malignant Epicardial Neoplasm C2607932 Malignant Malignant_Epicardial_Neoplasm Malignant Epicardial Neoplasm Malignant Epicardial Tumor Malignant Neoplasm of Epicardium Malignant Neoplasm of the Epicardium Malignant Tumor of Epicardium Malignant Tumor of the Epicardium Malignant Epicardial Neoplasm A rare extranodal lymphoma that arises from the pleura with no evidence of involvement of other sites at the time of diagnosis. This category includes primary effusion lymphoma and pyothorax-associated lymphoma. C45687 Neoplastic Process Pleural Lymphoma C1709575 Malignant Pleural_Lymphoma Pleural Lymphoma Primary Pleural Lymphoma Pleural Lymphoma A primary or metastatic malignant neoplasm that affects the myocardium. C4569 Neoplastic Process Malignant Myocardial Neoplasm C0346611 Malignant Malignant_Myocardial_Neoplasm Malignant Myocardial Neoplasm Malignant Myocardial Tumor Malignant Neoplasm of Myocardium Malignant Neoplasm of the Myocardium Malignant Tumor of Myocardium Malignant Tumor of the Myocardium Malignant Myocardial Neoplasm An aggressive diffuse large B-cell lymphoma arising in the pleural cavity of patients with a history of long standing pyothorax. Patients present with chest and back pain, fever, productive cough, dyspnea, and hemoptysis. C45691 Neoplastic Process Pyothorax-Associated Lymphoma C1709781 Cellosaurus Malignant Pyothorax-Associated_Lymphoma PAL Pleural Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation Pyothorax-Associated Lymphoma Pyothorax-Associated Lymphoma A low-grade malignant blood vessel neoplasm arising from the pleura. It is characterized by the presence of epithelioid endothelial cells. The neoplastic cells are arranged in cords and nests, which are embedded in a myxoid to hyalinized stroma. C45695 Neoplastic Process Pleural Epithelioid Hemangioendothelioma C1709573 Malignant Pleural_Epithelioid_Hemangioendothelioma Pleural Epithelioid Hemangioendothelioma Pleural Epithelioid Hemangioendothelioma A synovial sarcoma arising in the pleural cavity. C45696 Neoplastic Process Pleural Synovial Sarcoma Pleural Synovial Sarcoma C1709579 CTRP Malignant Pleural_Synovial_Sarcoma Pleural Synovial Sarcoma Pleural Synovial Sarcoma A monophasic synovial sarcoma arising in the pleural cavity. C45697 Neoplastic Process Pleural Monophasic Synovial Sarcoma C1709577 Malignant Pleural_Monophasic_Synovial_Sarcoma Pleural Monophasic Synovial Sarcoma Pleural Monophasic Synovial Sarcoma A biphasic synovial sarcoma arising in the pleural cavity. C45698 Neoplastic Process Pleural Biphasic Synovial Sarcoma C1709571 Malignant Pleural_Biphasic_Synovial_Sarcoma Pleural Biphasic Synovial Sarcoma Pleural Biphasic Synovial Sarcoma A thymoma that focally infiltrates the surrounding capsule and invades the mediastinal fat. This type of thymoma is usually recognized only after microscopic examination. Grossly, it appears indistinguishable from encapsulated thymoma. C45699 Neoplastic Process Minimally Invasive Thymoma C1709035 Malignant Minimally_Invasive_Thymoma Minimally Invasive Thymoma Minimally Invasive Thymoma A malignant neoplasm that affects the endocardium. C4570 Neoplastic Process Malignant Endocardial Neoplasm C0346612 Malignant Malignant_Endocardial_Neoplasm Malignant Endocardial Neoplasm Malignant Endocardial Tumor Malignant Neoplasm of Endocardium Malignant Neoplasm of the Endocardium Malignant Tumor of Endocardium Malignant Tumor of the Endocardium Malignant Endocardial Neoplasm A thymoma that spreads by direct extension into adjacent tissues (lung, pericardium, or large vessels). This type of thymoma usually appears invasive at the time of excision. C45700 Neoplastic Process Widely Invasive Thymoma C1710673 Malignant Widely_Invasive_Thymoma Widely Invasive Thymoma Widely Invasive Thymoma A rare type of thymoma characterized by the presence of multiple, well formed epithelial nodules separated by a lymphocytic stroma that usually contains germinal centers. Reported cases have not been associated with recurrences or metastases. C45706 Neoplastic Process Micronodular Thymoma with Lymphoid Stroma C1709024 Undetermined Micronodular_Thymoma Micronodular thymoma with lymphoid stroma Micronodular Thymoma Micronodular Thymoma with Lymphoid B-Cell Hyperplasia Micronodular Thymoma with Lymphoid Stroma Micronodular Thymoma with Lymphoid Stroma A rare type of well circumscribed or encapsulated thymoma with a biphasic architecture, consisting of epithelial cell islands and bundles of spindle cells. The vast majority of reported cases had a benign clinical course. C45707 Neoplastic Process Metaplastic Thymoma C1708993 Undetermined Metaplastic_Thymoma Biphasic Thymoma Low Grade Thymic Metaplastic Carcinoma Metaplastic Thymoma Mixed Polygonal and Spindle Cell Type Thymoma Thymoma with Pseudosarcomatous Stroma Metaplastic Thymoma A rare type of thymoma, composed of multifocal epithelial proliferations less than 1 mm in diameter. This type of thymoma usually occurs in myasthenia gravis patients without any macroscopic (gross) evidence of tumor. C45708 Neoplastic Process Microscopic Thymoma C1709028 Undetermined Microscopic_Thymoma Microscopic thymoma Microscopic Thymoma Nodular Hyperplasia of the Thymic Epithelium Microscopic Thymoma A rare type of thymoma, characterized by an exuberant amount of collagen-rich stroma. C45709 Neoplastic Process Sclerosing Thymoma C1710027 Undetermined Sclerosing_Thymoma Ancient Thymoma Sclerosing Thymoma Sclerosing Thymoma A primary or metastatic malignant neoplasm that affects the lung parenchyma, bronchial tree, or trachea. Representative examples include lung carcinoma, carcinoid tumor, lung lymphoma, lung sarcoma, and tracheal carcinoma. C4571 Neoplastic Process Malignant Respiratory System Neoplasm Malignant Respiratory System Neoplasm C0346616 CPTAC CTRP mCode Malignant Malignant_Respiratory_Tract_Neoplasm Malignant neoplasm of bronchus and lung Malignant neoplasm of bronchus and lung, unspecified Malignant neoplasm of ill-defined sites within the respiratory system Malignant neoplasm of left main bronchus Malignant neoplasm of lower lobe, bronchus or lung Malignant neoplasm of lower lobe, left bronchus or lung Malignant neoplasm of lower lobe, right bronchus or lung Malignant neoplasm of lower lobe, unspecified bronchus or lung Malignant neoplasm of main bronchus Malignant neoplasm of middle lobe, bronchus or lung Malignant neoplasm of other parts of bronchus or lung Malignant neoplasm of overlapping sites of right bronchus and lung Malignant neoplasm of overlapping sites of unspecified bronchus and lung Malignant neoplasm of right main bronchus Malignant neoplasm of trachea, bronchus, and lung Malignant neoplasm of unspecified main bronchus Malignant neoplasm of unspecified part of left bronchus or lung Malignant neoplasm of unspecified part of right bronchus or lung Malignant neoplasm of unspecified part of unspecified bronchus or lung Malignant neoplasm of upper lobe, bronchus or lung Malignant neoplasm of upper lobe, left bronchus or lung Malignant neoplasm of upper lobe, right bronchus or lung Malignant neoplasm of upper lobe, unspecified bronchus or lung Malignant neoplasm of upper respiratory tract, part unspecified Malignant neoplasm: Bronchus or lung, unspecified Malignant neoplasm: Lower lobe, bronchus or lung Malignant neoplasm: Main bronchus Malignant neoplasm: Middle lobe, bronchus or lung Malignant neoplasm: Overlapping lesion of bronchus and lung Malignant neoplasm: Upper lobe, bronchus or lung Malignant neoplasm: Upper respiratory tract, part unspecified Malignant Respiratory System Neoplasm Malignant Respiratory Tract Neoplasm Malignant neoplasm of unspecified part of unspecified bronchus or lung Malignant Respiratory System Neoplasm A benign thymic tumor morphologically resembling fibroadenoma of the breast. C45710 Disease or Syndrome Thymus Lipofibroadenoma C1710400 Benign Thymic_Lipofibroadenoma Thymic Lipofibroadenoma Thymus Lipofibroadenoma Thymus Lipofibroadenoma A primary thymic neuroendocrine tumor characterized by a high mitotic rate, often associated with the presence of necrosis and nuclear pleomorphism. This type of neuroendocrine tumor has a more aggressive clinical course, compared to grade 1 neuroendocrine tumors. C45719 Neoplastic Process Thymic Neuroendocrine Tumor G2 C1710396 mCode Undetermined Thymic_Atypical_Carcinoid_Tumor Malignant carcinoid tumor of the thymus Thymic Atypical Carcinoid Tumor Thymic Neuroendocrine Tumor G2 Thymic Neuroendocrine Tumor Grade 2 Thymic Neuroendocrine Tumor G2 A primary or metastatic malignant neoplasm involving the small intestine, large intestine, or both. Representative examples are carcinomas, lymphomas, and sarcomas. C4572 Neoplastic Process Malignant Intestinal Neoplasm C0346627 CPTAC mCode Malignant Malignant_Intestinal_Neoplasm Malignant neoplasm of intestinal tract, part unspecified Bowel Cancer Cancer of Intestine Cancer of the Intestine Intestinal Cancer Intestinal Neoplasms, Malignant Intestinal Tumors, Malignant Malignant Intestinal Neoplasm Malignant Intestinal Neoplasms Malignant Intestinal Tumor Malignant Intestinal Tumors Malignant Intestine Neoplasm Malignant Intestine Tumor Malignant Neoplasm of Intestine Malignant Neoplasm of the Intestine Malignant Tumor of Intestine Malignant Tumor of the Intestine Malignant neoplasm of intestinal tract, part unspecified Malignant Intestinal Neoplasm A primary thymic neuroendocrine tumor, characterized by the presence of uniform, polygonal neoplastic cells, a low mitotic rate, and absence of necrosis. C45720 Neoplastic Process Thymic Neuroendocrine Tumor G1 C1710403 Undetermined Thymic_Typical_Carcinoid_Tumor Thymic NET G1 Thymic Neuroendocrine Tumor G1 Thymic Neuroendocrine Tumor Grade 1 Thymic Typical Carcinoid Tumor Thymic Neuroendocrine Tumor G1 A primary thymic epithelial neoplasm, characterized by the presence of at least two distinct areas, one representing a thymoma and the other a carcinoma. The most aggressive component usually determines the clinical outcome. C45722 Neoplastic Process Combined Thymic Epithelial Neoplasm Combined Thymic Epithelial Neoplasm C1328043 CTRP Undetermined Combined_Thymic_Epithelial_Neoplasm Combined Thymic Carcinoma Combined Thymic Epithelial Neoplasm Combined Thymic Epithelial Tumor Composite Thymoma-Thymic Carcinoma Combined Thymic Epithelial Neoplasm A malignant neoplasm that arises from the skin appendages. C4573 Neoplastic Process Malignant Skin Appendage Neoplasm C0346770 Malignant Malignant_Skin_Appendage_Neoplasm Malignant Appendageal Neoplasm Malignant Appendageal Tumor Malignant Cutaneous Adnexal Neoplasm Malignant Skin Adnexal Neoplasm Malignant Skin Adnexal Tumor Malignant Skin Appendage Neoplasm Malignant Skin Appendageal Neoplasm Malignant Skin Appendageal Tumor Malignant Skin Appendage Neoplasm A rare extragonadal germ cell tumor that arises from the mediastinum and is associated with the presence of a somatic-type malignant component. The somatic malignancy is usually a sarcoma (e.g., embryonal rhabdomyosarcoma, angiosarcoma, or leiomyosarcoma), adenocarcinoma, squamous cell carcinoma, adenosquamous carcinoma, or primitive neuroectodermal tumor. The prognosis is poor. C45732 Neoplastic Process Mediastinal Germ Cell Tumor with Somatic-Type Malignancy C1708954 Malignant Mediastinal_Germ_Cell_Tumor_with_Somatic-Type_Malignancy Mediastinal Germ Cell Tumor with Somatic-Type Malignancy Mediastinal Germ Cell Tumor with Somatic-Type Malignancy An extragonadal non-seminomatous malignant germ cell tumor that arises from the mediastinum and is associated with a hematologic malignancy. The hematologic malignancies are clonally related to the malignant germ cell tumor and include acute leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, and mastocytosis. C45733 Neoplastic Process Malignant Mediastinal Germ Cell Tumor with Associated Hematologic Malignancy C1708955 GDC Malignant Mediastinal_Malignant_Germ_Cell_Tumor_with_Associated_Hematologic_Malignancy Germ cell tumor with associated hematological malignancy Germ cell tumors with associated hematological malignancy Germ Cell Tumor with Associated Hematological Malignancy Malignant Mediastinal Germ Cell Tumor with Associated Hematologic Malignancy Malignant Mediastinal Germ Cell Tumor with Associated Hematological Malignancy Malignant Mediastinal Germ Cell Tumor with Associated Hematologic Malignancy A precursor T-cell lymphoid neoplasm composed of small to medium-sized lymphoblasts that affects the mediastinum. C45738 Neoplastic Process Mediastinal T Lymphoblastic Leukemia/Lymphoma C1708959 Malignant Mediastinal_Precursor_T_Lymphoblastic_Leukemia_Lymphoma Mediastinal Precursor T-Lymphoblastic Lymphoma/Leukemia Mediastinal T Lymphoblastic Leukemia/Lymphoma Mediastinal T-Lymphoblastic Leukemia/Lymphoma Mediastinal T Lymphoblastic Leukemia/Lymphoma A precursor T-cell lymphoblastic leukemia that involves the mediastinum. It usually affects adolescent and young adult males. It is treated with aggressive chemotherapy and radiation. C45739 Neoplastic Process Mediastinal T Acute Lymphoblastic Leukemia C1711168 Malignant Mediastinal_Precursor_T-Lymphoblastic_Leukemia Mediastinal Precursor T-Lymphoblastic Leukemia Mediastinal T Acute Lymphoblastic Leukemia Mediastinal T-Acute Lymphoblastic Leukemia Mediastinal T-Cell Acute Lymphoblastic Leukemia Mediastinal T Acute Lymphoblastic Leukemia A primary or metastatic malignant neoplasm that affects the dermis. C4574 Neoplastic Process Malignant Dermal Neoplasm C0346811 Malignant Malignant_Dermal_Neoplasm Malignant Dermal Neoplasm Malignant Dermis Neoplasm Malignant Dermis Tumor Malignant Neoplasm of Dermis Malignant Neoplasm of the Dermis Malignant Tumor of Dermis Malignant Tumor of the Dermis Malignant Dermal Neoplasm A precursor T-lymphoblastic lymphoma that arises from the mediastinum. It usually presents with an anterior mediastinal mass and respiratory distress. It may present acutely with superior vena cava syndrome. It usually affects adolescent and young adult males. It is treated with aggressive chemotherapy and radiation. The prognosis is better in the pediatric patients. C45740 Neoplastic Process Mediastinal T Lymphoblastic Lymphoma C1708958 Malignant Mediastinal_Precursor_T-Lymphoblastic_Lymphoma Mediastinal Precursor T-Lymphoblastic Lymphoma Mediastinal T Lymphoblastic Lymphoma Mediastinal T-Lymphoblastic Lymphoma Primary Mediastinal Precursor T-Lymphoblastic Lymphoma Mediastinal T Lymphoblastic Lymphoma A mass-forming malignant neoplasm that arises from the mediastinum and is characterized by the proliferation of myeloblasts or immature myeloid cells. It may present in association with or precede acute myeloid leukemia, or it may be the first manifestation of relapse of acute myeloid leukemia. C45741 Neoplastic Process Mediastinal Myeloid Sarcoma C1708956 Malignant Mediastinal_Myeloid_Sarcoma Mediastinal Myeloid Sarcoma Mediastinal Myeloid Sarcoma An extra-adrenal parasympathetic paraganglioma that arises from paraganglia in the mediastinum. Clinical signs and symptoms include chest pain, cough, hoarseness, and dysphagia. C45743 Neoplastic Process Mediastinal Paraganglioma C1708957 Undetermined Mediastinal_Paraganglioma Mediastinal Paraganglioma Mediastinal Paraganglioma A localized neoplasm of probable fibroblastic derivation, that arises from the mediastinum. It is characterized by the presence of round to spindle-shaped cells, hylanized stroma formation, thin-walled branching blood vessels, and thin bands of collagen. C45744 Neoplastic Process Mediastinal Solitary Fibrous Tumor C1708960 Undetermined Mediastinal_Solitary_Fibrous_Tumor Mediastinal Solitary Fibrous Tumor Mediastinal Solitary Fibrous Tumor A rare cardiac rhabdomyoma occurring in adults. It is characterized by the presence of neoplastic striated muscle cells with eosinophilic granular cytoplasm and increased cellularity. C45747 Neoplastic Process Adult Cardiac Cellular Rhabdomyoma C1706729 GDC Benign Adult_Cardiac_Cellular_Rhabdomyoma 8904/0 Adult cellular rhabdomyoma Adult Cardiac Cellular Rhabdomyoma Adult Heart Cellular Rhabdomyoma Adult Cardiac Cellular Rhabdomyoma A cardiac myxoma arising from the ventricle. C45748 Neoplastic Process Ventricular Myxoma C1710629 Benign Ventricular_Myxoma Ventricular Myxoma Ventricular Myxoma A hemangioma arising from the heart. C45749 Neoplastic Process Cardiac Hemangioma C1707298 Benign Cardiac_Hemangioma Cardiac Hemangioma Heart Hemangioma Cardiac Hemangioma A hemangioma arising from the heart. It is characterized by the presence of cavernous vascular spaces. C45750 Neoplastic Process Cardiac Cavernous Hemangioma C1707296 Benign Cardiac_Cavernous_Hemangioma Cardiac Cavernous Hemangioma Heart Cavernous Hemangioma Cardiac Cavernous Hemangioma A capillary hemangioma arising from the heart. C45751 Neoplastic Process Cardiac Capillary Hemangioma C1711263 Benign Cardiac_Capillary_Hemangioma Cardiac Capillary Hemangioma Heart Capillary Hemangioma Cardiac Capillary Hemangioma A hemangioma arising from the myocardium. C45752 Neoplastic Process Cardiac Intramuscular Hemangioma C1707300 Benign Cardiac_Intramuscular_Hemangioma Cardiac Intramuscular Hemangioma Heart Intramuscular Hemangioma Cardiac Intramuscular Hemangioma An intermediate fibroblastic neoplasm arising from the heart. It is characterized by the presence of spindle-shaped fibroblasts and myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes, and plasma cells. C45753 Neoplastic Process Cardiac Inflammatory Myofibroblastic Tumor C1707299 Undetermined Cardiac_Inflammatory_Myofibroblastic_Tumor Cardiac Inflammatory Myofibroblastic Tumor Heart Inflammatory Myofibroblastic Tumor Cardiac Inflammatory Myofibroblastic Tumor A multicystic tumor arising in the inferior interatrial septum in the region of the atrioventricular node. The vast majority of patients present with complete heart block and a minority with partial heart block. Sudden death is reported in approximately 10% of the cases. It is a morphologically benign tumor composed of cuboidal, transitional, or squamoid cells. The cells may also show sebaceous differentiation and originate from the endoderm. C45754 Neoplastic Process Cystic Tumor of the Atrioventricular Node C1266075 GDC 8454/0 Benign Cystic_Tumor_of_Atrioventricular_Node 8454/0 Cystic tumor of atrio-ventricular node Benign Mesothelioma of Mahaim Cystic Tumor of Atrioventricular Node Cystic Tumor of the Atrioventricular Node Cystic tumor of atrio-ventricular node Endodermal Rest Intracardiac Endodermal Heterotopia Mesothelioma of Atrioventricular Node Tawarian Node Cystic Tumor of the Atrioventricular Node An undifferentiated pleomorphic sarcoma usually arising from the left atrium of the heart. It is characterized by the presence of fibrohistiocytic cells, giant cells, and spindle cells arrranged iin a storiform pattern. Clinical presentation includes signs and symptoms associated with left atrial hemodynamic changes. C45755 Neoplastic Process Cardiac Undifferentiated Pleomorphic Sarcoma C1704615 Malignant Cardiac_Malignant_Fibrous_Histiocytoma Cardiac Malignant Fibrous Histiocytoma Cardiac Unclassified Pleomorphic Sarcoma Cardiac Unclassified Pleomorphic Sarcoma (Formerly Cardiac "MFH") Cardiac Unclassified Pleomorphic Sarcoma (Formerly Cardiac "Malignant Fibrous Histiocytoma") Cardiac Undifferentiated Pleomorphic Sarcoma Heart Undifferentiated Pleomorphic Sarcoma Cardiac Undifferentiated Pleomorphic Sarcoma A synovial sarcoma arising from the heart. C45756 Neoplastic Process Cardiac Synovial Sarcoma C1707302 Malignant Cardiac_Synovial_Sarcoma Cardiac Synovial Sarcoma Heart Synovial Sarcoma Cardiac Synovial Sarcoma A biphasic synovial sarcoma arising from the heart. C45757 Neoplastic Process Cardiac Biphasic Synovial Sarcoma C1707293 Malignant Cardiac_Biphasic_Synovial_Sarcoma Cardiac Biphasic Synovial Sarcoma Heart Biphasic Synovial Sarcoma Cardiac Biphasic Synovial Sarcoma A monophasic synovial sarcoma arising from the heart. C45758 Neoplastic Process Cardiac Monophasic Synovial Sarcoma C1707301 Malignant Cardiac_Monophasic_Synovial_Sarcoma Cardiac Monophasic Synovial Sarcoma Heart Monophasic Synovial Sarcoma Cardiac Monophasic Synovial Sarcoma A rare malignant mesenchymal tumor with skeletal muscle differentiation arising within the myocardium. It is characterized by the presence of small round spindle cells. Most cardiac rhabodomyosarcomas are of embryonal type and usually present in children and young adults. C45759 Neoplastic Process Cardiac Rhabdomyosarcoma C1704616 Malignant Cardiac_Rhabdomyosarcoma Cardiac Rhabdomyosarcoma Heart Rhabdomyosarcoma Cardiac Rhabdomyosarcoma C4576 Neoplastic Process Malignant Thalamic Neoplasm C0346902 Malignant Malignant_Thalamic_Neoplasm Malignant Neoplasm of Thalamus Malignant Neoplasm of the Thalamus Malignant Thalamic Neoplasm Malignant Thalamic Neoplasms Malignant Thalamic Tumor Malignant Thalamic Tumors Malignant Thalamus Neoplasm Malignant Thalamus Neoplasms Malignant Thalamus Tumor Malignant Thalamus Tumors Malignant Tumor of Thalamus Malignant Tumor of the Thalamus Malignant Thalamic Neoplasm A rare benign or malignant germ cell tumor that arises from the pericardium. The reported cases have been teratomas and yolk sac tumors. C45761 Neoplastic Process Pericardial Germ Cell Tumor C1709503 Undetermined Pericardial_Germ_Cell_Tumor Pericardial Germ Cell Tumor Pericardial Germ Cell Tumor A malignant neoplasm that has spread to the pericardium from another primary anatomic site. C45762 Neoplastic Process Metastatic Malignant Neoplasm in the Pericardium C0685120 Malignant Metastatic_Neoplasm_to_the_Pericardium Metastatic Malignant Neoplasm in the Pericardium Metastatic Malignant Neoplasm to the Pericardium Metastatic Neoplasm to the Pericardium Metastatic Malignant Neoplasm in the Pericardium A malignant neoplasm involving the cerebrum. C4577 Neoplastic Process Malignant Cerebral Neoplasm Malignant Cerebral Neoplasm C0346903 CPTAC CTRP Malignant Malignant_Cerebral_Neoplasm Malignant neoplasm of cerebrum, except lobes and ventricles Malignant neoplasm of frontal lobe Malignant neoplasm of occipital lobe Malignant neoplasm of parietal lobe Malignant neoplasm of temporal lobe Malignant neoplasm of ventricles Malignant neoplasm: Cerebrum, except lobes and ventricles Malignant neoplasm: Frontal lobe Malignant neoplasm: Occipital lobe Malignant neoplasm: Parietal lobe Malignant neoplasm: Temporal lobe Cerebral Cancer Malignant Cerebral Hemispheric Neoplasm Malignant Cerebral Hemispheric Tumor Malignant Cerebral Neoplasm Malignant Cerebral Tumor Malignant Neoplasm of Cerebral Hemispheres Malignant Neoplasm of Cerebrum Malignant Neoplasm of the Cerebral Hemispheres Malignant Neoplasm of the Cerebrum Malignant Tumor of Cerebral Hemispheres Malignant Tumor of Cerebrum Malignant Tumor of the Cerebral Hemispheres Malignant Tumor of the Cerebrum Malignant Cerebral Neoplasm A Kaposi sarcoma arising from the conjunctiva. C4578 Neoplastic Process Conjunctival Kaposi Sarcoma Conjunctival Kaposi Sarcoma C0346935 CPTAC CTRP Malignant Conjunctival_Kaposi_s_Sarcoma Conjunctival Kaposi Sarcoma Conjunctival Kaposi's Sarcoma Kaposi's Sarcoma of Conjunctiva Kaposi's Sarcoma of the Conjunctiva Conjunctival Kaposi Sarcoma A Kaposi sarcoma arising from the cornea. C4579 Neoplastic Process Corneal Kaposi Sarcoma C0346936 Malignant Corneal_Kaposi_s_Sarcoma Corneal Kaposi Sarcoma Corneal Kaposi's Sarcoma Kaposi's Sarcoma of Cornea Kaposi's Sarcoma of the Cornea Corneal Kaposi Sarcoma A primary or metastatic malignant neoplasm that affects the structures of the chest wall. Representative examples include lymphoma and chondrosarcoma. C4580 Neoplastic Process Malignant Chest Wall Neoplasm C0346948 Malignant Malignant_Chest_Wall_Neoplasm Malignant Chest Wall Neoplasm Malignant Chest Wall Tumor Malignant Neoplasm of Chest Wall Malignant Neoplasm of the Chest Wall Malignant Tumor of Chest Wall Malignant Tumor of the Chest Wall Malignant Chest Wall Neoplasm The spread of a malignant neoplasm to the large intestine. This may be from a primary large intestine malignant neoplasm, or from a malignant neoplasm at a distant site. C4581 Neoplastic Process Metastatic Malignant Neoplasm in the Large Intestine C0346973 CPTAC mCode Malignant Metastatic_Neoplasm_to_the_Large_Intestine Secondary malignant neoplasm of large intestine and rectum Metastases to Large Intestine Metastasis to Large Bowel Metastasis to the Large Bowel Metastasis to the Large Intestine Metastatic Malignant Neoplasm in the Large Intestine Metastatic Malignant Neoplasm to the Large Intestine Metastatic Neoplasm to the Large Intestine Metastatic Tumor to the Large Intestine Secondary malignant neoplasm of large intestine and rectum Metastatic Malignant Neoplasm in the Large Intestine The spread of a malignant neoplasm from its original site of growth to the bone marrow. C4582 Neoplastic Process Metastatic Malignant Neoplasm in the Bone Marrow C0346979 mCode Cancer that has spread from the original (primary) tumor to the bone marrow. Malignant Metastatic_Neoplasm_to_the_Bone_Marrow Metastases to the Bone Marrow Metastasis to the Bone Marrow Metastatic Malignant Neoplasm in the Bone Marrow Metastatic Malignant Neoplasm to the Bone Marrow Metastatic Neoplasm to the Bone Marrow Metastatic Tumor to the Bone Marrow Secondary malignant neoplasm of bone marrow bone marrow metastasis Metastatic Malignant Neoplasm in the Bone Marrow The spread of a malignant neoplasm to the peritoneum from another primary anatomic site. C4583 Neoplastic Process Metastatic Malignant Neoplasm to the Peritoneum Metastatic Malignant Neoplasm in the Peritoneum C0346989 CTEP CTRP Malignant Metastatic_Neoplasm_to_the_Peritoneum Metastases to peritoneum, NOS Metastasis to the Peritoneum Metastatic Malignant Neoplasm in the Peritoneum Metastatic Malignant Neoplasm to the Peritoneum Metastatic Neoplasm to the Peritoneum Metastatic Malignant Neoplasm in the Peritoneum A non-functioning pancreatic neuroendocrine tumor measuring less than 0.5 cm in diameter. C45834 Neoplastic Process Pancreatic Neuroendocrine Microtumor C1709454 GDC 8150/0 Undetermined Pancreatic_Endocrine_Microadenoma Pancreatic endocrine tumor, benign Pancreatic microadenoma Pancreatic neuroendocrine microadenoma Pancreatic Endocrine Microadenoma Pancreatic Neuroendocrine Microadenoma Pancreatic Neuroendocrine Microtumor Pancreatic Neuroendocrine Microtumor A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the pancreas. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3-20%. C45835 Neoplastic Process Pancreatic Neuroendocrine Tumor G2 C1710668 Cellosaurus Undetermined Well_Differentiated_Pancreatic_Endocrine_Carcinoma Pancreatic NET G2 Pancreatic Neuroendocrine Tumor G2 Well Differentiated Pancreatic Endocrine Carcinoma Well Differentiated Pancreatic Neuroendocrine Carcinoma Pancreatic Neuroendocrine Tumor G2 A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the pancreas. It is characterized by the absence of a hormone-related clinical syndrome. C45837 Neoplastic Process Non-Functioning Pancreatic Neuroendocrine Tumor Non-Functioning Pancreatic Neuroendocrine Tumor C3839703 CTRP GDC 8150/3 Undetermined Non-Functioning_Well_Differentiated_Pancreatic_Endocrine_Neoplasm Pancreatic endocrine tumor, nonfunctioning Pancreatic neuroendocrine tumor, nonfunctioning Inactive Pancreatic Endocrine Tumor NF-PanNET Non-Functional Pancreatic Neuroendocrine Tumor Non-Functioning Pancreatic Endocrine Tumor Non-Functioning Pancreatic NET Non-Functioning Pancreatic Neuroendocrine Tumor Non-Functioning Well Differentiated Pancreatic Endocrine Tumor Non-Syndromic Pancreatic NET Non-Syndromic Pancreatic Neuroendocrine Tumor Nonfunctional Pancreatic NET Nonfunctional Pancreatic Neuroendocrine Tumor Nonfunctioning Pancreatic Neuroendocrine Tumor Nonsyndromic Pancreatic Endocrine Tumor Nonsyndromic Pancreatic Neuroendocrine Tumor Pancreatic endocrine tumor, nonfunctioning Non-Functioning Pancreatic Neuroendocrine Tumor An intermediate grade well differentiated neoplasm with neuroendocrine differentiation that arises from the pancreas. It is characterized by the absence of a hormone-related clinical syndrome. C45838 Neoplastic Process Non-Functioning Pancreatic Neuroendocrine Tumor G2 C1709241 Undetermined Non-Functioning_Well_Differentiated_Pancreatic_Endocrine_Carcinoma Non-Functional Pancreatic Neuroendocrine Tumor G2 Non-Functioning Pancreatic Neuroendocrine Tumor G2 Non-Functioning Well Differentiated Pancreatic Endocrine Carcinoma Nonfunctional Pancreatic Neuroendocrine Tumor G2 Nonfunctioning Pancreatic Neuroendocrine Tumor G2 Non-Functioning Pancreatic Neuroendocrine Tumor G2 A malignant neoplasm that has spread to the testis from another anatomic site. C4584 Neoplastic Process Metastatic Malignant Neoplasm in the Testis C0347003 Malignant Metastatic_Neoplasm_to_the_Testis Metastatic Malignant Neoplasm in the Testis Metastatic Malignant Neoplasm to the Testis Metastatic Neoplasm to the Testis Metastatic Tumor to the Testis Metastatic Malignant Neoplasm in the Testis A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the pancreas. It is characterized by the presence of a clinical syndrome that results from hormone hypersecretion. C45840 Neoplastic Process Functioning Pancreatic Neuroendocrine Tumor C1708107 Undetermined Functioning_Well_Differentiated_Pancreatic_Endocrine_Neoplasm Functional Neuroendocrine Tumor Functional Pancreatic NET Functional Pancreatic Neuroendocrine Tumor Functioning Pancreatic Endocrine Tumor Functioning Pancreatic NET Functioning Pancreatic Neuroendocrine Tumor Functioning Well Differentiated Pancreatic Endocrine Neoplasm Functioning Well Differentiated Pancreatic Endocrine Tumor Syndromic Pancreatic NET Syndromic Pancreatic Neuroendocrine Tumor Functioning Pancreatic Neuroendocrine Tumor A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the pancreas. It is characterized by the presence of a clinical syndrome that results from hormone hypersecretion. C45841 Neoplastic Process Functioning Pancreatic Neuroendocrine Tumor G2 C1708106 Undetermined Functioning_Well_Differentiated_Pancreatic_Endocrine_Carcinoma Functional Pancreatic Neuroendocrine Tumor G2 Functioning Pancreatic Neuroendocrine Tumor G2 Functioning Pancreatic Neuroendocrine Tumor G2 A rare carcinoma with a poor prognosis, characterized by the presence of a mixture of exocrine and neuroendocrine malignant epithelial cells in both the pancreas and metastatic sites. Symptoms include jaundice, abdominal pain, and weight loss. C45843 Neoplastic Process Pancreatic Mixed Adenoneuroendocrine Carcinoma C1709050 Cellosaurus GDC 8154/3 Malignant Mixed_Exocrine-Endocrine_Carcinoma 8154/3 Mixed pancreatic endocrine and exocrine tumor, malignant Mixed Exocrine-Endocrine Carcinoma of the Pancreas Mixed pancreatic endocrine and exocrine tumor, malignant Pancreatic Carcinoma with Mixed Differentiation Pancreatic Mixed Adenoneuroendocrine Carcinoma Pancreatic Mixed Neuroendocrine-Non-Neuroendocrine Carcinoma Pancreatic Mixed Adenoneuroendocrine Carcinoma A malignant neoplasm that has spread to the spinal cord from another anatomic site or system. Representative examples include carcinoma, lymphoma, and melanoma. C4585 Neoplastic Process Metastatic Malignant Neoplasm to the Spinal Cord Metastatic Malignant Neoplasm in the Spinal Cord C0347016 CTRP Malignant Metastasis_to_Spinal_Cord Metastasis to Spinal Cord Metastatic Malignant Neoplasm in the Spinal Cord Metastatic Malignant Neoplasm to the Spinal Cord Metastatic Neoplasm to the Spinal Cord Metastatic Tumor to the Spinal Cord Secondary Malignant Neoplasm to the Spinal Cord Secondary Malignant Tumor to the Spinal Cord Metastatic Malignant Neoplasm in the Spinal Cord A malignant neoplasm that has spread to the eye from another anatomic site. C4586 Neoplastic Process Metastatic Malignant Neoplasm in the Eye C0347019 Malignant Metastatic_Neoplasm_to_the_Eye Eye Metastasis Metastases to Eye Metastases to the Eye Metastasis to Eye Metastasis to the Eye Metastatic Malignant Neoplasm in the Eye Metastatic Malignant Neoplasm to the Eye Metastatic Neoplasm to the Eye Metastatic Tumor to the Eye Metastatic Malignant Neoplasm in the Eye Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C4587 Neoplastic Process Stage 0 Oral Cavity Cancer AJCC v6 and v7 Stage 0 Oral Cavity Cancer AJCC v6 and v7 C0347073 CPTAC CTRP mCode Malignant Stage_0_Oral_Cavity_Carcinoma Carcinoma in situ of hard palate Carcinoma in situ of Mouth Carcinoma in situ of Oral Cavity Carcinoma in situ of oral cavity, unspecified site Carcinoma in situ of the Mouth Carcinoma in situ of the Oral Cavity Mouth Carcinoma in situ Oral Cavity Carcinoma in situ Stage 0 Carcinoma of Mouth Stage 0 Carcinoma of Oral Cavity Stage 0 Carcinoma of the Mouth Stage 0 Carcinoma of the Oral Cavity Stage 0 Mouth Carcinoma Stage 0 Oral Cavity Cancer Stage 0 Oral Cavity Cancer AJCC v6 Stage 0 Oral Cavity Cancer AJCC v6 and v7 Stage 0 Oral Cavity Cancer AJCC v7 Stage 0 Oral Cavity Carcinoma Stage 0 Oral Cavity Cancer AJCC v6 and v7 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C4588 Neoplastic Process Stage 0 Lip Cancer AJCC v6 and v7 Stage 0 Lip Cancer AJCC v6 and v7 C0347082 CTRP mCode Malignant Stage_0_Lip_Cancer Carcinoma in situ of Lip Carcinoma in situ of skin of lip Carcinoma in situ of the Lip Lip Carcinoma in situ Stage 0 Cancer of Lip Stage 0 Cancer of the Lip Stage 0 Carcinoma of Lip Stage 0 Carcinoma of the Lip Stage 0 Lip Cancer Stage 0 Lip Cancer AJCC v6 Stage 0 Lip Cancer AJCC v6 and v7 Stage 0 Lip Cancer AJCC v7 Stage 0 Lip Carcinoma Stage 0 Lip Cancer AJCC v6 and v7 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th, 7th, and 8th eds.) C4589 Neoplastic Process Stage 0 Nasal Cavity Cancer AJCC v6, v7, and v8 Stage 0 Nasal Cavity Cancer AJCC v6, v7, and v8 C0347095 CTRP Malignant Stage_0_Nasal_Cavity_Carcinoma Carcinoma in situ of Nasal Cavity Carcinoma in situ of the Nasal Cavity Nasal Cavity Carcinoma in situ Stage 0 Carcinoma of Nasal Cavity Stage 0 Carcinoma of the Nasal Cavity Stage 0 Nasal Cavity Cancer Stage 0 Nasal Cavity Cancer AJCC v6, v7, and v8 Stage 0 Nasal Cavity Carcinoma Stage 0 Nasal Cavity Carcinoma AJCC v6 Stage 0 Nasal Cavity Carcinoma AJCC v7 Stage 0 Nasal Cavity Carcinoma AJCC v8 Stage 0 Nasal Cavity Cancer AJCC v6, v7, and v8 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C4590 Neoplastic Process Stage 0 Oropharyngeal Carcinoma AJCC v6 and v7 Stage 0 Oropharyngeal Carcinoma AJCC v6 and v7 C0347099 CTRP Abnormal cells are found in the lining of the oropharynx (the part of the throat at the back of the mouth). These abnormal cells may become cancer and spread into nearby normal tissue. Malignant Stage_0_Oropharyngeal_Carcinoma Carcinoma in situ of Oropharynx Carcinoma in situ of the Oropharynx Oropharyngeal Cancer Stage 0 Oropharyngeal Carcinoma in situ Oropharynx Carcinoma in situ Stage 0 Carcinoma of Oropharynx Stage 0 Carcinoma of the Oropharynx Stage 0 Oropharyngeal Cancer Stage 0 Oropharyngeal Carcinoma Stage 0 Oropharyngeal Carcinoma AJCC v6 Stage 0 Oropharyngeal Carcinoma AJCC v6 and v7 Stage 0 Oropharyngeal Carcinoma AJCC v7 Stage 0 Oropharyngeal Throat Cancer Stage 0 Oropharynx Carcinoma stage 0 oropharyngeal carcinoma in situ Stage 0 Oropharyngeal Carcinoma AJCC v6 and v7 A pituitary neuroendocrine tumor that produces gonadotropic hormones (FSH and/or LH). C45915 Neoplastic Process Gonadotropin-Producing Pituitary Gland Adenoma Gonadotroph Pituitary Neuroendocrine Tumor C1708249 CTRP NICHD A pituitary neuroendocrine tumor that produces one or more gonadotropins. Undetermined Gonadotropin_Producing_Pituitary_Gland_Adenoma Gonadotrope Adenoma Gonadotroph Cell Adenoma Gonadotroph PitNET/Adenoma Gonadotroph Pituitary Neuroendocrine Tumor Gonadotroph Pituitary Neuroendocrine Tumor/Adenoma Gonadotropin Producing Pituitary Gland Adenoma Gonadotropin-Producing Adenoma Gonadotropin-Producing Pituitary Gland Adenoma Gonadotropin-Secreting Pituitary Gland Adenoma Gonadotropinoma Gonadotroph Pituitary Neuroendocrine Tumor A pituitary neuroendocrine tumor that expresses adenohypophyseal hormones and belongs to more than one adenohypophysial cell lineage. C45916 Neoplastic Process Plurihormonal Pituitary Neuroendocrine Tumor C1709584 Undetermined Plurihormonal_Pituitary_Gland_Adenoma Multihormonal Adenoma Multihormonal Pituitary Gland Adenoma Plurihormonal Adenoma Plurihormonal PitNET/Adenoma Plurihormonal Pituitary Neuroendocrine Tumor Plurihormonal Pituitary Neuroendocrine Tumor/Adenoma Polyhormonal Adenoma Unusual Plurihormonal Tumor/Adenoma Plurihormonal Pituitary Neuroendocrine Tumor A tumor that arises in the sellar region and is characterized by the presence of mature ganglion cells and neuronal differentiation. It is often associated with the presence of pituitary neuroendocrine tumors/adenomas. C45917 Neoplastic Process Sellar Gangliocytoma C1709550 Undetermined Pituitary_Gland_Gangliocytoma Sellar Gangliocytoma Sellar Gangliocytoma A tumor characterized by the presence of mature ganglion cells and neuronal differentiation, arising in the hypothalamus. It is often associated with the presence of pituitary gland adenomas. Symptoms include acromegaly and precocious puberty. C45918 Neoplastic Process Hypothalamic Gangliocytoma C1708403 Undetermined Hypothalamic_Gangliocytoma Hypothalamic Gangliocytoma Hypothalamic Gangliocytoma Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th, 7th, and 8th eds.) C4592 Neoplastic Process Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8 Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8 C0347103 CTRP Malignant Stage_0_Epiglottic_Carcinoma Carcinoma in situ of Epiglottis Carcinoma in situ of the Epiglottis Epiglottic Carcinoma in situ Epiglottis Carcinoma in situ Stage 0 Epiglottic Carcinoma Stage 0 Epiglottic Carcinoma AJCC v6 Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8 Stage 0 Epiglottic Carcinoma AJCC v7 Stage 0 Epiglottic Carcinoma AJCC v8 Stage 0 Epiglottic Throat Cancer Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8 A neoplasm arising from the anterior lobe of the pituitary gland. The vast majority are pituitary neuroendocrine tumors (formerly pituitary adenomas). C45921 Neoplastic Process Anterior Pituitary Gland Neoplasm C1706819 Undetermined Anterior_Pituitary_Gland_Neoplasm Anterior Pituitary Gland Neoplasm Neoplasm of the Anterior Lobe of the Pituitary Gland Anterior Pituitary Gland Neoplasm A non-functioning pituitary neuroendocrine tumor without hormonal immunoreactivity or evidence of specific adenohypophyseal cell derivation. C45924 Neoplastic Process Null Cell Pituitary Neuroendocrine Tumor C1709286 Undetermined Null_Cell_Pituitary_Gland_Adenoma Hormone Immunonegative Adenoma Hormone Immunonegative Pituitary Gland Adenoma Null Cell Adenoma Null Cell PitNET/Adenoma Null Cell Pituitary Neuroendocrine Tumor Null Cell Pituitary Neuroendocrine Tumor/Adenoma Transcription Factor-Immunonegative Adenoma Null Cell Pituitary Neuroendocrine Tumor A growth hormone-producing pituitary neuroendocrine tumor composed of medium-sized acidophilic cells with granular cytoplasm and abundant secretory granules. C45925 Neoplastic Process Densely Granulated Somatotroph Pituitary Neuroendocrine Tumor C1707675 Undetermined Densely_Granulated_Pituitary_Gland_Somatotroph_Adenoma Densely Granulated Pituitary Gland Somatotroph Adenoma Densely Granulated Somatotroph PitNET/Adenoma Densely Granulated Somatotroph Pituitary Neuroendocrine Tumor Densely Granulated Somatotroph Pituitary Neuroendocrine Tumor/Adenoma Densely Granulated Somatotroph Pituitary Neuroendocrine Tumor A growth hormone-producing pituitary neuroendocrine tumor composed of small, round cells containing fibrous bodies and scarce, small secretory granules. C45926 Neoplastic Process Sparsely Granulated Somatotroph Pituitary Neuroendocrine Tumor C1710140 Undetermined Sparsely_Granulated_Pituitary_Gland_Somatotroph_Adenoma Sparsely Granulated Pituitary Gland Somatotroph Adenoma Sparsely Granulated Somatotroph PitNET/Adenoma Sparsely Granulated Somatotroph Pituitary Neuroendocrine Tumor Sparsely Granulated Somatotroph Pituitary Neuroendocrine Tumor/Adenoma Sparsely Granulated Somatotroph Pituitary Neuroendocrine Tumor A pituitary neuroendocrine tumor composed of an admixture of acidophilic and chromophobic cells that produce growth hormone and prolactin, respectively. Unlike mammosomatotroph pituitary neuroendocrine tumors, these two hormones are not localized in the same cell by immunohistochemistry. C45927 Neoplastic Process Mixed Somatotroph and Lactotroph Pituitary Neuroendocrine Tumor C1709052 NICHD A pituitary neuroendocrine tumor composed of an admixture of acidophilic and chromophobic cells that produce growth hormone and prolactin, respectively. Unlike mammosomatotroph pituitary neuroendocrine tumors, these two hormones are not localized in the same cell by immunohistochemistry. Undetermined Mixed_Somatotroph-Lactotroph_Pituitary_Gland_Adenoma Mixed GH-PRL Cell Adenoma Mixed Somatolactotrope Adenoma Mixed Somatotroph and Lactotroph Adenoma Mixed Somatotroph and Lactotroph PitNET/Adenoma Mixed Somatotroph and Lactotroph Pituitary Neuroendocrine Tumor Mixed Somatotroph and Lactotroph Pituitary Neuroendocrine Tumor/Adenoma Mixed Somatotroph-Lactotroph Adenoma Mixed Somatotroph-Lactotroph Pituitary Gland Adenoma Mixed Somatotroph and Lactotroph Pituitary Neuroendocrine Tumor A pituitary neuroendocrine tumor composed of acidophilic cells that produce both growth hormone and prolactin. Immunohistochemical studies reveal the presence of these two hormones localized in the same cell. C45928 Neoplastic Process Mammosomatotroph Pituitary Neuroendocrine Tumor C1708927 NICHD A pituitary neuroendocrine tumor composed of acidophilic cells that produce both growth hormone and prolactin. Immunohistochemical studies reveal the presence of these two hormones localized in the same cell. Undetermined Mammosomatotroph_Pituitary_Gland_Adenoma Mammosomatotrope Adenoma Mammosomatotroph Adenoma Mammosomatotroph PitNET/Adenoma Mammosomatotroph Pituitary Gland Adenoma Mammosomatotroph Pituitary Neuroendocrine Tumor Mammosomatotroph Pituitary Neuroendocrine Tumor/Adenoma Somatolactotrope Adenoma Somatomammotrope Adenoma Mammosomatotroph Pituitary Neuroendocrine Tumor An infrequent pituitary neuroendocrine tumor composed of cells showing immunoreactivity for prolactin and less often growth hormone. Electron microscopic studies reveal giant mitochondria, a finding not present in any other type of pituitary gland adenomas. C45929 Neoplastic Process Acidophil Stem Cell Pituitary Neuroendocrine Tumor C1706698 Undetermined Acidophil_Stem_Cell_Pituitary_Gland_Adenoma ASCA Acidophil Stem Cell Adenoma Acidophil Stem Cell PitNET/Adenoma Acidophil Stem Cell Pituitary Neuroendocrine Tumor Acidophil Stem Cell Pituitary Neuroendocrine Tumor/Adenoma Acidophil Stem Cell Pituitary Neuroendocrine Tumor Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial or invasion of lamina propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C4593 Neoplastic Process Stage 0 Appendix Carcinoma AJCC v7 Stage 0 Appendix Carcinoma AJCC v7 C0347125 CTRP Malignant Stage_0_Appendix_Carcinoma Carcinoma in situ of Appendix Carcinoma in situ of the Appendix Stage 0 Appendix Cancer Stage 0 Appendix Carcinoma Stage 0 Appendix Carcinoma AJCC v7 Stage 0 Appendix Carcinoma AJCC v7 A rare prolactin-producing pituitary neuroendocrine tumor composed of acidophilic cells with many large secretory granules. The endoplasmic reticulum is not as abundant as in the sparsely granulated subtype. C45931 Neoplastic Process Densely Granulated Lactotroph Pituitary Neuroendocrine Tumor C1707674 Undetermined Densely_Granulated_Pituitary_Gland_Lactotroph_Adenoma Densely Granulated Lactotroph PitNET/Adenoma Densely Granulated Lactotroph Pituitary Neuroendocrine Tumor Densely Granulated Lactotroph Pituitary Neuroendocrine Tumor/Adenoma Densely Granulated Pituitary Gland Lactotroph Adenoma Densely Granulated Lactotroph Pituitary Neuroendocrine Tumor A prolactin-producing pituitary neuroendocrine tumor composed of relatively large, chromophobic or slightly acidophilic cells with well developed, abundant endoplasmic reticulum, and many immature secretory granules. Mature secretory granules are sparse. C45932 Neoplastic Process Sparsely Granulated Lactotroph Pituitary Neuroendocrine Tumor C1710139 Undetermined Sparsely_Granulated_Pituitary_Gland_Lactotroph_Adenoma Sparsely Granulated Lactotroph PitNET/Adenoma Sparsely Granulated Lactotroph Pituitary Neuroendocrine Tumor Sparsely Granulated Lactotroph Pituitary Neuroendocrine Tumor/Adenoma Sparsely Granulated Pituitary Gland Lactotroph Adenoma Sparsely Granulated Lactotroph Pituitary Neuroendocrine Tumor Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial or invasion of lamina propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C4594 Neoplastic Process Cecum Carcinoma In Situ C0347126 Malignant Cecum_Carcinoma_in_situ Carcinoma In Situ of Cecum Carcinoma In Situ of the Cecum Cecum Carcinoma In Situ Cecum Carcinoma In Situ AJCC v6 Cecum Carcinoma In Situ AJCC v7 Stage 0 Cecum Carcinoma Cecum Carcinoma In Situ A precancerous neoplastic intraepithelial process involving either the squamous and transitional zones of the anal canal or the perianal skin (anal margin). C4595 Neoplastic Process Anal Intraepithelial Neoplasia Anal Intraepithelial Neoplasia C0347129 CTRP Undetermined Anal_Intraepithelial_Neoplasia AIN Anal Canal and Anal Margin Squamous Intraepithelial Neoplasia Anal Canal and Perianal Squamous Intraepithelial Neoplasia Anal Dysplasia Anal Intraepithelial Neoplasia Anal Squamous Dysplasia Anal Squamous Intraepithelial Neoplasia Intraepithelial Neoplasia of Anus Intraepithelial Neoplasia of the Anus Anal Intraepithelial Neoplasia A precancerous neoplastic lesion that arises from the penis. It is characterized by dysplastic changes of the squamous epithelium with an intact basement membrane. C4596 Neoplastic Process Penile Intraepithelial Neoplasia C0347180 Undetermined Penile_Intraepithelial_Neoplasia PeIN Penile Intraepithelial Neoplasia Penile Intraepithelial Neoplasia Stage 0is includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C4597 Neoplastic Process Stage 0is Renal Pelvis Cancer AJCC v7 Stage 0is Renal Pelvis Cancer AJCC v7 C0347184 CTRP Malignant Stage_0is_Renal_Pelvis_Carcinoma Carcinoma in situ of Kidney Pelvis Carcinoma in situ of Renal Pelvis Carcinoma in situ of the Kidney Pelvis Carcinoma in situ of the Renal Pelvis Kidney Pelvis Carcinoma in situ Renal Pelvis Carcinoma in situ Stage 0is Carcinoma of Kidney Pelvis Stage 0is Carcinoma of Renal Pelvis Stage 0is Carcinoma of the Kidney Pelvis Stage 0is Carcinoma of the Renal Pelvis Stage 0is Kidney Pelvis Carcinoma Stage 0is Renal Pelvis Cancer Stage 0is Renal Pelvis Cancer AJCC v7 Stage 0is Renal Pelvis Urothelial Carcinoma Stage 0is Renal Pelvis Urothelial Carcinoma AJCC v7 Stage 0is Renal Pelvis Cancer AJCC v7 A neoplasm that arises from the upper or lower gingiva and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4598 Neoplastic Process Benign Gingival Neoplasm C0347201 Benign Benign_Gingival_Neoplasm Benign Gingival Neoplasm Benign Gingival Tumor Benign Gum Neoplasm Benign Gum Tumor Benign Neoplasm of Gingiva Benign Neoplasm of Gum Benign Neoplasm of the Gingiva Benign Neoplasm of the Gum Benign Tumor of Gingiva Benign Tumor of Gum Benign Tumor of the Gingiva Benign Tumor of the Gum Benign Gingival Neoplasm A non-metastasizing neoplasm that arises from the hard palate, soft palate, or uvula. C4599 Neoplastic Process Benign Palate Neoplasm C0347203 Benign Benign_Palate_Neoplasm Benign Neoplasm of Palate Benign Neoplasm of the Palate Benign Palate Neoplasm Benign Palate Tumor Benign Tumor of Palate Benign Tumor of the Palate Benign Palate Neoplasm A neoplasm that arises from the major or minor salivary glands and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include Warthin tumor, monomorphic adenoma, and pleomorphic adenoma. C4600 Neoplastic Process Benign Salivary Gland Neoplasm C0347206 Benign Benign_Salivary_Gland_Neoplasm Benign Neoplasm of Salivary Gland Benign Neoplasm of the Salivary Gland Benign Salivary Gland Neoplasm Benign Salivary Gland Tumor Benign Tumor of Salivary Gland Benign Tumor of the Salivary Gland Salivary Gland Neoplasm, Benign Benign Salivary Gland Neoplasm A papillary carcinoma of the thyroid gland measuring 10mm or less in diameter. The survival rates of patients with this type of carcinoma are the same with those of the normal population. C46004 Neoplastic Process Thyroid Gland Papillary Microcarcinoma C1709457 GDC 8341/3 Malignant Papillary_Thyroid_Gland_Microcarcinoma 8341/3 Papillary microcarcinoma Papillary Microcarcinoma of the Thyroid Papillary Microcarcinoma of the Thyroid Gland Papillary Thyroid Gland Microcarcinoma Papillary Thyroid Microcarcinoma Papillary microcarcinoma Thyroid Gland Papillary Microcarcinoma Thyroid Gland Papillary Microcarcinoma Thyroid gland anaplastic carcinoma with focal or complete squamous differentiation. Primary thyroid gland squamous cell carcinomas have similar poor overall survival rates as compared to conventional anaplastic thyroid gland carcinomas and are now considered a subtype of the latter. C46008 Neoplastic Process Thyroid Gland Anaplastic Carcinoma, Squamous Cell Carcinoma Pattern C1710177 Cellosaurus Malignant Squamous_Cell_Thyroid_Gland_Carcinoma Thyroid Gland Anaplastic Carcinoma, Squamous Cell Carcinoma Pattern Thyroid Gland Squamous Cell Carcinoma Thyroid Gland Anaplastic Carcinoma, Squamous Cell Carcinoma Pattern A neoplasm that arises from the sublingual gland and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4601 Neoplastic Process Benign Sublingual Gland Neoplasm C0347208 Benign Benign_Sublingual_Gland_Neoplasm Benign Neoplasm of Sublingual Gland Benign Neoplasm of the Sublingual Gland Benign Sublingual Gland Neoplasm Benign Sublingual Gland Tumor Benign Tumor of Sublingual Gland Benign Tumor of the Sublingual Gland Benign Sublingual Gland Neoplasm A neoplasm that arises from the middle ear and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4602 Neoplastic Process Benign Middle Ear Neoplasm C0347213 Benign Benign_Middle_Ear_Neoplasm Benign Middle Ear Neoplasm Benign Middle Ear Tumor Benign Neoplasm of Middle Ear Benign Neoplasm of the Middle Ear Benign Tumor of Middle Ear Benign Tumor of the Middle Ear Benign Middle Ear Neoplasm A neoplasm that arises from the nasal cavity and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include Schneiderian papilloma and salivary gland-type adenoma. C4603 Neoplastic Process Benign Nasal Cavity Neoplasm C0347215 Benign Benign_Nasal_Cavity_Neoplasm Benign Nasal Cavity Neoplasm Benign Nasal Cavity Tumor Benign Neoplasm of Nasal Cavity Benign Neoplasm of the Nasal Cavity Benign Tumor of Nasal Cavity Benign Tumor of the Nasal Cavity Benign Nasal Cavity Neoplasm A neoplasm that arises from the oropharynx and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4604 Neoplastic Process Benign Oropharyngeal Neoplasm C0347228 Benign Benign_Oropharyngeal_Neoplasm Benign Neoplasm of Oropharynx Benign Neoplasm of the Oropharynx Benign Oropharyngeal Neoplasm Benign Oropharyngeal Tumor Benign Tumor of Oropharynx Benign Tumor of the Oropharynx Oropharyngeal Neoplasm Benign Benign Oropharyngeal Neoplasm A neoplasm that arises from the glottis and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4605 Neoplastic Process Benign Glottis Neoplasm C0347234 Benign Benign_Glottis_Neoplasm Benign Glottis Neoplasm Benign Glottis Tumor Benign Neoplasm of Glottis Benign Neoplasm of the Glottis Benign Tumor of Glottis Benign Tumor of the Glottis Benign Glottis Neoplasm A neoplasm that arises from the epiglottis and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4606 Neoplastic Process Benign Epiglottis Neoplasm C0347236 Benign Benign_Epiglottis_Neoplasm Benign Epiglottic Neoplasm Benign Epiglottic Tumor Benign Epiglottis Neoplasm Benign Epiglottis Tumor Benign Neoplasm of Epiglottis Benign Neoplasm of the Epiglottis Benign Tumor of Epiglottis Benign Tumor of the Epiglottis Benign Epiglottis Neoplasm An adenoma or carcinoma arising from the follicular cells of the thyroid gland. It is composed of large oncocytic cells with abundant granular eosinophilic cytoplasm. C46068 Neoplastic Process Thyroid Gland Oncocytic Neoplasm Thyroid Gland Oncocytic Neoplasm C0949541 CTEP CTRP GDC An uncommon type of thyroid tumor that can be benign or malignant. Undetermined Thyroid_Gland_Oncocytic_Neoplasm Hurthle cell tumor Hurthle Cell Neoplasm Hurthle Cell Tumor Hurthle cell neoplasm Hurthle cell neoplasm (thyroid) Hurthle cell tumor Thyroid Gland Hurthle (Oncocytic) Cell Neoplasm Thyroid Gland Hurthle (Oncocytic) Cell Tumor Thyroid Gland Hurthle Cell Neoplasm Thyroid Gland Oncocytic Neoplasm Thyroid Gland Oncocytic Neoplasm A neoplasm that arises from the myocardium and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4607 Neoplastic Process Benign Myocardial Neoplasm C0347253 Benign Benign_Myocardial_Neoplasm Benign Myocardial Neoplasm Benign Myocardial Tumor Benign Neoplasm of Myocardium Benign Neoplasm of the Myocardium Benign Tumor of Myocardium Benign Tumor of the Myocardium Benign Myocardial Neoplasm Breast carcinoma of one breast, or one side of the breast. C46073 Neoplastic Process Unilateral Breast Carcinoma Unilateral Breast Carcinoma C1710547 CTRP Malignant Unilateral_Breast_Carcinoma Unilateral Breast Cancer Unilateral Breast Carcinoma Unilateral Breast Carcinoma An ultrasound administered by using a tube containing flexible fibre optic wires that allows for the analysis of tissues inside the body. Ultrasound technology utilizes high frequency waves and their echoes to produce an image. 2005 C46078 Diagnostic Procedure Endoscopic Ultrasound Endoscopic Ultrasound C0376443 CDISC CTRP A procedure in which an endoscope is inserted into the body. An endoscope is a thin, tube-like instrument that has a light and a lens for viewing. A probe at the end of the endoscope is used to bounce high-energy sound waves (ultrasound) off internal organs to make a picture (sonogram). An endoscopic technique using a specialized endoscope that transmits high frequency sound waves to generate ultrasound images. Endoscopic_Ultrasound ENDOSCOPIC ULTRASOUND EUS Endoscopic Ultrasound endoscopic ultrasound endosonography Endoscopic Ultrasound A neoplasm that arises from the endocardium and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4608 Neoplastic Process Benign Endocardial Neoplasm C0347254 Benign Benign_Endocardial_Neoplasm Benign Endocardial Neoplasm Benign Endocardial Tumor Benign Neoplasm of Endocardium Benign Neoplasm of the Endocardium Benign Tumor of Endocardium Benign Tumor of the Endocardium Benign Endocardial Neoplasm A technique that uses radiofrequency waves and a magnet to image the body. The images are enhanced by the addition of contrast agents which selectively intensify anatomical regions to intensify the clarity of the image for diagnostic purposes. 2005 C46087 Diagnostic Procedure Contrast-enhanced Magnetic Resonance Imaging Contrast-enhanced Magnetic Resonance Imaging C1707501 CDISC CTRP A technique that uses radiofrequency waves and a magnet to image the body. The images are enhanced by the addition of contrast agents which selectively intensify anatomical regions to intensify the clarity of the image for diagnostic purposes. (NCI) Contrast-enhanced_Magnetic_Resonance_Imaging CONTRAST ENHANCED MRI Contrast-enhanced MRI Contrast-enhanced Magnetic Resonance Imaging MRI With Contrast Contrast-enhanced Magnetic Resonance Imaging A neoplasm that arises from the small or large intestine and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4609 Neoplastic Process Benign Intestinal Neoplasm C0347269 Benign Benign_Intestinal_Neoplasm Benign Intestinal Neoplasm Benign Intestinal Neoplasms Benign Intestinal Tumor Benign Intestinal Tumors Benign Intestine Neoplasm Benign Intestine Tumor Benign Neoplasm of Intestines Benign Neoplasm of the Intestines Benign Neoplasms of Large and/or Small Intestine Benign Neoplasms of the Large and/or Small Intestine Benign Tumor of Intestines Benign Tumor of the Intestines Intestinal Neoplasms, Benign Intestinal Tumors, Benign Benign Intestinal Neoplasm A morphologic variant of papillary carcinoma of the thyroid gland characterized by the predominance or the exclusive presence of macrofollicles. Some of the malignant follicular cells display the nuclear features that characterize the papillary adenocarcinomas of the thyroid gland. C46092 Neoplastic Process Macrofollicular Variant Thyroid Gland Papillary Carcinoma C1708851 Malignant Macrofollicular_Variant_Thyroid_Gland_Papillary_Carcinoma Macrofollicular Variant Thyroid Gland Papillary Carcinoma Macrofollicular Variant Thyroid Gland Papillary Carcinoma A morphologic variant of papillary carcinoma of the thyroid gland characterized by the presence of papillary or follicular structures, containing malignant follicular cells with abundant granular eosinophilic cytoplasm. These cells have the nuclear features that characterize the papillary carcinomas of the thyroid gland. C46093 Neoplastic Process Oncocytic Variant Thyroid Gland Papillary Carcinoma Oncocytic Variant Thyroid Gland Papillary Carcinoma C1709312 CTRP GDC 8342/3 Malignant Oncocytic_Variant_Thyroid_Gland_Papillary_Carcinoma 8342/3 Papillary carcinoma, oncocytic variant Papillary carcinoma, oxyphilic cell Oncocytic Variant Thyroid Gland Papillary Cancer Oncocytic Variant Thyroid Gland Papillary Carcinoma Oxyphilic Variant Thyroid Gland Papillary Carcinoma Papillary carcinoma, oxyphilic cell Oncocytic Variant Thyroid Gland Papillary Carcinoma A morphologic variant of papillary carcinoma of the thyroid gland characterized by the predominance of malignant follicular clear cells. These cells have the nuclear features that characterize the papillary carcinomas of the thyroid gland. C46094 Neoplastic Process Clear Cell Variant Thyroid Gland Papillary Carcinoma C1707410 Malignant Clear_Cell_Variant_Thyroid_Gland_Papillary_Carcinoma Clear Cell Variant Thyroid Gland Papillary Carcinoma Clear Cell Variant Thyroid Gland Papillary Carcinoma A morphologic variant of papillary carcinoma of the thyroid gland that predominantly affects children. It is characterized by the presence of a solid growth pattern. The malignant cells have nuclear features that are characteristic of papillary carcinomas of the thyroid gland. C46095 Neoplastic Process Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma C0334327 GDC Malignant Solid_Variant_Thyroid_Gland_Papillary_Carcinoma 8332/3 Follicular adenocarcinoma, trabecular Follicular adenocarcinoma, trabecular Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma A morphologic variant of follicular carcinoma of the thyroid gland characterized by the predominance of malignant follicular clear cells. These cells lack the nuclear features that characterize the papillary carcinomas of the thyroid gland. C46096 Neoplastic Process Thyroid Gland Follicular Carcinoma, Clear Cell Variant C1707409 Malignant Clear_Cell_Variant_Thyroid_Gland_Follicular_Carcinoma Clear Cell Variant Thyroid Gland Follicular Carcinoma Thyroid Gland Follicular Carcinoma, Clear Cell Variant Thyroid Gland Follicular Carcinoma, Clear Cell Variant A non-hereditary medullary carcinoma of the thyroid gland not associated with multiple endocrine neoplasia. The majority of thyroid gland medullary carcinomas are sporadic. C46098 Neoplastic Process Sporadic Thyroid Gland Medullary Carcinoma C1710166 Malignant Sporadic_Thyroid_Gland_Medullary_Carcinoma Sporadic Thyroid Gland Medullary Carcinoma Sporadic Thyroid Gland Medullary Carcinoma A medullary thyroid gland carcinoma inherited through an autosomal dominant mode. It is associated with multiple endocrine neoplasia type II (2a) or III (2b). C46099 Neoplastic Process Hereditary Thyroid Gland Medullary Carcinoma Hereditary Thyroid Gland Medullary Carcinoma C1833921 CTRP Cellosaurus An inherited form of medullary thyroid cancer (cancer that forms in the cells of the thyroid that make the hormone calcitonin). Malignant Hereditary_Thyroid_Gland_Medullary_Carcinoma Familial Thyroid Gland Medullary Carcinoma Hereditary Thyroid Gland Medullary Cancer Hereditary Thyroid Gland Medullary Carcinoma familial medullary thyroid cancer Hereditary Thyroid Gland Medullary Carcinoma A neoplasm that arises from the colon or rectum and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4610 Neoplastic Process Benign Colorectal Neoplasm C0347272 Benign Benign_Colorectal_Neoplasm Benign Colorectal Neoplasm Benign Colorectal Neoplasms Benign Colorectal Tumor Benign Colorectal Tumors Benign Large Bowel Neoplasm Benign Large Bowel Tumor Benign Large Intestine Neoplasm Benign Large Intestine Tumor Benign Neoplasm of Large Bowel Benign Neoplasm of Large Intestine Benign Neoplasm of the Large Bowel Benign Neoplasm of the Large Intestine Benign Tumor of Large Bowel Benign Tumor of Large Intestine Benign Tumor of the Large Bowel Benign Tumor of the Large Intestine Colorectal Neoplasms, Benign Colorectal Tumors, Benign Neoplasms, Colorectal, Benign Tumors, Colorectal, Benign Benign Colorectal Neoplasm A neoplastic process arising from the C-cells of the thyroid gland. It is considered a precursor of hereditary medullary thyroid gland carcinoma, and it is associated with mutations of the RET gene. C46101 Neoplastic Process Neoplastic C-Cell Hyperplasia C1709166 CDISC A benign neoplasm arising from C-cells of the thyroid gland. No tumor is found in the thyroid but abnormal cells are found by screening tests. These abnormal cells may become cancer and spread into nearby normal tissue. Uncertain Malignant Potential Neoplastic_C-Cell_Hyperplasia ADENOMA, C-CELL, BENIGN Neoplastic C-Cell Hyperplasia Parafollicular Cell Adenoma stage 0 medullary thyroid carcinoma in situ Neoplastic C-Cell Hyperplasia A sporadic thyroid gland medullary carcinoma measuring less than 10mm in diameter. C46103 Neoplastic Process Sporadic Thyroid Gland Micromedullary Carcinoma C1710167 Malignant Sporadic_Thyroid_Gland_Micromedullary_Carcinoma Sporadic Thyroid Gland Micromedullary Carcinoma Sporadic Thyroid Gland Micromedullary Carcinoma A primary carcinoma of the thyroid gland containing a medullary carcinoma component that is immunohistochemically positive for calcitonin, and follicular cell-derived carcinoma component that is immunohistochemically positive for thyroglobulin. C46104 Neoplastic Process Thyroid Gland Mixed Medullary and Follicular Cell-Derived Carcinoma C1710414 Malignant Thyroid_Gland_Mixed_Medullary_and_Follicular_Cell_Carcinoma MMFCC Mixed Medullary and Follicular Cell-Derived Thyroid Carcinoma Thyroid Gland Mixed Medullary and Follicular Cell-Derived Carcinoma Thyroid Gland Mixed Medullary and Follicular Cell-Derived Carcinoma A rare, slow growing malignant tumor of the thyroid gland arising from intrathyroidal thymic tissue. It is characterized by a lobulated architectural pattern and the presence of a biphasic cellular population composed of spindle epithelial cells and glandular cells. A small number of cases are composed exclusively of spindle epithelial cells or glandular cells. C46105 Neoplastic Process Thyroid Gland Spindle Epithelial Tumor with Thymus-Like Elements C1266099 GDC 8588/3 Malignant Thyroid_Gland_Spindle_Cell_Tumor_with_Thymus-Like_Differentiation 8588/3 SETTLE Spindle epithelial tumor with thymus-like differentiation Spindle epithelial tumor with thymus-like element SETTLE Spindle Epithelial Tumor with Thymus-Like Elements Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation Thyroid Gland Spindle Epithelial Tumor with Thymus-Like Elements Thyroid Gland Spindle Epithelial Tumor with Thymus-Like Elements A rare primary carcinoma of the thyroid gland, composed of groups of carcinoma cells with thymic epithelial differentiation. C46106 Neoplastic Process Intrathyroid Thymic Carcinoma C1266100 GDC 8589/3 Malignant Thyroid_Gland_Carcinoma_Showing_Thymus-Like_Differentiation 8589/3 CASTLE Carcinoma showing thymus-like differentiation Carcinoma showing thymus-like element Intrathyroid thymic carcinoma CASTLE CD5-Positive Thyroid Carcinoma Intrathyroid Thymic Carcinoma Intrathyroidal Carcinoma Showing Thymus-Like Elements Thyroid Gland Carcinoma Showing Thymus-Like Differentiation Intrathyroid Thymic Carcinoma A neoplasm that arises from the anus and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4611 Neoplastic Process Benign Anal Neoplasm C0347276 Benign Benign_Anal_Neoplasm Benign Anal Neoplasm Benign Anal Tumor Benign Neoplasm of Anus Benign Neoplasm of the Anus Benign Tumor of Anus Benign Tumor of the Anus Benign Anal Neoplasm A thyroid gland adenoma characterized by the presence of papillae lined by cells that range from cuboidal to columnar. The papillae are usually cystic and non-branching. Aggregates of follicles may be found within the papillary structures. C46111 Neoplastic Process Thyroid Gland Follicular Adenoma with Papillary Hyperplasia C1710412 Benign Thyroid_Gland_Follicular_Adenoma_with_Papillary_Hyperplasia Thyroid Gland Follicular Adenoma with Papillary Hyperplasia Thyroid Gland Follicular Adenoma with Papillary Hyperplasia A thyroid gland adenoma characterized by the presence of signet ring cells that stain positive for thyroglobulin. C46115 Neoplastic Process Thyroid Gland Signet Ring Cell Follicular Adenoma C1710417 Benign Thyroid_Gland_Signet_Ring_Cell_Follicular_Adenoma Thyroid Gland Signet Ring Cell Follicular Adenoma Thyroid Gland Signet-Ring Cell Follicular Adenoma Thyroid Gland Signet Ring Cell Follicular Adenoma A thyroid gland adenoma composed of follicles and characterized by the presence of abundant extracellular mucin. C46116 Neoplastic Process Thyroid Gland Mucinous Follicular Adenoma C1710415 Benign Thyroid_Gland_Mucinous_Follicular_Adenoma Thyroid Gland Mucinous Follicular Adenoma Thyroid Gland Mucinous Follicular Adenoma A thyroid gland adenoma composed of follicular structures and mature adipocytes. C46118 Neoplastic Process Thyroid Gland Lipoadenoma C1710413 Benign Thyroid_Gland_Lipoadenoma Thyroid Gland Adenolipoma Thyroid Gland Lipoadenoma Thyroid Gland Lipoadenoma A thyroid gland adenoma composed of follicular cells with cytoplasmic clearing. C46119 Neoplastic Process Thyroid Gland Clear Cell Follicular Adenoma C1710409 CDISC A benign epithelial neoplasm of the thyroid gland comprising follicular cells with cytoplasmic clearing. Benign Thyroid_Gland_Clear_Cell_Follicular_Adenoma ADENOMA, LIGHT CELL, BENIGN Thyroid Gland Clear Cell Follicular Adenoma Thyroid Gland Clear Cell Follicular Adenoma A neoplasm that arises from the pancreas and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4612 Neoplastic Process Benign Pancreatic Neoplasm Benign Pancreatic Neoplasm C0347284 CTRP Benign Benign_Pancreatic_Neoplasm Benign Neoplasm of Pancreas Benign Neoplasm of the Pancreas Benign Pancreas Neoplasm Benign Pancreas Tumor Benign Pancreatic Neoplasm Benign Pancreatic Neoplasm NOS Benign Pancreatic Tumor Benign Tumor of Pancreas Benign Tumor of the Pancreas Pancreas Neoplasm, Benign Pancreas Tumor, Benign Pancreatic Neoplasm, Benign Pancreatic Tumor, Benign Benign Pancreatic Neoplasm A thyroid gland adenoma producing thyroxin. It is associated with hyperthyroidism. Radioactive iodine scan reveals a hot nodule. C46122 Neoplastic Process Thyroid Gland Hyperfunctioning Adenoma C1710419 Benign Thyroid_Gland_Toxic_Hyperfunctioning_Adenoma Thyroid Gland Hot Adenoma Thyroid Gland Hyperfunctioning Adenoma Thyroid Gland Toxic (Hyperfunctioning) Adenoma Thyroid Gland Toxic Adenoma Thyroid Gland Hyperfunctioning Adenoma A thyroid gland adenoma containing follicular cells with large hyperchromatic nuclei. The clinical course is benign. C46123 Neoplastic Process Thyroid Gland Follicular Adenoma with Bizarre Nuclei C1710411 Benign Thyroid_Gland_Follicular_Adenoma_with_Bizarre_Nuclei Thyroid Gland Follicular Adenoma with Bizarre Nuclei Thyroid Gland Follicular Adenoma with Bizarre Nuclei A teratoma that arises from the thyroid gland. Thyroid gland teratomas with high grade/malignant histological features carry DICER1 gene mutations and have been reclassified as thyroblastomas. They are no longer considered true teratomas. C46124 Neoplastic Process Thyroid Gland Teratoma C1710418 Undetermined Thyroid_Gland_Teratoma Primary Thyroid Gland Teratoma Thyroid Gland Teratoma Thyroid Gland Teratoma A rare, circumscribed or encapsulated neuroendocrine tumor arising from the thyroid gland. Microscopically, it is characterized by the presence of tumor cells arranged in a nesting (Zellballen) growth pattern. The reported cases have followed a benign clinical course. C46125 Neoplastic Process Thyroid Gland Paraganglioma C1710416 Undetermined Thyroid_Gland_Paraganglioma Thyroid Gland Paraganglioma Thyroid Gland Paraganglioma A neoplasm that arises from the exocrine pancreas and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4613 Neoplastic Process Benign Exocrine Pancreas Neoplasm C0347285 CPTAC Benign Benign_Exocrine_Pancreatic_Neoplasm Benign neoplasm of pancreas, except islets of Langerhans Benign Exocrine Pancreas Neoplasm Benign Exocrine Pancreas Tumor Benign Exocrine Pancreatic Neoplasm Benign Neoplasm of Exocrine Pancreas Benign Neoplasm of the Exocrine Pancreas Benign Tumor of Exocrine Pancreas Benign Tumor of the Exocrine Pancreas Benign Exocrine Pancreas Neoplasm A benign papillary neoplastic growth on the skin composed of epithelial cells and a fibrous stalk. It usually develops in the eyelid, axilla, neck, upper chest, and groin. C4614 Neoplastic Process Skin Papilloma C0347390 CDISC A benign papillary neoplasm of the skin. Benign Skin_Papilloma BASOSQUAMOUS TUMOR, BENIGN Cutaneous Papilloma Papilloma of Skin Papilloma of the Skin Skin Papilloma Skin Papilloma A neoplasm that arises from the hair follicles, sebaceous glands, or sweat glands. It is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include cylindroma, hidrocystoma, hidradenoma, and sebaceoma. C4615 Neoplastic Process Benign Skin Appendage Neoplasm C0347391 GDC Benign Benign_Skin_Appendage_Neoplasm 8400/3 Skin appendage tumor, benign Benign Appendageal Neoplasm Benign Appendageal Tumor Benign Cutaneous Adnexal Neoplasm Benign Skin Appendage Neoplasm Benign Skin Appendageal Neoplasm Benign Skin Appendageal Tumor Skin appendage tumor, benign Benign Skin Appendage Neoplasm A benign adipose tissue neoplasm arising from the skin. C4616 Neoplastic Process Skin Lipoma C0347394 Benign Cutaneous_Lipoma Cutaneous Lipoma Lipoma of Skin Lipoma of the Skin Skin Lipoma Skin Lipoma A benign adipose tissue neoplasm of the external ear. C4618 Neoplastic Process External Ear Lipoma C0347423 Benign External_Ear_Lipoma External Ear Lipoma Lipoma of External Ear Lipoma of the External Ear External Ear Lipoma A benign adipose tissue neoplasm of the spinal cord. It is usually associated with dysraphism in which the intraspinal component communicates with a subcutaneous lipoma through a defect in the posterior elements of the spine. Non-dysraphic intramedullary spinal cord lipomas are very rare. C4619 Neoplastic Process Spinal Cord Lipoma C0347446 Benign Spinal_Cord_Lipoma Lipoma of Spinal Cord Spinal Cord Lipoma Spinal Cord Lipoma A neoplasm that arises from the breast in males and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4620 Neoplastic Process Benign Male Breast Neoplasm C0347482 Benign Benign_Male_Breast_Neoplasm Benign Male Breast Neoplasm Benign Male Breast Tumor Benign Neoplasm of Male Breast Benign Neoplasm of the Male Breast Benign Tumor of Male Breast Benign Tumor of the Male Breast Benign Male Breast Neoplasm An epithelial neoplasm that arises from an endocrine organ and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include thyroid gland follicular adenoma and parathyroid gland adenoma. C4621 Neoplastic Process Benign Endocrine Neoplasm C0347524 Benign Benign_Endocrine_Neoplasm Benign Endocrine Gland Neoplasm Benign Endocrine Gland Tumor Benign Endocrine Neoplasm Benign Endocrine Tumor Benign Neoplasm of Endocrine Gland Benign Neoplasm of the Endocrine Gland Benign Tumor of Endocrine Gland Benign Tumor of the Endocrine Gland Benign Endocrine Neoplasm A jugulotympanic paraganglioma that metastasizes to other anatomic sites. C4623 Neoplastic Process Metastatic Jugulotympanic Paraganglioma C0347856 Malignant Malignant_Jugulotympanic_Paraganglioma Metastatic_Jugulotympanic_Paraganglioma Malignant Glomus Jugulare Neoplasm Malignant Glomus Jugulare Tumor Malignant Jugulotympanic Paraganglioma Malignant Neoplasm of Glomus Jugulare Malignant Neoplasm of the Glomus Jugulare Malignant Tumor of Glomus Jugulare Metastatic Jugulotympanic Paraganglioma Metastatic Jugulotympanic Paraganglioma A primary or metastatic malignant neoplasm involving the brain or spinal cord. Representative examples include anaplastic astrocytoma, glioblastoma, anaplastic (malignant) meningioma, lymphoma, and metastatic carcinoma from another anatomic site. C4627 Neoplastic Process Malignant Central Nervous System Neoplasm Malignant Central Nervous System Neoplasm C0348374 CPTAC CTRP GDC mCode Malignant Malignant_Central_Nervous_System_Neoplasm Brain and Nervous System CNS Cancer Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system Malignant neoplasm: Central nervous system, unspecified CNS Cancer CNS Malignant Neoplasms CNS Neoplasms, Malignant Cancer of CNS Cancer of Central Nervous System Cancer of the CNS Cancer of the Central Nervous System Central Nervous System Cancer Central Nervous System Neoplasms, Malignant Malignant CNS Neoplasm Malignant CNS Neoplasms Malignant CNS Tumor Malignant Central Nervous System Neoplasm Malignant Central Nervous System Tumor Malignant Neoplasm of CNS Malignant Neoplasm of Central Nervous System Malignant Neoplasm of the CNS Malignant Neoplasm of the Central Nervous System Malignant Tumor of CNS Malignant Tumor of Central Nervous System Malignant Tumor of the CNS Malignant Tumor of the Central Nervous System Malignant neoplasm of central nervous system, unspecified Malignant Central Nervous System Neoplasm A primary or metastatic malignant tumor occurring in the meninges, which surround the brain and spinal cord. The most common are meningiomas. C4628 Neoplastic Process Malignant Meningeal Neoplasm Malignant Meningeal Neoplasm C0348375 CPTAC CTRP mCode Malignant Malignant_Neoplasms_of_the_Meninges Malignant neoplasm of cerebral meninges Malignant neoplasm: Cerebral meninges Malignant neoplasm: Meninges, unspecified Cancer of Meninges Cancer of the Meninges Malignant Meningeal Neoplasm Malignant Meningeal Tumor Malignant Meninges Neoplasm Malignant Meninges Tumor Malignant Neoplasm of Meninges Malignant Neoplasm of the Meninges Malignant Neoplasms of Meninges Malignant Tumor of Meninges Malignant Tumor of the Meninges Malignant neoplasm of meninges, unspecified Meningeal Cancer Meningeal Tumors, Malignant Malignant Meningeal Neoplasm Squamous or glandular cervical intraepithelial neoplasia characterized by the presence of mild dysplastic changes. C4630 Neoplastic Process Low Grade Cervical Intraepithelial Neoplasia C0349458 GDC 8077/0 Undetermined Low-Grade_Cervical_Intraepithelial_Neoplasia 8077/0 Cervical intraepithelial neoplasia, low grade Cervical intraepithelial neoplasia, low grade Low Grade Cervical Intraepithelial Neoplasia Low-Grade Cervix Intraepithelial Neoplasia Low-Grade Cervix Uteri Intraepithelial Neoplasia Low-Grade Intraepithelial Neoplasia of Cervix Low-Grade Intraepithelial Neoplasia of Cervix Uteri Low-Grade Intraepithelial Neoplasia of Uterine Cervix Low-Grade Intraepithelial Neoplasia of the Cervix Low-Grade Intraepithelial Neoplasia of the Cervix Uteri Low-Grade Intraepithelial Neoplasia of the Uterine Cervix Low-Grade Uterine Cervix Intraepithelial Neoplasia Low Grade Cervical Intraepithelial Neoplasia A benign tumor that possesses various epidermal derivatives and is due to sequestration of skin along the lines of embryonic closure. C4632 Neoplastic Process Skin Dermoid Cyst C0349502 Benign Dermoid_Cyst_of_the_Skin Cutaneous Dermoid Cyst Cystic Skin Teratoma Dermoid Cyst of Skin Dermoid Cyst of the Skin Skin Dermoid Skin Dermoid Cyst Subcutaneous Dermoid Cyst Skin Dermoid Cyst A rare cutaneous melanoma where most of the melanoma tumor cells are devoid of melanin pigment. Amelanotic melanomas are more likely to present at a more advanced stage of disease, compared with pigmented melanomas. C4633 Neoplastic Process Amelanotic Skin Melanoma Amelanotic Cutaneous Melanoma C0349515 CTRP Cellosaurus Malignant Amelanotic_Skin_Melanoma Amelanotic Cutaneous (Skin) Melanoma Amelanotic Cutaneous Melanoma Amelanotic Malignant Melanoma (of Skin) Amelanotic Malignant Melanoma of Skin Amelanotic Malignant Melanoma of the Skin Amelanotic Malignant Skin Melanoma Amelanotic Melanoma of Skin Amelanotic Melanoma of the Skin Amelanotic Skin Melanoma Amelanotic Cutaneous Melanoma A neoplasm arising from the dermis. It is characterized by the presence of neoplastic fibroblasts. C4634 Neoplastic Process Skin Fibroblastic Neoplasm C0349527 Undetermined Cutaneous_Fibrous_Tissue_Neoplasm Cutaneous Fibroblastic Neoplasm Cutaneous Fibroblastic Tumor Cutaneous Fibrocytic Neoplasm Cutaneous Fibrocytic Tumor Cutaneous Fibrous Tissue Neoplasm Cutaneous Fibrous Tissue Tumor Skin Fibroblastic Neoplasm Skin Fibrous Tissue Neoplasm Skin Fibrous Tissue Tumor Skin Fibroblastic Neoplasm A well differentiated, low grade neuroendocrine neoplasm that arises from the stomach. The vast majority of cases arise from the corpus-fundus region. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. It may be associated with autoimmune chronic atrophic gastritis, multiple endocrine neoplasia type 1, or it may be sporadic. C4635 Neoplastic Process Gastric Neuroendocrine Tumor G1 Gastric Neuroendocrine Tumor G1 C0349529 CPTAC CTRP Undetermined Gastric_Carcinoid_Tumor Gastric ECL Cell NET Gastric ECL Cell NET G1 Gastric ECL Cell, Histamine-Producing NET Gastric Enterochromaffin-Like Cell Neuroendocrine Tumor Gastric NET G1 Gastric Neuroendocrine Tumor G1 Gastric Neuroendocrine Tumor G1 An extranodal lymphoma that arises from the stomach with the bulk of the mass located in the stomach. The vast majority of cases are diffuse large B-cell lymphomas and B-cell lymphomas of the mucosa-associated lymphoid tissue. C4636 Neoplastic Process Gastric Lymphoma C0349532 Malignant Gastric_Lymphoma Gastric Lymphoma Lymphoma of Stomach Lymphoma of the Stomach Primary Gastric Lymphoma Gastric Lymphoma A well differentiated, low grade neuroendocrine neoplasm that arises from the small or large intestine. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. C4637 Neoplastic Process Intestinal Neuroendocrine Tumor G1 C0349535 Undetermined Intestinal_Carcinoid_Tumor Intestinal Carcinoid Tumor Intestinal NET G1 Intestinal Neuroendocrine Tumor G1 Intestinal Neuroendocrine Tumor G1 A well differentiated, low grade neuroendocrine neoplasm that arises from the small intestine. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. C4638 Neoplastic Process Small Intestinal Neuroendocrine Tumor G1 C0349536 CPTAC Undetermined Small_Intestinal_Carcinoid_Tumor Small Intestinal Carcinoid Tumor Small Intestinal NET G1 Small Intestinal Neuroendocrine Tumor G1 Small Intestinal Neuroendocrine Tumor G1 A melanoma arising from the anus. Clinical presentation includes rectal bleeding, tenesmus, pain, and change in bowel habit. The prognosis is usually poor. C4639 Neoplastic Process Anal Melanoma C0349538 mCode Malignant Anal_Melanoma Anal Malignant Melanoma Anal Melanoma Malignant Melanoma of Anus Malignant Melanoma of the Anus Malignant melanoma of anal skin Melanoma of Anus Melanoma of the Anus Anal Melanoma An aggressive malignant melanocytic neoplasm that arises from the rectum. C4640 Neoplastic Process Rectal Melanoma C0349539 Cellosaurus Malignant Rectal_Melanoma Malignant Melanoma of Rectum Malignant Melanoma of the Rectum Melanoma of Rectum Melanoma of the Rectum Rectal Malignant Melanoma Rectal Melanoma Rectal Melanoma A low or high grade astrocytoma that arises in the spinal cord. C4641 Neoplastic Process Spinal Cord Astrocytoma C0349540 Undetermined Spinal_Cord_Astrocytoma Astrocytoma of Spinal Cord Astrocytoma of the Spinal Cord Spinal Astrocytoma Spinal Cord Astrocytoma Spinal Cord Astrocytoma A glioblastoma that arises from the brain, usually the cerebral hemispheres. C4642 Neoplastic Process Brain Glioblastoma C0349543 Malignant Brain_Glioblastoma Brain Glioblastoma Brain Glioblastoma Multiforme Glioblastoma Multiforme of Brain Glioblastoma Multiforme of the Brain Brain Glioblastoma A rare squamous cell carcinoma that arises from the scrotum. It has been associated with exposure to environmental and industrial carcinogens. The prognosis depends on the extent of lymph node involvement. C4643 Neoplastic Process Scrotal Squamous Cell Carcinoma C0349551 Malignant Scrotal_Squamous_Cell_Carcinoma Scrotal Squamous Cell Carcinoma Squamous Cell Carcinoma of Scrotum Squamous Cell Carcinoma of the Scrotum Scrotal Squamous Cell Carcinoma Vaginal intraepithelial neoplasia characterized by the presence of koilocytosis and disorganization and thickening of the basal layer. C4644 Neoplastic Process Low Grade Vaginal Intraepithelial Neoplasia C0349554 Undetermined Low_Grade_Vaginal_Intraepithelial_Neoplasia Grade 1 Vaginal Intraepithelial Neoplasia Grade I Vaginal Intraepithelial Neoplasia Intraepithelial Neoplasia of Vagina Grade 1 Intraepithelial Neoplasia of the Vagina Grade 1 Low Grade VAIN Low Grade Vaginal Intraepithelial Neoplasia Low Grade Vaginal Squamous Intraepithelial Lesion Low-Grade Vaginal Squamous Intraepithelial Lesion VAIN 1 VAIN Grade 1 Vaginal Intraepithelial Neoplasia Grade 1 Vaginal LSIL Vaginal Low Grade Squamous Intraepithelial Lesion Vaginal Low-Grade Squamous Intraepithelial Lesion Low Grade Vaginal Intraepithelial Neoplasia Vaginal intraepithelial neoplasia characterized by the presence of nuclear intraepithelial neoplastic changes in the lower two-thirds of the epithelium and parakeratosis. C4645 Neoplastic Process Grade 2 Vaginal Intraepithelial Neoplasia C0349555 Undetermined Grade_II_Vaginal_Intraepithelial_Neoplasia Grade 2 VAIN Grade 2 Vaginal Intraepithelial Neoplasia Grade II Vaginal Intraepithelial Neoplasia Intraepithelial Neoplasia of Vagina Grade 2 Intraepithelial Neoplasia of the Vagina Grade 2 VAIN 2 VAIN II Vaginal Intraepithelial Neoplasia Grade 2 Grade 2 Vaginal Intraepithelial Neoplasia A rare, highly malignant epithelial tumor that develops from a hydatidiform mole (50%), following abortion (25%), or during normal pregnancy (22%). It is characterized by the presence of invasive and anaplastic trophoblastic tissue composed of intermediate trophoblastic cells, cytotrophoblasts and syncytiotrophoblasts, abundant vascularity, and secretion of human chorionic gonadotropin. Because of rapid growth and a high propensity for hemorrhage, this neoplasm often constitutes a medical emergency. C4646 Neoplastic Process Gestational Choriocarcinoma C0349557 Cellosaurus Malignant Gestational_Choriocarcinoma Gestational Choriocarcinoma Gestational Choriocarcinoma A benign, mesenchymal neoplasm that arises from the breast. It is surrounded by a thin capsule and composed of mature adipose tissue cells. Atypia is absent. C4647 Neoplastic Process Breast Lipoma C0349565 Benign Breast_Lipoma Breast Lipoma Lipoma of Breast Lipoma of the Breast Breast Lipoma A squamous cell carcinoma that arises from the tongue. It usually presents as a painful ulcerated or nodular lesion. The size of the tumor and the status of the lymph nodes are the most important factors that determine prognosis. C4648 Neoplastic Process Tongue Squamous Cell Carcinoma C0349566 Cellosaurus Malignant Tongue_Squamous_Cell_Carcinoma SCC of Tongue SCC of the Tongue Squamous Cell Carcinoma of Tongue Squamous Cell Carcinoma of the Tongue Tongue SCC Tongue Squamous Cell Carcinoma Tongue Squamous Cell Carcinoma A squamous cell carcinoma that arises from the hard or soft palate. C4649 Neoplastic Process Palate Squamous Cell Carcinoma C0349568 Malignant Palate_Squamous_Cell_Carcinoma Palate SCC Palate Squamous Cell Carcinoma SCC of Palate SCC of the Palate Squamous Cell Carcinoma of Palate Squamous Cell Carcinoma of the Palate Palate Squamous Cell Carcinoma A benign, slow-growing tumor that arises from the parotid gland. It is composed of cells that demonstrate both epithelial and mesenchymal differentiation. It is the most common neoplasm of salivary gland origin and women are more often affected than men. C4650 Neoplastic Process Parotid Gland Pleomorphic Adenoma C0349571 Cellosaurus Benign Parotid_Gland_Pleomorphic_Adenoma Benign Mixed Tumor of Parotid Gland Benign Mixed Tumor of the Parotid Gland Parotid Gland Benign Mixed Tumor Parotid Gland Pleomorphic Adenoma Parotid Pleomorphic Adenoma Pleomorphic Adenoma of Parotid Pleomorphic Adenoma of Parotid Gland Pleomorphic Adenoma of the Parotid Pleomorphic Adenoma of the Parotid Gland Parotid Gland Pleomorphic Adenoma A benign or malignant neoplasm that affects the pericardium. C4651 Neoplastic Process Pericardial Neoplasm C0349574 Undetermined Pericardial_Neoplasm Neoplasm of Pericardium Neoplasm of the Pericardium Pericardial Neoplasm Pericardial Tumor Tumor of Pericardium Tumor of the Pericardium Pericardial Neoplasm A benign or malignant neoplasm that affects the external ear. Representative examples include ceruminous adenoma, polyp, and carcinoma. C4652 Neoplastic Process External Ear Neoplasm C0349575 Undetermined External_Ear_Neoplasm External Ear Neoplasm External Ear Tumor Neoplasm of External Ear Neoplasm of the External Ear Tumor of External Ear Tumor of the External Ear External Ear Neoplasm A malignant neoplasm that affects the external ear. Representative examples include squamous cell carcinoma, basal cell carcinoma, and ceruminous adenocarcinoma. C4653 Neoplastic Process Malignant External Ear Neoplasm C0349576 CPTAC Malignant Malignant_External_Ear_Neoplasm Other and unspecified malignant neoplasm of skin of ear and external auditory canal Malignant External Ear Neoplasm Malignant External Ear Tumor Malignant Neoplasm of External Ear Malignant Neoplasm of the External Ear Malignant Tumor of External Ear Malignant Tumor of the External Ear Malignant External Ear Neoplasm A benign schwannoma occurring in the trigeminal nerve. C4655 Neoplastic Process Trigeminal Schwannoma C0349582 Benign Trigeminal_Schwannoma Fifth Cranial Nerve Neurilemmoma Fifth Cranial Nerve Schwannoma Neurilemmoma of Fifth Cranial Nerve Neurilemmoma of Trigeminal Nerve Neurilemmoma of the Fifth Cranial Nerve Neurilemmoma of the Trigeminal Nerve Schwannoma of Fifth Cranial Nerve Schwannoma of Trigeminal Nerve Schwannoma of the Fifth Cranial Nerve Schwannoma of the Trigeminal Nerve Trigeminal Neurilemmoma Trigeminal Schwannoma Trigeminal Schwannoma A meningioma that arises within the cranial cavity. C4656 Neoplastic Process Intracranial Meningioma C0349604 Cellosaurus Undetermined Intracranial_Meningioma Intracranial Meningioma Intracranial Meningioma A germ cell tumor that arises in the pineal region. Representative examples include teratoma, germinoma, and choriocarcinoma. C4659 Neoplastic Process Pineal Region Germ Cell Tumor C0349621 Undetermined Pineal_Region_Germ_Cell_Tumor Pineal Area Germ Cell Neoplasm Pineal Area Germ Cell Tumor Pineal Germ Cell Neoplasm Pineal Germ Cell Tumor Pineal Region Germ Cell Neoplasm Pineal Region Germ Cell Tumor Pineal Region Germ Cell Tumor A solitary fibrous tumor that arises from the meninges. C4660 Neoplastic Process Meningeal Solitary Fibrous Tumor C0349622 Undetermined Meningeal_Hemangiopericytoma Hemangiopericytoma of Meninges Hemangiopericytoma of the Meninges Meningeal Hemangiopericytoma Meningeal Solitary Fibrous Tumor Meningeal Solitary Fibrous Tumor/Hemangiopericytoma Meninges Hemangiopericytoma Meningeal Solitary Fibrous Tumor A melanocytic neoplasm that arises from the leptomeninges. This category includes diffuse proliferative processes (melanocytosis and melanomatosis) and circumscribed processes (melanocytoma and melanoma). C4661 Neoplastic Process Central Nervous System Melanocytic Neoplasm C0349623 C1332887 Undetermined Central_Nervous_System_Melanocytic_Neoplasm Primary_Melanocytic_Lesion_of_Meninges CNS Melanocytic Neoplasm CNS Melanocytic Tumor Central Nervous System Melanocytic Neoplasm Central Nervous System Melanocytic Tumor Primary Central Nervous System Melanocytic Neoplasm Primary Central Nervous System Melanocytic Tumor Primary Meningeal Melanocytic Neoplasm Primary Meningeal Melanocytic Tumor Central Nervous System Melanocytic Neoplasm A usually well differentiated melanocytic neoplasm arising from the meninges. It is characterized by the presence of epithelioid, fusiform, polyhedral, and spindle melanocytes without evidence of hemorrhage, necrosis, or high mitotic activity. Presenting symptoms include headache, vomiting, and neurological manifestations. Complete excision is usually curative. C4662 Neoplastic Process Meningeal Melanocytoma C1266113 GDC 8728/1 Benign Meningeal_Melanocytoma 8728/1 Meningeal melanocytoma Leptomeningeal Melanocytoma Melanocytoma of Meninges Melanocytoma of the Meninges Meningeal Melanocytoma Meningeal melanocytoma Meninges Melanocytoma Meningeal Melanocytoma A B-cell non-Hodgkin lymphoma composed of small lymphocytes which surround and replace the splenic white pulp germinal centers. It involves the spleen and splenic hilar lymph nodes, bone marrow, and often the peripheral blood. When lymphoma cells are present in the peripheral blood, they are usually, but not always, characterized by the presence of short polar villi. (WHO) C4663 Neoplastic Process Splenic Marginal Zone Lymphoma Splenic Marginal Zone Lymphoma C0349632 CTRP Cellosaurus GDC 9689/3 Malignant Splenic_Marginal_Zone_Lymphoma 9689/3 Splenic marginal zone B-cell lymphoma Splenic marginal zone lymphoma, NOS Marginal Zone Lymphoma of Spleen Marginal Zone Lymphoma of the Spleen SLVL SMZL Splenic Lymphoma with Circulating Villous Lymphocytes Splenic Marginal Zone B-Cell Lymphoma Splenic Marginal Zone B-Cell Lymphoma with Villous Lymphocytes Splenic Marginal Zone Lymphoma Splenic Marginal Zone Lymphoma with Villous Lymphocytes Splenic marginal zone B-cell lymphoma Splenic marginal zone lymphoma, NOS Splenic Marginal Zone Lymphoma A T-cell peripheral neoplasm characterized by a persistent (>6 months) increase in the number of peripheral blood large granular lymphocytes, without a clearly identified cause. (WHO, 2001) C4664 Neoplastic Process T-Cell Large Granular Lymphocyte Leukemia T-Cell Large Granular Lymphocyte Leukemia C1955861 CDISC CTEP CTRP Cellosaurus GDC A progressive, proliferative disease of blood cells which are large and granular, originating from lymphoid cells. A type of leukemia in which large T lymphocytes (a type of white blood cell) that contain granules (small particles) are found in the blood. It is a chronic disease that may last for a long time and get worse. 9768/1 9831/1 9831/3 Malignant T-Cell_Large_Granular_Lymphocyte_Leukemia 9768/1 9831/3 T-cell large granular lymphocytic leukemia T-cell large granular lymphocytosis T-gamma lymphoproliferative disease LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC, MALIGNANT LGLL Large Cell Granular Lymphogenous Leukemia Large Cell Granular Lymphoid Leukemia Large Granular Lymphocytic Leukemia Large Granular Lymphocytosis T Gamma Lymphoproliferative Disorder T Large Granular Lymphocyte Leukemia T-Cell Large Granular Lymphocyte Leukemia T-Cell Large Granular Lymphocytic Leukemia T-Gamma Lymphoproliferative Disorder T-LGL leukemia T-Large Granular Lymphocyte Leukemia T-cell large gran. lymph. leuk. T-cell large granular lymphocyte leukemia T-cell large granular lymphocytic leukemia T-cell large granular lymphocytosis T-gamma lymphoproliferative disease Tgamma Large Granular Lymphocyte Leukemia T-Cell Large Granular Lymphocyte Leukemia A clonal proliferation of immunoglobulin-secreting plasma cells. This category includes multiple myeloma, plasma cell leukemia, plasmacytoma, and plasma cell post-transplant lymphoproliferative disorder. C4665 Neoplastic Process Plasma Cell Neoplasm Plasma Cell Neoplasm C1136084 CDISC CPTAC CTRP GDC A malignant neoplasm composed of plasma cells. A tumor that begins in plasma cells (white blood cells that produce antibodies). Multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), and plasmacytoma are types of plasma cell tumors. Malignant Plasma_Cell_Neoplasm 9731/3 Multiple myeloma and malignant plasma cell neoplasms Neoplasm of uncertain behavior of plasma cells Plasma Cell Tumors Plasma cell tumor PLASMA CELL TUMOR, MALIGNANT Plasma Cell Dyscrasia Plasma Cell Neoplasm Plasma Cell Tumor Plasma Cell Tumors Plasma cell tumor Plasmacytic Neoplasm Plasmacytic Tumor Plasmacytic Tumour plasma cell tumor Plasma Cell Neoplasm A squamous cell carcinoma of the skin with a prominent spindle cell component. C4666 Neoplastic Process Skin Spindle Cell Squamous Cell Carcinoma C0349656 CPTAC Malignant Spindle_Cell_Sarcomatoid_Squamous_Cell_Skin_Carcinoma Skin Spindle Cell Squamous Carcinoma Skin Spindle Cell Squamous Cell Carcinoma Spindle Cell Squamous Carcinoma of Skin Spindle Cell Squamous Carcinoma of the Skin Spindle cell squamous cell carcinoma Skin Spindle Cell Squamous Cell Carcinoma An extragonadal immature teratoma that arises from the mediastinum. C4668 Neoplastic Process Mediastinal Immature Teratoma CL563153 Undetermined Immature_Mediastinal_Teratoma Immature Mediastinal Teratoma Immature Teratoma of Mediastinum Immature Teratoma of the Mediastinum Mediastinal Immature Teratoma Mediastinal Immature Teratoma A malignant mesenchymal cell neoplasm that affects the urinary bladder. C4669 Neoplastic Process Bladder Sarcoma C0349666 Malignant Bladder_Sarcoma Bladder Sarcoma Sarcoma of Bladder Sarcoma of Urinary Bladder Sarcoma of the Bladder Sarcoma of the Urinary Bladder Urinary Bladder Sarcoma Bladder Sarcoma A malignant mesenchymal neoplasm that arises from the breast. Representative examples include angiosarcoma, liposarcoma, leiomyosarcoma, rhabdomyosarcoma, and extraskeletal osteosarcoma. C4670 Neoplastic Process Breast Sarcoma C0349667 Malignant Breast_Sarcoma Breast Sarcoma Sarcoma of Breast Sarcoma of the Breast Breast Sarcoma A lymphoma that arises from the breast. There is no history of extramammary breast lymphoma and ipsilateral axillary lymph node involvement does not exclude the diagnosis of primary breast lymphoma. Most patients present with a painless breast lump. The vast majority of cases are B-cell non-Hodgkin lymphomas. Diffuse large B-cell lymphoma, follicular lymphoma, and extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue are the most common types of primary non-Hodgkin lymphoma of the breast. Primary Hodgkin lymphoma of the breast is rare. C4671 Neoplastic Process Breast Lymphoma C0349669 Malignant Breast_Lymphoma Breast Lymphoma Lymphoma of Breast Lymphoma of the Breast PBL Primary Breast Lymphoma Breast Lymphoma A sex cord-stromal tumor that arises from the testis and is characterized by the presence of neoplastic cells with features of Sertoli cells. It usually presents as a slow growing testicular mass. The vast majority of cases follow a benign clinical course. C4672 Neoplastic Process Testicular Sertoli Cell Tumor C0349671 NICHD A Sertoli cell tumor that occurs in the testis. Undetermined Testicular_Sertoli_Cell_Tumor Sertoli Cell Neoplasm of Testis Sertoli Cell Neoplasm of the Testis Sertoli Cell Tumor of Testis Sertoli Cell Tumor of the Testis Testicular Sertoli Cell Neoplasm Testicular Sertoli Cell Tumor Testicular Sertoli Cell Tumor An acute leukemia of ambiguous lineage characterized by blasts which coexpress myeloid and T or B lineage antigens or concurrent B and T lineage antigens. (WHO, 2001) C4673 Neoplastic Process Acute Biphenotypic Leukemia Acute Biphenotypic Leukemia C0023464 CTRP Cellosaurus GDC NICHD An acute leukemia characterized by a single population of blasts that coexpress myeloid and lymphoid antigens. 9805/3 Malignant Acute_Biphenotypic_Leukemia 9805/3 Acute biphenotypic leukemia Acute Biphenotypic Leukemia Acute biphenotypic leukemia Acute Biphenotypic Leukemia A benign or malignant neoplasm that affects the skull base. C4676 Neoplastic Process Skull Base Neoplasm C0376527 Undetermined Skull_Base_Neoplasm Neoplasm of Skull Base Neoplasm of the Skull Base Skull Base Neoplasm Skull Base Tumor Tumor of Skull Base Tumor of the Skull Base Skull Base Neoplasm A superficial fibromatosis arising from soft tissue of the plantar regions. It is characterized by the presence of spindle-shaped fibroblasts, hypercellularity, and an infiltrative growth pattern. C4680 Neoplastic Process Plantar Fibromatosis C0158360 Undetermined Plantar_Fibromatosis Ledderhose Disease Ledderhose's Disease Plantar Fibromatosis Plantar Fibromatosis A low grade fibroblastic neoplasm presenting as a nodular cutaneous mass, most often on the trunk and the proximal extremities. The tumor diffusely infiltrates the dermis and the subcutaneous tissues. It is considered a locally aggressive neoplasm, which often recurs but rarely metastasizes. C4683 Neoplastic Process Dermatofibrosarcoma Protuberans Dermatofibrosarcoma Protuberans C0392784 CTEP CTRP Cellosaurus GDC A type of tumor that begins as a hard nodule and grows slowly. These tumors are usually found in the dermis (the inner layer of the two main layers of tissue that make up the skin) of the limbs or trunk of the body. They can grow into surrounding tissue but do not spread to other parts of the body. These tumors are related to giant cell fibroblastomas. 8832/3 Undetermined Dermatofibrosarcoma_Protuberans 8832/3 Dermatofibrosarcoma protuberans, NOS Dermatofibrosarcoma, NOS DFSP Dermatofibrosarcoma Dermatofibrosarcoma Protuberans Dermatofibrosarcoma protuberans, NOS dermatofibrosarcoma protuberans Dermatofibrosarcoma Protuberans An aggressive, predominantly extranodal, mature T-cell non-Hodgkin lymphoma. It is characterized by an often angiocentric and angiodestructive cellular infiltrate composed of EBV positive NK/T cells. The nasal cavity is the most common site of involvement. Patients often present with midfacial destructive lesions (lethal midline granuloma). The disease may disseminate rapidly to various anatomic sites including the gastrointestinal tract, skin, testis, and cervical lymph nodes. It is also known as angiocentric T-cell lymphoma. The term "polymorphic reticulosis" has been widely used to describe the morphologic changes seen in this type of lymphoma. However, the latter term may also apply to lymphomatoid granulomatosis, which is an angiocentric and angiodestructive EBV positive B-cell lymphoproliferative disorder. C4684 Neoplastic Process Nasal Type Extranodal NK/T-Cell Lymphoma Nasal Type Extranodal NK/T-Cell Lymphoma C0392788 CDISC CTEP CTRP Cellosaurus GDC mCode A malignant lymphoid neoplasm composed of EBV-positive NK/T cells arranged in an angiocentric pattern. 9719/3 Malignant Nasal_Type_Extranodal_NK_T-Cell_Lymphoma 9719/3 Angiocentric T-cell lymphoma Extranodal NK/T-cell lymphoma, nasal type Malignant reticulosis, NOS NK/T-cell lymphoma, nasal and nasal type NK/T-cell lymphoma, nasal and nasal-type T/NK-cell lymphoma Angiocentric T-Cell Lymphoma Angiocentric T-cell lymphoma Extranodal NK/T lymphoma-nasal Extranodal NK/T-Cell Lymphoma Extranodal NK/T-Cell Lymphoma, Nasal Type Extranodal NK/T-cell lymphoma, nasal type NK/T-cell lymphoma, nasal and nasal-type Nasal Type Extranodal NK/T-Cell Lymphoma RETICULOSIS, MALIGNANT T/NK-cell lymphoma Nasal Type Extranodal NK/T-Cell Lymphoma A diverse group of pregnancy-related tumors characterized by excessive proliferation of trophoblasts. It includes gestational choriocarcinoma, epithelioid trophoblastic tumor, placental site trophoblastic tumor, and mixed trophoblastic tumor. C4699 Neoplastic Process Gestational Trophoblastic Tumor Gestational Trophoblastic Tumor C1135868 CPTAC CTEP CTRP Any of a group of tumors that develops from trophoblastic cells (cells that help an embryo attach to the uterus and help form the placenta) after fertilization of an egg by a sperm. The two main types of gestational trophoblastic tumors are hydatidiform mole and choriocarcinoma. Undetermined Gestational_Trophoblastic_Tumor GTT Gestational Trophoblastic Tumor gestational trophoblastic neoplasia gestational trophoblastic tumor Gestational Trophoblastic Tumor A rare, locally aggressive fibroblastic neoplasm typically affecting young patients (predominantly boys). It manifests with painless nodules in the dermis or subcutaneous tissues. Morphologically, it contains giant cells and wide vessel-like spaces. This tumor can recur but metastases have not been reported. C4700 Neoplastic Process Giant Cell Fibroblastoma C0406579 GDC A rare type of soft tissue tumor marked by painless nodules in the dermis (the inner layer of the two main layers of tissue that make up the skin) and subcutaneous (beneath the skin) tissue. These tumors may come back after surgery, but they do not spread to other parts of the body. They occur mostly in boys and are related to dermatofibrosarcoma protuberans. 8834/1 Undetermined Giant_Cell_Fibroblastoma 8834/1 Giant cell fibroblastoma GCF Giant Cell Fibroblastoma Giant cell fibroblastoma giant cell fibroblastoma Giant Cell Fibroblastoma A rare neoplastic syndrome characterized by the presence of unilateral lipomas of the cranium, face and neck, and ipsilateral cerebral malformations. C4701 Neoplastic Process Encephalocraniocutaneous Lipomatosis C0406612 Benign Encephalocraniocutaneous_Lipomatosis ECCL Encephalocraniocutaneous Lipomatosis Fishman Syndrome Encephalocraniocutaneous Lipomatosis An ependymoma which shows conspicuous cellularity without a significant increase in mitotic rate. (Adapted from WHO) C4713 Neoplastic Process Cellular Ependymoma C1384403 GDC Undetermined Cellular_Ependymoma 9391/3 Cellular ependymoma Cellular Ependymoma Cellular ependymoma Cellular Ependymoma An ependymoma, often supratentorial in location, characterized by the presence of ependymal cells with a perinuclear halo. C4714 Neoplastic Process Clear Cell Ependymoma C1384404 GDC Undetermined Clear_Cell_Ependymoma 9391/3 Clear cell ependymoma Clear Cell Ependymoma Clear cell ependymoma Clear Cell Ependymoma A malignant neoplasm arising from the choroid plexus. It shows anaplastic features and usually invades neighboring brain structures. Cerebrospinal fluid metastases are frequent. (Adapted from WHO) C4715 Neoplastic Process Choroid Plexus Carcinoma Choroid Plexus Carcinoma C0431109 CDISC CPTAC CTEP CTRP Cellosaurus GDC A malignant neoplasm arising from the choroid plexus of the brain. 9390/3 Malignant Choroid_Plexus_Carcinoma 9390/3 Choroid plexus carcinoma Choroid plexus papilloma, anaplastic Choroid plexus papilloma, malignant Anaplastic Choroid Plexus Papilloma CARCINOMA, CHOROID PLEXUS, MALIGNANT Cancer of Choroid Plexus Cancer of the Choroid Plexus Carcinoma of Choroid Plexus Carcinoma of the Choroid Plexus Choroid Plexus Cancer Choroid Plexus Carcinoma Choroid plexus carcinoma Choroid plexus papilloma, anaplastic Choroid plexus papilloma, malignant Choroid Plexus Carcinoma An exceedingly rare, aggressive malignant mesenchymal neoplasm characterized by the presence of a sarcomatous component and a ganglionic or a neuroectodermal component. C4716 Neoplastic Process Ectomesenchymoma C0431111 GDC A rare, fast-growing tumor of the nervous system or soft tissue that occurs in children and young adults. Ectomesenchymomas may form in the head and neck, abdomen, perineum, scrotum, or limbs. 8921/3 Malignant Rhabdomyosarcoma_with_Ganglionic_Differentiation 8921/3 Ectomesenchymoma Rhabdomyosarcoma with ganglionic differentiation Ectomesenchymoma Malignant Ectomesenchymoma Sarcoma with Ganglionic or Neuroectodermal Differentiation ectomesenchymoma malignant ectomesenchymoma Ectomesenchymoma A WHO grade III neuroepithelial neoplasm composed of neoplastic, mature ganglion cells and anaplastic glial cells. The anaplastic changes in the glial component and high MIB-1 and TP53 labeling indices may indicate aggressive behavior. However, the correlation of histological anaplasia with clinical outcome is inconsistent. (Adapted from WHO) C4717 Neoplastic Process Anaplastic Ganglioglioma C0431112 GDC 9505/3 Malignant Anaplastic_Ganglioglioma 9505/3 Ganglioglioma, anaplastic Anaplastic Ganglioglioma Ganglioglioma, anaplastic Anaplastic Ganglioglioma A WHO grade I meningioma characterized by the presence of epithelial differentiation and numerous intracellular PAS positive bodies that are rich in glycogen. C4718 Neoplastic Process Secretory Meningioma C1384406 GDC Undetermined Secretory_Meningioma 9530/0 Secretory meningioma Secretory Meningioma Secretory meningioma Secretory Meningioma A meningioma that affects the choroid plexus. C4719 Neoplastic Process Choroid Plexus Meningioma C0431118 Undetermined Choroid_Plexus_Meningioma Choroid Plexus Meningioma Meningioma of Choroid Plexus Meningioma of the Choroid Plexus Choroid Plexus Meningioma A WHO grade I meningioma characterized by the presence of prominent chronic inflammatory infiltrates that predominate over the meningioma cells. C4720 Neoplastic Process Lymphoplasmacyte-Rich Meningioma C0431119 GDC Undetermined Lymphoplasmacyte-Rich_Meningioma 9530/0 Lymphoplasmacyte-rich meningioma Lymphoplasmacyte-Rich Meningioma Lymphoplasmacyte-rich meningioma Lymphoplasmacyte-Rich Meningioma A WHO grade I meningioma characterized by the presence of intercellular microcystic spaces that contain mucinous fluid. C4721 Neoplastic Process Microcystic Meningioma C1384408 GDC Undetermined Microcystic_Meningioma 9530/0 Microcystic meningioma Microcystic Meningioma Microcystic meningioma Microcystic Meningioma A WHO grade II morphologic variant of meningioma characterized by the presence of clear glycogen-rich polygonal cells. C4722 Neoplastic Process Clear Cell Meningioma C0431121 GDC 9538/1 Undetermined Clear_Cell_Meningioma 9538/1 Clear cell meningioma Clear Cell Meningioma Clear cell meningioma Clear Cell Meningioma A WHO grade II meningioma characterized by the presence of brain invasion and an increased mitotic activity, or at least three of the following morphologic features: small cells, high cellularity, prominent nucleoli, lack of architectural pattern, and necrosis. C4723 Neoplastic Process Atypical Meningioma C0431122 GDC 9539/1 Undetermined Atypical_Meningioma 9539/1 Atypical meningioma Atypical Meningioma Atypical meningioma Atypical Meningioma A morphologic variant of schwannoma characterized by hypercellularity, Antoni A pattern, and the absence of well-formed Verocay bodies. C4724 Neoplastic Process Cellular Schwannoma C0431124 GDC Benign Cellular_Schwannoma 9560/0 Cellular schwannoma Cellular Neurilemmoma Cellular Neurinoma Cellular Schwannoma Cellular schwannoma Cellular Schwannoma A craniopharyngioma composed of sheets of squamous epithelium which separate to form pseudopapillae. This variant typically lacks nuclear palisading, wet keratin, calcification, and cholesterol deposits. Clinically, endocrine deficiencies are more often associated with papillary craniopharyngioma than with the adamantinomatous type. (Adapted from WHO) C4725 Neoplastic Process Papillary Craniopharyngioma C0431128 Cellosaurus GDC 9352/1 Benign Papillary_Craniopharyngioma 9352/1 Craniopharyngioma, papillary Craniopharyngioma, papillary PCP Papillary Craniopharyngioma Papillary Neoplasm of Rathke's Pouch Papillary Rathke Pouch Neoplasm Papillary Rathke's Pouch Neoplasm Papillary Rathke's Pouch Tumor Papillary Tumor of Rathke's Pouch Papillary Craniopharyngioma A craniopharyngioma consisting of broad strands, cords and bridges of a multistratified squamous epithelium with peripheral palisading of nuclei. Diagnostic features include nodules of compact 'wet' keratin and dystrophic calcification. (Adapted from WHO) C4726 Neoplastic Process Adamantinomatous Craniopharyngioma C0431129 GDC 9351/1 Benign Adamantinous_Craniopharyngioma 9351/1 Craniopharyngioma, adamantinomatous ACP Adamantinomatous Craniopharyngioma Adamantinous Craniopharyngioma Adamantinous Neoplasm of Rathke's Pouch Adamantinous Rathke's Pouch Neoplasm Adamantinous Rathke's Pouch Tumor Adamantinous Tumor of Rathke's Pouch Craniopharyngioma, adamantinomatous Adamantinomatous Craniopharyngioma A rapidly growing, poorly circumscribed, mass-forming proliferation that arises from the subcutaneous tissues. It is characterized by the presence of spindle-shaped fibroblasts, round ganglion-like cells, myxoid to collagenous stroma formation, and high mitotic activity. It recurs only rarely following local excision and does not metastasize. C4728 Neoplastic Process Proliferative Fasciitis C0432528 Benign Proliferative_Fasciitis Proliferative Fasciitis Proliferative Fasciitis A rare self-limiting, rapidly growing, non-encapsulated benign neoplasm that arises from the vessels. It is characterized by the presence of plump spindle-shaped fibroblasts, multinucleated osteoclast-like giant cells, chronic inflammatory infiltrate, red blood cell extravasation, and high mitotic activity. C4729 Neoplastic Process Intravascular Nodular Fasciitis C0432529 Benign Intravascular_Nodular_Fasciitis Intravascular Fasciitis Intravascular Nodular Fasciitis Intravascular Pseudosarcomatous Fasciitis Intravascular Nodular Fasciitis Lobular neoplasia characterized by lobular epithelial proliferation that does not completely fill the lobular unit of the breast. C4730 Neoplastic Process Atypical Lobular Breast Hyperplasia Breast Atypical Lobular Hyperplasia C0442835 CTRP A benign (not cancer) condition in which there are more cells than normal in the breast lobules and the cells look abnormal under a microscope. Having ALH increases the risk of breast cancer. Undetermined Atypical_Lobular_Breast_Hyperplasia ALH Atypical Breast Lobular Hyperplasia Atypical Lobular Breast Hyperplasia Atypical Lobular Hyperplasia of Breast Atypical Lobular Hyperplasia of the Breast Breast Atypical Lobular Hyperplasia atypical lobular breast hyperplasia atypical lobular hyperplasia Breast Atypical Lobular Hyperplasia A rare type of multiple myeloma in which the plasma cells synthesize but do not secrete immunoglobulins. As a result, none of the immunoglobulins appear out of the normal range. The symptoms are generally the same with those of immunoglobulin-secreting myeloma; however, the incidence of renal insufficiency is lower in non-secretory myeloma. The diagnosis can be missed because of the absence of monoclonal immunoglobulin in the serum or urine. C4734 Neoplastic Process Non-Secretory Multiple Myeloma C3898125 Malignant Non-Secretory_Myeloma Non-Secretory Multiple Myeloma Non-Secretory Plasma Cell Myeloma Non-Secretory Multiple Myeloma A mature T-cell and NK-cell non-Hodgkin lymphoma of intraepithelial T-lymphocytes. It usually arises from the small intestine, most commonly the jejunum or ileum. Other less frequent primary anatomic sites include the duodenum, stomach, colon, or outside the gastrointestinal tract. It is characterized by the presence of pleomorphic medium-sized to large T-lymphocytes with vesicular nuclei, prominent nucleoli, and moderate to abundant pale cytoplasm. It is associated with celiac disease. C4737 Neoplastic Process Enteropathy-Associated T-Cell Lymphoma Enteropathy-Associated T-Cell Lymphoma C0456889 CTRP GDC mCode 9717/3 Malignant Enteropathy-Type_T-Cell_Lymphoma 9717/3 Enteropathy associated T-cell lymphoma Enteropathy type intestinal T-cell lymphoma Intestinal T-cell lymphoma EATL Enteropathy Associated T-Cell Lymphoma Enteropathy associated T-cell lymphoma Enteropathy type intestinal T-cell lymphoma Enteropathy-Associated T-Cell Lymphoma Enteropathy-Type T-Cell Lymphoma Enteropathy-type (intestinal) T-cell lymphoma Enteropathy-Associated T-Cell Lymphoma A WHO grade I large cystic tumor that occurs almost exclusively in infants, with a prominent desmoplastic stroma having a neuroepithelial population of neoplastic astrocytes together with a variable neuronal component. It involves the superficial cerebral cortex and leptomeninges, and often attaches to the dura. Although clinically it presents as a large tumor, it generally has a good prognosis following surgical resection. (Adapted from WHO) C4738 Neoplastic Process Desmoplastic Infantile Ganglioglioma C1321878 GDC NICHD A WHO grade I large cystic tumor that occurs almost exclusively in infants. It involves the superficial cerebral cortex and leptomeninges, and often attaches to the dura. Undetermined Desmoplastic_Infantile_Ganglioglioma 9412/1 Desmoplastic infantile ganglioglioma DIG Desmoplastic Infantile Ganglioglioma Desmoplastic infantile ganglioglioma Desmoplastic Infantile Ganglioglioma A benign neoplasm that arises from the ovary and is composed of nests of neoplastic urothelial-type cells in a fibrotic stroma. There is no evidence of atypia or invasion. C4746 Neoplastic Process Benign Ovarian Brenner Tumor C0474834 Benign Benign_Brenner_Tumor Benign_Ovarian_Transitional_Cell_Tumor Benign Brenner Neoplasm of Ovary Benign Brenner Neoplasm of the Ovary Benign Brenner Tumor of Ovary Benign Brenner Tumor of the Ovary Benign Ovarian Brenner Neoplasm Benign Ovarian Brenner Tumor Benign Ovarian Transitional Cell Neoplasm Benign Ovarian Transitional Cell Tumor Benign Ovarian Brenner Tumor A group of central nervous system neoplasms with a variable amount of neuronal and, less consistently, glial differentiation. They occur at a low frequency and usually carry a favorable prognosis. Representative examples include dysplastic cerebellar gangliocytoma, desmoplastic infantile ganglioglioma, desmoplastic infantile astrocytoma, and dysembryoplastic neuroepithelial tumor. (Adapted from WHO) C4747 Neoplastic Process Glioneuronal and Neuronal Tumors C0474844 Undetermined Neuronal_and_Mixed_Neuronal-Glial_Tumor Glioneuronal and Neuronal Tumors Neuronal and Glio-Neuronal Neoplasm Neuronal and Glio-Neuronal Tumor Neuronal and Mixed Neuronal-Glial Tumor Neuronal and Mixed Neuronal-Glial Tumors Glioneuronal and Neuronal Tumors A rare variant of malignant peripheral nerve sheath tumor. It is characterized by the presence of malignant cells that contain melanin. C4748 Neoplastic Process Malignant Melanotic Peripheral Nerve Sheath Tumor C0474847 GDC Malignant Malignant_Melanocytic_Peripheral_Nerve_Sheath_Tumor 9540/3 Melanotic MPNST MMNST Malignant Melanocytic Neoplasm of Peripheral Nerve Sheath Malignant Melanocytic Neoplasm of the Peripheral Nerve Sheath Malignant Melanocytic Peripheral Nerve Sheath Tumor Malignant Melanotic Nerve Sheath Tumor Malignant Melanotic Peripheral Nerve Sheath Tumor Malignant Melanotic Schwannian Tumor Melanocytic MPNST Melanotic MPNST Malignant Melanotic Peripheral Nerve Sheath Tumor A cavernous hemangioma arising from the skin. C4750 Neoplastic Process Skin Cavernous Hemangioma C1710105 Benign Skin_Unilateral_Segmental_Cavernous_Hemangioma Skin Cavernous Hemangioma Skin Cavernous Hemangioma A subtype of Spitz nevus characterized by the presence of heavily pigmented spindle-shaped melanocytes that proliferate in the epidermis or in the epidermis and superficial dermis. It presents as a small and slightly elevated brown or black skin lesion with usually well-demarcated borders. Sometimes the clinical and morphologic features may be difficult to distinguish from melanoma. C4751 Neoplastic Process Pigmented Spindle Cell Nevus C0474967 GDC Benign Pigmented_Spindle_Cell_Nevus 8770/0 Pigmented spindle cell nevus of Reed PSCN Pigmented Spindle Cell Nevus Pigmented Spindle Cell Nevus of Reed Pigmented Spindle Cell Spitz Nevus Pigmented Spindle Cell Variant of Spitz Nevus Pigmented spindle cell nevus of Reed Reed Nevus Spindle Cell Nevus of Reed Pigmented Spindle Cell Nevus An aggressive T-cell leukemia, characterized by the proliferation of small to medium sized prolymphocytes with a mature T-cell phenotype, involving the blood, bone marrow, lymph nodes, liver, spleen, and skin. (WHO, 2001) C4752 Neoplastic Process T-Cell Prolymphocytic Leukemia T-Cell Prolymphocytic Leukemia C2363142 CTRP Cellosaurus GDC 9834/3 Malignant T-Cell_Prolymphocytic_Leukemia 9834/3 Prolymphocytic leukemia, T-cell type Prolymphocytic leukemia, T-cell type T Cell Prolymphocytic Leukemia T Prolymphocytic Leukemia T-Cell Prolymphocytic Leukemia T-Prolymphocytic Leukemia T-Cell Prolymphocytic Leukemia A malignant B-cell lymphoproliferative process affecting the blood, bone marrow, and spleen. The B-prolymphocytes are medium-sized, round lymphoid cells with prominent nucleoli. The B-prolymphocytes must exceed 55% of lymphoid cells in the blood. Cases of transformed chronic lymphocytic leukemia (CLL) and CLL with increased prolymphocytes are excluded. The prognosis is poor. (WHO, 2001) C4753 Neoplastic Process B-Cell Prolymphocytic Leukemia B-Cell Prolymphocytic Leukemia C0475801 CTRP Cellosaurus GDC 9833/3 Malignant B-Cell_Prolymphocytic_Leukemia 9833/3 Prolymphocytic leukemia, B-cell type B Prolymphocytic Leukemia B-Cell Prolymphocytic Leukemia Prolymphocytic leukemia, B-cell type B-Cell Prolymphocytic Leukemia A hemangioma characterized by the presence of spindle endothelial cells. C4754 Neoplastic Process Spindle Cell Hemangioma C1304508 GDC 9136/0 9136/1 Benign Spindle_Cell_Hemangioma 9136/1 Spindle cell angioendothelioma Spindle cell hemangioendothelioma SCH Spindle -Cell Hemangioma Spindle Cell Hemangioendothelioma Spindle Cell Hemangioma Spindle cell hemangioendothelioma Spindle Cell Hemangioma A benign, intermediate, or malignant cartilaginous matrix-producing neoplasm. Representative examples include osteochondroma, chondroblastoma, and chondrosarcoma. C4755 Neoplastic Process Chondrogenic Neoplasm C0476147 Undetermined Chondrogenic_Neoplasm Cartilaginous Neoplasm Cartilaginous Tumor Chondrogenic Neoplasm Chondrogenic Tumor Chondromatous Neoplasm Chondromatous Tumor Neoplasm of Cartilage Neoplasm of the Cartilage Tumor of Cartilage Tumor of the Cartilage Chondrogenic Neoplasm Intraepithelial neoplasia of the vulvar squamous epithelium. There is no evidence of invasion. It includes vulvar squamous intraepithelial lesion, HPV-associated and vulvar intraepithelial neoplasia, HPV-independent. C4756 Neoplastic Process Vulvar Intraepithelial Neoplasia Vulvar Intraepithelial Neoplasia C0346210 CTRP Cellosaurus Undetermined Vulvar_Intraepithelial_Neoplasia Intraepithelial Neoplasia of Vulva Intraepithelial Neoplasia of the Vulva Squamous Vulvar Intraepithelial Neoplasia VIN Vulva Intraepithelial Neoplasia Vulval Intraepithelial Neoplasia Vulvar Intraepithelial Neoplasia Vulvar Intraepithelial Neoplasia A malignant neoplasm that has spread to the liver from another (primary) anatomic site. Representative examples include carcinomas, lymphomas, melanomas, or sarcomas. C4758 Neoplastic Process Metastatic Malignant Neoplasm to the Liver Metastatic Malignant Neoplasm in the Liver C0494165 CPTAC CTEP CTRP mCode Cancer that has spread from the original (primary) tumor to the liver. Malignant Metastatic_Neoplasm_to_the_Liver Malignant neoplasm of liver, specified as secondary Secondary malignant neoplasm of liver and intrahepatic bile duct Liver Metastases Liver Metastasis Metastases to liver, NOS Metastatic Malignant Neoplasm in the Liver Metastatic Malignant Neoplasm to the Liver Metastatic Neoplasm to the Liver Metastatic Tumor to the Liver Secondary malignant neoplasm of liver and intrahepatic bile duct liver metastasis Metastatic Malignant Neoplasm in the Liver An intraepithelial lesion of the vulvar squamous epithelium associated with HPV infection. It is characterized by mild cytologic atypia. C4760 Neoplastic Process Low Grade Vulvar Squamous Intraepithelial Lesion C0495106 Undetermined Low_Grade_Vulvar_Intraepithelial_Neoplasia Grade 1 VIN Grade 1 Vulvar Intraepithelial Neoplasia Grade I VIN Grade I Vulvar Intraepithelial Neoplasia Intraepithelial Neoplasia of Vulva Grade 1 Intraepithelial Neoplasia of the Vulva Grade 1 Low Grade VIN Low Grade Vulvar Intraepithelial Neoplasia Low Grade Vulvar Squamous Intraepithelial Lesion VIN 1 VIN 1 of Usual Type VIN Grade 1 Vulva Intraepithelial Neoplasia Grade 1 Vulvar Flat Condyloma Vulvar Intraepithelial Neoplasia 1 of Usual Type Vulvar Intraepithelial Neoplasia Grade 1 Vulvar LSIL Vulvar Low Grade Squamous Intraepithelial Lesion Vulvar Low-Grade Squamous Intraepithelial Lesion Vulvar Mild Squamous Dysplasia Low Grade Vulvar Squamous Intraepithelial Lesion An intraepithelial lesion of the vulvar squamous epithelium associated with HPV infection. It is characterized by loss of maturation, nuclear hyperchromasia, high nuclear:cytoplasmic ratios, cytological and architectural atypia, and mitoses. Two morphological patterns have been described: basaloid (undifferentiated) and warty (condylomatous, bowenoid). It carries a significant but relatively low risk of progression to squamous cell carcinoma if untreated. (WHO 2020) C4761 Neoplastic Process High Grade Vulvar Squamous Intraepithelial Lesion C0495107 Undetermined Grade_II_Vulvar_Intraepithelial_Neoplasia Grade 2 VIN Grade 2 Vulvar Intraepithelial Neoplasia Grade 3 VIN Grade II VIN Grade II Vulvar Intraepithelial Neoplasia High Grade Vulvar Squamous Intraepithelial Lesion Intraepithelial Neoplasia of Vulva Grade 2 Intraepithelial Neoplasia of the Vulva Grade 2 VIN 2 VIN 2 of Usual Type VIN 3 VIN 3 of Usual Type VIN Grade 2 VIN, Usual Type Vulva Intraepithelial Neoplasia Grade 2 Vulva Intraepithelial Neoplasia Grade 3 Vulvar Bowen Disease Vulvar Bowenoid Dysplasia Vulvar HSIL Vulvar High Grade Squamous Intraepithelial Lesion Vulvar High-Grade Squamous Intraepithelial Lesion Vulvar Intraepithelial Neoplasia 2 of Usual Type Vulvar Intraepithelial Neoplasia 3 of Usual Type Vulvar Intraepithelial Neoplasia Grade 2 Vulvar Intraepithelial Neoplasia Grade 3 Vulvar Intraepithelial Neoplasia, Usual Type Vulvar Moderate Squamous Dysplasia Vulvar Severe Squamous Dysplasia High Grade Vulvar Squamous Intraepithelial Lesion A primary or metastatic malignant neoplasm affecting the major salivary glands. Representative examples include carcinoma, lymphoma, and sarcoma. C4762 Neoplastic Process Malignant Major Salivary Gland Neoplasm C0496763 CPTAC mCode Malignant Malignant_Major_Salivary_Gland_Neoplasm Malignant neoplasm of major salivary glands Malignant neoplasm: Major salivary gland, unspecified Malignant Major Salivary Gland Neoplasm Malignant Major Salivary Gland Tumor Malignant Neoplasm of Major Salivary Gland Malignant Neoplasm of the Major Salivary Gland Malignant Tumor of Major Salivary Gland Malignant Tumor of the Major Salivary Gland Malignant neoplasm of major salivary gland, unspecified Malignant Major Salivary Gland Neoplasm A primary or metastatic malignant neoplasm involving the cervical region of the esophagus. C4763 Neoplastic Process Malignant Neoplasm of the Cervical Esophagus C0496773 CPTAC Malignant Malignant_Neoplasm_of_the_Cervical_Esophagus Malignant neoplasm of cervical esophagus Malignant neoplasm: Cervical part of oesophagus Malignant Neoplasm of Cervical Esophagus Malignant Neoplasm of the Cervical Esophagus Malignant Neoplasm of the Cervical Esophagus A primary or metastatic malignant neoplasm involving the abdominal region of the esophagus. C4764 Neoplastic Process Malignant Neoplasm of the Abdominal Esophagus Malignant Neoplasm of the Abdominal Esophagus C0496775 CPTAC CTRP Malignant Malignant_Neoplasm_of_the_Abdominal_Esophagus Malignant neoplasm of abdominal esophagus Malignant Neoplasm of Abdominal Esophagus Malignant Neoplasm of the Abdominal Esophagus Malignant Tumor of Abdominal Esophagus Malignant Tumor of the Abdominal Esophagus Malignant Neoplasm of the Abdominal Esophagus A malignant neoplasm that affects the middle ear. Representative examples include adenocarcinoma and squamous cell carcinoma. C4765 Neoplastic Process Malignant Middle Ear Neoplasm C0496788 CPTAC mCode Malignant Malignant_Middle_Ear_Neoplasm Malignant neoplasm: Middle ear Malignant Middle Ear Neoplasm Malignant Middle Ear Tumor Malignant Neoplasm of Middle Ear Malignant Neoplasm of the Middle Ear Malignant Tumor of Middle Ear Malignant Tumor of the Middle Ear Malignant neoplasm of middle ear Malignant Middle Ear Neoplasm A malignant neoplasm that affects the ciliary body. Representative examples include melanoma and malignant medulloepithelioma. C4766 Neoplastic Process Malignant Ciliary Body Neoplasm Malignant Ciliary Body Neoplasm C0496833 CTRP mCode Malignant Malignant_Ciliary_Body_Neoplasm Malignant Ciliary Body Neoplasm Malignant Ciliary Body Tumor Malignant Neoplasm of Ciliary Body Malignant Neoplasm of the Ciliary Body Malignant Tumor of Ciliary Body Malignant Tumor of the Ciliary Body Malignant neoplasm of unspecified ciliary body Malignant Ciliary Body Neoplasm A primary or metastatic malignant neoplasm involving the structures of the eye (conjunctiva, cornea, uvea, retina), the lacrimal system, and the eyelid. Representative examples include melanoma, carcinoma, lymphoma, and retinoblastoma. C4767 Neoplastic Process Malignant Eye Neoplasm Malignant Eye Neoplasm C0496836 CPTAC CTEP CTRP mCode Cancer that forms in tissues of and around the eye. Some of the cancers that may affect the eye include melanoma (a rare cancer that begins in cells that make the pigment melanin in the eye), carcinoma (cancer that begins in tissues that cover structures in the eye), lymphoma (cancer that begins in immune system cells), and retinoblastoma (cancer that begins in the retina and usually occurs in children younger than 5 years). Malignant Malignant_Eye_Neoplasm Malignant neoplasm of eye Malignant neoplasm of eye and adnexa Malignant neoplasm of eye, part unspecified Malignant neoplasm of eyeball, except conjunctiva, cornea, retina, and choroid Cancer of Eye Cancer of the Eye Eye Cancer Eye Neoplasm, Malignant Malignant Eye Neoplasm Malignant Eye Tumor Malignant Neoplasm of Eye Malignant Neoplasm of the Eye Malignant Ocular Neoplasm Malignant Ocular Tumor Malignant Tumor of Eye Malignant Tumor of the Eye Malignant eye cancer, NOS Malignant neoplasm of unspecified site of unspecified eye eye cancer Malignant Eye Neoplasm A primary or metastatic malignant neoplasm affecting the olfactory nerve. C4768 Neoplastic Process Malignant Olfactory Nerve Neoplasm C0496838 mCode Malignant Malignant_Olfactory_Nerve_Neoplasm Malignant First Cranial Nerve Neoplasm Malignant First Cranial Nerve Tumor Malignant Neoplasm of First Cranial Nerve Malignant Neoplasm of Olfactory Nerve Malignant Neoplasm of the First Cranial Nerve Malignant Neoplasm of the Olfactory Nerve Malignant Olfactory Nerve Neoplasm Malignant Olfactory Nerve Tumor Malignant Tumor of First Cranial Nerve Malignant Tumor of Olfactory Nerve Malignant Tumor of the First Cranial Nerve Malignant Tumor of the Olfactory Nerve Malignant neoplasm of unspecified olfactory nerve Malignant Olfactory Nerve Neoplasm A primary or metastatic malignant neoplasm affecting the pituitary gland. C4769 Neoplastic Process Malignant Pituitary Gland Neoplasm C0496842 CPTAC mCode Malignant Malignant_Pituitary_Gland_Neoplasm Malignant neoplasm of pituitary gland and craniopharyngeal duct Malignant neoplasm: Pituitary gland Malignant Neoplasm of Pituitary Malignant Neoplasm of Pituitary Gland Malignant Neoplasm of the Pituitary Malignant Neoplasm of the Pituitary Gland Malignant Pituitary Gland Neoplasm Malignant Pituitary Gland Tumor Malignant Pituitary Neoplasm Malignant Pituitary Tumor Malignant Tumor of Pituitary Malignant Tumor of Pituitary Gland Malignant Tumor of the Pituitary Malignant Tumor of the Pituitary Gland Malignant neoplasm of pituitary gland Pituitary Neoplasms, Malignant Pituitary Tumor, Malignant Malignant Pituitary Gland Neoplasm A neoplasm that arises from the parotid gland and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include Warthin tumor, monomorphic adenoma, pleomorphic adenoma, and lipoma. C4770 Neoplastic Process Benign Parotid Gland Neoplasm C0496857 Benign Benign_Parotid_Gland_Neoplasm Benign Neoplasm of Parotid Benign Neoplasm of Parotid Gland Benign Neoplasm of the Parotid Benign Neoplasm of the Parotid Gland Benign Parotid Gland Neoplasm Benign Parotid Gland Tumor Benign Parotid Neoplasm Benign Parotid Tumor Benign Tumor of Parotid Benign Tumor of Parotid Gland Benign Tumor of the Parotid Benign Tumor of the Parotid Gland Benign Parotid Gland Neoplasm A neoplasm that arises from the major salivary glands and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include Warthin tumor, monomorphic adenoma, and pleomorphic adenoma. C4771 Neoplastic Process Benign Major Salivary Gland Neoplasm Benign Major Salivary Gland Neoplasm C0496858 CTRP Benign Benign_Major_Salivary_Gland_Neoplasm Benign Major Salivary Gland Neoplasm Benign Major Salivary Gland Tumor Benign Neoplasm of Major Salivary Gland Benign Neoplasm of the Major Salivary Gland Benign Tumor of Major Salivary Gland Benign Tumor of the Major Salivary Gland Benign Major Salivary Gland Neoplasm A neoplasm that arises from the cecum and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4772 Neoplastic Process Benign Cecum Neoplasm C0496859 Benign Benign_Cecum_Neoplasm Benign Cecum Neoplasm Benign Cecum Tumor Benign Neoplasm of Cecum Benign Neoplasm of the Cecum Benign Tumor of Cecum Benign Tumor of the Cecum Benign Cecum Neoplasm A neoplasm that arises from the appendix and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4773 Neoplastic Process Benign Appendix Neoplasm C0496860 Benign Benign_Appendix_Neoplasm Benign Appendix Neoplasm Benign Appendix Tumor Benign Neoplasm of Appendix Benign Neoplasm of the Appendix Benign Tumor of Appendix Benign Tumor of the Appendix Benign Appendix Neoplasm A neoplasm that arises from the rectum and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4774 Neoplastic Process Benign Rectal Neoplasm C0496867 Benign Benign_Rectal_Neoplasm Benign Neoplasm of Rectum Benign Neoplasm of the Rectum Benign Rectal Neoplasm Benign Rectal Neoplasms Benign Rectal Tumor Benign Rectal Tumors Benign Tumor of Rectum Benign Tumor of the Rectum Rectal Neoplasms, Benign Rectal Tumors, Benign Benign Rectal Neoplasm A neoplasm that arises from the duodenum and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.. C4775 Neoplastic Process Benign Duodenal Neoplasm C0496869 Benign Benign_Duodenal_Neoplasm Benign Duodenal Neoplasm Benign Duodenal Tumor Benign Neoplasm of Duodenum Benign Neoplasm of the Duodenum Benign Tumor of Duodenum Benign Tumor of the Duodenum Benign Duodenal Neoplasm A neoplasm that arises from the extrahepatic bile ducts and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4776 Neoplastic Process Benign Extrahepatic Bile Duct Neoplasm C0496871 Benign Benign_Extrahepatic_Bile_Duct_Neoplasm Benign Extrahepatic Bile Duct Neoplasm Benign Extrahepatic Bile Duct Tumor Benign Neoplasm of Extrahepatic Bile Duct Benign Neoplasm of the Extrahepatic Bile Duct Benign Tumor of Extrahepatic Bile Duct Benign Tumor of the Extrahepatic Bile Duct Benign Extrahepatic Bile Duct Neoplasm A neoplasm that arises from the male reproductive system and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include benign prostate phyllodes tumor, benign Sertoli cell tumor, seminal vesicle cystadenoma, and epididymal adenomatoid tumor. C4777 Neoplastic Process Benign Male Reproductive System Neoplasm C0947786 Benign Benign_Male_Reproductive_System_Neoplasm Benign Male Reproductive System Neoplasm Benign Male Reproductive System Tumor Benign Male Reproductive System Neoplasm A neoplasm that arises from the kidney and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4778 Neoplastic Process Benign Kidney Neoplasm C0496892 CPTAC Benign Benign_Renal_Neoplasm Benign neoplasm of kidney, except pelvis Benign Kidney Neoplasm Benign Kidney Tumor Benign Neoplasm of Kidney Benign Neoplasm of the Kidney Benign Renal Neoplasm Benign Renal Tumor Benign Tumor of Kidney Benign Tumor of the Kidney Renal Neoplasm, Benign Renal Tumor, Benign Benign Kidney Neoplasm A neoplasm that arises from the ciliary body and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4779 Neoplastic Process Benign Ciliary Body Neoplasm C0496894 Benign Benign_Ciliary_Body_Neoplasm Benign Ciliary Body Neoplasm Benign Ciliary Body Tumor Benign Neoplasm of Ciliary Body Benign Neoplasm of the Ciliary Body Benign Tumor of Ciliary Body Benign Tumor of the Ciliary Body Benign Ciliary Body Neoplasm A neoplasm that arises from the eye and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4780 Neoplastic Process Benign Eye Neoplasm C0496897 Benign Benign_Eye_Neoplasm Benign Eye Neoplasm Benign Eye Tumor Benign Neoplasm of Eye Benign Neoplasm of the Eye Benign Ocular Neoplasm Benign Ocular Tumor Benign Tumor of Eye Benign Tumor of the Eye Benign Eye Neoplasm A neoplasm that arises from the brain and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4781 Neoplastic Process Benign Brain Neoplasm C0496899 CPTAC MedDRA NICHD mCode An abnormal intracranial solid mass or growth arising within the brain without histologic features suggesting the potential to metastasize. Benign Benign_Brain_Neoplasm Benign neoplasm of brain Benign Brain Neoplasm Benign Brain Tumor Benign Neoplasm of Brain Benign Neoplasm of the Brain Benign Tumor of Brain Benign Tumor of the Brain Benign neoplasm of brain, unspecified Brain Neoplasms, Benign Benign Brain Neoplasm A neoplasm that arises from the anterior or posterior lobe of pituitary gland and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4782 Neoplastic Process Benign Pituitary Gland Neoplasm C0496901 CPTAC mCode Benign Benign_Pituitary_Gland_Neoplasm Benign neoplasm of pituitary gland and craniopharyngeal duct (pouch) Benign neoplasm: Pituitary gland Benign Neoplasm of Pituitary Benign Neoplasm of Pituitary Gland Benign Neoplasm of the Pituitary Benign Neoplasm of the Pituitary Gland Benign Pituitary Gland Neoplasm Benign Pituitary Gland Tumor Benign Pituitary Neoplasm Benign Pituitary Tumor Benign Tumor of Pituitary Benign Tumor of Pituitary Gland Benign Tumor of the Pituitary Benign Tumor of the Pituitary Gland Benign neoplasm of pituitary gland Pituitary Neoplasms, Benign Pituitary Tumor, Benign Benign Pituitary Gland Neoplasm A low grade epithelial tumor arising from the ovary. It is characterized by an atypical proliferation of epithelial cells. There is no evidence of stromal invasion. C4783 Neoplastic Process Borderline Ovarian Surface Epithelial-Stromal Tumor Borderline Ovarian Epithelial Tumor C0496920 CTEP CTRP A condition in which cells that may become cancer form in the thin layer of tissue that covers an ovary (female reproductive gland in which eggs are made). In this condition, tumor cells rarely spread outside of the ovary. Uncertain Malignant Potential Borderline_Ovarian_Epithelial_Neoplasm Borderline Epithelial Neoplasm of Ovary Borderline Epithelial Neoplasm of the Ovary Borderline Epithelial Tumor of Ovary Borderline Epithelial Tumor of the Ovary Borderline Ovarian Epithelial Neoplasm Borderline Ovarian Epithelial Tumor Borderline Ovarian Surface Epithelial-Stromal Tumor Epithelial Neoplasm of Ovary of Borderline Malignancy Epithelial Neoplasm of the Ovary of Borderline Malignancy Epithelial Ovarian Neoplasm of Borderline Malignancy Epithelial Ovarian Tumor of Borderline Malignancy Epithelial Tumor of Ovary of Borderline Malignancy Epithelial Tumor of the Ovary of Borderline Malignancy Low Malignant Potential Ovarian Tumor Ovarian tum. of low malig. poten. Ovarian tumors of low malignant potential ovarian borderline malignant tumor ovarian low malignant potential tumor Borderline Ovarian Epithelial Tumor An invasive carcinoma of the breast showing differentiation towards cartilaginous structures. C47847 Neoplastic Process Breast Carcinoma with Chondroid Metaplasia C1707042 GDC Malignant Breast_Carcinoma_with_Chondroid_Metaplasia Carcinoma with chondroid differentiation Breast Carcinoma with Cartilaginous Metaplasia Breast Carcinoma with Chondroid Metaplasia Breast Carcinoma with Chondroid Metaplasia An invasive breast carcinoma showing differentiation towards bone structures. C47848 Neoplastic Process Breast Carcinoma with Osseous Metaplasia C1711312 GDC Malignant Breast_Carcinoma_with_Osseous_Metaplasia Carcinoma with osseous differentiation Breast Carcinoma with Osseous Metaplasia Breast Carcinoma with Osseous Metaplasia The hemispheric projection, including the mammary gland, located on the anterior portion of the chest, lateral to the midline, on the side of the body to the west when facing north. C47855 Body Part, Organ, or Organ Component Left Breast C4266631 Left_Breast Left Breast Left Breast The hemispheric projection, including the mammary gland, located on the anterior portion of the chest, lateral to the midline, on the side of the body to the east when facing north. C47856 Body Part, Organ, or Organ Component Right Breast C4266628 Right_Breast Right Breast Right Breast A malignant neoplasm in which there is infiltration of the skin overlying the breast by neoplastic large cells with abundant pale cytoplasm and large nuclei with prominent nucleoli (Paget cells). It is almost always associated with an intraductal or invasive ductal carcinoma of the breast. The clinical features include focal skin reddening, and eczema. Retraction of the nipple may sometimes occur. C47857 Neoplastic Process Paget Disease of the Breast Breast Paget Disease C0030185 CTRP GDC 8540/3 Malignant Paget_s_Disease_of_the_Breast 8540/3 Paget disease of breast Paget disease, mammary Breast Paget Disease Mammary Paget's Disease Paget Disease of the Breast Paget disease of breast Paget disease, mammary Paget's Disease of Breast Paget's Disease of the Breast Breast Paget Disease Paget disease involving the skin overlying the mammary gland, without accompanying invasive ductal or lobular breast carcinoma. C47858 Neoplastic Process Breast Paget Disease without Invasive Carcinoma C1709447 GDC Malignant Paget_s_Disease_of_the_Breast_without_Invasive_Carcinoma Tis (Paget's) Breast Paget Disease without Invasive Carcinoma Paget Disease of the Breast without Invasive Carcinoma Paget's Disease of the Breast without Invasive Carcinoma Tis (Paget's) Tis (Paget) Breast Paget Disease without Invasive Carcinoma A neoplasm that arises from the digestive system and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4787 Neoplastic Process Benign Digestive System Neoplasm C0497538 CPTAC Benign Benign_Gastrointestinal_Neoplasm Benign neoplasm of rectum and anal canal Benign Digestive System Neoplasm Benign Digestive System Tumor Benign GI Neoplasm Benign GI System Neoplasm Benign GI System Tumor Benign GI Tumor Benign Gastrointestinal Neoplasm Benign Gastrointestinal System Tumor Benign Gastrointestinal Tumor Benign Neoplasm of Digestive System Benign Neoplasm of Gastrointestinal System Benign Neoplasm of the Digestive System Benign Tumor of Digestive System Benign Tumor of GI System Benign Tumor of Gastrointestinal System Benign Tumor of the Digestive System Benign Tumor of the GI System Benign Tumor of the Gastrointestinal System Benign Digestive System Neoplasm A primary or metastatic malignant neoplasm involving the nervous system. C4788 Neoplastic Process Malignant Nervous System Neoplasm C0497549 CPTAC Malignant Malignant_Nervous_System_Neoplasm Malignant neoplasm of nervous system, part unspecified Malignant neoplasm of other and unspecified parts of nervous system Malignant neoplasm of other specified sites of nervous system Malignant Neoplasm of Nervous System Malignant Neoplasm of the Nervous System Malignant Nervous System Neoplasm Malignant Nervous System Tumor Malignant Tumor of Nervous System Malignant Tumor of the Nervous System Nervous System Neoplasms, Malignant Malignant Nervous System Neoplasm A neoplasm that arises from the nervous system and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4789 Neoplastic Process Benign Nervous System Neoplasm C0497550 Benign Benign_Nervous_System_Neoplasm Benign Neoplasm of Nervous System Benign Neoplasm of the Nervous System Benign Nervous System Neoplasm Benign Nervous System Tumor Benign Tumor of Nervous System Benign Tumor of the Nervous System Nervous System Neoplasm, Benign Benign Nervous System Neoplasm A cardiac myxoma arising from the left atrium. C4791 Neoplastic Process Left Atrial Myxoma C0518959 Benign Left_Atrial_Myxoma Left Atrial Myxoma Myxoma of Left Atrium Myxoma of the Left Atrium Left Atrial Myxoma A cardiac myxoma arising from the right atrium. C4792 Neoplastic Process Right Atrial Myxoma C0518960 Benign Right_Atrial_Myxoma Myxoma of Right Atrium Myxoma of the Right Atrium Right Atrial Myxoma Right Atrial Myxoma An extranodal lymphoma that arises from the colon. The majority are B-cell non-Hodgkin lymphomas. C4793 Neoplastic Process Colon Lymphoma C0519037 Malignant Colon_Lymphoma Colon Lymphoma Colonic Lymphoma Lymphoma of Colon Lymphoma of the Colon Primary Colon Lymphoma Colon Lymphoma A rare non-Hodgkin or Hodgkin lymphoma that arises in and is confined to the lung at the time of diagnosis. C4794 Neoplastic Process Lung Lymphoma C0519063 Malignant Lung_Lymphoma Lung Lymphoma Lymphoma of Lung Lymphoma of the Lung Primary Lung Lymphoma Pulmonary Lymphoma Lung Lymphoma Focal benign glandular hyperplasia in the prostate gland. C4795 Neoplastic Process Prostate Adenoma C0520477 Benign Prostate_Adenoma Adenoma of Prostate Adenoma of the Prostate Prostate Adenoma Prostate Adenoma A benign or malignant neoplasm affecting the retina. Representative examples of benign neoplasms include retinocytoma and hemangioma. Representative examples of malignant neoplasms include retinoblastoma, lymphoma and melanoma. C4800 Neoplastic Process Retinal Neoplasm C0524801 Undetermined Retinal_Neoplasm Neoplasm of Retina Neoplasm of the Retina Retina Neoplasm Retina Tumor Retinal Neoplasm Retinal Tumor Tumor of Retina Tumor of the Retina Retinal Neoplasm A benign or malignant neoplasm that affects the optic nerve. Clinical features may include visual loss, proptosis, and local pain. The majority of optic nerve neoplasms are gliomas. C4801 Neoplastic Process Optic Nerve Neoplasm C0524802 Undetermined Optic_Nerve_Neoplasm Cranial Nerve II Neoplasms Neoplasm of Optic Nerve Neoplasm of Second Cranial Nerve Neoplasm of the Optic Nerve Neoplasm of the Second Cranial Nerve Neoplasms, Optic Nerve Neoplasms, Second Cranial Nerve Optic Nerve Neoplasm Optic Nerve Neoplasms Optic Nerve Tumor Second Cranial Nerve Neoplasm Second Cranial Nerve Neoplasms Second Cranial Nerve Tumor Tumor of Optic Nerve Tumor of Second Cranial Nerve Tumor of the Optic Nerve Tumor of the Second Cranial Nerve Optic Nerve Neoplasm A carcinoma that arises from the duodenum. The vast majority of cases are adenocarcinomas. C4803 Neoplastic Process Duodenal Carcinoma Duodenal Carcinoma C0541912 CTRP Malignant Duodenal_Carcinoma Cancer of Duodenum Cancer of the Duodenum Carcinoma of Duodenum Carcinoma of the Duodenum Duodenal Cancer Duodenal Carcinoma Duodenal Carcinoma A general term that refers to hyperplastic proliferations of the epithelial cells in the breast parenchyma. Examples include atypical ductal hyperplasia, usual ductal hyperplasia, columnar cell hyperplasia, and atypical lobular hyperplasia. C4804 Neoplastic Process Breast Hyperplasia Breast Hyperplasia C0542028 CTRP Undetermined Breast_Hyperplasia Breast Hyperplasia Breast Proliferative Disorder Breast Hyperplasia A meningioma that affects the cerebral hemispheres. C4807 Neoplastic Process Cerebral Meningioma C0542564 Undetermined Cerebral_Meningioma Cerebral Hemispheric Meningioma Cerebral Meningioma Meningioma of Cerebral Hemispheres Meningioma of Cerebrum Meningioma of the Cerebral Hemispheres Meningioma of the Cerebrum Cerebral Meningioma A malignant neoplasm that arises from the sweat glands. C4810 Neoplastic Process Malignant Sweat Gland Neoplasm C1321904 GDC Malignant Malignant_Sweat_Gland_Neoplasm 8400/3 Sweat gland tumor, malignant Malignant Neoplasm of Sweat Gland Malignant Neoplasm of the Sweat Gland Malignant Sweat Gland Neoplasm Malignant Tumor of Sweat Gland Malignant Tumor of the Sweat Gland Sweat Gland Neoplasms, Malignant Sweat gland tumor, malignant Malignant Sweat Gland Neoplasm A congenital benign lesion that occurs in the distal sternocleidomastoid muscle of infants. It is characterized by the presence of plump spindle cells, and collagenous stroma formation. C4811 Neoplastic Process Fibromatosis Colli C0549175 Benign Fibromatosis_Colli Congenital Muscular Torticollis Fibromatosis Colli Fibromatosis Colli A rare neoplasm arising from tooth-forming tissues. It occurs in the maxillofacial skeleton or the gingiva. Symptoms include swelling, pain, bleeding, mobility of affected teeth, and oral mucosa ulcerations. It may metastasize to lymph nodes and distant anatomic sites early. C4812 Neoplastic Process Malignant Odontogenic Neoplasm Malignant Odontogenic Neoplasm C0334558 CDISC CTRP GDC A malignant neoplasm of tooth origin. 9270/3 9342/3 Malignant Malignant_Odontogenic_Neoplasm 9270/3 Odontogenic tumor, malignant Malignant Odontogenic Neoplasm Malignant Odontogenic Tumor ODONTOMA, MALIGNANT Odontogenic tumor, malignant Malignant Odontogenic Neoplasm A carcinoma arising from the thyroid gland. It includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and anaplastic carcinoma. C4815 Neoplastic Process Thyroid Gland Carcinoma Thyroid Gland Carcinoma C0549473 CPTAC CTEP CTRP Cellosaurus GDC MedDRA NICHD A malignant tumor arising from the epithelial cells of the thyroid gland. Cancer that forms in the thyroid gland (an organ at the base of the throat that makes hormones that help control heart rate, blood pressure, body temperature, and weight). Four main types of thyroid cancer are papillary, follicular, medullary, and anaplastic thyroid cancer. The four types are based on how the cancer cells look under a microscope. Malignant Thyroid_Carcinoma Thyroid Cancer Thyroid cancer Cancer of Thyroid Cancer of the Thyroid Carcinoma of Thyroid Carcinoma of Thyroid Gland Carcinoma of the Thyroid Carcinoma of the Thyroid Gland THCA Thyroid Cancer Thyroid Carcinoma Thyroid Gland Cancer Thyroid Gland Carcinoma Thyroid cancer, NOS thyroid cancer Thyroid Gland Carcinoma A small round cell tumor that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation. It represents one of the two ends of the spectrum called Ewing sarcoma/peripheral neuroectodermal tumor. It affects mostly males under age 20, and it can occur in soft tissue or bone. Pain and the presence of a mass are the most common clinical symptoms. C4817 Neoplastic Process Ewing Sarcoma Ewing Sarcoma C0553580 CPTAC CTRP Cellosaurus GDC MedDRA NICHD A malignant neoplasm of the bone, or the soft tissue adjacent to bone, that is comprised of primitive neuroectodermal cells. A type of cancer that forms in bone or soft tissue. 9260/3 Malignant Ewing_s_Sarcoma 9260/3 Ewing Sarcoma Ewing sarcoma Ewing tumor Ewing's sarcoma ES Ewing Sarcoma Ewing sarcoma Ewing tumor Ewing's Sarcoma Ewing's Tumor Ewing Sarcoma A rare slow-growing benign neoplasm arising from the soft tissues in children. It is a poorly circumscribed tumor characterized by the presence of chondrocyte-like cells, nodular calcification, nuclear palisading, and in some cases osteoclastic giant cells. C4818 Neoplastic Process Calcifying Aponeurotic Fibroma C0553647 Benign Calcifying_Aponeurotic_Fibroma Calcifying aponeurotic fibroma Aponeurotic Fibroma CAF Calcifying Aponeurotic Fibroma Juvenile Aponeurotic Fibrosis Calcifying Aponeurotic Fibroma A carcinoma arising from the squamous cells of the epidermis. Skin squamous cell carcinoma is most commonly found on sun-exposed areas. The majority of the tumors are well-differentiated. C4819 Neoplastic Process Skin Squamous Cell Carcinoma Skin Squamous Cell Carcinoma C0553723 CPTAC CTEP CTRP Cellosaurus Malignant Skin_Squamous_Cell_Carcinoma Squamous cell carcinoma of overlapping sites of skin Squamous cell carcinoma of skin of other parts of face Squamous cell carcinoma of skin of scalp and neck Squamous cell carcinoma of skin of unspecified parts of face Squamous cell carcinoma of skin, site unspecified Squamous cell carcinoma of skin, unspecified Cutaneous Squamous Cell Carcinoma Epidermoid Carcinoma of Skin Epidermoid Carcinoma of the Skin Epidermoid Skin Carcinoma Skin Squamous Cell Cancer Skin Squamous Cell Carcinoma Squamous Cell Carcinoma of Skin Squamous Cell Carcinoma of the Skin Squamous Cell Skin Carcinoma Squamous cell carcinoma - skin Squamous cell carcinoma of the skin Skin Squamous Cell Carcinoma A grade 3 or grade 4 glioma arising from the central nervous system. This category includes glioblastoma, anaplastic astrocytoma, anaplastic ependymoma, anaplastic oligodendroglioma, and anaplastic oligoastrocytoma. C4822 Neoplastic Process Malignant Glioma Malignant Glioma C0555198 CDISC CTRP Cellosaurus GDC A malignant neuroglial neoplasm. The term can apply to several primary neoplasm of the brain and spinal cord, including astrocytoma and oligodendroglioma in addition to others. 9380/3 Malignant Malignant_Glioma 9380/3 Glioma, malignant GLIOMA, MALIGNANT Glioma, malignant High Grade Glioma High-Grade Glioma Malignant Glial Neoplasm Malignant Glial Tumor Malignant Glioma Malignant Neuroglial Neoplasm Malignant Neuroglial Tumor Malignant Glioma A malignant tumor arising from the epithelium that covers the tongue. The vast majority of tongue carcinomas are moderately or poorly differentiated squamous cell carcinomas. C4824 Neoplastic Process Tongue Carcinoma Tongue Carcinoma C0558353 CTRP GDC Cancer that begins in the tongue. When the cancer begins in the front two-thirds of the tongue, it is considered to be a type of oral cavity cancer; when the cancer begins in the back third of the tongue, it is considered to be a type of oropharyngeal or throat cancer. Malignant Tongue_Carcinoma Tongue Cancer Cancer of Tongue Cancer of the Tongue Carcinoma of Tongue Carcinoma of the Tongue Tongue Cancer Tongue Carcinoma tongue cancer Tongue Carcinoma A carcinoma arising from the tonsilar epithelium. C4825 Neoplastic Process Tonsillar Carcinoma Tonsillar Carcinoma C0558355 CTRP GDC Malignant Tonsillar_Carcinoma Tonsillar Cancer Cancer of Tonsil Cancer of the Tonsil Carcinoma of Tonsil Carcinoma of the Tonsil Tonsil Cancer Tonsil Carcinoma Tonsillar Cancer Tonsillar Carcinoma Tonsillar Carcinoma A neuroblastoma arising from the central nervous system. C4826 Neoplastic Process Central Nervous System Neuroblastoma Central Nervous System Neuroblastoma C0559458 CTRP Malignant Cerebral_Neuroblastoma Central Nervous System Neuroblastoma Central Neuroblastoma Cerebral Hemispheric Neuroblastoma Cerebral Neuroblastoma Cerebral Neuroblastoma, PNET Neuroblastoma of Cerebral Hemispheres Neuroblastoma of Cerebrum Neuroblastoma of the Cerebral Hemispheres Neuroblastoma of the Cerebrum Central Nervous System Neuroblastoma A neuroblastoma arising from the adrenal gland. C4827 Neoplastic Process Adrenal Gland Neuroblastoma C0559460 Cellosaurus Malignant Adrenal_Neuroblastoma Adrenal Gland Neuroblastoma Adrenal Neuroblastoma Neuroblastoma of Adrenal Neuroblastoma of Adrenal Gland Neuroblastoma of the Adrenal Neuroblastoma of the Adrenal Gland Adrenal Gland Neuroblastoma A parathyroid gland adenoma that contains mature adipocytes. C48283 Neoplastic Process Parathyroid Gland Lipoadenoma C1709467 Benign Parathyroid_Gland_Lipoadenoma Parathyroid Gland Hamartoma Parathyroid Gland Lipoadenoma Parathyroid Gland Lipoadenoma A parathyroid gland tumor that shares certain morphologic characteristics with parathyroid gland carcinomas (e.g. broad fibrous bands formation with or without hemosiderin deposition, presence of mitotic figures) but lacks unequivocal evidence of capsular or vascular invasion. It is considered a tumor of uncertain malignant potential. (WHO) C48285 Neoplastic Process Atypical Parathyroid Gland Tumor C1709465 Uncertain Malignant Potential Parathyroid_Gland_Atypical_Adenoma APT Atypical Parathyroid Gland Adenoma Atypical Parathyroid Gland Neoplasm Atypical Parathyroid Gland Tumor Atypical Parathyroid Neoplasm Atypical Parathyroid Tumor Parathyroid Gland Atypical Adenoma Parathyroid Gland Tumor of Low/Uncertain Malignant Potential Parathyroid Tumor of Low/Uncertain Malignant Potential Atypical Parathyroid Gland Tumor A carcinoma that arises from the urothelial lining of the ureter. C4830 Neoplastic Process Ureter Urothelial Carcinoma Ureter Urothelial Carcinoma C0577692 CTRP Cellosaurus Malignant Ureter_Transitional_Cell_Carcinoma Transitional Cell Carcinoma of Ureter Transitional Cell Carcinoma of the Ureter Ureter Transitional Cell Carcinoma Ureter Urothelial Cancer Ureter Urothelial Carcinoma Ureteral Transitional Cell Carcinoma Ureteral Urothelial Cell Carcinoma Urothelial Cell Carcinoma of Ureter Urothelial Cell Carcinoma of the Ureter Ureter Urothelial Carcinoma A sporadic or familial pheochromocytoma that is confined to the adrenal gland. C48305 Neoplastic Process Localized Adrenal Gland Pheochromocytoma Non-Metastatic Adrenal Gland Pheochromocytoma C0585440 CDISC CTRP A benign neoplasm of the adrenal gland medulla. Benign Undetermined Benign_Adrenal_Gland_Pheochromocytoma Localized_Pheochromocytoma Benign Adrenal Gland Pheochromocytoma Localized Pheochromocytoma Non-Metastatic Adrenal Gland Pheochromocytoma PHEOCHROMOCYTOMA, BENIGN Non-Metastatic Adrenal Gland Pheochromocytoma A neoplasm that arises from the adrenal medulla and combines morphologic characteristics of pheochromocytoma and neuroectodermal tumors such as neuroblastoma, ganglioneuroma, ganglioneuroblastoma, or peripheral nerve sheath tumor. C48306 Neoplastic Process Adrenal Gland Composite Pheochromocytoma C1706728 Undetermined Adrenal_Gland_Composite_Pheochromocytoma Adrenal Gland Composite Pheochromocytoma Adrenal Gland Composite Pheochromocytoma A hemangioma arising from the gums. C4831 Neoplastic Process Gingival Hemangioma C0582885 Benign Gingival_Hemangioma Angioma of Gingiva Angioma of Gum Angioma of the Gingiva Angioma of the Gum Gingival Angioma Gingival Hemangioma Gum Angioma Gum Hemangioma Hemangioma of Gingiva Hemangioma of Gum Hemangioma of the Gingiva Hemangioma of the Gum Gingival Hemangioma A paraganglioma that is confined to the site of origin. C48314 Neoplastic Process Non-Metastatic Paraganglioma C0346416 CDISC GDC A benign neoplasm arising from paraganglia located along nerves composed of neoplastic neuroectodermal chromaffin cells. 8680/0 Benign Benign_Paraganglionic_Neoplasm 8680/0 Paraganglioma, benign Benign Neuroendocrine Cell Tumor Benign Paraganglioma Benign Paraganglionic Neoplasm Non-Metastatic Paraganglioma PARAGANGLIOMA, BENIGN Paraganglioma, benign Non-Metastatic Paraganglioma An extra-adrenal paraganglioma arising from the nasopharynx and nose. Epistaxis or nasal obstruction are common presenting symptoms. C48316 Neoplastic Process Nasopharyngeal Paraganglioma C1709154 Undetermined Nasopharyngeal_Paraganglioma Nasopharyngeal Paraganglioma Nasopharyngeal Paraganglioma An extra-adrenal sympathetic paraganglioma arising from paraganglia located along the aorta, including suprarenal, infrarenal, and renal hilar sites. In functional tumors, the hypersecretion of catecholamines results in hypertension. C48317 Neoplastic Process Superior and Inferior Paraaortic Paraganglioma C1710250 Undetermined Superior_and_Inferior_Paraaortic_Paraganglioma Superior and Inferior Paraaortic Paraganglioma Superior and Inferior Paraaortic Paraganglioma An extra-adrenal paraganglioma arising from the cerebellum. C48318 Neoplastic Process Cerebellar Paraganglioma C1711268 Undetermined Cerebellar_Paraganglioma Cerebellar Paraganglioma Cerebellar Paraganglioma A benign adrenal cortical neoplasm deriving from mesothelial cells. C48319 Neoplastic Process Adrenal Cortical Adenomatoid Tumor C1706726 Benign Adrenal_Gland_Adenomatoid_Tumor Adrenal Cortex Adenomatoid Tumor Adrenal Cortical Adenomatoid Tumor Adrenal Gland Adenomatoid Tumor Benign Adrenal Cortical Mesothelioma Adrenal Cortical Adenomatoid Tumor A sarcoma that occurs in the retroperitoneal region. C4832 Neoplastic Process Retroperitoneal Sarcoma C0585129 Malignant Retroperitoneal_Sarcoma Retroperitoneal Sarcoma Retroperitoneal Sarcoma A rare malignant soft tissue neoplasm arising from the vascular endothelium of the adrenal gland. C48320 Neoplastic Process Adrenal Gland Angiosarcoma C1706727 Malignant Adrenal_Gland_Angiosarcoma Adrenal Gland Angiosarcoma Adrenal Gland Angiosarcoma A squamous cell carcinoma arising from the oral cavity. It affects predominantly adults in their fifth and sixth decades of life and is associated with alcohol and tobacco use. Human papillomavirus is present in approximately half of the cases. It is characterized by a tendency to metastasize early to the lymph nodes. When the tumor is small, patients are often asymptomatic. Physical examination may reveal erythematous or white lesions or plaques. The majority of patients present with signs and symptoms of locally advanced disease including mucosal ulceration, pain, difficulty with speaking, chewing, and swallowing, bleeding, weight loss, and neck swelling. Patients may also present with swollen neck lymph nodes without any symptoms from the oropharyngeal tumor. The most significant prognostic factors are the size of the tumor and the lymph nodes status. C4833 Neoplastic Process Oral Cavity Squamous Cell Carcinoma Oral Cavity Squamous Cell Carcinoma C0585362 CTRP Cellosaurus Malignant Oral_Cavity_Squamous_Cell_Carcinoma Mouth SCC Mouth Squamous Cell Carcinoma OSCC Oral Cavity SCC Oral Cavity Squamous Cell Cancer Oral Cavity Squamous Cell Carcinoma SCC of Mouth SCC of Oral Cavity SCC of the Mouth SCC of the Oral Cavity Squamous Cell Carcinoma of Mouth Squamous Cell Carcinoma of Oral Cavity Squamous Cell Carcinoma of the Mouth Squamous Cell Carcinoma of the Oral Cavity Oral Cavity Squamous Cell Carcinoma A usually aggressive malignant bone-forming mesenchymal neoplasm arising from the bone. It usually involves the long bones and predominantly affects adolescents and young adults. Pain and a palpable mass are the most frequent clinical sign and symptom. It may spread to other anatomic sites, particularly the lungs. C4834 Neoplastic Process Primary Bone Osteosarcoma C1704291 Malignant Primary_Bone_Osteosarcoma Primary Bone Osteosarcoma Primary Osteosarcoma of Bone Primary Bone Osteosarcoma A small round cell bone tumor that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation. It represents one of the two ends of the spectrum called Ewing sarcoma/peripheral neuroectodermal tumor. It often affects the diaphysis or metaphyseal-diaphyseal portion of long bones. Clinical findings include pain and a mass in the involved area. Fever, anemia, leukocytosis, and an increased sedimentation rate are often seen. X-ray examination reveals osteolytic lesions. The prognosis depends on the stage, anatomic location, and size of the tumor. C4835 Neoplastic Process Ewing Sarcoma of Bone Ewing Sarcoma of Bone C0585474 CTRP Malignant Ewing_s_Sarcoma_of_Bone Bone Ewing's Sarcoma Ewing Sarcoma of Bone Ewing's Sarcoma of Bone Ewing's Sarcoma, Osseous Osseous Ewing's Sarcoma Osseous Ewing's Tumor Skeletal Ewing's Sarcoma Skeletal Ewing's Tumor Ewing Sarcoma of Bone A malignant neoplasm that affects the epiglottis. The vast majority of cases are squamous cell carcinomas. C4836 Neoplastic Process Malignant Epiglottis Neoplasm C0585946 CPTAC Malignant Malignant_Epiglottis_Neoplasm Malignant neoplasm of anterior aspect of epiglottis Malignant neoplasm: Anterior surface of epiglottis Malignant Epiglottic Neoplasm Malignant Epiglottic Tumor Malignant Epiglottis Neoplasm Malignant Epiglottis Tumor Malignant Neoplasm of Epiglottis Malignant Neoplasm of the Epiglottis Malignant Tumor of Epiglottis Malignant Tumor of the Epiglottis Malignant Epiglottis Neoplasm A lesion that is characterized by architectural and cytologic abnormalities of the esophageal epithelium, and carries a predisposition for progression to invasive carcinoma. Intraepithelial neoplasia (dysplasia) of the esophagus is graded as low or high grade. In this two-tier system, severe dysplasia and carcinoma in situ are included under the rubric of high grade intraepithelial neoplasia and may have the same clinical implications. (WHO, 2000) C4839 Neoplastic Process Esophageal Intraepithelial Neoplasia C0586354 Undetermined Esophageal_Intraepithelial_Neoplasia Esophageal Dysplasia Esophageal Intraepithelial Neoplasia Intraepithelial Neoplasia of Esophagus Intraepithelial Neoplasia of the Esophagus Esophageal Intraepithelial Neoplasia A lesion in which the architectural and cytologic abnormalities are confined to the lower half of the esophageal epithelium. (WHO, 2000) C4840 Neoplastic Process Esophageal Low Grade Intraepithelial Neoplasia C0586355 Undetermined Esophageal_Low-Grade_Intraepithelial_Neoplasia Esophageal Low Grade Dysplasia Esophageal Low Grade Intraepithelial Neoplasia Esophageal Low Grade Intraepithelial Neoplasia A neoplastic, non-invasive lesion that affects the biliary epithelium. It is characterized by the presence of atypical epithelial cells with an increased nuclear/cytoplasmic ratio, nuclear hyperchromasia, and loss of nuclear polarity. C4843 Neoplastic Process Biliary Intraepithelial Neoplasia C3808264 Undetermined Biliary_Tract_Intraepithelial_Neoplasia BilIN Biliary Dysplasia Biliary Intraepithelial Neoplasia Biliary System Intraepithelial Neoplasia Biliary Intraepithelial Neoplasia A usually non-functioning variant of adrenal cortex adenoma, composed of large cells with abundant granular eosinophilic cytoplasm. C48447 Neoplastic Process Adrenal Cortical Oncocytic Adenoma C1706724 Benign Adrenal_Cortex_Oncocytic_Adenoma Adrenal Cortex Oncocytic Adenoma Adrenal Cortical Oncocytic Adenoma Adrenal Gland Oncocytic Adenoma Adrenal Cortical Oncocytic Adenoma An adenoma of the adrenal cortex that produces cortisol. It may be associated with Cushing syndrome. Clinical presentation includes weight gain, round face, easy bruising, muscle weakness, emotional changes, hirsutism, and hypertension. C48449 Neoplastic Process Cortisol-Producing Adrenal Cortical Adenoma C1707525 Benign Cortisol_Producing_Adrenal_Cortex_Adenoma Cortisol Producing Adrenal Cortex Adenoma Cortisol Producing Adrenal Cortical Adenoma Cortisol-Producing Adrenal Cortex Adenoma Cortisol-Producing Adrenal Cortical Adenoma Cortisol-Producing Adrenal Gland Adenoma Cortisol-Producing Adrenal Cortical Adenoma A pre-cancerous, non-invasive pancreatic epithelial neoplasm that arises from and is confined to the pancreatic ducts. It is a papillary or flat neoplasm that usually measures less than 5 mm in diameter. C4845 Neoplastic Process Pancreatic Intraepithelial Neoplasia C0586362 Uncertain Malignant Potential Pancreatic_Intraepithelial_Neoplasia PanIN Pancreatic Dysplasia Pancreatic Intraepithelial Neoplasia Pancreatic Intraepithelial Neoplasia An adenoma of the adrenal cortex that produces aldosterone. It may be associated with Conn syndrome. Clinical presentation includes hypertension, hypokalemia, and muscle weakness. C48451 Neoplastic Process Aldosterone-Producing Adrenal Cortical Adenoma C1706762 Benign Aldosterone_Producing_Adrenal_Cortex_Adenoma Aldosterone Producing Adrenal Cortex Adenoma Aldosterone Producing Adrenal Cortical Adenoma Aldosterone-Producing Adrenal Cortex Adenoma Aldosterone-Producing Adrenal Cortical Adenoma Aldosterone-Producing Adrenal Gland Adenoma Aldosterone-Producing Adrenal Cortical Adenoma A rare adenoma of the adrenal cortex that produces androgens or estrogens. C48452 Neoplastic Process Sex Hormone-Producing Adrenal Cortical Adenoma C1710067 Benign Sex_Hormone_Producing_Adrenal_Cortex_Adenoma Sex Hormone Producing Adrenal Cortex Adenoma Sex Hormone Producing Adrenal Cortical Adenoma Sex Hormone-Producing Adrenal Cortex Adenoma Sex Hormone-Producing Adrenal Cortical Adenoma Sex Hormone-Producing Adrenal Gland Adenoma Sex Hormone-Producing Adrenal Cortical Adenoma A rare adenoma of the adrenal cortex that produces androgens. Female patients usually have symptoms related to virilism. C48454 Neoplastic Process Androgen-Producing Adrenal Cortical Adenoma C1706810 Benign Androgen_Producing_Adrenal_Cortex_Adenoma Androgen Producing Adrenal Cortex Adenoma Androgen Producing Adrenal Cortical Adenoma Androgen-Producing Adrenal Cortex Adenoma Androgen-Producing Adrenal Cortical Adenoma Androgen-Producing Adrenal Gland Adenoma Androgen-Producing Adrenal Cortical Adenoma A rare adenoma of the adrenal cortex that produces estrogens. Male patients may develop gynecomastia and impotence. C48456 Neoplastic Process Estrogen-Producing Adrenal Cortical Adenoma C1707954 Benign Estrogen_Producing_Adrenal_Cortex_Adenoma Estrogen Producing Adrenal Cortex Adenoma Estrogen Producing Adrenal Cortical Adenoma Estrogen-Producing Adrenal Cortex Adenoma Estrogen-Producing Adrenal Cortical Adenoma Estrogen-Producing Adrenal Gland Adenoma Estrogen-Producing Adrenal Cortical Adenoma An adenoma of the adrenal cortex characterized by the absence of a hormonal syndrome or symptoms suggestive of adrenal disease. C48458 Neoplastic Process Non-Functioning Adrenal Cortical Adenoma C1709240 Benign Non-Functioning_Adrenal_Cortex_Adenoma Adrenal Cortical Incidentaloma Non-Functioning Adrenal Cortex Adenoma Non-Functioning Adrenal Cortical Adenoma Non-Functioning Adrenal Gland Adenoma Nonfunctional Adrenal Cortex Adenoma Nonfunctioning Adrenal Cortex Adenoma Non-Functioning Adrenal Cortical Adenoma A pancreatic mucinous intraepithelial neoplasia characterized by the presence of papillary and less often flat architectural patterns. Moderate cytological atypia is present with some loss of nuclear polarity, nuclear crowding or hyperchromatism. C4846 Neoplastic Process Pancreatic Intraepithelial Neoplasia-2 C0586364 CPTAC Uncertain Malignant Potential Grade_II_Pancreatic_Intraepithelial_Neoplasia Grade 2 Pancreatic Intraepithelial Neoplasia Grade II Pancreatic Intraepithelial Neoplasia PanIN-2 Pancreatic Intraepithelial Neoplasia-2 Pancreatic Intraepithelial Neoplasia-2 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial or invasion of the lamina propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C4853 Neoplastic Process Stage 0 Rectal Cancer AJCC v6 and v7 Stage 0 Rectal Cancer AJCC v6 and v7 C0154062 CPTAC CTRP mCode Malignant Stage_0_Rectal_Cancer Carcinoma in situ of rectum Carcinoma in situ of Rectum Carcinoma in situ of rectum Carcinoma in situ of the Rectum Marked Dysplasia of Rectum Marked Dysplasia of the Rectum Marked Rectal Dysplasia Rectal Carcinoma in situ Severe Dysplasia of Rectum Severe Dysplasia of the Rectum Severe Rectal Dysplasia Stage 0 Carcinoma of Rectum Stage 0 Carcinoma of the Rectum Stage 0 Rectal Cancer Stage 0 Rectal Cancer AJCC v6 Stage 0 Rectal Cancer AJCC v6 and v7 Stage 0 Rectal Cancer AJCC v7 Stage 0 Rectal Carcinoma Stage 0 Rectal Cancer AJCC v6 and v7 Carcinoma that arises from the laryngeal epithelium. More than 90% of laryngeal carcinomas are squamous cell carcinomas. The remainder are adenoid cystic carcinomas, mucoepidermoid carcinomas and carcinomas with neuroendocrine differentiation. C4855 Neoplastic Process Laryngeal Carcinoma Laryngeal Carcinoma C0595989 CPTAC CTRP GDC Cancer that forms in tissues of the larynx (area of the throat that contains the vocal cords and is used for breathing, swallowing, and talking). Most laryngeal cancers are squamous cell carcinomas (cancer that begins in flat cells lining the larynx). Malignant Laryngeal_Carcinoma Laryngeal Cancer Cancer of Larynx Cancer of the Larynx Carcinoma of Larynx Carcinoma of the Larynx Laryngeal Cancer Laryngeal Carcinoma Laryngeal Throat Cancer Larynx Cancer Larynx Carcinoma laryngeal cancer Laryngeal Carcinoma A benign or malignant (primary or metastatic) neoplasm affecting the adrenal medulla. C4856 Neoplastic Process Adrenal Medulla Neoplasm C0596046 Undetermined Adrenal_Medulla_Neoplasm Adrenal Medulla Neoplasm Adrenal Medulla Tumor Adrenal Medulla Neoplasm A sympathetic paraganglioma arising from paraganglia outside the adrenal gland. Clinical symptoms are related to secretion of catecholamines. Representative examples include the superior and inferior paraaortic and bladder paragangliomas. C48576 Neoplastic Process Extra-Adrenal Sympathetic Paraganglioma C1861852 Undetermined Extra-Adrenal_Sympathetic_Paraganglioma Extra-Adrenal Chromaffin Neoplasm Extra-Adrenal Chromaffinoma Extra-Adrenal Pheochromocytoma Extra-Adrenal Sympathetic Paraganglioma Extra-Adrenal Sympathetic Paraganglionic Neoplasm Extraadrenal Pheochromocytoma Extra-Adrenal Sympathetic Paraganglioma A benign or malignant neoplasm that affects the placenta. Representative examples include hemangioma and choriocarcinoma. C4858 Neoplastic Process Placental Neoplasm C0524541 Undetermined Placental_Neoplasm Neoplasm of Placenta Neoplasm of the Placenta Placenta Neoplasm Placenta Neoplasms Placenta Tumor Placenta Tumors Placental Neoplasm Placental Tumor Placental Tumors Tumor of Placenta Tumor of the Placenta Placental Neoplasm A carcinoma that is not confined to the prostatic epithelium but has spread to the surrounding stroma of the prostate gland. The vast majority of invasive prostate carcinomas are adenocarcinomas. C48596 Neoplastic Process Invasive Prostate Carcinoma Invasive Prostate Carcinoma C1708566 CTRP Malignant Invasive_Prostate_Carcinoma Infiltrating Prostate Carcinoma Invasive Prostate Cancer Invasive Prostate Carcinoma Invasive Prostate Carcinoma A malignant mesenchymal neoplasm that arises from the lung. Representative examples include Kaposi sarcoma, leiomyosarcoma, and synovial sarcoma. C4860 Neoplastic Process Lung Sarcoma Lung Sarcoma C0598790 CTRP Malignant Lung_Sarcoma Lung Sarcoma Pulmonary Sarcoma Sarcoma of Lung Sarcoma of the Lung Lung Sarcoma A melanoma of the skin that is not confined to the dermal-epidermal junction, and has infiltrated the dermis. C48607 Neoplastic Process Invasive Skin Melanoma Invasive Cutaneous Melanoma C1708565 CTRP Malignant Invasive_Melanoma Infiltrating Melanoma Invasive Cutaneous (Skin) Melanoma Invasive Cutaneous Melanoma Invasive Melanoma Invasive Skin Melanoma Invasive Cutaneous Melanoma An acute myeloid leukemia in which the majority of monocytic cells are promonocytes. (WHO, 2001) C4861 Neoplastic Process Acute Monocytic Leukemia C0023465 CDISC CPTAC GDC PCDC A progressive, proliferative disease of blood cells, originating from immature monocytes. 9891/3 Malignant Monocytic_Leukemia 9860/3 9891/3 Acute monocytic leukemia Acute monocytic leukemia without mention of having achieved remission Monocytic leukaemia Monocytic leukaemia, unspecified Monocytic leukemia Monocytic leukemia, NOS Monocytic leukemia, acute Other monocytic leukemia Other monocytic leukemia without mention of having achieved remission Other monocytic leukemia, not having achieved remission Unspecified monocytic leukemia Acute Monocytic Leukemia Acute Monocytic Leukemia (FAB M5b) Acute Monocytic Leukemia (Fab M5B) Acute monocytic leukemia LEUKEMIA, MONOCYTIC, MALIGNANT M5 Monocytic Leukemia Acute Monocytic Leukemia A melanocytic neoplasm displaying morphologic features that are intermediate between those of benign nevus and melanoma. It is characterized by a nodular architectural growth resembling a melanoma, and a loss of nevus cell maturation. The melanocytic cells forming the nodular growth are uniform, and they may display a high mitotic rate, but they do not show cytologic atypia. C48612 Neoplastic Process Minimal Deviation Melanoma Minimal Deviation Melanoma C0545071 CTRP Malignant Minimal_Deviation_Melanoma Minimal Deviation Cutaneous (Skin) Melanoma Minimal Deviation Melanoma Minimal Deviation Melanoma A melanoma of the skin arising in a congenital melanocytic nevus. C48613 Neoplastic Process Melanoma in Congenital Melanocytic Nevus Melanoma Arising in Congenital Melanocytic Nevus C1711221 CTRP Malignant Melanoma_in_Congenital_Melanocytic_Nevus Cutaneous (Skin) Melanoma in Congenital Melanocytic Nevus Melanoma Arising in Congenital Melanocytic Nevus Melanoma in Congenital Melanocytic Nevus Melanoma Arising in Congenital Melanocytic Nevus A desmoplastic melanoma characterized by the presence of nerve infiltration by atypical spindled melanocytes. C48614 Neoplastic Process Desmoplastic Neurotropic Melanoma C1709220 Malignant Neurotropic_Melanoma Desmoplastic Neurotropic Melanoma Neurotropic Melanoma Desmoplastic Neurotropic Melanoma A benign or malignant neoplasm that arises from the ovary and is composed of granulosa cells, Sertoli cells, Leydig cells, theca cells, and fibroblasts. Representative examples include thecoma, fibroma, Sertoli cell tumor, and granulosa cell tumor. C4862 Neoplastic Process Ovarian Sex Cord-Stromal Tumor C0600113 GDC NICHD A sex cord-stromal tumor that occurs in the ovary. Undetermined Ovarian_Sex_Cord-Stromal_Tumor 8590/1 Ovarian stromal tumor Ovarian Sex Cord-Stromal Neoplasm Ovarian Sex Cord-Stromal Tumor Ovarian stromal tumor Sex Cord-Stromal Neoplasm of Ovary Sex Cord-Stromal Neoplasm of the Ovary Sex Cord-Stromal Tumor of Ovary Sex Cord-Stromal Tumor of the Ovary Ovarian Sex Cord-Stromal Tumor One of the most common malignant tumors afflicting men. The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland. Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes. Adenocarcinomas represent the overwhelming majority of prostatic carcinomas. Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma. Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy. Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease. C4863 Neoplastic Process Prostate Carcinoma Prostate Carcinoma C0600139 CPTAC CTEP CTRP Cellosaurus GDC OORO Cancer that forms in tissues of the prostate (a gland in the male reproductive system found below the bladder and in front of the rectum). Prostate cancer usually occurs in older men. Malignant Prostate_Carcinoma Prostate Cancer Cancer of Prostate Cancer of the Prostate Carcinoma of Prostate Carcinoma of the Prostate Other Prostate Carcinoma Prostate Cancer Prostate Carcinoma Prostate cancer, NOS prostate cancer Prostate Carcinoma A carcinoma arising from the vulva. It usually affects elderly women but has been observed in premenopausal women as well. The most frequently seen histologic type is squamous cell carcinoma. The most common site of involvement is the labia majora. In many cases, the development of vulvar cancer is preceded by condyloma or squamous dysplasia. C4866 Neoplastic Process Vulvar Carcinoma Vulvar Carcinoma C0677055 CPTAC CTEP CTRP Cellosaurus Cancer of the vulva (the external female genital organs, including the clitoris, vaginal lips, and the opening to the vagina). Malignant Vulvar_Carcinoma Cancer of Vulva Cancer of the Vulva Carcinoma of Vulva Carcinoma of the Vulva Vulva Cancer Vulva Carcinoma Vulvar Cancer Vulvar Carcinoma Vulvar cancer, NOS vulvar cancer Vulvar Carcinoma A malignant neoplasm arising exclusively from the soft tissues. C4867 Neoplastic Process Malignant Soft Tissue Neoplasm CL336320 CPTAC GDC Malignant Malignant_Soft_Tissue_Neoplasm 8800/3 Malignant neoplasm of connective and other soft tissue Malignant neoplasm of connective and other soft tissue of abdomen Malignant neoplasm of connective and other soft tissue of head, face, and neck Malignant neoplasm of connective and other soft tissue of lower limb, including hip Malignant neoplasm of connective and other soft tissue of pelvis Malignant neoplasm of connective and other soft tissue of thorax Malignant neoplasm of connective and other soft tissue of trunk, unspecified Malignant neoplasm of connective and other soft tissue of upper limb, including shoulder Malignant neoplasm of connective and other soft tissue, site unspecified Malignant neoplasm of connective and soft tissue of left lower limb, including hip Malignant neoplasm of connective and soft tissue of left upper limb, including shoulder Malignant neoplasm of connective and soft tissue of right lower limb, including hip Malignant neoplasm of connective and soft tissue of right upper limb, including shoulder Malignant neoplasm of connective and soft tissue of unspecified lower limb, including hip Malignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder Malignant neoplasm of lower limb Malignant neoplasm of other connective and soft tissue Malignant neoplasm of other specified sites of connective and other soft tissue Malignant neoplasm of upper limb Malignant neoplasm: Connective and soft tissue of abdomen Malignant neoplasm: Connective and soft tissue of head, face and neck Malignant neoplasm: Connective and soft tissue of lower limb, including hip Malignant neoplasm: Connective and soft tissue of pelvis Malignant neoplasm: Connective and soft tissue of thorax Malignant neoplasm: Connective and soft tissue of trunk, unspecified Malignant neoplasm: Connective and soft tissue of upper limb, including shoulder Malignant neoplasm: Connective and soft tissue, unspecified Malignant neoplasm: Overlapping lesion of connective and soft tissue Soft tissue tumor, malignant Malignant Neoplasm of Soft Tissue Malignant Neoplasm of the Soft Tissue Malignant Soft Tissue Neoplasm Malignant Soft Tissue Tumor Malignant Tumor of Soft Tissue Malignant Tumor of the Soft Tissue Soft tissue tumor, malignant Malignant Soft Tissue Neoplasm A hemangioma arising from the fetal blood vessels in the placental villi. C4868 Disease or Syndrome Neoplastic Process Placental Hemangioma C0677608 GDC NICHD A hemangioma arising from the fetal blood vessels in the placental villi. Benign Placental_Hemangioma Chorioangioma Angioma of Placenta Angioma of the Placenta Chorangioma Chorangioma Placentae Chorangioma of the Placenta Chorioangioma Hemangioma of Placenta Hemangioma of the Placenta Placental Angioma Placental Hemangioma Placental Hemangioma A benign or malignant neoplasm that affects the brain stem. C4869 Neoplastic Process Brain Stem Neoplasm C0677866 A tumor in the part of the brain that connects to the spinal cord (the brain stem). Undetermined Brain_Stem_Neoplasm Brain Stem Neoplasm Brain Stem Tumor Brainstem Neoplasm Brainstem Tumor Neoplasm of Brain Stem Neoplasm of Brainstem Neoplasm of the Brain Stem Neoplasm of the Brainstem Tumor of Brain Stem Tumor of Brainstem Tumor of the Brain Stem Tumor of the Brainstem brain stem tumor Brain Stem Neoplasm A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla. C4872 Neoplastic Process Breast Carcinoma Breast Carcinoma C0678222 Patient Code (Appendix B) CPTAC CTEP CTRP Cellosaurus FDA GDC MedDRA NICHD A malignant neoplasm that develops or arises in breast tissue. Cancer that forms in tissues of the breast, usually the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It occurs in both men and women, although male breast cancer is rare. Malignant Breast_Carcinoma Breast Cancer Breast cancer IMDRF:E180101 Breast Cancer Breast Carcinoma Breast cancer, NOS Cancer of Breast Cancer of the Breast Carcinoma of Breast Carcinoma of the Breast Mammary Carcinoma breast cancer Breast Carcinoma A primary or metastatic neoplasm that affects the cerebral hemispheres. C4874 Neoplastic Process Cerebral Neoplasm C1263885 Undetermined Cerebral_Neoplasm Cerebral Hemispheric Neoplasm Cerebral Hemispheric Tumor Cerebral Neoplasm Cerebral Neoplasms Cerebral Tumor Neoplasm of Cerebral Hemispheres Neoplasm of Cerebrum Neoplasm of the Cerebral Hemispheres Neoplasm of the Cerebrum Tumor of Cerebral Hemispheres Tumor of Cerebrum Tumor of the Cerebral Hemispheres Tumor of the Cerebrum Cerebral Neoplasm A benign or malignant neoplasm that affects the rectosigmoid region. Representative examples of benign neoplasms include lipoma and leiomyoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma. Rectosigmoid adenomas always exhibit epithelial dysplasia and are considered premalignant neoplasms. C4877 Neoplastic Process Rectosigmoid Neoplasm C0345873 Undetermined Rectosigmoid_Neoplasm Neoplasm of Rectosigmoid Junction Neoplasm of the Rectosigmoid Junction Rectosigmoid Neoplasm Rectosigmoid Tumor Tumor of Rectosigmoid Junction Tumor of the Rectosigmoid Junction Rectosigmoid Neoplasm A carcinoma originating in the lung. Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas. Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas. Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors. C4878 Neoplastic Process Lung Carcinoma Lung Carcinoma C0684249 CPTAC CTEP CTRP Cellosaurus GDC Cancer that forms in tissues of the lung, usually in the cells lining air passages. The two main types are small cell lung cancer and non-small cell lung cancer. These types are diagnosed based on how the cells look under a microscope. Malignant Lung_Carcinoma Lung Cancer Lung Cancer (all types) Cancer of Lung Cancer of the Lung Carcinoma of Lung Carcinoma of the Lung Lung Cancer Lung Cancer (all types) Lung Carcinoma Lung cancer, NOS lung cancer Lung Carcinoma An epithelial neoplasm that arises from the sweat gland and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4879 Neoplastic Process Benign Sweat Gland Neoplasm C0684354 GDC Benign Benign_Sweat_Gland_Neoplasm 8400/0 Sweat gland tumor, benign Benign Neoplasm of Sweat Gland Benign Neoplasm of the Sweat Gland Benign Sweat Gland Neoplasm Benign Sweat Gland Tumor Benign Tumor of Sweat Gland Benign Tumor of the Sweat Gland Sweat Gland Neoplasm, Benign Sweat gland tumor, benign Benign Sweat Gland Neoplasm A mesenchymal neoplasm that arises from bone or articular cartilage and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4880 Neoplastic Process Benign Bone Neoplasm C0153959 CPTAC Benign Benign_Bone_Neoplasm Benign neoplasm of long bones of right lower limb Benign neoplasm of short bones of lower limb Benign neoplasm: Bone and articular cartilage, unspecified Benign Bone Neoplasm Benign Bone Tumor Benign Neoplasm of Bone Benign Neoplasm of the Bone Benign Osseous Neoplasm Benign Osseous Tumor Benign Tumor of Bone Benign Tumor of the Bone Benign Bone Neoplasm The spread of a malignant neoplasm to the spine. This may be from a primary spinal malignant neoplasm, or from a malignant neoplasm at a distant site. C4881 Neoplastic Process Metastatic Malignant Neoplasm to the Spine Metastatic Malignant Neoplasm in the Spine C0684550 CTRP Malignant Metastatic_Neoplasm_to_the_Spine Metastases to Spine Metastases to the Spine Metastasis to Spine Metastasis to the Spine Metastatic Cancer to the Spine Metastatic Cancer to the Vertebral Column Metastatic Malignant Neoplasm in the Spine Metastatic Malignant Neoplasm to the Spine Metastatic Neoplasm to the Spine Metastatic Neoplasm to the Vertebral Column Metastatic Tumor to the Spine Metastatic Tumor to the Vertebral Column Metastatic Malignant Neoplasm in the Spine A mesenchymal neoplasm that arises from smooth, skeletal, or cardiac muscle and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4882 Neoplastic Process Benign Muscle Neoplasm C0027086 GDC 8895/0 Benign Benign_Muscle_Neoplasm 8895/0 Myoma Benign Muscle Neoplasm Benign Muscle Tumor Benign Neoplasm of Muscle Benign Neoplasm of the Muscle Benign Tumor of Muscle Benign Tumor of the Muscle Myoma Benign Muscle Neoplasm A malignant neoplasm affecting the skeletal or smooth muscles. Malignant neoplasms arising from the skeletal muscles are called rhabdomyosarcomas. Malignant neoplasms arising from the smooth muscles are called leiomyosarcomas. C4883 Neoplastic Process Malignant Muscle Neoplasm Malignant Muscle Neoplasm C0684743 CPTAC CTRP GDC 8895/3 Malignant Malignant_Muscle_Neoplasm 8895/3 Myosarcoma Malignant Muscle Neoplasm Malignant Muscle Tumor Malignant Neoplasm of Muscle Malignant Neoplasm of the Muscle Malignant Tumor of Muscle Malignant Tumor of the Muscle Myosarcoma Malignant Muscle Neoplasm A neoplasm that arises from the neck region and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4884 Neoplastic Process Benign Neck Neoplasm C0684815 Benign Benign_Neck_Neoplasm Benign Neck Neoplasm Benign Neck Tumor Benign Neoplasm of Neck Benign Neoplasm of the Neck Benign Tumor of Neck Benign Tumor of the Neck Benign Neck Neoplasm A neoplasm that arises from the pyriform sinus and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4886 Neoplastic Process Benign Pyriform Fossa Neoplasm C0684968 Benign Benign_Pyriform_Fossa_Neoplasm Benign Neoplasm of Pyriform Fossa Benign Neoplasm of Pyriform Sinus Benign Neoplasm of the Pyriform Fossa Benign Neoplasm of the Pyriform Sinus Benign Pyriform Fossa Neoplasm Benign Pyriform Fossa Tumor Benign Pyriform Sinus Neoplasm Benign Pyriform Sinus Tumor Benign Tumor of Pyriform Fossa Benign Tumor of Pyriform Sinus Benign Tumor of the Pyriform Fossa Benign Tumor of the Pyriform Sinus Benign Pyriform Fossa Neoplasm A malignant neoplasm that has spread to the trachea from another anatomic site. C4887 Neoplastic Process Metastatic Malignant Neoplasm in the Trachea C0685016 Malignant Metastatic_Neoplasm_to_the_Trachea Metastasis to the Trachea Metastatic Malignant Neoplasm in the Trachea Metastatic Malignant Neoplasm to the Trachea Metastatic Neoplasm to the Trachea Metastatic Tumor to the Trachea Secondary Malignant Neoplasm to the Trachea Secondary Malignant Tumor to the Trachea Metastatic Malignant Neoplasm in the Trachea A non-Hodgkin lymphoma or rarely Hodgkin lymphoma that arises from the spleen. C48873 Neoplastic Process Splenic Lymphoma C0432562 Malignant Splenic_Lymphoma Primary Splenic Lymphoma Splenic Lymphoma Splenic Lymphoma A high-grade malignant bone tumor arising from the remnants of the notochord. It is characterized by a lobulated growth pattern, myxoid stroma formation, the presence of physaliphorous cells, and a sarcomatous component. C48876 Neoplastic Process Dedifferentiated Chordoma C1266174 GDC 9372/3 Malignant Dedifferentiated_Chordoma 9372/3 Dedifferentiated chordoma Dedifferentiated Chordoma Dedifferentiated chordoma Sarcomatoid Chordoma Dedifferentiated Chordoma A neoplasm that arises from the hilar region of lung and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4888 Neoplastic Process Benign Lung Hilum Neoplasm C0685024 Benign Benign_Lung_Hilum_Neoplasm Benign Hilar Lung Neoplasm Benign Hilar Lung Tumor Benign Lung Hilum Neoplasm Benign Lung Hilum Tumor Benign Lung Hilum Neoplasm A malignant neoplasm that has spread to the heart from another primary anatomic site. C4889 Neoplastic Process Metastatic Malignant Neoplasm in the Heart C0685110 Malignant Metastatic_Neoplasm_to_the_Heart Metastases to Heart Metastases to the Heart Metastasis to Heart Metastasis to the Heart Metastatic Malignant Neoplasm in the Heart Metastatic Malignant Neoplasm to the Heart Metastatic Neoplasm to the Heart Metastatic Tumor to the Heart Metastatic Malignant Neoplasm in the Heart A neoplastic process characterized by a diffuse poorly circumscribed overgrowth of adipose tissue in the breast and cervical areas, and an accumulation of visceral fat. It is associated with antiretroviral therapy. Clinical presentation includes hyperlipidemia, insulin resistance, and fat atrophy of the face and limbs. C48899 Neoplastic Process HIV Lipodystrophy C1708272 Benign HIV_Lipodystrophy HIV Lipodystrophy HIV-Lipodystrophy HIV Lipodystrophy A primary or metastatic malignant neoplasm involving any part of the digestive system. C4890 Neoplastic Process Malignant Digestive System Neoplasm Malignant Gastrointestinal Neoplasm Malignant Digestive System Neoplasm C0685938 CPTAC CTEP CTRP Malignant Malignant_Gastrointestinal_Neoplasm Malignant neoplasm of ill-defined sites within the digestive organs and peritoneum Malignant neoplasm of other and ill-defined sites within the digestive organs and peritoneum Malignant neoplasm of other sites of digestive system and intra-abdominal organs Malignant neoplasm of other sites of rectum, rectosigmoid junction, and anus Malignant neoplasm of rectum, rectosigmoid junction, and anus Malignant neoplasm: Ill-defined sites within the digestive system Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal Gastrointestinal Cancer Gastrointestinal System Cancer Gastrointestinal cancer, NOS Malignant Digestive System Neoplasm Malignant Gastrointestinal Neoplasm Malignant Gastrointestinal System Neoplasm Malignant Digestive System Neoplasm A neoplasm that arises from the submandibular gland and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4891 Neoplastic Process Benign Submandibular Gland Neoplasm C0685988 Benign Benign_Submandibular_Gland_Neoplasm Benign Neoplasm of Submandibular Gland Benign Neoplasm of the Submandibular Gland Benign Submandibular Gland Neoplasm Benign Submandibular Gland Tumor Benign Tumor of Submandibular Gland Benign Tumor of the Submandibular Gland Benign Submandibular Gland Neoplasm Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C4892 Neoplastic Process Stage 0 Small Intestinal Cancer AJCC v7 Stage 0 Small Intestinal Cancer AJCC v7 C0686083 CTRP Malignant Stage_0_Small_Intestinal_Cancer Small Intestine Cancer Stage 0 Small Intestine Carcinoma in situ Stage 0 Small Intestinal Cancer Stage 0 Small Intestinal Cancer AJCC v7 Stage 0 Small Intestine Carcinoma Stage 0 Small Intestinal Cancer AJCC v7 A neoplasm that arises from the organs that comprise the urinary system and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4893 Neoplastic Process Benign Urinary System Neoplasm C0496893 Benign Benign_Urinary_Tract_Neoplasm Benign Urinary System Neoplasm Benign Urinary System Tumor Benign Urinary System Neoplasm A neoplastic endometrial proliferation that is confined to the endometrium and does not have metastatic potential. C4894 Neoplastic Process Benign Endometrial Neoplasm C0686239 Benign Benign_Endometrial_Neoplasm Benign Endometrial Neoplasm Benign Endometrial Tumor Benign Endometrium Neoplasm Benign Endometrium Tumor Benign Neoplasm of Endometrium Benign Neoplasm of the Endometrium Benign Tumor of Endometrium Benign Tumor of the Endometrium Benign Endometrial Neoplasm A neoplasm that arises from the adrenal medulla and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4895 Neoplastic Process Benign Adrenal Medulla Neoplasm C0686512 Benign Benign_Adrenal_Medulla_Neoplasm Benign Adrenal Medulla Neoplasm Benign Adrenal Medulla Tumor Benign Neoplasm of Adrenal Medulla Benign Neoplasm of the Adrenal Medulla Benign Tumor of Adrenal Medulla Benign Tumor of the Adrenal Medulla Benign Adrenal Medulla Neoplasm A self-limiting, rapidly growing, non-encapsulated benign neoplasm arising from the subcutaneous tissues. It is characterized by the growth of plump spindle-shaped fibroblasts in a storiform pattern, multinucleated osteoclast-like giant cells, red blood cell extravasation, chronic inflammatory cells, and high mitotic activity. C48961 Neoplastic Process Subcutaneous Nodular Fasciitis C1710225 Benign Subcutaneous_Nodular_Fasciitis Subcutaneous Nodular Fasciitis Subcutaneous Nodular Fasciitis A benign, well circumscribed soft tissue neoplasm characterized by the presence of spindle shaped myofibroblasts and mast cells in a collagenous stroma. C49012 Neoplastic Process Myofibroblastoma C0242404 GDC 8825/0 Benign Myofibroblastoma 8825/0 Myofibroblastoma Myofibroblastoma Myofibroblastoma A benign myofibroblastic neoplasm, usually arising in the pelviperineal region. It is characterized by the presence of neoplastic spindle to round cells, dilated thin walled vessels, and stromal edema. Most patients present with painless circumscribed masses. C49016 Neoplastic Process Angiomyofibroblastoma C1266123 GDC 8826/0 Benign Angiomyofibroblastoma 8826/0 Angiomyofibroblastoma Angiomyofibroblastoma Angiomyofibroblastoma An uncommon, poorly circumscribed, benign neoplasm arising in the soft tissues of infants, children and adolescents. It is characterized by the presence of haphazardly arranged spindle-shaped fibroblasts, collagenous stroma formation, and plaque-like growth pattern. There is a strong genetic component associating the neoplasm with Gardners syndrome and deep fibromatosis/desmoid tumor. C49017 Neoplastic Process Gardner Fibroma C1708187 Benign Gardner_s_Fibroma Desmoid Precursor Lesion Gardner Fibroma Gardner's Fibroma Gardner-Associated Fibroma Gardner Fibroma A lymph node that drains lymph from a region of interest. C49018 Body Part, Organ, or Organ Component Regional Lymph Node C1184738 CDISC CPTAC GDC In oncology, a lymph node that drains lymph from the region around a tumor. Lymph node(s) that drains the lymph from a region of interest. Regional_Lymph_Node Lymph Node(s) Regional Lymph Node, Regional LYMPH NODE, REGIONAL Lymph Node(s) Regional Lymph Node, Regional REGIONAL LYMPH NODE Regional Lymph Node Regional Lymph Nodes Regional lymph node regional lymph node Regional Lymph Node A neoplasm that arises from the spleen and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4902 Neoplastic Process Benign Splenic Neoplasm C0686615 Benign Benign_Splenic_Neoplasm Benign Neoplasm of Spleen Benign Neoplasm of the Spleen Benign Splenic Neoplasm Benign Splenic Neoplasm A low-grade malignant neoplasm arising from the soft tissue and rarely bone. It is characterized by the presence of spindle-shaped myofibroblasts and collagenous stroma formation in a storiform growth pattern. Metastasis is very rare. C49024 Neoplastic Process Low Grade Myofibroblastic Sarcoma C1708751 GDC 8825/3 Malignant Low_Grade_Myofibroblastic_Sarcoma 8825/3 Low-grade myofibroblastic sarcoma Myofibroblastic sarcoma Low Grade Myofibroblastic Sarcoma Low-Grade Myofibroblastic Sarcoma Low-grade myofibroblastic sarcoma Myofibroblastic Sarcoma Myofibroblastic sarcoma Myofibrosarcoma Low Grade Myofibroblastic Sarcoma A low grade, locally aggressive, fibroblastic neoplasm that occurs primarily in the distal extremities. It is characterized by the presence of spindle-shaped fibroblasts, multivacuolated lipoblast-like cells, bizarre ganglion-like cells with inclusion-like nuclei, myxoid stroma formation, and a mixture of acute and chronic inflammatory cells. Distant metastases are very rare. C49025 Neoplastic Process Myxoinflammatory Fibroblastic Sarcoma C1709103 Cellosaurus GDC Malignant Myxoinflammatory_Fibroblastic_Sarcoma Myxoinflammatory fibroblastic sarcoma Myxoinflammatory fibroblastic sarcoma (MIFS) Acral Myxoinflammatory Fibroblastic Sarcoma Inflammatory Myxohyaline Tumor of the Distal Extremities with Virocyte/Reed-Sternberg-Like Cells Inflammatory Myxoid Tumor of the Soft Parts with Bizarre Giant Cells MIFS Myxoinflammatory Fibroblastic Sarcoma Myxoinflammatory fibroblastic sarcoma (MIFS) Myxoinflammatory Fibroblastic Sarcoma A well-circumscribed malignant fibroblastic neoplasm that usually arises from the soft tissue. It is characterized by the presence of nests of malignant epithelioid fibroblasts and sclerotic collagen stroma formation. C49027 Neoplastic Process Sclerosing Epithelioid Fibrosarcoma C1710026 GDC Malignant Sclerosing_Epithelioid_Fibrosarcoma Sclerosing epithelioid fibrosarcoma SEF Sclerosing Epithelioid Fibrosarcoma Sclerosing epithelioid fibrosarcoma Sclerosing Epithelioid Fibrosarcoma A malignant neoplasm that has spread to the thymus from another anatomic site. C4903 Neoplastic Process Metastatic Malignant Neoplasm in the Thymus C0686617 Malignant Metastatic_Neoplasm_to_the_Thymus Metastasis to the Thymus Metastatic Malignant Neoplasm in the Thymus Metastatic Malignant Neoplasm to the Thymus Metastatic Malignant Tumor to the Thymus Metastatic Neoplasm to the Thymus Metastatic Tumor to the Thymus Secondary Malignant Neoplasm to the Thymus Secondary Malignant Tumor to the Thymus Metastatic Malignant Neoplasm in the Thymus The spread of a malignant neoplasm from its original site of growth to lymph nodes. C4904 Neoplastic Process Metastatic Malignant Neoplasm in the Lymph Nodes Metastatic Malignant Neoplasm in the Lymph Nodes C0686619 CTRP Malignant Metastatic_Neoplasm_to_Lymph_Nodes Secondary and unspecified malignant neoplasm of lymph nodes Secondary and unspecified malignant neoplasm of lymph nodes of head, face, and neck Secondary and unspecified malignant neoplasm of lymph nodes of inguinal region and lower limb Secondary and unspecified malignant neoplasm of lymph nodes of multiple sites Secondary and unspecified malignant neoplasm of lymph nodes, site unspecified Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes Secondary and unspecified malignant neoplasm: Lymph node, unspecified Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck Metastases to Lymph Nodes Metastasis to Lymph Node Metastatic Malignant Neoplasm in Lymph Node Metastatic Malignant Neoplasm in the Lymph Nodes Metastatic Malignant Neoplasm to the Lymph Nodes Metastatic Neoplasm to the Lymph Node Metastatic Tumor to Lymph Node Metastatic Malignant Neoplasm in the Lymph Nodes A hemangioma arising from the skin. C4905 Neoplastic Process Skin Hemangioma C0687140 NICHD Benign Hemangioma_of_the_Skin Angioma of Skin Angioma of the Skin Hemangioma of Skin Hemangioma of the Skin Skin Angioma Skin Hemangioma Skin Hemangioma A malignant tumor arising from the parenchymal cells of the parathyroid gland. It is associated with the symptoms of primary hyperparathyroidism, resulting from the excessive production of parathyroid hormone. Morphologically, the differential diagnosis from parathyroid gland adenoma may be difficult. A definitive diagnosis of carcinoma is made only in the presence of capsular invasion, vascular invasion, and/or perineural invasion. C4906 Neoplastic Process Parathyroid Gland Carcinoma Parathyroid Gland Carcinoma C0687150 CDISC CPTAC CTEP CTRP Cellosaurus A malignant neoplasm arising from the Chief cells of the parathyroid gland. A rare cancer that forms in tissues of one or more of the parathyroid glands (four pea-sized glands in the neck that make parathyroid hormone, which helps the body store and use calcium). Malignant Parathyroid_Carcinoma Adenocarcinoma of Parathyroid Adenocarcinoma of Parathyroid Gland Adenocarcinoma of the Parathyroid Adenocarcinoma of the Parathyroid Gland CARCINOMA, PARATHYROID GLAND, MALIGNANT Cancer of Parathyroid Gland Cancer of the Parathyroid Gland Carcinoma of Parathyroid Carcinoma of Parathyroid Gland Carcinoma of the Parathyroid Carcinoma of the Parathyroid Gland Parathyroid Adenocarcinoma Parathyroid Cancer Parathyroid Carcinoma Parathyroid Gland Adenocarcinoma Parathyroid Gland Cancer Parathyroid Gland Carcinoma Parathyroid cancer, NOS parathyroid cancer Parathyroid Gland Carcinoma A morphologic variant of fibrous histiocytoma of the skin. It is characterized by the presence of spindle-shaped fibrohistiocytic cells and associated acanthosis. C49076 Neoplastic Process Skin Fibrous Histiocytoma, Fibroblastic Variant C1707545 Benign Cutaneous_Fibrous_Histiocytoma_Fibroblastic_Variant Cutaneous Fibrous Histiocytoma, Fibroblastic Variant Skin Fibrous Histiocytoma, Fibroblastic Variant Skin Fibrous Histiocytoma, Fibroblastic Variant A morphologic variant of fibrous histiocytoma of the skin. It is characterized by the presence of xanthomatous fibrohistiocytic cells, giant cells, and hemosiderin deposition. C49077 Neoplastic Process Skin Fibrous Histiocytoma, Histiocytic Variant C1707546 Benign Cutaneous_Fibrous_Histiocytoma_Histiocytic_Variant Cutaneous Fibrous Histiocytoma, Histiocytic Variant Skin Fibrous Histiocytoma, Histiocytic Variant Skin Fibrous Histiocytoma, Histiocytic Variant A morphologic variant of fibrous histiocytoma of the skin. It is characterized by the presence of spindle-shaped fibrohistiocytic cells and increased cellularity. C49078 Neoplastic Process Skin Fibrous Histiocytoma, Cellular Variant C1707543 Benign Cutaneous_Fibrous_Histiocytoma_Cellular_Variant Cutaneous Fibrous Histiocytoma, Cellular Variant Skin Fibrous Histiocytoma, Cellular Variant Skin Fibrous Histiocytoma, Cellular Variant A morphologic variant of fibrous histiocytoma of the skin. It is characterized by the presence of epithelioid fibrohistiocytic cells. C49079 Neoplastic Process Skin Fibrous Histiocytoma, Epithelioid Variant C1707544 Benign Cutaneous_Fibrous_Histiocytoma_Epithelioid_Variant Cutaneous Epithelioid Fibrous Histiocytoma Cutaneous Fibrous Histiocytoma, Epithelioid Variant Epithelioid Fibrous Histiocytoma Skin Fibrous Histiocytoma, Epithelioid Variant Skin Fibrous Histiocytoma, Epithelioid Variant A malignant neoplasm originating from the surface ovarian epithelium. It accounts for the greatest number of deaths from malignancies of the female genital tract and is the fifth leading cause of cancer fatalities in women. It is predominantly a disease of older white women of northern European extraction, but it is seen in all ages and ethnic groups. Adenocarcinomas constitute the vast majority of ovarian carcinomas. The pattern of metastatic spread in ovarian carcinoma is similar regardless of the microscopic type. The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver. Lung and pleura are the most common sites of extra-abdominal spread. The primary form of therapy is surgical. The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms. C4908 Neoplastic Process Ovarian Epithelial Cancer Ovarian Carcinoma C0677886 CPTAC CTEP CTRP Cellosaurus Cancer that occurs in the cells lining the ovaries. Malignant Ovarian_Carcinoma Carcinoma of Ovary Carcinoma of the Ovary Epithelial Ovarian Cancer Ovarian Cancer Ovarian Carcinoma Ovarian Epithelial Cancer Ovarian epithelial cancer epithelial ovarian cancer ovarian epithelial cancer Ovarian Carcinoma A magnetic resonance imaging technique that uses the difference between the magnetic signals of hemoglobin when it is carrying oxygen (oxyhemoglobin) and when it is not carrying oxygen (deoxyhemoglobin) to detect metabolic activity, and hence neurologic activity, in the brain. C49099 Diagnostic Procedure Blood Oxygen Level-Dependent Functional MRI Blood Oxygen Level-Dependent Functional MRI C1705491 CDISC CTRP A functional magnetic resonance imaging technique that uses the difference between the magnetic signals of hemoglobin when it is carrying oxygen (oxyhemoglobin) and when it is not carrying oxygen (deoxyhemoglobin) to detect metabolic activity, and hence neurologic activity, in the brain. (NCI) Blood_Oxygen_Level_Dependant_Imaging BLOOD OXYGEN LEVEL-DEPENDENT FUNCTIONAL MRI BOLD BOLD fMRI Blood Oxygen Level Dependent Functional Magnetic Resonance Imaging Blood Oxygen Level Dependent Imaging Blood Oxygen Level-Dependent Functional MRI Blood Oxygen Level-Dependent fMRI Blood Oxygen Level-Dependent Functional MRI A malignant epithelial neoplasm that arises from the colon and invades through the muscularis mucosa into the submucosa. The vast majority are adenocarcinomas. C4910 Neoplastic Process Colon Carcinoma Colon Carcinoma C0699790 CPTAC CTRP Cellosaurus Cancer that forms in the tissues of the colon (the longest part of the large intestine). Most colon cancers are adenocarcinomas (cancers that begin in cells that make and release mucus and other fluids). Malignant Colon_Carcinoma Carcinoma of Colon Carcinoma of the Colon Colon Cancer Colon Carcinoma Colonic Carcinoma colon cancer Colon Carcinoma A painless, well circumscribed tumor arising in soft tissue, usually of the upper and lower extremities. Morphologically, it is characterized by a multinodular growth pattern. The cellular infiltrate is composed of mononuclear round or oval cells and multinucleated osteoclast-like giant cells, in a rich vascular stroma. It rarely metastasizes. C49107 Neoplastic Process Giant Cell Tumor of Soft Tissue C0334553 GDC 9251/1 Undetermined Giant_Cell_Tumor_of_Soft_Tissue 9251/1 Giant cell tumor of soft parts, NOS GCT-ST Giant Cell Tumor of Low Malignant Potential Giant Cell Tumor of Soft Tissue Giant cell tumor of soft parts, NOS Osteoclastoma of Soft Tissue Giant Cell Tumor of Soft Tissue A malignant epithelial tumor of the stomach mucosa. The vast majority of gastric carcinomas are adenocarcinomas, arising from the gastric glandular epithelium. C4911 Neoplastic Process Gastric Carcinoma Gastric Carcinoma C0699791 CPTAC CTEP CTRP Cellosaurus GDC Cancer that forms in tissues lining the stomach. Malignant Gastric_Carcinoma Gastric Cancer Cancer of Stomach Cancer of the Stomach Carcinoma of Stomach Carcinoma of the Stomach Gastric (Stomach) Cancer Gastric Cancer Gastric Carcinoma Gastric cancer, NOS Stomach Cancer Stomach Carcinoma gastric cancer stomach cancer Gastric Carcinoma A morphologic variant of angioleiomyoma characterized by the presence of numerous small, slit-like vascular channels. C49110 Neoplastic Process Solid Angioleiomyoma C1710124 Benign Solid_Angioleiomyoma Solid Angioleiomyoma Solid Angiomyoma Solid Angioleiomyoma A morphologic variant of angioleiomyoma characterized by the presence of thick-walled veins. C49111 Neoplastic Process Venous Angioleiomyoma C1710624 Benign Venous_Angioleiomyoma Venous Angioleiomyoma Venous Angiomyoma Venous Angioleiomyoma A morphologic variant of angioleiomyoma characterized by the presence of markedly dilated vascular channels. C49115 Neoplastic Process Cavernous Angioleiomyoma C1707319 Benign Cavernous_Angioleiomyoma Cavernous Angioleiomyoma Cavernous Angioleiomyoma A carcinoma arising from the bladder epithelium. Approximately 90% of the bladder carcinomas are transitional cell carcinomas. The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas. C4912 Neoplastic Process Bladder Carcinoma Bladder Carcinoma C0699885 CPTAC CTRP Cellosaurus GDC Cancer that forms in tissues of the bladder (the organ that stores urine). Most bladder cancers are transitional cell carcinomas (cancer that begins in cells that normally make up the inner lining of the bladder). Other types include squamous cell carcinoma (cancer that begins in thin, flat cells) and adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids). The cells that form squamous cell carcinoma and adenocarcinoma develop in the inner lining of the bladder as a result of chronic irritation and inflammation. Malignant Bladder_Carcinoma Bladder Cancer Bladder Cancer Bladder Carcinoma Cancer of Bladder Cancer of Urinary Bladder Cancer of the Bladder Cancer of the Urinary Bladder Carcinoma of Bladder Carcinoma of Urinary Bladder Carcinoma of the Bladder Carcinoma of the Urinary Bladder Urinary Bladder Cancer Urinary Bladder Carcinoma bladder cancer Bladder Carcinoma A primary or metastatic malignant neoplasm involving the female reproductive system. Representative examples include endometrial carcinoma, cervical carcinoma, ovarian carcinoma, uterine corpus leiomyosarcoma, adenosarcoma, malignant mixed mesodermal (mullerian) tumor, and gestational choriocarcinoma. C4913 Neoplastic Process Malignant Female Reproductive System Neoplasm Malignant Female Reproductive System Neoplasm C0699889 CPTAC CTEP CTRP GDC mCode Cancer of the female reproductive tract, including the cervix, endometrium, fallopian tubes, ovaries, uterus, and vagina. Malignant Malignant_Female_Reproductive_System_Neoplasm Gynecologic Cancer Malignant neoplasm of female genital organ, site unspecified Malignant neoplasm of other and unspecified female genital organs Malignant neoplasm of ovary and other uterine adnexa Malignant neoplasm of uterine adnexa, unspecified Malignant neoplasm: Female genital organ, unspecified Malignant neoplasm: Other specified female genital organs Malignant neoplasm: Uterine adnexa, unspecified Female Reproductive Cancer Female reprod. system cancer, NOS Female reproductive system cancer, NOS Gynecologic Cancer Malignant Female Reproductive System Neoplasm Malignant Female Reproductive System Tumor Malignant Gynecologic Neoplasm Malignant Gynecologic Tumor Malignant Neoplasm of Female Reproductive System Malignant Neoplasm of the Female Reproductive System Malignant Tumor of Female Reproductive System Malignant Tumor of the Female Reproductive System Malignant neoplasm of female genital organ, unspecified gynecologic cancer Malignant Female Reproductive System Neoplasm Surgical removal of both non-diseased ovaries with the goal of preventing ovarian carcinoma. C49133 Therapeutic or Preventive Procedure Bilateral Prophylactic Oophorectomy C1706939 Bilateral_Prophylactic_Oophorectomy Bilateral Prophylactic Oophorectomy Bilateral Prophylactic Oophorectomy A carcinoma that arises from the skin. Representative examples are basal cell carcinoma and squamous cell carcinoma. C4914 Neoplastic Process Skin Carcinoma Skin Carcinoma C3281209 CPTAC CTRP Skin cancer that arises in basal cells or squamous cells but not in melanocytes (pigment-producing cells of the skin). Malignant Skin_Carcinoma Carcinoma of Skin Carcinoma of the Skin Non-Melanoma Cancer of Skin Non-Melanoma Cancer of the Skin Non-Melanoma Skin Cancer Non-melanoma Skin Cancer Skin Cancer, Non-Melanoma Skin Carcinoma nonmelanoma skin cancer Skin Carcinoma An aggressive embryonal tumor with multilayered rosettes characterized by the presence of amplification of the C19MC region on chromosome 19 (19q13.42). C4915 Neoplastic Process Embryonal Tumor with Multilayered Rosettes, C19MC-Altered C0700367 GDC Malignant Ependymoblastoma 9392/3 9478/3 Embryonal tumor with multilayered rosettes C19MC-altered Embryonal tumor with multilayered rosettes with C19MC alteration Ependymoblastoma ETMR, C19MC-Altered Embryonal Tumor with Abundant Neuropil and True Rosettes Embryonal Tumor with Multilayered Rosettes Embryonal Tumor with Multilayered Rosettes with C19MC Amplification Embryonal Tumor with Multilayered Rosettes, C19MC-Altered Embryonal tumor with multilayered rosettes C19MC-altered Ependymoblastoma Embryonal Tumor with Multilayered Rosettes, C19MC-Altered A benign mesenchymal neoplasm that shows mature skeletal muscle differentiation. C49166 Neoplastic Process Extracardiac Rhabdomyoma C1707985 Benign Extracardiac_Rhabdomyoma Extracardiac Rhabdomyoma Extracardiac Rhabdomyoma A highly aggressive carcinoma with neuroendocrine differentiation arising from the lung. It is characterized by the presence of malignant small cells and necrosis. Metastatic disease is usually present at the time of diagnosis. C4917 Neoplastic Process Small Cell Lung Carcinoma Lung Small Cell Carcinoma C0149925 CPTAC CTEP CTRP Cellosaurus An aggressive (fast-growing) cancer that forms in tissues of the lung and can spread to other parts of the body. The cancer cells look small and oval-shaped when looked at under a microscope. Malignant Small_Cell_Lung_Carcinoma Lung Oat Cell Carcinoma Lung Small Cell Carcinoma Lung Small Cell Neuroendocrine Carcinoma Oat Cell Carcinoma of Lung Oat Cell Carcinoma of the Lung Oat Cell Lung Carcinoma SCLC Small Cell Carcinoma of Lung Small Cell Carcinoma of the Lung Small Cell Lung Cancer Small Cell Lung Carcinoma Small Cell Neuroendocrine Carcinoma of Lung Small Cell Neuroendocrine Carcinoma of the Lung Small cell lung cancer small cell lung cancer Lung Small Cell Carcinoma A cardiac rhabdomyoma characterized by the presence of neoplastic large striated muscle cells with clear cytoplasm and spider cells. C49179 Neoplastic Process Conventional Cardiac Rhabdomyoma C1711171 Benign Conventional_Cardiac_Rhabdomyoma Conventional Cardiac Rhabdomyoma Conventional Heart Rhabdomyoma Conventional Cardiac Rhabdomyoma A malignant neoplasm affecting the nasal cavity. Representative examples include carcinoma and lymphoma. C4918 Neoplastic Process Malignant Nasal Cavity Neoplasm C0728864 CPTAC mCode Malignant Malignant_Nasal_Cavity_Neoplasm Malignant neoplasm of nasal cavities Malignant neoplasm: Nasal cavity Malignant Nasal Cavity Neoplasm Malignant Nasal Cavity Tumor Malignant Neoplasm of Nasal Cavity Malignant Neoplasm of the Nasal Cavity Malignant Tumor of Nasal Cavity Malignant Tumor of the Nasal Cavity Malignant neoplasm of nasal cavity Malignant Nasal Cavity Neoplasm A neoplasm that arises from the glandular epithelium of the rectal mucosa. It is characterized by a villous architectural pattern. The neoplastic glandular cells have dysplastic features. C4919 Neoplastic Process Rectal Villous Adenoma C0730199 Benign Rectal_Villous_Adenoma Rectal Villous Adenoma Villous Adenoma of Rectum Villous Adenoma of the Rectum Rectal Villous Adenoma A morphologic variant of embryonal rhabdomyosarcoma. It is characterized by the presence of large hyperchromatic and anaplastic cells. C49204 Neoplastic Process Anaplastic Embryonal Rhabdomyosarcoma C4055470 NICHD A morphologic variant of embryonal rhabdomyosarcoma; it is characterized by the presence of large, hyperchromatic, anaplastic cells. Malignant Anaplastic_Rhabdomyosarcoma Anaplastic Embryonal Rhabdomyosarcoma Embryonal Rhabdomyosarcoma with Diffuse Anaplasia Anaplastic Embryonal Rhabdomyosarcoma A cavernous hemangioma arising from the retina. C4921 Neoplastic Process Retinal Cavernous Hemangioma C0730304 Benign Retinal_Cavernous_Hemangioma Cavernous Angioma of Retina Cavernous Angioma of the Retina Cavernous Hemangioma of Retina Cavernous Hemangioma of the Retina Retina Cavernous Angioma Retina Cavernous Hemangioma Retinal Cavernous Angioma Retinal Cavernous Hemangioma Retinal Cavernous Hemangioma A carcinoma of the larynx that arises from the glottic area. C4923 Neoplastic Process Glottis Carcinoma Glottis Carcinoma C0740083 CTRP Malignant Glottis_Carcinoma Cancer of Glottis Cancer of the Glottis Carcinoma of Glottis Carcinoma of the Glottis Glottic Carcinoma Glottic Throat Cancer Glottis Cancer Glottis Carcinoma Glottis Carcinoma One of the many muciparous glands within the mucous membrane of the larynx. C49244 Anatomical Structure Laryngeal Mucous Salivary Gland C1708654 Laryngeal_Mucous_Salivary_Gland Laryngeal Mucous Salivary Gland Laryngeal Mucous Salivary Gland C49250 Tissue Left Lung Alveolar Duct C1708672 Left_Lung_Alveolar_Duct Left Lung Alveolar Duct Left Lung Alveolar Duct An undifferentiated pleomorphic sarcoma that has spread to other anatomic sites. C4926 Neoplastic Process Metastatic Undifferentiated Pleomorphic Sarcoma Metastatic Undifferentiated Pleomorphic Sarcoma C0740346 CTRP Malignant Metastatic_Malignant_Fibrous_Histiocytoma Malignant Fibrous Histiocytoma Metastatic Metastatic Malignant Fibrous Histiocytoma Metastatic Unclassified Pleomorphic Sarcoma Metastatic Unclassified Pleomorphic Sarcoma (Formerly Metastatic "MFH") Metastatic Unclassified Pleomorphic Sarcoma (Formerly Metastatic "Malignant Fibrous Histiocytoma") Metastatic Undifferentiated Pleomorphic Sarcoma Metastatic Undifferentiated Pleomorphic Sarcoma The tiny tubules with a very thin epithelial layer in the salivary glands running from the salivary acini into the striated duct. C49266 Anatomical Structure Intercalated Duct of the Salivary Gland System C1708529 Intercalated_Duct_of_the_Salivary_Gland_System Intercalated Duct of the Salivary Gland System Intercalated Duct of the Salivary Gland System The tiny tubules with a very thin epithelial layer in the pancreas running from the pancreatic acini into the striated duct. C49267 Anatomical Structure Intercalated Duct of the Pancreas C0227577 Intercalated_Duct_of_the_Pancreas Intercalated Duct of the Pancreas Intercalated Duct of the Pancreas C49277 Tissue Right Lung Alveolar Duct C1709958 Right_Lung_Alveolar_Duct Right Lung Alveolar Duct Right Lung Alveolar Duct A benign or malignant neoplasm that affects the structures of the chest wall. Representative examples include chest wall lipoma and chest wall lymphoma. C4929 Neoplastic Process Chest Wall Neoplasm C1290309 Undetermined Chest_Wall_Neoplasm Chest Wall Neoplasm Chest Wall Tumor Neoplasm of Chest Wall Neoplasm of the Chest Wall Tumor of Chest Wall Tumor of the Chest Wall Chest Wall Neoplasm Any of the glands located at the wall of the urethra of male mammals that produce and secrete mucus, a major component of semen. C49311 Anatomical Structure Gland of Littre C1314737 Urethral_Gland Gland of Littre Gland of Littré Periurethral Gland Urethral Gland Gland of Littre A circumscribed neoplasm that arises from the glandular epithelium of the duodenum. Morphologically, it is characterized by a proliferation of neoplastic glandular cells and it is associated with dysplasia. According to the growth pattern, it may be classified as tubular, villous, or tubulovillous. C4932 Neoplastic Process Duodenal Adenoma C0743301 Benign Duodenal_Adenoma Duodenal Adenoma Duodenal Adenoma The adrenal gland located on the left side of the body. C49322 Anatomical Structure Left Adrenal Gland C0229560 Left_Adrenal_Gland Left Adrenal Gland Left Adrenal Gland The testis on the left side of the body. C49323 Anatomical Structure Left Testis C0227998 Left_Testis Left Testis Left Testis The ureter connecting the left kidney to the bladder. C49324 Anatomical Structure Left Ureter C0227683 Left_Ureter Left Ureter Left Ureter The adrenal gland located on the right side of the body. C49325 Anatomical Structure Right Adrenal Gland C0229559 Right_Adrenal_Gland Right Adrenal Gland Right Adrenal Gland The testis on the right side of the body. C49326 Anatomical Structure Right Testis C0227997 Right_Testis Right Testis Right Testis The ureter connecting the right kidney to the bladder. C49327 Anatomical Structure Right Ureter C0227682 Right_Ureter Right Ureter Right Ureter A benign or malignant neoplasm that affects the epiglottis. C4933 Neoplastic Process Epiglottis Neoplasm C1290353 Undetermined Epiglottis_Neoplasm Epiglottic Neoplasm Epiglottic Tumor Epiglottis Neoplasm Epiglottis Tumor Neoplasm of Epiglottis Neoplasm of the Epiglottis Tumor of Epiglottis Tumor of the Epiglottis Epiglottis Neoplasm A neoplasm that arises from the female reproductive system and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4934 Neoplastic Process Benign Female Reproductive System Neoplasm Benign Female Reproductive System Neoplasm C0947770 CPTAC CTRP Benign Benign_Female_Reproductive_System_Neoplasm Benign neoplasm: Other specified female genital organs Benign Female Reproductive System Neoplasm Benign Female Reproductive System Tumor Benign Gynecologic Neoplasm Benign Gynecologic Tumor Benign Female Reproductive System Neoplasm A well differentiated, low grade neuroendocrine neoplasm that arises from the ileum. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. C4935 Neoplastic Process Ileal Neuroendocrine Tumor G1 C0745216 CPTAC Undetermined Ileal_Carcinoid_Tumor Ileal NET G1 Ileal Neuroendocrine Tumor G1 Ileal Neuroendocrine Tumor G1 The reemergence of Hodgkin lymphoma after a period of remission. C4937 Neoplastic Process Recurrent Hodgkin Lymphoma Recurrent Hodgkin Lymphoma C0746341 CTRP Malignant Recurrent_Hodgkin_s_Lymphoma Recurrent Hodgkin Lymphoma Recurrent Hodgkin's Disease Recurrent Hodgkin's Lymphoma Recurrent Hodgkin Lymphoma A lymphoma that is confined to a specific site without evidence of spread to other anatomic sites. C4938 Neoplastic Process Localized Lymphoma C0746343 CPTAC Malignant Localized_Lymphoma Localized Lymphoma Localized Lymphoma A primary or metastatic malignant neoplasm that affects the anatomic structures of the neck region. C4940 Neoplastic Process Malignant Neck Neoplasm C0746787 Malignant Malignant_Neck_Neoplasm Cancer of Neck Cancer of the Neck Malignant Neck Neoplasm Malignant Neck Tumor Malignant Neoplasm of Neck Malignant Neoplasm of the Neck Malignant Tumor of Neck Malignant Tumor of the Neck Neck Cancer Malignant Neck Neoplasm A squamous cell carcinoma that arises from the soft palate. It usually presents as an ulcerated or fungating mass. C4941 Neoplastic Process Soft Palate Squamous Cell Carcinoma C0747154 Malignant Soft_Palate_Squamous_Cell_Carcinoma SCC of Soft Palate SCC of the Soft Palate Soft Palate SCC Soft Palate Squamous Cell Carcinoma Squamous Cell Carcinoma of Soft Palate Squamous Cell Carcinoma of the Soft Palate Soft Palate Squamous Cell Carcinoma Stage 0 carcinoma of the pharynx according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions. C4942 Neoplastic Process Stage 0 Pharyngeal Cancer Stage 0 Pharyngeal Cancer C0347098 CPTAC CTRP mCode Malignant Stage_0_Pharyngeal_Cancer Carcinoma in situ of pharynx Carcinoma in situ of Pharynx Carcinoma in situ of pharynx Carcinoma in situ of the Pharynx Pharyngeal Cancer Stage 0 Pharyngeal Carcinoma in situ Pharynx Carcinoma in situ Stage 0 Carcinoma of Pharynx Stage 0 Carcinoma of the Pharynx Stage 0 Pharyngeal Cancer Stage 0 Pharyngeal Carcinoma Stage 0 Pharyngeal Throat Cancer Stage 0 Pharynx Carcinoma Stage 0 Pharyngeal Cancer A squamous cell carcinoma that arises from the pyriform sinus. Patients usually present with advanced stage disease and the prognosis is poor. C4943 Neoplastic Process Pyriform Fossa Squamous Cell Carcinoma C0748214 Cellosaurus Malignant Pyriform_Fossa_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Pyriform Fossa Epidermoid Carcinoma of Pyriform Sinus Epidermoid Carcinoma of the Pyriform Fossa Epidermoid Carcinoma of the Pyriform Sinus Pyriform Fossa Epidermoid Carcinoma Pyriform Fossa Squamous Cell Carcinoma Pyriform Sinus Epidermoid Carcinoma Pyriform Sinus Squamous Cell Carcinoma Squamous Cell Carcinoma of Pyriform Fossa Squamous Cell Carcinoma of Pyriform Sinus Squamous Cell Carcinoma of the Pyriform Fossa Squamous Cell Carcinoma of the Pyriform Sinus Pyriform Fossa Squamous Cell Carcinoma A benign or malignant neoplasm that occurs in the sellar region. Representative examples include craniopharyngioma and pituitary gland adenoma. C4944 Neoplastic Process Sellar Region Neoplasm C0748616 Undetermined Sella_Turcica_Neoplasm Neoplasm of Sella Turcica Neoplasm of the Sella Turcica Neoplasm of the Sellar Region Sella Turcica Neoplasm Sella Turcica Tumor Sellar Neoplasm Sellar Region Neoplasm Sellar Tumor Tumor of the Sella Turcica Tumor of the Sellar Region Sellar Region Neoplasm A squamous cell carcinoma of the larynx that arises from the supraglottic area. Signs and symptoms include dysphagia, a sensation of foreign body in the throat, and hemoptysis. It spreads to the space anterior to the epiglottis, pyriform sinus, and base of the tongue. C4945 Neoplastic Process Supraglottic Squamous Cell Carcinoma C0749163 Malignant Supraglottic_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Supraglottis Epidermoid Carcinoma of the Supraglottis Squamous Cell Carcinoma of Supraglottis Squamous Cell Carcinoma of the Supraglottis Supraglottic Epidermoid Carcinoma Supraglottic Squamous Cell Carcinoma Supraglottis Epidermoid Carcinoma Supraglottis Squamous Cell Carcinoma Supraglottic Squamous Cell Carcinoma A follicular carcinoma of the thyroid gland, characterized by the presence of large cells with eosinophilic granular cytoplasm and pleomorphic nuclei with prominent, eosinophilic nucleoli. The nuclear features that characterize the papillary carcinomas of the thyroid gland are absent. C4946 Neoplastic Process Thyroid Gland Oncocytic Carcinoma C0749424 Cellosaurus Malignant Thyroid_Hurthle_Cell_Carcinoma Hurthle Cell Carcinoma of Thyroid Hurthle Cell Carcinoma of Thyroid Gland Hurthle Cell Carcinoma of the Thyroid Hurthle Cell Carcinoma of the Thyroid Gland Hurthle Cell Thyroid Gland Carcinoma Oncocytic Carcinoma of Thyroid Oncocytic Carcinoma of the Thyroid Thyroid Gland Hurthle Cell Carcinoma Thyroid Gland Oncocytic Carcinoma Thyroid Gland Oncocytic Follicular Carcinoma Thyroid Hurthle Cell Carcinoma Thyroid Oncocytic Carcinoma Thyroid Gland Oncocytic Carcinoma A human papillomavirus-related neoplasm that arises from the vagina. It is characterized by papillomatosis, acanthotic changes, and hyperkeratosis. Koilocytosis is usually present. C4947 Neoplastic Process Vaginal Condyloma Acuminatum C1302539 Undetermined Vaginal_Condyloma_Acuminatum Condylomata Acuminata of Vagina Condylomata Acuminata of the Vagina Vaginal Condyloma Vaginal Condyloma Acuminatum Vaginal Condyloma Acuminatum The skin of the organ responsible for detecting sound and establishing balance. C49481 Anatomical Structure Ear Skin C0222110 CDISC The integument that covers the ear. Ear_Skin Ear Skin SKIN OF THE EAR Ear Skin A rare lymphoma that arises from the liver and the bulk of the tumor is located in the liver. The most frequent types of lymphoma that arise from the liver are diffuse large B-cell lymphoma and mucosa-associated lymphoid tissue lymphoma. C4949 Neoplastic Process Liver Lymphoma C1112746 Malignant Hepatic_Lymphoma Hepatic Lymphoma Liver Lymphoma Lymphoma of Liver Lymphoma of the Liver Primary Hepatic Lymphoma Primary Liver Lymphoma Liver Lymphoma An extranodal non-Hodgkin lymphoma that arises from the colon. The majority are B-cell non-Hodgkin lymphomas. C4950 Neoplastic Process Colon Non-Hodgkin Lymphoma C0750815 Malignant Colon_Non-Hodgkin_s_Lymphoma Colon Non-Hodgkin Lymphoma Colon Non-Hodgkin's Lymphoma Colon NonHodgkin's Lymphoma Colonic Non-Hodgkin's Lymphoma Colonic NonHodgkin's Lymphoma Non-Hodgkin's Lymphoma of Colon Non-Hodgkin's Lymphoma of the Colon Primary Colon Non-Hodgkin's Lymphoma Colon Non-Hodgkin Lymphoma An astrocytoma that arises from the cerebral hemispheres. C4951 Neoplastic Process Cerebral Astrocytoma C0750935 Undetermined Cerebral_Astrocytoma Astrocytoma of Cerebral Hemispheres Astrocytoma of Cerebrum Astrocytoma of the Cerebral Hemispheres Astrocytoma of the Cerebrum Cerebral Astrocytoma Cerebral Hemispheric Astrocytoma Cerebral Astrocytoma A brain neoplasm that is confined to a specific site without evidence of spread to other anatomic sites. C4952 Neoplastic Process Localized Brain Neoplasm CL1406302 Undetermined Primary_Brain_Neoplasm Localized Brain Neoplasm Non-Metastatic Brain Neoplasm Localized Brain Neoplasm A benign or malignant neoplasm that arises from or metastasizes to structures within the cranium. This includes meningeal and other tumors that occur in the spaces that surround the brain, and neoplasms of the brain. C4953 Neoplastic Process Intracranial Neoplasm C1527390 A tumor that occurs in the brain. Undetermined Intracranial_Neoplasm Intracranial Central Nervous System Neoplasm Intracranial Central Nervous System Tumor Intracranial Neoplasm Intracranial Tumor intracranial tumor Intracranial Neoplasm A malignant brain neoplasm that is confined to a specific site without evidence of spread to other anatomic sites. C4954 Neoplastic Process Localized Malignant Brain Neoplasm C0750979 Malignant Malignant_Primary_Brain_Neoplasm Localized Malignant Brain Neoplasm Non-Metastatic Malignant Brain Neoplasm Localized Malignant Brain Neoplasm A neoplasm that arises from the cerebellum and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4955 Neoplastic Process Benign Cerebellar Neoplasm C0750995 Benign Benign_Cerebellar_Neoplasm Benign Cerebellar Neoplasm Benign Cerebellar Neoplasms Benign Cerebellar Tumor Benign Neoplasm of Cerebellum Benign Neoplasm of the Cerebellum Benign Tumor of Cerebellum Benign Tumor of the Cerebellum Cerebellar Neoplasms, Benign Neoplasms, Benign, Cerebellar Neoplasms, Cerebellar, Benign Benign Cerebellar Neoplasm A medulloblastoma characterized by the presence of nodular, collagenous areas which do not contain reticulin, surrounded by hypercellular areas which contain an intercellular reticulin fiber network. C4956 Neoplastic Process Desmoplastic/Nodular Medulloblastoma C0751291 Cellosaurus GDC 9471/3 Malignant Desmoplastic_Medulloblastoma 9471/3 Circumscribed arachnoidal cerebellar sarcoma Desmoplastic medulloblastoma Desmoplastic nodular medulloblastoma Desmoplastic Medulloblastoma Desmoplastic Nodular Medulloblastoma Desmoplastic medulloblastoma Desmoplastic nodular medulloblastoma Desmoplastic/Nodular Medulloblastoma Desmoplastic/Nodular Medulloblastoma A neoplasm that arises from the meninges and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4957 Neoplastic Process Benign Neoplasm of the Meninges C0348426 CPTAC mCode Benign Benign_Neoplasms_of_the_Meninges Benign neoplasm of cerebral meninges Benign neoplasm: Cerebral meninges Benign neoplasm: Meninges, unspecified Benign Meningeal Neoplasm Benign Meningeal Neoplasms Benign Meningeal Tumor Benign Meningeal Tumors Benign Meninges Neoplasm Benign Meninges Tumor Benign Neoplasm of Meninges Benign Neoplasm of the Meninges Benign Neoplasms of Meninges Benign Neoplasms of the Meninges Benign Tumor of Meninges Benign Tumor of the Meninges Benign neoplasm of meninges Benign neoplasm of meninges, unspecified Meningeal Tumors, Benign Benign Neoplasm of the Meninges A malignant neoplasm that has spread from its original site to the two innermost layers of tissue that cover the brain and spinal cord. C4958 Neoplastic Process Leptomeningeal Neoplasm C0751297 CDISC A malignant neoplasm that has spread from its original site to the arachnoid mater and the pia mater, the two innermost layers of tissue that cover the brain and spinal cord. Undetermined Leptomeningeal_Neoplasm LEPTOMENINGEAL DISEASE Leptomeningeal Neoplasm Leptomeningeal Tumor Neoplasm of Leptomeninges Neoplasm of the Leptomeninges Tumor of Leptomeninges Tumor of the Leptomeninges Leptomeningeal Neoplasm A meningioma that affects the cerebral sulcus. C4959 Neoplastic Process Cerebral Convexity Meningioma C0751303 Undetermined Cerebral_Convexity_Meningioma Cerebral Convexity Meningioma Cerebral Hemispheric Convexity Meningioma Cerebral Convexity Meningioma A meningioma that affects the superior sagittal sinus and invades the parasagittal angle. C4960 Neoplastic Process Parasagittal Meningioma C0751304 Undetermined Parasagittal_Meningioma Parasagittal Meningioma Parasagittal Meningioma Malignant growth of cells in the peripheral nervous system (PNS)or Autonomic Nervous System (ANS), without specification as to location C4961 Neoplastic Process Malignant Peripheral Nervous System Neoplasm Malignant Peripheral Nervous System Neoplasm C0751428 CPTAC CTRP mCode Malignant Malignant_Peripheral_Nervous_System_Neoplasm Malignant neoplasm of peripheral nerves and autonomic nervous system Malignant neoplasm: Overlapping lesion of peripheral nerves and autonomic nervous system Malignant neoplasm: Peripheral nerves of head, face and neck Malignant Neoplasm of PNS Malignant Neoplasm of Peripheral Nerve Malignant Neoplasm of Peripheral Nervous System Malignant Neoplasm of the PNS Malignant Neoplasm of the Peripheral Nerve Malignant Neoplasm of the Peripheral Nervous System Malignant Neoplasms, Peripheral Nerve Malignant PNS Neoplasm Malignant PNS Tumor Malignant Peripheral Nerve Neoplasm Malignant Peripheral Nerve Tumor Malignant Peripheral Nervous System Neoplasm Malignant Peripheral Nervous System Tumor Malignant Tumor of PNS Malignant Tumor of Peripheral Nerve Malignant Tumor of Peripheral Nervous System Malignant Tumor of the PNS Malignant Tumor of the Peripheral Nerve Malignant Tumor of the Peripheral Nervous System Malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified Peripheral Nervous System Neoplasms, Malignant Malignant Peripheral Nervous System Neoplasm A primary or metastatic malignant neoplasm involving the thymus. This category includes malignant thymomas, thymic lymphomas, primary thymic carcinomas, and metastatic carcinomas from other anatomic sites. C4962 Neoplastic Process Malignant Thymus Neoplasm C0751552 CPTAC mCode Malignant Malignant_Thymus_Neoplasm Malignant neoplasm of thymus Cancer of Thymus Cancer of the Thymus Malignant Neoplasm of Thymus Malignant Neoplasm of the Thymus Malignant Thymus Neoplasm Malignant Thymus Tumor Malignant Tumor of Thymus Malignant Tumor of the Thymus Malignant neoplasm of thymus Thymus Cancer Malignant Thymus Neoplasm A neoplasm that arises from above the cerebellar tentorium and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4963 Neoplastic Process Benign Supratentorial Neoplasm C0751588 CPTAC mCode Benign Benign_Supratentorial_Neoplasm Benign neoplasm: Brain, supratentorial Benign Supratentorial Neoplasm Benign Supratentorial Neoplasms Benign Supratentorial Tumor Benign Supratentorial Tumors Benign neoplasm of brain, supratentorial Supratentorial Neoplasms, Benign Benign Supratentorial Neoplasm A malignant neoplasm that affects the various anatomic sites of the supratentorial brain. C4964 Neoplastic Process Malignant Supratentorial Neoplasm Malignant Supratentorial Neoplasm C0751589 CTRP Malignant Malignant_Supratentorial_Neoplasm Malignant Supratentorial Brain Tumor Malignant Supratentorial Neoplasm Malignant Supratentorial Tumor Supratentorial Neoplasms, Malignant Malignant Supratentorial Neoplasm A neoplasm that arises from the infratentorial region and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C4965 Neoplastic Process Benign Infratentorial Neoplasm C0751592 mCode Benign Benign_Infratentorial_Neoplasm Benign Infratentorial Neoplasm Benign Infratentorial Tumor Benign neoplasm of brain, infratentorial Benign Infratentorial Neoplasm Malignant neoplasms which arise or occur within the intracranial cavity below the tentorium cerebelli. This includes neoplasms within the brain and/or surrounding spaces. C4966 Neoplastic Process Malignant Infratentorial Neoplasm C0751593 Malignant Malignant_Infratentorial_Neoplasm Infratentorial Neoplasms, Malignant Malignant Infratentorial Neoplasm Malignant Infratentorial Tumor Malignant Infratentorial Tumors Malignant Infratentorial Neoplasm An acute lymphoblastic leukemia occurring during adulthood. C4967 Neoplastic Process Adult Acute Lymphoblastic Leukemia Adult Acute Lymphoblastic Leukemia C0751606 CTRP Malignant Adult_Acute_Lymphoblastic_Leukemia Acute Lymphoblastic Leukemia (ALL) Adult ALL Adult Acute Lymphoblastic Leukemia Adult Acute Lymphocytic Leukemia Adult Acute Lymphogenous Leukemia Adult Acute Lymphoid Leukemia Adult Precursor Lymphoblastic Leukemia Adult Acute Lymphoblastic Leukemia A central nervous system embryonal tumor, not otherwise specified arising from the cerebral hemispheres. C4970 Neoplastic Process Cerebral Embryonal Tumor, Not Otherwise Specified C0751675 Malignant Cerebral_Primitive_Neuroectodermal_Tumor Cerebral Embryonal Tumor, NOS Cerebral Embryonal Tumor, Not Otherwise Specified Cerebral Hemisphere PNET Cerebral Hemisphere Primitive Neuroectodermal Neoplasm Cerebral Hemisphere Primitive Neuroectodermal Tumor Cerebral PNET Cerebral Primitive Neuroectodermal Neoplasm Cerebral Primitive Neuroectodermal Tumor PNET of Cerebral Hemispheres PNET of Cerebrum PNET of the Cerebral Hemispheres PNET of the Cerebrum Primitive Neuroectodermal Neoplasm of Cerebral Hemispheres Primitive Neuroectodermal Neoplasm of Cerebrum Primitive Neuroectodermal Neoplasm of the Cerebral Hemispheres Primitive Neuroectodermal Neoplasm of the Cerebrum Primitive Neuroectodermal Tumor of Cerebral Hemispheres Primitive Neuroectodermal Tumor of Cerebrum Primitive Neuroectodermal Tumor of the Cerebral Hemispheres Primitive Neuroectodermal Tumor of the Cerebrum Cerebral Embryonal Tumor, Not Otherwise Specified A benign or malignant neoplasm arising from the perineural cells in the sheaths surrounding the nerves. Representative examples include neurofibroma, schwannoma, and malignant peripheral nerve sheath tumor. C4972 Neoplastic Process Nerve Sheath Neoplasm C0206727 GDC Undetermined Peripheral_Nerve_Sheath_Neoplasm Nerve Sheath Tumors Nerve sheath tumor, NOS Neoplasm of Nerve Sheath Neoplasm of the Nerve Sheath Nerve Sheath Neoplasm Nerve Sheath Tumor Nerve Sheath Tumors Tumor of Nerve Sheath Nerve Sheath Neoplasm A rare benign tumor composed entirely of neoplastic perineurial cells. It may occur in the soft tissues, intraneurally or in mucosal sites. C4973 Neoplastic Process Perineurioma C0751691 GDC 9571/0 Benign Perineurioma 9571/0 Perineurioma, NOS Perineurioma Perineurioma, NOS Perineurioma A neoplasm that originates from the brain stem. C4975 Neoplastic Process Primary Brain Stem Neoplasm C0751886 Undetermined Primary_Brain_Stem_Neoplasm Primary Brain Stem Neoplasm Primary Brain Stem Tumor Primary Brain Stem Neoplasm A primary or metastatic malignant neoplasm that affects the colon or rectum. Representative examples include carcinoma, lymphoma, and sarcoma. C4978 Neoplastic Process Malignant Colorectal Neoplasm C0346629 CPTAC Malignant Malignant_Colorectal_Neoplasm Malignant neoplasm of other specified sites of large intestine Malignant Colorectal Neoplasm Malignant Colorectal Tumor Malignant Large Bowel Neoplasm Malignant Large Bowel Tumor Malignant Large Intestine Neoplasm Malignant Large Intestine Tumor Malignant Neoplasm of Large Bowel Malignant Neoplasm of Large Intestine Malignant Neoplasm of the Large Bowel Malignant Neoplasm of the Large Intestine Malignant Tumor of Large Bowel Malignant Tumor of Large Intestine Malignant Tumor of the Large Bowel Malignant Tumor of the Large Intestine Malignant Colorectal Neoplasm A leukemia characterized by the absence of leukemic cells in the peripheral blood. C4982 Neoplastic Process Aleukemic Leukemia C0877858 CPTAC GDC Malignant Aleukemic_Leukemia 9800/3 Aleukemic leukemia, NOS Aleukemic Leukemia Aleukemic leukemia, NOS Aleukemic Leukemia Infiltration of the skin and subcutaneous tissue by leukemic cells without evidence of leukemia in the bone marrow and peripheral blood. It results in clinically identifiable skin lesions. It may be the first manifestation of acute leukemia, preceding the involvement of the bone marrow and peripheral blood by the leukemic process. C4983 Neoplastic Process Aleukemic Leukemia Cutis C0887846 Malignant Aleukemic_Leukemia_Cutis Aleukemic Leukemia Cutis Aleukemic Leukemia Cutis A benign, borderline, or malignant neoplasm involving the ovary. C4984 Neoplastic Process Ovarian Neoplasm Ovarian Neoplasm C0919267 CPTAC CTRP Undetermined Ovarian_Neoplasm Neoplasm of uncertain behavior of ovary Neoplasm of uncertain or unknown behaviour: Ovary Neoplasm of Ovary Neoplasm of the Ovary Ovarian Neoplasm Ovarian Tumor Ovarian Tumors Tumor of Ovary Tumor of the Ovary Ovarian Neoplasm An acute or chronic leukemia that occurs during childhood. C4989 Neoplastic Process Childhood Leukemia Childhood Leukemia C1332977 CPTAC CTRP NICHD An acute or chronic leukemia that occurs during childhood and adolescence. Malignant Childhood_Leukemia Childhood Leukemia Leukemia Childhood Leukemia Stage II includes: (T2a, N0, M0); (T2b, N0, M0). T2a: Tumor invades superficial muscle (inner half). T2b: Tumor invades deep muscle (outer half). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C4994 Neoplastic Process Stage II Bladder Squamous Cell Carcinoma AJCC v6 and v7 Stage II Bladder Squamous Cell Carcinoma AJCC v6 and v7 C0855189 CTRP Malignant Stage_II_Bladder_Squamous_Cell_Carcinoma Stage II Bladder Squamous Cell Cancer Stage II Bladder Squamous Cell Carcinoma Stage II Bladder Squamous Cell Carcinoma AJCC v6 Stage II Bladder Squamous Cell Carcinoma AJCC v6 and v7 Stage II Bladder Squamous Cell Carcinoma AJCC v7 Stage II Bladder Squamous Cell Carcinoma AJCC v6 and v7 A recurrence of adenocarcinoma of the bladder after a period of remission. C4995 Neoplastic Process Recurrent Bladder Adenocarcinoma C0855174 Malignant Recurrent_Bladder_Adenocarcinoma Bladder Adenocarcinoma, Recurrent Recurrent Adenocarcinoma of Bladder Recurrent Adenocarcinoma of Urinary Bladder Recurrent Adenocarcinoma of the Bladder Recurrent Adenocarcinoma of the Urinary Bladder Recurrent Bladder Adenocarcinoma Recurrent Urinary Bladder Adenocarcinoma Relapsed Adenocarcinoma of Bladder Relapsed Adenocarcinoma of Urinary Bladder Relapsed Adenocarcinoma of the Bladder Relapsed Adenocarcinoma of the Urinary Bladder Relapsed Bladder Adenocarcinoma Relapsed Urinary Bladder Adenocarcinoma Recurrent Bladder Adenocarcinoma Nodal marginal zone B-cell lymphoma resistant to treatment. C4997 Neoplastic Process Refractory Nodal Marginal Zone Lymphoma Refractory Nodal Marginal Zone Lymphoma C0855141 CTRP Malignant Refractory_Nodal_Marginal_Zone_B-Cell_Lymphoma Nodal Marginal Zone B-Cell Lymphoma Refractory Refractory Nodal Marginal Zone B-Cell Lymphoma Refractory Nodal Marginal Zone Lymphoma Refractory Nodal Marginal Zone Lymphoma The reemergence of nodal marginal zone lymphoma after a period of remission. C4998 Neoplastic Process Recurrent Nodal Marginal Zone Lymphoma Recurrent Nodal Marginal Zone Lymphoma C0855140 CTRP Malignant Recurrent_Nodal_Marginal_Zone_B-Cell_Lymphoma Recurrent Nodal Marginal Zone B-Cell Lymphoma Recurrent Nodal Marginal Zone Lymphoma Relapsed Nodal Marginal Zone Lymphoma Recurrent Nodal Marginal Zone Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C5006 Neoplastic Process Ann Arbor Stage IV Follicular Lymphoma Ann Arbor Stage IV Follicular Lymphoma C0855123 CTRP Malignant Stage_IV_Follicular_Lymphoma Ann Arbor Stage IV Follicular Lymphoma Follicle Centre Lymphoma, Follicular Grade I, II, III Stage IV Stage IV Follicular Lymphoma Ann Arbor Stage IV Follicular Lymphoma The reemergence of follicular lymphoma after a period of remission. C5007 Neoplastic Process Recurrent Follicular Lymphoma Recurrent Follicular Lymphoma C0855118 CTRP Malignant Recurrent_Follicular_Lymphoma Recurrent Follicular Lymphoma Recurrent Follicular Lymphoma The reemergence of Burkitt lymphoma after a period of remission. C5008 Neoplastic Process Recurrent Burkitt Lymphoma Recurrent Burkitt Lymphoma C0855104 CTRP Malignant Recurrent_Burkitt_s_Lymphoma Recurrent Burkitt Lymphoma Recurrent Burkitt's Lymphoma Relapsed Burkitt's Lymphoma Recurrent Burkitt Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the superior side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph node(s) with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript. C5009 Neoplastic Process Ann Arbor Stage II Supradiaphragmatic Hodgkin Lymphoma C1336322 Malignant Stage_II_Supradiaphragmatic_Hodgkin_s_Lymphoma Ann Arbor Stage II Supradiaphragmatic Hodgkin Lymphoma Stage II Hodgkin's Disease above the Diaphragm Stage II Hodgkin's Lymphoma above the Diaphragm Stage II Supradiaphragmatic Hodgkin Lymphoma Stage II Supradiaphragmatic Hodgkin's Disease Stage II Supradiaphragmatic Hodgkin's Lymphoma Ann Arbor Stage II Supradiaphragmatic Hodgkin Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the inferior side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph node(s) with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript. C5010 Neoplastic Process Ann Arbor Stage II Subdiaphragmatic Hodgkin Lymphoma C0153789 Malignant Stage_II_Subdiaphragmatic_Hodgkin_s_Lymphoma Ann Arbor Stage II Subdiaphragmatic Hodgkin Lymphoma Stage II Hodgkin's Disease below the Diaphragm Stage II Hodgkin's Lymphoma below the Diaphragm Stage II Subdiaphragmatic Hodgkin Lymphoma Stage II Subdiaphragmatic Hodgkin's Disease Stage II Subdiaphragmatic Hodgkin's Lymphoma Ann Arbor Stage II Subdiaphragmatic Hodgkin Lymphoma C5011 Neoplastic Process Ann Arbor Stage I Supradiaphragmatic Hodgkin Lymphoma C1336486 Malignant Stage_I_Supradiaphragmatic_Hodgkin_s_Lymphoma Ann Arbor Stage I Supradiaphragmatic Hodgkin Lymphoma Stage I Hodgkin's Disease above the Diaphragm Stage I Hodgkin's Lymphoma above the Diaphragm Stage I Supradiaphragmatic Hodgkin Lymphoma Stage I Supradiaphragmatic Hodgkin's Disease Stage I Supradiaphragmatic Hodgkin's Lymphoma Ann Arbor Stage I Supradiaphragmatic Hodgkin Lymphoma Stage I Hodgkin lymphoma involving the subdiaphragmatic region. C5012 Neoplastic Process Ann Arbor Stage I Subdiaphragmatic Hodgkin Lymphoma C0153790 Malignant Stage_I_Subdiaphragmatic_Hodgkin_s_Lymphoma Ann Arbor Stage I Subdiaphragmatic Hodgkin Lymphoma Stage I Hodgkin's Disease below the Diaphragm Stage I Hodgkin's Lymphoma below the Diaphragm Stage I Subdiaphragmatic Hodgkin Lymphoma Stage I Subdiaphragmatic Hodgkin's Disease Stage I Subdiaphragmatic Hodgkin's Lymphoma Ann Arbor Stage I Subdiaphragmatic Hodgkin Lymphoma The re-emergence of squamous cell lung carcinoma after a period of remission. C5014 Neoplastic Process Recurrent Lung Squamous Cell Carcinoma C0854989 Malignant Recurrent_Squamous_Cell_Lung_Carcinoma Recurrent Lung Squamous Cell Carcinoma Recurrent Squamous Cell Carcinoma of Lung Recurrent Squamous Cell Carcinoma of the Lung Recurrent Squamous Cell Lung Carcinoma Recurrent Lung Squamous Cell Carcinoma Stage II includes IIA (T3, N0, M0) and IIB (T4, N0, M0). T3: Tumor invades through the muscularis propria into the subserosa, or into nonperitonealized pericolic or perirectal tissues. T4: Tumor directly invades other organs or structures, and/or perforates the visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C5015 Neoplastic Process Stage II Rectosigmoid Cancer AJCC v6 Stage II Rectosigmoid Cancer AJCC v6 C0854782 CTRP Malignant Stage_II_Rectosigmoid_Cancer Stage II Rectosigmoid Cancer Stage II Rectosigmoid Cancer AJCC v6 Stage II Rectosigmoid Carcinoma AJCC v6 Stage II Rectosigmoid Cancer AJCC v6 Stage I includes: (T1, N0, M0); (T2, N0, M0). T1: Tumor invades submucosa. T2: Tumor invades muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C5016 Neoplastic Process Stage I Rectosigmoid Cancer AJCC v6 and v7 Stage I Rectosigmoid Cancer AJCC v6 and v7 C0854781 CTRP Malignant Stage_I_Rectosigmoid_Cancer Stage I Rectosigmoid Cancer Stage I Rectosigmoid Cancer AJCC v6 Stage I Rectosigmoid Cancer AJCC v6 and v7 Stage I Rectosigmoid Cancer AJCC v7 Stage I Rectosigmoid Carcinoma Stage I Rectosigmoid Cancer AJCC v6 and v7 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial or invasion of the lamina propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C5017 Neoplastic Process Stage 0 Rectosigmoid Cancer AJCC v6 and v7 Stage 0 Rectosigmoid Cancer AJCC v6 and v7 C0854780 CTRP mCode Malignant Stage_0_Rectosigmoid_Cancer Carcinoma in situ of rectosigmoid junction Stage 0 Rectosigmoid Cancer Stage 0 Rectosigmoid Cancer AJCC v6 Stage 0 Rectosigmoid Cancer AJCC v6 and v7 Stage 0 Rectosigmoid Cancer AJCC v7 Stage 0 Rectosigmoid Carcinoma Stage 0 Rectosigmoid Cancer AJCC v6 and v7 Carcinoma of the pancreas that is not amenable to surgical removal. C5018 Neoplastic Process Unresectable Pancreatic Carcinoma Unresectable Pancreatic Carcinoma C0854776 CTRP Malignant Unresectable_Pancreatic_Cancer Non-Resectable Carcinoma of Pancreas Non-Resectable Carcinoma of the Pancreas Non-Resectable Pancreas Carcinoma Non-Resectable Pancreatic Carcinoma Pancreatic Carcinoma, Non-Resectable Unresectable Pancreatic Cancer Unresectable Pancreatic Carcinoma Unresectable Pancreatic Carcinoma Stage IV includes: Any T, Any N, M1, Any G, Tumor location: Any. M1: Distant metastasis. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. (AJCC 7th ed.) C5019 Neoplastic Process Stage IV Esophageal Squamous Cell Carcinoma AJCC v7 Stage IV Esophageal Squamous Cell Carcinoma AJCC v7 C1142025 CTRP Malignant Stage_IV_Esophageal_Squamous_Cell_Carcinoma Esophageal Squamous Cell Carcinoma Stage IV Stage IV Esophageal Squamous Cell Cancer Stage IV Esophageal Squamous Cell Carcinoma Stage IV Esophageal Squamous Cell Carcinoma AJCC v7 Stage IV Esophagus Squamous Cell Carcinoma Stage IV Squamous Cell Carcinoma of Esophagus Stage IV Squamous Cell Carcinoma of the Esophagus Stage IV Esophageal Squamous Cell Carcinoma AJCC v7 Stage III includes: IIIA (T1-2, N2, M0, Any G, Tumor location: Any); (T3, N1, M0, Any G, Tumor location: Any); (T4a, N0, M0, Any G, Tumor location: Any); IIIB (T3, N2, M0, Any G, Tumor location: Any); IIIC (T4a, N1-2, M0, Any G, Tumor location: Any); (T4b, Any N, M0, Any G, Tumor location: Any); (Any T, N3, M0, Any G, Tumor location: Any). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades adventitia. T4a: Resectable tumor invading pleura, pericardium, or diaphragm. T4b: Unresectable tumor invading other adjacent structures, such as aorta, vertebral body, trachea, etc. N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. N2: Metastasis in 3-6 regional lymph nodes. N3: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. (AJCC 7th ed.) C5020 Neoplastic Process Stage III Esophageal Squamous Cell Carcinoma AJCC v7 Stage III Esophageal Squamous Cell Carcinoma AJCC v7 C0854773 CTRP Malignant Stage_III_Esophageal_Squamous_Cell_Carcinoma Esophageal Squamous Cell Carcinoma Stage III Oesophageal Squamous Cell Carcinoma Stage III Stage III Esophageal Squamous Cell Cancer Stage III Esophageal Squamous Cell Carcinoma Stage III Esophageal Squamous Cell Carcinoma AJCC v7 Stage III Esophagus Squamous Cell Carcinoma Stage III Squamous Cell Carcinoma of Esophagus Stage III Squamous Cell Carcinoma of the Esophagus Stage III Esophageal Squamous Cell Carcinoma AJCC v7 Stage II includes: IIA (T2-3, N0, M0, G1, GX, Tumor location: Upper, middle); (T2-3, N0, M0, G2-3, Tumor location: Lower, X); IIB (T2-3, N0, M0, G2-3, Tumor location: Upper, middle); (T1-2, N1, M0, Any G, Tumor location: Any). T2: Tumor invades muscularis propria. T3: Tumor invades adventitia. T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. M0: No distant metastasis. G1: Well differentiated. GX: Grade cannot be assessed-stage grouping as G1. G2: Moderately differentiated. G3: Poorly differentiated. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. (AJCC 7th ed.) C5021 Neoplastic Process Stage II Esophageal Squamous Cell Carcinoma AJCC v7 Stage II Esophageal Squamous Cell Carcinoma AJCC v7 C0854772 CTRP Malignant Stage_II_Esophageal_Squamous_Cell_Carcinoma Esophageal Squamous Cell Carcinoma Stage II Oesophageal Squamous Cell Carcinoma Stage II Stage II Esophageal Squamous Cell Cancer Stage II Esophageal Squamous Cell Carcinoma Stage II Esophageal Squamous Cell Carcinoma AJCC v7 Stage II Esophagus Squamous Cell Carcinoma Stage II Squamous Cell Carcinoma of Esophagus Stage II Squamous Cell Carcinoma of the Esophagus Stage II Esophageal Squamous Cell Carcinoma AJCC v7 Stage I includes: IA (T1, N0, M0, G1, GX, Tumor location: Any); IB (T1, N0, M0, G2-3, Tumor location: Any); (T2-3, N0, M0, G1, GX, Tumor location: Lower, X). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated. GX: Grade cannot be assessed-stage grouping as G1. G2: Moderately differentiated. G3: Poorly differentiated. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. (AJCC 7th ed.) C5022 Neoplastic Process Stage I Esophageal Squamous Cell Carcinoma AJCC v7 Stage I Esophageal Squamous Cell Carcinoma AJCC v7 C0854771 CTRP Malignant Stage_I_Esophageal_Squamous_Cell_Carcinoma Esophageal Squamous Cell Carcinoma Stage I Oesophageal Squamous Cell Carcinoma Stage I Stage I Esophageal Squamous Cell Cancer Stage I Esophageal Squamous Cell Carcinoma Stage I Esophageal Squamous Cell Carcinoma AJCC v7 Stage I Esophagus Squamous Cell Carcinoma Stage I Squamous Cell Carcinoma of Esophagus Stage I Squamous Cell Carcinoma of the Esophagus Stage I Esophageal Squamous Cell Carcinoma AJCC v7 Stage 0 includes: Tis (HGD), N0, M0, G1, GX, Tumor location: Any. Tis: High-grade dysplasia. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated. GX: Grade cannot be assessed-stage grouping as G1. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. (AJCC 7th ed.) C5023 Neoplastic Process Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7 Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7 C0854770 CTRP Malignant Stage_0_Esophageal_Squamous_Cell_Carcinoma Esophageal Squamous Cell Carcinoma Stage 0 Esophageal Squamous Cell Carcinoma in situ Esophagus Squamous Cell Carcinoma in situ Oesophageal Squamous Cell Carcinoma Stage 0 Squamous Cell Carcinoma in situ of Esophagus Squamous Cell Carcinoma in situ of the Esophagus Stage 0 Esophageal Squamous Cell Cancer Stage 0 Esophageal Squamous Cell Carcinoma Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7 Stage 0 Esophagus Squamous Cell Carcinoma Stage 0 Squamous Cell Carcinoma of Esophagus Stage 0 Squamous Cell Carcinoma of the Esophagus Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7 An extremely rare, slow-growing well-differentiated neuroendocrine neoplasm that affects the prostate gland. C5024 Neoplastic Process Prostate Neuroendocrine Tumor C0854489 OORO Undetermined Prostate_Carcinoid_Tumor Prostate Neuroendocrine Tumor Prostate Well Differentiated Neuroendocrine Tumor Prostate well-differentiated neuroendocrine tumor Prostate Neuroendocrine Tumor The reemergence of nasal type extranodal NK/T-cell lymphoma after a period of remission. C5026 Neoplastic Process Recurrent Nasal Type Extranodal NK/T-Cell Lymphoma Recurrent Nasal Type Extranodal NK/T-Cell Lymphoma C0854143 CTRP Malignant Recurrent_Nasal_Type_NK_T-Cell_Lymphoma Recurrent Angiocentric Lymphoma Recurrent Nasal Type Extranodal NK/T-Cell Lymphoma Relapsed Angiocentric Lymphoma Relapsed Nasal Type NK/T-Cell Lymphoma Recurrent Nasal Type Extranodal NK/T-Cell Lymphoma A classification of testicular cancers that arise in specialized sex cells called germ cells. Nonseminomas include embryonal carcinoma, teratoma, choriocarcinoma, and yolk sac tumor. C5027 Neoplastic Process Malignant Testicular Non-Seminomatous Germ Cell Tumor Malignant Testicular Non-Seminomatous Germ Cell Tumor C1334625 CTEP CTRP Malignant Malignant_Testicular_Non-Seminomatous_Germ_Cell_Tumor Malignant Non-Seminomatous Germ Cell Cancer of Testis Malignant Non-Seminomatous Germ Cell Cancer of the Testis Malignant Non-Seminomatous Germ Cell Neoplasm of Testis Malignant Non-Seminomatous Germ Cell Neoplasm of the Testis Malignant Non-Seminomatous Germ Cell Tumor of Testis Malignant Non-Seminomatous Germ Cell Tumor of the Testis Malignant Testicular Non-Seminomatous Germ Cell Neoplasm Malignant Testicular Non-Seminomatous Germ Cell Tumor Testicular Non-Seminomatous Germ Cell Cancer Testicular Non-Seminomatous Malignant Germ Cell Neoplasm Testicular nonseminomat. GCT, NOS Testicular nonseminomatous germ cell tumor, NOS Malignant Testicular Non-Seminomatous Germ Cell Tumor A malignant soft tissue neoplasm that arises from the extrahepatic bile ducts. Representative examples include Kaposi sarcoma, leiomyosarcoma, and rhabdomyosarcoma. C5029 Neoplastic Process Extrahepatic Bile Duct Sarcoma C2205442 Malignant Bile_Duct_Sarcoma Extrahepatic Bile Duct Sarcoma Sarcoma of Extrahepatic Bile Duct Sarcoma of the Extrahepatic Bile Duct Extrahepatic Bile Duct Sarcoma A usually slow growing, subcutaneous nodular neoplasm arising from myopericytes. It is composed of myoid cells arranged in a perivascular growth pattern. The vast majority of cases have a benign clinical course. C50401 Neoplastic Process Myopericytoma C1302808 8713/1 Undetermined Myopericytoma Hemangiopericytoma Myopericytoma Solitary Myofibroma Myopericytoma A malignant neoplasm arising from the anus and occurring in HIV-positive patients. Representative examples include squamous cell carcinoma and non-Hodgkin lymphoma. Homosexual HIV-positive men have an increased risk of developing such malignancies in comparison to the general male population. C5047 Neoplastic Process AIDS-Related Malignant Anal Neoplasm C1332049 Malignant AIDS-Related_Malignant_Anal_Neoplasm AIDS-Related Malignant Anal Neoplasm AIDS-Related Malignant Anal Tumor AIDS-Related Malignant Neoplasm of Anus AIDS-Related Malignant Neoplasm of the Anus AIDS-Related Malignant Tumor of Anus AIDS-Related Malignant Tumor of the Anus AIDS-Related Malignant Anal Neoplasm A non-Hodgkin lymphoma that develops in a patient with AIDS. C5051 Neoplastic Process AIDS-Related Non-Hodgkin Lymphoma C1332051 CTEP Cellosaurus Malignant AIDS-Related_Non-Hodgkin_s_Lymphoma AIDS-Related Non-Hodgkin Lymphoma AIDS-Related Non-Hodgkin's Lymphoma AIDS-related NHL AIDS-related Non-Hodgkin lymphoma AIDS-Related Non-Hodgkin Lymphoma A malignant neoplasm that arises from the cervix in a patient with acquired immunodeficiency syndrome. This category includes cervical carcinoma, Kaposi sarcoma, and non-Hodgkin lymphoma. C5052 Neoplastic Process AIDS-Related Malignant Cervical Neoplasm C1332050 Malignant AIDS-Related_Malignant_Cervical_Neoplasm AIDS-Related Malignant Cervical Neoplasm AIDS-Related Malignant Cervical Tumor AIDS-Related Malignant Cervix Neoplasm AIDS-Related Malignant Cervix Tumor AIDS-Related Malignant Cervix Uteri Neoplasm AIDS-Related Malignant Cervix Uteri Tumor AIDS-Related Malignant Neoplasm of Cervix AIDS-Related Malignant Neoplasm of Cervix Uteri AIDS-Related Malignant Neoplasm of Uterine Cervix AIDS-Related Malignant Neoplasm of the Cervix AIDS-Related Malignant Neoplasm of the Cervix Uteri AIDS-Related Malignant Neoplasm of the Uterine Cervix AIDS-Related Malignant Tumor of Cervix AIDS-Related Malignant Tumor of Cervix Uteri AIDS-Related Malignant Tumor of Uterine Cervix AIDS-Related Malignant Tumor of the Cervix AIDS-Related Malignant Tumor of the Cervix Uteri AIDS-Related Malignant Tumor of the Uterine Cervix AIDS-Related Malignant Uterine Cervix Neoplasm AIDS-Related Malignant Uterine Cervix Tumor AIDS-Related Malignant Cervical Neoplasm A neoplasm that affects the testis during childhood. C5053 Neoplastic Process Childhood Testicular Neoplasm C1333010 Undetermined Childhood_Testicular_Neoplasm Childhood Neoplasm of Testis Childhood Neoplasm of the Testis Childhood Testicular Neoplasm Pediatric Neoplasm of Testis Pediatric Neoplasm of the Testis Pediatric Testicular Neoplasm Testicular Tumor, Childhood Childhood Testicular Neoplasm A diffuse large B-cell lymphoma that arises in the cerebrum. C5054 Neoplastic Process Primary Cerebral Diffuse Large B-Cell Lymphoma C1335478 Malignant Primary_Cerebral_Lymphoma_in_Immunocompetent_Host Primary Cerebral Diffuse Large B-Cell Lymphoma Primary Cerebral Diffuse Large B-Cell Lymphoma A Hodgkin lymphoma that arises from the cerebral hemispheres as a primary lesion. C5055 Neoplastic Process Cerebral Hodgkin Lymphoma C1332908 Malignant Cerebral_Hodgkin_s_Lymphoma Cerebral Hodgkin Lymphoma Cerebral Hodgkin's Disease Cerebral Hodgkin's Lymphoma Primary Cerebral Hodgkin Lymphoma Primary Cerebral Hodgkin's Disease Primary Cerebral Hodgkin's Lymphoma Primary Hodgkin's Disease of Cerebrum Primary Hodgkin's Disease of the Cerebrum Primary Hodgkin's Lymphoma of Cerebrum Primary Hodgkin's Lymphoma of the Cerebrum Cerebral Hodgkin Lymphoma A Hodgkin lymphoma that has spread to the cerebral hemisphere following the initial presentation in another nodal or extranodal site. C5057 Neoplastic Process Secondary Cerebral Hodgkin Lymphoma C1335937 Malignant Secondary_Cerebral_Hodgkin_s_Lymphoma Metastatic Hodgkin Lymphoma in the Cerebral Hemisphere Metastatic Hodgkin Lymphoma to the Cerebral Hemisphere Metastatic Hodgkin's Lymphoma to Cerebral Hemisphere Secondary Cerebral Hodgkin Lymphoma Secondary Cerebral Hodgkin's Disease Secondary Cerebral Hodgkin's Lymphoma Secondary Cerebral Hodgkin Lymphoma The reemergence of epithelioid sarcoma after a period of remission C5059 Neoplastic Process Recurrent Epithelioid Sarcoma C0855041 Malignant Recurrent_Epithelioid_Sarcoma Epithelioid Sarcoma, Recurrent Recurrent Epithelioid Cell Sarcoma Recurrent Epithelioid Sarcoma Relapsed Epithelioid Cell Sarcoma Relapsed Epithelioid Sarcoma Recurrent Epithelioid Sarcoma Fibrosarcoma that is confined to a specific site without evidence of spread to other anatomic sites. C5060 Neoplastic Process Localized Fibrosarcoma C0855055 Malignant Primary_Fibrosarcoma Localized Fibrosarcoma Non-Metastatic Fibrosarcoma Primary Fibrosarcoma Localized Fibrosarcoma A rare benign neoplasm that arises from the urethra and is characterized by the presence of a papillary growth with a central fibrovascular core. The latter is lined by normal urothelium. C5061 Neoplastic Process Urethral Urothelial Papilloma C1519826 Benign Urethral_Papilloma Urethral Urothelial Papilloma Urethral Urothelial Papilloma A rare benign adipose tissue neoplasm located within the lumen of a bronchus. It is predominantly found in males and usually originates within the fatty tissue between bronchial cartilage. May cause irreversible pulmonary damage distally. Two-thirds of the tumors occur on the right side and most are located on the first three subdivisions of the tracheobronchial tree. C5063 Neoplastic Process Endobronchial Lipoma C0852937 Benign Endobronchial_Lipoma Endobronchial Lipoma Endobronchial Lipoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE) (rare in Hodgkin lymphoma). C5064 Neoplastic Process Ann Arbor Stage I Lymphocyte-Depleted Classic Hodgkin Lymphoma Ann Arbor Stage I Lymphocyte-Depleted Classic Hodgkin Lymphoma C1336463 CTRP Malignant Stage_I_Lymphocyte_Depleted_Hodgkin_s_Lymphoma Ann Arbor Stage I Lymphocyte-Depleted Classic Hodgkin Lymphoma Ann Arbor Stage I Lymphocyte-Depleted Classical Hodgkin Lymphoma Stage I Hodgkin's Disease Lymphocyte Depletion Type Stage I Hodgkin's Lymphoma Lymphocyte Depleted Stage I Hodgkin's Lymphoma Lymphocyte Depletion Type Stage I Lymphocyte Depleted Classical Hodgkin Lymphoma Stage I Lymphocyte Depleted Hodgkin Lymphoma Stage I Lymphocyte Depleted Hodgkin's Lymphoma Stage I Lymphocyte-Depleted Classical Hodgkin Lymphoma Ann Arbor Stage I Lymphocyte-Depleted Classic Hodgkin Lymphoma C5065 Neoplastic Process Ann Arbor Stage I Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma Ann Arbor Stage I Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma C1336484 CTRP Malignant Stage_I_Subdiaphragmatic_Lymphocyte_Depleted_Hodgkin_s_Lymphoma Ann Arbor Stage I Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma Ann Arbor Stage I Subdiaphragmatic Lymphocyte-Depleted Classical Hodgkin Lymphoma Stage I Hodgkin's Disease Lymphocyte Depletion Type below the Diaphragm Stage I Hodgkin's Lymphoma Lymphocyte Depletion Type below the Diaphragm Stage I Subdiaphragmatic Hodgkin Lymphoma Lymphocyte Depleted Stage I Subdiaphragmatic Hodgkin's Disease Lymphocyte Depletion Type Stage I Subdiaphragmatic Lymphocyte Depleted Classical Hodgkin Lymphoma Stage I Subdiaphragmatic Lymphocyte Depleted Hodgkin Lymphoma Stage I Subdiaphragmatic Lymphocyte Depleted Hodgkin's Lymphoma Stage I Subdiaphragmatic Lymphocyte-Depleted Classical Hodgkin Lymphoma Subdiaphragm Stage I Hodgkin's Lymphoma Lymphocyte Depletion Type Ann Arbor Stage I Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma C5066 Neoplastic Process Ann Arbor Stage I Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma Ann Arbor Stage I Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma C1336487 CTRP Malignant Stage_I_Supradiaphragmatic_Lymphocyte_Depleted_Hodgkin_s_Lymphoma Ann Arbor Stage I Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma Ann Arbor Stage I Supradiaphragmatic Lymphocyte-Depleted Classical Hodgkin Lymphoma Stage I Hodgkin's Disease Lymphocyte Depletion Type above the Diaphragm Stage I Hodgkin's Lymphoma Lymphocyte Depleted above the Diaphragm Stage I Supradiaphragmatic Hodgkin Lymphoma Lymphocyte Depleted Stage I Supradiaphragmatic Hodgkin's Disease Lymphocyte Depletion Type Stage I Supradiaphragmatic Hodgkin's Lymphoma Lymphocyte Depleted Stage I Supradiaphragmatic Lymphocyte Depleted Classical Hodgkin Lymphoma Stage I Supradiaphragmatic Lymphocyte Depleted Hodgkin Lymphoma Stage I Supradiaphragmatic Lymphocyte Depleted Hodgkin's Lymphoma Stage I Supradiaphragmatic Lymphocyte-Depleted Classical Hodgkin Lymphoma Ann Arbor Stage I Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C5067 Neoplastic Process Ann Arbor Stage II Lymphocyte-Depleted Classic Hodgkin Lymphoma Ann Arbor Stage II Lymphocyte-Depleted Classic Hodgkin Lymphoma C1336297 CTRP Malignant Stage_II_Lymphocyte_Depleted_Hodgkin_s_Lymphoma Ann Arbor Stage II Lymphocyte-Depleted Classic Hodgkin Lymphoma Ann Arbor Stage II Lymphocyte-Depleted Classical Hodgkin Lymphoma Stage II Hodgkin's Disease Lymphocyte Depletion Type Stage II Hodgkin's Lymphoma Lymphocyte Depleted Stage II Hodgkin's Lymphoma Lymphocyte Depletion Type Stage II Lymphocyte Depleted Classical Hodgkin Lymphoma Stage II Lymphocyte Depleted Hodgkin Lymphoma Stage II Lymphocyte Depleted Hodgkin's Lymphoma Stage II Lymphocyte-Depleted Classical Hodgkin Lymphoma Ann Arbor Stage II Lymphocyte-Depleted Classic Hodgkin Lymphoma C5068 Neoplastic Process Ann Arbor Stage II Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma Ann Arbor Stage II Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma C1336320 CTRP Malignant Stage_II_Subdiaphragmatic_Lymphocyte_Depleted_Hodgkin_s_Lymphoma Ann Arbor Stage II Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma Ann Arbor Stage II Subdiaphragmatic Lymphocyte-Depleted Classical Hodgkin Lymphoma Stage II Hodgkin's Disease Lymphocyte Depletion Type below the Diaphragm Stage II Hodgkin's Lymphoma Lymphocyte Depletion Type below the Diaphragm Stage II Subdiaphragmatic Hodgkin Lymphoma Lymphocyte Depleted Stage II Subdiaphragmatic Hodgkin's Disease Lymphocyte Depletion Type Stage II Subdiaphragmatic Hodgkin's Lymphoma Lymphocyte Depleted Stage II Subdiaphragmatic Lymphocyte Depleted Classical Hodgkin Lymphoma Stage II Subdiaphragmatic Lymphocyte Depleted Hodgkin Lymphoma Stage II Subdiaphragmatic Lymphocyte Depleted Hodgkin's Lymphoma Stage II Subdiaphragmatic Lymphocyte-Depleted Classical Hodgkin Lymphoma Subdiaphragm Stage II Hodgkin's Lymphoma Lymphocyte Depletion Type Ann Arbor Stage II Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma C5069 Neoplastic Process Ann Arbor Stage II Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma Ann Arbor Stage II Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma C1336323 CTRP Malignant Stage_II_Supradiaphragmatic_Lymphocyte_Depleted_Hodgkin_s_Lymphoma Ann Arbor Stage II Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma Ann Arbor Stage II Supradiaphragmatic Lymphocyte-Depleted Classical Hodgkin Lymphoma Stage II Hodgkin's Disease Lymphocyte Depletion Type above the Diaphragm Stage II Hodgkin's Lymphoma Lymphocyte Depletion Type above the Diaphragm Stage II Supradiaphragmatic Hodgkin Lymphoma Lymphocyte Depleted Stage II Supradiaphragmatic Hodgkin's Disease Lymphocyte Depletion Type Stage II Supradiaphragmatic Hodgkin's Lymphoma Lymphocyte Depleted Stage II Supradiaphragmatic Lymphocyte Depleted Classical Hodgkin Lymphoma Stage II Supradiaphragmatic Lymphocyte Depleted Hodgkin Lymphoma Stage II Supradiaphragmatic Lymphocyte Depleted Hodgkin's Lymphoma Stage II Supradiaphragmatic Lymphocyte-Depleted Classical Hodgkin Lymphoma Ann Arbor Stage II Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C5070 Neoplastic Process Ann Arbor Stage II Nodular Lymphocyte Predominant Hodgkin Lymphoma Ann Arbor Stage II Nodular Lymphocyte Predominant B-Cell Lymphoma C1336302 CTRP Malignant Stage_II_Nodular_Lymphocyte_Predominant_Hodgkin_s_Lymphoma Ann Arbor Stage II Nodular Lymphocyte Predominant B-Cell Lymphoma Ann Arbor Stage II Nodular Lymphocyte Predominant Hodgkin Lymphoma Stage II Hodgkin's Disease Nodular Lymphocyte Predominance Type Stage II Hodgkin's Lymphoma Nodular Lymphocyte Predominance Type Stage II Nodular Lymphocyte Predominant Hodgkin Lymphoma Stage II Nodular Lymphocyte Predominant Hodgkin's Disease Stage II Nodular Lymphocyte Predominant Hodgkin's Lymphoma Ann Arbor Stage II Nodular Lymphocyte Predominant B-Cell Lymphoma C5071 Neoplastic Process Ann Arbor Stage II Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma Ann Arbor Stage II Subdiaphragmatic Nodular Lymphocyte Predominant B-Cell Lymphoma C1336321 CTRP Malignant Stage_II_Subdiaphragmatic_Nodular_Lymphocyte_Predominant_Hodgkin_s_Lymphoma Ann Arbor Stage II Subdiaphragmatic Nodular Lymphocyte Predominant B-Cell Lymphoma Ann Arbor Stage II Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma Stage II Hodgkin's Disease Nodular Lymphocyte Predominance Type below the Diaphragm Stage II Hodgkin's Lymphoma Nodular Lymphocyte Predominance Type Below the Diaphragm Stage II Subdiaphragmatic Hodgkin Lymphoma Nodular Lymphocyte Predominant Type Stage II Subdiaphragmatic Hodgkin's Disease Nodular Lymphocyte Predominance Type Stage II Subdiaphragmatic Hodgkin's Lymphoma Nodular Lymphocyte Predominant Type Stage II Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma Stage II Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin's Lymphoma Subdiaphragm Stage II Hodgkin's Lymphoma Nodular Lymphocyte Predominance Type Ann Arbor Stage II Subdiaphragmatic Nodular Lymphocyte Predominant B-Cell Lymphoma C5072 Neoplastic Process Ann Arbor Stage II Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma Ann Arbor Stage II Supradiaphragmatic Nodular Lymphocyte Predominant B-Cell Lymphoma C1336324 CTRP Malignant Stage_II_Supradiaphragmatic_Nodular_Lymphocyte_Predominant_Hodgkin_s_Lymphoma Ann Arbor Stage II Supradiaphragmatic Nodular Lymphocyte Predominant B-Cell Lymphoma Ann Arbor Stage II Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma Stage II Hodgkin's Disease Nodular Lymphocyte Predominance Type above the Diaphragm Stage II Hodgkin's Lymphoma Nodular Lymphocyte Predominance Type above the Diaphragm Stage II Supradiaphragmatic Hodgkin Lymphoma Nodular Lymphocyte Predominant Type Stage II Supradiaphragmatic Hodgkin's Disease Nodular Lymphocyte Predominance Type Stage II Supradiaphragmatic Hodgkin's Lymphoma Nodular Lymphocyte Predominant Type Stage II Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma Stage II Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin's Lymphoma Ann Arbor Stage II Supradiaphragmatic Nodular Lymphocyte Predominant B-Cell Lymphoma C5073 Neoplastic Process Ann Arbor Stage I Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma Ann Arbor Stage I Subdiaphragmatic Nodular Lymphocyte Predominant B-Cell Lymphoma C1336485 CTRP Malignant Stage_I_Subdiaphragmatic_Nodular_Lymphocyte_Predominant_Hodgkin_s_Lymphoma Ann Arbor Stage I Subdiaphragmatic Nodular Lymphocyte Predominant B-Cell Lymphoma Ann Arbor Stage I Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma Stage I Hodgkin's Disease Nodular Lymphocyte Predominance Type below the Diaphragm Stage I Hodgkin's Lymphoma Nodular Lymphocyte Predominance Type below the Diaphragm Stage I Subdiaphragmatic Hodgkin's Disease Nodular Lymphocyte Predominance Type Stage I Subdiaphragmatic Hodgkin's Lymphoma Nodular Lymphocyte Predominant Type Stage I Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma Stage I Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin's Lymphoma Subdiaphragm Stage I Hodgkin's Lymphoma Nodular Lymphocyte Predominance Type Ann Arbor Stage I Subdiaphragmatic Nodular Lymphocyte Predominant B-Cell Lymphoma C5074 Neoplastic Process Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant B-Cell Lymphoma C1336488 CTRP Malignant Stage_I_Supradiaphragmatic_Nodular_Lymphocyte_Predominant_Hodgkin_s_Lymphoma Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant B-Cell Lymphoma Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma Stage I Hodgkin's Disease Nodular Lymphocyte Predominance Type above the Diaphragm Stage I Hodgkin's Lymphoma Nodular Lymphocyte Predominance Type above the Diaphragm Stage I Supradiaphragmatic Hodgkin Lymphoma Nodular Lymphocyte Predominant Type Stage I Supradiaphragmatic Hodgkin's Disease Nodular Lymphocyte Predominance Type Stage I Supradiaphragmatic Hodgkin's Lymphoma Nodular Lymphocyte Predominant Type Stage I Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma Stage I Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin's Lymphoma Supradiaphragm Stage I Hodgkin's Lymphoma Nodular Lymphocyte Predominance Type Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant B-Cell Lymphoma C5075 Neoplastic Process Ann Arbor Stage I Subdiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Stage I Subdiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma C0854726 CTRP Malignant Stage_I_Subdiaphragmatic_Mixed_Cellularity_Hodgkin_s_Lymphoma Ann Arbor Stage I Subdiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Stage I Subdiaphragmatic Mixed Cellularity Classical Hodgkin Lymphoma Stage I Mixed Cellularity Hodgkin's Disease below the Diaphragm Stage I Mixed Cellularity Hodgkin's Lymphoma below the Diaphragm Stage I Subdiaphragmatic Mixed Cellularity Classical Hodgkin Lymphoma Stage I Subdiaphragmatic Mixed Cellularity Hodgkin Lymphoma Stage I Subdiaphragmatic Mixed Cellularity Hodgkin's Disease Stage I Subdiaphragmatic Mixed Cellularity Hodgkin's Lymphoma Ann Arbor Stage I Subdiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma C5076 Neoplastic Process Ann Arbor Stage I Supradiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Stage I Supradiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma C0855198 CTRP Malignant Stage_I_Supradiaphragmatic_Mixed_Cellularity_Hodgkin_s_Lymphoma Ann Arbor Stage I Supradiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Stage I Supradiaphragmatic Mixed Cellularity Classical Hodgkin Lymphoma Stage I Mixed Cellularity Hodgkin's Disease above the Diaphragm Stage I Mixed Cellularity Hodgkin's Lymphoma above the Diaphragm Stage I Supradiaphragmatic Mixed Cellularity Classical Hodgkin Lymphoma Stage I Supradiaphragmatic Mixed Cellularity Hodgkin Lymphoma Stage I Supradiaphragmatic Mixed Cellularity Hodgkin's Disease Stage I Supradiaphragmatic Mixed Cellularity Hodgkin's Lymphoma Ann Arbor Stage I Supradiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C5077 Neoplastic Process Ann Arbor Stage II Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Stage II Mixed Cellularity Classic Hodgkin Lymphoma C1336299 CTRP Malignant Stage_II_Mixed_Cellularity_Hodgkin_s_Lymphoma Ann Arbor Stage II Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Stage II Mixed Cellularity Classical Hodgkin Lymphoma Mixed Cellularity Hodgkin's Disease Stage II Mixed Cellularity Hodgkin's Lymphoma Stage II Stage II Mixed Cellularity Classical Hodgkin Lymphoma Stage II Mixed Cellularity Hodgkin Lymphoma Stage II Mixed Cellularity Hodgkin's Disease Stage II Mixed Cellularity Hodgkin's Lymphoma Ann Arbor Stage II Mixed Cellularity Classic Hodgkin Lymphoma C5078 Neoplastic Process Ann Arbor Stage II Subdiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Stage II Subdiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma C0855200 CTRP Malignant Stage_II_Subdiaphragmatic_Mixed_Cellularity_Hodgkin_s_Lymphoma Ann Arbor Stage II Subdiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Stage II Subdiaphragmatic Mixed Cellularity Classical Hodgkin Lymphoma Stage II Mixed Cellularity Hodgkin's Disease below the Diaphragm Stage II Mixed Cellularity Hodgkin's Lymphoma below the Diaphragm Stage II Subdiaphragmatic Mixed Cellularity Classical Hodgkin Lymphoma Stage II Subdiaphragmatic Mixed Cellularity Hodgkin Lymphoma Stage II Subdiaphragmatic Mixed Cellularity Hodgkin's Disease Stage II Subdiaphragmatic Mixed Cellularity Hodgkin's Lymphoma Ann Arbor Stage II Subdiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma C5079 Neoplastic Process Ann Arbor Stage I Subdiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Stage I Subdiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma C0855202 CTRP Malignant Stage_I_Subdiaphragmatic_Nodular_Sclerosis_Hodgkin_s_Lymphoma Ann Arbor Stage I Subdiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Stage I Subdiaphragmatic Nodular Sclerosis Classical Hodgkin Lymphoma Stage I Nodular Sclerosis Hodgkin's Disease below the Diaphragm Stage I Nodular Sclerosis Hodgkin's Lymphoma below the Diaphragm Stage I Subdiaphragmatic Nodular Sclerosis Classical Hodgkin Lymphoma Stage I Subdiaphragmatic Nodular Sclerosis Hodgkin Lymphoma Stage I Subdiaphragmatic Nodular Sclerosis Hodgkin's Disease Stage I Subdiaphragmatic Nodular Sclerosis Hodgkin's Lymphoma Ann Arbor Stage I Subdiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma C5080 Neoplastic Process Ann Arbor Stage I Supradiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Stage I Supradiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma C0855628 CTRP Malignant Stage_I_Supradiaphragmatic_Nodular_Sclerosis_Hodgkin_s_Lymphoma Ann Arbor Stage I Supradiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Stage I Supradiaphragmatic Nodular Sclerosis Classical Hodgkin Lymphoma Stage I Nodular Sclerosis Hodgkin's Disease above the Diaphragm Stage I Nodular Sclerosis Hodgkin's Lymphoma above the Diaphragm Stage I Supradiaphragmatic Nodular Sclerosis Classical Hodgkin Lymphoma Stage I Supradiaphragmatic Nodular Sclerosis Hodgkin Lymphoma Stage I Supradiaphragmatic Nodular Sclerosis Hodgkin's Disease Stage I Supradiaphragmatic Nodular Sclerosis Hodgkin's Lymphoma Ann Arbor Stage I Supradiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C5081 Neoplastic Process Ann Arbor Stage II Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Stage II Nodular Sclerosis Classic Hodgkin Lymphoma C1336303 CTRP Malignant Stage_II_Nodular_Sclerosis_Hodgkin_s_Lymphoma Ann Arbor Stage II Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Stage II Nodular Sclerosis Classical Hodgkin Lymphoma Nodular Sclerosis Hodgkin's Disease Stage II Nodular Sclerosis Hodgkin's Lymphoma Stage II Stage II Nodular Sclerosis Classical Hodgkin Lymphoma Stage II Nodular Sclerosis Hodgkin Lymphoma Stage II Nodular Sclerosis Hodgkin's Disease Stage II Nodular Sclerosis Hodgkin's Lymphoma Ann Arbor Stage II Nodular Sclerosis Classic Hodgkin Lymphoma C5082 Neoplastic Process Ann Arbor Stage II Subdiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Stage II Subdiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma C0855798 CTRP Malignant Stage_II_Subdiaphragmatic_Nodular_Sclerosis_Hodgkin_s_Lymphoma Ann Arbor Stage II Subdiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Stage II Subdiaphragmatic Nodular Sclerosis Classical Hodgkin Lymphoma Stage II Nodular Sclerosis Hodgkin's Disease below the Diaphragm Stage II Nodular Sclerosis Hodgkin's Lymphoma below the Diaphragm Stage II Subdiaphragmatic Nodular Sclerosis Classical Hodgkin Lymphoma Stage II Subdiaphragmatic Nodular Sclerosis Hodgkin Lymphoma Stage II Subdiaphragmatic Nodular Sclerosis Hodgkin's Disease Stage II Subdiaphragmatic Nodular Sclerosis Hodgkin's Lymphoma Ann Arbor Stage II Subdiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma C5083 Neoplastic Process Ann Arbor Stage II Supradiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Stage II Supradiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma C0856009 CTRP Malignant Stage_II_Supradiaphragmatic_Nodular_Sclerosis_Hodgkin_s_Lymphoma Ann Arbor Stage II Supradiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Stage II Supradiaphragmatic Nodular Sclerosis Classical Hodgkin Lymphoma Stage II Nodular Sclerosis Hodgkin's Disease above the Diaphragm Stage II Nodular Sclerosis Hodgkin's Lymphoma above the Diaphragm Stage II Supradiaphragmatic Nodular Sclerosis Classical Hodgkin Lymphoma Stage II Supradiaphragmatic Nodular Sclerosis Hodgkin Lymphoma Stage II Supradiaphragmatic Nodular Sclerosis Hodgkin's Disease Stage II Supradiaphragmatic Nodular Sclerosis Hodgkin's Lymphoma Ann Arbor Stage II Supradiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C5084 Neoplastic Process Ann Arbor Stage IV Burkitt Lymphoma Ann Arbor Stage IV Burkitt Lymphoma C0855109 CTRP Malignant Stage_IV_Burkitt_s_Lymphoma Ann Arbor Stage IV Burkitt Lymphoma Burkitt's Lymphoma Stage IV Stage IV Burkitt Lymphoma Stage IV Burkitt's Lymphoma Ann Arbor Stage IV Burkitt Lymphoma Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue presenting as stage I disease. C5085 Neoplastic Process Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue C0856012 CTRP Malignant Stage_I_Extranodal_Marginal_Zone_B-Cell_Lymphoma_of_Mucosa-Associated_Lymphoid_Tissue Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Extranodal Marginal Zone B-Cell Lymphoma (MALT Type) Stage I MALT Type Extranodal Marginal Zone B-Cell Lymphoma Stage I Stage I Extranodal Marginal Zone B-Cell Lymphoma (MALT Type ) Stage I Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue presenting as stage II disease. C5086 Neoplastic Process Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue C0856013 CTRP Malignant Stage_II_Extranodal_Marginal_Zone_B-Cell_Lymphoma_of_Mucosa-Associated_Lymphoid_Tissue Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Extranodal Marginal Zone B-Cell Lymphoma (MALT Type) Stage II MALT Type Extranodal Marginal Zone B-Cell Lymphoma Stage II Stage II Extranodal Marginal Zone B-Cell Lymphoma (MALT Type ) Stage II Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue presenting as stage III disease. C5087 Neoplastic Process Ann Arbor Stage III Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Ann Arbor Stage III Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue C0856014 CTRP Malignant Stage_III_Extranodal_Marginal_Zone_B-Cell_Lymphoma_of_Mucosa-Associated_Lymphoid_Tissue Ann Arbor Stage III Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Extranodal Marginal Zone B-Cell Lymphoma (MALT Type) Stage III MALT Type Extranodal Marginal Zone B-Cell Lymphoma Stage III Stage III Extranodal Marginal Zone B-Cell Lymphoma (MALT Type ) Stage III Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Stage III Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Ann Arbor Stage III Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue presenting as stage IV disease. C5088 Neoplastic Process Ann Arbor Stage IV Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Ann Arbor Stage IV Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue C0856015 CTRP Malignant Stage_IV_Extranodal_Marginal_Zone_B-Cell_Lymphoma_of_Mucosa-Associated_Lymphoid_Tissue Ann Arbor Stage IV Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Extranodal Marginal Zone B-Cell Lymphoma (MALT Type) Stage IV MALT Type Extranodal Marginal Zone B-Cell Lymphoma Stage IV Stage IV Extranodal Marginal Zone B-Cell Lymphoma (MALT Type) Stage IV Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Stage IV Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Ann Arbor Stage IV Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue The reemergence of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue after a period of remission. C5089 Neoplastic Process Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue C0856010 CTRP Malignant Recurrent_Extranodal_Marginal_Zone_B-Cell_Lymphoma_of_Mucosa-Associated_Lymphoid_Tissue Recurrent Extranodal Marginal Zone B-Cell Lymphoma (MALT Type) Recurrent Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Relapsed Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Relapsed MALT Type Extranodal Marginal Zone B-Cell Lymphoma Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue that is resistant to treatment. C5090 Neoplastic Process Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue C0856011 CTRP Malignant Refractory_Extranodal_Marginal_Zone_B-Cell_Lymphoma_of_Mucosa-Associated_Lymphoid_Tissue Extranodal Marginal Zone B-Cell Lymphoma (MALT Type) Refractory Refractory Extranodal Marginal Zone B-Cell Lymphoma (MALT Type) Refractory Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue The reemergence of splenic marginal zone lymphoma after a period of remission. C5095 Neoplastic Process Recurrent Splenic Marginal Zone Lymphoma C0856022 Malignant Recurrent_Splenic_Marginal_Zone_B-Cell_Lymphoma Recurrent Splenic Marginal Zone B-Cell Lymphoma Recurrent Splenic Marginal Zone Lymphoma Relapsed Splenic Marginal Zone Lymphoma Recurrent Splenic Marginal Zone Lymphoma Splenic marginal zone lymphoma that is resistant to treatment. C5096 Neoplastic Process Refractory Splenic Marginal Zone Lymphoma C0856023 Malignant Refractory_Splenic_Marginal_Zone_B-Cell_Lymphoma Refractory Splenic Marginal Zone B-Cell Lymphoma Refractory Splenic Marginal Zone Lymphoma Refractory Splenic Marginal Zone Lymphoma A glioblastoma that arises from the brain stem. C5097 Neoplastic Process Brain Stem Glioblastoma C1332610 DIPG/DMG Malignant Brain_Stem_Glioblastoma Brain Stem Glioblastoma Brain Stem Glioblastoma Multiforme Brainstem Glioblastoma Brainstem Glioblastoma Multiforme Glioblastoma Multiforme Glioblastoma Multiforme of Brain Stem Glioblastoma Multiforme of Brainstem Glioblastoma Multiforme of the Brain Stem Glioblastoma Multiforme of the Brainstem Brain Stem Glioblastoma An ependymoma that arises from the brain stem. C5098 Neoplastic Process Brain Stem Ependymoma C1332609 Undetermined Brain_Stem_Ependymoma Brain Stem Ependymoma Brain Stem Ependymoma Carcinoma of the pancreas amenable to surgical removal. C5099 Neoplastic Process Resectable Pancreatic Carcinoma Resectable Pancreatic Carcinoma C0854778 CTRP Malignant Resectable_Pancreatic_Cancer Pancreatic Carcinoma, Resectable Resectable Carcinoma of Pancreas Resectable Carcinoma of the Pancreas Resectable Pancreas Carcinoma Resectable Pancreatic Cancer Resectable Pancreatic Carcinoma Resectable Pancreatic Carcinoma A benign, asymptomatic kidney tumor arising from renomedullary interstitial cells. It is often found incidentally at the time of nephrectomy in adults. These tumors are either single or multiple and usually measure 1-10 mm in diameter. Microscopically the tumor cells are small, stellate, or spindled cells, embedded in a faintly basophilic stroma reminiscent of renal medullary stroma. (WHO 2016) C5100 Neoplastic Process Renomedullary Interstitial Cell Tumor C1335742 GDC 8966/0 Benign Renal_Fibroma 8966/0 Renomedullary interstitial cell tumor Fibroma of Renal Medulla Kidney Fibroma Medullary Fibroma Renal Hamartoma Renomedullary Interstitial Cell Tumor Renomedullary interstitial cell tumor Renomedullary Interstitial Cell Tumor A rare benign adipose tissue neoplasm of the kidney. It predominantly affects middle-aged females. It may originate from renal parenchymal fat or fat cells within the renal capsule. Clinical presentation includes hematuria and pain. C5101 Neoplastic Process Kidney Lipoma C1335744 Benign Renal_Lipoma Kidney Lipoma Lipoma of Kidney Lipoma of the Kidney Renal Lipoma Kidney Lipoma A benign or malignant neoplasm that affects the lacrimal gland or the lacrimal drainage system. C5102 Neoplastic Process Lacrimal System Neoplasm C1334361 Undetermined Lacrimal_System_Neoplasm Lacrimal Apparatus Neoplasm Lacrimal System Neoplasm Lacrimal System Neoplasms Lacrimal System Tumor Neoplasm of Lacrimal System Neoplasm of the Lacrimal System Tumor of Lacrimal System Tumor of the Lacrimal System Lacrimal System Neoplasm The reemergence of carcinoma of the pharynx after a period of remission. C5103 Neoplastic Process Recurrent Pharyngeal Carcinoma Recurrent Pharyngeal Carcinoma C0854996 CTRP Malignant Recurrent_Pharyngeal_Cancer Pharyngeal Cancer, Recurrent Recurrent Cancer of Pharynx Recurrent Cancer of the Pharynx Recurrent Carcinoma of Pharynx Recurrent Carcinoma of the Pharynx Recurrent Pharyngeal Cancer Recurrent Pharyngeal Carcinoma Recurrent Pharyngeal Throat Cancer Recurrent Pharynx Cancer Recurrent Pharynx Carcinoma Relapsed Cancer of Pharynx Relapsed Cancer of the Pharynx Relapsed Carcinoma of Pharynx Relapsed Carcinoma of the Pharynx Relapsed Pharyngeal Cancer Relapsed Pharyngeal Carcinoma Relapsed Pharynx Cancer Relapsed Pharynx Carcinoma Recurrent Pharyngeal Carcinoma C5104 Neoplastic Process Ann Arbor Stage II Supradiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Stage II Supradiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma C0855201 CTRP Malignant Stage_II_Supradiaphragmatic_Mixed_Cellularity_Hodgkin_s_Lymphoma Ann Arbor Stage II Supradiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Stage II Supradiaphragmatic Mixed Cellularity Classical Hodgkin Lymphoma Stage II Mixed Cellularity Hodgkin's Disease above the Diaphragm Stage II Mixed Cellularity Hodgkin's Lymphoma above the Diaphragm Stage II Supradiaphragmatic Mixed Cellularity Classical Hodgkin Lymphoma Stage II Supradiaphragmatic Mixed Cellularity Hodgkin Lymphoma Stage II Supradiaphragmatic Mixed Cellularity Hodgkin's Disease Stage II Supradiaphragmatic Mixed Cellularity Hodgkin's Lymphoma Ann Arbor Stage II Supradiaphragmatic Mixed Cellularity Classic Hodgkin Lymphoma The most common type of colorectal carcinoma. It is characterized by the presence of malignant glandular epithelial cells invading through the muscularis mucosa into the submucosa. Histologic variants include mucinous adenocarcinoma, signet ring cell carcinoma, medullary carcinoma, serrated adenocarcinoma, cribriform comedo-type adenocarcinoma, and micropapillary adenocarcinoma. C5105 Neoplastic Process Colorectal Adenocarcinoma Colorectal Adenocarcinoma C1319315 CTRP Cellosaurus Malignant Colorectal_Adenocarcinoma Adenocarcinoma of Large Bowel Adenocarcinoma of Large Intestine Adenocarcinoma of the Large Bowel Adenocarcinoma of the Large Intestine Colorectal (Colon or Rectal) Adenocarcinoma Colorectal Adenocarcinoma Large Bowel Adenocarcinoma Large Intestine Adenocarcinoma Colorectal Adenocarcinoma A neoplasm that involves the intracranial area and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C5111 Neoplastic Process Benign Intracranial Neoplasm C1332509 Benign Benign_Intracranial_Neoplasm Benign Intracranial Neoplasm Benign Intracranial Tumor Intracranial Neoplasms, Benign Benign Intracranial Neoplasm Benign and malignant neoplasms which arise from or directly involve the central or peripheral elements of the autonomic nervous system. C5112 Neoplastic Process Autonomic Nervous System Neoplasm C1332356 Undetermined Autonomic_Nervous_System_Neoplasm Autonomic Nervous System Neoplasm Autonomic Nervous System Neoplasms Autonomic Nervous System Tumor Neoplasm of Autonomic Nervous System Neoplasm of the Autonomic Nervous System Tumor of Autonomic Nervous System Tumor of the Autonomic Nervous System Autonomic Nervous System Neoplasm The most common morphologic variant of glomus tumor. It is characterized by the presence of a nest of glomus cells surrounding capillary sized vessels. C51133 Neoplastic Process Solid Glomus Tumor C1710125 Undetermined Solid_Glomus_Tumor Solid Glomus Tumor Solid Glomus Tumor A malignant neoplasm involving the intracranial space. C5114 Neoplastic Process Malignant Intracranial Neoplasm C1334593 CPTAC Malignant Malignant_Intracranial_Neoplasm Intracranial Cancer Intracranial Neoplasms, Malignant Intracranial Tumors, Malignant Malignant Intracranial Neoplasm Malignant Intracranial Tumor Malignant Intracranial Neoplasm A malignant brain neoplasm occurring in adults. C5115 Neoplastic Process Malignant Adult Brain Neoplasm Adult Malignant Brain Neoplasm C1334557 CTRP Malignant Malignant_Adult_Brain_Neoplasm Adult Malignant Brain Neoplasm Brain Neoplasms, Adult, Malignant Malignant Adult Brain Tumor Malignant Brain Neoplasm Malignant Tumor of Adult Brain Malignant Tumor of the Adult Brain Adult Malignant Brain Neoplasm A benign neoplasm of the brain occurring in adults. C5116 Neoplastic Process Adult Benign Brain Neoplasm C1332466 Benign Benign_Adult_Brain_Neoplasm Adult Benign Brain Neoplasm Benign Adult Brain Neoplasm Benign Adult Brain Tumor Benign Neoplasm of Adult Brain Benign Neoplasm of the Adult Brain Benign Tumor of Adult Brain Benign Tumor of the Adult Brain Brain Neoplasms, Adult, Benign Adult Benign Brain Neoplasm A very rare, aggressive carcinoma of the sweat glands arising from malignant transformation of a long standing spiradenoma. It usually grows in the upper extremities, lower extremities, trunk, and head and neck. It has the tendency to recur and metastasize most often to the lymph nodes, bones, and lungs. C5117 Neoplastic Process Spiradenocarcinoma C1266063 GDC 8403/3 Malignant Malignant_Eccrine_Spiradenoma 8403/3 Malignant eccrine spiradenoma Carcinoma ex Eccrine Spiradenoma Malignant Eccrine Spiradenoma Malignant Spiradenoma Malignant eccrine spiradenoma Spiradenocarcinoma Spiradenocarcinoma Benign and malignant neoplasms arising from one or more of the cervical, thoracic, lumbar, sacral, or coccygeal nerve roots. The majority of these tumors are benign. Clinical manifestations may include pain, weakness and loss of sensation along the course of the involved nerve root. Large tumors may cause spinal cord compression. C5119 Neoplastic Process Nerve Root Neoplasm C1334946 Undetermined Nerve_Root_Neoplasm Neoplasm of Nerve Root Neoplasm of the Nerve Root Neoplasms, Nerve Root Nerve Root Neoplasm Nerve Root Neoplasms Nerve Root Tumor Nerve Root Tumors Tumor of Nerve Root Tumor of the Nerve Root Nerve Root Neoplasm A benign or malignant neoplasm affecting the eighth cranial nerve, also referred to as the vestibulocochlear nerve. Clinical features may include hearing loss, vertigo, tinnitus, headache and involvement of the trigeminal or facial nerves. C5120 Neoplastic Process Vestibulocochlear Nerve Neoplasm C0346330 Undetermined Vestibulocochlear_Nerve_Neoplasm Acoustic Nerve Neoplasm Acoustic Nerve Tumor Cranial Nerve Eight Neoplasms Eighth Cranial Nerve Neoplasm Eighth Cranial Nerve Neoplasms Eighth Cranial Nerve Tumor Neoplasm of Acoustic Nerve Neoplasm of Eighth Cranial Nerve Neoplasm of Vestibulocochlear Nerve Neoplasm of the Acoustic Nerve Neoplasm of the Eighth Cranial Nerve Neoplasm of the Vestibulocochlear Nerve Tumor of Acoustic Nerve Tumor of Eighth Cranial Nerve Tumor of Vestibulocochlear Nerve Tumor of the Acoustic Nerve Tumor of the Eighth Cranial Nerve Tumor of the Vestibulocochlear Nerve Vestibuloacoustic Nerve Neoplasms Vestibulocochlear Nerve Neoplasm Vestibulocochlear Nerve Neoplasms Vestibulocochlear Nerve Tumor Vestibulocochlear Nerve Neoplasm A benign or malignant neoplasm affecting the olfactory or first cranial nerve. Clinical features may include facial pain and impairments of taste or smell. C5121 Neoplastic Process Olfactory Nerve Neoplasm C0346319 Undetermined Olfactory_Nerve_Neoplasm Cranial Nerve I Neoplasms First Cranial Nerve Neoplasm First Cranial Nerve Neoplasms First Cranial Nerve Tumor Neoplasm of First Cranial Nerve Neoplasm of Olfactory Nerve Neoplasm of the First Cranial Nerve Neoplasm of the Olfactory Nerve Neoplasms, Cranial Nerve I Neoplasms, Olfactory Nerve Olfactory Nerve Neoplasm Olfactory Nerve Neoplasms Olfactory Nerve Tumor Olfactory Neural Neoplasm Olfactory Neural Tumor Tumor of First Cranial Nerve Tumor of Olfactory Nerve Tumor of the First Cranial Nerve Tumor of the Olfactory Nerve Olfactory Nerve Neoplasm A benign or malignant neoplasm affecting the trigeminal or fifth cranial nerve. Clinical features may include facial pain, sensory loss, and weakness of jaw closure. C5122 Neoplastic Process Trigeminal Nerve Neoplasm C1263897 Undetermined Trigeminal_Nerve_Neoplasm Cranial Nerve V Neoplasms Cranial Nerve V Tumors Fifth Cranial Nerve Neoplasm Fifth Cranial Nerve Tumor Neoplasm of Fifth Cranial Nerve Neoplasm of Trigeminal Nerve Neoplasm of the Fifth Cranial Nerve Neoplasm of the Trigeminal Nerve Neoplasms, Cranial Nerve V Trigeminal Nerve Neoplasm Trigeminal Nerve Neoplasms Trigeminal Nerve Tumor Trigeminal Nerve Tumors Tumor of Fifth Cranial Nerve Tumor of Trigeminal Nerve Tumor of the Fifth Cranial Nerve Tumor of the Trigeminal Nerve Tumors, Cranial Nerve V Trigeminal Nerve Neoplasm An anaplastic astrocytoma that arises from the cerebral hemispheres. C5123 Neoplastic Process Hemispheric Anaplastic Astrocytoma C1332282 Malignant Anaplastic_Hemispheric_Astrocytoma Anaplastic Astrocytoma of Cerebral Hemisphere Anaplastic Astrocytoma of the Cerebral Hemisphere Anaplastic Astrocytoma, Hemispheric Anaplastic Hemispheric Astrocytoma Cerebral Hemisphere Anaplastic Astrocytoma Grade 3 Astrocytic Neoplasm of Cerebral Hemisphere Grade 3 Astrocytic Neoplasm of the Cerebral Hemisphere Grade 3 Astrocytic Tumor of Cerebral Hemisphere Grade 3 Astrocytic Tumor of the Cerebral Hemisphere Grade 3 Astrocytoma of Cerebral Hemisphere Grade 3 Astrocytoma of the Cerebral Hemisphere Grade 3 Cerebral Hemisphere Astrocytic Neoplasm Grade 3 Cerebral Hemisphere Astrocytoma Grade 3 Hemispheric Astrocytic Neoplasm Grade 3 Hemispheric Astrocytic Tumor Grade 3 Hemispheric Astrocytoma Grade III Astrocytic Neoplasm of Cerebral Hemisphere Grade III Astrocytic Neoplasm of the Cerebral Hemisphere Grade III Astrocytic Tumor of Cerebral Hemisphere Grade III Astrocytic Tumor of the Cerebral Hemisphere Grade III Astrocytoma of Cerebral Hemisphere Grade III Cerebral Hemisphere Astrocytic Neoplasm Grade III Cerebral Hemisphere Astrocytic Tumor Grade III Cerebral Hemisphere Astrocytoma Grade III Hemispheric Astrocytic Neoplasm Grade III Hemispheric Astrocytic Tumor Grade III Hemispheric Astrocytoma Hemispheric Anaplastic Astrocytoma Undifferentiated Astrocytoma of Cerebral Hemisphere Undifferentiated Astrocytoma of the Cerebral Hemisphere Hemispheric Anaplastic Astrocytoma An anaplastic astrocytoma that occurs in the diencephalon. C5124 Neoplastic Process Anaplastic Diencephalic Astrocytoma C1332281 Malignant Anaplastic_Diencephalic_Astrocytoma Anaplastic Astrocytoma of Diencephalon Anaplastic Astrocytoma of the Diencephalon Anaplastic Diencephalic Astrocytoma Diencephalic Anaplastic Astrocytoma Grade 3 Astrocytic Neoplasm of Diencephalon Grade 3 Astrocytic Neoplasm of the Diencephalon Grade 3 Astrocytic Tumor of Diencephalon Grade 3 Astrocytic Tumor of the Diencephalon Grade 3 Astrocytoma of Diencephalon Grade 3 Astrocytoma of the Diencephalon Grade 3 Diencephalic Astrocytic Neoplasm Grade 3 Diencephalic Astrocytic Tumor Grade 3 Diencephalic Astrocytoma Grade III Astrocytic Neoplasm of Diencephalon Grade III Astrocytic Neoplasm of the Diencephalon Grade III Astrocytic Tumor of Diencephalon Grade III Astrocytic Tumor of the Diencephalon Grade III Astrocytoma of Diencephalon Grade III Astrocytoma of the Diencephalon Grade III Diencephalic Astrocytic Neoplasm Grade III Diencephalic Astrocytic Tumor Grade III Diencephalic Astrocytoma Undifferentiated Astrocytoma of Diencephalon Undifferentiated Astrocytoma of the Diencephalon Undifferentiated Diencephalic Astrocytoma Anaplastic Diencephalic Astrocytoma C5125 Neoplastic Process Diencephalic Neoplasm C1333286 Undetermined Diencephalic_Neoplasm Diencephalic Neoplasm Diencephalic Neoplasms Diencephalic Tumor Neoplasm of Diencephalon Neoplasm of the Diencephalon Tumor of Diencephalon Tumor of the Diencephalon Diencephalic Neoplasm A malignant neoplasm that occurs in the diencephalon. C5126 Neoplastic Process Malignant Diencephalic Neoplasm C1334576 Malignant Malignant_Diencephalic_Neoplasm Malignant Diencephalic Neoplasm Malignant Diencephalic Neoplasms Malignant Diencephalic Tumor Malignant Diencephalic Neoplasm A neoplasm that arises from the diencephalon and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C5127 Neoplastic Process Benign Diencephalic Neoplasm C1332491 Benign Benign_Diencephalic_Neoplasm Benign Diencephalic Neoplasm Benign Diencephalic Neoplasms Benign Diencephalic Tumor Benign Neoplasm of Diencephalon Benign Neoplasm of the Diencephalon Benign Tumor of Diencephalon Benign Tumor of the Diencephalon Benign Diencephalic Neoplasm C5128 Neoplastic Process Diencephalic Astrocytoma C1333284 Undetermined Diencephalic_Astrocytoma Astrocytoma of Diencephalon Astrocytoma of the Diencephalon Diencephalic Astrocytoma Diencephalic Astrocytomas Diencephalic Astrocytoma A glioblastoma that occurs in the diencephalon. C5129 Neoplastic Process Diencephalic Glioblastoma C1333285 Malignant Diencephalic_Glioblastoma Diencephalic GBM Diencephalic Glioblastoma Diencephalic Glioblastoma Multiforme GBM of Diencephalon GBM of the Diencephalon Glioblastoma Multiforme of Diencephalon Glioblastoma Multiforme of the Diencephalon Diencephalic Glioblastoma An adenoid cystic carcinoma primarily involving the breast. Three morphologic patterns are seen: cribriform, trabecular, and solid. The prognosis is excellent. C5130 Neoplastic Process Breast Adenoid Cystic Carcinoma C1332167 Malignant Adenoid_Cystic_Breast_Carcinoma Adenocystic Breast Carcinoma Adenocystic Carcinoma of Breast Adenocystic Carcinoma of the Breast Adenoid Cystic Breast Carcinoma Adenoid Cystic Carcinoma of Breast Adenoid Cystic Carcinoma of the Breast Breast Adenoid Cystic Carcinoma Mammary Adenocystic Carcinoma Breast Adenoid Cystic Carcinoma An autosomal dominant inherited syndrome caused by germline mutations in the FH gene. It is characterized by predisposition to renal cell carcinoma, leiomyomas of the skin and uterus, and leiomyosarcoma of the uterus. C51302 Neoplastic Process Hereditary Leiomyomatosis and Renal Cell Cancer Hereditary Leiomyomatosis and Renal Cell Carcinoma C1708350 CCPS CTRP Cellosaurus GDC A rare inherited disorder that increases the risk of developing benign (not cancer) tumors of the skin and the uterus (leiomyomas) and malignant (cancer) tumors of the uterus (leiomyosarcoma) and the kidney. Malignant Hereditary_Leiomyomatosis_and_Renal_Cell_Cancer Hereditary Leiomyomatosis and Renal Cell Carcinoma Hereditary leiomyomatosis & RCC-associated renal cell carcinoma Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome-associated renal cell carcinoma FH Deficiency HLRCC Hereditary Leiomyomatosis and Renal Cell Cancer Hereditary Leiomyomatosis and Renal Cell Carcinoma Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome Hereditary leiomyomatosis & RCC-associated renal cell carcinoma hereditary leiomyomatosis and renal cell cancer syndrome Hereditary Leiomyomatosis and Renal Cell Carcinoma A benign or malignant neoplasm of the brain, spinal cord, or meninges occurring in adults. Representative examples of primary neoplasms include astrocytoma, meningioma, pituitary adenoma, and neurilemoma. Representative examples of tumor metastases from other organs to the central nervous system include lung and breast carcinoma. C5131 Neoplastic Process Adult Central Nervous System Neoplasm Adult Central Nervous System Neoplasm C1377678 CTRP Undetermined Adult_Central_Nervous_System_Neoplasm Adult CNS Neoplasm Adult CNS Neoplasms Adult CNS Tumor Adult CNS Tumors Adult Central Nervous System Neoplasm Adult Central Nervous System Neoplasms Adult Central Nervous System Tumor Adult Central Nervous System Tumors Central Nervous System Neoplasm Neoplasm of Adult CNS Neoplasm of Adult Central Nervous System Neoplasm of the Adult CNS Neoplasm of the Adult Central Nervous System Tumor of Adult CNS Tumor of Adult Central Nervous System Tumor of the Adult CNS Tumor of the Adult Central Nervous System Adult Central Nervous System Neoplasm A benign or malignant neoplasm of the brain, spinal cord, or meninges occurring in children. Representative examples include posterior fossa astrocytoma, optic pathway glioma, medulloblastoma, ependymoma, and craniopharyngioma. C5132 Neoplastic Process Childhood Central Nervous System Neoplasm Childhood Central Nervous System Neoplasm C1377665 CTRP NICHD A primary, benign or malignant neoplasm of the brain, spinal cord, or meninges occurring in children. Undetermined Childhood_Central_Nervous_System_Neoplasm Central Nervous System Neoplasm Childhood CNS Neoplasm Childhood CNS Neoplasms Childhood CNS Tumor Childhood CNS Tumors Childhood Central Nervous System Neoplasm Childhood Central Nervous System Neoplasms Childhood Central Nervous System Tumor Childhood Central Nervous System Tumors Childhood Neoplasm of CNS Childhood Neoplasm of Central Nervous System Childhood Neoplasm of the CNS Childhood Neoplasm of the Central Nervous System Childhood Tumor of CNS Childhood Tumor of Central Nervous System Childhood Tumor of the CNS Childhood Tumor of the Central Nervous System Pediatric CNS Neoplasm Pediatric CNS Tumor Pediatric Central Nervous System Neoplasm Pediatric Central Nervous System Tumor Pediatric Neoplasm of CNS Pediatric Neoplasm of Central Nervous System Pediatric Neoplasm of the CNS Pediatric Neoplasm of the Central Nervous System Pediatric Tumor of CNS Pediatric Tumor of Central Nervous System Pediatric Tumor of the CNS Pediatric Tumor of the Central Nervous System Childhood Central Nervous System Neoplasm A grade I, slowly growing meningioma within the cranial cavity. C5133 Neoplastic Process Benign Intracranial Meningioma C1332508 mCode Benign Benign_Intracranial_Meningioma Benign Intracranial Meningioma Benign neoplasm of cerebral meninges Benign Intracranial Meningioma A meningioma that arises from the spinal meninges. C5134 Neoplastic Process Spinal Meningioma C1334264 Undetermined Intraspinal_Meningioma Intraspinal Meningioma Meningioma of Spinal Canal and Spinal Cord Meningioma of the Spinal Canal and Spinal Cord Spinal Canal and Spinal Cord Meningioma Spinal Meningioma Spinal Meningioma A neoplasm that occurs within the spinal canal in the space between the spinal cord and the dura mater. Representative examples include meningioma, neurofibroma, and sarcoma. Signs and symptoms include local and radicular pain, weakness and spinal cord compression. C5135 Neoplastic Process Intradural Extramedullary Spinal Canal Neoplasm C1334255 Undetermined Intradural_Extramedullary_Spinal_Canal_Neoplasm Intradural Extramedullary Neoplasm of Spinal Canal Intradural Extramedullary Neoplasm of the Spinal Canal Intradural Extramedullary Spinal Canal Neoplasm Intradural Extramedullary Spinal Canal Tumor Intradural Extramedullary Spinal Canal Tumors Intradural Extramedullary Spinal Neoplasms Intradural Extramedullary Spinal Tumors Intradural Extramedullary Tumor of Spinal Canal Intradural Extramedullary Tumor of the Spinal Canal Intradural Extramedullary Spinal Canal Neoplasm A glioblastoma that occurs during childhood. C5136 Neoplastic Process Childhood Glioblastoma Childhood Glioblastoma CL414408 CTRP NICHD A glioblastoma that occurs during childhood. Malignant Childhood_Glioblastoma Childhood Glioblastoma Childhood Glioblastoma Multiforme Glioblastoma Pediatric Glioblastoma Multiforme Childhood Glioblastoma Breast ductal carcinoma in situ characterized by the presence of sheets of tumor cells without evidence of central necrosis or cell death. C5137 Neoplastic Process Breast Ductal Carcinoma In Situ, Non-Comedo Type C1334250 Malignant Intraductal_Non-Comedo_Breast_Adenocarcinoma Breast Ductal Carcinoma In Situ, Non-Comedo Type Breast Intraductal Non-Comedo Adenocarcinoma Intraductal Non-Comedo Breast Adenocarcinoma Non-Comedo Breast Ductal Carcinoma in situ Non-Comedo DCIS of Breast Non-Comedo DCIS of the Breast Non-Comedo Ductal Carcinoma in situ of Breast Non-Comedo Ductal Carcinoma in situ of the Breast Non-Infiltrating Non-Comedo Ductal Breast Carcinoma Non-Infiltrating Non-Comedo Ductal Carcinoma of Breast Non-Infiltrating Non-Comedo Ductal Carcinoma of the Breast Non-Invasive Non-Comedo Ductal Breast Carcinoma Non-Invasive Non-Comedo Ductal Carcinoma of Breast Non-Invasive Non-Comedo Ductal Carcinoma of the Breast Breast Ductal Carcinoma In Situ, Non-Comedo Type Breast ductal carcinoma in situ characterized by the presence of a cribriform architectural pattern. C5138 Neoplastic Process Breast Ductal Carcinoma In Situ, Cribriform Pattern Breast Ductal Carcinoma In Situ, Cribriform Pattern C1334248 CTRP GDC 8201/2 Malignant Intraductal_Cribriform_Breast_Adenocarcinoma Ductal carcinoma in situ, cribriform type Breast Ductal Carcinoma In Situ with Cribriform Pattern Breast Ductal Carcinoma In Situ, Cribriform Pattern Breast Ductal Carcinoma In Situ, Cribriform Type Breast Intraductal Cribriform Adenocarcinoma Cribriform DCIS of Breast Cribriform DCIS of the Breast Cribriform Ductal Breast Carcinoma in situ Cribriform Ductal Carcinoma in situ of Breast Cribriform Ductal Carcinoma in situ of the Breast DCIS of Breast with Cribriform Pattern DCIS of the Breast with Cribriform Pattern Ductal Carcinoma in situ of Breast with Cribriform Pattern Ductal Carcinoma in situ of the Breast with Cribriform Pattern Intraductal Cribriform Breast Adenocarcinoma Non-Infiltrating Cribriform Ductal Breast Carcinoma Non-Invasive Cribriform Ductal Breast Carcinoma Breast Ductal Carcinoma In Situ, Cribriform Pattern Breast ductal carcinoma in situ characterized by the presence of neoplastic epithelial cells arranged in micropapillary patterns. C5139 Neoplastic Process Breast Micropapillary Ductal Carcinoma In Situ Breast Micropapillary Ductal Carcinoma In Situ C1334249 CTRP GDC 8507/2 Malignant Intraductal_Micropapillary_Breast_Carcinoma 8507/2 Intraductal micropapillary carcinoma Breast Intraductal Micropapillary Carcinoma Breast Micropapillary DCIS Breast Micropapillary Ductal Carcinoma In Situ Intraductal Micropapillary Breast Carcinoma Intraductal micropapillary carcinoma Micropapillary DCIS of Breast Micropapillary DCIS of the Breast Micropapillary Ductal Breast Carcinoma in situ Micropapillary Ductal Carcinoma In Situ Micropapillary Ductal Carcinoma in situ of Breast Micropapillary Ductal Carcinoma in situ of the Breast Non-Infiltrating Micropapillary Breast Carcinoma Non-Infiltrating Micropapillary Carcinoma of Breast Non-Infiltrating Micropapillary Carcinoma of the Breast Non-Infiltrating Micropapillary Ductal Breast Carcinoma Non-Infiltrating Micropapillary Ductal Carcinoma of Breast Non-Infiltrating Micropapillary Ductal Carcinoma of the Breast Non-Invasive Micropapillary Breast Carcinoma Non-Invasive Micropapillary Carcinoma of Breast Non-Invasive Micropapillary Carcinoma of the Breast Non-Invasive Micropapillary Ductal Breast Carcinoma Non-Invasive Micropapillary Ductal Carcinoma of Breast Non-Invasive Micropapillary Ductal Carcinoma of the Breast Breast Micropapillary Ductal Carcinoma In Situ A ductal breast carcinoma in situ, characterized by the presence of neoplastic epithelial cells with apocrine differentiation. C5140 Neoplastic Process Breast Apocrine Carcinoma In Situ C1332315 Malignant Apocrine_Breast_Carcinoma_in_situ Apocrine Breast Carcinoma In Situ Apocrine Carcinoma In Situ of Breast Apocrine Carcinoma In Situ of the Breast Breast Apocrine Carcinoma In Situ Breast Apocrine Carcinoma In Situ An adenocarcinoma of the breast characterized by the presence of two intermingled cellular components: cells with abundant granular, eosinophilic cytoplasm, and cells with abundant cytoplasm containing fine empty vacuoles. C5141 Neoplastic Process Breast Apocrine Carcinoma Breast Apocrine Carcinoma C1332316 CTRP Malignant Apocrine_Ductal_Breast_Carcinoma Apocrine Breast Carcinoma Apocrine Carcinoma of Breast Apocrine Carcinoma of the Breast Breast Apocrine Carcinoma Breast Apocrine Carcinoma An invasive adenocarcinoma of the breast with a favorable clinical outcome, characterized by the presence of a sieve-like or cribriform infiltrating pattern. C5142 Neoplastic Process Invasive Breast Cribriform Carcinoma C1334275 Malignant Invasive_Cribriform_Breast_Carcinoma Infiltrating Cribriform Breast Carcinoma Infiltrating Cribriform Carcinoma of Breast Infiltrating Cribriform Carcinoma of the Breast Infiltrating Cribriform Ductal Carcinoma of Breast Invasive Breast Cribriform Adenocarcinoma Invasive Breast Cribriform Carcinoma Invasive Cribriform Breast Carcinoma Invasive Cribriform Carcinoma of Breast Invasive Cribriform Carcinoma of the Breast Invasive Cribriform Ductal Carcinoma of Breast Invasive Breast Cribriform Carcinoma An adenomyoepithelioma of the breast in which the epithelial, myoepithelial, or both components have undergone malignant transformation. Such cases may follow an aggressive clinical course, including recurrences and local and distant metastases. C5143 Neoplastic Process Malignant Breast Adenomyoepithelioma C3839546 GDC Malignant Malignant_Breast_Adenomyoepithelioma 8983/3 Adenomyoepithelioma with carcinoma Adenomyoepithelioma with carcinoma Breast Adenomyoepithelioma with Malignant Change Malignant Adenomyoepithelioma of Breast Malignant Adenomyoepithelioma of the Breast Malignant Breast Adenomyoepithelioma Malignant Breast Adenomyoepithelioma A benign, nodular tumor that arises from the breast parenchyma. It is characterized by the proliferation of myoepithelial cells around spaces that are lined by epithelial cells. Occasionally, adenomyoepitheliomas may undergo malignant transformation. C5144 Neoplastic Process Benign Breast Adenomyoepithelioma C1332477 Benign Benign_Breast_Adenomyoepithelioma Benign Adenomyoepithelioma of Breast Benign Adenomyoepithelioma of the Breast Benign Breast Adenomyoepithelioma Benign Breast Adenomyoepithelioma A neurofibroma that arises from the spinal cord. C5145 Neoplastic Process Spinal Cord Neurofibroma Spinal Cord Neurofibroma C1336047 CTRP Benign Spinal_Cord_Neurofibroma Neurofibroma of Spinal Cord Spinal Cord Neurofibroma Spinal Cord Neurofibroma A hemangioblastoma that arises from the cerebellum. C5146 Neoplastic Process Cerebellar Hemangioblastoma C1332900 A benign, slow-growing tumor in the cerebellum (part of the brain at the back of the head), made up of abnormal blood vessel growth. People with von Hippel-Landau disease have an increased risk of developing hemangioblastomas. Undetermined Cerebellar_Hemangioblastoma Angioblastoma of Cerebellum Angioblastoma of the Cerebellum Cerebellar Angioblastoma Cerebellar Capillary Hemangioblastoma Cerebellar Hemangioblastoma Hemangioblastoma of Cerebellum Hemangioblastoma of the Cerebellum cerebellar hemangioblastoma Cerebellar Hemangioblastoma A hemangioblastoma arising from the brain stem. C5147 Neoplastic Process Brain Stem Hemangioblastoma C1332611 Undetermined Brain_Stem_Hemangioblastoma Angioblastoma of Brain Stem Angioblastoma of Brainstem Angioblastoma of the Brain Stem Angioblastoma of the Brainstem Brain Stem Angioblastoma Brain Stem Capillary Hemangioblastoma Brain Stem Hemangioblastoma Brainstem Angioblastoma Hemangioblastoma of Brain Stem Hemangioblastoma of Brainstem Hemangioblastoma of the Brain Stem Hemangioblastoma of the Brainstem Brain Stem Hemangioblastoma A glioblastoma that occurs in the infratentorial region. C5148 Neoplastic Process Infratentorial Glioblastoma C1334184 Malignant Infratentorial_Glioblastoma Infratentorial Glioblastoma Infratentorial Glioblastoma Multiforme Infratentorial Glioblastoma A glioblastoma that occurs in the supratentorial region. C5149 Neoplastic Process Supratentorial Glioblastoma C1336536 Malignant Supratentorial_Glioblastoma Supratentorial Glioblastoma Supratentorial Glioblastoma Multiforme Supratentorial Glioblastoma A glioblastoma that occurs in the cerebellum. C5150 Neoplastic Process Cerebellar Glioblastoma C1332899 Cellosaurus Malignant Cerebellar_Glioblastoma Cerebellar Glioblastoma Cerebellar Glioblastoma Multiforme Glioblastoma of Cerebellum Glioblastoma of the Cerebellum Cerebellar Glioblastoma A glioblastoma that occurs in the cerebrum. C5151 Neoplastic Process Cerebral Glioblastoma C1332906 Malignant Cerebral_Glioblastoma Cerebral Glioblastoma Cerebral Glioblastoma Multiforme Cerebral Hemisphere Glioblastoma Multiforme Glioblastoma Multiforme of Cerebral Hemisphere Glioblastoma Multiforme of the Cerebral Hemisphere Hemispheric Glioblastoma Multiforme Cerebral Glioblastoma A sarcoma that arises from the spinal cord. C5152 Neoplastic Process Spinal Cord Sarcoma C1336049 Malignant Spinal_Cord_Sarcoma Sarcoma of Spinal Cord Sarcoma of the Spinal Cord Spinal Cord Sarcoma Spinal Cord Sarcoma A sarcoma that arises from the central nervous system. C5153 Neoplastic Process Central Nervous System Sarcoma Central Nervous System Sarcoma C1332892 CTRP Malignant Central_Nervous_System_Sarcoma CNS Sarcoma Central Nervous System Sarcoma Sarcoma of CNS Sarcoma of Central Nervous System Sarcoma of the CNS Sarcoma of the Central Nervous System Central Nervous System Sarcoma A sarcoma arising from the brain. C5154 Neoplastic Process Brain Sarcoma C1332607 Malignant Brain_Sarcoma Brain Sarcoma Intracranial Sarcoma Primary Brain Sarcoma Primary Intracranial Sarcoma Sarcoma of Brain Sarcoma of the Brain Brain Sarcoma A neuroblastoma that affects the spinal cord. C5155 Neoplastic Process Spinal Cord Neuroblastoma Spinal Cord Neuroblastoma C1336046 CTRP Malignant Spinal_Cord_Neuroblastoma Neuroblastoma of Spinal Cord Neuroblastoma of the Spinal Cord Spinal Cord Neuroblastoma Spinal Cord Neuroblastoma A chordoma that arises from the spine. C5156 Neoplastic Process Spinal Chordoma C1859101 Cellosaurus Malignant Spinal_Chordoma Chordoma of Spinal Column Chordoma of Spine Chordoma of the Spinal Column Spinal Chordoma Spinal Chordomas Spinal Column Chordoma Spinal Chordoma A non-Hodgkin or Hodgkin lymphoma that arises in the spinal cord as a primary lesion. C5157 Neoplastic Process Spinal Cord Lymphoma C1336044 Malignant Spinal_Cord_Lymphoma Lymphoma of Spinal Cord Lymphoma of the Spinal Cord Primary Spinal Cord Lymphoma Spinal Cord Lymphoma Spinal Cord Lymphoma A melanoma that arises from the leptomeninges in the spinal cord. C5158 Neoplastic Process Spinal Cord Melanoma C1336045 Malignant Spinal_Cord_Melanoma Melanoma of Spinal Cord Melanoma of the Spinal Cord Primary Spinal Cord Melanoma Spinal Cord Melanoma Spinal Cord Melanoma Surgery to remove both ovaries. C51590 Therapeutic or Preventive Procedure Bilateral Oophorectomy C0278321 Bilateral_Oophorectomy Bilateral Oophorectomy Bilateral Oophorectomy A breast carcinoma characterized by the presence of a lobular and a ductal component. The ductal component comprises less than 50 percent of the tumor. C5160 Neoplastic Process Breast Mixed Ductal and Lobular Carcinoma CL007210 GDC Malignant Mixed_Lobular_and_Ductal_Breast_Carcinoma 8522/3 Lobular and ductal carcinoma Breast Mixed Ductal and Lobular Carcinoma Ductal and Lobular Carcinoma Mixed Ductal and Lobular Breast Carcinoma Mixed Ductal and Lobular Carcinoma Mixed Ductal and Lobular Carcinoma of Breast Mixed Ductal and Lobular Carcinoma of the Breast Mixed Lobular and Ductal Breast Carcinoma Mixed Lobular and Ductal Carcinoma Mixed Lobular and Ductal Carcinoma of Breast Mixed Lobular and Ductal Carcinoma of the Breast Breast Mixed Ductal and Lobular Carcinoma Surgery to remove the left ovary. C51601 Therapeutic or Preventive Procedure Left Oophorectomy C0563529 Left_Oophorectomy Left Oophorectomy Left Oophorectomy Surgery to remove the right ovary. C51602 Therapeutic or Preventive Procedure Right Oophorectomy C0563528 Right_Oophorectomy Right Oophorectomy Right Oophorectomy A rare, aggressive, high grade invasive ductal carcinoma, not otherwise specified. It is characterized by the presence of pleomorphic and bizarre malignant cells that constitute more than 50 percent of the malignant cellular infiltrate. C5161 Neoplastic Process Breast Pleomorphic Carcinoma C1514169 Cellosaurus Malignant Undifferentiated_Breast_Carcinoma Anaplastic Breast Carcinoma Breast Pleomorphic Carcinoma Pleomorphic Breast Carcinoma Breast Pleomorphic Carcinoma An invasive breast carcinoma characterized by the presence of a predominant squamous cell component that is admixed with the adenocarcinoma component. C5163 Neoplastic Process Breast Adenocarcinoma with Squamous Metaplasia C1332613 Malignant Breast_Adenocarcinoma_with_Squamous_Metaplasia Adenoacanthoma of Breast Adenoacanthoma of the Breast Adenocarcinoma of Breast with Squamous Metaplasia Adenocarcinoma of the Breast with Squamous Metaplasia Breast Adenoacanthoma Breast Adenocarcinoma with Squamous Metaplasia Breast Adenocarcinoma with Squamous Metaplasia A group of invasive breast carcinomas characterized by the presence of an adenocarcinomatous component which is admixed with a dominant component that is composed of squamous cells, spindle cells, or mesenchymal cells. C5164 Neoplastic Process Breast Metaplastic Carcinoma C1334708 Cellosaurus Malignant Metaplastic_Breast_Carcinoma Breast Metaplastic Carcinoma Metaplastic Breast Carcinoma Metaplastic Carcinoma of Breast Metaplastic Carcinoma of the Breast MpBC Breast Metaplastic Carcinoma A Hodgkin or non-Hodgkin lymphoma that occurs during childhood. C5165 Neoplastic Process Childhood Lymphoma Childhood Lymphoma C1332979 CPTAC CTRP Cellosaurus NICHD A Hodgkin or non-Hodgkin lymphoma that occurs during childhood. Malignant Childhood_Lymphoma Childhood Lymphoma Lymphoma Pediatric Lymphoma Childhood Lymphoma A carcinoma of the breast characterized by pools of mucin and islands of malignant squamous cells. Mucoepidermoid carcinomas of the breast are extremely rare. C5166 Neoplastic Process Breast Mucoepidermoid Carcinoma C1334813 Malignant Mucoepidermoid_Breast_Carcinoma Breast Mucoepidermoid Carcinoma Mucoepidermoid Breast Carcinoma Mucoepidermoid Carcinoma of Breast Mucoepidermoid Carcinoma of the Breast Breast Mucoepidermoid Carcinoma An aggressive mucoepidermoid carcinoma that arises from the breast. It is characterized by the presence of focal necrosis and high mitotic activity. Lymph node and distant metastases are common. The prognosis is usually poor. C5167 Neoplastic Process Breast High Grade Mucoepidermoid Carcinoma C1334006 Malignant High-Grade_Mucoepidermoid_Breast_Carcinoma Breast High Grade Mucoepidermoid Carcinoma Breast High-Grade Mucoepidermoid Carcinoma High Grade Breast Mucoepidermoid Carcinoma High Grade Mucoepidermoid Breast Carcinoma High-Grade Mucoepidermoid Carcinoma of Breast High-Grade Mucoepidermoid Carcinoma of the Breast Breast High Grade Mucoepidermoid Carcinoma A slow growing mucoepidermoid carcinoma that arises from the breast. It is characterized by the presence of keratinization in the neoplastic squamous cells and lumina formation by glandular neoplastic cells. Complete excision may be curative. C5168 Neoplastic Process Breast Low Grade Mucoepidermoid Carcinoma C1334417 Malignant Low-Grade_Mucoepidermoid_Breast_Carcinoma Breast Low Grade Mucoepidermoid Carcinoma Breast Low-Grade Mucoepidermoid Carcinoma Low Grade Breast Mucoepidermoid Carcinoma Low Grade Mucoepidermoid Breast Carcinoma Low-Grade Mucoepidermoid Carcinoma of Breast Low-Grade Mucoepidermoid Carcinoma of the Breast Breast Low Grade Mucoepidermoid Carcinoma A neoplasm that arises from the breast and is composed of cells exhibiting neuroendocrine differentiation. It is classified as neuroendocrine carcinoma or neuroendocrine tumor G1 and neuroendocrine tumor G2. Most cases are neuroendocrine carcinomas. Primary neuroendocrine tumors in the breast are very rare. C5169 Neoplastic Process Breast Neuroendocrine Neoplasm C1332635 Cellosaurus Undetermined Breast_Neuroendocrine_Neoplasm Breast Endocrine Neoplasm Breast Neuroendocrine Neoplasm Neuroendocrine Neoplasm of Breast Neuroendocrine Neoplasm of the Breast Breast Neuroendocrine Neoplasm A well-differentiated, low grade neuroendocrine neoplasm arising from the breast. C5170 Neoplastic Process Breast Neuroendocrine Tumor G1 C1332839 Undetermined Carcinoid_Tumor_of_the_Breast Breast Carcinoid Tumor Breast Neuroendocrine Tumor G1 Carcinoid Tumor of Breast Primary Breast Carcinoid Tumor Primary Carcinoid Tumor of Breast Primary Carcinoid Tumor of the Breast Breast Neuroendocrine Tumor G1 A well differentiated neuroendocrine tumor that arises from the breast and has metastasized to other anatomic sites. C5171 Neoplastic Process Metastatic Breast Neuroendocrine Tumor G1 C1334714 Malignant Metastatic_Breast_Carcinoid_Tumor Metastatic Breast Carcinoid Tumor Metastatic Breast Neuroendocrine Tumor G1 Metastatic Carcinoid Tumor of Breast Metastatic Carcinoid Tumor of the Breast Metastatic Breast Neuroendocrine Tumor G1 An invasive breast adenocarcinoma characterized by the presence of malignant epithelial cells with signet ring appearance. C5175 Neoplastic Process Breast Signet Ring Cell Carcinoma C1335964 Malignant Signet_Ring_Cell_Breast_Carcinoma Breast Signet Ring Cell Carcinoma Breast Signet-Ring Cell Carcinoma Mammary Signet Ring Cell Carcinoma Primary Mammary Signet Ring Cell Carcinoma Primary SRC Breast Carcinoma Primary SRC Carcinoma of Breast Primary SRC Carcinoma of the Breast Primary Signet Ring Cell Breast Carcinoma Primary Signet Ring Cell Carcinoma of Breast Primary Signet Ring Cell Carcinoma of the Breast SRC Breast Carcinoma SRC Carcinoma of Breast SRC Carcinoma of the Breast Signet Ring Cell Breast Carcinoma Signet Ring Cell Carcinoma of Breast Signet Ring Cell Carcinoma of the Breast Breast Signet Ring Cell Carcinoma A signet ring cell carcinoma that arises from the breast and has metastasized to other anatomic sites. C5176 Neoplastic Process Metastatic Breast Signet Ring Cell Carcinoma C1334740 Malignant Metastatic_Signet_Ring_Cell_Breast_Carcinoma Metastatic Breast Signet Ring Cell Carcinoma Metastatic Breast Signet-Ring Cell Carcinoma Metastatic Mammary Signet Ring Cell Carcinoma Metastatic SRC Breast Carcinoma Metastatic SRC Carcinoma of Breast Metastatic SRC Carcinoma of the Breast Metastatic Signet Ring Cell Breast Carcinoma Metastatic Signet Ring Cell Carcinoma of Breast Metastatic Signet Ring Cell Carcinoma of the Breast Metastatic Breast Signet Ring Cell Carcinoma A rare carcinoma that arises from the breast parenchyma and is entirely composed of squamous cells. C5177 Neoplastic Process Breast Squamous Cell Carcinoma C1336079 Malignant Squamous_Cell_Breast_Carcinoma Breast Squamous Cell Carcinoma Primary Squamous Cell Breast Carcinoma Primary Squamous Cell Carcinoma of Breast Primary Squamous Cell Carcinoma of the Breast SCC of Breast SCC of the Breast Squamous Breast Carcinoma Squamous Carcinoma of Breast Squamous Carcinoma of the Breast Squamous Cell Breast Carcinoma Squamous Cell Carcinoma of Breast Squamous Cell Carcinoma of the Breast Breast Squamous Cell Carcinoma A squamous cell carcinoma that arises from the breast parenchyma and has metastasized to other anatomic sites. C5178 Neoplastic Process Metastatic Breast Squamous Cell Carcinoma C1334743 Malignant Metastatic_Squamous_Cell_Breast_Carcinoma Metastatic Breast Squamous Cell Carcinoma Metastatic Squamous Cell Breast Carcinoma Metastatic Squamous Cell Carcinoma of Breast Metastatic Squamous Cell Carcinoma of the Breast Metastatic Breast Squamous Cell Carcinoma A rare tumor characterized by malignant transformation of an eccrine spiradenoma of the breast. C5180 Neoplastic Process Malignant Breast Spiradenoma C1334565 Malignant Malignant_Breast_Eccrine_Spiradenoma Malignant Breast Eccrine Spiradenoma Malignant Breast Spiradenoma Malignant Eccrine Spiradenoma of Breast Malignant Eccrine Spiradenoma of the Breast Malignant Breast Spiradenoma A non-Hodgkin lymphoma that arises from the breast. There is no history of extramammary breast non-Hodgkin lymphoma and ipsilateral axillary lymph node involvement does not exclude the diagnosis of primary breast non-Hodgkin lymphoma. Most patients present with a painless breast lump. The vast majority of cases are B-cell non-Hodgkin lymphomas. Diffuse large B-cell lymphoma, follicular lymphoma, and extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue are the most common types of primary non-Hodgkin lymphoma of the breast. C5181 Neoplastic Process Breast Non-Hodgkin Lymphoma C1335489 Malignant Primary_Non-Hodgkin_s_Breast_Lymphoma Breast Non-Hodgkin Lymphoma Non-Hodgkin Breast Lymphoma Non-Hodgkin's Breast Lymphoma Primary Non-Hodgkin Breast Lymphoma Primary Non-Hodgkin Lymphoma of Breast Primary Non-Hodgkin Lymphoma of the Breast Primary Non-Hodgkin's Breast Lymphoma Primary Non-Hodgkin's Lymphoma of Breast Primary Non-Hodgkin's Lymphoma of the Breast Breast Non-Hodgkin Lymphoma A T-cell non-Hodgkin lymphoma that arises from the breast as a primary tumor. Primary T-cell non-Hodgkin lymphomas of the breast are rare. C5182 Neoplastic Process Breast T-Cell Non-Hodgkin Lymphoma C1335493 Malignant Primary_T-Cell_Breast_Lymphoma Breast T-Cell Non-Hodgkin Lymphoma Breast T-Cell Non-Hodgkin's Lymphoma Primary T-Cell Breast Lymphoma Primary T-Cell Lymphoma of Breast Primary T-Cell Lymphoma of the Breast T-Cell Non-Hodgkin's Lymphoma of the Breast Breast T-Cell Non-Hodgkin Lymphoma A malignant vascular neoplasm arising from the breast. C5184 Neoplastic Process Breast Angiosarcoma C1332614 Malignant Breast_Angiosarcoma Angiosarcoma of Breast Angiosarcoma of the Breast Breast Angiosarcoma Breast Hemangiosarcoma Hemangiosarcoma of Breast Hemangiosarcoma of the Breast Breast Angiosarcoma A usually aggressive malignant neoplasm arising from the breast. It is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation in a herringbone growth pattern. C5185 Neoplastic Process Breast Fibrosarcoma C1332630 Malignant Breast_Fibrosarcoma Breast Fibrosarcoma Fibrosarcoma of Breast Fibrosarcoma of the Breast Breast Fibrosarcoma An aggressive malignant smooth muscle neoplasm, arising from the breast. It is characterized by a proliferation of neoplastic spindle cells. C5186 Neoplastic Process Breast Leiomyosarcoma C1332631 Malignant Breast_Leiomyosarcoma Breast Leiomyosarcoma Leiomyosarcoma of Breast Leiomyosarcoma of the Breast Breast Leiomyosarcoma A liposarcoma that arises from the breast parenchyma. C5187 Neoplastic Process Breast Liposarcoma C1332632 Malignant Breast_Liposarcoma Breast Liposarcoma Liposarcoma of Breast Liposarcoma of the Breast Breast Liposarcoma An osteosarcoma arising from the breast tissue. C5189 Neoplastic Process Breast Extraskeletal Osteosarcoma C1335149 Malignant Osteosarcoma_of_the_Breast Breast Extraskeletal Osteosarcoma Breast Osteosarcoma Osteogenic Breast Sarcoma Osteogenic Sarcoma of Breast Osteogenic Sarcoma of the Breast Osteosarcoma of Breast Osteosarcoma of the Breast Breast Extraskeletal Osteosarcoma A malignant mesenchymal tumor with skeletal muscle differentiation affecting the breast. C5190 Neoplastic Process Breast Rhabdomyosarcoma C1332637 Malignant Breast_Rhabdomyosarcoma Breast Rhabdomyosarcoma Rhabdomyosarcoma of Breast Rhabdomyosarcoma of the Breast Breast Rhabdomyosarcoma A very rare, benign sweat gland neoplasm that affects the breast. It is characterized by the proliferation of basaloid epithelial cells. C5193 Neoplastic Process Breast Spiradenoma C1332492 Benign Benign_Eccrine_Breast_Spiradenoma Benign Breast Eccrine Spiradenoma Benign Eccrine Breast Spiradenoma Benign Eccrine Spiradenoma of Breast Benign Eccrine Spiradenoma of the Breast Breast Spiradenoma Breast Spiradenoma A breast fibroadenoma that displays fibrocystic changes including apocrine metaplasia, sclerosing adenosis, and cyst formation. C5194 Neoplastic Process Breast Complex Fibroadenoma C1333137 Benign Complex_Breast_Fibroadenoma Breast Complex Fibroadenoma Complex Breast Fibroadenoma Complex Fibroadenoma Complex Fibroadenoma of Breast Complex Fibroadenoma of the Breast Breast Complex Fibroadenoma A general term that refers to atypical hyperplastic proliferations of the epithelial cells in the breast parenchyma. Examples include atypical ductal hyperplasia, atypical lobular hyperplasia, and columnar cell hyperplasia with atypia. C5195 Neoplastic Process Breast Atypical Hyperplasia C1297929 Undetermined Atypical_Hyperplasia_of_the_Breast Atypical Breast Hyperplasia Atypical Hyperplasia of Breast Atypical Hyperplasia of the Breast Breast Atypical Hyperplasia Breast Atypical Hyperplasia A usually unilateral, benign and well circumscribed biphasic neoplasm that arises from the breast. It usually affects middle-aged women. It is characterized by the presence of a double layer of epithelial cells that are arranged in clefts, surrounded by a cellular, monomorphic spindle cell mesenchymal component. Mitoses are rare. Necrotic changes may be present in large tumors. C5196 Neoplastic Process Benign Breast Phyllodes Tumor C1332533 Benign Benign_Phyllodes_Tumor_of_the_Breast Benign Breast Phyllodes Tumor Benign Phyllodes Neoplasm of Breast Benign Phyllodes Neoplasm of the Breast Benign Phyllodes Tumor of Breast Benign Phyllodes Tumor of the Breast Breast Benign Phyllodes Neoplasm Benign Breast Phyllodes Tumor A neoplasm that arises from the nipple and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C5197 Neoplastic Process Benign Nipple Neoplasm C1332519 Benign Benign_Nipple_Neoplasm Benign Neoplasm of Nipple Benign Neoplasm of the Nipple Benign Nipple Neoplasm Benign Nipple Tumor Benign Tumor of Nipple Benign Tumor of the Nipple Benign Nipple Neoplasm Benign papillary proliferation within the ductal system of the breast parenchyma. C5200 Neoplastic Process Breast Papillary Ductal Hyperplasia C1335323 Undetermined Papillary_Ductal_Breast_Hyperplasia Breast Papillary Ductal Hyperplasia Papillary Breast Hyperplasia Papillary Duct Hyperplasia of Breast Papillary Duct Hyperplasia of the Breast Papillary Ductal Breast Hyperplasia Papillary Hyperplasia of Breast Papillary Hyperplasia of the Breast Breast Papillary Ductal Hyperplasia A benign breast neoplasm characterized by the presence of multiple intraductal papillomas. C5201 Neoplastic Process Breast Intraductal Papillomatosis C1334247 Benign Breast_Papillomatosis Intraductal_Breast_Papillomatosis Breast Intraductal Papillomatosis Breast Multiple Intraductal Papillomas Breast Intraductal Papillomatosis C52011 Therapeutic or Preventive Procedure Endocrine Surgical Procedure C0038900 Endocrine_Surgical_Procedure Endocrine Surgical Procedure Endocrine Surgical Procedure A benign or malignant papillary neoplasm that arises from the breast. It is characterized by the presence of epithelial proliferations that are supported by fibrovascular cores. Representative examples are intraductal papilloma and papillary carcinoma. C5206 Neoplastic Process Breast Papillary Neoplasm C1335321 Undetermined Papillary_Breast_Neoplasm Breast Papillary Neoplasm Papillary Breast Neoplasm Papillary Breast Tumor Papillary Neoplasm of Breast Papillary Neoplasm of the Breast Papillary Tumor of Breast Papillary Tumor of the Breast Breast Papillary Neoplasm A benign or malignant vascular neoplasm that arises from the breast. C5209 Neoplastic Process Breast Vascular Neoplasm C1336947 Undetermined Vascular_Breast_Neoplasm Breast Vascular Neoplasm Vascular Breast Neoplasm Vascular Breast Tumor Vascular Neoplasm of Breast Vascular Neoplasm of the Breast Vascular Tumor of Breast Vascular Tumor of the Breast Breast Vascular Neoplasm A capillary hemangioma arising from the breast. C5210 Neoplastic Process Breast Capillary Hemangioma C1332619 Benign Breast_Capillary_Hemangioma Breast Capillary Angioma Breast Capillary Hemangioma Capillary Angioma of Breast Capillary Angioma of the Breast Capillary Hemangioma of Breast Capillary Hemangioma of the Breast Breast Capillary Hemangioma A hemangioma that arises from the breast. It is characterized by the presence of epithelioid endothelial cells. C5211 Neoplastic Process Breast Epithelioid Hemangioma C1332627 Benign Breast_Epithelioid_Hemangioma Breast Epithelioid Hemangioma Breast Histiocytoid Hemangioma Epithelioid Breast Hemangioma Epithelioid Hemangioma of Breast Epithelioid Hemangioma of the Breast Histiocytoid Breast Hemangioma Histiocytoid Hemangioma of Breast Histiocytoid Hemangioma of the Breast Breast Epithelioid Hemangioma A benign or malignant neoplasm that arises in the area of the nipple. C5212 Neoplastic Process Nipple Neoplasm C1112166 Undetermined Nipple_Neoplasm Neoplasm of Nipple Neoplasm of the Nipple Nipple Neoplasm Nipple Tumor Tumor of Nipple Tumor of the Nipple Nipple Neoplasm A malignant neoplasm that affects the area of the nipple. C5213 Neoplastic Process Malignant Nipple Neoplasm Malignant Nipple Neoplasm C0859086 CPTAC CTRP Malignant Malignant_Nipple_Neoplasm Malignant neoplasm: Nipple and areola Malignant Neoplasm of Nipple Malignant Neoplasm of the Nipple Malignant Nipple Neoplasm Malignant Nipple Tumor Malignant Tumor of Nipple Malignant Tumor of the Nipple Malignant Nipple Neoplasm The most common histologic type of breast carcinoma. Representative examples include invasive ductal carcinoma not otherwise specified, ductal carcinoma in situ, inflammatory carcinoma, secretory carcinoma, signet ring cell carcinoma, tubular carcinoma, invasive lobular carcinoma, and lobular carcinoma in situ. C5214 Neoplastic Process Breast Adenocarcinoma Breast Adenocarcinoma C0858252 CTRP Cellosaurus Malignant Breast_Adenocarcinoma Adenocarcinoma of Breast Adenocarcinoma of the Breast Breast Adenocarcinoma Mammary adenocarcinoma Breast Adenocarcinoma A thecoma of the ovary that does not metastasize to other anatomic sites. C5219 Neoplastic Process Benign Ovarian Thecoma C1332529 CDISC A benign sex-cord neoplasm of the ovary, originating from theca cells. Benign Benign_Ovarian_Thecoma Benign Ovarian Thecal Cell Neoplasm Benign Ovarian Thecal Cell Tumor Benign Ovarian Thecoma Benign Thecal Cell Neoplasm of Ovary Benign Thecal Cell Neoplasm of the Ovary Benign Thecal Cell Tumor of Ovary Benign Thecal Cell Tumor of the Ovary Benign Thecoma of Ovary Benign Thecoma of the Ovary THECOMA, BENIGN Thecal Cell Tumor, Benign Benign Ovarian Thecoma Stage IA includes: T1a, N0, M0. T1a: Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C5220 Neoplastic Process Stage IA Ovarian Cancer AJCC v6 and v7 Stage IA Ovarian Cancer AJCC v6 and v7 C1336121 CTRP Malignant Stage_IA_Ovarian_Cancer AJCC Stage IA Ovarian Cancer FIGO Stage IA Cancer of Ovary FIGO Stage IA Cancer of the Ovary FIGO Stage IA Carcinoma of Ovary FIGO Stage IA Carcinoma of the Ovary FIGO Stage IA Ovarian Cancer FIGO Stage IA Ovarian Carcinoma Ovarian Cancer Stage IA Stage IA Ovarian Cancer Stage IA Ovarian Cancer AJCC v6 Stage IA Ovarian Cancer AJCC v6 and v7 Stage IA Ovarian Cancer AJCC v7 Stage IA Ovarian Epithelial Cancer Stage IA Ovarian Cancer AJCC v6 and v7 Stage IB includes: T1b, N0, M0. T1b: Tumor limited to both ovaries; capsules intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C5221 Neoplastic Process Stage IB Ovarian Cancer AJCC v6 and v7 Stage IB Ovarian Cancer AJCC v6 and v7 C1336141 CTRP Malignant Stage_IB_Ovarian_Cancer AJCC Stage IB Ovarian Cancer FIGO Stage IB Cancer of Ovary FIGO Stage IB Cancer of the Ovary FIGO Stage IB Carcinoma of Ovary FIGO Stage IB Carcinoma of the Ovary FIGO Stage IB Ovarian Cancer FIGO Stage IB Ovarian Carcinoma Ovarian Cancer Stage IB Stage IB Ovarian Cancer Stage IB Ovarian Cancer AJCC v6 Stage IB Ovarian Cancer AJCC v6 and v7 Stage IB Ovarian Cancer AJCC v7 Stage IB Ovarian Epithelial Cancer Stage IB Ovarian Cancer AJCC v6 and v7 Stage IC includes: T1c, N0, M0. T1c: Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C5222 Neoplastic Process Stage IC Ovarian Cancer AJCC v6 and v7 Stage IC Ovarian Cancer AJCC v6 and v7 C1336150 CTRP Malignant Stage_IC_Ovarian_Cancer AJCC Stage IC Ovarian Cancer FIGO Stage IC Cancer of Ovary FIGO Stage IC Cancer of the Ovary FIGO Stage IC Carcinoma of Ovary FIGO Stage IC Carcinoma of the Ovary FIGO Stage IC Ovarian Cancer FIGO Stage IC Ovarian Carcinoma Ovarian Cancer Stage IC Stage IC Ovarian Cancer Stage IC Ovarian Cancer AJCC v6 Stage IC Ovarian Cancer AJCC v6 and v7 Stage IC Ovarian Cancer AJCC v7 Stage IC Ovarian Epithelial Cancer Stage IC Ovarian Cancer AJCC v6 and v7 Stage IIA includes: T2a, N0, M0. T2a: Extension and/or implants on uterus and/or tube(s). No malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C5223 Neoplastic Process Stage IIA Ovarian Cancer AJCC V6 and v7 Stage IIA Ovarian Cancer AJCC V6 and v7 C1336169 CTRP Malignant Stage_IIA_Ovarian_Cancer AJCC Stage IIA Ovarian Cancer FIGO Stage IIA Cancer of Ovary FIGO Stage IIA Cancer of the Ovary FIGO Stage IIA Carcinoma of Ovary FIGO Stage IIA Carcinoma of the Ovary FIGO Stage IIA Ovarian Cancer FIGO Stage IIA Ovarian Carcinoma Ovarian Cancer Stage IIA Stage IIA Ovarian Cancer Stage IIA Ovarian Cancer AJCC V6 Stage IIA Ovarian Cancer AJCC V6 and v7 Stage IIA Ovarian Cancer AJCC v7 Stage IIA Ovarian Epithelial Cancer Stage IIA Ovarian Cancer AJCC V6 and v7 Stage IIB includes: T2b N0, M0. T2b: Extension and/or implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C5224 Neoplastic Process Stage IIB Ovarian Cancer AJCC v6 and v7 Stage IIB Ovarian Cancer AJCC v6 and v7 C1336192 CTRP Malignant Stage_IIB_Ovarian_Cancer AJCC Stage IIB Ovarian Cancer FIGO Stage IIB Cancer of Ovary FIGO Stage IIB Cancer of the Ovary FIGO Stage IIB Carcinoma of Ovary FIGO Stage IIB Carcinoma of the Ovary FIGO Stage IIB Ovarian Cancer FIGO Stage IIB Ovarian Carcinoma Ovarian Cancer Stage IIB Stage IIB Ovarian Cancer Stage IIB Ovarian Cancer AJCC v6 Stage IIB Ovarian Cancer AJCC v6 and v7 Stage IIB Ovarian Cancer AJCC v7 Stage IIB Ovarian Epithelial Cancer Stage IIB Ovarian Cancer AJCC v6 and v7 Stage IIC includes: T2c, N0, M0. T2c: Pelvic extension and/or implants (T2a or T2b) with malignant cells in ascites or peritoneal washing. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C5225 Neoplastic Process Stage IIC Ovarian Cancer AJCC v6 and v7 Stage IIC Ovarian Cancer AJCC v6 and v7 C1336199 CTRP Malignant Stage_IIC_Ovarian_Cancer AJCC Stage IIC Ovarian Cancer FIGO Stage IIC Cancer of Ovary FIGO Stage IIC Cancer of the Ovary FIGO Stage IIC Carcinoma of Ovary FIGO Stage IIC Carcinoma of the Ovary FIGO Stage IIC Ovarian Cancer FIGO Stage IIC Ovarian Carcinoma Ovarian Cancer Stage IIC Stage IIC Ovarian Cancer Stage IIC Ovarian Cancer AJCC v6 Stage IIC Ovarian Cancer AJCC v6 and v7 Stage IIC Ovarian Cancer AJCC v7 Stage IIC Ovarian Epithelial Cancer Stage IIC Ovarian Cancer AJCC v6 and v7 A low grade serous epithelial neoplasm arising from the ovary. It is characterized by an atypical proliferation of serous-type epithelial cells without evidence of stromal invasion. It is often asymptomatic but rarely it may present with abdominal pain or abdominal enlargement due to rupture or torsion. C5226 Neoplastic Process Borderline Ovarian Serous Tumor Borderline Ovarian Serous Tumor C1332598 CTRP Cellosaurus Uncertain Malignant Potential Borderline_Ovarian_Serous_Neoplasm Serous borderline tumor, NOS Borderline Ovarian Serous Neoplasm Borderline Ovarian Serous Tumor Borderline Serous Neoplasm of Ovary Borderline Serous Neoplasm of the Ovary Borderline Serous Tumor of Ovary Borderline Serous Tumor of the Ovary Ovarian Serous Neoplasm of Low Malignant Potential Ovarian Serous Tumor of Low Malignant Potential Proliferating Ovarian Serous Neoplasm Proliferating Ovarian Serous Tumor Proliferating Serous Neoplasm of Ovary Proliferating Serous Neoplasm of the Ovary Proliferating Serous Tumor of Ovary Proliferating Serous Tumor of the Ovary Serous Neoplasm of Ovary with Low Malignant Potential Serous Neoplasm of the Ovary with Low Malignant Potential Serous Ovarian Neoplasm of Low Malignant Potential Serous Ovarian Tumor of Low Malignant Potential Serous Tumor of Ovary with Low Malignant Potential Serous Tumor of the Ovary with Low Malignant Potential Borderline Ovarian Serous Tumor An adenocarcinoma that arises from the ovary and is characterized by the presence of cystic structures. It includes the serous cystadenocarcinoma, mucinous cystadenocarcinoma, and clear cell cystadenocarcinoma. C5228 Neoplastic Process Ovarian Cystadenocarcinoma C1096638 Cellosaurus Malignant Ovarian_Cystadenocarcinoma Cystadenocarcinoma of Ovary Cystadenocarcinoma of the Ovary Ovarian Cystadenocarcinoma Ovarian Cystadenocarcinoma A rare, well-differentiated neuroendocrine neoplasm that arises from the ovary. C5229 Neoplastic Process Ovarian Neuroendocrine Tumor C1335153 Undetermined Ovarian_Carcinoid_Tumor Carcinoid Tumor of Ovary Carcinoid Tumor of the Ovary Ovarian Carcinoid Tumor Ovarian Neuroendocrine Tumor Ovarian Neuroendocrine Tumor A rare, benign steroid tumor that arises from the ovary and is composed of Leydig cells that contain Reinke crystals. It usually affects postmenopausal women and in most cases, is associated with androgenic manifestations. C5231 Neoplastic Process Ovarian Leydig Cell Tumor C1335164 NICHD A Leydig cell tumor that occurs in the ovary. Benign Ovarian_Leydig_Cell_Tumor Leydig cell tumor of ovary, NOS Leydig Cell Neoplasm of Ovary Leydig Cell Neoplasm of the Ovary Leydig Cell Tumor of Ovary Leydig Cell Tumor of the Ovary Ovarian Leydig Cell Neoplasm Ovarian Leydig Cell Tumor Ovarian Leydig Cell Tumor A malignant vascular neoplasm arising from the ovary. C5232 Neoplastic Process Ovarian Angiosarcoma C1335152 Malignant Ovarian_Angiosarcoma Angiosarcoma of Ovary Angiosarcoma of the Ovary Hemangiosarcoma of Ovary Hemangiosarcoma of the Ovary Ovarian Angiosarcoma Ovarian Hemangiosarcoma Ovarian Angiosarcoma A usually aggressive malignant neoplasm arising from the ovary. It is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation in a herringbone growth pattern. C5233 Neoplastic Process Ovarian Fibrosarcoma C1335161 Cellosaurus Malignant Ovarian_Fibrosarcoma Fibrosarcoma of Ovary Fibrosarcoma of the Ovary Ovarian Fibrosarcoma Ovarian Fibrosarcoma An aggressive malignant smooth muscle neoplasm, arising from the ovary. It is characterized by a proliferation of neoplastic spindle cells. C5234 Neoplastic Process Ovarian Leiomyosarcoma C1335163 Cellosaurus Malignant Ovarian_Leiomyosarcoma Leiomyosarcoma of Ovary Leiomyosarcoma of the Ovary Ovarian Leiomyosarcoma Ovarian Leiomyosarcoma A liposarcoma that arises from the ovary and is composed of round to oval mesenchymal cells, small signet ring lipoblasts, and a rich network of capillaries in a myxoid stroma. C5235 Neoplastic Process Ovarian Myxoid Liposarcoma C1335170 Malignant Ovarian_Myxoid_Liposarcoma Myxoid Liposarcoma of Ovary Myxoid Liposarcoma of the Ovary Ovarian Myxoid Liposarcoma Ovarian Myxoid Liposarcoma A malignant mesenchymal tumor with skeletal muscle differentiation affecting the ovaries. C5236 Neoplastic Process Ovarian Rhabdomyosarcoma C1335176 Malignant Ovarian_Rhabdomyosarcoma Ovarian Rhabdomyosarcoma Rhabdomyosarcoma of Ovary Rhabdomyosarcoma of the Ovary Ovarian Rhabdomyosarcoma An epithelial neoplasm with neuroendocrine differentiation that arises from the ovary. This category includes neuroendocrine tumors and neuroendocrine carcinomas. C5237 Neoplastic Process Ovarian Neuroendocrine Neoplasm C1335172 Undetermined Ovarian_Neuroendocrine_Neoplasm Neuroendocrine Neoplasm of Ovary Neuroendocrine Neoplasm of the Ovary Ovarian Neuroendocrine Neoplasm Ovarian Neuroendocrine Neoplasm A carcinoma that arises from the ovary and is characterized by the presence of large malignant cells exhibiting neuroendocrine differentiation. The prognosis is poor. C5238 Neoplastic Process Ovarian Large Cell Neuroendocrine Carcinoma C1335174 Malignant Ovarian_Non-Small-Cell_Type_Neuroendocrine_Carcinoma Large Cell Neuroendocrine Carcinoma of Ovary Large Cell Neuroendocrine Carcinoma of the Ovary Large-Cell Neuroendocrine Carcinoma of Ovary Large-Cell Neuroendocrine Carcinoma of the Ovary Non-Small-Cell Type Neuroendocrine Carcinoma of Ovary Non-Small-Cell Type Neuroendocrine Carcinoma of the Ovary Ovarian Large Cell NEC Ovarian Large Cell Neuroendocrine Carcinoma Ovarian Non-Small-Cell Type Neuroendocrine Carcinoma Ovarian Large Cell Neuroendocrine Carcinoma A carcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that resemble malignant urothelial cells. C5240 Neoplastic Process Ovarian Transitional Cell Carcinoma Ovarian Transitional Cell Carcinoma C1335184 CTRP Malignant Ovarian_Transitional_Cell_Carcinoma Ovarian Transitional Cell Cancer Ovarian Transitional Cell Carcinoma Transitional Cell Carcinoma of Ovary Transitional Cell Carcinoma of the Ovary Ovarian Transitional Cell Carcinoma A biphasic neoplasm that arises from the ovary or the testis. It is characterized by the presence of neoplastic germ cells and neoplastic sex cord-stromal cells. It includes the gonadoblastoma and mixed germ cell-sex cord stromal tumor, unclassifiable. C5241 Neoplastic Process Mixed Germ Cell-Sex Cord-Stromal Tumor C1321220 GDC NICHD A biphasic tumor that arises from the ovary or the testis. It is characterized by the presence of neoplastic germ cells and neoplastic sex cord-stromal cells; examples include the gonadoblastoma and mixed germ cell-sex cord stromal tumor, unclassifiable. Undetermined Mixed_Germ_Cell-Sex_Cord-Stromal_Tumor 8594/1 Mixed germ cell-sex cord-stromal tumor, NOS Mixed Germ Cell-Sex Cord Neoplasm Mixed Germ Cell-Sex Cord Tumor Mixed Germ Cell-Sex Cord-Stromal Neoplasm Mixed Germ Cell-Sex Cord-Stromal Tumor Mixed Germ Cell-Sex Cord-Stromal Tumor A benign, borderline, or malignant epithelial tumor of the ovary characterized by the presence of neoplastic epithelial cells that contain intracytoplasmic mucin and may resemble the epithelial cells of the endocervix or gastrointestinal tract. C5242 Neoplastic Process Ovarian Mucinous Tumor C1335168 Undetermined Ovarian_Mucinous_Neoplasm Mucinous Neoplasm of Ovary Mucinous Neoplasm of the Ovary Mucinous Tumor of Ovary Mucinous Tumor of the Ovary Ovarian Mucinous Neoplasm Ovarian Mucinous Tumor Ovarian Mucinous Tumor An invasive adenocarcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that contain intracytoplasmic mucin. There is cellular atypia, increased layering of cells, complexity of glands, and papillary formations. C5243 Neoplastic Process Ovarian Mucinous Adenocarcinoma Ovarian Mucinous Adenocarcinoma C1335167 CPTAC CTRP Cellosaurus Malignant Ovarian_Mucinous_Adenocarcinoma Mucinous Adenocarcinoma of Ovary Mucinous Adenocarcinoma of the Ovary Mucinous Carcinoma of Ovary Mucinous Carcinoma of the Ovary Mucinous carcinoma Ovarian Mucinous Adenocarcinoma Ovarian Mucinous Carcinoma Ovarian Mucinous Adenocarcinoma A benign, intermediate, or malignant mesenchymal neoplasm of the ovary. Representative examples include leiomyoma, myxoma, and sarcoma. C5244 Neoplastic Process Ovarian Soft Tissue Neoplasm C1335180 Undetermined Ovarian_Soft_Tissue_Neoplasm Ovarian Soft Tissue Neoplasm Ovarian Soft Tissue Tumor Soft Tissue Neoplasm of Ovary Soft Tissue Neoplasm of the Ovary Soft Tissue Tumor of Ovary Soft Tissue Tumor of the Ovary Ovarian Soft Tissue Neoplasm A myxoma arising from the ovary. C5245 Neoplastic Process Ovarian Myxoma C1335171 Benign Ovarian_Myxoma Myxoma of Ovary Myxoma of the Ovary Ovarian Myxoma Ovarian Myxoma An adenocarcinoma that arises from the gastric cardia. The majority of cases have been reclassified as gastroesophageal junction adenocarcinomas. C5247 Neoplastic Process Gastric Cardia Adenocarcinoma C1333762 Malignant Gastric_Cardia_Adenocarcinoma Adenocarcinoma of Cardia of Stomach Adenocarcinoma of Gastric Cardia Adenocarcinoma of the Cardia of the Stomach Adenocarcinoma of the Gastric Cardia Gastric Cardia Adenocarcinoma Gastric Cardia Adenocarcinoma A variant of gastric adenocarcinoma with more than half of the tumor containing extracellular mucinous pools. C5248 Neoplastic Process Gastric Mucinous Adenocarcinoma Gastric Mucinous Adenocarcinoma C1334809 CPTAC CTRP Cellosaurus Malignant Mucinous_Gastric_Adenocarcinoma Gastric Mucinous Adenocarcinoma Mucinous (Colloid) adenocarcinoma Mucinous Adenocarcinoma of Stomach Mucinous Adenocarcinoma of the Stomach Mucinous Gastric Adenocarcinoma Mucinous Stomach Adenocarcinoma Gastric Mucinous Adenocarcinoma A poorly cohesive gastric adenocarcinoma characterized by malignant cells containing intracytoplasmic mucin. C5250 Neoplastic Process Gastric Signet Ring Cell Adenocarcinoma C1335965 CPTAC Cellosaurus Malignant Signet_Ring_Cell_Gastric_Adenocarcinoma Gastric Signet Ring Cell Adenocarcinoma Gastric Signet-Ring Cell Adenocarcinoma Poorly cohesive carcinoma, including signet ring cell carcinoma Signet Ring Cell Adenocarcinoma of Stomach Signet Ring Cell Adenocarcinoma of the Stomach Signet Ring Cell Gastric Adenocarcinoma Signet Ring Cell Stomach Adenocarcinoma Gastric Signet Ring Cell Adenocarcinoma An extranodal Burkitt lymphoma that arises from the stomach with the bulk of the mass located in the stomach. C5251 Neoplastic Process Gastric Burkitt Lymphoma C1335482 Malignant Primary_Gastric_Burkitt_s_Lymphoma Gastric Burkitt Lymphoma Gastric Burkitt's Lymphoma Primary Burkitt's Lymphoma of Stomach Primary Burkitt's Lymphoma of the Stomach Primary Gastric Burkitt's Lymphoma Gastric Burkitt Lymphoma An extranodal diffuse large B-cell lymphoma that arises from the stomach with the bulk of the mass located in the stomach. C5253 Neoplastic Process Gastric Diffuse Large B-Cell Lymphoma C1335483 Malignant Primary_Gastric_Diffuse_Large_B-Cell_Lymphoma Gastric Diffuse Large B-Cell Lymphoma Primary Diffuse Large B-Cell Gastric Lymphoma Primary Diffuse Large B-Cell Lymphoma of Stomach Primary Diffuse Large B-Cell Lymphoma of the Stomach Primary Gastric DLBCL Primary Gastric Diffuse Large B-Cell Lymphoma Gastric Diffuse Large B-Cell Lymphoma A rare, extranodal T-cell non-Hodgkin lymphoma that arises from the stomach with the bulk of the mass located in the stomach. C5254 Neoplastic Process Gastric T-Cell Non-Hodgkin Lymphoma C1335484 Malignant Primary_Gastric_T-Cell_Non-Hodgkin_s_Lymphoma Gastric T-Cell Non-Hodgkin Lymphoma Gastric T-Cell Non-Hodgkin's Lymphoma Primary Gastric T-Cell Lymphoma Primary Gastric T-Cell Non-Hodgkin's Lymphoma Primary T-Cell Lymphoma of Stomach Primary T-Cell Lymphoma of the Stomach Gastric T-Cell Non-Hodgkin Lymphoma An immature teratoma that arises from the stomach. C5256 Neoplastic Process Gastric Immature Teratoma C1334151 Undetermined Immature_Gastric_Teratoma Gastric Immature Teratoma Immature Gastric Teratoma Gastric Immature Teratoma A rare benign adipose tissue neoplasm of the stomach. Clinical presentation includes obstruction and gastrointestinal bleeding. Gastric lipomas occur as solitary lesions most frequently in the antrum. C5258 Neoplastic Process Gastric Lipoma C1333777 Benign Gastric_Lipoma Gastric Lipoma Lipoma of Stomach Lipoma of the Stomach Gastric Lipoma A mature or immature teratoma that arises from the stomach. C5259 Neoplastic Process Gastric Teratoma C1333790 Undetermined Gastric_Teratoma Gastric Teratoma Teratoma of Stomach Teratoma of the Stomach Gastric Teratoma A benign teratoma that arises from the stomach. It contains mature tissue elements only. C5260 Neoplastic Process Mature Gastric Teratoma C1334635 Cellosaurus Benign Mature_Gastric_Teratoma Mature Gastric Teratoma Mature Teratoma of Stomach Mature Teratoma of the Stomach Mature Gastric Teratoma An extranodal marginal zone lymphoma that arises from the lung. It is characterized by the neoplastic proliferation of small B-lymphocytes, monocytoid cells and cells with plasma cell differentiation in the marginal zones of reactive lymphoid follicles. The neoplastic cells infiltrate the interfollicular areas and the bronchial epithelium forming lymphoepithelial lesions. The neoplasm is usually discovered as a mass in a chest x-ray in asymptomatic patients. When symptoms occur, they include cough, dyspnea, hemoptysis, and chest pain. If the lung lesions are resectable, surgery can result in prolonged remission. C5264 Neoplastic Process Lung Mucosa-Associated Lymphoid Tissue Lymphoma Lung Mucosa-Associated Lymphoid Tissue Lymphoma C1367652 CTRP GDC Malignant Bronchial_Mucosa-Associated_Lymphoid_Tissue_Lymphoma 9699/3 BALT lymphoma Bronchial-associated lymphoid tissue lymphoma BALT Lymphoma BALT lymphoma BALToma Bronchial MALT Lymphoma Bronchial Mucosa-Associated Lymphoid Tissue Lymphoma Bronchial-associated lymphoid tissue lymphoma Bronchus-Associated Lymphoid Tissue Lymphoma Lung Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Lung MALT Lymphoma Lung Mucosa-Associated Lymphoid Tissue Lymphoma Pulmonary Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Pulmonary MALT Lymphoma Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Lung Mucosa-Associated Lymphoid Tissue Lymphoma A lymphoma primarily involving the thyroid gland. The vast majority of cases are B-cell non-Hodgkin lymphomas. Hodgkin lymphomas involving the thyroid gland are exceedingly rare. C5265 Neoplastic Process Thyroid Gland Lymphoma C0349668 Malignant Thyroid_Lymphoma Lymphoma of Thyroid Lymphoma of Thyroid Gland Lymphoma of the Thyroid Lymphoma of the Thyroid Gland Primary Thyroid Gland Lymphoma Thyroid Gland Lymphoma Thyroid Lymphoma Thyroid Gland Lymphoma A low grade, indolent B-cell lymphoma, usually associated with Helicobacter pylori infection. Morphologically it is characterized by a dense mucosal atypical lymphocytic (centrocyte-like cell) infiltrate with often prominent lymphoepithelial lesions and plasmacytic differentiation. Approximately 40% of gastric MALT lymphomas carry the t(11;18)(q21;q21). Such cases are resistant to Helicobacter pylori therapy. C5266 Neoplastic Process Gastric Mucosa-Associated Lymphoid Tissue Lymphoma C1333782 Malignant Gastric_Mucosa-Associated_Lymphoid_Tissue_Lymphoma Gastric MALT Lymphoma Gastric MALToma Gastric Mucosa-Associated Lymphoid Tissue Lymphoma MALT Lymphoma of Stomach MALT Lymphoma of the Stomach MALToma of Stomach MALToma of the Stomach Primary Gastric B-Cell MALT Lymphoma Primary Gastric MALT Lymphoma Primary MALT Lymphoma of Stomach Primary MALT Lymphoma of the Stomach Gastric Mucosa-Associated Lymphoid Tissue Lymphoma A meningioma that affects the falx cerebri. C5267 Neoplastic Process Falx Cerebri Meningioma C1333597 Undetermined Falx_Meningioma Cerebral Falx Meningioma Falcine Meningioma Falx Cerebri Meningioma Meningioma of Cerebral Falx Meningioma of Falx Cerebri Meningioma of Falx of Cerebrum Meningioma of the Cerebral Falx Meningioma of the Falx Cerebri Meningioma of the Falx of the Cerebrum Falx Cerebri Meningioma A meningioma that affects the cavernous sinus. C5268 Neoplastic Process Cavernous Sinus Meningioma C1332865 Undetermined Cavernous_Sinus_Meningioma Cavernous Sinus Meningioma Meningioma of Cavernous Sinus Meningioma of the Cavernous Sinus Cavernous Sinus Meningioma A cystic meningioma that grows within the cerebral hemispheres. C5269 Neoplastic Process Intracerebral Cystic Meningioma C1334236 Undetermined Intracerebral_Cystic_Meningioma Intracerebral Cystic Meningioma Intracerebral Cystic Meningioma A papillary meningioma that affects the cerebellum. C5270 Neoplastic Process Cerebellar Papillary Meningioma C1332902 Malignant Cerebellar_Papillary_Meningioma Cerebellar Papillary Meningioma Papillary Meningioma of Cerebellum Papillary Meningioma of the Cerebellum Cerebellar Papillary Meningioma A meningioma that affects the petrous apex. C5271 Neoplastic Process Petrous Apex Meningioma C1335396 Undetermined Petrous_Apex_Meningioma Meningioma of Petrous Apex Meningioma of Petrous Ridge Meningioma of the Petrous Apex Meningioma of the Petrous Ridge Petrous Apex Meningioma Petrous Ridge Meningioma Petrous Apex Meningioma The skin covering the membrane that covers and protects each eye. C52718 Anatomical Structure Eyelid Skin C0222088 Eyelid_Skin Eyelid Skin Eyelid Skin The skin covering the toes. C52719 Anatomical Structure Foot Digit Skin C1708089 Foot_Digit_Skin Foot Digit Skin Foot Digit Skin A meningioma that arises from the skull base. C5272 Neoplastic Process Skull Base Meningioma C1335976 Undetermined Skull_Base_Meningioma Meningioma of Skull Base Meningioma of the Skull Base Skull Base Meningioma Skull Base Meningioma The skin covering the fingers or appendages of the hand. C52720 Anatomical Structure Hand Digit Skin C0222234 CDISC The integument that covers the finger. Hand_Digit_Skin Hand Digit Skin SKIN OF THE FINGER Skin of the Finger Hand Digit Skin A meningioma that affects the ventricles of the brain. C5273 Neoplastic Process Intraventricular Meningioma C1334271 Undetermined Intraventricular_Meningioma Intraventricular Meningioma Intraventricular Meningioma A meningioma that has spread from its original site of growth to another anatomic site. C5274 Neoplastic Process Metastatic Meningioma C1334722 Malignant Metastatic_Meningioma Metastatic Meningioma Metastatic Meningioma The skin or integument surrounding the leg. C52749 Anatomical Structure Leg Skin C0222279 CDISC The integument that covers the leg. Leg_Skin LEG SKIN Leg Skin Leg Skin Multiple meningiomas that arises from the spinal meninges. C5275 Neoplastic Process Multiple Intraspinal Meningiomas C1334825 Undetermined Multiple_Intraspinal_Meningiomas Multiple Intraspinal Meningiomas Multiple Meningiomas of Spinal Canal and Spinal Cord Multiple Meningiomas of the Spinal Canal and Spinal Cord Multiple Spinal Canal and Spinal Cord Meningiomas Multiple Intraspinal Meningiomas The skin covering the foot. C52750 Anatomical Structure Foot Skin C0222289 CDISC The integument that covers the foot. Foot_Skin Foot Skin SKIN OF THE FOOT Foot Skin The skin that surrounds the tissues of the ankle joint. C52751 Anatomical Structure Ankle Skin C0222286 Ankle_Skin Ankle Skin Ankle Skin The integumentary covering of one or both wrists. C52752 Anatomical Structure Wrist Skin C0222223 Wrist_Skin Wrist Skin Wrist Skin The skin covering the distal portion of the upper extremity. C52753 Anatomical Structure Hand Skin C0222224 CDISC The integument that covers the hand. Hand_Skin Hand Skin SKIN OF THE HAND Skin Of The Hand Hand Skin The skin or integument covering the arm. C52754 Anatomical Structure Arm Skin C0222204 CDISC The integument that covers the arm. Arm_Skin ARM SKIN Arm Skin Arm Skin The skin of the hinge joint that is located between the forearm and upper arm. C52755 Anatomical Structure Elbow Skin C0222213 CDISC The integument that covers the elbow joint. Elbow_Skin Elbow Skin SKIN OF THE ELBOW Elbow Skin The integumentary covering of the neck. C52756 Anatomical Structure Neck Skin C0205030 CDISC The integument that covers the neck. Neck_Skin Neck Skin SKIN OF THE NECK Neck Skin The integument that covers the head, including the face and scalp. C52757 Anatomical Structure Head Skin C0205029 CDISC The integument that covers the head, including the face and scalp. Head_Skin Head Skin SKIN OF THE HEAD Head Skin The skin or integument surrounding the abdomen. C52758 Body Part, Organ, or Organ Component Abdominal Skin C0222166 CDISC mCode The integument that covers the abdomen. Abdominal_Skin ABDOMINAL SKIN Abdomen Skin Abdominal Skin Skin structure of anterior abdominal wall (body structure) Abdominal Skin A rare meningioma that is present in the lung without clinical or radiologic evidence of central nervous system involvement. C5276 Neoplastic Process Primary Lung Meningioma C1335488 Undetermined Primary_Lung_Meningioma Primary Lung Meningioma Primary Meningioma of Lung Primary Meningioma of the Lung Primary Pulmonary Meningioma Primary Lung Meningioma A rare extracranial meningioma that arises from the skin. C5277 Neoplastic Process Primary Cutaneous Meningioma C1335481 Undetermined Primary_Cutaneous_Meningioma Primary Cutaneous Meningioma Primary Meningioma of Skin Primary Meningioma of the Skin Primary Skin Meningioma Primary Cutaneous Meningioma A meningioma that affects the petroclival region. C5278 Neoplastic Process Petroclival Meningioma C1335395 Undetermined Petroclival_Meningioma Petroclival Meningioma Petroclival Meningioma Multiple meningiomas that affect the skull base. C5279 Neoplastic Process Multiple Skull Base Meningiomas C1334829 Undetermined Multiple_Skull_Base_Meningioma Multiple Skull Base Meningiomas Multiple Skull Base Meningiomas A meningioma that affects the foramen magnum. C5280 Neoplastic Process Foramen Magnum Meningioma C1333630 Undetermined Foramen_Magnum_Meningioma Foramen Magnum Meningioma Meningioma of Foramen Magnum Meningioma of the Foramen Magnum Foramen Magnum Meningioma A meningioma that affects the anterior foramen magnum. C5281 Neoplastic Process Anterior Foramen Magnum Meningioma C1332302 Undetermined Anterior_Foramen_Magnum_Meningioma Anterior Foramen Magnum Meningioma Meningioma of Anterior Foramen Magnum Meningioma of the Anterior Foramen Magnum Anterior Foramen Magnum Meningioma A meningioma that affects the posterior foramen magnum. C5282 Neoplastic Process Posterior Foramen Magnum Meningioma C1335449 Undetermined Posterior_Foramen_Magnum_Meningioma Meningioma of Posterior Foramen Magnum Meningioma of the Posterior Foramen Magnum Posterior Foramen Magnum Meningioma Posterior Foramen Magnum Meningioma A meningioma that arises from the diaphragma sellae. C5283 Neoplastic Process Diaphragma Sellae Meningioma C1333283 Undetermined Diaphragma_Sellae_Meningioma Diaphragm Sellae Meningioma Diaphragma Sellae Meningioma Meningioma of Diaphragm Sellae Meningioma of Diaphragma Sellae Meningioma of the Diaphragm Sellae Meningioma of the Diaphragma Sellae Diaphragma Sellae Meningioma A meningioma that arises from the tuberculum sellae. C5284 Neoplastic Process Tuberculum Sellae Meningioma C1336829 Undetermined Tuberculum_Sellae_Meningioma Meningioma of Tuberculum Sellae Meningioma of the Tuberculum Sellae Tuberculum Sellae Meningioma Tuberculum Sellae Meningioma A meningioma that affects the sphenoorbital region. C5285 Neoplastic Process Sphenoorbital Meningioma C1336040 Undetermined Sphenoorbital_Meningioma Sphenoorbital Meningioma Sphenoorbital Meningioma A meningioma that affects the anterior cranial fossa. C5286 Neoplastic Process Anterior Cranial Fossa Meningioma C1332301 Undetermined Anterior_Cranial_Fossa_Meningioma Anterior Cranial Fossa Meningioma Anterior Fossa Meningioma Meningioma of Anterior Cranial Fossa Meningioma of Anterior Fossa Meningioma of the Anterior Cranial Fossa Meningioma of the Anterior Fossa Anterior Cranial Fossa Meningioma A clear cell meningioma arising in multiple areas of the spinal cord characterized by the presence of clear glycogen-rich polygonal cells. C5287 Neoplastic Process Spinal Multifocal Clear Cell Meningioma C1336051 Undetermined Spinal_Multifocal_Clear_Cell_Meningioma Multifocal Clear Cell Meningioma of Spine Multifocal Clear Cell Meningioma of the Spine Spinal Multifocal Clear Cell Meningioma Spinal Multifocal Clear Cell Meningioma A meningioma that affects the lower clivus. C5288 Neoplastic Process Lower Clivus Meningioma C1334434 Undetermined Lower_Clivus_Meningioma Lower Clivus Meningioma Meningioma of Lower Clivus Meningioma of the Lower Clivus Lower Clivus Meningioma A meningioma that affects the clivus. C5289 Neoplastic Process Clivus Meningioma C1333073 Undetermined Clivus_Meningioma Clivus Meningioma Meningioma of Clivus Meningioma of the Clivus Clivus Meningioma A meningioma that affects the upper clivus. C5290 Neoplastic Process Upper Clivus Meningioma C1336871 Undetermined Upper_Clivus_Meningioma Meningioma of Upper Clivus Meningioma of the Upper Clivus Upper Clivus Meningioma Upper Clivus Meningioma A meningioma that arises within the cranial cavity and results from exposure to radiation. C5291 Neoplastic Process Radiation-Induced Intracranial Meningioma C1335658 Undetermined Radiation-Induced_Intracranial_Meningioma Radiation-Induced Intracranial Meningioma Radiation-Induced Intracranial Meningioma A meningioma that affects the frontal sulcus. C5292 Neoplastic Process Frontal Convexity Meningioma C1333643 Undetermined Frontal_Convexity_Meningioma Frontal Convexity Meningioma Frontal Convexity Meningioma A meningioma that affects the jugular foramen. C5293 Neoplastic Process Jugular Foramen Meningioma C1334298 Undetermined Jugular_Foramen_Meningioma Jugular Foramen Meningioma Meningioma of Jugular Foramen Meningioma of the Jugular Foramen Jugular Foramen Meningioma A meningioma that is associated with deletion of chromosomal arm 1p. C5294 Neoplastic Process Deletion of the Short Arm of Chromosome 1 (1p) Associated Meningioma Deletion of the Short Arm of Chromosome 1 (1p) Associated Meningioma C1333271 CTRP Undetermined Deletions_of_the_Short_Arm_of_Chromosome_1_1p_Associated_Meningiomas Deletion of Short Arm of Chromosome 1 (1p) Associated Meningioma Deletion of the Short Arm of Chromosome 1 (1p) Associated Meningioma Deletion of the Short Arm of Chromosome 1 (1p) Associated Meningioma A morphologic variant of meningioma arising from the brain stem. It is characterized by the presence of clear glycogen-rich polygonal cells. C5295 Neoplastic Process Brain Stem Intraparenchymal Clear Cell Meningioma C1332612 Undetermined Brain_Stem_Intraparenchymal_Clear_Cell_Meningioma Brain Stem Intraparenchymal Clear Cell Meningioma Brainstem Intraparenchymal Clear Cell Meningioma Intraparenchymal Clear Cell Meningioma of Brainstem Intraparenchymal Clear Cell Meningioma of the Brainstem Brain Stem Intraparenchymal Clear Cell Meningioma A meningioma that arises from the meninges of the cervical region of the spinal cord. C5296 Neoplastic Process Cervical Intraspinal Meningioma C1332916 Undetermined Cervical_Intraspinal_Meningioma Cervical Intraspinal Meningioma Cervical Spinal Canal and Spinal Cord Meningioma Meningioma of Cervical Spinal Canal and Spinal Cord Meningioma of the Cervical Spinal Canal and Spinal Cord Cervical Intraspinal Meningioma A meningioma that arises from the meninges of the thoracic region of the spinal cord. C5297 Neoplastic Process Thoracic Intraspinal Meningioma C1336738 Undetermined Thoracic_Intraspinal_Meningioma Meningioma of Thoracic Spinal Canal and Spinal Cord Meningioma of the Thoracic Spinal Canal and Spinal Cord Thoracic Intraspinal Meningioma Thoracic Spinal Canal and Spinal Cord Meningioma Thoracic Intraspinal Meningioma A meningioma that arises from the meninges of the lumbar region of the spinal cord. C5298 Neoplastic Process Lumbar Intraspinal Meningioma C1334436 Undetermined Lumbar_Intraspinal_Meningioma Lumbar Intraspinal Meningioma Lumbar Spinal Canal and Spinal Cord Meningioma Meningioma of Lumbar Spinal Canal and Spinal Cord Meningioma of the Lumbar Spinal Canal and Spinal Cord Lumbar Intraspinal Meningioma A meningioma that arises from the meninges of the sacral region of the spinal cord. C5299 Neoplastic Process Sacral Intraspinal Meningioma C1335893 Undetermined Sacral_Intraspinal_Meningioma Meningioma of Sacral Spinal Canal and Spinal Cord Meningioma of the Sacral Spinal Canal and Spinal Cord Sacral Intraspinal Meningioma Sacral Spinal Canal and Spinal Cord Meningioma Sacral Intraspinal Meningioma A meningioma that affects the cerebellopontine angle. C5300 Neoplastic Process Cerebellopontine Angle Meningioma C1263882 Undetermined Cerebellopontine_Angle_Meningioma C-P Angle Meningioma Cerebellar Pontine Angle Meningioma Cerebellopontine Angle Meningioma Meningioma of C-P Angle Meningioma of Cerebellar Pontine Angle Meningioma of Cerebellopontine Angle Meningioma of the C-P Angle Meningioma of the Cerebellar Pontine Angle Meningioma of the Cerebellopontine Angle Cerebellopontine Angle Meningioma A meningioma that is transmitted from the parents to an offspring. C5301 Neoplastic Process Hereditary Meningioma Hereditary Meningioma C1333989 CTRP Undetermined Hereditary_Meningioma Familial Meningioma Hereditary Meningioma Hereditary Meningioma A meningioma that affects the lateral ventricle of the brain. C5302 Neoplastic Process Lateral Ventricle Meningioma C1334380 Undetermined Lateral_Ventricle_Meningioma Lateral Ventricle Meningioma Meningioma of Lateral Ventricle Meningioma of the Lateral Ventricle Lateral Ventricle Meningioma An ectopic meningioma that arises from the parapharyngeal space. C5303 Neoplastic Process Primary Parapharyngeal Meningioma C1335345 Undetermined Parapharyngeal_Meningioma Primary Parapharyngeal Meningioma Primary Parapharyngeal Meningioma Meningiomas that affects both optic nerves. C5304 Neoplastic Process Bilateral Optic Nerve Meningioma C1332551 Undetermined Bilateral_Optic_Nerve_Meningioma Bilateral Meningioma of Optic Nerve Bilateral Meningioma of the Optic Nerve Bilateral Optic Nerve Meningioma Bilateral Optic Nerve Meningioma A meningioma that is associated with deletion of chromosome 22. This abnormality is the most consistent cytogenetic finding that is detected in meningiomas. C5305 Neoplastic Process Deletion of Chromosome 22 Associated Meningioma Deletion of Chromosome 22 Associated Meningioma C1333269 CTRP Undetermined Deletions_of_Chromosome_22_Associated_Meningiomas Deletion of Chromosome 22 Associated Meningioma Deletion of Chromosome 22 Associated Meningioma A meningioma that is associated with deletion of chromosomal arm 3p. C5306 Neoplastic Process Deletion of Chromosome 3p Associated Meningioma Deletion of Chromosome 3p Associated Meningioma C1333270 CTRP Undetermined Deletions_of_Chromosome_3p_Associated_Meningiomas Deletion of Chromosome 3p Associated Meningioma Deletion of Chromosome 3p Associated Meningioma A meningioma that affects the internal auditory canal. C5307 Neoplastic Process Internal Auditory Canal Meningioma C1334227 Undetermined Internal_Auditory_Canal_Meningioma Internal Auditory Canal Meningioma Meningioma of Internal Auditory Canal Meningioma of the Internal Auditory Canal Internal Auditory Canal Meningioma A meningothelial neoplasm that arises from an anatomic site outside the intracranial and intraspinal compartments. C5308 Neoplastic Process Ectopic Meningioma C1333373 Undetermined Ectopic_Meningioma Ectopic Meningioma Primary Ectopic Meningioma Ectopic Meningioma An extremely rare meningioma that arises as a primary ectopic tumor in the ethmoid sinus. C5309 Neoplastic Process Ethmoid Sinus Primary Ectopic Meningioma C1333475 Undetermined Ethmoid_Sinus_Primary_Ectopic_Meningioma Ethmoid Sinus Primary Ectopic Meningioma Ethmoidal Sinus Primary Ectopic Meningioma Primary Ectopic Meningioma of Ethmoid Sinus Primary Ectopic Meningioma of Ethmoidal Sinus Primary Ectopic Meningioma of the Ethmoid Sinus Primary Ectopic Meningioma of the Ethmoidal Sinus Ethmoid Sinus Primary Ectopic Meningioma A meningioma that arises in the epidural spinal canal space. C5310 Neoplastic Process Epidural Spinal Canal Meningioma C1333417 Undetermined Epidural_Spinal_Canal_Meningioma Epidural Spinal Canal Meningioma Meningioma of Epidural Spinal Canal Meningioma of the Epidural Spinal Canal Epidural Spinal Canal Meningioma A meningioma that affects the pituitary stalk. C5311 Neoplastic Process Pituitary Stalk Meningioma C1335422 Undetermined Pituitary_Stalk_Meningioma Meningioma of Pituitary Stalk Meningioma of the Pituitary Stalk Pituitary Stalk Meningioma Pituitary Stalk Meningioma The reemergence of a meningioma after a period of remission. C5312 Neoplastic Process Recurrent Meningioma Recurrent Meningioma C1335713 CTRP Undetermined Recurrent_Meningioma Recurrent Meningioma Relapsed Meningioma Recurrent Meningioma A meningioma that affects the sphenocavernous region. C5313 Neoplastic Process Sphenocavernous Meningioma C1336036 Undetermined Sphenocavernous_Meningioma Sphenocavernous Meningioma Sphenocavernous Meningioma Lymph node located within the fat layer of the knee joint. C53146 Anatomical Structure Popliteal Lymph Node C0588057 CDISC GDC PCDC UBERON Lymph node(s) adjacent to the femorotibial joint. The lymph nodes which drain the legs; contained in the popliteal fossa. Popliteal_Lymph_Node Lymph Node(s) Popliteal Popliteal UBERON:0001543 LYMPH NODE, POPLITEAL Lymph Node(s) Popliteal POPLITEAL LYMPH NODE Popliteal Lymph Node Popliteal Nodes popliteal lymph node Popliteal Lymph Node A phyllodes tumor of the breast characterized by the presence of intermediate features and a stroma which usually resembles low grade fibrosarcoma. C5316 Neoplastic Process Borderline Breast Phyllodes Tumor C1332592 Uncertain Malignant Potential Borderline_Breast_Phyllodes_Tumor Borderline Breast Phyllodes Neoplasm Borderline Breast Phyllodes Tumor Borderline Phyllodes Neoplasm of Breast Borderline Phyllodes Neoplasm of the Breast Borderline Phyllodes Tumor of Breast Borderline Phyllodes Tumor of the Breast Low Grade Malignant Breast Phyllodes Tumor Borderline Breast Phyllodes Tumor A melanoma that arises from leptomeningeal melanocytes. C5317 Neoplastic Process Meningeal Melanoma C1332888 C1334386 GDC Malignant Central_Nervous_System_Melanoma Leptomeningeal_Melanoma Meningeal melanoma Central Nervous System Melanoma Leptomeningeal Melanoma Melanoma of Leptomeninges Melanoma of the Leptomeninges Meningeal Melanoma Meningeal melanoma Primary Central Nervous System Melanoma Meningeal Melanoma A melanoma that arises from leptomeningeal melanocytes and occurs during childhood. C5318 Neoplastic Process Childhood Meningeal Melanoma C1332976 NICHD A melanoma that arises from leptomeningeal melanocytes during childhood. Malignant Childhood_Leptomeningeal_Melanoma Childhood Central Nervous System Melanoma Childhood Leptomeningeal Melanoma Childhood Meningeal Melanoma Childhood Primary Central Nervous System Melanoma Pediatric Central Nervous System Melanoma Pediatric Leptomeningeal Melanoma Pediatric Meningeal Melanoma Pediatric Primary Central Nervous System Melanoma Childhood Meningeal Melanoma A melanoma that arises from leptomeningeal melanocytes and occurs during adulthood. C5319 Neoplastic Process Adult Meningeal Melanoma C1332204 Malignant Adult_Leptomeningeal_Melanoma Adult Central Nervous System Melanoma Adult Leptomeningeal Melanoma Adult Meningeal Melanoma Adult Primary Central Nervous System Melanoma Adult Meningeal Melanoma A malignant vascular neoplasm arising from the peripheral nerves. C5320 Neoplastic Process Peripheral Intraneural Angiosarcoma C1335388 Malignant Peripheral_Intraneural_Angiosarcoma Peripheral Intraneural Angiosarcoma Peripheral Intraneural Hemangiosarcoma Peripheral Intraneural Angiosarcoma The rarest histopathologic subtype of Schwannoma. The reported cases have been located in the gastrointestinal submucosa or subcutaneous tissue. Morphologically it is characterized by the presence of a microcyst-rich network of spindle cells with minimal amount of cytoplasm and Antoni A tissue. C5321 Neoplastic Process Microcystic/Reticular Schwannoma C4054526 Benign Macrocystic_Schwannoma Microcystic/Reticular Schwannoma Microcystic/Reticular Schwannoma An anaplastic large cell lymphoma that affects the brain, meninges, or spinal cord. C5322 Neoplastic Process Central Nervous System Anaplastic Large Cell Lymphoma C1335476 Malignant Primary_Central_Nervous_System_Anaplastic_Large_Cell_Lymphoma Anaplastic CNS Large Cell Lymphoma Anaplastic Central Nervous System Large Cell Lymphoma Anaplastic Large Cell Lymphoma of CNS Anaplastic Large Cell Lymphoma of Central Nervous System Anaplastic Large Cell Lymphoma of the CNS Anaplastic Large Cell Lymphoma of the Central Nervous System Central Nervous System Anaplastic Large Cell Lymphoma Primary CNS Anaplastic Large Cell Lymphoma Primary Central Nervous System Anaplastic Large Cell Lymphoma Central Nervous System Anaplastic Large Cell Lymphoma A rare intracranial schwannoma that affects the jugular foramen. C5323 Neoplastic Process Jugular Foramen Schwannoma C1334300 Benign Jugular_Foramen_Schwannoma Jugular Foramen Neurilemmoma Jugular Foramen Schwannoma Neurilemmoma of Jugular Foramen Neurilemmoma of the Jugular Foramen Schwannoma of Jugular Foramen Schwannoma of the Jugular Foramen Jugular Foramen Schwannoma A slow-growing, well-differentiated neuroendocrine neoplasm arising from the cauda equina. C5324 Neoplastic Process Cauda Equina Neuroendocrine Tumor C1332860 Undetermined Cauda_Equina_Paraganglioma Cauda Equina Neuroendocrine Tumor Cauda Equina Neuroendocrine Tumor (Previously Paraganglioma) Cauda Equina Paraganglioma Paraganglioma of Cauda Equina Paraganglioma of Filum Terminale Paraganglioma of the Cauda Equina Paraganglioma of the Filum Terminale Spinal Paraganglioma Cauda Equina Neuroendocrine Tumor A usually indolent neuroendocrine neoplasm that arises in the intestine. Patients may present with gastrointestinal hemorrhage. It is a triphasic tumor consisting of a mixture of epithelioid neuroendocrine cells, Schwann-like cells, and ganglion cell-like elements. C5325 Neoplastic Process Intestinal Composite Gangliocytoma/Neuroma and Neuroendocrine Tumor C1334232 8683/0 Undetermined Intestinal_Paraganglioma Gangliocytic Intestinal Paraganglioma Gangliocytic Paraganglioma of Intestine Gangliocytic Paraganglioma of the Intestine Intestinal Composite Gangliocytoma/Neuroma and Neuroendocrine Tumor Intestinal Gangliocytic Neuroendocrine Tumor Intestinal Gangliocytic Paraganglioma Intestinal Mixed Ganglioneuroma-Neuroendocrine Neoplasm Intestinal Composite Gangliocytoma/Neuroma and Neuroendocrine Tumor An extra-adrenal paraganglioma arising from the abdominal cavity. C5326 Neoplastic Process Intra-Abdominal Paraganglioma C1334235 Undetermined Intra-Abdominal_Paraganglioma Intra-Abdominal Paraganglioma Paraganglioma of Intra-Abdominal Area Paraganglioma of the Intra-Abdominal Area Intra-Abdominal Paraganglioma Relevant elements of medical history, including preexisting medical conditions, events and facts (e.g., allergies, race, pregnancy, smoking and alcohol use, hepatic/renal dysfunction, etc.) not listed in MedWatch form. C53263 Clinical Attribute Other Personal Medical History C1709357 FDA Other_Personal_Medical_History OTHER PERSONAL MEDICAL HISTORY Other Medical History Other Personal Medical History Other Relevant Medical History Other Personal Medical History A paraganglioma arising from paraganglia in the head and neck. Representative examples include the carotid body and jugulotympanic paragangliomas. C5327 Neoplastic Process Head and Neck Paraganglioma C1868636 Undetermined Head_and_Neck_Paraganglioma Head and Neck Paraganglioma Paraganglioma of Head and Neck Paraganglioma of the Head and Neck Head and Neck Paraganglioma The integumentary covering of the upper and lower extremities. C53276 Anatomical Structure Skin of the Extremity C1282135 Skin_of_the_Extremity Skin of the Extremity Skin of the Limb Skin of the Extremity A sympathetic paraganglioma arising from the retroperitoneum, outside the adrenal gland. C5328 Neoplastic Process Extra-Adrenal Retroperitoneal Paraganglioma C1333495 Cellosaurus Undetermined Extra-Adrenal_Retroperitoneal_Paragangliomas Extra-Adrenal Retroperitoneal Paraganglioma Paraganglioma of Extra-Adrenal Retroperitoneal Area Paraganglioma of the Extra-Adrenal Retroperitoneal Area Extra-Adrenal Retroperitoneal Paraganglioma A clinical stage I or II non-Hodgkin lymphoma without any of the following risk factors: large mediastinal mass, extranodal spread, elevated erythrocyte sedimentation rate, involvement of at least three lymph node areas, and B symptoms. C53280 Neoplastic Process Early Favorable Non-Hodgkin Lymphoma C1711314 Malignant Early_Favorable_Non-Hodgkin_s_Lymphoma Early Favorable Non-Hodgkin Lymphoma Early Favorable Non-Hodgkin's Lymphoma Early Favorable Non-Hodgkin Lymphoma A clinical stage I or II non-Hodgkin lymphoma with at least one of the following risk factors: large mediastinal mass, extranodal spread, elevated erythrocyte sedimentation rate, involvement of at least three lymph node areas, and B symptoms. C53282 Neoplastic Process Early Unfavorable Non-Hodgkin Lymphoma C1707876 Malignant Early_Unfavorable_Non-Hodgkin_s_Lymphoma Early Unfavorable Non-Hodgkin Lymphoma Early Unfavorable Non-Hodgkin's Lymphoma Early Unfavorable Non-Hodgkin Lymphoma A clinical stage II or IV non-Hodgkin lymphoma with up to three of the following risk factors: albumin level less than 4.0 g/dl, hemoglobin level of less than 10.5 g/dl, male sex, forty-five years of age or older, stage IV disease, white cell count of at least 15,000 per cubic millimeter, absolute lymphocytic count of less than 600 per cubic millimeter or a lymphocytic count of less than 8% of the total white cell count. C53283 Neoplastic Process Advanced Favorable Non-Hodgkin Lymphoma C1706733 Malignant Advanced_Favorable_Non-Hodgkin_s_Lymphoma Advanced Favorable Non-Hodgkin Lymphoma Advanced Favorable Non-Hodgkin's Lymphoma Advanced Favorable Non-Hodgkin Lymphoma A clinical stage II or IV non-Hodgkin lymphoma with at least four of the following risk factors: albumin level less than 4.0 g/dl, hemoglobin level of less than 10.5 g/dl, male sex, forty-five years of age or older, stage IV disease, white cell count of at least 15,000 per cubic millimeter, absolute lymphocytic count of less than 600 per cubic millimeter or a lymphocytic count of less than 8% of the total white cell count. C53284 Neoplastic Process Advanced Unfavorable Non-Hodgkin Lymphoma C1706734 Malignant Advanced_Unfavorable_Non-Hodgkin_s_Lymphoma Advanced Unfavorable Non-Hodgkin Lymphoma Advanced Unfavorable Non-Hodgkin's Lymphoma Advanced Unfavorable Non-Hodgkin Lymphoma A hereditary neoplasm arising from paraganglia. The majority of cases (up to 80%) are multifocal. It is caused by mutations in SDHA, SDHB, SDHC, SDHD, and SDHAF2 genes. C5329 Neoplastic Process Hereditary Paraganglioma Hereditary Paraganglioma C1333993 CTRP Undetermined Hereditary_Paraganglioma Familial Paraganglioma Hereditary Paraganglioma SDH-Related Familial Paraganglioma Hereditary Paraganglioma A lymphangioma characterized by the presence of thin-walled cavernous lymphatic spaces. C53316 Neoplastic Process Cavernous Lymphangioma C0205828 GDC 9172/0 Benign Cavernous_Lymphangioma 9172/0 Cavernous lymphangioma Cavernous Lymphangioma Cavernous lymphangioma Cavernous Lymphangioma An aggressive malignant smooth muscle neoplasm, arising from the esophagus. It is characterized by a proliferation of neoplastic spindle cells. C5334 Neoplastic Process Esophageal Leiomyosarcoma C1333454 Malignant Esophageal_Leiomyosarcoma Esophageal Leiomyosarcoma Esophagus Leiomyosarcoma Leiomyosarcoma of Esophagus Leiomyosarcoma of the Esophagus Esophageal Leiomyosarcoma A malignant soft tissue neoplasm that arises from the small intestine. Representative examples include leiomyosarcoma, angiosarcoma, and Kaposi sarcoma. C5335 Neoplastic Process Small Intestinal Sarcoma C1336007 Malignant Small_Intestinal_Sarcoma Sarcoma of Small Bowel Sarcoma of Small Intestine Sarcoma of the Small Bowel Sarcoma of the Small Intestine Sarcoma, Small Intestinal Small Bowel Sarcoma Small Intestinal Sarcoma Small Intestine Sarcoma Small Intestinal Sarcoma A usually aggressive malignant neoplasm arising from the small intestine. It is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation in a herringbone growth pattern. C5336 Neoplastic Process Small Intestinal Fibrosarcoma C1335994 Malignant Small_Intestinal_Fibrosarcoma Fibrosarcoma of Small Bowel Fibrosarcoma of Small Intestine Fibrosarcoma of the Small Bowel Fibrosarcoma of the Small Intestine Fibrosarcoma, Small Intestine Small Bowel Fibrosarcoma Small Intestinal Fibrosarcoma Small Intestine Fibrosarcoma Small Intestinal Fibrosarcoma A Hodgkin lymphoma that arises from the small intestine. C5337 Neoplastic Process Small Intestinal Hodgkin Lymphoma C1335998 Malignant Small_Intestinal_Hodgkin_s_Lymphoma Hodgkin's Disease of Small Bowel Hodgkin's Disease of Small Intestine Hodgkin's Disease of the Small Bowel Hodgkin's Disease of the Small Intestine Hodgkin's Lymphoma of Small Bowel Hodgkin's Lymphoma of Small Intestine Hodgkin's Lymphoma of the Small Bowel Hodgkin's Lymphoma of the Small Intestine Primary Small Intestinal Hodgkin's Lymphoma Small Bowel Hodgkin's Disease Small Bowel Hodgkin's Lymphoma Small Intestinal Hodgkin Lymphoma Small Intestinal Hodgkin's Lymphoma Small Intestine Hodgkin Lymphoma Small Intestine Hodgkin's Disease Small Intestine Hodgkin's Lymphoma Small Intestinal Hodgkin Lymphoma A neoplasm that arises from the glandular epithelium of the duodenum. It is characterized by a villous architectural pattern. The neoplastic glandular cells have dysplastic features. C5338 Neoplastic Process Duodenal Villous Adenoma C1333322 Benign Duodenal_Villous_Adenoma Duodenal Villous Adenoma Villous Adenoma of Duodenum Villous Adenoma of the Duodenum Villous Adenoma, Duodenum Duodenal Villous Adenoma A rare benign adipose tissue neoplasm of the small intestine. It usually arises from the submucosa and occasionally protrudes into the lumen. C5339 Neoplastic Process Small Intestinal Lipoma C1336001 Benign Small_Intestinal_Lipoma Lipoma of Small Bowel Lipoma of Small Intestine Lipoma of the Small Bowel Lipoma of the Small Intestine Small Bowel Lipoma Small Intestinal Lipoma Small Intestinal Lipoma A neoplasm that arises from the glandular epithelium of the small intestine. It is a polypoid or flat circumscribed lesion. Morphologically, it is characterized by a proliferation of neoplastic glandular cells and it is associated with dysplasia. According to the growth pattern, it may be classified as tubular, villous, or tubulovillous. C5340 Neoplastic Process Small Intestinal Adenoma C1302392 Benign Small_Intestinal_Adenoma Adenoma of Small Bowel Adenoma of Small Intestine Adenoma of the Small Bowel Adenoma of the Small Intestine Non-Ampullary Adenoma Small Bowel Adenoma Small Intestinal Adenoma Small Intestinal Adenoma A malignant soft tissue neoplasm that arises from the esophagus. Representative examples include Kaposi sarcoma, leiomyosarcoma, rhabdomyosarcoma, and synovial sarcoma. C5341 Neoplastic Process Esophageal Sarcoma C1333466 Malignant Esophageal_Sarcoma Esophageal Sarcoma Esophagus Sarcoma Sarcoma of Esophagus Sarcoma of the Esophagus Sarcoma, Esophagus Esophageal Sarcoma An infrequent esophageal carcinoma arising from esophageal glands. (WHO) C5342 Neoplastic Process Esophageal Adenoid Cystic Carcinoma Esophageal Adenoid Cystic Carcinoma C1333441 CTRP Malignant Esophageal_Adenoid_Cystic_Carcinoma Adenoid Cystic Carcinoma of Esophagus Adenoid Cystic Carcinoma of the Esophagus Adenoid Cystic Carcinoma, Esophagus Adenoid Cystic Esophagus Carcinoma Esophageal Adenoid Cystic Cancer Esophageal Adenoid Cystic Carcinoma Esophagus Adenoid Cystic Carcinoma Esophageal Adenoid Cystic Carcinoma A rare carcinoma of the esophagus which contains squamous cells, mucus secreting cells, and cells of an intermediate type. (WHO) C5343 Neoplastic Process Esophageal Mucoepidermoid Carcinoma Esophageal Mucoepidermoid Carcinoma C1333461 CTRP Malignant Esophageal_Mucoepidermoid_Carcinoma Esophageal Mucoepidermoid Cancer Esophageal Mucoepidermoid Carcinoma Mucoepidermoid Carcinoma of Esophagus Mucoepidermoid Carcinoma of the Esophagus Mucoepidermoid Esophageal Carcinoma Mucoepidermoid Esophagus Carcinoma Esophageal Mucoepidermoid Carcinoma A rare neoplasm arising from the distal third of the esophagus. Morphologically, it is characterized by the presence of fibrovascular cores covered by mature stratified squamous epithelium. Progression to squamous cell carcinoma is extremely rare. C5344 Neoplastic Process Esophageal Squamous Papilloma C1333467 Benign Esophageal_Squamous_Cell_Papilloma Esophageal Squamous Cell Papilloma Esophageal Squamous Papilloma Esophagus Squamous Cell Papilloma Squamous Cell Papilloma of Esophagus Squamous Cell Papilloma of the Esophagus Esophageal Squamous Papilloma A glomus tumor characterized by huge vascular channel formations. C5345 Neoplastic Process Telangiectatic Glomangioma C1336699 Benign Telangiectatic_Glomangioma Telangiectatic Glomangioma Telangiectatic Glomangioma An osteochondroma affecting a single anatomical site. C53455 Neoplastic Process Solitary Osteochondroma C1710126 Benign Solitary_Osteochondroma Solitary Osteochondroma Solitary Osteochondroma An autosomal dominant neoplastic chondrogenic process affecting multiple sites. It is caused by mutations in the EXT1 or EXT2 genes. Grossly and microscopically, the lesions resemble an osteochondroma. C53457 Neoplastic Process Multiple Osteochondromas C0206641 GDC PCDC 9210/1 Benign Multiple_Osteochondromas 9210/1 Ecchondrosis Osteochondromatosis, NOS Multiple Osteochondromas Osteochondromatosis Multiple Osteochondromas A benign well circumscribed neoplasm of hyaline cartilage arising from bone or soft tissue. It is characterized by the presence of chondrocytes. C53459 Neoplastic Process Chondroma C0936248 CDISC GDC A benign, well circumscribed neoplasm arising from the hyaline cartilage in soft tissue or bone. It is characterized by the presence of chondrocytes. 9220/0 Benign Chondroma 9220/0 Chondroma, NOS CHONDROMA, BENIGN Chondroma Chondroma, NOS Chondroma A benign or malignant neoplasm that affects the endocardium. C5346 Neoplastic Process Endocardial Neoplasm C1290401 Undetermined Endocardial_Neoplasm Endocardial Neoplasm Endocardial Tumor Neoplasm of Endocardium Neoplasm of the Endocardium Tumor of Endocardium Tumor of the Endocardium Endocardial Neoplasm A benign or malignant neoplasm that affects the inner layer of the pericardium. C5347 Neoplastic Process Epicardial Neoplasm C1290403 Undetermined Epicardial_Neoplasm Epicardial Neoplasm Epicardial Tumor Neoplasm of Epicardium Neoplasm of the Epicardium Tumor of Epicardium Tumor of the Epicardium Epicardial Neoplasm A benign or malignant neoplasm that affects the myocardium. C5349 Neoplastic Process Myocardial Neoplasm C1290402 Undetermined Myocardial_Neoplasm Myocardial Neoplasm Myocardial Tumor Neoplasm of Myocardium Neoplasm of the Myocardium Tumor of Myocardium Tumor of the Myocardium Myocardial Neoplasm A morphologic variant of chondrosarcoma arising from the bone. It is characterized by the presence of malignant small round cells, biphasic growth pattern, and well differentiated hyaline cartilage. Clinical presentation includes pain and swelling. The clinical course is aggressive, with local recurrences and distant metastases. C53493 Neoplastic Process Mesenchymal Chondrosarcoma of Bone C1708980 Malignant Mesenchymal_Chondrosarcoma_of_the_Bone Mesenchymal Chondrosarcoma of Bone Mesenchymal Chondrosarcoma of the Bone Mesenchymal Chondrosarcoma of Bone A familial glomus tumor. C5350 Neoplastic Process Hereditary Glomangioma C1333987 Cellosaurus Benign Hereditary_Glomangioma Familial Glomangioma Hereditary Glomangioma Hereditary Glomangioma A capillary or cavernous hemangioma arising from the breast. C5353 Neoplastic Process Breast Hemangioma C0853715 Benign Breast_Hemangioma Angioma of Breast Angioma of the Breast Breast Angioma Breast Hemangioma Hemangioma of Breast Hemangioma of the Breast Breast Hemangioma A benign, intermediate, or malignant vascular neoplasm that arises from the skin. C5354 Neoplastic Process Skin Vascular Neoplasm C1456853 Undetermined Cutaneous_Vascular_Neoplasm Blood Vessel Tumor of Skin Blood Vessel Tumor of the Skin Cutaneous Vascular Neoplasm Cutaneous Vascular Tumor Skin Vascular Neoplasm Skin Vascular Tumor Vascular Neoplasm of Skin Vascular Neoplasm of the Skin Vascular Skin Neoplasm Vascular Skin Tumor Vascular Tumor of Skin Vascular Tumor of the Skin Skin Vascular Neoplasm A morphologic variant of angioleiomyoma characterized by the adherence of neoplastic smooth muscle cells to the walls of vascular channels. C5355 Neoplastic Process Intravascular Angioleiomyoma C1334267 Benign Intravascular_Angiomyoma Intravascular Angioleiomyoma Intravascular Angiomyoma Intravascular Angioleiomyoma A header term that includes the following breast carcinoma subtypes determined by gene expression profiling: luminal A breast carcinoma, luminal B breast carcinoma, HER2 positive breast carcinoma, basal-like breast carcinoma, triple-negative breast carcinoma, and normal breast-like subtype of breast carcinoma. C53553 Neoplastic Process Breast Carcinoma by Gene Expression Profile C3642344 Malignant Invasive_Breast_Carcinoma_by_Gene_Expression_Profile Breast Carcinoma by Gene Expression Profile Breast Carcinoma by Gene Expression Profile A biologic subset of breast carcinoma defined by high expression of genes characteristic of luminal epithelial cells, including estrogen receptor (ER), estrogen regulated protein LIV-1, and the transcription factors hepatocyte nuclear factor 3, HNF3A, XBP1, and GATA 3. This subtype of breast cancer is associated with a good prognosis. C53554 Neoplastic Process Luminal A Breast Carcinoma Luminal A Breast Carcinoma C3642345 CTRP Malignant Luminal_A_Estrogen_Receptor_Positive_Subtype_of_Invasive_Breast_Carcinoma Luminal A Luminal A Breast Cancer Luminal A Breast Carcinoma Luminal A Estrogen Receptor Positive Subtype of Breast Carcinoma Luminal A Subtype of Breast Carcinoma Luminal A Breast Carcinoma A biologic subset of breast carcinoma defined by low to moderate expression of genes characteristic of luminal epithelial cells including estrogen receptor (ER), and high expression of GGH, LAPTM4B, and CCNE1. This subtype of breast cancer is associated with a good prognosis, although not as favorable as the luminal A subtype. C53555 Neoplastic Process Luminal B Breast Carcinoma C3642346 Malignant Luminal_B_Estrogen_Receptor_Positive_Subtype_of_Invasive_Breast_Carcinoma Luminal B Luminal B Breast Cancer Luminal B Breast Carcinoma Luminal B Estrogen Receptor Positive Subtype of Breast Carcinoma Luminal B Subtype of Breast Carcinoma Luminal B Breast Carcinoma A biologic subset of breast carcinoma defined by high expression of HER2, GRB7, and TRAP100, and by lack of expression of estrogen receptor (ER). C53556 Neoplastic Process HER2-Positive Breast Carcinoma C1699634 Malignant ERBB2_Overexpressing_Subtype_of_Invasive_Breast_Carcinoma ERBB2 Overexpressing Subtype of Breast Carcinoma HER2 Overexpressing Breast Carcinoma HER2 Overexpressing Subtype of Breast Carcinoma HER2 Positive Breast Cancer HER2 Positive Breast Carcinoma HER2-Positive Breast Carcinoma HER2-Positive Breast Carcinoma A biologic subset of breast carcinoma defined by high expression of many genes expressed by adipose and other non-epithelial tissues. C53557 Neoplastic Process Normal Breast-Like Subtype of Breast Carcinoma C3642471 Malignant Normal_Breast-Like_Subtype_of_Invasive_Breast_Carcinoma Normal Breast-Like Subtype of Breast Cancer Normal Breast-Like Subtype of Breast Carcinoma Normal Breast-Like Subtype of Breast Carcinoma A biologic subset of breast carcinoma defined by high expression of genes characteristic of basal epithelial cells, including KRT5 and KRT17, annexin 8, CX3CL1, and TRIM29, and usually by lack of expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). It is the most common subtype of breast cancer associated with BRCA1 mutations, and is associated with a poor prognosis. C53558 Neoplastic Process Basal-Like Breast Carcinoma C3642347 Malignant Basal-Like_Subtype_of_Invasive_Breast_Carcinoma Basal-Like Breast Cancer Basal-Like Breast Carcinoma Basal-Like Subtype of Breast Carcinoma Basal-Like Breast Carcinoma A rare benign neoplasm characterized by the presence of smooth muscle cells growing within the veins of the uterine corpus. The intravascular neoplasm growth occurs outside the confines of an adjacent leiomyoma. C5356 Neoplastic Process Uterine Corpus Intravenous Leiomyomatosis CL448313 Benign Intravascular_Leiomyomatosis_of_the_Uterus Intravascular Leiomyomatosis of Uterus Intravascular Leiomyomatosis of the Uterus Intravenous Leiomyomatosis of Uterus Intravenous Leiomyomatosis of the Uterus Uterine Corpus Intravenous Leiomyomatosis Uterine Corpus Intravenous Leiomyomatosis A germ cell tumor that arises within the myocardium or cardiac chambers. There is no evidence of atypia or metastases. C5357 Neoplastic Process Benign Cardiac Germ Cell Tumor C1332478 Benign Benign_Cardiac_Germ_Cell_Neoplasm Benign Cardiac Germ Cell Neoplasm Benign Cardiac Germ Cell Tumor Benign Germ Cell Neoplasm of Heart Benign Germ Cell Neoplasm of the Heart Benign Germ Cell Tumor of Heart Benign Germ Cell Tumor of the Heart Benign Heart Germ Cell Neoplasm Benign Heart Germ Cell Tumor Benign Cardiac Germ Cell Tumor A benign peripheral nervous system neoplasm that is composed of well-differentiated Schwann cells and affects the heart. C5358 Neoplastic Process Cardiac Schwannoma C1332479 CDISC A benign peripheral nervous system neoplasm that is composed of well-differentiated Schwann cells and affects the heart. Benign Benign_Cardiac_Schwannoma Benign Cardiac Neurilemmoma Benign Cardiac Schwannoma Benign Heart Neurilemmoma Benign Heart Schwannoma Benign Neurilemoma of Heart Benign Neurilemoma of the Heart CARDIAC SCHWANNOMA, BENIGN Cardiac Schwannoma Schwannoma, Endocardial, Benign Cardiac Schwannoma An intramuscular myxoma with increased cellularity and increased numbers of collagen fibers and blood vessels. C53589 Neoplastic Process Cellular Myxoma C1707332 Benign Cellular_Myxoma Cellular Myxoma Cellular Myxoma A rare neurofibroma that affects the heart. C5359 Neoplastic Process Cardiac Neurofibroma C1096349 Benign Cardiac_Neurofibroma Cardiac Neurofibroma Heart Neurofibroma Neurofibroma of Heart Neurofibroma of the Heart Cardiac Neurofibroma A non-metastasizing soft tissue neoplasm characterized by the presence of a neoplastic stroma containing spindle cells, dilated thin-walled vessels lined by fibrin, and a chronic inflammatory infiltrate. The majority of cases develop in the subcutaneous tissues usually in the lower extremities and present as slow growing masses. Recurrences occur in approximately half of the cases. C53594 Neoplastic Process Pleomorphic Hyalinizing Angiectatic Tumor of Soft Parts C1709569 Benign Pleomorphic_Hyalinizing_Angiectatic_Tumor_of_Soft_Parts Pleomorphic hyalinizing angiectatic tumor Early Pleomorphic Hyalinizing Angiectatic Tumor PHAT Pleomorphic Hyalinizing Angiectatic Tumor of Soft Parts Pleomorphic Hyalinizing Angiectatic Tumor of Soft Parts A rare, benign, well-circumscribed or encapsulated tumor that arises from the neck and occurs in adults. It is characterized by the presence of spindle cells, epithelial islands, and adipose tissue. C53595 Neoplastic Process Branchioma C1266098 GDC 8587/0 Benign Ectopic_Hamartomatous_Thymoma 8587/0 Ectopic hamartomatous thymoma Biphenotypic Branchioma Branchial Anlage Mixed Tumor Branchioma Ectopic Hamartomatous Thymoma Ectopic hamartomatous thymoma Neck Branchioma Branchioma A very rare granular cell tumor that arises from the heart. C5360 Neoplastic Process Cardiac Granular Cell Tumor C1332845 Undetermined Cardiac_Granular_Cell_Tumor Cardiac Granular Cell Neoplasm Cardiac Granular Cell Tumor Granular Cell Neoplasm of Heart Granular Cell Neoplasm of the Heart Granular Cell Tumor of Heart Granular Cell Tumor of the Heart Heart Granular Cell Tumor Cardiac Granular Cell Tumor A usually aggressive malignant neoplasm arising from the heart. It is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation in a herringbone growth pattern. C5361 Neoplastic Process Cardiac Fibrosarcoma C1332844 Malignant Cardiac_Fibrosarcoma Cardiac Fibrosarcoma Fibrosarcoma of Heart Fibrosarcoma of the Heart Heart Fibrosarcoma Cardiac Fibrosarcoma A low-grade malignant blood vessel neoplasm, arising from the heart. IIt is characterized by the presence of epithelioid endothelial cells. The neoplastic cells are arranged in cords and nests, which are embedded in a myxoid to hyalinized stroma. C5362 Neoplastic Process Cardiac Epithelioid Hemangioendothelioma C1332846 Malignant Cardiac_Hemangioendothelioma Cardiac Epithelioid Angioendothelioma Cardiac Epithelioid Hemangioendothelioma Epithelioid Angioendothelioma of Heart Epithelioid Angioendothelioma of the Heart Epithelioid Hemangioendothelioma of Heart Epithelioid Hemangioendothelioma of the Heart Heart Epithelioid Angioendothelioma Heart Epithelioid Hemangioendothelioma Cardiac Epithelioid Hemangioendothelioma A Kaposi sarcoma arising from the heart. C5363 Neoplastic Process Cardiac Kaposi Sarcoma C1332847 Malignant Cardiac_Kaposi_s_Sarcoma Cardiac Kaposi Sarcoma Cardiac Kaposi's Sarcoma Heart Kaposi Sarcoma Heart Kaposi's Sarcoma Kaposi's Sarcoma of Heart Kaposi's Sarcoma of the Heart Cardiac Kaposi Sarcoma An aggressive malignant smooth muscle neoplasm, arising from the heart. It is characterized by a proliferation of neoplastic spindle cells. C5364 Neoplastic Process Cardiac Leiomyosarcoma C1332848 Malignant Cardiac_Leiomyosarcoma Cardiac Leiomyosarcoma Heart Leiomyosarcoma Leiomyosarcoma of Heart Leiomyosarcoma of the Heart Cardiac Leiomyosarcoma A very rare malignant peripheral nerve sheath tumor that arises from the heart. C5367 Neoplastic Process Cardiac Malignant Peripheral Nerve Sheath Tumor C1334569 CDISC A malignant peripheral nerve sheath tumor that arises in cardiac tissue. Malignant Malignant_Cardiac_Peripheral_Nerve_Sheath_Tumor CARDIAC SCHWANNOMA, MALIGNANT Cardiac MPNST Cardiac Malignant Peripheral Nerve Sheath Tumor Heart MPNST Heart Malignant Peripheral Nerve Sheath Tumor MPNST of Heart MPNST of the Heart Malignant Cardiac Neurilemmoma Malignant Cardiac Peripheral Nerve Sheath Neoplasm Malignant Cardiac Peripheral Nerve Sheath Tumor Malignant Cardiac Schwannoma Malignant Heart Neurilemmoma Malignant Heart Peripheral Nerve Sheath Neoplasm Malignant Heart Peripheral Nerve Sheath Tumor Malignant Heart Schwannoma Malignant Neurilemmoma of Heart Malignant Neurilemmoma of the Heart Malignant Peripheral Nerve Sheath Neoplasm of Heart Malignant Peripheral Nerve Sheath Neoplasm of the Heart Malignant Peripheral Nerve Sheath Tumor of Heart Malignant Peripheral Nerve Sheath Tumor of the Heart Malignant Schwannoma of Heart Malignant Schwannoma of the Heart Cardiac Malignant Peripheral Nerve Sheath Tumor A malignant neoplasm arising from the large blood vessels. It is characterized by the presence of tumor cells that grow within the lumen of the blood vessels. The intraluminal tumor growth may result in vascular obstruction and spread of tumor emboli to peripheral organs. The prognosis is usually poor. C53677 Neoplastic Process Intimal Sarcoma C1708550 GDC Malignant Intimal_Sarcoma 9137/3 Intimal sarcoma Intimal Sarcoma Intimal sarcoma Intimal Sarcoma An extranodal lymphoma that arises from the heart. The majority of the cases are diffuse large B-cell lymphomas. Patients may present with chest pain, heart failure, pericardial effusion, arrhythmia, or syncope. C5368 Neoplastic Process Cardiac Lymphoma C1332850 Malignant Cardiac_Lymphoma Cardiac Lymphoma Heart Lymphoma Lymphoma of Heart Lymphoma of the Heart Primary Cardiac Lymphoma Primary Heart Lymphoma Cardiac Lymphoma A neoplasm that arises from connective and soft tissue and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include lipoma, leiomyoma, fibroma, and osteoma. C53684 Neoplastic Process Benign Connective and Soft Tissue Neoplasm C0347481 CDISC CPTAC A benign neoplasm arising from connective and soft tissues that does not invade adjacent tissues or metastasize to other anatomic sites. Benign Benign_Connective_and_Soft_Tissue_Neoplasm Other benign neoplasm of connective and other soft tissue of abdomen Other benign neoplasm of connective and other soft tissue, site unspecified Benign Connective and Soft Tissue Neoplasm Benign Connective and Soft Tissue Tumor Benign Mesenchymal Cell Neoplasm Benign Neoplasm of the Soft Tissue and Bone Benign Tumor of the Soft Tissue and Bone CONNECTIVE AND SOFT TISSUE NEOPLASM, BENIGN Benign Connective and Soft Tissue Neoplasm A choroid plexus papilloma characterized by increased mitotic activity. C53686 Neoplastic Process Atypical Choroid Plexus Papilloma C1266176 GDC 9390/1 Undetermined Atypical_Choroid_Plexus_Papilloma 9390/1 Atypical choroid plexus papilloma Atypical Choroid Plexus Papilloma Atypical choroid plexus papilloma Atypical Choroid Plexus Papilloma A lymphoma that has spread to the heart from another primary anatomic site. C5369 Neoplastic Process Secondary Heart Lymphoma C1335939 CPTAC Malignant Secondary_Lymphoma_of_Heart Metastatic Lymphoma in the Heart Secondary Cardiac Lymphoma Secondary Heart Lymphoma Secondary Lymphoma in the Heart Secondary Heart Lymphoma A rare extramedullary myeloid tumor that arises from the heart. It may present in association with or as a site of relapse of acute myeloid leukemia. Rare cases of myeloid sarcoma of the heart preceding acute myeloid leukemia have also been reported. C5370 Neoplastic Process Cardiac Myeloid Sarcoma C1333946 Malignant Heart_Myeloid_Sarcoma Cardiac Extramedullary Myeloid Neoplasm Cardiac Extramedullary Myeloid Tumor Cardiac Myeloid Sarcoma Extramedullary Myeloid Neoplasm of Heart Extramedullary Myeloid Neoplasm of the Heart Extramedullary Myeloid Tumor of Heart Extramedullary Myeloid Tumor of the Heart Heart Extramedullary Myeloid Neoplasm Heart Extramedullary Myeloid Tumor Heart Myeloid Sarcoma Cardiac Myeloid Sarcoma An osteosarcoma arising from a pre-existing lesion of the bone, usually Paget disease, or due to radiation therapy. C53704 Neoplastic Process Secondary Osteosarcoma C1710042 Malignant Secondary_Osteosarcoma Secondary Bone Osteosarcoma Secondary Osteosarcoma Secondary Osteosarcoma A high grade osteosarcoma arising in an irradiated bone. C53706 Neoplastic Process Radiation-Related Osteosarcoma C1709611 Malignant Postradiation_Osteosarcoma Postradiation Osteosarcoma Radiation-Associated Osteosarcoma Radiation-Related Osteosarcoma Radiation-Related Osteosarcoma A usually aggressive malignant bone-forming mesenchymal neoplasm arising from the bone. It may arise de novo or from a pre-existing lesion of the bone. Pain and a palpable mass are the most frequent clinical sign and symptom. It may spread to other anatomic sites, particularly the lungs. C53707 Neoplastic Process Bone Osteosarcoma Bone Osteosarcoma C0585442 CTRP Malignant Bone_Osteosarcoma Bone Osteosarcoma Osteosarcoma of Bone Bone Osteosarcoma A rare malignant germ cell tumor that arises within the myocardium or cardiac chambers. C5371 Neoplastic Process Malignant Cardiac Germ Cell Tumor C1334566 Malignant Malignant_Cardiac_Germ_Cell_Neoplasm Malignant Cardiac Germ Cell Neoplasm Malignant Cardiac Germ Cell Tumor Malignant Germ Cell Neoplasm of Heart Malignant Germ Cell Neoplasm of the Heart Malignant Germ Cell Tumor of Heart Malignant Germ Cell Tumor of the Heart Malignant Heart Germ Cell Neoplasm Malignant Heart Germ Cell Tumor Malignant Cardiac Germ Cell Tumor An aggressive malignant smooth muscle neoplasm, arising from the inferior vena cava. It is characterized by a proliferation of neoplastic spindle cells. C5372 Neoplastic Process Inferior Vena Cava Leiomyosarcoma C1334176 Malignant Inferior_Vena_Cava_Leiomyosarcoma Inferior Vena Cava Leiomyosarcoma Leiomyosarcoma of Inferior Vena Cava Leiomyosarcoma of the Inferior Vena Cava Inferior Vena Cava Leiomyosarcoma An aggressive malignant smooth muscle neoplasm, arising from the pulmonary artery It is characterized by a proliferation of neoplastic spindle cells. C5373 Neoplastic Process Pulmonary Artery Leiomyosarcoma C1335572 Malignant Pulmonary_Artery_Leiomyosarcoma Leiomyosarcoma of Pulmonary Artery Leiomyosarcoma of the Pulmonary Artery Pulmonary Artery Leiomyosarcoma Pulmonary Artery Leiomyosarcoma An aggressive malignant smooth muscle neoplasm, arising from the pulmonary vein. It is characterized by a proliferation of neoplastic spindle cells. C5374 Neoplastic Process Pulmonary Vein Leiomyosarcoma C1335575 Malignant Pulmonary_Vein_Leiomyosarcoma Leiomyosarcoma of Pulmonary Vein Leiomyosarcoma of the Pulmonary Vein Pulmonary Vein Leiomyosarcoma Pulmonary Vein Leiomyosarcoma A malignant vascular neoplasm arising from the aorta. C5376 Neoplastic Process Aortic Angiosarcoma C1332312 Malignant Aortic_Angiosarcoma Angiosarcoma of Aorta Angiosarcoma of the Aorta Aortic Angiosarcoma Aortic Hemangiosarcoma Hemangiosarcoma of Aorta Hemangiosarcoma of the Aorta Aortic Angiosarcoma A malignant vascular neoplasm arising from the superior vena cava. C5378 Neoplastic Process Superior Vena Cava Angiosarcoma C1336530 Malignant Superior_Vena_Cava_Angiosarcoma Angiosarcoma of Superior Vena Cava Angiosarcoma of the Superior Vena Cava Superior Vena Cava Angiosarcoma Superior Vena Cava Angiosarcoma The reemergence of angiosarcoma after a period of remission. C5384 Neoplastic Process Recurrent Angiosarcoma C0854894 Malignant Recurrent_Angiosarcoma Recurrent Angiosarcoma Recurrent Hemangiosarcoma Relapsed Angiosarcoma Relapsed Hemangiosarcoma Recurrent Angiosarcoma A malignant vascular neoplasm arising from the uterus. C5385 Neoplastic Process Uterine Angiosarcoma C1336899 Malignant Uterine_Angiosarcoma Angiosarcoma of Uterus Angiosarcoma of the Uterus Hemangiosarcoma of Uterus Hemangiosarcoma of the Uterus Uterine Angiosarcoma Uterine Hemangiosarcoma Uterine Angiosarcoma An aggressive malignant smooth muscle neoplasm, arising from the walls of the vascular system. It is characterized by a proliferation of neoplastic spindle cells. C5387 Neoplastic Process Leiomyosarcoma of Vessels C1336950 Malignant Vascular_Leiomyosarcoma Leiomyosarcoma of Vessels Leiomyosarcoma of the Vessels Vascular Leiomyosarcoma Leiomyosarcoma of Vessels An aggressive malignant smooth muscle neoplasm, arising from the renal vein. It is characterized by a proliferation of neoplastic spindle cells. C5388 Neoplastic Process Renal Vein Leiomyosarcoma C1335753 Malignant Renal_Vein_Leiomyosarcoma Leiomyosarcoma of Renal Vein Leiomyosarcoma of the Renal Vein Renal Vein Leiomyosarcoma Renal Vein Leiomyosarcoma A neoplasm that arises from the right or left atrium and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C5389 Neoplastic Process Benign Atrial Neoplasm C1332474 Benign Benign_Atrial_Neoplasm Benign Atrial Neoplasm Benign Atrial Tumor Benign Neoplasm of Atrium of Heart Benign Neoplasm of Cardiac Atrium Benign Neoplasm of the Atrium of the Heart Benign Neoplasm of the Cardiac Atrium Benign Tumor of Atrium of Heart Benign Tumor of Cardiac Atrium Benign Tumor of the Atrium of the Heart Benign Tumor of the Cardiac Atrium Benign Atrial Neoplasm An extra-adrenal paraganglioma arising from paraganglia located in the cardiac atrium. C5390 Neoplastic Process Atrial Paraganglioma C1332343 Undetermined Atrial_Paraganglioma Atrial Paraganglioma Paraganglioma of Atrium Paraganglioma of Atrium of Heart Paraganglioma of Cardiac Atrium Paraganglioma of the Atrium Paraganglioma of the Atrium of the Heart Paraganglioma of the Cardiac Atrium Atrial Paraganglioma A paraganglioma of the heart that metastasizes to regional or distant anatomic sites. C5392 Neoplastic Process Malignant Cardiac Paraganglioma Metastatic Cardiac Paraganglioma C1334568 CTRP Malignant Malignant_Cardiac_Paraganglioma Malignant Cardiac Paraganglioma Malignant Heart Paraganglioma Malignant Paraganglioma of Heart Malignant Paraganglioma of the Heart Metastatic Cardiac Paraganglioma Metastatic Cardiac Paraganglioma A lymphangioma arising from the parotid gland. C5393 Neoplastic Process Parotid Gland Lymphangioma C1335361 Benign Parotid_Gland_Lymphangioma Lymphangioma of Parotid Lymphangioma of Parotid Gland Lymphangioma of the Parotid Lymphangioma of the Parotid Gland Parotid Gland Lymphangioma Parotid Lymphangioma Parotid Gland Lymphangioma A solitary benign neoplasm arising from the fibrous soft tissues. The tumor is characterized by the presence of spindle-shaped fibroblasts. C5394 Neoplastic Process Solitary Adult Fibroma C1336031 Cellosaurus Benign Solitary_Adult_Fibroma Solitary Adult Cutaneous Fibroma Solitary Adult Fibroma Solitary Adult Skin Fibroma Solitary Adult Fibroma A cavernous hemangioma arising from the colon. C5395 Neoplastic Process Colon Cavernous Hemangioma C1333086 Benign Colon_Cavernous_Hemangioma Cavernous Angioma of Colon Cavernous Angioma of the Colon Cavernous Hemangioma of Colon Cavernous Hemangioma of the Colon Colon Cavernous Angioma Colon Cavernous Hemangioma Colonic Cavernous Angioma Colonic Cavernous Hemangioma Colon Cavernous Hemangioma A conventional osteosarcoma characterized by the predominance of osteoid matrix. C53953 Neoplastic Process Osteoblastic Osteosarcoma Osteoblastic Osteosarcoma C1704328 CTRP GDC PCDC Malignant Osteoblastic_Osteosarcoma 9180/3 Osteoblastic sarcoma Osteoblastic Osteosarcoma Osteoblastic sarcoma Osteoblastic Osteosarcoma A usually aggressive high grade malignant bone-forming mesenchymal neoplasm arising from the surface of the bone. C53958 Neoplastic Process High Grade Surface Osteosarcoma C1266165 GDC 9194/3 Malignant High_Grade_Surface_Osteosarcoma 9194/3 High grade surface osteosarcoma High Grade Surface Osteosarcoma High grade surface osteosarcoma High-Grade Surface Osteosarcoma High Grade Surface Osteosarcoma A locally aggressive hemangioma that arises from the bone. It is characterized by the presence of epithelioid endothelial cells. C5396 Neoplastic Process Bone Epithelioid Hemangioma C1332575 Benign Bone_Epithelioid_Hemangioma Bone Epithelioid Angioma Bone Epithelioid Hemangioma Epithelioid Angioma of Bone Epithelioid Angioma of the Bone Epithelioid Hemangioma of Bone Epithelioid Hemangioma of the Bone Osseous Epithelioid Angioma Osseous Epithelioid Hemangioma Bone Epithelioid Hemangioma A rare, benign neoplasm usually arising from the non-metaphyseal regions of long bones or pelvis. It is characterized by the presence of fibroblastic spindle cells arranged in a whorled storiform pattern, osteoclast-like giant cells, foam cells, inflammatory cells, hemosiderin deposition and stromal hemorrhage. C53963 Neoplastic Process Fibrous Histiocytoma of Bone C1706921 Benign Benign_Fibrous_Histiocytoma_of_Bone Benign Fibrous Histiocytoma of Bone Fibrous Histiocytoma of Bone Fibrous Histiocytoma of Bone A rare leiomyoma affecting the bone. C53964 Neoplastic Process Bone Leiomyoma C1706980 Benign Bone_Leiomyoma Bone Leiomyoma Bone Leiomyoma A hemangioma arising from the parotid gland. C5397 Neoplastic Process Parotid Gland Hemangioma C1335358 Benign Parotid_Gland_Hemangioma Angioma of Parotid Angioma of Parotid Gland Angioma of the Parotid Angioma of the Parotid Gland Hemangioma of Parotid Hemangioma of Parotid Gland Hemangioma of the Parotid Hemangioma of the Parotid Gland Parotid Angioma Parotid Gland Angioma Parotid Gland Hemangioma Parotid Hemangioma Parotid Gland Hemangioma Fibrous dysplasia presenting as a single bone lesion. C53971 Neoplastic Process Monostotic Fibrous Dysplasia C0016064 Benign Mostotic_Fibrous_Dysplasia Monostotic Fibrous Dysplasia Monostotic Fibrous Dysplasia of Bone Monostotic Fibrous Dysplasia A very rare, multisystem non-Langerhans cell histiocytosis that predominantly affects adults. It is characterized by the proliferation in the tissues of lipid-laden macrophages and the presence of multinucleated giant cells. It results in sclerosis of the long bones and failure of the affected organs. Patients may present with bone pain, exophthalmos, ataxia, liver failure, kidney failure, and hypopituitarism. C53972 Neoplastic Process Erdheim-Chester Disease C0878675 Undetermined Erdheim-Chester_Disease Erdheim-Chester disease ECD Erdheim-Chester Disease Lipogranulomatosis Polyostotic Sclerosing Histiocytosis Erdheim-Chester Disease A term that refers to central nervous system embryonal tumors which are not fully characterized. C5398 Neoplastic Process Central Nervous System Embryonal Tumor, Not Otherwise Specified C3887678 GDC A type of cancer that arises from a particular type of cell within the brain or spinal cord. Malignant Central_Nervous_System_Primitive_Neuroectodermal_Tumor 9473/3 CPNET Central primitive neuroectodermal tumor, NOS CNS Embryonal Tumor, NOS CNS Embryonal Tumor, Not Otherwise Specified CNS PNET CNS Primitive Neuroectodermal Neoplasm CNS Primitive Neuroectodermal Tumor CPNET Central Nervous System Embryonal Tumor, NOS Central Nervous System Embryonal Tumor, Not Otherwise Specified Central Nervous System PNET Central Nervous System Primitive Neuroectodermal Neoplasm Central Nervous System Primitive Neuroectodermal Tumor Central Nervous System Primitive Neuroectodermal Tumor (WHO Grade IV) Central Primitive Neuroectodermal Neoplasm Central Primitive Neuroectodermal Tumor Central primitive neuroectodermal tumor, NOS central nervous system primitive neuroectodermal tumor Central Nervous System Embryonal Tumor, Not Otherwise Specified A medulloblastoma which has spread from its original site to the leptomeninges surrounding the brain and spinal cord. C5399 Neoplastic Process Medulloblastoma with Leptomeningeal Spread C1334685 Malignant Medulloblastoma_with_Leptomeningeal_Spread Medulloblastoma with Leptomeningeal Spread Medulloblastoma with Leptomeningeal Spread An infiltrating high-grade malignant mesenchymal tumor arising from the uterine corpus, cervix, vagina, and ovary. C53994 Neoplastic Process Undifferentiated Stromal Sarcoma C1710535 Malignant Undifferentiated_Endometrial_Stromal_Sarcoma Undifferentiated Stromal Sarcoma Undifferentiated Stromal Sarcoma A gastrointestinal stromal tumor that is characterized by a maximum diameter equal or less than 5 cm (gastric localization), or equal or less than 2 cm (intestinal localization) and no more than 5 mitotic figures per 50 high power fields. C53998 Neoplastic Process Benign Gastrointestinal Stromal Tumor CL449186 CDISC GDC A benign neoplasm arising from specialized smooth muscle cells (i.e., interstitial cells of Cajal) in the tunica muscularis or myenteric plexus. (INHAND) 8936/0 Benign Probably_Benign_Gastrointestinal_Stromal_Tumor 8936/0 GIST, benign Gastrointestinal stromal tumor, benign Benign Gastrointestinal Stromal Tumor GASTROINTESTINAL STROMAL TUMOR, BENIGN GIST, Benign GIST, benign Gastrointestinal stromal tumor, benign Benign Gastrointestinal Stromal Tumor A gastrointestinal stromal tumor that is characterized by large size (diameter greater than 10 cm for gastric localization and greater than 5 cm for intestinal localization) or more than 5 mitotic figures per 50 high power fields. C53999 Neoplastic Process Malignant Gastrointestinal Stromal Tumor Malignant Gastrointestinal Stromal Tumor CL497447 CDISC CPTAC CTRP GDC A malignant neoplasm arising from specialized smooth muscle cells (i.e., interstitial cells of Cajal) in the tunica muscularis or myenteric plexus. (INHAND) 8936/3 Malignant Probably_Malignant_Gastrointestinal_Stromal_Tumor 8936/3 GIST, malignant Gastrointestinal stromal sarcoma Gastrointestinal stromal tumor Gastrointestinal stromal tumor, malignant GASTROINTESTINAL STROMAL TUMOR, MALIGNANT GIST, Malignant GIST, malignant Gastrointestinal stromal tumor, malignant Malignant Gastrointestinal Stromal Tumor Malignant Gastrointestinal Stromal Tumor A central nervous system embryonal tumor, not otherwise specified which has spread from its original site to the leptomeninges surrounding the brain and spinal cord. C5400 Neoplastic Process Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread C1335496 Malignant Primitive_Neuroectodermal_Tumor_with_Leptomeningeal_Spread Central Nervous System Embryonal Tumor, NOS with Leptomeningeal Spread Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread Primitive Neuroectodermal Tumor with Leptomeningeal Spread Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread A gastrointestinal stromal tumor that is characterized by a maximum diameter greater than 5 cm and equal or less than 10 cm (gastric localization), or greater than 2 cm and equal or less than 5 cm (intestinal localization) and no more than 5 mitotic figures per 50 high power fields. C54000 Neoplastic Process Gastrointestinal Stromal Tumor of Uncertain Malignant Potential C1704399 GDC Uncertain Malignant Potential Gastrointestinal_Stromal_Tumor_of_Uncertain_Malignant_Potential 8936/1 Gastrointestinal stromal tumor, uncertain malignant potential Gastrointestinal Stromal Tumor of Uncertain Malignant Potential Gastrointestinal stromal tumor, uncertain malignant potential Gastrointestinal Stromal Tumor of Uncertain Malignant Potential A medulloblastoma arising from the vermis of the cerebellum. C5401 Neoplastic Process Cerebellar Vermis Medulloblastoma C1332903 Malignant Cerebellar_Vermis_Medulloblastoma Cerebellar Vermis Medulloblastoma Medulloblastoma of Cerebellar Vermis Medulloblastoma of the Cerebellar Vermis Vermis Medulloblastoma Cerebellar Vermis Medulloblastoma A medulloblastoma characterized by the loss of one of the p13 regions of chromosome 17. Loss of genetic material of chromosome arm 17p is the most common molecular genetic abnormality found in medulloblastomas. C5402 Neoplastic Process Region 17p13 Allelic Loss Associated Medulloblastoma C1335732 Malignant Region_17p13_Allelic_Loss_Associated_Medulloblastomas Region 17p13 Allelic Loss Associated Medulloblastoma Region 17p13 Allelic Loss Associated Medulloblastoma A malignant germ cell tumor that affects the structures within the cranium. C5403 Neoplastic Process Malignant Intracranial Germ Cell Tumor C1334592 Malignant Malignant_Intracranial_Germ_Cell_Neoplasm Malignant Intracranial Germ Cell Neoplasm Malignant Intracranial Germ Cell Tumor Malignant Intracranial Germ Cell Tumor A medulloblastoma composed of malignant cells with hyperchromatic nucleus and scanty cytoplasm. Homer Wright rosettes may be present. C54039 Neoplastic Process Classic Medulloblastoma C1707400 GDC Malignant Classic_Medulloblastoma Medulloblastoma, classic Classic Medulloblastoma Medulloblastoma, classic Classic Medulloblastoma A medulloblastoma developing in patients with multiple basal cell carcinomas. It is observed in patients with nevoid basal cell carcinoma syndrome and it is associated with PTCH gene inactivation. C5405 Neoplastic Process Nevoid Basal Cell Carcinoma Syndrome Associated Medulloblastoma C1334963 Malignant Nevoid_Basal_Cell_Carcinoma_Syndrome_Associated_Medulloblastoma Nevoid Basal Cell Carcinoma Syndrome Associated Medulloblastoma Nevoid Basal Cell Carcinoma Syndrome Associated Medulloblastoma A central nervous system embryonal tumor, not otherwise specified arising from the spinal cord. C5406 Neoplastic Process Spinal Cord Embryonal Tumor, Not Otherwise Specified C0346298 Cellosaurus Malignant Spinal_Cord_Primitive_Neuroectodermal_Neoplasm Primitive Neuroectodermal Neoplasm of Spinal Cord Primitive Neuroectodermal Neoplasm of the Spinal Cord Primitive Neuroectodermal Tumor of Spinal Cord Primitive Neuroectodermal Tumor of the Spinal Cord Spinal Cord Embryonal Tumor, NOS Spinal Cord Embryonal Tumor, Not Otherwise Specified Spinal Cord PNET Spinal Cord Primitive Neuroectodermal Neoplasm Spinal Cord Primitive Neuroectodermal Tumor Spinal Cord Embryonal Tumor, Not Otherwise Specified A medulloblastoma characterized by nodularity and neuronal differentiation. C5407 Neoplastic Process Medulloblastoma with Extensive Nodularity C1334970 GDC 9471/3 Malignant Nodular_Medulloblastoma 9471/3 Medulloblastoma with extensive nodularity Cerebellar Neuroblastoma Medulloblastoma with Extensive Nodularity Medulloblastoma with Extensive Nodularity and Advanced Neuronal Differentiation Medulloblastoma with extensive nodularity Nodular Medulloblastoma Medulloblastoma with Extensive Nodularity C5408 Neoplastic Process Intradural Extramedullary Cauda Equina Astrocytoma C1334254 Undetermined Intradural_Extramedullary_Cauda_Equina_Astrocytoma Intradural Extramedullary Astrocytoma of Cauda Equina Intradural Extramedullary Astrocytoma of the Cauda Equina Intradural Extramedullary Cauda Equina Astrocytoma Intradural Extramedullary Cauda Equina Astrocytoma A T-cell lymphoblastic lymphoma or a mature T-cell and NK-cell neoplasm that affects the brain, meninges, or spinal cord. C5409 Neoplastic Process Central Nervous System T-Cell Non-Hodgkin Lymphoma C1332894 Malignant Central_Nervous_System_T-Cell_Non-Hodgkin_s_Lymphoma CNS T-Cell Lymphoma Central Nervous System T-Cell Lymphoma Central Nervous System T-Cell Non-Hodgkin Lymphoma Central Nervous System T-Cell Non-Hodgkin's Lymphoma Central Nervous System T-Cell and NK-Cell Non-Hodgkin's Lymphoma Primary Central Nervous System T-Cell Non-Hodgkin's Lymphoma T-Cell Lymphoma of CNS T-Cell Lymphoma of Central Nervous System T-Cell Lymphoma of the CNS T-Cell Lymphoma of the Central Nervous System Central Nervous System T-Cell Non-Hodgkin Lymphoma A benign or malignant granular cell tumor that arises from the stomach. C54094 Neoplastic Process Gastric Granular Cell Tumor C1708194 Undetermined Gastric_Granular_Cell_Tumor Gastric Granular Cell Tumor Gastric Granular Cell Tumor A germ cell tumor that affects the central nervous system, characterized by the presence of malignant morphologic characteristics. Representative examples include choriocarcinoma, embryonal carcinoma, and germinoma. C54099 Neoplastic Process Malignant Central Nervous System Germ Cell Tumor C1708864 CPTAC Malignant Malignant_Central_Nervous_System_Germ_Cell_Tumor Malignant Central Nervous System Germ Cell Neoplasm Malignant Central Nervous System Germ Cell Tumor Malignant Central Nervous System Germ Cell Tumor A central nervous system embryonal tumor, not otherwise specified that occurs in adults. C5411 Neoplastic Process Adult Central Nervous System Embryonal Tumor, Not Otherwise Specified C1332196 Malignant Adult_Central_Nervous_System_Primitive_Neuroectodermal_Tumor Adult CNS PNET Adult CNS Primitive Neuroectodermal Neoplasm Adult CNS Primitive Neuroectodermal Tumor Adult Central Nervous System Embryonal Tumor, NOS Adult Central Nervous System Embryonal Tumor, Not Otherwise Specified Adult Central Nervous System Primitive Neuroectodermal Neoplasm Adult Central Nervous System Primitive Neuroectodermal Tumor Adult Central Primitive Neuroectodermal Neoplasm Adult Central Primitive Neuroectodermal Tumour Adult Central Nervous System Embryonal Tumor, Not Otherwise Specified A chordoma that arises from the clivus. C5412 Neoplastic Process Clivus Chordoma C1333071 Cellosaurus Malignant Clival_Chordoma Chordoma of Clivus Chordoma of the Clivus Clival Chordoma Clivus Chordoma Clivus Chordoma A schwannoma occurring in the cerebellopontine angle. C5413 Neoplastic Process Cerebellopontine Angle Schwannoma C1332905 Benign Cerebellopontine_Angle_Schwannoma C-P Angle Neurinoma Cerebellar Pontine Angle Neurinoma Cerebellopontine Angle Neurinoma Cerebellopontine Angle Schwannoma Cerebellopontine Angle Schwannoma A neoplasm that affects the cerebellopontine angle. Representative examples include vestibular schwannoma and meningioma. C5414 Neoplastic Process Cerebellopontine Angle Neoplasm C0474740 Undetermined Cerebellopontine_Angle_Neoplasm C-P Angle Neoplasm C-P Angle Tumor Cerebellar Pontine Angle Neoplasm Cerebellar Pontine Angle Tumor Cerebellopontine Angle Neoplasm Cerebellopontine Angle Tumor Neoplasm of C-P Angle Neoplasm of Cerebellar Pontine Angle Neoplasm of Cerebellopontine Angle Neoplasm of the C-P Angle Neoplasm of the Cerebellar Pontine Angle Neoplasm of the Cerebellopontine Angle Tumor of C-P Angle Tumor of Cerebellar Pontine Angle Tumor of Cerebellopontine Angle Tumor of the C-P Angle Tumor of the Cerebellar Pontine Angle Tumor of the Cerebellopontine Angle Cerebellopontine Angle Neoplasm An anaplastic astrocytoma occurring in the supratentorial area secondary to a preexisting tumor. C5416 Neoplastic Process Secondary Supratentorial Anaplastic Astrocytoma C1332288 Malignant Anaplastic_Secondary_Supratentorial_Astrocytoma Anaplastic Secondary Supratentorial Astrocytoma Grade 3 Secondary Supratentorial Astrocytic Neoplasm Grade 3 Secondary Supratentorial Astrocytic Tumor Grade III Secondary Supratentorial Astrocytic Neoplasm Grade III Secondary Supratentorial Astrocytic Tumor Grade III Secondary Supratentorial Astrocytoma Secondary Supratentorial Anaplastic Astrocytoma Undifferentiated Secondary Supratentorial Astrocytoma Secondary Supratentorial Anaplastic Astrocytoma A benign schwannoma occurring in the pleura. C5418 Neoplastic Process Pleural Schwannoma C1335435 Benign Pleural_Schwannoma Neurilemmoma of Pleura Neurilemmoma of the Pleura Pleural Neurilemmoma Pleural Schwannoma Schwannoma of Pleura Schwannoma of the Pleura Pleural Schwannoma A morphologic spectrum of lesions that arise in the terminal ductal lobular units of the breast parenchyma. These lesions are characterized by the presence of columnar epithelial cells that line dilated terminal ductal lobular units. Cytological and architectural atypia may be absent or minimal, or significant enough to raise the possibility of atypical ductal hyperplasia or ductal carcinoma in situ. Columnar cell lesions are frequently found in breast biopsies but their biologic significance is not known. C54180 Neoplastic Process Breast Columnar Cell Lesion C1707448 Undetermined Columnar_Cell_Lesion_of_the_Breast Breast Columnar Cell Lesion Columnar Cell Lesion of Breast Columnar Cell Lesion of the Breast Breast Columnar Cell Lesion A columnar cell lesion characterized by the presence of enlarged terminal ductal lobular units with dilated acini. The acini are lined by one or two layers of columnar epithelial cells. Apical cytoplasmic snouts may be present, but they are not prominent. Secretions may be present in the lumina of the dilated acini. C54181 Neoplastic Process Columnar Cell Change of the Breast C1707444 Undetermined Columnar_Cell_Change_of_the_Breast Blunt Duct Adenosis of Breast Blunt Duct Adenosis of the Breast Breast Blunt Duct Adenosis Breast Columnar Cell Change CCC Columnar Cell Change Columnar Cell Change of Breast Columnar Cell Change of the Breast Columnar Cell Change of the Breast A columnar cell lesion characterized by the presence of enlarged terminal ductal lobular units with dilated acini. The acini are lined by one or two layers of columnar epithelial cells. Cytologic atypia is present. C54182 Neoplastic Process Columnar Cell Change of the Breast with Atypia C1707445 Undetermined Columnar_Cell_Change_of_the_Breast_with_Atypia Columnar Cell Change of Breast with Atypia Columnar Cell Change of the Breast with Atypia Columnar Cell Change with Atypia Columnar Cell Change of the Breast with Atypia A columnar cell lesion characterized by the presence of enlarged terminal ductal lobular units with dilated acini. The acini are lined by more than two layers of columnar epithelial cells. Prominent apical cytoplasmic snouts are present. Secretions are often present in the lumina of the dilated acini. C54183 Neoplastic Process Breast Columnar Cell Hyperplasia C1707446 Undetermined Columnar_Cell_Hyperplasia_of_the_Breast Breast Columnar Cell Hyperplasia CCH Columnar Cell Hyperplasia of Breast Columnar Cell Hyperplasia of the Breast Breast Columnar Cell Hyperplasia A columnar cell lesion characterized by the presence of enlarged terminal ductal lobular units with dilated acini. The acini are lined by more than two layers of columnar epithelial cells. Cytologic atypia is present. Prominent apical cytoplasmic snouts and intraluminal secretions are also present. C54184 Neoplastic Process Breast Columnar Cell Hyperplasia with Atypia C1707447 Undetermined Columnar_Cell_Hyperplasia_of_the_Breast_with_Atypia Breast Columnar Cell Hyperplasia with Atypia Columnar Cell Hyperplasia of Breast with Atypia Columnar Cell Hyperplasia of the Breast with Atypia Breast Columnar Cell Hyperplasia with Atypia An astrocytic tumor affecting young people. Morphologically, it is characterized by the presence of collagenous tissue surrounding neoplastic astrocytes. In some cases the collagen is produced by the tumor cells (desmoplastic astrocytoma), whereas in others it is produced by mesenchymal cells (mixed glioma/fibroma). C5419 Neoplastic Process Gliofibroma C1266178 GDC 9442/1 Undetermined Gliofibroma 9442/1 Gliofibroma Gliofibroma Gliofibroma A benign tumor derived from schwann cells of the peripheral sympathetic nervous system, including the sympathetic plexus. C5421 Neoplastic Process Sympathetic Schwannoma C1336543 Benign Sympathetic_Schwannoma Sympathetic Neurilemmoma Sympathetic Schwannoma Sympathetic Schwannoma C5423 Neoplastic Process Cervicomedullary Junction Neoplasm C1332923 Undetermined Cervicomedullary_Junction_Neoplasm Cervicomedullary Junction Neoplasm Cervicomedullary Junction Neoplasms Cervicomedullary Junction Tumor Neoplasm of Cervicomedullary Junction Neoplasm of the Cervicomedullary Junction Tumor of Cervicomedullary Junction Tumor of the Cervicomedullary Junction Cervicomedullary Junction Neoplasm An uncommon lipoma characterized by prominent vascularity arising in the epidural space of the spinal canal. C5424 Neoplastic Process Epidural Spinal Canal Angiolipoma C1333416 Benign Epidural_Spinal_Canal_Angiolipoma Angiolipoma of Epidural Spinal Canal Angiolipoma of Extradural Spinal Canal Angiolipoma of the Epidural Spinal Canal Angiolipoma of the Extradural Spinal Canal Epidural Spinal Canal Angiolipoma Extradural Spinal canal Angiolipoma Epidural Spinal Canal Angiolipoma C54246 Finding Solar Radiation Toxicity C1710121 Solar_Radiation_Toxicity Solar Radiation Toxicity Solar Radiation Toxicity An uncommon carcinoma that arises from the skin. It is characterized by the presence of malignant glandular and malignant squamous cellular components. C54250 Neoplastic Process Skin Adenosquamous Carcinoma Skin Adenosquamous Carcinoma C1710103 CTRP Malignant Skin_Adenosquamous_Carcinoma Skin Adenosquamous Cancer Skin Adenosquamous Carcinoma Skin Adenosquamous Carcinoma A chondroid chordoma that arises from the clivus. C5426 Neoplastic Process Clivus Chondroid Chordoma C1333072 Malignant Clivus_Chondroid_Chordoma Chondroid Chordoma of Clivus Chondroid Chordoma of the Clivus Clivus Chondroid Chordoma Clivus Chondroid Chordoma A carcinoma that arises from the ear. Representative examples include ceruminous adenocarcinoma and squamous cell carcinoma of the external ear and adenocarcinoma of the middle ear. C54262 Neoplastic Process Ear Carcinoma C0848859 Malignant Ear_Carcinoma Ear Carcinoma Ear Carcinoma A ganglioneuroma arising from the retroperitoneum. C5427 Neoplastic Process Retroperitoneal Ganglioneuroma C1335775 Benign Retroperitoneal_Ganglioneuroma Ganglioneuroma of Retroperitoneum Ganglioneuroma of the Retroperitoneum Retroperitoneal Ganglioneuroma Retroperitoneal Ganglioneuroma C5428 Neoplastic Process Intramedullary Spinal Cord Teratoma C1334259 Undetermined Intramedullary_Spinal_Cord_Teratoma Intramedullary Spinal Cord Teratoma Intramedullary Spinal Teratoma Intramedullary Teratoma of Spinal Cord Intramedullary Teratoma of the Spinal Cord Intramedullary Spinal Cord Teratoma A squamous cell carcinoma that arises from the head and neck region and is characterized by prominent production of keratin. C54283 Neoplastic Process Head and Neck Keratinizing Squamous Cell Carcinoma C1708602 Malignant Keratinizing_Head_and_Neck_Squamous_Cell_Carcinoma Head and Neck Keratinizing Squamous Cell Carcinoma Keratinizing Head and Neck Squamous Cell Carcinoma Head and Neck Keratinizing Squamous Cell Carcinoma A squamous cell carcinoma that arises from the paranasal sinuses and is characterized by prominent production of keratin. C54284 Neoplastic Process Paranasal Sinus Keratinizing Squamous Cell Carcinoma C1708603 Malignant Keratinizing_Paranasal_Sinus_Squamous_Cell_Carcinoma Keratinizing Paranasal Sinus Squamous Cell Carcinoma Paranasal Sinus Keratinizing Squamous Cell Carcinoma Paranasal Sinus Keratinizing Squamous Cell Carcinoma A squamous cell carcinoma that arises from the nasal cavity and is characterized by prominent production of keratin. C54285 Neoplastic Process Nasal Cavity Keratinizing Squamous Cell Carcinoma C1711386 Malignant Keratinizing_Nasal_Cavity_Squamous_Cell_Carcinoma Keratinizing Nasal Cavity Squamous Cell Carcinoma Nasal Cavity Keratinizing Squamous Cell Carcinoma Nasal Cavity Keratinizing Squamous Cell Carcinoma A squamous cell carcinoma of the sinonasal tract characterized by a plexiform or ribbon-like growth pattern, cytological atypia, and lack of histological evidence of keratinization. C54287 Neoplastic Process Sinonasal Non-Keratinizing Squamous Cell Carcinoma C0334270 GDC 8121/3 Malignant Non-Keratinizing_Sinonasal_Squamous_Cell_Carcinoma 8121/3 Cylindrical cell carcinoma Schneiderian carcinoma Non-Keratinizing Sinonasal Squamous Cell Carcinoma Ringertz Carcinoma Schneiderian Carcinoma Schneiderian carcinoma Sinonasal Cylindrical Cell Carcinoma Sinonasal Non-Keratinizing Squamous Cell Carcinoma Sinonasal Schneiderian Carcinoma Sinonasal Transitional Cell Carcinoma Sinonasal Non-Keratinizing Squamous Cell Carcinoma A peripheral nervous system neoplasm that arises in the mediastinum during childhood. C5429 Neoplastic Process Childhood Mediastinal Neurogenic Neoplasm C1332981 Undetermined Childhood_Mediastinal_Neurogenic_Neoplasm Childhood Mediastinal Neurogenic Neoplasm Childhood Mediastinal Neurogenic Tumor Childhood Neurogenic Neoplasm of Mediastinum Childhood Neurogenic Neoplasm of the Mediastinum Childhood Neurogenic Tumor of Mediastinum Childhood Neurogenic Tumor of the Mediastinum Pediatric Mediastinal Neurogenic Neoplasm Pediatric Mediastinal Neurogenic Tumor Pediatric Neurogenic Neoplasm of Mediastinum Pediatric Neurogenic Neoplasm of the Mediastinum Pediatric Neurogenic Tumor of Mediastinum Pediatric Neurogenic Tumor of the Mediastinum Childhood Mediastinal Neurogenic Neoplasm A carcinoma arising from the nasal cavity or paranasal sinuses. C54293 Neoplastic Process Nasal Cavity and Paranasal Sinus Carcinoma Sinonasal Carcinoma C1710095 CPTAC CTRP Cancer that forms in tissues of the paranasal sinuses (small hollow spaces in the bones around the nose) or nasal cavity (the inside of the nose). The most common type of paranasal sinus and nasal cavity cancer is squamous cell carcinoma (cancer that begins in flat cells lining these tissues and cavities). Malignant Sinonasal_Carcinoma Nasal Cavity and Paranasal Sinus Cancer Nasal Cavity and Paranasal Sinus Carcinoma Sinonasal Carcinoma paranasal sinus and nasal cavity cancer Sinonasal Carcinoma A rare, highly aggressive carcinoma that arises from the sinonasal tract. It is characterized by the presence of small to medium size malignant cells. The prognosis is poor. C54294 Neoplastic Process Sinonasal Undifferentiated Carcinoma Sinonasal Undifferentiated Carcinoma C1710096 CTRP Cellosaurus Malignant Sinonasal_Undifferentiated_Carcinoma Sinonasal Anaplastic Carcinoma Sinonasal Undifferentiated Carcinoma Undifferentiated Sinonasal Cancer Sinonasal Undifferentiated Carcinoma A rare carcinoma that arises centrally from the jaw and cannot be categorized as any other type of carcinoma. It derives from odontogenic cysts, odontogenic epithelial remnants, or other benign precursors. C54295 Neoplastic Process Primary Intraosseous Carcinoma, Not Otherwise Specified C1709663 Malignant Primary_Intraosseous_Squamous_Cell_Carcinoma PIOC Primary Intraosseous Carcinoma, NOS Primary Intraosseous Carcinoma, Not Otherwise Specified Primary Intraosseous Squamous Cell Carcinoma Primary Intraosseous Carcinoma, Not Otherwise Specified A rare, well differentiated, cytologically benign ameloblastoma which paradoxically metastasizes. C54297 Neoplastic Process Metastasizing Ameloblastoma C0334567 CDISC GDC A malignant odontogenic neoplasm arising from the epithelial component of the embryonic tooth. 9310/3 Malignant Metastasizing_Ameloblastoma 9310/3 Ameloblastoma, malignant Ameloblastoma, metastasizing AMELOBLASTOMA, MALIGNANT Ameloblastoma, malignant Malignant Ameloblastoma Metastasizing Ameloblastoma Metastasizing Ameloblastoma A very rare ameloblastic carcinoma that originates from a pre-existing intraosseous benign ameloblastoma. C54298 Neoplastic Process Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous C1706789 Malignant Ameloblastic_Carcinoma-Secondary_Type_Dedifferentiated_Intraosseous Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous Central Ameloblastic Carcinoma Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous A very rare ameloblastic carcinoma that originates from a pre-existing extraosseous benign ameloblastoma. C54299 Neoplastic Process Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral C1706790 Malignant Ameloblastic_Carcinoma-Secondary_Type_Dedifferentiated_Peripheral Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral Peripheral Ameloblastic Carcinoma Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Peripheral C5430 Neoplastic Process Intracranial Germinoma C1334240 Malignant Intracranial_Germinoma Intracranial Germinoma Intracranial Germinoma A usually aggressive malignant neoplasm arising from tooth-forming tissues. It more often affects older females and more frequently occurs in the mandible. It is characterized by the presence of malignant epithelial cells with clear cytoplasm and a fibrotic stroma formation. It may recur and metastasize. Metastases may occur in the lymph nodes, lungs, and bones. Treatment of choice is resection with clean margins. C54300 Neoplastic Process Clear Cell Odontogenic Carcinoma C0475829 Cellosaurus GDC 9341/1 9341/3 Malignant Clear_Cell_Odontogenic_Carcinoma 9341/1 9341/3 Clear cell odontogenic carcinoma Clear cell odontogenic tumor Clear Cell Ameloblastoma Clear Cell Odontogenic Carcinoma Clear Cell Odontogenic Tumor Clear cell odontogenic carcinoma Clear cell odontogenic tumor Clear Cell Odontogenic Carcinoma A slow growing, locally invasive neoplasm arising from tooth-forming tissues. It most often grows intraosseously in the mandible and less frequently in the maxilla. In a minority of cases it grows extraosseously in the gingiva. It is characterized by the presence of a fibrous stroma, epithelial cells with abundant eosinophilic cytoplasm, and amyloid material which is often calcified. Small tumors may be successfully treated with enucleation. Local resection is usually required for larger tumors. Recurrences have been reported in a minority of cases. C54301 Neoplastic Process Calcifying Epithelial Odontogenic Tumor Calcifying Epithelial Odontogenic Tumor C0334574 CTRP GDC 9340/0 Benign Calcifying_Epithelial_Odontogenic_Tumor 9340/0 Calcifying epithelial odontogenic tumor Pindborg tumor CEOT Calcifying Epithelial Odontogenic Tumor Calcifying epithelial odontogenic tumor Pindborg Tumor Pindborg tumor Calcifying Epithelial Odontogenic Tumor A rare primary intraosseous carcinoma, not otherwise specified, that arises from the lining of an odontogenic keratocyst. C54303 Neoplastic Process Primary Intraosseous Carcinoma, Not Otherwise Specified, Derived from Odontogenic Keratocyst C1709664 Malignant Primary_Intraosseous_Squamous_Cell_Carcinoma_Derived_From_Keratocystic_Odontogenic_Tumor Primary Intraosseous Carcinoma Derived From Keratocystic Odontogenic Tumor Primary Intraosseous Carcinoma Ex Keratocystic Odontogenic Tumor Primary Intraosseous Carcinoma, Not Otherwise Specified, Derived from Keratocystic Odontogenic Tumor Primary Intraosseous Carcinoma, Not Otherwise Specified, Derived from Odontogenic Keratocyst Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor Primary Intraosseous Carcinoma, Not Otherwise Specified, Derived from Odontogenic Keratocyst A tumor composed of mature adipocytes and fibrous tissue infiltrating the epineurium and peripheral nerves. It is often seen at birth or during childhood and may be associated with macrodactyly. C5431 Neoplastic Process Lipomatosis of Nerve C1335389 Benign Peripheral_Nerve_Fibrolipomatous_Hamartoma Fibrolipomatous Hamartoma of Peripheral Nerve Lipomatosis of Nerve Neural Fibrolipoma Peripheral Nerve Fibrolipomatous Hamartoma Lipomatosis of Nerve A benign, intraosseous or extraosseous cystic neoplasm arising from tooth-forming tissues. It is characterized by the presence of a cyst lined by an ameloblastoma-like epithelium and ghost cells formation. The ghost cells may undergo calcification. It is treated with enucleation. Few recurrences have been reported for intraosseous neoplasms whereas no recurrences have been reported for extraosseous neoplasms. C54319 Finding Neoplastic Process Calcifying Cystic Odontogenic Tumor C0206740 GDC 9301/0 Benign Calcifying_Cystic_Odontogenic_Tumor 9301/0 Calcifying odontogenic cyst Calcifying Cystic Odontogenic Tumor Calcifying Odontogenic Cyst Calcifying odontogenic cyst Gorlin Cyst Calcifying Cystic Odontogenic Tumor A cavernous hemangioma arising from the brain and meninges. C5432 Neoplastic Process Intracranial Cavernous Hemangioma C1334237 Benign Intracranial_Cavernous_Hemangioma Intracranial Cavernoma Intracranial Cavernous Angioma Intracranial Cavernous Hemangioma Intracranial Cavernous Hemangioma A benign but locally infiltrating neoplasm arising from tooth-forming tissues. It is more often intraosseous and less frequently extraosseous and occurs in the jaw. It is characterized by the presence of ameloblastoma-like epithelium, connective tissue stroma, ghost cells, and dysplastic dentin. Wide local resection is recommended for intraosseous neoplasms and enucleation for extraosseous neoplasms. C54323 Neoplastic Process Dentinogenic Ghost Cell Tumor Dentinogenic Ghost Cell Tumor C1704219 CTRP GDC 9302/0 Benign Dentinogenic_Ghost_Cell_Tumor 9271/0 9302/0 Dentinogenic ghost cell tumor Dentinoma Odontogenic ghost cell tumor Calcifying Ghost Cell Odontogenic Tumor DGCT Dentinoameloblastoma Dentinogenic Ghost Cell Tumor Dentinoma Odontogenic Ghost Cell Tumor Odontogenic ghost cell tumor Dentinogenic Ghost Cell Tumor A hemangioma arising from the cerebral hemisphere. C5433 Neoplastic Process Cerebral Hemangioma C0877388 Benign Cerebral_Hemangioma Angioma of Cerebral Hemispheres Angioma of Cerebrum Angioma of the Cerebral Hemispheres Angioma of the Cerebrum Cerebral Angioma Cerebral Hemangioma Cerebral Hemispheric Angioma Cerebral Hemispheric Hemangioma Hemangioma of Cerebral Hemispheres Hemangioma of Cerebrum Hemangioma of the Cerebral Hemispheres Hemangioma of the Cerebrum Cerebral Hemangioma An aggressive variant of squamous cell carcinoma that arises from the pyriform sinus or supraglottic area. It is characterized by the presence of small malignant cells with hyperchromatic nuclei and scant amount of cytoplasm forming lobules with peripheral palisading. Comedonecrosis may be present. An in situ or invasive keratinizing squamous cell carcinoma component is always present. Signs and symptoms include hoarseness, dysphagia, pain, and neck mass. C54334 Neoplastic Process Laryngeal Basaloid Squamous Cell Carcinoma C1708650 Malignant Laryngeal_Basaloid_Carcinoma Laryngeal Basaloid Carcinoma Laryngeal Basaloid Squamous Cell Carcinoma Laryngeal Basaloid Squamous Cell Carcinoma A variant of squamous cell carcinoma that arises from the larynx. It is characterized by exophytic and papillary growth usually in the supraglottic area. The papillae are covered by a malignant stratified squamous epithelium. C54335 Neoplastic Process Laryngeal Papillary Squamous Cell Carcinoma C2033294 Malignant Laryngeal_Papillary_Squamous_Cell_Carcinoma Laryngeal Papillary Squamous Cell Carcinoma Laryngeal Papillary Squamous Cell Carcinoma A squamous cell carcinoma that arises from the larynx. It is characterized by the presence of a malignant spindle cell cellular component. In some cases, there is a biphasic morphology due to the presence of a well-differentiated squamous cell carcinoma component. The latter is either in situ or invasive squamous cell carcinoma. C54336 Neoplastic Process Laryngeal Spindle Cell Squamous Carcinoma C1708656 Malignant Laryngeal_Squamous_Cell_Carcinoma_Spindle_Cell_Variant Laryngeal Carcinosarcoma Laryngeal Sarcomatoid Carcinoma Laryngeal Spindle Cell Carcinoma Laryngeal Spindle Cell Squamous Carcinoma Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant Laryngeal Spindle Cell Squamous Carcinoma A rare variant of squamous cell carcinoma that arises from the larynx. It is characterized by acantholysis of the tumor cells that results in the formation of pseudolumina that resemble glandular structures. C54337 Neoplastic Process Laryngeal Acantholytic Squamous Cell Carcinoma C1708648 Malignant Laryngeal_Acantholytic_Squamous_Cell_Carcinoma Laryngeal Acantholytic Squamous Cell Carcinoma Laryngeal Acantholytic Squamous Cell Carcinoma A rare, aggressive carcinoma that arises from the larynx. It is characterized by the presence of squamous cell carcinoma and adenocarcinoma components. Hoarseness, sore throat, and dysphagia are the presenting symptoms. C54338 Neoplastic Process Laryngeal Adenosquamous Carcinoma Laryngeal Adenosquamous Carcinoma C1708649 CTRP Malignant Laryngeal_Adenosquamous_Carcinoma Laryngeal Adenosquamous Carcinoma Laryngeal Throat Adenosquamous Cancer Laryngeal Adenosquamous Carcinoma An undifferentiated carcinoma that arises from the larynx. This category includes lymphoepithelial carcinoma and giant cell carcinoma. C54339 Neoplastic Process Laryngeal Undifferentiated Carcinoma Laryngeal Undifferentiated Carcinoma C2188069 CTRP Malignant Laryngeal_Undifferentiated_Carcinoma Laryngeal Undifferentiated Carcinoma Undifferentiated Laryngeal Throat Cancer Laryngeal Undifferentiated Carcinoma A benign schwannoma occurring in the twelfth cranial nerve. C5434 Neoplastic Process Schwannoma of the Twelfth Cranial Nerve C1335928 Benign Schwannoma_of_the_Twelfth_Cranial_Nerve Hypoglossal Nerve Neurilemmoma Hypoglossal Nerve Schwannoma Hypoglossal Neurilemmoma Hypoglossal Schwannoma Neurilemmoma of Hypoglossal Nerve Neurilemmoma of Twelfth Cranial Nerve Neurilemmoma of the Hypoglossal Nerve Neurilemmoma of the Twelfth Cranial Nerve Schwannoma of Hypoglossal Nerve Schwannoma of Twelfth Cranial Nerve Schwannoma of the Hypoglossal Nerve Schwannoma of the Twelfth Cranial Nerve Twelfth Cranial Nerve Neurilemmoma Twelfth Cranial Nerve Schwannoma Schwannoma of the Twelfth Cranial Nerve A rare and aggressive carcinoma that arises from the larynx. It is characterized by the presence of an undifferentiated carcinoma accompanied by a prominent reactive lymphoplasmacytic infiltrate. C54341 Neoplastic Process Laryngeal Lymphoepithelial Carcinoma C1708653 Malignant Laryngeal_Lymphoepithelial_Carcinoma Laryngeal Lymphoepithelial Carcinoma Laryngeal Lymphoepithelioma Laryngeal Undifferentiated Carcinoma of the Nasopharyngeal Type Laryngeal Lymphoepithelial Carcinoma A rare undifferentiated carcinoma that arises from the larynx. It is characterized by the presence of multiple bizarre multinucleated giant cells. The prognosis is poor. C54342 Neoplastic Process Laryngeal Giant Cell Carcinoma C2011252 Malignant Laryngeal_Giant_Cell_Carcinoma Laryngeal Anaplastic Carcinoma Laryngeal Giant Cell Carcinoma Laryngeal Giant Cell Carcinoma A benign neoplasm with exophytic and endophytic growth arising from the lateral nasal wall or the paranasal sinuses. It is characterized by the proliferation of columnar cells with oncocytic features. Microcysts containing mucin and neutrophils are present in the epithelium. Clinical manifestations include nasal obstruction and epistaxis. Occasionally, it is associated with the development or presence of a carcinoma, usually squamous cell carcinoma. C54345 Neoplastic Process Sinonasal Oncocytic Papilloma C1704453 GDC Benign Oncocytic_Schneiderian_Papilloma 8121/1 Oncocytic Schneiderian papilloma Oncocytic Schneiderian Papilloma Oncocytic Schneiderian papilloma Sinonasal Oncocytic Papilloma Sinonasal Oncocytic Schneiderian Papilloma Sinonasal Papilloma, Oncocytic Type Sinonasal Oncocytic Papilloma A benign nasal cavity exophytic papillary neoplasm with fibrovascular cores lined by epithelial cells. It arises from the lower anterior nasal septum. Clinical manifestations include nasal obstruction, epistaxis, and the presence of a mass. C54347 Neoplastic Process Nasal Cavity Exophytic Papilloma C1707964 Benign Exophytic_Schneiderian_Papilloma Nasal Cavity Exophytic Papilloma Nasal Cavity Exophytic Schneiderian Papilloma Nasal Cavity Exophytic Papilloma An olfactory neuroblastoma that extends beyond the nasal cavity and paranasal sinuses. C5435 Neoplastic Process Kadish Stage C Olfactory Neuroblastoma C1334317 Malignant Kadish_Stage_C_Olfactory_Neuroblastoma Kadish Stage C Olfactory Neuroblastoma Kadish Stage C Olfactory Neuroblastoma A central nervous system embryonal tumor, not otherwise specified arising from the cerebellopontine angle of the infratentorial brain. C5436 Neoplastic Process Cerebellopontine Angle Embryonal Tumor, Not Otherwise Specified C1332904 Malignant Cerebellopontine_Angle_Primitive_Neuroectodermal_Tumor C-P Angle PNET C-P Angle Primitive Neuroectodermal Neoplasm C-P Angle Primitive Neuroectodermal Tumor Cerebellar Pontine Angle PNET Cerebellar Pontine Angle Primitive Neuroectodermal Neoplasm Cerebellar Pontine Angle Primitive Neuroectodermal Tumor Cerebellopontine Angle Embryonal Tumor, NOS Cerebellopontine Angle Embryonal Tumor, Not Otherwise Specified Cerebellopontine Angle PNET Cerebellopontine Angle Primitive Neuroectodermal Neoplasm Cerebellopontine Angle Primitive Neuroectodermal Tumor Primitive Neuroectodermal Neoplasm of C-P Angle Primitive Neuroectodermal Neoplasm of Cerebellar Pontine Angle Primitive Neuroectodermal Neoplasm of Cerebellopontine Angle Primitive Neuroectodermal Neoplasm of the C-P Angle Primitive Neuroectodermal Neoplasm of the Cerebellar Pontine Angle Primitive Neuroectodermal Neoplasm of the Cerebellopontine Angle Primitive Neuroectodermal Tumor of C-P Angle Primitive Neuroectodermal Tumor of Cerebellar Pontine Angle Primitive Neuroectodermal Tumor of Cerebellopontine Angle Primitive Neuroectodermal Tumor of the C-P Angle Primitive Neuroectodermal Tumor of the Cerebellar Pontine Angle Primitive Neuroectodermal Tumor of the Cerebellopontine Angle Cerebellopontine Angle Embryonal Tumor, Not Otherwise Specified An aggressive variant of squamous cell carcinoma that arises from the nasopharynx. It is characterized by the presence of small malignant cells with hyperchromatic nuclei and scant amount of cytoplasm forming lobules with peripheral palisading. Comedonecrosis may be present. C54360 Neoplastic Process Nasopharyngeal Basaloid Squamous Cell Carcinoma C1711232 Malignant Nasopharyngeal_Basaloid_Squamous_Cell_Carcinoma Nasopharyngeal Basaloid Carcinoma Nasopharyngeal Basaloid Squamous Cell Carcinoma Nasopharyngeal Basaloid Squamous Cell Carcinoma A neuroblastoma arising from an anatomic site other than the brain. C5437 Neoplastic Process Extracranial Neuroblastoma Extracranial Neuroblastoma C1333499 CTRP Malignant Extracranial_Neuroblastoma Extracranial Neuroblastoma Extracranial Neuroblastoma A rare benign adipose tissue neoplasm of the corpus callosum. C5438 Neoplastic Process Corpus Callosum Lipoma C1333160 Benign Corpus_Callosum_Lipoma Corpus Callosum Lipoma Lipoma of Corpus Callosum Lipoma of the Corpus Callosum Corpus Callosum Lipoma A nonkeratinizing nasopharyngeal carcinoma characterized by the presence of cells without prominent nucleoli, cellular stratification, and a lymphoplasmacytic infiltrate. C54389 Neoplastic Process Nasopharyngeal Differentiated Carcinoma Nasopharyngeal Differentiated Carcinoma C1709153 CTRP Malignant Nasopharyngeal_Differentiated_Carcinoma Differentiated Nasopharyngeal Cancer Nasopharyngeal Differentiated Carcinoma Nasopharyngeal Non-Keratinizing Differentiated Carcinoma Nasopharyngeal Nonkeratinizing Differentiated Carcinoma Nasopharyngeal Differentiated Carcinoma An intradural extramedullary spinal metastasis from an intracranial tumor through the cerebrospinal fluid. C5439 Neoplastic Process Drop Metastasis in the Spinal Cord C1333313 Malignant Drop_Metastasis_to_Spinal_Cord Drop Metastasis in the Spinal Cord Drop Metastasis to the Spinal Cord Drop Metastatic Neoplasm to the Spinal Cord Drop Metastatic Tumor to the Spinal Cord Drop Secondary Malignant Neoplasm to the Spinal Cord Drop Secondary Malignant Tumor to the Spinal Cord Drop Metastasis in the Spinal Cord Leukemia infiltrating the central nervous system structures. C5440 Neoplastic Process Central Nervous System Leukemia Central Nervous System Leukemia C1332884 CPTAC CTRP Malignant Central_Nervous_System_Leukemia CNS Leukemia Central Nervous System Leukemia Leukemia of CNS Leukemia of Central Nervous System Leukemia of the CNS Leukemia of the Central Nervous System Central Nervous System Leukemia A low-grade exophytic adenocarcinoma with papillary growth that arises from the epithelium of the nasopharynx. If it is completely removed, the prognosis is excellent. C54400 Neoplastic Process Nasopharyngeal Papillary Adenocarcinoma Nasopharyngeal Low Grade Papillary Adenocarcinoma C1711278 CTRP Malignant Nasopharyngeal_Papillary_Adenocarcinoma Low Grade Nasopharyngeal Papillary Adenocarcinoma Low-Grade Nasopharyngeal Papillary Adenocarcinoma Nasopharyngeal Low Grade Papillary Adenocarcinoma Nasopharyngeal Low-Grade Papillary Adenocarcinoma Nasopharyngeal Papillary Adenocarcinoma Nasopharyngeal Throat Papillary Adenocarcinoma Nasopharyngeal Low Grade Papillary Adenocarcinoma A mature or immature teratoma that affects the central nervous system. C5441 Neoplastic Process Central Nervous System Teratoma C1332895 Undetermined Central_Nervous_System_Teratoma CNS Teratoma Central Nervous System Teratoma Teratoma of CNS Teratoma of Central Nervous System Teratoma of the CNS Teratoma of the Central Nervous System Central Nervous System Teratoma A melanoma that arises from the leptomeninges within the cranium. C5442 Neoplastic Process Intracranial Melanoma C1334243 Malignant Intracranial_Melanoma Brain Melanoma Intracranial Melanoma Primary Brain Melanoma Primary Intracranial Melanoma Intracranial Melanoma C5443 Neoplastic Process Conus Medullaris Neoplasm C1333153 Undetermined Conus_Medullaris_Neoplasm Conus Medullaris Neoplasm Conus Medullaris Tumor Neoplasm of Conus Medullaris Neoplasm of the Conus Medullaris Tumor of Conus Medullaris Tumor of the Conus Medullaris Conus Medullaris Neoplasm A rare benign adipose tissue neoplasm located in the intracranial region. It is a congenital hamartomatous malformation derived from the embryologic meninx primitiva. C5444 Neoplastic Process Intracranial Lipoma C1334241 Benign Intracranial_Lipoma Intracranial Lipoma Intracranial Lipoma Diffuse or multifocal infiltration of the meninges by malignant glioma. C5446 Neoplastic Process Meningeal Gliomatosis C1334695 Malignant Meningeal_Gliomatosis Gliomatosis of Meninges Gliomatosis of the Meninges Meningeal Gliomatosis Meninges Gliomatosis Meningeal Gliomatosis An anaplastic oligodendroglioma that arises from the central nervous system and occurs during childhood. C5447 Neoplastic Process Childhood Anaplastic Oligodendroglioma Childhood Anaplastic Oligodendroglioma C1332943 CTRP NICHD An anaplastic oligodendroglioma that occurs during childhood. Malignant Childhood_Anaplastic_Oligodendroglioma Anaplastic Childhood Oligodendroglioma Anaplastic Oligodendroglioma Anaplastic Pediatric Oligodendroglioma Childhood Anaplastic Oligodendroglioma Undifferentiated Childhood Oligodendroglioma Undifferentiated Pediatric Oligodendroglioma Childhood Anaplastic Oligodendroglioma A primary or metastatic malignant neoplasm that affects the central nervous system and occurs during childhood. C5448 Neoplastic Process Malignant Childhood Central Nervous System Neoplasm Childhood Malignant Central Nervous System Neoplasm C1334573 CTRP NICHD A malignant neoplasm of the brain, spinal cord, or meninges occurring in children. Malignant Malignant_Childhood_Central_Nervous_System_Neoplasm Childhood Malignant CNS Neoplasms Childhood Malignant CNS Tumors Childhood Malignant Central Nervous System Neoplasm Childhood Malignant Central Nervous System Neoplasms Childhood Malignant Central Nervous System Tumors Malignant Central Nervous System Neoplasm Malignant Central Nervous System Neoplasms of Childhood Malignant Central Nervous System Tumors of Childhood Malignant Childhood CNS Neoplasm Malignant Childhood CNS Tumor Malignant Childhood Central Nervous System Neoplasm Malignant Childhood Central Nervous System Neoplasms Malignant Childhood Central Nervous System Tumor Malignant Childhood Central Nervous System Tumors Malignant Childhood Neoplasm of CNS Malignant Childhood Neoplasm of Central Nervous System Malignant Childhood Neoplasm of the CNS Malignant Childhood Neoplasm of the Central Nervous System Malignant Childhood Tumor of CNS Malignant Childhood Tumor of Central Nervous System Malignant Childhood Tumor of the CNS Malignant Childhood Tumor of the Central Nervous System Malignant Pediatric CNS Neoplasm Malignant Pediatric CNS Tumor Malignant Pediatric Central Nervous System Neoplasm Malignant Pediatric Central Nervous System Tumor Malignant Pediatric Neoplasm of CNS Malignant Pediatric Neoplasm of Central Nervous System Malignant Pediatric Neoplasm of the CNS Malignant Pediatric Neoplasm of the Central Nervous System Malignant Pediatric Tumor of CNS Malignant Pediatric Tumor of Central Nervous System Malignant Pediatric Tumor of the CNS Malignant Pediatric Tumor of the Central Nervous System Childhood Malignant Central Nervous System Neoplasm A benign or malignant mesenchymal neoplasm originating in the central nervous system or the meninges and showing fibrous, fibrohistiocytic, adipose, myoid, endothelial, chondroid or osseous, but not meningothelial differentiation. Depending on the histological features and clinical behavior of these neoplasms, their grade ranges from benign (WHO grade I) to highly malignant (WHO grade IV). (Adapted from WHO) C5449 Neoplastic Process Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm C1332893 Undetermined Central_Nervous_System_Soft_Tissue_Neoplasm CNS Soft Tissue Neoplasm CNS Soft Tissue Tumor Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm Central Nervous System Mesenchymal, Non-Meningothelial Tumor Central Nervous System Soft Tissue Neoplasm Central Nervous System Soft Tissue Tumor Mesenchymal Non-Meningothelial Tumor of the Central Nervous System Mesenchymal, Non-Meningothelial Tumor of CNS Mesenchymal, Non-Meningothelial Tumor of Central Nervous System Mesenchymal, Non-Meningothelial Tumor of the CNS Soft Tissue Neoplasm of CNS Soft Tissue Neoplasm of Central Nervous System Soft Tissue Neoplasm of the CNS Soft Tissue Neoplasm of the Central Nervous System Soft Tissue Tumor of CNS Soft Tissue Tumor of Central Nervous System Soft Tissue Tumor of the CNS Soft Tissue Tumor of the Central Nervous System Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm A malignant vascular neoplasm arising from the brain, spinal cord or meninges. C5450 Neoplastic Process Central Nervous System Angiosarcoma C1332875 Malignant Central_Nervous_System_Angiosarcoma Angiosarcoma of CNS Angiosarcoma of Central Nervous System Angiosarcoma of the CNS Angiosarcoma of the Central Nervous System CNS Angiosarcoma CNS Hemangiosarcoma Central Nervous System Angiosarcoma Central Nervous System Hemangiosarcoma Hemangiosarcoma of CNS Hemangiosarcoma of Central Nervous System Hemangiosarcoma of the CNS Hemangiosarcoma of the Central Nervous System Central Nervous System Angiosarcoma A rare benign adipose tissue neoplasm of the central nervous system frequently found in midline locations such as the corpus callosum, the quadrigeminal plate, the hypothalamus, the spinal canal or the cauda equina. Some contain Schwann cells, bone, cartilage or hamartomatous blood vessels. C5451 Neoplastic Process Central Nervous System Lipoma C1332885 Benign Central_Nervous_System_Lipoma CNS Lipoma Central Nervous System Lipoma Lipoma of CNS Lipoma of Central Nervous System Lipoma of the CNS Lipoma of the Central Nervous System Central Nervous System Lipoma A rare benign adipose tissue neoplasm of the internal auditory canal, often presenting as an acoustic tumor. It may be intermixed with the vestibulocochlear nerve and may adhere to adjacent structures. C5452 Neoplastic Process Inner Ear Lipoma C1334226 Benign Internal_Auditory_Canal_Lipoma Inner Ear Lipoma Internal Auditory Canal Lipoma Internal Ear Lipoma Lipoma of Internal Auditory Canal Lipoma of the Internal Auditory Canal Inner Ear Lipoma A chordoma that arises from the base of the skull. C5453 Neoplastic Process Skull Base Chordoma C1335975 Malignant Skull_Base_Chordoma Chordoma of Skull Base Chordoma of the Skull Base Skull Base Chordoma Skull Base Chordoma Stage IIA includes: (T0, N1, M0); (T1, N1, M0); (T2, N0, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+). (AJCC 6th and 7th Eds.) C5454 Neoplastic Process Stage IIA Breast Cancer AJCC v6 and v7 Stage IIA Breast Cancer AJCC v6 and v7 C1336156 CTRP Stage II breast cancer is divided into stages IIA and IIB. In stage IIA, (1) no tumor is found in the breast, but cancer is found in the axillary (under the arm) lymph nodes; or (2) the tumor is 2 centimeters or smaller and has spread to the axillary lymph nodes; or (3) the tumor is larger than 2 centimeters but not larger than 5 centimeters and has not spread to the axillary lymph nodes. Malignant Stage_IIA_Breast_Cancer Breast Cancer Stage IIA Breast Carcinoma Stage IIA Stage IIA Breast Cancer Stage IIA Breast Cancer AJCC v6 Stage IIA Breast Cancer AJCC v6 and v7 Stage IIA Breast Cancer AJCC v7 Stage IIA Breast Carcinoma stage IIA breast cancer Stage IIA Breast Cancer AJCC v6 and v7 Stage IIB includes: (T2, N1, M0); (T3, N0, M0). T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. T3: Tumor more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+). (AJCC 6th and 7th Eds.) C5455 Neoplastic Process Stage IIB Breast Cancer AJCC v6 and v7 Stage IIB Breast Cancer AJCC v6 and v7 C1336178 CTRP Stage II breast cancer is divided into stages IIA and IIB. In stage IIB, (1) the tumor is larger than 2 centimeters but not larger than 5 centimeters and has spread to the axillary (under the arm) lymph nodes; or (2) the tumor is larger than 5 centimeters but has not spread to the axillary lymph nodes. Malignant Stage_IIB_Breast_Cancer Breast Cancer Stage IIB Breast Carcinoma Stage IIB Stage IIB Breast Cancer Stage IIB Breast Cancer AJCC v6 Stage IIB Breast Cancer AJCC v6 and v7 Stage IIB Breast Cancer AJCC v7 Stage IIB Breast Carcinoma stage IIB breast cancer Stage IIB Breast Cancer AJCC v6 and v7 An invasive breast adenocarcinoma with cytological and immunophenotypic characteristics of apocrine differentiation in more than 90 percent of the malignant cells. C5457 Neoplastic Process Invasive Breast Apocrine Carcinoma C1334272 Malignant Invasive_Apocrine_Breast_Carcinoma Infiltrating Apocrine Breast Carcinoma Infiltrating Apocrine Carcinoma of Breast Infiltrating Apocrine Carcinoma of the Breast Invasive Apocrine Breast Carcinoma Invasive Apocrine Carcinoma of Breast Invasive Apocrine Carcinoma of the Breast Invasive Breast Apocrine Carcinoma Invasive Breast Carcinoma with Apocrine Differentiation Invasive Breast Apocrine Carcinoma A unique group of rare tumors of the central nervous system that affect mainly children and adolescents. Their morphologic and biologic profile corresponds to that of homologous germ cell tumors that arise in the gonads and in other extragonadal sites. Representative examples include: germinoma, embryonal carcinoma, yolk sac tumor, choriocarcinoma, and teratoma. C5461 Neoplastic Process Central Nervous System Germ Cell Tumor Central Nervous System Germ Cell Tumor C1332880 CTRP Undetermined Central_Nervous_System_Germ_Cell_Neoplasm CNS Germ Cell Neoplasm CNS Germ Cell Tumor Central Nervous System Germ Cell Neoplasm Central Nervous System Germ Cell Tumor Germ Cell Neoplasm of CNS Germ Cell Neoplasm of Central Nervous System Germ Cell Neoplasm of the CNS Germ Cell Neoplasm of the Central Nervous System Germ Cell Tumor of CNS Germ Cell Tumor of Central Nervous System Germ Cell Tumor of the CNS Germ Cell Tumor of the Central Nervous System Central Nervous System Germ Cell Tumor An extraskeletal myxoid chondrosarcoma arising from the brain. C5462 Neoplastic Process Brain Extraskeletal Myxoid Chondrosarcoma C1334238 Malignant Intracranial_Chondrosarcoma Brain Extraskeletal Myxoid Chondrosarcoma Intracranial Extraskeletal Myxoid Chondrosarcoma Brain Extraskeletal Myxoid Chondrosarcoma A malignant mesenchymal neoplasm with skeletal muscle differentiation affecting the central nervous system. C5464 Neoplastic Process Central Nervous System Rhabdomyosarcoma C1332891 Malignant Central_Nervous_System_Rhabdomyosarcoma CNS Rhabdomyosarcoma Central Nervous System Rhabdomyosarcoma Rhabdomyosarcoma of CNS Rhabdomyosarcoma of Central Nervous System Rhabdomyosarcoma of the CNS Rhabdomyosarcoma of the Central Nervous System Central Nervous System Rhabdomyosarcoma A usually aggressive malignant neoplasm arising from the central nervous system. It is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation in a herringbone growth pattern. C5465 Neoplastic Process Central Nervous System Fibrosarcoma C1332879 Malignant Central_Nervous_System_Fibrosarcoma CNS Fibrosarcoma Central Nervous System Fibrosarcoma Fibrosarcoma of CNS Fibrosarcoma of Central Nervous System Fibrosarcoma of the CNS Fibrosarcoma of the Central Nervous System Central Nervous System Fibrosarcoma A benign melanocytic nevus that arises from the breast skin. C54658 Neoplastic Process Breast Nevus C1879898 Benign Breast_Nevus Breast Nevus Nevus of Breast Nevus of the Breast Breast Nevus A melanocytic nevus that arises from the palms, soles, and nails. C54659 Neoplastic Process Acral Nevus C1879545 Benign Acral_Skin_Nevus Acral nevus Acral Nevus Acral Skin Nevus Nevus of Acral Skin Acral Nevus An extra-adrenal paraganglioma arising from the central nervous system. C5466 Neoplastic Process Central Nervous System Paraganglioma C1332890 Undetermined Central_Nervous_System_Paraganglioma CNS Paraganglioma Central Nervous System Paraganglioma Paraganglioma of CNS Paraganglioma of Central Nervous System Paraganglioma of the CNS Paraganglioma of the Central Nervous System Central Nervous System Paraganglioma A benign nevus occurring in the flexural skin. C54660 Neoplastic Process Flexural Skin Nevus C1880790 Benign Flexural_Skin_Nevus Flexural Skin Nevus Nevus of Flexural Skin Flexural Skin Nevus A benign nevus that arises from the skin in the head and neck region. C54661 Neoplastic Process Head and Neck Nevus C1881034 Benign Head_and_Neck_Nevus Head and Neck Nevus Nevus of Head and Neck Head and Neck Nevus A rare variant of cutaneous melanoma occurring mostly in adults in their fifth decade. Morphologically it resembles an ordinary compound or dermal nevus. C54662 Neoplastic Process Nevoid Melanoma Nevoid Melanoma C1882081 CTRP Malignant Nevoid_Melanoma Nevoid Cutaneous (Skin) Melanoma Nevoid Melanoma Nevoid Melanoma A rare variant of cutaneous melanoma, characterized by the presence of malignant cells with signet-ring morphology. C54663 Neoplastic Process Signet Ring Melanoma Signet Ring Melanoma C1883030 CTRP Malignant Signet_Ring_Melanoma Signet Ring Cutaneous (Skin) Melanoma Signet Ring Melanoma Signet Ring Skin Melanoma Signet-Ring Melanoma Signet-Ring Skin Melanoma Signet Ring Melanoma A carcinoma with apocrine and less often eccrine differentiation, arising from the sweat glands. It usually presents as a solitary slow growing nodule in the dermis or subcutaneous tissues. It is characterized by a nodular growth pattern and it is often associated with necrotic changes. C54664 Neoplastic Process Hidradenocarcinoma CL480948 GDC 8402/3 Malignant Clear_Cell_Eccrine_Carcinoma 8402/3 Hidradenocarcinoma Nodular hidradenoma, malignant Clear Cell Eccrine Carcinoma Hidradenocarcinoma Hidradenocarcinoma A variant of basal cell carcinoma with the architectural features of a nodular basal cell carcinoma. It is characterized by the formation of keratin (horn cysts) in the center of the tumor islands. Dystrophic calcification is frequently present. C54665 Neoplastic Process Skin Keratotic Basal Cell Carcinoma C1304299 Malignant Keratotic_Basal_Cell_Carcinoma Keratotic Basal Cell Carcinoma Pilar Basal Cell Carcinoma Skin Keratotic Basal Cell Carcinoma Skin Keratotic Basal Cell Carcinoma Stage IA includes: T1, N0, M0. T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C5468 Neoplastic Process Stage IA Gastric Cancer AJCC v7 Stage IA Gastric Cancer AJCC v7 C1336115 CTRP Malignant Stage_IA_Gastric_Cancer Carcinoma of Stomach Stage IA Carcinoma of the Stomach Stage IA Gastric Cancer Stage IA Gastric Carcinoma Stage IA Stage IA Carcinoma of Stomach Stage IA Carcinoma of the Stomach Stage IA Gastric (Stomach) Cancer Stage IA Gastric Cancer Stage IA Gastric Cancer AJCC v7 Stage IA Gastric Carcinoma Stage IA Stomach Carcinoma Stomach Carcinoma Stage IA Stage IA Gastric Cancer AJCC v7 Stage IB includes: (T2, N0, M0); (T1, N1, M0). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C5469 Neoplastic Process Stage IB Gastric Cancer AJCC v7 Stage IB Gastric Cancer AJCC v7 C1336134 CTRP Malignant Stage_IB_Gastric_Cancer Carcinoma of Stomach Stage IB Carcinoma of the Stomach Stage IB Gastric Cancer Stage IB Gastric Carcinoma Stage IB Stage IB Carcinoma of Stomach Stage IB Carcinoma of the Stomach Stage IB Gastric (Stomach) Cancer Stage IB Gastric Cancer Stage IB Gastric Cancer AJCC v7 Stage IB Gastric Carcinoma Stage IB Stomach Carcinoma Stomach Carcinoma Stage IB Stage IB Gastric Cancer AJCC v7 An invasive lobular carcinoma characterized by the presence of malignant epithelial cells with large intracytoplasmic lumina that cause displacement of the nuclei towards one pole of the cells. C54691 Neoplastic Process Invasive Breast Lobular Carcinoma, Signet Ring Variant C1883029 Malignant Signet_Ring_Cell_Lobular_Breast_Carcinoma Invasive Breast Lobular Carcinoma, Signet Ring Variant Invasive Breast Lobular Carcinoma, Signet-Ring Variant Invasive Lobular Breast Carcinoma, Signet Ring Variant Signet Ring Cell Lobular Breast Carcinoma Invasive Breast Lobular Carcinoma, Signet Ring Variant Stage IIIB includes: (T4b, N0, M0); (T4b, N1, M0); (T4a, N2, M0); (T3, N3, M0). T3: Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures. T4a: Tumor invades serosa (visceral peritoneum). T4b: Tumor invades adjacent structures. N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. N2: Metastasis in 3-6 regional lymph nodes. N3: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C5470 Neoplastic Process Stage IIIB Gastric Cancer AJCC v7 Stage IIIB Gastric Cancer AJCC v7 C1336222 CTRP Malignant Stage_IIIB_Gastric_Cancer Carcinoma of Stomach Stage IIIB Carcinoma of the Stomach Stage IIIB Gastric Cancer Stage IIIB Gastric Carcinoma Stage IIIB Stage IIIB Carcinoma of Stomach Stage IIIB Carcinoma of the Stomach Stage IIIB Gastric (Stomach) Cancer Stage IIIB Gastric Cancer Stage IIIB Gastric Cancer AJCC v7 Stage IIIB Gastric Carcinoma Stage IIIB Stomach Carcinoma Stomach Carcinoma Stage IIIB Stage IIIB Gastric Cancer AJCC v7 Stage IIIA includes: (T4a, N1, M0); (T3, N2, M0); (T2, N3, M0). T2: Tumor invades the muscularis propria. T3: Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures. T4a: Tumor invades serosa (visceral peritoneum). N1: Metastasis in 1-2 regional lymph nodes. N2: Metastasis in 3-6 regional lymph nodes. N3: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C5471 Neoplastic Process Stage IIIA Gastric Cancer AJCC v7 Stage IIIA Gastric Cancer AJCC v7 C1336207 CTRP Malignant Stage_IIIA_Gastric_Cancer Carcinoma of Stomach Stage IIIA Carcinoma of the Stomach Stage IIIA Gastric Cancer Stage IIIA Gastric Carcinoma Stage IIIA Stage IIIA Carcinoma of Stomach Stage IIIA Carcinoma of the Stomach Stage IIIA Gastric (Stomach) Cancer Stage IIIA Gastric Cancer Stage IIIA Gastric Cancer AJCC v7 Stage IIIA Gastric Carcinoma Stage IIIA Stomach Carcinoma Stomach Carcinoma Stage IIIA Stage IIIA Gastric Cancer AJCC v7 A variant of gastric adenocarcinoma with exophytic growth and elongated finger-like processes lined by cylindrical or cuboidal cells supported by fibrovascular connective tissue cores. C5472 Neoplastic Process Gastric Papillary Adenocarcinoma C1333785 CPTAC Malignant Gastric_Papillary_Adenocarcinoma Gastric Papillary Adenocarcinoma Papillary Adenocarcinoma of Stomach Papillary Adenocarcinoma of the Stomach Papillary adenocarcinoma Gastric Papillary Adenocarcinoma A variant of gastric adenocarcinoma characterized by prominent dilated or slit-like tubules. C5473 Neoplastic Process Gastric Tubular Adenocarcinoma C1333791 CPTAC Cellosaurus Malignant Gastric_Tubular_Adenocarcinoma Gastric Tubular Adenocarcinoma Tubular Adenocarcinoma of Stomach Tubular Adenocarcinoma of the Stomach Tubular adenocarcinoma Gastric Tubular Adenocarcinoma A carcinoma that arises from the stomach and is characterized by the presence of malignant cells with glandular and squamous differentiation. C5474 Neoplastic Process Gastric Adenosquamous Carcinoma Gastric Adenosquamous Carcinoma C1333761 CTRP Cellosaurus Malignant Gastric_Adenosquamous_Carcinoma Adenosquamous Carcinoma of Stomach Adenosquamous Carcinoma of the Stomach Gastric (Stomach) Adenosquamous Cancer Gastric Adenosquamous Carcinoma Gastric Adenosquamous Carcinoma A rare carcinoma of the stomach resembling squamous cell carcinomas arising elsewhere in the body. C5475 Neoplastic Process Gastric Squamous Cell Carcinoma Gastric Squamous Cell Carcinoma C1333789 CTRP Malignant Gastric_Squamous_Cell_Carcinoma Gastric (Stomach) Squamous Cell Cancer Gastric Squamous Cell Carcinoma Squamous Cell Carcinoma of Stomach Squamous Cell Carcinoma of the Stomach Gastric Squamous Cell Carcinoma A carcinoma that arises from the stomach and is characterized by the absence of microscopic features of glandular or squamous differentiation. C5476 Neoplastic Process Undifferentiated Gastric Carcinoma Gastric Undifferentiated Carcinoma C1336858 CTRP Cellosaurus Malignant Undifferentiated_Gastric_Carcinoma Anaplastic Carcinoma of Stomach Anaplastic Carcinoma of the Stomach Anaplastic Gastric Carcinoma Gastric Undifferentiated Carcinoma Undifferentiated Carcinoma of Stomach Undifferentiated Carcinoma of the Stomach Undifferentiated Gastric (Stomach) Cancer Undifferentiated Gastric Carcinoma Gastric Undifferentiated Carcinoma C5478 Neoplastic Process Adult Intracranial Neoplasm C1332203 Undetermined Adult_Intracranial_Neoplasm Adult Intracranial Neoplasm Adult Intracranial Neoplasms Adult Intracranial Tumor Adult Intracranial Neoplasm C5479 Neoplastic Process Cauda Equina Neoplasm C1263892 Undetermined Cauda_Equina_Neoplasm Cauda Equina Neoplasm Cauda Equina Neoplasms Cauda Equina Tumor Neoplasm of Cauda Equina Neoplasm of the Cauda Equina Tumor of Cauda Equina Tumor of the Cauda Equina Cauda Equina Neoplasm A hemangioma arising from the stomach. C5481 Neoplastic Process Gastric Hemangioma C1333770 Benign Gastric_Hemangioma Angioma of Stomach Angioma of the Stomach Gastric Angioma Gastric Hemangioma Hemangioma of Stomach Hemangioma of the Stomach Gastric Hemangioma A lymphangioma arising from the stomach. C5482 Neoplastic Process Gastric Lymphangioma C1333779 Benign Gastric_Lymphangioma Gastric Lymphangioma Lymphangioma of Stomach Lymphangioma of the Stomach Gastric Lymphangioma A granular cell tumor that arises from the stomach and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C5483 Neoplastic Process Benign Gastric Granular Cell Tumor C1332503 Benign Benign_Gastric_Granular_Cell_Tumor Benign Gastric Granular Cell Neoplasm Benign Gastric Granular Cell Tumor Benign Granular Cell Neoplasm of Stomach Benign Granular Cell Neoplasm of the Stomach Benign Granular Cell Stomach Neoplasm Benign Granular Cell Stomach Tumor Benign Granular Cell Tumor of Stomach Benign Granular Cell Tumor of the Stomach Gastric Myoblastoma Myoblastoma of Stomach Myoblastoma of the Stomach Benign Gastric Granular Cell Tumor A metastasizing granular cell tumor that arises from the stomach. C5484 Neoplastic Process Malignant Gastric Granular Cell Tumor C1334585 Malignant Malignant_Gastric_Granular_Cell_Tumor Malignant Gastric Granular Cell Neoplasm Malignant Gastric Granular Cell Tumor Malignant Granular Cell Neoplasm of Stomach Malignant Granular Cell Neoplasm of the Stomach Malignant Granular Cell Stomach Neoplasm Malignant Granular Cell Stomach Tumor Malignant Granular Cell Tumor of Stomach Malignant Granular Cell Tumor of the Stomach Malignant Gastric Granular Cell Tumor A malignant germ cell tumor that arises from the stomach. It includes choriocarcinoma and immature teratoma. C5486 Neoplastic Process Malignant Gastric Germ Cell Tumor C1334584 Malignant Malignant_Gastric_Germ_Cell_Neoplasm Malignant Gastric Germ Cell Neoplasm Malignant Gastric Germ Cell Tumor Malignant Germ Cell Neoplasm of Stomach Malignant Germ Cell Neoplasm of the Stomach Malignant Germ Cell Tumor of Stomach Malignant Germ Cell Tumor of the Stomach Malignant Gastric Germ Cell Tumor A benign, intermediate, or malignant mesenchymal neoplasm that arises from the stomach. C5487 Neoplastic Process Gastric Soft Tissue Neoplasm C1708195 Undetermined Gastric_Mesenchymal_Neoplasm Gastric Soft Tissue Neoplasm Gastric Soft Tissue Tumor Soft Tissue Neoplasm of Stomach Soft Tissue Neoplasm of the Stomach Soft Tissue Tumor of Stomach Soft Tissue Tumor of the Stomach Gastric Soft Tissue Neoplasm A liposarcoma that arises from the stomach. C5488 Neoplastic Process Gastric Liposarcoma C1333778 Malignant Gastric_Liposarcoma Gastric Liposarcoma Liposarcoma of Stomach Liposarcoma of the Stomach Stomach Liposarcoma Gastric Liposarcoma A very rare colon carcinoma characterized by the presence of a malignant squamous cell infiltrate. C5490 Neoplastic Process Colon Squamous Cell Carcinoma Colon Squamous Cell Carcinoma C1333100 CTRP Malignant Colon_Squamous_Cell_Carcinoma Colon Epidermoid Carcinoma Colon Squamous Cell Cancer Colon Squamous Cell Carcinoma Colonic Epidermoid Carcinoma Colonic Squamous Cell Carcinoma Epidermoid Carcinoma of Colon Epidermoid Carcinoma of the Colon Squamous Cell Carcinoma of Colon Squamous Cell Carcinoma of the Colon Squamous Cell Colon Carcinoma Colon Squamous Cell Carcinoma An unusual colon carcinoma characterized by the presence of glandular and squamous carcinomatous components. The two carcinomatous components may be admixed within the tumor, or the two may appear separately in different areas. C5491 Neoplastic Process Colon Adenosquamous Carcinoma Colon Adenosquamous Carcinoma C1333082 CTRP Malignant Colon_Adenosquamous_Carcinoma Adenosquamous Carcinoma of Colon Adenosquamous Carcinoma of the Colon Adenosquamous Colon Carcinoma Colon Adenosquamous Cancer Colon Adenosquamous Carcinoma Colonic Adenosquamous Carcinoma Colon Adenosquamous Carcinoma A well-circumscribed benign smooth muscle neoplasm arising from the colon. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C5492 Neoplastic Process Colon Leiomyoma C1333092 Benign Colon_Leiomyoma Colon Leiomyoma Colonic Leiomyoma Leiomyoma of Colon Leiomyoma of the Colon Colon Leiomyoma A benign adipose tissue neoplasm originating in the colon. It is the second most common benign lesion of the colon after benign adenomatous polyps. Older patients are more likely to be affected, and most lesions are located at the right side of large bowel. Colon lipomas may lead to intestinal obstruction. C5493 Neoplastic Process Colon Lipoma C0940607 Benign Colon_Lipoma Colon Lipoma Colonic Lipoma Lipoma of Colon Lipoma of the Colon Colon Lipoma An aggressive malignant smooth muscle neoplasm that arises from the colon. It is characterized by a proliferation of neoplastic spindle cells. C5494 Neoplastic Process Colon Leiomyosarcoma C1333093 Malignant Colon_Leiomyosarcoma Colon Leiomyosarcoma Colonic Leiomyosarcoma Leiomyosarcoma of Colon Leiomyosarcoma of the Colon Colon Leiomyosarcoma A malignant soft tissue neoplasm that arises from the colon. Representative examples include angiosarcoma, Kaposi sarcoma, and leiomyosarcoma. C5495 Neoplastic Process Colon Sarcoma C1333098 Malignant Colon_Sarcoma Colon Sarcoma Colonic Sarcoma Sarcoma of Colon Sarcoma of the Colon Colon Sarcoma A neoplasm that arises from the glandular epithelium of the colonic mucosa. It is characterized by tubular and villous architectural patterns. The neoplastic glandular cells have dysplastic features. C5496 Neoplastic Process Colon Tubulovillous Adenoma C1112748 Benign Colon_Tubulovillous_Adenoma Colon Tubulovillous Adenoma Colonic Tubulovillous Adenoma Tubulovillous Adenoma of Colon Tubulovillous Adenoma of the Colon Colon Tubulovillous Adenoma A well differentiated, low grade neuroendocrine neoplasm that arises from the colon. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. C5497 Neoplastic Process Colon Neuroendocrine Tumor G1 C1333084 CPTAC Undetermined Colon_Carcinoid_Tumor Colon NET G1 Colon Neuroendocrine Tumor G1 Colon Neuroendocrine Tumor G1 An extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue that arises from the colon. C5498 Neoplastic Process Colon Mucosa-Associated Lymphoid Tissue Lymphoma Colon Mucosa-Associated Lymphoid Tissue Lymphoma C1333096 CTRP Malignant Colon_Mucosa-Associated_Lymphoid_Tissue_Lymphoma Colon MALT Lymphoma Colon MALToma Colon Mucosa-Associated Lymphoid Tissue Lymphoma Colonic MALT Lymphoma Colonic MALToma Colonic Mucosa-Associated Lymphoid Tissue Lymphoma MALT Lymphoma of Colon MALT Lymphoma of the Colon MALToma of Colon MALToma of the Colon Colon Mucosa-Associated Lymphoid Tissue Lymphoma An extranodal Hodgkin lymphoma that arises from the colon. C5499 Neoplastic Process Colon Hodgkin Lymphoma C1333089 Malignant Colon_Hodgkin_s_Lymphoma Colon Hodgkin Lymphoma Colon Hodgkin's Disease Colon Hodgkin's Lymphoma Colonic Hodgkin's Disease Colonic Hodgkin's Lymphoma Hodgkin's Lymphoma of Colon Hodgkin's Lymphoma of the Colon Primary Colon Hodgkin's Lymphoma Colon Hodgkin Lymphoma A lymphangioma arising from the colon. C5500 Neoplastic Process Colon Lymphangioma C1333094 Benign Colon_Lymphangioma Colon Lymphangioma Colonic Lymphangioma Lymphangioma of Colon Lymphangioma of the Colon Colon Lymphangioma A well differentiated, low grade neuroendocrine neoplasm that arises from the cecum. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. C5501 Neoplastic Process Cecum Neuroendocrine Tumor G1 Cecum Neuroendocrine Tumor G1 C0854488 CTRP Undetermined Cecum_Carcinoid_Tumor Cecum NET G1 Cecum Neuroendocrine Tumor G1 Cecum Neuroendocrine Tumor G1 A granular cell tumor that arises from a peripheral nerve and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C5502 Neoplastic Process Benign Peripheral Nerve Granular Cell Tumor C1332530 Benign Benign_Peripheral_Nerve_Granular_Cell_Tumor Benign Granular Cell Neoplasm of Peripheral Nerve Benign Granular Cell Neoplasm of the Peripheral Nerve Benign Granular Cell Tumor of Peripheral Nerve Benign Granular Cell Tumor of the Peripheral Nerve Benign Peripheral Nerve Granular Cell Neoplasm Benign Peripheral Nerve Granular Cell Tumor Benign Peripheral Nerve Granular Cell Tumor A neoplasm of hematopoietic and lymphoid cell origin that affects the brain, meninges, or spinal cord. C5503 Neoplastic Process Central Nervous System Hematopoietic and Lymphoid Cell Neoplasm C1332882 Undetermined Central_Nervous_System_Hematopoietic_Neoplasm CNS Hematopoietic Neoplasm CNS Hematopoietic Tumor Central Nervous System Hematopoietic Neoplasm Central Nervous System Hematopoietic Neoplasms Central Nervous System Hematopoietic Tumor Central Nervous System Hematopoietic and Lymphoid Cell Neoplasm Hematopoietic Neoplasm of CNS Hematopoietic Neoplasm of Central Nervous System Hematopoietic Neoplasm of the CNS Hematopoietic Neoplasm of the Central Nervous System Hematopoietic Tumor of Central Nervous System Hematopoietic Tumor of the Central Nervous System Lymphomas and Hemopoietic Neoplasms of CNS Lymphomas and Hemopoietic Neoplasms of the CNS Central Nervous System Hematopoietic and Lymphoid Cell Neoplasm A dermoid cyst arising in the central nervous system. C5508 Neoplastic Process Central Nervous System Dermoid Cyst C1332878 Benign Central_Nervous_System_Dermoid_Cyst CNS Dermoid Cyst Central Nervous System Dermoid Cyst Dermoid Cyst of CNS Dermoid Cyst of Central Nervous System Dermoid Cyst of the CNS Dermoid Cyst of the Central Nervous System Central Nervous System Dermoid Cyst A cystically dilated epithelial neoplasm arising from the appendix. It is characterized by the presence of a cystic structure that is filled with mucus. C5510 Neoplastic Process Appendix Mucinous Cystadenoma C1332518 Benign Benign_Mucinous_Appendix_Cystadenoma Appendix Mucinous Cystadenoma Colloid Appendiceal Cystadenoma Colloid Cystadenoma of Appendix Colloid Cystadenoma of the Appendix Colloidal Cystadenoma of Appendix Mucinous Appendiceal Cystadenoma Mucinous Appendix Cystadenoma Mucinous Cystadenoma of Appendix Mucinous Cystadenoma of the Appendix Appendix Mucinous Cystadenoma An adenocarcinoma arising from the appendix, characterized by the presence of mucinous stroma formation and cystic structures. C5511 Neoplastic Process Appendix Mucinous Cystadenocarcinoma C1096639 Malignant Appendix_Mucinous_Cystadenocarcinoma Appendiceal Colloid Cystadenocarcinoma Appendiceal Colloidal Cystadenocarcinoma Appendiceal Mucinous Cystadenocarcinoma Appendix Colloid Cystadenocarcinoma Appendix Colloidal Cystadenocarcinoma Appendix Mucinous Cystadenocarcinoma Colloid Cystadenocarcinoma of Appendix Colloid Cystadenocarcinoma of the Appendix Colloidal Cystadenocarcinoma of Appendix Colloidal Cystadenocarcinoma of the Appendix Mucinous Cystadenocarcinoma of Appendix Mucinous Cystadenocarcinoma of the Appendix Appendix Mucinous Cystadenocarcinoma An adenoma arising from the appendix. It is characterized by the presence of villous epithelial structures and it is associated with dysplasia. C5512 Neoplastic Process Appendix Villous Adenoma C1332329 Benign Appendix_Villous_Adenoma Appendix Villous Adenoma Villous Adenoma of Appendix Villous Adenoma of the Appendix Appendix Villous Adenoma A lymphoma arising from the appendix. The majority of lymphomas affecting the appendix represent disease extension from the intestinal wall; primary lymphomas of the appendix are rare. C5513 Neoplastic Process Appendix Lymphoma C1332328 Malignant Appendix_Lymphoma Appendiceal Lymphoma Appendix Lymphoma Lymphoma of Appendix Lymphoma of the Appendix Primary Appendix Lymphoma Appendix Lymphoma A well-circumscribed benign smooth muscle neoplasm arising from the appendix. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C5514 Neoplastic Process Appendix Leiomyoma C1332327 Benign Appendix_Leiomyoma Appendiceal Leiomyoma Appendix Leiomyoma Leiomyoma of Appendix Leiomyoma of the Appendix Appendix Leiomyoma An extranodal lymphoma that arises from the cecum. The majority are B-cell non-Hodgkin lymphomas. C5515 Neoplastic Process Cecum Lymphoma C1332867 Malignant Cecum_Lymphoma Cecal Lymphoma Cecum Lymphoma Lymphoma of Cecum Lymphoma of the Cecum Primary Cecum Lymphoma Cecum Lymphoma A Kaposi sarcoma arising from the colon. C5516 Neoplastic Process Colon Kaposi Sarcoma C1333091 Malignant Colon_Kaposi_s_Sarcoma Colon Kaposi Sarcoma Colon Kaposi's Sarcoma Colon Kaposis Sarcoma Colonic Kaposi Sarcoma Colonic Kaposi's Sarcoma Colonic Kaposis Sarcoma Kaposi's Sarcoma of Colon Kaposi's Sarcoma of the Colon Colon Kaposi Sarcoma A neoplasm that arises from the glandular epithelium of the cecal mucosa. It is characterized by a villous architectural pattern. The neoplastic glandular cells have dysplastic features. C5520 Neoplastic Process Cecum Villous Adenoma C1332869 Benign Cecum_Villous_Adenoma Cecal Villous Adenoma Cecum Villous Adenoma Villous Adenoma of Cecum Villous Adenoma of the Cecum Cecum Villous Adenoma An extranodal non-Hodgkin lymphoma that arises from the cecum. The majority are B-cell non-Hodgkin lymphomas. C5521 Neoplastic Process Cecum Non-Hodgkin Lymphoma C1332868 Malignant Cecum_Non-Hodgkin_s_Lymphoma Cecal Non-Hodgkin's Lymphoma Cecum Non-Hodgkin Lymphoma Cecum Non-Hodgkin's Lymphoma Non-Hodgkin's Lymphoma of Cecum Non-Hodgkin's Lymphoma of the Cecum Primary Cecum Non-Hodgkin's Lymphoma Cecum Non-Hodgkin Lymphoma A malignant mesenchymal neoplasm with skeletal muscle differentiation affecting the prostate. C5522 Neoplastic Process Prostate Rhabdomyosarcoma C1335518 Malignant Prostate_Rhabdomyosarcoma Prostate Rhabdomyosarcoma Rhabdomyosarcoma of Prostate Rhabdomyosarcoma of the Prostate Prostate Rhabdomyosarcoma A Kaposi sarcoma arising from the prostate. C5523 Neoplastic Process Prostate Kaposi Sarcoma C1335509 Malignant Prostate_Kaposi_s_Sarcoma Kaposi's Sarcoma of Prostate Kaposi's Sarcoma of the Prostate Prostate Kaposi Sarcoma Prostate Kaposi's Sarcoma Prostate Kaposi Sarcoma A rare malignant neoplasm arising from specialized prostatic stroma. It is characterized by the presence of stromal overgrowth and hypercellularity, increased number of mitotic figures, and pleomorphism. C5524 Neoplastic Process Prostate Stromal Sarcoma C1335521 Malignant Prostate_Stromal_Sarcoma Prostate Stromal Sarcoma Stromal Sarcoma of Prostate Stromal Sarcoma of the Prostate Prostate Stromal Sarcoma An embryonal rhabdomyosarcoma arising from the prostate gland. C5525 Neoplastic Process Prostate Embryonal Rhabdomyosarcoma C1335508 Malignant Prostate_Embryonal_Rhabdomyosarcoma Embryonal Rhabdomyosarcoma of Prostate Embryonal Rhabdomyosarcoma of the Prostate Prostate Embryonal Rhabdomyosarcoma Prostate Embryonal Rhabdomyosarcoma An aggressive malignant smooth muscle neoplasm, arising from the prostate. It is characterized by a proliferation of neoplastic spindle cells. C5526 Neoplastic Process Prostate Leiomyosarcoma C1335511 Malignant Prostate_Leiomyosarcoma Leiomyosarcoma of Prostate Leiomyosarcoma of the Prostate Prostate Leiomyosarcoma Prostate Leiomyosarcoma Myeloid sarcoma that affects the prostate gland. It may present in association with or as a site of relapse of acute myeloid leukemia. Cases of myeloid sarcoma of the prostate gland preceding acute myeloid leukemia have also been reported. C5527 Neoplastic Process Prostate Myeloid Sarcoma C1335514 Malignant Prostate_Myeloid_Sarcoma Extramedullary Myeloid Neoplasm of Prostate Extramedullary Myeloid Neoplasm of the Prostate Extramedullary Myeloid Tumor of Prostate Extramedullary Myeloid Tumor of the Prostate Prostate Extramedullary Myeloid Neoplasm Prostate Extramedullary Myeloid Tumor Prostate Myeloid Sarcoma Prostatic Chloroma Prostatic Extramedullary Myeloid Neoplasm Prostatic Extramedullary Myeloid Tumor Prostatic Myeloid Sarcoma Prostate Myeloid Sarcoma A malignant vascular neoplasm arising from the prostate. C5528 Neoplastic Process Prostate Angiosarcoma C1335504 Malignant Prostate_Angiosarcoma Angiosarcoma of Prostate Angiosarcoma of the Prostate Hemangiosarcoma of Prostate Hemangiosarcoma of the Prostate Prostate Angiosarcoma Prostate Hemangiosarcoma Prostatic Angiosarcoma Prostatic Hemangiosarcoma Prostate Angiosarcoma A Kaposi sarcoma arising from the stomach. C5529 Neoplastic Process Gastric Kaposi Sarcoma C1333776 Malignant Gastric_Kaposi_s_Sarcoma Gastric Kaposi Sarcoma Gastric Kaposi's Sarcoma Gastric Kaposi Sarcoma A rare acinar adenocarcinoma of the prostate gland with unfavorable prognosis. It is composed of both malignant glandular and sarcomatous components. The sarcomatous component contains a malignant spindle cell proliferation or specific mesenchymal elements including osteosarcoma, chondrosarcoma, and leiomyosarcoma. C5530 Neoplastic Process Prostate Acinar Sarcomatoid Carcinoma C1335519 GDC OORO Malignant Prostate_Sarcomatoid_Carcinoma Acinar adenocarcinoma, sarcomatoid Prostate Acinar Sarcomatoid Carcinoma Prostate Carcinosarcoma Prostate Sarcomatoid Carcinoma Prostate Sarcomatoid acinar adenocarcinoma Sarcomatoid Carcinoma of Prostate Sarcomatoid Carcinoma of the Prostate Prostate Acinar Sarcomatoid Carcinoma An unusual malignant tumor that arises from the prostate gland. It is characterized by the presence of glandular elements and a cellular stroma that exhibits mitotic activity and nuclear atypia. C5531 Neoplastic Process Malignant Prostate Phyllodes Tumor C1334615 Malignant Malignant_Prostate_Phyllodes_Tumor Malignant Phyllodes Neoplasm of Prostate Malignant Phyllodes Neoplasm of the Prostate Malignant Phyllodes Tumor of Prostate Malignant Phyllodes Tumor of the Prostate Malignant Prostate Phyllodes Neoplasm Malignant Prostate Phyllodes Tumor Malignant Prostate Phyllodes Tumor A rare benign neoplasm that arises from the prostate gland and is characterized by the presence of hyperplastic glands and stroma that contains spindle-shaped cells. C5532 Neoplastic Process Benign Prostate Phyllodes Tumor C1332535 Benign Benign_Prostate_Phyllodes_Tumor Benign Phyllodes Neoplasm of Prostate Benign Phyllodes Neoplasm of the Prostate Benign Phyllodes Tumor of Prostate Benign Phyllodes Tumor of the Prostate Benign Prostate Phyllodes Neoplasm Benign Prostate Phyllodes Tumor Benign Prostate Phyllodes Tumor A rare non-Hodgkin or Hodgkin lymphoma that arises from the prostate gland. C5533 Neoplastic Process Prostate Lymphoma C1335512 Malignant Prostate_Lymphoma Lymphoma of Prostate Lymphoma of the Prostate Primary Prostate Lymphoma Prostate Lymphoma Prostate Lymphoma A rare non-Hodgkin lymphoma that arises from the prostate gland. C5534 Neoplastic Process Prostate Non-Hodgkin Lymphoma C1335516 Malignant Prostate_Non-Hodgkin_s_Lymphoma Non-Hodgkin's Lymphoma of Prostate Non-Hodgkin's Lymphoma of the Prostate Primary Prostate Non-Hodgkin's Lymphoma Prostate Non-Hodgkin Lymphoma Prostate Non-Hodgkin's Lymphoma Prostate Non-Hodgkin Lymphoma Acinar adenocarcinoma of the prostate gland characterized by the presence of malignant cells with intracytoplasmic vacuoles that displace the nucleus to the periphery of the cell. C5535 Neoplastic Process Prostate Acinar Signet Ring Cell-Like Adenocarcinoma C1335520 OORO Malignant Prostate_Signet_Ring_Cell_Carcinoma Prostate Acinar Adenocarcinoma, Signet Ring Cell-Like Prostate Acinar Adenocarcinoma, Signet-Ring Cell-Like Prostate Acinar Signet Ring Cell-Like Adenocarcinoma Prostate Acinar Signet-Ring Cell-Like Adenocarcinoma Prostate Signet ring-like cell acinar adenocarcinoma Prostate Acinar Signet Ring Cell-Like Adenocarcinoma An invasive prostate carcinoma characterized by the presence of malignant cells with squamous differentiation. There is no evidence of glandular differentiation. C5536 Neoplastic Process Prostate Squamous Cell Carcinoma C1302530 Cellosaurus OORO Malignant Prostate_Squamous_Cell_Carcinoma Prostate Squamous Cell Carcinoma Prostate Squamous cell carcinoma Squamous Cell Carcinoma of Prostate Squamous Cell Carcinoma of the Prostate Prostate Squamous Cell Carcinoma Acinar adenocarcinoma of the prostate gland characterized by the presence of lakes of extracellular mucin. This diagnosis applies when at least 25% of the resected tumor contains extracellular mucin. C5537 Neoplastic Process Prostate Acinar Mucinous Adenocarcinoma C1335513 OORO Malignant Prostate_Mucinous_Adenocarcinoma Acinar Colloid Prostate Adenocarcinoma Acinar Prostate Mucinous Adenocarcinoma Colloid Adenocarcinoma of Prostate Colloid Adenocarcinoma of the Prostate Colloidal Adenocarcinoma of Prostate Colloidal Adenocarcinoma of the Prostate Colloidal Prostate Adenocarcinoma Mucinous Adenocarcinoma of Prostate Mucinous Adenocarcinoma of the Prostate Prostate Acinar Mucinous Adenocarcinoma Prostate Mucinous (colloid) acinar adenocarcinoma Prostate Acinar Mucinous Adenocarcinoma An infrequent invasive carcinoma of the prostate gland characterized by the presence of both glandular and squamous neoplastic components. It is more often located in the transitional zone of the prostate gland and it tends to rapidly metastasize to the bones. C5538 Neoplastic Process Prostate Adenosquamous Carcinoma C1335503 OORO Malignant Prostate_Adenosquamous_Carcinoma Adenosquamous Carcinoma of Prostate Adenosquamous Carcinoma of the Prostate Prostate Adenosquamous Carcinoma Prostate Adenosquamous carcinoma Prostate Adenosquamous Carcinoma An adenoid cystic carcinoma that arises from the prostate gland. C5539 Neoplastic Process Prostate Adenoid Cystic Carcinoma C1335502 Malignant Prostate_Adenoid_Cystic_Carcinoma Adenoid Cystic Carcinoma of Prostate Adenoid Cystic Carcinoma of the Prostate Prostate Adenoid Cystic Carcinoma Prostate Adenoid Cystic Carcinoma Prostatic intraepithelial neoplasia characterized by the presence of morphologically malignant cells lining the acini and ducts. The malignant cells are enlarged, contain prominent nucleoli, and have increased nuclear/cytoplasmic ratio. The malignant cells may grow within the ducts and acini in four architectural patterns: flat, tufting, micropapillary, and cribriform. The presence of high grade prostatic intraepithelial neoplasia in needle biopsy is a risk factor for the subsequent detection of carcinoma on repeat biopsy. C5541 Neoplastic Process High Grade Prostatic Intraepithelial Neoplasia High Grade Prostatic Intraepithelial Neoplasia C1168327 CTRP Cellosaurus GDC OORO Undetermined High-Grade_Prostatic_Intraepithelial_Neoplasia High-grade Prostatic Intraepithelial Neoplasia (PIN) HGPIN High Grade Prostatic Intraepithelial Neoplasia High-Grade Intraepithelial Neoplasia of Prostate High-Grade Intraepithelial Neoplasia of the Prostate High-Grade PIN High-Grade Prostatic Intraepithelial Neoplasia High-grade Prostatic Intraepithelial Neoplasia (PIN) Prostatic intraepithelial neoplasia (high grade) High Grade Prostatic Intraepithelial Neoplasia Prostatic intraepithelial neoplasia characterized by the proliferation of secretory cells with irregular spacing in the ducts and acini. Although some proliferating epithelial cells may contain prominent nucleoli, the cytologic atypia and architectural growth patterns that are seen in the high grade prostatic intraepithelial neoplasia are absent. The presence of low grade prostatic intraepithelial neoplasia in needle biopsy is not a risk factor for the subsequent detection of carcinoma on repeat biopsy. C5542 Neoplastic Process Low Grade Prostatic Intraepithelial Neoplasia C1168328 Undetermined Low-Grade_Prostatic_Intraepithelial_Neoplasia Grade 1 PIN Grade 1 Prostatic Intraepithelial Neoplasia Grade I PIN Grade I Prostatic Intraepithelial Neoplasia Low Grade Prostatic Intraepithelial Neoplasia Low-Grade Intraepithelial Neoplasia of Prostate Low-Grade Intraepithelial Neoplasia of the Prostate Low-Grade PIN Low-Grade Prostatic Intraepithelial Neoplasia PIN-1 Low Grade Prostatic Intraepithelial Neoplasia An adenocarcinoma arising from the cecum. It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease. Histologic variants include mucinous adenocarcinoma, signet ring cell carcinoma, medullary carcinoma, serrated adenocarcinoma, cribriform comedo-type adenocarcinoma, and micropapillary adenocarcinoma. C5543 Neoplastic Process Cecum Adenocarcinoma C1332866 Cellosaurus Malignant Cecum_Adenocarcinoma Adenocarcinoma of Cecum Adenocarcinoma of the Cecum Cecal Adenocarcinoma Cecum Adenocarcinoma Cecum Adenocarcinoma A benign smooth muscle neoplasm arising from the prostate. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C5544 Neoplastic Process Prostate Leiomyoma C1335510 Benign Prostate_Leiomyoma Leiomyoma of Prostate Leiomyoma of the Prostate Prostate Leiomyoma Prostatic Leiomyoma Prostate Leiomyoma A neoplasm with neuroendocrine differentiation that arises from the prostate gland. C5545 Neoplastic Process Prostate Neuroendocrine Neoplasm C1335515 Undetermined Prostate_Neuroendocrine_Neoplasm Neuroendocrine Neoplasm of Prostate Neuroendocrine Neoplasm of the Prostate Prostate Neuroendocrine Neoplasm Prostate Neuroendocrine Neoplasm An adenoma that arises from the rectum. The group of rectal adenomas includes tubular, villous, and tubulovillous adenomas, traditional serrated adenomas, sessile serrated adenomas/polyps, and familial adenomatous polyposis. C5546 Neoplastic Process Rectal Adenoma C1302652 Benign Rectal_Adenoma Adenoma of Rectum Adenoma of the Rectum Rectal Adenoma Rectal Adenoma A well differentiated, low grade neuroendocrine neoplasm that arises from the rectum. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. C5547 Neoplastic Process Rectal Neuroendocrine Tumor G1 C1335678 CPTAC Undetermined Rectal_Carcinoid_Tumor Rectal NET G1 Rectal Neuroendocrine Tumor G1 Rectal Neuroendocrine Tumor G1 A malignant soft tissue neoplasm that arises from the rectum. Representative examples include angiosarcoma, Kaposi sarcoma, and leiomyosarcoma. C5548 Neoplastic Process Rectal Sarcoma C1335688 Malignant Rectal_Sarcoma Rectal Sarcoma Sarcoma of Rectum Sarcoma of the Rectum Rectal Sarcoma An aggressive malignant smooth muscle neoplasm that arises from the rectum. It is characterized by a proliferation of neoplastic spindle cells. C5549 Neoplastic Process Rectal Leiomyosarcoma C1335683 Malignant Rectal_Leiomyosarcoma Leiomyosarcoma of Rectum Leiomyosarcoma of the Rectum Rectal Leiomyosarcoma Rectal Leiomyosarcoma A Kaposi sarcoma arising from the rectum. C5550 Neoplastic Process Rectal Kaposi Sarcoma C1335681 Malignant Rectal_Kaposi_s_Sarcoma Kaposi's Sarcoma of Rectum Kaposi's Sarcoma of the Rectum Rectal Kaposi Sarcoma Rectal Kaposi's Sarcoma Rectal Kaposi Sarcoma A benign adipose tissue neoplasm of the rectum. C5551 Neoplastic Process Rectal Lipoma C1335684 Benign Rectal_Lipoma Lipoma of Rectum Lipoma of the Rectum Rectal Lipoma Rectal Lipoma A well-circumscribed benign smooth muscle neoplasm arising from the rectum. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C5552 Neoplastic Process Rectal Leiomyoma C1335682 Benign Rectal_Leiomyoma Leiomyoma of Rectum Leiomyoma of the Rectum Rectal Leiomyoma Rectal Leiomyoma An extranodal lymphoma that arises from the rectum. The majority are B-cell non-Hodgkin lymphomas. C5553 Neoplastic Process Rectal Lymphoma C1335685 Malignant Rectal_Lymphoma Lymphoma of Rectum Lymphoma of the Rectum Primary Rectal Lymphoma Rectal Lymphoma Rectal Lymphoma A very rare rectal carcinoma characterized by the presence of a malignant squamous cell infiltrate. C5554 Neoplastic Process Rectal Squamous Cell Carcinoma Rectal Squamous Cell Carcinoma C1335690 CTRP Malignant Rectal_Squamous_Cell_Carcinoma Rectal Squamous Carcinoma Rectal Squamous Cell Cancer Rectal Squamous Cell Carcinoma Squamous Carcinoma of Rectum Squamous Carcinoma of the Rectum Squamous Cell Carcinoma of Rectum Squamous Cell Carcinoma of the Rectum Rectal Squamous Cell Carcinoma A carcinoma that arises from the transitional zone at the junction of the rectum and anus. C5555 Neoplastic Process Rectal Cloacogenic Carcinoma C1333074 Malignant Cloacogenic_Carcinoma_of_the_Rectum Cloacogenic Carcinoma of Rectum Cloacogenic Carcinoma of the Rectum Rectal Cloacogenic Carcinoma Rectal Transition Zone Carcinoma Rectal Transitional Zone Carcinoma Transition Zone Carcinoma of Rectum Transition Zone Carcinoma of the Rectum Transitional Zone Carcinoma of Rectum Transitional Zone Carcinoma of the Rectum Rectal Cloacogenic Carcinoma A biphasic rectal carcinoma with a spindle cell, sarcomatoid component. C5556 Neoplastic Process Rectal Sarcomatoid Carcinoma Rectal Sarcomatoid Carcinoma C1335689 CTRP Malignant Rectal_Sarcomatoid_Carcinoma Rectal Sarcomatoid Cancer Rectal Sarcomatoid Carcinoma Rectal Spindle Cell Carcinoma Sarcomatoid Carcinoma of Rectum Sarcomatoid Carcinoma of the Rectum Rectal Sarcomatoid Carcinoma An adenoma or carcinoma that arises from the ceruminous glands in the external auditory canal. C5558 Neoplastic Process Ceruminous Neoplasm C1332910 Undetermined Ceruminous_Neoplasm Ceruminous Neoplasm Ceruminous Tumor Ceruminous Neoplasm A malignant neoplasm that arises from the eccrine glands. C5559 Neoplastic Process Malignant Eccrine Neoplasm C1334577 Malignant Malignant_Eccrine_Neoplasm Malignant Eccrine Neoplasm Malignant Eccrine Neoplasm of Skin Malignant Eccrine Neoplasm of the Skin Malignant Eccrine Skin Neoplasm Malignant Eccrine Skin Tumor Malignant Eccrine Tumor Malignant Eccrine Tumor of Skin Malignant Eccrine Tumor of the Skin Malignant Eccrine Neoplasm A carcinoma with eccrine differentiation arising from the sweat glands. It may arise de novo or as a malignant transformation of a pre-existing poroma. It usually grows in the legs, buttocks, feet, and trunk and usually presents as an ulcerative plaque. It is characterized by the presence of intraepidermal and dermal nests of malignant epithelial cells. It may recur after excision and metastasize to the lymph nodes and less frequently to distal anatomic sites. C5560 Neoplastic Process Porocarcinoma C1266065 GDC 8409/3 Malignant Eccrine_Porocarcinoma 8409/3 Eccrine poroma, malignant Porocarcinoma Porocarcinoma, NOS Eccrine Porocarcinoma Epidermotropic Eccrine Carcinoma Malignant Eccrine Poroma Porocarcinoma Porocarcinoma An adipose tissue neoplasm arising from the skin. C5566 Neoplastic Process Skin Lipomatous Neoplasm C1333174 Undetermined Cutaneous_Lipomatous_Neoplasm Cutaneous Lipomatous Neoplasm Cutaneous Lipomatous Tumor Lipomatous Neoplasm of Skin Lipomatous Neoplasm of the Skin Lipomatous Skin Neoplasm Lipomatous Skin Tumor Lipomatous Tumor of Skin Lipomatous Tumor of the Skin Skin Lipomatous Neoplasm Skin Lipomatous Neoplasm C5567 Neoplastic Process Temporal Lobe Neoplasm C1263887 Undetermined Temporal_Lobe_Neoplasm Neoplasm of Temporal Lobe Neoplasm of the Temporal Lobe Temporal Lobe Neoplasm Temporal Lobe Tumor Tumor of Temporal Lobe Tumor of the Temporal Lobe Temporal Lobe Neoplasm A type of basal cell carcinoma of the skin. It appears as a flesh-colored papule with telangiectatic vessels on its surface. It grows slowly; as it enlarges it becomes necrotic forming a central ulcer with raised borders. C5568 Neoplastic Process Skin Nodulo-Ulcerative Basal Cell Carcinoma C0862887 GDC Malignant Nodulo-Ulcerative_Basal_Cell_Carcinoma Rodent ulcer Nodulo-Ulcerative Basal Cell Carcinoma Rodent Ulcer Rodent ulcer Skin Nodulo-Ulcerative Basal Cell Carcinoma Skin Nodulo-Ulcerative Basal Cell Carcinoma A benign schwannoma occurring in the skin. C5569 Neoplastic Process Cutaneous Schwannoma C1332490 Benign Benign_Dermal_Schwannoma Benign Dermal Neurilemmoma Benign Dermal Schwannoma Benign Neurilemmoma of Skin Benign Neurilemmoma of the Skin Benign Schwannoma of Skin Benign Schwannoma of the Skin Benign Skin Neurilemmoma Benign Skin Schwannoma Cutaneous Schwannoma Dermal Schwannoma Cutaneous Schwannoma C5572 Neoplastic Process Frontal Lobe Neoplasm C1263886 Undetermined Frontal_Lobe_Neoplasm Frontal Lobe Neoplasm Frontal Lobe Tumor Neoplasm of Frontal Lobe Neoplasm of the Frontal Lobe Tumor of Frontal Lobe Tumor of the Frontal Lobe Frontal Lobe Neoplasm C5573 Neoplastic Process Parietal Lobe Neoplasm C1263888 Undetermined Parietal_Lobe_Neoplasm Neoplasm of Parietal Lobe Neoplasm of the Parietal Lobe Parietal Lobe Neoplasm Parietal Lobe Tumor Tumor of Parietal Lobe Tumor of the Parietal Lobe Parietal Lobe Neoplasm C5574 Neoplastic Process Occipital Lobe Neoplasm C1263889 Undetermined Occipital_Lobe_Neoplasm Neoplasm of Occipital Lobe Neoplasm of the Occipital Lobe Occipital Lobe Neoplasm Occipital Lobe Tumor Tumor of Occipital Lobe Tumor of the Occipital Lobe Occipital Lobe Neoplasm An undifferentiated pleomorphic sarcoma arising from the skin. It is characterized by the presence of spindle cells in a storiform pattern and histiocytes with abundant cytoplasm. C5576 Neoplastic Process Skin Undifferentiated Pleomorphic Sarcoma C1275254 Malignant Malignant_Fibrous_Histiocytoma_of_the_Skin Cutaneous Malignant Fibrous Histiocytoma Cutaneous Unclassified Pleomorphic Sarcoma Cutaneous Unclassified Pleomorphic Sarcoma (Formerly Cutaneous "MFH") Cutaneous Unclassified Pleomorphic Sarcoma (Formerly Cutaneous "Malignant Fibrous Histiocytoma") Cutaneous Undifferentiated Pleomorphic Sarcoma Malignant Cutaneous Fibrous Histiocytoma Malignant Fibrous Histiocytoma of Skin Malignant Fibrous Histiocytoma of the Skin Malignant Skin Fibrous Histiocytoma PDS Pleomorphic Dermal Sarcoma Skin Undifferentiated Pleomorphic Sarcoma Skin Undifferentiated Pleomorphic Sarcoma Stage I includes: T1a, N0, M0. T1a: Iris: Tumor limited to the iris not more than 3 clock hours in size. Ciliary body and choroid: Tumor size category 1 without ciliary body involvement and extraocular extension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C5577 Neoplastic Process Stage I Uveal Melanoma AJCC v7 Stage I Uveal Melanoma AJCC v7 C1336494 CPTAC CTRP Malignant Stage_I_Uveal_Melanoma I Stage I Malignant Melanoma of Uvea Stage I Malignant Melanoma of the Uvea Stage I Melanoma of Uvea Stage I Melanoma of the Uvea Stage I Uveal Malignant Melanoma Stage I Uveal Melanoma Stage I Uveal Melanoma AJCC v7 Stage I Uveal Melanoma AJCC v7 Stage II includes: IIA (T1b-d, N0, M0); (T2a, N0, M0); IIB (T2b, N0, M0); (T3a, N0, M0). T1b: Iris: Tumor limited to the iris more than 3 clock hours in size. Ciliary body and choroid: Tumor size category 1 with ciliary body involvement. T1c: Iris: Tumor limited to the iris with secondary glaucoma. Ciliary body and choroid: Tumor size category 1 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in diameter. T1d: Ciliary body and choroid: Tumor size category 1 with ciliary body involvement and extraocular extension less than or equal to 5 mm in diameter. T2a: Iris: Tumor confluent with or extending into the ciliary body, choroid, or both, with secondary glaucoma. Ciliary body and choroid: Tumor size category 2 without ciliary body involvement and extraocular extension. T2b: Ciliary body and choroid: Tumor size category 2 with ciliary body involvement. T3a: Iris: Tumor confluent with or extending into the ciliary body, choroid, or both, with sclera extension and secondary glaucoma. Ciliary body and choroid: Tumor size category 3 without ciliary body involvement and extraocular extension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C5578 Neoplastic Process Stage II Uveal Melanoma AJCC v7 Stage II Uveal Melanoma AJCC v7 C1336330 CTRP Malignant Stage_II_Uveal_Melanoma Stage II Malignant Melanoma of Uvea Stage II Malignant Melanoma of the Uvea Stage II Melanoma of Uvea Stage II Melanoma of the Uvea Stage II Uveal Malignant Melanoma Stage II Uveal Melanoma Stage II Uveal Melanoma AJCC v7 Stage II Uveal Melanoma AJCC v7 Stage III includes: IIIA (T2c-d, N0, M0); (T3b-c, N0, M0); (T4a, N0, M0); IIIB (T3d, N0, M0); (T4b-c, N0, M0); IIIC (T4d-e, N0, M0). T2c: Ciliary body and choroid: Tumor size category 2 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in diameter. T2d: Ciliary body and choroid: Tumor size category 2 with ciliary body involvement and extraocular extension less than or equal to 5 mm in diameter. T3b: Ciliary body and choroid: Tumor size category 3 with ciliary body involvement. T3c: Ciliary body and choroid: Tumor size category 3 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in diameter. T4a: Iris: Tumor with extrascleral extension less than or equal to 5 mm in diameter. Ciliary body and choroid: Tumor size category 4 without ciliary body involvement and extraocular extension. T3d: Ciliary body and choroid: Tumor size category 3 with ciliary body involvement and extraocular extension less than or equal to 5 mm in diameter. T4b: Iris: Tumor with extrascleral extension more than 5 mm in diameter. Ciliary body and choroid: Tumor size category 4 with ciliary body involvement. T4c: Ciliary body and choroid: Tumor size category 4 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in diameter. T4d: Ciliary body and choroid: Tumor size category 4 with ciliary body involvement and extraocular extension less than or equal to 5 mm in diameter. T4e: Ciliary body and choroid: Any tumor size category with extraocular extension more than 5 mm in diameter. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C5579 Neoplastic Process Stage III Uveal Melanoma AJCC v7 Stage III Uveal Melanoma AJCC v7 C1336278 CTRP Malignant Stage_III_Uveal_Melanoma Stage III Malignant Melanoma of Uvea Stage III Malignant Melanoma of the Uvea Stage III Melanoma of Uvea Stage III Melanoma of the Uvea Stage III Uveal Malignant Melanoma Stage III Uveal Melanoma Stage III Uveal Melanoma AJCC v7 Stage III Uveal Melanoma AJCC v7 Stage IV includes: (Any T, N1, M0); (Any T, Any N, M1a-c). N1: Regional lymph node metastasis. M1a: Distant metastasis, with the largest diameter of the largest metastasis measuring 3 cm or less. M1b: Distant metastasis, with the largest diameter of the largest metastasis measuring 3.1-8.0 cm. M1c: Distant metastasis, with the largest diameter of the largest metastasis measuring 8.0 cm or more. (AJCC 7th ed.) C5580 Neoplastic Process Stage IV Uveal Melanoma AJCC v7 Stage IV Uveal Melanoma AJCC v7 C1336445 CPTAC CTRP Malignant Stage_IV_Uveal_Melanoma IV Stage IV Malignant Melanoma of Uvea Stage IV Malignant Melanoma of the Uvea Stage IV Melanoma of Uvea Stage IV Melanoma of the Uvea Stage IV Uveal Malignant Melanoma Stage IV Uveal Melanoma Stage IV Uveal Melanoma AJCC v7 Stage IV Uveal Melanoma AJCC v7 Stage I includes: T1, N0, M0. T1: Tumor 2 cm or less in greatest dimension with less than two high-risk features. High-risk features for the primary tumor staging are defined as follows: depth/invasion of more than 2 mm thickness, Clark level equal or greater than IV, and perineural invasion. Anatomic location: primary site ear and primary site non-hair-bearing lip. Differentiation: poorly differentiated or undifferentiated. N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. (AJCC 7th ed.) C5581 Neoplastic Process Stage I Skin Cancer Stage I Skin Cancer C1336481 CTRP Cancer that forms in squamous cells in the skin or in the lower part of the epidermis (the outer layer of the skin). The tumor is no more than 2 centimeters at its widest point. Malignant Stage_I_Skin_Cancer Carcinoma of Skin Stage I Carcinoma of the Skin Stage I Skin Cancer Stage I Skin Carcinoma Stage I Stage I Skin Cancer Stage I Skin Cancer AJCC v7 stage I nonmelanoma skin cancer Stage I Skin Cancer Stage II includes: T2, N0, M0. T2: Tumor size greater than 2 cm in greatest dimension or tumor of any size with two or more high-risk features. High-risk features for the primary tumor staging are defined as follows: depth/invasion of more than 2 mm thickness; Clark level equal or greater than IV; and perineural invasion. Anatomic location: primary site ear and primary site non-hair-bearing lip. Differentiation: poorly differentiated or undifferentiated. N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. (AJCC 7th ed.) C5582 Neoplastic Process Stage II Skin Cancer Stage II Skin Cancer C1336317 CTRP Cancer that forms in squamous cells in the skin or in the lower part of the epidermis (the outer layer of the skin). The tumor is more than 2 centimeters at its widest point. Malignant Stage_II_Skin_Cancer Carcinoma of Skin Stage II Carcinoma of the Skin Stage II Skin Cancer Stage II Skin Carcinoma Stage II Stage II Skin Cancer Stage II Skin Cancer AJCC v7 stage II nonmelanoma skin cancer Stage II Skin Cancer Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor with invasion of maxilla, mandible, orbit, or temporal bone. T1: Tumor 2 cm or less in greatest dimension with less than two high-risk features. T2: Tumor size greater than 2 cm in greatest dimension or tumor of any size with two or more high-risk features. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. M0: No clinical or radiographic evidence of distant metastasis. (AJCC 7th Ed.) C5583 Neoplastic Process Stage III Skin Cancer Stage III Skin Cancer C1336270 CTRP Cancer that forms in squamous cells in the skin or in the lower part of the epidermis (the outer layer of the skin). Cancer has spread below the skin to tissues such as cartilage, muscle, or bone and/or to nearby lymph nodes, but not to other parts of the body. Malignant Stage_III_Skin_Cancer Carcinoma of Skin Stage III Carcinoma of the Skin Stage III Skin Cancer Stage III Skin Carcinoma Stage III Stage III Skin Cancer Stage III Skin Cancer AJCC v7 Stage III Skin Carcinoma stage III nonmelanoma skin cancer Stage III Skin Cancer Stage IV includes: (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T Any, N3, M0); (T4, N Any, M0); (T Any, N Any, M1). T1: Tumor 2 cm or less in greatest dimension with less than two high-risk features. T2: Tumor size greater than 2 cm in greatest dimension or tumor of any size with two or more high-risk features. T3: Tumor with invasion of maxilla, mandible, orbit, or temporal bone. T4: Tumor with invasion of skeleton or perineural invasion of skull base. N0: No regional lymph node metastasis. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension; or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension; or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a lymph node, more than 6 cm in greatest dimension. M1: Distant metastases. (AJCC 7th Ed.) C5584 Neoplastic Process Stage IV Skin Cancer Stage IV Skin Cancer C1336439 CTRP Cancer that forms in squamous cells in the skin or in the lower part of the epidermis (the outer layer of the skin). Cancer has spread to other places in the body, such as the brain or lung. Malignant Stage_IV_Skin_Caner Carcinoma of Skin Stage IV Carcinoma of the Skin Stage IV Skin Cancer Stage IV Skin Carcinoma Stage IV Stage IV Skin Cancer Stage IV Skin Cancer AJCC v7 Stage IV Skin Carcinoma stage IV nonmelanoma skin cancer Stage IV Skin Cancer A sarcoma that arises from the skin. Representative examples include Kaposi sarcoma, angiosarcoma, lymphangiosarcoma, liposarcoma, and leiomyosarcoma. C5585 Neoplastic Process Skin Sarcoma C0856900 Cellosaurus Malignant Skin_Sarcoma Cutaneous Sarcoma Sarcoma of Skin Sarcoma of the Skin Skin Sarcoma Skin Sarcoma A meningioma that affects the middle cranial fossa. C5586 Neoplastic Process Middle Cranial Fossa Meningioma C1334757 Undetermined Middle_Cranial_Fossa_Meningioma Meningioma of Middle Cranial Fossa Meningioma of the Middle Cranial Fossa Middle Cranial Fossa Meningioma Middle Cranial Fossa Meningioma A meningioma that affects the visual pathway. C5587 Neoplastic Process Visual Pathway Meningioma C1336972 Undetermined Visual_Pathway_Meningioma Meningioma of Visual Pathway Meningioma of the Visual Pathway Visual Pathway Meningioma Visual Pathway Meningioma The reemergence of medulloblastoma after a period of remission. C5588 Neoplastic Process Recurrent Medulloblastoma C1335712 Malignant Recurrent_Medulloblastoma Recurrent Medulloblastoma Relapsed Medulloblastoma Recurrent Medulloblastoma A neoplasm that affects the jugular foramen. Representative examples include paraganglioma, schwannoma, and meningioma. C5589 Neoplastic Process Jugular Foramen Neoplasm C1334299 Undetermined Jugular_Foramen_Neoplasm Jugular Foramen Neoplasm Jugular Foramen Neoplasms Jugular Foramen Tumor Jugular Foramen Tumors Neoplasm of Jugular Foramen Neoplasm of the Jugular Foramen Tumor of Jugular Foramen Tumor of the Jugular Foramen Jugular Foramen Neoplasm A childhood neoplasm that arises from the central nervous system and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C5591 Neoplastic Process Benign Childhood Central Nervous System Neoplasm Childhood Benign Central Nervous System Neoplasm C1332483 CTRP Benign Benign_Childhood_Central_Nervous_System_Neoplasm Benign Central Nervous System Neoplasm Benign Childhood CNS Neoplasm Benign Childhood CNS Tumor Benign Childhood Central Nervous System Neoplasm Benign Childhood Central Nervous System Tumor Benign Childhood Neoplasm of CNS Benign Childhood Neoplasm of Central Nervous System Benign Childhood Neoplasm of the CNS Benign Childhood Neoplasm of the Central Nervous System Benign Childhood Tumor of CNS Benign Childhood Tumor of Central Nervous System Benign Childhood Tumor of the CNS Benign Childhood Tumor of the Central Nervous System Benign Pediatric CNS Neoplasm Benign Pediatric CNS Tumor Benign Pediatric Central Nervous System Neoplasm Benign Pediatric Central Nervous System Tumor Benign Pediatric Neoplasm of CNS Benign Pediatric Neoplasm of Central Nervous System Benign Pediatric Neoplasm of the CNS Benign Pediatric Neoplasm of the Central Nervous System Benign Pediatric Tumor of CNS Benign Pediatric Tumor of Central Nervous System Benign Pediatric Tumor of the CNS Benign Pediatric Tumor of the Central Nervous System Childhood Benign Central Nervous System Neoplasm Childhood Benign Central Nervous System Neoplasm A rare, slow-growing neuroepithelial neoplasm of uncertain origin affecting adults. It is located in the third ventricle. It is characterized by the presence of epithelioid cells which express GFAP, and mucinous stroma which contains lymphoplasmacytic infiltrates. C5592 Neoplastic Process Chordoid Glioma C1322252 GDC 9444/1 Undetermined Chordoid_Glioma 9444/1 Chordoid glioma Chordoid glioma of third ventricle Chordoid Glioma Chordoid Glioma of 3rd Ventricle Chordoid Glioma of Third Ventricle Chordoid Glioma of the 3rd Ventricle Chordoid Glioma of the Third Ventricle Chordoid Glioma of the Third Ventricle (WHO Grade 2) Chordoid Glioma of the Third Ventricle (WHO Grade II) Chordoid glioma Chordoid glioma of third ventricle Third Ventricle Chordoid Glioma Chordoid Glioma An invasive adenocarcinoma of the prostate gland composed of secretory cells. It is the most common histologic type of prostate adenocarcinoma. Several morphologic variants exist, including atrophic, pseudohyperplastic, foamy gland, and oncocytic variants. C5596 Neoplastic Process Prostate Acinar Adenocarcinoma C1332139 CPTAC OORO Malignant Acinar_Prostate_Adenocarcinoma Acinar Adenocarcinoma of Prostate Acinar Adenocarcinoma of the Prostate Acinar Prostate Adenocarcinoma Prostate Acinar Adenocarcinoma Prostate Acinar adenocarcinoma Prostate Adenocarcinoma, Acinar Type/NOS Prostatic Acinar Adenocarcinoma Prostate Acinar Adenocarcinoma An invasive prostate carcinoma characterized by the presence of undifferentiated malignant cells. C5597 Neoplastic Process Prostate Undifferentiated Carcinoma C1336863 Malignant Undifferentiated_Prostate_Carcinoma Prostate Undifferentiated Carcinoma Undifferentiated Carcinoma of Prostate Undifferentiated Carcinoma of the Prostate Undifferentiated Prostate Carcinoma Undifferentiated Prostatic Carcinoma Prostate Undifferentiated Carcinoma A slowly spreading, erythematous eczematoid plaque in the anal region. Histologically, the basal part or whole thickness of the squamous epithelium is infiltrated by large cells with abundant pale cytoplasm and large nuclei. Half of the cases are associated with an internal malignancy, most often a colorectal adenocarcinoma. The other half of the cases, have a high local recurrence rate and they may become invasive (WHO). C5598 Neoplastic Process Anal Paget Disease C1332274 Malignant Anal_Paget_s_Disease Anal Paget Disease Anal Paget's Disease Paget Disease of the Anus Paget's Disease of Anus Paget's Disease of the Anus Anal Paget Disease An aggressive malignant smooth muscle neoplasm, arising from the anus. It is characterized by a proliferation of neoplastic spindle cells. C5599 Neoplastic Process Anal Leiomyosarcoma C1332267 Malignant Anal_Leiomyosarcoma Anal Leiomyosarcoma Leiomyosarcoma of Anus Leiomyosarcoma of the Anus Anal Leiomyosarcoma An adenocarcinoma arising in the anal canal epithelium, including the mucosal surface, the anal glands, and the lining of fistulous tracts. The prognosis is related to the stage at diagnosis. C5600 Neoplastic Process Anal Adenocarcinoma Anal Adenocarcinoma C1332257 CTRP Malignant Anal_Adenocarcinoma Adenocarcinoma of Anus Adenocarcinoma of the Anus Anal Adenocarcinoma Anal Adenocarcinoma A usually large cell non-Hodgkin lymphoma of B-cell phenotype, arising from the anus. Lymphomas originating from the anal region are rare in the general population, but they are seen with a higher frequency in HIV-positive patients, particularly homosexual men. C5601 Neoplastic Process Anal Lymphoma C1332268 Malignant Anal_Lymphoma Anal Lymphoma Lymphoma of Anus Lymphoma of the Anus Primary Anal Lymphoma Anal Lymphoma A Kaposi sarcoma arising from the anus. HIV-positive patients have an increased risk of developing Kaposi sarcoma in the perianal region. C5602 Neoplastic Process Anal Kaposi Sarcoma C1332265 Malignant Anal_Kaposi_s_Sarcoma Anal Kaposi Sarcoma Anal Kaposi's Sarcoma Kaposi's Sarcoma of Anus Kaposi's Sarcoma of the Anus Anal Kaposi Sarcoma A neoplasm with neuroendocrine differentiation that arises from the anal canal. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms). C5603 Neoplastic Process Anal Canal Neuroendocrine Neoplasm C1332273 Undetermined Anal_Neuroendocrine_Neoplasm Anal Canal Neuroendocrine Neoplasm Anal Neuroendocrine Neoplasm Neuroendocrine Neoplasm of Anus Neuroendocrine Neoplasm of the Anus Anal Canal Neuroendocrine Neoplasm An anal adenocarcinoma characterized by the presence of mucoid stroma formation. C5606 Neoplastic Process Anal Mucinous Adenocarcinoma C1332272 Malignant Anal_Mucinous_Adenocarcinoma Anal Colloid Adenocarcinoma Anal Colloidal Adenocarcinoma Anal Mucinous Adenocarcinoma Colloid Adenocarcinoma of Anus Colloid Adenocarcinoma of the Anus Colloidal Adenocarcinoma of Anus Colloidal Adenocarcinoma of the Anus Mucinous Adenocarcinoma of Anus Mucinous Adenocarcinoma of the Anus Anal Mucinous Adenocarcinoma A granular cell tumor that arises from the anus and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C5607 Neoplastic Process Benign Anal Granular Cell Tumor C1332471 Benign Benign_Anal_Granular_Cell_Tumor Benign Anal Granular Cell Neoplasm Benign Anal Granular Cell Tumor Benign Anal Myoblastoma Benign Granular Cell Neoplasm of Anus Benign Granular Cell Neoplasm of the Anus Benign Granular Cell Tumor of Anus Benign Granular Cell Tumor of the Anus Benign Myoblastoma of Anus Benign Myoblastoma of the Anus Benign Anal Granular Cell Tumor A well-circumscribed benign smooth muscle neoplasm arising from the anus. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C5608 Neoplastic Process Anal Leiomyoma C1332266 Benign Anal_Leiomyoma Anal Leiomyoma Leiomyoma of Anus Leiomyoma of the Anus Anal Leiomyoma An anal adenocarcinoma arising from the epithelium of the anal glands. The overlying anal mucosa does not show evidence of neoplastic changes. C5609 Neoplastic Process Anal Glands Adenocarcinoma C1266027 GDC 8215/3 Malignant Anal_Glands_Adenocarcinoma 8215/3 Adenocarcinoma of anal ducts Adenocarcinoma of anal glands Adenocarcinoma of Anal Gland Adenocarcinoma of Anal Glands Adenocarcinoma of anal glands Adenocarcinoma of the Anal Gland Anal Glands Adenocarcinoma Anal Glands Adenocarcinoma A malignant mesenchymal tumor with skeletal muscle differentiation affecting the anus. C5610 Neoplastic Process Anal Rhabdomyosarcoma C1332276 Malignant Anal_Rhabdomyosarcoma Anal Rhabdomyosarcoma Rhabdomyosarcoma of Anus Rhabdomyosarcoma of the Anus Anal Rhabdomyosarcoma A malignant soft tissue neoplasm arising from the anus. Representative examples include leiomyosarcoma, rhabdomyosarcoma, and Kaposi sarcoma. C5611 Neoplastic Process Anal Sarcoma C1332277 Malignant Anal_Sarcoma Anal Sarcoma Sarcoma of Anus Sarcoma of the Anus Anal Sarcoma An anal canal carcinoma which has spread to another anatomic site. C5612 Neoplastic Process Metastatic Anal Canal Carcinoma C1369136 Malignant Metastatic_Anal_Carcinoma Metastatic Anal Canal Carcinoma Metastatic Anal Cancer Metastatic Anal Carcinoma Metastatic Cancer from the Anus Metastatic Carcinoma from the Anus Secondary Cancer from the Anus Secondary Carcinoma from the Anus Metastatic Anal Canal Carcinoma A malignant granular cell tumor that arises from the skin. C5614 Neoplastic Process Malignant Cutaneous Granular Cell Tumor C1334575 Malignant Malignant_Cutaneous_Granular_Cell_Tumor Cutaneous Malignant Granular Cell Tumor Malignant Cutaneous Granular Cell Tumor Malignant Granular Cell Neoplasm of Skin Malignant Granular Cell Neoplasm of the Skin Malignant Granular Cell Skin Neoplasm Malignant Granular Cell Skin Tumor Malignant Granular Cell Tumor of Skin Malignant Granular Cell Tumor of the Skin Malignant Cutaneous Granular Cell Tumor A liposarcoma that arises from the skin. C5615 Neoplastic Process Skin Liposarcoma C1333175 Malignant Cutaneous_Liposarcoma Cutaneous Liposarcoma Liposarcoma of Skin Liposarcoma of the Skin Skin Liposarcoma Skin Liposarcoma A basal cell carcinoma often presenting as elevated skin nodules which may become ulcerated or cystic. In cases which present as endophytic nodules, the overlying skin surface shows indurated flat lesions. It occurs most frequently on the head. Morphologically, the neoplastic basaloid cells form lobules with peripheral nuclear palisading. C5616 Neoplastic Process Skin Nodular Solid Basal Cell Carcinoma C1879347 8097/3 Malignant Solid_Nodular_Basal_Cell_Skin_Carcinoma Skin Nodular Solid Basal Cell Carcinoma Skin Nodular Solid Basal Cell Carcinoma A benign or malignant granular cell tumor that arises from the skin. C5617 Neoplastic Process Cutaneous Granular Cell Tumor C0346060 Undetermined Cutaneous_Granular_Cell_Tumor Cutaneous Granular Cell Neoplasm Cutaneous Granular Cell Tumor Granular Cell Neoplasm of Skin Granular Cell Neoplasm of the Skin Granular Cell Skin Tumor Granular Cell Tumor of Skin Granular Cell Tumor of the Skin Skin Granular Cell Neoplasm Cutaneous Granular Cell Tumor A neoplasm that arises from the glandular epithelium of the rectal mucosa. It is characterized by tubular and villous architectural patterns. The neoplastic glandular cells have dysplastic features. C5620 Neoplastic Process Rectal Tubulovillous Adenoma C1335691 Benign Rectal_Tubulovillous_Adenoma Rectal Tubulovillous Adenoma Rectal Villotubular Adenoma Tubulovillous Adenoma of Rectum Tubulovillous Adenoma of the Rectum Villotubular Adenoma of Rectum Villotubular Adenoma of the Rectum Rectal Tubulovillous Adenoma An adenoma that arises from the rectum. It is characterized by the presence of severe epithelial dysplasia. C5621 Neoplastic Process Rectal Adenoma with Severe Dysplasia C1335677 Benign Rectal_Adenoma_with_Severe_Dysplasia Adenoma of Rectum with Marked Dysplasia Adenoma of the Rectum with Marked Dysplasia Rectal Adenoma with Marked Dysplasia Rectal Adenoma with Severe Dysplasia Rectal Adenoma with Severe Dysplasia A Kaposi sarcoma arising from the stomach in patients who are infected with the human immunodeficiency virus. C5624 Neoplastic Process AIDS-Related Gastric Kaposi Sarcoma C1336925 Malignant V-SRC_Gene AIDS-Related Gastric Kaposi Sarcoma AIDS-Related Gastric Kaposi's Sarcoma AIDS-Related Kaposi's Sarcoma of Stomach AIDS-Related Kaposi's Sarcoma of the Stomach AIDS-Related Gastric Kaposi Sarcoma A malignant mesenchymal tumor with skeletal muscle differentiation affecting the rectum. C5627 Neoplastic Process Rectal Rhabdomyosarcoma C1335687 Malignant Rectal_Rhabdomyosarcoma Rectal Rhabdomyosarcoma Rhabdomyosarcoma of Rectum Rhabdomyosarcoma of the Rectum Rectal Rhabdomyosarcoma A carcinoma that has spread to the skin from its original site of gowth. C5628 Neoplastic Process Metastatic Carcinoma in the Skin C1947968 Malignant Metastatic_Skin_Cancer Carcinoma Metastatic in the Skin Carcinoma Metastatic to the Skin Metastatic Carcinoma in the Skin Metastatic Skin Cancer Metastatic Skin Carcinoma Metastatic Carcinoma in the Skin The spread of a malignant neoplasm to the skin. This may be from a primary skin malignant neoplasm, or from a malignant neoplasm at a distant site. C5629 Neoplastic Process Metastatic Malignant Neoplasm in the Skin Metastatic Malignant Neoplasm to the Skin Metastatic Malignant Neoplasm in the Skin C0153687 CPTAC CTEP CTRP mCode Malignant Metastasis_to_Skin Secondary malignant neoplasm of skin Metastases to Skin Metastases to skin, NOS Metastasis to Skin Metastatic Malignant Neoplasm in the Skin Metastatic Malignant Neoplasm to the Skin Metastatic Neoplasm to the Skin Metastatic Tumor to the Skin Secondary malignant neoplasm of skin Skin Metastases Skin Metastasis Metastatic Malignant Neoplasm in the Skin Aleukemic leukemia cutis where the skin in infiltrated by neoplastic monocytes. C5630 Neoplastic Process Aleukemic Monocytic Leukemia Cutis C1332232 Malignant Aleukemic_Monocytic_Leukemia_Cutis Aleukemic Monocytic Leukemia Cutis Aleukemic Monocytic Leukemia Cutis Aleukemic acute lymphoblastic leukemia that manifests with cutaneous involvement. C5631 Neoplastic Process Aleukemic Acute Lymphoblastic Leukemia Cutis C1332231 Malignant Aleukemic_Lymphoblastic_Leukemia_Cutis Aleukemic Acute Lymphoblastic Leukemia Cutis Aleukemic Lymphoblastic Leukemia Cutis Aleukemic Precursor Lymphoblastic Leukemia Cutis Aleukemic Acute Lymphoblastic Leukemia Cutis Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE) (rare in Hodgkin lymphoma). C5634 Neoplastic Process Ann Arbor Stage I Nodular Lymphocyte Predominant Hodgkin Lymphoma Ann Arbor Stage I Nodular Lymphocyte Predominant B-Cell Lymphoma C1336468 CTRP Malignant Stage_I_Nodular_Lymphocyte_Predominant_Hodgkin_s_Lymphoma Ann Arbor Stage I Nodular Lymphocyte Predominant B-Cell Lymphoma Ann Arbor Stage I Nodular Lymphocyte Predominant Hodgkin Lymphoma Stage I Hodgkin's Disease Nodular Lymphocyte Predominance Type Stage I Hodgkin's Lymphoma Nodular Lymphocyte Predominance Type Stage I Nodular Lymphocyte Predominant Hodgkin Lymphoma Stage I Nodular Lymphocyte Predominant Hodgkin's Disease Stage I Nodular Lymphocyte Predominant Hodgkin's Lymphoma Ann Arbor Stage I Nodular Lymphocyte Predominant B-Cell Lymphoma A mucosa-associated lymphoid tissue lymphoma (MALT) that arises from the small intestine. The morphologic characteristics are similar to those seen in gastric MALT lymphomas, with the exception of the lymphoepithelial lesions that are less prominent in the small intestine. C5635 Neoplastic Process Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma C1336004 CTRP Malignant Small_Intestinal_Mucosa-Associated_Lymphoid_Tissue_Lymphoma MALT Lymphoma of Small Bowel MALT Lymphoma of Small Intestine MALT Lymphoma of the Small Bowel MALT Lymphoma of the Small Intestine MALToma of Small Bowel MALToma of Small Intestine MALToma of the Small Bowel MALToma of the Small Intestine Mucosa-Associated Lymphoid Tissue Lymphoma of Small Bowel Mucosa-Associated Lymphoid Tissue Lymphoma of Small Intestine Mucosa-Associated Lymphoid Tissue Lymphoma of the Small Bowel Mucosa-Associated Lymphoid Tissue Lymphoma of the Small Intestine Small Bowel MALT Lymphoma Small Bowel MALToma Small Bowel Mucosa-Associated Lymphoid Tissue Lymphoma Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma Small Intestine MALT Lymphoma Small Intestine MALToma Small Intestine Mucosa-Associated Lymphoid Tissue Lymphoma Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma An anaplastic large cell lymphoma that occurs during childhood. C5636 Neoplastic Process Childhood Anaplastic Large Cell Lymphoma Childhood Anaplastic Large Cell Lymphoma C1332942 CTRP NICHD An anaplastic large cell lymphoma that occurs during childhood. Malignant Childhood_Anaplastic_Large_Cell_Lymphoma Anaplastic Large Cell Lymphoma Childhood Anaplastic Large Cell Lymphoma Childhood CD30+ Anaplastic Large Cell Lymphoma Childhood K-1+ Anaplastic Large Cell Lymphoma Pediatric Anaplastic Large Cell Lymphoma Pediatric CD30+ Anaplastic Large Cell Lymphoma Pediatric K-1+ Anaplastic Large Cell Lymphoma Childhood Anaplastic Large Cell Lymphoma A mature T- and NK-cell non-Hodgkin lymphoma that occurs during childhood. C5637 Neoplastic Process Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma C1332980 NICHD A mature T- and NK-cell non-Hodgkin lymphoma that occurs during childhood. Malignant Childhood_Mature_T-and_NK-Cell_Lymphoma Childhood Mature T- and NK-Cell Lymphoma Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Childhood Peripheral T Cell Lymphoma Pediatric Peripheral T Cell Lymphoma Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma An extremely rare Hodgkin lymphoma that arises from the stomach. C5638 Neoplastic Process Gastric Hodgkin Lymphoma C1333773 Malignant Gastric_Hodgkin_s_Lymphoma Gastric Hodgkin Lymphoma Gastric Hodgkin's Disease Gastric Hodgkin's Lymphoma Hodgkin's Lymphoma of Stomach Hodgkin's Lymphoma of the Stomach Primary Gastric Hodgkin Lymphoma Primary Gastric Hodgkin's Lymphoma Gastric Hodgkin Lymphoma T lymphoblastic leukemia/lymphoma that occurs during childhood. C5640 Neoplastic Process Childhood T Lymphoblastic Leukemia/Lymphoma C1332997 Malignant Childhood_Precursor_T-Lymphoblastic_Lymphoma_Leukemia Childhood Precursor T-Lymphoblastic Lymphoma/Leukemia Childhood T Lymphoblastic Leukemia/Lymphoma Childhood T-Cell Lymphoblastic Leukemia/Lymphoma Childhood T-Lymphoblastic Leukemia/Lymphoma Childhood T Lymphoblastic Leukemia/Lymphoma A lung carcinoma detectable by sputum cytology or bronchial washings only. The primary tumor is undetectable radiographically or during bronchoscopy; therefore, it can not be assessed. C5641 Neoplastic Process Occult Lung Carcinoma Occult Lung Carcinoma C1335097 CTRP Malignant Occult_Lung_Carcinoma Occult Carcinoma of Lung Occult Carcinoma of the Lung Occult Lung Cancer Occult Lung Carcinoma Occult Lung Carcinoma Stage IA includes: (T1a, N0, M0); (T1b, N0, M0). T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C5642 Neoplastic Process Stage IA Lung Cancer AJCC v7 Stage IA Lung Cancer AJCC v7 C1336118 CTRP Malignant Stage_IA_Lung_Carcinoma Stage IA Carcinoma of Lung Stage IA Carcinoma of the Lung Stage IA Lung Cancer Stage IA Lung Cancer AJCC v7 Stage IA Lung Carcinoma Stage IA Lung Cancer AJCC v7 Stage IB includes: T2a, N0, M0. T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C5643 Neoplastic Process Stage IB Lung Cancer AJCC v7 Stage IB Lung Cancer AJCC v7 C1336138 CTRP Malignant Stage_IB_Lung_Carcinoma Stage IB Carcinoma of Lung Stage IB Carcinoma of the Lung Stage IB Lung Cancer Stage IB Lung Cancer AJCC v7 Stage IB Lung Carcinoma Stage IB Lung Cancer AJCC v7 Stage IIA includes: (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C5644 Neoplastic Process Stage IIA Lung Cancer AJCC v7 Stage IIA Lung Cancer AJCC v7 C1336164 CTRP Malignant Stage_IIA_Lung_Carcinoma Stage IIA Carcinoma of Lung Stage IIA Carcinoma of the Lung Stage IIA Lung Cancer Stage IIA Lung Cancer AJCC v7 Stage IIA Lung Carcinoma Stage IIA Lung Cancer AJCC v7 Stage IIB includes: (T2b, N1, M0); (T3, N0, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C5645 Neoplastic Process Stage IIB Lung Cancer AJCC v7 Stage IIB Lung Cancer AJCC v7 C1336186 CTRP Malignant Stage_IIB_Lung_Carcinoma Stage IIB Carcinoma of Lung Stage IIB Carcinoma of the Lung Stage IIB Lung Cancer Stage IIB Lung Cancer AJCC v7 Stage IIB Lung Carcinoma Stage IIB Lung Cancer AJCC v7 Stage IIIA includes: (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C5646 Neoplastic Process Stage IIIA Lung Cancer AJCC v7 Stage IIIA Lung Cancer AJCC v7 C1336211 CTRP Malignant Stage_IIIA_Lung_Carcinoma Stage IIIA Carcinoma of Lung Stage IIIA Carcinoma of the Lung Stage IIIA Lung Cancer Stage IIIA Lung Cancer AJCC v7 Stage IIIA Lung Carcinoma Stage IIIA Lung Cancer AJCC v7 Stage IIIB includes: (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C5647 Neoplastic Process Stage IIIB Lung Cancer AJCC v7 Stage IIIB Lung Cancer AJCC v7 C1336226 CTRP Malignant Stage_IIIB_Lung_Carcinoma Stage IIIB Carcinoma of Lung Stage IIIB Carcinoma of the Lung Stage IIIB Lung Cancer Stage IIIB Lung Cancer AJCC v7 Stage IIIB Lung Carcinoma Stage IIIB Lung Cancer AJCC v7 A morphologic variant of lung adenocarcinoma characterized by the presence of acinar structures composed of columnar or cuboidal cells. (NCI05) C5649 Neoplastic Process Lung Acinar Adenocarcinoma C1332137 Malignant Acinar_Lung_Adenocarcinoma Acinar Adenocarcinoma of Lung Acinar Adenocarcinoma of the Lung Lung Acinar Adenocarcinoma Lung Acinar Adenocarcinoma A morphologic variant of lung adenocarcinoma characterized by the presence of papillary structures. C5650 Neoplastic Process Lung Papillary Adenocarcinoma Lung Papillary Adenocarcinoma C1335325 CTRP Cellosaurus Malignant Papillary_Lung_Adenocarcinoma Lung Papillary Adenocarcinoma Papillary Adenocarcinoma of Lung Papillary Adenocarcinoma of the Lung Papillary Lung Adenocarcinoma Lung Papillary Adenocarcinoma A morphologic variant of lung adenocarcinoma characterized by the presence of polygonal malignant cells forming sheets. Acinar, papillary, micropapillary, or lepidic growth patterns are absent. If the tumor is 100 percent solid, intracellular mucin should be present in at least five tumor cells in each of two high-power fields and confirmed with mucin immunohistochemical stains. Tumors formerly classified as large cell carcinomas expressing pneumocyte immunohistochemical markers, even if intracellular mucin is absent, are now included in this category. C5651 Neoplastic Process Solid Lung Adenocarcinoma C1336026 CPTAC Malignant Solid_Lung_Carcinoma_with_Mucus_Formation Lung Solid Adenocarcinoma with Mucin Pulmonary Solid Adenocarcinoma with Mucin Solid Adenocarcinoma of Lung with Mucin Solid Adenocarcinoma of the Lung with Mucin Solid Lung Adenocarcinoma Solid adenocarcinoma Solid Lung Adenocarcinoma Stage IA includes: (T1a, N0, M0); (T1b, N0, M0). T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C5652 Neoplastic Process Stage IA Non-Small Cell Lung Carcinoma AJCC v7 Stage IA Lung Non-Small Cell Carcinoma AJCC v7 C1336119 CTRP Stage I non-small cell lung cancer is divided into stages IA and IB. In stage IA, the tumor is in the lung only and is 3 centimeters or smaller. Malignant Stage_IA_Non-Small_Cell_Lung_Carcinoma Stage IA Lung Non-Small Cell Carcinoma AJCC v7 Stage IA Non-Oat Cell Carcinoma of Lung Stage IA Non-Oat Cell Carcinoma of the Lung Stage IA Non-Oat Cell Lung Carcinoma Stage IA Non-Small Cell Carcinoma of Lung Stage IA Non-Small Cell Carcinoma of the Lung Stage IA Non-Small Cell Lung Cancer Stage IA Non-Small Cell Lung Carcinoma Stage IA Non-Small Cell Lung Carcinoma AJCC v7 stage IA non-small cell lung cancer Stage IA Lung Non-Small Cell Carcinoma AJCC v7 Stage IB includes: T2a, N0, M0. T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C5653 Neoplastic Process Stage IB Non-Small Cell Lung Carcinoma AJCC v7 Stage IB Lung Non-Small Cell Carcinoma AJCC v7 C1336139 CTRP Stage I non-small cell lung cancer is divided into stages IA and IB. In stage IB, cancer has not spread to the lymph nodes and one or more of the following is true: (1) the tumor is larger than 3 centimeters but not larger than 5 centimeters; (2) cancer has spread to the main bronchus and is at least 2 centimeters below where the trachea joins the bronchus; (3) cancer has spread to the innermost layer of the membrane that covers the lung; and/or (4) part of the lung has collapsed or become inflamed. Malignant Stage_IB_Non-Small_Cell_Lung_Carcinoma Stage IB Lung Non-Small Cell Carcinoma AJCC v7 Stage IB Non-Oat Cell Carcinoma of Lung Stage IB Non-Oat Cell Carcinoma of the Lung Stage IB Non-Oat Cell Lung Carcinoma Stage IB Non-Small Cell Carcinoma of Lung Stage IB Non-Small Cell Carcinoma of the Lung Stage IB Non-Small Cell Lung Cancer Stage IB Non-Small Cell Lung Carcinoma Stage IB Non-Small Cell Lung Carcinoma AJCC v7 stage IB non-small cell lung cancer Stage IB Lung Non-Small Cell Carcinoma AJCC v7 Stage IIB includes: (T2b, N1, M0); (T3, N0, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C5654 Neoplastic Process Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 C1336190 CTRP Malignant Stage_IIB_Non-Small_Cell_Lung_Carcinoma Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 Stage IIB Non-Oat Cell Carcinoma of Lung Stage IIB Non-Oat Cell Carcinoma of the Lung Stage IIB Non-Oat Cell Lung Carcinoma Stage IIB Non-Small Cell Carcinoma of Lung Stage IIB Non-Small Cell Carcinoma of the Lung Stage IIB Non-Small Cell Lung Cancer Stage IIB Non-Small Cell Lung Carcinoma Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 stage IIB non-small cell lung cancer Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 Stage IIA includes: (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C5655 Neoplastic Process Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 C1336167 CTRP Stage II non-small cell lung cancer is divided into stages IIA and IIB. In stage IIA, cancer has spread to lymph nodes on the same side of the chest as the tumor. Also, one or more of the following is true: (1) the tumor is not larger than 5 centimeters; (2) cancer has spread to the main bronchus and is at least 2 centimeters below where the trachea joins the bronchus; (3) cancer has spread to the innermost layer of the membrane that covers the lung; and/or (4) part of the lung has collapsed or become inflamed. OR in stage IIA, cancer has not spread to lymph nodes and one or more of the following is true: (1) the tumor is larger than 5 centimeters but not larger than 7 centimeters; (2) cancer has spread to the main bronchus and is at least 2 centimeters below where the trachea joins the bronchus; (3) cancer has spread to the innermost layer of the membrane that covers the lung; and/or (4) part of the lung has collapsed or become inflamed. Malignant Stage_IIA_Non-Small_Cell_Lung_Carcinoma Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 Stage IIA Non-Oat Cell Carcinoma of Lung Stage IIA Non-Oat Cell Carcinoma of the Lung Stage IIA Non-Oat Cell Lung Carcinoma Stage IIA Non-Small Cell Carcinoma of Lung Stage IIA Non-Small Cell Carcinoma of the Lung Stage IIA Non-Small Cell Lung Cancer Stage IIA Non-Small Cell Lung Carcinoma Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 stage IIA non-small cell lung cancer Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 A benign tumor that arises from the lung. It is characterized by the presence of sclerotic, papillary, solid, and hemorrhagic patterns and hyperplastic type II pneumocytes. Cholesterol clefts, hemosiderin deposition, chronic inflammation, and calcifications may be present. In the majority of cases, it is a solitary and peripheral tumor. Patients are usually asymptomatic. C5656 Neoplastic Process Sclerosing Pneumocytoma C1334455 Benign Lung_Sclerosing_Hemangioma Lung Sclerosing Angioma Lung Sclerosing Hemangioma Pneumocytoma Sclerosing Angioma of Lung Sclerosing Angioma of the Lung Sclerosing Hemangioma of Lung Sclerosing Hemangioma of the Lung Sclerosing Pneumocytoma Sclerosing Pneumocytoma A benign tumor of the lung composed of mature adipocytes and smooth muscle cells. C5657 Neoplastic Process Lung Myolipoma C1334451 Benign Lung_Myolipoma Lung Myolipoma Myolipoma of Lung Myolipoma of the Lung Pulmonary Myolipoma Lung Myolipoma A benign neoplasm arising from the lung. It is characterized by the presence of spindle-shaped fibroblasts. C5658 Neoplastic Process Lung Fibroma C1334444 Benign Lung_Fibroma Fibroma of Lung Fibroma of the Lung Lung Fibroma Pulmonary Fibroma Lung Fibroma A benign smooth muscle neoplasm arising from the lung. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C5660 Neoplastic Process Lung Leiomyoma C1334447 Benign Lung_Leiomyoma Leiomyoma of Lung Leiomyoma of the Lung Lung Leiomyoma Pulmonary Leiomyoma Lung Leiomyoma A benign smooth muscle neoplasm arising endobronchially. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C5661 Neoplastic Process Endobronchial Leiomyoma C1333386 Benign Endobronchial_Leiomyoma Endobronchial Leiomyoma Endobronchial Leiomyoma A benign neoplasm that arises endobronchially. It is characterized by the presence of mesenchymal tissues admixed with entrapped respiratory epithelium. It presents with signs and symptoms of bronchial obstruction. Bronchoplastic resection is usually curative. Recurrence is very rare. C5662 Neoplastic Process Endobronchial Hamartoma C1333385 Benign Endobronchial_Hamartoma Endobronchial Hamartoma Endobronchial Hamartoma The presence of multiple hamartomas in the lungs. Hamartomas are usually solitary lesions on chest-x-rays. Multiple lung hamartomas are rare. C5663 Neoplastic Process Multiple Pulmonary Hamartomas C1334824 Benign Multiple_Chondromatous_Lung_Hamartoma Multiple Chondromatous Hamartoma of Lung Multiple Chondromatous Hamartoma of the Lung Multiple Chondromatous Lung Hamartoma Multiple Lung Hamartomas Multiple Pulmonary Hamartomas Multiple Pulmonary Hamartomas A benign adenomatous neoplasm that arises from the mucous glands in the bronchus. C5664 Neoplastic Process Lung Mucous Gland Adenoma C1332640 Benign Bronchial_Mucus_Gland_Adenoma Adenoma of Bronchial Mucous Gland Adenoma of the Bronchial Mucous Gland Bronchial Cystadenoma Lung Mucous Gland Adenoma Lung Polyadenoma Lung Mucous Gland Adenoma A preinvasive lesion in the lung. It is characterized by the presence of a small, localized proliferation of mildly to moderately atypical type II pneumocytes and/or Clara cells lining alveolar walls and sometimes respiratory bronchioles. C5665 Neoplastic Process Atypical Adenomatous Lung Hyperplasia C1332345 Cellosaurus GDC Undetermined Atypical_Adenomatous_Lung_Hyperplasia Adenosis (Atypical Adenomatous Hyperplasia) Atypical adenomatous hyperplasia AAH Atypical Adenomatous Hyperplasia of Lung Atypical Adenomatous Hyperplasia of the Lung Atypical Adenomatous Lung Hyperplasia Atypical Alveolar Hyperplasia Bronchioloalveolar Cell Adenoma Atypical Adenomatous Lung Hyperplasia A rare usually indolent lung carcinoma characterized by a cribiform and tubular pattern and the presence of glandular epithelial cells. Clinical symptoms include shortness of breath, cough, wheeze, hemopytsis and chest pain. C5666 Neoplastic Process Lung Adenoid Cystic Carcinoma Lung Adenoid Cystic Carcinoma C1334439 CTRP Malignant Lung_Adenoid_Cystic_Carcinoma Adenocystic Carcinoma of Lung Adenocystic Carcinoma of the Lung Adenoid Cystic Carcinoma of Lung Adenoid Cystic Carcinoma of the Lung Lung Adenocystic Carcinoma Lung Adenoid Cystic Cancer Lung Adenoid Cystic Carcinoma Pulmonary Adenocystic Carcinoma Pulmonary Adenoid Cystic Carcinoma Lung Adenoid Cystic Carcinoma An aggressive malignant smooth muscle neoplasm, arising from the lung. It is characterized by a proliferation of neoplastic spindle cells. C5667 Neoplastic Process Lung Leiomyosarcoma C1334448 Malignant Lung_Leiomyosarcoma Leiomyosarcoma of Lung Leiomyosarcoma of the Lung Lung Leiomyosarcoma Pulmonary Leiomyosarcoma Lung Leiomyosarcoma A primary or metastatic meningioma that is present in the lung. The lung is the most frequent site of metastasis of meningiomas. C5668 Neoplastic Process Lung Meningioma C1334450 Undetermined Lung_Meningioma Lung Meningioma Meningioma of Lung Meningioma of the Lung Pulmonary Meningioma Lung Meningioma A malignant neoplasm affecting the lungs and/or the pleura. Pleuropulmonary blastoma is seen in children. Microscopically, the tumor may show features of chondrosarcoma, leiomyosarcoma, rhabdomyosarcoma, liposarcoma, or undifferentiated sarcoma. In approximately 25% of patients with pleuropulmonary blastoma, there are other lesions or neoplasms that may affect patients or their families, including lung or kidney cysts, and ovarian or testicular neoplasms. Heterozygous germline mutations in DICER1 gene have been identified in families harboring pleuropulmonary blastomas. C5669 Neoplastic Process Pleuropulmonary Blastoma Pleuropulmonary Blastoma C1266144 CPTAC CTRP GDC NICHD A malignant neoplasm affecting the lungs and/or the pleura. Pleuropulmonary blastoma is seen in children. Microscopically, the tumor may show features of chondrosarcoma, leiomyosarcoma, rhabdomyosarcoma, liposarcoma, or undifferentiated sarcoma. In approximately 25% of patients there is a predisposition for other tumors. Heterozygous germline mutations in DICER1 gene have been identified in families harboring pleuropulmonary blastomas. A rare and very aggressive (fast-growing) cancer that forms in tissues of the lung and pleura (a thin layer of tissue that covers the lungs and lines the interior wall of the chest cavity). Pleuropulmonary blastoma is most common in children. 8973/3 Malignant Pleuropulmonary_Blastoma 8973/3 Pleuropulmonary blastoma PPB Pleuropulmonary Blastoma Pleuropulmonary blastoma Pulmonary Blastoma of Childhood pleuropulmonary blastoma Pleuropulmonary Blastoma A neoplasm with neuroendocrine differentiation that arises from the lung. This category includes typical carcinoid tumor, atypical carcinoid tumor, small cell carcinoma, large cell neuroendocrine carcinoma, and combined carcinoma. C5670 Neoplastic Process Lung Neuroendocrine Neoplasm C1334452 Undetermined Lung_Neuroendocrine_Neoplasm Lung Neuroendocrine Neoplasm Neuroendocrine Neoplasm of Lung Neuroendocrine Neoplasm of the Lung Pulmonary Neuroendocrine Neoplasm Lung Neuroendocrine Neoplasm A benign or malignant neoplasm that arises from the hilar region of the lung. C5671 Neoplastic Process Lung Hilum Neoplasm C1290358 Undetermined Lung_Hilum_Neoplasm Hilar Lung Neoplasm Hilar Lung Tumor Lung Hilum Neoplasm Lung Hilum Tumor Lung Hilum Neoplasm A high grade carcinoma that arises from the lung and is characterized by the presence of large neuroendocrine cells. It usually has an aggressive clinical course. C5672 Neoplastic Process Lung Large Cell Neuroendocrine Carcinoma Lung Large Cell Neuroendocrine Carcinoma C1334363 CTRP Cellosaurus Malignant Large_Cell_Neuroendocrine_Lung_Carcinoma LCNEC of the Lung Large Cell Lung Carcinoma with Neuroendocrine Differentiation Large Cell Lung Neuroendocrine Carcinoma Large Cell Neuroendocrine Carcinoma of Lung Large Cell Neuroendocrine Carcinoma of the Lung Lung Large Cell Neuroendocrine Carcinoma Pulmonary Large Cell Neuroendocrine Carcinoma Lung Large Cell Neuroendocrine Carcinoma An adenoma that arises from the colon or rectum. The group of colorectal adenomas includes tubular, villous, and tubulovillous adenomas, traditional serrated adenomas, sessile serrated adenomas/polyps, and familial adenomatous polyposis. C5673 Neoplastic Process Colorectal Adenoma C1302401 Cellosaurus Benign Colorectal_Adenoma Adenoma of Large Bowel Adenoma of Large Intestine Adenoma of the Large Bowel Adenoma of the Large Intestine Colorectal Adenoma Large Bowel Adenoma Large Intestine Adenoma Colorectal Adenoma An adenoma that arises from the colon or rectum. It is characterized by prominent serration of the glands. C5674 Neoplastic Process Colorectal Traditional Serrated Adenoma C1333116 Benign Colorectal_Serrated_Adenoma Colorectal Serrated Adenoma Colorectal Serrated Adenoma Type II Colorectal TSA Colorectal Traditional Serrated Adenoma Large Bowel Traditional Serrated Adenoma Traditional Serrated Adenoma of Large Bowel Traditional Serrated Adenoma of the Large Bowel Colorectal Traditional Serrated Adenoma A neoplasm that arises from the glandular epithelium of the colonic and rectal mucosa. It is characterized by tubular and villous architectural patterns. The neoplastic glandular cells have dysplastic features. C5675 Neoplastic Process Colorectal Tubulovillous Adenoma C1333118 Benign Colorectal_Tubulovillous_Adenoma Colorectal Tubulovillous Adenoma Large Bowel Tubulovillous Adenoma Tubulovillous Adenoma of Large Bowel Tubulovillous Adenoma of the Large Bowel Colorectal Tubulovillous Adenoma A neoplasm that arises from the glandular epithelium of the colonic and rectal mucosa. It is characterized by a villous architectural pattern. The neoplastic glandular cells have dysplastic features. C5676 Neoplastic Process Colorectal Villous Adenoma C1333119 Benign Colorectal_Villous_Adenoma Colorectal Villous Adenoma Large Bowel Villous Adenoma Villous Adenoma of Large Bowel Villous Adenoma of the Large Bowel Colorectal Villous Adenoma A well-circumscribed benign smooth muscle neoplasm arising from the colorectal area. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C5677 Neoplastic Process Colorectal Leiomyoma C1333113 Benign Colorectal_Leiomyoma Colorectal Leiomyoma Large Bowel Leiomyoma Large Intestine Leiomyoma Leiomyoma of Large Bowel Leiomyoma of Large Intestine Leiomyoma of the Large Bowel Leiomyoma of the Large Intestine Colorectal Leiomyoma A rare benign adipose tissue neoplasm arising from the wall of the colon and rectum. C5678 Neoplastic Process Colorectal Lipoma C1333114 Benign Colorectal_Lipoma Colorectal Lipoma Large Bowel Lipoma Large Intestine Lipoma Lipoma of Large Bowel Lipoma of Large Intestine Lipoma of the Large Bowel Lipoma of the Large Intestine Colorectal Lipoma A rare non-Hodgkin lymphoma that arises in and is confined to the lung at the time of diagnosis. Representative examples include mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma. C5684 Neoplastic Process Lung Non-Hodgkin Lymphoma C1334453 Malignant Lung_Non-Hodgkin_s_Lymphoma Lung Non-Hodgkin Lymphoma Lung Non-Hodgkin's Lymphoma Primary Lung Non-Hodgkin's Lymphoma Lung Non-Hodgkin Lymphoma An adenoma that arises from the colon or rectum. It is characterized by the presence of severe epithelial dysplasia. C5685 Neoplastic Process Colorectal Adenoma with Severe Dysplasia Colorectal Adenoma with Severe Dysplasia C1333108 CTRP Benign Colorectal_Adenoma_with_Severe_Dysplasia Colorectal Adenoma with Marked Dysplasia Colorectal Adenoma with Severe Dysplasia Colorectal Adenoma with Severe Dysplasia An extranodal lymphoma that arises from the esophagus with the bulk of the mass located in the esophagus. Dysphagia may be the presenting symptom. The vast majority of cases are diffuse large B-cell lymphomas and B-cell lymphomas of the mucosa-associated lymphoid tissue. C5687 Neoplastic Process Esophageal Lymphoma C1333459 Malignant Esophageal_Lymphoma Esophageal Lymphoma Esophagus Lymphoma Lymphoma of Esophagus Lymphoma of the Esophagus Primary Esophageal Lymphoma Esophageal Lymphoma An extranodal non-Hodgkin lymphoma that arises from the esophagus with the bulk of the mass located in the esophagus. Dysphagia may be the presenting symptom. The vast majority of cases are diffuse large B-cell lymphomas and B-cell lymphomas of the mucosa-associated lymphoid tissue. C5688 Neoplastic Process Esophageal Non-Hodgkin Lymphoma C1333464 Malignant Esophageal_Non-Hodgkin_s_Lymphoma Esophageal Non-Hodgkin Lymphoma Esophageal Non-Hodgkin's Lymphoma Esophagus Non-Hodgkin Lymphoma Non-Hodgkin's Esophagus Lymphoma Non-Hodgkin's Lymphoma of Esophagus Non-Hodgkin's Lymphoma of the Esophagus Primary Esophageal Non-Hodgkin's Lymphoma Esophageal Non-Hodgkin Lymphoma A very rare Hodgkin lymphoma that arises from the esophagus. C5689 Neoplastic Process Esophageal Hodgkin Lymphoma C1333452 Malignant Esophageal_Hodgkin_s_Lymphoma Esophageal Hodgkin Lymphoma Esophageal Hodgkin's Disease Esophageal Hodgkin's Lymphoma Esophagus Hodgkin Lymphoma Esophagus Hodgkin's Disease Esophagus Hodgkin's Lymphoma Hodgkin's Disease of Esophagus Hodgkin's Disease of the Esophagus Hodgkin's Lymphoma of Esophagus Hodgkin's Lymphoma of the Esophagus Primary Esophageal Hodgkin's Lymphoma Esophageal Hodgkin Lymphoma Stage IIA includes: For squamous cell carcinoma: (T2-3, N0, M0, G1, GX, Tumor location: Upper, middle); (T2-3, N0, M0, G2-3, Tumor location: Lower, X). For adenocarcinoma: (T2, N0, M0, G3). T2: Tumor invades muscularis propria. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated. GX: Grade cannot be assessed-stage grouping as G1. G2: Moderately differentiated. G3: Poorly differentiated. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. (AJCC 7th ed.) C5691 Neoplastic Process Stage IIA Esophageal Cancer AJCC v7 Stage IIA Esophageal Cancer AJCC v7 C1336159 CTRP Malignant Stage_IIA_Esophageal_Cancer Esophageal Cancer Stage IIA Stage IIA Carcinoma of Esophagus Stage IIA Carcinoma of the Esophagus Stage IIA Esophageal Cancer Stage IIA Esophageal Cancer AJCC v7 Stage IIA Esophageal Carcinoma Stage IIA Esophagus Carcinoma Stage IIA Esophageal Cancer AJCC v7 Stage IIB includes: For squamous cell carcinoma: (T2-3, N0, M0, G2-3, Tumor location: Upper, middle); (T1-2, N1, M0, Any G, Tumor location: Any). For adenocarcinoma: (T3, N0, M0, Any G); (T1-2, N1, M0, Any G). T2: Tumor invades muscularis propria. T3: Tumor invades adventitia. T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. M0: No distant metastasis. G1: Well differentiated. GX: Grade cannot be assessed-stage grouping as G1. G2: Moderately differentiated. G3: Poorly differentiated. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. (AJCC 7th ed.) C5692 Neoplastic Process Stage IIB Esophageal Cancer AJCC v7 Stage IIB Esophageal Cancer AJCC v7 C1336181 CTRP Malignant Stage_IIB_Esophageal_Cancer Esophageal Cancer Stage IIB Stage IIB Carcinoma of Esophagus Stage IIB Carcinoma of the Esophagus Stage IIB Esophageal Cancer Stage IIB Esophageal Cancer AJCC v7 Stage IIB Esophageal Carcinoma Stage IIB Esophagus Carcinoma Stage IIB Esophageal Cancer AJCC v7 A neoplasm with neuroendocrine differentiation that arises from the small or large intestine. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms). C5695 Neoplastic Process Intestinal Neuroendocrine Neoplasm C1334231 Undetermined Intestinal_Neuroendocrine_Neoplasm Intestinal Neuroendocrine Neoplasm Neuroendocrine Neoplasm of Intestine Neuroendocrine Neoplasm of the Intestine Intestinal Neuroendocrine Neoplasm A neoplasm with neuroendocrine differentiation that arises from the stomach. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms). C5696 Neoplastic Process Gastric Neuroendocrine Neoplasm C1333783 Undetermined Gastric_Neuroendocrine_Neoplasm Gastric Neuroendocrine Neoplasm Neuroendocrine Neoplasm of Stomach Neuroendocrine Neoplasm of the Stomach Stomach Neuroendocrine Neoplasm Gastric Neuroendocrine Neoplasm A neoplasm with neuroendocrine differentiation that arises from the colon. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms). C5697 Neoplastic Process Colon Neuroendocrine Neoplasm C1333097 Undetermined Colon_Neuroendocrine_Neoplasm Colon Neuroendocrine Neoplasm Colonic Neuroendocrine Neoplasm Neuroendocrine Neoplasm of Colon Neuroendocrine Neoplasm of the Colon Colon Neuroendocrine Neoplasm A neoplasm with neuroendocrine differentiation that arises from the rectum. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms). C5698 Neoplastic Process Rectal Neuroendocrine Neoplasm C1335686 Undetermined Rectal_Neuroendocrine_Neoplasm Neuroendocrine Neoplasm of Rectum Neuroendocrine Neoplasm of the Rectum Rectal Neuroendocrine Neoplasm Rectal Neuroendocrine Neoplasm A benign, elongated intraluminal polypoid neoplasm of the esophagus. It is characterized by the presence of adipose tissue lobules separated by dense fibrous tissue bands and dilated blood vessels. The polyp is covered by normal squamous epithelium. C5699 Disease or Syndrome Giant Fibrovascular Esophageal Polyp C1333816 Giant_Fibrovascular_Esophageal_Polyp Giant Fibrovascular Esophageal Polyp Giant Fibrovascular Esophagus Polyp Giant Fibrovascular Polyp of Esophagus Giant Fibrovascular Polyp of the Esophagus Giant Fibrovascular Esophageal Polyp A tumor that usually presents with small nodules or small sessile polyps, predominantly in the distal esophagus. Histologically, it is composed of sheets of oval to polygonal cells with a small central nucleus and abundant granular cytoplasm. This is usually a benign tumor. (WHO, 2000) C5700 Neoplastic Process Esophageal Granular Cell Tumor C1333448 Undetermined Esophageal_Granular_Cell_Tumor Esophageal Granular Cell Myoblastoma Esophageal Granular Cell Neoplasm Esophageal Granular Cell Tumor Granular Cell Esophageal Tumor Granular Cell Esophagus Myoblastoma Granular Cell Esophagus Neoplasm Granular Cell Esophagus Tumor Granular Cell Myoblastoma of Esophagus Granular Cell Myoblastoma of the Esophagus Granular Cell Neoplasm of Esophagus Granular Cell Neoplasm of the Esophagus Granular Cell Tumor of Esophagus Granular Cell Tumor of the Esophagus Esophageal Granular Cell Tumor A benign adipose tissue neoplasm of the esophagus. Clinical presentation includes obstruction, dysphagia, regurgitation, vomiting and reflux. It may be associated with aspiration and consecutive respiratory infections. C5701 Neoplastic Process Esophageal Lipoma C1333455 Benign Esophageal_Lipoma Esophageal Lipoma Lipoma of Esophagus Lipoma of the Esophagus Esophageal Lipoma A benign neoplasm arising from the fibrous soft tissue of the esophagus. It is characterized by the presence of spindle-shaped fibroblasts. C5702 Neoplastic Process Esophageal Fibroma C1333445 Benign Esophageal_Fibroma Esophageal Fibroma Fibroma of Esophagus Fibroma of the Esophagus Esophageal Fibroma A slowly growing, benign, usually encapsulated neoplasm arising from the esophagus. Morphologically, it is composed of neoplastic differentiated Schwann cells. C5703 Neoplastic Process Esophageal Schwannoma C1332495 Benign Benign_Esophageal_Schwannoma Benign Esophageal Neurilemmoma Benign Esophageal Schwannoma Benign Esophagus Neurilemmoma Benign Esophagus Schwannoma Benign Neurilemmoma of Esophagus Benign Neurilemmoma of the Esophagus Benign Schwannoma of Esophagus Benign Schwannoma of the Esophagus Esophageal Schwannoma Esophageal Schwannoma A non-metastasizing encapsulated neoplasm arising from nerves in the esophagus. Morphologically, it is characterized by the presence of fibroblasts and Schwann cells. C5704 Neoplastic Process Esophageal Neurofibroma C1333463 Benign Esophageal_Neurofibroma Esophageal Neurofibroma Esophagus Neurofibroma Neurofibroma of Esophagus Neurofibroma of the Esophagus Esophageal Neurofibroma A malignant adipose tissue neoplasm of the esophagus, characterized by multivacuolated lipoblasts with hyperchromatic nuclei, a solid pattern of growth, and a rich vascular network. It arises from the mucosal and submucosal layers of the lower esophagus. Clinical presentation includes progressive dysphagia, nausea, throat discomfort, and foreign body sensation. C5705 Neoplastic Process Esophageal Liposarcoma C1333456 Malignant Esophageal_Liposarcoma Esophageal Liposarcoma Esophagus Liposarcoma Liposarcoma of Esophagus Liposarcoma of the Esophagus Esophageal Liposarcoma A Kaposi sarcoma arising from the esophagus. C5706 Neoplastic Process Esophageal Kaposi Sarcoma C1333453 Malignant Esophageal_Kaposi_s_Sarcoma Esophageal Kaposi Sarcoma Esophageal Kaposi's Sarcoma Esophagus Kaposi's Sarcoma Kaposi's Sarcoma of Esophagus Kaposi's Sarcoma of the Esophagus Esophageal Kaposi Sarcoma A melanoma affecting the esophageal wall. Melanoma in the esophagus is more commonly metastatic than primary. Primary melanomas of the esophagus are polypoid and clinically aggressive. (WHO, 2000) C5707 Neoplastic Process Esophageal Melanoma C1333460 Malignant Esophageal_Melanoma Esophageal Melanoma Esophagus Melanoma Melanoma of Esophagus Melanoma of the Esophagus Esophageal Melanoma Stage III includes: IIIA: (T3a, N0, M0); IIIB: (T3b, N0, M0); IIIC: (T4, N0, M0). T3a: Multiple tumors more than 5 cm. T3b: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein. T4: Tumors(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C5708 Neoplastic Process Stage III Childhood Hepatocellular Carcinoma AJCC v7 Stage III Childhood Hepatocellular Carcinoma AJCC v7 C0278698 CTRP Either (1) the tumor cannot be removed by surgery; or (2) cancer that can be seen without a microscope remains after surgery; or (3) the cancer has spread to nearby lymph nodes. Malignant Stage_III_Childhood_Hepatocellular_Carcinoma Stage III Childhood Hepatocellular Carcinoma Stage III Childhood Hepatocellular Carcinoma AJCC v7 Stage III Childhood Hepatoma Stage III Childhood Liver Cell Carcinoma Stage III Hepatocellular Cancer Stage III Pediatric Hepatocellular Carcinoma Stage III Pediatric Hepatoma Stage III Pediatric Liver Cell Carcinoma stage III childhood liver cancer Stage III Childhood Hepatocellular Carcinoma AJCC v7 Stage II includes: T2, N0, M0. T2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C5709 Neoplastic Process Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7 Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7 C0278697 CTRP All of the cancer was removed by surgery, except for a small amount of cancer that can be seen only with a microscope, or tumor cells that may have spilled into the abdomen during surgery. Malignant Stage_II_Childhood_Hepatocellular_Carcinoma Stage II Childhood Hepatocellular Carcinoma AJCC v6 Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7 Stage II Childhood Hepatocellular Carcinoma AJCC v7 Stage II Childhood Hepatoma Stage II Childhood Liver Cell Carcinoma Stage II Hepatocellular Cancer Stage II Pediatric Hepatocellular Carcinoma Stage II Pediatric Hepatoma Stage II Pediatric Liver Cell Carcinoma stage II childhood liver cancer Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7 Stage I includes: T1, N0, M0. T1: Solitary tumor without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C5710 Neoplastic Process Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7 Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7 C0278696 CTRP All of the cancer was removed by surgery. Malignant Stage_I_Childhood_Hepatocellular_Carcinoma Stage I Childhood Hepatocellular Carcinoma AJCC v6 Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7 Stage I Childhood Hepatocellular Carcinoma AJCC v7 Stage I Childhood Hepatoma Stage I Childhood Liver Cell Carcinoma Stage I Hepatocellular Cancer Stage I Pediatric Hepatocellular Carcinoma Stage I Pediatric Hepatoma Stage I Pediatric Liver Cell Carcinoma stage I childhood liver cancer Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 6th and 7th Eds.) C5711 Neoplastic Process Stage IV Pancreatic Cancer AJCC v6 and v7 Stage IV Pancreatic Cancer AJCC v6 and v7 C1167725 CTRP Cancer may be of any size and has spread to distant organs, such as the liver, lung, and peritoneal cavity (the body cavity that contains most of the organs in the abdomen), and may have also spread to organs and tissues near the pancreas or to lymph nodes. Malignant Stage_IV_Pancreatic_Cancer Pancreatic Cancer Stage IV Stage IV Carcinoma of Pancreas Stage IV Carcinoma of the Pancreas Stage IV Exocrine and Endocrine Pancreatic Cancer AJCC v6 and v7 Stage IV Pancreatic Cancer Stage IV Pancreatic Cancer AJCC v6 Stage IV Pancreatic Cancer AJCC v6 and v7 Stage IV Pancreatic Cancer AJCC v7 Stage IV Pancreatic Carcinoma stage IV pancreatic cancer Stage IV Pancreatic Cancer AJCC v6 and v7 A benign, non-metastasizing cystic epithelial neoplasm arising from the exocrine pancreas. It is composed of glycogen-rich epithelial cells which produce a watery fluid. Signs and symptoms include abdominal mass, abdominal pain, nausea, vomiting, and weight loss. C5712 Neoplastic Process Pancreatic Serous Cystadenoma C1335316 Benign Pancreatic_Serous_Cystadenoma Pancreatic Microcystic Adenoma Pancreatic Serous Cystadenoma Serous Cystadenoma of Pancreas Serous Cystadenoma of the Pancreas Pancreatic Serous Cystadenoma A lymphoma that arises from the pancreas with the bulk of the tumor localized to this organ. The vast majority of cases are non-Hodgkin lymphomas of B-cell phenotype and include mucosa-associated lymphoid tissue lymphomas, follicular lymphomas, and diffuse large B-cell lymphomas. C5714 Neoplastic Process Pancreatic Lymphoma C1335307 Malignant Pancreatic_Lymphoma Lymphoma of Pancreas Lymphoma of the Pancreas Pancreatic Lymphoma Pancreatic Lymphoma A rare malignant soft tissue neoplasm that occurs primarily in the pancreas. C5715 Neoplastic Process Pancreatic Sarcoma C1096346 Malignant Pancreatic_Sarcoma Pancreatic Sarcoma Sarcoma of Pancreas Sarcoma of the Pancreas Pancreatic Sarcoma A group of epithelial neoplasms that arise from the exocrine pancreatic tissue and have the potential to evolve into invasive malignant neoplasms. This group includes the pancreatic intraepithelial neoplasias, non-invasive pancreatic mucinous-cystic neoplasms, pancreatic intraductal papillary-mucinous neoplasms, and pancreatic intraductal tubulopapillary neoplasms. C5716 Neoplastic Process Borderline Exocrine Pancreatic Neoplasm C1332593 Uncertain Malignant Potential Borderline_Exocrine_Pancreatic_Neoplasm Borderline Exocrine Pancreatic Neoplasm Borderline Exocrine Pancreatic Tumor Borderline Neoplasm of Exocrine Pancreas Borderline Neoplasm of the Exocrine Pancreas Borderline Tumor of Exocrine Pancreas Borderline Tumor of the Exocrine Pancreas Exocrine Pancreatic Neoplasm of Uncertain Malignant Potential Exocrine Pancreatic Tumor of Uncertain Malignant Potential Neoplasm of Uncertain Malignant Potential of Exocrine Pancreas Neoplasm of Uncertain Malignant Potential of the Exocrine Pancreas Tumor of Uncertain Malignant Potential of Exocrine Pancreas Tumor of Uncertain Malignant Potential of the Exocrine Pancreas Borderline Exocrine Pancreatic Neoplasm A rare pancreatic ductal adenocarcinoma with poor prognosis. It is characterized by the presence of malignant signet ring cells infiltrating the pancreatic parenchyma in an individual cell pattern. C5720 Neoplastic Process Pancreatic Signet Ring Cell Carcinoma C1335317 CPTAC Malignant Pancreatic_Signet_Ring_Cell_Carcinoma Pancreatic Signet Ring Cell Carcinoma Pancreatic Signet-Ring Cell Carcinoma Signet Ring Cell Carcinoma of Pancreas Signet Ring Cell Carcinoma of the Pancreas Signet ring cell carcinoma Pancreatic Signet Ring Cell Carcinoma A carcinoma that arises from the pancreas showing both ductal and squamous differentiation. The squamous component should represent at least 30% of the malignant cellular infiltrate. The prognosis is usually worse than that of ductal adenocarcinoma. C5721 Neoplastic Process Pancreatic Adenosquamous Carcinoma Pancreatic Adenosquamous Carcinoma C1335299 CPTAC CTRP Cellosaurus Malignant Pancreatic_Adenosquamous_Carcinoma Adenosquamous Carcinoma of Pancreas Adenosquamous Carcinoma of the Pancreas Adenosquamous carcinoma Pancreatic Adenoacanthoma Pancreatic Adenosquamous Cancer Pancreatic Adenosquamous Carcinoma Pancreatic Mixed Squamous and Adenocarcinoma Pancreatic Mucoepidermoid Carcinoma Pancreatic Adenosquamous Carcinoma A carcinoma with poor prognosis that arises from the pancreas. It is characterized by the presence of a significant malignant component that does not show differentiation. The malignant cells represent a mixture of large, pleomorphic cells and giant cells, or adenocarcinoma cells and spindle cells, or spindle cells. C5722 Neoplastic Process Pancreatic Undifferentiated Carcinoma C1336861 CPTAC Cellosaurus Malignant Undifferentiated_Pancreatic_Carcinoma Pancreatic Carcinosarcoma Pancreatic Undifferentiated Carcinoma Pleomorphic Large Cell Pancreatic Carcinoma Sarcomatoid Pancreatic Carcinoma Spindle Cell Pancreatic Carcinoma Undifferentiated (Anaplastic) Pancreatic Carcinoma Undifferentiated Carcinoma of Pancreas Undifferentiated Carcinoma of the Pancreas Undifferentiated Pancreatic Carcinoma Undifferentiated carcinoma Pancreatic Undifferentiated Carcinoma A rare variant of undifferentiated pancreatic carcinoma characterized by the presence of non-neoplastic osteoclast-like giant cells. C5723 Neoplastic Process Pancreatic Undifferentiated Carcinoma with Osteoclast-Like Giant Cells C2007059 CPTAC Malignant Pancreatic_Osteoclast-Like_Giant_Cell_Carcinoma Osteoclast-like Giant Cell Neoplasm of Pancreas Osteoclast-like Giant Cell Neoplasm of the Pancreas Pancreatic Osteoclast-Like Giant Cell Carcinoma Pancreatic Undifferentiated Carcinoma with Osteoclast-Like Giant Cells Undifferentiated Pancreatic Carcinoma with Osteoclast-Like Giant Cells Undifferentiated carcinoma with osteoclast-like giant cells Pancreatic Undifferentiated Carcinoma with Osteoclast-Like Giant Cells A metastasizing, slow-growing malignant epithelial neoplasm that arises from the exocrine pancreas. It is characterized by the presence of cysts and is composed of glycogen-rich malignant epithelial cells which produce a watery fluid. Signs and symptoms include upper gastrointestinal bleeding, weight loss, jaundice, and abdominal pain. C5724 Neoplastic Process Pancreatic Serous Cystadenocarcinoma C1335315 Malignant Pancreatic_Serous_Cystadenocarcinoma Pancreatic Serous Cystadenocarcinoma Serous Cystadenocarcinoma of Pancreas Serous Cystadenocarcinoma of the Pancreas Pancreatic Serous Cystadenocarcinoma A pancreatic intraductal papillary mucinous neoplasm characterized by the presence of a focal or multifocal invasive carcinomatous component. The invasive carcinoma is either colloid or ductal adenocarcinoma. C5726 Neoplastic Process Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma C1518871 GDC 8453/3 Malignant Pancreatic_Invasive_Papillary-Mucinous_Carcinoma 8453/3 Intraductal papillary mucinous neoplasm (IPMN) with an associated invasive carcinoma Intraductal papillary mucinous neoplasm with an associated invasive carcinoma Intraductal papillary-mucinous carcinoma, invasive Intraductal papillary mucinous neoplasm with an associated invasive carcinoma Intraductal papillary-mucinous carcinoma, invasive Pancreatic Intraductal Papillary Mucinous Neoplasm with an Associated Invasive Carcinoma Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma Pancreatic Invasive Intraductal Papillary-Mucinous Carcinoma Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma A cystic adenocarcinoma characterized by the presence of relatively uniform neoplastic cells which produce pancreatic enzymes and are arranged in acinar patterns. Signs and symptoms include abdominal pain, weight loss, nausea, and diarrhea. It usually has an aggressive clinical course. C5727 Neoplastic Process Pancreatic Acinar Cell Cystadenocarcinoma C1266087 GDC 8551/3 Malignant Pancreatic_Acinar_Cell_Cystadenocarcinoma 8551/3 Acinar cell cystadenocarcinoma Acinar Cell Cystadenocarcinoma Acinar Cell Cystadenocarcinoma of Pancreas Acinar Cell Cystadenocarcinoma of the Pancreas Acinar cell cystadenocarcinoma Pancreatic Acinar Cell Cystadenocarcinoma Pancreatic Acinar Cell Cystadenocarcinoma Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C5729 Neoplastic Process Stage 0 Pancreatic Cancer AJCC v6 and v7 Stage 0 Pancreatic Cancer AJCC v6 and v7 C0586365 CTRP Abnormal cells are found in the lining of the pancreas. These abnormal cells may become cancer and spread into nearby normal tissue. Malignant Stage_0_Pancreatic_Cancer Pancreatic Cancer Stage 0 Pancreatic Carcinoma in Situ Stage 0 Carcinoma of Pancreas Stage 0 Carcinoma of the Pancreas Stage 0 Exocrine and Endocrine Pancreatic Cancer AJCC v6 and v7 Stage 0 Pancreatic Cancer Stage 0 Pancreatic Cancer AJCC v6 Stage 0 Pancreatic Cancer AJCC v6 and v7 Stage 0 Pancreatic Cancer AJCC v7 Stage 0 Pancreatic Carcinoma stage 0 pancreatic carcinoma in situ Stage 0 Pancreatic Cancer AJCC v6 and v7 A gastrin-producing neuroendocrine tumor that arises from the duodenum. It is characterized by the presence of uniform cells that form pseudorosettes. The neoplastic cells have uniform nuclei and small amount of eosinophilic cytoplasm. C5731 Neoplastic Process Duodenal Gastrin-Producing Neuroendocrine Tumor C1333321 Undetermined Duodenal_G-Cell_Gastrin_Producing_Neoplasm Duodenal G-Cell Gastrin Producing Tumor Duodenal Gastrin-Producing NET Duodenal Gastrin-Producing Neuroendocrine Tumor Duodenal Gastrinoma Gastrin Producing Tumor of Duodenum Gastrin Producing Tumor of the Duodenum Gastrinoma of Duodenum Gastrinoma of the Duodenum Duodenal Gastrin-Producing Neuroendocrine Tumor A lymphoma that arises from the gallbladder, with the bulk of the tumor located at this site. C5734 Neoplastic Process Gallbladder Lymphoma C1333748 Malignant Gallbladder_Lymphoma Gallbladder Lymphoma Lymphoma of Gallbladder Lymphoma of the Gallbladder Primary Gallbladder Lymphoma Gallbladder Lymphoma A melanoma that arises from the gallbladder. C5735 Neoplastic Process Gallbladder Melanoma C1333749 Malignant Gallbladder_Melanoma Gallbladder Malignant Melanoma Gallbladder Melanoma Malignant Melanoma of Gallbladder Malignant Melanoma of the Gallbladder Melanoma of Gallbladder Melanoma of the Gallbladder Gallbladder Melanoma A malignant soft tissue neoplasm that arises from the gallbladder. Representative examples include Kaposi sarcoma, leiomyosarcoma, and rhabdomyosarcoma. C5736 Neoplastic Process Gallbladder Sarcoma C1333757 Malignant Gallbladder_Sarcoma Gallbladder Sarcoma Sarcoma of Gallbladder Sarcoma of the Gallbladder Gallbladder Sarcoma Stage I includes: IA: (T1, N0, M0); IB: (T2, N0, M0). T1: Tumor invades lamina propria or muscle layer. T1a: Tumor invades lamina propria. T1b: Tumor invades muscle layer. N0: No regional metastasis. M0: No distant metastasis. (AJCC 6th ed.) C5737 Neoplastic Process Stage I Gallbladder Cancer AJCC v6 Stage I Gallbladder Cancer AJCC v6 C1167716 CTRP Stage I gallbladder cancer is divided into stages IA and IB. In stage IA, cancer has spread beyond the innermost (mucosal) layer to the connective tissue or to the muscle layer. In stage IB, cancer has spread beyond the muscle layer to the connective tissue around the muscle. Malignant Stage_I_Gallbladder_Cancer Gallbladder Cancer Stage I AJCC v6 Gallbladder Carcinoma Stage I AJCC v6 Stage I Carcinoma of Gallbladder AJCC v6 Stage I Carcinoma of the Gallbladder AJCC v6 Stage I Gallbladder Cancer Stage I Gallbladder Cancer AJCC v6 Stage I Gallbladder Carcinoma AJCC v6 stage IA gallbladder cancer stage IB gallbladder cancer Stage I Gallbladder Cancer AJCC v6 Stage II includes: IIA: (T3, N0, M0); IIB: (T1, N0, M0); (T2, N0, M0); (T3, N0, M0). T2: Tumor perforates the serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, or pancreas, omentum or extrahepatic bile ducts. (AJCC 6th ed.) C5738 Neoplastic Process Stage II Gallbladder Cancer AJCC v6 Stage II Gallbladder Cancer AJCC v6 C1142296 CTRP Stage II gallbladder cancer is divided into stages IIA and IIB. In stage IIA, cancer has spread beyond the tissue that covers the gallbladder and/or to the liver and/or to one nearby organ, such as the stomach, small intestine, colon, pancreas, or bile ducts outside the liver. In stage IIB, cancer has spread in one of the following ways: (1) beyond the innermost layer to the connective tissue and to nearby lymph nodes; or (2) to the muscle layer and nearby lymph nodes; or (3) beyond the muscle layer to the connective tissue around the muscle and nearby lymph nodes; or (4) through the tissue that covers the gallbladder and/or to the liver and/or to one nearby organ, such as the stomach, small intestine, colon, pancreas, or bile ducts outside the liver, and to nearby lymph nodes. Malignant Stage_II_Gallbladder_Cancer Gallbladder Cancer Stage II AJCC v6 Gallbladder Carcinoma Stage II AJCC v6 Stage II Carcinoma of Gallbladder AJCC v6 Stage II Carcinoma of the Gallbladder AJCC v6 Stage II Gallbladder Cancer Stage II Gallbladder Cancer AJCC v6 Stage II Gallbladder Carcinoma AJCC v6 stage IIA gallbladder cancer stage IIB gallbladder cancer Stage II Gallbladder Cancer AJCC v6 Stage III includes: (T4, Any N, M0). T4: Tumor invades main portal vein or hepatic artery or invades multiple extrahepatic organs or structures. (AJCC 6th ed.) C5739 Neoplastic Process Stage III Gallbladder Cancer AJCC v6 Stage III Gallbladder Cancer AJCC v6 C1141952 CTRP Malignant Stage_III_Gallbladder_Cancer Gallbladder Cancer Stage III AJCC v6 Gallbladder Carcinoma Stage III AJCC v6 Stage III Carcinoma of Gallbladder AJCC v6 Stage III Carcinoma of the Gallbladder AJCC v6 Stage III Gallbladder Cancer Stage III Gallbladder Cancer AJCC v6 Stage III Gallbladder Carcinoma AJCC v6 Stage III Gallbladder Cancer AJCC v6 Stage IV includes: (Any T, Any N, M1). M1: Distant metastasis. (AJCC 6th ed.) C5740 Neoplastic Process Stage IV Gallbladder Cancer AJCC v6 Stage IV Gallbladder Cancer AJCC v6 C1141953 CTRP Malignant Stage_IV_Gallbladder_Cancer Gallbladder Cancer Stage IV AJCC v6 Gallbladder Carcinoma Stage IV AJCC v6 Stage IV Carcinoma of Gallbladder AJCC v6 Stage IV Carcinoma of the Gallbladder AJCC v6 Stage IV Gallbladder Cancer Stage IV Gallbladder Cancer AJCC v6 Stage IV Gallbladder Carcinoma AJCC v6 Stage IV Gallbladder Cancer AJCC v6 Stage IVA includes: T4, N0-1, M0. T4: Tumor invades the main portal vein or hepatic artery, or invades two or more extrahepatic organs or structures. N0: No regional lymph node metastasis. N1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery, and/or portal vein. M0: No distant metastasis. (from AJCC 7th Ed.) C5741 Neoplastic Process Stage IVA Gallbladder Cancer AJCC v7 Stage IVA Gallbladder Cancer AJCC v7 C1168199 CTRP Malignant Stage_IVA_Gallbladder_Cancer Gallbladder Cancer Stage IVA AJCC v7 Gallbladder Carcinoma Stage IVA AJCC v7 Stage IVA Carcinoma of Gallbladder AJCC v7 Stage IVA Carcinoma of the Gallbladder AJCC v7 Stage IVA Gallbladder Cancer Stage IVA Gallbladder Cancer AJCC v7 Stage IVA Gallbladder Carcinoma AJCC v7 Stage IVA Gallbladder Cancer AJCC v7 Stage IVB includes: (Any T, N2, M0); (Any T, Any N, M1). N2: Metastases to periaortic, pericaval, superior mesenteric artery, and/or celiac artery lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (from AJCC 7th Ed.) C5742 Neoplastic Process Stage IVB Gallbladder Cancer AJCC v7 Stage IVB Gallbladder Cancer AJCC v7 C1168200 CTRP Malignant Stage_IVB_Gallbladder_Cancer Gallbladder Cancer Stage IVB AJCC v7 Gallbladder Carcinoma Stage IVB AJCC v7 Stage IVB Carcinoma of Gallbladder AJCC v7 Stage IVB Carcinoma of the Gallbladder AJCC v7 Stage IVB Gallbladder Cancer Stage IVB Gallbladder Cancer AJCC v7 Stage IVB Gallbladder Carcinoma AJCC v7 Stage IVB Gallbladder Cancer AJCC v7 An intracholecystic papillary neoplasm, usually with high grade intraepithelial neoplasia, that arises from the gallbladder. It is associated with the presence of an invasive carcinoma. The carcinomatous component is an adenocarcinoma. C5743 Neoplastic Process Gallbladder Papillary Neoplasm with an Associated Invasive Carcinoma Gallbladder Intracholecystic Papillary Neoplasm with an Associated Invasive Carcinoma CL505190 CTRP 8503/3 Malignant Gallbladder_Papillary_Carcinoma Gallbladder ICPN with an Associated Invasive Carcinoma Gallbladder Intracholecystic Papillary (Tubular) Neoplasm with an Associated Invasive Carcinoma Gallbladder Intracholecystic Papillary Neoplasm with an Associated Invasive Carcinoma Gallbladder Intracystic/Intaductal Papillary Neoplasm with an Associated Invasive Carcinoma Gallbladder Papillary Neoplasm with an Associated Invasive Cancer Gallbladder Papillary Neoplasm with an Associated Invasive Carcinoma Intracystic Papillary Neoplasm with an Associated Invasive Carcinoma Papillary Carcinoma of Gallbladder Papillary Carcinoma of the Gallbladder Gallbladder Intracholecystic Papillary Neoplasm with an Associated Invasive Carcinoma An adenocarcinoma that arises from the gallbladder. It is characterized by the presence of extracellular mucin that constitutes more than fifty-percent of the tumor. C5744 Neoplastic Process Gallbladder Mucinous Adenocarcinoma C1333750 Malignant Gallbladder_Mucinous_Carcinoma Colloid Carcinoma of Gallbladder Colloid Carcinoma of the Gallbladder Colloidal Carcinoma of Gallbladder Colloidal Carcinoma of the Gallbladder Gallbladder Colloid Carcinoma Gallbladder Colloidal Carcinoma Gallbladder Mucinous Adenocarcinoma Mucinous Carcinoma of Gallbladder Mucinous Carcinoma of the Gallbladder Gallbladder Mucinous Adenocarcinoma An adenocarcinoma that arises from the gallbladder. It is characterized by the presence of signet ring malignant epithelial cells. C5745 Neoplastic Process Gallbladder Signet Ring Cell Carcinoma C1333758 Malignant Gallbladder_Signet_Ring_Cell_Carcinoma Gallbladder Signet Ring Cell Carcinoma Gallbladder Signet-Ring Cell Carcinoma Signet Ring Cell Carcinoma of Gallbladder Signet Ring Cell Carcinoma of the Gallbladder Gallbladder Signet Ring Cell Carcinoma A non-metastasizing encapsulated neoplasm arising from nerves in the gallbladder. Morphologically, it is characterized by the presence of fibroblasts and Schwann cells. C5746 Neoplastic Process Gallbladder Neurofibroma C1333751 Benign Gallbladder_Neurofibroma Gallbladder Neurofibroma Neurofibroma of Gallbladder Neurofibroma of the Gallbladder Gallbladder Neurofibroma A benign smooth muscle neoplasm arising from the gallbladder. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C5747 Neoplastic Process Gallbladder Leiomyoma C1333745 Benign Gallbladder_Leiomyoma Gallbladder Leiomyoma Leiomyoma of Gallbladder Leiomyoma of the Gallbladder Gallbladder Leiomyoma A non-epithelial neoplasm that arises from the liver and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include hemangioma, angiomyolipoma, and solitary fibrous tumor. C5749 Neoplastic Process Benign Liver Non-Epithelial Neoplasm C1332521 Benign Benign_Non-Epithelial_Hepatic_and_Intrahepatic_Bile_Duct_Neoplasm Benign Liver Non-Epithelial Neoplasm Benign Non-Epithelial Hepatic Neoplasm Benign Non-Epithelial Hepatic and Intrahepatic Bile Duct Neoplasm Benign Non-Epithelial Liver Neoplasm Benign Non-Epithelial Liver and Intrahepatic Bile Duct Neoplasm Liver and Intrahepatic Bile Duct Benign Non-Epithelial Neoplasm Benign Liver Non-Epithelial Neoplasm A rare benign adipose tissue neoplasm of the liver. C5750 Neoplastic Process Liver Lipoma C1333970 Benign Hepatic_Lipoma Hepatic Lipoma Lipoma of Liver Lipoma of the Liver Liver Lipoma Liver Lipoma A multicystic mesenchymal tumor that arises from the liver during fetal development. It is the third most common pediatric liver tumor following hepatoblastoma and infantile hemangioma. Cytogenetic and molecular studies have revealed the presence of chromosomal rearrangements involving chromosome 19q13.4 or androgenetic-biparental mosaicism. These findings support the evidence that it is a neoplastic process and not only a developmental process. Clinically, it usually presents as an abdominal mass associated with abdominal distention. Morphologically, it consists of hypocellular fibromyxoid stroma and bland spindle cell proliferation. It generally has a benign clinical course. Following resection, the prognosis is good. C5751 Neoplastic Process Liver Mesenchymal Hamartoma C1333971 Cellosaurus Benign Hepatic_Mesenchymal_Hamartoma HMH Hepatic Mesenchymal Hamartoma Liver MH Liver Mesenchymal Hamartoma Mesenchymal Hamartoma of Liver Mesenchymal Hamartoma of the Liver Liver Mesenchymal Hamartoma A solitary fibrous tumor that arises from the liver. It affects females more frequently than males. Signs and symptoms include the presence of an abdominal mass and abdominal discomfort. C5752 Neoplastic Process Liver Solitary Fibrous Tumor C1333965 Undetermined Hepatic_Fibroma Fibroma of Liver Fibroma of the Liver Hepatic Fibroma Liver Fibroma Liver Localized Fibrous Mesothelioma Liver Localized Fibrous Tumor Liver Solitary Fibrous Tumor Liver Solitary Fibrous Tumor A benign smooth muscle neoplasm arising from the liver. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C5753 Neoplastic Process Liver Leiomyoma C1333968 Benign Hepatic_Leiomyoma Hepatic Leiomyoma Leiomyoma of Liver Leiomyoma of the Liver Liver Leiomyoma Liver Leiomyoma A morphologic variant of hepatocellular carcinoma characterized by the presence of clear cells. C5754 Neoplastic Process Clear Cell Hepatocellular Carcinoma Clear Cell Hepatocellular Carcinoma C1333067 CTRP GDC 8174/3 Malignant Clear_Cell_Hepatocellular_Carcinoma 8174/3 Hepatocellular carcinoma, clear cell type Clear Cell Carcinoma of Liver Cells Clear Cell Carcinoma of the Liver Cells Clear Cell Hepatocellular Cancer Clear Cell Hepatocellular Carcinoma Hepatocellular Clear Cell Carcinoma Hepatocellular carcinoma, clear cell type Liver Cell Clear Cell Carcinoma Clear Cell Hepatocellular Carcinoma An aggressive malignant smooth muscle neoplasm, arising from the liver. It is characterized by a proliferation of neoplastic spindle cells. C5756 Neoplastic Process Liver Leiomyosarcoma C1333969 Malignant Hepatic_Leiomyosarcoma Hepatic Leiomyosarcoma Leiomyosarcoma of Liver Leiomyosarcoma of the Liver Liver Leiomyosarcoma Liver Leiomyosarcoma Stage I includes: T1, N0, M0. T1: Solitary tumor without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C5758 Neoplastic Process Stage I Hepatocellular Carcinoma AJCC v6 and v7 Stage I Hepatocellular Carcinoma AJCC v6 and v7 C1336456 CTRP Malignant Stage_I_Hepatocellular_Carcinoma Hepatocellular Cancer Stage I Liver Cell Cancer Stage I Stage I Hepatocellular Cancer Stage I Hepatocellular Carcinoma AJCC v6 Stage I Hepatocellular Carcinoma AJCC v6 and v7 Stage I Hepatocellular Carcinoma AJCC v7 Stage I Liver Cell Cancer Stage I Liver Cell Carcinoma Stage I Hepatocellular Carcinoma AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C5759 Neoplastic Process Stage II Hepatocellular Carcinoma AJCC v6 and v7 Stage II Hepatocellular Carcinoma AJCC v6 and v7 C1336290 CTRP Malignant Stage_II_Hepatocellular_Carcinoma Hepatocullular Cancer Stage II Liver Cell Cancer Stage II Stage II Hepatocellular Cancer Stage II Hepatocellular Carcinoma AJCC v6 Stage II Hepatocellular Carcinoma AJCC v6 and v7 Stage II Hepatocellular Carcinoma AJCC v7 Stage II Liver Cell Cancer Stage II Liver Cell Carcinoma Stage II Hepatocellular Carcinoma AJCC v6 and v7 Stage III includes: IIIA: (T3, N0, M0); IIIB: (T4, N0, M0); IIIC: (Any T, Any N, M0). IIIA: T3: Multiple tumors more than 5 cm or tumor involving a major branch of the portal or hepatic vein(s). T4: Tumors(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C5760 Neoplastic Process Stage III Hepatocellular Carcinoma AJCC v6 Stage III Hepatocellular Carcinoma AJCC v6 C1336248 CTRP Malignant Stage_III_Hepatocellular_Carcinoma Hepatocellular Cancer Stage III AJCC v6 Liver Cell Cancer Stage III AJCC v6 Stage III Carcinoma of Liver Cells AJCC v6 Stage III Carcinoma of the Liver Cells AJCC v6 Stage III Hepatocellular Cancer Stage III Hepatocellular Cancer AJCC v6 Stage III Hepatocellular Carcinoma AJCC v6 Stage III Liver Cell Cancer AJCC v6 Stage III Hepatocellular Carcinoma AJCC v6 Stage IIIA includes: T3a, N0, M0. T3a: Multiple tumors more than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C5761 Neoplastic Process Stage IIIA Hepatocellular Carcinoma AJCC v7 Stage IIIA Hepatocellular Carcinoma AJCC v7 C1336208 CTRP Malignant Stage_IIIA_Hepatocellular_Carcinoma Stage IIIA Carcinoma of Liver Cells Stage IIIA Carcinoma of the Liver Cells Stage IIIA Hepatocellular Cancer Stage IIIA Hepatocellular Carcinoma Stage IIIA Hepatocellular Carcinoma AJCC v7 Stage IIIA Liver Cancer Stage IIIA Liver Carcinoma Stage IIIA Liver Cell Carcinoma Stage IIIA Hepatocellular Carcinoma AJCC v7 Stage IIIB includes: T3b, N0, M0. T3b: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C5762 Neoplastic Process Stage IIIB Hepatocellular Carcinoma AJCC v7 Stage IIIB Hepatocellular Carcinoma AJCC v7 C1336223 CTRP Malignant Stage_IIIB_Hepatocellular_Carcinoma Stage IIIB Carcinoma of Liver Cells Stage IIIB Carcinoma of the Liver Cells Stage IIIB Hepatocellular Cancer Stage IIIB Hepatocellular Carcinoma Stage IIIB Hepatocellular Carcinoma AJCC v7 Stage IIIB Liver Cancer Stage IIIB Liver Carcinoma Stage IIIB Liver Cell Carcinoma Stage IIIB Hepatocellular Carcinoma AJCC v7 Stage IV includes (Any T, Any N, M1). M1: Distant metastasis. (AJCC 6th ed.) C5763 Neoplastic Process Stage IV Hepatocellular Carcinoma AJCC v6 Stage IV Hepatocellular Carcinoma AJCC v6 C1336418 CTRP Malignant Stage_IV_Hepatocellular_Carcinoma Hepatocellular Cancer Stage IV AJCC v6 Liver Cell Cancer Stage IV AJCC v6 Stage IV Hepatocellular Cancer Stage IV Hepatocellular Cancer AJCC v6 Stage IV Hepatocellular Carcinoma AJCC v6 Stage IV Liver Cell Cancer AJCC v6 Stage IV Liver Cell Carcinoma AJCC v6 Stage IV Hepatocellular Carcinoma AJCC v6 Stage IVA includes: Any T, N1, M0. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C5764 Neoplastic Process Stage IVA Hepatocellular Carcinoma AJCC v7 Stage IVA Hepatocellular Carcinoma AJCC v7 C1336339 CTRP Malignant Stage_IVA_Hepatocellular_Carcinoma Stage IVA Hepatocellular Cancer Stage IVA Hepatocellular Carcinoma Stage IVA Hepatocellular Carcinoma AJCC v7 Stage IVA Liver Cell Carcinoma Stage IVA Hepatocellular Carcinoma AJCC v7 Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C5765 Neoplastic Process Stage IVB Hepatocellular Carcinoma AJCC v7 Stage IVB Hepatocellular Carcinoma AJCC v7 C1336369 CTRP Malignant Stage_IVB_Hepatocellular_Carcinoma Stage IVB Carcinoma of Liver Cells Stage IVB Carcinoma of the Liver Cells Stage IVB Hepatocellular Cancer Stage IVB Hepatocellular Carcinoma Stage IVB Hepatocellular Carcinoma AJCC v7 Stage IVB Liver Cell Carcinoma Stage IVB Hepatocellular Carcinoma AJCC v7 A rare non-Hodgkin lymphoma that arises from the liver and the bulk of the tumor is located in the liver. The most frequent types of non-Hodgkin lymphoma that arise from the liver are diffuse large B-cell lymphoma and mucosa-associated lymphoid tissue lymphoma. C5766 Neoplastic Process Liver Non-Hodgkin Lymphoma C1333973 Malignant Hepatic_Non-Hodgkin_s_Lymphoma Hepatic Non-Hodgkin Lymphoma Hepatic Non-Hodgkin's Lymphoma Liver Non-Hodgkin Lymphoma Non-Hodgkin's Liver Lymphoma Non-Hodgkin's Lymphoma of Liver Non-Hodgkin's Lymphoma of the Liver Primary Hepatic Non-Hodgkin's Lymphoma Primary Liver Non-Hodgkin Lymphoma Liver Non-Hodgkin Lymphoma A rare mucosa-associated lymphoid tissue lymphoma that arises from the liver. It is characterized by the presence of centrocyte-like cells surrounding germinal centers. Lymphoepithelial lesions involving the bile duct epithelium may also be present. C5768 Neoplastic Process Liver Mucosa-Associated Lymphoid Tissue Lymphoma C1333972 Malignant Hepatic_Mucosa-Associated_Lymphoid_Tissue_Lymphoma Hepatic MALToma Hepatic Mucosa-Associated Lymphoid Tissue Lymphoma Liver MALToma Liver Mucosa-Associated Lymphoid Tissue Lymphoma MALT Hepatic Lymphoma MALT Liver Lymphoma MALT Lymphoma of Liver MALT Lymphoma of the Liver MALToma of Liver MALToma of the Liver Mucosa-Associated Lymphoid Tissue Liver Lymphoma Mucosa-Associated Lymphoid Tissue Lymphoma of Liver Mucosa-Associated Lymphoid Tissue Lymphoma of the Liver Liver Mucosa-Associated Lymphoid Tissue Lymphoma A morphologic variant of extrahepatic bile duct adenocarcinoma characterized by the presence of malignant glandular epithelium composed of clear cells. C5775 Neoplastic Process Extrahepatic Bile Duct Clear Cell Adenocarcinoma C0861855 Malignant Clear_Cell_Bile_Duct_Adenocarcinoma Bile Duct Clear Cell Adenocarcinoma Clear Cell Adenocarcinoma of Bile Duct Clear Cell Adenocarcinoma of the Bile Duct Clear Cell Bile Duct Adenocarcinoma Extrahepatic Bile Duct Clear Cell Adenocarcinoma Extrahepatic Bile Duct Clear Cell Adenocarcinoma An adenocarcinoma that arises from the extrahepatic bile ducts. It is characterized by the presence of signet ring malignant epithelial cells. C5776 Neoplastic Process Extrahepatic Bile Duct Signet Ring Cell Carcinoma C0861859 Malignant Signet_Ring_Cell_Bile_Duct_Carcinoma Bile Duct Signet Ring Cell Carcinoma Extrahepatic Bile Duct Signet Ring Cell Carcinoma Extrahepatic Bile Duct Signet-Ring Cell Carcinoma Signet Ring Cell Bile Duct Carcinoma Signet Ring Cell Carcinoma of Bile Duct Signet Ring Cell Carcinoma of the Bile Duct Extrahepatic Bile Duct Signet Ring Cell Carcinoma A carcinoma that arises from the extrahepatic bile ducts. It is composed entirely by malignant squamous epithelial cells. C5777 Neoplastic Process Extrahepatic Bile Duct Squamous Cell Carcinoma C0861861 Malignant Squamous_Cell_Bile_Duct_Carcinoma Bile Duct Squamous Cell Carcinoma Extrahepatic Bile Duct Squamous Cell Carcinoma Squamous Cell Bile Duct Carcinoma Squamous Cell Carcinoma of Bile Duct Squamous Cell Carcinoma of the Bile Duct Extrahepatic Bile Duct Squamous Cell Carcinoma A carcinoma that arises from the extrahepatic bile ducts. It is characterized by the presence of glandular and squamous malignant epithelial components. C5778 Neoplastic Process Extrahepatic Bile Duct Adenosquamous Carcinoma C0861854 Malignant Adenosquamous_Bile_Duct_Carcinoma Adenosquamous Bile Duct Carcinoma Adenosquamous Carcinoma of Bile Duct Adenosquamous Carcinoma of the Bile Duct Bile Duct Adenosquamous Carcinoma Extrahepatic Bile Duct Adenosquamous Carcinoma Extrahepatic Bile Duct Adenosquamous Carcinoma A carcinoma without evidence of differentiation arising from the extrahepatic bile ducts. C5780 Neoplastic Process Extrahepatic Bile Duct Undifferentiated Carcinoma C1336856 Malignant Undifferentiated_Extrahepatic_Bile_Duct_Carcinoma Anaplastic Carcinoma of Extrahepatic Bile Duct Anaplastic Carcinoma of the Extrahepatic Bile Duct Anaplastic Extrahepatic Bile Duct Carcinoma Extrahepatic Bile Duct Undifferentiated Carcinoma Undifferentiated Carcinoma of Extrahepatic Bile Duct Undifferentiated Carcinoma of the Extrahepatic Bile Duct Undifferentiated Extrahepatic Bile Duct Carcinoma Extrahepatic Bile Duct Undifferentiated Carcinoma An extremely rare, well differentiated neuroendocrine neoplasm arising from the liver. The neoplastic cells express immunohistochemical evidence of neuroendocrine differentiation. C5783 Neoplastic Process Liver Neuroendocrine Tumor C1333963 CPTAC Undetermined Hepatic_Carcinoid_Tumor Secondary carcinoid tumors of liver Secondary neuroendocrine tumor of liver HNET Hepatic Carcinoid Tumor Hepatic Neuroendocrine Tumor Liver Carcinoid Tumor Liver Neuroendocrine Tumor Liver Well Differentiated Neuroendocrine Neoplasm Liver Well-Differentiated Neuroendocrine Neoplasm Primary Hepatic Neuroendocrine Tumor Primary Liver Neuroendocrine Tumor Liver Neuroendocrine Tumor A somatostatin-producing neuroendocrine tumor that arises from the jejunum. C5787 Neoplastic Process Jejunal Somatostatin-Producing Neuroendocrine Tumor C1334297 Undetermined Jejunal_Delta_Cell_Somatostatin_Producing_Neoplasm Delta Cell Tumor of Jejunum Delta Cell Tumor of the Jejunum Jejunal Somatostatin Producing Tumor Jejunal Somatostatin-Producing NET Jejunal Somatostatin-Producing Neuroendocrine Tumor Jejunal Somatostatinoma Somatosatinoma of Jejunum Somatosatinoma of the Jejunum Jejunal Somatostatin-Producing Neuroendocrine Tumor A non-Hodgkin lymphoma that arises from the pancreas with the bulk of the tumor localized to this organ. The vast majority of cases are of B-cell phenotype and include mucosa-associated lymphoid tissue lymphomas, follicular lymphomas, and diffuse large B-cell lymphomas. C5789 Neoplastic Process Pancreatic Non-Hodgkin Lymphoma C1335312 Malignant Pancreatic_Non-Hodgkin_s_Lymphoma Pancreatic Non-Hodgkin Lymphoma Pancreatic Non-Hodgkin's Lymphoma Primary Pancreatic Non-Hodgkin's Lymphoma Pancreatic Non-Hodgkin Lymphoma C5790 Neoplastic Process Adult Central Nervous System Embryonal Carcinoma Adult Central Nervous System Embryonal Carcinoma C1370503 CTRP Malignant Adult_Central_Nervous_System_Embryonal_Carcinoma Adult CNS Embryonal Carcinoma Adult Central Nervous System Embryonal Carcinoma Central Nervous System Embryonal Carcinoma Embryonal Carcinoma of Adult CNS Embryonal Carcinoma of Adult Central Nervous System Embryonal Carcinoma of the Adult CNS Embryonal Carcinoma of the Adult Central Nervous System Adult Central Nervous System Embryonal Carcinoma C5792 Neoplastic Process Adult Central Nervous System Germinoma Adult Central Nervous System Germinoma C1370504 CTRP Malignant Adult_Central_Nervous_System_Germinoma Adult CNS Germinoma Adult Central Nervous System Germinoma Central Nervous System Germinoma Germinoma of Adult CNS Germinoma of Adult Central Nervous System Germinoma of the Adult CNS Germinoma of the Adult Central Nervous System Adult Central Nervous System Germinoma A choriocarcinoma affecting the central nervous system and occurring in adulthood. C5793 Neoplastic Process Adult Central Nervous System Choriocarcinoma Adult Central Nervous System Choriocarcinoma C1370505 CTRP Malignant Adult_Central_Nervous_System_Choriocarcinoma Adult CNS Choriocarcinoma Adult Central Nervous System Choriocarcinoma Central Nervous System Choriocarcinoma Choriocarcinoma of Adult CNS Choriocarcinoma of Adult Central Nervous System Choriocarcinoma of the Adult CNS Choriocarcinoma of the Adult Central Nervous System Adult Central Nervous System Choriocarcinoma A mature or immature teratoma affecting the central nervous system and occurring in adults. C5794 Neoplastic Process Adult Central Nervous System Teratoma Adult Central Nervous System Teratoma C1370506 CTRP Undetermined Adult_Central_Nervous_System_Teratoma Adult CNS Teratoma Adult Central Nervous System Teratoma Central Nervous System Teratoma Teratoma of Adult CNS Teratoma of Adult Central Nervous System Teratoma of the Adult CNS Teratoma of the Adult Central Nervous System Adult Central Nervous System Teratoma A germ cell tumor arising from brain during childhood. C5795 Neoplastic Process Childhood Brain Germ Cell Tumor Childhood Brain Germ Cell Tumor CL448320 CTRP Undetermined Childhood_Brain_Germ_Cell_Neoplasm Brain Germ Cell Tumor Childhood Brain Germ Cell Neoplasm Childhood Brain Germ Cell Tumor Childhood Germ Cell Brain Neoplasm Childhood Germ Cell Brain Tumor Germ Cell Neoplasm of Childhood Brain Germ Cell Neoplasm of Pediatric Brain Germ Cell Neoplasm of the Childhood Brain Germ Cell Neoplasm of the Pediatric Brain Germ Cell Tumor of Childhood Brain Germ Cell Tumor of Pediatric Brain Germ Cell Tumor of the Childhood Brain Germ Cell Tumor of the Pediatric Brain Pediatric Brain Germ Cell Neoplasm Pediatric Brain Germ Cell Tumor Childhood Brain Germ Cell Tumor A benign neoplasm of the cerebellum occurring in adults. C5796 Neoplastic Process Adult Benign Cerebellar Neoplasm C1332468 Benign Benign_Adult_Cerebellar_Neoplasm Adult Benign Cerebellar Neoplasm Adult Benign Cerebellar Neoplasms Benign Adult Cerebellar Neoplasm Benign Adult Cerebellar Tumor Benign Adult Cerebellar Tumors Benign Neoplasm of Adult Cerebellum Benign Neoplasm of the Adult Cerebellum Benign Tumor of Adult Cerebellum Benign Tumor of the Adult Cerebellum Adult Benign Cerebellar Neoplasm A benign neoplasm of the brain stem occurring in adults. C5797 Neoplastic Process Adult Benign Brain Stem Neoplasm C1332467 Benign Benign_Adult_Brain_Stem_Neoplasm Adult Benign Brain Stem Neoplasm Adult Benign Brain Stem Neoplasms Benign Adult Brain Stem Neoplasm Benign Adult Brain Stem Tumor Benign Adult Brain Stem Tumors Benign Adult Brainstem Neoplasm Benign Adult Brainstem Neoplasms Benign Adult Brainstem Tumor Benign Adult Brainstem Tumors Benign Neoplasm of Adult Brain Stem Benign Neoplasm of Adult Brainstem Benign Neoplasm of the Adult Brain Stem Benign Neoplasm of the Adult Brainstem Benign Tumor of Adult Brain Stem Benign Tumor of Adult Brainstem Benign Tumor of the Adult Brain Stem Benign Tumor of the Adult Brainstem Adult Benign Brain Stem Neoplasm A childhood neoplasm that arises from the brain and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C5798 Neoplastic Process Childhood Benign Brain Neoplasm C1332482 Benign Benign_Childhood_Brain_Neoplasm Benign Childhood Brain Neoplasm Benign Childhood Brain Tumor Benign Childhood Neoplasm of Brain Benign Childhood Neoplasm of the Brain Benign Childhood Tumor of Brain Benign Childhood Tumor of the Brain Benign Pediatric Brain Neoplasm Benign Pediatric Brain Tumor Benign Pediatric Neoplasm of Brain Benign Pediatric Neoplasm of the Brain Benign Pediatric Tumor of Brain Benign Pediatric Tumor of the Brain Childhood Benign Brain Neoplasm Childhood Benign Brain Neoplasm A childhood neoplasm that arises from the supratentorial region and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C5799 Neoplastic Process Childhood Benign Supratentorial Neoplasm C1332486 Benign Benign_Childhood_Supratentorial_Neoplasm Benign Childhood Supratentorial Neoplasm Benign Childhood Supratentorial Tumor Benign Pediatric Supratentorial Neoplasm Benign Pediatric Supratentorial Tumor Childhood Benign Supratentorial Neoplasm Childhood Benign Supratentorial Tumor Childhood Benign Supratentorial Neoplasm A choroid plexus papilloma that arises in the brain during childhood. C5800 Neoplastic Process Childhood Choroid Plexus Papilloma C1332963 Benign Childhood_Choroid_Plexus_Papilloma Childhood Choroid Plexus Papilloma Childhood Papilloma of Choroid Plexus Childhood Papilloma of the Choroid Plexus Pediatric Choroid Plexus Papilloma Pediatric Papilloma of Choroid Plexus Pediatric Papilloma of the Choroid Plexus Childhood Choroid Plexus Papilloma A neoplasm that affects the infratentorial region of the brain and occurs during childhood. C5802 Neoplastic Process Childhood Infratentorial Neoplasm C1332973 Undetermined Childhood_Infratentorial_Neoplasm Childhood Infratentorial Neoplasm Childhood Infratentorial Neoplasms Childhood Infratentorial Tumor Childhood Infratentorial Tumors Pediatric Infratentorial Neoplasm Pediatric Infratentorial Tumor Childhood Infratentorial Neoplasm A neoplasm with neuroendocrine differentiation that arises from the small intestine. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms). C5803 Neoplastic Process Small Intestinal Neuroendocrine Neoplasm C1336005 Undetermined Small_Intestinal_Neuroendocrine_Neoplasm Small Intestinal Neuroendocrine Neoplasm Small Intestine Neuroendocrine Neoplasm Small Intestinal Neuroendocrine Neoplasm A gastrointestinal stromal tumor that arises from the stomach. It covers a spectrum of benign to malignant soft tissue neoplasms and includes most gastric smooth muscle tumors, leiomyoblastomas, and tumors formerly called gastrointestinal autonomic nerve tumors. C5806 Neoplastic Process Gastric Gastrointestinal Stromal Tumor Gastric Gastrointestinal Stromal Tumor C1333768 CTRP mCode Undetermined Gastric_Gastrointestinal_Stromal_Tumor Digestive Stromal Neoplasm of Stomach Digestive Stromal Neoplasm of the Stomach Digestive Stromal Tumor of Stomach Digestive Stromal Tumor of the Stomach GIST of Stomach GIST of the Stomach Gastric (Stomach) Gastrointestinal Stromal Tumor (GIST) Gastric Digestive Stromal Neoplasm Gastric Digestive Stromal Tumor Gastric GIST Gastric Gastrointestinal Stromal Tumor Gastrointestinal Stromal Neoplasm of Stomach Gastrointestinal Stromal Neoplasm of the Stomach Gastrointestinal Stromal Tumor of Stomach Gastrointestinal Stromal Tumor of the Stomach Gastrointestinal stromal tumor of stomach Stomach Digestive Stromal Neoplasm Stomach Digestive Stromal Tumor Gastric Gastrointestinal Stromal Tumor Stage I includes: (T1, N0, M0); (T2, N0, M0). T1: Tumor invades lamina propria or submucosa. T2: Tumor invades muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C5807 Neoplastic Process Stage I Small Intestinal Cancer AJCC v7 Stage I Small Intestinal Cancer AJCC v7 C1167735 CTRP Malignant Stage_I_Small_Intestinal_Cancer Small Intestine Cancer Stage I Stage I Small Intestinal Cancer Stage I Small Intestinal Cancer AJCC v7 Stage I Small Intestine Carcinoma Stage I Small Intestinal Cancer AJCC v7 Stage II includes: IIA (T3, N0, M0); IIB (T4, N0, M0). T3: Tumor invades through the muscularis propria into the subserosa or into the nonperitonealized perimuscular tissue (mesentery or retroperitoneum) with extension 2 cm or less. T4: Tumor perforates the visceral peritoneum or directly invades other organs or structures (including other loops of small intestine, mesentery, or retroperitoneum more than 2 cm, and abdominal wall by way of serosa; for duodenum only, invasion of pancreas or bile duct). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C5808 Neoplastic Process Stage II Small Intestinal Cancer AJCC v7 Stage II Small Intestinal Cancer AJCC v7 C1167736 CTRP Malignant Stage_II_Small_Intestinal_Cancer Small Intestine Cancer Stage II Stage II Small Intestinal Cancer Stage II Small Intestinal Cancer AJCC v7 Stage II Small Intestine Carcinoma Stage II Small Intestinal Cancer AJCC v7 Stage III includes: IIIA (Any T, N1, M0); IIIB (Any T, N2, M0); N1: Metastasis in 1-3 regional lymph nodes. N2: Metastasis in four or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C5809 Neoplastic Process Stage III Small Intestinal Cancer AJCC v7 Stage III Small Intestinal Cancer AJCC v7 C1167737 CTRP Malignant Stage_III_Small_Intestinal_Cancer Small Intestine Cancer Stage III Stage III Small Intestinal Cancer Stage III Small Intestinal Cancer AJCC v7 Stage III Small Intestine Carcinoma Stage III Small Intestinal Cancer AJCC v7 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C5810 Neoplastic Process Stage IV Small Intestinal Cancer AJCC v7 Stage IV Small Intestinal Cancer AJCC v7 C1167738 CTRP Malignant Stage_IV_Small_Intestinal_Cancer Small Intestine Cancer Stage IV Stage IV Small Intestinal Cancer Stage IV Small Intestinal Cancer AJCC v7 Stage IV Small Intestine Carcinoma Stage IV Small Intestinal Cancer AJCC v7 A gastrointestinal stromal tumor that arises from the small intestine. It usually affects adults over fifty years of age. The majority of cases have spindle cell morphology. The prognosis depends on the tumor size and the mitotic activity. C5811 Neoplastic Process Small Intestinal Gastrointestinal Stromal Tumor Small Intestinal Gastrointestinal Stromal Tumor C1335996 CTRP mCode Undetermined Small_Intestinal_Gastrointestinal_Stromal_Tumor Digestive Stromal Neoplasm of Small Intestine Digestive Stromal Neoplasm of the Small Intestine Digestive Stromal Tumor of Small Intestine Digestive Stromal Tumor of the Small Intestine Gastrointestinal Stromal Neoplasm of Small Intestine Gastrointestinal Stromal Neoplasm of the Small Intestine Gastrointestinal Stromal Tumor of Small Intestine Gastrointestinal Stromal Tumor of the Small Intestine Gastrointestinal stromal tumor of small intestine Small Intestinal GIST Small Intestinal Gastrointestinal Stromal Tumor Small Intestinal Gastrointestinal Stromal Tumor (GIST) Small Intestine Digestive Stromal Neoplasm Small Intestine Digestive Stromal Tumor Small Intestine Gastrointestinal Stromal Neoplasm Small Intestinal Gastrointestinal Stromal Tumor A malignant neoplasm that has spread from its original site of growth to the brain in an adult patient. C5816 Neoplastic Process Metastatic Malignant Neoplasm in the Adult Brain Metastatic Adult Malignant Neoplasm in the Brain C1334723 Malignant Metastatic_Neoplasm_to_the_Adult_Brain Brain Metastases, Adult Metastasis to the Adult Brain Metastatic Adult Malignant Neoplasm in the Brain Metastatic Malignant Neoplasm to the Adult Brain Metastatic Neoplasm to the Adult Brain Metastatic Tumor to the Adult Brain Secondary Malignant Neoplasm to the Adult Brain Secondary Malignant Tumor to the Adult Brain Metastatic Adult Malignant Neoplasm in the Brain A central nervous system embryonal tumor, not otherwise specified arising from the brain. C5817 Neoplastic Process Intracranial Embryonal Tumor, Not Otherwise Specified C1334246 DIPG/DMG Malignant Intracranial_Primitive_Neuroectodermal_Neoplasm Embryonal Tumor Intracranial Embryonal Tumor, NOS Intracranial Embryonal Tumor, Not Otherwise Specified Intracranial PNET Intracranial Primitive Neuroectodermal Neoplasm Intracranial Primitive Neuroectodermal Tumor Intracranial Embryonal Tumor, Not Otherwise Specified An adenoid cystic carcinoma that arises from the pharynx. C5818 Neoplastic Process Pharyngeal Adenoid Cystic Carcinoma Pharyngeal Adenoid Cystic Carcinoma C1335399 CTRP Malignant Pharyngeal_Adenoid_Cystic_Carcinoma Adenoid Cystic Carcinoma of Pharynx Adenoid Cystic Carcinoma of the Pharynx Pharyngeal Adenoid Cystic Carcinoma Pharyngeal Throat Adenoid Cystic Cancer Pharynx Adenoid Cystic Carcinoma Pharyngeal Adenoid Cystic Carcinoma A benign, exophytic and polypoid growth that arises from the buccal mucosa. It is covered by hyperplastic epithelium. Some cases are caused by human papillomavirus infection. C5819 Neoplastic Process Buccal Squamous Papilloma C1332641 Benign Buccal_Mucosa_Papilloma Buccal Mucosa Papilloma Buccal Squamous Cell Papilloma Buccal Squamous Papilloma Papilloma of Buccal Mucosa Papilloma of the Buccal Mucosa Buccal Squamous Papilloma A rare, well differentiated, low grade neoplasm with neuroendocrine differentiation that arises from the esophagus. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. The majority of cases have a polypoid appearance, are small lesions, and found incidentally. C5820 Neoplastic Process Esophageal Neuroendocrine Tumor G1 C1333444 Undetermined Esophageal_Carcinoid_Tumor Esophageal NET G1 Esophageal Neuroendocrine Tumor G1 Esophageal Neuroendocrine Tumor G1 A neoplasm with neuroendocrine differentiation that arises from the esophagus. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms). C5821 Neoplastic Process Esophageal Neuroendocrine Neoplasm C1333462 Undetermined Esophageal_Neuroendocrine_Neoplasm Esophageal Neuroendocrine Neoplasm Neuroendocrine Neoplasm of Esophagus Neuroendocrine Neoplasm of the Esophagus Esophageal Neuroendocrine Neoplasm C5822 Neoplastic Process Nerve Plexus Neoplasm C1334945 Undetermined Nerve_Plexus_Neoplasm Neoplasm of Nerve Plexus Neoplasm of the Nerve Plexus Nerve Plexus Neoplasm Nerve Plexus Neoplasms Nerve Plexus Tumor Nerve Plexus Tumors Neural Plexus Neoplasms Neural Plexus Tumors Tumor of Nerve Plexus Tumor of the Nerve Plexus Nerve Plexus Neoplasm C5823 Neoplastic Process Brachial Plexus Neoplasm C1332602 Undetermined Brachial_Plexus_Neoplasm Brachial Plexus Neoplasm Brachial Plexus Neoplasms Brachial Plexus Tumor Neoplasm of Brachial Plexus Neoplasm of the Brachial Plexus Tumor of Brachial Plexus Tumor of the Brachial Plexus Brachial Plexus Neoplasm C5824 Neoplastic Process Lumbar Plexus Neoplasm C1334437 Undetermined Lumbar_Plexus_Neoplasm Lumbar Plexus Neoplasm Lumbar Plexus Neoplasms Lumbar Plexus Tumor Neoplasm of Lumbar Plexus Neoplasm of the Lumbar Plexus Tumor of Lumbar Plexus Tumor of the Lumbar Plexus Lumbar Plexus Neoplasm A benign or malignant neoplasm affecting the trochlear nerve (IVth cranial nerve). C5825 Neoplastic Process Trochlear Nerve Neoplasm C1263896 Undetermined Trochlear_Nerve_Neoplasm Fourth Cranial Nerve Neoplasm Fourth Cranial Nerve Neoplasms Fourth Cranial Nerve Tumor Fourth Cranial Nerve Tumors IVth Cranial Nerve Neoplasms IVth Cranial Nerve Tumors Neoplasm of Fourth Cranial Nerve Neoplasm of Trochlear Nerve Neoplasm of the Fourth Cranial Nerve Neoplasm of the Trochlear Nerve Trochlear Nerve Neoplasm Trochlear Nerve Neoplasms Trochlear Nerve Tumor Trochlear Nerve Tumors Tumor of Fourth Cranial Nerve Tumor of Trochlear Nerve Tumor of the Fourth Cranial Nerve Tumor of the Trochlear Nerve Trochlear Nerve Neoplasm C5826 Neoplastic Process Abducens Nerve Neoplasm C1263898 Undetermined Abducens_Nerve_Neoplasm Abducens Nerve Neoplasm Abducens Nerve Neoplasms Abducens Nerve Tumor Abducens Nerve Tumors Neoplasm of Abducens Nerve Neoplasm of Sixth Cranial Nerve Neoplasm of the Abducens Nerve Neoplasm of the Sixth Cranial Nerve Sixth Cranial Nerve Neoplasm Sixth Cranial Nerve Neoplasms Sixth Cranial Nerve Tumor Sixth Cranial Nerve Tumors Tumor of Abducens Nerve Tumor of Sixth Cranial Nerve Tumor of the Abducens Nerve Tumor of the Sixth Cranial Nerve VIth Cranial Nerve Neoplasms VIth Cranial Nerve Tumors Abducens Nerve Neoplasm C5827 Neoplastic Process Facial Nerve Neoplasm C1263899 Undetermined Facial_Nerve_Neoplasm Facial Nerve Neoplasm Facial Nerve Neoplasms Facial Nerve Tumor Facial Nerve Tumors Neoplasm of Facial Nerve Neoplasm of Seventh Cranial Nerve Neoplasm of the Facial Nerve Neoplasm of the Seventh Cranial Nerve Seventh Cranial Nerve Neoplasm Seventh Cranial Nerve Neoplasms Seventh Cranial Nerve Tumor Seventh Cranial Nerve Tumors Tumor of Facial Nerve Tumor of Seventh Cranial Nerve Tumor of the Facial Nerve Tumor of the Seventh Cranial Nerve VIIth Cranial Nerve Neoplasms VIIth Cranial Nerve Tumors Facial Nerve Neoplasm C5828 Neoplastic Process Glossopharyngeal Nerve Neoplasm C1263900 Undetermined Glossopharyngeal_Nerve_Neoplasm Glossopharyngeal Nerve Neoplasm Glossopharyngeal Nerve Neoplasms Glossopharyngeal Nerve Tumor Glossopharyngeal Nerve Tumors IXth Cranial Nerve Neoplasms IXth Cranial Nerve Tumors Neoplasm of Glossopharyngeal Nerve Neoplasm of Ninth Cranial Nerve Neoplasm of the Glossopharyngeal Nerve Neoplasm of the Ninth Cranial Nerve Ninth Cranial Nerve Neoplasm Ninth Cranial Nerve Neoplasms Ninth Cranial Nerve Tumor Ninth Cranial Nerve Tumors Tumor of Glossopharyngeal Nerve Tumor of Ninth Cranial Nerve Tumor of the Glossopharyngeal Nerve Tumor of the Ninth Cranial Nerve Glossopharyngeal Nerve Neoplasm C5829 Neoplastic Process Accessory Nerve Neoplasm C1263902 Undetermined Spinal_Accessory_Nerve_Neoplasm Accessory Nerve Neoplasm Eleventh Cranial Nerve Neoplasm Eleventh Cranial Nerve Neoplasms Eleventh Cranial Nerve Tumor Eleventh Cranial Nerve Tumors Neoplasm of Eleventh Cranial Nerve Neoplasm of Spinal Accessory Nerve Neoplasm of the Eleventh Cranial Nerve Neoplasm of the Spinal Accessory Nerve Spinal Accessory Nerve Neoplasm Spinal Accessory Nerve Neoplasms Spinal Accessory Nerve Tumor Spinal Accessory Nerve Tumors Tumor of Eleventh Cranial Nerve Tumor of Spinal Accessory Nerve Tumor of the Eleventh Cranial Nerve Tumor of the Spinal Accessory Nerve XIth Cranial Nerve Neoplasms XIth Cranial Nerve Tumors Accessory Nerve Neoplasm C5830 Neoplastic Process Hypoglossal Nerve Neoplasm C1263903 Undetermined Hypoglossal_Nerve_Neoplasm Hypoglossal Nerve Neoplasm Hypoglossal Nerve Neoplasms Hypoglossal Nerve Tumor Hypoglossal Nerve Tumors Neoplasm of Hypoglossal Nerve Neoplasm of Twelfth Cranial Nerve Neoplasm of the Hypoglossal Nerve Neoplasm of the Twelfth Cranial Nerve Tumor of Hypoglossal Nerve Tumor of Twelfth Cranial Nerve Tumor of the Hypoglossal Nerve Tumor of the Twelfth Cranial Nerve Twelfth Cranial Nerve Neoplasm Twelfth Cranial Nerve Neoplasms Twelfth Cranial Nerve Tumor Twelfth Cranial Nerve Tumors XIIth Cranial Nerve Neoplasms XIIth Cranial Nerve Tumors Hypoglossal Nerve Neoplasm A benign or malignant neoplasm affecting the vagus nerve (tenth cranial nerve). C5831 Neoplastic Process Vagus Nerve Neoplasm C1263901 Undetermined Vagus_Nerve_Neoplasm Neoplasm of Tenth Cranial Nerve Neoplasm of Vagus Nerve Neoplasm of the Tenth Cranial Nerve Neoplasm of the Vagus Nerve Tenth Cranial Nerve Neoplasm Tenth Cranial Nerve Neoplasms Tenth Cranial Nerve Tumor Tenth Cranial Nerve Tumors Tumor of Tenth Cranial Nerve Tumor of Vagus Nerve Tumor of the Tenth Cranial Nerve Tumor of the Vagus Nerve Vagus Nerve Neoplasm Vagus Nerve Neoplasms Vagus Nerve Tumor Vagus Nerve Tumors Xth Cranial Nerve Neoplasms Xth Cranial Nerve Tumors Vagus Nerve Neoplasm A usually aggressive malignant neoplasm arising from the liver. It is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation in a herringbone growth pattern. C5832 Neoplastic Process Liver Fibrosarcoma C1333966 Malignant Hepatic_Fibrosarcoma Fibrosarcoma of Liver Fibrosarcoma of the Liver Hepatic Fibrosarcoma Liver Fibrosarcoma Liver Fibrosarcoma An osteosarcoma arising from the liver. C5833 Neoplastic Process Liver Extraskeletal Osteosarcoma C1333974 Malignant Hepatic_Osteosarcoma Hepatic Extraskeletal Osteosarcoma Hepatic Osteogenic Sarcoma Hepatic Osteosarcoma Liver Extraskeletal Osteosarcoma Liver Osteogenic Sarcoma Liver Osteosarcoma Osteogenic Sarcoma of Liver Osteogenic Sarcoma of the Liver Osteosarcoma of Liver Osteosarcoma of the Liver Liver Extraskeletal Osteosarcoma A malignant mesenchymal tumor with skeletal muscle differentiation affecting the liver. C5834 Neoplastic Process Liver Rhabdomyosarcoma C1333975 Malignant Hepatic_Rhabdomyosarcoma Hepatic Rhabdomyosarcoma Liver Rhabdomyosarcoma Rhabdomyosarcoma of Liver Rhabdomyosarcoma of the Liver Liver Rhabdomyosarcoma A benign adipose tissue neoplasm involving the gallbladder wall. C5835 Neoplastic Process Gallbladder Lipoma C1333747 Benign Gallbladder_Lipoma Gallbladder Lipoma Lipoma of Gallbladder Lipoma of the Gallbladder Gallbladder Lipoma An undifferentiated carcinoma that arises from the gallbladder. It is characterized by the presence of spindle and giant malignant cells, including osteoclast-like giant cells. C5838 Neoplastic Process Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type C2348726 Malignant Gallbladder_Pleomorphic_Giant_Cell_Adenocarcinoma Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type Pleomorphic Spindle and Giant Cell Carcinoma of Gallbladder Pleomorphic Spindle and Giant Cell Carcinoma of the Gallbladder Undifferentiated Gallbladder Carcinoma, Spindle and Giant Cell Type Gallbladder Undifferentiated Carcinoma, Spindle and Giant Cell Type A malignant mesenchymal tumor with skeletal muscle differentiation affecting the gallbladder. C5839 Neoplastic Process Gallbladder Rhabdomyosarcoma C1333756 Malignant Gallbladder_Rhabdomyosarcoma Gallbladder Rhabdomyosarcoma Rhabdomyosarcoma of Gallbladder Rhabdomyosarcoma of the Gallbladder Gallbladder Rhabdomyosarcoma A malignant vascular neoplasm arising from the gallbladder. C5840 Neoplastic Process Gallbladder Angiosarcoma C1333742 Malignant Gallbladder_Angiosarcoma Angiosarcoma of Gallbladder Angiosarcoma of the Gallbladder Gallbladder Angiosarcoma Gallbladder Hemangiosarcoma Hemangiosarcoma of Gallbladder Hemangiosarcoma of the Gallbladder Gallbladder Angiosarcoma An aggressive malignant smooth muscle neoplasm, arising from the gallbladder. It is characterized by a proliferation of neoplastic spindle cells. C5841 Neoplastic Process Gallbladder Leiomyosarcoma C1333746 Malignant Gallbladder_Leiomyosarcoma Gallbladder Leiomyosarcoma Leiomyosarcoma of Gallbladder Leiomyosarcoma of the Gallbladder Gallbladder Leiomyosarcoma A Kaposi sarcoma arising from the gallbladder. C5842 Neoplastic Process Gallbladder Kaposi Sarcoma C1333744 Malignant Gallbladder_Kaposi_s_Sarcoma Gallbladder Kaposi Sarcoma Gallbladder Kaposi's Sarcoma Kaposi's Sarcoma of Gallbladder Kaposi's Sarcoma of the Gallbladder Gallbladder Kaposi Sarcoma An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the extrahepatic bile ducts. It is characterized by the presence of malignant small cells. C5845 Neoplastic Process Extrahepatic Bile Duct Small Cell Neuroendocrine Carcinoma C1335979 Malignant Small_Cell_Extrahepatic_Bile_Duct_Carcinoma Extrahepatic Bile Duct Small Cell Carcinoma Extrahepatic Bile Duct Small Cell NEC Extrahepatic Bile Duct Small Cell Neuroendocrine Carcinoma Oat Cell Carcinoma of Extrahepatic Bile Duct Oat Cell Carcinoma of the Extrahepatic Bile Duct Oat Cell Extrahepatic Bile Duct Carcinoma Small Cell Adenocarcinoma of Extrahepatic Bile Duct Small Cell Adenocarcinoma of the Extrahepatic Bile Duct Small Cell Extrahepatic Bile Duct Carcinoma Small Cell Extrahepatic Bile Duct Neuroendocrine Carcinoma Extrahepatic Bile Duct Small Cell Neuroendocrine Carcinoma An adenocarcinoma that arises from the extrahepatic bile ducts. It is characterized by the presence of extracellular mucin that constitutes more than fifty-percent of the tumor. C5846 Neoplastic Process Extrahepatic Bile Duct Mucinous Adenocarcinoma C0861856 Malignant Mucinous_Bile_Duct_Adenocarcinoma Bile Duct Colloid Carcinoma Bile Duct Colloidal Carcinoma Bile Duct Mucinous Adenocarcinoma Colloid Adenocarcinoma of Bile Duct Colloid Adenocarcinoma of Extrahepatic Bile Duct Colloid Adenocarcinoma of the Bile Duct Colloid Adenocarcinoma of the Extrahepatic Bile Duct Colloid Bile Duct Adenocarcinoma Colloid Bile Duct Carcinoma Colloid Carcinoma of Bile Duct Colloid Carcinoma of the Bile Duct Colloid Extrahepatic Bile Duct Adenocarcinoma Colloidal Adenocarcinoma of Bile Duct Colloidal Adenocarcinoma of Extrahepatic Bile Duct Colloidal Adenocarcinoma of the Bile Duct Colloidal Adenocarcinoma of the Extrahepatic Bile Duct Colloidal Bile Duct Adenocarcinoma Colloidal Bile Duct Carcinoma Colloidal Carcinoma of Bile Duct Colloidal Carcinoma of the Bile Duct Colloidal Extrahepatic Bile Duct Adenocarcinoma Extrahepatic Bile Duct Mucinous Adenocarcinoma Mucinous Adenocarcinoma of Bile Duct Mucinous Adenocarcinoma of Extrahepatic Bile Duct Mucinous Adenocarcinoma of the Bile Duct Mucinous Adenocarcinoma of the Extrahepatic Bile Duct Mucinous Bile Duct Adenocarcinoma Mucinous Carcinoma of Bile Duct Mucinous Carcinoma of the Bile Duct Mucinous Extrahepatic Bile Duct Adenocarcinoma Extrahepatic Bile Duct Mucinous Adenocarcinoma An embryonal rhabdomyosarcoma that arises from the extrahepatic bile ducts. C5847 Neoplastic Process Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma C1333505 Malignant Extrahepatic_Bile_Duct_Embryonal_Rhabdomyosarcoma Embryonal Extrahepatic Bile Duct Rhabdomyosarcoma Embryonal Rhabdomyosarcoma of Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma of the Extrahepatic Bile Duct Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma An aggressive malignant smooth muscle neoplasm, arising from an extrahepatic bile duct. It is characterized by a proliferation of neoplastic spindle cells. C5848 Neoplastic Process Extrahepatic Bile Duct Leiomyosarcoma C1333508 Malignant Extrahepatic_Bile_Duct_Leiomyosarcoma Bile Duct Leiomyosarcoma Extrahepatic Bile Duct Leiomyosarcoma Leiomyosarcoma of Bile Duct Leiomyosarcoma of Extrahepatic Bile Duct Leiomyosarcoma of the Bile Duct Leiomyosarcoma of the Extrahepatic Bile Duct Extrahepatic Bile Duct Leiomyosarcoma An adenoma that arises from the extrahepatic bile ducts. It is characterized by the presence of a papillary growth pattern. C5849 Neoplastic Process Extrahepatic Bile Duct Papillary Adenoma C1333510 Benign Extrahepatic_Bile_Duct_Papillary_Adenoma Extrahepatic Bile Duct Papillary Adenoma Papillary Adenoma of Extrahepatic Bile Duct Papillary Adenoma of the Extrahepatic Bile Duct Extrahepatic Bile Duct Papillary Adenoma An adenoma that arises from the extrahepatic bile ducts. It is characterized by the presence of a tubular pattern. C5850 Neoplastic Process Extrahepatic Bile Duct Tubular Adenoma C1333512 Benign Extrahepatic_Bile_Duct_Tubular_Adenoma Extrahepatic Bile Duct Tubular Adenoma Tubular Adenoma of Extrahepatic Bile Duct Tubular Adenoma of the Extrahepatic Bile Duct Extrahepatic Bile Duct Tubular Adenoma A mucinous cystic neoplasm that arises from the extrahepatic bile ducts. C5851 Neoplastic Process Extrahepatic Bile Duct Mucinous Cystic Neoplasm C1333504 Benign Extrahepatic_Bile_Duct_Cystadenoma Cystadenoma of Extrahepatic Bile Duct Cystadenoma of the Extrahepatic Bile Duct Extrahepatic Bile Duct Cystadenoma Extrahepatic Bile Duct MCN Extrahepatic Bile Duct Mucinous Cystic Neoplasm Extrahepatic Bile Duct Mucinous Cystic Neoplasm A granular cell tumor that arises from the extrahepatic bile ducts and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C5852 Neoplastic Process Extrahepatic Bile Duct Benign Granular Cell Tumor C1332507 Benign Benign_Granular_Cell_Tumor_of_Extrahepatic_Bile_Ducts Benign Extrahepatic Bile Duct Granular Cell Myoblastoma Benign Granular Cell Myoblastoma of Extrahepatic Bile Duct Benign Granular Cell Myoblastoma of the Extrahepatic Bile Duct Benign Granular Cell Tumor of Extrahepatic Bile Ducts Extrahepatic Bile Duct Benign Granular Cell Tumor Extrahepatic Bile Duct Benign Granular Cell Tumor A benign neoplasm arising from the extra hepatic bile duct. It is characterized by the presence of spindle-shaped fibroblasts. C5853 Neoplastic Process Extrahepatic Bile Duct Fibroma C1333506 Benign Extrahepatic_Bile_Duct_Fibroma Extrahepatic Bile Duct Fibroma Fibroma of Extrahepatic Bile Duct Fibroma of the Extrahepatic Bile Duct Extrahepatic Bile Duct Fibroma A rare benign adipose tissue neoplasm of the extrahepatic bile duct. C5854 Neoplastic Process Extrahepatic Bile Duct Lipoma C1333509 Benign Extrahepatic_Bile_Duct_Lipoma Extrahepatic Bile Duct Lipoma Lipoma of Extrahepatic Bile Duct Lipoma of the Extrahepatic Bile Duct Extrahepatic Bile Duct Lipoma A benign smooth muscle neoplasm arising from an extrahepatic bile duct. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C5855 Neoplastic Process Extrahepatic Bile Duct Leiomyoma C1333507 Benign Extrahepatic_Bile_Duct_Leiomyoma Extrahepatic Bile Duct Leiomyoma Leiomyoma of Extrahepatic Bile Duct Leiomyoma of the Extrahepatic Bile Duct Extrahepatic Bile Duct Leiomyoma A mesenchymal neoplasm that arises from the extrahepatic bile ducts and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C5856 Neoplastic Process Benign Extrahepatic Bile Duct Soft Tissue Neoplasm C1332497 Benign Benign_Extrahepatic_Bile_Duct_Mesenchymal_Neoplasm Benign Extrahepatic Bile Duct Soft Tissue Neoplasm Benign Extrahepatic Bile Duct Soft Tissue Tumor Benign Soft Tissue Neoplasm of Extrahepatic Bile Duct Benign Soft Tissue Neoplasm of the Extrahepatic Bile Duct Benign Soft Tissue Tumor of Extrahepatic Bile Duct Benign Soft Tissue Tumor of the Extrahepatic Bile Duct Benign Extrahepatic Bile Duct Soft Tissue Neoplasm An adenoma that arises from the extrahepatic bile ducts. It is classified as papillary, tubular, or tubulopapillary. C5857 Neoplastic Process Extrahepatic Bile Duct Adenoma C1331534 Benign Extrahepatic_Bile_Duct_Adenoma Adenoma of Extrahepatic Bile Duct Adenoma of the Extrahepatic Bile Duct Extrahepatic Bile Duct Adenoma Extrahepatic Bile Duct Adenoma A multinodular intermediate fibroblastic neoplasm arising from the liver. It is characterized by the presence of spindle-shaped fibroblasts and myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes and plasma cells. C5858 Neoplastic Process Liver Inflammatory Myofibroblastic Tumor C1333967 Undetermined Hepatic_Inflammatory_Pseudotumor Hepatic Inflammatory Myofibroblastic Tumor Inflammatory Pseudotumor of Liver Inflammatory Pseudotumor of the Liver Liver Inflammatory Myofibroblastic Tumor Liver Inflammatory Pseudotumor Liver Inflammatory Myofibroblastic Tumor A malignant mesenchymal tumor with skeletal muscle differentiation, arising from the extrahepatic bile ducts. C5860 Neoplastic Process Extrahepatic Bile Duct Rhabdomyosarcoma C2064434 Malignant Bile_Duct_Rhabdomyosarcoma Extrahepatic Bile Duct Rhabdomyosarcoma Rhabdomyosarcoma of Extrahepatic Bile Duct Rhabdomyosarcoma of the Extrahepatic Bile Duct Extrahepatic Bile Duct Rhabdomyosarcoma A well differentiated, low grade neuroendocrine neoplasm that arises from the extrahepatic bile ducts. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. C5861 Neoplastic Process Extrahepatic Bile Duct Neuroendocrine Tumor G1 C1333503 Undetermined Extrahepatic_Bile_Duct_Carcinoid_Tumor Extrahepatic Bile Duct NET G1 Extrahepatic Bile Duct Neuroendocrine Tumor G1 Extrahepatic Bile Duct Neuroendocrine Tumor G1 A mucoepidermoid carcinoma that arises from the extrahepatic bile ducts. C5862 Neoplastic Process Extrahepatic Bile Duct Mucoepidermoid Carcinoma C1332552 Malignant Bile_Duct_Mucoepidermoid_Carcinoma Bile Duct Mucoepidermoid Carcinoma Extrahepatic Bile Duct Mucoepidermoid Carcinoma Mucoepidermoid Carcinoma of Bile Duct Mucoepidermoid Carcinoma of the Bile Duct Extrahepatic Bile Duct Mucoepidermoid Carcinoma Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a: Oral cavity cancer with moderately advanced local disease. Tumor invades adjacent structures only (e.g., through cortical bone [mandible or maxilla] into deep [extrinsic] muscle of tongue [genioglossus, hyoglossus, palatoglossus, and styloglossus], maxillary sinus, skin of face). T1: Tumor 2 cm or less in greatest dimension. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3: Tumor more than 4 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension; or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension; or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C5863 Neoplastic Process Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 C1336350 CTRP Malignant Stage_IVA_Oral_Cavity_Adenoid_Cystic_Carcinoma Stage IVA Adenoid Cystic Carcinoma of Mouth Stage IVA Adenoid Cystic Carcinoma of Oral Cavity Stage IVA Adenoid Cystic Carcinoma of the Mouth Stage IVA Adenoid Cystic Carcinoma of the Oral Cavity Stage IVA Mouth Adenoid Cystic Carcinoma Stage IVA Oral Cavity Adenoid Cystic Cancer Stage IVA Oral Cavity Adenoid Cystic Carcinoma Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v7 Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 Stage IVB includes: (Any T, N3, M0); (T4b, Any N, M0). T4b: Oral cavity cancer with very advanced local disease. Tumor invades masticator space, pterygoid plates, or skull base and/or encases internal carotid artery. N3: Metastasis in a lymph node more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C5864 Neoplastic Process Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 C1336381 CTRP Malignant Stage_IVB_Oral_Cavity_Adenoid_Cystic_Carcinoma Stage IVB Adenoid Cystic Carcinoma of Mouth Stage IVB Adenoid Cystic Carcinoma of Oral Cavity Stage IVB Adenoid Cystic Carcinoma of the Mouth Stage IVB Adenoid Cystic Carcinoma of the Oral Cavity Stage IVB Mouth Adenoid Cystic Carcinoma Stage IVB Oral Cavity Adenoid Cystic Cancer Stage IVB Oral Cavity Adenoid Cystic Carcinoma Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v7 Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C5865 Neoplastic Process Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 C1336401 CTRP Malignant Stage_IVC_Oral_Cavity_Adenoid_Cystic_Carcinoma Stage IVC Adenoid Cystic Carcinoma of Mouth Stage IVC Adenoid Cystic Carcinoma of Oral Cavity Stage IVC Adenoid Cystic Carcinoma of the Mouth Stage IVC Adenoid Cystic Carcinoma of the Oral Cavity Stage IVC Mouth Adenoid Cystic Carcinoma Stage IVC Oral Cavity Adenoid Cystic Cancer Stage IVC Oral Cavity Adenoid Cystic Carcinoma Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v7 Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C5866 Neoplastic Process Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 C1336403 CTRP Malignant Stage_IVC_Oral_Cavity_Mucoepidermoid_Carcinoma Stage IVC Mouth Mucoepidermoid Carcinoma Stage IVC Mucoepidermoid Carcinoma of Mouth Stage IVC Mucoepidermoid Carcinoma of Oral Cavity Stage IVC Mucoepidermoid Carcinoma of the Mouth Stage IVC Mucoepidermoid Carcinoma of the Oral Cavity Stage IVC Oral Cavity Mucoepidermoid Cancer Stage IVC Oral Cavity Mucoepidermoid Carcinoma Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v7 Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 Stage IVB includes: (Any T, N3, M0); (T4b, Any N, M0). T4b: Oral cavity cancer with very advanced local disease. Tumor invades masticator space, pterygoid plates, or skull base and/or encases internal carotid artery. N3: Metastasis in a lymph node more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C5867 Neoplastic Process Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 C1336383 CTRP Malignant Stage_IVB_Oral_Cavity_Mucoepidermoid_Carcinoma Stage IVB Mouth Mucoepidermoid Carcinoma Stage IVB Mucoepidermoid Carcinoma of Mouth Stage IVB Mucoepidermoid Carcinoma of Oral Cavity Stage IVB Mucoepidermoid Carcinoma of the Mouth Stage IVB Mucoepidermoid Carcinoma of the Oral Cavity Stage IVB Oral Cavity Mucoepidermoid Cancer Stage IVB Oral Cavity Mucoepidermoid Carcinoma Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v7 Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a: Oral cavity cancer with moderately advanced local disease. Tumor invades adjacent structures only (e.g., through cortical bone [mandible or maxilla] into deep [extrinsic] muscle of tongue [genioglossus, hyoglossus, palatoglossus, and styloglossus], maxillary sinus, skin of face). T1: Tumor 2 cm or less in greatest dimension. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3: Tumor more than 4 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension; or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension; or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C5868 Neoplastic Process Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 C1336352 CTRP Malignant Stage_IVA_Oral_Cavity_Mucoepidermoid_Carcinoma Stage IVA Mouth Mucoepidermoid Carcinoma Stage IVA Mucoepidermoid Carcinoma of Mouth Stage IVA Mucoepidermoid Carcinoma of Oral Cavity Stage IVA Mucoepidermoid Carcinoma of the Mouth Stage IVA Mucoepidermoid Carcinoma of the Oral Cavity Stage IVA Oral Cavity Mucoepidermoid Cancer Stage IVA Oral Cavity Mucoepidermoid Carcinoma Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v7 Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 C5872 Neoplastic Process Stage IVC Basal Cell Lip Carcinoma Stage IVC Basal Cell Lip Carcinoma C1336391 CTRP Malignant Stage_IVC_Basal_Cell_Lip_Carcinoma Stage IVC Basal Cell Carcinoma of Lip Stage IVC Basal Cell Carcinoma of the Lip Stage IVC Basal Cell Lip Carcinoma Stage IVC Lip Basal Cell Cancer Stage IVC Basal Cell Lip Carcinoma C5873 Neoplastic Process Stage IVB Basal Cell Lip Carcinoma Stage IVB Basal Cell Lip Carcinoma C1336361 CTRP Malignant Stage_IVB_Basal_Cell_Lip_Carcinoma Stage IVB Basal Cell Carcinoma of Lip Stage IVB Basal Cell Carcinoma of the Lip Stage IVB Basal Cell Lip Carcinoma Stage IVB Lip Basal Cell Cancer Stage IVB Basal Cell Lip Carcinoma C5874 Neoplastic Process Stage IVA Basal Cell Lip Carcinoma Stage IVA Basal Cell Lip Carcinoma C1336331 CTRP Malignant Stage_IVA_Basal_Cell_Lip_Carcinoma Stage IVA Basal Cell Carcinoma of Lip Stage IVA Basal Cell Carcinoma of the Lip Stage IVA Basal Cell Lip Carcinoma Stage IVA Lip Basal Cell Cancer Stage IVA Basal Cell Lip Carcinoma Stage I includes: T1, N0, M0. T1: Tumor 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C5876 Neoplastic Process Stage I Lip Cancer AJCC v6 and v7 Stage I Lip Cancer AJCC v6 and v7 C1336461 CTRP Malignant Stage_I_Lip_Cancer Stage I Cancer of Lip Stage I Cancer of the Lip Stage I Carcinoma of Lip Stage I Carcinoma of the Lip Stage I Lip Cancer Stage I Lip Cancer AJCC v6 Stage I Lip Cancer AJCC v6 and v7 Stage I Lip Cancer AJCC v7 Stage I Lip Carcinoma Stage I Lip Cancer AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C5877 Neoplastic Process Stage II Lip Cancer AJCC v6 and v7 Stage II Lip Cancer AJCC v6 and v7 C1336295 CTRP Malignant Stage_II_Lip_Cancer Stage II Cancer of Lip Stage II Cancer of the Lip Stage II Carcinoma of Lip Stage II Carcinoma of the Lip Stage II Lip Cancer Stage II Lip Cancer AJCC v6 Stage II Lip Cancer AJCC v6 and v7 Stage II Lip Cancer AJCC v7 Stage II Lip Carcinoma Stage II Lip Cancer AJCC v6 and v7 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor more than 4 cm in greatest dimension. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 6th and 7th eds.) C5878 Neoplastic Process Stage III Lip Cancer AJCC v6 and v7 Stage III Lip Cancer AJCC v6 and v7 C1336253 CTRP Malignant Stage_III_Lip_Cancer Stage III Cancer of Lip Stage III Cancer of the Lip Stage III Carcinoma of Lip Stage III Carcinoma of the Lip Stage III Lip Cancer Stage III Lip Cancer AJCC v6 Stage III Lip Cancer AJCC v6 and v7 Stage III Lip Cancer AJCC v7 Stage III Lip Carcinoma Stage III Lip Cancer AJCC v6 and v7 Stage IV includes: IVA (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0);. IVB (Any T, N3, M0); (T4b, Any N, M0); IVC (Any T, Any N, M1). T4a (lip): Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin of face, i.e., chin or nose. T4b: Tumor invades masticator space, pterygoid plates, or skull base and/or encases internal carotid artery. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension; or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension; or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N2a: Metastasis in a single ipsilateral lymph node more than 3 cm but not more than 6 cm in dimension. N2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension. N2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a lymph node more than 6 cm in greatest dimension. M1: Distant metastasis. (AJCC 6th and 7th eds.) C5879 Neoplastic Process Stage IV Lip Cancer AJCC v6 and v7 Stage IV Lip Cancer AJCC v6 and v7 C1336422 CTRP Malignant Stage_IV_Lip_Cancer Stage IV Cancer of Lip Stage IV Cancer of the Lip Stage IV Carcinoma of Lip Stage IV Carcinoma of the Lip Stage IV Lip Cancer Stage IV Lip Cancer AJCC v6 Stage IV Lip Cancer AJCC v6 and v7 Stage IV Lip Cancer AJCC v7 Stage IV Lip Carcinoma Stage IV Lip Cancer AJCC v6 and v7 Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a: Lip cancer with moderately advanced local disease. Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin of face, i.e., chin or nose. T1: Tumor 2 cm or less in greatest dimension. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3: Tumor more than 4 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension; or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension; or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C5880 Neoplastic Process Stage IVA Lip Cancer AJCC v6 and v7 Stage IVA Lip Cancer AJCC v6 and v7 C1336345 CTRP Malignant Stage_IVA_Lip_Carcinoma Stage IVA Carcinoma of Lip Stage IVA Carcinoma of the Lip Stage IVA Lip Cancer Stage IVA Lip Cancer AJCC v6 Stage IVA Lip Cancer AJCC v6 and v7 Stage IVA Lip Cancer AJCC v7 Stage IVA Lip Carcinoma Stage IVA Lip Cancer AJCC v6 and v7 Stage IVB includes: (Any T, N3, M0); (T4b, Any N, M0). T4b: Lip cancer with very advanced local disease. Tumor invades masticator space, pterygoid plates, or skull base and/or encases internal carotid artery. N3: Metastasis in a lymph node more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C5881 Neoplastic Process Stage IVB Lip Cancer AJCC v6 and v7 Stage IVB Lip Cancer AJCC v6 and v7 C2217081 CTRP Malignant Stage_IVB_Lip_Carcinoma Stage IVB Carcinoma of Lip Stage IVB Carcinoma of the Lip Stage IVB Lip Cancer Stage IVB Lip Cancer AJCC v6 Stage IVB Lip Cancer AJCC v6 and v7 Stage IVB Lip Cancer AJCC v7 Stage IVB Lip Carcinoma Stage IVB Lip Cancer AJCC v6 and v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C5882 Neoplastic Process Stage IVC Lip Cancer AJCC v6 and v7 Stage IVC Lip Cancer AJCC v6 and v7 C1336397 CTRP Malignant Stage_IVC_Lip_Carcinoma Stage IVC Carcinoma of Lip Stage IVC Carcinoma of the Lip Stage IVC Lip Cancer Stage IVC Lip Cancer AJCC v6 Stage IVC Lip Cancer AJCC v6 and v7 Stage IVC Lip Cancer AJCC v7 Stage IVC Lip Carcinoma Stage IVC Lip Cancer AJCC v6 and v7 Stage I includes: T1, N0, M0. T1: Tumor 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C5883 Neoplastic Process Stage I Oral Cavity Cancer AJCC v6 and v7 Stage I Oral Cavity Cancer AJCC v6 and v7 C1336470 CTRP Malignant Stage_I_Oral_Cavity_Carcinoma Stage I Carcinoma of Mouth Stage I Carcinoma of Oral Cavity Stage I Carcinoma of the Mouth Stage I Carcinoma of the Oral Cavity Stage I Mouth Carcinoma Stage I Oral Cavity Cancer Stage I Oral Cavity Cancer AJCC v6 Stage I Oral Cavity Cancer AJCC v6 and v7 Stage I Oral Cavity Cancer AJCC v7 Stage I Oral Cavity Carcinoma Stage I Oral Cavity Cancer AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C5884 Neoplastic Process Stage II Oral Cavity Cancer AJCC v6 and v7 Stage II Oral Cavity Cancer AJCC v6 and v7 C1336306 CTRP Malignant Stage_II_Oral_Cavity_Carcinoma Stage II Carcinoma of Mouth Stage II Carcinoma of Oral Cavity Stage II Carcinoma of the Mouth Stage II Carcinoma of the Oral Cavity Stage II Mouth Carcinoma Stage II Oral Cavity Cancer Stage II Oral Cavity Cancer AJCC v6 Stage II Oral Cavity Cancer AJCC v6 and v7 Stage II Oral Cavity Cancer AJCC v7 Stage II Oral Cavity Carcinoma Stage II Oral Cavity Cancer AJCC v6 and v7 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor more than 4 cm in greatest dimension. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 6th and 7th eds.) C5885 Neoplastic Process Stage III Oral Cavity Cancer AJCC v6 and v7 Stage III Oral Cavity Cancer AJCC v6 and v7 C1336259 CTRP Malignant Stage_III_Oral_Cavity_Carcinoma Stage III Carcinoma of Mouth Stage III Carcinoma of Oral Cavity Stage III Carcinoma of the Mouth Stage III Carcinoma of the Oral Cavity Stage III Mouth Carcinoma Stage III Oral Cavity Cancer Stage III Oral Cavity Cancer AJCC v6 Stage III Oral Cavity Cancer AJCC v6 and v7 Stage III Oral Cavity Cancer AJCC v7 Stage III Oral Cavity Carcinoma Stage III Oral Cavity Cancer AJCC v6 and v7 Stage IV includes: IVA (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0);. IVB (Any T, N3, M0); (T4b, Any N, M0); IVC (Any T, Any N, M1). T4a: (oral cavity) Tumor invades adjacent structures (e.g., through cortical bone, into deep [extrinsic] muscles of tongue, maxillary sinus, skin of face). T4b: Tumor invades masticator space, pterygoid plates, or skull base and/or encases internal carotid artery. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension; or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension; or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N2a: Metastasis in a single ipsilateral lymph node more than 3 cm but not more than 6 cm in dimension. N2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension. N2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a lymph node more than 6 cm in greatest dimension. M1: Distant metastasis. (AJCC 6th and 7th eds.) C5886 Neoplastic Process Stage IV Oral Cavity Cancer AJCC v6 and v7 Stage IV Oral Cavity Cancer AJCC v6 and v7 C1336429 CTRP Malignant Stage_IV_Oral_Cavity_Carcinoma Stage IV Carcinoma of Mouth Stage IV Carcinoma of Oral Cavity Stage IV Carcinoma of the Mouth Stage IV Carcinoma of the Oral Cavity Stage IV Mouth Carcinoma Stage IV Oral Cavity Cancer Stage IV Oral Cavity Cancer AJCC v6 Stage IV Oral Cavity Cancer AJCC v6 and v7 Stage IV Oral Cavity Cancer AJCC v7 Stage IV Oral Cavity Carcinoma Stage IV Oral Cavity Cancer AJCC v6 and v7 Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a: Oral cavity cancer with moderately advanced local disease. Tumor invades adjacent structures only (e.g., through cortical bone [mandible or maxilla] into deep [extrinsic] muscle of tongue [genioglossus, hyoglossus, palatoglossus, and styloglossus], maxillary sinus, skin of face). T1: Tumor 2 cm or less in greatest dimension. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3: Tumor more than 4 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension; or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension; or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C5887 Neoplastic Process Stage IVA Oral Cavity Cancer AJCC v6 and v7 Stage IVA Oral Cavity Cancer AJCC v6 and v7 C1336351 CTRP Malignant Stage_IVA_Oral_Cavity_Carcinoma Stage IVA Carcinoma of Mouth Stage IVA Carcinoma of Oral Cavity Stage IVA Carcinoma of the Mouth Stage IVA Carcinoma of the Oral Cavity Stage IVA Mouth Carcinoma Stage IVA Oral Cavity Cancer Stage IVA Oral Cavity Cancer AJCC v6 Stage IVA Oral Cavity Cancer AJCC v6 and v7 Stage IVA Oral Cavity Cancer AJCC v7 Stage IVA Oral Cavity Carcinoma Stage IVA Oral Cavity Cancer AJCC v6 and v7 Stage IVB includes: (Any T, N3, M0); (T4b, Any N, M0). T4b: Oral cavity cancer with very advanced local disease. Tumor invades masticator space, pterygoid plates, or skull base and/or encases internal carotid artery. N3: Metastasis in a lymph node more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C5888 Neoplastic Process Stage IVB Oral Cavity Cancer AJCC v6 and v7 Stage IVB Oral Cavity Cancer AJCC v6 and v7 C1336382 CTRP Malignant Stage_IVB_Oral_Cavity_Carcinoma Stage IVB Carcinoma of Mouth Stage IVB Carcinoma of Oral Cavity Stage IVB Carcinoma of the Mouth Stage IVB Carcinoma of the Oral Cavity Stage IVB Mouth Carcinoma Stage IVB Oral Cavity Cancer Stage IVB Oral Cavity Cancer AJCC v6 Stage IVB Oral Cavity Cancer AJCC v6 and v7 Stage IVB Oral Cavity Cancer AJCC v7 Stage IVB Oral Cavity Carcinoma Stage IVB Oral Cavity Cancer AJCC v6 and v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C5889 Neoplastic Process Stage IVC Oral Cavity Cancer AJCC v6 and v7 Stage IVC Oral Cavity Cancer AJCC v6 and v7 C1336402 CTRP Malignant Stage_IVC_Oral_Cavity_Carcinoma Stage IVC Carcinoma of Mouth Stage IVC Carcinoma of Oral Cavity Stage IVC Carcinoma of the Mouth Stage IVC Carcinoma of the Oral Cavity Stage IVC Mouth Carcinoma Stage IVC Oral Cavity Cancer Stage IVC Oral Cavity Cancer AJCC v6 Stage IVC Oral Cavity Cancer AJCC v6 and v7 Stage IVC Oral Cavity Cancer AJCC v7 Stage IVC Oral Cavity Carcinoma Stage IVC Oral Cavity Cancer AJCC v6 and v7 C5893 Neoplastic Process Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7 Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7 C1336092 CTRP Malignant Stage_0_Lip_Basal_Cell_Carcinoma Basal Cell Carcinoma in situ of Lip Basal Cell Carcinoma in situ of the Lip Lip Basal Cell Carcinoma in situ Stage 0 Basal Cell Carcinoma of Lip Stage 0 Basal Cell Carcinoma of the Lip Stage 0 Lip Basal Cell Cancer Stage 0 Lip Basal Cell Carcinoma Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7 Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7 Stage I includes: T1, N0, M0. T1: Tumor measuring 2 cm or less in greatest dimension without extraparenchymal extension. Extraparenchymal extension is clinical or macroscopic evidence of invasion of soft tissues. Microscopic evidence alone does not constitute extraparenchymal extension for classification purposes. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C5895 Neoplastic Process Stage I Major Salivary Gland Cancer AJCC v7 Stage I Major Salivary Gland Cancer AJCC v7 C0278989 CTRP Cancer that is 2 centimeters or less in diameter and has not spread outside the salivary gland. Malignant Stage_I_Major_Salivary_Gland_Carcinoma Stage I Carcinoma of Major Salivary Gland Stage I Carcinoma of the Major Salivary Gland Stage I Major Salivary Gland Cancer Stage I Major Salivary Gland Cancer AJCC v7 Stage I Major Salivary Gland Carcinoma Stage I Major Salivary Gland Carcinoma AJCC v7 Stage I Salivary Gland Cancer Stage I Salivary Gland Carcinoma stage I salivary gland cancer Stage I Major Salivary Gland Cancer AJCC v7 Stage II includes: T2, N0, M0. T2: Tumor measuring more than 2 cm, but not more than 4 cm in greatest dimension without extraparenchymal extension. Extraparenchymal extension is clinical or macroscopic evidence of invasion of soft tissues. Microscopic evidence alone does not constitute extraparenchymal extension for classification purposes. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C5896 Neoplastic Process Stage II Major Salivary Gland Cancer AJCC v7 Stage II Major Salivary Gland Cancer AJCC v7 C0278990 CTRP Cancer that is larger than 2 centimeters but not larger than 4 centimeters in diameter and has not spread outside the salivary gland. Malignant Stage_II_Major_Salivary_Gland_Carcinoma Stage II Carcinoma of Major Salivary Gland Stage II Carcinoma of the Major Salivary Gland Stage II Major Salivary Gland Cancer Stage II Major Salivary Gland Cancer AJCC v7 Stage II Major Salivary Gland Carcinoma Stage II Major Salivary Gland Carcinoma AJCC v7 Stage II Salivary Gland Cancer Stage II Salivary Gland Carcinoma stage II salivary gland cancer Stage II Major Salivary Gland Cancer AJCC v7 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor measuring more than 4 cm in greatest dimension, and/or tumor having extraparenchymal extension. Extraparenchymal extension is clinical or macroscopic evidence of invasion of soft tissues. Microscopic evidence alone does not constitute extraparenchymal extension for classification purposes. T1: Tumor measuring 2 cm or less in greatest dimension without extraparenchymal extension. T2: Tumor measuring more than 2 cm, but not more than 4 cm in greatest dimension without extraparenchymal extension. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C5897 Neoplastic Process Stage III Major Salivary Gland Cancer AJCC v7 Stage III Major Salivary Gland Cancer AJCC v7 C0278991 CTRP In stage III salivary gland cancer, (1) the tumor is not larger than 4 centimeters and has spread to a single lymph node on the same side of the body as the tumor and the lymph node is 3 centimeters or smaller; or (2) the tumor is larger than 4 centimeters and/or has spread to soft tissue around the affected gland; cancer may have spread to a single lymph node on the same side as the tumor and the lymph node is 3 centimeters or smaller. Malignant Stage_III_Major_Salivary_Gland_Carcinoma Stage III Carcinoma of Major Salivary Gland Stage III Carcinoma of the Major Salivary Gland Stage III Major Salivary Gland Cancer Stage III Major Salivary Gland Cancer AJCC v7 Stage III Major Salivary Gland Carcinoma Stage III Major Salivary Gland Carcinoma AJCC v7 Stage III Salivary Gland Cancer stage III salivary gland cancer Stage III Major Salivary Gland Cancer AJCC v7 Stage IV includes: IVA (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB (T4b, Any N, M0); (Any T, N3, M0); IVC (Any T, Any N, M1). T4a: Moderately advanced disease. Tumor invades skin, mandible, ear canal, and/or facial nerve. T1: Tumor measuring 2 cm or less in greatest dimension without extraparenchymal extension. Extraparenchymal extension is clinical or macroscopic evidence of invasion of soft tissues. Microscopic evidence alone does not constitute extraparenchymal extension for classification purposes. T2: Tumor measuring more than 2 cm, but not more than 4 cm in greatest dimension without extraparenchymal extension. T3: Tumor measuring more than 4 cm in greatest dimension, and/or tumor having extraparenchymal extension. T4b: Very advanced disease. Tumor invades skull base and/or pterygoid plates and/or encases carotid artery. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a lymph node, more than 6 cm in greatest dimension. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C5898 Neoplastic Process Stage IV Major Salivary Gland Cancer AJCC v7 Stage IV Major Salivary Gland Cancer AJCC v7 C0278992 CTRP Stage IV salivary gland cancer is divided into stages IVA, IVB, and IVC. In stage IVA, (1) cancer has spread to one or more lymph nodes on either or both sides of the body and the lymph nodes are not larger than 6 centimeters; the tumor may be any size and may have spread to soft tissue around the affected gland; or (2) cancer has spread to the skin, jawbone, ear canal, and/or facial nerve, and may have spread to one or more lymph nodes on either or both sides of the body; the lymph nodes are not larger than 6 centimeters. In stage IVB, (1) cancer has spread to a lymph node larger than 6 centimeters; the tumor may be any size and may have spread to soft tissue around the affected gland; or (2) cancer has spread to the base of the skull and/or the carotid artery, and may have spread to one or more lymph nodes of any size on either or both sides of the body. In stage IVC, cancer has spread to distant parts of the body. Malignant Stage_IV_Major_Salivary_Gland_Carcinoma Stage IV Carcinoma of Major Salivary Gland Stage IV Carcinoma of the Major Salivary Gland Stage IV Major Salivary Gland Cancer Stage IV Major Salivary Gland Cancer AJCC v7 Stage IV Major Salivary Gland Carcinoma Stage IV Major Salivary Gland Carcinoma AJCC v7 Stage IV Salivary Gland Cancer stage IV salivary gland cancer Stage IV Major Salivary Gland Cancer AJCC v7 Stage IV carcinoma of the major salivary glands with regional lymph nodes and/or distant metastases. C5899 Neoplastic Process Stage IV Major Salivary Gland Carcinoma with Metastasis Stage IV Major Salivary Gland Carcinoma with Metastasis C1336424 CTRP Malignant Stage_IV_Major_Salivary_Gland_Carcinoma_with_Metastasis Stage IV Carcinoma of Major Salivary Gland with Metastasis Stage IV Carcinoma of the Major Salivary Gland with Metastasis Stage IV Major Salivary Gland Cancer with Metastasis Stage IV Major Salivary Gland Carcinoma with Metastasis Stage IV Major Salivary Gland Carcinoma with Metastasis Stage IV carcinoma of the major salivary glands without regional lymph nodes or distant metastases. C5900 Neoplastic Process Stage IV Major Salivary Gland Carcinoma without Metastasis Stage IV Major Salivary Gland Carcinoma without Metastasis C1336425 CTRP Malignant Stage_IV_Major_Salivary_Gland_Carcinoma_without_Metastasis Stage IV Carcinoma of Major Salivary Gland without Metastasis Stage IV Carcinoma of the Major Salivary Gland without Metastasis Stage IV Major Salivary Gland Cancer without Metastasis Stage IV Major Salivary Gland Carcinoma without Metastasis Stage IV Major Salivary Gland Carcinoma without Metastasis An adenocarcinoma with serous acinar cell differentiation that arises from the major salivary glands. The vast majority of cases occur in the parotid gland. Patients usually present with a slow growing mass in the parotid area. C5901 Neoplastic Process Major Salivary Gland Acinic Cell Carcinoma C1334546 Malignant Major_Salivary_Gland_Acinic_Cell_Carcinoma Acinic Cell Adenocarcinoma of Major Salivary Gland Acinic Cell Adenocarcinoma of the Major Salivary Gland Acinic Cell Carcinoma of Major Salivary Gland Acinic Cell Carcinoma of the Major Salivary Gland Major Salivary Gland Acinic Cell Adenocarcinoma Major Salivary Gland Acinic Cell Carcinoma Major Salivary Gland Acinic Cell Carcinoma A malignant tumor arising from the parotid gland, submandibular gland, or sublingual gland. It includes carcinoma ex pleomorphic adenoma, a malignant epithelial tumor arising from a pre-existing pleomorphic adenoma and carcinosarcoma which is characterized by a mixture of malignant epithelial and sarcomatous elements. C5902 Neoplastic Process Malignant Mixed Tumor of the Major Salivary Gland C1334604 Malignant Malignant_Mixed_Tumor_of_the_Major_Salivary_Gland Malignant Major Salivary Gland Mixed Neoplasm Malignant Major Salivary Gland Mixed Tumor Malignant Mixed Neoplasm of Major Salivary Gland Malignant Mixed Neoplasm of the Major Salivary Gland Malignant Mixed Tumor of Major Salivary Gland Malignant Mixed Tumor of the Major Salivary Gland Malignant Mixed Tumor of the Major Salivary Gland An adenocarcinoma that arises from the parotid gland, submandibular gland, or sublingual gland. C5903 Neoplastic Process Major Salivary Gland Adenocarcinoma Major Salivary Gland Adenocarcinoma C1334547 CTRP Malignant Major_Salivary_Gland_Adenocarcinoma Adenocarcinoma of Major Salivary Gland Adenocarcinoma of the Major Salivary Gland Major Salivary Gland Adenocarcinoma Major Salivary Gland Adenocarcinoma An aggressive, high grade adenocarcinoma that arises from the salivary glands. It usually affects elderly males and presents as a rapidly enlarging mass. It metastasizes to regional lymph nodes and distant anatomic sites. C5904 Neoplastic Process Salivary Duct Carcinoma C1301194 Cellosaurus GDC Malignant Salivary_Duct_Carcinoma Salivary duct carcinoma Carcinoma of Salivary Duct Carcinoma of the Salivary Duct High Grade Salivary Duct Carcinoma SDC Salivary Duct Carcinoma Salivary duct carcinoma Salivary Duct Carcinoma An aggressive carcinoma that arises from the major salivary glands. It is characterized by the presence of malignant epithelial and myoepithelial cells forming cribriform, tubular, and solid patterns. It usually presents as a slow growing mass. Patients develop pain because of the tendency of these carcinomas to invade perineural tissues. C5905 Neoplastic Process Major Salivary Gland Adenoid Cystic Carcinoma Major Salivary Gland Adenoid Cystic Carcinoma C1334548 CTRP Malignant Major_Salivary_Gland_Adenoid_Cystic_Carcinoma Adenoid Cystic Carcinoma of Major Salivary Gland Adenoid Cystic Carcinoma of the Major Salivary Gland Major Salivary Gland Adenoid Cystic Cancer Major Salivary Gland Adenoid Cystic Carcinoma Major Salivary Gland Adenoid Cystic Carcinoma A carcinoma that arises from the major salivary glands. It usually arises from the parotid gland. It is the most common primary carcinoma of the salivary glands and usually presents as a firm and painless mass. It is characterized by the presence of epidermoid cells, mucus producing cells, and cells of intermediate type. The majority of cases have a favorable outcome. C5906 Neoplastic Process Major Salivary Gland Mucoepidermoid Carcinoma Major Salivary Gland Mucoepidermoid Carcinoma C1334551 CTRP Malignant Major_Salivary_Gland_Mucoepidermoid_Carcinoma Major Salivary Gland Mucoepidermoid Cancer Major Salivary Gland Mucoepidermoid Carcinoma Mucoepidermoid Carcinoma of Major Salivary Gland Mucoepidermoid Carcinoma of the Major Salivary Gland Major Salivary Gland Mucoepidermoid Carcinoma A carcinoma that arises from the parotid gland, submandibular gland, or sublingual gland. C5907 Neoplastic Process Major Salivary Gland Carcinoma Major Salivary Gland Carcinoma C1334549 CTRP Malignant Major_Salivary_Gland_Carcinoma Carcinoma of Major Salivary Gland Carcinoma of the Major Salivary Gland Major Salivary Gland Cancer Major Salivary Gland Carcinoma Major Salivary Gland Carcinoma A carcinoma that arises from the salivary glands. It is the most common primary carcinoma of the salivary glands and usually presents as a firm and painless mass. It is characterized by the presence of squamous cells, mucus producing cells, and cells of intermediate type. The majority of cases have a favorable outcome. C5908 Neoplastic Process Salivary Gland Mucoepidermoid Carcinoma C1335903 Cellosaurus Malignant Salivary_Gland_Mucoepidermoid_Carcinoma Mucoepidermoid Carcinoma of Salivary Gland Mucoepidermoid Carcinoma of the Salivary Gland Salivary Gland Mucoepidermoid Carcinoma Salivary Gland Mucoepidermoid Carcinoma A benign smooth muscle neoplasm arising from the oral cavity. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C5909 Neoplastic Process Oral Cavity Leiomyoma C1335119 Benign Oral_Cavity_Leiomyoma Leiomyoma of Mouth Leiomyoma of Oral Cavity Leiomyoma of the Mouth Leiomyoma of the Oral Cavity Mouth Leiomyoma Oral Cavity Leiomyoma Oral Cavity Leiomyoma A benign adipose tissue neoplasm of the oral cavity. It usually occurs within the lingual and buccal mucosa. C5910 Neoplastic Process Oral Cavity Lipoma C1335120 Benign Oral_Cavity_Lipoma Lipoma of Mouth Lipoma of Oral Cavity Lipoma of the Mouth Lipoma of the Oral Cavity Mouth Lipoma Oral Cavity Lipoma Oral Cavity Lipoma A rare neoplasm that arises from the oral cavity, usually the tongue. It is characterized by the presence of plump eosinophilic cells with abundant granular cytoplasm. The neoplastic cells extend into the surrounding tissues, usually skeletal muscle. The vast majority of cases follow a benign clinical course. Recurrences are rare after removal of the tumor. C5912 Neoplastic Process Oral Cavity Granular Cell Tumor C1335118 Undetermined Oral_Cavity_Granular_Cell_Tumor Granular Cell Neoplasm of Mouth Granular Cell Neoplasm of Oral Cavity Granular Cell Neoplasm of the Mouth Granular Cell Neoplasm of the Oral Cavity Granular Cell Tumor of Mouth Granular Cell Tumor of Oral Cavity Granular Cell Tumor of the Mouth Granular Cell Tumor of the Oral Cavity Mouth Granular Cell Neoplasm Mouth Granular Cell Tumor Oral Cavity Granular Cell Neoplasm Oral Cavity Granular Cell Tumor Oral Cavity Granular Cell Tumor A monomorphic or pleomorphic adenoma that arises from the salivary glands in the oral cavity. C5913 Neoplastic Process Oral Cavity Adenoma C1335116 Benign Oral_Cavity_Adenoma Adenoma of Mouth Adenoma of Oral Cavity Adenoma of the Mouth Adenoma of the Oral Cavity Mouth Adenoma Oral Cavity Adenoma Oral Cavity Adenoma An adenocarcinoma that arises from the oral cavity. C5914 Neoplastic Process Oral Cavity Adenocarcinoma C1335115 Malignant Oral_Cavity_Adenocarcinoma Adenocarcinoma of Mouth Adenocarcinoma of Oral Cavity Adenocarcinoma of the Mouth Adenocarcinoma of the Oral Cavity Mouth Adenocarcinoma Oral Cavity Adenocarcinoma Oral Cavity Adenocarcinoma A rare melanoma that arises from the oral cavity. It is associated with a poor prognosis. C5915 Neoplastic Process Oral Cavity Mucosal Melanoma Oral Cavity Mucosal Melanoma C1335122 CTRP Cellosaurus Malignant Oral_Cavity_Mucosal_Melanoma Mouth Mucosal Melanoma Mucosal Melanoma of Mouth Mucosal Melanoma of Oral Cavity Mucosal Melanoma of the Mouth Mucosal Melanoma of the Oral Cavity Oral Cavity Mucosal Melanoma Oral Cavity Mucosal Melanoma A malignant soft tissue neoplasm that arises from the oral cavity. Representative examples include Kaposi sarcoma and angiosarcoma. C5916 Neoplastic Process Oral Cavity Sarcoma C1335124 Malignant Oral_Cavity_Sarcoma Mouth Sarcoma Oral Cavity Sarcoma Sarcoma of Mouth Sarcoma of Oral Cavity Sarcoma of the Mouth Sarcoma of the Oral Cavity Oral Cavity Sarcoma A verrucous carcinoma of the oral cavity that arises from the upper gingiva. C5917 Neoplastic Process Upper Gingival Verrucous Carcinoma C1336872 Malignant Upper_Gingival_Verrucous_Carcinoma Upper Gingival Verrucous Carcinoma Upper Gum Verrucous Carcinoma Verrucous Carcinoma of Upper Gingiva Verrucous Carcinoma of Upper Gum Verrucous Carcinoma of the Upper Gingiva Verrucous Carcinoma of the Upper Gum Upper Gingival Verrucous Carcinoma A primary lymphoma that affects the tonsil and the bulk of the tumor is in this anatomic area. The majority of cases are B-cell non-Hodgkin lymphomas. C5918 Neoplastic Process Tonsillar Lymphoma C1336765 Malignant Tonsillar_Lymphoma Lymphoma of Tonsil Lymphoma of the Tonsil Primary Tonsillar Lymphoma Tonsil Lymphoma Tonsillar Lymphoma Tonsillar Lymphoma Stage IIIA includes: (T1, N1, M0); (T2, N1, M0); (T3, N1, M0); (T4, N0, M0). T1: Tumor 2 cm or less in greatest dimension. T2: Tumor more than 2 cm but not more than 5 cm in greatest dimension. T3: Tumor more than 5 cm in greatest dimension. T4: Tumor of any size that invades adjacent organ(s). N1: Metastasis in perirectal lymph node(s). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C5925 Neoplastic Process Stage IIIA Anal Canal Cancer AJCC v6 and v7 Stage IIIA Anal Canal Cancer AJCC v6 and v7 C0278563 CTRP Stage III anal cancer is divided into stages IIIA and IIIB. In stage IIIA, the tumor may be any size and has spread to either (1) lymph nodes near the rectum; or (2) nearby organs, such as the vagina, urethra, and bladder. Malignant Stage_IIIA_Anal_Cancer Stage IIIA Anal Canal Cancer Stage IIIA Anal Canal Cancer AJCC v6 Stage IIIA Anal Canal Cancer AJCC v6 and v7 Stage IIIA Anal Canal Cancer AJCC v7 Stage IIIA Anal Canal Carcinoma AJCC v6 and v7 Stage IIIA Anal Carcinoma AJCC v6 and v7 stage IIIA anal cancer Stage IIIA Anal Canal Cancer AJCC v6 and v7 Stage IIIB includes: (T4, N1, M0); (Any T, N2, M0); (Any T, N3, M0). T4: Tumor of any size that invades adjacent organ(s). N1: Metastasis in perirectal lymph node(s). N2: Metastasis in unilateral internal iliac and/or inguinal lymph node(s). N3: Metastasis in perirectal and inguinal lymph nodes and/or bilateral internal iliac and/or inguinal lymph nodes. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C5926 Neoplastic Process Stage IIIB Anal Canal Cancer AJCC v6 and v7 Stage IIIB Anal Canal Cancer AJCC v6 and v7 C0278564 CTRP Stage III anal cancer is divided into stages IIIA and IIIB. In stage IIIB, the tumor may be any size and has spread to (1) nearby organs and to lymph nodes near the rectum; or (2) lymph nodes on one side of the pelvis and/or groin, and may have spread to nearby organs; or (3) lymph nodes near the rectum and in the groin, and/or to lymph nodes on both sides of the pelvis and/or groin, and may have spread to nearby organs. Malignant Stage_IIIB_Anal_Cancer Stage IIIB Anal Canal Cancer Stage IIIB Anal Canal Cancer AJCC v6 Stage IIIB Anal Canal Cancer AJCC v6 and v7 Stage IIIB Anal Canal Cancer AJCC v7 Stage IIIB Anal Canal Carcinoma AJCC v6 and v7 Stage IIIB Anal Carcinoma AJCC v6 and v7 stage IIIB anal cancer Stage IIIB Anal Canal Cancer AJCC v6 and v7 A rare benign epithelial neoplasm composed of oncocytes, which are large cells with a large amount of granular eosinophilic cytoplasm containing numerous tightly-packed mitochondria. Approximately 85% to 90% occur in the parotid gland; most of the remainder occur in the submandibular gland. The peak incidence is in the seventh through ninth decades of life. In almost all cases, swelling is the only complaint of the patient. C5932 Neoplastic Process Salivary Gland Oncocytoma C1335906 Benign Salivary_Gland_Oncocytoma Oncocytoma of Salivary Gland Oncocytoma of the Salivary Gland Oxyphilic Adenoma of Salivary Gland Oxyphilic Adenoma of the Salivary Gland Salivary Gland Oncocytoma Salivary Gland Oxyphilic Adenoma Salivary Gland Oncocytoma An adenocarcinoma with serous acinar cell differentiation that arises from the parotid gland. Patients usually present with a slow growing mass in the parotid area. C5933 Neoplastic Process Parotid Gland Acinic Cell Carcinoma C1335353 Malignant Parotid_Gland_Acinic_Cell_Carcinoma Acinic Cell Carcinoma of Parotid Acinic Cell Carcinoma of Parotid Gland Acinic Cell Carcinoma of the Parotid Acinic Cell Carcinoma of the Parotid Gland Parotid Acinic Cell Carcinoma Parotid Gland Acinic Cell Carcinoma Parotid Gland Acinic Cell Carcinoma An adenocarcinoma with serous acinar cell differentiation that arises from the submandibular gland. C5934 Neoplastic Process Submandibular Gland Acinic Cell Carcinoma C1336520 Malignant Submandibular_Gland_Acinic_Cell_Carcinoma Acinic Cell Carcinoma of Submandibular Gland Acinic Cell Carcinoma of Submaxillary Gland Acinic Cell Carcinoma of the Submandibular Gland Acinic Cell Carcinoma of the Submaxillary Gland Submandibular Gland Acinic Cell Carcinoma Submaxillary Gland Acinic Cell Carcinoma Submandibular Gland Acinic Cell Carcinoma An aggressive carcinoma that arises from the submandibular gland. It is characterized by the presence of malignant epithelial and myoepithelial cells forming cribriform, tubular, and solid patterns. It usually presents as a slow growing mass. Patients develop pain because of the tendency of these carcinomas to invade perineural tissues. C5935 Neoplastic Process Submandibular Gland Adenoid Cystic Carcinoma C1336522 Malignant Submandibular_Gland_Adenoid_Cystic_Carcinoma Adenoid Cystic Carcinoma of Submandibular Gland Adenoid Cystic Carcinoma of the Submandibular Gland Submandibular Gland Adenoid Cystic Carcinoma Submandibular Gland Adenoid Cystic Carcinoma An aggressive carcinoma that arises from the minor salivary glands. It is characterized by the presence of malignant epithelial and myoepithelial cells forming cribriform, tubular, and solid patterns. It usually presents as a slow growing mass. C5936 Neoplastic Process Minor Salivary Gland Adenoid Cystic Carcinoma C1334769 Malignant Minor_Salivary_Gland_Adenoid_Cystic_Carcinoma Adenoid Cystic Carcinoma of Minor Salivary Gland Adenoid Cystic Carcinoma of the Minor Salivary Gland Minor Salivary Gland Adenoid Cystic Carcinoma Minor Salivary Gland Adenoid Cystic Carcinoma An aggressive carcinoma that arises from the parotid gland. It is characterized by the presence of malignant epithelial and myoepithelial cells forming cribriform, tubular, and solid patterns. It usually presents as a slow growing mass. Patients develop pain because of the tendency of these carcinomas to invade perineural tissues. C5937 Neoplastic Process Parotid Gland Adenoid Cystic Carcinoma C1335355 Malignant Parotid_Gland_Adenoid_Cystic_Carcinoma Adenoid Cystic Carcinoma of Parotid Adenoid Cystic Carcinoma of Parotid Gland Adenoid Cystic Carcinoma of the Parotid Adenoid Cystic Carcinoma of the Parotid Gland Parotid Adenoid Cystic Carcinoma Parotid Gland Adenoid Cystic Carcinoma Parotid Gland Adenoid Cystic Carcinoma A carcinoma that arises from the parotid gland. It usually presents as a firm and painless mass. It is characterized by the presence of epidermoid cells, mucus producing cells, and cells of intermediate type. It usually spreads to pre-auricular lymph nodes. The majority of cases have a favorable outcome. C5938 Neoplastic Process Parotid Gland Mucoepidermoid Carcinoma C1335363 Cellosaurus Malignant Parotid_Gland_Mucoepidermoid_Carcinoma Mucoepidermoid Carcinoma of Parotid Mucoepidermoid Carcinoma of Parotid Gland Mucoepidermoid Carcinoma of the Parotid Mucoepidermoid Carcinoma of the Parotid Gland Parotid Gland Mucoepidermoid Carcinoma Parotid Mucoepidermoid Carcinoma Parotid Gland Mucoepidermoid Carcinoma A carcinoma that arises from the submandibular gland. It usually presents as a firm and painless mass. It is characterized by the presence of epidermoid cells, mucus producing cells, and cells of intermediate type. The majority of cases have a favorable outcome. C5939 Neoplastic Process Submandibular Gland Mucoepidermoid Carcinoma C1336524 Malignant Submandibular_Gland_Mucoepidermoid_Carcinoma Mucoepidermoid Carcinoma of Submandibular Gland Mucoepidermoid Carcinoma of the Submandibular Gland Submandibular Gland Mucoepidermoid Carcinoma Submandibular Gland Mucoepidermoid Carcinoma An adenocarcinoma that arises from the submandibular gland. Representative examples include polymorphic low-grade adenocarcinoma and acinic cell carcinoma. C5940 Neoplastic Process Submandibular Gland Adenocarcinoma C1336521 Malignant Submandibular_Gland_Adenocarcinoma Adenocarcinoma of Submandibular Gland Adenocarcinoma of the Submandibular Gland Submandibular Gland Adenocarcinoma Submandibular Gland Adenocarcinoma An adenocarcinoma that arises from the parotid gland. Representative examples include acinic cell carcinoma, basal cell adenocarcinoma, cystadenocarcinoma, and oncocytic carcinoma. C5941 Neoplastic Process Parotid Gland Adenocarcinoma C1335354 Cellosaurus Malignant Parotid_Gland_Adenocarcinoma Adenocarcinoma of Parotid Adenocarcinoma of Parotid Gland Adenocarcinoma of the Parotid Adenocarcinoma of the Parotid Gland Parotid Adenocarcinoma Parotid Gland Adenocarcinoma Parotid Gland Adenocarcinoma An invasive squamous cell carcinoma that arises from the parotid gland. It usually affects elderly patients and presents as a rapidly enlarging tumor mass, often associated with pain. C5942 Neoplastic Process Parotid Gland Squamous Cell Carcinoma C1335367 Cellosaurus Malignant Parotid_Gland_Squamous_Cell_Carcinoma Parotid Gland Squamous Cell Carcinoma Parotid Squamous Cell Carcinoma Squamous Cell Carcinoma of Parotid Squamous Cell Carcinoma of Parotid Gland Squamous Cell Carcinoma of the Parotid Squamous Cell Carcinoma of the Parotid Gland Parotid Gland Squamous Cell Carcinoma An invasive squamous cell carcinoma that arises from the submandibular gland. It usually affects elderly patients and presents as a rapidly enlarging tumor mass, often associated with pain. C5943 Neoplastic Process Submandibular Gland Squamous Cell Carcinoma C1336525 Cellosaurus Malignant Submandibular_Gland_Squamous_Cell_Carcinoma Squamous Cell Carcinoma of Submandibular Gland Squamous Cell Carcinoma of the Submandibular Gland Submandibular Gland Squamous Cell Carcinoma Submandibular Gland Squamous Cell Carcinoma A malignant tumor arising from the submandibular gland. It includes carcinoma ex pleomorphic adenoma, a malignant epithelial tumor arising from a pre-existing pleomorphic adenoma and carcinosarcoma which is characterized by a mixture of malignant epithelial and sarcomatous elements. C5944 Neoplastic Process Malignant Submandibular Gland Mixed Tumor C1334622 Malignant Malignant_Submandibular_Gland_Mixed_Tumor Malignant Mixed Neoplasm of Submandibular Gland Malignant Mixed Neoplasm of the Submandibular Gland Malignant Mixed Tumor of Submandibular Gland Malignant Mixed Tumor of the Submandibular Gland Malignant Submandibular Gland Mixed Neoplasm Malignant Submandibular Gland Mixed Tumor Malignant Submandibular Gland Mixed Tumor A malignant tumor arising from the parotid gland. It includes carcinoma ex pleomorphic adenoma, a malignant epithelial tumor arising from a pre-existing pleomorphic adenoma and carcinosarcoma which is characterized by a mixture of malignant epithelial and sarcomatous elements. C5945 Neoplastic Process Malignant Parotid Gland Mixed Tumor C1334610 Malignant Malignant_Parotid_Gland_Mixed_Tumor Malignant Mixed Neoplasm of Parotid Malignant Mixed Neoplasm of Parotid Gland Malignant Mixed Neoplasm of the Parotid Malignant Mixed Neoplasm of the Parotid Gland Malignant Mixed Tumor of Parotid Malignant Mixed Tumor of Parotid Gland Malignant Mixed Tumor of the Parotid Malignant Mixed Tumor of the Parotid Gland Malignant Parotid Gland Mixed Neoplasm Malignant Parotid Gland Mixed Tumor Malignant Parotid Mixed Neoplasm Malignant Parotid Mixed Tumor Malignant Parotid Gland Mixed Tumor A carcinoma that arises from the parotid gland and is characterized by the presence of undifferentiated, anaplastic malignant epithelial cells. C5946 Neoplastic Process Parotid Gland Undifferentiated Carcinoma C1336862 Malignant Undifferentiated_Parotid_Gland_Carcinoma Anaplastic Carcinoma of Parotid Anaplastic Carcinoma of Parotid Gland Anaplastic Carcinoma of the Parotid Anaplastic Carcinoma of the Parotid Gland Anaplastic Parotid Carcinoma Anaplastic Parotid Gland Carcinoma Parotid Gland Undifferentiated Carcinoma Undifferentiated Carcinoma of Parotid Undifferentiated Carcinoma of Parotid Gland Undifferentiated Carcinoma of the Parotid Undifferentiated Carcinoma of the Parotid Gland Undifferentiated Parotid Gland Carcinoma Parotid Gland Undifferentiated Carcinoma A carcinoma that arises from the submandibular gland and is characterized by the presence of undifferentiated, anaplastic malignant epithelial cells. C5947 Neoplastic Process Submandibular Gland Undifferentiated Carcinoma C1336526 Malignant Submandibular_Gland_Undifferentiated_Carcinoma Anaplastic Carcinoma of Submandibular Gland Anaplastic Carcinoma of the Submandibular Gland Submandibular Gland Undifferentiated Carcinoma Undifferentiated Carcinoma of Submandibular Gland Undifferentiated Carcinoma of the Submandibular Gland Submandibular Gland Undifferentiated Carcinoma An adenocarcinoma that arises from the minor salivary glands. C5948 Neoplastic Process Minor Salivary Gland Adenocarcinoma C1334768 Malignant Minor_Salivary_Gland_Adenocarcinoma Adenocarcinoma of Minor Salivary Gland Adenocarcinoma of the Minor Salivary Gland Minor Salivary Gland Adenocarcinoma Minor Salivary Gland Adenocarcinoma A rare, benign epithelial neoplasm that arises from the parotid gland. It is composed of irregular proliferating nests and islands of epithelium, including solid and gland-like sebaceous elements, surrounded by lymphoid stroma. Patients present with a progressively enlarging and painless mass. C5949 Neoplastic Process Parotid Gland Sebaceous Lymphadenoma C1335366 Benign Parotid_Gland_Sebaceous_Lymphadenoma Parotid Gland Sebaceous Lymphadenoma Sebaceous Lymphadenoma of the Parotid Gland Parotid Gland Sebaceous Lymphadenoma A salivary gland benign epithelial neoplasm with a uniform, monomorphic appearance that is dominated by basal cells forming trabecular structures. It is rare and occurs mostly on the parotid gland. The average age of patients has been reported to be 58 years. Swelling is the most constant clinical finding. C5950 Neoplastic Process Basal Cell Adenoma C0205646 GDC 8147/0 Benign Benign_Basal_Cell_Neoplasm Salivary_Gland_Basal_Cell_Adenoma 8147/0 Basal cell adenoma BCA Basal Cell Adenoma Basal Cell Adenoma of Salivary Gland Basal Cell Adenoma of the Salivary Gland Basal cell adenoma Salivary Gland Basal Cell Adenoma Basal Cell Adenoma A non-Hodgkin lymphoma that arises from the parotid gland. Representative examples include mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma. C5951 Neoplastic Process Parotid Gland Non-Hodgkin Lymphoma C1335365 Malignant Parotid_Gland_Non-Hodgkin_s_Lymphoma Non-Hodgkin's Lymphoma of Parotid Non-Hodgkin's Lymphoma of Parotid Gland Non-Hodgkin's Lymphoma of the Parotid Non-Hodgkin's Lymphoma of the Parotid Gland Parotid Gland Non-Hodgkin Lymphoma Parotid Gland Non-Hodgkin's Lymphoma Parotid Non-Hodgkin's Lymphoma Primary Parotid Gland Non-Hodgkin Lymphoma Primary Parotid Gland Non-Hodgkin's Lymphoma Parotid Gland Non-Hodgkin Lymphoma A Kaposi sarcoma arising from the parotid gland. C5952 Neoplastic Process Parotid Gland Kaposi Sarcoma C1335359 Malignant Parotid_Gland_Kaposi_s_Sarcoma Kaposi's Sarcoma of Parotid Kaposi's Sarcoma of Parotid Gland Kaposi's Sarcoma of the Parotid Kaposi's Sarcoma of the Parotid Gland Parotid Gland Kaposi Sarcoma Parotid Gland Kaposi's Sarcoma Parotid Kaposi's Sarcoma Parotid Gland Kaposi Sarcoma A carcinoma that arises from the minor salivary glands. It usually presents as a firm and painless mass. It is characterized by the presence of epidermoid cells, mucus producing cells, and cells of intermediate type. The majority of cases have a favorable outcome. C5953 Neoplastic Process Minor Salivary Gland Mucoepidermoid Carcinoma C1334773 Malignant Minor_Salivary_Gland_Mucoepidermoid_Carcinoma Minor Salivary Gland Mucoepidermoid Carcinoma Mucoepidermoid Carcinoma of Minor Salivary Gland Mucoepidermoid Carcinoma of the Minor Salivary Gland Minor Salivary Gland Mucoepidermoid Carcinoma A carcinoma that affects the minor salivary glands and is characterized by the presence of undifferentiated, anaplastic malignant epithelial cells. C5954 Neoplastic Process Minor Salivary Gland Undifferentiated Carcinoma C1334775 Malignant Minor_Salivary_Gland_Undifferentiated_Carcinoma Anaplastic Carcinoma of Minor Salivary Gland Anaplastic Carcinoma of the Minor Salivary Gland Anaplastic Minor Salivary Gland Carcinoma Minor Salivary Gland Undifferentiated Carcinoma Undifferentiated Carcinoma of Minor Salivary Gland Undifferentiated Carcinoma of the Minor Salivary Gland Minor Salivary Gland Undifferentiated Carcinoma A malignant tumor arising from the minor salivary glands. It includes carcinoma ex pleomorphic adenoma, a malignant epithelial tumor arising from a pre-existing pleomorphic adenoma and carcinosarcoma which is characterized by a mixture of malignant epithelial and sarcomatous elements. C5955 Neoplastic Process Malignant Mixed Tumor of the Minor Salivary Gland C1334605 Malignant Malignant_Mixed_Tumor_of_the_Minor_Salivary_Gland Malignant Minor Salivary Gland Mixed Neoplasm Malignant Minor Salivary Gland Mixed Tumor Malignant Mixed Neoplasm of Minor Salivary Gland Malignant Mixed Neoplasm of the Minor Salivary Gland Malignant Mixed Tumor of Minor Salivary Gland Malignant Mixed Tumor of the Minor Salivary Gland Malignant Mixed Tumor of the Minor Salivary Gland An infrequent small cell carcinoma that arises from a minor salivary gland. It is characterized by the presence of neuroendocrine differentiation and a high number of mitotic figures. C5956 Neoplastic Process Minor Salivary Gland Small Cell Neuroendocrine Carcinoma C1334770 Malignant Minor_Salivary_Gland_Anaplastic_Small_Cell_Carcinoma Minor Salivary Gland Neuroendocrine Carcinoma Minor Salivary Gland Oat Cell Carcinoma Minor Salivary Gland Small Cell Neuroendocrine Carcinoma Neuroendocrine Carcinoma of Minor Salivary Gland Neuroendocrine Carcinoma of the Minor Salivary Gland Oat Cell Carcinoma of Minor Salivary Gland Oat Cell Carcinoma of the Minor Salivary Gland Minor Salivary Gland Small Cell Neuroendocrine Carcinoma A carcinoma that arises from the minor salivary glands. Representative examples include adenoid cystic carcinoma, acinic cell carcinoma, polymorphous low grade adenocarcinoma, and mucinous adenocarcinoma. C5957 Neoplastic Process Minor Salivary Gland Carcinoma Minor Salivary Gland Carcinoma C1334771 CTRP Malignant Minor_Salivary_Gland_Carcinoma Carcinoma of Minor Salivary Gland Carcinoma of the Minor Salivary Gland Minor Salivary Gland Cancer Minor Salivary Gland Carcinoma Minor Salivary Gland Carcinoma An adenocarcinoma that arises from the sublingual gland. C5958 Neoplastic Process Sublingual Gland Adenocarcinoma C1336519 Malignant Sublingual_Gland_Adenocarcinoma Adenocarcinoma of Sublingual Gland Adenocarcinoma of the Sublingual Gland Sublingual Gland Adenocarcinoma Sublingual Gland Adenocarcinoma A squamous cell carcinoma that affects the minor salivary glands. C5959 Neoplastic Process Minor Salivary Gland Squamous Cell Carcinoma C1334774 Malignant Minor_Salivary_Gland_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Minor Salivary Gland Epidermoid Carcinoma of the Minor Salivary Gland Minor Salivary Gland Epidermoid Carcinoma Minor Salivary Gland Squamous Cell Carcinoma Squamous Cell Carcinoma of Minor Salivary Gland Squamous Cell Carcinoma of the Minor Salivary Gland Minor Salivary Gland Squamous Cell Carcinoma A neoplasm that affects the supratentorial region of the brain and occurs during childhood. C5960 Neoplastic Process Childhood Supratentorial Neoplasm C1333004 Undetermined Childhood_Supratentorial_Neoplasm Childhood Supratentorial Neoplasm Childhood Supratentorial Neoplasms Childhood Supratentorial Tumor Childhood Supratentorial Tumors Pediatric Supratentorial Neoplasm Pediatric Supratentorial Tumor Childhood Supratentorial Neoplasm A central nervous system embryonal tumor, not otherwise specified that occurs in childhood. C5961 Neoplastic Process Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified CL388355 CTRP NICHD A primitive neuroectodermal tumor that arises from the central nervous system during childhood. Malignant Childhood_Central_Nervous_System_Primitive_Neuroectodermal_Tumor Central Nervous System Embryonal Tumor, NOS Childhood CNS PNET Childhood CNS Primitive Neuroectodermal Neoplasm Childhood CNS Primitive Neuroectodermal Tumor Childhood Central Nervous System Embryonal Tumor, NOS Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified Childhood Central Nervous System PNET Childhood Central Nervous System Primitive Neuroectodermal Neoplasm Childhood Central Nervous System Primitive Neuroectodermal Tumor Childhood Central Primitive Neuroectodermal Neoplasm Childhood Central Primitive Neuroectodermal Tumor Pediatric CNS PNET Pediatric CNS Primitive Neuroectodermal Neoplasm Pediatric CNS Primitive Neuroectodermal Tumor Pediatric Central Nervous System Primitive Neuroectodermal Neoplasm Pediatric Central Nervous System Primitive Neuroectodermal Tumor Pediatric Central Primitive Neuroectodermal Neoplasm Pediatric Central Primitive Neuroectodermal Tumor Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified Prolactin-producing pituitary neuroendocrine tumor that has spread from its original site of growth to another anatomic site. C5962 Neoplastic Process Metastatic Lactotroph Pituitary Neuroendocrine Tumor C1334614 Malignant Malignant_Prolactin_Producing_Pituitary_Gland_Neoplasm Malignant Pituitary Gland Prolactinoma Malignant Pituitary Prolactinoma Malignant Prolactin Producing Neoplasm of Pituitary Malignant Prolactin Producing Neoplasm of Pituitary Gland Malignant Prolactin Producing Neoplasm of the Pituitary Malignant Prolactin Producing Neoplasm of the Pituitary Gland Malignant Prolactin Producing Pituitary Gland Neoplasm Malignant Prolactin Producing Pituitary Gland Tumor Malignant Prolactin Producing Pituitary Neoplasm Malignant Prolactin Producing Pituitary Tumor Malignant Prolactin Producing Tumor Malignant Prolactin Producing Tumor of Pituitary Malignant Prolactin Producing Tumor of Pituitary Gland Malignant Prolactin Producing Tumor of the Pituitary Malignant Prolactin Producing Tumor of the Pituitary Gland Malignant Prolactin Secreting Neoplasm of Pituitary Malignant Prolactin Secreting Neoplasm of Pituitary Gland Malignant Prolactin Secreting Neoplasm of the Pituitary Malignant Prolactin Secreting Neoplasm of the Pituitary Gland Malignant Prolactin Secreting Pituitary Gland Neoplasm Malignant Prolactin Secreting Pituitary Gland Tumor Malignant Prolactin Secreting Pituitary Neoplasm Malignant Prolactin Secreting Pituitary Tumor Malignant Prolactin Secreting Tumor of Pituitary Malignant Prolactin Secreting Tumor of Pituitary Gland Malignant Prolactin Secreting Tumor of the Pituitary Malignant Prolactin Secreting Tumor of the Pituitary Gland Malignant Prolactinoma Malignant Prolactinoma of Pituitary Malignant Prolactinoma of Pituitary Gland Malignant Prolactinoma of the Pituitary Malignant Prolactinoma of the Pituitary Gland Metastatic Lactotroph Pituitary Neuroendocrine Tumor Metastatic Prolactin-Producing PitNET PRL Producing Pituitary Gland Carcinoma Prolactin Producing Pituitary Gland Carcinoma Metastatic Lactotroph Pituitary Neuroendocrine Tumor Growth hormone-producing pituitary neuroendocrine tumor that has spread from its original site of growth to another anatomic site. C5963 Neoplastic Process Metastatic Somatotroph Pituitary Neuroendocrine Tumor C1334587 Malignant Malignant_Growth_Hormone_Secreting_Pituitary_Neoplasm Growth Hormone Producing Pituitary Gland Carcinoma Malignant Growth Hormone Producing Neoplasm of Pituitary Malignant Growth Hormone Producing Neoplasm of Pituitary Gland Malignant Growth Hormone Producing Neoplasm of the Pituitary Malignant Growth Hormone Producing Neoplasm of the Pituitary Gland Malignant Growth Hormone Producing Pituitary Gland Neoplasm Malignant Growth Hormone Producing Pituitary Gland Tumor Malignant Growth Hormone Producing Pituitary Neoplasm Malignant Growth Hormone Producing Pituitary Tumor Malignant Growth Hormone Producing Tumor Malignant Growth Hormone Producing Tumor of Pituitary Malignant Growth Hormone Producing Tumor of Pituitary Gland Malignant Growth Hormone Producing Tumor of the Pituitary Malignant Growth Hormone Producing Tumor of the Pituitary Gland Malignant Growth Hormone Secreting Neoplasm of Pituitary Malignant Growth Hormone Secreting Neoplasm of Pituitary Gland Malignant Growth Hormone Secreting Neoplasm of the Pituitary Malignant Growth Hormone Secreting Neoplasm of the Pituitary Gland Malignant Growth Hormone Secreting Pituitary Gland Neoplasm Malignant Growth Hormone Secreting Pituitary Gland Tumor Malignant Growth Hormone Secreting Pituitary Neoplasm Malignant Growth Hormone Secreting Pituitary Tumor Malignant Growth Hormone Secreting Tumor of Pituitary Malignant Growth Hormone Secreting Tumor of Pituitary Gland Malignant Growth Hormone Secreting Tumor of the Pituitary Malignant Growth Hormone Secreting Tumor of the Pituitary Gland Malignant Pituitary Gland Somatotrophinoma Malignant Pituitary Somatotrophinoma Malignant Somatotrophinoma of Pituitary Malignant Somatotrophinoma of Pituitary Gland Malignant Somatotrophinoma of the Pituitary Gland Metastatic Growth Hormone-Producing PitNET Metastatic Somatotroph Pituitary Neuroendocrine Tumor Metastatic Somatotroph Pituitary Neuroendocrine Tumor ACTH-producing pituitary neuroendocrine tumor that has spread from its original site of growth to another anatomic site. C5964 Neoplastic Process Metastatic Corticotroph Pituitary Neuroendocrine Tumor C1334556 Malignant Malignant_ACTH_Producing_Pituitary_Gland_Neoplasm ACTH Producing Pituitary Gland Carcinoma Malignant ACTH Producing Neoplasm of Pituitary Malignant ACTH Producing Neoplasm of Pituitary Gland Malignant ACTH Producing Neoplasm of the Pituitary Malignant ACTH Producing Neoplasm of the Pituitary Gland Malignant ACTH Producing Pituitary Gland Neoplasm Malignant ACTH Producing Pituitary Gland Tumor Malignant ACTH Producing Pituitary Neoplasm Malignant ACTH Producing Pituitary Tumor Malignant ACTH Producing Tumor of Pituitary Malignant ACTH Producing Tumor of Pituitary Gland Malignant ACTH Producing Tumor of the Pituitary Malignant ACTH Producing Tumor of the Pituitary Gland Malignant ACTH Secreting Neoplasm of Pituitary Malignant ACTH Secreting Neoplasm of Pituitary Gland Malignant ACTH Secreting Neoplasm of the Pituitary Malignant ACTH Secreting Neoplasm of the Pituitary Gland Malignant ACTH Secreting Pituitary Gland Tumor Malignant ACTH Secreting Pituitary Neoplasm Malignant ACTH Secreting Pituitary Tumor Malignant ACTH Secreting Tumor of Pituitary Malignant ACTH Secreting Tumor of Pituitary Gland Malignant ACTH Secreting Tumor of the Pituitary Malignant ACTH Secreting Tumor of the Pituitary Gland Malignant Adrenocorticotropin Producing Neoplasm of Pituitary Malignant Adrenocorticotropin Producing Neoplasm of Pituitary Gland Malignant Adrenocorticotropin Producing Neoplasm of the Pituitary Malignant Adrenocorticotropin Producing Neoplasm of the Pituitary Gland Malignant Adrenocorticotropin Producing Pituitary Gland Neoplasm Malignant Adrenocorticotropin Producing Pituitary Gland Tumor Malignant Adrenocorticotropin Producing Pituitary Neoplasm Malignant Adrenocorticotropin Producing Pituitary Tumor Malignant Adrenocorticotropin Producing Tumor of Pituitary Malignant Adrenocorticotropin Producing Tumor of Pituitary Gland Malignant Adrenocorticotropin Producing Tumor of the Pituitary Malignant Adrenocorticotropin Producing Tumor of the Pituitary Gland Malignant Adrenocorticotropin Secreting Pituitary Gland Neoplasm Malignant Adrenocorticotropin Secreting Pituitary Gland Tumor Malignant Adrenocorticotropin Secreting Pituitary Neoplasm Malignant Adrenocorticotropin Secreting Pituitary Tumor Malignant Corticotropin Secreting Pituitary Gland Neoplasm Malignant Corticotropinoma of Pituitary Malignant Corticotropinoma of Pituitary Gland Malignant Corticotropinoma of the Pituitary Malignant Corticotropinoma of the Pituitary Gland Malignant Pituitary Corticotropinoma Malignant Pituitary Gland Corticotropinoma Metastatic ACTH-Producing PitNET Metastatic Corticotroph Pituitary Neuroendocrine Tumor Metastatic Corticotroph Pituitary Neuroendocrine Tumor TSH-producing pituitary neuroendocrine tumor that has spread from its original site of growth to another anatomic site. C5965 Neoplastic Process Metastatic Thyrotroph Pituitary Neuroendocrine Tumor C1334627 Malignant Malignant_Thyroid_Stimulating_Hormone_Producing_Pituitary_Gland_Neoplasm Malignant Pituitary Gland Thyrotropinoma Malignant Pituitary Thyrotropinoma Malignant TSH Producing Neoplasm of Pituitary Malignant TSH Producing Neoplasm of Pituitary Gland Malignant TSH Producing Neoplasm of the Pituitary Malignant TSH Producing Neoplasm of the Pituitary Gland Malignant TSH Producing Pituitary Gland Neoplasm Malignant TSH Producing Pituitary Gland Tumor Malignant TSH Producing Pituitary Neoplasm Malignant TSH Producing Pituitary Tumor Malignant TSH Producing Tumor of Pituitary Malignant TSH Producing Tumor of Pituitary Gland Malignant TSH Producing Tumor of the Pituitary Malignant TSH Producing Tumor of the Pituitary Gland Malignant TSH Secreting Neoplasm of Pituitary Malignant TSH Secreting Neoplasm of Pituitary Gland Malignant TSH Secreting Neoplasm of the Pituitary Malignant TSH Secreting Neoplasm of the Pituitary Gland Malignant TSH Secreting Pituitary Gland Neoplasm Malignant TSH Secreting Pituitary Gland Tumor Malignant TSH Secreting Pituitary Neoplasm Malignant TSH Secreting Pituitary Tumor Malignant TSH Secreting Tumor of Pituitary Malignant TSH Secreting Tumor of Pituitary Gland Malignant TSH Secreting Tumor of the Pituitary Malignant TSH Secreting Tumor of the Pituitary Gland Malignant Thyroid Stimulating Hormone Producing Neoplasm of Pituitary Malignant Thyroid Stimulating Hormone Producing Neoplasm of Pituitary Gland Malignant Thyroid Stimulating Hormone Producing Neoplasm of the Pituitary Malignant Thyroid Stimulating Hormone Producing Neoplasm of the Pituitary Gland Malignant Thyroid Stimulating Hormone Producing Pituitary Gland Neoplasm Malignant Thyroid Stimulating Hormone Producing Pituitary Gland Tumor Malignant Thyroid Stimulating Hormone Producing Pituitary Neoplasm Malignant Thyroid Stimulating Hormone Producing Pituitary Tumor Malignant Thyroid Stimulating Hormone Producing Tumor Malignant Thyroid Stimulating Hormone Producing Tumor of Pituitary Malignant Thyroid Stimulating Hormone Producing Tumor of Pituitary Gland Malignant Thyroid Stimulating Hormone Producing Tumor of the Pituitary Malignant Thyroid Stimulating Hormone Producing Tumor of the Pituitary Gland Malignant Thyroid Stimulating Hormone Secreting Neoplasm of Pituitary Malignant Thyroid Stimulating Hormone Secreting Neoplasm of Pituitary Gland Malignant Thyroid Stimulating Hormone Secreting Neoplasm of the Pituitary Malignant Thyroid Stimulating Hormone Secreting Neoplasm of the Pituitary Gland Malignant Thyroid Stimulating Hormone Secreting Pituitary Gland Neoplasm Malignant Thyroid Stimulating Hormone Secreting Pituitary Gland Tumor Malignant Thyroid Stimulating Hormone Secreting Pituitary Neoplasm Malignant Thyroid Stimulating Hormone Secreting Pituitary Tumor Malignant Thyroid Stimulating Hormone Secreting Tumor of Pituitary Malignant Thyroid Stimulating Hormone Secreting Tumor of Pituitary Gland Malignant Thyroid Stimulating Hormone Secreting Tumor of the Pituitary Malignant Thyroid Stimulating Hormone Secreting Tumor of the Pituitary Gland Malignant Thyrotropinoma Malignant Thyrotropinoma of Pituitary Malignant Thyrotropinoma of Pituitary Gland Malignant Thyrotropinoma of the Pituitary Malignant Thyrotropinoma of the Pituitary Gland Metastatic TSH-Producing PitNET Metastatic Thyrotroph Pituitary Neuroendocrine Tumor TSH Producing Pituitary Gland Carcinoma Thyrotropin Producing Pituitary Gland Carcinoma Metastatic Thyrotroph Pituitary Neuroendocrine Tumor An anaplastic astrocytoma that arises from the brain stem. C5966 Neoplastic Process Anaplastic Brain Stem Astrocytoma C1332279 Malignant Anaplastic_Brain_Stem_Astrocytoma Anaplastic Brain Stem Astrocytoma Anaplastic Brainstem Astrocytoma Anaplastic Brain Stem Astrocytoma A benign or malignant, primary or metastatic neoplasm of the brain stem occurring in adults. C5967 Neoplastic Process Adult Brain Stem Neoplasm C1332192 Undetermined Adult_Brain_Stem_Neoplasm Adult Brain Stem Neoplasm Adult Brain Stem Tumor Adult Brainstem Neoplasm Adult Brainstem Tumor Neoplasm of Adult Brain Stem Neoplasm of Adult Brainstem Neoplasm of the Adult Brain Stem Neoplasm of the Adult Brainstem Tumor of Adult Brain Stem Tumor of Adult Brainstem Tumor of the Adult Brain Stem Tumor of the Adult Brainstem Adult Brain Stem Neoplasm A benign or malignant, primary or metastatic neoplasm of the cerebellum occurring in adults. C5968 Neoplastic Process Adult Cerebellar Neoplasm C1332197 Undetermined Adult_Cerebellar_Neoplasm Adult Cerebellar Neoplasm Adult Cerebellar Neoplasms Adult Cerebellar Tumor Adult Cerebellar Tumors Neoplasm of Adult Cerebellum Neoplasm of the Adult Cerebellum Tumor of Adult Cerebellum Tumor of the Adult Cerebellum Adult Cerebellar Neoplasm A neoplasm that affects the brain stem and occurs during childhood. C5969 Neoplastic Process Childhood Brain Stem Neoplasm Childhood Brain Stem Neoplasm C1332951 CTRP NICHD A neoplasm that affects the brain stem and occurs during childhood. Undetermined Childhood_Brain_Stem_Neoplasm Brain Stem Neoplasm Childhood Brain Stem Neoplasm Childhood Brain Stem Tumor Childhood Brainstem Neoplasm Childhood Brainstem Tumor Childhood Neoplasm of Brain Stem Childhood Neoplasm of Brainstem Childhood Neoplasm of the Brain Stem Childhood Neoplasm of the Brainstem Childhood Tumor of Brain Stem Childhood Tumor of Brainstem Childhood Tumor of the Brain Stem Childhood Tumor of the Brainstem Pediatric Brain Stem Neoplasm Pediatric Brain Stem Tumor Pediatric Brainstem Neoplasm Pediatric Brainstem Tumor Pediatric Neoplasm of Brain Stem Pediatric Neoplasm of Brainstem Pediatric Neoplasm of the Brain Stem Pediatric Neoplasm of the Brainstem Pediatric Tumor of Brain Stem Pediatric Tumor of Brainstem Pediatric Tumor of the Brain Stem Pediatric Tumor of the Brainstem Childhood Brain Stem Neoplasm A neoplasm that affects the cerebellum and occurs during childhood. C5970 Neoplastic Process Childhood Cerebellar Neoplasm C1332959 NICHD A neoplasm that affects the cerebellum and occurs during childhood. Undetermined Childhood_Cerebellar_Neoplasm Childhood Cerebellar Neoplasm Childhood Cerebellar Neoplasms Childhood Cerebellar Tumor Childhood Cerebellar Tumors Childhood Neoplasm of Cerebellum Childhood Neoplasm of the Cerebellum Childhood Tumor of Cerebellum Childhood Tumor of the Cerebellum Pediatric Cerebellar Neoplasm Pediatric Cerebellar Tumor Pediatric Neoplasm of Cerebellum Pediatric Neoplasm of the Cerebellum Pediatric Tumor of Cerebellum Pediatric Tumor of the Cerebellum Childhood Cerebellar Neoplasm A carcinoma of the larynx that arises from the subglottic area. C5972 Neoplastic Process Subglottic Carcinoma Subglottic Carcinoma C1299239 CTRP Malignant Subglottic_Carcinoma Cancer of Subglottis Cancer of the Subglottis Carcinoma of Subglottis Carcinoma of the Subglottis Subglottic Cancer Subglottic Carcinoma Subglottic Throat Cancer Subglottis Carcinoma Subglottic Carcinoma A carcinoma of the larynx that arises from the supraglottic area. C5973 Neoplastic Process Supraglottic Carcinoma Supraglottic Carcinoma C1299240 CTRP Malignant Supraglottic_Carcinoma Cancer of Supraglottis Cancer of the Supraglottis Carcinoma of Supraglottis Carcinoma of the Supraglottis Supraglottic Cancer Supraglottic Carcinoma Supraglottic Throat Cancer Supraglottis Carcinoma Supraglottic Carcinoma A carcinoma that arises from a pleomorphic adenoma in the parotid gland. Patients usually present with a history of a long-standing tumor mass which grew rapidly in the past few months. Patients with non-invasive or minimally invasive carcinoma have an excellent prognosis. In cases where there is invasion of the surrounding tissues, the clinical course is aggressive. C5974 Neoplastic Process Parotid Gland Carcinoma ex Pleomorphic Adenoma C1335356 Malignant Parotid_Gland_Carcinoma_Ex_Pleomorphic_Adenoma Carcinoma ex Pleomorphic Adenoma of Parotid Carcinoma ex Pleomorphic Adenoma of Parotid Gland Carcinoma ex Pleomorphic Adenoma of the Parotid Carcinoma ex Pleomorphic Adenoma of the Parotid Gland Parotid Carcinoma ex Pleomorphic Adenoma Parotid Gland Carcinoma ex Pleomorphic Adenoma Parotid Gland Carcinoma ex Pleomorphic Adenoma A carcinoma that arises from a pleomorphic adenoma in the major salivary glands. It usually originates in the parotid gland. Patients usually present with a history of a long-standing tumor mass which grew rapidly in the past few months. Patients with non-invasive or minimally invasive carcinoma have an excellent prognosis. In cases where there is invasion of the surrounding tissues, the clinical course is aggressive. C5975 Neoplastic Process Major Salivary Gland Carcinoma ex Pleomorphic Adenoma Major Salivary Gland Carcinoma ex Pleomorphic Adenoma C1334550 CTRP Malignant Major_Salivary_Gland_Carcinoma_Ex_Pleomorphic_Adenoma Carcinoma ex Pleomorphic Adenoma of Major Salivary Gland Carcinoma ex Pleomorphic Adenoma of the Major Salivary Gland Major Salivary Gland Carcinoma ex Pleomorphic Adenoma Major Salivary Gland Carcinoma ex Pleomorphic Adenoma A carcinoma that arises from a pleomorphic adenoma in the minor salivary glands. Patients usually present with a history of a long-standing tumor mass which grew rapidly in the past few months. Patients with non-invasive or minimally invasive carcinoma have an excellent prognosis. In cases where there is invasion of the surrounding tissues, the clinical course is aggressive. C5976 Neoplastic Process Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma C1334772 Cellosaurus Malignant Minor_Salivary_Gland_Carcinoma_Ex_Pleomorphic_Adenoma Carcinoma ex Pleomorphic Adenoma of Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma of the Minor Salivary Gland Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma A carcinoma that arises from a pleomorphic adenoma in the submandibular gland. Patients usually present with a history of a long-standing tumor mass which grew rapidly in the past few months. Patients with non-invasive or minimally invasive carcinoma have an excellent prognosis. In cases where there is invasion of the surrounding tissues, the clinical course is aggressive. C5977 Neoplastic Process Submandibular Gland Carcinoma ex Pleomorphic Adenoma C1336523 Cellosaurus Malignant Submandibular_Gland_Carcinoma_Ex_Pleomorphic_Adenoma Submandibular Gland Carcinoma ex Pleomorphic Adenoma Submaxillary Gland Carcinoma ex Pleomorphic Adenoma Submandibular Gland Carcinoma ex Pleomorphic Adenoma A rare benign tumor composed of sheets and islands of spindle, plasmacytoid, epithelioid, and clear cells that exhibit myoepithelial but not ductal differentiation. The average age of patients has been reported as 44 years. Clinically, these tumors present as asymptomatic masses. Discrimination between myoepithelioma and myoepithelial carcinoma is based primarily on the infiltrative growth of the latter. C5978 Neoplastic Process Salivary Gland Myoepithelioma C1332537 Cellosaurus Benign Benign_Salivary_Gland_Myoepithelioma Benign Myoepithelioma of the Salivary Gland Benign Salivary Gland Myoepithelioma Salivary Gland Myoepithelioma Salivary Gland Myoepithelioma A benign epithelial neoplasm primarily composed of branching and interconnecting cords of single and double-cell thick rows of columnar epithelium in a very loose stroma. It often occurs in the upper lip, where only pleomorphic adenoma is more frequent. Asymptomatic swelling of the upper lip is the most common clinical finding. It may present clinically and histologically as a multifocal lesion, a feature not generally seen with other intraoral salivary gland tumors. C5979 Neoplastic Process Salivary Gland Canalicular Adenoma C1266014 GDC 8149/0 Benign Salivary_Gland_Canalicular_Adenoma 8149/0 Canalicular adenoma Canalicular Adenoma of Salivary Gland Canalicular Adenoma of the Salivary Gland Canalicular adenoma Salivary Gland Canalicular Adenoma Salivary Gland Canalicular Adenoma A rare, low-grade adenocarcinoma that arises from the salivary glands. It presents as a slow growing asymptomatic mass and is characterized by the presence of multiple cystic spaces. C5980 Neoplastic Process Salivary Gland Cystadenocarcinoma C1335897 Malignant Salivary_Gland_Cystadenocarcinoma Cystadenocarcinoma of Salivary Gland Cystadenocarcinoma of the Salivary Gland Salivary Gland Cystadenocarcinoma Salivary Gland Cystadenocarcinoma A non-Hodgkin lymphoma that arises from the parotid gland, submandibular gland, or sublingual gland. Representative examples include mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma. C5981 Neoplastic Process Major Salivary Gland Non-Hodgkin Lymphoma C1334552 Malignant Major_Salivary_Gland_Non-Hodgkin_s_Lymphoma Major Salivary Gland Non-Hodgkin Lymphoma Major Salivary Gland Non-Hodgkin's Lymphoma Non-Hodgkin's Lymphoma of Major Salivary Gland Non-Hodgkin's Lymphoma of the Major Salivary Gland Primary Major Salivary Gland Non-Hodgkin's Lymphoma Major Salivary Gland Non-Hodgkin Lymphoma A lipoma that arises from the parotid gland. C5982 Neoplastic Process Parotid Gland Lipoma C1335360 Benign Parotid_Gland_Lipoma Lipoma of Parotid Lipoma of Parotid Gland Lipoma of the Parotid Lipoma of the Parotid Gland Parotid Gland Lipoma Parotid Lipoma Parotid Gland Lipoma A rare malignant soft tissue neoplasm that arises from the parotid gland, submandibular gland, or sublingual gland. Representative examples include fibrosarcoma, angiosarcoma, leiomyosarcoma, and Kaposi sarcoma. C5983 Neoplastic Process Major Salivary Gland Sarcoma C1334553 Malignant Major_Salivary_Gland_Sarcoma Major Salivary Gland Sarcoma Sarcoma of Major Salivary Gland Sarcoma of the Major Salivary Gland Major Salivary Gland Sarcoma Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a: Tumor with moderately advanced local disease. Tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible. Mucosal extension to lingual surface of epiglottis from primary tumors of the base of the tongue and vallecula does not constitute invasion of larynx. T1: Tumor 2 cm or less in greatest dimension. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3: Tumor measuring more than 4 centimeters in greatest dimension or extension to lingual surface of epiglottis. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Tumor with metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C5985 Neoplastic Process Stage IVA Oropharyngeal Carcinoma AJCC v7 Stage IVA Oropharyngeal Carcinoma AJCC v7 C1336355 CTRP Malignant Stage_IVA_Oropharyngeal_Carcinoma Stage IVA Carcinoma of Oropharynx Stage IVA Carcinoma of the Oropharynx Stage IVA Oropharyngeal Carcinoma Stage IVA Oropharyngeal Carcinoma AJCC v7 Stage IVA Oropharyngeal Throat Cancer Stage IVA Oropharynx Carcinoma Stage IVA Oropharyngeal Carcinoma AJCC v7 Stage IVB includes: (T4b, Any N, M0); (Any T, N3, M0). T4b: Tumor with very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery. N3: Tumor with metastasis in a lymph node more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C5986 Neoplastic Process Stage IVB Oropharyngeal Carcinoma AJCC v7 Stage IVB Oropharyngeal Carcinoma AJCC v7 C1336386 CTRP Malignant Stage_IVB_Oropharyngeal_Carcinoma Stage IVB Carcinoma of Oropharynx Stage IVB Carcinoma of the Oropharynx Stage IVB Oropharyngeal Carcinoma Stage IVB Oropharyngeal Carcinoma AJCC v7 Stage IVB Oropharyngeal Throat Cancer Stage IVB Oropharynx Carcinoma Stage IVB Oropharyngeal Carcinoma AJCC v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C5987 Neoplastic Process Stage IVC Oropharyngeal Carcinoma AJCC v7 Stage IVC Oropharyngeal Carcinoma AJCC v7 C1336406 CTRP Malignant Stage_IVC_Oropharyngeal_Carcinoma Stage IVC Carcinoma of Oropharynx Stage IVC Carcinoma of the Oropharynx Stage IVC Oropharyngeal Carcinoma Stage IVC Oropharyngeal Carcinoma AJCC v7 Stage IVC Oropharyngeal Throat Cancer Stage IVC Oropharynx Carcinoma Stage IVC Oropharyngeal Carcinoma AJCC v7 A benign exophytic growth that arises from the oropharynx. C5988 Neoplastic Process Oropharyngeal Polyp C1335140 Benign Oropharyngeal_Polyp Oropharyngeal Polyp Oropharynx Polyp Polyp of Oropharynx Polyp of the Oropharynx Oropharyngeal Polyp A benign adipose tissue neoplasm of the tonsils. C5989 Neoplastic Process Tonsillar Lipoma C1336764 Benign Tonsillar_Lipoma Lipoma of Tonsil Lipoma of the Tonsil Tonsil Lipoma Tonsillar Lipoma Tonsillar Lipoma A mucoepidermoid carcinoma arising from the minor salivary glands in the base of the tongue. C5990 Neoplastic Process Posterior Tongue Mucoepidermoid Carcinoma C1335453 Malignant Posterior_Tongue_Mucoepidermoid_Carcinoma Base of Tongue Mucoepidermoid Carcinoma Base of the Tongue Mucoepidermoid Carcinoma Mucoepidermoid Carcinoma of Base of Tongue Mucoepidermoid Carcinoma of Posterior Tongue Mucoepidermoid Carcinoma of the Base of the Tongue Mucoepidermoid Carcinoma of the Posterior Tongue Posterior Tongue Mucoepidermoid Carcinoma Posterior Tongue Mucoepidermoid Carcinoma An adenoid cystic carcinoma arising from the minor salivary glands in the base of the tongue. C5991 Neoplastic Process Posterior Tongue Adenoid Cystic Carcinoma C1335452 Malignant Posterior_Tongue_Adenoid_Cystic_Carcinoma Adenoid Cystic Carcinoma of Base of Tongue Adenoid Cystic Carcinoma of Posterior Tongue Adenoid Cystic Carcinoma of the Base of the Tongue Adenoid Cystic Carcinoma of the Posterior Tongue Base of Tongue Adenoid Cystic Carcinoma Base of the Tongue Adenoid Cystic Carcinoma Posterior Tongue Adenoid Cystic Carcinoma Posterior Tongue Adenoid Cystic Carcinoma Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a: Tumor with moderately advanced local disease. Tumor invades the thyroid/cricoid cartilage, hyoid bone, thyroid gland, or central compartment soft tissue. Central compartment soft tissue includes prelaryngeal strap muscles and subcutaneous fat. T1: Tumor limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimension. T2: Tumor invades more than one subsite of the hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx. T3: Tumor measuring more than 4 cm in greatest dimension or tumor with fixation of hemilarynx or extension to esophagus. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Tumor with metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C5992 Neoplastic Process Stage IVA Hypopharyngeal Carcinoma AJCC v7 Stage IVA Hypopharyngeal Carcinoma AJCC v7 C1336340 CTRP Stage IV hypopharyngeal cancer is divided into stages IVA, IVB, and IVC. In stage IVA, the tumor is (1) any size and has spread to nearby soft tissue, connective tissue, the thyroid, or the esophagus; cancer may be found either in one lymph node on the same side of the neck (the lymph node is 3 centimeters or smaller) or in one or more lymph nodes anywhere in the neck (all of these lymph nodes are 6 centimeters or smaller); or (2) in only one area of the hypopharynx, is 2 centimeters or smaller, and has also spread to one or more lymph nodes anywhere in the neck (all of these lymph nodes are 6 centimeters or smaller); or (3) in more than one area of the hypopharynx, is in nearby tissues, or is larger than 2 centimeters but not larger than 4 centimeters and has not spread to the larynx; cancer has spread to one or more lymph nodes anywhere in the neck (all of these lymph nodes are 6 centimeters or smaller); or (4) larger than 4 centimeters or has spread to the larynx; cancer has also spread to one or more lymph nodes anywhere in the neck (all of these lymph nodes are 6 centimeters or smaller). Malignant Stage_IVA_Hypopharyngeal_Carcinoma Stage IVA Carcinoma of Hypopharynx Stage IVA Carcinoma of the Hypopharynx Stage IVA Hypopharyngeal Carcinoma Stage IVA Hypopharyngeal Carcinoma AJCC v7 Stage IVA Hypopharyngeal Throat Cancer Stage IVA Hypopharynx Carcinoma stage IVA hypopharyngeal cancer Stage IVA Hypopharyngeal Carcinoma AJCC v7 Stage IVB includes: (T4b, Any N, M0); (Any T, N3, M0). T4b: Tumor with very advanced local disease. Tumor invades prevertebral fascia, encases carotid artery, or involves mediastinal structures. N3: Metastasis in a lymph node more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C5993 Neoplastic Process Stage IVB Hypopharyngeal Carcinoma AJCC v7 Stage IVB Hypopharyngeal Carcinoma AJCC v7 C1336371 CTRP Stage IV hypopharyngeal cancer is divided into stages IVA, IVB, and IVC. In stage IVB, the tumor either (1) has spread to nearby soft tissue, connective tissue, blood vessels, the thyroid, or the esophagus, and may have spread to lymph nodes of any size; or (2) is any size and has spread to lymph nodes that are larger than 6 centimeters. Malignant Stage_IVB_Hypopharyngeal_Carcinoma Stage IVB Carcinoma of Hypopharynx Stage IVB Carcinoma of the Hypopharynx Stage IVB Hypopharyngeal Carcinoma AJCC v7 Stage IVB Hypopharyngeal Throat Cancer Stage IVB Hypopharynx Carcinoma stage IVB hypopharyngeal cancer Stage IVB Hypopharyngeal Carcinoma AJCC v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C5994 Neoplastic Process Stage IVC Hypopharyngeal Carcinoma AJCC v7 Stage IVC Hypopharyngeal Carcinoma AJCC v7 C1336392 CTRP Stage IV hypopharyngeal cancer is divided into stages IVA, IVB, and IVC. In stage IVC, cancer has spread beyond the hypopharynx to other parts of the body. Malignant Stage_IVC_Hypopharyngeal_Carcinoma Stage IVC Carcinoma of Hypopharynx Stage IVC Carcinoma of the Hypopharynx Stage IVC Hypopharyngeal Carcinoma Stage IVC Hypopharyngeal Carcinoma AJCC v7 Stage IVC Hypopharyngeal Throat Cancer Stage IVC Hypopharynx Carcinoma stage IVC hypopharyngeal cancer Stage IVC Hypopharyngeal Carcinoma AJCC v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C5995 Neoplastic Process Stage IVC Nasopharyngeal Carcinoma AJCC v7 Stage IVC Nasopharyngeal Carcinoma AJCC v7 C1336399 CTRP Malignant Stage_IVC_Nasopharyngeal_Carcinoma Stage IVC Carcinoma of Nasopharynx Stage IVC Carcinoma of the Nasopharynx Stage IVC Nasopharyngeal Carcinoma Stage IVC Nasopharyngeal Carcinoma AJCC v7 Stage IVC Nasopharyngeal Throat Cancer Stage IVC Nasopharynx Carcinoma Stage IVC Nasopharyngeal Carcinoma AJCC v7 Stage IVB includes: Any T, N3, M0. N3: Nasopharyngeal cancer with metastasis in a lymph node (s) more than 6 cm in greatest dimension and/or to supraclavicular fossa. Supraclavicular zone or fossa is relevant to the staging of nasopharyngeal carcinoma and is the triangular region originally described by Ho. It is defined by three points: (1) the superior margin of the sternal end of the clavicle, (2) the superior margin of the lateral end of the clavicle, (3) the point where the neck meets the shoulder. This would include caudal portions of levels IV and VB. All cases with lymph nodes (whole or part) in the fossa are considered N3b. M0: No distant metastasis. (AJCC 7th ed.) C5996 Neoplastic Process Stage IVB Nasopharyngeal Carcinoma AJCC v7 Stage IVB Nasopharyngeal Carcinoma AJCC v7 C1336379 CTRP Malignant Stage_IVB_Nasopharyngeal_Carcinoma Stage IVB Carcinoma of Nasopharynx Stage IVB Carcinoma of the Nasopharynx Stage IVB Nasopharyngeal Carcinoma Stage IVB Nasopharyngeal Carcinoma AJCC v7 Stage IVB Nasopharyngeal Throat Cancer Stage IVB Nasopharynx Carcinoma Stage IVB Nasopharyngeal Carcinoma AJCC v7 Stage IVA includes: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0). T4: Nasopharyngeal cancer with intracranial extension and/or involvement of cranial nerves, hypopharynx, orbit, or with extension to the infratemporal fossa/masticator space. N0: No regional lymph node metastasis. N1: Nasopharyngeal cancer with unilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa, and/or unilateral or bilateral, retropharyngeal lymph nodes, 6 cm or less in greatest dimension. Midline nodes are considered ipsilateral nodes. N2: Nasopharyngeal cancer with bilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa. Midline nodes are considered ipsilateral nodes. M0: No distant metastasis. (AJCC 7th ed.) C5997 Neoplastic Process Stage IVA Nasopharyngeal Carcinoma AJCC v7 Stage IVA Nasopharyngeal Carcinoma AJCC v7 C1336348 CTRP Malignant Stage_IVA_Nasopharyngeal_Carcinoma Stage IVA Carcinoma of Nasopharynx Stage IVA Carcinoma of the Nasopharynx Stage IVA Nasopharyngeal Carcinoma Stage IVA Nasopharyngeal Carcinoma AJCC v7 Stage IVA Nasopharyngeal Throat Cancer Stage IVA Nasopharynx Carcinoma Stage IVA Nasopharyngeal Carcinoma AJCC v7 Stage IVA carcinoma of the pharynx according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions. C6000 Neoplastic Process Stage IVA Pharyngeal Cancer C1336359 Malignant Stage_IVA_Pharyngeal_Cancer Pharyngeal Cancer Stage IVA Stage IVA Carcinoma of Pharynx Stage IVA Carcinoma of the Pharynx Stage IVA Pharyngeal Cancer Stage IVA Pharyngeal Carcinoma Stage IVA Pharynx Carcinoma Stage IVA Pharyngeal Cancer Stage IVB carcinoma of the pharynx according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions. C6001 Neoplastic Process Stage IVB Pharyngeal Cancer C1336390 Malignant Stage_IVB_Pharyngeal_Cancer Pharyngeal Cancer Stage IVB Stage IVB Carcinoma of Pharynx Stage IVB Carcinoma of the Pharynx Stage IVB Pharyngeal Cancer Stage IVB Pharyngeal Carcinoma Stage IVB Pharynx Carcinoma Stage IVB Pharyngeal Cancer Stage IVC carcinoma of the pharynx according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions. C6002 Neoplastic Process Stage IVC Pharyngeal Cancer C1336409 Malignant Stage_IVC_Pharyngeal_Cancer Pharyngeal Cancer Stage IVC Stage IVC Carcinoma of Pharynx Stage IVC Carcinoma of the Pharynx Stage IVC Pharyngeal Cancer Stage IVC Pharyngeal Carcinoma Stage IVC Pharynx Carcinoma Stage IVC Pharyngeal Cancer Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C6003 Neoplastic Process Stage IVC Laryngeal Cancer AJCC v7 Stage IVC Laryngeal Cancer AJCC v7 C1336394 CTRP Stage IV is divided into stages IVA, IVB, and IVC. In stage IVC, cancer has spread beyond the larynx to distant parts of the body. Malignant Stage_IVC_Laryngeal_Cancer Laryngeal Cancer Stage IVC Stage IVC Carcinoma of Larynx Stage IVC Carcinoma of the Larynx Stage IVC Laryngeal Cancer Stage IVC Laryngeal Cancer AJCC v7 Stage IVC Laryngeal Carcinoma Stage IVC Laryngeal Throat Cancer Stage IVC Larynx Carcinoma stage IVC laryngeal cancer Stage IVC Laryngeal Cancer AJCC v7 Stage IVB includes: (T4b, Any N, M0); (Any T, N3, M0). T4b: Supraglottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. Glottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. Subglottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. N3: Metastasis in a lymph node, more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C6004 Neoplastic Process Stage IVB Laryngeal Cancer AJCC v7 Stage IVB Laryngeal Cancer AJCC v7 C1336373 CTRP Stage IV is divided into stages IVA, IVB, and IVC. In stage IVB, one of the following is found: (1) cancer has spread to the space in front of the spinal column and surrounds the carotid artery, or has spread to parts of the chest and may have spread to one or more lymph nodes anywhere in the neck (the lymph nodes may be any size); or (2) cancer has spread to a lymph node that is larger than 6 centimeters and may have spread as far as the space in front of the spinal column, around the carotid artery, or to parts of the chest. Vocal cords may not move normally. Malignant Stage_IVB_Laryngeal_Cancer Laryngeal Cancer Stage IVB Stage IVB Carcinoma of Larynx Stage IVB Carcinoma of the Larynx Stage IVB Laryngeal Cancer Stage IVB Laryngeal Cancer AJCC v7 Stage IVB Laryngeal Carcinoma Stage IVB Laryngeal Throat Cancer Stage IVB Larynx Carcinoma stage IVB laryngeal cancer Stage IVB Laryngeal Cancer AJCC v7 Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); T4a: Supraglottis: Moderately advanced local disease. Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus). Glottis: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus). Subglottis: Moderately advanced local disease. Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus). N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C6005 Neoplastic Process Stage IVA Laryngeal Cancer AJCC v7 Stage IVA Laryngeal Cancer AJCC v7 C1336342 CTRP Stage IV is divided into stages IVA, IVB, and IVC. In stage IVA, one of the following is found: (1) cancer has spread through the thyroid cartilage and/or has spread to tissues beyond the larynx such as the neck, trachea, thyroid, or esophagus; cancer may have spread to one lymph node on the same side of the neck as the original tumor and the lymph node is smaller than 3 centimeters; or (2) cancer has spread to one or more lymph nodes anywhere in the neck and the lymph nodes are smaller than 6 centimeters; cancer may have spread to tissues beyond the larynx, such as the neck, trachea, thyroid, or esophagus. Vocal cords may not move normally. Malignant Stage_IVA_Laryngeal_Cancer Laryngeal Cancer Stage IVA Stage IVA Carcinoma of Larynx Stage IVA Carcinoma of the Larynx Stage IVA Laryngeal Cancer Stage IVA Laryngeal Cancer AJCC v7 Stage IVA Laryngeal Carcinoma Stage IVA Laryngeal Throat Cancer Stage IVA Larynx Carcinoma stage IVA laryngeal cancer Stage IVA Laryngeal Cancer AJCC v7 Stage I includes: T1, N0, M0. T1: Maxillary sinus: Tumor limited to the maxillary sinus mucosa with no erosion or destruction of bone. Ethmoid sinus: Tumor restricted to any one subsite, with or without bony invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6006 Neoplastic Process Stage I Paranasal Sinus Cancer Stage I Paranasal Sinus Cancer C1336475 CTRP Malignant Stage_I_Paranasal_Sinus_Cancer Paranasal Sinus Cancer Stage I Stage I Accessory Sinus Carcinoma Stage I Carcinoma of Accessory Sinus Stage I Carcinoma of Paranasal Sinus Stage I Carcinoma of the Accessory Sinus Stage I Carcinoma of the Paranasal Sinus Stage I Paranasal Sinus Cancer Stage I Paranasal Sinus Cancer AJCC v6 Stage I Paranasal Sinus Cancer AJCC v7 Stage I Paranasal Sinus Carcinoma Stage I Paranasal Sinus Cancer Stage II includes: T2, N0, M0. T2: Maxillary sinus: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates. Ethmoid sinus: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6007 Neoplastic Process Stage II Paranasal Sinus Cancer AJCC v6 and v7 Stage II Paranasal Sinus Cancer AJCC v6 and v7 C1336311 CTRP Malignant Stage_II_Paranasal_Sinus_Cancer Paranasal Sinus Cancer Stage II Stage II Accessory Sinus Carcinoma Stage II Carcinoma of Accessory Sinus Stage II Carcinoma of Paranasal Sinus Stage II Carcinoma of the Accessory Sinus Stage II Carcinoma of the Paranasal Sinus Stage II Paranasal Sinus Cancer Stage II Paranasal Sinus Cancer AJCC v6 Stage II Paranasal Sinus Cancer AJCC v6 and v7 Stage II Paranasal Sinus Cancer AJCC v7 Stage II Paranasal Sinus Carcinoma Stage II Paranasal Sinus Cancer AJCC v6 and v7 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Maxillary sinus: Tumor invading any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, or ethmoid sinuses. Ethmoid sinus: Tumor invading the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate. T1: Maxillary sinus: Tumor limited to the maxillary sinus mucosa with no erosion or destruction of bone. Ethmoid sinus: Tumor restricted to any one subsite, with or without bony invasion. T2: Maxillary sinus: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates. Ethmoid sinus: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6008 Neoplastic Process Stage III Paranasal Sinus Cancer AJCC v6 and v7 Stage III Paranasal Sinus Cancer AJCC v6 and v7 C1336264 CTRP Malignant Stage_III_Paranasal_Sinus_Cancer Paranasal Sinus Cancer Stage III Stage III Accessory Sinus Carcinoma Stage III Carcinoma of Accessory Sinus Stage III Carcinoma of Paranasal Sinus Stage III Carcinoma of the Accessory Sinus Stage III Carcinoma of the Paranasal Sinus Stage III Paranasal Sinus Cancer Stage III Paranasal Sinus Cancer AJCC v6 Stage III Paranasal Sinus Cancer AJCC v6 and v7 Stage III Paranasal Sinus Cancer AJCC v7 Stage III Paranasal Sinus Carcinoma Stage III Paranasal Sinus Cancer AJCC v6 and v7 Stage IV includes: IVA: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB: (T4b, Any N, M0); (Any T, N3, M0); IVC: (Any T, Any N, M1). T4a: Maxillary sinus: Moderately advanced local disease. Tumor invades anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid or frontal sinuses. Ethmoid sinus: Moderately advanced local disease. Tumor invades any of the following: anterior orbital contents, skin of nose or cheek, minimal extension to anterior cranial fossa, pterygoid plates, sphenoid or frontal sinuses. T4b: Very advanced local disease. Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve, nasopharynx, or clivus. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a lymph node, more than 6 cm in greatest dimension. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C6009 Neoplastic Process Stage IV Paranasal Sinus Cancer AJCC v7 Stage IV Paranasal Sinus Cancer AJCC v7 C1336434 CTRP Malignant Stage_IV_Paranasal_Sinus_Cancer Paranasal Sinus Cancer Stage IV Stage IV Accessory Sinus Carcinoma Stage IV Carcinoma of Accessory Sinus Stage IV Carcinoma of Paranasal Sinus Stage IV Carcinoma of the Accessory Sinus Stage IV Carcinoma of the Paranasal Sinus Stage IV Paranasal Sinus Cancer Stage IV Paranasal Sinus Cancer AJCC v7 Stage IV Paranasal Sinus Carcinoma Stage IV Paranasal Sinus Cancer AJCC v7 Stage IV includes: IVA: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB: (T4b, Any N, M0); (Any T, N3, M0); IVC: (Any T, Any N, M1). T4a: Moderately advanced local disease. Tumor invades any of the following: anterior orbital contents, skin of nose or cheek, minimal extension to anterior cranial fossa, pterygoid plates, sphenoid or frontal sinuses. T4b: Very advanced local disease. Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve, nasopharynx, or clivus. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a lymph node, more than 6 cm in greatest dimension. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C6010 Neoplastic Process Stage IV Nasal Cavity Carcinoma AJCC v7 Stage IV Nasal Cavity Cancer C1336427 CTRP Malignant Stage_IV_Nasal_Cavity_Carcinoma Stage IV Carcinoma of Nasal Cavity Stage IV Carcinoma of the Nasal Cavity Stage IV Nasal Cavity Cancer Stage IV Nasal Cavity Carcinoma Stage IV Nasal Cavity Carcinoma AJCC v7 Stage IV Nasal Cavity Cancer Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor invading the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate. T1: Tumor restricted to any one subsite, with or without bony invasion. T2: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6011 Neoplastic Process Stage III Nasal Cavity Cancer AJCC v6 and v7 Stage III Nasal Cavity Cancer AJCC v6 and v7 C1336256 CTRP Malignant Stage_III_Nasal_Cavity_Carcinoma Stage III Carcinoma of Nasal Cavity Stage III Carcinoma of the Nasal Cavity Stage III Nasal Cavity Cancer Stage III Nasal Cavity Cancer AJCC v6 and v7 Stage III Nasal Cavity Carcinoma Stage III Nasal Cavity Carcinoma AJCC v6 Stage III Nasal Cavity Carcinoma AJCC v7 Stage III Nasal Cavity Cancer AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6012 Neoplastic Process Stage II Nasal Cavity Cancer AJCC v6 and v7 Stage II Nasal Cavity Cancer AJCC v6 and v7 C1336300 CTRP Malignant Stage_II_Nasal_Cavity_Carcinoma Stage II Carcinoma of Nasal Cavity Stage II Carcinoma of the Nasal Cavity Stage II Nasal Cavity Cancer Stage II Nasal Cavity Cancer AJCC v6 and v7 Stage II Nasal Cavity Carcinoma Stage II Nasal Cavity Carcinoma AJCC v6 Stage II Nasal Cavity Carcinoma AJCC v7 Stage II Nasal Cavity Cancer AJCC v6 and v7 Stage I includes: T1, N0, M0. T1:Tumor restricted to any one subsite, with or without bony invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6013 Neoplastic Process Stage I Nasal Cavity Cancer AJCC v6 and v7 Stage I Nasal Cavity Cancer AJCC v6 and v7 C1336466 CTRP Malignant Stage_I_Nasal_Cavity_Carcinoma Stage I Carcinoma of Nasal Cavity Stage I Carcinoma of the Nasal Cavity Stage I Nasal Cavity Cancer Stage I Nasal Cavity Cancer AJCC v6 and v7 Stage I Nasal Cavity Carcinoma Stage I Nasal Cavity Carcinoma AJCC v6 Stage I Nasal Cavity Carcinoma AJCC v7 Stage I Nasal Cavity Cancer AJCC v6 and v7 A malignant epithelial neoplasm arising in the paranasal sinus. C6014 Neoplastic Process Paranasal Sinus Carcinoma Paranasal Sinus Carcinoma CL448483 CTRP Malignant Paranasal_Sinus_Carcinoma Accessory Sinus Cancer Accessory Sinus Carcinoma Carcinoma of Accessory Sinus Carcinoma of Paranasal Sinus Carcinoma of the Accessory Sinus Carcinoma of the Paranasal Sinus Paranasal Sinus Cancer Paranasal Sinus Carcinoma Paranasal Sinus Carcinoma An adenocarcinoma that arises from the nasal cavity. C6015 Neoplastic Process Nasal Cavity Adenocarcinoma C1334920 Malignant Nasal_Cavity_Adenocarcinoma Adenocarcinoma of Nasal Cavity Adenocarcinoma of the Nasal Cavity Nasal Cavity Adenocarcinoma Nasal Cavity Adenocarcinoma An olfactory neuroblastoma arising in the paranasal sinus. C6016 Neoplastic Process Paranasal Sinus Olfactory Neuroblastoma CL448327 Malignant Paranasal_Sinus_Olfactory_Neuroblastoma Accessory Sinus Esthesioneuroblastoma Esthesioneuroblastoma of Accessory Sinus Esthesioneuroblastoma of Paranasal Sinus Esthesioneuroblastoma of the Accessory Sinus Esthesioneuroblastoma of the Paranasal Sinus Paranasal Sinus Esthesioneuroblastoma Paranasal Sinus Olfactory Neuroblastoma Paranasal Sinus Olfactory Neuroblastoma An adenocarcinoma that arises from the paranasal sinuses. C6017 Neoplastic Process Paranasal Sinus Adenocarcinoma C1335336 Malignant Paranasal_Sinus_Adenocarcinoma Accessory Sinus Adenocarcinoma Adenocarcinoma of Accessory Sinus Adenocarcinoma of Paranasal Sinus Adenocarcinoma of the Accessory Sinus Adenocarcinoma of the Paranasal Sinus Paranasal Sinus Adenocarcinoma Paranasal Sinus Adenocarcinoma A rare carcinoma that arises from the paranasal sinus. It is characterized by the presence of epidermoid cells, mucus producing cells, and cells of intermediate type. C6018 Neoplastic Process Paranasal Sinus Mucoepidermoid Carcinoma C1335340 Malignant Paranasal_Sinus_Mucoepidermoid_Carcinoma Accessory Sinus Mucoepidermoid Carcinoma Mucoepidermoid Carcinoma of Accessory Sinus Mucoepidermoid Carcinoma of Paranasal Sinus Mucoepidermoid Carcinoma of the Accessory Sinus Mucoepidermoid Carcinoma of the Paranasal Sinus Paranasal Sinus Mucoepidermoid Carcinoma Paranasal Sinus Mucoepidermoid Carcinoma A rare adenoid cystic carcinoma that arises from the paranasal sinuses. It usually has an aggressive clinical course characterized by high recurrence rates and distant metastases. C6019 Neoplastic Process Paranasal Sinus Adenoid Cystic Carcinoma C1335337 Malignant Paranasal_Sinus_Adenoid_Cystic_Carcinoma Accessory Sinus Adenoid Cystic Carcinoma Adenoid Cystic Carcinoma of Accessory Sinus Adenoid Cystic Carcinoma of Paranasal Sinus Adenoid Cystic Carcinoma of the Accessory Sinus Adenoid Cystic Carcinoma of the Paranasal Sinus Paranasal Sinus Adenoid Cystic Carcinoma Paranasal Sinus Adenoid Cystic Carcinoma A rare sarcoma that arises from soft tissue or hyaline cartilage of the larynx. C6020 Neoplastic Process Laryngeal Sarcoma C1334377 Malignant Laryngeal_Sarcoma Laryngeal Sarcoma Larynx Sarcoma Sarcoma of Larynx Sarcoma of the Larynx Laryngeal Sarcoma A rare malignant adipose tissue neoplasm of the larynx. It predominantly affects males. Clinical presentation includes dysphonia, dysphagia and respiratory symptoms. The supraglottis is the most common site of involvement. C6021 Neoplastic Process Laryngeal Liposarcoma C1334372 Malignant Laryngeal_Liposarcoma Laryngeal Liposarcoma Larynx Liposarcoma Liposarcoma of Larynx Liposarcoma of the Larynx Laryngeal Liposarcoma A leiomyosarcoma that arises from the larynx. C6022 Neoplastic Process Laryngeal Leiomyosarcoma C1334371 Malignant Laryngeal_Leiomyosarcoma Laryngeal Leiomyosarcoma Larynx Leiomyosarcoma Leiomyosarcoma of Larynx Leiomyosarcoma of the Larynx Laryngeal Leiomyosarcoma A neoplasm with neuroendocrine differentiation that arises from the larynx. This category includes neuroendocrine tumors, neuroendocrine carcinomas, and paragangliomas. C6023 Neoplastic Process Laryngeal Neuroendocrine Neoplasm C1334374 Undetermined Laryngeal_Neuroendocrine_Neoplasm Laryngeal Neuroendocrine Neoplasm Larynx Neuroendocrine Neoplasm Neuroendocrine Neoplasm of Larynx Neuroendocrine Neoplasm of the Larynx Laryngeal Neuroendocrine Neoplasm A small cell neuroendocrine carcinoma that arises from the larynx. C6025 Neoplastic Process Laryngeal Small Cell Carcinoma Laryngeal Small Cell Neuroendocrine Carcinoma Laryngeal Small Cell Neuroendocrine Carcinoma C1334378 CTRP Malignant Laryngeal_Small_Cell_Carcinoma Laryngeal Small Cell Carcinoma Laryngeal Small Cell Neuroendocrine Carcinoma Laryngeal Throat Small Cell Cancer Larynx Small Cell Carcinoma Small Cell Carcinoma of Larynx Small Cell Carcinoma of the Larynx Laryngeal Small Cell Neuroendocrine Carcinoma A hemangioma arising from the subglottic area. C6026 Neoplastic Process Subglottic Hemangioma C1336518 Benign Subglottic_Hemangioma Angioma of Subglottis Angioma of the Subglottis Hemangioma of Subglottis Hemangioma of the Subglottis Subglottic Angioma Subglottic Hemangioma Subglottis Angioma Subglottis Hemangioma Subglottic Hemangioma A benign smooth muscle neoplasm arising from the larynx. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C6027 Neoplastic Process Laryngeal Leiomyoma C1334370 Benign Laryngeal_Leiomyoma Laryngeal Leiomyoma Larynx Leiomyoma Leiomyoma of Larynx Leiomyoma of the Larynx Laryngeal Leiomyoma A malignant neoplasm that has spread to the hypopharynx from another anatomic site. C6028 Neoplastic Process Metastatic Malignant Neoplasm in the Hypopharynx C0684964 Malignant Metastatic_Neoplasm_to_the_Hypopharynx Metastatic Malignant Neoplasm in the Hypopharynx Metastatic Malignant Neoplasm to the Hypopharynx Metastatic Neoplasm to the Hypopharynx Metastatic Tumor to the Hypopharynx Metastatic Malignant Neoplasm in the Hypopharynx A malignant neoplasm that has spread to the oropharynx from another anatomic site. C6029 Neoplastic Process Metastatic Malignant Neoplasm in the Oropharynx C0686031 Malignant Metastatic_Neoplasm_to_the_Oropharynx Metastasis to the Oropharynx Metastatic Malignant Neoplasm in the Oropharynx Metastatic Malignant Neoplasm to the Oropharynx Metastatic Neoplasm to the Oropharynx Metastatic Tumor to the Oropharynx Metastatic Malignant Neoplasm in the Oropharynx A malignant neoplasm that has spread to the nasopharynx from another anatomic site. C6030 Neoplastic Process Metastatic Malignant Neoplasm in the Nasopharynx C1334731 Malignant Metastatic_Neoplasm_to_the_Nasopharynx Metastasis to the Nasopharynx Metastatic Malignant Neoplasm in the Nasopharynx Metastatic Malignant Neoplasm to the Nasopharynx Metastatic Neoplasm to the Nasopharynx Metastatic Tumor to the Nasopharynx Metastatic Malignant Neoplasm in the Nasopharynx A malignant neoplasm that has spread to the larynx from another anatomic site. C6031 Neoplastic Process Metastatic Malignant Neoplasm in the Larynx C0684984 Malignant Metastatic_Neoplasm_to_the_Larynx Metastatic Malignant Neoplasm in the Larynx Metastatic Malignant Neoplasm to the Larynx Metastatic Neoplasm to the Larynx Metastatic Tumor to the Larynx Metastatic Malignant Neoplasm in the Larynx A neoplasm that arises from mature B-lymphocytes or plasma cells in the lung. Representative examples include mucosa-associated lymphoid tissue lymphoma, diffuse large B-cell lymphoma, lymphomatoid granulomatosis, and primary pulmonary plasmacytoma. C60310 Neoplastic Process Lung Mature B-Cell Neoplasm C1881484 Undetermined Lung_Mature_B-Cell_Neoplasm Lung Mature B-Cell Lymphocytic Neoplasm Lung Mature B-Cell Neoplasm Lung Mature B-Cell Neoplasm A benign exophytic growth that arises from the nasopharynx. C6034 Neoplastic Process Nasopharyngeal Polyp C0008298 Benign Nasopharyngeal_Polyp Nasopharyngeal Polyp Nasopharynx Polyp Polyp of Nasopharynx Polyp of the Nasopharynx Nasopharyngeal Polyp Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th, 7th, and 8th eds.) C6035 Neoplastic Process Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8 Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8 C0862752 CTRP Malignant Stage_0_Nasopharyngeal_Undifferentiated_Carcinoma Nasopharyngeal Undifferentiated Carcinoma Stage O Stage 0 Lymphoepithelioma of Nasopharynx Stage 0 Lymphoepithelioma of the Nasopharynx Stage 0 Nasopharyngeal Lymphoepithelioma Stage 0 Nasopharyngeal Undifferentiated Carcinoma Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6 Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8 Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v7 Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v8 Stage 0 Nasopharynx Lymphoepithelioma Stage 0 Undifferentiated Nasopharyngeal Throat Cancer Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th, 7th, and 8th eds.) C6036 Neoplastic Process Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8 Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8 CL448329 CTRP Malignant Stage_0_Nasopharyngeal_Squamous_Cell_Carcinoma Keratinizing Epidermoid Carcinoma in situ of Nasopharynx Keratinizing Epidermoid Carcinoma in situ of the Nasopharynx Keratinizing Squamous Cell Carcinoma in situ of Nasopharynx Keratinizing Squamous Cell Carcinoma in situ of the Nasopharynx Nasopharyngeal Keratinizing Epidermoid Carcinoma in situ Nasopharyngeal Keratinizing Squamous Cell Carcinoma in situ Nasopharynx Keratinizing Epidermoid Carcinoma in situ Nasopharynx Keratinizing Squamous Cell Carcinoma in situ Stage 0 Keratinizing Epidermoid Carcinoma of Nasopharynx Stage 0 Keratinizing Epidermoid Carcinoma of the Nasopharynx Stage 0 Keratinizing Squamous Cell Carcinoma of Nasopharynx Stage 0 Keratinizing Squamous Cell Carcinoma of the Nasopharynx Stage 0 Nasopharyngeal Keratinizing Epidermoid Carcinoma Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6 Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8 Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v8 Stage 0 Nasopharyngeal Throat Keratinizing Squamous Cell Cancer Stage 0 Nasopharynx Keratinizing Epidermoid Carcinoma Stage 0 Nasopharynx Keratinizing Squamous Cell Carcinoma Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8 A benign exophytic neoplasm that arises from the nasopharynx. It is characterized by the presence of a connective tissue core covered by stratified squamous epithelium. C6037 Neoplastic Process Nasopharyngeal Squamous Papilloma C1336085 Benign Squamous_Papilloma_of_the_Nasopharynx Nasopharyngeal Papilloma Nasopharyngeal Squamous Cell Papilloma Nasopharyngeal Squamous Papilloma Nasopharynx Papilloma Papilloma of Nasopharynx Papilloma of the Nasopharynx Squamous Papilloma of Nasopharynx Squamous Papilloma of the Nasopharynx Nasopharyngeal Squamous Papilloma A benign exophytic neoplasm that arises from the oropharynx. It is characterized by the presence of a connective tissue core covered by stratified squamous epithelium. C6038 Neoplastic Process Oropharyngeal Squamous Papilloma C1335141 Benign Oropharyngeal_Squamous_Papilloma Oropharyngeal Papilloma Oropharyngeal Squamous Cell Papilloma Oropharyngeal Squamous Papilloma Oropharynx Papilloma Papilloma of Oropharynx Papilloma of the Oropharynx Squamous Papilloma of Oropharynx Squamous Papilloma of the Oropharynx Oropharyngeal Squamous Papilloma Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6039 Neoplastic Process Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7 C0861725 CTRP Malignant Stage_0_Oropharyngeal_Squamous_Cell_Carcinoma Epidermoid Carcinoma in situ of Oropharynx Epidermoid Carcinoma in situ of the Oropharynx Oropharyngeal Epidermoid Carcinoma in situ Oropharyngeal Squamous Cell Carcinoma in situ Oropharynx Epidermoid Carcinoma in situ Oropharynx Squamous Cell Carcinoma in situ Squamous Cell Carcinoma in situ of Oropharynx Squamous Cell Carcinoma in situ of the Oropharynx Stage 0 Epidermoid Carcinoma of Oropharynx Stage 0 Epidermoid Carcinoma of the Oropharynx Stage 0 Oropharyngeal Epidermoid Carcinoma Stage 0 Oropharyngeal Squamous Cell Carcinoma Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage 0 Oropharyngeal Throat Squamous Cell Cancer Stage 0 Oropharynx Epidermoid Carcinoma Stage 0 Oropharynx Squamous Cell Carcinoma Stage 0 Squamous Cell Carcinoma of Oropharynx Stage 0 Squamous Cell Carcinoma of the Oropharynx Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7 A follicular-derived thyroid gland carcinoma that is histologically poorly differentiated and has high-grade features. C6040 Neoplastic Process Poorly Differentiated Thyroid Gland Carcinoma Poorly Differentiated Thyroid Gland Carcinoma C1266050 CTRP Cellosaurus GDC 8337/3 Malignant Poorly_Differentiated_Thyroid_Carcinoma 8337/3 Insular carcinoma Poorly differentiated thyroid carcinoma Insular Carcinoma Insular carcinoma PDTC Poorly Differentiated Carcinoma of Thyroid Gland Poorly Differentiated Carcinoma of the Thyroid Gland Poorly Differentiated Thyroid Carcinoma Poorly Differentiated Thyroid Gland Cancer Poorly Differentiated Thyroid Gland Carcinoma Thyroid Gland Poorly Differentiated Carcinoma Poorly Differentiated Thyroid Gland Carcinoma A malignant mesenchymal neoplasm primarily involving the thyroid gland. C6041 Neoplastic Process Thyroid Gland Sarcoma C1336756 Cellosaurus NICHD A malignant mesenchymal neoplasm primarily involving the thyroid gland. Malignant Thyroid_Sarcoma Sarcoma of Thyroid Sarcoma of Thyroid Gland Sarcoma of the Thyroid Sarcoma of the Thyroid Gland Thyroid Gland Sarcoma Thyroid Sarcoma Thyroid Gland Sarcoma A thyroid gland adenoma composed of large cells with abundant granular eosinophilic cytoplasm and large nuclei with prominent nucleoli. C6042 Neoplastic Process Thyroid Gland Oncocytic Adenoma C1336750 GDC Benign Thyroid_Hurthle_Cell_Adenoma 8290/0 Hurthle cell adenoma Benign Oncocytoma of Thyroid Benign Oncocytoma of Thyroid Gland Benign Oncocytoma of the Thyroid Benign Oncocytoma of the Thyroid Gland Benign Thyroid Gland Oncocytoma Benign Thyroid Oncocytoma Follicular Adenoma of Thyroid Gland of Oxyphilic Cell Type Follicular Adenoma of Thyroid of Oxyphilic Cell Type Follicular Adenoma of the Thyroid Gland of the Oxyphilic Cell Type Follicular Adenoma of the Thyroid of the Oxyphilic Cell Type Hurthle Cell Adenoma Hurthle Cell Adenoma of Thyroid Hurthle Cell Adenoma of Thyroid Gland Hurthle Cell Adenoma of the Thyroid Hurthle Cell Adenoma of the Thyroid Gland Hurthle cell adenoma Oncocytic Adenoma of Thyroid Oncocytic Adenoma of Thyroid Gland Oncocytic Adenoma of the Thyroid Oncocytic Adenoma of the Thyroid Gland Thyroid Follicular Adenoma of Oxyphilic Cell Type Thyroid Follicular Adenoma of the Oxyphilic Cell Type Thyroid Gland Follicular Adenoma of Oxyphilic Cell Type Thyroid Gland Follicular Adenoma of the Oxyphilic Cell Type Thyroid Gland Hurthle Cell Adenoma Thyroid Gland Oncocytic Adenoma Thyroid Hurthle Cell Adenoma Thyroid Oncocytic Adenoma Thyroid Gland Oncocytic Adenoma A usually aggressive malignant vascular tumor primarily involving the thyroid gland. It is often associated with longstanding nodular goiter. C6043 Neoplastic Process Thyroid Gland Angiosarcoma C1336748 CDISC A malignant neoplasm located at the junction of the right atrium and the vena cava originating from mesothelial-like cells which form tubular and alveolar structures in a fibrous stroma. Malignant Thyroid_Angiosarcoma Angiosarcoma of Thyroid Angiosarcoma of Thyroid Gland Angiosarcoma of the Thyroid Angiosarcoma of the Thyroid Gland Hemangiosarcoma of Thyroid Hemangiosarcoma of Thyroid Gland Hemangiosarcoma of the Thyroid Hemangiosarcoma of the Thyroid Gland MESOTHELIOMA, ATRIOCAVAL, MALIGNANT Thyroid Angiosarcoma Thyroid Gland Angiosarcoma Thyroid Gland Hemangiosarcoma Thyroid Gland Malignant Hemangioendothelioma Thyroid Hemangiosarcoma Thyroid Gland Angiosarcoma A non-Hodgkin lymphoma primarily involving the thyroid gland. The vast majority of cases are either diffuse large B-cell lymphomas or extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue. Hashimoto (chronic lymphocytic) thyroiditis is almost always present. C6044 Neoplastic Process Thyroid Gland Non-Hodgkin Lymphoma C1336755 Malignant Thyroid_Non-Hodgkin_s_Lymphoma Non-Hodgkin's Lymphoma of Thyroid Non-Hodgkin's Lymphoma of Thyroid Gland Non-Hodgkin's Lymphoma of the Thyroid Non-Hodgkin's Lymphoma of the Thyroid Gland Primary Thyroid Gland Non-Hodgkin's Lymphoma Thyroid Gland Non-Hodgkin Lymphoma Thyroid Gland Non-Hodgkin's Lymphoma Thyroid Non-Hodgkin Lymphoma Thyroid Non-Hodgkin's Lymphoma Thyroid Gland Non-Hodgkin Lymphoma A diffuse large B-cell lymphoma primarily involving the thyroid gland. C6046 Neoplastic Process Thyroid Gland Diffuse Large B-Cell Lymphoma C1336749 Malignant Thyroid_Diffuse_Large_B-Cell_Lymphoma Diffuse Large B-Cell Lymphoma of Thyroid Diffuse Large B-Cell Lymphoma of Thyroid Gland Diffuse Large B-Cell Lymphoma of the Thyroid Diffuse Large B-Cell Lymphoma of the Thyroid Gland Primary Thyroid Gland Diffuse Large B-Cell Lymphoma Thyroid Diffuse Large B-Cell Lymphoma Thyroid Gland Diffuse Large B-Cell Lymphoma Thyroid Gland Diffuse Large B-Cell Lymphoma Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th, 7th, and 8th eds.) C6048 Neoplastic Process Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8 Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8 C0862651 CTRP Malignant Stage_0_Hypopharyngeal_Squamous_Cell_Carcinoma Epidermoid Carcinoma in situ of Hypopharynx Epidermoid Carcinoma in situ of the Hypopharynx Hypopharyngeal Epidermoid Carcinoma in situ Hypopharyngeal Squamous Cell Carcinoma in situ Hypopharynx Epidermoid Carcinoma in situ Hypopharynx Squamous Cell Carcinoma in situ Squamous Cell Carcinoma in situ of Hypopharynx Squamous Cell Carcinoma in situ of the Hypopharynx Stage 0 Epidermoid Carcinoma of Hypopharynx Stage 0 Epidermoid Carcinoma of the Hypopharynx Stage 0 Hypopharyngeal Epidermoid Carcinoma Stage 0 Hypopharyngeal Squamous Cell Carcinoma Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6 Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8 Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v8 Stage 0 Hypopharyngeal Throat Squamous Cell Cancer Stage 0 Hypopharynx Epidermoid Carcinoma Stage 0 Hypopharynx Squamous Cell Carcinoma Stage 0 Squamous Cell Carcinoma of Hypopharynx Stage 0 Squamous Cell Carcinoma of the Hypopharynx Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8 A benign smooth muscle neoplasm arising from the trachea. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C6049 Neoplastic Process Tracheal Leiomyoma C1336772 Benign Tracheal_Leiomyoma Leiomyoma of Trachea Leiomyoma of the Trachea Trachea Leiomyoma Tracheal Leiomyoma Tracheal Leiomyoma A rare malignant soft tissue neoplasm that arises from the trachea. C6050 Neoplastic Process Tracheal Sarcoma C1336774 Malignant Tracheal_Sarcoma Sarcoma of Trachea Sarcoma of the Trachea Trachea Sarcoma Tracheal Sarcoma Tracheal Sarcoma An adenoid cystic carcinoma that arises from the trachea. It spreads to the submucosal tracheal tissue and to regional lymph nodes. C6051 Neoplastic Process Tracheal Adenoid Cystic Carcinoma C0345945 Malignant Tracheal_Adenoid_Cystic_Carcinoma Adenoid Cystic Carcinoma of Trachea Adenoid Cystic Carcinoma of the Trachea Trachea Adenoid Cystic Carcinoma Tracheal Adenoid Cystic Carcinoma Tracheal Adenoid Cystic Carcinoma Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6052 Neoplastic Process Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 C0861571 CTRP Malignant Stage_0_Oral_Cavity_Squamous_Cell_Carcinoma Epidermoid Carcinoma in situ of Mouth Epidermoid Carcinoma in situ of Oral Cavity Epidermoid Carcinoma in situ of the Mouth Epidermoid Carcinoma in situ of the Oral Cavity Mouth Epidermoid Carcinoma in situ Mouth Squamous Cell Carcinoma in situ Oral Cavity Epidermoid Carcinoma in situ Oral Cavity Squamous Cell Carcinoma in situ Squamous Cell Carcinoma in situ of Mouth Squamous Cell Carcinoma in situ of Oral Cavity Squamous Cell Carcinoma in situ of the Mouth Squamous Cell Carcinoma in situ of the Oral Cavity Stage 0 Epidermoid Carcinoma of Mouth Stage 0 Epidermoid Carcinoma of Oral Cavity Stage 0 Epidermoid Carcinoma of the Mouth Stage 0 Epidermoid Carcinoma of the Oral Cavity Stage 0 Mouth Epidermoid Carcinoma Stage 0 Oral Cavity Epidermoid Carcinoma Stage 0 Oral Cavity Squamous Cell Cancer Stage 0 Oral Cavity Squamous Cell Carcinoma Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v7 Stage 0 Squamous Cell Carcinoma of Mouth Stage 0 Squamous Cell Carcinoma of Oral Cavity Stage 0 Squamous Cell Carcinoma of the Mouth Stage 0 Squamous Cell Carcinoma of the Oral Cavity Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage I includes: T1, N0, M0. T1: Tumor 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6053 Neoplastic Process Stage I Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage I Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 C0861585 CTRP Malignant Stage_I_Oral_Cavity_Squamous_Cell_Carcinoma Stage I Epidermoid Carcinoma of Mouth Stage I Epidermoid Carcinoma of Oral Cavity Stage I Epidermoid Carcinoma of the Mouth Stage I Epidermoid Carcinoma of the Oral Cavity Stage I Mouth Epidermoid Carcinoma Stage I Mouth Squamous Cell Carcinoma Stage I Oral Cavity Epidermoid Carcinoma Stage I Oral Cavity Squamous Cell Cancer Stage I Oral Cavity Squamous Cell Carcinoma Stage I Oral Cavity Squamous Cell Carcinoma AJCC v6 Stage I Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage I Oral Cavity Squamous Cell Carcinoma AJCC v7 Stage I Squamous Cell Carcinoma of Mouth Stage I Squamous Cell Carcinoma of Oral Cavity Stage I Squamous Cell Carcinoma of the Mouth Stage I Squamous Cell Carcinoma of the Oral Cavity Stage I Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6054 Neoplastic Process Stage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 C0861598 CTRP Malignant Stage_II_Oral_Cavity_Squamous_Cell_Carcinoma Stage II Epidermoid Carcinoma of Mouth Stage II Epidermoid Carcinoma of Oral Cavity Stage II Epidermoid Carcinoma of the Mouth Stage II Epidermoid Carcinoma of the Oral Cavity Stage II Mouth Epidermoid Carcinoma Stage II Mouth Squamous Cell Carcinoma Stage II Oral Cavity Epidermoid Carcinoma Stage II Oral Cavity Squamous Cell Cancer Stage II Oral Cavity Squamous Cell Carcinoma Stage II Oral Cavity Squamous Cell Carcinoma AJCC v6 Stage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage II Oral Cavity Squamous Cell Carcinoma AJCC v7 Stage II Squamous Cell Carcinoma of Mouth Stage II Squamous Cell Carcinoma of Oral Cavity Stage II Squamous Cell Carcinoma of the Mouth Stage II Squamous Cell Carcinoma of the Oral Cavity Stage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor more than 4 cm in greatest dimension. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6055 Neoplastic Process Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 C0861611 CTRP Malignant Stage_III_Oral_Cavity_Squamous_Cell_Carcinoma Stage III Epidermoid Carcinoma of Mouth Stage III Epidermoid Carcinoma of Oral Cavity Stage III Epidermoid Carcinoma of the Mouth Stage III Epidermoid Carcinoma of the Oral Cavity Stage III Mouth Epidermoid Carcinoma Stage III Mouth Squamous Cell Carcinoma Stage III Oral Cavity Epidermoid Carcinoma Stage III Oral Cavity Squamous Cell Cancer Stage III Oral Cavity Squamous Cell Carcinoma Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage III Oral Cavity Squamous Cell Carcinoma AJCC v7 Stage III Squamous Cell Carcinoma of Mouth Stage III Squamous Cell Carcinoma of Oral Cavity Stage III Squamous Cell Carcinoma of the Mouth Stage III Squamous Cell Carcinoma of the Oral Cavity Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IV includes: IVA (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0);. IVB (Any T, N3, M0); (T4b, Any N, M0); IVC (Any T, Any N, M1). T4a: (oral cavity) Tumor invades adjacent structures (e.g., through cortical bone, into deep [extrinsic] muscles of tongue, maxillary sinus, skin of face). T4b: Tumor invades masticator space, pterygoid plates, or skull base and/or encases internal carotid artery. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension; or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension; or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N2a: Metastasis in a single ipsilateral lymph node more than 3 cm but not more than 6 cm in dimension. N2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension. N2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a lymph node more than 6 cm in greatest dimension. M1: Distant metastasis. (AJCC 6th and 7th eds.) C6056 Neoplastic Process Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 C0861624 CTRP Malignant Stage_IV_Oral_Cavity_Squamous_Cell_Carcinoma Stage IV Epidermoid Carcinoma of Mouth Stage IV Epidermoid Carcinoma of Oral Cavity Stage IV Epidermoid Carcinoma of the Mouth Stage IV Epidermoid Carcinoma of the Oral Cavity Stage IV Mouth Epidermoid Carcinoma Stage IV Mouth Squamous Cell Carcinoma Stage IV Oral Cavity Epidermoid Carcinoma Stage IV Oral Cavity Squamous Cell Cancer Stage IV Oral Cavity Squamous Cell Carcinoma Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v7 Stage IV Squamous Cell Carcinoma of Mouth Stage IV Squamous Cell Carcinoma of Oral Cavity Stage IV Squamous Cell Carcinoma of the Mouth Stage IV Squamous Cell Carcinoma of the Oral Cavity Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a: Oral cavity cancer with moderately advanced local disease. Tumor invades adjacent structures only (e.g., through cortical bone [mandible or maxilla] into deep [extrinsic] muscle of tongue [genioglossus, hyoglossus, palatoglossus, and styloglossus], maxillary sinus, skin of face). T1: Tumor 2 cm or less in greatest dimension. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3: Tumor more than 4 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension; or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension; or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C6057 Neoplastic Process Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 C1336353 CTRP Malignant Stage_IVA_Oral_Cavity_Squamous_Cell_Carcinoma Stage IVA Epidermoid Carcinoma of Mouth Stage IVA Epidermoid Carcinoma of Oral Cavity Stage IVA Epidermoid Carcinoma of the Mouth Stage IVA Epidermoid Carcinoma of the Oral Cavity Stage IVA Mouth Epidermoid Carcinoma Stage IVA Mouth Squamous Cell Carcinoma Stage IVA Oral Cavity Epidermoid Carcinoma Stage IVA Oral Cavity Squamous Cell Cancer Stage IVA Oral Cavity Squamous Cell Carcinoma Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v7 Stage IVA Squamous Cell Carcinoma of Mouth Stage IVA Squamous Cell Carcinoma of Oral Cavity Stage IVA Squamous Cell Carcinoma of the Mouth Stage IVA Squamous Cell Carcinoma of the Oral Cavity Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVB includes: (Any T, N3, M0); (T4b, Any N, M0). T4b: Oral cavity cancer with very advanced local disease. Tumor invades masticator space, pterygoid plates, or skull base and/or encases internal carotid artery. N3: Metastasis in a lymph node more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C6058 Neoplastic Process Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 C1336384 CTRP Malignant Stage_IVB_Oral_Cavity_Squamous_Cell_Carcinoma Stage IVB Epidermoid Carcinoma of Mouth Stage IVB Epidermoid Carcinoma of Oral Cavity Stage IVB Epidermoid Carcinoma of the Mouth Stage IVB Epidermoid Carcinoma of the Oral Cavity Stage IVB Mouth Epidermoid Carcinoma Stage IVB Mouth Squamous Cell Carcinoma Stage IVB Oral Cavity Epidermoid Carcinoma Stage IVB Oral Cavity Squamous Cell Cancer Stage IVB Oral Cavity Squamous Cell Carcinoma Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v7 Stage IVB Squamous Cell Carcinoma of Mouth Stage IVB Squamous Cell Carcinoma of Oral Cavity Stage IVB Squamous Cell Carcinoma of the Mouth Stage IVB Squamous Cell Carcinoma of the Oral Cavity Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C6059 Neoplastic Process Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 C1336404 CTRP Malignant Stage_IVC_Oral_Cavity_Squamous_Cell_Carcinoma Stage IVC Epidermoid Carcinoma of Mouth Stage IVC Epidermoid Carcinoma of Oral Cavity Stage IVC Epidermoid Carcinoma of the Mouth Stage IVC Epidermoid Carcinoma of the Oral Cavity Stage IVC Mouth Epidermoid Carcinoma Stage IVC Mouth Squamous Cell Carcinoma Stage IVC Oral Cavity Epidermoid Carcinoma Stage IVC Oral Cavity Squamous Cell Cancer Stage IVC Oral Cavity Squamous Cell Carcinoma Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v7 Stage IVC Squamous Cell Carcinoma of Mouth Stage IVC Squamous Cell Carcinoma of Oral Cavity Stage IVC Squamous Cell Carcinoma of the Mouth Stage IVC Squamous Cell Carcinoma of the Oral Cavity Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Reemergence of squamous cell carcinoma of the oral cavity after a period of remission. C6060 Neoplastic Process Recurrent Oral Cavity Squamous Cell Carcinoma C0861556 Malignant Recurrent_Oral_Cavity_Squamous_Cell_Carcinoma Recurrent Epidermoid Carcinoma of Mouth Recurrent Epidermoid Carcinoma of Oral Cavity Recurrent Epidermoid Carcinoma of the Mouth Recurrent Epidermoid Carcinoma of the Oral Cavity Recurrent Mouth Epidermoid Carcinoma Recurrent Mouth Squamous Cell Carcinoma Recurrent Oral Cavity Epidermoid Carcinoma Recurrent Oral Cavity Squamous Cell Carcinoma Recurrent Squamous Cell Carcinoma of Mouth Recurrent Squamous Cell Carcinoma of Oral Cavity Recurrent Squamous Cell Carcinoma of the Mouth Recurrent Squamous Cell Carcinoma of the Oral Cavity Relapsed Epidermoid Carcinoma of Mouth Relapsed Epidermoid Carcinoma of Oral Cavity Relapsed Epidermoid Carcinoma of the Mouth Relapsed Epidermoid Carcinoma of the Oral Cavity Relapsed Mouth Epidermoid Carcinoma Relapsed Mouth Squamous Cell Carcinoma Relapsed Oral Cavity Epidermoid Carcinoma Relapsed Oral Cavity Squamous Cell Carcinoma Relapsed Squamous Cell Carcinoma of Mouth Relapsed Squamous Cell Carcinoma of Oral Cavity Relapsed Squamous Cell Carcinoma of the Mouth Relapsed Squamous Cell Carcinoma of the Oral Cavity Recurrent Oral Cavity Squamous Cell Carcinoma A primary or metastatic malignant neoplasm that affects the anterior portion of the tongue. C6061 Neoplastic Process Malignant Anterior Tongue Neoplasm C1334559 CPTAC mCode Malignant Malignant_Anterior_Tongue_Neoplasm Malignant neoplasm of anterior two-thirds of tongue, part unspecified Malignant neoplasm: Anterior two-thirds of tongue, part unspecified Malignant Anterior Tongue Neoplasm Malignant Anterior Tongue Tumor Malignant Neoplasm of Anterior Tongue Malignant Neoplasm of the Anterior Tongue Malignant Tumor of Anterior Tongue Malignant Tumor of the Anterior Tongue Malignant neoplasm of anterior two-thirds of tongue, part unspecified Malignant Anterior Tongue Neoplasm A benign or malignant neoplasm that affects the anterior portion of the tongue. C6062 Neoplastic Process Anterior Tongue Neoplasm C1332306 Undetermined Anterior_Tongue_Neoplasm Anterior Tongue Neoplasm Anterior Tongue Tumor Neoplasm of Anterior Tongue Neoplasm of the Anterior Tongue Tumor of Anterior Tongue Tumor of the Anterior Tongue Anterior Tongue Neoplasm A neoplasm that arises from the anterior portion of tongue and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C6063 Neoplastic Process Benign Anterior Tongue Neoplasm C1332472 Benign Benign_Anterior_Tongue_Neoplasm Benign Anterior Tongue Neoplasm Benign Anterior Tongue Tumor Benign Neoplasm of Anterior Tongue Benign Neoplasm of the Anterior Tongue Benign Tumor of Anterior Tongue Benign Tumor of the Anterior Tongue Benign Anterior Tongue Neoplasm An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the rectum. It is characterized by the presence of malignant small cells. C60639 Neoplastic Process Rectal Small Cell Neuroendocrine Carcinoma Rectal Small Cell Neuroendocrine Carcinoma C1882916 CTRP Cellosaurus Malignant Rectal_Small_Cell_Carcinoma Rectal Small Cell Carcinoma Rectal Small Cell Neuroendocrine Cancer Rectal Small Cell Neuroendocrine Carcinoma Rectal Small Cell Neuroendocrine Carcinoma A squamous cell carcinoma that arises from the mucosal epithelial surface of the maxillary sinus. Patients may present with nasal fullness, obstruction, and/or epistaxis. C6064 Neoplastic Process Maxillary Sinus Squamous Cell Carcinoma C1334647 Cellosaurus Malignant Maxillary_Sinus_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Maxillary Sinus Epidermoid Carcinoma of the Maxillary Sinus Maxillary Sinus Epidermoid Carcinoma Maxillary Sinus Squamous Cell Carcinoma Squamous Cell Carcinoma of Maxillary Sinus Squamous Cell Carcinoma of the Maxillary Sinus Maxillary Sinus Squamous Cell Carcinoma A rare, invasive rectal adenocarcinoma characterized by the presence of sheets of malignant epithelial cells with vesicular nuclei, prominent nucleoli, and abundant eosinophilic cytoplasm. It usually has a favorable prognosis. C60640 Neoplastic Process Rectal Medullary Carcinoma C1882915 Malignant Rectal_Medullary_Carcinoma Rectal Medullary Carcinoma Rectal Medullary Carcinoma A rare, invasive colon adenocarcinoma characterized by the presence of sheets of malignant epithelial cells with vesicular nuclei, prominent nucleoli, and abundant eosinophilic cytoplasm. It usually has a favorable prognosis. C60641 Neoplastic Process Colon Medullary Carcinoma C1880119 Malignant Colon_Medullary_Carcinoma Colon Medullary Carcinoma Colon Medullary Carcinoma A squamous cell carcinoma that arises from the mucosal epithelial surface of the ethmoid sinus. Patients may present with nasal fullness, obstruction, and/or epistaxis. C6065 Neoplastic Process Ethmoid Sinus Squamous Cell Carcinoma C1333477 Malignant Ethmoid_Sinus_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Ethmoid Sinus Epidermoid Carcinoma of Ethmoidal Sinus Epidermoid Carcinoma of the Ethmoid Sinus Epidermoid Carcinoma of the Ethmoidal Sinus Ethmoid Sinus Epidermoid Carcinoma Ethmoid Sinus Squamous Cell Carcinoma Ethmoidal Sinus Epidermoid Carcinoma Ethmoidal Sinus Squamous Cell Carcinoma Squamous Cell Carcinoma of Ethmoid Sinus Squamous Cell Carcinoma of Ethmoidal Sinus Squamous Cell Carcinoma of the Ethmoid Sinus Squamous Cell Carcinoma of the Ethmoidal Sinus Ethmoid Sinus Squamous Cell Carcinoma A squamous cell carcinoma that arises from the mucosal epithelial surface of the sphenoid sinus. Patients may present with nasal fullness, obstruction, and/or epistaxis. C6066 Neoplastic Process Sphenoid Sinus Squamous Cell Carcinoma C1336039 Malignant Sphenoid_Sinus_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Sphenoid Sinus Epidermoid Carcinoma of Sphenoidal Sinus Epidermoid Carcinoma of the Sphenoid Sinus Epidermoid Carcinoma of the Sphenoidal Sinus Sphenoid Sinus Epidermoid Carcinoma Sphenoid Sinus Squamous Cell Carcinoma Sphenoidal Sinus Epidermoid Carcinoma Sphenoidal Sinus Squamous Cell Carcinoma Squamous Cell Carcinoma of Sphenoid Sinus Squamous Cell Carcinoma of Sphenoidal Sinus Squamous Cell Carcinoma of the Sphenoid Sinus Squamous Cell Carcinoma of the Sphenoidal Sinus Sphenoid Sinus Squamous Cell Carcinoma A squamous cell carcinoma that arises from the mucosal epithelial surface of the frontal sinus. Patients may present with nasal fullness, obstruction, and/or epistaxis. C6067 Neoplastic Process Frontal Sinus Squamous Cell Carcinoma C1333646 Malignant Frontal_Sinus_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Frontal Sinus Epidermoid Carcinoma of the Frontal Sinus Frontal Sinus Epidermoid Carcinoma Frontal Sinus Squamous Cell Carcinoma Squamous Cell Carcinoma of Frontal Sinus Squamous Cell Carcinoma of the Frontal Sinus Frontal Sinus Squamous Cell Carcinoma A lymphoma that arises from the paranasal sinus. Representative examples include diffuse large B-cell lymphoma and extranodal NK/T-cell lymphoma, nasal type. C6068 Neoplastic Process Paranasal Sinus Lymphoma C1335339 Malignant Paranasal_Sinus_Lymphoma Accessory Sinus Lymphoma Lymphoma of Accessory Sinus Lymphoma of Paranasal Sinus Lymphoma of the Accessory Sinus Lymphoma of the Paranasal Sinus Paranasal Sinus Lymphoma Primary Paranasal Sinus Lymphoma Paranasal Sinus Lymphoma A non-Hodgkin lymphoma that arises from the paranasal sinus. Representative examples include diffuse large B-cell lymphoma and extranodal NK/T-cell lymphoma, nasal type. C6069 Neoplastic Process Paranasal Sinus Non-Hodgkin Lymphoma C1335341 Malignant Paranasal_Sinus_Non-Hodgkin_s_Lymphoma Accessory Sinus Non-Hodgkin's Lymphoma Non-Hodgkin's Lymphoma of Accessory Sinus Non-Hodgkin's Lymphoma of Paranasal Sinus Non-Hodgkin's Lymphoma of the Accessory Sinus Non-Hodgkin's Lymphoma of the Paranasal Sinus Paranasal Sinus Non-Hodgkin Lymphoma Paranasal Sinus Non-Hodgkin's Lymphoma Primary Paranasal Sinus Non-Hodgkin's Lymphoma Paranasal Sinus Non-Hodgkin Lymphoma Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); T4a: Maxillary sinus: Moderately advanced local disease. Tumor invades anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid or frontal sinuses. Ethmoid sinus: Moderately advanced local disease. Tumor invades any of the following: anterior orbital contents, skin of nose or cheek, minimal extension to anterior cranial fossa, pterygoid plates, sphenoid or frontal sinuses. T1: Maxillary sinus: Tumor limited to the maxillary sinus mucosa with no erosion or destruction of bone. Ethmoid sinus: Tumor restricted to any one subsite, with or without bony invasion. T2: Maxillary sinus: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates. Ethmoid sinus: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion. T3: Maxillary sinus: Tumor invading any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, or ethmoid sinuses. Ethmoid sinus: Tumor invading the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C6070 Neoplastic Process Stage IVA Paranasal Sinus Cancer AJCC v7 Stage IVA Paranasal Sinus Cancer AJCC v7 C1336358 CTRP Malignant Stage_IVA_Paranasal_Sinus_Cancer Paranasal Sinus Cancer Stage IVA Stage IVA Accessory Sinus Carcinoma Stage IVA Carcinoma of Accessory Sinus Stage IVA Carcinoma of Paranasal Sinus Stage IVA Carcinoma of the Accessory Sinus Stage IVA Carcinoma of the Paranasal Sinus Stage IVA Paranasal Sinus Cancer Stage IVA Paranasal Sinus Cancer AJCC v7 Stage IVA Paranasal Sinus Carcinoma Stage IVA Paranasal Sinus Cancer AJCC v7 A neoplasm with neuroendocrine differentiation that arises from the appendix. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms). C60709 Neoplastic Process Appendix Neuroendocrine Neoplasm C1879718 Undetermined Appendix_Neuroendocrine_Neoplasm Appendix Neuroendocrine Neoplasm Appendix Neuroendocrine Neoplasm Stage IVB includes: (T4b, Any N, M0); (Any T, N3, M0). T4b: Very advanced local disease. Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve, nasopharynx, or clivus. N3: Metastasis in a lymph node, more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C6071 Neoplastic Process Stage IVB Paranasal Sinus Cancer AJCC v7 Stage IVB Paranasal Sinus Cancer AJCC v7 C1336389 CTRP Malignant Stage_IVB_Paranasal_Sinus_Cancer Stage IVB Accessory Sinus Carcinoma Stage IVB Carcinoma of Accessory Sinus Stage IVB Carcinoma of Paranasal Sinus Stage IVB Carcinoma of the Accessory Sinus Stage IVB Carcinoma of the Paranasal Sinus Stage IVB Paranasal Sinus Cancer Stage IVB Paranasal Sinus Cancer AJCC v7 Stage IVB Paranasal Sinus Carcinoma Stage IVB Paranasal Sinus Cancer AJCC v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C6072 Neoplastic Process Stage IVC Paranasal Sinus Cancer AJCC v7 Stage IVC Paranasal Sinus Cancer AJCC v7 C1336408 CTRP Malignant Stage_IVC_Paranasal_Sinus_Cancer Paranasal Sinus Cancer Stage IVC Stage IVC Accessory Sinus Carcinoma Stage IVC Carcinoma of Accessory Sinus Stage IVC Carcinoma of Paranasal Sinus Stage IVC Carcinoma of the Accessory Sinus Stage IVC Carcinoma of the Paranasal Sinus Stage IVC Paranasal Sinus Cancer Stage IVC Paranasal Sinus Cancer AJCC v7 Stage IVC Paranasal Sinus Carcinoma Stage IVC Paranasal Sinus Cancer AJCC v7 A non-Hodgkin lymphoma that arises from the paranasal sinus and is characterized by the presence of a diffuse malignant infiltrate composed of large B-lymphocytes. C6073 Neoplastic Process Paranasal Sinus Diffuse Large B-Cell Lymphoma Paranasal Sinus Diffuse Large B-Cell Lymphoma C1335338 CTRP Malignant Paranasal_Sinus_Diffuse_Large_B-Cell_Lymphoma Accessory Sinus Diffuse Large B-Cell Lymphoma Diffuse Large B-Cell Lymphoma of Accessory Sinus Diffuse Large B-Cell Lymphoma of Paranasal Sinus Diffuse Large B-Cell Lymphoma of the Accessory Sinus Diffuse Large B-Cell Lymphoma of the Paranasal Sinus Paranasal Sinus Diffuse Large B-Cell Lymphoma Primary Paranasal Sinus Diffuse Large B-Cell Lymphoma Paranasal Sinus Diffuse Large B-Cell Lymphoma A primary lymphoma that affects the nasal cavity and the bulk of the tumor is in this anatomic area. C6074 Neoplastic Process Nasal Cavity Lymphoma C1334921 Malignant Nasal_Cavity_Lymphoma Lymphoma of Nasal Cavity Lymphoma of the Nasal Cavity Nasal Cavity Lymphoma Primary Nasal Cavity Lymphoma Nasal Cavity Lymphoma A primary non-Hodgkin lymphoma that affects the nasal cavity and the bulk of the tumor is in this anatomic area. The majority of the cases are nasal type extranodal NK/T-cell lymphomas and diffuse large B-cell lymphomas. C6075 Neoplastic Process Nasal Cavity Non-Hodgkin Lymphoma C1334922 Malignant Nasal_Cavity_Non-Hodgkin_s_Lymphoma Nasal Cavity Non-Hodgkin Lymphoma Nasal Cavity Non-Hodgkin's Lymphoma Non-Hodgkin's Lymphoma of Nasal Cavity Non-Hodgkin's Lymphoma of the Nasal Cavity Nasal Cavity Non-Hodgkin Lymphoma The reemergence of carcinoma in the oral cavity after a period of remission. C6076 Neoplastic Process Recurrent Oral Cavity Carcinoma C1335718 Malignant Recurrent_Oral_Cavity_Carcinoma Recurrent Carcinoma of Mouth Recurrent Carcinoma of Oral Cavity Recurrent Carcinoma of the Mouth Recurrent Carcinoma of the Oral Cavity Recurrent Mouth Carcinoma Recurrent Oral Cavity Cancer Recurrent Oral Cavity Carcinoma Relapsed Carcinoma of Mouth Relapsed Carcinoma of Oral Cavity Relapsed Carcinoma of the Mouth Relapsed Carcinoma of the Oral Cavity Relapsed Mouth Carcinoma Relapsed Oral Cavity Cancer Relapsed Oral Cavity Carcinoma Recurrent Oral Cavity Carcinoma A carcinoma that arises from the anatomic structures of the neck region. C6077 Neoplastic Process Neck Carcinoma C1334927 Malignant Neck_Carcinoma Carcinoma of Neck Carcinoma of the Neck Neck Carcinoma Neck Carcinoma A carcinoma that arises from the eyelid. Examples include basal cell carcinoma and squamous cell carcinoma. C6078 Neoplastic Process Eyelid Carcinoma CL448333 Malignant Eyelid_Carcinoma Carcinoma of Eyelid Carcinoma of the Eyelid Eyelid Carcinoma Eyelid Carcinoma An astrocytoma that occurs in the brain. C60780 Neoplastic Process Brain Astrocytoma Brain Astrocytoma C3695127 CTRP Undetermined Brain_Astrocytoma Brain Astrocytoma Brain Astrocytoma A tumor of the brain or spinal cord showing astrocytic differentiation. It includes the following clinicopathological entities: pilocytic astrocytoma, diffuse astrocytoma, anaplastic astrocytoma, pleomorphic xanthoastrocytoma, and subependymal giant cell astrocytoma. C60781 Neoplastic Process Astrocytoma Astrocytoma C0004114 CPTAC CTRP Cellosaurus GDC MedDRA NICHD A malignant neoplasm of the central nervous system that arises from astrocytes. A tumor that begins in the brain or spinal cord in small, star-shaped cells called astrocytes. 9400/3 Undetermined Astrocytoma 9400/3 Astrocytoma Astrocytoma, NOS Astrocytoma Astrocytoma, NOS astrocytoma Astrocytoma A carcinoma that arises from any of the structures of the eye. C6079 Neoplastic Process Eye Carcinoma C0848866 CPTAC Malignant Eye_Carcinoma Carcinoma of Eye Carcinoma of the Eye Eye Carcinoma Ocular Carcinoma Eye Carcinoma Actinic keratosis that develops in the skin of the external ear. C6080 Neoplastic Process External Ear Actinic Keratosis C1333490 Precancerous External_Ear_Actinic_Keratosis Actinic Keratosis of External Ear Actinic Keratosis of the External Ear External Ear Actinic Keratosis External Ear Actinic Keratosis One third of the tube-like structure carrying bile that is closest to the intestine and furthest from the hepatic and cystic ducts. C60800 Anatomical Structure Distal 1/3 of the Common Bile Duct C1880362 Distal_1_3_of_the_Common_Bile_Duct Distal 1/3 of the Common Bile Duct Distal 1/3 of the Common Bile Duct The section of the tube-like structure carrying bile that is closest to the intestine and furthest from the hepatic and cystic ducts. C60801 Anatomical Structure Distal Common Bile Duct C1880363 CDISC The portion of the common bile duct that is closest to the intestine and furthest from the hepatic and cystic ducts. Distal_Common_Bile_Duct DISTAL COMMON BILE DUCT Distal Bile Duct Distal Common Bile Duct Distal Common Bile Duct A carcinoma that arises from the external ear. This category includes squamous cell carcinoma, basal cell carcinoma, and ceruminous adenocarcinoma. C6081 Neoplastic Process External Ear Carcinoma C1333492 Malignant External_Ear_Carcinoma Carcinoma of External Ear Carcinoma of the External Ear External Ear Carcinoma External Ear Carcinoma A basal cell carcinoma that arises from the skin of the external ear. C6082 Neoplastic Process External Ear Basal Cell Carcinoma External Ear Basal Cell Carcinoma C1333491 CPTAC CTRP Malignant External_Ear_Basal_Cell_Carcinoma Basal cell carcinoma of skin of ear and external auditory canal Basal Cell Carcinoma of External Ear Basal Cell Carcinoma of the External Ear External Ear Basal Cell Carcinoma External Ear Basal Cell Carcinoma A squamous cell carcinoma that arises from the external ear. C6083 Neoplastic Process External Ear Squamous Cell Carcinoma C1333494 CPTAC Cellosaurus Malignant External_Ear_Squamous_Cell_Carcinoma Squamous cell carcinoma of skin of ear and external auditory canal Epidermoid Carcinoma of External Ear Epidermoid Carcinoma of the External Ear External Ear Epidermoid Carcinoma External Ear Squamous Cell Carcinoma Squamous Cell Carcinoma of External Ear Squamous Cell Carcinoma of the External Ear External Ear Squamous Cell Carcinoma A jugulotympanic paraganglioma arising from paraganglia in the middle ear. C6085 Neoplastic Process Middle Ear Paraganglioma C1334761 Undetermined Middle_Ear_Paraganglioma Middle ear paraganglioma Middle Ear Paraganglioma Non-Chromaffin Middle Ear Paraganglioma Non-Chromaffin Paraganglioma of Middle Ear Non-Chromaffin Paraganglioma of the Middle Ear Paraganglioma of Middle Ear Paraganglioma of the Middle Ear Middle Ear Paraganglioma A rare squamous cell carcinoma that arises from the middle ear. C6086 Neoplastic Process Middle Ear Squamous Cell Carcinoma C1334762 Malignant Middle_Ear_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Middle Ear Epidermoid Carcinoma of the Middle Ear Middle Ear Epidermoid Carcinoma Middle Ear Squamous Cell Carcinoma Squamous Cell Carcinoma of Middle Ear Squamous Cell Carcinoma of the Middle Ear Middle Ear Squamous Cell Carcinoma A benign epithelial neoplasm derived from ceruminous glands in the external auditory canal. It presents as a grey mass covered by skin. It is characterized by a proliferation of glands composed of cells with abundant eosinophilic and granular cytoplasm. C6088 Neoplastic Process Ceruminous Adenoma C0334352 CDISC GDC A benign epithelial neoplasm derived from ceruminous glands in the external auditory canal. 8420/0 Benign External_Auditory_Canal_Ceruminous_Adenoma 8420/0 Ceruminous adenoma ADENOMA, CERUMINOUS GLAND, BENIGN Ceruminoma Ceruminous Adenoma Ceruminous Adenoma of External Auditory Canal Ceruminous Adenoma of the External Auditory Canal Ceruminous adenoma External Auditory Canal Ceruminous Adenoma Ceruminous Adenoma A carcinoma that arises from the middle ear. This category includes adenocarcinoma and squamous cell carcinoma. C6089 Neoplastic Process Middle Ear Carcinoma C1334760 Malignant Middle_Ear_Carcinoma Carcinoma of Middle Ear Carcinoma of the Middle Ear Middle Ear Carcinoma Middle Ear Carcinoma An extremely rare carcinoma that arises from the lacrimal gland. It is characterized by the presence of infiltrating nests of epidermoid cells and mucus producing cells. C6091 Neoplastic Process Lacrimal Gland Mucoepidermoid Carcinoma C1334359 Malignant Lacrimal_Gland_Mucoepidermoid_Carcinoma Lacrimal Gland Mucoepidermoid Carcinoma Mucoepidermoid Carcinoma of Lacrimal Gland Mucoepidermoid Carcinoma of the Lacrimal Gland Lacrimal Gland Mucoepidermoid Carcinoma A squamous cell carcinoma that arises from the lacrimal sac and/or canaliculi. it is exceedingly rare in the nasolacrimal duct. (WHO 2018) C6092 Neoplastic Process Lacrimal Drainage System Squamous Cell Carcinoma C1334360 Malignant Lacrimal_Gland_Squamous_Cell_Carcinoma Lacrimal Drainage System Squamous Cell Carcinoma Squamous Cell Carcinoma of the Lacrimal Drainage System Lacrimal Drainage System Squamous Cell Carcinoma A precancerous neoplastic intraepithelial process involving the corneal epithelium. C6093 Neoplastic Process Corneal Squamous Intraepithelial Neoplasia C1333159 Undetermined Corneal_Intraepithelial_Neoplasia Cornea Intraepithelial Neoplasia Corneal Intraepithelial Neoplasia Corneal Squamous Intraepithelial Neoplasia Intraepithelial Neoplasia of Cornea Intraepithelial Neoplasia of the Cornea Corneal Squamous Intraepithelial Neoplasia A precancerous neoplastic intraepithelial process with low-grade dysplastic features involving the corneal epithelium. C6094 Neoplastic Process Low Grade Corneal Squamous Intraepithelial Neoplasia C1334422 Undetermined Low_Grade_Corneal_Intraepithelial_Neoplasia Grade 1 Corneal Intraepithelial Neoplasia Grade I Corneal Intraepithelial Neoplasia Low Grade Corneal Intraepithelial Neoplasia Low Grade Corneal Squamous Intraepithelial Neoplasia Low Grade Corneal Squamous Intraepithelial Neoplasia A malignant soft tissue neoplasm that arises from the structures of the orbit. The majority of the cases are rhabdomyosarcomas. C6095 Neoplastic Process Orbit Sarcoma C1335131 Malignant Orbit_Sarcoma Orbit Sarcoma Orbital Sarcoma Sarcoma of Orbit Sarcoma of the Orbit Orbit Sarcoma A precancerous neoplastic intraepithelial process with low-grade dysplastic features involving the conjunctival epithelium. C6097 Neoplastic Process Low Grade Conjunctival Squamous Intraepithelial Neoplasia C1334421 Undetermined Low_Grade_Conjunctival_Intraepithelial_Neoplasia Grade 1 Conjunctival Intraepithelial Neoplasia Grade I Conjunctival Intraepithelial Neoplasia Low Grade Conjunctival Intraepithelial Neoplasia Low Grade Conjunctival Squamous Intraepithelial Neoplasia Low Grade Conjunctival Squamous Intraepithelial Neoplasia A melanoma that arises from the iris. It is characterized by the presence of spindle-shaped melanocytes. C6098 Neoplastic Process Iris Spindle Cell Melanoma C1334287 Malignant Iris_Spindle_Cell_Melanoma Iris Spindle Cell Melanoma Spindle Cell Melanoma of Iris Spindle Cell Melanoma of the Iris Iris Spindle Cell Melanoma A melanoma that arises from the choroid. It is characterized by the presence of spindle-shaped melanocytes. C6099 Neoplastic Process Choroid Spindle Cell Melanoma C1333027 Malignant Choroid_Spindle_Cell_Melanoma Choroid Spindle Cell Melanoma Spindle Cell Melanoma of Choroid Spindle Cell Melanoma of the Choroid Choroid Spindle Cell Melanoma Choroid melanoma characterized by the presence of intermediate cells which are similar to but smaller than epithelioid cells. C6100 Neoplastic Process Choroid Intermediate Cell Type Melanoma C1334208 Malignant Intermediate_Cell_Type_Choroid_Melanoma Choroid Intermediate Cell Type Melanoma Intermediate Cell Type Choroid Melanoma Choroid Intermediate Cell Type Melanoma Iris melanoma characterized by the presence of intermediate cells which are similar to but smaller than epithelioid cells. C6101 Neoplastic Process Iris Intermediate Cell Type Melanoma C1334210 Malignant Intermediate_Cell_Type_Iris_Melanoma Intermediate Cell Type Iris Melanoma Iris Intermediate Cell Type Melanoma Iris Intermediate Cell Type Melanoma A choroid melanoma characterized by the presence of malignant large epithelioid melanocytes. C6102 Neoplastic Process Choroid Epithelioid Cell Melanoma C1333024 Malignant Choroid_Epithelioid_Cell_Melanoma Choroid Epithelioid Cell Melanoma Choroidal Epithelioid Cell Melanoma Epithelioid Cell Melanoma of Choroid Epithelioid Cell Melanoma of the Choroid Choroid Epithelioid Cell Melanoma A malignant neoplasm that has spread to the iris from another anatomic site. C6103 Neoplastic Process Metastatic Malignant Neoplasm in the Iris C1334728 Malignant Metastatic_Neoplasm_to_the_Iris Metastatic Malignant Neoplasm in the Iris Metastatic Malignant Neoplasm to the Iris Metastatic Neoplasm to the Iris Metastatic Tumor to the Iris Metastatic Malignant Neoplasm in the Iris A neoplasm that arises from the uvea and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.. C6104 Neoplastic Process Benign Uveal Neoplasm C0686467 Benign Benign_Uveal_Neoplasm Benign Neoplasm of Uvea Benign Neoplasm of the Uvea Benign Tumor of Uvea Benign Tumor of the Uvea Benign Uvea Neoplasm Benign Uvea Tumor Benign Uveal Neoplasm Benign Uveal Tract Neoplasm Benign Uveal Tumor Benign Uveal Neoplasm A primary or metastatic malignant neoplasm that affects the choroid, ciliary body, or iris. C6105 Neoplastic Process Malignant Uveal Neoplasm C0686470 Malignant Malignant_Uveal_Neoplasm Malignant Neoplasm of Uvea Malignant Neoplasm of the Uvea Malignant Tumor of Uvea Malignant Tumor of the Uvea Malignant Uvea Neoplasm Malignant Uvea Tumor Malignant Uveal Neoplasm Malignant Uveal Tract Neoplasm Malignant Uveal Tumor Malignant Uveal Neoplasm C61053 Finding Tobacco Toxicity C1883353 Tobacco_Toxicity Tobacco Toxicity Tobacco Toxicity C61054 Finding Cigarette Smoking Toxicity C1880083 Cigarette_Smoking_Toxicity Cigarette Smoking Toxicity Cigarette Smoking Toxicity C61055 Finding Tobacco Chewing Toxicity C1883352 Tobacco_Chewing_Toxicity Tobacco Chewing Toxicity Tobacco Chewing Toxicity A gland located in the anterior wall of the vagina that drains into the urethra at the opening. C61122 Anatomical Structure Skene Gland C0227782 GDC Skene_s_Gland Paraurethral gland Paraurethral Skene Gland Skene Gland Skene's Gland Skene Gland A melanoma that arises from the ciliary body. It is characterized by the presence of spindle-shaped melanocytes. C6117 Neoplastic Process Ciliary Body Spindle Cell Melanoma C1333052 Malignant Ciliary_Body_Spindle_Cell_Melanoma Ciliary Body Spindle Cell Melanoma Spindle Cell Melanoma of Ciliary Body Spindle Cell Melanoma of the Ciliary Body Ciliary Body Spindle Cell Melanoma Ciliary body melanoma characterized by the presence of intermediate cells which are similar to but smaller than epithelioid cells. C6118 Neoplastic Process Ciliary Body Intermediate Cell Type Melanoma C1334209 Malignant Intermediate_Cell_Type_Ciliary_Body_Melanoma Ciliary Body Intermediate Cell Type Melanoma Intermediate Cell Type Ciliary Body Melanoma Ciliary Body Intermediate Cell Type Melanoma A ciliary body melanoma characterized by the presence of malignant large epithelioid melanocytes. C6119 Neoplastic Process Ciliary Body Epithelioid Cell Melanoma C1333050 Malignant Ciliary_Body_Epithelioid_Cell_Melanoma Ciliary Body Epithelioid Cell Melanoma Epithelioid Cell Melanoma of Ciliary Body Epithelioid Cell Melanoma of the Ciliary Body Ciliary Body Epithelioid Cell Melanoma A precancerous neoplastic intraepithelial process involving the conjunctival squamous epithelium. C6120 Neoplastic Process Conjunctival Squamous Intraepithelial Neoplasia C1333148 Undetermined Conjunctival_Intraepithelial_Neoplasia Conjunctiva Intraepithelial Neoplasia Conjunctival Intraepithelial Neoplasia Conjunctival Squamous Intraepithelial Neoplasia Intraepithelial Neoplasia of Conjunctiva Intraepithelial Neoplasia of the Conjunctiva Conjunctival Squamous Intraepithelial Neoplasia Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th, 7th, and 8th eds.) C6121 Neoplastic Process Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8 Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8 C1336090 CTRP Malignant Stage_0_Laryngeal_Squamous_Cell_Carcinoma Epidermoid Carcinoma in situ of Larynx Epidermoid Carcinoma in situ of the Larynx Laryngeal Epidermoid Carcinoma in situ Laryngeal Squamous Cell Carcinoma in situ Larynx Epidermoid Carcinoma in situ Larynx Squamous Cell Carcinoma in situ Squamous Cell Carcinoma in situ of Larynx Squamous Cell Carcinoma in situ of the Larynx Stage 0 Epidermoid Carcinoma of Larynx Stage 0 Epidermoid Carcinoma of the Larynx Stage 0 Laryngeal Cancer AJCC v8 Stage 0 Laryngeal Carcinoma AJCC v8 Stage 0 Laryngeal Epidermoid Carcinoma Stage 0 Laryngeal Squamous Cell Carcinoma Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6 Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8 Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v7 Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v8 Stage 0 Laryngeal Throat Squamous Cell Cancer Stage 0 Larynx Epidermoid Carcinoma Stage 0 Larynx Squamous Cell Carcinoma Stage 0 Squamous Cell Carcinoma of Larynx Stage 0 Squamous Cell Carcinoma of the Larynx Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8 Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); T4a: Supraglottis: Moderately advanced local disease. Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus). Glottis: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus). Subglottis: Moderately advanced local disease. Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus). N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C6122 Neoplastic Process Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7 C1336343 CTRP Malignant Stage_IVA_Laryngeal_Squamous_Cell_Carcinoma Stage IVA Epidermoid Carcinoma of Larynx Stage IVA Epidermoid Carcinoma of the Larynx Stage IVA Laryngeal Epidermoid Carcinoma Stage IVA Laryngeal Squamous Cell Carcinoma Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IVA Laryngeal Throat Squamous Cell Cancer Stage IVA Larynx Epidermoid Carcinoma Stage IVA Larynx Squamous Cell Carcinoma Stage IVA Squamous Cell Carcinoma of Larynx Stage IVA Squamous Cell Carcinoma of the Larynx Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IVB includes: (T4b, Any N, M0); (Any T, N3, M0). T4b: Supraglottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. Glottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. Subglottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. N3: Metastasis in a lymph node, more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C6123 Neoplastic Process Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7 C1336374 CTRP Malignant Stage_IVB_Laryngeal_Squamous_Cell_Carcinoma Stage IVB Epidermoid Carcinoma of Larynx Stage IVB Epidermoid Carcinoma of the Larynx Stage IVB Laryngeal Epidermoid Carcinoma Stage IVB Laryngeal Squamous Cell Carcinoma Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IVB Laryngeal Throat Squamous Cell Cancer Stage IVB Larynx Epidermoid Carcinoma Stage IVB Larynx Squamous Cell Carcinoma Stage IVB Squamous Cell Carcinoma of Larynx Stage IVB Squamous Cell Carcinoma of the Larynx Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C6124 Neoplastic Process Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7 C1336395 CTRP Malignant Stage_IVC_Laryngeal_Squamous_Cell_Carcinoma Stage IVC Epidermoid Carcinoma of Larynx Stage IVC Epidermoid Carcinoma of the Larynx Stage IVC Laryngeal Epidermoid Carcinoma Stage IVC Laryngeal Squamous Cell Carcinoma Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IVC Laryngeal Throat Squamous Cell Cancer Stage IVC Larynx Epidermoid Carcinoma Stage IVC Larynx Squamous Cell Carcinoma Stage IVC Squamous Cell Carcinoma of Larynx Stage IVC Squamous Cell Carcinoma of the Larynx Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C6125 Neoplastic Process Stage IVC Laryngeal Verrucous Carcinoma AJCC v7 Stage IVC Laryngeal Verrucous Carcinoma AJCC v7 C1336396 CTRP Malignant Stage_IVC_Laryngeal_Verrucous_Carcinoma Stage IVC Laryngeal Throat Verrucous Cancer Stage IVC Laryngeal Verrucous Carcinoma Stage IVC Laryngeal Verrucous Carcinoma AJCC v7 Stage IVC Larynx Verrucous Carcinoma Stage IVC Verrucous Carcinoma of Larynx Stage IVC Verrucous Carcinoma of the Larynx Stage IVC Laryngeal Verrucous Carcinoma AJCC v7 Stage IVB includes: (T4b, Any N, M0); (Any T, N3, M0). T4b: Supraglottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. Glottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. Subglottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. N3: Metastasis in a lymph node, more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C6126 Neoplastic Process Stage IVB Laryngeal Verrucous Carcinoma AJCC v7 Stage IVB Laryngeal Verrucous Carcinoma AJCC v7 C1336375 CTRP Malignant Stage_IVB_Laryngeal_Verrucous_Carcinoma Stage IVB Laryngeal Throat Verrucous Cancer Stage IVB Laryngeal Verrucous Carcinoma Stage IVB Laryngeal Verrucous Carcinoma AJCC v7 Stage IVB Larynx Verrucous Carcinoma Stage IVB Verrucous Carcinoma of Larynx Stage IVB Verrucous Carcinoma of the Larynx Stage IVB Laryngeal Verrucous Carcinoma AJCC v7 Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); T4a: Supraglottis: Moderately advanced local disease. Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus). Glottis: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus). Subglottis: Moderately advanced local disease. Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus). N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C6127 Neoplastic Process Stage IVA Laryngeal Verrucous Carcinoma AJCC v7 Stage IVA Laryngeal Verrucous Carcinoma AJCC v7 C1336344 CTRP Malignant Stage_IVA_Laryngeal_Verrucous_Carcinoma Stage IVA Laryngeal Throat Verrucous Cancer Stage IVA Laryngeal Verrucous Carcinoma Stage IVA Laryngeal Verrucous Carcinoma AJCC v7 Stage IVA Larynx Verrucous Carcinoma Stage IVA Verrucous Carcinoma of Larynx Stage IVA Verrucous Carcinoma of the Larynx Stage IVA Laryngeal Verrucous Carcinoma AJCC v7 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th, 7th, and 8th eds.) C6128 Neoplastic Process Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8 Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8 C1336091 CTRP Malignant Stage_0_Laryngeal_Verrucous_Carcinoma Laryngeal Verrucous Carcinoma in situ Larynx Verrucous Carcinoma in situ Stage 0 Laryngeal Throat Verrucous Cancer Stage 0 Laryngeal Verrucous Carcinoma Stage 0 Laryngeal Verrucous Carcinoma AJCC v6 Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8 Stage 0 Laryngeal Verrucous Carcinoma AJCC v7 Stage 0 Laryngeal Verrucous Carcinoma AJCC v8 Stage 0 Larynx Verrucous Carcinoma Stage 0 Verrucous Carcinoma of Larynx Stage 0 Verrucous Carcinoma of the Larynx Verrucous Carcinoma in situ of Larynx Verrucous Carcinoma in situ of the Larynx Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8 A carcinoma that arises from the lacrimal glands. Representative examples include adenocarcinoma, carcinoma ex pleomorphic adenoma, squamous cell carcinoma, adenoid cystic carcinoma, and mucoepidermoid carcinoma. C6129 Neoplastic Process Lacrimal Gland Carcinoma C1334358 Malignant Lacrimal_Gland_Carcinoma Carcinoma of Lacrimal Gland Carcinoma of the Lacrimal Gland Lacrimal Gland Carcinoma Lacrimal Gland Carcinoma Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C6130 Neoplastic Process Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7 C1336393 CTRP Malignant Stage_IVC_Hypopharyngeal_Squamous_Cell_Carcinoma Stage IVC Epidermoid Carcinoma of Hypopharynx Stage IVC Epidermoid Carcinoma of the Hypopharynx Stage IVC Hypopharyngeal Epidermoid Carcinoma Stage IVC Hypopharyngeal Squamous Cell Carcinoma Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVC Hypopharyngeal Throat Squamous Cell Cancer Stage IVC Hypopharynx Epidermoid Carcinoma Stage IVC Hypopharynx Squamous Cell Carcinoma Stage IVC Squamous Cell Carcinoma of Hypopharynx Stage IVC Squamous Cell Carcinoma of the Hypopharynx Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVB includes: (T4b, Any N, M0); (Any T, N3, M0). T4b: Tumor with very advanced local disease. Tumor invades prevertebral fascia, encases carotid artery, or involves mediastinal structures. N3: Metastasis in a lymph node more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C6131 Neoplastic Process Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7 C1336372 CTRP Malignant Stage_IVB_Hypopharyngeal_Squamous_Cell_Carcinoma Stage IVB Epidermoid Carcinoma of Hypopharynx Stage IVB Epidermoid Carcinoma of the Hypopharynx Stage IVB Hypopharyngeal Epidermoid Carcinoma Stage IVB Hypopharyngeal Squamous Cell Carcinoma Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVB Hypopharyngeal Throat Squamous Cell Cancer Stage IVB Hypopharynx Epidermoid Carcinoma Stage IVB Hypopharynx Squamous Cell Carcinoma Stage IVB Squamous Cell Carcinoma of Hypopharynx Stage IVB Squamous Cell Carcinoma of the Hypopharynx Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a: Tumor with moderately advanced local disease. Tumor invades the thyroid/cricoid cartilage, hyoid bone, thyroid gland, or central compartment soft tissue. Central compartment soft tissue includes prelaryngeal strap muscles and subcutaneous fat. T1: Tumor limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimension. T2: Tumor invades more than one subsite of the hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx. T3: Tumor measuring more than 4 cm in greatest dimension or tumor with fixation of hemilarynx or extension to esophagus. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Tumor with metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C6132 Neoplastic Process Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7 C1336341 CTRP Malignant Stage_IVA_Hypopharyngeal_Squamous_Cell_Carcinoma Stage IVA Epidermoid Carcinoma of Hypopharynx Stage IVA Epidermoid Carcinoma of the Hypopharynx Stage IVA Hypopharyngeal Epidermoid Carcinoma Stage IVA Hypopharyngeal Squamous Cell Carcinoma Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVA Hypopharyngeal Throat Squamous Cell Cancer Stage IVA Hypopharynx Epidermoid Carcinoma Stage IVA Hypopharynx Squamous Cell Carcinoma Stage IVA Squamous Cell Carcinoma of Hypopharynx Stage IVA Squamous Cell Carcinoma of the Hypopharynx Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage I includes: T1, N0, M0. T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6133 Neoplastic Process Stage I Thyroid Gland Medullary Carcinoma AJCC v7 Stage I Thyroid Gland Medullary Carcinoma AJCC v7 C1336491 CTRP Malignant Stage_I_Thyroid_Medullary_Carcinoma Stage I Medullary Carcinoma of Thyroid Stage I Medullary Carcinoma of Thyroid Gland Stage I Medullary Carcinoma of the Thyroid Stage I Medullary Carcinoma of the Thyroid Gland Stage I Medullary Thyroid Gland Carcinoma Stage I Thyroid Gland Medullary Cancer Stage I Thyroid Gland Medullary Carcinoma Stage I Thyroid Gland Medullary Carcinoma AJCC v7 Stage I Thyroid Medullary Carcinoma Stage I Thyroid Gland Medullary Carcinoma AJCC v7 Stage II includes: (T2, N0, M0); (T3, N0, M0). T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland. T3: Tumor more than 4 cm in greatest dimension and limited to the thyroid gland, or tumor of any size with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6134 Neoplastic Process Stage II Thyroid Gland Medullary Carcinoma AJCC v7 Stage II Thyroid Gland Medullary Carcinoma AJCC v7 C1336327 CTRP Malignant Stage_II_Thyroid_Medullary_Carcinoma Stage II Medullary Carcinoma of Thyroid Stage II Medullary Carcinoma of Thyroid Gland Stage II Medullary Carcinoma of the Thyroid Stage II Medullary Carcinoma of the Thyroid Gland Stage II Medullary Thyroid Gland Carcinoma Stage II Thyroid Gland Medullary Cancer Stage II Thyroid Gland Medullary Carcinoma Stage II Thyroid Gland Medullary Carcinoma AJCC v7 Stage II Thyroid Medullary Carcinoma Stage II Thyroid Gland Medullary Carcinoma AJCC v7 Stage III includes: (T1, N1a, M0); (T2, N1a, M0); (T3, N1a, M0). T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland. T3: Tumor more than 4 cm in greatest dimension and limited to the thyroid gland, or tumor of any size with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues). N1a: Metastasis to pretracheal, paratracheal or prelaryngeal/Delphian lymph nodes (Level VI lymph nodes). M0: No distant metastasis. (AJCC 7th ed.) C6135 Neoplastic Process Stage III Thyroid Gland Medullary Carcinoma AJCC v7 Stage III Thyroid Gland Medullary Carcinoma AJCC v7 C1336274 CTRP Malignant Stage_III_Thyroid_Medullary_Carcinoma Stage III Medullary Carcinoma of Thyroid Stage III Medullary Carcinoma of Thyroid Gland Stage III Medullary Carcinoma of the Thyroid Stage III Medullary Carcinoma of the Thyroid Gland Stage III Medullary Thyroid Gland Carcinoma Stage III Thyroid Gland Medullary Cancer Stage III Thyroid Gland Medullary Carcinoma Stage III Thyroid Gland Medullary Carcinoma AJCC v7 Stage III Thyroid Medullary Carcinoma Stage III Thyroid Gland Medullary Carcinoma AJCC v7 Stage IV includes: IVA (T4a, N0, M0); (T4a, N1a, M0); (T1, N1b, M0); (T2, N1b, M0); (T3, N1b, M0); (T4a, N1b, M0); IVB (T4b, Any N, M0); IVC (Any T, Any N, M1). T4a: Moderately advanced local disease. Tumor of any size extending beyond the thyroid gland capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve. T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland. T3: Tumor more than 4 cm in greatest dimension and limited to the thyroid gland, or tumor of any size with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues). T4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels. N0: No regional lymph node metastasis. N1a: Metastasis to pretracheal, paratracheal or prelaryngeal/Delphian lymph nodes (Level VI lymph nodes). N1b: Metastasis to unilateral, bilateral or contralateral cervical (Levels I, II, III, IV, or V) or retropharyngeal or superior mediastinal lymph nodes (Level VII). M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C6136 Neoplastic Process Stage IV Thyroid Gland Medullary Carcinoma AJCC v7 Stage IV Thyroid Gland Medullary Carcinoma AJCC v7 C1336442 CTRP Malignant Stage_IV_Thyroid_Medullary_Carcinoma Stage IV Medullary Carcinoma of Thyroid Stage IV Medullary Carcinoma of Thyroid Gland Stage IV Medullary Carcinoma of the Thyroid Stage IV Medullary Carcinoma of the Thyroid Gland Stage IV Medullary Thyroid Gland Carcinoma Stage IV Thyroid Gland Medullary Cancer Stage IV Thyroid Gland Medullary Carcinoma Stage IV Thyroid Gland Medullary Carcinoma AJCC v7 Stage IV Thyroid Medullary Carcinoma Stage IV Thyroid Gland Medullary Carcinoma AJCC v7 Stage IVA includes: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0). T4: Nasopharyngeal cancer with intracranial extension and/or involvement of cranial nerves, hypopharynx, orbit, or with extension to the infratemporal fossa/masticator space. N0: No regional lymph node metastasis. N1: Nasopharyngeal cancer with unilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa, and/or unilateral or bilateral, retropharyngeal lymph nodes, 6 cm or less in greatest dimension. Midline nodes are considered ipsilateral nodes. N2: Nasopharyngeal cancer with bilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa. Midline nodes are considered ipsilateral nodes. M0: No distant metastasis. (AJCC 7th ed.) C6137 Neoplastic Process Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 C1336349 CTRP Malignant Stage_IVA_Nasopharyngeal_Squamous_Cell_Carcinoma Stage IVA Keratinizing Epidermoid Carcinoma of Nasopharynx Stage IVA Keratinizing Epidermoid Carcinoma of the Nasopharynx Stage IVA Keratinizing Squamous Cell Carcinoma of Nasopharynx Stage IVA Keratinizing Squamous Cell Carcinoma of the Nasopharynx Stage IVA Nasopharyngeal Keratinizing Epidermoid Carcinoma Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage IVA Nasopharyngeal Throat Keratinizing Squamous Cell Cancer Stage IVA Nasopharynx Keratinizing Epidermoid Carcinoma Stage IVA Nasopharynx Keratinizing Squamous Cell Carcinoma Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage IVB includes: Any T, N3, M0. N3: Nasopharyngeal cancer with metastasis in a lymph node (s) more than 6 cm in greatest dimension and/or to supraclavicular fossa. Supraclavicular zone or fossa is relevant to the staging of nasopharyngeal carcinoma and is the triangular region originally described by Ho. It is defined by three points: (1) the superior margin of the sternal end of the clavicle, (2) the superior margin of the lateral end of the clavicle, (3) the point where the neck meets the shoulder. This would include caudal portions of levels IV and VB. All cases with lymph nodes (whole or part) in the fossa are considered N3b. M0: No distant metastasis. (AJCC 7th ed.) C6138 Neoplastic Process Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 C1336380 CTRP Malignant Stage_IVB_Nasopharyngeal_Squamous_Cell_Carcinoma Stage IVB Keratinizing Epidermoid Carcinoma of Nasopharynx Stage IVB Keratinizing Epidermoid Carcinoma of the Nasopharynx Stage IVB Keratinizing Squamous Cell Carcinoma of Nasopharynx Stage IVB Keratinizing Squamous Cell Carcinoma of the Nasopharynx Stage IVB Nasopharyngeal Keratinizing Epidermoid Carcinoma Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage IVB Nasopharyngeal Throat Keratinizing Squamous Cell Cancer Stage IVB Nasopharynx Keratinizing Epidermoid Carcinoma Stage IVB Nasopharynx Keratinizing Squamous Cell Carcinoma Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 A testicular seminoma characterized by the presence of uniform round germ cells with glycogen-rich cytoplasm and large nuclei, and a lymphocytic infiltrate. C61383 Neoplastic Process Testicular Typical Seminoma C1883282 Malignant Testicular_Typical_Seminoma Testicular Typical Seminoma Testicular Typical Seminoma Stage IVB includes: (T4b, Any N, M0); (Any T, N3, M0). T4b: Tumor with very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery. N3: Tumor with metastasis in a lymph node more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C6139 Neoplastic Process Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7 C1336387 CTRP Malignant Stage_IVB_Oropharyngeal_Squamous_Cell_Carcinoma Stage IVB Epidermoid Carcinoma of Oropharynx Stage IVB Epidermoid Carcinoma of the Oropharynx Stage IVB Oropharyngeal Epidermoid Carcinoma Stage IVB Oropharyngeal Squamous Cell Carcinoma Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVB Oropharyngeal Throat Squamous Cell Cancer Stage IVB Oropharynx Epidermoid Carcinoma Stage IVB Oropharynx Squamous Cell Carcinoma Stage IVB Squamous Cell Carcinoma of Oropharynx Stage IVB Squamous Cell Carcinoma of the Oropharynx Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C6140 Neoplastic Process Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7 C1336407 CTRP Malignant Stage_IVC_Oropharyngeal_Squamous_Cell_Carcinoma Stage IVC Epidermoid Carcinoma of Oropharynx Stage IVC Epidermoid Carcinoma of the Oropharynx Stage IVC Oropharyngeal Epidermoid Carcinoma Stage IVC Oropharyngeal Squamous Cell Carcinoma Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVC Oropharyngeal Throat Squamous Cell Cancer Stage IVC Oropharynx Epidermoid Carcinoma Stage IVC Oropharynx Squamous Cell Carcinoma Stage IVC Squamous Cell Carcinoma of Oropharynx Stage IVC Squamous Cell Carcinoma of the Oropharynx Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a: Tumor with moderately advanced local disease. Tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible. Mucosal extension to lingual surface of epiglottis from primary tumors of the base of the tongue and vallecula does not constitute invasion of larynx. T1: Tumor 2 cm or less in greatest dimension. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3: Tumor measuring more than 4 centimeters in greatest dimension or extension to lingual surface of epiglottis. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Tumor with metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C6141 Neoplastic Process Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 C1336356 CTRP Malignant Stage_IVA_Oropharyngeal_Squamous_Cell_Carcinoma Stage IVA Epidermoid Carcinoma of Oropharynx Stage IVA Epidermoid Carcinoma of the Oropharynx Stage IVA Oropharyngeal Epidermoid Carcinoma Stage IVA Oropharyngeal Squamous Cell Carcinoma Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVA Oropharyngeal Throat Squamous Cell Cancer Stage IVA Oropharynx Epidermoid Carcinoma Stage IVA Oropharynx Squamous Cell Carcinoma Stage IVA Squamous Cell Carcinoma of Oropharynx Stage IVA Squamous Cell Carcinoma of the Oropharynx Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 A carcinoma arising in the renal pelvis. The majority of renal pelvis carcinomas are transitional cell and less frequently squamous cell carcinomas. C6142 Neoplastic Process Renal Pelvis Carcinoma Renal Pelvis Carcinoma C3163938 CPTAC CTRP Cellosaurus Malignant Renal_Pelvis_Carcinoma Carcinoma of Kidney Pelvis Carcinoma of Renal Pelvis Carcinoma of the Kidney Pelvis Carcinoma of the Renal Pelvis Kidney Pelvis Carcinoma Renal Pelvis Cancer Renal Pelvis Carcinoma Renal Pelvis Carcinoma Adenocarcinoma that affects the renal pelvis. C6143 Neoplastic Process Renal Pelvis Adenocarcinoma Renal Pelvis Adenocarcinoma C1335748 CTRP Malignant Renal_Pelvis_Adenocarcinoma Adenocarcinoma of Kidney Pelvis Adenocarcinoma of Renal Pelvis Adenocarcinoma of the Kidney Pelvis Adenocarcinoma of the Renal Pelvis Kidney Pelvis Adenocarcinoma Renal Pelvis Adenocarcinoma Renal Pelvis Adenocarcinoma Stage I includes: T1, M0, M0. T1: Tumor invades subepithelial connective tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6144 Neoplastic Process Stage I Renal Pelvis Cancer AJCC v7 Stage I Renal Pelvis Cancer AJCC v7 C1336477 CTRP Malignant Stage_I_Renal_Pelvis_Carcinoma Stage I Carcinoma of Renal Pelvis Stage I Carcinoma of the Renal Pelvis Stage I Renal Pelvis Cancer Stage I Renal Pelvis Cancer AJCC v7 Stage I Renal Pelvis Carcinoma Stage I Renal Pelvis Carcinoma AJCC v7 Stage I Renal Pelvis Cancer AJCC v7 Stage II includes: T2, N0, M0. T2: Tumor invades muscularis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6145 Neoplastic Process Stage II Renal Pelvis Cancer AJCC v7 Stage II Renal Pelvis Cancer AJCC v7 C1336313 CTRP Malignant Stage_II_Renal_Pelvis_Carcinoma Stage II Carcinoma of Renal Pelvis Stage II Carcinoma of the Renal Pelvis Stage II Renal Pelvis Cancer Stage II Renal Pelvis Cancer AJCC v7 Stage II Renal Pelvis Carcinoma Stage II Renal Pelvis Carcinoma AJCC v7 Stage II Renal Pelvis Cancer AJCC v7 Stage III includes: T3, N0, M0. T3: Tumor invades beyond muscularis into peripelvic fat or the renal parenchyma. N0: No lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6146 Neoplastic Process Stage III Renal Pelvis Cancer AJCC v7 Stage III Renal Pelvis Cancer AJCC v7 C1336266 CTRP Malignant Stage_III_Renal_Pelvis_Carcinoma Stage III Carcinoma of Renal Pelvis Stage III Carcinoma of the Renal Pelvis Stage III Renal Pelvis Cancer Stage III Renal Pelvis Cancer AJCC v7 Stage III Renal Pelvis Carcinoma Stage III Renal Pelvis Carcinoma AJCC v6 Stage III Renal Pelvis Carcinoma AJCC v7 Stage III Renal Pelvis Cancer AJCC v7 Stage IV includes: (T4, N0, M0); (Any T, N1, M0); (Any T, N2, M0); (Any T, N3, M0); (Any T, Any N, M1). T4: Tumor invades adjacent organs, or through the kidney into perinephric fat. N0: No regional lymph node metastasis. N1: Metastasis in a single lymph node, 2 cm or less in greatest dimension. N2: Metastasis in a single lymph node, more than 2 cm but not more than 5cm in greatest dimension; or multiple lymph nodes, none more than 5 cm in greatest dimension. N3: Metastasis in a lymph node, more than 5 cm in greatest dimension. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C6147 Neoplastic Process Stage IV Renal Pelvis Cancer AJCC v7 Stage IV Renal Pelvis Cancer AJCC v7 C1336436 CTRP Malignant Stage_IV_Renal_Pelvis_Carcinoma Stage IV Carcinoma of Renal Pelvis Stage IV Carcinoma of the Renal Pelvis Stage IV Renal Pelvis Cancer Stage IV Renal Pelvis Cancer AJCC v7 Stage IV Renal Pelvis Carcinoma Stage IV Renal Pelvis Carcinoma AJCC v7 Stage IV Renal Pelvis Cancer AJCC v7 A papillary urothelial carcinoma that arises from the renal pelvis. C6148 Neoplastic Process Renal Pelvis Papillary Urothelial Carcinoma C1377909 Malignant Renal_Pelvis_Papillary_Carcinoma Kidney Pelvis Papillary Carcinoma Papillary Carcinoma of Kidney Pelvis Papillary Carcinoma of Renal Pelvis Papillary Carcinoma of the Kidney Pelvis Papillary Carcinoma of the Renal Pelvis Renal Pelvis Papillary Urothelial Carcinoma Renal Pelvis Papillary Urothelial Carcinoma Stage 0 includes: 0a (Ta, N0, M0); 0is (Tis, N0, M0). Ta: Papillary noninvasive carcinoma. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6149 Neoplastic Process Stage 0 Ureter Cancer AJCC v7 Stage 0 Ureter Cancer AJCC v7 C1336098 CTRP Malignant Stage_0_Ureter_Cancer Stage 0 Carcinoma of Ureter Stage 0 Carcinoma of the Ureter Stage 0 Ureter Cancer Stage 0 Ureter Cancer AJCC v7 Stage 0 Ureter Carcinoma Stage 0 Ureter Urothelial Carcinoma Stage 0 Ureter Urothelial Carcinoma AJCC v7 Stage 0 Ureteral Carcinoma Ureter Cancer Stage 0 Stage 0 Ureter Cancer AJCC v7 Stage I includes: T1, N0, M0. T1: Tumor invades subepithelial connective tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6150 Neoplastic Process Stage I Ureter Cancer AJCC v7 Stage I Ureter Cancer AJCC v7 C1336492 CTRP Malignant Stage_I_Ureter_Cancer Stage I Carcinoma of Ureter Stage I Carcinoma of the Ureter Stage I Ureter Cancer Stage I Ureter Cancer AJCC v7 Stage I Ureter Carcinoma Stage I Ureteral Carcinoma Ureter Cancer Stage I Stage I Ureter Cancer AJCC v7 The radiographic examination of the bile ducts after a contrast medium has been injected. C61508 Diagnostic Procedure Cholangiography C0008307 Cholangiography Cholangiography Cholangiography Stage II includes: T2, N0, M0. T2: Tumor invades the muscularis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6151 Neoplastic Process Stage II Ureter Cancer AJCC v7 Stage II Ureter Cancer AJCC v7 C1336328 CTRP Malignant Stage_II_Ureter_Cancer Stage II Carcinoma of Ureter Stage II Carcinoma of the Ureter Stage II Ureter Cancer Stage II Ureter Cancer AJCC v7 Stage II Ureter Carcinoma Stage II Ureteral Carcinoma Ureter Cancer Stage II Stage II Ureter Cancer AJCC v7 Stage III includes: T3, N0, M0. T3: Tumor invades beyond muscularis into periureteric fat. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6152 Neoplastic Process Stage III Ureter Cancer AJCC v7 Stage III Ureter Cancer AJCC v7 C1336276 CTRP Malignant Stage_III_Ureter_Cancer Stage III Carcinoma of Ureter Stage III Carcinoma of the Ureter Stage III Ureter Cancer Stage III Ureter Cancer AJCC v7 Stage III Ureter Carcinoma Stage III Ureteral Carcinoma Ureter Cancer Stage III Stage III Ureter Cancer AJCC v7 Stage IV includes: (T4, N0, M0); (Any T, N1, M0); (Any T, N2, M0); (Any T, N3, M0); (Any T, Any N, M1). T4: Tumor invades adjacent organs, or through the kidney into the perinephric fat. N0: No regional lymph node metastasis. N1: Metastasis in a single lymph node, 2 cm or less in greatest dimension. N2: Metastasis in a single lymph node, more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, none more than 5 cm in greatest dimension. N3: Metastasis in a lymph node, more than 5 cm in greatest dimension. M0: No distant metastasis. N1: Distant metastasis. (AJCC 7th ed.) C6153 Neoplastic Process Stage IV Ureter Cancer AJCC v7 Stage IV Ureter Cancer AJCC v7 C1336443 CTRP Malignant Stage_IV_Ureter_Cancer Stage IV Carcinoma of Ureter Stage IV Carcinoma of the Ureter Stage IV Ureter Cancer Stage IV Ureter Cancer AJCC v7 Stage IV Ureter Carcinoma Stage IV Ureteral Carcinoma Ureter Cancer Stage IV Stage IV Ureter Cancer AJCC v7 A rare squamous cell carcinoma that arises from the ureter. C6154 Neoplastic Process Ureter Squamous Cell Carcinoma C1336879 Malignant Ureter_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Ureter Epidermoid Carcinoma of the Ureter Squamous Cell Carcinoma of Ureter Squamous Cell Carcinoma of the Ureter Ureter Epidermoid Carcinoma Ureter Squamous Cell Carcinoma Ureteral Epidermoid Carcinoma Ureteral Squamous Cell Carcinoma Ureter Squamous Cell Carcinoma Adenocarcinoma that affects the ureter. C6155 Neoplastic Process Ureter Adenocarcinoma C1336873 Malignant Ureter_Adenocarcinoma Adenocarcinoma of Ureter Adenocarcinoma of the Ureter Ureter Adenocarcinoma Ureteral Adenocarcinoma Ureter Adenocarcinoma An invasive urothelial carcinoma of the ureter that exhibits squamous differentiation. C6156 Neoplastic Process Invasive Ureter Urothelial Carcinoma with Squamous Differentiation C1336882 Malignant Ureter_Transitional_Cell_Carcinoma_with_Squamous_Differentiation Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation Invasive Ureter Urothelial Carcinoma with Squamous Differentiation Transitional Cell Carcinoma of Ureter with Squamous Differentiation Transitional Cell Carcinoma of the Ureter with Squamous Differentiation Ureteral Transitional Cell Carcinoma with Squamous Differentiation Invasive Ureter Urothelial Carcinoma with Squamous Differentiation An invasive urothelial carcinoma of the ureter that exhibits glandular differentiation. C6157 Neoplastic Process Invasive Ureter Urothelial Carcinoma with Glandular Differentiation C1336880 Malignant Ureter_Transitional_Cell_Carcinoma_with_Glandular_Differentiation Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation Invasive Ureter Urothelial Carcinoma with Glandular Differentiation Transitional Cell Carcinoma of Ureter with Glandular Differentiation Transitional Cell Carcinoma of the Ureter with Glandular Differentiation Ureteral Transitional Cell Carcinoma with Glandular Differentiation Invasive Ureter Urothelial Carcinoma with Glandular Differentiation A malignant neoplasm arising from the uterine corpus. This category includes endometrial carcinoma and carcinosarcoma. C61574 Neoplastic Process Uterine Corpus Cancer Uterine Corpus Cancer C1883486 CPTAC CTRP Malignant Uterine_Corpus_Cancer Cancer of the Corpus Uteri Corpus Uteri Cancer Uterine (Including Endometrial) Cancer Uterine Corpus Cancer Uterine Corpus Cancer Undifferentiated carcinoma that affects the ureter. C6159 Neoplastic Process Ureter Undifferentiated Carcinoma C1336866 Malignant Undifferentiated_Ureter_Carcinoma Anaplastic Carcinoma of Ureter Anaplastic Carcinoma of the Ureter Anaplastic Ureter Carcinoma Anaplastic Ureteral Carcinoma Undifferentiated Carcinoma of Ureter Undifferentiated Carcinoma of the Ureter Undifferentiated Ureter Carcinoma Undifferentiated Ureteral Carcinoma Ureter Undifferentiated Carcinoma Ureter Undifferentiated Carcinoma A rare benign neoplasm that arises from the ureter and is characterized by the presence of a papillary growth with a central fibrovascular core. The latter is lined by normal urothelium. C6160 Neoplastic Process Ureter Urothelial Papilloma C1519823 Benign Ureter_Papilloma Ureter Urothelial Papilloma Ureter Urothelial Papilloma A benign smooth muscle neoplasm arising from the ureter. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C6161 Neoplastic Process Ureter Leiomyoma C1336875 Benign Ureter_Leiomyoma Leiomyoma of Ureter Leiomyoma of the Ureter Ureter Leiomyoma Ureteral Leiomyoma Ureter Leiomyoma A benign nerve sheath tumor composed of Schwann cells, occurring in the ureter. C6162 Neoplastic Process Ureter Schwannoma C1336877 Benign Ureter_Schwannoma Neurilemmoma of Ureter Neurilemmoma of the Ureter Schwannoma of Ureter Schwannoma of the Ureter Ureter Neurilemmoma Ureter Schwannoma Ureteral Neurilemmoma Ureteral Schwannoma Ureter Schwannoma A variant of bladder adenocarcinoma with mucin containing signet ring cells. C6163 Neoplastic Process Bladder Signet Ring Cell Adenocarcinoma C1332563 Malignant Bladder_Signet_Ring_Cell_Adenocarcinoma Bladder Signet Ring Cell Adenocarcinoma Bladder Signet-Ring Cell Adenocarcinoma Signet Ring Cell Adenocarcinoma of Bladder Signet Ring Cell Adenocarcinoma of Urinary Bladder Signet Ring Cell Adenocarcinoma of the Bladder Signet Ring Cell Adenocarcinoma of the Urinary Bladder Urinary Bladder Signet Ring Adenocarcinoma Bladder Signet Ring Cell Adenocarcinoma A lymphoma involving the bladder. C6164 Neoplastic Process Bladder Lymphoma C1332561 Malignant Bladder_Lymphoma Bladder Lymphoma Lymphoma of Bladder Lymphoma of Urinary Bladder Lymphoma of the Bladder Lymphoma of the Urinary Bladder Primary Bladder Lymphoma Urinary Bladder Lymphoma Bladder Lymphoma A well differentiated, moderately differentiated, or poorly differentiated squamous cell carcinoma that arises from the male or female urethra. C6165 Neoplastic Process Urethral Squamous Cell Carcinoma Urethral Squamous Cell Carcinoma C1336890 CTRP Malignant Urethral_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Urethra Epidermoid Carcinoma of the Urethra Squamous Cell Carcinoma of Urethra Squamous Cell Carcinoma of the Urethra Urethra Epidermoid Carcinoma Urethra Squamous Cell Carcinoma Urethral Epidermoid Carcinoma Urethral Squamous Cell Cancer Urethral Squamous Cell Carcinoma Urethral Squamous Cell Carcinoma A urothelial carcinoma that arises from the male or female urethra. C6166 Neoplastic Process Urethral Urothelial Carcinoma Urethral Urothelial Carcinoma C0863015 CTRP Cellosaurus Malignant Urethral_Transitional_Cell_Carcinoma Transitional Cell Carcinoma of Urethra Transitional Cell Carcinoma of the Urethra Urethra Transitional Cell Carcinoma Urethral Transitional Cell Carcinoma Urethral Urothelial Cancer Urethral Urothelial Carcinoma Urethral Urothelial Carcinoma An adenocarcinoma that arises from the male or female urethra. C6167 Neoplastic Process Urethral Adenocarcinoma Urethral Adenocarcinoma C1336885 CTRP Malignant Urethral_Adenocarcinoma Adenocarcinoma of Urethra Adenocarcinoma of the Urethra Urethra Adenocarcinoma Urethral Adenocarcinoma Urethral Adenocarcinoma An undifferentiated carcinoma arising from the urethra. C6168 Neoplastic Process Undifferentiated Urethral Carcinoma Urethral Undifferentiated Carcinoma C1336867 CTRP Malignant Undifferentiated_Urethral_Carcinoma Anaplastic Carcinoma of Urethra Anaplastic Carcinoma of the Urethra Anaplastic Urethra Carcinoma Anaplastic Urethral Carcinoma Undifferentiated Carcinoma of Urethra Undifferentiated Carcinoma of the Urethra Undifferentiated Urethra Carcinoma Undifferentiated Urethral Cancer Undifferentiated Urethral Carcinoma Urethral Undifferentiated Carcinoma Urethral Undifferentiated Carcinoma A sexually transmitted papillary neoplasm that arises from the epithelial surface of the urethra, and caused by the human papillomavirus. C6169 Neoplastic Process Urethral Condyloma Acuminatum C1336883 Benign Urethra_Condyloma_Acuminatum Condylomata of Urethra Condylomata of the Urethra Urethral Condyloma Urethral Condyloma Acuminatum Urethral Condylomata Urethral Condyloma Acuminatum A benign smooth muscle neoplasm arising from the urethra. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C6171 Neoplastic Process Urethral Leiomyoma C1336888 Benign Urethral_Leiomyoma Leiomyoma of Urethra Leiomyoma of the Urethra Urethra Leiomyoma Urethral Leiomyoma Urethral Leiomyoma A morphologic variant of urethral adenocarcinoma characterized by the presence of tubulocystic or papillary structures lined with clear cuboidal or hobnail cells. C6172 Neoplastic Process Urethral Clear Cell Adenocarcinoma C1336886 Malignant Urethral_Clear_Cell_Adenocarcinoma Clear Cell Adenocarcinoma of Urethra Clear Cell Adenocarcinoma of the Urethra Urethra Clear Cell Adenocarcinoma Urethral Clear Cell Adenocarcinoma Urethral Clear Cell Adenocarcinoma An endophytic urothelial neoplasm arising from the urethra. It shares several morphologic features with urothelial papilloma. C6173 Neoplastic Process Urethral Inverted Papilloma C1336887 Benign Urethral_Inverted_Papilloma Inverted Papilloma of Urethra Inverted Papilloma of the Urethra Urethra Inverted Papilloma Urethral Inverted Papilloma Urethral Inverted Papilloma An endophytic urothelial neoplasm arising from the ureter. It shares several morphologic features with urothelial papilloma. C6174 Neoplastic Process Ureter Inverted Papilloma C1336874 Benign Ureter_Inverted_Papilloma Inverted Papilloma of Ureter Inverted Papilloma of the Ureter Ureter Inverted Papilloma Ureteral Inverted Papilloma Ureter Inverted Papilloma A lymphoma involving the ureter. C6175 Neoplastic Process Ureter Lymphoma C1336876 Malignant Ureter_Lymphoma Lymphoma of Ureter Lymphoma of the Ureter Primary Ureter Lymphoma Ureter Lymphoma Ureteral Lymphoma Ureter Lymphoma A rare small cell neuroendocrine carcinoma that arises from the ureter. C6176 Neoplastic Process Ureter Small Cell Neuroendocrine Carcinoma C1336878 Malignant Ureter_Small_Cell_Carcinoma Small Cell Carcinoma of Ureter Small Cell Carcinoma of the Ureter Ureter Small Cell Carcinoma Ureter Small Cell Neuroendocrine Carcinoma Ureteral Small Cell Carcinoma Ureter Small Cell Neuroendocrine Carcinoma A multinodular intermediate fibroblastic neoplasm arising from the bladder. It is characterized by the presence of spindle-shaped fibroblasts and myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes and plasma cells. C6177 Neoplastic Process Bladder Inflammatory Myofibroblastic Tumor C1336891 Undetermined Urinary_Bladder_Inflammatory_Myofibroblastic_Tumor Bladder Inflammatory Myofibroblastic Neoplasm Bladder Inflammatory Myofibroblastic Tumor Inflammatory Myofibroblastic Neoplasm of Bladder Inflammatory Myofibroblastic Neoplasm of Urinary Bladder Inflammatory Myofibroblastic Neoplasm of the Bladder Inflammatory Myofibroblastic Neoplasm of the Urinary Bladder Inflammatory Myofibroblastic Tumor of Bladder Inflammatory Myofibroblastic Tumor of Urinary Bladder Inflammatory Myofibroblastic Tumor of the Bladder Inflammatory Myofibroblastic Tumor of the Urinary Bladder Urinary Bladder Inflammatory Myofibroblastic Neoplasm Urinary Bladder Inflammatory Myofibroblastic Tumor Bladder Inflammatory Myofibroblastic Tumor A leiomyoma that arises from the bladder. Although it is an uncommon tumor in the bladder, it is the most common mesenchymal neoplasm affecting the bladder. C6178 Neoplastic Process Bladder Leiomyoma C1332560 Benign Bladder_Leiomyoma Bladder Leiomyoma Leiomyoma of Bladder Leiomyoma of Urinary Bladder Leiomyoma of the Bladder Leiomyoma of the Urinary Bladder Urinary Bladder Leiomyoma Bladder Leiomyoma A bladder adenocarcinoma characterized by the presence of malignant glandular epithelial cells and clear cells distributed in a tubulo-cystic, papillary, or diffuse pattern. There is a female predilection. Clinical presentation includes hematuria and dysuria. C6179 Neoplastic Process Bladder Clear Cell Adenocarcinoma C1332557 Malignant Bladder_Clear_Cell_Adenocarcinoma Bladder Clear Cell Adenocarcinoma Clear Cell Adenocarcinoma of Bladder Clear Cell Adenocarcinoma of Urinary Bladder Clear Cell Adenocarcinoma of the Bladder Clear Cell Adenocarcinoma of the Urinary Bladder Urinary Bladder Clear Cell Adenocarcinoma Bladder Clear Cell Adenocarcinoma Wilms tumor of the kidney which occurs in adults. C6180 Neoplastic Process Adult Kidney Wilms Tumor C1332219 Malignant Adult_Wilms_Tumor Adenosarcoma of Adult Kidney Adenosarcoma of the Adult Kidney Adult Kidney Adenosarcoma Adult Kidney Nephroblastoma Adult Kidney Wilms Tumor Adult Renal Adenosarcoma Adult Renal Wilms Tumor Adult Renal Wilms' Tumor Adult Kidney Wilms Tumor An osteosarcoma arising from the kidney. C6181 Neoplastic Process Kidney Extraskeletal Osteosarcoma C1335747 Malignant Renal_Osteosarcoma Kidney Extraskeletal Osteosarcoma Kidney Osteogenic Sarcoma Kidney Osteosarcoma Osteogenic Sarcoma of Kidney Osteogenic Sarcoma of the Kidney Osteosarcoma of Kidney Osteosarcoma of the Kidney Renal Extraskeletal Osteosarcoma Renal Osteogenic Sarcoma Renal Osteosarcoma Kidney Extraskeletal Osteosarcoma An aggressive malignant smooth muscle neoplasm, arising from the kidney. It is characterized by a proliferation of neoplastic spindle cells. C6183 Neoplastic Process Kidney Leiomyosarcoma C1335743 Malignant Renal_Leiomyosarcoma Kidney Leiomyosarcoma Leiomyosarcoma of Kidney Leiomyosarcoma of the Kidney Renal Leiomyosarcoma Kidney Leiomyosarcoma A rare malignant adipose tissue neoplasm of the fat cells surrounding the kidney, usually of the well-differentiated or myxoid type. It may be associated with tuberous sclerosis. C6185 Neoplastic Process Kidney Liposarcoma C1335745 Malignant Renal_Liposarcoma Kidney Liposarcoma Liposarcoma of Kidney Liposarcoma of the Kidney Renal Liposarcoma Kidney Liposarcoma An invasive urothelial carcinoma that arises from the renal pelvis and exhibits sarcomatoid features. C6186 Neoplastic Process Invasive Renal Pelvis Sarcomatoid Urothelial Carcinoma C1335752 Malignant Renal_Pelvis_Sarcomatoid_Transitional_Cell_Carcinoma Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant Invasive Renal Pelvis Sarcomatoid Urothelial Carcinoma Invasive Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant Kidney Pelvis Sarcomatoid Transitional Cell Carcinoma Sarcomatoid Transitional Cell Carcinoma of Kidney Pelvis Sarcomatoid Transitional Cell Carcinoma of Renal Pelvis Sarcomatoid Transitional Cell Carcinoma of the Kidney Pelvis Sarcomatoid Transitional Cell Carcinoma of the Renal Pelvis Invasive Renal Pelvis Sarcomatoid Urothelial Carcinoma An endophytic urothelial neoplasm arising from the renal pelvis. It shares several morphologic features with urothelial papilloma. C6187 Neoplastic Process Renal Pelvis Inverted Papilloma C1335751 Benign Renal_Pelvis_Inverted_Papilloma Inverted Papilloma of Kidney Pelvis Inverted Papilloma of Renal Pelvis Inverted Papilloma of the Kidney Pelvis Inverted Papilloma of the Renal Pelvis Kidney Pelvis Inverted Papilloma Renal Pelvis Inverted Papilloma Renal Pelvis Inverted Papilloma Stage 0 includes: 0a (Ta, N0, M0); 0is (Tis, N0, M0). Ta: Noninvasive papillary carcinoma. Tis: Carcinoma in situ: "flat tumor". N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6188 Neoplastic Process Stage 0 Bladder Urothelial Carcinoma AJCC v6 and v7 Stage 0 Bladder Urothelial Carcinoma AJCC v6 and v7 C1336089 CTRP Malignant Stage_0_Bladder_Transitional_Cell_Carcinoma Non-Invasive Bladder Urothelial Carcinoma Stage 0 Bladder Urothelial Cancer Stage 0 Bladder Urothelial Carcinoma Stage 0 Bladder Urothelial Carcinoma AJCC v6 and v7 Stage 0 Bladder Urothelial Carcinoma AJCC v7 Stage 0 Transitional Cell Carcinoma of Bladder Stage 0 Transitional Cell Carcinoma of Urinary Bladder Stage 0 Transitional Cell Carcinoma of the Bladder Stage 0 Transitional Cell Carcinoma of the Urinary Bladder Stage 0 Urinary Bladder Transitional Cell Carcinoma Stage 0 Bladder Urothelial Carcinoma AJCC v6 and v7 Stage I includes: T1, N0, M0. T1: Tumor invades subepithelial connective tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6191 Neoplastic Process Stage I Bladder Urothelial Carcinoma AJCC v6 and v7 Stage I Bladder Urothelial Carcinoma AJCC v6 and v7 C1336450 CTRP Malignant Stage_I_Bladder_Transitional_Cell_Carcinoma Stage I Bladder Urothelial Cancer Stage I Bladder Urothelial Carcinoma Stage I Bladder Urothelial Carcinoma AJCC v6 Stage I Bladder Urothelial Carcinoma AJCC v6 and v7 Stage I Bladder Urothelial Carcinoma AJCC v7 Stage I Transitional Cell Carcinoma of Bladder Stage I Transitional Cell Carcinoma of Urinary Bladder Stage I Transitional Cell Carcinoma of the Bladder Stage I Transitional Cell Carcinoma of the Urinary Bladder Stage I Urinary Bladder Transitional Cell Carcinoma Stage I Bladder Urothelial Carcinoma AJCC v6 and v7 An endophytic urothelial neoplasm arising from the urinary tract. It shares several morphologic features with urothelial papilloma. C6192 Neoplastic Process Inverted Urothelial Papilloma C1334282 Benign Inverted_Urothelial_Papilloma Inverted Papilloma of Urinary Tract Inverted Urothelial Papilloma Urinary Tract Inverted Papilloma Inverted Urothelial Papilloma Stage 0 includes: 0a (Ta, N0, M0); 0is (Tis, N0, M0). Ta: Papillary noninvasive carcinoma. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6193 Neoplastic Process Stage 0 Renal Pelvis Cancer AJCC v7 Stage 0 Renal Pelvis Cancer AJCC v7 C1336094 CTRP Malignant Stage_0_Renal_Pelvis_Carcinoma Stage 0 Carcinoma of Renal Pelvis Stage 0 Carcinoma of the Renal Pelvis Stage 0 Renal Pelvis Cancer Stage 0 Renal Pelvis Cancer AJCC v7 Stage 0 Renal Pelvis Urothelial Carcinoma Stage 0 Renal Pelvis Urothelial Carcinoma AJCC v7 Stage 0 Renal Pelvis Cancer AJCC v7 Also known as collecting duct carcinoma, this is a rare type of renal carcinoma. It arises from the collecting ducts of the renal medulla, and most authors suggest that this is an aggressive tumor. C6194 Neoplastic Process Collecting Duct Carcinoma C1266044 CTEP Cellosaurus GDC A rare type of kidney cancer that grows and spreads quickly. It begins in the duct of Bellini in the kidney. 8319/3 Malignant Collecting_Duct_Carcinoma 8319/3 Bellini duct carcinoma Collecting duct carcinoma Renal carcinoma, collecting duct type BDC Bellini Duct Carcinoma Bellini duct carcinoma Carcinoma of Collecting Ducts of Bellini Carcinoma of Kidney Collecting Duct Carcinoma of Renal Collecting Duct Carcinoma of the Collecting Ducts of Bellini Carcinoma of the Kidney Collecting Duct Carcinoma of the Renal Collecting Duct Collecting Duct Carcinoma Collecting Duct Renal Cell Carcinoma Collecting duct carcinoma Collecting duct renal cancer Kidney Collecting Duct Carcinoma Renal Collecting Duct Carcinoma Renal carcinoma, collecting duct type Collecting Duct Carcinoma Stage 0 includes: 0a (Ta, N0, M0); 0is (Tis, N0, M0); (Tis pu, N0, M0); (Tis pd, N0, M0). Ta: Noninvasive papillary, polypoid, or verrucous carcinoma. Tis: Carcinoma in situ. Tis pu: Carcinoma in situ, involvement of the prostatic urethra. Tis pd: Carcinoma in situ, involvement of the prostatic ducts. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6195 Neoplastic Process Stage 0 Urethral Cancer AJCC v7 Stage 0 Urethral Cancer AJCC v7 C1336099 CTRP Abnormal cells are found on the inside lining of the urethra. These abnormal cells may become cancer and spread into nearby normal tissue. Malignant Stage_0_Urethral_Cancer Stage 0 Carcinoma of Urethra Stage 0 Carcinoma of the Urethra Stage 0 Urethra Cancer Stage 0 Urethra Carcinoma Stage 0 Urethral Cancer Stage 0 Urethral Cancer AJCC v7 Stage 0 Urethral Carcinoma Urethra Cancer Stage 0 stage 0 urethral carcinoma in situ Stage 0 Urethral Cancer AJCC v7 Stage 0a includes: Ta, N0, M0. Ta: Noninvasive papillary, polypoid, or verrucous carcinoma. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6196 Neoplastic Process Stage 0a Urethral Cancer AJCC v7 Stage 0a Urethral Cancer AJCC v7 C1336103 CTRP Malignant Stage_0a_Urethral_Cancer Stage 0a Carcinoma of Urethra Stage 0a Carcinoma of the Urethra Stage 0a Urethra Cancer Stage 0a Urethra Carcinoma Stage 0a Urethral Cancer Stage 0a Urethral Cancer AJCC v7 Stage 0a Urethral Carcinoma Urethra Cancer Stage 0a Stage 0a Urethral Cancer AJCC v7 Stage I includes: T1, N0, M0. T1: Tumor invades subepithelial connective tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6197 Neoplastic Process Stage I Urethral Cancer AJCC v7 Stage I Urethral Cancer AJCC v7 C1336493 CTRP Malignant Stage_I_Urethral_Cancer Stage I Carcinoma of Urethra Stage I Carcinoma of the Urethra Stage I Urethra Cancer Stage I Urethra Carcinoma Stage I Urethral Cancer Stage I Urethral Cancer AJCC v7 Stage I Urethral Carcinoma Urethra Cancer Stage I Stage I Urethral Cancer AJCC v7 Stage II includes: T2, N0, M0. T2: Tumor invades any of the following: corpus spongiosum, prostate, periurethral muscle. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6198 Neoplastic Process Stage II Urethral Cancer AJCC v7 Stage II Urethral Cancer AJCC v7 C1336329 CTRP Malignant Stage_II_Urethral_Cancer Stage II Carcinoma of Urethra Stage II Carcinoma of the Urethra Stage II Urethra Carcinoma Stage II Urethral Cancer Stage II Urethral Cancer AJCC v7 Stage II Urethral Carcinoma Urethra Cancer Stage II Stage II Urethral Cancer AJCC v7 Stage III includes: (T1, N1, M0); (T2, N1, M0); (T3, N0, M0), (T3, N1, M0). T1: Tumor invades subepithelial connective tissue. T2: Tumor invades any of the following: corpus spongiosum, prostate, periurethral muscle. T3: Tumor invades any of the following: corpus cavernosum, beyond prostatic capsule, anterior vagina, bladder neck. N1: Metastasis in a single lymph node 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6199 Neoplastic Process Stage III Urethral Cancer AJCC v7 Stage III Urethral Cancer AJCC v7 C1336277 CTRP Malignant Stage_III_Urethral_Cancer Stage III Carcinoma of Urethra Stage III Carcinoma of the Urethra Stage III Urethra Cancer Stage III Urethra Carcinoma Stage III Urethral Cancer Stage III Urethral Cancer AJCC v7 Stage III Urethral Carcinoma Urethra Cancer Stage III Stage III Urethral Cancer AJCC v7 Stage IV includes: (T4, N0, M0); (T4, N1, M0); (Any T, N2, M0), (Any T, Any N, M1). T4: Tumor invades other adjacent organs. N0: No regional lymph node metastasis. N1: Metastasis in a single lymph node 2 cm or less in greatest dimension. N2: Metastasis in a single lymph node more than 2 cm in greatest dimension, or in multiple lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C6200 Neoplastic Process Stage IV Urethral Cancer AJCC v7 Stage IV Urethral Cancer AJCC v7 C1336444 CTRP Malignant Stage_IV_Urethral_Cancer Stage IV Carcinoma of Urethra Stage IV Carcinoma of the Urethra Stage IV Urethra Cancer Stage IV Urethra Carcinoma Stage IV Urethral Cancer Stage IV Urethral Cancer AJCC v7 Stage IV Urethral Carcinoma Urethra Cancer Stage IV Stage IV Urethral Cancer AJCC v7 Stage 0a includes: Ta, N0, M0. Ta: Papillary noninvasive carcinoma. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6202 Neoplastic Process Stage 0a Renal Pelvis Cancer AJCC v7 Stage 0a Renal Pelvis Cancer AJCC v7 C1336100 CTRP Malignant Stage_0a_Renal_Pelvis_Carcinoma Renal Pelvis Papillary Noninvasive Carcinoma Stage 0a Carcinoma of Renal Pelvis Stage 0a Carcinoma of the Renal Pelvis Stage 0a Renal Pelvis Cancer Stage 0a Renal Pelvis Cancer AJCC v7 Stage 0a Renal Pelvis Urothelial Carcinoma Stage 0a Renal Pelvis Urothelial Carcinoma AJCC v7 Stage 0a Renal Pelvis Cancer AJCC v7 Stage 0a includes: Ta, N0, M0. Ta: Papillary noninvasive carcinoma. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6203 Neoplastic Process Stage 0a Ureter Cancer AJCC v7 Stage 0a Ureter Cancer AJCC v7 C1336102 CTRP Malignant Stage_0a_Ureter_Cancer Stage 0a Carcinoma of Ureter Stage 0a Carcinoma of the Ureter Stage 0a Ureter Cancer Stage 0a Ureter Cancer AJCC v7 Stage 0a Ureter Carcinoma Stage 0a Ureter Urothelial Carcinoma Stage 0a Ureter Urothelial Carcinoma AJCC v7 Stage 0a Ureteral Carcinoma Ureter Cancer Stage 0a Ureter Papillary Noninvasive Carcinoma Stage 0a Ureter Cancer AJCC v7 A mature or immature teratoma affecting the central nervous system and occurring in children. C6204 Neoplastic Process Childhood Central Nervous System Teratoma Childhood Central Nervous System Teratoma C1377599 CTRP NICHD A mature or immature teratoma that arises from the central nervous system during childhood. Undetermined Childhood_Central_Nervous_System_Teratoma Central Nervous System Teratoma Childhood CNS Teratoma Childhood Central Nervous System Teratoma Childhood Teratoma of CNS Childhood Teratoma of Central Nervous System Childhood Teratoma of the CNS Childhood Teratoma of the Central Nervous System Pediatric CNS Teratoma Pediatric Central Nervous System Teratoma Pediatric Teratoma of CNS Pediatric Teratoma of Central Nervous System Pediatric Teratoma of the CNS Pediatric Teratoma of the Central Nervous System Childhood Central Nervous System Teratoma A germ cell tumor of the central nervous system occurring in children. C6205 Neoplastic Process Childhood Central Nervous System Germ Cell Tumor Childhood Central Nervous System Germ Cell Tumor C0278754 CTRP NICHD A germ cell tumor that arises from the central nervous system during childhood. Undetermined Childhood_Central_Nervous_System_Germ_Cell_Neoplasm Central Nervous System Germ Cell Tumor Childhood CNS Germ Cell Neoplasm Childhood CNS Germ Cell Tumor Childhood Central Nervous System Germ Cell Neoplasm Childhood Central Nervous System Germ Cell Tumor Childhood Germ Cell Neoplasm of CNS Childhood Germ Cell Neoplasm of Central Nervous System Childhood Germ Cell Neoplasm of the CNS Childhood Germ Cell Neoplasm of the Central Nervous System Childhood Germ Cell Tumor of CNS Childhood Germ Cell Tumor of Central Nervous System Childhood Germ Cell Tumor of the CNS Childhood Germ Cell Tumor of the Central Nervous System Pediatric CNS Germ Cell Neoplasm Pediatric CNS Germ Cell Tumor Pediatric Central Nervous System Germ Cell Neoplasm Pediatric Central Nervous System Germ Cell Tumor Pediatric Germ Cell Neoplasm of CNS Pediatric Germ Cell Neoplasm of Central Nervous System Pediatric Germ Cell Neoplasm of the CNS Pediatric Germ Cell Neoplasm of the Central Nervous System Pediatric Germ Cell Tumor of CNS Pediatric Germ Cell Tumor of Central Nervous System Pediatric Germ Cell Tumor of the CNS Pediatric Germ Cell Tumor of the Central Nervous System Childhood Central Nervous System Germ Cell Tumor A choriocarcinoma that arises from the central nervous system and occurs during childhood. C6206 Neoplastic Process Childhood Central Nervous System Choriocarcinoma Childhood Central Nervous System Choriocarcinoma C1377604 CTRP NICHD A choriocarcinoma that arises from the central nervous system during childhood. Malignant Childhood_Central_Nervous_System_Choriocarcinoma Central Nervous System Choriocarcinoma Childhood CNS Choriocarcinoma Childhood Central Nervous System Choriocarcinoma Choriocarcinoma of Childhood CNS Choriocarcinoma of Childhood Central Nervous System Choriocarcinoma of Pediatric CNS Choriocarcinoma of Pediatric Central Nervous System Choriocarcinoma of the Childhood CNS Choriocarcinoma of the Childhood Central Nervous System Choriocarcinoma of the Pediatric CNS Choriocarcinoma of the Pediatric Central Nervous System Pediatric CNS Choriocarcinoma Pediatric Central Nervous System Choriocarcinoma Childhood Central Nervous System Choriocarcinoma A germinoma arising from the brain during childhood. C6207 Neoplastic Process Childhood Brain Germinoma C1332948 Malignant Childhood_Brain_Germinoma Childhood Brain Germinoma Germinoma of Childhood Brain Germinoma of Pediatric Brain Germinoma of the Childhood Brain Germinoma of the Pediatric Brain Pediatric Brain Germ Cell Cancer Pediatric Brain Germinoma Childhood Brain Germinoma An embryonal carcinoma that arises from the central nervous system and occurs during childhood. C6208 Neoplastic Process Childhood Central Nervous System Embryonal Carcinoma C1377605 NICHD An embryonal carcinoma that arises from the central nervous system during childhood. Malignant Childhood_Central_Nervous_System_Embryonal_Carcinoma Childhood CNS Embryonal Cell Carcinoma Childhood Central Nervous System Embryonal Carcinoma Embryonal Carcinoma of Childhood CNS Embryonal Carcinoma of Childhood Central Nervous System Embryonal Carcinoma of Pediatric CNS Embryonal Carcinoma of Pediatric Central Nervous System Embryonal Carcinoma of the Childhood CNS Embryonal Carcinoma of the Childhood Central Nervous System Embryonal Carcinoma of the Pediatric CNS Embryonal Carcinoma of the Pediatric Central Nervous System Pediatric CNS Embryonal Cell Carcinoma Pediatric Central Nervous System Embryonal Carcinoma Childhood Central Nervous System Embryonal Carcinoma A yolk sac tumor that arises from the central nervous system and occurs during childhood. C6209 Neoplastic Process Childhood Central Nervous System Yolk Sac Tumor Childhood Central Nervous System Yolk Sac Tumor C1377613 CTRP NICHD A yolk sac tumor that arises from the central nervous system during childhood. Malignant Childhood_Central_Nervous_System_Yolk_Sac_Tumor Central Nervous System Yolk Sac Tumor Childhood Central Nervous System Endodermal Sinus Neoplasm Childhood Central Nervous System Endodermal Sinus Tumor Childhood Central Nervous System Yolk Sac Neoplasm Childhood Central Nervous System Yolk Sac Tumor Pediatric Central Nervous System Endodermal Sinus Neoplasm Pediatric Central Nervous System Endodermal Sinus Tumor Pediatric Central Nervous System Yolk Sac Neoplasm Pediatric Central Nervous System Yolk Sac Tumor Childhood Central Nervous System Yolk Sac Tumor A granular cell tumor that arises from the soft palate and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C6210 Neoplastic Process Soft Palate Benign Granular Cell Tumor C1336019 Benign Soft_Palate_Benign_Granular_Cell_Tumor Benign Granular Cell Neoplasm of Soft Palate Benign Granular Cell Neoplasm of the Soft Palate Benign Granular Cell Tumor of Soft Palate Benign Granular Cell Tumor of the Soft Palate Soft Palate Benign Granular Cell Neoplasm Soft Palate Benign Granular Cell Tumor Soft Palate Benign Granular Cell Tumor A benign, slow-growing and painless neoplasm that arises from the minor salivary glands in the soft palate. It is composed of cells that demonstrate both epithelial and mesenchymal differentiation. C6211 Neoplastic Process Soft Palate Pleomorphic Adenoma C1336020 Benign Soft_Palate_Pleomorphic_Adenoma Benign Mixed Tumor of Soft Palate Benign Mixed Tumor of the Soft Palate Pleomorphic Adenoma of Soft Palate Pleomorphic Adenoma of the Soft Palate Soft Palate Benign Mixed Salivary Tumor Soft Palate Benign Mixed Tumor Soft Palate Pleomorphic Adenoma Soft Palate Pleomorphic Adenoma A benign, slow-growing and painless neoplasm that arises from the minor salivary glands in the hard palate. It is composed of cells that demonstrate both epithelial and mesenchymal differentiation. C6212 Neoplastic Process Hard Palate Pleomorphic Adenoma C1333939 Benign Hard_Palate_Pleomorphic_Adenoma Benign Mixed Salivary Tumor of Hard Palate Benign Mixed Salivary Tumor of the Hard Palate Benign Mixed Tumor of Hard Palate Benign Mixed Tumor of the Hard Palate Hard Palate Benign Mixed Tumor Hard Palate Pleomorphic Adenoma Pleomorphic Adenoma of Hard Palate Pleomorphic Adenoma of the Hard Palate Hard Palate Pleomorphic Adenoma An adenoid cystic carcinoma arising from the minor salivary glands in the hard palate. C6213 Neoplastic Process Hard Palate Adenoid Cystic Carcinoma C1333936 Malignant Hard_Palate_Adenoid_Cystic_Carcinoma Adenoid Cystic Carcinoma of Hard Palate Adenoid Cystic Carcinoma of the Hard Palate Hard Palate Adenoid Cystic Carcinoma Hard Palate Adenoid Cystic Carcinoma A mucoepidermoid carcinoma arising from the minor salivary glands in the hard palate. C6214 Neoplastic Process Hard Palate Mucoepidermoid Carcinoma C1333938 Cellosaurus Malignant Hard_Palate_Mucoepidermoid_Carcinoma Hard Palate Mucoepidermoid Carcinoma Mucoepidermoid Carcinoma of Hard Palate Mucoepidermoid Carcinoma of the Hard Palate Hard Palate Mucoepidermoid Carcinoma An anaplastic astrocytoma that arises from the central nervous system and occurs during childhood. C6215 Neoplastic Process Childhood Anaplastic Astrocytoma Childhood Anaplastic Astrocytoma CL414453 CTRP NICHD An anaplastic astrocytoma that occurs during childhood. Malignant Childhood_Anaplastic_Astrocytoma Anaplastic Astrocytoma Anaplastic Childhood Astrocytoma Anaplastic Pediatric Astrocytoma Childhood Anaplastic Astrocytoma Grade 3 Childhood Astrocytic Neoplasm Grade 3 Childhood Astrocytic Tumor Grade 3 Childhood Astrocytoma Grade 3 Pediatric Astrocytic Neoplasm Grade 3 Pediatric Astrocytic Tumor Grade 3 Pediatric Astrocytoma Grade III Childhood Astrocytic Neoplasm Grade III Childhood Astrocytic Tumor Grade III Childhood Astrocytoma Grade III Pediatric Astrocytic Neoplasm Grade III Pediatric Astrocytic Tumor Grade III Pediatric Astrocytoma Undifferentiated Childhood Astrocytoma Undifferentiated Pediatric Astrocytoma Childhood Anaplastic Astrocytoma An astrocytoma that arises from the brain stem and occurs during childhood. C6216 Neoplastic Process Childhood Brain Stem Astrocytoma C1332950 NICHD An astrocytoma that arises from the brain stem and occurs during childhood. Undetermined Childhood_Brain_Stem_Astrocytoma Childhood Brain Stem Astrocytoma Childhood Brainstem Astrocytoma Childhood Brain Stem Astrocytoma The reemergence of brain stem astrocytoma in childhood after a period of remission. C6217 Neoplastic Process Recurrent Childhood Brain Stem Astrocytoma C1335695 Undetermined Recurrent_Childhood_Brain_Stem_Astrocytoma Recurrent Childhood Brain Stem Astrocytoma Recurrent Childhood Brainstem Astrocytoma Recurrent Childhood Brain Stem Astrocytoma A benign neoplasm of the cerebrum occurring in adults. C6218 Neoplastic Process Adult Benign Cerebral Neoplasm C1332469 Benign Benign_Adult_Cerebral_Neoplasm Adult Benign Cerebral Neoplasm Adult Benign Cerebral Neoplasms Benign Adult Cerebral Hemispheric Neoplasm Benign Adult Cerebral Hemispheric Tumor Benign Adult Cerebral Neoplasm Benign Adult Cerebral Tumor Benign Adult Neoplasm of Cerebral Hemispheres Benign Adult Neoplasm of Cerebrum Benign Adult Neoplasm of the Cerebral Hemispheres Benign Adult Neoplasm of the Cerebrum Benign Adult Tumor of Cerebral Hemispheres Benign Adult Tumor of Cerebrum Benign Adult Tumor of the Cerebral Hemispheres Benign Adult Tumor of the Cerebrum Adult Benign Cerebral Neoplasm A childhood neoplasm that arises from the cerebrum and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C6219 Neoplastic Process Childhood Benign Cerebral Neoplasm C1332484 Benign Benign_Childhood_Cerebral_Neoplasm Benign Childhood Cerebral Hemispheric Neoplasm Benign Childhood Cerebral Hemispheric Tumor Benign Childhood Cerebral Neoplasm Benign Childhood Cerebral Tumor Benign Childhood Neoplasm of Cerebral Hemispheres Benign Childhood Neoplasm of Cerebrum Benign Childhood Neoplasm of the Cerebral Hemispheres Benign Childhood Neoplasm of the Cerebrum Benign Childhood Tumor of Cerebral Hemispheres Benign Childhood Tumor of Cerebrum Benign Childhood Tumor of the Cerebral Hemispheres Benign Childhood Tumor of the Cerebrum Benign Pediatric Cerebral Hemispheric Neoplasm Benign Pediatric Cerebral Hemispheric Tumor Benign Pediatric Cerebral Neoplasm Benign Pediatric Cerebral Tumor Benign Pediatric Neoplasm of Cerebral Hemispheres Benign Pediatric Neoplasm of Cerebrum Benign Pediatric Neoplasm of the Cerebral Hemispheres Benign Pediatric Neoplasm of the Cerebrum Benign Pediatric Tumor of Cerebral Hemispheres Benign Pediatric Tumor of Cerebrum Benign Pediatric Tumor of the Cerebral Hemispheres Benign Pediatric Tumor of the Cerebrum Childhood Benign Cerebral Neoplasm Childhood Benign Cerebral Neoplasm A carcinoma that arises from the salivary glands, most often the minor salivary glands. It is characterized by the presence of a monomorphic population of malignant epithelial cells with clear cytoplasm and the absence of morphologic features that define other primary neoplasms of the salivary glands. C62191 Neoplastic Process Salivary Gland Clear Cell Carcinoma C1882971 Malignant Salivary_Gland_Clear_Cell_Carcinoma_Not_Otherwise_Specified Salivary Gland Clear Cell Carcinoma Salivary Gland Clear Cell Carcinoma A rare, low-grade adenocarcinoma that arises from the salivary glands. It is characterized by the presence of cystic structures lined by ductal cells which are arranged in cribriform patterns. Adjacent ducts show intraductal proliferation. C62192 Neoplastic Process Salivary Gland Intraductal Carcinoma C1882972 GDC Malignant Salivary_Gland_Low_Grade_Cribriform_Cystadenocarcinoma Low grade cribriform cystadenocarcinoma (LGCCC) Low Grade Salivary Duct Carcinoma Salivary Gland Intraductal Carcinoma Salivary Gland Low Grade Cribriform Cystadenocarcinoma Salivary Gland Intraductal Carcinoma A rare adenocarcinoma that arises from the salivary glands, most frequently the soft palate and the sublingual gland. It is characterized by the presence of large pools of extracellular mucin in which clusters of malignant epithelial cells are found. Patients usually present with a slow growing mass. It tends to recur locally and metastasize to regional lymph nodes. C62193 Neoplastic Process Salivary Gland Mucinous Adenocarcinoma C1882973 Malignant Salivary_Gland_Mucinous_Adenocarcinoma Salivary Gland Mucinous Adenocarcinoma Salivary Gland Mucinous Adenocarcinoma A high grade adenocarcinoma that arises from the salivary glands. The vast majority of cases have been described in the parotid gland. It is characterized by the presence of malignant oncocytes. It recurs and metastasizes to regional or distant anatomic sites. C62194 Neoplastic Process Salivary Gland Oncocytic Adenocarcinoma C1882974 Malignant Salivary_Gland_Oncocytic_Carcinoma Salivary Gland Oncocytic Adenocarcinoma Salivary Gland Oncocytic Carcinoma Salivary Gland Oncocytic Adenocarcinoma An adenocarcinoma that arises from the salivary glands. It exhibits ductal differentiation but lacks any of the morphologic features that characterize the other well-defined primary adenocarcinomas of the salivary glands. C62196 Neoplastic Process Salivary Gland Adenocarcinoma, Not Otherwise Specified C1882970 Malignant Salivary_Gland_Adenocarcinoma_Not_Otherwise_Specified Salivary Gland Adenocarcinoma, NOS Salivary Gland Adenocarcinoma, Not Otherwise Specified Salivary Gland Adenocarcinoma, Not Otherwise Specified A rare benign adipose tissue neoplasm within the cerebral hemisphere often associated with partial or complete agenesis of the corpus callosum. C6220 Neoplastic Process Cerebral Hemisphere Lipoma C1332907 Benign Cerebral_Hemisphere_Lipoma Cerebral Hemisphere Lipoma Lipoma of Cerebral Hemisphere Lipoma of the Cerebral Hemisphere Cerebral Hemisphere Lipoma C6221 Neoplastic Process Thalamic Neoplasm C1336733 Undetermined Thalamic_Neoplasm Neoplasm of Thalamus Neoplasm of the Thalamus Thalamic Neoplasm Thalamic Neoplasms Thalamic Tumor Thalamic Tumors Thalamus Neoplasm Thalamus Neoplasms Thalamus Tumor Thalamus Tumors Tumor of Thalamus Tumor of the Thalamus Thalamic Neoplasm A benign, well circumscribed neoplasm that arises from the breast. It is composed entirely of tubular structures that contain epithelial and myoepithelial cells. C62210 Neoplastic Process Breast Tubular Adenoma C1879899 Benign Breast_Tubular_Adenoma Breast Tubular Adenoma Breast Tubular Adenoma A neoplasm that arises from the thalamus and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C6222 Neoplastic Process Benign Thalamic Neoplasm C1332541 Benign Benign_Thalamic_Neoplasm Benign Neoplasm of Thalamus Benign Neoplasm of the Thalamus Benign Thalamic Neoplasm Benign Thalamic Neoplasms Benign Thalamic Tumor Benign Thalamic Tumors Benign Thalamus Neoplasm Benign Thalamus Neoplasms Benign Thalamus Tumor Benign Thalamus Tumors Benign Tumor of Thalamus Benign Tumor of the Thalamus Benign Thalamic Neoplasm A papilloma that arises from the conjunctival squamous epithelium. It is associated with human papillomavirus infection. C6224 Neoplastic Process Conjunctival Squamous Papilloma C1333149 Benign Conjunctival_Squamous_Cell_Papilloma Conjunctival Squamous Cell Papilloma Conjunctival Squamous Papilloma Squamous Cell Papilloma of Conjunctiva Squamous Cell Papilloma of the Conjunctiva Conjunctival Squamous Papilloma A basal cell carcinoma of the skin that often appears as elevated nodules which may become ulcerated. C62282 Neoplastic Process Skin Nodular Basal Cell Carcinoma C1367861 GDC Malignant Skin_Nodular_Basal_Cell_Carcinoma 8097/3 Basal cell carcinoma, nodular Nodular Basal Cell Carcinoma Nodular Basal Cell Carcinoma of Skin Nodular Basal Cell Carcinoma of the Skin Skin Nodular Basal Cell Carcinoma Skin Nodular Basal Cell Carcinoma A variant of basal cell carcinoma of the skin presenting as erythematous, often multiple patches. Morphologically, it is characterized by the presence of superficial lobules of basaloid cells projecting into the dermis. The basaloid cell lobules are surrounded by myxoid stroma and are usually confined to the papillary dermis. C62284 Neoplastic Process Superficial Basal Cell Carcinoma C0862889 Malignant Superficial_Basal_Cell_Carcinoma Superficial basal cell carcinoma Superficial Basal Cell Carcinoma Superficial Basal Cell Carcinoma A malignant tumor arising in the epithelial cells of the brain or spinal cord. C62332 Neoplastic Process Central Nervous System Carcinoma Central Nervous System Carcinoma C1880017 CPTAC CTRP Malignant Central_Nervous_System_Carcinoma Central Nervous System Carcinoma Primary Central Nervous System Carcinoma Central Nervous System Carcinoma Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C6236 Neoplastic Process Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 C1336400 CTRP Malignant Stage_IVC_Nasopharyngeal_Squamous_Cell_Carcinoma Nasopharyngeal Keratinizing Squamous Cell Carcinoma Stage IVC Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage IVC Nasopharyngeal Throat Keratinizing Squamous Cell Cancer Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 An adenocarcinoma that arises from the ethmoid sinus. C6237 Neoplastic Process Ethmoid Sinus Adenocarcinoma C1333472 Malignant Ethmoid_Sinus_Adenocarcinoma Adenocarcinoma of Ethmoid Sinus Adenocarcinoma of the Ethmoid Sinus Ethmoid Sinus Adenocarcinoma Ethmoid Sinus Adenocarcinoma An adenoid cystic carcinoma that affects the ethmoid sinus. C6238 Neoplastic Process Ethmoid Sinus Adenoid Cystic Carcinoma C1333473 Malignant Ethmoid_Sinus_Adenoid_Cystic_Carcinoma Adenoid Cystic Carcinoma of Ethmoid Sinus Adenoid Cystic Carcinoma of the Ethmoid Sinus Ethmoid Sinus Adenoid Cystic Carcinoma Ethmoid Sinus Adenoid Cystic Carcinoma An adenoid cystic carcinoma that arises from the maxillary sinus. It usually has an aggressive clinical course. C6239 Neoplastic Process Maxillary Sinus Adenoid Cystic Carcinoma C1334643 Malignant Maxillary_Sinus_Adenoid_Cystic_Carcinoma Adenoid Cystic Carcinoma of Maxillary Sinus Adenoid Cystic Carcinoma of the Maxillary Sinus Maxillary Sinus Adenoid Cystic Carcinoma Maxillary Sinus Adenoid Cystic Carcinoma An adenocarcinoma that arises from the maxillary sinus. C6240 Neoplastic Process Maxillary Sinus Adenocarcinoma C1334642 Malignant Maxillary_Sinus_Adenocarcinoma Adenocarcinoma of Maxillary Sinus Adenocarcinoma of the Maxillary Sinus Maxillary Sinus Adenocarcinoma Maxillary Sinus Adenocarcinoma C62406 Finding Ionizing Radiation Toxicity C1881258 Ionizing_Radiation_Toxicity Ionizing Radiation Toxicity Ionizing Radiation Toxicity A rare adenoid cystic carcinoma that arises from the oropharynx. C6241 Neoplastic Process Oropharyngeal Adenoid Cystic Carcinoma Oropharyngeal Adenoid Cystic Carcinoma C1335139 CTRP Malignant Oropharyngeal_Adenoid_Cystic_Carcinoma Adenoid Cystic Carcinoma of Oropharynx Adenoid Cystic Carcinoma of the Oropharynx Oropharyngeal Adenoid Cystic Carcinoma Oropharyngeal Throat Adenoid Cystic Cancer Oropharyngeal Adenoid Cystic Carcinoma A benign, slow-growing and painless neoplasm that arises from the salivary glands in the oral cavity. It is composed of cells that demonstrate both epithelial and mesenchymal differentiation. C6242 Neoplastic Process Oral Cavity Pleomorphic Adenoma C1335123 Cellosaurus Benign Oral_Cavity_Pleomorphic_Adenoma Benign Mixed Salivary Tumor of Oral Cavity Benign Mixed Salivary Tumor of the Oral Cavity Oral Cavity Pleomorphic Adenoma Pleomorphic Adenoma of Oral Cavity Pleomorphic Adenoma of the Oral Cavity Oral Cavity Pleomorphic Adenoma An adenocarcinoma with serous acinar cell differentiation that arises from the minor salivary glands. C6243 Neoplastic Process Minor Salivary Gland Acinic Cell Carcinoma C1334767 Malignant Minor_Salivary_Gland_Acinic_Cell_Carcinoma Acinic Cell Adenocarcinoma of Minor Salivary Gland Acinic Cell Adenocarcinoma of the Minor Salivary Gland Acinic Cell Carcinoma of Minor Salivary Gland Acinic Cell Carcinoma of the Minor Salivary Gland Minor Salivary Gland Acinic Cell Adenocarcinoma Minor Salivary Gland Acinic Cell Carcinoma Minor Salivary Gland Acinic Cell Carcinoma A lymphoma that arises from the structures of the orbit. Representative examples include mucosa-associated lymphoid tissue lymphoma, follicular lymphoma, and diffuse large B-cell lymphoma. C6244 Neoplastic Process Orbit Lymphoma C0271333 Malignant Orbit_Lymphoma Lymphoma of Orbit Lymphoma of the Orbit Orbit Lymphoma Primary Orbit Lymphoma Orbit Lymphoma A crease in the skin on the flexor side of a joint. C62447 Anatomical Structure Flexural Skin C1880789 Flexural_Skin Flexural Skin Flexural Skin A hemangioma arising from the orbit. C6245 Neoplastic Process Orbit Hemangioma C1335128 Benign Orbit_Hemangioma Angioma of Orbit Angioma of the Orbit Hemangioma of Orbit Hemangioma of the Orbit Orbit Angioma Orbit Hemangioma Orbit Hemangioma A malignant mesenchymal neoplasm that arises from the orbit. It is characterized by the presence of skeletal muscle tissue exhibiting embryonic features. C6246 Neoplastic Process Orbit Embryonal Rhabdomyosarcoma C1335127 Malignant Orbit_Embryonal_Rhabdomyosarcoma Embryonal Rhabdomyosarcoma of Orbit Embryonal Rhabdomyosarcoma of the Orbit Orbit Embryonal Rhabdomyosarcoma Orbit Embryonal Rhabdomyosarcoma A malignant mesenchymal neoplasm that arises in the orbit. It is characterized by the presence of round cells with myoblastic differentiation and a fibrovascular stroma. C6247 Neoplastic Process Orbit Alveolar Rhabdomyosarcoma C1335126 Malignant Orbit_Alveolar_Rhabdomyosarcoma Alveolar Rhabdomyosarcoma of Orbit Alveolar Rhabdomyosarcoma of the Orbit Orbit Alveolar Rhabdomyosarcoma Orbit Alveolar Rhabdomyosarcoma A rare lymphoma that arises from the trachea. Signs and symptoms include dyspnea, cough, wheezing, and stridor. C6248 Neoplastic Process Tracheal Lymphoma C1336773 Malignant Tracheal_Lymphoma Lymphoma of Trachea Lymphoma of the Trachea Primary Tracheal Lymphoma Tracheal Lymphoma Tracheal Lymphoma A carcinoma that arises from the anterior two-thirds of the tongue. Representative examples include squamous cell carcinoma, adenoid cystic carcinoma, and mucoepidermoid carcinoma. C6249 Neoplastic Process Anterior Tongue Carcinoma C1332304 Malignant Anterior_Tongue_Carcinoma Anterior Tongue Carcinoma Carcinoma of Anterior Tongue Carcinoma of the Anterior Tongue Anterior Tongue Carcinoma A mucoepidermoid carcinoma arising from the minor salivary glands in the anterior tongue. C6250 Neoplastic Process Anterior Tongue Mucoepidermoid Carcinoma C1332305 Malignant Anterior_Tongue_Mucoepidermoid_Carcinoma Anterior Tongue Mucoepidermoid Carcinoma Mucoepidermoid Carcinoma of Anterior Tongue Mucoepidermoid Carcinoma of the Anterior Tongue Anterior Tongue Mucoepidermoid Carcinoma An adenoid cystic carcinoma arising from the minor salivary glands in the anterior tongue. C6251 Neoplastic Process Anterior Tongue Adenoid Cystic Carcinoma C1332303 Malignant Anterior_Tongue_Adenoid_Cystic_Carcinoma Adenoid Cystic Carcinoma of Anterior Tongue Adenoid Cystic Carcinoma of the Anterior Tongue Anterior Tongue Adenoid Cystic Carcinoma Anterior Tongue Adenoid Cystic Carcinoma An anaplastic astrocytoma that arises from the brain and occurs during childhood. C6252 Neoplastic Process Childhood Brain Anaplastic Astrocytoma C1332947 Malignant Childhood_Brain_Anaplastic_Astrocytoma Anaplastic Childhood Astrocytoma of Brain Anaplastic Childhood Astrocytoma of the Brain Anaplastic Childhood Brain Astrocytoma Anaplastic Pediatric Astrocytoma of Brain Anaplastic Pediatric Astrocytoma of the Brain Anaplastic Pediatric Brain Astrocytoma Childhood Brain Anaplastic Astrocytoma Grade 3 Childhood Astrocytic Neoplasm of Brain Grade 3 Childhood Astrocytic Neoplasm of the Brain Grade 3 Childhood Astrocytic Tumor of Brain Grade 3 Childhood Astrocytic Tumor of the Brain Grade 3 Childhood Astrocytoma of Brain Grade 3 Childhood Astrocytoma of the Brain Grade 3 Childhood Brain Astrocytic Neoplasm Grade 3 Childhood Brain Astrocytic Tumor Grade 3 Childhood Brain Astrocytoma Grade 3 Pediatric Astrocytic Neoplasm of Brain Grade 3 Pediatric Astrocytic Neoplasm of the Brain Grade 3 Pediatric Astrocytic Tumor of Brain Grade 3 Pediatric Astrocytic Tumor of the Brain Grade 3 Pediatric Astrocytoma of Brain Grade 3 Pediatric Astrocytoma of the Brain Grade 3 Pediatric Brain Astrocytic Neoplasm Grade 3 Pediatric Brain Astrocytic Tumor Grade 3 Pediatric Brain Astrocytoma Grade III Childhood Astrocytic Neoplasm of Brain Grade III Childhood Astrocytic Neoplasm of the Brain Grade III Childhood Astrocytic Tumor of Brain Grade III Childhood Astrocytic Tumor of the Brain Grade III Childhood Astrocytoma of Brain Grade III Childhood Astrocytoma of the Brain Grade III Childhood Brain Astrocytic Neoplasm Grade III Childhood Brain Astrocytic Tumor Grade III Childhood Brain Astrocytoma Grade III Pediatric Astrocytic Neoplasm of Brain Grade III Pediatric Astrocytic Neoplasm of the Brain Grade III Pediatric Astrocytic Tumor of Brain Grade III Pediatric Astrocytic Tumor of the Brain Grade III Pediatric Astrocytoma of Brain Grade III Pediatric Astrocytoma of the Brain Grade III Pediatric Brain Astrocytic Neoplasm Grade III Pediatric Brain Astrocytic Tumor Grade III Pediatric Brain Astrocytoma Childhood Brain Anaplastic Astrocytoma An intracranial meningioma that occurs during childhood. C6253 Neoplastic Process Childhood Brain Meningioma Childhood Intracranial Meningioma C1332949 CTRP Undetermined Childhood_Brain_Meningioma Brain Meningioma Childhood Brain Meningioma Childhood Intracranial Meningioma Childhood Intracranial Meningioma A serous adenocarcinoma that arises from the ovary and is characterized by the presence of a papillary architectural pattern. C6256 Neoplastic Process Ovarian Serous Surface Papillary Adenocarcinoma Ovarian Serous Surface Papillary Adenocarcinoma C1335178 CTRP Cellosaurus Malignant Ovarian_Serous_Surface_Papillary_Carcinoma Ovarian Serous Surface Papillary Adenocarcinoma Serous Surface Papillary Carcinoma of Ovary Serous Surface Papillary Carcinoma of the Ovary Ovarian Serous Surface Papillary Adenocarcinoma A benign, borderline, or malignant epithelial tumor of the ovary characterized by the presence of glands and/or cysts lined by neoplastic cells that resemble endometrial cells. C6257 Neoplastic Process Ovarian Endometrioid Tumor C1335159 Undetermined Ovarian_Endometrioid_Tumor Endometrioid Neoplasm of Ovary Endometrioid Neoplasm of the Ovary Ovarian Endometrioid Neoplasm Ovarian Endometrioid Tumor Ovarian Endometrioid Tumor A form of squamous cell carcinoma in situ. It is a distinct clinicopathological entity and arises from the skin or the mucocutaneous junction. It affects predominantly white males in their 6-8th decades of life. Exposed and non-exposed skin sites are equally affected. UV damage and ingestion of inorganic arsenic may play a role in the development of the disease. On the skin surface, it presents as a single or multiple erythematous, scaly, keratotic patches or plaques. The clinical entity of erythroplasia of Queyrat is regarded as Bowen disease of the penis and it presents as an asymptomatic, red, circumscribed plaque. Morphologically, Bowen disease is characterized by the presence of hyperkeratosis, parakeratosis, dyskeratosis, and acanthosis. The keratotic squamous cells are atypical and display hyperchromatism and abnormal mitotic figures. The dermoepidermal basement membrane is intact. Complete surgical removal of the lesion may be curative. C62571 Neoplastic Process Bowen Disease of the Skin Bowen Disease of the Skin C0006079 CTRP GDC A skin disease marked by scaly or thickened patches on the skin and often caused by prolonged exposure to arsenic. The patches often occur on sun-exposed areas of the skin and in older white men. These patches may become malignant (cancer). 8081/2 Malignant Bowen_Disease_of_the_Skin 8081/2 Bowen disease Intraepidermal squamous cell carcinoma, Bowen type Bowen Disease Bowen Disease of the Skin Bowen disease Bowen's Disease of the Skin Intraepidermal Squamous Cell Carcinoma, Bowen Type Intraepidermal squamous cell carcinoma, Bowen type Bowen Disease of the Skin Stage IIIA includes: T3a, N0, M0. T3a: Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6258 Neoplastic Process Stage IIIA Ovarian Cancer AJCC v6 and v7 Stage IIIA Ovarian Cancer AJCC v6 and v7 C1336212 CTRP Malignant Stage_IIIA_Ovarian_Cancer AJCC Stage IIIA Ovarian Cancer FIGO Stage IIIA Cancer of Ovary FIGO Stage IIIA Cancer of the Ovary FIGO Stage IIIA Carcinoma of Ovary FIGO Stage IIIA Carcinoma of the Ovary FIGO Stage IIIA Ovarian Cancer FIGO Stage IIIA Ovarian Carcinoma Ovarian Cancer Stage IIIA Stage IIIA Ovarian Cancer Stage IIIA Ovarian Cancer AJCC v6 Stage IIIA Ovarian Cancer AJCC v6 and v7 Stage IIIA Ovarian Cancer AJCC v7 Stage IIIA Ovarian Epithelial Cancer Stage IIIA Ovarian Cancer AJCC v6 and v7 Stage IIIB includes: T3b, N0, M0. T3b: Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6259 Neoplastic Process Stage IIIB Ovarian Cancer AJCC v6 and v7 Stage IIIB Ovarian Cancer AJCC v6 and v7 C1336227 CTRP Malignant Stage_IIIB_Ovarian_Cancer AJCC Stage IIIB Ovarian Cancer FIGO Stage IIIB Cancer of Ovary FIGO Stage IIIB Cancer of the Ovary FIGO Stage IIIB Carcinoma of Ovary FIGO Stage IIIB Carcinoma of the Ovary FIGO Stage IIIB Ovarian Cancer FIGO Stage IIIB Ovarian Carcinoma Ovarian Cancer Stage IIIB Stage IIIB Ovarian Cancer Stage IIIB Ovarian Cancer AJCC v6 Stage IIIB Ovarian Cancer AJCC v6 and v7 Stage IIIB Ovarian Cancer AJCC v7 Stage IIIB Ovarian Epithelial Cancer Stage IIIB Ovarian Cancer AJCC v6 and v7 Stage IIIC includes: (T3c, N0, M0); (Any T, N1, M0). T3c: Peritoneal metastasis beyond pelvis more than 2cm in greatest dimension and/or regional lymph node metastasis. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6260 Neoplastic Process Stage IIIC Ovarian Cancer AJCC v6 and v7 Stage IIIC Ovarian Cancer AJCC v6 and v7 C1336237 CTRP Malignant Stage_IIIC_Ovarian_Cancer AJCC Stage IIIC Ovarian Cancer FIGO Stage IIIC Cancer of Ovary FIGO Stage IIIC Cancer of the Ovary FIGO Stage IIIC Carcinoma of Ovary FIGO Stage IIIC Carcinoma of the Ovary FIGO Stage IIIC Ovarian Cancer FIGO Stage IIIC Ovarian Carcinoma Ovarian Cancer Stage IIIC Stage IIIC Ovarian Cancer Stage IIIC Ovarian Cancer AJCC v6 Stage IIIC Ovarian Cancer AJCC v6 and v7 Stage IIIC Ovarian Cancer AJCC v7 Stage IIIC Ovarian Epithelial Cancer Stage IIIC Ovarian Cancer AJCC v6 and v7 A granulosa-stromal cell tumor that arises from the ovary. It is characterized by the presence of granulosa cells that comprise at least ten percent of the cellular population. The granulosa cells are often found in a background that contains theca and fibrous cells. There are two major subtypes recognized, adult and juvenile granulosa cell tumor. Clinically, patients may present with an abdominal mass. Symptoms depend on the patient's age. The most important indicator of prognosis is tumor stage. Age over forty years at the time of the initial diagnosis, large tumor size, bilaterality, cellular atypia, and increased mitotic activity are factors indicating a potentially aggressive clinical course and relative poor prognosis. C6261 Neoplastic Process Ovarian Granulosa Cell Tumor C1370419 Cellosaurus NICHD A granulosa cell tumor that occurs in the ovary. Undetermined Ovarian_Granulosa_Cell_Tumor Granulosa Cell Neoplasm of Ovary Granulosa Cell Neoplasm of the Ovary Granulosa Cell Tumor of Ovary Granulosa Cell Tumor of the Ovary Ovarian Granulosa Cell Neoplasm Ovarian Granulosa Cell Tumor Ovarian Granulosa Cell Tumor A neoplasm that affects the visual pathway. C6262 Neoplastic Process Visual Pathway Neoplasm C1336973 Undetermined Visual_Pathway_Neoplasm Neoplasm of Visual Pathway Neoplasm of the Visual Pathway Tumor of Visual Pathway Tumor of the Visual Pathway Visual Pathway Neoplasm Visual Pathway Neoplasms Visual Pathway Tumor Visual Pathway Neoplasm A thecoma of the ovary that contains lutein cells and may metastasize to other anatomic sites. It is usually characterized by nuclear atypia and mitotic activity. C6263 Neoplastic Process Malignant Ovarian Luteinized Thecoma C1334608 Malignant Malignant_Ovarian_Luteinized_Thecoma Malignant Luteinized Thecal Cell Neoplasm of Ovary Malignant Luteinized Thecal Cell Neoplasm of the Ovary Malignant Luteinized Thecal Cell Tumor of Ovary Malignant Luteinized Thecal Cell Tumor of the Ovary Malignant Luteinized Thecoma of Ovary Malignant Luteinized Thecoma of the Ovary Malignant Ovarian Luteinized Thecal Cell Neoplasm Malignant Ovarian Luteinized Thecal Cell Tumor Malignant Ovarian Luteinized Thecoma Malignant Ovarian Luteinized Thecoma A non-metastasizing thecoma of the ovary that is characterized by the presence of lutein cells. C6264 Neoplastic Process Benign Ovarian Luteinized Thecoma C1332524 Benign Benign_Ovarian_Luteinized_Thecoma Benign Luteinized Ovarian Thecoma Benign Luteinized Thecal Cell Neoplasm of Ovary Benign Luteinized Thecal Cell Neoplasm of the Ovary Benign Luteinized Thecal Cell Tumor of Ovary Benign Luteinized Thecal Cell Tumor of the Ovary Benign Luteinized Thecoma of Ovary Benign Luteinized Thecoma of the Ovary Benign Ovarian Luteinized Thecal Cell Neoplasm Benign Ovarian Luteinized Thecal Cell Tumor Benign Ovarian Luteinized Thecoma Benign Ovarian Luteinized Thecoma An adenocarcinoma that arises from the fallopian tube. Histologic subtypes include clear cell, endometrioid, serous, and mucinous adenocarcinoma. It spreads to adjacent organs, regional lymph nodes, and peritoneum. C6265 Neoplastic Process Fallopian Tube Adenocarcinoma Fallopian Tube Adenocarcinoma C1333590 CTRP Malignant Fallopian_Tube_Adenocarcinoma Adenocarcinoma of Fallopian Tube Adenocarcinoma of the Fallopian Tube Fallopian Tube Adenocarcinoma Fallopian Tube Adenocarcinoma A modification of contrast-enhanced MRI that allows observation of functional properties in addition to structural properties. C62665 Diagnostic Procedure Dynamic Contrast-Enhanced Magnetic Resonance Imaging Dynamic Contrast-Enhanced Magnetic Resonance Imaging C1831914 CDISC CTRP DIPG/DMG A type of contrast-enhanced MRI that allows observation of functional properties in addition to structural properties. Dynamic_Contrast-enhanced_Magnetic_Resonance_Imaging DCE DCE MRI DCE-MRI DYNAMIC CONTRAST ENHANCED MRI Dynamic Contrast-Enhanced Magnetic Resonance Imaging Dynamic Contrast-Enhanced Magnetic Resonance Imaging An ependymoma, not otherwise specified that arises from the cerebral hemispheres and occurs during childhood. C6268 Neoplastic Process Childhood Cerebral Ependymoma, Not Otherwise Specified CL448338 Undetermined Childhood_Cerebral_Ependymoma Childhood Cerebral Ependymoma, NOS Childhood Cerebral Ependymoma, Not Otherwise Specified Childhood Cerebral Ependymoma, Not Otherwise Specified Stage IA includes: T1a, N0, M0. T1a: Tumor limited to one tube, without penetrating the serosal surface; no ascites. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6269 Neoplastic Process Stage IA Fallopian Tube Cancer AJCC v6 and v7 Stage IA Fallopian Tube Cancer AJCC v6 and v7 C1336114 CTRP Malignant Stage_IA_Fallopian_Tube_Cancer AJCC Stage IA Fallopian Tube Cancer FIGO Stage IA Carcinoma of Fallopian Tube FIGO Stage IA Carcinoma of the Fallopian Tube FIGO Stage IA Fallopian Tube Carcinoma Fallopian Tube Cancer Stage IA Stage IA Fallopian Tube Cancer Stage IA Fallopian Tube Cancer AJCC v6 Stage IA Fallopian Tube Cancer AJCC v6 and v7 Stage IA Fallopian Tube Cancer AJCC v7 Stage IA Fallopian Tube Cancer AJCC v6 and v7 Stage IB includes: T1b, N0, M0. T1b: Tumor limited to both tubes, without penetrating the serosal surface; no ascites. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6270 Neoplastic Process Stage IB Fallopian Tube Cancer AJCC v6 and v7 Stage IB Fallopian Tube Cancer AJCC v6 and v7 C1336133 CTRP Malignant Stage_IB_Fallopian_Tube_Cancer AJCC Stage IB Fallopian Tube Cancer FIGO Stage IB Carcinoma of Fallopian Tube FIGO Stage IB Carcinoma of the Fallopian Tube FIGO Stage IB Fallopian Tube Carcinoma Fallopian Tube Cancer Stage IB Stage IB Fallopian Tube Cancer Stage IB Fallopian Tube Cancer AJCC v6 Stage IB Fallopian Tube Cancer AJCC v6 and v7 Stage IB Fallopian Tube Cancer AJCC v7 Stage IB Fallopian Tube Cancer AJCC v6 and v7 Stage IC includes: T1c, N0, M0. T1c: Tumor limited to one or both tubes with extension onto or through the tubal serosa, or with malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6271 Neoplastic Process Stage IC Fallopian Tube Cancer AJCC v6 and v7 Stage IC Fallopian Tube Cancer AJCC v6 and v7 C1336149 CTRP Malignant Stage_IC_Fallopian_Tube_Cancer AJCC Stage IC Fallopian Tube Cancer FIGO Stage IC Carcinoma of Fallopian Tube FIGO Stage IC Carcinoma of the Fallopian Tube FIGO Stage IC Fallopian Tube Carcinoma Fallopian Tube Cancer Stage IC Stage IC Fallopian Tube Cancer Stage IC Fallopian Tube Cancer AJCC v6 Stage IC Fallopian Tube Cancer AJCC v6 and v7 Stage IC Fallopian Tube Cancer AJCC v7 Stage IC Fallopian Tube Cancer AJCC v6 and v7 C62718 Therapeutic or Preventive Procedure Releasing Hormone Antagonist Therapy Releasing Hormone Antagonist Therapy C1831806 CTRP Releasing_Factor_Antagonist_Therapy Releasing Factor Antagonist Therapy Releasing Hormone Antagonist Therapy Releasing Hormone Antagonist Therapy Stage IIA includes: T2a, N0, M0. T2a: Extension and/or metastasis to the uterus and/or ovaries. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6272 Neoplastic Process Stage IIA Fallopian Tube Cancer AJCC v6 and v7 Stage IIA Fallopian Tube Cancer AJCC v6 and v7 C1336161 CTRP Malignant Stage_IIA_Fallopian_Tube_Cancer AJCC Stage IIA Fallopian Tube Cancer FIGO Stage IIA Carcinoma of Fallopian Tube FIGO Stage IIA Carcinoma of the Fallopian Tube FIGO Stage IIA Fallopian Tube Carcinoma Fallopian Tube Cancer Stage IIA Stage IIA Fallopian Tube Cancer Stage IIA Fallopian Tube Cancer AJCC v6 Stage IIA Fallopian Tube Cancer AJCC v6 and v7 Stage IIA Fallopian Tube Cancer AJCC v7 Stage IIA Fallopian Tube Cancer AJCC v6 and v7 Stage IIIA includes: T3a, N0, M0. T3a: Microscopic peritoneal metastasis outside the pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6273 Neoplastic Process Stage IIIA Fallopian Tube Cancer AJCC v7 Stage IIIA Fallopian Tube Cancer AJCC v7 C1336206 CTRP Malignant Stage_IIIA_Fallopian_Tube_Cancer AJCC Stage IIIA Fallopian Tube Cancer FIGO Stage IIIA Carcinoma of Fallopian Tube FIGO Stage IIIA Carcinoma of the Fallopian Tube FIGO Stage IIIA Fallopian Tube Carcinoma Fallopian Tube Cancer Stage IIIA Stage IIIA Fallopian Tube Cancer Stage IIIA Fallopian Tube Cancer AJCC v7 Stage IIIA Fallopian Tube Cancer AJCC v7 Stage IIIB includes: T3b, N0, M0. T3b: Macroscopic peritoneal metastasis outside the pelvis 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6274 Neoplastic Process Stage IIIB Fallopian Tube Cancer AJCC v7 Stage IIIB Fallopian Tube Cancer AJCC v7 C1336221 CTRP Malignant Stage_IIIB_Fallopian_Tube_Cancer AJCC Stage IIIB Fallopian Tube Cancer FIGO Stage IIIB Carcinoma of Fallopian Tube FIGO Stage IIIB Carcinoma of the Fallopian Tube FIGO Stage IIIB Fallopian Tube Carcinoma Fallopian Tube Cancer Stage IIIB Stage IIIB Fallopian Tube Cancer Stage IIIB Fallopian Tube Cancer AJCC v7 Stage IIIB Fallopian Tube Cancer AJCC v7 Stage IIIC includes: (T3c, N0, M0); (Any T, N1, M0). T3c: Peritoneal metastasis outside the pelvis and more than 2 cm in diameter. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6275 Neoplastic Process Stage IIIC Fallopian Tube Cancer AJCC v7 Stage IIIC Fallopian Tube Cancer AJCC v7 C1336236 CTRP Malignant Stage_IIIC_Fallopian_Tube_Cancer AJCC Stage IIIC Fallopian Tube Cancer FIGO Stage IIIC Carcinoma of Fallopian Tube FIGO Stage IIIC Carcinoma of the Fallopian Tube FIGO Stage IIIC Fallopian Tube Carcinoma Fallopian Tube Cancer Stage IIIC Stage IIIC Fallopian Tube Cancer Stage IIIC Fallopian Tube Cancer AJCC v7 Stage IIIC Fallopian Tube Cancer AJCC v7 Stage IIC includes: T2c, N0, M0. T2c: Pelvic extension with malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6276 Neoplastic Process Stage IIC Fallopian Tube Cancer AJCC v6 and v7 Stage IIC Fallopian Tube Cancer AJCC v6 and v7 C1336198 CTRP Malignant Stage_IIC_Fallopian_Tube_Cancer AJCC Stage IIC Fallopian Tube Cancer FIGO Stage IIC Carcinoma of Fallopian Tube FIGO Stage IIC Carcinoma of the Fallopian Tube FIGO Stage IIC Fallopian Tube Carcinoma Fallopian Tube Cancer Stage IIC Stage IIC Fallopian Tube Cancer Stage IIC Fallopian Tube Cancer AJCC v6 Stage IIC Fallopian Tube Cancer AJCC v6 and v7 Stage IIC Fallopian Tube Cancer AJCC v7 Stage IIC Fallopian Tube Cancer AJCC v6 and v7 Stage IIB includes: T2b, N0, M0. T2b: Extension to other pelvic structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6277 Neoplastic Process Stage IIB Fallopian Tube Cancer AJCC v6 and v7 Stage IIB Fallopian Tube Cancer AJCC v6 and v7 C1336183 CTRP Malignant Stage_IIB_Fallopian_Tube_Cancer AJCC Stage IIB Fallopian Tube Cancer FIGO Stage IIB Carcinoma of Fallopian Tube FIGO Stage IIB Carcinoma of the Fallopian Tube FIGO Stage IIB Fallopian Tube Carcinoma Fallopian Tube Cancer Stage IIB Stage IIB Fallopian Tube Cancer Stage IIB Fallopian Tube Cancer AJCC v6 Stage IIB Fallopian Tube Cancer AJCC v6 and v7 Stage IIB Fallopian Tube Cancer AJCC v7 Stage IIB Fallopian Tube Cancer AJCC v6 and v7 A malignant trophoblastic tumor that arises from the fallopian tube during pregnancy. C6278 Neoplastic Process Fallopian Tube Gestational Choriocarcinoma Fallopian Tube Gestational Choriocarcinoma C1333593 CTRP Malignant Fallopian_Tube_Gestational_Choriocarcinoma Fallopian Tube Gestational Choriocarcinoma Gestational Choriocarcinoma of Fallopian Tube Gestational Choriocarcinoma of the Fallopian Tube Fallopian Tube Gestational Choriocarcinoma Diagnostic imaging that uses sound waves (ultrasound) applying the Doppler effect, with frequency-shifted ultrasound reflections produced by moving targets (usually red blood cells) in the bloodstream along the ultrasound axis in direct proportion to the velocity of movement of the targets, to determine both direction and velocity of blood flow. C62781 Diagnostic Procedure Doppler Ultrasound Doppler Ultrasound C0162481 CDISC CTRP Diagnostic imaging that uses sound waves (ultrasound) applying the Doppler effect, with frequency-shifted ultrasound reflections produced by moving targets (usually red blood cells) in the bloodstream along the ultrasound axis in direct proportion to the velocity of movement of the targets, to determine both direction and velocity of blood flow. Doppler_Ultrasound DOPPLER ULTRASOUND Doppler Ultrasound Doppler Ultrasound An adenocarcinoma that arises from the fallopian tube and resembles the endometrioid adenocarcinoma of the uterus. It usually has a favorable prognosis. C6279 Neoplastic Process Fallopian Tube Endometrioid Adenocarcinoma C1333592 Malignant Fallopian_Tube_Endometrioid_Adenocarcinoma Endometrioid Adenocarcinoma of Fallopian Tube Endometrioid Adenocarcinoma of the Fallopian Tube Endometrioid Carcinoma of Fallopian Tube Endometrioid Carcinoma of the Fallopian Tube Fallopian Tube Endometrioid Adenocarcinoma Fallopian Tube Endometrioid Carcinoma Fallopian Tube Endometrioid Adenocarcinoma A rare adenocarcinoma of the fallopian tube composed of malignant glandular epithelium containing clear cells. C6280 Neoplastic Process Fallopian Tube Clear Cell Adenocarcinoma Fallopian Tube Clear Cell Adenocarcinoma C1333591 CTRP Malignant Fallopian_Tube_Clear_Cell_Adenocarcinoma Clear Cell Adenocarcinoma of Fallopian Tube Clear Cell Adenocarcinoma of the Fallopian Tube Clear Cell Carcinoma of Fallopian Tube Clear Cell Carcinoma of the Fallopian Tube Fallopian Tube Clear Cell Adenocarcinoma Fallopian Tube Clear Cell Carcinoma Fallopian Tube Clear Cell Adenocarcinoma An invasive carcinoma arising from the fallopian tube. It is characterized by the presence of a diffuse malignant infiltrate that is composed of epithelial cells without evidence of glandular or squamous differentiation. C6281 Neoplastic Process Undifferentiated Fallopian Tube Carcinoma Fallopian Tube Undifferentiated Carcinoma C1336857 CTRP Malignant Undifferentiated_Fallopian_Tube_Carcinoma Fallopian Tube Undifferentiated Carcinoma Undifferentiated Carcinoma of Fallopian Tube Undifferentiated Carcinoma of the Fallopian Tube Undifferentiated Fallopian Tube Cancer Undifferentiated Fallopian Tube Carcinoma Fallopian Tube Undifferentiated Carcinoma A rare squamous cell carcinoma that arises from the fallopian tube. C6282 Neoplastic Process Fallopian Tube Squamous Cell Carcinoma Fallopian Tube Squamous Cell Carcinoma C1333596 CTRP Malignant Fallopian_Tube_Squamous_Cell_Carcinoma Fallopian Tube Squamous Cell Cancer Fallopian Tube Squamous Cell Carcinoma Squamous Cell Carcinoma of Fallopian Tube Squamous Cell Carcinoma of the Fallopian Tube Fallopian Tube Squamous Cell Carcinoma A germinoma that occurs in the brain. C6284 Neoplastic Process Brain Germinoma C1332606 Malignant Brain_Germinoma Brain Germinoma Germinoma of Brain Germinoma of the Brain Brain Germinoma A germ cell tumor of the central nervous system occurring in adults. C6285 Neoplastic Process Adult Central Nervous System Germ Cell Tumor Adult Central Nervous System Germ Cell Tumor C0280796 CTRP Undetermined Adult_Central_Nervous_System_Germ_Cell_Neoplasm Adult CNS Germ Cell Neoplasm Adult CNS Germ Cell Tumor Adult Central Nervous System Germ Cell Neoplasm Adult Central Nervous System Germ Cell Tumor Central Nervous System Germ Cell Tumor Germ Cell Neoplasm of Adult CNS Germ Cell Neoplasm of Adult Central Nervous System Germ Cell Neoplasm of the Adult CNS Germ Cell Neoplasm of the Adult Central Nervous System Germ Cell Tumor of Adult CNS Germ Cell Tumor of Adult Central Nervous System Germ Cell Tumor of the Adult CNS Germ Cell Tumor of the Adult Central Nervous System Adult Central Nervous System Germ Cell Tumor Benign and malignant astrocytomas that arise from astrocytes in the cerebellum. More than 80% of childhood cerebellar astrocytomas are pilocytic astrocytomas which have a favorable prognosis. The remainder are composed of diffuse or fibrillary subtypes with malignant astrocytomas occurring only rarely in the cerebellum during childhood. C6286 Neoplastic Process Childhood Cerebellar Astrocytoma Childhood Cerebellar Astrocytoma C0278594 CTRP Undetermined Childhood_Cerebellar_Astrocytoma Cerebellar Astrocytoma Childhood Astrocytoma of Cerebellum Childhood Astrocytoma of the Cerebellum Childhood Cerebellar Astrocytoma Pediatric Astrocytoma of Cerebellum Pediatric Astrocytoma of the Cerebellum Pediatric Cerebellar Astrocytoma Childhood Cerebellar Astrocytoma A primary endometrial adenocarcinoma composed of neoplastic cells that form complex glandular patterns associated with budding and branching of the neoplastic glands. The neoplastic glands resemble those of the normal endometrium and may or may not be associated with sheet-like proliferation of malignant cells. Endometrioid adenocarcinoma is the most commonly seen morphologic variant of endometrial adenocarcinoma. C6287 Neoplastic Process Endometrial Endometrioid Adenocarcinoma C1336905 CTEP Malignant Uterine_Corpus_Endometrioid_Adenocarcinoma EEC Endometrial Endometrioid Adenocarcinoma Endometrial Endometrioid Carcinoma Endometrioid Adenocarcinoma of Endometrium Endometrioid Adenocarcinoma of the Endometrium Endometrioid Carcinoma of Endometrium Endometrioid Carcinoma of the Endometrium Endometrioid endomet. adenocar. Endometrioid endometrial adenocarcinoma Uterine Corpus Endometrioid Adenocarcinoma Uterine Corpus Endometrioid Carcinoma Endometrial Endometrioid Adenocarcinoma An endometrioid adenocarcinoma of the endometrium showing squamous differentiation. C6290 Neoplastic Process Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation C0279763 CTRP Cellosaurus GDC Malignant Endometrial_Adenosquamous_Carcinoma Endometrioid carcinoma with squamous differentiation Adenocanthoma of Endometrium Adenocanthoma of the Endometrium Endometrial Adenoacanthoma Endometrial Endometrioid Adenocarcinoma with Squamous Differentiation Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation Stage IA includes: (T1a, N0, M0). T1a: Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C6291 Neoplastic Process Stage IA Ovarian Germ Cell Tumor Stage IA Ovarian Germ Cell Tumor AJCC v6 and v7 C1336122 CTRP Malignant Stage_IA_Ovarian_Germ_Cell_Tumor FIGO Stage IA Malignant Germ Cell Neoplasm of Ovary FIGO Stage IA Malignant Germ Cell Neoplasm of the Ovary FIGO Stage IA Malignant Germ Cell Tumor of Ovary FIGO Stage IA Malignant Germ Cell Tumor of the Ovary FIGO Stage IA Malignant Ovarian Germ Cell Neoplasm FIGO Stage IA Malignant Ovarian Germ Cell Tumor Stage IA Ovarian Germ Cell Tumor Stage IA Ovarian Germ Cell Tumor AJCC v6 Stage IA Ovarian Germ Cell Tumor AJCC v6 and v7 Stage IA Ovarian Germ Cell Tumor AJCC v7 Stage IA Ovarian Germ Cell Tumor AJCC v6 and v7 Stage IB includes: (T1b, N0, M0). T1b: Tumor limited to both ovaries; capsules intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C6292 Neoplastic Process Stage IB Ovarian Germ Cell Tumor Stage IB Ovarian Germ Cell Tumor AJCC v6 and v7 C1336142 CTRP Malignant Stage_IB_Ovarian_Germ_Cell_Tumor FIGO Stage IB Malignant Germ Cell Neoplasm of Ovary FIGO Stage IB Malignant Germ Cell Neoplasm of the Ovary FIGO Stage IB Malignant Germ Cell Tumor of Ovary FIGO Stage IB Malignant Germ Cell Tumor of the Ovary FIGO Stage IB Malignant Ovarian Germ Cell Neoplasm FIGO Stage IB Malignant Ovarian Germ Cell Tumor Stage IB Ovarian Germ Cell Tumor Stage IB Ovarian Germ Cell Tumor AJCC v6 Stage IB Ovarian Germ Cell Tumor AJCC v6 and v7 Stage IB Ovarian Germ Cell Tumor AJCC v7 Stage IB Ovarian Germ Cell Tumor AJCC v6 and v7 Stage IC includes: (T1c, N0, M0). T1c: Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C6293 Neoplastic Process Stage IC Ovarian Germ Cell Tumor Stage IC Ovarian Germ Cell Tumor AJCC v6 and v7 C1336151 CTRP Malignant Stage_IC_Ovarian_Germ_Cell_Tumor FIGO Stage IC Malignant Germ Cell Neoplasm of Ovary FIGO Stage IC Malignant Germ Cell Neoplasm of the Ovary FIGO Stage IC Malignant Germ Cell Tumor of Ovary FIGO Stage IC Malignant Germ Cell Tumor of the Ovary FIGO Stage IC Malignant Ovarian Germ Cell Neoplasm FIGO Stage IC Malignant Ovarian Germ Cell Tumor Stage IC Ovarian Germ Cell Tumor Stage IC Ovarian Germ Cell Tumor AJCC v6 Stage IC Ovarian Germ Cell Tumor AJCC v6 and v7 Stage IC Ovarian Germ Cell Tumor AJCC v7 Stage IC Ovarian Germ Cell Tumor AJCC v6 and v7 Stage IIC includes: T2c, N0, M0. T2c: Pelvic extension and/or implants (T2a or T2b) with malignant cells in ascites or peritoneal washing. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6294 Neoplastic Process Stage IIC Ovarian Germ Cell Tumor Stage IIC Ovarian Germ Cell Tumor AJCC v6 and v7 C1336200 CTRP Malignant Stage_IIC_Ovarian_Germ_Cell_Tumor FIGO Stage IIC Malignant Germ Cell Neoplasm of Ovary FIGO Stage IIC Malignant Germ Cell Neoplasm of the Ovary FIGO Stage IIC Malignant Germ Cell Tumor of Ovary FIGO Stage IIC Malignant Germ Cell Tumor of the Ovary FIGO Stage IIC Malignant Ovarian Germ Cell Neoplasm FIGO Stage IIC Malignant Ovarian Germ Cell Tumor Stage IIC Ovarian Germ Cell Tumor Stage IIC Ovarian Germ Cell Tumor AJCC v6 Stage IIC Ovarian Germ Cell Tumor AJCC v6 and v7 Stage IIC Ovarian Germ Cell Tumor AJCC v7 Stage IIC Ovarian Germ Cell Tumor AJCC v6 and v7 Stage IIB includes: T2b N0, M0. T2b: Extension and/or implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6295 Neoplastic Process Stage IIB Ovarian Germ Cell Tumor Stage IIB Ovarian Germ Cell Tumor AJCC v6 and v7 C1336193 CTRP Malignant Stage_IIB_Ovarian_Germ_Cell_Tumor FIGO Stage IIB Malignant Germ Cell Neoplasm of Ovary FIGO Stage IIB Malignant Germ Cell Neoplasm of the Ovary FIGO Stage IIB Malignant Germ Cell Tumor of Ovary FIGO Stage IIB Malignant Germ Cell Tumor of the Ovary FIGO Stage IIB Malignant Ovarian Germ Cell Neoplasm FIGO Stage IIB Malignant Ovarian Germ Cell Tumor Stage IIB Ovarian Germ Cell Tumor Stage IIB Ovarian Germ Cell Tumor AJCC v6 Stage IIB Ovarian Germ Cell Tumor AJCC v6 and v7 Stage IIB Ovarian Germ Cell Tumor AJCC v7 Stage IIB Ovarian Germ Cell Tumor AJCC v6 and v7 Stage IIA includes: T2a, N0, M0. T2a: Extension and/or implants on uterus and/or tube(s). No malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6296 Neoplastic Process Stage IIA Ovarian Germ Cell Tumor Stage IIA Ovarian Germ Cell Tumor AJCC v6 and v7 C1336170 CTRP Malignant Stage_IIA_Ovarian_Germ_Cell_Tumor FIGO Stage IIA Malignant Germ Cell Neoplasm of Ovary FIGO Stage IIA Malignant Germ Cell Neoplasm of the Ovary FIGO Stage IIA Malignant Germ Cell Tumor of Ovary FIGO Stage IIA Malignant Germ Cell Tumor of the Ovary FIGO Stage IIA Malignant Ovarian Germ Cell Neoplasm FIGO Stage IIA Malignant Ovarian Germ Cell Tumor Stage IIA Ovarian Germ Cell Tumor Stage IIA Ovarian Germ Cell Tumor AJCC v6 Stage IIA Ovarian Germ Cell Tumor AJCC v6 and v7 Stage IIA Ovarian Germ Cell Tumor AJCC v7 Stage IIA Ovarian Germ Cell Tumor AJCC v6 and v7 Stage IIIA includes: T3a, N0, M0. T3a: Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6297 Neoplastic Process Stage IIIA Ovarian Germ Cell Tumor Stage IIIA Ovarian Germ Cell Tumor AJCC v6 and v7 C1336213 CTRP Malignant Stage_IIIA_Ovarian_Germ_Cell_Tumor FIGO Stage IIIA Malignant Germ Cell Neoplasm of Ovary FIGO Stage IIIA Malignant Germ Cell Neoplasm of the Ovary FIGO Stage IIIA Malignant Germ Cell Tumor of Ovary FIGO Stage IIIA Malignant Germ Cell Tumor of the Ovary FIGO Stage IIIA Malignant Ovarian Germ Cell Neoplasm FIGO Stage IIIA Malignant Ovarian Germ Cell Tumor Stage IIIA Ovarian Germ Cell Tumor Stage IIIA Ovarian Germ Cell Tumor AJCC v6 Stage IIIA Ovarian Germ Cell Tumor AJCC v6 and v7 Stage IIIA Ovarian Germ Cell Tumor AJCC v7 Stage IIIA Ovarian Germ Cell Tumor AJCC v6 and v7 Stage IIIB includes: T3b, N0, M0. T3b: Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6298 Neoplastic Process Stage IIIB Ovarian Germ Cell Tumor Stage IIIB Ovarian Germ Cell Tumor AJCC v6 and v7 C1336228 CTRP Malignant Stage_IIIB_Ovarian_Germ_Cell_Tumor FIGO Stage IIIB Malignant Germ Cell Neoplasm of Ovary FIGO Stage IIIB Malignant Germ Cell Neoplasm of the Ovary FIGO Stage IIIB Malignant Germ Cell Tumor of Ovary FIGO Stage IIIB Malignant Germ Cell Tumor of the Ovary FIGO Stage IIIB Malignant Ovarian Germ Cell Neoplasm FIGO Stage IIIB Malignant Ovarian Germ Cell Tumor Stage IIIB Ovarian Germ Cell Tumor Stage IIIB Ovarian Germ Cell Tumor AJCC v6 Stage IIIB Ovarian Germ Cell Tumor AJCC v6 and v7 Stage IIIB Ovarian Germ Cell Tumor AJCC v7 Stage IIIB Ovarian Germ Cell Tumor AJCC v6 and v7 Stage IIIC includes: (T3c, N0, M0); (Any T, N1, M0). T3c: Peritoneal metastasis beyond pelvis more than 2cm in greatest dimension and/or regional lymph node metastasis. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6299 Neoplastic Process Stage IIIC Ovarian Germ Cell Tumor Stage IIIC Ovarian Germ Cell Tumor AJCC v6 and v7 C1336238 CTRP Malignant Stage_IIIC_Ovarian_Germ_Cell_Tumor FIGO Stage IIIC Malignant Germ Cell Neoplasm of Ovary FIGO Stage IIIC Malignant Germ Cell Neoplasm of the Ovary FIGO Stage IIIC Malignant Germ Cell Tumor of Ovary FIGO Stage IIIC Malignant Germ Cell Tumor of the Ovary FIGO Stage IIIC Malignant Ovarian Germ Cell Neoplasm FIGO Stage IIIC Malignant Ovarian Germ Cell Tumor Stage IIIC Ovarian Germ Cell Tumor Stage IIIC Ovarian Germ Cell Tumor AJCC v6 Stage IIIC Ovarian Germ Cell Tumor AJCC v6 and v7 Stage IIIC Ovarian Germ Cell Tumor AJCC v7 Stage IIIC Ovarian Germ Cell Tumor AJCC v6 and v7 A benign or malignant neoplasm that affects the uterine corpus. Representative examples of benign neoplasms include leiomyoma, adenomyoma, endometrial stromal nodule, and endometrial polyp. Representative examples of malignant neoplasms include endometrial carcinoma, adenosarcoma, carcinosarcoma, and leiomyosarcoma. C6300 Neoplastic Process Uterine Corpus Neoplasm Uterine Corpus Neoplasm C1263777 CTRP Undetermined Uterine_Corpus_Neoplasm Corpus Uteri Neoplasm Corpus Uteri Tumor Neoplasm of Body of Uterus Neoplasm of Corpus Uteri Neoplasm of Uterine Body Neoplasm of Uterine Corpus Neoplasm of the Body of Uterus Neoplasm of the Corpus Uteri Neoplasm of the Uterine Body Neoplasm of the Uterine Corpus Tumor of Corpus Uteri Tumor of Uterine Body Tumor of Uterine Corpus Tumor of the Corpus Uteri Tumor of the Uterine Body Tumor of the Uterine Corpus Uterine Body Neoplasm Uterine Body Tumor Uterine Corpus Neoplasm Uterine Corpus Tumor Uterine Corpus Neoplasm Stage IA includes: T1a, N0, M0. T1a: Tumor limited to the endometrium or invades less than one-half of the myometrium. N0: No regional lymph node metastasis. M0: No distant metastasis. This staging applies to carcinomas and carcinosarcomas. (AJCC 7th ed.) C6301 Neoplastic Process Stage IA Uterine Corpus Cancer AJCC v7 Stage IA Uterine Corpus Cancer AJCC v7 C1336113 CTRP Malignant Stage_IA_Endometrial_Cancer Stage IA Uterine (including Endometrial) Cancer Stage IA Uterine Corpus Cancer Stage IA Uterine Corpus Cancer AJCC v7 Stage IA Uterine Corpus Cancer AJCC v7 Stage IB includes: T1b, N0, M0. T1b: Tumor invades one-half or more of the myometrium. N0: No regional lymph node metastasis. M0: No distant metastasis. This staging applies to carcinomas and carcinosarcomas. (AJCC 7th ed.) C6302 Neoplastic Process Stage IB Uterine Corpus Cancer AJCC v7 Stage IB Uterine Corpus Cancer AJCC v7 C1336132 CTRP Malignant Stage_IB_Endometrial_Cancer Stage IB Uterine (including Endometrial) Cancer Stage IB Uterine Corpus Cancer Stage IB Uterine Corpus Cancer AJCC v7 Stage IB Uterine Corpus Cancer AJCC v7 C6303 Neoplastic Process Stage IC Uterine Corpus Cancer AJCC v6 Stage IC Uterine Corpus Cancer AJCC v6 C1336148 CTRP Malignant Stage_IC_Endometrial_Cancer Stage IC Endometrial Cancer AJCC v6 Stage IC Uterine (including Endometrial) Cancer Stage IC Uterine Corpus Cancer AJCC v6 Stage IC Uterine Corpus Cancer AJCC v6 C6304 Neoplastic Process Stage IIA Uterine Corpus Cancer AJCC v6 Stage IIA Uterine Corpus Cancer AJCC v6 C1336157 CTRP Malignant Stage_IIA_Endometrial_Cancer Stage IIA Endometrial Cancer AJCC v6 Stage IIA Uterine (including Endometrial) Cancer Stage IIA Uterine Corpus Cancer AJCC v6 Stage IIA Uterine Corpus Cancer AJCC v6 C6305 Neoplastic Process Stage IIB Uterine Corpus Cancer AJCC v6 Stage IIB Uterine Corpus Cancer AJCC v6 C1336179 CTRP Malignant Stage_IIB_Endometrial_Cancer Stage IIB Endometrial Cancer AJCC v6 Stage IIB Uterine (including Endometrial) Cancer Stage IIB Uterine Corpus Cancer AJCC v6 Stage IIB Uterine Corpus Cancer AJCC v6 Stage IIIA includes: T3a, N0, M0. T3a: Tumor involves serosa and/or adnexa (direct extension or metastasis). N0: No regional lymph node metastasis. M0: No distant metastasis. This staging applies to carcinomas and carcinosarcomas. (AJCC 7th ed.) C6306 Neoplastic Process Stage IIIA Uterine Corpus Cancer AJCC v7 Stage IIIA Uterine Corpus Cancer AJCC v7 C1336205 CTRP Malignant Stage_IIIA_Endometrial_Cancer Stage IIIA Uterine (including Endometrial) Cancer Stage IIIA Uterine Corpus Cancer Stage IIIA Uterine Corpus Cancer AJCC v7 Stage IIIA Uterine Corpus Cancer AJCC v7 Stage IIIB includes: T3b, N0, M0. T3b: Tumor involves vagina (direct extension or metastasis) or parametrial tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. This staging applies to carcinomas and carcinosarcomas. (AJCC 7th ed.) C6307 Neoplastic Process Stage IIIB Uterine Corpus Cancer AJCC v7 Stage IIIB Uterine Corpus Cancer AJCC v7 C1336220 CTRP Malignant Stage_IIIB_Endometrial_Cancer Stage IIIB Uterine (including Endometrial) Cancer Stage IIIB Uterine Corpus Cancer Stage IIIB Uterine Corpus Cancer AJCC v7 Stage IIIB Uterine Corpus Cancer AJCC v7 Stage IIIC includes: IIIC1 (T1-T3, N1, M0); IIIC2 (T1-T3, N2, M0). T1: Tumor confined to corpus uteri. T2: Tumor invades stromal connective tissue of the cervix but does not extend beyond uterus. Endocervical glandular involvement only should be considered as Stage I and not as Stage II. T3: Tumor involves serosa and/or adnexa, vagina, or parametrial tissue. N1: Regional lymph node metastasis to pelvic lymph nodes. N2: Regional lymph node metastasis to para-aortic lymph nodes, with or without positive pelvic lymph nodes. M0: No distant metastasis. This staging applies to carcinomas and carcinosarcomas. (AJCC 7th ed.) C6308 Neoplastic Process Stage IIIC Uterine Corpus Cancer AJCC v7 Stage IIIC Uterine Corpus Cancer AJCC v7 C1336235 CTRP Malignant Stage_IIIC_Endometrial_Cancer Stage IIIC Uterine (including Endometrial) Cancer Stage IIIC Uterine Corpus Cancer Stage IIIC Uterine Corpus Cancer AJCC v7 Stage IIIC Uterine Corpus Cancer AJCC v7 Stage IVA includes: T4, Any N, M0. T4: Tumor invades bladder mucosa and/or bowel mucosa (bullous edema is not sufficient to classify a tumor as T4). M0: No distant metastasis. This staging applies to carcinomas and carcinosarcomas. (AJCC 7th ed.) C6309 Neoplastic Process Stage IVA Uterine Corpus Cancer AJCC v7 Stage IVA Uterine Corpus Cancer AJCC v7 C1336334 CTRP Malignant Stage_IVA_Endometrial_Cancer Stage IVA Uterine (including Endometrial) Cancer Stage IVA Uterine Corpus Cancer Stage IVA Uterine Corpus Cancer AJCC v7 Stage IVA Uterine Corpus Cancer AJCC v7 Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, or lung, liver, or bone. It excludes metastasis to para-aortic lymph nodes, vagina, pelvic serosa, or adnexa). This staging applies to carcinomas and carcinosarcomas. (AJCC 7th ed.) C6310 Neoplastic Process Stage IVB Uterine Corpus Cancer AJCC v7 Stage IVB Uterine Corpus Cancer AJCC v7 C1336364 CTRP Malignant Stage_IVB_Endometrial_Cancer Stage IVB Uterine (including Endometrial) Cancer Stage IVB Uterine Corpus Cancer Stage IVB Uterine Corpus Cancer AJCC v7 Stage IVB Uterine Corpus Cancer AJCC v7 A primary malignant neoplasm of the uterine corpus characterized by the presence of an epithelial and a mesenchymal component. This category includes carcinosarcoma, carcinofibroma, and adenosarcoma. C6311 Neoplastic Process Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm C1334628 Malignant Malignant_Uterine_Corpus_Mixed_Neoplasm Malignant Body of Uterus Mixed Neoplasm Malignant Body of Uterus Mixed Tumor Malignant Corpus Uteri Mixed Neoplasm Malignant Corpus Uteri Mixed Tumor Malignant Mixed Neoplasm of Body of Uterus Malignant Mixed Neoplasm of Corpus Uteri Malignant Mixed Neoplasm of Uterine Body Malignant Mixed Neoplasm of Uterine Corpus Malignant Mixed Neoplasm of the Body of Uterus Malignant Mixed Neoplasm of the Corpus Uteri Malignant Mixed Neoplasm of the Uterine Body Malignant Mixed Neoplasm of the Uterine Corpus Malignant Mixed Tumor of Body of Uterus Malignant Mixed Tumor of Corpus Uteri Malignant Mixed Tumor of Uterine Body Malignant Mixed Tumor of Uterine Corpus Malignant Mixed Tumor of the Body of Uterus Malignant Mixed Tumor of the Corpus Uteri Malignant Mixed Tumor of the Uterine Body Malignant Mixed Tumor of the Uterine Corpus Malignant Uterine Body Mixed Neoplasm Malignant Uterine Body Mixed Tumor Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm Malignant Uterine Corpus Mixed Tumor Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm Stage IA includes: IA (T1a, N0, M0); IA1 (T1a1, N0, M0); IA2 (T1a2, N0, M0). T1a: Invasive carcinoma diagnosed only by microscopy. Stromal invasion with a maximum depth of 5.0 mm measured from the base of the epithelium and a horizontal spread of 7.0 mm or less. Vascular space involvement, venous or lymphatic, does not affect classification. T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 or less horizontal spread. T1a2: Measured stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6313 Neoplastic Process Stage IA Cervical Cancer AJCC v6 and v7 Stage IA Cervical Cancer AJCC v6 and v7 CL448339 CTRP Malignant Stage_IA_Cervical_Cancer AJCC Stage IA Cervical Cancer Cervical Cancer Stage IA FIGO Stage IA Carcinoma of Cervix FIGO Stage IA Carcinoma of Cervix Uteri FIGO Stage IA Carcinoma of Uterine Cervix FIGO Stage IA Carcinoma of the Cervix FIGO Stage IA Carcinoma of the Cervix Uteri FIGO Stage IA Carcinoma of the Uterine Cervix FIGO Stage IA Cervical Carcinoma FIGO Stage IA Cervix Carcinoma FIGO Stage IA Cervix Uteri Carcinoma FIGO Stage IA Uterine Cervix Carcinoma Stage IA Cervical Cancer Stage IA Cervical Cancer AJCC v6 Stage IA Cervical Cancer AJCC v6 and v7 Stage IA Cervical Cancer AJCC v7 Stage IA Cervical Cancer AJCC v6 and v7 Stage IA1 includes: T1a1, N0, M0. T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6314 Neoplastic Process Stage IA1 Cervical Cancer AJCC v6 and v7 Stage IA1 Cervical Cancer AJCC v6 and v7 C1336109 CTRP Malignant Stage_IA1_Cervical_Cancer AJCC Stage IA1Cervical Cancer Cervical Cancer Stage IA1 FIGO Stage IA1 Carcinoma of Cervix FIGO Stage IA1 Carcinoma of Cervix Uteri FIGO Stage IA1 Carcinoma of Uterine Cervix FIGO Stage IA1 Carcinoma of the Cervix FIGO Stage IA1 Carcinoma of the Cervix Uteri FIGO Stage IA1 Carcinoma of the Uterine Cervix FIGO Stage IA1 Cervical Carcinoma FIGO Stage IA1 Cervix Carcinoma FIGO Stage IA1 Cervix Uteri Carcinoma FIGO Stage IA1 Uterine Cervix Carcinoma Stage IA1 Cervical Cancer Stage IA1 Cervical Cancer AJCC v6 Stage IA1 Cervical Cancer AJCC v6 and v7 Stage IA1 Cervical Cancer AJCC v7 Stage IA1 Cervical Cancer AJCC v6 and v7 Stage IA2 includes: T1a2, N0, M0. T1a2: Measured stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6315 Neoplastic Process Stage IA2 Cervical Cancer AJCC v6 and v7 Stage IA2 Cervical Cancer AJCC v6 and v7 C1336110 CTRP Malignant Stage_IA2_Cervical_Cancer AJCC Stage IA2 Cervical Cancer Cervical Cancer Stage IA2 FIGO Stage IA2 Carcinoma of Cervix FIGO Stage IA2 Carcinoma of Cervix Uteri FIGO Stage IA2 Carcinoma of Uterine Cervix FIGO Stage IA2 Carcinoma of the Cervix FIGO Stage IA2 Carcinoma of the Cervix Uteri FIGO Stage IA2 Carcinoma of the Uterine Cervix FIGO Stage IA2 Cervical Carcinoma FIGO Stage IA2 Cervix Carcinoma FIGO Stage IA2 Cervix Uteri Carcinoma FIGO Stage IA2 Uterine Cervix Carcinoma Stage IA2 Cervical Cancer Stage IA2 Cervical Cancer AJCC v6 and v7 Stage IA2 Cervical Cancer AJCC v7 Stage IA2 Cervical Cancer AJCC v6 and v7 Stage IB includes: IB (T1b, N0, M0); IB1(T1b1, N0, M0); IB2 (T1b2, N0, M0). T1b: Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a/IA2. T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6316 Neoplastic Process Stage IB Cervical Cancer AJCC v6 and v7 Stage IB Cervical Cancer AJCC v6 and v7 CL448340 CTRP Malignant Stage_IB_Cervical_Cancer AJCC Stage IB Cervical Cancer Cervical Cancer Stage IB FIGO Stage IB Carcinoma of Cervix FIGO Stage IB Carcinoma of Cervix Uteri FIGO Stage IB Carcinoma of Uterine Cervix FIGO Stage IB Carcinoma of the Cervix FIGO Stage IB Carcinoma of the Cervix Uteri FIGO Stage IB Carcinoma of the Uterine Cervix FIGO Stage IB Cervical Carcinoma FIGO Stage IB Cervix Carcinoma FIGO Stage IB Cervix Uteri Carcinoma FIGO Stage IB Uterine Cervix Carcinoma Stage IB Cervical Cancer Stage IB Cervical Cancer AJCC v6 Stage IB Cervical Cancer AJCC v6 and v7 Stage IB Cervical Cancer AJCC v7 Stage IB Cervical Cancer AJCC v6 and v7 Stage IB1 includes: T1b1, N0, M0. T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6317 Neoplastic Process Stage IB1 Cervical Cancer AJCC v6 and v7 Stage IB1 Cervical Cancer AJCC v6 and v7 C1336128 CTRP Malignant Stage_IB1_Cervical_Cancer AJCC Stage IB1 Cervical Cancer Cervical Cancer Stage IB1 FIGO Stage IB1 Carcinoma of Cervix FIGO Stage IB1 Carcinoma of Cervix Uteri FIGO Stage IB1 Carcinoma of Uterine Cervix FIGO Stage IB1 Carcinoma of the Cervix FIGO Stage IB1 Carcinoma of the Cervix Uteri FIGO Stage IB1 Carcinoma of the Uterine Cervix FIGO Stage IB1 Cervical Carcinoma FIGO Stage IB1 Cervix Carcinoma FIGO Stage IB1 Cervix Uteri Carcinoma FIGO Stage IB1 Uterine Cervix Carcinoma Stage IB1 Cervical Cancer Stage IB1 Cervical Cancer AJCC v6 Stage IB1 Cervical Cancer AJCC v6 and v7 Stage IB1 Cervical Cancer AJCC v7 Stage IB1 Cervical Cancer AJCC v6 and v7 Stage IB2 includes: T1b2, N0, M0. T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6318 Neoplastic Process Stage IB2 Cervical Cancer AJCC v6 and v7 Stage IB2 Cervical Cancer AJCC v6 and v7 C1336129 CTRP Malignant Stage_IB2_Cervical_Cancer AJCC Stage IB2 Cervical Cancer Cervical Cancer Stage IB2 FIGO Stage IB2 Carcinoma of Cervix FIGO Stage IB2 Carcinoma of Cervix Uteri FIGO Stage IB2 Carcinoma of Uterine Cervix FIGO Stage IB2 Carcinoma of the Cervix FIGO Stage IB2 Carcinoma of the Cervix Uteri FIGO Stage IB2 Carcinoma of the Uterine Cervix FIGO Stage IB2 Cervical Carcinoma FIGO Stage IB2 Cervix Carcinoma FIGO Stage IB2 Cervix Uteri Carcinoma FIGO Stage IB2 Uterine Cervix Carcinoma Stage IB2 Cervical Cancer Stage IB2 Cervical Cancer AJCC v6 Stage IB2 Cervical Cancer AJCC v6 and v7 Stage IB2 Cervical Cancer AJCC v7 Stage IB2 Cervical Cancer AJCC v6 and v7 Tumor without parametrial invasion. C6319 Neoplastic Process Stage IIA Cervical Cancer AJCC v6 Stage IIA Cervical Cancer AJCC v6 C0278588 CTRP Malignant Stage_IIA_Cervical_Cancer AJCC Stage IIA Cervical Cancer v6 Cervical Cancer Stage IIA AJCC v6 FIGO Stage IIA Carcinoma of Cervix FIGO Stage IIA Carcinoma of Cervix Uteri FIGO Stage IIA Carcinoma of Uterine Cervix FIGO Stage IIA Carcinoma of the Cervix FIGO Stage IIA Carcinoma of the Cervix Uteri FIGO Stage IIA Carcinoma of the Uterine Cervix FIGO Stage IIA Cervical Carcinoma FIGO Stage IIA Cervix Carcinoma FIGO Stage IIA Cervix Uteri Carcinoma FIGO Stage IIA Uterine Cervix Carcinoma Stage IIA Cervical Cancer Stage IIA Cervical Cancer AJCC v6 Stage IIA Cervical Cancer AJCC v6 Stage IIB includes: T2b, N0, M0. T2b: Tumor with parametrial invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6320 Neoplastic Process Stage IIB Cervical Cancer AJCC v6 and v7 Stage IIB Cervical Cancer AJCC v6 and v7 C0278583 CTRP Malignant Stage_IIB_Cervical_Cancer AJCC Stage IIB Cervical Cancer Cervical Cancer Stage II FIGO Stage IIB Carcinoma of Cervix FIGO Stage IIB Carcinoma of Cervix Uteri FIGO Stage IIB Carcinoma of Uterine Cervix FIGO Stage IIB Carcinoma of the Cervix FIGO Stage IIB Carcinoma of the Cervix Uteri FIGO Stage IIB Carcinoma of the Uterine Cervix FIGO Stage IIB Cervical Carcinoma FIGO Stage IIB Cervix Carcinoma FIGO Stage IIB Cervix Uteri Carcinoma FIGO Stage IIB Uterine Cervix Carcinoma Stage IIB Cervical Cancer Stage IIB Cervical Cancer AJCC v6 Stage IIB Cervical Cancer AJCC v6 and v7 Stage IIB Cervical Cancer AJCC v7 Stage IIB Cervical Cancer AJCC v6 and v7 Stage IIIB includes: (T3b, Any N, M0); (T1-3, N1, M0). T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6321 Neoplastic Process Stage IIIB Cervical Cancer AJCC v6 and v7 Stage IIIB Cervical Cancer AJCC v6 and v7 C1336219 CTRP Malignant Stage_IIIB_Cervical_Cancer AJCC Stage IIIB Cervical Cancer Cervical Cancer Stage IIIB FIGO Stage IIIB Carcinoma of Cervix FIGO Stage IIIB Carcinoma of Cervix Uteri FIGO Stage IIIB Carcinoma of Uterine Cervix FIGO Stage IIIB Carcinoma of the Cervix FIGO Stage IIIB Carcinoma of the Cervix Uteri FIGO Stage IIIB Carcinoma of the Uterine Cervix FIGO Stage IIIB Cervical Carcinoma FIGO Stage IIIB Cervix Carcinoma FIGO Stage IIIB Cervix Uteri Carcinoma FIGO Stage IIIB Uterine Cervix Carcinoma Stage IIIB Cervical Cancer Stage IIIB Cervical Cancer AJCC v6 Stage IIIB Cervical Cancer AJCC v6 and v7 Stage IIIB Cervical Cancer AJCC v7 Stage IIIB Cervical Cancer AJCC v6 and v7 Stage IIIA includes: T3a, N0, M0. T3a: Tumor involves lower third of vagina, no extension to pelvic wall. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C6322 Neoplastic Process Stage IIIA Cervical Cancer AJCC v6 and v7 Stage IIIA Cervical Cancer AJCC v6 and v7 C1336204 CTRP Malignant Stage_IIIA_Cervical_Cancer AJCC Stage IIIA Cervical Cancer Cervical Cancer Stage IIIA FIGO Stage IIIA Carcinoma of Cervix FIGO Stage IIIA Carcinoma of Cervix Uteri FIGO Stage IIIA Carcinoma of Uterine Cervix FIGO Stage IIIA Carcinoma of the Cervix FIGO Stage IIIA Carcinoma of the Cervix Uteri FIGO Stage IIIA Carcinoma of the Uterine Cervix FIGO Stage IIIA Cervical Carcinoma FIGO Stage IIIA Cervix Carcinoma FIGO Stage IIIA Cervix Uteri Carcinoma FIGO Stage IIIA Uterine Cervix Carcinoma Stage IIIA Cervical Cancer Stage IIIA Cervical Cancer AJCC v6 Stage IIIA Cervical Cancer AJCC v6 and v7 Stage IIIA Cervical Cancer AJCC v7 Stage IIIA Cervical Cancer AJCC v6 and v7 Stage IVA includes: T4, Any N, M0). T4: Tumor invades mucosa of bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4). M0: No distant metastasis. (AJCC 6th and 7th eds.) C6323 Neoplastic Process Stage IVA Cervical Cancer AJCC v6 and v7 Stage IVA Cervical Cancer AJCC v6 and v7 C0278589 CTRP Malignant Stage_IVA_Cervical_Cancer AJCC Stage IVA Cervical Cancer Cervical Cancer Stage IVA FIGO Stage IVA Carcinoma of Cervix FIGO Stage IVA Carcinoma of Cervix Uteri FIGO Stage IVA Carcinoma of Uterine Cervix FIGO Stage IVA Carcinoma of the Cervix FIGO Stage IVA Carcinoma of the Cervix Uteri FIGO Stage IVA Carcinoma of the Uterine Cervix FIGO Stage IVA Cervical Carcinoma FIGO Stage IVA Cervix Carcinoma FIGO Stage IVA Cervix Uteri Carcinoma FIGO Stage IVA Uterine Cervix Carcinoma Stage IVA Cervical Cancer Stage IVA Cervical Cancer AJCC v6 Stage IVA Cervical Cancer AJCC v6 and v7 Stage IVA Cervical Cancer AJCC v7 Stage IVA Cervical Cancer AJCC v6 and v7 Stage IVB includes: Any T, Any N, MI. M1: Distant metastasis. (AJCC 6th and 7th eds.) C6324 Neoplastic Process Stage IVB Cervical Cancer AJCC v6 and v7 Stage IVB Cervical Cancer AJCC v6 and v7 C1527418 CTRP Malignant Stage_IVB_Cervical_Cancer AJCC Stage IVB Cervical Cancer Cervical Cancer Stage IVB FIGO Stage IVB Carcinoma of Cervix FIGO Stage IVB Carcinoma of Cervix Uteri FIGO Stage IVB Carcinoma of Uterine Cervix FIGO Stage IVB Carcinoma of the Cervix FIGO Stage IVB Carcinoma of the Cervix Uteri FIGO Stage IVB Carcinoma of the Uterine Cervix FIGO Stage IVB Cervical Carcinoma FIGO Stage IVB Cervix Carcinoma FIGO Stage IVB Cervix Uteri Carcinoma FIGO Stage IVB Uterine Cervix Carcinoma Stage IVB Cervical Cancer Stage IVB Cervical Cancer AJCC v6 Stage IVB Cervical Cancer AJCC v6 and v7 Stage IVB Cervical Cancer AJCC v7 Stage IVB Cervical Cancer AJCC v6 and v7 A squamous cell carcinoma that arises from the vagina and is characterized by a papillary growth pattern, acanthotic epithelium with minimal or absent atypia, and pushing borders. C6325 Neoplastic Process Vaginal Verrucous Carcinoma C1336944 Malignant Vaginal_Verrucous_Carcinoma Vagina Verrucous Carcinoma Vagina Verrucous Squamous Cell Carcinoma Vaginal Verrucous Carcinoma Vaginal Verrucous Squamous Cell Carcinoma Verrucous Carcinoma of Vagina Verrucous Carcinoma of the Vagina Verrucous Squamous Cell Carcinoma of Vagina Verrucous Squamous Cell Carcinoma of the Vagina Vaginal Verrucous Carcinoma An aggressive malignant smooth muscle neoplasm, arising from the vagina. It is characterized by a proliferation of neoplastic spindle cells. C6326 Neoplastic Process Vaginal Leiomyosarcoma C1336940 Malignant Vaginal_Leiomyosarcoma Leiomyosarcoma of Vagina Leiomyosarcoma of the Vagina Vagina Leiomyosarcoma Vaginal Leiomyosarcoma Vaginal Leiomyosarcoma Stage IA includes: Tia, N0, M0. T1a: Tumor confined to the vulva or vulva and perineum, 2cm or less in greatest dimension, and with stromal invasion no greater than 1mm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C6328 Neoplastic Process Stage IA Vulvar Carcinoma AJCC v6 Stage IA Vulvar Carcinoma AJCC v6 C1336127 CTRP Malignant Stage_IA_Vulvar_Carcinoma Stage IA Carcinoma of Vulva AJCC v6 Stage IA Carcinoma of the Vulva AJCC v6 Stage IA Vulva Carcinoma AJCC v6 Stage IA Vulvar Cancer Stage IA Vulvar Carcinoma AJCC v6 Stage IA Vulvar Carcinoma AJCC v6 Stage IB includes: T1b, N0, M0. T1ab Tumor confined to the vulva or vulva and perineum, 2cm or less in greatest dimension, and with stromal invasion greater than 1mm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C6329 Neoplastic Process Stage IB Vulvar Carcinoma AJCC v6 Stage IB Vulvar Carcinoma AJCC v6 C1336147 CTRP Malignant Stage_IB_Vulvar_Carcinoma Stage IB Carcinoma of Vulva AJCC v6 Stage IB Carcinoma of the Vulva AJCC v6 Stage IB Vulva Carcinoma AJCC v6 Stage IB Vulvar Cancer Stage IB Vulvar Carcinoma AJCC v6 Stage IB Vulvar Carcinoma AJCC v6 Stage IVA includes: IVA (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4, Any N, M0). N2: Bilateral regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C6330 Neoplastic Process Stage IVA Vulvar Cancer AJCC v6 Stage IVA Vulvar Cancer AJCC v6 C1336360 CTRP Malignant Stage_IVA_Vulvar_Cancer Stage IVA Carcinoma of Vulva AJCC v6 Stage IVA Carcinoma of the Vulva AJCC v6 Stage IVA Vulva Cancer AJCC v6 Stage IVA Vulva Carcinoma AJCC v6 Stage IVA Vulval Cancer AJCC v6 Stage IVA Vulval Carcinoma AJCC v6 Stage IVA Vulvar Cancer Stage IVA Vulvar Cancer AJCC v6 Stage IVA Vulvar Carcinoma AJCC v6 Stage IVA Vulvar Cancer AJCC v6 A malignant neoplasm that has spread to the vulva from another anatomic site. C6332 Neoplastic Process Metastatic Malignant Neoplasm in the Vulva C0346998 Malignant Metastasis_to_the_Vulva Metastasis to the Vulva Metastatic Malignant Neoplasm in the Vulva Metastatic Malignant Neoplasm to the Vulva Metastatic Neoplasm to the Vulva Vulvar Metastasis Metastatic Malignant Neoplasm in the Vulva A malignant neoplasm that has spread to the vagina from another anatomic site. C6333 Neoplastic Process Metastatic Malignant Neoplasm in the Vagina C0346997 Malignant Metastasis_to_the_Vagina Metastasis to Vagina Metastasis to the Vagina Metastatic Malignant Neoplasm in the Vagina Metastatic Malignant Neoplasm to the Vagina Metastatic Neoplasm to the Vagina Secondary Tumor to Vagina Secondary Tumor to the Vagina Metastatic Malignant Neoplasm in the Vagina A carcinoma that has spread to the cervix from another anatomic site. C6334 Neoplastic Process Metastatic Carcinoma in the Uterine Cervix C0278584 Malignant Metastatic_Carcinoma_to_the_Uterine_Cervix Metastatic Carcinoma in the Uterine Cervix Metastatic Carcinoma to the Cervix Metastatic Carcinoma to the Cervix Uteri Metastatic Carcinoma to the Uterine Cervix Secondary Carcinoma to the Cervix Secondary Carcinoma to the Cervix Uteri Secondary Carcinoma to the Uterine Cervix Metastatic Carcinoma in the Uterine Cervix A non-metastasizing neoplasm that arises from the uterine corpus and is composed of epithelial and mesenchymal elements. Representative examples include adenomyoma and adenofibroma. C6335 Neoplastic Process Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm C1332542 Benign Benign_Uterine_Corpus_Mixed_Neoplasm Benign Corpus Uteri Mixed Neoplasm Benign Corpus Uteri Mixed Tumor Benign Mixed Neoplasm of Body of Uterus Benign Mixed Neoplasm of Corpus Uteri Benign Mixed Neoplasm of Uterine Body Benign Mixed Neoplasm of Uterine Corpus Benign Mixed Neoplasm of the Body of Uterus Benign Mixed Neoplasm of the Corpus Uteri Benign Mixed Neoplasm of the Uterine Body Benign Mixed Neoplasm of the Uterine Corpus Benign Mixed Tumor of Body of Uterus Benign Mixed Tumor of Corpus Uteri Benign Mixed Tumor of Uterine Body Benign Mixed Tumor of Uterine Corpus Benign Mixed Tumor of the Body of Uterus Benign Mixed Tumor of the Corpus Uteri Benign Mixed Tumor of the Uterine Body Benign Mixed Tumor of the Uterine Corpus Benign Uterine Body Mixed Neoplasm Benign Uterine Body Mixed Tumor Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm Benign Uterine Corpus Mixed Tumor Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm A primary polypoid malignant neoplasm of the uterine corpus characterized by the presence of a sarcomatous mesenchymal component and a benign epithelial component. Patients usually present with abnormal vaginal bleeding. It is considered a low grade malignant neoplasm and may recur following resection. C6336 Neoplastic Process Uterine Corpus Adenosarcoma C1336917 Malignant Uterine_Corpus_Mullerian_Adenosarcoma Adenosarcoma of Body of Uterus Adenosarcoma of Uterine Body Adenosarcoma of Uterine Corpus Adenosarcoma of the Body of Uterus Adenosarcoma of the Uterine Body Adenosarcoma of the Uterine Corpus Body of Uterus Adenosarcoma Uterine Body Adenosarcoma Uterine Corpus Adenosarcoma Uterine Corpus Mullerian Adenosarcoma Uterine Corpus Müllerian Adenosarcoma Uterine Corpus Adenosarcoma A usually polypoid, benign neoplasm that arises from the endometrial cavity. It is characterized by the presence of a mesenchymal core component and an epithelial component that forms a lining on the mesenchymal core. C6337 Neoplastic Process Uterine Corpus Adenofibroma C1336901 Benign Uterine_Corpus_Adenofibroma Adenofibroma of Body of Uterus Adenofibroma of Corpus Uteri Adenofibroma of Uterine Body Adenofibroma of Uterine Corpus Adenofibroma of the Body of Uterus Adenofibroma of the Corpus Uteri Adenofibroma of the Uterine Body Adenofibroma of the Uterine Corpus Corpus Uteri Adenofibroma Uterine Body Adenofibroma Uterine Corpus Adenofibroma Uterine Corpus Adenofibroma A usually polypoid, benign neoplasm that arises from the uterine corpus. It is characterized by the presence of benign epithelial glands embedded in benign fibromyomatous tissue. C6338 Neoplastic Process Uterine Corpus Adenomyoma C1336903 Benign Uterine_Corpus_Adenomyoma Adenomyoma of Body of Uterus Adenomyoma of Corpus Uteri Adenomyoma of Uterine Body Adenomyoma of Uterine Corpus Adenomyoma of the Body of Uterus Adenomyoma of the Corpus Uteri Adenomyoma of the Uterine Body Adenomyoma of the Uterine Corpus Corpus Uteri Adenomyoma Uterine Body Adenomyoma Uterine Corpus Adenomyoma Uterine Corpus Adenomyoma A malignant mesenchymal neoplasm arising from the wall of the uterine corpus (uterine body). The most representative examples are leiomyosarcoma and endometrial stromal sarcoma. C6339 Neoplastic Process Uterine Corpus Sarcoma Uterine Corpus Sarcoma C0338113 CPTAC CTRP Cellosaurus A rare type of uterine cancer that forms in muscle or other tissues of the uterus (the small, hollow, pear-shaped organ in a woman's pelvis in which a fetus develops). It usually occurs after menopause. The two main types are leiomyosarcoma (cancer that begins in smooth muscle cells) and endometrial stromal sarcoma (cancer that begins in connective tissue cells). Malignant Uterine_Corpus_Sarcoma Body of Uterus Sarcoma Corpus Uteri Sarcoma Sarcoma of Body of Uterus Sarcoma of Corpus Uteri Sarcoma of Uterine Body Sarcoma of Uterine Corpus Sarcoma of Uterus Sarcoma of the Body of Uterus Sarcoma of the Corpus Uteri Sarcoma of the Uterine Body Sarcoma of the Uterine Corpus Sarcoma of the Uterus Uterine Body Sarcoma Uterine Corpus Sarcoma Uterine Sarcoma Uterus Sarcoma uterine sarcoma Uterine Corpus Sarcoma An aggressive malignant smooth muscle neoplasm, arising from the uterine corpus. It is characterized by a proliferation of neoplastic spindle cells. C6340 Neoplastic Process Uterine Corpus Leiomyosarcoma Uterine Corpus Leiomyosarcoma C3549860 CTEP CTRP Cellosaurus Malignant Uterine_Corpus_Leiomyosarcoma Body of Uterus Leiomyosarcoma Corpus Uteri Leiomyosarcoma Leiomyosarcoma - uterus Leiomyosarcoma of Body of Uterus Leiomyosarcoma of Corpus Uteri Leiomyosarcoma of Uterine Body Leiomyosarcoma of Uterine Corpus Leiomyosarcoma of Uterus Leiomyosarcoma of the Body of Uterus Leiomyosarcoma of the Corpus Uteri Leiomyosarcoma of the Uterine Body Leiomyosarcoma of the Uterine Corpus Leiomyosarcoma of the Uterus Leiomyosarcoma of the uterus Uterine Body Leiomyosarcoma Uterine Corpus Leiomyosarcoma Uterine Corpus Leiomyosarcoma A malignant germ cell neoplasm arising from the testis. It is composed of primitive epithelial cells arranged in solid, papillary, and glandular configurations. Most patients present with a testicular mass, which may be associated with pain. More than half of the patients have metastatic disease at diagnosis. The form of treatment following radical orchiectomy is stage dependent. C6341 Neoplastic Process Testicular Embryonal Carcinoma Testicular Embryonal Carcinoma C0238448 CTRP Cellosaurus Malignant Testicular_Embryonal_Carcinoma Embryonal Carcinoma of Testis Embryonal Carcinoma of the Testis Testicular Embryonal Carcinoma Testicular Embryonal Carcinoma A papilloma that arises from the squamous epithelium of the cervix. C6342 Neoplastic Process Cervical Squamous Papilloma C1336900 Benign Uterine_Cervix_Squamous_Papilloma Cervical Squamous Cell Papilloma Cervical Squamous Papilloma Cervix Squamous Papilloma Cervix Uteri Squamous Papilloma Squamous Papilloma of Cervix Squamous Papilloma of Cervix Uteri Squamous Papilloma of Uterine Cervix Squamous Papilloma of the Cervix Squamous Papilloma of the Cervix Uteri Squamous Papilloma of the Uterine Cervix Uterine Cervix Squamous Papilloma Cervical Squamous Papilloma A cervical adenocarcinoma with the histologic characteristics of the endometrioid adenocarcinoma of the endometrium. It is not associated with human papillomavirus infection. C6343 Neoplastic Process Cervical Endometrioid Adenocarcinoma Cervical Endometrioid Adenocarcinoma C1332913 CTRP Cellosaurus Malignant Cervical_Endometrioid_Adenocarcinoma Cervical Endometrioid Adenocarcinoma Cervical Endometrioid Carcinoma Cervix Endometrioid Adenocarcinoma Cervix Endometrioid Carcinoma Cervix Uteri Endometrioid Adenocarcinoma Cervix Uteri Endometrioid Carcinoma Endometrioid Adenocarcinoma of Cervix Endometrioid Adenocarcinoma of Cervix Uteri Endometrioid Adenocarcinoma of Uterine Cervix Endometrioid Adenocarcinoma of the Cervix Endometrioid Adenocarcinoma of the Cervix Uteri Endometrioid Adenocarcinoma of the Uterine Cervix Endometrioid Carcinoma of Cervix Endometrioid Carcinoma of Cervix Uteri Endometrioid Carcinoma of Uterine Cervix Endometrioid Carcinoma of the Cervix Endometrioid Carcinoma of the Cervix Uteri Endometrioid Carcinoma of the Uterine Cervix Uterine Cervix Endometrioid Adenocarcinoma Uterine Cervix Endometrioid Carcinoma Cervical Endometrioid Adenocarcinoma Cervical adenocarcinoma not associated with human papillomavirus infection and characterized by the presence of clear and hobnail cells. It is associated with in utero exposure to diethylstilbestrol (DES). C6344 Neoplastic Process Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type C1332912 Cellosaurus Malignant Cervical_Clear_Cell_Carcinoma Cervical Clear Cell Adenocarcinoma Cervical Clear Cell Carcinoma Cervix Clear Cell Adenocarcinoma Cervix Clear Cell Carcinoma Cervix Uteri Clear Cell Adenocarcinoma Cervix Uteri Clear Cell Carcinoma Clear Cell Adenocarcinoma of Cervix Clear Cell Adenocarcinoma of Cervix Uteri Clear Cell Adenocarcinoma of Uterine Cervix Clear Cell Adenocarcinoma of the Cervix Clear Cell Adenocarcinoma of the Cervix Uteri Clear Cell Adenocarcinoma of the Uterine Cervix Clear Cell Carcinoma of Cervix Clear Cell Carcinoma of Cervix Uteri Clear Cell Carcinoma of Uterine Cervix Clear Cell Carcinoma of the Cervix Clear Cell Carcinoma of the Cervix Uteri Clear Cell Carcinoma of the Uterine Cervix HPV- Independent Cervical Adenocarcinoma, Clear Cell Type HPV- Independent Cervical Adenocarcinoma, Clear Cell-Type Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell Type Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type Uterine Cervix Clear Cell Adenocarcinoma Uterine Cervix Clear Cell Carcinoma Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type A rare carcinoma that arises from the cervix and is characterized by the lack of specific cellular differentiation. C6345 Neoplastic Process Cervical Undifferentiated Carcinoma Cervical Undifferentiated Carcinoma C0850327 CTRP Malignant Undifferentiated_Cervical_Carcinoma Cervical Undifferentiated Carcinoma Undifferentiated Cervical Cancer Cervical Undifferentiated Carcinoma A rare carcinoma that arises from the cervix. It is characterized by the presence of cystic spaces surrounded by palisaded epithelial cells. The cystic spaces contain eosinophilic hyaline material or mucin. Nuclear pleomorphism, necrotic changes, and a high mitotic rate are also present. C6346 Neoplastic Process Cervical Adenoid Cystic Carcinoma Cervical Adenoid Cystic Carcinoma C1332911 CTRP Malignant Cervical_Adenoid_Cystic_Carcinoma Adenoid Cystic Carcinoma of Cervix Adenoid Cystic Carcinoma of Cervix Uteri Adenoid Cystic Carcinoma of Uterine Cervix Adenoid Cystic Carcinoma of the Cervix Adenoid Cystic Carcinoma of the Cervix Uteri Adenoid Cystic Carcinoma of the Uterine Cervix Cervical Adenoid Cystic Cancer Cervical Adenoid Cystic Carcinoma Cervix Adenoid Cystic Carcinoma Cervix Uteri Adenoid Cystic Carcinoma Uterine Cervix Adenoid Cystic Carcinoma Cervical Adenoid Cystic Carcinoma A malignant germ cell tumor that arises from the testis and is characterized by the presence of more than one histologic component. Representative examples include mixed choriocarcinoma and embryonal carcinoma, mixed embryonal carcinoma and seminoma, and mixed yolk sac tumor and teratoma. C6347 Neoplastic Process Testicular Mixed Germ Cell Tumor Testicular Mixed Germ Cell Tumor C1336720 CTRP Malignant Testicular_Mixed_Germ_Cell_Neoplasm Mixed Germ Cell Neoplasm of Testis Mixed Germ Cell Neoplasm of the Testis Mixed Germ Cell Tumor of Testis Mixed Germ Cell Tumor of the Testis Testicular Germ Cell Tumor (Mixed) Testicular Mixed Germ Cell Neoplasm Testicular Mixed Germ Cell Tumor Testicular Mixed Germ Cell Tumor C63475 Therapeutic or Preventive Procedure Endocrine Drug Therapy C1880501 Endocrine_Drug_Therapy Endocrine Drug Therapy Endocrine Drug Therapy A malignant mixed germ cell tumor that arises from the testis and is characterized by the presence of choriocarcinoma and embryonal carcinoma morphologic components. C6348 Neoplastic Process Testicular Mixed Choriocarcinoma and Embryonal Carcinoma Testicular Mixed Choriocarcinoma and Embryonal Carcinoma C0279717 CTRP Malignant Testicular_Mixed_Choriocarcinoma_and_Embryonal_Carcinoma Mixed Choriocarcinoma and Embryonal Carcinoma of Testis Mixed Choriocarcinoma and Embryonal Carcinoma of the Testis Testicular Mixed Choriocarcinoma and Embryonal Carcinoma Testicular Mixed Choriocarcinoma and Embryonal Carcinoma A malignant mixed germ cell tumor arising from the testis. It is characterized by the presence of a teratomatous component and malignant syncytiotrophoblastic cells. C6349 Neoplastic Process Testicular Mixed Choriocarcinoma and Teratoma Testicular Mixed Choriocarcinoma and Teratoma C0279718 CTRP Malignant Testicular_Mixed_Choriocarcinoma_and_Teratoma Mixed Choriocarcinoma and Teratoma of Testis Mixed Choriocarcinoma and Teratoma of the Testis Testicular Mixed Choriocarcinoma and Teratoma Testicular Mixed Choriocarcinoma and Teratoma A malignant mixed germ cell tumor arising from the testis. It is characterized by the presence of a mixture of embryonal carcinoma and a seminomatous component. C6350 Neoplastic Process Testicular Mixed Embryonal Carcinoma and Seminoma Testicular Mixed Embryonal Carcinoma and Seminoma C0279713 CTRP Malignant Testicular_Mixed_Embryonal_Carcinoma_and_Seminoma Mixed Embryonal Carcinoma and Seminoma of Testis Mixed Embryonal Carcinoma and Seminoma of the Testis Testicular Mixed Embryonal Carcinoma and Seminoma Testicular Mixed Embryonal Carcinoma and Seminoma A malignant mixed germ cell tumor arising from the testis, characterized by the presence of an embryonal carcinomatous component and a teratomatous component. C6351 Neoplastic Process Testicular Mixed Embryonal Carcinoma and Teratoma Testicular Mixed Embryonal Carcinoma and Teratoma C0279709 CTRP Malignant Testicular_Mixed_Embryonal_Carcinoma_and_Teratoma Mixed Embryonal Carcinoma and Teratoma of Testis Mixed Embryonal Carcinoma and Teratoma of the Testis Testicular Mixed Embryonal Carcinoma and Teratoma Testicular Mixed Embryonal Carcinoma and Teratoma A malignant mixed germ cell tumor arising from the testis. It is characterized by the presence of a mixture of embryonal carcinoma, a teratomatous component, and a seminomatous component. C6352 Neoplastic Process Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma C0279710 CTRP Malignant Testicular_Mixed_Embryonal_Carcinoma_and_Teratoma_with_Seminoma Mixed Embryonal Carcinoma and Teratoma with Seminoma of Testis Mixed Embryonal Carcinoma and Teratoma with Seminoma of the Testis Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma An immature teratoma that arises from the testis. C6353 Neoplastic Process Immature Testicular Teratoma Testicular Immature Teratoma C1334154 CTRP Undetermined Immature_Testicular_Teratoma Immature Teratoma of Testis Immature Teratoma of the Testis Immature Testicular Teratoma Testicular Immature Teratoma Testicular Immature Teratoma A lymphoma that arises from the kidney. There is no evidence of a systemic lymphoproliferative disorder. C63532 Neoplastic Process Kidney Lymphoma C0341714 Malignant Renal_Lymphoma Kidney Lymphoma Primary Kidney Lymphoma Primary Renal Lymphoma Renal Lymphoma Kidney Lymphoma A diffuse large B-cell lymphoma that affects the kidney. C63533 Neoplastic Process Kidney Diffuse Large B-Cell Lymphoma Kidney Diffuse Large B-Cell Lymphoma C1882929 CTRP Malignant Renal_Diffuse_Large_B-Cell_Lymphoma Diffuse Large B-Cell Lymphoma of the Kidney Kidney Diffuse Large B-Cell Lymphoma Primary Kidney Diffuse Large B-Cell Lymphoma Kidney Diffuse Large B-Cell Lymphoma A teratoma that arises from the testis and is composed of well differentiated, adult-type tissues. C6355 Neoplastic Process Mature Testicular Teratoma Testicular Mature Teratoma C1334641 CTRP Benign Mature_Testicular_Teratoma Mature Teratoma of Testis Mature Teratoma of the Testis Mature Testicular Teratoma Testicular Mature Teratoma Testicular Mature Teratoma A sex cord-stromal tumor that arises from the testis and is characterized by the presence of cells that resemble the successive stages of development of Leydig cells. It usually presents as a painless testicular mass. Gynecomastia is present in approximately thirty percent of the cases. Libido may be decreased. In children, precocious puberty may be present. A minority of cases exhibit malignant characteristics. C6356 Neoplastic Process Testicular Leydig Cell Tumor C0863027 NICHD A Leydig cell tumor that occurs in the testis. Undetermined Testicular_Leydig_Cell_Tumor Leydig cell tumor of testis, NOS Leydig Cell Neoplasm of Testis Leydig Cell Neoplasm of the Testis Leydig Cell Tumor of Testis Leydig Cell Tumor of the Testis Testicular Leydig Cell Neoplasm Testicular Leydig Cell Tumor Testicular Leydig Cell Tumor A rare sex cord-stromal tumor that arises from the testis. It is characterized by the presence of granulosa-like cells and Call-Exner bodies. There are two variants described, the adult and the juvenile. C6357 Neoplastic Process Testicular Granulosa Cell Tumor C1336709 NICHD A granulosa cell tumor that occurs in the testis. Malignant Testicular_Granulosa_Cell_Tumor Granulosa Cell Neoplasm of Testis Granulosa Cell Neoplasm of the Testis Granulosa Cell Tumor of Testis Granulosa Cell Tumor of the Testis Testicular Granulosa Cell Neoplasm Testicular Granulosa Cell Tumor Testicular Granulosa Cell Tumor A benign or malignant tumor that arises from the testis. It is composed of granulosa cells, Leydig cells, Sertoli cells, and fibroblasts. Each of these cell types may constitute the only cellular component that is present in the tumor or it may be mixed with other cell types in various combinations. The prognosis can not always be predicted on histologic grounds alone. Approximately, ten percent of these tumors may metastasize. Representative examples include granulosa cell tumor, Leydig cell tumor, Sertoli cell tumor, and tumors of the thecoma-fibroma group. C6358 Neoplastic Process Testicular Sex Cord-Stromal Tumor C3840076 NICHD A sex cord-stromal tumor that occurs in the testis. Undetermined Testicular_Sex_Cord-Stromal_Tumor Sex Cord-Stromal Neoplasm of Testis Sex Cord-Stromal Neoplasm of the Testis Sex Cord-Stromal Tumor of Testis Sex Cord-Stromal Tumor of the Testis Testicular Sex Cord-Stromal Neoplasm Testicular Sex Cord-Stromal Tumor Testicular Sex Cord-Stromal Tumor A sarcoma that arises from the testis. The majority of cases arise from teratomas or spermatocytic seminomas. C6359 Neoplastic Process Testicular Sarcoma C1336727 Malignant Testicular_Sarcoma Sarcoma of Testis Sarcoma of the Testis Testicular Sarcoma Testicular Sarcoma A rare, usually well-differentiated neuroendocrine neoplasm that arises from the testis. It usually affects adults, and a minority of patients have carcinoid syndrome. It may occur in isolation or, less frequently, be associated with testicular teratoma. The majority of cases are not associated with isochromosome 12p or germ cell neoplasia in situ. The clinical course is usually benign. C6360 Neoplastic Process Testicular Neuroendocrine Tumor, Prepubertal-Type C1336705 Undetermined Testicular_Carcinoid_Tumor Prepubertal Type Testicular Neuroendocrine Tumor Prepubertal-Type Testicular Neuroendocrine Tumor Testicular Carcinoid Tumor Testicular Neuroendocrine Tumor, Prepubertal Type Testicular Neuroendocrine Tumor, Prepubertal-Type Testicular Neuroendocrine Tumor, Prepubertal-Type Stage IA includes: pT1, N0, M0, S0. pT1: Tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade into the tunica albuginea but not the tunica vaginalis. N0: No regional lymph node metastasis. M0: No distant metastasis. S0: Marker study levels within normal limits. (AJCC 6th and 7th eds.) C6361 Neoplastic Process Stage IA Testicular Cancer AJCC v6 and v7 Stage IA Testicular Cancer AJCC v6 and v7 C2217637 CTRP PCDC Malignant Stage_IA_Testicular_Cancer Stage IA Stage IA Cancer of Testis Stage IA Cancer of the Testis Stage IA Testicular Cancer Stage IA Testicular Cancer AJCC v6 Stage IA Testicular Cancer AJCC v6 and v7 Stage IA Testicular Cancer AJCC v7 Stage IA Testicular Cancer AJCC v6 and v7 Stage IB includes: (pT2, N0, M0, S0); (pT3, N0, M0, S0); (pT4, N0, M0, S0). pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis. pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion. pT4: Tumor invades the scrotum with or without vascular/lymphatic invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. S0: Marker study levels within normal limits. (AJCC 6th and 7th eds.) C6362 Neoplastic Process Stage IB Testicular Cancer AJCC v6 and v7 Stage IB Testicular Cancer AJCC v6 and v7 C2217638 CTRP PCDC Malignant Stage_IB_Testicular_Cancer Stage IB Stage IB Cancer of Testis Stage IB Cancer of the Testis Stage IB Testicular Cancer Stage IB Testicular Cancer AJCC v6 Stage IB Testicular Cancer AJCC v6 and v7 Stage IB Testicular Cancer AJCC v7 Stage IB Testicular Cancer AJCC v6 and v7 Stage IS includes: Any pT/TX, N0, M0, S1-3. pTX: Primary tumor cannot be assessed. N0: No regional lymph node metastasis. M0: No distant metastasis. S1: LDH less than 1.5 x N (N indicates the upper limit of normal for the LDH assay) and hCG less than 5,000 and AFP less than 1,000. S2: LDH 1.5-10 x N or hCG 5,000-50,000 or AFP 1,000-10,000. S3: LDH more than 10 x N or hCG more than 50,000 or AFP more than 10,000. (AJCC 6th and 7th eds.) C6363 Neoplastic Process Stage IS Testicular Cancer AJCC v6 and v7 Stage IS Testicular Cancer AJCC v6 and v7 C2217646 CTRP PCDC Malignant Stage_IC_Testicular_Cancer Stage IS Stage IS Cancer of Testis Stage IS Cancer of the Testis Stage IS Testicular Cancer Stage IS Testicular Cancer AJCC v6 Stage IS Testicular Cancer AJCC v6 and v7 Stage IS Testicular Cancer AJCC v7 Stage IS Testicular Cancer AJCC v6 and v7 Stage IIA includes: (Any pT/TX, N1, M0, S0); (Any pT/TX, N1, M0, S1). pTX: Primary tumor cannot be assessed. N1: Metastasis with a lymph node mass 2 cm or less in greatest dimension; or multiple lymph nodes, none more than 2cm in greatest dimension. M0: No distant metastasis. S0: Marker study levels within normal limits. S1: LDH less than 1.5 x N (N indicates the upper limit of normal for the LDH assay) and hCG less than 5,000 and AFP less than 1,000. (AJCC 6th and 7th eds.) C6364 Neoplastic Process Stage IIA Testicular Cancer AJCC v6 and v7 Stage IIA Testicular Cancer AJCC v6 and v7 C2217640 CTRP PCDC Malignant Stage_IIA_Testicular_Cancer Stage IIA Stage IIA Cancer of Testis Stage IIA Cancer of the Testis Stage IIA Testicular Cancer Stage IIA Testicular Cancer AJCC v6 Stage IIA Testicular Cancer AJCC v6 and v7 Stage IIA Testicular Cancer AJCC v7 Stage IIA Testicular Cancer AJCC v6 and v7 Stage IIB includes: (Any pT/TX, N2, M0, S0); (Any pT/TX, N2, M0, S1). pTX: Primary tumor cannot be assessed. N2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, any one mass greater than 2 cm but not more than 5 cm in greatest dimension. M0: No distant metastasis. S0: Marker study levels within normal limits. S1: LDH less than 1.5 x N (N indicates the upper limit of normal for the LDH assay) and hCG less than 5,000 and AFP less than 1,000. (AJCC 6th and 7th eds.) C6365 Neoplastic Process Stage IIB Testicular Cancer AJCC v6 and v7 Stage IIB Testicular Cancer AJCC v6 and v7 C2217641 CTRP PCDC Malignant Stage_IIB_Testicular_Cancer Stage IIB Stage IIB Cancer of Testis Stage IIB Cancer of the Testis Stage IIB Testicular Cancer Stage IIB Testicular Cancer AJCC v6 Stage IIB Testicular Cancer AJCC v6 and v7 Stage IIB Testicular Cancer AJCC v7 Stage IIB Testicular Cancer AJCC v6 and v7 Stage IIC includes: (Any pT/TX, N3, M0, S0); (Any pT/TX, N3, M0, S1). pTX: Primary tumor cannot be assessed. N3: Metastasis with a lymph node mass more than 5 cm in greatest dimension. M0: No distant metastasis. S0: Marker study levels within normal limits. S1: LDH less than 1.5 x N (N indicates the upper limit of normal for the LDH assay) and hCG less than 5,000 and AFP less than 1,000. (AJCC 6th and 7th eds.) C6366 Neoplastic Process Stage IIC Testicular Cancer AJCC v6 and v7 Stage IIC Testicular Cancer AJCC v6 and v7 C1336202 CTRP PCDC Malignant Stage_IIC_Testicular_Cancer Stage IIC Stage IIC Cancer of Testis Stage IIC Cancer of the Testis Stage IIC Testicular Cancer Stage IIC Testicular Cancer AJCC v6 Stage IIC Testicular Cancer AJCC v6 and v7 Stage IIC Testicular Cancer AJCC v7 Stage IIC Testicular Cancer AJCC v6 and v7 Stage IIIC includes: (Any pT/TX, N1-3, M0, S3); (Any pT/TX, Any N, M1a, S3); (Any pT/TX, Any N, M1b, Any S). N1: Metastasis with a lymph node mass 2 cm or less in greatest dimension; or multiple lymph nodes, none more than 2cm in greatest dimension. N2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, any one mass greater than 2 cm but not more than 5 cm in greatest dimension. N3: Metastasis with a lymph node mass more than 5 cm in greatest dimension. M0: No distant metastasis. M1a: Non-regional nodal or pulmonary metastasis. M1b: Distant metastasis other than to non-regional lymph nodes and lung. S3: LDH more than 10 x N (N indicates the upper limit of normal for the LDH assay) or hCG more than 50,000 or AFP more than 10,000. (AJCC 6th and 7th eds.) C6367 Neoplastic Process Stage IIIC Testicular Cancer AJCC v6 and v7 Stage IIIC Testicular Cancer AJCC v6 and v7 C2217645 CTRP PCDC Malignant Stage_IIIC_Testicular_Cancer Stage IIIC Stage IIIC Cancer of Testis Stage IIIC Cancer of the Testis Stage IIIC Testicular Cancer Stage IIIC Testicular Cancer AJCC v6 Stage IIIC Testicular Cancer AJCC v6 and v7 Stage IIIC Testicular Cancer AJCC v7 Stage IIIC Testicular Cancer AJCC v6 and v7 Stage IIIB includes: (Any pT/TX, N1-3, M0, S2); (Any pT/TX, Any N, M1a, S2). N1: Metastasis with a lymph node mass 2 cm or less in greatest dimension; or multiple lymph nodes, none more than 2cm in greatest dimension. N2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, any one mass greater than 2 cm but not more than 5 cm in greatest dimension. N3: Metastasis with a lymph node mass more than 5 cm in greatest dimension. M0: No distant metastasis. M1a: Non-regional nodal or pulmonary metastasis. S2: LDH 1.5-10 x N (N indicates the upper limit of normal for the LDH assay) or hCG 5,000-50,000 or AFP 1,000-10,000. (AJCC 6th and 7th eds.) C6368 Neoplastic Process Stage IIIB Testicular Cancer AJCC v6 and v7 Stage IIIB Testicular Cancer AJCC v6 and v7 C2217644 CTRP PCDC Malignant Stage_IIIB_Testicular_Cancer Stage IIIB Stage IIIB Cancer of Testis Stage IIIB Cancer of the Testis Stage IIIB Testicular Cancer Stage IIIB Testicular Cancer AJCC v6 Stage IIIB Testicular Cancer AJCC v6 and v7 Stage IIIB Testicular Cancer AJCC v7 Stage IIIB Testicular Cancer AJCC v6 and v7 Stage IIIA includes: (Any pT/TX, Any N, M1a, S0); (Any pT/TX, Any N, M1a, S1). M1a: Non-regional nodal or pulmonary metastasis. S0: Marker study levels within normal limits. S1: LDH less than 1.5 x N (N indicates the upper limit of normal for the LDH assay) and hCG less than 5,000 and AFP less than 1,000. (AJCC 6th and 7th eds.) C6369 Neoplastic Process Stage IIIA Testicular Cancer AJCC v6 and v7 Stage IIIA Testicular Cancer AJCC v6 and v7 C2217643 CTRP PCDC Malignant Stage_IIIA_Testicular_Cancer Stage IIIA Stage IIIA Cancer of Testis Stage IIIA Cancer of the Testis Stage IIIA Testicular Cancer Stage IIIA Testicular Cancer AJCC v6 and v7 Stage IIIA Testicular Cancer AJCC v7 Testicular Cancer Stage IIIA Stage IIIA Testicular Cancer AJCC v6 and v7 A lymph node located in the area below the clavicle. C63705 Body Part, Organ, or Organ Component Infraclavicular Lymph Node C0229743 CDISC GDC PCDC UBERON A lymph node located in the area below the clavicle. A lymph node located in the area below the clavicle. (NCI) Infraclavicular_Lymph_Node Lymph Node(s) Subclavicular UBERON:0035162 Deltopectoral Lymph Node Deltopectoral Node INFRACLAVICULAR LYMPH NODE Infraclavicular Lymph Node Infraclavicular Node Infraclavicular Nodes Lymph Node(s) Subclavicular Subclavicular Lymph Node Subclavicular Node deltopectoral lymph node deltopectoral node infraclavicular lymph node infraclavicular node nodus lymphaticus infraclavicularis axillae Infraclavicular Lymph Node A rare benign polypoid skeletal muscle neoplasm arising from the vagina. It is characterized by the presence of round striated muscle cells and strap-like skeletal muscle cells, and vascular space formations within a fibrous and myxoid stroma. C6372 Neoplastic Process Vaginal Rhabdomyoma C1336942 Benign Vaginal_Rhabdomyoma Rhabdomyoma of Vagina Rhabdomyoma of the Vagina Vaginal Rhabdomyoma Vaginal Rhabdomyoma A benign smooth muscle neoplasm arising from the vagina. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C6373 Neoplastic Process Vaginal Leiomyoma C1336939 Benign Vaginal_Leiomyoma Leiomyoma of Vagina Leiomyoma of the Vagina Vaginal Leiomyoma Vaginal Leiomyoma A benign papillary neoplasm that arises from the vagina and is characterized by the presence of a fibrovascular stalk lined by normal squamous epithelium. There is no evidence of atypia or relation to human papillomavirus. C6374 Neoplastic Process Vaginal Squamous Papilloma C1336943 Benign Vaginal_Squamous_Papilloma Squamous Papilloma of Vagina Squamous Papilloma of the Vagina Vaginal Squamous Cell Papilloma Vaginal Squamous Papilloma Vaginal Squamous Papilloma A benign squamous neoplasm that arises from the vulva. It is characterized by the proliferation of the basal cells in the squamous epithelium, acanthosis, hyperkeratosis, and cysts formation. C6375 Neoplastic Process Vulvar Seborrheic Keratosis C1336981 Benign Vulvar_Seborrheic_Keratosis Seborrheic Keratosis of Vulva Seborrheic Keratosis of the Vulva Vulvar Seborrheic Keratosis Vulvar Seborrheic Keratosis A benign papillary neoplasm that arises from the vulva and is characterized by the presence of a delicate fibrovascular stalk lined by squamous epithelium. There is no evidence of epithelial atypia. C6376 Neoplastic Process Vulvar Squamous Papilloma C1336982 Benign Vulvar_Squamous_Papilloma Vestibular Papilloma Vulvar Squamous Cell Papilloma Vulvar Squamous Papilloma Vulvar Squamous Papilloma A Kaposi sarcoma arising from the penis. C6377 Neoplastic Process Penile Kaposi Sarcoma C1335372 Malignant Penile_Kaposi_s_Sarcoma Kaposi's Sarcoma of Penis Kaposi's Sarcoma of the Penis Penile Kaposi Sarcoma Penile Kaposi's Sarcoma Penile Kaposi Sarcoma A malignant mesenchymal tumor with skeletal muscle differentiation affecting the testis. C6378 Neoplastic Process Testicular Rhabdomyosarcoma C1336726 Malignant Testicular_Rhabdomyosarcoma Rhabdomyosarcoma of Testis Rhabdomyosarcoma of the Testis Testicular Rhabdomyosarcoma Testicular Rhabdomyosarcoma A rare yolk sac tumor that arises from the vagina. C6379 Neoplastic Process Vaginal Yolk Sac Tumor C1336945 Malignant Vaginal_Yolk_Sac_Tumor Vaginal Endodermal Sinus Neoplasm Vaginal Endodermal Sinus Tumor Vaginal Yolk Sac Neoplasm Vaginal Yolk Sac Tumor Vaginal Yolk Sac Tumor An adenocarcinoma that arises from the vulva. Representative examples include Bartholin gland adenocarcinoma, eccrine adenocarcinoma, apocrine adenocarcinoma, and sebaceous carcinoma. C6380 Neoplastic Process Vulvar Adenocarcinoma Vulvar Adenocarcinoma C1336975 CTRP Malignant Vulvar_Adenocarcinoma Adenocarcinoma of Vulva Adenocarcinoma of the Vulva Vulvar Adenocarcinoma Vulvar Adenocarcinoma A slow growing, locally infiltrating carcinoma that arises from the vulva. It is characterized by the presence of malignant cells that resemble the basal cells that are present in the epidermis. C6381 Neoplastic Process Vulvar Basal Cell Carcinoma Vulvar Basal Cell Carcinoma C1336977 CTRP Malignant Vulvar_Basal_Cell_Carcinoma Basal Cell Carcinoma of Vulva Basal Cell Carcinoma of the Vulva Vulvar Basal Cell Cancer Vulvar Basal Cell Carcinoma Vulvar Basal Cell Carcinoma Toxicity that impairs or damages the immune system. C63814 Finding Immunotoxicity C0596763 PCDC Immunotoxicity Immunotoxicity TOXICITY_IMMUNE Immunotoxicity A benign, usually asymptomatic small mesothelial tumor that arises from the epididymis. C6382 Neoplastic Process Epididymal Adenomatoid Tumor C1333415 Benign Epididymal_Adenomatoid_Tumor Adenomatoid Tumor of Epididymis Adenomatoid Tumor of the Epididymis Benign Epididymal Mesothelioma Epididymal Adenomatoid Tumor Epididymal Adenomatoid Tumor A highly differentiated squamous cell carcinoma that arises from the vulva. It is characterized by the presence of a warty and hyperkeratinized surface, malignant cells with abundant eosinophilic cytoplasm, minimal cytologic atypia, and absence or rarity of mitotic figures. The tumor infiltrates the underlying stroma with a pushing border. C6383 Neoplastic Process Vulvar Verrucous Carcinoma C1336983 Malignant Vulvar_Verrucous_Carcinoma Verrucous Carcinoma of Vulva Verrucous Carcinoma of the Vulva Vulvar Verrucous Carcinoma Vulvar Verrucous Carcinoma A lipoma that arises from the paratesticular region. It is the most common paratesticular mesenchymal neoplasm. C6384 Neoplastic Process Paratesticular Lipoma C1335348 Benign Paratesticular_Lipoma Paratesticular Lipoma Paratesticular Lipoma A malignant neoplasm that has spread to the cervix from another anatomic site. C6385 Neoplastic Process Metastatic Malignant Neoplasm in the Uterine Cervix C0346996 Malignant Metastasis_to_the_Cervix Metastasis to the Cervix Metastasis to the Cervix Uteri Metastasis to the Uterine Cervix Metastatic Malignant Neoplasm in the Uterine Cervix Metastatic Malignant Neoplasm to the Cervix Metastatic Malignant Neoplasm to the Uterine Cervix Metastatic Malignant Tumor to the Cervix Metastatic Malignant Tumor to the Uterine Cervix Metastatic Malignant Neoplasm in the Uterine Cervix A basal cell carcinoma that arises from the scrotum. C6386 Neoplastic Process Scrotal Basal Cell Carcinoma C1335934 Malignant Scrotal_Basal_Cell_Carcinoma Basal Cell Carcinoma of Scrotum Basal Cell Carcinoma of the Scrotum Scrotal Basal Cell Carcinoma Scrotal Basal Cell Carcinoma A hemangioma arising from the skin of the scrotum. C6387 Neoplastic Process Scrotal Hemangioma C1335936 Benign Scrotal_Hemangioma Angioma of Scrotum Angioma of the Scrotum Hemangioma of Scrotum Hemangioma of the Scrotum Scrotal Angioma Scrotal Hemangioma Scrotal Hemangioma A carcinoma that arises from the scrotum. C6389 Neoplastic Process Scrotal Carcinoma C1370468 Malignant Scrotal_Carcinoma Cancer of Scrotum Cancer of the Scrotum Carcinoma of Scrotum Carcinoma of the Scrotum Scrotal Cancer Scrotal Carcinoma Scrotal Carcinoma An invasive ductal breast carcinoma associated with an invasive lobular carcinomatous component. C6393 Neoplastic Process Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma C1334276 Malignant Invasive_Ductal_and_Invasive_Lobular_Breast_Carcinoma Infiltrating Ductal and Infiltrating Lobular Breast Carcinoma Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma Invasive Ductal and Invasive Lobular Breast Carcinoma Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma An extra-adrenal paraganglioma arising from the orbit. Patients may present with visual disturbances or proptosis. C6408 Neoplastic Process Orbit Paraganglioma C1335130 Undetermined Orbit_Paraganglioma Orbit Paraganglioma Orbital Paraganglioma Paraganglioma of Orbit Paraganglioma of the Orbit Orbit Paraganglioma An extra-adrenal parasympathetic paraganglioma arising from paraganglia adjacent to the larynx. Patients may present with hoarseness and dysphagia. C6409 Neoplastic Process Laryngeal Paraganglioma C1334375 Undetermined Laryngeal_Paraganglioma Laryngeal Paraganglioma Larynx Paraganglioma Paraganglioma of Larynx Paraganglioma of the Larynx Laryngeal Paraganglioma An extra-adrenal paraganglioma arising from paraganglia located in the heart. C6410 Neoplastic Process Cardiac Paraganglioma C1332851 Undetermined Cardiac_Paraganglioma Cardiac Paraganglioma Heart Paraganglioma Paraganglioma of Heart Paraganglioma of the Heart Cardiac Paraganglioma An intrathoracic sympathetic paraganglioma arising from paravertebral paraganglia. In functional tumors, the hypersecretion of catecholamines results in hypertension. C6411 Neoplastic Process Intrathoracic Paravertebral Paraganglioma C1334265 Undetermined Intrathoracic_Paravertebral_Paraganglioma Intrathoracic Paravertebral Paraganglioma Intrathoracic Paravertebral Paraganglioma An intrathoracic paravertebral paraganglioma that metastasizes to other anatomic sites. C6413 Neoplastic Process Metastatic Intrathoracic Paravertebral Paraganglioma C1334595 Malignant Malignant_Intrathoracic_Paravertebral_Paraganglioma Malignant Intrathoracic Paravertebral Paraganglioma Metastatic Intrathoracic Paravertebral Paraganglioma Metastatic Intrathoracic Paravertebral Paraganglioma An extra-adrenal sympathetic paraganglioma arising from the urinary bladder. Clinical signs include hypertension and hematuria. C6414 Neoplastic Process Bladder Paraganglioma C1332562 Undetermined Bladder_Paraganglioma Bladder Paraganglioma Paraganglioma of Bladder Paraganglioma of Urinary Bladder Paraganglioma of the Bladder Paraganglioma of the Urinary Bladder Urinary Bladder Paraganglioma Bladder Paraganglioma An extra-adrenal sympathetic paraganglioma of the bladder that metastasizes to other anatomic sites. C6416 Neoplastic Process Metastatic Bladder Paraganglioma C1334563 Malignant Malignant_Bladder_Paraganglioma Malignant Bladder Paraganglioma Malignant Paraganglioma of Bladder Malignant Paraganglioma of Urinary Bladder Malignant Paraganglioma of the Bladder Malignant Paraganglioma of the Urinary Bladder Malignant Urinary Bladder Paraganglioma Metastatic Bladder Paraganglioma Metastatic Bladder Paraganglioma The reemergence of adrenal cortical carcinoma after a period of remission. C6417 Neoplastic Process Recurrent Adrenal Cortex Carcinoma Recurrent Adrenal Cortical Carcinoma C0278818 CTRP Malignant Recurrent_Adrenal_Cortex_Cancer Recurrent Adrenal Cortex Cancer Recurrent Adrenal Cortex Carcinoma Recurrent Adrenal Cortical Carcinoma Recurrent Adrenocortical Carcinoma Recurrent Carcinoma of Adrenal Cortex Recurrent Carcinoma of the Adrenal Cortex Relapsed Adrenal Cortex Carcinoma Relapsed Adrenocortical Carcinoma Relapsed Carcinoma of Adrenal Cortex Relapsed Carcinoma of the Adrenal Cortex Recurrent Adrenal Cortical Carcinoma A liposarcoma that arises from the ovary. C6419 Neoplastic Process Ovarian Liposarcoma C1335165 Malignant Ovarian_Liposarcoma Liposarcoma of Ovary Liposarcoma of the Ovary Ovarian Liposarcoma Ovarian Liposarcoma A neuroendocrine tumor that arises from the esophagus, stomach, or duodenum. C6421 Neoplastic Process Foregut Carcinoid Tumor Foregut Neuroendocrine Tumor C1333631 CTRP Undetermined Foregut_Carcinoid_Tumor Foregut Carcinoid Tumor Foregut Neuroendocrine Tumor Foregut Neuroendocrine Tumor A neuroendocrine tumor grade 1 that arises from the jejunum, ileum, proximal colon, or appendix. C6422 Neoplastic Process Midgut Neuroendocrine Tumor G1 Midgut Neuroendocrine Tumor G1 C1334763 CTRP Cellosaurus Undetermined Midgut_Carcinoid_Tumor Midgut Carcinoid Tumor Midgut Neuroendocrine Tumor G1 Midgut Neuroendocrine Tumor G1 A neuroendocrine tumor that arises from the sigmoid colon, descending colon, or rectum. C6423 Neoplastic Process Hindgut Neuroendocrine Tumor C1334029 Cellosaurus Undetermined Hindgut_Carcinoid_Tumor Hindgut Carcinoid Tumor Hindgut Neuroendocrine Tumor Hindgut Neuroendocrine Tumor A well differentiated, low grade neuroendocrine neoplasm that arises in a Meckel diverticulum. C6424 Neoplastic Process Meckel Diverticulum Neuroendocrine Tumor G1 C1334648 mCode Undetermined Meckel_s_Diverticulum_Carcinoid_Tumor Meckel Diverticulum Carcinoid Tumor Meckel Diverticulum NET G1 Meckel Diverticulum Neuroendocrine Tumor G1 Meckel's Diverticulum Carcinoid Tumor Meckel's diverticulum, malignant Meckel Diverticulum Neuroendocrine Tumor G1 A well differentiated, low grade neuroendocrine neoplasm that arises from the duodenum. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. C6425 Neoplastic Process Duodenal Neuroendocrine Tumor G1 C0919607 CPTAC Undetermined Duodenal_Carcinoid_Tumor Duodenal NET G1 Duodenal Neuroendocrine Tumor G1 Duodenal Neuroendocrine Tumor G1 A well differentiated, low grade neuroendocrine neoplasm that arises from the transverse colon. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. C6426 Neoplastic Process Transverse Colon Neuroendocrine Tumor G1 C1336819 Undetermined Transverse_Colon_Carcinoid_Tumor Transverse Colon NET G1 Transverse Colon Neuroendocrine Tumor G1 Transverse Colon Neuroendocrine Tumor G1 A well differentiated, low grade neuroendocrine neoplasm that arises from the ascending colon. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. C6427 Neoplastic Process Ascending Colon Neuroendocrine Tumor G1 C1332340 Undetermined Ascending_Colon_Carcinoid_Tumor Ascending Colon NET G1 Ascending Colon Neuroendocrine Tumor G1 Ascending Colon Neuroendocrine Tumor G1 A well differentiated, low grade neuroendocrine neoplasm that arises from the descending colon. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. C6428 Neoplastic Process Descending Colon Neuroendocrine Tumor G1 C1333279 CPTAC Undetermined Descending_Colon_Carcinoid_Tumor Descending Colon NET G1 Descending Colon Neuroendocrine Tumor G1 Descending Colon Neuroendocrine Tumor G1 A well differentiated, low grade neuroendocrine neoplasm that arises from the jejunum. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. C6429 Neoplastic Process Jejunal Neuroendocrine Tumor G1 C1334296 Undetermined Jejunal_Carcinoid_Tumor Jejunal NET G1 Jejunal Neuroendocrine Tumor G1 Jejunal Neuroendocrine Tumor G1 A well-differentiated neuroendocrine neoplasm that arises from the thymus and is often associated with Cushing syndrome. Two morphologic subtypes are recognized: grade 1 (G1-typical carcinoid tumor) and grade 2 (G2-atypical carcinoid tumor). Grade 2 neuroendocrine tumors have a more aggressive clinical course C6430 Neoplastic Process Thymic Neuroendocrine Tumor C1336746 Undetermined Thymus_Carcinoid_Tumor Carcinoid Tumor of Thymus Carcinoid Tumor of the Thymus Thymic Carcinoid Thymic Carcinoid Tumor Thymic Neuroendocrine Tumor Thymus Carcinoid Thymus Carcinoid Tumor Thymic Neuroendocrine Tumor An autosomal dominant inherited neoplastic syndrome characterized by the development of various endocrine neoplasms and abnormalities in various anatomic sites. There are four types recognized: type 1 (MEN 1), caused by inactivation of the tumor suppressor gene MEN-1, type 2A (MEN 2A), caused by mutation of the RET gene, type 2B (MEN 2B) also caused by mutation of the RET gene, and type 4 (MEN 4) caused by mutation of the CDKN1B gene. Patients with MEN 1 may develop hyperparathyroidism and parathyroid gland adenomas, pituitary gland adenomas, pancreatic islet cell neoplasms, and carcinoid tumors. Patients with MEN 2A develop medullary thyroid carcinomas and may also develop pheochromocytomas and parathyroid gland hyperplasia. Patients with MEN 2B develop medullary thyroid carcinomas and numerous neural defects including neuromas. Patients with MEN 4 develop endocrine neoplasms, particularly in the parathyroid glands, pituitary, and pancreas. C6432 Neoplastic Process Multiple Endocrine Neoplasia Multiple Endocrine Neoplasia C1955745 CTRP GDC NICHD A genetically heterogenous group of autosomal dominant neoplastic syndromes characterized by the development of neoplasms in various endocrine organs. An inherited condition that may result in the development of cancers of the endocrine system. There are several types of multiple endocrine neoplasia syndrome, and patients with each type may develop different types of cancer. The altered genes that cause each type can be detected with a blood test. 8360/1 Undetermined Multiple_Endocrine_Neoplasia 8360/1 Endocrine adenomatosis Multiple endocrine adenomas Endocrine adenomatosis MEN MEN Syndromes MEN syndrome Multiple Endocrine Adenomatosis Multiple Endocrine Neoplasia Multiple Endocrine Neoplasia Syndrome Multiple Endocrine Neoplasia Syndrome(s) Multiple endocrine adenomas multiple endocrine adenomatosis multiple endocrine neoplasia syndrome Multiple Endocrine Neoplasia A benign nodular lesion protruding above the surface of the endometrium. It is composed of a fibrous stroma that contains thick-walled blood vessels and dilated endometrial glands. Polypectomy is the treatment of choice. Only few cases with recurrence have been reported. C6433 Neoplastic Process Endometrial Polyp C1704273 CDISC GDC A benign polypoid neoplasm of the endometrium projecting into the endometrial cavity. Benign Endometrial_Polyp Endometrial polyp Endometrial Polyp Endometrial Stromal Polyp Endometrial polyp POLYP, ENDOMETRIAL STROMAL, BENIGN Polyp of Endometrium Polyp of the Endometrium Endometrial Polyp A benign or malignant neoplasm that affects the Bartholin gland. Representative examples include adenoma, adenomyoma, adenocarcinoma, and squamous cell carcinoma. C6434 Neoplastic Process Bartholin Gland Neoplasm C0220616 Undetermined Bartholin_s_Gland_Neoplasm Bartholin Gland Neoplasm Bartholin's Gland Neoplasm Bartholin's Gland Tumor Neoplasm of Bartholin's Gland Neoplasm of the Bartholin's Gland Tumor of Bartholin's Gland Tumor of the Bartholin's Gland Bartholin Gland Neoplasm A germ cell tumor that arises from the mediastinum. Representative examples include seminoma, embryonal carcinoma, yolk sac tumor, teratoma, and mixed germ cell tumor. C6437 Neoplastic Process Mediastinal Germ Cell Tumor C1334655 Undetermined Mediastinal_Germ_Cell_Neoplasm Germ Cell Neoplasm of Mediastinum Germ Cell Neoplasm of the Mediastinum Germ Cell Tumor of Mediastinum Germ Cell Tumor of the Mediastinum Mediastinal Germ Cell Neoplasm Mediastinal Germ Cell Tumor Thymic Germ Cell Tumor Mediastinal Germ Cell Tumor An extragonadal germ cell tumor that arises from the mediastinum. It is characterized by the presence of somatic tissues derived from two or three of the germ layers (ectoderm, endoderm, and mesoderm). C6438 Neoplastic Process Mediastinal Teratoma C1334682 Undetermined Mediastinal_Teratoma Mediastinal Teratoma Teratoma of Mediastinum Teratoma of the Mediastinum Thymic Teratoma Mediastinal Teratoma An extragonadal nongerminomatous malignant germ cell tumor that arises from the mediastinum. This category includes embryonal carcinoma, yolk sac tumor, choriocarcinoma, and mixed germ cell tumors. C6439 Neoplastic Process Malignant Mediastinal Nongerminomatous Germ Cell Tumor C1334666 Malignant Mediastinal_Malignant_Non-Seminomatous_Germ_Cell_Neoplasm Malignant Mediastinal Non-Seminomatous Germ Cell Tumor Malignant Mediastinal Nongerminomatous Germ Cell Tumor Mediastinal Malignant Non-Seminomatous Germ Cell Neoplasm Mediastinal Malignant Non-Seminomatous Germ Cell Tumor Non-Seminomatous Malignant Germ Cell Neoplasm of Mediastinum Non-Seminomatous Malignant Germ Cell Neoplasm of the Mediastinum Non-Seminomatous Malignant Germ Cell Tumor of Mediastinum Non-Seminomatous Malignant Germ Cell Tumor of the Mediastinum Malignant Mediastinal Nongerminomatous Germ Cell Tumor An extragonadal malignant germ cell tumor that arises from the mediastinum and is composed of syncytiotrophoblasts, cytotrophoblasts, and intermediate trophoblasts. The prognosis is usually poor. C6440 Neoplastic Process Mediastinal Choriocarcinoma C1334651 Malignant Mediastinal_Choriocarcinoma Choriocarcinoma of Mediastinum Choriocarcinoma of the Mediastinum Mediastinal Choriocarcinoma Mediastinal Choriocarcinoma An extragonadal malignant germ cell tumor that arises from the mediastinum and is composed of primitive large cells with clear or granular cytoplasm forming solid, glandular, or papillary patterns. It usually affects young males. It manifests with respiratory distress, thoracic or shoulder pain, fever, cough, superior vena cava syndrome, or hoarseness. C6441 Neoplastic Process Mediastinal Embryonal Carcinoma C1334652 Malignant Mediastinal_Embryonal_Carcinoma Embryonal Carcinoma of Mediastinum Embryonal Carcinoma of the Mediastinum Mediastinal Embryonal Carcinoma Mediastinal Embryonal Carcinoma An extragonadal non-seminomatous malignant germ cell tumor that arises from the mediastinum and contains teratoma and embryonal carcinoma components. C6442 Neoplastic Process Mediastinal Mixed Embryonal Carcinoma and Teratoma C1334670 Malignant Mediastinal_Mixed_Embryonal_Carcinoma_and_Teratoma Mediastinal Mixed Embryonal Carcinoma and Teratoma Mediastinal Teratocarcinoma Mixed Embryonal Carcinoma and Teratoma of Mediastinum Mixed Embryonal Carcinoma and Teratoma of the Mediastinum Teratocarcinoma of Mediastinum Teratocarcinoma of the Mediastinum Mediastinal Mixed Embryonal Carcinoma and Teratoma An extragonadal non-seminomatous malignant germ cell tumor that arises from the mediastinum. It is characterized by the presence of small pale cells with small amount of cytoplasm and round to oval nuclei with small nucleoli forming a variety of patterns, including microcystic, macrocystic, pseudopapillary, myxomatous, hepatoid, polyvesicular vitelline, and solid. It manifests with respiratory distress, thoracic pain, fever, and superior vena cava syndrome. C6443 Neoplastic Process Mediastinal Yolk Sac Tumor C1334683 Malignant Mediastinal_Yolk_Sac_Tumor Endodermal Sinus Neoplasm of Mediastinum Endodermal Sinus Neoplasm of the Mediastinum Endodermal Sinus Tumor of Mediastinum Endodermal Sinus Tumor of the Mediastinum Mediastinal Endodermal Sinus Neoplasm Mediastinal Endodermal Sinus Tumor Mediastinal Yolk Sac Neoplasm Mediastinal Yolk Sac Tumor Yolk Sac Neoplasm of Mediastinum Yolk Sac Neoplasm of the Mediastinum Yolk Sac Tumor of Mediastinum Yolk Sac Tumor of the Mediastinum Mediastinal Yolk Sac Tumor An extragonadal nongerminomatous malignant germ cell tumor that arises from the mediastinum and is composed of two or more germ cell tumor types. It manifests with respiratory distress, thoracic pain, cough, superior vena cava syndrome, or hoarseness. C6444 Neoplastic Process Mediastinal Mixed Nongerminomatous Germ Cell Tumor C1334671 Malignant Mediastinal_Mixed_Non-Seminomatous_Germ_Cell_Neoplasm Mediastinal Mixed Non-Seminomatous Germ Cell Neoplasm Mediastinal Mixed Non-Seminomatous Germ Cell Tumor Mediastinal Mixed Nongerminomatous Germ Cell Tumor Mixed Non-Seminomatous Germ Cell Neoplasm of Mediastinum Mixed Non-Seminomatous Germ Cell Neoplasm of the Mediastinum Mixed Non-Seminomatous Germ Cell Tumor of Mediastinum Mixed Non-Seminomatous Germ Cell Tumor of the Mediastinum Mediastinal Mixed Nongerminomatous Germ Cell Tumor A germ cell tumor that arises from the mediastinum. There is no evidence of atypia or metastases. C6445 Neoplastic Process Benign Mediastinal Germ Cell Tumor C1332511 Benign Benign_Mediastinal_Germ_Cell_Neoplasm Benign Germ Cell Neoplasm of Mediastinum Benign Germ Cell Neoplasm of the Mediastinum Benign Germ Cell Tumor of Mediastinum Benign Germ Cell Tumor of the Mediastinum Benign Mediastinal Germ Cell Neoplasm Benign Mediastinal Germ Cell Tumor Mediastinal Benign Germ Cell Tumor Thymic Benign Germ Cell Tumor Benign Mediastinal Germ Cell Tumor An extragonadal malignant germ cell tumor that arises from the mediastinum. This category includes seminoma, embryonal carcinoma, yolk sac tumor, choriocarcinoma, mixed germ cell tumors, and immature malignant teratoma. C6446 Neoplastic Process Malignant Mediastinal Germ Cell Tumor C1334597 Malignant Malignant_Mediastinal_Germ_Cell_Neoplasm Malignant Germ Cell Neoplasm of Mediastinum Malignant Germ Cell Neoplasm of the Mediastinum Malignant Germ Cell Tumor of Mediastinum Malignant Germ Cell Tumor of the Mediastinum Malignant Mediastinal Germ Cell Neoplasm Malignant Mediastinal Germ Cell Tumor Mediastinal Malignant Germ Cell Tumor Thymic Malignant Germ Cell Tumor Malignant Mediastinal Germ Cell Tumor C6447 Neoplastic Process Retroperitoneal Germ Cell Tumor C1335776 Undetermined Retroperitoneal_Germ_Cell_Neoplasm Germ Cell Neoplasm of Retroperitoneum Germ Cell Neoplasm of the Retroperitoneum Germ Cell Tumor of Retroperitoneum Germ Cell Tumor of the Retroperitoneum Retroperitoneal Germ Cell Neoplasm Retroperitoneal Germ Cell Tumor Retroperitoneal Germ Cell Tumor A benign or malignant germ cell tumor that arises from the stomach. Representative examples include teratoma and choriocarcinoma. C6448 Neoplastic Process Gastric Germ Cell Tumor C1333769 Undetermined Gastric_Germ_Cell_Neoplasm Gastric Germ Cell Neoplasm Gastric Germ Cell Tumor Germ Cell Neoplasm of Stomach Germ Cell Neoplasm of the Stomach Germ Cell Tumor of Stomach Germ Cell Tumor of the Stomach Stomach Germ Cell Neoplasm Stomach Germ Cell Tumor Gastric Germ Cell Tumor An epithelial neoplasm that affects the thymus gland. This category includes thymomas and carcinomas. C6450 Neoplastic Process Thymus Epithelial Neoplasm Thymic Epithelial Neoplasm C1266101 CTRP Undetermined Thymus_Epithelial_Neoplasm Epithelial Neoplasm of Thymus Epithelial Neoplasm of the Thymus Epithelial Tumor of Thymus Epithelial Tumor of the Thymus Thymic Epithelial Neoplasm Thymic Epithelial Tumor Thymic Epithelium Neoplasm Thymus Epithelial Neoplasm Thymus Epithelial Tumor Thymic Epithelial Neoplasm A lymphoma that arises from the thymus. Representative examples include mediastinal (thymic) large B-cell lymphoma and Hodgkin lymphoma. C6451 Neoplastic Process Thymic Lymphoma C1336745 Cellosaurus Malignant Thymic_Lymphoma Lymphoma of Thymus Lymphoma of the Thymus Primary Thymic Lymphoma Thymic Lymphoma Thymus Lymphoma Thymic Lymphoma A thymoma of any morphologic type that extends beyond the capsule and infiltrates the surrounding tissues. C6453 Neoplastic Process Invasive Thymoma CL448344 Malignant Invasive_Thymoma Infiltrating Thymoma Invasive Thymoma Invasive Thymoma A thymic epithelial neoplasm characterized by the presence of spindle and/or oval neoplastic epithelial cells. Lymphocytic infiltration is minimal or absent. It may be associated with myasthenia gravis or pure red cell aplasia. The majority of cases occur in the anterior mediastinum as Masaoka stage I tumors. Approximately 20% of the cases occur as stage II or stage III tumors. Type A thymoma generally behaves as a benign tumor and the overall survival is reported to be 100% at 5 and 10 years. C6454 Neoplastic Process Thymoma Type A Thymoma Type A C1266091 CTRP GDC 8581/1 Undetermined Thymoma_Type_A 8581/1 Thymoma, medullary, NOS Thymoma, spindle cell, NOS Thymoma, type A, NOS Medullary Thymoma Spindle Cell Thymoma Thymoma Type A Thymoma Type A A rare primary thymic carcinoma, characterized by the presence of keratinizing or non-keratinizing malignant squamous cells. Approximately 10-20% of cases occur in combination with thymoma. The prognosis depends on the tumor stage and the degree of cellular differentiation. C6455 Neoplastic Process Thymic Squamous Cell Carcinoma C1336082 Malignant Squamous_Cell_Thymic_Carcinoma Epidermoid Thymic Carcinoma Squamous Cell Carcinoma of Thymus Squamous Cell Carcinoma of the Thymus Thymic Squamous Cell Carcinoma Thymus Squamous Cell Carcinoma Thymic Squamous Cell Carcinoma A rare primary thymic carcinoma, characterized by the presence of tumor cell lobules with peripheral palisading, and a basophilic staining pattern. More than half of reported cases were associated with the presence of a multilocular thymic cyst. Metastases to lung and liver have been reported in approximately 30% of cases. C6456 Neoplastic Process Thymic Basaloid Squamous Cell Carcinoma C1332464 Malignant Basaloid_Thymic_Carcinoma Basaloid Carcinoma of Thymus Basaloid Carcinoma of the Thymus Thymic Basaloid Carcinoma Thymic Basaloid Squamous Cell Carcinoma Thymus Basaloid Carcinoma Thymic Basaloid Squamous Cell Carcinoma A rare primary thymic carcinoma, characterized by the presence of squamous cells, intermediate type cells, and mucus-producing cells. The prognosis depends on histologic grade and stage. C6457 Neoplastic Process Thymic Mucoepidermoid Carcinoma C1334814 Malignant Mucoepidermoid_Thymic_Carcinoma Mucoepidermoid Carcinoma of Thymus Mucoepidermoid Carcinoma of the Thymus Thymic Mucoepidermoid Carcinoma Thymus Mucoepidermoid Carcinoma Thymic Mucoepidermoid Carcinoma A rare carcinoma that arises from the thymus and is characterized by the presence of glandular and squamous carcinomatous components. C6458 Neoplastic Process Thymic Adenosquamous Carcinoma C1332171 Malignant Adenosquamous_Thymic_Carcinoma Adenosquamous Carcinoma of Thymus Adenosquamous Carcinoma of the Thymus Thymic Adenosquamous Carcinoma Thymus Adenosquamous Carcinoma Thymic Adenosquamous Carcinoma A rare primary thymic carcinoma, characterized by the presence of carcinoma cells with glandular differentiation. C6459 Neoplastic Process Thymic Adenocarcinoma C1336743 Malignant Thymic_Adenocarcinoma Adenocarcinoma of Thymus Adenocarcinoma of the Thymus Thymic Adenocarcinoma Thymus Adenocarcinoma Thymic Adenocarcinoma A small cell neuroendocrine carcinoma arising from the thymus. C6460 Neoplastic Process Thymic Small Cell Neuroendocrine Carcinoma C1335980 Malignant Small_Cell_Thymic_Carcinoma Small Cell Carcinoma of Thymus Small Cell Carcinoma of the Thymus Thymic Small Cell Carcinoma Thymic Small Cell Carcinoma Neuroendocrine Type Thymic Small Cell Neuroendocrine Carcinoma Thymus Small Cell Carcinoma Thymic Small Cell Neuroendocrine Carcinoma A large cell neuroendocrine carcinoma arising from the thymus. C6461 Neoplastic Process Thymic Large Cell Neuroendocrine Carcinoma C1334364 Malignant Large_Cell_Thymic_Carcinoma Large Cell Neuroendocrine Carcinoma of Thymus Large Cell Neuroendocrine Carcinoma of the Thymus Thymic LCNEC Thymic Large Cell Neuroendocrine Carcinoma Thymic Large Cell Neuroendocrine Carcinoma A rare, usually aggressive, primary thymic carcinoma, characterized by the presence of carcinoma cells with clear cytoplasm. C6462 Neoplastic Process Thymic Clear Cell Carcinoma C1333069 Malignant Clear_Cell_Thymic_Carcinoma Clear Cell Carcinoma of Thymus Clear Cell Carcinoma of the Thymus Thymic Clear Cell Carcinoma Thymus Clear Cell Carcinoma Thymic Clear Cell Carcinoma A rare, usually aggressive, primary thymic carcinoma, characterized by the presence of tumor cells morphologically resembling soft tissue sarcoma. C6463 Neoplastic Process Thymic Sarcomatoid Carcinoma C1335924 Malignant Sarcomatoid_Thymic_Carcinoma Sarcomatoid Carcinoma of Thymus Sarcomatoid Carcinoma of the Thymus Thymic Carcinosarcoma Thymic Sarcomatoid Carcinoma Thymic Spindle Cell Carcinoma Thymus Sarcomatoid Carcinoma Thymic Sarcomatoid Carcinoma Stage IA includes: T1, N0, M0, G1, G2, GX. T1: Tumor 8 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated-low grade. G2: Moderately differentiated-low grade. GX: Grade cannot be assessed. (AJCC 7th ed.) C6464 Neoplastic Process Stage IA Bone Sarcoma AJCC v7 Stage IA Bone Sarcoma AJCC v7 C1336112 CTRP Malignant Stage_IA_Bone_Sarcoma Stage IA Bone Sarcoma Stage IA Bone Sarcoma AJCC v7 Stage IA Sarcoma of Bone Stage IA Sarcoma of the Bone Stage IA Bone Sarcoma AJCC v7 Stage IB includes: (T2, N0, M0, G1, G2, GX); (T3, N0, M0, G1, G2, GX). T2: Tumor more than 8 cm in greatest dimension. T3: Discontinuous tumors in the primary bone site. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated-low grade. G2: Moderately differentiated-low grade. GX: Grade cannot be assessed. (AJCC 7th ed.) C6465 Neoplastic Process Stage IB Bone Sarcoma AJCC v7 Stage IB Bone Sarcoma AJCC v7 C1336131 CTRP Malignant Stage_IB_Bone_Sarcoma Stage IB Bone Sarcoma Stage IB Bone Sarcoma AJCC v7 Stage IB Sarcoma of Bone Stage IB Sarcoma of the Bone Stage IB Bone Sarcoma AJCC v7 Stage IIB includes: T2, N0, M0, G3, G4. T2: Tumor more than 8 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (AJCC 7th ed.) C6466 Neoplastic Process Stage IIB Bone Sarcoma AJCC v7 Stage IIB Bone Sarcoma AJCC v7 C1336177 CTRP Malignant Stage_IIB_Bone_Sarcoma Stage IIB Bone Sarcoma Stage IIB Bone Sarcoma AJCC v7 Stage IIB Sarcoma of Bone Stage IIB Sarcoma of the Bone Stage IIB Bone Sarcoma AJCC v7 Stage IIA includes: T1, N0, M0, G3, G4. T1: Tumor 8 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (AJCC 7th ed.) C6467 Neoplastic Process Stage IIA Bone Sarcoma AJCC v7 Stage IIA Bone Sarcoma AJCC v7 C1336155 CTRP Malignant Stage_IIA_Bone_Sarcoma Stage IIA Bone Sarcoma Stage IIA Bone Sarcoma AJCC v7 Stage IIA Sarcoma of Bone Stage IIA Sarcoma of the Bone Stage IIA Bone Sarcoma AJCC v7 Stage III includes: T3, N0, M0, G3, G4. T3: Tumor more than 8 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (AJCC 7th ed.) C6468 Neoplastic Process Stage III Bone Sarcoma AJCC v7 Stage III Bone Sarcoma AJCC v7 C1336243 CTRP Malignant Stage_III_Bone_Sarcoma Stage III Bone Sarcoma Stage III Bone Sarcoma AJCC v7 Stage III Sarcoma of Bone Stage III Sarcoma of the Bone Stage III Bone Sarcoma AJCC v7 A sarcomatous transformation of pre-existing Paget disease of the bone. Osteosarcomas arising from Paget disease of the bone are high grade lesions and usually have a poor prognosis. C6469 Neoplastic Process Osteosarcoma Arising in Paget Disease of Bone C0334546 GDC 9184/3 Malignant Osteosarcoma_Arising_in_Paget_s_Disease_of_Bone 9184/3 Osteosarcoma in Paget disease of bone Osteosarcoma Arising in Bone Paget's Disease Osteosarcoma Arising in Osseous Paget's Disease Osteosarcoma Arising in Osteitis Deformans Osteosarcoma Arising in Paget Disease of Bone Osteosarcoma Arising in Paget's Disease of Bone Osteosarcoma in Paget Disease of Bone Osteosarcoma in Paget disease of bone Paget Osteosarcoma Paget's Osteosarcoma Osteosarcoma Arising in Paget Disease of Bone A primary bone osteosarcoma affecting multiple bone sites. C6470 Neoplastic Process Multifocal Osteosarcoma C1334820 Cellosaurus Malignant Multifocal_Osteosarcoma Multicentric Osteosarcoma Multifocal Osteogenic Sarcoma Multifocal Osteosarcoma Multifocal Osteosarcoma A bone osteosarcoma affecting multiple skeletal sites, with multifocal lesions discovered within 6 months of the appearance of the initial tumor. It has a poor prognosis. C6471 Neoplastic Process Synchronous Multifocal Osteosarcoma C1336544 Malignant Synchronous_Multifocal_Osteosarcoma Synchronous Multifocal Osteogenic Sarcoma Synchronous Multifocal Osteosarcoma Synchronous Multifocal Osteosarcoma A bone osteosarcoma affecting multiple skeletal sites, with multifocal lesions discovered between 6 and 24 months after the appearance of the initial tumor. Patients with asynchronous tumors have a better prognosis than those with synchronous osteosarcomas. C6472 Neoplastic Process Asynchronous Multifocal Osteosarcoma C1332342 Malignant Asynchronous_Multifocal_Osteosarcoma Asynchronous Multifocal Osteogenic Sarcoma Asynchronous Multifocal Osteosarcoma Asynchronous Multifocal Osteosarcoma A low grade osteosarcoma arising from the medullary portion of the bone. It affects the long bones and is characterized by the presence of fibroblastic stroma and osteoid production. Pain and swelling are the usual sign and symptom. The prognosis is more favorable than conventional osteosarcoma. C6474 Neoplastic Process Low Grade Central Osteosarcoma C1266163 GDC 9187/3 Malignant Low_Grade_Central_Osteosarcoma 9187/3 Intraosseous low grade osteosarcoma Intraosseous well differentiated osteosarcoma Low grade central osteosarcoma Low-grade central osteosarcoma Low-grade intramedullary osteosarcoma Intraosseous Well Differentiated Osteosarcoma Intraosseous Well-Differentiated Osteogenic Sarcoma Intraosseous Well-Differentiated Osteosarcoma Intraosseous well differentiated osteosarcoma LGCOS Low Grade Central Osteosarcoma Low Grade Intramedullary Osteosarcoma Low-Grade Intramedullary Osteosarcoma Low-grade central osteosarcoma Low-grade intramedullary osteosarcoma Low Grade Central Osteosarcoma A rare, usually low grade chondrosarcoma characterized by the presence of tumor cells with clear cytoplasm. It usually arises in the epiphyseal ends of long bones. C6475 Neoplastic Process Clear Cell Chondrosarcoma C1266167 GDC 9242/3 Malignant Clear_Cell_Chondrosarcoma 9242/3 Clear cell chondrosarcoma Clear Cell Chondrosarcoma Clear cell chondrosarcoma Clear Cell Chondrosarcoma An aggressive morphologic variant of chondrosarcoma. It is composed of a low grade chondrosarcoma and a high grade non-cartilagenous sarcomatous component. Due to the aggressive nature of the disease, its prognosis is poor. C6476 Neoplastic Process Dedifferentiated Chondrosarcoma C0862878 Cellosaurus GDC 9243/3 Malignant Dedifferentiated_Chondrosarcoma 9243/3 Dedifferentiated chondrosarcoma Dedifferentiated Chondrosarcoma Dedifferentiated chondrosarcoma Dedifferentiated Chondrosarcoma A hemangioma arising in the bone. C6477 Neoplastic Process Bone Hemangioma C1332578 Benign Bone_Hemangioma Angioma of Bone Angioma of the Bone Bone Angioma Bone Hemangioma Hemangioma of Bone Hemangioma of the Bone Osseous Angioma Osseous Hemangioma Bone Hemangioma A benign, intermediate, or malignant vascular neoplasm that arises from the bone. C6478 Neoplastic Process Vascular Bone Neoplasm C1336946 Undetermined Vascular_Bone_Neoplasm Bone Vascular Neoplasm Bone Vascular Tumor Osseous Vascular Neoplasm Osseous Vascular Tumor Vascular Bone Neoplasm Vascular Neoplasm of Bone Vascular Neoplasm of the Bone Vascular Tumor of Bone Vascular Tumor of the Bone Vascular Bone Neoplasm A high-grade malignant vascular neoplasm that arises from the bone. It is characterized by the presence of neoplastic cells with endothelial differentiation. C6479 Neoplastic Process Bone Angiosarcoma C1332574 Malignant Bone_Angiosarcoma Bone Angioendothelial Sarcoma Bone Angiosarcoma Bone Hemangioendothelial Sarcoma Bone Hemangiosarcoma Osseous Angioendothelial Sarcoma Osseous Angiosarcoma Osseous Hemangiosarcoma Bone Angiosarcoma A benign or malignant glomus tumor arising from the bone. C6480 Neoplastic Process Bone Glomus Tumor C1332577 Undetermined Bone_Glomus_Tumor Bone Glomus Neoplasm Bone Glomus Tumor Glomus Neoplasm of Bone Glomus Neoplasm of the Bone Glomus Tumor of Bone Glomus Tumor of the Bone Osseous Glomus Neoplasm Osseous Glomus Tumor Bone Glomus Tumor A multinodular intermediate fibroblastic neoplasm that arises from soft tissue or viscera, in children and young adults. It is characterized by the presence of spindle-shaped fibroblasts and myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes, and plasma cells. C6481 Neoplastic Process Inflammatory Myofibroblastic Tumor C0334121 GDC 8825/1 Undetermined Inflammatory_Myofibroblastic_Tumor Inflammatory myofibroblastic tumor Myofibroblastic tumor, NOS IMT Inflammatory Fibrosarcoma Inflammatory Myofibroblastic Neoplasm Inflammatory Myofibroblastic Tumor Inflammatory Pseudotumor Inflammatory myofibroblastic tumor Inflammatory Myofibroblastic Tumor A benign neoplasm arising from the dermis. It is characterized by the presence of spindle-shaped fibroblasts. C6484 Neoplastic Process Dermal Fibroma C1333275 Benign Dermal_Fibroma Dermal Fibroma Fibroma of Skin Fibroma of the Skin Skin Fibroma Dermal Fibroma A small, slow growing, benign neoplasm arising from the tendon sheaths. The tumor is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation. C6485 Neoplastic Process Tendon Sheath Fibroma C1275236 Benign Tendon_Sheath_Fibroma Fibroma of tendon sheath Fibroma of Tendon Sheath Fibroma of the Tendon Sheath Tendon Sheath Fibroma Tendon Sheath Fibroma The skin of the hinge joint that is located between the thigh and lower leg. C64859 Anatomical Structure Knee Skin C0222275 CDISC The integument that covers the knee joint. Knee_Skin Knee Skin SKIN OF THE KNEE Knee Skin A rare non-encapsulated and poorly circumscribed tumor that usually arises from the posterior neck. It is seen more frequently in men and is characterized by the presence of thick collagen fibers. It may recur but does not metastasize. C6486 Neoplastic Process Nuchal-Type Fibroma C1532393 Benign Nuchal_Fibroma Nuchal Fibroma Nuchal-Type Fibroma Nuchal-Type Fibroma A type of diffusion-weighted magnetic resonance imaging (DW-MRI) that maps the diffusion of water in three dimensions, the principal purpose of which is to image the white matter of the brain, specifically measuring the anisotropy, location, and orientation of the neural tracts, which can demonstrate microstructural changes or differences with neuropathology and treatment. C64862 Diagnostic Procedure Diffusion Tensor Imaging Diffusion Tensor Imaging C1537007 CDISC CTRP DIPG/DMG A type of MRI technique that maps the diffusion of water in three dimensions. Diffusion_Tensor_Imaging DIFFUSION TENSOR MRI DT-MRI DTI Diffusion Tensor Imaging Diffusion Tensor Imaging C64866 Diagnostic Procedure Real-Time Contrast-Enhanced Ultrasonography Real-Time Contrast-Enhanced Ultrasonography C1832052 CTRP Real-Time_Contrast-Enhanced_Ultrasonography Real-Time Contrast-Enhanced Ultrasonography Real-Time Contrast-Enhanced Ultrasonography A benign well-circumscribed lesion arising from the soft tissues. It is characterized by the presence of fibroblasts, lymphoplasmacytic infiltrates, collagenous stroma formation, psammoma bodies, and dystrophic calcifications. C6488 Neoplastic Process Calcifying Fibrous Tumor C1332833 Benign Calcifying_Fibrous_Pseudotumor CFT Calcifying Fibrous Pseudotumor Calcifying Fibrous Tumor Calcifying Fibrous Tumor An insidious poorly circumscribed neoplasm arising from the soft tissues outside the abdomen. It is characterized by the presence of elongated spindle-shaped fibroblasts, vascular collagenous stroma formation, and an infiltrative growth pattern. C6489 Neoplastic Process Extraabdominal Fibromatosis C1275420 GDC Undetermined Extraabdominal_Fibromatosis 8821/1 Extra-abdominal desmoid Extra-abdominal desmoid Extraabdominal Desmoid Extraabdominal Desmoid Tumor Extraabdominal Fibromatosis Extraabdominal Fibromatosis A mesenchymal neoplasm composed of fibrohistiocytic cells, spindle fibroblastic cells, and histiocytes, in a storiform pattern. There is no evidence of atypical or malignant cytological and architectural features, invasive features, or metastases. C6490 Neoplastic Process Benign Fibrohistiocytic Neoplasm C1332500 Benign Benign_Fibrohistiocytic_Neoplasm Benign Fibrohistiocytic Neoplasm Benign Fibrohistiocytic Tumor Benign Fibrohistiocytic Neoplasm A fibrohistiocytic neoplasm usually affecting younger patients. It is characterized by an increased risk of local recurrence and a low risk of metastasis. C6491 Neoplastic Process Intermediate Fibrohistiocytic Neoplasm C1334213 Undetermined Intermediate_Fibrohistiocytic_Neoplasm Intermediate Fibrohistiocytic Neoplasm Intermediate Fibrohistiocytic Tumor Intermediate Fibrohistiocytic Neoplasm A rare, well-circumscribed, pseudo-encapsulated benign fibrous histiocytoma that arises entirely within the subcutaneous tissue or deep soft tissue. It usually affects the extremities or the head and neck region. It recurs locally in a minority of cases. C6492 Neoplastic Process Deep Fibrous Histiocytoma C1266125 GDC Benign Benign_Deep_Fibrous_Histiocytoma 8831/0 Deep histiocytoma Juvenile histiocytoma Benign Deep Fibrous Histiocytoma Deep Benign Fibrous Histiocytoma Deep Fibrous Histiocytoma Deep Fibrous Histiocytoma An intermediate fibrohistiocytic neoplasm of the skin that usually affects children and young adults. It is a multinodular, poorly circumscribed tumor characterized by the presence of multinucleated giant cells, mononuclear histiocyte-like cells, and spindle fibroblast-like cells arranged in a plexiform pattern. C6493 Neoplastic Process Plexiform Fibrohistiocytic Tumor C1266126 GDC 8835/1 Undetermined Plexiform_Fibrohistiocytic_Tumor 8835/1 Plexiform fibrohistiocytic tumor PFHT Plexiform Fibrohistiocytic Neoplasm Plexiform Fibrohistiocytic Tumor Plexiform fibrohistiocytic tumor Plexiform Fibrohistiocytic Tumor A low malignant potential soft tissue neoplasm of uncertain differentiation. It typically affects young patients, presenting as a slowly growing nodular or cystic tumor mass, most often in the subcutaneous tissues of the extremities. Occasionally, patients have systemic symptoms (anemia, fever, and weight loss). This tumor has a relatively good prognosis. A minority of patients develop local recurrences. Metastases are rare. C6494 Neoplastic Process Angiomatoid Fibrous Histiocytoma C1266127 GDC 8836/1 Undetermined Angiomatoid_Fibrous_Histiocytoma 8836/1 Angiomatoid fibrous histiocytoma AFH Angiomatoid Fibrous Histiocytoma Angiomatoid Malignant Fibrous Histiocytoma Angiomatoid fibrous histiocytoma Angiomatoid Fibrous Histiocytoma A malignant fibroblastic neoplasm arising from the soft tissue. It is characterized by the presence of spindle-shaped cells, cellular pleomorphism, thin-walled blood vessels, fibrous septa, and myxoid stroma. C6496 Neoplastic Process Myxofibrosarcoma Myxofibrosarcoma C0334454 CTRP Cellosaurus GDC 8811/3 Malignant Myxoid_Malignant_Fibrous_Histiocytoma 8811/3 Fibromyxosarcoma Myxofibrosarcoma Fibromyxosarcoma Myxofibrosarcoma Myxoid MFH Myxoid Malignant Fibrous Histiocytoma Myxofibrosarcoma An undifferentiated pleomorphic sarcoma characterized by the presence of numerous inflammatory cells. C6497 Neoplastic Process Undifferentiated Pleomorphic Sarcoma, Inflammatory Variant C1334180 Malignant Inflammatory_Malignant_Fibrous_Histiocytoma Inflammatory MFH Inflammatory Malignant Fibrous Histiocytoma Malignant Xanthogranuloma Undifferentiated Pleomorphic Sarcoma, Inflammatory Variant Undifferentiated Pleomorphic Sarcoma, Inflammatory Variant A benign well-circumscribed tumor, composed of mature adipocytes, that arises within deep soft tissues. C6498 Neoplastic Process Deep Lipoma C1333267 Benign Deep_Lipoma Deep Fatty Neoplasm Deep Fatty Tumor Deep Lipoma Deep Lipoma A benign tumor, composed of mature adipocytes, that arises within the tendon sheath. C6499 Neoplastic Process Tendon Sheath Lipoma C1336703 Benign Tendon_Sheath_Lipoma Lipoma of Tendon Sheath Lipoma of the Tendon Sheath Tendon Sheath Lipoma Tendon Sheath Lipoma A benign well-circumscribed tumor, composed of lobules of mature adipocytes, that arises within the lumbosacral tissue of the spine. C6500 Neoplastic Process Lumbosacral Lipoma C1334438 Benign Lumbosacral_Lipoma Lumbosacral Lipoma Lumbosacral Lipoma A rare benign adipose tissue neoplasm characterized by nests and cord of abundant univacuolated and multivacuolated lipoblasts and mature adipocytes in a prominent myxoid to hyalinized chondroid matrix admix. It predominantly affects females. C6503 Neoplastic Process Chondroid Lipoma C1266131 GDC 8862/0 Benign Chondroid_Lipoma 8862/0 Chondroid lipoma Chondroid Lipoma Chondroid lipoma Chondroid Lipoma A neoplastic process characterized by a diffuse poorly circumscribed overgrowth of adipose tissue. It has been associated with several genetic disorders and different clinical conditions such as liver disease, excessive alcohol intake, adrenocortical steroid therapy, and antiretroviral therapy. C6504 Neoplastic Process Diffuse Lipomatosis C1333298 Benign Diffuse_Lipomatosis Diffuse Lipomatosis Diffuse Lipomatosis A locally aggressive mesenchymal neoplasm composed either entirely or partly of an adipocytic proliferation showing at least focal nuclear atypia in both adipocytes and stromal cells. "Atypical lipomatous tumor" and "well-differentiated liposarcoma" are synonyms describing lesions that are morphologically and genetically identical. Amplification of MDM2 and/or CDK4 is almost always present. (WHO 2020) C6505 Neoplastic Process Atypical Lipomatous Tumor/Well Differentiated Liposarcoma C1266129 Cellosaurus GDC 8850/1 8851/3 Undetermined Atypical_Lipoma Well-Differentiated_Liposarcoma 8851/3 Atypical lipoma Atypical lipomatous tumor Liposarcoma, differentiated Liposarcoma, well differentiated Liposarcoma, well differentiated, NOS ALT ALT/WDLPS Atypical Lipoma Atypical Lipomatous Tumor Atypical Lipomatous Tumor/Well Differentiated Liposarcoma Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma Atypical lipoma Liposarcoma, differentiated Liposarcoma, well differentiated Well Differentiated Liposarcoma Well-Differentiated Liposarcoma Atypical Lipomatous Tumor/Well Differentiated Liposarcoma An atypical lipomatous tumor/well differentiated liposarcoma characterized by the presence of bizarre hyperchromatic stromal cells and rare multivacuolated lipoblasts within a fibrous stroma. C6507 Neoplastic Process Sclerosing Atypical Lipomatous Tumor/Well Differentiated Liposarcoma C0334469 GDC Undetermined Sclerosing_Liposarcoma 8851/3 Sclerosing liposarcoma Sclerosing ALT/WDLPS Sclerosing Atypical Lipomatous Tumor/Well Differentiated Liposarcoma Sclerosing Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma Sclerosing Liposarcoma Sclerosing liposarcoma Sclerosing Atypical Lipomatous Tumor/Well Differentiated Liposarcoma A rare morphologic variant of atypical lipomatous tumor/well differentiated liposarcoma occurring most often in the retroperitoneum. It is characterized by the presence of a predominant chronic inflammatory infiltrate. C6508 Neoplastic Process Inflammatory Atypical Lipomatous Tumor/Well Differentiated Liposarcoma C1370890 GDC Undetermined Inflammatory_Liposarcoma 8851/3 Inflammatory liposarcoma Inflammatory ALT/WDLPS Inflammatory Atypical Lipomatous Tumor/Well Differentiated Liposarcoma Inflammatory Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma Inflammatory Liposarcoma Inflammatory liposarcoma Inflammatory Atypical Lipomatous Tumor/Well Differentiated Liposarcoma A benign mesenchymal neoplasm arising from smooth muscle tissue. C6510 Neoplastic Process Benign Smooth Muscle Neoplasm C1332539 Benign Benign_Smooth_Muscle_Neoplasm Benign Neoplasm of Smooth Muscle Benign Neoplasm of the Smooth Muscle Benign Smooth Muscle Neoplasm Benign Smooth Muscle Tumor Benign Tumor of Smooth Muscle Benign Tumor of the Smooth Muscle Benign Smooth Muscle Neoplasm A malignant neoplasm arising from smooth muscle. C6511 Neoplastic Process Malignant Smooth Muscle Neoplasm C1334620 Malignant Malignant_Smooth_Muscle_Neoplasm Cancer of Smooth Muscle Cancer of the Smooth Muscle Malignant Neoplasm of Smooth Muscle Malignant Neoplasm of the Smooth Muscle Malignant Smooth Muscle Neoplasm Malignant Smooth Muscle Tumor Malignant Tumor of Smooth Muscle Malignant Tumor of the Smooth Muscle Smooth Muscle Cancer Malignant Smooth Muscle Neoplasm A rare benign smooth muscle neoplasm arising from deep tissue. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C6512 Neoplastic Process Deep Leiomyoma C1333266 Benign Deep_Leiomyoma Deep Leiomyoma Deep Leiomyoma A benign or malignant mesenchymal neoplasm arising from skeletal muscle. C6514 Neoplastic Process Skeletal Muscle Neoplasm C1335971 Undetermined Skeletal_Muscle_Neoplasm Neoplasm of Skeletal Muscle Neoplasm of the Skeletal Muscle Skeletal Muscle Neoplasm Skeletal Muscle Tumor Tumor of Skeletal Muscle Tumor of the Skeletal Muscle Skeletal Muscle Neoplasm A benign mesenchymal neoplasm arising from skeletal muscle tissue. C6515 Neoplastic Process Benign Skeletal Muscle Neoplasm C1332538 Benign Benign_Skeletal_Muscle_Neoplasm Benign Neoplasm of Skeletal Muscle Benign Neoplasm of the Skeletal Muscle Benign Skeletal Muscle Neoplasm Benign Skeletal Muscle Tumor Benign Tumor of Skeletal Muscle Benign Tumor of the Skeletal Muscle Benign Skeletal Muscle Neoplasm A malignant neoplasm arising from skeletal muscle. C6516 Neoplastic Process Malignant Skeletal Muscle Neoplasm C1334619 Malignant Malignant_Skeletal_Muscle_Neoplasm Malignant Neoplasm of Skeletal Muscle Malignant Neoplasm of the Skeletal Muscle Malignant Skeletal Muscle Neoplasm Malignant Skeletal Muscle Tumor Malignant Tumor of Skeletal Muscle Malignant Tumor of the Skeletal Muscle Malignant Skeletal Muscle Neoplasm A lymph node at the base of the celiac artery. C65166 Body Part, Organ, or Organ Component Celiac Lymph Node C0229766 CDISC PCDC A lymph node at the base of the celiac artery. (NCI) Celiac_Lymph_Node CELIAC LYMPH NODE Celiac Axis Lymph Node Celiac Lymph Node Celiac Nodes Celiac Lymph Node A rare benign skeletal muscle neoplasm arising from the female genital tract. It is characterized by the presence of small nucleated rhabdomyoblasts within a fibrous and myxoid stroma. C6517 Neoplastic Process Genital Rhabdomyoma C1266133 GDC 8905/0 Benign Genital_Rhabdomyoma 8905/0 Genital rhabdomyoma Genital Rhabdomyoma Genital rhabdomyoma Genital Rhabdomyoma A morphologic variant of fetal rhabdomyoma characterized by the presence of spindle cell myoblasts and strap-like skeletal muscle cells. C6518 Neoplastic Process Intermediate Rhabdomyoma C1334218 Benign Intermediate_Rhabdomyoma Cellular Rhabdomyoma Intermediate Rhabdomyoma Intermediate Rhabdomyoma An insulin-producing neuroendocrine tumor arising from the beta cells of the pancreas. Patients exhibit symptoms related to hypoglycemia due to inappropriate secretion of insulin. It displays vascular invasion and metastasizes to other anatomic sites. C65186 Neoplastic Process Malignant Pancreatic Insulinoma Malignant Pancreatic Insulinoma C0334281 CTRP GDC 8151/3 Malignant Malignant_Insulinoma 8151/3 Beta cell tumor, malignant Insulinoma, malignant Beta cell tumor, malignant Insulinoma, malignant Malignant Insulinoma Malignant Pancreatic Insulinoma Pancreatic Beta Islet Cell Carcinoma Pancreatic Insulin Producing Carcinoma Malignant Pancreatic Insulinoma A glucagon-producing neuroendocrine tumor arising from the alpha cells of the pancreas. It may be associated with necrolytic erythema migrans, diarrhea, diabetes, glossitis, weight loss, malabsorption, and anemia. It displays vascular invasion and metastasizes to other anatomic sites. C65187 Neoplastic Process Malignant Pancreatic Glucagonoma Malignant Pancreatic Glucagonoma C0334282 CTRP GDC 8152/3 Malignant Malignant_Glucagonoma 8152/3 Alpha cell tumor, malignant Glucagonoma, malignant Alpha cell tumor, malignant Glucagonoma, malignant Malignant Glucagonoma Malignant Pancreatic Glucagonoma Pancreatic Alpha Cell Carcinoma Malignant Pancreatic Glucagonoma A gastrin-producing neuroendocrine tumor. It is characterized by inappropriate secretion of gastrin and associated with Zollinger Ellison syndrome. It displays vascular invasion and metastasizes to other anatomic sites. C65188 Neoplastic Process Malignant Gastrinoma Malignant Gastrinoma C0334283 CTRP GDC 8153/3 Malignant Malignant_Gastrinoma 8153/3 G cell tumor, malignant Gastrin cell tumor, malignant Gastrinoma, malignant G cell tumor, malignant Gastrin cell tumor, malignant Gastrinoma, malignant Malignant Gastrinoma Malignant Gastrinoma An aggressive neuroendocrine tumor located in the pancreas or small intestine. It is composed of cells containing vasoactive intestinal peptide. It is associated with watery diarrhea, hypokalemia, and hypochlorhydria or achlorhydria. It displays vascular invasion and metastasizes to other anatomic sites. C65189 Neoplastic Process Malignant Vipoma C1881600 GDC 8155/3 Malignant Malignant_Vipoma 8155/3 Vipoma, malignant Malignant Vipoma Vipoma, malignant Malignant Vipoma An uncommon variant of rhabdomyosarcoma characterized by the presence of whorls of spindle cells forming a storiform pattern. In children it usually arises in the paratesticular region. In adults it usually arises from the deep soft tissues in the head and neck. C6519 Neoplastic Process Spindle Cell Rhabdomyosarcoma Spindle Cell Rhabdomyosarcoma C1266134 CTRP GDC NICHD An uncommon variant of rhabdomyosarcoma that is characterized by the presence of whorls of spindle cells forming a storiform pattern. In children, it usually arises in the paratesticular region; in adults it usually arises from the deep soft tissues in the head and neck. 8912/3 Malignant Spindle_Cell_Rhabdomyosarcoma 8912/3 Spindle cell rhabdomyosarcoma Spindle Cell Rhabdomyosarcoma Spindle cell rhabdomyosarcoma Spindle Cell Rhabdomyosarcoma A neuroendocrine tumor arising from delta cells which produce somatostatin. It displays vascular invasion and metastasizes to other anatomic sites. C65190 Neoplastic Process Malignant Somatostatinoma Malignant Somatostatinoma C1266015 CTRP GDC 8156/3 Malignant Malignant_Somatostatinoma 8156/3 Somatostatin cell tumor, malignant Somatostatinoma, malignant Delta Cell Carcinoma Malignant Somatostatinoma Malignant Somatostatinoma An adenoma of the gastrointestinal tract mucosa which grossly and morphologically does not appear as an elevated or polypoid lesion. C65193 Neoplastic Process Flat Adenoma C1266024 GDC 8212/0 Benign Flat_Adenoma 8212/0 Flat adenoma Flat Adenoma Flat adenoma GI Tract Flat Adenoma Gastrointestinal Tract Flat Adenoma Flat Adenoma An adenocarcinoma of the stomach arising from the parietal cells. It is characterized by the presence of malignant cells with eosinophilic, finely granular cytoplasm. C65194 Neoplastic Process Gastric Parietal Cell Adenocarcinoma C1266026 GDC 8214/3 Malignant Parietal_Cell_Adenocarcinoma 8214/3 Parietal cell adenocarcinoma Parietal cell carcinoma Gastric Parietal Cell Adenocarcinoma Parietal Cell Adenocarcinoma Parietal cell adenocarcinoma Gastric Parietal Cell Adenocarcinoma A follicular carcinoma of the thyroid gland showing capsular invasion only. C65200 Neoplastic Process Thyroid Gland Follicular Carcinoma, Minimally Invasive C1266048 GDC 8335/3 Malignant Thyroid_Gland_Follicular_Carcinoma_Minimally_Invasive 8335/3 Follicular carcinoma, minimally invasive FTC, Minimally Invasive Follicular carcinoma, minimally invasive Thyroid Gland Follicular Carcinoma, Minimally Invasive Thyroid Gland Follicular Carcinoma, Minimally Invasive A non-metastasizing sex cord-stromal tumor that arises from the testis. Morphologically, it is characterized by the presence of Sertoli cells forming tubules. Leydig cells are rare or absent. C6522 Neoplastic Process Benign Testicular Sertoli Cell Tumor C1332540 Benign Benign_Testicular_Sertoli_Cell_Tumor Benign Sertoli Cell Neoplasm of Testis Benign Sertoli Cell Neoplasm of the Testis Benign Sertoli Cell Tumor of Testis Benign Sertoli Cell Tumor of the Testis Benign Testicular Sertoli Cell Neoplasm Benign Testicular Sertoli Cell Tumor Benign Testicular Sertoli Cell Tumor A Sertoli cell tumor that arises from the testis and is characterized by nuclear pleomorphism, increased mitotic activity and necrotic changes. Metastases may be present at diagnosis. C6523 Neoplastic Process Malignant Testicular Sertoli Cell Tumor C1334626 Malignant Malignant_Testicular_Sertoli_Cell_Tumor Malignant Sertoli Cell Neoplasm of Testis Malignant Sertoli Cell Neoplasm of the Testis Malignant Sertoli Cell Tumor of Testis Malignant Sertoli Cell Tumor of the Testis Malignant Testicular Sertoli Cell Neoplasm Malignant Testicular Sertoli Cell Tumor Malignant Testicular Sertoli Cell Tumor A benign neoplasm arising from the lymphatic vessels. C6524 Neoplastic Process Benign Lymphatic Vessel Neoplasm C1274301 Benign Benign_Lymphatic_Vessel_Neoplasm Benign Lymph Vessel Neoplasm Benign Lymph Vessel Tumor Benign Lymphatic Vessel Neoplasm Benign Lymphatic Vessel Tumor Benign Neoplasm of Lymph Vessel Benign Neoplasm of Lymphatic Vessel Benign Neoplasm of the Lymph Vessel Benign Neoplasm of the Lymphatic Vessel Benign Tumor of Lymph Vessel Benign Tumor of Lymphatic Vessel Benign Tumor of the Lymph Vessel Benign Tumor of the Lymphatic Vessel Benign Lymphatic Vessel Neoplasm A rare hemangioma arising from synovium lining surfaces. C6525 Neoplastic Process Synovial Hemangioma C1336546 Benign Synovial_Hemangioma Angioma of Synovium Angioma of the Synovium Hemangioma of Synovium Hemangioma of the Synovium Synovial Angioma Synovial Hemangioma Synovial Hemangioma A hemangioma arising from perineural tissues. C6526 Neoplastic Process Perineural Hemangioma C1335382 Benign Perineural_Hemangioma Perineural Angioma Perineural Hemangioma Perineural Hemangioma A benign or malignant mesenchymal neoplasm arising from the perivascular cells of the connective and soft tissues. It is characterized by the presence of pericytes that grow in a circumferential pattern around vessels. C6528 Neoplastic Process Pericytic Neoplasm C1335392 Undetermined Perivascular_Neoplasm Pericytic Neoplasm Pericytic Tumor Perivascular Neoplasm Perivascular Tumor Pericytic Neoplasm A mesenchymal neoplasm arising from the perivascular cells of connective and soft tissue. It is characterized by the presence of pericytes that grow in a circumferential pattern around vessels. There is no evidence of atypical or malignant cytological and architectural features, invasive features, or metastases. C6529 Neoplastic Process Benign Pericytic Neoplasm C1332532 Benign Benign_Perivascular_Neoplasm Benign Pericytic Neoplasm Benign Pericytic Tumor Benign Perivascular Neoplasm Benign Perivascular Tumor Benign Pericytic Neoplasm A malignant mesenchymal neoplasm arising from the perivascular cells of the connective and soft tissues. It is characterized by the presence of pericytes that grow in a circumferential pattern around vessels, and cytologic atypia. C6530 Neoplastic Process Malignant Pericytic Neoplasm C1334611 GDC Malignant Malignant_Perivascular_Neoplasm Malignant perivascular epithelial cell tumor Malignant Pericytic Neoplasm Malignant Pericytic Tumor Malignant Perivascular Neoplasm Malignant Perivascular Tumor Malignant Pericytic Neoplasm A malignant neoplasm that affects the synovium. C6531 Neoplastic Process Malignant Synovial Neoplasm C1334624 Malignant Malignant_Synovial_Neoplasm Malignant Neoplasm of Synovium Malignant Neoplasm of the Synovium Malignant Synovial Neoplasm Malignant Synovial Tumor Malignant Tumor of Synovium Malignant Tumor of the Synovium Malignant Synovial Neoplasm A well-circumscribed, lobulated tumor, completely or partially covered by a fibrous capsule. It usually arises in the fingers. It is characterized by the presence of mononuclear cells, multinucleated osteoclast-like giant cells, hemosiderin-laden macrophages, foam cells, and an inflammatory infiltrate. The tumor is slow-growing, usually developing over several years. Clinical presentation includes painless edema of the affected site. C6532 Neoplastic Process Tenosynovial Giant Cell Tumor, Localized Type C0588125 Benign Localized_Giant_Cell_Tumor_of_Tendon_Sheath Localized Giant Cell Neoplasm of Tendon Sheath Localized Giant Cell Neoplasm of Tenosynovium Localized Giant Cell Neoplasm of the Tenosynovium Localized Giant Cell Tumor of Tendon Sheath Localized Giant Cell Tumor of Tenosynovium Localized Giant Cell Tumor of the Tenosynovium Localized Tenosynovial Giant Cell Neoplasm Localized Tenosynovial Giant Cell Tumor Nodular Tenosynovitis Tenosynovial Giant Cell Tumor, Localized Type Tenosynovial Giant Cell Tumor, Localized Type A synovial sarcoma characterized by the presence of an epithelial or a spindle cell component only. C6534 Neoplastic Process Monophasic Synovial Sarcoma C1334801 Cellosaurus Malignant Monophasic_Synovial_Sarcoma Monophasic Sarcoma of Synovium Monophasic Sarcoma of the Synovium Monophasic Synovial Sarcoma Monophasic Synovial Sarcoma An uncommon malignant tumor arising from the tendon sheath. Morphologically, it is characterized by the presence of a cellular infiltrate reminiscent of a giant cell tumor with prominent malignant characteristics. Recurrent giant cell tumors with a sarcomatous dedifferentiation are included in this category as well. C6535 Neoplastic Process Malignant Tenosynovial Giant Cell Tumor C1266168 Cellosaurus GDC 9252/3 Malignant Malignant_Giant_Cell_Tumor_of_Tendon_Sheath 9252/3 Giant cell tumor of tendon sheath, malignant Malignant tenosynovial giant cell tumor Giant cell tumor of tendon sheath, malignant Malignant Giant Cell Neoplasm of Tendon Sheath Malignant Giant Cell Neoplasm of the Tendon Sheath Malignant Giant Cell Tumor of Tendon Sheath Malignant Giant Cell Tumor of the Tendon Sheath Malignant Tendon Sheath Giant Cell Neoplasm Malignant Tendon Sheath Giant Cell Tumor Malignant Tenosynovial Giant Cell Tumor Malignant tenosynovial giant cell tumor Malignant Tenosynovial Giant Cell Tumor A mesothelial neoplasm that arises from the peritoneum and usually affects young to middle aged females. Grossly, it presents as a large multiloculated tumor mass, usually in the pelvic peritoneum. Histologically it is characterized by the presence of multiple cysts that are lined by one or more layers of mesothelial cells that do not show atypia. Patients usually present with abdominal or pelvic mass and pain. The clinical course is indolent. The tumor may reoccur, but transformation to malignant mesothelioma is rare. C6536 Neoplastic Process Peritoneal Multicystic Mesothelioma C1334818 GDC Undetermined Multicystic_Peritoneal_Mesothelioma 9055/0 Peritoneal inclusion cysts Multicystic Mesothelioma of Peritoneum Multicystic Mesothelioma of the Peritoneum Multilocular Peritoneal Inclusion Cyst Peritoneal Multicystic Mesothelioma Peritoneal Multicystic Mesothelioma Stage I includes: IA (T1a, N0, M0, G1, GX); (T1b, N0, M0, G1, GX); IB (T2a, N0, M0, G1, GX); (T2b, N0, M0, G1, GX). T1a: Superficial tumor 5 cm or less in greatest dimension. T1b: Deep tumor 5 cm or less in greatest dimension. T2a: Superficial tumor more than 5 cm in greatest dimension. T2b: Deep tumor more than 5 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Grade 1. GX: Grade cannot be assessed. (AJCC 7th ed.) C6537 Neoplastic Process Stage I Soft Tissue Sarcoma AJCC v7 Stage I Soft Tissue Sarcoma AJCC v7 C1336483 CTRP Stage I is divided into stages IA and IB. In stage IA, the tumor is low-grade (likely to grow and spread slowly) and 5 centimeters or smaller. It may be either superficial (in subcutaneous tissue with no spread into connective tissue or muscle below) or deep (in the muscle and may be in connective or subcutaneous tissue). In stage IB, the tumor is low-grade (likely to grow and spread slowly) and larger than 5 centimeters. It may be either superficial (in subcutaneous tissue with no spread into connective tissue or muscle below) or deep (in the muscle and may be in connective or subcutaneous tissue). Malignant Stage_I_Soft_Tissue_Sarcoma Stage I Sarcoma of Soft Tissue Stage I Sarcoma of the Soft Tissue Stage I Soft Tissue Sarcoma Stage I Soft Tissue Sarcoma AJCC v7 stage I soft tissue sarcoma Stage I Soft Tissue Sarcoma AJCC v7 Stage II includes: IIA (T1a, N0, M0, G2, G3); (T1b, N0, M0, G2, G3); IIB (T2a, N0, M0, G2); (T2b, N0, M0, G2). T1a: Superficial tumor 5 cm or less in greatest dimension. T1b: Deep tumor 5 cm or less in greatest dimension. T2a: Superficial tumor more than 5 cm in greatest dimension. T2b: Deep tumor more than 5 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G2: Grade 2. G3: Grade 3. (AJCC 7th ed.) C6538 Neoplastic Process Stage II Soft Tissue Sarcoma AJCC v7 Stage II Soft Tissue Sarcoma AJCC v7 C1336319 CTRP Stage II is divided into stages IIA and IIB. In stage IIA, the tumor is mid-grade (somewhat likely to grow and spread quickly) or high-grade (likely to grow and spread quickly) and 5 centimeters or smaller. It may be either superficial (in subcutaneous tissue with no spread into connective tissue or muscle below) or deep (in the muscle and may be in connective or subcutaneous tissue). In stage IIB, the tumor is mid-grade (somewhat likely to grow and spread quickly) and larger than 5 centimeters. It may be either superficial (in subcutaneous tissue with no spread into connective tissue or muscle below) or deep (in the muscle and may be in connective or subcutaneous tissue). Malignant Stage_II_Soft_Tissue_Sarcoma Stage II Sarcoma of Soft Tissue Stage II Sarcoma of the Soft Tissue Stage II Soft Tissue Sarcoma Stage II Soft Tissue Sarcoma AJCC v7 stage II soft tissue sarcoma Stage II Soft Tissue Sarcoma AJCC v7 A malignant testicular mixed germ cell neoplasm that occurs during childhood. It is characterized by the presence of embryonal carcinoma and teratoma components. C6539 Neoplastic Process Childhood Testicular Mixed Embryonal Carcinoma and Teratoma C1333008 NICHD A malignant testicular mixed germ cell neoplasm that occurs in children. Malignant Childhood_Testicular_Mixed_Embryonal_Carcinoma_and_Teratoma Childhood Teratocarcinoma of Testis Childhood Teratocarcinoma of the Testis Childhood Testicular Mixed Embryonal Carcinoma and Teratoma Childhood Testicular Teratocarcinoma Pediatric Testicular Teratocarcinoma Childhood Testicular Mixed Embryonal Carcinoma and Teratoma A teratoma that arises from the testis during childhood. C6540 Neoplastic Process Childhood Testicular Teratoma C1333011 NICHD A mature or immature teratoma that arises from the testis during childhood. Undetermined Childhood_Testicular_Teratoma Childhood Teratoma of Testis Childhood Teratoma of the Testis Childhood Testicular Teratoma Pediatric Testicular Teratoma Childhood Testicular Teratoma A malignant mixed germ cell neoplasm that arises from the testis during childhood. C6542 Neoplastic Process Childhood Testicular Mixed Germ Cell Tumor C1333009 NICHD A mixed germ cell tumor that arises from the testis during childhood. Malignant Childhood_Testicular_Mixed_Germ_Cell_Neoplasm Childhood Testicular Mixed Germ Cell Neoplasm Childhood Testicular Mixed Germ Cell Tumor Pediatric Testicular Mixed Germ Cell Neoplasm Pediatric Testicular Mixed Germ Cell Tumor Childhood Testicular Mixed Germ Cell Tumor A yolk sac tumor that arises from the testis during childhood. C6543 Neoplastic Process Childhood Testicular Yolk Sac Tumor C1333012 NICHD A yolk sac tumor that arises from the testis during childhood. Malignant Childhood_Testicular_Yolk_Sac_Tumor Childhood Testicular Endodermal Sinus Neoplasm Childhood Testicular Endodermal Sinus Tumor Childhood Testicular Yolk Sac Neoplasm Childhood Testicular Yolk Sac Tumor Pediatric Testicular Endodermal Sinus Neoplasm Pediatric Testicular Endodermal Sinus Tumor Pediatric Testicular Yolk Sac Neoplasm Pediatric Testicular Yolk Sac Tumor Childhood Testicular Yolk Sac Tumor A choriocarcinoma that arises from the testis during childhood. C6544 Neoplastic Process Childhood Testicular Choriocarcinoma C1333006 NICHD A choriocarcinoma that arises from the testis during childhood. Malignant Childhood_Testicular_Choriocarcinoma Childhood Choriocarcinoma of Testis Childhood Choriocarcinoma of the Testis Childhood Testicular Choriocarcinoma Pediatric Choriocarcinoma of Testis Pediatric Choriocarcinoma of the Testis Pediatric Testicular Choriocarcinoma Childhood Testicular Choriocarcinoma An embryonal carcinoma that arises from the testis during childhood. C6545 Neoplastic Process Childhood Testicular Embryonal Carcinoma C1333007 NICHD An embryonal carcinoma that arises from the testis during childhood. Malignant Childhood_Testicular_Embryonal_Carcinoma Childhood Embryonal Carcinoma of Testis Childhood Embryonal Carcinoma of the Testis Childhood Testicular Embryonal Carcinoma Pediatric Embryonal Carcinoma of Testis Pediatric Embryonal Carcinoma of the Testis Pediatric Testicular Embryonal Carcinoma Childhood Testicular Embryonal Carcinoma An embryonal carcinoma that arises from the ovary and occurs in children. C6546 Neoplastic Process Childhood Ovarian Embryonal Carcinoma C1332989 NICHD An embryonal carcinoma that arises from the ovary during childhood. Malignant Childhood_Ovarian_Embryonal_Carcinoma Childhood Embryonal Carcinoma of Ovary Childhood Embryonal Carcinoma of the Ovary Childhood Ovarian Embryonal Carcinoma Pediatric Embryonal Carcinoma of Ovary Pediatric Embryonal Carcinoma of the Ovary Pediatric Ovarian Embryonal Carcinoma Childhood Ovarian Embryonal Carcinoma An immature teratoma that arises from the ovary and occurs in children. C6547 Neoplastic Process Childhood Ovarian Immature Teratoma C1332990 NICHD An immature teratoma that arises from the ovary during childhood. Undetermined Childhood_Ovarian_Immature_Teratoma Childhood Immature Teratoma of Ovary Childhood Immature Teratoma of the Ovary Childhood Ovarian Immature Teratoma Pediatric Immature Teratoma of Ovary Pediatric Immature Teratoma of the Ovary Pediatric Ovarian Immature Teratoma Childhood Ovarian Immature Teratoma A mature teratoma that arises from the ovary and occurs in children. C6548 Neoplastic Process Childhood Ovarian Mature Teratoma C1332991 NICHD A mature teratoma that arises from the ovary during childhood. Benign Childhood_Ovarian_Mature_Teratoma Childhood Mature Teratoma of Ovary Childhood Mature Teratoma of the Ovary Childhood Ovarian Mature Teratoma Pediatric Mature Teratoma of Ovary Pediatric Mature Teratoma of the Ovary Pediatric Ovarian Mature Teratoma Childhood Ovarian Mature Teratoma A non-gestational choriocarcinoma that arises from the ovary and occurs in children. C6549 Neoplastic Process Childhood Ovarian Choriocarcinoma C1332987 NICHD A non-gestational choriocarcinoma that arises from the ovary during childhood. Malignant Childhood_Ovarian_Choriocarcinoma Childhood Choriocarcinoma of Ovary Childhood Choriocarcinoma of the Ovary Childhood Ovarian Choriocarcinoma Pediatric Choriocarcinoma of Ovary Pediatric Choriocarcinoma of the Ovary Pediatric Ovarian Choriocarcinoma Childhood Ovarian Choriocarcinoma A dysgerminoma that arises from the ovary and occurs in children. C6550 Neoplastic Process Childhood Ovarian Dysgerminoma C1332988 NICHD A dysgerminoma that occurs during childhood. Malignant Childhood_Ovarian_Dysgerminoma Childhood Dysgerminoma Childhood Ovarian Dysgerminoma Childhood Ovarian Germinomatous Germ Cell Tumor Pediatric Ovarian Dysgerminoma Childhood Ovarian Dysgerminoma A yolk sac tumor that arises from the ovary and occurs in children. C6551 Neoplastic Process Childhood Ovarian Yolk Sac Tumor C1332993 NICHD A yolk sac tumor that arises from the ovary during childhood. Malignant Childhood_Ovarian_Yolk_Sac_Tumor Childhood Ovarian Endodermal Sinus Neoplasm Childhood Ovarian Endodermal Sinus Tumor Childhood Ovarian Yolk Sac Neoplasm Childhood Ovarian Yolk Sac Tumor Pediatric Ovarian Endodermal Sinus Neoplasm Pediatric Ovarian Endodermal Sinus Tumor Pediatric Ovarian Yolk Sac Neoplasm Pediatric Ovarian Yolk Sac Tumor Childhood Ovarian Yolk Sac Tumor A germ cell tumor that arises from the testis during childhood. C6552 Neoplastic Process Childhood Testicular Germ Cell Tumor Childhood Testicular Germ Cell Tumor C0886477 CTRP NICHD A germ cell tumor that arises from the testis during childhood. Undetermined Childhood_Testicular_Germ_Cell_Tumor Childhood Testicular Germ Cell Neoplasm Childhood Testicular Germ Cell Tumor Pediatric Testicular Germ Cell Neoplasm Pediatric Testicular Germ Cell Tumor Testicular Germ Cell Tumor Childhood Testicular Germ Cell Tumor A teratoma that arises from the ovary and occurs in children. C6554 Neoplastic Process Childhood Ovarian Teratoma C1332992 NICHD A mature or immature teratoma that arises from the ovary during childhood. Undetermined Childhood_Ovarian_Teratoma Childhood Ovarian Teratoma Childhood Teratoma of Ovary Childhood Teratoma of the Ovary Pediatric Ovarian Teratoma Pediatric Teratoma of Ovary Pediatric Teratoma of the Ovary Childhood Ovarian Teratoma A hemangioma arising from the deep soft tissues. C6555 Neoplastic Process Deep Hemangioma C1333265 Benign Deep_Hemangioma Deep Angioma Deep Hemangioma Deep Hemangioma A schwannoma that is characterized by degenerative changes such as hyalinization, hemorrhage, calcification and cystic change. C6556 Neoplastic Process Ancient Schwannoma C1536561 GDC Benign Degenerated_Schwannoma 9560/0 Ancient schwannoma Degenerated schwannoma Ancient Neurilemmoma Ancient Schwannoma Ancient schwannoma Degenerated Neurilemmoma Degenerated Schwannoma Degenerated schwannoma Ancient Schwannoma Rare genetic disorder caused by mutations in the SMARCB1 and LZTR1 genes. It is characterized by the presence of multiple Schwannomas. C6557 Neoplastic Process Schwannomatosis C1335929 CCPS CPTAC Cellosaurus GDC 9560/1 Benign Schwannomatosis 9560/1 Neurinomatosis Schwannomatosis Neurilemmomatosis Neurinomatosis Schwannomatosis Schwannomatosis A rare neurofibroma with epithelioid morphology. C6558 Neoplastic Process Epithelioid Neurofibroma C1275264 Benign Epithelioid_Neurofibroma Epithelioid Neurofibroma Epithelioid Neurofibroma A variant of malignant peripheral nerve sheath tumor characterized by the presence of glandular epithelium. C6560 Neoplastic Process Glandular Malignant Peripheral Nerve Sheath Tumor C1333821 Malignant Glandular_Malignant_Peripheral_Nerve_Sheath_Tumor Glandular MPNST Glandular Malignant Peripheral Nerve Sheath Tumor Malignant Glandular Neoplasm of Peripheral Nerve Sheath Malignant Glandular Neoplasm of the Peripheral Nerve Sheath Malignant Glandular Peripheral Nerve Sheath Neoplasm Malignant Glandular Peripheral Nerve Sheath Tumor Malignant Glandular Schwannoma Malignant Glandular Tumor of Peripheral Nerve Sheath Malignant Glandular Tumor of the Peripheral Nerve Sheath Glandular Malignant Peripheral Nerve Sheath Tumor A rare variant of malignant peripheral nerve sheath tumor composed predominantly or exclusively of epithelioid cells. C6561 Neoplastic Process Epithelioid Malignant Peripheral Nerve Sheath Tumor C1321427 GDC Malignant Epithelioid_Malignant_Peripheral_Nerve_Sheath_Tumor 9540/3 9542/3 Epithelioid MPNST Epithelioid malignant peripheral nerve sheath tumor Malignant peripheral nerve sheath tumor, epithelioid Epithelioid MPNST Epithelioid Malignant Peripheral Nerve Sheath Tumor Epithelioid malignant peripheral nerve sheath tumor Malignant Epithelioid Neoplasm of Peripheral Nerve Sheath Malignant Epithelioid Neoplasm of the Peripheral Nerve Sheath Malignant Epithelioid Peripheral Nerve Sheath Neoplasm Malignant Epithelioid Peripheral Nerve Sheath Tumor Malignant Epithelioid Tumor of Peripheral Nerve Sheath Malignant Epithelioid Tumor of the Peripheral Nerve Sheath Epithelioid Malignant Peripheral Nerve Sheath Tumor A kidney neoplasm that occurs in children. C6563 Neoplastic Process Childhood Renal Neoplasm Childhood Kidney Neoplasm C1333003 CTRP Undetermined Childhood_Renal_Neoplasm Childhood Kidney Neoplasm Childhood Kidney Tumor Childhood Renal Neoplasm Childhood Renal Tumor Kidney Neoplasm Pediatric Kidney Neoplasm Pediatric Kidney Tumor Pediatric Renal Neoplasm Pediatric Renal Tumor Childhood Kidney Neoplasm An angiomyolipoma that arises from the kidney and occurs during childhood. C6565 Neoplastic Process Childhood Kidney Angiomyolipoma C1333000 Undetermined Childhood_Renal_Angiomyolipoma Childhood Kidney Angiomyolipoma Childhood Renal Angiomyolipoma Pediatric Kidney Angiomyolipoma Pediatric Renal Angiomyolipoma Childhood Kidney Angiomyolipoma A cystic neoplasm which arises from the kidney and occurs in children. It includes the cystic partially differentiated nephroblastoma and cases in which nephroblastomatous elements are not present. C6566 Neoplastic Process Childhood Multilocular Cystic Renal Neoplasm C1332983 Undetermined Childhood_Multilocular_Cystic_Renal_Neoplasm Childhood Multilocular Cystic Kidney Neoplasm Childhood Multilocular Cystic Kidney Tumor Childhood Multilocular Cystic Renal Neoplasm Childhood Multilocular Cystic Renal Tumor Pediatric Multilocular Cystic Kidney Neoplasm Pediatric Multilocular Cystic Kidney Tumor Pediatric Multilocular Cystic Renal Neoplasm Pediatric Multilocular Cystic Renal Tumor Childhood Multilocular Cystic Renal Neoplasm A renal cell carcinoma that occurs during childhood. C6568 Neoplastic Process Childhood Renal Cell Carcinoma Childhood Renal Cell Carcinoma C1333001 CTRP NICHD A renal cell carcinoma that occurs during childhood. Malignant Childhood_Renal_Cell_Carcinoma Childhood Kidney Cell Carcinoma Childhood Renal Cell Carcinoma Pediatric Kidney Cell Carcinoma Pediatric Renal Cell Carcinoma Renal Cell Cancer Childhood Renal Cell Carcinoma A low grade childhood congenital malignant neoplasm arising from the kidney. It is characterized by the presence of fibroblastic cells. The majority of cases occur in the first year of life. Complete excision is usually associated with an excellent prognosis. C6569 Neoplastic Process Congenital Mesoblastic Nephroma Congenital Mesoblastic Nephroma C1332965 CDISC CTRP Cellosaurus GDC NICHD A congenital malignant neoplasm of the kidney characterized by the presence of fibroblastic cells. A low grade childhood congenital malignant neoplasm arising from the kidney, which is characterized by the presence of fibroblastic cells. A type of kidney tumor that is usually found before birth by ultrasound or within the first 3 months of life. It contains fibroblastic cells (connective tissue cells), and may spread to the other kidney or to nearby tissue. Congenital mesoblastic nephroma is more common in males. 8960/1 Malignant Childhood_Congenital_Mesoblastic_Nephroma 8960/1 Mesoblastic nephroma CMN Congenital Mesoblastic Nephroma Mesoblastic Nephroma Mesoblastic nephroma STROMAL NEPHROMA, MALIGNANT congenital mesoblastic nephroma Congenital Mesoblastic Nephroma A benign or malignant mesenchymal neoplasm with cartilaginous or osseous differentiation arising from the soft tissues exclusively. Representative examples include chondroma, osteoma, and osteosarcoma. C6570 Neoplastic Process Extraskeletal Cartilaginous and Osseous Neoplasm C1333515 Undetermined Extraskeletal_Cartilaginous_and_Osseous_Neoplasm Extraskeletal Cartilaginous and Osseous Neoplasm Extraskeletal Cartilaginous and Osseous Tumor Extraskeletal Cartilaginous and Osseous Neoplasm A benign mesenchymal neoplasm with cartilaginous or osseous differentiation arising from the soft tissues exclusively. Representative examples include chondroma and osteoma. C6571 Neoplastic Process Benign Extraskeletal Cartilaginous and Osseous Neoplasm C1332499 Benign Benign_Extraskeletal_Cartilaginous_and_Osseous_Neoplasm Benign Extraskeletal Cartilaginous and Osseous Neoplasm Benign Extraskeletal Cartilaginous and Osseous Tumor Benign Extraskeletal Cartilaginous and Osseous Neoplasm A malignant mesenchymal neoplasm with cartilaginous or osseous differentiation arising from the soft tissues exclusively. Extraskeletal osteosarcoma is a representative example. C6572 Neoplastic Process Malignant Extraskeletal Cartilaginous and Osseous Neoplasm C1334583 Malignant Malignant_Extraskeletal_Cartilaginous_and_Osseous_Neoplasm Malignant Extraskeletal Cartilaginous and Osseous Neoplasm Malignant Extraskeletal Cartilaginous and Osseous Tumor Malignant Extraskeletal Cartilaginous and Osseous Neoplasm A self-limited benign neoplasm composed of spindle cells and osteoblasts. It usually occurs in the subcutaneous tissue of the proximal phalanx. Less frequently, it involves the toe. It presents with swelling and pain of the affected area. The prognosis is excellent. However, incomplete excision may lead to the re-growth of the lesion. C6573 Neoplastic Process Fibroosseous Pseudotumor of Digits C1333612 Benign Fibroosseous_Pseudotumor_of_the_Digits FP Fibroosseous Digital Pseudotumor Fibroosseous Pseudotumor of Digits Fibroosseous Pseudotumor of the Digits Fibroosseous Pseudotumor of Digits A benign soft tissue neoplasm characterized by the presence of spindle and stellate cells, lobulated growth pattern, and myxoid stroma formation. C6577 Neoplastic Process Myxoma C0027149 CDISC GDC A benign soft tissue neoplasm with a myxoid stroma formation. 8840/0 Benign Myxoma 8840/0 Myxoma, NOS MYXOMA, BENIGN Myxoma Myxoma, NOS Myxoma A myxoma arising from the dermis. C6578 Neoplastic Process Skin Myxoma C1333178 Benign Cutaneous_Myxoma Cutaneous Myxoma Skin Myxoma Skin Myxoma A benign, painless soft tissue tumor that arises in a muscle, usually in a large muscle of the thigh, buttocks, shoulder, or upper arm. It is associated with point mutations of the GNAS gene. Grossly it is characterized by a gelatinous and lobulated cut surface. Morphologically it is composed of uniform spindled and stellate-shaped cells without atypia. The cells are separated by myxoid stroma. No recurrences have been reported. C6579 Neoplastic Process Intramuscular Myxoma C1334260 Benign Intramuscular_Myxoma Intramuscular Myxoma Intramuscular Myxoma A rare myxoma that usually arises in an area close to a large joint. Morphologically it resembles a cellular myxoma. In contrast to an intramuscular myxoma, it is not associated with mutations of the GNAS gene. C6580 Neoplastic Process Juxta-Articular Myxoma C1334305 Benign Juxtaarticular_Myxoma Juxta-Articular Myxoma Juxtaarticular Myxoma Parameniscal Cyst Periarticular Myxoma Juxta-Articular Myxoma A rare, usually benign myoepithelial tumor characterized by the presence of epithelioid, often vacuolated neoplastic cells. Most patients present with painless swelling in the subcutaneous or subfascial soft tissues of the extremities. C6581 Neoplastic Process Parachordoma C1266175 GDC 9373/0 9373/1 Undetermined Parachordoma 9373/0 Parachordoma Parachordoma Parachordoma A rare soft tissue tumor of uncertain lineage characterized by the presence of neoplastic spindle to round cells forming cords in a fibromyxoid stroma. The lesions are associated with the formation of metaplastic bone. Most patients present with painless subcutaneous masses. Recurrences have been reported in a minority of patients. C6582 Neoplastic Process Ossifying Fibromyxoid Tumor C1266128 GDC 8842/0 Undetermined Ossifying_Fibromyxoid_Neoplasm 8842/0 Ossifying fibromyxoid tumor Ossifying fibromyxoid tumor, NOS OFMT Ossifying Fibromyxoid Neoplasm Ossifying Fibromyxoid Tumor Ossifying Fibromyxoma Ossifying fibromyxoid tumor Ossifying Fibromyxoid Tumor A rare soft tissue tumor of uncertain lineage characterized by the presence of neoplastic spindle to round cells forming cords in a fibromyxoid stroma. Metaplastic bone formation is not present. C6583 Neoplastic Process Nonossifying Fibromyxoid Tumor C1335063 Undetermined Nonossifying_Fibromyxoid_Neoplasm Nonossifying Fibromyxoid Neoplasm Nonossifying Fibromyxoid Tumor Nonossifying Fibromyxoma Nonossifying Fibromyxoid Tumor A myofibroblastoma arising from the inguinal lymph nodes. It is characterized by the presence of nuclear palisading. C6584 Neoplastic Process Intranodal Palisaded Myofibroblastoma C3164851 Benign Palisaded_Lymph_Node_Myofibroblastoma Intranodal Palisaded Myofibroblastoma Nodal Myofibroblastoma Palisaded Lymph Node Myofibroblastoma Palisaded Myofibroblastoma Palisaded Myofibroblastoma of Lymph Node Palisaded Myofibroblastoma of the Lymph Node Intranodal Palisaded Myofibroblastoma An osteosarcoma that occurs during childhood. C6585 Neoplastic Process Childhood Osteosarcoma Childhood Osteosarcoma C1332986 CTRP NICHD An osteosarcoma that occurs during childhood. Malignant Childhood_Osteosarcoma Childhood Osteogenic Sarcoma Childhood Osteosarcoma Osteosarcoma Pediatric Osteosarcoma Childhood Osteosarcoma A rhabdoid tumor which arises in the soft tissues. It occurs in infants and children and may be associated with loss of chromosome 22. It is characterized by the presence of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm. C6586 Neoplastic Process Extrarenal Rhabdoid Tumor C1304517 Cellosaurus NICHD A rhabdoid tumor that arises outside of the central nervous system or kidney. Malignant Extrarenal_Rhabdoid_Tumor Extrarenal Rhabdoid Tumor Malignant Extrarenal Rhabdoid Neoplasm Rhabdoid Tumor of Soft Tissue Extrarenal Rhabdoid Tumor A benign soft tissue neoplasm in which the line of differentiation is uncertain. C6587 Neoplastic Process Benign Soft Tissue Tumor of Uncertain Differentiation C1332517 Benign Benign_Miscellaneous_Mesenchymal_Neoplasm Benign Soft Tissue Neoplasm of Uncertain Differentiation Benign Soft Tissue Tumor of Uncertain Differentiation Benign Soft Tissue Tumor of Uncertain Differentiation A malignant soft tissue neoplasm in which the line of differentiation is uncertain. C6588 Neoplastic Process Malignant Soft Tissue Tumor of Uncertain Differentiation C1334601 Malignant Malignant_Miscellaneous_Mesenchymal_Neoplasm Malignant Soft Tissue Neoplasm of Uncertain Differentiation Malignant Soft Tissue Tumor of Uncertain Differentiation Malignant Soft Tissue Tumor of Uncertain Differentiation A low grade malignant bone-forming mesenchymal neoplasm arising from the surface of the bone. It occurs in childhood and usually affects the distal posterior femur, the proximal tibia, and proximal humerus. Painless swelling is the usual clinical sign. The prognosis is usually excellent. C6589 Neoplastic Process Childhood Parosteal Osteosarcoma C1332994 NICHD A parosteal osteosarcoma occurring during childhood. Malignant Childhood_Parosteal_Osteosarcoma Childhood Parosteal Osteogenic Sarcoma Childhood Parosteal Osteosarcoma Childhood Parosteal Osteosarcoma A high grade malignant bone-forming mesenchymal neoplasm that produces osteoid and occurs in childhood. It arises from the medullary portion of the bone. It affects the long bones, and most commonly, the distal femur, proximal tibia, and proximal humerus. Pain with or without a palpable mass is the most common clinical presentation. It usually has an aggressive growth and may metastasize through the hematogenous route. The lung is the most frequent site of metastasis. C6590 Neoplastic Process Childhood Conventional Osteosarcoma C1332974 NICHD A conventional osteosarcoma occurring during childhood. Malignant Childhood_Intracortical_Osteosarcoma Childhood Conventional Osteosarcoma Childhood Intracortical Osteosarcoma Childhood Conventional Osteosarcoma A neuroblastoma arising from the peripheral nervous system. C6591 Neoplastic Process Peripheral Neuroblastoma C0878524 Malignant Peripheral_Neuroblastoma Peripheral Neuroblastoma Peripheral Neuroblastoma A mesenchymal neoplasm that arises from the mediastinum and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include lipoma, leiomyoma, and rhabdomyoma. C6593 Neoplastic Process Benign Mediastinal Soft Tissue Neoplasm C1332516 Benign Benign_Mesenchymal_Mediastinal_Neoplasm Benign Mediastinal Soft Tissue Neoplasm Benign Soft Tissue Mediastinal Tumor Benign Soft Tissue Neoplasm of Mediastinum Benign Soft Tissue Neoplasm of the Mediastinum Benign Soft Tissue Tumor of Mediastinum Benign Soft Tissue Tumor of the Mediastinum Benign Mediastinal Soft Tissue Neoplasm A ganglioneuroblastoma arising from the peripheral nervous system. C6594 Neoplastic Process Peripheral Ganglioneuroblastoma C1335387 Malignant Peripheral_Ganglioneuroblastoma PNS Ganglioneuroblastoma Peripheral Ganglioneuroblastoma Peripheral Nervous System Ganglioneuroblastoma Peripheral Ganglioneuroblastoma A lymphangioma arising from the mediastinum. C6595 Neoplastic Process Mediastinal Lymphangioma C1334664 Benign Mediastinal_Lymphangioma Cystic Hygroma of Mediastinum Cystic Hygroma of the Mediastinum Lymphangioma of Mediastinum Lymphangioma of the Mediastinum Mediastinal Cystic Hygroma Mediastinal Lymphangioma Mediastinal Lymphangioma A benign neoplasm composed of hyaline cartilage arising from the mediastinum. It is characterized by the presence of chondrocytes, a lobulated growth pattern, and calcification. C6596 Neoplastic Process Mediastinal Chondroma C1334650 Benign Mediastinal_Chondroma Chondroma of Mediastinum Chondroma of the Mediastinum Mediastinal Chondroma Mediastinal Chondroma A benign smooth muscle neoplasm arising from the mediastium. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C6598 Neoplastic Process Mediastinal Leiomyoma C1334659 Benign Mediastinal_Leiomyoma Leiomyoma of Mediastinum Leiomyoma of the Mediastinum Mediastinal Leiomyoma Mediastinal Leiomyoma A benign adipose tissue neoplasm of the anterior, middle or posterior mediastinum. C6599 Neoplastic Process Mediastinal Lipoma C1334661 Benign Mediastinal_Lipoma Lipoma of Mediastinum Lipoma of the Mediastinum Mediastinal Lipoma Mediastinal Lipoma A rare benign skeletal muscle neoplasm arising from the mediastinum. C6600 Neoplastic Process Mediastinal Rhabdomyoma C1334676 Benign Mediastinal_Rhabdomyoma Mediastinal Rhabdomyoma Rhabdomyoma of Mediastinum Rhabdomyoma of the Mediastinum Mediastinal Rhabdomyoma An exceptionally rare, generally benign, granular cell tumor that arises from the mediastinum. All the reported cases were located in the posterior mediastinum. C6601 Neoplastic Process Mediastinal Granular Cell Tumor C1334656 Undetermined Mediastinal_Granular_Cell_Tumor Granular Cell Myoblastoma of Mediastinum Granular Cell Myoblastoma of the Mediastinum Granular Cell Neoplasm of Mediastinum Granular Cell Neoplasm of the Mediastinum Granular Cell Tumor of Mediastinum Granular Cell Tumor of the Mediastinum Mediastinal Granular Cell Myoblastoma Mediastinal Granular Cell Neoplasm Mediastinal Granular Cell Tumor Mediastinal Granular Cell Tumor A mesenchymal bone-forming neoplasm characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. This category includes osteoma, osteoid osteoma, and osteoblastoma. C6602 Neoplastic Process Benign Osteogenic Neoplasm C1332523 Benign Benign_Osteogenic_Neoplasm Benign Osseous Neoplasm Benign Osseous Tumor Benign Osteogenic Neoplasm Benign Osteogenic Tumor Benign Osteogenic Neoplasm A benign, intermediate, or malignant bone-forming neoplasm. Representative examples include osteoma, osteoblastoma, and osteosarcoma. C6603 Neoplastic Process Osteogenic Neoplasm C1335146 Undetermined Osteogenic_Neoplasm Osseous Neoplasm Osseous Tumor Osteogenic Neoplasm Osteogenic Tumor Osteogenic Neoplasm A usually aggressive malignant neoplasm arising from the bone. It is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation in a herringbone growth pattern. C6604 Neoplastic Process Bone Fibrosarcoma C2733623 Cellosaurus Malignant Bone_Fibrosarcoma Bone Fibrosarcoma Fibrosarcoma of Bone Fibrosarcoma of the Bone Bone Fibrosarcoma A usually aggressive malignant neoplasm arising from the soft tissue. It is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation in a herringbone growth pattern. C6605 Neoplastic Process Soft Tissue Fibrosarcoma C1336021 Cellosaurus Malignant Soft_Tissue_Fibrosarcoma Fibrosarcoma of Soft Tissue Fibrosarcoma of the Soft Tissue Soft Tissue Fibrosarcoma Soft Tissue Fibrosarcoma A rare sarcoma that arises from the mediastinum. Examples include liposarcoma, leiomyosarcoma, and angiosarcoma. C6606 Neoplastic Process Mediastinal Sarcoma C1334678 Malignant Mediastinal_Sarcoma Mediastinal Sarcoma Sarcoma of Mediastinum Sarcoma of the Mediastinum Mediastinal Sarcoma Stage IA includes: T1, N0, M0, G1, G2, GX. T1: Tumor 8 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated-low grade. G2: Moderately differentiated-low grade. GX: Grade cannot be assessed. (AJCC 7th ed.) C6607 Neoplastic Process Stage IA Osteosarcoma AJCC v7 Stage IA Osteosarcoma AJCC v7 C1336120 CTRP Malignant Stage_IA_Osteosarcoma Stage IA Osteogenic Sarcoma Stage IA Osteosarcoma Stage IA Osteosarcoma AJCC v7 Stage IA Osteosarcoma AJCC v7 Stage IB includes: (T2, N0, M0, G1, G2, GX); (T3, N0, M0, G1, G2, GX). T2: Tumor more than 8 cm in greatest dimension. T3: Discontinuous tumors in the primary bone site. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated-low grade. G2: Moderately differentiated-low grade. GX: Grade cannot be assessed. (AJCC 7th ed.) C6609 Neoplastic Process Stage IB Osteosarcoma AJCC v7 Stage IB Osteosarcoma AJCC v7 C1336140 CTRP Malignant Stage_IB_Osteosarcoma Stage IB Osteogenic Sarcoma Stage IB Osteosarcoma Stage IB Osteosarcoma AJCC v7 Stage IB Osteosarcoma AJCC v7 Stage IIA includes: T1, N0, M0, G3, G4. T1: Tumor 8 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (AJCC 7th ed.) C6610 Neoplastic Process Stage IIA Osteosarcoma AJCC v7 Stage IIA Osteosarcoma AJCC v7 C1336168 CTRP Malignant Stage_IIA_Osteosarcoma Stage IIA Osteogenic Sarcoma Stage IIA Osteosarcoma Stage IIA Osteosarcoma AJCC v7 Stage IIA Osteosarcoma AJCC v7 Stage IIB includes: T2, N0, M0, G3, G4. T2: Tumor more than 8 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (AJCC 7th ed.) C6611 Neoplastic Process Stage IIB Osteosarcoma AJCC v7 Stage IIB Osteosarcoma AJCC v7 C1336191 CTRP Malignant Stage_IIB_Osteosarcoma Stage IIB Osteogenic Sarcoma Stage IIB Osteosarcoma Stage IIB Osteosarcoma AJCC v7 Stage IIB Osteosarcoma AJCC v7 Stage III includes: T3, N0, M0, G3, G4. T3: Tumor more than 8 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (AJCC 7th ed.) C6612 Neoplastic Process Stage III Osteosarcoma AJCC v7 Stage III Osteosarcoma AJCC v7 C1336260 CTRP Malignant Stage_III_Osteosarcoma Stage III Osteogenic Sarcoma Stage III Osteosarcoma Stage III Osteosarcoma AJCC v7 Stage III Osteosarcoma AJCC v7 A malignant vascular neoplasm arising from the mediastinum. C6613 Neoplastic Process Mediastinal Angiosarcoma C1334649 Malignant Mediastinal_Angiosarcoma Angiosarcoma of Mediastinum Angiosarcoma of the Mediastinum Hemangiosarcoma of Mediastinum Hemangiosarcoma of the Mediastinum Mediastinal Angiosarcoma Mediastinal Hemangiosarcoma Mediastinal Angiosarcoma A liposarcoma that arises from the mediastinum. C6614 Neoplastic Process Mediastinal Liposarcoma C1334663 Malignant Mediastinal_Liposarcoma Liposarcoma of Mediastinum Liposarcoma of the Mediastinum Mediastinal Liposarcoma Mediastinal Liposarcoma An osteosarcoma arising from the mediastinum. C6615 Neoplastic Process Mediastinal Extraskeletal Osteosarcoma C1334675 Malignant Mediastinal_Osteosarcoma Mediastinal Extraskeletal Osteosarcoma Mediastinal Osteogenic Sarcoma Mediastinal Osteosarcoma Osteogenic Sarcoma of Mediastinum Osteogenic Sarcoma of the Mediastinum Osteosarcoma of Mediastinum Osteosarcoma of the Mediastinum Mediastinal Extraskeletal Osteosarcoma A malignant mesenchymal tumor with skeletal muscle differentiation affecting the mediastinum. C6617 Neoplastic Process Mediastinal Rhabdomyosarcoma C1334677 Malignant Mediastinal_Rhabdomyosarcoma Mediastinal Rhabdomyosarcoma Rhabdomyosarcoma of Mediastinum Rhabdomyosarcoma of the Mediastinum Mediastinal Rhabdomyosarcoma A synovial sarcoma arising from the mediastinum. C6618 Neoplastic Process Mediastinal Synovial Sarcoma C1334681 Malignant Mediastinal_Synovial_Sarcoma Mediastinal Synovial Sarcoma Synovial Sarcoma of Mediastinum Synovial Sarcoma of the Mediastinum Mediastinal Synovial Sarcoma An aggressive malignant smooth muscle neoplasm, arising from the mediastinum. It is characterized by a proliferation of neoplastic spindle cells. C6619 Neoplastic Process Mediastinal Leiomyosarcoma C1334660 Cellosaurus Malignant Mediastinal_Leiomyosarcoma Leiomyosarcoma of Mediastinum Leiomyosarcoma of the Mediastinum Mediastinal Leiomyosarcoma Mediastinal Leiomyosarcoma A rare non-Hodgkin lymphoma or, even more rarely, Hodgkin lymphoma that arises from the bone, without lymph node or other extranodal involvement. The femur, spine, and pelvic bones are the most commonly affected sites. The majority of patients present with bone pain in the affected area. A single bone or multiple skeletal sites may be involved. The prognosis is related to the cell type and the stage of the disease. C6620 Neoplastic Process Primary Bone Lymphoma C1332582 Malignant Bone_Lymphoma Primary Bone Lymphoma Primary Lymphoma of Bone Primary Lymphoma of the Bone Primary Bone Lymphoma An Ewing sarcoma of the bone which has spread from its original site of growth to another anatomic site. C6621 Neoplastic Process Metastatic Bone Ewing Sarcoma C1334713 Malignant Metastatic_Bone_Ewing_s_Sarcoma Metastatic Bone Ewing Sarcoma Metastatic Bone Ewing's Sarcoma Metastatic Ewing's Sarcoma of Bone Metastatic Ewing's Sarcoma of the Bone Metastatic Osseous Ewing's Sarcoma Metastatic Skeletal Ewing's Sarcoma Metastatic Bone Ewing Sarcoma The reemergence of Ewing sarcoma of the bone after a period of remission. C6622 Neoplastic Process Recurrent Bone Ewing Sarcoma C1335694 Malignant Recurrent_Bone_Ewing_s_Sarcoma Recurrent Bone Ewing Sarcoma Recurrent Bone Ewing's Sarcoma Recurrent Ewing's Sarcoma of Bone Recurrent Ewing's Sarcoma of the Bone Recurrent Osseous Ewing's Sarcoma Recurrent Skeletal Ewing's Sarcoma Relapsed Bone Ewing's Sarcoma Relapsed Ewing's Sarcoma of Bone Relapsed Ewing's Sarcoma of the Bone Relapsed Osseous Ewing's Sarcoma Relapsed Skeletal Ewing's Sarcoma Recurrent Bone Ewing Sarcoma Ewing sarcoma that is confined to a specific area of the bone and has not spread to other anatomic sites. C6623 Neoplastic Process Localized Bone Ewing Sarcoma C1334406 Malignant Localized_Bone_Ewing_s_Sarcoma Localized Bone Ewing Sarcoma Localized Bone Ewing's Sarcoma Localized Ewing's Sarcoma of Bone Localized Ewing's Sarcoma of the Bone Localized Osseous Ewing's Sarcoma Localized Skeletal Ewing's Sarcoma Localized Bone Ewing Sarcoma A neurogenic tumor that arises from the mediastinum. Neural tumors are the most common tumors that arise from the posterior mediastinum. Representative examples include Schwannoma, neurofibroma, and neuroblastoma. C6624 Neoplastic Process Mediastinal Neurogenic Neoplasm C1334672 Undetermined Mediastinal_Neural_Neoplasm Mediastinal Neural Neoplasm Mediastinal Neural Tumor Mediastinal Neurogenic Neoplasm Mediastinal Neurogenic Tumor Neurogenic Neoplasm of Mediastinum Neurogenic Neoplasm of the Mediastinum Neurogenic Tumor of Mediastinum Neurogenic Tumor of the Mediastinum Mediastinal Neurogenic Neoplasm A malignant peripheral nerve sheath tumor that arises from the mediastinum. It may be associated with neurofibromatosis. It often spreads to the lungs or pleura. C6626 Neoplastic Process Mediastinal Malignant Peripheral Nerve Sheath Tumor C1334667 Malignant Mediastinal_Malignant_Peripheral_Nerve_Sheath_Tumor MPNST of Mediastinum MPNST of the Mediastinum Malignant Mediastinal Peripheral Nerve Sheath Neoplasm Malignant Mediastinal Peripheral Nerve Sheath Tumor Malignant Peripheral Nerve Sheath Neoplasm of Mediastinum Malignant Peripheral Nerve Sheath Neoplasm of the Mediastinum Malignant Peripheral Nerve Sheath Tumor of Mediastinum Malignant Peripheral Nerve Sheath Tumor of the Mediastinum Mediastinal MPNST Mediastinal Malignant Peripheral Nerve Sheath Tumor Mediastinal Malignant Peripheral Nerve Sheath Tumor A ganglioneuroblastoma arising from the mediastinum. C6627 Neoplastic Process Mediastinal Ganglioneuroblastoma C1334653 Malignant Mediastinal_Ganglioneuroblastoma Ganglioneuroblastoma of Mediastinum Ganglioneuroblastoma of the Mediastinum Mediastinal Ganglioneuroblastoma Mediastinal Ganglioneuroblastoma A neuroblastoma arising from the mediastinum. C6628 Neoplastic Process Mediastinal Neuroblastoma C1334673 Malignant Mediastinal_Neuroblastoma Mediastinal Neuroblastoma Neuroblastoma of Mediastinum Neuroblastoma of the Mediastinum Mediastinal Neuroblastoma A rare variant of malignant peripheral nerve sheath tumor that arises from the mediastinum. It is characterized by the presence of malignant cells that contain melanin. C6630 Neoplastic Process Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum C1334600 Malignant Malignant_Melanocytic_Peripheral_Nerve_Sheath_Tumor_of_the_Mediastinum Malignant Mediastinal Melanocytic Peripheral Nerve Sheath Tumor Malignant Melanocytic Peripheral Nerve Sheath Tumor of Mediastinum Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum Mediastinal Melanocytic MPNST Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum A neurofibroma that arises from the posterior mediastinum. Excision is usually curative. C6631 Neoplastic Process Mediastinal Neurofibroma C1334674 Benign Mediastinal_Neurofibroma Mediastinal Neurofibroma Neurofibroma of Mediastinum Neurofibroma of the Mediastinum Mediastinal Neurofibroma A ganglioneuroma arising from the mediastinum. C6632 Neoplastic Process Mediastinal Ganglioneuroma C1334654 Benign Mediastinal_Ganglioneuroma Ganglioneuroma of Mediastinum Ganglioneuroma of the Mediastinum Mediastinal Ganglioneuroma Mediastinal Ganglioneuroma A lymphoma that arises from the mediastinum. Representative examples include mediastinal (thymic) large B-cell lymphoma and Hodgkin lymphoma. C6633 Neoplastic Process Mediastinal Lymphoma Mediastinal Lymphoma C1334665 CTRP Malignant Mediastinal_Lymphoma Lymphoma of Mediastinum Lymphoma of the Mediastinum Mediastinal Lymphoma Mediastinal Malignant Lymphoma Primary Mediastinal Lymphoma Mediastinal Lymphoma A Hodgkin lymphoma that arises from the mediastinum. It usually involves mediastinal lymph nodes and/or the thymus. Signs and symptoms include fever, weight loss, fatigue, and night sweats. C6634 Neoplastic Process Mediastinal Hodgkin Lymphoma C1334658 PCDC Malignant Mediastinal_Hodgkin_s_Lymphoma Hodgkin's Disease of Mediastinum Hodgkin's Disease of the Mediastinum Hodgkin's Lymphoma of Mediastinum Hodgkin's Lymphoma of the Mediastinum Mediastinal Hodgkin Lymphoma Mediastinal Hodgkin's Disease Mediastinal Hodgkin's Lymphoma Mediastinum Primary Mediastinal Hodgkin's Lymphoma Mediastinal Hodgkin Lymphoma A melanotic schwannoma that affects the mediastinum. C6635 Neoplastic Process Mediastinal Melanotic Schwannoma C1334668 Undetermined Mediastinal_Melanocytic_Schwannoma Mediastinal Melanocytic Neurilemmoma Mediastinal Melanocytic Schwannoma Mediastinal Melanotic Schwannoma Melanocytic Neurilemmoma of Mediastinum Melanocytic Neurilemmoma of the Mediastinum Melanocytic Schwannoma of Mediastinum Melanocytic Schwannoma of the Mediastinum Mediastinal Melanotic Schwannoma A schwannoma that arises from the posterior mediastinum. It is characterized by the presence of psammoma bodies. C6636 Neoplastic Process Mediastinal Psammomatous Schwannoma C1332513 Benign Benign_Mediastinal_Psammomatous_Schwannoma Benign Mediastinal Psammomatous Neurilemmoma Benign Mediastinal Psammomatous Schwannoma Benign Psammomatous Neurilemmoma of Mediastinum Benign Psammomatous Neurilemmoma of the Mediastinum Benign Psammomatous Schwannoma of Mediastinum Benign Psammomatous Schwannoma of the Mediastinum Mediastinal Psammomatous Schwannoma Mediastinal Psammomatous Schwannoma A benign or malignant mesenchymal neoplasm of the mediastinum. Representative examples of benign mediastinal soft tissue neoplasms include chondroma, leiomyoma, lipoma, and rhabdomyoma. Representative examples of malignant mediastinal soft tissue neoplasms include angiosarcoma, leiomyosarcoma, liposarcoma, osteosarcoma, rhabdomyosarcoma, and synovial sarcoma. C6637 Neoplastic Process Mediastinal Soft Tissue Neoplasm C1334669 Undetermined Mediastinal_Mesenchymal_Neoplasm Mediastinal Soft Tissue Neoplasm Mediastinal Soft Tissue Tumor Soft Tissue Neoplasm of Mediastinum Soft Tissue Neoplasm of the Mediastinum Soft Tissue Tumor of Mediastinum Soft Tissue Tumor of the Mediastinum Mediastinal Soft Tissue Neoplasm Localized tumor with complete gross excision, with or without microscopic residual disease; representative ipsilateral lymph nodes negative for tumor microscopically. (cancer.gov) C6638 Neoplastic Process Stage 1 Neuroblastoma Stage 1 Neuroblastoma C1336467 CTRP Tumor is only found in one area; all of the tumor that can be seen is completely removed during surgery. Malignant Stage_I_Neuroblastoma Stage 1 Neuroblastoma Stage I Neuroblastoma stage 1 neuroblastoma Stage 1 Neuroblastoma Stage 2 includes stage 2A and stage 2B. Stage 2A: Localized tumor with incomplete gross excision; representative ipsilateral nonadherent lymph nodes negative for tumor microscopically. Stage 2B: Localized tumor with or without complete gross excision, with ipsilateral nonadherent lymph nodes positive for tumor. Enlarged contralateral lymph nodes must be negative microscopically. (cancer.gov) C6639 Neoplastic Process Stage 2 Neuroblastoma Stage 2 Neuroblastoma C1336301 CTRP Stage 2 is divided into stages 2A and 2B. In stage 2A, the tumor is in one area only and not all of the tumor that can be seen can be completely removed during surgery. In stage 2B, the tumor is in one area only and all of the tumor that can be seen may be completely removed during surgery, but cancer cells are found in nearby lymph nodes. Malignant Stage_II_Neuroblastoma Stage 2 Neuroblastoma Stage II Neuroblastoma stage 2 neuroblastoma Stage 2 Neuroblastoma Unresectable unilateral tumor infiltrating across the midline, with or without regional lymph node involvement; or localized unilateral tumor with contralateral regional lymph node involvement; or midline tumor with bilateral extension by infiltration (unresectable) or by lymph node involvement. The midline is defined as the vertebral column. Tumors originating on one side and crossing the midline must infiltrate to or beyond the opposite side of the vertebral column. (cancer.gov) C6640 Neoplastic Process Stage 3 Neuroblastoma Stage 3 Neuroblastoma C1336257 CTRP In stage 3 neuroblastoma, the tumor (1) cannot be completely removed during surgery and has spread from one side of the body to the other side and may also have spread to nearby lymph nodes; or (2) is in one area of one side of the body only, but has spread to lymph nodes on the other side of the body; or (3) is in the middle of the body and has spread to tissues or lymph nodes on both sides of the body, and the tumor cannot be removed by surgery. Malignant Stage_III_Neuroblastoma Stage 3 Neuroblastoma Stage III Neuroblastoma stage 3 neuroblastoma Stage 3 Neuroblastoma Any primary tumor with dissemination to distant lymph nodes, bone, bone marrow, liver, skin, and/or other organs, except as defined for stage 4S. (cancer.gov) C6641 Neoplastic Process Stage 4 Neuroblastoma Stage 4 Neuroblastoma C0278694 CTRP Stage 4 neuroblastoma is divided into stages 4 and 4S. In stage 4, the tumor has spread to distant lymph nodes, the skin, and/or other parts of the body. In stage 4S, (1) the child is younger than 1 year; and (2) the cancer has spread to the skin, liver, and/or bone marrow; and (3) the tumor is in one area only and all of the tumor that can be seen may be completely removed during surgery; and/or (4) cancer cells may be found in the lymph nodes near the tumor. Malignant Stage_IV_Neuroblastoma Disseminated Neuroblastoma Stage 4 Neuroblastoma Stage IV Neuroblastoma stage 4 neuroblastoma Stage 4 Neuroblastoma A malignant mesenchymal neoplasm that arises from the mediastinum. C6642 Neoplastic Process Malignant Mediastinal Soft Tissue Neoplasm C1334599 Malignant Malignant_Mediastinal_Mesenchymal_Neoplasm Malignant Mediastinal Soft Tissue Neoplasm Malignant Mediastinal Soft Tissue Tumor Malignant Soft Tissue Neoplasm of Mediastinum Malignant Soft Tissue Neoplasm of the Mediastinum Malignant Soft Tissue Tumor of Mediastinum Malignant Soft Tissue Tumor of the Mediastinum Malignant Mediastinal Soft Tissue Neoplasm A schwannoma that arises from the posterior mediastinum. It is the most common neurogenic tumor of the mediastinum. Excision is usually curative. C6643 Neoplastic Process Mediastinal Schwannoma C1334679 Benign Mediastinal_Schwannoma Benign Mediastinal Neurilemmoma Benign Mediastinal Schwannoma Benign Neurilemmoma of Mediastinum Benign Neurilemmoma of the Mediastinum Benign Schwannoma of Mediastinum Benign Schwannoma of the Mediastinum Mediastinal Neurilemmoma Mediastinal Schwannoma Neurilemmoma of Mediastinum Neurilemmoma of the Mediastinum Schwannoma of Mediastinum Schwannoma of the Mediastinum Mediastinal Schwannoma A benign adipose tissue neoplasm of the pleural cavity. It may be purely intra-thoracic or extend to the chest wall. C6644 Neoplastic Process Pleural Lipoma C1335434 Benign Pleural_Lipoma Lipoma of Pleura Lipoma of the Pleura Pleural Lipoma Pleural Lipoma A capillary hemangioma that may regress spontaneously. It occurs in infants and children. C6645 Neoplastic Process Infantile Hemangioma C0206733 Cellosaurus GDC Benign Infantile_Hemangioendothelioma 9131/0 Hemangioma simplex Infantile hemangioma Juvenile hemangioma Plexiform hemangioma Cellular Hemangioma Infantile Hemangioendothelioma Infantile Hemangioma Infantile hemangioma Juvenile Capillary Hemangioma Juvenile Hemangioma Juvenile hemangioma Strawberry Nevus Infantile Hemangioma Stage I includes: (T1, N0, M0); IA: (T1a, N0, M0); IB: (T1b, N0, M0). T1: Pleural mesothelioma with a tumor limited to the ipsilateral parietal pleura with or without mediastinal pleura and with or without diaphragmatic pleural involvement. T1a: Pleural mesothelioma with no involvement of the visceral pleura. T1b: Pleural mesothelioma with a tumor also involving the visceral pleura N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6646 Neoplastic Process Stage I Pleural Malignant Mesothelioma AJCC v7 Stage I Pleural Malignant Mesothelioma AJCC v7 C1336476 CTRP Cancer is found in the lining of the chest wall and may also be found in the lining of the lung, the lining of the diaphragm (the thin muscle below the lungs and heart that separates the chest from the abdomen), or the lining of the sac that covers the heart on the same side of the chest. Malignant Stage_I_Mesothelioma Stage_I_Pleural_Mesothelioma Stage I Mesothelioma Stage I Mesothelioma of Pleura Stage I Mesothelioma of the Pleura Stage I Pleural Malignant Mesothelioma Stage I Pleural Malignant Mesothelioma AJCC v7 stage I malignant mesothelioma Stage I Pleural Malignant Mesothelioma AJCC v7 Stage II includes: T2, N0, M0. T2: Pleural mesothelioma with a tumor involving each of the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least one of the following: involvement of diaphragmatic muscle; extension of tumor from visceral pleura into the underlying pulmonary parenchyma. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6647 Neoplastic Process Stage II Pleural Malignant Mesothelioma AJCC v7 Stage II Pleural Malignant Mesothelioma AJCC v7 C1336312 CTRP Cancer is found in the lining of the chest wall and the lymph nodes on the same side of the chest. Cancer may also be found in the lining of the lung, the lining of the diaphragm (the thin muscle below the lungs and heart that separates the chest from the abdomen), or the lining of the sac that covers the heart on the same side of the chest. Stage II malignant mesothelioma is advanced malignant mesothelioma. Malignant Stage_II_Mesothelioma Stage_II_Pleural_Mesothelioma Stage II Mesothelioma Stage II Mesothelioma of Pleura Stage II Mesothelioma of the Pleura Stage II Pleural Malignant Mesothelioma Stage II Pleural Malignant Mesothelioma AJCC v7 stage II malignant mesothelioma Stage II Pleural Malignant Mesothelioma AJCC v7 Stage III includes: (T1, T2, N1, M0); (T1, T2, N2, M0); (T3, N0, N1, N2, M0). T1: Pleural mesothelioma with a tumor limited to the ipsilateral parietal pleura with or without mediastinal pleura and with or without diaphragmatic pleural involvement. T2: Pleural mesothelioma with a tumor involving each of the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least one of the following: involvement of diaphragmatic muscle; extension of tumor from visceral pleura into the underlying pulmonary parenchyma. T3: Pleural mesothelioma with a locally advanced but potentially respectable tumor. Tumor involving all the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least one of the following: involvement of the endothoracic fascia; extension into the mediastinal fat; solitary, completely respectable focus of tumor extending into the soft tissues of the chest wall; nontransmural involvement of the pericardium. N0: No regional lymph node metastasis. N1: Pleural mesothelioma with metastases in the ipsilateral bronchopulmonary or hilar lymph nodes. N2: Pleural mesothelioma with metastases in the subcarinal or the ipsilateral mediastinal lymph nodes including the ipsilateral internal mammary and peridiaphragmatic nodes. M0: No distant metastasis. (AJCC 7th ed.) C6648 Neoplastic Process Stage III Pleural Malignant Mesothelioma AJCC v7 Stage III Pleural Malignant Mesothelioma AJCC v7 C1336265 CTRP Cancer has spread to the chest wall, mediastinum, heart, lining of the peritoneum, and/or beyond the diaphragm. Cancer may also have spread to lymph nodes on the other side of the chest or outside the chest. Stage III malignant mesothelioma is advanced malignant mesothelioma. Malignant Stage_III_Mesothelioma Stage_III_Pleural_Mesothelioma Stage III Mesothelioma Stage III Mesothelioma of Pleura Stage III Mesothelioma of the Pleura Stage III Pleural Malignant Mesothelioma Stage III Pleural Malignant Mesothelioma AJCC v7 stage III malignant mesothelioma Stage III Pleural Malignant Mesothelioma AJCC v7 Stage IV includes: (T4, Any N, M0); (Any T, N3, M0); (Any T, Any N, M1). T4: Pleural mesothelioma with a locally advanced technically unresectable tumor. Tumor involving all the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least one of the following: diffuse extension or multifocal masses of tumor in the chest wall, with or without associated rib destruction; direct transdiaphragmatic extension of tumor to the peritoneum; direct extension of tumor to the contralateral pleura; direct extension of tumor to mediastinal organs; direct extension of tumor into the spine; tumor extending through to the internal surface of the pericardium with or without a pericardial effusion or tumor involving the myocardium. N3: Pleural mesothelioma with metastases in the contralateral mediastinal, contralateral internal mammary, ipsilateral or contralateral supraclavicular lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C6649 Neoplastic Process Stage IV Pleural Malignant Mesothelioma AJCC v7 Stage IV Pleural Malignant Mesothelioma AJCC v7 C1336435 CTRP Cancer has spread to distant organs or tissues. Stage IV malignant mesothelioma is advanced malignant mesothelioma. Malignant Stage_IV_Mesothelioma Stage_IV_Pleural_Mesothelioma Stage IV Mesothelioma Stage IV Mesothelioma of Pleura Stage IV Mesothelioma of the Pleura Stage IV Pleural Malignant Mesothelioma Stage IV Pleural Malignant Mesothelioma AJCC v7 stage IV malignant mesothelioma Stage IV Pleural Malignant Mesothelioma AJCC v7 An invasive carcinoma with glandular differentiation arising from the ampulla of Vater. Signs and symptoms include jaundice, abdominal pain, anorexia, nausea, vomiting, and weight loss. C6650 Neoplastic Process Ampulla of Vater Adenocarcinoma C1332243 Cellosaurus Malignant Ampulla_of_Vater_Adenocarcinoma Adenocarcinoma of Ampulla of Vater Ampulla of Vater Adenocarcinoma Ampullary Adenocarcinoma Invasive Adenocarcinoma of the Ampullary Region Ampulla of Vater Adenocarcinoma Stage I includes: IA (T1, N0, M0); IB (T2, N0, M0). T1: Tumor limited to ampulla of Vater or sphincter of Oddi. T2: Tumor invades duodenal wall. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C6651 Neoplastic Process Stage I Ampulla of Vater Cancer AJCC v7 Stage I Ampulla of Vater Cancer AJCC v7 C1336449 CTRP Malignant Stage_I_Ampulla_of_Vater_Cancer Ampulla of Vater Cancer Stage I Stage I Ampulla of Vater Cancer Stage I Ampulla of Vater Cancer AJCC v7 Stage I Ampulla of Vater Carcinoma Stage I Ampullary Carcinoma Stage I Ampulla of Vater Cancer AJCC v7 Stage II includes: IIA (T3, N0, M0); IIB (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor invades the pancreas. T1: Tumor limited to ampulla of Vater or sphincter of Oddi. T2: Tumor invades the duodenal wall. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C6652 Neoplastic Process Stage II Ampulla of Vater Cancer AJCC v7 Stage II Ampulla of Vater Cancer AJCC v7 C1336281 CTRP Malignant Stage_II_Ampulla_of_Vater_Cancer Ampulla of Vater Cancer Stage II Stage II Ampulla of Vater Cancer Stage II Ampulla of Vater Cancer AJCC v7 Stage II Ampulla of Vater Carcinoma Stage II Ampullary Carcinoma Stage II Ampulla of Vater Cancer AJCC v7 Stage III includes: T4, Any N, M0. T4: Tumor invades peripancreatic soft tissues or other adjacent organs or structures other than the pancreas. M0: No distant metastasis. (from AJCC 7th Ed.) C6653 Neoplastic Process Stage III Ampulla of Vater Cancer AJCC v7 Stage III Ampulla of Vater Cancer AJCC v7 C1336242 CTRP Malignant Stage_III_Ampulla_of_Vater_Cancer Ampulla of Vater Cancer Stage III Stage III Ampulla of Vater Cancer Stage III Ampulla of Vater Cancer AJCC v7 Stage III Ampulla of Vater Carcinoma Stage III Ampullary Carcinoma Stage III Ampulla of Vater Cancer AJCC v7 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 7th Ed.) C6654 Neoplastic Process Stage IV Ampulla of Vater Cancer AJCC v7 Stage IV Ampulla of Vater Cancer AJCC v7 C1336412 CTRP Malignant Stage_IV_Ampulla_of_Vater_Cancer Ampulla of Vater Cancer Stage IV Stage IV Ampulla of Vater Cancer Stage IV Ampulla of Vater Cancer AJCC v7 Stage IV Ampulla of Vater Carcinoma Stage IV Ampullary Carcinoma Stage IV Ampulla of Vater Cancer AJCC v7 An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the ampulla of Vater and the periampullary region. It is characterized by the presence of malignant small cells. C6655 Neoplastic Process Ampulla of Vater Small Cell Neuroendocrine Carcinoma C1332250 Malignant Ampulla_of_Vater_Small_Cell_Carcinoma Ampulla of Vater Small Cell Carcinoma Ampulla of Vater Small Cell NEC Ampulla of Vater Small Cell Neuroendocrine Carcinoma Ampullary Small Cell Carcinoma Small Cell Neuroendocrine Carcinoma of the Ampullary Region Ampulla of Vater Small Cell Neuroendocrine Carcinoma An adenocarcinoma arising from the ampulla of Vater. Morphologically, it is characterized by the presence of mucin-containing signet-ring cells. C6656 Neoplastic Process Ampulla of Vater Signet Ring Cell Carcinoma C1332249 Malignant Ampulla_of_Vater_Signet_Ring_Cell_Carcinoma Ampulla of Vater Signet Ring Cell Carcinoma Ampulla of Vater Signet-Ring Cell Carcinoma Ampullary Signet Ring Cell Carcinoma Ampulla of Vater Signet Ring Cell Carcinoma An adenoma that arises from the ampulla of Vater and resembles the adenomas of the small and large intestines. Morphologically, according to the growth pattern, it may be classified as tubular, tubulovillous, or villous. Dysplasia is always present. Jaundice may be an early symptom. C6657 Neoplastic Process Ampulla of Vater Adenoma, Intestinal-Type C1332244 Benign Ampulla_of_Vater_Adenoma Ampulla of Vater Adenoma Ampulla of Vater Adenoma, Intestinal-Type Ampulla of Vater Intestinal-Type Adenoma Ampullary Adenoma Ampulla of Vater Adenoma, Intestinal-Type An intestinal-type adenoma arising from the ampulla of Vater. It is characterized by the presence of villous epithelial structures and it is associated with dysplasia. C6658 Neoplastic Process Ampulla of Vater Villous Adenoma C1332255 Benign Ampulla_of_Vater_Villous_Adenoma Ampulla of Vater Villous Adenoma Ampullary Villous Adenoma Ampulla of Vater Villous Adenoma An intestinal-type adenoma arising from the ampulla of Vater. It is characterized by the presence of tubular epithelial structures and it is associated with dysplasia. C6659 Neoplastic Process Ampulla of Vater Tubular Adenoma C1332252 Benign Ampulla_of_Vater_Tubular_Adenoma Ampulla of Vater Tubular Adenoma Ampullary Tubular Adenoma Ampulla of Vater Tubular Adenoma Stage II includes: IIA (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0) and IIB (T2b, N1, M0); (T3, N0, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C6660 Neoplastic Process Stage II Large Cell Lung Carcinoma AJCC v7 Stage II Lung Large Cell Carcinoma AJCC v7 C0854980 CTRP Malignant Stage_II_Large_Cell_Lung_Carcinoma Stage II Large Cell Carcinoma of Lung Stage II Large Cell Carcinoma of the Lung Stage II Large Cell Lung Cancer Stage II Large Cell Lung Carcinoma Stage II Lung Large Cell Carcinoma AJCC v7 Stage II Lung Large Cell Carcinoma AJCC v7 Stage IA includes: (T1a, N0, M0); (T1b, N0, M0). T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6661 Neoplastic Process Stage IA Large Cell Lung Carcinoma AJCC v7 Stage IA Lung Large Cell Carcinoma AJCC v7 C1336116 CTRP Malignant Stage_IA_Large_Cell_Lung_Carcinoma Stage IA Large Cell Carcinoma of Lung Stage IA Large Cell Carcinoma of the Lung Stage IA Large Cell Lung Cancer Stage IA Large Cell Lung Carcinoma Stage IA Lung Large Cell Carcinoma AJCC v7 Stage IA Lung Large Cell Carcinoma AJCC v7 Stage IB includes: T2a, N0, M0. T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6662 Neoplastic Process Stage IB Large Cell Lung Carcinoma AJCC v7 Stage IB Lung Large Cell Carcinoma AJCC v7 C1336136 CTRP Malignant Stage_IB_Large_Cell_Lung_Carcinoma Stage IB Large Cell Carcinoma of Lung Stage IB Large Cell Carcinoma of the Lung Stage IB Large Cell Lung Cancer Stage IB Large Cell Lung Carcinoma Stage IB Lung Large Cell Carcinoma AJCC v7 Stage IB Lung Large Cell Carcinoma AJCC v7 Stage IIB includes: (T2b, N1, M0); (T3, N0, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C6663 Neoplastic Process Stage IIB Large Cell Lung Carcinoma AJCC v7 Stage IIB Lung Large Cell Carcinoma AJCC v7 C1336184 CTRP Malignant Stage_IIB_Large_Cell_Lung_Carcinoma Stage IIB Large Cell Carcinoma of Lung Stage IIB Large Cell Carcinoma of the Lung Stage IIB Large Cell Lung Cancer Stage IIB Large Cell Lung Carcinoma Stage IIB Lung Large Cell Carcinoma AJCC v7 Stage IIB Lung Large Cell Carcinoma AJCC v7 Stage IIIB includes: (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C6664 Neoplastic Process Stage IIIB Large Cell Lung Carcinoma AJCC v7 Stage IIIB Lung Large Cell Carcinoma AJCC v7 C1336224 CTRP Malignant Stage_IIIB_Large_Cell_Lung_Carcinoma Stage IIIB Large Cell Carcinoma of Lung Stage IIIB Large Cell Carcinoma of the Lung Stage IIIB Large Cell Lung Cancer Stage IIIB Large Cell Lung Carcinoma Stage IIIB Lung Large Cell Carcinoma AJCC v7 Stage IIIB Lung Large Cell Carcinoma AJCC v7 Stage IIIA includes: (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C6665 Neoplastic Process Stage IIIA Large Cell Lung Carcinoma AJCC v7 Stage IIIA Lung Large Cell Carcinoma AJCC v7 C1336209 CTRP Malignant Stage_IIIA_Large_Cell_Lung_Carcinoma Stage IIIA Large Cell Carcinoma of Lung Stage IIIA Large Cell Carcinoma of the Lung Stage IIIA Large Cell Lung Cancer Stage IIIA Large Cell Lung Carcinoma Stage IIIA Lung Large Cell Carcinoma AJCC v7 Stage IIIA Lung Large Cell Carcinoma AJCC v7 Stage IIA includes: (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C6666 Neoplastic Process Stage IIA Large Cell Lung Carcinoma AJCC v7 Stage IIA Lung Large Cell Carcinoma AJCC v7 C1336162 CTRP Malignant Stage_IIA_Large_Cell_Lung_Carcinoma Stage IIA Large Cell Carcinoma of Lung Stage IIA Large Cell Carcinoma of the Lung Stage IIA Large Cell Lung Cancer Stage IIA Large Cell Lung Carcinoma Stage IIA Lung Large Cell Carcinoma AJCC v7 Stage IIA Lung Large Cell Carcinoma AJCC v7 Stage IIA includes: (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C6667 Neoplastic Process Stage IIA Adenosquamous Lung Carcinoma AJCC v7 Stage IIA Lung Adenosquamous Carcinoma AJCC v7 C1336153 CTRP Malignant Stage_IIA_Adenosquamous_Lung_Carcinoma Stage IIA Adenosquamous Cell Carcinoma of Lung Stage IIA Adenosquamous Cell Carcinoma of the Lung Stage IIA Adenosquamous Cell Lung Carcinoma Stage IIA Adenosquamous Lung Cancer Stage IIA Adenosquamous Lung Carcinoma Stage IIA Lung Adenosquamous Carcinoma AJCC v7 Stage IIA Lung Adenosquamous Carcinoma AJCC v7 Stage IA includes: (T1a, N0, M0); (T1b, N0, M0). T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6668 Neoplastic Process Stage IA Adenosquamous Lung Carcinoma AJCC v7 Stage IA Lung Adenosquamous Carcinoma AJCC v7 C1336111 CTRP Malignant Stage_IA_Adenosquamous_Cell_Lung_Carcinoma Stage IA Adenosquamous Cell Carcinoma of Lung Stage IA Adenosquamous Cell Carcinoma of the Lung Stage IA Adenosquamous Cell Lung Carcinoma Stage IA Adenosquamous Lung Cancer Stage IA Adenosquamous Lung Carcinoma Stage IA Lung Adenosquamous Carcinoma AJCC v7 Stage IA Lung Adenosquamous Carcinoma AJCC v7 Stage IB includes: T2a, N0, M0. T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6669 Neoplastic Process Stage IB Adenosquamous Lung Carcinoma AJCC v7 Stage IB Lung Adenosquamous Carcinoma AJCC v7 C1336130 CTRP Malignant Stage_IB_Adenosquamous_Cell_Lung_Carcinoma Stage IB Adenosquamous Cell Carcinoma of Lung Stage IB Adenosquamous Cell Carcinoma of the Lung Stage IB Adenosquamous Cell Lung Carcinoma Stage IB Adenosquamous Lung Cancer Stage IB Adenosquamous Lung Carcinoma Stage IB Lung Adenosquamous Carcinoma AJCC v7 Stage IB Lung Adenosquamous Carcinoma AJCC v7 Stage IIB includes: (T2b, N1, M0); (T3, N0, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C6670 Neoplastic Process Stage IIB Adenosquamous Lung Carcinoma AJCC v7 Stage IIB Lung Adenosquamous Carcinoma AJCC v7 C1336175 CTRP Malignant Stage_IIB_Adenosquamous_Lung_Carcinoma Stage IIB Adenosquamous Cell Carcinoma of Lung Stage IIB Adenosquamous Cell Carcinoma of the Lung Stage IIB Adenosquamous Cell Lung Carcinoma Stage IIB Adenosquamous Lung Cancer Stage IIB Adenosquamous Lung Carcinoma Stage IIB Lung Adenosquamous Carcinoma AJCC v7 Stage IIB Lung Adenosquamous Carcinoma AJCC v7 Stage I includes: IA: (T1a, N0, M0); (T1b, N0, M0) and IB: (T2a, N0, M0). T1a: Lung cancer with a tumor size of 2 cm or less n greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6671 Neoplastic Process Stage I Non-Small Cell Lung Cancer AJCC v7 Stage I Lung Non-Small Cell Cancer AJCC v7 C0278504 CTRP Malignant Stage_I_Non-Small_Cell_Lung_Cancer Stage I Lung Non-Small Cell Cancer AJCC v7 Stage I NSCLC Stage I Non-Oat Cell Carcinoma of Lung Stage I Non-Oat Cell Carcinoma of the Lung Stage I Non-Oat Cell Lung Carcinoma Stage I Non-Small Cell Carcinoma of Lung Stage I Non-Small Cell Carcinoma of the Lung Stage I Non-Small Cell Lung Cancer Stage I Non-Small Cell Lung Cancer AJCC v7 Stage I Non-Small Cell Lung Carcinoma Stage I Lung Non-Small Cell Cancer AJCC v7 An invasive ductal breast carcinoma characterized by the presence of a predominantly syncytial architectural pattern. It may have some, but not all the strictly defined additional morphologic criteria which are necessary for the diagnosis of medullary breast carcinoma (presence of a diffuse lymphoplasmacytic infiltrate, neoplastic round cells with abundant cytoplasm and vesicular nuclei, complete histological circumscription, and absence of glandular or tubular structures). It does not have the relatively favorable outcome that characterizes medullary breast carcinoma. C66719 Neoplastic Process Breast Atypical Medullary Carcinoma C1879758 GDC 8513/3 Malignant Atypical_Medullary_Breast_Carcinoma 8513/3 Atypical medullary carcinoma Atypical Medullary Breast Carcinoma Atypical medullary carcinoma Breast Atypical Medullary Carcinoma Infiltrating Ductal Breast Carcinoma with Medullary Features Breast Atypical Medullary Carcinoma Stage I includes: IA: (T1a, N0, M0); (T1b, N0, M0) and IB: (T2a, N0, M0). T1a: Lung cancer with a tumor size of 2 cm or less n greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6673 Neoplastic Process Stage I Small Cell Lung Carcinoma AJCC v7 Stage I Lung Small Cell Carcinoma AJCC v7 C1336482 CTRP Malignant Stage_I_Small_Cell_Lung_Carcinoma Stage I Lung Small Cell Carcinoma AJCC v7 Stage I Small Cell Carcinoma of Lung Stage I Small Cell Carcinoma of the Lung Stage I Small Cell Lung Cancer Stage I Small Cell Lung Carcinoma Stage I Lung Small Cell Carcinoma AJCC v7 Stage IA includes: (T1a, N0, M0); (T1b, N0, M0). T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6674 Neoplastic Process Stage IA Small Cell Lung Carcinoma AJCC v7 Stage IA Lung Small Cell Carcinoma AJCC v7 C1336124 CTRP Malignant Stage_IA_Small_Cell_Lung_Carcinoma Stage IA Lung Small Cell Carcinoma AJCC v7 Stage IA Small Cell Carcinoma of Lung Stage IA Small Cell Carcinoma of the Lung Stage IA Small Cell Lung Cancer Stage IA Small Cell Lung Carcinoma Stage IA Lung Small Cell Carcinoma AJCC v7 A sex cord-stromal tumor of the testis in which the neoplastic cells do not show specific differentiation. C66748 Neoplastic Process Testicular Sex Cord-Stromal Tumor, Not Otherwise Specified C1266102 GDC 8591/1 Undetermined Sex_Cord-Gonadal_Stromal_Tumor_Incompletely_Differentiated 8591/1 Sex cord-gonadal stromal tumor, incompletely differentiated Sex Cord-Gonadal Stromal Tumor, Incompletely Differentiated Sex cord-gonadal stromal tumor, incompletely differentiated Testicular Sex Cord-Gonadal Stromal Tumor with Indeterminate Differentiation Testicular Sex Cord-Gonadal Stromal Tumor, Incompletely Differentiated Testicular Sex Cord-Stromal Tumor, NOS Testicular Sex Cord-Stromal Tumor, Not Otherwise Specified Unclassified Testicular Sex Cord-Gonadal Stromal Tumor Unclassified Testicular Sex Cord-Stromal Tumor Testicular Sex Cord-Stromal Tumor, Not Otherwise Specified A rare, benign sex cord-stromal tumor of the ovary characterized by the presence of a fibrothecomatous stroma and scattered sex cord elements. Although it is usually hormonally inactive, cases associated with endometrial hyperplasia or adenocarcinoma have been reported. C66749 Neoplastic Process Ovarian Stromal Tumor with Minor Sex Cord Elements C1883177 GDC 8593/1 Benign Stromal_Tumor_with_Minor_Sex_Cord_Elements 8593/1 Stromal tumor with minor sex cord elements Ovarian Stromal Tumor with Minor Sex Cord Elements Stromal Tumor with Minor Sex Cord Elements Stromal tumor with minor sex cord elements Ovarian Stromal Tumor with Minor Sex Cord Elements Stage IB includes: T2a, N0, M0. T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6675 Neoplastic Process Stage IB Small Cell Lung Carcinoma AJCC v7 Stage IB Lung Small Cell Carcinoma AJCC v7 C1336144 CTRP Malignant Stage_IB_Small_Cell_Lung_Carcinoma Stage IB Lung Small Cell Carcinoma AJCC v7 Stage IB Small Cell Carcinoma of Lung Stage IB Small Cell Carcinoma of the Lung Stage IB Small Cell Lung Cancer Stage IB Small Cell Lung Carcinoma Stage IB Lung Small Cell Carcinoma AJCC v7 A low-grade malignant sex cord-stromal tumor occurring in the ovary and rarely in the testis. It is composed of granulosa cells in an often fibrothecomatous stroma. The neoplastic cells may form various patterns including the microfollicular, which is characterized by the presence of Call-Exner bodies, macrofollicular, insular, trabecular, and diffuse pattern. In females, it affects middle aged to post-menopausal women. Signs and symptoms include abdominal mass, hemoperitoneum, and ascites. Estrogenic and rarely androgenic manifestations may be present. The vast majority of cases present as stage I tumors; however, all tumors have a potential for aggressive clinical course. In males, it is reported in the age range of 16-76 years and the average age at presentation is 44 years. A minority of patients have gynecomastia. Metastases have been reported in a minority of patients. C66750 Neoplastic Process Adult Granulosa Cell Tumor C1879643 GDC 8620/1 Malignant Adult_Type_Granulosa_Cell_Tumor 8620/1 Adult granulosa cell tumor Granulosa cell tumor, adult type Adult Granulosa Cell Tumor Adult Type Granulosa Cell Tumor Adult granulosa cell tumor Granulosa cell tumor, adult type Adult Granulosa Cell Tumor A melanoma arising from an atypical intraepithelial melanocytic hyperplasia. C66753 Neoplastic Process Malignant Melanoma in Precancerous Melanosis Melanoma in Precancerous Melanosis C0431098 CTRP GDC 8741/3 Malignant Malignant_Melanoma_in_Precancerous_Melanosis 8741/3 Malignant melanoma in precancerous melanosis Malignant Cutaneous (Skin) Melanoma in Precancerous Melanosis Malignant Melanoma in Precancerous Melanosis Malignant melanoma in precancerous melanosis Melanoma in Precancerous Melanosis Melanoma in Precancerous Melanosis A congenital melanocytic nevus of small size, with a diameter smaller than 15 mm. It presents as a macular, papular or plaque-like lesion. C66754 Congenital Abnormality Disease or Syndrome Small Congenital Melanocytic Nevus C1883045 GDC 8761/0 Benign Small_Congenital_Melanocytic_Nevus 8761/0 Small congenital nevus Small Congenital Melanocytic Nevus Small Congenital Nevus Small congenital nevus Small Congenital Melanocytic Nevus A benign proliferation of epithelioid or spindled melanocytes usually in the upper or mid dermis in a background of congenital melanocytic nevus. The congenital melanocytic nevus is usually of the deep type, involving the dermis and extending into the subcutaneous tissue. It presents as a dark plaque or nodule above a giant congenital melanocytic nevus. C66755 Neoplastic Process Proliferative Nodules in Congenital Melanocytic Nevus C1266117 GDC 8762/1 Benign Proliferative_Dermal_Lesion_in_Congenital_Nevus 8762/1 Proliferative dermal lesion in congenital nevus Proliferative Dermal Lesion in Congenital Nevus Proliferative Nodules in Congenital Melanocytic Nevus Proliferative dermal lesion in congenital nevus Proliferative Nodules in Congenital Melanocytic Nevus A Spitz nevus characterized by the presence of large epithelioid melanocytes. C66757 Neoplastic Process Epithelioid Cell Nevus C0259820 GDC 8771/0 Benign Epithelioid_Cell_Nevus 8771/0 Epithelioid cell nevus Epithelioid Cell Nevus Epithelioid cell nevus Epithelioid Cell Nevus A Spitz nevus characterized by the presence of spindle-shaped melanocytes. C66758 Neoplastic Process Spindle Cell Nevus C0206738 8772/0 Benign Spindle_Cell_Nevus Spindle Cell Nevus Spindle Cell Nevus Stage IIB includes: (T2b, N1, M0); (T3, N0, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C6676 Neoplastic Process Stage IIB Small Cell Lung Carcinoma AJCC v7 Stage IIB Lung Small Cell Carcinoma AJCC v7 C1336195 CTRP Malignant Stage_IIB_Small_Cell_Lung_Carcinoma Stage IIB Lung Small Cell Carcinoma AJCC v7 Stage IIB Small Cell Carcinoma of Lung Stage IIB Small Cell Carcinoma of the Lung Stage IIB Small Cell Lung Cancer Stage IIB Small Cell Lung Carcinoma Stage IIB Lung Small Cell Carcinoma AJCC v7 A soft tissue tumor of uncertain lineage characterized by the presence of neoplastic spindle-shaped to round cells in a fibromyxoid stroma. Metaplastic bone formation may or may not be present. C66760 Neoplastic Process Fibromyxoid Tumor C0205766 CDISC GDC A benign soft-tissue neoplasm of uncertain lineage, characterized by the presence of neoplastic spindle-shaped to round cells and a fibromyxoid stroma. 8811/0 Undetermined Fibromyxoid_Neoplasm 8811/0 Fibromyxoma Fibromyxoma, NOS Myxofibroma, NOS Myxoid fibroma FIBROMYXOMA, BENIGN Fibromyxoid Neoplasm Fibromyxoid Tumor Fibromyxoma Fibromyxoid Tumor A benign fibrous neoplasm arising from the periosteal connective tissue that surrounds a bone. C66761 Neoplastic Process Periosteal Fibroma C0334455 GDC 8812/0 Benign Periosteal_Fibroma 8812/0 Periosteal fibroma Periosteal Fibroma Periosteal fibroma Periosteal Fibroma A benign fibrous tumor arising from the fascial connective tissue. C66764 Neoplastic Process Fascial Fibroma C0334457 GDC 8813/0 Benign Fascial_Fibroma 8813/0 Fascial fibroma Fascial Fibroma Fascial fibroma Fascial Fibroma A malignant fibroblastic neoplasm arising from the fascial connective tissue. C66765 Neoplastic Process Fascial Fibrosarcoma C0334458 GDC 8813/3 Malignant Fascial_Fibrosarcoma 8813/3 Fascial fibrosarcoma Fascial Fibrosarcoma Fascial fibrosarcoma Fascial Fibrosarcoma Stage IIA includes: (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C6677 Neoplastic Process Stage IIA Small Cell Lung Carcinoma AJCC v7 Stage IIA Lung Small Cell Carcinoma AJCC v7 C1336172 CTRP Malignant Stage_IIA_Small_Cell_Lung_Carcinoma Stage IIA Lung Small Cell Carcinoma AJCC v7 Stage IIA Small Cell Carcinoma of Lung Stage IIA Small Cell Carcinoma of the Lung Stage IIA Small Cell Lung Cancer Stage IIA Small Cell Lung Carcinoma Stage IIA Lung Small Cell Carcinoma AJCC v7 A benign neoplasm of the kidney occurring in infants. It develops as an intracalyceal mass and is characterized by the presence of osteoid formation, osteoblast-like cells, and spindle cells. C66774 Neoplastic Process Ossifying Renal Tumor of Infancy C1882198 GDC 8967/0 Benign Ossifying_Renal_Tumor_of_Infancy 8967/0 Ossifying renal tumor ORTI Ossifying Renal Tumor of Infancy Ossifying renal tumor Ossifying Renal Tumor of Infancy A low malignant potential adenofibroma of the ovary It is characterized by an atypical epithelial hyperplasia. The epithelial cells contain intracytoplasmic mucin. There is no evidence of stromal destructive invasion. C66775 Neoplastic Process Borderline Ovarian Mucinous Adenofibroma C1266154 GDC 9015/1 Uncertain Malignant Potential Mucinous_Adenofibroma_of_Borderline_Malignancy 9015/1 Mucinous adenofibroma of borderline malignancy Borderline Ovarian Mucinous Adenofibroma Mucinous adenofibroma of borderline malignancy Ovarian Mucinous Adenofibroma of Borderline Malignancy Borderline Ovarian Mucinous Adenofibroma Stage II includes: IIA (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0) and IIB (T2b, N1, M0); (T3, N0, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C6678 Neoplastic Process Stage II Small Cell Lung Carcinoma AJCC v7 Stage II Lung Small Cell Carcinoma AJCC v7 C1336318 CTRP Malignant Stage_II_Small_Cell_Lung_Carcinoma Stage II Lung Small Cell Carcinoma AJCC v7 Stage II Small Cell Carcinoma of Lung Stage II Small Cell Carcinoma of the Lung Stage II Small Cell Lung Cancer Stage II Small Cell Lung Carcinoma Stage II Lung Small Cell Carcinoma AJCC v7 Stage III includes: IIIA (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0) and IIIB (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C6679 Neoplastic Process Stage III Small Cell Lung Carcinoma AJCC v7 Stage III Lung Small Cell Carcinoma AJCC v7 C1336271 CTRP Malignant Stage_III_Small_Cell_Lung_Carcinoma Stage III Lung Small Cell Carcinoma AJCC v7 Stage III Small Cell Carcinoma of Lung Stage III Small Cell Carcinoma of the Lung Stage III Small Cell Lung Cancer Stage III Small Cell Lung Carcinoma Stage III Small Cell Lung Carcinoma AJCC v7 Stage III Lung Small Cell Carcinoma AJCC v7 A hemorrhagic lymphatic lesion characterized by the presence of dilated lymphatic spaces, extravasation of red blood cells, hemosiderin deposition, and fibrosis. C66792 Neoplastic Process Hemolymphangioma C0334544 GDC 9175/0 Benign Lymphangioma_with_Hemorrhage 9175/0 Hemolymphangioma Hemolymphangioma Lymphangioma with Hemorrhage Hemolymphangioma An osteoblastoma characterized by the presence of prominent epithelioid osteoblasts and recurrences. C66796 Neoplastic Process Aggressive Osteoblastoma C0334547 GDC 9200/1 Undetermined Aggressive_Osteoblastoma 9200/1 Aggressive osteoblastoma Aggressive Osteoblastoma Aggressive osteoblastoma Aggressive Osteoblastoma A rare chondroblastoma that has metastasized to another anatomic site. C66799 Neoplastic Process Metastasizing Chondroblastoma C0334550 GDC 9230/3 Malignant Malignant_Chondroblastoma 9230/3 Chondroblastoma, malignant Chondroblastoma, malignant Metastasizing Chondroblastoma Metastasizing Chondroblastoma Stage IIIA includes: (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C6680 Neoplastic Process Stage IIIA Small Cell Lung Carcinoma AJCC v7 Stage IIIA Lung Small Cell Carcinoma AJCC v7 C1336215 CTRP Malignant Stage_IIIA_Small_Cell_Lung_Carcinoma Stage IIIA Lung Small Cell Carcinoma AJCC v7 Stage IIIA Small Cell Carcinoma of Lung Stage IIIA Small Cell Carcinoma of the Lung Stage IIIA Small Cell Lung Cancer Stage IIIA Small Cell Lung Carcinoma Stage IIIA Lung Small Cell Carcinoma AJCC v7 A rare neoplasm arising from tooth-forming tissues. It usually arises from the posterior mandible. It is characterized by the presence of an epithelial component, fibromyxoid stroma, and dentin formation. It is treated with enucleation and curettage. Recurrences may occur. C66800 Neoplastic Process Ameloblastic Fibrodentinoma C0457520 GDC 9271/0 Benign Ameloblastic_Fibrodentinoma 9271/0 Ameloblastic fibrodentinoma Ameloblastic Fibrodentinoma Ameloblastic fibrodentinoma Ameloblastic Fibrodentinoma Extensive and diffuse infiltration of tissues by ganglioneuroma. C66804 Neoplastic Process Ganglioneuromatosis C0334595 GDC 9491/0 Benign Ganglioneuromatosis 9491/0 Ganglioneuromatosis Ganglioneuromatosis Ganglioneuromatosis A rare, unilateral, benign or malignant embryonal neoplasm typically presenting as a ciliary body mass during childhood. It arises from primitive medullary epithelium. C66806 Neoplastic Process Ciliary Body Medulloepithelioma C1883694 Undetermined Intraocular_Medulloepithelioma Ciliary Body Medulloepithelioma Intraocular Medulloepithelioma Ciliary Body Medulloepithelioma A rare, unilateral, benign embryonal neoplasm typically presenting as a ciliary body mass during childhood. It arises from primitive medullary epithelium. C66807 Neoplastic Process Ciliary Body Benign Medulloepithelioma C1879808 GDC 9501/0 Benign Benign_Intraocular_Medulloepithelioma 9501/0 Medulloepithelioma, benign Benign Ciliary Body Medulloepithelioma Benign Intraocular Medulloepithelioma Ciliary Body Benign Medulloepithelioma Medulloepithelioma, benign Ciliary Body Benign Medulloepithelioma A rare, unilateral, benign embryonal neoplasm typically presenting as a ciliary body mass during childhood. It arises from primitive medullary epithelium and contains heterologous elements, particularly cartilage, skeletal muscle, and brain tissue. C66809 Neoplastic Process Ciliary Body Benign Teratoid Medulloepithelioma C1879809 GDC 9502/0 Benign Benign_Intraocular_Teratoid_Medulloepithelioma 9502/0 Teratoid medulloepithelioma, benign Benign Intraocular Teratoid Medulloepithelioma Ciliary Body Benign Teratoid Medulloepithelioma Teratoid medulloepithelioma, benign Ciliary Body Benign Teratoid Medulloepithelioma Stage IIIB includes: (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C6681 Neoplastic Process Stage IIIB Small Cell Lung Carcinoma AJCC v7 Stage IIIB Lung Small Cell Carcinoma AJCC v7 C1336230 CTRP Malignant Stage_IIIB_Small_Cell_Lung_Carcinoma Stage IIIB Lung Small Cell Carcinoma AJCC v7 Stage IIIB Small Cell Carcinoma of Lung Stage IIIB Small Cell Carcinoma of the Lung Stage IIIB Small Cell Lung Cancer Stage IIIB Small Cell Lung Carcinoma Stage IIIB Small Cell Lung Carcinoma AJCC v7 Stage IIIB Lung Small Cell Carcinoma AJCC v7 A rare, unilateral, benign or malignant embryonal neoplasm typically presenting as a ciliary body mass during childhood. It arises from primitive medullary epithelium and contains heterologous elements, particularly cartilage, skeletal muscle, and brain tissue. C66810 Neoplastic Process Ciliary Body Teratoid Medulloepithelioma C1881244 GDC 9502/3 Undetermined Intraocular_Teratoid_Medulloepithelioma 9502/3 Teratoid medulloepithelioma Teratoid medulloepithelioma, NOS Ciliary Body Teratoid Medulloepithelioma Intraocular Teratoid Medulloepithelioma Teratoid medulloepithelioma Ciliary Body Teratoid Medulloepithelioma A rare, unilateral or bilateral benign neoplasm that arises from the retina. There is an increased risk of malignant transformation to retinoblastoma; therefore, patients with a diagnosis of retinocytoma should be closely observed. C66812 Neoplastic Process Retinocytoma C0346396 GDC 9510/0 Benign Retinocytoma 9510/0 Retinocytoma Retinocytoma Retinoma Retinocytoma A retinoblastoma with well differentiated features. It often produces Flexner-Wintersteiner rosettes or Homer-Wright rosettes. In some cases the tumor cells form fleurettes. C66813 Neoplastic Process Differentiated Retinoblastoma C0334600 GDC 9511/3 Malignant Differentiated_Retinoblastoma 9511/3 Retinoblastoma, differentiated Differentiated Retinoblastoma Retinoblastoma, differentiated Differentiated Retinoblastoma A retinoblastoma composed of small, undifferentiated cells. It is often associated with necrotic changes. C66814 Neoplastic Process Undifferentiated Retinoblastoma Undifferentiated Retinoblastoma C0334601 CTRP GDC 9512/3 Malignant Undifferentiated_Retinoblastoma 9512/3 Retinoblastoma, undifferentiated Retinoblastoma, undifferentiated Undifferentiated Retinoblastoma Undifferentiated Retinoblastoma A retinoblastoma characterized by the absence of a distinct retinal mass and the presence of malignant cells diffusely infiltrating the retina. It is often confused with uveitis and endophthalmitis, resulting in delayed diagnosis of the malignancy. C66815 Neoplastic Process Diffuse Retinoblastoma C1266185 GDC 9513/3 Malignant Diffuse_Retinoblastoma 9513/3 Retinoblastoma, diffuse Diffuse Retinoblastoma Diffuse Retinoblastoma Stage IV includes: (Any T, Any N, M1a); (Any T, Any N, M1b). M1a: Lung cancer with separate tumor nodule(s) in a contralateral lobe; tumor with pleural nodules or malignant pleural (or pericardial) effusion. M1b: Distant metastasis. (AJCC 7th ed.) C6682 Neoplastic Process Stage IV Small Cell Lung Carcinoma AJCC v7 Stage IV Lung Small Cell Carcinoma AJCC v7 C1336440 CTRP Malignant Stage_IV_Small_Cell_Lung_Carcinoma Stage IV Lung Small Cell Carcinoma AJCC v7 Stage IV Small Cell Carcinoma of Lung Stage IV Small Cell Carcinoma of the Lung Stage IV Small Cell Lung Cancer Stage IV Small Cell Lung Carcinoma Stage IV Lung Small Cell Carcinoma AJCC v7 A small cell lung carcinoma detectable by sputum cytology only. The primary tumor is undetectable radiographically or during bronchoscopy; therefore, it can not be assessed. C6683 Neoplastic Process Occult Lung Small Cell Carcinoma C1335099 Malignant Occult_Small_Cell_Lung_Carcinoma Occult Lung Small Cell Carcinoma Occult Small Cell Carcinoma of Lung Occult Small Cell Carcinoma of the Lung Occult Small Cell Lung Carcinoma Occult Lung Small Cell Carcinoma An adenosquamous lung carcinoma detectable by sputum cytology only. The primary tumor is undetectable radiographically or during bronchoscopy; therefore, it can not be assessed. C6684 Neoplastic Process Occult Lung Adenosquamous Carcinoma C1335094 Malignant Occult_Adenosquamous_Lung_Carcinoma Occult Adenosquamous Cell Carcinoma of Lung Occult Adenosquamous Cell Carcinoma of the Lung Occult Adenosquamous Cell Lung Carcinoma Occult Lung Adenosquamous Carcinoma Occult Lung Adenosquamous Carcinoma A rare neurofibroma characterized by the presence of melanin-laden cells and the absence of atypia. C66841 Neoplastic Process Melanotic Neurofibroma CL497402 GDC 9541/0 Benign Melanotic_Neurofibroma 9541/0 Melanotic neurofibroma Melanotic Neurofibroma Melanotic neurofibroma Pigmented Neurofibroma Melanotic Neurofibroma A very rare malignant tumor with morphologic features similar to those of benign perineurioma of soft tissue along with hypercellularity, nuclear atypia, hyperchromasia, and a high mitotic rate. C66845 Neoplastic Process Malignant Peripheral Nerve Sheath Tumor with Perineurial Differentiation C1266188 GDC 9571/3 Malignant Malignant_Peripheral_Nerve_Sheath_Tumor_with_Perineurial_Differentiation 9571/3 Perineural MPNST Perineurioma, malignant Malignant Perineurioma Malignant Peripheral Nerve Sheath Tumor with Perineurial Differentiation Perineural MPNST Perineurial Malignant Peripheral Nerve Sheath Tumor Perineurioma, malignant Malignant Peripheral Nerve Sheath Tumor with Perineurial Differentiation A large cell lung carcinoma detectable by sputum cytology only. The primary tumor is undetectable radiographically or during bronchoscopy; therefore, it can not be assessed. C6685 Neoplastic Process Occult Lung Large Cell Carcinoma C1335095 Malignant Occult_Large_Cell_Lung_Carcinoma Occult Large Cell Carcinoma of Lung Occult Large Cell Carcinoma of the Lung Occult Large Cell Lung Carcinoma Occult Lung Large Cell Carcinoma Occult Lung Large Cell Carcinoma A papillary carcinoma of the thyroid gland which is encapsulated and resembles an encapsulated follicular neoplasm. Capsular invasion is present. The malignant follicular cells display the nuclear features that characterize the papillary adenocarcinomas of the thyroid gland. C66850 Neoplastic Process Invasive Encapsulated Follicular Variant Thyroid Gland Papillary Carcinoma C1880498 GDC 8343/3 Malignant Encapsulated_Thyroid_Gland_Papillary_Carcinoma 8509/3 Encapsulated papillary carcinoma with invasion Invasive encapsulated follicular variant of papillary thyroid carcinoma (invasive EFVPTC) Solid papillary carcinoma with invasion Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion IEFVPTC Invasive Encapsulated Follicular Variant Papillary Carcinoma Invasive Encapsulated Follicular Variant Thyroid Gland Papillary Carcinoma Invasive encapsulated follicular variant of papillary thyroid carcinoma (invasive EFVPTC) Solid papillary carcinoma with invasion Invasive Encapsulated Follicular Variant Thyroid Gland Papillary Carcinoma A squamous cell lung carcinoma detectable by sputum cytology only. The primary tumor is undetectable radiographically or during bronchoscopy; therefore, it can not be assessed. C6686 Neoplastic Process Occult Lung Squamous Cell Carcinoma C1335100 Malignant Occult_Squamous_Cell_Lung_Carcinoma Occult Lung Squamous Cell Carcinoma Occult Squamous Cell Carcinoma of Lung Occult Squamous Cell Carcinoma of the Lung Occult Squamous Cell Lung Carcinoma Occult Lung Squamous Cell Carcinoma An adenoma that arises from the parotid gland. It is characterized by an oncocytic, often papillary, epithelial component, dense lymphoid stroma, and cystic spaces. A strong association with smoking has been reported. It typically presents as a painless swelling in the lower portion of the parotid gland. C66865 Neoplastic Process Parotid Gland Warthin Tumor C1883714 Benign Parotid_Gland_Warthin_Tumor Parotid Gland Adenolymphoma Parotid Gland Papillary Cystadenoma Lymphomatosum Parotid Gland Warthin Tumor Parotid Gland Warthin's Tumor Parotid Gland Warthin Tumor Stage IA includes: (T1a, N0, M0); (T1b, N0, M0). T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6687 Neoplastic Process Stage IA Squamous Cell Lung Carcinoma AJCC v7 Stage IA Lung Squamous Cell Carcinoma AJCC v7 C1336125 CTRP Malignant Stage_IA_Squamous_Cell_Lung_Carcinoma Stage IA Lung Squamous Cell Carcinoma AJCC v7 Stage IA Squamous Cell Carcinoma of Lung Stage IA Squamous Cell Carcinoma of the Lung Stage IA Squamous Cell Lung Cancer Stage IA Squamous Cell Lung Carcinoma Stage IA Squamous Cell Lung Carcinoma AJCC v7 Stage IA Lung Squamous Cell Carcinoma AJCC v7 Stage IIA includes: (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C6688 Neoplastic Process Stage IIA Squamous Cell Lung Carcinoma AJCC v7 Stage IIA Lung Squamous Cell Carcinoma AJCC v7 C1336173 CTRP Malignant Stage_IIA_Squamous_Cell_Lung_Carcinoma Stage IIA Lung Squamous Cell Carcinoma AJCC v7 Stage IIA Squamous Cell Carcinoma of Lung Stage IIA Squamous Cell Carcinoma of the Lung Stage IIA Squamous Cell Lung Cancer Stage IIA Squamous Cell Lung Carcinoma Stage IIA Squamous Cell Lung Carcinoma AJCC v7 Stage IIA Lung Squamous Cell Carcinoma AJCC v7 Stage IIIA includes: (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C6689 Neoplastic Process Stage IIIA Squamous Cell Lung Carcinoma AJCC v7 Stage IIIA Lung Squamous Cell Carcinoma AJCC v7 C1336216 CTRP Malignant Stage_IIIA_Squamous_Cell_Lung_Carcinoma Stage IIIA Lung Squamous Cell Carcinoma AJCC v7 Stage IIIA Squamous Cell Carcinoma of Lung Stage IIIA Squamous Cell Carcinoma of the Lung Stage IIIA Squamous Cell Lung Cancer Stage IIIA Squamous Cell Lung Carcinoma Stage IIIA Squamous Cell Lung Carcinoma AJCC v7 Stage IIIA Lung Squamous Cell Carcinoma AJCC v7 Stage IIIB includes: (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C6690 Neoplastic Process Stage IIIB Squamous Cell Lung Carcinoma AJCC v7 Stage IIIB Lung Squamous Cell Carcinoma AJCC v7 C1336233 CTRP Malignant Stage_IIIB_Squamous_Cell_Lung_Carcinoma Stage IIIB Lung Squamous Cell Carcinoma AJCC v7 Stage IIIB Squamous Cell Carcinoma of Lung Stage IIIB Squamous Cell Carcinoma of the Lung Stage IIIB Squamous Cell Lung Cancer Stage IIIB Squamous Cell Lung Carcinoma Stage IIIB Squamous Cell Lung Carcinoma AJCC v7 Stage IIIB Lung Squamous Cell Carcinoma AJCC v7 Stage IIB includes: (T2b, N1, M0); (T3, N0, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C6691 Neoplastic Process Stage IIB Squamous Cell Lung Carcinoma AJCC v7 Stage IIB Lung Squamous Cell Carcinoma AJCC v7 C1336196 CTRP Malignant Stage_IIB_Squamous_Cell_Lung_Carcinoma Stage IIB Lung Squamous Cell Carcinoma AJCC v7 Stage IIB Squamous Cell Carcinoma of Lung Stage IIB Squamous Cell Carcinoma of the Lung Stage IIB Squamous Cell Lung Cancer Stage IIB Squamous Cell Lung Carcinoma Stage IIB Squamous Cell Lung Carcinoma AJCC v7 Stage IIB Lung Squamous Cell Carcinoma AJCC v7 Stage IB includes: T2a, N0, M0. T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6692 Neoplastic Process Stage IB Squamous Cell Lung Carcinoma AJCC v7 Stage IB Lung Squamous Cell Carcinoma AJCC v7 C1336145 CTRP Malignant Stage_IB_Squamous_Cell_Lung_Carcinoma Stage IB Lung Squamous Cell Carcinoma AJCC v7 Stage IB Squamous Cell Carcinoma of Lung Stage IB Squamous Cell Carcinoma of the Lung Stage IB Squamous Cell Lung Cancer Stage IB Squamous Cell Lung Carcinoma Stage IB Squamous Cell Lung Carcinoma AJCC v7 Stage IB Lung Squamous Cell Carcinoma AJCC v7 A record of a patient's medical background regarding cardiovasular disease. C66921 Clinical Attribute Cardiovascular History C1880008 Cardiovascular_History Cardiovascular History Cardiovascular History An event in the personal medical history of sustained, inadequate tissue perfusion secondary to cardiac dysfunction, generally defined as systolic blood pressure of less than 90 mm Hg of more than 1 hour and not responsive to fluid resuscitation alone. Associated signs of peripheral hypoperfusion (e.g. cool extremities, oliguria, altered sensorium) or a cardiac index of less than 2.2L/min/m^(2) are present. This clinical entity includes instances in which the systolic blood pressure is raised to 90 mmHg or more using inotropic agents, within the first hour. (from NIH Roadmap Cardiovascular Data Standards Working Group) C66922 Clinical Attribute History of Cardiogenic Shock C1881054 History_of_Cardiogenic_Shock History of Cardiogenic Shock History of Cardiogenic Shock An event in the personal medical history of peripheral vascular disease as evidenced by: 1. Claudication either with exertion or at rest; 2. Amputation for arterial vascular insufficiency; 3. Aorto-iliac occlusive disease reconstruction, peripheral vascular bypass surgery, angioplasty or stent; or percutaneous intervention to the extremities; 4. Documented abdominal aortic aneurysm (AAA) repair or stent; 5. Positive non-invasive/invasive test. It does not include procedures such as vein stripping, carotid disease, or procedures originating above the diaphragm. (from NIH Roadmap Cardiovascular Data Standards Working Group) C66923 Clinical Attribute History of Peripheral Vascular Disease C1881056 History_of_Peripheral_Vascular_Disease History of Peripheral Vascular Disease History of Peripheral Vascular Disease An event in the personal medical history of coronary artery disease as evidenced by one of the following: 1) prior coronary artery bypass surgery (CABG), 2) prior percutaneous coronary intervention (PCI), 3) angiographically documented coronary artery stenosis greater than or equal to 50 percent 4) angiographically documented coronary atherosclerosis (not greater than 50 percent), 5) a positive stress test, 6) alternatively documented coronary atherosclerosis using other imaging techniques, 7) prior myocardial infarction, or 8) prior angina pectoris. (from NIH Roadmap Cardiovascular Data Standards Working Group) C66924 Clinical Attribute Personal History of Coronary Artery Disease C1881055 History_of_Coronary_Artery_Disease History of Coronary Artery Disease Personal History of Coronary Artery Disease Personal History of Coronary Artery Disease An event in the personal medical history of heart failure, a condition in which the heart is unable to pump enough blood to meet the body's requirements. C66926 Clinical Attribute History of Heart Failure C0455531 History_of_Heart_Failure History of Heart Failure History of Heart Failure An event in the personal medical histroy of cardiac arrest that is reversed, usually by CPR and/or defibrillation or cardioversion, or cardiac pacing. C66927 Clinical Attribute History of Resuscitated Cardiac Arrest C1881057 History_of_Resuscitated_Cardiac_Arrest History of Resuscitated Cardiac Arrest History of Resuscitated Cardiac Arrest Damage to the inner ear as a result of exposure to drugs or chemicals. C66929 Finding Ototoxicity Ototoxicity C0235280 CTRP PCDC Ototoxicity Ototoxicity Ototoxicity Stage IB includes: T2a, N0, M0. T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6693 Neoplastic Process Stage IB Lung Adenocarcinoma AJCC v7 Stage IB Lung Adenocarcinoma AJCC v7 C1336137 CTRP Malignant Stage_IB_Lung_Adenocarcinoma Stage IB Adenocarcinoma of Lung Stage IB Adenocarcinoma of the Lung Stage IB Lung Adenocarcinoma Stage IB Lung Adenocarcinoma AJCC v7 Stage IB Lung Adenocarcinoma AJCC v7 Breast ductal carcinoma in situ in which the tumor cells fill the ductal spaces as solid sheets. C66933 Neoplastic Process Breast Ductal Carcinoma In Situ, Solid Type C1880424 GDC 8230/2 Malignant Ductal_Carcinoma_in_situ_of_the_Breast_Solid_Type 8230/2 Ductal carcinoma in situ, solid type Breast Ductal Carcinoma In Situ, Solid Type Ductal Breast Carcinoma In Situ, Solid Type Ductal Breast Carcinoma in Situ, Solid Type Ductal carcinoma in situ, solid type Breast Ductal Carcinoma In Situ, Solid Type Stage IA includes: (T1a, N0, M0); (T1b, N0, M0). T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C6694 Neoplastic Process Stage IA Lung Adenocarcinoma AJCC v7 Stage IA Lung Adenocarcinoma AJCC v7 C1336117 CTRP Malignant Stage_IA_Lung_Adenocarcinoma Stage IA Adenocarcinoma of Lung Stage IA Adenocarcinoma of the Lung Stage IA Lung Adenocarcinoma Stage IA Lung Adenocarcinoma AJCC v7 Stage IA Lung Adenocarcinoma AJCC v7 Stage IIA includes: (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C6695 Neoplastic Process Stage IIA Lung Adenocarcinoma AJCC v7 Stage IIA Lung Adenocarcinoma AJCC v7 C1336163 CTRP Malignant Stage_IIA_Lung_Adenocarcinoma Stage IIA Adenocarcinoma of Lung Stage IIA Adenocarcinoma of the Lung Stage IIA Lung Adenocarcinoma Stage IIA Lung Adenocarcinoma AJCC v7 Stage IIA Lung Adenocarcinoma AJCC v7 Stage IIB includes: (T2b, N1, M0); (T3, N0, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C6696 Neoplastic Process Stage IIB Lung Adenocarcinoma AJCC v7 Stage IIB Lung Adenocarcinoma AJCC v7 C1336185 CTRP Malignant Stage_IIB_Lung_Adenocarcinoma Stage IIB Adenocarcinoma of Lung Stage IIB Adenocarcinoma of the Lung Stage IIB Lung Adenocarcinoma Stage IIB Lung Adenocarcinoma AJCC v7 Stage IIB Lung Adenocarcinoma AJCC v7 Stage IIIB includes: (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C6697 Neoplastic Process Stage IIIB Lung Adenocarcinoma AJCC v7 Stage IIIB Lung Adenocarcinoma AJCC v7 C0862793 CTRP Malignant Stage_IIIB_Lung_Adenocarcinoma Stage IIIB Adenocarcinoma of Lung Stage IIIB Adenocarcinoma of the Lung Stage IIIB Lung Adenocarcinoma Stage IIIB Lung Adenocarcinoma AJCC v7 Stage IIIB Lung Adenocarcinoma AJCC v7 Stage IIIA includes: (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C6698 Neoplastic Process Stage IIIA Lung Adenocarcinoma AJCC v7 Stage IIIA Lung Adenocarcinoma AJCC v7 C0862792 CTRP Malignant Stage_IIIA_Lung_Adenocarcinoma Stage IIIA Adenocarcinoma of Lung Stage IIIA Adenocarcinoma of the Lung Stage IIIA Lung Adenocarcinoma Stage IIIA Lung Adenocarcinoma AJCC v7 Stage IIIA Lung Adenocarcinoma AJCC v7 A stromal tumor that arises from the ovary and is characterized by the presence of cells that contain lipid and resemble theca cells. The vast majority of cases are benign. C66989 Neoplastic Process Ovarian Thecoma C1882229 Undetermined Ovarian_Thecoma Ovarian Theca Cell Neoplasm Ovarian Theca Cell Tumor Ovarian Thecoma Theca Cell Neoplasm of Ovary Theca Cell Neoplasm of the Ovary Theca Cell Tumor of Ovary Theca Cell Tumor of the Ovary Thecoma of Ovary Thecoma of the Ovary Ovarian Thecoma A lung adenocarcinoma detectable by sputum cytology only. The primary tumor is undetectable radiographically or during bronchoscopy; therefore, it can not be assessed. C6699 Neoplastic Process Occult Lung Adenocarcinoma C1335096 Malignant Occult_Lung_Adenocarcinoma Occult Adenocarcinoma of Lung Occult Adenocarcinoma of the Lung Occult Lung Adenocarcinoma Occult Lung Adenocarcinoma A sex cord-stromal tumor of the testis which may contain any combination of cell types, for example Sertoli cells, Leydig cells, and granulosa cells. Symptoms include testicular swelling and gynecomastia. C66991 Neoplastic Process Testicular Mixed Sex Cord-Stromal Tumor C1266103 GDC 8592/1 Undetermined Testicular_Sex_Cord-Gonadal_Stromal_Tumor_Mixed_Forms 8592/1 Sex cord-gonadal stromal tumor, mixed forms Mixed Testicular Sex Cord-Gonadal Stromal Tumor Mixed Testicular Sex Cord-Stromal Tumor Sex Cord-Gonadal Stromal Tumor, Mixed Forms Sex cord-gonadal stromal tumor, mixed forms Testicular Mixed Sex Cord-Stromal Tumor Testicular Sex Cord-Gonadal Stromal Tumor, Mixed Forms Testicular Mixed Sex Cord-Stromal Tumor A carcinoma that arises from the pyriform sinus. Patients usually present with advanced stage disease and the prognosis is poor. C6700 Neoplastic Process Pyriform Fossa Carcinoma Pyriform Fossa Carcinoma C1335579 CTRP Malignant Pyriform_Fossa_Carcinoma Carcinoma of Pyriform Fossa Carcinoma of Pyriform Sinus Carcinoma of the Pyriform Fossa Carcinoma of the Pyriform Sinus Pyriform Fossa Carcinoma Pyriform Fossa Throat Cancer Pyriform Sinus Carcinoma Pyriform Fossa Carcinoma A Sertoli cell tumor that arises from the testis or the ovary. It is characterized by nuclear pleomorphism, increased mitotic activity and necrotic changes. Metastases may be present at diagnosis. C67006 Neoplastic Process Malignant Sertoli Cell Tumor C0334406 CDISC GDC A malignant neoplasm of the testis or ovary, originating from Sertoli cells. 8630/3 8640/3 Malignant Malignant_Sertoli_Cell_Tumor 8640/3 Androblastoma, malignant Arrhenoblastoma, malignant Sertoli cell carcinoma Malignant Androblastoma Malignant Sertoli Cell Tumor SERTOLI CELL TUMOR, MALIGNANT Sertoli cell carcinoma Malignant Sertoli Cell Tumor Stage IV includes: IVA (Any T, N0, M1a, Any G); IVB (Any T, N1, Any M, Any G); (Any T, Any N, M1b, Any G). N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M1a: Distant metastasis to lung. M1b: Metastasis to other distant sites. (AJCC 7th ed.) C6701 Neoplastic Process Stage IV Osteosarcoma AJCC v7 Stage IV Osteosarcoma AJCC v7 C1336430 CTRP Malignant Stage_IV_Osteosarcoma Stage IV Osteogenic Sarcoma Stage IV Osteosarcoma Stage IV Osteosarcoma AJCC v7 Stage IV Osteosarcoma AJCC v7 A Sertoli cell tumor of the testis or the ovary which remains localized and does not metastasize to another anatomic site. C67012 Neoplastic Process Benign Sertoli Cell Tumor C0334405 CDISC GDC A benign neoplasm of the testis or ovary, originating from Sertoli cells. 8630/0 Benign Benign_Sertoli_Cell_Tumor 8630/0 Androblastoma, benign Arrhenoblastoma, benign Benign Androblastoma Benign Sertoli Cell Tumor SERTOLI CELL TUMOR, BENIGN Benign Sertoli Cell Tumor Stage IVA includes: Any T, N0, M1a, Any G. N0: No regional lymph node metastasis. M1a: Distant metastasis to lung. (AJCC 7th ed.) C6702 Neoplastic Process Stage IVA Osteosarcoma AJCC v7 Stage IVA Osteosarcoma AJCC v7 C1336357 CTRP Malignant Stage_IVA_Osteosarcoma Stage IVA Osteogenic Sarcoma Stage IVA Osteosarcoma Stage IVA Osteosarcoma AJCC v7 Stage IVA Osteosarcoma AJCC v7 Stage IVB includes: (Any T, N1, Any M, Any G); (Any T, Any N, M1b, Any G). N1: Regional lymph node metastasis. M1b: Metastasis to other distant sites. (AJCC 7th ed.) C6703 Neoplastic Process Stage IVB Osteosarcoma AJCC v7 Stage IVB Osteosarcoma AJCC v7 C1336388 CTRP Malignant Stage_IVB_Osteosarcoma Stage IVB Osteogenic Sarcoma Stage IVB Osteosarcoma Stage IVB Osteosarcoma AJCC v7 Stage IVB Osteosarcoma AJCC v7 Stage I includes: IA (T1, N0, M0, G1, G2, GX); IB (T2, N0, M0, G1, G2, GX); (T3, N0, M0, G1, G2, GX). T1: Tumor 8 cm or less in greatest dimension. T2: Tumor more than 8 cm in greatest dimension. T3: Discontinuous tumors in the primary bone site. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated-low grade. G2: Moderately differentiated-low grade. GX: Grade cannot be assessed. (AJCC 7th ed.) C6704 Neoplastic Process Stage I Bone Sarcoma AJCC v7 Stage I Bone Sarcoma AJCC v7 C1336451 CTRP Malignant Stage_I_Bone_Sarcoma Stage I Bone Sarcoma Stage I Bone Sarcoma AJCC v7 Stage I Sarcoma of Bone Stage I Sarcoma of the Bone Stage I Bone Sarcoma AJCC v7 Stage II includes: IIA (T1, N0, M0, G3, G4); IIB (T2, N0, M0, G3, G4). T1: Tumor 8 cm or less in greatest dimension. T2: Tumor more than 8 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (AJCC 7th ed.) C6705 Neoplastic Process Stage II Bone Sarcoma AJCC v7 Stage II Bone Sarcoma AJCC v7 C1336282 CTRP Malignant Stage_II_Bone_Sarcoma Stage II Bone Sarcoma Stage II Bone Sarcoma AJCC v7 Stage II Sarcoma of Bone Stage II Sarcoma of the Bone Stage II Bone Sarcoma AJCC v7 Stage IV includes: IVA (Any T, N0, M1a, Any G); IVB (Any T, N1, Any M, Any G); (Any T, Any N, M1b, Any G). N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M1a: Distant metastasis to lung. M1b: Metastasis to other distant sites. (AJCC 7th ed.) C6706 Neoplastic Process Stage IV Bone Sarcoma AJCC v7 Stage IV Bone Sarcoma AJCC v7 C1336413 CTRP Malignant Stage_IV_Bone_Sarcoma Stage IV Bone Sarcoma Stage IV Bone Sarcoma AJCC v7 Stage IV Sarcoma of Bone Stage IV Sarcoma of the Bone Stage IV Bone Sarcoma AJCC v7 Stage IVA includes: Any T, N0, M1a, Any G. N0: No regional lymph node metastasis. M1a: Distant metastasis to lung. (AJCC 7th ed.) C6707 Neoplastic Process Stage IVA Bone Sarcoma AJCC v7 Stage IVA Bone Sarcoma AJCC v7 C1336333 CTRP Malignant Stage_IVA_Bone_Sarcoma Stage IVA Bone Sarcoma Stage IVA Bone Sarcoma AJCC v7 Stage IVA Sarcoma of Bone Stage IVA Sarcoma of the Bone Stage IVA Bone Sarcoma AJCC v7 Stage IVB includes: (Any T, N1, Any M, Any G); (Any T, Any N, M1b, Any G). N1: Regional lymph node metastasis. M1b: Metastasis to other distant sites. (AJCC 7th ed.) C6708 Neoplastic Process Stage IVB Bone Sarcoma AJCC v7 Stage IVB Bone Sarcoma AJCC v7 C1336363 CTRP Malignant Stage_IVB_Bone_Sarcoma Stage IVB Bone Sarcoma Stage IVB Bone Sarcoma AJCC v7 Stage IVB Sarcoma of Bone Stage IVB Sarcoma of the Bone Stage IVB Bone Sarcoma AJCC v7 Stage I includes: IA (T1, N0, M0, G1, G2, GX); IB (T2, N0, M0, G1, G2, GX); (T3, N0, M0, G1, G2, GX). T1: Tumor 8 cm or less in greatest dimension. T2: Tumor more than 8 cm in greatest dimension. T3: Discontinuous tumors in the primary bone site. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated-low grade. G2: Moderately differentiated-low grade. GX: Grade cannot be assessed. (AJCC 7th ed.) C6709 Neoplastic Process Stage I Osteosarcoma AJCC v7 Stage I Osteosarcoma AJCC v7 C1336471 CTRP Malignant Stage_I_Osteosarcoma Stage I Osteogenic Sarcoma Stage I Osteosarcoma Stage I Osteosarcoma AJCC v7 Stage I Osteosarcoma AJCC v7 A benign or borderline adenofibroma characterized by the presence of serous secretory cells and minute cystic spaces filled with watery fluid. A representative example is the ovarian serous adenofibroma. C67090 Neoplastic Process Serous Adenofibroma C0334498 GDC 9014/0 Undetermined Serous_Adenofibroma 9014/0 Serous adenofibroma, NOS Serous Adenofibroma Serous Adenofibroma A malignant neoplasm of the ovary with an invasive epithelial component and a fibrotic stroma. The epithelial component is characterized by the presence of malignant epithelial cells of serous type, forming glandular, papillary, and solid patterns. C67092 Neoplastic Process Ovarian Serous Adenocarcinofibroma C1266153 GDC 9014/3 Malignant Ovarian_Serous_Adenocarcinofibroma 9014/3 Serous adenocarcinofibroma Ovarian Serous Adenocarcinofibroma Serous adenocarcinofibroma Ovarian Serous Adenocarcinofibroma Stage II includes: IIA (T1, N0, M0, G3, G4); IIB (T2, N0, M0, G3, G4). T1: Tumor 8 cm or less in greatest dimension. T2: Tumor more than 8 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (AJCC 7th ed.) C6710 Neoplastic Process Stage II Osteosarcoma AJCC v7 Stage II Osteosarcoma AJCC v7 C1336307 CTRP Malignant Stage_II_Osteosarcoma Stage II Osteogenic Sarcoma Stage II Osteosarcoma Stage II Osteosarcoma AJCC v7 Stage II Osteosarcoma AJCC v7 A solitary plasmacytoma that arises in the chest wall. C6711 Neoplastic Process Chest Wall Solitary Plasmacytoma C1332936 Malignant Chest_Wall_Solitary_Plasmacytoma Chest Wall Solitary Plasmacytoma Solitary Plasmacytoma of Chest Wall Solitary Plasmacytoma of the Chest Wall Chest Wall Solitary Plasmacytoma A lymphoma that affects the structures of the chest wall. The majority of cases are diffuse large B-cell lymphomas. C6712 Neoplastic Process Chest Wall Lymphoma C1332933 Malignant Chest_Wall_Lymphoma Chest Wall Lymphoma Lymphoma of Chest Wall Lymphoma of the Chest Wall Primary Chest Wall Lymphoma Chest Wall Lymphoma An extraabdominal fibromatosis arising from the soft tissue of the chest wall. It is characterized by the presence of elongated spindle-shaped fibroblasts, collagenous stroma formation, and an infiltrative growth pattern. C6713 Neoplastic Process Chest Wall Fibromatosis C1332930 Undetermined Chest_Wall_Fibromatosis Chest Wall Desmoid Neoplasm Chest Wall Desmoid Tumor Chest Wall Fibromatosis Desmoid Neoplasm of Chest Wall Desmoid Neoplasm of the Chest Wall Desmoid Tumor of Chest Wall Desmoid Tumor of the Chest Wall Chest Wall Fibromatosis An uncommon benign cartilaginous neoplasm arising from the sternum. It is characterized by the presence of spindle-shaped or stellate chondrocytes, a lobulated growth pattern, myxoid stroma formation, and sometimes multinucleated giant cells. C6714 Neoplastic Process Sternal Chondromyxoid Fibroma C1336501 Benign Sternal_Chondromyxoid_Fibroma Chondromyxoid Fibroma of Sternum Chondromyxoid Fibroma of the Sternum Sternal Chondromyxoid Fibroma Sternal Chondromyxoid Fibroma A rare, benign (olfactory neurocytoma) or malignant (olfactory neuroblastoma) neuroectodermal tumor originating from olfactory receptor cells in the nasal cavity. C67155 Neoplastic Process Olfactory Neurogenic Tumor C0334602 GDC 9520/3 Undetermined Olfactory_Neurogenic_Tumor 9520/3 Olfactory neurogenic tumor Olfactory Neurogenic Tumor Olfactory neurogenic tumor Olfactory Neurogenic Tumor A rare benign neuroectodermal tumor originating from olfactory receptor cells in the nasal cavity. Microscopically, it is characterized by the absence of malignant characteristics and the absence of rosettes formation. C67156 Neoplastic Process Olfactory Neurocytoma CL031140 GDC 9521/3 Benign Olfactory_Neurocytoma 9521/3 Olfactory neurocytoma Olfactory Neurocytoma Olfactory neurocytoma Olfactory Neurocytoma A rare lymphoma that arises from the bone or soft tissue of the sternum. C6716 Neoplastic Process Sternal Lymphoma C1336504 Malignant Sternal_Lymphoma Lymphoma of Sternum Lymphoma of the Sternum Primary Sternal Lymphoma Sternal Lymphoma Sternal Lymphoma A nodular sclerosis Hodgkin lymphoma characterized by the presence of lacunar cells, nodular growth, and the absence of fibrosis. C67171 Neoplastic Process Nodular Sclerosis Classic Hodgkin Lymphoma, Cellular Phase C0334627 GDC 9664/3 Malignant Hodgkin_s_Disease_Nodular_Sclerosis_Cellular_Phase 9664/3 Classical Hodgkin lymphoma, nodular sclerosis, cellular phase Hodgkin lymphoma, nodular sclerosis, cellular phase Classical Hodgkin lymphoma, nodular sclerosis, cellular phase Hodgkin lymphoma, nodular sclerosis, cellular phase Hodgkin's Disease Nodular Sclerosis, Cellular Phase Nodular Sclerosis Classic Hodgkin Lymphoma, Cellular Phase Nodular Sclerosis Classical Hodgkin Lymphoma, Cellular Phase Nodular Sclerosis Hodgkin Lymphoma, Cellular Phase Nodular Sclerosis Classic Hodgkin Lymphoma, Cellular Phase A rare schwannoma that arises from the sternum. C6718 Neoplastic Process Sternal Intraosseous Schwannoma C1336503 Benign Sternal_Intraosseous_Schwannoma Intraosseous Neurilemmoma of Sternum Intraosseous Neurilemmoma of the Sternum Intraosseous Schwannoma of Sternum Intraosseous Schwannoma of the Sternum Sternal Intraosseous Neurilemmoma Sternal Intraosseous Schwannoma Sternal Intraosseous Schwannoma A benign adipose tissue neoplasm of the chest wall. C6719 Neoplastic Process Chest Wall Lipoma C1332932 Benign Chest_Wall_Lipoma Chest Wall Lipoma Lipoma of Chest Wall Lipoma of the Chest Wall Chest Wall Lipoma A parachordoma arising from the chest wall. C6720 Neoplastic Process Chest Wall Parachordoma C1332934 Undetermined Chest_Wall_Parachordoma Chest Wall Parachordoma Parachordoma of Chest Wall Parachordoma of the Chest Wall Chest Wall Parachordoma An intermediate fibrohistiocytic neoplasm arising from the skin in the chest wall. It is a multinodular poorly circumscribed tumor, characterized by the presence of multinucleated giant cells, mononuclear histiocyte-like cells, and spindle fibroblast-like cells arranged in a plexiform pattern. C6721 Neoplastic Process Chest Wall Plexiform Fibrohistiocytic Tumor C1332935 Undetermined Chest_Wall_Plexiform_Fibrohistiocytic_Neoplasm Chest Wall Plexiform Fibrohistiocytic Neoplasm Chest Wall Plexiform Fibrohistiocytic Tumor Plexiform Fibrohistiocytic Neoplasm of Chest Wall Plexiform Fibrohistiocytic Neoplasm of the Chest Wall Plexiform Fibrohistiocytic Tumor of Chest Wall Plexiform Fibrohistiocytic Tumor of the Chest Wall Chest Wall Plexiform Fibrohistiocytic Tumor A small round cell tumor with neural differentiation arising from the kidney. C67214 Neoplastic Process Peripheral Primitive Neuroectodermal Tumor of the Kidney Peripheral Primitive Neuroectodermal Tumor of the Kidney C1134517 CTRP Malignant Peripheral_Primitive_Neuroectodermal_Tumor_of_the_Kidney Malignant Neuroepithelial Tumor of the Kidney Neuroepithelial Tumor of the Kidney Peripheral Primitive Neuroectodermal Tumor of the Kidney Peripheral Primitive Neuroectodermal Tumor of the Kidney A Hodgkin lymphoma that affects the structures of the chest wall. C6723 Neoplastic Process Chest Wall Hodgkin Lymphoma C1332931 Malignant Chest_Wall_Hodgkin_s_Lymphoma Chest Wall Hodgkin Lymphoma Chest Wall Hodgkin's Disease Chest Wall Hodgkin's Lymphoma Hodgkin's Disease of Chest Wall Hodgkin's Disease of the Chest Wall Hodgkin's Lymphoma of Chest Wall Hodgkin's Lymphoma of the Chest Wall Primary Chest Wall Hodgkin's Lymphoma Chest Wall Hodgkin Lymphoma An extremely rare, benign or malignant mesenchymal tumor arising from soft tissue or bone. It is a distinctive tumor, usually displaying the following morphologic characteristics: low cellularity, myxoid changes, presence of spindled cells and osteoclasts, hemangiopericytoma-like vessels, hemorrhage, and osteoid-like matrix. It is associated with the presence of a paraneoplastic syndrome called oncogenic osteomalacia. This syndrome usually precedes the appearance of the tumor, and it is characterized by phosphaturia, hypophosphatemia, normal serum calcium levels, and decreased levels of 1,25-dihydroxyvitamin D3. Patients present with bone and muscle pain, severe muscle weakness, fractures, gait disturbances, skeletal deformity, height loss, and slow growth. The metabolic disturbances improve or completely disappear after the complete resection of the tumor. C67237 Neoplastic Process Phosphaturic Mesenchymal Tumor Phosphaturic Mesenchymal Tumor C1831619 CTRP Undetermined Phosphaturic_Mesenchymal_Tumor PMT Phosphaturic Mesenchymal Tumor Phosphaturic Mesenchymal Tumor, Mixed Connective Tissue Type Phosphaturic Mesenchymal Tumor, Mixed Connective Tissue Variant Phosphaturic Mesenchymal Tumor An uncommon malignant neoplasm that arises from the chest wall bones. Representative examples include chondrosarcoma, osteosarcoma, and Ewing sarcoma/peripheral primitive neuroectodermal tumor. C6724 Neoplastic Process Malignant Chest Wall Bone Neoplasm C1334572 Malignant Malignant_Chest_Wall_Bone_Neoplasm Malignant neoplasm of ribs, sternum, and clavicle Malignant neoplasm: Ribs, sternum and clavicle Malignant Bone Neoplasm of Chest Wall Malignant Bone Neoplasm of the Chest Wall Malignant Bone Tumor of Chest Wall Malignant Bone Tumor of the Chest Wall Malignant Chest Wall Bone Neoplasm Malignant Chest Wall Bone Tumor Malignant Chest Wall Bone Neoplasm A benign or malignant neoplasm that affects the sternum. C6730 Neoplastic Process Sternal Neoplasm C1290244 Undetermined Sternal_Neoplasm Neoplasm of Sternum Neoplasm of the Sternum Sternal Neoplasm Sternal Tumor Tumor of Sternum Tumor of the Sternum Sternal Neoplasm Stage IIA includes: T2, N0, M0, G3. T2: Tumor invades muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. (AJCC 7th ed.) C6731 Neoplastic Process Stage IIA Esophageal Adenocarcinoma AJCC v7 Stage IIA Esophageal Adenocarcinoma AJCC v7 C1336158 CTRP Malignant Stage_IIA_Esophageal_Adenocarcinoma Stage IIA Adenocarcinoma of Esophagus Stage IIA Adenocarcinoma of the Esophagus Stage IIA Esophageal Adenocarcinoma Stage IIA Esophageal Adenocarcinoma AJCC v7 Stage IIA Esophagus Adenocarcinoma Stage IIA Esophageal Adenocarcinoma AJCC v7 Stage IIB includes: (T3, N0, M0, Any G); (T1-2, N1, M0, Any G). T3: Tumor invades adventitia. T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades muscularis propria. N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C6732 Neoplastic Process Stage IIB Esophageal Adenocarcinoma AJCC v7 Stage IIB Esophageal Adenocarcinoma AJCC v7 C1336180 CTRP Malignant Stage_IIB_Esophageal_Adenocarcinoma Stage IIB Adenocarcinoma of Esophagus Stage IIB Adenocarcinoma of the Esophagus Stage IIB Esophageal Adenocarcinoma Stage IIB Esophageal Adenocarcinoma AJCC v7 Stage IIB Esophagus Adenocarcinoma Stage IIB Esophageal Adenocarcinoma AJCC v7 A neuroendocrine tumor that arises from the delta cells of the pancreas. It is characterized by inappropriate secretion of somatostatin and associated with diabetes mellitus, hypochlorhydria, gallbladder disease, diarrhea, steatorrhea, anemia, and weight loss. It displays vascular invasion and metastasizes to other anatomic sites. C67369 Neoplastic Process Malignant Pancreatic Somatostatinoma Malignant Pancreatic Somatostatinoma C0279727 CTRP Malignant Pancreatic_Malignant_Somatostatinoma Malignant Pancreatic Somatostatinoma Pancreatic Delta Cell Carcinoma Pancreatic Malignant Somatostatinoma Malignant Pancreatic Somatostatinoma Stage IIB includes: (T2-3, N0, M0, G2-3, Tumor location: Upper, middle); (T1-2, N1, M0, Any G, Tumor location: Any). T2: Tumor invades muscularis propria. T3: Tumor invades adventitia. T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. M0: No distant metastasis. G2: Moderately differentiated. G3: Poorly differentiated. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. (AJCC 7th ed.) C6737 Neoplastic Process Stage IIB Esophageal Squamous Cell Carcinoma AJCC v7 Stage IIB Esophageal Squamous Cell Carcinoma AJCC v7 C1336182 CTRP Malignant Stage_IIB_Esophageal_Squamous_Cell_Carcinoma Stage IIB Esophageal Squamous Cell Cancer Stage IIB Esophageal Squamous Cell Carcinoma Stage IIB Esophageal Squamous Cell Carcinoma AJCC v7 Stage IIB Esophagus Squamous Cell Carcinoma Stage IIB Squamous Cell Carcinoma of Esophagus Stage IIB Squamous Cell Carcinoma of the Esophagus Stage IIB Esophageal Squamous Cell Carcinoma AJCC v7 Stage IIA includes: (T2-3, N0, M0, G1, GX, Tumor location: Upper, middle); (T2-3, N0, M0, G2-3, Tumor location: Lower, X). T2: Tumor invades muscularis propria. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated. GX: Grade cannot be assessed-stage grouping as G1. G2: Moderately differentiated. G3: Poorly differentiated. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. (AJCC 7th ed.) C6738 Neoplastic Process Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7 Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7 C1336160 CTRP Malignant Stage_IIA_Esophageal_Squamous_Cell_Carcinoma Stage IIA Esophageal Squamous Cell Cancer Stage IIA Esophageal Squamous Cell Carcinoma Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7 Stage IIA Esophagus Squamous Cell Carcinoma Stage IIA Squamous Cell Carcinoma of Esophagus Stage IIA Squamous Cell Carcinoma of the Esophagus Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7 A well circumscribed benign tumor arising from cardiac muscle. It usually affects children and may be present in the fetus. Depending on tumor location and size, cardiac, respiratory, and hemodynamic parameters may be affected. There is an association between cardiac rhabdomyoma and tuberous sclerosis. C6739 Neoplastic Process Cardiac Rhabdomyoma C1332852 Benign Cardiac_Rhabdomyoma Cardiac Rhabdomyoma Heart Rhabdomyoma Rhabdomyoma of Heart Rhabdomyoma of the Heart Cardiac Rhabdomyoma A rare benign adipose tissue neoplasm of the heart usually originating in the epicardial or pericardial fatty tissue. C6741 Neoplastic Process Cardiac Lipoma C1332849 Benign Cardiac_Lipoma Cardiac Lipoma Heart Lipoma Lipoma of Heart Lipoma of the Heart Cardiac Lipoma A rare benign adipose tissue neoplasm of the epicardium of the heart. C6742 Neoplastic Process Epicardial Lipoma C1333411 Benign Epicardial_Lipoma Epicardial Lipoma Lipoma of Epicardium Lipoma of the Epicardium Epicardial Lipoma A benign smooth muscle neoplasm arising from the pericardium. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C6743 Neoplastic Process Pericardial Leiomyoma C1335380 Benign Pericardial_Leiomyoma Leiomyoma of Pericardium Leiomyoma of the Pericardium Pericardial Leiomyoma Pericardial Leiomyoma A mature teratoma that arises from the pericardium. C6744 Neoplastic Process Pericardial Mature Teratoma C1334638 Benign Mature_Pericardial_Teratoma Mature Pericardial Teratoma Mature Teratoma of Pericardium Mature Teratoma of the Pericardium Pericardial Mature Teratoma Pericardial Mature Teratoma An aggressive malignant smooth muscle neoplasm, arising from the superior vena cava. It is characterized by a proliferation of neoplastic spindle cells. C6745 Neoplastic Process Superior Vena Cava Leiomyosarcoma C1336531 Malignant Superior_Vena_Cava_Leiomyosarcoma Leiomyosarcoma of Superior Vena Cava Leiomyosarcoma of the Superior Vena Cava Superior Vena Cava Leiomyosarcoma Superior Vena Cava Leiomyosarcoma A gastrin-producing neuroendocrine tumor arising from the pancreas. It is characterized by inappropriate secretion of gastrin and associated with Zollinger Ellison syndrome. It displays vascular invasion and metastasizes to other anatomic sites. C67458 Neoplastic Process Malignant Pancreatic Gastrinoma Malignant Pancreatic Gastrinoma C0279723 CTRP Malignant Malignant_Pancreatic_Gastrinoma Malignant Pancreatic Gastrinoma Pancreatic G-Cell Carcinoma Malignant Pancreatic Gastrinoma A malignant vascular neoplasm arising from the pulmonary artery. C6746 Neoplastic Process Pulmonary Artery Angiosarcoma C1335570 Malignant Pulmonary_Artery_Angiosarcoma Pulmonary Artery Angiosarcoma Pulmonary Artery Hemangiosarcoma Pulmonary Artery Angiosarcoma A pancreatic neuroendocrine tumor producing vasoactive intestinal peptide (VIP). It is associated with watery diarrhea, hypokalemia, and hypochlorhydria or achlorhydria. It displays vascular invasion and metastasizes to other anatomic sites. One third of cases are metastatic at the time of diagnosis. C67461 Neoplastic Process Malignant Pancreatic Vipoma C1881586 Malignant Malignant_Pancreatic_Vipoma Malignant Pancreatic Vipoma Malignant Pancreatic Vipoma A glomus tumor of small size characterized by the absence of nuclear atypia and mitotic activity. C6748 Neoplastic Process Benign Glomus Tumor C1332506 Benign Benign_Glomus_Tumor Benign Glomus Neoplasm Benign Glomus Tumor Benign Glomus Tumor Kaposi sarcoma arising from the palate. C6749 Neoplastic Process Palate Kaposi Sarcoma C0153562 CPTAC mCode Malignant Palate_Kaposi_s_Sarcoma Kaposi's sarcoma, palate Kaposi's Sarcoma of Palate Kaposi's Sarcoma of the Palate Kaposi's sarcoma of palate Palate Kaposi Sarcoma Palate Kaposi's Sarcoma Palate Kaposi Sarcoma Biliary intraepithelial neoplasia characterized by the presence of low grade epithelial atypia. C67491 Neoplastic Process Biliary Intraepithelial Neoplasia-1 C2348873 8148/0 Undetermined Grade_1_Biliary_Intraepithelial_Neoplasia BilIN-1 Biliary Intraepithelial Neoplasia-1 Grade 1 Biliary Intraepithelial Neoplasia Biliary Intraepithelial Neoplasia-1 Biliary intraepithelial neoplasia characterized by the presence of moderate epithelial atypia. C67492 Neoplastic Process Biliary Intraepithelial Neoplasia-2 C2348874 Undetermined Grade_2_Biliary_Intraepithelial_Neoplasia BilIN-2 Biliary Intraepithelial Neoplasia-2 Grade 2 Biliary Intraepithelial Neoplasia Biliary Intraepithelial Neoplasia-2 Biliary intraepithelial neoplasia characterized by the presence of high grade epithelial dysplasia. C67493 Neoplastic Process High-Grade Biliary Intraepithelial Neoplasia C2348875 GDC 8148/2 Malignant Grade_3_Biliary_Intraepithelial_Neoplasia 8148/2 Biliary intraepithelial neoplasia, grade 3 Biliary intraepithelial neoplasia, high grade BilIN-3 Biliary Intraepithelial Neoplasia-3 Biliary intraepithelial neoplasia, grade 3 Biliary intraepithelial neoplasia, high grade Grade 3 Biliary Intraepithelial Neoplasia High Grade BilIN High Grade Biliary Intraepithelial Neoplasia High-Grade BilIN High-Grade Biliary Intraepithelial Neoplasia High-Grade Biliary Intraepithelial Neoplasia A glomus tumor arising from the skin. It is characterized by the presence of dilated veins surrounded by glomus cells. C6750 Neoplastic Process Skin Glomangioma C1275226 Benign Cutaneous_Glomangioma Cutaneous Glomangioma Glomangioma of Skin Glomangioma of the Skin Skin Glomangioma Skin Glomangioma C6752 Neoplastic Process Pineal Region Yolk Sac Tumor C1335420 Malignant Pineal_Region_Yolk_Sac_Tumor Endodermal Sinus Tumor of Pineal Region Endodermal Sinus Tumor of the Pineal Region Pineal Endodermal Sinus Neoplasm Pineal Endodermal Sinus Tumor Pineal Region Endodermal Sinus Neoplasm Pineal Region Endodermal Sinus Tumor Pineal Region Yolk Sac Neoplasm Pineal Region Yolk Sac Tumor Yolk Sac Tumor of Pineal Region Yolk Sac Tumor of the Pineal Region Pineal Region Yolk Sac Tumor An adenocarcinoma that arises from the gastric mucosa and is characterized by the presence of both glandular and poorly cohesive malignant cellular components. C67526 Neoplastic Process Gastric Mixed Adenocarcinoma Gastric Mixed Adenocarcinoma C0279638 CPTAC CTRP Malignant Gastric_Mixed_Adenocarcinoma Gastric Mixed Adenocarcinoma Mixed Gastric Mixed Adenocarcinoma A mature or immature teratoma that arises in the pineal region. C6753 Neoplastic Process Pineal Region Teratoma C1335419 Undetermined Pineal_Region_Teratoma Pineal Area Teratoma Pineal Region Teratoma Teratoma of Pineal Area Teratoma of Pineal Region Teratoma of the Pineal Area Teratoma of the Pineal Region Pineal Region Teratoma A mature teratoma that arises from the pineal region. C6754 Neoplastic Process Pineal Region Mature Teratoma C1335417 Benign Pineal_Region_Mature_Teratoma Mature Teratoma of Pineal Area Mature Teratoma of Pineal Region Mature Teratoma of the Pineal Area Mature Teratoma of the Pineal Region Pineal Area Mature Teratoma Pineal Region Mature Teratoma Pineal Region Mature Teratoma A malignant germ cell tumor arising from the testis. It is characterized by a mixture of choriocarcinoma and yolk sac tumor morphologic elements. Patients may present with painless or painful testicular swelling. C67548 Neoplastic Process Testicular Mixed Choriocarcinoma and Yolk Sac Tumor Testicular Mixed Choriocarcinoma and Yolk Sac Tumor C0279716 CTRP Malignant Testicular_Mixed_Choriocarcinoma_and_Yolk_Sac_Tumor Testicular Mixed Choriocarcinoma and Yolk Sac Tumor Testicular Mixed Choriocarcinoma and Yolk Sac Tumor C6755 Neoplastic Process Pineal Region Immature Teratoma C1335416 Undetermined Pineal_Region_Immature_Teratoma Atypical Pineal Teratoma Immature Teratoma of Pineal Area Immature Teratoma of Pineal Region Immature Teratoma of the Pineal Area Immature Teratoma of the Pineal Region Pineal Area Immature Teratoma Pineal Region Immature Teratoma Pineal Region Immature Teratoma Stage I includes: T1, N0, M0. T1: Maxillary sinus: Tumor limited to the maxillary sinus mucosa with no erosion or destruction of bone. Nasal cavity and ethmoid sinus: Tumor restricted to any one subsite, with or without bony invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C67554 Neoplastic Process Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7 Stage I Sinonasal Cancer AJCC v6 and v7 CL033791 CTRP Malignant Stage_I_Nasal_Cavity_and_Paranasal_Sinus_Cancer Stage I Nasal Cavity and Paranasal Sinus Cancer Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v6 Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7 Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v7 Stage I Sinonasal Cancer AJCC v6 and v7 Stage I Sinonasal Carcinoma AJCC v6 and v7 Stage I Sinonasal Cancer AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: Maxillary sinus: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates. Nasal cavity and ethmoid sinus: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th ed.) C67555 Neoplastic Process Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7 Stage II Sinonasal Cancer AJCC v6 and v7 CL033792 CTRP Malignant Stage_II_Nasal_Cavity_and_Paranasal_Sinus_Cancer Stage II Nasal Cavity and Paranasal Sinus Cancer Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v6 Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7 Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v7 Stage II Sinonasal Cancer AJCC v6 and v7 Stage II Sinonasal Carcinoma AJCC v6 and v7 Stage II Sinonasal Cancer AJCC v6 and v7 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Maxillary sinus: Tumor invading any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, or ethmoid sinuses. Nasal cavity and ethmoid sinus: Tumor invading the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate. T1: Maxillary sinus: Tumor limited to the maxillary sinus mucosa with no erosion or destruction of bone. Nasal cavity and ethmoid sinus: Tumor restricted to any one subsite, with or without bony invasion. T2: Maxillary sinus: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates. Nasal cavity and ethmoid sinus: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 6th and 7th eds.) C67556 Neoplastic Process Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7 Stage III Sinonasal Cancer AJCC v6 and v7 CL033793 CTRP Malignant Stage_III_Nasal_Cavity_and_Paranasal_Sinus_Cancer Stage III Nasal Cavity and Paranasal Sinus Cancer Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v6 Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7 Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v7 Stage III Sinonasal Cancer AJCC v6 and v7 Stage III Sinonasal Carcinoma AJCC v6 and v7 Stage III Sinonasal Cancer AJCC v6 and v7 Stage IV maxillary sinus cancer: Stage IV is divided into stages IVA, IVB, and IVC. Stage IVA: cancer has spread to either one lymph node on the same side of the neck as the cancer and the lymph node is larger than 3 centimeters but smaller than 6 centimeters; or, cancer has spread to more than one lymph node anywhere in the neck, and all are 6 centimeters or smaller; cancer is also found in any of the following areas: the maxillary sinus, bones around the maxillary sinus, tissues under the skin, the eye socket, the base of the skull, and the ethmoid sinuses or cancer is found in one or more lymph nodes in the neck, none larger than 6 centimeters, and in any of the following areas: the front of the eye, the skin of the cheek, the base of the skull, behind the jaw, the bone between the eyes, and the sphenoid or frontal sinuses. Stage IVB: cancer has spread to either: one or more lymph nodes larger than 6 centimeters; or the back of the eye, the brain, the base and middle parts of the skull, nerves in the head, and/or the upper part of the throat behind the nose; cancer may also be found in one or more lymph nodes. Stage IVC: cancer has spread to other parts of the body. Stage IV nasal cavity and ethmoid sinus cancer: Stage IV is divided into stages IVA, IVB, and IVC. Stage IVA: cancer has spread to either one lymph node on the same side of the neck as the cancer and the lymph node is larger than 3 centimeters but smaller than 6 centimeters; or, cancer has spread to more than one lymph node anywhere in the neck, and all are 6 centimeters or smaller; cancer is also found in any of the following places: the nasal cavity or ethmoid sinus., the eye socket, the maxillary sinus, the roof of the mouth, and the bone between the eyes or cancer is found in one or more lymph nodes in the neck, and the lymph nodes are 6 centimeters or smaller; cancer is also found in any of the following areas: the front of the eye, the skin of the nose or cheek, front parts of the skull, the base of the skull, and the sphenoid or frontal sinuses. Stage IVB: cancer is found in any of the following areas: the back of the eye, the brain, the middle parts of the skull, nerves in the head the upper part of the throat behind the nose and the base of the skull. Cancer may also be found in one or more lymph nodes or cancer is found in a lymph node that is larger than 6 centimeters. Stage IVC: cancer has spread to other parts of the body (from PDQ). C67557 Neoplastic Process Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v6 Stage IV Sinonasal Cancer AJCC v6 C2987466 CTRP Malignant Stage_IV_Nasal_Cavity_and_Paranasal_Sinus_Cancer Stage IV Nasal Cavity and Paranasal Sinus Cancer Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v6 Stage IV Sinonasal Cancer AJCC v6 Stage IV Sinonasal Carcinoma AJCC v6 Stage IV Sinonasal Cancer AJCC v6 The reemergence of nasal cavity or paranasal sinus carcinoma after a period of remission. C67558 Neoplastic Process Recurrent Nasal Cavity and Paranasal Sinus Carcinoma Recurrent Sinonasal Carcinoma CL033795 CTRP Malignant Recurrent_Nasal_Cavity_and_Paranasal_Sinus_Cancer Recurrent Nasal Cavity and Paranasal Sinus Cancer Recurrent Nasal Cavity and Paranasal Sinus Carcinoma Recurrent Sinonasal Carcinoma Recurrent Sinonasal Carcinoma A central nervous system neoplasm arising from the fourth ventricle. It is characterized by the presence of neurocytes forming pseudorosettes and astrocytes which contain Rosenthal fibers. Cytologic atypia is minimal. C67559 Neoplastic Process Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle C2347979 0000/0 9509/1 Undetermined Rosette-Forming_Glioneuronal_Tumor_of_the_Fourth_Ventricle Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle A meningioma that affects the pineal gland. C6756 Neoplastic Process Pineal Region Meningioma C1335418 Undetermined Pineal_Region_Meningioma Meningioma of Pineal Area Meningioma of Pineal Gland Meningioma of Pineal Region Meningioma of the Pineal Area Meningioma of the Pineal Gland Meningioma of the Pineal Region Pineal Area Meningioma Pineal Gland Meningioma Pineal Meningioma Pineal Region Meningioma Pineal Region Meningioma A rare, low-grade malignant epithelial tumor arising from the endolymphatic sac in the temporal bone. Morphologically, it is characterized by the presence of papillary and cystic structures. As tumors grow, they may destroy petrous temporal bone and extend into the middle ear and the middle and posterior cranial fossae and into the cerebellopontine angle. (WHO 2017) C67560 Neoplastic Process Endolymphatic Sac Tumor Endolymphatic Sac Tumor C2348239 CTRP 8260/1 Malignant Aggressive_Papillary_Tumor_of_the_Temporal_Bone ELST Endolymphatic Sac Tumor Heffner Tumor Low Grade Papillary Adenocarcinoma of Endolymphatic Sac Origin Low-Grade Papillary Adenocarcinoma of Endolymphatic Sac Origin Endolymphatic Sac Tumor A gonadal sex cord-stromal tumor with malignant characteristics. It includes the poorly differentiated ovarian Sertoli-Leydig cell tumor, malignant ovarian granulosa cell tumor, malignant ovarian steroid cell tumor, and malignant ovarian thecoma. C67561 Neoplastic Process Malignant Sex Cord-Stromal Tumor C1848186 CDISC A malignant neoplasm originating from the gonadal sex cord stroma. 8590/3 Malignant Malignant_Sex_Cord-Stromal_Tumor Malignant Sex Cord-Stromal Tumor STROMAL TUMOR, GONADAL, MALIGNANT Sex Cord Stromal Tumor, Malignant Malignant Sex Cord-Stromal Tumor A leiomyoma characterized by the presence of abundant myxoid matrix. C67563 Neoplastic Process Myxoid Leiomyoma C2347314 8896/0 Benign Myxoid_Leiomyoma Myxoid leiomyoma Myxoid Leiomyoma Myxoid Leiomyoma A mesenchymal, non-meningothelial neoplasm that arises from the central nervous system and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C6757 Neoplastic Process Benign Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm C1332481 Benign Benign_Central_Nervous_System_Soft_Tissue_Neoplasm Benign CNS Soft Tissue Neoplasm Benign CNS Soft Tissue Tumor Benign Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm Benign Central Nervous System Mesenchymal, Non-Meningothelial Tumor Benign Central Nervous System Soft Tissue Neoplasm Benign Central Nervous System Soft Tissue Tumor Benign Soft Tissue Neoplasm of CNS Benign Soft Tissue Neoplasm of Central Nervous System Benign Soft Tissue Neoplasm of the CNS Benign Soft Tissue Neoplasm of the Central Nervous System Benign Soft Tissue Tumor of CNS Benign Soft Tissue Tumor of Central Nervous System Benign Soft Tissue Tumor of the CNS Benign Soft Tissue Tumor of the Central Nervous System Benign Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm A metastasizing mesenchymal, non-meningothelial neoplasm that arises from the central nervous system. C6758 Neoplastic Process Malignant Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm C1334571 CPTAC Malignant Malignant_Central_Nervous_System_Soft_Tissue_Neoplasm Malignant CNS Soft Tissue Neoplasm Malignant CNS Soft Tissue Tumor Malignant Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm Malignant Central Nervous System Mesenchymal, Non-Meningothelial Tumor Malignant Central Nervous System Soft Tissue Neoplasm Malignant Central Nervous System Soft Tissue Tumor Malignant Soft Tissue Neoplasm of CNS Malignant Soft Tissue Neoplasm of Central Nervous System Malignant Soft Tissue Neoplasm of the CNS Malignant Soft Tissue Neoplasm of the Central Nervous System Malignant Soft Tissue Tumor of CNS Malignant Soft Tissue Tumor of Central Nervous System Malignant Soft Tissue Tumor of the CNS Malignant Soft Tissue Tumor of the Central Nervous System Soft Tissue Cancer of Central Nervous System Soft Tissue Cancer of the Central Nervous System Malignant Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm C6759 Neoplastic Process Pineal Region Choriocarcinoma C1335414 Malignant Pineal_Region_Choriocarcinoma Choriocarcinoma of Pineal Area Choriocarcinoma of Pineal Region Choriocarcinoma of the Pineal Area Choriocarcinoma of the Pineal Region Pineal Area Choriocarcinoma Pineal Choriocarcinoma Pineal Region Choriocarcinoma Pineal Region Choriocarcinoma A poorly differentiated neuroendocrine carcinoma that arises from the breast. It is characterized by the presence of small neuroendocrine cells and high mitotic activity. C6760 Neoplastic Process Breast Small Cell Neuroendocrine Carcinoma C1332638 Malignant Breast_Small_Cell_Carcinoma Breast Small Cell Carcinoma Breast Small Cell Neuroendocrine Carcinoma Oat Cell Carcinoma of Breast Oat Cell Carcinoma of the Breast Small Cell Carcinoma of Breast Small Cell Carcinoma of the Breast Small Cell Neuroendocrine Carcinoma of Breast Small Cell Neuroendocrine Carcinoma of the Breast Breast Small Cell Neuroendocrine Carcinoma An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the colon. It is characterized by the presence of malignant small cells. C6761 Neoplastic Process Colon Small Cell Neuroendocrine Carcinoma Colon Small Cell Neuroendocrine Carcinoma C1333099 CTRP Cellosaurus Malignant Colon_Small_Cell_Carcinoma Colon Oat Cell Carcinoma Colon Small Cell Carcinoma Colon Small Cell Neuroendocrine Cancer Colon Small Cell Neuroendocrine Carcinoma Colonic Oat Cell Carcinoma Colonic Small Cell Carcinoma Oat Cell Carcinoma of Colon Oat Cell Carcinoma of the Colon Oat Cell Colon Carcinoma Small Cell Carcinoma of Colon Small Cell Carcinoma of the Colon Small Cell Colon Carcinoma Colon Small Cell Neuroendocrine Carcinoma An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the esophagus. It is characterized by the presence of malignant small cells. C6762 Neoplastic Process Esophageal Small Cell Neuroendocrine Carcinoma C1112474 Cellosaurus Malignant Esophageal_Small_Cell_Carcinoma Esophageal Oat Cell Carcinoma Esophageal Small Cell Carcinoma Esophageal Small Cell NEC Esophageal Small Cell Neuroendocrine Carcinoma Esophagus Oat Cell Carcinoma Esophagus Small Cell Carcinoma Oat Cell Carcinoma of Esophagus Oat Cell Carcinoma of the Esophagus Small Cell Carcinoma of Esophagus Small Cell Carcinoma of the Esophagus Small Cell Carcinoma, Esophagus Esophageal Small Cell Neuroendocrine Carcinoma An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the gallbladder. It is characterized by the presence of malignant small cells. C6763 Neoplastic Process Gallbladder Small Cell Neuroendocrine Carcinoma C1333759 Malignant Gallbladder_Small_Cell_Carcinoma Gallbladder Oat Cell Carcinoma Gallbladder Small Cell Carcinoma Gallbladder Small Cell NEC Gallbladder Small Cell Neuroendocrine Carcinoma Oat Cell Carcinoma of Gallbladder Oat Cell Carcinoma of the Gallbladder Small Cell Carcinoma of Gallbladder Small Cell Carcinoma of the Gallbladder Gallbladder Small Cell Neuroendocrine Carcinoma An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the stomach. It is characterized by the presence of malignant small cells. C6764 Neoplastic Process Gastric Small Cell Neuroendocrine Carcinoma C1333788 Cellosaurus Malignant Gastric_Small_Cell_Carcinoma Gastric Oat Cell Carcinoma Gastric Small Cell Carcinoma Gastric Small Cell Neuroendocrine Carcinoma Oat Cell Carcinoma of Stomach Oat Cell Carcinoma of the Stomach Small Cell Carcinoma of Stomach Small Cell Carcinoma of the Stomach Gastric Small Cell Neuroendocrine Carcinoma A rare small cell neuroendocrine carcinoma that arises from the prostate gland. C6766 Neoplastic Process Prostate Small Cell Neuroendocrine Carcinoma C1300585 Cellosaurus OORO Malignant Prostate_Small_Cell_Carcinoma Oat Cell Carcinoma of Prostate Oat Cell Carcinoma of the Prostate Prostate Oat Cell Carcinoma Prostate Small Cell Carcinoma Prostate Small Cell NEC Prostate Small Cell Neuroendocrine Carcinoma Small Cell Carcinoma of Prostate Small Cell Carcinoma of the Prostate Prostate Small Cell Neuroendocrine Carcinoma A malignant germ cell tumor that arises in the pineal region. Representative examples include germinoma, immature teratoma, choriocarcinoma, embryonal carcinoma and yolk sac tumor. C6767 Neoplastic Process Malignant Pineal Region Germ Cell Tumor C1334612 Malignant Malignant_Pineal_Region_Germ_Cell_Neoplasm Malignant Germ Cell Neoplasm of Pineal Gland Malignant Germ Cell Neoplasm of Pineal Parenchyma Malignant Germ Cell Neoplasm of the Pineal Gland Malignant Germ Cell Neoplasm of the Pineal Parenchyma Malignant Germ Cell Tumor of Pineal Gland Malignant Germ Cell Tumor of Pineal Parenchyma Malignant Germ Cell Tumor of the Pineal Gland Malignant Germ Cell Tumor of the Pineal Parenchyma Malignant Pineal Area Germ Cell Neoplasm Malignant Pineal Area Germ Cell Tumor Malignant Pineal Gland Germ Cell Neoplasm Malignant Pineal Gland Germ Cell Tumor Malignant Pineal Parenchymal Germ Cell Neoplasm Malignant Pineal Parenchymal Germ Cell Tumor Malignant Pineal Region Germ Cell Neoplasm Malignant Pineal Region Germ Cell Tumor Pineal Germ Cell Neoplasm, Malignant Malignant Pineal Region Germ Cell Tumor An astrocytoma occurring in the optic nerve. C6769 Neoplastic Process Optic Nerve Astrocytoma C1335114 Undetermined Optic_Nerve_Astrocytoma Astrocytoma of Optic Nerve Astrocytoma of the Optic Nerve Optic Nerve Astrocytoma Optic Nerve Astrocytoma A group of neoplasms which arise from the ependymal lining of the cerebral ventricles and from the remnants of the central canal of the spinal cord. Ependymal tumors occur predominantly in children and young adults with varied morphological features and biological behavior. There are 4 types: ependymoma, anaplastic ependymoma, myxopapillary ependymoma and subependymoma. (WHO) C6770 Neoplastic Process Ependymal Tumor C1333407 A type of brain tumor that usually begins in the central canal of the spinal cord. Ependymal tumors may also develop in the cells lining the ventricles of the brain, which produce and store the special fluid (cerebrospinal fluid) that protects the brain and spinal cord. Undetermined Ependymal_Tumor Ependymal Neoplasm Ependymal Tumor ependymal tumor Ependymal Tumor A meningioma that affects the olfactory sulcus. C6771 Neoplastic Process Olfactory Groove Meningioma C1335107 Undetermined Olfactory_Groove_Meningioma Meningioma of Olfactory Groove Meningioma of the Olfactory Groove Olfactory Groove Meningioma Olfactory Groove Meningioma An embryonal tumor with multilayered rosettes, C19MC-altered that arises from the supratentorial brain and occurs in children. C6772 Neoplastic Process Childhood Supratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered CL448348 Malignant Childhood_Supratentorial_Ependymoblastoma Childhood Supratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered Childhood Supratentorial Ependymoblastoma Pediatric Supratentorial Ependymoblastoma Childhood Supratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered An embryonal tumor with multilayered rosettes, C19MC-altered that arises from the infratentorial region and occurs in children. C6773 Neoplastic Process Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered C1332972 Malignant Childhood_Infratentorial_Ependymoblastoma Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered Childhood Infratentorial Ependymoblastoma Pediatric Infratentorial Ependymoblastoma Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered The reemergence of childhood medulloblastoma after a period of remission. C6774 Neoplastic Process Recurrent Childhood Medulloblastoma Recurrent Childhood Medulloblastoma C0338342 CTRP Malignant Recurrent_Childhood_Medulloblastoma Recurrent Childhood Medulloblastoma Recurrent Medulloblastoma Recurrent Pediatric Medulloblastoma Relapsed Childhood Medulloblastoma Relapsed Pediatric Medulloblastoma Recurrent Childhood Medulloblastoma A meningioma that affects the posterior cranial fossa. C6775 Neoplastic Process Posterior Fossa Meningioma C1335448 Undetermined Posterior_Cranial_Fossa_Meningioma Meningioma of Posterior Cranial Fossa Meningioma of the Posterior Cranial Fossa Posterior Cranial Fossa Meningioma Posterior Fossa Meningioma Posterior Fossa Meningioma A meningioma that arises from the suprasellar region. C6776 Neoplastic Process Suprasellar Meningioma C1336535 Undetermined Suprasellar_Meningioma Suprasellar Meningioma Suprasellar Meningioma A meningioma that affects the periocular region. C6777 Neoplastic Process Periocular Meningioma C1335383 Undetermined Periocular_Meningioma Periocular Meningioma Periocular Meningioma A meningioma that affects the intraorbital structures. C6778 Neoplastic Process Intraorbital Meningioma C1334261 Undetermined Intraorbital_Meningioma Intraorbital Meningioma Intraorbital Meningioma A meningioma that affects the trigeminal ganglion. C6779 Neoplastic Process Gasserian Meningioma C1333760 Undetermined Gasserian_Meningioma Gasserian Ganglion Meningioma Gasserian Meningioma Meningioma of Gasserian Ganglion Meningioma of the Gasserian Ganglion Gasserian Meningioma A benign or malignant mesenchymal neoplasm composed of stromal cells. Representative examples include gastrointestinal stromal tumor, endometrial stromal sarcoma, and prostate stromal sarcoma. C6781 Neoplastic Process Stromal Neoplasm C0879615 GDC A tumor that arises in the supporting connective tissue of an organ. 8935/1 Undetermined Stromal_Neoplasm 8935/1 Stromal tumor, NOS Stromal Neoplasm Stromal Tumor stromal tumor Stromal Neoplasm A primary or metastatic malignant neoplasm that affects the eyelid. C6786 Neoplastic Process Malignant Eyelid Neoplasm Malignant Eyelid Neoplasm CL448349 CPTAC CTRP Malignant Malignant_Eyelid_Neoplasm Other and unspecified malignant neoplasm of skin of eyelid, including canthus Unspecified malignant neoplasm of eyelid, including canthus Malignant Eyelid Neoplasm Malignant Eyelid Tumor Malignant Neoplasm of Eyelid Malignant Neoplasm of the Eyelid Malignant Tumor of Eyelid Malignant Tumor of the Eyelid Malignant Eyelid Neoplasm A carcinoma that arises from the parotid gland. Representative examples include mucoepidermoid carcinoma, adenoid cystic carcinoma, adenocarcinoma, and carcinoma ex pleomorphic adenoma. C6791 Neoplastic Process Parotid Gland Carcinoma Parotid Gland Carcinoma C0345602 CTRP Malignant Parotid_Gland_Carcinoma Carcinoma of Parotid Carcinoma of Parotid Gland Carcinoma of the Parotid Carcinoma of the Parotid Gland Parotid Carcinoma Parotid Gland Cancer Parotid Gland Carcinoma Parotid Gland Carcinoma A benign or malignant neoplasm that affects the sphenoid sinus. Representative examples of benign neoplasms include Schneiderian papilloma and salivary gland-type adenoma. Representative examples of malignant neoplasms include carcinoma and lymphoma. C6792 Neoplastic Process Sphenoid Sinus Neoplasm C0345676 Undetermined Sphenoid_Sinus_Neoplasm Neoplasm of Sphenoid Sinus Neoplasm of Sphenoidal Sinus Neoplasm of the Sphenoid Sinus Neoplasm of the Sphenoidal Sinus Sphenoid Sinus Neoplasm Sphenoid Sinus Tumor Sphenoidal Sinus Neoplasm Sphenoidal Sinus Tumor Tumor of Sphenoid Sinus Tumor of Sphenoidal Sinus Tumor of the Sphenoid Sinus Tumor of the Sphenoidal Sinus Sphenoid Sinus Neoplasm A benign or malignant neoplasm that affects the supraglottic area of the larynx. C6793 Neoplastic Process Supraglottis Neoplasm C0345726 Undetermined Supraglottis_Neoplasm Neoplasm of Supraglottis Neoplasm of the Supraglottis Supraglottic Neoplasm Supraglottic Tumor Supraglottis Neoplasm Supraglottis Tumor Tumor of Supraglottis Tumor of the Supraglottis Supraglottis Neoplasm A carcinoma that arises from the gastric cardia. C6794 Neoplastic Process Gastric Cardia Carcinoma Gastric Cardia Carcinoma C0345794 CTRP Malignant Gastric_Cardia_Carcinoma Cancer of Gastric Cardia Cancer of the Gastric Cardia Carcinoma of Cardia of Stomach Carcinoma of Gastric Cardia Carcinoma of the Cardia of the Stomach Carcinoma of the Gastric Cardia Gastric Cardia (Stomach) Cancer Gastric Cardia Cancer Gastric Cardia Carcinoma Gastric Cardia Carcinoma A carcinoma that arises from the pylorus. C6795 Neoplastic Process Gastric Pylorus Carcinoma Gastric Pylorus Carcinoma C0345814 CTRP Malignant Gastric_Pylorus_Carcinoma Cancer of Gastric Pylorus Cancer of Pylorus of Stomach Cancer of the Gastric Pylorus Cancer of the Pylorus of the Stomach Carcinoma of Gastric Pylorus Carcinoma of Pylorus of Stomach Carcinoma of the Gastric Pylorus Carcinoma of the Pylorus of the Stomach Gastric Pylorus (Stomach) Cancer Gastric Pylorus Cancer Gastric Pylorus Carcinoma Gastric Pylorus Carcinoma A benign or malignant neoplasm that arises from the eccrine glands. C6796 Neoplastic Process Eccrine Neoplasm C1333371 Undetermined Eccrine_Neoplasm Eccrine Neoplasm Eccrine Neoplasm of Skin Eccrine Neoplasm of the Skin Eccrine Skin Neoplasm Eccrine Skin Tumor Eccrine Tumor Eccrine Tumor of Skin Eccrine Tumor of the Skin Eccrine Neoplasm An epithelial neoplasm that arises from the eccrine glands and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include hidrocystoma, syringoma, and syringofibroadenoma. C6797 Neoplastic Process Benign Eccrine Neoplasm C0346021 Benign Benign_Eccrine_Neoplasm Benign Eccrine Neoplasm Benign Eccrine Neoplasm of Skin Benign Eccrine Neoplasm of the Skin Benign Eccrine Skin Neoplasm Benign Eccrine Skin Tumor Benign Eccrine Tumor Benign Eccrine Tumor of Skin Benign Eccrine Tumor of the Skin Benign Eccrine Neoplasm A benign or malignant sweat gland neoplasm with apocrine differentiation. Representative examples include apocrine adenoma, ceruminous adenocarcinoma, and apocrine breast carcinoma. C6798 Neoplastic Process Apocrine Neoplasm C0346028 Undetermined Apocrine_Neoplasm Apocrine Neoplasm Apocrine Neoplasm of Skin Apocrine Neoplasm of the Skin Apocrine Skin Neoplasm Apocrine Skin Tumor Apocrine Tumor Apocrine Tumor of Skin Apocrine Tumor of the Skin Apocrine Neoplasm An epithelial neoplasm that arises from the apocrine glands and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C6799 Neoplastic Process Benign Apocrine Neoplasm C0346029 Benign Benign_Apocrine_Neoplasm Benign Apocrine Neoplasm Benign Apocrine Neoplasm of Skin Benign Apocrine Neoplasm of the Skin Benign Apocrine Skin Neoplasm Benign Apocrine Skin Tumor Benign Apocrine Tumor Benign Apocrine Tumor of Skin Benign Apocrine Tumor of the Skin Benign Apocrine Neoplasm A malignant neoplasm that arises from the apocrine glands. C6800 Neoplastic Process Malignant Apocrine Neoplasm C0346031 Malignant Malignant_Apocrine_Neoplasm Malignant Apocrine Neoplasm Malignant Apocrine Neoplasm of Skin Malignant Apocrine Neoplasm of the Skin Malignant Apocrine Skin Neoplasm Malignant Apocrine Skin Tumor Malignant Apocrine Tumor Malignant Apocrine Tumor of Skin Malignant Apocrine Tumor of the Skin Malignant Apocrine Neoplasm A solitary, slowly growing, nodular tumor most often affecting the extremities. It is composed of fibrous and histiocytic cells which infiltrate the dermis and occasionally the underlying subcutaneous tissue. Usually local excision is curative. Recurrences are reported only in a small minority of cases. C6801 Neoplastic Process Skin Fibrous Histiocytoma C0002991 GDC 8832/0 Benign Cutaneous_Fibrous_Histiocytoma 8832/0 Cutaneous histiocytoma, NOS Dermatofibroma lenticulare Dermatofibroma, NOS Sclerosing hemangioma Benign Cutaneous Fibrous Histiocytoma Benign Fibrous Cutaneous Histiocytoma Benign Fibrous Histiocytoma of Skin Benign Fibrous Histiocytoma of the Skin Benign Skin Fibrous Histiocytoma Cutaneous Fibrous Histiocytoma Dermatofibroma Fibrous Histiocytoma of Skin Fibrous Histiocytoma of the Skin Skin Fibrous Histiocytoma Skin Fibrous Histiocytoma A sex cord-stromal tumor arising from the ovary, without metastatic potential. C6803 Neoplastic Process Benign Ovarian Sex Cord-Stromal Tumor C0346176 Benign Benign_Ovarian_Sex_Cord-Stromal_Tumor Sex cord-stromal tumor, benign Benign Ovarian Sex Cord-Stromal Neoplasm Benign Ovarian Sex Cord-Stromal Tumor Benign Sex Cord-Stromal Neoplasm of Ovary Benign Sex Cord-Stromal Neoplasm of the Ovary Benign Sex Cord-Stromal Tumor of Ovary Benign Sex Cord-Stromal Tumor of the Ovary Benign Ovarian Sex Cord-Stromal Tumor A carcinoma arising in a pre-existing pleomorphic adenoma in the lacrimal gland. C6804 Neoplastic Process Lacrimal Gland Carcinoma ex Pleomorphic Adenoma C0346342 Malignant Lacrimal_Gland_Carcinoma_Ex_Pleomorphic_Adenoma Carcinoma ex Pleomorphic Adenoma of Lacrimal Gland Carcinoma ex Pleomorphic Adenoma of the Lacrimal Gland Lacrimal Gland Carcinoma ex Pleomorphic Adenoma Lacrimal Gland Malignant Mixed Neoplasm Lacrimal Gland Malignant Mixed Tumor Malignant Mixed Neoplasm of Lacrimal Gland Malignant Mixed Neoplasm of the Lacrimal Gland Malignant Mixed Tumor of Lacrimal Gland Malignant Mixed Tumor of the Lacrimal Gland Lacrimal Gland Carcinoma ex Pleomorphic Adenoma A malignant neoplasm metastasizing to the pituitary gland from another anatomic site. The vast majority are carcinomas usually arising from the breast, lung, and gastrointestinal tract. C6805 Neoplastic Process Metastatic Malignant Neoplasm in the Pituitary Gland C0347015 Malignant Metastasis_to_Pituitary_Gland Metastasis to Pituitary Gland Metastatic Malignant Neoplasm in the Pituitary Gland Metastatic Malignant Neoplasm to the Pituitary Gland Metastatic Neoplasm to the Pituitary Gland Metastatic Malignant Neoplasm in the Pituitary Gland A benign neoplasm arising from the dermis. It is characterized by the presence of neoplastic fibroblasts without malignant characteristics. C6806 Neoplastic Process Benign Skin Fibroblastic Neoplasm C0349526 Benign Benign_Cutaneous_Fibrous_Neoplasm Benign Cutaneous Fibroblastic Neoplasm Benign Cutaneous Fibroblastic Tumor Benign Cutaneous Fibrocytic Neoplasm Benign Cutaneous Fibrous Neoplasm Benign Cutaneous Fibrous Tissue Neoplasm Benign Fibrous Tissue Neoplasm of Skin Benign Fibrous Tissue Skin Neoplasm Benign Fibrous Tissue Skin Tumor Benign Fibrous Tissue Tumor of Skin Benign Skin Fibroblastic Neoplasm Benign Skin Fibroblastic Neoplasm A neoplasm that arises from the external ear and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include ceruminous adenoma, polyp, and lipoma. C6807 Neoplastic Process Benign External Ear Neoplasm C0349577 Benign Benign_External_Ear_Neoplasm Benign External Ear Neoplasm Benign External Ear Tumor Benign Neoplasm of External Ear Benign Neoplasm of the External Ear Benign Tumor of External Ear Benign Tumor of the External Ear Benign External Ear Neoplasm A dermoid cyst that arises from the spinal cord. C6808 Neoplastic Process Dermoid Cyst of the Spinal Cord C0349607 Benign Dermoid_Cyst_of_the_Spinal_Cord Dermoid Cyst of Spinal Cord Dermoid Cyst of the Spinal Cord Spinal Cord Dermoid Spinal Cord Dermoid Cyst Dermoid Cyst of the Spinal Cord A WHO Grade 1 astrocytoma which arises in the cerebellum. The tumor is composed of spindle shaped cells with numerous collections of reddish astrocytic fibers called Rosenthal fibers. Over 80% or the cerebellar astrocytomas of childhood are pilocytic. Pilocytic astrocytomas may rarely occur in adults. They are usually treated by surgical resection and in most cases have a favorable prognosis. C6809 Neoplastic Process Cerebellar Pilocytic Astrocytoma C0349620 Undetermined Cerebellar_Pilocytic_Astrocytoma Cerebellar Pilocytic Astrocytoma Pilocytic Astrocytoma of Cerebellum Pilocytic Astrocytoma of the Cerebellum Cerebellar Pilocytic Astrocytoma A lymphoma that arises from the testis and is not associated with lymphoma in another anatomic site. C6810 Neoplastic Process Testicular Lymphoma Testicular Lymphoma C0349644 CTRP Malignant Testicular_Lymphoma Lymphoma of Testis Lymphoma of the Testis Primary Testicular Lymphoma Testicular Lymphoma Testicular Lymphoma A verrucous carcinoma that arises from the plantar aspect of the foot. C6811 Neoplastic Process Plantar Verrucous Carcinoma C1335424 Malignant Plantar_Verrucous_Skin_Carcinoma Plantar Verrucous Carcinoma Plantar Verrucous Carcinoma of Skin Plantar Verrucous Carcinoma of the Skin Plantar Verrucous Skin Carcinoma Plantar Verrucous Carcinoma An extragonadal malignant germ cell tumor that arises from the mediastinum. It is characterized by the presence of uniform cells with clear or eosinophilic cytoplasm, round nucleus with one or more nucleoli, and distinct cellular borders. It usually arises from the anterior mediastinum. It may present with respiratory distress, chest pain, or superior vena cava syndrome or it may be asymptomatic, with the tumor detected on routine chest x-ray. The prognosis of mediastinal pure seminomas is favorable compared to the mediastinal non-seminomatous malignant germ cell tumors. C6812 Neoplastic Process Mediastinal Seminoma C0349664 Cellosaurus Malignant Mediastinal_Seminoma Mediastinal Seminoma Seminoma of Mediastinum Seminoma of the Mediastinum Mediastinal Seminoma A usually aggressive invasive adenocarcinoma of the prostate gland composed of large glands containing tall columnar cells. The columnar cells have abundant cytoplasm and are reminiscent of endometrial carcinoma. This type of adenocarcinoma has a tendency to metastasize to the lung and penis. C6813 Neoplastic Process Prostate Ductal Adenocarcinoma C0349672 OORO Malignant Prostate_Ductal_Adenocarcinoma Ductal Adenocarcinoma of Prostate Ductal Adenocarcinoma of the Prostate Endometrioid Adenocarcinoma of Prostate Endometrioid Adenocarcinoma of the Prostate Endometrioid Carcinoma of Prostate Endometrioid Carcinoma of the Prostate Prostate Ductal Adenocarcinoma Prostate Endometrioid Adenocarcinoma Prostate Endometrioid Carcinoma Prostate ductal Adenocarcinoma Prostatic Endometrioid Carcinoma Prostate Ductal Adenocarcinoma A poorly circumscribed, intermediate fibrocytic neoplasm arising from the superficial soft tissues. It is characterized by the presence of spindle-shaped fibroblasts, and an infiltrative growth pattern. C6814 Neoplastic Process Superficial Fibromatosis C0406571 Undetermined Superficial_Fibromatosis Superficial Fibromatosis Superficial Fibromatosis A pancreatic intraepithelial neoplasia characterized by the presence of tall columnar cells that form flat or papillary, micropapillary, and basally pseudostratified architectural patterns. Mild cytological atypia is present. C6820 Neoplastic Process Pancreatic Intraepithelial Neoplasia-1 C1333869 Uncertain Malignant Potential Grade_I_Pancreatic_Intraepithelial_Neoplasia Grade 1 Pancreatic Intraepithelial Neoplasia Grade I Pancreatic Intraepithelial Neoplasia PanIN-1 Pancreatic Intraepithelial Neoplasia-1 Pancreatic Intraepithelial Neoplasia-1 A neuroendocrine tumor that arises from the mucosa of the middle ear. Recurrences have been reported in a minority of cases and metastasis is very rare. C6834 Neoplastic Process Middle Ear Neuroendocrine Tumor C1334759 Undetermined Middle_Ear_Adenoma MeNET Middle Ear Adenoma Middle Ear Carcinoid Tumor Middle Ear Neuroendocrine Tumor Middle Ear Neuroendocrine Tumor A papilloma that arises from the ciliated respiratory mucosa that lines the paranasal sinuses. C6835 Neoplastic Process Paranasal Sinus Papilloma C1335343 Benign Paranasal_Sinus_Schneiderian_Papilloma Accessory Sinus Schneiderian Papilloma Paranasal Sinus Papilloma Paranasal Sinus Schneiderian Papilloma Schneiderian Papilloma of Accessory Sinus Schneiderian Papilloma of Paranasal Sinus Schneiderian Papilloma of the Accessory Sinus Schneiderian Papilloma of the Paranasal Sinus Paranasal Sinus Papilloma A papilloma that arises from the ciliated respiratory mucosa that lines the ethmoid sinus. C6836 Neoplastic Process Ethmoid Sinus Papilloma C1333476 Benign Ethmoid_Sinus_Schneiderian_Papilloma Ethmoid Sinus Papilloma Ethmoid Sinus Schneiderian Papilloma Schneiderian Papilloma of Ethmoid Sinus Schneiderian Papilloma of the Ethmoid Sinus Ethmoid Sinus Papilloma A papilloma that arises from the ciliated respiratory mucosa that lines the frontal sinus. C6837 Neoplastic Process Frontal Sinus Papilloma C1333645 Benign Frontal_Sinus_Schneiderian_Papilloma Frontal Sinus Papilloma Frontal Sinus Schneiderian Papilloma Schneiderian Papilloma of Frontal Sinus Schneiderian Papilloma of the Frontal Sinus Frontal Sinus Papilloma A papilloma that arises from the ciliated respiratory mucosa that lines the sphenoid sinus. C6838 Neoplastic Process Sphenoid Sinus Papilloma C1336038 Benign Sphenoid_Sinus_Schneiderian_Papilloma Schneiderian Papilloma of Sphenoid Sinus Schneiderian Papilloma of the Sphenoid Sinus Sphenoid Sinus Papilloma Sphenoid Sinus Schneiderian Papilloma Sphenoid Sinus Papilloma A papilloma that arises from the ciliated respiratory mucosa that lines the maxillary sinus. C6839 Neoplastic Process Maxillary Sinus Papilloma C1334646 Benign Maxillary_Sinus_Schneiderian_Papilloma Maxillary Sinus Papilloma Maxillary Sinus Schneiderian Papilloma Schneiderian Papilloma of Maxillary Sinus Schneiderian Papilloma of the Maxillary Sinus Maxillary Sinus Papilloma A benign neoplasm that arises from the ciliated respiratory mucosa that lines the maxillary sinus. It results from the invagination and proliferation of epithelial cells in the underlying stroma. C6840 Neoplastic Process Maxillary Sinus Inverted Papilloma C1334645 Benign Maxillary_Sinus_Inverted_Papilloma Inverted Papilloma of Maxillary Sinus Inverted Papilloma of the Maxillary Sinus Maxillary Sinus Inverted Papilloma Maxillary Sinus Inverted Schneiderian Papilloma Maxillary Sinus Inverted Papilloma A benign neoplasm that arises from the ciliated respiratory mucosa that lines the sphenoid sinus. It results from the invagination and proliferation of epithelial cells in the underlying stroma. C6841 Neoplastic Process Sphenoid Sinus Inverted Papilloma C1336037 Benign Sphenoid_Sinus_Inverted_Papilloma Inverted Papilloma of Sphenoid Sinus Inverted Papilloma of the Sphenoid Sinus Sphenoid Sinus Inverted Papilloma Sphenoid Sinus Inverted Schneiderian Papilloma Sphenoid Sinus Inverted Papilloma A benign neoplasm that arises from the ciliated respiratory mucosa that lines the frontal sinus. It results from the invagination and proliferation of epithelial cells in the underlying stroma. C6842 Neoplastic Process Frontal Sinus Inverted Papilloma C1333644 Benign Frontal_Sinus_Inverted_Papilloma Frontal Sinus Inverted Papilloma Frontal Sinus Inverted Schneiderian Papilloma Inverted Papilloma of Frontal Sinus Inverted Papilloma of the Frontal Sinus Frontal Sinus Inverted Papilloma A benign neoplasm that arises from the ciliated respiratory mucosa that lines the ethmoid sinus. It results from the invagination and proliferation of epithelial cells in the underlying stroma. C6843 Neoplastic Process Ethmoid Sinus Inverted Papilloma C1333474 Benign Ethmoid_Sinus_Inverted_Papilloma Ethmoid Sinus Inverted Papilloma Ethmoid Sinus Inverted Schneiderian Papilloma Inverted Papilloma of Ethmoid Sinus Inverted Papilloma of the Ethmoid Sinus Ethmoid Sinus Inverted Papilloma A benign epithelial neoplasm arising from the minor salivary glands in the hard palate. It is characterized by the presence of a monomorphic cellular infiltrate. C6844 Neoplastic Process Hard Palate Monomorphic Adenoma C1333937 Benign Hard_Palate_Monomorphic_Adenoma Hard Palate Monomorphic Adenoma Monomorphic Adenoma of Hard Palate Monomorphic Adenoma of the Hard Palate Hard Palate Monomorphic Adenoma A benign epithelial neoplasm arising from the salivary glands in the oral cavity. It is characterized by the presence of a monomorphic cellular infiltrate. C6845 Neoplastic Process Oral Cavity Monomorphic Adenoma C1335121 Benign Oral_Cavity_Monomorphic_Adenoma Monomorphic Adenoma of Oral Cavity Monomorphic Adenoma of the Oral Cavity Oral Cavity Monomorphic Adenoma Oral Cavity Monomorphic Adenoma A rare, circumscribed or encapsulated tumor arising from the follicular cells of the thyroid gland. It is characterized by a trabecular growth pattern and hyalinized stroma formation. The vast majority of cases have a benign clinical course. C6846 Neoplastic Process Thyroid Gland Hyalinizing Trabecular Tumor Thyroid Gland Hyalinizing Trabecular Tumor C1266049 CTRP GDC 8336/0 Undetermined Thyroid_Hyalinizing_Trabecular_Adenoma 8336/0 Hyalinizing trabecular adenoma Hyalinizing trabecular tumor HTT Hyalinizing Trabecular Adenoma Hyalinizing Trabecular Adenoma of Thyroid Hyalinizing Trabecular Adenoma of the Thyroid Hyalinizing Trabecular Tumor PLAT Paraganglioma-like Adenoma Thyroid Gland Hyalinizing Trabecular Tumor Thyroid Hyalinizing Trabecular Adenoma Thyroid Gland Hyalinizing Trabecular Tumor A benign epithelial neoplasm that arises from the parotid gland. It is characterized by the presence of a monomorphic cellular infiltrate. C6847 Neoplastic Process Parotid Gland Monomorphic Adenoma C1335362 Benign Parotid_Gland_Monomorphic_Adenoma Monomorphic Adenoma of Parotid Monomorphic Adenoma of Parotid Gland Monomorphic Adenoma of the Parotid Monomorphic Adenoma of the Parotid Gland Parotid Gland Monomorphic Adenoma Parotid Monomorphic Adenoma Parotid Gland Monomorphic Adenoma A rare adenocarcinoma that arises from the middle ear. C6848 Neoplastic Process Middle Ear Adenocarcinoma C1334758 Malignant Middle_Ear_Adenocarcinoma Adenocarcinoma of Middle Ear Adenocarcinoma of the Middle Ear Middle Ear Adenocarcinoma Middle Ear Adenocarcinoma A malignant soft tissue neoplasm that arises from the paranasal sinus. C6849 Neoplastic Process Paranasal Sinus Sarcoma C1335342 Malignant Paranasal_Sinus_Sarcoma Accessory Sinus Sarcoma Paranasal Sinus Sarcoma Sarcoma of Accessory Sinus Sarcoma of Paranasal Sinus Sarcoma of the Accessory Sinus Sarcoma of the Paranasal Sinus Paranasal Sinus Sarcoma An aggressive malignant soft tissue neoplasm that arises from the paranasal sinus. It is characterized by the presence of high-grade histologic features. C6850 Neoplastic Process High Grade Paranasal Sinus Sarcoma C1334018 Malignant High_Grade_Paranasal_Sinus_Sarcoma High Grade Accessory Sinus Sarcoma High Grade Paranasal Sinus Sarcoma High Grade Sarcoma of Accessory Sinus High Grade Sarcoma of Paranasal Sinus High Grade Sarcoma of the Accessory Sinus High Grade Sarcoma of the Paranasal Sinus High Grade Paranasal Sinus Sarcoma A malignant soft tissue neoplasm that arises from the paranasal sinus. It is characterized by the presence of low-grade histologic features. C6851 Neoplastic Process Low Grade Paranasal Sinus Sarcoma C1334426 Malignant Low_Grade_Paranasal_Sinus_Sarcoma Low Grade Accessory Sinus Sarcoma Low Grade Paranasal Sinus Sarcoma Low Grade Sarcoma of Accessory Sinus Low Grade Sarcoma of Paranasal Sinus Low Grade Sarcoma of the Accessory Sinus Low Grade Sarcoma of the Paranasal Sinus Low Grade Paranasal Sinus Sarcoma An atypical meningioma that occurs during adulthood. C6852 Neoplastic Process Adult Atypical Meningioma Adult Atypical Meningioma C1332184 CTRP Undetermined Adult_Atypical_Meningioma Adult Atypical Meningioma Atypical Meningioma Adult Atypical Meningioma An olfactory neuroblastoma that is confined to the nasal cavity C6853 Neoplastic Process Kadish Stage A Olfactory Neuroblastoma C1334315 Malignant Kadish_Stage_A_Olfactory_Neuroblastoma Kadish Stage A Olfactory Neuroblastoma Kadish Stage A Olfactory Neuroblastoma An olfactory neuroblastoma that involves the nasal cavity and paranasal sinuses. C6854 Neoplastic Process Kadish Stage B Olfactory Neuroblastoma C1334316 Malignant Kadish_Stage_B_Olfactory_Neuroblastoma Kadish Stage B Olfactory Neuroblastoma Kadish Stage B Olfactory Neuroblastoma A benign endocervical polypoid epithelial hyperplasia characterized by the presence of tightly packed glandular structures. It is usually seen in women on oral contraceptive therapy and during pregnancy. C6856 Neoplastic Process Cervical Microglandular Polyp C1332918 Benign Cervical_Microglandular_Polyp Cervical Microglandular Polyp Microglandular Polyp of Cervix Microglandular Polyp of Uterine Cervix Microglandular Polyp of the Cervix Microglandular Polyp of the Uterine Cervix Uterine Cervix Microglandular Polyp Cervical Microglandular Polyp A B-cell non-Hodgkin lymphoma arising from the skin. Representative examples include cutaneous marginal zone B-cell lymphoma and cutaneous follicle center lymphoma. C6858 Neoplastic Process Cutaneous B-Cell Non-Hodgkin Lymphoma Primary Cutaneous B-Cell Non-Hodgkin Lymphoma C1511566 CTRP Malignant Cutaneous_B-Cell_Lymphoma CBCL Cutaneous (Skin) B-Cell Non-Hodgkin Lymphoma PCBCL Primary B-Cell Non-Hodgkin Lymphoma of Skin Primary Cutaneous B-Cell Non-Hodgkin Lymphoma Primary Cutaneous B-Cell Non-Hodgkin's Lymphoma Primary Cutaneous B-Cell Non-Hodgkin Lymphoma A cutaneous lymphoma which contains more than 15 centroblasts per 40X high-power microscopic field. C6859 Neoplastic Process Grade 3 Cutaneous Follicular Lymphoma C1333842 Malignant Grade_3_Cutaneous_Follicular_Lymphoma Cutaneous Large B Cell Follicular Lymphoma Grade 3 Cutaneous Follicular Lymphoma Large B Cell Follicular Lymphoma of Skin Large B Cell Follicular Lymphoma of the Skin Grade 3 Cutaneous Follicular Lymphoma An anaplastic large cell lymphoma limited to the skin at the time of diagnosis. Most patients present with solitary or localized skin lesions, which may be tumors, nodules or papules. The t(2;5) translocation that is present in many cases of systemic anaplastic large cell lymphoma, is not found in this disease. (WHO, 2001) C6860 Neoplastic Process Primary Cutaneous Anaplastic Large Cell Lymphoma Primary Cutaneous Anaplastic Large Cell Lymphoma C1301362 CTEP CTRP GDC Malignant Primary_Cutaneous_Anaplastic_Large_Cell_Lymphoma 9718/3 Primary cutaneous CD30+ large T-cell lymphoma Primary cutaneous anaplastic large cell lymphoma ALCL, cutaneous Anaplastic large-cell lymphoma, primary cutaneous type C-ALCL Primary Anaplastic Large Cell Lymphoma of Skin Primary Anaplastic Large Cell Lymphoma of the Skin Primary Cutaneous Anaplastic Large Cell Lymphoma Primary Cutaneous CD30 Positive Anaplastic Large Cell Lymphoma Primary Cutaneous CD30+ ALCL Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma Primary cutaneous anaplastic large cell lymphoma Primary Cutaneous Anaplastic Large Cell Lymphoma A choroid melanoma characterized by the presence of malignant spindle-shaped melanocytes with slender nuclei and no visible nucleoli. C6861 Neoplastic Process Choroid Spindle Cell Type A Melanoma C1333028 Malignant Choroid_Spindle_Cell_Type_A_Melanoma Choroid Spindle Cell Type A Melanoma Spindle Cell Type A Melanoma of Choroid Spindle Cell Type A Melanoma of the Choroid Choroid Spindle Cell Type A Melanoma A non-keratinizing carcinoma arising from the oropharynx. It is characterized by the presence of large malignant cells with vesicular nuclei, prominent nucleoli, syncytial growth pattern, and a lymphoplasmacytic infiltrate. C68610 Neoplastic Process Oropharyngeal Undifferentiated Carcinoma Oropharyngeal Undifferentiated Carcinoma C0280318 CTRP Malignant Oropharyngeal_Undifferentiated_Carcinoma Oropharyngeal Lymphoepithelioma Oropharyngeal Undifferentiated Carcinoma Undifferentiated Oropharyngeal Throat Cancer Oropharyngeal Undifferentiated Carcinoma A rare, keratinizing or non-keratinizing squamous cell carcinoma arising from the mucosal epithelium of the nasal cavity or the paranasal sinuses. It affects most often the maxillary sinus. Less frequently, it arises from the nasal cavity, ethmoid sinus, sphenoid sinus, and frontal sinus. Symptoms include nasal fullness, epistaxis, rhinorhea, pain, and paresthesia. Patients with nasal squamous cell carcinoma usually present earlier than patients with maxillary sinus carcinoma and have a better prognosis compared to the latter group. C68611 Neoplastic Process Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Sinonasal Squamous Cell Carcinoma C0280332 CTRP Cellosaurus Malignant Nasal_Cavity_and_Paranasal_Sinus_Squamous_Cell_Carcinoma Nasal Cavity and Paranasal Sinus Squamous Cell Cancer Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Sinonasal Squamous Cell Carcinoma Sinonasal Squamous Cell Carcinoma A choroid melanoma characterized by the presence of malignant spindle-shaped melanocytes with larger nuclei and distinct nucleoli. C6862 Neoplastic Process Choroid Spindle Cell Type B Melanoma C1333029 Malignant Choroid_Spindle_Cell_Type_B_Melanoma Choroid Spindle Cell Type B Melanoma Spindle Cell Type B Melanoma of Choroid Spindle Cell Type B Melanoma of the Choroid Choroid Spindle Cell Type B Melanoma A malignant germ cell tumor in children arising from the testis. It includes the embryonal carcinoma, yolk sac tumor, choriocarcinoma, and mixed germ cell tumors. C68628 Neoplastic Process Childhood Malignant Testicular Germ Cell Tumor Childhood Malignant Testicular Germ Cell Tumor CL448432 CTRP NICHD A malignant germ cell tumor in children arising from the testis. Malignant Childhood_Malignant_Testicular_Germ_Cell_Tumor Childhood Malignant Testicular Germ Cell Tumor Malignant Testicular Germ Cell Tumor Childhood Malignant Testicular Germ Cell Tumor A malignant germ cell tumor in children arising from the ovary. It includes the dysgerminoma, yolk sac tumor, choriocarcinoma, embryonal carcinoma and immature teratoma. C68629 Neoplastic Process Childhood Malignant Ovarian Germ Cell Tumor Childhood Malignant Ovarian Germ Cell Tumor C0886483 CTRP NICHD A malignant germ cell tumor in children arising from the ovary. Malignant Childhood_Malignant_Ovarian_Germ_Cell_Tumor Childhood Malignant Ovarian Germ Cell Tumor Malignant Ovarian Germ Cell Tumor Childhood Malignant Ovarian Germ Cell Tumor A ciliary body melanoma characterized by the presence of malignant spindle-shaped melanocytes with larger nuclei and distinct nucleoli. C6863 Neoplastic Process Ciliary Body Spindle Cell Type B Melanoma C1333054 Malignant Ciliary_Body_Spindle_Cell_Type_B_Melanoma Ciliary Body Spindle Cell Type B Melanoma Spindle Cell Type B Melanoma of Ciliary Body Spindle Cell Type B Melanoma of the Ciliary Body Ciliary Body Spindle Cell Type B Melanoma An atypical teratoid/rhabdoid tumor occurring in children. C68634 Neoplastic Process Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Atypical Teratoid/Rhabdoid Tumor CL372028 CTRP NICHD A rare, clinically aggressive tumor of the CNS that most often affects children aged 3 years and younger, but that can occur in older children and adults. Malignant Childhood_Atypical_Teratoid_Rhabdoid_Tumor Atypical Teratoid/Rhabdoid Tumor Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Atypical Teratoid/Rhabdoid Tumor A carcinoma that arises from the adrenal cortex and is characterized by the presence of twenty or less mitoses per ten square millimeters. C68635 Neoplastic Process Well Differentiated Adrenal Cortex Carcinoma Adrenal Cortical Low Grade Carcinoma C2349148 CTRP Malignant Well-Differentiated_Adrenal_Cortex_Carcinoma Adrenal Cortex Low Grade Carcinoma Adrenal Cortex Low-Grade Carcinoma Adrenal Cortical Low Grade Carcinoma Adrenal Cortical Low-Grade Carcinoma Well Differentiated Adrenal Cortex Cancer Well Differentiated Adrenal Cortex Carcinoma Adrenal Cortical Low Grade Carcinoma A ciliary body melanoma characterized by the presence of malignant spindle-shaped melanocytes with slender nuclei and no visible nucleoli. C6864 Neoplastic Process Ciliary Body Spindle Cell Type A Melanoma C1333053 Malignant Ciliary_Body_Spindle_Cell_Type_A_Melanoma Ciliary Body Spindle Cell Type A Melanoma Spindle Cell Type A Melanoma of Ciliary Body Spindle Cell Type A Melanoma of the Ciliary Body Ciliary Body Spindle Cell Type A Melanoma A carcinoma that arises from the adrenal cortex and is characterized by the partial or complete loss of adrenal cortical differentiation. C68644 Neoplastic Process Anaplastic Adrenal Cortex Carcinoma Adrenal Cortical Sarcomatoid Carcinoma C0279579 CTRP Malignant Anaplastic_Adrenal_Cortex_Carcinoma Adrenal Cortex Anaplastic Carcinoma Adrenal Cortex Sarcomatoid Carcinoma Adrenal Cortical Sarcomatoid Carcinoma Anaplastic Adrenal Cortex Cancer Adrenal Cortical Sarcomatoid Carcinoma A choroid melanoma characterized by the presence of tumor cell necrosis. C6865 Neoplastic Process Choroid Necrotic Melanoma C1333026 Malignant Choroid_Necrotic_Melanoma Choroid Necrotic Melanoma Necrotic Choroid Melanoma Necrotic Melanoma of Choroid Necrotic Melanoma of the Choroid Choroid Necrotic Melanoma A B acute lymphoblastic leukemia that occurs during childhood. It is characterized by the presence of lymphoblasts that carry a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome. C68659 Neoplastic Process Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 CL374485 CTRP Cellosaurus NICHD Acute lymphoblastic leukemia occurring during childhood that is characterized by the presence of the Philadelphia chromosome t(9;22), which leads to production of a BCR-ABL1 fusion protein with tyrosine kinase activity. Malignant Philadelphia_Positive_Childhood_Precursor_Lymphoblastic_Leukemia B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR::ABL1 Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1 Childhood B-Cell Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1 Philadelphia Positive Childhood Acute Lymphoblastic Leukemia Philadelphia Positive Childhood Precursor Lymphoblastic Leukemia Philadelphia-Positive ALL Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 A Hodgkin lymphoma with favorable prognosis. C68660 Neoplastic Process Favorable Hodgkin Lymphoma C2348517 Malignant Favorable_Hodgkin_Lymphoma Favorable Hodgkin Lymphoma Favorable Hodgkin Lymphoma An early Hodgkin lymphoma with favorable prognosis. C68661 Neoplastic Process Early Favorable Hodgkin Lymphoma C2348369 Malignant Early_Favorable_Hodgkin_Lymphoma Early Favorable Hodgkin Lymphoma Early Favorable Hodgkin Lymphoma An advanced Hodgkin lymphoma with favorable prognosis. C68662 Neoplastic Process Advanced Favorable Hodgkin Lymphoma C2347756 Malignant Advanced_Favorable_Hodgkin_Lymphoma Advanced Favorable Hodgkin Lymphoma Advanced Favorable Hodgkin Lymphoma A Hodgkin lymphoma with unfavorable prognosis. C68663 Neoplastic Process Unfavorable Hodgkin Lymphoma C2349019 Malignant Unfavorable_Hodgkin_Lymphoma Unfavorable Hodgkin Lymphoma Unfavorable Hodgkin Lymphoma An early Hodgkin lymphoma with unfavorable prognosis. C68664 Neoplastic Process Early Unfavorable Hodgkin Lymphoma C2348370 Malignant Early_Unfavorable_Hodgkin_Lymphoma Early Unfavorable Hodgkin Lymphoma Early Unfavorable Hodgkin Lymphoma An advanced Hodgkin lymphoma with unfavorable prognosis. C68665 Neoplastic Process Advanced Unfavorable Hodgkin Lymphoma C2347992 Malignant Advanced_Unfavorable_Hodgkin_Lymphoma Advanced Unfavorable Hodgkin Lymphoma Advanced Unfavorable Hodgkin Lymphoma C68666 Neoplastic Process Hodgkin Lymphoma by Clinical Course C2348985 Malignant Hodgkin_Lymphoma_by_Clinical_Course Hodgkin Lymphoma by Clinical Course Hodgkin Lymphoma by Clinical Course A myelodysplastic syndrome characterized by a deletion between bands q31 and 33 on chromosome 5. The number of blasts in the bone marrow and blood is <5%. The bone marrow is usually hypercellular or normocellular with increased number of often hypolobated megakaryocytes. The peripheral blood shows macrocytic anemia. This syndrome occurs predominantly but not exclusively in middle age to older women. The prognosis is good and transformation to acute leukemia is rare. (WHO, 2001) C6867 Neoplastic Process Myelodysplastic Syndrome with Isolated del(5q) Myelodysplastic Syndrome with del(5q) C1292779 CPTAC CTRP GDC mCode A rare disorder caused by loss of part of the long arm (Q arm) of human chromosome 5. This syndrome affects myeloid (bone marrow) cells, causing treatment-resistant anemia, and myelodysplastic syndromes that may lead to acute myelogenous leukemia. 9986/3 Malignant Myelodysplastic_Syndrome_Associated_with_Isolated_del_5q_Chromosome_Abnormality 9986/3 Myelodysplastic syndrome with 5q deletion Myelodysplastic syndrome with 5q deletion (5q-) syndrome Myelodysplastic syndrome with isolated del (5q) Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality 5Q minus syndrome 5Q- syndrome 5q- Syndrome MDS-del(5q) Myelodysplastic Neoplasm with Low Blasts and 5q Deletion Myelodysplastic Syndrome Associated with Isolated del (5q) Chromosome Abnormality Myelodysplastic Syndrome with 5q Deletion Myelodysplastic Syndrome with Isolated Del (5Q) Myelodysplastic Syndrome with Isolated del(5q) Myelodysplastic Syndrome with del(5q) Myelodysplastic syndrome with 5q deletion (5q-) syndrome Myelodysplastic syndrome with isolated del (5q) Myelodysplastic syndrome with isolated del (5q) chromosomal abnormality Myelodysplastic Syndrome with del(5q) Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C68678 Neoplastic Process Ann Arbor Stage I Marginal Zone Lymphoma Ann Arbor Stage I Marginal Zone Lymphoma C1541263 CTRP Malignant Stage_I_Marginal_Zone_B-Cell_Lymphoma Ann Arbor Stage I Marginal Zone Lymphoma Stage I Marginal Zone B-Cell Lymphoma Stage I Marginal Zone Lymphoma Ann Arbor Stage I Marginal Zone Lymphoma Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (PDQ) C68679 Neoplastic Process Ann Arbor Stage II Marginal Zone Lymphoma Ann Arbor Stage II Marginal Zone Lymphoma C1541264 CTRP Malignant Stage_II_Marginal_Zone_B-Cell_Lymphoma Ann Arbor Stage II Marginal Zone Lymphoma Stage II Marginal Zone B-Cell Lymphoma Stage II Marginal Zone Lymphoma Ann Arbor Stage II Marginal Zone Lymphoma Stage IV includes: IVA: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB: (T4b, Any N, M0); (Any T, N3, M0); IVC: (Any T, Any N, M1). T4: (Supraglottis) T4a: Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus). T4b: Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. (Glottis) T4a: Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus). T4b: Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. (Subglottis) T4a: Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus). T4b: Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N2a: Metastasis in a single ipsilateral lymph node more than 3 cm but not more than 6 cm in greatest dimension. N2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension. N2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a lymph node more than 6 cm in greatest dimension. M1: Distant metastasis. (AJCC 6th ed.) C6868 Neoplastic Process Stage IV Laryngeal Cancer AJCC v6 Stage IV Laryngeal Cancer AJCC v6 C0851139 CTRP Stage IV is divided into stage IVA, stage IVB, and stage IVC. In stage IVA, (1) cancer has spread through the thyroid cartilage and/or has spread to tissues beyond the larynx, such as the neck, trachea, thyroid, or esophagus; cancer may have spread to one lymph node on the same side of the neck as the original tumor and the lymph node is 3 centimeters or smaller; or (2) cancer has spread to one lymph node on the same side of the neck as the original tumor and the lymph node is larger than 3 centimeters but not larger than 6 centimeters, or has spread to more than one lymph node anywhere in the neck with none larger than 6 centimeters; cancer may have spread to tissues beyond the larynx, such as the neck, trachea, thyroid, or esophagus. The vocal cords may not move normally. In stage IVB, (1) cancer has spread to the space in front of the spinal column, surrounds the carotid artery, or has spread to parts of the chest; cancer may have spread to one or more lymph nodes anywhere in the neck and the lymph nodes may be any size; or (2) cancer has spread to a lymph node that is larger than 6 centimeters and may have spread as far as the space in front of the spinal column, around the carotid artery, or to parts of the chest. The vocal cords may not move normally. In stage IVC, cancer has spread to other parts of the body, such as the lungs, liver, or bone. Malignant Stage_IV_Laryngeal_Cancer Laryngeal Cancer, Stage IV AJCC v6 Stage IV Carcinoma of Larynx AJCC v6 Stage IV Carcinoma of the Larynx AJCC v6 Stage IV Laryngeal Cancer AJCC v6 Stage IV Laryngeal Carcinoma AJCC v6 Stage IV Laryngeal Throat Cancer Stage IV Larynx Carcinoma AJCC v6 stage IV laryngeal cancer Stage IV Laryngeal Cancer AJCC v6 Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C68682 Neoplastic Process Ann Arbor Stage III Marginal Zone Lymphoma Ann Arbor Stage III Marginal Zone Lymphoma C1541269 CTRP Malignant Stage_III_Marginal_Zone_B-Cell_Lymphoma Ann Arbor Stage III Marginal Zone Lymphoma Stage III Marginal Zone B-Cell Lymphoma Stage III Marginal Zone Lymphoma Ann Arbor Stage III Marginal Zone Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C68683 Neoplastic Process Ann Arbor Stage IV Marginal Zone Lymphoma Ann Arbor Stage IV Marginal Zone Lymphoma C1541270 CTRP Malignant Stage_IV_Marginal_Zone_B-Cell_Lymphoma Ann Arbor Stage IV Marginal Zone Lymphoma Stage IV Marginal Zone B-Cell Lymphoma Stage IV Marginal Zone Lymphoma Ann Arbor Stage IV Marginal Zone Lymphoma The reemergence of marginal zone lymphoma after a period of remission. C68684 Neoplastic Process Recurrent Marginal Zone Lymphoma Recurrent Marginal Zone Lymphoma C1541273 CTRP Malignant Recurrent_Marginal_Zone_B-Cell_Lymphoma Recurrent Marginal Zone B-Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Marginal Zone Lymphoma Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ) C68686 Neoplastic Process Ann Arbor Stage II Aggressive Adult Non-Hodgkin Lymphoma Ann Arbor Stage II Aggressive Adult Non-Hodgkin Lymphoma CL336729 CTRP Malignant Stage_II_Aggressive_Adult_Non-Hodgkin_s_Lymphoma Ann Arbor Stage II Aggressive Adult Non-Hodgkin Lymphoma Stage II Aggressive Adult Non-Hodgkin Lymphoma Stage II Aggressive Non-Hodgkin Lymphoma Ann Arbor Stage II Aggressive Adult Non-Hodgkin Lymphoma Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ) C68688 Neoplastic Process Ann Arbor Stage II Indolent Adult Non-Hodgkin Lymphoma Ann Arbor Stage II Indolent Adult Non-Hodgkin Lymphoma CL336700 CTRP Malignant Stage_II_Indolent_Adult_Non-Hodgkin_s_Lymphoma Ann Arbor Stage II Indolent Adult Non-Hodgkin Lymphoma Stage II Indolent Adult Non-Hodgkin Lymphoma Stage II Indolent Non-Hodgkin Lymphoma Ann Arbor Stage II Indolent Adult Non-Hodgkin Lymphoma An ependymal tumor of the central nervous system occurring in adults. C68690 Neoplastic Process Adult Ependymal Tumor Adult Ependymal Tumor C1541566 CTRP Undetermined Adult_Ependymal_Tumor Adult Ependymal Tumor Ependymal Tumor Adult Ependymal Tumor An oligodendroglial tumor of the central nervous system occurring in adults. C68691 Neoplastic Process Adult Oligodendroglial Tumor Adult Oligodendroglial Tumor C1541567 CTRP Undetermined Adult_Oligodendroglial_Tumor Adult Oligodendroglial Tumor Oligodendroglial Tumor Adult Oligodendroglial Tumor A nasal type extranodal NK/T-cell lymphoma occurring in childhood. C68692 Neoplastic Process Childhood Nasal Type Extranodal NK/T-Cell Lymphoma Childhood Nasal Type Extranodal NK/T-Cell Lymphoma C1879280 CTRP GDC NICHD A nasal type of non-anaplastic peripheral NK/T cell lymphoma occurring during childhood. Malignant Childhood_Nasal_Type_Extranodal_NK_T-Cell_Lymphoma 9719/3 Childhood Nasal Type Extranodal NK/T-Cell Lymphoma Nasal Type Extranodal NK/T-Cell Lymphoma Childhood Nasal Type Extranodal NK/T-Cell Lymphoma A pure erythroid leukemia occurring in adults. C68693 Neoplastic Process Adult Pure Erythroid Leukemia Adult Pure Erythroid Leukemia C1541340 CTRP Cellosaurus Malignant Adult_Pure_Erythroid_Leukemia Adult Pure Erythroid Leukemia Pure Erythroid Leukemia Adult Pure Erythroid Leukemia An erythroleukemia occurring in adults. C68694 Neoplastic Process Adult Erythroleukemia Adult Erythroleukemia C1541339 CTRP Malignant Adult_Erythroleukemia Adult Erythroleukemia Erythroleukemia Adult Erythroleukemia An acute myeloid leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A occurring in adults. C68696 Neoplastic Process Adult Acute Myeloid Leukemia with t(9;11)(p22;q23); MLLT3-MLL Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A C1541334 CTRP Malignant Adult_Acute_Myeloid_Leukemia_with_11q23_MLL_Abnormalities Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); MLLT3-KMT2A Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A Fusion Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3::KMT2A Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3::KMT2A Fusion Adult Acute Myeloid Leukemia with t(9;11)(p21;q23); MLLT3-MLL Adult Acute Myeloid Leukemia with t(9;11)(p21;q23); MLLT3::MLL Adult Acute Myeloid Leukemia with t(9;11)(p22;q23); MLLT3-MLL Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A An acute myeloid leukemia with inv(16)(p13.1q22); CBFB-MYH11 occurring in adults. C68697 Neoplastic Process Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 C2825114 CTRP Malignant Adult_Acute_Myeloid_Leukemia_with_inv_16_p13_q22 Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia with inv(16)(p13.1q22) Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 Fusion Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB::MYH11 Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB::MYH11 Fusion Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 An acute myeloid leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 occurring in adults. C68698 Neoplastic Process Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 C1541332 CTRP Malignant Adult_Acute_Myeloid_Leukemia_with_t_16_16_p13_q22 Acute Myeloid Leukemia (AML) with t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 Fusion Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB::MYH11 Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB::MYH11 Fusion Adult Acute Myeloid Leukemia with t(16;16)(p13;q22) Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 An acute myeloid leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1 occurring in adults. C68699 Neoplastic Process Adult Acute Myeloid Leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1 C1541331 CTRP Malignant Adult_Acute_Myeloid_Leukemia_with_t_8_21_q22_q22_AML1_CBFa_ETO Acute Myeloid Leukemia (AML) with t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1::RUNX1T1 Adult Acute Myeloid Leukemia with t(8;21)(q22;q22)(AML1(CBFa)/ETO) Adult Acute Myeloid Leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Fusion Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1::RUNX1T1 Fusion Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1 A well circumscribed, low grade neoplasm that arises from the breast. It is characterized by the presence of sheets of malignant epithelial cells that are supported by fibrovascular structures. When there is an invasive component present, it is usually a mucinous carcinoma. C6870 Neoplastic Process Breast Solid Papillary Carcinoma C1336027 GDC Malignant Solid_Papillary_Carcinoma_of_the_Breast Solid papillary carcinoma in situ Breast Solid Papillary Carcinoma Solid Papillary Breast Carcinoma Solid Papillary Carcinoma of the Breast Breast Solid Papillary Carcinoma An acute myeloid leukemia with recurrent genetic abnormalities occurring in adults. C68700 Neoplastic Process Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities C2347539 CTRP Malignant Adult_Acute_Myeloid_Leukemia_with_Recurrent_Genetic_Abnormalities Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities A gliosarcoma occurring in adults. C68701 Neoplastic Process Adult Gliosarcoma Adult Gliosarcoma C1541317 CTRP Malignant Adult_Gliosarcoma Adult Gliosarcoma Gliosarcoma Adult Gliosarcoma A giant cell glioblastoma occurring in adults. C68702 Neoplastic Process Adult Giant Cell Glioblastoma Adult Giant Cell Glioblastoma C1541316 CTRP Malignant Adult_Giant_Cell_Glioblastoma Adult Giant Cell Glioblastoma Giant Cell Glioblastoma Adult Giant Cell Glioblastoma A supratentorial embryonal tumor, not otherwise specified that occurs in adults. C68703 Neoplastic Process Adult Supratentorial Embryonal Tumor, Not Otherwise Specified Adult Supratentorial Embryonal Tumor, Not Otherwise Specified C1541315 CTRP Malignant Adult_Supratentorial_Primitive_Neuroectodermal_Tumor Adult Supratentorial Embryonal Tumor, NOS Adult Supratentorial Embryonal Tumor, Not Otherwise Specified Adult Supratentorial Primitive Neuroectodermal Tumor Supratentorial Embryonal Tumor, NOS Adult Supratentorial Embryonal Tumor, Not Otherwise Specified A benign neoplasm that arises from the ciliated respiratory mucosa that lines the nasal cavity or paranasal sinuses. It results from the invagination and proliferation of epithelial cells in the underlying stroma. Clinical manifestations include nasal obstruction, epistaxis, and anosmia. It has the tendency to recur and extend to adjacent structures. Inverted papillomas are occasionally associated with the development or presence of carcinomas, usually squamous cell carcinomas. C6871 Neoplastic Process Inverted Schneiderian Papilloma Sinonasal Inverted Papilloma C1537102 CTRP Cellosaurus GDC Benign Inverted_Schneiderian_Papilloma 8121/1 Schneiderian papilloma, inverted Sinonasal papilloma, inverted Inverted Schneiderian Papilloma Schneiderian papilloma, inverted Sinonasal Inverted Papilloma Sinonasal Inverted Schneiderian Papilloma Sinonasal Papilloma, Inverted Type Sinonasal Inverted Papilloma Stage IV includes: (Any T, Any N, M1). M1: Distant metastasis. (AJCC 6th and 7th Eds.) C6873 Neoplastic Process Stage IV Anal Canal Cancer AJCC v6 and v7 Stage IV Anal Canal Cancer AJCC v6 and v7 C0861424 CTRP The tumor may be any size, and cancer has spread to distant parts of the body. It may also have spread to lymph nodes and nearby organs. Malignant Stage_IV_Anal_Canal_Cancer Stage IV Anal Canal Cancer Stage IV Anal Canal Cancer AJCC v6 Stage IV Anal Canal Cancer AJCC v6 and v7 Stage IV Anal Canal Cancer AJCC v7 Stage IV Anal Canal Carcinoma AJCC v6 and v7 Stage IV Anal Carcinoma AJCC v6 and v7 stage IV anal cancer Stage IV Anal Canal Cancer AJCC v6 and v7 An uncommon hematologic malignancy occurring during childhood. Many of the morphologic, immunophenotypic, and genetic changes seen in adult myelodysplastic syndromes are also observed in the childhood variants of the disease. Children present with neutropenia and thrombocytopenia more often than adults, and bone marrow hypocellularity is more often seen in children than adults. C68744 Neoplastic Process Childhood Myelodysplastic Syndrome Childhood Myelodysplastic Syndrome C2347761 CTRP NICHD An uncommon hematologic malignancy occurring during childhood. Children present with neutropenia and thrombocytopenia more often than adults, and bone marrow hypocellularity is more often seen in children than adults. Childhood MDS includes persistent cytopenia with less than 20% blasts. Malignant Childhood_Myelodysplastic_Syndrome Childhood MDS Childhood Myelodysplastic Syndrome Myelodysplastic Syndrome cMDS Childhood Myelodysplastic Syndrome An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant large cells. C6875 Neoplastic Process Large Cell Neuroendocrine Carcinoma C1265996 CPTAC GDC 8013/3 Malignant Large_Cell_Neuroendocrine_Carcinoma 8013/3 Large cell neuroendocrine carcinoma LCNEC Large Cell NEC Large Cell Neuroendocrine Carcinoma Large cell neuroendocrine carcinoma Large-cell neuroendocrine carcinoma Large Cell Neuroendocrine Carcinoma A large cell lung carcinoma characterized by the presence of rhabdoid cells. C6876 Neoplastic Process Lung Large Cell Carcinoma with Rhabdoid Phenotype C1265997 GDC 8014/3 Malignant Large_Cell_Lung_Carcinoma_with_Rhabdoid_Phenotype 8014/3 Large cell carcinoma with rhabdoid phenotype Large Cell Carcinoma with Rhabdoid Phenotype Large Cell Lung Carcinoma with Rhabdoid Phenotype Large cell carcinoma with rhabdoid phenotype Lung Large Cell Carcinoma with Rhabdoid Phenotype Lung Large Cell Carcinoma with Rhabdoid Phenotype A carcinoma that arises from the pancreas and is composed of acinar carcinoma and neuroendocrine carcinoma components in both the primary tumor and the metastatic sites. C6878 Neoplastic Process Pancreatic Mixed Acinar Carcinoma-Neuroendocrine Carcinoma C2063878 CDISC A malignant pancreatic neoplasm characterized by the presence of a mixture of acinar and islet cell elements. Malignant Mixed_Acinar-Endocrine_Carcinoma ACINAR-ISLET CELL TUMOR, MALIGNANT Mixed Acinar-Endocrine Carcinoma of the Pancreas Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas Mixed Carcinoid-Adenocarcinoma of the Pancreas Mucinous Carcinoid Tumor of the Pancreas Pancreatic Mixed Acinar Adenocarcinoma-Neuroendocrine Carcinoma Pancreatic Mixed Acinar Carcinoma-Neuroendocrine Carcinoma Pancreatic Mixed Acinar-Neuroendocrine Carcinoma Pancreatic Mixed Acinar Carcinoma-Neuroendocrine Carcinoma A carcinoma that arises from the pancreas and is composed of ductal adenocarcinoma and neuroendocrine carcinoma components in both the primary tumor and the metastatic sites. C6879 Neoplastic Process Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Carcinoma C1301048 GDC Malignant Mixed_Ductal-Endocrine_Carcinoma Mixed ductal-endocrine carcinoma Mixed Ductal-Endocrine Carcinoma Mixed Ductal-Endocrine Carcinoma of the Pancreas Mixed Ductal-Neuroendocrine Carcinoma of the Pancreas Mixed ductal-endocrine carcinoma Pancreatic Mixed Ductal Adenocarcinoma-NEC Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Carcinoma Pancreatic Mixed Ductal-Neuroendocrine Carcinoma Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Carcinoma An intraductal papillary neoplasm that arises from the epithelium of the intrahepatic or extrahepatic bile ducts. C6881 Neoplastic Process Bile Duct Intraductal Papillary Neoplasm C1879344 GDC 8503/0 Benign Bile_Duct_Papillomatosis 8264/0 8503/0 Biliary papillomatosis Intraductal papillary neoplasm, NOS Bile Duct IPN Bile Duct Intraductal Papillary Neoplasm Bile Duct Papillomatosis Biliary Papillomatosis Biliary papillomatosis Intraductal papillary neoplasm, NOS Bile Duct Intraductal Papillary Neoplasm A non-Hodgkin lymphoma with favorable prognosis. C68837 Neoplastic Process Favorable Non-Hodgkin Lymphoma C2348518 Malignant Favorable_Non-Hodgkin_Lymphoma Favorable Non-Hodgkin Lymphoma Favorable Non-Hodgkin's Lymphoma Favorable Non-Hodgkin Lymphoma A non-Hodgkin lymphoma with unfavorable prognosis. C68838 Neoplastic Process Unfavorable Non-Hodgkin Lymphoma C2349020 Malignant Unfavorable_Non-Hodgkin_Lymphoma Unfavorable Non-Hodgkin Lymphoma Unfavorable Non-Hodgkin's Lymphoma Unfavorable Non-Hodgkin Lymphoma A thymic epithelial neoplasm characterized by the presence of a lymphocyte-poor component similar to that seen in type A thymoma and a lymphocyte-rich component which contains neoplastic small polygonal epithelial cells. It may be associated with myasthenia gravis and pure red cell aplasia. The majority of cases occur in the anterior mediastinum as Masaoka stage I tumors. A minority of the cases occur as stage II or stage III tumors. The overall survival is reported to be 80-100% at 5 and 10 years. C6885 Neoplastic Process Thymoma Type AB Thymoma Type AB C1266092 CTRP Cellosaurus GDC 8582/1 Undetermined Thymoma_Type_AB 8582/1 Thymoma, mixed type, NOS Thymoma, type AB, NOS Mixed Type Thymoma Thymoma Type AB Thymoma, type AB, NOS Thymoma Type AB A type AB thymoma which is characterized by an aggressive clinical course (capsular invasion, infiltration of the surrounding tissues) and can metastasize. C6886 Neoplastic Process Malignant Type AB Thymoma Malignant Type AB Thymoma C1266093 CTRP GDC 8582/3 Malignant Malignant_Type_AB_Thymoma 8582/3 Thymoma, mixed type, malignant Thymoma, type AB Thymoma, type AB, malignant Malignant Type AB Thymoma Thymoma, type AB, malignant Malignant Type AB Thymoma A thymic epithelial neoplasm characterized by the presence of expanded areas which resemble the normal thymic cortex. The neoplastic epithelial cells are small and scant and there is a dense T-lymphocytic component present. Areas of medullary differentiation with or without Hassall's corpuscles are also present. It may be associated with myasthenia gravis, pure red cell aplasia, and hypogammaglobulinemia. It has a low grade malignant potential. The majority of cases occur in the anterior mediastinum as Masaoka stage I tumors. A minority of the cases occur as stage II tumors. C6887 Neoplastic Process Thymoma Type B1 Thymoma Type B1 C1266094 CTRP Cellosaurus GDC 8583/1 Undetermined Thymoma_Type_B1 8583/1 Thymoma, lymphocyte-rich, NOS Thymoma, lymphocytic, NOS Thymoma, organoid, NOS Thymoma, predominantly cortical, NOS Thymoma, type B1, NOS Lymphocyte-Predominant Thymoma Lymphocyte-Rich Thymoma Organoid Thymoma Predominantly Cortical Thymoma Thymoma Type B1 Thymoma, type B1, NOS Thymoma Type B1 A thymic epithelial neoplasm characterized by the presence of neoplastic large, polygonal epithelial cells with large vesicular nuclei and prominent nucleoli. The neoplastic cells are arranged around perivascular spaces and along septa. Immature T-lymphocytes are also present. It may be associated with myasthenia gravis, pure red cell aplasia, and hypogammaglobulinemia. It is a tumor of moderate malignancy. The majority of cases occur in the anterior mediastinum as Masaoka stage I, stage II, or stage III tumors. Metastatic, stage IV tumors occur less frequently. C6888 Neoplastic Process Thymoma Type B2 Thymoma Type B2 C1266095 CTRP GDC 8584/1 Undetermined Thymoma_Type_B2 8584/1 Thymoma, cortical, NOS Thymoma, type B2, NOS Cortical Thymoma Polygonal Cell Thymoma Thymoma Type B2 Thymoma, type B2, NOS Thymoma Type B2 A type B2 thymoma which is characterized by an aggressive clinical course (capsular invasion, infiltration of the surrounding tissues) and can metastasize. C6889 Neoplastic Process Malignant Type B2 Thymoma Malignant Type B2 Thymoma C1266096 CTRP GDC 8584/3 Malignant Malignant_Type_B2_Thymoma 8584/3 Thymoma, cortical, malignant Thymoma, type B2 Thymoma, type B2, malignant Malignant Type B2 Thymoma Thymoma, type B2, malignant Malignant Type B2 Thymoma A diffuse or multifocal proliferation of uniform nevoid polygonal cells in the leptomeninges. Cells may spread into the Virchow-Robin spaces without frank invasion of the brain. Diffuse melanocytosis carries a poor prognosis even in the absence of histologic malignancy. (WHO) C6890 Neoplastic Process Meningeal Melanocytosis C1266112 GDC 8728/0 Malignant Diffuse_Melanocytosis 8728/0 Diffuse melanocytosis Meningeal melanocytosis Diffuse Melanocytosis Diffuse Melanosis Diffuse Meningeal Melanocytosis Diffuse melanocytosis Meningeal Melanocytosis Meningeal Melanocytosis A rare condition in patients with leptomeningeal melanoma characterized by diffuse or multifocal proliferation of melanoma cells in the leptomeninges. It is often associated with invasion of the central nervous system. C6891 Neoplastic Process Meningeal Melanomatosis C1266114 C1334691 CPTAC Cellosaurus GDC 8728/3 Malignant Melanomatosis Meningeal_Melanomatosis 8728/3 Meningeal melanomatosis Leptomeningeal Melanomatosis Melanomatosis Meningeal Melanomatosis Meningeal melanomatosis Meningeal Melanomatosis A morphologic variant of fibroma characterized by increased cellularity. C6892 Neoplastic Process Cellular Fibroma C1266118 GDC 8810/1 Benign Cellular_Fibroma 8810/1 Cellular fibroma Cellular Fibroma Cellular fibroma Cellular Fibroma A malignant neoplasm of probable fibroblastic derivation. It is characterized by the presence of atypical round to spindle-shaped cells, increased cellularity, necrotic change and high mitotic activity. C6894 Neoplastic Process Malignant Solitary Fibrous Tumor C1266120 CPTAC GDC 8815/3 Malignant Malignant_Solitary_Fibrous_Tumor 8815/3 Solitary fibrous tumor, malignant Malignant Hemangiopericytoma Malignant Solitary Fibrous Tumor Solitary fibrous tumor, malignant Malignant Solitary Fibrous Tumor An adenomyoma characterized by the presence of marked glandular architectural complexity. C6895 Neoplastic Process Atypical Polypoid Adenomyoma C1300347 GDC Benign Atypical_Polypoid_Adenomyoma 8932/0 Atypical polypoid adenomyoma Atypical Polypoid Adenomyoma Atypical polypoid adenomyoma Atypical Polypoid Adenomyoma A variant of Wilms tumor of the kidney characterized by the presence of cystic spaces separated by septa. The septa contain immature epithelial cells, immature stromal cells, and blastema cells. Surgical resection is usually curative. C6897 Neoplastic Process Cystic Partially Differentiated Kidney Nephroblastoma C1266139 GDC NICHD A rare, cystic variant of Wilms tumor wholly comprising cysts in which their thin septa form the only solid portion of the tumor. 8959/1 8959/3 Malignant Cystic_Partially_Differentiated_Nephroblastoma 8959/1 8959/3 Cystic partially differentiated nephroblastoma Malignant cystic nephroma Malignant multilocular cystic nephroma Cystic Partially Differentiated Kidney Nephroblastoma Cystic Partially Differentiated Nephroblastoma Cystic partially differentiated nephroblastoma Malignant Cystic Nephroma Malignant Multilocular Cystic Nephroma Malignant cystic nephroma Malignant multilocular cystic nephroma Cystic Partially Differentiated Kidney Nephroblastoma A usually benign tumor arising from the breast. It is characterized by the proliferation of cells with myoepithelial differentiation around spaces which are lined by epithelial cells. Rarely, the epithelial and/or myoepithelial cells may undergo malignant transformation. Cases with malignant transformation may follow an aggressive clinical course, including recurrences and local and distant metastases. C6899 Neoplastic Process Breast Adenomyoepithelioma C1266146 GDC 8983/0 Benign Adenomyoepithelioma 8983/0 Adenomyoepithelioma Adenomyoepithelioma, NOS Adenomyoepithelioma Adenomyoepithelioma of the Breast Breast Adenomyoepithelioma Breast Adenomyoepithelioma A gestational trophoblastic tumor characterized by the presence of a monomorphous cellular population of intermediate trophoblastic cells infiltrating in a nodular pattern. C6900 Neoplastic Process Epithelioid Trophoblastic Tumor Epithelioid Trophoblastic Tumor C1266159 CTRP GDC 9105/3 Undetermined Epithelioid_Trophoblastic_Tumor 9105/3 Trophoblastic tumor, epithelioid ETT Epithelioid Trophoblastic Tumor Trophoblastic tumor, epithelioid Epithelioid Trophoblastic Tumor A slow-growing malignant bone tumor arising from the remnants of the notochord and occurring in the base of the skull. The tumor is characterized by a lobulated growth pattern, myxoid stroma formation, and the presence of physaliphorous cells and cartilage. C6902 Neoplastic Process Chondroid Chordoma C1266173 GDC 9371/3 Malignant Chondroid_Chordoma 9371/3 Chondroid chordoma Chondroid Chordoma Chondroid chordoma Chondroid Chordoma A variant of ependymoma, often found in the spinal cord, with tumor cells arranged in fascicles of variable width and cell density. Ependymal rosettes are generally absent, so this lesion must be distinguished from astrocytic neoplasms, but its EM characteristics are ependymal. (Adapted from WHO.) C6903 Neoplastic Process Tanycytic Ependymoma C1370500 GDC Undetermined Tanycytic_Ependymoma 9391/3 Tanycytic ependymoma Tanycytic Ependymoma Tanycytic ependymoma Tanycytic Ependymoma A medulloblastoma composed of large cells with prominent nucleoli and a larger amount of cytoplasm in contrast with the cells of the classic medulloblastoma. C6904 Neoplastic Process Large Cell Medulloblastoma C1266180 GDC 9474/3 Malignant Large_Cell_Medulloblastoma 9474/3 Large cell medulloblastoma Large Cell Medulloblastoma Large cell medulloblastoma Large Cell Medulloblastoma A rare, WHO grade II cerebellar neoplasm which shows consistent neuronal, variable astrocytic and focal lipomatous differentiation. It occurs in adults, has a low proliferative potential and usually has a favorable prognosis. (Adapted from WHO) C6905 Neoplastic Process Cerebellar Liponeurocytoma C1370507 GDC 0000/0 Undetermined Cerebellar_Liponeurocytoma 9506/1 Cerebellar liponeurocytoma Lipomatous medulloblastoma Medullocytoma Neurolipocytoma Cerebellar Liponeurocytoma Cerebellar Liponeurocytoma (WHO Grade 2) Cerebellar Liponeurocytoma (WHO Grade II) Cerebellar liponeurocytoma Lipomatous Medulloblastoma Lipomatous medulloblastoma Cerebellar Liponeurocytoma An aggressive malignant embryonal neoplasm arising from the central nervous system. It is composed of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm. Mutations of the SMARCB1 gene or very rarely SMARCA4 (BRG1) gene are present. The vast majority of cases occur in childhood. Symptoms include lethargy, vomiting, cranial nerve palsy, headache, and hemiplegia. C6906 Neoplastic Process Atypical Teratoid/Rhabdoid Tumor C1266184 CPTAC CTEP Cellosaurus GDC 9508/3 Malignant Atypical_Teratoid_Rhabdoid_Tumor 9508/3 Atypical teratoid/rhabdoid tumor AT/RT ATRT ATT/RHT Atypical Teratoid/Rhabdoid Tumor Atypical Teratoid/Rhabdoid Tumor (WHO Grade 4) Atypical Teratoid/Rhabdoid Tumor (WHO Grade IV) Atypical teratoid/rhabdoid tumor CNS Rhabdoid Neoplasm CNS Rhabdoid Tumor Central Nervous System Rhabdoid Neoplasm Central Nervous System Rhabdoid Tumor Malignant Brain Rhabdoid Neoplasm Malignant Brain Rhabdoid Tumor Malignant Rhabdoid Neoplasm of Brain Malignant Rhabdoid Neoplasm of the Brain Malignant Rhabdoid Tumor of Brain Malignant Rhabdoid Tumor of the Brain Primary Malignant Brain Rhabdoid Neoplasm Primary Malignant Brain Rhabdoid Tumor Primary Malignant Rhabdoid Neoplasm of Brain Primary Malignant Rhabdoid Neoplasm of the Brain Primary Malignant Rhabdoid Tumor of Brain Primary Malignant Rhabdoid Tumor of the Brain Rhabdoid Neoplasm of CNS Rhabdoid Neoplasm of Central Nervous System Rhabdoid Neoplasm of the CNS Rhabdoid Neoplasm of the Central Nervous System Rhabdoid Tumor of CNS Rhabdoid Tumor of Central Nervous System Rhabdoid Tumor of the CNS Rhabdoid Tumor of the Central Nervous System atypical teratoid/rhabdoid tumor Atypical Teratoid/Rhabdoid Tumor A WHO grade I meningioma characterized by the presence of a prominent mesenchymal component. The mesenchymal component may be osseous, cartilaginous, myxoid, lipomatous, or a mixture of mesenchymal elements. C6907 Neoplastic Process Metaplastic Meningioma C1384407 GDC Undetermined Metaplastic_Meningioma 9530/0 Metaplastic meningioma Metaplastic Meningioma Metaplastic meningioma Metaplastic Meningioma A WHO grade II, usually recurring meningioma characterized by the predominance of tissues that are histologically similar to chordoma. C6908 Neoplastic Process Chordoid Meningioma C1370510 GDC Undetermined Chordoid_Meningioma 9538/1 Chordoid meningioma Chordoid Meningioma Chordoid meningioma Chordoid Meningioma A WHO grade III meningioma characterized by the predominant presence of rhabdoid cells forming sheets. C6909 Neoplastic Process Rhabdoid Meningioma C0259786 GDC Malignant Rhabdoid_Meningioma 9538/3 Rhabdoid meningioma Rhabdoid Meningioma Rhabdoid meningioma Rhabdoid Meningioma A malignant peripheral nerve sheath tumor characterized by the presence of malignant cells that contain melanin and formation of psammoma bodies. C6910 Neoplastic Process Malignant Melanotic Psammomatous Peripheral Nerve Sheath Tumor C1321709 GDC Malignant Melanotic_Psammomatous_Malignant_Peripheral_Nerve_Sheath_Tumor Melanotic psammomatous MPNST Malignant Melanotic Psammomatous Peripheral Nerve Sheath Tumor Melanocytic Psammomatous MPNST Melanocytic Psammomatous Malignant Peripheral Nerve Sheath Tumor Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor Melanotic psammomatous MPNST Malignant Melanotic Psammomatous Peripheral Nerve Sheath Tumor A WHO grade I perineurioma that arises within the endoneurium. It is characterized by the formation of pseudo-onion bulbs by the proliferating perineural cells. C6911 Neoplastic Process Intraneural Perineurioma C1370658 GDC Benign Intraneural_Perineurioma 9571/0 Intraneural perineurioma Intraneural Perineurioma Intraneural Perineurioma (WHO Grade I) Intraneural perineurioma Intraneural Perineurioma A perineurioma not associated with a nerve, arising from the soft tissues. C6912 Neoplastic Process Soft Tissue Perineurioma C1370657 GDC Benign Soft_Tissue_Perineurioma 9571/0 Soft tissue perineurioma Soft Tissue Perineurioma Soft Tissue Perineurioma (WHO Grades I, II, or III) Soft tissue perineurioma Soft Tissue Perineurioma A subtype of classic Hodgkin lymphoma with scattered Hodgkin and Reed-Sternberg cells and a nodular or less often diffuse cellular background consisting of small lymphocytes and with an absence of neutrophils and eosinophils. (WHO, 2008) C6913 Neoplastic Process Lymphocyte-Rich Classic Hodgkin Lymphoma Lymphocyte-Rich Classic Hodgkin Lymphoma C1266194 CPTAC CTRP GDC PCDC mCode 9651/3 Malignant Lymphocyte_Rich_Classical_Hodgkin_s_Lymphoma 9651/3 Classical Hodgkin lymphoma, lymphocyte-rich Hodgkin disease, lymphocyte predominance, diffuse Hodgkin lymphoma, lymphocyte-rich Lymphocyte-rich classical Hodgkin lymphoma, lymph nodes of head, face, and neck Lymphocyte-rich classical Hodgkin lymphoma, lymph nodes of multiple sites Lymphocyte-rich classical Hodgkin lymphoma, unspecified site Classical Hodgkin lymphoma, lymphocyte-rich Hodgkin Lymphoma, Lymphocyte-Rich Hodgkin lymphoma, lymphocyte-rich LRCHL Lymphocyte Rich Classical Hodgkin Lymphoma Lymphocyte Rich Classical Hodgkin's Disease Lymphocyte Rich Classical Hodgkin's Lymphoma Lymphocyte Rich Hodgkin Lymphoma Lymphocyte Rich Hodgkin's Disease Lymphocyte Rich Hodgkin's Lymphoma Lymphocyte-Rich Classic Hodgkin Lymphoma Lymphocyte-Rich Classical Hodgkin Lymphoma Lymphocyte-Rich Classical Hodgkin's Lymphoma Lymphocyte-rich classical Hodgkin lymphoma, unspecified site Lymphocyte-Rich Classic Hodgkin Lymphoma Classic Hodgkin lymphoma that occurs in adults. C69138 Neoplastic Process Adult Classic Hodgkin Lymphoma Adult Classic Hodgkin Lymphoma C2347747 CTRP Malignant Adult_Classical_Hodgkin_s_Lymphoma Adult Classic Hodgkin Lymphoma Adult Classical Hodgkin Lymphoma Classical Hodgkin Lymphoma Adult Classic Hodgkin Lymphoma Classic Hodgkin lymphoma that occurs during childhood. C69142 Neoplastic Process Childhood Classic Hodgkin Lymphoma C2347757 NICHD A classical Hodgkin lymphoma that occurs during childhood. Four subtypes are included: mixed cellularity, nodular sclerosis, lymphocyte-depleted, lymphocyte-rich. Malignant Childhood_Classical_Hodgkin_s_Lymphoma Childhood Classic Hodgkin Lymphoma Childhood Classical Hodgkin Lymphoma Childhood Classic Hodgkin Lymphoma C69144 Neoplastic Process Recurrent Grade III Lymphomatoid Granulomatosis C2347915 Malignant Recurrent_Grade_III_Lymphomatoid_Granulomatosis Recurrent Grade III Lymphomatoid Granulomatosis Recurrent Grade III Lymphomatoid Granulomatosis A large B-cell lymphoma usually presenting as a serous effusion without detectable tumor masses. It is universally associated with human herpes virus 8 (HHV8), also called Kaposi sarcoma-associated herpesvirus. It mostly occurs in the setting of immunodeficiency. The most common sites of involvement are the pleural, pericardial, and peritoneal cavities. Rare HHV8-positive lymphomas indistinguishable from primary effusion lymphomas (PEL) present as solid tumor masses, and have been termed extracavitary PEL. The prognosis is extremely unfavorable. (WHO 2017) C6915 Neoplastic Process Primary Effusion Lymphoma Primary Effusion Lymphoma C1292753 CTEP CTRP Cellosaurus GDC A rare, aggressive (fast-growing) type of B-cell non-Hodgkin lymphoma marked by an abnormal build-up of fluids in a body cavity. It usually occurs together with a human herpesvirus in people who have weakened immune systems, such as in AIDS. 9678/3 Malignant Primary_Effusion_Lymphoma 9678/3 Primary effusion lymphoma PEL Primary Effusion Lymphoma Primary effusion lymphoma primary effusion lymphoma Primary Effusion Lymphoma A diffuse large B-cell lymphoma variant characterized by the presence of large round, oval, or polygonal cells with bizarre pleomorphic nuclei resembling Hodgkin or Reed-Sternberg cells. It is unrelated to anaplastic large cell lymphoma which is a T-cell non-Hodgkin lymphoma. C6916 Neoplastic Process Anaplastic Lymphoma C1321546 GDC Malignant Anaplastic_Lymphoma 9680/3 Anaplastic large B-cell lymphoma Anaplastic Large B-Cell Lymphoma Anaplastic Lymphoma Anaplastic large B-cell lymphoma Anaplastic Lymphoma A morphologic variant of Burkitt lymphoma characterized by marked nuclear pleomorphism, abundant apoptotic debris, and the presence of tangible body macrophages. C6917 Neoplastic Process Atypical Burkitt/Burkitt-Like Lymphoma C1368771 GDC Malignant Atypical_Burkitt_s_Burkitt_s-Like_Lymphoma 9687/3 Burkitt-like lymphoma Atypical Burkitt's/Burkitt's-Like Lymphoma Atypical Burkitt/Burkitt-Like Lymphoma Burkitt's-like Lymphoma Burkitt-like Lymphoma Burkitt-like lymphoma Atypical Burkitt/Burkitt-Like Lymphoma A cytotoxic primary cutaneous T-cell lymphoma. Recent studies suggest there are at least two groups of subcutaneous panniculitis-like T-cell lymphomas, each with distinct histologic features, immunophenotypic profile, and prognosis. One group has an alpha/beta, CD8 positive phenotype, involves only subcutaneous tissues, and usually has an indolent clinical course. The second group has a gamma/delta phenotype, is CD8 negative, often co-expresses CD56, is not confined to the subcutaneous tissues, and usually has a poor prognosis. In the recent WHO-EORTC classification, the term subcutaneous panniculitis-like T-cell lymphoma is reserved for cases with an alpha/beta, CD8 positive phenotype. Cases with a gamma/delta phenotype are included in the group of cutaneous gamma/delta T-cell lymphomas. C6918 Neoplastic Process Subcutaneous Panniculitis-Like T-Cell Lymphoma Subcutaneous Panniculitis-Like T-Cell Lymphoma C0522624 CTRP GDC mCode 9708/3 Malignant Subcutaneous_Panniculitis-Like_T-Cell_Lymphoma 9708/3 Subcutaneous panniculitis-like T-cell lymphoma SPTCL Subcutaneous Panniculitis-Like T-Cell Lymphoma Subcutaneous Panniculitis-Like T-Cell Lymphoma (Alpha/Beta Type) Subcutaneous Panniculitis-Like T-Cell Lymphoma, Alpha/Beta Type Subcutaneous panniculitis-like T-cell lymphoma Subcutaneous Panniculitis-Like T-Cell Lymphoma The most frequent type of lymphoblastic lymphoma. It comprises approximately 85-90% of cases. It is more frequently seen in adolescent males. It frequently presents with a mass lesion in the mediastinum. Pleural effusions are common. (WHO, 2001) C6919 Neoplastic Process T Lymphoblastic Lymphoma T Lymphoblastic Lymphoma C1292758 CTEP CTRP GDC A type of non-Hodgkin lymphoma in which too many T-cell lymphoblasts (immature white blood cells) are found in the lymph nodes and spleen. It is most common in young men. 9729/3 Malignant Precursor_T_Lymphoblastic_Lymphoma 9729/3 Precursor T-cell lymphoblastic lymphoma Precur. T-lymphoblastic lymphoma Precursor T Lymphoblastic Lymphoma Precursor T-Cell Lymphoblastic Lymphoma Precursor T-Lymphoblastic Lymphoma Precursor T-cell lymphoblastic lymphoma Precursor T-lymphoblastic lymphoma T Lymphoblastic Lymphoma T-Lymphoblastic Lymphoma T-lymphoblastic lymphoma precursor T-lymphoblastic lymphoma T Lymphoblastic Lymphoma A multifocal, unisystem form of Langerhans-cell histiocytosis. There is involvement of multiple sites in one organ system, most frequently the bone. Patients are usually young children presenting with multiple destructive bone lesions. C6920 Neoplastic Process Hand-Schuller-Christian Disease C0268205 CPTAC GDC NICHD mCode A multifocal, unisystem form of Langerhans-cell histiocytosis. There is involvement of multiple sites in one organ system, most frequently the bone. Patients are usually young children presenting with multiple destructive bone lesions. 9753/1 Undetermined Hand-Schuller-Christian_Disease 9751/3 Hand-Schuller-Christian disease Multifocal and unisystemic Langerhans-cell histiocytosis Classic Multifocal Langerhans Cell Histiocytosis Hand-Schuller-Christian Disease Hand-Schuller-Christian disease Hand-Schüller-Christian Disease Multifocal Unisystem Langerhans Cell Histiocytosis Multifocal and unisystemic Langerhans-cell histiocytosis Hand-Schuller-Christian Disease A neoplastic proliferation of Langerhans cells with overtly malignant cytologic features. It can be considered a higher grade variant of Langerhans cell histiocytosis (LCH) and it can present de novo or progress from antecedent LCH. (WHO, 2001) C6921 Neoplastic Process Langerhans Cell Sarcoma C1260327 CPTAC GDC 9756/3 Malignant Langerhans_Cell_Sarcoma 9756/3 Langerhans cell sarcoma Langerhans Cell Sarcoma Langerhans cell sarcoma Langerhans Cell Sarcoma A type of magnetic resonance imaging used to determine the velocity of moving fluids. C69228 Intellectual Product Velocity Encoded MRI C2349114 The image is derived by calculating values based on velocity encoded (e.g., phase contrast). Velocity_Encoded Velocity Encoded Velocity Encoded MRI Velocity Encoded MRI An acute leukemia of ambiguous lineage in which there is a dual population of blasts with each population expressing markers of a distinct lineage (myeloid and lymphoid or B-and T-lymphocyte). (WHO, 2001) C6923 Neoplastic Process Acute Bilineal Leukemia Acute Bilineal Leukemia C0349680 CTRP GDC NICHD An acute leukemia in which there is a dual population of blasts with each population expressing markers of a distinct lineage (myeloid and lymphoid or B-and T-lymphocyte). Malignant Acute_Bilineal_Leukemia 9805/3 Acute bilineal leukemia Acute mixed lineage leukemia Acute Bilineal Leukemia Acute bilineal leukemia Acute Bilineal Leukemia A term referring to acute myeloid leukemias with rearrangement of the KMT2A gene that results in translocations with various genes other than the MLLT3 (AF9) gene. C6924 Neoplastic Process Acute Myeloid Leukemia with a Variant KMT2A Rearrangement C2825116 NICHD A term referring to acute myeloid leukemias with rearrangement of the MLL gene which results in translocations with more than 50 partner genes other than the MLLT3 (AF9) gene. 9897/3 Malignant Acute_Myeloid_Leukemia_with_11q23_MLL_Abnormalities AML with Other KMT2A Rearrangements AML with Variant MLL Translocations Acute Myeloid Leukemia with Other KMT2A Rearrangements Acute Myeloid Leukemia with Variant MLL Rearrangement Acute Myeloid Leukemia with Variant MLL Translocations Acute Myeloid Leukemia with a Variant KMT2A Rearrangement Acute Myeloid Leukemia with a Variant MLL Rearrangement Acute Myeloid Leukemia with a Variant MLL Translocation Acute Myeloid Leukemia with a Variant KMT2A Rearrangement A squamous cell carcinoma arising from the perianal skin. C6925 Neoplastic Process Anal Margin Squamous Cell Carcinoma C1412037 Malignant Anal_Margin_Squamous_Cell_Carcinoma Anal Margin Squamous Cell Carcinoma Perianal Skin Squamous Cell Carcinoma Squamous Cell Carcinoma of Anal Margin Squamous Cell Carcinoma of the Anal Margin Anal Margin Squamous Cell Carcinoma A malignant neoplasm characterized by the presence of atypical mesenchymal-stromal cells. Representative examples include endometrial stromal sarcoma and prostate stromal sarcoma. C6926 Neoplastic Process Stromal Sarcoma C1370723 CDISC GDC A malignant neoplasm characterized by the presence of atypical mesenchymal-stromal cells. 8935/3 Malignant Stromal_Sarcoma 8935/3 Stromal sarcoma, NOS STROMAL SARCOMA, MALIGNANT Stromal Sarcoma Stromal Tumor, Malignant Stromal Sarcoma A thecoma of the ovary which may metastasize to another anatomic site. It is usually characterized by nuclear atypia and mitotic activity. Malignant thecomas are rare. C6929 Neoplastic Process Malignant Ovarian Thecoma C0334398 CDISC Cellosaurus GDC A malignant sex-cord neoplasm of the ovary, originating from theca cells. 8600/3 Malignant Malignant_Thecoma 8600/3 Thecoma, malignant Malignant Ovarian Thecal Cell Neoplasm Malignant Ovarian Thecal Cell Tumor Malignant Ovarian Thecoma Malignant Thecal Cell Neoplasm of Ovary Malignant Thecal Cell Neoplasm of the Ovary Malignant Thecal Cell Tumor of Ovary Malignant Thecal Cell Tumor of the Ovary Malignant Thecoma of Ovary Malignant Thecoma of the Ovary THECOMA, OVARIAN, MALIGNANT Thecoma, Malignant Thecoma, malignant Malignant Ovarian Thecoma A localized malignant neoplasm that arises in the bony skeleton or soft tissue. It is composed of clonal (malignant) plasma cells forming a tumor mass. C6932 Neoplastic Process Solitary Plasmacytoma CL018710 CTEP GDC Malignant Solitary_Plasmacytoma 9731/3 Solitary myeloma Solitary plasmacytoma Solitary Plasmacytoma Solitary plasmacytoma Solitary Plasmacytoma A well differentiated, slow growing neuroepithelial neoplasm composed of neoplastic, mature ganglion cells. C6934 Neoplastic Process Gangliocytoma CL378224 GDC 9492/0 Undetermined Gangliocytoma 9492/0 Gangliocytoma Gangliocytoma, NOS Gangliocytoma Gangliocytoma A meningioma that affects the spinal cord. C6935 Neoplastic Process Spinal Cord Meningioma C0347515 Undetermined Spinal_Cord_Meningioma Meningioma of Spinal Cord Meningioma of the Spinal Cord Spinal Cord Meningioma Spinal Cord Meningioma A locally infiltrating, non-metastasizing angiomyxoma arising from the pelviperineal region. It may recur following resection C6936 Neoplastic Process Deep (Aggressive) Angiomyxoma C1306242 GDC Benign Aggressive_Angiomyxoma 8841/1 Aggressive angiomyxoma Aggressive Angiomyxoma Aggressive angiomyxoma Deep "Aggressive" Angiomyxoma Deep (Aggressive) Angiomyxoma Deep Angiomyxoma Deep (Aggressive) Angiomyxoma A carcinoma arising from the sweat glands. Representative examples include tubular carcinoma, spiradenocarcinoma, eccrine carcinoma, hidradenocarcinoma, and apocrine carcinoma. C6938 Neoplastic Process Sweat Gland Carcinoma C1412016 CDISC GDC A malignant neoplasm arising from sweat glands. 8400/3 Malignant Sweat_Gland_Carcinoma 8400/3 Sweat gland adenocarcinoma Sweat gland carcinoma CARCINOMA, SWEAT GLAND, MALIGNANT Carcinoma of Sweat Gland Carcinoma of the Sweat Gland Sweat Gland Adenocarcinoma Sweat Gland Carcinoma Sweat gland carcinoma Sweat Gland Carcinoma A breast carcinoma characterized by the presence of a ductal carcinoma in situ component and an invasive lobular carcinomatous component. C6939 Neoplastic Process Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma CL018755 GDC Malignant Ductal_Carcinoma_in_situ_and_Infiltrating_Lobular_Carcinoma 8522/3 8524/3 Infiltrating lobular carcinoma and ductal carcinoma in situ Infiltrating lobular mixed with other types of carcinoma Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma DCIS and ILC DCIS and Infiltrating Lobular Carcinoma Ductal Breast Carcinoma In Situ and Invasive Lobular Carcinoma Ductal Carcinoma in situ and Infiltrating Lobular Carcinoma Infiltrating lobular mixed with other types of carcinoma Non-Infiltrating Ductal Carcinoma and ILC Non-Infiltrating Ductal Carcinoma and Infiltrating Lobular Carcinoma Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma A rare benign heart neoplasm usually occurring in young children. It is characterized by the presence of bland spindle cells and collagenous stroma formation. Clinical presentation may include cardiac arrhythmia, cyanosis, heart failure or sudden death. C6947 Neoplastic Process Cardiac Fibroma C1096654 Benign Cardiac_Fibroelastic_Hamartoma Cardiac Fibroelastic Hamartoma Cardiac Fibroma Cardiac Fibrous Hamartoma Fibroelastic Hamartoma of Heart Fibroelastic Hamartoma of the Heart Heart Fibroelastic Hamartoma Heart Fibroma Heart Fibrous Hamartoma Cardiac Fibroma Wilms tumor of the kidney characterized by the absence of nuclear anaplasia. C6951 Neoplastic Process Nonanaplastic Kidney Wilms Tumor C1335062 Malignant Nonanaplastic_Wilms_Tumor Nonanaplastic Kidney Wilms Tumor Nonanaplastic Renal Wilm's Tumor Nonanaplastic Renal Wilms Tumor Nonanaplastic Renal Wilms' Tumor Nonanaplastic Kidney Wilms Tumor Wilms tumor of the kidney characterized by the presence of nuclear anaplasia. Anaplasia is defined by the presence of all of the following: multipolar polyploid mitotic figures, marked nuclear enlargement, and hyperchromasia. When anaplasia is diffuse, it is associated with an unfavorable clinical outcome. C6952 Neoplastic Process Anaplastic Kidney Wilms Tumor C1332289 Malignant Anaplastic_Wilms_Tumor Anaplastic Kidney Wilms Tumor Anaplastic Renal Wilm's Tumor Anaplastic Renal Wilms Tumor Anaplastic Renal Wilms' Tumor Anaplastic Kidney Wilms Tumor An astrocytoma of the brain stem that occurs during adulthood. C6954 Neoplastic Process Adult Brain Stem Astrocytoma C1332191 Undetermined Adult_Brain_Stem_Astrocytoma Adult Brain Stem Astrocytoma Adult Brainstem Astrocytoma Adult Brain Stem Astrocytoma A neuroblastoma arising from the retina. C6956 Neoplastic Process Retinal Neuroblastoma C1867287 Malignant Retinal_Neuroblastoma Neuroblastoma of Retina Neuroblastoma of the Retina Retinal Neuroblastoma Retinal Neuroblastoma An embryonal tumor with multilayered rosettes, C19MC-altered that arises from the cerebral hemispheres and occurs in children. C6957 Neoplastic Process Childhood Cerebral Embryonal Tumor with Multilayered Rosettes, C19MC-Altered C1332962 Malignant Childhood_Cerebral_Ependymoblastoma Childhood Cerebral Embryonal Tumor with Multilayered Rosettes, C19MC-Altered Childhood Cerebral Ependymoblastoma Pediatric Cerebral Ependymoblastoma Childhood Cerebral Embryonal Tumor with Multilayered Rosettes, C19MC-Altered A glial tumor of the brain or spinal cord showing astrocytic differentiation. It includes the following clinicopathological entities: pilocytic astrocytoma, diffuse astrocytoma, anaplastic astrocytoma, pleomorphic xanthoastrocytoma, subependymal giant cell astrocytoma, and glioblastoma. C6958 Neoplastic Process Astrocytic Tumor CL357919 GDC Undetermined Astrocytic_Tumor 9400/3 Astrocytic glioma Astroglioma Astrocytic Neoplasm Astrocytic Tumor Astroglioma Astrocytic Tumor An oligoastrocytoma characterized by the presence of increased cellularity, nuclear atypia, pleomorphism, and high mitotic activity. C6959 Neoplastic Process Anaplastic Oligoastrocytoma C0431108 CPTAC Cellosaurus GDC Malignant Anaplastic_Oligoastrocytoma 9382/3 Anaplastic oligoastrocytoma Anaplastic Mixed Glioma Anaplastic Oligoastrocytoma Anaplastic oligoastrocytoma WHO Grade 3 Mixed Glioma WHO Grade III Mixed Glioma Anaplastic Oligoastrocytoma A neoplasm of the central nervous system composed predominantly of cells morphologically resembling oligodendroglia. Oligodendroglial tumors histologically comprise a continuous spectrum ranging from well-differentiated neoplasms to frankly malignant tumors. WHO grading system recognizes two malignancy grades: WHO grade 2 for well-differentiated tumors (oligodendroglioma) and WHO grade 3 for anaplastic oligodendroglioma. (Adapted from WHO) C6960 Neoplastic Process Oligodendroglial Tumor C1335110 A rare, slow-growing tumor that begins in the oligodendrocytes (brain cells that provide support and nourishment for nerve cells). Undetermined Oligodendroglial_Tumor Oligodendroglial Neoplasm Oligodendroglial Tumor oligodendroglial tumor Oligodendroglial Tumor A group of nervous system tumors which display neuronal differentiation. It includes tumors that are composed of immature round cells and tumors that display advanced differentiation and the formation of ganglion cells. C6963 Neoplastic Process Neuroblastic Tumor C1334953 Malignant Neuroblastic_Tumor Neuroblastic Tumor Neuroblastic Tumor A common pediatric extracranial tumor arising from neural crest cells. It involves the adrenal medulla and the sympathetic nervous system. C6964 Neoplastic Process Neuroblastoma of the Adrenal Gland and Sympathetic Nervous System C1334955 Malignant Neuroblastomas_of_the_Adrenal_Gland_and_Sympathetic_Nervous_System Neuroblastoma of the Adrenal Gland and Sympathetic Nervous System Neuroblastomas of Adrenal Gland and Sympathetic Nervous System Neuroblastoma of the Adrenal Gland and Sympathetic Nervous System A neoplasm arising from the pineocyte, a cell with photosensory and neuroendocrine functions. It may be composed of mature elements or primitive, immature cells. The cellular composition determines the biological behavior and clinical outcome. Three types are recognized: pineoblastoma, pineocytoma, and pineal parenchymal tumor of intermediate differentiation (Adapted from WHO.) C6965 Neoplastic Process Pineal Parenchymal Cell Neoplasm C0031941 CTEP 9360/1 Undetermined Pineal_Parenchymal_Cell_Neoplasm Neoplasm of Pineal Gland Neoplasm of the Pineal Gland Pineal Gland Neoplasm Pineal Gland Tumor Pineal Parenchymal Cell Neoplasm Pineal Parenchymal Cell Tumor Pineal Parenchymal Neoplasm Pineal Parenchymal Tumor Pineal parenchymal tumor Pineocytic Neoplasm Pineocytic Tumor Tumor of Pineal Gland Tumor of the Pineal Gland Pineal Parenchymal Cell Neoplasm A WHO grade 1 slow growing tumor, more frequently affecting young adults. It is composed of small, uniform, mature cells resembling pineocytes with occasional large pineocytomatous rosettes. It may show a wide range of divergent phenotypes, including neuronal, glial, melanocytic, photoreceptor and mesenchymal differentiation. Pineocytoma generally has a relatively favorable prognosis. (Adapted from WHO) C6966 Neoplastic Process Pineocytoma C0917890 CDISC GDC NICHD mCode A benign neoplasm of the brain arising from the pineal gland. A benign, slow growing, pineal parenchymal tumor that more frequently affects young adults. A slow growing type of brain tumor that occurs in or around the pineal gland, a tiny organ near the center of the brain. 9361/1 Benign Pineocytoma 9361/1 Pineocytoma Benign Pinealoma Benign neoplasm of pineal gland PINEOCYTOMA, BENIGN Pinealocytoma Pineocytoma Pineocytoma (WHO Grade 1) Pineocytoma (WHO Grade I) pineocytoma Pineocytoma A WHO grade 2 or 3 pineal parenchymal neoplasm of intermediate-grade malignancy, affecting all ages. It is composed of diffuse sheets or large lobules of uniform cells with mild to moderate nuclear atypia and low to moderate level mitotic activity. (Adapted from WHO) C6967 Neoplastic Process Pineal Parenchymal Tumor of Intermediate Differentiation C1367859 GDC Undetermined Pineal_Parenchymal_Tumor_of_Intermediate_Differentiation 9362/3 Pineal parenchymal tumor of intermediate differentiation PPTID Pineal Parenchymal Tumor of Intermediate Differentiation Pineal parenchymal tumor of intermediate differentiation Pineal Parenchymal Tumor of Intermediate Differentiation A central nervous system embryonal tumor, not otherwise specified arising from the supratentorial region. C6968 Neoplastic Process Supratentorial Embryonal Tumor, Not Otherwise Specified C1336538 CTEP GDC Malignant Supratentorial_Primitive_Neuroectodermal_Tumor 9473/3 Supratentorial PNET CNS/Supratentorial PNET Supratent. primitive neuro. tumor Supratentorial Embryonal Tumor, NOS Supratentorial Embryonal Tumor, Not Otherwise Specified Supratentorial PNET Supratentorial Primitive Neuroectodermal Tumor Supratentorial primitive neuroectodermal tumor Supratentorial Embryonal Tumor, Not Otherwise Specified A schwannoma characterized by a plexiform or multinodular growth pattern. It usually arises from the skin or subcutaneous tissues in the extremities, trunk, and head and neck. C6969 Neoplastic Process Plexiform Schwannoma C1370659 GDC Benign Plexiform_Schwannoma 9560/0 Plexiform schwannoma Plexiform Neurilemmoma Plexiform Neurinoma Plexiform Schwannoma Plexiform schwannoma Plexiform Schwannoma A rare circumscribed, non-encapsulated and grossly pigmented nerve sheath tumor. It is composed of cells with the immunophenotypic and electron microscopic features of Schwann cells which contain melanosomes and are positive for melanoma markers. It usually involves spinal nerve roots but may occur in other locations. It may be associated with PRKAR1A gene mutation and Carney complex. Malignant behavior has been reported in a significant number of patients. C6970 Neoplastic Process Melanotic Schwannoma C1306247 GDC Undetermined Melanocytic_Schwannoma 9560/0 Melanotic schwannoma Pigmented schwannoma Melanocytic Neurilemmoma Melanocytic Schwannoma Melanotic Neurilemmoma Melanotic Neurinoma Melanotic Schwannoma Melanotic schwannoma Pigmented Neurilemmoma Pigmented Schwannoma Pigmented schwannoma Melanotic Schwannoma A neoplasm that arises from meningothelial cells. This category refers to meningiomas. C6971 Neoplastic Process Meningothelial Cell Neoplasm C1334698 Undetermined Meningothelial_Cell_Neoplasm Meningothelial Cell Neoplasm Meningothelial Cell Tumor Primary Meningeal Neoplasm Primary Meningeal Tumor Tumor of Meningothelial Cells Meningothelial Cell Neoplasm A liposarcoma arising from the brain. C6973 Neoplastic Process Brain Liposarcoma C1334242 Malignant Intracranial_Liposarcoma Brain Liposarcoma Intracranial Liposarcoma Brain Liposarcoma Also known as chromophil carcinoma, it represents a minority of renal cell carcinomas. It can be hereditary or sporadic. The sporadic papillary renal cell carcinoma is characterized by trisomy of chromosomes 7, 16, and 17, and loss of chromosome Y. The peak incidence is in the sixth and seven decades. It is classified as type 1 or 2, based on the cytoplasmic volume and the thickness of the lining neoplastic cells. The prognosis is more favorable than for conventional (clear cell) renal cell carcinoma. C6975 Neoplastic Process Papillary Renal Cell Carcinoma Papillary Renal Cell Carcinoma C1306837 CTEP CTRP Cellosaurus GDC Malignant Papillary_Renal_Cell_Carcinoma 51 71 8260/3 Papillary Renal Cell Papillary renal cell carcinoma Chromophil Carcinoma of Kidney Chromophil Carcinoma of the Kidney Chromophil Renal Cell Carcinoma PRCC Papillary (Chromophil) Renal Cell Carcinoma Papillary RCC Papillary Renal Cell Cancer Papillary Renal Cell Carcinoma Papillary renal cell carcinoma Papillary Renal Cell Carcinoma A squamous cell carcinoma that arises from the penis and cannot be classified according to other morphologic subtypes. C6979 Neoplastic Process Penile Squamous Cell Carcinoma, Usual Type C1336081 Malignant Squamous_Cell_Carcinoma_of_the_Penis_Usual_Type Penile Squamous Cell Carcinoma, Usual Type Squamous Cell Carcinoma of Penis, Usual Type Squamous Cell Carcinoma of the Penis, Usual Type Penile Squamous Cell Carcinoma, Usual Type An aggressive, human papillomavirus-related squamous cell carcinoma that arises from the penis. It is characterized by the presence of nests of small malignant cells. The malignant cells tend to invade deeply into the adjacent tissues. Comedo-type necrosis is often present. C6980 Neoplastic Process Penile Basaloid Squamous Cell Carcinoma C1332462 Malignant Basaloid_Carcinoma_of_the_Penis Basaloid Carcinoma of Penis Basaloid Carcinoma of the Penis Basaloid Penile Squamous Cell Carcinoma Basaloid Squamous Cell Carcinoma of Penis Penile Basaloid Squamous Cell Carcinoma Squamous Cell Carcinoma of Penis, Basaloid Type Squamous Cell Carcinoma of the Penis, Basaloid Type Penile Basaloid Squamous Cell Carcinoma A squamous cell carcinoma that arises from the penis. It is characterized by a papillary growth pattern, hyperkeratosis and parakeratosis. Koilocytotic atypia is present. Human papillomavirus types 16 and 6 have been identified in some cases. C6981 Neoplastic Process Penile Warty Carcinoma C1337009 Malignant Warty_Carcinoma_of_the_Penis Condylomatous Carcinoma of Penis Condylomatous Carcinoma of the Penis Condylomatous Penile Squamous Cell Carcinoma Condylomatous Squamous Cell Carcinoma of Penis Condylomatous Squamous Cell Carcinoma of the Penis Penile Warty Carcinoma Squamous Cell Carcinoma of Penis, Condylomatous Type Squamous Cell Carcinoma of Penis, Warty Type Squamous Cell Carcinoma of the Penis, Condylomatous Type Squamous Cell Carcinoma of the Penis, Warty Type Warty Carcinoma of Penis Warty Carcinoma of the Penis Warty Penile Squamous Cell Carcinoma Warty Squamous Cell Carcinoma of Penis Warty Squamous Cell Carcinoma of the Penis Penile Warty Carcinoma A slow growing, locally recurring, very well differentiated papillary squamous cell carcinoma that arises from the penis. It is characterized by the presence of acanthosis and hyperkeratosis. The neoplastic infiltrate extends into the underlying stroma with a pushing border. Koilocytotic atypia is not present. C6982 Neoplastic Process Penile Verrucous Carcinoma C1336955 Malignant Verrucous_Carcinoma_of_the_Penis Penile Verrucous Carcinoma Squamous Carcinoma of Penis, Verrucous Type Squamous Carcinoma of the Penis, Verrucous Type Verrucous Carcinoma of Penis Verrucous Carcinoma of the Penis Verrucous Penile Carcinoma Verrucous Penile Squamous Carcinoma Verrucous Squamous Carcinoma of Penis Verrucous Squamous Carcinoma of the Penis Penile Verrucous Carcinoma A squamous cell carcinoma that arises from the penis and is characterized by the presence of a papillary growth pattern. C6983 Neoplastic Process Penile Papillary Carcinoma C1335322 Malignant Papillary_Carcinoma_of_the_Penis Papillary Carcinoma of Penis Papillary Carcinoma of the Penis Papillary Penile Carcinoma Papillary Penile Squamous Carcinoma Papillary Squamous Carcinoma of Penis Papillary Squamous Carcinoma of the Penis Penile Papillary Carcinoma Squamous Carcinoma of Penis, Papillary Type Squamous Carcinoma of the Penis, Papillary Type Penile Papillary Carcinoma A squamous cell carcinoma that arises from the penis and is characterized by the presence of malignant spindle-shaped cells. C6984 Neoplastic Process Penile Sarcomatoid Carcinoma C1335923 Malignant Sarcomatoid_Carcinoma_of_the_Penis Penile Sarcomatoid Carcinoma Penile Spindle Cell Carcinoma Sarcomatoid Carcinoma of the Penis Sarcomatoid Penile Carcinoma Sarcomatoid Penile Squamous Cell Carcinoma Sarcomatous Carcinoma of the Penis Spindle Cell Carcinoma of the Penis Squamous Cell Carcinoma of Penis, Sarcomatoid Type Squamous Cell Carcinoma of the Penis, Sarcomatoid Type Penile Sarcomatoid Carcinoma A complete hydatidiform mole or very rarely a partial mole that invades the myometrium. C6985 Neoplastic Process Invasive Hydatidiform Mole Invasive Hydatidiform Mole C0008493 CTRP GDC NICHD A complete hydatidiform mole or very rarely a partial mole that invades the myometrium. A type of cancer that grows into the muscular wall of the uterus. It is formed after conception (fertilization of an egg by a sperm). It may spread to other parts of the body, such as the vagina, vulva, and lung. 9100/1 Undetermined Invasive_Hydatidiform_Mole 9100/1 Chorioadenoma Chorioadenoma destruens Invasive hydatidiform mole Invasive mole, NOS Malignant hydatidiform mole Chorioadenoma Chorioadenoma Destruens Chorioadenoma destruens Invasive Gestational Trophoblastic Neoplasm Invasive Hydatidiform Mole Invasive Mole Invasive hydatidiform mole chorioadenoma destruens invasive hydatidiform mole Invasive Hydatidiform Mole An invasive breast carcinoma characterized by the presence of a predominant squamous cell component that is admixed with the ductal carcinomatous component. C6987 Neoplastic Process Breast Ductal Carcinoma with Squamous Metaplasia C1333319 Malignant Ductal_Breast_Carcinoma_with_Squamous_Metaplasia Breast Ductal Carcinoma with Squamous Metaplasia Ductal Breast Carcinoma with Squamous Metaplasia Ductal Carcinoma of Breast with Squamous Metaplasia Ductal Carcinoma of the Breast with Squamous Metaplasia Breast Ductal Carcinoma with Squamous Metaplasia A malignant neoplasm of embryonal origin, arising from the central nervous system. It usually affects children. Representative examples include ependymoblastoma, medulloblastoma, and atypical teratoid/rhabdoid tumor. C6990 Neoplastic Process Central Nervous System Embryonal Tumor C1333378 CPTAC Malignant Embryonal_Neoplasm_of_the_CNS CNS embryonal tumor, NOS CNS Embryonal Neoplasm CNS Embryonal Tumor Central Nervous System Embryonal Neoplasm Central Nervous System Embryonal Tumor Embryonal Neoplasm of CNS Embryonal Neoplasm of Central Nervous System Embryonal Neoplasm of the CNS Embryonal Neoplasm of the Central Nervous System Embryonal Tumor of CNS Embryonal Tumor of Central Nervous System Embryonal Tumor of the CNS Embryonal Tumor of the Central Nervous System Central Nervous System Embryonal Tumor A benign or malignant neoplasm involving the oculomotor nerve. C6994 Neoplastic Process Oculomotor Nerve Neoplasm C1263895 Undetermined Oculomotor_Nerve_Neoplasm Cranial Nerve III Tumor IIIrd Cranial Nerve Tumor Oculomotor Nerve Neoplasm Oculomotor Nerve Tumor Oculomotor Nerve Neoplasm A primary or metastatic malignant neoplasm involving the oculomotor nerve. C6995 Neoplastic Process Malignant Oculomotor Nerve Neoplasm C0686417 Malignant Malignant_Oculomotor_Nerve_Neoplasm IIIrd Cranial Nerve Neoplasm, Malignant Malignant Oculomotor Nerve Neoplasm Oculomotor Nerve Neoplasm, Malignant Malignant Oculomotor Nerve Neoplasm A central nervous system benign and slow growing adipose tissue tumor characterized by the presence of polygonal brown fat cells with abundant cytoplasm. C6997 Neoplastic Process Central Nervous System Hibernoma C1708362 Benign Hibernoma_of_the_Nervous_System Central Nervous System Hibernoma Hibernoma of Central Nervous System Hibernoma of the Central Nervous System Central Nervous System Hibernoma A benign smooth muscle neoplasm arising from the central nervous system. It is characterized by the presence of intersecting fascicles composed of spindle cells that often lack mitotic activity. C6998 Neoplastic Process Central Nervous System Leiomyoma C1334382 Benign Leiomyoma_of_the_Central_Nervous_System Central Nervous System Leiomyoma Leiomyoma of CNS Leiomyoma of Central Nervous System Leiomyoma of the CNS Leiomyoma of the Central Nervous System Central Nervous System Leiomyoma An aggressive malignant smooth muscle neoplasm, arising from the central nervous system. It is characterized by a proliferation of neoplastic spindle cells. C6999 Neoplastic Process Central Nervous System Leiomyosarcoma C1334385 Malignant Leiomyosarcoma_of_the_Central_Nervous_System CNS Leiomyosarcoma Central Nervous System Leiomyosarcoma Leiomyosarcoma of CNS Leiomyosarcoma of Central Nervous System Leiomyosarcoma of the CNS Leiomyosarcoma of the Central Nervous System Central Nervous System Leiomyosarcoma A benign mesenchymal neoplasm arising from the central nervous system. It consists of mature skeletal muscle tissue. C7000 Neoplastic Process Central Nervous System Rhabdomyoma C1335780 Benign Rhabdomyoma_of_the_Central_Nervous_System Central Nervous System Rhabdomyoma Rhabdomyoma of Central Nervous System Rhabdomyoma of the Central Nervous System Central Nervous System Rhabdomyoma An extraskeletal chondroma usually arising from the dura. C7001 Neoplastic Process Central Nervous System Chondroma C1333019 Benign Chondroma_of_the_Central_Nervous_System CNS Chondroma CNS Osteochondroma Central Nervous System Chondroma Central Nervous System Osteochondroma Chondroma of CNS Chondroma of Central Nervous System Chondroma of the CNS Chondroma of the Central Nervous System Osteochondroma of CNS Osteochondroma of Central Nervous System Osteochondroma of the CNS Osteochondroma of the Central Nervous System Central Nervous System Chondroma An osteosarcoma arising from the brain or spinal cord. C7002 Neoplastic Process Central Nervous System Extraskeletal Osteosarcoma C1335150 Malignant Osteosarcoma_of_the_Central_Nervous_System Central Nervous System Extraskeletal Osteosarcoma Osteosarcoma of Central Nervous System Osteosarcoma of the Central Nervous System Central Nervous System Extraskeletal Osteosarcoma A hemangioma arising from the brain and spinal cord. C7004 Neoplastic Process Central Nervous System Hemangioma C1333957 Benign Hemangioma_of_the_Central_Nervous_System Central Nervous System Hemangioma Hemangioma of CNS Hemangioma of Central Nervous System Hemangioma of the CNS Hemangioma of the Central Nervous System Central Nervous System Hemangioma A Kaposi sarcoma arising from the brain, spinal cord, or meninges. C7006 Neoplastic Process Central Nervous System Kaposi Sarcoma C1334318 Malignant Kaposi_Sarcoma_of_the_Central_Nervous_System CNS Kaposi Sarcoma Central Nervous System Kaposi Sarcoma Kaposi Sarcoma of CNS Kaposi Sarcoma of Central Nervous System Kaposi Sarcoma of the CNS Kaposi Sarcoma of the Central Nervous System Central Nervous System Kaposi Sarcoma A rare, slow-growing, WHO grade I tumor of uncertain histogenesis that arises from the central nervous system. It is composed of stromal cells and abundant capillaries. It can occur sporadically or as part of von Hippel- Lindau syndrome. C7007 Neoplastic Process Central Nervous System Hemangioblastoma C1333955 Undetermined Hemangioblastoma_of_the_Central_Nervous_System CNS Hemangioblastoma Central Nervous System Capillary Hemangioblastoma Central Nervous System Hemangioblastoma Hemangioblastoma of CNS Hemangioblastoma of Central Nervous System Hemangioblastoma of the CNS Central Nervous System Hemangioblastoma A myeloid sarcoma that affects the meninges or the cerebral hemispheres. C7008 Neoplastic Process Intracranial Myeloid Sarcoma C1334244 Malignant Intracranial_Myeloid_Sarcoma Intracranial Chloroma Intracranial Myeloid Sarcoma Intracranial Myeloid Sarcoma A malignant germ cell tumor arising from the central nervous system. It is composed of uniform cells resembling primitive germ cells. These cells have large, vesicular nuclei, prominent nucleoli and a clear, glycogen-rich cytoplasm. Additional features are lymphoid or lymphoplasmacytic infiltrates and, less frequently, scattered syncytiotrophoblastic giant cells. (Adapted from WHO) C7009 Neoplastic Process Germinoma Central Nervous System Germinoma C1333813 CPTAC CTEP CTRP GDC NICHD PCDC A germinomatous germ cell tumor arising in the central nervous system; it is histologically identical to the dysgerminoma and seminoma. 9064/3 Malignant Germinoma_of_the_Central_Nervous_System 9064/3 Germinoma Central Nervous System Germinoma Germinoma Germinoma of CNS Germinoma of Central Nervous System Germinoma of the CNS Germinoma of the Central Nervous System Central Nervous System Germinoma A malignant germ cell tumor of the central nervous system composed of large cells that proliferate in cohesive nests and sheets. In rare occasions, tumor cells may replicate the structure of the early embryo, forming "embryoid bodies" replete with germ discs and miniature amniotic cavities. Additional morphologic characteristics include enlarged nucleoli, abundant clear to somewhat violet-hued cytoplasm, a high mitotic rate and zones of coagulative necrosis. (Adapted from WHO) C7010 Neoplastic Process Central Nervous System Embryonal Carcinoma C1333377 Malignant Embryonal_Carcinoma_of_the_CNS Central Nervous System Embryonal Carcinoma Embryonal Carcinoma of CNS Embryonal Carcinoma of the Central Nervous System Central Nervous System Embryonal Carcinoma A malignant germ cell tumor of the central nervous system composed of primitive-appearing epithelial cells - putatively representing yolk sac endoderm - set in a loose, variably cellular, and often conspicuously myxoid matrix, resembling extra-embryonic mesoblast. Eosinophilic hyaline globules immunoreactive for AFP are a diagnostic feature. (WHO) C7011 Neoplastic Process Central Nervous System Yolk Sac Tumor C1337040 Malignant Yolk_Sac_Tumor_of_the_CNS CNS Yolk Sac Tumor Central Nervous System Yolk Sac Tumor Yolk Sac Tumor of CNS Yolk Sac Tumor of Central Nervous System Yolk Sac Tumor of the CNS Yolk Sac Tumor of the Central Nervous System Central Nervous System Yolk Sac Tumor A malignant germ cell tumor of the central nervous system characterized by extra-embryonic differentiation along trophoblastic lines. The diagnosis requires the identification of cytotrophoblastic elements, as well as syncytiotrophoblastic giant cells. (WHO) C7012 Neoplastic Process Central Nervous System Choriocarcinoma C1332876 Malignant Central_Nervous_System_Choriocarcinoma Central Nervous System Choriocarcinoma Choriocarcinoma of CNS Choriocarcinoma of the CNS Central Nervous System Choriocarcinoma A mature teratoma arising in the central nervous system. C7013 Neoplastic Process Central Nervous System Mature Teratoma C1332886 Benign Central_Nervous_System_Mature_Teratoma CNS Mature Teratoma Central Nervous System Mature Teratoma Mature Teratoma of CNS Mature Teratoma of Central Nervous System Mature Teratoma of the CNS Mature Teratoma of the Central Nervous System Central Nervous System Mature Teratoma A teratoma involving the central nervous system and characterized by the presence of an extensive component of immature, fetal-type tissues. C7014 Neoplastic Process Central Nervous System Immature Teratoma C1332883 Undetermined Central_Nervous_System_Immature_Teratoma CNS Immature Teratoma Central Nervous System Immature Teratoma Immature Teratoma of CNS Immature Teratoma of Central Nervous System Immature Teratoma of the CNS Immature Teratoma of the Central Nervous System Central Nervous System Immature Teratoma A central nervous system teratoma characterized by the presence of a malignant component. The malignant component most often is sarcomatous (rhabdomyosarcoma or undifferentiated sarcoma) or carcinomatous (squamous cell carcinoma or adenocarcinoma). C7015 Neoplastic Process Central Nervous System Teratoma with Malignant Transformation C1336704 Malignant Teratoma_of_the_CNS_with_Malignant_Transformation CNS Teratoma with Malignant Transformation Central Nervous System Teratoma with Malignant Transformation Teratoma of CNS with Malignant Transformation Teratoma of Central Nervous System with Malignant Transformation Teratoma of the CNS with Malignant Transformation Teratoma of the Central Nervous System with Malignant Transformation Central Nervous System Teratoma with Malignant Transformation A malignant germ cell tumor of the central nervous system characterized by the presence of at least two types of germ cell neoplasia. C7016 Neoplastic Process Central Nervous System Mixed Germ Cell Tumor C1334785 Malignant Mixed_Germ_Cell_Neoplasms_of_the_Central_Nervous_System CNS Mixed Germ Cell Tumor Central Nervous System Mixed Germ Cell Tumor Mixed Germ Cell Neoplasm of the Central Nervous System Mixed Germ Cell Tumor of CNS Mixed Germ Cell Tumor of the CNS Mixed Germ Cell Tumor of the Central Nervous System Central Nervous System Mixed Germ Cell Tumor A generally benign intrasellar and/or suprasellar mass arising from the neurohypophysis or infundibulum. It is composed of nests of large cells with granular, eosinophilic cytoplasm due to abundant intracytoplasmic lysosomes. It generally has a slow progression and lacks invasive growth. (Adapted from WHO) C7017 Neoplastic Process Granular Cell Tumor of the Sellar Region C1333873 GDC 9582/0 Undetermined Granular_Cell_Tumor_of_the_Neurohypophysis 9582/0 Granular cell tumor of sellar region Granular cell tumor of the sellar region Granular Cell Tumor of Neurohypophysis Granular Cell Tumor of the Neurohypophysis Granular Cell Tumor of the Neurohypophysis (WHO Grade 1) Granular Cell Tumor of the Neurohypophysis (WHO Grade I) Granular Cell Tumor of the Posterior Pituitary Gland Granular Cell Tumor of the Sellar Region Granular Cell Tumour of the Sellar Region/Granular Cell Pituicytoma Granular cell tumor of the sellar region Granular Cell Tumor of the Sellar Region A benign neoplasm arising from nerve sheaths. It is characterized by the presence of a myxoid stroma. C7018 Neoplastic Process Nerve Sheath Myxoma C0206730 GDC 9562/0 Benign Neurothekeoma 9562/0 Nerve sheath myxoma Neurothekeoma Nerve Sheath Myxoma Nerve sheath myxoma Neurothekeoma Nerve Sheath Myxoma Trilateral retinoblastoma refers to bilateral (or less often unilateral) retinoblastoma associated with an intracranial primitive neuroectodermal tumor in the pineal or suprasellar region. This syndrome is often associated with a increased familial incidence of retinoblastoma. (From Cancer 86(1): 135-141, 1999). C7019 Neoplastic Process Trilateral Retinoblastoma C2608045 Malignant Trilateral_Retinoblastoma Trilateral Retinoblastoma Trilateral Retinoblastoma A multinodular intermediate fibroblastic neoplasm affecting the central nervous system. It is characterized by the presence of spindle-shaped fibroblasts and myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes and plasma cells. C7020 Neoplastic Process Central Nervous System Inflammatory Myofibroblastic Tumor C1334183 Undetermined Inflammatory_Pseudotumor_Intracranial Central Nervous System Inflammatory Myofibroblastic Tumor Central Nervous System Inflammatory Myofibroblastic Tumor A multinodular intermediate fibroblastic neoplasm arising from the stomach. It is characterized by the presence of spindle-shaped fibroblasts and myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes and plasma cells. C7022 Neoplastic Process Gastric Inflammatory Myofibroblastic Tumor C1333774 Undetermined Gastric_Inflammatory_Myofibroblastic_Tumor Gastric Inflammatory Myofibroblastic Neoplasm Gastric Inflammatory Myofibroblastic Tumor Inflammatory Gastric Pseudotumor Inflammatory Myofibroblastic Neoplasm of Stomach Inflammatory Myofibroblastic Neoplasm of the Stomach Inflammatory Myofibroblastic Tumor of Stomach Inflammatory Myofibroblastic Tumor of the Stomach Inflammatory Pseudotumor of Stomach Inflammatory Pseudotumor of the Stomach Gastric Inflammatory Myofibroblastic Tumor Multiple myeloma that is resistant to treatment. C7024 Neoplastic Process Refractory Plasma Cell Myeloma Refractory Multiple Myeloma CL388335 CTRP Malignant Refractory_Plasma_Cell_Myeloma Refractory Multiple Myeloma Refractory Multiple Myeloma/Plasma Cell Myeloma Refractory Plasma Cell Myeloma Refractory Multiple Myeloma The reemergence of multiple myeloma after a period of remission. C7025 Neoplastic Process Recurrent Plasma Cell Myeloma Recurrent Multiple Myeloma C2349261 CTRP mCode Malignant Recurrent_Plasma_Cell_Myeloma Multiple myeloma in relapse Recurrent Multiple Myeloma Recurrent Multiple Myeloma/Plasma Cell Myeloma Recurrent Plasma Cell Myeloma Relapsed Plasma Cell Myeloma Recurrent Multiple Myeloma An adenocarcinoma arising from Barrett metaplastic epithelium in the esophagus. There is evidence supporting the idea that the Barrett adenocarcinomas develop through a stepwise progression through intestinal metaplastic epithelium to epithelial dysplasia to malignancy. Adenocarcinomas arising in the setting of Barrett esophagus are typically papillary and/or tubular. In terms of grading, they are well or moderately differentiated adenocarcinomas. C7027 Neoplastic Process Barrett Adenocarcinoma Barrett Adenocarcinoma C1332460 CTRP Cellosaurus Malignant Barrett_s_Adenocarcinoma Adenocarcinoma Arising in Barrett's Mucosa Barrett Adenocarcinoma Barrett's Adenocarcinoma Barrett Adenocarcinoma A rare morphologic variant of esophageal squamous cell carcinoma. Histologically, it is composed of closely packed cells with hyperchromatic nuclei and scant basophilic cytoplasm. It has a similar prognosis to the conventional squamous cell carcinoma of the esophagus. (WHO) C7032 Neoplastic Process Esophageal Basaloid Carcinoma Esophageal Basaloid Squamous Cell Carcinoma C1333443 CTRP Malignant Esophageal_Basaloid_Squamous_Cell_Carcinoma Basaloid Squamous Carcinoma of Esophagus Basaloid Squamous Carcinoma of the Esophagus Esophageal Basaloid Carcinoma Esophageal Basaloid Squamous Cell Carcinoma Esophageal Basaloid Squamous Cell Carcinoma An intestinal-type adenoma that arises from the stomach. It is characterized by the presence of a tubular architectural pattern. C7036 Neoplastic Process Gastric Tubular Adenoma C1333792 Benign Gastric_Tubular_Adenoma Gastric Tubular Adenoma Tubular Adenoma of Stomach Tubular Adenoma of the Stomach Gastric Tubular Adenoma An intestinal-type adenoma that arises from the stomach. It is characterized by the presence of a tubulovillous architectural pattern. C7037 Neoplastic Process Gastric Tubulovillous Adenoma C1333793 Benign Gastric_Tubulovillous_Adenoma Gastric Tubulovillous Adenoma Tubulovillous Adenoma of Stomach Tubulovillous Adenoma of the Stomach Gastric Tubulovillous Adenoma An intestinal-type adenoma that arises from the stomach. It is characterized by the presence of a villous architectural pattern. C7038 Neoplastic Process Gastric Villous Adenoma C1333794 Benign Gastric_Villous_Adenoma Gastric Villous Adenoma Villous Adenoma of Stomach Villous Adenoma of the Stomach Gastric Villous Adenoma A usually polypoid neoplasm that arises from the glandular epithelium of the colonic mucosa. It is characterized by a tubular architectural pattern. The neoplastic glandular cells have dysplastic features. C7041 Neoplastic Process Colon Tubular Adenoma C1112503 Benign Colon_Tubular_Adenoma Colon Tubular Adenoma Colon Tubular Adenoma A ganglioneuroma that arises from the colon. It usually presents as a small mucosal polyp. C7042 Neoplastic Process Colon Ganglioneuroma C1333087 Benign Colon_Ganglioneuroma Colon Ganglioneuroma Colonic Ganglioneuroma Colon Ganglioneuroma An extra-adrenal paraganglioma that arises from the urinary system. C7046 Neoplastic Process Urinary System Paraganglioma C1336894 Undetermined Urogenital_System_Paraganglioma Urinary System Paraganglioma Urinary Tract Paraganglioma Urinary System Paraganglioma A meningioma that affects the supratentorial brain. C7048 Neoplastic Process Supratentorial Meningioma C1336537 Undetermined Supratentorial_Meningioma Supratentorial Meningioma Supratentorial Meningioma An astrocytic tumor occurring during adulthood. Representative examples include diffuse astrocytoma, anaplastic astrocytoma, and glioblastoma. C7049 Neoplastic Process Adult Astrocytic Tumor Adult Astrocytic Tumor C1332183 CTRP Undetermined Adult_Astrocytic_Tumor Adult Astrocytic Neoplasm Adult Astrocytic Tumor Astrocytic Tumor Adult Astrocytic Tumor C7051 Neoplastic Process Meningioma by Site C1334697 Header_Concept Undetermined Meningioma_by_Site Meningioma by Site Meningioma by Site A benign, localized, nodular and well-circumscribed neoplasm usually seen as a congenital neoplasm or in the first year of life. It is characterized by a biphasic growth pattern and is composed of small, undifferentiated mesenchymal cells associated with branching thin-walled vessels and more mature neoplastic spindle cells with abundant eosinophilic cytoplasm in a collagenous stroma. C7052 Neoplastic Process Myofibroma Myofibroma C4228279 CTRP GDC 8824/0 Benign Solitary_Myofibromatosis 8824/0 Myofibroma Myofibroma Myofibroma A cavernous hemangioma arising from the face. C7053 Neoplastic Process Cavernous Hemangioma of the Face C1332863 Benign Cavernous_Hemangioma_of_the_Face Cavernous Hemangioma of Face Cavernous Hemangioma of the Face Cavernous Hemangioma of the Face Lymphocyte-rich classic Hodgkin lymphoma occurring in childhood. C7054 Neoplastic Process Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma C1332978 CTRP NICHD A lymphocyte-rich, classical Hodgkin lymphoma that occurs during childhood. Malignant Childhood_Lymphocyte_Rich_Classical_Hodgkin_s_Lymphoma Childhood Lymphocyte Rich Classical Hodgkin Lymphoma Childhood Lymphocyte Rich Classical Hodgkin's Disease Childhood Lymphocyte Rich Classical Hodgkin's Lymphoma Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma Childhood Lymphocyte-Rich Classical Hodgkin Lymphoma Lymphocyte-Rich Classical Hodgkin Lymphoma Pediatric Lymphocyte Rich Classical Hodgkin's Disease Pediatric Lymphocyte Rich Classical Hodgkin's Lymphoma Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma A neoplasm of immature malignant lymphocytes (lymphoblasts) committed to the B-cell or T-cell lineage. Neoplasms involving the bone marrow and the peripheral blood are called precursor lymphoblastic leukemias or acute lymphoblastic leukemias. Neoplasms involving primarily lymph nodes or extranodal sites are called lymphoblastic lymphomas. C7055 Neoplastic Process Precursor Lymphoid Neoplasm C1335469 CPTAC Malignant Precursor_Lymphoblastic_Leukemia_Lymphoma Precursor Lymphoblastic Leukemia/Lymphoma Precursor Lymphoblastic Lymphoma/Leukemia Precursor Lymphoid Neoplasm Precursor Lymphoid Neoplasm A non-Hodgkin lymphoma that originates from mature B lymphocytes. Representative examples include diffuse large B-cell lymphoma, follicular lymphoma, marginal zone lymphoma, mantle cell lymphoma, and small lymphocytic lymphoma. C7056 Neoplastic Process Mature B-Cell Non-Hodgkin Lymphoma Mature B-Cell Non-Hodgkin Lymphoma C1334634 CTRP GDC Malignant Mature_B-Cell_Non-Hodgkin_s_Lymphoma Mature B-Cell Lymphomas Mature B-Cell Lymphoma Mature B-Cell Lymphomas Mature B-Cell Non-Hodgkin Lymphoma Mature B-Cell Non-Hodgkin's Lymphoma Mature B-Cell Non-Hodgkin Lymphoma A benign, intermediate, or malignant neoplasm that arises from the mesenchyma-derived cells of the soft tissue or bone. Representative examples include lipoma, leiomyoma, leiomyosarcoma and osteosarcoma. C7059 Neoplastic Process Mesenchymal Cell Neoplasm C1334699 Undetermined Mesenchymal_Cell_Neoplasm Mesenchymal Cell Neoplasm Mesenchymal Cell Tumor Mesenchymal Neoplasm Mesenchymal Tumor Mesenchymal Cell Neoplasm A neoplasm arising from the neural retina. This category includes retinoblastoma and retinocytoma. C7061 Neoplastic Process Retinal Cell Neoplasm C1335765 Undetermined Retinal_Cell_Neoplasm Retinal Cell Neoplasm Retinal Cell Tumor Retinal Neural Cell Neoplasm Retinal Cell Neoplasm A bone tumor arising from the remnants of the fetal notochord. This category includes the chordoma and benign notochordal cell tumor. C7063 Neoplastic Process Notochordal Tumor C1335069 Undetermined Notochordal_Neoplasm Notochordal Neoplasm Notochordal Tumor Notochordal Tumor A neoplasm affecting cells of the erythroid lineage. C7064 Neoplastic Process Erythroid Neoplasm C1333438 Malignant Erythroid_Neoplasm Erythroid Neoplasm Erythroid Tumor Erythroid Neoplasm A neoplasm composed of a lymphocytic cell population which is usually malignant (clonal) by molecular genetic and/or immunophenotypic analysis. Lymphocytic neoplasms include Hodgkin and non-Hodgkin lymphomas, acute and chronic lymphocytic leukemias, and plasma cell neoplasms. C7065 Neoplastic Process Lymphocytic Neoplasm C0598798 CPTAC Undetermined Lymphocytic_Neoplasm Other immunoproliferative neoplasms Lymphocytic Neoplasm Lymphocytic Tumor Lymphocytic and Plasma Cell Neoplasm Lymphocytic and Plasma Cell Tumor Lymphocytic and Plasma Cell Tumour Lymphocytic and Plasmacytic Neoplasm Lymphoid Neoplasm Lymphoid Tumor Lymphoid and Plasma Cell Tumor Lymphoid and Plasma Cell Tumour Lymphoid and Plasmacytic Neoplasm Lymphoid and Plasmacytic Tumor Lymphoid and Plasmacytic Tumour Lymphocytic Neoplasm Multiple myeloma with beta-2-microglobulin less than 3.5 and albumin greater than or equal to 3.5 (median survival of 62 months). Note that the older Durie/Salmon staging system defines stage I quite differently. (PDQ) C70658 Neoplastic Process ISS Stage I Plasma Cell Myeloma ISS Stage I Multiple Myeloma C2346458 CTRP GDC Malignant ISS_Stage_I_Plasma_Cell_Myeloma I I ISS Stage I Multiple Myeloma ISS Stage I Multiple Myeloma/Plasma Cell Myeloma ISS Stage I Plasma Cell Myeloma International Staging System Stage I Multiple Myeloma International Staging System Stage I Plasma Cell Myeloma Multiple Myeloma Stage I Stage I Multiple Myeloma Stage I Plasma Cell Myeloma ISS Stage I Multiple Myeloma Multiple myeloma with blood levels of beta-2-microglobulin between 3.5 and 5.5 mg/L. C70659 Neoplastic Process ISS Stage II Plasma Cell Myeloma ISS Stage II Multiple Myeloma C2346457 CTRP GDC Malignant ISS_Stage_II_Plasma_Cell_Myeloma II II ISS Stage II Multiple Myeloma ISS Stage II Multiple Myeloma/Plasma Cell Myeloma ISS Stage II Plasma Cell Myeloma International Staging System Stage II Multiple Myeloma International Staging System Stage II Plasma Cell Myeloma Multiple Myeloma Stage II Stage II Multiple Myeloma Stage II Plasma Cell Myeloma ISS Stage II Multiple Myeloma A neoplasm affecting cells of the megakaryocytic lineage. C7066 Neoplastic Process Megakaryocytic Neoplasm C1334687 Malignant Megakaryocytic_Neoplasm Megakaryocytic Neoplasm Megakaryocytic Tumor Megakaryocytic Neoplasm Multiple myeloma with beta-2-microglobulin greater than or equal to 5.5 (median survival of 29 months). Note that the older Durie/Salmon staging system defines stage III quite differently. (PDQ) C70660 Neoplastic Process ISS Stage III Plasma Cell Myeloma ISS Stage III Multiple Myeloma C2346456 CTRP GDC Malignant ISS_Stage_III_Plasma_Cell_Myeloma III III ISS Stage III Multiple Myeloma ISS Stage III Multiple Myeloma/Plasma Cell Myeloma ISS Stage III Plasma Cell Myeloma International Staging System Stage III Multiple Myeloma International Staging System Stage III Plasma Cell Myeloma Multiple Myeloma Stage III Stage III Multiple Myeloma Stage III Plasma Cell Myeloma ISS Stage III Multiple Myeloma A benign, intermediate, or malignant mesenchymal neoplasm characterized by the presence of neoplastic fibroblasts. C7075 Neoplastic Process Fibroblastic Neoplasm C0206643 Cellosaurus Undetermined Fibrocytic_Neoplasm Fibroblastic Neoplasm Fibroblastic Tumor Fibrocytic Neoplasm Fibrocytic Tumor Fibrogenic Neoplasm FibrogenicTumor Fibrous Neoplasm Fibrous Tumor Fibroblastic Neoplasm Mammography that uses multiple X-ray pictures of each breast to produce a 3-dimensional rendering of the entire breast. C70761 Diagnostic Procedure Digital Tomosynthesis Mammography Digital Tomosynthesis Mammography C3472347 CTRP Digital_Tomosynthesis_Mammography DBT Digital Breast Tomosynthesis Digital Tomosynthesis Mammography Digital Tomosynthesis of the Breast Digital Tomosynthesis Mammography A term that refers to the staging of prostate carcinoma according to the Whitmore-Jewett staging system. C7079 Neoplastic Process Prostate Cancer by Whitmore-Jewett Stage C0677967 Header_Concept Malignant Prostate_Cancer_by_Whitmore-Jewett_Stage Prostate Cancer by Jewett Stage Prostate Cancer by Whitmore Stage Prostate Cancer by Whitmore-Jewett Stage Prostate Cancer by Whitmore-Jewett Stage The spread of a malignant neoplasm to the prostate gland from an adjacent or distant anatomic site. C7080 Neoplastic Process Metastatic Malignant Neoplasm in the Prostate Gland C0347001 Malignant Metastatic_Neoplasm_to_the_Prostate Metastases to Prostate Metastases to the Prostate Metastasis to Prostate Metastasis to the Prostate Metastatic Malignant Neoplasm in the Prostate Gland Metastatic Malignant Neoplasm to the Prostate Gland Metastatic Neoplasm to the Prostate Metastatic Tumor to the Prostate Metastatic Malignant Neoplasm in the Prostate Gland An aggressive malignant smooth muscle neoplasm, arising from the small intestine. It is characterized by a proliferation of neoplastic spindle cells. C7085 Neoplastic Process Small Intestine Leiomyosarcoma Small Intestinal Leiomyosarcoma C0920305 CTRP Malignant Small_Intestine_Leiomyosarcoma Leiomyosarcoma of Small Bowel Leiomyosarcoma of Small Intestine Leiomyosarcoma of the Small Bowel Leiomyosarcoma of the Small Intestine Small Bowel Leiomyosarcoma Small Intestinal Leiomyosarcoma Small Intestine Leiomyosarcoma Small Intestinal Leiomyosarcoma Cutaneous melanoma characterized by the disappearance of the melanoma cells from the primary tumor. C7089 Neoplastic Process Regressing Skin Melanoma Regressing Cutaneous Melanoma C1335733 CTRP Malignant Regressing_Melanoma_of_the_Skin Regressing Cutaneous (Skin) Melanoma Regressing Cutaneous Melanoma Regressing Malignant Melanoma of Skin Regressing Malignant Melanoma of the Skin Regressing Malignant Skin Melanoma Regressing Melanoma of Skin Regressing Melanoma of the Skin Regressing Skin Melanoma Regressing Cutaneous Melanoma A melanoma that arises from any part of the digestive system. C7091 Neoplastic Process Mucosal Melanoma of the Digestive System C1333798 Malignant Gastrointestinal_Melanoma Digestive System Melanoma Digestive System Mucosal Melanoma Gastrointestinal Melanoma Mucosal Melanoma of the Digestive System Mucosal Melanoma of the Digestive System A hepatoblastoma composed of small cells resembling the fetal hepatocytes, forming thin trabeculae. C7093 Neoplastic Process Hepatoblastoma with Pure Fetal Epithelial Differentiation C1333982 NICHD A hepatoblastoma comprising small cells resembling the fetal hepatocytes, forming thin trabeculae. 8970/3 Malignant Hepatoblastoma_with_Pure_Fetal_Epithelial_Differentiation Hepatoblastoma with Pure Fetal Epithelial Differentiation Hepatoblastoma with Pure Fetal Epithelial Differentiation A hepatoblastoma composed of cells resembling fetal epithelial cells and small round cells resembling blastema cells. C7094 Neoplastic Process Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation C1333981 NICHD A hepatoblastoma comprising cells resembling fetal epithelial cells and small round cells resembling blastema cells. Malignant Hepatoblastoma_with_Combined_Fetal_Epithelial_Differentiation Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation Hepatoblastoma with Mixed Fetal and Embryonal Epithelial Differentiation Mixed Embryonal/Fetal Hepatoblastoma Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation An epithelial hepatoblastoma characterized by the presence of broad trabeculae. C7095 Neoplastic Process Macrotrabecular Hepatoblastoma C1334543 Malignant Macrotrabecular_Hepatoblastoma Macrotrabecular Hepatoblastoma Macrotrabecular Hepatoblastoma A hepatoblastoma composed exclusively of noncohesive sheets of small undifferentiated cells. Cases showing loss of INI1 nuclear staining should be classified as rhabdoid tumors. C7096 Neoplastic Process Small Cell Undifferentiated Hepatoblastoma C1335981 NICHD A hepatoblastoma exclusively comprising noncohesive sheets of small undifferentiated cells. Malignant Small_Cell_Undifferentiated_Hepatoblastoma SCUD HBL Small Cell Undifferentiated Hepatoblastoma Small Cell Undifferentiated Hepatoblastoma A subtype of hepatoblastoma characterized by the presence of epithelial and mesenchymal components. C7097 Neoplastic Process Mixed Epithelial and Mesenchymal Hepatoblastoma C1334784 GDC NICHD A subtype of hepatoblastoma characterized by the presence of epithelial and mesenchymal components. 8970/3 Malignant Mixed_Epithelial_and_Mesenchymal_Hepatoblastoma 8970/3 Hepatoblastoma, mixed epithelial-mesenchymal Hepatoblastoma, mixed epithelial-mesenchymal Mixed Epithelial and Mesenchymal Hepatoblastoma Mixed Epithelial and Mesenchymal Hepatoblastoma A mixed epithelial and mesenchymal hepatoblastoma characterized by the presence of heterologous elements. The latter include neuroectoderm, endoderm, or melanin-holding cells. Muscle, cartilage and osteoid may or may not be present. C7098 Neoplastic Process Teratoid Hepatoblastoma C1334786 Malignant Mixed_Hepatoblastoma_with_Teratoid_Features Mixed Hepatoblastoma with Teratoid Features Teratoid Hepatoblastoma Teratoid Hepatoblastoma Metastatic disease. C7099 Neoplastic Process Stage D Prostate Cancer Stage D Prostate Cancer C3146265 CTRP A prostate cancer stage defined by the Jewett staging system. Stage D prostate cancer is cancer that began in the prostate and has spread to lymph nodes near or far from the prostate, or to other parts of the body, often to the bones. Stage D is divided into stages D0, D1, D2, and D3. In stage D0, the level of prostatic acid phosphatase (PAP) is high. In stage D1, the cancer has spread to local lymph nodes only. In stage D2, the cancer has spread to distant lymph nodes and to bones or internal organs. In stage D3, prostate cancer has come back in patients who had received hormone therapy. Malignant Stage_D_Prostate_Cancer Cancer of Prostate Stage D Cancer of the Prostate Stage D Prostate Cancer Stage D Stage D Prostate Cancer stage D prostate cancer Stage D Prostate Cancer An invasive malignant epithelial tumor that arises from the colon. There is no morphologic, immunophenotypic, or molecular biological evidence of glandular or squamous differentiation. C7100 Neoplastic Process Colon Undifferentiated Carcinoma Colon Undifferentiated Carcinoma C2355642 CTRP Malignant Undifferentiated_Colon_Carcinoma Carcinoma Simplex of the Colon. Colon Anaplastic Carcinoma Colon Undifferentiated Carcinoma Undifferentiated Carcinoma of Colon Undifferentiated Carcinoma of the Colon Undifferentiated Colon Cancer Undifferentiated Colonic Carcinoma Colon Undifferentiated Carcinoma A pilocytic astrocytoma occurring in adults. C71016 Neoplastic Process Adult Pilocytic Astrocytoma Adult Pilocytic Astrocytoma C0280781 CTRP Undetermined Adult_Pilocytic_Astrocytoma Adult Pilocytic Astrocytoma Pilocytic Astrocytoma Adult Pilocytic Astrocytoma A subependymal giant cell astrocytoma occurring in adults. C71017 Neoplastic Process Adult Subependymal Giant Cell Astrocytoma Adult Subependymal Giant Cell Astrocytoma C1832033 CTRP Undetermined Adult_Subependymal_Astrocytoma Adult Subependymal Giant Cell Astrocytoma Subependymal Giant Cell Astrocytoma Adult Subependymal Giant Cell Astrocytoma C71024 Neoplastic Process Adult Spinal Cord Neoplasm Adult Spinal Cord Neoplasm CL377660 CTRP Undetermined Adult_Spinal_Cord_Neoplasm Adult Spinal Cord Neoplasm Adult Spinal Cord Tumor Spinal Cord Tumor Adult Spinal Cord Neoplasm A benign or malignant neoplasm that affects the liver parenchyma or intrahepatic bile ducts. Representative examples of benign neoplasms include hepatocellular adenoma, and bile duct adenoma. Representative examples of malignant neoplasms include hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and lymphoma. C7103 Neoplastic Process Liver and Intrahepatic Bile Duct Neoplasm Liver Neoplasm C1333976 CTRP Undetermined Hepatic_and_Intrahepatic_Bile_Duct_Neoplasm Hepatic and Intrahepatic Bile Duct Neoplasm Liver Neoplasm Liver and Intrahepatic Bile Duct Neoplasm Liver Neoplasm An extragonadal mature teratoma that arises from the mediastinum. It is usually encapsulated and characterized by the presence of unilocular or multilocular cysts. The cysts can contain clear fluid, mucoid material, sebaceous debris, fat, hair, cartilage, and rarely teeth or bone. C7104 Neoplastic Process Mediastinal Mature Teratoma C1334636 Benign Mature_Mediastinal_Teratoma Mature Mediastinal Teratoma Mature Teratoma of Mediastinum Mature Teratoma of the Mediastinum Mediastinal Mature Teratoma Mediastinal Mature Teratoma A benign or malignant epithelial neoplasm that affects the liver. C7106 Neoplastic Process Liver Epithelial Neoplasm C1333419 Cellosaurus Undetermined Epithelial_Hepatic_and_Intrahepatic_Bile_Duct_Neoplasm Epithelial Hepatic and Intrahepatic Bile Duct Neoplasm Liver Epithelial Neoplasm Liver and Intrahepatic Bile Duct Epithelial Neoplasm Liver Epithelial Neoplasm A benign or malignant non-epithelial neoplasm that affects the liver. C7107 Neoplastic Process Liver Non-Epithelial Neoplasm C1334976 Undetermined Non-Epithelial_Hepatic_and_Intrahepatic_Bile_Duct_Neoplasm Hepatic and Intrahepatic Bile Duct Non-Epithelial Neoplasm Liver Non-Epithelial Neoplasm Liver and Intrahepatic Bile Duct Non-Epithelial Neoplasm Non-Epithelial Hepatic and Intrahepatic Bile Duct Neoplasm Liver Non-Epithelial Neoplasm A carcinoma that arises from the common bile duct distal to the insertion of the cystic duct. C7109 Neoplastic Process Distal Bile Duct Carcinoma Distal Bile Duct Carcinoma C1333308 CPTAC CTRP Malignant Distal_Biliary_Tract_Carcinoma Distal Bile Duct Carcinoma Extrahepatic (Distal) Bile Duct Cancer Distal Bile Duct Carcinoma The reemergence of liver carcinoma after a period of remission. C7110 Neoplastic Process Recurrent Liver Carcinoma Recurrent Liver Carcinoma C0854794 CTRP Malignant Recurrent_Liver_Cancer Recurrent Cancer of Liver Recurrent Cancer of the Liver Recurrent Liver Cancer Recurrent Liver Carcinoma Relapsed Cancer of Liver Relapsed Cancer of the Liver Relapsed Liver Cancer Recurrent Liver Carcinoma An ameloblastoma that does not recur or metastasize. C7111 Neoplastic Process Benign Ameloblastoma C1332470 CDISC A benign odontogenic neoplasm arising from the epithelial component of the embryonic tooth. Benign Benign_Ameloblastoma AMELOBLASTOMA, BENIGN Benign Ameloblastoma Benign Ameloblastoma A rare, locally invasive neoplasm arising from tooth-forming tissues. It usually grows intraosseously in the mandible. The maxilla is less frequently involved. It is characterized by the presence of well differentiated squamous cells which form islands. Recurrences may rarely occur and probably are related to incomplete excision of the tumor. C7112 Neoplastic Process Squamous Odontogenic Tumor C1458142 GDC 9312/0 Benign Squamous_Odontogenic_Tumor 9312/0 Squamous odontogenic tumor SOT Squamous Odontogenic Neoplasm Squamous Odontogenic Tumor Squamous odontogenic tumor Squamous Odontogenic Tumor An epithelial neoplasm arising from the thymus. It may be associated with myasthenia gravis, pure red cell aplasia, and hypogammaglobulinemia. It includes thymoma type B1 which is a thymoma of low grade malignant potential, thymoma type B2 which is a thymoma of moderate malignancy, and thymoma type B3 which is also known as well differentiated thymic carcinoma. C7114 Neoplastic Process Thymoma Type B Thymoma Type B C1328042 CTRP Undetermined Thymoma_Type_B Dendritic Cell Thymoma Epithelioid Thymoma Plump Cell Thymoma Thymoma Type B Thymoma Type B A primary or metastatic malignant non-epithelial neoplasm that affects the liver. C7115 Neoplastic Process Malignant Liver Non-Epithelial Neoplasm C1334607 Malignant Malignant_Non-Epithelial_Hepatic_and_Intrahepatic_Bile_Duct_Neoplasm Liver and Intrahepatic Bile Duct Malignant Non-Epithelial Neoplasm Malignant Liver Non-Epithelial Neoplasm Malignant Non-Epithelial Hepatic and Intrahepatic Bile Duct Neoplasm Malignant Liver Non-Epithelial Neoplasm Stage I carcinoma of the liver according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions. C7116 Neoplastic Process Stage I Liver Cancer Stage I Liver Cancer C1336462 CTRP Malignant Stage_I_Liver_Cancer Stage I Liver Cancer Stage I Liver Carcinoma Stage I Liver Cancer Stage II carcinoma of the liver according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions. C7117 Neoplastic Process Stage II Liver Cancer Stage II Liver Cancer C1336296 CTRP Malignant Stage_II_Liver_Cancer Stage II Liver Cancer Stage II Liver Carcinoma Stage II Liver Cancer Stage III carcinoma of the liver according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions. C7118 Neoplastic Process Stage III Liver Cancer Stage III Liver Cancer C1336254 CTRP Malignant Stage_III_Liver_Cancer Stage III Liver Cancer Stage III Liver Carcinoma Stage III Liver Cancer Stage IV carcinoma of the liver according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions. C7121 Neoplastic Process Stage IV Liver Cancer Stage IV Liver Cancer C1336423 CTRP Malignant Stage_IV_Liver_Cancer Stage IV Liver Cancer Stage IV Liver Carcinoma Stage IV Liver Cancer Stage IVA carcinoma of the liver according to the American Joint Committee on Cancer, 7th and 8th editions. C7122 Neoplastic Process Stage IVA Liver Cancer Stage IVA Liver Cancer CL448367 CTRP Malignant Stage_IVA_Liver_Cancer Stage IVA Liver Cancer Stage IVA Liver Carcinoma Stage IVA Liver Cancer Stage IVB carcinoma of the liver according to the American Joint Committee on Cancer, 7th and 8th editions. C7123 Neoplastic Process Stage IVB Liver Cancer Stage IVB Liver Cancer C1336377 CTRP Malignant Stage_IVB_Liver_Cancer Stage IVB Liver Cancer Stage IVB Liver Carcinoma Stage IVB Liver Cancer An intraductal papillary neoplasm that arises from the epithelium of the extrahepatic bile ducts. C7124 Neoplastic Process Extrahepatic Bile Duct Intraductal Papillary Neoplasm C1333511 Benign Extrahepatic_Bile_Duct_Papillomatosis Extrahepatic Bile Duct IPN Extrahepatic Bile Duct Intraductal Papillary Neoplasm Extrahepatic Bile Duct Papillary Neoplasm Extrahepatic Bile Duct Papillomatosis Extrahepatic Biliary Papillomatosis Extrahepatic Bile Duct Intraductal Papillary Neoplasm An intraductal papillary neoplasm that arises from the epithelium of the intrahepatic bile ducts. C7125 Neoplastic Process Intrahepatic Bile Duct Intraductal Papillary Neoplasm C1334258 Benign Intrahepatic_Bile_Duct_Papillomatosis Intrahepatic Bile Duct IPN Intrahepatic Bile Duct Intraductal Papillary Neoplasm Intrahepatic Bile Duct Papillary Neoplasm Intrahepatic Bile Duct Papillomatosis Intrahepatic Biliary Papillomatosis Intrahepatic Bile Duct Intraductal Papillary Neoplasm A rare adenoma that arises from the intrahepatic biliary tree. C7126 Neoplastic Process Intrahepatic Bile Duct Adenoma C1331535 CDISC A benign neoplasm arising from the intrahepatic bile duct. Benign Intrahepatic_Bile_Duct_Adenoma ADENOMA, HEPATOCHOLANGIOCELLULAR, BENIGN Adenoma of Intrahepatic Bile Duct Adenoma of the Intrahepatic Bile Duct Intrahepatic Bile Duct Adenoma Intrahepatic Bile Duct Adenoma An adenoma that arises from the intrahepatic bile ducts and it is characterized by the presence of microcystic changes. C7127 Neoplastic Process Intrahepatic Bile Duct Microcystic Adenoma C3275163 Benign Intrahepatic_Bile_Duct_Cystadenoma Intrahepatic Bile Duct Microcystic Adenoma Intrahepatic Bile Duct Microcystic Adenoma A neoplasm that arises from the non-epithelial tissues of the extrahepatic bile ducts and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C7128 Neoplastic Process Benign Extrahepatic Bile Duct Non-Epithelial Neoplasm C1332498 Benign Benign_Extrahepatic_Bile_Duct_Non-Epithelial_Neoplasm Benign Extrahepatic Bile Duct Non-Epithelial Neoplasm Benign Extrahepatic Bile Duct Non-Epithelial Neoplasm A non-epithelial neoplasm that arises from the gallbladder and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include leiomyoma, lipoma, and neurofibroma. C7129 Neoplastic Process Gallbladder Benign Non-Epithelial Neoplasm C1332520 Benign Benign_Non-Epithelial_Gallbladder_Neoplasm Benign Non-Epithelial Gallbladder Neoplasm Gallbladder Benign Non-Epithelial Neoplasm Gallbladder Benign Non-Epithelial Neoplasm A grade I meningioma that occurs during adulthood. C71299 Neoplastic Process Adult Grade I Meningioma Adult Grade 1 Meningioma CL377658 CTRP Undetermined Adult_Grade_I_Meningioma Adult Grade 1 Meningioma Adult Grade I Meningioma Grade I Meningioma Adult Grade 1 Meningioma An intracholecystic papillary neoplasm that arises from the epithelium of the gallbladder. Intraepithelial neoplasia is present. C7130 Neoplastic Process Gallbladder Intracholecystic Papillary Neoplasm C1333754 Benign Gallbladder_Papillomatosis Gallbladder ICPN Gallbladder Intracholecystic Papillary (Tubular) Neoplasm Gallbladder Intracholecystic Papillary Neoplasm Gallbladder Intracystic/Intaductal Papillary Neoplasm Gallbladder Papillary Neoplasm Gallbladder Papillomatosis Intracystic Papillary Neoplasm Gallbladder Intracholecystic Papillary Neoplasm A grade I meningioma that occurs during childhood. C71300 Neoplastic Process Childhood Grade I Meningioma Childhood Grade 1 Meningioma CL377570 CTRP Undetermined Childhood_Grade_I_Meningioma Childhood Grade 1 Meningioma Childhood Grade I Meningioma Grade I Meningioma Childhood Grade 1 Meningioma A grade II meningioma that occurs during childhood. C71301 Neoplastic Process Childhood Grade II Meningioma Childhood Grade 2 Meningioma CL377569 CTRP Undetermined Childhood_Grade_II_Meningioma Childhood Grade 2 Meningioma Childhood Grade II Meningioma Grade II Meningioma Childhood Grade 2 Meningioma A grade III meningioma that occurs during childhood. C71303 Neoplastic Process Childhood Grade III Meningioma Childhood Grade 3 Meningioma CL377568 CTRP Malignant Childhood_Grade_III_Meningioma Childhood Grade 3 Meningioma Childhood Grade III Meningioma Grade III Meningioma Childhood Grade 3 Meningioma A grade II meningioma that occurs during adulthood. C71304 Neoplastic Process Adult Grade II Meningioma Adult Grade 2 Meningioma CL377657 CTRP Undetermined Adult_Grade_II_Meningioma Adult Grade 2 Meningioma Adult Grade II Meningioma Grade II Meningioma Adult Grade 2 Meningioma A grade III meningioma that occurs during adulthood. C71305 Neoplastic Process Adult Grade III Meningioma Adult Grade 3 Meningioma CL377656 CTRP Malignant Adult_Grade_III_Meningioma Adult Grade 3 Meningioma Adult Grade III Meningioma Grade III Meningioma Adult Grade 3 Meningioma A granular cell tumor that arises from the gallbladder and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C7131 Neoplastic Process Gallbladder Benign Granular Cell Tumor C1332502 Benign Benign_Gallbladder_Granular_Cell_Tumor Benign Gallbladder Granular Cell Neoplasm Benign Gallbladder Granular Cell Tumor Gallbladder Benign Granular Cell Tumor Gallbladder Benign Granular Cell Tumor A rare, typically benign ovarian neoplasm composed of Sertoli cells. Patients may present with pseudoprecocity, menometrorrhagia, amenorrhea, hirsutism, and hoarseness. Rarely it may invade the ovarian stroma and extend beyond the ovary. C7133 Neoplastic Process Ovarian Sertoli Cell Tumor C1519663 NICHD A Sertoli cell tumor that occurs in the ovary. Benign Tubular_Androblastoma-Sertoli_Cell_Tumor Ovarian Sertoli Cell Tumor Ovarian Sertoli Cell Tumor A usually aggressive malignant bone-forming mesenchymal neoplasm arising from the surface of the bone. C7134 Neoplastic Process Bone Surface (Peripheral) Osteosarcoma C1332591 PCDC Malignant Bone_Surface_Peripheral_Osteosarcoma Bone Surface (Peripheral) Osteosarcoma Peripheral Osteosarcoma Surface Osteosarcoma Bone Surface (Peripheral) Osteosarcoma A rare malignant neoplasm of the soft tissues. It is typically a disease of children and young adults. Most commonly occurs in the paravertebral region, chest wall, pelvis and lower extremities. Treatment includes local excision with consideration for post-operative chemotherapy and/or radiotherapy. C7135 Neoplastic Process Extraosseous Ewing Sarcoma Extraskeletal Ewing Sarcoma Extraskeletal Ewing Sarcoma C0279980 CPTAC CTRP Cellosaurus Malignant Extraosseous_Ewing_s_Sarcoma EES Extra-Osseous Ewing's Sarcoma Extraosseous Ewing Sarcoma Extraosseous Ewing's Sarcoma Extraosseous Ewing's Tumor Extraskeletal Ewing Sarcoma Extraskeletal Ewing sarcoma Extraskeletal Ewing's Sarcoma Extraskeletal Ewing Sarcoma A localized mast cell neoplasm involving extracutaneous sites. C7136 Neoplastic Process Extracutaneous Mastocytoma Extracutaneous Mastocytoma C0272202 CTRP GDC 9740/1 Undetermined Extracutaneous_Mastocytoma 9740/1 Extracutaneous mastocytoma Extracutaneous Mastocytoma Extracutaneous mastocytoma Extracutaneous Mastocytoma A form of mastocytosis characterized by mast cell infiltration of the skin. (WHO, 2001) C7137 Neoplastic Process Cutaneous Mastocytosis Cutaneous Mastocytosis C1136033 CTRP Cellosaurus GDC 9740/1 Undetermined Cutaneous_Mastocytosis 9740/1 Cutaneous mastocytosis CM Cutaneous (Skin) Mastocytosis Cutaneous Mastocytosis Cutaneous mastocytosis Cutaneous Mastocytosis A method of ultrasound imaging in which the ultrasound probe is pressed against the skin of the abdomen in order to create an image of the abdominal organs. C71375 Diagnostic Procedure Transabdominal Ultrasound Transabdominal Ultrasound C2348813 CDISC CTRP A procedure used to examine the organs in the abdomen. The ultrasound device is pressed firmly against the skin of the abdomen. Sound waves from the device bounce off tissues and create echoes. A computer uses the echoes to make a picture called a sonogram. An ultrasound imaging technique in which the ultrasound probe is pressed against the skin of the abdomen in order to create an image of the abdominal organs. Transabdominal_Ultrasound TRANSABDOMINAL ULTRASOUND TUS Transabdominal Ultrasound abdominal ultrasound transabdominal ultrasound Transabdominal Ultrasound A benign, solitary, well-demarcated, yellow-brown or reddish-brown mast cell neoplasm that arises from the skin, most commonly in infants and children. The lesions are typically 2-5 cm in size, are characterized by infiltration of the dermis by neoplastic mast cells, and occasionally resolve spontaneously. C7138 Neoplastic Process Solitary Mastocytoma of the Skin C0343115 GDC 9740/1 Benign Solitary_Mastocytoma_of_the_Skin 9740/1 Solitary mastocytoma of skin Cutaneous Solitary Mastocytoma Skin Solitary Mastocytoma Solitary Mastocytoma of Skin Solitary Mastocytoma of the Skin Solitary mastocytoma of skin Solitary Mastocytoma of the Skin An internationally developed presurgical anatomic staging system using imaging techniques: Tumor involves only 1 quadrant; 3 adjoining liver quadrants are free of tumor. (from PDQ 2004) C7139 Neoplastic Process PRETEXT Stage 1 Hepatoblastoma PRETEXT I Hepatoblastoma C1335255 CTRP Malignant PRETEXT_Stage_1_Hepatoblastoma PRETEXT I Hepatoblastoma PRETEXT Stage 1 Hepatoblastoma PRETEXT Stage I Hepatoblastoma Stage 1 Hepatoblastoma PRETEXT I Hepatoblastoma An internationally developed presurgical anatomic staging system using imaging techniques: Tumor involves 2 adjoining quadrants; 2 adjoining quadrants are free of tumor. (from PDQ 2004) C7140 Neoplastic Process PRETEXT Stage 2 Hepatoblastoma PRETEXT II Hepatoblastoma C1335256 CTRP Malignant PRETEXT_Stage_2_Hepatoblastoma PRETEXT II Hepatoblastoma PRETEXT Stage 2 Hepatoblastoma PRETEXT Stage II Hepatoblastoma Stage 2 Hepatoblastoma PRETEXT II Hepatoblastoma An internationally developed presurgical anatomic staging system using imaging techniques: Tumor involves 3 adjoining quadrants or 2 nonadjoining quadrants; 1 quadrant or 2 nonadjoining quadrants are free of tumor. (from PDQ 2004) C7141 Neoplastic Process PRETEXT Stage 3 Hepatoblastoma PRETEXT III Hepatoblastoma C1335257 CTRP Malignant PRETEXT_Stage_3_Hepatoblastoma PRETEXT III Hepatoblastoma PRETEXT Stage 3 Hepatoblastoma PRETEXT Stage III Hepatoblastoma Stage 3 Hepatoblastoma PRETEXT III Hepatoblastoma An internationally developed presurgical anatomic staging system using imaging techniques: Tumor involves all 4 quadrants; there is no quadrant free of tumor. (from PDQ 2004) C7142 Neoplastic Process PRETEXT Stage 4 Hepatoblastoma PRETEXT IV Hepatoblastoma C1335258 CTRP Malignant PRETEXT_Stage_4_Hepatoblastoma PRETEXT IV Hepatoblastoma PRETEXT Stage 4 Hepatoblastoma PRETEXT Stage IV Hepatoblastoma Stage 4 Hepatoblastoma PRETEXT IV Hepatoblastoma Distant metastases, regardless of the extent of liver involvement. (from PDQ 2004) C7143 Neoplastic Process Postsurgical Stage IV Hepatoblastoma Postsurgical Stage IV Hepatoblastoma C1335460 CTRP Malignant Postsurgical_Stage_IV_Hepatoblastoma Postsurgical Stage IV Hepatoblastoma Stage IV Hepatoblastoma Postsurgical Stage IV Hepatoblastoma No distant metastases, tumor unresectable or resected with gross residual tumor, or positive lymph nodes. (from PDQ 2004) C7144 Neoplastic Process Postsurgical Stage III Hepatoblastoma Postsurgical Stage III Hepatoblastoma C1335458 CTRP Malignant Postsurgical_Stage_III_Hepatoblastoma Postsurgical Stage III Hepatoblastoma Stage III Hepatoblastoma Postsurgical Stage III Hepatoblastoma No metastases, tumor grossly resected with microscopic residual disease (i.e., positive margins); or tumor rupture, or tumor spill at the time of surgery. (from PDQ 2004) C7145 Neoplastic Process Postsurgical Stage II Hepatoblastoma Postsurgical Stage II Hepatoblastoma C1335459 CTRP Malignant Postsurgical_Stage_II_Hepatoblastoma Postsurgical Stage II Hepatoblastoma Stage II Hepatoblastoma Postsurgical Stage II Hepatoblastoma No metastases, tumor completely resected. (from PDQ 2004) C7146 Neoplastic Process Postsurgical Stage I Hepatoblastoma Postsurgical Stage I Hepatoblastoma C1335461 CTRP Malignant Postsurgical_Stage_I_Hepatoblastoma Postsurgical Stage I Hepatoblastoma Stage I Hepatoblastoma Postsurgical Stage I Hepatoblastoma A benign mesenchymal neoplasm characterized by the presence of neoplastic fibroblasts without malignant characteristics. C7147 Neoplastic Process Benign Fibroblastic Neoplasm C1332501 Benign Benign_Fibrous_Soft_Tissue_Neoplasm Benign Fibroblastic Neoplasm Benign Fibroblastic Tumor Benign Fibrocytic Neoplasm Benign Fibrocytic Tumor Benign Fibrogenic Neoplasm Benign Fibrogenic Tumor Benign Fibrous Neoplasm Benign Fibrous Tumor Benign Fibroblastic Neoplasm A benign,intermediate, or malignant soft tissue neoplasm in which the line of differentiation is uncertain. Representative examples include neoplasm with perivascular epithelioid cell differentiation, alveolar soft part sarcoma, desmoplastic small round cell tumor, epithelioid sarcoma, extraskeletal myxoid chondrosarcoma, and synovial sarcoma. C7148 Neoplastic Process Soft Tissue Tumor of Uncertain Differentiation C1334776 Undetermined Miscellaneous_Mesenchymal_Neoplasm Soft Tissue Neoplasm of Uncertain Differentiation Soft Tissue Tumor of Uncertain Differentiation Soft Tissue Tumor of Uncertain Differentiation Multiple myeloma lacking clinical manifestations and organ impairment. C7149 Neoplastic Process Smoldering Plasma Cell Myeloma Smoldering Multiple Myeloma C1531608 CTRP A very slow-growing type of myeloma in which abnormal plasma cells (a type of white blood cell) make too much of a single type of monoclonal antibody (a protein). This protein builds up in the blood or is passed in the urine. Patients with smoldering myeloma usually have no symptoms, but need to be checked often for signs of progression to fully developed multiple myeloma. Malignant Smoldering_Myeloma Asymptomatic Myeloma Asymptomatic Plasma Cell Myeloma Indolent Multiple Myeloma Smoldering Multiple Myeloma Smoldering Multiple Myeloma/Plasma Cell Myeloma Smoldering Myeloma Smoldering Plasma Cell Myeloma smoldering myeloma Smoldering Multiple Myeloma A mature B-cell neoplasm characterized by the deposition of immunoglobulin in tissues, resulting in impaired organ function. It includes the following entities: primary amyloidosis, heavy chain deposition disease, and light chain deposition disease. C7151 Neoplastic Process Monoclonal Immunoglobulin Deposition Disease Monoclonal Immunoglobulin Deposition Disease CL357425 CPTAC CTRP GDC 9769/1 Undetermined Monoclonal_Immunoglobulin_Deposition_Disease 9769/1 Immunoglobulin deposition disease Immunoglobulin Deposition Disease Immunoglobulin deposition disease Monoclonal Immunoglobulin Deposition Disease Monoclonal Immunoglobulin Deposition Disease Acute erythroid leukemia characterised by the presence of at least 50% erythroid precursors and at least 20% myeloblasts in the bone marrow. C7152 Neoplastic Process Erythroleukemia CL432980 Cellosaurus GDC Cancer of the blood-forming tissues in which large numbers of immature, abnormal red blood cells are found in the blood and bone marrow. Malignant Erythroleukemia Erythroleukemia M6A Erythroleukemia Erythroleukemia (Erythroid/Myeloid) Erythroleukemia, Erythroid/Myeloid M6A M6a erythroleukemia Erythroleukemia An adenocarcinoma that arises from the thyroid gland and shows extensive evidence of follicular cell differentiation. According to the nuclear features of the malignant follicular cells, it is classified either as papillary or follicular carcinoma. C7153 Neoplastic Process Differentiated Thyroid Gland Carcinoma Differentiated Thyroid Gland Carcinoma C1337013 CTRP Malignant Well-differentiated_Thyroid_Carcinoma Differentiated Thyroid Cancer Differentiated Thyroid Carcinoma Differentiated Thyroid Gland Cancer Differentiated Thyroid Gland Carcinoma Follicular/Papillary Thyroid Gland Carcinoma Thyroid Gland Differentiated Carcinoma Thyroid Gland Well Differentiated Carcinoma Well Differentiated Thyroid Carcinoma Well Differentiated Thyroid Gland Carcinoma Well-Differentiated Thyroid Cancer Differentiated Thyroid Gland Carcinoma A rare aggressive malignant smooth muscle neoplasm, arising from the bone. It is characterized by a proliferation of neoplastic spindle cells. C7154 Neoplastic Process Bone Leiomyosarcoma C1332579 Cellosaurus Malignant Bone_Leiomyosarcoma Bone Leiomyosarcoma Leiomyosarcoma of Bone Bone Leiomyosarcoma A chondrosarcoma arising from the central portion of bone without a benign precursor. C7155 Neoplastic Process Primary Central Chondrosarcoma C1335473 CDISC Cellosaurus A malignant cartiliginous neoplasm of bone. Malignant Primary_Bone_Chondrosarcoma OSTEOCHONDROSARCOMA, MALIGNANT Primary Bone Chondrosarcoma Primary Central Chondrosarcoma Primary Chondrosarcoma Primary Chondrosarcoma of Bone Primary Chondrosarcoma of the Bone Primary Central Chondrosarcoma A low-grade neoplasm that arises from the neurohypophysis. It includes pituicytoma, granular cell tumor of the sellar region, spindle cell oncocytoma, and ependymal pituicytoma. C7157 Neoplastic Process Posterior Pituitary Gland Neoplasm C1334957 Undetermined Neurohypophysis_Neoplasm Neurohypophysis Neoplasm Neurohypophysis Tumor Pituicyte Tumor Pituicyte Tumor Family Posterior Pituitary Gland Neoplasm Posterior Pituitary Gland Tumor Posterior Pituitary Neoplasm Posterior Pituitary Tumor Posterior Pituitary Gland Neoplasm A neoplasm that arises from the dermis and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C7158 Neoplastic Process Benign Dermal Neoplasm C1332489 Benign Benign_Dermal_Neoplasm Benign Dermal Neoplasm Benign Dermal Neoplasm A neoplasm that arises from melanocytes in the skin. This category includes nevi, melanocytomas, and melanomas. C7161 Neoplastic Process Skin Melanocytic Neoplasm Skin Melanocytic Neoplasm C0349501 CTRP Undetermined Melanocytic_Skin_Neoplasm Cutaneous Melanocytic Neoplasm Melanocytic Neoplasm of Skin Melanocytic Skin Neoplasm Skin Melanocytic Neoplasm Skin Melanocytic Neoplasm C7162 Neoplastic Process Cutaneous Lymphoma Primary Cutaneous Lymphoma Primary Cutaneous Lymphoma CL524081 CTRP GDC Malignant Cutaneous_Lymphoma 9709/3 Cutaneous lymphoma, NOS Cutaneous (Skin) Lymphoma Primary Cutaneous Lymphoma Primary Skin Lymphoma Primary Cutaneous Lymphoma A category of Hodgkin lymphomas that includes the following four histologic subtypes: lymphocyte-rich, nodular sclerosis, mixed cellularity, and lymphocyte-depleted classic Hodgkin lymphoma. The vast majority of Hodgkin lymphomas belong to this category. C7164 Neoplastic Process Classic Hodgkin Lymphoma Classic Hodgkin Lymphoma C1333064 CPTAC CTRP The most common type of Hodgkin lymphoma, which is a cancer of the immune system. Classical Hodgkin lymphoma is marked by the presence of a type of cell called the Reed-Sternberg cell. Malignant Classical_Hodgkin_s_Lymphoma Other classical Hodgkin lymphoma, lymph nodes of head, face, and neck Other classical Hodgkin lymphoma, lymph nodes of multiple sites Other classical Hodgkin lymphoma, unspecified site CHL Classic Hodgkin Lymphoma Classical Hodgkin Lymphoma cHL classical Hodgkin lymphoma Classic Hodgkin Lymphoma Nodular sclerosis Hodgkin lymphoma in which at least 75% of the tumor nodules contain scattered Reed-Sternberg cells. The background cellular infiltrate is lymphocytic, mixed, or fibrohistiocytic. C7165 Neoplastic Process Grade 1 Nodular Sclerosis Classic Hodgkin Lymphoma C1521899 GDC 9665/3 Malignant Grade_1_Nodular_Sclerosis_Hodgkin_s_Lymphoma 9665/3 Classical Hodgkin lymphoma, nodular sclerosis, grade 1 Hodgkin lymphoma, nodular sclerosis, grade 1 Hodgkin lymphoma,nodular sclerosis, grade 1 Grade 1 Nodular Sclerosis Classic Hodgkin Lymphoma Grade 1 Nodular Sclerosis Classical Hodgkin Lymphoma Grade 1 Nodular Sclerosis Hodgkin Lymphoma Grade 1 Nodular Sclerosis Hodgkin's Lymphoma Grade I Nodular Sclerosis Hodgkin's Lymphoma Grade 1 Nodular Sclerosis Classic Hodgkin Lymphoma Nodular sclerosis Hodgkin lymphoma in which at least 25% of the tumor nodules contain increased numbers of Reed-Sternberg cells. C7166 Neoplastic Process Grade 2 Nodular Sclerosis Classic Hodgkin Lymphoma Grade 2 Nodular Sclerosis Classic Hodgkin Lymphoma CL448834 CTRP GDC 9667/3 Malignant Grade_2_Nodular_Sclerosis_Hodgkin_s_Lymphoma 9667/3 Classical Hodgkin lymphoma, nodular sclerosis, grade 2 Hodgkin lymphoma, nodular sclerosis, grade 2 Classical Hodgkin lymphoma, nodular sclerosis, grade 2 Grade 2 Nodular Sclerosis Classic Hodgkin Lymphoma Grade 2 Nodular Sclerosis Classical Hodgkin Lymphoma Grade 2 Nodular Sclerosis Hodgkin Lymphoma Grade 2 Nodular Sclerosis Hodgkin's Lymphoma Grade II Nodular Sclerosis Hodgkin's Lymphoma Hodgkin lymphoma, nodular sclerosis, grade 2 Grade 2 Nodular Sclerosis Classic Hodgkin Lymphoma A myelodysplastic syndrome characterized by the presence of dysplasia in one or more hematopoietic cell lineages and 10-19% blasts in bone marrow or peripheral blood. C7168 Neoplastic Process Myelodysplastic Syndrome/Acute Myeloid Leukemia C1318551 CPTAC GDC mCode Malignant RAEB-2 RAEB II Refractory anemia with excess of blasts 2 MDS with Increased Blasts-2 MDS-EB-2 MDS-EB2 MDS-IB-2 MDS-IB2 MDS/AML Myelodysplastic Syndrome with Excess Blasts-2 Myelodysplastic Syndrome/Acute Myeloid Leukemia RAEB II RAEB-2 RAEB-II Refractory anemia with excess of blasts 2 Myelodysplastic Syndrome/Acute Myeloid Leukemia The reemergence of a brain neoplasm after a period of remission. C71698 Neoplastic Process Recurrent Brain Neoplasm C0750977 Undetermined Recurrent_Brain_Neoplasm Recurrent Brain Neoplasm Recurrent Brain Tumor Recurrent Brain Neoplasm The reemergence of a spinal cord neoplasm after a period of remission. C71699 Neoplastic Process Recurrent Spinal Cord Neoplasm C2347917 Undetermined Recurrent_Spinal_Cord_Neoplasm Recurrent Spinal Cord Neoplasm Recurrent Spinal Cord Tumor Recurrent Spinal Cord Neoplasm The reemergence of a primary central nervous system neoplasm after a period of remission. C71700 Neoplastic Process Recurrent Primary Central Nervous System Neoplasm Recurrent Primary Central Nervous System Neoplasm C2347913 CTRP Undetermined Recurrent_Central_Nervous_System_Neoplasm Recurrent Primary Central Nervous System Neoplasm Recurrent Primary Central Nervous System Tumor Recurrent Primary Central Nervous System Neoplasm A primary central nervous system neoplasm that is resistant to treatment. C71701 Neoplastic Process Refractory Central Nervous System Neoplasm Refractory Primary Central Nervous System Neoplasm C2347924 CTRP Undetermined Refractory_Central_Nervous_System_Neoplasm Refractory Central Nervous System Neoplasm Refractory Primary Central Nervous System Neoplasm Refractory Primary Central Nervous System Tumor Refractory Primary Central Nervous System Neoplasm Brain neoplasm that is resistant to treatment. C71702 Neoplastic Process Refractory Brain Neoplasm C2347923 Undetermined Refractory_Brain_Neoplasm Refractory Brain Neoplasm Refractory Brain Tumor Refractory Brain Neoplasm Spinal cord neoplasm resistant to treatment. C71703 Neoplastic Process Refractory Spinal Cord Neoplasm C2347926 Undetermined Refractory_Spinal_Cord_Neoplasm Refractory Spinal Cord Neoplasm Refractory Spinal Cord Tumor Refractory Spinal Cord Neoplasm An acute myeloid leukemia in which the monoblasts represent 80% or more of the total cellular population. (WHO, 2001) C7171 Neoplastic Process Acute Monoblastic Leukemia C0457334 Cellosaurus GDC Malignant Acute_Monoblastic_Leukemia 9891/3 Acute monoblastic leukemia Monoblastic leukemia, NOS Acute Monoblastic Leukemia Acute Monoblastic Leukemia (FAB M5a) Acute monoblastic leukemia Acute Monoblastic Leukemia The reemergence of a spinal cord neoplasm in childhood after a period of remission. C71712 Neoplastic Process Recurrent Childhood Spinal Cord Neoplasm Recurrent Childhood Spinal Cord Neoplasm CL378326 CTRP Undetermined Recurrent_Childhood_Spinal_Cord_Neoplasm Recurrent Childhood Spinal Cord Neoplasm Recurrent Childhood Spinal Cord Tumor Recurrent Spinal Cord Tumor Recurrent Childhood Spinal Cord Neoplasm The reemergence of a spinal cord neoplasm in adulthood after a period of remission. C71713 Neoplastic Process Recurrent Adult Spinal Cord Neoplasm Recurrent Adult Spinal Cord Neoplasm CL378324 CTRP Undetermined Recurrent_Adult_Spinal_Cord_Neoplasm Recurrent Adult Spinal Cord Neoplasm Recurrent Adult Spinal Cord Tumor Recurrent Spinal Cord Neoplasm Recurrent Adult Spinal Cord Neoplasm Spinal cord neoplasm in childhood which is resistant to treatment. C71714 Neoplastic Process Refractory Childhood Spinal Cord Neoplasm C2347925 Undetermined Refractory_Childhood_Spinal_Cord_Neoplasm Refractory Childhood Spinal Cord Neoplasm Refractory Childhood Spinal Cord Tumor Refractory Childhood Spinal Cord Neoplasm Spinal cord neoplasm in adulthood which is resistant to treatment. C71715 Neoplastic Process Refractory Adult Spinal Cord Neoplasm C2347922 Undetermined Refractory_Adult_Spinal_Cord_Neoplasm Refractory Adult Spinal Cord Neoplasm Refractory Adult Spinal Cord Tumor Refractory Adult Spinal Cord Neoplasm A diffuse large B-cell lymphoma arising from the central nervous system. C71720 Neoplastic Process Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System C2026186 CTRP GDC 9680/3 Malignant Central_Nervous_System_Diffuse_Large_B-Cell_Lymphoma Primary diffuse large B-cell lymphoma of the CNS CNS DLBCL CNS Primary Large B-Cell Lymphoma Central Nervous System Diffuse Large B-Cell Lymphoma Central Nervous System Primary Large B-Cell Lymphoma PCNS-LBCL Primary DLBCL of the CNS Primary Diffuse Large B-Cell Lymphoma of the CNS Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Primary Large B-Cell Lymphoma of the CNS Primary Large B-Cell Lymphoma of the Central Nervous System Primary diffuse large B-cell lymphoma of the CNS Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System A low-grade (WHO grade 2) astrocytic neoplasm. It is characterized by diffuse infiltration of neighboring central nervous system structures. These lesions typically affect young adults and have a tendency for progression to anaplastic astrocytoma and glioblastoma. Based on the IDH genes mutation status, diffuse astrocytomas are classified as IDH-mutant, IDH-wildtype, and not otherwise specified. C7173 Neoplastic Process Diffuse Astrocytoma C0280785 CDISC CTEP GDC A malignant astrocytic neoplasm characterized by a high degree of cellular differentiation, slow growth, and diffuse infiltration of neighboring brain structures. Undetermined Diffuse_Astrocytoma 9400/3 Astrocytoma, low grade Cystic astrocytoma Diffuse astrocytoma Diffuse astrocytoma, low grade ASTROCYTOMA, DIFFUSE, MALIGNANT Astrocytoma, Diffuse Diffuse Astrocytoma Diffuse astrocytoma Grade 2 Astrocytic Neoplasm Grade 2 Astrocytic Tumor Grade 2 Astrocytoma Grade II Astrocytic Neoplasm Grade II Astrocytic Tumor Grade II Astrocytoma Low-grade astrocytoma, NOS WHO Grade 2 Astrocytoma WHO Grade II Astrocytoma Diffuse Astrocytoma An invasive breast carcinoma which is negative for expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). C71732 Neoplastic Process Triple-Negative Breast Carcinoma Triple-Negative Breast Carcinoma C3539878 CTRP Cellosaurus Malignant Triple-Negative_Invasive_Breast_Carcinoma Triple Negative Breast Carcinoma Triple-Negative Breast Cancer Triple-Negative Breast Carcinoma Triple-Negative Breast Carcinoma A low grade (WHO grade II) astrocytoma occurring during adulthood. It is characterized by a high degree of cellular differentiation, slow growth, and diffuse infiltration of neighboring brain structures. C7174 Neoplastic Process Adult Diffuse Astrocytoma Adult Diffuse Astrocytoma C0281329 CTRP Undetermined Adult_Diffuse_Astrocytoma Adult Diffuse Astrocytoma Diffuse Astrocytoma WHO Grade 2 Astrocytoma WHO Grade II Astrocytoma Adult Diffuse Astrocytoma A group of acute myeloid leukemias characterized by recurrent genetic abnormalities, mainly balanced translocations. (WHO, 2001) C7175 Neoplastic Process Acute Myeloid Leukemia with Recurrent Genetic Abnormalities C1275661 NICHD A group of acute myeloid leukemias characterized by recurrent genetic abnormalities, mainly balanced translocations. (WHO, 2001) Malignant Acute_Myeloid_Leukemia_with_Recurrent_Genetic_Abnormalities AML with Recurrent Genetic Abnormalities AML-RGA Acute Myeloid Leukemia with Balanced Translocations/Inversions Acute Myeloid Leukemia with Defining Genetic Abnormalities Acute Myeloid Leukemia with Recurrent Genetic Abnormalities Acute Myeloid Leukemia with Recurrent Genetic Abnormalities C71751 Diagnostic Procedure Computed Tomography Laser Mammography CL378266 Computed_Tomography_Laser_Mammography Computed Tomography Laser Mammography Computed Tomography Laser Mammography C7176 Neoplastic Process Aleukemic Chronic Lymphocytic Leukemia C3282876 GDC Malignant Aleukemic_Lymphocytic_Leukemia 9820/3 Aleukemic lymphocytic leukemia Aleukemic Chronic Lymphocytic Leukemia Aleukemic Lymphocytic Leukemia Aleukemic lymphocytic leukemia Aleukemic Chronic Lymphocytic Leukemia C7177 Neoplastic Process Aleukemic Acute Lymphoblastic Leukemia C1332230 Malignant Aleukemic_Lymphoblastic_Leukemia Aleukemic Acute Lymphoblastic Leukemia Aleukemic Lymphoblastic Leukemia Aleukemic Precursor Lymphoblastic Leukemia Aleukemic Acute Lymphoblastic Leukemia An adult T-cell leukemia/lymphoma characterized by less than 5% neoplastic lymphocytes in the peripheral blood, absence of lymphadenopathy and hypercalcemia, and occasional skin or pulmonary lesions. C7178 Neoplastic Process Smoldering Adult T-Cell Leukemia/Lymphoma Smoldering Adult T-Cell Leukemia/Lymphoma C1336015 CTRP Malignant Smoldering_Adult_T-Cell_Lymphoma_Leukemia Smoldering Adult T-Cell Leukemia/Lymphoma Smoldering Adult T-Cell Lymphoma/Leukemia Smoldering Adult T-Cell Leukemia/Lymphoma An adult T-cell leukemia/ lymphoma associated with skin lesions and mild lymphadenopathy. Neoplastic lymphocytes are not numerous in the peripheral blood. Hypercalcemia is absent. C7179 Neoplastic Process Chronic Adult T-Cell Leukemia/Lymphoma Chronic Adult T-Cell Leukemia/Lymphoma C1333032 CTRP Malignant Chronic_Adult_T-Cell_Lymphoma_Leukemia Chronic Adult T-Cell Leukemia/Lymphoma Chronic Adult T-Cell Lymphoma/Leukemia Chronic Adult T-Cell Leukemia/Lymphoma A benign lipomatous neoplasm characterized by the presence of an admixture of mature adipose tissue and bland spindle cells. The pleomorphic variant contains in addition multinucleated giant cells. It usually arises in the neck and upper trunk in older males. C7180 Neoplastic Process Spindle Cell/Pleomorphic Lipoma C1336053 Benign Spindle_Cell_Pleomorphic_Lipoma SCL/PL Spindle Cell/Pleomorphic Lipoma Spindle Cell/Pleomorphic Lipoma A B-cell lymphoproliferative disorder with uncertain malignant potential. The representative example of this category is lymphomatoid granulomatosis. C7182 Neoplastic Process B-Cell Proliferation of Uncertain Malignant Potential C1332363 Uncertain Malignant Potential B-Cell_Proliferation_of_Uncertain_Malignant_Potential B-Cell Proliferation of Uncertain Malignant Potential B-Cell Proliferation of Uncertain Malignant Potential A clonal B-cell lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterized by destructive infiltration of lymph nodes and extranodal sites by a polymorphic B-cell infiltrate composed of small and medium sized lymphocytes, immunoblasts, and plasma cells. In some cases, reduction of the immunosuppression therapy may lead to regression of the lesions. In other cases the lesions may progress to lymphoma. C7183 Neoplastic Process Polymorphic Post-Transplant Lymphoproliferative Disorder Polymorphic Post-Transplant Lymphoproliferative Disorder C1301361 CTRP GDC 9971/3 Uncertain Malignant Potential Polymorphic_Post-Transplant_Lymphoproliferative_Disorder 9971/3 Polymorphic post transplant lymphoproliferative disorder Polymorphic B-Cell Lymphoma Polymorphic B-Cell Post-Transplant Lymphoproliferative Disorder Polymorphic PTLD Polymorphic Post-Transplant Lymphoproliferative Disorder Polymorphic Post-Transplant Lymphoproliferative Disorder A header term comprising lymphomas classified based on anatomic location. C7185 Neoplastic Process Lymphoma by Site C1334465 Header_Concept Malignant Lymphoma_by_Site Lymphoma by Site Lymphoma by Site A Burkitt lymphoma characterized by the presence of a uniform malignant lymphocytic infiltrate that is composed of medium-sized cells with round nuclei and multiple basophilic nucleoli, abundant mitotic figures, and a starry-sky pattern due to the presence of multiple tangible body macrophages. C7188 Neoplastic Process Classical Burkitt Lymphoma C1333063 Malignant Classical_Burkitt_s_Lymphoma Classical Burkitt Lymphoma Classical Burkitt's Lymphoma Classical Burkitt Lymphoma Burkitt lymphoma characterized by the presence of malignant cells with eccentric basophilic cytoplasm. The nucleoli of these cells are often single and central. This morphologic variant of Burkitt lymphoma is more often seen in patients with immunodeficiency. C7189 Neoplastic Process Burkitt Lymphoma with Plasmacytoid Differentiation C1332644 Malignant Burkitt_s_Lymphoma_with_Plasmacytoid_Differentiation Burkitt Lymphoma with Plasmacytoid Differentiation Burkitt's Lymphoma with Plasmacytoid Differentiation Burkitt Lymphoma with Plasmacytoid Differentiation A primary or metastatic malignant neoplasm that affects the hypopharynx. C7190 Neoplastic Process Malignant Hypopharyngeal Neoplasm Malignant Hypopharyngeal Neoplasm CL371823 CPTAC CTRP mCode Malignant Malignant_Hypopharyngeal_Neoplasm Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect Malignant neoplasm of hypopharynx Malignant neoplasm of hypopharynx, unspecified Malignant neoplasm: Aryepiglottic fold, hypopharyngeal aspect Malignant neoplasm: Hypopharynx, unspecified Malignant neoplasm: Overlapping lesion of hypopharynx Malignant neoplasm: Posterior wall of hypopharynx Malignant Hypopharyngeal Neoplasm Malignant Hypopharyngeal Tumor Malignant Neoplasm of Hypopharynx Malignant Neoplasm of the Hypopharynx Malignant Tumor of Hypopharynx Malignant Tumor of the Hypopharynx Malignant neoplasm of hypopharynx, unspecified Malignant Hypopharyngeal Neoplasm A grade 3 follicular lymphoma in which centrocytes are present. C7191 Neoplastic Process Grade 3a Follicular Lymphoma C1333846 CPTAC GDC mCode 9698/3 Malignant Grade_3a_Follicular_Lymphoma 9698/3 Follicular lymphoma grade IIIa, lymph nodes of multiple sites Follicular lymphoma grade IIIa, unspecified site Follicular lymphoma, grade 3A Follicular Lymphoma Grade 3a Follicular lymphoma grade IIIa, unspecified site Follicular lymphoma, grade 3A Grade 3a Grade 3a Follicular Lymphoma WHO Follicular Lymphoma Histologic Grade 3a Grade 3a Follicular Lymphoma A grade 3 follicular lymphoma composed of solid sheets of centroblasts. C7192 Neoplastic Process Grade 3b Follicular Lymphoma Grade 3b Follicular Lymphoma C2853827 CTRP GDC mCode 9698/3 Malignant Grade_3b_Follicular_Lymphoma 9698/3 Follicular lymphoma, grade 3B FLBCL Follicular Large B-Cell Lymphoma Follicular Lymphoma Grade 3b Follicular lymphoma grade IIIb, unspecified site Follicular lymphoma, grade 3B Grade 3b Grade 3b Follicular Lymphoma Grade 3b Follicular Lymphoma A spectrum of lymphoproliferative disorders characterized by CD30 (Ki-1)-positive cutaneous T-cell infiltrates. The two ends of the spectrum include lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. C7195 Neoplastic Process Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder C1371159 GDC mCode 9718/3 Undetermined Primary_Cutaneous_CD30-Positive_T-Cell_Lymphoproliferative_Disorder 9718/3 Primary cutaneous CD30 positive T-cell lymphoproliferative disorder Primary cutaneous CD30+ T-cell lymphoproliferative disorder Primary Cutaneous CD30+ T-Cell Lymphoproliferative Disorder Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder Primary cutaneous CD30+ T-cell lymphoproliferative disorder Primary cutaneous CD30-positive T-cell proliferations Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder A CD30-positive T-cell lymphoproliferative disorder that arises from the skin and is characterized by overlapping morphological features between anaplastic large cell lymphoma and lymphomatoid papulosis. C7196 Neoplastic Process Borderline Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder C1332601 Uncertain Malignant Potential Borderline_Primary_Cutaneous_CD30-Positive_T-Cell_Lymphoproliferative_Disorder Borderline Primary Cutaneous CD30+ T-Cell Lymphoproliferative Disorder Borderline Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder Borderline Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder A variant of lymphomatoid papulosis characterized by the presence of scattered anaplastic large lymphocytes, often resembling Reed-Sternberg cells, admixed with acute and chronic inflammatory cells. C7197 Neoplastic Process Type A Lymphomatoid Papulosis C1336841 Uncertain Malignant Potential Type_A_Lymphomatoid_Papulosis Type A LyP Type A Lymphomatoid Papulosis Type A Lymphomatoid Papulosis A variant of lymphomatoid papulosis characterized by an epidermotropic infiltrate composed of small atypical cerebriform-like lymphocytes. C7198 Neoplastic Process Type B Lymphomatoid Papulosis C1336842 Uncertain Malignant Potential Type_B_Lymphomatoid_Papulosis Type B LyP Type B Lymphomatoid Papulosis Type B Lymphomatoid Papulosis A variant of lymphomatoid papulosis characterized clinically by regressing skin papules, and morphologically by features resembling anaplastic large cell lymphoma. C7199 Neoplastic Process Type C Lymphomatoid Papulosis C1333297 Uncertain Malignant Potential Diffuse_Large_Cell_Type_Lymphomatoid_Papulosis Diffuse Large Cell Type LyP Diffuse Large Cell Type Lymphomatoid Papulosis Type C LyP Type C Lymphomatoid Papulosis Type C Lymphomatoid Papulosis A clinically aggressive neoplasm derived from the precursors of plasmacytoid dendritic cells (also called professional type I interferon-producing cells or plasmacytoid monocytes), with a high frequency of cutaneous and bone marrow involvement and leukemic dissemination. (WHO 2017) C7203 Neoplastic Process Blastic Plasmacytoid Dendritic Cell Neoplasm Blastic Plasmacytoid Dendritic Cell Neoplasm C1301363 CTRP Cellosaurus GDC mCode 9727/3 Malignant Blastic_NK-Cell_Lymphoma 9727/3 Blastic NK cell lymphoma Blastic plasmacytoid dendritic cell neoplasm Agranular CD4+ CD56+ Hematodermic Neoplasm/Tumor Agranular CD4+ Natural Killer Cell Leukemia BPDCN Blastic NK Cell Lymphoma Blastic NK-Cell Lymphoma Blastic NK-cell lymphoma Blastic Natural Killer Leukemia/Lymphoma Blastic Plasmacytoid Dendritic Cell Neoplasm Blastic plasmacytoid dendritic cell neoplasm CD4+/CD56+ Hematodermic Neoplasm Monomorphic NK-Cell Lymphoma Blastic Plasmacytoid Dendritic Cell Neoplasm A variant of peripheral T-cell lymphoma, not otherwise specified. It is characterized by the presence of neoplastic small lymphocytes infiltrating the lymph nodes in a diffuse and less frequently interfollicular pattern. There is an associated proliferation of epithelioid histiocytes forming confluent clusters. C7205 Neoplastic Process Lymphoepithelioid Variant Peripheral T-Cell Lymphoma, Not Otherwise Specified C1621719 Cellosaurus GDC Malignant Lymphoepithelioid_Cell_Variant_Peripheral_T-Cell_Lymphoma 9702/3 Lennert lymphoma Lymphoepithelioid lymphoma Lennert Lymphoma Lennert Variant Peripheral T-Cell Lymphoma Lennert lymphoma Lennert's Lymphoma Lennert's Variant Peripheral T-Cell Lymphoma Lymphoepithelioid Cell Variant Peripheral T-Cell Lymphoma Lymphoepithelioid Variant Peripheral T-Cell Lymphoma Lymphoepithelioid Variant Peripheral T-Cell Lymphoma, NOS Lymphoepithelioid Variant Peripheral T-Cell Lymphoma, Not Otherwise Specified Lymphoepithelioid Variant Peripheral T-Cell Lymphoma, Not Otherwise Specified An anaplastic large cell lymphoma, characterized by CD30 positive lymphoid cells. C7206 Neoplastic Process Common Variant Anaplastic Large Cell Lymphoma C1333133 Malignant Common_Variant_Anaplastic_Large_Cell_Lymphoma Common Variant Anaplastic Large Cell Lymphoma Common Variant Anaplastic Large Cell Lymphoma A histologic variant of anaplastic large cell lymphoma characterized by the presence of a large number of histiocytes admixed with the anaplastic lymphoma cells. C7207 Neoplastic Process Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma C1334463 Malignant Lymphohistiocytic_Variant_Anaplastic_Large_Cell_Lymphoma Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma A well-differentiated, intermediate-grade epithelial neoplasm with neuroendocrine differentiation. It usually arises from the digestive system, lung, and head and neck. C72074 Neoplastic Process Neuroendocrine Tumor G2 C0391970 GDC mCode Undetermined Atypical_Carcinoid_Tumor 8249/3 Atypical carcinoid tumor Malignant carcinoid tumor of unknown primary site Malignant carcinoid tumor of unspecified site Malignant carcinoid tumors of other and unspecified sites Malignant carcinoid tumors of other sites Atypical Carcinoid Tumor Atypical carcinoid tumor Malignant carcinoid tumor of unspecified site NET G2 Neuroendocrine Tumor G2 Neuroendocrine Tumor Grade 2 Neuroendocrine Tumor G2 A histologic variant of anaplastic large cell lymphoma characterized by the presence of a predominant population of small to medium size malignant cells with irregular nuclei. C7208 Neoplastic Process Small Cell Variant Anaplastic Large Cell Lymphoma C1335983 Malignant Small_Cell_Variant_Anaplastic_Large_Cell_Lymphoma Small Cell Variant Anaplastic Large Cell Lymphoma Small Cell Variant Anaplastic Large Cell Lymphoma A B-lymphoblastic lymphoma that occurs during childhood. C7209 Neoplastic Process Childhood B Lymphoblastic Lymphoma Childhood B Lymphoblastic Lymphoma C1332996 CTRP NICHD A B-lymphoblastic lymphoma that occurs during childhood. Malignant Childhood_Precursor_B_Lymphoblastic_Lymphoma B Lymphoblastic Lymphoma Childhood B Lymphoblastic Lymphoma Childhood B-Lymphoblastic Lymphoma Childhood Precursor B-Lymphoblastic Lymphoma Childhood B Lymphoblastic Lymphoma A T-lymphoblastic lymphoma that occurs during childhood. C7210 Neoplastic Process Childhood T Lymphoblastic Lymphoma Childhood T Lymphoblastic Lymphoma C1332998 CTRP Cellosaurus NICHD A T-lymphoblastic lymphoma that occurs during childhood. Malignant Childhood_Precursor_T_Lymphoblastic_Lymphoma Childhood Precursor T-Lymphoblastic Lymphoma Childhood T Lymphoblastic Lymphoma Childhood T-Lymphoblastic Lymphoma T Lymphoblastic Lymphoma Childhood T Lymphoblastic Lymphoma An anaplastic large cell lymphoma that occurs during childhood and is limited to the skin at the time of diagnosis. C7211 Neoplastic Process Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma C1332999 NICHD An anaplastic large cell lymphoma that occurs during childhood, and is limited to the skin at the time of diagnosis. Malignant Childhood_Primary_Cutaneous_Anaplastic_Large_Cell_Lymphoma Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma Childhood Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma Childhood Primary Cutaneous CD30-Positive Anaplastic Large Cell Lymphoma Childhood Primary Cutaneous Ki-1 Positive Anaplastic Large Cell Lymphoma Childhood Primary Cutaneous Ki-1+ Anaplastic Large Cell Lymphoma Pediatric Primary Cutaneous Anaplastic Large Cell Lymphoma Pediatric Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma Pediatric Primary Cutaneous K-1+ Anaplastic Large Cell Lymphoma Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma A diffuse large B-cell lymphoma occurring in HIV-positive patients. C7212 Neoplastic Process AIDS-Related Diffuse Large B-cell Lymphoma C1332042 Malignant AIDS-Related_Diffuse_Large_B-cell_Lymphoma AIDS-Related Diffuse Large B-cell Lymphoma AIDS-Related Diffuse Large B-cell Lymphoma C7215 Neoplastic Process Non-Hodgkin Lymphoma by Clinical Course C1334979 Header_Concept Malignant Non-Hodgkin_s_Lymphoma_by_Clinical_Course Non-Hodgkin Lymphoma by Clinical Course Non-Hodgkin's Lymphoma by Clinical Course Non-Hodgkin Lymphoma by Clinical Course A primary lymphoma of the skin composed of various numbers of small and large irregular neoplastic follicle center cells. Its morphologic pattern can be nodular, diffuse, or nodular and diffuse. It presents with solitary or grouped plaques and tumors, and it usually involves the scalp, forehead, or trunk. It rarely involves the legs. This type of cutaneous lymphoma tends to remain localized to the skin. C7217 Neoplastic Process Primary Cutaneous Follicle Center Lymphoma Primary Cutaneous Follicle Center Lymphoma C1333171 CTRP GDC mCode 9597/3 Malignant Cutaneous_Follicle_Center_Lymphoma 9597/3 Primary cutaneous follicle center lymphoma Primary cutaneous follicle centre lymphoma Crosti's Disease Cutaneous Follicle Center Lymphoma Cutaneous Follicle Centre Lymphoma Cutaneous follicle center lymphoma, unspecified site PCFCL Primary Cutaneous Follicle Center Lymphoma Reticulohistiocytoma of the Dorsum Primary Cutaneous Follicle Center Lymphoma A follicular lymphoma involving the skin. A cutaneous follicular lymphoma may be metastatic to the skin from the lymph nodes or other anatomic sites or primary (cutaneous follicle center lymphoma). C7218 Neoplastic Process Cutaneous Follicular Lymphoma C1333172 Malignant Cutaneous_Follicular_Lymphoma Cutaneous Follicular Lymphoma Cutaneous Follicular Lymphoma A cutaneous lymphoma which contains 6-15 centroblasts per 40X high-power microscopic field. C7219 Neoplastic Process Grade 2 Cutaneous Follicular Lymphoma Grade 2 Cutaneous Follicular Lymphoma C1333836 CTRP Malignant Grade_2_Cutaneous_Follicular_Lymphoma Grade 2 Cutaneous Follicular Lymphoma Grade 2 Cutaneous Follicular Lymphoma A cutaneous lymphoma which contains up to 5 centroblasts per 40X high-power microscopic field. C7220 Neoplastic Process Grade 1 Cutaneous Follicular Lymphoma C1333830 Malignant Grade_1_Cutaneous_Follicular_Lymphoma Grade 1 Cutaneous Follicular Lymphoma Grade 1 Cutaneous Follicular Lymphoma Hodgkin lymphoma primarily involving the skin. This diagnosis can only be made when there is no evidence of Hodgkin lymphoma in the lymph nodes or other anatomic sites. Patients usually present with papules or nodular lesions. Morphologically, primary cutaneous Hodgkin lymphoma may resemble lymphomatoid papulosis or anaplastic large cell lymphoma. Immunohistochemical tissue evaluation is essential in establishing the diagnosis. C7221 Neoplastic Process Primary Cutaneous Hodgkin Lymphoma C1333173 Malignant Cutaneous_Hodgkin_s_Lymphoma PCHL Primary Cutaneous Hodgkin Disease Primary Cutaneous Hodgkin Lymphoma Primary Cutaneous Hodgkin's Disease Primary Cutaneous Hodgkin's Lymphoma Primary Cutaneous Hodgkin Lymphoma Lymphocyte-rich classic Hodgkin lymphoma that occurs in adults. C7223 Neoplastic Process Adult Lymphocyte-Rich Classic Hodgkin Lymphoma Adult Lymphocyte-Rich Classic Hodgkin Lymphoma C1332205 CTRP Malignant Adult_Lymphocyte_Rich_Classical_Hodgkin_s_Lymphoma Adult Lymphocyte Rich Classical Hodgkin Lymphoma Adult Lymphocyte Rich Classical Hodgkin's Disease Adult Lymphocyte Rich Classical Hodgkin's Lymphoma Adult Lymphocyte-Rich Classic Hodgkin Lymphoma Adult Lymphocyte-Rich Classical Hodgkin Lymphoma Lymphocyte-Rich Classical Hodgkin Lymphoma Adult Lymphocyte-Rich Classic Hodgkin Lymphoma An aggressive diffuse large B-cell lymphoma frequently arising in the setting of HIV infection and characterized by the presence of large neoplastic cells resembling B-immunoblasts which have the immunophenotypic profile of plasma cells. Sites of involvement include the oral cavity, sinonasal cavity, skin, soft tissues, gastrointestinal tract, and bone. C7224 Neoplastic Process Plasmablastic Lymphoma Plasmablastic Lymphoma C3472614 CTRP Cellosaurus GDC 9684/3 9735/3 Malignant Plasmablastic_Lymphoma 9735/3 Plasmablastic lymphoma PBL Plasmablastic Lymphoma Plasmablastic lymphoma Plasmablastic Lymphoma A usually aggressive large B-cell lymphoma characterized by the presence of monomorphic immunoblast-like neoplastic B-lymphocytes in a sinusoidal growth pattern. The neoplastic B-lymphocytes express the ALK kinase but they lack the 2;5 translocation. C7225 Neoplastic Process ALK-Positive Large B-Cell Lymphoma C1333294 GDC 9737/3 Malignant Diffuse_Large_B-Cell_Lymphoma_with_Expression_of_Full-Length_ALK 9737/3 ALK positive large B-cell lymphoma ALK positive large B-cell lymphoma ALK-DLBCL ALK-Positive Large B-Cell Lymphoma Diffuse Large B-Cell Lymphoma with Expression of Full-Length ALK Diffuse Large B-Cell Lymphoma with Expression of Full-Length Anaplastic Lymphoma Kinase ALK-Positive Large B-Cell Lymphoma T-lymphoblastic lymphoma occurring in adults. C7226 Neoplastic Process Adult T Lymphoblastic Lymphoma Adult T Lymphoblastic Lymphoma C1332213 CTRP Cellosaurus Malignant Adult_Precursor_T_Lymphoblastic_Lymphoma Adult Precursor T-Lymphoblastic Lymphoma Adult T Lymphoblastic Lymphoma T Lymphoblastic Lymphoma Adult T Lymphoblastic Lymphoma T-lymphoblastic lymphoma that does not respond to treatment. C7227 Neoplastic Process Refractory T Lymphoblastic Lymphoma C1335731 Malignant Refractory_Precursor_T_Lymphoblastic_Lymphoma Refractory Precursor T-Lymphoblastic Lymphoma Refractory T Lymphoblastic Lymphoma Refractory T-Lymphoblastic Lymphoma Refractory T Lymphoblastic Lymphoma Mature B-cell non-Hodgkin lymphoma that does not respond to treatment. C7228 Neoplastic Process Refractory Mature B-Cell Non-Hodgkin Lymphoma C1335726 Malignant Refractory_Mature_B-Cell_Non-Hodgkin_s_Lymphoma Refractory Mature B-Cell Lymphoma Refractory Mature B-Cell Neoplasm Refractory Mature B-Cell Non-Hodgkin Lymphoma Refractory Mature B-Cell Non-Hodgkin's Lymphoma Refractory Mature B-Cell Non-Hodgkin Lymphoma An aggressive mantle cell lymphoma characterized by the presence of neoplastic B-lymphocytes resembling lymphoblasts. C7229 Neoplastic Process Blastoid Variant Mantle Cell Lymphoma C1332569 Malignant Blastoid_Variant_Mantle_Cell_Lymphoma Blastoid Variant Mantle Cell Lymphoma Classic Blastoid Variant Mantle Cell Lymphoma Blastoid Variant Mantle Cell Lymphoma A B-cell lymphoproliferative disorder that arises from the skin. It was previously known as primary cutaneous marginal zone lymphoma of mucosa-associated lymphoid tissue. Two subtypes are recognized: heavy chain class-switched primary cutaneous marginal zone lymphoproliferative disorder and IgM-positive primary cutaneous marginal zone lymphoproliferative disorder. The majority of cases are class-switched and predominantly IgG-positive. C7230 Neoplastic Process Primary Cutaneous Marginal Zone Lymphoproliferative Disorder C1275321 GDC Undetermined Cutaneous_Marginal_Zone_B_Cell_Lymphoma_of_Mucosa-Associated_Lymphoid_Tissue 9699/3 SALT lymphoma Skin-associated lymphoid tissue lymphoma C-MALT Cutaneous Immunocytoma Marginal Zone B Cell Lymphoma of Skin Marginal Zone B Cell Lymphoma of the Skin PCMZL Primary Cutaneous Marginal Zone B Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Primary Cutaneous Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Primary Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Primary Cutaneous Marginal Zone Lymphoproliferative Disorder SALT Lymphoma SALT lymphoma Skin-Associated Lymphoid Tissue Lymphoma Skin-associated lymphoid tissue lymphoma Primary Cutaneous Marginal Zone Lymphoproliferative Disorder A B-cell or T-cell non-Hodgkin lymphoma that arises from the small intestine. Representative examples of B-cell non-Hodgkin lymphoma include diffuse large B-cell lymphoma, MALT lymphoma, alpha heavy chain disease/immunoproliferative small intestinal disease, Burkitt lymphoma, follicular lymphoma, and mantle cell lymphoma. The T-cell non-Hodgkin lymphomas are the enteropathy-associated T-cell lymphoma and the monomorphic CD56 positive intestinal T-cell lymphoma. C7231 Neoplastic Process Small Intestinal Non-Hodgkin Lymphoma C1336006 Malignant Small_Intestinal_Non-Hodgkin_s_Lymphoma Primary Small Intestinal Non-Hodgkin's Lymphoma Small Intestinal Non-Hodgkin Lymphoma Small Intestinal Non-Hodgkin's Lymphoma Small Intestine Non-Hodgkin's Lymphoma Small Intestinal Non-Hodgkin Lymphoma A lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterized by the presence of tissue destruction and effacement of the architecture of the involved tissues. It includes the following variants: polymorphic, monomorphic, and classical Hodgkin lymphoma post-transplant lymphoproliferative disorders. C7232 Neoplastic Process Neoplastic Post-Transplant Lymphoproliferative Disorder C1334942 Undetermined Neoplastic_Post-Transplant_Lymphoproliferative_Disorder Neoplastic PTLD Neoplastic Post-Transplant Lymphoproliferative Disorder Post-Transplant Lymphocytic Neoplasm Post-Transplant Lymphoproliferative Neoplasm Post-Transplant Neoplastic Lymphoproliferative Disorder Neoplastic Post-Transplant Lymphoproliferative Disorder A clonal lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterized by destructive infiltration of lymph nodes and extranodal sites by a monotonous population of transformed lymphocytes or plasma cells. It includes two variants: monomorphic B-cell and monomorphic T/NK cell post-transplant lymphoproliferative disorders. C7233 Neoplastic Process Monomorphic Post-Transplant Lymphoproliferative Disorder C1334798 CTEP Malignant Monomorphic_Post-Transplant_Lymphoproliferative_Disorder Monomorphic PTLD Monomorphic Post-Transplant Lymphoproliferative Disorder PTLD (Monoclonal) Post-transplant lymphoproliferative disorder (Monoclonal), NOS Monomorphic Post-Transplant Lymphoproliferative Disorder A clonal B-cell lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterized by destructive infiltration of lymph nodes and extranodal sites by a monotonous population of transformed B-lymphocytes or plasma cells. The clonal cellular infiltrates fulfill the criteria for a diffuse large B-cell lymphoma, Burkitt lymphoma, or a plasma cell neoplasm. C7237 Neoplastic Process Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder C1334797 Malignant Monomorphic_B-Cell_PTLD Monomorphic B-Cell PTLD Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder A clonal T-cell lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterized by destructive infiltration of lymph nodes and extranodal sites by a monotonous population of transformed T-lymphocytes/NK-cells. The clonal cellular infiltrates fulfill the criteria for any of the T-cell or natural killer cell lymphomas. C7238 Neoplastic Process Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder C1334799 Malignant Monomorphic_T-Cell_PTLD Monomorphic T-Cell PTLD Monomorphic T-Cell Post-Transplant Lymphoproliferative Disorder Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder A plasma cell neoplasm that arises in a patient with a history of organ transplantation. C7240 Neoplastic Process Plasma Cell Post-Transplant Lymphoproliferative Disorder C1335426 Malignant Plasma_Cell_PTLD Plasma Cell PTLD Plasma Cell Post-Transplant Lymphoproliferative Disorder Plasma Cell Post-Transplant Lymphoproliferative Disorder A plasmacytoma-like hematologic malignancy that arises in a patient with a history of organ transplantation. C7241 Neoplastic Process Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder C1335429 Malignant Plasmacytoma-Like_PTLD Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder Plasmacytoma-like PTLD Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder A lymphoproliferative disorder that develops following an organ transplantation and exhibits multiple myeloma features. C7242 Neoplastic Process Multiple Myeloma Post-Transplant Lymphoproliferative Disorder C1335425 Malignant Plasma_Cell_Myeloma_PTLD Multiple Myeloma PTLD Multiple Myeloma Post-Transplant Lymphoproliferative Disorder Plasma Cell Myeloma PTLD Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder Multiple Myeloma Post-Transplant Lymphoproliferative Disorder A lymphoproliferative disorder that fulfills the criteria for classic Hodgkin lymphoma and arises as a result of post-transplant immunosuppression therapy. It is most often seen in renal transplant patients. C7243 Neoplastic Process Classic Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder C1334037 CTEP Malignant Hodgkin_s_Lymphoma_PTLD Classic Hodgkin Lymphoma PTLD Classic Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder Classic Hodgkin Lymphoma Type PTLD Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder Classical Hodgkin Lymphoma Type PTLD Classical Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder Hodgkin Lymphoma PTLD Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder Hodgkin lymphoma - like PTLD Hodgkin lymphoma-like post-transplant lymphoproliferative disorder Hodgkin's Lymphoma PTLD Hodgkin's Lymphoma Post-Transplant Lymphoproliferative Disorder Hodgkin-Like Post-Transplant Lymphoproliferative Disorder Classic Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder A Burkitt lymphoma that arises in a patient with a history of organ transplantation. C7244 Neoplastic Process Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder C1332643 Malignant Burkitt_s_Lymphoma_PTLD Burkitt Lymphoma PTLD Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder Burkitt's Lymphoma PTLD Burkitt's Lymphoma Post-Transplant Lymphoproliferative Disorder Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder A Burkitt-like lymphoma that arises in a patient with a history of organ transplantation. C7245 Neoplastic Process Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder C1332642 Malignant Burkitt_s-Like_Lymphoma_PTLD Burkitt's-Like Lymphoma Post-Transplant Lymphoproliferative Disorder Burkitt's-like Lymphoma PTLD Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder Burkitt-like Lymphoma PTLD Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder A diffuse large B-cell lymphoma that arises in a patient with a history of organ transplantation. C7246 Neoplastic Process Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder C1333293 Malignant Diffuse_Large_B-Cell_Lymphoma_PTLD Diffuse Large B-Cell Lymphoma PTLD Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder An anaplastic lymphoma that arises in a patient with a history of organ transplantation. C7247 Neoplastic Process Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder C1332284 Malignant Anaplastic_Lymphoma_PTLD Anaplastic Diffuse Large B-Cell Lymphoma PTLD Anaplastic Lymphoma PTLD Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder A centroblastic lymphoma that arises in a patient with a history of organ transplantation. C7248 Neoplastic Process Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder C1332898 Malignant Centroblastic_Lymphoma_PTLD Centroblastic Diffuse Large B-Cell Lymphoma PTLD Centroblastic Lymphoma PTLD Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder An immunoblastic lymphoma that arises in a patient with a history of organ transplantation. C7249 Neoplastic Process Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder C1334157 Malignant Immunoblastic_Lymphoma_PTLD Immunoblastic Diffuse Large B-Cell Lymphoma PTLD Immunoblastic Lymphoma PTLD Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder A primary or metastatic malignant neoplasm that affects the testis. Representative examples include seminoma, embryonal carcinoma, sarcoma, leukemia, and lymphoma. C7251 Neoplastic Process Malignant Testicular Neoplasm Malignant Testicular Neoplasm C0153594 CPTAC CTRP mCode Malignant Malignant_Testicular_Neoplasm Malignant neoplasm of left testis, unspecified whether descended or undescended Malignant neoplasm of other and unspecified testis Malignant neoplasm of right testis, unspecified whether descended or undescended Malignant neoplasm of testis Malignant neoplasm of undescended testis Malignant neoplasm of unspecified testis, unspecified whether descended or undescended Malignant neoplasm of unspecified undescended testis Malignant neoplasm: Testis, unspecified Malignant Neoplasm of Testis Malignant Neoplasm of the Testis Malignant Testicular Neoplasm Malignant Testicular Tumor Malignant Tumor of Testis Malignant Tumor of the Testis Malignant neoplasm of unspecified testis, unspecified whether descended or undescended Testicular Cancer Malignant Testicular Neoplasm A peripheral T-cell lymphoma that develops in patients who are immunosuppressed with methotrexate. C7252 Neoplastic Process Methotrexate-Associated Peripheral T-Cell Lymphoma C1334750 Malignant Methotrexate-Associated_Peripheral_T-Cell_Lymphoma Methotrexate-Associated Peripheral T-Cell Lymphoma Methotrexate-Associated Peripheral T-Cell Lymphoma A diffuse large B-cell lymphoma that develops in patients who are immunosuppressed with methotrexate. C7253 Neoplastic Process Methotrexate-Associated Diffuse Large B-Cell Lymphoma C1334746 Malignant Methotrexate-Associated_Diffuse_Large_B-Cell_Lymphoma Methotrexate-Associated Diffuse Large B-Cell Lymphoma Methotrexate-Associated Diffuse Large B-Cell Lymphoma A follicular lymphoma that develops in patients who are immunosuppressed with methotrexate. C7254 Neoplastic Process Methotrexate-Associated Follicular Lymphoma C1334747 Malignant Methotrexate-Associated_Follicular_Lymphoma Methotrexate-Associated Follicular Lymphoma Methotrexate-Associated Follicular Lymphoma A Burkitt lymphoma that develops in patients who are immunosuppressed with methotrexate. C7255 Neoplastic Process Methotrexate-Related Burkitt Lymphoma C1334745 Malignant Methotrexate-Associated_Burkitt_s_Lymphoma Methotrexate-Related Burkitt Lymphoma Methotrexate-Related Burkitt's Lymphoma Methotrexate-Related Burkitt Lymphoma A Hodgkin lymphoma that develops in patients who are immunosuppressed with methotrexate. C7256 Neoplastic Process Methotrexate-Associated Hodgkin Lymphoma C1334748 Malignant Methotrexate-Associated_Hodgkin_s_Lymphoma Methotrexate-Associated Hodgkin Lymphoma Methotrexate-Associated Hodgkin's Lymphoma Methotrexate-Associated Hodgkin Lymphoma A B-cell lymphoma characterized by the presence of scattered clonal cells known as lymphocyte predominant cells (LP cells) in a background of reactive lymphocytes and histiocytes, and formation of a nodular or nodular and diffuse growth pattern. C7258 Neoplastic Process Nodular Lymphocyte Predominant Hodgkin Lymphoma Nodular Lymphocyte Predominant B-Cell Lymphoma C1334968 CPTAC CTEP CTRP Cellosaurus GDC PCDC mCode A rare type of Hodgkin lymphoma, which is a cancer of the immune system. It is marked by the presence of a type of cell called a popcorn cell, which is different from the typical Reed-Sternberg cell found in classical Hodgkin lymphoma. This type of Hodgkin lymphoma may change into diffuse large B-cell lymphoma. 9659/3 Malignant Nodular_Lymphocyte_Predominant_Hodgkin_s_Lymphoma 9659/3 Hodgkin lymphoma, lymphocyte predominance, nodular Hodgkin lymphoma, nodular lymphocyte predominance Hodgkin lymphoma, nodular lymphocyte predominant Hodgkin's disease, lymphocytic-histiocytic predominance Hodgkin's disease, lymphocytic-histiocytic predominance involving lymph nodes of axilla and upper limb Hodgkin's disease, lymphocytic-histiocytic predominance involving lymph nodes of head, face, and neck Hodgkin's disease, lymphocytic-histiocytic predominance involving lymph nodes of inguinal region and lower limb Hodgkin's disease, lymphocytic-histiocytic predominance involving lymph nodes of multiple sites Hodgkin's disease, lymphocytic-histiocytic predominance, unspecified site, extranodal and solid organ sites Nodular lymphocyte predominant Hodgkin lymphoma Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of inguinal region and lower limb Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site Hodgkin Lymphoma, Nodular Lymphocyte Predominance Hodgkin lymphoma nodular LP, NOS Hodgkin lymphoma nodular lymphocyte predominant type, NOS Hodgkin lymphoma, lymphocyte predominance, nodular Hodgkin lymphoma, nodular lymphocyte predominance NLP-BCL NLPBL NLPHL Nodular Lymphocyte Predominant B-Cell Lymphoma Nodular Lymphocyte Predominant B-Cell Lymphoma/Nodular Lymphocyte Predominant Hodgkin Lymphoma Nodular Lymphocyte Predominant Hodgkin Lymphoma Nodular Lymphocyte Predominant Hodgkin's Lymphoma Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site nodular lymphocyte-predominant Hodgkin lymphoma Nodular Lymphocyte Predominant B-Cell Lymphoma The reemergence of nodular lymphocyte predominant B-cell lymphoma after a period of remission. C7259 Neoplastic Process Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma C1335716 CTRP Malignant Recurrent_Nodular_Lymphocyte_Predominant_Hodgkin_s_Lymphoma Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma Recurrent Nodular Lymphocyte Predominant Hodgkin's Disease Recurrent Nodular Lymphocyte Predominant Hodgkin's Lymphoma Relapsed Nodular Lymphocyte Predominant Hodgkin's Disease Relapsed Nodular Lymphocyte Predominant Hodgkin's Lymphoma Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma Nodular lymphocyte predominant B-cell lymphoma that is resistant to treatment. C7260 Neoplastic Process Refractory Nodular Lymphocyte Predominant Hodgkin Lymphoma Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma C1335730 CTRP Malignant Refractory_Nodular_Lymphocyte_Predominant_Hodgkin_s_Lymphoma Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma Refractory Nodular Lymphocyte Predominant Hodgkin Lymphoma Refractory Nodular Lymphocyte Predominant Hodgkin's Disease Refractory Nodular Lymphocyte Predominant Hodgkin's Lymphoma Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C7261 Neoplastic Process Ann Arbor Stage IV Nodular Lymphocyte Predominant Hodgkin Lymphoma Ann Arbor Stage IV Nodular Lymphocyte Predominant B-Cell Lymphoma C1336428 CTRP Malignant Stage_IV_Nodular_Lymphocyte_Predominant_Hodgkin_s_Lymphoma Ann Arbor Stage IV Nodular Lymphocyte Predominant B-Cell Lymphoma Ann Arbor Stage IV Nodular Lymphocyte Predominant Hodgkin Lymphoma Stage IV Nodular Lymphocyte Predominant Hodgkin Lymphoma Stage IV Nodular Lymphocyte Predominant Hodgkin's Disease Stage IV Nodular Lymphocyte Predominant Hodgkin's Lymphoma Ann Arbor Stage IV Nodular Lymphocyte Predominant B-Cell Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C7262 Neoplastic Process Ann Arbor Stage III Nodular Lymphocyte Predominant Hodgkin Lymphoma Ann Arbor Stage III Nodular Lymphocyte Predominant B-Cell Lymphoma C1336258 CTRP Malignant Stage_III_Nodular_Lymphocyte_Predominant_Hodgkin_s_Lymphoma Ann Arbor Stage III Nodular Lymphocyte Predominant B-Cell Lymphoma Ann Arbor Stage III Nodular Lymphocyte Predominant Hodgkin Lymphoma Stage III Nodular Lymphocyte Predominant Hodgkin Lymphoma Stage III Nodular Lymphocyte Predominant Hodgkin's Disease Stage III Nodular Lymphocyte Predominant Hodgkin's Lymphoma Ann Arbor Stage III Nodular Lymphocyte Predominant B-Cell Lymphoma A diffuse large B-cell lymphoma variant, primarily involving the thyroid gland. It is composed predominantly of immunoblasts. C7263 Neoplastic Process Thyroid Gland Immunoblastic Lymphoma C1336752 Malignant Thyroid_Immunoblastic_Lymphoma Immunoblastic Lymphoma of Thyroid Immunoblastic Lymphoma of Thyroid Gland Immunoblastic Lymphoma of the Thyroid Immunoblastic Lymphoma of the Thyroid Gland Primary Thyroid Gland Immunoblastic Lymphoma Thyroid Gland Immunoblastic Lymphoma Thyroid Immunoblastic Lymphoma Thyroid Gland Immunoblastic Lymphoma A lymphoma with the morphologic and immunophenotypic features of a follicular lymphoma characterized by the presence of a diffuse growth pattern with only focal and usually small micronodular foci. C7264 Neoplastic Process Follicular Lymphoma with Predominantly Diffuse Growth Pattern C1333290 mCode Malignant Diffuse_Follicle_Center_Lymphoma Diffuse Follicle Centre Lymphoma Diffuse Follicular Lymphoma Diffuse follicle center lymphoma, unspecified site Follicle Centre Lymphoma Diffuse Follicular Lymphoma with Predominantly Diffuse Growth Pattern dFL Follicular Lymphoma with Predominantly Diffuse Growth Pattern A large cell lung carcinoma characterized by the presence of a solid nodular or anastomotic trabecular growth pattern, peripheral palisading, and comedo type necrosis. C7266 Neoplastic Process Lung Basaloid Large Cell Carcinoma C1332463 Malignant Basaloid_Lung_Carcinoma Lung Basaloid Large Cell Carcinoma Lung Basaloid Large Cell Carcinoma A subtype of large cell neuroendocrine lung carcinoma characterized by the presence of large neuroendocrine cells in combination with adenocarcinoma, squamous cell carcinoma, giant cell carcinoma and/ or spindle cell carcinoma. C7267 Neoplastic Process Combined Lung Large Cell Neuroendocrine Carcinoma C1333122 GDC Malignant Combined_Large_Cell_Neuroendocrine_Carcinoma_of_the_Lung Combined large cell neuroendocrine carcinoma Combined Large Cell Lung Neuroendocrine Carcinoma Combined Large Cell Neuroendocrine Carcinoma of Lung Combined Large Cell Neuroendocrine Carcinoma of the Lung Combined Lung Large Cell Neuroendocrine Carcinoma Lung Combined Large Cell Neuroendocrine Carcinoma Pulmonary Combined Large Cell Neuroendocrine Carcinoma Combined Lung Large Cell Neuroendocrine Carcinoma A morphologic variant of minimally invasive lung adenocarcinoma characterized by tall columnar cells and mucin production. C7268 Neoplastic Process Minimally Invasive Lung Mucinous Adenocarcinoma C1266035 GDC 8253/3 Malignant Mucinous_Bronchiolo-Alveolar_Lung_Carcinoma Bronchio-alveolar carcinoma, mucinous Bronchiolo-alveolar carcinoma, goblet cell type Minimally invasive adenocarcinoma, mucinous Minimally Invasive Lung Mucinous Adenocarcinoma Mucinous Bronchioloalveolar Carcinoma Mucinous Bronchioloalveolar Lung Carcinoma Mucinous Bronchoalveolar Lung Carcinoma Mucinous Minimally Invasive Lung Adenocarcinoma Minimally Invasive Lung Mucinous Adenocarcinoma A morphologic variant of minimally invasive lung adenocarcinoma characterized by the presence of Clara cells and/or type II cells. C7269 Neoplastic Process Minimally Invasive Lung Non-Mucinous Adenocarcinoma Minimally Invasive Lung Non-Mucinous Adenocarcinoma C1266034 CTRP GDC 8252/3 Malignant Non-Mucinous_Bronchiolo-Alveolar_Lung_Carcinoma 8252/3 Bronchiolo-alveolar carcinoma, Clara cell Bronchiolo-alveolar carcinoma, non- mucinous Bronchiolo-alveolar carcinoma, non-mucinous Bronchiolo-alveolar carcinoma; type II pneumocyte Minimally invasive adenocarcinoma, non-mucinous Minimally Invasive Lung Non-Mucinous Adenocarcinoma Non-Mucinous Bronchioloalveolar Carcinoma Non-Mucinous Bronchioloalveolar Lung Carcinoma Non-Mucinous Bronchoalveolar Lung Carcinoma Non-Mucinous Minimally Invasive Lung Adenocarcinoma Minimally Invasive Lung Non-Mucinous Adenocarcinoma A morphologic variant of minimally invasive lung adenocarcinoma characterized by the presence of Clara cells and/or type II cells, tall columnar cells, and mucin production. C7270 Neoplastic Process Minimally Invasive Lung Mixed Non-Mucinous and Mucinous Adenocarcinoma C1266036 GDC 8254/3 Malignant Mixed_Mucinous_and_Non-Mucinous_Bronchiolo-Alveolar_Lung_Carcinoma 8254/3 Adenocarcinoma of lung, mixed mucinous and non-mucinous Bronchio-alveolar carcinoma, mixed mucinous and non-mucinous Bronchiolo-alveolar carcinoma, Clara cell and goblet cell type Bronchiolo-alveolar carcinoma, indeterminate type Bronchiolo-alveolar carcinoma, mixed mucinous and non-mucinous Bronchiolo-alveolar carcinoma, type II pneumocyte and goblet cell type Indeterminate Bronchioloalveolar Carcinoma Minimally Invasive Lung Mixed Non-Mucinous and Mucinous Adenocarcinoma Mixed Mucinous and Non-Mucinous Bronchioloalveolar Carcinoma Mixed Mucinous and Non-Mucinous Bronchioloalveolar Lung Carcinoma Mixed Mucinous and Non-Mucinous Bronchoalveolar Lung Carcinoma Minimally Invasive Lung Mixed Non-Mucinous and Mucinous Adenocarcinoma A serous cystadenoma of the ovary characterized by the presence of small papillary projections in the inner surface of the cysts. C7278 Neoplastic Process Ovarian Papillary Cystadenoma C1335175 Cellosaurus Benign Ovarian_Papillary_Cystadenoma Ovarian Papillary Cystadenoma Ovarian Papillary Cystadenoma A benign serous neoplasm characterized by the presence of papillary proliferations on the surface of the ovary. C7279 Neoplastic Process Ovarian Surface Papilloma C1335183 Benign Ovarian_Surface_Papilloma Ovarian Surface Papilloma Ovarian Surface Papilloma A low grade, non-invasive ovarian epithelial neoplasm characterized by the presence of atypical neoplastic serous and mucinous cells. C7281 Neoplastic Process Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor C1332596 8323/1 Uncertain Malignant Potential Borderline_Ovarian_Mixed_Epithelial_Neoplasm Seromucinous borderline tumor Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor A non-metastasizing mixed epithelial neoplasm that arises from the ovary. It is characterized by the presence of more than one epithelial cell type, most often serous and endocervical-type mucinous. There is no evidence of atypia. This category includes seromucinous cystadenoma and seromucinous adenofibroma. C7282 Neoplastic Process Benign Ovarian Seromucinous Tumor C1332525 Benign Benign_Ovarian_Mixed_Epithelial_Neoplasm Benign Ovarian Seromucinous Tumor Benign Seromucinous Cystadenoma/Adenofibroma Benign Ovarian Seromucinous Tumor A teratoma that arises from the ovary and is characterized by the presence of cystic structures. Representative example is the dermoid cyst. C7283 Neoplastic Process Ovarian Cystic Teratoma C1335155 Undetermined Ovarian_Cystic_Teratoma Ovarian Cystic Teratoma Ovarian Cystic Teratoma An adult-type tumor that has derived from an ovarian dermoid cyst. Representative examples include dermoid cyst with secondary carcinoma, dermoid cyst with secondary sarcoma, and dermoid cyst with pituitary-type tumor. C7284 Neoplastic Process Ovarian Dermoid Cyst with Secondary Tumor C1335156 Undetermined Ovarian_Dermoid_Cyst_with_Secondary_Tumor Dermoid Cyst with Secondary Tumor Ovarian Dermoid Cyst with Secondary Tumor Somatic Neoplasm Arising from Ovarian Teratoma Ovarian Dermoid Cyst with Secondary Tumor A mature teratoma that arises from the ovary and presents as a large solid mass. It contains multiple cysts that vary in size. Small foci of hemorrhage are also present. C7285 Neoplastic Process Ovarian Solid Teratoma C1335181 Benign Ovarian_Solid_Teratoma Ovarian Solid Teratoma Ovarian Solid Teratoma A teratoma that arises from the ovary and is characterized by the presence of tissues derived exclusively from one embryonic germ cell layer. C7286 Neoplastic Process Ovarian Monodermal Teratoma C1302569 Undetermined Ovarian_Monodermal_Teratoma Monodermal Teratoma Ovarian Monodermal Teratoma Ovarian Monodermal Teratoma A group of sex cord-stromal tumors that arise from the ovary. These tumors are characterized by the presence of granulosa cells, stromal cells, and/or theca cells. This group includes granulosa cell tumor and tumors of the thecoma/fibroma group. C7287 Neoplastic Process Ovarian Granulosa-Stromal Cell Tumor C1335162 NICHD A granulosa cell-stromal tumor that occurs in the ovary. Undetermined Ovarian_Granulosa-Stromal_Cell_Tumor Ovarian Granulosa-Stromal Cell Tumor Ovarian Granulosa-Stromal Tumor Ovarian Granulosa-Stromal Cell Tumor A low-grade malignant sex cord-stromal tumor that occurs in the ovary and affects middle aged to post-menopausal women. It is composed of granulosa cells in an often fibrothecomatous stroma. The neoplastic cells may form various patterns including the microfollicular, which is characterized by the presence of Call-Exner bodies, macrofollicular, insular, trabecular, and diffuse pattern. Signs and symptoms include abdominal mass, hemoperitoneum, and ascites. Estrogenic and rarely androgenic manifestations may be present. The vast majority of cases present as stage I tumors; however, all tumors have a potential for aggressive clinical course. C7288 Neoplastic Process Adult Type Ovarian Granulosa Cell Tumor Adult Ovarian Granulosa Cell Tumor C1332218 CTRP Malignant Adult_Type_Ovarian_Granulosa_Cell_Tumor Adult granulosa cell tumor of ovary Adult Ovarian Granulosa Cell Tumor Adult Type Ovarian Granulosa Cell Tumor Ovarian Granulosa Cell Tumor Adult Ovarian Granulosa Cell Tumor An ovarian granulosa cell tumor that affects females in the first three decades of life. It presents unilaterally as stage I disease in the vast majority of cases. The prognosis is usually good. C7289 Neoplastic Process Juvenile Ovarian Granulosa Cell Tumor C1334304 NICHD A granulosa cell tumor that affects females within the first three decades of life. Uncertain Malignant Potential Juvenile_Type_Ovarian_Granulosa_Cell_Tumor Juvenile Ovarian Granulosa Cell Tumor Juvenile Type Ovarian Granulosa Cell Tumor Juvenile Ovarian Granulosa Cell Tumor A group of neoplasms that arise from the ovary and represent a spectrum of tumors ranging from neoplasms that are composed entirely of fibroblasts to those that are composed predominantly of theca cells. C7290 Neoplastic Process Ovarian Tumor of the Thecoma/Fibroma Group C1336734 Undetermined Thecoma-Fibroma_Group_Ovarian_Tumor Ovarian Tumor of the Thecoma/Fibroma Group Thecoma/Fibroma Group Ovarian Tumor Ovarian Tumor of the Thecoma/Fibroma Group A benign neoplasm arising from soft tissue of the ovary. It is characterized by the presence of spindle-shaped fibroblasts and increased cellularity. C7291 Neoplastic Process Ovarian Cellular Fibroma C1335154 Benign Ovarian_Cellular_Fibroma Ovarian Cellular Fibroma Ovarian Cellular Fibroma A malignant mesenchymal neoplasm that arises from the spleen. C7292 Neoplastic Process Malignant Splenic Soft Tissue Neoplasm C1334621 Malignant Malignant_Splenic_Soft_Tissue_Tumor Malignant Soft Tissue Neoplasm of Spleen Malignant Soft Tissue Neoplasm of the Spleen Malignant Soft Tissue Tumor of Spleen Malignant Soft Tissue Tumor of the Spleen Malignant Splenic Soft Tissue Neoplasm Malignant Splenic Soft Tissue Tumor Malignant Splenic Soft Tissue Neoplasm Non-Hodgkin lymphoma involving the spleen. C7294 Neoplastic Process Splenic Non-Hodgkin Lymphoma C1336071 mCode Malignant Splenic_Non-Hodgkin_s_Lymphoma Non-Hodgkin Lymphoma of Spleen Non-Hodgkin Lymphoma of the Spleen Non-Hodgkin lymphoma, spleen Non-Hodgkin's Lymphoma of Spleen Non-Hodgkin's Lymphoma of the Spleen Primary Splenic Non-Hodgkin's Lymphoma Splenic Non-Hodgkin Lymphoma Splenic Non-Hodgkin's Lymphoma Splenic Non-Hodgkin Lymphoma A rare Hodgkin lymphoma that arises from the spleen. C7295 Neoplastic Process Splenic Hodgkin Lymphoma C0153791 PCDC mCode Malignant Splenic_Hodgkin_s_Lymphoma Hodgkin lymphoma, unspecified, spleen Hodgkin's Disease of Spleen Hodgkin's Disease of the Spleen Hodgkin's Lymphoma of Spleen Hodgkin's Lymphoma of the Spleen Primary Splenic Hodgkin's Lymphoma Spleen Splenic Hodgkin Lymphoma Splenic Hodgkin's Disease Splenic Hodgkin's Lymphoma Splenic Hodgkins Lymphoma Splenic Hodgkin Lymphoma Infiltration and expansion of the white and/or red pulp and sinusoids of the spleen by leukemic cells. C7296 Neoplastic Process Splenic Manifestation of Leukemia Splenic Manifestation of Leukemia C1336065 CPTAC CTRP Malignant Splenic_Manifestation_of_Leukemia Splenic Manifestation of Leukemia Splenic Manifestation of Leukemia Infiltration and expansion of the white and red pulp of the spleen by prolymphocytic leukemia. C7297 Neoplastic Process Splenic Manifestation of Prolymphocytic Leukemia C1336066 Malignant Splenic_Manifestation_of_Prolymphocytic_Leukemia Splenic Manifestation of Prolymphocytic Leukemia Splenic Manifestation of Prolymphocytic Leukemia Infiltration and expansion of the white and red pulp of the spleen by T-cell prolymphocytic leukemia. C7298 Neoplastic Process Splenic Manifestation of T-Cell Prolymphocytic Leukemia C1336068 Malignant Splenic_Manifestation_of_T-Cell_Prolymphocytic_Leukemia Splenic Manifestation of T-Cell Prolymphocytic Leukemia Splenic Manifestation of T-Cell Prolymphocytic Leukemia Infiltration and expansion of the white and red pulp of the spleen by B-cell prolymphocytic leukemia. C7299 Neoplastic Process Splenic Manifestation of B-Cell Prolymphocytic Leukemia C1336061 Malignant Splenic_Manifestation_of_B-Cell_Prolymphocytic_Leukemia Splenic Manifestation of B-Cell Prolymphocytic Leukemia Splenic Manifestation of B-Cell Prolymphocytic Leukemia Infiltration of the spleen by chronic lymphocytic leukemia. It primarily involves the white pulp. C7300 Neoplastic Process Splenic Manifestation of Chronic Lymphocytic Leukemia C1336062 Malignant Splenic_Manifestation_of_Chronic_Lymphocytic_Leukemia Splenic Manifestation of CLL Splenic Manifestation of Chronic Lymphocytic Leukemia Splenic Manifestation of Chronic Lymphocytic Leukemia Infiltration and expansion of the red pulp of the spleen by hairy cell leukemia. C7301 Neoplastic Process Splenic Manifestation of Hairy Cell Leukemia C1336064 Malignant Splenic_Manifestation_of_Hairy_Cell_Leukemia Splenic Manifestation of Hairy Cell Leukemia Splenic Manifestation of Hairy Cell Leukemia Infiltration and expansion of the red pulp cords and sinusoids of the spleen by T-cell large granular lymphocyte leukemia. The white pulp of the spleen is not involved and is often hyperplastic. C7302 Neoplastic Process Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia C1336067 Malignant Splenic_Manifestation_of_T-Cell_Large_Granular_Lymphocyte_Leukemia Splenic Manifestation of LGL Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia Infiltration and expansion of the red pulp and sinusoids of the spleen by chronic myeloid leukemia, BCR-ABL1 positive. C7303 Neoplastic Process Splenic Manifestation of Chronic Myeloid Leukemia, BCR-ABL1 Positive C1336063 Malignant Splenic_Manifestation_of_Chronic_Myelogenous_Leukemia Splenic Manifestation of CML Splenic Manifestation of Chronic Myelogenous Leukemia Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive Splenic Manifestation of Chronic Myelogenous Leukemia, BCR::ABL1 Positive Splenic Manifestation of Chronic Myeloid Leukemia Splenic Manifestation of Chronic Myeloid Leukemia, BCR-ABL1 Positive Splenic Manifestation of Chronic Myeloid Leukemia, BCR::ABL1 Positive Splenic Manifestation of Chronic Myeloid Leukemia, BCR-ABL1 Positive Small lymphocytic lymphoma occurring in the spleen. C7304 Neoplastic Process Splenic Small Lymphocytic Lymphoma Splenic Small Lymphocytic Lymphoma C1336075 CTRP mCode Malignant Splenic_Small_Lymphocytic_Lymphoma Small cell B-cell lymphoma, spleen Splenic Small Lymphocytic Lymphoma Splenic Small Lymphocytic Lymphoma A lymphoplasmacytic lymphoma occurring in the spleen. C7305 Neoplastic Process Splenic Lymphoplasmacytic Lymphoma C2018776 Malignant Splenic_Lymphoplasmacytic_Lymphoma_Waldenstrom_s_Macroglobulinemia Splenic Lymphoplasmacytic Lymphoma Splenic Lymphoplasmacytic Lymphoma A mantle cell lymphoma occurring in the spleen. C7306 Neoplastic Process Splenic Mantle Cell Lymphoma C2018777 mCode Malignant Splenic_Mantle_Cell_Lymphoma Mantle cell lymphoma, spleen Splenic Mantle Cell Lymphoma Splenic Mantle Cell Lymphoma A follicular lymphoma occurring in the spleen. C7307 Neoplastic Process Splenic Follicular Lymphoma C2018769 mCode Malignant Splenic_Follicular_Lymphoma Follicular lymphoma, unspecified, spleen Primary Splenic Follicular Lymphoma Splenic Follicular Lymphoma Splenic Follicular Lymphoma A rare diffuse large B-cell lymphoma that arises from the spleen. C7308 Neoplastic Process Splenic Diffuse Large B-Cell Lymphoma C2018774 mCode Malignant Splenic_Diffuse_Large_B-Cell_Lymphoma Diffuse large B-cell lymphoma, spleen Primary Splenic Diffuse Large B-Cell Lymphoma Splenic Diffuse Large B-Cell Lymphoma Splenic Diffuse Large B-Cell Lymphoma Burkitt lymphoma that involves the spleen. C7309 Neoplastic Process Splenic Burkitt Lymphoma C0686546 mCode Malignant Splenic_Burkitt_s_Lymphoma Burkitt lymphoma, spleen Primary Splenic Burkitt's Lymphoma Splenic Burkitt Lymphoma Splenic Burkitt's Lymphoma Splenic Burkitt Lymphoma B-lymphoblastic lymphoma that involves the spleen. C7310 Neoplastic Process Splenic B Lymphoblastic Lymphoma C1336072 Malignant Splenic_Precursor_B_Lymphoblastic_Lymphoma Splenic B Lymphoblastic Lymphoma Splenic B-Lymphoblastic Lymphoma Splenic Precursor B-Lymphoblastic Lymphoma Splenic B Lymphoblastic Lymphoma T-lymphoblastic lymphoma that affects the spleen. C7311 Neoplastic Process Splenic T Lymphoblastic Lymphoma C1336074 Malignant Splenic_Precursor_T_Lymphoblastic_Lymphoma Splenic Precursor T-Lymphoblastic Lymphoma Splenic T Lymphoblastic Lymphoma Splenic T-Lymphoblastic Lymphoma Splenic T Lymphoblastic Lymphoma Lymphoblastic lymphoma that affects the spleen. C7312 Neoplastic Process Splenic Lymphoblastic Lymphoma C1336073 mCode Malignant Splenic_Precursor_Lymphoblastic_Lymphoma Lymphoblastic (diffuse) lymphoma, spleen Splenic Lymphoblastic Lymphoma Splenic Precursor Lymphoblastic Lymphoma Splenic Lymphoblastic Lymphoma A non-metastasizing neoplasm that arises from the ovary and is characterized by the presence of neoplastic epithelium that resembles the epithelium of the fallopian tube. There is no evidence of atypia. It includes serous cystadenoma, serous adenofibroma, serous cystadenofibroma, and surface papilloma. C7313 Neoplastic Process Benign Ovarian Serous Tumor C1332527 Benign Benign_Ovarian_Serous_Neoplasm Benign Ovarian Serous Neoplasm Benign Ovarian Serous Tumor Benign Ovarian Serous Tumor A biphasic neoplasm that arises from the ovary and is characterized by the presence of mullerian-type epithelial tissue in a mesenchymal sarcomatous stroma. The presence of a high grade sarcomatous component is associated with recurrences and metastases. C7317 Neoplastic Process Ovarian Adenosarcoma Ovarian Adenosarcoma C1335169 CTRP Malignant Ovarian_Mullerian_Adenosarcoma Ovarian Adenosarcoma Ovarian Mesodermal Adenosarcoma Ovarian Mullerian Adenosarcoma Ovarian Müllerian Adenosarcoma Ovarian Adenosarcoma Acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage, including monoblasts, promonocytes, and monocytes. Bleeding disorders are common presenting features. C7318 Neoplastic Process Acute Monoblastic and Monocytic Leukemia C3831784 CPTAC GDC NICHD PCDC Acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage, including monoblasts, promonocytes, and monocytes. 9891/3 Malignant Acute_Monoblastic_Leukemia_and_Acute_Monocytic_Leukemia 9891/3 Acute monoblastic and monocytic leukemia Acute monoblastic/monocytic leukaemia Acute monoblastic/monocytic leukemia, not having achieved remission FAB M5 (includes all variants) M5 Acute Monoblastic Leukemia and Acute Monocytic Leukemia Acute Monoblastic and Monocytic Leukemia Acute Monoblastic/Monocytic Leukemia Acute Myeloid Leukemia M5 Acute monoblastic and monocytic leukemia FAB M5 (includes all variants) M5 Acute Monoblastic and Monocytic Leukemia An acute monoblastic and monocytic leukemia occurring in adults. C7319 Neoplastic Process Adult Acute Monoblastic and Monocytic Leukemia Adult Acute Monoblastic and Monocytic Leukemia C1332181 CPTAC CTRP Malignant Adult_Acute_Monoblastic_Leukemia_and_Acute_Monocytic_Leukemia Acute Monoblastic and Monocytic Leukemia Adult Acute Monoblastic Leukemia and Acute Monocytic Leukemia Adult Acute Monoblastic and Monocytic Leukemia Adult Acute Monoblastic and Monocytic Leukemia (FAB M5) Adult Acute Monoblastic and Monocytic Leukemia (M5) M5 Adult Acute Monoblastic and Monocytic Leukemia M5 OR Acute Monoblastic/Monocytic Leukemia Adult Acute Monoblastic and Monocytic Leukemia A chronic myeloid leukemia, BCR-ABL1 positive occurring during childhood. C7320 Neoplastic Process Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive Childhood Chronic Myeloid Leukemia, BCR-ABL1 Positive C1327920 CTRP Cellosaurus NICHD A BCR-ABL1 positive chronic myelogenous leukemia occurring during childhood. Malignant Childhood_Chronic_Myelogenous_Leukemia Childhood CML Childhood Chronic Myelogenous Leukemia Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive Childhood Chronic Myelogenous Leukemia, BCR::ABL1 Positive Childhood Chronic Myeloid Leukemia Childhood Chronic Myeloid Leukemia, BCR-ABL1 Positive Childhood Chronic Myeloid Leukemia, BCR::ABL1 Positive Chronic Myelogenous Leukemia (CML) Childhood Chronic Myeloid Leukemia, BCR-ABL1 Positive A neoplasm that arises from the ovary and is characterized by the presence of germ cell and sex cord-stromal tissues that are intimately admixed. If there is no malignant germ cell component present, the clinical course is benign. C7321 Neoplastic Process Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor C1335166 NICHD A mixed germ cell-sex cord-stromal tumor that occurs in the ovary. Undetermined Ovarian_Mixed_Germ_Cell-Sex_Cord-Stromal_Tumor Ovarian Germ Cell-Sex Cord-Stromal Tumor Ovarian Mixed Germ Cell-Sex Cord Neoplasm Ovarian Mixed Germ Cell-Sex Cord Tumor Ovarian Mixed Germ Cell-Sex Cord-Stromal Neoplasm Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor A tumor that arises from the testis and is characterized by the presence of a neoplastic germ cell component and a neoplastic sex cord-stromal component. C7322 Neoplastic Process Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor C1336719 NICHD A mixed germ cell-sex cord-stromal tumor that occurs in the testis. Undetermined Testicular_Mixed_Germ_Cell-Sex_Cord-Stromal_Tumor Testicular Mixed Germ Cell-Sex Cord Neoplasm Testicular Mixed Germ Cell-Sex Cord Tumor Testicular Mixed Germ Cell-Sex Cord-Stromal Neoplasm Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor Intratubular germ cell neoplasia characterized by the filling of the seminiferous tubules by non-seminomatous malignant germ cells. The non-seminomatous malignant germ cells are usually of embryonal carcinoma type. C7325 Neoplastic Process Intratubular Non-Seminoma C1336096 Malignant Stage_0_Testicular_Embryonal_Carcinoma Intratubular Non-Seminoma Intratubular Non-Seminoma A malignant neoplasm that arises from the testis and is characterized by the presence of large germ cells with abundant cytoplasm in the seminiferous tubules, associated with an invasive germ cell tumor in the adjacent tissues. C7326 Neoplastic Process Testicular Germ Cell Neoplasia In Situ with Extratubular Extension C1336710 Malignant Testicular_Intratubular_Germ_Cell_Neoplasia_with_Extratubular_Extension Testicular Germ Cell Neoplasia In Situ with Extratubular Extension Testicular Intratubular Germ Cell Neoplasia with Extratubular Extension Testicular Germ Cell Neoplasia In Situ with Extratubular Extension A malignant germ cell tumor arising from the testis. It is believed that it is derived from the sexually undifferentiated embryonic gonad. Treatment with radiotherapy is highly successful when the tumor is diagnosed in localized stages, which represents the majority of presentations of seminoma. C7328 Neoplastic Process Testicular Seminoma Testicular Seminoma C2242808 CTEP CTRP Cellosaurus Malignant Testicular_Seminoma Seminoma of Testis Seminoma of the Testis Testicular Seminoma Testicular Seminoma Pure Testicular seminoma Testicular Seminoma Intratubular germ cell neoplasia characterized by the complete filling of the seminiferous tubules by seminoma cells. C7329 Neoplastic Process Stage 0 Testicular Seminoma AJCC v6 and v7 Intratubular Seminoma C1336097 CTRP Malignant Stage_0_Testicular_Seminoma Intratubular Seminoma Stage 0 Seminoma Stage 0 Seminoma of Testis Stage 0 Seminoma of the Testis Stage 0 Testicular Seminoma Stage 0 Testicular Seminoma AJCC v6, v7, and v8 Intratubular Seminoma A locally aggressive or rarely metastasizing neoplasm that arises from the soft tissues. It is characterized by the presence of neoplastic spindle-shaped fibroblasts. C7333 Neoplastic Process Intermediate Fibroblastic Neoplasm C1334212 Undetermined Intermediate_Fibrocytic_Neoplasm Intermediate Fibroblastic Neoplasm Intermediate Fibroblastic Tumor Intermediate Fibrocytic Neoplasm Intermediate Fibrocytic Tumor Intermediate Fibrogenic Neoplasm Intermediate Fibrogenic Tumor Intermediate Fibrous Neoplasm Intermediate Fibrous Tumor Intermediate Fibroblastic Neoplasm A vascular neoplasm with borderline malignant potential. C7334 Neoplastic Process Intermediate Vascular Neoplasm C1334225 Undetermined Intermediate_Vascular_Neoplasm Intermediate Vascular Neoplasm Intermediate Vascular Tumor Intermediate Vascular Neoplasm A benign or malignant endocrine neoplasm that arises from the testis or the ovary. C7335 Neoplastic Process Reproductive Endocrine Neoplasm C1335756 Undetermined Reproductive_Endocrine_Neoplasm Reproductive Endocrine Neoplasm Reproductive System Endocrine Neoplasm Reproductive Endocrine Neoplasm A benign or malignant neoplasm that affects the nasal cavity or paranasal sinuses. Representative examples of benign neoplasms include Schneiderian papilloma and salivary gland-type adenoma. Representative examples of malignant neoplasms include carcinoma and lymphoma. C7336 Neoplastic Process Sinonasal Neoplasm C1334925 Undetermined Nasal_Cavity_and_Paranasal_Sinus_Neoplasm Nasal Cavity and Paranasal Sinus Neoplasm Sinonasal Neoplasm Sinonasal Neoplasm A benign or malignant, primary or metastatic neoplasm that affects the peritoneum and/or retroperitoneum. C7337 Neoplastic Process Peritoneal and Retroperitoneal Neoplasm C1335391 Undetermined Peritoneal_and_Retroperitoneal_Neoplasms Peritoneal and Retroperitoneal Neoplasm Peritoneal and Retroperitoneal Tumor Peritoneal and Retroperitoneal Neoplasm B-lymphoblastic lymphoma that occurs in adults. C7338 Neoplastic Process Adult B Lymphoblastic Lymphoma Adult B Lymphoblastic Lymphoma C1332212 CTRP Malignant Adult_Precursor_B_Lymphoblastic_Lymphoma Adult B Lymphoblastic Lymphoma Adult B-Lymphoblastic Lymphoma Adult Precursor B-Lymphoblastic Lymphoma B Lymphoblastic Lymphoma Adult B Lymphoblastic Lymphoma A subtype of monoclonal immunoglobulin deposition disease in which heavy chain deposition results in non-amyloid tissue deposits which may cause organ dysfunction. C7339 Neoplastic Process Heavy Chain Deposition Disease C1333947 Undetermined Heavy_Chain_Deposition_Disease HCDD Heavy Chain Deposition Disease Heavy Chain Deposition Disease An epithelial neoplasm that arises from the skin and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C7341 Neoplastic Process Benign Epithelial Skin Neoplasm C0345981 Benign Benign_Epithelial_Skin_Neoplasm Benign Epithelial Skin Neoplasm Benign Epithelial Skin Tumor Benign Skin Epithelium Neoplasm Benign Skin Epithelium Tumor Benign Epithelial Skin Neoplasm A benign, premalignant, or malignant neoplasm that arises from epithelial cells and involves the skin. C7342 Neoplastic Process Epithelial Skin Neoplasm C0345976 Undetermined Epithelial_Skin_Neoplasm Epithelial Skin Neoplasm Epithelial Skin Tumor Skin Epithelium Neoplasm Skin Epithelium Tumor Epithelial Skin Neoplasm A benign neoplasm arising from the skin. It is composed of fibrohistiocytic cells, spindle fibroblastic cells, and histiocytes arranged in a storiform pattern. C7343 Neoplastic Process Benign Skin Fibrohistiocytic Neoplasm C1274305 Benign Benign_Cutaneous_Fibrohistiocytic_Neoplasm Benign Cutaneous Fibrohistiocytic Neoplasm Benign Skin Fibrohistiocytic Neoplasm Benign Skin Fibrohistiocytic Neoplasm A borderline fibrohistiocytic neoplasm arising from the dermis and extending to the subcutaneous tissues. C7344 Neoplastic Process Skin Intermediate Fibrohistiocytic Neoplasm C1334211 Undetermined Intermediate_Cutaneous_Fibrohistiocytic_Neoplasm Intermediate Cutaneous Fibrohistiocytic Neoplasm Skin Intermediate Fibrohistiocytic Neoplasm Skin Intermediate Fibrohistiocytic Neoplasm A neoplastic process that affects the squamous epithelium of the cervix. It is classified as cervical squamous intraepithelial neoplasia 1, 2, or 3, according to the degree of squamous cell maturation and cellular atypia, and the number of mitotic figures. C7346 Neoplastic Process Cervical Squamous Intraepithelial Neoplasia C1332922 Undetermined Cervical_Squamous_Intraepithelial_Neoplasia CIN Cervical SIL Cervical Squamous Intraepithelial Lesion Cervical Squamous Intraepithelial Neoplasia Cervix Squamous Intraepithelial Lesion Cervix Uteri SIL Cervix Uteri Squamous Intraepithelial Lesion Squamous Intraepithelial Lesion of Cervix Squamous Intraepithelial Lesion of Cervix Uteri Squamous Intraepithelial Lesion of Uterine Cervix Squamous Intraepithelial Lesion of the Cervix Squamous Intraepithelial Lesion of the Cervix Uteri Squamous Intraepithelial Lesion of the Uterine Cervix Uterine Cervix SIL Uterine Cervix Squamous Intraepithelial Lesion Cervical Squamous Intraepithelial Neoplasia Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. FIGO no longer includes stage 0. (AJCC 7th ed.) C7347 Neoplastic Process Cervical Squamous Cell Carcinoma In Situ C1320453 Abnormal cells are found in the cervical epithelium (the innermost lining of the cervix). These abnormal cells may become cancer and spread into nearby normal tissue. Malignant Cervical_Squamous_Cell_Carcinoma_in_situ CIN 3 Cervical Squamous Cell Carcinoma In Situ Cervical Squamous Cell Carcinoma In Situ AJCC v7 Cervical Squamous Intraepithelial Neoplasia 3 Cervix Squamous Cell Carcinoma In Situ Cervix Uteri Squamous Cell Carcinoma In Situ Severe Squamous Dysplasia of the Cervix Squamous Cell Carcinoma In Situ of Cervix Squamous Cell Carcinoma In Situ of Cervix Uteri Squamous Cell Carcinoma In Situ of Uterine Cervix Squamous Cell Carcinoma In Situ of the Cervix Squamous Cell Carcinoma In Situ of the Cervix Uteri Squamous Cell Carcinoma In Situ of the Uterine Cervix Uterine Cervix Squamous Cell Carcinoma In Situ cervical squamous intraepithelial neoplasia 3 Cervical Squamous Cell Carcinoma In Situ A rare carcinoma that arises from the retroperitoneal space. C7352 Neoplastic Process Retroperitoneal Carcinoma Retroperitoneal Carcinoma C0948749 CPTAC CTRP Malignant Retroperitoneal_Carcinoma Carcinoma of Retroperitoneum Carcinoma of the Retroperitoneum Retroperitoneal Cancer Retroperitoneal Carcinoma Retroperitoneal Carcinoma A lymphoma involving the retroperitoneal area. C7353 Neoplastic Process Retroperitoneal Lymphoma C1335779 Malignant Retroperitoneal_Lymphoma Primary Retroperitoneal Lymphoma Retroperitoneal Lymphoma Retroperitoneal Lymphoma A rare benign neoplasm that arises from the mesothelial cells of the peritoneum. It is characterized by the presence of gland-like structures. Cytologic atypia is absent. C7354 Neoplastic Process Peritoneal Adenomatoid Tumor C0346113 Benign Benign_Peritoneal_Mesothelioma Benign Peritoneal Mesothelioma Peritoneal Adenomatoid Tumor Peritoneal Adenomatoid Tumor A carcinoma that arises from the urothelial lining of the renal pelvis. It is associated with tobacco use and usually presents with gross or microscopic hematuria. Urothelial carcinomas of the renal pelvis are usually of higher grade and higher stage compared to bladder urothelial carcinomas. C7355 Neoplastic Process Renal Pelvis Urothelial Carcinoma Renal Pelvis Urothelial Carcinoma C0238410 CTRP Cellosaurus Malignant Renal_Pelvis_Transitional_Cell_Carcinoma Renal Pelvis Transitional Cell Carcinoma Renal Pelvis Urothelial Cancer Renal Pelvis Urothelial Carcinoma Transitional Cell Carcinoma of Renal Pelvis Transitional Cell Carcinoma of the Renal Pelvis Urothelial Cell Carcinoma of Renal Pelvis Urothelial Cell Carcinoma of the Renal Pelvis Renal Pelvis Urothelial Carcinoma A carcinoma that arises from the gallbladder. It is characterized by the presence of glandular and squamous malignant epithelial components. C7356 Neoplastic Process Gallbladder Adenosquamous Carcinoma Gallbladder Adenosquamous Carcinoma C1333741 CTRP Cellosaurus Malignant Gallbladder_Adenosquamous_Carcinoma Adenosquamous Carcinoma of Gallbladder Adenosquamous Carcinoma of the Gallbladder Gallbladder Adenosquamous Cancer Gallbladder Adenosquamous Carcinoma Gallbladder Adenosquamous Carcinoma A chondrosarcoma arising from the surface of bone. It is characterized by a lobulated growth pattern, high mitotic activity, myxoid stroma formation, and necrotic changes. It occurs in adults. Clinical presentation includes pain, and sometimes swelling. C7357 Neoplastic Process Periosteal Chondrosarcoma C0334549 GDC 9221/3 Malignant Periosteal_Chondrosarcoma 9221/3 Juxtacortical chondrosarcoma Periosteal chondrosarcoma Juxtacortical Chondrosarcoma Juxtacortical chondrosarcoma Periosteal Chondrosarcoma Periosteal chondrosarcoma Periosteal Chondrosarcoma An adenocarcinoma arising from the uterine body cavity. This is the most frequent malignant tumor affecting the uterine body, and is linked to estrogen therapy. Most patients present with uterine bleeding and are over age 40 at the time of diagnosis. The prognosis depends on the stage of the tumor, the depth of the uterine wall invasion, and the histologic subtype. Endometrioid adenocarcinoma is the most frequently seen morphologic variant of endometrial adenocarcinoma. C7359 Neoplastic Process Endometrial Adenocarcinoma Endometrial Adenocarcinoma C1153706 CDISC CTRP Cellosaurus A malignant glandular neoplasm of the uterine lining. Malignant Endometrial_Adenocarcinoma ADENOCARCINOMA, ENDOMETRIAL, MALIGNANT Adenocarcinoma of Endometrium Adenocarcinoma of the Endometrium Endometrial Adenocarcinoma Endometrial Adenocarcinoma, Not Otherwise Specified Endometrial Adenocarcinoma High grade prostatic intraepithelial neoplasia characterized by the presence of moderate architectural and cytologic abnormalities. C7360 Neoplastic Process Grade II Prostatic Intraepithelial Neoplasia C1333864 Undetermined Grade_II_Prostatic_Intraepithelial_Neoplasia Grade II PIN Grade II Prostatic Intraepithelial Neoplasia Grade II Prostatic Intraepithelial Neoplasia A melanoma arising from the scrotum. C7361 Neoplastic Process Scrotal Melanoma Scrotal Melanoma C1331544 CTRP Malignant Scrotal_Melanoma Melanoma of Scrotum Melanoma of the Scrotum Scrotal Melanoma Scrotal Melanoma An infiltrating ductal breast carcinoma associated with stromal fibrosis. C7362 Neoplastic Process Breast Scirrhous Carcinoma C0346151 Cellosaurus GDC 8514/3 Malignant Scirrhous_Carcinoma_of_the_Breast 8514/3 Duct carcinoma, desmoplastic type Breast Scirrhous Carcinoma Duct carcinoma, desmoplastic type Infiltrating Carcinoma of Breast with Fibrotic Stroma Infiltrating Carcinoma of the Breast with Fibrotic Stroma Scirrhous Breast Carcinoma Scirrhous Carcinoma of Breast Scirrhous Carcinoma of the Breast Breast Scirrhous Carcinoma A benign or malignant neoplasm arising from the hair follicle. C7367 Neoplastic Process Hair Follicle Neoplasm C0859920 Undetermined Hair_Follicle_Neoplasm Hair Follicle Neoplasm Hair Follicle Tumor Hair Matrix Neoplasm Hair Matrix Tumor Neoplasm of Hair Follicle Neoplasm of the Hair Follicle Hair Follicle Neoplasm A benign adnexal neoplasm arising from hair-bearing skin surfaces, usually the head and neck and upper extremities. It usually presents as a solitary, slow-growing nodular mass. Morphologically, it displays differentiation towards the matrix and inner sheath of the normal hair follicle and the hair cortex. Complete surgical excision is usually curative. Occasionally, it may recur. C7368 Neoplastic Process Pilomatricoma C0206711 CDISC GDC A benign hair follicle neoplasm in the outer hair sheath and infundibulum, characterized by abrupt keratinization and central lumen with ghost cells. 8110/0 Benign Pilomatricoma 8110/0 Calcifying epithelioma of Malherbe Pilomatricoma, NOS Pilomatrixoma, NOS Benign Hair Follicle Neoplasm Benign Pilomatricoma Benign Pilomatrixoma Calcifying Epithelioma of Malherbe Calcifying Epitherlioma of Malherbe Calcifying epithelioma of Malherbe PILOMATRIXOMA, BENIGN Pilomatricoma Pilomatricoma, NOS Pilomatrixoma Pilomatricoma An adenocarcinoma arising in the accessory urethral glands. C7371 Neoplastic Process Accessory Urethral Gland Adenocarcinoma C1335352 Malignant Paraurethral_Gland_Carcinoma Accessory Urethral Gland Adenocarcinoma Accessory Urethral Gland Carcinoma Accessory Urethral Gland Adenocarcinoma Glioneuronal and neuronal tumors occurring in the cerebellum. C7372 Neoplastic Process Cerebellar Glioneuronal and Neuronal Tumors C1332901 Undetermined Cerebellar_Neuronal_and_Mixed_Neuronal-Glial_Tumor Cerebellar Glioneuronal and Neuronal Tumors Cerebellar Neuronal and Mixed Neuronal-Glial Tumor Neuronal and Mixed Neuronal-Glial Tumor of Cerebellum Cerebellar Glioneuronal and Neuronal Tumors A nasopharyngeal carcinoma characterized by the lack of keratinization and the presence of a dense lymphoplasmacytic infiltrate. It is subdivided into undifferentiated and differentiated types, based on the cytologic features of the malignant cells. The undifferentiated type is characterized by the presence of cells with large vesicular nuclei with prominent nucleoli and a syncytial pattern of growth. The differentiated type is characterized by the presence of smaller cells and cellular stratification reminiscent of transitional cell carcinoma. While morphologically distinct, both types have similar clinical presentation and prognosis. C7373 Neoplastic Process Nasopharyngeal Nonkeratinizing Carcinoma Nasopharyngeal Non-Keratinizing Carcinoma C1334926 CTRP Malignant Nasopharyngeal_Nonkeratinizing_Carcinoma EBV positive nasopharyngeal carcinoma NK-NPC Nasopharyngeal Non-Keratinizing Carcinoma Nasopharyngeal Nonkeratinizing Carcinoma Nasopharyngeal Throat Nonkeratinizing Cancer Nasopharyngeal Non-Keratinizing Carcinoma A malignant neoplasm that arises from mesothelial cells in the pleura and shows a diffuse growth pattern. It arises on the parietal and sometimes visceral pleura as multiple small nodules that later become confluent and invade the chest wall adipose tissue and muscle. Asbestos exposure is the main cause for the development of pleural malignant mesothelioma. It usually affects patients over sixty years of age. The latency period is long. Patients usually present with pleural effusion, dyspnea and chest wall pain. Additional signs and symptoms include chills, sweating, weight loss, and weakness. Morphologic variants include epithelioid, desmoplastic, sarcomatoid, and biphasic mesothelioma. The clinical course is usually aggressive. C7376 Neoplastic Process Pleural Malignant Mesothelioma Pleural Malignant Mesothelioma C0812413 CTRP Cellosaurus Malignant Malignant_Pleural_Mesothelioma Malignant Mesothelioma of Pleura Malignant Mesothelioma of the Pleura Malignant Pleural Mesothelioma Pleural Diffuse Malignant Mesothelioma Pleural Malignant Mesothelioma Pleural Malignant Mesothelioma A primary or metastatic malignant neoplasm involving the lung. C7377 Neoplastic Process Malignant Lung Neoplasm Malignant Lung Neoplasm C0242379 CTRP Malignant Malignant_Lung_Neoplasm Malignant Lung Neoplasm Malignant Lung Tumor Malignant Neoplasm of Lung Malignant Neoplasm of the Lung Malignant Tumor of Lung Malignant Tumor of the Lung Malignant Lung Neoplasm A primary or metastatic malignant tumor involving the prostate gland. The vast majority are carcinomas. C7378 Neoplastic Process Malignant Prostate Neoplasm Malignant Prostate Neoplasm C0376358 CPTAC CTRP mCode Malignant Malignant_Prostate_Neoplasm Malignant neoplasm of prostate Malignant Neoplasm of Prostate Malignant Neoplasm of the Prostate Malignant Prostate Neoplasm Malignant Prostate Tumor Malignant Tumor of Prostate Malignant Tumor of the Prostate Malignant neoplasm of prostate Malignant Prostate Neoplasm A primary or metastatic malignant neoplasm that affects the anal canal or perianal skin. Representative examples include carcinomas, lymphomas, and melanomas. C7379 Neoplastic Process Malignant Anal Neoplasm Malignant Anal Neoplasm C0153446 CPTAC CTRP mCode Malignant Malignant_Anal_Neoplasm Malignant neoplasm of anal canal Malignant neoplasm of anus and anal canal Malignant neoplasm of anus, unspecified Malignant neoplasm: Anal canal Malignant neoplasm: Anus, unspecified Malignant Anal Neoplasm Malignant Anal Tumor Malignant Neoplasm of Anus Malignant Neoplasm of the Anus Malignant Tumor of Anus Malignant Tumor of the Anus Malignant neoplasm of anus, unspecified Malignant Anal Neoplasm A nonencapsulated, infiltrating papillary carcinoma of the thyroid gland characterized by the predominance of follicular structures. The malignant follicular cells display the nuclear features that characterize the papillary adenocarcinomas of the thyroid gland. C7381 Neoplastic Process Invasive Follicular Variant Thyroid Gland Papillary Carcinoma CL505075 8340/3 Malignant Follicular_Variant_Papillary_Carcinoma Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype Invasive Follicular Variant Thyroid Gland Papillary Carcinoma Invasive Follicular Variant Thyroid Gland Papillary Carcinoma An invasive or non-invasive papillary urothelial carcinoma of the urinary bladder. It is classified as low or high-grade. C7383 Neoplastic Process Bladder Papillary Urothelial Carcinoma Bladder Papillary Urothelial Carcinoma C1518882 CTRP Malignant Papillary_Urothelial_Carcinoma Bladder Papillary Urothelial Carcinoma Urothelial Papillary Carcinoma of the Bladder Bladder Papillary Urothelial Carcinoma A thymoma that is confined within the capsule and may display benign or malignant morphologic characteristics. C7386 Neoplastic Process Encapsulated Thymoma C1333383 Undetermined Encapsulated_Thymoma Encapsulated Thymoma Encapsulated Thymoma A mesenchymal neoplasm that arises from vascular tissue usually of the skin. It is characterized by the presence of vascular channel formation and endothelial cells. There is no evidence of atypical or malignant cytological and architectural features, invasive features, or metastases. C7389 Neoplastic Process Benign Vascular Neoplasm C1377916 Benign Benign_Vascular_Neoplasm Benign Vascular Neoplasm Benign Vascular Tumor Vascular Neoplasms, Benign Benign Vascular Neoplasm A borderline blood vessel neoplasm that can be locally aggressive, and may metastasize on rare occasions. C7391 Neoplastic Process Intermediate Blood Vessel Neoplasm C1334207 Undetermined Intermediate_Blood_Vessel_Neoplasm Intermediate Blood Vessel Neoplasm Intermediate Blood Vessel Tumor Intermediate Blood Vessel Neoplasm A hemangioma arising from the skin. It is characterized by the presence of epithelioid endothelial cells. C7393 Neoplastic Process Skin Epithelioid Hemangioma C0002989 Benign Skin_Epithelioid_Hemangioma Angiolymphoid Cutaneous Hyperplasia Angiolymphoid Hyperplasia of Skin Angiolymphoid Hyperplasia of the Skin Epithelioid Hemangioma of Skin Epithelioid Hemangioma of the Skin Histiocytoid Hemangioma of Skin Histiocytoid Hemangioma of the Skin Skin Epithelioid Hemangioma Skin Epithelioid Hemangioma Stage I includes: T1, N0, M0. T1: Tumor confined to the nasopharynx. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C7395 Neoplastic Process Stage I Nasopharyngeal Carcinoma AJCC v6 Stage I Nasopharyngeal Carcinoma AJCC v6 C1377917 CTRP Cancer (1) is found in the nasopharynx only; or (2) has spread from the nasopharynx to the oropharynx (the middle part of the throat, including the soft palate, base of the tongue, and tonsils) and/or to the nasal cavity. Malignant Stage_I_Nasopharyngeal_Carcinoma Nasopharyngeal Cancer, Stage I AJCC v6 Stage I Carcinoma of Nasopharynx AJCC v6 Stage I Carcinoma of the Nasopharynx AJCC v6 Stage I Nasopharyngeal Cancer AJCC v6 Stage I Nasopharyngeal Carcinoma AJCC v6 Stage I Nasopharyngeal Throat Cancer Stage I Nasopharynx Carcinoma AJCC v6 stage I nasopharynx cancer Stage I Nasopharyngeal Carcinoma AJCC v6 Stage III includes: (T1, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N0, M0); (T3, N1, M0); (T3, N2, M0). T3: Tumor involves bony structures and/or paranasal sinuses. N2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa. M0: No distant metastasis. (AJCC 6th ed.) C7396 Neoplastic Process Stage III Nasopharyngeal Carcinoma AJCC v6 Stage III Nasopharyngeal Carcinoma AJCC v6 C1377918 CTRP Cancer (1) is found in the nasopharynx only or has spread from the nasopharynx to the oropharynx (the middle part of the throat, including the soft palate, base of the tongue, and tonsils) and/or to the nasal cavity. Cancer has spread to one or more lymph nodes on both sides of the neck and the affected lymph nodes are 6 centimeters or smaller; or (2) is found in the parapharyngeal space (area near the pharynx, between the base of the skull and the lower jaw). Cancer has spread to one or more lymph nodes on both sides of the neck and the affected lymph nodes are 6 centimeters or smaller; or (3) has spread to nearby bones or sinuses. Cancer may have spread to one or more lymph nodes on one or both sides of the neck and/or to lymph nodes behind the pharynx, and the affected lymph nodes are 6 centimeters or smaller. Malignant Stage_III_Nasopharyngeal_Carcinoma Nasopharyngeal Cancer, Stage III AJCC v6 Stage III Carcinoma of Nasopharynx AJCC v6 Stage III Carcinoma of the Nasopharynx AJCC v6 Stage III Nasopharyngeal Cancer AJCC v6 Stage III Nasopharyngeal Carcinoma AJCC v6 Stage III Nasopharyngeal Throat Cancer Stage III Nasopharynx Carcinoma AJCC v6 stage III nasopharynx cancer Stage III Nasopharyngeal Carcinoma AJCC v6 Stage IV includes: IVA: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0); IVB (Any T, N3, M0); IVC (Any T, Any N, M1). T4: Tumor with intracranial extension and/or involvement of cranial nerves, infratemporal fossa, hypopharynx, orbit, or masticator space. N3: Metastasis in a lymph node(s). N3a: greater than 6 cm in dimension. N3b: extension to the supraclavicular fossa. M1: Distant metastasis. (AJCC 6th ed.) C7397 Neoplastic Process Stage IV Nasopharyngeal Carcinoma AJCC v6 Stage IV Nasopharyngeal Carcinoma AJCC v6 C1377919 CTRP Stage IV nasopharyngeal cancer is divided into stages IVA, IVB, and IVC. In stage IVA, cancer has spread beyond the nasopharynx and may have spread to the cranial nerves, the hypopharynx (bottom part of the throat), areas in and around the side of the skull or jawbone, and/or the bone around the eye. Cancer may have spread to one or more lymph nodes on one or both sides of the neck and/or to lymph nodes behind the pharynx, and the affected lymph nodes are 6 centimeters or smaller. In stage IVB, cancer has spread to lymph nodes between the collarbone and the top of the shoulder and/or the affected lymph nodes are larger than 6 centimeters. In stage IVC, cancer has spread beyond nearby lymph nodes to other parts of the body. Malignant Stage_IV_Nasopharyngeal_Carcinoma Nasopharyngeal Cancer, Stage IV AJCC v6 Stage IV Carcinoma of Nasopharynx AJCC v6 Stage IV Carcinoma of the Nasopharynx AJCC v6 Stage IV Nasopharyngeal Cancer AJCC v6 Stage IV Nasopharyngeal Carcinoma AJCC v6 Stage IV Nasopharyngeal Throat Cancer Stage IV Nasopharynx Carcinoma AJCC v6 stage IV nasopharynx cancer Stage IV Nasopharyngeal Carcinoma AJCC v6 A primary or metastatic malignant neoplasm that affects the oropharynx. C7398 Neoplastic Process Malignant Oropharyngeal Neoplasm C0153382 CPTAC mCode Malignant Malignant_Oropharyngeal_Neoplasm Malignant neoplasm of junctional region of oropharynx Malignant neoplasm of oropharynx Malignant neoplasm of oropharynx, unspecified Malignant neoplasm of other specified sites of oropharynx Malignant neoplasm of posterior wall of oropharynx Malignant neoplasm of tonsillar fossa Malignant neoplasm of tonsillar pillars (anterior) (posterior) Malignant neoplasm of vallecula Malignant neoplasm: Lateral wall of oropharynx Malignant neoplasm: Oropharynx, unspecified Malignant neoplasm: Overlapping lesion of lip, oral cavity and pharynx Malignant neoplasm: Overlapping lesion of oropharynx Malignant neoplasm: Posterior wall of oropharynx Malignant neoplasm: Tonsillar fossa Malignant neoplasm: Tonsillar pillar (anterior)(posterior) Malignant Neoplasm of Oropharynx Malignant Neoplasm of the Oropharynx Malignant Oropharyngeal Neoplasm Malignant Oropharyngeal Tumor Malignant Tumor of Oropharynx Malignant Tumor of the Oropharynx Malignant neoplasm of oropharynx, unspecified Malignant Oropharyngeal Neoplasm An adenoma arising from the glandular epithelium of the gastrointestinal tract. It is characterized by the presence of a villous architectural pattern. Most often it occurs in the large intestine, small intestine, and the stomach. The neoplastic epithelial cells show dysplastic features. C7399 Neoplastic Process Villous Adenoma C0206674 GDC A neoplasm that grows in the colon and other places in the gastrointestinal tract and sometimes in other parts of the body. These adenomas may become malignant (cancerous). 8261/0 Benign Undetermined Villous_Adenoma 8261/0 Villous adenoma, NOS GI Tract Villous Adenoma Gastrointestinal Tract Villous Adenoma Villous Adenoma Villous adenoma, NOS villous adenoma Villous Adenoma The leukemic counterpart of Burkitt's lymphoma. The characteristic Burkitt cells are seen in the bone marrow and the peripheral blood. This is an aggressive leukemia. C7400 Neoplastic Process Burkitt Leukemia Burkitt Leukemia C0023435 CPTAC CTEP CTRP GDC A rare, fast-growing type of leukemia (blood cancer) in which too many white blood cells called B lymphocytes form in the blood and bone marrow. It may start in the lymph nodes as Burkitt lymphoma and then spread to the blood and bone marrow, or it may start in the blood and bone marrow without involvement of the lymph nodes. Both Burkitt leukemia and Burkitt lymphoma have been linked to infection with the Epstein-Barr virus. 9826/3 Malignant Burkitt_s_Cell_Leukemia 9826/3 Acute leukemia, Burkitt type Acute lymphoblastic leukemia, mature B-cell type Burkitt cell leukemia FAB L3 Mature B-cell leukemia Burkitt-type not having achieved remission Burkitt Leukemia Burkitt cell leukemia Burkitt lymphoma/leukemia Burkitt's Cell Leukemia Burkitt's Leukemia Burkitt's leukemia FAB L3 L3 Acute Lymphoblastic Leukemia L3 Acute Lymphocytic Leukemia L3 Acute Lymphogenous Leukemia L3 Acute Lymphoid Leukemia Burkitt Leukemia An indolent chronic B-cell leukemia resembling classic hairy cell leukemia but shows variant cytologic, hematologic, and immunophenotypic features and is resistant to the conventional therapy applied to hairy cell leukemia. Biologically, it is not related to hairy cell leukemia. C7401 Neoplastic Process Hairy Cell Leukemia Variant C0349633 Provisional_Concept Cellosaurus GDC 9591/3 Malignant Hairy_Cell_Leukemia_Variant 9591/3 9940/3 Hairy cell leukaemia variant Hairy cell leukemia variant HCL-V Hairy Cell Leukemia Variant Hairy Cell Leukemia-Variant Hairy cell leukaemia variant Hairy cell leukemia variant Prolymphocytic Variant of Hairy Cell Leukemia Splenic B-Cell Lymphoma/Leukemia with Prominent Nucleoli Hairy Cell Leukemia Variant A neoplasm of small B-lymphocytes with "hairy" projections in bone marrow, spleen, and peripheral blood. Most patients present with splenomegaly and pancytopenia. (WHO, 2001) C7402 Neoplastic Process Hairy Cell Leukemia Hairy Cell Leukemia C0023443 CPTAC CTEP CTRP Cellosaurus GDC A rare type of leukemia in which abnormal B-lymphocytes (a type of white blood cell) are present in the bone marrow, spleen, and peripheral blood. When viewed under a microscope, these cells appear to be covered with tiny hair-like projections. 9940/3 Malignant Hairy_Cell_Leukemia 9940/3 Hairy cell leukemia Hairy cell leukemia, NOS Leukemic reticuloendotheliosis HCL Hairy Cell Leukemia Hairy cell leukemia Leukemic Reticuloendotheliosis Leukemic reticuloendotheliosis hairy cell leukemia Hairy Cell Leukemia A primary or metastatic malignant neoplasm that affects the tonsil. C7404 Neoplastic Process Malignant Tonsillar Neoplasm C0751560 CPTAC mCode Malignant Malignant_Tonsillar_Neoplasm Malignant neoplasm of lingual tonsil Malignant neoplasm of tonsil Malignant neoplasm of waldeyer's ring Malignant neoplasm: Lingual tonsil Malignant neoplasm: Overlapping lesion of tonsil Malignant neoplasm: Tonsil, unspecified Malignant Neoplasm of Tonsil Malignant Neoplasm of the Tonsil Malignant Tonsil Neoplasm Malignant Tonsil Tumor Malignant Tonsillar Neoplasm Malignant Tonsillar Tumor Malignant Tumor of Tonsil Malignant Tumor of the Tonsil Malignant neoplasm of tonsil, unspecified Malignant Tonsillar Neoplasm A primary or metastatic malignant neoplasm involving the vagina. Representative examples include carcinomas and sarcomas. C7410 Neoplastic Process Malignant Vaginal Neoplasm C0042237 CPTAC mCode Malignant Malignant_Vaginal_Neoplasm Malignant neoplasm of vagina Malignant Neoplasm of Vagina Malignant Neoplasm of the Vagina Malignant Tumor of Vagina Malignant Tumor of the Vagina Malignant Vagina Neoplasm Malignant Vagina Tumor Malignant Vaginal Neoplasm Malignant Vaginal Tumor Malignant neoplasm of vagina Malignant Vaginal Neoplasm A pathologic process that arises from the pancreas and has the potential to evolve into a malignant neoplasm. C7412 Neoplastic Process Pancreatic Precancerous Condition C1335314 Header_Concept Undetermined Pancreatic_Precancerous_Condition Pancreatic Precancerous Condition Pancreatic Premalignant Condition Pancreatic Precancerous Condition An exophytic glandular neoplasm of the bladder, morphologically similar to its intestinal counterpart. It often coexists with in situ or infiltrating bladder adenocarcinoma. C7414 Neoplastic Process Bladder Villous Adenoma C1336893 Benign Urinary_Bladder_Villous_Adenoma Bladder Villous Adenoma Urinary Bladder Villous Adenoma Villous Adenoma of Urinary Bladder Villous Adenoma of the Urinary Bladder Bladder Villous Adenoma A primary or metastatic malignant neoplasm that affects the rectum. Representative examples include carcinoma, lymphoma, and sarcoma. C7418 Neoplastic Process Malignant Rectal Neoplasm Malignant Rectal Neoplasm C0949022 CPTAC CTRP mCode Malignant Malignant_Rectal_Neoplasm Malignant neoplasm of rectum Malignant Neoplasm of Rectum Malignant Neoplasm of the Rectum Malignant Rectal Neoplasm Malignant Rectal Tumor Malignant Tumor of Rectum Malignant Tumor of the Rectum Malignant neoplasm of rectum Malignant Rectal Neoplasm A benign skin neoplasm composed of epithelial cells. C7419 Neoplastic Process Acanthoma C0846967 Benign Acanthoma Acanthoma Acanthoma A primary or metastatic malignant neoplasm that affects the rectosigmoid area. Representative examples include carcinoma, lymphoma, and sarcoma. C7420 Neoplastic Process Malignant Rectosigmoid Neoplasm Malignant Rectosigmoid Neoplasm C0153443 CPTAC CTRP mCode Malignant Malignant_Rectosigmoid_Neoplasm Malignant neoplasm of rectosigmoid junction Malignant neoplasm of sigmoid colon Malignant neoplasm: Sigmoid colon Malignant Neoplasm of Rectosigmoid Junction Malignant Neoplasm of the Rectosigmoid Junction Malignant Rectosigmoid Neoplasm Malignant Rectosigmoid Tumor Malignant Tumor of Rectosigmoid Junction Malignant Tumor of the Rectosigmoid Junction Malignant neoplasm of rectosigmoid junction Malignant Rectosigmoid Neoplasm A malignant epithelial neoplasm that arises from the rectosigmoid area and invades through the muscularis mucosa into the submucosa. The vast majority are adenocarcinomas. About 50% of colorectal carcinomas occur in the rectosigmoid area. C7421 Neoplastic Process Rectosigmoid Carcinoma Rectosigmoid Carcinoma C1327709 CTRP Cellosaurus Malignant Rectosigmoid_Carcinoma Rectosigmoid Cancer Rectosigmoid Carcinoma Rectosigmoid Carcinoma The spread of a malignant neoplasm to the rectum. This may be from a primary large intestine malignant neoplasm, or from a malignant neoplasm at a distant site. C7426 Neoplastic Process Metastatic Malignant Neoplasm in the Rectum C0346975 Malignant Metastatic_Neoplasm_to_the_Rectum Metastasis to the Rectum Metastatic Malignant Neoplasm in the Rectum Metastatic Malignant Neoplasm to the Rectum Metastatic Neoplasm to the Rectum Metastatic Tumor to the Rectum Metastatic Malignant Neoplasm in the Rectum A morphologic variant of papillary carcinoma of the thyroid gland that more often affects young patients and commonly metastasizing to the lungs. It is characterized by a diffuse infiltration of the thyroid gland by malignant follicular cells, squamous metaplasia, stromal fibrosis, and lymphocytic infiltration. C7427 Neoplastic Process Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma CL017960 GDC 8350/3 Malignant Nonencapsulated_Sclerosing_Carcinoma 8350/3 Nonencapsulated sclerosing adenocarcinoma Nonencapsulated sclerosing carcinoma Nonencapsulated sclerosing tumor Papillary carcinoma, diffuse sclerosing Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma Nonencapsulated Sclerosing Adenocarcinoma Nonencapsulated Sclerosing Carcinoma Nonencapsulated Sclerosing Neoplasm Nonencapsulated Sclerosing Papillary Thyroid Carcinoma Nonencapsulated Sclerosing Tumor Nonencapsulated sclerosing adenocarcinoma Nonencapsulated sclerosing carcinoma Nonencapsulated sclerosing tumor Thyroid Gland Diffuse Sclerosing Papillary Carcinoma Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma A malignant neoplasm that arises from the epithelial cells of the exocrine pancreatic tissue. C7430 Neoplastic Process Malignant Exocrine Pancreas Neoplasm C0346648 Malignant Malignant_Exocrine_Pancreas_Neoplasm Malignant Exocrine Pancreas Neoplasm Malignant Exocrine Pancreas Tumor Malignant Neoplasm of Exocrine Pancreas Malignant Neoplasm of the Exocrine Pancreas Malignant Tumor of Exocrine Pancreas Malignant Tumor of the Exocrine Pancreas Malignant Exocrine Pancreas Neoplasm A primary or metastatic malignant neoplasm involving the ovary. Most primary malignant ovarian neoplasms are either carcinomas (serous, mucinous, or endometrioid adenocarcinomas) or malignant germ cell tumors. Metastatic malignant neoplasms to the ovary include carcinomas, lymphomas, and melanomas. C7431 Neoplastic Process Malignant Ovarian Neoplasm Malignant Ovarian Neoplasm C3810371 CPTAC CTEP CTRP GDC mCode Cancer that forms in tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed). Most ovarian cancers are either ovarian epithelial carcinomas (cancer that begins in the cells on the surface of the ovary) or malignant germ cell tumors (cancer that begins in egg cells). Malignant Malignant_Ovarian_Neoplasm Malignant neoplasm of left ovary Malignant neoplasm of ovary Malignant neoplasm of right ovary Malignant neoplasm of unspecified ovary Ovarian Cancer Cancer of Ovary Cancer of the Ovary Malignant Neoplasm of Ovary Malignant Neoplasm of the Ovary Malignant Ovarian Neoplasm Malignant Ovarian Tumor Malignant Tumor of Ovary Malignant Tumor of the Ovary Malignant neoplasm of unspecified ovary Ovarian Cancer Ovarian cancer, NOS ovarian cancer Malignant Ovarian Neoplasm A carcinoma that arises from the cervix in a patient with acquired immunodeficiency syndrome. C7432 Neoplastic Process AIDS-Related Cervical Carcinoma AIDS-Related Cervical Carcinoma C1332040 CTEP CTRP Malignant AIDS-Related_Cervical_Carcinoma AIDS Related Carcinoma of Uterine Cervix AIDS Related Carcinoma of the Uterine Cervix AIDS Related Cervical Cancer AIDS-Related Cancer of Uterine Cervix AIDS-Related Cancer of the Uterine Cervix AIDS-Related Cervical Cancer AIDS-Related Cervical Carcinoma AIDS-Related Cervix Carcinoma AIDS-Related Uterine Cervix Cancer AIDS-Related Uterine Cervix Carcinoma AIDS-related cervical cancer AIDS-Related Cervical Carcinoma A Kaposi sarcoma arising from the cervix in patients who are infected with the human immunodeficiency virus. C7433 Neoplastic Process AIDS-Related Cervical Kaposi Sarcoma C1336924 Malignant V-Ras-Ha_Gene AIDS-Related Cervical Kaposi Sarcoma AIDS-Related Cervical Kaposi's Sarcoma AIDS-Related Kaposi's Sarcoma of Cervix AIDS-Related Kaposi's Sarcoma of the Cervix AIDS-Related Cervical Kaposi Sarcoma A non-Hodgkin lymphoma that arises from the cervix in a patient with acquired immunodeficiency syndrome. C7434 Neoplastic Process AIDS-Related Non-Hodgkin Lymphoma of the Cervix C1332052 Malignant AIDS-Related_Non-Hodgkin_s_Lymphoma_of_the_Cervix AIDS-Related Non-Hodgkin Lymphoma of the Cervix AIDS-Related Non-Hodgkin's Lymphoma of Cervix AIDS-Related Non-Hodgkin's Lymphoma of the Cervix AIDS-Related Uterine Cervical Non-Hodgkin's Lymphoma AIDS-Related Non-Hodgkin Lymphoma of the Cervix A term referring to neoplastic changes in the bronchial epithelium manifested as dysplasia. C7436 Neoplastic Process Bronchial Intraepithelial Neoplasia Bronchial Intraepithelial Neoplasia C1336084 CTRP Undetermined Squamous_Lung_Dysplasia Bronchial Intraepithelial Neoplasia Lung Squamous Dysplasia Bronchial Intraepithelial Neoplasia A breast adenocarcinoma characterized by the presence of intraductal and invasive papillary carcinomatous components. C7439 Neoplastic Process Breast Papillary Ductal Carcinoma In Situ with Invasion Breast Papillary Ductal Carcinoma In Situ with Invasion C0334373 CTRP GDC 8503/3 Malignant Intraductal_Papillary_Adenocarcinoma_with_Invasion 8503/3 Intraductal papillary adenocarcinoma with invasion Intraductal papillary neoplasm with associated invasive carcinoma Breast Intraductal Papillary Adenocarcinoma with Invasion Breast Papillary Ductal Carcinoma In Situ with Invasion Intraductal Papillary Adenocarcinoma with Invasion Intraductal papillary adenocarcinoma with invasion Breast Papillary Ductal Carcinoma In Situ with Invasion A tumor with myoepithelial differentiation that lacks an infiltrative growth pattern and does not metastasize. C7442 Neoplastic Process Benign Myoepithelioma C1947949 CDISC GDC A benign neoplasm composed of myoepithelial cells. Benign Benign_Myoepithelioma 8982/0 Myoepithelial adenoma Benign Myoepithelioma MYOEPITHELIOMA, BENIGN Benign Myoepithelioma An astrocytoma that arises from the brain stem. C7445 Neoplastic Process Brain Stem Astrocytoma C1332608 Undetermined Brain_Stem_Astrocytoma Brain Stem Astrocytoma Brainstem Astrocytoma Brain Stem Astrocytoma An anaplastic glioma that arises from the brain stem. C7446 Neoplastic Process Anaplastic Brain Stem Glioma C1332280 Malignant Anaplastic_Brain_Stem_Glioma Anaplastic Brain Stem Glioma Anaplastic Brainstem Glioma Anaplastic Glioma of Brain Stem Anaplastic Glioma of Brainstem Anaplastic Glioma of the Brain Stem Anaplastic Glioma of the Brainstem Brain Stem Glioma, Grade III Brainstem Glioma, Grade III Grade 3 Brain Stem Glioma Grade 3 Brainstem Glioma Grade 3 Glioma of Brain Stem Grade 3 Glioma of Brainstem Grade 3 Glioma of the Brain Stem Grade 3 Glioma of the Brainstem Grade III Brain Stem Glioma Grade III Brainstem Glioma Grade III Glioma of Brain Stem Grade III Glioma of Brainstem Grade III Glioma of the Brain Stem Grade III Glioma of the Brainstem Undifferentiated Brain Stem Glioma Undifferentiated Brainstem Glioma Undifferentiated Glioma of Brain Stem Undifferentiated Glioma of Brainstem Undifferentiated Glioma of the Brain Stem Undifferentiated Glioma of the Brainstem Anaplastic Brain Stem Glioma An uncommon lipoma characterized by prominent vascularity that invades the surrounding deep tissue. C7449 Neoplastic Process Infiltrating Angiolipoma C1305256 GDC Benign Infiltrating_Angiolipoma 8856/0 Infiltrating angiolipoma Infiltrating Angiolipoma Infiltrating angiolipoma Infiltrating Angiolipoma A benign tumor, composed of mature adipocytes, that arises within skeletal muscle fibers. C7450 Neoplastic Process Intramuscular Lipoma C0334473 GDC 8856/0 Benign Intramuscular_Lipoma 8856/0 Intramuscular lipoma Intramuscular Lipoma Intramuscular lipoma Intramuscular Lipoma A benign tumor, composed of lobules of mature adipocytes, that penetrates the surrounding tissue from which it arises. There is usually a higher local recurrence rate when compared with non-infiltrating lipomas. C7451 Neoplastic Process Infiltrating Lipoma CL028013 GDC Benign Infiltrating_Lipoma 8856/0 Infiltrating lipoma Infiltrating Lipoma Infiltrating lipoma Infiltrating Lipoma An intraosseous odontogenic neoplasm with good prognosis, arising from the mandible and less frequently from the maxilla. It is characterized by the presence of stellate cells, myxoid stroma formation, and prominent collagen. Small tumors may be cured with enucleation. Complete excision may be required for larger tumors. C7452 Neoplastic Process Odontogenic Myxofibroma C1377940 GDC Benign Odontogenic_Myxofibroma 9320/0 Odontogenic myxofibroma Odontogenic Myxofibroma Odontogenic myxofibroma Odontogenic Myxofibroma A carcinoma that arises from the squamous epithelium of the exocervix. C7453 Neoplastic Process Exocervical Carcinoma Exocervical Carcinoma C1299238 CTRP Malignant Exocervical_Carcinoma Carcinoma of Exocervix Carcinoma of the Exocervix Exocervical Cancer Exocervical Carcinoma Exocervix Carcinoma Exocervical Carcinoma A lung carcinoma arising from the hilum of the lung. C7454 Neoplastic Process Lung Hilum Carcinoma Lung Hilum Carcinoma C1334445 CTRP Malignant Lung_Hilum_Carcinoma Hilar Lung Carcinoma Lung Hilum Cancer Lung Hilum Carcinoma Lung Hilum Carcinoma The spread of a malignant neoplasm to the ovary. This may be from a primary ovarian malignant neoplasm involving the opposite ovary, or from a malignant neoplasm at a distant site. C7456 Neoplastic Process Metastatic Malignant Neoplasm in the Ovary C3647143 CPTAC mCode Malignant Metastatic_Malignant_Neoplasm_to_the_Ovary Secondary malignant neoplasm of ovary Metastases to Ovary Metastasis to Ovary Metastatic Malignant Neoplasm in the Ovary Metastatic Malignant Neoplasm to the Ovary Metastatic Malignant Tumor to the Ovary Ovarian Metastasis Secondary malignant neoplasm of ovary Secondary malignant neoplasm of unspecified ovary Metastatic Malignant Neoplasm in the Ovary A common hemangioma characterized by the presence of capillary-sized vascular channels without prominent epithelioid endothelial cells. C7457 Neoplastic Process Capillary Hemangioma C2748741 GDC 9131/0 Benign Capillary_Hemangioma 9131/0 Capillary hemangioma Capillary Angioma Capillary Hemangioma Capillary hemangioma Capillary Hemangioma Serous gland with distended lumen. It includes the gland of Krause in the lacrimal sac and the gland of Wolfring on the inner surface of the upper eyelid. C74586 Body Part, Organ, or Organ Component Accessory Lacrimal Gland C0266586 Accessory_Lacrimal_Gland Accessory Lacrimal Gland Accessory Lacrimal Gland An epithelial or non-epithelial malignant neoplasm that has spread to the anus from another anatomic site. C7460 Neoplastic Process Metastatic Malignant Neoplasm in the Anus C0686106 Malignant Metastatic_Malignant_Neoplasm_to_the_Anus Metastatic Malignant Neoplasm in the Anus Metastatic Malignant Neoplasm to the Anus Metastatic Malignant Neoplasm in the Anus A pituitary neuroendocrine tumor that produces growth hormone. C7461 Neoplastic Process Growth Hormone-Producing Pituitary Gland Tumor Somatotroph Pituitary Neuroendocrine Tumor C0346302 CTRP NICHD A pituitary neuroendocrine tumor that produces growth hormone. Undetermined Growth_Hormone_Secreting_Pituitary_Adenoma Growth Hormone Producing Adenoma of Pituitary Gland Growth Hormone Producing Pituitary Adenoma Growth Hormone Producing Pituitary Gland Adenoma Growth Hormone Secreting Adenoma of Pituitary Growth Hormone Secreting Adenoma of Pituitary Gland Growth Hormone Secreting Adenoma of the Pituitary Gland Growth Hormone Secreting Pituitary Gland Adenoma Growth Hormone-Producing Pituitary Adenoma Growth Hormone-Producing Pituitary Gland Adenoma Growth Hormone-Producing Pituitary Gland Tumor Somatotrope Adenoma Somatotroph PitNET/Adenoma Somatotroph Pituitary Neuroendocrine Tumor Somatotroph Pituitary Neuroendocrine Tumor/Adenoma Somatotrophinoma Somatotroph Pituitary Neuroendocrine Tumor A pituitary neuroendocrine tumor that produces adrenocorticotropic hormone. C7462 Neoplastic Process ACTH-Producing Pituitary Gland Adenoma Corticotroph Pituitary Neuroendocrine Tumor C1306214 CTRP NICHD A pituitary neuroendocrine tumor that produces adrenocorticotropic hormone. Undetermined Pituitary_Corticotropin_Secreting_Adenoma ACTH Producing Pituitary Gland Adenoma ACTH Secreting Adenoma of Pituitary ACTH Secreting Adenoma of the Pituitary ACTH-Producing Pituitary Adenoma ACTH-Producing Pituitary Gland Adenoma ACTH-Producing Tumor ACTHoma Adrenocorticotropin Producing Adenoma of Pituitary Adrenocorticotropin Producing Adenoma of Pituitary Gland Adrenocorticotropin Producing Adenoma of the Pituitary Adrenocorticotropin Producing Adenoma of the Pituitary Gland Adrenocorticotropin Producing Pituitary Adenoma Adrenocorticotropin Producing Pituitary Gland Adenoma Adrenocorticotropin Secreting Adenoma of Pituitary Adrenocorticotropin Secreting Adenoma of Pituitary Gland Adrenocorticotropin Secreting Adenoma of the Pituitary Adrenocorticotropin Secreting Adenoma of the Pituitary Gland Adrenocorticotropin Secreting Pituitary Adenoma Adrenocorticotropin Secreting Pituitary Gland Adenoma Corticotroph PitNET/Adenoma Corticotroph Pituitary Neuroendocrine Tumor Corticotroph Pituitary Neuroendocrine Tumor/Adenoma Corticotropic Adenoma Corticotropin Secreting Adenoma of the Pituitary Corticotropin Secreting Pituitary Gland Adenoma Corticotropinoma Pituitary ACTH Secreting Adenoma Pituitary ACTH-Secreting Adenoma Pituitary Corticotropin Secreting Adenoma Pituitary Gland ACTH-Secreting Adenoma Corticotroph Pituitary Neuroendocrine Tumor An acute leukemia characterized by the proliferation of both neutrophil and monocyte precursors. (WHO, 2001) C7463 Neoplastic Process Acute Myelomonocytic Leukemia C0023479 CPTAC Cellosaurus GDC NICHD PCDC An acute leukemia characterized by the proliferation of both neutrophil and monocyte precursors. (WHO, 2001) 9867/3 Malignant Acute_Myelomonocytic_Leukemia 9867/3 Acute myelomonocytic leukaemia Acute myelomonocytic leukemia Acute myelomonocytic leukemia, NOS Acute myelomonocytic leukemia, not having achieved remission FAB M4 M4 AMML Acute M4 Myeloid Leukemia Acute Myelomonocytic Leukemia Acute Myelomonocytic Leukemia (FAB Type M4) Acute myelomonocytic leukemia M4 M4 OR Acute Myelomonocytic Leukemia Acute Myelomonocytic Leukemia An acute leukemia in which the blasts lack sufficient evidence to classify as myeloid or lymphoid or they have morphologic and/or immunophenotypic characteristics of both myeloid and lymphoid cells. (WHO, 2001) C7464 Neoplastic Process Acute Leukemia of Ambiguous Lineage Acute Leukemia of Ambiguous Lineage C1301357 CTRP Cellosaurus GDC NICHD PCDC A rare subtype of acute leukemia in which the blasts lack sufficient evidence to classify as myeloid or lymphoid, or they have morphologic and/or immunophenotypic characteristics of both myeloid and lymphoid cells. These subtypes account for less than 4% of cases of acute leukemia. Malignant Acute_Leukemia_of_Ambiguous_Lineage Acute Leukemia of Ambiguous Lineage (ALAL) ALAL Acute Leukemia of Ambiguous Lineage Acute Leukemia of Ambiguous Lineage (ALAL) Acute Leukemia of Indeterminate Lineage Acute Leukemia, ambiguous lineage (mixed or biphenotypic) Acute Leukemia of Ambiguous Lineage A non-Hodgkin lymphoma arising from the anus and occurring in HIV-positive patients. Homosexual HIV-positive men have an increased risk of developing anal non-Hodgkin lymphoma in comparison to the general male population. The majority of the cases are large cell lymphomas of B-cell phenotype. C7465 Neoplastic Process AIDS-Related Anal Non-Hodgkin Lymphoma C1332674 Malignant AIDS-Related_Anal_Non-Hodgkins_Lymphoma AIDS-Related Anal Non-Hodgkin Lymphoma AIDS-Related Anal Non-Hodgkin's Lymphoma AIDS-Related Primary Anal Non-Hodgkin's Lymphoma AIDS-Related Anal Non-Hodgkin Lymphoma Acute erythroid leukemia characterized by the presence of immature erythroid cells in the bone marrow (at least 80% of the cellular component), without evidence of a significant myeloblastic cell population present. C7467 Neoplastic Process Pure Erythroid Leukemia CL028054 GDC PCDC Malignant Pure_Erythroid_Leukemia 9840/3 Acute erythremic myelosis Di Guglielmo disease Erythremic myelosis, NOS M6B Acute Erythremic Myelosis Acute Myeloid Leukemia M6b Acute erythremic myelosis Di Guglielmo Disease Di Guglielmo disease Di Guglielmo's Disease Erythremic Myelosis M6B M6b PEL Pure Erythroid Leukemia Pure Erythroid Leukemia An ovarian mature teratoma characterized by the presence of aberrant thyroid tissue. C7468 Neoplastic Process Struma Ovarii C0038478 GDC 9090/0 Benign Undetermined Struma_Ovarii 9090/0 Struma ovarii, NOS Struma Ovarii Struma Ovarii A squamous cell carcinoma arising from the mucosa of the anal canal. C7469 Neoplastic Process Anal Canal Squamous Cell Carcinoma C1332262 Malignant Anal_Canal_Squamous_Cell_Carcinoma Anal Canal Squamous Cell Carcinoma Anal Canal Squamous Cell Carcinoma A large, well differentiated squamous cell carcinoma with a cauliflower-like appearance, characterized by the presence of an exophytic and endophytic growth pattern. Morphologically, there is papillomatosis and acanthosis present, however cytologically the neoplastic squamous cells have a benign appearance. Dysplastic changes are minimal. It does not respond to conservative treatment and it is regarded by many authors as an intermediate lesion between condyloma acuminatum and squamous cell carcinoma. C7470 Neoplastic Process Anal Verrucous Carcinoma C1332278 Malignant Anal_Verrucous_Carcinoma Anal Buschke-Lowenstein Tumor Anal Giant (Malignant) Condyloma Anal Verrucous Carcinoma Anal Verrucous Carcinoma An anal adenocarcinoma arising from the anal canal mucosa. Morphologically, it resembles the adenocarcinoma which arises from the colorectal glandular epithelium. Symptoms include anal pruritus, discomfort when sitting, pain, change in bowel habit, and bleeding. C7471 Neoplastic Process Anal Canal Adenocarcinoma C1332259 Malignant Anal_Canal_Adenocarcinoma Adenocarcinoma Arising in Anal Mucosa Adenocarcinoma Arising in the Anal Mucosa Adenocarcinoma of Anal Canal Adenocarcinoma of the Anal Canal Anal Canal Adenocarcinoma Anal Canal Adenocarcinoma A carcinoma arising in the anal margin or perianal skin (below the anal verge and involving the perianal hair-bearing skin). It includes basal cell and squamous cell carcinoma. Anal margin carcinoma is staged as a skin carcinoma, separately from anal canal carcinoma. C7472 Neoplastic Process Anal Margin Carcinoma Anal Margin Carcinoma C0349534 CTRP Malignant Anal_Margin_Carcinoma Anal Margin Cancer Anal Margin Carcinoma Carcinoma of Anal Margin Carcinoma of the Anal Margin Perianal Skin Carcinoma Anal Margin Carcinoma A basal cell carcinoma arising from the perianal skin. Local excision is the treatment of choice. Metastases are extremely rare. C7473 Neoplastic Process Anal Margin Basal Cell Carcinoma C1332269 Malignant Anal_Margin_Basal_Cell_Carcinoma Anal Margin Basal Cell Carcinoma Basal Cell Carcinoma of Anal Margin Basal Cell Carcinoma of Perianal Skin Basal Cell Carcinoma of the Anal Margin Basal Cell Carcinoma of the Perianal Skin Perianal Skin Basal Cell Carcinoma Anal Margin Basal Cell Carcinoma An anal adenocarcinoma arising from the lining of an anorectal fistulous tract or the anal glands. The overlying anal mucosa does not show evidence of neoplastic changes. It usually presents as a submucosal tumor. C7474 Neoplastic Process Anal Extramucosal (Perianal) Adenocarcinoma C1332263 Malignant Anal_Extramucosal_Perianal_Adenocarcinoma Anal Extramucosal (Perianal) Adenocarcinoma Extramucosal (Perianal) Adenocarcinoma of Anus Extramucosal (Perianal) Adenocarcinoma of the Anus Anal Extramucosal (Perianal) Adenocarcinoma An anal adenocarcinoma arising from the lining of an anorectal fistulous tract. The overlying anal mucosa does not show evidence of neoplastic changes. Some cases are associated with Crohn disease. C7475 Neoplastic Process Anal Adenocarcinoma within Anorectal Fistula C1332258 Malignant Anal_Adenocarcinoma_within_Anorectal_Fistula Adenocarcinoma of Anus within Anorectal Fistula Adenocarcinoma of the Anus within Anorectal Fistula Anal Adenocarcinoma within Anorectal Fistula Anal Adenocarcinoma within Anorectal Fistula Paget disease involving the perianal skin. C7476 Neoplastic Process Anal Margin Paget Disease C1332270 Malignant Anal_Margin_Paget_s_Disease Anal Margin Paget Disease Anal Margin Paget's Disease Paget Disease of the Anal Margin Paget's Disease of the Anal Margin Perianal Skin Paget's Disease Anal Margin Paget Disease Paget disease involving the squamous epithelium of the anal canal. C7477 Neoplastic Process Anal Canal Paget Disease C1332261 Malignant Anal_Canal_Paget_s_Disease Anal Canal Paget Disease Anal Canal Paget's Disease Paget Disease of the Anal Canal Paget's Disease of Anal Canal Paget's Disease of the Anal Canal Anal Canal Paget Disease A primary or metastatic malignant neoplasm involving the esophagus. C7478 Neoplastic Process Malignant Esophageal Neoplasm C0546837 CPTAC mCode Malignant Malignant_Esophageal_Neoplasm Malignant neoplasm of esophagus Malignant neoplasm of esophagus, unspecified Malignant neoplasm of oesophagus Malignant neoplasm of other specified part of esophagus Malignant neoplasm: Oesophagus, unspecified Malignant neoplasm: Overlapping lesion of oesophagus Malignant Esophageal Neoplasm Malignant Esophageal Tumor Malignant Esophagus Tumor Malignant Neoplasm of Esophagus Malignant Neoplasm of the Esophagus Malignant Tumor of Esophagus Malignant Tumor of the Esophagus Malignant neoplasm of esophagus, unspecified Malignant Esophageal Neoplasm A malignant neoplasm that has spread to the esophagus from another organ or system, or from another primary esophageal tumor. The primary esophageal tumor is not in continuity with the metastatic lesion. Representative examples of metastatic cancers to the esophagus include breast and lung metastatic carcinomas and melanomas. C7479 Neoplastic Process Metastatic Malignant Neoplasm in the Esophagus C0686055 Malignant Metastatic_Neoplasm_to_the_Esophagus Esophageal Metastasis Metastases to Esophagus Metastases to the Esophagus Metastasis to Esophagus Metastasis to the Esophagus Metastatic Malignant Neoplasm in the Esophagus Metastatic Malignant Neoplasm to the Esophagus Metastatic Neoplasm to the Esophagus Metastatic Tumor to the Esophagus Metastatic Malignant Neoplasm in the Esophagus A primary or metastatic malignant neoplasm that affects the fallopian tube. Representative examples include carcinoma, carcinosarcoma, and leiomyosarcoma. C7480 Neoplastic Process Malignant Fallopian Tube Neoplasm C0153579 CPTAC mCode Malignant Malignant_Fallopian_Tube_Neoplasm Malignant neoplasm of fallopian tube Malignant neoplasm of left fallopian tube Malignant neoplasm of unspecified fallopian tube Malignant neoplasm: Fallopian tube Fallopian Tube Malignant Neoplasm Fallopian Tube Malignant Tumor Malignant Fallopian Tube Neoplasm Malignant Fallopian Tube Tumor Malignant Neoplasm of Fallopian Tube Malignant Neoplasm of the Fallopian Tube Malignant Tumor of Fallopian Tube Malignant Tumor of the Fallopian Tube Malignant neoplasm of unspecified fallopian tube Neoplasm, Fallopian Tube, Malignant Tumor, Fallopian Tube, Malignant Malignant Fallopian Tube Neoplasm A primary or metastatic malignant neoplasm that affects the gallbladder. Representative examples include carcinoma, lymphoma, melanoma, and sarcoma. C7481 Neoplastic Process Gallbladder Malignant Neoplasm Gallbladder Malignant Neoplasm C0153452 CPTAC CTRP mCode Malignant Malignant_Gallbladder_Neoplasm Malignant neoplasm of gallbladder Gallbladder Malignant Neoplasm Malignant Gallbladder Neoplasm Malignant Gallbladder Tumor Malignant Neoplasm of Gallbladder Malignant Neoplasm of the Gallbladder Malignant Tumor of Gallbladder Malignant Tumor of the Gallbladder Malignant neoplasm of gallbladder Gallbladder Malignant Neoplasm A malignant neoplasm that has spread to the gallbladder from another anatomic site. Representative examples include metastatic melanoma, and metastatic carcinomas from the breast and the stomach. C7482 Neoplastic Process Metastatic Malignant Neoplasm in the Gallbladder C1868728 Malignant Metastatic_Neoplasm_to_the_Gallbladder Metastatic Malignant Neoplasm in the Gallbladder Metastatic Malignant Neoplasm to the Gallbladder Metastatic Neoplasm to the Gallbladder Metastatic Tumor to the Gallbladder Secondary Malignant Neoplasm to the Gallbladder Secondary Malignant Tumor to the Gallbladder Metastatic Malignant Neoplasm in the Gallbladder A primary or metastatic malignant neoplasm that affects the extrahepatic bile ducts. Representative examples include carcinoma and sarcoma. C7483 Neoplastic Process Malignant Extrahepatic Bile Duct Neoplasm C0153453 CPTAC mCode Malignant Malignant_Extrahepatic_Bile_Duct_Neoplasm Malignant neoplasm of extrahepatic bile ducts Malignant neoplasm: Extrahepatic bile duct Malignant Extrahepatic Bile Duct Neoplasm Malignant Extrahepatic Bile Duct Tumor Malignant Neoplasm of Extrahepatic Bile Duct Malignant Neoplasm of the Extrahepatic Bile Duct Malignant Tumor of Extrahepatic Bile Duct Malignant Tumor of the Extrahepatic Bile Duct Malignant neoplasm of extrahepatic bile duct Malignant Extrahepatic Bile Duct Neoplasm A primary or metastatic malignant neoplasm involving the larynx. The majority are carcinomas. C7484 Neoplastic Process Malignant Laryngeal Neoplasm C0007107 CPTAC mCode Malignant Malignant_Laryngeal_Neoplasm Malignant neoplasm of larynx Malignant neoplasm of larynx, unspecified Malignant neoplasm of other specified sites of larynx Malignant neoplasm: Laryngeal cartilage Malignant neoplasm: Larynx, unspecified Malignant neoplasm: Overlapping lesion of larynx Malignant Laryngeal Neoplasm Malignant Laryngeal Tumor Malignant Larynx Neoplasm Malignant Larynx Tumor Malignant Neoplasm of Larynx Malignant Neoplasm of the Larynx Malignant Tumor of Larynx Malignant Tumor of the Larynx Malignant neoplasm of larynx, unspecified Malignant Laryngeal Neoplasm A primary or metastatic malignant neoplasm involving the lip. C7485 Neoplastic Process Malignant Lip Neoplasm Malignant Lip Neoplasm C0153340 CPTAC CTRP mCode Malignant Malignant_Lip_Neoplasm Malignant neoplasm of lip Malignant neoplasm of lip, unspecified, inner aspect Malignant neoplasm of lip, unspecified, vermilion border Malignant neoplasm of lower lip, inner aspect Malignant neoplasm of lower lip, vermilion border Malignant neoplasm of upper lip, vermilion border Malignant neoplasm: External lip, unspecified Malignant neoplasm: External upper lip Malignant neoplasm: Skin of lip Other malignant neoplasm of skin of lip Unspecified malignant neoplasm of skin of lip Malignant Lip Neoplasm Malignant Lip Tumor Malignant Neoplasm of Lip Malignant Neoplasm of the Lip Malignant Tumor of Lip Malignant Tumor of the Lip Malignant neoplasm of lip, unspecified Malignant Lip Neoplasm A primary or metastatic malignant neoplasm involving the paranasal sinuses. C7487 Neoplastic Process Malignant Paranasal Sinus Neoplasm C0153474 CPTAC mCode Malignant Malignant_Paranasal_Sinus_Neoplasm Malignant neoplasm of accessory sinuses Malignant neoplasm: Accessory sinus, unspecified Malignant Accessory Sinus Neoplasm Malignant Accessory Sinus Tumor Malignant Neoplasm of Accessory Sinus Malignant Neoplasm of Paranasal Sinus Malignant Neoplasm of the Accessory Sinus Malignant Neoplasm of the Paranasal Sinus Malignant Paranasal Sinus Neoplasm Malignant Paranasal Sinus Tumor Malignant Tumor of Accessory Sinus Malignant Tumor of Paranasal Sinus Malignant Tumor of the Accessory Sinus Malignant Tumor of the Paranasal Sinus Malignant neoplasm of accessory sinus, unspecified Malignant Paranasal Sinus Neoplasm A benign or malignant neoplasm that affects the paranasal sinuses. Representative examples of benign neoplasms include Schneiderian papilloma and salivary gland-type adenoma. Representative examples of malignant neoplasms include carcinoma and lymphoma. C7488 Neoplastic Process Paranasal Sinus Neoplasm C0030470 Undetermined Paranasal_Sinus_Neoplasm Accessory Sinus Neoplasm Accessory Sinus Tumor Neoplasm of Accessory Sinus Neoplasm of Paranasal Sinus Neoplasm of the Accessory Sinus Neoplasm of the Paranasal Sinus Paranasal Sinus Neoplasm Paranasal Sinus Neoplasms Paranasal Sinus Tumor Tumor of Accessory Sinus Tumor of Paranasal Sinus Tumor of the Accessory Sinus Tumor of the Paranasal Sinus Paranasal Sinus Neoplasm A squamous cell carcinoma or less frequently an adenocarcinoma, often associated with human papillomavirus (HPV) infection. Homosexual men are at particular risk. The most important prognostic factors are tumor stage and nodal status. C7489 Neoplastic Process Anal Canal Carcinoma Anal Canal Carcinoma C0563211 CTRP Malignant Anal_Canal_Carcinoma Anal Canal Cancer Anal Canal Carcinoma Anal Canal and Perianal Gland Cancer Anal Canal and Perianal Gland Carcinoma Anal Canal Carcinoma A precancerous neoplastic intraepithelial process involving the anal canal. When it is clinically noticeable, it may appear as an eczematous or papillary lesion, plaques, or papules. Morphologically, it is characterized by loss of epithelial stratification and nuclear polarity, cytologic atypia, and the presence of mitotic figures. It may be classified as low or high grade. C7490 Neoplastic Process Anal Canal Intraepithelial Neoplasia C1332260 Undetermined Anal_Canal_Intraepithelial_Neoplasia ACIN ASIN Anal Canal Dysplasia Anal Canal Intraepithelial Neoplasia Anal Canal Squamous Dysplasia Anal Canal Squamous Intraepithelial Neoplasia Anal Squamous Intraepithelial Neoplasia Anal Canal Intraepithelial Neoplasia A rare, cytologically malignant ameloblastoma that may metastasize. C7492 Neoplastic Process Ameloblastic Carcinoma C1314678 CDISC GDC A malignant neoplasm arising from tooth-forming tissues with-enamel organ differentiation (but without enamel formation). Malignant Ameloblastic_Carcinoma 9270/3 Ameloblastic carcinoma AC Ameloblastic Carcinoma Ameloblastic carcinoma ODONTOMA, AMELOBLASTIC, MALIGNANT Ameloblastic Carcinoma A rare, aggressive odontogenic malignant tumor that arises usually from the mandible and less frequently from the maxilla. It combines the histologic features of an ameloblastoma and carcinoma. C7493 Neoplastic Process Ameloblastic Carcinoma-Primary Type C1333260 Malignant De_novo_Ameloblastic_Carcinoma Ameloblastic Carcinoma-Primary Type De novo Ameloblastic Carcinoma Primary Ameloblastic Carcinoma Ameloblastic Carcinoma-Primary Type A very rare ameloblastic carcinoma that originates from a pre-existing benign ameloblastoma. C7496 Neoplastic Process Ameloblastic Carcinoma-Secondary Type (Dedifferentiated) C1332241 Malignant Ameloblastic_Carcinoma_ex_Ameloblastoma Ameloblastic Carcinoma Ex Ameloblastoma Ameloblastic Carcinoma-Secondary Type (Dedifferentiated) Ameloblastic Carcinoma-Secondary Type (Dedifferentiated) A rare, aggressive malignant tumor that originates from an odontogenic cyst in the maxillomandibular region. It combines the histologic features of an ameloblastoma and carcinoma. C7497 Neoplastic Process Ameloblastic Carcinoma Derived From Odontogenic Cyst C1332242 Malignant Ameloblastic_Carcinoma_ex_Odontogenic_Cyst Ameloblastic Carcinoma Derived From Odontogenic Cyst Ameloblastic Carcinoma Ex Odontogenic Cyst Ameloblastic Carcinoma Derived From Odontogenic Cyst A rare primary intraosseous carcinoma, not otherwise specified, that arises from the lining of an odontogenic cyst. C7500 Neoplastic Process Primary Intraosseous Carcinoma, Not Otherwise Specified, Derived from Odontogenic Cyst C1335487 Malignant Primary_Intraosseous_Carcinoma_ex_Odontogenic_Cyst Primary Intraosseous Carcinoma Ex Odontogenic Cyst Primary Intraosseous Carcinoma, Not Otherwise Specified, Derived from Odontogenic Cyst Primary Intraosseous Squamous Cell Carcinoma Derived From Odontogenic Cyst Primary Intraosseous Carcinoma, Not Otherwise Specified, Derived from Odontogenic Cyst An intraosseous odontogenic neoplasm with good prognosis, arising from the mandible and less frequently from the maxilla. It is characterized by the presence of stellate cells and abundant myxoid stroma formation. Small tumors may be cured with enucleation. Complete excision may be required for larger tumors. C7501 Neoplastic Process Odontogenic Myxoma C0334569 GDC 9320/0 Benign Odontogenic_Myxoma 9320/0 Odontogenic myxoma Odontogenic Myxoma Odontogenic myxoma Odontogenic Myxoma A primary or metastatic malignant neoplasm involving the vulva. C7502 Neoplastic Process Malignant Vulvar Neoplasm C0375071 CPTAC mCode Malignant Malignant_Vulvar_Neoplasm Malignant neoplasm of vulva Malignant neoplasm of vulva, unspecified Malignant neoplasm: Vulva, unspecified Malignant Neoplasm of Vulva Malignant Neoplasm of the Vulva Malignant Tumor of Vulva Malignant Tumor of the Vulva Malignant Vulva Neoplasm Malignant Vulva Tumor Malignant Vulvar Neoplasm Malignant Vulvar Tumor Malignant neoplasm of vulva, unspecified Malignant Vulvar Neoplasm A localized, well-circumscribed multilocular tumor lined by hobnail epithelium. It was previously classified along with pediatric cystic nephroma, as a separate entity from mixed epithelial and stromal tumors. Now it is classified within the spectrum of the mixed epithelial and stromal tumor family. Most of these tumors are benign. (WHO 2016). C7504 Neoplastic Process Cystic Nephroma Adult Cystic Nephroma C1266138 CTRP GDC 8959/0 Undetermined Cystic_Nephroma 8959/0 Benign cystic nephroma Adult Cystic Nephroma Benign cystic nephroma Cystic Nephroma Adult Cystic Nephroma Myelodysplastic syndrome characterized by the presence of 5-9% blasts in bone marrow and 2-9% blasts in peripheral blood. C7506 Neoplastic Process Myelodysplastic Syndrome with Excess Blasts Myelodysplastic Syndrome with Excess Blasts C0002894 CPTAC CTRP GDC mCode 9983/3 Malignant RAEB-1 Refractory_Anemia_with_Excess_Blasts 9983/3 Myelodysplastic syndrome with excess blasts RAEB RAEB I Refractory anaemia with excess of blasts Refractory anemia with excess blasts Refractory anemia with excess of blasts, unspecified MDS-EB MDS-EB-1 MDS-IB MDS-IB-1 MDS-IB1 Myelodysplastic Neoplasm with Increased Blasts Myelodysplastic Syndrome with Excess Blasts Myelodysplastic Syndrome with Excess Blasts-1 Myelodysplastic Syndrome with Increased Blasts RAEB RAEB I RAEB-1 RAEB-I Refractory Anemia with Excess Blasts Refractory Anemia with an Excess of Blasts Refractory anemia with excess blasts Refractory anemia with excess of blasts 1 Refractory anemia with excess of blasts, unspecified Myelodysplastic Syndrome with Excess Blasts A primary or metastatic malignant neoplasm involving the urethra. C7507 Neoplastic Process Malignant Urethral Neoplasm C0153620 CPTAC mCode Malignant Malignant_Urethral_Neoplasm Malignant neoplasm of urethra Malignant neoplasm: Urethra Malignant Neoplasm of Urethra Malignant Neoplasm of the Urethra Malignant Tumor of Urethra Malignant Tumor of the Urethra Malignant Urethra Neoplasm Malignant Urethra Tumor Malignant Urethral Neoplasm Malignant Urethral Tumor Malignant neoplasm of urethra Malignant Urethral Neoplasm The reemergence of urethral carcinoma after a period of remission C7508 Neoplastic Process Recurrent Urethral Carcinoma Recurrent Urethral Carcinoma C0279912 CTRP Malignant Recurrent_Urethral_Cancer Recurrent Cancer of Urethra Recurrent Cancer of the Urethra Recurrent Urethra Cancer Recurrent Urethra Carcinoma Recurrent Urethral Cancer Recurrent Urethral Carcinoma Relapsed Cancer of Urethra Relapsed Cancer of the Urethra Relapsed Urethra Cancer Relapsed Urethra Carcinoma Relapsed Urethral Cancer Urethral Cancer, Recurrent Recurrent Urethral Carcinoma A malignant neoplasm either directly extending to the thyroid gland from adjacent structures (e.g. pharynx, larynx, esophagus, cervical lymph nodes), or spreading to the thyroid gland from distant anatomic sites, most frequently kidney, lung, uterus, breast, and skin. The majority of cases are carcinomas, lymphomas, and melanomas. C7509 Neoplastic Process Metastatic Malignant Neoplasm in the Thyroid Gland C0347023 Malignant Metastatic_Neoplasm_to_the_Thyroid_Gland Metastasis to the Thyroid Metastasis to the Thyroid Gland Metastatic Malignant Neoplasm in the Thyroid Gland Metastatic Malignant Neoplasm to the Thyroid Metastatic Malignant Neoplasm to the Thyroid Gland Metastatic Malignant Tumor to the Thyroid Metastatic Malignant Tumor to the Thyroid Gland Metastatic Neoplasm to the Thyroid Metastatic Neoplasm to the Thyroid Gland Metastatic Tumor to the Thyroid Metastatic Tumor to the Thyroid Gland Secondary Malignant Neoplasm to the Thyroid Secondary Malignant Neoplasm to the Thyroid Gland Secondary Malignant Tumor to the Thyroid Secondary Malignant Tumor to the Thyroid Gland Metastatic Malignant Neoplasm in the Thyroid Gland A primary or metastatic malignant neoplasm affecting the thyroid gland. C7510 Neoplastic Process Malignant Thyroid Gland Neoplasm C0007115 CPTAC mCode Malignant Malignant_Thyroid_Neoplasm Malignant neoplasm of thyroid gland Malignant Neoplasm of Thyroid Malignant Neoplasm of Thyroid Gland Malignant Neoplasm of the Thyroid Malignant Neoplasm of the Thyroid Gland Malignant Thyroid Gland Neoplasm Malignant Thyroid Gland Tumor Malignant Thyroid Neoplasm Malignant Thyroid Tumor Malignant Tumor of Thyroid Malignant Tumor of Thyroid Gland Malignant Tumor of the Thyroid Malignant Tumor of the Thyroid Gland Malignant neoplasm of thyroid gland Malignant Thyroid Gland Neoplasm The spread of a malignant neoplasm to the breast. This may be from a primary breast malignant neoplasm on the opposite side, or from a malignant neoplasm at a distant site. C7511 Neoplastic Process Metastatic Malignant Neoplasm in the Breast C0346993 CPTAC mCode Malignant Metastatic_Neoplasm_to_the_Breast Secondary malignant neoplasm of breast Breast Metastases Breast Metastasis Metastatic Cancer to the Breast Metastatic Malignant Neoplasm in the Breast Metastatic Malignant Neoplasm to the Breast Metastatic Neoplasm to the Breast Metastatic Tumor to the Breast Secondary malignant neoplasm of breast Metastatic Malignant Neoplasm in the Breast C7512 Neoplastic Process Malignant Esophageal Neoplasm by Anatomic Region C1334578 Header_Concept Malignant Malignant_Esophageal_Neoplasm_by_Anatomic_Region Malignant Esophageal Neoplasm by Anatomic Region Malignant Esophageal Neoplasm by Anatomic Region Esophageal segments used primarily in pathology, and distinct from the anatomic segments used for clinical purposes. C7513 Neoplastic Process Malignant Esophageal Neoplasm by Topographic Region C1334579 Header_Concept Malignant Malignant_Esophageal_Neoplasm_by_Topographic_Region Malignant Esophageal Neoplasm by Topographic Region Malignant Esophageal Neoplasm by Topographic Region A benign or malignant, primary or metastatic neoplasm affecting the kidney and ureter. C7514 Neoplastic Process Kidney and Ureter Neoplasm C1334323 Undetermined Kidney_and_Ureter_Neoplasm Kidney and Ureter Neoplasm Kidney and Ureter Tumor Renal and Ureteral Neoplasm Renal and Ureteral Tumor Kidney and Ureter Neoplasm Carcinoma that affects the renal pelvis and ureter. C7515 Neoplastic Process Renal Pelvis and Ureter Carcinoma Renal Pelvis and Ureter Carcinoma C1370932 CTRP Malignant Renal_Pelvis_and_Ureter_Carcinoma Carcinoma of the Upper Urinary Tract Renal Pelvis and Ureter Cancer Renal Pelvis and Ureter Carcinoma Upper Urinary Tract Carcinoma Renal Pelvis and Ureter Carcinoma Stage 0a includes: Ta, N0, M0. Ta: Papillary noninvasive carcinoma. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C7517 Neoplastic Process Stage 0a Renal Pelvis and Ureter Cancer AJCC v7 Stage 0a Renal Pelvis and Ureter Cancer AJCC v7 C1336101 CTRP Malignant Stage_0a_Renal_Pelvis_and_Ureter_Carcinoma Stage 0a Renal Pelvis and Ureter Cancer Stage 0a Renal Pelvis and Ureter Cancer AJCC v7 Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma AJCC v7 Stage 0a Renal Pelvis and Ureter Cancer AJCC v7 Stage 0is includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C7518 Neoplastic Process Stage 0is Renal Pelvis and Ureter Cancer AJCC v7 Stage 0is Renal Pelvis and Ureter Cancer AJCC v7 C1336104 CTRP Malignant Stage_0is_Renal_Pelvis_and_Ureter_Carcinoma Stage 0is Renal Pelvis and Ureter Cancer Stage 0is Renal Pelvis and Ureter Cancer AJCC v7 Stage 0is Renal Pelvis and Ureter Urothelial Carcinoma Stage 0is Renal Pelvis and Ureter Urothelial Carcinoma AJCC v7 Stage 0is Renal Pelvis and Ureter Cancer AJCC v7 Stage I includes: T1, N0, M0. T1: Tumor invades subepithelial connective tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C7519 Neoplastic Process Stage I Renal Pelvis and Ureter Cancer AJCC v7 Stage I Renal Pelvis and Ureter Cancer AJCC v7 C1336478 CTRP Cancer has spread through the lining of the renal pelvis and/or ureter, into the layer of connective tissue. Malignant Stage_I_Renal_Pelvis_and_Ureter_Carcinoma Stage I Renal Pelvis and Ureter Cancer Stage I Renal Pelvis and Ureter Cancer AJCC v7 Stage I Renal Pelvis and Ureter Carcinoma Stage I Renal Pelvis and Ureter Carcinoma AJCC v7 stage I transitional cell cancer of the renal pelvis and ureter Stage I Renal Pelvis and Ureter Cancer AJCC v7 Stage II includes: T2, N0, M0. T2: Tumor invades the muscularis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C7520 Neoplastic Process Stage II Renal Pelvis and Ureter Cancer AJCC v7 Stage II Renal Pelvis and Ureter Cancer AJCC v7 C1336314 CTRP Cancer has spread through the layer of connective tissue to the muscle layer of the renal pelvis and/or ureter. Malignant Stage_II_Renal_Pelvis_and_Ureter_Carcinoma Stage II Renal Pelvis and Ureter Cancer Stage II Renal Pelvis and Ureter Cancer AJCC v7 Stage II Renal Pelvis and Ureter Carcinoma Stage II Renal Pelvis and Ureter Carcinoma AJCC v7 stage II transitional cell cancer of the renal pelvis and ureter Stage II Renal Pelvis and Ureter Cancer AJCC v7 Stage III includes: T3, N0, M0. T3: For renal pelvis only: tumor invades beyond muscularis into peripelvic fat or the renal parenchyma. For ureter only: tumor invades beyond muscularis into periureteric fat. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C7521 Neoplastic Process Stage III Renal Pelvis and Ureter Cancer AJCC v7 Stage III Renal Pelvis and Ureter Cancer AJCC v7 C1336267 CTRP Cancer has spread either (1) to the layer of fat outside the renal pelvis and/or ureter; or (2) into the wall of the kidney. Malignant Stage_III_Renal_Pelvis_and_Ureter_Carcinoma Stage III Renal Pelvis and Ureter Cancer Stage III Renal Pelvis and Ureter Cancer AJCC v7 Stage III Renal Pelvis and Ureter Carcinoma Stage III Renal Pelvis and Ureter Carcinoma AJCC v7 stage III transitional cell cancer of the renal pelvis and ureter Stage III Renal Pelvis and Ureter Cancer AJCC v7 Stage IV includes: (T4, N0, M0); (Any T, N1, M0); (Any T, N2, M0); (Any T, N3, M0); (Any T, Any N, M1). T4: Tumor invades adjacent organs, or through the kidney into the perinephric fat. N0: No regional lymph node metastasis. N1: Metastasis in a single lymph node, 2 cm or less in greatest dimension. N2: Metastasis in a single lymph node, more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, none more than 5 cm in greatest dimension. N3: Metastasis in a lymph node, more than 5 cm in greatest dimension. M0: No distant metastasis. N1: Distant metastasis. (AJCC 7th ed.) C7522 Neoplastic Process Stage IV Renal Pelvis and Ureter Cancer AJCC v7 Stage IV Renal Pelvis and Ureter Cancer AJCC v7 C1336437 CTRP Cancer has spread to a nearby organ and/or to the layer of fat surrounding the kidney. Malignant Stage_IV_Renal_Pelvis_and_Ureter_Carcinoma Stage IV Renal Pelvis and Ureter Cancer Stage IV Renal Pelvis and Ureter Cancer AJCC v7 Stage IV Renal Pelvis and Ureter Carcinoma Stage IV Renal Pelvis and Ureter Carcinoma AJCC v7 stage IV transitional cell cancer of the renal pelvis and ureter Stage IV Renal Pelvis and Ureter Cancer AJCC v7 A primary or metastatic malignant neoplasm involving the small intestine. C7523 Neoplastic Process Malignant Small Intestinal Neoplasm Malignant Small Intestinal Neoplasm C0153425 CPTAC CTRP mCode Malignant Malignant_Small_Intestinal_Neoplasm Malignant neoplasm of ileum Malignant neoplasm of jejunum Malignant neoplasm of small intestine Malignant neoplasm of small intestine, including duodenum Malignant neoplasm of small intestine, unspecified Malignant neoplasm: Ileum Malignant neoplasm: Small intestine, unspecified Malignant Neoplasm of Small Bowel Malignant Neoplasm of Small Intestine Malignant Neoplasm of the Small Bowel Malignant Neoplasm of the Small Intestine Malignant Small Bowel Neoplasm Malignant Small Bowel Tumor Malignant Small Intestinal Neoplasm Malignant Small Intestine Neoplasm Malignant Small Intestine Tumor Malignant Tumor of Small Bowel Malignant Tumor of Small Intestine Malignant Tumor of the Small Bowel Malignant Tumor of the Small Intestine Malignant neoplasm of small intestine, unspecified Malignant Small Intestinal Neoplasm A malignant neoplasm that has spread to the small intestine from another anatomic site. C7524 Neoplastic Process Metastatic Malignant Neoplasm in the Small Intestine C0494164 mCode Malignant Metastasis_to_the_Small_Intestine Metastases to Small Intestine Metastasis to the Small Bowel Metastasis to the Small Intestine Metastatic Malignant Neoplasm in the Small Intestine Metastatic Malignant Neoplasm to the Small Intestine Metastatic Neoplasm to the Small Intestine Secondary Malignant Neoplasm to the Small Bowel Secondary Malignant Neoplasm to the Small Intestine Secondary Malignant Tumor to the Small Bowel Secondary Malignant Tumor to the Small Intestine Secondary malignant neoplasm of small intestine Metastatic Malignant Neoplasm in the Small Intestine A primary or metastatic malignant neoplasm that affects the renal pelvis. C7525 Neoplastic Process Malignant Renal Pelvis Neoplasm Malignant Renal Pelvis Neoplasm C0153618 CPTAC CTRP mCode Malignant Malignant_Renal_Pelvis_Neoplasm Malignant neoplasm of left renal pelvis Malignant neoplasm of renal pelvis Malignant neoplasm of right renal pelvis Malignant neoplasm of unspecified renal pelvis Malignant Neoplasm of Renal Pelvis Malignant Neoplasm of the Renal Pelvis Malignant Renal Pelvis Neoplasm Malignant Renal Pelvis Tumor Malignant Tumor of Renal Pelvis Malignant Tumor of the Renal Pelvis Malignant neoplasm of unspecified renal pelvis Malignant Renal Pelvis Neoplasm An intermediate, rarely metastasizing blood vessel neoplasm. It is characterized by the presence of lymphatic-like vascular channels and papillary endothelial proliferation. C7526 Neoplastic Process Papillary Intralymphatic Angioendothelioma C0346087 GDC 9135/1 Undetermined Endovascular_Papillary_Angioendothelioma 9135/1 Dabska tumor Endovascular papillary angioendothelioma Papillary intralymphatic angioendothelioma Dabska Tumor Dabska tumor Endovascular papillary angioendothelioma Malignant Endothelial Papillary Angioendothelioma PILA Papillary Endovascular Angioendothelioma Papillary Intralymphatic Angioendothelioma Papillary Intralymphatic Angioendothelioma A malignant neoplasm originating from the apical lung. Most malignant superior sulcus neoplasms are bronchogenic carcinomas. This tumor may be associated with Pancoast syndrome. It is also known as Pancoast tumor. C7527 Neoplastic Process Malignant Superior Sulcus Neoplasm C0549471 A type of lung cancer that begins in the upper part of a lung and spreads to nearby tissues such as the ribs and vertebrae. Most Pancoast tumors are non-small cell cancers. Malignant Malignant_Superior_Sulcus_Neoplasm Malignant Superior Sulcus Lung Neoplasm Malignant Superior Sulcus Lung Tumor Malignant Superior Sulcus Neoplasm Malignant Superior Sulcus Neoplasm of Lung Malignant Superior Sulcus Neoplasm of the Lung Malignant Superior Sulcus Tumor Malignant Superior Sulcus Tumor of Lung Malignant Superior Sulcus Tumor of the Lung Pancoast Tumor Pancoast tumor Pancoast's Tumor Malignant Superior Sulcus Neoplasm An aggressive follicular helper T-cell lymphoma affecting lymph nodes and other sites. It is characterized by a polymorphous infiltrate and prominent proliferation of high endothelial venules and follicular dendritic cells. It is associated with EBV infection and affects mainly older adults. C7528 Neoplastic Process Angioimmunoblastic T-Cell Lymphoma Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type C0020981 CPTAC CTRP GDC mCode An aggressive (fast-growing) type of T-cell non-Hodgkin lymphoma marked by enlarged lymph nodes and hypergammaglobulinemia (increased antibodies in the blood). Other symptoms may include a skin rash, fever, weight loss, or night sweats. 9705/3 9767/1 Malignant Angioimmunoblastic_T-Cell_Lymphoma 9705/3 9767/1 Angioimmunoblastic T-cell lymphoma Angioimmunoblastic lymphadenopathy Angioimmunoblastic lymphadenopathy (AIC) Angioimmunoblastic lymphadenopathy (AIL) Angioimmunoblastic lymphoma Peripheral T-cell lymphoma, AILD (Angioimmunoblastic Lymphadenopathy with Dysproteinemia) AILD AITL Angioimmunoblastic Lymphadenopathy Angioimmunoblastic Lymphadenopathy Type T-Cell Lymphoma Angioimmunoblastic Lymphadenopathy with Dysproteinemia Angioimmunoblastic T-Cell Lymphoma Angioimmunoblastic T-cell lymphoma Angioimmunoblastic lymphadenopathy Follicular Helper T-Cell Lymphoma, Angioimmunoblastic Type (Angioimmunoblastic T-Cell Lymphoma) Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type angioimmunoblastic T-cell lymphoma Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type The reemergence of visual pathway glioma in childhood after a period of remission. C7529 Neoplastic Process Recurrent Childhood Visual Pathway Glioma Recurrent Childhood Visual Pathway Glioma C0338336 CTRP Undetermined Recurrent_Childhood_Visual_Pathway_Glioma Recurrent Childhood Visual Pathway Glioma Recurrent Glioma of Childhood Visual Pathway Recurrent Glioma of Pediatric Visual Pathway Recurrent Glioma of the Childhood Visual Pathway Recurrent Glioma of the Pediatric Visual Pathway Recurrent Pediatric Visual Pathway Glioma Recurrent Visual Pathway Glioma Relapsed Childhood Visual Pathway Glioma Relapsed Glioma of Childhood Visual Pathway Relapsed Glioma of Pediatric Visual Pathway Relapsed Glioma of the Childhood Visual Pathway Relapsed Glioma of the Pediatric Visual Pathway Relapsed Pediatric Visual Pathway Glioma Recurrent Childhood Visual Pathway Glioma The reemergence of visual pathway astrocytoma in childhood after a period of remission. C7530 Neoplastic Process Recurrent Childhood Visual Pathway Astrocytoma C1335699 Undetermined Recurrent_Childhood_Visual_Pathway_Astrocytoma Recurrent Childhood Visual Pathway Astrocytoma Recurrent Pediatric Visual Pathway Astrocytoma Recurrent Childhood Visual Pathway Astrocytoma The reemergence of optic nerve glioma in childhood after a period of remission. C7531 Neoplastic Process Recurrent Childhood Optic Nerve Glioma Recurrent Childhood Optic Nerve Glioma C1370943 CTRP Undetermined Recurrent_Childhood_Optic_Nerve_Glioma Recurrent Childhood Optic Nerve Glioma Recurrent Optic Nerve Glioma Recurrent Pediatric Optic Nerve Glioma Recurrent Childhood Optic Nerve Glioma The reemergence of optic nerve astrocytoma in childhood after a period of remission. C7532 Neoplastic Process Recurrent Childhood Optic Nerve Astrocytoma C1335698 Undetermined Recurrent_Childhood_Optic_Nerve_Astrocytoma Recurrent Childhood Optic Nerve Astrocytoma Recurrent Pediatric Optic Nerve Astrocytoma Recurrent Childhood Optic Nerve Astrocytoma An astrocytoma that affects the visual pathway. This condition can be seen in association with neurofibromatosis 1. It is most commonly seen in the pediatric age group. C7533 Neoplastic Process Visual Pathway Astrocytoma C1336971 Undetermined Visual_Pathway_Astrocytoma Visual Pathway Astrocytoma Visual Pathway Astrocytoma An astrocytoma that arises from the visual pathway and occurs during childhood. C7534 Neoplastic Process Childhood Visual Pathway Astrocytoma C1333014 NICHD An astrocytoma affecting the optic tract that occurs during childhood. Undetermined Childhood_Visual_Pathway_Astrocytoma Childhood Visual Pathway Astrocytoma Pediatric Visual Pathway Astrocytoma Childhood Visual Pathway Astrocytoma A glioma that arises from the visual pathway and occurs during childhood. C7535 Neoplastic Process Childhood Visual Pathway Glioma Childhood Visual Pathway Glioma CL448377 CTRP NICHD A glioma that arises from the visual pathway and occurs during childhood. Undetermined Childhood_Visual_Pathway_Glioma Childhood Visual Pathway Glioma Glioma of Childhood Visual Pathway Glioma of Pediatric Visual Pathway Glioma of the Childhood Visual Pathway Glioma of the Pediatric Visual Pathway Pediatric Visual Pathway Glioma Visual Pathway Glioma Childhood Visual Pathway Glioma A meningioma that affects the anterior visual pathway. C7538 Neoplastic Process Anterior Visual Pathway Meningioma C1332308 Undetermined Anterior_Visual_Pathway_Meningioma Anterior Visual Pathway Meningioma Anterior Visual Pathway Meningioma A malignant lymphocytic neoplasm of B-cell or T-cell lineage involving primarily the bone marrow and the peripheral blood. This category includes precursor or acute lymphoblastic leukemias and chronic leukemias. C7539 Neoplastic Process Lymphoid Leukemia Lymphoid Leukemia C0023448 CDISC CPTAC CTRP Cellosaurus GDC A progressive, proliferative disease of blood cells, originating from lymphoid cells. A type of cancer in which the bone marrow makes too many lymphocytes (white blood cells). 981-983 9820/3 Malignant Lymphoid_Leukemia 9820/3 Lymphatic leukemic, NOS Lymphocytic leukemia, NOS Lymphoid Leukemias Lymphoid leukaemia Lymphoid leukaemia, unspecified Lymphoid leukemia Lymphoid leukemia, NOS Lymphoid leukemia, subacute Lymphoid leukemia, unspecified not having achieved remission Lymphosarcoma cell leukemia Other lymphoid leukemia Other lymphoid leukemia not having achieved remission Other lymphoid leukemia without mention of having achieved remission Unspecified lymphoid leukemia Unspecified lymphoid leukemia without mention of having achieved remission LEUKEMIA, LYMPHOCYTIC, MALIGNANT Lymphocytic Leukemia Lymphogenous Leukemia Lymphoid Leukemia Lymphoid leukemia, NOS lymphocytic leukemia Lymphoid Leukemia A non-Hodgkin lymphoma composed of monomorphic small, round B-lymphocytes in the lymph nodes. When the lymphoid process predominantly involves the bone marrow and the peripheral blood it is called chronic lymphocytic leukemia. (WHO, 2001) C7540 Neoplastic Process Small Lymphocytic Lymphoma Small Lymphocytic Lymphoma C0855095 CDISC CPTAC CTEP CTRP Cellosaurus GDC mCode A malignant neoplasm composed of small lymphocytes. An indolent (slow-growing) type of lymphoma in which too many immature lymphocytes (white blood cells) are found mostly in the lymph nodes. This causes the lymph nodes to become larger than normal. Sometimes cancer cells are found in the blood and bone marrow, and the disease is called chronic lymphocytic leukemia. The disease is most often seen in people older than 50 years. SLL is a type of non-Hodgkin Lymphoma. 9670/3 Malignant Small_Lymphocytic_Lymphoma 9670/3 Malignant lymphoma, lymphocytic, NOS Malignant lymphoma, lymphocytic, diffuse, NOS Malignant lymphoma, lymphocytic, well differentiated, diffuse Malignant lymphoma, small B lymphocytic, NOS Malignant lymphoma, small cell diffuse Malignant lymphoma, small cell, NOS Malignant lymphoma, small lymphocytic, NOS Malignant lymphoma, small lymphocytic, diffuse Small cell B-cell lymphoma Small cell B-cell lymphoma, unspecified site B-Cell Small Lymphocytic Lymphoma Diffuse Well Differentiated Lymphocytic Lymphoma LYMPHOMA, SMALL LYMPHOCYTIC, MALIGNANT Lymphoma, Lymphocytic, Malignant SLL Small B-Cell Lymphocytic Lymphoma Small Lymphocytic Lymphoma Small cell B-cell lymphoma, unspecified site Small lymphocytic lymphoma, NOS small lymphocytic lymphoma well-differentiated lymphocytic lymphoma Small Lymphocytic Lymphoma A malignant tumor that originates in the nuclear layer of the retina. As the most common primary tumor of the eye in children, retinoblastoma is still relatively uncommon, accounting for only 1% of all malignant tumors in pediatric patients. Approximately 95% of cases are diagnosed before age 5. These tumors may be multifocal, bilateral, congenital, inherited, or acquired. Seventy-five percent of retinoblastomas are unilateral; 60% occur sporadically. A predisposition to retinoblastoma has been associated with 13q14 cytogenetic abnormalities. Patients with the inherited form also appear to be at increased risk for secondary nonocular malignancies such as osteosarcoma, malignant fibrous histiocytoma, and fibrosarcoma. C7541 Neoplastic Process Retinoblastoma Retinoblastoma C0035335 CDISC CPTAC CTEP CTRP Cellosaurus GDC MedDRA NICHD PCDC A malignant neoplasm originating in the nuclear layer of the retina. A malignant tumor that originates in the nuclear layer of the retina. As the most common primary tumor of the eye in children, retinoblastoma is still relatively uncommon, accounting for only 1% of all malignant tumors in pediatric patients. Approximately 95% of cases are diagnosed before age 5. These tumors may be multifocal, bilateral, congenital, inherited, or acquired. Seventy-five percent of retinoblastomas are unilateral; 60% occur sporadically. A predisposition to retinoblastoma has been associated with 13q14 cytogenetic abnormalities. Patients with the inherited form also appear to be at increased risk for secondary nonocular malignancies such as osteosarcoma, malignant fibrous histiocytoma, and fibrosarcoma. Cancer that forms in the tissues of the retina (the light-sensitive layers of nerve tissue at the back of the eye). Retinoblastoma usually occurs in children younger than 5 years. It may be hereditary or nonhereditary (sporadic). 9510/3 Malignant Retinoblastoma 9510/3 Retinoblastoma Retinoblastoma, NOS RB RETINOBLASTOMA, MALIGNANT Retinoblastoma Retinoblastoma, NOS retinoblastoma Retinoblastoma A primitive neuroectodermal tumor (small round blue cell tumor) of the thorax which can involve the periosteum, thoracic wall and/or pleura though it spares the lung parenchyma. C7542 Neoplastic Process Askin Tumor Askin Tumor C0877849 CTRP Cellosaurus GDC 9365/3 Malignant Askin_s_Tumor 9365/3 Askin tumor Askin Tumor Askin tumor Askin's Tumor PNET of Thoracopulmonary Region Peripheral Neuroectodermal Tumor of Thoracopulmonary Region Small Cell Tumor of Thoracopulmonary Region Askin Tumor A primary or metastatic malignant tumor involving the ureter. The majority are carcinomas. C7543 Neoplastic Process Malignant Ureter Neoplasm Malignant Ureter Neoplasm C0153619 CPTAC CTRP mCode Malignant Malignant_Ureter_Neoplasm Malignant neoplasm of right ureter Malignant neoplasm of ureter Malignant neoplasm of ureteric orifice Malignant Neoplasm of Ureter Malignant Neoplasm of the Ureter Malignant Tumor of Ureter Malignant Tumor of the Ureter Malignant Ureter Neoplasm Malignant Ureter Tumor Malignant Ureteral Neoplasm Malignant Ureteral Tumor Malignant neoplasm of unspecified ureter Malignant Ureter Neoplasm A malignant neoplasm that has spread to the ureter from another anatomic site. C7544 Neoplastic Process Metastatic Malignant Neoplasm in the Ureter C0347010 Malignant Metastatic_Neoplasm_to_the_Ureter Metastasis to the Ureter Metastatic Malignant Neoplasm in the Ureter Metastatic Malignant Neoplasm to the Ureter Metastatic Neoplasm to the Ureter Metastatic Tumor to the Ureter Metastatic Malignant Neoplasm in the Ureter A primary or metastatic malignant neoplasm that affects the pharynx. C7545 Neoplastic Process Malignant Pharyngeal Neoplasm Malignant Pharyngeal Neoplasm C0153405 CPTAC CTRP mCode Malignant Malignant_Pharyngeal_Neoplasm Malignant neoplasm of pharynx, unspecified Malignant neoplasm: Pharynx, unspecified Malignant Pharyngeal Neoplasm Malignant Pharyngeal Tumor Malignant Pharynx Neoplasm Malignant Pharynx Tumor Malignant Tumor of Pharynx Malignant Tumor of the Pharynx Malignant neoplasm of pharynx, unspecified Malignant Pharyngeal Neoplasm A malignant neoplasm that has spread to the pharynx from another anatomic site. C7546 Neoplastic Process Metastatic Malignant Neoplasm in the Pharynx C0684963 Malignant Metastatic_Neoplasm_to_the_Pharynx Metastasis to the Pharynx Metastatic Malignant Neoplasm in the Pharynx Metastatic Malignant Neoplasm to the Pharynx Metastatic Neoplasm to the Pharynx Metastatic Tumor to the Pharynx Metastatic Malignant Neoplasm in the Pharynx A primary or metastatic malignant neoplasm that affects the penis. Representative examples include penile carcinoma and penile sarcoma. C7547 Neoplastic Process Malignant Penile Neoplasm C0153601 CPTAC mCode Malignant Malignant_Penile_Neoplasm Malignant neoplasm of body of penis Malignant neoplasm of glans penis Malignant neoplasm of penis Malignant neoplasm of penis, part unspecified Malignant Neoplasm of Penis Malignant Neoplasm of the Penis Malignant Penile Neoplasm Malignant Penile Tumor Malignant Tumor of Penis Malignant Tumor of the Penis Malignant neoplasm of penis, unspecified Malignant Penile Neoplasm Primary or metastatic malignant neoplasm involving the kidney. C7548 Neoplastic Process Malignant Kidney Neoplasm Malignant Kidney Neoplasm C0740457 CPTAC CTRP Malignant Malignant_Renal_Neoplasm Malignant carcinoid tumor of the kidney Malignant Kidney Neoplasm Malignant Kidney Tumor Malignant Neoplasm of Kidney Malignant Neoplasm of the Kidney Malignant Renal Neoplasm Malignant Renal Tumor Malignant Tumor of Kidney Malignant Tumor of the Kidney Malignant Kidney Neoplasm The spread of a malignant neoplasm to the kidney. This may be from a primary kidney malignant neoplasm involving the opposite kidney, or from a malignant neoplasm at a distant site. C7549 Neoplastic Process Metastatic Malignant Neoplasm in the Kidney C0153685 mCode Malignant Metastatic_Neoplasm_to_the_Kidney Metastases to Kidney Metastases to the Kidney Metastasis to Kidney Metastasis to the Kidney Metastatic Malignant Neoplasm in the Kidney Metastatic Malignant Neoplasm to the Kidney Metastatic Neoplasm to the Kidney Metastatic Tumor to the Kidney Renal Metastases Renal Metastasis Secondary malignant neoplasm of kidney and renal pelvis Secondary malignant neoplasm of unspecified kidney and renal pelvis Metastatic Malignant Neoplasm in the Kidney An adenocarcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that, in well differentiated tumors, resemble the epithelium of the fallopian tube or, in poorly differentiated tumors, show anaplastic features and marked nuclear atypia. C7550 Neoplastic Process Ovarian Serous Adenocarcinoma Ovarian Serous Adenocarcinoma C1335177 CPTAC CTRP Cellosaurus Malignant Ovarian_Serous_Adenocarcinoma Ovarian Serous Adenocarcinoma Ovarian Serous Carcinoma Serous Adenocarcinoma of Ovary Serous Adenocarcinoma of the Ovary Serous Carcinoma of Ovary Serous Carcinoma of the Ovary Serous carcinoma Ovarian Serous Adenocarcinoma Stage III includes: T3, N0, M0, Any G. T3: Tumor extends through the prostatic capsule. T3a: Extracapsular extension (unilateral or bilateral). T3b: Tumor invades seminal vesicle(s). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C7551 Neoplastic Process Stage III Prostate Cancer AJCC v6 Stage III Prostate Cancer AJCC v6 C0278836 CTRP Cancer has spread beyond the outer layer of the prostate on one or both sides and may have spread to the seminal vesicles (glands that help produce semen). The prostate-specific antigen (PSA) level can be any level and the Gleason score can range from 2 to 10. Malignant Stage_III_Prostate_Cancer Cancer of Prostate Stage III AJCC v6 Cancer of the Prostate Stage III AJCC v6 Prostate Cancer Stage III AJCC v6 Prostate Carcinoma Stage III AJCC v6 Stage III Cancer of Prostate AJCC v6 Stage III Cancer of the Prostate AJCC v6 Stage III Prostate Cancer Stage III Prostate Cancer AJCC v6 Stage III Prostate Carcinoma AJCC v6 Stage III Prostatic Cancer AJCC v6 Stage III Prostatic Carcinoma AJCC v6 stage III prostate cancer Stage III Prostate Cancer AJCC v6 Tumor is clinically localized to the periprostatic area, but extends through the prostatic capsule; the seminal vesicles may be involved. C7552 Neoplastic Process Stage C Prostate Cancer Stage C Prostate Cancer C1370962 CTRP A prostate cancer stage defined by the Jewett staging system. Stage C prostate cancer is cancer that began in the prostate, has grown beyond the outer layer of the prostate to nearby tissues, and may be found in the seminal vesicles (glands that help produce semen). Stage C is divided into stages C1 and C2. In stage C1, the cancer has grown outside the prostate but has not spread to lymph nodes or other places in the body. In stage C2, the cancer has grown outside the prostate and blocks urine flow from the bladder or through the ureters. Malignant Stage_C_Prostate_Cancer Stage C Prostate Cancer Stage C Prostate Carcinoma stage C prostate cancer Stage C Prostate Cancer Stage II includes: (T1a, N0, M0, G2, 3-4); (T1b, N0, M0, Any G); (T1c, N0, M0, Any G); (T1, N0, M0, Any G); (T2, N0, M0, Any G). T1: Clinically inapparent tumor neither palpable nor visible by imaging. T1a: Tumor incidental histologic finding in 5% of tissue resected. T1c: Tumor identified by needle biopsy (e.g. because of elevated PSA). T2: Tumor confined with in the prostate. N0: No regional lymph node metastasis. M0: No distant metastasis. G2: Moderately differentiated (moderate anaplasia) (Gleason 5-6). G 3-4: Poorly differentiated/undifferentiated (marked anaplasia) (Gleason 7-10). (AJCC 6th ed.) C7553 Neoplastic Process Stage II Prostate Cancer AJCC v6 Stage II Prostate Cancer AJCC v6 C0278835 CTRP Stage II prostate cancer is divided into stages IIA and IIB. In stage IIA, cancer is found (1) by needle biopsy or in a small amount of tissue during surgery for other reasons; the prostate-specific antigen (PSA) level is lower than 20 and the Gleason score is 7; or (2) by needle biopsy or in a small amount of tissue during surgery for other reasons; the PSA level is at least 10 but lower than 20 and the Gleason score is 6 or lower; or (3) in one-half or less of one lobe of the prostate; the PSA level is at least 10 but lower than 20 and the Gleason score is 6 or lower; or (4) in one-half or less of one lobe of the prostate; the PSA level is lower than 20 and the Gleason score is 7; or (5) in more than one-half of one lobe of the prostate; the PSA level is lower than 20 and the Gleason score is 7 or lower; or (6) in more than one-half of one lobe of the prostate, and the PSA level and Gleason score are not known. In stage IIB, cancer (1) is found in both lobes of the prostate; the PSA can be any level and the Gleason score can range from 2 to 10; or (2) cannot be felt during a digital rectal exam and is not visible by imaging, and the tumor has not spread outside the prostate; the PSA level is 20 or higher and the Gleason score can range from 2 to 10; or (3) cannot be felt during a digital rectal exam and is not visible by imaging, and the tumor has not spread outside the prostate; the PSA can be any level and the Gleason score is 8 or higher. Malignant Stage_II_Prostate_Cancer Cancer of Prostate Stage II AJCC v6 Cancer of the Prostate Stage II AJCC v6 Prostate Cancer Stage II AJCC v6 Prostate Carcinoma Stage II AJCC v6 Stage II Cancer of Prostate AJCC v6 Stage II Cancer of the Prostate AJCC v6 Stage II Prostate Cancer Stage II Prostate Cancer AJCC v6 Stage II Prostate Carcinoma AJCC v6 Stage II Prostatic Cancer AJCC v6 Stage II Prostatic Carcinoma AJCC v6 stage II prostate cancer Stage II Prostate Cancer AJCC v6 Tumor is clinically palpable but confined to the prostate. C7554 Neoplastic Process Stage B Prostate Cancer Stage B Prostate Cancer C1370963 CTRP A prostate cancer stage defined by the Jewett staging system. Stage B prostate cancer is cancer that began in the prostate and is more advanced than stage A, but has not spread outside the prostate. Stage B is divided into stages B0, B1, and B2. In stage B0, the cancer is detected only by increased blood levels of PSA (prostate-specific antigen). In stage B1, cancer is in one area of one lobe of the prostate. In stage B2, there is more cancer in one or both lobes of the prostate. Malignant Stage_B_Prostate_Cancer Stage B Prostate Cancer Stage B Prostate Carcinoma Stage B Prostatic Cancer Stage B Prostatic Carcinoma stage B prostate cancer Stage B Prostate Cancer Stage I includes: T1, N0, M0, G1. T1: Tumor invades subepithelial connective tissue. N0: No regional metastasis. M0: No distant metastasis. G1: Well differentiated (slight anaplasia) (Gleason 2-4). (AJCC 6th ed.) C7555 Neoplastic Process Stage I Prostate Cancer AJCC v6 Stage I Prostate Cancer AJCC v6 C0278834 CTRP Cancer is found in the prostate only. The cancer (1) is found by needle biopsy or in a small amount of tissue during surgery for other reasons; the prostate-specific antigen (PSA) level is lower than 10 and the Gleason score is 6 or lower; or (2) is found in one-half or less of one lobe of the prostate; the PSA level is lower than 10 and the Gleason score is 6 or lower; or (3) cannot be felt during a digital rectal exam and is not visible by imaging; cancer is found in one-half or less of one lobe of the prostate and the PSA level and Gleason score are not known. Malignant Stage_I_Prostate_Cancer Cancer of Prostate Stage I AJCC v6 Cancer of the Prostate Stage I AJCC v6 Prostate Cancer Stage I AJCC v6 Prostate Carcinoma Stage I AJCC v6 Stage I Cancer of Prostate AJCC v6 Stage I Cancer of the Prostate AJCC v6 Stage I Prostate Cancer Stage I Prostate Cancer AJCC v6 Stage I Prostate Carcinoma AJCC v6 Stage I Prostatic Cancer AJCC v6 Stage I Prostatic Carcinoma AJCC v6 stage I prostate cancer Stage I Prostate Cancer AJCC v6 A clinically undetectable tumor confined to the prostate gland, normally an incidental finding during surgery. C7556 Neoplastic Process Stage A Prostate Cancer Stage A Prostate Cancer C1370970 CTRP A prostate cancer stage defined by the Jewett staging system. Stage A prostate cancer is cancer that began in the prostate and is found in the prostate only. It is usually found during surgery for other reasons, such as benign prostatic hyperplasia (a condition in which an overgrowth of prostate tissue occurs). Stage A is divided into stages A1 and A2. In stage A1, the cancer cells do not look very different from normal cells. In stage A2, the cancer cells look more abnormal or are in several areas in the prostate. Malignant Stage_A_Prostate_Cancer Stage A Prostate Cancer Stage A Prostate Carcinoma stage A prostate cancer Stage A Prostate Cancer A malignant tumor arising from the epithelium that lines the cavity of the uterine body. The vast majority of endometrial carcinomas are adenocarcinomas; squamous cell and adenosquamous carcinomas represent a minority of the cases. Endometrioid adenocarcinoma is the most frequently seen variant of endometrial adenocarcinoma. Uterine bleeding is an initial clinical sign. The prognosis depends on the stage of the tumor, the depth of myometrial wall invasion, and the degree of differentiation. C7558 Neoplastic Process Endometrial Carcinoma Endometrial Carcinoma C0476089 CDISC CPTAC CTRP Cellosaurus GDC A malignant epithelial neoplasm arising from the lining of the uterine body cavity. Cancer that forms in the tissue lining the uterus (the small, hollow, pear-shaped organ in a woman's pelvis in which a fetus develops). Most endometrial cancers are adenocarcinomas (cancers that begin in cells that make and release mucus and other fluids). Malignant Endometrial_Carcinoma 81 CARCINOMA, ENDOMETRIAL, MALIGNANT Carcinoma of Endometrium Carcinoma of the Endometrium Endometrial Cancer Endometrial Carcinoma UCEC Uterine Corpus Endomential Carcinoma endometrial cancer Endometrial Carcinoma A benign epithelial neoplasm arising from the sweat glands. Representative examples include tubular apocrine adenoma, syringofibroadenoma, and hidradenoma. C7560 Neoplastic Process Sweat Gland Adenoma C0019522 CDISC GDC A benign epithelias neoplasm arising from sweat glands. 8400/0 Benign Sweat_Gland_Adenoma 8400/0 Sweat gland adenoma ADENOMA, SWEAT GLAND, BENIGN Adenoma of Sweat Gland Adenoma of the Sweat Gland Sweat Gland Adenoma Sweat gland adenoma Sweat Gland Adenoma A benign epithelial neoplasm arising from the sweat glands. Variants include the clear cell, nodular, and solid cystic hidradenoma. C7563 Neoplastic Process Hidradenoma C0206671 GDC Benign Hidradenoma 8400/0 8402/0 Eccrine acrospiroma Hidradenoma, NOS Acrospiroma Eccrine Acrospiroma Eccrine acrospiroma Hidradenoma Hidradenoma, NOS Hidradenoma A benign sweat gland cystic lesion that arises from the dermis. It is lined by a thin epithelial layer of cells with a slightly eosinophilic cytoplasm. C7565 Neoplastic Process Eccrine Hidrocystoma C1704334 GDC Benign Eccrine_Cystadenoma 8404/0 Eccrine cystadenoma Eccrine Cystadenoma Eccrine Hidrocystoma Eccrine cystadenoma Eccrine Hidrocystoma A carcinoma that arises from the breast and is not caused by inherited genetic mutations. C7566 Neoplastic Process Sporadic Breast Carcinoma Sporadic Breast Carcinoma C1336076 CTRP Malignant Sporadic_Breast_Carcinoma Sporadic Breast Cancer Sporadic Breast Carcinoma Sporadic Breast Carcinoma A hidradenoma with apocrine differentiation. It is characterized by the presence of cells with vesicular nuclei and eosinophilic cytoplasm and cells with clear cytoplasm and often eccentrically located nuclei. C7567 Neoplastic Process Clear Cell Hidradenoma C1370701 GDC Benign Clear_Cell_Hidradenoma 8402/0 Clear cell hidradenoma Clear Cell Hidradenoma Clear cell hidradenoma Hidradenoma with Apocrine Differentiation Clear Cell Hidradenoma A hidradenoma characterized by a nodular growth pattern. It presents as a nodular lesion usually in the scalp, trunk, and proximal extremities. Complete excision is curative. C7568 Neoplastic Process Nodular Hidradenoma C1370700 GDC 8402/0 Benign Nodular_Hidradenoma 8402/0 Nodular hidradenoma Nodular Hidradenoma Nodular hidradenoma Nodular Hidradenoma A diverse group of carcinomas of the thymus gland, previously known as thymoma type C. It includes morphologic variants derived from purely epithelial cells, as well as from cells with neuroendocrine differentiation. C7569 Neoplastic Process Thymic Carcinoma Thymic Carcinoma C0205969 CPTAC CTRP Cellosaurus GDC A rare type of thymus gland cancer. It usually spreads, has a high risk of recurrence, and has a poor survival rate. Thymic carcinoma is divided into subtypes, depending on the types of cells in which the cancer began. 8586/3 Malignant Thymoma_Type_C 8586/3 Thymic carcinoma, NOS Thymoma, type C Thymic Carcinoma Thymic Carcinoma (Excluding Well Differentiated Thymic Carcinoma) Thymic Carcinoma Excluding Well Differentiated Thymic Carcinoma Thymoma Type C thymic carcinoma type C thymoma Thymic Carcinoma A circumscribed proliferation of melanocytes in the skin. It is characterized by the absence of atypical or malignant cytological features, and absence of invasive features or metastatic potential. Variants include the Spitz nevus, halo nevus, blue nevus, and balloon cell nevus. C7571 Neoplastic Process Benign Skin Melanocytic Nevus C1456781 Benign Benign_Melanocytic_Nevus Benign Melanocytic Nevus of Skin Benign Melanocytic Nevus of the Skin Benign Nevus of Skin Benign Nevus of the Skin Benign Skin Melanocytic Nevus Benign Skin Nevus Benign Skin Melanocytic Nevus A type of renal carcinoma affecting mostly young African-Americans. It is located in the medulla of the kidney, and follows an aggressive clinical course. Most reported cases have shown metastatic disease at the time of diagnosis. C7572 Neoplastic Process Kidney Medullary Carcinoma C4049328 Cellosaurus GDC Malignant Renal_Medullary_Carcinoma Renal medullary carcinoma Kidney Medullary Carcinoma Renal Medullary Carcinoma Renal medullary carcinoma Kidney Medullary Carcinoma A malignant neoplasm that has spread to the urethra from another anatomic site. C7573 Neoplastic Process Metastatic Malignant Neoplasm in the Urethra C0347012 Malignant Metastatic_Neoplasm_to_the_Urethra Metastasis to the Urethra Metastatic Malignant Neoplasm in the Urethra Metastatic Malignant Neoplasm to the Urethra Metastatic Neoplasm to the Urethra Metastatic Malignant Neoplasm in the Urethra An unusual, biphasic benign or malignant neoplasm that arises from the prostate gland. It is characterized by the presence of an epithelial glandular component and a proliferating stroma. C7574 Neoplastic Process Prostate Phyllodes Tumor C1335409 Undetermined Phyllodes_Tumor_of_the_Prostate Cystosarcoma Phyllodes of Prostate Cystosarcoma Phyllodes of the Prostate Phyllodes Neoplasm of Prostate Phyllodes Neoplasm of the Prostate Phyllodes Tumor of Prostate Phyllodes Tumor of the Prostate Prostate Cystosarcoma Phyllodes Prostate Phyllodes Neoplasm Prostate Phyllodes Tumor Prostate Phyllodes Tumor A benign, malignant, or borderline circumscribed biphasic neoplasm that arises from the breast. It usually affects middle-aged women. It is characterized by the presence of a double layer of epithelial cells that are arranged in clefts, surrounded by a spindle cell mesenchymal (stromal) component. C7575 Neoplastic Process Breast Phyllodes Tumor C0238031 CTEP Undetermined Phyllodes_Tumor_of_the_Breast Breast Cystosarcoma Phyllodes Breast Phyllodes Neoplasm Breast Phyllodes Tumor Cystosarcoma Phyllodes of Breast Cystosarcoma Phyllodes of the Breast Cystosarcoma phylloides - breast Cystosarcoma phylloides of the breast Phyllodes Breast Neoplasm Phyllodes Breast Tumor Phyllodes Neoplasm of Breast Phyllodes Neoplasm of the Breast Phyllodes Tumor of Breast Phyllodes Tumor of the Breast Breast Phyllodes Tumor A nevus that recurs after incomplete surgical removal, biopsy, or trauma. (WHO 2018) C7577 Neoplastic Process Recurrent Nevus C1335715 Benign Recurrent_Nevus Persistent Nevus Pseudomelanoma Recurrent Nevus Traumatized Nevus Recurrent Nevus A nevus that arises from the female genital organs. This category includes congenital nevus, acquired nevus, dysplastic nevus, blue nevus, and atypical melanocytic nevus of the genital type. C7578 Neoplastic Process Nevus of Female Genitalia C1518315 Undetermined Nevus_of_External_Female_Genitalia Nevus of Female Genitalia Nevus of Female Genitalia A benign epithelial neoplasm arising from the sebaceous or sweat glands. Representative examples include sebaceous adenoma, tubular apocrine adenoma, and hidradenoma. C7580 Neoplastic Process Skin Appendage Adenoma C0334342 CDISC GDC A benign epithelial neoplasm arising from the sebaceous or sweat glands. 8390/0 Benign Skin_Appendage_Adenoma 8390/0 Adnexal tumor, benign Skin appendage adenoma ADENOMA, ADNEXAL, BENIGN Adenoma of Adnexa Adenoma of Skin Appendage Adnexal Adenoma Skin Appendage Adenoma Skin appendage adenoma Skin Appendage Adenoma A low grade adenocarcinoma with ductal differentiation, arising from the sweat glands. It presents as a scar usually in the face. It is characterized by the formation of small ducts and it frequently involves nerves and perineural spaces. C7581 Neoplastic Process Microcystic Adnexal Carcinoma C0346027 GDC 8407/3 Malignant Microcystic_Adnexal_Carcinoma 8407/3 Microcystic adnexal carcinoma Sclerosing sweat duct carcinoma Syringomatous carcinoma Eccrine Epithelioma Microcystic Adnexal Carcinoma Microcystic adnexal carcinoma Syringomatous Carcinoma Syringomatous carcinoma Microcystic Adnexal Carcinoma A lymphoma that occurs in adults. C7587 Neoplastic Process Adult Lymphoma Adult Lymphoma C1332206 CPTAC CTRP Malignant Adult_Lymphoma Adult Lymphoma Lymphoma Adult Lymphoma A lung carcinoma characterized by the presence of large or small neuroendocrine carcinoma cells in combination with malignant glandular or squamous epithelial cells. C7591 Neoplastic Process Combined Lung Carcinoma Combined Lung Carcinoma C1333123 CTRP Malignant Combined_Lung_Carcinoma Combined Carcinoma of Lung Combined Carcinoma of the Lung Combined Lung Cancer Combined Lung Carcinoma Combined Lung Carcinoma An infiltrating malignant tumor characterized by the presence of atypical cells with myoepithelial differentiation. Representative examples include malignant breast myoepithelioma and salivary gland myoepithelial carcinoma. C7596 Neoplastic Process Malignant Myoepithelioma C0334699 CDISC CPTAC GDC A malignant neoplasm composed of myoepithelial cells. 8982/3 Malignant Myoepithelial_Carcinoma 8982/3 Malignant myoepithelioma Myoepithelial carcinoma MYOEPITHELIOMA, MALIGNANT Malignant Myoepithelioma Malignant myoepithelioma Myoepithelial Carcinoma Myoepithelial carcinoma Malignant Myoepithelioma Stage IV includes: IVA: (T4, Any N, M0) and IVB: (Any T, Any N, M1). T4: Tumor invades mucosa of the bladder or rectum and/or extends beyond the true pelvis (bullous edema is not sufficient evidence to classify tumor as T4). M0: No distant metastasis. M1: Distant metastasis. (AJCC 6th and 7th eds.) C7597 Neoplastic Process Stage IV Vaginal Cancer AJCC v6 and v7 Stage IV Vaginal Cancer AJCC v6 and v7 C1336446 CTRP Stage IV vaginal cancer is divided into stages IVA and IVB. In stage IVA, cancer has spread from the vagina (birth canal) to the lining of the bladder or rectum and/or beyond the pelvis; cancer may have also spread to lymph nodes in the pelvis or groin. In stage IVB, cancer has spread to distant parts of the body. Malignant Stage_IV_Vaginal_Cancer FIGO Stage IV Vaginal Carcinoma Stage IV Vaginal Cancer Stage IV Vaginal Cancer AJCC v6 Stage IV Vaginal Cancer AJCC v6 and v7 Stage IV Vaginal Cancer AJCC v7 Stage IV Vaginal Carcinoma Stage IV Vaginal Carcinoma AJCC v6 Stage IV Vaginal Carcinoma AJCC v7 stage IV vaginal cancer Stage IV Vaginal Cancer AJCC v6 and v7 A very rare liposarcoma that arises from the bone. C7598 Neoplastic Process Bone Liposarcoma C1332581 Malignant Bone_Liposarcoma Bone Liposarcoma Liposarcoma of Bone Liposarcoma of the Bone Bone Liposarcoma An acute myeloid leukemia with at least 20% blasts in the bone marrow or blood, and either a previous history of myelodysplastic syndrome, multilineage dysplasia or myelodysplastic syndrome-related cytogenetic abnormalities. There is no history of prior cytotoxic therapy for an unrelated disorder, and there is absence of the molecular abnormalities that are present in acute myeloid leukemia with recurrent genetic abnormalities. C7600 Neoplastic Process Acute Myeloid Leukemia, Myelodysplasia-Related C2825139 CPTAC Cellosaurus GDC NICHD PCDC An acute myeloid leukemia with at least 20% blasts in the bone marrow or blood and one of the following: a previous history of myelodysplastic syndrome; multilineage dysplasia; or myelodysplastic syndrome-related cytogenetic abnormalities. 9895/3 Malignant Acute_Myeloid_Leukemia_with_Multilineage_Dysplasia 9895/3 Acute myeloid leukemia with myelodysplasia-related changes AML with Myelodysplasia-Related Changes AML with Myelodysplasia-related Changes AML with myelodysplasia-related changes AML-MRC Acute Myeloid Leukemia with Myelodysplasia-Related Changes Acute Myeloid Leukemia, Myelodysplasia-Related Acute myeloid leukemia with myelodysplasia-related changes Acute Myeloid Leukemia, Myelodysplasia-Related An extranodal marginal zone B-cell lymphoma arising from mucosa-associated lymphoid tissue in the thyroid gland. The vast majority of cases are associated with chronic lymphocytic thyroiditis. C7601 Neoplastic Process Thyroid Gland Mucosa-Associated Lymphoid Tissue Lymphoma C1336754 Malignant Thyroid_Mucosa-Associated_Lymphoid_Tissue_Lymphoma Thyroid Gland Mucosa-Associated Lymphoid Tissue Lymphoma Thyroid MALT Lymphoma Thyroid Mucosa-Associated Lymphoid Tissue Lymphoma Thyroid Gland Mucosa-Associated Lymphoid Tissue Lymphoma A melanocytic nevus characterized by circumferential depigmentation. It is usually associated with a brisk lymphocytic infiltrate. C7602 Neoplastic Process Halo Nevus C0474824 GDC 8723/0 Benign Halo_Nevus 8723/0 Halo nevus Halo Nevus Halo nevus Leukoderma Acquisitum Centrifugum Perinevoid Leukoderma Perinevoid Vitiligo Sutton Nevus Halo Nevus A nevus associated with focal regression-like changes. C7603 Neoplastic Process Regressing Nevus C1377589 GDC Benign Regressing_Nevus 8723/0 Regressing nevus Regressing Nevus Regressing nevus Regressing Nevus An olfactory neuroblastoma arising in the nasal cavity. C7604 Neoplastic Process Nasal Cavity Olfactory Neuroblastoma C1334923 Malignant Nasal_Cavity_Olfactory_Neuroblastoma Nasal Cavity Olfactory Neuroblastoma Olfactory Neuroblastoma of Nasal Cavity Olfactory Neuroblastoma of the Nasal Cavity Nasal Cavity Olfactory Neuroblastoma A granular cell tumor that arises from the oral cavity and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C7605 Neoplastic Process Oral Cavity Benign Granular Cell Tumor C1335117 Benign Oral_Cavity_Benign_Granular_Cell_Tumor Oral Cavity Benign Granular Cell Neoplasm Oral Cavity Benign Granular Cell Tumor Oral Cavity Benign Granular Cell Tumor A benign or malignant neoplasm that affects the oral cavity. C7606 Neoplastic Process Oral Cavity Neoplasm C0026640 Undetermined Oral_Cavity_Neoplasm Mouth Neoplasm Mouth Tumor Oral Cavity Neoplasm Oral Cavity Tumor Oral Cavity Neoplasm A neoplasm that arises from the oral cavity and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include hemangioma, tongue lipoma, and buccal mucosa papilloma. C7607 Neoplastic Process Benign Oral Cavity Neoplasm C0347197 Benign Benign_Oral_Cavity_Neoplasm Benign Mouth Neoplasm Benign Mouth Tumor Benign Neoplasm of Mouth Benign Neoplasm of Oral Cavity Benign Neoplasm of the Mouth Benign Neoplasm of the Oral Cavity Benign Oral Cavity Neoplasm Benign Oral Cavity Tumor Benign Tumor of Mouth Benign Tumor of Oral Cavity Benign Tumor of the Mouth Benign Tumor of the Oral Cavity Benign Oral Cavity Neoplasm A neoplasm that arises from the oral cavity or the lips and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C7608 Neoplastic Process Benign Oral Neoplasm CL448473 Benign Benign_Oral_Neoplasm Benign Oral Neoplasm Benign Oral Tumor Oral Neoplasm, Benign Benign Oral Neoplasm A non-Hodgkin lymphoma that arises in the cerebral hemispheres as a primary lesion. C7609 Neoplastic Process Cerebral Non-Hodgkin Lymphoma C1332909 Malignant Cerebral_Non-Hodgkin_s_Lymphoma Cerebral Non-Hodgkin Lymphoma Cerebral Non-Hodgkin's Lymphoma Primary Cerebral Non-Hodgkin Lymphoma Primary Cerebral Non-Hodgkin's Lymphoma Cerebral Non-Hodgkin Lymphoma A non-Hodgkin or Hodgkin lymphoma that arises in the cerebral hemispheres as a primary lesion. C7611 Neoplastic Process Cerebral Lymphoma C0240803 Malignant Cerebral_Lymphoma Cerebral Lymphoma Primary Cerebral Lymphoma Primary Lymphoma of Cerebrum Primary Lymphoma of the Cerebrum Primary Lymphoma, Brain Cerebral Lymphoma A thymoma that has an aggressive clinical course (capsular invasion, infiltration of the surrounding tissues) and can metastasize. Although any morphologic subtype of thymoma may eventually have a malignant clinical course, this term is most often associated with thymoma types B3 and C. C7612 Neoplastic Process Malignant Thymoma Malignant Thymoma CL371354 CDISC CTRP GDC A malignant neoplasm of the thymus, originating from epithelial thymus cells. 8580/3 Malignant Malignant_Thymoma 8580/3 Thymoma, malignant, NOS Malignant Thymoma THYMOMA, MALIGNANT Malignant Thymoma A diffuse large B-cell lymphoma occurring in adults. C7615 Neoplastic Process Adult Diffuse Large B-Cell Lymphoma Adult Diffuse Large B-Cell Lymphoma C1332201 CTRP Malignant Adult_Diffuse_Large_B-Cell_Lymphoma Adult Diffuse Large B-Cell Lymphoma Diffuse Large B-Cell Lymphoma Adult Diffuse Large B-Cell Lymphoma A diffuse large B-cell lymphoma that occurs during childhood. C7616 Neoplastic Process Childhood Diffuse Large B-Cell Lymphoma Childhood Diffuse Large B-Cell Lymphoma C1332967 CTRP NICHD A diffuse large B-cell lymphoma that occurs during childhood. Malignant Childhood_Diffuse_Large_B_Cell_Lymphoma Childhood DLBCL Childhood Diffuse Large B-Cell Lymphoma Diffuse Large B-Cell Lymphoma Pediatric Diffuse Large B Cell Lymphoma Childhood Diffuse Large B-Cell Lymphoma A neoplasm that arises from the male or female reproductive system and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C7617 Neoplastic Process Benign Reproductive System Neoplasm C1332536 Benign Benign_Reproductive_System_Neoplasm Benign Reproductive System Neoplasm Benign Reproductive System Neoplasm The reemergence of female reproductive system carcinoma after a period of remission. C7620 Neoplastic Process Recurrent Female Reproductive System Carcinoma C1335700 Malignant Recurrent_Female_Reproductive_System_Cancer Recurrent Female Reproductive System Cancer Recurrent Female Reproductive System Carcinoma Recurrent Female Reproductive System Carcinoma The reemergence of a carcinoma that affects the male reproductive system after a period of remission. C7621 Neoplastic Process Recurrent Male Reproductive System Carcinoma C1335705 Malignant Recurrent_Male_Reproductive_System_Cancer Recurrent Male Reproductive System Cancer Recurrent Male Reproductive System Carcinoma Recurrent Male Reproductive System Carcinoma The reemergence of carcinoma in any part of the digestive system after a period of remission. C7622 Neoplastic Process Recurrent Digestive System Carcinoma Recurrent Digestive System Carcinoma C1335702 CTRP Malignant Recurrent_Gastrointestinal_System_Cancer Recurrent Digestive System Carcinoma Recurrent Gastrointestinal System Cancer Recurrent Gastrointestinal System Carcinoma Recurrent Digestive System Carcinoma Reemergence of a urinary system carcinoma after a period of remission. C7623 Neoplastic Process Recurrent Urinary System Carcinoma C1335721 Malignant Recurrent_Urinary_Tract_Cancer Recurrent Urinary System Carcinoma Recurrent Urinary System Carcinoma The reemergence of carcinoma in the head and neck region after a period of remission. C7624 Neoplastic Process Recurrent Head and Neck Carcinoma C1335703 Malignant Recurrent_Head_and_Neck_Cancer Recurrent Head and Neck Carcinoma Recurrent Head and Neck Carcinoma The reemergence of pancreatic carcinoma after a period of remission. C7626 Neoplastic Process Recurrent Pancreatic Carcinoma Recurrent Pancreatic Carcinoma C0854777 CTRP Malignant Recurrent_Pancreatic_Cancer Pancreatic Carcinoma, Recurrent Recurrent Cancer of Pancreas Recurrent Cancer of the Pancreas Recurrent Carcinoma of Pancreas Recurrent Carcinoma of the Pancreas Recurrent Pancreatic Cancer Recurrent Pancreatic Carcinoma Relapsed Cancer of Pancreas Relapsed Cancer of the Pancreas Relapsed Carcinoma of Pancreas Relapsed Carcinoma of the Pancreas Relapsed Pancreatic Cancer Relapsed Pancreatic Carcinoma Recurrent Pancreatic Carcinoma A lipomatous neoplasm characterized by a high risk of local recurrence and no risk of metastasis. C7630 Neoplastic Process Intermediate Lipomatous Neoplasm C1334217 Undetermined Intermediate_Lipomatous_Neoplasm Intermediate Lipomatous Neoplasm Intermediate Lipomatous Neoplasm A rare malignant mesothelioma that arises from the pericardium. Clinical presentation includes pericardial effusion, congestive heart failure, a mass or cardiac tamponade. Surgical resection is the treatment of choice. Adjunct treatments of chemotherapy or radiation have not improved outcomes. The prognosis is extremely poor due to its late presentation and difficulty obtaining complete surgical excision. In most cases the diagnosis is made at autopsy or postoperatively. C7631 Neoplastic Process Pericardial Malignant Mesothelioma C0346110 mCode Malignant Malignant_Pericardial_Mesothelioma Pericardial_Mesothelioma Malignant Mesothelioma of Pericardium Malignant Mesothelioma of the Pericardium Mesothelioma of pericardium Pericardial Malignant Mesothelioma Pericardial Malignant Mesothelioma A ductal breast carcinoma that has spread from the original site of growth to another anatomic site. C76326 Neoplastic Process Metastatic Breast Ductal Carcinoma C2698203 Malignant Metastatic_Ductal_Breast_Carcinoma Metastatic Breast Ductal Carcinoma Metastatic Ductal Breast Carcinoma Metastatic Breast Ductal Carcinoma A lobular breast carcinoma that has spread from the original site of growth to another anatomic site. C76328 Neoplastic Process Metastatic Lobular Breast Carcinoma Metastatic Breast Lobular Carcinoma C2698204 CTRP Cellosaurus Malignant Metastatic_Lobular_Breast_Carcinoma Metastatic Breast Lobular Carcinoma Metastatic Lobular Breast Carcinoma Metastatic Breast Lobular Carcinoma A mesothelial neoplasm that arises from the peritoneum. It includes adenomatoid tumor, well differentiated papillary mesothelial tumor, multicystic mesothelioma, and malignant mesothelioma. C7633 Neoplastic Process Peritoneal Mesothelial Neoplasm C1377610 CPTAC mCode Undetermined Peritoneal_Mesothelioma Mesothelioma of peritoneum Mesothelial Neoplasm of Peritoneum Mesothelial Neoplasm of the Peritoneum Mesothelial Tumor of Peritoneum Mesothelial Tumor of the Peritoneum Mesothelioma of peritoneum Peritoneal Mesothelial Neoplasm Peritoneal Mesothelial Tumor Peritoneal Mesothelioma Peritoneal Mesothelial Neoplasm A localized neoplasm of probable fibroblastic derivation. It is characterized by the presence of round to spindle-shaped cells, hylanized stroma formation, thin-walled branching blood vessels, and thin bands of collagen. C7634 Neoplastic Process Solitary Fibrous Tumor C1266119 GDC 8815/0 8815/1 9051/0 Undetermined Solitary_Fibrous_Tumor 8815/0 Localized fibrous tumor Solitary fibrous tumor Solitary fibrous tumor, NOS Hemangiopericytoma Localized Fibrous Mesothelioma Localized Fibrous Tumor Localized fibrous tumor SFT Solitary Fibrous Tumor Solitary fibrous tumor Submesothelial Fibroma Solitary Fibrous Tumor A malignant neoplasm that affects the labia minora. C7637 Neoplastic Process Malignant Labia Minora Neoplasm C0496815 mCode Malignant Malignant_Labia_Minora_Neoplasm Malignant Labia Minora Neoplasm Malignant Labia Minora Tumor Malignant Neoplasm of Labia Minora Malignant Neoplasm of the Labia Minora Malignant Tumor of Labia Minora Malignant Tumor of the Labia Minora Malignant neoplasm of labium minus Malignant Labia Minora Neoplasm A malignant neoplasm that affects the labia majora. C7638 Neoplastic Process Malignant Labia Majora Neoplasm C0496814 CPTAC mCode Malignant Malignant_Labia_Majora_Neoplasm Malignant neoplasm of labia majora Malignant Labia Majora Neoplasm Malignant Labia Majora Tumor Malignant Neoplasm of Labia Majora Malignant Neoplasm of the Labia Majora Malignant Tumor of Labia Majora Malignant Tumor of the Labia Majora Malignant neoplasm of labium majus Malignant Labia Majora Neoplasm A urethral carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C7639 Neoplastic Process Locally Advanced Urethral Carcinoma C0854918 Malignant Regional_Malignant_Urethral_Neoplasm Locally Advanced Urethral Carcinoma Locally Advanced Urethral Carcinoma A malignant neoplasm that affects the portion of the urethra that is close to the bladder. C7640 Neoplastic Process Posterior Urethral Malignant Neoplasm C0279931 A disease in which malignant (cancer) cells are found in the part of the urethra (the tube through which urine leaves the body) that connects to the bladder (the organ that stores urine). Malignant Posterior_Urethral_Malignant_Neoplasm Malignant Neoplasm of Posterior Urethra Malignant Neoplasm of the Posterior Urethra Malignant Tumor of Posterior Urethra Malignant Tumor of the Posterior Urethra Posterior Urethra Malignant Neoplasm Posterior Urethra Malignant Tumor Posterior Urethral Malignant Neoplasm Posterior Urethral Malignant Tumor posterior urethral cancer Posterior Urethral Malignant Neoplasm A primary or metastatic malignant neoplasm involving the anterior portion of the urethra. C7641 Neoplastic Process Anterior Urethral Malignant Neoplasm C0279930 A disease in which malignant (cancer) cells are found in the part of the urethra (the tube through which urine leaves the body) that is closest to the outside of the body. Malignant Anterior_Urethral_Malignant_Neoplasm Anterior Urethra Malignant Neoplasm Anterior Urethra Malignant Tumor Anterior Urethral Malignant Neoplasm Anterior Urethral Malignant Tumor Malignant Neoplasm of Anterior Urethra Malignant Neoplasm of the Anterior Urethra Malignant Tumor of Anterior Urethra Malignant Tumor of the Anterior Urethra anterior urethral cancer Anterior Urethral Malignant Neoplasm A disorder seen following cancer chemotherapy. It typically manifests a few years after initiation of epipodophyllotoxin chemotherapy. Mutagenic potential of these non-intercalating DNA topoisomerase II inhibitors is believed to be increased with concurrent use of asparaginase or granulocyte colony-stimulating factor. Balanced translocations involving chromosomal bands 11q23 and 21q22 are commonly associated with this disorder. Clinical signs may include fatigue, dyspnea, bruising and frequent infections. Clinical course usually progresses to acute myeloid leukemia though most epipodophyllotoxin-related leukemias do not have an antecedent myelodysplastic phase. Prognosis is dismal with survivability usually less than one year. C7642 Neoplastic Process Epipodophyllotoxin-Related Myelodysplastic Syndrome C1333418 GDC Malignant Epipodophyllotoxin-Related_Myelodysplastic_Syndrome 9987/3 Therapy-related myelodysplastic syndrome, epipodophyllotoxin-related Epipodophyllotoxin Related Myelodysplastic Syndrome Epipodophyllotoxin-Related Myelodysplastic Syndrome Therapy-related myelodysplastic syndrome, epipodophyllotoxin-related Epipodophyllotoxin-Related Myelodysplastic Syndrome A disorder seen following cancer chemotherapy. It is the most common cause of therapy-related myelodysplastic syndromes. It typically manifests several years after initiation of single or multi-agent chemotherapy with alkylators. Mutagenic potential of alkylating agents is believed to be age and cumulative dose-dependent. Deletions in chromosomes 5 and 7 are associated with susceptibility to this disorder. Clinical signs may include fatigue, dyspnea, bruising and frequent infections. Clinical course may progress to bone marrow failure or acute myeloid leukemia that is refractory to treatment. Prognosis is dismal with survivability usually less than one year. C7643 Neoplastic Process Alkylating Agent-Related Myelodysplastic Syndrome C1332235 GDC Malignant Alkylating_Agent-Related_Myelodysplastic_Syndrome 9987/3 Therapy-related myelodysplastic syndrome, alkylating agent related Alkylating Agent Related Myelodysplastic Syndrome Alkylating Agent-Related Myelodysplastic Syndrome Therapy-related myelodysplastic syndrome, alkylating agent related Alkylating Agent-Related Myelodysplastic Syndrome A low grade malignant neoplasm arising from the long bones. The tibia is the most frequently affected bone site. Patients present with swelling which may or may not be associated with pain. Morphologically, it is characterized by a biphasic pattern consisting of an epithelial and an osteofibrous component. The vast majority of cases recur if they are not treated with radical surgery. In a minority of cases the tumor may metastasize to other anatomic sites including lymph nodes, lungs, liver, brain, and skeleton. C7644 Neoplastic Process Adamantinoma C0334556 CDISC GDC A low-grade malignant neoplasm composed of epithelial cells and a spindle cell osteo-fibrous proliferation. 9261/3 Malignant Adamantinoma 9261/3 Adamantinoma of long bones Adamantinoma, malignant ADAMANTINOMA, MALIGNANT Adamantinoma Adamantinoma of Long Bones Adamantinoma of long bones Adamantinoma, malignant Extragnathic Adamantinoma Adamantinoma A ganglioneuroblastoma arising from the adrenal gland. C7646 Neoplastic Process Adrenal Gland Ganglioneuroblastoma C1332176 Malignant Adrenal_Ganglioneuroblastoma Adrenal Ganglioneuroblastoma Adrenal Gland Ganglioneuroblastoma Adrenal Gland Ganglioneuroblastoma A carcinoma that arises from the gallbladder and it has not spread to other anatomic sites. C7649 Neoplastic Process Localized Gallbladder Carcinoma Localized Gallbladder Carcinoma C0877355 CTRP Cancer found only in the tissues that make up the wall of the gallbladder. Localized gallbladder cancer can be removed completely in an operation. Malignant Localized_Gallbladder_Carcinoma Gallbladder Cancer, Localized Localized Cancer of Gallbladder Localized Cancer of the Gallbladder Localized Gallbladder Cancer Localized Gallbladder Carcinoma localized gallbladder cancer Localized Gallbladder Carcinoma The spread of a malignant neoplasm to the urinary bladder wall from an adjacent or distant anatomic site. C7650 Neoplastic Process Metastatic Malignant Neoplasm in the Bladder C0347011 CPTAC mCode Malignant Metastatic_Neoplasm_to_the_Bladder Secondary malignant neoplasm of other urinary organs Metastases to Bladder Metastasis to Bladder Metastatic Malignant Neoplasm in the Bladder Metastatic Malignant Neoplasm to the Bladder Metastatic Neoplasm to the Bladder Metastatic Neoplasm to the Urinary Bladder Metastatic Tumor to the Bladder Metastatic Tumor to the Urinary Bladder Secondary malignant neoplasm of bladder Metastatic Malignant Neoplasm in the Bladder A soft tissue neoplasm characterized by an increased risk of local recurrence and/or a low risk of metastasis. C7653 Neoplastic Process Intermediate Soft Tissue Neoplasm C1334224 Undetermined Intermediate_Soft_Tissue_Neoplasm Intermediate Soft Tissue Neoplasm Intermediate Soft Tissue Tumor Intermediate Soft Tissue Neoplasm A premalignant neoplastic nodular lesion of the liver that usually measures less than 15 mm. It is found during microscopic examination of liver tissues, usually in cirrhotic livers. Based on the degree of atypia, it is classified as low or high grade. C7656 Neoplastic Process Liver Dysplastic Nodule C1333964 Undetermined Hepatic_Dysplastic_Nodule DN Dysplastic Nodule of Liver Dysplastic Nodule of the Liver Hepatic DN Hepatic Dysplastic Nodule Liver Dysplastic Nodule Liver Dysplastic Nodule A precancerous neoplastic process that affects the small or large intestine. It is characterized by low or high grade dysplasia of the mucosal epithelium. There is no evidence of invasion. C7658 Neoplastic Process Intestinal Intraepithelial Neoplasia C1334229 Undetermined Intestinal_Intraepithelial_Neoplasia Bowel Dysplasia Intestinal Dysplasia Intestinal Intraepithelial Neoplasia Intestinal Intraepithelial Neoplasia Vaginal intraepithelial neoplasia characterized by the presence of moderate or severe dysplastic changes. C7663 Neoplastic Process High Grade Vaginal Intraepithelial Neoplasia C2721738 Undetermined High_Grade_Vaginal_Intraepithelial_Neoplasia High Grade VAIN High Grade Vaginal Intraepithelial Neoplasia High Grade Vaginal Squamous Intraepithelial Lesion High-Grade Vaginal Squamous Intraepithelial Lesion High Grade Vaginal Intraepithelial Neoplasia Penile intraepithelial neoplasia characterized by the proliferation of transformed basaloid cells that occupy the lower two thirds of the epithelial thickness. C7665 Neoplastic Process Grade II Penile Intraepithelial Neoplasia C1333863 Undetermined Grade_II_Penile_Intraepithelial_Neoplasia Grade 2 Penile Intraepithelial Neoplasia Grade II PeIN Grade II Penile Intraepithelial Neoplasia Grade II Penile Intraepithelial Neoplasia Penile intraepithelial neoplasia characterized by the proliferation of transformed basaloid cells that occupy the lower one third of the epithelial thickness. C7666 Neoplastic Process Low Grade Penile Intraepithelial Neoplasia C1334427 Undetermined Low_Grade_Penile_Intraepithelial_Neoplasia Grade 1 Penile Intraepithelial Neoplasia Grade I PeIN Grade I Penile Intraepithelial Neoplasia Low Grade PeIN Low Grade Penile Intraepithelial Neoplasia Low Grade Penile Intraepithelial Neoplasia Penile intraepithelial neoplasia characterized by the proliferation of transformed basaloid cells that occupy either the lower two thirds of the epithelial thickness (grade II) or the entire thickness of the epithelium (grade III, Bowen atypia, or squamous cell carcinoma in situ). C7667 Neoplastic Process High Grade Penile Intraepithelial Neoplasia C1334019 Undetermined High_Grade_Penile_Intraepithelial_Neoplasia High Grade PeIN High Grade Penile Intraepithelial Neoplasia High Grade Penile Intraepithelial Neoplasia A precancerous neoplastic intraepithelial process with high-grade dysplastic features involving the conjunctival epithelium. C7668 Neoplastic Process High Grade Conjunctival Squamous Intraepithelial Neoplasia C1334012 Undetermined High_Grade_Conjunctival_Intraepithelial_Neoplasia High Grade Conjunctival Intraepithelial Neoplasia High Grade Conjunctival Squamous Intraepithelial Neoplasia High Grade Conjunctival Squamous Intraepithelial Neoplasia A precancerous neoplastic intraepithelial process with high-grade dysplastic features involving the corneal epithelium. C7669 Neoplastic Process High Grade Corneal Squamous Intraepithelial Neoplasia C1334013 Undetermined High_Grade_Corneal_Intraepithelial_Neoplasia High Grade Corneal Intraepithelial Neoplasia High Grade Corneal Squamous Intraepithelial Neoplasia High Grade Corneal Squamous Intraepithelial Neoplasia Squamous or glandular cervical intraepithelial neoplasia characterized by the presence of moderate or severe dysplastic changes. C7670 Neoplastic Process High Grade Cervical Intraepithelial Neoplasia C1334011 Undetermined High_Grade_Cervical_Intraepithelial_Neoplasia High Grade Cervical Intraepithelial Neoplasia High Grade Cervical Intraepithelial Neoplasia A neoplastic process that affects the glandular epithelial cells of the cervix. There is no evidence of invasion. It is classified as low or high grade. C7673 Neoplastic Process Cervical Glandular Intraepithelial Neoplasia C2044987 Undetermined Cervical_Glandular_Intraepithelial_Neoplasia CGIN Cervical Glandular Intraepithelial Neoplasia Cervical Glandular Intraepithelial Neoplasia Cervical glandular intraepithelial neoplasia characterized by the presence of mild dysplastic changes. C7674 Neoplastic Process Low Grade Cervical Glandular Intraepithelial Neoplasia C1334420 Undetermined Low_Grade_Cervical_Glandular_Intraepithelial_Neoplasia Low Grade Cervical Glandular Intraepithelial Neoplasia Low Grade Cervical Glandular Intraepithelial Neoplasia Cervical glandular intraepithelial neoplasia characterized by the presence of severe dysplastic changes. C7675 Neoplastic Process High Grade Cervical Glandular Intraepithelial Neoplasia C1334010 Undetermined High_Grade_Cervical_Glandular_Intraepithelial_Neoplasia High Grade Cervical Glandular Intraepithelial Neoplasia High Grade Cervical Glandular Intraepithelial Neoplasia An invasive ductal breast carcinoma associated with a lobular carcinomatous component. The lobular carcinomatous component may be in situ or invasive. C7688 Neoplastic Process Invasive Breast Ductal Carcinoma and Lobular Carcinoma Invasive Breast Ductal Carcinoma and Lobular Carcinoma C1334277 CTRP Cellosaurus GDC 8522/3 Malignant Invasive_Ductal_and_Lobular_Carcinoma 8522/3 8523/3 Infiltrating duct and lobular carcinoma Infiltrating duct mixed with other types of carcinoma Infiltrating Ductal and Lobular Carcinoma Infiltrating duct and lobular carcinoma Infiltrating duct mixed with other types of carcinoma Invasive Breast Ductal Carcinoma and Lobular Carcinoma Invasive Duct and Lobular Carcinoma Invasive Ductal and Lobular Carcinoma Invasive Breast Ductal Carcinoma and Lobular Carcinoma An invasive ductal breast carcinoma associated with an in situ lobular carcinomatous component. C7689 Neoplastic Process Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ C0334384 GDC Malignant Infiltrating_Ductal_and_Lobular_Carcinoma_in_situ 8522/3 Infiltrating duct and lobular carcinoma in situ Infiltrating Ductal and Lobular Carcinoma in situ Infiltrating duct and lobular carcinoma in situ Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ Invasive Ductal and Lobular Carcinoma In Situ LCIS and Infiltrating Ductal Carcinoma Lobular Carcinoma in situ and Infiltrating Ductal Carcinoma Lobular Carcinoma in situ and Invasive Ductal Carcinoma Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ A breast carcinoma characterized by the presence of a ductal carcinoma in situ component and an in situ or invasive lobular carcinomatous component. C7690 Neoplastic Process Breast Ductal Carcinoma In Situ and Lobular Carcinoma CL028597 GDC Malignant Intraductal_and_Lobular_Carcinoma 8522/3 Intraductal and lobular carcinoma Breast Ductal Carcinoma In Situ and Lobular Carcinoma Breast Intraductal and Lobular Carcinoma Intraductal and Lobular Carcinoma Intraductal and lobular carcinoma Breast Ductal Carcinoma In Situ and Lobular Carcinoma A hepatocellular carcinoma that is amenable to surgical resection. C7691 Neoplastic Process Resectable Hepatocellular Carcinoma Resectable Hepatocellular Carcinoma C0863194 CTRP Malignant Resectable_Hepatocellular_Carcinoma Hepatocellular Carcinoma, Resectable Resectable Carcinoma of Liver Cell Resectable Carcinoma of the Liver Cell Resectable Hepatocellular Cancer Resectable Hepatocellular Carcinoma Resectable Hepatoma Resectable Liver Cell Carcinoma Resectable Hepatocellular Carcinoma A malignant liver neoplasm that is amenable to surgical resection. C7692 Neoplastic Process Resectable Malignant Liver Neoplasm C0854795 Malignant Resectable_Hepatic_Malignant_Neoplasm Resectable Hepatic Malignant Neoplasm Resectable Malignant Liver Neoplasm Resectable Malignant Neoplasm of Liver Resectable Malignant Liver Neoplasm A rare, serous papillary adenocarcinoma that arises from the lining of the peritoneum. It affects females. The clinical behavior and pathologic characteristics are similar to the serous papillary adenocarcinoma that arises from the ovary. C7695 Neoplastic Process Primary Peritoneal Serous Papillary Adenocarcinoma C1368918 Cellosaurus GDC Malignant Primary_Serous_Papillary_Carcinoma_of_Peritoneum 8461/3 Primary serous papillary carcinoma of peritoneum Primary Peritoneal Serous Papillary Adenocarcinoma Primary Peritoneal Serous Papillary Carcinoma Primary Serous Papillary Carcinoma of Peritoneum Primary serous papillary carcinoma of peritoneum Primary Peritoneal Serous Papillary Adenocarcinoma An inflammatory carcinoma of the breast that has spread to other anatomic sites. C7696 Neoplastic Process Stage IV Inflammatory Breast Carcinoma Stage IV Breast Inflammatory Carcinoma C0853972 CTRP Malignant Stage_IV_Inflammatory_Breast_Carcinoma Inflammatory Carcinoma of Breast Stage IV Stage IV Breast Inflammatory Carcinoma Stage IV Inflammatory Breast Cancer Stage IV Inflammatory Breast Carcinoma Stage IV Breast Inflammatory Carcinoma A neoplastic polyp that arises from the stomach. This category includes intestinal-type adenomatous polyps, gastric-type adenomas, and fundic gland polyps. C7699 Neoplastic Process Gastric Adenoma C0149826 Benign Gastric_Adenoma Adenoma of Stomach Adenoma of the Stomach Gastric Adenoma Gastric Adenoma An adenocarcinoma that arises from the ovary. It is the most common type of ovarian carcinoma. It includes the serous adenocarcinoma, mucinous adenocarcinoma, clear cell adenocarcinoma, and endometrioid adenocarcinoma. C7700 Neoplastic Process Ovarian Adenocarcinoma Ovarian Adenocarcinoma C0948216 CTRP Cellosaurus Malignant Ovarian_Adenocarcinoma Adenocarcinoma of Ovary Adenocarcinoma of the Ovary Ovarian Adenocarcinoma Ovarian Adenocarcinoma Hodgkin lymphoma occurring in adults. C7702 Neoplastic Process Adult Hodgkin Lymphoma Adult Hodgkin Lymphoma C0220597 CTRP Malignant Adult_Hodgkin_s_Lymphoma Adult HD Adult Hodgkin Lymphoma Adult Hodgkin's Disease Adult Hodgkin's Lymphoma Hodgkin Lymphoma Adult Hodgkin Lymphoma A benign or malignant, primary or metastatic neoplasm of the brain occurring in children. C7703 Neoplastic Process Childhood Brain Neoplasm Childhood Brain Neoplasm C0220603 CTRP NICHD A benign or malignant, primary or metastatic neoplasm of the brain, occurring in children. Undetermined Childhood_Brain_Neoplasm Brain Neoplasm Brain Neoplasms, Childhood Childhood Brain Neoplasm Childhood Brain Tumor Childhood Neoplasm of Brain Childhood Neoplasm of the Brain Childhood Tumor of Brain Childhood Tumor of the Brain Pediatric Brain Neoplasm Pediatric Brain Tumor Pediatric Neoplasm of Brain Pediatric Neoplasm of the Brain Pediatric Tumor of Brain Pediatric Tumor of the Brain Childhood Brain Neoplasm Non-Hodgkin lymphoma occurring in adults. C7704 Neoplastic Process Adult Non-Hodgkin Lymphoma Adult Non-Hodgkin Lymphoma C0220605 CTRP Malignant Adult_Non-Hodgkin_s_Lymphoma Adult NHL Adult Non-Hodgkin Lymphoma Adult Non-Hodgkin's Lymphoma Non-Hodgkin Lymphoma Adult Non-Hodgkin Lymphoma An aggressive malignant mesenchymal neoplasm arising from skeletal muscle in children. Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomic sites. C7705 Neoplastic Process Childhood Rhabdomyosarcoma Childhood Rhabdomyosarcoma C0220611 CTRP NICHD An aggressive, malignant, mesenchymal neoplasm arising from skeletal muscle in children; the most common sites are the head, the genitourinary tract, and the extremities. Malignant Childhood_Rhabdomyosarcoma Childhood Rhabdomyosarcoma Pediatric Rhabdomyosarcoma Rhabdomyosarcoma Childhood Rhabdomyosarcoma Non-Hodgkin lymphoma occurring in childhood. C7706 Neoplastic Process Childhood Non-Hodgkin Lymphoma Childhood Non-Hodgkin Lymphoma C0220612 CTRP NICHD A high-grade lymphoma occurring in children of either B, T, or NK cell lineage, with either precursor or mature cell phenotype. Malignant Childhood_Non-Hodgkin_s_Lymphoma Childhood NHL Childhood Non-Hodgkin Lymphoma Childhood Non-Hodgkin's Lymphoma Non-Hodgkin Lymphoma Pediatric Non-Hodgkin Lymphoma Pediatric Non-Hodgkin's Lymphoma Childhood Non-Hodgkin Lymphoma Soft tissue sarcoma occurring in adults. C7707 Neoplastic Process Adult Soft Tissue Sarcoma Adult Soft Tissue Sarcoma C0220613 CTRP Malignant Adult_Soft_Tissue_Sarcoma Adult Sarcoma of Soft Tissue Adult Sarcoma of the Soft Tissue Adult Soft Tissue Sarcoma Soft Tissue Sarcoma Adult Soft Tissue Sarcoma A malignant neoplasm that affects the liver and occurs during childhood. C7708 Neoplastic Process Childhood Malignant Liver Neoplasm Childhood Malignant Liver Neoplasm C2945767 CTRP GDC NICHD A malignant tumor of the liver occurring during childhood. Malignant Childhood_Liver_Cancer Pediatric Liver Cancer Childhood Cancer of Liver Childhood Cancer of the Liver Childhood Liver Cancer Childhood Malignant Liver Neoplasm Childhood Malignant Liver Tumor Malignant Liver Neoplasm Pediatric Cancer of Liver Pediatric Cancer of the Liver Pediatric Liver Cancer Pediatric Malignant Liver Neoplasm Childhood Malignant Liver Neoplasm A well differentiated neuroendocrine neoplasm of low grade arising from the digestive system. It is composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with small vesicular nuclei. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. The tumor can occur anywhere in the digestive system; approximately 90% arise in the appendix. C7709 Neoplastic Process Gastrointestinal Neuroendocrine Tumor G1 Digestive System Neuroendocrine Tumor G1 C0220620 CTRP An indolent (slow-growing) cancer that forms in cells that make hormones in the lining of the gastrointestinal tract (the stomach and intestines). It usually occurs in the appendix (a small fingerlike pouch of the large intestine), small intestine, or rectum. Having gastrointestinal carcinoid tumor increases the risk of forming other cancers of the digestive system. 8240/3 Undetermined Gastrointestinal_Carcinoid_Tumor Carcinoid Tumor of Digestive System Carcinoid Tumor of GI System Carcinoid Tumor of Gastrointestinal System Carcinoid Tumor of the Digestive System Carcinoid Tumor of the GI System Carcinoid Tumor of the Gastrointestinal System Digestive Carcinoid Tumor Digestive System Carcinoid Tumor Digestive System Neuroendocrine Tumor G1 GCT GI Carcinoid Tumor Gastrointestinal Carcinoid Tumor Gastrointestinal NET G1 Gastrointestinal Neuroendocrine Tumor G1 Gastrointestinal System Carcinoid Tumor gastrointestinal carcinoid tumor Digestive System Neuroendocrine Tumor G1 A benign or malignant, primary or metastatic neoplasm of the brain occurring in adults. C7710 Neoplastic Process Adult Brain Neoplasm Adult Brain Neoplasm C0220624 CTRP Undetermined Adult_Brain_Neoplasm Adult Brain Neoplasm Adult Brain Tumor Brain Neoplasm Brain Neoplasms, Adult Neoplasm of Adult Brain Neoplasm of the Adult Brain Tumor of Adult Brain Tumor of the Adult Brain Adult Brain Neoplasm A hepatocellular carcinoma or intrahepatic cholangiocarcinoma that occurs during adulthood. C7711 Neoplastic Process Adult Liver Carcinoma Adult Liver Carcinoma C0220630 CTRP Malignant Adult_Liver_Carcinoma Adult Liver Carcinoma Adult Primary Cancer of Liver Adult Primary Cancer of the Liver Adult Primary Liver Cancer Adult Primary Liver Carcinoma Liver Cancer Adult Liver Carcinoma A melanoma derived from melanocytes of the uveal tract. It is the most common primary intraocular tumor in the United States and Western Europe. Similar to melanoma of the skin, it is rare in Africa and Asia. Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound. Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection. Recent treatments also include radiotherapy or photo coagulation. Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types. The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B. C7712 Neoplastic Process Intraocular Melanoma Uveal Melanoma C0220633 CDISC CPTAC CTRP Cellosaurus A malignant neoplasm of the uvea composed of melanocytes. A rare cancer of melanocytes (cells that produce the pigment melanin) found in the eye. Malignant Uveal_Melanoma Intraocular Melanoma MELANOMA, UVEAL, MALIGNANT Melanoma of Uvea Melanoma of the Uvea UVM Uveal Melanoma Uveal Tract Melanoma intraocular melanoma Uveal Melanoma A squamous cell carcinoma that has metastasized to the neck lymph nodes from an unknown primary anatomic site. C7713 Neoplastic Process Squamous Cell Carcinoma Metastatic in the Neck with Occult Primary Neck Squamous Cell Carcinoma of Unknown Primary C0279696 CTRP Malignant Squamous_Cell_Carcinoma_Metastatic_to_the_Neck_with_Occult_Primary Epidermoid Carcinoma Metastatic to the Neck with Occult Primary Head and Neck Squamous Cell Carcinoma of Unknown Primary Neck CUP Neck Carcinoma of Unknown Primary Neck Squamous Cell CUP Neck Squamous Cell Carcinoma of Unknown Primary Squamous Cell Cancer Metastatic to the Neck with Occult Primary Squamous Cell Carcinoma Metastatic in the Neck with Occult Primary Squamous Cell Carcinoma Metastatic to the Neck with Occult Primary Neck Squamous Cell Carcinoma of Unknown Primary Hodgkin lymphoma occurring in childhood. C7714 Neoplastic Process Childhood Hodgkin Lymphoma Childhood Hodgkin Lymphoma C0220644 CTRP NICHD A lymphoma arising from germinal center B cells, which is characterized by multinucleated giant cells (Reed-Sternberg cells) in a background of inflammatory cells. Malignant Childhood_Hodgkin_s_Lymphoma Childhood HD Childhood Hodgkin Lymphoma Childhood Hodgkin's Disease Childhood Hodgkin's Lymphoma Hodgkin Lymphoma Pediatric HD Pediatric Hodgkin's Disease Pediatric Hodgkin's Lymphoma Childhood Hodgkin Lymphoma Soft tissue sarcoma occurring in childhood. C7715 Neoplastic Process Childhood Soft Tissue Sarcoma Childhood Soft Tissue Sarcoma C0220645 CTRP NICHD A heterogeneous group of malignant tumors in childhood that originate from primitive mesenchymal tissue. Malignant Childhood_Soft_Tissue_Sarcoma Childhood Sarcoma of Soft Tissue Childhood Sarcoma of the Soft Tissue Childhood Soft Tissue Sarcoma Pediatric Sarcoma of Soft Tissue Pediatric Sarcoma of the Soft Tissue Pediatric Soft Tissue Sarcoma Soft Tissue Sarcoma Childhood Soft Tissue Sarcoma A urothelial carcinoma that arises from the renal pelvis and ureter. C7716 Neoplastic Process Renal Pelvis and Ureter Urothelial Carcinoma Renal Pelvis and Ureter Urothelial Carcinoma C0220648 CTRP Malignant Transitional_Cell_Carcinoma_of_the_Renal_Pelvis_and_Ureter Renal Pelvis and Ureter TCC Renal Pelvis and Ureter Transitional Cell Cancer Renal Pelvis and Ureter Transitional Cell Carcinoma Renal Pelvis and Ureter Urothelial Cancer Renal Pelvis and Ureter Urothelial Carcinoma TCC of Renal Pelvis and Ureter TCC of the Renal Pelvis and Ureter Transitional Cell Cancer of Renal Pelvis and Ureter Transitional Cell Cancer of the Renal Pelvis and Ureter Transitional Cell Carcinoma of Renal Pelvis and Ureter Upper Urinary Tract Urothelial Carcinoma Urothelial Carcinoma of the Renal Pelvis and Ureter Urothelial Carcinoma of the Upper Urinary Tract Renal Pelvis and Ureter Urothelial Carcinoma A malignant neoplasm arising from the glandular epithelium of the appendix with invasion of the appendiceal wall beyond the muscularis mucosa. The majority of cases are well differentiated adenocarcinomas with mucinous stroma formation. Clinically, it may present as an abdominal mass or with symptoms of acute appendicitis. Patients with chronic ulcerative colitis are at a higher risk in developing appendiceal adenocarcinomas compared to the general population. C7718 Neoplastic Process Appendix Adenocarcinoma C0238003 Malignant Appendix_Adenocarcinoma Adenocarcinoma of Appendix Adenocarcinoma of the Appendix Appendiceal Adenocarcinoma Appendix Adenocarcinoma Appendix Adenocarcinoma An adenocarcinoma that arises from the Bartholin gland. Subtypes include papillary and mucinous adenocarcinoma. C7719 Neoplastic Process Bartholin Gland Adenocarcinoma C0238016 Malignant Bartholin_s_Gland_Adenocarcinoma Adenocarcinoma of Bartholin's Gland Adenocarcinoma of the Bartholin's Gland Bartholin Gland Adenocarcinoma Bartholin's Gland Adenocarcinoma Bartholin Gland Adenocarcinoma A polypoid epithelial neoplasm that arises from the gallbladder. According to the neoplastic growth pattern, it is classified as tubular, tubulopapillary, or papillary. C7720 Neoplastic Process Gallbladder Adenoma C0238137 Benign Gallbladder_Adenoma Adenoma of Gallbladder Adenoma of the Gallbladder Gallbladder Adenoma Gallbladder Adenoma A carcinoma of the oral cavity that arises from the upper or lower gingiva. C7721 Neoplastic Process Gingival Carcinoma C0238141 Malignant Gingival_Carcinoma Carcinoma of Gingiva Carcinoma of Gum Carcinoma of the Gingiva Carcinoma of the Gum Gingival Carcinoma Gum Carcinoma Gingival Carcinoma A malignant mesenchymal neoplasm that arises from the heart. The majority of cases are angiosarcomas. C7723 Neoplastic Process Cardiac Sarcoma C0238152 A rare cancer that develops in tissues of the heart. Malignant Cardiac_Sarcoma Cardiac Sarcoma Heart Sarcoma Sarcoma of Heart Sarcoma of the Heart cardiac sarcoma Cardiac Sarcoma A carcinoma arising from the small intestine. The vast majority are adenocarcinomas. The remaining cases are adenosquamous, squamous, or undifferentiated carcinomas. C7724 Neoplastic Process Small Intestinal Carcinoma Small Intestinal Carcinoma C0238196 CPTAC CTEP CTRP Cellosaurus A rare cancer that forms in tissues of the small intestine (the part of the digestive tract between the stomach and the large intestine). The most common type is adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids). Other types of small intestine cancer include sarcoma (cancer that begins in connective or supportive tissue), carcinoid tumor (a slow-growing type of cancer), gastrointestinal stromal tumor (a type of soft tissue sarcoma), and lymphoma (cancer that begins in immune system cells). Malignant Small_Intestinal_Carcinoma Cancer of Small Bowel Cancer of the Small Bowel Carcinoma of Small Bowel Carcinoma of Small Intestine Carcinoma of the Small Bowel Carcinoma of the Small Intestine Small Bowel Cancer Small Bowel Carcinoma Small Intestinal Cancer Small Intestinal Carcinoma Small Intestine Cancer Small intestine cancer, NOS small intestine cancer Small Intestinal Carcinoma A benign smooth muscle neoplasm arising from the small intestine. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. C7725 Neoplastic Process Small Intestinal Leiomyoma C0238197 Benign Small_Intestinal_Leiomyoma Leiomyoma of Small Bowel Leiomyoma of Small Intestine Leiomyoma of the Small Bowel Leiomyoma of the Small Intestine Leiomyoma, Small Bowel Leiomyoma, Small Intestine Small Bowel Leiomyoma Small Intestinal Leiomyoma Small Intestine Leiomyoma Small Intestinal Leiomyoma A usually aggressive malignant neoplasm arising from the kidney. It is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation in a herringbone growth pattern. C7726 Neoplastic Process Kidney Fibrosarcoma C0238208 Malignant Renal_Fibrosarcoma Fibrosarcoma of Kidney Fibrosarcoma of the Kidney Kidney Fibrosarcoma Renal Fibrosarcoma Kidney Fibrosarcoma A condition in which plasma cells secrete immunoglobulin light chains of only one type, kappa or lambda. Light chain deposition disease is often associated with multiple myeloma or lymphoproliferative disease, but as many as 50% of patients have no evidence of neoplastic plasma cell proliferation. Light chains excreted in the urine are known as Bence Jones protein. Amyloidosis and severe renal failure occur more frequently than in multiple myeloma. Also known as Bence Jones myeloma. L-chain disease, L-chain myeloma, and LCDD. C7727 Neoplastic Process Light Chain Deposition Disease Light Chain Deposition Disease C0238239 CTRP GDC Undetermined Light_Chain_Deposition_Disease 9769/1 Systemic light chain disease Bence Jones Myeloma Light Chain Deposition Disease Light Chain Disease Light Chain Gammopathy Light Chain Deposition Disease A rare form of Paget disease that arises from the scrotum. It is usually not associated with an underlying malignancy. It presents as a red plaque or raised lesion. Microscopically, it is characterized by the presence of the typical Paget cells which are large, round cells with abundant cytoplasm and prominent nuclei. C7728 Neoplastic Process Scrotal Paget Disease C0238330 Malignant Scrotal_Paget_s_Disease Paget Disease of the Scrotum Paget's Disease of Scrotum Paget's Disease of the Scrotum Scrotal Paget Disease Scrotal Paget's Disease Scrotal Paget Disease A squamous cell carcinoma arising from the penis. It occurs chiefly in the squamous epithelium of the glans, coronal sulcus, and foreskin. Etiologic factors include phimosis, lichen sclerosus, smoking, ultraviolet irradiation, history of warts or condylomas, and lack of circumcision. Human papilloma virus is present in a subset of penile squamous cell carcinomas. Patients may present with an exophytic or flat ulcerative mass in the glans or a large primary tumor with inguinal nodal and skin metastases. (WHO, 2004) C7729 Neoplastic Process Squamous Cell Carcinoma of the Penis Penile Squamous Cell Carcinoma C0238348 CTEP CTRP Cellosaurus Malignant Squamous_Cell_Carcinoma_of_the_Penis Epidermoid Carcinoma of Penis Epidermoid Carcinoma of the Penis Epidermoid Cell Carcinoma of Penis Epidermoid Cell Carcinoma of the Penis Penile Epidermoid Carcinoma Penile Epidermoid Cell Carcinoma Penile Squamous Cell Cancer Penile Squamous Cell Carcinoma Penile squamous car.(epidermoid) Penile squamous carcinoma (epidermoid) Squamous Cell Carcinoma of Penis Squamous Cell Carcinoma of the Penis Penile Squamous Cell Carcinoma A malignant mesenchymal neoplasm that arises from the penis. Representative examples include Kaposi sarcoma, leiomyosarcoma, and angiosarcoma. C7730 Neoplastic Process Penile Sarcoma C0238352 Malignant Penile_Sarcoma Penile Sarcoma Sarcoma of Penis Sarcoma of the Penis Penile Sarcoma A rare malignant mesenchymal neoplasm that arises from the prostate gland. Representative examples include leiomyosarcoma, rhabdomyosarcoma, and stromal sarcoma. C7731 Neoplastic Process Prostate Sarcoma C0238393 Malignant Prostate_Sarcoma Prostate Sarcoma Sarcoma of Prostate Sarcoma of the Prostate Prostate Sarcoma Squamous cell carcinoma that affects the renal pelvis. C7732 Neoplastic Process Renal Pelvis Squamous Cell Carcinoma Renal Pelvis Squamous Cell Carcinoma C0238409 CTRP Cellosaurus Malignant Renal_Pelvis_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Kidney Pelvis Epidermoid Carcinoma of Renal Pelvis Epidermoid Carcinoma of the Kidney Pelvis Epidermoid Carcinoma of the Renal Pelvis Kidney Pelvis Epidermoid Carcinoma Kidney Pelvis Squamous Cell Carcinoma Renal Pelvis Epidermoid Carcinoma Renal Pelvis Squamous Cell Cancer Renal Pelvis Squamous Cell Carcinoma Squamous Cell Carcinoma of Kidney Pelvis Squamous Cell Carcinoma of Renal Pelvis Squamous Cell Carcinoma of the Kidney Pelvis Squamous Cell Carcinoma of the Renal Pelvis Renal Pelvis Squamous Cell Carcinoma A malignant germ cell tumor arising from the testis. It represents the rarest of the testicular germ cell tumors. Histologically it is characterized by the presence of syncytiotrophoblasts and cytotrophoblasts. C7733 Neoplastic Process Testicular Choriocarcinoma Testicular Choriocarcinoma C0238449 CTRP Cellosaurus Malignant Testicular_Choriocarcinoma Choriocarcinoma of Testis Choriocarcinoma of the Testis Testicular Choriocarcinoma Testicular Choriocarcinoma A benign adipose tissue neoplasm of the tongue. C7734 Neoplastic Process Tongue Lipoma C0238467 Benign Tongue_Lipoma Lipoma of Tongue Lipoma of the Tongue Tongue Lipoma Tongue Lipoma A morphologic variant of adenocarcinoma that arises from the vagina. It is characterized by the presence of malignant glandular epithelium and clear cells containing glycogen. C7735 Neoplastic Process Vaginal Clear Cell Adenocarcinoma Vaginal Clear Cell Adenocarcinoma C0238517 CTRP Malignant Vaginal_Clear_Cell_Adenocarcinoma Clear Cell Adenocarcinoma of Vagina Clear Cell Adenocarcinoma of the Vagina Vagina Clear Cell Adenocarcinoma Vaginal Clear Cell Adenocarcinoma Vaginal Clear Cell Adenocarcinoma Vaginal squamous cell carcinoma in which information on the p16 immunohistochemistry or HPV testing status is not available. C7736 Neoplastic Process Vaginal Squamous Cell Carcinoma, Not Otherwise Specified Vaginal Squamous Cell Carcinoma, Not Otherwise Specified C0238518 CTRP Cellosaurus Malignant Vaginal_Squamous_Cell_Carcinoma Vaginal Squamous Cell Cancer, NOS Vaginal Squamous Cell Carcinoma, NOS Vaginal Squamous Cell Carcinoma, Not Otherwise Specified Vaginal Squamous Cell Carcinoma, Not Otherwise Specified A malignant mesenchymal neoplasm that arises from the vagina. Representative examples include botryoid-type embryonal rhabdomyosarcoma, leiomyosarcoma, and endometrioid stromal sarcoma. C7737 Neoplastic Process Vaginal Sarcoma C0238519 Malignant Vaginal_Sarcoma Sarcoma of Vagina Sarcoma of the Vagina Vagina Sarcoma Vaginal Sarcoma Vaginal Sarcoma A hemangioma arising from the brain. C7739 Neoplastic Process Brain Hemangioma C0238814 Benign Brain_Hemangioma Brain Angioma Brain Hemangioma Brain Hemangioma A hemangioma arising from any part of the digestive system. C7741 Neoplastic Process Digestive System Hemangioma C0239707 Benign Gastrointestinal_Hemangioma Angioma of Digestive System Angioma of Gastrointestinal System Angioma of the Digestive System Angioma of the Gastrointestinal System Digestive Angioma Digestive Hemangioma Digestive System Angioma Digestive System Hemangioma Gastrointestinal Angioma Gastrointestinal Hemangioma Gastrointestinal System Angioma Gastrointestinal System Hemangioma Hemangioma of Digestive System Hemangioma of Gastrointestinal System Hemangioma of the Digestive System Hemangioma of the Gastrointestinal System Digestive System Hemangioma A benign exophytic neoplasm that arises from the larynx, usually the true vocal cords. It is related to human papillomavirus infection and may arise as a single or multiple lesions. It is characterized by the presence of a connective tissue core covered by stratified squamous epithelium. Hoarseness is the presenting symptom. Transformation to carcinoma is rare. C7742 Neoplastic Process Laryngeal Squamous Papilloma C0240164 Benign Squamous_Papilloma_of_the_Larynx Laryngeal Papilloma Laryngeal Squamous Cell Papilloma Laryngeal Squamous Papilloma Larynx Papilloma Papilloma of Larynx Papilloma of the Larynx Squamous Papilloma of Larynx Squamous Papilloma of the Larynx Laryngeal Squamous Papilloma A hemangioma arising from the mucous membranes. C7744 Neoplastic Process Mucous Membrane Hemangioma C0240392 Benign Mucous_Membrane_Hemangioma Mucous Membrane Hemangioma Mucous Membrane Hemangioma A myxoma arising from the endocardium. C7748 Neoplastic Process Cardiac Myxoma C0262929 Benign Endocardial_Myxoma Cardiac Myxoma Endocardial Myxoma Endocardium, Myxoma Myxoma of Endocardium Myxoma of the Endocardium Cardiac Myxoma A skin neoplasm composed of fibrohistiocytic cells, spindle fibrous cells, and histiocytes in a storiform pattern. C7749 Neoplastic Process Skin Fibrohistiocytic Neoplasm C0263010 Undetermined Cutaneous_Fibrohistiocytic_Neoplasm Cutaneous Fibrohistiocytic Neoplasm Skin Fibrohistiocytic Neoplasm Skin Fibrohistiocytic Neoplasm Pericarditis caused by the infiltration of the pericardium by a malignant neoplasm. The diagnosis is based on the cytological examination of pericardial fluid or the histologic examination of pericardial tissue. C7753 Neoplastic Process Malignant Pericarditis C0265156 Malignant Malignant_Pericarditis Malignant Pericarditis Pericarditis, Malignant Malignant Pericarditis A large apocrine gland located in the area surrounding the anal orifice. C77610 Body Part, Organ, or Organ Component Circumanal Gland C0031021 CDISC Superficial sebaceous glands located around the anus and contain fat. (Textbook of Small Animal Surgery - Volume 1. Slatter D (Ed.) (2003) Elsevier Health Sciences, Philadelpha PA) Circumanal_Gland Circumanal Gland GLAND, CIRCUMANAL Circumanal Gland Any of the lymph nodes adjacent to the stomach and duodenum. C77640 Body Part, Organ, or Organ Component Hepatic Lymph Node C0229769 CDISC Lymph node(s) adjacent to the liver. Hepatic_Lymph_Node HEPATIC LYMPH NODE Hepatic Lymph Node LYMPH NODE, HEPATIC Hepatic Lymph Node A lymph node located in the mesentery. C77641 Body Part, Organ, or Organ Component Mesenteric Lymph Node C0229792 CDISC GDC PCDC UBERON Lymph node(s) in or adjacent to the mesentery. The lymph nodes located in the mesentery, of which there are 3 classes: ileocolic, juxtaintestinal mesenteric, and central superior group. Mesenteric_Lymph_Node Lymph Node(s) Mesenteric Mesenteric Mesenteric lymph nodes UBERON:0002509 LYMPH NODE, MESENTERIC Lymph Node(s) Mesenteric MESENTERIC LYMPH NODE Mesenteric Lymph Node Mesenteric Nodes Mesenteric lymph nodes mesenteric lymph node mesenteric node Mesenteric Lymph Node A lymph node of the pancreas. C77642 Body Part, Organ, or Organ Component Pancreatic Lymph Node C0229783 CDISC Lymph node(s) in or adjacent to the pancreas. Pancreatic_Lymph_Node LYMPH NODE, PANCREATIC PERIPANCREATIC LYMPH NODE Pancreatic Lymph Node Pancreatic Lymph Node A lymph node located adjacent to the lumbar region of the spine. C77643 Body Part, Organ, or Organ Component Paraaortic Lymph Node C0229789 CDISC GDC PCDC UBERON mCode Lymph node(s) adjacent to the lumbar vertebral column. The paraaortic lymph nodes (also known as para-aortic, periaortic, and peri-aortic) are a group of lymph nodes that lie in front of the lumbar vertebral bodies near the aorta. These lymph nodes receive drainage from the lower gastrointestinal tract and the pelvic organs. Paraaortic_Lymph_Node Aortic Lymph Node(s) Paraaortic Paraaortic Paraaortic lymph nodes UBERON:0016386 Aortic Lymph Node LYMPH NODE, LUMBAR Lymph Node(s) Paraaortic Lymph Node, Para-Aortic PARA-AORTIC LYMPH NODE Para-Aortic Nodes Paraaortic Lymph Node Paraaortic lymph nodes Structure of aortic lymph node (body structure) lateral aortic lymph node lateral aortic node para-aortic lymph node paraaortic lymph node Paraaortic Lymph Node A lymph node located in the peritoneum. C77644 Body Part, Organ, or Organ Component Peritoneal Lymph Node C2698769 CDISC A lymph node located in the peritoneum. Peritoneal_Lymph_Node PERITONEAL LYMPH NODE Peritoneal Lymph Node Peritoneal Lymph Node Lymph nodes surrounding the portal vein. C77645 Body Part, Organ, or Organ Component Portal Lymph Node CL387033 CDISC Lymph node(s) adjacent to the portal vein. Portal_Lymph_Node LYMPH NODE, PORTAL PORTAL LYMPH NODE Periportal Lymph Node Portal Lymph Node Portal Lymph Node A lymph node located in the hilar area of the kidney or the fat surrounding the kidney. C77646 Body Part, Organ, or Organ Component Renal Lymph Node C2699031 CDISC Lymph node(s) adjacent to the hilar region of the kidney. Renal_Lymph_Node LYMPH NODE, RENAL Renal Lymph Node Renal Lymph Node A lymph node located in the sacral region. C77647 Body Part, Organ, or Organ Component Sacral Lymph Node C0229827 CDISC Lymph node(s) in the sacral region. Sacral_Lymph_Node LYMPH NODE, SACRAL Sacral Lymph Node Sacral Lymph Node A lymph node located in the retrosacral region. C77648 Body Part, Organ, or Organ Component Retrosacral Lymph Node C2699070 Retrosacral_Lymph_Node Retrosacral Lymph Node Retrosacral Lymph Node A lymph node located in the retropharyngeal space behind the upper part of the pharynx. C77649 Body Part, Organ, or Organ Component Retropharyngeal Lymph Node C0229737 CDISC mCode Lymph node(s) in the retropharyngeal space. Retropharyngeal_Lymph_Node LYMPH NODE, RETROPHARYNGEAL Lymph node level VIIA (qualifier value) RETROPHARYNGEAL LYMPH NODE Retropharyngeal Lymph Node Suprapharyngeal Lymph Node Retropharyngeal Lymph Node Multiple myeloma associated with osteosclerotic and fibrotic changes in the bone trabeculae. Often, the lymph nodes show changes resembling the plasma cell variant of Castleman disease. It is often part of POEMS syndrome which is characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes. C7765 Neoplastic Process Osteosclerotic Multiple Myeloma C3898068 Malignant Osteosclerotic_Myeloma Osteosclerotic Multiple Myeloma Osteosclerotic Plasma Cell Myeloma Osteosclerotic Multiple Myeloma A lymph node located beneath the floor of the oral cavity. C77650 Body Part, Organ, or Organ Component Submandibular Lymph Node C0229722 CDISC GDC UBERON Lymph node(s) adjacent to the mandible. The submandibular lymph nodes (submaxillary glands in older texts), three to six in number, are placed beneath the body of the mandible in the submaxillary triangle, and rest on the superficial surface of the submaxillary salivary gland. One gland, the middle gland of Stahr, which lies on the external maxillary artery as it turns over the mandible, is the most constant of the series; small lymph glands are sometimes found on the deep surface of the submaxillary salivary glands. The afferents of the submaxillary glands drain the medial palpebral commissure, the cheek, the side of the nose, the upper lip, the lateral part of the lower lip, the gums, and the anterior part of the margin of the tongue. Efferent vessels from the facial and submental glands also enter the submaxillary glands. Their efferent vessels pass to the superior deep cervical glands. Submandibular_Lymph_Node Lymph Node(s) Submandibular Submandibular Submandibular lymph nodes UBERON:0002520 LYMPH NODE, MANDIBULAR Lymph Node(s) Submandibular Lymph Node, Submandibular SUBMANDIBULAR LYMPH NODE Submandibular Lymph Node Submandibular lymph nodes submandibular lymph node submandibular node Submandibular Lymph Node A lymph node located near the bifurcation of the trachea. C77651 Body Part, Organ, or Organ Component Tracheobronchial Lymph Node C0229751 CDISC mCode Lymph node(s) adjacent to the bifurcation of the trachea. Tracheobronchial_Lymph_Node LYMPH NODE, TRACHEOBRONCHIAL Tracheobronchial Lymph Node Tracheobronchial lymph node group (body structure) Tracheobronchial Lymph Node A lymph node located in the intercostal space of the thoracic wall. C77652 Body Part, Organ, or Organ Component Intercostal Lymph Node C0229761 CDISC mCode Lymph node(s) in the intercostal space. Intercostal_Lymph_Node Intercostal Lymph Node Intercostal lymph node (body structure) LYMPH NODE, INTERCOSTAL Intercostal Lymph Node Stage III includes: IIIA (T1-T2, N1, M0); IIIB (T3-T4, N1, M0); IIIC (Any T, N2, M0). N1: Metastasis in 1 to 3 regional lymph nodes. N2: Metastasis in 4 or more regional lymph nodes. M0: No distant metastasis. (AJCC 6th ed.) C7766 Neoplastic Process Stage III Colon Cancer AJCC v6 Stage III Colon Cancer AJCC v6 C0278480 CTRP Malignant Stage_III_Colon_Cancer AJCC Stage III Colon Cancer v6 Colon Cancer Stage III AJCC v6 Colon Cancer, Stage III AJCC v6 Dukes C Carcinoma of Colon Dukes C Carcinoma of the Colon Dukes C Colon Carcinoma Dukes C Colonic Carcinoma Stage III Carcinoma of Colon AJCC v6 Stage III Carcinoma of the Colon AJCC v6 Stage III Colon Cancer Stage III Colon Cancer AJCC v6 Stage III Colon Carcinoma AJCC v6 Stage III Colonic Carcinoma AJCC v6 Stage III Colon Cancer AJCC v6 Stage 1 includes T1, NO, MO. T1: Tumor 2.0 cm or less in greatest dimension. T1mic: Microinvasion 0.1 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th Ed.)-2003 C7767 Neoplastic Process Stage I Breast Cancer AJCC v6 Stage I Breast Cancer AJCC v6 C0278485 CTRP Stage I breast cancer is divided into stages IA and IB. In stage IA, the tumor is 2 centimeters or smaller and has not spread outside the breast. In stage IB, (1) no tumor is found in the breast, but small clusters of cancer cells (larger than 0.2 millimeter but not larger than 2 millimeters) are found in the lymph nodes; or (2) the tumor is 2 centimeters or smaller and small clusters of cancer cells (larger than 0.2 millimeter but not larger than 2 millimeters) are found in the lymph nodes. Malignant Stage_I_Breast_Cancer Breast Cancer Stage I AJCC v6 Breast Carcinoma Stage I AJCC v6 Stage I Breast Cancer Stage I Breast Cancer AJCC v6 Stage I Breast Carcinoma AJCC v6 stage I breast cancer Stage I Breast Cancer AJCC v6 Stage II includes: IIA: (T0, N1, M0); (T1, N1, M0); (T2, N0, M0) and IIB: (T2, N1, M0); (T3, N0, M0). T0: No evidence of primary tumor. T1: Tumor 2.0 cm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. T2: Tumor more than 2.0 cm but not more than 5.0 cm in greatest dimension. T3: Tumor more than 5.0 cm in greatest dimension. N1: Metastasis to movable ipsilateral axillary lymph node(s). M0: No distant metastasis. (AJCC 6th and 7th Eds.) C7768 Neoplastic Process Stage II Breast Cancer AJCC v6 and v7 Stage II Breast Cancer AJCC v6 and v7 C0278486 CTRP Stage II breast cancer is divided into stages IIA and IIB. In stage IIA, (1) no tumor is found in the breast, but cancer is found in the axillary (under the arm) lymph nodes; or (2) the tumor is 2 centimeters or smaller and has spread to the axillary lymph nodes; or (3) the tumor is larger than 2 centimeters but not larger than 5 centimeters and has not spread to the axillary lymph nodes. In stage IIB, the tumor is (1) larger than 2 centimeters but not larger than 5 centimeters and has spread to the axillary lymph nodes; or (2) larger than 5 centimeters but has not spread to the axillary lymph nodes. Malignant Stage_II_Breast_Cancer Breast Cancer Stage II Carcinoma of Breast Stage II Carcinoma of the Breast Stage II Stage II Breast Cancer Stage II Breast Cancer AJCC v6 Stage II Breast Cancer AJCC v6 and v7 Stage II Breast Cancer AJCC v7 Stage II Breast Carcinoma stage II breast cancer Stage II Breast Cancer AJCC v6 and v7 Bone marrow in the femoral bone. C77686 Body Part, Organ, or Organ Component Bone Marrow, Femur C2698535 CDISC Bone marrow in the femoral bone. (NCI) Bone_Marrow_Femur BONE MARROW, FEMUR Bone Marrow, Femoral Bone Marrow, Femur Bone Marrow, Femur Bone marrow in the humerus bone. C77687 Body Part, Organ, or Organ Component Bone Marrow, Humerus C2698536 CDISC Bone marrow in the humerus bone. (NCI) Bone_Marrow_Humerus BONE MARROW, HUMERUS Bone Marrow, Humerus Bone Marrow, Humerus Bone marrow in the rib. C77688 Body Part, Organ, or Organ Component Bone Marrow, Rib C0729291 CDISC Bone marrow in the rib. (NCI) Bone_Marrow_Rib BONE MARROW, RIB Bone Marrow, Rib Bone Marrow, Rib Bone marrow in the scapula. C77689 Body Part, Organ, or Organ Component Bone Marrow, Scapula C2698537 CDISC Bone marrow in the scapula. (NCI) Bone_Marrow_Scapula BONE MARROW, SCAPULA Bone Marrow, Scapula Bone Marrow, Scapula Stage III is divided into two stages IIIA and IIIB. Stage IIIA includes: (T0, N2, M0); (T1, N2, M0); (T2, N2, M0); (T3, N1, M0); (T3, N2, M0). Stage IIIB includes: (T4, any N, M0). T4: Tumor of any size with direct extension to (a) chest wall or (b) skin. N2: Metastases in ipsilateral axillary lymph nodes fixed or matted, or in clinically apparent ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastasis. N3: Metastasis in ipsilateral infraclavicular lymph nodes(s) with or without axillary lymph node involvement, or in clinically apparent ipsilateral internal mammary lymph node(s); and in the presence of clinically evident axillary lymph node metastasis or metastasis in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement. M0: No distant metastasis. (AJCC 6th Ed.) C7769 Neoplastic Process Stage III Breast Cancer AJCC v6 Stage III Breast Cancer AJCC v6 C0278487 CTRP Stage III breast cancer is divided into stages IIIA, IIIB, and IIIC. In stage IIIA, (1) no tumor is found in the breast, but cancer is found in axillary (under the arm) lymph nodes that are attached to each other or to other structures, or cancer may be found in lymph nodes near the breastbone; or (2) the tumor is 2 centimeters or smaller and cancer has spread to axillary lymph nodes that are attached to each other or to other structures, or the cancer may have spread to lymph nodes near the breastbone; or (3) the tumor is larger than 2 centimeters but not larger than 5 centimeters and cancer has spread to axillary lymph nodes that are attached to each other or to other structures, or cancer may have spread to lymph nodes near the breastbone; or (4) the tumor is larger than 5 centimeters and cancer has spread to axillary lymph nodes that may be attached to each other or to other structures, or the cancer may have spread to lymph nodes near the breastbone. In stage IIIB, the tumor may be any size and cancer (1) has spread to the chest wall and/or the skin of the breast; and (2) may have spread to axillary lymph nodes that may be attached to each other or to other structures, or the cancer may have spread to lymph nodes near the breastbone. In stage IIIC, there may be no sign of cancer in the breast or the tumor may be any size and may have spread to the chest wall and/or the skin of the breast. Also, cancer (1) has spread to lymph nodes above or below the collarbone, and (2) may have spread to axillary lymph nodes or to lymph nodes near the breastbone. In operable stage IIIC, the cancer is found (1) in ten or more axillary lymph nodes; or (2) in the lymph nodes below the collarbone; or (3) is found in axillary lymph nodes and in lymph nodes near the breastbone. In inoperable stage IIIC, the cancer has spread to the lymph nodes above the collarbone. Malignant Stage_III_Breast_Cancer Breast Cancer Stage III AJCC v6 Breast Carcinoma Stage III AJCC v6 Stage III Breast Cancer Stage III Breast Cancer AJCC v6 Stage III Breast Carcinoma AJCC v6 stage III breast cancer Stage III Breast Cancer AJCC v6 Bone marrow in the sternum. C77690 Body Part, Organ, or Organ Component Bone Marrow, Sternum C0229620 CDISC Bone marrow in the sternum. (NCI) Bone_Marrow_Sternum BONE MARROW, STERNUM Bone Marrow, Sternal Bone Marrow, Sternum Bone Marrow, Sternum Bone marrow in the tibia bone. C77691 Body Part, Organ, or Organ Component Bone Marrow, Tibia C2698539 CDISC Bone marrow in the tibia bone. (NCI) Bone_Marrow_Tibia BONE MARROW, TIBIA Bone Marrow, Tibia Bone Marrow, Tibia Bone marrow in a vertebral bone. C77692 Body Part, Organ, or Organ Component Bone Marrow, Vertebral C0229622 CDISC Bone marrow in a vertebral bone. (NCI) Bone_Marrow_Vertebral BONE MARROW, VERTEBRUM Bone Marrow, Vertebral Bone Marrow, Vertebral Stage IIIA includes: (T0, N2, M0); (T1, N2, M0); (T2, N2, M0); (T3, N1, M0); (T3, N2, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. T3: Tumor more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+). (AJCC 7th Ed.) C7770 Neoplastic Process Stage IIIA Breast Cancer AJCC v7 Stage IIIA Breast Cancer AJCC v7 C0278489 CTRP Stage III breast cancer is divided into stages IIIA, IIIB, and IIIC. In stage IIIA, (1) no tumor is found in the breast, but cancer is found in axillary (under the arm) lymph nodes that are attached to each other or to other structures, or cancer may be found in lymph nodes near the breastbone; or (2) the tumor is 2 centimeters or smaller and cancer has spread to axillary lymph nodes that are attached to each other or to other structures, or the cancer may have spread to lymph nodes near the breastbone; or (3) the tumor is larger than 2 centimeters but not larger than 5 centimeters and cancer has spread to axillary lymph nodes that are attached to each other or to other structures. Malignant Stage_IIIA_Breast_Cancer Breast Cancer Stage IIIA Breast Carcinoma Stage IIIA Stage IIIA Breast Cancer Stage IIIA Breast Cancer AJCC v7 Stage IIIA Breast Carcinoma stage IIIA breast cancer Stage IIIA Breast Cancer AJCC v7 The reemergence of carcinoma in the breast after a period of remission. C7771 Neoplastic Process Recurrent Breast Carcinoma Recurrent Breast Carcinoma C0278493 CTRP Malignant Recurrent_Breast_Cancer Breast Cancer, Recurrent Recurrent Breast Cancer Recurrent Breast Carcinoma Recurrent Breast Carcinoma Stage I includes: IA: (T1, N0, M0) and IB: (T1, N1, M0); (Ta/b, N0, M0). T1: Tumor invades lamina propria or submucosa. T2: Tumor invades the muscularis propria or the subserosa. T2a: Tumor invades muscularis propria. T2b: Tumor invades subserosa. N0: No regional lymph node metastasis. N1: Metastasis in 1 to 6 regional lymph nodes. N2: Metastasis in 7 to 15 regional lymph nodes. M0: No distant metastasis. (AJCC 6th ed.) C7772 Neoplastic Process Stage I Gastric Cancer AJCC v6 Stage I Gastric Cancer AJCC v6 C0278495 CTRP Stage I is divided into stage IA and stage IB, depending on where the cancer has spread. In stage IA, cancer has spread completely through the mucosal (innermost) layer of the stomach wall. In stage IB, cancer has spread completely through the mucosal (innermost) layer of the stomach wall and is found in up to 6 lymph nodes near the tumor, or has spread to the muscularis (middle) layer of the stomach wall. Malignant Stage_I_Gastric_Cancer Carcinoma of Stomach Stage I AJCC v6 Carcinoma of the Stomach Stage I AJCC v6 Gastric Carcinoma Stage I AJCC v6 Gastric Carcinoma, Stage I AJCC v6 Stage I Carcinoma of Stomach AJCC v6 Stage I Carcinoma of the Stomach AJCC v6 Stage I Gastric (Stomach) Cancer Stage I Gastric Cancer AJCC v6 Stage I Gastric Carcinoma AJCC v6 Stage I Stomach Carcinoma AJCC v6 Stomach Cancer Stage I AJCC v6 Stomach Carcinoma Stage I AJCC v6 stage I stomach cancer Stage I Gastric Cancer AJCC v6 Stage II includes: (T1, N2, M0), (T2a/b, N1, M0), (T3, N0, M0). T1: Tumor invades lamina propria or submucosa. T2: Tumor invades muscularis propria or submucosa. T2a: Tumor invades muscularis propria. T2b: Tumor invades subserosa. T3: Tumor penetrates serosa (visceral peritoneum) without invasion of adjacent structures. N1: Metastasis in 1 to 6 regional lymph nodes. Metastasis in 7 to 15 regional lymph nodes. M0: No distant metastasis. (AJCC 6th ed.) C7773 Neoplastic Process Stage II Gastric Cancer AJCC v6 Stage II Gastric Cancer AJCC v6 C0278496 CTRP Cancer has spread (1) completely through the mucosal (innermost) layer of the stomach wall and is found in 7 to 15 lymph nodes near the tumor, or (2) to the muscularis (middle) layer of the stomach wall and is found in up to 6 lymph nodes near the tumor, or (3) to the serosal (outermost) layer of the stomach wall but not to lymph nodes or other organs. Malignant Stage_II_Gastric_Cancer Carcinoma of Stomach Stage II AJCC v6 Carcinoma of the Stomach Stage II AJCC v6 Gastric Carcinoma Stage II AJCC v6 Gastric Carcinoma, Stage II AJCC v6 Stage II Carcinoma of Stomach AJCC v6 Stage II Carcinoma of the Stomach AJCC v6 Stage II Gastric (Stomach) Cancer Stage II Gastric Cancer AJCC v6 Stage II Gastric Carcinoma AJCC v6 Stage II Stomach Cancer AJCC v6 Stage II Stomach Carcinoma AJCC v6 Stomach Cancer Stage II AJCC v6 Stomach Carcinoma Stage II AJCC v6 stage II stomach cancer Stage II Gastric Cancer AJCC v6 Stage III includes: IIIA (T2a/b, N2, M0); (T3, N1, M0); (T4, N0, M0). IIIB: (T3, N2, M0). N0: No regional lymph node metastasis. N1: Metastasis in 1 to 6 regional lymph nodes. N2: Metastasis in 7 to 15 regional lymph nodes. T2a: Tumor invades muscularis propria. T2b: Tumor invades subserosa. T3: Tumor penetrates serosa (visceral peritoneum) without invasion of adjacent structures. T4: Tumor invades adjacent structures. M0: No distant metastasis. (AJCC 6th ed.) C7774 Neoplastic Process Stage III Gastric Cancer AJCC v6 Stage III Gastric Cancer AJCC v6 C0278497 CTRP Stage III is divided into stage IIIA and stage IIIB depending on where the cancer has spread. In stage IIIA, cancer has spread to (1) the muscularis (middle) layer of the stomach wall and is found in 7 to 15 lymph nodes near the tumor, or (2) the serosal (outermost) layer of the stomach wall and is found in 1 to 6 lymph nodes near the tumor, or (3) to organs next to the stomach but not to lymph nodes or other parts of the body. In stage IIIB, cancer has spread to the serosal (outermost) layer of the stomach wall and is found in 7 to 15 lymph nodes near the tumor. Malignant Stage_III_Gastric_Cancer Carcinoma of Stomach Stage III AJCC v6 Carcinoma of the Stomach Stage III AJCC v6 Gastric Carcinoma Stage III AJCC v6 Gastric Carcinoma, Stage III AJCC v6 Stage III Carcinoma of Stomach AJCC v6 Stage III Carcinoma of the Stomach AJCC v6 Stage III Gastric (Stomach) Cancer Stage III Gastric Cancer AJCC v6 Stage III Gastric Carcinoma AJCC v6 Stage III Stomach Cancer AJCC v6 Stage III Stomach Carcinoma AJCC v6 Stomach Cancer Stage III AJCC v6 Stomach Carcinoma Stage III AJCC v6 stage III stomach cancer Stage III Gastric Cancer AJCC v6 Stage II includes: (T2, N0, M0); (T3,N0, M0). T2: Tumor more than 2 cm but not more than 5 cm in greatest dimension. T3: Tumor more than 5 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C7775 Neoplastic Process Stage II Anal Canal Cancer AJCC v6 and v7 Stage II Anal Canal Cancer AJCC v6 and v7 C0278500 CTRP Cancer that has spread beyond the top layer of anal tissue and is larger than 2 centimeters (about 1 inch) but has not spread to nearby organs or lymph nodes. Malignant Stage_II_Anal_Canal_Cancer Stage II Anal Canal Cancer Stage II Anal Canal Cancer AJCC v6 Stage II Anal Canal Cancer AJCC v6 and v7 Stage II Anal Canal Cancer AJCC v7 Stage II Anal Canal Carcinoma AJCC v6 and v7 Stage II Anal Carcinoma AJCC v6 and v7 stage II anal cancer Stage II Anal Canal Cancer AJCC v6 and v7 Stage III includes: IIIA (T1, N1, M0); (T2, N1, M0); (T3, N1, M0); (T4, N0, M0); IIIB (T4, N1, M0); (Any T, N2, M0); (Any T, N3, M0). T1: Tumor 2 cm or less in greatest dimension. T2: tumor more than 2 cm but not more than 5 cm in greatest dimension. T3: Tumor more than 5 cm in greatest dimension. T4: Tumor of any size that invades adjacent organ(s). N1: Metastasis in perirectal lymph node(s). N2: Metastasis in unilateral internal iliac and/or inguinal lymph node(s). N3: Metastasis in perirectal and inguinal lymph nodes and/or bilateral internal iliac and/or inguinal lymph nodes. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C7776 Neoplastic Process Stage III Anal Canal Cancer AJCC v6 and v7 Stage III Anal Canal Cancer AJCC v6 and v7 C0278501 CTRP Stage III anal cancer is divided into stages IIIA and IIIB. In stage IIIA, the tumor may be any size and has spread to either (1) lymph nodes near the rectum; or (2) nearby organs, such as the vagina, urethra, and bladder. In stage IIIB, the tumor may be any size and has spread to (1) nearby organs and to lymph nodes near the rectum; or (2) lymph nodes on one side of the pelvis and/or groin, and may have spread to nearby organs; or (3) lymph nodes near the rectum and in the groin, and/or to lymph nodes on both sides of the pelvis and/or groin, and may have spread to nearby organs. Malignant Stage_III_Anal_Canal_Cancer Stage III Anal Canal Cancer Stage III Anal Canal Cancer AJCC v6 Stage III Anal Canal Cancer AJCC v6 and v7 Stage III Anal Canal Cancer AJCC v7 Stage III Anal Canal Carcinoma AJCC v6 and v7 Stage III Anal Carcinoma AJCC v6 and v7 stage III anal cancer Stage III Anal Canal Cancer AJCC v6 and v7 Stage II includes: IIA (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0) and IIB (T2b, N1, M0); (T3, N0, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C7777 Neoplastic Process Stage II Non-Small Cell Lung Cancer AJCC v7 Stage II Lung Non-Small Cell Cancer AJCC v7 C0278505 CTRP Malignant Stage_II_Non-Small_Cell_Lung_Cancer Non -Small Cell Lung Cancer Stage II Non Small Cell Lung Cancer Stage II Stage II Lung Non-Small Cell Cancer AJCC v7 Stage II Non-Oat Cell Carcinoma of Lung Stage II Non-Oat Cell Carcinoma of the Lung Stage II Non-Oat Cell Lung Carcinoma Stage II Non-Small Cell Carcinoma of Lung Stage II Non-Small Cell Carcinoma of the Lung Stage II Non-Small Cell Lung Cancer Stage II Non-Small Cell Lung Cancer AJCC v7 Stage II Non-Small Cell Lung Carcinoma Stage II Lung Non-Small Cell Cancer AJCC v7 Stage III includes: IIIA (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0) and IIIB (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C7778 Neoplastic Process Stage III Non-Small Cell Lung Cancer AJCC v7 Stage III Lung Non-Small Cell Cancer AJCC v7 C0278506 CTRP Malignant Stage_III_Non-Small_Cell_Lung_Cancer Stage III Lung Non-Small Cell Cancer AJCC v7 Stage III NSCLC Stage III Non-Oat Cell Carcinoma of Lung Stage III Non-Oat Cell Carcinoma of the Lung Stage III Non-Oat Cell Lung Carcinoma Stage III Non-Small Cell Carcinoma of Lung Stage III Non-Small Cell Carcinoma of the Lung Stage III Non-Small Cell Lung Cancer Stage III Non-Small Cell Lung Cancer AJCC v7 Stage III Non-Small Cell Lung Carcinoma Stage III Lung Non-Small Cell Cancer AJCC v7 A carcinoma originating from the apical lung. Most superior sulcus lung carcinomas are bronchogenic carcinomas. This carcinoma may be associated with Pancoast syndrome. lt is also known as Pancoast tumor. C7779 Neoplastic Process Superior Sulcus Lung Carcinoma C1336529 Malignant Superior_Sulcus_Lung_Carcinoma Superior Sulcus Carcinoma of Lung Superior Sulcus Carcinoma of the Lung Superior Sulcus Lung Carcinoma Superior Sulcus Lung Carcinoma Osteosarcoma that is confined to a specific site without evidence of spread to other anatomic sites. C7780 Neoplastic Process Localized Osteosarcoma Localized Osteosarcoma C0278511 CTRP Malignant Localized_Osteosarcoma Localized Osteogenic Sarcoma Localized Osteosarcoma Osteosarcoma, Localized Localized Osteosarcoma An osteosarcoma which has spread to another anatomical site. C7781 Neoplastic Process Metastatic Osteosarcoma Metastatic Osteosarcoma C0278512 CTRP Malignant Metastatic_Osteosarcoma Metastatic Osteogenic Sarcoma Metastatic Osteosarcoma Osteosarcoma, Metastatic Metastatic Osteosarcoma Stage IIIB includes: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0). T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules). N0: No regional lymph node metastasis. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+). (AJCC 7th Ed.) C7782 Neoplastic Process Stage IIIB Breast Cancer AJCC v7 Stage IIIB Breast Cancer AJCC v7 C0278513 CTRP Stage III breast cancer is divided into stages IIIA, IIIB, and IIIC. In stage IIIB, the tumor may be any size and cancer (1) has spread to the chest wall and/or the skin of the breast; and (2) may have spread to axillary (under the arm) lymph nodes that may be attached to each other or to other structures, or the cancer may have spread to lymph nodes near the breastbone. Malignant Stage_IIIB_Breast_Cancer Breast Cancer Stage IIIB Breast Carcinoma Stage IIIB Stage IIIB Breast Cancer Stage IIIB Breast Cancer AJCC v7 Stage IIIB Breast Carcinoma stage IIIB breast cancer Stage IIIB Breast Cancer AJCC v7 The re-emergence of non-small cell lung carcinoma after a period of remission. C7783 Neoplastic Process Recurrent Non-Small Cell Lung Carcinoma Recurrent Lung Non-Small Cell Carcinoma C0278517 CTRP Malignant Recurrent_Non-Small_Cell_Lung_Cancer Non Small Cell Lung Cancer Recurrent Non Small Cell Lung Cancer, Recurrent Recurrent Lung Non-Small Cell Carcinoma Recurrent NSCLC Recurrent Non-Small Cell Cancer of Lung Recurrent Non-Small Cell Cancer of the Lung Recurrent Non-Small Cell Lung Cancer Recurrent Non-Small Cell Lung Carcinoma Recurrent Lung Non-Small Cell Carcinoma The reemergence of acute lymphoblastic leukemia in childhood after a period of remission. C7784 Neoplastic Process Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia C0278519 CTRP Malignant Recurrent_Childhood_Acute_Lymphoblastic_Leukemia Recurrent Acute Lymphoblastic Leukemia (ALL) Recurrent Childhood ALL Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphocytic Leukemia Recurrent Childhood Acute Lymphogenous Leukemia Recurrent Childhood Acute Lymphoid Leukemia Recurrent Childhood Precursor Lymphoblastic Leukemia Recurrent Pediatric ALL Recurrent Pediatric Acute Lymphoblastic Leukemia Recurrent Pediatric Acute Lymphocytic Leukemia Recurrent Pediatric Acute Lymphogenous Leukemia Recurrent Pediatric Acute Lymphoid Leukemia Relapsed Childhood ALL Relapsed Childhood Acute Lymphoblastic Leukemia Relapsed Childhood Acute Lymphocytic Leukemia Relapsed Pediatric ALL Relapsed Pediatric Acute Lymphoblastic Leukemia Relapsed Pediatric Acute Lymphocytic Leukemia Relapsed Pediatric Acute Lymphogenous Leukemia Relapsed Pediatric Acute Lymphoid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Stage I includes: IA (T1, N0, M0); IB (T2, N0, M0). T1: Tumor limited to the pancreas 2 cm or less in greatest dimension. T2: Tumor limited to the pancreas, more than 2 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C7785 Neoplastic Process Stage I Pancreatic Cancer AJCC v6 and v7 Stage I Pancreatic Cancer AJCC v6 and v7 C1167720 CTRP Cancer is found in the pancreas only. Stage I is divided into stage IA and stage IB based on tumor size. In stage IA, the tumor is no larger than 2 centimeters and in stage IB, the tumor is larger than 2 centimeters. Malignant Stage_I_Pancreatic_Cancer Pancreatic Cancer Stage I Stage I Carcinoma of Pancreas Stage I Carcinoma of the Pancreas Stage I Exocrine and Endocrine Pancreatic Cancer AJCC v6 and v7 Stage I Pancreatic Cancer Stage I Pancreatic Cancer AJCC v6 Stage I Pancreatic Cancer AJCC v6 and v7 Stage I Pancreatic Cancer AJCC v7 Stage I Pancreatic Carcinoma stage I pancreatic cancer Stage I Pancreatic Cancer AJCC v6 and v7 Stage II includes: IIA (T3, N0, M0); IIB (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T1: Tumor limited to the pancreas 2 cm or less in greatest dimension. T2: Tumor limited to the pancreas, more than 2 cm in greatest dimension. T3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C7786 Neoplastic Process Stage II Pancreatic Cancer AJCC v6 and v7 Stage II Pancreatic Cancer AJCC v6 and v7 C1167721 CTRP Stage II is divided into stages IIA and IIB, based on where the cancer has spread. In stage IIA, cancer has spread to nearby tissue and organs but has not spread to nearby lymph nodes. In stage IIB, cancer has spread to nearby lymph nodes and may have spread to nearby tissue and organs. Malignant Stage_II_Pancreatic_Cancer Pancreatic Cancer Stage II Stage II Carcinoma of Pancreas Stage II Carcinoma of the Pancreas Stage II Exocrine and Endocrine Pancreatic Cancer AJCC v6 and v7 Stage II Pancreatic Cancer Stage II Pancreatic Cancer AJCC v6 Stage II Pancreatic Cancer AJCC v6 and v7 Stage II Pancreatic Cancer AJCC v7 Stage II Pancreatic Carcinoma stage II pancreatic cancer Stage II Pancreatic Cancer AJCC v6 and v7 Stage III includes: T4, Any N, M0. T4: Tumor involves the celiac axis or the superior mesenteric artery. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C7787 Neoplastic Process Stage III Pancreatic Cancer AJCC v6 and v7 Stage III Pancreatic Cancer AJCC v6 and v7 C1167722 CTRP Cancer has spread to the major blood vessels near the pancreas, and may have spread to nearby lymph nodes. Malignant Stage_III_Pancreatic_Cancer Pancreatic Cancer Stage III Stage III Carcinoma of Pancreas Stage III Carcinoma of the Pancreas Stage III Exocrine and Endocrine Pancreatic Cancer AJCC v6 and v7 Stage III Pancreatic Cancer Stage III Pancreatic Cancer AJCC v6 Stage III Pancreatic Cancer AJCC v6 and v7 Stage III Pancreatic Cancer AJCC v7 Stage III Pancreatic Carcinoma stage III pancreatic cancer Stage III Pancreatic Cancer AJCC v6 and v7 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C7788 Neoplastic Process Stage 0 Gastric Cancer AJCC v6 and v7 Stage 0 Gastric Cancer AJCC v6 and v7 C0154060 CPTAC CTRP mCode Abnormal cells are found in the inside lining of the mucosal (innermost) layer of the stomach wall. These abnormal cells may become cancer and spread into nearby normal tissue. Malignant Stage_0_Gastric_Cancer Carcinoma in situ of stomach Carcinoma in situ of Stomach Carcinoma in situ of stomach Carcinoma in situ of the Stomach Carcinoma of Stomach Stage 0 Carcinoma of the Stomach Stage 0 Gastric Carcinoma Stage 0 Gastric Carcinoma in situ Gastric Carcinoma, Stage 0 Stage 0 Carcinoma of Stomach Stage 0 Carcinoma of the Stomach Stage 0 Gastric (Stomach) Cancer Stage 0 Gastric Cancer Stage 0 Gastric Cancer AJCC v6 Stage 0 Gastric Cancer AJCC v6 and v7 Stage 0 Gastric Cancer AJCC v7 Stage 0 Gastric Carcinoma Stage 0 Stomach Cancer Stage 0 Stomach Carcinoma Stomach Carcinoma Stage 0 Stomach Carcinoma in situ stage 0 gastric carcinoma in situ Stage 0 Gastric Cancer AJCC v6 and v7 The reemergence of Hodgkin lymphoma in adulthood after a period of remission. C7789 Neoplastic Process Recurrent Adult Hodgkin Lymphoma Recurrent Adult Hodgkin Lymphoma C0278530 CTRP Malignant Recurrent_Adult_Hodgkin_s_Lymphoma Recurrent Adult Hodgkin Lymphoma Recurrent Adult Hodgkin's Disease Recurrent Adult Hodgkin's Lymphoma Recurrent Hodgkin Lymphoma Relapsed Adult Hodgkin's Disease Relapsed Adult Hodgkin's Lymphoma Recurrent Adult Hodgkin Lymphoma Stage I includes: (T1, N0, M0); (T2, N0, M0). T1: Tumor invades submucosa. T2: Tumor invades muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C7790 Neoplastic Process Stage I Rectal Cancer AJCC v6 and v7 Stage I Rectal Cancer AJCC v6 and v7 C0278535 CTRP Malignant Stage_I_Rectal_Cancer AJCC Stage I Rectal Cancer Dukes A Carcinoma of Rectum Dukes A Carcinoma of the Rectum Dukes A Rectal Carcinoma Rectal Cancer Stage I Stage I Carcinoma of Rectum Stage I Carcinoma of the Rectum Stage I Rectal Cancer Stage I Rectal Cancer AJCC v6 Stage I Rectal Cancer AJCC v6 and v7 Stage I Rectal Cancer AJCC v7 Stage I Rectal Carcinoma Stage I Rectal Cancer AJCC v6 and v7 Stage II includes IIA (T3, N0, M0) and IIB (T4, N0, M0). T3: Tumor invades through the muscularis propria into the subserosa, or into nonperitonealized pericolic or perirectal tissues. T4: Tumor directly invades other organs or structures, and/or perforates the visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C7791 Neoplastic Process Stage II Rectal Cancer AJCC v6 Stage II Rectal Cancer AJCC v6 C0278544 CTRP Malignant Stage_II_Rectal_Cancer AJCC Stage II Rectal Cancer v6 Dukes B Carcinoma of Rectum Dukes B Carcinoma of the Rectum Dukes B Rectal Carcinoma Rectal Cancer Stage II AJCC v6 Stage II Carcinoma of Rectum AJCC v6 Stage II Carcinoma of the Rectum AJCC v6 Stage II Rectal Cancer Stage II Rectal Cancer AJCC v6 Stage II Rectal Carcinoma AJCC v6 Stage II Rectal Cancer AJCC v6 Stage III includes: IIIA (T1-T2, N0, M0); IIIB (T3-T4, N1, M0); IIIC (Any T, N2, M0). N1: Metastasis in 1 to 3 regional lymph nodes. N2: Metastasis in 4 or more regional lymph nodes. (AJCC 6th ed.) C7792 Neoplastic Process Stage III Rectal Cancer AJCC v6 Stage III Rectal Cancer AJCC v6 C0278545 CTRP Malignant Stage_III_Rectal_Cancer AJCC Stage III Rectal Cancer v6 Dukes C Carcinoma of Rectum Dukes C Carcinoma of the Rectum Dukes C Rectal Carcinoma Rectal Cancer Stage III AJCC v6 Stage III Carcinoma of Rectum AJCC v6 Stage III Carcinoma of the Rectum AJCC v6 Stage III Rectal Cancer Stage III Rectal Cancer AJCC v6 Stage III Rectal Carcinoma AJCC v6 Stage III Rectal Cancer AJCC v6 The reemergence of anal carcinoma after a period of remission. C7793 Neoplastic Process Recurrent Anal Canal Carcinoma Recurrent Anal Canal Carcinoma C0278556 CTRP Malignant Recurrent_Anal_Canal_Cancer Recurrent Anal Canal Cancer Recurrent Anal Canal Carcinoma Recurrent Anal Cancer Recurrent Anal Canal Carcinoma Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C7794 Neoplastic Process Stage 0 Anal Canal Cancer AJCC v6 and v7 Stage 0 Anal Canal Cancer AJCC v6 and v7 C0154064 CTRP Abnormal cells are found in the innermost lining of the anus. These abnormal cells may become cancer and spread into nearby normal tissue. Malignant Stage_0_Anal_Canal_Cancer Anal Canal Carcinoma in situ Stage 0 Anal Canal Cancer Stage 0 Anal Canal Cancer AJCC v6 Stage 0 Anal Canal Cancer AJCC v6 and v7 Stage 0 Anal Canal Cancer AJCC v7 Stage 0 Anal Canal Carcinoma AJCC v6 and v7 Stage 0 Anal Carcinoma AJCC v6 and v7 stage 0 anal carcinoma in situ Stage 0 Anal Canal Cancer AJCC v6 and v7 Stage I includes: IA (T1, N0, M0, B0-1); IB (T2, N0, M0, B0-1). T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. May further stratify into T1a (patch only) vs. T1b (plaque +/- patch). T2: Patches, papules, or plaques covering 10% or more of the skin surface. May further stratify into T2a (patch only) vs. T2b (plaque +/- patch). N0: No clinically abnormal peripheral lymph nodes; biopsy not required. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 7th ed.) C7796 Neoplastic Process Stage I Mycosis Fungoides AJCC v7 Stage I Mycosis Fungoides AJCC v7 C0278567 CTRP Malignant Stage_I_Mycosis_Fungoides Mycosis Fungoides Stage I Stage I Mycosis Fungoides Stage I Mycosis Fungoides AJCC v7 Stage I Mycosis Fungoides AJCC v7 Stage II includes: IIA (T1-2, N1-2, M0, B0-1); IIB (T3, N0-2, M0, B0-1). T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. May further stratify into T1a (patch only) vs. T1b (plaque +/- patch). T2: Patches, papules, or plaques covering 10% or more of the skin surface. May further stratify into T2a (patch only) vs. T2b (plaque +/- patch). T3: One or more tumors (equal or greater than 1 cm diameter). N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or NCI LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 7th ed.) C7798 Neoplastic Process Stage II Mycosis Fungoides AJCC v7 Stage II Mycosis Fungoides AJCC v7 C0278569 CTRP Malignant Stage_II_Mycosis_Fungoides Mycosis Fungoides Stage II Stage II Mycosis Fungoides Stage II Mycosis Fungoides AJCC v7 Stage II Mycosis Fungoides AJCC v7 Stage III includes: (T4, N0-2, M0, B0-1); IIIA (T4, N0-2, M0, B0); IIIB (T4, N0-2, M0, B1). T4: Confluence of erythema covering 80% or more of body surface area. N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or NCI LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 7th ed.) C7800 Neoplastic Process Stage III Mycosis Fungoides AJCC v7 Stage III Mycosis Fungoides AJCC v7 C0278571 CTRP Malignant Stage_III_Mycosis_Fungoides Mycosis Fungoides Stage III Stage III Mycosis Fungoides Stage III Mycosis Fungoides AJCC v7 Stage III Mycosis Fungoides AJCC v7 Stage IV includes: IVA1 (T1-4, N0-2, M0, B2); IVA2 (T1-4, N3, M0, B0-2); IVB (T1-4, N0-3, M1, B0-2). T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. May further stratify into T1a (patch only) vs. T1b (plaque +/- patch). T2: Patches, papules, or plaques covering 10% or more of the skin surface. May further stratify into T2a (patch only) vs. T2b (plaque +/- patch). T3: One or more tumors (equal or greater than 1 cm diameter). T4: Confluence of erythema covering 80% or more of body surface area. N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or NCI LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. N3: Clinically abnormal peripheral lymph nodes; histopathology Dutch grades 3-4 or NCI LN4; clone positive or negative. M0: No visceral organ involvement. M1: Visceral involvement (must have pathology confirmation and organ involved should be specified). B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. B2: High blood tumor burden: 1000/microL Sezary cells or more with positive clone. (AJCC 7th ed.) C7802 Neoplastic Process Stage IV Mycosis Fungoides AJCC v7 Stage IV Mycosis Fungoides AJCC v7 C0278573 CTRP Malignant Stage_IV_Mycosis_Fungoides Mycosis Fungoides Stage IV Stage IV Mycosis Fungoides Stage IV Mycosis Fungoides AJCC v7 Stage IV Mycosis Fungoides AJCC v7 Stage II includes: II (T2, N0, M0); IIA (T2a, N0, M0); IIB (T2b, N0, M0). T2: Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina. T2a: Tumor without parametrial invasion. T2b: Tumor with parametrial invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C7803 Neoplastic Process Stage II Cervical Cancer AJCC v6 Stage II Cervical Cancer AJCC v6 C0278576 CTRP Cancer has spread beyond the cervix but not to the pelvic wall (the tissues that line the part of the body between the hips). Stage II is divided into stages IIA and IIB, based on how far the cancer has spread. In stage IIA, cancer has spread to the upper two thirds of the vagina but not to tissues around the uterus. In stage IIB, cancer has spread to the upper two thirds of the vagina and to the tissues around the uterus. Malignant Stage_II_Cervical_Cancer AJCC Stage II Cervical Cancer v6 Cervical Cancer Stage II AJCC v6 Cervical Carcinoma Stage II AJCC v6 Cervix Cancer Stage II AJCC v6 FIGO Stage II Carcinoma of Cervix FIGO Stage II Carcinoma of Cervix Uteri FIGO Stage II Carcinoma of Uterine Cervix FIGO Stage II Carcinoma of the Cervix FIGO Stage II Carcinoma of the Cervix Uteri FIGO Stage II Carcinoma of the Uterine Cervix FIGO Stage II Cervical Carcinoma FIGO Stage II Cervix Carcinoma FIGO Stage II Cervix Uteri Carcinoma FIGO Stage II Uterine Cervix Carcinoma Stage II Cervical Cancer Stage II Cervical Cancer AJCC v6 Uterine Cervix Cancer Stage II AJCC v6 stage II cancer of the cervix Stage II Cervical Cancer AJCC v6 The reemergence of cervical carcinoma after a period of remission. C7804 Neoplastic Process Recurrent Cervical Carcinoma Recurrent Cervical Carcinoma C0278579 CTRP Malignant Recurrent_Cervical_Carcinoma Cervical Carcinoma Recurrent Recurrent Carcinoma of Cervix Recurrent Carcinoma of Cervix Uteri Recurrent Carcinoma of Uterine Cervix Recurrent Carcinoma of the Cervix Recurrent Carcinoma of the Cervix Uteri Recurrent Carcinoma of the Uterine Cervix Recurrent Cervical Cancer Recurrent Cervical Carcinoma Recurrent Cervix Uteri Carcinoma Recurrent Uterine Cervix Carcinoma Relapsed Carcinoma of Cervix Relapsed Carcinoma of Cervix Uteri Relapsed Carcinoma of Uterine Cervix Relapsed Carcinoma of the Cervix Relapsed Carcinoma of the Cervix Uteri Relapsed Carcinoma of the Uterine Cervix Relapsed Cervical Carcinoma Relapsed Cervix Carcinoma Relapsed Cervix Uteri Carcinoma Relapsed Uterine Cervix Carcinoma Recurrent Cervical Carcinoma The reemergence of primary cutaneous T-cell non-Hodgkin lymphoma after a period of remission. C7805 Neoplastic Process Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma C0278580 CTRP Malignant Recurrent_Cutaneous_T-Cell_Lymphoma Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma Recurrent Cutaneous T-Cell Non-Hodgkin's Lymphoma Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Recurrent Skin T-Cell Lymphoma Recurrent T-Cell Lymphoma of Skin Recurrent T-Cell Lymphoma of the Skin Relapsed Cutaneous T-Cell Lymphoma Relapsed Skin T-Cell Lymphoma Relapsed T-Cell Lymphoma of Skin Relapsed T-Cell Lymphoma of the Skin Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Ewing sarcoma that is confined to a specific site without evidence of spread to other anatomic sites. C7806 Neoplastic Process Localized Ewing Sarcoma C0863029 Malignant Localized_Ewing_s_Sarcoma Ewing's Sarcoma, Localized Localized Ewing Sarcoma Localized Ewing's Sarcoma Localized Ewing's Tumor Localized Ewing Sarcoma Ewing sarcoma that has spread from its original site of growth to another anatomic site. C7807 Neoplastic Process Metastatic Ewing Sarcoma C0278586 Malignant Metastatic_Ewing_s_Sarcoma Ewing's Sarcoma, Metastatic Metastatic Ewing Sarcoma Metastatic Ewing's Sarcoma Metastatic Ewing Sarcoma Ewing sarcoma which has recurred after treatment and/or remission. While initial complete responses are not uncommon, there is a fair chance of relapse as late as one to two decades after initial therapy. C7808 Neoplastic Process Recurrent Ewing Sarcoma C0278590 Malignant Recurrent_Ewing_s_Sarcoma Ewing's Sarcoma, Recurrent Recurrent Ewing Sarcoma Recurrent Ewing's Sarcoma Relapsed Ewing's Sarcoma Recurrent Ewing Sarcoma A malignant mesenchymal neoplasm composed of fibroblasts. It is characterized by collagen production and a herringbone architectural pattern. It is more commonly seen in middle-aged and older adults. It usually affects the deep soft tissues of extremities, trunk, head and neck. Adult fibrosarcomas may recur and metastasize to the lungs and bones. C7809 Neoplastic Process Adult Fibrosarcoma Adult Fibrosarcoma CL324520 CTRP Malignant Adult_Fibrosarcoma Adult Fibrosarcoma Fibrosarcoma Fibrosarcoma (excluding infantile fibrosarcoma) Fibrosarcoma - not infantile Adult Fibrosarcoma An aggressive malignant smooth muscle neoplasm, occurring in adults. It is characterized by a proliferation of neoplastic spindle cells. C7810 Neoplastic Process Adult Leiomyosarcoma Adult Leiomyosarcoma C0278607 CTRP Malignant Adult_Leiomyosarcoma Adult Leiomyosarcoma Leiomyosarcoma Adult Leiomyosarcoma A liposarcoma occurring during adulthood. C7811 Neoplastic Process Adult Liposarcoma Adult Liposarcoma C0278608 CTRP Malignant Adult_Liposarcoma Adult Liposarcoma Liposarcoma Adult Liposarcoma A localized malignant neoplasm that arises in the bone. It is composed of clonal (malignant) plasma cells forming a tumor mass. The most commonly affected bones are the vertebrae, ribs, skull, pelvis, and femur. C7812 Neoplastic Process Solitary Osseous Plasmacytoma Solitary Plasmacytoma of Bone C0272256 CTRP GDC Malignant Solitary_Osseous_Plasmacytoma 9731/3 Plasmacytoma of bone Bone Solitary Plasmacytoma SPB Solitary Osseous Plasmacytoma Solitary Plasmacytoma of Bone Solitary Plasmacytoma of Bone A plasma cell neoplasm that is resistant to treatment. C7813 Neoplastic Process Refractory Plasma Cell Neoplasm C0278620 Malignant Refractory_Plasma_Cell_Neoplasm Refractory Plasma Cell Neoplasm Refractory Plasma Cell Neoplasm A malignant peripheral nerve sheath tumor occurring during adulthood. C7814 Neoplastic Process Adult Malignant Peripheral Nerve Sheath Tumor Adult Malignant Peripheral Nerve Sheath Tumor C0278622 CTRP Malignant Adult_Malignant_Peripheral_Nerve_Sheath_Tumor Adult MPNST Adult Malignant Neoplasm of Peripheral Nerve Sheath Adult Malignant Neoplasm of the Peripheral Nerve Sheath Adult Malignant Neurilemmoma Adult Malignant Peripheral Nerve Sheath Neoplasm Adult Malignant Peripheral Nerve Sheath Tumor Adult Malignant Schwannoma Adult Malignant Tumor of Peripheral Nerve Sheath Adult Malignant Tumor of the Peripheral Nerve Sheath Malignant Peripheral Nerve Sheath Tumor Adult Malignant Peripheral Nerve Sheath Tumor The reemergence of childhood rhabdomyosarcoma after a period of remission. C7815 Neoplastic Process Recurrent Childhood Rhabdomyosarcoma Recurrent Childhood Rhabdomyosarcoma C0278649 CTRP Malignant Recurrent_Childhood_Rhabdomyosarcoma Recurrent Childhood Rhabdomyosarcoma Recurrent Pediatric Rhabdomyosarcoma Recurrent Rhabdomyosarcoma Relapsed Childhood Rhabdomyosarcoma Relapsed Pediatric Rhabdomyosarcoma Recurrent Childhood Rhabdomyosarcoma A craniopharyngioma that occurs during childhood. The vast majority of cases are adamantinomatous craniopharyngiomas. Clinical signs and symptoms include endocrine deficiencies and visual disturbances. C7816 Neoplastic Process Childhood Craniopharyngioma Childhood Craniopharyngioma C0278652 CTRP NICHD A craniopharyngioma that occurs during childhood. The vast majority of cases are adamantinomatous craniopharyngiomas. Clinical signs and symptoms include endocrine deficiencies and visual disturbances. Benign Childhood_Craniopharyngioma Benign Childhood Neoplasm of Rathke's Pouch Benign Childhood Rathke's Pouch Neoplasm Benign Childhood Rathke's Pouch Tumor Benign Childhood Tumor of Rathke's Pouch Benign Pediatric Neoplasm of Rathke's Pouch Benign Pediatric Rathke's Pouch Neoplasm Benign Pediatric Rathke's Pouch Tumor Benign Pediatric Tumor of Rathke's Pouch Childhood Craniopharyngioma Childhood Neoplasm of Rathke's Pouch Childhood Rathke's Pouch Neoplasm Childhood Rathke's Pouch Tumor Childhood Tumor of Rathke's Pouch Craniopharyngioma Pediatric Craniopharyngioma Pediatric Neoplasm of Rathke's Pouch Pediatric Rathke's Pouch Neoplasm Pediatric Rathke's Pouch Tumor Pediatric Tumor of Rathke's Pouch Childhood Craniopharyngioma A synovial sarcoma occurring in adults. C7817 Neoplastic Process Adult Synovial Sarcoma Adult Synovial Sarcoma C0278660 CTRP Malignant Adult_Synovial_Sarcoma Adult Synovial Sarcoma Synovial Sarcoma Adult Synovial Sarcoma Stage I includes: IA (T1a, N0, M0, G1, GX); (T1b, N0, M0, G1, GX); IB (T2a, N0, M0, G1, GX); (T2b, N0, M0, G1, GX). T1a: Superficial tumor 5 cm or less in greatest dimension. T1b: Deep tumor 5 cm or less in greatest dimension. T2a: Superficial tumor more than 5 cm in greatest dimension. T2b: Deep tumor more than 5 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Grade 1. GX: Grade cannot be assessed. (AJCC 7th ed.) C7818 Neoplastic Process Stage I Adult Soft Tissue Sarcoma AJCC v7 Stage I Adult Soft Tissue Sarcoma AJCC v7 C0278661 CTRP Cancer of soft tissue (muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body) that is any size, low grade (likely to grow and spread slowly), and may be either superficial (close to the skin's surface) or deep. Malignant Stage_I_Adult_Soft_Tissue_Sarcoma Stage I Adult Sarcoma of Soft Tissue Stage I Adult Sarcoma of the Soft Tissue Stage I Adult Soft Tissue Sarcoma AJCC v7 Stage I Soft Tissue Sarcoma stage I adult soft tissue sarcoma Stage I Adult Soft Tissue Sarcoma AJCC v7 Stage II includes: IIA (T1a, N0, M0, G2, G3); (T1b, N0, M0, G2, G3); IIB (T2a, N0, M0, G2); (T2b, N0, M0, G2). T1a: Superficial tumor 5 cm or less in greatest dimension. T1b: Deep tumor 5 cm or less in greatest dimension. T2a: Superficial tumor more than 5 cm in greatest dimension. T2b: Deep tumor more than 5 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G2: Grade 2. G3: Grade 3. (AJCC 7th ed.) C7819 Neoplastic Process Stage II Adult Soft Tissue Sarcoma AJCC v7 Stage II Adult Soft Tissue Sarcoma AJCC v7 C0278662 CTRP Cancer of soft tissue (muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body) that is high grade (likely to grow and spread quickly) and is either (a) 5 centimeters or smaller and can be superficial (close to the skin's surface) or deep; or (b) larger than 5 centimeters and superficial. Malignant Stage_II_Adult_Soft_Tissue_Sarcoma Stage II Adult Sarcoma of Soft Tissue Stage II Adult Sarcoma of the Soft Tissue Stage II Adult Soft Tissue Sarcoma AJCC v7 Stage II Soft Tissue Sarcoma stage II adult soft tissue sarcoma Stage II Adult Soft Tissue Sarcoma AJCC v7 C7820 Neoplastic Process Stage III Adult Soft Tissue Sarcoma AJCC v7 Stage III Adult Soft Tissue Sarcoma AJCC v7 C0278663 CTRP Malignant Stage_III_Adult_Soft_Tissue_Sarcoma Stage III Adult Sarcoma of Soft Tissue Stage III Adult Sarcoma of the Soft Tissue Stage III Adult Soft Tissue Sarcoma AJCC v7 Stage III Soft Tissue Sarcoma Stage III Adult Soft Tissue Sarcoma AJCC v7 Stage IV includes: Any T, Any N, M1, Any G. M1: Distant metastasis. (AJCC 7th ed.) C7821 Neoplastic Process Stage IV Adult Soft Tissue Sarcoma AJCC v7 Stage IV Adult Soft Tissue Sarcoma AJCC v7 C0278664 CTRP Malignant Stage_IV_Adult_Soft_Tissue_Sarcoma Stage IV Adult Sarcoma of Soft Tissue Stage IV Adult Sarcoma of the Soft Tissue Stage IV Adult Soft Tissue Sarcoma AJCC v7 Stage IV Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma AJCC v7 A soft tissue sarcoma occurring in adults that has recurred after a period of remission. C7822 Neoplastic Process Recurrent Adult Soft Tissue Sarcoma Recurrent Adult Soft Tissue Sarcoma C0278665 CTRP Malignant Recurrent_Adult_Soft_Tissue_Sarcoma Recurrent Adult Sarcoma of Soft Tissue Recurrent Adult Sarcoma of the Soft Tissue Recurrent Adult Soft Tissue Sarcoma Recurrent Soft Tissue Sarcoma Relapsed Adult Sarcoma of Soft Tissue Relapsed Adult Sarcoma of the Soft Tissue Relapsed Adult Soft Tissue Sarcoma Recurrent Adult Soft Tissue Sarcoma Stage I includes: T1, N0, M0. T1: Lesions have been divided into T1a and T1b. T1a is defined as tumor 4 cm or less in greatest dimension, limited to the kidney. T1b is defined as tumor greater than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C7823 Neoplastic Process Stage I Renal Cell Cancer AJCC v6 and v7 Stage I Renal Cell Cancer AJCC v6 and v7 C0278675 CTRP The tumor is 7 centimeters or smaller and is found in the kidney only. Malignant Stage_I_Renal_Cell_Cancer Renal Cell Cancer Stage I Renal Cell Carcinoma, Stage I Stage I Renal Cell Cancer Stage I Renal Cell Cancer AJCC v6 Stage I Renal Cell Cancer AJCC v6 and v7 Stage I Renal Cell Cancer AJCC v7 Stage I Renal Cell Carcinoma stage I kidney cancer stage I renal cell cancer Stage I Renal Cell Cancer AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: Tumor more than 7 cm in greatest dimension limited to the kidney. N0: No regional lymph node metastases. M0: No distant metastasis. (AJCC 6th Ed.) C7824 Neoplastic Process Stage II Renal Cell Cancer AJCC v6 Stage II Renal Cell Cancer AJCC v6 C0278676 CTRP The tumor is larger than 7 centimeters and is found in the kidney only. Malignant Stage_II_Renal_Cell_Cancer Renal Cell Cancer Stage II AJCC v6 Renal Cell Carcinoma, Stage II AJCC v6 Stage II Renal Cell Cancer Stage II Renal Cell Cancer AJCC v6 Stage II Renal Cell Carcinoma AJCC v6 stage II kidney cancer stage II renal cell cancer Stage II Renal Cell Cancer AJCC v6 A reemergence of renal cell carcinoma after a period of remission. C7825 Neoplastic Process Recurrent Renal Cell Carcinoma Recurrent Renal Cell Carcinoma C0862435 CTRP Malignant Recurrent_Renal_Cell_Carcinoma Recurrent Renal Cell Cancer Recurrent Renal Cell Carcinoma Relapsed Renal Cell Carcinoma Renal Cell Carcinoma, Recurrent Recurrent Renal Cell Carcinoma A parathyroid gland carcinoma that has not spread to other anatomic sites. C7826 Neoplastic Process Localized Parathyroid Gland Carcinoma Localized Parathyroid Gland Carcinoma C0278680 CTRP Malignant Localized_Parathyroid_Carcinoma Localized Parathyroid Cancer Localized Parathyroid Carcinoma Localized Parathyroid Gland Cancer Localized Parathyroid Gland Carcinoma Localized Parathyroid Gland Carcinoma The reemergence of parathyroid gland carcinoma after a period of remission. C7828 Neoplastic Process Recurrent Parathyroid Gland Carcinoma Recurrent Parathyroid Gland Carcinoma C0278684 CTRP Malignant Recurrent_Parathyroid_Carcinoma Recurrent Parathyroid Cancer Recurrent Parathyroid Carcinoma Recurrent Parathyroid Gland Cancer Recurrent Parathyroid Gland Carcinoma Recurrent Parathyroid Gland Carcinoma Stage I includes: T1, N0, M0. T1: Tumor limited to ovaries (one or both). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C7829 Neoplastic Process Stage I Ovarian Cancer AJCC v6 and v7 Stage I Ovarian Cancer AJCC v6 and v7 C0278685 CTRP Malignant Stage_I_Ovarian_Cancer AJCC Stage I Ovarian Cancer FIGO Stage I Cancer of Ovary FIGO Stage I Cancer of the Ovary FIGO Stage I Carcinoma of Ovary FIGO Stage I Carcinoma of the Ovary FIGO Stage I Ovarian Cancer FIGO Stage I Ovarian Carcinoma Ovarian Cancer Stage I Stage I Ovarian Cancer Stage I Ovarian Cancer AJCC v6 Stage I Ovarian Cancer AJCC v6 and v7 Stage I Ovarian Cancer AJCC v7 Stage I Ovarian Carcinoma Stage I Ovarian Epithelial Cancer stage I ovarian epithelial cancer Stage I Ovarian Cancer AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: Tumor involves one or both ovaries with pelvic extension and/or implants. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C7830 Neoplastic Process Stage II Ovarian Cancer AJCC v6 and v7 Stage II Ovarian Cancer AJCC v6 and v7 C0278686 CTRP Cancer that began in tissue covering the ovary and has spread from one or both ovaries into other areas of the pelvis. Stage II is divided into stages IIA, IIB, and IIC. In stage IIA, cancer has spread to the uterus and/or the fallopian tubes. In stage IIB, cancer has spread to other tissues within the pelvis. In stage IIC, cancer has spread to the uterus and/or fallopian tubes and/or other tissue within the pelvis and cancer cells are found in fluid from the peritoneal cavity (the body cavity that contains most of the organs in the abdomen). Malignant Stage_II_Ovarian_Cancer AJCC Stage II Ovarian Cancer FIGO Stage II Cancer of Ovary FIGO Stage II Cancer of the Ovary FIGO Stage II Carcinoma of Ovary FIGO Stage II Carcinoma of the Ovary FIGO Stage II Ovarian Cancer FIGO Stage II Ovarian Carcinoma Ovarian Cancer Stage II Stage II Ovarian Cancer Stage II Ovarian Cancer AJCC v6 Stage II Ovarian Cancer AJCC v6 and v7 Stage II Ovarian Cancer AJCC v7 Stage II Ovarian Carcinoma Stage II Ovarian Epithelial Cancer stage II ovarian epithelial cancer Stage II Ovarian Cancer AJCC v6 and v7 Stage III includes: T3, N0, M0. T3: Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C7831 Neoplastic Process Stage III Ovarian Cancer AJCC v6 and v7 Stage III Ovarian Cancer AJCC v6 and v7 C0278687 CTRP Cancer that began in tissue covering the ovary and has spread from one or both ovaries to other parts of the abdomen. Stage III is divided into stages IIIA, IIIB, and IIIC. In stage IIIA, the tumor is found in the pelvis only, but cancer cells have spread to the surface of the peritoneum (tissue that lines the abdominal wall and covers most of the organs in the abdomen). In stage IIIB, cancer has spread to the peritoneum and is 2 centimeters or smaller in diameter. In stage IIIC, cancer has spread to the peritoneum and is larger than 2 centimeters in diameter and/or has spread to lymph nodes in the abdomen. Cancer that has spread to the surface of the liver is stage III disease. Malignant Stage_III_Ovarian_Cancer AJCC Stage III Ovarian Cancer FIGO Stage III Cancer of Ovary FIGO Stage III Cancer of the Ovary FIGO Stage III Carcinoma of Ovary FIGO Stage III Carcinoma of the Ovary FIGO Stage III Ovarian Cancer FIGO Stage III Ovarian Carcinoma Ovarian Cancer Stage III Stage III Ovarian Cancer Stage III Ovarian Cancer AJCC v6 Stage III Ovarian Cancer AJCC v6 and v7 Stage III Ovarian Cancer AJCC v7 Stage III Ovarian Carcinoma Stage III Ovarian Epithelial Cancer stage III ovarian epithelial cancer Stage III Ovarian Cancer AJCC v6 and v7 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis (excludes peritoneal metastasis). (AJCC 6th and 7th eds.) C7832 Neoplastic Process Stage IV Ovarian Cancer AJCC v6 and v7 Stage IV Ovarian Cancer AJCC v6 and v7 C0278688 CTRP Cancer that began in tissue covering the ovary is found in one or both ovaries and has spread beyond the abdomen to distant parts of the body. Ovarian cancer that is found in tissues of the liver is stage IV disease. Malignant Stage_IV_Ovarian_Cancer AJCC Stage IV Ovarian Cancer FIGO Stage IV Cancer of Ovary FIGO Stage IV Cancer of the Ovary FIGO Stage IV Carcinoma of Ovary FIGO Stage IV Carcinoma of the Ovary FIGO Stage IV Ovarian Cancer FIGO Stage IV Ovarian Carcinoma Ovarian Cancer Stage IV Stage IV Ovarian Cancer Stage IV Ovarian Cancer AJCC v6 Stage IV Ovarian Cancer AJCC v6 and v7 Stage IV Ovarian Cancer AJCC v7 Stage IV Ovarian Carcinoma Stage IV Ovarian Epithelial Cancer stage IV ovarian epithelial cancer Stage IV Ovarian Cancer AJCC v6 and v7 The reemergence of ovarian carcinoma after a period of remission. C7833 Neoplastic Process Recurrent Ovarian Carcinoma Recurrent Ovarian Carcinoma C0278689 CTRP Malignant Recurrent_Ovarian_Cancer Recurrent Carcinoma of Ovary Recurrent Carcinoma of the Ovary Recurrent Epithelial Cancer of Ovary Recurrent Epithelial Cancer of the Ovary Recurrent Ovarian Cancer Recurrent Ovarian Carcinoma Recurrent Ovarian Epithelial Cancer Relapsed Carcinoma of Ovary Relapsed Carcinoma of the Ovary Relapsed Epithelial Cancer of Ovary Relapsed Epithelial Cancer of the Ovary Relapsed Ovarian Carcinoma Relapsed Ovarian Epithelial Cancer Recurrent Ovarian Carcinoma The reemergence of brain neoplasm in childhood after a period of remission. C7834 Neoplastic Process Recurrent Childhood Brain Neoplasm Recurrent Childhood Brain Neoplasm C0278690 CTRP Undetermined Recurrent_Childhood_Brain_Neoplasm Recurrent Brain Neoplasm Recurrent Childhood Brain Neoplasm Recurrent Childhood Brain Tumor Recurrent Neoplasm of Childhood Brain Recurrent Neoplasm of Pediatric Brain Recurrent Neoplasm of the Childhood Brain Recurrent Neoplasm of the Pediatric Brain Recurrent Pediatric Brain Neoplasm Recurrent Pediatric Brain Tumor Recurrent Tumor of Childhood Brain Recurrent Tumor of Pediatric Brain Recurrent Tumor of the Childhood Brain Recurrent Tumor of the Pediatric Brain Relapsed Childhood Brain Neoplasm Relapsed Childhood Brain Tumor Relapsed Neoplasm of Childhood Brain Relapsed Neoplasm of Pediatric Brain Relapsed Neoplasm of the Childhood Brain Relapsed Neoplasm of the Pediatric Brain Relapsed Pediatric Brain Neoplasm Relapsed Pediatric Brain Tumor Relapsed Tumor of Childhood Brain Relapsed Tumor of Pediatric Brain Relapsed Tumor of the Childhood Brain Relapsed Tumor of the Pediatric Brain Recurrent Childhood Brain Neoplasm Neuroblastoma that is confined to a specific site and is amenable to surgical removal. C7835 Neoplastic Process Localized Resectable Neuroblastoma Localized Resectable Neuroblastoma C0278691 CTRP Malignant Localized_Resectable_Neuroblastoma Localized Resectable Neuroblastoma Localized Resectable Neuroblastoma A neuroblastoma confined to a specific anatomic region without evidence of dissemination. C7836 Neoplastic Process Regional Neuroblastoma Regional Neuroblastoma C0278692 CTRP Malignant Regional_Neuroblastoma Regional Neuroblastoma Regional Neuroblastoma The reemergence of neuroblastoma after a period of remission. C7837 Neoplastic Process Recurrent Neuroblastoma Recurrent Neuroblastoma C0278695 CTRP Malignant Recurrent_Neuroblastoma Recurrent Neuroblastoma Relapsed Neuroblastoma Recurrent Neuroblastoma Stage IV includes: IVA: (Any T, N1, M0); IVB: (Any T, Any N, M1). N1: Regional lymph node metastasis. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C7838 Neoplastic Process Stage IV Childhood Hepatocellular Carcinoma AJCC v7 Stage IV Childhood Hepatocellular Carcinoma AJCC v7 C0278699 CTRP The cancer has spread to other parts of the body. Malignant Stage_IV_Childhood_Hepatocellular_Carcinoma Stage IV Childhood Hepatocellular Carcinoma Stage IV Childhood Hepatocellular Carcinoma AJCC v7 Stage IV Childhood Hepatoma Stage IV Childhood Liver Cell Carcinoma Stage IV Hepatocellular Cancer Stage IV Pediatric Hepatocellular Carcinoma Stage IV Pediatric Hepatoma Stage IV Pediatric Liver Cell Carcinoma stage IV childhood liver cancer Stage IV Childhood Hepatocellular Carcinoma AJCC v7 A malignant neoplasm of the liver that occurs during childhood and has recurred after a period of remission. C7839 Neoplastic Process Recurrent Childhood Liver Cancer Recurrent Childhood Malignant Liver Neoplasm C0278700 CTRP Malignant Recurrent_Childhood_Liver_Cancer Recurrent Childhood Cancer of Liver Recurrent Childhood Cancer of the Liver Recurrent Childhood Liver Cancer Recurrent Childhood Malignant Liver Neoplasm Recurrent Liver Cancer Recurrent Pediatric Cancer of Liver Recurrent Pediatric Cancer of the Liver Recurrent Pediatric Liver Cancer Relapsed Childhood Cancer of Liver Relapsed Childhood Cancer of the Liver Relapsed Childhood Liver Cancer Relapsed Pediatric Cancer of Liver Relapsed Pediatric Cancer of the Liver Relapsed Pediatric Liver Cancer Recurrent Childhood Malignant Liver Neoplasm Wilms tumor that is found in one kidney and can be completely removed with surgery. (National Wilms Tumor Study Group Staging System) C7840 Neoplastic Process Stage I Kidney Wilms Tumor Stage I Kidney Wilms Tumor C0278711 CTRP The tumor was completely removed by surgery and all of the following are true: (1) cancer was found only in the kidney and did not spread to blood vessels of the kidney; (2) the outer layer of the kidney did not break open; (3) the tumor did not break open; (4) a biopsy of the tumor was not done; and (5) no cancer cells were found at the edges of the area where the tumor was removed. Malignant Stage_I_Wilms_Tumor Stage I Kidney Nephroblastoma Stage I Kidney Wilms Tumor Stage I Renal Wilms Tumor Stage I Renal Wilms' Tumor Stage I Wilms Tumor stage I Wilms tumor Stage I Kidney Wilms Tumor Wilms tumor that is found in the kidney and in the fat, soft tissue, or blood vessels near the kidney. It may have spread to the renal sinus. The renal sinus is the part of the kidney where blood and fluid enter and exit the organ. The tumor can be completely removed with surgery. (National Wilms Tumor Study Group Staging System) C7841 Neoplastic Process Stage II Kidney Wilms Tumor Stage II Kidney Wilms Tumor C0278712 CTRP Cancer spread out of the kidney to nearby soft tissue or to blood vessels of the kidney and was completely removed by surgery. No cancer cells were found at the edges of the area where the cancer was removed. Malignant Stage_II_Wilms_Tumor Stage II Kidney Nephroblastoma Stage II Kidney Wilms Tumor Stage II Renal Wilms Tumor Stage II Renal Wilms' Tumor Stage II Wilms Tumor stage II Wilms tumor Stage II Kidney Wilms Tumor Wilms tumor that is found in areas near the kidney and cannot be completely removed with surgery. The tumor may have spread to nearby organs and blood vessels or throughout the abdomen and to nearby lymph nodes. Lymph nodes are tiny, bean-shaped organs that help fight infection. Stage III cancer has not spread outside the abdomen. (National Wilms Tumor Study Group Staging System) C7842 Neoplastic Process Stage III Kidney Wilms Tumor Stage III Kidney Wilms Tumor C0278713 CTRP Cancer remains in the abdomen after surgery and at least one of the following is true: (1) cancer has spread to lymph nodes in the abdomen or pelvis (the part of the body between the hips); (2) cancer has spread to or through the surface of the peritoneum (the layer of tissue that lines the abdominal cavity and covers most organs in the abdomen); (3) a biopsy of the tumor was done during surgery to remove it; (4) the tumor was removed in more than one piece. Malignant Stage_III_Wilms_Tumor Stage III Kidney Nephroblastoma Stage III Kidney Wilms Tumor Stage III Renal Wilms Tumor Stage III Renal Wilms' Tumor Stage III Wilms Tumor stage III Wilms tumor Stage III Kidney Wilms Tumor Wilms tumor that has spread to other more distant organs, such as the lungs, liver, bones, and brain, or to lymph nodes outside the abdomen (National Wilms Tumor Study Group Staging System) C7843 Neoplastic Process Stage IV Kidney Wilms Tumor Stage IV Kidney Wilms Tumor C0278714 CTRP Cancer has spread through the blood to organs such as the lungs, liver, bone, or brain, or to lymph nodes outside of the abdomen and pelvis (the part of the body between the hips). Malignant Stage_IV_Wilms_Tumor Stage IV Kidney Nephroblastoma Stage IV Kidney Wilms Tumor Stage IV Renal Wilms Tumor Stage IV Renal Wilms' Tumor Stage IV Wilms Tumor stage IV Wilms tumor Stage IV Kidney Wilms Tumor Wilms tumor that affects both kidneys at the same time. The tumor in each kidney is staged separately (National Wilms Tumor Study Group Staging System) C7844 Neoplastic Process Stage V Kidney Wilms Tumor Stage V Kidney Wilms Tumor C0278715 CTRP Cancer cells are found in both kidneys when the disease is first diagnosed. Each kidney is staged separately as I, II, III, or IV. Malignant Stage_V_Wilms_Tumor Stage V Kidney Nephroblastoma Stage V Kidney Wilms Tumor Stage V Renal Wilms Tumor Stage V Renal Wilms' Tumor Stage V Wilms Tumor stage V Wilms tumor Stage V Kidney Wilms Tumor The reemergence of Wilms tumor of the kidney after a period of remission. C7845 Neoplastic Process Recurrent Kidney Wilms Tumor C0278716 Malignant Recurrent_Wilms_Tumor Recurrent Kidney Adenosarcoma Recurrent Kidney Nephroblastoma Recurrent Kidney Wilms Tumor Recurrent Renal Adenosarcoma Recurrent Renal Wilms Tumor Recurrent Renal Wilms' Tumor Relapsed Kidney Adenosarcoma Relapsed Kidney Nephroblastoma Relapsed Renal Adenosarcoma Relapsed Renal Wilms' Tumor Recurrent Kidney Wilms Tumor Retinoblastoma restricted to local involvement. C7846 Neoplastic Process Intraocular Retinoblastoma Intraocular Retinoblastoma C0278717 CTRP Malignant Intraocular_Retinoblastoma Intraocular Retinoblastoma Intraocular Retinoblastoma Risk: Low; Findings: Lymphocytosis only; Survival (months): more than 120. (from AJCC 8th Ed.) C7847 Neoplastic Process Stage 0 Chronic Lymphocytic Leukemia Stage 0 Chronic Lymphocytic Leukemia C0278718 CTRP There are too many lymphocytes in the blood, but there are no other symptoms of leukemia. Stage 0 is indolent (slow-growing). Malignant Stage_0_Chronic_Lymphocytic_Leukemia CLL Stage 0 Chronic Lymphocytic Leukemia Stage 0 Stage 0 CLL Stage 0 Chronic Lymphocytic Leukemia Stage 0 Chronic Lymphocytic Leukemia (CLL) Stage 0 Chronic Lymphocytic Leukemia- Modified Rai Staging System stage 0 chronic lymphocytic leukemia Stage 0 Chronic Lymphocytic Leukemia Retinoblastoma that has spread beyond the eye e.g. to brain, soft tissue/bone, bone marrow. C7848 Neoplastic Process Extraocular Retinoblastoma Extraocular Retinoblastoma C0278719 CTRP Malignant Extraocular_Retinoblastoma Extraocular Retinoblastoma Metastatic Retinoblastoma Extraocular Retinoblastoma The reemergence of retinoblastoma after a period of remission. C7849 Neoplastic Process Recurrent Retinoblastoma Recurrent Retinoblastoma C0278720 CTRP Malignant Recurrent_Retinoblastoma Recurrent Retinoblastoma Relapsed Retinoblastoma Recurrent Retinoblastoma Multiple myeloma with all of the following: 1. Hemoglobin greater than 10 g/Dl, 2. Normal serum calcium, 3. Normal bone structure, 4. Low monoclonal (or myeloma) protein (M protein) production as shown by: a. IgG less than 5.0 g/dL, b. IgA less than 3.0 g/dL, c. Urinary kappa or lamda less than 4 g/24 hours. Estimated myeloma cell mass: less than 0.6 trillion (1012)/m2 (low burden). The following subclassification of stages is used: a. Creatinine less than 2.0 mg/dL, b. Creatinine greater than or equal to 2.0 mg/dL. Impaired renal function worsens prognosis regardless of stage. Note that the newer International Staging System defines stage I quite differently: Beta-2-microglobulin less than 3.5 and albumin greater than or equal to 3.5 (median survival of 62 months). (PDQ) C7850 Neoplastic Process DS Stage I Plasma Cell Myeloma DS Stage I Multiple Myeloma C0278722 CTRP Relatively few cancer cells have spread throughout the body. There may be no symptoms of disease. Malignant Stage_I_Multiple_Myeloma DS Stage I Multiple Myeloma DS Stage I Multiple Myeloma/Plasma Cell Myeloma DS Stage I Plasma Cell Myeloma Durie/Salmon Stage I Multiple Myeloma Durie/Salmon Stage I Plasma Cell Myeloma Multiple Myeloma Stage I Stage I Multiple Myeloma Stage I Plasma Cell Myeloma stage I multiple myeloma DS Stage I Multiple Myeloma Multiple myeloma that fits in neither stage I nor stage III. Estimated myeloma cell mass: 0.6 to 1.2 trillion (1012)/m2 (intermediate burden). The following subclassification of stages is used: a. Creatinine less than 2.0 mg/dL, b. Creatinine greater than or equal to 2.0 mg/dL. Impaired renal function worsens prognosis regardless of stage. Note that the newer International Staging System defines stage II quite differently: Beta-2-microglobulin less than 3.5 and albumin less than 3.5 or beta-2-microglobulin 3.5 to less than 5.5 (median survival of 44 months). (PDQ) C7851 Neoplastic Process DS Stage II Plasma Cell Myeloma DS Stage II Multiple Myeloma C0278723 CTRP Cancer in which a moderate number of cancer cells have spread throughout the body. Malignant Stage_II_Multiple_Myeloma DS Stage II Multiple Myeloma DS Stage II Multiple Myeloma/Plasma Cell Myeloma DS Stage II Plasma Cell Myeloma Durie/Salmon Stage II Multiple Myeloma Durie/Salmon Stage II Plasma Cell Myeloma Multiple Myeloma Stage II Stage II Multiple Myeloma Stage II Plasma Cell Myeloma stage II multiple myeloma DS Stage II Multiple Myeloma Multiple myeloma with one or more of the following: 1. Hemoglobin less than 8.5 g/dL. 2. Serum calcium greater than 12.0 mg/dL. 3. More than three lytic bone lesions. 4. High M protein production as shown by: a. IgG greater than 7.0 g/dL. b. IgA greater than 5.0 g/dL. c. Urinary kappa or lamda greater than 12.0 g/24 hours. Estimated myeloma cell mass: greater than 1.2 trillion (1012)/m2 (high burden). The following subclassification of stages is used: a. Creatinine less than 2.0 mg/dL. b. Creatinine greater than or equal to 2.0 mg/dL. Serum beta-2-microglobulin has been shown to be a reliable marker for prognosis. Since the great majority of symptomatic myeloma patients are classified as stage III by the Durie/Salmon criteria, this staging system has not proven to be very useful for identifying the patients with intermediate and poor prognosis. Note that the newer International Staging System defines stage III quite differently: Beta-2-microglobulin greater than or equal to 5.5 (median survival of 29 months). (PDQ) C7852 Neoplastic Process DS Stage III Plasma Cell Myeloma DS Stage III Multiple Myeloma C0278724 CTRP A relatively large number of cancer cells have spread throughout the body. There may be one or more of the following: 1) a decrease in the number of red blood cells, causing anemia; 2) the amount of calcium in the blood is very high, because the bones are being damaged; 3) more than three bone tumors (plasmacytomas) are found; or 4) high levels of M protein are found in the blood or urine. Malignant Stage_III_Multiple_Myeloma DS Stage III Multiple Myeloma DS Stage III Multiple Myeloma/Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma Durie/Salmon Stage III Multiple Myeloma Durie/Salmon Stage III Plasma Cell Myeloma Multiple Myeloma Stage III Stage III Multiple Myeloma Stage III Plasma Cell Myeloma stage III multiple myeloma DS Stage III Multiple Myeloma Small cell lung carcinoma which is confined to one hemi-thorax and the regional lymph nodes. C7853 Neoplastic Process Limited Stage Small Cell Lung Carcinoma Limited Stage Lung Small Cell Carcinoma C0278725 CTRP Cancer is found in one lung, the tissues between the lungs, and nearby lymph nodes only. Malignant Limited_Stage_Small_Cell_Lung_Carcinoma Limited Stage Lung Small Cell Carcinoma Limited Stage Small Cell Carcinoma of Lung Limited Stage Small Cell Carcinoma of the Lung Limited Stage Small Cell Lung Cancer Limited Stage Small Cell Lung Carcinoma limited-stage small cell lung cancer Limited Stage Lung Small Cell Carcinoma Stage I includes: T1, N0, M0. T1: Tumor confined to the vulva or vulva and perineum, 2cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.). C7854 Neoplastic Process Stage I Vulvar Cancer AJCC v6 Stage I Vulvar Cancer AJCC v6 C0854960 CTRP Stage I vulvar cancer is divided into stages IA and IB. In both IA and IB, cancer is found only in the vulva or in the vulva and perineum (area between the rectum and the vagina) and the tumor is 2 centimeters or smaller. In stage IA, the tumor has spread 1 millimeter or less into the tissue of the vulva. In stage IB, the tumor has spread more than 1 millimeter into the tissue of the vulva. Malignant Stage_I_Vulvar_Cancer AJCC Stage I Vulvar Cancer AJCC v6 FIGO Stage I Carcinoma of Vulva AJCC v6 FIGO Stage I Carcinoma of the Vulva AJCC v6 FIGO Stage I Vulva Carcinoma AJCC v6 FIGO Stage I Vulvar Carcinoma AJCC v6 Stage I Vulva Cancer AJCC v6 Stage I Vulval Cancer AJCC v6 Stage I Vulval Carcinoma AJCC v6 Stage I Vulvar Cancer Stage I Vulvar Cancer AJCC v6 Stage I Vulvar Carcinoma AJCC v6 Vulvar Cancer Stage I AJCC v6 stage I vulvar cancer Stage I Vulvar Cancer AJCC v6 Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C7855 Neoplastic Process Stage 0 Vaginal Cancer AJCC v6 Stage 0 Vaginal Cancer AJCC v6 C0686277 CTRP GDC Malignant Stage_0_Vaginal_Cancer 8077/2 Vaginal intraepithelial neoplasia, grade III AJCC Stage 0 Vaginal Cancer v6 Carcinoma in situ of Vagina AJCC v6 Carcinoma in situ of the Vagina AJCC v6 FIGO Stage 0 Carcinoma of Vagina FIGO Stage 0 Carcinoma of the Vagina FIGO Stage 0 Vagina Carcinoma FIGO Stage 0 Vaginal Carcinoma Grade 3 Vaginal Intraepithelial Neoplasia AJCC v6 Grade III Vaginal Intraepithelial Neoplasia AJCC v6 Intraepithelial Neoplasia of Vagina Grade 3 AJCC v6 Intraepithelial Neoplasia of the Vagina Grade 3 AJCC v6 Stage 0 Vaginal Cancer Stage 0 Vaginal Cancer AJCC v6 VAIN 3 AJCC v6 VAIN Grade 3 AJCC v6 VAIN III AJCC v6 Vagina Carcinoma in situ AJCC v6 Vaginal Cancer Stage 0 AJCC v6 Vaginal Carcinoma in situ AJCC v6 Vaginal Intraepithelial Neoplasia Grade 3 AJCC v6 Stage 0 Vaginal Cancer AJCC v6 Stage I includes: (T1, N0, M0). T1: Tumor confined to vagina. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C7856 Neoplastic Process Stage I Vaginal Cancer AJCC v6 and v7 Stage I Vaginal Cancer AJCC v6 and v7 C0278741 CTRP Cancer that is found only in the vagina (birth canal). Malignant Stage_I_Vaginal_Cancer AJCC Stage I Vaginal Cancer FIGO Stage I Carcinoma of Vagina FIGO Stage I Carcinoma of the Vagina FIGO Stage I Vagina Carcinoma FIGO Stage I Vaginal Carcinoma Stage I Vaginal Cancer Stage I Vaginal Cancer AJCC v6 Stage I Vaginal Cancer AJCC v6 and v7 Stage I Vaginal Cancer AJCC v7 Stage I Vaginal Carcinoma AJCC v6 Stage I Vaginal Carcinoma AJCC v7 Vaginal Cancer Stage I stage I vaginal cancer Stage I Vaginal Cancer AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: Tumor invades paravaginal tissues but not to pelvic wall. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C7857 Neoplastic Process Stage II Vaginal Cancer AJCC v6 and v7 Stage II Vaginal Cancer AJCC v6 and v7 C0278742 CTRP Cancer that has spread from the vagina (birth canal) to the tissue around the vagina. Malignant Stage_II_Vaginal_Cancer AJCC Stage II Vaginal Cancer FIGO Stage II Carcinoma of Vagina FIGO Stage II Carcinoma of the Vagina FIGO Stage II Vagina Carcinoma FIGO Stage II Vaginal Carcinoma Stage II Vaginal Cancer Stage II Vaginal Cancer AJCC v6 Stage II Vaginal Cancer AJCC v6 and v7 Stage II Vaginal Cancer AJCC v7 Stage II Vaginal Carcinoma AJCC v6 Stage II Vaginal Carcinoma AJCC v7 Vaginal Cancer Stage II stage II vaginal cancer Stage II Vaginal Cancer AJCC v6 and v7 Stage III includes: (T1-3, N1, M0) and (T3, N0, M0). T1: Tumor confined to vagina. T2: Tumor invades paravaginal tissues but not to pelvic wall. T3: Tumor extends to pelvic wall. N0: No regional lymph node metastasis. N1: Pelvic or inguinal lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C7858 Neoplastic Process Stage III Vaginal Cancer AJCC v6 and v7 Stage III Vaginal Cancer AJCC v6 and v7 C0278743 CTRP Cancer that has spread from the vagina (birth canal) to the lymph nodes in the pelvis or groin, or to the pelvis, or both. Malignant Stage_III_Vaginal_Cancer AJCC Stage III Vaginal Cancer FIGO Stage III Carcinoma of Vagina FIGO Stage III Carcinoma of the Vagina FIGO Stage III Vagina Carcinoma FIGO Stage III Vaginal Carcinoma Stage III Vaginal Cancer Stage III Vaginal Cancer AJCC v6 Stage III Vaginal Cancer AJCC v6 and v7 Stage III Vaginal Cancer AJCC v7 Stage III Vaginal Carcinoma AJCC v6 Stage III Vaginal Carcinoma AJCC v7 Vaginal Cancer Stage III stage III vaginal cancer Stage III Vaginal Cancer AJCC v6 and v7 Stage IVA includes: T4, Any N, M0. T4: Tumor invades mucosa of the bladder or rectum and/or extends beyond the true pelvis (bullous edema is not sufficient evidence to classify a tumor as T4). M0: No distant metastasis. (AJCC 6th and 7th eds.) C7859 Neoplastic Process Stage IVA Vaginal Cancer AJCC v6 and v7 Stage IVA Vaginal Cancer AJCC v6 and v7 C0278744 CTRP Malignant Stage_IVA_Vaginal_Cancer AJCC Stage IVA Vaginal Cancer FIGO Stage IVA Carcinoma of Vagina FIGO Stage IVA Carcinoma of the Vagina FIGO Stage IVA Vagina Carcinoma FIGO Stage IVA Vaginal Carcinoma Stage IVA Vaginal Cancer Stage IVA Vaginal Cancer AJCC v6 Stage IVA Vaginal Cancer AJCC v6 and v7 Stage IVA Vaginal Cancer AJCC v7 Stage IVA Vaginal Carcinoma AJCC v6 Stage IVA Vaginal Carcinoma AJCC v7 Vaginal Cancer Stage IVA Stage IVA Vaginal Cancer AJCC v6 and v7 The reemergence of vaginal carcinoma after a period of remission. C7860 Neoplastic Process Recurrent Vaginal Carcinoma Recurrent Vaginal Carcinoma C0278746 CTRP Malignant Recurrent_Vaginal_Cancer Recurrent Cancer of Vagina Recurrent Cancer of the Vagina Recurrent Vagina Cancer Recurrent Vaginal Cancer Recurrent Vaginal Carcinoma Relapsed Cancer of Vagina Relapsed Cancer of the Vagina Relapsed Vagina Cancer Relapsed Vaginal Cancer Recurrent Vaginal Carcinoma Digestive system neuroendocrine tumor G1 that is restricted to the site of origin without evidence of metastasis. C7861 Neoplastic Process Localized Gastrointestinal Neuroendocrine Tumor G1 Localized Digestive System Neuroendocrine Tumor G1 C0278747 CTRP Undetermined Localized_Gastrointestinal_Carcinoid_Tumor Localized Digestive System Neuroendocrine Tumor G1 Localized GI Carcinoid Tumor Localized Gastrointestinal Neuroendocrine Tumor G1 Localized Digestive System Neuroendocrine Tumor G1 Digestive system neuroendocrine tumor G1 that has not spread to other regions. C7862 Neoplastic Process Regional Gastrointestinal Neuroendocrine Tumor G1 Regional Digestive System Neuroendocrine Tumor G1 C0278748 CTRP Undetermined Regional_Gastrointestinal_Carcinoid_Tumor Regional Digestive Carcinoid Tumor Regional Digestive System Neuroendocrine Tumor G1 Regional GI Carcinoid Tumor Regional Gastrointestinal Carcinoid Tumor Regional Gastrointestinal Neuroendocrine Tumor G1 Regional Digestive System Neuroendocrine Tumor G1 The reemergence of digestive system neuroendocrine tumor G1 after a period of remission. C7864 Neoplastic Process Recurrent Gastrointestinal Neuroendocrine Tumor G1 Recurrent Digestive System Neuroendocrine Tumor G1 C0278750 CTRP Undetermined Recurrent_Gastrointestinal_Carcinoid_Tumor Recurrent Digestive Carcinoid Tumor Recurrent Digestive System Neuroendocrine Tumor G1 Recurrent GI Carcinoid Tumor Recurrent Gastrointestinal Carcinoid Tumor Recurrent Gastrointestinal Neuroendocrine Tumor G1 Relapsed Digestive Carcinoid Tumor Relapsed Gastrointestinal Carcinoid Tumor Recurrent Digestive System Neuroendocrine Tumor G1 Stage I includes: (T1, N0, M0). T1: Tumor invades subepithelial connective tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C7867 Neoplastic Process Stage I Penile Cancer AJCC v6 Stage I Penile Cancer AJCC v6 C2981176 CTRP Malignant Stage_I_Penile_Cancer Penile Cancer Stage I AJCC v6 Penile Carcinoma Stage I AJCC v6 Stage I Carcinoma of Penis AJCC v6 Stage I Carcinoma of the Penis AJCC v6 Stage I Penile Cancer Stage I Penile Cancer AJCC v6 Stage I Penile Carcinoma AJCC v6 Stage I Penis Cancer AJCC v6 Stage I Penis Carcinoma AJCC v6 Stage I Penile Cancer AJCC v6 Stage II includes: (T1, N1, M0); (T2, N0, M0); (T2, N1, M0). T1: Tumor invades subepithelial connective tissue. N0: No regional lymph node metastasis. N1: Metastasis in a single superficial, inguinal lymph node. M0: No distant metastasis. (AJCC 6th ed.) C7868 Neoplastic Process Stage II Penile Cancer AJCC v6 Stage II Penile Cancer AJCC v6 C2981177 CTRP Malignant Stage_II_Penile_Cancer Penile Cancer Stage II AJCC v6 Penile Carcinoma Stage II AJCC v6 Stage II Carcinoma of Penis AJCC v6 Stage II Carcinoma of the Penis AJCC v6 Stage II Penile Cancer Stage II Penile Cancer AJCC v6 Stage II Penile Carcinoma AJCC v6 Stage II Penis Cancer AJCC v6 Stage II Penis Carcinoma AJCC v6 Stage II Penile Cancer AJCC v6 Stage III includes: (T1, N2, M0); (T2, N2, M0); (T3, N0, M0); (T3, N1, M0); (T3, N2, M0). T1: Tumor invades subepithelial connective tissue. T2: Tumor invades corpus spongiosum or cavernosum. T3: Tumor invades urethra or prostate. N0: No regional lymph node metastasis. N1: Metastasis in single superficial, inguinal lymph node. N2: Metastasis in multiple or bilateral superficial inguinal lymph nodes. M0: No distant metastasis. (AJCC 6th ed.) C7869 Neoplastic Process Stage III Penile Cancer AJCC v6 Stage III Penile Cancer AJCC v6 C2981178 CTRP Malignant Stage_III_Penile_Cancer Penile Cancer Stage III AJCC v6 Penile Carcinoma Stage III AJCC v6 Stage III Carcinoma of Penis AJCC v6 Stage III Carcinoma of the Penis AJCC v6 Stage III Penile Cancer Stage III Penile Cancer AJCC v6 Stage III Penile Carcinoma AJCC v6 Stage III Penis Cancer AJCC v6 Stage III Penis Carcinoma AJCC v6 Stage III Penile Cancer AJCC v6 A carcinoma of the penis that reappears after a period of remission. C7870 Neoplastic Process Recurrent Penile Carcinoma Recurrent Penile Carcinoma C0854964 CTRP Malignant Recurrent_Penile_Cancer Recurrent Carcinoma of Penis Recurrent Carcinoma of the Penis Recurrent Penile Cancer Recurrent Penile Carcinoma Recurrent Penis Cancer Recurrent Penis Carcinoma Relapsed Carcinoma of Penis Relapsed Carcinoma of the Penis Relapsed Penile Carcinoma Recurrent Penile Carcinoma A morphologic variant of diffuse large B-cell lymphoma occurring in adults. It is characterized by the presence of large lymphoid cells with abundant cytoplasm and prominent nucleoli. C7873 Neoplastic Process Adult Immunoblastic Lymphoma Adult Immunoblastic Lymphoma C0278763 CTRP Cellosaurus Malignant Adult_Immunoblastic_Lymphoma Adult Immunoblastic Large Cell Lymphoma Adult Immunoblastic Lymphoma Immunoblastic Lymphoma Adult Immunoblastic Lymphoma Risk: Intermediate; Findings: Lymphocytosis and adenopathy; Survival (months): 95. (from AJCC 8th Ed.) C7874 Neoplastic Process Stage I Chronic Lymphocytic Leukemia Stage I Chronic Lymphocytic Leukemia C0278767 CTRP There are too many lymphocytes in the blood and the lymph nodes are larger than normal. Malignant Stage_I_Chronic_Lymphocytic_Leukemia CLL Stage I Chronic Lymphocytic Leukemia Stage I Stage I CLL Stage I Chronic Lymphocytic Leukemia Stage I Chronic Lymphocytic Leukemia (CLL) Stage I Chronic Lymphocytic Leukemia- Modified Rai Staging System stage I chronic lymphocytic leukemia Stage I Chronic Lymphocytic Leukemia Risk: Intermediate; Findings: Lymphocytosis, adenopathy, and enlarged spleen and/or liver; Survival (months): 72. (from AJCC 8th Ed.) C7875 Neoplastic Process Stage II Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia C0854803 CTRP There are too many lymphocytes in the blood, the liver or spleen is larger than normal, and the lymph nodes may be larger than normal. Malignant Stage_II_Chronic_Lymphocytic_Leukemia CLL Stage II Chronic Lymphocytic Leukemia Stage II Stage II CLL Stage II Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia (CLL) Stage II Chronic Lymphocytic Leukemia- Modified Rai Staging System stage II chronic lymphocytic leukemia Stage II Chronic Lymphocytic Leukemia Risk: High; Findings: Lymphocytosis and hemoglobin less than 11 g/dL; Survival (months): 30. (from AJCC 8th Ed.) C7876 Neoplastic Process Stage III Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia C0278769 CTRP There are too many lymphocytes in the blood and there are too few red blood cells. The lymph nodes, liver, or spleen may be larger than normal. Malignant Stage_III_Chronic_Lymphocytic_Leukemia CLL Stage III Chronic Lymphocytic Leukemia Stage III Stage III CLL Stage III Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia (CLL) Stage III Chronic Lymphocytic Leukemia- Modified Rai Staging System stage III chronic lymphocytic leukemia Stage III Chronic Lymphocytic Leukemia A localized hepatocellular carcinoma or intrahepatic cholangiocarcinoma that occurs during adulthood and it is amenable to surgical resection. C7877 Neoplastic Process Localized Resectable Adult Liver Carcinoma Localized Resectable Adult Liver Carcinoma C0278772 CTRP Malignant Localized_Resectable_Adult_Liver_Cancer Localized Resectable Adult Liver Cancer Localized Resectable Adult Liver Carcinoma Localized Resectable Adult Primary Cancer of Liver Localized Resectable Adult Primary Cancer of the Liver Localized Resectable Adult Primary Liver Cancer Resectable Liver Cancer Localized Resectable Adult Liver Carcinoma A localized hepatocellular carcinoma or intrahepatic cholangiocarcinoma that occurs during adulthood and it is not amenable to surgical resection. C7878 Neoplastic Process Localized Unresectable Adult Liver Carcinoma Localized Unresectable Adult Liver Carcinoma C0278773 CTRP Malignant Localized_Unresectable_Adult_Liver_Cancer Localized Non-Resectable Adult Liver Cancer Localized Non-Resectable Adult Liver Carcinoma Localized Unresectable Adult Liver Carcinoma Localized Unresectable Adult Primary Cancer of Liver Localized Unresectable Adult Primary Cancer of the Liver Localized Unresectable Adult Primary Liver Cancer Unresectable Liver Cancer Localized Unresectable Adult Liver Carcinoma A hepatocellular carcinoma or intrahepatic cholangiocarcinoma that occurs during adulthood and has recurred after a period of remission. C7880 Neoplastic Process Recurrent Adult Liver Cancer Recurrent Adult Liver Carcinoma C0278775 CTRP Malignant Recurrent_Adult_Liver_Cancer Recurrent Adult Liver Cancer Recurrent Adult Liver Carcinoma Recurrent Adult Primary Cancer of Liver Recurrent Adult Primary Cancer of the Liver Recurrent Adult Primary Liver Cancer Recurrent Liver Cancer Relapsed Adult Liver Cancer Relapsed Adult Primary Cancer of Liver Relapsed Adult Primary Cancer of the Liver Relapsed Adult Primary Liver Cancer Recurrent Adult Liver Carcinoma The reemergence of osteosarcoma after a period of remission. C7881 Neoplastic Process Recurrent Osteosarcoma Recurrent Osteosarcoma C0278779 CTRP Malignant Recurrent_Osteosarcoma Osteosarcoma, Recurrent Recurrent Osteogenic Sarcoma Recurrent Osteosarcoma Relapsed Osteogenic Sarcoma Relapsed Osteosarcoma Recurrent Osteosarcoma The reemergence of acute myeloid leukemia in adults after a period of remission. C7882 Neoplastic Process Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Acute Myeloid Leukemia C0278780 CTRP Malignant Recurrent_Adult_Acute_Myeloid_Leukemia Recurrent Acute Myeloid Leukemia (AML) Recurrent Adult AML Recurrent Adult Acute Myelogenous Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Acute Non-Lymphocytic Leukemia Relapsed Adult AML Relapsed Adult Acute Myelogenous Leukemia Relapsed Adult Acute Myeloid Leukemia Recurrent Adult Acute Myeloid Leukemia The reemergence of acute lymphoblastic leukemia in adults after a period of remission. C7883 Neoplastic Process Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia C0278785 CTRP Malignant Recurrent_Adult_Acute_Lymphoblastic_Leukemia Recurrent Acute Lymphoblastic Leukemia (ALL) Recurrent Adult ALL Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Lymphocytic Leukemia Recurrent Adult Acute Lymphogenous Leukemia Recurrent Adult Acute Lymphoid Leukemia Recurrent Adult Precursor Lymphoblastic Leukemia Relapsed Adult ALL Relapsed Adult Acute Lymphoblastic Leukemia Relapsed Adult Acute Lymphocytic Leukemia Relapsed Adult Acute Lymphogenous Leukemia Relapsed Adult Acute Lymphoid Leukemia Recurrent Adult Acute Lymphoblastic Leukemia The reemergence of brain neoplasm in adulthood after a period of remission. C7884 Neoplastic Process Recurrent Adult Brain Neoplasm Recurrent Adult Brain Neoplasm C0278786 CTRP Undetermined Recurrent_Adult_Brain_Neoplasm Recurrent Adult Brain Neoplasm Recurrent Adult Brain Tumor Recurrent Brain Neoplasm Recurrent Neoplasm of Adult Brain Recurrent Neoplasm of the Adult Brain Recurrent Tumor of Adult Brain Recurrent Tumor of the Adult Brain Relapsed Adult Brain Neoplasm Relapsed Adult Brain Tumor Relapsed Neoplasm of Adult Brain Relapsed Neoplasm of the Adult Brain Relapsed Tumor of Adult Brain Relapsed Tumor of the Adult Brain Recurrent Adult Brain Neoplasm Chronic myeloid leukemia, BCR-ABL1 positive that is resistant to treatment. C7885 Neoplastic Process Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive C1370868 CTRP Malignant Refractory_Chronic_Myelogenous_Leukemia Refractory CGL Refractory CML Refractory Chronic Granulocytic Leukemia Refractory Chronic Myelocytic Leukemia Refractory Chronic Myelogenous Leukemia Refractory Chronic Myelogenous Leukemia (CML) Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive Refractory Chronic Myelogenous Leukemia, BCR::ABL1 Positive Refractory Chronic Myeloid Leukemia Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive Refractory Chronic Myeloid Leukemia, BCR::ABL1 Positive Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive Chronic lymphocytic leukemia that is resistant to treatment. C7886 Neoplastic Process Refractory Chronic Lymphocytic Leukemia Refractory Chronic Lymphocytic Leukemia C0278791 CTRP Malignant Refractory_Chronic_Lymphocytic_Leukemia Chronic Lymphocytic Leukemia Refractory Refractory B-Cell Chronic Lymphocytic Leukemia Refractory CLL Refractory Chronic Lymphocytic Leukemia Refractory Chronic Lymphocytic Leukemia (CLL) Refractory Chronic Lymphoid Leukemia Refractory Chronic Lymphocytic Leukemia The reemergence of gestational trophoblastic tumor after a period of remission. C7887 Neoplastic Process Recurrent Gestational Trophoblastic Tumor Recurrent Gestational Trophoblastic Tumor C0278796 CTRP Undetermined Recurrent_Gestational_Trophoblastic_Tumor Recurrent GTT Recurrent Gestational Trophoblastic Disease Recurrent Gestational Trophoblastic Neoplasm Recurrent Gestational Trophoblastic Tumor Relapsed GTT Relapsed Gestational Trophoblastic Disease Relapsed Gestational Trophoblastic Neoplasm Relapsed Gestational Trophoblastic Tumor Recurrent Gestational Trophoblastic Tumor An adenocarcinoma that arises from the small intestine. Histologic variants include mucinous adenocarcinoma and signet ring cell carcinoma. C7888 Neoplastic Process Small Intestinal Adenocarcinoma Small Intestinal Adenocarcinoma C0278803 CTEP CTRP Cellosaurus Malignant Small_Intestinal_Adenocarcinoma Adenocarcinoma - small intest. Adenocarcinoma of Small Bowel Adenocarcinoma of Small Intestine Adenocarcinoma of the Small Bowel Adenocarcinoma of the Small Intestine Adenocarcinoma of the small intestine Non-Ampullary Adenocarcinoma Small Bowel Adenocarcinoma Small Intestinal Adenocarcinoma Small Intestinal Adenocarcinoma An adenocarcinoma that arises from the duodenum. Histologic variants include mucinous adenocarcinoma and signet ring cell carcinoma. C7889 Neoplastic Process Duodenal Adenocarcinoma C0278804 Cellosaurus Malignant Duodenal_Adenocarcinoma Adenocarcinoma of Duodenum Adenocarcinoma of the Duodenum Duodenal Adenocarcinoma Duodenal Adenocarcinoma A carcinoma that arises from the gallbladder and it is not amenable to surgical resection. C7890 Neoplastic Process Unresectable Gallbladder Carcinoma Unresectable Gallbladder Carcinoma C0876982 CTRP Cancer that has spread to the tissues around the gallbladder (such as the liver, stomach, pancreas, intestine, or lymph nodes in the area) and cannot be surgically removed. Malignant Unresectable_Gallbladder_Cancer Gallbladder Cancer Unresectable Gallbladder Carcinoma Unresectable Unresectable Cancer of Gallbladder Unresectable Cancer of the Gallbladder Unresectable Gallbladder Cancer Unresectable Gallbladder Carcinoma unresectable gallbladder cancer Unresectable Gallbladder Carcinoma A carcinoma that arises from the extrahepatic bile ducts and it has not spread to other anatomic sites. C7891 Neoplastic Process Localized Extrahepatic Bile Duct Carcinoma Localized Extrahepatic Bile Duct Carcinoma C0278810 CTRP Malignant Localized_Extrahepatic_Bile_Duct_Carcinoma Localized Cancer of Extrahepatic Bile Duct Localized Cancer of the Extrahepatic Bile Duct Localized Extrahepatic Bile Duct Cancer Localized Extrahepatic Bile Duct Carcinoma Localized Extrahepatic Bile Duct Carcinoma Extrahepatic bile duct carcinoma that is not amenable to surgical removal. C7892 Neoplastic Process Unresectable Extrahepatic Bile Duct Carcinoma Unresectable Extrahepatic Bile Duct Carcinoma C0278811 CTRP Malignant Unresectable_Extrahepatic_Bile_Duct_Carcinoma Non-Resectable Extrahepatic Bile Duct Carcinoma Unresectable Cancer of Extrahepatic Bile Duct Unresectable Cancer of the Extrahepatic Bile Duct Unresectable Extrahepatic (Distal) Bile Duct Cancer Unresectable Extrahepatic Bile Duct Cancer Unresectable Extrahepatic Bile Duct Carcinoma Unresectable Extrahepatic Bile Duct Carcinoma The reemergence of an extrahepatic bile duct carcinoma after a period of remission. C7893 Neoplastic Process Recurrent Extrahepatic Bile Duct Carcinoma Recurrent Extrahepatic Bile Duct Carcinoma C0278812 CTRP Malignant Recurrent_Extrahepatic_Bile_Duct_Carcinoma Recurrent Cancer of Extrahepatic Bile Duct Recurrent Cancer of the Extrahepatic Bile Duct Recurrent Extrahepatic Bile Duct Cancer Recurrent Extrahepatic Bile Duct Carcinoma Relapsed Cancer of Extrahepatic Bile Duct Relapsed Cancer of the Extrahepatic Bile Duct Recurrent Extrahepatic Bile Duct Carcinoma The reemergence of small intestine carcinoma after a period of remission. C7894 Neoplastic Process Recurrent Small Intestinal Carcinoma Recurrent Small Intestinal Carcinoma C0854788 CTRP Malignant Recurrent_Small_Intestinal_Cancer Recurrent Cancer of Small Intestine Recurrent Cancer of the Small Intestine Recurrent Carcinoma of Small Bowel Recurrent Carcinoma of Small Intestine Recurrent Carcinoma of the Small Bowel Recurrent Carcinoma of the Small Intestine Recurrent Small Bowel Carcinoma Recurrent Small Intestinal Cancer Recurrent Small Intestinal Carcinoma Recurrent Small Intestine Carcinoma Relapsed Cancer of Small Intestine Relapsed Cancer of the Small Intestine Relapsed Carcinoma of Small Bowel Relapsed Carcinoma of Small Intestine Relapsed Carcinoma of the Small Bowel Relapsed Carcinoma of the Small Intestine Relapsed Small Bowel Carcinoma Relapsed Small Intestine Cancer Relapsed Small Intestine Carcinoma Small Intestine Carcinoma, Recurrent Recurrent Small Intestinal Carcinoma Stage 0 includes: 0a (Ta, N0, M0); 0is (Tis, N0, M0). Ta: Noninvasive papillary carcinoma. Tis: Carcinoma in situ: "flat tumor". N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C7895 Neoplastic Process Stage 0 Bladder Cancer AJCC v6 and v7 Stage 0 Bladder Cancer AJCC v6 and v7 C0278820 CTRP Abnormal cells are found in tissue lining the inside of the bladder. These abnormal cells may become cancer and spread into nearby normal tissue. Stage 0 is divided into stage 0a (papillary carcinoma) and stage 0is (carcinoma in situ), depending on the type of tumor. Stage 0a may look like tiny mushrooms growing from the lining of the bladder. Stage 0is is a flat tumor in the tissue lining the inside of the bladder. Malignant Stage_0_Bladder_Cancer Bladder Cancer Stage 0 Stage 0 Bladder Cancer Stage 0 Bladder Cancer AJCC v6 Stage 0 Bladder Cancer AJCC v6 and v7 Stage 0 Bladder Cancer AJCC v7 Stage 0 Bladder Carcinoma Stage 0 Carcinoma of Bladder Stage 0 Carcinoma of Urinary Bladder Stage 0 Carcinoma of the Bladder Stage 0 Carcinoma of the Urinary Bladder Stage 0 Urinary Bladder Carcinoma stage 0 bladder carcinoma in situ Stage 0 Bladder Cancer AJCC v6 and v7 Stage I includes: T1, N0, M0. T1: Tumor invades subepithelial connective tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C7896 Neoplastic Process Stage I Bladder Cancer AJCC v6 and v7 Stage I Bladder Cancer AJCC v6 and v7 C0278822 CTRP Cancer has spread to the layer of tissue under the inner lining of the bladder. Malignant Stage_I_Bladder_Cancer Bladder Cancer Stage I Jewett-Marshall Stage A Bladder Cancer Jewett-Marshall Stage A Bladder Carcinoma Jewett-Marshall Stage A Urinary Bladder Cancer Jewett-Marshall Stage A Urinary Bladder Carcinoma Stage I Bladder Cancer Stage I Bladder Cancer AJCC v6 Stage I Bladder Cancer AJCC v6 and v7 Stage I Bladder Cancer AJCC v7 Stage I Bladder Carcinoma Stage I Bladder Carcinoma AJCC v6 Stage I Bladder Carcinoma AJCC v7 Stage I Carcinoma of Bladder Stage I Carcinoma of Urinary Bladder Stage I Carcinoma of the Bladder Stage I Carcinoma of the Urinary Bladder Stage I Urinary Bladder Carcinoma stage I bladder cancer Stage I Bladder Cancer AJCC v6 and v7 Stage II includes: (T2a, N0, M0); (T2b, N0, M0). T2a: Tumor invades superficial muscle (inner half). T2b: Tumor invades deep muscle (outer half). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C7897 Neoplastic Process Stage II Bladder Cancer AJCC v6 and v7 Stage II Bladder Cancer AJCC v6 and v7 C0278823 CTRP Cancer has spread to either the inner half or outer half of the muscle wall of the bladder. Malignant Stage_II_Bladder_Cancer Cancer of Bladder Stage II Cancer of the Bladder Stage II Jewett-Marshall Stage B Bladder Cancer Jewett-Marshall Stage B Bladder Carcinoma Jewett-Marshall Stage B Urinary Bladder Cancer Jewett-Marshall Stage B Urinary Bladder Carcinoma Stage II Bladder Cancer Stage II Bladder Cancer AJCC v6 Stage II Bladder Cancer AJCC v6 and v7 Stage II Bladder Cancer AJCC v7 Stage II Bladder Carcinoma Stage II Bladder Carcinoma AJCC v6 Stage II Bladder Carcinoma AJCC v7 Stage II Carcinoma of Bladder Stage II Carcinoma of Urinary Bladder Stage II Carcinoma of the Bladder Stage II Carcinoma of the Urinary Bladder Stage II Urinary Bladder Carcinoma stage II bladder cancer Stage II Bladder Cancer AJCC v6 and v7 Stage III includes: (T3a, N0, M0); (T3b, N0, M0); (T4a, N0, M0). T3a: Tumor microscopically invades perivesical tissue. T3b: Tumor macroscopically invades perivesical tissue (extravesical mass). T4a: Tumor invades prostatic stroma, uterus, vagina. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C7898 Neoplastic Process Stage III Bladder Cancer AJCC v6 and v7 Stage III Bladder Cancer AJCC v6 and v7 C0278824 CTRP Cancer has spread from the bladder to the fatty layer of tissue surrounding it and may have spread to the reproductive organs (prostate, seminal vesicles, uterus, or vagina). Malignant Stage_III_Bladder_Cancer Cancer of Bladder Stage III Cancer of the Bladder Stage III Jewett-Marshall Stage C Bladder Cancer Jewett-Marshall Stage C Urinary Bladder Cancer Jewett-Marshall Stage C Urinary Bladder Carcinoma Stage III Bladder Cancer Stage III Bladder Cancer AJCC v6 Stage III Bladder Cancer AJCC v6 and v7 Stage III Bladder Cancer AJCC v7 Stage III Bladder Carcinoma Stage III Bladder Carcinoma AJCC v6 Stage III Bladder Carcinoma AJCC v7 Stage III Carcinoma of Bladder Stage III Carcinoma of Urinary Bladder Stage III Carcinoma of the Bladder Stage III Carcinoma of the Urinary Bladder Stage III Urinary Bladder Carcinoma stage III bladder cancer Stage III Bladder Cancer AJCC v6 and v7 The reemergence of bladder carcinoma after a period of remission. C7899 Neoplastic Process Recurrent Bladder Carcinoma Recurrent Bladder Carcinoma C0278827 CTRP Cellosaurus Malignant Recurrent_Bladder_Cancer Bladder Cancer, Recurrent Bladder Carcinoma Recurrent Recurrent Bladder Cancer Recurrent Bladder Carcinoma Recurrent Cancer of Bladder Recurrent Cancer of Urinary Bladder Recurrent Cancer of the Bladder Recurrent Cancer of the Urinary Bladder Recurrent Urinary Bladder Cancer Relapsed Bladder Cancer Relapsed Cancer of Bladder Relapsed Cancer of Urinary Bladder Relapsed Cancer of the Bladder Relapsed Cancer of the Urinary Bladder Relapsed Urinary Bladder Cancer Recurrent Bladder Carcinoma Stage IV includes the following: T4b, N0, M0; Any T, N1, M0; Any T, N2 M0; Any T, N3 M0; Any T, Any N, M1. T4b: Tumor invades the pelvic wall, abdominal wall. N1: Metastasis in a single lymph node, 2 cm or less in greatest dimension. N2: Metastasis in a single lymph node, more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, none more than 5 cm in greatest dimension. N3: Metastasis in a lymph node more than 5 cm in greatest dimension. M1: Distant metastasis. (AJCC 6th Ed.) C7900 Neoplastic Process Stage IV Bladder Cancer AJCC v6 Stage IV Bladder Cancer AJCC v6 C0278828 CTRP Cancer has spread from the bladder to the wall of the abdomen or pelvis. Cancer may have spread to one or more lymph nodes or to other parts of the body. Malignant Stage_IV_Bladder_Cancer Cancer of Bladder Stage IV AJCC v6 Cancer of the Bladder Stage IV AJCC v6 Jewett-Marshall Stage D Bladder Cancer Jewett-Marshall Stage D Bladder Carcinoma Jewett-Marshall Stage D Urinary Bladder Cancer Jewett-Marshall Stage D Urinary Bladder Carcinoma Stage IV Bladder Cancer Stage IV Bladder Cancer AJCC v6 Stage IV Bladder Carcinoma AJCC v6 Stage IV Carcinoma of Bladder AJCC v6 Stage IV Carcinoma of Urinary Bladder AJCC v6 Stage IV Carcinoma of the Bladder AJCC v6 Stage IV Carcinoma of the Urinary Bladder AJCC v6 Stage IV Urinary Bladder Carcinoma AJCC v6 stage IV bladder cancer Stage IV Bladder Cancer AJCC v6 Stage I includes: pT1-4, N0, M0, SX. pT1: Tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade into the tunica albuginea but not the tunica vaginalis. pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis. pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion. pT4: Tumor invades the scrotum with or without vascular/lymphatic invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C7901 Neoplastic Process Stage I Testicular Cancer AJCC v6 and v7 Stage I Testicular Cancer AJCC v6 and v7 C0278831 CTRP PCDC Stage I is divided into stage IA, stage IB, and stage IS, and is determined after a radical inguinal orchiectomy (surgery to remove the testicle) is done. In stage IA, cancer is in the testicle and epididymis and may have spread to the inner layer of the membrane surrounding the testicle; all tumor marker levels are normal. In stage IB, cancer is in the testicle and the epididymis and has spread to the blood or lymph vessels in the testicle; or has spread to the outer layer of the membrane surrounding the testicle; or is in the spermatic cord or the scrotum and may be in the blood or lymph vessels of the testicle; all tumor marker levels are normal. In stage IS, cancer is found anywhere within the testicle, spermatic cord, or the scrotum, and either all tumor marker levels are slightly above normal or one or more tumor marker levels are moderately above normal or high. Malignant Stage_I_Testicular_Cancer Stage I Stage I Cancer of Testis Stage I Cancer of the Testis Stage I Testicular Cancer Stage I Testicular Cancer AJCC v6 Stage I Testicular Cancer AJCC v6 and v7 Stage I Testicular Cancer AJCC v7 stage I testicular cancer Stage I Testicular Cancer AJCC v6 and v7 Prostate carcinoma reemerging after a period of remission. C7902 Neoplastic Process Recurrent Prostate Carcinoma Recurrent Prostate Carcinoma C0278838 CTRP Malignant Recurrent_Prostate_Cancer Recurrent Cancer of Prostate Recurrent Cancer of the Prostate Recurrent Prostate Cancer Recurrent Prostate Carcinoma Recurrent Prostate Carcinoma A carcinoma of the skin that has recurred after a period of remission. C7903 Neoplastic Process Recurrent Skin Carcinoma Recurrent Skin Carcinoma C0278839 CTRP Malignant Recurrent_Skin_Cancer Recurrent Cancer of Skin Recurrent Cancer of the Skin Recurrent Carcinoma of Skin Recurrent Carcinoma of the Skin Recurrent Cutaneous Carcinoma Recurrent Skin Cancer Recurrent Skin Carcinoma Recurrent Skin Carcinoma A malignant thymoma that extends beyond the capsule and infiltrates the surrounding tissues. C7904 Neoplastic Process Invasive Malignant Thymoma C0278846 Malignant Invasive_Malignant_Thymoma Invasive Malignant Thymoma Malignant Thymoma, Invasive Thymoma Malignant Invasive Invasive Malignant Thymoma Reemergence of malignant thymoma after a period of remission. C7905 Neoplastic Process Recurrent Malignant Thymoma C0278848 Malignant Recurrent_Malignant_Thymoma Malignant Thymoma, Recurrent Recurrent Malignant Thymoma Thymoma Malignant Recurrent Recurrent Malignant Thymoma An extremely rare morphologic variant of anaplastic carcinoma of the thyroid gland, characterized by the presence of large numbers of non-neoplastic, osteoclast-like giant cells. C7906 Neoplastic Process Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant CL563151 Malignant Anaplastic_Giant_Cell_Thyroid_Carcinoma Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant The reemergence of thyroid gland carcinoma after a period of remission. C7908 Neoplastic Process Recurrent Thyroid Gland Carcinoma Recurrent Thyroid Gland Carcinoma C0278861 CTRP Malignant Recurrent_Thyroid_Carcinoma Recurrent Cancer of Thyroid Recurrent Cancer of Thyroid Gland Recurrent Cancer of the Thyroid Recurrent Cancer of the Thyroid Gland Recurrent Thyroid Cancer Recurrent Thyroid Carcinoma Recurrent Thyroid Gland Cancer Recurrent Thyroid Gland Carcinoma Relapsed Cancer of Thyroid Relapsed Cancer of Thyroid Gland Relapsed Cancer of the Thyroid Relapsed Cancer of the Thyroid Gland Relapsed Thyroid Cancer Relapsed Thyroid Gland Cancer Recurrent Thyroid Gland Carcinoma The reemergence of a pituitary gland neoplasm after a period of remission. C7912 Neoplastic Process Recurrent Anterior Pituitary Gland Neoplasm Recurrent Anterior Pituitary Gland Neoplasm C0278865 CTRP Undetermined Recurrent_Pituitary_Gland_Neoplasm Recurrent Anterior Pituitary Gland Neoplasm Recurrent Anterior Pituitary Gland Tumor Recurrent Anterior Pituitary Neoplasm Recurrent Anterior Pituitary Tumor Recurrent Neoplasm of Anterior Pituitary Recurrent Neoplasm of Anterior Pituitary Gland Recurrent Neoplasm of the Anterior Pituitary Recurrent Neoplasm of the Anterior Pituitary Gland Recurrent Tumor of Anterior Pituitary Recurrent Tumor of Anterior Pituitary Gland Recurrent Tumor of the Anterior Pituitary Recurrent Tumor of the Anterior Pituitary Gland Relapsed Anterior Pituitary Gland Neoplasm Relapsed Anterior Pituitary Gland Tumor Relapsed Anterior Pituitary Neoplasm Relapsed Anterior Pituitary Tumor Relapsed Neoplasm of Anterior Pituitary Relapsed Neoplasm of Anterior Pituitary Gland Relapsed Neoplasm of the Anterior Pituitary Relapsed Neoplasm of the Anterior Pituitary Gland Relapsed Tumor of Anterior Pituitary Gland Relapsed Tumor of the Anterior Pituitary Gland Recurrent Anterior Pituitary Gland Neoplasm A melanoma arising from and extending beyond the structures of the eye. C7913 Neoplastic Process Ocular Melanoma with Extraocular Extension Ocular Melanoma with Extraocular Extension C0278869 CPTAC CTRP Malignant Extraocular_Extension_Melanoma Extraocular Extension Melanoma Extraocular Extension of Melanoma Ocular Melanoma with Extraocular Extension Ocular Melanoma with Extraocular Extension The reemergence of uveal melanoma after a period of remission. C7914 Neoplastic Process Recurrent Uveal Melanoma Recurrent Uveal Melanoma C0278870 CTRP Malignant Recurrent_Uveal_Melanoma Recurrent Melanoma of Uvea Recurrent Melanoma of the Uvea Recurrent Uveal Melanoma Recurrent Uveal Melanoma A pituitary neuroendocrine tumor that produces thyroid-stimulating hormone. C7915 Neoplastic Process TSH-Producing Pituitary Gland Adenoma TSH-Producing Pituitary Gland Neoplasm Thyrotroph Pituitary Neuroendocrine Tumor C2362538 CTRP NICHD A pituitary neuroendocrine tumor that produces thyroid-stimulating hormone. Undetermined Thyroid_Stimulating_Hormone_Producing_Pituitary_Gland_Neoplasm Thyroid_Stimulating_Hormone_Secreting_Pituitary_Gland_Adenoma TSH Producing Adenoma of Pituitary TSH Producing Adenoma of Pituitary Gland TSH Producing Adenoma of the Pituitary TSH Producing Adenoma of the Pituitary Gland TSH Producing Pituitary Adenoma TSH Producing Pituitary Gland Adenoma TSH Secreting Adenoma of Pituitary TSH Secreting Adenoma of Pituitary Gland TSH Secreting Adenoma of the Pituitary TSH Secreting Adenoma of the Pituitary Gland TSH Secreting Pituitary Adenoma TSH Secreting Pituitary Gland Adenoma TSH-Producing Pituitary Gland Adenoma TSH-Producing Pituitary Gland Tumor TSH-producing Adenoma TSHoma Thyroid Stimulating Hormone Producing Adenoma of Pituitary Thyroid Stimulating Hormone Producing Adenoma of Pituitary Gland Thyroid Stimulating Hormone Producing Adenoma of the Pituitary Thyroid Stimulating Hormone Producing Adenoma of the Pituitary Gland Thyroid Stimulating Hormone Producing Pituitary Adenoma Thyroid Stimulating Hormone Producing Pituitary Gland Adenoma Thyroid Stimulating Hormone Secreting Adenoma of Pituitary Thyroid Stimulating Hormone Secreting Adenoma of Pituitary Gland Thyroid Stimulating Hormone Secreting Adenoma of the Pituitary Thyroid Stimulating Hormone Secreting Adenoma of the Pituitary Gland Thyroid Stimulating Hormone Secreting Pituitary Adenoma Thyroid Stimulating Hormone Secreting Pituitary Gland Adenoma Thyroid Stimulating Hormone-Producing Adenoma Thyrotrope Adenoma Thyrotroph PitNET/Adenoma Thyrotroph Pituitary Neuroendocrine Tumor Thyrotroph Pituitary Neuroendocrine Tumor/Adenoma Thyrotropin Producing Pituitary Gland Adenoma Thyrotroph Pituitary Neuroendocrine Tumor Stage I includes: IA (T1a, N0, M0); IB (T1b, N0, M0); (T2a, N0, M0). T1a: Melanoma is less than or equal to 1.0mm in thickness with or without ulceration. T1b: Melanoma is less than or equal to 1.0mm in thickness and level IV or V with ulceration. T2a: Melanoma 1.01-2.0 mm in thickness, no ulceration. N0: No regional lymph node metastasis. M0: No distant metastasis.-2003 C7916 Neoplastic Process Stage I Cutaneous Melanoma AJCC v6 Stage I Cutaneous Melanoma AJCC v6 C0855025 CTRP Stage I is divided into stages IA and IB. In stage IA, the tumor is not more than 1 millimeter thick, with no ulceration (a break in the skin). In stage IB, (1) the tumor is not more than 1 millimeter thick and it has ulceration; or (2) the tumor is more than 1 but not more than 2 millimeters thick, with no ulceration. Malignant Stage_I_Melanoma_of_the_Skin Malignant Melanoma (of Skin), Stage I AJCC v6 Stage I Cutaneous (Skin) Melanoma Stage I Cutaneous Melanoma AJCC v6 Stage I Malignant Cutaneous Melanoma AJCC v6 Stage I Malignant Melanoma of Skin AJCC v6 Stage I Malignant Melanoma of the Skin AJCC v6 Stage I Malignant Skin Melanoma AJCC v6 Stage I Melanoma of Skin AJCC v6 Stage I Melanoma of the Skin AJCC v6 stage I melanoma Stage I Cutaneous Melanoma AJCC v6 Stage II includes: IIA: (T2b, N0, M0); (T3a, N0, M0); IIB: (T3b, N0, M0); (T4a, N0, M0); IIC: (T4b, N0, M0). T2b: Cutaneous melanoma with a tumor measuring 1.01-2.0 mm in thickness, with ulceration. T3a: Cutaneous melanoma with a tumor measuring 2.01-4.0 mm in thickness, without ulceration. T3b: Cutaneous melanoma with a tumor measuring 2.01-4.0 mm in thickness, with ulceration. T4a: Cutaneous melanoma with a tumor measuring more than 4.0 mm in thickness, without ulceration. T4b: Cutaneous melanoma with a tumor measuring more than 4.0 mm in thickness, with ulceration. N0: No regional lymph node metastases. M0: No detectable evidence of distant metastases. (from AJCC 6th and 7th Eds.) C7917 Neoplastic Process Stage II Cutaneous Melanoma AJCC v6 and v7 Stage II Cutaneous Melanoma AJCC v6 and v7 C0855026 CTRP Stage II is divided into stages IIA, IIB, and IIC. In stage IIA, (1) the tumor is more than 1 but not more than 2 millimeters thick, with ulceration (a break in the skin); or (2) more than 2 but not more than 4 millimeters thick, with no ulceration. In stage IIB, (1) the tumor is either more than 2 but not more than 4 millimeters thick, with ulceration; or (2) more than 4 millimeters thick, with no ulceration. In stage IIC, the tumor is more than 4 millimeters thick, with ulceration. Malignant Stage_II_Melanoma_of_the_Skin Malignant Melanoma (of Skin), Stage II Stage II Cutaneous (Skin) Melanoma Stage II Cutaneous Melanoma Stage II Cutaneous Melanoma AJCC v6 and v7 Stage II Malignant Cutaneous Melanoma Stage II Malignant Melanoma of Skin Stage II Malignant Melanoma of the Skin Stage II Malignant Skin Melanoma Stage II Melanoma Stage II Melanoma of Skin Stage II Melanoma of the Skin Stage II Skin Melanoma AJCC v6 Stage II Skin Melanoma AJCC v7 stage II melanoma Stage II Cutaneous Melanoma AJCC v6 and v7 Stage III includes: (Any T, N1, M0); (Any T, N2, M0); (Any T, N3, M0). N1: Metastasis in one lymph node. N2: Metastasis in two to three regional lymph nodes or intralymphatic regional metastasis without nodal metastases. N3: Metastasis in four or more regional nodes, or matted metastatic nodes, or in-transit metastasis or satellite(s) with metastasis in regional node(s). C7918 Neoplastic Process Stage III Cutaneous Melanoma AJCC v6 Stage III Cutaneous Melanoma AJCC v6 C0855027 CTRP The tumor may be any thickness, with or without ulceration (a break in the skin), and one or more of the following is true: (1) cancer has spread to one or more lymph nodes; (2) lymph nodes may be joined together (matted); (3) cancer may be in a lymph vessel between the primary tumor and nearby lymph nodes; and/or (4) very small tumors may be found on or under the skin, not more than 2 centimeters away from where the cancer first started. Malignant Stage_III_Melanoma_of_the_Skin Malignant Melanoma (of Skin), Stage III AJCC v6 Stage III Cutaneous (Skin) Melanoma Stage III Cutaneous Melanoma AJCC v6 Stage III Malignant Cutaneous Melanoma AJCC v6 Stage III Malignant Melanoma of Skin AJCC v6 Stage III Malignant Melanoma of the Skin AJCC v6 Stage III Malignant Skin Melanoma AJCC v6 Stage III Melanoma of Skin AJCC v6 Stage III Melanoma of the Skin AJCC v6 Stage III Skin Melanoma AJCC v6 stage III melanoma Stage III Cutaneous Melanoma AJCC v6 Stage II includes: IIA (T2a, N0, M0); IIB (T1, N1, M0), (T2, N1, M0), (T2a, N1, M0); (T2b, N0, M0); (T2b, N0, M0); (T2b, N1, M0). T2: Tumor extends to soft tissues. T2a: Tumor extends to the oropharynx and/or nasal cavity without parapharyngeal extension. T2b: Any tumor with parapharyngeal extension. N1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa. M0: No distant metastasis. (AJCC 6th ed.) C7920 Neoplastic Process Stage II Nasopharyngeal Carcinoma AJCC v6 Stage II Nasopharyngeal Carcinoma AJCC v6 C0278949 CTRP Cancer (1) is found in the nasopharynx only or has spread from the nasopharynx to the oropharynx (the middle part of the throat, including the soft palate, base of the tongue, and tonsils) and/or to the nasal cavity. Cancer has spread to one or more lymph nodes on one side of the neck and/or to lymph nodes behind the pharynx, and the affected lymph nodes are 6 centimeters or smaller; or (2) is found in the parapharyngeal space (area near the pharynx, between the base of the skull and the lower jaw). Cancer may have spread to one or more lymph nodes on one side of the neck and/or to lymph nodes behind the pharynx, and the affected lymph nodes are 6 centimeters or smaller. Malignant Stage_II_Nasopharyngeal_Carcinoma Nasopharyngeal Cancer, Stage II AJCC v6 Stage II Carcinoma of Nasopharynx AJCC v6 Stage II Carcinoma of the Nasopharynx AJCC v6 Stage II Nasopharyngeal Cancer AJCC v6 Stage II Nasopharyngeal Carcinoma AJCC v6 Stage II Nasopharyngeal Throat Cancer Stage II Nasopharynx Carcinoma AJCC v6 stage II nasopharynx cancer Stage II Nasopharyngeal Carcinoma AJCC v6 An extraskeletal myxoid chondrosarcoma occurring in adults. C7924 Neoplastic Process Adult Extraskeletal Myxoid Chondrosarcoma Adult Extraskeletal Myxoid Chondrosarcoma C0278982 CTRP Malignant Adult_Extraskeletal_Chondrosarcoma Adult_Myxoid_Chondrosarcoma Adult Extraosseous Myxoid Chondrosarcoma Adult Extraskeletal Myxoid Chondrosarcoma Adult Myxoid Chondrosarcoma Extraskeletal Myxoid Chondrosarcoma Adult Extraskeletal Myxoid Chondrosarcoma An osteosarcoma arising from the soft tissue, and occurring in adults. C7925 Neoplastic Process Adult Extraskeletal Osteosarcoma Adult Extraskeletal Osteosarcoma C0278985 CTRP Malignant Adult_Extraskeletal_Osteosarcoma Adult Extraosseous Osteosarcoma Adult Extraskeletal Osteosarcoma Extraskeletal Osteosarcoma Adult Extraskeletal Osteosarcoma The reemergence of salivary gland carcinoma after a period of remission. C7926 Neoplastic Process Recurrent Salivary Gland Carcinoma Recurrent Salivary Gland Carcinoma C0278993 CTRP Malignant Recurrent_Salivary_Gland_Carcinoma Recurrent Cancer of Salivary Gland Recurrent Cancer of the Salivary Gland Recurrent Carcinoma of Salivary Gland Recurrent Carcinoma of the Salivary Gland Recurrent Salivary Gland Cancer Recurrent Salivary Gland Carcinoma Relapsed Cancer of Salivary Gland Relapsed Cancer of the Salivary Gland Relapsed Carcinoma of Salivary Gland Relapsed Carcinoma of the Salivary Gland Relapsed Salivary Gland Cancer Relapsed Salivary Gland Carcinoma Salivary Gland Cancer, Recurrent Recurrent Salivary Gland Carcinoma A carcinoma that arises from the hepatocytes or intrahepatic bile ducts. The main subtypes are hepatocellular carcinoma (hepatoma) and cholangiocarcinoma. C7927 Neoplastic Process Liver Cancer Liver Carcinoma C0279000 CPTAC CTEP CTRP GDC Primary liver cancer is cancer that forms in the tissues of the liver. Secondary liver cancer is cancer that spreads to the liver from another part of the body. Malignant Liver_and_Intrahepatic_Biliary_Tract_Carcinoma Liver Cancer Malignant neoplasm: Other specified carcinomas of liver Biliary Tract Cancer Cancer of Liver Cancer of Liver and Intrahepatic Bile Duct Cancer of Liver and Intrahepatic Biliary Tract Cancer of the Liver Cancer of the Liver and Intrahepatic Biliary Tract Liver Cancer Liver Carcinoma Liver and Intrahepatic Bile Duct Cancer Liver and Intrahepatic Bile Duct Carcinoma Liver and Intrahepatic Biliary Tract Cancer Liver and Intrahepatic Biliary Tract Carcinoma Liver and hepatobiliary cancer, NOS Liver/hepatobiliary cancer Primary Liver Carcinoma liver cancer Liver Carcinoma An angiocentric and angiodestructive lymphoproliferative disease involving extranodal sites, comprised of Epstein-Barr virus (EBV)-positive B-cells admixed with reactive T-cells. Incidence is higher among adult males; patients with a history of immunodeficiency are at increased risk. The most common site of involvement is the lung; other common sites include brain, kidney, liver, and skin. Morphologically, three grades are recognized: grade I, II, and III. Grade III lymphomatoid granulomatosis should be approached clinically as a subtype of diffuse large B-cell lymphoma. C7930 Neoplastic Process Lymphomatoid Granulomatosis C0024307 CTEP GDC Destructive growth of lymph cells, usually involving the lungs, skin, kidneys, and central nervous system. Grades I and II are not considered cancerous, but grade III is considered a lymphoma. 9766/1 Uncertain Malignant Potential Lymphomatoid_Granulomatosis 9766/1 Lymphomatoid granulomatosis LYG Lymphomatoid Granulomatosis Lymphomatoid granulomatosis lymphomatoid granulomatosis Lymphomatoid Granulomatosis Lymphomatoid granulomatosis characterized by the presence of a polymorphous lymphoid infiltrate without cytologic atypia. Large lymphocytes are absent or rare. By in situ hybridization, EBV-positive cells are infrequently seen. C7931 Neoplastic Process Grade I Lymphomatoid Granulomatosis Grade I Lymphomatoid Granulomatosis C0279065 CTRP Uncertain Malignant Potential Grade_I_Lymphomatoid_Granulomatosis Angiocentric Immunoproliferative Lesion Grade I Grade I Angiocentric Immunoproliferative Lesion Grade I Angiocentric Immunoproliferative Lesions Grade I LYG Grade I Lymphomatoid Granulomatosis Grade I Lymphomatoid Granulomatosis Lymphomatoid granulomatosis characterized by the presence of occasional large lymphoid cells or immunoblasts in a polymorphous background. Necrosis is more commonly seen as compared to grade I lymphomatoid granulomatosis. By in situ hybridization, EBV-positive cells are readily seen. C7932 Neoplastic Process Grade II Lymphomatoid Granulomatosis Grade II Lymphomatoid Granulomatosis CL448397 CTRP Uncertain Malignant Potential Grade_II_Lymphomatoid_Granulomatosis Angiocentric Immunoproliferative Lesion Grade II Grade II Angiocentric Immunoproliferative Lesion Grade II Angiocentric Immunoproliferative Lesions Grade II LYG Grade II Lymphomatoid Granulomatosis Grade II Lymphomatoid Granulomatosis Lymphomatoid granulomatosis characterized by the presence of aggregates of neoplastic large B-lymphocytes, usually admixed with pleomorphic and Hodgkin-like cells, in a background of chronic inflammation. Necrotic changes are present and are usually extensive. Grade III lymphomatoid granulomatosis should be approached clinically as a subtype of diffuse large B-cell lymphoma. C7933 Neoplastic Process Grade III Lymphomatoid Granulomatosis C0279067 Malignant Grade_III_Lymphomatoid_Granulomatosis Lymphomatoid granulomatosis, grade 3 Angiocentric Immunoproliferative Lesion Grade III Grade III Angiocentric Immunoproliferative Lesion Grade III Angiocentric Immunoproliferative Lesions Grade III LYG Grade III Lymphomatoid Granulomatosis Grade III Lymphomatoid Granulomatosis The reemergence of lymphomatoid granulomatosis after a period of remission. C7934 Neoplastic Process Recurrent Lymphomatoid Granulomatosis C0279069 Uncertain Malignant Potential Recurrent_Lymphomatoid_Granulomatosis Recurrent Angiocentric Immunoproliferative Lesion Recurrent LYG Recurrent Lymphomatoid Granulomatosis Relapsed Angiocentric Immunoproliferative Lesion Recurrent Lymphomatoid Granulomatosis The reemergence of Kaposi sarcoma after a period of remission. C7935 Neoplastic Process Recurrent Kaposi Sarcoma Recurrent Kaposi Sarcoma C0279087 CTRP Malignant Recurrent_Kaposi_Sarcoma Recurrent Kaposi Sarcoma Recurrent Kaposi's Sarcoma Recurrent Multiple Hemorrhagic Sarcoma Recurrent Kaposi Sarcoma Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C7939 Neoplastic Process Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7 Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7 C0854756 CPTAC CTRP Abnormal cells are found in the lining of the lips and oral cavity (mouth). These abnormal cells may become cancer and spread into nearby normal tissue. Malignant Stage_0_Lip_and_Oral_Cavity_Cancer Carcinoma in situ of lip, oral cavity, and pharynx Lip and Oral Cavity Cancer Stage 0 Lip and Oral Cavity Carcinoma Stage 0 Stage 0 Lip and Oral Cavity Cancer Stage 0 Lip and Oral Cavity Cancer AJCC v6 Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7 Stage 0 Lip and Oral Cavity Cancer AJCC v7 Stage 0 Lip and Oral Cavity Carcinoma stage 0 lip and oral cavity carcinoma in situ Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7 An acute monoblastic and monocytic leukemia occurring in children. C7940 Neoplastic Process Childhood Acute Monoblastic and Monocytic Leukemia Childhood Acute Monoblastic and Monocytic Leukemia C1332941 CTRP NICHD An acute monoblastic and monocytic leukemia occurring during childhood. Malignant Childhood_Acute_Monoblastic_Leukemia_and_Acute_Monocytic_Leukemia Acute Monoblastic and Monocytic Leukemia Childhood Acute Monoblastic Leukemia and Acute Monocytic Leukemia Childhood Acute Monoblastic and Monocytic Leukemia Childhood Acute Monoblastic and Monocytic Leukemia (M5) Childhood Acute Monoblastic and Monocytic Leukemia Mammography done after suspicious results on a screening mammogram or after other signs of possible breast cancer. C79416 Diagnostic Procedure Diagnostic Mammography Diagnostic Mammography C0411881 CTRP X-ray of the breasts used to check for breast cancer after a lump or other sign or symptom of breast cancer has been found. Diagnostic_Mammography Diagnostic Mammography diagnostic mammogram Diagnostic Mammography C79417 Diagnostic Procedure Screening Mammography Screening Mammography C0203028 CTRP X-rays of the breasts taken to check for breast cancer in the absence of signs or symptoms. Screening_Mammography Screening Mammography screening mammogram Screening Mammography A nodular lymphocyte predominant B-cell lymphoma occurring in adults. C7942 Neoplastic Process Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma Adult Nodular Lymphocyte Predominant B-Cell Lymphoma C1332210 CTRP Malignant Adult_Nodular_Lymphocyte_Predominant_Hodgkin_s_Lymphoma Adult NLPBL Adult NLPHD Adult Nodular Lymphocyte Predominant B-Cell Lymphoma Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma Adult Nodular Lymphocyte Predominant Hodgkin's Disease Adult Nodular Lymphocyte Predominant Hodgkin's Lymphoma Nodular Lymphocyte Predominant Hodgkin Lymphoma Adult Nodular Lymphocyte Predominant B-Cell Lymphoma An alveolar soft part sarcoma occurring in adults. The most common site of involvement is the extremity, particularly the deep soft tissues of the thigh. C7943 Neoplastic Process Adult Alveolar Soft Part Sarcoma Adult Alveolar Soft Part Sarcoma C0279544 CTRP Malignant Adult_Alveolar_Soft_Part_Sarcoma Adult Alveolar Soft Part Sarcoma Adult Alveolar Soft-Part Sarcoma Alveolar Soft Part Sarcoma Adult Alveolar Soft Part Sarcoma An epithelioid sarcoma occurring in adults. C7944 Neoplastic Process Adult Epithelioid Sarcoma Adult Epithelioid Sarcoma C0279545 CTRP Malignant Adult_Epithelioid_Sarcoma Adult Epithelioid Sarcoma Epithelioid Sarcoma Adult Epithelioid Sarcoma Breast ductal carcinoma in situ characterized by the presence of neoplastic cells with severe dysplasia and the formation of micropapillary, cribriform, or solid patterns. The nuclei show marked pleomorphism and have prominent nucleoli. Mitotic activity is usually present. There is comedo-type of necrosis present in the ducts. The necrotic debris is surrounded by pleomorphic malignant cells. C7949 Neoplastic Process High Grade Ductal Breast Carcinoma In Situ Breast Ductal Carcinoma In Situ, High Grade C1334002 CTRP GDC A condition in which cells that look very different from normal cells under a microscope are found in the lining of a breast duct. There may also be areas of dead cells in the abnormal tissue. The abnormal cells have not spread outside the duct to other tissues in the breast. Grade III ductal carcinoma in situ tends to grow more quickly than grade I or grade II ductal carcinoma in situ and is more likely to come back or spread to other tissues. Also called grade III DCIS, high-grade DCIS, and high-grade ductal carcinoma in situ. 8501/2 Malignant High-Grade_Ductal_Carcinoma_In_Situ_of_the_Breast 8500/2 DIN 3 Ductal intraepithelial neoplasia 3 Breast Ductal Carcinoma In Situ, High Grade DCIS Grade 3 DIN 3 Ductal Intraepithelial Neoplasia, Grade 3 High Grade Ductal Breast Carcinoma In Situ High-Grade DCIS of Breast High-Grade DCIS of the Breast High-Grade Ductal Carcinoma In Situ of Breast grade III ductal carcinoma in situ Breast Ductal Carcinoma In Situ, High Grade An infiltrating lobular adenocarcinoma of the breast. The malignant cells lack cohesion and are arranged individually or in a linear manner (Indian files), or as narrow trabeculae within the stroma. The malignant cells are usually smaller than those of ductal carcinoma, are less pleomorphic, and have fewer mitotic figures. C7950 Neoplastic Process Invasive Lobular Breast Carcinoma Invasive Breast Lobular Carcinoma C0279565 CTRP Cellosaurus GDC Malignant Invasive_Lobular_Breast_Carcinoma 8520/3 Infiltrating lobular carcinoma, NOS Invasive lobular carcinoma Classic Invasive Lobular Carcinoma Infiltrating Lobular Adenocarcinoma Infiltrating Lobular Breast Carcinoma Infiltrating Lobular Carcinoma of Breast Infiltrating Lobular Carcinoma of the Breast Invasive Breast Lobular Carcinoma Invasive Lobular Adenocarcinoma Invasive Lobular Breast Carcinoma Invasive Lobular Carcinoma Invasive Lobular Carcinoma of Breast Invasive Lobular Carcinoma of the Breast Invasive Lobular Carcinoma, Classic Type Invasive lobular carcinoma Invasive Breast Lobular Carcinoma Paget disease involving the skin overlying the mammary gland, accompanied by invasive ductal breast carcinoma. C7951 Neoplastic Process Paget Disease of the Breast with Invasive Ductal Carcinoma Breast Paget Disease with Invasive Ductal Carcinoma C0279567 CTRP GDC 8541/3 Malignant Paget_s_Disease_of_the_Breast_with_Invasive_Ductal_Carcinoma 8541/3 Paget disease and infiltrating duct carcinoma of breast Breast Paget Disease with Invasive Ductal Carcinoma Paget Disease and Infiltrating Duct Carcinoma of Breast Paget Disease of the Breast with Invasive Ductal Carcinoma Paget disease and infiltrating duct carcinoma of breast Paget's Disease and Infiltrating Ductal Carcinoma of Breast Paget's Disease and Infiltrating Ductal Carcinoma of the Breast Paget's Disease and Invasive Ductal Carcinoma of Breast Paget's Disease and Invasive Ductal Carcinoma of the Breast Paget's Disease of Breast with Infiltrating Ductal Carcinoma Paget's Disease of Breast with Invasive Ductal Carcinoma Paget's Disease of the Breast with Infiltrating Ductal Carcinoma Paget's Disease of the Breast with Invasive Ductal Carcinoma Breast Paget Disease with Invasive Ductal Carcinoma The leukemic counterpart of Burkitt lymphoma occurring in children. The characteristic Burkitt cells are seen in the bone marrow and the peripheral blood. This is an aggressive leukemia. C7952 Neoplastic Process Childhood Burkitt Leukemia Childhood Burkitt Leukemia C0279582 CTRP NICHD A mature B cell leukemia that is the leukemic counterpart of Burkitt lymphoma occurring in children. Malignant Childhood_Burkitt_s_Leukemia Burkitt Leukemia Childhood Burkitt Leukemia Childhood Burkitt's Leukemia L3 Childhood ALL L3 Childhood Acute Lymphoblastic Leukemia L3 Childhood Acute Lymphocytic Leukemia L3 Pediatric ALL L3 Pediatric Acute Lymphoblastic Leukemia L3 Pediatric Acute Lymphocytic Leukemia Pediatric Burkitt's Leukemia Childhood Burkitt Leukemia An acute lymphoblastic leukemia of T-cell origin occurring in children. C7953 Neoplastic Process Childhood T Acute Lymphoblastic Leukemia Childhood T Acute Lymphoblastic Leukemia C0279583 CTRP Cellosaurus NICHD An acute T-lymphoblastic leukemia occurring during childhood. Malignant Childhood_Precursor_T_Lymphoblastic_Leukemia Childhood Precursor T-Lymphoblastic Leukemia Childhood T Acute Lymphoblastic Leukemia Childhood T-ALL Childhood T-Acute Lymphoblastic Leukemia Childhood T-Cell Acute Lymphoblastic Leukemia T Acute Lymphoblastic Leukemia T-Cell Childhood ALL T-Cell Childhood Acute Lymphoblastic Leukemia T-Cell Childhood Acute Lymphocytic Leukemia T-Cell Pediatric ALL T-Cell Pediatric Acute Lymphoblastic Leukemia T-Cell Pediatric Acute Lymphocytic Leukemia Childhood T Acute Lymphoblastic Leukemia The leukemic counterpart of Burkitt lymphoma occurring in adults. The characteristic Burkitt cells are seen in the bone marrow and the peripheral blood. This is an aggressive leukemia. C7954 Neoplastic Process Adult Burkitt Leukemia Adult Burkitt Leukemia C0279591 CTRP Cellosaurus Malignant Adult_Burkitt_s_Leukemia Adult Burkitt Leukemia Adult Burkitt's Leukemia Burkitt Leukemia L3 Adult ALL L3 Adult Acute Lymphoblastic Leukemia L3 Adult Acute Lymphocytic Leukemia Adult Burkitt Leukemia A hepatocellular carcinoma that occurs during childhood. C7955 Neoplastic Process Childhood Hepatocellular Carcinoma Childhood Hepatocellular Carcinoma C0279606 CTRP Cellosaurus NICHD A malignant tumor that arises from hepatocytes in children. It is associated with perinatally-acquired Hepatitis B virus. Cells are epithelial in appearance and typically arise in the right lobe of the liver. Malignant Childhood_Hepatocellular_Carcinoma Childhood Carcinoma of Liver Cell Childhood Carcinoma of the Liver Cell Childhood Hepatocellular Carcinoma Childhood Hepatoma Childhood Liver Cell Carcinoma Hepatocellular Cancer Pediatric Carcinoma of Liver Cell Pediatric Carcinoma of the Liver Cell Pediatric Hepatocellular Carcinoma Pediatric Hepatoma Pediatric Liver Cell Carcinoma Childhood Hepatocellular Carcinoma A hepatocellular carcinoma occurring in adults. C7956 Neoplastic Process Adult Hepatocellular Carcinoma Adult Hepatocellular Carcinoma C0279607 CTRP Cellosaurus Malignant Adult_Hepatocellular_Carcinoma Adult Hepatocellular Carcinoma Adult Hepatoma Adult Primary Carcinoma of Liver Cell Adult Primary Carcinoma of the Liver Cell Adult Primary Hepatocellular Carcinoma Adult Primary Hepatoma Adult Primary Liver Cell Carcinoma Hepatocellular Cancer Adult Hepatocellular Carcinoma A poorly circumscribed morphologic variant of rhabdomyosarcoma occurring in children. The neoplasm is characterized by the presence of primitive skeletal muscle in any stage of myogenesis. C7957 Neoplastic Process Childhood Embryonal Rhabdomyosarcoma Childhood Embryonal Rhabdomyosarcoma C0279612 CTRP NICHD A poorly circumscribed morphologic variant of rhabdomyosarcoma that generally arises in the head and neck region or in the genitourinary tract. Malignant Childhood_Embryonal_Rhabdomyosarcoma Childhood Embryonal Rhabdomyosarcoma Embryonal Childhood Rhabdomyosarcoma Embryonal Rhabdomyosarcoma Pediatric Embryonal Rhabdomyosarcoma Childhood Embryonal Rhabdomyosarcoma An aggressive malignant mesenchymal neoplasm occurring in children. It is characterized by the presence of round cells with myoblastic differentiation, and a fibrovascular stroma resembling an alveolar growth pattern. C7958 Neoplastic Process Childhood Alveolar Rhabdomyosarcoma Childhood Alveolar Rhabdomyosarcoma C0279613 CTRP NICHD A histologic subset of rhabdomyosarcoma consisting of a malignant mesenchymal neoplasm occurring in children. It is characterized by the presence of round cells with myoblastic differentiation, and a fibrovascular stroma resembling an alveolar growth pattern. Malignant Childhood_Alveolar_Rhabdomyosarcoma Alveolar Childhood Rhabdomyosarcoma Alveolar Rhabdomyosarcoma Childhood Alveolar Rhabdomyosarcoma Pediatric Alveolar Rhabdomyosarcoma Childhood Alveolar Rhabdomyosarcoma A rare aggressive rhabdomyosarcoma occurring in children. The neoplasm is characterized by the presence of bizarre round, spindle, and polygonal cells. C7959 Neoplastic Process Childhood Pleomorphic Rhabdomyosarcoma Childhood Pleomorphic Rhabdomyosarcoma C0279614 CTRP NICHD A pleomorphic rhabdomyosarcoma occurring in children. Malignant Childhood_Pleomorphic_Rhabdomyosarcoma Childhood Anaplastic Rhabdomyosarcoma Childhood Pleomorphic Rhabdomyosarcoma Pediatric Pleomorphic Rhabdomyosarcoma Pleomorphic Childhood Rhabdomyosarcoma Pleomorphic Rhabdomyosarcoma Childhood Pleomorphic Rhabdomyosarcoma A mixed rhabdomyosarcoma that occurs in children. The neoplasm is composed of embryonic and alveolar components. It is characterized by the presence of spindle cells with myoblastic differentiation and a myxoid and a fibrous stroma. C7960 Neoplastic Process Childhood Mixed Alveolar Rhabdomyosarcoma Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features C0279615 CTRP Malignant Childhood_Mixed_Rhabdomyosarcoma Childhood Mixed Alveolar Rhabdomyosarcoma Childhood Mixed Cell Type Rhabdomyosarcoma Childhood Mixed Type Rhabdomyosarcoma Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features Mixed Alveolar Rhabdomyosarcoma Mixed Childhood Rhabdomyosarcoma Pediatric Mixed Cell Type Rhabdomyosarcoma Pediatric Mixed Rhabdomyosarcoma Pediatric Mixed Type Rhabdomyosarcoma Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features An acute myeloid leukemia with maturation occurring in adults. C7961 Neoplastic Process Adult Acute Myeloid Leukemia with Maturation Adult Acute Myeloid Leukemia with Maturation C0279624 CTRP Cellosaurus Malignant Adult_Acute_Myeloid_Leukemia_with_Maturation Acute Myeloid Leukemia (AML) with Maturation Adult Acute Granulocytic Leukemia with Maturation Adult Acute M2 Leukemia Adult Acute Myeloblastic Leukemia with Maturation Adult Acute Myeloblastic Leukemia with Maturation (M2) Adult Acute Myelocytic Leukemia with Maturation Adult Acute Myelogenous Leukemia with Maturation Adult Acute Myeloid Leukemia with Maturation M2 Adult Acute Granulocytic Leukemia M2 Adult Acute Granulocytic Leukemia with Maturation M2 Adult Acute Myeloblastic Leukemia M2 Adult Acute Myeloblastic Leukemia with Maturation M2 Adult Acute Myelocytic Leukemia M2 Adult Acute Myelocytic Leukemia with Maturation M2 Adult Acute Myelogenous Leukemia M2 Adult Acute Myelogenous Leukemia with Maturation M2 Adult Acute Myeloid Leukemia M2 Adult Acute Myeloid Leukemia with Maturation Adult Acute Myeloid Leukemia with Maturation An acute myelomonocytic leukemia occurring in adults. C7962 Neoplastic Process Adult Acute Myelomonocytic Leukemia Adult Acute Myelomonocytic Leukemia C0279627 CTRP Malignant Adult_Acute_Myelomonocytic_Leukemia Acute Myelomonocytic Leukemia Adult AMMoL Adult Acute M4 Leukemia Adult Acute Myelomonocytic Leukemia Adult Acute Myelomonocytic Leukemia (M4) M4 Adult Acute Leukemia M4 Adult Acute Myelomonocytic Leukemia Adult Acute Myelomonocytic Leukemia An acute basophilic leukemia occurring in adults. C7964 Neoplastic Process Adult Acute Basophilic Leukemia Adult Acute Basophilic Leukemia C0279631 CTRP Malignant Adult_Acute_Basophilic_Leukemia Acute Basophilic Leukemia Adult Acute Basophilic Leukemia Adult Acute Basophilic Leukemia An acute megakaryoblastic leukemia occurring in adults. C7965 Neoplastic Process Adult Acute Megakaryoblastic Leukemia Adult Acute Megakaryoblastic Leukemia C0279632 CTRP Cellosaurus Malignant Adult_Acute_Megakaryoblastic_Leukemia Acute Megakaryoblastic Leukemia Adult Acute M7 Leukemia Adult Acute Megakaryoblastic Leukemia Adult Acute Megakaryocytic Leukemia Adult Acute Megakaryocytic Leukemia (M7) M7 Adult Acute Leukemia M7 Adult Acute Megakaryocytic Leukemia Adult Acute Megakaryoblastic Leukemia An invasive adenocarcinoma of the colon characterized by the presence of pools of extracellular mucin. Malignant glandular epithelial cells are present in the mucin collections. Mucin constitutes more than 50% of the lesion. C7966 Neoplastic Process Colon Mucinous Adenocarcinoma Colon Mucinous Adenocarcinoma C0279639 CTRP Cellosaurus Malignant Colon_Mucinous_Adenocarcinoma Colloid Adenocarcinoma of Colon Colloid Adenocarcinoma of the Colon Colloid Colon Adenocarcinoma Colloidal Adenocarcinoma of Colon Colloidal Adenocarcinoma of the Colon Colloidal Colon Adenocarcinoma Colon Colloid Adenocarcinoma Colon Colloidal Adenocarcinoma Colon Mucinous Adenocarcinoma Colonic Colloid Adenocarcinoma Colonic Colloidal Adenocarcinoma Colonic Mucinous Adenocarcinoma Mucinous Adenocarcinoma of Colon Mucinous Adenocarcinoma of the Colon Mucinous Colon Adenocarcinoma Colon Mucinous Adenocarcinoma An invasive adenocarcinoma of the colon characterized by the presence of malignant glandular epithelial cells which contain prominent intracytoplasmic mucin (signet ring cells). The signet ring cells constitute more than 50% of the malignant cells. C7967 Neoplastic Process Colon Signet Ring Cell Adenocarcinoma Colon Signet Ring Cell Adenocarcinoma C1707436 CTRP Cellosaurus Malignant Colon_Signet_Ring_Adenocarcinoma Colon Signet Ring Cell Adenocarcinoma Colon Signet-Ring Cell Adenocarcinoma Colonic Signet Ring Cell Adenocarcinoma Signet Ring Cell Adenocarcinoma of Colon Signet Ring Cell Adenocarcinoma of the Colon Signet Ring Cell Colon Adenocarcinoma Colon Signet Ring Cell Adenocarcinoma An acute promyelocytic leukemia with PML-RARA fusion occurring in children. C7968 Neoplastic Process Childhood Acute Promyelocytic Leukemia with t(15;17)(q22;q12); PML-RARA Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA C0279641 CTRP NICHD PCDC An acute promyelocytic leukemia occurring in children. Malignant Childhood_Acute_Promyelocytic_Leukemia APL with PML-RARA Acute Promyelocytic Leukemia with PML-RARA Childhood APL Childhood APL with t(15;17)(q24.1;q21.2); PML-RARA Childhood APML Childhood APML with t(15;17)(q24.1;q21.2); PML-RARA Childhood Acute M3 Leukemia Childhood Acute Progranulocytic Leukemia Childhood Acute Promyelocytic Leukemia Childhood Acute Promyelocytic Leukemia (M3) Childhood Acute Promyelocytic Leukemia with PML-RARA Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA Fusion Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML::RARA Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML::RARA Fusion Childhood M3 APL M3 Childhood Acute Promyelocytic Leukemia M3 Pediatric Acute Promyelocytic Leukemia Pediatric APL Pediatric Acute M3 Leukemia Pediatric Acute Progranulocytic Leukemia Pediatric Acute Promyelocytic Leukemia Pediatric M3 APL Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA An acute myelomonocytic leukemia occurring in children. C7970 Neoplastic Process Childhood Acute Myelomonocytic Leukemia Childhood Acute Myelomonocytic Leukemia C0279644 CTRP NICHD An acute myelomonocytic leukemia occurring in children. This type corresponds to M4 in the FAB classification. Malignant Childhood_Acute_Myelomonocytic_Leukemia Acute Myelomonocytic Leukemia Childhood AMML Childhood AMMoL Childhood Acute M4 Leukemia Childhood Acute Myelomonocytic Leukemia Childhood Acute Myelomonocytic Leukemia (M4) M4 Childhood Acute Myelomonocytic Leukemia M4 Pediatric Acute Myelomonocytic Leukemia Pediatric AMML Pediatric AMMoL Pediatric Acute M4 Leukemia Pediatric Acute Myelomonocytic Leukemia Childhood Acute Myelomonocytic Leukemia An acute basophilic leukemia occurring in children. C7971 Neoplastic Process Childhood Acute Basophilic Leukemia Childhood Acute Basophilic Leukemia C0279649 CTRP Malignant Childhood_Acute_Basophilic_Leukemia Acute Basophilic Leukemia Childhood Acute Basophilic Leukemia Pediatric Acute Basophilic Leukemia Childhood Acute Basophilic Leukemia An acute megakaryoblastic leukemia occurring in children. C7972 Neoplastic Process Childhood Acute Megakaryoblastic Leukemia Childhood Acute Megakaryoblastic Leukemia C0279650 CTRP Cellosaurus NICHD A subtype of acute myeloid leukemia involving the megakaryocytic line. The majority of the cases are associated with t(1;22)(p13;q13). The following recurrent genetic abnormalities have been reported with pediatric AMKL: NUP98/JARID1A, RBM15/MKL, and CBFA2T3/GLIS2. GATA1 mutations are not observed in non-Trisomy 21 (Down syndrome) children with AMKL. Malignant Childhood_Acute_Megakaryoblastic_Leukemia Acute Megakaryoblastic Leukemia Childhood AMKL Childhood Acute M7 Leukemia Childhood Acute Megakaryoblastic Leukemia Childhood Acute Megakaryocytic Leukemia Childhood Acute Megakaryocytic Leukemia (M7) M7 Childhood Acute Megakaryocytic Leukemia M7 Pediatric Acute Megakaryocytic Leukemia Pediatric Acute M7 Leukemia Pediatric Acute Megakaryoblastic Leukemia Pediatric Acute Megakaryocytic Leukemia Childhood Acute Megakaryoblastic Leukemia An invasive adenocarcinoma of the rectum characterized by the presence of pools of extracellular mucin. Malignant glandular epithelial cells are present in the mucin collections. Mucin constitutes more than 50% of the lesion. C7973 Neoplastic Process Rectal Mucinous Adenocarcinoma Rectal Mucinous Adenocarcinoma C0279652 CTRP Cellosaurus Malignant Rectal_Mucinous_Adenocarcinoma Colloid Adenocarcinoma of Rectum Colloid Adenocarcinoma of the Rectum Colloidal Adenocarcinoma of Rectum Colloidal Adenocarcinoma of the Rectum Mucinous Adenocarcinoma of Rectum Mucinous Adenocarcinoma of the Rectum Rectal Colloid Adenocarcinoma Rectal Colloidal Adenocarcinoma Rectal Mucinous Adenocarcinoma Rectal Mucinous Adenocarcinoma An invasive malignant epithelial tumor that arises from the rectum. There is no morphologic, immunophenotypic, or molecular biological evidence of glandular or squamous differentiation. C7974 Neoplastic Process Rectal Undifferentiated Carcinoma Rectal Undifferentiated Carcinoma C0279657 CTRP Malignant Undifferentiated_Rectal_Carcinoma Anaplastic Carcinoma of Rectum Anaplastic Carcinoma of the Rectum Carcinoma Simplex of the Rectum. Rectal Anaplastic Carcinoma Rectal Undifferentiated Carcinoma Undifferentiated Carcinoma of Rectum Undifferentiated Carcinoma of the Rectum Undifferentiated Rectal Cancer Undifferentiated Rectal Carcinoma Rectal Undifferentiated Carcinoma An adenocarcinoma arising from the epithelium of the extrahepatic bile ducts. Signs and symptoms include abdominal pain, anorexia, jaundice, pruritus, nausea and vomiting, and weight loss. C7975 Neoplastic Process Extrahepatic Bile Duct Adenocarcinoma Extrahepatic Bile Duct Adenocarcinoma C0279659 CTRP Malignant Extrahepatic_Bile_Duct_Adenocarcinoma Adenocarcinoma of Extrahepatic Bile Duct Adenocarcinoma of the Extrahepatic Bile Duct Extrahepatic Bile Duct Adenocarcinoma Extrahepatic Bile Duct Adenocarcinoma An adenocarcinoma that arises from the common bile duct distal to the insertion of the cystic duct. C7976 Neoplastic Process Distal Bile Duct Adenocarcinoma Distal Bile Duct Adenocarcinoma C1333307 CTRP Malignant Distal_1_3_of_the_Common_Bile_Duct_Adenocarcinoma Adenocarcinoma of the Distal Common Bile Duct Distal Bile Duct Adenocarcinoma Distal Cholangiocarcinoma Distal Bile Duct Adenocarcinoma An adenocarcinoma arising from the pancreas. It is characterized by the presence of relatively uniform malignant cells which form acinar patterns. It usually occurs during adulthood. Signs and symptoms include abdominal pain, weight loss, nausea, and diarrhea. It may metastasize to regional lymph nodes and the liver. A minority of patients develop lipase hypersecretion syndrome. This syndrome may be seen in patients with liver metastases and it is characterized by excessive secretion of lipase in the serum, polyarthralgia, and subcutaneous fat necrosis. C7977 Neoplastic Process Pancreatic Acinar Cell Cancer Pancreatic Acinar Cell Carcinoma C0279661 CTRP Cellosaurus Malignant Pancreatic_Acinar_Cell_Carcinoma Acinar Cell Adenocarcinoma of Pancreas Acinar Cell Adenocarcinoma of the Pancreas Acinar Cell Carcinoma of Pancreas Acinar Cell Carcinoma of the Pancreas Pancreas Acinar Cell Adenocarcinoma Pancreatic Acinar Cell Adenocarcinoma Pancreatic Acinar Cell Cancer Pancreatic Acinar Cell Carcinoma Pancreatic Acinar Cell Carcinoma A malignant serous cystic epithelial neoplasm arising from the ovary. It is characterized by the presence of glandular, papillary, or solid structures. Psammoma bodies may be present. In well differentiated cases the malignant epithelial cells resemble the cells of fallopian tube epithelium. In poorly differentiated cases the malignant epithelial cells show anaplastic features. C7978 Neoplastic Process Ovarian Serous Cystadenocarcinoma Ovarian Serous Cystadenocarcinoma C0279663 CTRP Cellosaurus GDC Malignant Ovarian_Serous_Cystadenocarcinoma 15 21 40 Ovarian Serous Cystadenocarcinoma Ovarian Serous Cystadenocarcinoma An endometrioid adenocarcinoma arising from the ovary. It comprises 10% to 25% of all primary ovarian carcinomas. Grossly, endometrioid carcinoma may present as a cystic or solid mass. Microscopically, the tumor greatly resembles the appearance of the ordinary type of endometrial adenocarcinoma. As a group, endometrioid carcinoma has a prognosis twice as good as that of serous or mucinous carcinoma. C7979 Neoplastic Process Ovarian Endometrioid Adenocarcinoma Ovarian Endometrioid Adenocarcinoma C0346163 CTRP Cellosaurus Malignant Ovarian_Endometrioid_Adenocarcinoma Endometrioid Adenocarcinoma of Ovary Endometrioid Adenocarcinoma of the Ovary Endometrioid Cancer of Ovary Endometrioid Cancer of the Ovary Endometrioid Carcinoma of Ovary Endometrioid Carcinoma of the Ovary Ovarian Endometrioid Adenocarcinoma Ovarian Endometrioid Cancer Ovarian Endometrioid Carcinoma Ovarian Endometrioid Adenocarcinoma A malignant glandular epithelial neoplasm arising from the ovary. It is characterized by the presence of clear and hobnail cells and cystic structures. C7980 Neoplastic Process Ovarian Clear Cell Cystadenocarcinoma Ovarian Clear Cell Cystadenocarcinoma C0279667 CTRP Malignant Ovarian_Clear_Cell_Cystadenocarcinoma Ovarian Clear Cell Cystadenocarcinoma Ovarian Clear Cell Cystadenocarcinoma An adenocarcinoma arising from the vagina. Morphologic variants include the clear cell, endometrioid, mesonephric, and mucinous adenocarcinoma. C7981 Neoplastic Process Vaginal Adenocarcinoma Vaginal Adenocarcinoma C0279668 CTRP Malignant Vaginal_Adenocarcinoma Adenocarcinoma of Vagina Adenocarcinoma of the Vagina Vagina Adenocarcinoma Vaginal Adenocarcinoma Vaginal Adenocarcinoma A small cell neuroendocrine carcinoma arising from the cervix. C7982 Neoplastic Process Cervical Small Cell Carcinoma Cervical Small Cell Neuroendocrine Carcinoma C0279674 CTRP Cellosaurus Malignant Cervical_Small_Cell_Carcinoma Cervical Small Cell Cancer Cervical Small Cell Carcinoma Cervical Small Cell Neuroendocrine Carcinoma Cervix Small Cell Carcinoma Cervix Uteri Small Cell Carcinoma Small Cell Carcinoma of Cervix Small Cell Carcinoma of Cervix Uteri Small Cell Carcinoma of Uterine Cervix Small Cell Carcinoma of the Cervix Small Cell Carcinoma of the Cervix Uteri Small Cell Carcinoma of the Uterine Cervix Uterine Cervix Small Cell Carcinoma Cervical Small Cell Neuroendocrine Carcinoma An epithelial neoplasm that arises from the ovary characterized by the presence of glandular or cystic spaces which contain atypical glandular epithelial cells resembling endometrial cells. The surrounding ovarian stroma is often fibrotic. There is no evidence of stromal invasion. C7983 Neoplastic Process Borderline Ovarian Endometrioid Tumor/Atypical Proliferative Ovarian Endometrioid Tumor Borderline Ovarian Endometrioid Tumor/Atypical Proliferative Ovarian Endometrioid Tumor C0334338 CTRP GDC 8380/1 8381/1 Uncertain Malignant Potential Borderline_Ovarian_Endometrioid_Tumor 8380/1 Atypical proliferative endometrioid tumor Endometrioid adenoma, borderline malignancy Endometrioid cystadenoma, borderline malignancy Endometrioid tumor of low malignant potential Borderline Endometrioid Neoplasm of Ovary Borderline Endometrioid Neoplasm of the Ovary Borderline Endometrioid Tumor of Ovary Borderline Endometrioid Tumor of the Ovary Borderline Ovarian Endometrioid Neoplasm Borderline Ovarian Endometrioid Tumor Borderline Ovarian Endometrioid Tumor/Atypical Proliferative Ovarian Endometrioid Tumor EBT/APET Endometrioid Neoplasm of Low Malignant Potential Endometrioid Neoplasm with Proliferating Activity, Ovarian Endometrioid Tumor of Low Malignant Potential Endometrioid Tumor with Proliferating Activity, Ovarian Endometrioid tumor of low malignant potential Low Malignant Potential Endometrioid Neoplasm of Ovary Low Malignant Potential Endometrioid Neoplasm of the Ovary Low Malignant Potential Endometrioid Tumor of Ovary Low Malignant Potential Endometrioid Tumor of the Ovary Low Malignant Potential Ovarian Endometrioid Neoplasm Low Malignant Potential Ovarian Endometrioid Tumor Ovarian Endometrioid Borderline Neoplasm Ovarian Endometrioid Borderline Tumor Ovarian Endometrioid Neoplasm of Low Malignant Potential Ovarian Endometrioid Neoplasm with Proliferating Activity Ovarian Endometrioid Tumor of Low Malignant Potential Ovarian Endometrioid Tumor with Proliferating Activity Proliferating Endometrioid Neoplasm of Ovary Proliferating Endometrioid Neoplasm of the Ovary Proliferating Endometrioid Tumor of Ovary Proliferating Endometrioid Tumor of the Ovary Proliferating Ovarian Endometrioid Neoplasm Proliferating Ovarian Endometrioid Tumor Borderline Ovarian Endometrioid Tumor/Atypical Proliferative Ovarian Endometrioid Tumor A melanoma arising from the choroid, ciliary body, or the iris. It is characterized by the presence of spindle-shaped melanocytes. C7986 Neoplastic Process Spindle Cell Uveal Melanoma Uveal Spindle Cell Melanoma C0279687 CTRP Malignant Spindle_Cell_Uveal_Melanoma Spindle Cell Intraocular Melanoma Spindle Cell Melanoma of Uvea Spindle Cell Melanoma of the Uvea Spindle Cell Uveal Melanoma Uveal Spindle Cell Melanoma Uveal Spindle Cell Melanoma A uveal melanoma characterized by the presence of malignant spindle-shaped melanocytes with slender nuclei and no visible nucleoli. C7987 Neoplastic Process Spindle Cell Type A Uveal Melanoma Uveal Spindle Cell Type A Melanoma C0279688 CTRP Malignant Spindle_Cell_Type_A_Uveal_Melanoma Spindle Cell Type A Melanoma of Uvea Spindle Cell Type A Melanoma of the Uvea Spindle Cell Type A Uveal Melanoma Uveal Spindle Cell Type A Melanoma Uveal Spindle Cell Type A Melanoma A uveal melanoma characterized by the presence of malignant spindle-shaped melanocytes with larger nuclei and distinct nucleoli. C7988 Neoplastic Process Spindle Cell Type B Uveal Melanoma Uveal Spindle Cell Type B Melanoma C0279689 CTRP Malignant Spindle_Cell_Type_B_Uveal_Melanoma Spindle Cell Type B Melanoma of Uvea Spindle Cell Type B Melanoma of the Uvea Spindle Cell Type B Uveal Melanoma Uveal Spindle Cell Type B Melanoma Uveal Spindle Cell Type B Melanoma Uveal melanoma characterized by the presence of intermediate cells which are similar to but smaller than epithelioid cells. C7989 Neoplastic Process Intermediate Cell Type Uveal Melanoma Uveal Intermediate Cell Type Melanoma C0862911 CTRP Malignant Intermediate_Cell_Type_Uveal_Melanoma Intermediate Cell Type Intraocular Melanoma Intermediate Cell Type Uveal Melanoma Uveal Intermediate Cell Type Melanoma Uveal Intermediate Cell Type Melanoma A uveal melanoma characterized by the presence of tumor cell necrosis. C7990 Neoplastic Process Necrotic Uveal Melanoma Uveal Necrotic Melanoma C0279695 CTRP Malignant Necrotic_Uveal_Melanoma Necrotic Uveal Melanoma Uveal Necrotic Melanoma Uveal Necrotic Melanoma A squamous cell carcinoma arising from the salivary glands. The majority of patients are in their sixth through eight decades. It usually presents as a rapidly enlarging mass, which may be painful. It usually has an aggressive clinical course. C7991 Neoplastic Process Salivary Gland Squamous Cell Carcinoma Salivary Gland Squamous Cell Carcinoma C0279697 CTRP Malignant Salivary_Gland_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Salivary Gland Epidermoid Carcinoma of the Salivary Gland SCC of Salivary Gland SCC of the Salivary Gland Salivary Gland Epidermoid Carcinoma Salivary Gland SCC Salivary Gland Squamous Cell Cancer Salivary Gland Squamous Cell Carcinoma Squamous Cell Carcinoma of Salivary Gland Squamous Cell Carcinoma of the Salivary Gland Salivary Gland Squamous Cell Carcinoma A squamous cell carcinoma that arises from the nasopharynx and is characterized by prominent production of keratin. C7992 Neoplastic Process Nasopharyngeal Keratinizing Squamous Cell Carcinoma Nasopharyngeal Keratinizing Squamous Cell Carcinoma C0279698 CTRP Malignant Nasopharyngeal_Squamous_Cell_Carcinoma K-NPC Keratinizing Epidermoid Carcinoma of Nasopharynx Keratinizing Epidermoid Carcinoma of the Nasopharynx Keratinizing Squamous Cell Carcinoma of Nasopharynx Keratinizing Squamous Cell Carcinoma of the Nasopharynx Nasopharyngeal Keratinizing Epidermoid Carcinoma Nasopharyngeal Keratinizing Squamous Cell Carcinoma Nasopharyngeal Keratinizing Squamous Cell Carcinoma A parathyroid gland adenoma composed predominantly of neoplastic cells with clear cytoplasm. C7993 Neoplastic Process Parathyroid Gland Clear Cell Adenoma Parathyroid Gland Clear Cell Adenoma C0279700 CTRP Benign Parathyroid_Clear_Cell_Adenoma Clear Cell Adenoma of Parathyroid Clear Cell Adenoma of Parathyroid Gland Clear Cell Adenoma of the Parathyroid Clear Cell Adenoma of the Parathyroid Gland Parathyroid Clear Cell Adenoma Parathyroid Gland Clear Cell Adenoma Parathyroid Gland Transitional Clear Cell Adenoma Parathyroid Transitional Clear Cell Adenoma Transitional Clear Cell Adenoma of Parathyroid Transitional Clear Cell Adenoma of Parathyroid Gland Transitional Clear Cell Adenoma of the Parathyroid Transitional Clear Cell Adenoma of the Parathyroid Gland Parathyroid Gland Clear Cell Adenoma A parathyroid gland adenoma that contains a mixture of neoplastic cells (chief cells, oncocytes, and clear cells). C7994 Neoplastic Process Parathyroid Gland Mixed Cell Type Adenoma Parathyroid Gland Mixed Cell Type Adenoma C0279701 CTRP Benign Parathyroid_Mixed_Cell_Type_Adenoma Mixed Cell Type Adenoma of Parathyroid Mixed Cell Type Adenoma of Parathyroid Gland Mixed Cell Type Adenoma of the Parathyroid Mixed Cell Type Adenoma of the Parathyroid Gland Parathyroid Gland Mixed Cell Type Adenoma Parathyroid Mixed Cell Type Adenoma Parathyroid Gland Mixed Cell Type Adenoma A solitary fibrous tumor characterized by the presence of areas of abrupt transition to high grade sarcoma. C79948 Neoplastic Process Dedifferentiated Solitary Fibrous Tumor C2699572 Malignant Dedifferentiated_Solitary_Fibrous_Tumor Dedifferentiated Solitary Fibrous Tumor Dedifferentiated Solitary Fibrous Tumor A paraganglioma that arises from and is confined to the carotid body. C79950 Neoplastic Process Non-Metastatic Carotid Body Paraganglioma C2698359 CDISC A benign neoplasm of the chemoreceptor system (e.g. carotid body, glomus jugulare, glomus vagale). Benign Benign_Carotid_Body_Paraganglioma Benign Carotid Body Paraganglioma Benign Chemodectoma CHEMODECTOMA, BENIGN Non-Metastatic Carotid Body Paraganglioma Non-Metastatic Carotid Body Paraganglioma A type B1 thymoma which is characterized by an aggressive clinical course (capsular invasion, infiltration of the surrounding tissues) and can metastasize. C7996 Neoplastic Process Malignant Type B1 Thymoma Malignant Type B1 Thymoma C0279704 CTRP GDC 8583/3 Malignant Malignant_Type_B1_Thymoma 8583/3 Thymoma, lymphocyte-rich, malignant Thymoma, lymphocytic, malignant Thymoma, organoid, malignant Thymoma, predominantly cortical, malignant Thymoma, type B1 Thymoma, type B1, malignant Malignant Type B1 Thymoma Thymoma, type B1, malignant Malignant Type B1 Thymoma Also known as well-differentiated thymic carcinoma, atypical thymoma, or epithelial thymoma, this type of thymoma displays morphologic characteristics of a well-differentiated carcinoma. The majority of cases occur in the anterior mediastinum as Masaoka stage II or stage III tumors. It is almost always invasive, it recurs frequently, and metastasizes in approximately 20% of the cases. C7997 Neoplastic Process Thymoma Type B3 Thymoma Type B3 C0279705 CTRP GDC 8585/1 8585/3 Malignant Thymoma_Type_B3 8585/1 8585/3 Thymoma, atypical, NOS Thymoma, atypical, malignant Thymoma, epithelial, NOS Thymoma, epithelial, malignant Thymoma, type B3 Thymoma, type B3, NOS Thymoma, type B3, malignant Well differentiated thymic carcinoma Atypical Thymoma Epithelial Malignant Thymoma Epithelial Thymoma Malignant Thymoma Type B3 Squamoid Thymoma Thymoma Type B3 Thymoma, atypical, NOS Thymoma, atypical, malignant Thymoma, epithelial, NOS Thymoma, epithelial, malignant Thymoma, type B3, NOS Thymoma, type B3, malignant Well Differentiated Thymic Carcinoma Well differentiated thymic carcinoma Well-Differentiated Thymic Carcinoma Thymoma Type B3 A rare, usually aggressive primary thymic carcinoma, characterized by a syncytial growth of undifferentiated carcinoma cells and the presence of a lymphoplasmacytic infiltrate. More than 40% of cases are associated with Epstein-Barr virus infection. C7998 Neoplastic Process Thymic Lymphoepithelial Carcinoma C0279706 Malignant Lymphoepithelioma-Like_Thymic_Carcinoma Lymphoepithelial Cancer of Thymus Lymphoepithelial Cancer of the Thymus Lymphoepithelial Thymus Cancer Lymphoepithelioma-like Carcinoma of Thymus Lymphoepithelioma-like Carcinoma of the Thymus Lymphoepithelioma-like Thymic Carcinoma Lymphoepithelioma-like Thymus Carcinoma Malignant Lymphoepithelial Thymoma Thymic Lymphoepithelial Carcinoma Thymic Lymphoepithelioma-Like Carcinoma Thymic Lymphoepithelial Carcinoma A type A thymoma which is characterized by an aggressive clinical course (capsular invasion, infiltration of the surrounding tissues) and can metastasize. C7999 Neoplastic Process Malignant Type A Thymoma Malignant Type A Thymoma C0279707 CTRP GDC 8581/3 Malignant Malignant_Type_A_Thymoma 8581/3 Thymoma, medullary, malignant Thymoma, spindle cell, malignant Thymoma, type A Thymoma, type A, malignant Malignant Type A Thymoma Thymoma, type A, malignant Malignant Type A Thymoma A non-seminomatous malignant germ cell tumor arising from the testis. It affects infants, young children, and postpubertal males. It is the most frequently seen testicular neoplasm during childhood. The vast majority of patients present with an asymptomatic scrotal mass. The tumor mimics the yolk sac of the embryo and produces alpha-fetoprotein (AFP). It metastasizes to distant anatomic sites. Prognostic factors relate to the clinical stage and the degree of AFP elevation. C8000 Neoplastic Process Testicular Yolk Sac Tumor Testicular Yolk Sac Tumor C0279708 CTRP Cellosaurus Malignant Testicular_Yolk_Sac_Tumor Endodermal Sinus Neoplasm of Testis Endodermal Sinus Neoplasm of the Testis Endodermal Sinus Tumor of Testis Endodermal Sinus Tumor of the Testis Testicular Endodermal Sinus Neoplasm Testicular Endodermal Sinus Tumor Testicular Yolk Sac Neoplasm Testicular Yolk Sac Tumor Yolk Sac Neoplasm of Testis Yolk Sac Neoplasm of the Testis Yolk Sac Tumor of Testis Yolk Sac Tumor of the Testis Testicular Yolk Sac Tumor A malignant non-seminomatous germ cell tumor arising from the testis. It is characterized by a mixture of embryonal carcinoma and yolk sac morphologic elements. Patients may present with painless or painful testicular swelling. C8001 Neoplastic Process Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor C0279711 CTRP Malignant Testicular_Mixed_Embryonal_Carcinoma_and_Yolk_Sack_Tumor Mixed Embryonal Carcinoma and Endodermal Sinus Neoplasm of Testis Mixed Embryonal Carcinoma and Endodermal Sinus Neoplasm of the Testis Mixed Embryonal Carcinoma and Endodermal Sinus Tumor of Testis Mixed Embryonal Carcinoma and Endodermal Sinus Tumor of the Testis Mixed Embryonal Carcinoma and Yolk Sac Neoplasm of Testis Mixed Embryonal Carcinoma and Yolk Sac Neoplasm of the Testis Mixed Embryonal Carcinoma and Yolk Sac Tumor of Testis Mixed Embryonal Carcinoma and Yolk Sac Tumor of the Testis Testicular Mixed Embryonal Carcinoma and Endodermal Sinus Neoplasm Testicular Mixed Embryonal Carcinoma and Endodermal Sinus Tumor Testicular Mixed Embryonal Carcinoma and Yolk Sac Neoplasm Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor A malignant non-seminomatous germ cell tumor arising from the testis. It is characterized by a mixture of yolk sac and teratomatous morphologic elements. Patients may present with painless or painful testicular swelling. C8002 Neoplastic Process Testicular Mixed Yolk Sac Tumor and Teratoma Testicular Mixed Yolk Sac Tumor and Teratoma C0279714 CTRP Malignant Testicular_Mixed_Yolk_Sac_Tumor_and_Teratoma Mixed Endodermal Sinus Neoplasm and Teratoma of Testis Mixed Endodermal Sinus Neoplasm and Teratoma of the Testis Mixed Endodermal Sinus Tumor and Teratoma of Testis Mixed Endodermal Sinus Tumor and Teratoma of the Testis Mixed Yolk Sac Neoplasm and Teratoma of Testis Mixed Yolk Sac Neoplasm and Teratoma of the Testis Mixed Yolk Sac Tumor and Teratoma of Testis Mixed Yolk Sac Tumor and Teratoma of the Testis Testicular Mixed Endodermal Sinus Neoplasm and Teratoma Testicular Mixed Endodermal Sinus Tumor and Teratoma Testicular Mixed Yolk Sac Neoplasm and Teratoma Testicular Mixed Yolk Sac Tumor and Teratoma Testicular Mixed Yolk Sac Tumor and Teratoma A malignant germ cell tumor arising from the testis. It is characterized by a mixture of yolk sac, teratomatous, and seminomatous morphologic elements. Patients may present with painless or painful testicular swelling. C8003 Neoplastic Process Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma C0279715 CTRP Malignant Testicular_Mixed_Yolk_Sac_Tumor_and_Teratoma_with_Seminoma Mixed Endodermal Sinus Neoplasm and Teratoma with Seminoma of Testis Mixed Endodermal Sinus Neoplasm and Teratoma with Seminoma of the Testis Mixed Endodermal Sinus Tumor and Teratoma with Seminoma of Testis Mixed Endodermal Sinus Tumor and Teratoma with Seminoma of the Testis Mixed Yolk Sac Neoplasm and Teratoma with Seminoma of Testis Mixed Yolk Sac Neoplasm and Teratoma with Seminoma of the Testis Mixed Yolk Sac Tumor and Teratoma with Seminoma of Testis Mixed Yolk Sac Tumor and Teratoma with Seminoma of the Testis Testicular Mixed Endodermal Sinus Neoplasm and Teratoma with Seminoma Testicular Mixed Endodermal Sinus Tumor and Teratoma with Seminoma Testicular Mixed Yolk Sac Neoplasm and Teratoma with Seminoma Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma A usually malignant, somatostatin producing neuroendocrine tumor, arising from the delta cells of the pancreas. It may or may not be associated with inappropriate secretion of somatostatin and an associated clinical syndrome. C8006 Neoplastic Process Pancreatic Somatostatin-Producing Neuroendocrine Tumor CL427993 Undetermined Pancreatic_Delta_Cell_Somatostatin_Producing_Neoplasm Pancreatic Somatostatin Producing NET Pancreatic Somatostatin Producing Neuroendocrine Tumor Pancreatic Somatostatin Producing Tumor Pancreatic Somatostatin-Producing Neuroendocrine Tumor Pancreatic Somatostatin-Producing Neuroendocrine Tumor A salivary gland carcinoma with low-grade histopathologic features. It includes the salivary gland polymorphous low grade adenocarcinoma, salivary gland low grade cribriform cystadenocarcinoma, and low grade salivary gland mucoepidermoid carcinoma. It usually follows a non-aggressive clinical course. C8012 Neoplastic Process Low Grade Salivary Gland Carcinoma Salivary Gland Low Grade Carcinoma C0279737 CTRP Malignant Low-Grade_Salivary_Gland_Carcinoma Low Grade Salivary Gland Cancer Low Grade Salivary Gland Carcinoma Low-Grade Carcinoma of Salivary Gland Low-Grade Carcinoma of the Salivary Gland Salivary Gland Low Grade Carcinoma Salivary Gland Low-Grade Carcinoma Salivary Gland Low Grade Carcinoma A carcinoma of the salivary gland characterized by serous acinar cell differentiation. The vast majority of cases occur in the parotid gland. It usually presents as a slowly enlarging mass. A minority of patients experience pain. It may recur or metastasize. Multiple recurrences and metastasis to cervical lymph nodes are usually associated with a poor prognosis. C8013 Neoplastic Process Salivary Gland Acinic Cell Carcinoma Salivary Gland Acinic Cell Carcinoma C0279738 CTRP Malignant Salivary_Gland_Acinic_Cell_Carcinoma Acinic Cell Carcinoma of Salivary Gland Acinic Cell Carcinoma of the Salivary Gland Acinic Cell Neoplasm of Salivary Gland Acinic Cell Neoplasm of the Salivary Gland Acinic Cell Tumor of Salivary Gland Acinic Cell Tumor of the Salivary Gland Salivary Gland Acinic Cell Cancer Salivary Gland Acinic Cell Carcinoma Salivary Gland Acinic Cell Neoplasm Salivary Gland Acinic Cell Tumor Salivary Gland Acinic Cell Carcinoma A basal cell carcinoma arising from the lip. C8014 Neoplastic Process Lip Basal Cell Carcinoma Lip Basal Cell Carcinoma C0279739 CPTAC CTRP Malignant Lip_Basal_Cell_Carcinoma Basal cell carcinoma of skin of lip Basal Cell Carcinoma of Lip Basal Cell Carcinoma of the Lip Lip Basal Cell Cancer Lip Basal Cell Carcinoma Lip Basal Cell Carcinoma A salivary gland mucoepidermoid carcinoma with low-grade histopathologic features. It usually follows a non-aggressive clinical course. C8015 Neoplastic Process Low Grade Salivary Gland Mucoepidermoid Carcinoma Salivary Gland Low Grade Mucoepidermoid Carcinoma C0279740 CTRP Malignant Low-Grade_Salivary_Gland_Mucoepidermoid_Carcinoma Grade I Mucoepidermoid Carcinoma of Salivary Gland Grade I Mucoepidermoid Carcinoma of the Salivary Gland Grade I Salivary Gland Mucoepidermoid Carcinoma Low Grade Salivary Gland Mucoepidermoid Carcinoma Low-Grade Mucoepidermoid Carcinoma of Salivary Gland Low-Grade Mucoepidermoid Carcinoma of the Salivary Gland Salivary Gland Low Grade Mucoepidermoid Carcinoma Salivary Gland Low-Grade Mucoepidermoid Carcinoma Salivary Gland Low Grade Mucoepidermoid Carcinoma A salivary gland mucoepidermoid carcinoma with intermediate-grade histopathologic features. C8017 Neoplastic Process Salivary Gland Intermediate Grade Mucoepidermoid Carcinoma C0279742 Malignant Grade_II_Salivary_Gland_Mucoepidermoid_Carcinoma Grade II Mucoepidermoid Carcinoma of Salivary Gland Grade II Mucoepidermoid Carcinoma of the Salivary Gland Grade II Salivary Gland Mucoepidermoid Carcinoma Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma Salivary Gland Intermediate Grade Mucoepidermoid Carcinoma Salivary Gland Intermediate Grade Mucoepidermoid Carcinoma A usually aggressive salivary gland carcinoma with high-grade histopathologic features. It includes the salivary duct carcinoma, salivary gland oncocytic carcinoma, and high grade salivary gland mucoepidermoid carcinoma. C8018 Neoplastic Process High Grade Salivary Gland Carcinoma Salivary Gland High Grade Carcinoma C0279743 CTRP Malignant High-Grade_Salivary_Gland_Carcinoma High Grade Salivary Gland Cancer High Grade Salivary Gland Carcinoma High-Grade Carcinoma of Salivary Gland High-Grade Carcinoma of the Salivary Gland Salivary Gland High Grade Carcinoma Salivary Gland High-Grade Carcinoma Salivary Gland High Grade Carcinoma A salivary gland mucoepidermoid carcinoma with high-grade histopathologic features. It usually follows an aggressive clinical course. C8019 Neoplastic Process High Grade Salivary Gland Mucoepidermoid Carcinoma Salivary Gland High Grade Mucoepidermoid Carcinoma C0279744 CTRP Malignant High-Grade_Salivary_Gland_Mucoepidermoid_Carcinoma Grade III Mucoepidermoid Carcinoma of Salivary Gland Grade III Mucoepidermoid Carcinoma of the Salivary Gland Grade III Salivary Gland Mucoepidermoid Carcinoma High Grade Salivary Gland Mucoepidermoid Carcinoma High-Grade Mucoepidermoid Carcinoma of Salivary Gland High-Grade Mucoepidermoid Carcinoma of the Salivary Gland Salivary Gland High Grade Mucoepidermoid Carcinoma Salivary Gland High-Grade Mucoepidermoid Carcinoma Salivary Gland High Grade Mucoepidermoid Carcinoma An adenocarcinoma arising from the salivary gland. It includes the salivary gland polymorphous low grade adenocarcinoma, salivary gland oncocytic carcinoma, salivary gland mucinous adenocarcinoma, salivary gland low grade cribriform cystadenocarcinoma, salivary gland cystadenocarcinoma, salivary gland basal cell adenocarcinoma, salivary gland acinic cell carcinoma, salivary duct carcinoma, and salivary gland adenocarcinoma not otherwise specified. C8021 Neoplastic Process Salivary Gland Adenocarcinoma Salivary Gland Adenocarcinoma C0279746 CTRP Malignant Salivary_Gland_Adenocarcinoma Adenocarcinoma of Salivary Gland Adenocarcinoma of the Salivary Gland Salivary Gland Adenocarcinoma Salivary Gland Adenocarcinoma A poorly differentiated squamous cell carcinoma arising from the salivary gland. C8022 Neoplastic Process Poorly Differentiated Salivary Gland Squamous Cell Carcinoma Salivary Gland Poorly Differentiated Squamous Cell Carcinoma C0279747 CTRP Malignant Poorly_Differentiated_Salivary_Gland_Carcinoma Poorly Differentiated Salivary Gland Squamous Cell Cancer Poorly Differentiated Salivary Gland Squamous Cell Carcinoma Poorly Differentiated Squamous Cell Carcinoma of the Salivary Gland Salivary Gland Poorly Differentiated Squamous Cell Carcinoma Salivary Gland Poorly Differentiated Squamous Cell Carcinoma A nonkeratinizing nasopharyngeal carcinoma characterized by the presence of large cells with vesicular nuclei and prominent nucleoli, a syncytial growth pattern, and a lymphoplasmacytic infiltrate. C8023 Neoplastic Process Nasopharyngeal Undifferentiated Carcinoma Nasopharyngeal Undifferentiated Carcinoma C0279748 CTRP Malignant Nasopharyngeal_Undifferentiated_Carcinoma Lymphoepithelioma of Nasopharynx Lymphoepithelioma of the Nasopharynx Nasopharyngeal Lymphoepithelial Carcinoma Nasopharyngeal Lymphoepithelioma Nasopharyngeal Non-Keratinizing Undifferentiated Carcinoma Nasopharyngeal Nonkeratinizing Undifferentiated Carcinoma Nasopharyngeal Undifferentiated Carcinoma Undifferentiated Carcinoma of Nasopharynx Undifferentiated Carcinoma of the Nasopharynx Undifferentiated Nasopharyngeal Throat Cancer Nasopharyngeal Undifferentiated Carcinoma A salivary gland carcinoma characterized by the presence of undifferentiated, anaplastic malignant epithelial cells. C8024 Neoplastic Process Salivary Gland Undifferentiated Carcinoma Salivary Gland Undifferentiated Carcinoma C0279749 CTRP Malignant Undifferentiated_Salivary_Gland_Carcinoma Anaplastic Carcinoma of Salivary Gland Anaplastic Carcinoma of the Salivary Gland Anaplastic Salivary Gland Carcinoma Salivary Gland Anaplastic Carcinoma Salivary Gland Undifferentiated Carcinoma Undifferentiated Carcinoma of Salivary Gland Undifferentiated Carcinoma of the Salivary Gland Undifferentiated Salivary Gland Cancer Undifferentiated Salivary Gland Carcinoma Salivary Gland Undifferentiated Carcinoma A malignant tumor arising from the salivary gland. It includes carcinoma ex pleomorphic adenoma, a malignant epithelial tumor arising from a pre-existing pleomorphic adenoma and carcinosarcoma which is characterized by a mixture of malignant epithelial and sarcomatous elements. C8025 Neoplastic Process Malignant Mixed Tumor of the Salivary Gland Malignant Mixed Tumor of the Salivary Gland C0344459 CTRP Cellosaurus GDC Malignant Malignant_Mixed_Tumor_of_the_Salivary_Gland Mixed tumor, malignant, NOS Mixed tumor, salivary gland type, malignant Malignant Mixed Cell Type Neoplasm of Salivary Gland Malignant Mixed Cell Type Neoplasm of the Salivary Gland Malignant Mixed Neoplasm of Salivary Gland Malignant Mixed Neoplasm of the Salivary Gland Malignant Mixed Tumor of Salivary Gland Malignant Mixed Tumor of the Salivary Gland Malignant Salivary Gland Mixed Cell Type Neoplasm Malignant Salivary Gland Mixed Cell Type Tumor Malignant Salivary Gland Mixed Neoplasm Malignant Salivary Gland Mixed Tumor Mixed Malignant Neoplasm of Salivary Gland Mixed Malignant Neoplasm of the Salivary Gland Mixed Malignant Salivary Gland Neoplasm Mixed Malignant Salivary Gland Tumor Mixed Malignant Tumor of Salivary Gland Mixed Malignant Tumor of the Salivary Gland Mixed tumor, salivary gland type, malignant Malignant Mixed Tumor of the Salivary Gland An adenoid cystic carcinoma arising from the salivary gland. It is characterized by the presence of epithelial and myoepithelial cells forming tubular, cribriform, and solid patterns. It usually presents as a slow growing mass. Patients may experience pain because of the tumor propensity for perineural invasion. The tumor may follow an aggressive clinical course with recurrences and mestastases to distant sites including lungs, bones, brain, and liver. C8026 Neoplastic Process Salivary Gland Adenoid Cystic Carcinoma Salivary Gland Adenoid Cystic Carcinoma C0279751 CTRP Cellosaurus Malignant Salivary_Gland_Adenoid_Cystic_Carcinoma Adenoid Cystic Carcinoma of Salivary Gland Adenoid Cystic Carcinoma of the Salivary Gland Salivary Gland Adenoid Cystic Cancer Salivary Gland Adenoid Cystic Carcinoma Salivary Gland Adenoid Cystic Carcinoma A high-grade endometrial adenocarcinoma characterized by the presence of large neoplastic cells that display at least focal cytoplasmic clearing. The neoplastic cells form papillary, glandular, or sheet-like structures. C8028 Neoplastic Process Endometrial Clear Cell Adenocarcinoma Endometrial Clear Cell Adenocarcinoma C0279765 CPTAC CTRP Cellosaurus Malignant Endometrial_Clear_Cell_Carcinoma Clear Cell Carcinoma of Endometrium Clear Cell Carcinoma of the Endometrium Clear cell carcinoma Endometrial Clear Cell Adenocarcinoma Endometrial Clear Cell Adenocarcinoma A term referring to a group of diffuse large B-cell lymphomas which are biologically heterogeneous. These lymphomas have a centroblastic, immunoblastic, or anaplastic morphology. C80280 Neoplastic Process Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Diffuse Large B-Cell Lymphoma, Not Otherwise Specified C2699777 CTRP GDC Malignant Diffuse_Large_B-Cell_Lymphoma_Not_Otherwise_Specified 9680/3 Diffuse large B-cell lymphoma, NOS Malignant lymphoma, large B-cell, NOS Malignant lymphoma, large B-cell, diffuse, NOS Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Diffuse Large B-Cell Lymphoma, Not Otherwise Specified A diffuse large B-cell lymphoma originally described in patients older than 50 years, but it has been increasingly recognized in younger patients. Epstein-Barr virus is present in all cases. There is no known history of immunodeficiency or prior lymphoma. C80281 Neoplastic Process Epstein-Barr Virus Positive Diffuse Large B-Cell Lymphoma of the Elderly EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified C2700007 CTRP GDC 9680/3 Malignant Epstein-Barr_Virus_Positive_Diffuse_Large_B-Cell_Lymphoma_of_the_Elderly 9680/3 EBV positive diffuse large B-cell lymphoma of the elderly Age-Related EBV Positive B-Cell Lymphoproliferative Disorder EBV Positive Diffuse Large B-Cell Lymphoma of the Elderly EBV positive diffuse large B-cell lymphoma of the elderly EBV-Positive DLBCL, NOS EBV-Positive Diffuse Large B-Cell Lymphoma EBV-Positive Diffuse Large B-Cell Lymphoma, NOS EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Epstein-Barr Virus Positive DLBCL, NOS Epstein-Barr Virus Positive Diffuse Large B-Cell Lymphoma of the Elderly Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Senile EBV-Associated B-Cell Lymphoproliferative Disorder EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified A diffuse large B-cell lymphoma arising in body cavities or narrow spaces of long standing chronic inflammation. The classic example is the pyothorax-associated lymphoma that arises in the pleural cavity of patients with a history of long standing pyothorax. C80289 Neoplastic Process Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation C2699776 GDC 9680/3 Malignant Diffuse_Large_B-Cell_Lymphoma_Associated_with_Chronic_Inflammation 9680/3 Diffuse large B-cell lymphoma associated with chronic inflammation DLBCL-CI Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation Diffuse large B-cell lymphoma associated with chronic inflammation Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation A hairy cell leukemia requiring initial treatment because of the presence of signs of progression. Signs of progression include cytopenia (especially if symptomatic), increasing splenomegaly, and infectious complications. Therapy is not necessary if the patients are asymptomatic and the blood counts are maintained in an acceptable range. C8029 Neoplastic Process Progressive Hairy Cell Leukemia Initial Treatment Progressive Hairy Cell Leukemia Initial Treatment C0279779 CTRP Malignant Progressive_Hairy_Cell_Leukemia_Initial_Treatment Progressive Hairy Cell Leukemia Initial Treatment Progressive Hairy Cell Leukemia, Initial Treatment Progressive Hairy Cell Leukemia Initial Treatment A plasmablastic lymphoma that arises from the oral mucosa. It is usually associated with HIV infection. C80290 Neoplastic Process Oral Cavity Plasmablastic Lymphoma C2698832 Malignant Plasmablastic_Lymphoma_of_the_Oral_Mucosa Oral Cavity Plasmablastic Lymphoma Oral Mucosa Plasmablastic Lymphoma Plasmablastic Lymphoma of the Oral Cavity Plasmablastic Lymphoma of the Oral Mucosa Oral Cavity Plasmablastic Lymphoma High-grade B-cell lymphoma with blastoid features or features between diffuse large B-cell lymphoma and Burkitt lymphoma that lacks MYC, BCL2, and BCL6 gene rearrangements. C80291 Neoplastic Process High Grade B-Cell Lymphoma, Not Otherwise Specified High Grade B-Cell Lymphoma, Not Otherwise Specified C2698294 CTRP Cellosaurus GDC 9680/3 Malignant B-Cell_Lymphoma_Unclassifiable_with_Features_Intermediate_between_Diffuse_Large_B-Cell_Lymphoma_and_Burkitt_Lymphoma 9680/3 B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma BCLU HGBL, NOS High Grade B-Cell Lymphoma, NOS High Grade B-Cell Lymphoma, Not Otherwise Specified High-Grade B-Cell Lymphoma, NOS High-Grade B-Cell Lymphoma, Not Otherwise Specified High Grade B-Cell Lymphoma, Not Otherwise Specified A nodal follicular lymphoma with favorable prognosis. It lacks BCL-2 rearrangement and 14;18 translocation. Nearly all cases are localized. It is usually seen in the pediatric population but similar lymphomas may occur in adults. C80297 Neoplastic Process Pediatric-Type Follicular Lymphoma C2698750 NICHD A variant of follicular lymphoma seen in children and adolescents that lacks the translocation of t(14;18)(q32;q21) involving BCL2, which is generally found in adults. Malignant Pediatric_Follicular_Lymphoma Childhood Follicular Lymphoma PTFL Pediatric Follicular Lymphoma Pediatric-Type Follicular Lymphoma Pediatric-Type Follicular Lymphoma A follicular lymphoma arising from the intestine. The majority of cases occur in the small intestine, particularly the duodenum. Usually the patients have localized disease and a favorable clinical outcome. C80298 Neoplastic Process Intestinal Follicular Lymphoma C2698878 Malignant Primary_Intestinal_Follicular_Lymphoma Intestinal Follicular Lymphoma Primary Intestinal Follicular Lymphoma Intestinal Follicular Lymphoma A nodal marginal zone lymphoma affecting the pediatric population, predominantly males. It presents with asymptomatic and localized (mainly head and neck) disease in the vast majority of cases. Morphologically there is often progressive transformation of the germinal centers. The prognosis is excellent. C80299 Neoplastic Process Pediatric Nodal Marginal Zone Lymphoma C2698751 Provisional_Concept NICHD A nodal marginal zone lymphoma affecting the pediatric population, predominantly males. It presents with asymptomatic and localized (mainly head and neck) disease in the vast majority of cases. Malignant Pediatric_Nodal_Marginal_Zone_Lymphoma Childhood Nodal Marginal Zone Lymphoma Pediatric Nodal Marginal Zone Lymphoma Pediatric Nodal Marginal Zone Lymphoma Hairy cell leukemia that is resistant to treatment. C8030 Neoplastic Process Refractory Hairy Cell Leukemia Refractory Hairy Cell Leukemia CL512813 CTRP Malignant Refractory_Hairy_Cell_Leukemia Hairy Cell Leukemia, Refractory Refractory Hairy Cell Leukemia Refractory Hairy Cell Leukemia A syndrome characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes. It is associated with plasma cell dyscrasia. C80303 Neoplastic Process POEMS Syndrome POEMS Syndrome C0085404 CTRP Cellosaurus Malignant POEMS_Syndrome Crow-Fukase syndrome POEMS Syndrome POEMS Syndrome Lymphoplasmacytic lymphoma associated with bone marrow involvement and IgM monoclonal gammopathy. C80307 Neoplastic Process Waldenstrom Macroglobulinemia Waldenstrom Macroglobulinemia C0024419 CTRP Cellosaurus GDC mCode An indolent (slow-growing) type of non-Hodgkin lymphoma marked by abnormal levels of IgM antibodies in the blood and an enlarged liver, spleen, or lymph nodes. Malignant Waldenstrom_Macroglobulinemia 9761/3 Waldenstrom macroglobulinemia Waldenstrom Macroglobulinemia Waldenstrom macroglobulinemia Waldenstrom's Macroglobulinemia Waldenstrom's macroglobulinemia Waldenström Macroglobulinemia Waldenstrom Macroglobulinemia A small B-cell clonal lymphoproliferative disorder of the spleen that does not fall into any of the other categories of mature B-cell neoplasms. C80308 Neoplastic Process Splenic B-Cell Lymphoma/Leukemia, Unclassifiable C2699507 Provisional_Concept GDC 9591/3 Malignant Splenic_B-Cell_Lymphoma_Leukemia_Unclassifiable 9591/3 Splenic B-cell lymphoma/leukemia, unclassifiable Splenic B-Cell Lymphoma/Leukemia, Unclassifiable Splenic B-cell lymphoma/leukemia, unclassifiable Splenic B-Cell Lymphoma/Leukemia, Unclassifiable An uncommon, indolent B-cell non-Hodgkin lymphoma composed of small B-lymphocytes involving the red pulp of the spleen, bone marrow, and peripheral blood. Patients often have massive splenomegaly. The peripheral blood examination reveals villous lymphocytes. C80309 Neoplastic Process Splenic Diffuse Red Pulp Small B-Cell Lymphoma C2699508 Provisional_Concept GDC 9591/3 Malignant Splenic_Diffuse_Red_Pulp_Small_B-Cell_Lymphoma 9591/3 Splenic diffuse red pulp small B-cell lymphoma Splenic Diffuse Red Pulp Small B-Cell Lymphoma Splenic diffuse red pulp small B-cell lymphoma Splenic Diffuse Red Pulp Small B-Cell Lymphoma A monoclonal expansion of B-lymphocytes with or without the characteristic immunophenotype of chronic lymphocytic leukemia. It precedes virtually all cases of chronic lymphocytic leukemia/small lymphocytic lymphoma. C80310 Neoplastic Process Monoclonal B-Cell Lymphocytosis Monoclonal B-Cell Lymphocytosis C2698259 CTRP A condition in which a higher-than-normal number of identical B cells are found in the blood. People with MBL may develop other B-cell diseases, such as chronic lymphocytic leukemia (CLL). Undetermined Monoclonal_B-Cell_Lymphocytosis Monoclonal B-cell lymphocytosis, CLL type Monoclonal B-cell lymphocytosis, NOS MBL Monoclonal B-Cell Lymphocytosis monoclonal B-cell lymphocytosis Monoclonal B-Cell Lymphocytosis B-lymphoblastic leukemias/lymphomas characterized by the absence of recurrent genetic abnormalities. C80326 Neoplastic Process B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified C2698310 CTRP GDC 9811/3 Malignant B_Lymphoblastic_Leukemia_Lymphoma_Not_Otherwise_Specified 9811/3 B lymphoblastic leukemia/lymphoma, NOS B Lymphoblastic Leukemia/Lymphoma, NOS B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified B lymphoblastic leukemia/lymphoma, NOS B-Lymphoblastic Leukemia/Lymphoma, NOS B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified B-lymphoblastic leukemias/lymphomas characterized by the presence of recurring cytogenetic and/or molecular abnormalities. C80328 Neoplastic Process B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities C2698313 Malignant B_Lymphoblastic_Leukemia_Lymphoma_with_Recurrent_Genetic_Abnormalities B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities Stage I includes: T1, N0, M0. T1: Tumor 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8033 Neoplastic Process Stage I Lip and Oral Cavity Cancer AJCC v6 and v7 Stage I Lip and Oral Cavity Cancer AJCC v6 and v7 C0854757 CTRP The tumor is 2 centimeters or smaller. Cancer has not spread to lymph nodes. Malignant Stage_I_Lip_and_Oral_Cavity_Cancer Lip and Oral Cavity Cancer Stage I Lip and Oral Cavity Carcinoma Stage I Stage I Lip and Oral Cavity Cancer Stage I Lip and Oral Cavity Cancer AJCC v6 Stage I Lip and Oral Cavity Cancer AJCC v6 and v7 Stage I Lip and Oral Cavity Cancer AJCC v7 Stage I Lip and Oral Cavity Carcinoma stage I lip and oral cavity cancer Stage I Lip and Oral Cavity Cancer AJCC v6 and v7 A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome. C80331 Neoplastic Process B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 C2698317 GDC 9812/3 Malignant B_Lymphoblastic_Leukemia_Lymphoma_with_t_9_22_q34_q11_2_BCR-ABL_1 9812/3 B lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1 B Lymphoblastic Leukemia/Lymphoma with BCR-ABL1 Fusion B Lymphoblastic Leukemia/Lymphoma with BCR::ABL1 Fusion B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR::ABL1 B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34;q11.2); BCR-ABL1 B lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1 B-Lymphoblastic Leukemia/Lymphoma with BCR-ABL1 Fusion B-Lymphoblastic Leukemia/Lymphoma with BCR::ABL1 Fusion B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34;q11.2); BCR-ABL1 B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the KMT2A gene at 11q23.3 and another gene partner resulting in the production of an KMT2A related fusion protein. C80332 Neoplastic Process B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged C2698309 GDC 9813/3 Malignant B_Lymphoblastic_Leukemi_Lymphoma_with_t_v_11q23_MLL_Rearranged 9813/3 B lymphoblastic leukemia/lymphoma with t(v;11q23); MLL rearranged B Lymphoblastic Leukemia/Lymphoma with KMT2A Rearrangement B Lymphoblastic Leukemia/Lymphoma with T(V;11Q23); MLL Rearranged B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); MLL Rearranged B lymphoblastic leukemia/lymphoma with t(v;11q23); MLL rearranged B-Lymphoblastic Leukemia/Lymphoma with KMT2A Rearrangement B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); MLL Rearranged B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the TEL gene on chromosome 12 and the AML1 gene on chromosome 21, (p13.2;q22.1). It results in the production of the TEL-AML1 (ETV6-RUNX1) fusion protein. It has a favorable clinical outcome. C80334 Neoplastic Process B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 C2698314 Cellosaurus GDC 9814/3 Malignant B_Lymphoblastic_Leukemia_Lymphoma_with_t_12-21_p13_q22_TEL-AML1_ETV6-RUNX1 9814/3 B lymphoblastic leukemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) B Lymphoblastic Leukemia/Lymphoma with ETV6-RUNX1 Fusion B Lymphoblastic Leukemia/Lymphoma with ETV6::RUNX1 Fusion B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6::RUNX1 B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) B lymphoblastic leukemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) B-Lymphoblastic Leukemia/Lymphoma with ETV6-RUNX1 Fusion B-Lymphoblastic Leukemia/Lymphoma with ETV6::RUNX1 Fusion B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 A precursor lymphoid neoplasm composed of B-lymphoblasts which contain more than 50 and usually less than 66 chromosomes. It has a favorable clinical outcome. C80335 Neoplastic Process Hyperdiploid B Lymphoblastic Leukemia/Lymphoma C2698311 GDC 9815/3 Malignant B_Lymphoblastic_Leukemia_Lymphoma_with_Hyperdiploidy 9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy B Lymphoblastic Leukemia/Lymphoma with High Hyperdiploidy B Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy B lymphoblastic leukemia/lymphoma with hyperdiploidy B-Lymphoblastic Leukemia/Lymphoma with High Hyperdiploidy B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy High Hyperdiploidy Hyperdiploid B Lymphoblastic Leukemia/Lymphoma Hyperdiploid B Lymphoblastic Leukemia/Lymphoma A precursor lymphoid neoplasm composed of B-lymphoblasts which contain less than 46 chromosomes. It has an unfavorable clinical outcome. C80338 Neoplastic Process Hypodiploid B Lymphoblastic Leukemia/Lymphoma C2698312 GDC 9816/3 Malignant B_Lymphoblastic_Leukemia_Lymphoma_with_Hypodiploidy 9816/3 B lymphoblastic leukemia/lymphoma with hypodiploidy (Hypodiploid ALL) B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy Hypodiploid B Lymphoblastic Leukemia/Lymphoma Hypodiploid B Lymphoblastic Leukemia/Lymphoma Stage II includes: T2, N0, M0. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8034 Neoplastic Process Stage II Lip and Oral Cavity Cancer AJCC v6 and v7 Stage II Lip and Oral Cavity Cancer AJCC v6 and v7 C0854758 CTRP The tumor is larger than 2 centimeters but not larger than 4 centimeters, and cancer has not spread to lymph nodes. Malignant Stage_II_Lip_and_Oral_Cavity_Cancer Lip and Oral Cavity Cancer Stage II Lip and Oral Cavity Carcinoma Stage II Stage II Lip and Oral Cavity Cancer Stage II Lip and Oral Cavity Cancer AJCC v6 Stage II Lip and Oral Cavity Cancer AJCC v6 and v7 Stage II Lip and Oral Cavity Cancer AJCC v7 Stage II Lip and Oral Cavity Carcinoma stage II lip and oral cavity cancer Stage II Lip and Oral Cavity Cancer AJCC v6 and v7 A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the IL3 gene on chromosome 5 and the IGH locus on chromosome 14, (q31.1;q32.3). It results in eosinophilia. C80340 Neoplastic Process B Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.3); IL3-IGH C2698316 GDC 9817/3 Malignant B_Lymphoblastic_Leukemia_Lymphoma_with_t_5_14_q31_q32_IL3-IGH 9817/3 B lymphoblastic leukemia/lymphoma with t(5;14)(q31;q32); IL3-IGH B Lymphoblastic Leukemia/Lymphoma with IGH-IL3 Fusion B Lymphoblastic Leukemia/Lymphoma with IGH::IL3 Fusion B Lymphoblastic Leukemia/Lymphoma with IL3-IGH Fusion B Lymphoblastic Leukemia/Lymphoma with IL3::IGH Fusion B Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.3); IL3-IGH B Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.3); IL3::IGH B Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31;q32); IL3-IGH B lymphoblastic leukemia/lymphoma with t(5;14)(q31;q32); IL3-IGH B-Lymphoblastic Leukemia/Lymphoma with IGH-IL3 Fusion B-Lymphoblastic Leukemia/Lymphoma with IGH::IL3 Fusion B-Lymphoblastic Leukemia/Lymphoma with IL3-IGH Fusion B-Lymphoblastic Leukemia/Lymphoma with IL3::IGH Fusion B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31;q32); IL3-IGH B Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.3); IL3-IGH A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the E2A gene on chromosome 19 and the PBX1 gene on chromosome 1. C80341 Neoplastic Process B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1 C2698315 GDC 9818/3 Malignant B_Lymphoblastic_Leukemia_Lymphoma_with_t_1_19_q23_p13_3_E2A-PBX1_TCF3-PBX1 9818/3 B lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) B Lymphoblastic Leukemia/Lymphoma with TCF3-PBX1 Fusion B Lymphoblastic Leukemia/Lymphoma with TCF3::PBX1 Fusion B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1 B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3::PBX1 B lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) B-Lymphoblastic Leukemia/Lymphoma with TCF3-PBX1 Fusion B-Lymphoblastic Leukemia/Lymphoma with TCF3::PBX1 Fusion B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1 A B-cell acute leukemia characterized by the presence of lymphoblasts that carry a translocation between the KMT2A gene at 11q23.3 and another gene partner resulting in the production of an KMT2A related fusion protein. It is the most commonly seen leukemia in the pediatric population under the age of one year. The prognosis is unfavorable. C80342 Neoplastic Process B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged C2698308 Cellosaurus Malignant B_Acute_Lymphoblastic_Leukemia_with_t_v_11q23_MLL_Rearranged B Acute Lymphoblastic Leukemia with KMT2A Rearrangement B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged B Acute Lymphoblastic Leukemia with t(v;11q23.3); MLL Rearranged B-ALL with t(v;11q23.3)/KMT2A Rearranged B-ALL with t(v;11q23.3); KMT2A Rearranged B-Acute Lymphoblastic Leukemia with KMT2A Rearrangement B-Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged B-Acute Lymphoblastic Leukemia with t(v;11q23.3); MLL Rearranged B-Cell Acute Lymphoblastic Leukemia with t(v;11q23.3); MLL Rearranged B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged A B-cell acute leukemia characterized by the presence of lymphoblasts that carry a translocation between the TEL gene on chromosome 12 and the AML1 gene on chromosome 21, (p13.2;q22.1). It results in the production of the TEL-AML1 (ETV6-RUNX1) fusion protein. It is commonly seen in children and rarely in adults. It has a favorable clinical outcome. C80343 Neoplastic Process B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1 C2698305 Malignant B_Acute_Lymphoblastic_Leukemia_with_t_12_21_p13_q22_TEL-AML1_ETV6-RUNX1 B Acute Lymphoblastic Leukemia with ETV6-RUNX1 Fusion B Acute Lymphoblastic Leukemia with ETV6::RUNX1 Fusion B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1 B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6::RUNX1 B Acute Lymphoblastic Leukemia with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) B-ALL with t(12;21)(p13.2;q22.1)/ETV6-RUNX1 B-ALL with t(12;21)(p13.2;q22.1); ETV6-RUNX1 B-Acute Lymphoblastic Leukemia with ETV6-RUNX1 Fusion B-Acute Lymphoblastic Leukemia with ETV6::RUNX1 Fusion B-Acute Lymphoblastic Leukemia with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) B-Cell Acute Lymphoblastic Leukemia with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1 A B-cell acute leukemia characterized by the presence of lymphoblasts which contain more than 50 and usually less than 66 chromosomes. It is commonly seen in children and rarely in adults. It has a favorable clinical outcome. C80344 Neoplastic Process Hyperdiploid B Acute Lymphoblastic Leukemia C2697636 GDC Malignant Hyperdiploid_B_Acute_Lymphoblastic_Leukemia 9816/3 B Acute Lymphoblastic Leukemia with High Hyperdiploidy B-Acute Lymphoblastic Leukemia with High Hyperdiploidy Hyperdiploid ALL Hyperdiploid Acute Lymphoblastic Leukemia Hyperdiploid B Acute Lymphoblastic Leukemia Hyperdiploid B-Acute Lymphoblastic Leukemia Hyperdiploid B-Cell Acute Lymphoblastic Leukemia Hyperdiploid B Acute Lymphoblastic Leukemia A B-cell acute leukemia characterized by the presence of lymphoblasts which contain less than 46 chromosomes. It occurs in both children and adults. It has an unfavorable clinical outcome. C80345 Neoplastic Process Hypodiploid B Acute Lymphoblastic Leukemia C2697638 Malignant Hypodiploid_B_Acute_Lymphoblastic_Leukemia B Acute Lymphoblastic Leukemia with Hypodiploidy B-Acute Lymphoblastic Leukemia with Hypodiploidy Hypodiploid ALL Hypodiploid Acute Lymphoblastic Leukemia Hypodiploid B Acute Lymphoblastic Leukemia Hypodiploid B-Acute Lymphoblastic Leukemia Hypodiploid B-Cell Acute Lymphoblastic Leukemia Hypodiploid B Acute Lymphoblastic Leukemia A rare B-cell acute leukemia characterized by the presence of lymphoblasts that carry a translocation between the IL3 gene on chromosome 5 and the IGH locus on chromosome 14, (q31.1;q32.3). It results in eosinophilia. C80346 Neoplastic Process B Acute Lymphoblastic Leukemia with t(5;14)(q31.1;q32.3); IL3-IGH C2698307 Malignant B_Acute_Lymphoblastic_Leukemia_with_t_5_14_q31_q32_IL3-IGH B Acute Lymphoblastic Leukemia with IGH-IL3 Fusion B Acute Lymphoblastic Leukemia with IGH::IL3 Fusion B Acute Lymphoblastic Leukemia with IL3-IGH Fusion B Acute Lymphoblastic Leukemia with IL3::IGH Fusion B Acute Lymphoblastic Leukemia with t(5;14)(q31.1;q32.3); IL3-IGH B Acute Lymphoblastic Leukemia with t(5;14)(q31.1;q32.3); IL3::IGH B Acute Lymphoblastic Leukemia with t(5;14)(q31;q32); IL3-IGH B-ALL with t(5;14)(q31.1;q32.3); IL3-IGH B-ALL with t(5;14)(q31.1;q32.3); IL3::IGH B-Acute Lymphoblastic Leukemia with IGH-IL3 Fusion B-Acute Lymphoblastic Leukemia with IGH::IL3 Fusion B-Acute Lymphoblastic Leukemia with IL3-IGH Fusion B-Acute Lymphoblastic Leukemia with IL3::IGH Fusion B-Acute Lymphoblastic Leukemia with t(5;14)(q31;q32); IL3-IGH B-Cell Acute Lymphoblastic Leukemia with t(5;14)(q31;q32); IL3-IGH B Acute Lymphoblastic Leukemia with t(5;14)(q31.1;q32.3); IL3-IGH A B-cell acute leukemia characterized by the presence of lymphoblasts that carry a translocation between the E2A gene on chromosome 19 and the PBX1 gene on chromosome 1. It occurs in children and less often in adults. C80347 Neoplastic Process B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); TCF3-PBX1 C2698306 Cellosaurus Malignant B_Acute_Lymphoblastic_Leukemia_with_t_1_19_q23_p13_3_E2A-PBX1_TCF3-PBX1 B Acute Lymphoblastic Leukemia with TCF3-PBX1 Fusion B Acute Lymphoblastic Leukemia with TCF3::PBX1 Fusion B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); TCF3-PBX1 B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); TCF3::PBX1 B-ALL with t(1;19)(q23;p13.3); TCF3-PBX1 B-ALL with t(1;19)(q23;p13.3); TCF3::PBX1 B-Acute Lymphoblastic Leukemia with TCF3-PBX1 Fusion B-Acute Lymphoblastic Leukemia with TCF3::PBX1 Fusion B-Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) B-Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); TCF3-PBX1 B-Cell Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); TCF3-PBX1 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor more than 4 cm in greatest dimension. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8035 Neoplastic Process Stage III Lip and Oral Cavity Cancer AJCC v6 and v7 Stage III Lip and Oral Cavity Cancer AJCC v6 and v7 C0854759 CTRP The tumor may be any size and has spread to one lymph node that is 3 centimeters or smaller, on the same side of the neck as the tumor; or the tumor is larger than 4 centimeters. Malignant Stage_III_Lip_and_Oral_Cavity_Cancer Lip and Oral Cavity Cancer Stage III Lip and Oral Cavity Carcinoma Stage III Stage III Lip and Oral Cavity Cancer Stage III Lip and Oral Cavity Cancer AJCC v6 Stage III Lip and Oral Cavity Cancer AJCC v6 and v7 Stage III Lip and Oral Cavity Cancer AJCC v7 Stage III Lip and Oral Cavity Carcinoma stage III lip and oral cavity cancer Stage III Lip and Oral Cavity Cancer AJCC v6 and v7 Stage IV includes: IVA (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB (Any T, N3, M0); (T4b, Any N, M0); IVC (Any T, Any N, M1). T4a (lip): Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin of face, i.e., chin or nose. T4a (oral cavity): Tumor invades adjacent structures (e.g., through cortical bone, into deep [extrinsic] muscles of tongue, maxillary sinus, skin of face). T4b: Tumor invades masticator space, pterygoid plates, or skull base and/or encases internal carotid artery. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension; or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension; or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N2a: Metastasis in a single ipsilateral lymph node more than 3 cm but not more than 6 cm in dimension. N2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension. N2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a lymph node more than 6 cm in greatest dimension. M1: Distant metastasis. (AJCC 6th and 7th eds.) C8036 Neoplastic Process Stage IV Lip and Oral Cavity Cancer AJCC v6 and v7 Stage IV Lip and Oral Cavity Cancer AJCC v6 and v7 C0854760 CTRP Stage IV is divided into stages IVA, IVB, and IVC. In stage IVA, (1) the tumor has spread through tissue in the lip or oral cavity into nearby tissue and/or bone (jaw, tongue, floor of mouth, maxillary sinus, or skin of chin or nose); cancer may have spread to one lymph node that is 3 centimeters or smaller, on the same side of the neck as the tumor; or (2) the tumor is any size or has spread through tissue in the lip or oral cavity into nearby tissue and/or bone (jaw, tongue, floor of mouth, maxillary sinus, or skin of chin or nose). Cancer has spread to one lymph node on the same side of the neck as the tumor and the lymph node is larger than 3 centimeters but not larger than 6 centimeters, or to more than one lymph node on the same side of the neck as the tumor and the lymph nodes are not larger than 6 centimeters, or to lymph nodes on the opposite side of the neck as the tumor or on both sides of the neck, and the lymph nodes are not larger than 6 centimeters. In stage IVB, (1) the tumor may be any size and has spread to one or more lymph nodes that are larger than 6 centimeters; or (2) the tumor has spread further into the muscles or bones in the oral cavity, or to the base of the skull and/or the carotid artery. Cancer may have spread to one or more lymph nodes anywhere in the neck. In stage IVC, the tumor has spread beyond the lip or oral cavity to distant parts of the body, such as the lungs. The tumor may be any size and may have spread to lymph nodes. Malignant Stage_IV_Lip_and_Oral_Cavity_Cancer Lip and Oral Cavity Cancer Stage IV Lip and Oral Cavity Carcinoma Stage IV Stage IV Lip and Oral Cavity Cancer Stage IV Lip and Oral Cavity Cancer AJCC v6 and v7 Stage IV Lip and Oral Cavity Cancer v6 Stage IV Lip and Oral Cavity Cancer v7 Stage IV Lip and Oral Cavity Carcinoma stage IV lip and oral cavity cancer Stage IV Lip and Oral Cavity Cancer AJCC v6 and v7 The reemergence of lip and/or oral cavity carcinoma after a period of remission. C8037 Neoplastic Process Recurrent Lip and Oral Cavity Carcinoma Recurrent Lip and Oral Cavity Carcinoma C0854755 CTRP Malignant Recurrent_Lip_and_Oral_Cavity_Cancer Recurrent Lip and Oral Cavity Cancer Recurrent Lip and Oral Cavity Carcinoma Recurrent Lip and Oral Cavity Carcinoma An Epstein-Barr virus-associated mature T-cell/NK-cell lymphoproliferative group of disorders affecting children. It occurs with increased frequency in Asians and Native Americans. It includes the systemic EBV-positive T-cell lymphoma of childhood and the hydroa vacciniforme-like lymphoma. C80373 Neoplastic Process EBV-Positive T-Cell/NK-Cell Lymphoproliferative Disorder of Childhood C2699838 Undetermined EBV-Positive_T-Cell_Lymphoproliferative_Disorder_of_Childhood EBV-Positive T-Cell Lymphoproliferative Disease of Childhood EBV-Positive T-Cell Lymphoproliferative Disorder of Childhood EBV-Positive T-Cell/NK-Cell Lymphoproliferative Disorder of Childhood EBV-Positive T-Cell/NK-Cell Lymphoproliferative Disorder of Childhood An aggressive and life-threatening, EBV-positive T-cell lymphoma affecting children. It is more prevalent in Taiwan and Japan. Clinically, it presents with acute onset of fever and generalized malaise, followed by hepatosplenomegaly and liver failure. Morphologically it is characterized by the presence of infiltrating T-lymphocytes which are usually small and erythrophagocytosis. Most patients have a fulminant clinical course. C80374 Neoplastic Process Systemic EBV-Positive T-Cell Lymphoma of Childhood C2699747 GDC NICHD An aggressive, life-threatening, EBV-positive T-cell lymphoproliferative disorder affecting children. 9724/3 Malignant Systemic_EBV-Positive_T-Cell_Lymphoproliferative_Disease_of_Childhood 9724/3 Systemic EBV positive T-cell lymphoproliferative disease of childhood Systemic EBV-Positive T-Cell Lymphoma of Childhood Systemic EBV-Positive T-Cell Lymphoproliferative Disease of Childhood Systemic EBV-Positive T-Cell Lymphoproliferative Disorder of Childhood Systemic Epstein-Barr Virus-Positive T-Cell Lymphoma of Childhood Systemic EBV-Positive T-Cell Lymphoma of Childhood Follicular helper T-cell lymphoma with a predominantly follicular growth pattern. C80375 Neoplastic Process Follicular Helper T-Cell Lymphoma, Follicular-Type C2700204 Malignant Follicular_Variant_Peripheral_T-Cell_Lymphoma FTCL Follicular Helper T-Cell Lymphoma, Follicular-Type Follicular T-Cell Lymphoma Follicular Variant Peripheral T-Cell Lymphoma Follicular Helper T-Cell Lymphoma, Follicular-Type Stage I includes: T1, N0, M0. T1: Tumor limited to one subsite of the hypopharynx and 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C8038 Neoplastic Process Stage I Hypopharyngeal Carcinoma AJCC v6 Stage I Hypopharyngeal Carcinoma AJCC v6 C0279799 CTRP The tumor is found only in one area of the hypopharynx and is 2 centimeters or smaller. Malignant Stage_I_Hypopharyngeal_Carcinoma Stage I Carcinoma of Hypopharynx AJCC v6 Stage I Carcinoma of the Hypopharynx AJCC v6 Stage I Hypopharyngeal Carcinoma AJCC v6 Stage I Hypopharyngeal Throat Cancer Stage I Hypopharynx Carcinoma AJCC v6 stage I hypopharynx cancer Stage I Hypopharyngeal Carcinoma AJCC v6 Stage II includes: T2, N0, M0. T2: Tumor invades more than one subsite of the hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8039 Neoplastic Process Stage II Hypopharyngeal Carcinoma AJCC v6 and v7 Stage II Hypopharyngeal Carcinoma AJCC v6 and v7 C0279800 CTRP The tumor is either (1) larger than 2 centimeters but not larger than 4 centimeters and has not spread to the larynx (voice box); or (2) found in more than one area of the hypopharynx or in nearby tissues. Malignant Stage_II_Hypopharyngeal_Carcinoma Stage II Carcinoma of Hypopharynx Stage II Carcinoma of the Hypopharynx Stage II Hypopharyngeal Carcinoma Stage II Hypopharyngeal Carcinoma AJCC v6 Stage II Hypopharyngeal Carcinoma AJCC v6 and v7 Stage II Hypopharyngeal Carcinoma AJCC v7 Stage II Hypopharyngeal Throat Cancer Stage II Hypopharynx Carcinoma stage II hypopharyngeal cancer Stage II Hypopharyngeal Carcinoma AJCC v6 and v7 A first-degree relative (parent, sibling, child) documented to have died suddenly of presumed cardiac etiology without other obvious cause. C80397 Group Attribute History of Sudden Cardiac Death C2825161 ACC/AHA Death that occurs unexpectedly, and not within 30 days of an acute MI. History_of_Sudden_Cardiac_Death History of Sudden Cardiac Death Sudden cardiac death History of Sudden Cardiac Death History of a first-degree relative (less than 55 years for male relatives or less than 65 years for female relatives) having had any of the following: coronary artery disease, myocardial infarction, coronary artery bypass graft surgery, percutaneous coronary intervention, or sudden cardiac death without obvious cause. C80398 Group Attribute Family History of Coronary Artery Disease CL406692 ACC/AHA Narrowing of the coronary arteries due to fatty deposits inside the arterial walls. The diagnostic criteria may include documented history of any of the following: documented coronary artery stenosis Greater than or equal to 50% (by cardiac catheterization or other modality of direct imaging of the coronary arteries); previous coronary artery bypass graft (CABG), previous percutaneous coronary intervention (PCI), previous myocardial infarction. Family_History_of_Coronary_Artery_Disease CAD Family History of CAD Family History of Coronary Artery Disease Family History of Coronary Artery Disease Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor more than 4 cm in greatest dimension or with fixation of hemilarynx. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 6th ed.) C8040 Neoplastic Process Stage III Hypopharyngeal Carcinoma AJCC v6 Stage III Hypopharyngeal Carcinoma AJCC v6 C0279801 CTRP In stage III hypopharyngeal cancer the tumor is (1) found only in one area of the hypopharynx and is 2 centimeters or smaller; cancer has also spread to a single lymph node on the same side of the neck and the lymph node is 3 centimeters or smaller; or (2) in more than one area of the hypopharynx, is in nearby tissues, or is larger than 2 centimeters but not larger than 4 centimeters and is not in the larynx; cancer has also spread to a single lymph node on the same side of the neck and the lymph node is 3 centimeters or smaller; or (3) larger than 4 centimeters or has spread to the larynx; cancer may have spread to a single lymph node on the same side of the neck and the lymph node is 3 centimeters or smaller. Malignant Stage_III_Hypopharyngeal_Carcinoma Stage III Carcinoma of Hypopharynx AJCC v6 Stage III Carcinoma of the Hypopharynx AJCC v6 Stage III Hypopharyngeal Carcinoma AJCC v6 Stage III Hypopharyngeal Throat Cancer Stage III Hypopharynx Carcinoma AJCC v6 stage III hypopharynx cancer Stage III Hypopharyngeal Carcinoma AJCC v6 A study using magnetic resonance to observe cardiac activity during the administration of pharmacologic stressors. C80409 Diagnostic Procedure Stress Cardiac Magnetic Resonance Imaging Stress Cardiac Magnetic Resonance Imaging C2825166 CTRP Stress_Cardiac_Magnetic_Resonance_Imaging Stress Cardiac Magnetic Resonance Imaging Stress Cardiac Magnetic Resonance Imaging Stage I includes: T1, N0, M0. T1: (Supraglottis) Tumor limited to one subsite of supraglottis with normal vocal cord mobility. (Glottis) Tumor limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility. (Subglottis) Tumor limited to the subglottis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8041 Neoplastic Process Stage I Laryngeal Cancer AJCC v6 and v7 Stage I Laryngeal Cancer AJCC v6 and v7 C0863182 CTRP Cancer is found only in the area where it started. Stage I laryngeal cancer depends on where cancer is found in the larynx. If it started in the supraglottis, then cancer is in one area of the supraglottis only and the vocal cords can move normally. If it started in the glottis, then cancer is in one or both vocal cords and the vocal cords can move normally. If it started in the subglottis, then cancer is in the subglottis only. Malignant Stage_I_Laryngeal_Cancer Laryngeal Cancer, Stage I Stage I Carcinoma of Larynx Stage I Carcinoma of the Larynx Stage I Laryngeal Cancer Stage I Laryngeal Cancer AJCC v6 Stage I Laryngeal Cancer AJCC v6 and v7 Stage I Laryngeal Cancer AJCC v7 Stage I Laryngeal Carcinoma Stage I Laryngeal Throat Cancer Stage I Larynx Carcinoma stage I laryngeal cancer Stage I Laryngeal Cancer AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: (Supraglottis) Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx. (Glottis) Tumor extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility. (Subglottis) Tumor extends to vocal cord(s) with normal or impaired mobility. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8042 Neoplastic Process Stage II Laryngeal Cancer AJCC v6 and v7 Stage II Laryngeal Cancer AJCC v6 and v7 C0279815 CTRP Stage II depends on where the cancer started. If it started in the supraglottis, then cancer is in more than one area of the supraglottis or surrounding tissue. If it started in the glottis, then cancer has spread to the supraglottis and/or the subglottis, and/or the vocal cords cannot move normally. If it started in the subglottis, then cancer has spread to one or both vocal cords, which may not move normally. Malignant Stage_II_Laryngeal_Cancer Laryngeal Cancer, Stage II Stage II Carcinoma of Larynx Stage II Carcinoma of the Larynx Stage II Laryngeal Cancer Stage II Laryngeal Cancer AJCC v6 Stage II Laryngeal Cancer AJCC v6 and v7 Stage II Laryngeal Cancer AJCC v7 Stage II Laryngeal Carcinoma Stage II Laryngeal Throat Cancer Stage II Larynx Carcinoma stage II laryngeal cancer Stage II Laryngeal Cancer AJCC v6 and v7 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T1: Supraglottis: Tumor limited to one subsite of supraglottis with normal vocal cord mobility. Glottis: Tumor limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility. Subglottis: Tumor limited to the subglottis. T2: Supraglottis: Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx. Glottis: Tumor extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility. Subglottis: Tumor extends to vocal cord(s) with normal or impaired mobility. T3: Supraglottis: Tumor limited to larynx with vocal cord fixation and/or invades any of the following: postcricoid area, pre-epiglottic tissues, paraglottic space, and/or inner cortex of thyroid cartilage. Glottis: Tumor limited to the larynx with vocal cord fixation and/or invasion of paraglottic space, and/or inner cortex of the thyroid cartilage. Subglottis: Tumor limited to larynx with vocal cord fixation. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3cm or less in greatest dimension. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8043 Neoplastic Process Stage III Laryngeal Cancer AJCC v6 and v7 Stage III Laryngeal Cancer AJCC v6 and v7 C0279816 CTRP Stage III laryngeal cancer depends on whether cancer has spread from the supraglottis, glottis, or subglottis. In stage III cancer of the supraglottis, (1) cancer is in the larynx only and the vocal cords cannot move, and/or cancer is in tissues next to the larynx; cancer may have spread to one lymph node on the same side of the neck as the original tumor and the lymph node is 3 centimeters or smaller; or (2) cancer is in one area of the supraglottis and in one lymph node on the same side of the neck as the original tumor; the lymph node is 3 centimeters or smaller and the vocal cords can move normally; or (3) cancer is in more than one area of the supraglottis or surrounding tissues and in one lymph node on the same side of the neck as the original tumor; the lymph node is 3 centimeters or smaller. In stage III cancer of the glottis, (1) cancer is in the larynx only and the vocal cords cannot move, and/or cancer is in tissues next to the larynx; cancer may have spread to one lymph node on the same side of the neck as the original tumor and the lymph node is 3 centimeters or smaller; or (2) cancer is in one or both vocal cords and in one lymph node on the same side of the neck as the original tumor; the lymph node is 3 centimeters or smaller and the vocal cords can move normally; or (3) cancer has spread to the supraglottis and/or the subglottis, and/or the vocal cords cannot move normally; cancer has also spread to one lymph node on the same side of the neck as the original tumor and the lymph node is 3 centimeters or smaller. In stage III cancer of the subglottis, (1) cancer is in the larynx and the vocal cords cannot move; cancer may have spread to one lymph node on the same side of the neck as the original tumor and the lymph node is 3 centimeters or smaller; or (2) cancer is in the subglottis and in one lymph node on the same side of the neck as the original tumor; the lymph node is 3 centimeters or smaller; or (3) cancer has spread to one or both vocal cords, which may not move normally; cancer has also spread to one lymph node on the same side of the neck as the original tumor and the lymph node is 3 centimeters or smaller. Malignant Stage_III_Laryngeal_Cancer Laryngeal Cancer, Stage III Stage III Carcinoma of Larynx Stage III Carcinoma of the Larynx Stage III Laryngeal Cancer Stage III Laryngeal Cancer AJCC v6 Stage III Laryngeal Cancer AJCC v6 and v7 Stage III Laryngeal Cancer AJCC v7 Stage III Laryngeal Carcinoma Stage III Laryngeal Throat Cancer Stage III Larynx Carcinoma stage III laryngeal cancer Stage III Laryngeal Cancer AJCC v6 and v7 A pheochromocytoma that has not spread to other regions. C8045 Neoplastic Process Regional Adrenal Gland Pheochromocytoma Regional Adrenal Gland Pheochromocytoma C1709884 CTRP Undetermined Regional_Pheochromocytoma Regional Adrenal Gland Chromaffin Neoplasm Regional Adrenal Gland Chromaffin Paraganglioma Regional Adrenal Gland Chromaffin Tumor Regional Adrenal Gland Chromaffinoma Regional Adrenal Gland Pheochromocytoma Regional Adrenal Gland Pheochromocytoma The reemergence of pheochromocytoma following surgical removal. C8047 Neoplastic Process Recurrent Adrenal Gland Pheochromocytoma Recurrent Adrenal Gland Pheochromocytoma C1709872 CTRP Undetermined Recurrent_Pheochromocytoma Recurrent Adrenal Gland Chromaffin Neoplasm Recurrent Adrenal Gland Chromaffin Paraganglioma Recurrent Adrenal Gland Chromaffin Tumor Recurrent Adrenal Gland Chromaffinoma Recurrent Adrenal Gland Pheochromocytoma Relapsed Adrenal Gland Chromaffin Neoplasm Relapsed Adrenal Gland Chromaffin Paraganglioma Relapsed Adrenal Gland Chromaffin Tumor Relapsed Adrenal Gland Chromaffinoma Relapsed Adrenal Gland Pheochromocytoma Recurrent Adrenal Gland Pheochromocytoma Stage I includes: T1, N0, M0. T1: Tumor 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8048 Neoplastic Process Stage I Oropharyngeal Carcinoma AJCC v6 and v7 Stage I Oropharyngeal Carcinoma AJCC v6 and v7 C0279834 CTRP Cancer that is 2 centimeters or smaller and has not spread outside the oropharynx. Malignant Stage_I_Oropharyngeal_Carcinoma Oropharyngeal Cancer, Stage I Stage I Carcinoma of Oropharynx Stage I Carcinoma of the Oropharynx Stage I Oropharyngeal Cancer Stage I Oropharyngeal Carcinoma Stage I Oropharyngeal Carcinoma AJCC v6 Stage I Oropharyngeal Carcinoma AJCC v6 and v7 Stage I Oropharyngeal Carcinoma AJCC v7 Stage I Oropharyngeal Throat Cancer Stage I Oropharynx Carcinoma stage I oropharyngeal cancer Stage I Oropharyngeal Carcinoma AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8049 Neoplastic Process Stage II Oropharyngeal Carcinoma AJCC v6 and v7 Stage II Oropharyngeal Carcinoma AJCC v6 and v7 C0279835 CTRP Cancer that is larger than 2 centimeters, but not larger than 4 centimeters, and has not spread outside the oropharynx. Malignant Stage_II_Oropharyngeal_Carcinoma Oropharyngeal Cancer, Stage II Stage II Carcinoma of Oropharynx Stage II Carcinoma of the Oropharynx Stage II Oropharyngeal Cancer Stage II Oropharyngeal Carcinoma Stage II Oropharyngeal Carcinoma AJCC v6 Stage II Oropharyngeal Carcinoma AJCC v6 and v7 Stage II Oropharyngeal Carcinoma AJCC v7 Stage II Oropharyngeal Throat Cancer Stage II Oropharynx Carcinoma stage II oropharyngeal cancer Stage II Oropharyngeal Carcinoma AJCC v6 and v7 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N2, M0). T3: Tumor more than 4 cm in greatest dimension. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6cm in greatest dimension. M0: No distant metastasis. (AJCC 6th ed.) C8050 Neoplastic Process Stage III Oropharyngeal Carcinoma AJCC v6 Stage III Oropharyngeal Carcinoma AJCC v6 C0279836 CTRP Cancer that is either (1) larger than 4 centimeters and has not spread outside the oropharynx; or (2) any size and has spread to only one lymph node on the same side of the neck as the cancer, and the lymph node with cancer is 3 centimeters or smaller. Malignant Stage_III_Oropharyngeal_Carcinoma Oropharyngeal Cancer, Stage III AJCC v6 Stage III Carcinoma of Oropharynx AJCC v6 Stage III Carcinoma of the Oropharynx AJCC v6 Stage III Oropharyngeal Cancer AJCC v6 Stage III Oropharyngeal Carcinoma AJCC v6 Stage III Oropharyngeal Throat Cancer Stage III Oropharynx Carcinoma AJCC v6 stage III oropharynx cancer Stage III Oropharyngeal Carcinoma AJCC v6 The reemergence of oropharyngeal carcinoma after a period of remission. C8051 Neoplastic Process Recurrent Oropharyngeal Carcinoma Recurrent Oropharyngeal Carcinoma C0279838 CTRP Malignant Recurrent_Oropharyngeal_Cancer Oropharyngeal Cancer, Recurrent Recurrent Cancer of Oropharynx Recurrent Cancer of the Oropharynx Recurrent Carcinoma of Oropharynx Recurrent Carcinoma of the Oropharynx Recurrent Oropharyngeal Cancer Recurrent Oropharyngeal Carcinoma Recurrent Oropharyngeal Throat Cancer Recurrent Oropharynx Carcinoma Relapsed Cancer of Oropharynx Relapsed Cancer of the Oropharynx Relapsed Carcinoma of Oropharynx Relapsed Carcinoma of the Oropharynx Relapsed Oropharyngeal Cancer Relapsed Oropharyngeal Carcinoma Relapsed Oropharynx Carcinoma Recurrent Oropharyngeal Carcinoma A malignant neoplasm arising from the ovary. This category includes the poorly differentiated ovarian Sertoli-Leydig cell tumor, malignant ovarian granulosa cell tumor, malignant ovarian steroid cell tumor, and malignant ovarian thecoma. C8053 Neoplastic Process Malignant Ovarian Sex Cord-Stromal Tumor C1334609 Malignant Malignant_Ovarian_Sex_Cord-Stromal_Tumor Malignant Ovarian Sex Cord-Stromal Neoplasm Malignant Ovarian Sex Cord-Stromal Tumor Malignant Sex Cord-Stromal Tumor of Ovary Malignant Sex Cord-Stromal Tumor of the Ovary Malignant Ovarian Sex Cord-Stromal Tumor A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland. The nuclear features which characterize the thyroid gland papillary carcinoma are absent. Radiation exposure is a risk factor and it comprises approximately 10% to 15% of thyroid cancers. Clinically, it usually presents as a solitary mass in the thyroid gland. It is generally unifocal and thickly encapsulated and shows invasion of the capsule or the vessels. Diagnostic procedures include thyroid ultrasound and fine needle biopsy. C8054 Neoplastic Process Thyroid Gland Follicular Carcinoma Thyroid Gland Follicular Carcinoma C0206682 CDISC CTEP CTRP Cellosaurus GDC NICHD A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland. The nuclear features which characterize the thyroid gland papillary carcinoma are absent. A malignant neoplasia arising from follicular cells of the thyroid gland. Cancer that forms in follicular cells in the thyroid. It grows slowly and is highly treatable. 8330/3 8331/3 Malignant Follicular_Thyroid_Carcinoma 8330/3 8331/3 Follicular adenocarcinoma, NOS Follicular adenocarcinoma, well differentiated Follicular carcinoma, NOS Follicular carcinoma, well differentiated CARCINOMA, FOLLICULAR CELL, MALIGNANT FTC Follicular Adenocarcinoma Follicular Cancer of Thyroid Follicular Cancer of Thyroid Gland Follicular Cancer of the Thyroid Follicular Cancer of the Thyroid Gland Follicular Carcinoma Follicular Carcinoma of Thyroid Follicular Carcinoma of Thyroid Gland Follicular Carcinoma of the Thyroid Follicular Carcinoma of the Thyroid Gland Follicular Thyroid Cancer Follicular Thyroid Carcinoma Follicular Thyroid Gland Carcinoma Follicular adenocarcinoma, well differentiated Follicular carcinoma, NOS Follicular carcinoma, well differentiated Follicular thyroid carcinoma Thyroid Follicular Carcinoma Thyroid Gland Follicular Cancer Thyroid Gland Follicular Carcinoma Well-Differentiated Follicular Adenocarcinoma Well-Differentiated Follicular Carcinoma Well-differentiated Follicular Adenocarcinoma Well-differentiated Follicular Carcinoma follicular thyroid cancer Thyroid Gland Follicular Carcinoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8055 Neoplastic Process Ann Arbor Stage II Childhood Hodgkin Lymphoma Ann Arbor Stage II Childhood Hodgkin Lymphoma C0279914 CTRP Stage II is divided into stages II and IIE. In stage II, cancer is found in two or more lymph node groups above or below the diaphragm (the thin muscle below the lungs that helps breathing and separates the chest from the abdomen). In stage IIE, cancer is found in one or more lymph node groups above or below the diaphragm and outside the lymph nodes in a nearby organ or area. Malignant Stage_II_Pediatric_Hodgkin_s_Lymphoma Ann Arbor Stage II Childhood Hodgkin Lymphoma Childhood Hodgkin's Disease Stage II Childhood Hodgkin's Lymphoma Stage II Pediatric Hodgkin's Disease Stage II Pediatric Hodgkin's Lymphoma Stage II Stage II Childhood Hodgkin Lymphoma Stage II Childhood Hodgkin's Lymphoma Stage II Hodgkin Lymphoma Stage II Pediatric Hodgkin's Lymphoma stage II childhood Hodgkin lymphoma Ann Arbor Stage II Childhood Hodgkin Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE) (rare in Hodgkin lymphoma). C8056 Neoplastic Process Ann Arbor Stage I Childhood Hodgkin Lymphoma Ann Arbor Stage I Childhood Hodgkin Lymphoma C0279915 CTRP Stage I is divided into stages I and IE. In stage I, cancer is found in one or more lymph nodes in one lymph node group. In stage IE, cancer is found outside the lymph nodes in one organ or area. Malignant Stage_I_Pediatric_Hodgkin_s_Lymphoma Ann Arbor Stage I Childhood Hodgkin Lymphoma Childhood Hodgkin's Disease Stage I Childhood Hodgkin's Lymphoma Stage I Pediatric Hodgkin's Disease Stage I Pediatric Hodgkin's Lymphoma Stage I Stage I Childhood Hodgkin Lymphoma Stage I Childhood Hodgkin's Disease Stage I Childhood Hodgkin's Lymphoma Stage I Hodgkin Lymphoma Stage I Pediatric Hodgkin's Disease Stage I Pediatric Hodgkin's Lymphoma stage I childhood Hodgkin lymphoma Ann Arbor Stage I Childhood Hodgkin Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8057 Neoplastic Process Ann Arbor Stage III Childhood Hodgkin Lymphoma Ann Arbor Stage III Childhood Hodgkin Lymphoma C0279916 CTRP Stage III is divided into stages III, IIIE, IIIS, and IIIE+S. In stage III, cancer is found in one or more lymph node groups above and below the diaphragm (the thin muscle below the lungs that helps breathing and separates the chest from the abdomen). In stage IIIE, cancer is found in lymph node groups above and below the diaphragm and outside the lymph nodes in a nearby organ or area. In stage IIIS, cancer is found in lymph node groups above and below the diaphragm and in the spleen. In stage IIIE+S, cancer is found in lymph node groups above and below the diaphragm, in a nearby area or organ, and in the spleen. Malignant Stage_III_Pediatric_Hodgkin_s_Lymphoma Ann Arbor Stage III Childhood Hodgkin Lymphoma Childhood Hodgkin's Disease Stage III Childhood Hodgkin's Lymphoma Stage III Pediatric Hodgkin's Disease Stage III Pediatric Hodgkin's Lymphoma Stage III Stage III Childhood Hodgkin Lymphoma Stage III Childhood Hodgkin's Lymphoma Stage III Hodgkin Lymphoma Stage III Pediatric Hodgkin's Lymphoma stage III childhood Hodgkin lymphoma Ann Arbor Stage III Childhood Hodgkin Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8058 Neoplastic Process Ann Arbor Stage IV Childhood Hodgkin Lymphoma Ann Arbor Stage IV Childhood Hodgkin Lymphoma C0279917 CTRP Cancer is found (1) outside the lymph nodes throughout one or more organs and may be in the lymph nodes near those organs; or (2) outside the lymph nodes in one organ and has spread to lymph nodes far away from the organ; or (3) in the lung, liver, or bone marrow. Malignant Stage_IV_Pediatric_Hodgkin_s_Lymphoma Ann Arbor Stage IV Childhood Hodgkin Lymphoma Childhood Hodgkin's Disease Stage IV Childhood Hodgkin's Lymphoma Stage IV Pediatric Hodgkin's Disease Stage IV Pediatric Hodgkin's Lymphoma Stage IV Stage IV Childhood Hodgkin Lymphoma Stage IV Childhood Hodgkin's Lymphoma Stage IV Hodgkin Lymphoma Stage IV Pediatric Hodgkin Lymphoma Stage IV Pediatric Hodgkin's Lymphoma stage IV childhood Hodgkin lymphoma Ann Arbor Stage IV Childhood Hodgkin Lymphoma The reemergence of Hodgkin lymphoma after a period of remission during childhood. C8059 Neoplastic Process Recurrent Childhood Hodgkin Lymphoma Recurrent Childhood Hodgkin Lymphoma C0279918 CTRP Malignant Recurrent_Childhood_Hodgkin_s_Lymphoma Recurrent Childhood Hodgkin Lymphoma Recurrent Childhood Hodgkin's Disease Recurrent Childhood Hodgkin's Lymphoma Recurrent Hodgkin Lymphoma Recurrent Pediatric Hodgkin's Disease Recurrent Pediatric Hodgkin's Lymphoma Relapsed Childhood Hodgkin's Disease Relapsed Childhood Hodgkin's Lymphoma Relapsed Pediatric Hodgkin's Disease Relapsed Pediatric Hodgkin's Lymphoma Recurrent Childhood Hodgkin Lymphoma A nodular lymphocyte predominant B-cell lymphoma occurring in children. C8060 Neoplastic Process Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma C1332985 CTRP NICHD A nodular lymphocyte-predominant, non-classical Hodgkin lymphoma that occurs during childhood. Malignant Childhood_Nodular_Lymphocyte_Predominant_Hodgkin_s_Lymphoma Childhood NLPBL Childhood NLPHD Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma Childhood Nodular Lymphocyte Predominant Hodgkin's Disease Childhood Nodular Lymphocyte Predominant Hodgkin's Lymphoma Nodular Lymphocyte Predominant Hodgkin Lymphoma Pediatric NLPHD Pediatric Nodular Lymphocyte Predominant Hodgkin's Disease Pediatric Nodular Lymphocyte Predominant Hodgkin's Lymphoma Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma Lymphocyte-depleted classic Hodgkin lymphoma occurring in childhood. C8061 Neoplastic Process Childhood Lymphocyte-Depleted Classic Hodgkin Lymphoma Childhood Lymphocyte-Depleted Classic Hodgkin Lymphoma C0279920 CTRP NICHD A lymphocyte-depleted, classical Hodgkin lymphoma that occurs during childhood. Malignant Childhood_Lymphocyte_Depleted_Hodgkin_s_Lymphoma Childhood LDHD Childhood Lymphocyte Depleted Classical Hodgkin Lymphoma Childhood Lymphocyte Depleted Hodgkin Lymphoma Childhood Lymphocyte Depleted Hodgkin's Lymphoma Childhood Lymphocyte Depletion Hodgkin's Disease Childhood Lymphocyte Depletion Hodgkin's Lymphoma Childhood Lymphocyte-Depleted Classic Hodgkin Lymphoma Childhood Lymphocyte-Depleted Classical Hodgkin Lymphoma Lymphocyte Depleted Classical Hodgkin Lymphoma Pediatric LDHD Pediatric Lymphocyte Depleted Hodgkin's Lymphoma Pediatric Lymphocyte Depletion Hodgkin's Lymphoma Childhood Lymphocyte-Depleted Classic Hodgkin Lymphoma Nodular sclerosis classic Hodgkin lymphoma occurring in childhood. C8062 Neoplastic Process Childhood Nodular Sclerosis Classic Hodgkin Lymphoma Childhood Nodular Sclerosis Classic Hodgkin Lymphoma C0279921 CTRP NICHD A nodular sclerosis, classical Hodgkin lymphoma that occurs during childhood. Malignant Childhood_Nodular_Sclerosis_Hodgkin_s_Lymphoma Childhood Hodgkin's Nodular Sclerosis Childhood NSHD Childhood Nodular Sclerosis Classic Hodgkin Lymphoma Childhood Nodular Sclerosis Classical Hodgkin Lymphoma Childhood Nodular Sclerosis Hodgkin Lymphoma Childhood Nodular Sclerosis Hodgkin's Lymphoma Nodular Sclerosis Classical Hodgkin Lymphoma Pediatric Hodgkin's Nodular Sclerosis Pediatric NSHD Pediatric Nodular Sclerosis Hodgkin's Disease Pediatric Nodular Sclerosis Hodgkin's Lymphoma Childhood Nodular Sclerosis Classic Hodgkin Lymphoma Mixed cellularity classic Hodgkin lymphoma occurring in childhood. C8063 Neoplastic Process Childhood Mixed Cellularity Classic Hodgkin Lymphoma Childhood Mixed Cellularity Classic Hodgkin Lymphoma C0279922 CTRP NICHD A mixed cellularity, classical Hodgkin lymphoma that occurs during childhood. Malignant Childhood_Mixed_Cellularity_Hodgkin_s_Lymphoma Childhood MCHD Childhood Mixed Cellularity Classic Hodgkin Lymphoma Childhood Mixed Cellularity Classical Hodgkin Lymphoma Childhood Mixed Cellularity Hodgkin Lymphoma Childhood Mixed Cellularity Hodgkin's Disease Childhood Mixed Cellularity Hodgkin's Lymphoma Mixed Cellularity Classical Hodgkin Lymphoma Pediatric MCHD Pediatric Mixed Cellularity Hodgkin's Disease Pediatric Mixed Cellularity Hodgkin's Lymphoma Childhood Mixed Cellularity Classic Hodgkin Lymphoma A urothelial carcinoma of the renal pelvis and ureter that has spread from its original site of growth to another anatomic site. C8064 Neoplastic Process Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter Metastatic Renal Pelvis and Ureter Urothelial Carcinoma C0279937 CTRP Malignant Metastatic_Transitional_Cell_Carcinoma_of_the_Renal_Pelvis_and_Ureter Metastatic Renal Pelvis and Ureter Urothelial Carcinoma Metastatic Transitional Cell Cancer of Renal Pelvis and Ureter Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter Metastatic Transitional Cell Carcinoma of Renal Pelvis and Ureter Metastatic Upper Urinary Tract Urothelial Carcinoma Metastatic Urothelial Cancer of the Renal Pelvis and Ureter Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter Metastatic Renal Pelvis and Ureter Urothelial Carcinoma Rhabdomyosarcoma that occurs during childhood and is confined to a specific site without evidence of spread to other anatomic sites. C8065 Neoplastic Process Localized Childhood Rhabdomyosarcoma C0279941 Malignant Primary_Childhood_Soft_Tissue_Sarcoma Localized Childhood Rhabdomyosarcoma Non-Metastatic Childhood Rhabdomyosarcoma Localized Childhood Rhabdomyosarcoma A sarcoma that arises from the soft tissues during childhood and has spread from the original site of growth to another anatomic site. C8066 Neoplastic Process Metastatic Childhood Soft Tissue Sarcoma Metastatic Childhood Soft Tissue Sarcoma C0279942 CTRP NICHD A sarcoma that arises from the soft tissues during childhood, and has spread from the original site of growth to another anatomic site. Malignant Metastatic_Childhood_Soft_Tissue_Sarcoma Metastatic Childhood Sarcoma of Soft Tissue Metastatic Childhood Sarcoma of the Soft Tissue Metastatic Childhood Soft Tissue Sarcoma Metastatic Pediatric Sarcoma of Soft Tissue Metastatic Pediatric Sarcoma of the Soft Tissue Metastatic Pediatric Soft Tissue Sarcoma Metastatic Soft Tissue Sarcoma Metastatic Childhood Soft Tissue Sarcoma The reemergence of soft tissue sarcoma in childhood after a period of remission. C8067 Neoplastic Process Recurrent Childhood Soft Tissue Sarcoma Recurrent Childhood Soft Tissue Sarcoma C0279943 CTRP Malignant Recurrent_Childhood_Soft_Tissue_Sarcoma Recurrent Childhood Sarcoma of Soft Tissue Recurrent Childhood Sarcoma of the Soft Tissue Recurrent Childhood Soft Tissue Sarcoma Recurrent Pediatric Sarcoma of Soft Tissue Recurrent Pediatric Sarcoma of the Soft Tissue Recurrent Pediatric Soft Tissue Sarcoma Recurrent Soft Tissue Sarcoma Relapsed Childhood Sarcoma of Soft Tissue Relapsed Childhood Sarcoma of the Soft Tissue Relapsed Childhood Soft Tissue Sarcoma Relapsed Pediatric Sarcoma of Soft Tissue Relapsed Pediatric Sarcoma of the Soft Tissue Relapsed Pediatric Soft Tissue Sarcoma Recurrent Childhood Soft Tissue Sarcoma A leukemia arising as a result of the mutagenic effect of chemotherapy agents that are used for the treatment of a malignant tumor or exposure to ionizing radiation. C80683 Neoplastic Process Therapy-Related Leukemia C2825306 CPTAC MedDRA NICHD Leukemia arising as a result of the mutagenic effect of prior therapy. Malignant Therapy-Related_Leukemia Treatment related leukemia Therapy Related Leukemia Therapy-Related Leukemia Treatment Induced Leukemia Treatment Related Leukemia Therapy-Related Leukemia A leukemia arising as a result of the mutagenic effect of chemotherapy agents that are used for the treatment of a malignant tumor. C80691 Neoplastic Process Chemotherapy-Related Leukemia C0863127 A disorder characterized by leukemia arising as a result of the mutagenic effect of chemotherapy agents. Malignant Chemotherapy-Related_Leukemia Chemotherapy-Related Leukemia Leukemia secondary to oncology chemotherapy Chemotherapy-Related Leukemia Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8070 Neoplastic Process Ann Arbor Stage I Small Lymphocytic Lymphoma Ann Arbor Stage I Small Lymphocytic Lymphoma C0855098 CTRP Malignant Stage_I_Small_Lymphocytic_Lymphoma Ann Arbor Stage I Small Lymphocytic Lymphoma B-Cell Small Lymphocytic Lymphoma Stage I Small Lymphocytic Lymphoma Stage I Stage I B-Cell Small Lymphocytic Lymphoma Stage I Small Lymphocytic Lymphoma Ann Arbor Stage I Small Lymphocytic Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8071 Neoplastic Process Ann Arbor Stage I Grade 1 Follicular Lymphoma Ann Arbor Stage I Grade 1 Follicular Lymphoma C0279954 CTRP PCDC Malignant Stage_I_Grade_1_Follicular_Lymphoma Ann Arbor Stage I Grade 1 Follicular Lymphoma Follicular Small Cleaved Cell Lymphoma Stage I Grade I Follicular Lymphoma Stage I Grade I Follicular Small Cleaved Cell Lymphoma Stage I Stage I Stage I Follicular Small Cleaved Cell Lymphoma Stage I Grade 1 Follicular Lymphoma Stage I Grade I Follicular Lymphoma Stage I Grade I Follicular Small Cleaved Cell Lymphoma Ann Arbor Stage I Grade 1 Follicular Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8072 Neoplastic Process Ann Arbor Stage I Grade 2 Follicular Lymphoma Ann Arbor Stage I Grade 2 Follicular Lymphoma C0279955 CTRP Malignant Stage_I_Grade_2_Follicular_Lymphoma Ann Arbor Stage I Grade 2 Follicular Lymphoma Follicular Mixed Cell Lymphoma Stage I Grade II Follicular Lymphoma Stage I Grade II Follicular Mixed Cell Lymphoma Stage I Stage I Follicular Mixed Cell Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade II Follicular Lymphoma Stage I Grade II Follicular Mixed Cell Lymphoma Ann Arbor Stage I Grade 2 Follicular Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8073 Neoplastic Process Ann Arbor Stage I Grade 3 Follicular Lymphoma Ann Arbor Stage I Grade 3 Follicular Lymphoma C0279956 CTRP Malignant Stage_I_Grade_3_Follicular_Lymphoma Ann Arbor Stage I Grade 3 Follicular Lymphoma Follicular Large Cell Lymphoma Stage I Follicular Lymphoma Grade III Stage I Grade III Follicular Lymphoma Stage I Stage I Follicular Large Cell Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Grade III Follicular Large Cell Lymphoma Stage I Grade III Follicular Lymphoma Ann Arbor Stage I Grade 3 Follicular Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8078 Neoplastic Process Ann Arbor Stage I Adult Immunoblastic Lymphoma Ann Arbor Stage I Adult Immunoblastic Lymphoma C0279961 CTRP Malignant Stage_I_Adult_Immunoblastic_Lymphoma Adult Immunoblastic Large Cell Lymphoma Stage I Ann Arbor Stage I Adult Immunoblastic Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Adult Immunoblastic Lymphoma Stage I Immunoblastic Lymphoma Ann Arbor Stage I Adult Immunoblastic Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8079 Neoplastic Process Ann Arbor Stage I Adult Lymphoblastic Lymphoma Ann Arbor Stage I Adult Lymphoblastic Lymphoma C0279962 CTRP Malignant Stage_I_Adult_Lymphoblastic_Lymphoma Adult Lymphoblastic Lymphoma Stage I Adult Stage I Lymphoblastic Lymphoma Ann Arbor Stage I Adult Lymphoblastic Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Adult Precursor Lymphoblastic Lymphoma Stage I Lymphoblastic Lymphoma Ann Arbor Stage I Adult Lymphoblastic Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8080 Neoplastic Process Ann Arbor Stage I Adult Burkitt Lymphoma Ann Arbor Stage I Adult Burkitt Lymphoma C0279963 CTRP Malignant Stage_I_Adult_Burkitt_s_Lymphoma Adult Diffuse Small Non-Cleaved Cell Lymphoma Stage I Adult Diffuse Small Non-Cleaved Cell/Burkitt's Lymphoma Stage I Ann Arbor Stage I Adult Burkitt Lymphoma Stage I Adult Burkitt Lymphoma Stage I Adult Burkitt's Lymphoma Stage I Adult Diffuse Small Non-Cleaved Cell Lymphoma Stage I Adult Diffuse Small Non-Cleaved Cell/Burkitt's Lymphoma Stage I Burkitt Lymphoma Ann Arbor Stage I Adult Burkitt Lymphoma Stage I includes: (T1, N0, M0). T1: Tumor limited to ovaries (one or both). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C8083 Neoplastic Process Stage I Ovarian Germ Cell Tumor Stage I Ovarian Germ Cell Tumor AJCC v6 and v7 C0854936 CTRP The tumor is found in one or both ovaries. Stage I ovarian germ cell tumor is divided into stages IA, IB, and IC. In stage IA, cancer is found in a single ovary. In stage IB, cancer is found in both ovaries. In stage IC, cancer is found in one or both ovaries and one of the following is true: cancer is found on the outside surface of one or both ovaries; or the capsule (outer covering) of the tumor has ruptured (broken open); or cancer cells are found in the fluid of the peritoneal cavity (the body cavity that contains most of the organs in the abdomen). Malignant Stage_I_Ovarian_Germ_Cell_Tumor Stage I Malignant Germ Cell Neoplasm of Ovary Stage I Malignant Germ Cell Neoplasm of the Ovary Stage I Malignant Germ Cell Tumor of Ovary Stage I Malignant Germ Cell Tumor of the Ovary Stage I Malignant Ovarian Germ Cell Neoplasm Stage I Ovarian Germ Cell Tumor Stage I Ovarian Germ Cell Tumor AJCC v6 Stage I Ovarian Germ Cell Tumor AJCC v6 and v7 Stage I Ovarian Germ Cell Tumor AJCC v7 stage I ovarian germ cell tumor Stage I Ovarian Germ Cell Tumor AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: Tumor involves one or both ovaries with pelvic extension and/or implants. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8084 Neoplastic Process Stage II Ovarian Germ Cell Tumor Stage II Ovarian Germ Cell Tumor AJCC v6 and v7 C0854937 CTRP The tumor is found in one or both ovaries and has spread into other areas of the pelvis. Stage II ovarian germ cell tumor is divided into stages IIA, IIB, and IIC. In stage IIA, cancer has spread to the uterus and/or the fallopian tubes (the long slender tubes through which eggs pass from the ovaries to the uterus). In stage IIB, cancer has spread to other tissue within the pelvis. In stage IIC, cancer has spread to the uterus and/or fallopian tubes and/or other tissue within the pelvis and cancer cells are found in the fluid of the peritoneal cavity (the body cavity that contains most of the organs in the abdomen). Malignant Stage_II_Ovarian_Germ_Cell_Tumor Stage II Malignant Germ Cell Neoplasm of Ovary Stage II Malignant Germ Cell Neoplasm of the Ovary Stage II Malignant Germ Cell Tumor of Ovary Stage II Malignant Germ Cell Tumor of the Ovary Stage II Malignant Ovarian Germ Cell Neoplasm Stage II Malignant Ovarian Germ Cell Tumor Stage II Ovarian Germ Cell Tumor Stage II Ovarian Germ Cell Tumor AJCC v6 Stage II Ovarian Germ Cell Tumor AJCC v6 and v7 Stage II Ovarian Germ Cell Tumor AJCC v7 stage II ovarian germ cell tumor Stage II Ovarian Germ Cell Tumor AJCC v6 and v7 Stage III includes: T3, N0, M0. T3: Tumor involves one or both both ovaries with microscopically confirmed peritoneal metastasis outside pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8085 Neoplastic Process Stage III Ovarian Germ Cell Tumor Stage III Ovarian Germ Cell Tumor AJCC v6 and v7 C0854940 CTRP The tumor is found in one or both ovaries and has spread to other parts of the abdomen. Stage III ovarian germ cell tumor is divided into stages IIIA, IIIB, and IIIC. In stage IIIA, the tumor is found in the pelvis only, but cancer cells have spread to the surface of the peritoneum (the tissue that lines the abdominal wall and covers most of the organs in the abdomen). In stage IIIB, cancer has spread to the peritoneum but is 2 centimeters or smaller in diameter. In stage IIIC, cancer has spread to the peritoneum and is larger than 2 centimeters in diameter and/or has spread to lymph nodes in the abdomen. Cancer that has spread to the surface of the liver is considered stage III disease. Malignant Stage_III_Ovarian_Germ_Cell_Tumor Stage III Malignant Germ Cell Neoplasm of Ovary Stage III Malignant Germ Cell Neoplasm of the Ovary Stage III Malignant Germ Cell Tumor of Ovary Stage III Malignant Germ Cell Tumor of the Ovary Stage III Malignant Ovarian Germ Cell Neoplasm Stage III Malignant Ovarian Germ Cell Tumor Stage III Ovarian Germ Cell Tumor Stage III Ovarian Germ Cell Tumor AJCC v6 Stage III Ovarian Germ Cell Tumor AJCC v6 and v7 Stage III Ovarian Germ Cell Tumor AJCC v7 stage III ovarian germ cell tumor Stage III Ovarian Germ Cell Tumor AJCC v6 and v7 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis (excludes peritoneal metastasis). (AJCC 6th and 7th eds.) C8086 Neoplastic Process Stage IV Ovarian Germ Cell Tumor Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7 C0279974 CTRP Cancer is found in one or both ovaries and has metastasized (spread) beyond the abdomen to other parts of the body. Cancer that has spread to tissues in the liver is considered stage IV disease. Malignant Stage_IV_Ovarian_Germ_Cell_Tumor Stage IV Malignant Germ Cell Neoplasm of Ovary Stage IV Malignant Germ Cell Neoplasm of the Ovary Stage IV Malignant Germ Cell Tumor of Ovary Stage IV Malignant Germ Cell Tumor of the Ovary Stage IV Malignant Ovarian Germ Cell Neoplasm Stage IV Malignant Ovarian Germ Cell Tumor Stage IV Ovarian Germ Cell Tumor Stage IV Ovarian Germ Cell Tumor AJCC v6 Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7 Stage IV Ovarian Germ Cell Tumor AJCC v7 stage IV ovarian germ cell tumor Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7 The reemergence of ovarian germ cell tumor after a period of remission. C8087 Neoplastic Process Recurrent Ovarian Germ Cell Tumor Recurrent Ovarian Germ Cell Tumor C0279975 CTRP Malignant Recurrent_Ovarian_Germ_Cell_Tumor Recurrent Germ Cell Neoplasm of Ovary Recurrent Germ Cell Neoplasm of the Ovary Recurrent Germ Cell Tumor of Ovary Recurrent Germ Cell Tumor of the Ovary Recurrent Ovarian Germ Cell Neoplasm Recurrent Ovarian Germ Cell Tumor Relapsed Germ Cell Neoplasm of Ovary Relapsed Germ Cell Neoplasm of the Ovary Relapsed Germ Cell Tumor of Ovary Relapsed Germ Cell Tumor of the Ovary Relapsed Ovarian Germ Cell Neoplasm Relapsed Ovarian Germ Cell Tumor Recurrent Ovarian Germ Cell Tumor A malignant neoplasm arising from the deep soft tissues in children. It is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation in a herringbone growth pattern. C8088 Neoplastic Process Childhood Fibrosarcoma Childhood Fibrosarcoma C0279981 CTRP NICHD A fibrosarcoma occurring during childhood. Malignant Childhood_Fibrosarcoma Childhood Fibrosarcoma Fibrosarcoma Pediatric Fibrosarcoma Childhood Fibrosarcoma A synovial sarcoma occurring in childhood. C8089 Neoplastic Process Childhood Synovial Sarcoma Childhood Synovial Sarcoma C0279982 CTRP NICHD A synovial sarcoma occurring during childhood. Malignant Childhood_Synovial_Sarcoma Childhood Synovial Sarcoma Pediatric Synovial Sarcoma Synovial Sarcoma Childhood Synovial Sarcoma A liposarcoma occurring during childhood. C8091 Neoplastic Process Childhood Liposarcoma Childhood Liposarcoma C0279984 CTRP NICHD A liposarcoma occurring during childhood. Malignant Childhood_Liposarcoma Childhood Liposarcoma Liposarcoma Pediatric Liposarcoma Childhood Liposarcoma An alveolar soft part sarcoma occurring in children. The most common site of involvement is the head and neck, particularly the orbit and tongue. C8092 Neoplastic Process Childhood Alveolar Soft Part Sarcoma Childhood Alveolar Soft Part Sarcoma C0279985 CTRP NICHD An alveolar soft part sarcoma occurring in children; the most common site of involvement is the head and neck, particularly the orbit and tongue. It is associated with t(X;17)(p11.2;q25). Malignant Childhood_Alveolar_Soft_Part_Sarcoma Alveolar Soft Part Sarcoma Childhood Alveolar Soft Part Sarcoma Childhood Alveolar Soft-Part Sarcoma Pediatric Alveolar Soft Part Sarcoma Childhood Alveolar Soft Part Sarcoma An aggressive malignant smooth muscle neoplasm, occurring in children. It is characterized by a proliferation of neoplastic spindle cells. C8093 Neoplastic Process Childhood Leiomyosarcoma Childhood Leiomyosarcoma C0279986 CTRP NICHD A leiomyosarcoma occurring during childhood. Malignant Childhood_Leiomyosarcoma Childhood Leiomyosarcoma Leiomyosarcoma Pediatric Leiomyosarcoma Childhood Leiomyosarcoma A malignant peripheral nerve sheath tumor occurring in children. C8094 Neoplastic Process Childhood Malignant Peripheral Nerve Sheath Tumor Childhood Malignant Peripheral Nerve Sheath Tumor C0279987 CTRP NICHD A malignant peripheral nerve sheath tumor occurring in children. Malignant Childhood_Malignant_Peripheral_Nerve_Sheath_Tumor Childhood MPNST Childhood Malignant Neoplasm of Peripheral Nerve Sheath Childhood Malignant Neoplasm of the Peripheral Nerve Sheath Childhood Malignant Neurilemmoma Childhood Malignant Peripheral Nerve Sheath Neoplasm Childhood Malignant Peripheral Nerve Sheath Tumor Childhood Malignant Schwannoma Childhood Malignant Tumor of Peripheral Nerve Sheath Childhood Malignant Tumor of the Peripheral Nerve Sheath Childhood Neurofibrosarcoma Childhood Neurogenic Sarcoma Malignant Peripheral Nerve Sheath Tumor Pediatric MPNST Pediatric Malignant Neoplasm of Peripheral Nerve Sheath Pediatric Malignant Neoplasm of the Peripheral Nerve Sheath Pediatric Malignant Neurilemmoma Pediatric Malignant Peripheral Nerve Sheath Neoplasm Pediatric Malignant Peripheral Nerve Sheath Tumor Pediatric Malignant Schwannoma Pediatric Malignant Tumor of Peripheral Nerve Sheath Pediatric Malignant Tumor of the Peripheral Nerve Sheath Childhood Malignant Peripheral Nerve Sheath Tumor An epithelioid sarcoma occurring in childhood. C8095 Neoplastic Process Childhood Epithelioid Sarcoma Childhood Epithelioid Sarcoma C0279989 CTRP NICHD An epithelioid sarcoma occurring during childhood. Malignant Childhood_Epithelioid_Sarcoma Childhood Epithelioid Sarcoma Epithelioid Sarcoma Pediatric Epithelioid Sarcoma Childhood Epithelioid Sarcoma The reemergence of non-Hodgkin lymphoma in adults after a period of remission. C8098 Neoplastic Process Recurrent Adult Non-Hodgkin Lymphoma Recurrent Adult Non-Hodgkin Lymphoma C0279999 CTRP Malignant Recurrent_Adult_Non-Hodgkin_s_Lymphoma Adult Recurrent Non-Hodgkin's Lymphoma Adult Relapsed Non-Hodgkin's Lymphoma Recurrent Adult Non-Hodgkin Lymphoma Recurrent Adult Non-Hodgkin's Lymphoma Recurrent Non-Hodgkin Lymphoma Relapsed Adult Non-Hodgkin's Lymphoma Recurrent Adult Non-Hodgkin Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8102 Neoplastic Process Ann Arbor Stage I Adult Non-Hodgkin Lymphoma Ann Arbor Stage I Adult Non-Hodgkin Lymphoma C0280114 CTRP Stage I is divided into stages I and IE. In stage I, cancer is found in one lymphatic area (lymph nodes, tonsils, thymus, or spleen). In stage IE, cancer is found in one organ or area outside the lymph nodes. Malignant Stage_I_Adult_Non-Hodgkin_s_Lymphoma Ann Arbor Stage I Adult Non-Hodgkin Lymphoma Stage I Adult Non-Hodgkin Lymphoma Stage I Adult Non-Hodgkin's Lymphoma Stage I Non-Hodgkin Lymphoma stage I adult non-Hodgkin lymphoma Ann Arbor Stage I Adult Non-Hodgkin Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). The number of regions involved may be indicated by a subscript (e.g., II3). C8103 Neoplastic Process Ann Arbor Stage II Adult Non-Hodgkin Lymphoma Ann Arbor Stage II Adult Non-Hodgkin Lymphoma C0280115 CTRP Stage II is divided into stages II and IIE. In stage II, cancer is found in two or more lymph node groups, and both are either above or below the diaphragm (the thin muscle below the lungs that helps breathing and separates the chest from the abdomen). In stage IIE, cancer is found in one or more lymph node groups either above or below the diaphragm and outside the lymph nodes in an organ or area on the same side of the diaphragm as the lymph nodes with cancer. Malignant Stage_II_Adult_Non-Hodgkin_s_Lymphoma Adult Non-Hodgkin's Lymphoma Stage II Ann Arbor Stage II Adult Non-Hodgkin Lymphoma Stage II Adult Non-Hodgkin Lymphoma Stage II Adult Non-Hodgkin's Lymphoma Stage II Non-Hodgkin Lymphoma stage II adult non-Hodgkin lymphoma Ann Arbor Stage II Adult Non-Hodgkin Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8104 Neoplastic Process Ann Arbor Stage III Adult Non-Hodgkin Lymphoma Ann Arbor Stage III Adult Non-Hodgkin Lymphoma C0280116 CTRP Stage III is divided into stages III, IIIE, IIIS, and IIIE+S. In stage III, cancer is found in one or more lymph node groups above and below the diaphragm (the thin muscle below the lungs that helps breathing and separates the chest from the abdomen). In stage IIIE, cancer is found in lymph node groups above and below the diaphragm and outside the lymph nodes in a nearby organ or area. In stage IIIS, cancer is found in lymph node groups above and below the diaphragm and in the spleen. In stage IIIE+S, cancer is found in lymph node groups above and below the diaphragm, outside the lymph nodes in a nearby organ or area, and in the spleen. Malignant Stage_III_Adult_Non-Hodgkin_s_Lymphoma Adult Non-Hodgkin's Lymphoma Stage III Ann Arbor Stage III Adult Non-Hodgkin Lymphoma Stage III Adult Non-Hodgkin Lymphoma Stage III Adult Non-Hodgkin's Lymphoma Stage III Non-Hodgkin Lymphoma stage III adult non-Hodgkin lymphoma Ann Arbor Stage III Adult Non-Hodgkin Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8105 Neoplastic Process Ann Arbor Stage IV Adult Non-Hodgkin Lymphoma Ann Arbor Stage IV Adult Non-Hodgkin Lymphoma C0280117 CTRP Cancer is found (1) throughout one or more organs that are not part of a lymphatic area (lymph nodes, tonsils, thymus or spleen) and may be in lymph nodes near those organs; or (2) in one organ that is not part of a lymphatic area and has spread to organs or lymph nodes far away from that organ; or (3) in the liver, bone marrow, cerebrospinal fluid (CSF), or lungs (other than cancer that has spread to the lungs from nearby areas). Malignant Stage_IV_Adult_Non-Hodgkin_s_Lymphoma Adult Non-Hodgkin's Lymphoma Stage IV Ann Arbor Stage IV Adult Non-Hodgkin Lymphoma Stage IV Adult Non-Hodgkin Lymphoma Stage IV Adult Non-Hodgkin's Lymphoma Stage IV Non-Hodgkin Lymphoma stage IV adult non-Hodgkin lymphoma Ann Arbor Stage IV Adult Non-Hodgkin Lymphoma A malignant germ cell tumor arising from the ovary. Morphologically, it is identical to seminoma and consists of a monotonous population of germ cells with abundant pale cytoplasm and uniform nuclei. The stroma invariably contains chronic inflammatory cells, mostly T-lymphocytes. It responds to chemotherapy or radiotherapy and the prognosis relates to the tumor stage. C8106 Neoplastic Process Ovarian Dysgerminoma Ovarian Dysgerminoma C0346185 CDISC CPTAC CTEP CTRP Cellosaurus GDC NICHD PCDC A malignant germ cell neoplasm characterized by the presence of a monotonous primitive germ cell population, primarily in the ovary. A seminomatous germ cell tumor originating in the ovary. A type of tumor that begins in the type of cells that give rise to egg cells and is most often found in the ovaries. Dysgerminomas may also occur in other places in the body, including the central nervous system. They are the most common type of ovarian germ cell tumor and can spread to other parts of the body. They are most common in females who are younger than 20 years old. 9060/3 Malignant Ovarian_Dysgerminoma 9060/3 Dysgerminoma DYSGERMINOMA, MALIGNANT Dysgerminoma Dysgerminoma of Ovary Dysgerminoma of the Ovary Germ Cell Dysgerminoma of Ovary Germ Cell Dysgerminoma of the Ovary Ovarian Dysgerminoma Ovarian Germ Cell Dysgerminoma Ovarian dysgerminoma dysgerminoma Ovarian Dysgerminoma A usually rapidly growing malignant germ cell tumor arising from the ovary. It usually occurs in children and adolescents. Signs and symptoms include abdominal pain and a large abdominal or pelvic mass. The serum alpha-fetoprotein is almost always elevated preoperatively. Morphologically, there is marked heterogeneity due to numerous patterns of differentiation coexisting in the same tumor. The most common pattern is reticular. C8107 Neoplastic Process Ovarian Yolk Sac Tumor Ovarian Yolk Sac Tumor C0346188 CTRP Cellosaurus Malignant Ovarian_Yolk_Sac_Tumor Endodermal Sinus Neoplasm of Ovary Endodermal Sinus Neoplasm of the Ovary Endodermal Sinus Tumor of Ovary Endodermal Sinus Tumor of the Ovary Germ Cell Endodermal Sinus Neoplasm of Ovary Germ Cell Endodermal Sinus Neoplasm of the Ovary Germ Cell Endodermal Sinus Tumor of Ovary Germ Cell Endodermal Sinus Tumor of the Ovary Ovarian Endodermal Sinus Neoplasm Ovarian Endodermal Sinus Tumor Ovarian Germ Cell Endodermal Sinus Neoplasm Ovarian Germ Cell Endodermal Sinus Tumor Ovarian Yolk Sac Neoplasm Ovarian Yolk Sac Tumor Yolk Sac Neoplasm of Ovary Yolk Sac Neoplasm of the Ovary Yolk Sac Tumor of Ovary Yolk Sac Tumor of the Ovary Ovarian Yolk Sac Tumor An embryonal carcinoma arising from the ovary. Signs and symptoms include the presence of an abdominal mass and abdominal pain. C8108 Neoplastic Process Ovarian Embryonal Carcinoma Ovarian Embryonal Carcinoma C0346183 CTRP Malignant Ovarian_Embryonal_Carcinoma Embryonal Carcinoma of Ovary Embryonal Carcinoma of the Ovary Ovarian Embryonal Carcinoma Ovarian Embryonal Carcinoma A benign, immature, or malignant teratoma arising from the ovary. C8110 Neoplastic Process Ovarian Teratoma Ovarian Teratoma C0280131 CTRP Cellosaurus Undetermined Ovarian_Teratoma Germ Cell Teratoma of Ovary Germ Cell Teratoma of the Ovary Ovarian Germ Cell Teratoma Ovarian Teratoma Teratoma of Ovary Teratoma of the Ovary Ovarian Teratoma An immature teratoma arising from the ovary. It usually affects females in their first two decades of life. C8111 Neoplastic Process Immature Ovarian Teratoma Immature Ovarian Teratoma C0346182 CTRP Cellosaurus Undetermined Immature_Ovarian_Teratoma Grade 2 Ovarian Teratoma Immature Germ Cell Teratoma of Ovary Immature Germ Cell Teratoma of the Ovary Immature Ovarian Teratoma Immature Teratoma of Ovary Immature Teratoma of the Ovary Ovarian Germ Cell Immature Teratoma Ovarian Immature Germ Cell Teratoma Ovarian Immature Teratoma Immature Ovarian Teratoma An ovarian teratoma which may be cystic, composed entirely of well differentiated, adult-type tissues, without evidence of fetal-type tissues. C8112 Neoplastic Process Mature Ovarian Teratoma Mature Ovarian Teratoma C1334637 CTRP Benign Mature_Ovarian_Teratoma Mature Ovarian Teratoma Mature Teratoma of Ovary Mature Teratoma of the Ovary Mature Ovarian Teratoma A teratoma of the ovary composed exclusively or predominantly of a single type of tissue derived from the ectoderm or endoderm. A representative example is struma ovarii which is a teratoma composed exclusively or predominantly of thyroid tissue. C8113 Neoplastic Process Ovarian Monodermal and Highly Specialized Teratoma Ovarian Monodermal and Highly Specialized Teratoma C0280134 CTRP Undetermined Ovarian_Monodermal_and_Highly_Specialized_Teratoma Ovarian Germ Cell Monodermal and Highly Specialized Teratoma Ovarian Monodermal and Highly Specialized Teratoma Ovarian Monodermal and Highly Specialized Teratoma An ovarian malignant germ cell tumor characterized by the presence of at least two different germ cell tumor components. The most common combination of germ cell tumors is dysgerminoma and yolk sac tumor. C8114 Neoplastic Process Ovarian Mixed Germ Cell Tumor Ovarian Mixed Germ Cell Tumor C0280135 CTRP Cellosaurus Malignant Ovarian_Mixed_Germ_Cell_Tumor Mixed Germ Cell Neoplasm of Ovary Mixed Germ Cell Neoplasm of the Ovary Mixed Germ Cell Tumor of Ovary Mixed Germ Cell Tumor of the Ovary Ovarian Mixed Germ Cell Neoplasm Ovarian Mixed Germ Cell Tumor Ovarian Mixed Germ Cell Tumor Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8115 Neoplastic Process Ann Arbor Stage II Small Lymphocytic Lymphoma Ann Arbor Stage II Small Lymphocytic Lymphoma C0855099 CTRP Malignant Stage_II_Small_Lymphocytic_Lymphoma Ann Arbor Stage II Small Lymphocytic Lymphoma B-Cell Small Lymphocytic Lymphoma Stage II Small Lymphocytic Lymphoma Stage II Stage II B-Cell Small Lymphocytic Lymphoma Stage II Small Lymphocytic Lymphoma Ann Arbor Stage II Small Lymphocytic Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8116 Neoplastic Process Ann Arbor Stage II Grade 1 Follicular Lymphoma Ann Arbor Stage II Grade 1 Follicular Lymphoma C0280143 CTRP PCDC Malignant Stage_II_Grade_1_Follicular_Lymphoma Ann Arbor Stage II Grade 1 Follicular Lymphoma Follicular Small Cleaved Cell Lymphoma Stage II Grade I Follicular Lymphoma Stage II Grade I Follicular Small Cleaved Cell Lymphoma Stage II Stage II Stage II Follicular Small Cleaved Cell Lymphoma Stage II Grade 1 Follicular Lymphoma Stage II Grade I Follicular Lymphoma Stage II Grade I Follicular Small Cleaved Cell Lymphoma Ann Arbor Stage II Grade 1 Follicular Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8117 Neoplastic Process Ann Arbor Stage II Grade 2 Follicular Lymphoma Ann Arbor Stage II Grade 2 Follicular Lymphoma C0280144 CTRP Malignant Stage_II_Grade_2_Follicular_Lymphoma Ann Arbor Stage II Grade 2 Follicular Lymphoma Follicular Mixed Cell Lymphoma Stage II Grade II Follicular Lymphoma Stage II Grade II Follicular Mixed Cell Lymphoma Stage II Stage II Follicular Mixed Cell Lymphoma Stage II Grade 2 Follicular Lymphoma Stage II Grade II Follicular Lymphoma Stage II Grade II Follicular Mixed Cell Lymphoma Ann Arbor Stage II Grade 2 Follicular Lymphoma The historical fact that a legal or consanguineous family member has died. C81180 Group Attribute Deceased Family Member C0425043 GDC Deceased_Family_Member Deceased Family Member relative deceased relative_deceased Deceased Family Member Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8119 Neoplastic Process Ann Arbor Stage II Grade 3 Follicular Lymphoma Ann Arbor Stage II Grade 3 Follicular Lymphoma C0280146 CTRP Malignant Stage_II_Grade_3_Follicular_Lymphoma Ann Arbor Stage II Grade 3 Follicular Lymphoma Follicular Large Cell Lymphoma Stage II Follicular Lymphoma Grade III Stage II Grade III Follicular Lymphoma Stage II Grade III Stage II Follicular Large Cell Lymphoma Grade III Stage II Follicular Lymphoma Stage II Follicular Large Cell Lymphoma Stage II Grade 3 Follicular Lymphoma Stage II Grade III Follicular Large Cell Lymphoma Ann Arbor Stage II Grade 3 Follicular Lymphoma C81193 Finding Immunosuppression-Related Post-Transplant Toxicity C2825503 Immunosuppression-Related_Post-Transplant_Toxicity Immunosuppression-Related Post-Transplant Toxicity Immunosuppression-Related Post-Transplant Toxicity C81194 Finding Methotrexate Toxicity C0568062 Methotrexate_Toxicity Methotrexate Toxicity Methotrexate Toxicity A description of an individual's current and past experience with alcoholic beverage consumption. C81229 Clinical Attribute Alcohol Use History C0552479 ACC/AHA CPTAC GDC NICHD Current or previous use by the patient of any alcohol. Alcohol_Use_History Alcohol History Alcohol Use Alcohol Use History alcohol history alcohol_history Alcohol Use History Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). The number of regions involved may be indicated by a subscript (e.g., II3). C8124 Neoplastic Process Ann Arbor Stage II Adult Immunoblastic Lymphoma Ann Arbor Stage II Adult Immunoblastic Lymphoma C0280151 CTRP Malignant Stage_II_Adult_Immunoblastic_Lymphoma Adult Immunoblastic Large Cell Lymphoma Stage II Ann Arbor Stage II Adult Immunoblastic Lymphoma Stage II Adult Immunoblastic Large Cell Lymphoma Stage II Adult Immunoblastic Lymphoma Stage II Immunoblastic Lymphoma Ann Arbor Stage II Adult Immunoblastic Lymphoma The historical fact that a legal or consanguineous brother or sister has died. C81244 Clinical Attribute Deceased Sibling C2825541 NICHD Deceased_Sibling Deceased Sibling Deceased Sibling A description of an individual's current and past use and/or abuse of drugs and chemicals. This includes prescription medication, illicit drugs and recreational substances. C81246 Clinical Attribute Drug Use History C2239127 NICHD Drug_Use_History Drug Use History Drug Use History Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ) C8125 Neoplastic Process Ann Arbor Stage II Adult Lymphoblastic Lymphoma Ann Arbor Stage II Adult Lymphoblastic Lymphoma C0280152 CTRP Malignant Stage_II_Adult_Lymphoblastic_Lymphoma Adult Lymphoblastic Lymphoma Stage II Adult Stage II Lymphoblastic Lymphoma Ann Arbor Stage II Adult Lymphoblastic Lymphoma Stage II Adult Lymphoblastic Lymphoma Stage II Adult Precursor Lymphoblastic Lymphoma Stage II Lymphoblastic Lymphoma Ann Arbor Stage II Adult Lymphoblastic Lymphoma The organ of hearing located on the left side of the head. C81259 Anatomical Structure Left Ear C0229299 NICHD Left_Ear Left Ear Left Ear Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8126 Neoplastic Process Ann Arbor Stage II Adult Burkitt Lymphoma Ann Arbor Stage II Adult Burkitt Lymphoma C0280153 CTRP Malignant Stage_II_Adult_Burkitt_s_Lymphoma Adult Diffuse Small Non-Cleaved Cell Lymphoma Stage II Adult Diffuse Small Non-Cleaved Cell/Burkitt's Lymphoma Stage II Ann Arbor Stage II Adult Burkitt Lymphoma Stage II Adult Burkitt Lymphoma Stage II Adult Burkitt's Lymphoma Stage II Adult Diffuse Small Non-Cleaved Cell Lymphoma Stage II Adult Diffuse Small Non-Cleaved Cell/Burkitt's Lymphoma Stage II Burkitt Lymphoma Ann Arbor Stage II Adult Burkitt Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8128 Neoplastic Process Ann Arbor Stage III Small Lymphocytic Lymphoma Ann Arbor Stage III Small Lymphocytic Lymphoma C0855100 CTRP Malignant Stage_III_Small_Lymphocytic_Lymphoma Ann Arbor Stage III Small Lymphocytic Lymphoma B-Cell Small Lymphocytic Lymphoma Stage III Small Lymphocytic Lymphoma Stage III Stage III B-Cell Small Lymphocytic Lymphoma Stage III Small Lymphocytic Lymphoma Ann Arbor Stage III Small Lymphocytic Lymphoma The organ of hearing located on the right side of the head. C81285 Anatomical Structure Right Ear C0229298 NICHD Right_Ear Right Ear Right Ear Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8129 Neoplastic Process Ann Arbor Stage III Grade 1 Follicular Lymphoma Ann Arbor Stage III Grade 1 Follicular Lymphoma C0280156 CTRP PCDC Malignant Stage_III_Grade_1_Follicular_Lymphoma Ann Arbor Stage III Grade 1 Follicular Lymphoma Follicular Small Cleaved Cell Lymphoma Stage III Grade I Follicular Lymphoma Stage III Grade I Follicular Small Cleaved Cell Lymphoma Stage III Stage III Stage III Follicular Small Cleaved Cell Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade I Follicular Lymphoma Stage III Grade I Follicular Small Cleaved Cell Lymphoma Ann Arbor Stage III Grade 1 Follicular Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8130 Neoplastic Process Ann Arbor Stage III Grade 2 Follicular Lymphoma Ann Arbor Stage III Grade 2 Follicular Lymphoma C0280157 CTRP Malignant Stage_III_Grade_2_Follicular_Lymphoma Ann Arbor Stage III Grade 2 Follicular Lymphoma Follicular Mixed Cell Lymphoma Stage III Grade II Follicular Lymphoma Stage III Grade II Follicular Mixed Cell Lymphoma Stage III Stage III Follicular Mixed Cell Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade II Follicular Lymphoma Stage III Grade II Follicular Mixed Cell Lymphoma Ann Arbor Stage III Grade 2 Follicular Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8132 Neoplastic Process Ann Arbor Stage III Grade 3 Follicular Lymphoma Ann Arbor Stage III Grade 3 Follicular Lymphoma C0280159 CTRP Malignant Stage_III_Grade_3_Follicular_Lymphoma Ann Arbor Stage III Grade 3 Follicular Lymphoma Follicular Large Cell Lymphoma Stage III Follicular Lymphoma Grade III Stage III Grade III Follicular Large Cell Lymphoma Stage III Grade III Follicular Lymphoma Stage III Stage III Follicular Large Cell Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Grade III Follicular Large Cell Lymphoma Ann Arbor Stage III Grade 3 Follicular Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8137 Neoplastic Process Ann Arbor Stage III Adult Immunoblastic Lymphoma Ann Arbor Stage III Adult Immunoblastic Lymphoma C0280164 CTRP Malignant Stage_III_Adult_Immunoblastic_Lymphoma Adult Immunoblastic Large Cell Lymphoma Stage III Ann Arbor Stage III Adult Immunoblastic Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Immunoblastic Lymphoma Stage III Immunoblastic Lymphoma Ann Arbor Stage III Adult Immunoblastic Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8138 Neoplastic Process Ann Arbor Stage III Adult Lymphoblastic Lymphoma Ann Arbor Stage III Adult Lymphoblastic Lymphoma C0280165 CTRP Malignant Stage_III_Adult_Lymphoblastic_Lymphoma Adult Lymphoblastic Lymphoma Stage III Adult Stage III Lymphoblastic Lymphoma Ann Arbor Stage III Adult Lymphoblastic Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Adult Precursor Lymphoblastic Lymphoma Stage III Lymphoblastic Lymphoma Ann Arbor Stage III Adult Lymphoblastic Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8139 Neoplastic Process Ann Arbor Stage III Adult Burkitt Lymphoma Ann Arbor Stage III Adult Burkitt Lymphoma C0280166 CTRP Malignant Stage_III_Adult_Burkitt_s_Lymphoma Adult Diffuse Small Non-Cleaved Cell Lymphoma Stage III Adult Diffuse Small Non-Cleaved Cell/Burkitt's Lymphoma Stage III Ann Arbor Stage III Adult Burkitt Lymphoma Stage III Adult Burkitt Lymphoma Stage III Adult Burkitt's Lymphoma Stage III Adult Diffuse Small Non-Cleaved Cell Lymphoma Stage III Adult Diffuse Small Non-Cleaved Cell/Burkitt's Lymphoma Stage III Burkitt Lymphoma Ann Arbor Stage III Adult Burkitt Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8141 Neoplastic Process Ann Arbor Stage IV Small Lymphocytic Lymphoma Ann Arbor Stage IV Small Lymphocytic Lymphoma C0855101 CTRP Malignant Stage_IV_Small_Lymphocytic_Lymphoma Ann Arbor Stage IV Small Lymphocytic Lymphoma B-Cell Small Lymphocytic Lymphoma Stage IV Small Lymphocytic Lymphoma Stage IV Stage IV B-Cell Small Lymphocytic Lymphoma Stage IV Small Lymphocytic Lymphoma Ann Arbor Stage IV Small Lymphocytic Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8142 Neoplastic Process Ann Arbor Stage IV Grade 1 Follicular Lymphoma Ann Arbor Stage IV Grade 1 Follicular Lymphoma C0280169 CTRP PCDC Malignant Stage_IV_Grade_1_Follicular_Lymphoma Ann Arbor Stage IV Grade 1 Follicular Lymphoma Follicular Small Cleaved Cell Lymphoma Stage IV Grade I Follicular Lymphoma Stage IV Grade I Follicular Small Cleaved Cell Lymphoma Stage IV Grade I Stage IV Follicular Lymphoma Grade I Stage IV Follicular Small Cleaved Cell Lymphoma Stage IV Stage IV Follicular Small Cleaved Cell Lymphoma Stage IV Grade 1 Follicular Lymphoma Ann Arbor Stage IV Grade 1 Follicular Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8143 Neoplastic Process Ann Arbor Stage IV Grade 2 Follicular Lymphoma Ann Arbor Stage IV Grade 2 Follicular Lymphoma C0280170 CTRP Malignant Stage_IV_Grade_2_Follicular_Lymphoma Ann Arbor Stage IV Grade 2 Follicular Lymphoma Follicular Mixed Cell Lymphoma Stage IV Grade II Follicular Lymphoma Stage IV Grade II Follicular Mixed Cell Lymphoma Stage IV Stage IV Follicular Mixed Cell Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade II Follicular Lymphoma Stage IV Grade II Follicular Mixed Cell Lymphoma Ann Arbor Stage IV Grade 2 Follicular Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8145 Neoplastic Process Ann Arbor Stage IV Grade 3 Follicular Lymphoma Ann Arbor Stage IV Grade 3 Follicular Lymphoma C0280172 CTRP Malignant Stage_IV_Grade_3_Follicular_Lymphoma Ann Arbor Stage IV Grade 3 Follicular Lymphoma Follicular Large Cell Lymphoma Stage IV Grade III Follicular Lymphoma Stage IV Grade III Stage IV Follicular Large Cell Lymphoma Stage IV Follicular Large Cell Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Grade III Follicular Large Cell Lymphoma Stage IV Grade III Follicular Lymphoma Ann Arbor Stage IV Grade 3 Follicular Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8150 Neoplastic Process Ann Arbor Stage IV Adult Immunoblastic Lymphoma Ann Arbor Stage IV Adult Immunoblastic Lymphoma C0280177 CTRP Malignant Stage_IV_Adult_Immunoblastic_Lymphoma Adult Immunoblastic Large Cell Lymphoma Stage IV Ann Arbor Stage IV Adult Immunoblastic Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Immunoblastic Lymphoma Stage IV Immunoblastic Lymphoma Ann Arbor Stage IV Adult Immunoblastic Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8151 Neoplastic Process Ann Arbor Stage IV Adult Lymphoblastic Lymphoma Ann Arbor Stage IV Adult Lymphoblastic Lymphoma C0280178 CTRP Malignant Stage_IV_Adult_Lymphoblastic_Lymphoma Adult Lymphoblastic Lymphoma Stage IV Adult Stage IV Lymphoblastic Lymphoma Ann Arbor Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult Precursor Lymphoblastic Lymphoma Stage IV Lymphoblastic Lymphoma Ann Arbor Stage IV Adult Lymphoblastic Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8152 Neoplastic Process Ann Arbor Stage IV Adult Burkitt Lymphoma Ann Arbor Stage IV Adult Burkitt Lymphoma C0280179 CTRP Malignant Stage_IV_Adult_Burkitt_s_Lymphoma Adult Diffuse Small Non-Cleaved Cell Lymphoma Stage IV Adult Diffuse Small Non-Cleaved Cell/Burkitt's Lymphoma Stage IV Ann Arbor Stage IV Adult Burkitt Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Burkitt's Lymphoma Stage IV Adult Diffuse Small Non-Cleaved Cell Lymphoma Stage IV Adult Diffuse Small Non-Cleaved Cell/Burkitt's Lymphoma Stage IV Burkitt Lymphoma Ann Arbor Stage IV Adult Burkitt Lymphoma The reemergence of small lymphocytic lymphoma after a period of remission. C8154 Neoplastic Process Recurrent Small Lymphocytic Lymphoma Recurrent Small Lymphocytic Lymphoma C0855096 CTRP Malignant Recurrent_Small_Lymphocytic_Lymphoma Recurrent B-Cell Small Lymphocytic Lymphoma Recurrent Small Lymphocytic Lymphoma Relapsed B-Cell Small Lymphocytic Lymphoma Relapsed Small Lymphocytic Lymphoma Recurrent Small Lymphocytic Lymphoma The reemergence of grade 1 follicular lymphoma after a period of remission. C8155 Neoplastic Process Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 1 Follicular Lymphoma C0280182 CTRP Malignant Recurrent_Grade_1_Follicular_Lymphoma Recurrent Follicular Small Cleaved Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade I Follicular Lymphoma Recurrent Grade I Follicular Small Cleaved Cell Lymphoma Relapsed Follicular Small Cleaved Cell Lymphoma Relapsed Grade I Follicular Lymphoma Relapsed Grade I Follicular Small Cleaved Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma The reemergence of grade 2 follicular lymphoma after a period of remission. C8156 Neoplastic Process Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma C0280183 CTRP Malignant Recurrent_Grade_2_Follicular_Lymphoma Recurrent Follicular Mixed Cell Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade II Follicular Lymphoma Recurrent Grade II Follicular Mixed Cell Lymphoma Relapsed Follicular Mixed Cell Lymphoma Relapsed Grade II Follicular Lymphoma Relapsed Grade II Follicular Mixed Cell Lymphoma Recurrent Grade 2 Follicular Lymphoma The reemergence of grade 3 follicular lymphoma after a period of remission. C8158 Neoplastic Process Recurrent Grade 3 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma C0280185 CTRP Malignant Recurrent_Grade_3_Follicular_Lymphoma Recurrent Follicular Large Cell Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Grade III Follicular Large Cell Lymphoma Recurrent Grade III Follicular Lymphoma Relapsed Follicular Large Cell Lymphoma Relapsed Grade III Follicular Large Cell Lymphoma Relapsed Grade III Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma The reemergence of adult Burkitt lymphoma after a period of remission. C8159 Neoplastic Process Recurrent Adult Burkitt Lymphoma Recurrent Adult Burkitt Lymphoma C0280186 CTRP Malignant Recurrent_Adult_Burkitt_s_Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Burkitt's Lymphoma Recurrent Adult Diffuse Small Non-Cleaved Cell Lymphoma Recurrent Adult Small Non-Cleaved Cell/Burkitt's Lymphoma Recurrent Burkitt Lymphoma Relapsed Adult Small Non-Cleaved Cell/Burkitt's Lymphoma Recurrent Adult Burkitt Lymphoma The reemergence of adult immunoblastic lymphoma after a period of remission. C8163 Neoplastic Process Recurrent Adult Immunoblastic Lymphoma Recurrent Adult Immunoblastic Lymphoma C0280190 CTRP Malignant Recurrent_Adult_Immunoblastic_Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Immunoblastic Lymphoma Recurrent Immunoblastic Lymphoma Relapsed Adult Immunoblastic Large Cell Lymphoma Relapsed Adult Immunoblastic Lymphoma Recurrent Adult Immunoblastic Lymphoma The reemergence of adult lymphoblastic lymphoma after a period of remission. C8164 Neoplastic Process Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult Lymphoblastic Lymphoma C0280191 CTRP Malignant Recurrent_Adult_Lymphoblastic_Lymphoma Adult Recurrent Lymphoblastic Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult Precursor Lymphoblastic Lymphoma Recurrent Lymphoblastic Lymphoma Recurrent Adult Lymphoblastic Lymphoma Urothelial carcinoma of the renal pelvis or ureter that has not spread to adjacent tissues, regional lymph nodes, or distant anatomic sites. C8167 Neoplastic Process Localized Urothelial Cancer of the Renal Pelvis and Ureter Localized Renal Pelvis and Ureter Urothelial Carcinoma C0280240 CTRP Malignant Localized_Transitional_Cell_Carcinoma_of_the_Renal_Pelvis_and_Ureter Localized Renal Pelvis and Ureter Urothelial Carcinoma Localized Transitional Cell Cancer of Renal Pelvis and Ureter Localized Transitional Cell Cancer of the Renal Pelvis and Ureter Localized Transitional Cell Carcinoma of Renal Pelvis and Ureter Localized Upper Urinary Tract Urothelial Carcinoma Localized Urothelial Cancer of the Renal Pelvis and Ureter Localized Urothelial Carcinoma of the Renal Pelvis and Ureter Upper Urinary Tract Localized Urothelial Carcinoma Localized Renal Pelvis and Ureter Urothelial Carcinoma Urothelial carcinoma of the renal pelvis or ureter that has spread to adjacent tissues and/or regional lymph nodes but not to distant anatomic sites. C8168 Neoplastic Process Regional Urothelial Cancer of the Renal Pelvis and Ureter Regional Renal Pelvis and Ureter Urothelial Carcinoma C0280281 CTRP Malignant Regional_Transitional_Cell_Carcinoma_of_the_Renal_Pelvis_and_Ureter Regional Renal Pelvis and Ureter Urothelial Carcinoma Regional Transitional Cell Cancer of Renal Pelvis and Ureter Regional Transitional Cell Cancer of the Renal Pelvis and Ureter Regional Transitional Cell Carcinoma of Renal Pelvis and Ureter Regional Upper Urinary Tract Urothelial Carcinoma Regional Urothelial Cancer of the Renal Pelvis and Ureter Regional Urothelial Carcinoma of the Renal Pelvis and Ureter Regional Renal Pelvis and Ureter Urothelial Carcinoma A squamous cell carcinoma that arises from the anterior two-thirds of the tongue. It usually presents as a painful ulcerated or nodular lesion. C8169 Neoplastic Process Anterior Tongue Squamous Cell Carcinoma Anterior Tongue Squamous Cell Carcinoma C0280298 CTRP Malignant Anterior_Tongue_Squamous_Cell_Carcinoma Anterior Tongue SCC Anterior Tongue Squamous Cell Carcinoma Squamous Cell Carcinoma of Anterior Tongue Squamous Cell Carcinoma of the Anterior Tongue Anterior Tongue Squamous Cell Carcinoma A squamous cell carcinoma that arises from the hard palate. It usually presents as a papillary or exophytic mass. C8170 Neoplastic Process Hard Palate Squamous Cell Carcinoma C0280301 Malignant Hard_Palate_Squamous_Cell_Carcinoma Hard Palate SCC Hard Palate Squamous Cell Carcinoma SCC of Hard Palate SCC of the Hard Palate Squamous Cell Carcinoma of Hard Palate Squamous Cell Carcinoma of the Hard Palate Hard Palate Squamous Cell Carcinoma A squamous cell carcinoma of the oral cavity that arises from the lower gingiva. C8171 Neoplastic Process Lower Gingival Squamous Cell Carcinoma C0280303 Cellosaurus Malignant Lower_Gingival_Squamous_Cell_Carcinoma Lower Gingival SCC Lower Gingival Squamous Cell Carcinoma Lower Gum SCC Lower Gum Squamous Cell Carcinoma SCC of Lower Gingiva SCC of Lower Gum SCC of the Lower Gingiva SCC of the Lower Gum Squamous Cell Carcinoma of Lower Gingiva Squamous Cell Carcinoma of Lower Gum Squamous Cell Carcinoma of the Lower Gingiva Squamous Cell Carcinoma of the Lower Gum Lower Gingival Squamous Cell Carcinoma A squamous cell carcinoma that arises from the retromolar trigone. Pain, often radiating to the ear, is the presenting symptom. The prognosis is poor. C8172 Neoplastic Process Retromolar Trigone Squamous Cell Carcinoma C0280304 Cellosaurus Malignant Retromolar_Trigone_Squamous_Cell_Carcinoma Retromolar Trigone Squamous Cell Carcinoma Squamous Cell Carcinoma of Retromolar Trigone Squamous Cell Carcinoma of the Retromolar Trigone Retromolar Trigone Squamous Cell Carcinoma A squamous cell carcinoma of the oral cavity that arises from the upper gingiva. C8173 Neoplastic Process Upper Gingival Squamous Cell Carcinoma C0280305 Cellosaurus Malignant Upper_Gingival_Squamous_Cell_Carcinoma SCC of Upper Gingiva SCC of Upper Gum SCC of the Upper Gingiva SCC of the Upper Gum Squamous Cell Carcinoma of Upper Gingiva Squamous Cell Carcinoma of Upper Gum Squamous Cell Carcinoma of the Upper Gingiva Squamous Cell Carcinoma of the Upper Gum Upper Gingival SCC Upper Gingival Squamous Cell Carcinoma Upper Gum SCC Upper Gum Squamous Cell Carcinoma Upper Gingival Squamous Cell Carcinoma A well differentiated squamous cell carcinoma arising from the oral cavity. It is an exophytic, warty, slow growing tumor, usually affecting older males. Chronic use of smokeless tobacco is associated with the development of verrucous carcinoma in the oral cavity. Five year disease-free survival rates between 80% and 90% have been reported in patients who underwent extensive surgical removal of the tumor. C8174 Neoplastic Process Oral Cavity Verrucous Carcinoma Oral Cavity Verrucous Carcinoma C0280306 CTRP Malignant Oral_Cavity_Verrucous_Carcinoma Ackerman Tumor Mouth Verrucous Carcinoma Oral Cavity Verrucous Cancer Oral Cavity Verrucous Carcinoma Verrucous Carcinoma of Mouth Verrucous Carcinoma of Oral Cavity Verrucous Carcinoma of the Mouth Verrucous Carcinoma of the Oral Cavity Oral Cavity Verrucous Carcinoma A verrucous carcinoma of the oral cavity that arises from the buccal mucosa. C8175 Neoplastic Process Buccal Mucosa Verrucous Carcinoma C0280307 Malignant Buccal_Mucosa_Verrucous_Carcinoma Buccal Mucosa Verrucous Carcinoma Verrucous Carcinoma of Buccal Mucosa Verrucous Carcinoma of the Buccal Mucosa Buccal Mucosa Verrucous Carcinoma A very rare dendritic cell sarcoma affecting the lymph nodes, spleen, and soft tissues. Morphologically it is similar to the interdigitating dendritic cell sarcoma or follicular dendritic cell sarcoma. The tumor cells are positive for cytokeratin and CD68. C81758 Neoplastic Process Fibroblastic Reticular Cell Tumor Fibroblastic Reticular Cell Sarcoma C2825739 CPTAC CTRP GDC 9759/3 Malignant Fibroblastic_Reticular_Cell_Tumor 9759/3 Fibroblastic reticular cell tumor Fibroblastic Dendritic Cell Tumor Fibroblastic Reticular Cell Sarcoma Fibroblastic Reticular Cell Tumor Fibroblastic reticular cell tumor Fibroblastic Reticular Cell Sarcoma A verrucous carcinoma of the oral cavity that arises from the lower gingiva. C8176 Neoplastic Process Lower Gingival Verrucous Carcinoma C0280308 Malignant Lower_Gingival_Verrucous_Carcinoma Lower Gingival Verrucous Carcinoma Lower Gum Verrucous Carcinoma Verrucous Carcinoma of Lower Gingiva Verrucous Carcinoma of Lower Gum Verrucous Carcinoma of the Lower Gingiva Verrucous Carcinoma of the Lower Gum Lower Gingival Verrucous Carcinoma A very rare dendritic cell tumor composed of spindle to ovoid cells with a phenotype that is similar to the Langerhans cells. Patients usually present with cutaneous papules, nodules, and plaques. Systemic symptoms are usually absent. The clinical course is variable. C81767 Neoplastic Process Indeterminate Dendritic Cell Histiocytosis C2825741 GDC 9757/3 Undetermined Indeterminate_Dendritic_Cell_Tumor 9757/3 Indeterminate dendritic cell tumor IDCT Indeterminate Cell Histiocytosis Indeterminate Dendritic Cell Histiocytosis Indeterminate Dendritic Cell Tumor Indeterminate dendritic cell tumor Indeterminate Dendritic Cell Histiocytosis A mucoepidermoid carcinoma arising from the minor salivary glands in the oral cavity. It is often asymptomatic and detected during a routine dental examination. C8177 Neoplastic Process Oral Cavity Mucoepidermoid Carcinoma Oral Cavity Mucoepidermoid Carcinoma C0280309 CTRP Malignant Oral_Cavity_Mucoepidermoid_Carcinoma Mucoepidermoid Carcinoma of Oral Cavity Mucoepidermoid Carcinoma of the Oral Cavity Oral Cavity Mucoepidermoid Cancer Oral Cavity Mucoepidermoid Carcinoma Oral Cavity Mucoepidermoid Carcinoma Juvenile xanthogranuloma disseminated to extracutaneous sites including mucosal surfaces, lung, central nervous system, pituitary, lymph nodes, eye, liver, and bone marrow. It is characterized by the presence of lipid-laden, foamy histiocytes and Touton-type giant cells forming nodules in the affected anatomic sites. C81772 Neoplastic Process Disseminated Juvenile Xanthogranuloma C2825742 NICHD Juvenile xanthogranuloma disseminated to extracutaneous sites, including mucosal surfaces, lung, central nervous system, pituitary, lymph nodes, eye, liver, and bone marrow. Undetermined Disseminated_Juvenile_Xanthogranuloma Disseminated JXG Disseminated Juvenile Xanthogranuloma Disseminated Juvenile Xanthogranuloma A mucoepidermoid carcinoma of the oral cavity that arises from the floor of the mouth. C8178 Neoplastic Process Floor of Mouth Mucoepidermoid Carcinoma C0280310 Malignant Floor_of_Mouth_Mucoepidermoid_Carcinoma Floor of Mouth Mucoepidermoid Carcinoma Mucoepidermoid Carcinoma of Floor of Mouth Mucoepidermoid Carcinoma of the Floor of Mouth Floor of Mouth Mucoepidermoid Carcinoma An adenoid cystic carcinoma arising from the minor salivary glands in the oral cavity. C8179 Neoplastic Process Oral Cavity Adenoid Cystic Carcinoma Oral Cavity Adenoid Cystic Carcinoma C0280311 CTRP Malignant Oral_Cavity_Adenoid_Cystic_Carcinoma Adenoid Cystic Carcinoma of Mouth Adenoid Cystic Carcinoma of Oral Cavity Adenoid Cystic Carcinoma of the Mouth Adenoid Cystic Carcinoma of the Oral Cavity Mouth Adenoid Cystic Carcinoma Oral Cavity Adenoid Cystic Cancer Oral Cavity Adenoid Cystic Carcinoma Oral Cavity Adenoid Cystic Carcinoma An adenoid cystic carcinoma of the oral cavity that arises from the floor of the mouth. C8180 Neoplastic Process Floor of Mouth Adenoid Cystic Carcinoma C0280312 Malignant Floor_of_Mouth_Adenoid_Cystic_Carcinoma Adenoid Cystic Carcinoma of Floor of Mouth Adenoid Cystic Carcinoma of the Floor of Mouth Floor of Mouth Adenoid Cystic Carcinoma Floor of Mouth Adenoid Cystic Carcinoma A squamous cell carcinoma arising from the oropharynx. It predominantly affects adults in their fifth and sixth decades of life and is associated with alcohol and tobacco use. Human papillomavirus is present in approximately half of the cases. It is characterized by a tendency to metastasize early to the lymph nodes. When the tumor is small, patients are often asymptomatic. Physical examination may reveal erythematous or white lesions or plaques. The majority of patients present with locally advanced disease. Signs and symptoms include mucosal ulceration, pain, bleeding, weight loss, neck swelling, and difficulty speaking, chewing, and swallowing. Patients may also present with swollen neck lymph nodes without any symptoms from the oropharyngeal tumor. The most significant prognostic factors are the size of the tumor and the lymph nodes status. C8181 Neoplastic Process Oropharyngeal Squamous Cell Carcinoma Oropharyngeal Squamous Cell Carcinoma CL497390 CTRP Cellosaurus Malignant Oropharyngeal_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Oropharynx Epidermoid Carcinoma of the Oropharynx OPSCC Oropharyngeal Epidermoid Carcinoma Oropharyngeal Squamous Cell Carcinoma Oropharyngeal Throat Squamous Cell Cancer Squamous Cell Carcinoma of Oropharynx Squamous Cell Carcinoma of the Oropharynx Oropharyngeal Squamous Cell Carcinoma A squamous cell carcinoma that arises from the base of the tongue. It usually presents as a painful ulcerated lesion. C8182 Neoplastic Process Posterior Tongue Squamous Cell Carcinoma C0280315 Malignant Posterior_Tongue_Squamous_Cell_Carcinoma Posterior Tongue SCC Posterior Tongue Squamous Cell Carcinoma SCC of Posterior Tongue SCC of the Posterior Tongue Squamous Cell Carcinoma of Posterior Tongue Squamous Cell Carcinoma of the Posterior Tongue Posterior Tongue Squamous Cell Carcinoma A squamous cell carcinoma that arises from the mucosal lining of the tonsil and tends to metastasize early to the lymph nodes. It predominantly affects middle aged and elderly patients who have a history of alcohol and tobacco use. Patients may present with tonsillar swelling, sore throat, pain radiating to the ipsilateral ear, or a neck mass. C8183 Neoplastic Process Tonsillar Squamous Cell Carcinoma C0280317 Cellosaurus Malignant Tonsillar_Squamous_Cell_Carcinoma SCC of Tonsil SCC of the Tonsil Squamous Cell Carcinoma of Tonsil Squamous Cell Carcinoma of the Tonsil Tonsil SCC Tonsil Squamous Cell Carcinoma Tonsillar SCC Tonsillar Squamous Cell Carcinoma Tonsillar Squamous Cell Carcinoma A non-keratinizing carcinoma arising from the tonsil. It is characterized by the presence of large malignant cells with vesicular nuclei, prominent nucleoli, syncytial growth pattern, and a lymphoplasmacytic infiltrate. C8184 Neoplastic Process Tonsillar Undifferentiated Carcinoma C1336766 Malignant Tonsillar_Undifferentiated_Carcinoma Tonsillar Lymphoepithelioma Tonsillar Undifferentiated Carcinoma Tonsillar Undifferentiated Carcinoma A squamous cell carcinoma of the hypopharynx that arises from the postcricoid region. C8185 Neoplastic Process Postcricoid Squamous Cell Carcinoma C0280322 Malignant Postcricoid_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Postcricoid Area Epidermoid Carcinoma of the Postcricoid Area Postcricoid Epidermoid Carcinoma Postcricoid Squamous Cell Carcinoma Squamous Cell Carcinoma of Postcricoid Area Squamous Cell Carcinoma of the Postcricoid Area Postcricoid Squamous Cell Carcinoma An epithelioid cell type gastrointestinal stromal tumor with an indolent clinical course. C81854 Neoplastic Process Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor C2825772 Benign Benign_Epithelioid_Cell_Type_Gastrointestinal_Stromal_Tumor Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor Benign Leiomyoblastoma Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor An epithelioid cell type gastrointestinal stromal tumor with an aggressive clinical course. C81855 Neoplastic Process Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor C2825773 Malignant Malignant_Epithelioid_Cell_Type_Gastrointestinal_Stromal_Tumor Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor Malignant Leiomyoblastoma Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor A squamous cell carcinoma of the larynx that arises from the glottic area. It may remain localized for a long period then in late disease stage, it may spread to the opposite true vocal cord, supraglottic and subglottic areas, and the soft tissues of the neck. Hoarseness is the presenting symptom. C8186 Neoplastic Process Glottic Squamous Cell Carcinoma C0280325 Malignant Glottis_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Glottis Epidermoid Carcinoma of the Glottis Glottic Epidermoid Carcinoma Glottic Squamous Cell Carcinoma Glottis Epidermoid Carcinoma Glottis Squamous Cell Carcinoma Squamous Cell Carcinoma of Glottis Squamous Cell Carcinoma of the Glottis Glottic Squamous Cell Carcinoma A squamous cell carcinoma of the larynx that arises from the subglottic area. Symptoms include dyspnea and stridor. It spreads to the hypopharynx, trachea, and thyroid gland. C8187 Neoplastic Process Subglottic Squamous Cell Carcinoma C0280326 Malignant Subglottic_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Subglottis Epidermoid Carcinoma of the Subglottis Squamous Cell Carcinoma of Subglottis Squamous Cell Carcinoma of the Subglottis Subglottic Epidermoid Carcinoma Subglottic Squamous Cell Carcinoma Subglottis Epidermoid Carcinoma Subglottis Squamous Cell Carcinoma Subglottic Squamous Cell Carcinoma A well differentiated, non-metastasizing squamous cell carcinoma arising from the larynx. It is an exophytic, warty, and slow growing tumor affecting predominantly older men. It is associated with tobacco smoking. Symptoms include hoarseness, airway obstruction, weight loss, dysphagia, and throat pain. If left untreated, it may cause extensive local destruction. C8188 Neoplastic Process Laryngeal Verrucous Carcinoma Laryngeal Verrucous Carcinoma C0280328 CTRP Malignant Laryngeal_Verrucous_Carcinoma Laryngeal Throat Verrucous Cancer Laryngeal Verrucous Carcinoma Larynx Verrucous Carcinoma Verrucous Carcinoma of Larynx Verrucous Carcinoma of the Larynx Laryngeal Verrucous Carcinoma An exophytic, slow growing, well differentiated and non-metastasizing squamous cell carcinoma with pushing margins that arises from the glottic area of the larynx. It usually presents with hoarseness. C8189 Neoplastic Process Glottis Verrucous Carcinoma C0280329 Malignant Glottis_Verrucous_Carcinoma Glottic Verrucous Carcinoma Glottis Verrucous Carcinoma Verrucous Carcinoma of Glottis Verrucous Carcinoma of the Glottis Glottis Verrucous Carcinoma An exophytic, slow growing, well differentiated and non-metastasizing squamous cell carcinoma with pushing margins that arises from the subglottic area of the larynx. C8190 Neoplastic Process Subglottic Verrucous Carcinoma C0280330 Malignant Subglottic_Verrucous_Carcinoma Subglottic Verrucous Carcinoma Subglottis Verrucous Carcinoma Verrucous Carcinoma of Subglottis Verrucous Carcinoma of the Subglottis Subglottic Verrucous Carcinoma An exophytic, slow growing, well differentiated and non-metastasizing squamous cell carcinoma with pushing margins that arises from the supraglottic area of the larynx. C8191 Neoplastic Process Supraglottic Verrucous Carcinoma C0280331 Malignant Supraglottic_Verrucous_Carcinoma Supraglottic Verrucous Carcinoma Supraglottis Verrucous Carcinoma Verrucous Carcinoma of Supraglottis Verrucous Carcinoma of the Supraglottis Supraglottic Verrucous Carcinoma A squamous cell carcinoma that arises from the nasal cavity mucosa. Signs and symptoms include nasal fullness and obstruction, pain, epistaxis, and the presence of a nasal mass. C8192 Neoplastic Process Nasal Cavity Squamous Cell Carcinoma C0280333 Cellosaurus Malignant Nasal_Cavity_Squamous_Cell_Carcinoma Nasal Cavity Squamous Cell Carcinoma Squamous Cell Carcinoma of Nasal Cavity Squamous Cell Carcinoma of the Nasal Cavity Nasal Cavity Squamous Cell Carcinoma A squamous cell carcinoma that arises from the mucosal epithelial surface of the ethmoid, frontal, maxillary, or sphenoid sinus. Patients may present with nasal fullness, obstruction, and/or epistaxis. C8193 Neoplastic Process Paranasal Sinus Squamous Cell Carcinoma C0280334 Malignant Paranasal_Sinus_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Paranasal Sinus Epidermoid Carcinoma of the Paranasal Sinus Paranasal Sinus Epidermoid Carcinoma Paranasal Sinus Squamous Cell Carcinoma Squamous Cell Carcinoma of Paranasal Sinus Squamous Cell Carcinoma of the Paranasal Sinus Paranasal Sinus Squamous Cell Carcinoma A benign neoplasm that arises from the ciliated respiratory mucosa that lines the nasal cavity. It results from the invagination and proliferation of epithelial cells in the underlying stroma. Clinical manifestations include nasal obstruction, epistaxis, and anosmia. It has the tendency to recur and extend to adjacent structures. Inverted papillomas are occasionally associated with the development or presence of carcinomas, usually squamous cell carcinomas. C8194 Neoplastic Process Nasal Cavity Inverted Papilloma C0280336 Benign Nasal_Cavity_Inverted_Papilloma Inverting Papilloma of Nasal Cavity Inverting Papilloma of the Nasal Cavity Nasal Cavity Inverted Papilloma Nasal Cavity Inverted Schneiderian Papilloma Nasal Cavity Schneiderian Papilloma, Inverted Type Nasal Cavity Inverted Papilloma A benign neoplasm that arises from the ciliated respiratory mucosa that lines the paranasal sinuses. It results from the invagination and proliferation of epithelial cells in the underlying stroma. C8195 Neoplastic Process Paranasal Sinus Inverted Papilloma C0280337 Undetermined Paranasal_Sinus_Inverted_Papilloma Accessory Sinus Inverted Papilloma Accessory Sinus Inverting Papilloma Inverted Papilloma of Accessory Sinus Inverted Papilloma of Paranasal Sinus Inverted Papilloma of the Accessory Sinus Inverted Papilloma of the Paranasal Sinus Inverting Papilloma of Accessory Sinus Inverting Papilloma of Paranasal Sinus Inverting Papilloma of the Accessory Sinus Inverting Papilloma of the Paranasal Sinus Paranasal Sinus Inverted Papilloma Paranasal Sinus Inverted Schneiderian Papilloma Paranasal Sinus Inverting Papilloma Paranasal Sinus Inverted Papilloma C8197 Neoplastic Process Stage I Lip Basal Cell Carcinoma Stage I Lip Basal Cell Carcinoma C0280344 CTRP Malignant Stage_I_Lip_Basal_Cell_Carcinoma Stage I Basal Cell Carcinoma of Lip Stage I Basal Cell Carcinoma of the Lip Stage I Lip Basal Cell Cancer Stage I Lip Basal Cell Carcinoma Stage I Lip Basal Cell Carcinoma Stage I includes: T1, N0, M0. T1: Tumor 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8199 Neoplastic Process Stage I Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 Stage I Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 C0280346 CTRP Malignant Stage_I_Oral_Cavity_Mucoepidermoid_Carcinoma Stage I Mouth Mucoepidermoid Carcinoma Stage I Mucoepidermoid Carcinoma of Mouth Stage I Mucoepidermoid Carcinoma of Oral Cavity Stage I Mucoepidermoid Carcinoma of the Mouth Stage I Mucoepidermoid Carcinoma of the Oral Cavity Stage I Oral Cavity Mucoepidermoid Cancer Stage I Oral Cavity Mucoepidermoid Carcinoma Stage I Oral Cavity Mucoepidermoid Carcinoma AJCC v6 Stage I Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 Stage I Oral Cavity Mucoepidermoid Carcinoma AJCC v7 Stage I Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 Stage I includes: T1, N0, M0. T1: Tumor 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8200 Neoplastic Process Stage I Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 Stage I Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 C0280347 CTRP Malignant Stage_I_Oral_Cavity_Adenoid_Cystic_Carcinoma Stage I Adenoid Cystic Carcinoma of Mouth Stage I Adenoid Cystic Carcinoma of Oral Cavity Stage I Adenoid Cystic Carcinoma of the Mouth Stage I Adenoid Cystic Carcinoma of the Oral Cavity Stage I Mouth Adenoid Cystic Carcinoma Stage I Oral Cavity Adenoid Cystic Cancer Stage I Oral Cavity Adenoid Cystic Carcinoma Stage I Oral Cavity Adenoid Cystic Carcinoma AJCC v6 Stage I Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 Stage I Oral Cavity Adenoid Cystic Carcinoma AJCC v7 Stage I Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 C8201 Neoplastic Process Stage II Lip Basal Cell Carcinoma Stage II Lip Basal Cell Carcinoma C0280349 CTRP Malignant Stage_II_Lip_Basal_Cell_Carcinoma Stage II Basal Cell Carcinoma of Lip Stage II Basal Cell Carcinoma of the Lip Stage II Lip Basal Cell Cancer Stage II Lip Basal Cell Carcinoma Stage II Lip Basal Cell Carcinoma Stage II includes: T2, N0, M0. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8203 Neoplastic Process Stage II Oral Cavity Mucoepidermoid Carcinoma Stage II Oral Cavity Mucoepidermoid Carcinoma C0280351 CTRP Malignant Stage_II_Oral_Cavity_Mucoepidermoid_Carcinoma Stage II Mouth Mucoepidermoid Carcinoma Stage II Mucoepidermoid Carcinoma of Mouth Stage II Mucoepidermoid Carcinoma of Oral Cavity Stage II Mucoepidermoid Carcinoma of the Mouth Stage II Mucoepidermoid Carcinoma of the Oral Cavity Stage II Oral Cavity Mucoepidermoid Cancer Stage II Oral Cavity Mucoepidermoid Carcinoma Stage II Oral Cavity Mucoepidermoid Carcinoma AJCC v6 Stage II Oral Cavity Mucoepidermoid Carcinoma AJCC v7 Stage II Oral Cavity Mucoepidermoid Carcinoma Stage II includes: T2, N0, M0. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8204 Neoplastic Process Stage II Oral Cavity Adenoid Cystic Carcinoma Stage II Oral Cavity Adenoid Cystic Carcinoma C0280352 CTRP Malignant Stage_II_Oral_Cavity_Adenoid_Cystic_Carcinoma Stage II Adenoid Cystic Carcinoma of Mouth Stage II Adenoid Cystic Carcinoma of Oral Cavity Stage II Adenoid Cystic Carcinoma of the Mouth Stage II Adenoid Cystic Carcinoma of the Oral Cavity Stage II Mouth Adenoid Cystic Carcinoma Stage II Oral Cavity Adenoid Cystic Cancer Stage II Oral Cavity Adenoid Cystic Carcinoma Stage II Oral Cavity Adenoid Cystic Carcinoma AJCC v6 Stage II Oral Cavity Adenoid Cystic Carcinoma AJCC v7 Stage II Oral Cavity Adenoid Cystic Carcinoma C8205 Neoplastic Process Stage III Lip Basal Cell Carcinoma Stage III Lip Basal Cell Carcinoma C0280354 CTRP Malignant Stage_III_Lip_Basal_Cell_Carcinoma Stage III Basal Cell Carcinoma of Lip Stage III Basal Cell Carcinoma of the Lip Stage III Lip Basal Cell Cancer Stage III Lip Basal Cell Carcinoma Stage III Lip Basal Cell Carcinoma Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor more than 4 cm in greatest dimension. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8207 Neoplastic Process Stage III Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 Stage III Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 C0280356 CTRP Malignant Stage_III_Oral_Cavity_Mucoepidermoid_Carcinoma Stage III Mouth Mucoepidermoid Carcinoma Stage III Mucoepidermoid Carcinoma of Mouth Stage III Mucoepidermoid Carcinoma of Oral Cavity Stage III Mucoepidermoid Carcinoma of the Mouth Stage III Mucoepidermoid Carcinoma of the Oral Cavity Stage III Oral Cavity Mucoepidermoid Cancer Stage III Oral Cavity Mucoepidermoid Carcinoma Stage III Oral Cavity Mucoepidermoid Carcinoma AJCC v6 Stage III Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 Stage III Oral Cavity Mucoepidermoid Carcinoma AJCC v7 Stage III Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor more than 4 cm in greatest dimension. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8208 Neoplastic Process Stage III Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 Stage III Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 C0280357 CTRP Malignant Stage_III_Oral_Cavity_Adenoid_Cystic_Carcinoma Stage III Adenoid Cystic Carcinoma of Mouth Stage III Adenoid Cystic Carcinoma of Oral Cavity Stage III Adenoid Cystic Carcinoma of the Mouth Stage III Adenoid Cystic Carcinoma of the Oral Cavity Stage III Mouth Adenoid Cystic Carcinoma Stage III Oral Cavity Adenoid Cystic Cancer Stage III Oral Cavity Adenoid Cystic Carcinoma Stage III Oral Cavity Adenoid Cystic Carcinoma AJCC v6 Stage III Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 Stage III Oral Cavity Adenoid Cystic Carcinoma AJCC v7 Stage III Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 C8209 Neoplastic Process Stage IV Lip Basal Cell Carcinoma Stage IV Lip Basal Cell Carcinoma C0280359 CTRP Malignant Stage_IV_Lip_Basal_Cell_Carcinoma Stage IV Basal Cell Carcinoma of Lip Stage IV Basal Cell Carcinoma of the Lip Stage IV Lip Basal Cell Cancer Stage IV Lip Basal Cell Carcinoma Stage IV Lip Basal Cell Carcinoma Stage IV includes: IVA (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0);. IVB (Any T, N3, M0); (T4b, Any N, M0); IVC (Any T, Any N, M1). T4a: (oral cavity) Tumor invades adjacent structures (e.g., through cortical bone, into deep [extrinsic] muscles of tongue, maxillary sinus, skin of face). T4b: Tumor invades masticator space, pterygoid plates, or skull base and/or encases internal carotid artery. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension; or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension; or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N2a: Metastasis in a single ipsilateral lymph node more than 3 cm but not more than 6 cm in dimension. N2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension. N2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a lymph node more than 6 cm in greatest dimension. M1: Distant metastasis. (AJCC 6th and 7th eds.) C8211 Neoplastic Process Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 C0280361 CTRP Malignant Stage_IV_Oral_Cavity_Mucoepidermoid_Carcinoma Stage IV Mouth Mucoepidermoid Carcinoma Stage IV Mucoepidermoid Carcinoma of Mouth Stage IV Mucoepidermoid Carcinoma of Oral Cavity Stage IV Mucoepidermoid Carcinoma of the Mouth Stage IV Mucoepidermoid Carcinoma of the Oral Cavity Stage IV Oral Cavity Mucoepidermoid Cancer Stage IV Oral Cavity Mucoepidermoid Carcinoma Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v7 Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7 C8212 Neoplastic Process Stage IV Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 Stage IV Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 C0280362 CTRP Malignant Stage_IV_Oral_Cavity_Adenoid_Cystic_Carcinoma Stage IV Adenoid Cystic Carcinoma of Mouth Stage IV Adenoid Cystic Carcinoma of Oral Cavity Stage IV Adenoid Cystic Carcinoma of the Mouth Stage IV Adenoid Cystic Carcinoma of the Oral Cavity Stage IV Mouth Adenoid Cystic Carcinoma Stage IV Oral Cavity Adenoid Cystic Cancer Stage IV Oral Cavity Adenoid Cystic Carcinoma Stage IV Oral Cavity Adenoid Cystic Carcinoma AJCC v6 Stage IV Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 Stage IV Oral Cavity Adenoid Cystic Carcinoma AJCC v7 Stage IV Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7 Reemergence of basal cell carcinoma of the lip after a period of remission. C8213 Neoplastic Process Recurrent Lip Basal Cell Carcinoma Recurrent Lip Basal Cell Carcinoma C0280364 CTRP Malignant Recurrent_Lip_Basal_Cell_Carcinoma Recurrent Basal Cell Carcinoma of Lip Recurrent Basal Cell Carcinoma of the Lip Recurrent Lip Basal Cell Cancer Recurrent Lip Basal Cell Carcinoma Relapsed Basal Cell Carcinoma of Lip Relapsed Basal Cell Carcinoma of the Lip Relapsed Lip Basal Cell Carcinoma Recurrent Lip Basal Cell Carcinoma Reemergence of verrucous carcinoma of the oral cavity after a period of remission. C8214 Neoplastic Process Recurrent Oral Cavity Verrucous Carcinoma Recurrent Oral Cavity Verrucous Carcinoma C0280365 CTRP Malignant Recurrent_Oral_Cavity_Verrucous_Carcinoma Recurrent Mouth Verrucous Carcinoma Recurrent Oral Cavity Verrucous Cancer Recurrent Oral Cavity Verrucous Carcinoma Recurrent Verrucous Carcinoma of Mouth Recurrent Verrucous Carcinoma of Oral Cavity Recurrent Verrucous Carcinoma of the Mouth Recurrent Verrucous Carcinoma of the Oral Cavity Relapsed Mouth Verrucous Carcinoma Relapsed Oral Cavity Verrucous Carcinoma Relapsed Verrucous Carcinoma of Mouth Relapsed Verrucous Carcinoma of Oral Cavity Relapsed Verrucous Carcinoma of the Mouth Relapsed Verrucous Carcinoma of the Oral Cavity Recurrent Oral Cavity Verrucous Carcinoma The reemergence of mucoepidermoid carcinoma in the oral cavity after a period of remission. C8215 Neoplastic Process Recurrent Oral Cavity Mucoepidermoid Carcinoma Recurrent Oral Cavity Mucoepidermoid Carcinoma C0280366 CTRP Malignant Recurrent_Oral_Cavity_Mucoepidermoid_Carcinoma Recurrent Mouth Mucoepidermoid Carcinoma Recurrent Mucoepidermoid Carcinoma of Mouth Recurrent Mucoepidermoid Carcinoma of Oral Cavity Recurrent Mucoepidermoid Carcinoma of the Mouth Recurrent Mucoepidermoid Carcinoma of the Oral Cavity Recurrent Oral Cavity Mucoepidermoid Carcinoma Relapsed Mouth Mucoepidermoid Carcinoma Relapsed Mucoepidermoid Carcinoma of Mouth Relapsed Mucoepidermoid Carcinoma of Oral Cavity Relapsed Mucoepidermoid Carcinoma of the Mouth Relapsed Mucoepidermoid Carcinoma of the Oral Cavity Relapsed Oral Cavity Mucoepidermoid Carcinoma Recurrent Oral Cavity Mucoepidermoid Carcinoma The reemergence of adenoid cystic carcinoma in the oral cavity after a period of remission. C8216 Neoplastic Process Recurrent Oral Cavity Adenoid Cystic Carcinoma Recurrent Oral Cavity Adenoid Cystic Carcinoma C0280367 CTRP Malignant Recurrent_Oral_Cavity_Adenoid_Cystic_Carcinoma Recurrent Adenoid Cystic Carcinoma of Mouth Recurrent Adenoid Cystic Carcinoma of Oral Cavity Recurrent Adenoid Cystic Carcinoma of the Mouth Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Recurrent Mouth Adenoid Cystic Carcinoma Recurrent Oral Cavity Adenoid Cystic Cancer Recurrent Oral Cavity Adenoid Cystic Carcinoma Relapsed Adenoid Cystic Carcinoma of Mouth Relapsed Adenoid Cystic Carcinoma of Oral Cavity Relapsed Adenoid Cystic Carcinoma of the Mouth Relapsed Adenoid Cystic Carcinoma of the Oral Cavity Relapsed Mouth Adenoid Cystic Carcinoma Relapsed Oral Cavity Adenoid Cystic Carcinoma Recurrent Oral Cavity Adenoid Cystic Carcinoma Stage I includes: T1, N0, M0. T1: Tumor 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8217 Neoplastic Process Stage I Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage I Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7 C0280368 CTRP Malignant Stage_I_Oropharyngeal_Squamous_Cell_Carcinoma Stage I Epidermoid Carcinoma of Oropharynx Stage I Epidermoid Carcinoma of the Oropharynx Stage I Oropharyngeal Epidermoid Carcinoma Stage I Oropharyngeal SCC Stage I Oropharyngeal Squamous Cell Carcinoma Stage I Oropharyngeal Squamous Cell Carcinoma AJCC v6 Stage I Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage I Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage I Oropharyngeal Throat Squamous Cell Cancer Stage I SCC of Oropharynx Stage I SCC of the Oropharynx Stage I Squamous Cell Carcinoma of Oropharynx Stage I Squamous Cell Carcinoma of the Oropharynx Stage I Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7 An acute leukemia of ambiguous lineage. It is characterized by the presence of either separate populations of blasts of more than one lineage, or one population of blasts co-expressing markers of more than one lineage. C82179 Neoplastic Process Mixed Phenotype Acute Leukemia Mixed Phenotype Acute Leukemia C2826025 CPTAC CTRP Cellosaurus NICHD PCDC An acute leukemia of ambiguous lineage. It is characterized by the presence of either separate populations of blasts of more than one lineage or one population of blasts co-expressing markers of more than one lineage. Malignant Mixed_Phenotype_Acute_Leukemia MPAL Mixed Phenotype Acute Leukemia Mixed phenotype (biphenotypic) acute leukemia Mixed Phenotype Acute Leukemia Stage II includes: T2, N0, M0. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8218 Neoplastic Process Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7 C0280370 CTRP Malignant Stage_II_Oropharyngeal_Squamous_Cell_Carcinoma Stage II Epidermoid Carcinoma of Oropharynx Stage II Epidermoid Carcinoma of the Oropharynx Stage II Oropharyngeal Epidermoid Carcinoma Stage II Oropharyngeal SCC Stage II Oropharyngeal Squamous Cell Carcinoma Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage II Oropharyngeal Throat Squamous Cell Cancer Stage II SCC of Oropharynx Stage II SCC of the Oropharynx Stage II Squamous Cell Carcinoma of Oropharynx Stage II Squamous Cell Carcinoma of the Oropharynx Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T1: Tumor 2 cm or less in greatest dimension. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3: Tumor measuring more than 4 centimeters in greatest dimension or extension to lingual surface of epiglottis. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C8219 Neoplastic Process Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 C0280372 CTRP Malignant Stage_III_Oropharyngeal_Squamous_Cell_Carcinoma Stage III Epidermoid Carcinoma of Oropharynx Stage III Epidermoid Carcinoma of the Oropharynx Stage III Oropharyngeal Epidermoid Carcinoma Stage III Oropharyngeal SCC Stage III Oropharyngeal Squamous Cell Carcinoma Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage III Oropharyngeal Throat Squamous Cell Cancer Stage III SCC of Oropharynx Stage III SCC of the Oropharynx Stage III Squamous Cell Carcinoma of Oropharynx Stage III Squamous Cell Carcinoma of the Oropharynx Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 A rare mixed phenotype acute leukemia in which the blasts carry the chromosomal translocation t(9;22)(q34.1;q11.2) that results in BCR-ABL1 gene fusion. The prognosis is usually unfavorable. C82192 Neoplastic Process Mixed Phenotype Acute Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 Mixed Phenotype Acute Leukemia with BCR-ABL1 Fusion C2826037 CTRP Cellosaurus GDC 9806/3 Malignant Mixed_Phenotype_Acute_Leukemia_with_t_9_22_q34_q11_2_BCR-ABL1 9806/3 Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1 MPAL with t(9;22)(q34.1;q11.2); BCR-ABL1 MPAL with t(9;22)(q34.1;q11.2); BCR::ABL1 Mixed Phenotype Acute Leukemia with BCR-ABL1 Fusion Mixed Phenotype Acute Leukemia with BCR::ABL1 Fusion Mixed Phenotype Acute Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 Mixed Phenotype Acute Leukemia with t(9;22)(q34.1;q11.2); BCR::ABL1 Mixed Phenotype Acute Leukemia with t(9;22)(q34;q11.2); BCR-ABL1 Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1 Mixed-Phenotype Acute Leukemia with BCR-ABL1 Fusion Mixed-Phenotype Acute Leukemia with BCR::ABL1 Fusion Mixed Phenotype Acute Leukemia with BCR-ABL1 Fusion Stage IV includes: IVA (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB (T4b, Any N, M0); (Any T, N3, M0); IVC (Any T, Any N, M1). T4a: Tumor with moderately advanced local disease. Tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible. Mucosal extension to lingual surface of epiglottis from primary tumors of the base of the tongue and vallecula does not constitute invasion of larynx. T1: Tumor 2 cm or less in greatest dimension. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3: Tumor measuring more than 4 centimeters in greatest dimension or extension to lingual surface of epiglottis. T4b: Tumor with very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Tumor with metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Tumor with metastasis in a lymph node more than 6 cm in greatest dimension. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C8220 Neoplastic Process Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7 C0280374 CTRP Malignant Stage_IV_Oropharyngeal_Squamous_Cell_Carcinoma Stage IV Epidermoid Carcinoma of Oropharynx Stage IV Epidermoid Carcinoma of the Oropharynx Stage IV Oropharyngeal Epidermoid Carcinoma Stage IV Oropharyngeal SCC Stage IV Oropharyngeal Squamous Cell Carcinoma Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IV Oropharyngeal Throat Squamous Cell Cancer Stage IV Oropharynx Epidermoid Carcinoma Stage IV Oropharynx Squamous Cell Carcinoma Stage IV SCC of Oropharynx Stage IV SCC of the Oropharynx Stage IV Squamous Cell Carcinoma of Oropharynx Stage IV Squamous Cell Carcinoma of the Oropharynx Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7 A rare mixed phenotype acute leukemia in which the blasts carry a translocation between the KMT2A gene at 11q23.3 and another gene partner. The prognosis is usually unfavorable. C82203 Neoplastic Process Mixed Phenotype Acute Leukemia with KMT2A Rearrangement C2826048 GDC 9807/3 Malignant Mixed_Phenotype_Acute_Leukemia_with_t_v_11q23_MLL_Rearranged 9807/3 Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged MPAL with t(v;11q23.3); KMT2A Rearranged MPAL, with t(v;11q23.3); KMT2A Rearranged Mixed Phenotype Acute Leukemia with KMT2A Rearrangement Mixed Phenotype Acute Leukemia with t(v;11q23); MLL Rearranged Mixed Phenotype Acute Leukemia with t(v;11q23.3); KMT2A Rearranged Mixed Phenotype Acute Leukemia with t(v;11q23.3); MLL Rearranged Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged Mixed-Phenotype Acute Leukemia with KMT2A Rearrangement Mixed Phenotype Acute Leukemia with KMT2A Rearrangement Reemergence of squamous cell carcinoma of the oropharynx after a period of remission. C8221 Neoplastic Process Recurrent Oropharyngeal Squamous Cell Carcinoma Recurrent Oropharyngeal Squamous Cell Carcinoma C0280376 CTRP Malignant Recurrent_Oropharyngeal_Squamous_Cell_Carcinoma Recurrent Epidermoid Carcinoma of Oropharynx Recurrent Epidermoid Carcinoma of the Oropharynx Recurrent Oropharyngeal Epidermoid Carcinoma Recurrent Oropharyngeal SCC Recurrent Oropharyngeal Squamous Cell Carcinoma Recurrent Oropharyngeal Throat Squamous Cell Cancer Recurrent SCC of Oropharynx Recurrent SCC of the Oropharynx Recurrent Squamous Cell Carcinoma of Oropharynx Recurrent Squamous Cell Carcinoma of the Oropharynx Relapsed Epidermoid Carcinoma of Oropharynx Relapsed Epidermoid Carcinoma of the Oropharynx Relapsed Oropharyngeal Epidermoid Carcinoma Relapsed Oropharyngeal SCC Relapsed Oropharyngeal Squamous Cell Carcinoma Relapsed SCC of Oropharynx Relapsed SCC of the Oropharynx Relapsed Squamous Cell Carcinoma of Oropharynx Relapsed Squamous Cell Carcinoma of the Oropharynx Recurrent Oropharyngeal Squamous Cell Carcinoma A rare mixed phenotype acute leukemia in which the blasts express B-lymphoid and myeloid lineage markers but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. The prognosis is usually unfavorable. C82212 Neoplastic Process Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified Mixed Phenotype Acute Leukemia, B/Myeloid C3472616 CTRP GDC 9808/3 Malignant Mixed_Phenotype_Acute_Leukemia_B_Myeloid_Not_Otherwise_Specified 9808/3 Mixed phenotype acute leukemia, B/myeloid, NOS MPAL, B/Myeloid, NOS Mixed Phenotype Acute Leukemia, B/Myeloid Mixed Phenotype Acute Leukemia, B/Myeloid, NOS Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified Mixed phenotype acute leukemia, B/myeloid, NOS Mixed Phenotype Acute Leukemia, B/Myeloid A rare mixed phenotype acute leukemia in which the blasts express T-lymphoid and myeloid lineage markers but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. The prognosis is usually unfavorable. C82213 Neoplastic Process Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified Mixed Phenotype Acute Leukemia, T/Myeloid C2826055 CTRP GDC 9809/3 Malignant Mixed_Phenotype_Acute_Leukemia_T_Myeloid_Not_Otherwise_Specified 9809/3 Mixed phenotype acute leukemia, T/myeloid, NOS MPAL, T/Myeloid, NOS Mixed Phenotype Acute Leukemia, T/Myeloid Mixed Phenotype Acute Leukemia, T/Myeloid, NOS Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified Mixed phenotype acute leukemia, T/myeloid, NOS Mixed Phenotype Acute Leukemia, T/Myeloid A precursor lymphoid neoplasm that expresses CD56 and immature T-cell markers, lacks B-lymphoid and myeloid markers, and has immunoglobulin and T-cell receptor genes in the germline configuration. C82217 Neoplastic Process Natural Killer Cell Lymphoblastic Leukemia/Lymphoma C2826059 Cellosaurus Malignant Natural_Killer_Cell_Lymphoblastic_Leukemia_Lymphoma NK Cell Lymphoblastic Leukemia/Lymphoma NK Lymphoblastic Leukemia/Lymphoma NK-ALL/LBL NK-Lymphoblastic Leukemia/Lymphoma Natural Killer Cell Lymphoblastic Leukemia/Lymphoma Precursor NK Cell Lymphoblastic Leukemia/Lymphoma Precursor Natural Killer Cell Lymphoblastic Leukemia/Lymphoma Natural Killer Cell Lymphoblastic Leukemia/Lymphoma Stage I includes: T1, N0, M0. T1: Nasopharyngeal cancer with tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C8222 Neoplastic Process Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 C0280378 CTRP Malignant Stage_I_Nasopharyngeal_Squamous_Cell_Carcinoma Stage I Keratinizing Epidermoid Carcinoma of Nasopharynx Stage I Keratinizing Epidermoid Carcinoma of the Nasopharynx Stage I Keratinizing Squamous Cell Carcinoma of Nasopharynx Stage I Keratinizing Squamous Cell Carcinoma of the Nasopharynx Stage I Nasopharyngeal Keratinizing Epidermoid Carcinoma Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage I Nasopharyngeal Throat Keratinizing Squamous Cell Cancer Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage I includes: T1, N0, M0. T1: Nasopharyngeal cancer with tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C8223 Neoplastic Process Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7 Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7 C0280379 CTRP Malignant Stage_I_Nasopharyngeal_Undifferentiated_Carcinoma Nasopharyngeal Undifferentiated Carcinoma Stage I Stage I Lymphoepithelioma of Nasopharynx Stage I Lymphoepithelioma of the Nasopharynx Stage I Nasopharyngeal Lymphoepithelioma Stage I Nasopharyngeal Undifferentiated Carcinoma Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7 Stage I Undifferentiated Nasopharyngeal Throat Cancer Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7 Stage II includes: (T1, N1, M0); (T2, N0, M0); (T2, N1, M0). T1: Nasopharyngeal cancer with tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. T2: Nasopharyngeal cancer with parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. N0: No regional lymph node metastasis. N1: Nasopharyngeal cancer with unilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa, and/or unilateral or bilateral, retropharyngeal lymph nodes, 6 cm or less in greatest dimension. Midline nodes are considered ipsilateral nodes. M0: No distant metastasis. (AJCC 7th ed.) C8224 Neoplastic Process Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 C0280380 CTRP Malignant Stage_II_Nasopharyngeal_Squamous_Cell_Carcinoma Stage II Keratinizing Epidermoid Carcinoma of Nasopharynx Stage II Keratinizing Epidermoid Carcinoma of the Nasopharynx Stage II Keratinizing Squamous Cell Carcinoma of Nasopharynx Stage II Keratinizing Squamous Cell Carcinoma of the Nasopharynx Stage II Nasopharyngeal Keratinizing Epidermoid Carcinoma Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage II Nasopharyngeal Throat Keratinizing Squamous Cell Cancer Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage II includes: (T1, N1, M0); (T2, N0, M0); (T2, N1, M0). T1: Nasopharyngeal cancer with tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. T2: Nasopharyngeal cancer with parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. N0: No regional lymph node metastasis. N1: Nasopharyngeal cancer with unilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa, and/or unilateral or bilateral, retropharyngeal lymph nodes, 6 cm or less in greatest dimension. Midline nodes are considered ipsilateral nodes. M0: No distant metastasis. (AJCC 7th ed.) C8225 Neoplastic Process Stage II Nasopharyngeal Undifferentiated Carcinoma AJCC v7 Stage II Nasopharyngeal Undifferentiated Carcinoma AJCC v7 C0280381 CTRP Malignant Stage_II_Nasopharyngeal_Undifferentiated_Carcinoma Nasopharyngeal Undifferentiated Carcinoma Stage II Stage II Lymphoepithelioma of Nasopharynx Stage II Lymphoepithelioma of the Nasopharynx Stage II Nasopharyngeal Lymphoepithelioma Stage II Nasopharyngeal Undifferentiated Carcinoma Stage II Nasopharyngeal Undifferentiated Carcinoma AJCC v7 Stage II Undifferentiated Nasopharyngeal Throat Cancer Stage II Nasopharyngeal Undifferentiated Carcinoma AJCC v7 Stage III includes: (T1, N2, M0); (T2, N2, M0); (T3, N0, M0); (T3, N1, M0); (T3, N2, M0). T1: Nasopharyngeal cancer with tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. T2: Nasopharyngeal cancer with parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. T3: Nasopharyngeal cancer with tumor involving bony structures of skull base and/or paranasal sinuses. N0: No regional lymph node metastasis. N1: Nasopharyngeal cancer with unilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa, and/or unilateral or bilateral, retropharyngeal lymph nodes, 6 cm or less in greatest dimension. Midline nodes are considered ipsilateral nodes. N2: Nasopharyngeal cancer with bilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa. Midline nodes are considered ipsilateral nodes. M0: No distant metastasis. (AJCC 7th ed.) C8226 Neoplastic Process Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 C0280382 CTRP Malignant Stage_III_Nasopharyngeal_Squamous_Cell_Carcinoma Stage III Keratinizing Epidermoid Carcinoma of Nasopharynx Stage III Keratinizing Epidermoid Carcinoma of the Nasopharynx Stage III Keratinizing Squamous Cell Carcinoma of Nasopharynx Stage III Keratinizing Squamous Cell Carcinoma of the Nasopharynx Stage III Nasopharyngeal Keratinizing Epidermoid Carcinoma Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage III Nasopharyngeal Throat Keratinizing Squamous Cell Cancer Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage III includes: (T1, N2, M0); (T2, N2, M0); (T3, N0, M0); (T3, N1, M0); (T3, N2, M0). T1: Nasopharyngeal cancer with tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. T2: Nasopharyngeal cancer with parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. T3: Nasopharyngeal cancer with tumor involving bony structures of skull base and/or paranasal sinuses. N0: No regional lymph node metastasis. N1: Nasopharyngeal cancer with unilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa, and/or unilateral or bilateral, retropharyngeal lymph nodes, 6 cm or less in greatest dimension. Midline nodes are considered ipsilateral nodes. N2: Nasopharyngeal cancer with bilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa. Midline nodes are considered ipsilateral nodes. M0: No distant metastasis. (AJCC 7th ed.) C8227 Neoplastic Process Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7 Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7 C0280383 CTRP Malignant Stage_III_Nasopharyngeal_Undifferentiated_Carcinoma Nasopharyngeal Undifferentiated Carcinoma Stage III Stage III Lymphoepithelioma of Nasopharynx Stage III Lymphoepithelioma of the Nasopharynx Stage III Nasopharyngeal Lymphoepithelioma Stage III Nasopharyngeal Undifferentiated Carcinoma Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7 Stage III Undifferentiated Nasopharyngeal Throat Cancer Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7 Stage IV includes: IVA: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0); IVB (Any T, N3, M0); IVC (Any T, Any N, M1). T4: Nasopharyngeal cancer with intracranial extension and/or involvement of cranial nerves, hypopharynx, orbit, or with extension to the infratemporal fossa/masticator space. N0: No regional lymph node metastasis. N1: Nasopharyngeal cancer with unilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa, and/or unilateral or bilateral, retropharyngeal lymph nodes, 6 cm or less in greatest dimension. Midline nodes are considered ipsilateral nodes. N2: Nasopharyngeal cancer with bilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa. Midline nodes are considered ipsilateral nodes. N3: Nasopharyngeal cancer with metastasis in a lymph node (s) more than 6 cm in greatest dimension and/or to supraclavicular fossa. Supraclavicular zone or fossa is relevant to the staging of nasopharyngeal carcinoma and is the triangular region originally described by Ho. It is defined by three points: (1) the superior margin of the sternal end of the clavicle, (2) the superior margin of the lateral end of the clavicle, (3) the point where the neck meets the shoulder. This would include caudal portions of levels IV and VB. All cases with lymph nodes (whole or part) in the fossa are considered N3b. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C8228 Neoplastic Process Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 C0280384 CTRP Malignant Stage_IV_Nasopharyngeal_Squamous_Cell_Carcinoma Stage IV Keratinizing Epidermoid Carcinoma of Nasopharynx Stage IV Keratinizing Epidermoid Carcinoma of the Nasopharynx Stage IV Keratinizing Squamous Cell Carcinoma of Nasopharynx Stage IV Keratinizing Squamous Cell Carcinoma of the Nasopharynx Stage IV Nasopharyngeal Keratinizing Epidermoid Carcinoma Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage IV Nasopharyngeal Throat Keratinizing Squamous Cell Cancer Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage IV includes: IVA: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0); IVB (Any T, N3, M0); IVC (Any T, Any N, M1). T4: Nasopharyngeal cancer with intracranial extension and/or involvement of cranial nerves, hypopharynx, orbit, or with extension to the infratemporal fossa/masticator space. N0: No regional lymph node metastasis. N1: Nasopharyngeal cancer with unilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa, and/or unilateral or bilateral, retropharyngeal lymph nodes, 6 cm or less in greatest dimension. Midline nodes are considered ipsilateral nodes. N2: Nasopharyngeal cancer with bilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa. Midline nodes are considered ipsilateral nodes. N3: Nasopharyngeal cancer with metastasis in a lymph node (s) more than 6 cm in greatest dimension and/or to supraclavicular fossa. Supraclavicular zone or fossa is relevant to the staging of nasopharyngeal carcinoma and is the triangular region originally described by Ho. It is defined by three points: (1) the superior margin of the sternal end of the clavicle, (2) the superior margin of the lateral end of the clavicle, (3) the point where the neck meets the shoulder. This would include caudal portions of levels IV and VB. All cases with lymph nodes (whole or part) in the fossa are considered N3b. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C8229 Neoplastic Process Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7 Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7 C0280385 CTRP Malignant Stage_IV_Nasopharyngeal_Undifferentiated_Carcinoma Nasopharyngeal Undifferentiated Carcinoma Stage IV Stage IV Lymphoepithelioma of Nasopharynx Stage IV Lymphoepithelioma of the Nasopharynx Stage IV Nasopharyngeal Lymphoepithelioma Stage IV Nasopharyngeal Undifferentiated Carcinoma Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7 Stage IV Undifferentiated Nasopharyngeal Throat Cancer Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7 The reemergence of keratinizing squamous cell carcinoma of the nasopharynx after a period of remission. C8230 Neoplastic Process Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma C0280386 CTRP Malignant Recurrent_Nasopharyngeal_Squamous_Cell_Carcinoma Recurrent Keratinizing Epidermoid Carcinoma of Nasopharynx Recurrent Keratinizing Epidermoid Carcinoma of the Nasopharynx Recurrent Keratinizing Squamous Cell Carcinoma of Nasopharynx Recurrent Keratinizing Squamous Cell Carcinoma of the Nasopharynx Recurrent Nasopharyngeal Keratinizing Epidermoid Carcinoma Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma Recurrent Nasopharyngeal Throat Keratinizing Squamous Cell Cancer Relapsed Keratinizing Epidermoid Carcinoma of Nasopharynx Relapsed Keratinizing Epidermoid Carcinoma of the Nasopharynx Relapsed Keratinizing Squamous Cell Carcinoma of Nasopharynx Relapsed Keratinizing Squamous Cell Carcinoma of the Nasopharynx Relapsed Nasopharyngeal Keratinizing Epidermoid Carcinoma Relapsed Nasopharyngeal Keratinizing Squamous Cell Carcinoma Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma The reemergence of undifferentiated carcinoma of the nasopharynx after a period of remission. C8231 Neoplastic Process Recurrent Nasopharyngeal Undifferentiated Carcinoma Recurrent Nasopharyngeal Undifferentiated Carcinoma C0280387 CTRP Malignant Recurrent_Nasopharyngeal_Undifferentiated_Carcinoma Recurrent Lymphoepithelioma of Nasopharynx Recurrent Lymphoepithelioma of the Nasopharynx Recurrent Nasopharyngeal Lymphoepithelioma Recurrent Nasopharyngeal Throat Undifferentiated Carcinoma Recurrent Nasopharyngeal Undifferentiated Carcinoma Recurrent Undifferentiated Carcinoma of Nasopharynx Recurrent Undifferentiated Carcinoma of the Nasopharynx Relapsed Lymphoepithelioma of Nasopharynx Relapsed Lymphoepithelioma of the Nasopharynx Relapsed Nasopharyngeal Lymphoepithelioma Relapsed Nasopharyngeal Undifferentiated Carcinoma Relapsed Undifferentiated Carcinoma of Nasopharynx Relapsed Undifferentiated Carcinoma of the Nasopharynx Recurrent Nasopharyngeal Undifferentiated Carcinoma Stage I includes: T1, N0, M0. T1: Tumor limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C8232 Neoplastic Process Stage I Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage I Hypopharyngeal Squamous Cell Carcinoma AJCC v7 C0280388 CTRP Malignant Stage_I_Hypopharyngeal_Squamous_Cell_Carcinoma Stage I Epidermoid Carcinoma of Hypopharynx Stage I Epidermoid Carcinoma of the Hypopharynx Stage I Hypopharyngeal Epidermoid Carcinoma Stage I Hypopharyngeal Squamous Cell Carcinoma Stage I Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage I Hypopharyngeal Throat Squamous Cell Cancer Stage I Squamous Cell Carcinoma of Hypopharynx Stage I Squamous Cell Carcinoma of the Hypopharynx Stage I Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage II includes: T2, N0, M0. T2: Tumor invades more than one subsite of the hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8233 Neoplastic Process Stage II Hypopharyngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage II Hypopharyngeal Squamous Cell Carcinoma AJCC v6 and v7 C0280389 CTRP Malignant Stage_II_Hypopharyngeal_Squamous_Cell_Carcinoma Stage II Epidermoid Carcinoma of Hypopharynx Stage II Epidermoid Carcinoma of the Hypopharynx Stage II Hypopharyngeal Epidermoid Carcinoma Stage II Hypopharyngeal Squamous Cell Carcinoma Stage II Hypopharyngeal Squamous Cell Carcinoma AJCC v6 Stage II Hypopharyngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage II Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage II Hypopharyngeal Throat Squamous Cell Cancer Stage II Squamous Cell Carcinoma of Hypopharynx Stage II Squamous Cell Carcinoma of the Hypopharynx Stage II Hypopharyngeal Squamous Cell Carcinoma AJCC v6 and v7 Hematologic neoplasms occurring in individuals with Down syndrome. There is an increased risk of acute leukemias in both children and adults with Down syndrome. In particular, the incidence of acute myeloid leukemia in Down syndrome children of less than five years of age is particularly high, it is usually an acute megakaryoblastic leukemia, and is associated with GATA1 gene mutation. This group of disorders also includes the entity transient abnormal myelopoiesis which occurs in neonates and is associated with GATA1 gene mutation. C82338 Neoplastic Process Myeloid Proliferations Related to Down Syndrome Hematologic Neoplasm Associated with Down Syndrome C2826104 CTRP PCDC Malignant Myeloid_Proliferations_Related_to_Down_Syndrome Hematologic Neoplasm Associated with Down Syndrome Myeloid Proliferation Associated with Down Syndrome Myeloid Proliferations Associated with Down Syndrome Myeloid Proliferations Related to Down Syndrome Hematologic Neoplasm Associated with Down Syndrome A myeloid proliferation occurring in newborns with Down syndrome. It is clinically and morphologically indistinguishable from acute myeloid leukemia and is associated with GATA1 mutations. The blasts display morphologic and immunophenotypic features of megakaryocytic lineage. In the majority of patients the myeloid proliferation undergoes spontaneous remission. C82339 Neoplastic Process Transient Abnormal Myelopoiesis Associated with Down Syndrome C1834582 Cellosaurus GDC NICHD PCDC A myeloid proliferation occurring in newborns with Down syndrome. It is clinically and morphologically indistinguishable from acute myeloid leukemia and is associated with GATA1 mutations. The blasts display morphologic and immunophenotypic features of megakaryocytic lineage. In the majority of patients, the myeloid proliferation undergoes spontaneous remission. AML diagnosed within four years of a diagnosis of Transient Abnormal Myelopoiesis Associated with Down Syndrome (a myeloid proliferation occurring in newborns with Down syndrome). Transient Abnormal Myelopoiesis Associated with Down Syndrome is clinically and morphologically indistinguishable from acute myeloid leukemia and is associated with GATA1 mutations. 9898/1 Malignant Transient_Abnormal_Myelopoiesis 9898/1 Transient abnormal myelopoiesis TAM Transient Abnormal Myelopoiesis Transient Abnormal Myelopoiesis (TAM) Transient Abnormal Myelopoiesis Associated with Down Syndrome Transient Myeloproliferative Disorder Transient abnormal myelopoiesis Transient Abnormal Myelopoiesis Associated with Down Syndrome Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor measuring more than 4 cm in greatest dimension or with fixation of hemilarynx or extension to esophagus. T1: Tumor limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimension. T2: Tumor invades more than one subsite of the hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C8234 Neoplastic Process Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 C0280390 CTRP Malignant Stage_III_Hypopharyngeal_Squamous_Cell_Carcinoma Stage III Epidermoid Carcinoma of Hypopharynx Stage III Epidermoid Carcinoma of the Hypopharynx Stage III Hypopharyngeal Epidermoid Carcinoma Stage III Hypopharyngeal Squamous Cell Carcinoma Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage III Hypopharyngeal Throat Squamous Cell Cancer Stage III Squamous Cell Carcinoma of Hypopharynx Stage III Squamous Cell Carcinoma of the Hypopharynx Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage IV includes: IVA: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB: (T4b, Any N, M0); (Any T, N3, M0); IVC: (Any T, Any N, M1). T4a: Tumor with moderately advanced local disease. Tumor invades the thyroid/cricoid cartilage, hyoid bone, thyroid gland, or central compartment soft tissue. Central compartment soft tissue includes prelaryngeal strap muscles and subcutaneous fat. T1: Tumor limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimension. T2: Tumor invades more than one subsite of the hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx. T3: Tumor measuring more than 4 cm in greatest dimension or tumor with fixation of hemilarynx or extension to esophagus. T4b: Tumor with very advanced local disease. Tumor invades prevertebral fascia, encases carotid artery, or involves mediastinal structures. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Tumor with metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a lymph node more than 6 cm in greatest dimension. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C8235 Neoplastic Process Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 C0280391 CTRP Malignant Stage_IV_Hypopharyngeal_Squamous_Cell_Carcinoma Stage IV Epidermoid Carcinoma of Hypopharynx Stage IV Epidermoid Carcinoma of the Hypopharynx Stage IV Hypopharyngeal Epidermoid Carcinoma Stage IV Hypopharyngeal Squamous Cell Carcinoma Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage IV Hypopharyngeal Throat Squamous Cell Cancer Stage IV Squamous Cell Carcinoma of Hypopharynx Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Reemergence of squamous cell carcinoma of the hypopharynx after a period of remission. C8236 Neoplastic Process Recurrent Hypopharyngeal Squamous Cell Carcinoma Recurrent Hypopharyngeal Squamous Cell Carcinoma C0280392 CTRP Malignant Recurrent_Hypopharyngeal_Squamous_Cell_Carcinoma Recurrent Epidermoid Carcinoma of Hypopharynx Recurrent Epidermoid Carcinoma of the Hypopharynx Recurrent Hypopharyngeal Epidermoid Carcinoma Recurrent Hypopharyngeal Squamous Cell Carcinoma Recurrent Hypopharyngeal Throat Squamous Cell Cancer Recurrent Squamous Cell Carcinoma of Hypopharynx Recurrent Squamous Cell Carcinoma of the Hypopharynx Relapsed Epidermoid Carcinoma of Hypopharynx Relapsed Epidermoid Carcinoma of the Hypopharynx Relapsed Hypopharyngeal Epidermoid Carcinoma Relapsed Hypopharyngeal Squamous Cell Carcinoma Relapsed Squamous Cell Carcinoma of Hypopharynx Relapsed Squamous Cell Carcinoma of the Hypopharynx Recurrent Hypopharyngeal Squamous Cell Carcinoma Stage I includes: T1, N0, M0. T1: (Supraglottis) Tumor limited to one subsite of supraglottis with normal vocal cord mobility. (Glottis) Tumor limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility. (Subglottis) Tumor limited to the subglottis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8237 Neoplastic Process Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 C0280393 CTRP Malignant Stage_I_Laryngeal_Squamous_Cell_Carcinoma Stage I Epidermoid Carcinoma of Larynx Stage I Epidermoid Carcinoma of the Larynx Stage I Laryngeal Epidermoid Carcinoma Stage I Laryngeal Squamous Cell Carcinoma Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage I Laryngeal Squamous Cell Carcinoma AJCC v7 Stage I Laryngeal Throat Squamous Cell Cancer Stage I Larynx Epidermoid Carcinoma Stage I Larynx Squamous Cell Carcinoma Stage I Squamous Cell Carcinoma of Larynx Stage I Squamous Cell Carcinoma of the Larynx Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage I includes: T1, N0, M0. T1: (Supraglottis) Tumor limited to one subsite of supraglottis with normal vocal cord mobility. (Glottis) Tumor limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility. (Subglottis) Tumor limited to the subglottis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8238 Neoplastic Process Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7 Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7 C0280394 CTRP Malignant Stage_I_Laryngeal_Verrucous_Carcinoma Stage I Laryngeal Throat Verrucous Cancer Stage I Laryngeal Verrucous Carcinoma Stage I Laryngeal Verrucous Carcinoma AJCC v6 Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7 Stage I Laryngeal Verrucous Carcinoma AJCC v7 Stage I Larynx Verrucous Carcinoma Stage I Verrucous Carcinoma of Larynx Stage I Verrucous Carcinoma of the Larynx Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: (Supraglottis) Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx. (Glottis) Tumor extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility. (Subglottis) Tumor extends to vocal cord(s) with normal or impaired mobility. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8239 Neoplastic Process Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 C0280395 CTRP Malignant Stage_II_Laryngeal_Squamous_Cell_Carcinoma Stage II Epidermoid Carcinoma of Larynx Stage II Epidermoid Carcinoma of the Larynx Stage II Laryngeal Epidermoid Carcinoma Stage II Laryngeal Squamous Cell Carcinoma Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage II Laryngeal Squamous Cell Carcinoma AJCC v7 Stage II Laryngeal Throat Squamous Cell Cancer Stage II Larynx Epidermoid Carcinoma Stage II Larynx Squamous Cell Carcinoma Stage II Squamous Cell Carcinoma of Larynx Stage II Squamous Cell Carcinoma of the Larynx Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 A magnetic resonance imaging (MRI) pulse sequence that uses an inversion recovery technique to null fluids present in the imaging area, improving clarity of the object of interest. C82392 Diagnostic Procedure Fluid Attenuated Inversion Recovery C2826145 CDISC A type of magnetic resonance imaging that uses an inversion recovery sequence with a long inversion time to null fluids present in the imaging area, improving clarity of the object of interest. Fluid_Attenuated_Inversion_Recovery FLAIR FLAIR MRI FLUID ATTENUATED INVERSION RECOVERY MRI Fluid Attenuated Inversion Recovery Fluid Attenuated Inversion Recovery MRI MRI FLAIR Fluid Attenuated Inversion Recovery A myelodysplastic/myeloproliferative neoplasm arising as a result of the mutagenic effect of chemotherapy agents and/or radiation that are used for the treatment of neoplastic or non-neoplastic disorders. C82397 Neoplastic Process Myelodysplastic/Myeloproliferative Neoplasm Post Cytotoxic Therapy C2826148 Malignant Therapy-Related_Myelodysplastic_Myeloproliferative_Neoplasm Myelodysplastic/Myeloproliferative Neoplasm Post Cytotoxic Therapy Therapy-Related Myelodysplastic/Myeloproliferative Disease Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm t-MDS/MPN Myelodysplastic/Myeloproliferative Neoplasm Post Cytotoxic Therapy Stage II includes: T2, N0, M0. T2: (Supraglottis) Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx. (Glottis) Tumor extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility. (Subglottis) Tumor extends to vocal cord(s) with normal or impaired mobility. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8240 Neoplastic Process Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7 Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7 C0280396 CTRP Malignant Stage_II_Laryngeal_Verrucous_Carcinoma Stage II Laryngeal Throat Verrucous Cancer Stage II Laryngeal Verrucous Carcinoma Stage II Laryngeal Verrucous Carcinoma AJCC v6 Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7 Stage II Laryngeal Verrucous Carcinoma AJCC v7 Stage II Larynx Verrucous Carcinoma Stage II Verrucous Carcinoma of Larynx Stage II Verrucous Carcinoma of the Larynx Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7 An acute myeloid leukemia associated with t(9;11)(p21.3;q23.3) and MLLT3-KMT2A fusion protein expression. Morphologically it usually has monocytic features. It may present at any age but it is more commonly seen in children. Patients may present with disseminated intravascular coagulation. C82403 Neoplastic Process Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A C2919692 CPTAC CTRP GDC NICHD PCDC 9897/3 Malignant Acute_Myeloid_Leukemia_with_t_9_11_p22_q23_MLLT3-MLL Acute myeloid leukemia with t(9;11)(p22;q23); MLLT3-MLL AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 AML with t(9;11)(p22;q33);MLLT3-MLL Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3 (AF9)-KMT2A Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A Fusion Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-MLL Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3::KMT2A Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3::KMT2A Fusion Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3::MLL Acute myeloid leukemia with t(9;11)(p22;q23); MLLT3-MLL Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T1: Supraglottis: Tumor limited to one subsite of supraglottis with normal vocal cord mobility. Glottis: Tumor limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility. Subglottis: Tumor limited to the subglottis. T2: Supraglottis: Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx. Glottis: Tumor extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility. Subglottis: Tumor extends to vocal cord(s) with normal or impaired mobility. T3: Supraglottis: Tumor limited to larynx with vocal cord fixation and/or invades any of the following: postcricoid area, pre-epiglottic tissues, paraglottic space, and/or inner cortex of thyroid cartilage. Glottis: Tumor limited to the larynx with vocal cord fixation and/or invasion of paraglottic space, and/or inner cortex of the thyroid cartilage. Subglottis: Tumor limited to larynx with vocal cord fixation. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3cm or less in greatest dimension. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8241 Neoplastic Process Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 C0280397 CTRP Malignant Stage_III_Laryngeal_Squamous_Cell_Carcinoma Stage III Epidermoid Carcinoma of Larynx Stage III Epidermoid Carcinoma of the Larynx Stage III Laryngeal Epidermoid Carcinoma Stage III Laryngeal Squamous Cell Carcinoma Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage III Laryngeal Squamous Cell Carcinoma AJCC v7 Stage III Laryngeal Throat Squamous Cell Cancer Stage III Larynx Epidermoid Carcinoma Stage III Larynx Squamous Cell Carcinoma Stage III Squamous Cell Carcinoma of Larynx Stage III Squamous Cell Carcinoma of the Larynx Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T1: Supraglottis: Tumor limited to one subsite of supraglottis with normal vocal cord mobility. Glottis: Tumor limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility. Subglottis: Tumor limited to the subglottis. T2: Supraglottis: Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx. Glottis: Tumor extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility. Subglottis: Tumor extends to vocal cord(s) with normal or impaired mobility. T3: Supraglottis: Tumor limited to larynx with vocal cord fixation and/or invades any of the following: postcricoid area, pre-epiglottic tissues, paraglottic space, and/or inner cortex of thyroid cartilage. Glottis: Tumor limited to the larynx with vocal cord fixation and/or invasion of paraglottic space, and/or inner cortex of the thyroid cartilage. Subglottis: Tumor limited to larynx with vocal cord fixation. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3cm or less in greatest dimension. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8242 Neoplastic Process Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7 Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7 C0280398 CTRP Malignant Stage_III_Laryngeal_Verrucous_Carcinoma Stage III Laryngeal Throat Verrucous Cancer Stage III Laryngeal Verrucous Carcinoma Stage III Laryngeal Verrucous Carcinoma AJCC v6 Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7 Stage III Laryngeal Verrucous Carcinoma AJCC v7 Stage III Larynx Verrucous Carcinoma Stage III Verrucous Carcinoma of Larynx Stage III Verrucous Carcinoma of the Larynx Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7 An acute myeloid leukemia associated with t(6;9)(p22.3;q34.1) resulting in DEK-NUP214(CAN) fusion protein expression. It is often associated with multilineage dysplasia and basophilia. It affects both children and adults and it usually has an unfavorable clinical outcome. C82423 Neoplastic Process Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214 Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214 C2826169 CPTAC CTRP GDC NICHD PCDC An acute myeloid leukemia associated with t(6;9)(p22.3;q34), resulting in DEK-NUP214(CAN) fusion protein expression. It is often associated with multilineage dysplasia and basophilia. It is rare in children. 9865/3 Malignant Acute_Myeloid_Leukemia_with_t_6_9_p23_q34_DEK-NUP214 9865/3 Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214 AML with t(6;9)(p23;q34); DEK-NUP214 AML with t(6;9)(p23;q34);DEK-NUP214 AML with t(6;9)(p23;q34.1);DEK-NUP214 Acute Myeloid Leukemia with t(6;9) Acute Myeloid Leukemia with t(6;9) (p22.3;q34.1); DEK-NUP214 Fusion Acute Myeloid Leukemia with t(6;9) (p22.3;q34.1); DEK::NUP214 Fusion Acute Myeloid Leukemia with t(6;9)(p22.3;q34); DEK-NUP214 Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214 Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK::NUP214 Acute Myeloid Leukemia with t(6;9)(p23;q34); DEK-NUP214 Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214 Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214 An acute myeloid leukemia associated with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2) resulting in the reposition of a distal GATA2 enhancer to activate MECOM expression. It may present de novo or follow a myelodysplastic syndrome. The clinical course is aggressive. C82426 Neoplastic Process Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM C2826172 Cellosaurus GDC NICHD PCDC An acute myeloid leukemia associated with inv(3)(q21q26.2) or t(3;3)(q21;q26.2), resulting in the expression of RPN1-EVI1 fusion protein. There have been rare cases in children that have been reported in the literature. 9869/3 Malignant Acute_Myeloid_Leukemia_with_inv_3_q2_q26_2_or_t_3_3_q21_q26_2_RPN1-EVI1 9869/3 Acute myeloid leukemia with inv(3)(q21;q26.2) or t(3.3)(q21;q26.2); RPN1-EVI1 Acute myeloid leukemia with inv(3)(q21;q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1 Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1 AML with MECOM Rearrangements AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1 Acute Myeloid Leukemia with MECOM Rearrangements Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, EVI1 Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM(EVI1) Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2::MECOM Acute Myeloid Leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1 Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1 Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM An acute myeloid leukemia associated with t(1;22)(p13.3;q13.1) resulting in the expression of RBM15-MKL1 fusion protein. It affects infants and children and usually shows megakaryocytic maturation. C82427 Neoplastic Process Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1 Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1 C2826173 CPTAC CTRP GDC NICHD PCDC An acute myeloid leukemia typically showing megakaryocytic maturation and associated with t(1;22)(p13;q13), resulting in the expression of RBM15-MKL1 fusion protein. 9911/3 Malignant Acute_Myeloid_Leukemia_Megakaryoblastic_with_t_1_22_p13_q13_RBM15-MKL1 9911/3 Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1 AML (Megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1 AML (megakaryoblastic) with t(1;22) (p13;q13); RBM15-MKL1 AML (megakaryoblastic) with t(1;22)(p13.3;q13.3); RBM15-MKL1 Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15- MRTFA Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1 Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1 Fusion Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15::MLK1 Fusion Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15::MRTFA Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1 Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1 Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1 Stage IV includes: IVA: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB: (T4b, Any N, M0); (Any T, N3, M0); IVC: (Any T, Any N, M1). T4a: Supraglottis: Moderately advanced local disease. Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus). Glottis: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus). Subglottis: Moderately advanced local disease. Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus). T4b: Supraglottis, Glottis, and Subglottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a lymph node, more than 6 cm in greatest dimension. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C8243 Neoplastic Process Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7 C0280399 CTRP Malignant Stage_IV_Laryngeal_Squamous_Cell_Carcinoma Stage IV Epidermoid Carcinoma of Larynx Stage IV Epidermoid Carcinoma of the Larynx Stage IV Laryngeal Epidermoid Carcinoma Stage IV Laryngeal Squamous Cell Carcinoma Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IV Laryngeal Throat Squamous Cell Cancer Stage IV Larynx Epidermoid Carcinoma Stage IV Larynx Squamous Cell Carcinoma Stage IV Squamous Cell Carcinoma of Larynx Stage IV Squamous Cell Carcinoma of the Larynx Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7 A group of acute myeloid leukemias characterized by the presence of gene mutations that are associated with myelodysplasia. C82430 Neoplastic Process Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations C2826176 Malignant Acute_Myeloid_Leukemia_with_Gene_Mutations AML MDS-R Gene Mutations AML with MDS-R Gene Mutations AML with Myelodysplasia-Related Gene Mutations Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations An acute myeloid leukemia with mutation of the nucleophosmin gene. It is usually associated with normal karyotype and frequently has myelomonocytic or monocytic features. It usually responds to induction therapy. C82431 Neoplastic Process Acute Myeloid Leukemia with NPM1 Mutation C2826177 CPTAC GDC NICHD PCDC An acute myeloid leukemia (AML) with mutation of the nucleophosmin gene. It is usually associated with normal karyotype. It is seen in 8% of children with AML. 9861/3 Malignant Acute_Myeloid_Leukemia_with_Mutated_NPM1 9861/3 Acute myeloid leukemia with mutated NPM1 AML with Mutated NPM1 AML with mutated NPM1 Acute Myeloid Leukemia with Cytoplasmic Nucleophosmin Acute Myeloid Leukemia with Mutated NPM1 Acute Myeloid Leukemia with NPM1 Mutation Acute myeloid leukemia with mutated NPM1 NPMc+ AML Acute Myeloid Leukemia with NPM1 Mutation An acute myeloid leukemia with non-germline mutations of the CEBPA gene. C82433 Neoplastic Process Acute Myeloid Leukemia with CEBPA Mutation C2826178 CPTAC GDC NICHD An acute myeloid leukemia (AML) with mutation of the CEBPA gene. It is usually associated with normal karyotype, and most cases meet the criteria for AML with or without maturation. 9861/3 Malignant Acute_Myeloid_Leukemia_with_Mutated_CEBPA 9861/3 Acute myeloid leukemia with mutated CEBPA AML with Mutated CEBPA AML with mutated CEBPA Acute Myeloid Leukemia with CEBPA Mutation Acute Myeloid Leukemia with Mutated CEBPA Acute Myeloid Leukemia with Non-Germline Mutated CEBPA Acute myeloid leukemia with mutated CEBPA Non-Familial Acute Myeloid Leukemia with Mutated CEBPA Acute Myeloid Leukemia with CEBPA Mutation Stage IV includes: IVA: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB: (T4b, Any N, M0); (Any T, N3, M0); IVC: (Any T, Any N, M1). T4a: Supraglottis: Moderately advanced local disease. Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus). Glottis: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus). Subglottis: Moderately advanced local disease. Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus). T4b: Supraglottis, Glottis, and Subglottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a lymph node, more than 6 cm in greatest dimension. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C8244 Neoplastic Process Stage IV Laryngeal Verrucous Carcinoma AJCC v7 Stage IV Laryngeal Verrucous Carcinoma AJCC v7 C0280400 CTRP Malignant Stage_IV_Laryngeal_Verrucous_Carcinoma Stage IV Laryngeal Throat Verrucous Cancer Stage IV Laryngeal Verrucous Carcinoma Stage IV Laryngeal Verrucous Carcinoma AJCC v7 Stage IV Larynx Verrucous Carcinoma Stage IV Verrucous Carcinoma of Larynx Stage IV Verrucous Carcinoma of the Larynx Stage IV Laryngeal Verrucous Carcinoma AJCC v7 The reemergence of squamous cell carcinoma of the larynx after a period of remission. C8245 Neoplastic Process Recurrent Laryngeal Squamous Cell Carcinoma Recurrent Laryngeal Squamous Cell Carcinoma C0280401 CTRP Malignant Recurrent_Laryngeal_Squamous_Cell_Carcinoma Recurrent Epidermoid Carcinoma of Larynx Recurrent Epidermoid Carcinoma of the Larynx Recurrent Laryngeal Epidermoid Carcinoma Recurrent Laryngeal Squamous Cell Carcinoma Recurrent Laryngeal Throat Squamous Cell Carcinoma Recurrent Larynx Epidermoid Carcinoma Recurrent Larynx Squamous Cell Carcinoma Recurrent Squamous Cell Carcinoma of Larynx Recurrent Squamous Cell Carcinoma of the Larynx Relapsed Epidermoid Carcinoma of Larynx Relapsed Epidermoid Carcinoma of the Larynx Relapsed Laryngeal Epidermoid Carcinoma Relapsed Laryngeal Squamous Cell Carcinoma Relapsed Larynx Epidermoid Carcinoma Relapsed Larynx Squamous Cell Carcinoma Relapsed Squamous Cell Carcinoma of Larynx Relapsed Squamous Cell Carcinoma of the Larynx Recurrent Laryngeal Squamous Cell Carcinoma The reemergence of verrucous carcinoma of the larynx after a period of remission. C8246 Neoplastic Process Recurrent Laryngeal Verrucous Carcinoma Recurrent Laryngeal Verrucous Carcinoma C0280402 CTRP Malignant Recurrent_Laryngeal_Verrucous_Carcinoma Recurrent Laryngeal Throat Verrucous Cancer Recurrent Laryngeal Verrucous Carcinoma Recurrent Larynx Verrucous Carcinoma Recurrent Verrucous Carcinoma of Larynx Recurrent Verrucous Carcinoma of the Larynx Relapsed Laryngeal Verrucous Carcinoma Relapsed Larynx Verrucous Carcinoma Relapsed Verrucous Carcinoma of Larynx Relapsed Verrucous Carcinoma of the Larynx Recurrent Laryngeal Verrucous Carcinoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8247 Neoplastic Process Ann Arbor Stage I Adult T-Cell Leukemia/Lymphoma Ann Arbor Stage I Adult T-Cell Leukemia/Lymphoma C0280423 CTRP Malignant Stage_I_Adult_T-Cell_Lymphoma_Leukemia Adult T-Cell Lymphoma/Leukemia Stage I Ann Arbor Stage I Adult T-Cell Leukemia/Lymphoma HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia Stage I Stage I Adult T-Cell Leukemia/Lymphoma Stage I Adult T-Cell Lymphoma/Leukemia Stage I HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia Ann Arbor Stage I Adult T-Cell Leukemia/Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8248 Neoplastic Process Stage II Adult T-Cell Leukemia/Lymphoma Ann Arbor Stage II Adult T-Cell Leukemia/Lymphoma C0280424 CTRP Malignant Stage_II_Adult_T-Cell_Lymphoma_Leukemia Adult T-Cell Lymphoma/Leukemia Stage II Ann Arbor Stage II Adult T-Cell Leukemia/Lymphoma HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia Stage II Stage II Adult T-Cell Leukemia/Lymphoma Stage II Adult T-Cell Lymphoma/Leukemia Stage II HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia Ann Arbor Stage II Adult T-Cell Leukemia/Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8249 Neoplastic Process Stage III Adult T-Cell Leukemia/Lymphoma Ann Arbor Stage III Adult T-Cell Leukemia/Lymphoma C0280425 CTRP Malignant Stage_III_Adult_T-Cell_Lymphoma_Leukemia Adult T-Cell Lymphoma/Leukemia Stage III Ann Arbor Stage III Adult T-Cell Leukemia/Lymphoma HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia Stage III Stage III Adult T-Cell Leukemia/Lymphoma Stage III Adult T-Cell Lymphoma/Leukemia Stage III HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia Ann Arbor Stage III Adult T-Cell Leukemia/Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8250 Neoplastic Process Ann Arbor Stage IV Adult T-Cell Leukemia/Lymphoma Ann Arbor Stage IV Adult T-Cell Leukemia/Lymphoma C0280426 CTRP Malignant Stage_IV_Adult_T-Cell_Lymphoma_Leukemia Adult T-Cell Lymphoma/Leukemia Stage IV Ann Arbor Stage IV Adult T-Cell Leukemia/Lymphoma HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia Stage IV Stage IV Adult T-Cell Leukemia/Lymphoma Stage IV Adult T-Cell Lymphoma/Leukemia Stage IV HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia Ann Arbor Stage IV Adult T-Cell Leukemia/Lymphoma The reemergence of adult T-cell leukemia/lymphoma after a period of remission C8251 Neoplastic Process Recurrent Adult T-Cell Leukemia/Lymphoma Recurrent Adult T-Cell Leukemia/Lymphoma C0280427 CTRP mCode Malignant Recurrent_Adult_T-Cell_Lymphoma_Leukemia Adult T-Cell Lymphoma/Leukemia Recurrent Adult T-cell lymphoma/leukemia (HTLV-1-associated) in relapse HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia Recurrent HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia Relapsed Recurrent Adult T-Cell Leukemia/Lymphoma Recurrent Adult T-Cell Lymphoma/Leukemia Recurrent HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia Relapsed HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia Recurrent Adult T-Cell Leukemia/Lymphoma An acute myeloid leukemia arising as a result of the mutagenic effect of chemotherapy agents and/or ionizing radiation. (WHO, 2001) C8252 Neoplastic Process Therapy-Related Acute Myeloid Leukemia Acute Myeloid Leukemia Post Cytotoxic Therapy C1336735 CTEP CTRP Cellosaurus GDC 9920/3 Malignant Therapy-Related_Acute_Myeloid_Leukemia 9920/3 Therapy-related acute myeloid leukemia, NOS Acute Myeloid Leukemia Post Cytotoxic Therapy High-Grade Treatment-Related Myeloid Neoplasm Therapy-Related Acute Myeloid Leukemia Treatment Related AML Treatment Related Acute Myelogenous Leukemia Treatment Related Acute Myeloid Leukemia Treatment related AML Treatment related acute myeloid leukemia Treatment-Related AML Treatment-Related Acute Myelogenous Leukemia Treatment-related Acute Myeloid Leukemia t-AML Acute Myeloid Leukemia Post Cytotoxic Therapy A primary myelodysplastic syndrome not associated with prior radiation or chemotherapy treatment. C8253 Neoplastic Process de novo Myelodysplastic Syndrome de novo Myelodysplastic Syndrome C0280451 CTRP Malignant de_novo_Myelodysplastic_Syndrome Untreated Myelodysplastic Syndrome de novo Myelodysplastic Syndrome de novo Myelodysplastic Syndrome The reemergence of renal pelvis and ureter urothelial carcinoma after a period of remission. C8254 Neoplastic Process Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter Recurrent Renal Pelvis and Ureter Urothelial Carcinoma C0280468 CTRP Malignant Recurrent_Transitional_Cell_Carcinoma_of_the_Renal_Pelvis_and_Ureter Recurrent Renal Pelvis and Ureter Urothelial Carcinoma Recurrent Transitional Cell Cancer of Renal Pelvis and Ureter Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter Recurrent Transitional Cell Carcinoma of Renal Pelvis and Ureter Recurrent Upper Urinary Tract Urothelial Carcinoma Recurrent Urothelial Cancer of the Renal Pelvis and Ureter Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter Relapsed Transitional Cell Cancer of Renal Pelvis and Ureter Relapsed Transitional Cell Cancer of the Renal Pelvis and Ureter Relapsed Transitional Cell Carcinoma of Renal Pelvis and Ureter Relapsed Transitional Cell Carcinoma of the Renal Pelvis and Ureter Recurrent Renal Pelvis and Ureter Urothelial Carcinoma An anal carcinoma arising from the transitional zone of the anal canal. C8255 Neoplastic Process Anal Canal Cloacogenic Carcinoma Anal Canal Cloacogenic Carcinoma C0334273 CTRP GDC 8124/3 Malignant Anal_Cloacogenic_Carcinoma 8124/3 Cloacogenic carcinoma Anal Canal Cloacogenic Cancer Anal Canal Cloacogenic Carcinoma Anal Canal Transitional Zone Carcinoma Anal Cloacogenic Carcinoma Cloacogenic Anal Carcinoma Cloacogenic Carcinoma Cloacogenic Carcinoma of Anus Cloacogenic Carcinoma of the Anus Cloacogenic carcinoma Anal Canal Cloacogenic Carcinoma An anal squamous cell carcinoma characterized by the presence of malignant cells with hyperchromatic nuclei and peripheral nuclear palisading. C8256 Neoplastic Process Anal Basaloid Carcinoma Anal Basaloid Squamous Cell Carcinoma C0280470 CTRP Malignant Anal_Basaloid_Carcinoma Anal Basaloid Carcinoma Anal Basaloid Squamous Cell Carcinoma Basaloid Carcinoma of Anus Basaloid Carcinoma of the Anus Anal Basaloid Squamous Cell Carcinoma An astrocytoma occurring in adults that is characterized by the presence of high mitotic activity, cytologic atypia, and architectural distortion. C8257 Neoplastic Process Adult Anaplastic Astrocytoma Adult Anaplastic Astrocytoma C0280483 CTRP Malignant Adult_Anaplastic_Astrocytoma Adult Anaplastic Astrocytoma Adult Grade 3 Astrocytoma Adult Grade III Astrocytoma Adult Undifferentiated Astrocytoma Anaplastic Astrocytoma Anaplastic Astrocytoma of Adult Anaplastic Astrocytoma of the Adult Grade 3 Adult Astrocytic Neoplasm Grade 3 Adult Astrocytic Tumor Grade 3 Adult Astrocytoma Grade III Adult Astrocytic Neoplasm Grade III Adult Astrocytic Tumor Grade III Adult Astrocytoma Undifferentiated Astrocytoma of Adult Undifferentiated Astrocytoma of the Adult Adult Anaplastic Astrocytoma Stage I includes: T1, N0, M0. T1: Tumor limited to the uterus. N0: No regional lymph node metastasis. M0: No distant metastasis. This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.) C8258 Neoplastic Process Stage I Uterine Sarcoma AJCC v7 Stage I Uterine Sarcoma AJCC v7 C0280624 CTRP Stage I uterine sarcoma is divided into stages IA, IB, and IC based on how far the cancer has spread into the wall of the uterus. In stage IA, cancer is in the endometrium only. In stage IB, cancer has spread into the inner half of the myometrium (muscle layer of the uterus). In stage IC, cancer has spread to the outer half of the myometrium. Malignant Stage_I_Uterine_Sarcoma Stage I Uterine Sarcoma Stage I Uterine Sarcoma AJCC v7 stage I uterine sarcoma Stage I Uterine Sarcoma AJCC v7 Stage II includes: T2, N0, M0. T2: Tumor extends beyond the uterus, within the pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.) C8259 Neoplastic Process Stage II Uterine Sarcoma AJCC v7 Stage II Uterine Sarcoma AJCC v7 C0280625 CTRP Stage II uterine sarcoma is divided into stages IIA and IIB based on how far the cancer has spread into the cervix. In stage IIA, cancer has spread to the glands where the cervix and uterus meet. In stage IIB, cancer has spread into the connective tissue of the cervix. Malignant Stage_II_Uterine_Sarcoma Stage II Uterine Sarcoma Stage II Uterine Sarcoma AJCC v7 stage II uterine sarcoma Stage II Uterine Sarcoma AJCC v7 A myelodysplastic syndrome characterized by dysplastic changes involving only one myeloid cell lineage in the bone marrow. C82591 Neoplastic Process Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia C0334678 Malignant Refractory_Cytopenia_with_Unilineage_Dysplasia Myelodysplastic syndrome with single lineage dysplasia MDS with Low Blasts and Single Lineage Dysplasia MDS-LB-SLD MDS-SLD Myelodysplastic Syndrome with Low Blasts and Single Lineage Dysplasia Myelodysplastic Syndrome with Single Lineage Dysplasia Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia RCUD Refractory Cytopenia with Unilineage Dysplasia Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia A myelodysplastic syndrome characterized by the presence of at least 10% dysplastic neutrophils in the bone marrow or the peripheral blood. C82593 Neoplastic Process Refractory Neutropenia C2826320 GDC 9991/3 Malignant Refractory_Neutropenia 9991/3 Refractory neutropenia RN Refractory Neutropenia Refractory neutropenia Refractory Neutropenia A myelodysplastic syndrome characterized by the presence of at least 10% dysplastic megakaryocytes, found within at least 30 megakaryocytes examined in the bone marrow. C82594 Neoplastic Process Refractory Thrombocytopenia C2826321 GDC 9992/3 Malignant Refractory_Thrombocytopenia 9992/3 Refractory thrombocytopenia RT Refractory Thrombocytopenia Refractory thrombocytopenia Refractory Thrombocytopenia Myelodysplastic syndrome with excess blasts associated with significant reticulin fibrosis of the bone marrow. C82595 Neoplastic Process Myelodysplastic Syndrome with Excess Blasts and Fibrosis C2826322 Malignant RAEB_with_Fibrosis MDS-f Myelodysplastic Neoplasm with Increased Blasts and Fibrosis Myelodysplastic Syndrome with Excess Blasts and Fibrosis Myelodysplastic Syndrome with Increased Blasts and Fibrosis RAEB with Fibrosis RAEB-F Myelodysplastic Syndrome with Excess Blasts and Fibrosis A myeloid disorder that occurs in childhood and is characterized by persistent cytopenia, dysplastic changes in at least two hematopoietic lineages or in 10% or more of cells in one hematopoietic lineage, less than 5% blasts in bone marrow, and less than 2% blasts in peripheral blood, absence of bone marrow fibrosis, and absence of history of prior cytotoxic chemotherapy or radiation therapy. In a subset of cases, somatic mutations or cytogenetic abnormalities can be identified. Other cases are the result of pre-existing disorders with germline mutations, including Fanconi anemia, Shwachman-Diamond syndrome, and dyskeratosis congenita. C82596 Neoplastic Process Refractory Cytopenia of Childhood C2826323 GDC NICHD The most common subtype of the myelodysplastic syndromes affecting children. It is characterized by persistent cytopenia with less than 5% blasts in the bone marrow and less than 2% blasts in the peripheral blood. Most cases are associated with a normal karyotype, however, when abnormal, monosomy 7 is the most frequently seen cytogenetic abnormality. 9985/3 Malignant Refractory_Cytopenia_of_Childhood 9985/3 Refractory cytopenia of childhood RCC Refractory Cytopenia of Childhood Refractory cytopenia of childhood Refractory Cytopenia of Childhood Stage III includes: IIIA (T3a, N0, M0); IIIB (T3b, N0, M0); IIIC (T1-T3, N1, M0). T1: Tumor limited to the uterus. T2: Tumor extends beyond the uterus, within the pelvis. T3: Tumor infiltrates abdominal tissues. T3a: Tumor infiltrates abdominal tissues, one side. T3b: Tumor infiltrates abdominal tissues, more than one side. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.) C8260 Neoplastic Process Stage III Uterine Sarcoma AJCC v7 Stage III Uterine Sarcoma AJCC v7 C0280626 CTRP Stage III uterine sarcoma is divided into stages IIIA and IIIB based on how far the cancer has spread within the pelvis (lower part of the abdomen between the hip bones). In stage IIIA, cancer has spread to the outermost layer of the uterus; and /or tissues just beyond the uterus; and/or the peritoneum. In stage IIIB, cancer has spread to lymph nodes in the pelvis and/or near the uterus. Malignant Stage_III_Uterine_Sarcoma Stage III Uterine Sarcoma Stage III Uterine Sarcoma AJCC v7 stage III uterine sarcoma Stage III Uterine Sarcoma AJCC v7 The reemergence of uterine corpus sarcoma after a period of remission. C8261 Neoplastic Process Recurrent Uterine Corpus Sarcoma Recurrent Uterine Corpus Sarcoma C3642433 CTRP Malignant Recurrent_Uterine_Sarcoma Recurrent Sarcoma of Uterine Corpus Recurrent Sarcoma of the Uterine Corpus Recurrent Uterine Corpus Sarcoma Relapsed Sarcoma of Uterine Corpus Relapsed Sarcoma of the Uterine Corpus Relapsed Uterine Corpus Sarcoma Recurrent Uterine Corpus Sarcoma A myelodysplastic/myeloproliferative neoplasm characterized by marked thrombocytosis, anemia, erythroid lineage dysplasia, presence or absence of multilineage dysplasia, 15% or more ring sideroblasts, blasts less than 5% in bone marrow and less than 1% in peripheral blood, absence of BCR/ABL fusion, absence of SF3B1 mutation, absence of genetic abnormalities associated with myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions, and no history of other myelodysplastic/myeloproliferative neoplasms or myeloproliferative neoplasms and myelodysplastic syndromes. C82616 Neoplastic Process Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified C2826330 GDC 9982/3 Malignant Refractory_Anemia_with_Ring_Sideroblasts_Associated_with_Marked_Thrombocytosis 9982/3 Refractory anemia with ring sideroblasts associated with marked thrombocytosis Essential Thrombocythemia with Ring Sideroblasts MDS/MPN with Ring Sideroblasts and Thrombocytosis MDS/MPN-RS-T MDS/MPN-RS-T, NOS Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, NOS Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified RARS-T Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis Refractory anemia with ring sideroblasts associated with marked thrombocytosis Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified An acute monocytic leukemia occurring in adults. C8263 Neoplastic Process Adult Acute Monocytic Leukemia Adult Acute Monocytic Leukemia C0280634 CTRP Cellosaurus Malignant Adult_Acute_Differentiated_Monocytic_Leukemia Acute Monocytic Leukemia Adult Acute Differentiated Monocytic Leukemia (M5b) Adult Acute Monocytic Leukemia M5b Adult Acute Differentiated Monocytic Leukemia M5b Adult Acute Leukemia Adult Acute Monocytic Leukemia A meningioma that occurs during childhood. C8264 Neoplastic Process Childhood Meningioma Childhood Meningioma C0280656 CTRP NICHD A meningioma that occurs during childhood. Undetermined Childhood_Meningioma Childhood Meningioma Meningioma Pediatric Meningioma Childhood Meningioma A cholangiocarcinoma occurring in adults. C8265 Neoplastic Process Adult Cholangiocarcinoma Adult Cholangiocarcinoma C0280725 CTRP Malignant Adult_Primary_Cholangiocarcinoma Adult Cholangiocarcinoma Adult Primary Cholangiocarcinoma Adult Primary Cholangiocellular Carcinoma Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) Adult Cholangiocarcinoma A rare, aggressive malignant mesenchymal neoplasm that arises from the ovary. The prognosis is poor. C8267 Neoplastic Process Ovarian Sarcoma Ovarian Sarcoma C0280746 CTRP Malignant Ovarian_Sarcoma Ovarian Sarcoma Sarcoma of Ovary Sarcoma of the Ovary Ovarian Sarcoma An anaplastic ependymoma occurring in adults. C8269 Neoplastic Process Adult Anaplastic Ependymoma Adult Anaplastic Ependymoma C0280787 CTRP Malignant Adult_Anaplastic_Ependymoma Adult Anaplastic Ependymoma Adult Malignant Ependymoma Anaplastic Ependymoma Malignant Adult Ependymoma Adult Anaplastic Ependymoma C8270 Neoplastic Process Adult Anaplastic Oligodendroglioma Adult Anaplastic Oligodendroglioma C0280790 CTRP Malignant Adult_Anaplastic_Oligodendroglioma Adult Anaplastic Oligodendroglioma Adult Undifferentiated Oligodendroglioma Anaplastic Oligodendroglioma Adult Anaplastic Oligodendroglioma A tumor of mixed cell type with astrocytic components as well as ependymoma components. C8271 Neoplastic Process Mixed Astrocytoma-Ependymoma C0280791 Undetermined Mixed_Astrocytoma-Ependymoma Mixed Astrocytoma-Ependymoma Mixed Astrocytoma-Ependymoma A mixed glioma characterized by the presence of astrocytic, ependymal, and oligodendroglial neoplastic components. C8272 Neoplastic Process Mixed Astrocytoma-Ependymoma-Oligodendroglioma C0280792 Undetermined Mixed_Astrocytoma-Ependymoma-Oligodendroglioma Mixed Astrocytoma-Ependymoma-Oligodendroglioma Mixed Astrocytoma-Ependymoma-Oligodendroglioma A pineal parenchymal cell neoplasm (pineocytoma or pineoblastoma) occurring in adults. C8273 Neoplastic Process Adult Pineal Parenchymal Cell Neoplasm Adult Pineal Parenchymal Cell Neoplasm C0280794 CTRP Undetermined Adult_Pineal_Parenchymal_Cell_Neoplasm Adult Pineal Gland Neoplasm Adult Pineal Gland Tumor Adult Pineal Parenchymal Cell Neoplasm Adult Pineal Parenchymal Cell Tumor Adult Pineal Parenchymal Neoplasm Adult Pineal Parenchymal Tumor Parenchymal Neoplasm of Adult Pineal Gland Parenchymal Neoplasm of the Adult Pineal Gland Parenchymal Tumor of Adult Pineal Gland Parenchymal Tumor of the Adult Pineal Gland Pineal Parenchymal Cell Tumor Adult Pineal Parenchymal Cell Neoplasm C8274 Neoplastic Process Pineal Gland Astrocytoma C0280795 Undetermined Pineal_Gland_Astrocytoma Astrocytoma of Pineal Gland Astrocytoma of the Pineal Gland Pineal Astrocytoma Pineal Gland Astrocytoma Pineal Gland Astrocytoma An anaplastic (malignant) meningioma occurring in adults. C8275 Neoplastic Process Adult Anaplastic (Malignant) Meningioma Adult Anaplastic (Malignant) Meningioma C3468050 CTRP Malignant Adult_Anaplastic_Malignant_Meningioma Adult Anaplastic (Malignant) Meningioma Adult Anaplastic Meningioma Adult Malignant Meningioma Anaplastic (Malignant) Meningioma Adult Anaplastic (Malignant) Meningioma Neuroblastoma that is confined to a specific site and is not amenable to surgical removal. C8277 Neoplastic Process Localized Unresectable Neuroblastoma Localized Unresectable Neuroblastoma C0280822 CTRP Malignant Localized_Unresectable_Neuroblastoma Localized Unresectable Neuroblastoma Localized Unresectable Neuroblastoma A lymphoma (non-Hodgkin or Hodgkin) arising from the central nervous system and occurring in HIV-positive patients. C8284 Neoplastic Process AIDS-Related Primary Central Nervous System Lymphoma AIDS-Related Primary Central Nervous System Lymphoma C0281241 CTEP CTRP Malignant AIDS-Related_Primary_Central_Nervous_System_Lymphoma AIDS Related Lymphoma of Primary Central Nervous System AIDS Related Lymphoma of the Primary Central Nervous System AIDS Related Primary CNS Lymphoma AIDS Related Primary Central Nervous System Lymphoma AIDS-Related Lymphoma of Primary Central Nervous System AIDS-Related Lymphoma of the Primary Central Nervous System AIDS-Related Primary CNS Lymphoma AIDS-Related Primary Central Nervous System Lymphoma AIDS-related primary CNS lymphoma AIDS-Related Primary Central Nervous System Lymphoma A morphologic variant of diffuse large B-cell lymphoma occurring in HIV-positive patients. C8285 Neoplastic Process AIDS Related Immunoblastic Lymphoma AIDS-Related Immunoblastic Lymphoma C1720728 CTRP Cellosaurus Malignant AIDS_Related_Immunoblastic_Lymphoma AIDS Associated Immunoblastic Lymphoma AIDS Related Immunoblastic Large Cell Lymphoma AIDS Related Immunoblastic Lymphoma AIDS-Associated Immunoblastic Large Cell Lymphoma AIDS-Related Immunoblastic Lymphoma AIDS-Related Immunoblastic Lymphoma A Burkitt lymphoma occurring in HIV-positive patients. C8286 Neoplastic Process AIDS-Related Burkitt Lymphoma AIDS-Related Burkitt Lymphoma C1720008 CTRP Cellosaurus Malignant ENV_Gene AIDS Related Burkitt's Lymphoma AIDS Related Small Non Cleaved Cell Lymphoma AIDS-Associated Burkitt's Lymphoma AIDS-Associated Small Non Cleaved Cell Lymphoma AIDS-Related Burkitt Lymphoma AIDS-Related Burkitt's Lymphoma AIDS-Related Small Non-Cleaved Cell Lymphoma AIDS-Related Burkitt Lymphoma A benign melanocytic nevus surrounded by eczematous changes. C82862 Neoplastic Process Meyerson Nevus C2826543 Benign Meyerson_Nevus Halo Dermatitis Halo Eczema Meyerson Nevus Meyerson Nevus A Spitz nevus associated with fibrous stroma formation. C82864 Neoplastic Process Desmoplastic Spitz Nevus C1275419 Benign Desmoplastic_Spitz_Nevus Desmoplastic Spitz Nevus Desmoplastic Spitz Nevus Carcinoma that affects both breasts in a simultaneous or non-simultaneous manner. C8287 Neoplastic Process Bilateral Breast Carcinoma Bilateral Breast Carcinoma C0281267 CTRP Malignant Bilateral_Breast_Carcinoma Bilateral Breast Cancer Bilateral Breast Carcinoma Bilateral Breast Carcinoma An infiltrating astrocytic tumor of the brain occurring in adults. C8289 Neoplastic Process Adult Infiltrating Astrocytic Tumor CL448401 Undetermined Adult_Infiltrating_Astrocytoma Adult Infiltrating Astrocytic Neoplasm Adult Infiltrating Astrocytic Tumor Adult Infiltrating Astrocytic Tumor A premalignant neoplastic lesion of the liver. It is characterized by the presence of hepatocytes with enlarged nuclei and cytoplasm, nuclear pleomorphism, multinucleation, and hyperchromasia. C82891 Neoplastic Process Hepatocellular Large Cell Change CL449007 Undetermined Large_Cell_Dysplasia Hepatocellular Large Cell Change Large Cell Dysplasia Hepatocellular Large Cell Change An embryonal tumor with multilayered rosettes, C19MC-altered, occurring in adults. C8290 Neoplastic Process Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered C0281330 CTRP Malignant Adult_Ependymoblastoma Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered Adult Ependymoblastoma Embryonal Tumor with Multilayered Rosettes, C19MC-Altered Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered A pineocytoma occurring in adults. C8291 Neoplastic Process Adult Pineocytoma Adult Pineocytoma C0281331 CTRP Undetermined Adult_Pineocytoma Adult Pineocytoma Pineocytoma Adult Pineocytoma A pineoblastoma occurring in adults. C8292 Neoplastic Process Adult Pineoblastoma Adult Pineoblastoma C0281332 CTRP Malignant Adult_Pineoblastoma Adult Pineoblastoma Pineoblastoma Adult Pineoblastoma A papillary meningioma occurring in adults. C8293 Neoplastic Process Adult Papillary Meningioma Adult Papillary Meningioma C0281334 CTRP Malignant Adult_Papillary_Meningioma Adult Papillary Meningioma Papillary Meningioma Adult Papillary Meningioma An adenocarcinoma which arises from the exocrine pancreas. Ductal adenocarcinoma and its variants are the most common types of pancreatic adenocarcinoma. C8294 Neoplastic Process Pancreatic Adenocarcinoma Pancreatic Adenocarcinoma C0281361 CTEP CTRP Cellosaurus Malignant Pancreatic_Adenocarcinoma Adenocarcinoma - pancreas Adenocarcinoma of Pancreas Adenocarcinoma of the Pancreas Adenocarcinoma of the pancreas Pancreas Adenocarcinoma Pancreatic Adenocarcinoma Pancreatic Adenocarcinoma A benign papillary neoplasm that arises endobronchially. It is classified as squamous cell, glandular, or mixed squamous cell and glandular papilloma. Patients usually present with signs and symptoms of bronchial obstruction. C8295 Neoplastic Process Bronchial Papilloma CL030646 Benign Respiratory_Papilloma Bronchial Papilloma Lung Papilloma Papilloma of Respiratory Tract Papilloma of the Respiratory Tract Respiratory Tract Papilloma Bronchial Papilloma An extraskeletal osteosarcoma affecting the duodenum. C82972 Neoplastic Process Duodenal Extraskeletal Osteosarcoma C2826601 Malignant Duodenal_Extraskeletal_Osteosarcoma Duodenal Extraskeletal Osteosarcoma Duodenal Extraskeletal Osteosarcoma A lymphoblastic lymphoma occurring in HIV-positive patients. C8298 Neoplastic Process AIDS-Related Lymphoblastic Lymphoma AIDS-Related Lymphoblastic Lymphoma C0281464 CTRP Malignant AIDS-Related_Lymphoblastic_Lymphoma AIDS Associated Lymphoblastic lymphoma AIDS Related Lymphoblastic lymphoma AIDS-Associated Lymphoblastic lymphoma AIDS-Related Lymphoblastic Lymphoma AIDS-Related Precursor Lymphoblastic Lymphoma AIDS-Related Lymphoblastic Lymphoma A plasma cell neoplasm that secretes an abnormal immunoglobulin, which deposits in various tissues and forms a beta-pleated sheet structure that binds Congo red dye with characteristic birefringence. The sites of involvement include heart, liver, kidney, gut, tongue, nerves, and bone. (WHO, 2001) C8299 Neoplastic Process Primary Systemic Amyloidosis Primary Systemic Amyloidosis C0268380 CTRP Undetermined Primary_Systemic_Amyloidosis Primary Systemic Amyloidosis Primary Systemic Amyloidosis An aggressive malignant soft tissue neoplasm of uncertain differentiation. It is characterized by a recurrent chromosomal translocation t(11;22)(p13;q12) and the presence of small round cells in a desmoplastic stroma. It usually affects children and young adults. The most common site of involvement is the abdomen. Patients usually present with abdominal distention, pain, ascites, and a palpable abdominal mass. The prognosis is usually poor. C8300 Neoplastic Process Desmoplastic Small Round Cell Tumor Desmoplastic Small Round Cell Tumor C0281508 CTEP CTRP GDC A rare, aggressive cancer that usually affects young males and usually is located in the abdomen. 8806/3 Malignant Desmoplastic_Small_Round_Cell_Tumor 8806/3 Desmoplastic small round cell tumor DSRCT Desmoplas. small round cell tumor Desmoplastic Small Round Cell Tumor Desmoplastic Small Round-Cell Neoplasm Desmoplastic Small Round-Cell Tumor Desmoplastic small round cell tumor Polyphenotypic Small Round Cell Tumor desmoplastic small round cell tumor Desmoplastic Small Round Cell Tumor An acute myeloid leukemia with minimal differentiation occurring in adults. C8303 Neoplastic Process Adult Acute Myeloid Leukemia with Minimal Differentiation Adult Acute Myeloid Leukemia with Minimal Differentiation C0281641 CPTAC CTRP Cellosaurus Malignant Adult_Acute_Myeloid_Leukemia_Minimally_Differentiated Acute Myeloid Leukemia (AML) with Minimal Differentiation Adult Acute M0 Leukemia Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Myeloblastic Leukemia with Minimal Differentiation Adult Acute Myelogenous Leukemia with Minimal Differentiation Adult Acute Myeloid Leukemia Minimally Differentiated Adult Acute Myeloid Leukemia with Minimal Differentiation M0 Adult AML M0 Adult ANLL M0 Adult Acute Leukemia M0 Adult Acute Myeloblastic Leukemia M0 Adult Acute Myeloblastic Leukemia with Minimal Differentiation M0 Adult Acute Myelogenous Leukemia M0 Adult Acute Myelogenous Leukemia with Minimal Differentiation M0 Adult Acute Myeloid Leukemia with Minimal Differentiation M0 Undifferentiated OR AML with minimal differentiation Adult Acute Myeloid Leukemia with Minimal Differentiation An acute myeloid leukemia with minimal differentiation occurring in children. C8304 Neoplastic Process Childhood Acute Myeloid Leukemia with Minimal Differentiation Childhood Acute Myeloid Leukemia with Minimal Differentiation C0281642 CTRP NICHD An acute myeloid leukemia with minimal differentiation occurring in children. Malignant Childhood_Acute_Myeloid_Leukemia_Minimally_Differentiated Acute Myeloid Leukemia (AML) with Minimal Differentiation Childhood Acute M0 Leukemia Childhood Acute Minimally Differentiated Myeloid Leukemia Childhood Acute Minimally Differentiated Myeloid Leukemia (M0) Childhood Acute Myeloid Leukemia Minimally Differentiated Childhood Acute Myeloid Leukemia with Minimal Differentiation M0 Childhood Acute Minimally Differentiated Myeloid Leukemia M0 Pediatric Acute Minimally Differentiated Myeloid Leukemia Pediatric Acute M0 Leukemia Pediatric Acute Minimally Differentiated Myeloid Leukemia Childhood Acute Myeloid Leukemia with Minimal Differentiation A sarcoma arising from the leptomeninges. C8312 Neoplastic Process Leptomeningeal Sarcoma C1384416 CDISC GDC A malignant mesenchymal neoplasm arising from the leptomeninges. Malignant Leptomeningeal_Sarcoma 9530/3 Leptomeningeal sarcoma Leptomeningeal Sarcoma Leptomeningeal sarcoma SARCOMA, LEPTOMENINGEAL, MALIGNANT Sarcoma of Leptomeninges Sarcoma of the Leptomeninges Sarcoma, Meningeal Leptomeningeal Sarcoma Breast classic lobular carcinoma in situ characterized by the presence of neoplastic cells with uniform nuclei. C83170 Neoplastic Process Breast Classic Lobular Carcinoma In Situ Type A C2826777 Malignant Lobular_Neoplasia_Type_A Breast Classic Lobular Carcinoma In Situ Type A Breast Classic Lobular Carcinoma In Situ Type A Breast classic lobular carcinoma in situ characterized by the presence of neoplastic cells with nuclei of various sizes and shapes. C83171 Neoplastic Process Breast Classic Lobular Carcinoma In Situ Type B C2826778 Malignant Lobular_Neoplasia_Type_B Breast Classic Lobular Carcinoma In Situ Type B Breast Classic Lobular Carcinoma In Situ Type B Polyps that arises from the colon or rectum. They are characterized by the presence of serrated glands and the absence of generalized dysplasia. C83176 Neoplastic Process Colorectal Serrated Lesions and Polyps C2826783 Benign Colorectal_Mixed_Hyperplastic_Adenomatous_Polyp Colorectal Mixed Hyperplastic Adenomatous Polyp Colorectal Mixed Hyperplastic Adenomatous Polyp/Serrated Adenoma Colorectal SSA Colorectal SSA/P Colorectal SSP Colorectal Serrated Lesions and Polyps Colorectal Sessile Serrated Adenoma Colorectal Sessile Serrated Adenoma/Polyp Colorectal Sessile Serrated Polyp Colorectal Serrated Lesions and Polyps Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE) (rare in Hodgkin lymphoma). C8318 Neoplastic Process Ann Arbor Stage I Lymphoma Ann Arbor Stage I Lymphoma C0332424 CTRP Malignant Stage_I_Lymphoma Ann Arbor Stage I Lymphoma Lymphoma Stage I Stage I Lymphoma Ann Arbor Stage I Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8319 Neoplastic Process Ann Arbor Stage II Lymphoma Ann Arbor Stage II Lymphoma C0332426 CTRP Malignant Stage_II_Lymphoma Ann Arbor Stage II Lymphoma Lymphoma Stage II Stage II Lymphoma Ann Arbor Stage II Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8320 Neoplastic Process Ann Arbor Stage III Lymphoma Ann Arbor Stage III Lymphoma C0332428 CTRP Malignant Stage_III_Lymphoma Ann Arbor Stage III Lymphoma Lymphoma Stage III Stage III Lymphoma Ann Arbor Stage III Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8321 Neoplastic Process Ann Arbor Stage IV Lymphoma Ann Arbor Stage IV Lymphoma C0332434 CTRP Malignant Stage_IV_Lymphoma Ann Arbor Stage IV Lymphoma Lymphoma Stage IV Stage IV Lymphoma Ann Arbor Stage IV Lymphoma A laboratory test designed to quantify or qualify the poisonous nature of a sample. C83323 Finding Laboratory Test Toxicity C2826913 Laboratory_Test_Toxicity LBTOX Laboratory Test Toxicity Laboratory Test Toxicity An undifferentiated pleomorphic sarcoma characterized by the presence of osteoclast-like giant cells and cellular pleomorphism. C8380 Neoplastic Process Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells C0334554 GDC 9251/3 Malignant Giant_Cell_Fibrous_Histiocytoma 9250/3 9251/3 Malignant giant cell tumor of soft parts Osteoblastoma, malignant Giant Cell Fibrous Histiocytoma Giant Cell Malignant Fibrous Histiocytoma Malignant Giant Cell Neoplasm of Soft Parts Malignant Giant Cell Tumor of Soft Parts Malignant giant cell tumor of soft parts Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells An adenoma arising from the renal cortex. C8383 Neoplastic Process Kidney Adenoma C0334684 CDISC A benign neoplasm arising from the renal cortex. Benign Renal_Adenoma ADENOMA, RENAL CELL, BENIGN Kidney Adenoma Renal Adenoma Renal Tubule Adenoma Kidney Adenoma A category of mesenchymal gynecologic neoplasms. It includes endometrial stromal nodule, endometrioid stromal sarcoma, and undifferentiated sarcoma. Endometrial stromal nodule has been described in the uterine corpus only. Histologically, it is characterized by the lack of infiltration of the surrounding tissues. Endometrioid stromal sarcoma affects the uterine corpus, and rarely, the ovaries, cervix, vagina, peritoneum, and retroperitoneum. In the uterine corpus it is classified as low grade or high grade endometrial stromal sarcoma. In the remainder of the anatomic sites it is classified as low grade endometrioid stromal sarcoma. Undifferentiated sarcoma was previously also known as high grade endometrial stromal sarcoma. In 2014, high grade endometrial stromal sarcoma was reclassified and is currently considered a distinct and rare neoplasm that affects the uterine corpus only. It appears to have a prognosis that falls between low grade endometrial stromal sarcoma and undifferentiated sarcoma. The latter affects the uterine corpus and rarely the remainder of the anatomic sites. C8384 Neoplastic Process Endometrioid Stromal and Related Neoplasms C3642437 Undetermined Endometrial_Stromal_Neoplasm Endometrioid Stromal and Related Neoplasms Endometrioid Stromal and Related Tumors Endometrioid Stromal and Related Neoplasms A diffuse astrocytoma that arises from the cerebral hemispheres and occurs during childhood. C8387 Neoplastic Process Childhood Cerebral Diffuse Astrocytoma C1332961 Undetermined Childhood_Cerebral_Diffuse_Astrocytoma Childhood Cerebral Diffuse Astrocytoma Childhood Cerebral Diffuse Astrocytoma A hormone producing pituitary neuroendocrine tumor associated with a hormonal syndrome. C8388 Neoplastic Process Functioning Pituitary Gland Adenoma Functioning Pituitary Neuroendocrine Tumor C0854486 CTRP Undetermined Functioning_Pituitary_Gland_Adenoma Functioning Adenoma of Pituitary Functioning Adenoma of Pituitary Gland Functioning Adenoma of the Pituitary Functioning Adenoma of the Pituitary Gland Functioning PitNET/Adenoma Functioning Pituitary Adenoma Functioning Pituitary Gland Adenoma Functioning Pituitary Neuroendocrine Tumor Functioning Pituitary Neuroendocrine Tumor/Adenoma Secretory Adenoma of Pituitary Secretory Adenoma of Pituitary Gland Secretory Adenoma of the Pituitary Secretory Adenoma of the Pituitary Gland Secretory Pituitary Adenoma Secretory Pituitary Gland Adenoma Functioning Pituitary Neuroendocrine Tumor Regrowth of benign and malignant childhood cerebellar astrocytomas that have previously been subjected to surgical resection and less frequently other forms of therapy such as radiation or chemotherapy. Recurrence of benign tumors (e.g., (pilocytic astrocytoma) may respond to a second surgical procedure. C8389 Neoplastic Process Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebellar Astrocytoma C0338338 CTRP Undetermined Recurrent_Childhood_Cerebellar_Astrocytoma Recurrent Cerebellar Astrocytoma Recurrent Childhood Astrocytoma of Cerebellum Recurrent Childhood Astrocytoma of the Cerebellum Recurrent Childhood Cerebellar Astrocytoma Recurrent Pediatric Astrocytoma of Cerebellum Recurrent Pediatric Astrocytoma of the Cerebellum Recurrent Pediatric Cerebellar Astrocytoma Relapsed Childhood Astrocytoma of Cerebellum Relapsed Childhood Astrocytoma of the Cerebellum Relapsed Childhood Cerebellar Astrocytoma Relapsed Pediatric Astrocytoma of Cerebellum Relapsed Pediatric Astrocytoma of the Cerebellum Relapsed Pediatric Cerebellar Astrocytoma Recurrent Childhood Cerebellar Astrocytoma A carcinoma of the oral cavity that arises from the upper gingiva. C8392 Neoplastic Process Upper Gingival Carcinoma C0345531 Malignant Upper_Gingival_Carcinoma Carcinoma of Upper Gingiva Carcinoma of Upper Gum Carcinoma of the Upper Gingiva Carcinoma of the Upper Gum Upper Gingival Carcinoma Upper Gum Carcinoma Upper Gingival Carcinoma A carcinoma of the oral cavity that arises from the lower gingiva. C8393 Neoplastic Process Lower Gingival Carcinoma C0345535 Malignant Lower_Gingival_Carcinoma Carcinoma of Lower Gingiva Carcinoma of Lower Gum Carcinoma of the Lower Gingiva Carcinoma of the Lower Gum Lower Gingival Carcinoma Lower Gum Carcinoma Lower Gingival Carcinoma A carcinoma that arises from the hard palate. Representative examples include squamous cell carcinoma, adenoid cystic carcinoma, and mucoepidermoid carcinoma. C8394 Neoplastic Process Hard Palate Carcinoma C0345550 Malignant Hard_Palate_Carcinoma Carcinoma of Hard Palate Carcinoma of the Hard Palate Hard Palate Carcinoma Hard Palate Carcinoma A carcinoma that arises from the soft palate. The majority are squamous cell carcinomas. C8395 Neoplastic Process Soft Palate Carcinoma Soft Palate Carcinoma C0345555 CTRP Malignant Soft_Palate_Carcinoma Carcinoma of Soft Palate Carcinoma of the Soft Palate Soft Palate Cancer Soft Palate Carcinoma Soft Palate Carcinoma A carcinoma that arises from the submandibular gland. Representative examples include mucoepidermoid carcinoma, adenoid cystic carcinoma, and carcinoma ex pleomorphic adenoma. C8396 Neoplastic Process Submandibular Gland Carcinoma Submandibular Gland Carcinoma C0345607 CTRP Malignant Submandibular_Gland_Carcinoma Carcinoma of Submandibular Gland Carcinoma of the Submandibular Gland Submandibular Gland Cancer Submandibular Gland Carcinoma Submandibular Gland Carcinoma A carcinoma that arises from the sublingual gland. Representative examples include cystadenocarcinoma and mucoepidermoid carcinoma. C8397 Neoplastic Process Sublingual Gland Carcinoma Sublingual Gland Carcinoma C0345611 CTRP Malignant Sublingual_Gland_Carcinoma Carcinoma of Sublingual Gland Carcinoma of the Sublingual Gland Sublingual Gland Cancer Sublingual Gland Carcinoma Sublingual Gland Carcinoma A carcinoma that arises from the fundus of the stomach. C8398 Neoplastic Process Gastric Fundus Carcinoma Gastric Fundus Carcinoma C0345799 CTRP Cellosaurus Malignant Gastric_Fundus_Carcinoma Cancer of Fundus of Stomach Cancer of Gastric Fundus Cancer of the Fundus of the Stomach Cancer of the Gastric Fundus Carcinoma of Fundus of Stomach Carcinoma of Gastric Fundus Carcinoma of the Fundus of the Stomach Carcinoma of the Gastric Fundus Gastric Fundus (Stomach) Cancer Gastric Fundus Cancer Gastric Fundus Carcinoma Gastric Fundus Carcinoma A carcinoma that arises from the body of the stomach. C8399 Neoplastic Process Gastric Body Carcinoma Gastric Body Carcinoma C0345804 CTRP Malignant Gastric_Body_Carcinoma Cancer of Body of Stomach Cancer of Gastric Body Cancer of the Body of the Stomach Cancer of the Gastric Body Carcinoma of Body of Stomach Carcinoma of Gastric Body Carcinoma of the Body of the Stomach Carcinoma of the Gastric Body Gastric Body (Stomach) Cancer Gastric Body Cancer Gastric Body Carcinoma Gastric Body Carcinoma Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8400 Neoplastic Process Gastric Antrum Carcinoma In Situ AJCC v6 and v7 C0345810 Malignant Carcinoma_in_situ_of_the_Antrum Carcinoma In Situ of the Antrum Carcinoma in situ of Antrum Gastric Antrum Carcinoma In Situ Gastric Antrum Carcinoma In Situ AJCC v6 and v7 Gastric Antrum Carcinoma in situ Stage 0 Carcinoma of Gastric Antrum Stage 0 Carcinoma of the Gastric Antrum Gastric Antrum Carcinoma In Situ AJCC v6 and v7 A benign or malignant neoplasm that affects the wall of the jejunum. Representative examples include adenoma, carcinoma, and lymphoma. C8401 Neoplastic Process Jejunal Neoplasm C0022374 Undetermined Jejunal_Neoplasm Jejunal Neoplasm Jejunal Tumor Neoplasm of Jejunum Neoplasm of the Jejunum Tumor of Jejunum Tumor of the Jejunum Jejunal Neoplasm A benign, intermediate, or malignant mesenchymal neoplasm composed of fibrohistiocytic cells, spindle fibroblastic cells, and histiocytes, in a storiform pattern. C8402 Neoplastic Process Fibrohistiocytic Neoplasm C0346049 Undetermined Fibrohistiocytic_Neoplasm Fibrohistiocytic Neoplasm Fibrohistiocytic Tumor Fibrohistiocytic Neoplasm An aggressive granulosa cell tumor that arises from the ovary and metastasizes to other anatomic sites. C8403 Neoplastic Process Malignant Ovarian Granulosa Cell Tumor C0346175 Malignant Malignant_Ovarian_Granulosa_Cell_Tumor Malignant Granulosa Cell Neoplasm of Ovary Malignant Granulosa Cell Neoplasm of the Ovary Malignant Granulosa Cell Tumor of Ovary Malignant Granulosa Cell Tumor of the Ovary Malignant Ovarian Granulosa Cell Neoplasm Malignant Ovarian Granulosa Cell Tumor Malignant Ovarian Granulosa Cell Tumor A neoplasm involving the renal pelvis. C8404 Neoplastic Process Renal Pelvis Neoplasm C0346260 Undetermined Renal_Pelvis_Neoplasm Kidney Pelvis Neoplasm Kidney Pelvis Tumor Neoplasm of Kidney Pelvis Neoplasm of Renal Pelvis Neoplasm of the Kidney Pelvis Neoplasm of the Renal Pelvis Renal Pelvis Neoplasm Renal Pelvis Tumor Tumor of Kidney Pelvis Tumor of Renal Pelvis Tumor of the Kidney Pelvis Tumor of the Renal Pelvis Renal Pelvis Neoplasm A neoplasm that arises from the choroid plexus and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C8405 Neoplastic Process Benign Choroid Plexus Neoplasm C0346290 Benign Benign_Choroid_Plexus_Neoplasm Benign Choroid Plexus Neoplasm Benign Choroid Plexus Neoplasms Benign Choroid Plexus Tumor Benign Choroid Plexus Tumors Benign Neoplasm of Choroid Plexus Benign Neoplasm of the Choroid Plexus Benign Tumor of Choroid Plexus Benign Tumor of the Choroid Plexus Benign Choroid Plexus Neoplasm A carcinoma that arises from the base of the tongue. Representative examples include squamous cell carcinoma, adenoid cystic carcinoma, and mucoepidermoid carcinoma. C8407 Neoplastic Process Posterior Tongue Carcinoma Posterior Tongue Carcinoma C0346564 CTRP Malignant Posterior_Tongue_Carcinoma Base of Tongue Carcinoma Base of the Tongue Carcinoma Carcinoma of Base of Tongue Carcinoma of Posterior Tongue Carcinoma of the Base of the Tongue Carcinoma of the Posterior Tongue Posterior Tongue Carcinoma Posterior Tongue Carcinoma A primary or metastatic malignant neoplasm that affects the sternum. C8408 Neoplastic Process Malignant Sternal Neoplasm C0346672 Malignant Malignant_Sternal_Neoplasm Malignant Neoplasm of Sternum Malignant Neoplasm of the Sternum Malignant Sternal Neoplasm Malignant Sternal Tumor Malignant Tumor of Sternum Malignant Tumor of the Sternum Malignant Sternal Neoplasm A rare malignant neoplasm that arises from the sebaceous glands. C8409 Neoplastic Process Malignant Sebaceous Neoplasm C1382026 Malignant Malignant_Sebaceous_Neoplasm Malignant Neoplasm of Sebaceous Gland Malignant Neoplasm of the Sebaceous Gland Malignant Sebaceous Gland Neoplasm Malignant Sebaceous Gland Tumor Malignant Sebaceous Neoplasm Malignant Sebaceous Tumor Malignant Tumor of Sebaceous Gland Malignant Tumor of the Sebaceous Gland Malignant Sebaceous Neoplasm A melanoma that arises usually from the breast skin and less often from the breast glandular tissue. Primary breast melanomas are rare. C8410 Neoplastic Process Breast Melanoma C0346787 CPTAC Malignant Breast_Melanoma Breast Melanoma Malignant Breast Melanoma Malignant Melanoma of Breast Malignant Melanoma of the Breast Breast Melanoma The spread of a malignant neoplasm to the colon. This may be from a primary large intestine malignant neoplasm, or from a malignant neoplasm at a distant site. C8411 Neoplastic Process Metastatic Malignant Neoplasm in the Colon Metastatic Malignant Neoplasm in the Colon C0346974 CTRP Malignant Metastatic_Neoplasm_to_the_Colon Metastatic Malignant Neoplasm in the Colon Metastatic Malignant Neoplasm to the Colon Metastatic Neoplasm to the Colon Metastatic Tumor to the Colon Metastatic Malignant Neoplasm in the Colon Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 6th ed.) C8412 Neoplastic Process Stage IV Rectal Cancer AJCC v6 Stage IV Rectal Cancer AJCC v6 C0861772 CTRP Malignant Stage_IV_Rectal_Cancer AJCC Stage IV Rectal Cancer v6 Astler-Coller D Rectal Carcinoma Dukes D Carcinoma of Rectum Dukes D Carcinoma of the Rectum Dukes D Rectal Carcinoma Rectal Cancer Stage IV AJCC v6 Stage IV Carcinoma of Rectum AJCC v6 Stage IV Carcinoma of the Rectum AJCC v6 Stage IV Rectal Cancer Stage IV Rectal Cancer AJCC v6 Stage IV Rectal Carcinoma AJCC v6 Stage IV Rectal Cancer AJCC v6 A neoplasm that arises from the supraglottis and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C8414 Neoplastic Process Benign Supraglottis Neoplasm C0347235 Benign Benign_Supraglottis_Neoplasm Benign Neoplasm of Supraglottis Benign Neoplasm of the Supraglottis Benign Supraglottic Neoplasm Benign Supraglottic Tumor Benign Supraglottis Neoplasm Benign Supraglottis Tumor Benign Tumor of Supraglottis Benign Tumor of the Supraglottis Benign Supraglottis Neoplasm A neoplasm that arises from the sternum and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C8416 Neoplastic Process Benign Sternal Neoplasm C0347312 Benign Benign_Sternal_Neoplasm Benign Neoplasm of Sternum Benign Neoplasm of the Sternum Benign Sternal Neoplasm Benign Sternal Tumor Benign Tumor of Sternum Benign Tumor of the Sternum Benign Sternal Neoplasm A neoplasm that arises from the ear and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C8417 Neoplastic Process Benign Ear Neoplasm C0347354 Benign Benign_Ear_Neoplasm Aural Neoplasms, Benign Benign Ear Neoplasm Benign Ear Tumor Benign Neoplasm of Ear Benign Neoplasm of the Ear Benign Tumor of Ear Benign Tumor of the Ear Benign Ear Neoplasm A non-metastasizing neoplasm that arises from the Bartholin gland. Representative examples include adenoma and adenomyoma. C8418 Neoplastic Process Benign Bartholin Gland Neoplasm C0347500 Benign Benign_Bartholin_s_Gland_Neoplasm Benign Bartholin Gland Neoplasm Benign Bartholin's Gland Neoplasm Benign Bartholin's Gland Tumor Benign Neoplasm of Bartholin's Gland Benign Neoplasm of the Bartholin's Gland Benign Tumor of Bartholin's Gland Benign Tumor of the Bartholin's Gland Benign Bartholin Gland Neoplasm A benign, WHO grade I cerebellar mass, which occurs in young adults and is composed of dysplastic ganglion cells. It is the major CNS manifestation of Cowden disease, an autosomal dominant condition that causes a variety of hamartomas and neoplasms. C8419 Neoplastic Process Dysplastic Cerebellar Gangliocytoma C0391826 GDC 9493/0 Undetermined Dysplastic_Cerebellar_Gangliocytoma 9493/0 Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) Dysplastic Cerebellar Gangliocytoma Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease) Dysplastic Gangliocytoma of Cerebellum Dysplastic Gangliocytoma of the Cerebellum Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) Lhermitte-Duclos Disease Dysplastic Cerebellar Gangliocytoma A benign neoplasm that arises from the cervix. It is associated with human papillomavirus infection and is characterized by the presence of papillary structures with fibrovascular cores. The papillary structures are covered with stratified squamous epithelium. Koilocytosis is usually present. C8421 Neoplastic Process Cervical Condyloma Acuminatum C0742136 Benign Uterine_Cervix_Condyloma_Acuminatum Cervical Condyloma Cervical Condyloma Acuminatum Cervix Condylomata Cervix Condylomata Acuminata Cervix Uteri Condyloma Condyloma of Cervix Condyloma of Cervix Uteri Condyloma of Uterine Cervix Condyloma of the Cervix Condyloma of the Cervix Uteri Condyloma of the Uterine Cervix Condylomata Acuminata of Cervix Condylomata Acuminata of Cervix Uteri Condylomata Acuminata of Uterine Cervix Condylomata Acuminata of the Cervix Condylomata Acuminata of the Cervix Uteri Condylomata Acuminata of the Uterine Cervix Uterine Cervix Condyloma Uterine Cervix Condyloma Acuminatum Cervical Condyloma Acuminatum A well circumscribed lesion of the bone, most frequently arising from the posterior mandible. It is characterized by the presence of fibrous tissue and a mineralized component which may be woven bone, lamellar bone, or cementum-like material. Complete removal is recommended, since it continues to enlarge if left untreated. C8422 Neoplastic Process Cemento-Ossifying Fibroma C0206640 CDISC GDC A benign fibrous neoplasm characterized by a mineralized component (woven bone, lamellar bone, or cementum-like material). 9262/0 9274/0 Benign Cementifying_Fibroma 9274/0 Cementifying fibroma Cemento-ossifying fibroma COF Cementifying Fibroma Cementifying fibroma Cemento-Ossifying Fibroma Cemento-ossifying fibroma FIBROMA, CEMENTO-OSSIFYING, BENIGN Fibroma, Cementifying/Ossifying Cemento-Ossifying Fibroma Stage 0 includes: Tis, N0, M0. Tis: Melanoma in situ. N0: No regional lymph node metastases. M0: No detectable evidence of distant metastases. (from AJCC 6th and 7th Eds.) C8423 Neoplastic Process Stage 0 Cutaneous Melanoma AJCC v6 and v7 Stage 0 Cutaneous Melanoma AJCC v6 and v7 C0346040 CPTAC CTRP GDC mCode Abnormal melanocytes (cells that make melanin, the pigment that gives skin its color) are found in the epidermis (outer layer of the skin). These abnormal melanocytes may become cancer and spread into nearby normal tissue. 8720/2 Malignant Stage_0_Melanoma_of_the_Skin 8720/2 Melanoma in situ Melanoma in situ of other part of trunk Melanoma in situ of other sites Melanoma in situ of scalp and neck Melanoma in situ, unspecified Cutaneous Melanoma in situ Malignant Cutaneous Melanoma in situ Malignant Skin Melanoma in situ Melanoma In Situ Melanoma in situ Melanoma in situ of Skin Melanoma in situ of skin Melanoma in situ of the Skin Skin Melanoma in situ Stage 0 Cutaneous (Skin) Melanoma Stage 0 Cutaneous Melanoma Stage 0 Cutaneous Melanoma AJCC v6 and v7 Stage 0 Malignant Cutaneous Melanoma Stage 0 Malignant Melanoma Stage 0 Malignant Skin Melanoma Stage 0 Melanoma Stage 0 Melanoma of Skin Stage 0 Melanoma of the Skin Stage 0 Skin Melanoma AJCC v6 Stage 0 Skin Melanoma AJCC v6 and v7 Stage 0 Skin Melanoma AJCC v7 melanoma in situ stage 0 melanoma Stage 0 Cutaneous Melanoma AJCC v6 and v7 A rare neurofibroma with an infiltrative growth pattern. It involves the skin and subcutaneous tissue and grows in a plaque-like fashion. Malignant transformation is rare. C8426 Neoplastic Process Diffuse Neurofibroma C0432361 Benign Diffuse_Neurofibroma Diffuse Neurofibroma Diffuse Neurofibroma A clonal myeloproliferative neoplasm characterized by the proliferation and accumulation of neoplastic mast cells in one or multiple organs or organ systems. It is a heterogeneous group of neoplasms, ranging from cutaneous proliferations which may regress spontaneously, to aggressive neoplasms associated with organ failure and short survival. C84269 Neoplastic Process Mastocytosis Mastocytosis C0024899 CTRP Undetermined Mast Cell Disease Mastocytosis Mastocytosis An extra-adrenal parasympathetic paraganglioma arising from paraganglia in the vagus nerve. Patients may present with a slow growing painless mass in the neck, hoarseness, vocal cord paralysis, and dysphagia. C8427 Neoplastic Process Vagal Paraganglioma C0474819 Undetermined Vagus_Nerve_Paraganglioma Paraganglioma of Vagal Body Paraganglioma of Vagus Nerve Paraganglioma of the Vagal Body Paraganglioma of the Vagus Nerve Vagal Body Paraganglioma Vagal Paraganglioma Vagus Nerve Paraganglioma Vagal Paraganglioma A group of rare myeloid and lymphoid neoplasms characterized by rearrangement of the PDGFRA, PDGFRB, FGFR1, or JAK2 genes, resulting in the formation of tyrosine kinase fusion transcripts. Eosinophilia is a characteristic finding but it is not always present. C84270 Neoplastic Process Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions C2827356 Malignant M/LN-eo with Tyrosine Kinase Gene Fusions Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB, or FGFR1 Myeloid and Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2 Myeloid/Lymphoid Neoplasms with Eosinophilia and Defining Gene Rearrangements Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2 Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions Hematologic neoplasms characterized by the rearrangement of the PDGFRA gene, most often resulting in the formation of FIP1L1-PDGFRA fusion transcripts. Patients usually present with chronic eosinophilic leukemia, and less often with acute myeloid leukemia or T-lymphoblastic leukemia. C84275 Neoplastic Process Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement C2827360 GDC 9965/3 Malignant 9965/3 Myeloid and lymphoid neoplasms with PDGFRA rearrangement Myeloid or lymphoid neoplasm with PDGFRA rearrangement M/LN-eo with PDGFRA Rearrangement Myeloid and Lymphoid Neoplasms with PDGFRA Rearrangement Myeloid and lymphoid neoplasms with PDGFRA rearrangement Myeloid/Lymphoid Neoplasm with PDGFRA Rearrangement Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement Myeloid and rarely lymphoid neoplasms characterized by the rearrangement of the PDGFRB gene, most often resulting in the formation of ETV6-PDGFRB fusion transcripts. Patients usually present with chronic myelomonocytic leukemia and less often with atypical chronic myeloid leukemia, or chronic eosinophilic leukemia. C84276 Neoplastic Process Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement C3472621 GDC 9966/3 Malignant 9966/3 Myeloid neoplasms with PDGFRB rearrangement M/LN-eo with PDGFRB Rearrangement Myeloid Neoplasms with PDGFRB Rearrangement Myeloid and Lymphoid Neoplasms with PDGFRB Rearrangement Myeloid neoplasms with PDGFRB rearrangement Myeloid/Lymphoid Neoplasm with PDGFRB Rearrangement Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement Hematologic neoplasms characterized by the rearrangement of the FGFR1 gene, resulting in translocations with an 8p11 breakpoint. Patients present with a myeloproliferative neoplasm, acute myeloid leukemia, lymphoblastic lymphoma/leukemia of T or B-cell lineage, or acute leukemia of mixed phenotype. C84277 Neoplastic Process Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement CL497893 GDC 9967/3 Malignant 9967/3 Myeloid and lymphoid neoplasms with FGFR1 abnormalities Myeloid or lymphoid neoplasm with FGFR1 abnormalities 8p11 Myeloproliferative Syndrome 8p11 Stem Cell Leukemia/Lymphoma Syndrome 8p11 Stem Cell Lymphoma/Leukemia Syndrome 8p11 Stem Cell Syndrome M/LN-eo with FGFR1 Rearrangement Myeloid and Lymphoid Neoplasms with FGFR1 Rearrangement Myeloid and lymphoid neoplasms with FGFR1 abnormalities Myeloid/Lymphoid Neoplasm with FGFR1 Rearrangement Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement A middle ear paraganglioma arising from paraganglia around the tympanum. Signs and symptoms include a mass behind the tympanum, tinnitus, and conductive hearing loss. C8428 Neoplastic Process Tympanic Paraganglioma C1866555 Undetermined Tympanic_Paraganglioma Tympanic Paraganglioma Tympanic Paraganglioma A benign, borderline, or malignant epithelial tumor that arises from the ovary and is characterized by the presence of papillary proliferations. Representative examples include surface papilloma, borderline serous surface papillary tumor, and serous surface papillary adenocarcinoma. C8430 Neoplastic Process Ovarian Papillary Tumor C0476121 Undetermined Ovarian_Papillary_Neoplasm Ovarian Papillary Neoplasm Ovarian Papillary Tumor Papillary Neoplasm of Ovary Papillary Neoplasm of the Ovary Papillary Tumor of Ovary Papillary Tumor of the Ovary Ovarian Papillary Tumor A benign, borderline, or malignant epithelial tumor of the ovary characterized by the presence of neoplastic epithelial cells that, in well differentiated tumors, resemble the epithelial cells of the fallopian tube and, in poorly differentiated tumors, show anaplastic features. Approximately thirty to fifty percent of the tumors are bilateral. Grossly, the better differentiated tumors consist of cystic masses, usually unilocular, containing a clear but sometimes viscous fluid. Papillary formations are often present. The more malignant tumors tend to be solid and invasive, with areas of necrosis and hemorrhage. C8431 Neoplastic Process Ovarian Serous Tumor C0476122 Undetermined Ovarian_Serous_Neoplasm Ovarian Serous Neoplasm Ovarian Serous Tumor Serous Neoplasm of Ovary Serous Neoplasm of the Ovary Serous Tumor of Ovary Serous Tumor of the Ovary Ovarian Serous Tumor An astroblastoma, MN1-altered, characterized by the presence of high mitotic activity, cytologic atypia, and architectural distortion. C84347 Neoplastic Process Anaplastic Astroblastoma, MN1-Altered C2827403 Malignant Anaplastic Astroblastoma Anaplastic Astroblastoma, MN1-Altered Anaplastic Astroblastoma, MN1-Altered A neoplastic process that arises from the terminal ductal lobular unit of the breast parenchyma. It is usually solitary and confined to a single lobular unit. It is characterized by the presence of a monomorphic epithelial proliferation in a cribriform, micropapillary, or solid growth pattern. Focal architectural features of low grade ductal carcinoma in situ are present. There is an increased risk for development of invasive breast carcinoma. C8436 Neoplastic Process Atypical Ductal Breast Hyperplasia Breast Atypical Ductal Hyperplasia C1332347 CTRP A benign (not cancer) condition in which there are more cells than normal in the breast lobules and the cells look abnormal under a microscope. Having atypical lobular hyperplasia increases the risk of breast cancer. Undetermined Atypical_Ductal_Breast_Hyperplasia ADH Atypical Breast Ductal Hyperplasia Atypical Ductal Breast Hyperplasia Atypical Ductal Hyperplasia of Breast Atypical Ductal Hyperplasia of the Breast Breast Atypical Ductal Hyperplasia DIN 1B Ductal Intraepithelial Neoplasia, Grade 1B atypical ductal breast hyperplasia atypical ductal hyperplasia Breast Atypical Ductal Hyperplasia An extranodal, mature T-cell non-Hodgkin lymphoma that originates from cytotoxic T-cells, usually of gamma/delta T-cell type. It is characterized by the presence of medium-size neoplastic lymphocytes infiltrating the hepatic sinusoids. A similar infiltrating pattern is also present in the spleen and bone marrow that are usually involved at the time of the diagnosis. C8459 Neoplastic Process Hepatosplenic T-Cell Lymphoma Hepatosplenic T-Cell Lymphoma C0522627 CTRP Cellosaurus GDC mCode 9716/3 Malignant Hepatosplenic_T-Cell_Lymphoma 9716/3 Hepatosplenic T-cell lymphoma Hepatosplenic gamma-delta cell lymphoma Hepatosplenic Gamma/Delta T-Cell Lymphoma Hepatosplenic T-Cell Lymphoma Hepatosplenic T-cell lymphoma Hepatosplenic gamma-delta cell lymphoma Hepatosplenic T-Cell Lymphoma An acute myeloid leukemia (AML) in which the blasts do not show evidence of myeloid differentiation by morphology and conventional cytochemistry. (WHO, 2001) C8460 Neoplastic Process Acute Myeloid Leukemia with Minimal Differentiation C0522631 CPTAC Cellosaurus GDC NICHD PCDC An acute myeloid leukemia (AML) in which the blasts do not show evidence of myeloid differentiation by morphology and conventional cytochemistry. (WHO, 2001) 9872/3 Malignant Acute_Myeloid_Leukemia_Minimally_Differentiated 9872/3 Acute myeloid leukemia, minimal differentiation FAB MO M0 AML with Minimal Differentiation Acute Myeloblastic Leukemia with Minimal Differentiation Acute Myeloblastic Leukemia, Minimally Differentiated Acute Myelogenous Leukemia with Minimal Differentiation Acute Myeloid Leukemia with Minimal Differentiation Acute Myeloid Leukemia with Minimal Differentiation (MO) Acute Myeloid Leukemia, Minimally Differentiated Acute myeloid leukemia, minimal differentiation M0 M0 Acute Myeloblastic Leukemia M0 Acute Myelogenous Leukemia M0 Acute Myelogenous Leukemia with Minimal Differentiation M0 Myeloid Leukemia M0 Myeloid Leukemia with Minimal Differentiation Acute Myeloid Leukemia with Minimal Differentiation An adamantinoma arising from the tibia. The tibia is the site which is more frequently involved by adamantinoma (80-90% of cases). C8461 Neoplastic Process Tibial Adamantinoma C1273017 GDC Malignant Tibial_Adamantinoma 9261/3 Tibial adamantinoma Tibial Adamantinoma Tibial adamantinoma Tibial Adamantinoma A cavernous hemangioma arising from the central nervous system. C84621 Neoplastic Process Central Nervous System Cavernous Hemangioma C0752160 Benign Central Nervous System Cavernous Hemangioma Central Nervous System Cavernous Hemangioma A carcinoma that arises from the hard or soft palate. Representative examples include squamous cell carcinoma, adenoid cystic carcinoma, and mucoepidermoid carcinoma. C8463 Neoplastic Process Palate Carcinoma C0558354 Malignant Palate_Carcinoma Carcinoma of Palate Carcinoma of the Palate Palate Carcinoma Palate Carcinoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8464 Neoplastic Process Ann Arbor Stage I Indolent Adult Non-Hodgkin Lymphoma Ann Arbor Stage I Indolent Adult Non-Hodgkin Lymphoma C0677682 CTRP Malignant Stage_I_Indolent_Adult_Non-Hodgkin_s_Lymphoma Ann Arbor Stage I Indolent Adult Non-Hodgkin Lymphoma Indolent Adult Non-Hodgkin's Lymphoma Stage I Indolent Stage I Adult Non-Hodgkin's Lymphoma Stage I Indolent Adult Non-Hodgkin Lymphoma Stage I Indolent Adult Non-Hodgkin's Lymphoma Stage I Indolent Non-Hodgkin Lymphoma Ann Arbor Stage I Indolent Adult Non-Hodgkin Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8465 Neoplastic Process Ann Arbor Stage I Mantle Cell Lymphoma Ann Arbor Stage I Mantle Cell Lymphoma C0677683 CTRP Malignant Stage_I_Mantle_Cell_Lymphoma Ann Arbor Stage I Mantle Cell Lymphoma Mantle Cell Lymphoma Stage I Stage I Mantle Cell Lymphoma Ann Arbor Stage I Mantle Cell Lymphoma Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ) C8466 Neoplastic Process Ann Arbor Stage II Contiguous Adult Non-Hodgkin Lymphoma Ann Arbor Stage II Contiguous Adult Non-Hodgkin Lymphoma C0677685 CTRP Malignant Stage_II_Contiguous_Adult_Non-Hodgkin_s_Lymphoma Adult Contiguous Non-Hodgkin's Lymphoma Stage II Adult Contiguous Stage II Non-Hodgkin's Lymphoma Ann Arbor Stage II Contiguous Adult Non-Hodgkin Lymphoma Contiguous Adult Non-Hodgkin's Lymphoma Stage II Contiguous Stage II Adult Non-Hodgkin's Lymphoma Stage II Adult Contiguous Non-Hodgkin's Lymphoma Stage II Contiguous Adult Non-Hodgkin Lymphoma Stage II Contiguous Adult Non-Hodgkin's Lymphoma Stage II Non-Hodgkin Lymphoma Ann Arbor Stage II Contiguous Adult Non-Hodgkin Lymphoma Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ) C8467 Neoplastic Process Ann Arbor Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma Ann Arbor Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma C0677686 CTRP Malignant Stage_II_Contiguous_Adult_Indolent_Non-Hodgkin_s_Lymphoma Adult Indolent Contiguous Non-Hodgkin's Lymphoma Stage II Ann Arbor Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma Indolent Adult Contiguous Non-Hodgkin's Lymphoma Stage II Indolent Adult Contiguous Stage II Non-Hodgkin's Lymphoma Indolent Contiguous Stage II Adult Non-Hodgkin's Lymphoma Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma Stage II Contiguous Adult Indolent Non-Hodgkin's Lymphoma Stage II Indolent Adult Contiguous Non-Hodgkin's Lymphoma Stage II Indolent Non-Hodgkin Lymphoma Ann Arbor Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8468 Neoplastic Process Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma C0677687 CTRP Malignant Stage_II_Grade_1_Contiguous_Follicular_Lymphoma Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma Contiguous Follicular Small Cleaved Cell Lymphoma Stage II Contiguous Grade I Follicular Lymphoma Stage II Contiguous Grade I Follicular Small Cleaved Cell Lymphoma Stage II Contiguous Stage II Follicular Small Cleaved Cell Lymphoma Contiguous Stage II Grade I Follicular Lymphoma Contiguous Stage II Grade I Follicular Small Cleaved Cell Lymphoma Stage II Contiguous Follicular Small Cleaved Cell Lymphoma Stage II Grade 1 Contiguous Follicular Lymphoma Stage II Grade 1 Follicular Lymphoma Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8469 Neoplastic Process Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma C0677688 CTRP Malignant Stage_II_Grade_2_Contiguous_Follicular_Lymphoma Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma Contiguous Follicular Mixed Cell Lymphoma Stage II Contiguous Grade II Follicular Lymphoma Stage II Contiguous Grade II Follicular Mixed Cell Lymphoma Stage II Contiguous Stage II Follicular Mixed Cell Lymphoma Contiguous Stage II Grade II Follicular Lymphoma Contiguous Stage II Grade II Follicular Mixed Cell Lymphoma Stage II Contiguous Follicular Mixed Cell Lymphoma Stage II Grade 2 Contiguous Follicular Lymphoma Stage II Grade 2 Follicular Lymphoma Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8470 Neoplastic Process Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma C0677689 CTRP Malignant Stage_II_Grade_3_Contiguous_Follicular_Lymphoma Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma Contiguous Follicular Large Cell Lymphoma Stage II Contiguous Grade III Follicular Large Cell Lymphoma Stage II Contiguous Grade III Follicular Lymphoma Stage II Contiguous Stage II Follicular Large Cell Lymphoma Contiguous Stage II Grade III Follicular Large Cell Lymphoma Contiguous Stage II Grade III Follicular Lymphoma Stage II Contiguous Follicular Large Cell Lymphoma Stage II Grade 3 Contiguous Follicular Lymphoma Stage II Grade 3 Follicular Lymphoma Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ) C8472 Neoplastic Process Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma C0677691 CTRP Malignant Stage_II_Contiguous_Adult_Aggressive_Non-Hodgkin_s_Lymphoma Adult Aggressive Contiguous Non-Hodgkin's Lymphoma Stage II Adult Aggressive Contiguous Stage II Non-Hodgkin's Lymphoma Aggressive Contiguous Adult Non-Hodgkin's Lymphoma Stage II Aggressive Contiguous Stage II Adult Non-Hodgkin's Lymphoma Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma Stage II Aggressive Adult Contiguous Non-Hodgkin's Lymphoma Stage II Aggressive Non-Hodgkin Lymphoma Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma Stage II Contiguous Adult Aggressive Non-Hodgkin's Lymphoma Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8473 Neoplastic Process Ann Arbor Stage II Contiguous Mantle Cell Lymphoma Ann Arbor Stage II Contiguous Mantle Cell Lymphoma C0677692 CTRP Malignant Stage_II_Contiguous_Mantle_Cell_Lymphoma Ann Arbor Stage II Contiguous Mantle Cell Lymphoma Contiguous Mantle Cell Lymphoma Stage II Contiguous Stage II Mantle Cell Lymphoma Stage II Contiguous Mantle Cell Lymphoma Stage II Mantle Cell Lymphoma Ann Arbor Stage II Contiguous Mantle Cell Lymphoma Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ) C8476 Neoplastic Process Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma C0677697 Obsolete_Concept CTRP Malignant Stage_II_Contiguous_Adult_Lymphoblastic_Lymphoma Adult Contiguous Lymphoblastic Lymphoma Stage II Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma Contiguous Adult Lymphoblastic Lymphoma Stage II Contiguous Adult Stage II Lymphoblastic Lymphoma Stage II Contiguous Adult Lymphoblastic Lymphoma Stage II Contiguous Adult Precursor Lymphoblastic Lymphoma Stage II Lymphoblastic Lymphoma Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ) C8477 Neoplastic Process Ann Arbor Stage II Non-Contiguous Adult Non-Hodgkin Lymphoma Ann Arbor Stage II Non-Contiguous Adult Non-Hodgkin Lymphoma C0677699 CTRP Malignant Stage_II_Non-Contiguous_Adult_Non-Hodgkin_s_Lymphoma Adult Non-Contiguous Non-Hodgkin's Lymphoma Stage II Adult Non-Contiguous Stage II Non-Hodgkin's Lymphoma Adult NonContiguous Non-Hodgkin's Lymphoma Stage II Ann Arbor Stage II Non-Contiguous Adult Non-Hodgkin Lymphoma Non-Contiguous Adult Non-Hodgkin's Lymphoma Stage II Non-Contiguous Stage II Adult Non-Hodgkin's Lymphoma Stage II Adult Non-Contiguous Non-Hodgkin's Lymphoma Stage II Adult NonContiguous Non-Hodgkin's Lymphoma Stage II Non-Contiguous Adult Non-Hodgkin Lymphoma Stage II Non-Contiguous Adult Non-Hodgkin's Lymphoma Stage II Non-Hodgkin Lymphoma Ann Arbor Stage II Non-Contiguous Adult Non-Hodgkin Lymphoma Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ) C8478 Neoplastic Process Ann Arbor Stage II Non-Contiguous Adult Indolent Non-Hodgkin Lymphoma Ann Arbor Stage II Non-Contiguous Adult Indolent Non-Hodgkin Lymphoma C0677700 CTRP Malignant Stage_II_Non-Contiguous_Adult_Indolent_Non-Hodgkin_s_Lymphoma Adult Indolent Non-Contiguous Non-Hodgkin's Lymphoma Stage II Adult Indolent Non-Contiguous Stage II Non-Hodgkin's Lymphoma Adult Indolent NonContiguous Non-Hodgkin's Lymphoma Stage II Ann Arbor Stage II Non-Contiguous Adult Indolent Non-Hodgkin Lymphoma Indolent Non-Contiguous Adult Non-Hodgkin's Lymphoma Stage II Indolent Non-Contiguous Stage II Adult Non-Hodgkin's Lymphoma Stage II Adult Indolent Non-Contiguous Non-Hodgkin's Lymphoma Stage II Adult Indolent NonContiguous Non-Hodgkin's Lymphoma Stage II Indolent Non-Hodgkin Lymphoma Stage II Non-Contiguous Adult Indolent Non-Hodgkin Lymphoma Stage II Non-Contiguous Adult Indolent Non-Hodgkin's Lymphoma Ann Arbor Stage II Non-Contiguous Adult Indolent Non-Hodgkin Lymphoma Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ) C8479 Neoplastic Process Ann Arbor Stage II Non-Contiguous Aggressive Adult Non-Hodgkin Lymphoma Ann Arbor Stage II Non-Contiguous Aggressive Adult Non-Hodgkin Lymphoma C0677706 CTRP Malignant Stage_II_Non-Contiguous_Aggressive_Adult_Non-Hodgkin_s_Lymphoma Aggressive Non-Contiguous Adult Non-Hodgkin's Lymphoma Stage II Aggressive Non-Contiguous Stage II Adult Non-Hodgkin's Lymphoma Aggressive NonContiguous Adult Non-Hodgkin's Lymphoma Stage II Ann Arbor Stage II Non-Contiguous Aggressive Adult Non-Hodgkin Lymphoma Stage II Aggressive Non-Contiguous Adult Non-Hodgkin's Lymphoma Stage II Aggressive Non-Hodgkin Lymphoma Stage II Aggressive NonContiguous Adult Non-Hodgkin's Lymphoma Stage II Non-Contiguous Aggressive Adult Non-Hodgkin Lymphoma Stage II Non-Contiguous Aggressive Adult Non-Hodgkin's Lymphoma Ann Arbor Stage II Non-Contiguous Aggressive Adult Non-Hodgkin Lymphoma Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ) C8481 Neoplastic Process Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma C0677711 Obsolete_Concept CTRP Malignant Stage_II_Non-Contiguous_Adult_Lymphoblastic_Lymphoma Adult Non-Contiguous Lymphoblastic Lymphoma Stage II Adult Non-Contiguous Stage II Lymphoblastic Lymphoma Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma Non-Contiguous Adult Lymphoblastic Lymphoma Stage II Non-Contiguous Stage II Adult Lymphoblastic Lymphoma NonContiguous Adult Lymphoblastic Lymphoma Stage II Stage II Adult Non-Contiguous Lymphoblastic Lymphoma Stage II Lymphoblastic Lymphoma Stage II Non-Contiguous Adult Lymphoblastic Lymphoma Stage II Non-Contiguous Adult Precursor Lymphoblastic Lymphoma Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8482 Neoplastic Process Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma C0677712 CTRP Malignant Stage_III_Indolent_Adult_Non-Hodgkin_s_Lymphoma Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma Indolent Adult Non-Hodgkin's Lymphoma Stage III Indolent Stage III Adult Non-Hodgkin's Lymphoma Stage III Indolent Adult Non-Hodgkin Lymphoma Stage III Indolent Adult Non-Hodgkin's Lymphoma Stage III Indolent Non-Hodgkin Lymphoma Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8483 Neoplastic Process Ann Arbor Stage III Mantle Cell Lymphoma Ann Arbor Stage III Mantle Cell Lymphoma C0677714 CTRP Malignant Stage_III_Mantle_Cell_Lymphoma Ann Arbor Stage III Mantle Cell Lymphoma Mantle Cell Lymphoma Stage III Stage III Mantle Cell Lymphoma Ann Arbor Stage III Mantle Cell Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8484 Neoplastic Process Ann Arbor Stage III Aggressive Adult Non-Hodgkin Lymphoma Ann Arbor Stage III Aggressive Adult Non-Hodgkin Lymphoma C0677718 CTRP Malignant Stage_III_Aggressive_Adult_Non-Hodgkin_s_Lymphoma Aggressive Adult Non-Hodgkin's Lymphoma Stage III Aggressive Stage III Adult Non-Hodgkin's Lymphoma Ann Arbor Stage III Aggressive Adult Non-Hodgkin Lymphoma Stage III Aggressive Adult Non-Hodgkin Lymphoma Stage III Aggressive Adult Non-Hodgkin's Lymphoma Stage III Aggressive Non-Hodgkin Lymphoma Ann Arbor Stage III Aggressive Adult Non-Hodgkin Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8485 Neoplastic Process Ann Arbor Stage IV Indolent Adult Non-Hodgkin Lymphoma Ann Arbor Stage IV Indolent Adult Non-Hodgkin Lymphoma C0677719 CTRP Malignant Stage_IV_Indolent_Adult_Non-Hodgkin_s_Lymphoma Ann Arbor Stage IV Indolent Adult Non-Hodgkin Lymphoma Indolent Adult Non-Hodgkin's Lymphoma Stage IV Indolent Stage IV Adult Non-Hodgkin's Lymphoma Stage IV Indolent Adult Non-Hodgkin Lymphoma Stage IV Indolent Adult Non-Hodgkin's Lymphoma Stage IV Indolent Non-Hodgkin Lymphoma Ann Arbor Stage IV Indolent Adult Non-Hodgkin Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8486 Neoplastic Process Ann Arbor Stage IV Mantle Cell Lymphoma Ann Arbor Stage IV Mantle Cell Lymphoma C0677721 CTRP Malignant Stage_IV_Mantle_Cell_Lymphoma Ann Arbor Stage IV Mantle Cell Lymphoma Mantle Cell Lymphoma Stage IV Stage IV Mantle Cell Lymphoma Ann Arbor Stage IV Mantle Cell Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8487 Neoplastic Process Ann Arbor Stage IV Aggressive Adult Non-Hodgkin Lymphoma Ann Arbor Stage IV Aggressive Adult Non-Hodgkin Lymphoma C0677722 CTRP Malignant Stage_IV_Aggressive_Adult_Non-Hodgkin_s_Lymphoma Aggressive Adult Non-Hodgkin's Lymphoma Stage IV Aggressive Stage IV Adult Non-Hodgkin's Lymphoma Ann Arbor Stage IV Aggressive Adult Non-Hodgkin Lymphoma Stage IV Aggressive Adult Non-Hodgkin Lymphoma Stage IV Aggressive Adult Non-Hodgkin's Lymphoma Stage IV Aggressive Non-Hodgkin Lymphoma Ann Arbor Stage IV Aggressive Adult Non-Hodgkin Lymphoma The reemergence of indolent non-Hodgkin lymphoma in adults after a period of remission. C8488 Neoplastic Process Recurrent Indolent Adult Non-Hodgkin Lymphoma Recurrent Indolent Adult Non-Hodgkin Lymphoma C0677723 CTRP Malignant Recurrent_Indolent_Adult_Non-Hodgkin_s_Lymphoma Recurrent Adult Indolent Non-Hodgkin's Lymphoma Recurrent Indolent Adult Non-Hodgkin Lymphoma Recurrent Indolent Adult Non-Hodgkin's Lymphoma Recurrent Indolent Non-Hodgkin Lymphoma Recurrent Indolent Adult Non-Hodgkin Lymphoma The reemergence of a mantle cell lymphoma after a period of remission. C8489 Neoplastic Process Recurrent Mantle Cell Lymphoma Recurrent Mantle Cell Lymphoma C0677725 CTRP Malignant Recurrent_Mantle_Cell_Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Mantle Cell Lymphoma The reemergence of an aggressive adult non-Hodgkin lymphoma after a period of remission. C8490 Neoplastic Process Recurrent Aggressive Adult Non-Hodgkin Lymphoma Recurrent Aggressive Adult Non-Hodgkin Lymphoma C0677726 CTRP Malignant Recurrent_Aggressive_Adult_Non-Hodgkin_s_Lymphoma Aggressive Recurrent Adult Non-Hodgkin's Lymphoma Recurrent Adult Aggressive Non-Hodgkin's Lymphoma Recurrent Aggressive Adult Non-Hodgkin Lymphoma Recurrent Aggressive Adult Non-Hodgkin's Lymphoma Recurrent Aggressive Non-Hodgkin Lymphoma Recurrent Aggressive Adult Non-Hodgkin Lymphoma An indolent non-Hodgkin lymphoma occurring in adults. Representative examples include small lymphocytic lymphoma, lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia, marginal zone B-cell lymphoma, and grade 1 and 2 follicular lymphoma. C8491 Neoplastic Process Indolent Adult Non-Hodgkin Lymphoma Indolent Adult Non-Hodgkin Lymphoma C0677728 CTRP Malignant Indolent_Adult_Non-Hodgkin_s_Lymphoma Adult Indolent Non-Hodgkin's Lymphoma Indolent Adult Non-Hodgkin Lymphoma Indolent Adult Non-Hodgkin's Lymphoma Indolent Non-Hodgkin Lymphoma Indolent Adult Non-Hodgkin Lymphoma An aggressive non-Hodgkin lymphoma occurring in adults. Representative examples include Burkitt lymphoma, precursor B-lymphoblastic lymphoma, precursor T-lymphoblastic lymphoma, and adult T-cell lymphoma/leukemia. C8492 Neoplastic Process Aggressive Adult Non-Hodgkin Lymphoma Aggressive Adult Non-Hodgkin Lymphoma C0677730 CTRP Malignant Aggressive_Adult_Non-Hodgkin_s_Lymphoma Adult Aggressive Non-Hodgkin's Lymphoma Aggressive Adult Non-Hodgkin Lymphoma Aggressive Adult Non-Hodgkin's Lymphoma Aggressive Non-Hodgkin Lymphoma Aggressive Adult Non-Hodgkin Lymphoma An inherited malignant tumor that originates in the nuclear layer of the retina. A predisposition to retinoblastoma has been associated with 13q14 cytogenetic abnormalities affecting the RB1 gene. Patients with the inherited form appear to be at increased risk for secondary non-ocular malignancies such as osteosarcoma, malignant fibrous histiocytoma, and fibrosarcoma. C8495 Neoplastic Process Hereditary Retinoblastoma C0751483 CCPS PCDC Malignant Hereditary_Retinoblastoma_RB1 Familial Retinoblastoma Hereditary Retinoblastoma Retinoblastoma Syndrome Hereditary Retinoblastoma Familial embryonal neoplasm derived from nephrogenic blastemal cells. Several lines of differentiation, including blastemal, stromal and epithelial, are usually expressed. Comprises approximately 1% of Wilms tumors. (AFIP fascicle version 2.0) C8496 Neoplastic Process Hereditary Wilms Tumor Hereditary Kidney Wilms Tumor C0677779 CTRP Malignant Hereditary_Wilms_Tumor Familial Kidney Wilms Tumor Hereditary Kidney Adenosarcoma Hereditary Kidney Nephroblastoma Hereditary Kidney Wilms Tumor Hereditary Renal Adenosarcoma Hereditary Wilms Tumor Hereditary Kidney Wilms Tumor A melanoma defined by the presence of multiple cases of cutaneous melanoma among blood-relatives on the same side of the family. It is caused by germline mutations in the CDKN2A or CDK4 genes. It is associated with an increased risk of pancreatic cancer in a subset of CDKN2A families (WHO, 2006). C8498 Neoplastic Process Hereditary Melanoma Hereditary Melanoma C1512419 CTRP Cellosaurus A genetic predispostion to developing melanoma due to germline mutation in CDKN2A or CDK4. Subsets of patients are also at risk for pancreatic cancer or astrocytoma. Malignant Hereditary_Melanoma_1_and_2_CDKN2_CDK4 Familial Cutaneous Melanoma Familial Melanoma Hereditary Cutaneous (Skin) Melanoma Hereditary Cutaneous Melanoma Hereditary Melanoma Melanoma, Familial Hereditary Melanoma A glioma that arises from the brain stem. C8501 Neoplastic Process Brain Stem Glioma C0677865 CTEP A tumor located in the part of the brain that connects to the spinal cord (the brain stem). It may grow rapidly or slowly, depending on the grade of the tumor. Undetermined Brain_Stem_Glioma Brain Stem Glioma Brain Stem Neuroglial Neoplasm Brain Stem Neuroglial Tumor Brainstem Glioma Brainstem Neuroglial Neoplasm Brainstem Neuroglial Tumor Diffuse brainstem glioma Glioma of Brain Stem Glioma of Brainstem Glioma of the Brain Stem Glioma of the Brainstem brain stem glioma Brain Stem Glioma A non-Hodgkin lymphoma with an indolent clinical course. C8504 Neoplastic Process Indolent Non-Hodgkin Lymphoma C1334170 CTEP A type of lymphoma that tends to grow and spread slowly, and has few symptoms. Malignant Indolent_Non-Hodgkin_s_Lymphoma Indolent Non-Hodgkin Lymphoma Indolent Non-Hodgkin's Lymphoma NHL, indolent, NOS Non-Hodgkin lymphoma, indolent, NOS indolent lymphoma Indolent Non-Hodgkin Lymphoma A primary or metastatic malignant tumor involving the leptomeninges. C8506 Neoplastic Process Malignant Leptomeningeal Neoplasm C1334596 Malignant Malignant_Leptomeningeal_Neoplasm Malignant Leptomeningeal Neoplasm Malignant Leptomeningeal Tumor Malignant Neoplasm of Leptomeninges Malignant Neoplasm of the Leptomeninges Malignant Tumor of Leptomeninges Malignant Tumor of the Leptomeninges leptomeningeal cancer Malignant Leptomeningeal Neoplasm Stage I includes: (T1, N0, M0); (T2, N0, M0). T1: Tumor invades submucosa. T2: Tumor invades muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8513 Neoplastic Process Stage I Colorectal Cancer AJCC v6 and v7 Stage I Colorectal Cancer AJCC v6 and v7 C0677947 CTRP Cancer has spread from the mucosa (innermost layer) of the colon and/or rectal wall to the submucosa (layer of tissue under the mucosa) of the colon and/or rectal wall. Cancer may have spread to the muscle layer of the colon and/or rectal wall. Malignant Stage_I_Colorectal_Cancer Colorectal Cancer, Stage I Dukes A Colorectal Carcinoma Dukes A colorectal cancer Stage I Colorectal (Colon or Rectal) Cancer Stage I Colorectal Cancer AJCC v6 Stage I Colorectal Cancer AJCC v6 and v7 Stage I Colorectal Cancer AJCC v7 Stage I Colorectal Carcinoma stage I colorectal cancer Stage I Colorectal Cancer AJCC v6 and v7 Stage Group II is subdivided into IIA and IIB on the basis of whether the primary tumor is T3 or T4, respectively. T3: Tumor invades through the muscularis propria into the subserosa, or into non-peritonealized pericolic or perirectal tissues. T4: Tumor directly invades other organs or structures, and/or perforates visceral peritoneum. (AJCC 6th ed.) C8514 Neoplastic Process Stage II Colorectal Cancer AJCC v6 Stage II Colorectal Cancer AJCC v6 C0677948 CTRP Stage II colorectal cancer is divided into stage IIA, stage IIB, and stage IIC. In stage IIA, cancer has spread through the muscle layer of the colon and/or rectal wall to the serosa (outermost layer) of the colon and/or rectal wall. In stage IIB, cancer has spread through the serosa of the colon and/or rectal wall but has not spread to nearby organs. In stage IIC, cancer has spread through the serosa of the colon and/or rectal wall to nearby organs. Malignant Stage_II_Colorectal_Cancer Colorectal Cancer, Stage II AJCC v6 Colorectal Carcinoma Stage II AJCC v6 Dukes B Colorectal Carcinoma Dukes B colorectal cancer Stage II Colorectal (Colon or Rectal) Cancer Stage II Colorectal Cancer AJCC v6 Stage II Colorectal Carcinoma AJCC v6 stage II colorectal cancer Stage II Colorectal Cancer AJCC v6 Stage Group III is subdivided into IIIA (T1-2, N1, M0), IIIB (T3-4, N1, M0) or IIIC (any T, N2 M0). T1: Tumor invades the submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues. T4: Tumor directly invades other organs or structures, and/or perforates visceral peritoneum. N1: Metastasis in 1 to 3 regional lymph nodes N2: Metastasis in 4 or more regional lymph nodes. M0: No distant metastasis. (AJCC 6th ed.) C8515 Neoplastic Process Stage III Colorectal Cancer AJCC v6 Stage III Colorectal Cancer AJCC v6 C0677949 CTRP Stage III colorectal cancer is divided into stage IIIA, stage IIIB, and stage IIIC. In stage IIIA, (1) cancer may have spread through the mucosa (innermost layer) of the colon and/or rectal wall to the submucosa (layer of tissue under the mucosa) and may have spread to the muscle layer of the colon and/or rectal wall. Cancer has spread to at least one but not more than 3 nearby lymph nodes, or cancer cells have formed in tissues near the lymph nodes; or (2) cancer has spread through the mucosa of the colon and/or rectal wall to the submucosa. Cancer has spread to at least 4 but not more than 6 nearby lymph nodes.In stage IIIB, (1) cancer has spread through the muscle layer of the colon and/or rectal wall to the serosa (outermost layer) of the colon and/or rectal wall or has spread through the serosa but not to nearby organs. Cancer has spread to at least one but not more than 3 nearby lymph nodes, or cancer cells have formed in tissues near the lymph nodes; or (2) cancer has spread to the muscle layer of the colon and/or rectal wall or to the serosa of the colon and/or rectal wall. Cancer has spread to at least 4 but not more than 6 nearby lymph nodes; or (3) cancer has spread through the mucosa of the colon and/or rectal wall to the submucosa and may have spread to the muscle layer of the colon and/or rectal wall. Cancer has spread to 7 or more nearby lymph nodes. In stage IIIC, (1) cancer has spread through the serosa of the colon and/or rectal wall but has not spread to nearby organs. Cancer has spread to at least 4 but not more than 6 nearby lymph nodes; or (2) cancer has spread through the muscle layer of the colon and/or rectal wall to the serosa of the colon and/or rectal wall or has spread through the serosa but has not spread to nearby organs. Cancer has spread to 7 or more nearby lymph nodes; or (3) cancer has spread through the serosa of the colon and/or rectal wall and has spread to nearby organs. Cancer has spread to one or more nearby lymph nodes, or cancer cells have formed in tissues near the lymph nodes. Malignant Stage_III_Colorectal_Cancer Colorectal Cancer, Stage III AJCC v6 Dukes C Colorectal Carcinoma Dukes C colorectal cancer Stage III Colorectal (Colon or Rectal) Cancer Stage III Colorectal Cancer AJCC v6 Stage III Colorectal Carcinoma AJCC v6 stage III colorectal cancer Stage III Colorectal Cancer AJCC v6 Stage IV includes: Any T, any N, M1. M1: Distant metastasis. (AJCC 6th ed.) C8516 Neoplastic Process Stage IV Colorectal Cancer AJCC v6 Stage IV Colorectal Cancer AJCC v6 C0677950 CTRP Stage IV colorectal cancer is divided into stage IVA and stage IVB. In stage IVA, cancer may have spread through the colon and/or rectal wall and may have spread to nearby organs or lymph nodes. Cancer has spread to one organ that is not near the colon and/or rectum, such as the liver, lung, or ovary, or to a distant lymph node. In stage IVB, cancer may have spread through the colon and/or rectal wall and may have spread to nearby organs or lymph nodes. Cancer has spread to more than one organ that is not near the colon and/or rectum or into the lining of the abdominal wall. Malignant Stage_IV_Colorectal_Cancer Astler-Coller D Colorectal Cancer Colorectal Cancer, Stage IV AJCC v6 Colorectal Carcinoma Stage IV AJCC v6 Dukes D Colorectal Carcinoma Stage IV Colorectal (Colon or Rectal) Cancer Stage IV Colorectal Cancer AJCC v6 Stage IV Colorectal Carcinoma AJCC v6 stage IV colorectal cancer Stage IV Colorectal Cancer AJCC v6 Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE) (rare in Hodgkin lymphoma). C8517 Neoplastic Process Ann Arbor Stage I Hodgkin Lymphoma Ann Arbor Stage I Hodgkin Lymphoma C0677951 CTRP Malignant Stage_I_Hodgkin_s_Lymphoma Ann Arbor Stage I Hodgkin Lymphoma Hodgkin's Disease Stage I Hodgkin's Lymphoma Stage I Stage I Hodgkin Lymphoma Stage I Hodgkin's Disease Stage I Hodgkin's Lymphoma Ann Arbor Stage I Hodgkin Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8518 Neoplastic Process Ann Arbor Stage II Hodgkin Lymphoma Ann Arbor Stage II Hodgkin Lymphoma C0677952 CTRP Malignant Stage_II_Hodgkin_s_Lymphoma Ann Arbor Stage II Hodgkin Lymphoma Hodgkin's Disease Stage II Hodgkin's Lymphoma Stage II Stage II Hodgkin Lymphoma Stage II Hodgkin's Disease Stage II Hodgkin's Lymphoma Ann Arbor Stage II Hodgkin Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8519 Neoplastic Process Ann Arbor Stage IV Hodgkin Lymphoma Ann Arbor Stage IV Hodgkin Lymphoma C0677954 CTRP Malignant Stage_IV_Hodgkin_s_Lymphoma Ann Arbor Stage IV Hodgkin Lymphoma Hodgkin's Disease Stage IV Hodgkin's Lymphoma Stage IV Stage IV Hodgkin Lymphoma Stage IV Hodgkin's Disease Stage IV Hodgkin's Lymphoma Ann Arbor Stage IV Hodgkin Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8520 Neoplastic Process Ann Arbor Stage I Non-Hodgkin Lymphoma C0677955 Malignant Stage_I_Non-Hodgkin_s_Lymphoma Ann Arbor Stage I Non-Hodgkin Lymphoma Non-Hodgkin's Lymphoma Stage I Stage I Non-Hodgkin Lymphoma Stage I Non-Hodgkin's Lymphoma Ann Arbor Stage I Non-Hodgkin Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). The number of regions involved may be indicated by a subscript (e.g., II3). C8521 Neoplastic Process Ann Arbor Stage II Non-Hodgkin Lymphoma C0677956 Malignant Stage_II_Non-Hodgkin_s_Lymphoma Ann Arbor Stage II Non-Hodgkin Lymphoma Non-Hodgkin's Lymphoma Stage II Stage II Non-Hodgkin Lymphoma Stage II Non-Hodgkin's Lymphoma Ann Arbor Stage II Non-Hodgkin Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8522 Neoplastic Process Ann Arbor Stage III Non-Hodgkin Lymphoma C0677957 Malignant Stage_III_Non-Hodgkin_s_Lymphoma Ann Arbor Stage III Non-Hodgkin Lymphoma Non-Hodgkin's Lymphoma Stage III Stage III Non-Hodgkin Lymphoma Stage III Non-Hodgkin's Lymphoma Ann Arbor Stage III Non-Hodgkin Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8523 Neoplastic Process Ann Arbor Stage IV Non-Hodgkin Lymphoma C0677958 Malignant Stage_IV_Non-Hodgkin_s_Lymphoma Ann Arbor Stage IV Non-Hodgkin Lymphoma Non-Hodgkin's Lymphoma Stage IV Stage IV Non-Hodgkin Lymphoma Stage IV Non-Hodgkin's Lymphoma Ann Arbor Stage IV Non-Hodgkin Lymphoma An epithelial neoplasm that arises from the sebaceous gland and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C8525 Neoplastic Process Benign Sebaceous Neoplasm C0684358 Benign Benign_Sebaceous_Neoplasm Benign Neoplasm of Sebaceous Gland Benign Neoplasm of the Sebaceous Gland Benign Sebaceous Gland Neoplasm Benign Sebaceous Gland Tumor Benign Sebaceous Neoplasm Benign Sebaceous Skin Neoplasm Benign Sebaceous Skin Tumor Benign Sebaceous Tumor Benign Tumor of Sebaceous Gland Benign Tumor of the Sebaceous Gland Benign Sebaceous Neoplasm A malignant neoplasm that has spread to the sternum from another anatomic site. C8527 Neoplastic Process Metastatic Malignant Neoplasm in the Sternum C0684572 Malignant Metastasis_to_the_Sternum Metastasis to the Sternum Metastatic Malignant Neoplasm in the Sternum Metastatic Malignant Neoplasm to the Sternum Metastatic Malignant Tumor to the Sternum Metastatic Neoplasm to the Sternum Metastatic Tumor to the Sternum Metastatic Malignant Neoplasm in the Sternum A malignant neoplasm that has spread to the neck region from a malignancy in a local or distant anatomic site. C8528 Neoplastic Process Metastatic Malignant Neoplasm in the Neck C0684817 Malignant Metastatic_Neoplasm_to_the_Neck Metastases to Neck Metastasis to the Neck Metastatic Malignant Neoplasm in the Neck Metastatic Malignant Neoplasm to the Neck Metastatic Neoplasm to the Neck Metastatic Tumor to the Neck Metastatic Malignant Neoplasm in the Neck A neoplasm that arises from the chest wall and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C8529 Neoplastic Process Benign Chest Wall Neoplasm C0684831 Benign Benign_Chest_Wall_Neoplasm Benign Chest Wall Neoplasm Benign Chest Wall Tumor Benign Neoplasm of Chest Wall Benign Neoplasm of the Chest Wall Benign Tumor of Chest Wall Benign Tumor of the Chest Wall Benign Chest Wall Neoplasm A malignant neoplasm that has spread to the structures of the chest wall from another primary anatomic site. C8530 Neoplastic Process Metastatic Malignant Neoplasm in the Chest Wall C0684833 Malignant Metastasis_to_the_Chest_Wall Metastasis to the Chest Wall Metastatic Malignant Neoplasm in the Chest Wall Metastatic Malignant Neoplasm to the Chest Wall Metastatic Neoplasm to the Chest Wall Metastatic Tumor to the Chest Wall Secondary Malignant Neoplasm to the Chest Wall Secondary Malignant Tumor to the Chest Wall Metastatic Malignant Neoplasm in the Chest Wall A neoplasm that arises from the respiratory system and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C8531 Neoplastic Process Benign Respiratory System Neoplasm C0588348 CPTAC Benign Benign_Respiratory_Tract_Neoplasm Benign neoplasm of bronchus and lung Benign neoplasm of right bronchus and lung Benign neoplasm of unspecified bronchus and lung Benign neoplasm: Bronchus and lung Benign Respiratory System Neoplasm Benign Respiratory Tract Neoplasm Benign Respiratory System Neoplasm A neoplasm that arises from the paranasal sinuses and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include Schneiderian papilloma and salivary gland-type adenoma. C8532 Neoplastic Process Benign Paranasal Sinus Neoplasm C0347222 Benign Benign_Paranasal_Sinus_Neoplasm Benign Accessory Sinus Neoplasm Benign Accessory Sinus Tumor Benign Nasal Sinus Neoplasm Benign Nasal Sinus Tumor Benign Neoplasm of Accessory Sinus Benign Neoplasm of Nasal Sinus Benign Neoplasm of Paranasal Sinus Benign Neoplasm of the Accessory Sinus Benign Neoplasm of the Nasal Sinus Benign Neoplasm of the Paranasal Sinus Benign Paranasal Sinus Neoplasm Benign Paranasal Sinus Tumor Benign Tumor of Accessory Sinus Benign Tumor of Nasal Sinus Benign Tumor of Paranasal Sinus Benign Tumor of the Accessory Sinus Benign Tumor of the Nasal Sinus Benign Tumor of the Paranasal Sinus Benign Paranasal Sinus Neoplasm Stage IV includes: IVA (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB (T4b, Any N, M0); (Any T, N3, M0); IVC (Any T, Any N, M1). T4a: Tumor invades thyroid/cricoid cartilage, hyoid bone, thyroid gland, esophagus, or central compartment soft tissue. T4b: Tumor invades prevertebral fascia, encases carotid artery, or involves mediastinal structures. N2: Metastasis in a single ipsilateral lymph node, more than 3cm but not more than 6cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N2a: Metastasis in a single ipsilateral lymph node more than 3 cm but not more than 6 cm in greatest dimension. N2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension. N2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a lymph node more than 6 cm in greatest dimension. M1: Distant metastasis. (AJCC 6th ed.) C8533 Neoplastic Process Stage IV Hypopharyngeal Carcinoma AJCC v6 Stage IV Hypopharyngeal Carcinoma AJCC v6 C1510473 CTRP Stage IV hypopharyngeal cancer is divided into stages IVA, IVB, and IVC. In stage IVA, the tumor is (1) any size and has spread to nearby soft tissue, connective tissue, the thyroid, or the esophagus; cancer may be found either in one lymph node on the same side of the neck (the lymph node is 3 centimeters or smaller) or in one or more lymph nodes anywhere in the neck (all of these lymph nodes are 6 centimeters or smaller); or (2) in only one area of the hypopharynx, is 2 centimeters or smaller, and has also spread to one or more lymph nodes anywhere in the neck (all of these lymph nodes are 6 centimeters or smaller); or (3) in more than one area of the hypopharynx, is in nearby tissues, or is larger than 2 centimeters but not larger than 4 centimeters and has not spread to the larynx; cancer has spread to one or more lymph nodes anywhere in the neck (all of these lymph nodes are 6 centimeters or smaller); or (4) larger than 4 centimeters or has spread to the larynx; cancer has also spread to one or more lymph nodes anywhere in the neck (all of these lymph nodes are 6 centimeters or smaller). In stage IVB, the tumor either (1) has spread to nearby soft tissue, connective tissue, blood vessels, the thyroid, or the esophagus, and may have spread to lymph nodes of any size; or (2) is any size and has spread to lymph nodes that are larger than 6 centimeters. In stage IVC, cancer has spread beyond the hypopharynx to other parts of the body. Malignant Stage_IV_Hypopharyngeal_Carcinoma Stage IV Carcinoma of Hypopharynx AJCC v6 Stage IV Carcinoma of the Hypopharynx AJCC v6 Stage IV Hypopharyngeal Carcinoma AJCC v6 Stage IV Hypopharyngeal Throat Cancer Stage IV Hypopharynx Carcinoma AJCC v6 stage IV hypopharynx cancer Stage IV Hypopharyngeal Carcinoma AJCC v6 A neoplasm that arises from the inner layer of pericardium and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C8535 Neoplastic Process Benign Epicardial Neoplasm C0685115 Benign Benign_Epicardial_Neoplasm Benign Epicardial Neoplasm Benign Epicardial Tumor Benign Neoplasm of Epicardium Benign Neoplasm of the Epicardium Benign Tumor of Epicardium Benign Tumor of the Epicardium Benign Epicardial Neoplasm A neoplasm that arises from the pericardium and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C8536 Neoplastic Process Benign Pericardial Neoplasm C0685118 Benign Benign_Pericardial_Neoplasm Benign Neoplasm of Pericardium Benign Neoplasm of the Pericardium Benign Pericardial Neoplasm Benign Pericardial Tumor Benign Tumor of Pericardium Benign Tumor of the Pericardium Benign Pericardial Neoplasm A benign neoplasm arising from arteries or veins. C8537 Neoplastic Process Benign Blood Vessel Neoplasm C0685121 Benign Benign_Blood_Vessel_Neoplasm Benign Blood Vessel Neoplasm Benign Blood Vessel Tumor Benign Blood Vessel Neoplasm A hemangioma arising from the subcutaneous soft tissues. C8540 Neoplastic Process Subcutaneous Hemangioma C0685200 Benign Subcutaneous_Tissue_Hemangioma Angioma of Subcutaneous Tissue Angioma of the Subcutaneous Tissue Hemangioma of Subcutaneous Tissue Hemangioma of the Subcutaneous Tissue Subcutaneous Angioma Subcutaneous Hemangioma Subcutaneous Tissue Angioma Subcutaneous Tissue Hemangioma Subcutaneous Hemangioma A hemangioma arising from the spleen. C8541 Neoplastic Process Splenic Hemangioma C0685201 Benign Splenic_Hemangioma Angioma of Spleen Angioma of the Spleen Hemangioma of Spleen Hemangioma of the Spleen Spleen Angioma Spleen Hemangioma Splenic Angioma Splenic Hemangioma Splenic Hemangioma A malignant neoplasm that has spread to the lip from another anatomic site. C8542 Neoplastic Process Metastatic Malignant Neoplasm in the Lip C0685943 Malignant Metastatic_Neoplasm_to_the_Lip Metastasis to the Lip Metastatic Malignant Neoplasm in the Lip Metastatic Malignant Neoplasm to the Lip Metastatic Neoplasm to the Lip Metastatic Tumor to the Lip Metastatic Malignant Neoplasm in the Lip A malignant neoplasm that has spread to the pancreas from another anatomic site. Representative examples include metastatic carcinomas from the gastrointestinal tract, metastatic melanomas, and renal cell carcinomas. C8543 Neoplastic Process Metastatic Malignant Neoplasm in the Pancreas C0346976 Malignant Metastatic_Neoplasm_to_the_Pancreas Metastatic Cancer to the Pancreas Metastatic Malignant Neoplasm in the Pancreas Metastatic Malignant Neoplasm to the Pancreas Metastatic Neoplasm to the Pancreas Metastatic Tumor to the Pancreas Secondary Cancer to the Pancreas Secondary Malignant Neoplasm to the Pancreas Secondary Malignant Tumor to the Pancreas Metastatic Malignant Neoplasm in the Pancreas A malignant neoplasm that has metastasized to the epididymis from another anatomic site. C8544 Neoplastic Process Metastatic Malignant Neoplasm in the Epididymis C0347004 Malignant Metastatic_Neoplasm_to_the_Epididymis Metastatic Malignant Neoplasm in the Epididymis Metastatic Malignant Neoplasm to the Epididymis Metastatic Neoplasm to the Epididymis Metastatic Tumor to the Epididymis Metastatic Malignant Neoplasm in the Epididymis A neoplasm that arises from the placenta and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C8545 Neoplastic Process Benign Placental Neoplasm C0686274 Benign Benign_Placental_Neoplasm Benign Neoplasm of Placenta Benign Neoplasm of the Placenta Benign Placenta Neoplasm Benign Placenta Tumor Benign Placental Neoplasm Benign Placental Tumor Benign Tumor of Placenta Benign Tumor of the Placenta Placental Neoplasms, Benign Benign Placental Neoplasm A malignant neoplasm that has spread to the placenta from another anatomic site. C8546 Neoplastic Process Metastatic Malignant Neoplasm in the Placenta C0877294 Malignant Metastatic_Neoplasm_to_the_Placenta Metastasis to Placenta Metastasis to the Placenta Metastatic Malignant Neoplasm in the Placenta Metastatic Malignant Neoplasm to the Placenta Metastatic Neoplasm to the Placenta Metastatic Tumor to the Placenta Metastatic Malignant Neoplasm in the Placenta The spread of a malignant neoplasm to the nervous system. This may be from a primary nervous system malignant neoplasm, or from a malignant neoplasm at a distant site. C8547 Neoplastic Process Metastatic Malignant Neoplasm in the Nervous System C0347014 CPTAC mCode Malignant Metastasis_to_the_Nervous_System Secondary malignant neoplasm of other parts of nervous system Metastases to Nervous System Metastasis to the Nervous System Metastatic Malignant Neoplasm in the Nervous System Metastatic Malignant Neoplasm to the Nervous System Metastatic Neoplasm to the Nervous System Metastatic Tumor to the Nervous System Secondary Malignant Neoplasm to the Nervous System Secondary Malignant Tumor to the Nervous System Secondary malignant neoplasm of unspecified part of nervous system Metastatic Malignant Neoplasm in the Nervous System A neoplasm that arises from the cerebrum and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C8548 Neoplastic Process Benign Cerebral Neoplasm C0686378 Benign Benign_Cerebral_Neoplasm Benign Cerebral Hemispheric Neoplasm Benign Cerebral Hemispheric Tumor Benign Cerebral Neoplasm Benign Cerebral Tumor Benign Neoplasm of Cerebral Hemispheres Benign Neoplasm of Cerebrum Benign Neoplasm of the Cerebral Hemispheres Benign Neoplasm of the Cerebrum Benign Tumor of Cerebral Hemispheres Benign Tumor of Cerebrum Benign Tumor of the Cerebral Hemispheres Benign Tumor of the Cerebrum Benign Cerebral Neoplasm A neoplasm that arises from the brain stem and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C8549 Neoplastic Process Benign Brain Stem Neoplasm C0686400 Benign Benign_Brain_Stem_Neoplasm Benign Brain Stem Neoplasm Benign Brain Stem Neoplasms Benign Brain Stem Tumor Benign Brainstem Neoplasm Benign Brainstem Neoplasms Benign Brainstem Tumor Benign Brainstem Tumors Benign Neoplasm of Brain Stem Benign Neoplasm of Brainstem Benign Neoplasm of the Brain Stem Benign Neoplasm of the Brainstem Benign Neoplasms of Brainstem Benign Neoplasms of the Brainstem Benign Tumor of Brain Stem Benign Tumor of Brainstem Benign Tumor of the Brain Stem Benign Tumor of the Brainstem Benign Tumors of Brainstem Benign Tumors of the Brainstem Benign Brain Stem Neoplasm A malignant neoplasm that has spread from its original site of growth to the brain stem. C8550 Neoplastic Process Metastatic Malignant Neoplasm in the Brain Stem C0686402 Malignant Metastatic_Neoplasm_to_the_Brain_Stem Metastatic Malignant Neoplasm in the Brain Stem Metastatic Malignant Neoplasm to the Brain Stem Metastatic Neoplasm to the Brain Stem Metastatic Neoplasm to the Brainstem Metastatic Tumor to the Brain Stem Metastatic Tumor to the Brainstem Metastatic Malignant Neoplasm in the Brain Stem A malignant neoplasm that has spread to the ciliary body from another anatomic site. C8553 Neoplastic Process Metastatic Malignant Neoplasm in the Ciliary Body C0686463 Malignant Metastasis_to_the_Ciliary_Body Metastasis to the Ciliary Body Metastatic Malignant Neoplasm in the Ciliary Body Metastatic Malignant Neoplasm to the Ciliary Body Metastatic Neoplasm to the Ciliary Body Metastatic Tumor to the Ciliary Body Metastatic Malignant Neoplasm in the Ciliary Body A malignant neoplasm that has spread to the choroid from another anatomic site. C8554 Neoplastic Process Metastatic Malignant Neoplasm in the Choroid C0347021 Malignant Metastatic_Neoplasm_to_the_Choroid Metastatic Malignant Neoplasm in the Choroid Metastatic Malignant Neoplasm to the Choroid Metastatic Neoplasm to the Choroid Metastatic Tumor to the Choroid Metastatic Malignant Neoplasm in the Choroid A malignant neoplasm that has spread to the retina from another anatomic site. C8555 Neoplastic Process Metastatic Malignant Neoplasm in the Retina C0686477 Malignant Metastatic_Neoplasm_to_the_Retina Metastasis to the Retina Metastatic Malignant Neoplasm in the Retina Metastatic Malignant Neoplasm to the Retina Metastatic Neoplasm to the Retina Metastatic Tumor to the Retina Metastatic Malignant Neoplasm in the Retina A malignant neoplasm that has spread to the orbit from another anatomic site. C8556 Neoplastic Process Metastatic Malignant Neoplasm in the Orbit C0347020 Malignant Metastatic_Neoplasm_to_the_Orbit Metastasis to the Orbit Metastatic Malignant Neoplasm in the Orbit Metastatic Malignant Neoplasm to the Orbit Metastatic Neoplasm to the Orbit Metastatic Tumor to the Orbit Metastatic Malignant Neoplasm in the Orbit A malignant neoplasm either directly extending to the parathyroid glands from adjacent anatomic structures, or spreading to the parathyroid glands from distant anatomic sites, most frequently breast, lung, kidney, soft tissues, and skin. C8557 Neoplastic Process Metastatic Malignant Neoplasm in the Parathyroid Glands C0686507 Malignant Metastatic_Neoplasm_to_the_Parathyroid Metastasis to the Parathyroid Gland Metastatic Malignant Neoplasm in the Parathyroid Glands Metastatic Malignant Neoplasm to the Parathyroid Glands Metastatic Neoplasm to the Parathyroid Metastatic Neoplasm to the Parathyroid Gland Metastatic Tumor to the Parathyroid Metastatic Tumor to the Parathyroid Gland Metastatic Malignant Neoplasm in the Parathyroid Glands A paraganglioma that metastasizes to regional or distant anatomic sites. Extraadrenal paragangliomas have a higher tendency to metastasize, as compared to pheochromocytomas. Common sites of metastasis include the lymph nodes, lungs, bones, and liver. C8559 Neoplastic Process Malignant Paraganglioma Metastatic Paraganglioma Metastatic Paraganglioma C1533592 CDISC CPTAC CTRP GDC A malignant neoplasm arising from paraganglia located along nerves composed of neoplastic neuroectodermal chromaffin cells. 8680/3 Malignant Malignant_Paraganglionic_Neoplasm 8680/3 Malignant neoplasm of aortic body and other paraganglia Malignant neoplasm: Aortic body and other paraganglia Paraganglioma, malignant Malignant Neoplasm of Paraganglion Malignant Neoplasm of the Paraganglion Malignant Paraganglioma Malignant Paraganglion Neoplasm Malignant Paraganglion Tumor Malignant Paraganglionic Neoplasm Malignant Paraganglionic Tumor Malignant Tumor of Paraganglion Malignant Tumor of the Paraganglion Metastatic Paraganglioma PARAGANGLIOMA, MALIGNANT Paraganglioma, malignant Paraganglion Neoplasm, Malignant Metastatic Paraganglioma A primary or metastatic malignant neoplasm involving the male reproductive system. Representative examples include prostate carcinoma, penile carcinoma, testicular seminoma, and testicular embryonal carcinoma. C8561 Neoplastic Process Malignant Male Reproductive System Neoplasm Malignant Male Reproductive System Neoplasm C0153606 CPTAC CTEP CTRP mCode Malignant Malignant_Male_Reproductive_System_Neoplasm Malignant neoplasm of male genital organ, site unspecified Malignant neoplasm of other specified sites of male genital organs Malignant neoplasm of penis and other male genital organs Male reprod. system cancer, NOS Male reproductive system cancer, NOS Malignant Male Reproductive System Neoplasm Malignant Male Reproductive System Tumor Malignant Neoplasm of Male Reproductive System Malignant Neoplasm of the Male Reproductive System Malignant Tumor of Male Reproductive System Malignant Tumor of the Male Reproductive System Malignant neoplasm of male genital organ, unspecified Malignant Male Reproductive System Neoplasm A melanoma that arises from the structures of the eye or ocular adnexa. C8562 Neoplastic Process Ocular Melanoma Ocular Melanoma C0558356 CPTAC CTRP Cellosaurus A rare cancer of melanocytes (cells that produce the pigment melanin) found in the eye. Malignant Ocular_Melanoma Eye Melanoma Melanoma of Eye Melanoma of the Eye Ocular Melanoma ocular melanoma Ocular Melanoma A rare, high-grade pleomorphic malignant neoplasm arising from the bone. It usually presents with pain which may or may not be associated with swelling in the affected area. It is characterized by the presence of spindle-shaped cells, polygonal or epithelioid cells, multinucleated giant cells, and inflammatory cells. The neoplastic cells exhibit nuclear pleomorphism and high mitotic activity. It metastasizes frequently, most often in the lungs. C8563 Neoplastic Process Undifferentiated High Grade Pleomorphic Sarcoma of Bone Undifferentiated High Grade Pleomorphic Sarcoma of Bone C0740479 CTRP GDC Malignant Malignant_Bone_Fibrous_Histiocytoma Malignant fibrous histiocytoma (MFH) of bone Undifferentiated high-grade pleomorphic sarcoma Malignant Bone Fibrous Histiocytoma Malignant Fibrous Histiocytoma of Bone Malignant Fibrous Histiocytoma of the Bone Malignant fibrous histiocytoma (MFH) of bone Undifferentiated High Grade Pleomorphic Sarcoma Undifferentiated High Grade Pleomorphic Sarcoma of Bone Undifferentiated High-Grade Pleomorphic Sarcoma Undifferentiated high-grade pleomorphic sarcoma Undifferentiated High Grade Pleomorphic Sarcoma of Bone Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ) C8564 Neoplastic Process Stage II Adult Contiguous Immunoblastic Lymphoma Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma C0796292 Obsolete_Concept CTRP Malignant Stage_II_Adult_Contiguous_Immunoblastic_Lymphoma Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma Contiguous Adult Immunoblastic Large Cell Lymphoma Stage II Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Stage II Adult Contiguous Immunoblastic Lymphoma Stage II Contiguous Adult Immunoblastic Large Cell Lymphoma Stage II Immunoblastic Lymphoma Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ) C8565 Neoplastic Process Stage II Adult Non-Contiguous Immunoblastic Lymphoma Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma C0796293 Obsolete_Concept CTRP Malignant Stage_II_Adult_Non-Contiguous_Immunoblastic_Lymphoma Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma Non-Contiguous Adult Immunoblastic Large Cell Lymphoma Stage II Non-Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma NonContiguous Adult Immunoblastic Large Cell Lymphoma Stage II Stage II Adult Non-Contiguous Immunoblastic Lymphoma Stage II Immunoblastic Lymphoma Stage II Non-Contiguous Adult Immunoblastic Large Cell Lymphoma Stage II NonContiguous Adult Immunoblastic Large Cell Lymphoma Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma A glioma that arises from the visual pathway. This condition can be seen in association with neurofibromatosis 1. It is most commonly seen in the pediatric age group. C8567 Neoplastic Process Visual Pathway Glioma C0796418 A rare, slow-growing tumor that usually forms in the optic nerve, optic chiasm, or optic tract. These are parts of the nervous system that carry messages from the eye to the brain. Undetermined Visual_Pathway_Glioma Glioma of Visual Pathway Glioma of the Visual Pathway Optic Pathway Glioma Visual Pathway Glioma optic pathway glioma visual pathway glioma Visual Pathway Glioma A neoplasm of the choroid plexus occurring in adults. C8568 Neoplastic Process Adult Choroid Plexus Neoplasm Adult Choroid Plexus Neoplasm C0796430 CTRP Undetermined Adult_Choroid_Plexus_Neoplasm Adult Choroid Plexus Neoplasm Adult Choroid Plexus Tumor Choroid Plexus Neoplasm Neoplasm of Adult Choroid Plexus Neoplasm of the Adult Choroid Plexus Tumor of Adult Choroid Plexus Tumor of the Adult Choroid Plexus Adult Choroid Plexus Neoplasm C8569 Neoplastic Process Stage IA Adult Soft Tissue Sarcoma AJCC v7 Stage IA Adult Soft Tissue Sarcoma AJCC v7 C0796433 CTRP Malignant Stage_IA_Adult_Soft_Tissue_Sarcoma Stage IA Adult Sarcoma of Soft Tissue Stage IA Adult Sarcoma of the Soft Tissue Stage IA Adult Soft Tissue Sarcoma AJCC v7 Stage IA Soft Tissue Sarcoma Stage IA Adult Soft Tissue Sarcoma AJCC v7 C8570 Neoplastic Process Stage IB Adult Soft Tissue Sarcoma AJCC v7 Stage IB Adult Soft Tissue Sarcoma AJCC v7 C0796434 CTRP Malignant Stage_IB_Adult_Soft_Tissue_Sarcoma Stage IB Adult Sarcoma of Soft Tissue Stage IB Adult Sarcoma of the Soft Tissue Stage IB Adult Soft Tissue Sarcoma AJCC v7 Stage IB Soft Tissue Sarcoma Stage IB Adult Soft Tissue Sarcoma AJCC v7 C8571 Neoplastic Process Stage IIA Adult Soft Tissue Sarcoma AJCC v7 Stage IIA Adult Soft Tissue Sarcoma AJCC v7 C0796437 CTRP Malignant Stage_IIA_Adult_Soft_Tissue_Sarcoma Stage IIA Adult Sarcoma of Soft Tissue Stage IIA Adult Sarcoma of the Soft Tissue Stage IIA Adult Soft Tissue Sarcoma AJCC v7 Stage IIA Soft Tissue Sarcoma Stage IIA Adult Soft Tissue Sarcoma AJCC v7 C8572 Neoplastic Process Stage IIB Adult Soft Tissue Sarcoma AJCC v7 Stage IIB Adult Soft Tissue Sarcoma AJCC v7 C0796438 CTRP Malignant Stage_IIB_Adult_Soft_Tissue_Sarcoma Stage IIB Adult Sarcoma of Soft Tissue Stage IIB Adult Sarcoma of the Soft Tissue Stage IIB Adult Soft Tissue Sarcoma AJCC v7 Stage IIB Soft Tissue Sarcoma Stage IIB Adult Soft Tissue Sarcoma AJCC v7 A myelodysplastic syndrome characterized by bi-cytopenia or pancytopenia and dysplastic changes in 10% or more of the cells in two or more of the myeloid cell lines. (WHO, 2001) C8574 Neoplastic Process Myelodysplastic Syndrome with Multilineage Dysplasia Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia C0796466 CTRP GDC 9985/3 Malignant Refractory_Cytopenia_with_Multilineage_Dysplasia 9985/3 Myelodysplastic syndrome with multilineage dysplasia Refractory cytopenia with multilineage dysplasia MDS, NOS with Multilineage Dysplasia MDS-LB-MLD MDS-MLD Myelodysplastic Neoplasm with Low Blasts and Multilineage Dysplasia Myelodysplastic Syndrome with Low Blasts and Multilineage Dysplasia Myelodysplastic Syndrome with Multilineage Dysplasia Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia RCMD Refractory Cytopenia with Multilineage Dysplasia Refractory cytopenia with multilineage dysplasia Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia A carcinoma that arises from the cervix and invades into the stromal tissue. C8577 Neoplastic Process Infiltrating Cervical Carcinoma Invasive Cervical Carcinoma C1334177 CTRP Cancer that has spread from the surface of the cervix to tissue deeper in the cervix or to other parts of the body. Malignant Infiltrating_Cervical_Carcinoma Infiltrating Cervical Cancer Infiltrating Cervical Carcinoma Invasive Cervical Carcinoma invasive cervical cancer Invasive Cervical Carcinoma An ependymoma that arises from the central nervous system and occurs during childhood. C8578 Neoplastic Process Childhood Ependymoma Childhood Ependymoma CL448406 CTRP NICHD An ependymoma that occurs during childhood. Undetermined Childhood_Ependymoma Childhood Ependymoma Ependymoma Pediatric Ependymoma Childhood Ependymoma The reemergence of ependymoma in childhood after a period of remission. C8579 Neoplastic Process Recurrent Childhood Ependymoma Recurrent Childhood Ependymoma C0796612 CTRP Undetermined Recurrent_Childhood_Ependymoma Recurrent Childhood Ependymoma Recurrent Ependymoma Recurrent Pediatric Ependymoma Relapsed Childhood Ependymoma Relapsed Pediatric Ependymoma Recurrent Childhood Ependymoma Stage IB includes: (T2a, N0, M0, G1, GX); (T2b, N0, M0, G1, GX). T2a: Superficial tumor more than 5 cm in greatest dimension. T2b: Deep tumor more than 5 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Grade 1. GX: Grade cannot be assessed. (AJCC 7th ed.) C8580 Neoplastic Process Stage IB Soft Tissue Sarcoma AJCC v7 Stage IB Soft Tissue Sarcoma AJCC v7 C0796618 CTRP Stage I is divided into stages IA and IB. In stage IB, the tumor is low-grade (likely to grow and spread slowly) and larger than 5 centimeters. It may be either superficial (in subcutaneous tissue with no spread into connective tissue or muscle below) or deep (in the muscle and may be in connective or subcutaneous tissue). Malignant Stage_IB_Soft_Tissue_Sarcoma Stage IB Sarcoma of Soft Tissue Stage IB Sarcoma of the Soft Tissue Stage IB Soft Tissue Sarcoma Stage IB Soft Tissue Sarcoma AJCC v7 stage IB soft tissue sarcoma Stage IB Soft Tissue Sarcoma AJCC v7 Stage IIA includes: (T1a, N0, M0, G2, G3); (T1b, N0, M0, G2, G3). T1a: Superficial tumor 5 cm or less in greatest dimension. T1b: Deep tumor 5 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G2: Grade 2. G3: Grade 3. (AJCC 7th ed.) C8581 Neoplastic Process Stage IIA Soft Tissue Sarcoma AJCC v7 Stage IIA Soft Tissue Sarcoma AJCC v7 C0796619 CTRP Stage II is divided into stages IIA and IIB. In stage IIA, the tumor is mid-grade (somewhat likely to grow and spread quickly) or high-grade (likely to grow and spread quickly) and 5 centimeters or smaller. It may be either superficial (in subcutaneous tissue with no spread into connective tissue or muscle below) or deep (in the muscle and may be in connective or subcutaneous tissue). Malignant Stage_IIA_Soft_Tissue_Sarcoma Stage IIA Sarcoma of Soft Tissue Stage IIA Sarcoma of the Soft Tissue Stage IIA Soft Tissue Sarcoma Stage IIA Soft Tissue Sarcoma AJCC v7 stage IIA soft tissue sarcoma Stage IIA Soft Tissue Sarcoma AJCC v7 Stage IIB includes: (T2a, N0, M0, G2); (T2b, N0, M0, G2). T2a: Superficial tumor more than 5 cm in greatest dimension. T2b: Deep tumor more than 5 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G2: Grade 2. (AJCC 7th ed.) C8582 Neoplastic Process Stage IIB Soft Tissue Sarcoma AJCC v7 Stage IIB Soft Tissue Sarcoma AJCC v7 C0796620 CTRP Stage II is divided into stages IIA and IIB. In stage IIB, the tumor is mid-grade (somewhat likely to grow and spread quickly) and larger than 5 centimeters. It may be either superficial (in subcutaneous tissue with no spread into connective tissue or muscle below) or deep (in the muscle and may be in connective or subcutaneous tissue). Malignant Stage_IIB_Soft_Tissue_Sarcoma Stage IIB Sarcoma of Soft Tissue Stage IIB Sarcoma of the Soft Tissue Stage IIB Soft Tissue Sarcoma Stage IIB Soft Tissue Sarcoma AJCC v7 stage IIB soft tissue sarcoma Stage IIB Soft Tissue Sarcoma AJCC v7 Stage IA includes: (T1a, N0, M0, G1, GX); (T1b, N0, M0, G1, GX). T1a: Superficial tumor 5 cm or less in greatest dimension. T1b: Deep tumor 5 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Grade 1. GX: Grade cannot be assessed. (AJCC 7th ed.) C8583 Neoplastic Process Stage IA Soft Tissue Sarcoma AJCC v7 Stage IA Soft Tissue Sarcoma AJCC v7 C0796621 CTRP Stage I is divided into stages IA and IB. In stage IA, the tumor is low-grade (likely to grow and spread slowly) and 5 centimeters or smaller. It may be either superficial (in subcutaneous tissue with no spread into connective tissue or muscle below) or deep (in the muscle and may be in connective or subcutaneous tissue). Malignant Stage_IA_Soft_Tissue_Sarcoma Stage IA Sarcoma of Soft Tissue Stage IA Sarcoma of the Soft Tissue Stage IA Soft Tissue Sarcoma Stage IA Soft Tissue Sarcoma AJCC v7 stage IA soft tissue sarcoma Stage IA Soft Tissue Sarcoma AJCC v7 Stage IA includes: T1, N0, M0. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+). (AJCC 7th Ed.) C85835 Neoplastic Process Stage IA Breast Cancer AJCC v7 Stage IA Breast Cancer AJCC v7 CL413891 CTRP Stage I breast cancer is divided into stages IA and IB. In stage IA, the tumor is 2 centimeters or smaller and has not spread outside the breast. Malignant Stage IA Breast Cancer Stage IA Breast Cancer AJCC v7 stage IA breast cancer Stage IA Breast Cancer AJCC v7 Stage IB includes: (T0, N1mi, M0); (T1, N1mi, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. N1mi: Nodal micrometastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+). (AJCC 7th Ed.) C85836 Neoplastic Process Stage IB Breast Cancer AJCC v7 Stage IB Breast Cancer AJCC v7 CL413892 CTRP Stage I breast cancer is divided into stages IA and IB. In stage IB, (1) no tumor is found in the breast, but small clusters of cancer cells (larger than 0.2 millimeter but not larger than 2 millimeters) are found in the lymph nodes; or (2) the tumor is 2 centimeters or smaller and small clusters of cancer cells (larger than 0.2 millimeter but not larger than 2 millimeters) are found in the lymph nodes. Malignant Stage IB Breast Cancer Stage IB Breast Cancer AJCC v7 stage IB breast cancer Stage IB Breast Cancer AJCC v7 Stage III includes: (T2a, T2b, N0, M0, G3); (Any T, N1, M0, Any G). T2a: Superficial tumor more than 5 cm in greatest dimension. T2b: Deep tumor more than 5 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. G3: Grade 3. There is no T2a for the pathologic group. (AJCC 7th ed.) C8585 Neoplastic Process Stage III Soft Tissue Sarcoma AJCC v7 Stage III Soft Tissue Sarcoma AJCC v7 C0796623 CTRP The tumor is either (1) high-grade (likely to grow and spread quickly), larger than 5 centimeters, and either superficial (in subcutaneous tissue with no spread into connective tissue or muscle below) or deep (in the muscle and may be in connective or subcutaneous tissue); or (2) any grade, any size, and has spread to nearby lymph nodes. Malignant Stage_III_Soft_Tissue_Sarcoma Stage III Sarcoma of Soft Tissue Stage III Sarcoma of the Soft Tissue Stage III Soft Tissue Sarcoma Stage III Soft Tissue Sarcoma AJCC v7 stage III soft tissue sarcoma Stage III Soft Tissue Sarcoma AJCC v7 Stage IV includes: Any T, Any N, M1, Any G. M1: Distant metastasis. (AJCC 7th ed.) C8586 Neoplastic Process Stage IV Soft Tissue Sarcoma AJCC v7 Stage IV Soft Tissue Sarcoma AJCC v7 C0796624 CTRP The tumor is any grade, any size, and may have spread to nearby lymph nodes. Cancer has spread to distant parts of the body, such as the lungs. Malignant Stage_IV_Soft_Tissue_Sarcoma Stage IV Sarcoma of Soft Tissue Stage IV Sarcoma of the Soft Tissue Stage IV Soft Tissue Sarcoma Stage IV Soft Tissue Sarcoma AJCC v7 stage IV soft tissue sarcoma Stage IV Soft Tissue Sarcoma AJCC v7 A germ cell tumor that arises from the ovary and occurs in children. C8588 Neoplastic Process Childhood Ovarian Germ Cell Tumor Childhood Ovarian Germ Cell Tumor C0796664 CTRP NICHD A germ cell tumor that arises from the ovary during childhood. Undetermined Childhood_Ovarian_Germ_Cell_Tumor Childhood Ovarian Germ Cell Neoplasm Childhood Ovarian Germ Cell Tumor Ovarian Germ Cell Tumor Pediatric Ovarian Germ Cell Neoplasm Pediatric Ovarian Germ Cell Tumor Childhood Ovarian Germ Cell Tumor Stage 0 includes: Tis, N0, M0. Tis: In situ primary tumor. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C85887 Neoplastic Process Stage 0 Cutaneous Merkel Cell Carcinoma AJCC v7 C2828010 Abnormal cells are found in the place where they first formed and have not spread. These abnormal cells may become cancer and spread to lymph nodes or distant parts of the body. Malignant Stage 0 Cutaneous Merkel Cell Carcinoma Stage 0 Cutaneous Merkel Cell Carcinoma AJCC v7 stage 0 Merkel cell carcinoma in situ Stage 0 Cutaneous Merkel Cell Carcinoma AJCC v7 Stage I includes: IA: (T1, pN0, M0) and IB: (T1, cN0, M0). T1: Primary tumor equal or less than 2 cm in size. pN0: No regional lymph node metastasis by pathologic examination. cN0: No regional lymph node metastasis by clinical examination. M0: No distant metastasis. (AJCC 7th Ed.) C85889 Neoplastic Process Stage I Merkel Cell Carcinoma AJCC v7 Stage I Cutaneous Merkel Cell Carcinoma AJCC v7 CL343402 CTRP Stage I Merkel cell carcinoma is divided into stages IA and IB. In stage IA, the tumor is 2 centimeters or smaller at its widest point and no cancer is found when the lymph nodes are checked under a microscope. In stage IB, the tumor is 2 centimeters or smaller at its widest point and no swollen lymph nodes are found by a physical exam or imaging tests. Malignant Stage I Cutaneous Merkel Cell Carcinoma Stage I Cutaneous Merkel Cell Carcinoma AJCC v7 Stage I Merkel Cell Cancer stage I Merkel cell carcinoma Stage I Cutaneous Merkel Cell Carcinoma AJCC v7 Stage IA includes: T1, pN0, M0. T1: Primary tumor equal or less than 2 cm in size. pN0: No regional lymph node metastasis by pathologic examination. M0: No distant metastasis. (AJCC 7th Ed.) C85890 Neoplastic Process Stage IA Cutaneous Merkel Cell Carcinoma AJCC v7 C2828011 Malignant Stage IA Cutaneous Merkel Cell Carcinoma Stage IA Cutaneous Merkel Cell Carcinoma AJCC v7 Stage IA Cutaneous Merkel Cell Carcinoma AJCC v7 Stage IB includes: T1, cN0, M0. T1: Primary tumor equal or less than 2 cm in size. cN0: No regional lymph node metastasis by clinical examination. M0: No distant metastasis. (AJCC 7th Ed.) C85892 Neoplastic Process Stage IB Cutaneous Merkel Cell Carcinoma AJCC v7 C2828012 Malignant Stage IB Cutaneous Merkel Cell Carcinoma Stage IB Cutaneous Merkel Cell Carcinoma AJCC v7 Stage IB Cutaneous Merkel Cell Carcinoma AJCC v7 Stage II includes: IIA: (T2/T3, pN0, M0), IIB: (T2/T3, cN0, M0), and IIC: (T4, N0, M0). T2: Primary tumor greater than 2 cm but not more than 5 cm in maximum dimension. T3: Primary tumor over 5 cm in maximum dimension. T4: Primary tumor invades bone, muscle, fascia, or cartilage. pN0: No regional lymph node metastasis by pathologic examination. cN0: No regional lymph node metastasis by clinical examination. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th Ed.) C85893 Neoplastic Process Stage II Merkel Cell Carcinoma AJCC v7 Stage II Cutaneous Merkel Cell Carcinoma AJCC v7 CL343403 CTRP Stage II Merkel cell carcinoma is divided into stages IIA, IIB, and IIC. In stage IIA, the tumor is larger than 2 centimeters and no cancer is found when the lymph nodes are checked under a microscope. In stage IIB, the tumor is larger than 2 centimeters and no swollen lymph nodes are found by a physical exam or imaging tests. In stage IIC, the tumor may be any size and has spread to nearby bone, muscle, connective tissue, or cartilage. It is has not spread to lymph nodes or distant parts of the body. Malignant Stage II Cutaneous Merkel Cell Carcinoma Stage II Cutaneous Merkel Cell Carcinoma AJCC v7 Stage II Merkel Cell Cancer stage II Merkel cell carcinoma Stage II Cutaneous Merkel Cell Carcinoma AJCC v7 Stage IIA includes: T2/T3, pN0, M0. T2: Primary tumor greater than 2 cm but not more than 5 cm in maximum dimension. T3: Primary tumor over 5 cm in maximum dimension. pN0: No regional lymph node metastasis by pathologic examination. M0: No distant metastasis. (AJCC 7th Ed.) C85894 Neoplastic Process Stage IIA Cutaneous Merkel Cell Carcinoma AJCC v7 C2828013 Malignant Stage IIA Cutaneous Merkel Cell Carcinoma Stage IIA Cutaneous Merkel Cell Carcinoma AJCC v7 Stage IIA Cutaneous Merkel Cell Carcinoma AJCC v7 Stage IIB includes: T2/T3, cN0, M0. T2: Primary tumor greater than 2 cm but not more than 5 cm in maximum dimension. T3: Primary tumor over 5 cm in maximum dimension. cN0: No regional lymph node metastasis by clinical examination. M0: No distant metastasis. (AJCC 7th Ed.) C85895 Neoplastic Process Stage IIB Cutaneous Merkel Cell Carcinoma AJCC v7 C2828014 Malignant Stage IIB Cutaneous Merkel Cell Carcinoma Stage IIB Cutaneous Merkel Cell Carcinoma AJCC v7 Stage IIB Cutaneous Merkel Cell Carcinoma AJCC v7 Stage IIC includes: T4, N0, M0. T4: Primary tumor invades bone, muscle, fascia, or cartilage. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th Ed.) C85896 Neoplastic Process Stage IIC Cutaneous Merkel Cell Carcinoma AJCC v7 C2828015 Malignant Stage IIC Cutaneous Merkel Cell Carcinoma Stage IIC Cutaneous Merkel Cell Carcinoma AJCC v7 Stage IIC Cutaneous Merkel Cell Carcinoma AJCC v7 Stage III includes: IIIA: (Any T, N1a, M0) and IIIB: (Any T, N1b/N2, M0). N1a: Micrometastasis in regional lymph nodes. N1b: Macrometastasis in regional lymph nodes. N2: In transit metastasis. M0: No distant metastasis. (AJCC 7th Ed.) C85897 Neoplastic Process Stage III Merkel Cell Carcinoma AJCC v7 Stage III Cutaneous Merkel Cell Carcinoma AJCC v7 CL343404 CTRP Stage III Merkel cell cancer is divided into stages IIIA and IIIB. In stage IIIA, the tumor may be any size and may have spread to nearby bone, muscle, connective tissue, or cartilage. Cancer is found in the lymph nodes when they are checked under a microscope. In stage IIIB, the tumor may be any size and may have spread to nearby bone, muscle, connective tissue, or cartilage. Cancer has spread to the lymph nodes near the tumor and is found by physical exam or imaging test. The lymph nodes are removed and cancer is found in the lymph nodes when they are checked under a microscope. There may also be a second tumor, which is either between the primary tumor and nearby lymph nodes or farther away from the center of the body than the primary tumor is. Malignant Stage III Cutaneous Merkel Cell Carcinoma Stage III Cutaneous Merkel Cell Carcinoma AJCC v7 Stage III Merkel Cell Cancer stage III Merkel cell carcinoma Stage III Cutaneous Merkel Cell Carcinoma AJCC v7 Stage IIIA includes: Any T, N1a, M0. N1a: Micrometastasis in regional lymph nodes. M0: No distant metastasis. (AJCC 7th Ed.) C85898 Neoplastic Process Stage IIIA Cutaneous Merkel Cell Carcinoma AJCC v7 C2828016 Malignant Stage IIIA Cutaneous Merkel Cell Carcinoma Stage IIIA Cutaneous Merkel Cell Carcinoma AJCC v7 Stage IIIA Cutaneous Merkel Cell Carcinoma AJCC v7 Stage IIIB includes: Any T, N1b/N2, M0. N1b: Macrometastasis in regional lymph nodes. N2: In transit metastasis. M0: No distant metastasis. (AJCC 7th Ed.) C85899 Neoplastic Process Stage IIIB Cutaneous Merkel Cell Carcinoma AJCC v7 C2828017 Malignant Stage IIIB Cutaneous Merkel Cell Carcinoma Stage IIIB Cutaneous Merkel Cell Carcinoma AJCC v7 Stage IIIB Cutaneous Merkel Cell Carcinoma AJCC v7 Stage IV includes: Any T, Any N, M1. M1: Metastasis beyond regional lymph nodes. (AJCC 7th Ed.) C85900 Neoplastic Process Stage IV Merkel Cell Carcinoma AJCC v7 Stage IV Cutaneous Merkel Cell Carcinoma AJCC v7 CL413612 CTRP The tumor may be any size and has spread to distant parts of the body, such as the liver, lung, bone, or brain. Malignant Stage IV Cutaneous Merkel Cell Carcinoma Stage IV Cutaneous Merkel Cell Carcinoma AJCC v7 Stage IV Merkel Cell Cancer stage IV Merkel cell carcinoma Stage IV Cutaneous Merkel Cell Carcinoma AJCC v7 A germ cell tumor arising from the testis. Representative examples include teratoma, seminoma, embryonal carcinoma, and yolk sac tumor. C8591 Neoplastic Process Testicular Germ Cell Tumor Testicular Germ Cell Tumor C1336708 CTRP MedDRA NICHD A neoplasm arising from gonadal tissue within the testes. Undetermined Testicular_Germ_Cell_Neoplasm Testicular germ cell tumor Germ Cell Neoplasm of Testis Germ Cell Neoplasm of the Testis Germ Cell Tumor of Testis Germ Cell Tumor of the Testis TGCT Testicular Germ Cell Neoplasm Testicular Germ Cell Neoplasms Testicular Germ Cell Tumor Testicular Germ Cell Tumor A cartilaginous matrix-producing neoplasm characterized by the presence of neoplastic chondrocytes. There is no evidence of atypical or malignant cytological and architectural features, invasive features, or metastases. Representative examples include osteochondroma and chondroma. C8592 Neoplastic Process Benign Chondrogenic Neoplasm C0852519 Benign Benign_Chondrogenic_Neoplasm Benign Cartilaginous Neoplasm Benign Cartilaginous Tumor Benign Chondrogenic Neoplasm Benign Chondrogenic Tumor Benign Neoplasm of Cartilage Benign Neoplasm of the Cartilage Benign Tumor of Cartilage Benign Tumor of the Cartilage Benign Chondrogenic Neoplasm A usually terminal event in the clinical course of lymphomas. The term indicates the presence of atypical, clonal (malignant) lymphocytes (lymphoma cells) in the peripheral blood. C8594 Neoplastic Process Leukemic Phase of Lymphoma C0852709 Malignant Leukemic_Phase_of_Lymphoma Leukemic Lymphoma Leukemic Phase of Lymphoma Leukemic Phase of Non-Hodgkin Lymphoma Leukemic Phase of Non-Hodgkin's Lymphoma Leukemic Phase of Lymphoma A carcinoma of the hypopharynx that arises from the postcricoid region. C8595 Neoplastic Process Postcricoid Carcinoma Postcricoid Carcinoma C0852722 CTRP Malignant Postcricoid_Carcinoma Cancer of Postcricoid Area Cancer of the Postcricoid Area Postcricoid Cancer Postcricoid Carcinoma Postcricoid Throat Cancer Postcricoid Carcinoma A melanoma affecting the retinal portion of the eye. C8601 Neoplastic Process Retinal Melanoma C0853394 CPTAC Malignant Retinal_Melanoma Malignant Melanoma of Retina Malignant Melanoma of the Retina Malignant Retinal Melanoma Melanoma of Retina Melanoma of the Retina Retinal Melanoma Retinal Melanoma Stage IA includes: T1a, N0, M0. T1a: Cutaneous melanoma with a tumor measuring 1.0 mm or less in thickness, without ulceration and with mitosis less than 1/mm2. N0: No regional lymph node metastases. M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.) C86026 Neoplastic Process Stage IA Cutaneous Melanoma AJCC v7 Stage IA Cutaneous Melanoma AJCC v7 CL413970 CTRP Malignant Stage IA Cutaneous (Skin) Melanoma Stage IA Cutaneous Melanoma AJCC v7 Stage IA Skin Melanoma AJCC v7 Stage IA Cutaneous Melanoma AJCC v7 A neoplasm with papillary architectural pattern arising from the renal pelvis urothelial cells. C8603 Neoplastic Process Renal Pelvis Papillary Urothelial Neoplasm C0853688 Undetermined Renal_Pelvis_Papillary_Neoplasm Papillary Neoplasm of Renal Pelvis Papillary Neoplasm of the Renal Pelvis Papillary Tumor of Renal Pelvis Papillary Tumor of the Renal Pelvis Renal Pelvis Papillary Tumor Renal Pelvis Papillary Urothelial Neoplasm Renal Pelvis Papillary Urothelial Neoplasm Stage IB includes: (T1b, N0, M0); (T2a, N0, M0). T1b: Cutaneous melanoma with a tumor measuring 1.0 mm or less in thickness, with ulceration or mitoses equal or more than 1/mm2. T2a: Cutaneous melanoma with a tumor measuring 1.01-2.0 mm in thickness, without ulceration. N0: No regional lymph node metastases. M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.) C86030 Neoplastic Process Stage IB Cutaneous Melanoma AJCC v7 Stage IB Cutaneous Melanoma AJCC v7 CL413971 CTRP Malignant Stage IB Cutaneous (Skin) Melanoma Stage IB Cutaneous Melanoma AJCC v7 Stage IB Skin Melanoma AJCC v7 Stage IB Cutaneous Melanoma AJCC v7 Stage IIA includes: (T2b, N0, M0); (T3a, N0, M0). T2b: Cutaneous melanoma with a tumor measuring 1.01-2.0 mm in thickness, with ulceration. T3a: Cutaneous melanoma with a tumor measuring 2.01-4.0 mm in thickness, without ulceration. N0: No regional lymph node metastases. M0: No detectable evidence of distant metastases. (from AJCC 6th and 7th Eds.) C86033 Neoplastic Process Stage IIA Cutaneous Melanoma AJCC v6 and v7 Stage IIA Cutaneous Melanoma AJCC v6 and v7 CL413972 CTRP Malignant Stage IIA Cutaneous (Skin) Melanoma Stage IIA Cutaneous Melanoma AJCC v6 and v7 Stage IIA Skin Melanoma Stage IIA Skin Melanoma AJCC v6 Stage IIA Skin Melanoma AJCC v7 Stage IIA Cutaneous Melanoma AJCC v6 and v7 Stage IIC includes: T4b, N0, M0. T4b: Cutaneous melanoma with a tumor measuring more than 4.0 mm in thickness, with ulceration. N0: No regional lymph node metastases. M0: No detectable evidence of distant metastases. (from AJCC 6th and 7th Eds.) C86034 Neoplastic Process Stage IIC Cutaneous Melanoma AJCC v6 and v7 Stage IIC Cutaneous Melanoma AJCC v6 and v7 CL413973 CTRP Malignant Stage IIC Cutaneous (Skin) Melanoma Stage IIC Cutaneous Melanoma AJCC v6 and v7 Stage IIC Skin Melanoma Stage IIC Skin Melanoma AJCC v6 Stage IIC Skin Melanoma AJCC v7 Stage IIC Cutaneous Melanoma AJCC v6 and v7 The reemergence of lymphoplasmacytic lymphoma after a period of remission. C8604 Neoplastic Process Recurrent Lymphoplasmacytic Lymphoma Recurrent Lymphoplasmacytic Lymphoma C0861979 CTRP Malignant Recurrent_Lymphoplasmacytic_Lymphoma_Waldenstrom_s_Macroglobulinemia Recurrent Lymphoplasmacytic Lymphoma Recurrent Lymphoplasmacytoid Lymphoma/Immunocytoma Relapsed Lymphoplasmacytoid Lymphoma/Immunocytoma Recurrent Lymphoplasmacytic Lymphoma Stage IIIA includes: (T1-4a, N1a, M0); (T1-4a, N2a, M0). T1-4a: Non-ulcerated cutaneous melanoma of any thickness. N1a: Cutaneous melanoma with micrometastasis in one regional lymph node. N2a: Cutaneous melanoma with micrometastases in 2-3 regional lymph nodes. M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.) C86049 Neoplastic Process Stage IIIA Cutaneous Melanoma AJCC v7 Stage IIIA Cutaneous Melanoma AJCC v7 CL413975 CTRP Malignant Stage IIIA Cutaneous (Skin) Melanoma Stage IIIA Cutaneous Melanoma AJCC v7 Stage IIIA Skin Melanoma AJCC v7 Stage IIIA Cutaneous Melanoma AJCC v7 An anaplastic (malignant) meningioma involving the spinal meninges. C8605 Neoplastic Process Anaplastic (Malignant) Intraspinal Meningioma C0853826 Malignant Anaplastic_Malignant_Intraspinal_Meningioma Anaplastic (Malignant) Intraspinal Meningioma Anaplastic Intraspinal Meningioma Malignant Intraspinal Meningioma Malignant Meningioma of Spinal Canal and Spinal Cord Malignant Meningioma of the Spinal Canal and Spinal Cord Malignant Spinal Canal and Spinal Cord Meningioma Anaplastic (Malignant) Intraspinal Meningioma Stage IIIB includes: (T1-4b, N1a, M0); (T1-4b, N2a, M0); (T1-4a, N1b, M0); (T1-4a, N2b, M0); (T1-4a, N2c, M0). T1-4b: Ulcerated cutaneous melanoma of any thickness. T1-4a: Non-ulcerated cutaneous melanoma of any thickness. N1a: Cutaneous melanoma with micrometastasis in one regional lymph node. N2a: Cutaneous melanoma with micrometastases in 2-3 regional lymph nodes. N1b: Cutaneous melanoma with macrometastasis in one regional lymph node. N2b: Cutaneous melanoma with macrometastases in 2-3 regional lymph nodes. N2c: Cutaneous melanoma with intralymphatic metastases (in transit or satellite metastases) without metastatic nodes. M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.) C86051 Neoplastic Process Stage IIIB Cutaneous Melanoma AJCC v7 Stage IIIB Cutaneous Melanoma AJCC v7 CL413976 CTRP Malignant Stage IIIB Cutaneous (Skin) Melanoma Stage IIIB Cutaneous Melanoma AJCC v7 Stage IIIB Skin Melanoma AJCC v7 Stage IIIB Cutaneous Melanoma AJCC v7 Stage IIIC includes: (T1-4b, N1b, M0); (T1-4b, N2b, M0); (T1-4b, N2c, M0); (Any T, N3, M0). T1-4b: Ulcerated cutaneous melanoma of any thickness. N1b: Cutaneous melanoma with macrometastasis in one regional lymph node. N2b: Cutaneous melanoma with macrometastases in 2-3 regional lymph nodes. N2c: Cutaneous melanoma with intralymphatic metastases (in transit or satellite metastases) without metastatic nodes. N3: Cutaneous melanoma with 4 or more metastatic nodes, or matted nodes, or in transit met(s)/satellite(s) with metastatic node(s). M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.) C86053 Neoplastic Process Stage IIIC Cutaneous Melanoma AJCC v7 Stage IIIC Cutaneous Melanoma AJCC v7 CL413977 CTRP Malignant Stage IIIC Cutaneous (Skin) Melanoma Stage IIIC Cutaneous Melanoma AJCC v7 Stage IIIC Skin Melanoma AJCC v7 Stage IIIC Cutaneous Melanoma AJCC v7 Stage II includes: Any pT/TX, N1-3, M0, SX. pTX: Primary tumor cannot be assessed. N1: Metastasis with a lymph node mass 2 cm or less in greatest dimension; or multiple lymph nodes, none more than 2cm in greatest dimension. N2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, any one mass greater than 2 cm but not more than 5 cm in greatest dimension. N3: Metastasis with a lymph node mass more than 5 cm in greatest dimension. M0: No distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C8606 Neoplastic Process Stage II Testicular Choriocarcinoma AJCC v6 and v7 Stage II Testicular Choriocarcinoma AJCC v6 and v7 C0853869 CTRP Malignant Stage_II_Testicular_Choriocarcinoma Stage II Testicular Choriocarcinoma Stage II Testicular Choriocarcinoma AJCC v6 Stage II Testicular Choriocarcinoma AJCC v6 and v7 Stage II Testicular Choriocarcinoma AJCC v7 Testicular Choriocarcinoma Stage II Stage II Testicular Choriocarcinoma AJCC v6 and v7 The reemergence of inflammatory carcinoma of the breast after a period of remission C8607 Neoplastic Process Recurrent Breast Inflammatory Carcinoma C0853968 Malignant Recurrent_Inflammatory_Breast_Carcinoma Recurrent Breast Inflammatory Carcinoma Recurrent Inflammatory Breast Carcinoma Recurrent Inflammatory Carcinoma of Breast Recurrent Inflammatory Carcinoma of the Breast Recurrent Breast Inflammatory Carcinoma A malignant neoplasm that affects the liver parenchyma, bile ducts, and gallbladder. Representative examples include hepatocellular carcinoma, intrahepatic and extrahepatic cholangiocarcinoma, and gallbladder carcinoma. C8609 Neoplastic Process Malignant Hepatobiliary Neoplasm Malignant Hepatobiliary Neoplasm C0854176 CPTAC CTRP mCode Malignant Malignant_Hepato-Biliary_Neoplasm Malignant neoplasm of biliary tract, part unspecified Malignant neoplasm of gallbladder and extrahepatic bile ducts Malignant neoplasm of intrahepatic bile ducts Malignant neoplasm of liver and intrahepatic bile ducts Malignant neoplasm of liver, not specified as primary or secondary Malignant neoplasm of other and unspecified parts of biliary tract Malignant neoplasm of other specified sites of gallbladder and extrahepatic bile ducts Malignant neoplasm: Biliary tract, unspecified Malignant Hepato-Biliary Neoplasm Malignant Hepatobiliary Neoplasm Malignant Liver and Biliary Neoplasm Malignant Liver and Biliary System Neoplasm Malignant neoplasm of biliary tract, unspecified Malignant Hepatobiliary Neoplasm A malignant tumor that has spread to the adrenal gland from an adjacent or distant anatomic site. The majority of cases are metastatic carcinomas, and less frequently lymphomas. C8610 Neoplastic Process Metastatic Malignant Neoplasm in the Adrenal Gland C0153691 CPTAC mCode Malignant Metastatic_Neoplasm_to_the_Adrenal_Gland Secondary malignant neoplasm of right adrenal gland Metastases to Adrenals Metastasis to Adrenals Metastatic Malignant Neoplasm in the Adrenal Gland Metastatic Malignant Neoplasm to the Adrenal Gland Metastatic Neoplasm to the Adrenal Gland Metastatic Neoplasm to the Adrenals Metastatic Tumor to the Adrenal Gland Metastatic Tumor to the Adrenals Secondary malignant neoplasm of adrenal gland Secondary malignant neoplasm of unspecified adrenal gland Metastatic Malignant Neoplasm in the Adrenal Gland A neoplasm that arises from the peritoneum and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C8612 Neoplastic Process Benign Peritoneal Neoplasm C0496874 Benign Benign_Peritoneal_Neoplasm Benign Peritoneal Neoplasm Benign Peritoneal Neoplasm A benign or malignant neoplasm that affects the liver parenchyma, bile ducts, and gallbladder. Representative examples of benign neoplasms include hepatocellular adenoma, bile duct adenoma, and gallbladder lipoma. Representative examples of malignant neoplasms include hepatocellular carcinoma, intrahepatic and extrahepatic cholangiocarcinoma, and gallbladder carcinoma. C8614 Neoplastic Process Hepatobiliary Neoplasm Hepatobiliary Neoplasm C0854196 CPTAC CTRP Undetermined Hepato-Biliary_Neoplasm Neoplasm of uncertain behavior of liver and biliary passages Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts Hepatic and Biliary Neoplasms Hepatic and Biliary Tumors Hepatic, Biliary, and Gallbladder Neoplasms Hepato-Biliary Neoplasm Hepato-Biliary Tumor Hepatobiliary Neoplasm Hepatobiliary Tumor Hepatobiliary Tumors Liver and Biliary Neoplasm Liver and Biliary System Neoplasm Hepatobiliary Neoplasm The reemergence of colorectal carcinoma after a period of remission. C8625 Neoplastic Process Recurrent Colorectal Carcinoma Recurrent Colorectal Carcinoma C0854750 CTRP Malignant Recurrent_Colorectal_Cancer Colorectal Cancer, Recurrent Colorectal Carcinoma Recurrent Recurrent Colorectal (Colon or Rectal) Cancer Recurrent Colorectal Cancer Recurrent Colorectal Carcinoma Recurrent Colorectal Carcinoma An esophageal adenocarcinoma which has reappeared after a period of remission or after presumed treatment. C8627 Neoplastic Process Recurrent Esophageal Adenocarcinoma Recurrent Esophageal Adenocarcinoma C0854762 CTRP Malignant Recurrent_Esophageal_Adenocarcinoma Esophageal Adenocarcinoma, Recurrent Oesophageal Adenocarcinoma Recurrent Recurrent Adenocarcinoma of Esophagus Recurrent Adenocarcinoma of the Esophagus Recurrent Esophageal Adenocarcinoma Recurrent Esophagus Adenocarcinoma Relapsed Adenocarcinoma of Esophagus Relapsed Adenocarcinoma of the Esophagus Relapsed Esophageal Adenocarcinoma Relapsed Esophagus Adenocarcinoma Recurrent Esophageal Adenocarcinoma Stage II includes: IIA (T2, N0, M0, G3); IIB (T3, N0, M0, Any G); (T1-2, N1, M0, Any G). T2: Tumor invades muscularis propria. T3: Tumor invades adventitia. T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. M0: No distant metastasis. G3: Poorly differentiated. (AJCC 7th ed.) C8628 Neoplastic Process Stage II Esophageal Adenocarcinoma AJCC v7 Stage II Esophageal Adenocarcinoma AJCC v7 C0854763 CTRP Malignant Stage_II_Esophageal_Adenocarcinoma Esophageal Adenocarcinoma, Stage II Oesophageal Adenocarcinoma Stage II Stage II Adenocarcinoma of Esophagus Stage II Adenocarcinoma of the Esophagus Stage II Esophageal Adenocarcinoma Stage II Esophageal Adenocarcinoma AJCC v7 Stage II Esophagus Adenocarcinoma Stage II Esophageal Adenocarcinoma AJCC v7 Stage 0 includes: Tis (HGD), N0, M0, G1,GX. Tis: High-grade dysplasia. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated. GX: Grade cannot be assessed-stage grouping as G1. (AJCC 7th ed.) C8629 Neoplastic Process Stage 0 Esophageal Adenocarcinoma AJCC v7 Stage 0 Esophageal Adenocarcinoma AJCC v7 C0854764 CTRP Malignant Stage_0_Esophageal_Adenocarcinoma Adenocarcinoma in situ of Esophagus Adenocarcinoma in situ of the Esophagus Esophageal Adenocarcinoma in situ Esophageal Adenocarcinoma, Stage 0 Esophagus Adenocarcinoma in situ Oesophageal Adenocarcinoma Stage 0 Stage 0 Adenocarcinoma of Esophagus Stage 0 Adenocarcinoma of the Esophagus Stage 0 Esophageal Adenocarcinoma Stage 0 Esophageal Adenocarcinoma AJCC v7 Stage 0 Esophagus Adenocarcinoma Stage 0 Esophageal Adenocarcinoma AJCC v7 Stage I includes: IA (T1, N0, M0, G1-2, X); IB (T1, N0, M0, G3); (T2, N0, M0, G1-2, GX). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated. G2: Moderately differentiated. G3: Poorly differentiated. GX: Grade cannot be assessed-stage grouping as G1. (AJCC 7th ed.) C8630 Neoplastic Process Stage I Esophageal Adenocarcinoma AJCC v7 Stage I Esophageal Adenocarcinoma AJCC v7 C0854765 CTRP Malignant Stage_I_Esophageal_Adenocarcinoma Esophageal Adenocarcinoma, Stage I Oesophageal Adenocarcinoma Stage I Stage I Adenocarcinoma of Esophagus Stage I Adenocarcinoma of the Esophagus Stage I Esophageal Adenocarcinoma Stage I Esophageal Adenocarcinoma AJCC v7 Stage I Esophagus Adenocarcinoma Stage I Esophageal Adenocarcinoma AJCC v7 Stage III includes: IIIA (T1-2, N2, M0, Any G); (T3, N1, M0, Any G); (T4a, N0, M0, Any G); IIIB (T3, N2, M0, Any G); IIIC (T4a, N1-2, M0, Any G); (T4b, Any N, M0, Any G); (Any T, N3, M0, Any G). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades adventitia. T4a: Resectable tumor invading pleura, pericardium, or diaphragm. T4b: Unresectable tumor invading other adjacent structures, such as aorta, vertebral body, trachea, etc. N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. N2: Metastasis in 3-6 regional lymph nodes. N3: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C8631 Neoplastic Process Stage III Esophageal Adenocarcinoma AJCC v7 Stage III Esophageal Adenocarcinoma AJCC v7 C0854766 CTRP Malignant Stage_III_Esophageal_Adenocarcinoma Esophageal Adenocarcinoma, Stage III Oesophageal Adenocarcinoma Stage III Stage III Adenocarcinoma of Esophagus Stage III Adenocarcinoma of the Esophagus Stage III Esophageal Adenocarcinoma Stage III Esophageal Adenocarcinoma AJCC v7 Stage III Esophagus Adenocarcinoma Stage III Esophageal Adenocarcinoma AJCC v7 Stage IV includes: Any T, Any N, M1, Any G. M1: Distant metastasis. (AJCC 7th ed.) C8632 Neoplastic Process Stage IV Esophageal Adenocarcinoma AJCC v7 Stage IV Esophageal Adenocarcinoma AJCC v7 C1142347 CTRP Malignant Stage_IV_Esophageal_Adenocarcinoma Esophageal Adenocarcinoma, Stage IV Oesophageal Adenocarcinoma Stage IV Stage IV Adenocarcinoma of Esophagus Stage IV Adenocarcinoma of the Esophagus Stage IV Esophageal Adenocarcinoma Stage IV Esophageal Adenocarcinoma AJCC v7 Stage IV Esophagus Adenocarcinoma Stage IV Esophageal Adenocarcinoma AJCC v7 An esophageal squamous cell carcinoma which has reappeared after a period of remission or after presumed treatment. C8633 Neoplastic Process Recurrent Esophageal Squamous Cell Carcinoma Recurrent Esophageal Squamous Cell Carcinoma C0854769 CTRP Malignant Recurrent_Esophageal_Squamous_Cell_Carcinoma Recurrent Esophageal Squamous Cell Cancer Recurrent Esophageal Squamous Cell Carcinoma Recurrent Squamous Cell Carcinoma of Esophagus Recurrent Squamous Cell Carcinoma of the Esophagus Recurrent Esophageal Squamous Cell Carcinoma The reemergence of rectosigmoid carcinoma after a period of remission. C8634 Neoplastic Process Recurrent Rectosigmoid Carcinoma Recurrent Rectosigmoid Carcinoma C0854779 CTRP Malignant Recurrent_Rectosigmoid_Carcinoma Rectosigmoid Cancer, Recurrent Recurrent Rectosigmoid Cancer Recurrent Rectosigmoid Carcinoma Relapsed Rectosigmoid Cancer Recurrent Rectosigmoid Carcinoma Stage III includes: IIIA (T1-T2, N1, M0); IIIB (T3-T4, N1, M0); IIIC (Any T, N2, M0). N1: Metastasis in 1 to 3 regional lymph nodes. N2: Metastasis in 4 or more regional lymph nodes. M0: No distant metastasis. (AJCC 6th ed.) C8635 Neoplastic Process Stage III Rectosigmoid Cancer AJCC v6 Stage III Rectosigmoid Cancer AJCC v6 C0854783 CTRP Malignant Stage_III_Rectosigmoid_Cancer Stage III Rectosigmoid Cancer Stage III Rectosigmoid Cancer AJCC v6 Stage III Rectosigmoid Carcinoma AJCC v6 Stage III Rectosigmoid Cancer AJCC v6 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 6th ed.) C8636 Neoplastic Process Stage IV Rectosigmoid Cancer AJCC v6 Stage IV Rectosigmoid Cancer AJCC v6 C0854784 CTRP Malignant Stage_IV_Rectosigmoid_Cancer Stage IV Rectosigmoid Cancer Stage IV Rectosigmoid Cancer AJCC v6 Stage IV Rectosigmoid Carcinoma AJCC v6 Stage IV Rectosigmoid Cancer AJCC v6 A carcinoma that arises from the small intestine and it has metastasized to other anatomic sites. C8637 Neoplastic Process Metastatic Small Intestinal Carcinoma Metastatic Small Intestinal Carcinoma C0854786 CTRP Malignant Metastatic_Small_Intestinal_Carcinoma Metastatic Carcinoma from the Small Bowel Metastatic Carcinoma from the Small Intestine Metastatic Small Bowel Carcinoma Metastatic Small Intestinal Cancer Metastatic Small Intestinal Carcinoma Metastatic Small Intestine Cancer Metastatic Small Intestinal Carcinoma Carcinoma of the small intestine not amendable to resection. C8638 Neoplastic Process Unresectable Small Intestinal Carcinoma Unresectable Small Intestinal Carcinoma C0854787 CTRP Malignant Unresectable_Small_Intestinal_Cancer Non-Resectable Carcinoma of Small Bowel Non-Resectable Carcinoma of Small Intestine Non-Resectable Carcinoma of the Small Bowel Non-Resectable Carcinoma of the Small Intestine Non-Resectable Small Bowel Carcinoma Non-Resectable Small Intestine Carcinoma Small Intestine Carcinoma, Non-Resectable Unresectable Small Intestinal Cancer Unresectable Small Intestinal Carcinoma Unresectable Small Intestine Carcinoma Unresectable Small Intestinal Carcinoma Carcinoma of the small intestine amendable to resection. C8639 Neoplastic Process Resectable Small Intestinal Carcinoma Resectable Small Intestinal Carcinoma C0854789 CTRP Malignant Resectable_Small_Intestinal_Cancer Resectable Carcinoma of Small Bowel Resectable Carcinoma of Small Intestine Resectable Carcinoma of the Small Bowel Resectable Carcinoma of the Small Intestine Resectable Small Bowel Carcinoma Resectable Small Intestinal Cancer Resectable Small Intestinal Carcinoma Resectable Small Intestine Carcinoma Small Intestine Carcinoma, Resectable Resectable Small Intestinal Carcinoma Extrahepatic bile duct carcinoma that is amenable to surgical removal. C8640 Neoplastic Process Resectable Extrahepatic Bile Duct Carcinoma C0854792 Malignant Resectable_Extrahepatic_Bile_Duct_Carcinoma Bile Duct Cancer, Resectable Resectable Bile Duct Cancer Resectable Cancer of Bile Duct Resectable Cancer of the Bile Duct Resectable Extrahepatic Bile Duct Carcinoma Resectable Extrahepatic Bile Duct Carcinoma Hepatoblastoma not amenable to surgical removal. C8641 Neoplastic Process Unresectable Hepatoblastoma Unresectable Hepatoblastoma C0854796 CTRP Malignant Unresectable_Hepatoblastoma Hepatoblastoma, Nonresectable Non-Resectable Hepatoblastoma Unresectable Hepatoblastoma Unresectable Hepatoblastoma Hepatoblastoma amenable to surgical removal. C8642 Neoplastic Process Resectable Hepatoblastoma Resectable Hepatoblastoma C0854797 CTRP Malignant Resectable_Hepatoblastoma Hepatoblastoma, Resectable Resectable Hepatoblastoma Resectable Hepatoblastoma The reemergence of hepatoblastoma after a period of remission. C8643 Neoplastic Process Recurrent Hepatoblastoma Recurrent Hepatoblastoma C0854798 CTRP Malignant Recurrent_Hepatoblastoma Hepatoblastoma, Recurrent Recurrent Hepatoblastoma Relapsed Hepatoblastoma Recurrent Hepatoblastoma The most frequent type of acute lymphoblastic leukemia. Approximately 75% of cases occur in children under six years of age. This is a good prognosis leukemia. In the pediatric age group the complete remission rate is approximately 95% and the disease free survival rate is 70%. Approximately 80% of children appear to be cured. In the adult age group the complete remission rate is 60-85%. (WHO, 2001) C8644 Neoplastic Process B Acute Lymphoblastic Leukemia B Acute Lymphoblastic Leukemia C4227542 CTEP CTRP Cellosaurus GDC NICHD PCDC An acute lymphoblastic leukemia of B-lineage origin. An aggressive (fast-growing) type of leukemia (blood cancer) in which too many B-cell lymphoblasts (immature white blood cells) are found in the bone marrow and blood. It is the most common type of acute lymphoblastic leukemia (ALL). 9836/3 Malignant Precursor_B_Lymphoblastic_Leukemia 9826/3 9836/3 B-ALL Precursor B-cell lymphoblastic leukemia Acute B Cell Lymphocytic Leukemia Acute B-Cell Lymphocytic Leukemia B Acute Lymphoblastic Leukemia B Cell Acute Lymphocytic Leukemia B Cell Precursor Type Acute Leukemia B-ALL B-Acute Lymphoblastic Leukemia B-Cell ALL B-Cell Acute Lymphoblastic Leukemia B-Cell Acute Lymphocytic Leukemia B-Cell Lymphoblastic Leukemia B-Cell Precursor Type Acute Leukemia B-Cell Type Acute Leukemia B-cell acute lymphoblastic leukemia B-cell acute lymphocytic leukemia B-precursor ALL Precursor B-Cell Lymphoblastic Leukemia Precursor B-Lymphoblastic Leukemia Precursor B-cell lymphoblastic leukemia Precursor B-lymphoblastic leukemia (B-precursor ALL) precursor B-lymphoblastic leukemia B Acute Lymphoblastic Leukemia The reemergence of chronic lymphocytic leukemia after a period of remission. C8645 Neoplastic Process Recurrent Chronic Lymphocytic Leukemia Recurrent Chronic Lymphocytic Leukemia C0854802 CPTAC CTRP mCode Malignant Recurrent_Chronic_Lymphocytic_Leukemia Chronic lymphocytic leukemia of B-cell type in relapse Chronic Lymphocytic Leukemia Recurrent Chronic lymphocytic leukemia of B-cell type in relapse Recurrent B-Cell Chronic Lymphocytic Leukemia Recurrent Chronic Lymphocytic Leukemia Recurrent Chronic Lymphocytic Leukemia (CLL) Recurrent Chronic Lymphoid Leukemia Relapsed Chronic Lymphocytic Leukemia Relapsed Chronic Lymphoid Leukemia Recurrent Chronic Lymphocytic Leukemia Risk: High; Findings: Lymphocytosis and platelets less than 100,000/microliter; Survival (months): 30. (from AJCC 8th Ed.) C8646 Neoplastic Process Stage IV Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia C0854804 CTRP There are too many lymphocytes in the blood and too few platelets. The lymph nodes, liver, or spleen may be larger than normal and there may be too few red blood cells. Malignant Stage_IV_Chronic_Lymphocytic_Leukemia CLL Stage IV Chronic Lymphocytic Leukemia Stage IV Stage IV CLL Stage IV Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia (CLL) Stage IV Chronic Lymphocytic Leukemia- Modified Rai Staging System stage IV chronic lymphocytic leukemia Stage IV Chronic Lymphocytic Leukemia A rare, highly aggressive, Epstein-Barr virus-associated leukemia, also known as aggressive NK-cell leukemia/lymphoma; it may represent the leukemic counterpart of nasal type extranodal NK/T-cell lymphomas. It affects primarily teenagers and young adults. It is characterized by the systemic proliferation of NK cells in the peripheral blood, bone marrow, liver, and spleen. C8647 Neoplastic Process Aggressive NK-Cell Leukemia Aggressive NK-Cell Leukemia C1292777 CTRP GDC 9948/3 Malignant Aggressive_NK-Cell_Leukemia 9948/3 Aggressive NK-cell leukaemia Aggressive NK-cell leukemia Aggressive NK-Cell Leukemia Aggressive NK-Cell Leukemia/Lymphoma Aggressive NK-cell leukaemia NK Cell Leukemia NK-Cell Leukemia Natural Killer Cell Leukemia Aggressive NK-Cell Leukemia The reemergence of lymphocyte-depleted classic Hodgkin lymphoma after a period of remission. C8649 Neoplastic Process Recurrent Lymphocyte-Depleted Classic Hodgkin Lymphoma Recurrent Lymphocyte-Depleted Classic Hodgkin Lymphoma C0854810 CTRP Malignant Recurrent_Lymphocyte_Depleted_Hodgkin_s_Lymphoma Recurrent Hodgkin's Disease Lymphocyte Depletion Type Recurrent Hodgkin's Lymphoma Lymphocyte Depleted Recurrent Hodgkin's Lymphoma Lymphocyte Depletion Type Recurrent Lymphocyte Depleted Classical Hodgkin Lymphoma Recurrent Lymphocyte Depleted Hodgkin Lymphoma Recurrent Lymphocyte Depleted Hodgkin's Lymphoma Recurrent Lymphocyte-Depleted Classic Hodgkin Lymphoma Recurrent Lymphocyte-Depleted Classical Hodgkin Lymphoma Relapsed Hodgkin's Disease Lymphocyte Depletion Type Relapsed Hodgkin's Lymphoma Lymphocyte Depletion Type Recurrent Lymphocyte-Depleted Classic Hodgkin Lymphoma Lymphocyte-depleted classic Hodgkin lymphoma that is resistant to treatment. C8650 Neoplastic Process Refractory Lymphocyte-Depleted Classic Hodgkin Lymphoma Refractory Lymphocyte-Depleted Classic Hodgkin Lymphoma C0854811 CTRP Malignant Refractory_Lymphocyte_Depleted_Hodgkin_s_Lymphoma Refractory Hodgkin's Disease Lymphocyte Depleted Refractory Hodgkin's Lymphoma Lymphocyte Depleted Refractory Hodgkin's Lymphoma Lymphocyte Depletion Type Refractory Lymphocyte Depleted Classical Hodgkin Lymphoma Refractory Lymphocyte Depleted Hodgkin Lymphoma Refractory Lymphocyte Depleted Hodgkin's Disease Refractory Lymphocyte Depleted Hodgkin's Lymphoma Refractory Lymphocyte-Depleted Classic Hodgkin Lymphoma Refractory Lymphocyte-Depleted Classical Hodgkin Lymphoma Refractory Lymphocyte-Depleted Classic Hodgkin Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8651 Neoplastic Process Ann Arbor Stage IV Lymphocyte-Depleted Classic Hodgkin Lymphoma Ann Arbor Stage IV Lymphocyte-Depleted Classic Hodgkin Lymphoma C0375085 CTRP Malignant Stage_IV_Lymphocyte_Depleted_Hodgkin_s_Lymphoma Ann Arbor Stage IV Lymphocyte-Depleted Classic Hodgkin Lymphoma Ann Arbor Stage IV Lymphocyte-Depleted Classical Hodgkin Lymphoma Stage IV Hodgkin's Disease Lymphocyte Depleted Stage IV Hodgkin's Disease Lymphocyte Depletion Type Stage IV Hodgkin's Lymphoma Lymphocyte Depletion Type Stage IV Lymphocyte Depleted Classical Hodgkin Lymphoma Stage IV Lymphocyte Depleted Hodgkin Lymphoma Stage IV Lymphocyte Depleted Hodgkin's Lymphoma Stage IV Lymphocyte-Depleted Classical Hodgkin Lymphoma Ann Arbor Stage IV Lymphocyte-Depleted Classic Hodgkin Lymphoma Lymphoplasmacytic lymphoma resistant to treatment. C8652 Neoplastic Process Refractory Lymphoplasmacytic Lymphoma Refractory Lymphoplasmacytic Lymphoma C0854813 CTRP Malignant Refractory_Lymphoplasmacytic_Lymphoma_Waldenstrom_s_Macroglobulinemia Refractory Lymphoplasmacytic Lymphoma Refractory Lymphoplasmacytoid Lymphoma/Immunocytoma Refractory Lymphoplasmacytic Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8653 Neoplastic Process Ann Arbor Stage I Lymphoplasmacytic Lymphoma Ann Arbor Stage I Lymphoplasmacytic Lymphoma C0854814 CTRP Malignant Stage_I_Lymphoplasmacytic_Lymphoma_Waldenstrom_s_Macroglobulinemia Ann Arbor Stage I Lymphoplasmacytic Lymphoma Lymphoplasmacytoid Lymphoma/Immunocytoma Stage I Stage I Lymphoplasmacytic Lymphoma Stage I Lymphoplasmacytoid Lymphoma/Immunocytoma Ann Arbor Stage I Lymphoplasmacytic Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8654 Neoplastic Process Ann Arbor Stage II Lymphoplasmacytic Lymphoma Ann Arbor Stage II Lymphoplasmacytic Lymphoma C0854815 CTRP Malignant Stage_II_Lymphoplasmacytic_Lymphoma_Waldenstrom_s_Macroglobulinemia Ann Arbor Stage II Lymphoplasmacytic Lymphoma Lymphoplasmacytoid Lymphoma/Immunocytoma Stage II Stage II Lymphoplasmacytic Lymphoma Stage II Lymphoplasmacytoid Lymphoma/Immunocytoma Ann Arbor Stage II Lymphoplasmacytic Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8655 Neoplastic Process Ann Arbor Stage III Lymphoplasmacytic Lymphoma Ann Arbor Stage III Lymphoplasmacytic Lymphoma C0854816 CTRP Malignant Stage_III_Lymphoplasmacytic_Lymphoma_Waldenstrom_s_Macroglobulinemia Ann Arbor Stage III Lymphoplasmacytic Lymphoma Lymphoplasmacytoid Lymphoma/Immunocytoma Stage III Stage III Lymphoplasmacytic Lymphoma Stage III Lymphoplasmacytoid Lymphoma/Immunocytoma Ann Arbor Stage III Lymphoplasmacytic Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8656 Neoplastic Process Ann Arbor Stage IV Lymphoplasmacytic Lymphoma Ann Arbor Stage IV Lymphoplasmacytic Lymphoma C0854817 CTRP Malignant Stage_IV_Lymphoplasmacytic_Lymphoma_Waldenstrom_s_Macroglobulinemia Ann Arbor Stage IV Lymphoplasmacytic Lymphoma Lymphoplasmacytoid Lymphoma/Immunocytoma Stage IV Stage IV Lymphoplasmacytic Lymphoma Stage IV Lymphoplasmacytoid Lymphoma/Immunocytoma Ann Arbor Stage IV Lymphoplasmacytic Lymphoma Adult T-cell leukemia/lymphoma that is resistant to treatment. C8657 Neoplastic Process Refractory Adult T-Cell Leukemia/Lymphoma Refractory Adult T-Cell Leukemia/Lymphoma C0854818 CTRP Malignant Refractory_Adult_T-Cell_Lymphoma_Leukemia Adult T-Cell Lymphoma/Leukemia Refractory Refractory Adult T-Cell Leukemia/Lymphoma Refractory Adult T-Cell Lymphoma/Leukemia Refractory Adult T-Cell Leukemia/Lymphoma Anaplastic large cell lymphoma resistant to treatment. C8658 Neoplastic Process Refractory Anaplastic Large Cell Lymphoma Refractory Anaplastic Large Cell Lymphoma C0854821 CTRP Malignant Refractory_Anaplastic_Large_Cell_Lymphoma Anaplastic Large Cell Lymphoma T- and Null-cell Types Refractory Refractory Anaplastic Large Cell Lymphoma Refractory Anaplastic Large Cell Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8659 Neoplastic Process Ann Arbor Stage I Noncutaneous Anaplastic Large Cell Lymphoma Ann Arbor Stage I Noncutaneous Anaplastic Large Cell Lymphoma C0854822 CTRP Malignant Stage_I_Anaplastic_Large_Cell_Lymphoma Anaplastic Large Cell Lymphoma Stage I Anaplastic Large Cell Lymphoma T- and Null-Cell Types Stage I Ann Arbor Stage I Anaplastic Large Cell Lymphoma Ann Arbor Stage I Noncutaneous Anaplastic Large Cell Lymphoma Stage I Anaplastic Large Cell Lymphoma Ann Arbor Stage I Noncutaneous Anaplastic Large Cell Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8660 Neoplastic Process Ann Arbor Stage II Noncutaneous Anaplastic Large Cell Lymphoma Ann Arbor Stage II Noncutaneous Anaplastic Large Cell Lymphoma C0854823 CTRP Malignant Stage_II_Anaplastic_Large_Cell_Lymphoma Anaplastic Large Cell Lymphoma Stage II Anaplastic Large Cell Lymphoma T- and Null-Cell Types Stage II Ann Arbor Stage II Anaplastic Large Cell Lymphoma Ann Arbor Stage II Noncutaneous Anaplastic Large Cell Lymphoma Stage II Anaplastic Large Cell Lymphoma Ann Arbor Stage II Noncutaneous Anaplastic Large Cell Lymphoma Ann Arbor Classification. Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8661 Neoplastic Process Ann Arbor Stage III Noncutaneous Anaplastic Large Cell Lymphoma Ann Arbor Stage III Noncutaneous Anaplastic Large Cell Lymphoma C0854824 CTRP Malignant Stage_III_Anaplastic_Large_Cell_Lymphoma Anaplastic Large Cell Lymphoma Stage III Anaplastic Large Cell Lymphoma T- and Null-Cell Types Stage III Ann Arbor Stage III Anaplastic Large Cell Lymphoma Ann Arbor Stage III Noncutaneous Anaplastic Large Cell Lymphoma Stage III Anaplastic Large Cell Lymphoma Ann Arbor Stage III Noncutaneous Anaplastic Large Cell Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8662 Neoplastic Process Ann Arbor Stage IV Noncutaneous Anaplastic Large Cell Lymphoma Ann Arbor Stage IV Noncutaneous Anaplastic Large Cell Lymphoma C0854825 CTRP Malignant Stage_IV_Anaplastic_Large_Cell_Lymphoma Anaplastic Large Cell Lymphoma Stage IV Anaplastic Large Cell Lymphoma T- and Null-Cell Types Stage IV Ann Arbor Stage IV Anaplastic Large Cell Lymphoma Ann Arbor Stage IV Noncutaneous Anaplastic Large Cell Lymphoma Stage IV Anaplastic Large Cell Lymphoma Ann Arbor Stage IV Noncutaneous Anaplastic Large Cell Lymphoma The reemergence of T-cell non-Hodgkin lymphoma after a period of remission. C8663 Neoplastic Process Recurrent T-Cell Non-Hodgkin Lymphoma Recurrent T-Cell Non-Hodgkin Lymphoma C0854826 CTRP Malignant Recurrent_T-Cell_Non-Hodgkin_s_Lymphoma Recurrent T-Cell Lymphoma Recurrent T-Cell Non-Hodgkin Lymphoma Recurrent T-Cell Non-Hodgkin's Lymphoma Recurrent T-Cell and NK-Cell Non-Hodgkin's Lymphoma Relapsed T-Cell Lymphoma T-Cell Lymphoma Recurrent T-Cell Lymphoma Relapsed Recurrent T-Cell Non-Hodgkin Lymphoma T-cell non-Hodgkin lymphoma that is resistant to treatment. C8664 Neoplastic Process Refractory T-Cell Non-Hodgkin Lymphoma Refractory T-Cell Non-Hodgkin Lymphoma C0854827 CTRP Malignant Refractory_T-Cell_Non-Hodgkin_s_Lymphoma Refractory T-Cell Lymphoma Refractory T-Cell Non-Hodgkin Lymphoma Refractory T-Cell Non-Hodgkin's Lymphoma Refractory T-Cell and NK-Cell Non-Hodgkin's Lymphoma T-Cell Lymphoma Refractory Refractory T-Cell Non-Hodgkin Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8665 Neoplastic Process Ann Arbor Stage I T-Cell Non-Hodgkin Lymphoma C0854828 Malignant Stage_I_T-Cell_Non-Hodgkin_s_Lymphoma Ann Arbor Stage I T-Cell Non-Hodgkin Lymphoma Stage I T Cell Lymphoma Stage I T-Cell Lymphoma Stage I T-Cell Non-Hodgkin Lymphoma Stage I T-Cell Non-Hodgkin's Lymphoma T Cell Lymphoma Stage I T-Cell Lymphoma Stage I Ann Arbor Stage I T-Cell Non-Hodgkin Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). The number of regions involved may be indicated by a subscript (e.g., II3). C8666 Neoplastic Process Ann Arbor Stage II T-Cell Non-Hodgkin Lymphoma C0854829 Malignant Stage_II_T-Cell_Non-Hodgkin_s_Lymphoma Ann Arbor Stage II T-Cell Non-Hodgkin Lymphoma Stage II T Cell Lymphoma Stage II T-Cell Lymphoma Stage II T-Cell Non-Hodgkin Lymphoma Stage II T-Cell Non-Hodgkin's Lymphoma T Cell Lymphoma Stage II T-Cell Lymphoma Stage II Ann Arbor Stage II T-Cell Non-Hodgkin Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8667 Neoplastic Process Ann Arbor Stage III T-Cell Non-Hodgkin Lymphoma C0854830 Malignant Stage_III_T-Cell_Non-Hodgkin_s_Lymphoma Ann Arbor Stage III T-Cell Non-Hodgkin Lymphoma Stage III T Cell Lymphoma Stage III T-Cell Lymphoma Stage III T-Cell Non-Hodgkin Lymphoma Stage III T-Cell Non-Hodgkin's Lymphoma T Cell Lymphoma Stage III T-Cell Lymphoma Stage III Ann Arbor Stage III T-Cell Non-Hodgkin Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8668 Neoplastic Process Ann Arbor Stage IV T-Cell Non-Hodgkin Lymphoma C0854831 Malignant Stage_IV_T-Cell_Non-Hodgkin_s_Lymphoma Ann Arbor Stage IV T-Cell Non-Hodgkin Lymphoma Stage IV T Cell Lymphoma Stage IV T-Cell Lymphoma Stage IV T-Cell Non-Hodgkin Lymphoma Stage IV T-Cell Non-Hodgkin's Lymphoma T Cell Lymphoma Stage IV T-Cell Lymphoma Stage IV Ann Arbor Stage IV T-Cell Non-Hodgkin Lymphoma Nasal type extranodal NK/T-cell lymphoma that does not respond to treatment. C8669 Neoplastic Process Refractory Nasal Type Extranodal NK/T-Cell Lymphoma Refractory Nasal Type Extranodal NK/T-Cell Lymphoma C0854832 CTRP Malignant Refractory_Nasal_Type_Extranodal_NK_T-Cell_Lymphoma Angiocentric Lymphoma Refractory Refractory Angiocentric Lymphoma Refractory Nasal Type Extranodal NK/T-Cell Lymphoma Refractory Nasal/Nasal Type T/NK-Cell Lymphoma Refractory Nasal Type Extranodal NK/T-Cell Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8670 Neoplastic Process Ann Arbor Stage I Nasal Type NK/T-Cell Lymphoma Ann Arbor Stage I Nasal Type NK/T-Cell Lymphoma C0854833 CTRP Malignant Stage_I_Nasal_Type_NK_T-Cell_Lymphoma Angiocentric Lymphoma Stage I Ann Arbor Stage I Nasal Type NK/T-Cell Lymphoma Stage I Angiocentric Lymphoma Stage I Nasal Type NK/T-Cell Lymphoma Ann Arbor Stage I Nasal Type NK/T-Cell Lymphoma Follicular helper T-cell lymphoma, angioimmunoblastic-type that is resistant to treatment. C8671 Neoplastic Process Refractory Angioimmunoblastic T-Cell Lymphoma Refractory Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type C0854834 CTRP Malignant Refractory_Angioimmunoblastic_T-cell_Lymphoma Angioimmunoblastic T-Cell Lymphoma Refractory Refractory Angioimmunoblastic T-Cell Lymphoma Refractory Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type Refractory Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8672 Neoplastic Process Ann Arbor Stage I Angioimmunoblastic T-Cell Lymphoma Ann Arbor Stage I Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type C0854835 CTRP Malignant Stage_I_Angioimmunoblastic_T-cell_Lymphoma Angioimmunoblastic T-Cell Lymphoma Stage I Ann Arbor Stage I Angioimmunoblastic T-Cell Lymphoma Ann Arbor Stage I Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type Stage I Angioimmunoblastic T-Cell Lymphoma Ann Arbor Stage I Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8673 Neoplastic Process Ann Arbor Stage II Nasal Type NK/T-Cell Lymphoma Ann Arbor Stage II Nasal Type NK/T-Cell Lymphoma C0854836 CTRP Malignant Stage_II_Nasal_Type_NK_T-Cell_Lymphoma Angiocentric Lymphoma Stage II Ann Arbor Stage II Nasal Type NK/T-Cell Lymphoma Stage II Angiocentric Lymphoma Stage II Nasal Type NK/T-Cell Lymphoma Ann Arbor Stage II Nasal Type NK/T-Cell Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8674 Neoplastic Process Ann Arbor Stage III Nasal Type NK/T-Cell Lymphoma Ann Arbor Stage III Nasal Type NK/T-Cell Lymphoma C0854837 CTRP Malignant Stage_III_Nasal_Type_NK_T-Cell_Lymphoma Angiocentric Lymphoma Stage III Ann Arbor Stage III Nasal Type NK/T-Cell Lymphoma Stage III Angiocentric Lymphoma Stage III Nasal Type NK/T-Cell Lymphoma Ann Arbor Stage III Nasal Type NK/T-Cell Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8675 Neoplastic Process Ann Arbor Stage IV Nasal Type NK/T-Cell Lymphoma Ann Arbor Stage IV Nasal Type NK/T-Cell Lymphoma C0854838 CTRP Malignant Stage_IV_Nasal_Type_NK_T-Cell_Lymphoma Angiocentric Lymphoma Stage IV Ann Arbor Stage IV Nasal Type NK/T-Cell Lymphoma Stage IV Angiocentric Lymphoma Stage IV Nasal Type NK/T-Cell Lymphoma Ann Arbor Stage IV Nasal Type NK/T-Cell Lymphoma The reemergence of follicular helper T-cell lymphoma, angioimmunoblastic-type after a period of remission C8676 Neoplastic Process Recurrent Angioimmunoblastic T-Cell Lymphoma Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type C0854839 CTRP Malignant Recurrent_Angioimmunoblastic_T-cell_Lymphoma Recurrent Angioimmunoblastic T-Cell Lymphoma Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type Relapsed Angioimmunoblastic T-Cell Lymphoma Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8677 Neoplastic Process Ann Arbor Stage II Angioimmunoblastic T-Cell Lymphoma Ann Arbor Stage II Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type C0854840 CTRP Malignant Stage_II_Angioimmunoblastic_T-cell_Lymphoma Angioimmunoblastic T-Cell Lymphoma Stage II Ann Arbor Stage II Angioimmunoblastic T-Cell Lymphoma Ann Arbor Stage II Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type Stage II Angioimmunoblastic T-Cell Lymphoma Ann Arbor Stage II Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8678 Neoplastic Process Ann Arbor Stage III Angioimmunoblastic T-Cell Lymphoma Ann Arbor Stage III Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type C0854841 CTRP Malignant Stage_III_Angioimmunoblastic_T-cell_Lymphoma Angioimmunoblastic T-Cell Lymphoma Stage III Ann Arbor Stage III Angioimmunoblastic T-Cell Lymphoma Ann Arbor Stage III Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type Stage III Angioimmunoblastic T-Cell Lymphoma Ann Arbor Stage III Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8679 Neoplastic Process Ann Arbor Stage IV Angioimmunoblastic T-Cell Lymphoma Ann Arbor Stage IV Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type C0854842 CTRP Malignant Stage_IV_Angioimmunoblastic_T-cell_Lymphoma Angioimmunoblastic T-Cell Lymphoma Stage IV Ann Arbor Stage IV Angioimmunoblastic T-Cell Lymphoma Ann Arbor Stage IV Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type Stage IV Angioimmunoblastic T-Cell Lymphoma Ann Arbor Stage IV Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type The reemergence of enteropathy-associated T-cell lymphoma after a period of remission. C8680 Neoplastic Process Recurrent Enteropathy-Associated T-Cell Lymphoma Recurrent Enteropathy-Associated T-Cell Lymphoma C0854843 CTRP Malignant Recurrent_Enteropathy-type_T-Cell_Lymphoma Recurrent Enteropathy-Associated T-Cell Lymphoma Recurrent Intestinal T-Cell Lymphoma Relapsed Intestinal T-Cell Lymphoma Recurrent Enteropathy-Associated T-Cell Lymphoma Enteropathy-associated T-cell lymphoma that is resistant to treatment. C8681 Neoplastic Process Refractory Enteropathy-Associated T-Cell Lymphoma Refractory Enteropathy-Associated T-Cell Lymphoma C0854844 CTRP Malignant Refractory_Enteropathy-type_T-Cell_Lymphoma Intestinal T-Cell Lymphoma Refractory Refractory Enteropathy-Associated T-Cell Lymphoma Refractory Intestinal T-Cell Lymphoma Refractory Enteropathy-Associated T-Cell Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8682 Neoplastic Process Ann Arbor Stage I Enteropathy-Associated T-Cell Lymphoma Ann Arbor Stage I Enteropathy-Associated T-Cell Lymphoma C0854845 CTRP Malignant Stage_I_Enteropathy-type_T-Cell_Lymphoma Ann Arbor Stage I Enteropathy-Associated T-Cell Lymphoma Intestinal T-Cell Lymphoma Stage I Stage I Enteropathy-Associated T-Cell Lymphoma Stage I Enteropathy-type T-Cell Lymphoma Stage I Intestinal T-Cell Lymphoma Ann Arbor Stage I Enteropathy-Associated T-Cell Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8683 Neoplastic Process Ann Arbor Stage II Enteropathy-Associated T-Cell Lymphoma Ann Arbor Stage II Enteropathy-Associated T-Cell Lymphoma C0854846 CTRP Malignant Stage_II_Enteropathy-type_T-Cell_Lymphoma Ann Arbor Stage II Enteropathy-Associated T-Cell Lymphoma Intestinal T-Cell Lymphoma Stage II Stage II Enteropathy-Associated T-Cell Lymphoma Stage II Enteropathy-type T-Cell Lymphoma Stage II Intestinal T-Cell Lymphoma Ann Arbor Stage II Enteropathy-Associated T-Cell Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8684 Neoplastic Process Ann Arbor Stage III Enteropathy-Associated T-Cell Lymphoma Ann Arbor Stage III Enteropathy-Associated T-Cell Lymphoma C0854847 CTRP Malignant Stage_III_Enteropathy-type_T-Cell_Lymphoma Ann Arbor Stage III Enteropathy-Associated T-Cell Lymphoma Intestinal T-Cell Lymphoma Stage III Stage III Enteropathy-Associated T-Cell Lymphoma Stage III Enteropathy-type T-Cell Lymphoma Stage III Intestinal T-Cell Lymphoma Ann Arbor Stage III Enteropathy-Associated T-Cell Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8685 Neoplastic Process Ann Arbor Stage IV Enteropathy-Associated T-Cell Lymphoma Ann Arbor Stage IV Enteropathy-Associated T-Cell Lymphoma C0854848 CTRP Malignant Stage_IV_Enteropathy-type_T-Cell_Lymphoma Ann Arbor Stage IV Enteropathy-Associated T-Cell Lymphoma Intestinal T-Cell Lymphoma Stage IV Stage IV Enteropathy-Associated T-Cell Lymphoma Stage IV Enteropathy-type T-Cell Lymphoma Stage IV Intestinal T-Cell Lymphoma Ann Arbor Stage IV Enteropathy-Associated T-Cell Lymphoma The reemergence of mycosis fungoides after a period of remission. C8686 Neoplastic Process Recurrent Mycosis Fungoides Recurrent Mycosis Fungoides C0854849 CTRP Malignant Recurrent_Mycosis_Fungoides Mycosis Fungoides Recurrent Mycosis Fungoides Relapsed Recurrent Mycosis Fungoides Relapsed Mycosis Fungoides Recurrent Mycosis Fungoides Mycosis fungoides resistant to treatment. C8687 Neoplastic Process Refractory Mycosis Fungoides Refractory Mycosis Fungoides C0854850 CTRP Malignant Refractory_Mycosis_Fungoides Mycosis Fungoides Refractory Refractory Mycosis Fungoides Refractory Mycosis Fungoides The reemergence of mature T-cell and NK-cell non-Hodgkin lymphoma after a period of remission. C8688 Neoplastic Process Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma C0854851 CTRP Malignant Recurrent_Mature_T-and_NK-Cell_Non-Hodgkin_s_Lymphoma Recurrent Mature T- and NK-Cell Lymphoma Recurrent Mature T- and NK-Cell Non-Hodgkin's Lymphoma Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Recurrent Peripheral T-cell Lymphoma Relapsed Peripheral T-cell Lymphoma Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Mature T-cell and NK-cell non-Hodgkin lymphoma that is resistant to treatment. C8689 Neoplastic Process Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma C1335727 CTRP Malignant Refractory_Mature_T-Cell_and_NK-Cell_Non-Hodgkin_s_Lymphoma Peripheral T-Cell Lymphoma Refractory Refractory Mature T- and NK-Cell Lymphoma Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Refractory Mature T-Cell and NK-Cell Non-Hodgkin's Lymphoma Refractory Peripheral T-cell Lymphoma Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8690 Neoplastic Process Ann Arbor Stage I Mature T- and NK-Cell Lymphoma C0854853 Malignant Stage_I_Mature_T-and_NK-Cell_Lymphoma Ann Arbor Stage I Mature T- and NK-Cell Lymphoma Peripheral T-cell Lymphoma Stage I Stage I Mature T- and NK-Cell Lymphoma Stage I Peripheral T-cell Lymphoma Ann Arbor Stage I Mature T- and NK-Cell Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). The number of regions involved may be indicated by a subscript (e.g., II3). C8691 Neoplastic Process Ann Arbor Stage II Mature T- and NK-Cell Lymphoma C0854854 Malignant Stage_II_Mature_T-and_NK-Cell_Lymphoma Ann Arbor Stage II Mature T- and NK-Cell Lymphoma Peripheral T-Cell Lymphoma Stage II Stage II Mature T- and NK-Cell Lymphoma Stage II Peripheral T-cell Lymphoma Ann Arbor Stage II Mature T- and NK-Cell Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8692 Neoplastic Process Ann Arbor Stage III Mature T- and NK-Cell Lymphoma C0854855 Malignant Stage_III_Mature_T-and_NK-Cell_Lymphoma Ann Arbor Stage III Mature T- and NK-Cell Lymphoma Peripheral T-Cell Lymphoma Stage III Stage III Mature T- and NK-Cell Lymphoma Stage III Peripheral T-cell Lymphoma Ann Arbor Stage III Mature T- and NK-Cell Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8693 Neoplastic Process Ann Arbor Stage IV Mature T- and NK-Cell Lymphoma C0854856 Malignant Stage_IV_Mature_T-and_NK-Cell_Lymphoma Ann Arbor Stage IV Mature T- and NK-Cell Lymphoma Peripheral T-Cell Lymphoma Stage IV Stage IV Mature T- and NK-Cell Lymphoma Stage IV Peripheral T-cell Lymphoma Ann Arbor Stage IV Mature T- and NK-Cell Lymphoma A neoplasm of lymphoblasts committed to the T-cell lineage, typically composed of small to medium-sized blast cells. When the neoplasm involves predominantly the bone marrow and the peripheral blood, it is called T acute lymphoblastic leukemia. When it involves nodal or extranodal sites it is called T lymphoblastic lymphoma. (WHO, 2001) C8694 Neoplastic Process T Lymphoblastic Leukemia/Lymphoma T Lymphoblastic Leukemia/Lymphoma C1301359 CTRP GDC 9837/3 Malignant Precursor_T_Lymphoblastic_Leukemia_Lymphoma 9837/3 T lymphoblastic leukemia/lymphoma Precursor T Lymphoblastic Leukemia/Lymphoma Precursor T Lymphoblastic Lymphoma/Leukemia Precursor T-Lymphoblastic Lymphoma/Leukemia T Lymphoblastic Leukemia/Lymphoma T lymphoblastic leukemia/lymphoma T-Cell Lymphoblastic Leukemia/Lymphoma T-Lymphoblastic Leukemia/Lymphoma T Lymphoblastic Leukemia/Lymphoma The reemergence of T-lymphoblastic leukemia/lymphoma after a period of remission. C8695 Neoplastic Process Recurrent T Lymphoblastic Leukemia/Lymphoma Recurrent T Lymphoblastic Leukemia/Lymphoma C0854858 CTRP Malignant Recurrent_Precursor_T_Lymphoblastic_Lymphoma_Leukemia Recurrent Precursor T-Lymphoblastic Lymphoma/Leukemia Recurrent T Lymphoblastic Leukemia/Lymphoma Recurrent T-Lymphoblastic Leukemia/Lymphoma Relapsed Precursor T Lymphoblastic Lymphoma/Leukemia Recurrent T Lymphoblastic Leukemia/Lymphoma T-lymphoblastic leukemia/lymphoma that is resistant to treatment C8696 Neoplastic Process Refractory T Lymphoblastic Leukemia/Lymphoma Refractory T Lymphoblastic Leukemia/Lymphoma C0854859 CTRP Malignant Refractory_Precursor_T_Lymphoblastic_Lymphoma_Leukemia Precursor T Lymphoblastic Lymphoma/Leukemia Refractory Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia Refractory T Lymphoblastic Leukemia/Lymphoma Refractory T-Lymphoblastic Leukemia/Lymphoma Refractory T Lymphoblastic Leukemia/Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE) (Rare in Hodgkin lymphoma). C8697 Neoplastic Process Stage I T Lymphoblastic Leukemia/Lymphoma Stage I T Lymphoblastic Leukemia/Lymphoma C0854860 CTRP Malignant Stage_I_Precursor_T-Lymphoblastic_Lymphoma_Leukemia Precursor T-Lymphoblastic Lymphoma/Leukemia Stage I Stage I Precursor T-Lymphoblastic Lymphoma/Leukemia Stage I T Lymphoblastic Leukemia/Lymphoma Stage I T-Lymphoblastic Leukemia/Lymphoma Stage I T Lymphoblastic Leukemia/Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in a with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8698 Neoplastic Process Stage II T Lymphoblastic Leukemia/Lymphoma Stage II T Lymphoblastic Leukemia/Lymphoma C0854861 CTRP Malignant Stage_II_Precursor_T-Lymphoblastic_Lymphoma_Leukemia Precursor T-Lymphoblastic Lymphoma/Leukemia Stage II Stage II Precursor T-Lymphoblastic Lymphoma/Leukemia Stage II T Lymphoblastic Leukemia/Lymphoma Stage II T-Lymphoblastic Leukemia/Lymphoma Stage II T Lymphoblastic Leukemia/Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8699 Neoplastic Process Stage III T Lymphoblastic Leukemia/Lymphoma Stage III T Lymphoblastic Leukemia/Lymphoma C0854862 CTRP Malignant Stage_III_Precursor_T-Lymphoblastic_Lymphoma_Leukemia Precursor T-Lymphoblastic Lymphoma/Leukemia Stage III Stage III Precursor T-Lymphoblastic Lymphoma/Leukemia Stage III T Lymphoblastic Leukemia/Lymphoma Stage III T-Lymphoblastic Leukemia/Lymphoma Stage III T Lymphoblastic Leukemia/Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, or nodular involvement of the lungs(s). C8700 Neoplastic Process Stage IV T Lymphoblastic Leukemia/Lymphoma Stage IV T Lymphoblastic Leukemia/Lymphoma C0854864 CTRP Malignant Stage_IV_Precursor_T-Lymphoblastic_Lymphoma_Leukemia Precursor T-Lymphoblastic Lymphoma/Leukemia Stage IV Stage IV Precursor T-Lymphoblastic Lymphoma/Leukemia Stage IV T Lymphoblastic Leukemia/Lymphoma Stage IV T-Lymphoblastic Leukemia/Lymphoma Stage IV T Lymphoblastic Leukemia/Lymphoma Stage IIIA includes: (T1/T2, N1a/N1b, M0); T1: Invasive vulvar cancer confined to the vulva or perineum. T2: Vulvar cancer with tumor of any size with extension to adjacent perineal structures (lower/distal 1/3 urethra, lower/distal 1/3 vagina, anal involvement). N1a: Vulvar cancer with one or two lymph node metastasis each measuring 5 mm or less. N1b: Vulvar cancer with one lymph node metastasis measuring 5 mm or greater. M0: No distant metastasis. (AJCC 7th ed.) C87003 Neoplastic Process Stage IIIA Vulvar Cancer AJCC v7 Stage IIIA Vulvar Cancer AJCC v7 C2828099 CTRP Malignant Stage IIIA Vulvar Cancer Stage IIIA Vulvar Cancer AJCC v7 Stage IIIA Vulvar Carcinoma Stage IIIA Vulvar Carcinoma AJCC v7 Stage IIIA Vulvar Cancer AJCC v7 Stage IIIB includes: (T1/T2, N2a/N2b, M0). T1: Invasive vulvar cancer confined to the vulva or perineum. T2: Vulvar cancer with tumor of any size with extension to adjacent perineal structures (lower/distal 1/3 urethra, lower/distal 1/3 vagina, anal involvement). N2a: Vulvar cancer with three or more lymph node metastases each measuring 5 mm or less. N2b: Vulvar cancer with two or more lymph node metastases measuring 5 mm or greater. M0: No distant metastasis. (AJCC 7th ed.) C87004 Neoplastic Process Stage IIIB Vulvar Cancer AJCC v7 Stage IIIB Vulvar Cancer AJCC v7 C2828100 CTRP Malignant Stage IIIB Vulvar Cancer Stage IIIB Vulvar Cancer AJCC v7 Stage IIIB Vulvar Carcinoma Stage IIIB Vulvar Carcinoma AJCC v7 Stage IIIB Vulvar Cancer AJCC v7 Stage IIIC includes: (T1/T2, N2c, M0). T1: Invasive vulvar cancer confined to the vulva or perineum. T2: Vulvar cancer with tumor of any size with extension to adjacent perineal structures (lower/distal 1/3 urethra, lower/distal 1/3 vagina, anal involvement). N2c: Vulvar cancer with lymph node metastasis with extracapsular spread. M0: No distant metastasis. (AJCC 7th ed.) C87005 Neoplastic Process Stage IIIC Vulvar Cancer AJCC v7 Stage IIIC Vulvar Cancer AJCC v7 C2828101 CTRP Malignant Stage IIIC Vulvar Cancer Stage IIIC Vulvar Cancer AJCC v7 Stage IIIC Vulvar Carcinoma Stage IIIC Vulvar Carcinoma AJCC v7 Stage IIIC Vulvar Cancer AJCC v7 A non-Hodgkin lymphoma which does not respond to treatment. C8701 Neoplastic Process Refractory Non-Hodgkin Lymphoma C0854867 Malignant Refractory_Non-Hodgkin_s_Lymphoma Non-Hodgkin's Lymphoma Refractory NonHodgkin's Lymphoma Refractory Refractory Non-Hodgkin Lymphoma Refractory Non-Hodgkin's Lymphoma Refractory Non-Hodgkin Lymphoma The reemergence of non-Hodgkin lymphoma transformed after a period of remission. C8702 Neoplastic Process Transformed Recurrent Non-Hodgkin Lymphoma Recurrent Transformed Non-Hodgkin Lymphoma C0854868 CTRP Malignant Transformed_Recurrent_Non-Hodgkin_s_Lymphoma Non-Hodgkin's Lymphoma Transformed Recurrent NonHodgkin's Lymphoma Transformed Recurrent Recurrent Transformed Non-Hodgkin Lymphoma Transformed Lymphoma Transformed Recurrent Non-Hodgkin Lymphoma Transformed Recurrent Non-Hodgkin's Lymphoma Recurrent Transformed Non-Hodgkin Lymphoma A malignant mesothelioma extensively involving the pericardium. C8703 Neoplastic Process Advanced Pericardial Malignant Mesothelioma C0854883 Malignant Advanced_Malignant_Pericardial_Mesothelioma Advanced Pericardial Malignant Mesothelioma Pericardial Mesothelioma Malignant Advanced Advanced Pericardial Malignant Mesothelioma A malignant mesothelioma that arises from the peritoneum and has spread in the abdominal cavity. It may result in bowel obstruction. C8704 Neoplastic Process Advanced Peritoneal Malignant Mesothelioma Advanced Peritoneal Malignant Mesothelioma C0854886 CTRP Malignant Advanced_Malignant_Peritoneal_Mesothelioma Advanced Malignant Mesothelioma of Peritoneum Advanced Malignant Mesothelioma of the Peritoneum Advanced Peritoneal Malignant Mesothelioma Malignant Peritoneal Mesothelioma, Advanced Advanced Peritoneal Malignant Mesothelioma The reemergence of malignant peritoneal mesothelioma after a period of remission. C8705 Neoplastic Process Recurrent Peritoneal Malignant Mesothelioma C0854888 Malignant Recurrent_Malignant_Peritoneal_Mesothelioma Malignant Peritoneal Mesothelioma Recurrent Recurrent Malignant Mesothelioma of Peritoneum Recurrent Malignant Mesothelioma of the Peritoneum Recurrent Peritoneal Malignant Mesothelioma Relapsed Malignant Mesothelioma of Peritoneum Relapsed Malignant Mesothelioma of the Peritoneum Relapsed Malignant Peritoneal Mesothelioma Recurrent Peritoneal Malignant Mesothelioma A squamous cell carcinoma that arises from the oropharynx and is associated with human papillomavirus type 16 infection. C87055 Neoplastic Process Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus-Related Squamous Cell Carcinoma C2828150 CTRP Malignant HPV-Associated Oropharyngeal Squamous Cell Carcinoma HPV-Positive Oropharyngeal Squamous Cell Carcinoma Human Papilloma Virus Associated Oropharyngeal Squamous Cell Carcinoma Human Papilloma Virus Positive Oropharyngeal Squamous Cell Carcinoma Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma Oropharyngeal HPV-Associated Squamous Cell Carcinoma Oropharyngeal HPV-Positive Squamous Cell Carcinoma Oropharyngeal HPV-Related Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus Positive Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus-Associated Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus-Related Squamous Cell Carcinoma Oropharyngeal Human Papillomavirus-Related Squamous Cell Carcinoma Malignant mesothelioma that arises from the pleura and is classified as stage II, stage III, or stage IV. C8706 Neoplastic Process Advanced Pleural Malignant Mesothelioma Advanced Pleural Malignant Mesothelioma C0854889 CTRP Malignant Advanced_Malignant_Pleural_Mesothelioma Advanced Malignant Mesothelioma of Pleura Advanced Malignant Mesothelioma of the Pleura Advanced Pleural Malignant Mesothelioma Malignant Pleural Mesothelioma, Advanced Advanced Pleural Malignant Mesothelioma The reemergence of pleural malignant mesothelioma after a period of remission. C8707 Neoplastic Process Recurrent Pleural Malignant Mesothelioma C0854891 Malignant Recurrent_Malignant_Pleural_Mesothelioma Malignant Pleural Mesothelioma Recurrent Recurrent Pleural Malignant Mesothelioma Relapsed Malignant Mesothelioma of Pleura Relapsed Malignant Mesothelioma of the Pleura Relapsed Malignant Pleural Mesothelioma Recurrent Pleural Malignant Mesothelioma An angiosarcoma that has spread to another anatomical site. C8708 Neoplastic Process Metastatic Angiosarcoma C0854892 Malignant Metastatic_Angiosarcoma Metastatic Angiosarcoma Metastatic Hemangiosarcoma Metastatic Angiosarcoma A germinoma that arises from the pineal gland. C8712 Neoplastic Process Pineal Region Germinoma C0854912 Cellosaurus A type of germ cell tumor that is found in the pineal gland in the brain. Symptoms of pineal germinomas include headaches, changes in vision, nausea, and vomiting. Malignant Pineal_Germinoma Pineal Germinoma Pineal Region Germinoma germinoma Pineal Region Germinoma Retinoblastoma involving both eyes. This occurs in the majority of patients with the inherited variant. A minority of patient with bilateral retinoblastoma were found to have involvement of the pineal gland as well. C8713 Neoplastic Process Bilateral Retinoblastoma C0854914 Cellosaurus Malignant Bilateral_Retinoblastoma Bilateral Retinoblastoma Bilateral Retinoblastoma Stage IA includes: T1a, N0, M0. T1a: For leiomyosarcoma and endometrial stromal sarcoma: tumor 5 cm or less in greatest dimension. For adenosarcoma: tumor limited to endometrium/endocervix. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87132 Neoplastic Process Stage IA Uterine Sarcoma AJCC v7 Stage IA Uterine Sarcoma AJCC v7 C2219531 CTRP Malignant Stage IA Uterine Sarcoma Stage IA Uterine Sarcoma AJCC v7 Stage IA Uterine Sarcoma AJCC v7 Stage IB includes: T1b, N0, M0. T1b: For leiomyosarcoma and endometrial stromal sarcoma: tumor more than 5 cm in greatest dimension. For adenosarcoma: tumor invades to less than half of the myometrium. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87133 Neoplastic Process Stage IB Uterine Sarcoma AJCC v7 Stage IB Uterine Sarcoma AJCC v7 C2219532 CTRP Malignant Stage IB Uterine Sarcoma Stage IB Uterine Sarcoma AJCC v7 Stage IB Uterine Sarcoma AJCC v7 Stage IC includes: T1c, N0, M0. T1c: For adenosarcoma: tumor invades more than half of the myometrium. N0: No regional lymph node metastasis. M0: No distant metastasis. Stage IC does not apply for leiomyosarcoma and endometrial stromal sarcoma. (AJCC 7th ed.) C87134 Neoplastic Process Stage IC Uterine Sarcoma AJCC v7 Stage IC Uterine Sarcoma AJCC v7 C2219533 CTRP Malignant Stage IC Uterine Sarcoma Stage IC Uterine Sarcoma AJCC v7 Stage IC Uterine Sarcoma AJCC v7 Stage IIIA includes: T3a, N0, M0. T3a: Tumor infiltrates abdominal tissues, one side. N0: No regional lymph node metastasis. M0: No distant metastasis. This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.) C87135 Neoplastic Process Stage IIIA Uterine Sarcoma AJCC v7 Stage IIIA Uterine Sarcoma AJCC v7 C2219536 CTRP Malignant Stage IIIA Uterine Sarcoma Stage IIIA Uterine Sarcoma AJCC v7 Stage IIIA Uterine Sarcoma AJCC v7 Stage IIIB includes: T3b, N0, M0. T3b: Tumor infiltrates abdominal tissues, more than one side. N0: No regional lymph node metastasis. M0: No distant metastasis. This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.) C87137 Neoplastic Process Stage IIIB Uterine Sarcoma AJCC v7 Stage IIIB Uterine Sarcoma AJCC v7 C2219537 CTRP Malignant Stage IIIB Uterine Sarcoma Stage IIIB Uterine Sarcoma AJCC v7 Stage IIIB Uterine Sarcoma AJCC v7 Stage IIIC includes: T1-T3, N1, M0. T1: Tumor limited to the uterus. T2: Tumor extends beyond the uterus, within the pelvis. T3: Tumor infiltrates abdominal tissues. N1: Regional lymph node metastasis. M0: No distant metastasis. This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.) C87138 Neoplastic Process Stage IIIC Uterine Sarcoma AJCC v7 Stage IIIC Uterine Sarcoma AJCC v7 C2828179 CTRP Malignant Stage IIIC Uterine Sarcoma Stage IIIC Uterine Sarcoma AJCC v7 Stage IIIC Uterine Sarcoma AJCC v7 A retinoblastoma that only involves a single eye. C8714 Neoplastic Process Unilateral Retinoblastoma C0854915 Cellosaurus Malignant Unilateral_Retinoblastoma Unilateral Retinoblastoma Unilateral Retinoblastoma Stage IVA includes: T4, Any N, M0. T4: Tumor involves bladder or rectum. M0: No distant metastasis. This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.) C87140 Neoplastic Process Stage IVA Uterine Sarcoma AJCC v7 Stage IVA Uterine Sarcoma AJCC v7 C2219538 CTRP Malignant Stage IVA Uterine Sarcoma Stage IVA Uterine Sarcoma AJCC v7 Stage IVA Uterine Sarcoma AJCC v7 Stage IVB includes: Any T, Any N, M1. M1: Distal metastasis (excluding adnexa, pelvic and abdominal tissues). This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.) C87144 Neoplastic Process Stage IVB Uterine Sarcoma AJCC v7 Stage IVB Uterine Sarcoma AJCC v7 C2219539 CTRP Malignant Stage IVB Uterine Sarcoma Stage IVB Uterine Sarcoma AJCC v7 Stage IVB Uterine Sarcoma AJCC v7 A rhabdoid tumor that arises from the kidney. It occurs in children and it is associated with abnormalities of chromosome 22. It is characterized by the presence of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm. The prognosis is poor. C8715 Neoplastic Process Rhabdoid Tumor of the Kidney Rhabdoid Tumor of the Kidney C0854917 CTEP CTRP Cellosaurus GDC NICHD A rhabdoid tumor that arises in the kidney. Malignant Rhabdoid_Tumour_of_the_Kidney Rhabdoid tumor (kidney) (RT) Kidney Rhabdoid Tumor MRTK Malignant Rhabdoid Tumor of Kidney Malignant Rhabdoid Tumor of the Kidney Renal Rhabdoid Neoplasm Renal Rhabdoid Tumor Rhabdoid Neoplasm of Kidney Rhabdoid Neoplasm of the Kidney Rhabdoid Tumor of the Kidney Rhabdoid Tumor of the Kidney (RTK) Rhabdoid Tumour of Kidney Rhabdoid Tumour of the Kidney Rhabdoid tumor (kidney) (RT) Rhabdoid tumor of the kidney Rhabdoid Tumor of the Kidney Stage I includes: (T1, M0, Risk factors: unknown); IA (T1, M0, Risk factors: low risk); IB (T1, M0, Risk factors: high risk). T1: Tumor confined to uterus. M0: No distant metastasis. (AJCC 7th ed.) C87150 Neoplastic Process Stage I Gestational Trophoblastic Tumor Stage I Gestational Trophoblastic Tumor AJCC v7 C2828182 CTRP Undetermined Stage I Gestational Trophoblastic Tumor Stage I Gestational Trophoblastic Tumor AJCC v7 Stage I Gestational Trophoblastic Tumor AJCC v7 Stage IA includes: T1, M0, Risk factors: low risk. T1: Tumor confined to uterus. M0: No distant metastasis. (AJCC 7th ed.) C87151 Neoplastic Process Stage IA Gestational Trophoblastic Tumor AJCC v7 Stage IA Gestational Trophoblastic Tumor AJCC v7 C2828183 CTRP Undetermined Stage IA Gestational Trophoblastic Tumor Stage IA Gestational Trophoblastic Tumor AJCC v7 Stage IA Gestational Trophoblastic Tumor AJCC v7 Stage IB includes: T1, M0, Risk factors: high risk. T1: Tumor confined to uterus. M0: No distant metastasis. (AJCC 7th ed.) C87152 Neoplastic Process Stage IB Gestational Trophoblastic Tumor AJCC v7 Stage IB Gestational Trophoblastic Tumor AJCC v7 C2828184 CTRP Undetermined Stage IB Gestational Trophoblastic Tumor Stage IB Gestational Trophoblastic Tumor AJCC v7 Stage IB Gestational Trophoblastic Tumor AJCC v7 Stage II includes: (T2, M0, Risk factors: unknown); IIA (T2, M0, Risk factors: low risk); IIB (T2, M0, Risk factors: high risk). T2: Tumor extends to other genital structures (ovary, tube, vagina, broad ligaments) by metastasis or direct extension. M0: No distant metastasis. (AJCC 7th ed.) C87153 Neoplastic Process Stage II Gestational Trophoblastic Tumor AJCC v7 Stage II Gestational Trophoblastic Tumor AJCC v7 C2828185 CTRP Undetermined Stage II Gestational Trophoblastic Tumor Stage II Gestational Trophoblastic Tumor AJCC v7 Stage II Gestational Trophoblastic Tumor AJCC v7 Stage IIA includes: T2, M0, Risk factors: low risk. T2: Tumor extends to other genital structures (ovary, tube, vagina, broad ligaments) by metastasis or direct extension. M0: No distant metastasis. (AJCC 7th ed.) C87154 Neoplastic Process Stage IIA Gestational Trophoblastic Tumor AJCC v7 Stage IIA Gestational Trophoblastic Tumor AJCC v7 C2828186 CTRP Undetermined Stage IIA Gestational Trophoblastic Tumor Stage IIA Gestational Trophoblastic Tumor AJCC v7 Stage IIA Gestational Trophoblastic Tumor AJCC v7 Stage IIB includes: T2, M0, Risk factors: high risk. T2: Tumor extends to other genital structures (ovary, tube, vagina, broad ligaments) by metastasis or direct extension. M0: No distant metastasis. (AJCC 7th ed.) C87155 Neoplastic Process Stage IIB Gestational Trophoblastic Tumor AJCC v7 Stage IIB Gestational Trophoblastic Tumor AJCC v7 C2828187 CTRP Undetermined Stage IIB Gestational Trophoblastic Tumor Stage IIB Gestational Trophoblastic Tumor AJCC v7 Stage IIB Gestational Trophoblastic Tumor AJCC v7 Stage III includes: (Any T, M1a, Risk factors: unknown); IIIA (Any T, M1a, Risk factors: low risk); IIIB (Any T, M1a, Risk factors: high risk). M1a: Lung metastasis. (AJCC 7th ed.) C87156 Neoplastic Process Stage III Gestational Trophoblastic Tumor AJCC v7 Stage III Gestational Trophoblastic Tumor AJCC v7 C2828188 CTRP Undetermined Stage III Gestational Trophoblastic Tumor Stage III Gestational Trophoblastic Tumor AJCC v7 Stage III Gestational Trophoblastic Tumor AJCC v7 Stage IIIA includes: Any T, M1a, Risk factors: low risk. M1a: Lung metastasis. (AJCC 7th ed.) C87157 Neoplastic Process Stage IIIA Gestational Trophoblastic Tumor AJCC v7 Stage IIIA Gestational Trophoblastic Tumor AJCC v7 C2828189 CTRP Undetermined Stage IIIA Gestational Trophoblastic Tumor Stage IIIA Gestational Trophoblastic Tumor AJCC v7 Stage IIIA Gestational Trophoblastic Tumor AJCC v7 Stage IIIB includes: Any T, M1a, Risk factors: high risk. M1a: Lung metastasis. (AJCC 7th ed.) C87158 Neoplastic Process Stage IIIB Gestational Trophoblastic Tumor AJCC v7 Stage IIIB Gestational Trophoblastic Tumor AJCC v7 C2828190 CTRP Undetermined Stage IIIB Gestational Trophoblastic Tumor Stage IIIB Gestational Trophoblastic Tumor AJCC v7 Stage IIIB Gestational Trophoblastic Tumor AJCC v7 Stage IV includes: (Any T, M1b, Risk factors: unknown); IVA (Any T, M1b, Risk factors: low risk); IVB (Any T, M1b, Risk factors: high risk). M1b: All other distant metastasis. (AJCC 7th ed.) C87159 Neoplastic Process Stage IV Gestational Trophoblastic Tumor AJCC v7 Stage IV Gestational Trophoblastic Tumor AJCC v7 C2828191 CTRP Undetermined Stage IV Gestational Trophoblastic Tumor Stage IV Gestational Trophoblastic Tumor AJCC v7 Stage IV Gestational Trophoblastic Tumor AJCC v7 A ureter carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment. C8716 Neoplastic Process Advanced Ureter Carcinoma CL448947 Malignant Regional_Malignant_Ureter_Neoplasm Advanced Ureter Carcinoma Advanced Ureter Carcinoma Stage IVA includes: Any T, M1b, Risk factors: low risk. M1b: All other distant metastasis. (AJCC 7th ed.) C87160 Neoplastic Process Stage IVA Gestational Trophoblastic Tumor AJCC v7 Stage IVA Gestational Trophoblastic Tumor AJCC v7 C2828192 CTRP Undetermined Stage IVA Gestational Trophoblastic Tumor Stage IVA Gestational Trophoblastic Tumor AJCC v7 Stage IVA Gestational Trophoblastic Tumor AJCC v7 Stage IVB includes: Any T, M1b, Risk factors: high risk. M1b: All other distant metastasis. (AJCC 7th ed.) C87161 Neoplastic Process Stage IVB Gestational Trophoblastic Tumor AJCC v7 Stage IVB Gestational Trophoblastic Tumor AJCC v7 C2828193 CTRP Undetermined Stage IVB Gestational Trophoblastic Tumor Stage IVB Gestational Trophoblastic Tumor AJCC v7 Stage IVB Gestational Trophoblastic Tumor AJCC v7 Stage I includes: IA (T1, N0, M0, G1, G2, GX); IB (T2, N0, M0, G1, G2, GX); (T3, N0, M0, G1, G2, GX). T1: Tumor 8 cm or less in greatest dimension. T2: Tumor more than 8 cm in greatest dimension. T3: Discontinuous tumors in the primary bone site. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated-low grade. G2: Moderately differentiated-low grade. GX: Grade cannot be assessed. (AJCC 7th ed.) C87178 Neoplastic Process Stage I Bone Cancer AJCC v7 Stage I Bone Cancer AJCC v7 C2828198 CTRP Malignant Stage I Bone Cancer Stage I Bone Cancer AJCC v7 Stage I Bone Cancer AJCC v7 Stage IA includes: T1, N0, M0, G1, G2, GX. T1: Tumor 8 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated-low grade. G2: Moderately differentiated-low grade. GX: Grade cannot be assessed. (AJCC 7th ed.) C87179 Neoplastic Process Stage IA Bone Cancer AJCC v7 Stage IA Bone Cancer AJCC v7 C2828199 CTRP Malignant Stage IA Bone Cancer Stage IA Bone Cancer AJCC v7 Stage IA Bone Cancer AJCC v7 Stage IB includes: (T2, N0, M0, G1, G2, GX); (T3, N0, M0, G1, G2, GX). T2: Tumor more than 8 cm in greatest dimension. T3: Discontinuous tumors in the primary bone site. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated-low grade. G2: Moderately differentiated-low grade. GX: Grade cannot be assessed. (AJCC 7th ed.) C87180 Neoplastic Process Stage IB Bone Cancer AJCC v7 Stage IB Bone Cancer AJCC v7 C2828200 CTRP Malignant Stage IB Bone Cancer Stage IB Bone Cancer AJCC v7 Stage IB Bone Cancer AJCC v7 Stage II includes: IIA (T1, N0, M0, G3, G4); IIB (T2, N0, M0, G3, G4). T1: Tumor 8 cm or less in greatest dimension. T2: Tumor more than 8 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (AJCC 7th ed.) C87181 Neoplastic Process Stage II Bone Cancer AJCC v7 Stage II Bone Cancer AJCC v7 C2828201 CTRP Malignant Stage II Bone Cancer Stage II Bone Cancer AJCC v7 Stage II Bone Cancer AJCC v7 Stage IIA includes: T1, N0, M0, G3, G4. T1: Tumor 8 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (AJCC 7th ed.) C87182 Neoplastic Process Stage IIA Bone Cancer AJCC v7 Stage IIA Bone Cancer AJCC v7 C2828202 CTRP Malignant Stage IIA Bone Cancer Stage IIA Bone Cancer AJCC v7 Stage IIA Bone Cancer AJCC v7 Stage IIB includes: T2, N0, M0, G3, G4. T2: Tumor more than 8 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (AJCC 7th ed.) C87183 Neoplastic Process Stage IIB Bone Cancer AJCC v7 Stage IIB Bone Cancer AJCC v7 C2828203 CTRP Malignant Stage IIB Bone Cancer Stage IIB Bone Cancer AJCC v7 Stage IIB Bone Cancer AJCC v7 Stage III includes: T3, N0, M0, G3, G4. T3: Tumor more than 8 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (AJCC 7th ed.) C87184 Neoplastic Process Stage III Bone Cancer AJCC v7 Stage III Bone Cancer AJCC v7 C2828204 CTRP Malignant Stage III Bone Cancer Stage III Bone Cancer AJCC v7 Stage III Bone Cancer AJCC v7 Stage IV includes: IVA (Any T, N0, M1a, Any G); IVB (Any T, N1, Any M, Any G); (Any T, Any N, M1b, Any G). N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M1a: Distant metastasis to lung. M1b: Metastasis to other distant sites. (AJCC 7th ed.) C87185 Neoplastic Process Stage IV Bone Cancer AJCC v7 Stage IV Bone Cancer AJCC v7 C2828205 CTRP Malignant Stage IV Bone Cancer Stage IV Bone Cancer AJCC v7 Stage IV Bone Cancer AJCC v7 Stage IVA includes: Any T, N0, M1a, Any G. N0: No regional lymph node metastasis. M1a: Distant metastasis to lung. (AJCC 7th ed.) C87186 Neoplastic Process Stage IVA Bone Cancer AJCC v7 Stage IVA Bone Cancer AJCC v7 C2828206 CTRP Malignant Stage IVA Bone Cancer Stage IVA Bone Cancer AJCC v7 Stage IVA Bone Cancer AJCC v7 Stage IVB includes: (Any T, N1, Any M, Any G); (Any T, Any N, M1b, Any G). N1: Regional lymph node metastasis. M1b: Metastasis to other distant sites. (AJCC 7th ed.) C87187 Neoplastic Process Stage IVB Bone Cancer AJCC v7 Stage IVB Bone Cancer AJCC v7 C2828207 CTRP Malignant Stage IVB Bone Cancer Stage IVB Bone Cancer AJCC v7 Stage IVB Bone Cancer AJCC v7 A primary carcinoma of the endometrium characterized by the presence of malignant squamous cells. C8719 Neoplastic Process Endometrial Squamous Cell Carcinoma Endometrial Squamous Cell Carcinoma C0854925 CTRP Malignant Endometrial_Squamous_Cell_Carcinoma Endometrial Squamous Cell Carcinoma Squamous Cell Carcinoma of Endometrium Squamous Cell Carcinoma of the Endometrium Endometrial Squamous Cell Carcinoma Stage IA includes: T1a, N0, M0. T1a: Pleural mesothelioma with no involvement of the visceral pleura. N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87195 Neoplastic Process Stage IA Pleural Malignant Mesothelioma AJCC v7 Stage IA Pleural Malignant Mesothelioma AJCC v7 CL522562 CTRP Malignant Stage IA Pleural Malignant Mesothelioma Stage IA Pleural Malignant Mesothelioma AJCC v7 Stage IA Pleural Malignant Mesothelioma AJCC v7 Stage IB includes: T1b, N0, M0. T1b: Pleural mesothelioma with a tumor also involving the visceral pleura N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87196 Neoplastic Process Stage IB Pleural Malignant Mesothelioma AJCC v7 Stage IB Pleural Malignant Mesothelioma AJCC v7 CL522563 CTRP Malignant Stage IB Pleural Malignant Mesothelioma Stage IB Pleural Malignant Mesothelioma AJCC v7 Stage IB Pleural Malignant Mesothelioma AJCC v7 Stage I includes: (T1, N0, M0); IA (T1a, N0, M0); IB (T1b, N0, M0); IC (T1c, N0, M0). T1: Tumor limited to the fallopian tube(s). T1a: Tumor limited to one tube, without penetrating the serosal surface; no ascites. T1b: Tumor limited to both tubes, without penetrating the serosal surface; no ascites. T1c: Tumor limited to one or both tubes with extension onto or through the tubal serosa, or with malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8720 Neoplastic Process Stage I Fallopian Tube Cancer AJCC v6 and v7 Stage I Fallopian Tube Cancer AJCC v6 and v7 C0854926 CTRP Malignant Stage_I_Fallopian_Tube_Cancer AJCC Stage I Fallopian Tube Cancer FIGO Stage I Carcinoma of Fallopian Tube FIGO Stage I Carcinoma of the Fallopian Tube FIGO Stage I Fallopian Tube Carcinoma Fallopian Tube Cancer Stage I Stage I Fallopian Tube Cancer Stage I Fallopian Tube Cancer AJCC v6 Stage I Fallopian Tube Cancer AJCC v6 and v7 Stage I Fallopian Tube Cancer AJCC v7 Stage I Fallopian Tube Cancer AJCC v6 and v7 Stage II includes: (T2, N0, M0); IIA: (T2a, N0, M0); IIB (T2b, N0, M0); IIC (T2c, N0, M0). T2: Tumor involves one or both fallopian tubes with pelvic extension. T2a: Extension and/or metastasis to the uterus and/or ovaries. T2b: Extension to other pelvic structures. T2c: Pelvic extension with malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8721 Neoplastic Process Stage II Fallopian Tube Cancer AJCC v6 and v7 Stage II Fallopian Tube Cancer AJCC v6 and v7 C0854927 CTRP Malignant Stage_II_Fallopian_Tube_Cancer AJCC Stage II Fallopian Tube Cancer FIGO Stage II Carcinoma of Fallopian Tube FIGO Stage II Carcinoma of the Fallopian Tube FIGO Stage II Fallopian Tube Carcinoma Fallopian Tube Cancer Stage II Stage II Fallopian Tube Cancer Stage II Fallopian Tube Cancer AJCC v6 Stage II Fallopian Tube Cancer AJCC v6 and v7 Stage II Fallopian Tube Cancer AJCC v7 Stage II Fallopian Tube Cancer AJCC v6 and v7 Stage III includes: (T3, N0, M0); IIIA (T3a, N0, M0); IIIB (T3b, N0, M0); IIIC (T3c, N0, M0). T3: Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis. T3a: Microscopic peritoneal metastasis outside the pelvis. T3b: Macroscopic peritoneal metastasis outside the pelvis 2cm or less in greatest dimension. T3c: Peritoneal metastasis more than 2cm in diameter. (AJCC 6th ed.) C8722 Neoplastic Process Stage III Fallopian Tube Cancer AJCC v6 Stage III Fallopian Tube Cancer AJCC v6 C1378107 CTRP Malignant Stage_III_Fallopian_Tube_Cancer AJCC Stage III Fallopian Tube Cancer v6 FIGO Stage III Carcinoma of Fallopian Tube FIGO Stage III Carcinoma of the Fallopian Tube AJCC v6 FIGO Stage III Fallopian Tube Carcinoma Fallopian Tube Cancer Stage III AJCC v6 Stage III Fallopian Tube Cancer Stage III Fallopian Tube Cancer AJCC v6 Stage III Fallopian Tube Cancer AJCC v6 Stage I includes: (T1, N0, M0). T1: Tumor limited to ovaries (one or both). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C8723 Neoplastic Process Stage I Ovarian Dysgerminoma Stage I Ovarian Dysgerminoma AJCC v6 and v7 C0854931 CTRP Malignant Stage_I_Ovarian_Dysgerminoma Stage I Ovarian Dysgerminoma Stage I Ovarian Dysgerminoma AJCC v6 Stage I Ovarian Dysgerminoma AJCC v6 and v7 Stage I Ovarian Dysgerminoma AJCC v7 Stage I Ovarian Dysgerminoma AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: Tumor involves one or both ovaries with pelvic extension and/or implants. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8724 Neoplastic Process Stage II Ovarian Dysgerminoma Stage II Ovarian Dysgerminoma AJCC v6 and v7 C0854932 CTRP Malignant Stage_II_Ovarian_Dysgerminoma Stage II Ovarian Dysgerminoma Stage II Ovarian Dysgerminoma AJCC v6 Stage II Ovarian Dysgerminoma AJCC v6 and v7 Stage II Ovarian Dysgerminoma AJCC v7 Stage II Ovarian Dysgerminoma AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: Tumor involves one or both ovaries with pelvic extension and/or implants. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8725 Neoplastic Process Stage II Ovarian Embryonal Carcinoma Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7 C0854933 CTRP Malignant Stage_II_Ovarian_Embryonal_Carcinoma Ovarian Embryonal Carcinoma, Stage II Stage II Ovarian Embryonal Carcinoma Stage II Ovarian Embryonal Carcinoma AJCC v6 Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7 Stage II Ovarian Embryonal Carcinoma AJCC v7 Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7 Stage III includes: T3, N0, M0. T3: Tumor involves one or both both ovaries with microscopically confirmed peritoneal metastasis outside pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8726 Neoplastic Process Stage III Ovarian Dysgerminoma Stage III Ovarian Dysgerminoma AJCC v6 and v7 C0854934 CTRP Malignant Stage_III_Ovarian_Dysgerminoma Stage III Ovarian Dysgerminoma Stage III Ovarian Dysgerminoma AJCC v6 Stage III Ovarian Dysgerminoma AJCC v6 and v7 Stage III Ovarian Dysgerminoma AJCC v7 Stage III Ovarian Dysgerminoma AJCC v6 and v7 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis (excludes peritoneal metastasis). (AJCC 6th and 7th eds.) C8727 Neoplastic Process Stage IV Ovarian Dysgerminoma Stage IV Ovarian Dysgerminoma AJCC v6 and v7 C0854935 CTRP Malignant Stage_IV_Ovarian_Dysgerminoma Stage IV Ovarian Dysgerminoma Stage IV Ovarian Dysgerminoma AJCC v6 Stage IV Ovarian Dysgerminoma AJCC v6 and v7 Stage IV Ovarian Dysgerminoma AJCC v7 Stage IV Ovarian Dysgerminoma AJCC v6 and v7 Stage III includes: T3, N0, M0. T3: Tumor involves one or both both ovaries with microscopically confirmed peritoneal metastasis outside pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8728 Neoplastic Process Stage III Ovarian Embryonal Carcinoma Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7 C0854938 CTRP Malignant Stage_III_Ovarian_Embryonal_Carcinoma Ovarian Embryonal Carcinoma, Stage III Stage III Ovarian Embryonal Carcinoma Stage III Ovarian Embryonal Carcinoma AJCC v6 Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7 Stage III Ovarian Embryonal Carcinoma AJCC v7 Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis (excludes peritoneal metastasis). (AJCC 6th and 7th eds.) C8729 Neoplastic Process Stage IV Ovarian Embryonal Carcinoma Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7 C0854939 CTRP Malignant Stage_IV_Ovarian_Embryonal_Carcinoma Ovarian Embryonal Carcinoma Stage IV Stage IV Ovarian Embryonal Carcinoma Stage IV Ovarian Embryonal Carcinoma AJCC v6 Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7 Stage IV Ovarian Embryonal Carcinoma AJCC v7 Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7 Stage I includes: T1, N0, M0. T1: Tumor limited to ovaries (one or both). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8730 Neoplastic Process Stage I Ovarian Choriocarcinoma Stage I Ovarian Choriocarcinoma C0854941 CTRP Malignant Stage_I_Ovarian_Choriocarcinoma Stage I Ovarian Choriocarcinoma Stage I Ovarian Choriocarcinoma AJCC v6 Stage I Ovarian Choriocarcinoma AJCC v7 Stage I Ovarian Germ Cell Choriocarcinoma Stage I Ovarian Choriocarcinoma Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0). T4a: Lip and oral cavity cancer with moderately advanced local disease. Lip: Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin of face, i.e., chin or nose. Oral cavity: Tumor invades adjacent structures only (e.g., through cortical bone [mandible or maxilla] into deep [extrinsic] muscle of tongue [genioglossus, hyoglossus, palatoglossus, and styloglossus], maxillary sinus, skin of face). T1: Tumor 2 cm or less in greatest dimension. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3: Tumor more than 4 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension; or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension; or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C87301 Neoplastic Process Stage IVA Lip and Oral Cavity Cancer AJCC v6 and v7 Stage IVA Lip and Oral Cavity Cancer AJCC v6 and v7 C2828251 CTRP Stage IV is divided into stages IVA, IVB, and IVC. In stage IVA, the tumor has spread to nearby tissues in the lip and oral cavity (mouth); and/or cancer has spread to one or more lymph nodes in the neck and the involved lymph nodes are 6 centimeters (about 2 inches) or smaller. Malignant Stage IVA Lip and Oral Cavity Cancer Stage IVA Lip and Oral Cavity Cancer AJCC v6 Stage IVA Lip and Oral Cavity Cancer AJCC v6 and v7 Stage IVA Lip and Oral Cavity Cancer AJCC v7 stage IVA lip and oral cavity cancer Stage IVA Lip and Oral Cavity Cancer AJCC v6 and v7 Stage IVB includes: (Any T, N3, M0); (T4b, Any N, M0). T4b: Lip and oral cavity cancer with very advanced local disease. Tumor invades masticator space, pterygoid plates, or skull base and/or encases internal carotid artery. N3: Metastasis in a lymph node more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C87302 Neoplastic Process Stage IVB Lip and Oral Cavity Cancer AJCC v6 and v7 Stage IVB Lip and Oral Cavity Cancer AJCC v6 and v7 C2828252 CTRP Stage IV is divided into stages IVA, IVB, and IVC. In stage IVB, the tumor has spread to one or more lymph nodes that are larger than 6 centimeters (about 2 inches); or cancer has spread to the muscles or bones in the oral cavity (mouth), or to the base of the skull, and/or the carotid artery (blood vessel that carries blood from the heart to the head). Cancer may also have spread to one or more lymph nodes in the neck. Malignant Stage IVB Lip and Oral Cavity Cancer Stage IVB Lip and Oral Cavity Cancer AJCC v6 Stage IVB Lip and Oral Cavity Cancer AJCC v6 and v7 Stage IVB Lip and Oral Cavity Cancer AJCC v7 stage IVB lip and oral cavity cancer Stage IVB Lip and Oral Cavity Cancer AJCC v6 and v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C87303 Neoplastic Process Stage IVC Lip and Oral Cavity Cancer AJCC v6 and v7 Stage IVC Lip and Oral Cavity Cancer AJCC v6 and v7 C2828253 CTRP Stage IV is divided into stages IVA, IVB, and IVC. In stage IVC, the tumor has spread beyond the lip and oral cavity (mouth) to other parts of the body. Cancer may have spread to the lymph nodes. Malignant Stage IVC Lip and Oral Cavity Cancer Stage IVC Lip and Oral Cavity Cancer AJCC v6 Stage IVC Lip and Oral Cavity Cancer AJCC v6 and v7 Stage IVC Lip and Oral Cavity Cancer AJCC v7 stage IVC lip and oral cavity cancer Stage IVC Lip and Oral Cavity Cancer AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: Tumor involves one or both ovaries with pelvic extension and/or implants. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8731 Neoplastic Process Stage II Ovarian Choriocarcinoma Stage II Ovarian Choriocarcinoma C0854942 CTRP Malignant Stage_II_Ovarian_Choriocarcinoma Ovarian Germ Cell Choriocarcinoma Stage II Ovarian Germ Cell Choriocarcinoma, Stage II Stage II Ovarian Choriocarcinoma Stage II Ovarian Choriocarcinoma AJCC v6 Stage II Ovarian Choriocarcinoma AJCC v7 Stage II Ovarian Germ Cell Choriocarcinoma Stage II Ovarian Choriocarcinoma Stage III includes: T3, N0, M0. T3: Tumor involves one or both both ovaries with microscopically confirmed peritoneal metastasis outside pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8732 Neoplastic Process Stage III Ovarian Choriocarcinoma Stage III Ovarian Choriocarcinoma C0854943 CTRP Malignant Stage_III_Ovarian_Choriocarcinoma Ovarian Germ Cell Choriocarcinoma Stage III Ovarian Germ Cell Choriocarcinoma, Stage III Stage III Ovarian Choriocarcinoma Stage III Ovarian Choriocarcinoma AJCC v6 Stage III Ovarian Choriocarcinoma AJCC v7 Stage III Ovarian Germ Cell Choriocarcinoma Stage III Ovarian Choriocarcinoma Stage IV includes: Any T, Any N, M1. M1: Distant metastasis (excludes peritoneal metastasis). (AJCC 6th and 7th eds.) C8733 Neoplastic Process Stage IV Ovarian Choriocarcinoma Stage IV Ovarian Choriocarcinoma C0854944 CTRP Malignant Stage_IV_Ovarian_Choriocarcinoma Ovarian Germ Cell Choriocarcinoma Stage IV Ovarian Germ Cell Choriocarcinoma, Stage IV Stage IV Ovarian Choriocarcinoma Stage IV Ovarian Choriocarcinoma AJCC v6 Stage IV Ovarian Choriocarcinoma AJCC v7 Stage IV Ovarian Germ Cell Choriocarcinoma Stage IV Ovarian Choriocarcinoma Stage I includes: (T1, N0, M0). T1: Tumor limited to ovaries (one or both). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C8734 Neoplastic Process Stage I Ovarian Embryonal Carcinoma Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7 C0854945 CTRP Malignant Stage_I_Ovarian_Embryonal_Carcinoma Ovarian Embryonal Carcinoma, Stage I Stage I Ovarian Embryonal Carcinoma Stage I Ovarian Embryonal Carcinoma AJCC v6 Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7 Stage I Ovarian Embryonal Carcinoma AJCC v7 Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7 Stage I includes: (T1, N0, M0). T1: Tumor limited to ovaries (one or both). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C8735 Neoplastic Process Stage I Ovarian Yolk Sac Tumor Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7 C0854946 CTRP Malignant Stage_I_Ovarian_Yolk_Sac_Tumor Ovarian Yolk Sac Tumor Stage I Stage I Ovarian Yolk Sac Tumor Stage I Ovarian Yolk Sac Tumor AJCC v6 Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7 Stage I Ovarian Yolk Sac Tumor AJCC v7 Yolk Sac Tumor of Ovary Stage I Yolk Sac Tumor of the Ovary Stage I Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: Tumor involves one or both ovaries with pelvic extension and/or implants. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8736 Neoplastic Process Stage II Ovarian Yolk Sac Tumor Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7 C1336310 CTRP Malignant Stage_II_Ovarian_Yolk_Sac_Tumor Ovarian Yolk Sac Tumor Stage II Stage II Ovarian Yolk Sac Tumor Stage II Ovarian Yolk Sac Tumor AJCC v6 Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7 Stage II Ovarian Yolk Sac Tumor AJCC v7 Yolk Sac Tumor of Ovary Stage II Yolk Sac Tumor of the Ovary Stage II Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7 Stage III includes: T3, N0, M0. T3: Tumor involves one or both both ovaries with microscopically confirmed peritoneal metastasis outside pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8737 Neoplastic Process Stage III Ovarian Yolk Sac Tumor Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7 C0854948 CTRP Malignant Stage_III_Ovarian_Yolk_Sac_Tumor Ovarian Yolk Sac Tumor Stage III Stage III Ovarian Yolk Sac Tumor Stage III Ovarian Yolk Sac Tumor AJCC v6 Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7 Stage III Ovarian Yolk Sac Tumor AJCC v7 Yolk Sac Tumor of Ovary Stage III Yolk Sac Tumor of the Ovary Stage III Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis (excludes peritoneal metastasis). (AJCC 6th and 7th eds.) C8738 Neoplastic Process Stage IV Ovarian Yolk Sac Tumor Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7 C0854949 CTRP Malignant Stage_IV_Ovarian_Yolk_Sac_Tumor Ovarian Yolk Sac Tumor Stage IV Stage IV Ovarian Yolk Sac Tumor Stage IV Ovarian Yolk Sac Tumor AJCC v6 Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7 Stage IV Ovarian Yolk Sac Tumor AJCC v7 Yolk Sac Tumor of Ovary Stage IV Yolk Sac Tumor of the Ovary Stage IV Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7 Stage I includes: (T1, N0, M0). T1: Tumor limited to ovaries (one or both). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C8739 Neoplastic Process Stage I Ovarian Polyembryoma Stage I Ovarian Polyembryoma AJCC v6 and v7 C0854950 CTRP Malignant Stage_I_Ovarian_Polyembryoma Ovarian Polyembryoma Stage I Stage I Ovarian Polyembryoma Stage I Ovarian Polyembryoma AJCC v6 Stage I Ovarian Polyembryoma AJCC v6 and v7 Stage I Ovarian Polyembryoma AJCC v7 Stage I Ovarian Polyembryoma AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: Tumor involves one or both ovaries with pelvic extension and/or implants. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8740 Neoplastic Process Stage II Ovarian Polyembryoma Stage II Ovarian Polyembryoma AJCC v6 and v7 C0854951 CTRP Malignant Stage_II_Ovarian_Polyembryoma Ovarian Polyembryoma Stage II Stage II Ovarian Polyembryoma Stage II Ovarian Polyembryoma AJCC v6 Stage II Ovarian Polyembryoma AJCC v6 and v7 Stage II Ovarian Polyembryoma AJCC v7 Stage II Ovarian Polyembryoma AJCC v6 and v7 Stage III includes: T3, N0, M0. T3: Tumor involves one or both both ovaries with microscopically confirmed peritoneal metastasis outside pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8741 Neoplastic Process Stage III Ovarian Polyembryoma Stage III Ovarian Polyembryoma AJCC v6 and v7 C0854952 CTRP Malignant Stage_III_Ovarian_Polyembryoma Ovarian Polyembryoma Stage III Stage III Ovarian Polyembryoma Stage III Ovarian Polyembryoma AJCC v6 Stage III Ovarian Polyembryoma AJCC v6 and v7 Stage III Ovarian Polyembryoma AJCC v7 Stage III Ovarian Polyembryoma AJCC v6 and v7 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis (excludes peritoneal metastasis). (AJCC 6th and 7th eds.) C8742 Neoplastic Process Stage IV Ovarian Polyembryoma Stage IV Ovarian Polyembryoma AJCC v6 and v7 C0854953 CTRP Malignant Stage_IV_Ovarian_Polyembryoma Ovarian Polyembryoma Stage IV Stage IV Ovarian Polyembryoma Stage IV Ovarian Polyembryoma AJCC v6 Stage IV Ovarian Polyembryoma AJCC v6 and v7 Stage IV Ovarian Polyembryoma AJCC v7 Stage IV Ovarian Polyembryoma AJCC v6 and v7 Stage I includes: (T1, N0, M0). T1: Tumor limited to ovaries (one or both). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C8743 Neoplastic Process Stage I Ovarian Teratoma Stage I Ovarian Teratoma AJCC v6 and v7 C0854955 CTRP Malignant Stage_I_Ovarian_Teratoma Stage I Ovarian Germ Cell Teratoma Stage I Ovarian Teratoma Stage I Ovarian Teratoma AJCC v6 Stage I Ovarian Teratoma AJCC v6 and v7 Stage I Ovarian Teratoma AJCC v7 Stage I Ovarian Teratoma AJCC v6 and v7 Stage II includes: T2, N0, M0. T2: Tumor involves one or both ovaries with pelvic extension and/or implants. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8744 Neoplastic Process Stage II Ovarian Teratoma Stage II Ovarian Teratoma AJCC v6 and v7 C0854956 CTRP Malignant Stage_II_Ovarian_Teratoma Ovarian Germ Cell Teratoma Stage II Ovarian Germ Cell Teratoma, Stage II Stage II Ovarian Germ Cell Teratoma Stage II Ovarian Teratoma Stage II Ovarian Teratoma AJCC v6 Stage II Ovarian Teratoma AJCC v6 and v7 Stage II Ovarian Teratoma AJCC v7 Stage II Ovarian Teratoma AJCC v6 and v7 Stage III includes: T3, N0, M0. T3: Tumor involves one or both both ovaries with microscopically confirmed peritoneal metastasis outside pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8745 Neoplastic Process Stage III Ovarian Teratoma Stage III Ovarian Teratoma AJCC v6 and v7 C0854957 CTRP Malignant Stage_III_Ovarian_Teratoma Ovarian Germ Cell Teratoma Stage III Ovarian Germ Cell Teratoma, Stage III Stage III Ovarian Germ Cell Teratoma Stage III Ovarian Teratoma Stage III Ovarian Teratoma AJCC v6 Stage III Ovarian Teratoma AJCC v6 and v7 Stage III Ovarian Teratoma AJCC v7 Stage III Ovarian Teratoma AJCC v6 and v7 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis (excludes peritoneal metastasis). (AJCC 6th and 7th eds.) C8746 Neoplastic Process Stage IV Ovarian Teratoma Stage IV Ovarian Teratoma AJCC v6 and v7 C0854958 CTRP Malignant Stage_IV_Ovarian_Teratoma Ovarian Germ Cell Teratoma Stage IV Ovarian Germ Cell Teratoma, Stage IV Stage IV Ovarian Germ Cell Teratoma Stage IV Ovarian Teratoma Stage IV Ovarian Teratoma AJCC v6 Stage IV Ovarian Teratoma AJCC v6 and v7 Stage IV Ovarian Teratoma AJCC v7 Stage IV Ovarian Teratoma AJCC v6 and v7 The reemergence of adenosquamous lung carcinoma after a period of remission. C8747 Neoplastic Process Recurrent Lung Adenosquamous Carcinoma C0854970 Malignant Recurrent_Adenosquamous_Cell_Lung_Carcinoma Adenosquamous Cell Lung Carcinoma Recurrent Recurrent Adenosquamous Cell Carcinoma of Lung Recurrent Adenosquamous Cell Carcinoma of the Lung Recurrent Adenosquamous Cell Lung Carcinoma Recurrent Lung Adenosquamous Carcinoma Recurrent Lung Adenosquamous Carcinoma Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8748 Neoplastic Process Stage 0 Adenosquamous Lung Carcinoma AJCC v6 and v7 Stage 0 Lung Adenosquamous Carcinoma AJCC v6 and v7 C0854971 CTRP Malignant Stage_0_Adenosquamous_Lung_Carcinoma Adenosquamous Cell Carcinoma in situ of Lung Adenosquamous Cell Carcinoma in situ of the Lung Lung Adenosquamous Cell Carcinoma in situ Stage 0 Adenosquamous Cell Carcinoma of Lung Stage 0 Adenosquamous Cell Carcinoma of the Lung Stage 0 Adenosquamous Cell Lung Carcinoma Stage 0 Adenosquamous Lung Cancer Stage 0 Adenosquamous Lung Carcinoma AJCC v6 Stage 0 Adenosquamous Lung Carcinoma AJCC v7 Stage 0 Lung Adenosquamous Carcinoma AJCC v6 and v7 Stage 0 Lung Adenosquamous Carcinoma AJCC v6 and v7 Stage I includes: IA: (T1a, N0, M0); (T1b, N0, M0) and IB: (T2a, N0, M0). T1a: Lung cancer with a tumor size of 2 cm or less n greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C8749 Neoplastic Process Stage I Adenosquamous Lung Carcinoma AJCC v7 Stage I Lung Adenosquamous Carcinoma AJCC v7 C0854972 CTRP Malignant Stage_I_Adenosquamous_Lung_Carcinoma Stage I Adenosquamous Cell Carcinoma of Lung Stage I Adenosquamous Cell Carcinoma of the Lung Stage I Adenosquamous Cell Lung Carcinoma Stage I Adenosquamous Lung Cancer Stage I Adenosquamous Lung Carcinoma Stage I Lung Adenosquamous Carcinoma AJCC v7 Stage I Lung Adenosquamous Carcinoma AJCC v7 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th, 7th, and 8th eds.) C87498 Neoplastic Process Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v6, v7, and v8 Stage 0 Sinonasal Cancer AJCC v6, v7, and v8 CL414925 CTRP Abnormal cells are found in the innermost lining of the nasal cavity or ethmoid sinus. These abnormal cells may become cancer and spread into nearby normal tissue. Malignant Stage 0 Nasal Cavity and Paranasal Sinus Cancer Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v6 Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v6, v7, and v8 Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v7 Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v8 Stage 0 Nasal Cavity and Paranasal Sinus Carcinoma AJCC v8 Stage 0 Sinonasal Cancer AJCC v6, v7, and v8 Stage 0 Sinonasal Carcinoma AJCC v6, v7, and v8 stage 0 nasal cavity and ethmoid sinus carcinoma in situ Stage 0 Sinonasal Cancer AJCC v6, v7, and v8 Stage II includes: IIA (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0) and IIB (T2b, N1, M0); (T3, N0, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C8750 Neoplastic Process Stage II Adenosquamous Lung Carcinoma AJCC v7 Stage II Lung Adenosquamous Carcinoma AJCC v7 C0854973 CTRP Malignant Stage_II_Adenosquamous_Lung_Carcinoma Stage II Adenosquamous Cell Carcinoma of Lung Stage II Adenosquamous Cell Carcinoma of the Lung Stage II Adenosquamous Cell Lung Carcinoma Stage II Adenosquamous Lung Cancer Stage II Adenosquamous Lung Carcinoma Stage II Lung Adenosquamous Carcinoma AJCC v7 Stage II Lung Adenosquamous Carcinoma AJCC v7 Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); T4a: Maxillary sinus: Moderately advanced local disease. Tumor invades anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid or frontal sinuses. Nasal cavity and ethmoid sinus: Moderately advanced local disease. Tumor invades any of the following: anterior orbital contents, skin of nose or cheek, minimal extension to anterior cranial fossa, pterygoid plates, sphenoid or frontal sinuses. T1: Maxillary sinus: Tumor limited to the maxillary sinus mucosa with no erosion or destruction of bone. Nasal cavity and ethmoid sinus: Tumor restricted to any one subsite, with or without bony invasion. T2: Maxillary sinus: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates. Nasal cavity and ethmoid sinus: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion. T3: Maxillary sinus: Tumor invading any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, or ethmoid sinuses. Nasal cavity and ethmoid sinus: Tumor invading the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C87501 Neoplastic Process Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v7 Stage IVA Sinonasal Cancer AJCC v7 C2981251 CTRP Malignant Stage IVA Nasal Cavity and Paranasal Sinus Cancer Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v7 Stage IVA Sinonasal Cancer AJCC v7 Stage IVA Sinonasal Carcinoma AJCC v7 Stage IVA Sinonasal Cancer AJCC v7 Stage IVB includes: (T4b, Any N, M0); (Any T, N3, M0). T4b: Very advanced local disease. Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve, nasopharynx, or clivus. N3: Metastasis in a lymph node, more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C87502 Neoplastic Process Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v7 Stage IVB Sinonasal Cancer AJCC v7 C2981252 CTRP Malignant Stage IVB Nasal Cavity and Paranasal Sinus Cancer Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v7 Stage IVB Sinonasal Cancer AJCC v7 Stage IVB Sinonasal Carcinoma AJCC v7 Stage IVB Sinonasal Cancer AJCC v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C87503 Neoplastic Process Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v7 Stage IVC Sinonasal Cancer AJCC v7 C2981253 CTRP Malignant Stage IVC Nasal Cavity and Paranasal Sinus Cancer Stage IVC Nasal Cavity and Paranasal Sinus Cancer AJCC v7 Stage IVC Sinonasal Cancer AJCC v7 Stage IVC Sinonasal Carcinoma AJCC v7 Stage IVC Sinonasal Cancer AJCC v7 Stage III includes: IIIA (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0) and IIIB (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C8751 Neoplastic Process Stage III Adenosquamous Lung Carcinoma AJCC v7 Stage III Lung Adenosquamous Carcinoma AJCC v7 C0854974 CTRP Malignant Stage_III_Adenosquamous_Lung_Carcinoma Stage III Adenosquamous Cell Carcinoma of Lung Stage III Adenosquamous Cell Carcinoma of the Lung Stage III Adenosquamous Cell Lung Carcinoma Stage III Adenosquamous Lung Cancer Stage III Adenosquamous Lung Carcinoma Stage III Lung Adenosquamous Carcinoma AJCC v7 Stage III Lung Adenosquamous Carcinoma AJCC v7 Stage IV includes: (Any T, Any N, M1a); (Any T, Any N, M1b). M1a: Lung cancer with separate tumor nodule(s) in a contralateral lobe; tumor with pleural nodules or malignant pleural (or pericardial) effusion. M1b: Distant metastasis. (AJCC 7th ed.) C8752 Neoplastic Process Stage IV Adenosquamous Lung Carcinoma AJCC v7 Stage IV Lung Adenosquamous Carcinoma AJCC v7 C0854975 CTRP Malignant Stage_IV_Adenosquamous_Lung_Carcinoma Stage IV Adenosquamous Cell Carcinoma of Lung Stage IV Adenosquamous Cell Carcinoma of the Lung Stage IV Adenosquamous Cell Lung Carcinoma Stage IV Adenosquamous Lung Cancer Stage IV Adenosquamous Lung Carcinoma Stage IV Lung Adenosquamous Carcinoma AJCC v7 Stage IV Lung Adenosquamous Carcinoma AJCC v7 The reemergence of large cell lung carcinoma after a period of remission. C8753 Neoplastic Process Recurrent Lung Large Cell Carcinoma C0854977 Malignant Recurrent_Large_Cell_Lung_Carcinoma Recurrent Large Cell Carcinoma of Lung Recurrent Large Cell Carcinoma of the Lung Recurrent Large Cell Lung Carcinoma Recurrent Lung Large Cell Carcinoma Relapsed Large Cell Carcinoma of Lung Relapsed Large Cell Carcinoma of the Lung Relapsed Large Cell Lung Carcinoma Recurrent Lung Large Cell Carcinoma Stage III includes: T3, N0, M0. T3: Mucosal disease N0: No regional lymph node metastases. M0: No distant metastasis. (AJCC 7th ed.) C87532 Neoplastic Process Stage III Mucosal Melanoma of the Head and Neck AJCC v7 Stage III Mucosal Melanoma of the Head and Neck AJCC v7 C2981256 CTRP Malignant Stage III Mucosal Melanoma of the Head and Neck Stage III Mucosal Melanoma of the Head and Neck AJCC v7 Stage III Mucosal Melanoma of the Head and Neck AJCC v7 Stage IVA includes: (T4a, N0, M0); (T3-T4a, N1, M0). T4a: Moderately advanced disease. Tumor involves deep soft tissue, cartilage, bone, or overlying skin. T3: Mucosal disease. N0: No regional lymph node metastases. N1: Tumor with regional lymph node metastases. M0: No distant metastasis. (AJCC 7th ed.) C87533 Neoplastic Process Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7 Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7 C2981257 CTRP Malignant Stage IVA Mucosal Melanoma of the Head and Neck Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7 Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7 Stage IVB includes: T4b, Any N, M0. T4b: Very advanced disease. Tumor involves brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, prevertebral space, or mediastinal structures. M0: No distant metastasis. (AJCC 7th ed.) C87534 Neoplastic Process Stage IVB Mucosal Melanoma of the Head and Neck AJCC v7 Stage IVB Mucosal Melanoma of the Head and Neck AJCC v7 C2981258 CTRP Malignant Stage IVB Mucosal Melanoma of the Head and Neck Stage IVB Mucosal Melanoma of the Head and Neck AJCC v7 Stage IVB Mucosal Melanoma of the Head and Neck AJCC v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C87535 Neoplastic Process Stage IVC Mucosal Melanoma of the Head and Neck AJCC v7 Stage IVC Mucosal Melanoma of the Head and Neck AJCC v7 C2981259 CTRP Malignant Stage IVC Mucosal Melanoma of the Head and Neck Stage IVC Mucosal Melanoma of the Head and Neck AJCC v7 Stage IVC Mucosal Melanoma of the Head and Neck AJCC v7 Stage I includes: Under 45 years: Any T, Any N, M0. 45 years and older: T1, N0, M0. T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland. N0: No regional lymph node metastasis. M0: No evidence of distant metastasis. (from AJCC 7th Ed.) C87543 Neoplastic Process Stage I Differentiated Thyroid Gland Carcinoma AJCC v7 Stage I Differentiated Thyroid Gland Carcinoma AJCC v7 C2981267 CTRP Malignant Stage I Differentiated Thyroid Gland Cancer Stage I Differentiated Thyroid Gland Carcinoma Stage I Differentiated Thyroid Gland Carcinoma AJCC v7 Stage I Thyroid Gland Papillary or Follicular Carcinoma Stage I Differentiated Thyroid Gland Carcinoma AJCC v7 Stage II includes: Under 45 years: Any T, Any N, M1. 45 years and older: T2, N0, M0. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland. N0: No regional lymph node metastasis. M1: Distant metastasis. M0: No evidence of distant metastasis. (from AJCC 7th Ed.) C87544 Neoplastic Process Stage II Differentiated Thyroid Gland Carcinoma AJCC v7 Stage II Differentiated Thyroid Gland Carcinoma AJCC v7 C2981268 CTRP Malignant Stage II Differentiated Thyroid Gland Cancer Stage II Differentiated Thyroid Gland Carcinoma Stage II Differentiated Thyroid Gland Carcinoma AJCC v7 Stage II Thyroid Gland Papillary or Follicular Carcinoma Stage II Differentiated Thyroid Gland Carcinoma AJCC v7 Stage III includes: (T3, N0, M0); (T1, N1a, M0); (T2, N1a, M0); (T3, N1a, M0). T3: Tumor greater than 4 cm in greatest dimension and limited to the thyroid gland, or tumor of any size with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues). T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland. N0: No regional lymph node metastasis. N1a: Metastasis to pretracheal, paratracheal or prelaryngeal/Delphian lymph nodes (Level VI lymph nodes). M0: No distant metastasis. (AJCC 7th ed.) C87545 Neoplastic Process Stage III Differentiated Thyroid Gland Carcinoma AJCC v7 Stage III Differentiated Thyroid Gland Carcinoma AJCC v7 C2981269 CTRP Malignant Stage III Differentiated Thyroid Gland Cancer Stage III Differentiated Thyroid Gland Carcinoma Stage III Differentiated Thyroid Gland Carcinoma AJCC v7 Stage III Thyroid Gland Papillary or Follicular Carcinoma Stage III Differentiated Thyroid Gland Carcinoma AJCC v7 Stage IVA includes: (T4a, N0, M0); (T4a, N1a, M0); (T1, N1b, M0); (T2, N1b, M0); (T3, N1b, M0); (T4a, N1b, M0). T4a: Moderately advanced local disease. Tumor of any size extending beyond the thyroid gland capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve. T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland. T3: Tumor more than 4 cm in greatest dimension and limited to the thyroid gland, or tumor of any size with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues). N0: No regional lymph node metastasis. N1a: Metastasis to pretracheal, paratracheal or prelaryngeal/Delphian lymph nodes (Level VI lymph nodes). N1b: Metastasis to unilateral, bilateral or contralateral cervical (Levels I, II, III, IV, or V) or retropharyngeal or superior mediastinal lymph nodes (Level VII). M0: No distant metastasis. (AJCC 7th ed.) C87546 Neoplastic Process Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7 Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7 C2981270 CTRP Malignant Stage IVA Differentiated Thyroid Gland Cancer Stage IVA Differentiated Thyroid Gland Carcinoma Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7 Stage IVA Thyroid Gland Papillary or Follicular Carcinoma Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7 Stage IVB includes: T4b, Any N, M0. T4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels. M0: No distant metastasis. (AJCC 7th ed.) C87547 Neoplastic Process Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7 Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7 C2981271 CTRP Malignant Stage IVB Differentiated Thyroid Gland Cancer Stage IVB Differentiated Thyroid Gland Carcinoma Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7 Stage IVB Thyroid Gland Papillary or Follicular Carcinoma Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C87548 Neoplastic Process Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7 Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7 C2981272 CTRP Malignant Stage IVC Differentiated Thyroid Gland Cancer Stage IVC Differentiated Thyroid Gland Carcinoma Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7 Stage IVC Thyroid Gland Papillary or Follicular Carcinoma Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7 Stage IVA includes: (T4a, N0, M0); (T4a, N1a, M0); (T1, N1b, M0); (T2, N1b, M0); (T3, N1b, M0); (T4a, N1b, M0). T4a: Moderately advanced local disease. Tumor of any size extending beyond the thyroid gland capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve. T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland. T3: Tumor more than 4 cm in greatest dimension and limited to the thyroid gland, or tumor of any size with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues). T4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels. N0: No regional lymph node metastasis. N1a: Metastasis to pretracheal, paratracheal or prelaryngeal/Delphian lymph nodes (Level VI lymph nodes). N1b: Metastasis to unilateral, bilateral or contralateral cervical (Levels I, II, III, IV, or V) or retropharyngeal or superior mediastinal lymph nodes (Level VII). M0: No distant metastasis. (AJCC 7th ed.) C87549 Neoplastic Process Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7 Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7 C2981273 CTRP Malignant Stage IVA Thyroid Gland Medullary Cancer Stage IVA Thyroid Gland Medullary Carcinoma Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7 Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7 Stage I includes: IA: (T1a, N0, M0); (T1b, N0, M0) and IB: (T2a, N0, M0). T1a: Lung cancer with a tumor size of 2 cm or less n greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C8755 Neoplastic Process Stage I Large Cell Lung Carcinoma AJCC v7 Stage I Lung Large Cell Carcinoma AJCC v7 C0854979 CTRP Malignant Stage_I_Large_Cell_Lung_Carcinoma Stage I Large Cell Carcinoma of Lung Stage I Large Cell Carcinoma of the Lung Stage I Large Cell Lung Cancer Stage I Large Cell Lung Carcinoma Stage I Lung Large Cell Carcinoma AJCC v7 Stage I Lung Large Cell Carcinoma AJCC v7 Stage IVB includes: T4b, Any N, M0. T4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels. M0: No distant metastasis. (AJCC 7th ed.) C87550 Neoplastic Process Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7 Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7 C2981274 CTRP Malignant Stage IVB Thyroid Gland Medullary Cancer Stage IVB Thyroid Gland Medullary Carcinoma Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7 Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C87551 Neoplastic Process Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7 Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7 C2981275 CTRP Malignant Stage IVC Thyroid Gland Medullary Cancer Stage IVC Thyroid Gland Medullary Carcinoma Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7 Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7 Stage IVA includes: T4a, Any N, M0. T4a: Intrathyroidal anaplastic carcinoma. M0: No distant metastasis. (AJCC 7th ed.) C87552 Neoplastic Process Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7 Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v7 C2981276 CTRP Malignant Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v7 Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7 Undifferentiated (Anaplastic) Stage IVA Thyroid Gland Cancer Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v7 Stage IVB includes: T4b, Any N, M0. T4b: Anaplastic carcinoma with gross extrathyroid extension. M0: No distant metastasis. (AJCC 7th ed.) C87553 Neoplastic Process Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7 Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v7 C2981277 CTRP Malignant Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v7 Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7 Undifferentiated (Anaplastic) Stage IVB Thyroid Gland Cancer Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v7 Stage IVC includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C87554 Neoplastic Process Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7 Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v7 C2981278 CTRP Malignant Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v7 Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7 Undifferentiated (Anaplastic) Stage IVC Thyroid Gland Cancer Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v7 Stage IV includes: (Any T, Any N, M1a); (Any T, Any N, M1b). M1a: Lung cancer with separate tumor nodule(s) in a contralateral lobe; tumor with pleural nodules or malignant pleural (or pericardial) effusion. M1b: Distant metastasis. (AJCC 7th ed.) C8756 Neoplastic Process Stage IV Large Cell Lung Carcinoma AJCC v7 Stage IV Lung Large Cell Carcinoma AJCC v7 C0854982 CTRP Malignant Stage_IV_Large_Cell_Lung_Carcinoma Stage IV Large Cell Carcinoma of Lung Stage IV Large Cell Carcinoma of the Lung Stage IV Large Cell Lung Cancer Stage IV Large Cell Lung Carcinoma Stage IV Lung Large Cell Carcinoma AJCC v7 Stage IV Lung Large Cell Carcinoma AJCC v7 The re-emergence of lung adenocarcinoma after a period of remission. C8757 Neoplastic Process Recurrent Lung Adenocarcinoma C0854983 Malignant Recurrent_Lung_Adenocarcinoma Lung Adenocarcinoma, Recurrent Recurrent Adenocarcinoma of Lung Recurrent Adenocarcinoma of the Lung Recurrent Lung Adenocarcinoma Recurrent Lung Adenocarcinoma Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8758 Neoplastic Process Stage 0 Lung Adenocarcinoma AJCC v6 and v7 Stage 0 Lung Adenocarcinoma AJCC v6 and v7 C0854984 CTRP Malignant Stage_0_Lung_Adenocarcinoma Adenocarcinoma in situ of Lung Adenocarcinoma in situ of the Lung Lung Adenocarcinoma in situ Lung Adenocarcinoma, Stage 0 AJCC v6 and v7 Stage 0 Adenocarcinoma of Lung AJCC v6 and v7 Stage 0 Adenocarcinoma of the Lung AJCC v6 and v7 Stage 0 Lung Adenocarcinoma Stage 0 Lung Adenocarcinoma AJCC v6 Stage 0 Lung Adenocarcinoma AJCC v6 and v7 Stage 0 Lung Adenocarcinoma AJCC v7 Stage 0 Lung Adenocarcinoma AJCC v6 and v7 Stage I includes: IA: (T1a, N0, M0); (T1b, N0, M0) and IB: (T2a, N0, M0). T1a: Lung cancer with a tumor size of 2 cm or less n greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C8759 Neoplastic Process Stage I Lung Adenocarcinoma AJCC v7 Stage I Lung Adenocarcinoma AJCC v7 C0854985 CTRP Malignant Stage_I_Lung_Adenocarcinoma Lung Adenocarcinoma, Stage I Stage I Adenocarcinoma of Lung Stage I Adenocarcinoma of the Lung Stage I Lung Adenocarcinoma Stage I Lung Adenocarcinoma AJCC v7 Stage I Lung Adenocarcinoma AJCC v7 Stage II includes: IIA (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0) and IIB (T2b, N1, M0); (T3, N0, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C8760 Neoplastic Process Stage II Lung Adenocarcinoma AJCC v7 Stage II Lung Adenocarcinoma AJCC v7 C0854986 CTRP Malignant Stage_II_Lung_Adenocarcinoma Lung Adenocarcinoma Stage II Lung Adenocarcinoma, Stage II Stage II Adenocarcinoma of Lung Stage II Adenocarcinoma of the Lung Stage II Lung Adenocarcinoma Stage II Lung Adenocarcinoma AJCC v7 Stage II Lung Adenocarcinoma AJCC v7 Stage III includes: IIIA (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0) and IIIB (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C8761 Neoplastic Process Stage III Lung Adenocarcinoma AJCC v7 Stage III Lung Adenocarcinoma AJCC v7 C0854987 CTRP Malignant Stage_III_Lung_Adenocarcinoma Lung Adenocarcinoma Stage III Lung Adenocarcinoma, Stage III Stage III Adenocarcinoma of Lung Stage III Adenocarcinoma of the Lung Stage III Lung Adenocarcinoma Stage III Lung Adenocarcinoma AJCC v7 Stage III Lung Adenocarcinoma AJCC v7 Stage IV includes: (Any T, Any N, M1a); (Any T, Any N, M1b). M1a: Lung cancer with separate tumor nodule(s) in a contralateral lobe; tumor with pleural nodules or malignant pleural (or pericardial) effusion. M1b: Distant metastasis. (AJCC 7th ed.) C8762 Neoplastic Process Stage IV Lung Adenocarcinoma AJCC v7 Stage IV Lung Adenocarcinoma AJCC v7 C0854988 CTRP Malignant Stage_IV_Lung_Adenocarcinoma Lung Adenocarcinoma, Stage IV Stage IV Adenocarcinoma of Lung Stage IV Adenocarcinoma of the Lung Stage IV Lung Adenocarcinoma Stage IV Lung Adenocarcinoma AJCC v7 Stage IV Lung Adenocarcinoma AJCC v7 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8763 Neoplastic Process Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7 Stage 0 Lung Squamous Cell Carcinoma AJCC v6 and v7 C0854990 CTRP Malignant Stage_0_Squamous_Cell_Lung_Carcinoma Epidermoid Cell Carcinoma In Situ of Lung Epidermoid Cell Carcinoma In Situ of the Lung Lung Epidermoid Cell Carcinoma In Situ Lung Squamous Cell Carcinoma In Situ Squamous Cell Carcinoma In Situ of Lung Squamous Cell Carcinoma In Situ of the Lung Stage 0 Epidermoid Cell Carcinoma of Lung Stage 0 Epidermoid Cell Carcinoma of the Lung Stage 0 Epidermoid Cell Lung Carcinoma Stage 0 Lung Squamous Cell Carcinoma AJCC v6 and v7 Stage 0 Squamous Cell Carcinoma of Lung Stage 0 Squamous Cell Carcinoma of the Lung Stage 0 Squamous Cell Lung Cancer Stage 0 Squamous Cell Lung Carcinoma AJCC v6 Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7 Stage 0 Squamous Cell Lung Carcinoma AJCC v7 Stage 0 Lung Squamous Cell Carcinoma AJCC v6 and v7 Stage I includes: IA: (T1a, N0, M0); (T1b, N0, M0) and IB: (T2a, N0, M0). T1a: Lung cancer with a tumor size of 2 cm or less n greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C8764 Neoplastic Process Stage I Squamous Cell Lung Carcinoma AJCC v7 Stage I Lung Squamous Cell Carcinoma AJCC v7 C0854991 CTRP Malignant Stage_I_Squamous_Cell_Lung_Carcinoma Stage I Epidermoid Cell Carcinoma of Lung Stage I Epidermoid Cell Carcinoma of the Lung Stage I Epidermoid Cell Lung Carcinoma Stage I Lung Squamous Cell Carcinoma AJCC v7 Stage I Squamous Cell Carcinoma of Lung Stage I Squamous Cell Carcinoma of the Lung Stage I Squamous Cell Lung Cancer Stage I Squamous Cell Lung Carcinoma Stage I Squamous Cell Lung Carcinoma AJCC v7 Stage I Lung Squamous Cell Carcinoma AJCC v7 Stage II includes: IIA (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0) and IIB (T2b, N1, M0); (T3, N0, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C8765 Neoplastic Process Stage II Squamous Cell Lung Carcinoma AJCC v7 Stage II Lung Squamous Cell Carcinoma AJCC v7 C0854992 CTRP Malignant Stage_II_Squamous_Cell_Lung_Carcinoma Lung Squamous Cell Carcinoma Stage II Stage II Epidermoid Cell Carcinoma of Lung Stage II Epidermoid Cell Carcinoma of the Lung Stage II Epidermoid Cell Lung Carcinoma Stage II Lung Squamous Cell Carcinoma AJCC v7 Stage II Squamous Cell Carcinoma of Lung Stage II Squamous Cell Carcinoma of the Lung Stage II Squamous Cell Lung Cancer Stage II Squamous Cell Lung Carcinoma Stage II Squamous Cell Lung Carcinoma AJCC v7 Stage II Lung Squamous Cell Carcinoma AJCC v7 Stage III includes: IIIA (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0) and IIIB (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C8766 Neoplastic Process Stage III Squamous Cell Lung Carcinoma AJCC v7 Stage III Lung Squamous Cell Carcinoma AJCC v7 C0854993 CTRP Malignant Stage_III_Squamous_Cell_Lung_Carcinoma Lung Squamous Cell Carcinoma Stage III Stage III Epidermoid Cell Carcinoma of Lung Stage III Epidermoid Cell Carcinoma of the Lung Stage III Epidermoid Cell Lung Carcinoma Stage III Lung Squamous Cell Carcinoma AJCC v7 Stage III Squamous Cell Carcinoma of Lung Stage III Squamous Cell Carcinoma of the Lung Stage III Squamous Cell Lung Cancer Stage III Squamous Cell Lung Carcinoma Stage III Squamous Cell Lung Carcinoma AJCC v7 Stage III Lung Squamous Cell Carcinoma AJCC v7 Stage IV includes: (Any T, Any N, M1a); (Any T, Any N, M1b). M1a: Lung cancer with separate tumor nodule(s) in a contralateral lobe; tumor with pleural nodules or malignant pleural (or pericardial) effusion. M1b: Distant metastasis. (AJCC 7th ed.) C8767 Neoplastic Process Stage IV Squamous Cell Lung Carcinoma AJCC v7 Stage IV Lung Squamous Cell Carcinoma AJCC v7 C0854994 CTRP Malignant Stage_IV_Squamous_Cell_Lung_Carcinoma Stage IV Epidermoid Cell Carcinoma of Lung Stage IV Epidermoid Cell Carcinoma of the Lung Stage IV Epidermoid Cell Lung Carcinoma Stage IV Lung Squamous Cell Carcinoma AJCC v7 Stage IV Squamous Cell Carcinoma of Lung Stage IV Squamous Cell Carcinoma of the Lung Stage IV Squamous Cell Lung Cancer Stage IV Squamous Cell Lung Carcinoma Stage IV Squamous Cell Lung Carcinoma AJCC v7 Stage IV Lung Squamous Cell Carcinoma AJCC v7 Stage I carcinoma of the pharynx according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions. C8768 Neoplastic Process Stage I Pharyngeal Cancer Stage I Pharyngeal Cancer C0854998 CTRP Malignant Stage_I_Pharyngeal_Cancer Pharyngeal Cancer Stage I Stage I Pharyngeal Cancer Stage I Pharyngeal Throat Cancer Stage I Pharyngeal Cancer Stage II carcinoma of the pharynx according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions. C8769 Neoplastic Process Stage II Pharyngeal Cancer Stage II Pharyngeal Cancer C0854999 CTRP Malignant Stage_II_Pharyngeal_Cancer Pharyngeal Cancer Stage II Stage II Carcinoma of Pharynx Stage II Carcinoma of the Pharynx Stage II Pharyngeal Cancer Stage II Pharyngeal Carcinoma Stage II Pharyngeal Throat Cancer Stage II Pharynx Carcinoma Stage II Pharyngeal Cancer Stage III carcinoma of the pharynx according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions. C8770 Neoplastic Process Stage III Pharyngeal Cancer Stage III Pharyngeal Cancer C0855000 CTRP Malignant Stage_III_Pharyngeal_Cancer Pharyngeal Cancer Stage III Stage III Carcinoma of Pharynx Stage III Carcinoma of the Pharynx Stage III Pharyngeal Cancer Stage III Pharyngeal Carcinoma Stage III Pharyngeal Throat Cancer Stage III Pharynx Carcinoma Stage III Pharyngeal Cancer Stage IV carcinoma of the pharynx according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions. C8771 Neoplastic Process Stage IV Pharyngeal Cancer Stage IV Pharyngeal Cancer C0855001 CTRP Malignant Stage_IV_Pharyngeal_Cancer Pharyngeal Cancer Stage IV Stage IV Carcinoma of Pharynx Stage IV Carcinoma of the Pharynx Stage IV Pharyngeal Cancer Stage IV Pharyngeal Carcinoma Stage IV Pharyngeal Throat Cancer Stage IV Pharynx Carcinoma Stage IV Pharyngeal Cancer Stage I includes: IA: (TI, N0, M0) and IB: (T2, N0, M0). TI: Tumor 3 cm or less in greatest dimension surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus. T2: Tumor with any of the following features of size or extent: More than 3cm in greatest dimension. Involves main bronchus, 2cm or more distal to the carina. Invades the visceral pleura. N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 6th ed.) C8772 Neoplastic Process Stage I Lung Cancer AJCC v6 Stage I Lung Cancer AJCC v6 C2981344 CTRP Malignant Stage_I_Lung_Cancer Stage I Carcinoma of Lung AJCC v6 Stage I Carcinoma of the Lung AJCC v6 Stage I Lung Cancer Stage I Lung Cancer AJCC v6 Stage I Lung Carcinoma AJCC v6 Stage I Lung Cancer AJCC v6 Stage III includes: IIIA (T1, N2, M0); (T2, N2, M0); (T3, N1,M0); (T3, N2, M0) or IIIB (Any T, N3, M0); (T4, Any N, M0). N1: Metastasis to ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, and intrapulmonary nodes including involvement by direct extension of the primary tumor. N2: Metastasis to ipsilateral mediastinal and/or subcarinal lymph node(s). N3: Metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s). T1: Tumor is 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, and without bronchoscopic evidence of invasion more proximal than the lobar bronchus. T2: Tumor has any of the following features of size or extent: more than 3 cm in greatest dimension; involves the main bronchus, 2 cm or more distal to the carina; invades the visceral pleura; associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung. T3: Tumor (of any size) directly invades any of the following: chest wall (including superior sulcus tumors), diaphragm, mediastinal pleura, parietal pericardium; or tumor in the main bronchus less than 2 cm distal to the carina but without involvement of the carina; or associated atelectasis or obstructive pneumonitis of the entire lung. T4: Tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, esophagus, vertebral body, carina; or separate tumor nodules in the same lobe; or tumor with a malignant pleural effusion. M0: No distant metastasis. (AJCC 6th ed.) C8773 Neoplastic Process Stage III Lung Cancer AJCC v6 Stage III Lung Cancer AJCC v6 C2981348 CTRP Malignant Stage_III_Lung_Cancer Stage III Carcinoma of Lung AJCC v6 Stage III Carcinoma of the Lung AJCC v6 Stage III Lung Cancer Stage III Lung Cancer AJCC v6 Stage III Lung Carcinoma AJCC v6 Stage III Lung Cancer AJCC v6 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis present. (AJCC 6th ed.) C8774 Neoplastic Process Stage IV Lung Cancer AJCC v6 Stage IV Lung Cancer AJCC v6 C2981352 CTRP Malignant Stage_IV_Lung_Cancer Stage IV Carcinoma of Lung AJCC v6 Stage IV Carcinoma of the Lung AJCC v6 Stage IV Lung Cancer Stage IV Lung Cancer AJCC v6 Stage IV Lung Carcinoma AJCC v6 Unspecified Stage IV Carcinoma of Lung AJCC v6 Unspecified Stage IV Carcinoma of the Lung AJCC v6 Stage IV Lung Cancer AJCC v6 A small round cell tumor with neural differentiation arising from the bone. It may be associated with pain. C8776 Neoplastic Process Peripheral Primitive Neuroectodermal Tumor of Bone C0855009 Cellosaurus Malignant Peripheral_Neuroectodermal_Tumor_of_Bone Bone Peripheral Neuroepithelioma Osseous Peripheral Neuroepithelioma Peripheral Neuroectodermal Tumor of Bone Peripheral Neuroectodermal Tumor of the Bone Peripheral Neuroepithelioma of Bone Peripheral Neuroepithelioma of the Bone Peripheral Primitive Neuroectodermal Tumor of Bone Peripheral Primitive Neuroectodermal Tumor of Bone Stage IIA includes: (T3, N0, M0); (T2, N1, M0); (T1, N2, M0). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures. N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. N2: Metastasis in 3-6 regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C87775 Neoplastic Process Stage IIA Gastric Cancer AJCC v7 Stage IIA Gastric Cancer AJCC v7 CL415534 CTRP Malignant Stage IIA Gastric (Stomach) Cancer Stage IIA Gastric Cancer Stage IIA Gastric Cancer AJCC v7 Stage IIA Gastric Cancer AJCC v7 Stage IIB includes: (T4a, N0, M0); (T3, N1, M0); (T2, N2, M0); (T1, N3, M0). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures. T4a: Tumor invades serosa (visceral peritoneum). N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. N2: Metastasis in 3-6 regional lymph nodes. N3: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C87776 Neoplastic Process Stage IIB Gastric Cancer AJCC v7 Stage IIB Gastric Cancer AJCC v7 CL415535 CTRP Malignant Stage IIB Gastric (Stomach) Cancer Stage IIB Gastric Cancer Stage IIB Gastric Cancer AJCC v7 Stage IIB Gastric Cancer AJCC v7 Stage IIIC includes: (T4b, N2, M0); (T4b, N3, M0); (T4a, N3, M0). T4a: Tumor invades serosa (visceral peritoneum). T4b: Tumor invades adjacent structures. N2: Metastasis in 3-6 regional lymph nodes. N3: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C87777 Neoplastic Process Stage IIIC Gastric Cancer AJCC v7 Stage IIIC Gastric Cancer AJCC v7 CL415536 CTRP Malignant Stage IIIC Gastric (Stomach) Cancer Stage IIIC Gastric Cancer Stage IIIC Gastric Cancer AJCC v7 Stage IIIC Gastric Cancer AJCC v7 A non-disseminated skeletal or extraskeletal chondrosarcoma. C8778 Neoplastic Process Localized Chondrosarcoma C0855011 Malignant Localized_Chondrosarcoma Chondrosarcoma, Localized Localized Chondrosarcoma Localized Chondrosarcoma Stage IA includes: T1, N0, M0, G1, GX, Tumor location: Any. T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated. GX: Grade cannot be assessed-stage grouping as G1. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. (AJCC 7th ed.) C87780 Neoplastic Process Stage IA Esophageal Squamous Cell Carcinoma AJCC v7 Stage IA Esophageal Squamous Cell Carcinoma AJCC v7 C2981368 CTRP Malignant Stage IA Esophageal Squamous Cell Cancer Stage IA Esophageal Squamous Cell Carcinoma Stage IA Esophageal Squamous Cell Carcinoma AJCC v7 Stage IA Esophageal Squamous Cell Carcinoma AJCC v7 Stage IB includes: (T1, N0, M0, G2-3, Tumor location: Any); (T2-3, N0, M0, G1, GX, Tumor location: Lower, X). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated. GX: Grade cannot be assessed-stage grouping as G1. G2: Moderately differentiated. G3: Poorly differentiated. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. (AJCC 7th ed.) C87781 Neoplastic Process Stage IB Esophageal Squamous Cell Carcinoma AJCC v7 Stage IB Esophageal Squamous Cell Carcinoma AJCC v7 C2981369 CTRP Malignant Stage IB Esophageal Squamous Cell Cancer Stage IB Esophageal Squamous Cell Carcinoma Stage IB Esophageal Squamous Cell Carcinoma AJCC v7 Stage IB Esophageal Squamous Cell Carcinoma AJCC v7 Stage IA includes: T1, N0, M0, G1-2, X. T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated. G2: Moderately differentiated. GX: Grade cannot be assessed-stage grouping as G1. (AJCC 7th ed.) C87782 Neoplastic Process Stage IA Esophageal Adenocarcinoma AJCC v7 Stage IA Esophageal Adenocarcinoma AJCC v7 C2981370 CTRP Malignant Stage IA Esophageal Adenocarcinoma Stage IA Esophageal Adenocarcinoma AJCC v7 Stage IA Esophageal Adenocarcinoma AJCC v7 Stage IB includes: (T1, N0, M0, G3); (T2, N0, M0, G1-2, GX). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated. G2: Moderately differentiated. G3: Poorly differentiated. GX: Grade cannot be assessed-stage grouping as G1. (AJCC 7th ed.) C87783 Neoplastic Process Stage IB Esophageal Adenocarcinoma AJCC v7 Stage IB Esophageal Adenocarcinoma AJCC v7 C2981371 CTRP Malignant Stage IB Esophageal Adenocarcinoma Stage IB Esophageal Adenocarcinoma AJCC v7 Stage IB Esophageal Adenocarcinoma AJCC v7 Stage IIIA includes: (T1-2, N2, M0, Any G); (T3, N1, M0, Any G); (T4a, N0, M0, Any G). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades adventitia. T4a: Resectable tumor invading pleura, pericardium, or diaphragm. N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. N2: Metastasis in 3-6 regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C87784 Neoplastic Process Stage IIIA Esophageal Adenocarcinoma AJCC v7 Stage IIIA Esophageal Adenocarcinoma AJCC v7 C2981372 CTRP Malignant Stage IIIA Esophageal Adenocarcinoma Stage IIIA Esophageal Adenocarcinoma AJCC v7 Stage IIIA Esophageal Adenocarcinoma AJCC v7 Stage IIIB includes: T3, N2, M0, Any G. T3: Tumor invades adventitia. N2: Metastasis in 3-6 regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C87785 Neoplastic Process Stage IIIB Esophageal Adenocarcinoma AJCC v7 Stage IIIB Esophageal Adenocarcinoma AJCC v7 C2981373 CTRP Malignant Stage IIIB Esophageal Adenocarcinoma Stage IIIB Esophageal Adenocarcinoma AJCC v7 Stage IIIB Esophageal Adenocarcinoma AJCC v7 Stage IIIC includes: (T4a, N1-2, M0, Any G); (T4b, Any N, M0, Any G); (Any T, N3, M0, Any G). T4a: Resectable tumor invading pleura, pericardium, or diaphragm. T4b: Unresectable tumor invading other adjacent structures, such as aorta, vertebral body, trachea, etc. N1: Metastasis in 1-2 regional lymph nodes. N2: Metastasis in 3-6 regional lymph nodes. N3: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C87786 Neoplastic Process Stage IIIC Esophageal Adenocarcinoma AJCC v7 Stage IIIC Esophageal Adenocarcinoma AJCC v7 C2981374 CTRP Malignant Stage IIIC Esophageal Adenocarcinoma Stage IIIC Esophageal Adenocarcinoma AJCC v7 Stage IIIC Esophageal Adenocarcinoma AJCC v7 Stage IIIA includes: (T1-2, N2, M0, Any G, Tumor location: Any); (T3, N1, M0, Any G, Tumor location: Any); (T4a, N0, M0, Any G, Tumor location: Any). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades adventitia. T4a: Resectable tumor invading pleura, pericardium, or diaphragm. N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. N2: Metastasis in 3-6 regional lymph nodes. M0: No distant metastasis. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. (AJCC 7th ed.) C87787 Neoplastic Process Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v7 Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v7 C2981375 CTRP Malignant Stage IIIA Esophageal Squamous Cell Cancer Stage IIIA Esophageal Squamous Cell Carcinoma Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v7 Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v7 Stage IIIB includes: T3, N2, M0, Any G, Tumor location: Any. T3: Tumor invades adventitia. N2: Metastasis in 3-6 regional lymph nodes. M0: No distant metastasis. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. (AJCC 7th ed.) C87788 Neoplastic Process Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7 Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7 C2981376 CTRP Malignant Stage IIIB Esophageal Squamous Cell Cancer Stage IIIB Esophageal Squamous Cell Carcinoma Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7 Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7 Stage IIIC includes: (T4a, N1-2, M0, Any G, Tumor location: Any); (T4b, Any N, M0, Any G, Tumor location: Any); (Any T, N3, M0, Any G, Tumor location: Any). T4a: Resectable tumor invading pleura, pericardium, or diaphragm. T4b: Unresectable tumor invading other adjacent structures, such as aorta, vertebral body, trachea, etc. N1: Metastasis in 1-2 regional lymph nodes. N2: Metastasis in 3-6 regional lymph nodes. N3: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. (AJCC 7th ed.) C87789 Neoplastic Process Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7 Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7 C2981377 CTRP Malignant Stage IIIC Esophageal Squamous Cell Cancer Stage IIIC Esophageal Squamous Cell Carcinoma Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7 Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7 A chondrosarcoma that has spread to a secondary anatomical site. C8779 Neoplastic Process Metastatic Chondrosarcoma C0855012 Malignant Metastatic_Chondrosarcoma Chondrosarcoma, Metastatic Metastatic Chondrosarcoma Metastatic Chondrosarcoma Stage IIA includes: T3, N0, M0. T3: Tumor invades through the muscularis propria into the subserosa or into the nonperitonealized perimuscular tissue (mesentery or retroperitoneum) with extension 2 cm or less. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87791 Neoplastic Process Stage IIA Small Intestinal Cancer AJCC v7 Stage IIA Small Intestinal Cancer AJCC v7 C2981378 CTRP Malignant Stage IIA Small Intestinal Cancer Stage IIA Small Intestinal Cancer AJCC v7 Stage IIA Small Intestinal Cancer AJCC v7 Stage IIB includes: T4, N0, M0. T4: Tumor perforates the visceral peritoneum or directly invades other organs or structures (including other loops of small intestine, mesentery, or retroperitoneum more than 2 cm, and abdominal wall by way of serosa; for duodenum only, invasion of pancreas or bile duct). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87792 Neoplastic Process Stage IIB Small Intestinal Cancer AJCC v7 Stage IIB Small Intestinal Cancer AJCC v7 C2981379 CTRP Malignant Stage IIB Small Intestinal Cancer Stage IIB Small Intestinal Cancer AJCC v7 Stage IIB Small Intestinal Cancer AJCC v7 Stage IIIA includes: Any T, N1, M0. N1: Metastasis in 1-3 regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C87793 Neoplastic Process Stage IIIA Small Intestinal Cancer AJCC v7 Stage IIIA Small Intestinal Cancer AJCC v7 C2981380 CTRP Malignant Stage IIIA Small Intestinal Cancer Stage IIIA Small Intestinal Cancer AJCC v7 Stage IIIA Small Intestinal Cancer AJCC v7 Stage IIIB includes: Any T, N2, M0. N2: Metastasis in four or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C87795 Neoplastic Process Stage IIIB Small Intestinal Cancer AJCC v7 Stage IIIB Small Intestinal Cancer AJCC v7 C2981381 CTRP Malignant Stage IIIB Small Intestinal Cancer Stage IIIB Small Intestinal Cancer AJCC v7 Stage IIIB Small Intestinal Cancer AJCC v7 A non-Hodgkin or Hodgkin lymphoma that has spread to the central nervous system following the initial presentation in another nodal or extranodal site. C87797 Neoplastic Process Secondary Central Nervous System Lymphoma Secondary Central Nervous System Lymphoma C1704231 CTRP Malignant Secondary Central Nervous System Lymphoma Secondary Central Nervous System Lymphoma Stage I includes: (T1, N0, M0); (T2, N0, M0). T1: Tumor invades submucosa. T2: Tumor invades muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87798 Neoplastic Process Stage I Appendix Carcinoma AJCC v7 Stage I Appendix Carcinoma AJCC v7 C2981384 CTRP Malignant Stage I Appendix Cancer Stage I Appendix Carcinoma Stage I Appendix Carcinoma AJCC v7 Stage I Appendix Carcinoma AJCC v7 Stage IIA includes: T3, N0, M0. T3: Tumor invades through the muscularis propria into subserosa or into mesoappendix. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87799 Neoplastic Process Stage IIA Appendix Carcinoma AJCC v7 Stage IIA Appendix Carcinoma AJCC v7 C2981385 CTRP Malignant Stage IIA Appendix Cancer Stage IIA Appendix Carcinoma Stage IIA Appendix Carcinoma AJCC v7 Stage IIA Appendix Carcinoma AJCC v7 The reemergence of chondrosarcoma after a period of remission. C8780 Neoplastic Process Recurrent Chondrosarcoma C0855013 Malignant Recurrent_Chondrosarcoma Chondrosarcoma, Recurrent Recurrent Chondrosarcoma Relapsed Chondrosarcoma Recurrent Chondrosarcoma Stage IIB includes: T4a, N0, M0. T4a: Tumor penetrates visceral peritoneum including mucinous peritoneal tumor within the right lower quadrant. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87800 Neoplastic Process Stage IIB Appendix Carcinoma AJCC v7 Stage IIB Appendix Carcinoma AJCC v7 C2981386 CTRP Malignant Stage IIB Appendix Cancer Stage IIB Appendix Carcinoma Stage IIB Appendix Carcinoma AJCC v7 Stage IIB Appendix Carcinoma AJCC v7 Stage IIC includes: T4b, N0, M0. T4b: Tumor directly invades other organs or structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87801 Neoplastic Process Stage IIC Appendix Carcinoma AJCC v7 Stage IIC Appendix Carcinoma AJCC v7 C2981387 CTRP Malignant Stage IIC Appendix Cancer Stage IIC Appendix Carcinoma Stage IIC Appendix Carcinoma AJCC v7 Stage IIC Appendix Carcinoma AJCC v7 Stage IIIA includes: (T1, N1, M0); (T2, N1, M0). T1: Tumor invades submucosa. T2: Tumor invades muscularis propria. N1: Metastasis in 1-3 regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C87803 Neoplastic Process Stage IIIA Appendix Carcinoma AJCC v7 Stage IIIA Appendix Carcinoma AJCC v7 C2981388 CTRP Malignant Stage IIIA Appendix Cancer Stage IIIA Appendix Carcinoma Stage IIIA Appendix Carcinoma AJCC v7 Stage IIIA Appendix Carcinoma AJCC v7 Stage IIIB includes: (T3, N1, M0); (T4, N1, M0). T3: Tumor invades through the muscularis propria into subserosa or into mesoappendix. T4: Tumor penetrates visceral peritoneum including mucinous peritoneal tumor within the right lower quadrant and/or directly invades other organs or structures. N1: Metastasis in 1-3 regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C87804 Neoplastic Process Stage IIIB Appendix Carcinoma AJCC v7 Stage IIIB Appendix Carcinoma AJCC v7 C2981389 CTRP Malignant Stage IIIB Appendix Cancer Stage IIIB Appendix Carcinoma Stage IIIB Appendix Carcinoma AJCC v7 Stage IIIB Appendix Carcinoma AJCC v7 Stage IIIC includes: Any T, N2, M0. N2: Metastasis in four or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C87805 Neoplastic Process Stage IIIC Appendix Carcinoma AJCC v7 Stage IIIC Appendix Carcinoma AJCC v7 C2981390 CTRP Malignant Stage IIIC Appendix Cancer Stage IIIC Appendix Carcinoma Stage IIIC Appendix Carcinoma AJCC v7 Stage IIIC Appendix Carcinoma AJCC v7 Stage IVA includes: Any T, N0, M1a, G1. N0: No regional lymph node metastasis. M1a: Intraperitoneal metastasis beyond the right lower quadrant, including pseudomyxoma peritonei. G1: Well differentiated tumor. (AJCC 7th ed.) C87806 Neoplastic Process Stage IVA Appendix Carcinoma AJCC v7 Stage IVA Appendix Carcinoma AJCC v7 C2981391 CTRP Malignant Stage IVA Appendix Cancer Stage IVA Appendix Carcinoma Stage IVA Appendix Carcinoma AJCC v7 Stage IVA Appendix Carcinoma AJCC v7 Stage IVB includes: (Any T, N0, M1a, G2, G3); (Any T, N1, M1a, Any G); (Any T, N2, M1a, Any G). N0: No regional lymph node metastasis. N1: Metastasis in 1-3 regional lymph nodes. N2: Metastasis in four or more regional lymph nodes. M1a: Intraperitoneal metastasis beyond the right lower quadrant, including pseudomyxoma peritonei. G2: Moderately differentiated tumor. G3: Poorly differentiated tumor. (AJCC 7th ed.) C87807 Neoplastic Process Stage IVB Appendix Carcinoma AJCC v7 Stage IVB Appendix Carcinoma AJCC v7 C2981392 CTRP Malignant Stage IVB Appendix Cancer Stage IVB Appendix Carcinoma Stage IVB Appendix Carcinoma AJCC v7 Stage IVB Appendix Carcinoma AJCC v7 Stage IVC includes: Any T, Any N, M1b, Any G. M1b: Nonperitoneal metastasis. (AJCC 7th ed.) C87808 Neoplastic Process Stage IVC Appendix Carcinoma AJCC v7 Stage IVC Appendix Carcinoma AJCC v7 C2981393 CTRP Malignant Stage IVC Appendix Cancer Stage IVC Appendix Carcinoma Stage IVC Appendix Carcinoma AJCC v7 Stage IVC Appendix Carcinoma AJCC v7 Stage I includes: T1, N0, M0. T1: Tumor 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87809 Neoplastic Process Stage I Appendix Neuroendocrine Tumor AJCC v7 Stage I Appendix Neuroendocrine Tumor AJCC v7 C2981394 CTRP Malignant Stage I Appendix Carcinoid Tumor Stage I Appendix Carcinoid Tumor AJCC v7 Stage I Appendix Neuroendocrine Tumor Stage I Appendix Neuroendocrine Tumor AJCC v7 Stage I Appendix Neuroendocrine Tumor AJCC v7 Stage I includes: IA: (T1a, N0, M0); IB: (T1b, N0, M0); (T2a, N0, M0). T1a: Cutaneous melanoma with a tumor measuring 1.0 mm or less in thickness, without ulceration and mitosis less than 1/mm2. T1b: Cutaneous melanoma with a tumor measuring 1.0 mm or less in thickness, with ulceration or mitoses equal to or more than 1/mm2. T2a: Cutaneous melanoma with a tumor measuring 1.01-2.0 mm in thickness, without ulceration. N0: No regional lymph node metastases. M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.) C8781 Neoplastic Process Stage I Acral Lentiginous Melanoma AJCC v7 Stage I Acral Lentiginous Melanoma AJCC v7 C0855015 CTRP Malignant Stage_I_Acral_Lentiginous_Melanoma Stage I Acral Lentiginous Melanoma Stage I Acral Lentiginous Melanoma AJCC v7 Stage I Acral Melanoma AJCC v7 Stage I Acral Lentiginous Melanoma AJCC v7 Stage II includes: T2, T3, N0, M0. T2: Tumor more than 2 cm but not more than 4 cm or with extension to the cecum. T3: Tumor more than 4 cm or with extension to the ileum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87810 Neoplastic Process Stage II Appendix Neuroendocrine Tumor AJCC v7 Stage II Appendix Neuroendocrine Tumor AJCC v7 C2981395 CTRP Malignant Stage II Appendix Carcinoid Tumor Stage II Appendix Carcinoid Tumor AJCC v7 Stage II Appendix Neuroendocrine Tumor Stage II Appendix Neuroendocrine Tumor AJCC v7 Stage II Appendix Neuroendocrine Tumor AJCC v7 Stage III includes: (T4, N0, M0); (Any T, N1, M0). T4: Tumor directly invades other adjacent organs or structures, e.g., abdominal wall and skeletal muscle. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87811 Neoplastic Process Stage III Appendix Neuroendocrine Tumor AJCC v7 Stage III Appendix Neuroendocrine Tumor AJCC v7 C2981396 CTRP Malignant Stage III Appendix Carcinoid Tumor Stage III Appendix Carcinoid Tumor AJCC v7 Stage III Appendix Neuroendocrine Tumor Stage III Appendix Neuroendocrine Tumor AJCC v7 Stage III Appendix Neuroendocrine Tumor AJCC v7 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C87812 Neoplastic Process Stage IV Appendix Neuroendocrine Tumor AJCC v7 Stage IV Appendix Neuroendocrine Tumor AJCC v7 C2981397 CTRP Malignant Stage IV Appendix Carcinoid Tumor Stage IV Appendix Carcinoid Tumor AJCC v7 Stage IV Appendix Neuroendocrine Tumor Stage IV Appendix Neuroendocrine Tumor AJCC v7 Stage IV Appendix Neuroendocrine Tumor AJCC v7 Stage IIA includes: T3, N0, M0. T3: Tumor invades through the muscularis propria into pericolorectal tissues. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87813 Neoplastic Process Stage IIA Colorectal Cancer AJCC v7 Stage IIA Colorectal Cancer AJCC v7 C2981398 CTRP Malignant Stage IIA Colorectal (Colon or Rectal) Cancer Stage IIA Colorectal Cancer Stage IIA Colorectal Cancer AJCC v7 Stage IIA Colorectal Cancer AJCC v7 Stage IIB includes: T4a, N0, M0. T4a: Tumor penetrates to the surface of the visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87814 Neoplastic Process Stage IIB Colorectal Cancer AJCC v7 Stage IIB Colorectal Cancer AJCC v7 C2981399 CTRP Malignant Stage IIB Colorectal (Colon or Rectal) Cancer Stage IIB Colorectal Cancer Stage IIB Colorectal Cancer AJCC v7 Stage IIB Colorectal Cancer AJCC v7 Stage IIC includes: T4b, N0, M0. T4b: Tumor directly invades or is adherent to other organs or structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87815 Neoplastic Process Stage IIC Colorectal Cancer AJCC v7 Stage IIC Colorectal Cancer AJCC v7 C2981400 CTRP Malignant Stage IIC Colorectal (Colon or Rectal) Cancer Stage IIC Colorectal Cancer Stage IIC Colorectal Cancer AJCC v7 Stage IIC Colorectal Cancer AJCC v7 Stage IIIA includes: (T1-T2, N1/N1c, M0); (T1, N2a, M0). T1: Tumor invades submucosa. T2: Tumor invades muscularis propria. N1: Metastasis in 1-3 regional lymph nodes. N1c: Tumor deposit(s) in the subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional lymph node metastasis. N2a: Metastasis in 4-6 regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C87816 Neoplastic Process Stage IIIA Colorectal Cancer AJCC v7 Stage IIIA Colorectal Cancer AJCC v7 C2981401 CTRP Malignant Stage IIIA Colorectal (Colon or Rectal) Cancer Stage IIIA Colorectal Cancer Stage IIIA Colorectal Cancer AJCC v7 Stage IIIA Colorectal Cancer AJCC v7 Stage IIIB includes: (T3-T4a, N1/N1c, M0); (T2-T3, N2a, M0); (T1-T2, N2b, M0). T1: Tumor invades submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor penetrates to the surface of the visceral peritoneum. N1: Metastasis in 1-3 regional lymph nodes. N1c: Tumor deposit(s) in the subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional lymph node metastasis. N2a: Metastasis in 4-6 regional lymph nodes. N2b: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C87817 Neoplastic Process Stage IIIB Colorectal Cancer AJCC v7 Stage IIIB Colorectal Cancer AJCC v7 C2981402 CTRP Malignant Stage IIIB Colorectal (Colon or Rectal) Cancer Stage IIIB Colorectal Cancer Stage IIIB Colorectal Cancer AJCC v7 Stage IIIB Colorectal Cancer AJCC v7 Stage IIIC includes: (T4a, N2a, M0); (T3-T4a, N2b, M0); (T4b, N1-N2, M0). T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor penetrates to the surface of the visceral peritoneum. T4b: Tumor directly invades or is adherent to other organs or structures. N1: Metastasis in 1-3 regional lymph nodes. N2: Metastasis in four or more regional lymph nodes. N2a: Metastasis in 4-6 regional lymph nodes. N2b: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C87818 Neoplastic Process Stage IIIC Colorectal Cancer AJCC v7 Stage IIIC Colorectal Cancer AJCC v7 C2981403 CTRP Malignant Stage IIIC Colorectal (Colon or Rectal) Cancer Stage IIIC Colorectal Cancer Stage IIIC Colorectal Cancer AJCC v7 Stage IIIC Colorectal Cancer AJCC v7 Stage IVA includes: Any T, Any N, M1a. M1a: Metastasis confined to one organ or site (e.g., liver, lung, ovary, nonregional node). (AJCC 7th ed.) C87819 Neoplastic Process Stage IVA Colorectal Cancer AJCC v7 Stage IVA Colorectal Cancer AJCC v7 C2981404 CTRP Malignant Stage IVA Colorectal (Colon or Rectal) Cancer Stage IVA Colorectal Cancer Stage IVA Colorectal Cancer AJCC v7 Stage IVA Colorectal Cancer AJCC v7 Stage II includes: IIA: (T2b, N0, M0); (T3a, N0, M0); IIB: (T3b, N0, M0); (T4a, N0, M0); IIC: (T4b, N0, M0). T2b: Cutaneous melanoma with a tumor measuring 1.01-2.0 mm in thickness, with ulceration. T3a: Cutaneous melanoma with a tumor measuring 2.01-4.0 mm in thickness, without ulceration. T3b: Cutaneous melanoma with a tumor measuring 2.01-4.0 mm in thickness, with ulceration. T4a: Cutaneous melanoma with a tumor measuring more than 4.0 mm in thickness, without ulceration. T4b: Cutaneous melanoma with a tumor measuring more than 4.0 mm in thickness, with ulceration. N0: No regional lymph node metastases. M0: No detectable evidence of distant metastases. (from AJCC 6th and 7th Ed.) C8782 Neoplastic Process Stage II Acral Lentiginous Melanoma AJCC v6 and v7 Stage II Acral Lentiginous Melanoma AJCC v6 and v7 C0855016 CTRP Malignant Stage_II_Acral_Lentiginous_Melanoma Stage II Acral Lentiginous Melanoma Stage II Acral Lentiginous Melanoma AJCC v6 and v7 Stage II Acral Melanoma AJCC v6 and v7 Stage II Acral Lentiginous Melanoma AJCC v6 and v7 Stage IVB includes: Any T, Any N, M1b. M1b: Metastases in more than one organ/site or the peritoneum. (AJCC 7th ed.) C87820 Neoplastic Process Stage IVB Colorectal Cancer AJCC v7 Stage IVB Colorectal Cancer AJCC v7 C2981405 CTRP Malignant Stage IVB Colorectal (Colon or Rectal) Cancer Stage IVB Colorectal Cancer Stage IVB Colorectal Cancer AJCC v7 Stage IVB Colorectal Cancer AJCC v7 Stage IA includes: T1 or T2, N0, M0, Mitotic rate: Low. T1: Tumor 2 cm or less in greatest dimension. T2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87825 Neoplastic Process Stage IA Gastric Gastrointestinal Stromal Tumor Stage IA Gastric Gastrointestinal Stromal Tumor C2981409 CTRP Undetermined Stage IA Gastric (Stomach) Gastrointestinal Stromal Tumor (GIST) Stage IA Gastric Gastrointestinal Stromal Tumor Stage IA Gastric Gastrointestinal Stromal Tumor AJCC v7 Stage IA Gastric Gastrointestinal Stromal Tumor Stage IB includes: T3, N0, M0, Mitotic rate: Low. T3: Tumor more than 5 cm, but not more than 10 cm, in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87826 Neoplastic Process Stage IB Gastric Gastrointestinal Stromal Tumor Stage IB Gastric Gastrointestinal Stromal Tumor C2981410 CTRP Undetermined Stage IB Gastric (Stomach) Gastrointestinal Stromal Tumor (GIST) Stage IB Gastric Gastrointestinal Stromal Tumor Stage IB Gastric Gastrointestinal Stromal Tumor AJCC v7 Stage IB Gastric Gastrointestinal Stromal Tumor Stage II includes: (T1, N0, M0, Mitotic rate: High); (T2, N0, M0, Mitotic rate: High); (T4, N0, M0, Mitotic rate: Low). T1: Tumor 2 cm or less in greatest dimension. T2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension. T4: Tumor more than 10 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87827 Neoplastic Process Stage II Gastric Gastrointestinal Stromal Tumor Stage II Gastric Gastrointestinal Stromal Tumor C2981411 CTRP Undetermined Stage II Gastric (Stomach) Gastrointestinal Stromal Tumor (GIST) Stage II Gastric Gastrointestinal Stromal Tumor Stage II Gastric Gastrointestinal Stromal Tumor AJCC v7 Stage II Gastric Gastrointestinal Stromal Tumor Stage IIIA includes: T3, N0, M0, Mitotic rate: High. T3: Tumor more than 5 cm, but not more than 10 cm, in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87828 Neoplastic Process Stage IIIA Gastric Gastrointestinal Stromal Tumor Stage IIIA Gastric Gastrointestinal Stromal Tumor C2981412 CTRP Undetermined Stage IIIA Gastric (Stomach) Gastrointestinal Stromal Tumor (GIST) Stage IIIA Gastric Gastrointestinal Stromal Tumor Stage IIIA Gastric Gastrointestinal Stromal Tumor AJCC v7 Stage IIIA Gastric Gastrointestinal Stromal Tumor Stage IIIB includes: T4, N0, M0, Mitotic rate: High. T4: Tumor more than 10 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87829 Neoplastic Process Stage IIIB Gastric Gastrointestinal Stromal Tumor Stage IIIB Gastric Gastrointestinal Stromal Tumor C2981413 CTRP Undetermined Stage IIIB Gastric (Stomach) Gastrointestinal Stromal Tumor (GIST) Stage IIIB Gastric Gastrointestinal Stromal Tumor Stage IIIB Gastric Gastrointestinal Stromal Tumor AJCC v7 Stage IIIB Gastric Gastrointestinal Stromal Tumor Stage III includes: Any T, N1-3, M0. Stage III is divided into three pathologic subgroups: IIIA, IIIB, and IIIC. There are no clinical subgroups for stage III. N1: Cutaneous melanoma with metastasis in one regional lymph node. N2: Cutaneous melanoma with metastases in 2-3 regional lymph nodes or in transit met(s)/satellite(s) without metastatic nodes. N3: Cutaneous melanoma with 4 or more metastatic nodes, or matted nodes, or in transit met(s)/satellite(s) with metastatic node(s). M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.) C8783 Neoplastic Process Stage III Acral Lentiginous Melanoma AJCC v7 Stage III Acral Lentiginous Melanoma AJCC v7 C0855017 CTRP Malignant Stage_III_Acral_Lentiginous_Melanoma Stage III Acral Lentiginous Melanoma Stage III Acral Lentiginous Melanoma AJCC v7 Stage III Acral Melanoma AJCC v7 Stage III Acral Lentiginous Melanoma AJCC v7 Stage IV includes: (Any T, N1, M0, Mitotic rate: Any rate); (Any T, Any N, M1, Mitotic rate: Any rate). N1: Regional lymph node metastasis. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C87830 Neoplastic Process Stage IV Gastric Gastrointestinal Stromal Tumor Stage IV Gastric Gastrointestinal Stromal Tumor C2981414 CTRP Undetermined Stage IV Gastric (Stomach) Gastrointestinal Stromal Tumor (GIST) Stage IV Gastric Gastrointestinal Stromal Tumor Stage IV Gastric Gastrointestinal Stromal Tumor AJCC v7 Stage IV Gastric Gastrointestinal Stromal Tumor Stage I includes: T1 or T2, N0, M0, Mitotic rate: Low. T1: Tumor 2 cm or less in greatest dimension. T2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87831 Neoplastic Process Stage I Small Intestinal Gastrointestinal Stromal Tumor Stage I Small Intestinal Gastrointestinal Stromal Tumor C2981415 CTRP Undetermined Stage I Small Intestinal Gastrointestinal Stromal Tumor Stage I Small Intestinal Gastrointestinal Stromal Tumor (GIST) Stage I Small Intestinal Gastrointestinal Stromal Tumor AJCC v7 Stage I Small Intestinal Gastrointestinal Stromal Tumor Stage II includes: T3, N0, M0, Mitotic rate: Low. T3: Tumor more than 5 cm, but not more than 10 cm, in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87832 Neoplastic Process Stage II Small Intestinal Gastrointestinal Stromal Tumor Stage II Small Intestinal Gastrointestinal Stromal Tumor C2981416 CTRP Undetermined Stage II Small Intestinal Gastrointestinal Stromal Tumor Stage II Small Intestinal Gastrointestinal Stromal Tumor (GIST) Stage II Small Intestinal Gastrointestinal Stromal Tumor AJCC v7 Stage II Small Intestinal Gastrointestinal Stromal Tumor Stage IIIA includes: (T1, N0, M0, Mitotic rate: High); (T4, N0, M0, Mitotic rate: Low). T1: Tumor 2 cm or less in greatest dimension. T4: Tumor more than 10 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87833 Neoplastic Process Stage IIIA Small Intestinal Gastrointestinal Stromal Tumor Stage IIIA Small Intestinal Gastrointestinal Stromal Tumor C2981417 CTRP Undetermined Stage IIIA Small Intestinal Gastrointestinal Stromal Tumor Stage IIIA Small Intestinal Gastrointestinal Stromal Tumor (GIST) Stage IIIA Small Intestinal Gastrointestinal Stromal Tumor AJCC v7 Stage IIIA Small Intestinal Gastrointestinal Stromal Tumor Stage IIIB includes: (T2, N0, M0, Mitotic rate: High); (T3, N0, M0, Mitotic rate: High); (T4, N0, M0, Mitotic rate: High). T2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension. T3: Tumor more than 5 cm, but not more than 10 cm, in greatest dimension. T4: Tumor more than 10 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C87834 Neoplastic Process Stage IIIB Small Intestinal Gastrointestinal Stromal Tumor Stage IIIB Small Intestinal Gastrointestinal Stromal Tumor C2981418 CTRP Undetermined Stage IIIB Small Intestinal Gastrointestinal Stromal Tumor Stage IIIB Small Intestinal Gastrointestinal Stromal Tumor (GIST) Stage IIIB Small Intestinal Gastrointestinal Stromal Tumor AJCC v7 Stage IIIB Small Intestinal Gastrointestinal Stromal Tumor Stage IV includes: (Any T, N1, M0, Mitotic rate: Any rate); (Any T, Any N, M1, Mitotic rate: Any rate). N1: Regional lymph node metastasis. M1: Distant metastasis. (AJCC 7th ed.) C87835 Neoplastic Process Stage IV Small Intestinal Gastrointestinal Stromal Tumor Stage IV Small Intestinal Gastrointestinal Stromal Tumor C2981419 CTRP Undetermined Stage IV Small Intestinal Gastrointestinal Stromal Tumor Stage IV Small Intestinal Gastrointestinal Stromal Tumor (GIST) Stage IV Small Intestinal Gastrointestinal Stromal Tumor AJCC v7 Stage IV Small Intestinal Gastrointestinal Stromal Tumor Stage IV includes: (Any T, Any N, M1). M1: Distant metastasis. (from AJCC 6th and 7th Eds.) C8784 Neoplastic Process Stage IV Acral Lentiginous Melanoma AJCC v6 and v7 Stage IV Acral Lentiginous Melanoma AJCC v6 and v7 C0855018 CTRP Malignant Stage_IV_Acral_Lentiginous_Melanoma Stage IV Acral Lentiginous Melanoma Stage IV Acral Lentiginous Melanoma AJCC v6 and v7 Stage IV Acral Melanoma AJCC v6 and v7 Stage IV Acral Lentiginous Melanoma AJCC v6 and v7 The reemergence of lentigo maligna after a period of remission C8785 Neoplastic Process Recurrent Lentigo Maligna Melanoma C0855020 Malignant Recurrent_Lentigo_Maligna_Melanoma Lentigo Maligna Recurrent Recurrent Lentigo Maligna Melanoma Recurrent Lentigo Maligna Melanoma Stage I includes: IA: (T1a, N0, M0); IB: (T1b, N0, M0); (T2a, N0, M0). T1a: Cutaneous melanoma with a tumor measuring 1.0 mm or less in thickness, without ulceration and mitosis less than 1/mm2. T1b: Cutaneous melanoma with a tumor measuring 1.0 mm or less in thickness, with ulceration or mitoses equal to or more than 1/mm2. T2a: Cutaneous melanoma with a tumor measuring 1.01-2.0 mm in thickness, without ulceration. N0: No regional lymph node metastases. M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.) C8786 Neoplastic Process Stage I Lentigo Maligna Melanoma AJCC v7 Stage I Lentigo Maligna Melanoma AJCC v7 C0855021 CTRP Malignant Stage_I_Lentigo_Maligna_Melanoma Stage I Lentigo Maligna AJCC v7 Stage I Lentigo Maligna Melanoma Stage I Lentigo Maligna Melanoma AJCC v7 Stage I Lentigo Maligna Melanoma AJCC v7 Stage II includes: IIA: (T2b, N0, M0); (T3a, N0, M0); IIB: (T3b, N0, M0); (T4a, N0, M0); IIC: (T4b, N0, M0). T2b: Cutaneous melanoma with a tumor measuring 1.01-2.0 mm in thickness, with ulceration. T3a: Cutaneous melanoma with a tumor measuring 2.01-4.0 mm in thickness, without ulceration. T3b: Cutaneous melanoma with a tumor measuring 2.01-4.0 mm in thickness, with ulceration. T4a: Cutaneous melanoma with a tumor measuring more than 4.0 mm in thickness, without ulceration. T4b: Cutaneous melanoma with a tumor measuring more than 4.0 mm in thickness, with ulceration. N0: No regional lymph node metastases. M0: No detectable evidence of distant metastases. (from AJCC 6th and 7th Ed.) C8787 Neoplastic Process Stage II Lentigo Maligna Melanoma AJCC v6 and v7 Stage II Lentigo Maligna Melanoma AJCC v6 and v7 C0855022 CTRP Malignant Stage_II_Lentigo_Maligna_Melanoma Stage II Lentigo Maligna Stage II Lentigo Maligna Melanoma Stage II Lentigo Maligna Melanoma AJCC v6 and v7 Stage II Lentigo Maligna Melanoma AJCC v6 and v7 Stage III includes: Any T, N1-3, M0. Stage III is divided into three pathologic subgroups: IIIA, IIIB, and IIIC. There are no clinical subgroups for stage III. N1: Cutaneous melanoma with metastasis in one regional lymph node. N2: Cutaneous melanoma with metastases in 2-3 regional lymph nodes or in transit met(s)/satellite(s) without metastatic nodes. N3: Cutaneous melanoma with 4 or more metastatic nodes, or matted nodes, or in transit met(s)/satellite(s) with metastatic node(s). M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.) C8788 Neoplastic Process Stage III Lentigo Maligna Melanoma AJCC v7 Stage III Lentigo Maligna Melanoma AJCC v7 C0855023 CTRP Malignant Stage_III_Lentigo_Maligna_Melanoma Stage III Lentigo Maligna AJCC v7 Stage III Lentigo Maligna Melanoma Stage III Lentigo Maligna Melanoma AJCC v7 Stage III Lentigo Maligna Melanoma AJCC v7 Stage IV includes: (Any T, Any N, M1). M1: Distant metastasis. (from AJCC 6th and 7th Eds.) C8789 Neoplastic Process Stage IV Lentigo Maligna Melanoma AJCC v6 and v7 Stage IV Lentigo Maligna Melanoma AJCC v6 and v7 C0855024 CTRP Malignant Stage_IV_Lentigo_Maligna_Melanoma Stage IV Lentigo Maligna Stage IV Lentigo Maligna Melanoma Stage IV Lentigo Maligna Melanoma AJCC v6 and v7 Stage IV Lentigo Maligna Melanoma AJCC v6 and v7 Stage I includes: IA: (T1a, N0, M0); IB: (T1b, N0, M0); (T2a, N0, M0). T1a: Cutaneous melanoma with a tumor measuring 1.0 mm or less in thickness, without ulceration and mitosis less than 1/mm2. T1b: Cutaneous melanoma with a tumor measuring 1.0 mm or less in thickness, with ulceration or mitoses equal to or more than 1/mm2. T2a: Cutaneous melanoma with a tumor measuring 1.01-2.0 mm in thickness, without ulceration. N0: No regional lymph node metastases. M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.) C8790 Neoplastic Process Stage I Superficial Spreading Melanoma AJCC v7 Stage I Low-CSD Melanoma AJCC v7 C0855030 CTRP Malignant Stage_I_Superficial_Spreading_Melanoma Stage I Low-CSD Melanoma Stage I Low-CSD Melanoma AJCC v7 Stage I Low-CSD Melanoma AJCC v7 Stage II includes: IIA: (T2b, N0, M0); (T3a, N0, M0); IIB: (T3b, N0, M0); (T4a, N0, M0); IIC: (T4b, N0, M0). T2b: Cutaneous melanoma with a tumor measuring 1.01-2.0 mm in thickness, with ulceration. T3a: Cutaneous melanoma with a tumor measuring 2.01-4.0 mm in thickness, without ulceration. T3b: Cutaneous melanoma with a tumor measuring 2.01-4.0 mm in thickness, with ulceration. T4a: Cutaneous melanoma with a tumor measuring more than 4.0 mm in thickness, without ulceration. T4b: Cutaneous melanoma with a tumor measuring more than 4.0 mm in thickness, with ulceration. N0: No regional lymph node metastases. M0: No detectable evidence of distant metastases. (from AJCC 6th and 7th Ed.) C8791 Neoplastic Process Stage II Superficial Spreading Melanoma AJCC v6 and v7 Stage II Low-CSD Melanoma AJCC v7 C0855031 CTRP Malignant Stage_II_Superficial_Spreading_Melanoma Stage II Low-CSD Melanoma Stage II Low-CSD Melanoma AJCC v7 Stage II Low-CSD Melanoma AJCC v7 Stage III includes: Any T, N1-3, M0. Stage III is divided into three pathologic subgroups: IIIA, IIIB, and IIIC. There are no clinical subgroups for stage III. N1: Cutaneous melanoma with metastasis in one regional lymph node. N2: Cutaneous melanoma with metastases in 2-3 regional lymph nodes or in transit met(s)/satellite(s) without metastatic nodes. N3: Cutaneous melanoma with 4 or more metastatic nodes, or matted nodes, or in transit met(s)/satellite(s) with metastatic node(s). M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.) C8792 Neoplastic Process Stage III Superficial Spreading Melanoma AJCC v7 Stage III Low-CSD Melanoma AJCC v7 C0855032 CTRP Malignant Stage_III_Superficial_Spreading_Melanoma Stage III Low-CSD Melanoma Stage III Low-CSD Melanoma AJCC v7 Stage III Low-CSD Melanoma AJCC v7 Stage IV includes: (Any T, Any N, M1). M1: Distant metastasis. (from AJCC 6th and 7th Eds.) C8793 Neoplastic Process Stage IV Superficial Spreading Melanoma AJCC v6 and v7 Stage IV Low-CSD Melanoma AJCC v7 C0855033 CTRP Malignant Stage_IV_Superficial_Spreading_Melanoma Stage IV Low-CSD Melanoma Stage IV Low-CSD Melanoma AJCC v7 Stage IV Low-CSD Melanoma AJCC v7 Reemergence of undifferentiated pleomorphic sarcoma after a period of remission. C8795 Neoplastic Process Recurrent Undifferentiated Pleomorphic Sarcoma C0855035 Cellosaurus Malignant Recurrent_Malignant_Fibrous_Histiocytoma Malignant Fibrous Histiocytoma Recurrent Recurrent Malignant Fibrous Histiocytoma Recurrent Unclassified Pleomorphic Sarcoma Recurrent Unclassified Pleomorphic Sarcoma (Formerly Recurrent "MFH") Recurrent Unclassified Pleomorphic Sarcoma (Formerly Recurrent "Malignant Fibrous Histiocytoma") Recurrent Undifferentiated Pleomorphic Sarcoma Relapsed Malignant Fibrous Histiocytoma Recurrent Undifferentiated Pleomorphic Sarcoma An alveolar soft part sarcoma which has spread to another anatomic site. C8796 Neoplastic Process Metastatic Alveolar Soft Part Sarcoma C0855036 Malignant Metastatic_Alveolar_Soft_Part_Sarcoma Alveolar Soft Part Sarcoma Metastatic Metastatic Alveolar Soft Part Sarcoma Metastatic Alveolar Soft Part Sarcoma Alveolar soft part sarcoma that is confined to a specific site without evidence of spread to other anatomic sites. C8797 Neoplastic Process Localized Alveolar Soft Part Sarcoma C0855037 Malignant Primary_Alveolar_Soft_Part_Sarcoma Alveolar Soft Part Sarcoma Nonmetastatic Localized Alveolar Soft Part Sarcoma Non-Metastatic Alveolar Soft Part Sarcoma Localized Alveolar Soft Part Sarcoma The reemergence of alveolar soft part sarcoma after a period of remission. C8798 Neoplastic Process Recurrent Alveolar Soft Part Sarcoma C0855038 Malignant Recurrent_Alveolar_Soft_Part_Sarcoma Alveolar Soft Part Sarcoma Recurrent Recurrent Alveolar Soft Part Sarcoma Relapsed Alveolar Soft Part Sarcoma Recurrent Alveolar Soft Part Sarcoma An epithelioid sarcoma which has spread to another anatomic site. C8799 Neoplastic Process Metastatic Epithelioid Sarcoma C0855039 Malignant Metastatic_Epithelioid_Sarcoma Epithelioid Sarcoma, Metastatic Metastatic Epithelioid Cell Sarcoma Metastatic Epithelioid Sarcoma Metastatic Epithelioid Sarcoma Epithelioid sarcoma that is confined to a specific site without evidence of spread to other anatomic sites. C8800 Neoplastic Process Localized Epithelioid Sarcoma C0855040 Malignant Primary_Epithelioid_Sarcoma Epithelioid Sarcoma, Nonmetastatic Localized Epithelioid Sarcoma Non-Metastatic Epithelioid Sarcoma Localized Epithelioid Sarcoma An Ewing sarcoma of the soft tissues which has spread from its original site of growth to another anatomic site. C8801 Neoplastic Process Metastatic Extraskeletal Ewing Sarcoma C0855042 Malignant Metastatic_Extraosseous_Ewing_s_Sarcoma Extra-Osseous Ewing's Sarcoma, Metastatic Metastatic Extra-Osseous Ewing's Sarcoma Metastatic Extraosseous Ewing Sarcoma Metastatic Extraosseous Ewing's Sarcoma Metastatic Extraskeletal Ewing Sarcoma Metastatic Extraskeletal Ewing's Sarcoma Metastatic Extraskeletal Ewing Sarcoma Ewing sarcoma that arises from the soft tissue and is confined to a specific site without evidence of spread to other anatomic sites. C8802 Neoplastic Process Localized Extraskeletal Ewing Sarcoma C0855043 Malignant Non-Metastatic_Extraosseous_Ewing_s_Sarcoma Extra-Osseous Ewing's Sarcoma, Nonmetastatic Localized Extraskeletal Ewing Sarcoma Non-Metastatic Extra-Osseous Ewing's Sarcoma Non-Metastatic Extraosseous Ewing Sarcoma Non-Metastatic Extraosseous Ewing's Sarcoma Non-Metastatic Extraskeletal Ewing Sarcoma Non-Metastatic Extraskeletal Ewing's Sarcoma Localized Extraskeletal Ewing Sarcoma Stage 0 includes: Tis, N0, M0. Tis (applies only to stomach): Carcinoma in situ/dysplasia (tumor size less than 0.5 mm), confined to mucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88027 Neoplastic Process Stage 0 Digestive System Neuroendocrine Tumor AJCC v7 Stage 0 Digestive System Neuroendocrine Tumor AJCC v7 C2981609 CTRP Malignant Stage 0 Digestive System Neuroendocrine Neoplasm Stage 0 Digestive System Neuroendocrine Neoplasm AJCC v7 Stage 0 Digestive System Neuroendocrine Tumor Stage 0 Digestive System Neuroendocrine Tumor AJCC v7 Stage 0 Gastrointestinal Neuroendocrine Neoplasm Stage 0 Gastrointestinal Neuroendocrine Neoplasm AJCC v7 Stage 0 Digestive System Neuroendocrine Tumor AJCC v7 Stage I includes: T1, N0, M0. T1: Stomach: tumor invades lamina propria or submucosa and is 1 cm or less in size; duodenum /jejunum/ileum: tumor invades lamina propria or submucosa and is 1 cm or less in size; ampulla: tumor 1 cm or less; colon or rectum: tumor invades lamina propria or submucosa and is 2 cm or less. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88028 Neoplastic Process Stage I Digestive System Neuroendocrine Tumor AJCC v7 Stage I Digestive System Neuroendocrine Tumor AJCC v7 C2981610 CTRP Malignant Stage I Digestive System Neuroendocrine Neoplasm Stage I Digestive System Neuroendocrine Neoplasm AJCC v7 Stage I Digestive System Neuroendocrine Tumor Stage I Digestive System Neuroendocrine Tumor AJCC v7 Stage I Gastrointestinal Neuroendocrine Neoplasm Stage I Gastrointestinal Neuroendocrine Neoplasm AJCC v7 Stage I Digestive System Neuroendocrine Tumor AJCC v7 Stage IIA includes: T2, N0, M0. T2: Stomach/ duodenum /jejunum/ileum: tumor invades muscularis propria or is more than 1 cm in size; ampulla: tumor is more than 1 cm in size; colon or rectum: tumor invades muscularis propria or is more than 2 cm in size with invasion of lamina propria or submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88029 Neoplastic Process Stage IIA Digestive System Neuroendocrine Tumor AJCC v7 Stage IIA Digestive System Neuroendocrine Tumor AJCC v7 C2981611 CTRP Malignant Stage IIA Digestive System Neuroendocrine Neoplasm Stage IIA Digestive System Neuroendocrine Neoplasm AJCC v7 Stage IIA Digestive System Neuroendocrine Tumor Stage IIA Digestive System Neuroendocrine Tumor AJCC v7 Stage IIA Gastrointestinal Neuroendocrine Neoplasm Stage IIA Gastrointestinal Neuroendocrine Neoplasm AJCC v7 Stage IIA Digestive System Neuroendocrine Tumor AJCC v7 Reemergence of extraskeletal Ewing sarcoma after a period of remission. C8803 Neoplastic Process Recurrent Extraskeletal Ewing Sarcoma C0855045 Malignant Recurrent_Extraosseous_Ewing_s_Sarcoma Extra-Osseous Ewing's Sarcoma, Recurrent Recurrent Extra-Osseous Ewing's Sarcoma Recurrent Extraosseous Ewing Sarcoma Recurrent Extraosseous Ewing's Sarcoma Recurrent Extraskeletal Ewing Sarcoma Recurrent Extraskeletal Ewing's Sarcoma Relapsed Extra-Osseous Ewing's Sarcoma Recurrent Extraskeletal Ewing Sarcoma Stage IIB includes: T3, N0, M0. T3: Stomach: tumor penetrates subserosa; jejunum/ileum: tumor invades through the muscularis propria into subserosal tissue without penetration of overlying serosa or invades into non-peritonealized tissues; ampulla/duodenum: tumor invades pancreas or retroperitoneum or into non-peritonealized tissues; colon or rectum: tumor invades through the muscularis propria into the subserosa, or into non-peritonealized pericolic or perirectal tissues. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88030 Neoplastic Process Stage IIB Digestive System Neuroendocrine Tumor AJCC v7 Stage IIB Digestive System Neuroendocrine Tumor AJCC v7 C2981612 CTRP Malignant Stage IIB Digestive System Neuroendocrine Neoplasm Stage IIB Digestive System Neuroendocrine Neoplasm AJCC v7 Stage IIB Digestive System Neuroendocrine Tumor Stage IIB Digestive System Neuroendocrine Tumor AJCC v7 Stage IIB Gastrointestinal Neuroendocrine Neoplasm Stage IIB Gastrointestinal Neuroendocrine Neoplasm AJCC v7 Stage IIB Digestive System Neuroendocrine Tumor AJCC v7 Stage IIIA includes: T4, N0, M0. T4: Stomach/duodenum/ampulla/jejunum/ileum: tumor invades visceral peritoneum (serosa) or invades other organs or adjacent structures; colon or rectum: tumor invades peritoneum or other organs. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88031 Neoplastic Process Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7 Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7 C2981613 CTRP Malignant Stage IIIA Digestive System Neuroendocrine Neoplasm Stage IIIA Digestive System Neuroendocrine Neoplasm AJCC v7 Stage IIIA Digestive System Neuroendocrine Tumor Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7 Stage IIIA Gastrointestinal Neuroendocrine Neoplasm Stage IIIA Gastrointestinal Neuroendocrine Neoplasm AJCC v7 Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7 Stage IIIB includes: Any T, N1, M0. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88032 Neoplastic Process Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7 Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7 C2981614 CTRP Malignant Stage IIIB Digestive System Neuroendocrine Neoplasm Stage IIIB Digestive System Neuroendocrine Neoplasm AJCC v7 Stage IIIB Digestive System Neuroendocrine Tumor Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7 Stage IIIB Gastrointestinal Neuroendocrine Neoplasm Stage IIIB Gastrointestinal Neuroendocrine Neoplasm AJCC v7 Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C88033 Neoplastic Process Stage IV Digestive System Neuroendocrine Tumor AJCC v7 Stage IV Digestive System Neuroendocrine Tumor AJCC v7 C2981615 CTRP Malignant Stage IV Digestive System Neuroendocrine Neoplasm Stage IV Digestive System Neuroendocrine Neoplasm AJCC v7 Stage IV Digestive System Neuroendocrine Tumor Stage IV Digestive System Neuroendocrine Tumor AJCC v7 Stage IV Gastrointestinal Neuroendocrine Neoplasm Stage IV Gastrointestinal Neuroendocrine Neoplasm AJCC v7 Stage IV Digestive System Neuroendocrine Tumor AJCC v7 An extraskeletal myxoid chondrosarcoma which has spread to another anatomic site. C8804 Neoplastic Process Metastatic Extraskeletal Myxoid Chondrosarcoma C1708996 Malignant Metastatic_Extraskeletal_Chondrosarcoma Extraskeletal Myxoid Chondrosarcoma, Metastatic Metastatic Extraosseous Myxoid Chondrosarcoma Metastatic Extraskeletal Myxoid Chondrosarcoma Metastatic Extraskeletal Myxoid Chondrosarcoma Stage IIIC includes: T4, N0, M0. T4: Tumors(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88044 Neoplastic Process Stage IIIC Hepatocellular Carcinoma AJCC v7 Stage IIIC Hepatocellular Carcinoma AJCC v7 C2981620 CTRP Stage III adult primary liver cancer is divided into stages IIIA, IIIB, and IIIC. In stage IIIC, the cancer has spread to nearby lymph nodes. Malignant Stage IIIC Hepatocellular Cancer Stage IIIC Hepatocellular Carcinoma Stage IIIC Hepatocellular Carcinoma AJCC v7 stage IIIC adult primary liver cancer Stage IIIC Hepatocellular Carcinoma AJCC v7 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ (intraductal tumor). N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88049 Neoplastic Process Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7 Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7 C2981623 CTRP Malignant Stage 0 Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7 Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7 Stage I includes: T1, N0, M0. T1: Solitary tumor without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88050 Neoplastic Process Stage I Intrahepatic Cholangiocarcinoma AJCC v7 Stage I Intrahepatic Cholangiocarcinoma AJCC v7 C2981624 CTRP Malignant Stage I Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) Stage I Intrahepatic Cholangiocarcinoma AJCC v7 Stage I Intrahepatic Cholangiocarcinoma AJCC v7 Stage II includes: T2, N0, M0. T2: Solitary tumor with vascular invasion or multiple tumors, with or without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88051 Neoplastic Process Stage II Intrahepatic Cholangiocarcinoma AJCC v7 Stage II Intrahepatic Cholangiocarcinoma AJCC v7 C2981625 CTRP Malignant Stage II Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) Stage II Intrahepatic Cholangiocarcinoma Stage II Intrahepatic Cholangiocarcinoma AJCC v7 Stage II Intrahepatic Cholangiocarcinoma AJCC v7 Stage III includes: T3, N0, M0. T3: Tumor perforating the visceral peritoneum or involving the local extra hepatic structures by direct invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88052 Neoplastic Process Stage III Intrahepatic Cholangiocarcinoma AJCC v7 Stage III Intrahepatic Cholangiocarcinoma AJCC v7 C2981626 CTRP Malignant Stage III Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) Stage III Intrahepatic Cholangiocarcinoma Stage III Intrahepatic Cholangiocarcinoma AJCC v7 Stage III Intrahepatic Cholangiocarcinoma AJCC v7 Stage IVA includes: (T4, N0, M0); (Any T, N1, M0). T4: Tumor with periductal invasion. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88053 Neoplastic Process Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7 Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7 C2981627 CTRP Malignant Stage IVA Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) Stage IVA Intrahepatic Cholangiocarcinoma Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7 Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7 Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 7th Ed.) C88054 Neoplastic Process Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7 Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7 C2981628 CTRP Malignant Stage IVB Intrahepatic Bile Duct Cancer (Cholangiocarcinoma) Stage IVB Intrahepatic Cholangiocarcinoma Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7 Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7 Stage IIIA includes: T3, N0, M0. T3: Tumor perforates the serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88056 Neoplastic Process Stage IIIA Gallbladder Cancer AJCC v7 Stage IIIA Gallbladder Cancer AJCC v7 CL415796 CTRP Malignant Stage IIIA Gallbladder Cancer Stage IIIA Gallbladder Cancer AJCC v7 Stage IIIA Gallbladder Carcinoma AJCC v7 Stage IIIA Gallbladder Cancer AJCC v7 Stage IIIB includes: T1-3, N1, M0. T1: Tumor invades lamina propria or muscular layer. T2: Tumor invades perimuscular connective tissue; no extension beyond serosa or into liver. T3: Tumor perforates the serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts. N1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery, and/or portal vein. M0: No distant metastasis. (from AJCC 7th Ed.) C88057 Neoplastic Process Stage IIIB Gallbladder Cancer AJCC v7 Stage IIIB Gallbladder Cancer AJCC v7 CL415797 CTRP Malignant Stage IIIB Gallbladder Cancer Stage IIIB Gallbladder Cancer AJCC v7 Stage IIIB Gallbladder Carcinoma AJCC v7 Stage IIIB Gallbladder Cancer AJCC v7 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88058 Neoplastic Process Stage 0 Hilar Cholangiocarcinoma AJCC v7 Stage 0 Hilar Cholangiocarcinoma AJCC v7 C2981632 CTRP Malignant Stage 0 Hilar Cholangiocarcinoma Stage 0 Hilar Cholangiocarcinoma AJCC v7 Stage 0 Hilar Cholangiocarcinoma AJCC v7 Stage I includes: T1, N0, M0. T1: Tumor confined to the bile duct, with extension up to the muscle layer or fibrous tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88059 Neoplastic Process Stage I Hilar Cholangiocarcinoma AJCC v7 Stage I Hilar Cholangiocarcinoma AJCC v7 C2981633 CTRP Malignant Stage I Hilar Cholangiocarcinoma Stage I Hilar Cholangiocarcinoma AJCC v7 Stage I Hilar Cholangiocarcinoma AJCC v7 Stage II includes: T2a-b, N0, M0. T2a: Tumor invades beyond the wall of the bile duct to surrounding adipose tissue. T2b: Tumor invades adjacent hepatic parenchyma. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88060 Neoplastic Process Stage II Hilar Cholangiocarcinoma AJCC v7 Stage II Hilar Cholangiocarcinoma AJCC v7 C2981634 CTRP Malignant Stage II Hilar Cholangiocarcinoma Stage II Hilar Cholangiocarcinoma AJCC v7 Stage II Hilar Cholangiocarcinoma AJCC v7 Stage IIIA includes: T3, N0, M0. T3: Tumor invades unilateral branches of the portal vein or hepatic artery. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88061 Neoplastic Process Stage IIIA Hilar Cholangiocarcinoma AJCC v7 Stage IIIA Hilar Cholangiocarcinoma AJCC v7 C2981635 CTRP Malignant Stage IIIA Hilar Cholangiocarcinoma Stage IIIA Hilar Cholangiocarcinoma AJCC v7 Stage IIIA Hilar Cholangiocarcinoma AJCC v7 Stage IIIB includes: T1-3, N1, M0. T1: Tumor confined to the bile duct, with extension up to the muscle layer or fibrous tissue. T2a: Tumor invades beyond the wall of the bile duct to surrounding adipose tissue. T2b: Tumor invades adjacent hepatic parenchyma. T3: Tumor invades unilateral branches of the portal vein or hepatic artery. N1: Regional lymph node metastasis (including nodes along the cystic duct, common bile duct, hepatic artery, and portal vein). M0: No distant metastasis. (from AJCC 7th Ed.) C88062 Neoplastic Process Stage IIIB Hilar Cholangiocarcinoma AJCC v7 Stage IIIB Hilar Cholangiocarcinoma AJCC v7 C2981636 CTRP Malignant Stage IIIB Hilar Cholangiocarcinoma Stage IIIB Hilar Cholangiocarcinoma AJCC v7 Stage IIIB Hilar Cholangiocarcinoma AJCC v7 Stage IVA includes: T4, N0-1, M0. T4: Tumor invades the main portal vein or its branches bilaterally; or the common hepatic artery; or the second-order biliary radicals bilaterally; or unilateral second-order biliary radicals with contralateral portal vein or hepatic artery involvement. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis (including nodes along the cystic duct, common bile duct, hepatic artery, and portal vein). M0: No distant metastasis. (from AJCC 7th Ed.) C88063 Neoplastic Process Stage IVA Hilar Cholangiocarcinoma AJCC v7 Stage IVA Hilar Cholangiocarcinoma AJCC v7 C2981637 CTRP Malignant Stage IVA Hilar Cholangiocarcinoma Stage IVA Hilar Cholangiocarcinoma AJCC v7 Stage IVA Hilar Cholangiocarcinoma AJCC v7 Stage IVB includes: (Any T, N2, M0); (Any T, Any N, M1). N2: MetastasIs to periaortic, pericaval, superior mesenteric artery, and/or celiac artery lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (from AJCC 7th Ed.) C88064 Neoplastic Process Stage IVB Hilar Cholangiocarcinoma AJCC v7 Stage IVB Hilar Cholangiocarcinoma AJCC v7 C2981638 CTRP Malignant Stage IVB Hilar Cholangiocarcinoma Stage IVB Hilar Cholangiocarcinoma AJCC v7 Stage IVB Hilar Cholangiocarcinoma AJCC v7 Reemergence of extraskeletal myxoid chondrosarcoma after a period of remission C8807 Neoplastic Process Recurrent Extraskeletal Myxoid Chondrosarcoma C1709871 Malignant Recurrent_Extraskeletal_Chondrosarcoma Extraskeletal Myxoid Chondrosarcoma, Recurrent Recurrent Extraosseous Myxoid Chondrosarcoma Recurrent Extraskeletal Myxoid Chondrosarcoma Relapsed Extraskeletal Myxoid Chondrosarcoma Recurrent Extraskeletal Myxoid Chondrosarcoma A soft tissue osteosarcoma which has spread to another anatomical site. C8808 Neoplastic Process Metastatic Extraskeletal Osteosarcoma C0855050 Malignant Metastatic_Extraskeletal_Osteosarcoma Extraskeletal Osteosarcoma, Metastatic Metastatic Extraosseous Osteosarcoma Metastatic Extraskeletal Osteogenic Sarcoma Metastatic Extraskeletal Osteosarcoma Metastatic Extraskeletal Osteosarcoma Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88089 Neoplastic Process Stage 0 Distal Bile Duct Cancer AJCC v7 Stage 0 Distal Bile Duct Cancer AJCC v7 C2981663 CTRP Malignant Stage 0 Distal Bile Duct Cancer Stage 0 Distal Bile Duct Cancer AJCC v7 Stage 0 Extrahepatic (Distal) Bile Duct Cancer Stage 0 Distal Bile Duct Cancer AJCC v7 Osteosarcoma that arises from the soft tissue and is confined to a specific site without evidence of spread to other anatomic sites. C8809 Neoplastic Process Localized Extraskeletal Osteosarcoma C0855051 Malignant Non-Metastatic_Extraskeletal_Osteosarcoma Extraskeletal Osteosarcoma, Nonmetastatic Localized Extraskeletal Osteosarcoma Non-Metastatic Extraosseous Osteosarcoma Non-Metastatic Extraskeletal Osteogenic Sarcoma Non-Metastatic Extraskeletal Osteosarcoma Localized Extraskeletal Osteosarcoma Stage IA includes: T1, N0, M0. T1: Tumor confined to the bile duct histologically. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88090 Neoplastic Process Stage IA Distal Bile Duct Cancer AJCC v7 Stage IA Distal Bile Duct Cancer AJCC v7 C2981664 CTRP Malignant Stage IA Distal Bile Duct Cancer Stage IA Distal Bile Duct Cancer AJCC v7 Stage IA Extrahepatic (Distal) Bile Duct Cancer Stage IA Distal Bile Duct Cancer AJCC v7 Stage IB includes: T2, N0, M0. T2: Tumor invades beyond the wall of the bile duct. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88091 Neoplastic Process Stage IB Distal Bile Duct Cancer AJCC v7 Stage IB Distal Bile Duct Cancer AJCC v7 C2981665 CTRP Malignant Stage IB Distal Bile Duct Cancer Stage IB Distal Bile Duct Cancer AJCC v7 Stage IB Extrahepatic (Distal) Bile Duct Cancer Stage IB Distal Bile Duct Cancer AJCC v7 Stage IIA includes: T3, N0, M0. T3: Tumor invades the gallbladder, pancreas, duodenum, or other adjacent organs without involvement of the celiac axis or the superior mesenteric artery. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88092 Neoplastic Process Stage IIA Distal Bile Duct Cancer AJCC v7 Stage IIA Distal Bile Duct Cancer AJCC v7 C2981666 CTRP Malignant Stage IIA Distal Bile Duct Cancer Stage IIA Distal Bile Duct Cancer AJCC v7 Stage IIA Extrahepatic (Distal) Bile Duct Cancer Stage IIA Distal Bile Duct Cancer AJCC v7 Stage IIB includes: (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T1: Tumor confined to the bile duct histologically. T2: Tumor invades beyond the wall of the bile duct. T3: Tumor invades the gallbladder, pancreas, duodenum, or other adjacent organs without involvement of the celiac axis or the superior mesenteric artery. N1: Regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88093 Neoplastic Process Stage IIB Distal Bile Duct Cancer AJCC v7 Stage IIB Distal Bile Duct Cancer AJCC v7 C2981667 CTRP Malignant Stage IIB Distal Bile Duct Cancer Stage IIB Distal Bile Duct Cancer AJCC v7 Stage IIB Extrahepatic (Distal) Bile Duct Cancer Stage IIB Distal Bile Duct Cancer AJCC v7 Stage III includes: T4, Any N, M0. T4: Tumor involves the celiac axis or the superior mesenteric artery. M0: No distant metastasis. (from AJCC 7th Ed.) C88094 Neoplastic Process Stage III Distal Bile Duct Cancer AJCC v7 Stage III Distal Bile Duct Cancer AJCC v7 C2981668 CTRP Malignant Stage III Distal Bile Duct Cancer Stage III Distal Bile Duct Cancer AJCC v7 Stage III Extrahepatic (Distal) Bile Duct Cancer Stage III Distal Bile Duct Cancer AJCC v7 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 7th Ed.) C88095 Neoplastic Process Stage IV Distal Bile Duct Cancer AJCC v7 Stage IV Distal Bile Duct Cancer AJCC v7 C2981669 CTRP Malignant Stage IV Distal Bile Duct Cancer Stage IV Distal Bile Duct Cancer AJCC v7 Stage IV Extrahepatic (Distal) Bile Duct Cancer Stage IV Distal Bile Duct Cancer AJCC v7 Stage IA includes: T1, N0, M0. T1: Tumor limited to ampulla of Vater or sphincter of Oddi. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88096 Neoplastic Process Stage IA Ampulla of Vater Cancer AJCC v7 Stage IA Ampulla of Vater Cancer AJCC v7 C2981670 CTRP Malignant Stage IA Ampulla of Vater Cancer Stage IA Ampulla of Vater Cancer AJCC v7 Stage IA Ampulla of Vater Cancer AJCC v7 Stage IB includes: T2, N0, M0. T2: Tumor invades the duodenal wall. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88097 Neoplastic Process Stage IB Ampulla of Vater Cancer AJCC v7 Stage IB Ampulla of Vater Cancer AJCC v7 C2981671 CTRP Malignant Stage IB Ampulla of Vater Cancer Stage IB Ampulla of Vater Cancer AJCC v7 Stage IB Ampulla of Vater Cancer AJCC v7 Stage IIA includes: T3, N0, M0. T3: Tumor invades the pancreas. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88098 Neoplastic Process Stage IIA Ampulla of Vater Cancer AJCC v7 Stage IIA Ampulla of Vater Cancer AJCC v7 C2981672 CTRP Malignant Stage IIA Ampulla of Vater Cancer Stage IIA Ampulla of Vater Cancer AJCC v7 Stage IIA Ampulla of Vater Cancer AJCC v7 Stage IIB includes: (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T1: Tumor limited to ampulla of Vater or sphincter of Oddi. T2: Tumor invades the duodenal wall. T3: Tumor invades the pancreas. N1: Regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88099 Neoplastic Process Stage IIB Ampulla of Vater Cancer AJCC v7 Stage IIB Ampulla of Vater Cancer AJCC v7 C2981673 CTRP Malignant Stage IIB Ampulla of Vater Cancer Stage IIB Ampulla of Vater Cancer AJCC v7 Stage IIB Ampulla of Vater Cancer AJCC v7 An osteosarcoma arising from the soft tissue. C8810 Neoplastic Process Extraskeletal Osteosarcoma C0855052 CDISC Cellosaurus A malignant bone-forming neoplasm, arising in tissue other than bone. Malignant Extraskeletal_Osteosarcoma Extraosseous Osteosarcoma Extraskeletal Osteogenic Sarcoma Extraskeletal Osteosarcoma OSTEOSARCOMA, EXTRASKELETAL, MALIGNANT Soft Tissue Osteosarcoma Extraskeletal Osteosarcoma Stage IA includes: T1, N0, M0. T1: Tumor limited to the pancreas, 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88100 Neoplastic Process Stage IA Pancreatic Cancer AJCC v6 and v7 Stage IA Pancreatic Cancer AJCC v6 and v7 CL415840 CTRP Malignant Stage IA Exocrine and Endocrine Pancreatic Cancer AJCC v6 and v7 Stage IA Pancreatic Cancer Stage IA Pancreatic Cancer AJCC v6 and v7 Stage IA Pancreatic Cancer AJCC v6 and v7 Stage IB includes: T2, N0, M0. T2: Tumor limited to the pancreas, more than 2 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88101 Neoplastic Process Stage IB Pancreatic Cancer AJCC v6 and v7 Stage IB Pancreatic Cancer AJCC v6 and v7 CL415841 CTRP Malignant Stage IB Exocrine and Endocrine Pancreatic Cancer AJCC v6 and v7 Stage IB Pancreatic Cancer Stage IB Pancreatic Cancer AJCC v6 and v7 Stage IB Pancreatic Cancer AJCC v6 and v7 Stage IIA includes: T3, N0, M0. T3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88102 Neoplastic Process Stage IIA Pancreatic Cancer AJCC v6 and v7 Stage IIA Pancreatic Cancer AJCC v6 and v7 CL415842 CTRP Malignant Stage IIA Exocrine and Endocrine Pancreatic Cancer AJCC v6 and v7 Stage IIA Pancreatic Cancer Stage IIA Pancreatic Cancer AJCC v6 and v7 Stage IIA Pancreatic Cancer AJCC v6 and v7 Stage IIB includes: (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T1: Tumor limited to the pancreas, 2 cm or less in greatest dimension. T2: Tumor limited to the pancreas, more than 2 cm in greatest dimension. T3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery. N1: Regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C88103 Neoplastic Process Stage IIB Pancreatic Cancer AJCC v6 and v7 Stage IIB Pancreatic Cancer AJCC v6 and v7 CL415843 CTRP Malignant Stage IIB Exocrine and Endocrine Pancreatic Cancer AJCC v6 and v7 Stage IIB Pancreatic Cancer Stage IIB Pancreatic Cancer AJCC v6 and v7 Stage IIB Pancreatic Cancer AJCC v6 and v7 Stage IIIa includes: T1-3, N1, M0. T1: Tumor invades subepithelial connective tissue without lymph vascular invasion and is not poorly differentiated (i.e., grade 3-4) or tumor invades subepithelial connective tissue with lymph vascular invasion or is poorly differentiated. T2: Tumor invades corpus spongiosum or cavernosum. T3: Tumor invades urethra. cN1: Palpable mobile unilateral inguinal lymph node. pN1: Metastasis in a single inguinal lymph node. M0: No distant metastasis. (AJCC 7th ed.) C88104 Neoplastic Process Stage IIIa Penile Cancer AJCC v7 Stage IIIa Penile Cancer AJCC v7 CL415844 CTRP Malignant Stage IIIA Penile Cancer Stage IIIa Penile Cancer Stage IIIa Penile Cancer AJCC v7 Stage IIIa Penile Cancer AJCC v7 Stage IIIb includes: T1-3, N2, M0. T1: Tumor invades subepithelial connective tissue without lymph vascular invasion and is not poorly differentiated (i.e., grade 3-4) or tumor invades subepithelial connective tissue with lymph vascular invasion or is poorly differentiated. T2: Tumor invades corpus spongiosum or cavernosum. T3: Tumor invades urethra. cN2: Palpable mobile multiple or bilateral inguinal lymph nodes. pN2: Metastasis in multiple or bilateral superficial inguinal lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C88105 Neoplastic Process Stage IIIb Penile Cancer AJCC v7 Stage IIIb Penile Cancer AJCC v7 CL415845 CTRP Malignant Stage IIIB Penile Cancer Stage IIIb Penile Cancer Stage IIIb Penile Cancer AJCC v7 Stage IIIb Penile Cancer AJCC v7 Stage IIA includes: (T1a-c, N0, M0, PSA less than 20, Gleason 7); (T1a-c, N0, M0, PSA equal or more than 10 and less than 20, Gleason equal or less than 6); (T2a, N0, M0, PSA less than 20, Gleason equal or less than 7); (T2b, N0, M0, PSA less than 20, Gleason equal or less than 7); (T2b, N0, M0, PSA X, Gleason X). T1a: Tumor incidental histologic finding in 5% or less of tissue resected. T1b: Tumor incidental histologic finding in more than 5% of tissue resected. T1c: Tumor identified by needle biopsy (e.g., because of elevated PSA). T2a: Tumor involves one-half of one lobe or less. T2b: Tumor involves more than one-half of one lobe, but not both lobes. cN0: No regional lymph node metastasis. pN0: No positive regional nodes. M0: No distant metastasis. Gleason 7: Moderately differentiated (moderate anaplasia). Gleason Equal or Less than 6: Well differentiated (slight anaplasia). (AJCC 7th ed.) C88106 Neoplastic Process Stage IIA Prostate Cancer AJCC v7 Stage IIA Prostate Cancer AJCC v7 CL415846 CTRP Malignant Stage IIA Prostate Cancer Stage IIA Prostate Cancer AJCC v7 Stage IIA Prostate Cancer AJCC v7 Stage IIB includes: (T2c, N0, M0, Any PSA, Any Gleason); (T1-2, N0, M0, PSA equal or more than 20, Any Gleason); (T1-2, N0, M0, Any PSA, Gleason equal or more than 8). T2c: Tumor involves both lobes. T1a: Tumor incidental histologic finding in 5% or less of tissue resected. T1b: Tumor incidental histologic finding in more than 5% of tissue resected. T1c: Tumor identified by needle biopsy (e.g., because of elevated PSA). T2a: Tumor involves one-half of one lobe or less. T2b: Tumor involves more than one-half of one lobe, but not both lobes. cN0: No regional lymph node metastasis. pN0: No positive regional nodes. M0: No distant metastasis. Gleason equal or more than 8: Poorly differentiated/undifferentiated (marked anaplasia). (AJCC 7th ed.) C88107 Neoplastic Process Stage IIB Prostate Cancer AJCC v7 Stage IIB Prostate Cancer AJCC v7 CL415847 CTRP Malignant Stage IIB Prostate Cancer Stage IIB Prostate Cancer AJCC v7 Stage IIB Prostate Cancer AJCC v7 The reemergence of extraskeletal osteosarcoma after a period of remission. C8811 Neoplastic Process Recurrent Extraskeletal Osteosarcoma C0855053 Malignant Recurrent_Extraskeletal_Osteosarcoma Extraskeletal Osteosarcoma, Recurrent Recurrent Extraosseous Osteosarcoma Recurrent Extraskeletal Osteogenic Sarcoma Recurrent Extraskeletal Osteosarcoma Relapsed Extraskeletal Osteogenic Sarcoma Relapsed Extraskeletal Osteosarcoma Recurrent Extraskeletal Osteosarcoma Fibrosarcoma that has spread from its original site of growth to another anatomic site. C8812 Neoplastic Process Metastatic Fibrosarcoma C0855054 Malignant Metastatic_Fibrosarcoma Metastatic Fibrosarcoma Metastatic Fibrosarcoma Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88120 Neoplastic Process Stage 0 Eyelid Carcinoma AJCC v7 C2981692 Malignant Stage 0 Eyelid Carcinoma Stage 0 Eyelid Carcinoma AJCC v7 Stage 0 Eyelid Carcinoma AJCC v7 Stage IA includes: T1, N0, M0. T1: Tumor 5 mm or less in greatest dimension. No invasion of the tarsal plate or eyelid margin. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88121 Neoplastic Process Stage IA Eyelid Carcinoma AJCC v7 C2981693 Malignant Stage IA Eyelid Carcinoma Stage IA Eyelid Carcinoma AJCC v7 Stage IA Eyelid Carcinoma AJCC v7 Stage IB includes: T2a, N0, M0. T2a: Tumor more than 5 mm, but not more than 10 mm in greatest dimension. Or, any tumor that invades the tarsal plate or eyelid margin. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88122 Neoplastic Process Stage IB Eyelid Carcinoma AJCC v7 C2981694 Malignant Stage IB Eyelid Carcinoma Stage IB Eyelid Carcinoma AJCC v7 Stage IB Eyelid Carcinoma AJCC v7 Stage IC includes: T2b, N0, M0. T2b: Tumor more than 10 mm, but not more than 20 mm in greatest dimension. Or, tumor involves full thickness of the eyelid. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88125 Neoplastic Process Stage IC Eyelid Carcinoma AJCC v7 C2981697 Malignant Stage IC Eyelid Carcinoma Stage IC Eyelid Carcinoma AJCC v7 Stage IC Eyelid Carcinoma AJCC v7 Stage II includes: T3a, N0, M0. T3a: Tumor more than 20 mm in greatest dimension. Or, any tumor that invades adjacent ocular or orbital structures. Or, any T with perineural tumor invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88127 Neoplastic Process Stage II Eyelid Carcinoma AJCC v7 C2981699 Malignant Stage II Eyelid Carcinoma Stage II Eyelid Carcinoma AJCC v7 Stage II Eyelid Carcinoma AJCC v7 Stage IIIA includes: T3b, N0, M0. T3b: Complete tumor resection requires enucleation, exenteration, or bone resection. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88129 Neoplastic Process Stage IIIA Eyelid Carcinoma AJCC v7 C2981701 Malignant Stage IIIA Eyelid Carcinoma Stage IIIA Eyelid Carcinoma AJCC v7 Stage IIIA Eyelid Carcinoma AJCC v7 A leiomyosarcoma that has spread to other anatomic sites. C8813 Neoplastic Process Metastatic Leiomyosarcoma C0855056 Malignant Metastatic_Leiomyosarcoma Leiomyosarcoma Metastatic Metastatic Leiomyosarcoma Metastatic Leiomyosarcoma Stage IIIB includes: Any T, N1, M0. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88131 Neoplastic Process Stage IIIB Eyelid Carcinoma AJCC v7 C2981703 Malignant Stage IIIB Eyelid Carcinoma Stage IIIB Eyelid Carcinoma AJCC v7 Stage IIIB Eyelid Carcinoma AJCC v7 Stage IIIC includes: T4, Any N, M0. T4: Tumor is not resectable due to extensive invasion of ocular, orbital, craniofacial structures, or brain. M0: No distant metastasis. (AJCC 7th ed.) C88132 Neoplastic Process Stage IIIC Eyelid Carcinoma AJCC v7 C2981704 Malignant Stage IIIC Eyelid Carcinoma Stage IIIC Eyelid Carcinoma AJCC v7 Stage IIIC Eyelid Carcinoma AJCC v7 Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 7th ed.) C88133 Neoplastic Process Stage IV Eyelid Carcinoma AJCC v7 C2981705 Malignant Stage IV Eyelid Carcinoma Stage IV Eyelid Carcinoma AJCC v7 Stage IV Eyelid Carcinoma AJCC v7 Stage IIA includes: (T1b-d, N0, M0); (T2a, N0, M0). T1b: Iris: Tumor limited to the iris more than 3 clock hours in size. Ciliary body and choroid: Tumor size category 1 with ciliary body involvement. T1c: Iris: Tumor limited to the iris with secondary glaucoma. Ciliary body and choroid: Tumor size category 1 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in diameter. T1d: Ciliary body and choroid: Tumor size category 1 with ciliary body involvement and extraocular extension less than or equal to 5 mm in diameter. T2a: Iris: Tumor confluent with or extending into the ciliary body, choroid, or both, with secondary glaucoma. Ciliary body and choroid: Tumor size category 2 without ciliary body involvement and extraocular extension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88135 Neoplastic Process Stage IIA Uveal Melanoma AJCC v7 Stage IIA Uveal Melanoma AJCC v7 C2981706 CPTAC CTRP Malignant IIA Stage IIA Uveal Melanoma Stage IIA Uveal Melanoma AJCC v7 Stage IIA Uveal Melanoma AJCC v7 Stage IIB includes: (T2b, N0, M0); (T3a, N0, M0). T2b: Ciliary body and choroid: Tumor size category 2 with ciliary body involvement. T3a: Iris: Tumor confluent with or extending into the ciliary body, choroid, or both, with sclera extension and secondary glaucoma. Ciliary body and choroid: Tumor size category 3 without ciliary body involvement and extraocular extension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88136 Neoplastic Process Stage IIB Uveal Melanoma AJCC v7 Stage IIB Uveal Melanoma AJCC v7 C2981707 CPTAC CTRP Malignant IIB Stage IIB Uveal Melanoma Stage IIB Uveal Melanoma AJCC v7 Stage IIB Uveal Melanoma AJCC v7 Stage IIIA includes: (T2c-d, N0, M0); (T3b-c, N0, M0); (T4a, N0, M0). T2c: Ciliary body and choroid: Tumor size category 2 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in diameter. T2d: Ciliary body and choroid: Tumor size category 2 with ciliary body involvement and extraocular extension less than or equal to 5 mm in diameter. T3b: Ciliary body and choroid: Tumor size category 3 with ciliary body involvement. T3c: Ciliary body and choroid: Tumor size category 3 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in diameter. T4a: Iris: Tumor with extrascleral extension less than or equal to 5 mm in diameter. Ciliary body and choroid: Tumor size category 4 without ciliary body involvement and extraocular extension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88137 Neoplastic Process Stage IIIA Uveal Melanoma AJCC v7 Stage IIIA Uveal Melanoma AJCC v7 C2981708 CPTAC CTRP Malignant IIIA Stage IIIA Uveal Melanoma Stage IIIA Uveal Melanoma AJCC v7 Stage IIIA Uveal Melanoma AJCC v7 Stage IIIB includes: (T3d, N0, M0); (T4b-c, N0, M0). T3d: Ciliary body and choroid: Tumor size category 3 with ciliary body involvement and extraocular extension less than or equal to 5 mm in diameter. T4b: Iris: Tumor with extrascleral extension more than 5 mm in diameter. Ciliary body and choroid: Tumor size category 4 with ciliary body involvement. T4c: Ciliary body and choroid: Tumor size category 4 without ciliary body involvement but with extraocular extension less than or equal to 5 mm in diameter. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88138 Neoplastic Process Stage IIIB Uveal Melanoma AJCC v7 Stage IIIB Uveal Melanoma AJCC v7 C2981709 CPTAC CTRP Malignant IIIB Stage IIIB Uveal Melanoma Stage IIIB Uveal Melanoma AJCC v7 Stage IIIB Uveal Melanoma AJCC v7 Stage IIIC includes: T4d-e, N0, M0. T4d: Ciliary body and choroid: Tumor size category 4 with ciliary body involvement and extraocular extension less than or equal to 5 mm in diameter. T4e: Ciliary body and choroid: Any tumor size category with extraocular extension more than 5 mm in diameter. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88139 Neoplastic Process Stage IIIC Uveal Melanoma AJCC v7 Stage IIIC Uveal Melanoma AJCC v7 C2981710 CPTAC CTRP Malignant IIIC Stage IIIC Uveal Melanoma Stage IIIC Uveal Melanoma AJCC v7 Stage IIIC Uveal Melanoma AJCC v7 Leiomyosarcoma that is confined to a specific site without evidence of spread to other anatomic sites. C8814 Neoplastic Process Localized Leiomyosarcoma C0855057 Malignant Primary_Leiomyosarcoma Leiomyosarcoma Nonmetastatic Localized Leiomyosarcoma Non-Metastatic Leiomyosarcoma Localized Leiomyosarcoma A pelvic lymph node located along the obturator artery. C88141 Body Part, Organ, or Organ Component Obturator Lymph Node C0229822 CDISC mCode A pelvic lymph node located along the obturator artery. OBTURATOR LYMPH NODE Obturator Lymph Node Structure of obturator lymph node (body structure) Obturator Lymph Node A lymph node located along the internal iliac artery. C88142 Body Part, Organ, or Organ Component Internal Iliac Lymph Node CL1773650 CDISC mCode A lymph node located along the internal iliac artery. (NCI) INTERNAL ILIAC LYMPH NODE Internal Iliac Lymph Node Internal iliac lymph node group (body structure) Structure of internal iliac lymph node (body structure) Internal Iliac Lymph Node A lymph node located along the external iliac artery. C88143 Body Part, Organ, or Organ Component External Iliac Lymph Node C0229815 CDISC GDC UBERON mCode A lymph node located along the external iliac artery. (NCI) The external iliac lymph nodes, from eight to ten in number, lie along the external iliac vessels. They are arranged in three groups, one on the lateral, another on the medial, and a third on the anterior aspect of the vessels; the third group is, however, sometimes absent. Their principal afferents are derived from the inguinal lymph nodes, the deep lymphatics of the abdominal wall below the umbilicus and of the adductor region of the thigh, and the lymphatics from the glans penis vel clitoridis, the membranous urethra, the prostate, the fundus of the urinary bladder, the cervix uteri, and upper part of the vagina. Iliac-external Lymph Node(s) Iliac-External UBERON:0015880 EXTERNAL ILIAC LYMPH NODE External Iliac Lymph Node Lymph Node(s) Iliac-External Structure of external iliac lymph node (body structure) external iliac lymph node external iliac node External Iliac Lymph Node A non-Hodgkin lymphoma arising from the conjunctiva, lacrimal gland, lacrimal drainage apparatus, eyelids, or other orbital tissues around the eye. The vast majority of cases are extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue, however, other histologic types of lymphomas can originate from ocular adnexal tissues, including rare cases of NK/T-cell lymphomas of nasal type. C88145 Neoplastic Process Ocular Adnexal Non-Hodgkin Lymphoma C2981712 Malignant OAL Ocular Adnexal Lymphoma Ocular Adnexal Non-Hodgkin Lymphoma Primary Ocular Adnexal Lymphoma Primary Ocular Adnexal Non-Hodgkin Lymphoma Ocular Adnexal Non-Hodgkin Lymphoma The reemergence of leiomyosarcoma after a period of remission C8815 Neoplastic Process Recurrent Leiomyosarcoma C0855058 Malignant Recurrent_Leiomyosarcoma Leiomyosarcoma Recurrent Recurrent Leiomyosarcoma Relapsed Leiomyosarcoma Recurrent Leiomyosarcoma Stage I includes: IA (T1, N0, M0, B0-1); IB (T2, N0, M0, B0-1). T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. May further stratify into T1a (patch only) vs. T1b (plaque +/- patch). T2: Patches, papules, or plaques covering 10% or more of the skin surface. May further stratify into T2a (patch only) vs. T2b (plaque +/- patch). N0: No clinically abnormal peripheral lymph nodes; biopsy not required. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 7th ed.) C88150 Neoplastic Process Stage I Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage I Mycosis Fungoides and Sezary Syndrome AJCC v7 C0862211 CTRP Stage I is divided into stages IA and IB. In stage IA, less than 10% of the skin surface is covered with patches and/or plaques (areas of abnormal tissue). In stage IB, 10% or more of the skin surface is covered with patches and/or plaques. Stage I may also be classified based on how many abnormal lymphocytes (white blood cells) are found in the blood. Malignant Stage I Mycosis Fungoides and Sezary Syndrome Stage I Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage I Mycosis Fungoides and Sézary Syndrome Stage I Mycosis Fungoides and Sézary Syndrome AJCC v7 stage I mycosis fungoides and the Sezary syndrome Stage I Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IA includes: T1, N0, M0, B0-1. T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. May further stratify into T1a (patch only) vs. T1b (plaque +/- patch). N0: No clinically abnormal peripheral lymph nodes; biopsy not required. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 7th ed.) C88151 Neoplastic Process Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7 CL416011 CTRP Malignant Stage IA Mycosis Fungoides and Sezary Syndrome Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IA Mycosis Fungoides and Sézary Syndrome Stage IA Mycosis Fungoides and Sézary Syndrome AJCC v7 Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IB includes: T2, N0, M0, B0-1. T2: Patches, papules, or plaques covering 10% or more of the skin surface. May further stratify into T2a (patch only) vs. T2b (plaque +/- patch). N0: No clinically abnormal peripheral lymph nodes; biopsy not required. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 7th ed.) C88152 Neoplastic Process Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7 CL416012 CTRP Malignant Stage IB Mycosis Fungoides and Sezary Syndrome Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IB Mycosis Fungoides and Sézary Syndrome Stage IB Mycosis Fungoides and Sézary Syndrome AJCC v7 Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage II includes: IIA (T1-2, N1-2, M0, B0-1); IIB (T3, N0-2, M0, B0-1). T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. May further stratify into T1a (patch only) vs. T1b (plaque +/- patch). T2: Patches, papules, or plaques covering 10% or more of the skin surface. May further stratify into T2a (patch only) vs. T2b (plaque +/- patch). T3: One or more tumors (equal or greater than 1 cm diameter). N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or NCI LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 7th ed.) C88153 Neoplastic Process Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7 C0862216 CTRP Stage II is divided into stages IIA and IIB. In stage IIA, any amount of the skin surface is covered with patches and/or plaques (areas of abnormal tissue). Lymph nodes are enlarged but cancer has not spread to them. In stage IIB, one or more tumors (lumps of malignant cells) are found on the skin. Lymph nodes may be enlarged but cancer has not spread to them. Stage II may also be classified based on how many abnormal lymphocytes (white blood cells) are found in the blood. Malignant Stage II Mycosis Fungoides and Sezary Syndrome Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage II Mycosis Fungoides and Sézary Syndrome Stage II Mycosis Fungoides and Sézary Syndrome AJCC v7 stage II mycosis fungoides and the Sezary syndrome Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IIA includes: T1-2, N1-2, M0, B0-1. T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. May further stratify into T1a (patch only) vs. T1b (plaque +/- patch). T2: Patches, papules, or plaques covering 10% or more of the skin surface. May further stratify into T2a (patch only) vs. T2b (plaque +/- patch). N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or NCI LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 7th ed.) C88154 Neoplastic Process Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7 CL416013 CTRP Malignant Stage IIA Mycosis Fungoides and Sezary Syndrome Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IIA Mycosis Fungoides and Sézary Syndrome Stage IIA Mycosis Fungoides and Sézary Syndrome AJCC v7 Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IIB includes: T3, N0-2, M0, B0-1. T3: One or more tumors (equal or greater than 1 cm diameter). N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or NCI LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 7th ed.) C88155 Neoplastic Process Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7 CL416014 CTRP Malignant Stage IIB Mycosis Fungoides and Sezary Syndrome Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IIB Mycosis Fungoides and Sézary Syndrome Stage IIB Mycosis Fungoides and Sézary Syndrome AJCC v7 Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v7 Cutaneous involvement by an acute or chronic leukemia. C88156 Neoplastic Process Leukemia Cutis C0948976 CPTAC Malignant Leukemia Cutis Leukemia Cutis Stage III includes: (T4, N0-2, M0, B0-1); IIIA (T4, N0-2, M0, B0); IIIB (T4, N0-2, M0, B1). T4: Confluence of erythema covering 80% or more of body surface area. N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or NCI LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 7th ed.) C88157 Neoplastic Process Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7 C0862221 CTRP In stage III, nearly all of the skin is reddened and there may be patches, plaques, or tumors. Lymph nodes may be enlarged but cancer has not spread to them. Stage III may also be classified based on how many abnormal lymphocytes (white blood cells) are found in the blood. Malignant Stage III Mycosis Fungoides and Sezary Syndrome Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage III Mycosis Fungoides and Sézary Syndrome Stage III Mycosis Fungoides and Sézary Syndrome AJCC v7 stage III mycosis fungoides and the Sezary syndrome Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IIIA includes: T4, N0-2, M0, B0. T4: Confluence of erythema covering 80% or more of body surface area. N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or NCI LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). (AJCC 7th ed.) C88158 Neoplastic Process Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7 CL416015 CTRP Malignant Stage IIIA Mycosis Fungoides and Sezary Syndrome Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IIIA Mycosis Fungoides and Sézary Syndrome Stage IIIA Mycosis Fungoides and Sézary Syndrome AJCC v7 Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IIIB includes: T4, N0-2, M0, B1. T4: Confluence of erythema covering 80% or more of body surface area. N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or NCI LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. M0: No visceral organ involvement. B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. (AJCC 7th ed.) C88159 Neoplastic Process Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7 CL416016 CTRP Malignant Stage IIIB Mycosis Fungoides and Sezary Syndrome Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IIIB Mycosis Fungoides and Sézary Syndrome Stage IIIB Mycosis Fungoides and Sézary Syndrome AJCC v7 Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v7 A liposarcoma that has metastasized to a secondary site. C8816 Neoplastic Process Metastatic Liposarcoma C0855059 Malignant Metastatic_Liposarcoma Liposarcoma Metastatic Metastatic Liposarcoma Metastatic Liposarcoma Stage IV includes: IVA1 (T1-4, N0-2, M0, B2); IVA2 (T1-4, N3, M0, B0-2); IVB (T1-4, N0-3, M1, B0-2). T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. May further stratify into T1a (patch only) vs. T1b (plaque +/- patch). T2: Patches, papules, or plaques covering 10% or more of the skin surface. May further stratify into T2a (patch only) vs. T2b (plaque +/- patch). T3: One or more tumors (equal or greater than 1 cm diameter). T4: Confluence of erythema covering 80% or more of body surface area. N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or NCI LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. N3: Clinically abnormal peripheral lymph nodes; histopathology Dutch grades 3-4 or NCI LN4; clone positive or negative. M0: No visceral organ involvement. M1: Visceral involvement (must have pathology confirmation and organ involved should be specified). B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. B2: High blood tumor burden: 1000/microL Sezary cells or more with positive clone. (AJCC 7th ed.) C88160 Neoplastic Process Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v7 C0862226 CTRP Stage IV is divided into stages IVA and IVB. In stage IVA, most of the skin is reddened, and any amount of the skin is covered with patches and/or plaques (areas of abnormal tissue) or tumors (lumps of malignant cells). Cancer has spread to lymph nodes, and the lymph nodes may be enlarged. In stage IVB, most of the skin is reddened, and any amount of the skin is covered with lesions or tumors. Cancer has spread to other organs in the body. Lymph nodes may be enlarged and cancer may have spread to them. Stage IV may also be classified based on how many abnormal lymphocytes (white blood cells) are found in the blood. Malignant Stage IV Mycosis Fungoides and Sezary Syndrome Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IV Mycosis Fungoides and Sézary Syndrome Stage IV Mycosis Fungoides and Sézary Syndrome AJCC v7 stage IV mycosis fungoides and the Sezary syndrome Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IVA includes: IVA1 (T1-4, N0-2, M0, B2); IVA2 (T1-4, N3, M0, B0-2). T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. May further stratify into T1a (patch only) vs. T1b (plaque +/- patch). T2: Patches, papules, or plaques covering 10% or more of the skin surface. May further stratify into T2a (patch only) vs. T2b (plaque +/- patch). T3: One or more tumors (equal or greater than 1 cm diameter). T4: Confluence of erythema covering 80% or more of body surface area. N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or NCI LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. N3: Clinically abnormal peripheral lymph nodes; histopathology Dutch grades 3-4 or NCI LN4; clone positive or negative. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. B2: High blood tumor burden: 1000/microL Sezary cells or more with positive clone. (AJCC 7th ed.) C88161 Neoplastic Process Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7 CL416017 CTRP Malignant Stage IVA Mycosis Fungoides and Sezary Syndrome Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IVA Mycosis Fungoides and Sézary Syndrome Stage IVA Mycosis Fungoides and Sézary Syndrome AJCC v7 Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IVB includes: T1-4, N0-3, M1, B0-2. T1: Limited patches, papules, and/or plaques covering less than 10% of the skin surface. May further stratify into T1a (patch only) vs. T1b (plaque +/- patch). T2: Patches, papules, or plaques covering 10% or more of the skin surface. May further stratify into T2a (patch only) vs. T2b (plaque +/- patch). T3: One or more tumors (equal or greater than 1 cm diameter). T4: Confluence of erythema covering 80% or more of body surface area. N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or NCI LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. N3: Clinically abnormal peripheral lymph nodes; histopathology Dutch grades 3-4 or NCI LN4; clone positive or negative. M1: Visceral involvement (must have pathology confirmation and organ involved should be specified). B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypical (Sezary cells). B1: Low blood tumor burden: more than 5% of peripheral blood lymphocytes are atypical (Sezary cells) but does not meet the criteria of B2. B2: High blood tumor burden: 1000/microL Sezary cells or more with positive clone. (AJCC 7th ed.) C88162 Neoplastic Process Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7 CL416018 CTRP Malignant Stage IVB Mycosis Fungoides and Sezary Syndrome Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7 Stage IVB Mycosis Fungoides and Sézary Syndrome Stage IVB Mycosis Fungoides and Sézary Syndrome AJCC v7 Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7 Liposarcoma that is confined to a specific site without evidence of spread to other anatomic sites. C8817 Neoplastic Process Localized Liposarcoma C0855060 Malignant Primary_Liposarcoma Liposarcoma Nonmetastatic Localized Liposarcoma Non-Metastatic Liposarcoma Localized Liposarcoma The reemergence of liposarcoma after a period of remission. C8818 Neoplastic Process Recurrent Liposarcoma C0855061 Malignant Recurrent_Liposarcoma Liposarcoma Recurrent Recurrent Liposarcoma Relapsed Liposarcoma Recurrent Liposarcoma The presence of malignant Schwann cell growth (benign variant is known as neurofibroma) at a site removed from the primary site of tumor growth. C8822 Neoplastic Process Metastatic Malignant Peripheral Nerve Sheath Tumor Metastatic Malignant Peripheral Nerve Sheath Tumor C0855065 CTRP Malignant Metastatic_Malignant_Peripheral_Nerve_Sheath_Tumor Metastatic MPNST Metastatic Malignant Peripheral Nerve Sheath Tumor Metastatic Malignant Peripheral Nerve Sheath Tumor The reemergence of malignant peripheral nerve sheath tumor after a period of remission. C8823 Neoplastic Process Recurrent Malignant Peripheral Nerve Sheath Tumor C0855067 Malignant Recurrent_Malignant_Peripheral_Nerve_Sheath_Tumor Recurrent MPNST Recurrent Malignant Peripheral Nerve Sheath Neoplasm Recurrent Malignant Peripheral Nerve Sheath Tumor Relapsed MPNST Relapsed Malignant Peripheral Nerve Sheath Neoplasm Relapsed Malignant Peripheral Nerve Sheath Tumor Recurrent Malignant Peripheral Nerve Sheath Tumor The reemergence of rhabdomyosarcoma after a period of remission. C8824 Neoplastic Process Recurrent Rhabdomyosarcoma C0855069 Malignant Recurrent_Rhabdomyosarcoma Recurrent Rhabdomyosarcoma Relapsed Rhabdomyosarcoma Rhabdomyosarcoma Recurrent Recurrent Rhabdomyosarcoma A synovial sarcoma that has metastasized to other anatomic sites. C8825 Neoplastic Process Metastatic Synovial Sarcoma C0855070 Malignant Metastatic_Synovial_Sarcoma Metastatic Synovial Sarcoma Synovial Sarcoma Metastatic Metastatic Synovial Sarcoma Synovial sarcoma that is confined to a specific site without evidence of spread to other anatomic sites. C8826 Neoplastic Process Localized Synovial Sarcoma C0855071 Malignant Primary_Synovial_Sarcoma Localized Synovial Sarcoma Non-Metastatic Synovial Sarcoma Synovial Sarcoma Nonmetastatic Localized Synovial Sarcoma The reemergence of synovial sarcoma after a period of remission C8827 Neoplastic Process Recurrent Synovial Sarcoma C0855072 Malignant Recurrent_Synovial_Sarcoma Recurrent Synovial Sarcoma Relapsed Synovial Sarcoma Synovial Sarcoma Recurrent Recurrent Synovial Sarcoma The reemergence of mixed cellularity classic Hodgkin lymphoma after a period of remission. C8832 Neoplastic Process Recurrent Mixed Cellularity Classic Hodgkin Lymphoma Recurrent Mixed Cellularity Classic Hodgkin Lymphoma C0855078 CTRP Malignant Recurrent_Mixed_Cellularity_Hodgkin_s_Lymphoma Recurrent Mixed Cellularity Classic Hodgkin Lymphoma Recurrent Mixed Cellularity Classical Hodgkin Lymphoma Recurrent Mixed Cellularity Hodgkin Lymphoma Recurrent Mixed Cellularity Hodgkin's Disease Recurrent Mixed Cellularity Hodgkin's Lymphoma Relapsed Mixed Cellularity Hodgkin's Disease Relapsed Mixed Cellularity Hodgkin's Lymphoma Recurrent Mixed Cellularity Classic Hodgkin Lymphoma Mixed cellularity classic Hodgkin lymphoma that is resistant to treatment. C8833 Neoplastic Process Refractory Mixed Cellularity Classic Hodgkin Lymphoma Refractory Mixed Cellularity Classic Hodgkin Lymphoma C0855079 CTRP Malignant Refractory_Mixed_Cellularity_Hodgkin_s_Lymphoma Refractory Mixed Cellularity Classic Hodgkin Lymphoma Refractory Mixed Cellularity Classical Hodgkin Lymphoma Refractory Mixed Cellularity Hodgkin Lymphoma Refractory Mixed Cellularity Hodgkin's Lymphoma Refractory Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE) (rare in Hodgkin lymphoma). C8834 Neoplastic Process Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma C0855080 CTRP Malignant Stage_I_Mixed_Cellularity_Hodgkin_s_Lymphoma Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Stage I Mixed Cellularity Classical Hodgkin Lymphoma Mixed Cellularity Hodgkin's Disease Stage I Mixed Cellularity Hodgkin's Lymphoma Stage I Stage I Mixed Cellularity Classical Hodgkin Lymphoma Stage I Mixed Cellularity Hodgkin Lymphoma Stage I Mixed Cellularity Hodgkin's Disease Stage I Mixed Cellularity Hodgkin's Lymphoma Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8835 Neoplastic Process Ann Arbor Stage IV Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Stage IV Mixed Cellularity Classic Hodgkin Lymphoma C0375084 CTRP Malignant Stage_IV_Mixed_Cellularity_Hodgkin_s_Lymphoma Ann Arbor Stage IV Mixed Cellularity Classic Hodgkin Lymphoma Ann Arbor Stage IV Mixed Cellularity Classical Hodgkin Lymphoma Mixed Cellularity Hodgkin's Disease Stage IV Mixed Cellularity Hodgkin's Lymphoma Stage IV Stage IV Mixed Cellularity Classical Hodgkin Lymphoma Stage IV Mixed Cellularity Hodgkin Lymphoma Stage IV Mixed Cellularity Hodgkin's Disease Stage IV Mixed Cellularity Hodgkin's Lymphoma Ann Arbor Stage IV Mixed Cellularity Classic Hodgkin Lymphoma Hodgkin lymphoma resistant to treatment C8836 Neoplastic Process Refractory Hodgkin Lymphoma Refractory Hodgkin Lymphoma C0855082 CTRP Malignant Refractory_Hodgkin_s_Lymphoma Refractory Hodgkin Lymphoma Refractory Hodgkin's Disease Refractory Hodgkin's Lymphoma Refractory Hodgkin Lymphoma The reemergence of nodular sclerosis classic Hodgkin lymphoma after a period of remission. C8837 Neoplastic Process Recurrent Nodular Sclerosis Classic Hodgkin Lymphoma Recurrent Nodular Sclerosis Classic Hodgkin Lymphoma C0855085 CTRP Malignant Recurrent_Nodular_Sclerosis_Hodgkin_s_Lymphoma Recurrent Nodular Sclerosis Classic Hodgkin Lymphoma Recurrent Nodular Sclerosis Classical Hodgkin Lymphoma Recurrent Nodular Sclerosis Hodgkin Lymphoma Recurrent Nodular Sclerosis Hodgkin's Disease Recurrent Nodular Sclerosis Hodgkin's Lymphoma Relapsed Nodular Sclerosis Hodgkin's Disease Relapsed Nodular Sclerosis Hodgkin's Lymphoma Recurrent Nodular Sclerosis Classic Hodgkin Lymphoma Stage I includes: IA: T1, N0, M0 and IB: (T0, N1mi, M0); (T1, N1mi, M0). T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. T0: No evidence of primary tumor. N0: No regional lymph node metastasis. N1mi: Nodal micrometastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+). (AJCC 7th Ed.) C88375 Neoplastic Process Stage I Breast Cancer AJCC v7 Stage I Breast Cancer AJCC v7 C2216695 CTRP Malignant Stage I Breast Cancer Stage I Breast Cancer AJCC v7 Stage I Breast Cancer AJCC v7 Stage III includes: IIIA : (T0, N2, M0); (T1, N2, M0); (T2, N2, M0); (T3, N1, M0); (T3, N2, M0), IIIB: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0), and IIIC: (any T, N3, M0). T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules). N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases. N3: Metastases in ipsilateral infraclavicular (level III) axillary lymph nodes(s) with or without level I, II axillary lymph node involvement; or in clinically detected ipsilateral internal mammary lymph node(s) with clinically evident level I, II axillary lymph node metastases; or metastases in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+). (AJCC 7th Ed.) C88376 Neoplastic Process Stage III Breast Cancer AJCC v7 Stage III Breast Cancer AJCC v7 C3146271 CTRP Malignant Stage III Breast Cancer Stage III Breast Cancer AJCC v7 Stage III Breast Cancer AJCC v7 Stage IIIC includes: Any T, N3, M0. N3: Metastases in ipsilateral infraclavicular (level III) axillary lymph nodes(s) with or without level I, II axillary lymph node involvement; or in clinically detected ipsilateral internal mammary lymph node(s) with clinically evident level I, II axillary lymph node metastases; or metastases in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+). (AJCC 7th Ed.) C88377 Neoplastic Process Stage IIIC Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 C2980042 CTRP Stage III breast cancer is divided into stages IIIA, IIIB, and IIIC. In stage IIIC, there may be no sign of cancer in the breast or the tumor may be any size and may have spread to the chest wall and/or the skin of the breast. Also, cancer (1) has spread to lymph nodes above or below the collarbone and (2) may have spread to axillary (under the arm) lymph nodes or to lymph nodes near the breastbone. In operable stage IIIC, the cancer is found (1) in ten or more axillary lymph nodes; or (2) in the lymph nodes below the collarbone; or (3) in axillary lymph nodes and in lymph nodes near the breastbone. In inoperable stage IIIC, the cancer has spread to the lymph nodes above the collarbone. Malignant Stage IIIC Breast Cancer Stage IIIC Breast Cancer AJCC v7 stage IIIC breast cancer Stage IIIC Breast Cancer AJCC v7 Nodular sclerosis classic Hodgkin lymphoma that is resistant to treatment. C8838 Neoplastic Process Refractory Nodular Sclerosis Classic Hodgkin Lymphoma Refractory Nodular Sclerosis Classic Hodgkin Lymphoma C0855086 CTRP Malignant Refractory_Nodular_Sclerosis_Hodgkin_s_Lymphoma Refractory Nodular Sclerosis Classic Hodgkin Lymphoma Refractory Nodular Sclerosis Classical Hodgkin Lymphoma Refractory Nodular Sclerosis Hodgkin Lymphoma Refractory Nodular Sclerosis Hodgkin's Disease Refractory Nodular Sclerosis Hodgkin's Lymphoma Refractory Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE) (rare in Hodgkin lymphoma). C8839 Neoplastic Process Ann Arbor Stage I Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Stage I Nodular Sclerosis Classic Hodgkin Lymphoma C0855087 CTRP Malignant Stage_I_Nodular_Sclerosis_Hodgkin_s_Lymphoma Ann Arbor Stage I Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Stage I Nodular Sclerosis Classical Hodgkin Lymphoma Nodular Sclerosis Hodgkin's Disease Stage I Nodular Sclerosis Hodgkin's Lymphoma Stage I Stage I Nodular Sclerosis Classical Hodgkin Lymphoma Stage I Nodular Sclerosis Hodgkin Lymphoma Stage I Nodular Sclerosis Hodgkin's Disease Stage I Nodular Sclerosis Hodgkin's Lymphoma Ann Arbor Stage I Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8840 Neoplastic Process Ann Arbor Stage IV Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Stage IV Nodular Sclerosis Classic Hodgkin Lymphoma C0855088 CTRP Malignant Stage_IV_Nodular_Sclerosis_Hodgkin_s_Lymphoma Ann Arbor Stage IV Nodular Sclerosis Classic Hodgkin Lymphoma Ann Arbor Stage IV Nodular Sclerosis Classical Hodgkin Lymphoma Nodular Sclerosis Hodgkin's Disease Stage IV Nodular Sclerosis Hodgkin's Lymphoma Stage IV Stage IV Nodular Sclerosis Classical Hodgkin Lymphoma Stage IV Nodular Sclerosis Hodgkin Lymphoma Stage IV Nodular Sclerosis Hodgkin's Disease Stage IV Nodular Sclerosis Hodgkin's Lymphoma Ann Arbor Stage IV Nodular Sclerosis Classic Hodgkin Lymphoma The reemergence of B-cell non-Hodgkin lymphoma after a period of remission. C8841 Neoplastic Process Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent B-Cell Non-Hodgkin Lymphoma C0855089 CTRP Malignant Recurrent_B-Cell_Non-Hodgkin_s_Lymphoma B-Cell Lymphoma Recurrent Recurrent B-Cell Lymphoma Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent B-Cell Non-Hodgkin's Lymphoma Recurrent B-Cell Non-Hodgkin Lymphoma Stage I includes: IA: (T1a, N0, M0); IB: (T1b, N0, M0); (T2a, N0, M0). T1a: Cutaneous melanoma with a tumor measuring 1.0 mm or less in thickness, without ulceration and mitosis less than 1/mm2. T1b: Cutaneous melanoma with a tumor measuring 1.0 mm or less in thickness, with ulceration or mitoses equal to or more than 1/mm2. T2a: Cutaneous melanoma with a tumor measuring 1.01-2.0 mm in thickness, without ulceration. N0: No regional lymph node metastases. M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.) C88414 Neoplastic Process Stage I Cutaneous Melanoma AJCC v7 Stage I Cutaneous Melanoma AJCC v7 C2981925 CTRP Malignant Stage I Cutaneous (Skin) Melanoma Stage I Cutaneous Melanoma AJCC v7 Stage I Skin Melanoma AJCC v7 Stage I Cutaneous Melanoma AJCC v7 Stage III includes: Any T, N1-3, M0. Stage III is divided into three pathologic subgroups: IIIA, IIIB, and IIIC. There are no clinical subgroups for stage III. N1: Cutaneous melanoma with metastasis in one regional lymph node. N2: Cutaneous melanoma with metastases in 2-3 regional lymph nodes or in transit met(s)/satellite(s) without metastatic nodes. N3: Cutaneous melanoma with 4 or more metastatic nodes, or matted nodes, or in transit met(s)/satellite(s) with metastatic node(s). M0: No detectable evidence of distant metastases. (from AJCC 7th Ed.) C88415 Neoplastic Process Stage III Cutaneous Melanoma AJCC v7 Stage III Cutaneous Melanoma AJCC v7 C2981926 CTRP Malignant Stage III Cutaneous (Skin) Melanoma Stage III Cutaneous Melanoma AJCC v7 Stage III Skin Melanoma AJCC v7 Stage III Cutaneous Melanoma AJCC v7 B-cell non-Hodgkin lymphoma that is resistant to treatment. C8842 Neoplastic Process Refractory B-Cell Non-Hodgkin Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma C0855090 CTRP Malignant Refractory_B-Cell_Non-Hodgkin_s_Lymphoma B-Cell Lymphoma Refractory Refractory B-Cell Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma Refractory B-Cell Non-Hodgkin's Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). The number of regions involved may be indicated by a subscript (e.g., II3). C8843 Neoplastic Process Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma C0855092 CTRP Malignant Stage_II_B-Cell_Non-Hodgkin_s_Lymphoma Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma B Cell Lymphoma Stage II B-Cell Lymphoma Stage II Stage II B Cell Lymphoma Stage II B-Cell Lymphoma Stage II B-Cell Non-Hodgkin Lymphoma Stage II B-Cell Non-Hodgkin's Lymphoma Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8844 Neoplastic Process Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma C0855093 CTRP Malignant Stage_III_B-Cell_Non-Hodgkin_s_Lymphoma Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma B Cell Lymphoma Stage III B-Cell Lymphoma Stage III Stage III B Cell Lymphoma Stage III B-Cell Lymphoma Stage III B-Cell Non-Hodgkin Lymphoma Stage III B-Cell Non-Hodgkin's Lymphoma Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8845 Neoplastic Process Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma C0855094 CTRP Malignant Stage_IV_B-Cell_Non-Hodgkin_s_Lymphoma Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma B Cell Lymphoma Stage IV B-Cell Lymphoma Stage IV Stage IV B Cell Lymphoma Stage IV B-Cell Lymphoma Stage IV B-Cell Non-Hodgkin Lymphoma Stage IV B-Cell Non-Hodgkin's Lymphoma Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma B-cell small lymphocytic lymphoma that is resistant to treatment. C8846 Neoplastic Process Refractory Small Lymphocytic Lymphoma Refractory Small Lymphocytic Lymphoma C0855097 CTRP Malignant Refractory_Small_Lymphocytic_Lymphoma B-Cell Small Lymphocytic Lymphoma Refractory Refractory B-Cell Small Lymphocytic Lymphoma Refractory Small Lymphocytic Lymphoma Refractory Small Lymphocytic Lymphoma Burkitt lymphoma that is resistant to treatment. C8847 Neoplastic Process Refractory Burkitt Lymphoma Refractory Burkitt Lymphoma C0855105 CTRP Malignant Refractory_Burkitt_s_Lymphoma Burkitt's Lymphoma Refractory Refractory Burkitt Lymphoma Refractory Burkitt's Lymphoma Refractory Burkitt Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8848 Neoplastic Process Ann Arbor Stage I Burkitt Lymphoma Ann Arbor Stage I Burkitt Lymphoma C0855106 CTRP Malignant Stage_I_Burkitt_s_Lymphoma Ann Arbor Stage I Burkitt Lymphoma Burkitt's Lymphoma Stage I Stage I Burkitt Lymphoma Stage I Burkitt's Lymphoma Ann Arbor Stage I Burkitt Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8849 Neoplastic Process Ann Arbor Stage II Burkitt Lymphoma Ann Arbor Stage II Burkitt Lymphoma C0855107 CTRP Malignant Stage_II_Burkitt_s_Lymphoma Ann Arbor Stage II Burkitt Lymphoma Burkitt's Lymphoma Stage II Stage II Burkitt Lymphoma Stage II Burkitt's Lymphoma Ann Arbor Stage II Burkitt Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8850 Neoplastic Process Ann Arbor Stage III Burkitt Lymphoma Ann Arbor Stage III Burkitt Lymphoma C0855108 CTRP Malignant Stage_III_Burkitt_s_Lymphoma Ann Arbor Stage III Burkitt Lymphoma Burkitt's Lymphoma Stage III Stage III Burkitt Lymphoma Stage III Burkitt's Lymphoma Ann Arbor Stage III Burkitt Lymphoma A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes. It is the most frequently seen type of non-Hodgkin lymphoma, representing 30%-40% of the cases. Morphologic variants include centroblastic lymphoma, immunoblastic lymphoma, and anaplastic lymphoma. Subtypes/entities include T-cell/histiocyte rich large B-cell lymphoma, primary diffuse large B-cell lymphoma of the central nervous system, plasmablastic lymphoma, primary cutaneous diffuse large B-cell lymphoma, leg type, and ALK-positive large B-cell lymphoma. C8851 Neoplastic Process Diffuse Large B-Cell Lymphoma Diffuse Large B-Cell Lymphoma C0079744 CPTAC CTEP CTRP Cellosaurus GDC mCode A type of B-cell non-Hodgkin lymphoma (cancer of the immune system) that is usually aggressive (fast-growing). It is the most common type of non-Hodgkin lymphoma, and is marked by rapidly growing tumors in the lymph nodes, spleen, liver, bone marrow, or other organs. Other symptoms include fever, night sweats, and weight loss. There are several subtypes of diffuse large B-cell lymphoma. 9680/3 Malignant Diffuse_Large_B-Cell_Lymphoma 9680/3 Diffuse Large B-Cell Lymphoma (DLBCL) Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma, extranodal and solid organ sites Diffuse large B-cell lymphoma, intra-abdominal lymph nodes Diffuse large B-cell lymphoma, intrathoracic lymph nodes Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck Diffuse large B-cell lymphoma, lymph nodes of multiple sites Diffuse large B-cell lymphoma, unspecified site Malignant lymphoma, histiocytic, NOS Malignant lymphoma, large cell, cleaved and noncleaved Malignant lymphoma, large cell, diffuse, NOS Non-follicular lymphoma Other non-follicular lymphoma, extranodal and solid organ sites DLBCL Diffuse Large B-Cell Lymphoma Diffuse Large B-Cell Lymphoma (DLBCL) Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma, unspecified site Non-follicular (diffuse) lymphoma, unspecified, unspecified site diffuse large B-cell lymphoma Diffuse Large B-Cell Lymphoma The reemergence of diffuse large B-cell lymphoma after a period of remission. C8852 Neoplastic Process Recurrent Diffuse Large B-Cell Lymphoma Recurrent Diffuse Large B-Cell Lymphoma C0855111 CTRP Malignant Recurrent_Diffuse_Large_B-Cell_Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Relapsed Diffuse Large B-Cell Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Diffuse large B-cell lymphoma that is resistant to treatment. C8853 Neoplastic Process Refractory Diffuse Large B-Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma C0855112 CTRP Malignant Refractory_Diffuse_Large_B-Cell_Lymphoma Diffuse Large B-Cell Lymphoma Refractory Refractory Diffuse Large B-Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8854 Neoplastic Process Ann Arbor Stage I Diffuse Large B-Cell Lymphoma Ann Arbor Stage I Diffuse Large B-Cell Lymphoma C0855113 CTRP Malignant Stage_I_Diffuse_Large_B-Cell_Lymphoma Ann Arbor Stage I Diffuse Large B-Cell Lymphoma Diffuse Large B-Cell Lymphoma Stage I Stage I Diffuse Large B-Cell Lymphoma Ann Arbor Stage I Diffuse Large B-Cell Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8855 Neoplastic Process Ann Arbor Stage II Diffuse Large B-Cell Lymphoma Ann Arbor Stage II Diffuse Large B-Cell Lymphoma C0855114 CTRP Malignant Stage_II_Diffuse_Large_B-Cell_Lymphoma Ann Arbor Stage II Diffuse Large B-Cell Lymphoma Diffuse Large B-Cell Lymphoma Stage II Stage II Diffuse Large B-Cell Lymphoma Ann Arbor Stage II Diffuse Large B-Cell Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8856 Neoplastic Process Ann Arbor Stage III Diffuse Large B-Cell Lymphoma Ann Arbor Stage III Diffuse Large B-Cell Lymphoma C0855115 CTRP Malignant Stage_III_Diffuse_Large_B-Cell_Lymphoma Ann Arbor Stage III Diffuse Large B-Cell Lymphoma Diffuse Large B-Cell Lymphoma Stage III Stage III Diffuse Large B-Cell Lymphoma Ann Arbor Stage III Diffuse Large B-Cell Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8857 Neoplastic Process Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma C0855116 CTRP Malignant Stage_IV_Diffuse_Large_B-Cell_Lymphoma Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma Diffuse Large B-Cell Lymphoma Stage IV Stage IV Diffuse Large B-Cell Lymphoma Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma Follicular lymphoma grade I, II, III that is resistant to treatment. C8858 Neoplastic Process Refractory Follicular Lymphoma Refractory Follicular Lymphoma C0855119 CTRP Malignant Refractory_Follicular_Lymphoma Refractory Follicular Lymphoma Refractory Follicular Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8859 Neoplastic Process Ann Arbor Stage I Follicular Lymphoma Ann Arbor Stage I Follicular Lymphoma C0855120 CTRP Malignant Stage_I_Follicular_Lymphoma Ann Arbor Stage I Follicular Lymphoma Stage I Follicular Lymphoma Ann Arbor Stage I Follicular Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8860 Neoplastic Process Ann Arbor Stage II Follicular Lymphoma Ann Arbor Stage II Follicular Lymphoma C0855121 CTRP Malignant Stage_II_Follicular_Lymphoma Ann Arbor Stage II Follicular Lymphoma Stage II Follicular Lymphoma Ann Arbor Stage II Follicular Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8861 Neoplastic Process Ann Arbor Stage III Follicular Lymphoma Ann Arbor Stage III Follicular Lymphoma C0855122 CTRP Malignant Stage_III_Follicular_Lymphoma Ann Arbor Stage III Follicular Lymphoma Stage III Follicular Lymphoma Ann Arbor Stage III Follicular Lymphoma Mantle cell lymphoma resistant to treatment. C8862 Neoplastic Process Refractory Mantle Cell Lymphoma Refractory Mantle Cell Lymphoma C0855138 CTRP Malignant Refractory_Mantle_Cell_Lymphoma Mantle Cell Lymphoma Refractory Refractory Mantle Cell Lymphoma Refractory Mantle Cell Lymphoma A primary nodal B-cell non-Hodgkin lymphoma which morphologically resembles lymph nodes involved by marginal zone lymphomas of extranodal or splenic types, but without evidence of extranodal or splenic disease. (WHO, 2001) C8863 Neoplastic Process Nodal Marginal Zone Lymphoma Nodal Marginal Zone Lymphoma C0855139 CTEP CTRP GDC Malignant Nodal_Marginal_Zone_B-Cell_Lymphoma 9699/3 Monocytoid B-cell lymphoma Nodal marginal zone lymphoma Monocytoid B-Cell Lymphoma Monocytoid B-cell lymphoma Nodal Marginal Zone B-Cell Lymphoma Nodal Marginal Zone Lymphoma Nodal marginal zone B-cell lymph. Nodal marginal zone B-cell lymphoma Nodal marginal zone lymphoma Nodal Marginal Zone Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8864 Neoplastic Process Ann Arbor Stage I Nodal Marginal Zone Lymphoma Ann Arbor Stage I Nodal Marginal Zone Lymphoma C0855142 CTRP Malignant Stage_I_Nodal_Marginal_Zone_B-Cell_Lymphoma Ann Arbor Stage I Nodal Marginal Zone Lymphoma Nodal Marginal Zone B-Cell Lymphoma Stage I Stage I Nodal Marginal Zone B-Cell Lymphoma Stage I Nodal Marginal Zone Lymphoma Ann Arbor Stage I Nodal Marginal Zone Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8865 Neoplastic Process Ann Arbor Stage II Nodal Marginal Zone Lymphoma Ann Arbor Stage II Nodal Marginal Zone Lymphoma C0855143 CTRP Malignant Stage_II_Nodal_Marginal_Zone_B-Cell_Lymphoma Ann Arbor Stage II Nodal Marginal Zone Lymphoma Nodal Marginal Zone B-Cell Lymphoma Stage II Stage II Nodal Marginal Zone B-Cell Lymphoma Stage II Nodal Marginal Zone Lymphoma Ann Arbor Stage II Nodal Marginal Zone Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8866 Neoplastic Process Ann Arbor Stage III Nodal Marginal Zone Lymphoma Ann Arbor Stage III Nodal Marginal Zone Lymphoma C0855144 CTRP Malignant Stage_III_Nodal_Marginal_Zone_B-Cell_Lymphoma Ann Arbor Stage III Nodal Marginal Zone Lymphoma Nodal Marginal Zone B-Cell Lymphoma Stage III Stage III Nodal Marginal Zone B-Cell Lymphoma Stage III Nodal Marginal Zone Lymphoma Ann Arbor Stage III Nodal Marginal Zone Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8867 Neoplastic Process Ann Arbor Stage IV Nodal Marginal Zone Lymphoma Ann Arbor Stage IV Nodal Marginal Zone Lymphoma C0855145 CTRP Malignant Stage_IV_Nodal_Marginal_Zone_B-Cell_Lymphoma Ann Arbor Stage IV Nodal Marginal Zone Lymphoma Nodal Marginal Zone B-Cell Lymphoma Stage IV Stage IV Nodal Marginal Zone B-Cell Lymphoma Stage IV Nodal Marginal Zone Lymphoma Ann Arbor Stage IV Nodal Marginal Zone Lymphoma An uncommon type of lymphoma. It constitutes approximately 10% of cases of lymphoblastic lymphoma. Approximately 75% of cases reported in a literature review involved patients who were less than 18 years of age. The most commonly affected sites are the skin, bone, soft tissue, and lymph nodes. It has a high remission rate with a median survival of approximately 60 months. (WHO, 2001) C8868 Neoplastic Process B Lymphoblastic Lymphoma B Lymphoblastic Lymphoma C1292757 CTEP CTRP GDC 9728/3 Malignant Precursor_B_Lymphoblastic_Lymphoma 9728/3 Precursor B-cell lymphoblastic lymphoma B Lymphoblastic Lymphoma B-Lymphoblastic Lymphoma Precur. B-lymphoblastic lymphoma Precursor B-Lymphoblastic Lymphoma Precursor B-cell lymphoblastic lymphoma Precursor B-lymphoblastic lymphoma B Lymphoblastic Lymphoma The reemergence of B-lymphoblastic lymphoma after a period of remission. C8869 Neoplastic Process Recurrent B Lymphoblastic Lymphoma Recurrent B Lymphoblastic Lymphoma C0855147 CTRP Malignant Recurrent_Precursor_B-Lymphoblastic_Lymphoma Recurrent B Lymphoblastic Lymphoma Recurrent B-Lymphoblastic Lymphoma Recurrent Precursor B-Lymphoblastic Lymphoma Relapsed Precursor B-Lymphoblastic Lymphoma Recurrent B Lymphoblastic Lymphoma B-lymphoblastic lymphoma that does not respond to treatment. C8870 Neoplastic Process Refractory B Lymphoblastic Lymphoma Refractory B Lymphoblastic Lymphoma C0855148 CTRP Malignant Refractory_Precursor_B-Lymphoblastic_Lymphoma Precursor B-Lymphoblastic Lymphoma Refractory Refractory B Lymphoblastic Lymphoma Refractory B-Lymphoblastic Lymphoma Refractory Precursor B-Lymphoblastic Lymphoma Refractory B Lymphoblastic Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8871 Neoplastic Process Ann Arbor Stage I B Lymphoblastic Lymphoma Ann Arbor Stage I B Lymphoblastic Lymphoma C0855149 CTRP Malignant Stage_I_Precursor_B-Lymphoblastic_Lymphoma Ann Arbor Stage I B Lymphoblastic Lymphoma Precursor B-Lymphoblastic Lymphoma Stage I Stage I B Lymphoblastic Lymphoma Stage I B-Lymphoblastic Lymphoma Stage I Precursor B-Lymphoblastic Lymphoma Ann Arbor Stage I B Lymphoblastic Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8872 Neoplastic Process Ann Arbor Stage III B Lymphoblastic Lymphoma Ann Arbor Stage III B Lymphoblastic Lymphoma C0855150 CTRP Malignant Stage_III_Precursor_B-Lymphoblastic_Lymphoma Ann Arbor Stage III B Lymphoblastic Lymphoma Precursor B-Lymphoblastic Lymphoma Stage III Stage III B Lymphoblastic Lymphoma Stage III B-Lymphoblastic Lymphoma Stage III Precursor B-Lymphoblastic Lymphoma Ann Arbor Stage III B Lymphoblastic Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8873 Neoplastic Process Ann Arbor Stage IV B Lymphoblastic Lymphoma Ann Arbor Stage IV B Lymphoblastic Lymphoma C0855151 CTRP Malignant Stage_IV_Precursor_B-Lymphoblastic_Lymphoma Ann Arbor Stage IV B Lymphoblastic Lymphoma Precursor B-Lymphoblastic Lymphoma Stage IV Stage IV B Lymphoblastic Lymphoma Stage IV B-Lymphoblastic Lymphoma Stage IV Precursor B-Lymphoblastic Lymphoma Ann Arbor Stage IV B Lymphoblastic Lymphoma The reemergence of primary mediastinal large B-cell lymphoma after a period of remission. C8874 Neoplastic Process Recurrent Mediastinal (Thymic) Large B-Cell Cell Lymphoma Recurrent Primary Mediastinal Large B-Cell Lymphoma C0855153 CTRP Malignant Recurrent_Mediastinal_Thymic_Large_B-Cell_Cell_Lymphoma Recurrent Mediastinal (Thymic) Large B-Cell Lymphoma Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma Recurrent Primary Mediastinal Large B-Cell Lymphoma Relapsed Primary Mediastinal (Thymic) Large B-Cell Lymphoma Relapsed Primary Mediastinal Large B-Cell Lymphoma Recurrent Primary Mediastinal Large B-Cell Lymphoma Primary mediastinal large B-cell lymphoma that is resistant to treatment. C8875 Neoplastic Process Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Refractory Primary Mediastinal Large B-Cell Lymphoma C0855154 CTRP Malignant Refractory_Mediastinal_Thymic_Large_B-Cell_Cell_Lymphoma Refractory Mediastinal (Thymic) Large B-Cell Lymphoma Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma Refractory Primary Mediastinal Large B-Cell Lymphoma Refractory Primary Mediastinal Large B-Cell Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8876 Neoplastic Process Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Ann Arbor Stage I Primary Mediastinal Large B-Cell Lymphoma C0855155 CTRP Malignant Stage_I_Mediastinal_Thymic_Large_B-Cell_Cell_Lymphoma Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma Ann Arbor Stage I Primary Mediastinal Large B-Cell Lymphoma Primary Mediastinal Large B-Cell Lymphoma Stage I Stage I Mediastinal (Thymic) Large B-Cell Lymphoma Stage I Primary Mediastinal Large B-Cell Lymphoma Ann Arbor Stage I Primary Mediastinal Large B-Cell Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8877 Neoplastic Process Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Ann Arbor Stage II Primary Mediastinal Large B-Cell Lymphoma C0855156 CTRP Malignant Stage_II_Mediastinal_Thymic_Large_B-Cell_Cell_Lymphoma Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Lymphoma Ann Arbor Stage II Primary Mediastinal Large B-Cell Lymphoma Primary Mediastinal Large B-Cell Lymphoma Stage II Stage II Mediastinal (Thymic) Large B-Cell Lymphoma Stage II Primary Mediastinal Large B-Cell Lymphoma Ann Arbor Stage II Primary Mediastinal Large B-Cell Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8878 Neoplastic Process Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Ann Arbor Stage III Primary Mediastinal Large B-Cell Lymphoma C0855157 CTRP Malignant Stage_III_Mediastinal_Thymic_Large_B-Cell_Cell_Lymphoma Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Lymphoma Ann Arbor Stage III Primary Mediastinal Large B-Cell Lymphoma Primary Mediastinal Large B-Cell Lymphoma Stage III Stage III Mediastinal (Thymic) Large B-Cell Lymphoma Stage III Primary Mediastinal Large B-Cell Lymphoma Ann Arbor Stage III Primary Mediastinal Large B-Cell Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8879 Neoplastic Process Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Ann Arbor Stage IV Primary Mediastinal Large B-Cell Lymphoma C0855158 CTRP Malignant Stage_IV_Mediastinal_Thymic_Large_B-Cell_Cell_Lymphoma Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Lymphoma Ann Arbor Stage IV Primary Mediastinal Large B-Cell Lymphoma Primary Mediastinal Large B-Cell Lymphoma Stage IV Stage IV Mediastinal (Thymic) Large B-Cell Lymphoma Stage IV Primary Mediastinal Large B-Cell Lymphoma Ann Arbor Stage IV Primary Mediastinal Large B-Cell Lymphoma Stage I includes: IA: (T1a, N0, M0); (T1b, N0, M0) and IB: (T2a, N0, M0). T1a: Lung cancer with a tumor size of 2 cm or less n greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. N0: No regional lymph metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88888 Neoplastic Process Stage I Lung Cancer AJCC v7 Stage I Lung Cancer AJCC v7 C0855003 CTRP Malignant Stage I Lung Cancer Stage I Lung Cancer AJCC v7 Stage I Lung Cancer AJCC v7 Stage II includes: IIA (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0) and IIB (T2b, N1, M0); (T3, N0, M0). T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension. T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension. T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.) C88889 Neoplastic Process Stage II Lung Cancer AJCC v7 Stage II Lung Cancer AJCC v7 C0862836 CTRP Malignant Stage II Lung Cancer Stage II Lung Cancer AJCC v7 Stage II Lung Cancer AJCC v7 Stage III includes: IIIA (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0) and IIIB (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C88890 Neoplastic Process Stage III Lung Cancer AJCC v7 Stage III Lung Cancer AJCC v7 C0862847 CTRP Malignant Stage III Lung Cancer Stage III Lung Cancer AJCC v7 Stage III Lung Cancer AJCC v7 Stage IV includes: (Any T, Any N, M1a); (Any T, Any N, M1b). M1a: Lung cancer with separate tumor nodule(s) in a contralateral lobe; tumor with pleural nodules or malignant pleural (or pericardial) effusion. M1b: Distant metastasis. (AJCC 7th ed.) C88891 Neoplastic Process Stage IV Lung Cancer AJCC v7 Stage IV Lung Cancer AJCC v7 C0855005 CTRP Malignant Stage IV Lung Cancer Stage IV Lung Cancer AJCC v7 Stage IV Lung Cancer AJCC v7 Choriocarcinoma that develops in the placenta. It is the rarest form of gestational choriocarcinoma. Metastases to the mother and infant may occur. C8893 Neoplastic Process Placental Choriocarcinoma C0855173 Malignant Placental_Choriocarcinoma Choriocarcinoma of Placenta Choriocarcinoma of the Placenta Placenta Choriocarcinoma Placental Choriocarcinoma Placental Choriocarcinoma Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C8894 Neoplastic Process Stage 0 Bladder Adenocarcinoma AJCC v6 and v7 Stage 0 Bladder Adenocarcinoma AJCC v6 and v7 C0855175 CTRP Malignant Stage_0_Bladder_Adenocarcinoma Stage 0 Bladder Adenocarcinoma Stage 0 Bladder Adenocarcinoma AJCC v6 Stage 0 Bladder Adenocarcinoma AJCC v6 and v7 Stage 0 Bladder Adenocarcinoma AJCC v7 Stage 0 Bladder Adenocarcinoma AJCC v6 and v7 Stage I includes: T1, N0, M0. T1: Tumor invades subepithelial connective tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8895 Neoplastic Process Stage I Bladder Adenocarcinoma AJCC v6 and v7 Stage I Bladder Adenocarcinoma AJCC v6 and v7 C0855176 CTRP Malignant Stage_I_Bladder_Adenocarcinoma Bladder Adenocarcinoma Stage I Stage I Bladder Adenocarcinoma Stage I Bladder Adenocarcinoma AJCC v6 Stage I Bladder Adenocarcinoma AJCC v6 and v7 Stage I Bladder Adenocarcinoma AJCC v7 Stage I Bladder Adenocarcinoma AJCC v6 and v7 Stage II includes: (T2a, N0, M0); (T2b, N0, M0). T2a: Tumor invades superficial muscle (inner half). T2b: Tumor invades deep muscle (outer half). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8896 Neoplastic Process Stage II Bladder Adenocarcinoma AJCC v6 and v7 Stage II Bladder Adenocarcinoma AJCC v6 and v7 C0855177 CTRP Malignant Stage_II_Bladder_Adenocarcinoma Stage II Bladder Adenocarcinoma Stage II Bladder Adenocarcinoma AJCC v6 Stage II Bladder Adenocarcinoma AJCC v6 and v7 Stage II Bladder Adenocarcinoma AJCC v7 Stage II Bladder Adenocarcinoma AJCC v6 and v7 Stage III includes: (T3a, N0, M0); (T3b, N0, M0); (T4a, N0, M0). T3a: Tumor microscopically invades perivesical tissue. T3b: Tumor macroscopically invades perivesical tissue (extravesical mass). T4a: Tumor invades prostatic stroma, uterus, vagina. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8897 Neoplastic Process Stage III Bladder Adenocarcinoma AJCC v6 and v7 Stage III Bladder Adenocarcinoma AJCC v6 and v7 C0855178 CTRP Malignant Stage_III_Bladder_Adenocarcinoma Stage III Bladder Adenocarcinoma Stage III Bladder Adenocarcinoma AJCC v6 Stage III Bladder Adenocarcinoma AJCC v6 and v7 Stage III Bladder Adenocarcinoma AJCC v7 Stage III Bladder Adenocarcinoma AJCC v6 and v7 Stage IV includes: (T4b, N0, M0); (Any T, N1-3, M0); (Any T, Any N, M1). T4b: Tumor invades pelvic wall, abdominal wall. N0: No regional lymph node metastasis. N1: Single regional lymph node metastasis in the true pelvis (hypogastric, obturator, external iliac, or presacral lymph node). N2: Multiple regional lymph node metastases in the true pelvis (hypogastric, obturator, external iliac, or presacral lymph node metastasis). N3: Metastasis to the common iliac lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C8898 Neoplastic Process Stage IV Bladder Adenocarcinoma AJCC v7 Stage IV Bladder Adenocarcinoma AJCC v7 C0855179 CTRP Malignant Stage_IV_Bladder_Adenocarcinoma Stage IV Bladder Adenocarcinoma Stage IV Bladder Adenocarcinoma AJCC v7 Stage IV Bladder Adenocarcinoma AJCC v7 Stage I includes: T1, N0, M0. T1: Nasopharyngeal cancer with tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C88981 Neoplastic Process Stage I Nasopharyngeal Carcinoma AJCC v7 Stage I Nasopharyngeal Carcinoma AJCC v7 CL449079 CTRP Malignant Stage I Nasopharyngeal Carcinoma Stage I Nasopharyngeal Carcinoma AJCC v7 Stage I Nasopharyngeal Throat Cancer Stage I Nasopharyngeal Carcinoma AJCC v7 Stage II includes: (T1, N1, M0); (T2, N0, M0); (T2, N1, M0). T1: Nasopharyngeal cancer with tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. T2: Nasopharyngeal cancer with parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. N0: No regional lymph node metastasis. N1: Nasopharyngeal cancer with unilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa, and/or unilateral or bilateral, retropharyngeal lymph nodes, 6 cm or less in greatest dimension. Midline nodes are considered ipsilateral nodes. M0: No distant metastasis. (AJCC 7th ed.) C88982 Neoplastic Process Stage II Nasopharyngeal Carcinoma AJCC v7 Stage II Nasopharyngeal Carcinoma AJCC v7 C2982437 CTRP Malignant Stage II Nasopharyngeal Carcinoma Stage II Nasopharyngeal Carcinoma AJCC v7 Stage II Nasopharyngeal Throat Cancer Stage II Nasopharyngeal Carcinoma AJCC v7 Stage III includes: (T1, N2, M0); (T2, N2, M0); (T3, N0, M0); (T3, N1, M0); (T3, N2, M0). T1: Nasopharyngeal cancer with tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. T2: Nasopharyngeal cancer with parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. T3: Nasopharyngeal cancer with tumor involving bony structures of skull base and/or paranasal sinuses. N0: No regional lymph node metastasis. N1: Nasopharyngeal cancer with unilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa, and/or unilateral or bilateral, retropharyngeal lymph nodes, 6 cm or less in greatest dimension. Midline nodes are considered ipsilateral nodes. N2: Nasopharyngeal cancer with bilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa. Midline nodes are considered ipsilateral nodes. M0: No distant metastasis. (AJCC 7th ed.) C88983 Neoplastic Process Stage III Nasopharyngeal Carcinoma AJCC v7 Stage III Nasopharyngeal Carcinoma AJCC v7 CL449080 CTRP Malignant Stage III Nasopharyngeal Carcinoma Stage III Nasopharyngeal Carcinoma AJCC v7 Stage III Nasopharyngeal Throat Cancer Stage III Nasopharyngeal Carcinoma AJCC v7 Stage IV includes: IVA: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0); IVB (Any T, N3, M0); IVC (Any T, Any N, M1). T4: Nasopharyngeal cancer with intracranial extension and/or involvement of cranial nerves, hypopharynx, orbit, or with extension to the infratemporal fossa/masticator space. N0: No regional lymph node metastasis. N1: Nasopharyngeal cancer with unilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa, and/or unilateral or bilateral, retropharyngeal lymph nodes, 6 cm or less in greatest dimension. Midline nodes are considered ipsilateral nodes. N2: Nasopharyngeal cancer with bilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa. Midline nodes are considered ipsilateral nodes. N3: Nasopharyngeal cancer with metastasis in a lymph node (s) more than 6 cm in greatest dimension and/or to supraclavicular fossa. Supraclavicular zone or fossa is relevant to the staging of nasopharyngeal carcinoma and is the triangular region originally described by Ho. It is defined by three points: (1) the superior margin of the sternal end of the clavicle, (2) the superior margin of the lateral end of the clavicle, (3) the point where the neck meets the shoulder. This would include caudal portions of levels IV and VB. All cases with lymph nodes (whole or part) in the fossa are considered N3b. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C88984 Neoplastic Process Stage IV Nasopharyngeal Carcinoma AJCC v7 Stage IV Nasopharyngeal Carcinoma AJCC v7 C3146259 CTRP Malignant Stage IV Nasopharyngeal Carcinoma Stage IV Nasopharyngeal Carcinoma AJCC v7 Stage IV Nasopharyngeal Throat Cancer Stage IV Nasopharyngeal Carcinoma AJCC v7 Stage I bladder carcinoma associated with the presence of bladder carcinoma in situ. C8899 Neoplastic Process Stage I Bladder Cancer with Carcinoma In Situ Stage I Bladder Cancer with Carcinoma In Situ C0855183 CTRP Malignant Stage_I_Bladder_Cancer_with_Carcinoma_in_situ Stage I Bladder Cancer with Cancer in situ Stage I Bladder Cancer with Carcinoma In Situ Stage I Bladder Carcinoma with Carcinoma in situ Stage I Bladder Cancer with Carcinoma In Situ Stage III includes: Any pT/TX, Any N, M1, SX. M1: Distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C8900 Neoplastic Process Stage III Testicular Choriocarcinoma AJCC v6 and v7 Stage III Testicular Choriocarcinoma AJCC v6 and v7 C0855184 CTRP Malignant Stage_III_Testicular_Choriocarcinoma Stage III Testicular Choriocarcinoma Stage III Testicular Choriocarcinoma AJCC v6 Stage III Testicular Choriocarcinoma AJCC v6 and v7 Stage III Testicular Choriocarcinoma AJCC v7 Stage III Testicular Choriocarcinoma AJCC v6 and v7 Stage I includes: T1, N0, M0. T1: Tumor invades subepithelial connective tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8901 Neoplastic Process Stage I Bladder Cancer without Carcinoma In Situ Stage I Bladder Cancer without Carcinoma In Situ C0855185 CTRP Malignant Stage_I_Bladder_Cancer_without_Carcinoma_in_situ Stage I Bladder Cancer without Cancer in situ Stage I Bladder Cancer without Carcinoma In Situ Stage I Bladder Cancer without Carcinoma In Situ AJCC v6 Stage I Bladder Cancer without Carcinoma In Situ AJCC v7 Stage I Bladder Carcinoma without Carcinoma in situ Stage I Bladder Cancer without Carcinoma In Situ The reemergence of bladder squamous cell carcinoma after a period of remission. C8902 Neoplastic Process Recurrent Bladder Squamous Cell Carcinoma C0855186 Malignant Recurrent_Bladder_Squamous_Cell_Carcinoma Recurrent Bladder Epidermoid Carcinoma Recurrent Bladder Squamous Cell Carcinoma Recurrent Epidermoid Carcinoma of Bladder Recurrent Epidermoid Carcinoma of Urinary Bladder Recurrent Epidermoid Carcinoma of the Bladder Recurrent Epidermoid Carcinoma of the Urinary Bladder Recurrent Squamous Cell Carcinoma of Bladder Recurrent Squamous Cell Carcinoma of Urinary Bladder Recurrent Squamous Cell Carcinoma of the Bladder Recurrent Squamous Cell Carcinoma of the Urinary Bladder Recurrent Urinary Bladder Epidermoid Carcinoma Recurrent Urinary Bladder Squamous Cell Carcinoma Relapsed Bladder Epidermoid Carcinoma Relapsed Bladder Squamous Cell Carcinoma Relapsed Epidermoid Carcinoma of Bladder Relapsed Epidermoid Carcinoma of Urinary Bladder Relapsed Epidermoid Carcinoma of the Bladder Relapsed Epidermoid Carcinoma of the Urinary Bladder Relapsed Squamous Cell Carcinoma of Bladder Relapsed Squamous Cell Carcinoma of Urinary Bladder Relapsed Squamous Cell Carcinoma of the Bladder Relapsed Squamous Cell Carcinoma of the Urinary Bladder Relapsed Urinary Bladder Epidermoid Carcinoma Relapsed Urinary Bladder Squamous Cell Carcinoma Squamous Cell Carcinoma of Bladder, Recurrent Squamous Cell Carcinoma of the Bladder, Recurrent Recurrent Bladder Squamous Cell Carcinoma Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T1: Tumor 2 cm or less in greatest dimension. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3: Tumor measuring more than 4 centimeters in greatest dimension or extension to lingual surface of epiglottis. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C89021 Neoplastic Process Stage III Oropharyngeal Carcinoma AJCC v7 Stage III Oropharyngeal Carcinoma AJCC v7 C2982461 CTRP Malignant Stage III Oropharyngeal Carcinoma Stage III Oropharyngeal Carcinoma AJCC v7 Stage III Oropharyngeal Throat Cancer Stage III Oropharyngeal Carcinoma AJCC v7 Stage IV includes: IVA (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB (T4b, Any N, M0); (Any T, N3, M0); IVC (Any T, Any N, M1). T4a: Tumor with moderately advanced local disease. Tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible. Mucosal extension to lingual surface of epiglottis from primary tumors of the base of the tongue and vallecula does not constitute invasion of larynx. T1: Tumor 2 cm or less in greatest dimension. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. T3: Tumor measuring more than 4 centimeters in greatest dimension or extension to lingual surface of epiglottis. T4b: Tumor with very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Tumor with metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Tumor with metastasis in a lymph node more than 6 cm in greatest dimension. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C89023 Neoplastic Process Stage IV Oropharyngeal Carcinoma AJCC v7 Stage IV Oropharyngeal Carcinoma AJCC v7 C3146258 CTRP Malignant Stage IV Oropharyngeal Carcinoma Stage IV Oropharyngeal Carcinoma AJCC v7 Stage IV Oropharyngeal Throat Cancer Stage IV Oropharyngeal Carcinoma AJCC v7 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C8903 Neoplastic Process Stage 0 Bladder Squamous Cell Carcinoma AJCC v6 and v7 Stage 0 Bladder Squamous Cell Carcinoma AJCC v6 and v7 C0855187 CTRP Malignant Stage_0_Bladder_Squamous_Cell_Carcinoma Stage 0 Bladder Squamous Cell Cancer Stage 0 Bladder Squamous Cell Carcinoma Stage 0 Bladder Squamous Cell Carcinoma AJCC v6 and v7 Stage 0 Bladder Squamous Cell Carcinoma AJCC v7 Stage 0 Squamous Cell Carcinoma of Bladder Stage 0 Squamous Cell Carcinoma of the Bladder Stage 0 Bladder Squamous Cell Carcinoma AJCC v6 and v7 Stage I includes: T1, N0, M0. T1: Tumor invades subepithelial connective tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8904 Neoplastic Process Stage I Squamous Cell Carcinoma of the Bladder AJCC v6 and v7 Stage I Squamous Cell Carcinoma of the Bladder AJCC v6 and v7 C0855188 CTRP Malignant Stage_I_Squamous_Cell_Carcinoma_of_the_Bladder Bladder Squamous Cell Carcinoma Stage I Stage I Bladder Squamous Cell Cancer Stage I Squamous Cell Carcinoma of Bladder Stage I Squamous Cell Carcinoma of the Bladder Stage I Squamous Cell Carcinoma of the Bladder AJCC v6 Stage I Squamous Cell Carcinoma of the Bladder AJCC v6 and v7 Stage I Squamous Cell Carcinoma of the Bladder AJCC v7 Stage I Squamous Cell Carcinoma of the Bladder AJCC v6 and v7 Stage I includes: T1, N0, M0. T1: Tumor limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C89045 Neoplastic Process Stage I Hypopharyngeal Carcinoma AJCC v7 Stage I Hypopharyngeal Carcinoma AJCC v7 C3146260 CTRP Malignant Stage I Hypopharyngeal Carcinoma Stage I Hypopharyngeal Carcinoma AJCC v7 Stage I Hypopharyngeal Throat Cancer Stage I Hypopharyngeal Carcinoma AJCC v7 Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor measuring more than 4 cm in greatest dimension or with fixation of hemilarynx or extension to esophagus. T1: Tumor limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimension. T2: Tumor invades more than one subsite of the hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) C89046 Neoplastic Process Stage III Hypopharyngeal Carcinoma AJCC v7 Stage III Hypopharyngeal Carcinoma AJCC v7 C2982480 CTRP Malignant Stage III Hypopharyngeal Carcinoma Stage III Hypopharyngeal Carcinoma AJCC v7 Stage III Hypopharyngeal Throat Cancer Stage III Hypopharyngeal Carcinoma AJCC v7 Stage IV includes: IVA: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB: (T4b, Any N, M0); (Any T, N3, M0); IVC: (Any T, Any N, M1). T4a: Tumor with moderately advanced local disease. Tumor invades the thyroid/cricoid cartilage, hyoid bone, thyroid gland, or central compartment soft tissue. Central compartment soft tissue includes prelaryngeal strap muscles and subcutaneous fat. T1: Tumor limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimension. T2: Tumor invades more than one subsite of the hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx. T3: Tumor measuring more than 4 cm in greatest dimension or tumor with fixation of hemilarynx or extension to esophagus. T4b: Tumor with very advanced local disease. Tumor invades prevertebral fascia, encases carotid artery, or involves mediastinal structures. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Tumor with metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a lymph node more than 6 cm in greatest dimension. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C89047 Neoplastic Process Stage IV Hypopharyngeal Carcinoma AJCC v7 Stage IV Hypopharyngeal Carcinoma AJCC v7 C2982481 CTRP Malignant Stage IV Hypopharyngeal Carcinoma Stage IV Hypopharyngeal Carcinoma AJCC v7 Stage IV Hypopharyngeal Throat Cancer Stage IV Hypopharyngeal Carcinoma AJCC v7 Stage III includes: (T3a, N0, M0); (T3b, N0, M0); (T4a, N0, M0). T3a: Tumor microscopically invades perivesical tissue. T3b: Tumor macroscopically invades perivesical tissue (extravesical mass). T4a: Tumor invades prostatic stroma, uterus, vagina. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8905 Neoplastic Process Stage III Bladder Squamous Cell Carcinoma AJCC v6 and v7 Stage III Bladder Squamous Cell Carcinoma AJCC v6 and v7 C0855190 CTRP Malignant Stage_III_Bladder_Squamous_Cell_Carcinoma Stage III Bladder Squamous Cell Cancer Stage III Bladder Squamous Cell Carcinoma Stage III Bladder Squamous Cell Carcinoma AJCC v6 Stage III Bladder Squamous Cell Carcinoma AJCC v6 and v7 Stage III Bladder Squamous Cell Carcinoma AJCC v7 Stage III Bladder Squamous Cell Carcinoma AJCC v6 and v7 Stage IV includes: (T4b, N0, M0); (Any T, N1-3, M0); (Any T, Any N, M1). T4b: Tumor invades pelvic wall, abdominal wall. N0: No regional lymph node metastasis. N1: Single regional lymph node metastasis in the true pelvis (hypogastric, obturator, external iliac, or presacral lymph node). N2: Multiple regional lymph node metastases in the true pelvis (hypogastric, obturator, external iliac, or presacral lymph node metastasis). N3: Metastasis to the common iliac lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C8906 Neoplastic Process Stage IV Bladder Squamous Cell Carcinoma AJCC v7 Stage IV Bladder Squamous Cell Carcinoma AJCC v7 C0855191 CTRP Malignant Stage_IV_Bladder_Squamous_Cell_Carcinoma Stage IV Bladder Squamous Cell Cancer Stage IV Bladder Squamous Cell Carcinoma Stage IV Bladder Squamous Cell Carcinoma AJCC v7 Stage IV Bladder Squamous Cell Carcinoma AJCC v7 Stage I includes: pT1-4, N0, M0, SX. pT1: Tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade into the tunica albuginea but not the tunica vaginalis. pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis. pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion. pT4: Tumor invades the scrotum with or without vascular/lymphatic invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C8907 Neoplastic Process Stage I Testicular Choriocarcinoma AJCC v6 and v7 Stage I Testicular Choriocarcinoma AJCC v6 and v7 C0855193 CTRP Malignant Stage_I_Testicular_Choriocarcinoma Stage I Testicular Choriocarcinoma Stage I Testicular Choriocarcinoma AJCC v6 Stage I Testicular Choriocarcinoma AJCC v6 and v7 Stage I Testicular Choriocarcinoma AJCC v7 Stage I Testicular Choriocarcinoma AJCC v6 and v7 Stage I includes: pT1-4, N0, M0, SX. pT1: Tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade into the tunica albuginea but not the tunica vaginalis. pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis. pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion. pT4: Tumor invades the scrotum with or without vascular/lymphatic invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C8908 Neoplastic Process Stage I Testicular Embryonal Carcinoma AJCC v6 and v7 Stage I Testicular Embryonal Carcinoma AJCC v6 and v7 C0855194 CTRP Malignant Stage_I_Testicular_Embryonal_Carcinoma Stage I Testicular Embryonal Carcinoma Stage I Testicular Embryonal Carcinoma AJCC v6 Stage I Testicular Embryonal Carcinoma AJCC v6 and v7 Stage I Testicular Embryonal Carcinoma AJCC v7 Stage I Testicular Embryonal Carcinoma AJCC v6 and v7 Stage II includes: Any pT/TX, N1-3, M0, SX. pTX: Primary tumor cannot be assessed. N1: Metastasis with a lymph node mass 2 cm or less in greatest dimension; or multiple lymph nodes, none more than 2cm in greatest dimension. N2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, any one mass greater than 2 cm but not more than 5 cm in greatest dimension. N3: Metastasis with a lymph node mass more than 5 cm in greatest dimension. M0: No distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C8909 Neoplastic Process Stage II Testicular Embryonal Carcinoma AJCC v6 and v7 Stage II Testicular Embryonal Carcinoma AJCC v6 and v7 C0855195 CTRP Malignant Stage_II_Testicular_Embryonal_Carcinoma Stage II Testicular Embryonal Carcinoma Stage II Testicular Embryonal Carcinoma AJCC v6 Stage II Testicular Embryonal Carcinoma AJCC v6 and v7 Stage II Testicular Embryonal Carcinoma AJCC v7 Stage II Testicular Embryonal Carcinoma AJCC v6 and v7 Stage IV includes: IVA: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB: (T4b, Any N, M0); (Any T, N3, M0); IVC: (Any T, Any N, M1). T4a: Supraglottis: Moderately advanced local disease. Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus). Glottis: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus). Subglottis: Moderately advanced local disease. Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus). T4b: Supraglottis, Glottis, and Subglottis: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a lymph node, more than 6 cm in greatest dimension. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C89091 Neoplastic Process Stage IV Laryngeal Cancer AJCC v7 Stage IV Laryngeal Cancer AJCC v7 CL448441 CTRP Malignant Stage IV Laryngeal Cancer Stage IV Laryngeal Cancer AJCC v7 Stage IV Laryngeal Throat Cancer Stage IV Laryngeal Cancer AJCC v7 Stage III includes: Any pT/TX, Any N, M1, SX. M1: Distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C8910 Neoplastic Process Stage III Testicular Embryonal Carcinoma AJCC v6 and v7 Stage III Testicular Embryonal Carcinoma AJCC v6 and v7 C0855196 CTRP Malignant Stage_III_Testicular_Embryonal_Carcinoma Stage III Testicular Embryonal Carcinoma Stage III Testicular Embryonal Carcinoma AJCC v6 Stage III Testicular Embryonal Carcinoma AJCC v6 and v7 Stage III Testicular Embryonal Carcinoma AJCC v7 Stage III Testicular Embryonal Carcinoma AJCC v6 and v7 Stage II includes: Any pT/TX, N1-3, M0, SX. pTX: Primary tumor cannot be assessed. N1: Metastasis with a lymph node mass 2 cm or less in greatest dimension; or multiple lymph nodes, none more than 2cm in greatest dimension. N2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, any one mass greater than 2 cm but not more than 5 cm in greatest dimension. N3: Metastasis with a lymph node mass more than 5 cm in greatest dimension. M0: No distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C8911 Neoplastic Process Stage II Testicular Mixed Germ Cell Tumor AJCC v6 and v7 Stage II Testicular Mixed Germ Cell Tumor AJCC v6 and v7 C0855199 CTRP Malignant Stage_II_Testicular_Mixed_Germ_Cell_Tumor Stage II Testicular Mixed Germ Cell Tumor Stage II Testicular Mixed Germ Cell Tumor AJCC v6 Stage II Testicular Mixed Germ Cell Tumor AJCC v6 and v7 Stage II Testicular Mixed Germ Cell Tumor AJCC v7 Stage II Testicular Mixed Germ Cell Tumor AJCC v6 and v7 Stage IV includes: IVA: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB: (T4b, Any N, M0); (Any T, N3, M0); IVC: (Any T, Any N, M1). T4a: Maxillary sinus: Moderately advanced local disease. Tumor invades anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid or frontal sinuses. Nasal cavity and ethmoid sinus: Moderately advanced local disease. Tumor invades any of the following: anterior orbital contents, skin of nose or cheek, minimal extension to anterior cranial fossa, pterygoid plates, sphenoid or frontal sinuses. T4b: Very advanced local disease. Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve, nasopharynx, or clivus. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. N3: Metastasis in a lymph node, more than 6 cm in greatest dimension. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C89117 Neoplastic Process Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v7 Stage IV Sinonasal Cancer AJCC v7 CL033794 CTRP Malignant Stage IV Nasal Cavity and Paranasal Sinus Cancer Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v7 Stage IV Sinonasal Cancer AJCC v7 Stage IV Sinonasal Carcinoma AJCC v7 Stage IV Sinonasal Cancer AJCC v7 Stage I includes: pT1-4, N0, M0, SX. pT1: Tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade into the tunica albuginea but not the tunica vaginalis. pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis. pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion. pT4: Tumor invades the scrotum with or without vascular/lymphatic invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C8912 Neoplastic Process Stage I Testicular Mixed Germ Cell Tumor AJCC v6 and v7 Stage I Testicular Mixed Germ Cell Tumor AJCC v6 and v7 C0855203 CTRP Malignant Stage_I_Testicular_Mixed_Germ_Cell_Tumor Stage I Testicular Mixed Germ Cell Tumor Stage I Testicular Mixed Germ Cell Tumor AJCC v6 Stage I Testicular Mixed Germ Cell Tumor AJCC v6 and v7 Stage I Testicular Mixed Germ Cell Tumor AJCC v7 Stage I Testicular Mixed Germ Cell Tumor AJCC v6 and v7 Stage III includes: Any pT/TX, Any N, M1, SX. M1: Distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C8913 Neoplastic Process Stage III Testicular Mixed Germ Cell Tumor AJCC v6 and v7 Stage III Testicular Mixed Germ Cell Tumor AJCC v6 and v7 C0855204 CTRP Malignant Stage_III_Testicular_Mixed_Germ_Cell_Tumor Stage III Testicular Mixed Germ Cell Tumor Stage III Testicular Mixed Germ Cell Tumor AJCC v6 Stage III Testicular Mixed Germ Cell Tumor AJCC v6 and v7 Stage III Testicular Mixed Germ Cell Tumor AJCC v7 Stage III Testicular Mixed Germ Cell Tumor AJCC v6 and v7 Stage I includes: pT1-4, N0, M0, SX. pT1: Tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade into the tunica albuginea but not the tunica vaginalis. pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis. pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion. pT4: Tumor invades the scrotum with or without vascular/lymphatic invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C8914 Neoplastic Process Stage I Immature Testicular Teratoma AJCC v6 and v7 Stage I Testicular Immature Teratoma AJCC v6 and v7 C0855205 CTRP Malignant Stage_I_Immature_Testicular_Teratoma Stage I Immature Testicular Teratoma Stage I Immature Testicular Teratoma AJCC v6 Stage I Immature Testicular Teratoma AJCC v6 and v7 Stage I Immature Testicular Teratoma AJCC v7 Stage I Testicular Immature Teratoma AJCC v6 and v7 Stage I Testicular Immature Teratoma AJCC v6 and v7 Stage II includes: Any pT/TX, N1-3, M0, SX. pTX: Primary tumor cannot be assessed. N1: Metastasis with a lymph node mass 2 cm or less in greatest dimension; or multiple lymph nodes, none more than 2cm in greatest dimension. N2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, any one mass greater than 2 cm but not more than 5 cm in greatest dimension. N3: Metastasis with a lymph node mass more than 5 cm in greatest dimension. M0: No distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C8915 Neoplastic Process Stage II Immature Testicular Teratoma AJCC v6 and v7 Stage II Testicular Immature Teratoma AJCC v6 and v7 C0855206 CTRP Malignant Stage_II_Immature_Testicular_Teratoma Stage II Immature Testicular Teratoma Stage II Immature Testicular Teratoma AJCC v6 Stage II Immature Testicular Teratoma AJCC v6 and v7 Stage II Immature Testicular Teratoma AJCC v7 Stage II Testicular Immature Teratoma AJCC v6 and v7 Stage II Testicular Immature Teratoma AJCC v6 and v7 Stage III includes: Any pT/TX, Any N, M1, SX. M1: Distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C8916 Neoplastic Process Stage III Immature Testicular Teratoma AJCC v6 and v7 Stage III Testicular Immature Teratoma AJCC v6 and v7 C0855207 CTRP Malignant Stage_III_Immature_Testicular_Teratoma Stage III Immature Testicular Teratoma Stage III Immature Testicular Teratoma AJCC v6 Stage III Immature Testicular Teratoma AJCC v6 and v7 Stage III Immature Testicular Teratoma AJCC v7 Stage III Testicular Immature Teratoma AJCC v6 and v7 Stage III Testicular Immature Teratoma AJCC v6 and v7 Stage I includes: pT1-4, N0, M0, SX. pT1: Tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade into the tunica albuginea but not the tunica vaginalis. pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis. pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion. pT4: Tumor invades the scrotum with or without vascular/lymphatic invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C8917 Neoplastic Process Stage I Testicular Seminoma AJCC v6 and v7 Stage I Testicular Seminoma AJCC v6 and v7 C0855208 CTRP Malignant Stage_I_Testicular_Seminoma Stage I Seminoma Stage I Seminoma of Testis Stage I Seminoma of the Testis Stage I Testicular Seminoma Stage I Testicular Seminoma AJCC v6 Stage I Testicular Seminoma AJCC v6 and v7 Stage I Testicular Seminoma AJCC v7 Stage I Testicular Seminoma AJCC v6 and v7 Stage II includes: Any pT/TX, N1-3, M0, SX. pTX: Primary tumor cannot be assessed. N1: Metastasis with a lymph node mass 2 cm or less in greatest dimension; or multiple lymph nodes, none more than 2cm in greatest dimension. N2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, any one mass greater than 2 cm but not more than 5 cm in greatest dimension. N3: Metastasis with a lymph node mass more than 5 cm in greatest dimension. M0: No distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C8918 Neoplastic Process Stage II Testicular Seminoma AJCC v6 and v7 Stage II Testicular Seminoma AJCC v6 and v7 C0855209 CTRP Malignant Stage_II_Testicular_Seminoma Stage II Seminoma Stage II Seminoma of Testis Stage II Seminoma of the Testis Stage II Testicular Seminoma Stage II Testicular Seminoma AJCC v6 Stage II Testicular Seminoma AJCC v6 and v7 Stage II Testicular Seminoma AJCC v7 Stage II Testicular Seminoma AJCC v6 and v7 Stage III includes: Any pT/TX, Any N, M1, SX. M1: Distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C8919 Neoplastic Process Stage III Testicular Seminoma AJCC v6 and v7 Stage III Testicular Seminoma AJCC v6 and v7 C0855210 CTRP Malignant Stage_III_Testicular_Seminoma Stage III Seminoma Stage III Testicular Seminoma Stage III Testicular Seminoma AJCC v6 Stage III Testicular Seminoma AJCC v6 and v7 Stage III Testicular Seminoma AJCC v7 Stage III Testicular Seminoma AJCC v6 and v7 Stage 0 includes: (Tis, N0, M0); (Ta, N0, M0). Tis: Carcinoma in situ. Ta: Non-invasive verrucous carcinoma. cN0: No palpable or visibly enlarged inguinal lymph nodes. pN0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C89194 Neoplastic Process Stage 0 Penile Cancer AJCC v7 Stage 0 Penile Cancer AJCC v7 C1321897 CTRP Malignant Stage 0 Penile Cancer Stage 0 Penile Cancer AJCC v7 Stage 0 Penile Cancer AJCC v7 Stage I includes: T1a, N0, M0. T1a: Tumor invades subepithelial connective tissue without lymph vascular invasion and is not poorly differentiated (i.e., grade 3-4). cN0: No palpable or visibly enlarged inguinal lymph nodes. pN0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C89195 Neoplastic Process Stage I Penile Cancer AJCC v7 Stage I Penile Cancer AJCC v7 C0854965 CTRP Cancer is found in connective tissue just under the skin of the penis. Malignant Stage I Penile Cancer Stage I Penile Cancer AJCC v7 stage I penile cancer Stage I Penile Cancer AJCC v7 Stage II includes: (T1b, N0, M0); (T2, N0, M0); (T3, N0, M0). T1b: Tumor invades subepithelial connective tissue with lymph vascular invasion or is poorly differentiated. T2: Tumor invades corpus spongiosum or cavernosum. T3: Tumor invades urethra. cN0: No palpable or visibly enlarged inguinal lymph nodes. pN0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C89196 Neoplastic Process Stage II Penile Cancer AJCC v7 Stage II Penile Cancer AJCC v7 C0854966 CTRP Cancer has spread to connective tissue just under the skin of the penis and to one lymph node in the groin; or cancer has spread to erectile tissue (spongy tissue that fills with blood to make an erection) and may have spread to one lymph node in the groin. Malignant Stage II Penile Cancer Stage II Penile Cancer AJCC v7 stage II penile cancer Stage II Penile Cancer AJCC v7 Stage III includes: IIIa (T1-3, N1, M0); IIIb (T1-3, N2, M0). T1: Tumor invades subepithelial connective tissue without lymph vascular invasion and is not poorly differentiated (i.e., grade 3-4) or tumor invades subepithelial connective tissue with lymph vascular invasion or is poorly differentiated. T2: Tumor invades corpus spongiosum or cavernosum. T3: Tumor invades urethra. cN1: Palpable mobile unilateral inguinal lymph node. pN1: Metastasis in a single inguinal lymph node. cN2: Palpable mobile multiple or bilateral inguinal lymph nodes. pN2: Metastasis in multiple or bilateral superficial inguinal lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C89197 Neoplastic Process Stage III Penile Cancer AJCC v7 Stage III Penile Cancer AJCC v7 C0854967 CTRP Cancer has spread to connective tissue or erectile tissue of the penis and to more than one lymph node in the groin; or cancer has spread to the urethra or prostate and may have spread to one or more lymph nodes in the groin. Malignant Stage III Penile Cancer Stage III Penile Cancer AJCC v7 stage III penile cancer Stage III Penile Cancer AJCC v7 Stage IV includes: (T4, Any N, M0); (Any T, N3, M0); (Any T, Any N, M1). T4: Tumor invades other adjacent structures. cN3: Palpable fixed inguinal nodal mass or pelvic lymphadenopathy unilateral or bilateral. pN3: Extranodal extension of lymph node metastasis or pelvic lymph node(s) unilateral or bilateral. M0: No distant metastasis. M1: Distant metastasis (lymph node metastasis outside of the true pelvis in addition to visceral or bone sites). (AJCC 7th ed.) C89198 Neoplastic Process Stage IV Penile Cancer AJCC v7 Stage IV Penile Cancer AJCC v7 C0854963 CTRP Cancer has spread to tissues near the penis and may have spread to lymph nodes in the groin or pelvis; or cancer has spread anywhere in or near the penis and to one or more lymph nodes deep in the pelvis or groin; or cancer has spread to distant parts of the body. Malignant Stage IV Penile Cancer Stage IV Penile Cancer AJCC v7 stage IV penile cancer Stage IV Penile Cancer AJCC v7 Stage I includes: pT1-4, N0, M0, SX. pT1: Tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade into the tunica albuginea but not the tunica vaginalis. pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis. pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion. pT4: Tumor invades the scrotum with or without vascular/lymphatic invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C8920 Neoplastic Process Stage I Testicular Yolk Sac Tumor AJCC v6 and v7 Stage I Testicular Yolk Sac Tumor AJCC v6 and v7 C0855213 CTRP Malignant Stage_I_Testicular_Yolk_Sac_Tumor Stage I Testicular Yolk Sac Tumor Stage I Testicular Yolk Sac Tumor AJCC v6 Stage I Testicular Yolk Sac Tumor AJCC v6 and v7 Stage I Testicular Yolk Sac Tumor AJCC v7 Stage I Testicular Yolk Sac Tumor AJCC v6 and v7 Stage II includes: Any pT/TX, N1-3, M0, SX. pTX: Primary tumor cannot be assessed. N1: Metastasis with a lymph node mass 2 cm or less in greatest dimension; or multiple lymph nodes, none more than 2cm in greatest dimension. N2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, any one mass greater than 2 cm but not more than 5 cm in greatest dimension. N3: Metastasis with a lymph node mass more than 5 cm in greatest dimension. M0: No distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C8921 Neoplastic Process Stage II Testicular Yolk Sac Tumor AJCC v6 and v7 Stage II Testicular Yolk Sac Tumor AJCC v6 and v7 C0855214 CTRP Malignant Stage_II_Testicular_Yolk_Sac_Tumor Stage II Testicular Yolk Sac Tumor Stage II Testicular Yolk Sac Tumor AJCC v6 Stage II Testicular Yolk Sac Tumor AJCC v6 and v7 Stage II Testicular Yolk Sac Tumor AJCC v7 Stage II Testicular Yolk Sac Tumor AJCC v6 and v7 Stage III includes: Any pT/TX, Any N, M1, SX. M1: Distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C8922 Neoplastic Process Stage III Testicular Yolk Sac Tumor AJCC v6 and v7 Stage III Testicular Yolk Sac Tumor AJCC v6 and v7 C0855215 CTRP Malignant Stage_III_Testicular_Yolk_Sac_Tumor Stage III Testicular Yolk Sac Tumor Stage III Testicular Yolk Sac Tumor AJCC v6 Stage III Testicular Yolk Sac Tumor AJCC v6 and v7 Stage III Testicular Yolk Sac Tumor AJCC v7 Stage III Testicular Yolk Sac Tumor AJCC v6 and v7 An acute myeloid leukemia characterized by a predominant immature erythroid population. There are two subtypes recognized: erythroleukemia and pure erythroid leukemia. (WHO, 2001) C8923 Neoplastic Process Acute Erythroid Leukemia Acute Erythroid Leukemia C0023440 CDISC CPTAC CTRP Cellosaurus GDC NICHD PCDC A progressive, proliferative disease of blood cells, originating from immature erythroid cells. An acute myeloid leukemia characterized by a predominant immature erythroid population. 9840/3 Malignant Acute_Erythroid_Leukemia 9840/3 AML M6 Acute erythremia Acute erythremia and erythroleukemia Acute erythremia and erythroleukemia without mention of having achieved remission Acute erythroid leukaemia Acute erythroid leukemia Acute erythroid leukemia, not having achieved remission Acute myeloid leukemia, M6 type FAB M6 M6 AEL Acute Erythroblastic Leukemia Acute Erythroid Leukemia Acute erythroid leukaemia Erythroblastic Leukemia FAB M6 Fab M6 LEUKEMIA, ERYTHROID, MALIGNANT M6 M6 Acute Myeloid Leukemia M6 OR Acute Erythroid Leukemia Acute Erythroid Leukemia Stage I includes: (T1a-c, N0, M0, PSA less than 10, Gleason equal or less than 6); (T2a, N0, M0, PSA less than 10, Gleason equal or less than 6); (T1-2a, N0, M0, PSA X, Gleason X). T1a: Tumor incidental histologic finding in 5% or less of tissue resected. T1b: Tumor incidental histologic finding in more than 5% of tissue resected. T1c: Tumor identified by needle biopsy (e.g., because of elevated PSA). T2a: Tumor involves one-half of one lobe or less. cN0: No regional lymph node metastasis. pN0: No positive regional nodes. M0: No distant metastasis. Gleason Equal or Less than 6: Well differentiated (slight anaplasia). Gleason X: Gleason score cannot be processed. (AJCC 7th ed.) C89232 Neoplastic Process Stage I Prostate Cancer AJCC v7 Stage I Prostate Cancer AJCC v7 C3146263 CTRP Malignant Stage I Prostate Cancer Stage I Prostate Cancer AJCC v7 Stage I Prostate Cancer AJCC v7 Stage II includes: IIA (T1a-c, N0, M0, PSA less than 20, Gleason 7); (T1a-c, N0, M0, PSA equal or more than 10 and less than 20, Gleason equal or less than 6); (T2a, N0, M0, PSA less than 20, Gleason equal or less than 7); (T2b, N0, M0, PSA less than 20, Gleason equal or less than 7); (T2b, N0, M0, PSA X, Gleason X); IIB (T2c, N0, M0, Any PSA, Any Gleason); (T1-2, N0, M0, PSA equal or more than 20, Any Gleason); (T1-2, N0, M0, Any PSA, Gleason equal or more than 8). T1a: Tumor incidental histologic finding in 5% or less of tissue resected. T1b: Tumor incidental histologic finding in more than 5% of tissue resected. T1c: Tumor identified by needle biopsy (e.g., because of elevated PSA). T2a: Tumor involves one-half of one lobe or less. T2b: Tumor involves more than one-half of one lobe, but not both lobes. T2c: Tumor involves both lobes. cN0: No regional lymph node metastasis. pN0: No positive regional nodes. M0: No distant metastasis. Gleason 7: Moderately differentiated (moderate anaplasia). Gleason Equal or Less than 6: Well differentiated (slight anaplasia). Gleason equal or more than 8: Poorly differentiated/undifferentiated (marked anaplasia). (AJCC 7th ed.) C89233 Neoplastic Process Stage II Prostate Cancer AJCC v7 Stage II Prostate Cancer AJCC v7 C3146261 CTRP Malignant Stage II Prostate Cancer Stage II Prostate Cancer AJCC v7 Stage II Prostate Cancer AJCC v7 Stage III includes: T3a-b, N0, M0, Any PSA, Any Gleason. cT3a: Tumor with extracapsular extension (unilateral or bilateral). pT3a: Tumor with extraprostatic extension or microscopic invasion of bladder neck. T3b: Tumor invades seminal vesicle(s). cN0: No regional lymph node metastasis. pN0: No positive regional nodes. M0: No distant metastasis. (AJCC 7th ed.) C89234 Neoplastic Process Stage III Prostate Cancer AJCC v7 Stage III Prostate Cancer AJCC v7 C3146262 CTRP Malignant Stage III Prostate Cancer Stage III Prostate Cancer AJCC v7 Stage III Prostate Cancer AJCC v7 Stage IV includes: (T4, N0, M0, Any PSA, Any Gleason); (Any T, N1, M0, Any PSA, Any Gleason); (Any T, Any N, M1, Any PSA, Any Gleason). cT4: Tumor is fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, and/or pelvic wall. pT4: Invasion of rectum, levator muscles, and/or pelvic wall. N1: Metastasis in regional lymph node(s). M1: Distant metastasis. (AJCC 7th ed.) C89235 Neoplastic Process Stage IV Prostate Cancer AJCC v7 Stage IV Prostate Cancer AJCC v7 C3146264 CTRP Malignant Stage IV Prostate Cancer Stage IV Prostate Cancer AJCC v7 Stage IV Prostate Cancer AJCC v7 The reemergence of centroblastic lymphoma after a period of remission. C8926 Neoplastic Process Recurrent Centroblastic Lymphoma Recurrent Centroblastic Lymphoma C0861212 CTRP Malignant Recurrent_Centroblastic_Lymphoma Recurrent Centroblastic Lymphoma Recurrent Centroblastic Lymphoma Centroblastic lymphoma, resistant to treatment. C8927 Neoplastic Process Refractory Centroblastic Lymphoma Refractory Centroblastic Lymphoma C0861214 CTRP Malignant Refractory_Centroblastic_Lymphoma Refractory Centroblastic Lymphoma Refractory Centroblastic Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C8928 Neoplastic Process Ann Arbor Stage I Centroblastic Lymphoma Ann Arbor Stage I Centroblastic Lymphoma C0861216 CTRP Malignant Stage_I_Centroblastic_Lymphoma Ann Arbor Stage I Centroblastic Lymphoma Stage I Centroblastic Lymphoma Ann Arbor Stage I Centroblastic Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). The number of regions involved may be indicated by a subscript (e.g., II3). C8929 Neoplastic Process Ann Arbor Stage II Centroblastic Lymphoma Ann Arbor Stage II Centroblastic Lymphoma C0861218 CTRP Malignant Stage_II_Centroblastic_Lymphoma Ann Arbor Stage II Centroblastic Lymphoma Stage II Centroblastic Lymphoma Ann Arbor Stage II Centroblastic Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C8930 Neoplastic Process Ann Arbor Stage III Centroblastic Lymphoma Ann Arbor Stage III Centroblastic Lymphoma C0861220 CTRP Malignant Stage_III_Centroblastic_Lymphoma Ann Arbor Stage III Centroblastic Lymphoma Stage III Centroblastic Lymphoma Ann Arbor Stage III Centroblastic Lymphoma Stage II includes: T2, N0, M0. T2: Lesions have been divided into T2a and T2b. T2a is defined as tumor more than 7 cm but less than or equal to 10 cm in greatest dimension, limited to the kidney. T2b is defined as tumor greater than 10 cm, limited to the kidney. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C89301 Neoplastic Process Stage II Renal Cell Cancer AJCC v7 Stage II Renal Cell Cancer AJCC v7 C3146247 CTRP Malignant Stage II Renal Cell Cancer Stage II Renal Cell Cancer AJCC v7 Stage II Renal Cell Carcinoma Stage II Renal Cell Carcinoma AJCC v7 Stage II Renal Cell Cancer AJCC v7 Stage III includes: (T1 or T2, N1, M0); (T3, N0 or N1, M0). T1: Lesions have been divided into T1a and T1b. T1a is defined as tumor 4 cm or less in greatest dimension, limited to the kidney. T1b is defined as tumor greater than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney. T2: Lesions have been divided into T2a and T2b. T2a is defined as tumor more than 7 cm but less than or equal to 10 cm in greatest dimension, limited to the kidney. T2b is defined as tumor greater than 10 cm, limited to the kidney. T3: Tumor extends into major veins or perinephric tissues, but not into the ipsilateral adrenal gland and not beyond Gerota's fascia. Lesions have been divided into T3a, T3b, and T3c. T3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) branches, or tumor invades perirenal and/or renal sinus fat but not beyond Gerota's fascia. T3b: Tumor grossly extends into the vena cava below the diaphragm. T3c: Tumor grossly extends into the vena cava above the diaphragm or invades the wall of the vena cava. N0: No regional lymph node metastasis. N1: Metastasis in regional lymph node(s). M0: No distant metastasis. (AJCC 7th ed.) C89302 Neoplastic Process Stage III Renal Cell Cancer AJCC v7 Stage III Renal Cell Cancer AJCC v7 C3146248 CTRP Malignant Stage III Renal Cell Cancer Stage III Renal Cell Cancer AJCC v7 Stage III Renal Cell Carcinoma Stage III Renal Cell Carcinoma AJCC v7 Stage III Renal Cell Cancer AJCC v7 Stage IV includes: (T4, Any N, M0); (Any T, Any N, M1). T4: Tumor invades beyond Gerota's fascia (including contiguous extension into the ipsilateral adrenal gland). M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C89303 Neoplastic Process Stage IV Renal Cell Cancer AJCC v7 Stage IV Renal Cell Cancer AJCC v7 C3146249 CTRP Malignant Stage IV Renal Cell Cancer Stage IV Renal Cell Cancer AJCC v7 Stage IV Renal Cell Carcinoma Stage IV Renal Cell Carcinoma AJCC v7 Stage IV Renal Cell Cancer AJCC v7 Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C8931 Neoplastic Process Ann Arbor Stage IV Centroblastic Lymphoma Ann Arbor Stage IV Centroblastic Lymphoma C0861222 CTRP Malignant Stage_IV_Centroblastic_Lymphoma Ann Arbor Stage IV Centroblastic Lymphoma Stage IV Centroblastic Lymphoma Ann Arbor Stage IV Centroblastic Lymphoma Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ: intraepithelial or invasion of the lamina propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8932 Neoplastic Process Stage 0 Colorectal Cancer AJCC v6 and v7 Stage 0 Colorectal Cancer AJCC v6 and v7 C0854751 CTRP Abnormal cells are found in the mucosa (innermost layer) of the colon and/or rectal wall. These abnormal cells may become cancer. Malignant Stage_0_Colorectal_Cancer Colorectal Cancer, Stage 0 Colorectal Carcinoma Stage 0 Colorectal Carcinoma in situ Stage 0 Colorectal (Colon or Rectal) Cancer Stage 0 Colorectal Cancer AJCC v6 Stage 0 Colorectal Cancer AJCC v6 and v7 Stage 0 Colorectal Cancer AJCC v7 Stage 0 Colorectal Carcinoma stage 0 colorectal carcinoma in situ Stage 0 Colorectal Cancer AJCC v6 and v7 An adenocarcinoma that arises from the exocrine pancreatic tissue and has metastasized to other anatomic sites. C8933 Neoplastic Process Metastatic Pancreatic Adenocarcinoma Metastatic Pancreatic Adenocarcinoma C0861727 CTRP Malignant Metastatic_Pancreatic_Adenocarcinoma Metastatic Pancreatic Adenocarcinoma Metastatic Pancreatic Adenocarcinoma An adenocarcinoma that arises from the small intestine and has metastasized to other anatomic sites. C8934 Neoplastic Process Metastatic Small Intestinal Adenocarcinoma C0861819 Malignant Metastatic_Small_Intestinal_Adenocarcinoma Metastatic Small Intestinal Adenocarcinoma Metastatic Small Intestinal Adenocarcinoma A neoplasm of lymphoblasts committed to the B-cell lineage, typically composed of small to medium-sized blast cells. When the neoplasm involves predominantly the bone marrow and the peripheral blood, it is called B acute lymphoblastic leukemia. When it involves nodal or extranodal sites, it is called B lymphoblastic lymphoma. (WHO, 2001) C8936 Neoplastic Process B Lymphoblastic Leukemia/Lymphoma C0023485 Malignant Precursor_B_Lymphoblastic_Leukemia_Lymphoma B Lymphoblastic Leukemia/Lymphoma B-Cell Lymphoblastic Leukemia/Lymphoma B-Lymphoblastic Leukemia/Lymphoma Precursor B Lymphoblastic Leukemia/Lymphoma Precursor B-Lymphoblastic Lymphoma/Leukemia B Lymphoblastic Leukemia/Lymphoma Stage IV includes: (T4b, N0, M0); (Any T, N1-3, M0); (Any T, Any N, M1). T4b: Tumor invades pelvic wall, abdominal wall. N0: No regional lymph node metastasis. N1: Single regional lymph node metastasis in the true pelvis (hypogastric, obturator, external iliac, or presacral lymph node). N2: Multiple regional lymph node metastases in the true pelvis (hypogastric, obturator, external iliac, or presacral lymph node metastasis). N3: Metastasis to the common iliac lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C89366 Neoplastic Process Stage IV Bladder Cancer AJCC v7 Stage IV Bladder Cancer AJCC v7 C2987497 CTRP Malignant Stage IV Bladder Cancer Stage IV Bladder Cancer AJCC v7 Stage IV Bladder Carcinoma Stage IV Bladder Carcinoma AJCC v7 Stage IV Bladder Cancer AJCC v7 Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C8937 Neoplastic Process Ann Arbor Stage II B Lymphoblastic Lymphoma Ann Arbor Stage II B Lymphoblastic Lymphoma C0862039 CTRP Malignant Stage_II_Precursor_B-Lymphoblastic_Lymphoma Ann Arbor Stage II B Lymphoblastic Lymphoma Precursor B-Lymphoblastic Lymphoma Stage II Stage II B Lymphoblastic Lymphoma Stage II B-Lymphoblastic Lymphoma Stage II Precursor B-Lymphoblastic Lymphoma Ann Arbor Stage II B Lymphoblastic Lymphoma A T-cell non-Hodgkin lymphoma that arises from the skin and does not respond to treatment. C8938 Neoplastic Process Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma C1709881 CTRP Malignant Refractory_Cutaneous_T-Cell_Lymphoma Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma Refractory Cutaneous T-Cell Non-Hodgkin's Lymphoma Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Stage II includes: (T2a, N0, M0); (T2b, N0, M0). T2a: Tumor invades superficial muscle (inner half). T2b: Tumor invades deep muscle (outer half). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C8939 Neoplastic Process Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 C0862402 CTRP Malignant Stage_II_Bladder_Transitional_Cell_Carcinoma Stage II Bladder Urothelial Cancer Stage II Bladder Urothelial Carcinoma Stage II Bladder Urothelial Carcinoma AJCC v6 Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 Stage II Bladder Urothelial Carcinoma AJCC v7 Stage II Transitional Cell Carcinoma of Bladder Stage II Transitional Cell Carcinoma of Urinary Bladder Stage II Transitional Cell Carcinoma of the Bladder Stage II Transitional Cell Carcinoma of the Urinary Bladder Stage II Urinary Bladder Transitional Cell Carcinoma Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 Stage III includes: (T3a, N0, M0); (T3b, N0, M0); (T4a, N0, M0). T3a: Tumor microscopically invades perivesical tissue. T3b: Tumor macroscopically invades perivesical tissue (extravesical mass). T4a: Tumor invades prostatic stroma, uterus, vagina. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C8940 Neoplastic Process Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 C0862417 CTRP Malignant Stage_III_Bladder_Transitional_Cell_Carcinoma Stage III Bladder Urothelial Cancer Stage III Bladder Urothelial Carcinoma Stage III Bladder Urothelial Carcinoma AJCC v6 Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 Stage III Bladder Urothelial Carcinoma AJCC v7 Stage III Transitional Cell Carcinoma of Bladder Stage III Transitional Cell Carcinoma of Urinary Bladder Stage III Transitional Cell Carcinoma of the Bladder Stage III Transitional Cell Carcinoma of the Urinary Bladder Stage III Urinary Bladder Transitional Cell Carcinoma Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 Stage IV includes: (T4b, N0, M0); (Any T, N1-3, M0); (Any T, Any N, M1). T4b: Tumor invades pelvic wall, abdominal wall. N0: No regional lymph node metastasis. N1: Single regional lymph node metastasis in the true pelvis (hypogastric, obturator, external iliac, or presacral lymph node). N2: Multiple regional lymph node metastases in the true pelvis (hypogastric, obturator, external iliac, or presacral lymph node metastasis). N3: Metastasis to the common iliac lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C8941 Neoplastic Process Stage IV Bladder Urothelial Carcinoma AJCC v7 Stage IV Bladder Urothelial Carcinoma AJCC v7 C0862432 CTRP Malignant Stage_IV_Bladder_Transitional_Cell_Carcinoma Stage IV Bladder Urothelial Cancer Stage IV Bladder Urothelial Carcinoma Stage IV Bladder Urothelial Carcinoma AJCC v7 Stage IV Transitional Cell Carcinoma of Bladder Stage IV Transitional Cell Carcinoma of Urinary Bladder Stage IV Transitional Cell Carcinoma of the Bladder Stage IV Transitional Cell Carcinoma of the Urinary Bladder Stage IV Urinary Bladder Transitional Cell Carcinoma Stage IV Bladder Urothelial Carcinoma AJCC v7 An adenocarcinoma which originated in the endometrium and has spread to another anatomic site. C8942 Neoplastic Process Metastatic Endometrial Adenocarcinoma C0862489 Malignant Metastatic_Endometrial_Adenocarcinoma Metastatic Endometrial Adenocarcinoma Metastatic Endometrial Adenocarcinoma An adenocarcinoma that arises from the vagina and has metastasized to other anatomic sites. C8944 Neoplastic Process Metastatic Vaginal Adenocarcinoma C0862601 Malignant Vaginal_Metastatic_Adenocarcinoma Metastatic Vaginal Adenocarcinoma Metastatic Vaginal Adenocarcinoma Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ (preinvasive carcinoma). N0: No regional lymph node metastasis. M0: No distant metastasis. FIGO no longer includes stage 0. (AJCC 7th ed.) C89445 Neoplastic Process Stage 0 Vulvar Cancer AJCC v7 Stage 0 Vulvar Cancer AJCC v7 C2987483 CTRP mCode Abnormal cells are found on the surface of the vulvar skin. These abnormal cells may become cancer and spread into nearby normal tissue. Malignant Carcinoma in situ of vulva Stage 0 Vulvar Cancer Stage 0 Vulvar Cancer AJCC v7 Stage 0 Vulvar Carcinoma Stage 0 Vulvar Carcinoma AJCC v7 stage 0 vulvar carcinoma in situ Stage 0 Vulvar Cancer AJCC v7 Stage I includes: T1, N0, M0. T1: Invasive vulvar cancer confined to the vulva or perineum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C89447 Neoplastic Process Stage I Vulvar Cancer AJCC v7 Stage I Vulvar Cancer AJCC v7 C2987498 CTRP Malignant Stage I Vulvar Cancer Stage I Vulvar Cancer AJCC v7 Stage I Vulvar Carcinoma Stage I Vulvar Carcinoma AJCC v7 Stage I Vulvar Cancer AJCC v7 Stage IA includes: T1a, N0, M0. T1a: Tumor confined to the vulva and perineum, 2 cm or less in greatest dimension, and with stromal invasion no greater than 1 mm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C89448 Neoplastic Process Stage IA Vulvar Cancer AJCC v7 Stage IA Vulvar Cancer AJCC v7 C2217807 CTRP Malignant Stage IA Vulvar Cancer Stage IA Vulvar Cancer AJCC v7 Stage IA Vulvar Carcinoma Stage IA Vulvar Carcinoma AJCC v7 Stage IA Vulvar Cancer AJCC v7 Stage IB includes: T1b, N0, M0. T1b: Vulvar cancer with tumor size greater than 2 cm, or any size with stromal invasion more than 1.0 mm, confined to the vulva or perineum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C89449 Neoplastic Process Stage IB Vulvar Cancer AJCC v7 Stage IB Vulvar Cancer AJCC v7 C2217808 CTRP Malignant Stage IB Vulvar Cancer Stage IB Vulvar Cancer AJCC v7 Stage IB Vulvar Carcinoma Stage IB Vulvar Carcinoma AJCC v7 Stage IB Vulvar Cancer AJCC v7 An adenocarcinoma that arises from the prostate gland and has spread to other anatomic sites. C8945 Neoplastic Process Metastatic Prostatic Adenocarcinoma Metastatic Prostate Adenocarcinoma C0862636 CTRP Malignant Metastatic_Prostatic_Adenocarcinoma Metastatic Prostate Adenocarcinoma Metastatic Prostatic Adenocarcinoma Metastatic Prostate Adenocarcinoma Stage II includes: T2, N0, M0. T2: Vulvar cancer with tumor of any size with extension to adjacent perineal structures (lower/distal 1/3 urethra, lower/distal 1/3 vagina, anal involvement). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C89451 Neoplastic Process Stage II Vulvar Cancer AJCC v7 Stage II Vulvar Cancer AJCC v7 C2987477 CTRP Malignant Stage II Vulvar Cancer Stage II Vulvar Cancer AJCC v7 Stage II Vulvar Carcinoma Stage II Vulvar Carcinoma AJCC v7 Stage II Vulvar Cancer AJCC v7 Stage III includes: IIIA: (T1/T2, N1a/N1b, M0); IIIB: (T1/T2, N2a/N2b, M0); IIIC: (T1/T2, N2c, M0). T1: Invasive vulvar cancer confined to the vulva or perineum. T2: Vulvar cancer with tumor of any size with extension to adjacent perineal structures (lower/distal 1/3 urethra, lower/distal 1/3 vagina, anal involvement). N1a: Vulvar cancer with one or two lymph node metastasis each measuring 5 mm or less. N1b: Vulvar cancer with one lymph node metastasis measuring 5 mm or greater. N2a: Vulvar cancer with three or more lymph node metastases each measuring 5 mm or less. N2b: Vulvar cancer with two or more lymph node metastases measuring 5 mm or greater. N2c: Vulvar cancer with lymph node metastasis with extracapsular spread. M0: No distant metastasis. (AJCC 7th ed.) C89452 Neoplastic Process Stage III Vulvar Cancer AJCC v7 Stage III Vulvar Cancer AJCC v7 C2987478 CTRP Malignant Stage III Vulvar Cancer Stage III Vulvar Cancer AJCC v7 Stage III Vulvar Carcinoma Stage III Vulvar Carcinoma AJCC v7 Stage III Vulvar Cancer AJCC v7 Stage IV includes: IVA: (T1/T2, N3, M0); (T3, Any N, M0); IVB: (Any T, Any N, M1). T1: Invasive vulvar cancer confined to the vulva or perineum. T2: Vulvar cancer with tumor of any size with extension to adjacent perineal structures (lower/distal 1/3 urethra, lower/distal 1/3 vagina, anal involvement). T3: Vulvar cancer with tumor of any size with extension to any of the following: upper/proximal 2/3 urethra, upper/proximal 2/3 vagina, bladder mucosa, rectal mucosa, or fixed to pelvic bone. N3: Vulvar cancer with fixed or ulcerated regional lymph node metastasis. M1: distant metastasis (including pelvic lymph node metastasis). (AJCC 7th ed.) C89453 Neoplastic Process Stage IV Vulvar Cancer AJCC v7 Stage IV Vulvar Cancer AJCC v7 C3146270 CTRP Stage IV vulvar cancer is divided into stages IVA and IVB. In stage IVA, the cancer (1) has spread to nearby lymph nodes on both sides of the groin, or (2) has spread beyond nearby tissues to the upper part of the urethra, bladder, or rectum, or (3) is attached to the pelvic bone and may have spread to lymph nodes. In stage IVB, the cancer has spread to distant parts of the body. Malignant Stage IV Vulvar Cancer Stage IV Vulvar Cancer AJCC v7 Stage IV Vulvar Carcinoma Stage IV Vulvar Carcinoma AJCC v7 stage IV vulvar cancer Stage IV Vulvar Cancer AJCC v7 Stage IVA includes: (T1/T2, N3, M0); (T3, Any N, M0). T1: Invasive vulvar cancer confined to the vulva or perineum. T2: Vulvar cancer with tumor of any size with extension to adjacent perineal structures (lower/distal 1/3 urethra, lower/distal 1/3 vagina, anal involvement). T3: Vulvar cancer with tumor of any size with extension to any of the following: upper/proximal 2/3 urethra, upper/proximal 2/3 vagina, bladder mucosa, rectal mucosa, or fixed to pelvic bone. N3: Vulvar cancer with fixed or ulcerated regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C89454 Neoplastic Process Stage IVA Vulvar Cancer AJCC v7 Stage IVA Vulvar Cancer AJCC v7 C2217809 CTRP Malignant Stage IVA Vulvar Cancer Stage IVA Vulvar Cancer AJCC v7 Stage IVA Vulvar Carcinoma Stage IVA Vulvar Carcinoma AJCC v7 Stage IVA Vulvar Cancer AJCC v7 A carcinoma that arises from the prostate gland and has spread to other anatomic sites. C8946 Neoplastic Process Metastatic Prostate Carcinoma Metastatic Prostate Carcinoma C1282496 CTRP Malignant Metastatic_Prostate_Cancer Metastatic Prostate Cancer Metastatic Prostate Carcinoma Prostate Cancer Metastatic Prostate Carcinoma Metastatic Metastatic Prostate Carcinoma Stage I includes: (T1a-c, N0, M0, PSA less than 10, Gleason equal or less than 6); (T2a, N0, M0, PSA less than 10, Gleason equal or less than 6); (T1-2a, N0, M0, PSA X, Gleason X). T1a: Tumor incidental histologic finding in 5% or less of tissue resected. T1b: Tumor incidental histologic finding in more than 5% of tissue resected. T1c: Tumor identified by needle biopsy (e.g., because of elevated PSA). T2a: Tumor involves one-half of one lobe or less. cN0: No regional lymph node metastasis. pN0: No positive regional nodes. M0: No distant metastasis. Gleason Equal or Less than 6: Well differentiated (slight anaplasia). Gleason X: Gleason score cannot be processed. (AJCC 7th ed.) C8947 Neoplastic Process Stage I Prostate Adenocarcinoma AJCC v7 Stage I Prostate Adenocarcinoma AJCC v7 C0862640 CTRP Malignant Stage_I_Prostate_Adenocarcinoma Stage I Prostate Adenocarcinoma Stage I Prostate Adenocarcinoma AJCC v7 Stage I Prostate Adenocarcinoma AJCC v7 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ (preinvasive carcinoma). N0: No regional lymph node metastasis. M0: No distant metastasis. FIGO no longer includes stage 0. (AJCC 7th ed.) C89476 Neoplastic Process Stage 0 Vaginal Cancer AJCC v7 Stage 0 Vaginal Cancer AJCC v7 C3146269 CTRP GDC mCode Abnormal cells are found in tissue lining the inside of the vagina (birth canal). These abnormal cells may become cancer and spread into nearby normal tissue. Malignant VAIN III Carcinoma in situ of vagina Grade III Vaginal Intraepithelial Neoplasia Grade III Vaginal Intraepithelial Neoplasia AJCC v7 Stage 0 Vaginal Cancer Stage 0 Vaginal Cancer AJCC v7 VAIN 3 VAIN 3 AJCC v7 VAIN III VAIN III AJCC v7 Vaginal Intraepithelial Neoplasia Grade 3 Vaginal Intraepithelial Neoplasia Grade 3 AJCC v7 stage 0 vaginal carcinoma in situ Stage 0 Vaginal Cancer AJCC v7 Stage II includes: IIA (T1a-c, N0, M0, PSA less than 20, Gleason 7); (T1a-c, N0, M0, PSA equal or more than 10 and less than 20, Gleason equal or less than 6); (T2a, N0, M0, PSA less than 20, Gleason equal or less than 7); (T2b, N0, M0, PSA less than 20, Gleason equal or less than 7); (T2b, N0, M0, PSA X, Gleason X); IIB (T2c, N0, M0, Any PSA, Any Gleason); (T1-2, N0, M0, PSA equal or more than 20, Any Gleason); (T1-2, N0, M0, Any PSA, Gleason equal or more than 8). T1a: Tumor incidental histologic finding in 5% or less of tissue resected. T1b: Tumor incidental histologic finding in more than 5% of tissue resected. T1c: Tumor identified by needle biopsy (e.g., because of elevated PSA). T2a: Tumor involves one-half of one lobe or less. T2b: Tumor involves more than one-half of one lobe, but not both lobes. T2c: Tumor involves both lobes. cN0: No regional lymph node metastasis. pN0: No positive regional nodes. M0: No distant metastasis. Gleason 7: Moderately differentiated (moderate anaplasia). Gleason Equal or Less than 6: Well differentiated (slight anaplasia). Gleason equal or more than 8: Poorly differentiated/undifferentiated (marked anaplasia). (AJCC 7th ed.) C8948 Neoplastic Process Stage II Prostate Adenocarcinoma AJCC v7 Stage II Prostate Adenocarcinoma AJCC v7 C0862641 CTRP Malignant Stage_II_Prostate_Adenocarcinoma Stage II Prostate Adenocarcinoma Stage II Prostate Adenocarcinoma AJCC v7 Stage II Prostate Adenocarcinoma AJCC v7 Stage III includes: T3a-b, N0, M0, Any PSA, Any Gleason. cT3a: Tumor with extracapsular extension (unilateral or bilateral). pT3a: Tumor with extraprostatic extension or microscopic invasion of bladder neck. T3b: Tumor invades seminal vesicle(s). cN0: No regional lymph node metastasis. pN0: No positive regional nodes. M0: No distant metastasis. (AJCC 7th ed.) C8949 Neoplastic Process Stage III Prostate Adenocarcinoma AJCC v7 Stage III Prostate Adenocarcinoma AJCC v7 C0862642 CTRP Malignant Stage_III_Prostate_Adenocarcinoma Stage III Prostate Adenocarcinoma Stage III Prostate Adenocarcinoma AJCC v7 Stage III Prostate Adenocarcinoma AJCC v7 Stage IV includes: (T4, N0, M0, Any PSA, Any Gleason); (Any T, N1, M0, Any PSA, Any Gleason); (Any T, Any N, M1, Any PSA, Any Gleason). cT4: Tumor is fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, and/or pelvic wall. pT4: Invasion of rectum, levator muscles, and/or pelvic wall. N1: Metastasis in regional lymph node(s). M1: Distant metastasis. (AJCC 7th ed.) C8950 Neoplastic Process Stage IV Prostate Adenocarcinoma AJCC v7 Stage IV Prostate Adenocarcinoma AJCC v7 C0862643 CTRP Malignant Stage_IV_Prostate_Adenocarcinoma Stage IV Prostate Adenocarcinoma Stage IV Prostate Adenocarcinoma AJCC v7 Stage IV Prostate Adenocarcinoma AJCC v7 Stage IIIA includes: (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C8951 Neoplastic Process Stage IIIA Adenosquamous Lung Carcinoma AJCC v7 Stage IIIA Lung Adenosquamous Carcinoma AJCC v7 C0862779 CTRP Malignant Stage_IIIA_Adenosquamous_Lung_Carcinoma Stage IIIA Adenosquamous Cell Carcinoma of Lung Stage IIIA Adenosquamous Cell Carcinoma of the Lung Stage IIIA Adenosquamous Cell Lung Carcinoma Stage IIIA Adenosquamous Lung Cancer Stage IIIA Adenosquamous Lung Carcinoma Stage IIIA Lung Adenosquamous Carcinoma AJCC v7 Stage IIIA Lung Adenosquamous Carcinoma AJCC v7 Stage IIIB includes: (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C8952 Neoplastic Process Stage IIIB Adenosquamous Lung Carcinoma AJCC v7 Stage IIIB Lung Adenosquamous Carcinoma AJCC v7 C0862780 CTRP Malignant Stage_IIIB_Adenosquamous_Lung_Carcinoma Stage IIIB Adenosquamous Cell Carcinoma of Lung Stage IIIB Adenosquamous Cell Carcinoma of the Lung Stage IIIB Adenosquamous Cell Lung Carcinoma Stage IIIB Adenosquamous Lung Cancer Stage IIIB Adenosquamous Lung Carcinoma Stage IIIB Lung Adenosquamous Carcinoma AJCC v7 Stage IIIB Lung Adenosquamous Carcinoma AJCC v7 Lung carcinoma that has re-emerged after a period of remission. C8953 Neoplastic Process Recurrent Lung Carcinoma Recurrent Lung Carcinoma C0855002 CTRP Malignant Recurrent_Lung_Cancer Recurrent Lung Cancer Recurrent Lung Carcinoma Recurrent Unspecified Carcinoma of Lung Recurrent Unspecified Carcinoma of the Lung Recurrent Unspecified Lung Carcinoma Relapsed Unspecified Carcinoma of Lung Relapsed Unspecified Carcinoma of the Lung Relapsed Unspecified Lung Carcinoma Recurrent Lung Carcinoma Stage II includes: IIA (T1, N1, M0) and IIB (T2, N1, M0) or (T3, N0, M0). T1: Tumor is 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, and without bronchoscopic evidence of invasion more proximal than the lobar bronchus. T2: Tumor has any of the following features of size or extent: more than 3 cm in greatest dimension; involves the main bronchus, 2 cm or more distal to the carina; invades the visceral pleura; associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung. T3: Tumor (of any size) directly invades any of the following: chest wall (including superior sulcus tumors), diaphragm, mediastinal pleura, parietal pericardium; or tumor in the main bronchus less than 2 cm distal to the carina but without involvement of the carina; or associated atelectasis or obstructive pneumonitis of the entire lung. N0: No regional lymph node metastasis. N1: Metastasis to ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, and intrapulmonary nodes including involvement by direct extension of the primary tumor. M0: No distant metastasis. (AJCC 6th ed.) C8954 Neoplastic Process Stage II Lung Cancer AJCC v6 Stage II Lung Cancer AJCC v6 C2982916 CTRP Malignant Stage_II_Lung_Cancer Stage II Carcinoma of Lung AJCC v6 Stage II Carcinoma of the Lung AJCC v6 Stage II Lung Cancer Stage II Lung Cancer AJCC v6 Stage II Lung Carcinoma AJCC v6 Stage II Lung Cancer AJCC v6 A rare adenocarcinoma that arises from the rete testis. It usually presents with a scrotal mass or lumbar pain. C8955 Neoplastic Process Rete Testis Adenocarcinoma C0863024 CDISC A malignant carcinoma that arises from the rete testis. Malignant Rete_Testis_Adenocarcinoma Adenocarcinoma of Rete Testis Adenocarcinoma of the Rete Testis CARCINOMA, RETE TESTIS, MALIGNANT Rete Testis Adenocarcinoma Rete Testis Adenocarcinoma Stage 0 includes: (Tis, N0, M0). Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. FIGO no longer includes stage 0. (AJCC 7th ed.) C89550 Neoplastic Process Stage 0 Cervical Cancer AJCC v7 Stage 0 Cervical Cancer AJCC v7 C2987516 CPTAC CTRP mCode Abnormal cells are found in the cervical epithelium (the innermost lining of the cervix). These abnormal cells may become cancer and spread into nearby normal tissue. Malignant Carcinoma in situ of cervix uteri CIN 3 CIN 3 AJCC v7 CIN Grade 3 CIN Grade 3 AJCC v7 Carcinoma in situ of cervix, unspecified Carcinoma in situ of the Cervix Carcinoma in situ of the Cervix AJCC v7 Cervical Carcinoma in situ Cervical Carcinoma in situ AJCC v7 Cervix Intraepithelial Neoplasia Grade 3 Cervix Intraepithelial Neoplasia Grade 3 AJCC v7 Severe Cervical Dysplasia Severe Cervical Dysplasia AJCC v7 Severe Dysplasia of Uterine Cervix Severe Dysplasia of Uterine Cervix AJCC v7 Stage 0 Cervical Cancer Stage 0 Cervical Cancer AJCC v7 stage 0 cervical carcinoma in situ Stage 0 Cervical Cancer AJCC v7 Stage II includes: II (T2, N0, M0); IIA (T2a, N0, M0); IIA1 (T2a1, N0, M0); IIA2 (T2a2, N0, M0); IIB (T2b, N0, M0); T2: Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina. T2a: Tumor without parametrial invasion. T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension. T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension. T2b: Tumor with parametrial invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C89551 Neoplastic Process Stage II Cervical Cancer AJCC v7 Stage II Cervical Cancer AJCC v7 C2987519 CTRP Malignant Stage II Cervical Cancer Stage II Cervical Cancer AJCC v7 Stage II Cervical Cancer AJCC v7 Stage IIA includes: IIA (T2a, N0, M0); IIA1 (T2a1, N0, M0); IIA2 (T2a2, N0, M0). T2a: Tumor without parametrial invasion. T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension. T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C89552 Neoplastic Process Stage IIA Cervical Cancer AJCC v7 Stage IIA Cervical Cancer AJCC v7 C2216727 CTRP Malignant Stage IIA Cervical Cancer Stage IIA Cervical Cancer AJCC v7 Stage IIA Cervical Cancer AJCC v7 Stage IV includes: (T4, Any N, M0); (Any T, N3, M0); (Any T, Any N, M1). T4: Tumor invades other adjacent structures. N3: Metastasis in deep inguinal or pelvic lymph node(s) unilateral or bilateral. M1: Distant metastasis. (AJCC 6th ed.) C8959 Neoplastic Process Stage IV Penile Cancer AJCC v6 Stage IV Penile Cancer AJCC v6 C2982964 CTRP Malignant Stage_IV_Penile_Cancer Penile Cancer Stage IV AJCC v6 Stage IV Carcinoma of Penis AJCC v6 Stage IV Carcinoma of the Penis AJCC v6 Stage IV Penile Cancer Stage IV Penile Cancer AJCC v6 Stage IV Penile Carcinoma AJCC v6 Stage IV Penis Cancer AJCC v6 Stage IV Penis Carcinoma AJCC v6 Stage IV Penile Cancer AJCC v6 An inherited condition characterized by the development of kidney oncocytomas which are often bilateral and multifocal. This condition may be connected to Birt-Hogg-Dube syndrome. C8960 Neoplastic Process Hereditary Renal Oncocytoma Hereditary Kidney Oncocytoma C0879606 CTRP GDC Undetermined Familial_Renal_Oncocytoma Hereditary Kidney Oncocytoma Familial Renal Oncocytoma Hereditary Kidney Oncocytoma Hereditary Renal Oncocytoma Hereditary Kidney Oncocytoma The most common gastric polyp in the Western hemisphere. The lesion consists of a localized hyperplasia of the deep epithelial compartment of the oxyntic mucosa, with variable degrees of cystic dilatation. Malignant transformation is the exception. (WHO, 2000) C8961 Neoplastic Process Fundic Gland Polyp C0920184 Benign Fundic_Gland_Polyp Fundic Gland Polyp Fundic Gland Polyp A non-invasive neoplastic process that affects the epithelium of any part of the digestive system. It is characterized by the presence of morphologic features of dysplasia (e.g., architectural and cytological epithelial alterations) or, in a minority of cases, lack of such morphologic features, as in colonic sessile serrated adenomas/polyps. C8962 Neoplastic Process Digestive System Intraepithelial Neoplasia C0920207 Undetermined Gastrointestinal_Intraepithelial_Neoplasia Digestive System Intraepithelial Neoplasia Gastrointestinal Intraepithelial Neoplasia Gastrointestinal Noninvasive Neoplasia Gastrointestinal System Intraepithelial Neoplasia Digestive System Intraepithelial Neoplasia Stage IV includes: (Any T, Any N, M1). M1: Distant metastasis (excludes metastasis within the peritoneal cavity). (AJCC 6th and 7th eds.) C8963 Neoplastic Process Stage IV Fallopian Tube Cancer AJCC v6 and v7 Stage IV Fallopian Tube Cancer AJCC v6 and v7 C0920280 CTRP Malignant Stage_IV_Fallopian_Tube_Cancer AJCC Stage IV Fallopian Tube Cancer FIGO Stage IV Carcinoma of Fallopian Tube FIGO Stage IV Carcinoma of the Fallopian Tube FIGO Stage IV Fallopian Tube Carcinoma Fallopian Tube Cancer Stage IV Stage IV Fallopian Tube Cancer Stage IV Fallopian Tube Cancer AJCC v6 Stage IV Fallopian Tube Cancer AJCC v6 and v7 Stage IV Fallopian Tube Cancer AJCC v7 Stage IV Fallopian Tube Cancer AJCC v6 and v7 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. This staging applies to carcinomas and carcinosarcomas. FIGO no longer includes Stage 0 (Tis). (AJCC 7th ed.) C89632 Neoplastic Process Stage 0 Uterine Corpus Cancer AJCC v7 Stage 0 Uterine Corpus Cancer AJCC v7 C2983007 CTRP Malignant Stage 0 Uterine (including Endometrial) Cancer Stage 0 Uterine Corpus Cancer Stage 0 Uterine Corpus Cancer AJCC v7 Stage 0 Uterine Corpus Cancer AJCC v7 Stage I includes: I (T1, N0, M0); IA: (T1a, N0, M0); IB (T1b, N0, M0). T1: Tumor confined to corpus uteri. T1a: Tumor limited to the endometrium or invades less than one-half of the myometrium. T1b: Tumor invades one-half or more of the myometrium. N0: No regional lymph node metastasis. M0: No distant metastasis. This staging applies to carcinomas and carcinosarcomas. (AJCC 7th ed.) C89633 Neoplastic Process Stage I Uterine Corpus Cancer AJCC v7 Stage I Uterine Corpus Cancer AJCC v7 C2983008 CTRP Malignant Stage I Uterine (including Endometrial) Cancer Stage I Uterine Corpus Cancer Stage I Uterine Corpus Cancer AJCC v7 Stage I Uterine Corpus Cancer AJCC v7 Stage II includes: T2, N0, M0. T2: Tumor invades stromal connective tissue of the cervix but does not extend beyond uterus. Endocervical glandular involvement only should be considered as Stage I and not as Stage II. N0: No regional lymph node metastasis. M0: No distant metastasis. This staging applies to carcinomas and carcinosarcomas. (AJCC 7th ed.) C89634 Neoplastic Process Stage II Uterine Corpus Cancer AJCC v7 Stage II Uterine Corpus Cancer AJCC v7 C2983009 CTRP Malignant Stage II Uterine (including Endometrial) Cancer Stage II Uterine Corpus Cancer Stage II Uterine Corpus Cancer AJCC v7 Stage II Uterine Corpus Cancer AJCC v7 Stage III includes: III (T3, N0, M0); IIIA (T3a, N0, M0); IIIB (T3b, N0, M0); IIIC (T1-T3, N1/N2, M0); IIIC1 (T1-T3, N1, M0); IIIC2 (T1-T3, N2, M0). T3: Tumor involves serosa and/or adnexa, vagina, or parametrial tissue. T3a: Tumor involves serosa and/or adnexa (direct extension or metastasis). T3b: Tumor involves vagina (direct extension or metastasis) or parametrial tissue. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis to pelvic lymph nodes. N2: Regional lymph node metastasis to para-aortic lymph nodes, with or without positive pelvic lymph nodes. M0: No distant metastasis. This staging applies to carcinomas and carcinosarcomas. (AJCC 7th ed.) C89635 Neoplastic Process Stage III Uterine Corpus Cancer AJCC v7 Stage III Uterine Corpus Cancer AJCC v7 C2983010 CTRP Malignant Stage III Uterine (including Endometrial) Cancer Stage III Uterine Corpus Cancer Stage III Uterine Corpus Cancer AJCC v7 Stage III Uterine Corpus Cancer AJCC v7 Stage IV includes: IVA: (T4, Any N, M0); IVB: (Any T, Any N, M1). T4: Tumor invades bladder mucosa and/or bowel mucosa (bullous edema is not sufficient to classify a tumor as T4). M0: No distant metastasis. M1: Distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, or lung, liver, or bone. It excludes metastasis to para-aortic lymph nodes, vagina, pelvic serosa, or adnexa). This staging applies to carcinomas and carcinosarcomas. (AJCC 7th ed.) C89636 Neoplastic Process Stage IV Uterine Corpus Cancer AJCC v7 Stage IV Uterine Corpus Cancer AJCC v7 C2983011 CTRP Malignant Stage IV Uterine (including Endometrial) Cancer Stage IV Uterine Corpus Cancer Stage IV Uterine Corpus Cancer AJCC v7 Stage IV Uterine Corpus Cancer AJCC v7 A benign or malignant soft tissue neoplasm arising exclusively from the synovial membrane. Examples include the diffuse giant cell tumor of tendon sheath, localized giant cell tumor of tendon sheath, and malignant giant cell tumor of tendon sheath. C8964 Neoplastic Process Synovial Neoplasm C0476203 Undetermined Synovial_Neoplasm Neoplasm of Synovium Neoplasm of the Synovium Synovial Neoplasm Synovial Tumor Tumor of Synovium Tumor of the Synovium Synovial Neoplasm A benign lesion composed of dilated lymphatic channels. Painless swelling is the usual clinical manifestation. C8965 Neoplastic Process Lymphangioma Lymphangioma C0024221 CDISC CTRP GDC NICHD A benign neoplasm arising from the lymphatics. 9170/0 Benign Lymphangioma 9170/0 9171/0 Capillary lymphangioma Lymphangioma, NOS Capillary lymphangioma LYMPHANGIOMA, BENIGN Lymphangioma Lymphangioma, NOS Lymphangioma A follicular lymphoma which contains 6-15 centroblasts per 40X high-power microscopic field. C8968 Neoplastic Process Grade 2 Follicular Lymphoma Grade 2 Follicular Lymphoma C0079758 CPTAC CTRP GDC mCode An indolent (slow-growing) type of B-cell non-Hodgkin lymphoma (cancer of the lymphatic system) in which there are both small and large cancer cells. 9691/3 Malignant Grade_2_Follicular_Lymphoma 9691/3 Follicular lymphoma grade II, intrathoracic lymph nodes Follicular lymphoma grade II, lymph nodes of multiple sites Follicular lymphoma, grade 2 Malignant lymphoma, mixed cell type, follicular Malignant lymphoma, mixed cell type, nodular Malignant lymphoma, mixed lymphocytic-histiocytic, nodular Malignant lymphoma, mixed small cleaved and large cell, follicular Follicular Lymphoma Grade 2 Follicular Mixed Cell Lymphoma Follicular Mixed Lymphocytic-Histiocytic Lymphoma Follicular lymphoma grade II, unspecified site Follicular lymphoma, grade 2 Grade 2 Grade 2 Follicular Lymphoma Grade II Follicular Lymphoma Grade II Follicular Mixed Cell Lymphoma Nodular Mixed Lymphoma WHO Follicular Lymphoma Histologic Grade 2 follicular mixed cell lymphoma grade 2 follicular lymphoma Grade 2 Follicular Lymphoma A low grade malignant bone-forming mesenchymal neoplasm arising from the surface of the bone. It usually affects the distal posterior femur, the proximal tibia, and proximal humerus. Painless swelling is the usual clinical sign. Most patients are young adults and the prognosis is usually excellent. C8969 Neoplastic Process Parosteal Osteosarcoma C0206642 GDC PCDC 9192/3 Malignant Parosteal_Osteosarcoma 9192/3 Juxtacortical osteosarcoma Parosteal osteosarcoma Juxtacortical Osteogenic Sarcoma Juxtacortical Osteosarcoma Juxtacortical osteosarcoma Parosteal Parosteal Osteogenic Sarcoma Parosteal Osteosarcoma Parosteal osteosarcoma Parosteal Osteosarcoma Stage III includes: (T3, N0, M0); IIIA (T3a, N0, M0); IIIB (T3b, N0, M0); IIIC (T3c, N0, M0); (Any T, N1, M0). T3: Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis. T3a: Microscopic peritoneal metastasis outside the pelvis. T3b: Macroscopic peritoneal metastasis outside the pelvis 2 cm or less in greatest dimension. T3c: Peritoneal metastasis outside the pelvis and more than 2 cm in diameter. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C89692 Neoplastic Process Stage III Fallopian Tube Cancer AJCC v7 Stage III Fallopian Tube Cancer AJCC v7 C0854928 CTRP Malignant Stage III Fallopian Tube Cancer Stage III Fallopian Tube Cancer AJCC v7 Stage III Fallopian Tube Cancer AJCC v7 An intermediate grade malignant bone-forming mesenchymal neoplasm with chondroblastic differentiation. It arises from the surface of the bone and affects the diaphysis or diaphyseal- metaphyseal portion of the long bones. A painless mass or swelling is the most common clinical sign. It is associated with a better prognosis than conventional osteosarcoma. C8970 Neoplastic Process Periosteal Osteosarcoma C1377843 GDC PCDC 9193/3 Malignant Periosteal_Osteosarcoma 9193/3 Periosteal osteosarcoma Juxtacortical Chondroblastic Osteosarcoma Periosteal Osteosarcoma Periosteal osteosarcoma Surface Periosteal Periosteal Osteosarcoma A poorly circumscribed morphologic variant of rhabdomyosarcoma. It is characterized by the presence of primitive skeletal muscle differentiation in any stage of myogenesis. C8971 Neoplastic Process Embryonal Rhabdomyosarcoma C0206656 CTEP Cellosaurus GDC A soft tissue tumor that is most common in infants and young children. It begins in muscles, usually in the head, neck, or genitourinary tract. 8910/3 Malignant Embryonal_Rhabdomyosarcoma 8910/3 Embryonal rhabdomyosarcoma, NOS ERMS Embryonal Rhabdomyosarcoma Embryonal rhabdomyosarcoma embryonal rhabdomyosarcoma Embryonal Rhabdomyosarcoma A rare, high grade sarcoma that arises from the endometrial stroma or myometrium without a specific type of differentiation. It was previously also known as high grade endometrial stromal sarcoma. In 2014, high grade endometrial stromal sarcoma was reclassified and is currently considered a distinct and rare neoplasm. Undifferentiated uterine sarcoma has a worse prognosis. C8972 Neoplastic Process Uterine Corpus Undifferentiated Sarcoma CL033042 GDC Malignant Undifferentiated_Uterine_Sarcoma Undifferentiated uterine sarcoma Undifferentiated Uterine Sarcoma Undifferentiated uterine sarcoma Uterine Corpus Undifferentiated Endometrial Sarcoma Uterine Corpus Undifferentiated Sarcoma Uterine Corpus Undifferentiated Sarcoma A malignant mesenchymal neoplasm that affects the uterine corpus, and rarely, the ovaries, cervix, and vagina. In the uterine corpus it is classified as low grade or high grade endometrial stromal sarcoma. In the remainder of the anatomic sites it is classified as low grade endometrioid stromal sarcoma. C8973 Neoplastic Process Endometrioid Stromal Sarcoma Endometrioid Stromal Sarcoma C0206630 CDISC CTEP CTRP Cellosaurus GDC A malignant, mesenchymal tumor of the uterine stroma. 8930/3 Malignant Endometrial_Stromal_Sarcoma 8930/3 Endometrial sarcoma, NOS Endometrial stromal sarcoma, NOS ESS Endometrial Stromal Sarcoma Endometrial stromal sarcoma Endometrioid Stromal Sarcoma STROMAL SARCOMA, ENDOMETRIAL, MALIGNANT Sarcoma, Endometrial Stromal Endometrioid Stromal Sarcoma An aggressive malignant tumor of the female reproductive system, affecting predominantly elderly menopausal women. The endometrium and ovary are the most common sites of tumor origin. Morphologically, it is a high grade tumor, composed of carcinomatous and sarcomatous elements. C8975 Neoplastic Process Malignant Mixed Mesodermal (Mullerian) Tumor C1334603 CDISC GDC A malignant neoplasm of the female reproductive tract (mostly uterus and ovaries) originating from the Mullerian ducts and composed of carcinomatous and sarcomatous elements. A rare type of tumor that is a mixture of carcinoma and sarcoma cells. MMMT usually occurs in the uterus. Malignant Malignant_Mixed_Mesodermal_Mullerian_Tumor 8981/3 Carcinosarcoma, embryonal Carcinosarcoma, embryonal MMMT MULLERIAN TUMOR, MIXED, MALIGNANT Malignant Mixed Mesodermal (Mullerian) Tumor Malignant Mixed Mesodermal (Müllerian) Tumor Malignant Mixed Mesodermal Tumor Malignant Mixed Mullerian Tumor Malignant Mixed Müllerian Tumor malignant mixed Mullerian tumor Malignant Mixed Mesodermal (Mullerian) Tumor Stage 0 includes: For squamous cell carcinoma: Tis (HGD), N0, M0, G1, GX, Tumor location: Any. For adenocarcinoma: Tis (HGD), N0, M0, G1, GX. Tis: High-grade dysplasia. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated. GX: Grade cannot be assessed-stage grouping as G1. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. (AJCC 7th ed.) C89771 Neoplastic Process Stage 0 Esophageal Cancer AJCC v7 Stage 0 Esophageal Cancer AJCC v7 C0154059 CTRP mCode Abnormal cells are found in the innermost layer of tissue lining the esophagus. These abnormal cells may become cancer and spread into nearby normal tissue. Malignant Carcinoma in situ of esophagus Esophageal Carcinoma in situ Esophageal Carcinoma in situ AJCC v7 Severe Esophageal Dysplasia Severe Esophageal Dysplasia AJCC v7 Stage 0 Esophageal Cancer Stage 0 Esophageal Cancer AJCC v7 stage 0 esophageal carcinoma in situ Stage 0 Esophageal Cancer AJCC v7 A benign or borderline adenofibroma characterized by the presence of epithelial cells which contain intracytoplasmic mucin and a fibrotic stroma. A representative example is the ovarian mucinous adenofibroma. C8978 Neoplastic Process Mucinous Adenofibroma C0334499 GDC 9015/0 Undetermined Mucinous_Adenofibroma 9015/0 Mucinous adenofibroma, NOS Mucinous Adenofibroma Mucinous Adenofibroma A lymph node located in proximity to any of the scalene muscles. C89780 Anatomical Structure Scalene Lymph Node C0229744 CDISC GDC A lymph node located in proximity to any of the scalene muscles. Lymph Node(s) Scalene Inferior Deep Cervical Lymph Node Lymph Node(s) Scalene SCALENE LYMPH NODE Scalene Lymph Node Scalene Lymph Node A benign neoplasm characterized by the presence of cystic structures lined by mucinous columnar epithelial cells in a fibrotic stroma. C8979 Neoplastic Process Mucinous Cystadenofibroma C1377844 GDC Benign Mucinous_Cystadenofibroma 9015/0 Mucinous cystadenofibroma, NOS Mucinous Cystadenofibroma Mucinous Cystadenofibroma Stage I includes: For squamous cell carcinoma: IA (T1, N0, M0, G1, GX, Tumor location: Any); IB (T1, N0, M0, G2-3, Tumor location: Any); (T2-3, N0, M0, G1, GX, Tumor location: Lower, X). For adenocarcinoma: IA (T1, N0, M0, G1-2, X); IB (T1, N0, M0, G3); (T2, N0, M0, G1-2, GX). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated. GX: Grade cannot be assessed-stage grouping as G1. G2: Moderately differentiated. G3: Poorly differentiated. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. (AJCC 7th ed.) C89793 Neoplastic Process Stage I Esophageal Cancer AJCC v7 Stage I Esophageal Cancer AJCC v7 C3146268 CTRP Malignant Stage I Esophageal Cancer Stage I Esophageal Cancer AJCC v7 Stage I Esophageal Cancer AJCC v7 Stage II includes: For squamous cell carcinoma: IIA (T2-3, N0, M0, G1, GX, Tumor location: Upper, middle); (T2-3, N0, M0, G2-3, Tumor location: Lower, X); IIB (T2-3, N0, M0, G2-3, Tumor location: Upper, middle); (T1-2, N1, M0, Any G, Tumor location: Any). For adenocarcinoma: IIA (T2, N0, M0, G3); IIB (T3, N0, M0, Any G); (T1-2, N1, M0, Any G). T2: Tumor invades muscularis propria. T3: Tumor invades adventitia. T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. M0: No distant metastasis. G1: Well differentiated. GX: Grade cannot be assessed-stage grouping as G1. G2: Moderately differentiated. G3: Poorly differentiated. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. (AJCC 7th ed.) C89794 Neoplastic Process Stage II Esophageal Cancer AJCC v7 Stage II Esophageal Cancer AJCC v7 C3146267 CTRP Malignant Stage II Esophageal Cancer Stage II Esophageal Cancer AJCC v7 Stage II Esophageal Cancer AJCC v7 Stage III includes: For squamous cell carcinoma: IIIA (T1-2, N2, M0, Any G, Tumor location: Any); (T3, N1, M0, Any G, Tumor location: Any); (T4a, N0, M0, Any G, Tumor location: Any); IIIB (T3, N2, M0, Any G, Tumor location: Any); IIIC (T4a, N1-2, M0, Any G, Tumor location: Any); (T4b, Any N, M0, Any G, Tumor location: Any); (Any T, N3, M0, Any G, Tumor location: Any). For adenocarcinoma: IIIA (T1-2, N2, M0, Any G); (T3, N1, M0, Any G); (T4a, N0, M0, Any G); IIIB (T3, N2, M0, Any G); IIIC (T4a, N1-2, M0, Any G); (T4b, Any N, M0, Any G); (Any T, N3, M0, Any G). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades adventitia. T4a: Resectable tumor invading pleura, pericardium, or diaphragm. T4b: Unresectable tumor invading other adjacent structures, such as aorta, vertebral body, trachea, etc. N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. N2: Metastasis in 3-6 regional lymph nodes. N3: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. (AJCC 7th ed.) C89795 Neoplastic Process Stage III Esophageal Cancer AJCC v7 Stage III Esophageal Cancer AJCC v7 C3146266 CTRP Malignant Stage III Esophageal Cancer Stage III Esophageal Cancer AJCC v7 Stage III Esophageal Cancer AJCC v7 Stage IV includes: For squamous cell carcinoma: Any T, Any N, M1, Any G, Tumor location: Any. For adenocarcinoma: Any T, Any N, M1, Any G. M1: Distant metastasis. Tumor location: Location of the primary cancer site is defined by the position of the upper (proximal) edge of the tumor in the esophagus. (AJCC 7th ed.) C89804 Neoplastic Process Stage IV Esophageal Cancer AJCC v7 Stage IV Esophageal Cancer AJCC v7 CL449084 CTRP Malignant Stage IV Esophageal Cancer Stage IV Esophageal Cancer AJCC v7 Stage IV Esophageal Cancer AJCC v7 The skin which covers the top of the head and which is usually covered by hair. C89807 Body Part, Organ, or Organ Component Scalp C0036270 CDISC GDC PCDC UBERON mCode The outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendonous galea aponeurotica; Loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL). The skin which covers the top of the head and which is usually covered by hair. (NCI) Scalp UBERON:0000403 SCALP Scalp Scalp structure (body structure) scalp Scalp A carcinoma that originates from the colonic wall and has spread to the lungs. C89815 Neoplastic Process Colon Carcinoma Metastatic in the Lung C2983137 Malignant Colon Carcinoma Metastatic in the Lung Colon Carcinoma Metastatic to the Lung Colon Carcinoma Metastatic in the Lung A benign or borderline neoplasm characterized by the presence of connective tissue stroma and epithelial structures. It occurs in the ovary, fallopian tube, uterine corpus, and cervix. C8984 Neoplastic Process Female Reproductive System Adenofibroma C0001422 CDISC GDC Benign mixed neoplasm comprised of epithelial/glandular and mesenchymal structures. 9013/0 Undetermined Adenofibroma 9013/0 Adenofibroma, NOS ADENOFIBROMA, BENIGN Benign Mixed Muellerian Tumor Female Reproductive System Adenofibroma Female Reproductive System Adenofibroma A benign or borderline neoplasm that arises from the ovaries and the fallopian tubes. It is characterized by the presence of cystic glandular structures and fibrous tissue. C8985 Neoplastic Process Cystadenofibroma C0334317 GDC Undetermined Cystadenofibroma 9013/0 Cystadenofibroma, NOS Cystadenofibroma Cystadenofibroma, NOS Cystadenofibroma Stage I includes: IA (T1, N0, M0); IB (T2, N0, M0); (T1, N1, M0). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C89856 Neoplastic Process Stage I Gastric Cancer AJCC v7 Stage I Gastric Cancer AJCC v7 CL449085 CTRP Malignant Stage I Gastric (Stomach) Cancer Stage I Gastric Cancer Stage I Gastric Cancer AJCC v7 Stage I Gastric Cancer AJCC v7 Stage II includes: IIA (T3, N0, M0); (T2, N1, M0); (T1, N2, M0); IIB (T4a, N0, M0); (T3, N1, M0); (T2, N2, M0); (T1, N3, M0). T1: Tumor invades lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. T3: Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures. T4a: Tumor invades serosa (visceral peritoneum). N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. N2: Metastasis in 3-6 regional lymph nodes. N3: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C89859 Neoplastic Process Stage II Gastric Cancer AJCC v7 Stage II Gastric Cancer AJCC v7 CL449086 CTRP Malignant Stage II Gastric (Stomach) Cancer Stage II Gastric Cancer Stage II Gastric Cancer AJCC v7 Stage II Gastric Cancer AJCC v7 A biphasic polypoid neoplasm characterized by the presence of papillary projections that are lined by epithelial cells and fibrotic stroma. C8986 Neoplastic Process Papillary Adenofibroma C1377850 GDC Undetermined Papillary_Adenofibroma 9013/0 Papillary adenofibroma Papillary Adenofibroma Papillary adenofibroma Papillary Adenofibroma Stage III includes: IIIA (T4a, N1, M0); (T3, N2, M0); (T2, N3, M0); IIIB (T4b, N0, M0); (T4b, N1, M0); (T4a, N2, M0); (T3, N3, M0); IIIC (T4b, N2, M0); (T4b, N3, M0); (T4a, N3, M0). T2: Tumor invades the muscularis propria. T3: Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures. T4a: Tumor invades serosa (visceral peritoneum). T4b: Tumor invades adjacent structures. N0: No regional lymph node metastasis. N1: Metastasis in 1-2 regional lymph nodes. N2: Metastasis in 3-6 regional lymph nodes. N3: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C89860 Neoplastic Process Stage III Gastric Cancer AJCC v7 Stage III Gastric Cancer AJCC v7 CL449087 CTRP Malignant Stage III Gastric (Stomach) Cancer Stage III Gastric Cancer Stage III Gastric Cancer AJCC v7 Stage III Gastric Cancer AJCC v7 Stage IV includes: (Any T, Any N, M1). M1: Distant metastasis. (AJCC 7th ed.) C89861 Neoplastic Process Stage IV Gastric Cancer AJCC v7 Stage IV Gastric Cancer AJCC v7 CL449088 CTRP Malignant Stage IV Gastric (Stomach) Cancer Stage IV Gastric Cancer Stage IV Gastric Cancer AJCC v7 Stage IV Gastric Cancer AJCC v7 A benign or borderline neoplasm characterized by the presence of glandular structures which contain clear cells and a fibrotic stroma. C8987 Neoplastic Process Clear Cell Adenofibroma CL448546 GDC 8313/0 Undetermined Clear_Cell_Adenofibroma 8313/0 Clear cell adenofibroma Clear Cell Adenofibroma Clear cell adenofibroma Clear Cell Adenofibroma A benign or borderline neoplasm characterized by the presence of cystic glandular and fibrous tissues and clear cells. C8988 Neoplastic Process Clear Cell Cystadenofibroma C1377853 GDC Undetermined Clear_Cell_Cystadenofibroma 8313/0 Clear cell cystadenofibroma Clear Cell Cystadenofibroma Clear cell cystadenofibroma Clear Cell Cystadenofibroma A benign or malignant neoplasm involving the oral cavity and/or the lips. C8989 Neoplastic Process Oral Neoplasm CL448420 Undetermined Oral_Neoplasm Lip and Oral Cavity Neoplasm Lip and Oral Cavity Tumor Lip and Oral Cavity Tumour Oral Neoplasm Oral Tumor Oral Neoplasm A carcinoma arising in the oral cavity. Most oral cavity carcinomas are squamous cell carcinomas of the tongue, buccal mucosa, or gums. Less frequent morphologic variants include mucoepidermoid carcinoma and adenocarcinoma. C8990 Neoplastic Process Oral Cavity Carcinoma Oral Cavity Carcinoma C0151546 CPTAC CTRP Cancer that forms in tissues of the oral cavity (the mouth). The tissues of the oral cavity include the lips, the lining inside the cheeks and lips, the front two thirds of the tongue, the upper and lower gums, the floor of the mouth under the tongue, the bony roof of the mouth, and the small area behind the wisdom teeth. Malignant Oral_Cavity_Carcinoma Carcinoma of Mouth Carcinoma of Oral Cavity Carcinoma of the Oral Cavity Mouth Cancer Mouth Carcinoma Oral Cavity Cancer Oral Cavity Carcinoma oral cavity cancer Oral Cavity Carcinoma A group of malignant mast cell disorders including aggressive systemic mastocytosis, mast cell leukemia, mast cell sarcoma, and systemic mastocytosis with an associated myeloid neoplasm. Individuals with advanced systemic mastocytosis have a reduced life expectancy, with median survival measured in months to years. C8991 Neoplastic Process Malignant Mastocytosis C1541840 CDISC CPTAC GDC mCode A malignant neoplasm composed of mast cells. 9741/3 Malignant Malignant_Mastocytosis 9741/3 Malignant mast cell tumors Malignant mastocytosis MAST CELL TUMOR, MALIGNANT Malignant Mastocytosis Malignant mast cell neoplasm, unspecified Malignant mast cell tumor Malignant mastocytosis Malignant Mastocytosis A carcinoma of the ureter. The majority of ureter carcinomas are transitional cell and less frequently squamous cell carcinomas or adenocarcinomas. C8993 Neoplastic Process Ureter Carcinoma Ureter Carcinoma C0600079 CPTAC CTRP Cellosaurus Malignant Ureter_Carcinoma Carcinoma of Ureter Carcinoma of the Ureter Ureter Cancer Ureter Carcinoma Ureteral Carcinoma Ureter Carcinoma Stage II includes: IIA (T3, N0, M0); IIB (T4a, N0, M0); IIC (T4b, N0, M0). T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor penetrates to the surface of the visceral peritoneum. T4b: Tumor directly invades or is adherent to other organs or structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C89989 Neoplastic Process Stage II Colorectal Cancer AJCC v7 Stage II Colorectal Cancer AJCC v7 C3146252 CTRP Malignant Stage II Colorectal (Colon or Rectal) Cancer Stage II Colorectal Cancer Stage II Colorectal Cancer AJCC v7 Stage II Colorectal Cancer AJCC v7 Stage II includes: IIA (T3, N0, M0); IIB (T4a, N0, M0); IIC (T4b, N0, M0). T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor penetrates to the surface of the visceral peritoneum. T4b: Tumor directly invades or is adherent to other organs or structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C89990 Neoplastic Process Stage II Colon Cancer AJCC v7 Stage II Colon Cancer AJCC v7 C3146257 CTRP Malignant Stage II Colon Cancer Stage II Colon Cancer AJCC v7 Stage II Colon Cancer AJCC v7 Stage II includes: IIA (T3, N0, M0); IIB (T4a, N0, M0); IIC (T4b, N0, M0). T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor penetrates to the surface of the visceral peritoneum. T4b: Tumor directly invades or is adherent to other organs or structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C89991 Neoplastic Process Stage II Rectal Cancer AJCC v7 Stage II Rectal Cancer AJCC v7 C3146256 CTRP Malignant Stage II Rectal Cancer Stage II Rectal Cancer AJCC v7 Stage II Rectal Cancer AJCC v7 Stage II includes: IIA (T3, N0, M0); IIB (T4a, N0, M0); IIC (T4b, N0, M0). T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor penetrates to the surface of the visceral peritoneum. T4b: Tumor directly invades or is adherent to other organs or structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C89992 Neoplastic Process Stage II Rectosigmoid Cancer AJCC v7 Stage II Rectosigmoid Cancer AJCC v7 CL449091 CTRP Malignant Stage II Rectosigmoid Cancer Stage II Rectosigmoid Cancer AJCC v7 Stage II Rectosigmoid Cancer AJCC v7 Stage III includes: IIIA (T1-T2, N1/N1c, M0); (T1, N2a, M0); IIIB (T3-T4a, N1/N1c, M0); (T2-T3, N2a, M0); (T1-T2, N2b, M0); IIIC (T4a, N2a, M0); (T3-T4a, N2b, M0); (T4b, N1-N2, M0). T1: Tumor invades submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor penetrates to the surface of the visceral peritoneum. T4b: Tumor directly invades or is adherent to other organs or structures. N0: No regional lymph node metastasis. N1: Metastasis in 1-3 regional lymph nodes. N1c: Tumor deposit(s) in the subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional lymph node metastasis. N2: Metastasis in four or more regional lymph nodes. N2a: Metastasis in 4-6 regional lymph nodes. N2b: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C89994 Neoplastic Process Stage III Colorectal Cancer AJCC v7 Stage III Colorectal Cancer AJCC v7 C3146250 CTRP Malignant Stage III Colorectal (Colon or Rectal) Cancer Stage III Colorectal Cancer Stage III Colorectal Cancer AJCC v7 Stage III Colorectal Cancer AJCC v7 Stage III includes: IIIA (T1-T2, N1/N1c, M0); (T1, N2a, M0); IIIB (T3-T4a, N1/N1c, M0); (T2-T3, N2a, M0); (T1-T2, N2b, M0); IIIC (T4a, N2a, M0); (T3-T4a, N2b, M0); (T4b, N1-N2, M0). T1: Tumor invades submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor penetrates to the surface of the visceral peritoneum. T4b: Tumor directly invades or is adherent to other organs or structures. N0: No regional lymph node metastasis. N1: Metastasis in 1-3 regional lymph nodes. N1c: Tumor deposit(s) in the subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional lymph node metastasis. N2: Metastasis in four or more regional lymph nodes. N2a: Metastasis in 4-6 regional lymph nodes. N2b: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C89995 Neoplastic Process Stage III Colon Cancer AJCC v7 Stage III Colon Cancer AJCC v7 C3146254 CTRP Malignant Stage III Colon Cancer Stage III Colon Cancer AJCC v7 Stage III Colon Cancer AJCC v7 Stage III includes: IIIA (T1-T2, N1/N1c, M0); (T1, N2a, M0); IIIB (T3-T4a, N1/N1c, M0); (T2-T3, N2a, M0); (T1-T2, N2b, M0); IIIC (T4a, N2a, M0); (T3-T4a, N2b, M0); (T4b, N1-N2, M0). T1: Tumor invades submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor penetrates to the surface of the visceral peritoneum. T4b: Tumor directly invades or is adherent to other organs or structures. N0: No regional lymph node metastasis. N1: Metastasis in 1-3 regional lymph nodes. N1c: Tumor deposit(s) in the subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional lymph node metastasis. N2: Metastasis in four or more regional lymph nodes. N2a: Metastasis in 4-6 regional lymph nodes. N2b: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C89996 Neoplastic Process Stage III Rectal Cancer AJCC v7 Stage III Rectal Cancer AJCC v7 C3146253 CTRP Malignant Stage III Rectal Cancer Stage III Rectal Cancer AJCC v7 Stage III Rectal Cancer AJCC v7 Stage III includes: IIIA (T1-T2, N1/N1c, M0); (T1, N2a, M0); IIIB (T3-T4a, N1/N1c, M0); (T2-T3, N2a, M0); (T1-T2, N2b, M0); IIIC (T4a, N2a, M0); (T3-T4a, N2b, M0); (T4b, N1-N2, M0). T1: Tumor invades submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades through the muscularis propria into pericolorectal tissues. T4a: Tumor penetrates to the surface of the visceral peritoneum. T4b: Tumor directly invades or is adherent to other organs or structures. N1: Metastasis in 1-3 regional lymph nodes. N1c: Tumor deposit(s) in the subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional lymph node metastasis. N2: Metastasis in four or more regional lymph nodes. N2a: Metastasis in 4-6 regional lymph nodes. N2b: Metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C89997 Neoplastic Process Stage III Rectosigmoid Cancer AJCC v7 Stage III Rectosigmoid Cancer AJCC v7 CL449092 CTRP Malignant Stage III Rectosigmoid Cancer Stage III Rectosigmoid Cancer AJCC v7 Stage III Rectosigmoid Cancer AJCC v7 Stage IV includes: IVA: (Any T, Any N, M1a); IVB: (Any T, Any N, M1b). M1a: Metastasis confined to one organ or site (e.g., liver, lung, ovary, nonregional node). M1b: Metastases in more than one organ/site or the peritoneum. (AJCC 7th ed.) C89998 Neoplastic Process Stage IV Colorectal Cancer AJCC v7 Stage IV Colorectal Cancer AJCC v7 C3146251 CTRP Malignant Stage IV Colorectal (Colon or Rectal) Cancer Stage IV Colorectal Cancer Stage IV Colorectal Cancer AJCC v7 Stage IV Colorectal Cancer AJCC v7 Stage IV includes: IVA: (Any T, Any N, M1a); IVB: (Any T, Any N, M1b). M1a: Metastasis confined to one organ or site (e.g., liver, lung, ovary, nonregional node). M1b: Metastases in more than one organ/site or the peritoneum. (AJCC 7th ed.) C89999 Neoplastic Process Stage IV Colon Cancer AJCC v7 Stage IV Colon Cancer AJCC v7 C2217040 CTRP Malignant Stage IV Colon Cancer Stage IV Colon Cancer AJCC v7 Stage IV Colon Cancer AJCC v7 Stage IV includes: IVA: (Any T, Any N, M1a); IVB: (Any T, Any N, M1b). M1a: Metastasis confined to one organ or site (e.g., liver, lung, ovary, nonregional node). M1b: Metastases in more than one organ/site or the peritoneum. (AJCC 7th ed.) C90016 Neoplastic Process Stage IV Rectal Cancer AJCC v7 Stage IV Rectal Cancer AJCC v7 C3146255 CTRP Malignant Stage IV Rectal Cancer Stage IV Rectal Cancer AJCC v7 Stage IV Rectal Cancer AJCC v7 Stage IV includes: IVA: (Any T, Any N, M1a); IVB: (Any T, Any N, M1b). M1a: Metastasis confined to one organ or site (e.g., liver, lung, ovary, nonregional node). M1b: Metastases in more than one organ/site or the peritoneum. (AJCC 7th ed.) C90019 Neoplastic Process Stage IV Rectosigmoid Cancer AJCC v7 Stage IV Rectosigmoid Cancer AJCC v7 CL449090 CTRP Malignant Stage IV Rectosigmoid Cancer Stage IV Rectosigmoid Cancer AJCC v7 Stage IV Rectosigmoid Cancer AJCC v7 A benign neoplasm that can arise from any of the adrenal cortical layers. It can be associated with the overproduction of glucocorticoids (Cushing's syndrome), androgenic or estrogenic steroids (adrenogenital syndrome), or mineralocorticoids (Conn's syndrome). (Sternberg Diagnostic Surgical Pathology, 3rd ed.) C9003 Neoplastic Process Adrenal Cortical Adenoma C0206667 CDISC GDC A benign neoplasm arising from any of the adrenal cortical layers. 8370/0 Benign Adrenal_Cortex_Adenoma 8370/0 Adrenal cortical adenoma, NOS ADENOMA, ADRENOCORTICAL, BENIGN Adenoma of Adrenal Cortex Adenoma of Adrenal Gland Adenoma of the Adrenal Cortex Adenoma of the Adrenal Gland Adrenal Adenoma Adrenal Cortex Adenoma Adrenal Cortical Adenoma Adrenal Gland Adenoma Adrenocortical Adenoma Benign Adenoma of Adrenal Gland Benign Adenoma of the Adrenal Gland Benign Adrenal Adenoma Benign Adrenal Gland Adenoma Cortical Cell Adenoma Adrenal Cortical Adenoma A neoplasm that arises from the adrenal cortex and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C9004 Neoplastic Process Benign Adrenal Cortical Neoplasm C1368669 GDC Benign Benign_Adrenal_Cortex_Neoplasm 8370/0 Adrenal cortical tumor, benign Adrenal cortical tumor, benign Benign Adrenal Cortex Neoplasm Benign Adrenal Cortex Tumor Benign Adrenal Cortical Neoplasm Benign Adrenal Cortical Neoplasm A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma. C9005 Neoplastic Process Malignant Pancreatic Neoplasm Malignant Pancreatic Neoplasm C0346647 CPTAC CTRP mCode Malignant Malignant_Pancreatic_Neoplasm Malignant neoplasm of body of pancreas Malignant neoplasm of head of pancreas Malignant neoplasm of other specified sites of pancreas Malignant neoplasm of pancreas Malignant neoplasm of pancreas, part unspecified Malignant neoplasm of pancreatic duct Malignant neoplasm of tail of pancreas Malignant neoplasm: Body of pancreas Malignant neoplasm: Head of pancreas Malignant neoplasm: Other parts of pancreas Malignant neoplasm: Overlapping lesion of pancreas Malignant neoplasm: Pancreas, unspecified Malignant neoplasm: Pancreatic duct Malignant neoplasm: Tail of pancreas Malignant Neoplasm of Pancreas Malignant Neoplasm of the Pancreas Malignant Pancreatic Neoplasm Malignant neoplasm of pancreas, unspecified Malignant Pancreatic Neoplasm A common benign neoplasm usually affecting older individuals. The lesions usually arise in the trunk, head and neck, but they can occur on any skin surface other than the palms, soles, and mucosal surfaces. They appear as flat-based papules or plaques. Histologically, there is intraepidermal proliferation of basaloid keratinocytes, acanthosis, hyperkeratosis, and cysts formation. C9006 Neoplastic Process Seborrheic Keratosis C0022603 Benign Seborrheic_Keratosis Basal Cell Papilloma Keratosis Seborrheica Seborrheic Keratosis Seborrheic Keratosis Seborrheic keratosis that arises from follicular structures in the skin. It presents as a solitary nodule in the skin and is characterized by the presence of prominent squamous eddies. C9007 Neoplastic Process Inverted Follicular Keratosis C0334019 Benign Inverted_Follicular_Keratosis Inverted Follicular Keratosis Inverted Follicular Keratosis A plasmablastic oral mucosa lymphoma in a patient with acquired immunodeficiency syndrome. C9016 Neoplastic Process AIDS-Related Oral Cavity Plasmablastic Lymphoma C1332057 Malignant AIDS-Related_Plasmablastic_Lymphoma_of_the_Oral_Cavity AIDS-Related Oral Cavity Plasmablastic Lymphoma AIDS-Related Oral Mucosa Plasmablastic Lymphoma AIDS-Related Plasmablastic Lymphoma of Oral Mucosa AIDS-Related Plasmablastic Lymphoma of the Oral Mucosa AIDS-Related Oral Cavity Plasmablastic Lymphoma Primary effusion lymphoma occurring in HIV-positive patients. C9017 Neoplastic Process AIDS-Related Primary Effusion Lymphoma C1332059 Malignant AIDS-Related_Primary_Effusion_Lymphoma AIDS-Related Primary Effusion Lymphoma AIDS-Related Primary Effusion Lymphoma Acute myeloid leukemia characterized by the presence of abnormal bone marrow eosinophils and the characteristic cytogenetic abnormality inv(16)(p13.1q22) which results in the expression of the fusion protein CBFB-MYH11. C9018 Neoplastic Process Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 C1332154 GDC Malignant Acute_Myeloid_Leukemia_with_inv_16_p13_q22 Acute myeloid leukemia, inv(16)(p13;q22) Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 Fusion Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB::MYH11 Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB::MYH11 Fusion Acute Myeloid Leukemia with inv(16)(p13q22) Acute Myeloid Leukemia with inv(16)(p13q22)(CBFb/MYH11) Acute Myeloid Leukemia, inv(16)(p13q22) Acute myeloid leukemia, inv(16)(p13;q22) Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 Stage III includes: IIIA: (T3a, N0, M0); IIIB: (T3b, N0, M0); IIIC: (T4, N0, M0). T3a: Multiple tumors more than 5 cm. T3b: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein. T4: Tumors(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C90180 Neoplastic Process Stage III Hepatocellular Carcinoma AJCC v7 Stage III Hepatocellular Carcinoma AJCC v7 C2983423 CTRP Malignant Stage III Hepatocellular Cancer Stage III Hepatocellular Carcinoma Stage III Hepatocellular Carcinoma AJCC v7 Stage III Hepatocellular Carcinoma AJCC v7 Stage IV includes: IVA: (Any T, N1, M0); IVB: (Any T, Any N, M1). N1: Regional lymph node metastasis. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C90181 Neoplastic Process Stage IV Hepatocellular Carcinoma AJCC v7 Stage IV Hepatocellular Carcinoma AJCC v7 C2983424 CTRP Malignant Stage IV Hepatocellular Cancer Stage IV Hepatocellular Carcinoma Stage IV Hepatocellular Carcinoma AJCC v7 Stage IV Hepatocellular Carcinoma AJCC v7 Acute myeloid leukemia characterized by the presence of abnormal bone marrow eosinophils and the characteristic cytogenetic abnormality t(16;16)(p13.1;q22) which results in the expression of the fusion protein CBFB-MYH11. C9019 Neoplastic Process Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 C1332155 GDC Malignant Acute_Myeloid_Leukemia_with_t_16_16_p13_q22 Acute myeloid leukemia, t(16;16)(p 13;q 11) Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 Fusion Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB::MYH11 Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB::MYH11 Fusion Acute Myeloid Leukemia with t(16;16)(p13;q22) Acute Myeloid Leukemia, t(16;16)(p13;q22) Acute myeloid leukemia, t(16;16)(p 13;q 11) Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 Acute myelomonocytic leukemia characterized by the presence of abnormal bone marrow eosinophils. It is associated with inv(16)(p13.1;q22) or t(16;16)(p13.1;q22). It has a favorable prognosis. C9020 Neoplastic Process Acute Myelomonocytic Leukemia with Abnormal Eosinophils C1332156 CPTAC GDC PCDC Malignant Acute_Myelomonocytic_Leukemia_with_Abnormal_Eosinophils 9871/3 Acute myelomonocytic leukemia with abnormal eosinophils FAB M4Eo AMML Eo Acute Myelomonocytic Leukemia with Abnormal Eosinophils Acute myelomonocytic leukemia with abnormal eosinophils FAB M4Eo M4eo M4eos Acute Myelomonocytic Leukemia with Abnormal Eosinophils Stage I includes: T1, N0, M0. T1: Tumor invades lamina propria or muscular layer. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C90216 Neoplastic Process Stage I Gallbladder Cancer AJCC v7 Stage I Gallbladder Cancer AJCC v7 CL421191 CTRP Malignant Stage I Gallbladder Cancer Stage I Gallbladder Cancer AJCC v7 Stage I Gallbladder Carcinoma AJCC v7 Stage I Gallbladder Cancer AJCC v7 Stage II includes: T2, N0, M0. T2: Tumor invades perimuscular connective tissue; no extension beyond serosa or into liver. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C90217 Neoplastic Process Stage II Gallbladder Cancer AJCC v7 Stage II Gallbladder Cancer AJCC v7 CL421188 CTRP Malignant Stage II Gallbladder Cancer Stage II Gallbladder Cancer AJCC v7 Stage II Gallbladder Carcinoma AJCC v7 Stage II Gallbladder Cancer AJCC v7 Stage III includes: IIIA (T3, N0, M0); IIIB (T1-3, N1, M0). T3: Tumor perforates the serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts. T1: Tumor invades lamina propria or muscular layer. T2: Tumor invades perimuscular connective tissue; no extension beyond serosa or into liver. N0: No regional lymph node metastasis. N1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery, and/or portal vein. M0: No distant metastasis. (from AJCC 7th Ed.) C90218 Neoplastic Process Stage III Gallbladder Cancer AJCC v7 Stage III Gallbladder Cancer AJCC v7 C2987503 CTRP In stage III, cancer has spread to a main blood vessel in the liver or to nearby organs and may have spread to nearby lymph nodes. Malignant Stage III Gallbladder Cancer Stage III Gallbladder Cancer AJCC v7 Stage III Gallbladder Carcinoma AJCC v7 stage III gallbladder cancer Stage III Gallbladder Cancer AJCC v7 Stage IV includes: IVA (T4, N0-1, M0); IVB (Any T, N2, M0); (Any T, Any N, M1). T4: Tumor invades the main portal vein or hepatic artery, or invades two or more extrahepatic organs or structures. N0: No regional lymph node metastasis. N1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery, and/or portal vein. N2: Metastases to periaortic, pericaval, superior mesenteric artery, and/or celiac artery lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (from AJCC 7th Ed.) C90219 Neoplastic Process Stage IV Gallbladder Cancer AJCC v7 Stage IV Gallbladder Cancer AJCC v7 CL421187 CTRP In stage IV, cancer has spread to nearby lymph nodes and/or to organs far away from the gallbladder. Malignant Stage IV Gallbladder Cancer Stage IV Gallbladder Cancer AJCC v7 Stage IV Gallbladder Carcinoma AJCC v7 stage IV gallbladder cancer Stage IV Gallbladder Cancer AJCC v7 An astrocytic tumor appearing before the age of twenty one without designation of benign or malignant nor designated location. C9022 Neoplastic Process Childhood Astrocytic Tumor Childhood Astrocytic Tumor C1321865 CTRP GDC NICHD An astrocytic tumor arising during childhood, without designation of benign or malignant, nor a designated location. Undetermined Childhood_Astrocytic_Tumor 9421/1 Juvenile astrocytoma Astrocytic Tumor Astrocytic Tumors, Childhood Childhood Astrocytic Neoplasm Childhood Astrocytic Tumor Childhood Astrocytic Tumour Juvenile astrocytoma Pediatric Astrocytic Neoplasm Pediatric Astrocytic Tumor Childhood Astrocytic Tumor Grading of sarcomas according to the French Federation of Cancer Centers Sarcoma Group (FNCLCC). This sarcoma grading system is based on three factors: differentiation, mitotic count, and tumor necrosis. The scores for each factor are added to determine the grade (1 to 3) for the sarcoma. C9023 Neoplastic Process Sarcoma by FNCLCC Grade C1335920 Header_Concept CPTAC Malignant Sarcoma_by_AJCC_Grade Sarcoma_by_FNCLCC_Grade FNCLCC Histologic Grade FNCLCC Histologic Grading System FNCLCC Tumor Grade in Sarcoma Histologic Grade (FNCLCC Grading system) (excludes GISTs) Sarcoma by AJCC Grade Sarcoma by FNCLCC Grade Sarcoma by FNCLCC Histologic Grade Sarcoma by FNCLCC Grade A sarcoma with a total score of 2 or 3 according to the FNCLCC guidelines. C9024 Neoplastic Process Sarcoma G1 C1335913 CPTAC Malignant AJCC_Grade_1_Sarcoma Sarcoma_Differentiation_Score_1 AJCC G1 Sarcoma AJCC Grade 1 Sarcoma AJCC Grade I Sarcoma FNCLCC Sarcoma Grade 1 G1 Grade 1 Sarcoma FNCLCC Grade 1 Sarcoma G1 Sarcoma Grade 1 Well Differentiated Sarcoma Sarcoma G1 A well-differentiated malignant neoplasm arising from the deep soft tissues. It is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation in a herringbone growth pattern. C9025 Neoplastic Process Well Differentiated Fibrosarcoma C1337015 Malignant Well_Differentiated_Fibrosarcoma Well Differentiated Fibrosarcoma Well Differentiated Fibrosarcoma A malignant peripheral nerve sheath tumor that is low-grade. C9026 Neoplastic Process Low Grade Malignant Peripheral Nerve Sheath Tumor C1334416 Malignant Low-Grade_Malignant_Peripheral_Nerve_Sheath_Tumor Low Grade Malignant Peripheral Nerve Sheath Tumor Low-Grade Malignant Peripheral Nerve Sheath Tumor Well Differentiated Malignant Peripheral Nerve Sheath Tumor Low Grade Malignant Peripheral Nerve Sheath Tumor A low-grade chondrosarcoma characterized by the presence of moderate cellularity, hyperchromatic and plump nuclei of uniform size, and occasional binucleated cells. Mitotic figures are absent. C9027 Neoplastic Process Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1 C1337014 Malignant Well_Differentiated_Chondrosarcoma ACT/CS1 Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1 Atypical Cartilaginous Tumor/Grade I Chondrosarcoma Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1 A sarcoma with a total score of 4 or 5 according to the FNCLCC guidelines. C9028 Neoplastic Process Sarcoma G2 C1335914 CPTAC Malignant AJCC_Grade_2_Sarcoma Sarcoma_Differentiation_Score_2 AJCC G2 Sarcoma AJCC Grade 2 Sarcoma FNCLCC Sarcoma Grade 2 G2 Grade 2 Moderately Differentiated Sarcoma Sarcoma FNCLCC Grade 2 Sarcoma G2 Sarcoma Grade 2 Sarcoma G2 A sarcoma with a total score of 6 or higher according to the FNCLCC guidelines. C9029 Neoplastic Process Sarcoma G3 C1335915 CPTAC Malignant AJCC_Grade_3_Sarcoma Sarcoma_Differentiation_Score_3 AJCC G3 Sarcoma AJCC Grade 3 Sarcoma FNCLCC Sarcoma Grade 3 G3 Grade 3 Sarcoma FNCLCC Grade 3 Sarcoma G3 Sarcoma Grade 3 Sarcoma G3 A malignant peripheral nerve sheath tumor that is high-grade. C9030 Neoplastic Process High Grade Malignant Peripheral Nerve Sheath Tumor C1334005 Malignant High-Grade_Malignant_Peripheral_Nerve_Sheath_Tumor High Grade Malignant Peripheral Nerve Sheath Tumor High-Grade Malignant Peripheral Nerve Sheath Tumor Poorly Differentiated Malignant Peripheral Nerve Sheath Tumor High Grade Malignant Peripheral Nerve Sheath Tumor An angiosarcoma characterized by the presence of significant cytologic atypia, necrosis and high mitotic activity. C9031 Neoplastic Process Poorly Differentiated Angiosarcoma C1335441 Malignant Poorly_Differentiated_Angiosarcoma Poorly Differentiated Angiosarcoma Poorly Differentiated Angiosarcoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE) (rare in Hodgkin lymphoma). C9032 Neoplastic Process Ann Arbor Stage I Adult Hodgkin Lymphoma Ann Arbor Stage I Adult Hodgkin Lymphoma C0278470 CTRP Stage I is divided into stages I and IE. In stage I, cancer is found in one or more lymph nodes in one lymph node group. In stage IE, cancer is found outside the lymph nodes in one organ or area. Malignant Stage_I_Adult_Hodgkin_s_Lymphoma Adult Hodgkin's Disease Stage I Adult Hodgkin's Lymphoma Stage I Ann Arbor Stage I Adult Hodgkin Lymphoma Stage I Adult Hodgkin Lymphoma Stage I Adult Hodgkin's Disease Stage I Adult Hodgkin's Lymphoma Stage I Hodgkin Lymphoma stage I adult Hodgkin lymphoma Ann Arbor Stage I Adult Hodgkin Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C9033 Neoplastic Process Ann Arbor Stage II Adult Hodgkin Lymphoma Ann Arbor Stage II Adult Hodgkin Lymphoma C0278471 CTRP Stage II is divided into stages II and IIE. In stage II, cancer is found in two or more lymph node groups above or below the diaphragm (the thin muscle below the lungs that helps breathing and separates the chest from the abdomen). In stage IIE, cancer is found in one or more lymph node groups above or below the diaphragm and outside the lymph nodes in a nearby organ or area. Malignant Stage_II_Adult_Hodgkin_s_Lymphoma Adult Hodgkin's Disease Stage II Adult Hodgkin's Lymphoma Stage II Ann Arbor Stage II Adult Hodgkin Lymphoma Stage II Adult Hodgkin Lymphoma Stage II Adult Hodgkin's Disease Stage II Adult Hodgkin's Lymphoma Stage II Hodgkin Lymphoma stage II adult Hodgkin lymphoma Ann Arbor Stage II Adult Hodgkin Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C9034 Neoplastic Process Ann Arbor Stage III Adult Hodgkin Lymphoma Ann Arbor Stage III Adult Hodgkin Lymphoma C0278472 CTRP Stage III is divided into stages III, IIIE, IIIS, and IIIE+S. In stage III, cancer is found in one or more lymph node groups above and below the diaphragm (the thin muscle below the lungs that helps breathing and separates the chest from the abdomen). In stage IIIE, cancer is found in lymph node groups above and below the diaphragm and outside the lymph nodes in a nearby organ or area. In stage IIIS, cancer is found in lymph node groups above and below the diaphragm and in the spleen. In stage IIIE+S, cancer is found in lymph node groups above and below the diaphragm, in a nearby area or organ, and in the spleen. Stage III is also divided into stages III(1) and III(2). In stage III(1), cancer is found only in the upper abdomen above the renal vein. In stage III(2), cancer is found in lymph nodes in the pelvis and/or near the aorta. Malignant Stage_III_Adult_Hodgkin_s_Lymphoma Adult Hodgkin's Disease Stage III Adult Hodgkin's Lymphoma Stage III Ann Arbor Stage III Adult Hodgkin Lymphoma Stage III Adult Hodgkin Lymphoma Stage III Adult Hodgkin's Disease Stage III Adult Hodgkin's Lymphoma Stage III Hodgkin Lymphoma stage III adult Hodgkin lymphoma Ann Arbor Stage III Adult Hodgkin Lymphoma A term that refers to the staging of renal cell cancer according to the American Joint Committee on Cancer, 6th edition. C90343 Neoplastic Process Renal Cell Cancer by AJCC v6 Stage C2983569 Malignant Renal Cell Cancer by AJCC v6 Stage Renal Cell Carcinoma by AJCC v6 Stage Renal Cell Cancer by AJCC v6 Stage A term that refers to the staging of bladder cancer according to the American Joint Committee on Cancer, 6th edition. C90344 Neoplastic Process Bladder Cancer by AJCC v6 Stage C2983570 Malignant Bladder Cancer by AJCC v6 Stage Bladder Carcinoma by AJCC v6 Stage Bladder Cancer by AJCC v6 Stage A term that refers to the staging of vulvar carcinoma according to the American Joint Committee on Cancer, 6th edition. C90345 Neoplastic Process Vulvar Cancer by AJCC v6 Stage C2983571 Malignant Vulvar Cancer by AJCC v6 Stage Vulvar Carcinoma by AJCC v6 Stage Vulvar Cancer by AJCC v6 Stage A term that refers to the staging of vaginal cancer according to the American Joint Committee on Cancer, 6th edition. C90347 Neoplastic Process Vaginal Cancer by AJCC v6 Stage C2983572 Malignant Vaginal Cancer by AJCC v6 Stage Vaginal Carcinoma by AJCC v6 Stage Vaginal Cancer by AJCC v6 Stage Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C9035 Neoplastic Process Ann Arbor Stage IV Adult Hodgkin Lymphoma Ann Arbor Stage IV Adult Hodgkin Lymphoma C0278473 CTRP Malignant Stage_IV_Adult_Hodgkin_s_Lymphoma Adult Hodgkin's Disease Stage IV Adult Hodgkin's Lymphoma Stage IV Ann Arbor Stage IV Adult Hodgkin Lymphoma Stage IV Adult Hodgkin Lymphoma Stage IV Adult Hodgkin's Disease Stage IV Adult Hodgkin's Lymphoma Stage IV Hodgkin Lymphoma stage IV adult Hodgkin lymphoma Ann Arbor Stage IV Adult Hodgkin Lymphoma Stage IV includes: (T4, N1-3, M0); (T1-3, N3, M0); (Any T, Any N, M1). M1:Distant metastasis. (AJCC 6th ed.) C9036 Neoplastic Process Stage IV Gastric Cancer AJCC v6 Stage IV Gastric Cancer AJCC v6 C0278498 CTRP Cancer has spread (1) to organs next to the stomach and to at least one lymph node, or (2) to more than 15 lymph nodes, or (3) to other parts of the body. Malignant Stage_IV_Gastric_Cancer Carcinoma of Stomach Stage IV AJCC v6 Carcinoma of the Stomach Stage IV AJCC v6 Gastric Carcinoma Stage IV AJCC v6 Gastric Carcinoma, Stage IV AJCC v6 Stage IV Carcinoma of Stomach AJCC v6 Stage IV Carcinoma of the Stomach AJCC v6 Stage IV Gastric (Stomach) Cancer Stage IV Gastric Cancer AJCC v6 Stage IV Gastric Carcinoma AJCC v6 Stage IV Stomach Carcinoma AJCC v6 Stomach Cancer Stage IV AJCC v6 Stomach Carcinoma Stage IV AJCC v6 stage IV stomach cancer Stage IV Gastric Cancer AJCC v6 Stage I includes: T1, N0, M0. T1: Tumor 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.) C9037 Neoplastic Process Stage I Anal Canal Cancer AJCC v6 and v7 Stage I Anal Canal Cancer AJCC v6 and v7 C0278499 CTRP Cancer that has spread beyond the top layer of anal tissue and is smaller than 2 centimeters (smaller than 1 inch). Malignant Stage_I_Anal_Canal_Cancer Stage I Anal Canal Cancer Stage I Anal Canal Cancer AJCC v6 Stage I Anal Canal Cancer AJCC v6 and v7 Stage I Anal Canal Cancer AJCC v7 Stage I Anal Canal Carcinoma AJCC v6 and v7 Stage I Anal Carcinoma AJCC v6 and v7 stage I anal cancer Stage I Anal Canal Cancer AJCC v6 and v7 A non-small cell lung carcinoma detectable by sputum cytology only. The primary tumor is undetectable radiographically or during bronchoscopy; therefore, it can not be assessed. C9038 Neoplastic Process Occult Non-Small Cell Lung Carcinoma Occult Lung Non-Small Cell Carcinoma C1335098 CTRP Cancer cells are found in sputum (mucus coughed up from the lungs), but no tumor can be found in the lung by imaging tests or bronchoscopy, or the tumor is too small to be checked. Malignant Occult_Non-Small_Cell_Lung_Carcinoma Occult Lung Non-Small Cell Carcinoma Occult Non-Small Cell Carcinoma of Lung Occult Non-Small Cell Carcinoma of the Lung Occult Non-Small Cell Lung Cancer Occult Non-Small Cell Lung Carcinoma occult stage non-small cell lung cancer Occult Lung Non-Small Cell Carcinoma A carcinoma arising from either the exocervical squamous epithelium or the endocervical glandular epithelium. The major histologic types of cervical carcinoma are squamous cell carcinoma and adenocarcinoma. C9039 Neoplastic Process Cervical Carcinoma Cervical Carcinoma C0302592 CPTAC CTEP CTRP Cellosaurus GDC NICHD Cancer that forms in tissues of the cervix (the organ connecting the uterus and vagina). It is usually a slow-growing cancer that may not have symptoms but can be found with regular Pap tests (a procedure in which cells are scraped from the cervix and looked at under a microscope). Cervical cancer is almost always caused by human papillomavirus (HPV) infection. Malignant Cervical_Carcinoma Cervical Cancer Cervical Cancer (all types) Cancer of Cervix Cancer of Uterine Cervix Cancer of the Cervix Cancer of the Uterine Cervix Carcinoma of Cervix Carcinoma of Cervix Uteri Carcinoma of Uterine Cervix Carcinoma of the Cervix Carcinoma of the Cervix Uteri Carcinoma of the Uterine Cervix Cervical Cancer Cervical Cancer (all types) Cervical Carcinoma Cervical cancer, NOS Cervix Cancer Cervix Carcinoma Cervix Uteri Carcinoma Uterine Cervix Cancer Uterine Cervix Carcinoma cervical cancer Cervical Carcinoma An angiosarcoma occurring in the adult population. C9040 Neoplastic Process Adult Angiosarcoma Adult Angiosarcoma C0278592 CTRP Malignant Adult_Angiosarcoma Adult Angiosarcoma Adult Hemangiosarcoma Angiosarcoma Adult Angiosarcoma An ependymoma that arises from the infratentorial region of the brain and occurs during childhood. C9041 Neoplastic Process Childhood Infratentorial Ependymoma Childhood Infratentorial Ependymoma C0278599 CTRP Undetermined Childhood_Infratentorial_Ependymoma Childhood Infratentorial Ependymoma Infratentorial Ependymoma Pediatric Infratentorial Ependymoma Childhood Infratentorial Ependymoma A glioma that arises from the brain stem and occurs during childhood. C9042 Neoplastic Process Childhood Brain Stem Glioma Childhood Brain Stem Glioma C0278600 CTRP NICHD An abnormal growth of the cells that comprise the tissues of the brainstem. While the tumor may be histologically benign, it can produce great morbidity due to its location. It presents most commonly during the first two decades of life. Undetermined Childhood_Brain_Stem_Glioma Brain Stem Glioma Childhood Brain Stem Glioma Childhood Brainstem Glioma Childhood Glioma of Brain Stem Childhood Glioma of Brainstem Childhood Glioma of the Brain Stem Childhood Glioma of the Brainstem Pediatric Brain Stem Glioma Pediatric Brainstem Glioma Pediatric Glioma of Brain Stem Pediatric Glioma of Brainstem Pediatric Glioma of the Brain Stem Pediatric Glioma of the Brainstem Childhood Brain Stem Glioma An ependymoma, not otherwise specified that arises from the supratentorial region of the brain and occurs during childhood. C9043 Neoplastic Process Childhood Supratentorial Ependymoma Childhood Supratentorial Ependymoma, Not Otherwise Specified C0278650 CTRP Undetermined Childhood_Supratentorial_Ependymoma Childhood Supratentorial Ependymoma, NOS Childhood Supratentorial Ependymoma, Not Otherwise Specified Supratentorial Ependymoma Childhood Supratentorial Ependymoma, Not Otherwise Specified A parathyroid gland carcinoma that has spread to other anatomic sites. C9044 Neoplastic Process Metastatic Parathyroid Gland Carcinoma Metastatic Parathyroid Gland Carcinoma C0278681 CTRP Malignant Metastatic_Parathyroid_Carcinoma Metastatic Parathyroid Cancer Metastatic Parathyroid Carcinoma Metastatic Parathyroid Gland Cancer Metastatic Parathyroid Gland Carcinoma Metastatic Parathyroid Gland Carcinoma The reemergence of central nervous system neoplasm in childhood after a period of remission. C9045 Neoplastic Process Recurrent Childhood Central Nervous System Neoplasm Recurrent Childhood Central Nervous System Neoplasm C1335697 CTRP Undetermined Recurrent_Childhood_Central_Nervous_System_Neoplasm Recurrent Central Nervous System Neoplasm Recurrent Childhood Central Nervous System Neoplasm Recurrent Childhood Central Nervous System Tumor Recurrent Childhood Central Nervous System Neoplasm A hepatocellular carcinoma that occurs during childhood and has recurred after a period of remission. C9046 Neoplastic Process Recurrent Childhood Hepatocellular Carcinoma Recurrent Childhood Hepatocellular Carcinoma C1370832 CTRP Malignant Recurrent_Childhood_Hepatocellular_Carcinoma Recurrent Childhood Hepatocellular Carcinoma Recurrent Childhood Hepatoma Recurrent Hepatocellular Cancer Recurrent Pediatric Hepatocellular Carcinoma Recurrent Pediatric Hepatoma Recurrent Childhood Hepatocellular Carcinoma Retinoblastoma during childhood that has not spread beyond the eye. C9047 Neoplastic Process Childhood Intraocular Retinoblastoma Childhood Intraocular Retinoblastoma C1321869 CTRP NICHD Retinoblastoma localized to the eye. It may be confined to the retina or may extend to involve other structures such as the choroid, ciliary body, anterior chamber, and optic nerve head. Malignant Childhood_Intraocular_Retinoblastoma Childhood Intraocular Retinoblastoma Intraocular Retinoblastoma Pediatric Intraocular Retinoblastoma Childhood Intraocular Retinoblastoma Retinoblastoma during childhood that has spread beyond the eye. C9048 Neoplastic Process Childhood Extraocular Retinoblastoma C1321870 NICHD Retinoblastoma that has spread beyond the eye. Malignant Childhood_Extraocular_Retinoblastoma Childhood Extraocular Retinoblastoma Childhood Metastatic Retinoblastoma Extraocular Retinoblastoma Pediatric Extraocular Retinoblastoma Childhood Extraocular Retinoblastoma Small cell lung carcinoma which has spread beyond one hemi-thorax and the regional lymph nodes. C9049 Neoplastic Process Extensive Stage Small Cell Lung Carcinoma Extensive Stage Lung Small Cell Carcinoma C0278726 CTRP Cancer has spread outside of the lung in which it began or to other parts of the body. Malignant Extensive_Stage_Small_Cell_Lung_Carcinoma Extensive Disease Small Cell Lung Cancer Extensive Disease Small Cell Lung Carcinoma Extensive Stage Lung Small Cell Carcinoma Extensive Stage Oat Cell Carcinoma of Lung Extensive Stage Oat Cell Carcinoma of the Lung Extensive Stage Oat Cell Lung Carcinoma Extensive Stage SCLC Extensive Stage Small Cell Carcinoma of Lung Extensive Stage Small Cell Carcinoma of the Lung Extensive Stage Small Cell Lung Cancer Extensive Stage Small Cell Lung Carcinoma Small Cell Lung Cancer, Extensive Stage extensive-stage small cell lung cancer Extensive Stage Lung Small Cell Carcinoma A term that refers to the staging of cervical cancer according to the American Joint Committee on Cancer, 6th edition. C90493 Neoplastic Process Cervical Cancer by AJCC v6 Stage C2983695 Malignant Cervical Cancer by AJCC v6 Stage Cervical Carcinoma by AJCC v6 Stage Cervical Cancer by AJCC v6 Stage A term that refers to the staging of uterine corpus cancer according to the American Joint Committee on Cancer, 6th edition. C90494 Neoplastic Process Uterine Corpus Cancer by AJCC v6 Stage C2983696 Malignant Uterine Corpus Cancer by AJCC v6 Stage Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v6 Stage Uterine Corpus Cancer by AJCC v6 Stage A term that refers to the staging of fallopian tube carcinoma according to the American Joint Committee on Cancer, 6th edition. C90499 Neoplastic Process Fallopian Tube Cancer by AJCC v6 Stage C2983700 Malignant Fallopian Tube Cancer by AJCC v6 Stage Fallopian Tube Carcinoma by AJCC v6 Stage Fallopian Tube Cancer by AJCC v6 Stage The reemergence of small cell carcinoma of the lung after a period of remission. C9050 Neoplastic Process Recurrent Small Cell Lung Carcinoma Recurrent Lung Small Cell Carcinoma C0278727 CTRP Malignant Recurrent_Small_Cell_Lung_Carcinoma Recurrent Lung Small Cell Carcinoma Recurrent Small Cell Carcinoma of Lung Recurrent Small Cell Carcinoma of the Lung Recurrent Small Cell Lung Cancer Recurrent Small Cell Lung Carcinoma Relapsed Small Cell Carcinoma of Lung Relapsed Small Cell Carcinoma of the Lung Relapsed Small Cell Lung Cancer Relapsed Small Cell Lung Carcinoma Recurrent Lung Small Cell Carcinoma A term that refers to the staging of esophageal carcinoma according to the American Joint Committee on Cancer, 6th edition. C90500 Neoplastic Process Esophageal Cancer by AJCC v6 Stage C2983701 Malignant Esophageal Cancer by AJCC v6 Stage Esophageal Carcinoma by AJCC v6 Stage Esophageal Cancer by AJCC v6 Stage C90503 Neoplastic Process Gastric Cancer by AJCC v6 Stage C2983703 Malignant Gastric Cancer by AJCC v6 Stage Gastric Carcinoma by AJCC v6 Stage Gastric Cancer by AJCC v6 Stage A term that refers to the staging of colorectal carcinoma according to the American Joint Committee on Cancer, 6th edition. C90506 Neoplastic Process Colorectal Cancer by AJCC v6 Stage C2983705 Malignant Colorectal Cancer by AJCC v6 Stage Colorectal Carcinoma by AJCC v6 Stage Colorectal Cancer by AJCC v6 Stage A term that refers to the staging of colon carcinoma according to the American Joint Committee on Cancer, 6th edition. C90507 Neoplastic Process Colon Cancer by AJCC v6 Stage C2983706 Malignant Colon Cancer by AJCC v6 Stage Colon Carcinoma by AJCC v6 Stage Colon Cancer by AJCC v6 Stage A term that refers to the staging of rectal carcinoma according to the American Joint Committee on Cancer, 6th edition. C90508 Neoplastic Process Rectal Cancer by AJCC v6 Stage C2983707 Malignant Rectal Cancer by AJCC v6 Stage Rectal Carcinoma by AJCC v6 Stage Rectal Cancer by AJCC v6 Stage A term that refers to the staging of rectosigmoid carcinoma according to the American Joint Committee on Cancer, 6th edition. C90509 Neoplastic Process Rectosigmoid Cancer by AJCC v6 Stage C2983708 Malignant Rectosigmoid Cancer by AJCC v6 Stage Rectosigmoid Carcinoma by AJCC v6 Stage Rectosigmoid Cancer by AJCC v6 Stage Stage II includes: T2, N0, M0. T2: Tumor confined to the vulva or vulva and perineum, more than 2cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C9051 Neoplastic Process Stage II Vulvar Cancer AJCC v6 Stage II Vulvar Cancer AJCC v6 C0854961 CTRP Cancer that is found only in the vulva or in the vulva and perineum (area between the rectum and the vagina), and the tumor is larger than 2 centimeters. Malignant Stage_II_Vulvar_Cancer AJCC Stage II Vulva Cancer v6 FIGO Stage II Carcinoma of Vulva FIGO Stage II Carcinoma of the Vulva FIGO Stage II Vulva Carcinoma FIGO Stage II Vulvar Carcinoma Stage II Vulva Cancer AJCC v6 Stage II Vulvar Cancer Stage II Vulvar Cancer AJCC v6 Vulva Cancer Stage II AJCC v6 Vulval Cancer Stage II AJCC v6 stage II vulvar cancer Stage II Vulvar Cancer AJCC v6 A term that refers to the staging of hepatocellular carcinoma according to the American Joint Committee on Cancer, 6th edition. C90510 Neoplastic Process Hepatocellular Carcinoma by AJCC v6 Stage C2983709 Malignant Hepatocellular Carcinoma by AJCC v6 Stage Hepatocellular Carcinoma by AJCC v6 Stage A term that refers to the staging of gallbladder cancer according to the American Joint Committee on Cancer, 6th edition. C90512 Neoplastic Process Gallbladder Cancer by AJCC v6 Stage C2983711 Malignant Gallbladder Cancer by AJCC v6 Stage Gallbladder Carcinoma by AJCC v6 Stage Gallbladder Cancer by AJCC v6 Stage A term that refers to the staging of breast cancer according to the American Joint Committee on Cancer, 6th edition. C90513 Neoplastic Process Breast Cancer by AJCC v6 Stage C2983712 Malignant Breast Cancer by AJCC v6 Stage Breast Carcinoma by AJCC v6 Stage Breast Cancer by AJCC v6 Stage A term that refers to the staging of cutaneous melanoma, following the rules of the TNM AJCC v6 classification system. C90514 Neoplastic Process Cutaneous Melanoma by AJCC v6 Stage C2983713 Malignant Cutaneous Melanoma by AJCC v6 Stage Cutaneous Melanoma by AJCC v6 Stage A term that refers to the staging of lung carcinoma according to the American Joint Committee on Cancer, 6th edition. C90519 Neoplastic Process Lung Cancer by AJCC v6 Stage C2983716 Malignant Lung Cancer by AJCC v6 Stage Lung Carcinoma by AJCC v6 Stage Lung Cancer by AJCC v6 Stage Stage III includes: (T1, N1, M0); (T2, N1, M0); (T3, N0, M0); (T3, N1, M0). T3: Tumor of any size with contiguous spread to the lower urethra and/or vagina or anus. N1: Unilateral regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C9052 Neoplastic Process Stage III Vulvar Cancer AJCC v6 Stage III Vulvar Cancer AJCC v6 C0854962 CTRP The tumor may be any size and cancer is either (1) in the vulva only or in the vulva and perineum (area between the rectum and the vagina) and has spread to tissue under the skin and to nearby lymph nodes on one side of the groin; or (2) has spread to nearby tissues such as the lower part of the urethra and/or vagina or anus, and may have spread to nearby lymph nodes on one side of the groin. Malignant Stage_III_Vulvar_Cancer AJCC Stage III Vulva Cancer AJCC v6 FIGO Stage III Carcinoma of Vulva FIGO Stage III Carcinoma of the Vulva FIGO Stage III Vulva Carcinoma FIGO Stage III Vulvar Carcinoma Stage III Vulva Cancer AJCC v6 Stage III Vulvar Cancer Stage III Vulvar Cancer AJCC v6 Vulva Cancer Stage III AJCC v6 Vulval Cancer Stage III AJCC v6 stage III vulvar cancer Stage III Vulvar Cancer AJCC v6 A term that refers to the staging of penile carcinoma according to the American Joint Committee on Cancer, 6th edition. C90520 Neoplastic Process Penile Cancer by AJCC v6 Stage C2983717 Malignant Penile Cancer by AJCC v6 Stage Penile Carcinoma by AJCC v6 Stage Penile Cancer by AJCC v6 Stage A term that refers to the staging of prostate carcinoma according to the American Joint Committee on Cancer, 6th edition. C90521 Neoplastic Process Prostate Cancer by AJCC v6 Stage C2983718 Malignant Prostate Cancer by AJCC v6 Stage Prostate Carcinoma by AJCC v6 Stage Prostate Cancer by AJCC v6 Stage A term that refers to the staging of nasopharyngeal carcinoma according to the American Joint Committee on Cancer, 6th edition. C90522 Neoplastic Process Nasopharyngeal Carcinoma by AJCC v6 Stage C2983719 Malignant Nasopharyngeal Carcinoma by AJCC v6 Stage Nasopharyngeal Carcinoma by AJCC v6 Stage A term that refers to the staging of oropharyngeal carcinoma according to the American Joint Committee on Cancer, 6th edition. C90523 Neoplastic Process Oropharyngeal Carcinoma by AJCC v6 Stage C2983720 Malignant Oropharyngeal Carcinoma by AJCC v6 Stage Oropharyngeal Carcinoma by AJCC v6 Stage A term that refers to the staging of hypopharyngeal carcinoma according to the American Joint Committee on Cancer, 6th edition. C90524 Neoplastic Process Hypopharyngeal Carcinoma by AJCC v6 Stage C2983721 Malignant Hypopharyngeal Carcinoma by AJCC v6 Stage Hypopharyngeal Carcinoma by AJCC v6 Stage A term that refers to the staging of pharyngeal carcinoma according to the American Joint Committee on Cancer, 6th edition. C90525 Neoplastic Process Pharyngeal Carcinoma by AJCC v6 Stage C2983722 Malignant Pharyngeal Carcinoma by AJCC v6 Stage Pharyngeal Carcinoma by AJCC v6 Stage A term that refers to the staging of laryngeal carcinoma according to the American Joint Committee on Cancer, 6th edition. C90527 Neoplastic Process Laryngeal Cancer by AJCC v6 Stage C2983723 Malignant Laryngeal Cancer by AJCC v6 Stage Laryngeal Carcinoma by AJCC v6 Stage Laryngeal Cancer by AJCC v6 Stage A term that refers to the staging of nasal cavity and paranasal sinus carcinoma according to the American Joint Committee on Cancer, 6th edition. C90528 Neoplastic Process Sinonasal Cancer by AJCC v6 Stage C2983724 Malignant Nasal Cavity and Paranasal Sinus Cancer by AJCC v6 Stage Nasal Cavity and Paranasal Sinus Carcinoma by AJCC v6 Stage Sinonasal Cancer by AJCC v6 Stage Sinonasal Carcinoma by AJCC v6 Stage Sinonasal Cancer by AJCC v6 Stage Stage IV includes: IVA (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4, Any N, M0); IVB (Any T, Any N, M1). T4: Tumor invades any of the following: upper urethra bladder mucosa, rectal mucosa, or is fixed to the pubic bone. N2: Bilateral regional lymph node metastasis. M1: distant metastasis (including pelvic lymph node metastasis). (AJCC 6th ed.) C9053 Neoplastic Process Stage IV Vulvar Cancer AJCC v6 Stage IV Vulvar Cancer AJCC v6 C0278733 CTRP Stage IV vulvar cancer is divided into stages IVA and IVB. In stage IVA, the cancer (1) has spread to nearby lymph nodes on both sides of the groin, or (2) has spread beyond nearby tissues to the upper part of the urethra, bladder, or rectum, or (3) is attached to the pelvic bone and may have spread to lymph nodes. In stage IVB, the cancer has spread to distant parts of the body. Malignant Stage_IV_Vulvar_Cancer AJCC Stage IV Vulva Cancer v6 FIGO Stage IV Carcinoma of Vulva FIGO Stage IV Carcinoma of the Vulva FIGO Stage IV Vulva Carcinoma FIGO Stage IV Vulvar Carcinoma Stage IV Vulva Cancer AJCC v6 Stage IV Vulvar Cancer Stage IV Vulvar Cancer AJCC v6 Vulva Cancer Stage IV AJCC v6 Vulval Cancer Stage IV AJCC v6 stage IV vulvar cancer Stage IV Vulvar Cancer AJCC v6 The reemergence of vulvar carcinoma after a period of remission. C9054 Neoplastic Process Recurrent Vulvar Carcinoma Recurrent Vulvar Carcinoma C0854959 CTRP Malignant Recurrent_Vulvar_Cancer Recurrent Cancer of Vulva Recurrent Cancer of the Vulva Recurrent Vulva Cancer Recurrent Vulvar Cancer Recurrent Vulvar Carcinoma Relapsed Cancer of Vulva Relapsed Cancer of the Vulva Relapsed Vulva Cancer Relapsed Vulvar Cancer Recurrent Vulvar Carcinoma A carcinoma that arises from the Bartholin gland. It usually affects women over fifty and presents with enlargement of the Bartholin gland. Various histologic subtypes have been identified and include adenocarcinoma, squamous cell carcinoma, adenoid cystic carcinoma, adenosquamous carcinoma, transitional cell carcinoma, and small cell carcinoma. C9055 Neoplastic Process Bartholin Gland Carcinoma Bartholin Gland Carcinoma C0349561 CTRP Malignant Bartholin_s_Gland_Carcinoma Bartholin Gland Cancer Bartholin Gland Carcinoma Bartholin's Gland Cancer Bartholin's Gland Carcinoma Carcinoma of Bartholin's Gland Carcinoma of the Bartholin's Gland Bartholin Gland Carcinoma Stage I: A single tumor or nodal area is involved, excluding the abdomen and mediastinum (from PDQ). C9056 Neoplastic Process Ann Arbor Stage I Childhood Lymphoblastic Lymphoma Ann Arbor Stage I Childhood Lymphoblastic Lymphoma C0278735 CTRP Malignant Stage_I_Childhood_Lymphoblastic_Lymphoma Ann Arbor Stage I Childhood Lymphoblastic Lymphoma Childhood Lymphoblastic Lymphoma Stage I Pediatric Lymphoblastic Lymphoma Stage I Stage I Childhood Lymphoblastic Lymphoma Stage I Childhood Precursor Lymphoblastic Lymphoma Stage I Lymphoblastic Lymphoma Stage I Pediatric Lymphoblastic Lymphoma Ann Arbor Stage I Childhood Lymphoblastic Lymphoma Stage II: Disease extent is limited to a single tumor with regional node involvement, 2 or more tumors or nodal areas involved on one side of the diaphragm, or a primary gastrointestinal tract tumor (completely resected) with or without regional node involvement (from PDQ). C9057 Neoplastic Process Ann Arbor Stage II Childhood Lymphoblastic Lymphoma Ann Arbor Stage II Childhood Lymphoblastic Lymphoma C0278736 CTRP Malignant Stage_II_Childhood_Lymphoblastic_Lymphoma Ann Arbor Stage II Childhood Lymphoblastic Lymphoma Childhood Lymphoblastic Lymphoma Stage II Pediatric Lymphoblastic Lymphoma Stage II Stage II Childhood Lymphoblastic Lymphoma Stage II Childhood Precursor Lymphoblastic Lymphoma Stage II Lymphoblastic Lymphoma Stage II Pediatric Lymphoblastic Lymphoma Ann Arbor Stage II Childhood Lymphoblastic Lymphoma Stage III: Tumors or involved lymph node areas occur on both sides of the diaphragm. Stage III also includes any primary intrathoracic (mediastinal, pleural, or thymic) disease, extensive primary intra-abdominal disease, or any paraspinal or epidural tumors (from PDQ). C9058 Neoplastic Process Ann Arbor Stage III Childhood Lymphoblastic Lymphoma Ann Arbor Stage III Childhood Lymphoblastic Lymphoma C0278737 CTRP Malignant Stage_III_Childhood_Lymphoblastic_Lymphoma Ann Arbor Stage III Childhood Lymphoblastic Lymphoma Childhood Lymphoblastic Lymphoma Stage III Pediatric Lymphoblastic Lymphoma Stage III Stage III Childhood Lymphoblastic Lymphoma Stage III Childhood Precursor Lymphoblastic Lymphoma Stage III Lymphoblastic Lymphoma Stage III Pediatric Lymphoblastic Lymphoma Ann Arbor Stage III Childhood Lymphoblastic Lymphoma Stage IV: Tumors involve bone marrow and/or central nervous system (CNS) regardless of other sites of involvement (from PDQ). C9059 Neoplastic Process Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma C0278738 CTRP Malignant Stage_IV_Childhood_Lymphoblastic_Lymphoma Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma Childhood Lymphoblastic Lymphoma Stage IV Childhood Stage IV Lymphoblastic Lymphoma Pediatric Lymphoblastic Lymphoma Stage IV Pediatric Stage IV Lymphoblastic Lymphoma Stage IV Childhood Lymphoblastic Lymphoma Stage IV Childhood Precursor Lymphoblastic Lymphoma Stage IV Lymphoblastic Lymphoma Stage IV Pediatric Lymphoblastic Lymphoma Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma The reemergence of lymphoblastic lymphoma in childhood after a period of remission. C9060 Neoplastic Process Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Lymphoblastic Lymphoma C0278739 CTRP Malignant Recurrent_Childhood_Lymphoblastic_Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Precursor Lymphoblastic Lymphoma Recurrent Lymphoblastic Lymphoma Recurrent Pediatric Lymphoblastic Lymphoma Relapsed Childhood Lymphoblastic Lymphoma Relapsed Pediatric Lymphoblastic Lymphoma Recurrent Childhood Lymphoblastic Lymphoma A carcinoma that arises from the penis. Risk factors include phimosis and human papillomavirus infection. The majority of penile carcinomas are squamous cell carcinomas. The most frequent clinical presentation is an irregular mass in the glans of the penis. Treatment includes surgical management and radiation therapy. C9061 Neoplastic Process Penile Carcinoma Penile Carcinoma C0853105 CPTAC CTEP CTRP A rare cancer that forms in the penis (an external male reproductive organ). Most penile cancers are squamous cell carcinomas (cancer that begins in flat cells lining the penis). Malignant Penile_Carcinoma Cancer of Penis Cancer of the Penis Carcinoma of Penis Carcinoma of the Penis Penile Cancer Penile Carcinoma Penile cancer, NOS penile cancer Penile Carcinoma A Burkitt lymphoma occurring in adults. C9062 Neoplastic Process Adult Burkitt Lymphoma Adult Burkitt Lymphoma C0278764 CTRP Malignant Adult_Burkitt_s_Lymphoma Adult Burkitt Lymphoma Adult Burkitt's Lymphoma Adult Diffuse Small Non-Cleaved Cell/Burkitt's Lymphoma Adult Small Non-Cleaved Cell Lymphoma Burkitt Lymphoma Adult Burkitt Lymphoma A malignant germ cell tumor that arises from the testis. It predominantly affects young men. Seminoma is the most frequently seen malignant testicular germ cell tumor, followed by embryonal carcinoma and yolk sac tumor. C9063 Neoplastic Process Malignant Testicular Germ Cell Tumor Malignant Testicular Germ Cell Tumor C0855197 CTEP CTRP GDC Cancer that forms in tissues of the testis (one of two egg-shaped glands inside the scrotum that make sperm and male hormones). Testicular cancer usually occurs in young or middle-aged men. Two main types of testicular cancer are seminomas (cancers that grow slowly and are sensitive to radiation therapy) and nonseminomas (different cell types that grow more quickly than seminomas). Malignant Malignant_Testicular_Germ_Cell_Tumor Testicular Cancer Malignant Germ Cell Neoplasm of Testis Malignant Germ Cell Neoplasm of the Testis Malignant Germ Cell Tumor of Testis Malignant Germ Cell Tumor of the Testis Malignant Testicular Germ Cell Neoplasm Malignant Testicular Germ Cell Tumor Testicular Cancer Testicular Germ Cell Cancer Testicular ca. (no germ/tropho.) Testicular cancer (excluding germ cell or trophoblastic cancer) testicular cancer Malignant Testicular Germ Cell Tumor A localized hepatocellular carcinoma that occurs during adulthood and it is amenable to surgical resection. C9064 Neoplastic Process Localized Resectable Adult Hepatocellular Carcinoma C1708717 Malignant Localized_Resectable_Adult_Primary_Hepatoma Localized Resectable Adult Hepatocellular Carcinoma Localized Resectable Adult Hepatocellular Carcinoma A localized hepatocellular carcinoma that occurs during adulthood and it is not amenable to surgical resection. C9065 Neoplastic Process Localized Unresectable Adult Hepatocellular Carcinoma Localized Unresectable Adult Hepatocellular Carcinoma C1708718 CTRP Malignant Localized_Unresectable_Adult_Primary_Hepatoma Localized Non-Resectable Adult Hepatocellular Carcinoma Localized Unresectable Adult Hepatocellular Carcinoma Unresectable Hepatocellular Cancer Localized Unresectable Adult Hepatocellular Carcinoma A hepatocellular carcinoma that occurs during adulthood and has recurred after a period of remission. C9067 Neoplastic Process Recurrent Adult Hepatocellular Carcinoma Recurrent Adult Hepatocellular Carcinoma C1711391 CTRP Malignant Recurrent_Adult_Primary_Hepatoma Recurrent Adult Hepatocellular Carcinoma Recurrent Hepatocellular Cancer Recurrent Adult Hepatocellular Carcinoma The reemergence of acute myeloid leukemia in childhood after a period of remission. C9068 Neoplastic Process Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia C0278776 CTRP Malignant Recurrent_Childhood_Acute_Myeloid_Leukemia Recurrent Acute Myeloid Leukemia (AML) Recurrent Childhood AML Recurrent Childhood Acute Myeloblastic Leukemia Recurrent Childhood Acute Myelogenous Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Acute Non-Lymphocytic Leukemia Recurrent Pediatric AML Recurrent Pediatric Acute Myeloblastic Leukemia Recurrent Pediatric Acute Myelogenous Leukemia Recurrent Pediatric Acute Myeloid Leukemia Relapsed Childhood AML Relapsed Childhood Acute Myeloblastic Leukemia Relapsed Childhood Acute Myelogenous Leukemia Relapsed Childhood Acute Myeloid Leukemia Relapsed Pediatric AML Relapsed Pediatric Acute Myeloblastic Leukemia Relapsed Pediatric Acute Myelogenous Leukemia Relapsed Pediatric Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia A usually malignant gastrin-producing neuroendocrine tumor arising from the pancreas. It may or may not be associated with inappropriate secretion of gastrin and an associated clinical syndrome. C9069 Neoplastic Process Pancreatic Gastrin-Producing Neuroendocrine Tumor Pancreatic Gastrin-Producing Neuroendocrine Tumor CL427994 CTRP Undetermined Pancreatic_G-Cell_Gastrin_Producing_Neoplasm Pancreatic Gastrin Producing NET Pancreatic Gastrin Producing Tumor Pancreatic Gastrin-Producing Neuroendocrine Tumor Pancreatic Gastrin-Producing Neuroendocrine Tumor The reemergence of chronic myeloid leukemia, BCR-ABL1 positive after a period of remission. C9070 Neoplastic Process Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive C0278787 CPTAC CTRP mCode Malignant Relapsed_Chronic_Myelogenous_Leukemia Chronic myeloid leukemia, BCR/ABL-positive, in relapse Chronic myeloid leukemia, BCR/ABL-positive, in relapse Recurrent Chronic Myelogenous Leukemia Recurrent Chronic Myelogenous Leukemia (CML) Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Recurrent Chronic Myelogenous Leukemia, BCR::ABL1 Positive Recurrent Chronic Myeloid Leukemia Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive Recurrent Chronic Myeloid Leukemia, BCR::ABL1 Positive Relapsed CGL Relapsed CML Relapsed Chronic Myelogenous Leukemia Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C9071 Neoplastic Process Stage 0 Uterine Corpus Cancer AJCC v6 Stage 0 Uterine Corpus Cancer AJCC v6 C2983845 CTRP Malignant Stage_0_Endometrial_Cancer Endometrial Carcinoma in situ AJCC v6 Stage 0 Uterine (including Endometrial) Cancer Stage 0 Uterine Corpus Cancer AJCC v6 Stage 0 Uterine Corpus Cancer AJCC v6 The reemergence of uterine corpus cancer after a period of remission. C9072 Neoplastic Process Recurrent Uterine Corpus Carcinoma Recurrent Uterine Corpus Cancer C0278802 CTRP Malignant Recurrent_Endometrial_Carcinoma Recurrent Corpus Uteri Cancer Recurrent Uterine (Including Endometrial) Cancer Recurrent Uterine Corpus Cancer Recurrent Uterine Corpus Cancer Stage II includes: Any pT/TX, N1-3, M0, SX. pTX: Primary tumor cannot be assessed. N1: Metastasis with a lymph node mass 2 cm or less in greatest dimension; or multiple lymph nodes, none more than 2cm in greatest dimension. N2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, any one mass greater than 2 cm but not more than 5 cm in greatest dimension. N3: Metastasis with a lymph node mass more than 5 cm in greatest dimension. M0: No distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C9073 Neoplastic Process Stage II Testicular Cancer AJCC v6 and v7 Stage II Testicular Cancer AJCC v6 and v7 C0278832 CTRP PCDC Stage II is divided into stage IIA, stage IIB, and stage IIC, and is determined after a radical inguinal orchiectomy (surgery to remove the testicle) is done. In stage IIA, cancer is anywhere within the testicle, spermatic cord, or scrotum; and has spread to up to 5 lymph nodes in the abdomen (none larger than 2 centimeters); all tumor marker levels are normal or slightly above normal. In stage IIB, cancer is anywhere within the testicle, spermatic cord, or scrotum; and has spread to up to 5 lymph nodes in the abdomen (at least one of the lymph nodes is larger than 2 centimeters, but none is larger than 5 centimeters), or has spread to more than 5 lymph nodes (the lymph nodes are not larger than 5 centimeters); all tumor marker levels are normal or slightly above normal. In stage IIC, cancer is anywhere within the testicle, spermatic cord, or scrotum; and has spread to a lymph node in the abdomen that is larger than 5 centimeters; all tumor marker levels are normal or slightly above normal. Malignant Stage_II_Testicular_Cancer Stage II Stage II Cancer of Testis Stage II Cancer of the Testis Stage II Testicular Cancer Stage II Testicular Cancer AJCC v6 Stage II Testicular Cancer AJCC v6 and v7 Stage II Testicular Cancer AJCC v7 stage II testicular cancer Stage II Testicular Cancer AJCC v6 and v7 Stage III includes: Any pT/TX, Any N, M1, SX. M1: Distant metastasis. SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.) C9074 Neoplastic Process Stage III Testicular Cancer AJCC v6 and v7 Stage III Testicular Cancer AJCC v6 and v7 C0278833 CTRP PCDC Stage III is divided into stage IIIA, stage IIIB, and stage IIIC, and is determined after a radical inguinal orchiectomy (surgery to remove the testicle) is done. In stage IIIA, cancer is anywhere within the testicle, spermatic cord, or scrotum; may have spread to one or more lymph nodes in the abdomen; and has spread to distant lymph nodes or to the lungs; tumor marker levels may range from normal to slightly above normal. In stage IIIB, cancer is anywhere within the testicle, spermatic cord, or scrotum; and may have spread to one or more lymph nodes in the abdomen, to distant lymph nodes or to the lungs; the level of one or more tumor markers is moderately above normal. In stage IIIC, cancer is anywhere within the testicle, spermatic cord, or scrotum; and may have spread to one or more lymph nodes in the abdomen, to distant lymph nodes, or to the lungs; the level of one or more tumor markers is high; OR, cancer is anywhere within the testicle, spermatic cord, or scrotum; and may have spread to one or more lymph nodes in the abdomen; and has not spread to distant lymph nodes or the lung but has spread to other parts of the body; tumor marker levels may range from normal to high. Malignant Stage_III_Testicular_Cancer Stage III Stage III Cancer of Testis Stage III Cancer of the Testis Stage III Testicular Cancer Stage III Testicular Cancer AJCC v6 Stage III Testicular Cancer AJCC v6 and v7 Stage III Testicular Cancer AJCC v7 stage III testicular cancer Stage III Testicular Cancer AJCC v6 and v7 Stage IV includes: (T4, N0, M0); (Any T, N1, M0); (Any T, Any N, M1) (Any G). T4: Tumor is fixed or invades adjacent structures other than seminal vesicles: bladder neck, external sphincter, rectum, levator muscles, and/or pelvic wall. N1: Metastasis in regional lymph node(s). M1: Distant metastasis. (AJCC 6th ed.) C9075 Neoplastic Process Stage IV Prostate Cancer AJCC v6 Stage IV Prostate Cancer AJCC v6 C0278837 CTRP Cancer (1) has spread beyond the seminal vesicles to nearby tissue or organs, such as the rectum, bladder, or pelvic wall; or (2) has spread to nearby lymph nodes; and may have spread to the seminal vesicles or to nearby tissue or organs, such as the rectum, bladder, or pelvic wall; or (3) has spread to distant parts of the body, which may include lymph nodes or bones. Also, the prostate-specific antigen (PSA) can be any level and the Gleason score can range from 2 to 10. Malignant Stage_IV_Prostate_Cancer Cancer of Prostate Stage IV AJCC v6 Cancer of the Prostate Stage IV AJCC v6 Prostate Cancer Stage IV AJCC v6 Prostate Carcinoma Stage IV AJCC v6 Stage IV Cancer of Prostate AJCC v6 Stage IV Cancer of the Prostate AJCC v6 Stage IV Prostate Cancer Stage IV Prostate Cancer AJCC v6 Stage IV Prostate Carcinoma AJCC v6 Stage IV Prostatic Cancer AJCC v6 Stage IV Prostatic Carcinoma AJCC v6 stage IV prostate cancer Stage IV Prostate Cancer AJCC v6 Malignant testicular germ cell tumor that is resistant to treatment. C9077 Neoplastic Process Refractory Malignant Testicular Germ Cell Tumor Refractory Malignant Testicular Germ Cell Tumor C1377904 CTRP Malignant Refractory_Testicular_Cancer Refractory Cancer of Testis Refractory Cancer of the Testis Refractory Malignant Testicular Germ Cell Tumor Refractory Testicular Cancer Refractory Malignant Testicular Germ Cell Tumor An immunoblastic lymphoma (a variant of diffuse large B-cell lymphoma) occurring in children. C9079 Neoplastic Process Childhood Immunoblastic Lymphoma Childhood Immunoblastic Lymphoma C0278844 CTRP NICHD An immunoblastic lymphoma (a variant of diffuse large B-cell lymphoma) occurring in children. Malignant Childhood_Immunoblastic_Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Immunoblastic Lymphoma Immunoblastic Lymphoma Pediatric Immunoblastic Large Cell Lymphoma Pediatric Immunoblastic Lymphoma Childhood Immunoblastic Lymphoma A morphologically malignant thymoma that is entirely confined within the capsule. C9080 Neoplastic Process Noninvasive Malignant Thymoma C0278847 Malignant Noninvasive_Malignant_Thymoma Malignant Thymoma, Noninvasive Noninvasive Malignant Thymoma Thymoma Malignant Noninvasive Noninvasive Malignant Thymoma Stage I includes: Under 45 years: Any T, Any N, M0. 45 years and older: T1, N0, M0. T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland. N0: No regional lymph node metastasis. M0: No evidence of distant metastasis. (from AJCC 7th Ed.) C9081 Neoplastic Process Stage I Thyroid Gland Papillary Carcinoma AJCC v7 Stage I Thyroid Gland Papillary Carcinoma AJCC v7 C0278849 CTRP Malignant Stage_I_Thyroid_Papillary_Carcinoma Stage I Papillary Carcinoma of Thyroid Stage I Papillary Carcinoma of Thyroid Gland Stage I Papillary Carcinoma of the Thyroid Stage I Papillary Carcinoma of the Thyroid Gland Stage I Papillary Thyroid Cancer Stage I Papillary Thyroid Gland Carcinoma Stage I Thyroid Gland Papillary Cancer Stage I Thyroid Gland Papillary Carcinoma Stage I Thyroid Gland Papillary Carcinoma AJCC v7 Stage I Thyroid Papillary Carcinoma Stage I Thyroid Gland Papillary Carcinoma AJCC v7 Stage II includes: Under 45 years: Any T, Any N, M1. 45 years and older: T2, N0, M0. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland. N0: No regional lymph node metastasis. M1: Distant metastasis. M0: No evidence of distant metastasis. (from AJCC 7th Ed.) C9082 Neoplastic Process Stage II Thyroid Gland Papillary Carcinoma AJCC v7 Stage II Thyroid Gland Papillary Carcinoma AJCC v7 C0278850 CTRP Malignant Stage_II_Thyroid_Papillary_Carcinoma Stage II Papillary Carcinoma of Thyroid Stage II Papillary Carcinoma of Thyroid Gland Stage II Papillary Carcinoma of the Thyroid Stage II Papillary Carcinoma of the Thyroid Gland Stage II Papillary Thyroid Cancer Stage II Papillary Thyroid Gland Carcinoma Stage II Thyroid Gland Papillary Cancer Stage II Thyroid Gland Papillary Carcinoma Stage II Thyroid Gland Papillary Carcinoma AJCC v7 Stage II Thyroid Papillary Carcinoma Stage II Thyroid Gland Papillary Carcinoma AJCC v7 Stage IV includes: IVA (T4a, N0, M0); (T4a, N1a, M0); (T1, N1b, M0); (T2, N1b, M0); (T3, N1b, M0); (T4a, N1b, M0); IVB (T4b, Any N, M0); IVC (Any T, Any N, M1). T4a: Moderately advanced local disease. Tumor of any size extending beyond the thyroid gland capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve. T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland. T3: Tumor more than 4 cm in greatest dimension and limited to the thyroid gland, or tumor of any size with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues). T4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels. N0: No regional lymph node metastasis. N1a: Metastasis to pretracheal, paratracheal or prelaryngeal/Delphian lymph nodes (Level VI lymph nodes). N1b: Metastasis to unilateral, bilateral or contralateral cervical (Levels I, II, III, IV, or V) or retropharyngeal or superior mediastinal lymph nodes (Level VII). M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C9083 Neoplastic Process Stage IV Thyroid Gland Papillary Carcinoma AJCC v7 Stage IV Thyroid Gland Papillary Carcinoma AJCC v7 C0278851 CTRP Malignant Stage_IV_Thyroid_Papillary_Carcinoma Stage IV Papillary Carcinoma of Thyroid Stage IV Papillary Carcinoma of Thyroid Gland Stage IV Papillary Carcinoma of the Thyroid Stage IV Papillary Carcinoma of the Thyroid Gland Stage IV Papillary Thyroid Cancer Stage IV Papillary Thyroid Gland Carcinoma Stage IV Thyroid Gland Papillary Cancer Stage IV Thyroid Gland Papillary Carcinoma Stage IV Thyroid Gland Papillary Carcinoma AJCC v7 Stage IV Thyroid Papillary Carcinoma Stage IV Thyroid Gland Papillary Carcinoma AJCC v7 Stage I includes: Under 45 years: Any T, Any N, M0. 45 years and older: T1, N0, M0. T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland. N0: No regional lymph node metastasis. M0: No evidence of distant metastasis. (from AJCC 7th Ed.) C9084 Neoplastic Process Stage I Thyroid Gland Follicular Carcinoma AJCC v7 Stage I Thyroid Gland Follicular Carcinoma AJCC v7 C0278852 CTRP Malignant Stage_I_Thyroid_Follicular_Carcinoma Stage I Follicular Carcinoma of Thyroid Stage I Follicular Carcinoma of Thyroid Gland Stage I Follicular Carcinoma of the Thyroid Stage I Follicular Carcinoma of the Thyroid Gland Stage I Follicular Thyroid Gland Carcinoma Stage I Thyroid Follicular Cancer Stage I Thyroid Follicular Carcinoma Stage I Thyroid Gland Follicular Cancer Stage I Thyroid Gland Follicular Carcinoma Stage I Thyroid Gland Follicular Carcinoma AJCC v7 Stage I Thyroid Gland Follicular Carcinoma AJCC v7 Stage II includes: Under 45 years: Any T, Any N, M1. 45 years and older: T2, N0, M0. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland. N0: No regional lymph node metastasis. M1: Distant metastasis. M0: No evidence of distant metastasis. (from AJCC 7th Ed.) C9085 Neoplastic Process Stage II Thyroid Gland Follicular Carcinoma AJCC v7 Stage II Thyroid Gland Follicular Carcinoma AJCC v7 C0278853 CTRP Malignant Stage_II_Thyroid_Follicular_Carcinoma Stage II Follicular Carcinoma of Thyroid Stage II Follicular Carcinoma of Thyroid Gland Stage II Follicular Carcinoma of the Thyroid Stage II Follicular Carcinoma of the Thyroid Gland Stage II Follicular Thyroid Gland Carcinoma Stage II Thyroid Follicular Cancer Stage II Thyroid Follicular Carcinoma Stage II Thyroid Gland Follicular Cancer Stage II Thyroid Gland Follicular Carcinoma Stage II Thyroid Gland Follicular Carcinoma AJCC v7 Stage II Thyroid Gland Follicular Carcinoma AJCC v7 Stage IV includes: IVA (T4a, N0, M0); (T4a, N1a, M0); (T1, N1b, M0); (T2, N1b, M0); (T3, N1b, M0); (T4a, N1b, M0); IVB (T4b, Any N, M0); IVC (Any T, Any N, M1). T4a: Moderately advanced local disease. Tumor of any size extending beyond the thyroid gland capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve. T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland. T3: Tumor more than 4 cm in greatest dimension and limited to the thyroid gland, or tumor of any size with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues). T4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels. N0: No regional lymph node metastasis. N1a: Metastasis to pretracheal, paratracheal or prelaryngeal/Delphian lymph nodes (Level VI lymph nodes). N1b: Metastasis to unilateral, bilateral or contralateral cervical (Levels I, II, III, IV, or V) or retropharyngeal or superior mediastinal lymph nodes (Level VII). M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C9086 Neoplastic Process Stage IV Thyroid Gland Follicular Carcinoma AJCC v7 Stage IV Thyroid Gland Follicular Carcinoma AJCC v7 C0278854 CTRP Malignant Stage_IV_Thyroid_Follicular_Carcinoma Stage IV Thyroid Gland Follicular Cancer Stage IV Thyroid Gland Follicular Carcinoma Stage IV Thyroid Gland Follicular Carcinoma AJCC v7 Stage IV Thyroid Gland Follicular Carcinoma AJCC v7 A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS). C9087 Neoplastic Process Kaposi Sarcoma Kaposi Sarcoma C3552576 CPTAC CTRP GDC mCode A type of cancer characterized by the abnormal growth of blood vessels that develop into skin lesions or occur internally. 9140/3 Malignant Kaposi_s_Sarcoma 9140/3 Kaposi Sarcoma Kaposi sarcoma Kaposi sarcoma of soft tissue Kaposi's sarcoma Kaposi's sarcoma of gastrointestinal sites Kaposi's sarcoma, gastrointestinal sites Multiple hemorrhagic sarcoma KS Kaposi Sarcoma Kaposi sarcoma Kaposi's Sarcoma Kaposi's sarcoma Kaposi's sarcoma, unspecified Multiple Hemorrhagic Sarcoma Multiple hemorrhagic sarcoma Kaposi Sarcoma A uveal melanoma that arises from the iris. It is the most common primary malignant neoplasm of the iris. The majority arise in preexisting nevi. C9088 Neoplastic Process Iris Melanoma Iris Melanoma C0346373 CTRP Malignant Iris_Melanoma Iris Malignant Melanoma Iris Melanoma Malignant Melanoma of Iris Malignant Melanoma of the Iris Melanoma of Iris Melanoma of the Iris Iris Melanoma Ciliary body and choroid melanoma measuring less than 10 mm in greatest diameter. C9089 Neoplastic Process Small Size Posterior Uveal Melanoma Small Size Posterior Uveal Melanoma CL448422 CTRP Malignant Small_Size_Posterior_Uveal_Melanoma Small Size Ciliary Body and Choroid Melanoma Small Size Posterior Uveal Melanoma Small Size Posterior Uveal Melanoma Ciliary body and choroid melanoma measuring between 2.5 mm and 10 mm in height and 16 mm or less in basal diameter (medium-sized) or more than 10 mm in height or more than 2 mm in height and more than 16 mm in basal diameter or more than 8 mm in height with optic nerve involvement (large-sized). (Collaborative Ocular Melanoma Study) C9090 Neoplastic Process Medium/Large Size Posterior Uveal Melanoma Medium/Large Size Posterior Uveal Melanoma CL448423 CTRP Malignant Medium_Large_Size_Posterior_Uveal_Melanoma Medium/Large Size Ciliary Body and Choroid Melanoma Medium/Large Size Posterior Uveal Melanoma Medium/Large Size Posterior Uveal Melanoma A brain stem glioma that occurs during adulthood. C9091 Neoplastic Process Adult Brain Stem Glioma Adult Brain Stem Glioma C0278873 CTRP Undetermined Adult_Brain_Stem_Glioma Adult Brain Stem Glioma Adult Brainstem Glioma Adult Brainstem Neuroglial Neoplasm Adult Brainstem Neuroglial Tumor Brain Stem Glioma Glioma of Adult Brain Stem Glioma of the Adult Brain Stem Adult Brain Stem Glioma An ependymoma occurring in adults. C9092 Neoplastic Process Adult Ependymoma Adult Ependymoma C0278874 CTRP Undetermined Adult_Ependymoma Adult Ependymoma Adult Well-Differentiated Ependymoma Ependymoma Well-Differentiated Adult Ependymoma Adult Ependymoma A meningioma that occurs during adulthood. C9093 Neoplastic Process Adult Meningioma Adult Meningioma C0278877 CTRP Undetermined Adult_Meningioma Adult Meningioma Meningioma Adult Meningioma A glioblastoma occurring in adults. C9094 Neoplastic Process Adult Glioblastoma Adult Glioblastoma C0278878 CTRP Malignant Adult_Glioblastoma Adult Glioblastoma Adult Glioblastoma Multiforme Glioblastoma Adult Glioblastoma A Burkitt lymphoma occurring in children. C9095 Neoplastic Process Childhood Burkitt Lymphoma Childhood Burkitt Lymphoma C0278879 CTRP NICHD An aggressive lymphoma showing a mature B cell phenotype with the malignant cells expressing surface immunoglobulin. It is characterized by a consistent chromosomal translocation, usually t(8;14), or rarely t(8;22) or t(2;8). It accounts for 40% of childhood non-Hodgkin lymphoma. Malignant Childhood_Burkitt_s_Lymphoma Burkitt Lymphoma Childhood Burkitt Lymphoma Childhood Burkitt's Lymphoma Childhood Small Non-Cleaved Cell Lymphoma Pediatric Burkitt's Lymphoma Pediatric Small Non-Cleaved Cell Lymphoma Childhood Burkitt Lymphoma Stage IV includes: (Any T, Any N, M1). M1: Distant metastasis. (from AJCC 6th and 7th Eds.) C9096 Neoplastic Process Stage IV Cutaneous Melanoma AJCC v6 and v7 Stage IV Cutaneous Melanoma AJCC v6 and v7 C0854698 CTRP Cancer has spread to other places in the body, such as the lung, liver, brain, bone, soft tissue, gastrointestinal (GI) tract, or to places in the skin far away from where the cancer first started. Malignant Stage_IV_Melanoma_of_the_Skin Malignant Melanoma (of Skin), Stage IV Stage IV Cutaneous (Skin) Melanoma Stage IV Cutaneous Malignant Melanoma Stage IV Cutaneous Melanoma Stage IV Cutaneous Melanoma AJCC v6 and v7 Stage IV Malignant Melanoma of Skin Stage IV Malignant Melanoma of the Skin Stage IV Malignant Skin Melanoma Stage IV Melanoma of Skin Stage IV Melanoma of the Skin Stage IV Skin Melanoma AJCC v6 Stage IV Skin Melanoma AJCC v7 stage IV melanoma Stage IV Cutaneous Melanoma AJCC v6 and v7 Reemergence of a melanoma of the skin after a period of remission. C9097 Neoplastic Process Recurrent Melanoma of the Skin Recurrent Cutaneous Melanoma CL448424 CTRP Malignant Recurrent_Melanoma_of_the_Skin Recurrent Cutaneous (Skin) Melanoma Recurrent Cutaneous Melanoma Recurrent Malignant Melanoma of Skin Recurrent Malignant Melanoma of the Skin Recurrent Malignant Skin Melanoma Recurrent Melanoma of Skin Recurrent Melanoma of the Skin Recurrent Cutaneous Melanoma Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th, 7th, and 8th eds.) C9099 Neoplastic Process Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8 Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8 C0347096 CTRP Abnormal cells are found in the lining of the nasopharynx (the upper part of the throat behind the nose). These abnormal cells may become cancer and spread into nearby normal tissue. Malignant Stage_0_Nasopharyngeal_Carcinoma Carcinoma in situ of Nasopharynx Carcinoma in situ of the Nasopharynx Nasopharyngeal Carcinoma in situ Stage 0 Carcinoma of Nasopharynx Stage 0 Carcinoma of the Nasopharynx Stage 0 Nasopharyngeal Cancer Stage 0 Nasopharyngeal Carcinoma Stage 0 Nasopharyngeal Carcinoma AJCC v6 Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8 Stage 0 Nasopharyngeal Carcinoma AJCC v7 Stage 0 Nasopharyngeal Carcinoma AJCC v8 Stage 0 Nasopharyngeal Throat Cancer Stage 0 Nasopharynx Carcinoma stage 0 nasopharyngeal carcinoma in situ Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th, 7th, and 8th eds.) C9100 Neoplastic Process Stage 0 Laryngeal Cancer AJCC v6, v7, and V8 Stage 0 Laryngeal Cancer AJCC v6, v7, and V8 C0154069 CTRP mCode Abnormal cells are found in the lining of the larynx. These abnormal cells may become cancer and spread into nearby normal tissue. Malignant Stage_0_Laryngeal_Cancer Carcinoma in situ of Larynx Carcinoma in situ of larynx Carcinoma in situ of the Larynx Laryngeal Cancer Stage 0 Laryngeal Carcinoma Stage 0 Laryngeal Carcinoma in situ Larynx Carcinoma in situ Stage 0 Carcinoma of Larynx Stage 0 Carcinoma of the Larynx Stage 0 Laryngeal Cancer Stage 0 Laryngeal Cancer AJCC v6 Stage 0 Laryngeal Cancer AJCC v6, v7, and V8 Stage 0 Laryngeal Cancer AJCC v7 Stage 0 Laryngeal Cancer AJCC v8 Stage 0 Laryngeal Carcinoma Stage 0 Laryngeal Throat Cancer Stage 0 Larynx Carcinoma stage 0 laryngeal carcinoma in situ Stage 0 Laryngeal Cancer AJCC v6, v7, and V8 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th, 7th, and 8th eds.) C9101 Neoplastic Process Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8 Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8 C0347100 CTRP Abnormal cells are found in the lining of the hypopharynx. These abnormal cells may become cancer and spread into nearby normal tissue. Malignant Stage_0_Hypopharyngeal_Cancer Carcinoma In Situ of the Hypopharynx Carcinoma in situ of Hypopharynx Carcinoma in situ of the Hypopharynx Hypopharyngeal Carcinoma in situ Hypopharynx Carcinoma in situ Stage 0 Carcinoma of Hypopharynx Stage 0 Carcinoma of the Hypopharynx Stage 0 Hypopharyngeal Cancer Stage 0 Hypopharyngeal Carcinoma Stage 0 Hypopharyngeal Carcinoma AJCC v6 Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8 Stage 0 Hypopharyngeal Carcinoma AJCC v7 Stage 0 Hypopharyngeal Carcinoma AJCC v8 Stage 0 Hypopharyngeal Throat Cancer Stage 0 Hypopharynx Carcinoma stage 0 hypopharyngeal carcinoma in situ Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8 Stage IIIA includes: (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C9102 Neoplastic Process Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIA Lung Non-Small Cell Cancer AJCC v7 C0278983 CTRP Stage III non-small cell lung cancer is divided into stages IIIA and IIIB. In stage IIIA, cancer has spread to lymph nodes on the same side of the chest as the tumor. Also, (1) the tumor may be any size; (2) part of the lung (where the trachea joins the bronchus) or the whole lung may have collapsed or become inflamed; (3) there may be one or more separate tumors in the same lobe of the lung; and/or (4) cancer may have spread to any of the following: main bronchus (but not the area where the trachea joins the bronchus), chest wall, diaphragm and the nerve that controls it, or membrane around the heart, lung, or lining the chest wall. OR in stage IIIA, cancer has spread to lymph nodes on the same side of the chest as the tumor. Also, (1) the tumor may be any size; (2) the whole lung may have collapsed or become inflamed; (3) there may be one or more separate tumors in any of the lobes of the lung with cancer; and/or (4) cancer may have spread to any of the following: main bronchus (but not the area where the trachea joins the bronchus), chest wall, diaphragm and the nerve that controls it, membrane around the lung or lining the chest wall, heart or the membrane around it, trachea, carina (where the trachea joins the bronchi), esophagus, sternum (chest bone), backbone, major blood vessels that lead to or from the heart, or the nerve that controls the larynx (voice box). OR in stage IIIA, cancer has not spread to the lymph nodes and the tumor may be any size. Cancer has spread to any of the following: trachea, carina, esophagus, sternum, backbone, heart, major blood vessels that lead to or from the heart, or the nerve that controls the larynx. Malignant Stage_IIIA_Non-Small_Cell_Lung_Cancer Non Small Cell Lung Cancer Stage IIIA Non Small Cell Lung Cancer, Stage IIIA Stage IIIA Lung Non-Small Cell Cancer AJCC v7 Stage IIIA NSCLC Stage IIIA Non-Oat Cell Carcinoma of Lung Stage IIIA Non-Oat Cell Carcinoma of the Lung Stage IIIA Non-Oat Cell Lung Carcinoma Stage IIIA Non-Small Cell Carcinoma of Lung Stage IIIA Non-Small Cell Carcinoma of the Lung Stage IIIA Non-Small Cell Lung Cancer Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIA Non-Small Cell Lung Carcinoma stage IIIA non-small cell lung cancer Stage IIIA Lung Non-Small Cell Cancer AJCC v7 Stage IIIB includes: (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C9103 Neoplastic Process Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Stage IIIB Lung Non-Small Cell Cancer AJCC v7 C0278984 CTRP Stage III non-small cell lung cancer is divided into stages IIIA and IIIB. In stage IIIB, cancer has spread to lymph nodes above the collarbone or in the opposite side of the chest as the tumor. Also, (1) the tumor may be any size; (2) part of the lung (where the trachea joins the bronchus) or the whole ung may have collapsed or become inflamed; (3) there may be one or more separate tumors in any of the lobes of the lung with cancer; and/or (4) cancer may have spread to any of the following: main bronchus, diaphragm and the nerve that controls it, membrane around the lung, chest wall or the membrane that lines it, trachea, carina (where the trachea joins the bronchi), esophagus, sternum (chest bone), backbone, heart or the membrane around it, major blood vessels that lead to or from the heart, or the nerve that controls the larynx (voice box). OR in stage IIIB, cancer has spread to lymph nodes on the same side of the chest as the tumor. Also, (1) the tumor may be any size; (2) there may be separate tumors in different lobes of the same lung; and/or (3) cancer has spread to any of the following: trachea, carina, esophagus, sternum, backbone, major blood vessels that lead to or from the heart, or the nerve that controls the larynx. Malignant Stage_IIIB_Non-Small_Cell_Lung_Cancer Non Small Cell Lung Cancer Stage IIIB Non Small Cell Lung Cancer, Stage IIIB Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Stage IIIB NSCLC Stage IIIB Non-Oat Cell Carcinoma of Lung Stage IIIB Non-Oat Cell Carcinoma of the Lung Stage IIIB Non-Oat Cell Lung Carcinoma Stage IIIB Non-Small Cell Carcinoma of Lung Stage IIIB Non-Small Cell Carcinoma of the Lung Stage IIIB Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Stage IIIB Non-Small Cell Lung Carcinoma stage IIIB non-small cell lung cancer Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C9104 Neoplastic Process Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7 Stage 0 Lung Non-Small Cell Cancer AJCC v6 and v7 C0278986 CTRP Abnormal cells are found in the lining of the airways. These abnormal cells may become cancer and spread into nearby normal tissue. Malignant Stage_0_Non-Small_Cell_Lung_Cancer Lung Non-Small Cell Carcinoma in situ Non-Small Cell Carcinoma in situ of Lung Non-Small Cell Carcinoma in situ of the Lung Stage 0 Lung Non-Small Cell Cancer AJCC v6 and v7 Stage 0 NSCLC Stage 0 Non-Small Cell Carcinoma of Lung Stage 0 Non-Small Cell Carcinoma of the Lung Stage 0 Non-Small Cell Lung Cancer Stage 0 Non-Small Cell Lung Cancer AJCC v6 Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7 Stage 0 Non-Small Cell Lung Cancer AJCC v7 Stage 0 Non-Small Cell Lung Carcinoma stage 0 non-small cell lung carcinoma in situ Stage 0 Lung Non-Small Cell Cancer AJCC v6 and v7 Carcinoma, predominantly squamous cell, arising from the epithelial cells of the oropharynx. C9105 Neoplastic Process Oropharyngeal Carcinoma Oropharyngeal Carcinoma C2349952 CPTAC CTRP Cancer that forms in tissues of the oropharynx (the part of the throat at the back of the mouth, including the soft palate, the base of the tongue, and the tonsils). Most oropharyngeal cancers are squamous cell carcinomas (cancer that begins in flat cells lining the oropharynx). Malignant Oropharyngeal_Carcinoma Cancer of Oropharynx Cancer of the Oropharynx Carcinoma of Oropharynx Carcinoma of the Oropharynx Oropharyngeal Cancer Oropharyngeal Carcinoma Oropharyngeal Throat Cancer Oropharynx Carcinoma oropharyngeal cancer Oropharyngeal Carcinoma A carcinoma that arises from the urethra. Morphologically, the tumors are similar to those described in the bladder. C9106 Neoplastic Process Urethral Carcinoma Urethral Carcinoma C0700101 CPTAC CTRP A rare cancer that forms in tissues of the urethra (the tube through which urine empties the bladder and leaves the body). Types of urethral cancer include transitional cell carcinoma (cancer that begins in cells that can change shape and stretch without breaking apart), squamous cell carcinoma (cancer that begins in flat cells lining the urethra), and adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids). Malignant Urethral_Carcinoma Carcinoma of Urethra Carcinoma of the Urethra Urethra Carcinoma Urethral Cancer Urethral Carcinoma urethral cancer Urethral Carcinoma An advanced phase of chronic myeloid leukemia. It is characterized by: 1. the presence of blasts in the peripheral blood or bone marrow that are at least 20% of the peripheral blood white cells or of the nucleated cells in the bone marrow respectively, or 2. an extramedullary proliferation of blasts, and/or 3. when there are large aggregates and clusters of blasts in the bone marrow biopsy specimen (adapted from WHO, 2001). C9110 Neoplastic Process Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive C0005699 Cellosaurus A phase of chronic myelogenous leukemia in which 20% or more of the cells in the blood or bone marrow are blast cells (immature blood cells). When tiredness, fever, and an enlarged spleen occur during the blastic phase, it is called blast crisis. Malignant Blast_Phase_Chronic_Myelogenous_Leukemia Blast Phase CML Blast Phase Chronic Granulocytic Leukemia Blast Phase Chronic Myelocytic Leukemia Blast Phase Chronic Myelogenous Leukemia Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Blast Phase Chronic Myelogenous Leukemia, BCR::ABL1 Positive Blast Phase Chronic Myeloid Leukemia Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive Blast Phase Chronic Myeloid Leukemia, BCR::ABL1 Positive Blastic Phase CML Blastic Phase Chronic Granulocytic Leukemia Blastic Phase Chronic Myelocytic Leukemia Blastic Phase Chronic Myelogenous Leukemia Blastic Phase Chronic Myeloid Leukemia blast crisis blastic phase chronic myelogenous leukemia Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive Infiltration of the meninges by chronic myeloid leukemia, BCR-ABL1 positive. C9111 Neoplastic Process Meningeal Chronic Myeloid Leukemia, BCR-ABL1 Positive C0279083 Malignant Meningeal_Chronic_Myelogenous_Leukemia Meningeal Chronic Myelogenous Leukemia Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive Meningeal Chronic Myelogenous Leukemia, BCR::ABL1 Positive Meningeal Chronic Myeloid Leukemia Meningeal Chronic Myeloid Leukemia, BCR-ABL1 Positive Meningeal Chronic Myeloid Leukemia, BCR::ABL1 Positive Meningeal Chronic Myeloid Leukemia, BCR-ABL1 Positive A vascular sarcoma that commonly occurs in the lower extremities. It occurs predominantly in elderly male patients of southern European ancestry. It is characterized by the presence of purple, red-blue, or dark brown macular lesions, plaques and nodules. This disease is usually slow growing, although it can spread to the lungs and the gastrointestinal tract. If necessary, cutaneous lesions can be treated with radiation. C9112 Neoplastic Process Classic Kaposi Sarcoma Classic Kaposi Sarcoma C0279084 CTRP Malignant Classic_Kaposi_s_Sarcoma Classic Kaposi Sarcoma Classic Kaposi's Sarcoma Kaposi Sarcoma Classical Type Kaposi Sarcoma, Classic Kaposi's Sarcoma, Classical Type Classic Kaposi Sarcoma A Kaposi sarcoma that develops after immunosuppressive treatment. C9113 Neoplastic Process Kaposi Sarcoma Related to Immunosuppressive Treatment Kaposi Sarcoma Related to Immunosuppressive Treatment C0279085 CTRP Malignant Kaposi_s_Sarcoma_Related_to_Immunosuppressive_Treatment Immunosuppressive Treatment Related Kaposi Sarcoma Immunosuppressive Treatment Related Kaposi's Sarcoma Kaposi Sarcoma Related to Immunosuppressive Treatment Kaposi's Sarcoma Related to Immunosuppressive Treatment Kaposi Sarcoma Related to Immunosuppressive Treatment The reemergence of metastatic squamous cell carcinoma of unknown primary in the neck region after a period of remission. C9117 Neoplastic Process Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary Recurrent Neck Squamous Cell Carcinoma of Unknown Primary C1335714 CTRP Malignant Recurrent_Metastatic_Squamous_Cell_Carcinoma_to_the_Neck_with_Occult_Primary Recurrent Head and Neck Squamous Cell Carcinoma of Unknown Primary Recurrent Metastatic Epidermoid Carcinoma to the Neck with Occult Primary Recurrent Metastatic Squamous Cell Cancer to the Neck with Occult Primary Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary Recurrent Neck Squamous Cell CUP Recurrent Neck Squamous Cell Carcinoma of Unknown Primary Relapsed Metastatic Epidermoid Carcinoma to the Neck with Occult Primary Relapsed Metastatic Squamous Cell Carcinoma to the Neck with Occult Primary Recurrent Neck Squamous Cell Carcinoma of Unknown Primary A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma. C9118 Neoplastic Process Sarcoma Sarcoma C1261473 CDISC CPTAC CTRP Cellosaurus GDC NICHD PCDC A cancer of the bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. A malignant mesenchymal neoplasm. A general term for which the transformed cell type has not been specified. 8800/3 Malignant Sarcoma_of_the_Soft_Tissue_and_Bone 8800/3 Mesenchymal tumor, malignant Sarcoma Sarcoma, NOS Mesenchymal Tumor, Malignant Mesenchymal tumor, malignant SAR SARCOMA, MALIGNANT Sarcoma Sarcoma of Soft Tissue and Bone Sarcoma of the Soft Tissue and Bone Sarcoma, NOS Sarcoma, Not Otherwise Specified sarcoma Sarcoma An infiltrating breast carcinoma with a relatively favorable prognosis. It is an uncommon carcinoma, accounting for less than 1% of all infiltrating breast carcinomas. It is well circumscribed, with soft cut surface and often of considerable size. Microscopically, the predominant growth pattern is syncytial with broad anastomosing bands or sheets of malignant cells. The malignant cells are round with abundant cytoplasm and vesicular nuclei. The sheets of malignant cells are associated with a marked lymphoplasmacytic infiltrate. Glandular or tubular structures are absent. C9119 Neoplastic Process Breast Medullary Carcinoma Medullary Breast Carcinoma Breast Medullary Carcinoma C0860580 CTRP Cellosaurus GDC A rare type of breast cancer that often can be treated successfully. It is marked by lymphocytes (a type of white blood cell) in and around the tumor that can be seen when viewed under a microscope. 8512/3 Malignant Medullary_Breast_Carcinoma 8512/3 Medullary carcinoma with lymphoid stroma Breast Medullary Carcinoma Infiltrating Medullary Carcinoma of Breast Infiltrating Medullary Carcinoma of the Breast Invasive Medullary Breast Carcinoma Invasive Medullary Carcinoma of Breast Invasive Medullary Carcinoma of the Breast Medullary Breast Cancer Medullary Breast Carcinoma Medullary Breast Carcinoma with Lymphoid Stroma Medullary Carcinoma of Breast Medullary Carcinoma of the Breast Medullary carcinoma with lymphoid stroma medullary breast carcinoma Breast Medullary Carcinoma An infiltrating adenocarcinoma that arises from the epithelial cells of the pancreas. It affects males more often than females and the patients are usually over 50 years of age. Microscopically it is characterized by the presence of glandular (ductal) differentiation and desmoplastic stroma formation. Signs and symptoms include pain, loss of weight, and jaundice. It grows rapidly and is usually detected after it has metastasized to other anatomic sites. The prognosis is usually poor. C9120 Neoplastic Process Pancreatic Ductal Adenocarcinoma Pancreatic Ductal Adenocarcinoma C1335302 CTRP Cellosaurus Malignant Pancreatic_Ductal_Adenocarcinoma Ductal Adenocarcinoma of Pancreas Ductal Adenocarcinoma of the Pancreas PDA PDAC Pancreas Ductal Adenocarcinoma Pancreatic Ductal Adenocarcinoma Pancreatic Tubular Adenocarcinoma Pancreatic Ductal Adenocarcinoma A term that refers to the staging of renal cell cancer according to the American Joint Committee on Cancer, 7th edition. C91201 Neoplastic Process Renal Cell Cancer by AJCC v7 Stage C2984067 Malignant Renal Cell Cancer by AJCC v7 Stage Renal Cell Carcinoma by AJCC v7 Stage Renal Cell Cancer by AJCC v7 Stage A term that refers to the staging of bladder cancer according to the American Joint Committee on Cancer, 7th edition. C91202 Neoplastic Process Bladder Cancer by AJCC v7 Stage C2984068 Malignant Bladder Cancer by AJCC v7 Stage Bladder Carcinoma by AJCC v7 Stage Bladder Cancer by AJCC v7 Stage A term that refers to the staging of vulvar carcinoma according to the American Joint Committee on Cancer, 7th edition. C91203 Neoplastic Process Vulvar Cancer by AJCC v7 Stage C2984069 Malignant Vulvar Cancer by AJCC v7 Stage Vulvar Carcinoma by AJCC v7 Stage Vulvar Cancer by AJCC v7 Stage A term that refers to the staging of vaginal cancer according to the American Joint Committee on Cancer, 7th edition. C91204 Neoplastic Process Vaginal Cancer by AJCC v7 Stage C2984070 Malignant Vaginal Cancer by AJCC v7 Stage Vaginal Carcinoma by AJCC v7 Stage Vaginal Cancer by AJCC v7 Stage A term that refers to the staging of cervical cancer according to the American Joint Committee on Cancer, 7th edition. C91208 Neoplastic Process Cervical Cancer by AJCC v7 Stage C2984073 Malignant Cervical Cancer by AJCC v7 Stage Cervical Carcinoma by AJCC v7 Stage Cervical Cancer by AJCC v7 Stage Stage III includes: (T3, N0, M0); (T1, N1a, M0); (T2, N1a, M0); (T3, N1a, M0). T3: Tumor greater than 4 cm in greatest dimension and limited to the thyroid gland, or tumor of any size with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues). T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland. N0: No regional lymph node metastasis. N1a: Metastasis to pretracheal, paratracheal or prelaryngeal/Delphian lymph nodes (Level VI lymph nodes). M0: No distant metastasis. (AJCC 7th ed.) C9121 Neoplastic Process Stage III Thyroid Gland Follicular Carcinoma AJCC v7 Stage III Thyroid Gland Follicular Carcinoma AJCC v7 C0279178 CTRP Malignant Stage_III_Thyroid_Follicular_Carcinoma Stage III Follicular Carcinoma of Thyroid Stage III Follicular Carcinoma of Thyroid Gland Stage III Follicular Carcinoma of the Thyroid Stage III Follicular Carcinoma of the Thyroid Gland Stage III Follicular Thyroid Gland Carcinoma Stage III Thyroid Follicular Carcinoma Stage III Thyroid Gland Follicular Cancer Stage III Thyroid Gland Follicular Carcinoma Stage III Thyroid Gland Follicular Carcinoma AJCC v7 Stage III Thyroid Gland Follicular Carcinoma AJCC v7 A term that refers to the staging of uterine corpus cancer (carcinoma or carcinosarcoma) according to the American Joint Committee on Cancer, 7th edition. C91218 Neoplastic Process Uterine Corpus Cancer by AJCC v7 Stage C2984082 Malignant Uterine Corpus Cancer by AJCC v7 Stage Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage Uterine Corpus Cancer by AJCC v7 Stage A term that refers to the staging of fallopian tube carcinoma according to the American Joint Committee on Cancer, 7th edition. C91219 Neoplastic Process Fallopian Tube Cancer by AJCC v7 Stage C2984083 Malignant Fallopian Tube Cancer by AJCC v7 Stage Fallopian Tube Carcinoma by AJCC v7 Stage Fallopian Tube Cancer by AJCC v7 Stage Stage III includes: (T3, N0, M0); (T1, N1a, M0); (T2, N1a, M0); (T3, N1a, M0). T3: Tumor greater than 4 cm in greatest dimension and limited to the thyroid gland, or tumor of any size with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues). T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland. T2: Tumor more than 2 cm but not more than 4 cm in greatest dimension, limited to the thyroid gland. N0: No regional lymph node metastasis. N1a: Metastasis to pretracheal, paratracheal or prelaryngeal/Delphian lymph nodes (Level VI lymph nodes). M0: No distant metastasis. (AJCC 7th ed.) C9122 Neoplastic Process Stage III Thyroid Gland Papillary Carcinoma AJCC v7 Stage III Thyroid Gland Papillary Carcinoma AJCC v7 C1336275 CTRP Malignant Stage_III_Thyroid_Papillary_Carcinoma Stage III Papillary Carcinoma of Thyroid Stage III Papillary Carcinoma of Thyroid Gland Stage III Papillary Carcinoma of the Thyroid Stage III Papillary Carcinoma of the Thyroid Gland Stage III Papillary Thyroid Gland Carcinoma Stage III Thyroid Gland Papillary Cancer Stage III Thyroid Gland Papillary Carcinoma Stage III Thyroid Gland Papillary Carcinoma AJCC v7 Stage III Thyroid Papillary Carcinoma Stage III Thyroid Gland Papillary Carcinoma AJCC v7 A term that refers to the staging of esophageal carcinoma according to the American Joint Committee on Cancer, 7th edition. C91221 Neoplastic Process Esophageal Cancer by AJCC v7 Stage C2984085 Malignant Esophageal Cancer by AJCC v7 Stage Esophageal Carcinoma by AJCC v7 Stage Esophageal Cancer by AJCC v7 Stage A term that refers to the staging of gastric carcinoma according to the American Joint Committee on Cancer, 7th edition. C91222 Neoplastic Process Gastric Cancer by AJCC v7 Stage C2984086 Malignant Gastric Cancer by AJCC v7 Stage Gastric Carcinoma by AJCC v7 Stage Gastric Cancer by AJCC v7 Stage A term that refers to the staging of colorectal carcinoma according to the American Joint Committee on Cancer, 7th edition. C91223 Neoplastic Process Colorectal Cancer by AJCC v7 Stage C2984087 Malignant Colorectal Cancer by AJCC v7 Stage Colorectal Carcinoma by AJCC v7 Stage Colorectal Cancer by AJCC v7 Stage A term that refers to the staging of colon carcinoma according to the American Joint Committee on Cancer, 7th edition. C91224 Neoplastic Process Colon Cancer by AJCC v7 Stage C2984088 Malignant Colon Cancer by AJCC v7 Stage Colon Carcinoma by AJCC v7 Stage Colon Cancer by AJCC v7 Stage A term that refers to the staging of rectal carcinoma according to the American Joint Committee on Cancer, 7th edition. C91225 Neoplastic Process Rectal Cancer by AJCC v7 Stage C2984089 Malignant Rectal Cancer by AJCC v7 Stage Rectal Carcinoma by AJCC v7 Stage Rectal Cancer by AJCC v7 Stage A term that refers to the staging of rectosigmoid carcinoma according to the American Joint Committee on Cancer, 7th edition. C91226 Neoplastic Process Rectosigmoid Cancer by AJCC v7 Stage C2984090 Malignant Rectosigmoid Cancer by AJCC v7 Stage Rectosigmoid Carcinoma by AJCC v7 Stage Rectosigmoid Cancer by AJCC v7 Stage A term that refers to the staging of hepatocellular carcinoma according to the American Joint Committee on Cancer, 7th edition. C91228 Neoplastic Process Hepatocellular Carcinoma by AJCC v7 Stage C2984092 Malignant Hepatocellular Carcinoma by AJCC v7 Stage Hepatocellular Carcinoma by AJCC v7 Stage A term that refers to the staging of gallbladder cancer according to the American Joint Committee on Cancer, 7th edition. C91229 Neoplastic Process Gallbladder Cancer by AJCC v7 Stage C2984093 Malignant Gallbladder Cancer by AJCC v7 Stage Gallbladder Carcinoma by AJCC v7 Stage Gallbladder Cancer by AJCC v7 Stage A term that refers to the staging of breast cancer according to the American Joint Committee on Cancer, 7th edition. C91230 Neoplastic Process Breast Cancer by AJCC v7 Stage C2984094 Malignant Breast Cancer by AJCC v7 Stage Breast Carcinoma by AJCC v7 Stage Breast Cancer by AJCC v7 Stage A term that refers to the staging of cutaneous melanoma, following the rules of the TNM AJCC v7 classification system. C91231 Neoplastic Process Cutaneous Melanoma by AJCC v7 Stage C2984095 Malignant Cutaneous Melanoma by AJCC v7 Stage Cutaneous Melanoma by AJCC v7 Stage A term that refers to the staging of lung carcinoma according to the American Joint Committee on Cancer, 7th edition. C91232 Neoplastic Process Lung Cancer by AJCC v7 Stage C2984096 Malignant Lung Cancer by AJCC v7 Stage Lung Carcinoma by AJCC v7 Stage Lung Cancer by AJCC v7 Stage A term that refers to the staging of prostate carcinoma according to the American Joint Committee on Cancer, 7th edition. C91233 Neoplastic Process Prostate Cancer by AJCC v7 Stage C2984097 Malignant Prostate Cancer by AJCC v7 Stage Prostate Carcinoma by AJCC v7 Stage Prostate Cancer by AJCC v7 Stage A term that refers to the staging of penile carcinoma according to the American Joint Committee on Cancer, 7th edition. C91234 Neoplastic Process Penile Cancer by AJCC v7 Stage C2984098 Malignant Penile Cancer by AJCC v7 Stage Penile Carcinoma by AJCC v7 Stage Penile Cancer by AJCC v7 Stage A lymphoblastic lymphoma occurring in children. C9124 Neoplastic Process Childhood Lymphoblastic Lymphoma Childhood Lymphoblastic Lymphoma C0279525 CTRP NICHD A lymphoma occurring in children primarily derived from precursor T cells and less frequently precursor B cells. Malignant Childhood_Lymphoblastic_Lymphoma Childhood Lymphoblastic Lymphoma Childhood Precursor Lymphoblastic Lymphoma Lymphoblastic Lymphoma Pediatric Lymphoblastic Lymphoma Childhood Lymphoblastic Lymphoma A term that refers to the staging of nasopharyngeal carcinoma according to the American Joint Committee on Cancer, 7th edition. C91244 Neoplastic Process Nasopharyngeal Carcinoma by AJCC v7 Stage C2984108 Malignant Nasopharyngeal Carcinoma by AJCC v7 Stage Nasopharyngeal Carcinoma by AJCC v7 Stage A term that refers to the staging of oropharyngeal carcinoma according to the American Joint Committee on Cancer, 7th edition. C91248 Neoplastic Process Oropharyngeal Carcinoma by AJCC v7 Stage C2984110 Malignant Oropharyngeal Carcinoma by AJCC v7 Stage Oropharyngeal Carcinoma by AJCC v7 Stage Lymphocyte-depleted classic Hodgkin lymphoma occurring in adults. C9125 Neoplastic Process Adult Lymphocyte-Depleted Classic Hodgkin Lymphoma Adult Lymphocyte-Depleted Classic Hodgkin Lymphoma C0279540 CTRP Malignant Adult_Lymphocyte_Depleted_Hodgkin_s_Lymphoma Adult HDLD Adult LDHD Adult Lymphocyte Depleted Classical Hodgkin Lymphoma Adult Lymphocyte Depleted Hodgkin Lymphoma Adult Lymphocyte Depleted Hodgkin's Lymphoma Adult Lymphocyte Depletion Hodgkin's Disease Adult Lymphocyte-Depleted Classic Hodgkin Lymphoma Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma Lymphocyte-Depleted Classical Hodgkin Lymphoma Adult Lymphocyte-Depleted Classic Hodgkin Lymphoma A term that refers to the staging of hypopharyngeal carcinoma according to the American Joint Committee on Cancer, 7th edition. C91251 Neoplastic Process Hypopharyngeal Carcinoma by AJCC v7 Stage C2984113 Malignant Hypopharyngeal Carcinoma by AJCC v7 Stage Hypopharyngeal Carcinoma by AJCC v7 Stage A term that refers to the staging of pharyngeal carcinoma according to the American Joint Committee on Cancer, 7th edition. C91252 Neoplastic Process Pharyngeal Carcinoma by AJCC v7 Stage C2984114 Malignant Pharyngeal Carcinoma by AJCC v7 Stage Pharyngeal Carcinoma by AJCC v7 Stage A term that refers to the staging of nasal cavity and paranasal sinus carcinoma according to the American Joint Committee on Cancer, 7th edition. C91255 Neoplastic Process Sinonasal Cancer by AJCC v7 Stage C2984117 Malignant Nasal Cavity and Paranasal Sinus Cancer by AJCC v7 Stage Nasal Cavity and Paranasal Sinus Carcinoma by AJCC v7 Stage Sinonasal Cancer by AJCC v7 Stage Sinonasal Carcinoma by AJCC v7 Stage Sinonasal Cancer by AJCC v7 Stage A term that refers to the staging of laryngeal carcinoma according to the American Joint Committee on Cancer, 7th edition. C91256 Neoplastic Process Laryngeal Cancer by AJCC v7 Stage C2984118 Malignant Laryngeal Cancer by AJCC v7 Stage Laryngeal Carcinoma by AJCC v7 Stage Laryngeal Cancer by AJCC v7 Stage Nodular sclerosis classic Hodgkin lymphoma occurring in adults. C9126 Neoplastic Process Adult Nodular Sclerosis Classic Hodgkin Lymphoma Adult Nodular Sclerosis Classic Hodgkin Lymphoma C0279541 CTRP Malignant Adult_Nodular_Sclerosis_Hodgkin_s_Lymphoma Adult Hodgkin's Nodular Sclerosis Adult NSHD Adult Nodular Sclerosis Classic Hodgkin Lymphoma Adult Nodular Sclerosis Classical Hodgkin Lymphoma Adult Nodular Sclerosis Hodgkin Lymphoma Adult Nodular Sclerosis Hodgkin's Disease Adult Nodular Sclerosis Hodgkin's Lymphoma Nodular Sclerosis Classical Hodgkin Lymphoma Adult Nodular Sclerosis Classic Hodgkin Lymphoma Mixed cellularity classic Hodgkin lymphoma occurring in adults. C9127 Neoplastic Process Adult Mixed Cellularity Classic Hodgkin Lymphoma Adult Mixed Cellularity Classic Hodgkin Lymphoma C0279542 CTRP Malignant Adult_Mixed_Cellularity_Hodgkin_s_Lymphoma Adult MCHD Adult Mixed Cellularity Classic Hodgkin Lymphoma Adult Mixed Cellularity Classical Hodgkin Lymphoma Adult Mixed Cellularity Hodgkin Lymphoma Adult Mixed Cellularity Hodgkin's Disease Adult Mixed Cellularity Hodgkin's Lymphoma Mixed Cellularity Classical Hodgkin Lymphoma Adult Mixed Cellularity Classic Hodgkin Lymphoma A chronic myeloid leukemia characterized by the t(9;22)(q34;q11) chromosomal translocation, resulting in the presence of the Philadelphia chromosome and the BCR-ABL1 fusion gene. C9128 Neoplastic Process Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive C1292771 CTEP CTRP GDC Malignant Philadelphia_Chromosome_Positive_Chronic_Myelogenous_Leukemia 9875/3 Chronic granulocytic leukemia, BCR/ABL Chronic granulocytic leukemia, Philadelphia chromosome (Ph1) positive Chronic granulocytic leukemia, t(9;22)(q34;q11) Chronic myelogenous leukemia, Philadelphia chromosome (Ph 1) positive Chronic myelogenous leukemia, t(9;22)(q34;q11) CML - Philadelphia chromosome Chronic Myeloid Leukemia t(9;22) (q34;q11), BCR/ABL Positive Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR::ABL1 Positive Chronic granulocytic leukemia, BCR/ABL Chronic granulocytic leukemia, Philadelphia chromosome (Ph1) positive Chronic granulocytic leukemia, t(9;22)(q34;q11) Chronic myelogenous leukemia, Philadelphia chromosome (Ph 1) positive Chronic myelogenous leukemia, Philadelphia chromosome positive Chronic myelogenous leukemia, t(9;22)(q34;q11) Ph' Chromosome Positive Chronic Myelocytic Leukemia Ph' Chromosome Positive Chronic Myelogenous Leukemia Ph' Chromosome Positive Chronic Myeloid Leukemia Ph' Positive Chronic Granulocytic Leukemia Ph1 Chromosome Positive Chronic Myelocytic Leukemia Ph1 Chromosome Positive Chronic Myelogenous Leukemia Ph1 Chromosome Positive Chronic Myeloid Leukemia Ph1 Positive Chronic Granulocytic Leukemia Philadelphia Chromosome Positive CML Philadelphia Chromosome Positive Chronic Granulocytic Leukemia Philadelphia Chromosome Positive Chronic Myelocytic Leukemia Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Philadelphia Chromosome Positive Chronic Myeloid Leukemia Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia Philadelphia Chromosome Positive, BCR::ABL1 Positive Chronic Myelogenous Leukemia Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive A chronic myeloid leukemia that does not have the characteristic t(9;22)(q34;q11.2) translocation but it has either a variant translocation or a cryptic translocation that cannot be detected by conventional cytogenetic analysis. In such cases the BCR-ABL1 fusion gene is always detected by RT-PCR, FISH, or Southern blot analysis. C9129 Neoplastic Process Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Chronic Myeloid Leukemia, Philadelphia Chromosome Negative, BCR-ABL1 Positive C0279549 CTRP Malignant Philadelphia_Chromosome_Negative_Chronic_Myelogenous_Leukemia Chronic Myeloid Leukemia, Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myeloid Leukemia, Philadelphia Chromosome Negative, BCR::ABL1 Positive Ph Negative CML Ph Negative Chronic Myelogenous Leukemia Ph' Chromosome Negative Chronic Granulocytic Leukemia Ph' Chromosome Negative Chronic Myelocytic Leukemia Ph' Chromosome Negative Chronic Myeloid Leukemia Ph' Negative Chronic Granulocytic Leukemia Ph- CML Ph- Chronic Myelogenous Leukemia Ph1 Chromosome Negative Chronic Myelocytic Leukemia Ph1 Chromosome Negative Chronic Myelogenous Leukemia Philadelphia Chromosome Negative BCR-ABL1 Positive Chronic Myelogenous Leukemia Philadelphia Chromosome Negative CML Philadelphia Chromosome Negative Chronic Granulocytic Leukemia Philadelphia Chromosome Negative Chronic Myelocytic Leukemia Philadelphia Chromosome Negative Chronic Myelogenous Leukemia Philadelphia Chromosome Negative Chronic Myeloid Leukemia Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Philadelphia Chromosome Negative, BCR::ABL1 Positive Chronic Myelogenous Leukemia Chronic Myeloid Leukemia, Philadelphia Chromosome Negative, BCR-ABL1 Positive An aggressive malignant mesenchymal neoplasm arising from skeletal muscle in adults. C9130 Neoplastic Process Adult Rhabdomyosarcoma Adult Rhabdomyosarcoma C0279550 CTRP Malignant Adult_Rhabdomyosarcoma Adult Rhabdomyosarcoma Rhabdomyosarcoma Adult Rhabdomyosarcoma An invasive adenocarcinoma of the breast characterized by the presence of islands of small and uniform cells, surrounded by large amounts of mucin. Pure mucinous breast carcinomas generally have a favorable prognosis. C9131 Neoplastic Process Mucinous Breast Carcinoma Breast Mucinous Carcinoma C1334807 CTRP Malignant Mucinous_Breast_Carcinoma Breast Mucinous Carcinoma Colloid Breast Carcinoma Colloid Carcinoma of Breast Colloid Carcinoma of the Breast Infiltrating Colloid Breast Carcinoma Infiltrating Mucinous Breast Carcinoma Invasive Colloid Breast Carcinoma Invasive Mucinous Breast Carcinoma Mucinous Breast Cancer Mucinous Breast Carcinoma Mucinous Carcinoma of Breast Mucinous Carcinoma of the Breast Breast Mucinous Carcinoma An invasive breast carcinoma of no special type characterized by the presence of a predominant ductal carcinoma in situ component and a minor component of invasive carcinoma. C9132 Neoplastic Process Invasive Ductal Breast Carcinoma with Predominant Intraductal Component Invasive Breast Carcinoma of No Special Type with Predominant Intraductal Component C0279556 CTRP Malignant Invasive_Ductal_Breast_Carcinoma_with_Predominant_Intraductal_Component Infiltrating Ductal Breast Carcinoma with Predominant Intraductal Component Invasive Breast Carcinoma of No Special Type with Predominant Intraductal Component Invasive Breast Ductal Carcinoma with Predominant Intraductal Component Invasive Ductal Breast Carcinoma with Predominant Intraductal Component Invasive Breast Carcinoma of No Special Type with Predominant Intraductal Component An aggressive carcinoma with a poor prognosis characterized by a presence of both malignant squamous cells and glandular cells. C9133 Neoplastic Process Adenosquamous Lung Carcinoma Lung Adenosquamous Carcinoma C0279557 CTRP Cellosaurus Malignant Adenosquamous_Lung_Carcinoma Adenosquamous Cell Lung Carcinoma Adenosquamous Lung Cancer Adenosquamous Lung Carcinoma Lung Adenosquamous Carcinoma Lung Adenosquamous Carcinoma A breast carcinoma characterized by the formation of irregular, finger-like projections of fibrous stroma covered with neoplastic epithelial cells. C9134 Neoplastic Process Papillary Breast Carcinoma Breast Papillary Carcinoma C3812899 CTRP Malignant Papillary_Breast_Carcinoma Breast Papillary Carcinoma Papillary Breast Cancer Papillary Breast Carcinoma Papillary Carcinoma of Breast Papillary Carcinoma of the Breast Breast Papillary Carcinoma An invasive adenocarcinoma of the breast with a favorable prognosis. It is composed of tubular structures lined by a single layer of epithelium. C9135 Neoplastic Process Tubular Breast Carcinoma Breast Tubular Carcinoma C1328544 CTRP Malignant Tubular_Breast_Carcinoma Breast Tubular Carcinoma Infiltrating Tubular Breast Carcinoma Infiltrating Tubular Carcinoma of Breast Infiltrating Tubular Carcinoma of the Breast Invasive Tubular Breast Carcinoma Invasive Tubular Carcinoma of Breast Invasive Tubular Carcinoma of the Breast Tubular Breast Cancer Tubular Breast Carcinoma Tubular Carcinoma of Breast Tubular Carcinoma of the Breast Breast Tubular Carcinoma A breast carcinoma characterized by the presence of a predominant lobular carcinoma in situ component and a minor component of invasive carcinoma. C9136 Neoplastic Process Invasive Lobular Breast Carcinoma with Predominant In Situ Component Invasive Breast Lobular Carcinoma with Predominant In Situ Component C0279564 CTRP Malignant Invasive_Lobular_Breast_Carcinoma_with_Predominant_In_Situ_Component Infiltrating Lobular Breast Carcinoma with Predominant In Situ Component Invasive Breast Lobular Carcinoma with Predominant In Situ Component Invasive Lobular Breast Carcinoma with Predominant In Situ Component Invasive Breast Lobular Carcinoma with Predominant In Situ Component A morphologic variant of small cell lung carcinoma in combination with a non-small cell carcinoma. C9137 Neoplastic Process Combined Small Cell Lung Carcinoma Combined Lung Small Cell Carcinoma C0334240 CTRP GDC 8045/3 Malignant Combined_Type_Small_Cell_Lung_Carcinoma 8045/3 Combined small cell carcinoma Combined small cell-squamous cell carcinoma Mixed small cell carcinoma Combined Lung Small Cell Carcinoma Combined Small Cell Carcinoma Combined Small Cell Carcinoma of Lung Combined Small Cell Carcinoma of the Lung Combined Small Cell Lung Cancer Combined Small Cell Lung Carcinoma Combined Small Cell and Large Cell Lung Carcinoma Combined Small Cell-Adenocarcinoma Combined Small Cell-Large Carcinoma Combined Small and Large Cell Lung Cancer Combined Small and Large Cell Lung Carcinoma Combined Type Small Cell Carcinoma of Lung Combined Type Small Cell Carcinoma of the Lung Combined Type Small Cell Lung Carcinoma Mixed Small Cell and Large Cell Carcinoma of Lung Mixed Small Cell and Large Cell Carcinoma of the Lung Mixed Small Cell and Large Cell Lung Carcinoma Small Cell and Large Cell Carcinoma of Lung Small Cell and Large Cell Carcinoma of the Lung Small Cell and Large Cell Lung Carcinoma Combined Lung Small Cell Carcinoma A B acute lymphoblastic leukemia that occurs during childhood. C9140 Neoplastic Process Childhood B Acute Lymphoblastic Leukemia Childhood B Acute Lymphoblastic Leukemia C0279584 CTRP Cellosaurus NICHD A B acute lymphoblastic leukemia that occurs during childhood. Malignant Childhood_Precursor_B_Lymphoblastic_Leukemia B Acute Lymphoblastic Leukemia B Cell Childhood ALL B Cell Childhood Acute Lymphoblastic Leukemia B Cell Childhood Acute Lymphocytic Leukemia B Cell Pediatric ALL B Cell Pediatric Acute Lymphoblastic Leukemia B Cell Pediatric Acute Lymphocytic Leukemia B-Cell Childhood ALL B-Cell Childhood Acute Lymphoblastic Leukemia B-Cell Childhood Acute Lymphocytic Leukemia B-Cell Childhood Acute Lymphogenous Leukemia B-Cell Childhood Acute Lymphoid Leukemia B-Cell Pediatric ALL B-Cell Pediatric Acute Lymphoblastic Leukemia B-Cell Pediatric Acute Lymphocytic Leukemia B-Cell Pediatric Acute Lymphogenous Leukemia B-Cell Pediatric Acute Lymphoid Leukemia Childhood B Acute Lymphoblastic Leukemia Childhood B-ALL Childhood Precursor B-Lymphoblastic Leukemia Childhood B Acute Lymphoblastic Leukemia A T-acute lymphoblastic leukemia occurring in adults. C9142 Neoplastic Process Adult T Acute Lymphoblastic Leukemia Adult T Acute Lymphoblastic Leukemia C0279592 CTRP Cellosaurus Malignant Adult_Precursor_T_Lymphoblastic_Leukemia Adult Precursor T-Lymphoblastic Leukemia Adult T Acute Lymphoblastic Leukemia Adult T-Acute Lymphoblastic Leukemia Adult T-Cell Acute Lymphoblastic Leukemia T Acute Lymphoblastic Leukemia T Cell Adult ALL T-Cell Adult ALL T-Cell Adult Acute Lymphocytic Leukemia Adult T Acute Lymphoblastic Leukemia A B acute lymphoblastic leukemia that occurs during adulthood. C9143 Neoplastic Process Adult B Acute Lymphoblastic Leukemia Adult B Acute Lymphoblastic Leukemia C0279593 CTRP Cellosaurus Malignant Adult_Precursor_B_Lymphoblastic_Leukemia Adult B Acute Lymphoblastic Leukemia Adult B Cell ALL Adult B Cell Acute Lymphoblastic Leukemia Adult B Cell Acute Lymphocytic Leukemia Adult B-Cell ALL Adult B-Cell Acute Lymphoblastic Leukemia Adult B-Cell Acute Lymphocytic Leukemia Adult Precursor B-Lymphoblastic Leukemia B Acute Lymphoblastic Leukemia B Cell Adult ALL B Cell Adult Acute Lymphoblastic Leukemia B Cell Adult Acute Lymphocytic Leukemia B-Cell Adult ALL B-Cell Adult Acute Lymphoblastic Leukemia B-Cell Adult Acute Lymphocytic Leukemia Adult B Acute Lymphoblastic Leukemia A usually aggressive malignant bone-forming mesenchymal neoplasm, predominantly affecting adolescents and young adults. It usually involves bones and less frequently extraosseous sites. It often involves the long bones (particularly distal femur, proximal tibia, and proximal humerus). Pain with or without a palpable mass is the most frequent clinical symptom. It may spread to other anatomic sites, particularly the lungs. C9145 Neoplastic Process Osteosarcoma Osteosarcoma C0029463 CDISC CPTAC CTEP CTRP Cellosaurus GDC MedDRA NICHD A cancer of the bone that usually affects the large bones of the arm or leg. It occurs most commonly in young people and affects more males than females. A malignant neoplasm of connective tissue origin that produces bone or osteoid. A malignant neoplasm usually arising from bone. 9180/3 Malignant Osteosarcoma 9180/3 Osteogenic sarcoma, NOS Osteosarcoma Osteosarcoma (OS) Osteosarcoma, NOS OSTEOSARCOMA, MALIGNANT Osteogenic Sarcoma Osteosarcoma Osteosarcoma, NOS osteogenic sarcoma osteosarcoma Osteosarcoma Wilms tumor of the kidney characterized by the predominance of the epithelial component. The epithelial cells may form papillary and tubular patterns and pseudorosettes. C9146 Neoplastic Process Epithelial Predominant Kidney Wilms Tumor Epithelial Predominant Kidney Wilms Tumor C0279608 CTRP Malignant Epithelial_Predominant_Wilms_Tumor Epithelial Predominant Kidney Adenosarcoma Epithelial Predominant Kidney Nephroblastoma Epithelial Predominant Kidney Wilms Tumor Epithelial Predominant Renal Adenosarcoma Epithelial Predominant Renal Wilm's Tumor Epithelial Predominant Renal Wilms Tumor Epithelial Predominant Renal Wilms' Tumor Epithelial Predominant Wilms Tumor Epithelial Predominant Kidney Wilms Tumor Wilms tumor of the kidney characterized by the predominance of the blastema component. C9147 Neoplastic Process Blastema Predominant Kidney Wilms Tumor Blastema Predominant Kidney Wilms Tumor C0279609 CTRP Malignant Blastema_Predominant_Wilms_Tumor Blastema Predominant Kidney Adenosarcoma Blastema Predominant Kidney Wilms Tumor Blastema Predominant Nephroblastoma Blastema Predominant Renal Adenosarcoma Blastema Predominant Renal Wilm's Tumor Blastema Predominant Renal Wilms Tumor Blastema Predominant Renal Wilms' Tumor Blastema Predominant Wilms Tumor Blastema Predominant Kidney Wilms Tumor Wilms tumor of the kidney characterized by the predominance of the mesenchymal component. C9148 Neoplastic Process Stromal Predominant Kidney Wilms Tumor Stromal Predominant Kidney Wilms Tumor C0279610 CTRP Malignant Stromal_Predominant_Wilms_Tumor Stromal Predominant Kidney Adenosarcoma Stromal Predominant Kidney Wilms Tumor Stromal Predominant Nephroblastoma Stromal Predominant Renal Adenosarcoma Stromal Predominant Renal Wilm's Tumor Stromal Predominant Renal Wilms Tumor Stromal Predominant Renal Wilms' Tumor Stromal Predominant Wilms Tumor Stromal Predominant Kidney Wilms Tumor Wilms tumor of the kidney characterized by the presence of blastema, epithelial, and mesenchymal components (triphasic pattern) or a combination of two of them (biphasic pattern). C9149 Neoplastic Process Mixed Cell Type Kidney Wilms Tumor Mixed Cell Type Kidney Wilms Tumor C0279611 CTRP Malignant Mixed_Cell_Type_Wilms_Tumor Mixed Cell Type Kidney Adenosarcoma Mixed Cell Type Kidney Nephroblastoma Mixed Cell Type Kidney Wilms Tumor Mixed Cell Type Renal Adenosarcoma Mixed Cell Type Renal Wilm's Tumor Mixed Cell Type Renal Wilms Tumor Mixed Cell Type Renal Wilms' Tumor Mixed Cell Type Wilms Tumor Mixed Cell Type Kidney Wilms Tumor A morphologic variant of embryonal rhabdomyosarcoma arising from organs with a mucosal epithelial surface. It is characterized by the formation of a cambium layer in the affected tissue and polypoid nodules within an abundant myxoid stroma. C9150 Neoplastic Process Botryoid-Type Embryonal Rhabdomyosarcoma C1306573 GDC Malignant Botryoid-Type_Embryonal_Rhabdomyosarcoma 8910/3 Botryoid sarcoma Sarcoma botryoides Botryoid Sarcoma Botryoid sarcoma Botryoid-Type Embryonal Rhabdomyosarcoma Sarcoma Botryoides Sarcoma botryoides Botryoid-Type Embryonal Rhabdomyosarcoma A melanoma of the skin characterized by single cell infiltration of the papillary dermis by atypical melanocytes, in a background of lentigo maligna changes. C9151 Neoplastic Process Lentigo Maligna Melanoma Lentigo Maligna Melanoma C2739810 CTRP GDC 8742/3 Malignant Lentigo_Maligna_Melanoma 8742/3 Lentigo maligna melanoma Malignant melanoma in Hutchinson melanotic freckle LMM Lentigo Maligna Melanoma Lentigo maligna melanoma Malignant Lentigo Melanoma Melanoma in Hutchinson Melanotic Freckle Lentigo Maligna Melanoma A cutaneous melanoma that develops on sun-exposed sites with low cumulative sun damage (CSD). It typically occurs in light-skinned individuals ranging in age from young adults to the elderly. It arises from any cutaneous site, except the palms and soles. C9152 Neoplastic Process Low-CSD Melanoma C0334438 8743/3 Malignant Superficial_Spreading_Melanoma_of_the_Skin Low Degree of Cumulative Sun Damage Melanoma Low-CSD Melanoma Non-CSD Melanoma Low-CSD Melanoma An acute erythroid leukemia occurring in adults. C9153 Neoplastic Process Adult Acute Erythroid Leukemia Adult Acute Erythroid Leukemia C0279619 CTRP Malignant Adult_Acute_Erythroid_Leukemia Acute Erythroid Leukemia Adult Acute Erythroid Leukemia Adult Acute M6 Leukemia Adult Acute Erythroid Leukemia An acute myeloid leukemia occurring in adults. C9154 Neoplastic Process Adult Acute Myeloid Leukemia Adult Acute Myeloid Leukemia C0220615 CTRP Cellosaurus Malignant Adult_Acute_Myeloid_Leukemia Acute Myeloid Leukemia (AML) Adult AML Adult ANLL Adult Acute Myeloblastic Leukemia Adult Acute Myelogenous Leukemia Adult Acute Myeloid Leukemia Adult Acute Non-Lymphoblastic Leukemia Adult Acute NonLymphoblastic Leukemia Adult Acute Myeloid Leukemia An acute promyelocytic leukemia with t(15;17)(q24.1;q21.2); PML-RARA occurring in adults. C9155 Neoplastic Process Adult Acute Promyelocytic Leukemia with t(15;17)(q22;q12); PML-RARA Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA C0279625 CTRP Malignant Adult_Acute_Promyelocytic_Leukemia Acute Promyelocytic Leukemia with PML-RARA Adult APL Adult Acute M3 Leukemia Adult Acute Promyelocytic Leukemia Adult Acute Promyelocytic Leukemia (M3) Adult Acute Promyelocytic Leukemia with PML-RARA Adult Acute Promyelocytic Leukemia with PML::RARA Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2)(PML/RARa) Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA Fusion Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML/RARA Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML::RARA Fusion M3 Adult Acute Leukemia M3 Adult Acute Promyelocytic Leukemia Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA An acute monoblastic leukemia occurring in adults. C9156 Neoplastic Process Adult Acute Monoblastic Leukemia Adult Acute Monoblastic Leukemia C0279629 CTRP Malignant Adult_Acute_Poorly_Differentiated_Monoblastic_Leukemia Acute Monoblastic Leukemia Adult Acute M5a Leukemia Adult Acute Monoblastic Leukemia M5a Adult Acute Leukemia M5a Adult Acute Poorly Differentiated Monoblastic Leukemia Adult Acute Monoblastic Leukemia An adenocarcinoma of the stomach arising on a background of intestinal metaplasia. Microscopically, it is characterized by a glandular pattern and it closely resembles a colonic adenocarcinoma. C9157 Neoplastic Process Gastric Intestinal Type Adenocarcinoma Gastric Intestinal-Type Adenocarcinoma Gastric Intestinal-Type Adenocarcinoma C0279633 CPTAC CTRP Malignant Gastric_Intestinal_Type_Adenocarcinoma Gastric Intestinal Type Adenocarcinoma Gastric Intestinal-Type Adenocarcinoma Intestinal Intestinal Adenocarcinoma of Stomach Intestinal Adenocarcinoma of the Stomach Intestinal Gastric Adenocarcinoma Intestinal Stomach Adenocarcinoma Gastric Intestinal-Type Adenocarcinoma An acute myeloid leukemia without maturation occurring in children. C9158 Neoplastic Process Childhood Acute Myeloid Leukemia without Maturation Childhood Acute Myeloid Leukemia without Maturation C0279634 CTRP NICHD An acute myeloid leukemia without maturation occurring in children. Malignant Childhood_Acute_Myeloid_Leukemia_without_Maturation Acute Myeloid Leukemia (AML) without Maturation Childhood AML without Maturation Childhood Acute M1 Leukemia Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myeloblastic Leukemia without Maturation Childhood Acute Myelogenous Leukemia without Maturation Childhood Acute Myeloid Leukemia without Maturation M1 Childhood Acute Myeloblastic Leukemia without Maturation M1 Childhood Acute Myelogenous Leukemia without Maturation M1 Childhood Acute Myeloid Leukemia without Maturation M1 Pediatric Acute Myeloblastic Leukemia without Maturation M1 Pediatric Acute Myelogenous Leukemia M1 Pediatric Acute Myelogenous Leukemia without Maturation M1 Pediatric Acute Myeloid Leukemia without Maturation Pediatric AML without Maturation Pediatric Acute M1 Leukemia Pediatric Acute Myeloblastic Leukemia without Maturation Pediatric Acute Myelogenous Leukemia without Maturation Pediatric Acute Myeloid Leukemia without Maturation Childhood Acute Myeloid Leukemia without Maturation An adenocarcinoma arising from the stomach. Microscopically, it is characterized by the presence of a diffuse infiltrate, composed of individual adenocarcinoma cells or groups of adenocarcinoma cells in a fibrous or mucoid stroma. Many cells contain mucin droplets, producing a signet-ring configuration. C9159 Neoplastic Process Diffuse Gastric Adenocarcinoma Gastric Diffuse Adenocarcinoma Gastric Diffuse Adenocarcinoma C0279635 CPTAC CTRP Cellosaurus Malignant Diffuse_Gastric_Adenocarcinoma Adenocarcinoma of Linitis Plastica Type Adenocarcinoma of the Linitis Plastica Type Diffuse Diffuse Adenocarcinoma of Stomach Diffuse Adenocarcinoma of the Stomach Diffuse Gastric Adenocarcinoma Diffuse Stomach Adenocarcinoma Gastric Diffuse Adenocarcinoma Gastric Diffuse Adenocarcinoma Acute myeloid leukemia occurring in childhood. C9160 Neoplastic Process Childhood Acute Myeloid Leukemia (AML) Childhood Acute Myeloid Leukemia C0220621 CTRP Cellosaurus NICHD An acute myeloid leukemia occurring during childhood. Malignant Childhood_Acute_Myeloid_Leukemia Acute Myeloid Leukemia (AML) Childhood AML Childhood Acute Myeloblastic Leukemia Childhood Acute Myelogenous Leukemia Childhood Acute Myeloid Leukemia Pediatric AML Pediatric Acute Myeloblastic Leukemia Pediatric Acute Myelogenous Leukemia Pediatric Acute Myeloid Leukemia Childhood Acute Myeloid Leukemia A squamous cell carcinoma (SCC) arising from the anal canal or the anal margin (perianal skin). Human papillomavirus is detected in the majority of cases. Homosexual HIV-positive men have an increased risk of developing anal squamous cell carcinoma in comparison to the general male population. Symptoms include anal pruritus, discomfort when sitting, pain, change in bowel habit, and bleeding. The prognosis is generally better for anal margin SCC than for anal canal SCC. C9161 Neoplastic Process Anal Squamous Cell Carcinoma Anal Squamous Cell Carcinoma C1412036 CTEP CTRP Cellosaurus Malignant Anal_Squamous_Cell_Carcinoma Anal Squamous Cell Cancer Anal Squamous Cell Carcinoma Epidermoid Anal Carcinoma Epidermoid Carcinoma of Anus Epidermoid Carcinoma of the Anus Squamous Cell Anal Carcinoma Squamous Cell Carcinoma of Anus Squamous Cell Carcinoma of the Anus Squamous cell carcinoma - anus Squamous cell carcinoma of the anus Anal Squamous Cell Carcinoma An acute monoblastic leukemia occurring in children. C9162 Neoplastic Process Childhood Acute Monoblastic Leukemia Childhood Acute Monoblastic Leukemia C0279645 CTRP NICHD An acute monoblastic leukemia occurring during childhood. Malignant Childhood_Acute_Monoblastic_Leukemia_without_Differentiation Acute Monoblastic Leukemia Childhood Acute M5a Leukemia Childhood Acute Monoblastic Leukemia Childhood Acute Monoblastic Leukemia without Differentiation M5a Childhood Acute Monoblastic Leukemia without Differentiation M5a Pediatric Acute Monoblastic Leukemia without Differentiation Pediatric Acute M5a Leukemia Pediatric Acute Monoblastic Leukemia without Differentiation Childhood Acute Monoblastic Leukemia An acute monocytic leukemia occurring in children. C9163 Neoplastic Process Childhood Acute Monocytic Leukemia Childhood Acute Monocytic Leukemia C0279646 CTRP Cellosaurus NICHD An acute monocytic leukemia occurring during childhood. Malignant Childhood_Acute_Differentiated_Monocytic_Leukemia Acute Monocytic Leukemia Childhood Acute Differentiated Monocytic Leukemia (M5b) Childhood Acute M5b Leukemia Childhood Acute Monocytic Leukemia Childhood Acute Monocytic Leukemia with Differentiation M5b Childhood Acute Differentiated Monocytic Leukemia M5b Pediatric Acute Differentiated Monocytic Leukemia Pediatric Acute Differentiated Monocytic Leukemia Pediatric Acute M5b Leukemia Pediatric Acute Monocytic Leukemia with Differentiation Childhood Acute Monocytic Leukemia An acute erythroid leukemia occurring in children. C9164 Neoplastic Process Childhood Acute Erythroid Leukemia Childhood Acute Erythroid Leukemia C0279647 CTRP NICHD A subtype of acute myeloid leukemia occurring in children that involves the erythroid line. Malignant Childhood_Acute_Erythroid_Leukemia Acute Erythroid Leukemia Childhood Acute Erythroid Leukemia Childhood M6 Leukemia Pediatric Acute Erythroid Leukemia Pediatric M6 Leukemia Childhood Acute Erythroid Leukemia An adenocarcinoma arising from the gallbladder. It is the most common malignant tumor of the gallbladder and it is usually well to moderately differentiated. The incidence is higher in patients with gallstones than in patients without gallstones. Signs and symptoms usually present late in the course of the disease and are reminiscent of those of chronic cholecystitis including right upper quadrant pain. Histologic variants include adenocarcinoma of the intestinal type, clear cell adenocarcinoma, mucinous adenocarcinoma, papillary adenocarcinoma, and signet ring adenocarcinoma. C9166 Neoplastic Process Gallbladder Adenocarcinoma Gallbladder Adenocarcinoma C0279651 CTRP Cellosaurus Malignant Gallbladder_Adenocarcinoma Adenocarcinoma of Gallbladder Adenocarcinoma of the Gallbladder Gallbladder Adenocarcinoma Gallbladder Adenocarcinoma A carcinoma without evidence of differentiation arising from the gallbladder. The most common variant is the spindle and giant cell type which resembles a sarcoma. C9167 Neoplastic Process Undifferentiated Gallbladder Carcinoma Gallbladder Undifferentiated Carcinoma C0279653 CTRP Cellosaurus Malignant Undifferentiated_Gallbladder_Carcinoma Anaplastic Carcinoma of Gallbladder Anaplastic Carcinoma of the Gallbladder Anaplastic Gallbladder Carcinoma Gallbladder Undifferentiated Carcinoma Undifferentiated Carcinoma of Gallbladder Undifferentiated Carcinoma of the Gallbladder Undifferentiated Gallbladder Cancer Undifferentiated Gallbladder Carcinoma Gallbladder Undifferentiated Carcinoma An infiltrating adenocarcinoma arising from the rectum. It is characterized by the presence of malignant glandular cells with prominent intracytoplasmic mucin. These cells constitute more than 50% of the malignant cellular population. C9168 Neoplastic Process Rectal Signet Ring Cell Adenocarcinoma Rectal Signet Ring Cell Adenocarcinoma C0279654 CTRP Malignant Rectal_Signet_Ring_Cell_Adenocarcinoma Rectal Signet Ring Cell Adenocarcinoma Rectal Signet-Ring Cell Adenocarcinoma Signet Ring Adenocarcinoma of Rectum Signet Ring Adenocarcinoma of the Rectum Signet Ring Cell Adenocarcinoma of Rectum Signet Ring Cell Adenocarcinoma of the Rectum Rectal Signet Ring Cell Adenocarcinoma An infiltrating adenocarcinoma of the gallbladder characterized by the presence of metaplastic changes of the malignant glandular cells to squamous cells. C9169 Neoplastic Process Gallbladder Adenocarcinoma with Squamous Metaplasia Gallbladder Adenocarcinoma with Squamous Metaplasia C0279655 CTRP Malignant Gallbladder_Adenocarcinoma_with_Squamous_Metaplasia Adenocarcinoma of Gallbladder with Squamous Metaplasia Adenocarcinoma of the Gallbladder with Squamous Metaplasia Gallbladder Adenocarcinoma with Squamous Metaplasia Gallbladder Adenocarcinoma with Squamous Metaplasia A carcinoma that arises from the gallbladder. It is composed entirely by malignant squamous epithelial cells. C9170 Neoplastic Process Gallbladder Squamous Cell Carcinoma Gallbladder Squamous Cell Carcinoma C0279658 CTRP Malignant Gallbladder_Squamous_Cell_Carcinoma Epidermoid Carcinoma of Gallbladder Epidermoid Carcinoma of the Gallbladder Epidermoid Gallbladder Carcinoma Gallbladder Squamous Cell Cancer Gallbladder Squamous Cell Carcinoma Squamous Cell Carcinoma of Gallbladder Squamous Cell Carcinoma of the Gallbladder Squamous Cell Gallbladder Carcinoma Gallbladder Squamous Cell Carcinoma A malignant germ cell tumor arising from the testis. It is characterized by a mixture of embryonal carcinoma, yolk sac, and seminomatous morphologic elements. Patients may present with painless or painful testicular swelling. C9172 Neoplastic Process Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma C0279712 CTRP Malignant Mixed_Embryonal_Carcinoma_and_Yolk_Sac_Neoplasm_with_Seminoma_of_the_Testis Mixed Embryonal Carcinoma and Endodermal Sinus Neoplasm with Seminoma of Testis Mixed Embryonal Carcinoma and Endodermal Sinus Neoplasm with Seminoma of the Testis Mixed Embryonal Carcinoma and Endodermal Sinus Tumor with Seminoma of Testis Mixed Embryonal Carcinoma and Endodermal Sinus Tumor with Seminoma of the Testis Mixed Embryonal Carcinoma and Yolk Sac Neoplasm with Seminoma of Testis Mixed Embryonal Carcinoma and Yolk Sac Neoplasm with Seminoma of the Testis Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma of Testis Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma of the Testis Testicular Mixed Embryonal Carcinoma and Endodermal Sinus Tumor with Seminoma Testicular Mixed Embryonal Carcinoma and Yolk Sac Neoplasm with Seminoma Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma A malignant germ cell tumor arising from the testis. It is characterized by a mixture of choriocarcinoma and seminomatous morphologic elements. Patients may present with painless or painful testicular swelling. C9173 Neoplastic Process Testicular Mixed Choriocarcinoma and Seminoma Testicular Mixed Choriocarcinoma and Seminoma C0279720 CTRP Malignant Testicular_Mixed_Choriocarcinoma_and_Seminoma Mixed Choriocarcinoma and Seminoma of Testis Mixed Choriocarcinoma and Seminoma of the Testis Testicular Mixed Choriocarcinoma and Seminoma Testicular Mixed Choriocarcinoma and Seminoma An angiosarcoma occurring in childhood. C9174 Neoplastic Process Childhood Angiosarcoma Childhood Angiosarcoma C0279988 CTRP NICHD An angiosarcoma occurring during childhood. Malignant Childhood_Angiosarcoma Angiosarcoma Childhood Angiosarcoma Childhood Hemangiosarcoma Pediatric Angiosarcoma Pediatric Hemangiosarcoma Childhood Angiosarcoma An intraepithelial squamous cell carcinoma that arises from the external auditory canal without evidence of invasion. C91741 Neoplastic Process External Auditory Canal Squamous Cell Carcinoma In Situ CL1922348 Malignant External Auditory Canal Squamous Cell Carcinoma In Situ Squamous Cell Carcinoma In Situ of the External Auditory Canal External Auditory Canal Squamous Cell Carcinoma In Situ Gestational trophoblastic tumor that is confined to the site in which it initially manifested. C9176 Neoplastic Process Non-Metastatic Gestational Trophoblastic Tumor Non-Metastatic Gestational Trophoblastic Tumor C0280478 CTRP Undetermined Non-Metastatic_Gestational_Trophoblastic_Tumor Non-Metastatic GTT Non-Metastatic Gestational Trophoblastic Neoplasm Non-Metastatic Gestational Trophoblastic Tumor Nonmetastatic Gestational Trophoblastic Tumor Non-Metastatic Gestational Trophoblastic Tumor Metastatic gestational trophoblastic tumor in which risk factors are absent. C9177 Neoplastic Process Good Prognosis Metastatic Gestational Trophoblastic Tumor Good Prognosis Metastatic Gestational Trophoblastic Tumor C0280479 CTRP Malignant Good_Prognosis_Metastatic_Gestational_Trophoblastic_Tumor Good Prognosis Metastatic Gestational Trophoblastic Tumor Good Prognosis Metastatic Gestational Trophoblastic Tumor Metastatic gestational trophoblastic tumor in which risk factors are present. C9178 Neoplastic Process Poor Prognosis Metastatic Gestational Trophoblastic Tumor Poor Prognosis Metastatic Gestational Trophoblastic Tumor C0280481 CTRP Malignant Poor_Prognosis_Metastatic_Gestational_Trophoblastic_Tumor Poor Prognosis Metastatic Gestational Trophoblastic Tumor Poor Prognosis Metastatic Gestational Trophoblastic Tumor Stage IV includes: IVA (T4, Any N, M0); IVB (Any T, Any N, M1). T4: Tumor involves bladder or rectum. M0: No distant metastasis. M1: Distal metastasis (excluding adnexa, pelvic and abdominal tissues). This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.) C9179 Neoplastic Process Stage IV Uterine Sarcoma AJCC v7 Stage IV Uterine Sarcoma AJCC v7 C0280627 CTRP Stage IV uterine sarcoma is divided into stages IVA and IVB. In stage IVA, cancer has spread to the bladder and/or bowel wall. In stage IVB, cancer has spread to other parts of the body beyond the pelvis, including lymph nodes in the abdomen and groin. Malignant Stage_IV_Uterine_Sarcoma Stage IV Uterine Sarcoma Stage IV Uterine Sarcoma AJCC v7 stage IV uterine sarcoma Stage IV Uterine Sarcoma AJCC v7 An aggressive malignant mixed epithelial and mesenchymal tumor that arises from the uterine corpus. It usually affects elderly postmenopausal women and presents with vaginal bleeding. It is characterized by the presence of a malignant epithelial component that is usually glandular and a sarcomatous component. C9180 Neoplastic Process Uterine Corpus Carcinosarcoma Uterine Corpus Carcinosarcoma C1704376 CTRP Malignant Uterine_Corpus_Malignant_Mixed_Mesodermal_Mullerian_Tumor Carcinosarcoma of Corpus Uteri Carcinosarcoma of Uterine Body Carcinosarcoma of Uterine Corpus Carcinosarcoma of the Corpus Uteri Carcinosarcoma of the Uterine Body Carcinosarcoma of the Uterine Corpus Corpus Uteri Malignant Mixed Mesodermal Tumor Malignant Mixed Mesodermal Neoplasm of Uterine Body Malignant Mixed Mesodermal Neoplasm of Uterine Corpus Malignant Mixed Mesodermal Neoplasm of the Uterine Body Malignant Mixed Mesodermal Neoplasm of the Uterine Corpus Malignant Mixed Mesodermal Tumor of Uterine Body Malignant Mixed Mesodermal Tumor of Uterine Corpus Malignant Mixed Mesodermal Tumor of the Uterine Body Malignant Mixed Mesodermal Tumor of the Uterine Corpus Uterine Body Carcinosarcoma Uterine Body Malignant Mixed Mesodermal Neoplasm Uterine Body Malignant Mixed Mesodermal Tumor Uterine Corpus Carcinosarcoma Uterine Corpus Malignant Mixed Mesodermal (Mullerian) Tumor Uterine Corpus Malignant Mixed Mesodermal (Müllerian) Tumor Uterine Corpus Malignant Mixed Mesodermal Neoplasm Uterine Corpus Malignant Mixed Mesodermal Tumor Uterine Corpus Malignant Mixed Mullerian Neoplasm Uterine Corpus Malignant Mixed Mullerian Tumor Uterine Corpus Malignant Mixed Müllerian Neoplasm Uterine Corpus Malignant Mixed Müllerian Tumor Uterine Corpus Carcinosarcoma An insidious, locally aggressive, poorly circumscribed neoplasm arising from the deep soft tissues. It is characterized by the presence of elongated spindle-shaped fibroblasts, collagenous stroma formation, and an infiltrative growth pattern. It lacks metastatic potential. C9182 Neoplastic Process Deep Fibromatosis/Desmoid Tumor Desmoid Fibromatosis C0079218 CTRP GDC A tumor of the tissue that surrounds muscles, usually in the abdomen. A desmoid tumor rarely metastasizes (spreads to other parts of the body). 8821/1 Undetermined Deep_Fibromatosis_Desmoid_Tumor 8821/1 Aggressive fibromatosis Desmoid, NOS Invasive fibroma Aggressive Fibromatosis Aggressive fibromatosis Deep Fibromatosis Deep Fibromatosis/Desmoid Tumor Desmoid Fibromatosis Desmoid Tumor Desmoid-Type Fibromatosis desmoid tumor Desmoid Fibromatosis A solitary fibrous tumor, grade 3 that arises from the brain and occurs in adults. C9183 Neoplastic Process Malignant Adult Intracranial Hemangiopericytoma Adult Central Nervous System Solitary Fibrous Tumor, Grade 3 C1334558 CTRP Malignant Malignant_Adult_Intracranial_Hemangiopericytoma Adult CNS Solitary Fibrous Tumor, Grade 3 Adult Central Nervous System Solitary Fibrous Tumor, Grade 3 Adult Intracranial Anaplastic Hemangiopericytoma Adult Intracranial Malignant Hemangiopericytoma Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3 Adult Malignant Intracranial Hemangiopericytoma Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3 Malignant Adult Intracranial Hemangiopericytoma Adult Central Nervous System Solitary Fibrous Tumor, Grade 3 A non-Hodgkin lymphoma that arises within the eyeball. C9184 Neoplastic Process Intraocular Lymphoma Primary Intraocular Non-Hodgkin Lymphoma C0730306 CTRP Malignant Intraocular_Lymphoma Intraocular Lymphoma PIOL Primary Intraocular Lymphoma Primary Intraocular Non-Hodgkin Lymphoma Primary Intraocular Non-Hodgkin Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C9185 Neoplastic Process Ann Arbor Stage I Childhood Burkitt Lymphoma Ann Arbor Stage I Childhood Burkitt Lymphoma C0281700 CTRP Malignant Stage_I_Childhood_Burkitt_s_Lymphoma Ann Arbor Stage I Childhood Burkitt Lymphoma Childhood Small Non-Cleaved Cell Lymphoma Stage I Pediatric Small Non-Cleaved Cell Lymphoma Stage I Stage I Burkitt Lymphoma Stage I Childhood Burkitt Lymphoma Stage I Childhood Burkitt's Lymphoma Stage I Childhood Small Non-Cleaved Cell Lymphoma Stage I Pediatric Small Non-Cleaved Cell Lymphoma Ann Arbor Stage I Childhood Burkitt Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C9186 Neoplastic Process Ann Arbor Stage II Childhood Burkitt Lymphoma Ann Arbor Stage II Childhood Burkitt Lymphoma C0281702 CTRP Malignant Stage_II_Childhood_Burkitt_s_Lymphoma Ann Arbor Stage II Childhood Burkitt Lymphoma Childhood Small Non-Cleaved Cell Lymphoma Stage II Pediatric Small Non-Cleaved Cell Lymphoma Stage II Stage II Burkitt Lymphoma Stage II Childhood Burkitt Lymphoma Stage II Childhood Burkitt's Lymphoma Stage II Childhood Small Non-Cleaved Cell Lymphoma Stage II Pediatric Small Non-Cleaved Cell Lymphoma Ann Arbor Stage II Childhood Burkitt Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C9187 Neoplastic Process Ann Arbor Stage III Childhood Burkitt Lymphoma Ann Arbor Stage III Childhood Burkitt Lymphoma C0281704 CTRP Malignant Stage_III_Childhood_Burkitt_s_Lymphoma Ann Arbor Stage III Childhood Burkitt Lymphoma Childhood Small Non-Cleaved Cell Lymphoma Stage III Pediatric Small Non-Cleaved Cell Lymphoma Stage III Stage III Burkitt Lymphoma Stage III Childhood Burkitt Lymphoma Stage III Childhood Burkitt's Lymphoma Stage III Childhood Small Non-Cleaved Cell Lymphoma Stage III Pediatric Small Non-Cleaved Cell Lymphoma Ann Arbor Stage III Childhood Burkitt Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C9188 Neoplastic Process Ann Arbor Stage IV Childhood Burkitt Lymphoma Ann Arbor Stage IV Childhood Burkitt Lymphoma C0281706 CTRP Malignant Stage_IV_Childhood_Burkitt_s_Lymphoma Ann Arbor Stage IV Childhood Burkitt Lymphoma Childhood Small Non-Cleaved Cell Lymphoma Stage IV Pediatric Small Non-Cleaved Cell Lymphoma Stage IV Stage IV Burkitt Lymphoma Stage IV Childhood Burkitt Lymphoma Stage IV Childhood Burkitt's Lymphoma Stage IV Childhood Small Non-Cleaved Cell Lymphoma Stage IV Pediatric Small Non-Cleaved Cell Lymphoma Ann Arbor Stage IV Childhood Burkitt Lymphoma The reemergence of Burkitt lymphoma in childhood after a period of remission. C9189 Neoplastic Process Recurrent Childhood Burkitt Lymphoma Recurrent Childhood Burkitt Lymphoma C0281708 CTRP Malignant Recurrent_Childhood_Burkitt_s_Lymphoma Recurrent Burkitt Lymphoma Recurrent Childhood Burkitt Lymphoma Recurrent Childhood Burkitt's Lymphoma Recurrent Childhood Small Non-Cleaved Cell Lymphoma Recurrent Pediatric Small Non-Cleaved Cell Lymphoma Relapsed Childhood Small Non-Cleaved Cell Lymphoma Relapsed Pediatric Small Non-Cleaved Cell Lymphoma Recurrent Childhood Burkitt Lymphoma The reemergence of brain stem glioma in childhood after a period of remission. C9190 Neoplastic Process Recurrent Childhood Brain Stem Glioma Recurrent Childhood Brain Stem Glioma C0338329 CTRP Undetermined Recurrent_Childhood_Brain_Stem_Glioma Recurrent Brain Stem Glioma Recurrent Childhood Brain Stem Glioma Recurrent Childhood Brainstem Glioma Recurrent Childhood Glioma of Brain Stem Recurrent Childhood Glioma of Brainstem Recurrent Childhood Glioma of the Brain Stem Recurrent Childhood Glioma of the Brainstem Recurrent Pediatric Brain Stem Glioma Recurrent Pediatric Brainstem Glioma Recurrent Pediatric Glioma of Brain Stem Recurrent Pediatric Glioma of Brainstem Recurrent Pediatric Glioma of the Brain Stem Recurrent Pediatric Glioma of the Brainstem Relapsed Childhood Brain Stem Glioma Relapsed Childhood Brainstem Glioma Relapsed Childhood Glioma of Brain Stem Relapsed Childhood Glioma of Brainstem Relapsed Childhood Glioma of the Brain Stem Relapsed Childhood Glioma of the Brainstem Relapsed Pediatric Brain Stem Glioma Relapsed Pediatric Brainstem Glioma Relapsed Pediatric Glioma of Brain Stem Relapsed Pediatric Glioma of Brainstem Relapsed Pediatric Glioma of the Brain Stem Relapsed Pediatric Glioma of the Brainstem Recurrent Childhood Brain Stem Glioma The reemergence of cerebral astrocytoma in childhood after a period of remission. C9191 Neoplastic Process Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Cerebral Astrocytoma C0338339 CTRP Undetermined Recurrent_Childhood_Cerebral_Astrocytoma Recurrent Cerebral Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Cerebral Astrocytoma A highly aggressive malignant neoplasm arising from the ovary. Morphologically, it is a high grade tumor, composed of carcinomatous and sarcomatous elements. C9192 Neoplastic Process Ovarian Carcinosarcoma Ovarian Carcinosarcoma C0392998 CTRP Cellosaurus Malignant Ovarian_Malignant_Mixed_Mesodermal_Mullerian_Tumor Carcinosarcoma of Ovary Carcinosarcoma of the Ovary Malignant Mixed Mesodermal Mullerian Neoplasm of Ovary Malignant Mixed Mesodermal Mullerian Neoplasm of the Ovary Malignant Mixed Mesodermal Mullerian Tumor of Ovary Malignant Mixed Mesodermal Mullerian Tumor of the Ovary Malignant Mixed Mesodermal Müllerian Neoplasm of Ovary Malignant Mixed Mesodermal Müllerian Neoplasm of the Ovary Malignant Mixed Mesodermal Müllerian Tumor of Ovary Malignant Mixed Mesodermal Müllerian Tumor of the Ovary Ovarian Carcinosarcoma Ovarian MMMT Ovarian Malignant Mesodermal (Mullerian) Mixed Tumor Ovarian Malignant Mesodermal (Müllerian) Mixed Tumor Ovarian Malignant Mixed Mesodermal (Mullerian) Tumor Ovarian Malignant Mixed Mesodermal (Müllerian) Tumor Ovarian Malignant Mixed Mesodermal Mullerian Neoplasm Ovarian Malignant Mixed Mesodermal Mullerian Tumor Ovarian Malignant Mixed Mesodermal Müllerian Neoplasm Ovarian Malignant Mixed Mesodermal Müllerian Tumor Ovarian Malignant Mixed Mullerian Neoplasm Ovarian Malignant Mixed Mullerian Tumor Ovarian Malignant Mixed Müllerian Neoplasm Ovarian Malignant Mixed Müllerian Tumor Ovarian Carcinosarcoma Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ) C9193 Neoplastic Process Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma C0677696 Obsolete_Concept CTRP Malignant Stage_II_Contiguous_Adult_Burkitt_s_Lymphoma Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma Stage II Burkitt Lymphoma Stage II Contiguous Adult Burkitt Lymphoma Stage II Contiguous Adult Burkitt's Lymphoma Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ) C9194 Neoplastic Process Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma C0677701 CTRP Malignant Stage_II_Grade_1_Non-Contiguous_Follicular_Lymphoma Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma Non-Contiguous Follicular Small Cleaved Cell Lymphoma Stage II Non-Contiguous Grade I Follicular Lymphoma Stage II Non-Contiguous Grade I Follicular Small Cleaved Cell Lymphoma Stage II Non-Contiguous Stage II Follicular Small Cleaved Cell Lymphoma Non-Contiguous Stage II Grade I Follicular Lymphoma Non-Contiguous Stage II Grade I Follicular Small Cleaved Cell Lymphoma Stage II Grade 1 Follicular Lymphoma Stage II Grade 1 Non-Contiguous Follicular Lymphoma Stage II Non-Contiguous Follicular Small Cleaved Cell Lymphoma Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ) C9195 Neoplastic Process Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma C0677702 CTRP Malignant Stage_II_Grade_2_Non-Contiguous_Follicular_Lymphoma Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma Non-Contiguous Follicular Mixed Cell Lymphoma Stage II Non-Contiguous Grade II Follicular Lymphoma Stage II Non-Contiguous Grade II Follicular Mixed Cell Lymphoma Stage II Non-Contiguous Stage II Follicular Mixed Cell Lymphoma Non-Contiguous Stage II Grade II Follicular Lymphoma Non-Contiguous Stage II Grade II Follicular Mixed Cell Lymphoma Stage II Grade 2 Follicular Lymphoma Stage II Grade 2 Non-Contiguous Follicular Lymphoma Stage II Non-Contiguous Follicular Mixed Cell Lymphoma Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ) C9196 Neoplastic Process Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma C0677703 CTRP Malignant Stage_II_Grade_3_Non-Contiguous_Follicular_Lymphoma Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma Non-Contiguous Follicular Large Cell Lymphoma Stage II Non-Contiguous Grade III Follicular Large Cell Lymphoma Stage II Non-Contiguous Grade III Follicular Lymphoma Stage II Non-Contiguous Stage II Follicular Large Cell Lymphoma Non-Contiguous Stage II Grade III Follicular Large Cell Lymphoma Non-Contiguous Stage II Grade III Follicular Lymphoma Stage II Grade 3 Follicular Lymphoma Stage II Grade 3 Non-Contiguous Follicular Lymphoma Stage II Non-Contiguous Follicular Large Cell Lymphoma Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ) C9198 Neoplastic Process Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma C0677705 CTRP Malignant Stage_II_Non-Contiguous_Mantle_Cell_Lymphoma Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma Non-Contiguous Mantle Cell Lymphoma Stage II Non-Contiguous Stage II Mantle Cell Lymphoma Stage II Mantle Cell Lymphoma Stage II Non-Contiguous Mantle Cell Lymphoma Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (from PDQ) C9200 Neoplastic Process Stage II Non-Contiguous Adult Burkitt Lymphoma Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma C0677710 Obsolete_Concept CTRP Malignant Stage_II_Non-Contiguous_Adult_Burkitt_s_Lymphoma Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma Stage II Burkitt Lymphoma Stage II Non-Contiguous Adult Burkitt Lymphoma Stage II Non-Contiguous Adult Burkitt's Lymphoma Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C9202 Neoplastic Process Ann Arbor Stage II Mantle Cell Lymphoma Ann Arbor Stage II Mantle Cell Lymphoma C0677745 CTRP Malignant Stage_II_Mantle_Cell_Lymphoma Ann Arbor Stage II Mantle Cell Lymphoma Mantle Cell Lymphoma Stage II Stage II Mantle Cell Lymphoma Ann Arbor Stage II Mantle Cell Lymphoma Stage I includes: I (T1, N0, M0); IA (T1a, N0, M0); IA1 (T1a1, N0, M0); IA2 (T1a2, N0, M0); IB (T1b, N0, M0); IB1(T1b1, N0, M0); IB2 (T1b2, N0, M0). T1: Cervical carcinoma confined to uterus (extension to corpus should be disregarded). T1a: Invasive carcinoma diagnosed only by microscopy. Stromal invasion with a maximum depth of 5.0 mm measured from the base of the epithelium and a horizontal spread of 7.0 mm or less. Vascular space involvement, venous or lymphatic, does not affect classification. T1a1: Measured stromal invasion 3.0 mm or less in depth and 7.0 or less horizontal spread. T1a2: Measured stromal invasion more than 3.0mm and not more than 5.0 mm with a horizontal spread 7.0mm or less. T1b: Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a/IA2. T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C9204 Neoplastic Process Stage I Cervical Cancer AJCC v6 and v7 Stage I Cervical Cancer AJCC v6 and v7 C0278575 CTRP Cancer is found in the cervix only. Stage I is divided into stages IA and IB, based on the amount of cancer that is found. In stage IA, a very small amount of cancer that can only be seen with a microscope is found in the tissues of the cervix. The cancer is not deeper than 5 millimeters and not wider than 7 millimeters. In stage IB, the cancer is still within the cervix and either (1) can only be seen with a microscope and is deeper than 5 millimeters or wider than 7 millimeters; or (2) can be seen without a microscope and may be larger than 4 centimeters. Malignant Stage_I_Cervical_Cancer AJCC Stage I Cervical Cancer Cervical Cancer Stage I Cervical Carcinoma Stage I FIGO Stage I Carcinoma of Cervix FIGO Stage I Carcinoma of Cervix Uteri FIGO Stage I Carcinoma of Uterine Cervix FIGO Stage I Carcinoma of the Cervix FIGO Stage I Carcinoma of the Cervix Uteri FIGO Stage I Carcinoma of the Uterine Cervix FIGO Stage I Cervical Carcinoma FIGO Stage I Cervix Carcinoma FIGO Stage I Cervix Uteri Carcinoma FIGO Stage I Uterine Cervix Carcinoma Stage I Cervical Cancer Stage I Cervical Cancer AJCC v6 Stage I Cervical Cancer AJCC v6 and v7 Stage I Cervical Cancer AJCC v7 Uterine Cervix Cancer Stage I stage I cancer of the cervix Stage I Cervical Cancer AJCC v6 and v7 Stage III includes: III (T3, N0, M0); IIIA (T3a, N0, M0); IIIB (T1, N1, M0), (T2, N1, M0), (T3a, N1, M0), (T3b, Any N, M0). T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3a: Tumor involves lower third of vagina, no extension to pelvic wall. T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non functioning kidney. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C9205 Neoplastic Process Stage III Cervical Cancer AJCC v6 and v7 Stage III Cervical Cancer AJCC v6 and v7 C0278577 CTRP Cancer has spread to the lower third of the vagina and may have spread to the pelvic wall (the tissues that line the part of the body between the hips), and nearby lymph nodes. Stage III is divided into stages IIIA and IIIB, based on now far the cancer has spread. In stage IIIA, cancer has spread to the lower third of the vagina but not to the pelvic wall. In stage IIIB, cancer has spread to the pelvic wall and/or the tumor has become large enough to block the ureters (the tubes that connect the kidneys to the bladder). This blockage can cause the kidneys to enlarge or stop working. Cancer may also have spread to lymph nodes in the pelvis. Malignant Stage_III_Cervical_Cancer Cervical Cancer Stage III Cervical Carcinoma Stage III FIGO Stage III Carcinoma of Cervix FIGO Stage III Carcinoma of Cervix Uteri FIGO Stage III Carcinoma of Uterine Cervix FIGO Stage III Carcinoma of the Cervix FIGO Stage III Carcinoma of the Cervix Uteri FIGO Stage III Carcinoma of the Uterine Cervix FIGO Stage III Cervical Carcinoma FIGO Stage III Cervix Carcinoma FIGO Stage III Cervix Uteri Carcinoma FIGO Stage III Uterine Cervix Carcinoma Stage III Cervical Cancer Stage III Cervical Cancer AJCC v6 Stage III Cervical Cancer AJCC v6 and v7 Stage III Cervical Cancer AJCC v7 stage III cancer of the cervix Stage III Cervical Cancer AJCC v6 and v7 Stage IV includes: IVA: (T4, Any N, M0); IVB (Any T, Any N, MI). T4: Tumor invades mucosa of bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4). M1: Distant metastasis. (AJCC 6th and 7th eds.) C9206 Neoplastic Process Stage IV Cervical Cancer AJCC v6 and v7 Stage IV Cervical Cancer AJCC v6 and v7 C0278578 CTRP Cancer has spread to the bladder, rectum, or other parts of the body. Stage IV is divided into stages IVA and IVB. In stage IVA, cancer has spread to the bladder or rectal wall and may have spread to lymph nodes in the pelvis. In stage IVB, cancer has spread beyond the pelvis and pelvic lymph nodes to other places in the body, such as the abdomen, liver, intestinal tract, or lungs. Malignant Stage_IV_Cervical_Cancer AJCC Stage IV Cervical Cancer Cervical Cancer Stage IV Cervical Carcinoma Stage IV FIGO Stage IV Carcinoma of Cervix FIGO Stage IV Carcinoma of Cervix Uteri FIGO Stage IV Carcinoma of Uterine Cervix FIGO Stage IV Carcinoma of the Cervix FIGO Stage IV Carcinoma of the Cervix Uteri FIGO Stage IV Carcinoma of the Uterine Cervix FIGO Stage IV Cervical Carcinoma FIGO Stage IV Cervix Carcinoma FIGO Stage IV Cervix Uteri Carcinoma FIGO Stage IV Uterine Cervix Carcinoma Stage IV Cervical Cancer Stage IV Cervical Cancer AJCC v6 Stage IV Cervical Cancer AJCC v6 and v7 Stage IV Cervical Cancer AJCC v7 stage IV cancer of the cervix Stage IV Cervical Cancer AJCC v6 and v7 Stage I includes: I (T1, N0, M0); IA: (T1a, N0, M0); IB (T1b, N0, M0); IC (T1c, N0, M0). T1: Tumor confined to corpus uteri. T1a: Tumor limited to the endometrium. T1b: Tumor invades less than one-half of the myometrium. T1c: Tumor invades one-half or more of the myometrium. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C9207 Neoplastic Process Stage I Uterine Corpus Cancer AJCC v6 Stage I Uterine Corpus Cancer AJCC v6 C0278798 CTRP Cancer found in only the main part of the uterus, not the cervix. Malignant Stage_I_Endometrial_Cancer Stage I Cancer of Uterine Corpus AJCC v6 Stage I Cancer of the Corpus Uteri AJCC v6 Stage I Cancer of the Uterine Corpus AJCC v6 Stage I Endometrial Cancer AJCC v6 Stage I Uterine (including Endometrial) Cancer Stage I Uterine Corpus Cancer AJCC v6 stage I cancer of the uterus stage I endometrial cancer Stage I Uterine Corpus Cancer AJCC v6 Stage II includes: II (T2, N0, M0); IIA (T2a, N0, M0); IIB (T2b, N0, M0). T2: Tumor invades cervix but does not extend beyond uterus. T2a: Tumor limited to the glandular epithelium of the endocervix. There is no evidence of connective tissue stromal invasion. T2b: Invasion of the stromal connective tissue of the cervix. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) C9208 Neoplastic Process Stage II Uterine Corpus Cancer AJCC v6 Stage II Uterine Corpus Cancer AJCC v6 C0278799 CTRP Cancer that has spread to the cervix. Malignant Stage_II_Endometrial_Cancer Stage II Cancer of Uterine Corpus AJCC v6 Stage II Cancer of the Corpus Uteri AJCC v6 Stage II Cancer of the Uterine Corpus AJCC v6 Stage II Endometrial Cancer AJCC v6 Stage II Uterine (including Endometrial) Cancer Stage II Uterine Corpus Cancer AJCC v6 stage II cancer of the uterus stage II endometrial cancer Stage II Uterine Corpus Cancer AJCC v6 Stage III includes: III (T3, N0, M0); IIIA (T3a, N0, M0); IIIB (T3b, N0, M0); IIIC (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Local and/or regional spread as defined below. T3a: Tumor invades serosa and/or adnexa (direct extension or metastasis) and/or cancer cells in ascites or peritoneal washings. T3b Vaginal involvement (direct extension or metastasis). N0: No regional lymph node metastasis. N1: Regional lymph node metastasis to pelvic and/or para-aortic nodes. M0: No distant metastasis. (AJCC 6th ed.) C9209 Neoplastic Process Stage III Uterine Corpus Cancer AJCC v6 Stage III Uterine Corpus Cancer AJCC v6 C0278800 CTRP Cancer cells have spread outside the uterus to the vagina and/or lymph nodes in the pelvis but have not spread outside the pelvis. Malignant Stage_III_Endometrial_Cancer Stage III Cancer of Uterine Corpus AJCC v6 Stage III Cancer of the Corpus Uteri AJCC v6 Stage III Cancer of the Uterine Corpus AJCC v6 Stage III Endometrial Cancer AJCC v6 Stage III Uterine (including Endometrial) Cancer Stage III Uterine Corpus Cancer AJCC v6 stage III cancer of the uterus stage III endometrial cancer Stage III Uterine Corpus Cancer AJCC v6 Stage I includes: T1, N0, M0. TI: Tumor invades lamina propria or submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) -2003 C9210 Neoplastic Process Stage I Esophageal Cancer AJCC v6 Stage I Esophageal Cancer AJCC v6 C0278559 CTRP Cancer has spread beyond the innermost layer of tissue to the next layer of tissue in the wall of the esophagus. Malignant Stage_I_Esophageal_Cancer Esophageal Cancer Stage I AJCC v6 Stage I Carcinoma of Esophagus AJCC v6 Stage I Carcinoma of the Esophagus AJCC v6 Stage I Esophageal Cancer Stage I Esophageal Cancer AJCC v6 Stage I Esophageal Carcinoma AJCC v6 Stage I Esophagus Carcinoma AJCC v6 stage I cancer of the esophagus Stage I Esophageal Cancer AJCC v6 Stage II includes: IIA: (T2, N0, M0); (T3, N0, M0) and IIB: (TI, NI, M0); (T2, NI, M0). TI: Tumor invades lamina propria or submucosa. T2: Tumor invades muscularis propria. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) -2003 C9211 Neoplastic Process Stage II Esophageal Cancer AJCC v6 Stage II Esophageal Cancer AJCC v6 C0278560 CTRP Stage II is divided into stage IIA and stage IIB, depending on where the cancer has spread. In stage IIA, cancer has spread to the layer of esophageal muscle or to the outer wall of the esophagus. In stage IIB, cancer may have spread to any of the first three layers of the esophagus and to nearby lymph nodes. Malignant Stage_II_Esophageal_Cancer Esophageal Cancer Stage II AJCC v6 Stage II Carcinoma of Esophagus AJCC v6 Stage II Carcinoma of the Esophagus AJCC v6 Stage II Esophageal Cancer Stage II Esophageal Cancer AJCC v6 Stage II Esophageal Carcinoma AJCC v6 Stage II Esophagus Carcinoma AJCC v6 stage II cancer of the esophagus Stage II Esophageal Cancer AJCC v6 Stage III includes: T3, N1, M0 and T4, Any N, M0) T3: Tumor invades adventitia. T4: Tumor invades adjacent structures. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) -2003 C9212 Neoplastic Process Stage III Esophageal Cancer AJCC v6 Stage III Esophageal Cancer AJCC v6 C0278561 CTRP Cancer has spread to the outer wall of the esophagus and may have spread to tissues or lymph nodes near the esophagus. Malignant Stage_III_Esophageal_Cancer Esophageal Cancer Stage III AJCC v6 Stage III Carcinoma of Esophagus AJCC v6 Stage III Carcinoma of the Esophagus AJCC v6 Stage III Esophageal Cancer Stage III Esophageal Cancer AJCC v6 Stage III Esophageal Carcinoma AJCC v6 Stage III Esophagus Carcinoma AJCC v6 stage III cancer of the esophagus Stage III Esophageal Cancer AJCC v6 Stage IV includes: Any T, Any N, M1. IVA: Any T, Any N, M1a. IVB: Any T, Any N, M1b. M1: Distant Metastasis. (AJCC 6th ed.) -2003 C9213 Neoplastic Process Stage IV Esophageal Cancer AJCC v6 Stage IV Esophageal Cancer AJCC v6 C0278562 CTRP Stage IV esophageal cancer is divided into stage IVA and stage IVB, depending on where the cancer has spread. In stage IVA, cancer has spread to nearby or distant lymph nodes. In stage IVB, cancer has spread to distant lymph nodes and/or organs in other parts of the body. Malignant Stage_IV_Esophageal_Cancer Stage IV Carcinoma of Esophagus AJCC v6 Stage IV Carcinoma of the Esophagus AJCC v6 Stage IV Esophageal Cancer Stage IV Esophageal Cancer AJCC v6 Stage IV Esophageal Carcinoma AJCC v6 Stage IV Esophagus Carcinoma AJCC v6 stage IV cancer of the esophagus Stage IV Esophageal Cancer AJCC v6 Stage I includes: T1, N0, M0. T1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C9214 Neoplastic Process Stage I Adrenal Cortex Carcinoma AJCC v7 Stage I Adrenal Cortical Carcinoma AJCC v7 C0678050 CTRP Cancer of the adrenal gland that is smaller than 5 centimeters (smaller than 2 inches) and is found in the adrenal gland only. Malignant Stage_I_Adrenal_Cortex_Carcinoma Stage I Adrenal Cortex Cancer Stage I Adrenal Cortex Carcinoma Stage I Adrenal Cortex Carcinoma AJCC v7 Stage I Adrenal Cortical Carcinoma AJCC v7 Stage I Adrenocortical Carcinoma Stage I Carcinoma of Adrenal Cortex Stage I Carcinoma of the Adrenal Cortex stage I adrenocortical cancer Stage I Adrenal Cortical Carcinoma AJCC v7 Stage II includes: T2, N0, M0. T2: Tumor greater than 5 cm, no extra-adrenal invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C9215 Neoplastic Process Stage II Adrenal Cortex Carcinoma AJCC v7 Stage II Adrenal Cortical Carcinoma AJCC v7 C0678051 CTRP Cancer of the adrenal gland that is larger than 5 centimeters (about 2 inches) and is found in the adrenal gland only. Malignant Stage_II_Adrenal_Cortex_Carcinoma Stage II Adrenal Cortex Cancer Stage II Adrenal Cortex Carcinoma Stage II Adrenal Cortex Carcinoma AJCC v7 Stage II Adrenal Cortical Carcinoma AJCC v7 Stage II Adrenocortical Carcinoma Stage II Carcinoma of Adrenal Cortex Stage II Carcinoma of the Adrenal Cortex stage II adrenocortical cancer Stage II Adrenal Cortical Carcinoma AJCC v7 Stage III includes: (T1, N1, M0); (T2, N1, M0); (T3, N0, M0). T1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion. T2: Tumor greater than 5 cm, no extra-adrenal invasion. T3: Tumor of any size with local invasion, but not invading adjacent organs. N1: Metastasis in regional lymph node(s). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C9216 Neoplastic Process Stage III Adrenal Cortex Carcinoma AJCC v7 Stage III Adrenal Cortical Carcinoma AJCC v7 C0678052 CTRP Cancer of the adrenal gland that has spread into fat and lymph nodes near the adrenal gland. Malignant Stage_III_Adrenal_Cortex_Carcinoma Stage III Adrenal Cortex Cancer Stage III Adrenal Cortex Carcinoma Stage III Adrenal Cortex Carcinoma AJCC v7 Stage III Adrenal Cortical Carcinoma AJCC v7 Stage III Adrenocortical Carcinoma Stage III Carcinoma of Adrenal Cortex Stage III Carcinoma of the Adrenal Cortex stage III adrenocortical cancer Stage III Adrenal Cortical Carcinoma AJCC v7 Stage IV includes: (T3, N1, M0); (T4, N0, M0); (T4, N1, M0); (Any T, Any N, M1). T3: Tumor of any size with local invasion, but not invading adjacent organs. T4: Tumor of any size with invasion of adjacent organs. N1: Metastasis in regional lymph node(s). N0: No regional lymph node metastasis. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.) C9217 Neoplastic Process Stage IV Adrenal Cortex Carcinoma AJCC v7 Stage IV Adrenal Cortical Carcinoma AJCC v7 C0678053 CTRP Cancer of the adrenal gland that has spread to fat or organs and to lymph nodes near the adrenal gland or to other parts of the body, such as lungs, liver, bones, and abdomen. Malignant Stage_IV_Adrenal_Cortex_Carcinoma Stage IV Adrenal Cortex Cancer Stage IV Adrenal Cortex Carcinoma Stage IV Adrenal Cortex Carcinoma AJCC v7 Stage IV Adrenal Cortical Carcinoma AJCC v7 Stage IV Adrenocortical Carcinoma Stage IV Carcinoma of Adrenal Cortex Stage IV Carcinoma of the Adrenal Cortex stage IV adrenocortical cancer Stage IV Adrenal Cortical Carcinoma AJCC v7 Stage IV includes: IVA (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); IVB (T4b, Any N, M0); IVC (Any T, Any N, M1). T4a: Tumor invades the larynx, deep/extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible. T4b: Tumor invades lateral pterygoid muscle, pterygoid plates lateral nasopharynx, or skull base or encases carotid artery. M1: Distant Metastasis. (AJCC 6th ed.) C9218 Neoplastic Process Stage IV Oropharyngeal Carcinoma AJCC v6 Stage IV Oropharyngeal Carcinoma AJCC v6 C1378462 CTRP Stage IV oropharyngeal cancer is divided into stages IVA, IVB, and IVC. In stage IVA, the cancer either: (1) has spread to tissues near the oropharynx, including the voice box, roof of the mouth, lower jaw, muscle of the tongue, or central muscles of the jaw, and may have spread to one or more nearby lymph nodes, none larger than 6 centimeters; OR (2) is any size and has spread to one lymph node that is larger than 3 centimeters but not larger than 6 centimeters on the same side of the neck as the cancer, or to more than one lymph node, none larger than 6 centimeters, on one or both sides of the neck. In stage IVB, the cancer either: (1) surrounds the main artery in the neck or has spread to bones in the jaw or skull, to muscle in the side of the jaw, or to the upper part of the throat behind the nose, and may have spread to nearby lymph nodes; OR (2) has spread to a lymph node that is larger than 6 centimeters and may have spread to tissues around the oropharynx. In stage IVC, cancer has spread to other parts of the body; the tumor may be any size and may have spread to lymph nodes. Malignant Stage_IV_Oropharyngeal_Carcinoma Oropharyngeal Cancer Stage IV AJCC v6 Stage IV Carcinoma of Oropharynx AJCC v6 Stage IV Carcinoma of the Oropharynx AJCC v6 Stage IV Oropharyngeal Cancer AJCC v6 Stage IV Oropharyngeal Carcinoma AJCC v6 Stage IV Oropharyngeal Throat Cancer Stage IV Oropharynx Carcinoma AJCC v6 stage IV oropharynx cancer Stage IV Oropharyngeal Carcinoma AJCC v6 A composite pheochromocytoma that is confined to the adrenal gland. C92181 Neoplastic Process Non-Metastatic Adrenal Gland Composite Pheochromocytoma C2984897 CDISC A benign neoplasm of the adrenal gland medulla, composed of medullary and neuroectodermal components. Benign Benign Adrenal Gland Composite Pheochromocytoma Non-Metastatic Adrenal Gland Composite Pheochromocytoma PHEOCHROMOCYTOMA, COMPLEX, BENIGN Non-Metastatic Adrenal Gland Composite Pheochromocytoma A benign schwannoma occurring in the eye. C92182 Neoplastic Process Intraocular Schwannoma C2984898 Benign Benign Intraocular Schwannoma Intraocular Schwannoma Intraocular Schwannoma An adrenal gland composite pheochromocytoma that metastasizes to other anatomic sites. C92184 Neoplastic Process Metastatic Adrenal Gland Composite Pheochromocytoma C2984900 CDISC A malignant neoplasm of the adrenal gland medulla, composed of medullary and neuroectodermal components. Malignant Malignant Adrenal Gland Composite Pheochromocytoma Metastatic Adrenal Gland Composite Pheochromocytoma PHEOCHROMOCYTOMA, COMPLEX, MALIGNANT Metastatic Adrenal Gland Composite Pheochromocytoma A malignant peripheral nerve sheath tumor that affects the esophageal wall. C92185 Neoplastic Process Esophageal Malignant Peripheral Nerve Sheath Tumor C2984901 Malignant Esophageal Malignant Peripheral Nerve Sheath Tumor Malignant Esophageal Peripheral Nerve Sheath Tumor Esophageal Malignant Peripheral Nerve Sheath Tumor A malignant peripheral nerve sheath tumor that occurs in the intraocular area. C92186 Neoplastic Process Intraocular Malignant Peripheral Nerve Sheath Tumor C2984902 Malignant Intraocular Malignant Peripheral Nerve Sheath Tumor Malignant Intraocular Peripheral Nerve Sheath Tumor Intraocular Malignant Peripheral Nerve Sheath Tumor Stage III includes: (T1, N1, M0); (T2, N1, M0); (T3, N0, M0); (T3, N1, M0); (T3a, N0, M0); (T3a, N1, M0); (T3b, N0, M0); (T3b, N1, M0); (T3c, N0, M0); (T3c, N1, M0). T3: Tumor extends into major veins or invades adrenal gland or perinephric tissues but not beyond Gerota's fascia. T3a: Tumor directly invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia. T3b: Tumor grossly extends into the renal vein or its segmental (muscle containing) branches, or vena cava below the diaphragm. T3c: Tumor grossly extends into the vena cava above the diaphragm or invades the wall of the vena cava. N0: No regional lymph node metastases. N1: Metastasis in a single regional lymph node. M0: No distant metastasis. (AJCC 6th Ed.) C9220 Neoplastic Process Stage III Renal Cell Cancer AJCC v6 Stage III Renal Cell Cancer AJCC v6 C0278677 CTRP (1) The tumor is any size and cancer is found only in the kidney and in 1 or more nearby lymph nodes; or (2) cancer is found in the main blood vessels of the kidney or in the layer of fatty tissue around the kidney. Cancer may be found in 1 or more nearby lymph nodes. Malignant Stage_III_Renal_Cell_Cancer Renal Cell Cancer Stage III AJCC v6 Stage III Renal Cell Cancer Stage III Renal Cell Cancer AJCC v6 Stage III Renal Cell Carcinoma AJCC v6 stage III kidney cancer stage III renal cell cancer Stage III Renal Cell Cancer AJCC v6 A familial carcinoma inherited in an autosomal dominant trait. It is characterized by the development of multiple, bilateral papillary renal cell carcinomas. The carcinomas range from microscopic lesions to clinically symptomatic tumors. It is associated with activating mutations of the MET oncogene. C9222 Neoplastic Process Hereditary Papillary Renal Cell Carcinoma Hereditary Papillary Renal Cell Carcinoma C0879257 CTRP GDC Malignant Hereditary_Renal_Papillary_Carcinoma Hereditary Papillary Renal Cell Carcinoma Familial Renal Papillary Carcinoma Hereditary Kidney Papillary Carcinoma Hereditary Papillary Carcinoma of Kidney Hereditary Papillary Carcinoma of the Kidney Hereditary Papillary Renal Carcinoma Hereditary Papillary Renal Cell Cancer Hereditary Papillary Renal Cell Carcinoma Hereditary Papillary Renal Cell Carcinoma An axillary lymph node along the brachial vein. C92221 Body Part, Organ, or Organ Component Brachial Lymph Node C0229840 CDISC mCode Lymph node(s) adjacent to the brachial vein. BRACHIAL LYMPH NODE Brachial Lymph Node LYMPH NODE, BRACHIAL Structure of lateral axillary lymph node (body structure) Brachial Lymph Node A lymph node along the left gastric artery or greater omentum. C92222 Anatomical Structure Gastric Lymph Node C1282334 CDISC Lymph node(s) adjacent to the stomach. Gastric Lymph Node LYMPH NODE, GASTRIC Gastric Lymph Node A rare aggressive neuroendocrine carcinoma that usually arises from the skin. Rarely, it arises from extracutaneous sites, including the oral cavity, salivary glands, breast, vulva, and vaginal wall. The tumor is composed of small round cells with scanty cytoplasm. Merkel cell polyomavirus is implicated in the majority of cases. C9231 Neoplastic Process Merkel Cell Carcinoma Merkel Cell Carcinoma C0007129 CPTAC CTEP CTRP Cellosaurus GDC mCode 8247/3 Malignant Neuroendocrine_Carcinoma_of_the_Skin 8247/3 Merkel cell carcinoma Merkel cell carcinoma of other sites Merkel cell tumor MCC Merkel Cell Cancer Merkel Cell Carcinoma Merkel cell cancer Merkel cell carcinoma Merkel cell carcinoma, unspecified Merkel cell tumor Merkel Cell Carcinoma A clonal myeloid disorder of childhood previously classified as myelodysplastic/myeloproliferative neoplasm. It is characterized by the presence of monocytic proliferation in peripheral blood, less than 20% blasts in bone marrow and peripheral blood, splenomegaly, and the absence of BCR-ABL1 fusion. Almost all patients carry mutations of the RAS pathway. C9233 Neoplastic Process Juvenile Myelomonocytic Leukemia Juvenile Myelomonocytic Leukemia C0349639 CPTAC CTEP CTRP Cellosaurus GDC NICHD A myelodysplastic/myeloproliferative neoplasm of childhood that is principally characterized by proliferation of the granulocytic and monocytic lineages. A rare form of childhood leukemia in which cancer cells often spread into tissues such as the skin, lung, and intestines. 9946/3 Malignant Juvenile_Myelomonocytic_Leukemia 9946/3 Juvenile chronic myelomonocytic leukemia Juvenile myelomonocytic leukemia Juvenile myelomonocytic leukemia, NOS Juvenile myelomonocytic leukemia, not having achieved remission JCML JMML Juvenile Chronic Myelogenous Leukemia Juvenile Chronic Myeloid Leukemia Juvenile Chronic Myelomonocytic Leukemia Juvenile Myelomonocytic Leukemia Juvenile myelomonocytic leukemia juvenile myelomonocytic leukemia Juvenile Myelomonocytic Leukemia A benign or malignant neoplasm affecting the spinal cord during childhood. C9234 Neoplastic Process Childhood Spinal Cord Neoplasm Childhood Spinal Cord Neoplasm C1134515 CTRP NICHD A benign or malignant neoplasm affecting the spinal cord during childhood. Undetermined Childhood_Spinal_Cord_Neoplasm Childhood Spinal Cord Neoplasm Childhood Spinal Cord Tumor Spinal Cord Tumor Childhood Spinal Cord Neoplasm Systemic infiltration of extracutaneous sites by clonal mast cells, with or without evidence of skin involvement. C9235 Neoplastic Process Systemic Mastocytosis Systemic Mastocytosis C0221013 CTEP CTRP Cellosaurus GDC mCode A rare disease in which too many mast cells (a type of immune system cell) are found in the skin, bones, joints, lymph nodes, liver, spleen, and gastrointestinal tract. Mast cells give off chemicals such as histamine that can cause flushing (a hot, red face), itching, abdominal cramps, muscle pain, nausea, vomiting, diarrhea, low blood pressure, and shock. Undetermined Primary_Systemic_Mastocytosis Systemic_Mastocytosis 9741/3 Systemic tissue mast cell disease Systemic Mastocytosis Systemic Tissue Mast Cell Disease Systemic mastocytosis Systemic mastocytosis, NOS Systemic tissue mast cell disease systemic mastocytosis Systemic Mastocytosis The reemergence of gastric carcinoma after a period of remission. C9237 Neoplastic Process Recurrent Gastric Carcinoma Recurrent Gastric Carcinoma C0278502 CTRP Malignant Recurrent_Gastric_Cancer Gastric Carcinoma, Recurrent Recurrent Cancer of Stomach Recurrent Cancer of the Stomach Recurrent Carcinoma of Stomach Recurrent Carcinoma of the Stomach Recurrent Gastric (Stomach) Cancer Recurrent Gastric Cancer Recurrent Gastric Carcinoma Recurrent Stomach Cancer Recurrent Stomach Carcinoma Recurrent Gastric Carcinoma The reemergence of rectal carcinoma after a period of remission. C9238 Neoplastic Process Recurrent Rectal Carcinoma Recurrent Rectal Carcinoma C0278554 CTRP Malignant Recurrent_Rectal_Cancer Rectal Cancer, Recurrent Recurrent Cancer of Rectum Recurrent Cancer of the Rectum Recurrent Rectal Cancer Recurrent Rectal Carcinoma Recurrent Rectal Carcinoma The reemergence of nasopharyngeal carcinoma after a period of remission. C9240 Neoplastic Process Recurrent Nasopharynx Carcinoma Recurrent Nasopharyngeal Carcinoma C0278952 CTRP Malignant Recurrent_Nasopharyngeal_Carcinoma Nasopharyngeal Cancer, Recurrent Recurrent Cancer of Nasopharynx Recurrent Cancer of the Nasopharynx Recurrent Carcinoma of Nasopharynx Recurrent Carcinoma of the Nasopharynx Recurrent Nasopharyngeal Cancer Recurrent Nasopharyngeal Carcinoma Recurrent Nasopharyngeal Throat Cancer Relapsed Cancer of Nasopharynx Relapsed Cancer of the Nasopharynx Relapsed Carcinoma of Nasopharynx Relapsed Carcinoma of the Nasopharynx Relapsed Nasopharyngeal Cancer Relapsed Nasopharyngeal Carcinoma Relapsed Nasopharynx Carcinoma Recurrent Nasopharyngeal Carcinoma The reemergence of hypopharyngeal carcinoma after a period of remission. C9241 Neoplastic Process Recurrent Hypopharyngeal Carcinoma Recurrent Hypopharyngeal Carcinoma C1378463 CTRP Malignant Recurrent_Hypopharyngeal_Carcinoma Recurrent Cancer of Hypopharynx Recurrent Cancer of the Hypopharynx Recurrent Carcinoma of Hypopharynx Recurrent Carcinoma of the Hypopharynx Recurrent Hypopharyngeal Cancer Recurrent Hypopharyngeal Carcinoma Recurrent Hypopharyngeal Throat Cancer Recurrent Hypopharynx Carcinoma Relapsed Cancer of Hypopharynx Relapsed Cancer of the Hypopharynx Relapsed Carcinoma of Hypopharynx Relapsed Carcinoma of the Hypopharynx Relapsed Hypopharyngeal Cancer Relapsed Hypopharyngeal Carcinoma Relapsed Hypopharynx Carcinoma Recurrent Hypopharyngeal Carcinoma A primary or metastatic malignant neoplasm that affects the colon. Representative examples include carcinoma, lymphoma, and sarcoma. C9242 Neoplastic Process Malignant Colon Neoplasm C0007102 CPTAC mCode Malignant Malignant_Colon_Neoplasm Malignant neoplasm of ascending colon Malignant neoplasm of colon Malignant neoplasm of colon, unspecified Malignant neoplasm of descending colon Malignant neoplasm of hepatic flexure Malignant neoplasm of splenic flexure Malignant neoplasm of transverse colon Malignant neoplasm: Ascending colon Malignant neoplasm: Colon, unspecified Malignant neoplasm: Descending colon Malignant neoplasm: Hepatic flexure Malignant neoplasm: Overlapping lesion of colon Malignant neoplasm: Splenic flexure Malignant neoplasm: Transverse colon Colon Neoplasm, Malignant Colon Tumor, Malignant Malignant Colon Neoplasm Malignant Colon Tumor Malignant Colonic Neoplasm Malignant Colonic Tumor Malignant Neoplasm of Colon Malignant Neoplasm of the Colon Malignant Tumor of Colon Malignant Tumor of the Colon Malignant neoplasm of colon, unspecified Malignant Colon Neoplasm A lymph node located under the tongue in the floor of the mouth. C92434 Anatomical Structure Sublingual Lymph Node C2985100 CDISC Lymph node(s) adjacent to the tongue in the floor of the oral cavity. LYMPH NODE, SUBLINGUAL Sublingual Lymph Node Sublingual Lymph Node A non-Hodgkin lymphoma with an aggressive clinical course. Representative examples include Burkitt lymphoma, mantle cell lymphoma, and angioimmunoblastic T-cell lymphoma. C9244 Neoplastic Process Aggressive Non-Hodgkin Lymphoma C0852469 CTEP A type of lymphoma that grows and spreads quickly and has severe symptoms. Malignant Aggressive_Non-Hodgkin_s_Lymphoma Aggressive Non-Hodgkin Lymphoma Aggressive Non-Hodgkin's Lymphoma NHL, aggressive, NOS Non-Hodgkin lymphoma, aggressive, NOS aggressive lymphoma Aggressive Non-Hodgkin Lymphoma A carcinoma that infiltrates the breast parenchyma. The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU). Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ. It is the most common carcinoma affecting women. C9245 Neoplastic Process Invasive Breast Carcinoma Invasive Breast Carcinoma C0853879 CTEP CTRP GDC Cancer that has spread from where it started in the breast into surrounding, healthy tissue. Most invasive breast cancers start in the ducts (tubes that carry milk from the lobules to the nipple). Invasive breast cancer can spread to other parts of the body through the blood and lymph systems. Malignant Invasive_Breast_Carcinoma 61 80 Invasive mammary carcinoma Infiltrating Breast Carcinoma Infiltrating Carcinoma of Breast Infiltrating Carcinoma of the Breast Invasive Breast Cancer Invasive Breast Carcinoma Invasive Carcinoma of Breast Invasive Carcinoma of the Breast Invasive Mammary Carcinoma Invasive breast carcinoma Invasive mammary carcinoma infiltrating breast cancer invasive breast cancer Invasive Breast Carcinoma Inflammatory breast carcinoma is classified as AJCC Stage IIIB (T4d) unless other criteria indicate more advanced staging. C9246 Neoplastic Process Stage IIIB Inflammatory Breast Carcinoma Stage IIIB Breast Inflammatory Carcinoma C0853971 CTRP Malignant Stage_IIIB_Inflammatory_Breast_Carcinoma Stage IIIB Breast Inflammatory Carcinoma Stage IIIB Inflammatory Breast Cancer Stage IIIB Inflammatory Breast Carcinoma Stage IIIB Breast Inflammatory Carcinoma The reemergence of anal canal carcinoma in HIV-positive patients after a period of remission. C9249 Neoplastic Process Recurrent AIDS-Related Anal Canal Carcinoma C0854742 Malignant Recurrent_AIDS-Related_Anal_Canal_Cancer Recurrent AIDS-Related Anal Canal Cancer Recurrent AIDS-Related Anal Canal Carcinoma Recurrent AIDS-Related Anal Cancer Recurrent AIDS-Related Anal Carcinoma Recurrent AIDS-Related Anal Canal Carcinoma The reemergence of anaplastic large cell lymphoma after a period of remission. C9250 Neoplastic Process Recurrent Anaplastic Large Cell Lymphoma Recurrent Anaplastic Large Cell Lymphoma C0854820 CTRP Malignant Recurrent_Anaplastic_Large_Cell_Lymphoma Recurrent Anaplastic Large Cell Lymphoma Relapsed Anaplastic Large Cell Lymphoma Recurrent Anaplastic Large Cell Lymphoma The reemergence of non-Hodgkin lymphoma after a period of remission. C9251 Neoplastic Process Recurrent Non-Hodgkin Lymphoma C0854866 Malignant Recurrent_Non-Hodgkin_s_Lymphoma Non-Hodgkin's Lymphoma Relapsed Recurrent Non-Hodgkin Lymphoma Recurrent Non-Hodgkin's Lymphoma Relapsed Non-Hodgkin's Lymphoma Recurrent Non-Hodgkin Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C9252 Neoplastic Process Ann Arbor Stage I Aggressive Adult Non-Hodgkin Lymphoma Ann Arbor Stage I Aggressive Adult Non-Hodgkin Lymphoma C0677684 CTRP Malignant Stage_I_Aggressive_Adult_Non-Hodgkin_s_Lymphoma Aggressive Adult Non-Hodgkin's Lymphoma Stage I Aggressive Stage I Adult Non-Hodgkin's Lymphoma Ann Arbor Stage I Aggressive Adult Non-Hodgkin Lymphoma Stage I Aggressive Adult Non-Hodgkin Lymphoma Stage I Aggressive Adult Non-Hodgkin's Lymphoma Stage I Aggressive Non-Hodgkin Lymphoma Ann Arbor Stage I Aggressive Adult Non-Hodgkin Lymphoma The reemergence of malignant mesothelioma in the pericardium after a period of remission. C9253 Neoplastic Process Recurrent Pericardial Malignant Mesothelioma C0854885 Malignant Recurrent_Malignant_Pericardial_Mesothelioma Recurrent Pericardial Malignant Mesothelioma Recurrent Pericardial Malignant Mesothelioma The occurrence of multiple and independent glioblastomas that are unrelated to inherited neoplastic syndromes. C92549 Neoplastic Process Multifocal Glioblastomas C2985170 Malignant Multifocal Glioblastomas Multifocal Glioblastomas The reemergence of ureter carcinoma after a period of remission C9255 Neoplastic Process Recurrent Ureter Carcinoma C0854920 Malignant Recurrent_Ureter_Cancer Recurrent Ureter Cancer Recurrent Ureter Carcinoma Relapsed Cancer of Ureter Relapsed Cancer of the Ureter Relapsed Ureter Cancer Relapsed Ureteral Cancer Ureteric Cancer, Recurrent Recurrent Ureter Carcinoma A rare, WHO grade II or III infiltrating astrocytoma characterized by the presence of sharply demarcated foci, composed of a neuropil-like matrix. C92550 Neoplastic Process Glioneuronal Tumor with Neuropil-Like Islands C2985171 Cellosaurus Undetermined Glioneuronal Tumor with Neuropil-Like Islands Glioneuronal Tumor with Neuropil-Like Islands A WHO grade 1, slow-growing brain neoplasm of children and young adults, associated with epilepsy. Morphologically it is characterized by an angiocentric pattern, monomorphic cellular infiltrate, and ependymal differentiation. C92552 Neoplastic Process Angiocentric Glioma C2363903 GDC 9431/1 Undetermined 9431/1 Angiocentric glioma Angiocentric Glioma Angiocentric Glioma (WHO Grade 1) Angiocentric Glioma (WHO Grade I) Angiocentric Neuroepithelial Tumor Angiocentric glioma Monomorphus Angiocentric Glioma Angiocentric Glioma A WHO grade 1, indolent and relatively circumscribed brain tumor. Morphologically it is characterized by the presence of astrocytes that line vascular and hyalinized pseudopapillae. In between the pseudopapillae aggregates of neurocytes, large neurons, and ganglioid cells are present. C92554 Neoplastic Process Papillary Glioneuronal Tumor C2985174 GDC 9509/1 Undetermined 9509/1 Papillary glioneuronal tumor PGNT Papillary Glioneuronal Tumor Papillary Glioneuronal Tumor (WHO Grade 1) Papillary Glioneuronal Tumor (WHO Grade I) Papillary glioneuronal tumor Papillary Glioneuronal Tumor A WHO grade 2 neoplasm that arises from the brain parenchyma. Morphologically it is characterized by the presence of neoplastic uniform, round cells with neuronal differentiation. Unlike central neurocytoma, it does not involve the lateral ventricles. It usually affects young adults and has a favorable prognosis. C92555 Neoplastic Process Extraventricular Neurocytoma C2985175 GDC 9506/1 Undetermined 9506/1 Extraventricular neurocytoma Extraventricular Neurocytoma Extraventricular Neurocytoma (WHO Grade 2) Extraventricular Neurocytoma (WHO Grade II) Extraventricular neurocytoma Extraventricular Neurocytoma Stage III includes: IIIA (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0) and IIIB (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0). T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe. N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes. N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes. M0: No distant metastasis. (AJCC 7th ed.) C9257 Neoplastic Process Stage III Large Cell Lung Carcinoma AJCC v7 Stage III Lung Large Cell Carcinoma AJCC v7 C0854981 CTRP Malignant Stage_III_Large_Cell_Lung_Carcinoma Stage III Large Cell Carcinoma of Lung Stage III Large Cell Carcinoma of the Lung Stage III Large Cell Lung Cancer Stage III Large Cell Lung Carcinoma Stage III Lung Large Cell Carcinoma AJCC v7 Stage III Lung Large Cell Carcinoma AJCC v7 Reemergence of a lip or oral cavity malignant neoplasm after a period of remission. C9262 Neoplastic Process Recurrent Malignant Oral Neoplasm Recurrent Malignant Oral Neoplasm C0861555 CTRP Malignant Recurrent_Malignant_Oral_Neoplasm Recurrent Malignant Lip and Oral Cavity Neoplasm Recurrent Malignant Oral Neoplasm Recurrent Malignant Oral Neoplasm A rare tumor that arises from the pineal region and affects adults. It is characterized by the presence of neuroepithelial cells and a papillary architecture. Electron microscopic studies suggest ependymal differentiation. The clinical course is variable. C92624 Neoplastic Process Papillary Tumor of the Pineal Region C2985219 GDC 9395/3 Undetermined 9395/3 Papillary tumor of pineal region Papillary tumor of the pineal region PTPR Papillary Tumor of the Pineal Region Papillary tumor of the pineal region Papillary Tumor of the Pineal Region A medulloblastoma characterized by marked nuclear pleomorphism, and high mitotic activity. C92625 Neoplastic Process Anaplastic Medulloblastoma C2985220 GDC 9474/3 Malignant 9474/3 Anaplastic medulloblastoma Anaplastic Medulloblastoma Anaplastic medulloblastoma Anaplastic Medulloblastoma A malignant central nervous system neoplasm characterized by the presence of poorly differentiated or undifferentiated neuroepithelial cells and ganglion cells. C92629 Neoplastic Process Central Nervous System Ganglioneuroblastoma C2985223 Malignant Central Nervous System Ganglioneuroblastoma Cerebral Ganglioneuroblastoma Central Nervous System Ganglioneuroblastoma The reemergence of a malignant duodenal neoplasm after a period of remission. C9263 Neoplastic Process Recurrent Malignant Duodenal Neoplasm C0861834 Malignant Recurrent_Malignant_Duodenal_Neoplasm Recurrent Malignant Duodenal Neoplasm Recurrent Malignant Duodenal Neoplasm The reemergence of hepatocellular carcinoma after a period of remission C9264 Neoplastic Process Recurrent Hepatocellular Carcinoma Recurrent Hepatocellular Carcinoma CL415252 CTRP Malignant Recurrent_Hepatocellular_Carcinoma Hepatocellular Carcinoma, Recurrent Recurrent Carcinoma of Liver Cell Recurrent Carcinoma of the Liver Cell Recurrent Hepatocellular Cancer Recurrent Hepatocellular Carcinoma Recurrent Hepatoma Recurrent Liver Cell Carcinoma Relapsed Carcinoma of Liver Cell Relapsed Carcinoma of the Liver Cell Relapsed Hepatocellular Carcinoma Relapsed Hepatoma Relapsed Liver Cell Carcinoma Recurrent Hepatocellular Carcinoma A malignant peripheral nerve sheath tumor characterized by the presence of mesenchymal differentiation. Representative example is the malignant Triton tumor which contains a rhabdomyosarcomatous component. C92647 Neoplastic Process Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation C2985230 Malignant Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation Mature T and NK neoplasms predominantly affecting the skin and the peripheral blood. Peripheral blood involvement by abnormal T-cells (cerebriform cells) is a late manifestation of mycosis fungoides, whereas it is the presenting finding in Sezary syndrome. C9265 Neoplastic Process Mycosis Fungoides and Sezary Syndrome Mycosis Fungoides and Sezary Syndrome C0862196 CTRP Malignant Mycosis_Fungoides_and_Sezary_Syndrome Mycosis Fungoides and Sezary Syndrome Mycosis Fungoides and Sézary Syndrome Mycosis Fungoides and Sezary Syndrome A solitary fibrous tumor that arises from the meninges. It most often corresponds to the tumor previously diagnosed as anaplastic hemangiopericytoma. C92652 Neoplastic Process Meningeal Central Nervous System Solitary Fibrous Tumor, Grade 3 C2985234 Malignant Meningeal Anaplastic Hemangiopericytoma Meningeal Anaplastic Hemangiopericytoma (WHO Grade III) Meningeal CNS Solitary Fibrous Tumor, Grade 3 Meningeal Central Nervous System Solitary Fibrous Tumor, Grade 3 Meningeal Malignant Hemangiopericytoma Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3 Meningeal Central Nervous System Solitary Fibrous Tumor, Grade 3 The reemergence of a malignant bladder neoplasm after a period of remission. C9266 Neoplastic Process Recurrent Malignant Bladder Neoplasm C0862326 Malignant Recurrent_Malignant_Bladder_Neoplasm Recurrent Malignant Bladder Neoplasm Recurrent Malignant Bladder Neoplasm Stage 0a includes: Ta, N0, M0. Ta: Papillary noninvasive carcinoma. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C9267 Neoplastic Process Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7 Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7 C1266011 CTRP Malignant Stage_0a_Bladder_Cancer Non-Invasive Papillary Carcinoma of Bladder Non-Invasive Papillary Carcinoma of Urinary Bladder Non-Invasive Papillary Carcinoma of the Bladder Non-Invasive Papillary Carcinoma of the Urinary Bladder Non-Invasive Papillary Urothelial Carcinoma Stage 0a Bladder Cancer Stage 0a Bladder Carcinoma Stage 0a Bladder Urothelial Cancer Stage 0a Bladder Urothelial Carcinoma Stage 0a Bladder Urothelial Carcinoma AJCC v6 Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7 Stage 0a Bladder Urothelial Carcinoma AJCC v7 Stage 0a Carcinoma of Bladder Stage 0a Carcinoma of Urinary Bladder Stage 0a Carcinoma of the Bladder Stage 0a Carcinoma of the Urinary Bladder Stage 0a Urinary Bladder Carcinoma Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7 The reemergence of a nasopharyngeal malignant neoplasm after a period of remission. C9268 Neoplastic Process Recurrent Malignant Nasopharyngeal Neoplasm C1377767 Malignant Recurrent_Malignant_Nasopharyngeal_Neoplasm Recurrent Malignant Nasopharyngeal Neoplasm Recurrent Malignant Nasopharyngeal Neoplasm The reemergence of a malignant neoplasm of the endocervix after a period of remission. C9269 Neoplastic Process Recurrent Malignant Endocervical Neoplasm C0863018 Malignant Recurrent_Malignant_Endocervical_Neoplasm Recurrent Malignant Endocervical Neoplasm Recurrent Malignant Endocervical Neoplasm A carcinoma that arises from the major or minor salivary glands. Representative examples include carcinoma ex pleomorphic adenoma, adenocarcinoma, adenoid cystic carcinoma, and mucoepidermoid carcinoma. C9272 Neoplastic Process Salivary Gland Carcinoma Salivary Gland Carcinoma C0948750 CPTAC CTRP Malignant Salivary_Gland_Carcinoma Carcinoma of Salivary Gland Carcinoma of the Salivary Gland Salivary Gland Cancer Salivary Gland Carcinoma Salivary Gland Carcinoma Angiosarcoma that is confined to a specific site without evidence of spread to other anatomic sites. C9275 Neoplastic Process Localized Angiosarcoma C0854893 Malignant Primary_Angiosarcoma Angiosarcoma Nonmetastatic Localized Angiosarcoma Non-Metastatic Angiosarcoma Non-Metastatic Hemangiosarcoma Localized Angiosarcoma A carcinoma that has spread to the adrenal medulla from an adjacent or distant anatomic site. C9276 Neoplastic Process Metastatic Carcinoma in the Adrenal Medulla C1334717 Malignant Metastatic_Carcinoma_to_Adrenal_Medulla Metastatic Carcinoma in the Adrenal Medulla Metastatic Carcinoma to the Adrenal Medulla Metastatic Carcinoma in the Adrenal Medulla A myeloid or more commonly lymphoid leukemia (acute or chronic) affecting the testis. Microscopically, there is interstitial infiltration of the testis by leukemic cells. Acute lymphoblastic leukemia with testicular involvement is not uncommon in boys. Sometimes (up to 10% of the cases), testicular involvement may be the initial manifestation of relapsed acute lymphoblastic leukemia. --03 C9277 Neoplastic Process Testicular Leukemia C1336711 CPTAC Malignant Testicular_Leukemia Testicular Leukemia Testicular Leukemia A carcinoma arising from the anus and occurring in HIV-positive patients. Homosexual HIV-positive men have an increased risk of developing anal squamous cell carcinoma in comparison to the general male population. Sexually transmitted human papillomavirus is detected in the majority of the cases. C9278 Neoplastic Process AIDS-Related Anal Carcinoma C1332038 CTEP Malignant AIDS-Related_Anal_Carcinoma AIDS-Related Anal Cancer AIDS-Related Anal Carcinoma AIDS-related anal cancer AIDS-Related Anal Carcinoma Hodgkin lymphoma secondary to AIDS. An increased incidence of Hodgkin lymphomas has been observed in HIV positive patients. Most cases are morphologically classified as lymphocyte depleted or mixed cellularity Hodgkin lymphomas. C9279 Neoplastic Process AIDS-Related Hodgkin Lymphoma AIDS-Related Hodgkin Lymphoma C0281293 CTEP CTRP Malignant AIDS-Related_Hodgkin_s_Lymphoma AIDS-Associated Hodgkin's Disease AIDS-Associated Hodgkin's Lymphoma AIDS-Related Hodgkin Lymphoma AIDS-Related Hodgkin's Disease AIDS-Related Hodgkin's Lymphoma AIDS-related Hodgkin lymphoma HIV-Associated Hodgkin's Disease HIV-Associated Hodgkin's Lymphoma HIV-Related Hodgkin's Disease HIV-Related Hodgkin's Lymphoma AIDS-Related Hodgkin Lymphoma A large B-cell non-Hodgkin lymphoma arising in the mediastinum. Morphologically it is characterized by a massive diffuse lymphocytic proliferation associated with compartmentalizing fibrosis. Response to intensive chemotherapy, with or without radiotherapy, is usually good. (WHO, 2001) C9280 Neoplastic Process Primary Mediastinal (Thymic) Large B-Cell Lymphoma Primary Mediastinal Large B-Cell Lymphoma C1292754 CPTAC CTEP CTRP Cellosaurus GDC mCode 9679/3 Malignant Mediastinal_Thymic_Large_B-Cell_Cell_Lymphoma 9679/3 Mediastinal (thymic) large B-cell lymphoma Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes Mediastinal large B-cell lymphoma Thymic large B-cell lymphoma B-Cell Diffuse Large Cell Lymphoma of Mediastinum B-Cell Diffuse Large Cell Lymphoma of the Mediastinum Mediastinal (Thymic) Large B-Cell Lymphoma Mediastinal (thymic) large B-cell lymphoma Mediastinal (thymic) large B-cell lymphoma, unspecified site Mediastinal B-Cell Diffuse Large Cell Lymphoma Mediastinal Diffuse Large Cell Lymphoma with Sclerosis Mediastinal large B-cell lymphoma PMBL PMLCL Primary Mediastinal (Thymic) Large B-Cell Lymphoma Primary Mediastinal Clear Cell Lymphoma of B-Cell Type Primary Mediastinal Large B-Cell Lymphoma Thymic large B-cell lymphoma Primary Mediastinal Large B-Cell Lymphoma A neoplasm composed of spindle to ovoid cells which have morphologic and immunophenotypic characteristics of follicular dendritic cells. It affects lymph nodes and other sites including the tonsils, gastrointestinal tract, spleen, liver, soft tissues, skin, and oral cavity. It usually behaves as a low grade sarcoma. Treatment options include complete surgical removal of the tumor with or without adjuvant chemotherapy or radiotherapy. Recurrences have been reported in up to half of the cases. C9281 Neoplastic Process Follicular Dendritic Cell Sarcoma Follicular Dendritic Cell Sarcoma C1260325 CPTAC CTRP GDC 9758/1 9758/3 Malignant Follicular_Dendritic_Cell_Sarcoma 9758/3 Follicular dendritic cell sarcoma Follicular dendritic cell tumor FDCS Follicular Dendritic Cell Sarcoma Follicular Dendritic Cell Sarcoma/Tumor Follicular dendritic cell sarcoma Follicular dendritic cell tumor Follicular Dendritic Cell Sarcoma A neoplastic proliferation of spindle to ovoid cells which show phenotypic features similar to those of interdigitating dendritic cells. The clinical course is generally aggressive. (WHO, 2008) C9282 Neoplastic Process Interdigitating Dendritic Cell Sarcoma Interdigitating Dendritic Cell Sarcoma C1260326 CPTAC CTRP Cellosaurus GDC 9757/1 9757/3 Malignant Interdigitating_Dendritic_Cell_Sarcoma 9757/3 Interdigitating cell sarcoma Interdigitating dendritic cell sarcoma Interdigitating Cell Sarcoma/Tumor Interdigitating Dendritic Cell Sarcoma Interdigitating Dendritic Cell Sarcoma/Tumor Interdigitating dendritic cell sarcoma Interdigitating Dendritic Cell Sarcoma A diffuse subtype of classic Hodgkin lymphoma which is rich in Hodgkin and Reed-Sternberg cells and/or depleted in non-neoplastic lymphocytes. (WHO, 2008) C9283 Neoplastic Process Lymphocyte-Depleted Classic Hodgkin Lymphoma Lymphocyte-Depleted Classic Hodgkin Lymphoma C0152267 CPTAC CTRP GDC PCDC mCode 9653/3 9662/3 Malignant Lymphocyte_Depleted_Hodgkin_s_Lymphoma 9653/3 9654/3 9655/3 Classical Hodgkin lymphoma, lymphocyte depletion, NOS Classical Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis Hodgkin lymphoma, lymphocyte depletion, NOS Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis Hodgkin lymphoma, lymphocyte depletion, reticular Hodgkin's disease, lymphocytic depletion Hodgkin's sarcoma Hodgkin's sarcoma involving intra-abdominal lymph nodes Lymphocyte depleted classical Hodgkin lymphoma Lymphocyte depleted classical Hodgkin lymphoma, unspecified site Classical Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis Hodgkin Lymphoma Lymphocyte Depleted Hodgkin Lymphoma, Lymphocyte Depletion, NOS Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis Hodgkin lymphoma, lymphocyte depletion, reticular Hodgkin's Disease Lymphocyte Depletion Hodgkin's Lymphoma Lymphocyte Depleted LDCHL LDHL Lymphocyte Depleted Classical Hodgkin Lymphoma Lymphocyte Depleted Classical Hodgkin's Lymphoma Lymphocyte Depleted Hodgkin Lymphoma Lymphocyte Depleted Hodgkin's Disease Lymphocyte Depleted Hodgkin's Lymphoma Lymphocyte depleted classical Hodgkin lymphoma, unspecified site Lymphocyte-Depleted Classic Hodgkin Lymphoma Lymphocyte-Depleted Classical Hodgkin Lymphoma Lymphocyte-Depleted Hodgkin's Disease Lymphocyte-Depleted Hodgkin's Lymphoma Lymphocyte-Depleted Classic Hodgkin Lymphoma A group of small sebaceous glands that secrete into the areolae of the mother's breast to lubricate the nipple during breastfeeding. C92833 Body Part, Organ, or Organ Component Montgomery Tubercle C0929386 Montgomery Tubercle Montgomery's Tubercle Montgomery Tubercle A disorder characterized by systemic infiltration of internal organs by aggregates of clonal mast cells and the presence of a clonal non-mast cell myeloid neoplasm (e.g., myelodysplastic syndrome, myeloproliferative neoplasm, and acute myeloid leukemia). C9284 Neoplastic Process Systemic Mastocytosis with an Associated Myeloid Neoplasm C1301365 GDC 9741/3 Malignant Systemic_Mastocytosis_with_Associated_Clonal_Hematological_non-Mast-Cell_Lineage_Disease 9741/3 Systemic mastocytosis with AHNMD Systemic mastocytosis with associated hematological clonal non-mast cell disorder SM-AHN SM-AHNMD SM-AMN Systemic Mastocytosis with Associated Clonal Hematological non-Mast-Cell Lineage Disease Systemic Mastocytosis with an Associated Hematologic Neoplasm Systemic Mastocytosis with an Associated Hematological Neoplasm (SM-AHN) Systemic Mastocytosis with an Associated Myeloid Neoplasm Systemic mastocytosis with AHNMD Systemic mastocytosis with associated hematological clonal non-mast cell disorder Systemic Mastocytosis with an Associated Myeloid Neoplasm An aggressive and progressive mast cell neoplasm characterized by systemic infiltration of internal organs by aggregates of neoplastic mast cells. There is no evidence of mast cell leukemia or clonal hematologic malignancy. Clinical symptoms include hepatomegaly, splenomegaly, portal hypertension, malabsorption syndrome, and pathologic fractures. C9285 Neoplastic Process Aggressive Systemic Mastocytosis Aggressive Systemic Mastocytosis C1112486 CTRP GDC mCode 9741/3 Malignant Aggressive_Systemic_Mastocytosis 9741/3 Aggressive systemic mastocytosis ASM Advanced Systemic Mastocytosis Aggressive Systemic Mastocytosis Aggressive systemic mastocytosis Aggressive Systemic Mastocytosis An indolent mast cell neoplasm characterized by systemic infiltration of skin and internal organs by aggregates of neoplastic mast cells. There is no evidence of mast cell leukemia or clonal hematologic malignancy. Clinically, there is no evidence of palpable hepatomegaly and splenomegaly, malabsorption syndrome, or pathologic fractures. C9286 Neoplastic Process Indolent Systemic Mastocytosis Indolent Systemic Mastocytosis C0272203 CTRP GDC 9741/1 Undetermined Indolent_Systemic_Mastocytosis 9741/1 Indolent systemic mastocytosis ISM Indolent Systemic Mastocytosis Indolent systemic mastocytosis Indolent Systemic Mastocytosis An acute myeloid leukemia with monocytic and granulocytic differentiation and the presence of a characteristically abnormal eosinophil component in the bone marrow. This type of acute myeloid leukemia has a favorable prognosis. (WHO, 2001) C9287 Neoplastic Process Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 C0522630 CPTAC GDC NICHD PCDC Acute myeloid leukemia characterized by the presence of abnormal bone marrow eosinophils and the characteristic cytogenetic abnormality inv(16)(p13.1q22) or t(16;16)(p13.1;q22), which results in the expression of the fusion protein CBFB-MYH11. This is seen in 7-9% of children with AML. 9871/3 Malignant Acute_Myeloid_Leukemia_with_Abnormal_Marrow_Eosinophils 9871/3 Acute myeloid leukemia with abnormal marrow eosinophils Acute myeloid leukemia with abnormal marrow eosinophils (includes all variants) Acute myeloid leukemia, CBF-beta/MYH11 AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 AML with inv(16)(p13q22) or t(16;16) (p13.1;q22), (CBFB/MYH11) Acute Myeloid Leukemia with Abnormal Marrow Eosinophils Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 Fusion Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB::MYH11 Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB::MYH11 Fusion Acute Myeloid Leukemia, CBF-beta/MYH11 Acute Myeloid Leukemia, CBFB-MYH11 Acute myeloid leukemia, CBF-beta/MYH11 Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 An acute myeloid leukemia with t(8;21)(q22; q22.1) giving rise to RUNX1/RUNX1T1 fusion transcript and showing maturation in the neutrophil lineage. The bone marrow and the peripheral blood show large myeloblasts with abundant basophilic cytoplasm, often containing azurophilic granules. This type of AML is associated with good response to chemotherapy and high complete remission rate. C9288 Neoplastic Process Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1 Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1 C1292774 CPTAC CTRP GDC NICHD PCDC An acute myeloid leukemia (AML) associated with t(8;21)(q22;q22) resulting in RUNX1-RUNX1T1 fusion protein expression. This is seen in 12% of children with AML. 9896/3 Malignant Acute_Myeloid_Leukemia_with_t_8_21_q22_q22_AML1_CBFa_ETO 9896/3 Acute myeloid leukaemia, t(8;21)(q22;q22) Acute myeloid leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1 Acute myeloid leukemia, AML1(CBF-alpha)/ETO Acute myeloid leukemia, t(8;21)(q22;q22) FAB M2, AML1(CBF-alpha)/ETO FAB M2, t(8;21)(q22;q22) AML with t(8;21)(q22;q22), RUNX1 RUNX1T1 AML with t(8;21)(q22;q22); RUNX1-RUNX1T1 AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1 Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1 Fusion Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1::RUNX1T1 Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1::RUNX1T1 Fusion Acute Myeloid Leukemia with t(8;21)(q22;q22) Acute Myeloid Leukemia with t(8;21)(q22;q22)(AML1(CBFa)/ETO) Acute Myeloid Leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1 Acute Myeloid Leukemia, t(8;21)(q22;q22) Acute myeloid leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1 Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1 An acute myeloid leukemia arising de novo and not as a result of treatment. It is characterized by the presence of myelodysplastic features in at least 50% of the cells of at least two hematopoietic cell lines. Patients often present with severe cytopenia. C9289 Neoplastic Process Acute Myeloid Leukemia with Multilineage Dysplasia C1292773 CPTAC GDC 9895/3 Malignant De_novo_Acute_Myeloid_Leukemia_with_Multilineage_Dysplasia 9895/3 Acute myeloid leukemia with multilineage dysplasia Acute myeloid leukemia with multilineage dysplasia, not having achieved remission AML with Multilineage Dysplasia AML-MLD Acute Myeloid Leukemia with Multilineage Dysplasia Acute myeloid leukemia with multilineage dysplasia De novo Acute Myeloid Leukemia with Multilineage Dysplasia Acute Myeloid Leukemia with Multilineage Dysplasia Proliferation of myeloid cells originating from a primitive stem cell. C9290 Neoplastic Process Myeloid Neoplasm Myeloid Neoplasm C2939461 CPTAC CTRP 9975/1 Undetermined Myeloid_Neoplasm Myeloid Neoplasm Myeloid Neoplasm A carcinoma that arises from the anus. Anal carcinomas include the anal canal and perianal area (anal margin) carcinomas. Perianal carcinomas are staged separately as skin carcinomas in AJCC v6 and v7 editions. The AJCC v8 edition staging system applies to all carcinomas arising in the anal canal, including carcinomas that arise within anorectal fistulas and those arising in the perianal area (anal margin). C9291 Neoplastic Process Anal Carcinoma Anal Carcinoma C0279637 CPTAC CTEP CTRP GDC Cancer that forms in tissues of the anus. The anus is the opening of the rectum (last part of the large intestine) to the outside of the body. Malignant Anal_Carcinoma Anal Cancer (all types) Anal Cancer Anal Cancer (all types) Anal Carcinoma Anal cancer Anal cancer, NOS Cancer of Anus Cancer of the Anus Carcinoma of Anus Carcinoma of the Anus anal cancer Anal Carcinoma A benign or malignant, primary or metastatic neoplasm that affects the brain, meninges, or spinal cord. Representative examples of primary neoplasms include astrocytoma, oligodendroglioma, ependymoma, and meningioma. Representative examples of metastatic neoplasms include carcinoma and leukemia. C9293 Neoplastic Process Central Nervous System Neoplasm Central Nervous System Neoplasm C0085136 CPTAC CTRP mCode A tumor of the central nervous system, including brain stem glioma, craniopharyngioma, medulloblastoma, and meningioma. Undetermined Central_Nervous_System_Neoplasm Neoplasm of uncertain behavior of brain and spinal cord Brain/Spinal Cord Tumor CNS Neoplasm CNS Tumor CNS tumor Central Nervous System Neoplasm Central Nervous System Tumor Neoplasm of CNS Neoplasm of Central Nervous System Neoplasm of the Central Nervous System Neoplasm of uncertain behavior of central nervous system, unspecified Tumor of CNS Tumor of Central Nervous System Tumor of the CNS Tumor of the Central Nervous System central nervous system tumor Central Nervous System Neoplasm A group of rare tumors that affect the hematopoietic and lymphoid tissues. The cells of origin are the histiocytes and accessory cells. This category includes the following: Langerhans cell histiocytosis, Langerhans cell sarcoma, indeterminate dendritic cell histiocytosis, interdigitating dendritic cell sarcoma, histiocytic sarcoma, disseminated juvenile xanthogranuloma, Erdheim-Chester disease, Rosai-Dorfman-Destombes disease, ALK-positive histiocytosis, and follicular dendritic cell sarcoma. C9294 Neoplastic Process Histiocytic and Dendritic Cell Neoplasm C1334030 CPTAC Undetermined Histiocytic_and_Dendritic_Cell_Neoplasms Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue involving intra-abdominal lymph nodes Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, unspecified site, extranodal and solid organ sites Other malignant neoplasms of lymphoid and histiocytic tissue Histiocytic and Dendritic Cell Neoplasm Histiocytic and Dendritic Cell Neoplasms Histiocytic and Dendritic Cell Tumors Histiocytic and Dendritic Cell Neoplasm A neoplasm that originates from histiocytes and accessory cells and affects the central nervous system. It is usually associated with the presence of identical tumors outside the central nervous system. Representative examples include Langerhans cell histiocytosis, histiocytic sarcoma, and follicular dendritic cell sarcoma. C92944 Neoplastic Process Central Nervous System Histiocytic and Dendritic Cell Neoplasm C2985357 Undetermined Central Nervous System Histiocytic and Dendritic Cell Neoplasm Central Nervous System Histiocytic and Dendritic Cell Neoplasm A heterogeneous group of disorders characterized by the abnormal growth and accumulation of mast cells in one or more organ systems. Recent data suggest that most variants of mast cell neoplasms are clonal disorders. (WHO, 2001) C9295 Neoplastic Process Mast Cell Neoplasm C0334664 GDC A growth or lump of mast cells (a type of white blood cell). Mast cell tumors can involve the skin, subcutaneous tissue, and muscle tissue. Undetermined Mast_Cell_Neoplasm 9740/1 Mast Cell Tumors Mast cell tumor, NOS Mast Cell Neoplasm Mast Cell Proliferative Disease Mast Cell Tumor Mast Cell Tumors Mast cell tumor, NOS Neoplasm of Mast Cells Neoplasm of the Mast Cells Tumor of Mast Cells Tumor of the Mast Cells mast cell tumor Mast Cell Neoplasm An adenocarcinoma that arises from and straddles the junction of the stomach and esophagus. The category of adenocarcinomas of the gastroesophageal junction also includes the majority of adenocarcinomas previously called gastric cardia adenocarcinomas. Squamous cell carcinomas that affect or cross the junction of the stomach and esophagus are classified as carcinomas of the distal esophagus. Adenocarcinoma of the gastroesophageal junction occurs more often in Caucasian middle aged and elderly males. Clinical signs and symptoms include dysphagia, abdominal pain, and weight loss. The prognosis depends on the completeness of the surgical resection, the number of lymph nodes involved by cancer, and the presence or absence of postoperative complications. The presence of TP53 mutations indicates worse prognosis. C9296 Neoplastic Process Gastroesophageal Junction Adenocarcinoma Gastroesophageal Junction Adenocarcinoma C1332166 CTEP CTRP Cellosaurus Malignant Adenocarcinoma_of_the_Gastroesophageal_Junction Adenocarcinoma - GEJ Adenocarcinoma of Cardioesophageal Junction Adenocarcinoma of Gastroesophageal Junction Adenocarcinoma of the Cardioesophageal Junction Adenocarcinoma of the EG Junction Adenocarcinoma of the Esophagogastric Junction Adenocarcinoma of the GE Junction Adenocarcinoma of the Gastroesophageal Junction Adenocarcinoma of the gastroesophageal junction Gastroesophageal Junction Adenocarcinoma Gastroesophageal Junction Adenocarcinoma A primary or metastatic malignant neoplasm involving the urinary system. C9297 Neoplastic Process Malignant Urinary System Neoplasm Malignant Urinary System Neoplasm C0751571 CPTAC CTRP mCode Malignant Malignant_Urinary_Tract_Neoplasm Malignant neoplasm of kidney and other and unspecified urinary organs Malignant neoplasm of other specified sites of urinary organs Malignant neoplasm of urinary organ, site unspecified Malignant neoplasm: Urinary organ, unspecified Malignant Urinary System Neoplasm Malignant Urinary System Tumor Malignant neoplasm of urinary organ, unspecified Malignant Urinary System Neoplasm A rare acute leukemia of ambiguous lineage in which the blasts do not express markers specific to myeloid or lymphoid lineage. C9298 Neoplastic Process Acute Undifferentiated Leukemia Acute Undifferentiated Leukemia C1378511 CTRP GDC NICHD A rare acute leukemia in which the blasts do not express markers specific to myeloid or lymphoid lineage. Malignant Stem_Cell_Leukemia Acute leukemia, NOS Stem cell leukemia Acute Undifferentiated Leukemia Acute leukemia, NOS Leukemia Stem Cell Stem Cell Acute Leukemia Stem Cell Leukemia Stem cell leukemia Undifferentiated Acute Leukemia Acute Undifferentiated Leukemia A clonal (malignant) hematopoietic disorder with an acute onset, affecting the bone marrow and the peripheral blood. The malignant cells show minimal differentiation and are called blasts, either myeloid blasts (myeloblasts) or lymphoid blasts (lymphoblasts). C9300 Neoplastic Process Acute Leukemia Acute Leukemia C0085669 CPTAC CTRP GDC A rapidly progressing cancer that starts in blood-forming tissue such as the bone marrow, and causes large numbers of white blood cells to be produced and enter the blood stream. 9801/3 Malignant Acute_Leukemia 9801/3 Acute leukaemia of unspecified cell type Acute leukemia of unspecified cell type not having achieved remission Acute leukemia of unspecified cell type without mention of having achieved remission Acute leukemia, NOS Blast cell leukemia Leukemia of unspecified cell type, acute Undifferentiated leukaemia Acute Leukemia acute leukemia Acute Leukemia C93009 Diagnostic Procedure Intraoperative Ultrasound Intraoperative Ultrasound C2368278 CTRP A procedure that uses ultrasound (high-energy sound waves that are bounced off internal tissues and organs) during surgery. Sonograms (pictures made by ultrasound) of the inside of the body are viewed on a computer to help a surgeon find tumors or other problems during the operation. IOUS Intraoperative Ultrasound intraoperative ultrasound Intraoperative Ultrasound A non-Hodgkin or Hodgkin lymphoma that arises in the brain or spinal cord as a primary lesion. There is no evidence of lymphoma outside the central nervous system at the time of diagnosis. C9301 Neoplastic Process Central Nervous System Lymphoma Central Nervous System Lymphoma C0280803 CPTAC CTEP CTRP Cellosaurus GDC Cancer that forms in the lymph tissue of the brain, spinal cord, meninges (outer covering of the brain), or eye (called ocular lymphoma). Malignant Central_Nervous_System_Lymphoma 9590/3 Microglioma Primary central nervous system lymphoma CNS Lymphoma Central Nervous System Lymphoma Malignant Lymphomas of CNS Malignant Lymphomas of the CNS PCNSL Primary CNS Lymphoma Primary CNS lymphoma Primary Central Nervous System Lymphoma primary CNS lymphoma primary central nervous system lymphoma Central Nervous System Lymphoma MRI that uses a magnet capable of producing a 3 tesla field strength. In theory, 3.0 T magnets have the capability to provide better image quality, with improved diagnostic performance. C93013 Diagnostic Procedure 3 Tesla Magnetic Resonance Imaging 3 Tesla Magnetic Resonance Imaging CL412383 CTRP A procedure in which radio waves and a powerful magnet linked to a computer are used to make detailed pictures of areas inside the body. These pictures can show the difference between normal and abnormal tissue. 3T MRI has a stronger magnet and makes better images of organs and soft tissue than other types of MRI do. It is used to make images of the brain, the spine, the soft tissue of joints, and the inside of bones and blood vessels. 3 Tesla MRI 3 Tesla Magnetic Resonance Imaging 3 Tesla magnetic resonance imaging 3T MRI 3 Tesla Magnetic Resonance Imaging C93015 Therapeutic or Preventive Procedure Rapid Hormone Cycling C2985396 A procedure in which drugs that block the production of male hormones are alternated with male hormones and/or drugs that promote the production of male hormones. This procedure is being studied in the treatment of prostate cancer. Rapid Hormone Cycling rapid hormone cycling Rapid Hormone Cycling A localized tumor composed of sheets of mast cells without atypia. It includes the cutaneous mastocytoma which involves the dermis and subcutaneous tissue, and the extracutaneous mastocytoma. Most cases of extracutaneous mastocytoma have been reported in the lung. C9303 Neoplastic Process Mastocytoma C0024897 GDC A growth or lump of mast cells (a type of white blood cell). Mast cell tumors can involve the skin, subcutaneous tissue, and muscle tissue. 9740/1 Undetermined Mastocytoma 9740/1 Mastocytoma, NOS Mastocytoma Mastocytoma, NOS mastocytoma Mastocytoma A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones. C9306 Neoplastic Process Soft Tissue Sarcoma Soft Tissue Sarcoma C2211494 CPTAC CTEP CTRP Cellosaurus GDC MedDRA NICHD A solid, malignant neoplasm originating in muscle, tendon, fat, blood vessels, nerves, connective or joint tissue. Malignant Soft_Tissue_Sarcoma 8800/3 Soft tissue sarcoma Soft tissue sarcoma, non-rhabdomyosarcoma Non-Rhabdo. soft tissue sarcoma Non-Rhabdomyosarcoma soft tissue sarcoma, NOS Sarcoma of Soft Tissue Sarcoma of the Soft Tissue Soft Tissue Sarcoma Soft tissue sarcoma soft tissue sarcoma Soft Tissue Sarcoma A primary or metastatic malignant neoplasm involving the cervix. C9311 Neoplastic Process Malignant Cervical Neoplasm Malignant Cervical Neoplasm C0007847 CPTAC CTRP mCode Malignant Malignant_Cervical_Neoplasm Malignant neoplasm of cervix uteri Malignant neoplasm of cervix uteri, unspecified Malignant neoplasm of other specified sites of cervix Malignant neoplasm: Cervix uteri, unspecified Malignant neoplasm: Overlapping lesion of cervix uteri Malignant Cervical Neoplasm Malignant Cervical Tumor Malignant Cervix Neoplasm Malignant Cervix Tumor Malignant Cervix Uteri Neoplasm Malignant Cervix Uteri Tumor Malignant Neoplasm of Cervix Malignant Neoplasm of Cervix Uteri Malignant Neoplasm of Uterine Cervix Malignant Neoplasm of the Cervix Malignant Neoplasm of the Cervix Uteri Malignant Neoplasm of the Uterine Cervix Malignant Tumor of Cervix Malignant Tumor of Cervix Uteri Malignant Tumor of Uterine Cervix Malignant Tumor of the Cervix Malignant Tumor of the Cervix Uteri Malignant Tumor of the Uterine Cervix Malignant Uterine Cervix Neoplasm Malignant Uterine Cervix Tumor Malignant neoplasm of cervix uteri, unspecified Malignant Cervical Neoplasm A sarcoma that arises from the bone. Representative examples are osteosarcoma and chondrosarcoma. C9312 Neoplastic Process Bone Sarcoma Bone Sarcoma C1704327 CPTAC CTRP Cellosaurus Malignant Bone_Sarcoma Bone Sarcoma Osseous Sarcoma Sarcoma of Bone Sarcoma of the Bone Skeletal Sarcoma Bone Sarcoma A sarcoma that arises in the bones or soft tissues following exposure to ionizing or non-ionizing radiation. C93125 Neoplastic Process Radiation-Related Sarcoma C2985448 CPTAC Malignant Radiation-Related Sarcoma Radiation-Related Sarcoma A testicular germ cell tumor characterized by the absence of a seminomatous component. It includes embryonal carcinoma, yolk sac tumor, choriocarcinoma, teratoma, and mixed forms. C9313 Neoplastic Process Testicular Non-Seminomatous Germ Cell Tumor Testicular Non-Seminomatous Germ Cell Tumor C1336724 CTRP 9065/3 Undetermined Testicular_Non-Seminomatous_Germ_Cell_Tumor Testicular Germ Cell Tumor Non-Seminomatous Testicular Non-Seminomatous Germ Cell Tumor Testicular Non-Seminomatous Germ Cell Tumor A primary or metastatic malignant neoplasm involving the oral cavity. The majority are squamous cell carcinomas. C9314 Neoplastic Process Malignant Oral Cavity Neoplasm Malignant Oral Cavity Neoplasm C0153381 CPTAC CTRP mCode Malignant Malignant_Oral_Cavity_Neoplasm Malignant neoplasm of mouth, unspecified Malignant neoplasm of other and unspecified parts of mouth Malignant neoplasm of other specified parts of mouth Malignant neoplasm of retromolar area Malignant neoplasm of vestibule of mouth Malignant neoplasm: Mouth, unspecified Malignant neoplasm: Overlapping lesion of other and unspecified parts of mouth Malignant neoplasm: Retromolar area Malignant Mouth Neoplasm Malignant Mouth Tumor Malignant Neoplasm of Mouth Malignant Neoplasm of the Mouth Malignant Oral Cavity Neoplasm Malignant Oral Cavity Tumor Malignant Tumor of Mouth Malignant Tumor of the Mouth Malignant neoplasm of mouth, unspecified Malignant Oral Cavity Neoplasm A carcinoma arising in the lip or oral cavity. Most oral cavity carcinomas are squamous cell carcinomas of the tongue, buccal mucosa, or gums. Less frequent morphologic variants include mucoepidermoid carcinoma and adenocarcinoma. Lip carcinomas are usually basal cell or squamous cell carcinomas. C9315 Neoplastic Process Lip and Oral Cavity Carcinoma Lip and Oral Cavity Carcinoma C0220641 CPTAC CTRP Cancer that forms in tissues of the oral cavity (the mouth) or the oropharynx (the part of the throat at the back of the mouth). Malignant Lip_and_Oral_Cavity_Carcinoma Lip and Oral Cavity Cancer Lip and Oral Cavity Carcinoma Oral Cancer Oral Carcinoma oral cancer Lip and Oral Cavity Carcinoma A primary or metastatic malignant neoplasm that affects the lip and/or oral cavity. The majority of cases are carcinomas. C9316 Neoplastic Process Malignant Oral Neoplasm CL448458 CPTAC Malignant Malignant_Oral_Neoplasm Malignant neoplasm of ill-defined sites within the lip and oral cavity Malignant neoplasm of other and ill-defined sites within the lip, oral cavity, and pharynx Malignant neoplasm of other sites within the lip and oral cavity Malignant Lip and Oral Cavity Neoplasm Malignant Oral Neoplasm Malignant Oral Neoplasm A primary or metastatic malignant neoplasm that affects the gums. C9317 Neoplastic Process Malignant Gingival Neoplasm Malignant Gingival Neoplasm C0153364 CPTAC CTRP mCode Malignant Malignant_Gingival_Neoplasm Malignant neoplasm of gum Malignant neoplasm of gum, unspecified Malignant neoplasm of lower gum Malignant neoplasm of other sites of gum Malignant neoplasm of upper gum Malignant neoplasm: Gum, unspecified Malignant neoplasm: Lower gum Malignant Gingival Neoplasm Malignant Gingival Tumor Malignant Gum Neoplasm Malignant Gum Tumor Malignant Neoplasm of Gingiva Malignant Neoplasm of Gum Malignant Neoplasm of the Gingiva Malignant Neoplasm of the Gum Malignant Tumor of Gingiva Malignant Tumor of Gum Malignant Tumor of the Gingiva Malignant Tumor of the Gum Malignant neoplasm of gum, unspecified Malignant Gingival Neoplasm A primary or metastatic malignant neoplasm that affects the floor of the mouth. The majority of cases are carcinomas. C9318 Neoplastic Process Malignant Floor of the Mouth Neoplasm C0153368 CPTAC mCode Malignant Malignant_Floor_of_the_Mouth_Neoplasm Malignant neoplasm of anterior portion of floor of mouth Malignant neoplasm of floor of mouth Malignant neoplasm of floor of mouth, part unspecified Malignant neoplasm of lateral portion of floor of mouth Malignant neoplasm of other sites of floor of mouth Malignant neoplasm: Anterior floor of mouth Malignant neoplasm: Floor of mouth, unspecified Malignant neoplasm: Overlapping lesion of floor of mouth Malignant Floor of Mouth Neoplasm Malignant Floor of Mouth Tumor Malignant Floor of the Mouth Neoplasm Malignant Floor of the Mouth Tumor Malignant Neoplasm of Floor of Mouth Malignant Neoplasm of the Floor of the Mouth Malignant Tumor of Floor of Mouth Malignant Tumor of the Floor of the Mouth Malignant neoplasm of floor of mouth, unspecified Malignant Floor of the Mouth Neoplasm A carcinoma of the oral cavity that arises from the floor of the mouth. Representative examples include squamous cell carcinoma, mucoepidermoid carcinoma, and adenoid cystic carcinoma. C9319 Neoplastic Process Floor of the Mouth Carcinoma C3164417 Malignant Floor_of_the_Mouth_Carcinoma Carcinoma of Floor of Mouth Carcinoma of the Floor of the Mouth Floor of Mouth Carcinoma Floor of the Mouth Carcinoma Mouth Floor Cancer Floor of the Mouth Carcinoma A primary or metastatic malignant neoplasm involving the buccal mucosa. C9320 Neoplastic Process Malignant Buccal Mucosa Neoplasm C0153373 CPTAC mCode Malignant Malignant_Buccal_Mucosa_Neoplasm Malignant neoplasm of cheek mucosa Malignant neoplasm: Cheek mucosa Malignant Buccal Mucosa Neoplasm Malignant Buccal Mucosa Tumor Malignant Neoplasm of Buccal Mucosa Malignant Neoplasm of the Buccal Mucosa Malignant Tumor of Buccal Mucosa Malignant Tumor of the Buccal Mucosa Malignant neoplasm of cheek mucosa Malignant Buccal Mucosa Neoplasm A procedure in which a small amount of carbon-11 choline (a radioactive form of the vitamin choline) is injected into a vein. A scanner and a computer are used to make detailed pictures of areas inside the body where the carbon-11 choline collects. Cancer cells take up more carbon-11 choline than normal cells, so the pictures can be used to find cancer cells in the body. C93201 Diagnostic Procedure Carbon-11 Choline PET-CT Scan C2985492 OORO A procedure in which a small amount of carbon-11 choline (a radioactive form of the vitamin choline) is injected into a vein. A scanner and a computer are used to make detailed pictures of areas inside the body where the carbon-11 choline collects. Cancer cells take up more carbon-11 choline than normal cells, so the pictures can be used to find cancer cells in the body. C-11 choline PET-CT scan Carbon-11 Choline PET-CT Scan PET-CT (C-11 choline) carbon-11 choline PET-CT scan Carbon-11 Choline PET-CT Scan Computed tomography that uses F[18] as a positron source for 3-dimensional imaging. C93202 Diagnostic Procedure F-18 Sodium Fluoride Positron Emission Tomography F-18 Sodium Fluoride Positron Emission Tomography C2985493 CTRP A procedure used to find out if cancer has spread to the bone. A small amount of a radioactive substance called fluorine F 18 sodium fluoride is injected into a vein. A PET scan is then used to make detailed pictures of the bones. Bones with cancer in them take up more fluorine F18 sodium fluoride than normal bones do. F 18 sodium fluoride positron emission tomography F-18 NaF PET F-18 Sodium Fluoride Positron Emission Tomography F-18 Sodium Fluoride Positron Emission Tomography and Computed Tomography Scan fluorine F 18 sodium fluoride PET F-18 Sodium Fluoride Positron Emission Tomography A primary or metastatic malignant neoplasm involving the nasopharynx. C9321 Neoplastic Process Malignant Nasopharyngeal Neoplasm Malignant Nasopharyngeal Neoplasm C0153392 CPTAC CTRP mCode Malignant Malignant_Nasopharyngeal_Neoplasm Malignant neoplasm of anterior wall of nasopharynx Malignant neoplasm of lateral wall of nasopharynx Malignant neoplasm of nasopharynx Malignant neoplasm of nasopharynx, unspecified Malignant neoplasm of other specified sites of nasopharynx Malignant neoplasm of posterior wall of nasopharynx Malignant neoplasm of superior wall of nasopharynx Malignant neoplasm: Nasopharynx, unspecified Malignant neoplasm: Posterior wall of nasopharynx Malignant Nasopharyngeal Neoplasm Malignant Nasopharyngeal Tumor Malignant Neoplasm of Nasopharynx Malignant Neoplasm of the Nasopharynx Malignant Tumor of Nasopharynx Malignant Tumor of the Nasopharynx Malignant neoplasm of nasopharynx, unspecified Malignant Nasopharyngeal Neoplasm A primary or metastatic malignant neoplasm affecting the parathyroid glands. C9322 Neoplastic Process Malignant Parathyroid Gland Neoplasm C0153653 CPTAC mCode Malignant Malignant_Parathyroid_Neoplasm Malignant neoplasm: Parathyroid gland Malignant Neoplasm of Parathyroid Malignant Neoplasm of Parathyroid Gland Malignant Neoplasm of the Parathyroid Malignant Neoplasm of the Parathyroid Gland Malignant Parathyroid Gland Neoplasm Malignant Parathyroid Gland Tumor Malignant Parathyroid Neoplasm Malignant Parathyroid Tumor Malignant Tumor of Parathyroid Malignant Tumor of Parathyroid Gland Malignant Tumor of the Parathyroid Malignant Tumor of the Parathyroid Gland Malignant neoplasm of parathyroid gland Malignant Parathyroid Gland Neoplasm A primary or metastatic malignant neoplasm that affects the postcricoid region. C9323 Neoplastic Process Malignant Postcricoid Neoplasm C0496769 CPTAC Malignant Malignant_Postcricoid_Neoplasm Malignant neoplasm of postcricoid region of hypopharynx Malignant Neoplasm of Postcricoid Area Malignant Neoplasm of the Postcricoid Area Malignant Postcricoid Neoplasm Malignant Postcricoid Tumor Malignant Tumor of Postcricoid Area Malignant Tumor of the Postcricoid Area Malignant Postcricoid Neoplasm A diagnostic procedure to assess the circulatory perfusion of an anatomical location using a magnetic resonance imaging machine. C93243 Diagnostic Procedure Perfusion Magnetic Resonance Imaging Perfusion Magnetic Resonance Imaging CL505186 CDISC CTRP DIPG/DMG A special type of magnetic resonance imaging (MRI) that uses an injected dye in order to see blood flow through tissues. A type of contrast-enhanced magnetic resonance imaging technique that assesses the circulatory perfusion of an anatomical location. PERFUSION MRI Perfusion Magnetic Resonance Imaging Perfusion Sequence magnetic resonance perfusion imaging perfusion magnetic resonance imaging Perfusion Magnetic Resonance Imaging A rare, usually large (greater than 5cm), malignant epithelial tumor arising from the adrenal cortical cells. Symptoms are usually related to the excessive production of hormones, and include Cushing's syndrome and virilism in women. Common sites of metastasis include liver, lung, bone, and retroperitoneal lymph nodes. Advanced radiologic procedures have enabled the detection of small tumors, resulting in the improvement of the 5-year survival. C9325 Neoplastic Process Adrenal Cortex Carcinoma Adrenal Cortical Carcinoma C0206686 CDISC CPTAC CTEP CTRP Cellosaurus GDC A malignant epithelial neoplasm arising from adrenal cortical cells. A rare cancer that forms in the outer layer of tissue of the adrenal gland (a small organ on top of each kidney that makes steroid hormones, adrenaline, and noradrenaline to control heart rate, blood pressure, and other body functions). 8370/3 Malignant Adrenal_Cortex_Carcinoma 8370/3 Adrenal cortical adenocarcinoma Adrenal cortical carcinoma Adenocarcinoma, Adrenocortical, Malignant Adrenal Cortex Adenocarcinoma Adrenal Cortex Cancer Adrenal Cortex Carcinoma Adrenal Cortical Adenocarcinoma Adrenal Cortical Carcinoma Adrenal cortical adenocarcinoma Adrenal cortical carcinoma Adrenocortical Carcinoma Adrenocortical carcinoma Adrenocortical carcinoma, NOS CARCINOMA, ADRENOCORTICAL, MALIGNANT Carcinoma of Adrenal Cortex Carcinoma of the Adrenal Cortex Cortical Cell Carcinoma adrenocortical cancer adrenocortical carcinoma cancer of the adrenal cortex Adrenal Cortical Carcinoma A primary or metastatic malignant neoplasm affecting the adrenal cortex. C9327 Neoplastic Process Malignant Adrenal Cortical Neoplasm C0346402 CPTAC GDC mCode Malignant Malignant_Adrenal_Cortex_Neoplasm 8370/3 Adrenal cortical tumor, malignant Malignant neoplasm of cortex of left adrenal gland Adrenal cortical tumor, malignant Malignant Adrenal Cortex Neoplasm Malignant Adrenal Cortex Tumor Malignant Adrenal Cortical Neoplasm Malignant Adrenocortical Neoplasm Malignant Adrenocortical Tumor Malignant Neoplasm of Adrenal Cortex Malignant Neoplasm of the Adrenal Cortex Malignant Tumor of Adrenal Cortex Malignant Tumor of the Adrenal Cortex Malignant neoplasm of cortex of unspecified adrenal gland Malignant Adrenal Cortical Neoplasm C93278 Diagnostic Procedure Vibro-acoustography Imaging C2985531 A technique being studied in the diagnosis of breast cancer and other types of cancer. Vibro-acoustography imaging uses ultrasound (high-energy sound waves) to cause tissues to vibrate. The sound made by the vibrating tissues is picked up by a microphone and is used to make an image of the object on a computer. Cancer tissue can be seen because it is denser and vibrates at a different rate than normal tissue. Vibro-acoustography Imaging vibro-acoustography imaging Vibro-acoustography Imaging A primary or metastatic malignant neoplasm that affects the duodenum. Representative examples include carcinoma, lymphoma, and sarcoma. C9328 Neoplastic Process Malignant Duodenal Neoplasm C0153426 CPTAC mCode Malignant Malignant_Duodenal_Neoplasm Malignant neoplasm of duodenum Malignant neoplasm: Duodenum Malignant Duodenal Neoplasm Malignant Duodenal Tumor Malignant Neoplasm of Duodenum Malignant Neoplasm of the Duodenum Malignant Tumor of Duodenum Malignant Tumor of the Duodenum Malignant neoplasm of duodenum Malignant Duodenal Neoplasm A primary or metastatic malignant neoplasm that affects the cecum. Representative examples include carcinoma, lymphoma, and sarcoma. C9329 Neoplastic Process Malignant Cecum Neoplasm Malignant Cecum Neoplasm C0153437 CPTAC CTRP mCode Malignant Malignant_Cecum_Neoplasm Malignant neoplasm of cecum Malignant neoplasm: Caecum Malignant Cecal Neoplasm Malignant Cecum Neoplasm Malignant Cecum Tumor Malignant Neoplasm of Cecum Malignant Neoplasm of the Cecum Malignant Tumor of Cecum Malignant Tumor of the Cecum Malignant neoplasm of cecum Malignant Cecum Neoplasm A malignant epithelial neoplasm arising from the appendix. The vast majority of the cases are adenocarcinomas. C9330 Neoplastic Process Appendix Carcinoma Appendix Carcinoma C3163821 CPTAC CTRP Malignant Appendix_Carcinoma Appendiceal Cancer Appendix Cancer Appendix Carcinoma Carcinoma of Appendix Carcinoma of the Appendix Appendix Carcinoma A primary or metastatic malignant neoplasm involving the stomach. C9331 Neoplastic Process Malignant Gastric Neoplasm Malignant Gastric Neoplasm C0024623 CPTAC CTRP mCode Malignant Malignant_Gastric_Neoplasm Malignant neoplasm of body of stomach Malignant neoplasm of cardia Malignant neoplasm of other specified sites of stomach Malignant neoplasm of pyloric antrum Malignant neoplasm of pylorus Malignant neoplasm of stomach Malignant neoplasm of stomach, unspecified Malignant neoplasm: Body of stomach Malignant neoplasm: Cardia Malignant neoplasm: Overlapping lesion of stomach Malignant neoplasm: Pyloric antrum Malignant neoplasm: Stomach, unspecified Malignant Gastric Neoplasm Malignant Gastric Tumor Malignant Neoplasm of Stomach Malignant Neoplasm of the Stomach Malignant Tumor of Stomach Malignant Tumor of the Stomach Malignant neoplasm of stomach, unspecified Malignant Gastric Neoplasm A carcinoma that arises from the maxillary sinus. Representative examples include squamous cell carcinoma, adenocarcinoma, and adenoid cystic carcinoma. C9332 Neoplastic Process Maxillary Sinus Carcinoma C0740487 Malignant Maxillary_Sinus_Carcinoma Maxillary Sinus Cancer Maxillary Sinus Carcinoma Maxillary Sinus Carcinoma A primary or metastatic malignant neoplasm that affects the appendix. Representative examples include carcinoma and lymphoma. C9333 Neoplastic Process Malignant Appendix Neoplasm C0496779 CPTAC mCode Malignant Malignant_Appendix_Neoplasm Malignant neoplasm of appendix vermiformis Malignant neoplasm: Appendix Malignant Appendix Neoplasm Malignant Appendix Tumor Malignant Neoplasm of Appendix Malignant Neoplasm of Appendix Vermiformis Malignant Neoplasm of the Appendix Malignant Tumor of Appendix Malignant Tumor of the Appendix Malignant neoplasm of appendix Malignant Appendix Neoplasm A primary or metastatic malignant neoplasm involving the bladder. C9334 Neoplastic Process Malignant Bladder Neoplasm Malignant Bladder Neoplasm C0005684 CPTAC CTRP mCode Malignant Malignant_Bladder_Neoplasm Malignant neoplasm of anterior wall of urinary bladder Malignant neoplasm of bladder Malignant neoplasm of bladder neck Malignant neoplasm of bladder, part unspecified Malignant neoplasm of dome of urinary bladder Malignant neoplasm of lateral wall of urinary bladder Malignant neoplasm of other specified sites of bladder Malignant neoplasm of posterior wall of urinary bladder Malignant neoplasm of trigone of urinary bladder Malignant neoplasm: Bladder, unspecified Malignant neoplasm: Dome of bladder Malignant neoplasm: Overlapping lesion of bladder Malignant neoplasm: Posterior wall of bladder Malignant Bladder Neoplasm Malignant Bladder Tumor Malignant Neoplasm of Bladder Malignant Neoplasm of Urinary Bladder Malignant Neoplasm of the Bladder Malignant Neoplasm of the Urinary Bladder Malignant Neoplasm, Bladder Malignant Neoplasm, Urinary Bladder Malignant Tumor of Bladder Malignant Tumor of Urinary Bladder Malignant Tumor of the Bladder Malignant Tumor of the Urinary Bladder Malignant Tumor, Urinary Bladder Malignant Urinary Bladder Neoplasm Malignant Urinary Bladder Tumor Malignant neoplasm of bladder, unspecified Urinary Bladder Malignant Neoplasm Urinary Bladder Malignant Tumor Malignant Bladder Neoplasm A primary or metastatic malignant neoplasm involving the breast. The vast majority of cases are carcinomas arising from the breast parenchyma or the nipple. Malignant breast neoplasms occur more frequently in females than in males. C9335 Neoplastic Process Malignant Breast Neoplasm Malignant Breast Neoplasm C3281210 CPTAC CTRP Malignant Malignant_Breast_Neoplasm Malignant neoplasm of axillary tail of female breast Malignant neoplasm of breast Malignant neoplasm of breast of unspecified site, female Malignant neoplasm of central portion of female breast Malignant neoplasm of central portion of left female breast Malignant neoplasm of central portion of right female breast Malignant neoplasm of female breast Malignant neoplasm of lower-inner quadrant of female breast Malignant neoplasm of lower-inner quadrant of left female breast Malignant neoplasm of lower-inner quadrant of right female breast Malignant neoplasm of lower-inner quadrant of unspecified female breast Malignant neoplasm of lower-outer quadrant of female breast Malignant neoplasm of lower-outer quadrant of left female breast Malignant neoplasm of lower-outer quadrant of right female breast Malignant neoplasm of lower-outer quadrant of unspecified female breast Malignant neoplasm of male breast Malignant neoplasm of other and unspecified sites of male breast Malignant neoplasm of other specified sites of female breast Malignant neoplasm of overlapping sites of left female breast Malignant neoplasm of overlapping sites of right female breast Malignant neoplasm of overlapping sites of unspecified female breast Malignant neoplasm of unspecified site of left female breast Malignant neoplasm of unspecified site of right female breast Malignant neoplasm of unspecified site of unspecified female breast Malignant neoplasm of unspecified site of unspecified male breast Malignant neoplasm of upper-inner quadrant of female breast Malignant neoplasm of upper-inner quadrant of left female breast Malignant neoplasm of upper-inner quadrant of right female breast Malignant neoplasm of upper-inner quadrant of unspecified female breast Malignant neoplasm of upper-outer quadrant of female breast Malignant neoplasm of upper-outer quadrant of left female breast Malignant neoplasm of upper-outer quadrant of right female breast Malignant neoplasm of upper-outer quadrant of unspecified female breast Malignant neoplasm: Axillary tail of breast Malignant neoplasm: Breast, unspecified Malignant neoplasm: Central portion of breast Malignant neoplasm: Lower-inner quadrant of breast Malignant neoplasm: Lower-outer quadrant of breast Malignant neoplasm: Overlapping lesion of breast Malignant neoplasm: Upper-inner quadrant of breast Malignant neoplasm: Upper-outer quadrant of breast Malignant Breast Neoplasm Malignant Breast Tumor Malignant Neoplasm of Breast Malignant Neoplasm of the Breast Malignant Tumor of Breast Malignant Tumor of the Breast Malignant Breast Neoplasm A malignant epithelial neoplasm arising in the nasal cavity. C9336 Neoplastic Process Nasal Cavity Carcinoma Nasal Cavity Carcinoma C3163933 CTRP Malignant Nasal_Cavity_Carcinoma Cancer of Nasal Cavity Cancer of the Nasal Cavity Carcinoma of Nasal Cavity Carcinoma of the Nasal Cavity Nasal Cavity Cancer Nasal Cavity Carcinoma Nasal Cavity Carcinoma A malignant neoplasm that affects the ear. Representative examples include ceruminous adenocarcinoma and squamous cell carcinoma of the external ear and adenocarcinoma of the middle ear. C9337 Neoplastic Process Malignant Ear Neoplasm C0751094 Malignant Malignant_Ear_Neoplasm Malignant Ear Neoplasm Malignant Ear Tumor Malignant Neoplasm of Ear Malignant Neoplasm of the Ear Malignant Tumor of Ear Malignant Tumor of the Ear Malignant Ear Neoplasm A primary or metastatic malignant neoplasm affecting the adrenal gland. C9338 Neoplastic Process Malignant Adrenal Gland Neoplasm Malignant Adrenal Gland Neoplasm C0750887 CTRP GDC mCode Cancer that forms in the tissues of the adrenal glands (two glands located just above the kidneys). The adrenal glands make hormones that control heart rate, blood pressure, and other important body functions. Adrenal cancer that starts in the outside layer of the adrenal gland is called adrenocortical carcinoma. Adrenal cancer that starts in the center of the adrenal gland is called malignant pheochromocytoma. Malignant Malignant_Adrenal_Gland_Neoplasm Adrenal Gland Cancer Malignant neoplasm of adrenal gland Malignant neoplasm of unspecified part of left adrenal gland Malignant neoplasm of unspecified part of right adrenal gland Malignant neoplasm of unspecified part of unspecified adrenal gland Malignant neoplasm: Adrenal gland, unspecified Malignant Adrenal Gland Neoplasm Malignant Adrenal Gland Tumor Malignant Adrenal Neoplasm Malignant Adrenal Tumor Malignant Neoplasm of Adrenal Gland Malignant Neoplasm of the Adrenal Gland Malignant Tumor of Adrenal Gland Malignant Tumor of the Adrenal Gland Malignant neoplasm of unspecified part of unspecified adrenal gland adrenal cancer Malignant Adrenal Gland Neoplasm Peripheral T-cell lymphoma, not otherwise specified that is resistant to treatment. C9339 Neoplastic Process Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified C0854852 Malignant Refractory_Peripheral_T-Cell_Lymphoma_Unspecified Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified Refractory Unspecified Peripheral T-Cell Lymphoma Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified A small round cell tumor with neural differentiation arising from the soft tissues or bone. C9341 Neoplastic Process Peripheral Primitive Neuroectodermal Tumor Peripheral Primitive Neuroectodermal Tumor C3489398 CTRP Cellosaurus GDC PCDC A type of cancer that forms in bone or soft tissue. 9364/3 Malignant Peripheral_Primitive_Neuroectodermal_Tumor 9364/3 PPNET Peripheral neuroectodermal tumor Peripheral primitive neuroectodermal tumor, NOS Neuro-Differentiated Ewing Tumor PPNET Peripheral Neuroectodermal Neoplasm Peripheral Neuroectodermal Tumor Peripheral Neuroepithelioma Peripheral PNET Peripheral Primitive Neuroectodermal Neoplasm Peripheral Primitive Neuroectodermal Tumor Peripheral neuroectodermal tumor pPNET peripheral primitive neuroectodermal tumor Peripheral Primitive Neuroectodermal Tumor A benign, intermediate, or malignant neoplasm involving the bone or articular cartilage. C9343 Neoplastic Process Bone Neoplasm Bone Neoplasm C0005967 CPTAC CTRP GDC Undetermined Bone_Neoplasm Miscellaneous Bone Tumors Neoplasm of uncertain behavior of bone and articular cartilage Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage Bone Neoplasm Bone Neoplasms Bone Tumor Bone Tumors Neoplasm of Bone Neoplasm of the Bone Osseous Neoplasm Osseous Tumor Tumor of Bone Tumor of the Bone Bone Neoplasm A poorly differentiated malignant embryonal neoplasm arising from the pineal region. It usually occurs in children and it is characterized by the presence of small immature neuroepithelial cells. It may follow an aggressive clinical course. C9344 Neoplastic Process Pineoblastoma Pineoblastoma C0205898 CDISC CPTAC CTRP GDC A fast growing type of brain tumor that occurs in or around the pineal gland, a tiny organ near the center of the brain. A poorly differentiated malignant embryonal neoplasm arising from the pineal region of the brain. 9362/3 Malignant Pineoblastoma 9362/3 Pineoblastoma PINEOBLASTOMA, MALIGNANT PNET of Pineal Gland PNET of the Pineal Gland Pineal Gland PNET Pineal Gland Primitive Neuroectodermal Neoplasm Pineal Gland Primitive Neuroectodermal Tumor Pineal PNET Pineal Primitive Neuroectodermal Neoplasm Pineal Primitive Neuroectodermal Tumor Pineoblastoma Pineoblastoma (WHO Grade 4) Pineoblastoma (WHO Grade IV) Primitive Neuroectodermal Neoplasm of Pineal Gland Primitive Neuroectodermal Neoplasm of the Pineal Gland Primitive Neuroectodermal Tumor of Pineal Gland Primitive Neuroectodermal Tumor of the Pineal Gland pineoblastoma Pineoblastoma A malignant neoplasm affecting the tongue. The vast majority of cases are carcinomas. C9345 Neoplastic Process Malignant Tongue Neoplasm Malignant Tongue Neoplasm C0153349 CPTAC CTRP mCode Malignant Malignant_Tongue_Neoplasm Malignant neoplasm of dorsal surface of tongue Malignant neoplasm of other and unspecified parts of tongue Malignant neoplasm of other sites of tongue Malignant neoplasm of tip and lateral border of tongue Malignant neoplasm of tongue Malignant neoplasm of tongue, unspecified Malignant neoplasm of ventral surface of tongue Malignant neoplasm: Border of tongue Malignant neoplasm: Dorsal surface of tongue Malignant neoplasm: Tongue, unspecified Malignant neoplasm: Ventral surface of tongue Malignant Neoplasm of Tongue Malignant Neoplasm of the Tongue Malignant Tongue Neoplasm Malignant Tongue Tumor Malignant Tumor of Tongue Malignant Tumor of the Tongue Malignant neoplasm of tongue, unspecified Tongue Neoplasm Malignant Stage Unspecified Tongue Neoplasm, Malignant Malignant Tongue Neoplasm A primary or metastatic malignant neoplasm involving the trachea. C9346 Neoplastic Process Malignant Tracheal Neoplasm C0153489 CPTAC mCode Malignant Malignant_Tracheal_Neoplasm Malignant neoplasm of trachea Malignant Neoplasm of Trachea Malignant Neoplasm of the Trachea Malignant Trachea Neoplasm Malignant Trachea Tumor Malignant Tracheal Neoplasm Malignant Tracheal Tumor Malignant Tumor of Trachea Malignant Tumor of the Trachea Malignant neoplasm of trachea Malignant Tracheal Neoplasm Malignant epithelial neoplasm arising from the tracheal mucosa. C9347 Neoplastic Process Tracheal Carcinoma C1744708 CPTAC Malignant Tracheal_Carcinoma Cancer of Trachea Cancer of the Trachea Carcinoma of Trachea Carcinoma of the Trachea Trachea Cancer Trachea Carcinoma Tracheal Carcinoma Tracheal Carcinoma A rare malignant neoplasm characterized by localized but destructive growth of a tumor consisting of highly atypical, immature mast cells. (WHO, 2001) C9348 Neoplastic Process Mast Cell Sarcoma Mast Cell Sarcoma C0036221 CTRP GDC mCode 9740/3 Malignant Mast_Cell_Sarcoma 9740/3 Malignant mast cell tumor Malignant mastocytoma Mast cell sarcoma MCS Mast Cell Sarcoma Mast cell sarcoma Mast Cell Sarcoma A malignant neoplasm characterized by the presence of a monoclonal population of plasma cells forming a tumor mass. C9349 Neoplastic Process Plasmacytoma Plasmacytoma C0032131 CPTAC CTRP GDC A type of cancer that begins in plasma cells (white blood cells that produce antibodies). A plasmacytoma may turn into multiple myeloma. 9731/3 Malignant Plasmacytoma 9731/3 Plasmacytoma, NOS Plasmacytoma Plasmacytoma, NOS plasmacytoma Plasmacytoma An aggressive malignant mesothelioma that arises from the peritoneum. Patients usually present with abdominal pain and ascites. C9350 Neoplastic Process Peritoneal Malignant Mesothelioma Peritoneal Malignant Mesothelioma C0346109 CTRP Cellosaurus Malignant Malignant_Peritoneal_Mesothelioma Malignant Mesothelioma of Peritoneum Malignant Mesothelioma of the Peritoneum Malignant Peritoneal Mesothelioma Peritoneal Malignant Mesothelioma Peritoneal Malignant Mesothelioma A mesothelial neoplasm that arises from the pleura. It includes adenomatoid tumor, well differentiated papillary mesothelial tumor, and malignant mesothelioma. C9351 Neoplastic Process Pleural Mesothelial Neoplasm C1377913 CPTAC mCode Undetermined Pleural_Mesothelioma Mesothelioma of pleura Mesothelial Neoplasm of Pleura Mesothelial Neoplasm of the Pleura Mesothelial Tumor of Pleura Mesothelial Tumor of the Pleura Mesothelioma of pleura Pleural Mesothelial Neoplasm Pleural Mesothelial Tumor Pleural Mesothelioma Pleural Mesothelial Neoplasm The reemergence of duodenal carcinoma after a period of remission. C9352 Neoplastic Process Recurrent Duodenal Carcinoma C0861832 Malignant Recurrent_Duodenal_Cancer Recurrent Duodenal Cancer Recurrent Duodenal Carcinoma Recurrent Duodenal Carcinoma The reemergence of a hypopharyngeal malignant neoplasm after a period of remission. C9353 Neoplastic Process Recurrent Malignant Hypopharyngeal Neoplasm C0279803 Malignant Recurrent_Malignant_Hypopharyngeal_Neoplasm Recurrent Malignant Hypopharyngeal Neoplasm Recurrent Malignant Hypopharyngeal Neoplasm The reemergence of a malignant neoplasm of the stomach after a period of remission. C9354 Neoplastic Process Recurrent Malignant Gastric Neoplasm C1335708 Malignant Recurrent_Malignant_Gastric_Neoplasm Recurrent Malignant Gastric Neoplasm Recurrent Malignant Gastric Neoplasm Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 6th and 7th eds.) C9355 Neoplastic Process Stage IVB Vaginal Cancer AJCC v6 and v7 Stage IVB Vaginal Cancer AJCC v6 and v7 C1377787 CTRP Malignant Stage_IVB_Vaginal_Cancer AJCC Stage IVB Vaginal Cancer FIGO Stage IVB Carcinoma of Vagina FIGO Stage IVB Carcinoma of the Vagina FIGO Stage IVB Vagina Carcinoma FIGO Stage IVB Vaginal Carcinoma Stage IVB Vaginal Cancer Stage IVB Vaginal Cancer AJCC v6 Stage IVB Vaginal Cancer AJCC v6 and v7 Stage IVB Vaginal Cancer AJCC v7 Stage IVB Vaginal Carcinoma AJCC v6 Stage IVB Vaginal Carcinoma AJCC v7 Vaginal Cancer Stage IVB Stage IVB Vaginal Cancer AJCC v6 and v7 A ureter carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes. C9356 Neoplastic Process Locally Advanced Ureter Carcinoma C0854921 Malignant Regional_Ureter_Cancer Locally Advanced Ureter Carcinoma Locally Advanced Ureter Carcinoma A lymphoma characterized by the presence of relatively few malignant cells called Reed-Sternberg cells and mononuclear Hodgkin cells that are admixed with nonneoplastic inflammatory cells. The malignant cells have a distinctive immunophenotype; they are positive for CD30 and CD15 and negative for CD3, CD20, and CD45. C9357 Neoplastic Process Hodgkin Lymphoma Hodgkin Lymphoma C0019829 CPTAC CTEP CTRP Cellosaurus GDC MedDRA NICHD PCDC mCode A cancer of the immune system that is marked by the presence of a type of cell called the Reed-Sternberg cell. The two major types of Hodgkin lymphoma are classical Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma. Symptoms include the painless enlargement of lymph nodes, spleen, or other immune tissue. Other symptoms include fever, weight loss, fatigue, or night sweats. A malignant neoplasm of the lymphatic system that is comprised of abnormal lymphocytes and is characterized by the presence of Reed-Sternberg cells. 9650/3 Malignant Hodgkin_s_Lymphoma 9650/3 Hodgkin Lymphoma Hodgkin disease, NOS Hodgkin lymphoma Hodgkin lymphoma, NOS Hodgkin lymphoma, unspecified Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck Hodgkin lymphoma, unspecified, lymph nodes of multiple sites Hodgkin lymphoma, unspecified, unspecified site Hodgkin's disease Hodgkin's disease, unspecified type Hodgkin's disease, unspecified type, involving intra-abdominal lymph nodes Hodgkin's disease, unspecified type, involving intrapelvic lymph nodes Hodgkin's disease, unspecified type, involving intrathoracic lymph nodes Hodgkin's disease, unspecified type, involving lymph nodes of head, face, and neck Hodgkin's disease, unspecified type, involving lymph nodes of multiple sites Hodgkin's disease, unspecified type, unspecified site, extranodal and solid organ sites Hodgkin's lymphoma Malignant lymphoma, Hodgkin HL Hodgkin Lymphoma Hodgkin Lymphoma, NOS Hodgkin disease Hodgkin disease, NOS Hodgkin lymphoma Hodgkin lymphoma, NOS Hodgkin lymphoma, unspecified, unspecified site Hodgkin's Disease Hodgkin's Lymphoma Malignant lymphoma, Hodgkin Hodgkin Lymphoma Stage I includes: (T1, N0, M0); (T2, N0, M0). T1: Tumor invades submucosa. T2: Tumor invades muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C9358 Neoplastic Process Stage I Colon Cancer AJCC v6 and v7 Stage I Colon Cancer AJCC v6 and v7 C0278474 CTRP Malignant Stage_I_Colon_Cancer AJCC Stage I Colon Cancer Colon Cancer Stage I Colon Cancer, Stage I Dukes A Carcinoma of Colon Dukes A Carcinoma of the Colon Dukes A Colon Carcinoma Dukes A Colonic Carcinoma Stage I Carcinoma of Colon Stage I Carcinoma of the Colon Stage I Colon Cancer Stage I Colon Cancer AJCC v6 Stage I Colon Cancer AJCC v6 and v7 Stage I Colon Cancer AJCC v7 Stage I Colon Carcinoma Stage I Colonic Carcinoma Stage I Colon Cancer AJCC v6 and v7 A basal cell carcinoma that contains large amounts of melanin. The melanin is produced by symbiotic nontumoral proliferating melanocytes. C9359 Neoplastic Process Skin Pigmented Basal Cell Carcinoma C1368275 GDC Malignant Pigmented_Basal_Cell_Carcinoma 8090/3 Pigmented basal cell carcinoma Pigmented Basal Cell Carcinoma Pigmented basal cell carcinoma Skin Pigmented Basal Cell Carcinoma Skin Pigmented Basal Cell Carcinoma A lymphoma composed of immature small to medium-sized precursor lymphoid cells (lymphoblasts). It includes the B- and T-cell lymphoblastic lymphoma. C9360 Neoplastic Process Lymphoblastic Lymphoma Lymphoblastic Lymphoma C0079748 CDISC CPTAC CTRP Cellosaurus GDC mCode A malignant neoplasm composed of lymphoblasts (lymphoid precursor cells). An aggressive (fast-growing) type of non-Hodgkin lymphoma in which too many lymphoblasts (immature white blood cells) are found in the lymph nodes and the thymus gland. These lymphoblasts may spread to other places in the body. It is most common in teenagers and young adults and affects more males than females. It may be a T or B cell type. 9727/3 Malignant Precursor_Lymphoblastic_Lymphoma 9727/3 Lymphoblastic (diffuse) lymphoma Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites Lymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes Lymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck Lymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites Lymphoblastic (diffuse) lymphoma, unspecified site Lymphoblastoma Malignant lymphoma, lymphoblastic, NOS Precursor Cell Lymphoblastic Lymphoma Precursor cell lymphoblastic lymphoma, NOS LBL LYMPHOMA, LYMPHOBLASTIC, MALIGNANT Lymphoblastic (diffuse) lymphoma, unspecified site Lymphoblastic Lymphoma Precursor Cell Lymphoblastic Lymphoma Precursor Lymphoblastic Lymphoma lymphoblastic lymphoma precursor lymphoblastic lymphoma Lymphoblastic Lymphoma A lymphoblastic lymphoma occurring in adults. C9361 Neoplastic Process Adult Lymphoblastic Lymphoma Adult Lymphoblastic Lymphoma C0278721 CTRP Malignant Adult_Lymphoblastic_Lymphoma Adult Lymphoblastic Lymphoma Adult Precursor Lymphoblastic Lymphoma Lymphoblastic Lymphoma Adult Lymphoblastic Lymphoma A carcinoma that arises from the clitoris. C9362 Neoplastic Process Clitoral Carcinoma Clitoral Carcinoma C1333070 CTRP Malignant Clitoral_Carcinoma Carcinoma of Clitoris Carcinoma of the Clitoris Clitoral Cancer Clitoral Carcinoma Clitoris Carcinoma Clitoral Carcinoma A carcinoma that arises from the labia majora. C9363 Neoplastic Process Labia Majora Carcinoma Labia Majora Carcinoma C1334356 CTRP Malignant Labia_Majora_Carcinoma Carcinoma of Labia Majora Carcinoma of the Labia Majora Labia Majora Cancer Labia Majora Carcinoma Labia Majora Carcinoma A carcinoma that arises from the labia minora. C9364 Neoplastic Process Labia Minora Carcinoma Labia Minora Carcinoma C1334357 CTRP Malignant Labia_Minora_Carcinoma Carcinoma of Labia Minora Carcinoma of the Labia Minora Labia Minora Cancer Labia Minora Carcinoma Labia Minora Carcinoma Malignant testicular germ cell tumor reemerging after a period of remission. C9369 Neoplastic Process Recurrent Malignant Testicular Germ Cell Tumor Recurrent Malignant Testicular Germ Cell Tumor C0278841 CTRP Malignant Recurrent_Testicular_Cancer Recurrent Cancer of Testis Recurrent Cancer of the Testis Recurrent Malignant Testicular Germ Cell Tumor Recurrent Testicular Cancer Relapsed Cancer of Testis Relapsed Cancer of the Testis Relapsed Testicular Cancer Recurrent Malignant Testicular Germ Cell Tumor A gliosarcoma of the brain stem that occurs during adulthood. C9370 Neoplastic Process Adult Brain Stem Gliosarcoma C1377914 Malignant Adult_Brain_Stem_Gliosarcoma Adult Brain Stem Gliosarcoma Adult Brain Stem Gliosarcoma A mixed glioma of the brain stem that occurs during adulthood. C9371 Neoplastic Process Adult Brain Stem Mixed Glioma C1377915 Undetermined Adult_Brain_Stem_Mixed_Glioma Adult Brain Stem Mixed Glioma Adult Brainstem Mixed Glioma Adult Brain Stem Mixed Glioma An ependymoma that arises from the brain and occurs in adults. C9372 Neoplastic Process Adult Brain Ependymoma Adult Brain Ependymoma C1332186 CTRP Undetermined Adult_Brain_Ependymoma Adult Brain Ependymoma Brain Ependymoma Adult Brain Ependymoma An intracranial meningioma that occurs during adulthood. C9374 Neoplastic Process Adult Intracranial Meningioma C1332189 Undetermined Adult_Brain_Meningioma Adult Brain Meningioma Adult Intracranial Meningioma Adult Intracranial Meningioma A brain glioblastoma that occurs during adulthood. C9375 Neoplastic Process Adult Brain Glioblastoma Adult Brain Glioblastoma C1332187 CTRP Malignant Adult_Brain_Glioblastoma Adult Brain Glioblastoma Adult Brain Glioblastoma Multiforme Brain Glioblastoma Adult Brain Glioblastoma C9376 Neoplastic Process Adult Brain Oligodendroglioma Adult Brain Oligodendroglioma C1332190 CTRP Undetermined Adult_Brain_Oligodendroglioma Adult Brain Oligodendroglioma Brain Oligodendroglioma Adult Brain Oligodendroglioma C9377 Neoplastic Process Brain Oligodendroglioma C0346286 Undetermined Brain_Oligodendroglioma Brain Oligodendroglioma Oligodendroglioma of Brain Oligodendroglioma of the Brain Brain Oligodendroglioma A lung carcinoma characterized by a combination of small cell carcinoma and adenocarcinoma. C9379 Neoplastic Process Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma C1332165 GDC Malignant Adenocarcinoma_and_Small_Cell_Lung_Carcinoma Combined small cell-adenocarcinoma Adenocarcinoma and Small Cell Carcinoma of Lung Adenocarcinoma and Small Cell Carcinoma of the Lung Adenocarcinoma and Small Cell Lung Carcinoma Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma Combined Small Cell Lung Carcinoma and Lung Adenocarcinoma Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma An acute myeloid leukemia without maturation occurring in adults. C9380 Neoplastic Process Adult Acute Myeloid Leukemia without Maturation Adult Acute Myeloid Leukemia without Maturation C0279623 CPTAC CTRP Malignant Adult_Acute_Myeloid_Leukemia_without_Maturation Acute Myeloid Leukemia (AML) without Maturation Adult Acute Myeloblastic Leukemia Adult Acute Myeloblastic Leukemia without Maturation Adult Acute Myeloblastic Leukemia without Maturation (M1) Adult Acute Myelogenous Leukemia without Maturation Adult Acute Myeloid Leukemia without Maturation M1 M1 Adult Acute Myeloblastic Leukemia M1 Adult Acute Myelogenous Leukemia M1 Adult Acute Myelogenous Leukemia without Maturation M1 Adult Acute Myeloid Leukemia M1 Adult Acute Myeloid Leukemia without Maturation Adult Acute Myeloid Leukemia without Maturation An acute myeloid leukemia with maturation occurring in children. C9381 Neoplastic Process Childhood Acute Myeloid Leukemia with Maturation Childhood Acute Myeloid Leukemia with Maturation C0279636 CTRP Cellosaurus NICHD An acute myeloid leukemia with maturation occurring in children. Malignant Childhood_Acute_Myeloid_Leukemia_with_Maturation Acute Myeloid Leukemia (AML) with Maturation Childhood Acute M2 Leukemia Childhood Acute Myeloblastic Leukemia with Maturation Childhood Acute Myeloblastic Leukemia with Maturation (M2) Childhood Acute Myelogenous Leukemia with Maturation Childhood Acute Myeloid Leukemia with Maturation M2 Childhood Acute Myeloblastic Leukemia with Maturation M2 Childhood Acute Myelogenous Leukemia M2 Childhood Acute Myelogenous Leukemia with Maturation M2 Childhood Acute Myeloid Leukemia with Maturation M2 Pediatric AGL M2 Pediatric Acute Myeloblastic Leukemia with Maturation M2 Pediatric Acute Myelogenous Leukemia M2 Pediatric Acute Myelogenous Leukemia with Maturation M2 Pediatric Acute Myeloid Leukemia with Maturation Pediatric Acute M2 Leukemia Pediatric Acute Myeloblastic Leukemia with Maturation Pediatric Acute Myelogenous Leukemia with Maturation Pediatric Acute Myeloid Leukemia with Maturation Childhood Acute Myeloid Leukemia with Maturation A malignant epithelial neoplasm that arises from the rectum. The vast majority are adenocarcinomas. C9382 Neoplastic Process Rectal Carcinoma Rectal Carcinoma C0007113 CPTAC CTRP GDC Cancer that forms in the tissues of the rectum (the last several inches of the large intestine closest to the anus). Malignant Rectal_Carcinoma Rectal Cancer Cancer of Rectum Cancer of the Rectum Carcinoma of Rectum Carcinoma of the Rectum Rectal Cancer Rectal Carcinoma Rectum Cancer rectal cancer Rectal Carcinoma An adenocarcinoma arising from the rectum. It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease. Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits. According to the degree of cellular differentiation, rectal adenocarcinomas are divided into well, moderately, and poorly differentiated. Histologic variants include mucinous adenocarcinoma, signet ring cell carcinoma, medullary carcinoma, serrated adenocarcinoma, cribriform comedo-type adenocarcinoma, and micropapillary adenocarcinoma. C9383 Neoplastic Process Rectal Adenocarcinoma Rectal Adenocarcinoma C0149978 CTEP CTRP Cellosaurus Malignant Rectal_Adenocarcinoma Adenocarcinoma - rectum Adenocarcinoma of Rectum Adenocarcinoma of the Rectum Adenocarcinoma of the rectum Rectal Adenocarcinoma Rectal Adenocarcinoma A carcinoma arising from the epithelium of the renal parenchyma or the renal pelvis. The majority are renal cell carcinomas. Kidney carcinomas usually affect middle aged and elderly adults. Hematuria, abdominal pain, and a palpable mass are common symptoms. C9384 Neoplastic Process Kidney Cancer Kidney Carcinoma C1378703 CPTAC CTEP CTRP GDC Cancer that forms in tissues of the kidneys. Kidney cancer includes renal cell carcinoma (cancer that forms in the lining of very small tubes in the kidney that filter the blood and remove waste products) and renal pelvis carcinoma (cancer that forms in the center of the kidney where urine collects). It also includes Wilms tumor, which is a type of kidney cancer that usually develops in children under the age of 5. Malignant Renal_Carcinoma Kidney Cancer Kidney (including Renal Cell) Cancer Kidney Cancer Kidney Carcinoma Kidney cancer, NOS Renal Cancer Renal Carcinoma kidney cancer Kidney Carcinoma A carcinoma arising from the renal parenchyma. There is a strong correlation between cigarette smoking and the development of renal cell carcinoma. The clinical presentation includes : hematuria, flank pain and a palpable lumbar mass. A high percentage of renal cell carcinomas are diagnosed when an ultrasound is performed for other purposes. Radical nephrectomy is the standard intervention procedure. Renal cell carcinoma is generally considered to be resistant to radiation treatment and chemotherapy. C9385 Neoplastic Process Renal Cell Carcinoma Renal Cell Carcinoma C1861854 CDISC CTEP CTRP Cellosaurus GDC NICHD A malignant neoplasm arising from renal parenchyma. A malignant neoplasm arising from the renal parenchyma. The most common type of kidney cancer. It begins in the lining of the renal tubules in the kidney. The renal tubules filter the blood and produce urine. 8311/1 8312/3 Malignant Renal_Cell_Carcinoma Renal cell adenocarcinoma Adenocarcinoma of Kidney Adenocarcinoma of the Kidney CARCINOMA, RENAL CELL, MALIGNANT Kidney Adenocarcinoma RCC Renal Cell Adenocarcinoma Renal Cell Cancer Renal Cell Carcinoma Renal Cell Carcinoma, Stage Unspecified Renal cell adenocarcinoma renal cell adenocarcinoma renal cell cancer renal cell carcinoma Renal Cell Carcinoma Grade I malignant smooth muscle neoplasm. It is characterized by a proliferation of neoplastic spindle cells. C9389 Neoplastic Process Well Differentiated Leiomyosarcoma C1337016 Malignant Well_Differentiated_Leiomyosarcoma Well Differentiated Leiomyosarcoma Well Differentiated Leiomyosarcoma A usually aggressive malignant neoplasm arising from the deep soft tissue. It is characterized by the presence of poorly-differentiated spindle-shaped fibroblasts, collagenous stroma formation and increased mitotic activity. C9404 Neoplastic Process Poorly Differentiated Fibrosarcoma C1335442 Malignant Poorly_Differentiated_Fibrosarcoma Poorly Differentiated Fibrosarcoma Poorly Differentiated Fibrosarcoma A sarcoma with the morphologic features of a low-grade tumor and presence of cellular differentiation. C9417 Neoplastic Process Low Grade Sarcoma C1334419 Malignant Low-Grade_Sarcoma Low Grade Sarcoma Low-Grade Sarcoma Well or Moderately Differentiated Sarcoma Low Grade Sarcoma A sarcoma with the morphologic features of a high-grade tumor and lack of cellular differentiation. C9418 Neoplastic Process High Grade Sarcoma C1334008 Malignant High-Grade_Sarcoma High Grade Sarcoma High-Grade Sarcoma Poorly Differentiated or Undifferentiated Sarcoma High Grade Sarcoma C94186 Diagnostic Procedure Ultrasound Biomicroscopy Ultrasound Biomicroscopy C1301497 CTRP A type of ultrasound eye exam that makes a more detailed image than regular ultrasound. High-energy sound waves are bounced off the inside of the eye and the echo patterns are shown on the screen of an ultrasound machine. This makes a picture called a sonogram. Ultrasound Biomicroscopy Ultrasound Biomicroscopy (UBM) ultrasound biomicroscopy Ultrasound Biomicroscopy A lung carcinoma characterized by a combination of small cell carcinoma and squamous cell carcinoma. C9423 Neoplastic Process Combined Lung Small Cell and Squamous Cell Carcinoma C1334788 Malignant Mixed_Small_Cell_and_Squamous_Cell_Lung_Carcinoma Combined Lung Small Cell and Squamous Cell Carcinoma Combined Small Cell and Squamous Cell Lung Carcinoma Mixed Small Cell and Squamous Cell Carcinoma of Lung Mixed Small Cell and Squamous Cell Carcinoma of the Lung Small Cell and Squamous Cell Carcinoma of Lung Small Cell and Squamous Cell Carcinoma of the Lung Small Cell and Squamous Cell Lung Carcinoma Combined Lung Small Cell and Squamous Cell Carcinoma Chemotherapy combined with immunotherapy. Chemotherapy uses different drugs to kill or slow the growth of cancer cells; immunotherapy uses treatments to stimulate or restore the ability of the immune system to fight cancer. C94251 Therapeutic or Preventive Procedure Chemoimmunotherapy C2986423 PCDC Chemotherapy combined with immunotherapy. Chemotherapy uses different drugs to kill or slow the growth of cancer cells; immunotherapy uses treatments to stimulate or restore the ability of the immune system to fight cancer. Chemoimmunotherapy chemoimmunotherapy Chemoimmunotherapy An angiosarcoma characterized by the presence of malignant spindle endothelial cells. C9426 Neoplastic Process Conventional Angiosarcoma C1333155 Malignant Conventional_Angiosarcoma Conventional Angiosarcoma Conventional Angiosarcoma An uncommon, aggressive malignant smooth muscle neoplasm. It is characterized by the presence of atypical large spindle or round cells, nuclear palisading, tumor cell necrosis, mitotic figures and may be associated with vascular invasion. C9428 Neoplastic Process Conventional Leiomyosarcoma C1333157 Malignant Conventional_Leiomyosarcoma Classic Leiomyosarcoma Conventional Leiomyosarcoma Conventional Leiomyosarcoma A malignant mesenchymal neoplasm composed of fibroblasts, and characterized by collagen production and usually a herringbone architectural pattern. C9429 Neoplastic Process Conventional Fibrosarcoma C1333156 Malignant Conventional_Fibrosarcoma Classic Fibrosarcoma Classical Fibrosarcoma Conventional Fibrosarcoma Conventional Fibrosarcoma A morphologic variant of dermatofibrosarcoma protuberans characterized by the presence of melanin-pigmented dendritic cells. C9430 Neoplastic Process Pigmented Dermatofibrosarcoma Protuberans C0334464 GDC 8833/3 Undetermined Pigmented_Dermatofibrosarcoma_Protuberans_Bednar_Tumor 8833/3 Bednar tumor Pigmented dermatofibrosarcoma protuberans Bednar Tumor Bednar tumor Pigmented Dermatofibrosarcoma Protuberans Pigmented Dermatofibrosarcoma Protuberans (Bednar Tumor) Pigmented dermatofibrosarcoma protuberans Pigmented Dermatofibrosarcoma Protuberans A neoplasm of hematopoietic and lymphoid cell origin that occurs during childhood. Representative examples include acute leukemias and lymphomas. C9431 Neoplastic Process Childhood Hematopoietic Neoplasm Childhood Hematopoietic and Lymphoid Cell Neoplasm C1332970 CTRP Undetermined Childhood_Hematopoietic_Neoplasm Childhood Hematopoietic and Lymphoid Cell Neoplasm Hematopoietic Neoplasm Pediatric Hematopoietic and Lymphoid Cell Neoplasm Childhood Hematopoietic and Lymphoid Cell Neoplasm C94440 Therapeutic or Preventive Procedure Prophylactic Oophorectomy C2945703 Surgery intended to reduce the risk of ovarian cancer by removing the ovaries before disease develops. Prophylactic Oophorectomy prophylactic oophorectomy Prophylactic Oophorectomy A colorectal adenocarcinoma characterized by the presence of a malignant cellular infiltrate with more than 95% glandular formation. C9446 Neoplastic Process Grade 1 Colorectal Adenocarcinoma C1333867 Malignant Grade_I_Colorectal_Adenocarcinoma Grade 1 Colorectal Adenocarcinoma Grade I Colorectal Adenocarcinoma Low Grade Colorectal Adenocarcinoma Well Differentiated Colorectal Adenocarcinoma Grade 1 Colorectal Adenocarcinoma A colorectal adenocarcinoma characterized by the presence of a malignant cellular infiltrate with 50-95% glandular formation. C9447 Neoplastic Process Grade 2 Colorectal Adenocarcinoma C1333860 Malignant Grade_II_Colorectal_Adenocarcinoma Grade 2 Colorectal Adenocarcinoma Grade II Colorectal Adenocarcinoma Low Grade Colorectal Adenocarcinoma Moderately Differentiated Colorectal Adenocarcinoma Grade 2 Colorectal Adenocarcinoma Tissue necrosis due to radiation exposure. C94479 Finding Radiation Necrosis C1963737 The death of healthy tissue caused by radiation therapy. Radiation necrosis is a side effect of radiation therapy given to kill cancer cells, and can occur after cancer treatment has ended. Radiation Necrosis radiation necrosis Radiation Necrosis A colorectal adenocarcinoma characterized by the presence of a malignant cellular infiltrate with less than 50% glandular formation. C9448 Neoplastic Process Grade 3 Colorectal Adenocarcinoma C1333856 Malignant Grade_III_Colorectal_Adenocarcinoma Grade 3 Colorectal Adenocarcinoma Grade III Colorectal Adenocarcinoma High Grade Colorectal Adenocarcinoma Poorly Differentiated Colorectal Adenocarcinoma Grade 3 Colorectal Adenocarcinoma A rectal adenocarcinoma characterized by the presence of a malignant cellular infiltrate with less than 50% glandular formation. C9449 Neoplastic Process Grade 3 Rectal Adenocarcinoma C1333858 Malignant Grade_III_Rectal_Adenocarcinoma Grade 3 Rectal Adenocarcinoma Grade III Rectal Adenocarcinoma Poorly Differentiated Rectal Adenocarcinoma Grade 3 Rectal Adenocarcinoma A rectal adenocarcinoma characterized by the presence of a malignant cellular infiltrate with 50-95% glandular formation. C9450 Neoplastic Process Grade 2 Rectal Adenocarcinoma C1333865 Malignant Grade_II_Rectal_Adenocarcinoma Grade 2 Rectal Adenocarcinoma Grade II Rectal Adenocarcinoma Moderately Differentiated Rectal Adenocarcinoma Grade 2 Rectal Adenocarcinoma A rectal adenocarcinoma characterized by the presence of a malignant cellular infiltrate with more than 95% glandular formation. C9451 Neoplastic Process Grade 1 Rectal Adenocarcinoma C1333870 Malignant Grade_I_Rectal_Adenocarcinoma Grade 1 Rectal Adenocarcinoma Grade I Rectal Adenocarcinoma Well Differentiated Rectal Adenocarcinoma Grade 1 Rectal Adenocarcinoma A colon adenocarcinoma characterized by the presence of a malignant cellular infiltrate with more than 95% glandular formation. C9452 Neoplastic Process Grade 1 Colon Adenocarcinoma C1333866 Malignant Grade_I_Colon_Adenocarcinoma Grade 1 Colon Adenocarcinoma Grade I Colon Adenocarcinoma Well Differentiated Colon Adenocarcinoma Grade 1 Colon Adenocarcinoma An extremely rare, WHO grade 1, circumscribed and slow-growing tumor that arises from the neurohypophysis or infundibulum and described in adults. It is characterized by the presence of elongated, spindle-shaped neoplastic glial cells that form storiform patterns or interlacing fascicular arrangements. Signs and symptoms include visual disturbances, headache, amenorrhea, and decreased libido. C94524 Neoplastic Process Pituicytoma C2986550 CDISC Cellosaurus GDC A benign neoplasm arising from the posterior lobe of the pituitary gland. 9432/1 Undetermined 9432/1 Pituicytoma PITUICYTOMA, BENIGN Pituicytoma Pituicytoma (WHO Grade 1) Pituicytoma (WHO Grade I) Posterior Pituitary Astrocytoma Pituicytoma A colon adenocarcinoma characterized by the presence of a malignant cellular infiltrate with 50-95% glandular formation. C9453 Neoplastic Process Grade 2 Colon Adenocarcinoma C1333859 Malignant Grade_II_Colon_Adenocarcinoma Grade 2 Colon Adenocarcinoma Grade II Colon Adenocarcinoma Moderately Differentiated Colon Adenocarcinoma Grade 2 Colon Adenocarcinoma A very rare, WHO grade 1 neoplasm of the posterior pituitary. It is characterized by the presence of spindle cells with eosinophilic, granular cytoplasm forming fascicles. Electron microscopic studies demonstrate the accumulation of intracytoplasmic mitochondria and lack of secretory granules. Immunohistochemical studies are negative for pituitary hormones. Patients may present with pituitary hypofunction, visual disturbances, headache, nausea and vomiting. The clinical course is usually benign. C94537 Neoplastic Process Spindle Cell Oncocytoma C2986561 GDC 8290/0 Undetermined Pituitary_Gland_Oncocytoma Spindle cell oncocytoma Folliculo-Stellate Cell Tumor of the Pituitary SCO Spindle Cell Oncocytoma Spindle Cell Oncocytoma of the Adenohypophysis Spindle Cell Oncocytoma of the Adenohypophysis (WHO Grade 1) Spindle Cell Oncocytoma/Oncocytic Pituicytoma Spindle cell oncocytoma Spindle Cell Oncocytoma A colon adenocarcinoma characterized by the presence of a malignant cellular infiltrate with less than 50% glandular formation. C9454 Neoplastic Process Grade 3 Colon Adenocarcinoma C1333855 Malignant Grade_III_Colon_Adenocarcinoma Grade 3 Colon Adenocarcinoma Grade III Colon Adenocarcinoma Poorly Differentiated Colon Adenocarcinoma Grade 3 Colon Adenocarcinoma Breast ductal carcinoma in situ characterized by the presence of monomorphic neoplastic cells that form cribriform, micropapillary, or solid patterns. Intraluminal necrosis is present in some ducts. Ducts that contain neoplastic cells with occasional nucleoli and coarse chromatin may also be present. C9456 Neoplastic Process Breast Ductal Carcinoma In Situ, Intermediate Grade C1334206 Malignant Intermediate-Grade_Ductal_Carcinoma_In_Situ_of_the_Breast Breast Ductal Carcinoma In Situ, Intermediate Grade DCIS Grade 2 DIN 2 Ductal Intraepithelial Neoplasia, Grade 2 Intermediate Grade Ductal Breast Carcinoma In Situ Intermediate-Grade DCIS Intermediate-Grade Ductal Carcinoma In Situ of Breast Breast Ductal Carcinoma In Situ, Intermediate Grade Breast ductal carcinoma in situ characterized by the presence of small, monomorphic neoplastic cells that form cribriform, micropapillary, or solid patterns. The nuclei are uniform and mitotic figures are rare. C9457 Neoplastic Process Breast Ductal Carcinoma In Situ, Low Grade C1334413 Malignant Low-Grade_Ductal_Carcinoma_In_Situ_of_the_Breast Breast Ductal Carcinoma In Situ, Low Grade DCIS Grade 1 DIN 1C Ductal Intraepithelial Neoplasia, Grade 1C Low Grade Ductal Breast Carcinoma In Situ Low-Grade DCIS Low-Grade Ductal Carcinoma In Situ of Breast Breast Ductal Carcinoma In Situ, Low Grade A neoplasm of low malignant potential arising from the ovary. It is characterized by the presence of neoplastic atypical urothelial-type cells in a fibrotic stroma without evidence of invasion. C9459 Neoplastic Process Borderline Ovarian Brenner Tumor C0334494 GDC 9000/1 Uncertain Malignant Potential Borderline_Brenner_Tumor Borderline_Ovarian_Transitional_Cell_Tumor 9000/1 Brenner tumor, borderline malignancy Brenner tumor, proliferating Borderline Brenner Neoplasm of Ovary Borderline Brenner Neoplasm of the Ovary Borderline Brenner Tumor of Ovary Borderline Brenner Tumor of the Ovary Borderline Ovarian Brenner Neoplasm Borderline Ovarian Brenner Tumor Borderline Ovarian Brenner Tumor/Atypical Proliferative Ovarian Brenner Tumor Borderline Ovarian Transitional Cell Neoplasm Borderline Ovarian Transitional Cell Tumor Low Malignancy Potential Brenner Neoplasm of Ovary Low Malignancy Potential Brenner Neoplasm of the Ovary Low Malignancy Potential Brenner Tumor of Ovary Low Malignancy Potential Brenner Tumor of the Ovary Low Malignancy Potential Ovarian Brenner Neoplasm Low Malignancy Potential Ovarian Brenner Tumor Proliferating Brenner Neoplasm of Ovary Proliferating Brenner Neoplasm of the Ovary Proliferating Brenner Tumor of Ovary Proliferating Brenner Tumor of the Ovary Proliferating Ovarian Brenner Neoplasm Proliferating Ovarian Brenner Tumor Borderline Ovarian Brenner Tumor C94605 Diagnostic Procedure Film Mammography C2986595 The use of x-rays to create a picture of the breast on a film. Film Mammography film mammography Film Mammography A small cell neuroendocrine carcinoma arising from the bladder. C9461 Neoplastic Process Bladder Small Cell Neuroendocrine Carcinoma Bladder Small Cell Neuroendocrine Carcinoma C1332564 CTRP Malignant Bladder_Small_Cell_Neuroendocrine_Carcinoma Bladder Small Cell Carcinoma Bladder Small Cell Neuroendocrine Cancer Bladder Small Cell Neuroendocrine Carcinoma Small Cell Neuroendocrine Carcinoma of Urinary Bladder Small Cell Neuroendocrine Carcinoma of the Urinary Bladder Bladder Small Cell Neuroendocrine Carcinoma C94614 Therapeutic or Preventive Procedure Total Androgen Blockade C2986598 GDC Therapy used to eliminate male sex hormones (androgens) in the body. This may be done with surgery, hormonal therapy, or a combination. Total Androgen Blockade Total Androgen Blockade total androgen blockade Total Androgen Blockade A rare adenoid cystic carcinoma of the larynx. It usually arises from the supraglottic or subglottic area. It is characterized by slow progression and late distant metastases. C9462 Neoplastic Process Laryngeal Adenoid Cystic Carcinoma Laryngeal Adenoid Cystic Carcinoma C1334368 CTRP Malignant Laryngeal_Adenoid_Cystic_Carcinoma Adenoid Cystic Carcinoma of Larynx Adenoid Cystic Carcinoma of the Larynx Laryngeal Adenoid Cystic Carcinoma Laryngeal Throat Adenoid Cystic Cancer Laryngeal Adenoid Cystic Carcinoma A rare mucoepidermoid carcinoma of the larynx. It usually arises from the supraglottic area. Hoarseness and dysphagia are the presenting symptoms. C9463 Neoplastic Process Laryngeal Mucoepidermoid Carcinoma Laryngeal Mucoepidermoid Carcinoma C1334373 CTRP Malignant Laryngeal_Mucoepidermoid_Carcinoma Laryngeal Mucoepidermoid Carcinoma Laryngeal Throat Mucoepidermoid Cancer Mucoepidermoid Carcinoma of Larynx Mucoepidermoid Carcinoma of the Larynx Laryngeal Mucoepidermoid Carcinoma C94632 Therapeutic or Preventive Procedure Antihormone Therapy Antihormone Therapy C2986607 CTRP Treatment with drugs, surgery, or radiation in order to block the production or action of a hormone. Antihormone therapy may be used in cancer treatment because certain hormones are able to stimulate the growth of some types of tumors. Antihormone Therapy antihormone therapy Antihormone Therapy C94633 Therapeutic or Preventive Procedure Thyroid Hormone Treatment C2986608 Treatment with thyroid hormone, which is a hormone that affects heart rate, blood pressure, body temperature, and weight. Thyroid Hormone Treatment thyroid hormone treatment Thyroid Hormone Treatment Carcinoma, predominantly squamous cell, arising from the epithelial cells of the hypopharynx. C9465 Neoplastic Process Hypopharyngeal Carcinoma Hypopharyngeal Carcinoma C0153398 CPTAC CTRP Cancer that forms in tissues of the hypopharynx (the bottom part of the throat). The most common type is squamous cell carcinoma (cancer that begins in flat cells lining the hypopharynx). Malignant Hypopharyngeal_Carcinoma Cancer of Hypopharynx Cancer of the Hypopharynx Carcinoma of Hypopharynx Carcinoma of the Hypopharynx Hypopharyngeal Cancer Hypopharyngeal Carcinoma Hypopharyngeal Throat Cancer hypopharyngeal cancer Hypopharyngeal Carcinoma Carcinoma, predominantly squamous cell, arising from the epithelial cells of the pharynx. C9466 Neoplastic Process Pharyngeal Carcinoma Pharyngeal Carcinoma C0747548 CPTAC CTRP Cancer that forms in tissues of the pharynx (the hollow tube inside the neck that starts behind the nose and ends at the top of the windpipe and esophagus). Pharyngeal cancer includes cancer of the nasopharynx (the upper part of the throat behind the nose), the oropharynx (the middle part of the pharynx), and the hypopharynx (the bottom part of the pharynx). Cancer of the larynx (voice box) may also be included as a type of pharyngeal cancer. Most pharyngeal cancers are squamous cell carcinomas (cancer that begins in thin, flat cells that look like fish scales). Malignant Pharyngeal_Carcinoma Cancer of Pharynx Cancer of the Pharynx Carcinoma of Pharynx Carcinoma of the Pharynx Pharyngeal Cancer Pharyngeal Carcinoma Pharyngeal Throat Cancer Pharynx Cancer Pharynx Carcinoma pharyngeal cancer Pharyngeal Carcinoma A neoplastic process in the cervix characterized by morphologic features of both moderate and severe intraepithelial neoplasia. C94676 Neoplastic Process Cervical Intraepithelial Neoplasia Grade 2/3 Cervical Intraepithelial Neoplasia Grade 2/3 C2986622 CTRP A condition in which abnormal cells grow on the thin layer of tissue that covers the cervix (the lower, narrow end of the uterus). These abnormal cells are not malignant (cancer) but may become cancer. CIN 2/3 has features of CIN 2 and CIN 3. Undetermined CIN 2/3 Cervical Intraepithelial Neoplasia Grade 2/3 cervical intraepithelial neoplasia grade 2/3 Cervical Intraepithelial Neoplasia Grade 2/3 An anaplastic large cell lymphoma that is not confined to a single anatomic site and involves multiple nodal and/or extranodal sites. C9470 Neoplastic Process Systemic Anaplastic Large Cell Lymphoma C1336548 CTEP Malignant Systemic_Anaplastic_Large_Cell_Lymphoma ALCL, systemic Anaplastic large-cell lymphoma, primary systemic type Systemic Anaplastic Large Cell Lymphoma Systemic Anaplastic Large Cell Lymphoma A systemic anaplastic large cell lymphoma that occurs during childhood. C9471 Neoplastic Process Childhood Systemic Anaplastic Large Cell Lymphoma C1333005 NICHD A systemic, anaplastic, large cell lymphoma that occurs during childhood. Malignant Childhood_Systemic_Anaplastic_Large_Cell_Lymphoma Childhood Systemic Anaplastic Large Cell Lymphoma Childhood Systemic CD30+ Anaplastic Large Cell Lymphoma Childhood Systemic K-1+ Anaplastic Large Cell Lymphoma Pediatric Systemic Anaplastic Large Cell Lymphoma Pediatric Systemic CD30+ Anaplastic Large Cell Lymphoma Pediatric Systemic K-1+ Anaplastic Large Cell Lymphoma Childhood Systemic Anaplastic Large Cell Lymphoma A tubular type adenoma of the breast in which, during pregnancy and lactation, the epithelial cells show extensive secretory changes. C9473 Neoplastic Process Lactating Adenoma C1266023 GDC 8204/0 Benign Lactating_Adenoma 8204/0 Lactating adenoma Lactating Adenoma Lactating adenoma Pregnancy Adenoma Lactating Adenoma A low grade malignant neoplasm characterized by the presence of a benign epithelial component (tubular and cleft-like glands) and a low grade sarcomatous component that contains varying amounts of fibrous and smooth muscle tissues. In a minority of cases, the sarcomatous component contains heterologous elements including striated muscle, cartilage, and fat. It occurs in the uterine corpus, ovary, fallopian tube, cervix, and vagina. It may recur and in a minority of cases may metastasize to distant anatomic sites. C9474 Neoplastic Process Adenosarcoma Adenosarcoma C0001442 CTRP GDC A tumor that is a mixture of an adenoma (a tumor that starts in the gland-like cells of epithelial tissue) and a sarcoma (a tumor that starts in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue). An example of an adenosarcoma is Wilms tumor. 8933/3 Malignant Mullerian_Adenosarcoma 8933/3 Adenosarcoma Mullerian adenosarcoma Adenosarcoma Mullerian Adenosarcoma Mullerian adenosarcoma Müllerian Adenosarcoma adenosarcoma Adenosarcoma Benign and malignant neoplasms of the cerebellum that arise from astrocytes. During childhood the majority are benign pilocytic astrocytomas. In adults both benign and relatively higher grade forms may occur. The most common presenting symptoms are headache, nausea, vomiting, ataxia of gait or limb, paresis, diplopia, and dizziness. Objective signs include weakness, long tract signs, dysmetria, gait ataxia, papilledema, and nystagmus. Surgical resection is often curative. C9475 Neoplastic Process Cerebellar Astrocytoma C0740480 Undetermined Cerebellar_Astrocytoma Astrocytoma of Cerebellum Astrocytoma of the Cerebellum Astrocytoma, Cerebellar Cerebellar Astrocytoma Cerebellar Astrocytoma Infiltration of the meninges by an acute or chronic leukemia. C94754 Neoplastic Process Meningeal Leukemia Meningeal Leukemia C0948840 CTRP A serious problem that may occur in leukemia. In meningeal leukemia, cancer cells have spread from the original (primary) tumor to the meninges (thin layers of tissue that cover and protect the brain and spinal cord). The cancer may cause the meninges to be inflamed. Malignant Leukemic Leptomeningitis Leukemic Meningitis Meningeal Leukemia leukemic leptomeningitis leukemic meningitis meningeal leukemia Meningeal Leukemia Involvement of the meninges by Hodgkin or non-Hodgkin lymphoma. C94756 Neoplastic Process Meningeal Lymphoma Meningeal Lymphoma C2213017 CTRP A serious problem that may occur in lymphoma. In lymphomatous meningitis, cancer cells have spread from the original (primary) tumor to the meninges (thin layers of tissue that cover and protect the brain and spinal cord). The cancer may cause the meninges to be inflamed. Malignant Leptomeningeal Lymphoma Lymphomatous Meningitis Meningeal Lymphoma lymphomatous leptomeningitis lymphomatous meningitis Meningeal Lymphoma A hormone producing endocrine neoplasm, associated with a hormonal syndrome. C94759 Neoplastic Process Functioning Endocrine Neoplasm C2986655 GDC A tumor that is found in endocrine tissue and makes hormones (chemicals that travel in the bloodstream and control the actions of other cells or organs). 8158/1 Undetermined 8158/1 Endocrine tumor, functioning, NOS Functioning Endocrine Neoplasm functioning tumor Functioning Endocrine Neoplasm A WHO grade I large cystic tumor that occurs almost exclusively in infants, with a prominent desmoplastic stroma having a neuroepithelial population consisting mainly of neoplastic astrocytes. It involves the superficial cerebral cortex and leptomeninges, and often attaches to the dura. Although clinically it presents as large tumor, it generally has a good prognosis following surgical resection. (Adapted from WHO) C9476 Neoplastic Process Desmoplastic Infantile Astrocytoma C0457179 GDC NICHD A WHO grade I large cystic tumor that occurs almost exclusively in infants, and which involves the superficial cerebral cortex and leptomeninges. 9412/1 Undetermined Desmoplastic_Infantile_Astrocytoma 9412/1 Desmoplastic infantile astrocytoma DIA Desmoplastic Astrocytoma of Infancy Desmoplastic Infantile Astrocytoma Desmoplastic infantile astrocytoma Desmoplastic Infantile Astrocytoma A hormone producing or non-producing endocrine neoplasm, not associated with a hormonal syndrome. C94760 Neoplastic Process Non-Functioning Endocrine Neoplasm C2986656 A tumor that is found in endocrine tissue but does not make extra hormones. Endocrine-inactive tumors usually do not cause symptoms until they grow large or spread to other parts of the body. Undetermined Non-Functioning Endocrine Neoplasm Nonfunctional Endocrine Neoplasm Nonfunctioning Endocrine Neoplasm endocrine-inactive tumor nonfunctioning tumor Non-Functioning Endocrine Neoplasm A glioma that grows diffusely in the pons. It usually affects children and has a poor prognosis. C94764 Neoplastic Process Diffuse Intrinsic Pontine Glioma C2986658 Cellosaurus DIPG/DMG A type of central nervous system tumor that forms from glial (supportive) tissue of the brain and spinal cord. Diffuse intrinsic pontine glioma usually occurs in children. It forms in the brain stem. Malignant DIPG Diffuse Intrinsic Pontine Glioma Pontine (DIPG) diffuse intrinsic pontine glioma Diffuse Intrinsic Pontine Glioma Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th, 7th, and 8th eds.) C94768 Neoplastic Process Stage 0 Paranasal Sinus Cancer AJCC v6, v7, and v8 Stage 0 Paranasal Sinus Cancer AJCC v6, v7, and v8 C2986660 CTRP Abnormal cells are found in the innermost lining of the maxillary sinus. These abnormal cells may become cancer and spread into nearby normal tissue. Malignant Stage 0 Paranasal Sinus Cancer Stage 0 Paranasal Sinus Cancer AJCC v6 Stage 0 Paranasal Sinus Cancer AJCC v6, v7, and v8 Stage 0 Paranasal Sinus Cancer AJCC v7 Stage 0 Paranasal Sinus Cancer AJCC v8 stage 0 maxillary sinus carcinoma in situ Stage 0 Paranasal Sinus Cancer AJCC v6, v7, and v8 A diffusely infiltrating, WHO grade 3 astrocytoma with focal or dispersed anaplasia, and a marked proliferative potential. It may arise from a low-grade astrocytoma, but it can also be diagnosed at first biopsy, without indication of a less malignant precursor lesion. It has an intrinsic tendency for malignant progression to glioblastoma. (WHO) C9477 Neoplastic Process Anaplastic Astrocytoma C0334579 CPTAC CTEP Cellosaurus DIPG/DMG GDC 9401/3 Malignant Anaplastic_Astrocytoma 9401/3 Astrocytoma, anaplastic Astrocytoma, anaplastic, NOS Anaplastic Astrocytoma Anaplastic astrocytoma Astrocytoma, anaplastic Grade 3 Astrocytic Neoplasm Grade 3 Astrocytic Tumor Grade 3 Astrocytoma Grade III Astrocytic Neoplasm Grade III Astrocytic Tumor Grade III Astrocytoma High Grade Astrocytoma High-Grade Astrocytoma High-grade astrocytoma, NOS Malignant Astrocytoma Anaplastic Astrocytoma A breast carcinoma characterized by the presence of multiple cancerous tumors that originate from the same clone and are usually located in the same quadrant of the breast. C94770 Neoplastic Process Multifocal Breast Carcinoma Multifocal Breast Carcinoma C2986662 CTRP Breast cancer in which there is more than one tumor, all of which have arisen from one original tumor. The tumors are likely to be in the same quadrant (section) of the breast. Malignant Multifocal Breast Cancer Multifocal Breast Carcinoma multifocal breast cancer Multifocal Breast Carcinoma A breast carcinoma characterized by the presence of multiple cancerous tumors that originate from different clones and are usually located in different quadrants of the breast. C94772 Neoplastic Process Multicentric Breast Carcinoma Multicentric Breast Carcinoma C2986664 CTRP Breast cancer in which there is more than one tumor, all of which have formed separately from one another. The tumors are likely to be in different quadrants (sections) of the breast. Multicentric breast cancers are rare. Malignant Multicentric Breast Cancer Multicentric Breast Carcinoma multicentric breast cancer Multicentric Breast Carcinoma Breast carcinoma that has not spread beyond the breast and the axillary lymph nodes. C94774 Neoplastic Process Early-Stage Breast Carcinoma Early Stage Breast Carcinoma C2986665 CTRP Malignant Early Stage Breast Carcinoma Early-Stage Breast Cancer Early-Stage Breast Carcinoma early-stage breast cancer Early Stage Breast Carcinoma For hepatocellular carcinoma: Stage I includes: T1, N0, M0. T1: Solitary tumor without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. For intrahepatic cholangiocarcinoma: Stage I includes: T1, N0, M0. T1: Solitary tumor without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C94775 Neoplastic Process Stage I Adult Liver Cancer AJCC v7 Stage I Adult Liver Cancer AJCC v7 C2986666 CTRP There is one tumor and it has not spread to nearby blood vessels. Malignant Stage I Adult Liver Cancer AJCC v7 Stage I Liver Cancer stage I adult primary liver cancer Stage I Adult Liver Cancer AJCC v7 For hepatocellular carcinoma: Stage II includes: T2, N0, M0. T2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. For intrahepatic cholangiocarcinoma: Stage II includes: T2, N0, M0. T2: Solitary tumor with vascular invasion or multiple tumors, with or without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C94776 Neoplastic Process Stage II Adult Liver Cancer AJCC v7 Stage II Adult Liver Cancer AJCC v7 C2986667 CTRP There is either (1) one tumor that has spread to nearby blood vessels; or (2) there is more than one tumor, none of which is larger than 5 centimeters. Malignant Stage II Adult Liver Cancer AJCC v7 Stage II Liver Cancer stage II adult primary liver cancer Stage II Adult Liver Cancer AJCC v7 For hepatocellular carcinoma: Stage III includes: IIIA: (T3a, N0, M0); IIIB: (T3b, N0, M0); IIIC: (T4, N0, M0). T3a: Multiple tumors more than 5 cm. T3b: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein. T4: Tumors(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. For intrahepatic cholangiocarcinoma: Stage III includes: T3, N0, M0. T3: Tumor perforating the visceral peritoneum or involving the local extra hepatic structures by direct invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.) C94777 Neoplastic Process Stage III Adult Liver Cancer AJCC v7 Stage III Adult Liver Cancer AJCC v7 C2986668 CTRP Malignant Stage III Adult Liver Cancer AJCC v7 Stage III Liver Cancer Stage III Adult Liver Cancer AJCC v7 For hepatocellular carcinoma: Stage IIIA includes: T3a, N0, M0. T3a: Multiple tumors more than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C94779 Neoplastic Process Stage IIIA Adult Liver Cancer AJCC v7 Stage IIIA Adult Liver Cancer AJCC v7 C2986670 CTRP Stage III adult primary liver cancer is divided into stages IIIA, IIIB, and IIIC. In stage IIIA there is either (1) more than one tumor larger than 5 centimeters; or (2) one tumor that has spread to a major branch of blood vessels near the liver. Malignant Stage III Liver Cancer Stage IIIA Adult Liver Cancer AJCC v7 stage IIIA adult primary liver cancer Stage IIIA Adult Liver Cancer AJCC v7 For hepatocellular carcinoma: Stage IIIB includes: T3b, N0, M0. T3b: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C94780 Neoplastic Process Stage IIIB Adult Liver Cancer AJCC v7 Stage IIIB Adult Liver Cancer AJCC v7 C2986671 CTRP Stage III adult primary liver cancer is divided into stages IIIA, IIIB, and IIIC. In stage IIIB, there are one or more tumors of any size that have either (1) spread to nearby organs other than the gallbladder; or (2) broken through the lining of the peritoneal cavity. Malignant Stage III Liver Cancer Stage IIIB Adult Liver Cancer AJCC v7 stage IIIB adult primary liver cancer Stage IIIB Adult Liver Cancer AJCC v7 For hepatocellular carcinoma: Stage IIIC includes: T4, N0, M0. T4: Tumors(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C94781 Neoplastic Process Stage IIIC Adult Liver Cancer AJCC v7 Stage IIIC Adult Liver Cancer AJCC v7 C2986672 CTRP Malignant Stage III Liver Cancer Stage IIIC Adult Liver Cancer AJCC v7 Stage IIIC Adult Liver Cancer AJCC v7 For hepatocellular carcinoma: Stage IV includes: IVA: (Any T, N1, M0); IVB: (Any T, Any N, M1). N1: Regional lymph node metastasis. M0: No distant metastasis. M1: Distant metastasis. For intrahepatic cholangiocarcinoma: Stage IVA includes: (T4, N0, M0); (Any T, N1, M0). T4: Tumor with periductal invasion. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 7th Ed.) C94782 Neoplastic Process Stage IV Adult Liver Cancer AJCC v7 Stage IV Adult Liver Cancer AJCC v7 C2986673 CTRP Cancer has spread beyond the liver to other places in the body, such as the bones or lungs. The tumors may be of any size and may also have spread to nearby blood vessels and/or lymph nodes. Malignant Stage IV Adult Liver Cancer AJCC v7 Stage IV Liver Cancer stage IV adult primary liver cancer Stage IV Adult Liver Cancer AJCC v7 Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE). C94791 Neoplastic Process Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma C2986677 Cancer is found (1) in one group of lymph nodes; or (2) in one area outside the lymph nodes. No cancer is found in the abdomen or mediastinum (area between the lungs). Malignant Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma Stage I Childhood Non-Hodgkin Lymphoma stage I childhood non-Hodgkin lymphoma Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C94792 Neoplastic Process Ann Arbor Stage II Childhood Non-Hodgkin Lymphoma C2986678 Cancer is found (1) in one area outside the lymph nodes and in nearby lymph nodes; or (2) in two or more areas above or below the diaphragm (the thin muscle below the lungs that helps breathing and separates the chest from the abdomen), and may or may not have spread to nearby lymph nodes; or (3) to have started in the stomach or intestines and can be completely removed by surgery. Cancer may or may not have spread to certain nearby lymph nodes. Malignant Ann Arbor Stage II Childhood Non-Hodgkin Lymphoma Stage II Childhood Non-Hodgkin Lymphoma stage II childhood non-Hodgkin lymphoma Ann Arbor Stage II Childhood Non-Hodgkin Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C94793 Neoplastic Process Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma C2986679 CTRP Malignant Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma Stage III Childhood Non-Hodgkin Lymphoma Stage III Non-Hodgkin Lymphoma stage III childhood non-Hodgkin lymphoma Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C94794 Neoplastic Process Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma C2986680 CTRP Cancer is found in the bone marrow, brain, or cerebrospinal fluid. Cancer may also be found in other parts of the body. Malignant Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma Stage IV Childhood Non-Hodgkin Lymphoma Stage IV Non-Hodgkin Lymphoma stage IV childhood non-Hodgkin lymphoma Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE) (rare in Hodgkin lymphoma). C94797 Neoplastic Process Ann Arbor Stage I AIDS-Related Lymphoma Ann Arbor Stage I AIDS-Related Lymphoma C2986683 CTRP Stage I AIDS-related lymphoma is divided into stages I and IE. In stage I, cancer is found in one group of lymph nodes. In stage IE, cancer is found in one area of one organ or tissue that is not part of the lymph system. Malignant Ann Arbor Stage I AIDS-Related Lymphoma Stage I AIDS-Related Lymphoma stage I AIDS-related lymphoma Ann Arbor Stage I AIDS-Related Lymphoma Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). C94798 Neoplastic Process Stage II AIDS-Related Lymphoma Ann Arbor Stage II AIDS-Related Lymphoma C2986684 CTRP Stage II AIDS-related lymphoma is divided into stages II and IIE. In stage II, cancer is found in two or more lymph node groups on the same side of the diaphragm (the muscle below the lungs and heart that separates the chest from the abdomen). In stage IIE, cancer is found in one area of one organ or tissue that is not part of the lymph system and in nearby lymph nodes. Cancer may also be found in other lymph node groups on the same side of the diaphragm. Malignant Ann Arbor Stage II AIDS-Related Lymphoma Stage II AIDS-Related Lymphoma stage II AIDS-related lymphoma Ann Arbor Stage II AIDS-Related Lymphoma Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S). C94799 Neoplastic Process Ann Arbor Stage III AIDS-Related Lymphoma Ann Arbor Stage III AIDS-Related Lymphoma C2986685 CTRP Stage III AIDS-related lymphoma is divided into stages III, IIIE, IIIS, and IIIS+E. In stage III, cancer is found in lymph node groups on both sides of the diaphragm (the muscle below the lungs and heart that separates the chest from the abdomen). In stage IIIE, cancer is found in lymph node groups on both sides of the diaphragm and in one area of an organ or tissue that is not part of the lymph system. In stage IIIS, cancer is found in lymph node groups on both sides of the diaphragm and in the spleen. In stage IIIS+E, cancer is found in lymph node groups on both sides of the diaphragm, in the spleen, and in one area of an organ or tissue that is not part of the lymph system. Malignant Ann Arbor Stage III AIDS-Related Lymphoma Stage III AIDS-Related Lymphoma stage III AIDS-related lymphoma Ann Arbor Stage III AIDS-Related Lymphoma Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid. C94800 Neoplastic Process Ann Arbor Stage IV AIDS-Related Lymphoma Ann Arbor Stage IV AIDS-Related Lymphoma C2986686 CTRP In stage IV AIDS-related lymphoma, the cancer is found (1) in several areas throughout one or more organs that are not part of the lymph system, and it may be in nearby lymph nodes; or (2) in one organ that is not part of the lymph system, and it has spread to lymph nodes far away from that organ. Malignant Ann Arbor Stage IV AIDS-Related Lymphoma Stage IV AIDS-Related Lymphoma stage IV AIDS-related lymphoma Ann Arbor Stage IV AIDS-Related Lymphoma A benign neoplasm arising from the extraskeletal soft tissues near tendons and joints. It is a well circumscribed tumor characterized by the presence of chondrocytes, a lobulated hyaline cartilage growth pattern, and in some cases calcification. C9482 Neoplastic Process Soft Tissue Chondroma C1275277 Benign Extraskeletal_Chondroma Chondroma of Soft Parts Extraskeletal Chondroma Extraskeletal Osteochondroma Soft Tissue Chondroma Soft Tissue Chondroma Stage I includes: T1, N0, M0. T1: Tumor limited to ovaries (one or both). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C94821 Neoplastic Process Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor CL376171 CTRP The tumor is found in one or both ovaries. Stage I is divided into stages IA, IB, and IC. In stage IA, the tumor is found in a single ovary. In stage IB, the tumor is found in both ovaries. In stage IC, the tumor is found in one or both ovaries and one of the following is true: (1) abnormal cells are found on the outside surface of one or both ovaries; or (2) the capsule (outer covering) of the tumor has ruptured (broken open); or (3) tumor cells are found in the fluid of the peritoneal cavity (the body cavity that contains most of the organs in the abdomen). Uncertain Malignant Potential Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor Stage I Ovarian Low Malignant Potential Tumor stage I ovarian low malignant potential tumor Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor Stage II includes: T2, N0, M0. T2: Tumor involves one or both ovaries with pelvic extension and/or implants. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C94822 Neoplastic Process Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor CL376172 CTRP The tumor is found in one or both ovaries and has spread into other areas of the pelvis. Stage II is divided into stage IIA, IIB, and IIC. In stage IIA, the tumor has spread to the uterus and/or the fallopian tubes (the long, slender tubes through which eggs pass from the ovaries to the uterus). In stage IIB, the tumor has spread to other tissue within the pelvis. In stage IIC, (1) the tumor has spread to the uterus and/or the fallopian tubes and/or other tissue within the pelvis; and (2) tumor cells are found in the fluid of the peritoneal cavity (the body cavity that contains most of the organs in the abdomen). Malignant Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor Stage II Ovarian Low Malignant Potential Tumor stage II ovarian low malignant potential tumor Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor Stage III includes: T3, N0, M0. T3: Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) C94824 Neoplastic Process Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor CL376173 CTRP The tumor is found in one or both ovaries and has spread to other parts of the abdomen. Stage III is divided into stage IIIA, stage IIIB, and stage IIIC. In stage IIIA, the tumor is found only in the pelvis, but tumor cells have spread to the surface of the peritoneum (tissue that lines the abdominal wall and covers most of the organs in the abdomen). In stage IIIB, the tumor has spread to the peritoneum but is 2 centimeters or smaller in diameter. In stage IIIC, the tumor has spread to the peritoneum and is larger than 2 centimeters in diameter and/or has spread to lymph nodes in the abdomen. The spread of tumor cells to the surface of the liver is considered stage III disease. Malignant Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor Stage III Ovarian Low Malignant Potential Tumor stage III ovarian low malignant potential tumor Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor Stage IV includes: Any T, Any N, M1. M1: Distant metastasis (excludes peritoneal metastasis). (AJCC 6th and 7th eds.) C94825 Neoplastic Process Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor CL376174 CTRP The tumor is found in one or both ovaries and has metastasized (spread) beyond the abdomen to other parts of the body. The spread of tumor cells to tissues in the liver is considered stage IV disease. Malignant Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor Stage IV Ovarian Low Malignant Potential Tumor stage IV ovarian low malignant potential tumor Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor Hyperplasia of the epithelial cells in the breast ducts. It includes the atypical ductal hyperplasia, papillary intraductal hyperplasia, intraductal myoepitheliosis, and ductal hyperplasia of the usual type. C9492 Neoplastic Process Breast Ductal Hyperplasia C0741698 Undetermined Ductal_Breast_Hyperplasia Breast Ductal Hyperplasia Breast Epithelial Hyperplasia Ductal Breast Hyperplasia Ductal Hyperplasia of Breast Ductal Hyperplasia of the Breast Epithelial Hyperplasia of Breast Epithelial Hyperplasia of the Breast Breast Ductal Hyperplasia A large B-cell lymphoma characterized by the presence of a limited number of scattered neoplastic large B-lymphocytes which are admixed with numerous non-neoplastic T-lymphocytes and frequently histiocytes. C9496 Neoplastic Process T-Cell/Histiocyte-Rich Large B-Cell Lymphoma T-Cell/Histiocyte-Rich Large B-Cell Lymphoma C1321547 CTRP GDC 9680/3 9688/3 Malignant T-Cell_Histiocyte_Rich_Lymphoma 9680/3 9688/3 Histiocyte-rich large B-cell lymphoma T-cell rich large B-cell lymphoma T-cell rich/histiocyte-rich large B-cell lymphoma T-cell/histiocyte rich large B-cell lymphoma T-Cell Rich/Histiocyte-Rich Large B-Cell Lymphoma T-Cell/Histiocyte Rich Lymphoma T-Cell/Histiocyte-Rich Large B-Cell Lymphoma T-cell rich/histiocyte-rich large B-cell lymphoma THRLBCL T-Cell/Histiocyte-Rich Large B-Cell Lymphoma A rare malignant embryonal neoplasm characterized by the presence of small cells which resemble the cells of classic medulloblastoma and a minor population of melanin-forming neuroepithelial cells. It usually has an unfavorable clinical course. C9497 Neoplastic Process Melanocytic Medulloblastoma C1275668 GDC Malignant Melanotic_Medulloblastoma 9470/3 Melanotic medulloblastoma Medulloblastoma with Melanotic Differentiation Melanocytic Medulloblastoma Melanotic Medulloblastoma Melanotic medulloblastoma Melanocytic Medulloblastoma A benign extrauterine tumor composed of mature adipocytes and smooth muscle cells. C9502 Neoplastic Process Myolipoma C1096309 GDC Benign Myolipoma Lipoleiomyoma Extrauterine Lipoleiomyoma Myolipoma Myolipoma of Soft Tissue Myolipoma A benign, usually solitary, well circumscribed multicystic neoplasm that arises from the breast and typically affects young females. The cysts are lined by papillary proliferations that contain epithelial and myoepithelial layers. In a minority of cases, atypia may be present. C9503 Neoplastic Process Juvenile Breast Papillomatosis C1334303 NICHD A rare, localized, proliferative process in the breast, in which multiple peripheral papillomas are present (in peripheral ducts). It is a marker for familial breast cancer, and is associated with carcinoma in up to 15% of the cases. Benign Juvenile_Breast_Papillomatosis Juvenile Breast Papillomatosis Juvenile Papillomatosis of Breast Juvenile Papillomatosis of the Breast Swiss Cheese Disease Juvenile Breast Papillomatosis A liposarcoma that arises from the thymus gland. It is characterized by the presence of a liposarcomatous malignant infiltrate that entraps lobules of thymic tissue. C95038 Neoplastic Process Thymoliposarcoma C2986863 Malignant Thymoliposarcoma Thymoliposarcoma Localized primary tumor, as defined for stage 1, 2A, or 2B, with dissemination limited to skin, liver, and/or bone marrow (limited to infants younger than 1 year). Marrow involvement should be minimal (i.e., <10% of total nucleated cells identified as malignant by bone biopsy or by bone marrow aspirate). More extensive bone marrow involvement would be considered stage 4 disease. The results of the MIBG scan, if performed, should be negative for disease in the bone marrow. (cancer.gov) C9504 Neoplastic Process Stage 4S Neuroblastoma Stage 4S Neuroblastoma C1135161 CTRP Malignant Stage_IVS_Neuroblastoma Neuroblastoma Stage IVS Pepper's Syndrome Stage 4S Neuroblastoma Stage IVS Neuroblastoma Stage 4S Neuroblastoma A benign or malignant mesenchymal neoplasm that arises from the thymus gland. It is characterized by the presence of spindle cell fibroblasts and collagen tissue. C95044 Neoplastic Process Thymus Solitary Fibrous Tumor C2986867 Undetermined Thymic Solitary Fibrous Tumor Thymus Solitary Fibrous Tumor Thymus Solitary Fibrous Tumor A thymoma that arises in the cervical region and is not connected with the thymus gland. C95048 Neoplastic Process Ectopic Cervical Thymoma C2986869 Undetermined Ectopic Cervical Thymoma Ectopic Cervical Thymoma A glial-neuronal neoplasm located in the cortex. It occurs in children and young adults with a long-standing history of partial seizures. A histologic hallmark of this tumor is the 'specific glioneuronal element', characterized by columns, made up of bundles of axons, oriented perpendicularly to the cortical surface. (Adapted from WHO) C9505 Neoplastic Process Dysembryoplastic Neuroepithelial Tumor C1266177 GDC 9413/0 Undetermined Dysembryoplastic_Neuroepithelial_Tumor 9413/0 Dysembryoplastic neuroepithelial tumor DNET DNT Dysembryoplastic Neuroepithelial Neoplasm Dysembryoplastic Neuroepithelial Tumor Dysembryoplastic neuroepithelial tumor Dysembryoplastic Neuroepithelial Tumor A Hodgkin lymphoma that arises from the thymus gland. It is usually of the nodular sclerosis subtype and is often associated with cystic changes in the thymic epithelium. C95057 Neoplastic Process Thymic Hodgkin Lymphoma C2986875 Malignant Thymic Hodgkin Lymphoma Thymic Hodgkin Lymphoma Stage IIA1 includes: T2a1, N0, M0. Tumor invades beyond uterus but no to pelvic wall or to lower third of vagina. No parametrial invasion. T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C95172 Neoplastic Process Stage IIA1 Cervical Cancer AJCC v7 Stage IIA1 Cervical Cancer AJCC v7 C2986961 CTRP Malignant FIGO Stage IIA1 Cervical Carcinoma Stage IIA1 Cervical Cancer Stage IIA1 Cervical Cancer AJCC v7 Stage IIA1 Cervical Cancer AJCC v7 Stage IIA2 includes: T2a2, N0, M0. Tumor invades beyond uterus but no to pelvic wall or to lower third of vagina. No parametrial invasion. T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.) C95173 Neoplastic Process Stage IIA2 Cervical Cancer AJCC v7 Stage IIA2 Cervical Cancer AJCC v7 C2986962 CTRP Malignant FIGO Stage IIA2 Cervical Carcinoma Stage IIA2 Cervical Cancer Stage IIA2 Cervical Cancer AJCC v7 Stage IIA2 Cervical Cancer AJCC v7 Stage IIIC1 includes: T1-T3, N1, M0. T1: Tumor confined to corpus uteri. T2: Tumor invades stromal connective tissue of the cervix but does not extend beyond uterus. T3: Tumor involves serosa and/or adnexa, vagina, or parametrial tissue. N1: Regional lymph node metastasis to pelvic lymph nodes. M0: No distant metastasis. This staging applies to carcinomas and carcinosarcomas. (AJCC 7th ed.) C95174 Neoplastic Process Stage IIIC1 Uterine Corpus Cancer AJCC v7 Stage IIIC1 Uterine Corpus Cancer AJCC v7 C2986963 CTRP Malignant Stage IIIC1 Uterine (including Endometrial) Cancer Stage IIIC1 Uterine Corpus Cancer Stage IIIC1 Uterine Corpus Cancer AJCC v7 Stage IIIC1 Uterine Corpus Cancer AJCC v7 Stage IIIC2 includes: T1-T3, N2, M0. T1: Tumor confined to corpus uteri. T2: Tumor invades stromal connective tissue of the cervix but does not extend beyond uterus. T3: Tumor involves serosa and/or adnexa, vagina, or parametrial tissue. N2: Regional lymph node metastasis to para-aortic lymph nodes, with or without positive pelvic lymph nodes. M0: No distant metastasis. This staging applies to carcinomas and carcinosarcomas. (AJCC 7th ed.) C95176 Neoplastic Process Stage IIIC2 Uterine Corpus Cancer AJCC v7 Stage IIIC2 Uterine Corpus Cancer AJCC v7 C2986965 CTRP Malignant Stage IIIC2 Uterine (including Endometrial) Cancer Stage IIIC2 Uterine Corpus Cancer Stage IIIC2 Uterine Corpus Cancer AJCC v7 Stage IIIC2 Uterine Corpus Cancer AJCC v7 A well-differentiated neuroendocrine neoplasm of low, intermediate, or high grade arising from the digestive system. It is characterized by the presence of cells with features similar to those of the normal endocrine cells of the digestive system. The neoplastic cells express immunohistochemical evidence of neuroendocrine differentiation and hormones. C95404 Neoplastic Process Digestive System Neuroendocrine Tumor Digestive System Neuroendocrine Tumor CL507814 CTRP Undetermined Neuroendocrine tumor, NOS Digestive System NET Digestive System Neuroendocrine Tumor Digestive System Well Differentiated Neuroendocrine Tumor GEP-NET Gastroenteropancreatic NET Gastroenteropancreatic Neuroendocrine Tumor Gastrointestinal NET Gastrointestinal Neuroendocrine Tumor Gastrointestinal System Neuroendocrine Tumor Digestive System Neuroendocrine Tumor A high grade poorly differentiated carcinoma arising from the digestive system. It is composed of small or large neoplastic cells that express immunohistochemical evidence of neuroendocrine differentiation. There is marked nuclear atypia, necrosis, and more than 20 mitoses per 10 HPF. C95405 Neoplastic Process Digestive System Neuroendocrine Carcinoma C2987128 Malignant Digestive System Neuroendocrine Carcinoma Gastrointestinal NEC Gastrointestinal NEC G3 Gastrointestinal Neuroendocrine Carcinoma Gastrointestinal System Neuroendocrine Carcinoma Digestive System Neuroendocrine Carcinoma A carcinoma that arises from the digestive system and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component. At least 30% of either component should be present for the diagnosis to be made. C95406 Neoplastic Process Digestive System Mixed Adenoneuroendocrine Carcinoma Digestive System Mixed Adenoneuroendocrine Carcinoma C2987129 CTRP GDC 8244/3 Malignant 8244/3 MANEC Mixed adenoneuroendocrine carcinoma Mixed carcinoid-adenocarcinoma Digestive System Mixed Adenoneuroendocrine Cancer Digestive System Mixed Adenoneuroendocrine Carcinoma Gastrointestinal MANEC Gastrointestinal Mixed Adenoneuroendocrine Carcinoma MANEC Mixed Adenoneuroendocrine Carcinoma Mixed adenoneuroendocrine carcinoma Digestive System Mixed Adenoneuroendocrine Carcinoma A pancreatic ductal adenocarcinoma characterized by the presence of duct-like structures and medium-sized malignant glandular structures. C95426 Neoplastic Process Pancreatic Well Differentiated Ductal Adenocarcinoma C2987139 Malignant Pancreatic Well Differentiated Ductal Adenocarcinoma Pancreatic Well-Differentiated Ductal Adenocarcinoma Pancreatic Well Differentiated Ductal Adenocarcinoma A pancreatic ductal adenocarcinoma characterized by the presence of medium-sized duct-like structures and small malignant tubular glandular structures. C95427 Neoplastic Process Pancreatic Moderately Differentiated Ductal Adenocarcinoma C2987140 Malignant Pancreatic Moderately Differentiated Ductal Adenocarcinoma Pancreatic Moderately Differentiated Ductal Adenocarcinoma A pancreatic ductal adenocarcinoma characterized by the presence of small and irregular malignant glandular structures, solid sheets of malignant cells, and single malignant cells. C95428 Neoplastic Process Pancreatic Poorly Differentiated Ductal Adenocarcinoma C2987141 Malignant Pancreatic Poorly Differentiated Ductal Adenocarcinoma Pancreatic Poorly Differentiated Ductal Adenocarcinoma A pancreatic intraepithelial neoplasia characterized by the presence of tall columnar cells that form flat architectural patterns. Mild cytological atypia is present. C95429 Neoplastic Process Pancreatic Intraepithelial Neoplasia-1A C2987142 CPTAC Uncertain Malignant Potential PanIN-1A Pancreatic Intraepithelial Neoplasia-1A Pancreatic Intraepithelial Neoplasia-1A A pancreatic intraepithelial neoplasia characterized by the presence of tall columnar cells that form papillary, micropapillary, or basally pseudostratified architectural patterns. Mild cytological atypia is present. C95430 Neoplastic Process Pancreatic Intraepithelial Neoplasia-1B C2987143 CPTAC Uncertain Malignant Potential PanIN-1B Pancreatic Intraepithelial Neoplasia-1B Pancreatic Intraepithelial Neoplasia-1B A pancreatic epithelial neoplasia characterized by the presence of papillary and rarely flat architectural patterns with formation of cribriform patterns and luminal necrosis. Severe dysplasia is present. C95432 Neoplastic Process High Grade Pancreatic Intraepithelial Neoplasia C2987145 CPTAC Uncertain Malignant Potential Grade 3 Pancreatic Intraepithelial Neoplasia Grade III Pancreatic Intraepithelial Neoplasia High Grade PanIN High Grade Pancreatic Intraepithelial Neoplasia High-Grade PanIN High-Grade Pancreatic Intraepithelial Neoplasia PanIN-3 Pancreatic Intraepithelial Neoplasia-3 High Grade Pancreatic Intraepithelial Neoplasia A carcinoma that arises from the pancreas showing either extensive mucin accumulation and acinar neoplastic cells or a mixture of columnar or signet-ring cells and acinar neoplastic cells. C95458 Neoplastic Process Pancreatic Mixed Acinar-Ductal Carcinoma C3472609 GDC 8552/3 Malignant 8552/3 Mixed acinar-ductal carcinoma Mixed acinar-endocrine-ductal carcinoma Mixed Acinar-Ductal Carcinoma of the Pancreas Mixed acinar-ductal carcinoma Pancreatic Mixed Acinar-Ductal Carcinoma Pancreatic Mixed Acinar-Ductal Carcinoma A very rare carcinoma that arises from the pancreas and is composed of ductal adenocarcinoma, acinar carcinoma, and neuroendocrine carcinoma components. C95460 Neoplastic Process Pancreatic Mixed Ductal Adenocarcinoma-Acinar Carcinoma-Neuroendocrine Carcinoma C2987162 8154/3 Malignant Mixed Acinar-Neuroendocrine-Ductal Carcinoma of the Pancreas Pancreatic Mixed Acinar Carcinoma-Ductal Adenocarcinoma-Neuroendocrine Carcinoma Pancreatic Mixed Acinar-Ductal Neuroendocrine Carcinoma Pancreatic Mixed Ductal Adenocarcinoma-Acinar Carcinoma-Neuroendocrine Carcinoma Pancreatic Mixed Ductal Adenocarcinoma-Acinar Carcinoma-Neuroendocrine Carcinoma A rare adenocarcinoma that arises from the pancreas. It is characterized by marked hepatocellular differentiation. C95465 Neoplastic Process Pancreatic Hepatoid Adenocarcinoma C2987165 CPTAC Malignant Hepatoid carcinoma Pancreatic Hepatoid Adenocarcinoma Pancreatic Hepatoid Carcinoma Pancreatic Hepatoid Adenocarcinoma A pancreatic ductal adenocarcinoma characterized by poor differentiation and a prominent syncytial growth pattern. The prognosis is more favorable compared to conventional pancreatic ductal adenocarcinoma. C95466 Neoplastic Process Pancreatic Medullary Carcinoma C2987166 CPTAC Malignant Medullary carcinoma Pancreatic Medullary Carcinoma Pancreatic Medullary Carcinoma A benign, non-metastasizing, usually cystic epithelial neoplasm arising from the exocrine pancreas. It is composed of glycogen-rich epithelial cells which produce a watery fluid. Signs and symptoms include abdominal mass, abdominal pain, nausea, vomiting, and weight loss. C95470 Neoplastic Process Pancreatic Serous Adenoma C2987169 Benign Pancreatic Serous Adenoma Pancreatic Serous Adenoma A benign, non-metastasizing epithelial neoplasm arising from the exocrine pancreas. It is characterized by the presence of a few large cysts and is composed of glycogen-rich epithelial cells which produce a watery fluid. C95471 Neoplastic Process Pancreatic Macrocystic Serous Cystadenoma C2987170 Benign Pancreatic Macrocystic Serous Cystadenoma Pancreatic Macrocystic Serous Cystadenoma A well-circumscribed serous adenoma that is solid and lacks cystic changes. C95475 Neoplastic Process Pancreatic Solid Serous Adenoma C2987173 Benign Pancreatic Solid Serous Adenoma Pancreatic Solid Serous Adenoma A serous adenoma that develops in a patient with Von Hippel-Lindau syndrome. Usually there are multiple serous adenomas present of the macrocystic type. C95476 Neoplastic Process Von Hippel Lindau Syndrome-Associated Pancreatic Serous Adenoma C2987174 Benign VHL-Associated Pancreatic Serous Adenoma Von Hippel Lindau Syndrome-Associated Pancreatic Serous Adenoma Von Hippel-Lindau Syndrome-Associated Pancreatic Serous Adenoma Von Hippel Lindau Syndrome-Associated Pancreatic Serous Adenoma A non-invasive mucinous cystic neoplasm that arises from the pancreas and is characterized by the presence of mild dysplasia and absence of mitotic figures. C95483 Neoplastic Process Pancreatic Mucinous-Cystic Neoplasm, Low Grade C2987179 8470/0 Uncertain Malignant Potential Pancreatic Mucinous Cystic Neoplasm with Low Grade Dysplasia Pancreatic Mucinous Cystic Neoplasm with Low-Grade Dysplasia Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia Pancreatic Mucinous-Cystic Neoplasm, Low Grade Pancreatic Mucinous-Cystic Neoplasm, Low-Grade Pancreatic Mucinous-Cystic Neoplasm, Low Grade A proprietary, robotic radiosurgery system designed to deliver precise beams of high dose radiation to tumors with extreme accuracy. C95484 Therapeutic or Preventive Procedure CyberKnife CL449164 CPTAC GDC Radiation, Cyberknife CyberKnife Radiation, Cyberknife CyberKnife A cystic epithelial neoplasm that arises from the pancreas and is characterized by the presence of columnar mucin-producing epithelial cells, ovarian-type stroma formation, and the absence of an invasive carcinomatous component. C95488 Neoplastic Process Non-Invasive Pancreatic Mucinous-Cystic Neoplasm C2987182 Uncertain Malignant Potential Non-Invasive Pancreatic Mucinous Cystic Neoplasm Non-Invasive Pancreatic Mucinous-Cystic Neoplasm Noninvasive Pancreatic Mucinous Cystic Neoplasm Non-Invasive Pancreatic Mucinous-Cystic Neoplasm A non-invasive mucinous cystic neoplasm that arises from the pancreas and is characterized by the presence of severe dysplasia. The neoplastic columnar mucin-producing epithelial cells form papillae with irregular branching and budding. There is nuclear stratification, prominent nucleoli, and cellular pleomorphism. Mitotic activity is present and the mitoses may be atypical. C95493 Neoplastic Process Pancreatic Mucinous-Cystic Neoplasm, High Grade CL497910 GDC 8470/2 Uncertain Malignant Potential 8470/2 Mucinous cystic neoplasm with high grade dysplasia Mucinous cystic neoplasm with high-grade dysplasia Mucinous cystic neoplasm with high-grade dysplasia Pancreatic Mucinous Cystic Neoplasm with High Grade Dysplasia Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia Pancreatic Mucinous-Cystic Neoplasm, High Grade Pancreatic Mucinous-Cystic Neoplasm, High-Grade Pancreatic Mucinous-Cystic Neoplasm, High Grade A group of cystic or mass-forming epithelial neoplasms that arise from the exocrine pancreas, exhibit ductal differentiation, and grow mostly within the pancreatic ducts. This group includes the pancreatic intraductal papillary mucinous neoplasms and the pancreatic intraductal tubulopapillary neoplasms. C95505 Neoplastic Process Pancreatic Intraductal Neoplasm C2987188 Undetermined Pancreatic Intraductal Neoplasm Pancreatic Intraductal Neoplasm An epithelial neoplasm that arises from the exocrine pancreas characterized by the formation of tubular structures, high grade dysplasia, and ductal differentiation. Grossly, it is characterized by the presence of intraductal nodular masses. Morphologically, there are nodules of tubular glands and occasional papillary structures growing in dilated ducts. There is no significant mucin production. Signs and symptoms include epigastric pain, weight loss, vomiting, steatorrhea, and diabetes mellitus. C95506 Neoplastic Process Pancreatic Intraductal Tubulopapillary Neoplasm C2987189 Cellosaurus GDC 8503/0 8503/2 Uncertain Malignant Potential Intraductal tubulopapillary neoplasm ITPN Pancreatic ITPN Pancreatic Intraductal Tubular Neoplasm Pancreatic Intraductal Tubulopapillary Neoplasm Pancreatic Intraductal Tubulopapillary Neoplasm A pancreatic intraductal tubulopapillary neoplasm characterized by the presence of an invasive carcinomatous component. The invasive carcinoma has a tubular pattern. C95507 Neoplastic Process Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma C2987190 Malignant Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma A pancreatic intraductal papillary mucinous neoplasm characterized by the presence of neoplastic epithelial cells that are similar to gastric foveolar epithelial cells. C95508 Neoplastic Process Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type C2987191 Undetermined Gastric foveolar Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type A pancreatic intraductal papillary mucinous neoplasm characterized by the presence of neoplastic epithelial cells that form tall papillae, similar to those that are present in colonic villous adenomas. C95510 Neoplastic Process Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type C2987193 Undetermined Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type A pancreatic intraductal papillary mucinous neoplasm characterized by the presence of neoplastic epithelial cells that form thin-branching papillae and exhibit high grade dysplasia. C95512 Neoplastic Process Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type C2987195 Undetermined Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type A pancreatic intraductal papillary mucinous neoplasm characterized by the presence of neoplastic epithelial cells with abundant eosinophilic granular cytoplasm. C95514 Neoplastic Process Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type C2987197 GDC Undetermined 8453/0 Intraductal papillary mucinous adenoma Intraductal papillary-mucinous adenoma Intraductal papillary-mucinous adenoma Pancreatic IOPN Pancreatic Intraductal Oncocytic Papillary Neoplasm Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type An epithelial neoplasm that arises from the exocrine pancreas. It is characterized by the presence of neoplastic cells that resemble acinar cells and produce pancreatic exocrine enzymes. The vast majority are carcinomas. C95542 Neoplastic Process Pancreatic Acinar Cell Neoplasm C2987218 Undetermined Pancreatic Acinar Cell Neoplasm Pancreatic Acinar Cell Neoplasm A teratoma that arises from the pancreas. C95558 Neoplastic Process Pancreatic Teratoma C2987226 Undetermined Pancreatic Teratoma Pancreatic Teratoma A mature teratoma that arises from the pancreas. C95559 Neoplastic Process Pancreatic Mature Teratoma C2063869 Benign Mature Pancreatic Teratoma Pancreatic Mature Teratoma Pancreatic Mature Teratoma An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the pancreas. It is characterized by the presence of malignant large cells. C95582 Neoplastic Process Pancreatic Large Cell Neuroendocrine Carcinoma C2987239 Cellosaurus Malignant Pancreatic Large Cell NEC Pancreatic Large Cell NEC G3 Pancreatic Large Cell Neuroendocrine Carcinoma Pancreatic Large Cell Neuroendocrine Carcinoma An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the pancreas. It is characterized by the presence of malignant small cells. C95583 Neoplastic Process Pancreatic Small Cell Neuroendocrine Carcinoma C2987240 Cellosaurus Malignant Pancreatic Small Cell Carcinoma Pancreatic Small Cell NEC Pancreatic Small Cell NEC G3 Pancreatic Small Cell Neuroendocrine Carcinoma Pancreatic Small Cell Neuroendocrine Carcinoma A well differentiated, low grade neoplasm with neuroendocrine differentiation that arises from the pancreas. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal or less than 2%. C95584 Neoplastic Process Pancreatic Neuroendocrine Tumor G1 C2987241 Undetermined Pancreatic NET G1 Pancreatic Neuroendocrine Tumor G1 Pancreatic Neuroendocrine Tumor G1 A low grade well differentiated neoplasm with neuroendocrine differentiation that arises from the pancreas. It is characterized by the absence of a hormone-related clinical syndrome. C95585 Neoplastic Process Non-Functioning Pancreatic Neuroendocrine Tumor G1 Non-Functioning Pancreatic Neuroendocrine Tumor G1 C2987242 CTRP Undetermined Non-Functional Pancreatic Neuroendocrine Tumor G1 Non-Functioning Pancreatic Neuroendocrine Tumor G1 Nonfunctional Pancreatic Neuroendocrine Tumor G1 Nonfunctioning Pancreatic Neuroendocrine Tumor G1 Non-Functioning Pancreatic Neuroendocrine Tumor G1 A neuroendocrine tumor arising from the delta cells of the pancreas. It is characterized by inappropriate secretion of somatostatin and associated with diabetes mellitus, hypochlorhydria, gallbladder disease, diarrhea, steatorrhea, anemia, and weight loss. C95595 Neoplastic Process Pancreatic Somatostatinoma Pancreatic Somatostatinoma C1368041 CTRP Cellosaurus Undetermined Pancreatic Somatostatinoma Pancreatic Somatostatinoma A neuroendocrine tumor arising from the pancreas. It is characterized by inappropriate secretion of gastrin and associated with Zollinger Ellison syndrome. The latter is characterized by the presence of peptic ulcer, gastroesophageal reflux disease, abdominal pain, diarrhea, and malabsorption. C95596 Neoplastic Process Pancreatic Gastrinoma C1368066 Undetermined Pancreatic Gastrinoma Pancreatic Gastrinoma A usually malignant, glucagon-producing neuroendocrine tumor arising from the pancreatic alpha cells. It may be associated with necrolytic erythema migrans, diarrhea, diabetes, glossitis, weight loss, malabsorption, and anemia. Almost 25% of patients experience thromboembolic complications, and 50% have liver metastases at the time of diagnosis. C95597 Neoplastic Process Pancreatic Glucagonoma Pancreatic Glucagonoma CL428078 CTRP GDC A rare pancreatic tumor that produces a hormone called glucagon. Glucagonomas can produce symptoms similar to diabetes. Undetermined 8152/1 Glucagonoma Glucagonoma, NOS Glucagonoma Pancreatic Glucagonoma glucagonoma Pancreatic Glucagonoma An insulin-producing neuroendocrine tumor arising from the beta cells of the pancreas. Patients exhibit symptoms related to hypoglycemia due to inappropriate secretion of insulin. C95598 Neoplastic Process Pancreatic Insulinoma Pancreatic Insulinoma C0021670 CTRP Cellosaurus GDC MedDRA NICHD A usually benign tumor of insulin secreting pancreatic beta cells, associated with hypoglycemia. An abnormal mass that grows in the beta cells of the pancreas that make insulin. Beta cell neoplasms are usually benign (not cancer). They secrete insulin and are the most common cause of low blood sugar caused by having too much insulin in the body. Undetermined 8151/0 Insulinoma Insulinoma, NOS Insulinoma Pancreatic Insulinoma insulinoma Pancreatic Insulinoma A usually malignant pancreatic neuroendocrine tumor producing vasoactive intestinal peptide (VIP). It is associated with watery diarrhea, hypokalemia, and hypochlorhydria or achlorhydria. One third of cases are metastatic at the time of diagnosis. C95599 Neoplastic Process Pancreatic Vipoma C2033037 Undetermined Pancreatic Vipoma Pancreatic Vipoma An esophageal squamous cell carcinoma characterized by the presence of a spindle-cell carcinomatous component. Crossly it has a polypoid appearance and usually arises from the middle or lower third of the esophagus. C95608 Neoplastic Process Esophageal Spindle Cell Carcinoma Esophageal Spindle Cell Carcinoma C2987252 CTRP Malignant Esophageal Carcinoma with Mesenchymal Stroma Esophageal Carcinosarcoma Esophageal Metaplastic Carcinoma Esophageal Polypoid Carcinoma Esophageal Pseudosarcomatous Squamous Cell Carcinoma Esophageal Sarcomatoid Carcinoma Esophageal Spindle Cell Cancer Esophageal Spindle Cell Carcinoma Esophageal Squamous Cell Carcinoma with a Spindle-Cell Component Esophageal Spindle Cell Carcinoma An esophageal squamous cell carcinoma characterized by the presence of prominent keratinization and low mitotic activity. C95610 Neoplastic Process Esophageal Well Differentiated Squamous Cell Carcinoma Esophageal Well Differentiated Squamous Cell Carcinoma C2987254 CTRP Malignant Esophageal Well Differentiated Squamous Cell Carcinoma Well Differentiated Esophageal Squamous Cell Cancer Esophageal Well Differentiated Squamous Cell Carcinoma An esophageal squamous cell carcinoma characterized by the presence of variable morphologic characteristics that include areas of prominent and poor keratinization. C95611 Neoplastic Process Esophageal Moderately Differentiated Squamous Cell Carcinoma Esophageal Moderately Differentiated Squamous Cell Carcinoma C2987255 CTRP Malignant Esophageal Moderately Differentiated Squamous Cell Carcinoma Moderately Differentiated Esophageal Squamous Cell Cancer Esophageal Moderately Differentiated Squamous Cell Carcinoma An esophageal squamous cell carcinoma characterized by the presence of basal-like malignant squamous cells that form nests, often associated with central necrosis. C95612 Neoplastic Process Esophageal Poorly Differentiated Squamous Cell Carcinoma Esophageal Poorly Differentiated Squamous Cell Carcinoma C2987256 CTRP Malignant Esophageal Poorly Differentiated Squamous Cell Carcinoma Poorly Differentiated Esophageal Squamous Cell Cancer Esophageal Poorly Differentiated Squamous Cell Carcinoma Glandular intraepithelial neoplasia arising in Barrett esophagus. C95613 Neoplastic Process Intraepithelial Neoplasia in Barrett Esophagus C2987257 Undetermined Intraepithelial Neoplasia in Barrett Esophagus Intraepithelial Neoplasia in Barrett Esophagus A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the esophagus. C95616 Neoplastic Process Esophageal Neuroendocrine Tumor C2987260 Undetermined Esophageal NET Esophageal Neuroendocrine Tumor Esophageal Well Differentiated Neuroendocrine Neoplasm Esophageal Well-Differentiated Neuroendocrine Neoplasm Esophageal Neuroendocrine Tumor A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the esophagus. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3 to 20 percent. C95617 Neoplastic Process Esophageal Neuroendocrine Tumor G2 C2987261 Undetermined Esophageal Neuroendocrine Tumor G2 Esophageal Neuroendocrine Tumor G2 An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the esophagus. The mitotic count is more than 20 per 10 HPF. It is classified as either small or large cell neuroendocrine carcinoma based on the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm. C95619 Neoplastic Process Esophageal Neuroendocrine Carcinoma Esophageal Neuroendocrine Carcinoma C2987262 CTRP Malignant Esophageal High Grade Neuroendocrine Carcinoma Esophageal NEC Esophageal NEC G3 Esophageal Neuroendocrine Cancer Esophageal Neuroendocrine Carcinoma Esophageal Poorly Differentiated Endocrine Carcinoma Esophageal Small and Large Cell Endocrine Carcinoma Esophageal Neuroendocrine Carcinoma An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the esophagus. It is characterized by the presence of malignant large cells. C95620 Neoplastic Process Esophageal Large Cell Neuroendocrine Carcinoma Esophageal Large Cell Neuroendocrine Carcinoma C2987263 CTRP Malignant Esophageal Large Cell NEC Esophageal Large Cell Neuroendocrine Carcinoma Esophageal Large Cell Neuroendocrine Carcinoma A carcinoma that arises from the esophagus and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component. At least 30 percent of either component should be present for the diagnosis to be made. C95621 Neoplastic Process Esophageal Mixed Adenoneuroendocrine Carcinoma Esophageal Mixed Adenoneuroendocrine Carcinoma C2987264 CTRP Malignant Esophageal MANEC Esophageal Mixed Adenoneuroendocrine Cancer Esophageal Mixed Adenoneuroendocrine Carcinoma Esophageal Mixed Adenoneuroendocrine Carcinoma A capillary or cavernous hemangioma that arises from the esophagus. The majority of cases are polypoid intraluminal lesions. C95622 Neoplastic Process Esophageal Hemangioma C2987265 Benign Esophageal Hemangioma Esophageal Hemangioma A rhabdomyosarcoma arising from the esophageal wall. C95623 Neoplastic Process Esophageal Rhabdomyosarcoma C2987266 Malignant Esophageal Rhabdomyosarcoma Esophageal Rhabdomyosarcoma A synovial sarcoma that affects the esophageal wall. C95624 Neoplastic Process Esophageal Synovial Sarcoma C2987267 Malignant Esophageal Synovial Sarcoma Esophageal Synovial Sarcoma An extranodal diffuse large B-cell lymphoma that arises from the esophagus with the bulk of the mass located in the esophagus. C95625 Neoplastic Process Esophageal Diffuse Large B-Cell Lymphoma C2987268 Malignant Esophageal DLBCL Esophageal Diffuse Large B-Cell Lymphoma Primary Esophageal DLBCL Primary Esophageal Diffuse Large B-Cell Lymphoma Esophageal Diffuse Large B-Cell Lymphoma An extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue that arises from the esophagus with the bulk of the mass located in the esophagus. C95626 Neoplastic Process Esophageal Mucosa-Associated Lymphoid Tissue Lymphoma C2987269 Malignant Esophageal MALT Lymphoma Esophageal Mucosa-Associated Lymphoid Tissue Lymphoma Esophageal Mucosa-Associated Lymphoid Tissue Lymphoma An adenocarcinoma that arises from the gastric mucosa and is characterized by the presence of isolated malignant cells or malignant cells that form small aggregates. This category includes signet ring cell adenocarcinomas, adenocarcinomas that are composed of malignant cells resembling lymphocytes and histiocytes, and adenocarcinomas that are composed of malignant cells with deeply eosinophilic cytoplasm. C95743 Neoplastic Process Gastric Poorly Cohesive Adenocarcinoma C2987393 8490/3 Malignant Gastric Poorly Cohesive Adenocarcinoma Gastric Poorly Cohesive Carcinoma Poorly Cohesive Gastric Adenocarcinoma Poorly Cohesive Gastric Carcinoma Gastric Poorly Cohesive Adenocarcinoma A rare adenocarcinoma that arises from the gastric mucosa and is characterized by the presence of large polygonal malignant cells with eosinophilic cytoplasm resembling hepatocytes. C95747 Neoplastic Process Gastric Hepatoid Adenocarcinoma C2987396 Cellosaurus Malignant Gastric Hepatoid Adenocarcinoma Gastric Hepatoid Adenocarcinoma A rare adenocarcinoma that arises from the gastric mucosa and is characterized by the presence of prominent lymphocytic stromal infiltration and poorly formed tubular structures. C95748 Neoplastic Process Gastric Carcinoma with Lymphoid Stroma C2987397 Malignant Gastric Carcinoma with Lymphoid Stroma Gastric Lymphoepithelioma-Like Carcinoma Gastric Medullary Carcinoma Gastric Carcinoma with Lymphoid Stroma A malignant germ cell tumor that arises from the stomach. It is characterized by the presence of syncytiotrophoblast and cytotrophoblast cellular components. It is often associated with lymph node and hematogenous metastases. C95749 Neoplastic Process Gastric Choriocarcinoma C2987398 Cellosaurus Malignant Gastric Choriocarcinoma Gastric Choriocarcinoma A neoplasm that arises from the gastric glandular epithelium and invades the lamina propria but not the submucosa. There is marked glandular crowding, branching and budding, intraluminal necrosis, and prominent mitotic activity. Desmoplastic changes may be present or absent. C95763 Neoplastic Process Gastric Intramucosal Adenocarcinoma C2987406 Malignant Gastric Intramucosal Adenocarcinoma Gastric Intramucosal Carcinoma Gastric Intramucosal Invasive Neoplasia Gastric Intramucosal Invasive Neoplasia/ Intramucosal Carcinoma Gastric Intramucosal Adenocarcinoma A neoplastic polyp that arises from the stomach. It is associated with intestinal-type differentiation. The presence of high grade dysplasia and a size of more than 2 cm are factors that increase the risk of malignant transformation. C95773 Neoplastic Process Gastric Adenoma, Intestinal-Type C3146245 Benign Gastric Adenoma, Intestinal-Type Gastric Adenomatous Polyp Gastric Adenomatous Polyp, Intestinal-Type Gastric Adenoma, Intestinal-Type A neoplastic polyp that arises from the stomach. It is characterized by the presence of gastric epithelial differentiation. It includes pyloric gland adenomas and foveolar-type adenomas. C95775 Neoplastic Process Gastric Adenoma, Gastric-Type C2987415 Benign Gastric Adenoma, Gastric-Type Gastric Adenoma, Gastric-Type A rare neoplastic polyp that arises from the stomach. It is characterized by the presence of foveolar-type epithelium. It may be seen in patients with familial adenomatous polyposis. C95779 Neoplastic Process Foveolar-Type Adenoma C2987419 Benign Foveolar-Type Adenoma Gastric foveolar Foveolar-Type Adenoma A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the stomach. C95871 Neoplastic Process Gastric Neuroendocrine Tumor C3272399 Undetermined Gastric NET Gastric Neuroendocrine Tumor Gastric Well Differentiated Neuroendocrine Neoplasm Gastric Well-Differentiated Neuroendocrine Neoplasm Gastric Neuroendocrine Tumor A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the stomach. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3 to 20 percent. C95880 Neoplastic Process Gastric Neuroendocrine Tumor G2 Gastric Neuroendocrine Tumor G2 C3272407 CTRP Undetermined Malignant carcinoid tumor of the stomach Gastric NET G2 Gastric Neuroendocrine Tumor G2 Gastric Neuroendocrine Tumor G2 An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the stomach. The mitotic count is more than 20 per 10 HPF. It is classified as either small or large cell neuroendocrine carcinoma based on the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm. C95884 Neoplastic Process Gastric Neuroendocrine Carcinoma Gastric Neuroendocrine Carcinoma C3272409 CTRP Malignant Gastric (Stomach) Neuroendocrine Cancer Gastric NEC Gastric Neuroendocrine Carcinoma Gastric Neuroendocrine Carcinoma An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the stomach. It is characterized by the presence of malignant large cells. C95885 Neoplastic Process Gastric Large Cell Neuroendocrine Carcinoma C3272410 Malignant Gastric Large Cell Neuroendocrine Carcinoma Gastric Large Cell Neuroendocrine Carcinoma A carcinoma that arises from the stomach and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component. At least 30 percent of either component should be present for the diagnosis to be made. C95886 Neoplastic Process Gastric Mixed Adenoneuroendocrine Carcinoma Gastric Mixed Adenoneuroendocrine Carcinoma C3272411 CTRP Malignant Gastric (Stomach) Mixed Adenoneuroendocrine Cancer Gastric MANEC Gastric Mixed Adenoneuroendocrine Carcinoma Gastric Mixed Adenoneuroendocrine Carcinoma A gastrointestinal stromal tumor arising from the stomach. It is characterized by a maximum diameter equal or less than 5 cm and no more than 5 mitotic figures per 50 high power fields. C95895 Neoplastic Process Benign Gastric Gastrointestinal Stromal Tumor C3272419 Undetermined Benign Gastric Gastrointestinal Stromal Tumor Benign Gastric Gastrointestinal Stromal Tumor A gastrointestinal stromal tumor arising from the stomach. It is characterized by large size (diameter greater than 10 cm) or more than 5 mitotic figures per 50 high power fields. C95897 Neoplastic Process Gastric Malignant Gastrointestinal Stromal Tumor Gastric Malignant Gastrointestinal Stromal Tumor C3272421 CTRP Malignant Gastric Malignant Gastrointestinal Stromal Tumor Malignant Gastric Gastrointestinal Stromal Tumor Gastric Malignant Gastrointestinal Stromal Tumor A gastrointestinal stromal tumor arising from the stomach. It is characterized by a maximum diameter greater than 5 cm and equal or less than 10 cm and no more than 5 mitotic figures per 50 high power fields. C95898 Neoplastic Process Gastric Gastrointestinal Stromal Tumor of Uncertain Malignant Potential C3272422 Uncertain Malignant Potential Gastric Gastrointestinal Stromal Tumor of Uncertain Malignant Potential Gastric Gastrointestinal Stromal Tumor of Uncertain Malignant Potential A rare synovial sarcoma that arises from the stomach. C95899 Neoplastic Process Gastric Synovial Sarcoma C3272423 Malignant Gastric Synovial Sarcoma Gastric Synovial Sarcoma A rare glomus tumor that arises from the stomach. It is seen in adults, especially women. The majority of cases follow a benign clinical course. C95900 Neoplastic Process Gastric Glomus Tumor C3272424 Undetermined Gastric Glomus Tumor Gastric Glomus Tumor A rare schwannoma that arises from the stomach. It follows a benign clinical course. C95901 Neoplastic Process Gastric Schwannoma C3272425 Benign Gastric Schwannoma Gastric Schwannoma A rare soft tissue neoplasm arising from the stomach. It occurs in the antrum and pyloric region and it may extend into the duodenum. It occurs in all ages and affects men and women equally. Morphologically it is characterized by a multinodular plexiform mass that involves the muscular layer. The neoplastic cells are spindle-shaped and the mitotic activity is low. It follows a benign clinical course. C95902 Neoplastic Process Gastric Plexiform Fibromyxoma CL497919 8811/0 Benign Gastric Plexiform Fibromyxoma Plexiform Fibromyxoma Gastric Plexiform Fibromyxoma A malignant neoplasm that has spread to the stomach from another organ or system, or from another primary gastric tumor. The primary gastric tumor is not in continuity with the metastatic lesion. Representative examples of metastatic malignant neoplasms to the stomach include breast, lung, and esophageal metastatic carcinomas and melanomas. C95903 Neoplastic Process Metastatic Malignant Neoplasm in the Stomach C0686068 Malignant Metastatic Malignant Neoplasm in the Stomach Metastatic Malignant Neoplasm to the Stomach Metastatic Malignant Neoplasm in the Stomach A premalignant neoplastic and dysplastic lesion that arises from the ampulla of Vater. It is characterized by the absence of invasion. This category includes intestinal-type adenomas, noninvasive papillary neoplasms of pancreatobiliary type, and flat intraepithelial neoplasia. C95909 Neoplastic Process Preinvasive Neoplasm of the Ampullary Region Preinvasive Neoplasm of the Ampullary Region C3272431 CTRP Undetermined Preinvasive Neoplasm of the Ampullary Region Preinvasive Neoplasm of the Ampullary Region An exophytic, preinvasive, papillary epithelial neoplasm that arises from the ampulla of Vater. Histologically it resembles the papillary neoplasms of the biliary tree. This category includes neoplasms with low grade dysplasia and high grade dysplasia. C95913 Neoplastic Process Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type C3272433 GDC 8163/0 Undetermined 8163/0 Pancreatobiliary neoplasm, non-invasive Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type Noninvasive Papillary Neoplasm, Pancreatobiliary Type Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type An ampullary noninvasive papillary neoplasm of the pancreatobiliary type characterized by the presence of low grade dysplasia. C95914 Neoplastic Process Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia C3272434 GDC 8163/0 Undetermined 8163/0 Noninvasive pancreatobiliary papillary neoplasm with low grade dysplasia Noninvasive pancreatobiliary papillary neoplasm with low grade intraepithelial neoplasia Ampullary Low Grade Intraepithelial Neoplasia Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia An ampullary noninvasive papillary neoplasm of the pancreatobiliary type characterized by the presence of high grade dysplasia. C95915 Neoplastic Process Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia C3472606 GDC 8163/2 Undetermined 8163/2 Noninvasive pancreatobiliary papillary neoplasm with high grade dysplasia Noninvasive pancreatobiliary papillary neoplasm with high grade intraepithelial neoplasia Papillary neoplasm, pancreatobiliary type, with high grade intraepithelial neoplasia Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia Ampullary High Grade Intraepithelial Neoplasia Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia A non-polypoid, preinvasive neoplasm that arises from the ampulla of Vater. It is characterized by the presence of high grade dysplasia. C95918 Neoplastic Process Ampullary Flat Intraepithelial Neoplasia, High Grade C3272438 8148/2 Undetermined Ampullary Flat Intraepithelial Neoplasia (Dysplasia), High Grade Ampullary Flat Intraepithelial Neoplasia, High Grade Flat Intraepithelial Glandular Neoplasia, High Grade Ampullary Flat Intraepithelial Neoplasia, High Grade An invasive adenocarcinoma that arises from the ampulla of Vater. It is characterized by the presence of malignant cells that resemble the malignant cells of the pancreatic ductal or extrahepatic bile duct carcinomas. C95963 Neoplastic Process Ampulla of Vater Pancreatobiliary Type Adenocarcinoma C3472607 GDC 8163/3 Malignant 8163/3 Pancreatobiliary type carcinoma Pancreatobiliary-type carcinoma Ampulla of Vater Pancreatobiliary Type Adenocarcinoma Pancreatobiliary-type carcinoma Ampulla of Vater Pancreatobiliary Type Adenocarcinoma A rare variant of undifferentiated carcinoma that arises from the ampulla of Vater. It is characterized by the presence of non-neoplastic, histiocytic, osteoclast-like multinucleated giant cells. C95965 Neoplastic Process Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells C3272463 Malignant Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells A very rare adenocarcinoma that arises from the ampulla of Vater. It is usually of the intestinal type and is characterized by the presence of malignant polygonal cells with abundant eosinophilic cytoplasm resembling hepatocytes. C95966 Neoplastic Process Ampulla of Vater Hepatoid Adenocarcinoma C3272464 Cellosaurus Malignant Ampulla of Vater Hepatoid Adenocarcinoma Ampulla of Vater Hepatoid Adenocarcinoma An invasive adenocarcinoma that arises from an exophytic papillary neoplasm of the ampulla of Vater. C95967 Neoplastic Process Ampulla of Vater Invasive Papillary Adenocarcinoma C3272465 Malignant Ampulla of Vater Invasive Papillary Adenocarcinoma Ampulla of Vater Invasive Papillary Adenocarcinoma A neoplasm with neuroendocrine differentiation that arises from the ampulla of Vater and periampullary region. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms). C95980 Neoplastic Process Ampulla of Vater Neuroendocrine Neoplasm C3272476 Undetermined Ampulla of Vater Neuroendocrine Neoplasm Neuroendocrine Neoplasm of the Ampullary Region Ampulla of Vater Neuroendocrine Neoplasm A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the ampulla of Vater and periampullary region. C95981 Neoplastic Process Ampulla of Vater Neuroendocrine Tumor C3272477 Undetermined Ampulla of Vater NET Ampulla of Vater Neuroendocrine Tumor Neuroendocrine Tumor of the Ampullary Region Ampulla of Vater Neuroendocrine Tumor A well differentiated, low grade neoplasm with neuroendocrine differentiation that arises from the ampulla of Vater and the periampullary region. The mitotic count is less than 2 per 10 HPF. C95982 Neoplastic Process Ampulla of Vater Neuroendocrine Tumor G1 C1282463 Undetermined Ampulla of Vater NET G1 Ampulla of Vater Neuroendocrine Tumor G1 Neuroendocrine Tumor G1 of the Ampullary Region Ampulla of Vater Neuroendocrine Tumor G1 A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the ampulla of Vater and the periampullary region. The mitotic count is 2-20 per 10 HPF. C95983 Neoplastic Process Ampulla of Vater Neuroendocrine Tumor G2 C3272479 Undetermined Ampulla of Vater Neuroendocrine Tumor G2 Neuroendocrine Tumor G2 of the Ampullary Region Ampulla of Vater Neuroendocrine Tumor G2 An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the ampulla of Vater. The mitotic count is more than 20 per 10 HPF. It is classified as either small or large cell neuroendocrine carcinoma based on the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm. C95984 Neoplastic Process Ampulla of Vater Neuroendocrine Carcinoma Ampulla of Vater Neuroendocrine Carcinoma C3272480 CTRP Malignant Ampulla of Vater High Grade Neuroendocrine Carcinoma Ampulla of Vater NEC Ampulla of Vater NEC G3 Ampulla of Vater Neuroendocrine Carcinoma Ampulla of Vater Poorly Differentiated Endocrine Carcinoma Ampulla of Vater Small and Large Cell Endocrine Carcinoma Neuroendocrine Carcinoma of the Ampullary Region Ampulla of Vater Neuroendocrine Carcinoma An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the ampulla of Vater and the periampullary region. It is characterized by the presence of malignant large cells. C95985 Neoplastic Process Ampulla of Vater Large Cell Neuroendocrine Carcinoma C3272481 Malignant Ampulla of Vater Large Cell NEC Ampulla of Vater Large Cell Neuroendocrine Carcinoma Large Cell Neuroendocrine Carcinoma of the Ampullary Region Ampulla of Vater Large Cell Neuroendocrine Carcinoma A carcinoma that arises from the ampulla of Vater and the periampullary region. It is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component. At least 30 percent of either component should be present for the diagnosis to be made. C95986 Neoplastic Process Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma C3272482 Malignant Ampulla of Vater MANEC Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma A well differentiated neuroendocrine tumor that arises from the ampulla of Vater and the periampullary region. It produces serotonin. C95987 Neoplastic Process Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor C3272483 Undetermined Ampulla of Vater EC Cell Serotonin-Producing NET Ampulla of Vater EC-Cell Serotonin-Producing Neuroendocrine Tumor Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor of the Ampullary Region Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor A well differentiated neuroendocrine tumor that arises from the ampulla of Vater and the periampullary region. It produces somatostatin. C95988 Neoplastic Process Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor C3272484 Undetermined Ampulla of Vater Somatostatin Producing NET Ampulla of Vater Somatostatin Producing Neuroendocrine Tumor Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor Somatostatin Producing Neuroendocrine Tumor of the Ampullary Region Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor An extra-adrenal paraganglioma that arises from the ampulla of Vater and the periampullary region. It consists of a mixture of neuroendocrine cells, Schwann-like cells, and ganglion cells. C95989 Neoplastic Process Ampulla of Vater Gangliocytic Paraganglioma C3272485 Undetermined Ampulla of Vater Gangliocytic Paraganglioma Gangliocytic Paraganglioma of the Ampullary Region Ampulla of Vater Gangliocytic Paraganglioma A rare, primary marginal zone lymphoma of mucosa-associated lymphoid tissue that arises from the meningeal dura. The majority of cases have been described in middle aged women. Radiologically, the lymphomatous dural infiltration mimics meningioma. C95991 Neoplastic Process Dural Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue C3272487 Malignant Dural Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue MALT Lymphoma of the Dura Dural Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue A B-cell non-Hodgkin lymphoma that arises from the small intestine. Representative examples include diffuse large B-cell lymphoma, mucosa-associated lymphoid tissue lymphoma, alpha heavy chain disease/immunoproliferative small intestinal disease, Burkitt lymphoma, follicular lymphoma, and mantle cell lymphoma. C96053 Neoplastic Process Small Intestinal B-Cell Non-Hodgkin Lymphoma C3272520 Malignant Small Intestinal B-Cell Non-Hodgkin Lymphoma Small Intestinal B-Cell Non-Hodgkin Lymphoma A T-cell non-Hodgkin lymphoma that arises from the small intestine. It includes the enteropathy-associated T-cell lymphoma and the monomorphic CD56 positive intestinal T-cell lymphoma. C96054 Neoplastic Process Small Intestinal T-Cell Non-Hodgkin Lymphoma C3272521 Malignant Small Intestinal T-Cell Non-Hodgkin Lymphoma Small Intestinal T-Cell Non-Hodgkin Lymphoma A diffuse large B-cell lymphoma that arises from the small intestine. C96055 Neoplastic Process Small Intestinal Diffuse Large B-Cell Lymphoma C3272522 Malignant Primary Small Intestinal DLBCL Primary Small Intestinal Diffuse Large B-Cell Lymphoma Small Intestinal DLBCL Small Intestinal Diffuse Large B-Cell Lymphoma Small Intestinal Diffuse Large B-Cell Lymphoma A follicular lymphoma that arises from the small intestine. It most often affects the duodenum. C96056 Neoplastic Process Small Intestinal Follicular Lymphoma C3272523 Malignant Primary Small Intestinal Follicular Lymphoma Small Intestinal Follicular Lymphoma Small Intestinal Follicular Lymphoma High-grade B-cell lymphoma, not otherwise specified, that arises from the small intestine. C96057 Neoplastic Process Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified C3272524 Malignant Primary Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified Primary Small Intestinal High-Grade B-Cell Lymphoma, Not Otherwise Specified Small Intestinal B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified Small Intestinal High-Grade B-Cell Lymphoma, Not Otherwise Specified Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified A mature T-cell and NK-cell non-Hodgkin lymphoma of intraepithelial T-lymphocytes. It usually arises from the small intestine. A minority of cases arise from the large intestine or the stomach. It is characterized by the presence of a monomorphic cellular infiltrate of small to medium-sized T-lymphocytes that are cytotoxic and express CD56. It is not associated with celiac disease. C96058 Neoplastic Process Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma C3272525 Malignant MEITL Monomorphic CD56+ Intestinal T-Cell Lymphoma Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma Type II EATL Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma A Kaposi sarcoma that arises from the small intestine. C96059 Neoplastic Process Small Intestinal Kaposi Sarcoma C3272526 Malignant Small Intestinal Kaposi Sarcoma Small Intestinal Kaposi Sarcoma An angiosarcoma that arises from the small intestine. C96060 Neoplastic Process Small Intestinal Angiosarcoma C3272527 Malignant Small Intestinal Angiosarcoma Small Intestinal Angiosarcoma A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the small intestine. C96061 Neoplastic Process Small Intestinal Neuroendocrine Tumor C3272528 Undetermined Small Intestinal NET Small Intestinal Neuroendocrine Tumor Small Intestinal Well Differentiated Neuroendocrine Neoplasm Small Intestinal Well-Differentiated Neuroendocrine Neoplasm Small Intestinal Neuroendocrine Tumor A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the small or large intestine. C96062 Neoplastic Process Intestinal Neuroendocrine Tumor C3272529 Undetermined Intestinal NET Intestinal Neuroendocrine Tumor Intestinal Well Differentiated Neuroendocrine Neoplasm Intestinal Well-Differentiated Neuroendocrine Neoplasm Intestinal Neuroendocrine Tumor An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the small or large intestine. The mitotic count is more than 20 per 10 HPF. It is classified as either small or large cell neuroendocrine carcinoma based on the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm. C96063 Neoplastic Process Intestinal Neuroendocrine Carcinoma C3272530 Malignant Intestinal High Grade Neuroendocrine Carcinoma Intestinal NEC Intestinal NEC G3 Intestinal Neuroendocrine Carcinoma Intestinal Poorly Differentiated Endocrine Carcinoma Intestinal Neuroendocrine Carcinoma An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the small intestine. The mitotic count is more than 20 per 10 HPF. It is classified as either small or large cell neuroendocrine carcinoma based on the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm. C96064 Neoplastic Process Small Intestinal Neuroendocrine Carcinoma Small Intestinal Neuroendocrine Carcinoma C3272531 CTRP Malignant Small Intestinal High Grade Neuroendocrine Carcinoma Small Intestinal NEC Small Intestinal Neuroendocrine Cancer Small Intestinal Neuroendocrine Carcinoma Small Intestinal Poorly Differentiated Endocrine Carcinoma Small Intestinal Neuroendocrine Carcinoma An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the small intestine. It is characterized by the presence of malignant large cells. C96065 Neoplastic Process Small Intestinal Large Cell Neuroendocrine Carcinoma C3272532 Malignant Small Intestinal Large Cell Neuroendocrine Carcinoma Small Intestinal Large Cell Neuroendocrine Carcinoma A carcinoma that arises from the small intestine and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component. At least 30 percent of either component should be present for the diagnosis to be made. C96066 Neoplastic Process Small Intestinal Mixed Adenoneuroendocrine Carcinoma Small Intestinal Mixed Adenoneuroendocrine Carcinoma C3272533 CTRP Malignant Small Intestinal MANEC Small Intestinal Mixed Adenoneuroendocrine Cancer Small Intestinal Mixed Adenoneuroendocrine Carcinoma Small Intestinal Mixed Adenoneuroendocrine Carcinoma A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the small intestine. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3 to 20 percent. C96067 Neoplastic Process Small Intestinal Neuroendocrine Tumor G2 C3272534 Undetermined Malignant carcinoid tumor of the small intestine, unspecified portion Malignant carcinoid tumors of the small intestine Small Intestinal NET G2 Small Intestinal Neuroendocrine Tumor G2 Small Intestinal Neuroendocrine Tumor G2 A usually indolent neuroendocrine neoplasm that arises in the small intestine. Patients may present with gastrointestinal hemorrhage. It is a triphasic tumor consisting of a mixture of epithelioid neuroendocrine cells, Schwann-like cells, and ganglion cell-like elements. C96073 Neoplastic Process Small Intestinal Composite Gangliocytoma/Neuroma and Neuroendocrine Tumor C3272539 Undetermined Small Intestinal Composite Gangliocytoma/Neuroma and Neuroendocrine Tumor Small Intestinal Gangliocytic Neuroendocrine Tumor Small Intestinal Gangliocytic Paraganglioma Small Intestinal Mixed Ganglioneuroma-Neuroendocrine Neoplasm Small Intestinal Composite Gangliocytoma/Neuroma and Neuroendocrine Tumor A neoplasm with neuroendocrine differentiation that arises from the colon or rectum. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms). C96152 Neoplastic Process Colorectal Neuroendocrine Neoplasm C3272603 Undetermined Colorectal Neuroendocrine Neoplasm Large Intestinal Neuroendocrine Neoplasm Colorectal Neuroendocrine Neoplasm An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the colon or rectum. The mitotic count is more than 20 per 10 HPF. It is classified as either small or large cell neuroendocrine carcinoma based on the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm. C96156 Neoplastic Process Colorectal Neuroendocrine Carcinoma Colorectal Neuroendocrine Carcinoma C3272607 CTRP Cellosaurus Malignant Colorectal (Colon or Rectal) Neuroendocrine Cancer Colorectal NEC Colorectal Neuroendocrine Carcinoma Large Intestinal Neuroendocrine Carcinoma Colorectal Neuroendocrine Carcinoma An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the colon or rectum. It is characterized by the presence of malignant large cells. C96157 Neoplastic Process Colorectal Large Cell Neuroendocrine Carcinoma C3272608 Cellosaurus Malignant Colorectal Large Cell Neuroendocrine Carcinoma Large Intestinal Large Cell Neuroendocrine Carcinoma Colorectal Large Cell Neuroendocrine Carcinoma A carcinoma that arises from the colon or rectum and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component. At least 30 percent of either component should be present for the diagnosis to be made. C96158 Neoplastic Process Colorectal Mixed Adenoneuroendocrine Carcinoma Colorectal Mixed Adenoneuroendocrine Carcinoma C3272609 CTRP Malignant Colorectal (Colon or Rectal) Mixed Adenoneuroendocrine Cancer Colorectal MANEC Colorectal Mixed Adenoneuroendocrine Carcinoma Colorectal Mixed Adenoneuroendocrine Carcinoma A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the colon or rectum. C96159 Neoplastic Process Colorectal Neuroendocrine Tumor C3272610 Undetermined Colorectal NET Colorectal Neuroendocrine Tumor Colorectal Well Differentiated Neuroendocrine Neoplasm Colorectal Well-Differentiated Neuroendocrine Neoplasm Large Intestinal Neuroendocrine Tumor Colorectal Neuroendocrine Tumor A well differentiated, low grade neuroendocrine neoplasm that arises from the colon or rectum. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. C96160 Neoplastic Process Colorectal Neuroendocrine Tumor G1 C3272611 Undetermined Colorectal Carcinoid Tumor Colorectal NET G1 Colorectal Neuroendocrine Tumor G1 Large Intestinal Neuroendocrine Tumor G1 Colorectal Neuroendocrine Tumor G1 A neuroendocrine tumor that arises from the colon or rectum and produces glucagon-like peptides. Morphologically, it is characterized by the presence of neoplastic cells forming tubular or trabecular patterns. C96161 Neoplastic Process Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor C3272612 Undetermined Colorectal L-Cell Glucagon-Like Peptide-Producing NET Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor A well differentiated neuroendocrine tumor that arises from the colon or rectum and produces serotonin. C96162 Neoplastic Process Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor C3272613 Undetermined Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the colon or rectum. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3 to 20 percent. C96163 Neoplastic Process Colorectal Neuroendocrine Tumor G2 C3272614 Undetermined Colorectal NET G2 Colorectal Neuroendocrine Tumor G2 Large Intestinal Neuroendocrine Tumor G2 Colorectal Neuroendocrine Tumor G2 A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the small or large intestine. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3 to 20 percent. C96165 Neoplastic Process Intestinal Neuroendocrine Tumor G2 C3272616 Undetermined Intestinal NET G2 Intestinal Neuroendocrine Tumor G2 Intestinal Neuroendocrine Tumor G2 A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the digestive system. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3 to 20 percent. C96166 Neoplastic Process Digestive System Neuroendocrine Tumor G2 C3272617 8249/3 Undetermined Neuroendocrine tumor, grade 2 Digestive System Neuroendocrine Tumor G2 Gastrointestinal NET G2 Gastrointestinal Neuroendocrine Tumor G2 Digestive System Neuroendocrine Tumor G2 A parathyroid gland embedded within the thyroid gland parenchyma. C96188 Body Part, Organ, or Organ Component Intrathyroidal Parathyroid C3272635 Intrathyroidal Parathyroid Intrathyroidal Parathyroid Polyps that arises from the large intestine and the appendix. They are characterized by the presence of serrated glands and the absence of generalized dysplasia. C96414 Neoplastic Process Serrated Lesions and Polyps C2732618 GDC 8213/0 Benign 8213/0 Sessile serrated adenoma Sessile serrated polyp SSA SSA/P SSP Serrated Adenoma Type I Serrated Lesions and Polyps Serrated Polyp with Abnormal Proliferation Sessile Serrated Adenoma Sessile Serrated Adenoma/Polyp Sessile Serrated Polyp Sessile Serrated Polyp/Adenoma Sessile serrated adenoma Sessile serrated polyp Serrated Lesions and Polyps Polyps that arises from the appendix. They are characterized by the presence of serrated glands and the absence of generalized dysplasia. C96415 Neoplastic Process Appendix Serrated Lesions and Polyps C3272760 Benign Appendix SSA Appendix SSA/P Appendix SSP Appendix Serrated Lesions and Polyps Appendix Sessile Serrated Adenoma Appendix Sessile Serrated Adenoma/Polyp Appendix Sessile Serrated Polyp Appendix Serrated Lesions and Polyps A precancerous intraepithelial neoplastic lesion that affects the appendix. It is characterized by low or high grade dysplasia of the mucosal epithelium. There is no evidence of invasion. C96418 Neoplastic Process Appendix Intraepithelial Neoplasia C3272763 Undetermined Appendiceal Dysplasia Appendix Dysplasia Appendix Intraepithelial Neoplasia Appendix Intraepithelial Neoplasia A precancerous intraepithelial neoplastic lesion that affects the appendix. It is characterized by the presence of mild dysplasia and mild architectural alterations of the mucosal epithelium. There is no evidence of invasion. C96419 Neoplastic Process Appendix Low Grade Intraepithelial Neoplasia C3272764 Undetermined Appendiceal Low Grade Dysplasia Appendiceal Low Grade Intraepithelial Neoplasia Appendix Low Grade Dysplasia Appendix Low Grade Intraepithelial Neoplasia Appendix Low Grade Intraepithelial Neoplasia A precancerous intraepithelial neoplastic lesion that affects the appendix. It is characterized by the presence of moderate or severe dysplasia and complex architectural alterations of the mucosal epithelium. There is no evidence of invasion. C96420 Neoplastic Process Appendix High Grade Intraepithelial Neoplasia C3272765 Undetermined Appendiceal High Grade Dysplasia Appendiceal High Grade Intraepithelial Neoplasia Appendix High Grade Dysplasia Appendix High Grade Intraepithelial Neoplasia Appendix High Grade Intraepithelial Neoplasia A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the appendix. C96422 Neoplastic Process Appendix Neuroendocrine Tumor Appendix Neuroendocrine Tumor C3272767 CTRP Undetermined Appendix NET Appendix Neuroendocrine Tumor Appendix Well Differentiated Neuroendocrine Neoplasm Appendix Well-Differentiated Neuroendocrine Neoplasm Appendix Neuroendocrine Tumor A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the appendix. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3 to 20 percent. C96423 Neoplastic Process Appendix Neuroendocrine Tumor G2 C3272768 mCode Undetermined Malignant carcinoid tumor of the appendix Appendix NET G2 Appendix Neuroendocrine Tumor G2 Malignant carcinoid tumor of the appendix Appendix Neuroendocrine Tumor G2 A well differentiated neuroendocrine tumor arising from the wall of the appendix. It is characterized by the presence of neoplastic cells forming round solid nests and occasionally glandular structures. The majority of the cases are asymptomatic, and they are found incidentally in appendectomy specimens. The majority of the tumors are located in the distal end of the appendix and they are enterochromaffin-cell carcinoid tumors producing serotonin. Most cases show morphologic evidence of appendiceal wall and lymphatic vessel invasion by tumor cells. Despite the morphologic evidence of invasion, appendiceal carcinoid tumors only infrequently produce lymph node or distant metastases. C96424 Neoplastic Process Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor C3272769 Undetermined Appendix EC Cell Serotonin-Producing NET Appendix EC-Cell Serotonin-Producing Neuroendocrine Tumor Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the appendix. The mitotic count is more than 20 per 10 HPF. It is classified as either small or large cell neuroendocrine carcinoma based on the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm. C96425 Neoplastic Process Appendix Neuroendocrine Carcinoma C2205024 Malignant Appendix High Grade Neuroendocrine Carcinoma Appendix NEC Appendix NEC G3 Appendix Neuroendocrine Carcinoma Appendix Poorly Differentiated Endocrine Carcinoma Appendix Neuroendocrine Carcinoma An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the appendix. It is characterized by the presence of malignant large cells. C96426 Neoplastic Process Appendix Large Cell Neuroendocrine Carcinoma C2111708 Malignant Appendix Large Cell Neuroendocrine Carcinoma Appendix Large Cell Neuroendocrine Carcinoma A rare Kaposi sarcoma that arises from the appendiceal wall. C96434 Neoplastic Process Appendix Kaposi Sarcoma C3272778 Malignant Appendix Kaposi Sarcoma Appendix Kaposi Sarcoma A rare leiomyosarcoma that arises from the appendiceal wall. C96435 Neoplastic Process Appendix Leiomyosarcoma C2168280 Malignant Appendix Leiomyosarcoma Appendix Leiomyosarcoma An adenoma that arises from the rectum. It is characterized by prominent serration of the glands. C96463 Neoplastic Process Rectal Traditional Serrated Adenoma C3272790 Benign Rectal Serrated Adenoma Rectal Serrated Adenoma Type II Rectal TSA Rectal Traditional Serrated Adenoma Rectal Traditional Serrated Adenoma Polyps that arise from the colon, and are characterized by the presence of serrated glands and the absence of generalized dysplasia. C96464 Neoplastic Process Colon Serrated Lesions and Polyps C3272791 Benign Colon SSA Colon SSA/P Colon SSP Colon Serrated Lesions and Polyps Colon Sessile Serrated Adenoma Colon Sessile Serrated Adenoma/Polyp Colon Sessile Serrated Polyp Colon Serrated Lesions and Polyps Polyps that arises from the rectum. They are characterized by the presence of serrated glands and the absence of generalized dysplasia. C96465 Neoplastic Process Rectal Serrated Lesions and Polyps C3272792 Benign Rectal SSA Rectal SSA/P Rectal SSP Rectal Serrated Lesions and Polyps Rectal Sessile Serrated Adenoma Rectal Sessile Serrated Adenoma/Polyp Rectal Sessile Serrated Polyp Rectal Serrated Lesions and Polyps A traditional serrated adenoma characterized by the presence of prominent villous projections of the neoplastic epithelium. C96466 Neoplastic Process Digestive System Filiform Serrated Adenoma C3272793 Benign Digestive System Filiform Serrated Adenoma FSA Filiform Serrated Adenoma Digestive System Filiform Serrated Adenoma A traditional serrated adenoma that arises from the colon or rectum. It is characterized by the presence of prominent villous projections of the neoplastic epithelium. C96468 Neoplastic Process Colorectal Filiform Serrated Adenoma C3272795 Benign Colorectal FSA Colorectal Filiform Serrated Adenoma Colorectal Filiform Serrated Adenoma A usually polypoid neoplasm that arises from the glandular epithelium of the rectal mucosa. It is characterized by a tubular architectural pattern. The neoplastic glandular cells have dysplastic features. C96477 Neoplastic Process Rectal Tubular Adenoma C3272804 Benign Rectal Tubular Adenoma Rectal Tubular Adenoma A polypoid adenoma that arises from and protrudes into the lumen of the colon or rectum. Epithelial dysplasia is always present. According to the architectural pattern it is classified as tubular, tubulovillous, or villous. C96478 Neoplastic Process Colorectal Adenomatous Polyp C3272805 Benign Adenomatous Polyp of Large Bowel Adenomatous Polyp of the Large Bowel Colorectal Adenomatous Polyp Large Bowel Adenomatous Polyp Colorectal Adenomatous Polyp A polypoid adenoma that arises from and protrudes into the lumen of the colon. Epithelial dysplasia is always present. According to the architectural pattern it is classified as tubular, tubulovillous, or villous. C96479 Neoplastic Process Colon Adenomatous Polyp C1868071 Benign Adenomatous Polyp of Colon Adenomatous Polyp of the Colon Colon Adenomatous Polyp Colonic Adenomatous Polyp Colon Adenomatous Polyp A polypoid adenoma that arises from and protrudes into the lumen of the rectum. Epithelial dysplasia is always present. According to the architectural pattern it is classified as tubular, tubulovillous, or villous. C96480 Neoplastic Process Rectal Adenomatous Polyp C3272806 Benign Adenomatous Polyp of Rectum Adenomatous Polyp of the Rectum Rectal Adenomatous Polyp Rectal Adenomatous Polyp A rare, invasive colorectal adenocarcinoma characterized by the presence of a malignant infiltrate with serrated glandular architecture. C96485 Neoplastic Process Colorectal Serrated Adenocarcinoma C3472623 GDC 8213/3 Malignant 8213/3 Serrated adenocarcinoma Colorectal Serrated Adenocarcinoma Serrated adenocarcinoma Colorectal Serrated Adenocarcinoma A rare, invasive colon adenocarcinoma characterized by the presence of a malignant infiltrate with serrated glandular architecture. C96486 Neoplastic Process Colon Serrated Adenocarcinoma C3272810 Malignant Colon Serrated Adenocarcinoma Colon Serrated Adenocarcinoma A rare, invasive rectal adenocarcinoma characterized by the presence of a malignant infiltrate with serrated glandular architecture. C96487 Neoplastic Process Rectal Serrated Adenocarcinoma C3272811 Malignant Rectal Serrated Adenocarcinoma Rectal Serrated Adenocarcinoma A rare, invasive colorectal adenocarcinoma characterized by the presence of malignant cribriform glands with central necrotic changes. C96488 Neoplastic Process Colorectal Cribriform Comedo-Type Adenocarcinoma C3272812 8201/3 Malignant Colorectal Cribriform Comedo-Type Adenocarcinoma Colorectal Cribriform Comedo-Type Adenocarcinoma A rare, invasive colon adenocarcinoma characterized by the presence of malignant cribriform glands with central necrotic changes. C96489 Neoplastic Process Colon Cribriform Comedo-Type Adenocarcinoma C3272813 Malignant Colon Cribriform Comedo-Type Adenocarcinoma Colon Cribriform Comedo-Type Adenocarcinoma A rare, invasive rectal adenocarcinoma characterized by the presence of malignant cribriform glands with central necrotic changes. C96490 Neoplastic Process Rectal Cribriform Comedo-Type Adenocarcinoma C3272814 Malignant Rectal Cribriform Comedo-Type Adenocarcinoma Rectal Cribriform Comedo-Type Adenocarcinoma A rare, invasive colorectal adenocarcinoma characterized by the presence of clusters of malignant glandular cells within stromal spaces. C96491 Neoplastic Process Colorectal Micropapillary Adenocarcinoma C3272815 8265/3 Malignant Colorectal Micropapillary Adenocarcinoma Colorectal Micropapillary Adenocarcinoma A rare, invasive colon adenocarcinoma characterized by the presence of clusters of malignant glandular cells within stromal spaces. C96492 Neoplastic Process Colon Micropapillary Adenocarcinoma C3272816 Malignant Colon Micropapillary Adenocarcinoma Colon Micropapillary Adenocarcinoma A rare, invasive rectal adenocarcinoma characterized by the presence of clusters of malignant glandular cells within stromal spaces. C96493 Neoplastic Process Rectal Micropapillary Adenocarcinoma C3272817 Malignant Rectal Micropapillary Adenocarcinoma Rectal Micropapillary Adenocarcinoma A biphasic colorectal carcinoma with a spindle cell, sarcomatoid component. C96494 Neoplastic Process Colorectal Sarcomatoid Carcinoma Colorectal Sarcomatoid Carcinoma C3272818 CTRP Malignant Colorectal (Colon or Rectal) Sarcomatoid Cancer Colorectal Carcinoma With Sarcomatoid Components Colorectal Sarcomatoid Carcinoma Colorectal Spindle Cell Carcinoma Colorectal Sarcomatoid Carcinoma A colorectal adenocarcinoma that develops in patients with a history of ulcerative colitis. Such carcinomas are usually multiple and flat. Histologically, they are usually mucinous or signet-ring cell type. C96496 Neoplastic Process Ulcerative Colitis-Associated Colorectal Adenocarcinoma C3272820 Malignant UC-Associated CRC Ulcerative Colitis-Associated Colorectal Adenocarcinoma Ulcerative Colitis-Associated Colorectal Carcinoma Ulcerative Colitis-Associated Colorectal Adenocarcinoma A colorectal adenocarcinoma that develops in patients with a history of Crohn disease. C96497 Neoplastic Process Crohn Disease-Associated Colorectal Adenocarcinoma C3272821 Malignant Crohn Disease-Associated Colorectal Adenocarcinoma Crohn's Disease-Associated Colorectal Adenocarcinoma Crohn Disease-Associated Colorectal Adenocarcinoma An extranodal lymphoma that arises from the colon or rectum. The majority are B-cell non-Hodgkin lymphomas. C96498 Neoplastic Process Colorectal Lymphoma C3272822 Malignant Colorectal Lymphoma Large Intestinal Lymphoma Primary Colorectal Lymphoma Colorectal Lymphoma An extranodal non-Hodgkin lymphoma that arises from the colon or rectum. The majority are B-cell non-Hodgkin lymphomas. C96499 Neoplastic Process Colorectal Non-Hodgkin Lymphoma C3272823 Malignant Colorectal Non-Hodgkin Lymphoma Primary Colorectal Non-Hodgkin Lymphoma Colorectal Non-Hodgkin Lymphoma An extranodal Hodgkin lymphoma that arises from the colon or rectum. C96500 Neoplastic Process Colorectal Hodgkin Lymphoma C3272824 Malignant Colorectal Hodgkin Lymphoma Primary Colorectal Hodgkin Lymphoma Colorectal Hodgkin Lymphoma High-grade B-cell lymphoma, not otherwise specified, that arises from the colorectal region. C96501 Neoplastic Process Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified C3272825 Malignant Colorectal B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified Colorectal High-Grade B-Cell Lymphoma, Not Otherwise Specified Primary Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified Primary Colorectal High-Grade B-Cell Lymphoma, Not Otherwise Specified Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified A rare Burkitt lymphoma that arises from the colon or rectum. C96502 Neoplastic Process Colorectal Burkitt Lymphoma C3272826 Malignant Colorectal Burkitt Lymphoma Colorectal Burkitt Lymphoma A diffuse large B-cell lymphoma that arises from the colon or rectum. C96503 Neoplastic Process Colorectal Diffuse Large B-Cell Lymphoma C3272827 Malignant Colorectal DLBCL Colorectal Diffuse Large B-Cell Lymphoma Primary Colorectal DLBCL Primary Colorectal Diffuse Large B-Cell Lymphoma Colorectal Diffuse Large B-Cell Lymphoma A diffuse large B-cell lymphoma that arises from the colon. It is the most frequent type of lymphoma found in the colon. C96504 Neoplastic Process Colon Diffuse Large B-Cell Lymphoma C3272828 Malignant Colon DLBCL Colon Diffuse Large B-Cell Lymphoma Primary Colon DLBCL Primary Colon Diffuse Large B-Cell Lymphoma Colon Diffuse Large B-Cell Lymphoma A mantle cell lymphoma that arises from the colon or rectum. It often presents as a polypoid lesion. C96505 Neoplastic Process Colorectal Mantle Cell Lymphoma C3272829 Malignant Colorectal Mantle Cell Lymphoma Colorectal Mantle Cell Lymphoma An extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue that arises from the colon or rectum. C96506 Neoplastic Process Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma C3272830 Malignant Colorectal MALT Lymphoma Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma A malignant soft tissue neoplasm that arises from the colon or rectum. Representative examples include angiosarcoma, Kaposi sarcoma, and leiomyosarcoma. C96508 Neoplastic Process Colorectal Sarcoma C3272831 Malignant Colorectal Sarcoma Large Intestinal Sarcoma Colorectal Sarcoma An aggressive malignant smooth muscle neoplasm that arises from the colon or rectum. It is characterized by a proliferation of neoplastic spindle cells. C96509 Neoplastic Process Colorectal Leiomyosarcoma C3272832 Malignant Colorectal Leiomyosarcoma Colorectal Leiomyosarcoma A Kaposi sarcoma that arises from the colon or rectum. C96510 Neoplastic Process Colorectal Kaposi Sarcoma C3272833 Malignant Colorectal Kaposi Sarcoma Large Intestinal Kaposi Sarcoma Colorectal Kaposi Sarcoma An angiosarcoma that arises from the colon or rectum. C96511 Neoplastic Process Colorectal Angiosarcoma C3272834 Malignant Colorectal Angiosarcoma Colorectal Angiosarcoma A schwannoma that arises from the colon or rectum. It may cause gastrointestinal bleeding and luminal obstruction. C96512 Neoplastic Process Colorectal Schwannoma C3272835 Benign Colorectal Schwannoma Colorectal Schwannoma A perineurioma that arises from the colon or rectum. It usually presents as a small sessile polyp. C96513 Neoplastic Process Colorectal Perineurioma C3272836 Benign Colorectal Fibroblastic Polyp Colorectal Perineurioma Colorectal Perineurioma A ganglioneuroma that arises from the colon or rectum. It usually presents as a small mucosal polyp. C96514 Neoplastic Process Colorectal Ganglioneuroma C3272837 Benign Colorectal Ganglioneuroma Colorectal Ganglioneuroma A granular cell tumor that arises from the colon or rectum and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. C96516 Neoplastic Process Colorectal Benign Granular Cell Tumor C3272838 Undetermined Colorectal Benign Granular Cell Tumor Colorectal Benign Granular Cell Tumor A usually aggressive malignant epithelial neoplasm that arises from the anal canal. It is composed of malignant cells which do not display evidence of glandular or squamous differentiation. C96529 Neoplastic Process Anal Canal Undifferentiated Carcinoma C2064242 Malignant Anal Canal Undifferentiated Carcinoma Anal Canal Undifferentiated Carcinoma A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the anal canal. C96540 Neoplastic Process Anal Canal Neuroendocrine Tumor C3272849 Undetermined Anal Canal NET Anal Canal Neuroendocrine Tumor Anal NET Anal Neuroendocrine Tumor Anal Canal Neuroendocrine Tumor A well differentiated, low grade neoplasm with neuroendocrine differentiation that arises from the anal canal. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. C96543 Neoplastic Process Anal Canal Neuroendocrine Tumor G1 C3272852 Undetermined Anal Canal NET G1 Anal Canal Neuroendocrine Tumor G1 Anal NET G1 Anal Neuroendocrine Tumor G1 Anal Canal Neuroendocrine Tumor G1 A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the anal canal. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3 to 20 percent. C96546 Neoplastic Process Anal Canal Neuroendocrine Tumor G2 C3272854 Undetermined Anal Canal NET G2 Anal Canal Neuroendocrine Tumor G2 Anal NET G2 Anal Neuroendocrine Tumor G2 Anal Canal Neuroendocrine Tumor G2 An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the anal canal. The mitotic count is more than 20 per 10 HPF. It is classified as either small or large cell neuroendocrine carcinoma based on the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm. C96549 Neoplastic Process Anal Canal Neuroendocrine Carcinoma C2205189 Cellosaurus Malignant Anal Canal High Grade Neuroendocrine Carcinoma Anal Canal NEC Anal Canal NEC G3 Anal Canal Neuroendocrine Carcinoma Anal High Grade Neuroendocrine Carcinoma Anal NEC Anal NEC G3 Anal Neuroendocrine Carcinoma Anal Canal Neuroendocrine Carcinoma An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the anal canal. It is characterized by the presence of malignant large cells. C96550 Neoplastic Process Anal Canal Large Cell Neuroendocrine Carcinoma C2111706 Malignant Anal Canal Large Cell NEC Anal Canal Large Cell Neuroendocrine Carcinoma Anal Large Cell NEC Anal Large Cell Neuroendocrine Carcinoma Anal Canal Large Cell Neuroendocrine Carcinoma An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the anal canal. It is characterized by the presence of malignant small cells. C96551 Neoplastic Process Anal Canal Small Cell Neuroendocrine Carcinoma C3272855 Malignant Anal Canal Small Cell Carcinoma Anal Canal Small Cell NEC Anal Canal Small Cell Neuroendocrine Carcinoma Anal Small Cell NEC Anal Small Cell Neuroendocrine Carcinoma Anal Canal Small Cell Neuroendocrine Carcinoma A carcinoma that arises from the anal canal. It is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component. At least 30 percent of either component should be present for the diagnosis to be made. C96553 Neoplastic Process Anal Canal Mixed Adenoneuroendocrine Carcinoma C3272856 Malignant Anal Canal MANEC Anal Canal Mixed Adenoneuroendocrine Carcinoma Anal MANEC Anal Mixed Adenoneuroendocrine Carcinoma Anal Canal Mixed Adenoneuroendocrine Carcinoma A benign epithelial neoplasm that arises from the anal canal. It is characterized by a papillary growth pattern and a proliferation of neoplastic squamous cells without morphologic evidence of malignancy. C96554 Neoplastic Process Anal Canal Squamous Papilloma C3272857 Benign Anal Canal Squamous Cell Papilloma Anal Canal Squamous Papilloma Anal Canal Squamous Papilloma A diagnostic radiologic test that involves the examination of the entire body in a single procedure. C96640 Diagnostic Procedure Total Body Radiography C3272922 CDISC A diagnostic radiologic test that involves the examination of the entire body in a single procedure. TOTAL BODY RADIOGRAPHY Total Body Radiography Total Body Radiography A benign neoplasm arising from the perianal sweat glands. It presents as a cystic nodular lesion and is characterized by the presence of cystic and papillary structures. The papillary structures contain connective tissue and are covered by two layers of epithelium. C96699 Neoplastic Process Anal Hidradenoma Papilliferum C3272973 Benign Anal Hidradenoma Papilliferum Anal Papillary Hidradenoma Anal Hidradenoma Papilliferum A neoplasm that arises from the hepatocytes or intrahepatic bile duct epithelial cells and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential. Representative examples include hepatocellular adenoma and bile duct adenoma. C96756 Neoplastic Process Benign Liver Epithelial Neoplasm C3273007 CPTAC Benign Benign neoplasm of liver and biliary passages Benign Liver Epithelial Neoplasm Benign Liver and Intrahepatic Bile Duct Epithelial Neoplasm Benign Liver Epithelial Neoplasm A hepatocellular adenoma caused by inactivating mutations of the HNF1A gene. It is characterized by the presence of lobulated contours, steatosis, and absence of inflammation or nuclear atypia. C96758 Neoplastic Process HNF1alpha-Inactivated Hepatocellular Adenoma C3273008 Benign H-HCA HNF1alpha-Inactivated Hepatocellular Adenoma HNF1alpha-Inactivated Hepatocellular Adenoma A hepatocellular adenoma caused by activating mutations of beta-catenin. It is characterized by the presence of nuclear atypia and absence of inflammation or steatosis. There is an increased risk of malignant transformation. C96759 Neoplastic Process Beta-Catenin-Activated Hepatocellular Adenoma C3273009 Benign Beta-Catenin-Activated Hepatocellular Adenoma b-HCA Beta-Catenin-Activated Hepatocellular Adenoma A hepatocellular adenoma that occurs more often in women. It is characterized by increased levels of inflammation-associated proteins. It is usually associated with steatosis and obesity. C96760 Neoplastic Process Inflammatory Hepatocellular Adenoma C3273010 Benign IHCA Inflammatory Hepatocellular Adenoma Telangiectatic Adenoma Telangiectatic Hepatocellular Adenoma Inflammatory Hepatocellular Adenoma A hepatocellular adenoma without distinguished morphologic characteristics or known molecular abnormalities. C96761 Neoplastic Process Unclassified Hepatocellular Adenoma C3273011 Benign Unclassified Hepatocellular Adenoma Unclassified Hepatocellular Adenoma A premalignant neoplastic lesion of the liver. It is characterized by the presence of hepatocytes with decreased cell volume, increased nuclear/cytoplasmic ratio, basophilia, mild nuclear pleomorphism, and hyperchromasia. C96765 Neoplastic Process Hepatocellular Small Cell Change C3273014 Undetermined Hepatocellular Small Cell Change Small Cell Dysplasia Hepatocellular Small Cell Change A carcinoma that has spread to the liver from another primary anatomic site. Representative examples include metastatic carcinomas from the colon, breast, and lung. C96767 Neoplastic Process Metastatic Carcinoma in the Liver C3282903 Malignant Metastatic Carcinoma in the Liver Metastatic Carcinoma to the Liver Metastatic Carcinoma in the Liver A hepatic dysplastic nodule characterized by the presence of high grade atypical cellular changes. C96768 Neoplastic Process High Grade Liver Dysplastic Nodule C3273016 GDC Malignant High Grade Liver Dysplastic Nodule HGDN High Grade Hepatic Dysplastic Nodule High Grade Liver Dysplastic Nodule High Grade Liver Dysplastic Nodule A hepatic dysplastic nodule characterized by the presence of low grade atypical cellular changes. C96770 Neoplastic Process Low Grade Liver Dysplastic Nodule C3273018 GDC Malignant Low Grade Liver Dysplastic Nodule LGDN Low Grade Hepatic Dysplastic Nodule Low Grade Liver Dysplastic Nodule Low Grade Liver Dysplastic Nodule A low grade, well differentiated small hepatocellular carcinoma. It lacks obvious stromal invasion and significant atypia. C96772 Neoplastic Process Early Hepatocellular Carcinoma Early Hepatocellular Carcinoma C3273019 CTRP Malignant Early Hepatocellular Cancer Early Hepatocellular Carcinoma eHCC Early Hepatocellular Carcinoma An extremely rare neoplasm with neuroendocrine differentiation that arises from the liver. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms). C96786 Neoplastic Process Liver Neuroendocrine Neoplasm C3273030 Undetermined Hepatic Neuroendocrine Neoplasm Liver Neuroendocrine Neoplasm Primary Hepatic Neuroendocrine Neoplasm Primary Liver Neuroendocrine Neoplasm Liver Neuroendocrine Neoplasm An extremely rare, aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the liver. C96787 Neoplastic Process Liver Neuroendocrine Carcinoma Liver Neuroendocrine Carcinoma C3273031 CTRP Malignant HNEC Hepatic Neuroendocrine Carcinoma Liver Neuroendocrine Cancer Liver Neuroendocrine Carcinoma Primary Hepatic Neuroendocrine Carcinoma Primary Liver Neuroendocrine Carcinoma Liver Neuroendocrine Carcinoma A rare type of hepatocellular carcinoma characterized by the presence of pleomorphic malignant cells that are intermixed with lymphocytes. C96788 Neoplastic Process Lymphoepithelioma-Like Hepatocellular Carcinoma Lymphocyte-Rich Hepatocellular Carcinoma C3273032 CTRP Malignant Lymphocyte-Rich Hepatocellular Carcinoma Lymphoepithelioma-Like Hepatocellular Cancer Lymphoepithelioma-Like Hepatocellular Carcinoma Lymphocyte-Rich Hepatocellular Carcinoma A hepatocellular carcinoma characterized by the presence of malignant cells with mild atypia and an increased nuclear/cytoplasmic ratio forming thin trabecular patterns. It is usually associated with small tumors and an early stage. C96789 Neoplastic Process Well Differentiated Hepatocellular Carcinoma Well Differentiated Hepatocellular Carcinoma C3273033 CTRP Malignant Well Differentiated Hepatocellular Cancer Well Differentiated Hepatocellular Carcinoma Well Differentiated Hepatocellular Carcinoma A hepatocellular carcinoma characterized by the presence of malignant cells with abundant eosinophilic cytoplasm forming trabecular and pseudoglandular patterns. It is usually associated with tumors that are larger than 3 cm in diameter. C96790 Neoplastic Process Moderately Differentiated Hepatocellular Carcinoma Moderately Differentiated Hepatocellular Carcinoma C3273034 CTRP Malignant Moderately Differentiated Hepatocellular Cancer Moderately Differentiated Hepatocellular Carcinoma Moderately Differentiated Hepatocellular Carcinoma A hepatocellular carcinoma characterized by the presence of malignant pleomorphic cells forming solid patterns. C96791 Neoplastic Process Poorly Differentiated Hepatocellular Carcinoma Poorly Differentiated Hepatocellular Carcinoma C3273035 CTRP Malignant Poorly Differentiated Hepatocellular Cancer Poorly Differentiated Hepatocellular Carcinoma Poorly Differentiated Hepatocellular Carcinoma A rare carcinoma that arises from the liver. The diagnosis is made by immunohistochemical studies. Morphologic studies alone cannot establish the diagnosis of carcinoma or further subclassify the malignant tumor. C96792 Neoplastic Process Undifferentiated Liver Carcinoma Liver Undifferentiated Carcinoma C2064401 CTRP Cellosaurus Malignant Liver Undifferentiated Carcinoma Undifferentiated Liver Cancer Undifferentiated Liver Carcinoma Undifferentiated Primary Liver Carcinoma Liver Undifferentiated Carcinoma The larger bile ducts which are located within the liver and drain bile from the smaller peripheral intrahepatic bile ducts into the right and left hepatic ducts. C96803 Body Part, Organ, or Organ Component Intrahepatic Large Bile Duct C3273046 CDISC The larger bile ducts which are located within the liver and drain bile from the smaller peripheral intrahepatic bile ducts into the right and left hepatic ducts. INTRAHEPATIC LARGE BILE DUCT Intrahepatic Large Bile Duct Perihilar Bile Duct Periphilar Bile Duct Intrahepatic Large Bile Duct An intrahepatic cholangiocarcinoma that arises from the intrahepatic large bile ducts. C96804 Neoplastic Process Large Duct Intrahepatic Cholangiocarcinoma C3273047 8162/3 Malignant Large Duct Intrahepatic Cholangiocarcinoma Large Duct Intrahepatic Cholangiocarcinoma An intrahepatic cholangiocarcinoma that arises from the small interlobular bile ducts. C96805 Neoplastic Process Small Duct Intrahepatic Cholangiocarcinoma C3273048 CDISC Cellosaurus A malignant intrahepatic neoplasm arising from the small interlobular bile ducts. Malignant PERIPHERAL CHOLANGIOCARCINOMA, MALIGNANT Peripheral Cholangiocarcinoma Peripheral ICC Peripheral Intrahepatic Cholangiocarcinoma Small Duct Intrahepatic Cholangiocarcinoma Small Duct Intrahepatic Cholangiocarcinoma An intraductal papillary neoplasm that arises from the epithelium of the intrahepatic or extrahepatic bile ducts. It is characterized by the presence of mild epithelial atypia. C96807 Neoplastic Process Bile Duct Intraductal Papillary Neoplasm, Low Grade C3273049 GDC 8503/0 Undetermined 8503/0 Intraductal papillary neoplasm with low grade intraepithelial neoplasia Bile Duct IPN with Low Grade Intraepithelial Neoplasia Bile Duct Intraductal Papillary Neoplasm with Low Grade Intraepithelial Neoplasia Bile Duct Intraductal Papillary Neoplasm, Low Grade Bile Duct Intraductal Papillary Neoplasm, Low-Grade Bile Duct Papillary Neoplasm with Low Grade Intraepithelial Neoplasia Intraductal Papillary Neoplasm with Low Grade Intraepithelial Neoplasia Intraductal papillary neoplasm with low grade intraepithelial neoplasia Bile Duct Intraductal Papillary Neoplasm, Low Grade An intraductal papillary neoplasm that arises from the epithelium of the intrahepatic or extrahepatic bile ducts. It is characterized by the presence of severe epithelial atypia. C96809 Neoplastic Process Bile Duct Intraductal Papillary Neoplasm, High Grade C3273051 GDC 8503/2 Undetermined 8503/2 Intraductal papillary neoplasm with high grade intraepithelial neoplasia Bile Duct IPN with High Grade Intraepithelial Neoplasia Bile Duct Intraductal Papillary Neoplasm with High Grade Intraepithelial Neoplasia Bile Duct Intraductal Papillary Neoplasm, High Grade Bile Duct Intraductal Papillary Neoplasm, High-Grade Bile Duct Papillary Neoplasm with High Grade Intraepithelial Neoplasia Intraductal Papillary Neoplasm with High Grade Intraepithelial Neoplasia Intraductal papillary neoplasm with high grade intraepithelial neoplasia Bile Duct Intraductal Papillary Neoplasm, High Grade An intraductal papillary neoplasm that arises from the epithelium of the intrahepatic or extrahepatic bile ducts and it is associated with an invasive carcinomatous component. C96810 Neoplastic Process Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma C3273052 8503/3 Malignant Bile Duct IPN with an Associated Invasive Carcinoma Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma Bile Duct Papillary Adenocarcinoma Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma Intraductal Papillary Neoplasm with Associated Invasive Carcinoma Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma An adenoma that arises from the extrahepatic bile ducts. It is characterized by the presence of tubular and papillary growth patterns. C96811 Neoplastic Process Extrahepatic Bile Duct Tubulopapillary Adenoma C2064425 Benign Extrahepatic Bile Duct Tubulopapillary Adenoma Extrahepatic Bile Duct Tubulopapillary Adenoma A rare benign neoplasm that arises from the intrahepatic bile ducts. It is characterized by the presence of biliary epithelial tissue and fibroblastic stroma. C96826 Neoplastic Process Biliary Adenofibroma C3273066 Benign BAF Biliary Adenofibroma Intrahepatic Bile Duct Adenofibroma Biliary Adenofibroma A rare malignant tumor that arises from the liver and occurs in children. It is characterized by the presence of nested epithelioid and spindle cells. Desmoplasia, calcifications, and bone formation may also be present. C96830 Neoplastic Process Calcifying Nested Stromal-Epithelial Tumor C3273067 GDC 8975/1 Malignant 8975/1 Calcifying fibrous tumor Calcifying nested epithelial stromal tumor Calcifying nested stromal-epithelial tumor CNSET Calcifying Nested Epithelial Stromal Tumor of the Liver Calcifying Nested Epithelial-Stromal Tumor of the Liver Calcifying Nested Stromal Epithelial Tumor of the Liver Calcifying Nested Stromal-Epithelial Tumor Calcifying Nested Stromal-Epithelial Tumor of the Liver Calcifying nested epithelial stromal tumor Calcifying Nested Stromal-Epithelial Tumor A mucinous cystic neoplasm that arises from the intrahepatic bile ducts. C96835 Neoplastic Process Intrahepatic Bile Duct Mucinous Cystic Neoplasm C1334257 Undetermined Intrahepatic Bile Duct Cystadenoma Intrahepatic Bile Duct MCN Intrahepatic Bile Duct Mucinous Cystic Neoplasm Intrahepatic Bile Duct Mucinous Cystic Neoplasm A non-invasive mucinous cystic neoplasm that arises from the intrahepatic or extrahepatic bile ducts. It is characterized by the presence of mild atypia. C96836 Neoplastic Process Bile Duct Mucinous Cystic Neoplasm, Low Grade C3273069 Undetermined Bile Duct MCN with Low Grade Intraepithelial Neoplasia Bile Duct Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia Bile Duct Mucinous Cystic Neoplasm, Low Grade Bile Duct Mucinous Cystic Neoplasm, Low-Grade Bile Duct Mucinous Cystic Neoplasm, Low Grade A non-invasive mucinous cystic neoplasm that arises from the intrahepatic or extrahepatic bile ducts. It is characterized by the presence of severe atypia. C96838 Neoplastic Process Bile Duct Mucinous Cystic Neoplasm, High Grade C3273071 Undetermined Bile Duct MCN with High Grade Intraepithelial Neoplasia Bile Duct Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia Bile Duct Mucinous Cystic Neoplasm, High Grade Bile Duct Mucinous Cystic Neoplasm, High-Grade Bile Duct Mucinous Cystic Neoplasm, High Grade A hemangioma with cavernous vascular spaces arising from the liver. It is the most frequent benign tumor of the liver and usually affects young females. C96839 Neoplastic Process Liver Cavernous Hemangioma C3282904 Benign Liver Cavernous Hemangioma Liver Cavernous Hemangioma A capillary hemangioma that arises from the liver. It occurs in infants and children. C96840 Neoplastic Process Liver Infantile Hemangioma C3273072 Benign HIH Hepatic Infantile Hemangioma Liver Infantile Hemangioendothelioma Liver Infantile Hemangioma Liver Infantile Hemangioma A rare lymphangioma that arises from the liver. It usually occurs in children and adolescents. C96841 Neoplastic Process Liver Lymphangioma C3273073 Benign Liver Lymphangioma Liver Lymphangioma Multiple lymphangiomas that affect the liver and other anatomic sites. Although histologically benign, diffuse lymphangiomatosis that affects the liver and multiple organs has a poor prognosis. C96842 Neoplastic Process Liver Lymphangiomatosis C3273074 Undetermined Liver Lymphangiomatosis Liver Lymphangiomatosis A rare diffuse large B-cell lymphoma that arises from the liver and the bulk of the tumor is located in the liver. C96843 Neoplastic Process Liver Diffuse Large B-Cell Lymphoma C2184126 Malignant Hepatic Diffuse Large B-Cell Lymphoma Liver Diffuse Large B-Cell Lymphoma Primary Hepatic Diffuse Large B-Cell Lymphoma Primary Liver DLBCL Primary Liver Diffuse Large B-Cell Lymphoma Liver Diffuse Large B-Cell Lymphoma A Kaposi sarcoma that arises from the liver. C96844 Neoplastic Process Liver Kaposi Sarcoma C2064411 Malignant Hepatic Kaposi Sarcoma Liver Kaposi Sarcoma Liver Kaposi Sarcoma A synovial sarcoma that affects the liver. C96845 Neoplastic Process Liver Synovial Sarcoma C3273075 Malignant Hepatic Synovial Sarcoma Liver Synovial Sarcoma Liver Synovial Sarcoma A low-grade malignant blood vessel neoplasm that arises from the liver. It is characterized by the presence of epithelioid endothelial cells. The neoplastic cells are arranged in cords and nests, which are embedded in a myxoid to hyalinized stroma. Patients may be asymptomatic or present with an abdominal mass, ascites, and jaundice. C96846 Neoplastic Process Liver Epithelioid Hemangioendothelioma C2064402 Malignant Hepatic Epithelioid Hemangioendothelioma Liver Epithelioid Hemangioendothelioma Liver Epithelioid Hemangioendothelioma A rare, aggressive primary malignant tumor of the liver that occurs in childhood. It is characterized by the presence of a diffuse infiltrate of undifferentiated cells with rhabdoid features. C96847 Neoplastic Process Extrarenal Rhabdoid Tumor of the Liver C3273076 Cellosaurus Malignant Extrarenal Malignant Rhabdoid Tumor of the Liver Extrarenal Rhabdoid Tumor of the Liver Extrarenal Rhabdoid Tumor of the Liver An aggressive carcinoma with a sarcomatous component that arises from the liver. The sarcomatous component is clonally related to the more differentiated, carcinomatous component. The prognosis is usually poor. C96848 Neoplastic Process Liver Carcinosarcoma Liver Carcinosarcoma C2007076 CTRP Malignant Hepatic Carcinosarcoma Liver Carcinosarcoma Liver Carcinosarcoma A benign or malignant extragonadal germ cell tumor that arises from the liver. Representative examples include teratoma and yolk sac tumor. C96849 Neoplastic Process Liver Germ Cell Tumor C3273077 Undetermined Hepatic Germ Cell Tumor Liver Germ Cell Tumor Liver Germ Cell Tumor A teratoma that arises from the liver. C96850 Neoplastic Process Liver Teratoma C1402865 Undetermined Hepatic Teratoma Liver Teratoma Liver Teratoma A yolk sac tumor that arises from the liver. C96851 Neoplastic Process Liver Yolk Sac Tumor C3273078 Malignant Hepatic Yolk Sac Tumor Liver Yolk Sac Tumor Liver Yolk Sac Tumor An intracholecystic papillary neoplasm that arises from the epithelium of the gallbladder. It is characterized by the presence of mild epithelial atypia. C96877 Neoplastic Process Gallbladder Intracholecystic Papillary Neoplasm, Low Grade C3273093 GDC 8503/0 Undetermined 8503/0 Intracystic papillary neoplasm with low grade intraepithelial neoplasia Gallbladder ICPN with Low Grade Intraepithelial Neoplasia Gallbladder Intracholecystic Papillary (Tubular) Neoplasm with Low Grade Intraepithelial Neoplasia Gallbladder Intracholecystic Papillary Neoplasm with Low Grade Intraepithelial Neoplasia Gallbladder Intracholecystic Papillary Neoplasm, Low Grade Gallbladder Intracholecystic Papillary Neoplasm, Low-Grade Gallbladder Intracystic/Intaductal Papillary Neoplasm with Low Grade Intraepithelial Neoplasia Gallbladder Papillary Neoplasm with Low Grade Intraepithelial Neoplasia Intracystic Papillary Neoplasm with Low Grade Intraepithelial Neoplasia Intracystic papillary neoplasm with low grade intraepithelial neoplasia Gallbladder Intracholecystic Papillary Neoplasm, Low Grade An intracholecystic papillary neoplasm that arises from the epithelium of the gallbladder. It is characterized by the presence of severe epithelial atypia. C96879 Neoplastic Process Gallbladder Intracholecystic Papillary Neoplasm, High Grade C3273095 8503/2 Undetermined Gallbladder ICPN with High Grade Intraepithelial Neoplasia Gallbladder Intracholecystic Papillary (Tubular) Neoplasm with High Grade Intraepithelial Neoplasia Gallbladder Intracholecystic Papillary Neoplasm with High Grade Intraepithelial Neoplasia Gallbladder Intracholecystic Papillary Neoplasm, High Grade Gallbladder Intracholecystic Papillary Neoplasm, High-Grade Gallbladder Intracystic/Intaductal Papillary Neoplasm with High Grade Intraepithelial Neoplasia Gallbladder Papillary Neoplasm with High Grade Intraepithelial Neoplasia Intracystic Papillary Neoplasm with High Grade Intraepithelial Neoplasia Intracystic Papillary Tumor With High Grade Intraepithelial Neoplasia Gallbladder Intracholecystic Papillary Neoplasm, High Grade An epithelial, usually multiloculated neoplasm arising from the gallbladder. It occurs predominantly in females. Signs and symptoms include abdominal mass, abdominal pain, and jaundice. Morphologically, the cystic spaces are lined by columnar epithelium and contain mucinous or serous fluid. C96881 Neoplastic Process Gallbladder Mucinous Cystic Neoplasm C3273096 Undetermined Gallbladder MCN Gallbladder Mucinous Cystic Neoplasm Gallbladder Mucinous Cystic Neoplasm A non-invasive mucinous cystic neoplasm that arises from the gallbladder epithelium. It is characterized by the presence of mild atypia. C96883 Neoplastic Process Gallbladder Mucinous Cystic Neoplasm, Low Grade C3273098 Malignant Gallbladder MCN with Low Grade Intraepithelial Neoplasia Gallbladder Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia Gallbladder Mucinous Cystic Neoplasm, Low Grade Gallbladder Mucinous Cystic Neoplasm, Low-Grade Gallbladder Mucinous Cystic Neoplasm, Low Grade A non-invasive mucinous cystic neoplasm that arises from the gallbladder epithelium. It is characterized by the presence of severe atypia. C96886 Neoplastic Process Gallbladder Mucinous Cystic Neoplasm, High Grade C3273101 Malignant Gallbladder MCN with High Grade Intraepithelial Neoplasia Gallbladder Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia Gallbladder Mucinous Cystic Neoplasm, High Grade Gallbladder Mucinous Cystic Neoplasm, High-Grade Gallbladder Mucinous Cystic Neoplasm, High Grade A mucinous cystic neoplasm that arises from the gallbladder and it is associated with an invasive carcinomatous component. C96887 Neoplastic Process Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma C3273102 Malignant Gallbladder Cystadenocarcinoma Gallbladder MCN with an Associated Invasive Carcinoma Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma A carcinoma that arises from the gallbladder and it is characterized by the presence of a sarcomatous component. The sarcomatous component may contain osteosarcoma, chondrosarcoma, or rhabdomyosarcoma elements. C96888 Neoplastic Process Gallbladder Carcinosarcoma Gallbladder Carcinosarcoma C2007070 CTRP Malignant Gallbladder Carcinosarcoma Gallbladder Carcinosarcoma A rare variant of gallbladder adenocarcinoma. It is characterized by the presence of a malignant glandular epithelial infiltrate that resembles hepatocellular carcinoma. C96890 Neoplastic Process Gallbladder Hepatoid Adenocarcinoma C2030691 Malignant Gallbladder Hepatoid Adenocarcinoma Gallbladder Hepatoid Adenocarcinoma A rare variant of gallbladder adenocarcinoma. It is characterized by the presence of a malignant glandular epithelial infiltrate with a cribriform growth pattern. C96891 Neoplastic Process Gallbladder Cribriform Carcinoma C3273103 Malignant Gallbladder Cribriform Carcinoma Gallbladder Cribriform Carcinoma A well or moderately differentiated adenocarcinoma that arises from the gallbladder. It is the most common type of gallbladder carcinoma and is characterized by the presence of malignant tubular glands. Intestinal differentiation may be present. C96915 Neoplastic Process Gallbladder Adenocarcinoma, Biliary Type C3273113 Malignant Gallbladder Adenocarcinoma, Biliary Type Gallbladder Adenocarcinoma, Biliary Type An unusual, well differentiated adenocarcinoma that arises from the gallbladder. It is characterized by the presence of tall malignant columnar cells with mucin-containing cytoplasm and basally located nuclei. C96916 Neoplastic Process Gallbladder Adenocarcinoma, Gastric Foveolar Type C3273114 Malignant Gallbladder Adenocarcinoma, Gastric Foveolar Type Gallbladder Adenocarcinoma, Gastric Foveolar Type A neoplasm with neuroendocrine differentiation that arises from the gallbladder. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms). C96917 Neoplastic Process Gallbladder Neuroendocrine Neoplasm C3273115 Undetermined Gallbladder Neuroendocrine Neoplasm Gallbladder Neuroendocrine Neoplasm A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the gallbladder. C96918 Neoplastic Process Gallbladder Neuroendocrine Tumor C3273116 Undetermined Gallbladder NET Gallbladder Neuroendocrine Tumor Gallbladder Well Differentiated Neuroendocrine Neoplasm Gallbladder Well-Differentiated Neuroendocrine Neoplasm Gallbladder Neuroendocrine Tumor An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the gallbladder. The mitotic count is more than 20 per 10 HPF. It is classified as either small or large cell neuroendocrine carcinoma based on the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm. C96919 Neoplastic Process Gallbladder Neuroendocrine Carcinoma Gallbladder Neuroendocrine Carcinoma C3273117 CTRP Malignant Gallbladder G3 Gallbladder High Grade Neuroendocrine Carcinoma Gallbladder NEC Gallbladder Neuroendocrine Cancer Gallbladder Neuroendocrine Carcinoma Gallbladder Poorly Differentiated Endocrine Carcinoma Gallbladder Neuroendocrine Carcinoma An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the gallbladder. It is characterized by the presence of malignant large cells. C96921 Neoplastic Process Gallbladder Large Cell Neuroendocrine Carcinoma C2010353 Malignant Gallbladder Large Cell NEC Gallbladder Large Cell Neuroendocrine Carcinoma Gallbladder Large Cell Neuroendocrine Carcinoma A well differentiated, low grade neuroendocrine neoplasm that arises from the gallbladder. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. C96924 Neoplastic Process Gallbladder Neuroendocrine Tumor G1 C3273119 Undetermined Gallbladder NET G1 Gallbladder Neuroendocrine Tumor G1 Gallbladder Neuroendocrine Tumor G1 A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the gallbladder. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3 to 20 percent. C96925 Neoplastic Process Gallbladder Neuroendocrine Tumor G2 C3273120 Undetermined Gallbladder NET G2 Gallbladder Neuroendocrine Tumor G2 Gallbladder Neuroendocrine Tumor G2 A carcinoma that arises from the gallbladder and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component. At least 30 percent of either component should be present for the diagnosis to be made. C96927 Neoplastic Process Gallbladder Mixed Adenoneuroendocrine Carcinoma Gallbladder Mixed Adenoneuroendocrine Carcinoma C3273122 CTRP Malignant Gallbladder MANEC Gallbladder Mixed Adenoneuroendocrine Cancer Gallbladder Mixed Adenoneuroendocrine Carcinoma Gallbladder Mixed Adenoneuroendocrine Carcinoma An invasive mixed adenoneuroendocrine carcinoma of the gallbladder characterized by the presence of neoplastic signet-ring cells resembling goblet cells of the intestine. C96928 Neoplastic Process Gallbladder Goblet Cell Adenocarcinoma C3273123 Malignant Gallbladder Goblet Cell Adenocarcinoma Gallbladder Goblet Cell Carcinoid Gallbladder Goblet Cell Adenocarcinoma A neuroendocrine tumor that arises from the gallbladder. It does not show the morphologic characteristics of typical carcinoid tumors (neoplastic cells forming solid nests). In contrast, the tumor cells form small discrete tubules. C96930 Neoplastic Process Gallbladder Tubular Carcinoid C3273124 Undetermined Gallbladder Tubular Carcinoid Gallbladder Tubular Carcinoid Tumor Gallbladder Tubular Carcinoid A well or moderately differentiated adenocarcinoma that arises from the extrahepatic bile ducts. It is characterized by the presence of malignant tubular glands. C96936 Neoplastic Process Extrahepatic Bile Duct Adenocarcinoma, Biliary Type C3273126 Malignant Extrahepatic Bile Duct Adenocarcinoma, Biliary Type Extrahepatic Bile Duct Adenocarcinoma, Biliary Type An unusual, well differentiated adenocarcinoma that arises from the extrahepatic bile ducts. It is characterized by the presence of tall malignant columnar cells with mucin-containing cytoplasm and basally located nuclei. C96937 Neoplastic Process Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type C3273127 Malignant Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type An adenocarcinoma that arises from the extrahepatic bile ducts. It is characterized by the presence of neoplastic tubular glands lined by columnar cells or neoplastic glands lined by goblet cells. C96938 Neoplastic Process Extrahepatic Bile Duct Adenocarcinoma, Intestinal Type C2064429 Malignant Extrahepatic Bile Duct Adenocarcinoma, Intestinal Type Extrahepatic Bile Duct Adenocarcinoma, Intestinal Type A carcinoma that arises from the extrahepatic bile ducts and it is characterized by the presence of a sarcomatous component. C96939 Neoplastic Process Extrahepatic Bile Duct Carcinosarcoma C2007068 Malignant Extrahepatic Bile Duct Carcinosarcoma Extrahepatic Bile Duct Carcinosarcoma A neoplastic, non-invasive lesion that affects the extrahepatic bile duct epithelium. It is characterized by the presence of atypical epithelial cells with an increased nuclear/cytoplasmic ratio, nuclear hyperchromasia, and loss of nuclear polarity. C96942 Neoplastic Process Extrahepatic Bile Duct Biliary Intraepithelial Neoplasia C3273130 Undetermined Extrahepatic Bile Duct BilIN Extrahepatic Bile Duct Biliary Intraepithelial Neoplasia Extrahepatic Bile Duct Dysplasia Extrahepatic Bile Duct Biliary Intraepithelial Neoplasia A neoplastic, non-invasive lesion that affects the intrahepatic bile duct epithelium. It is characterized by the presence of atypical epithelial cells with an increased nuclear/cytoplasmic ratio, nuclear hyperchromasia, and loss of nuclear polarity. C96943 Neoplastic Process Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia C3273131 Undetermined Intrahepatic Bile Duct BilIN Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia Intrahepatic Bile Duct Dysplasia Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia A neoplastic, non-invasive lesion that affects the intrahepatic or extrahepatic bile duct epithelium. It is characterized by the presence of atypical epithelial cells with an increased nuclear/cytoplasmic ratio, nuclear hyperchromasia, and loss of nuclear polarity. C96945 Neoplastic Process Bile Duct Biliary Intraepithelial Neoplasia C3273133 Undetermined Bile Duct BilIN Bile Duct Biliary Intraepithelial Neoplasia Intraductal BilIN Intraductal Biliary Intraepithelial Neoplasia Bile Duct Biliary Intraepithelial Neoplasia A mucinous cystic neoplasm that arises from the extrahepatic bile ducts and it is associated with an invasive carcinomatous component. C96946 Neoplastic Process Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma C3273134 Malignant Extrahepatic Bile Duct Cystadenocarcinoma Extrahepatic Bile Duct MCN with an Associated Invasive Carcinoma Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma A mucinous cystic neoplasm that arises from the intrahepatic bile ducts and it is associated with an invasive carcinomatous component. C96947 Neoplastic Process Intrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma Intrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma C2064409 CTRP Malignant Intrahepatic Bile Duct Cystadenocarcinoma Intrahepatic Bile Duct MCN with an Associated Invasive Carcinoma Intrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Cancer Intrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma Intrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma A papillary neoplasm that arises from the epithelium of the extrahepatic bile ducts and it is associated with an invasive carcinomatous component. The carcinomatous component is an adenocarcinoma. C96948 Neoplastic Process Extrahepatic Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma C3273135 Malignant Extrahepatic Bile Duct IPN with an Associated Invasive Carcinoma Extrahepatic Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma Extrahepatic Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma A papillary neoplasm that arises from the epithelium of the intrahepatic bile ducts and it is associated with an invasive carcinomatous component. The carcinomatous component is an intrahepatic cholangiocarcinoma. C96949 Neoplastic Process Intrahepatic Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma C3273136 Malignant Intrahepatic Bile Duct IPN with an Associated Invasive Carcinoma Intrahepatic Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma Intrahepatic Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma A Kaposi sarcoma that arises from the extrahepatic bile ducts. C96951 Neoplastic Process Extrahepatic Bile Duct Kaposi Sarcoma C2064435 Malignant Extrahepatic Bile Duct Kaposi Sarcoma Extrahepatic Bile Duct Kaposi Sarcoma A lymphoma that arises from the extrahepatic bile ducts, with the bulk of the disease located at this site. C96952 Neoplastic Process Extrahepatic Bile Duct Lymphoma C3273137 Malignant Extrahepatic Bile Duct Lymphoma Primary Extrahepatic Bile Duct Lymphoma Extrahepatic Bile Duct Lymphoma A malignant neoplasm that has spread to the extrahepatic bile ducts from another anatomic site. Representative examples include metastatic melanoma and metastatic breast and gastric carcinomas. C96953 Neoplastic Process Metastatic Malignant Neoplasm in the Extrahepatic Bile Ducts C0686114 Malignant Metastatic Malignant Neoplasm in the Extrahepatic Bile Ducts Metastatic Malignant Neoplasm to the Extrahepatic Bile Ducts Metastatic Malignant Neoplasm in the Extrahepatic Bile Ducts A neoplasm with neuroendocrine differentiation that arises from the extrahepatic bile ducts. It includes neuroendocrine tumors (well-differentiated neuroendocrine neoplasms) and neuroendocrine carcinomas (poorly differentiated neuroendocrine neoplasms). C96954 Neoplastic Process Extrahepatic Bile Duct Neuroendocrine Neoplasm C3273138 Undetermined Extrahepatic Bile Duct Neuroendocrine Neoplasm Extrahepatic Bile Duct Neuroendocrine Neoplasm A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the extrahepatic bile ducts. C96955 Neoplastic Process Extrahepatic Bile Duct Neuroendocrine Tumor C3273139 Undetermined Extrahepatic Bile Duct NET Extrahepatic Bile Duct Neuroendocrine Tumor Extrahepatic Bile Duct Neuroendocrine Tumor An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the extrahepatic bile ducts. The mitotic count is more than 20 per 10 HPF. It is classified as either small or large cell neuroendocrine carcinoma based on the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm. C96956 Neoplastic Process Extrahepatic Bile Duct Neuroendocrine Carcinoma C3273140 Malignant Extrahepatic Bile Duct G3 Extrahepatic Bile Duct High Grade Neuroendocrine Carcinoma Extrahepatic Bile Duct NEC Extrahepatic Bile Duct Neuroendocrine Carcinoma Extrahepatic Bile Duct Poorly Differentiated Endocrine Carcinoma Extrahepatic Bile Duct Neuroendocrine Carcinoma A well differentiated, intermediate grade neoplasm with neuroendocrine differentiation that arises from the extrahepatic bile ducts. The mitotic count is 2-20 per 10 HPF and/or the Ki67 index is 3 to 20 percent. C96957 Neoplastic Process Extrahepatic Bile Duct Neuroendocrine Tumor G2 C3273141 Undetermined Extrahepatic Bile Duct NET G2 Extrahepatic Bile Duct Neuroendocrine Tumor G2 Extrahepatic Bile Duct Neuroendocrine Tumor G2 An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the extrahepatic bile ducts. It is characterized by the presence of malignant large cells. C96958 Neoplastic Process Extrahepatic Bile Duct Large Cell Neuroendocrine Carcinoma C2111716 Malignant Extrahepatic Bile Duct Large Cell NEC Extrahepatic Bile Duct Large Cell Neuroendocrine Carcinoma Extrahepatic Bile Duct Large Cell Neuroendocrine Carcinoma A carcinoma that arises from the extrahepatic bile ducts and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component. At least 30 percent of either component should be present for the diagnosis to be made. C96959 Neoplastic Process Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma C3273142 Malignant Extrahepatic Bile Duct MANEC Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma A malignant neoplasm that arises from the epithelium of any part of the digestive system. Representative examples include colorectal carcinoma, esophageal carcinoma, and pancreatic carcinoma. C96963 Neoplastic Process Digestive System Carcinoma Digestive System Carcinoma C0151544 CPTAC CTRP Malignant Carcinoma of the Gastrointestinal System Digestive System Carcinoma Gastrointestinal System Carcinoma Digestive System Carcinoma An acanthoma characterized by the presence of psoriasiform epidermal acanthosis and basal cells with pale cytoplasm. C97041 Neoplastic Process Clear Cell Acanthoma C0333992 Benign Clear cell acanthoma Clear Cell Acanthoma Degos Acanthoma Pale (Clear Cell) Acanthoma Clear Cell Acanthoma A grade I invasive lobular carcinoma of the breast, characterized by the presence of round groups of neoplastic cells. C97049 Neoplastic Process Invasive Breast Lobular Carcinoma, Alveolar Variant C3273215 GDC Malignant Invasive lobular carcinoma, alveolar type Invasive Breast Lobular Carcinoma, Alveolar Variant Invasive Lobular Breast Carcinoma, Alveolar Variant Invasive Breast Lobular Carcinoma, Alveolar Variant A grade II invasive lobular carcinoma of the breast, characterized by the presence of neoplastic cells with large and atypical nuclei. C97051 Neoplastic Process Invasive Breast Lobular Carcinoma, Pleomorphic Variant C3273216 GDC Malignant Pleomorphic lobular carcinoma Invasive Breast Lobular Carcinoma, Pleomorphic Variant Invasive Lobular Breast Carcinoma, Pleomorphic Variant Invasive Breast Lobular Carcinoma, Pleomorphic Variant A grade I invasive lobular carcinoma of the breast, characterized by the presence of neoplastic cells that form trabeculae and groups infiltrating collagen bundles. C97052 Neoplastic Process Invasive Breast Lobular Carcinoma, Solid Variant C3273217 GDC Malignant Invasive lobular carcinoma, solid type Invasive Breast Lobular Carcinoma, Solid Variant Invasive Lobular Breast Carcinoma, Solid Variant Invasive Breast Lobular Carcinoma, Solid Variant An invasive lobular carcinoma of the breast, characterized by the presence of neoplastic cells forming small tubular structures. C97053 Neoplastic Process Invasive Breast Lobular Carcinoma, Tubulolobular Variant C3273218 GDC Malignant Invasive lobular carcinoma, tubulolobular variant Tubulolobular carcinoma Invasive Breast Lobular Carcinoma, Tubulolobular Variant Invasive Lobular Breast Carcinoma, Tubulolobular Variant Invasive Breast Lobular Carcinoma, Tubulolobular Variant A congenital mesoblastic nephroma characterized by the presence of classic and cellular areas. C97058 Neoplastic Process Mixed Congenital Mesoblastic Nephroma C3273220 NICHD A congenital, mesoblastic nephroma that is characterized by the presence of classic and cellular areas. Malignant Mixed Congenital Mesoblastic Nephroma Mixed Mesoblastic Nephroma Mixed Congenital Mesoblastic Nephroma A rare, slow-growing, locally aggressive soft tissue tumor characterized by the presence of oval to spindle cells forming concentric aggregates around small vessels. Giant multinucleated cells are also present. C97076 Neoplastic Process Giant Cell Angioblastoma C3273226 Undetermined Giant Cell Angioblastoma Giant Cell Angioblastoma A rare, benign, well-circumscribed salivary gland neoplasm that predominantly affects females. It is characterized by the presence of microcysts, ducts, and acini in a sclerotic stroma. Focal lymphocytic infiltrates may also be present. C97135 Neoplastic Process Sclerosing Polycystic Adenoma C3273251 Benign Salivary Gland Sclerosing Polycystic Adenosis Sclerosing Polycystic Adenoma Sclerosing Polycystic Adenosis Sclerosing Polycystic Adenoma Myelodysplastic syndrome characterized by the presence of somatic mutations. C97310 Neoplastic Process Myelodysplastic Syndrome with Somatic Mutation C3273350 Malignant Myelodysplastic Syndrome with Somatic Mutation Myelodysplastic Syndrome with Somatic Mutation A lymph node located above and adjacent to the elbow. C98182 Anatomical Structure Epitrochlear Lymph Node C0229847 CDISC GDC PCDC A lymph node located above and adjacent to the elbow. (NCI) Epitrochlear Lymph Node(s) Epitrochlear EPITROCHLEAR LYMPH NODE Epitrochlear Epitrochlear Lymph Node Lymph Node(s) Epitrochlear Epitrochlear Lymph Node A lymph node located in the upper inner portion of the thigh. C98183 Anatomical Structure Femoral Lymph Node C0877794 CDISC GDC A lymph node located in the upper inner portion of the thigh. (NCI) Femoral Lymph Node(s) Femoral FEMORAL LYMPH NODE Femoral Femoral Lymph Node Lymph Node(s) Femoral Femoral Lymph Node A lymph node located in the hilum of the lung. C98187 Body Part, Organ, or Organ Component Pulmonary Hilar Lymph Node C0733936 CDISC mCode A lymph node located in the hilum of the lung within the mediastinum. Bronchopulmonary lymph node group (body structure) HILAR LYMPH NODE Hilar Lymph Node Pulmonary Hilar Lymph Node Pulmonary Hilar Lymph Node A lymph node located in the back of the head adjacent to the trapezius muscle. C98188 Body Part, Organ, or Organ Component Occipital Lymph Node C0229711 CDISC GDC UBERON mCode A lymph node located in the back of the head adjacent to the trapezius muscle. Lymph Node(s) Occipital Occipital UBERON:0035204 Lymph Node(s) Occipital Lymph node level XB (qualifier value) OCCIPITAL LYMPH NODE Occipital Lymph Node occipital lymph node occipital node Occipital Lymph Node A lymph node located in the retroperitoneal space. C98189 Anatomical Structure Retroperitoneal Lymph Node C0229802 CDISC GDC UBERON A lymph node located in the retroperitoneal space. A lymph node located in the retroperitoneal space. (NCI) Lymph Node(s) Retroperitoneal Retroperitoneal Retroperitoneal lymph nodes UBERON:0035371 Lymph Node(s) Retroperitoneal RETROPERITONEAL LYMPH NODE Retroperitoneal Lymph Node Retroperitoneal lymph nodes retroperitoneal lymph node retroperitoneal node Retroperitoneal Lymph Node A teratoma that is found at the base of the coccyx. It is the most commonly seen tumor in newborns. C99055 Neoplastic Process Sacrococcygeal Teratoma C0559459 Cellosaurus NICHD A teratoma that is found at the base of the coccyx; it is the most commonly seen tumor in newborns. Undetermined Pre-Sacral Teratoma Presacral Teratoma Sacrococcygeal Teratoma Sacrococcygeal Teratoma A rare infantile hemangioma in the airway, usually in the subglottic area or trachea. It may or may not be associated with cutaneous lesions. It is a potentially life-threatening condition and the infant should be closely monitored for signs of airway disease. C99086 Neoplastic Process Airway Infantile Hemangioma C3274531 NICHD Benign Airway Hemangioma Airway Infantile Hemangioma Airway Infantile Hemangioma A rare, slow-growing, painless tumor of infancy and early childhood that usually affects the distal extremities. It is characterized by the presence of alternating bands of mature adipose tissue and spindle-cell fibrous tissue, without destruction of the adipose tissue architecture. It does not metastasize, however the rate of local recurrences is high. C99180 Neoplastic Process Lipofibromatosis C3274592 Undetermined Lipofibromatosis Infantile Fibromatosis, Non-Desmoid Type Lipofibromatosis Lipofibromatosis Breast carcinoma that develops in the opposite breast of a patient with an already diagnosed primary breast carcinoma. C99390 Neoplastic Process Contralateral Breast Carcinoma C3274709 Malignant Contralateral Breast Carcinoma Contralateral Breast Carcinoma An invasive procedure in which sound waves (called ultrasound) are bounced off of vascular tissues from within the vessel and the echoes produce a picture (sonogram). C99535 Health Care Activity Intravascular Ultrasound C1456025 CDISC An invasive procedure in which sound waves (called ultrasound) are bounced off of vascular tissues from within the vessel and the echoes produce a picture (sonogram). INTRAVASCULAR ULTRASOUND IVUS Intravascular Ultrasound Intravascular Ultrasound There was less than 50% stenosis (reduction in cross-sectional area) in all coronary artery branches. (ACC) C99993 Finding No Evidence of Coronary Artery Disease C3275117 CDISC There was no stenosis in any coronary artery or branch vessel. NO DISEASE No Evidence of Coronary Artery Disease No Evidence of Coronary Artery Disease Cellulitis is a musculoskeletal system symptom characterized as a diffuse and especially subcutaneous inflammation of connective tissue. symptoms SYMP:0000000 doid/symp duplicate cellulitis SYMP:0000000 stomach cramp symptoms SYMP:0000001 abdominal cramp SYMP:0000001 symptoms SYMP:0000002 abdominal distention SYMP:0000002 A neurological and physiological symptom that is characterized by an inability to coordinate voluntary muscular movements that is symptomatic of some nervous disorders. uncoordination symptoms SYMP:0000005 ataxia SYMP:0000005 A pain that is characterized by occurring in the lower back. back pain symptoms SYMP:0000006 backache SYMP:0000006 A general symptom that is characterized as an act, instance, or result of being bled or the process by which something is bled: as a the escape of blood from vessels. symptoms SYMP:0000007 bleeding SYMP:0000007 symptoms SYMP:0000008 doid/symp duplicate blindness SYMP:0000008 A skin and integumentary tissue symptom that is characterized by a fluid-filled elevation of the epidermis. symptoms SYMP:0000009 blister SYMP:0000009 A vision symptom that is characterized by a decreased clarity or sharpness in vision, which can be caused by eye conditions myopia or hyperopia. symptoms SYMP:0000012 blurred vision SYMP:0000012 symptoms SYMP:0000015 giddiness SYMP:0000015 A balance symptom that is characterized by a disturbance of consciousness characterized by inability to engage in orderly thought or by lack of power to distinguish, choose, or act decisively. symptoms SYMP:0000016 confusion SYMP:0000016 symptoms SYMP:0000017 crinkle SYMP:0000017 symptoms SYMP:0000018 darkening of skin SYMP:0000018 symptoms SYMP:0000019 deafness SYMP:0000019 A nutrition, metabolism, and development symptom that is characterized by an abnormal depletion of body fluids. symptoms SYMP:0000020 dehydration SYMP:0000020 A neurological and physiological symptom that is characterized by a mental disturbance characterized by confusion, disordered speech, and hallucinations. symptoms SYMP:0000021 delirium SYMP:0000021 A neurological and physiological symptom that is characterized by a chronic feeling of emptiness, sadness, or inability to feel pleasure that may appear to happen for no clear reason. Additionally one may experience feelings of hopelessness, pessimism, irritability, frustration, or restlessness, guilt, worthlessness and thoughts of death or suicide. MESH:D003863 symptoms SYMP:0000022 depression SYMP:0000022 A confusion that is characterized by an usually transient state of confusion especially as to time, place, or identity; often as a result of disease or drugs. symptoms SYMP:0000023 disorientation SYMP:0000023 A neurological and physiological symptom that is characterized by a feeling of being more sleepy than normal during the day. People who are drowsy may fall asleep in when they do not want to or at times which can lead to safety concerns. drowsy somnolence symptoms SYMP:0000024 drowsiness SYMP:0000024 A cough that is characterized by a lack of accompanied phlegm production. nonproductive cough symptoms SYMP:0000025 dry cough SYMP:0000025 A nervous system symptom that is characterized by a complete or partial loss of function especially when involving the power of motion or of sensation in any part of the body. symptoms SYMP:0000030 paralysis SYMP:0000030 symptoms SYMP:0000032 flaccidity SYMP:0000032 symptoms SYMP:0000033 flat keratotic capsule SYMP:0000033 haemorrhagic gastroenteritis symptoms SYMP:0000036 hemorrhagic gastroenteritis SYMP:0000036 A respiratory system and chest symptom that is characterized by being short or breath or out of air (dyspnea), with inflammation of the small intestine (enteritis). symptoms SYMP:0000038 dyspneic enteritis SYMP:0000038 Enteritis is a digestive system symptom involving the inflammation of the small intestines and especially of the human ileum. symptoms SYMP:0000039 enteritis SYMP:0000039 A urinary system symptom that is characterized by the presence of blood or blood cells in the urine. symptoms SYMP:0000040 hematuria SYMP:0000040 A cardiovascular system symptom that is characterized by an acute loss of blood from a damaged blood vessel. symptoms SYMP:0000041 hemorrhage SYMP:0000041 symptoms SYMP:0000045 hepatic necrosis SYMP:0000045 symptoms SYMP:0000046 doid/symp duplicate hepatitis SYMP:0000046 symptoms SYMP:0000047 hepatosplenomegaly SYMP:0000047 symptoms SYMP:0000051 doid/symp duplicate hydrocephalus SYMP:0000051 symptoms SYMP:0000054 hypergammaglobulinemia SYMP:0000054 A skin and integumentary tissue symptom that is characterized by an excess pigmentation in a bodily part or tissue, as the skin. symptoms SYMP:0000056 hyperpigmentation SYMP:0000056 symptoms SYMP:0000058 hyperreflexia SYMP:0000058 symptoms SYMP:0000059 hypotension SYMP:0000059 Inflammation is a general symptom where there is a local response to cellular injury that is marked by capillary dilatation, leukocytic infiltration, redness, heat, pain, swelling, and often loss of function and that serves as a mechanism initiating the elimination of noxious agents and of damaged tissue. symptoms SYMP:0000061 inflammation SYMP:0000061 symptoms SYMP:0000063 intestinal hemorrhage SYMP:0000063 A pain that is characterized by a pain situated, or occurring, in or around a joint. arthralgia arthromyalgia symptoms SYMP:0000064 joint pain SYMP:0000064 symptoms SYMP:0000066 keratotic nodules of the skin SYMP:0000066 symptoms SYMP:0000068 doid/symp duplicate laryngitis SYMP:0000068 larynx and trachea inflammation symptoms SYMP:0000069 doid/symp duplicate laryngotracheitis SYMP:0000069 symptoms SYMP:0000070 lesions in myocardium SYMP:0000070 A fatigue that is characterized by abnormal drowsiness. symptoms SYMP:0000075 lethargy SYMP:0000075 languid symptoms SYMP:0000076 listlessness SYMP:0000076 A nervous system symptom that is characterized by the harmonious functioning of interrelated organs and body parts; in particular the working together of muscle groups in the execution of complicated movements. symptoms SYMP:0000079 coordination symptom SYMP:0000079 symptoms SYMP:0000082 lesions in lung SYMP:0000082 symptoms SYMP:0000083 doid/symp duplicate lymphangitis SYMP:0000083 symptoms SYMP:0000084 lymphoblastoma SYMP:0000084 symptoms SYMP:0000086 doid/symp duplicate lymphopenia SYMP:0000086 symptoms SYMP:0000087 massive hepatic necrosis SYMP:0000087 A nervous system symptom that is characterized by an inflammation of the brain and meninges. symptoms SYMP:0000089 doid/symp duplicate meningoencephalitis SYMP:0000089 A nervous system symptom that is characterized by inflammation of the brain tissue, which is typically caused by a viral infection, but it may also be caused by bacterial or parasitic infections, cancer, or certain drugs or toxins. symptoms SYMP:0000090 doid/symp duplicate encephalitis SYMP:0000090 An encephalitis that is not intense (not severe). symptoms SYMP:0000091 mild encephalitis SYMP:0000091 A skin and integumentary tissue symptom that is characterized by an abnormal change in structure of the skin that is especially circumscribed and well defined due to injury or disease. symptoms SYMP:0000092 skin lesion SYMP:0000092 symptoms SYMP:0000093 muscle cramp SYMP:0000093 symptoms SYMP:0000094 muscle weakness SYMP:0000094 symptoms SYMP:0000095 doid/symp duplicate myocarditis SYMP:0000095 A urinary system symptom that is characterized by the acute or chronic inflammation of the kidney affecting the structure (as of the glomerulus or parenchyma) and caused by infection, a degenerative process, or vascular disease. symptoms SYMP:0000098 doid/symp duplicate nephritis SYMP:0000098 A sensation perception that is characterized by an unpleasant sensation that usually indicates the body is threatened or damaged. The sensation may be sharp or dull, short-lived or chronic, intermittent or continual, confined to one area or spread over the entire body. symptoms SYMP:0000099 pain SYMP:0000099 symptoms SYMP:0000100 lesions in pancreas SYMP:0000100 A skin and integumentary tissue symptom that is characterized by an inflammation of the peritoneum. symptoms SYMP:0000102 doid/symp duplicate peritonitis SYMP:0000102 symptoms SYMP:0000106 plasmacytosis SYMP:0000106 A skin and integumentary tissue symptom that is characterized by an exudation of fluid from the blood or lymph into a pleural cavity. symptoms SYMP:0000107 pleural effusion SYMP:0000107 symptoms SYMP:0000109 mouth papules SYMP:0000109 symptoms SYMP:0000112 doid/symp duplicate tracheitis SYMP:0000112 symptoms SYMP:0000114 doid/symp duplicate thrombocytopenia SYMP:0000114 Prostration is a general symptom characterized by complete physical or mental exhaustion. symptoms SYMP:0000116 prostration SYMP:0000116 An abnormal chest sound that is characterized by the clicking, rattling, or crackling noises heard on auscultation of (listening to) the lung with a stethoscope during inhalation. The sounds are caused by the 'popping open' of small airways and alveoli collapsed by fluid, exudate, or lack of aeration during expiration. The word 'rales' derives from the French word rale meaning 'rattle'. Rales can be heard in patients with pneumonia, atelectasis, pulmonary fibrosis, acute bronchitis, or bronchiectasis. Pulmonary edema secondary to left-sided congestive heart failure can also cause rales. crackles crepitations symptoms SYMP:0000118 rales SYMP:0000118 symptoms SYMP:0000124 seizure SYMP:0000124 symptoms SYMP:0000125 liver inflammation SYMP:0000125 intense back pain symptoms SYMP:0000127 severe backache SYMP:0000127 symptoms SYMP:0000128 doid/symp duplicate conjunctivitis SYMP:0000128 symptoms SYMP:0000129 severe conjunctivitis SYMP:0000129 symptoms SYMP:0000130 severe headache SYMP:0000130 A joint pain that is characterized by a pain situated, or occurring, in or around a joint that is intense (severe). intense join pain symptoms SYMP:0000131 severe joint pain SYMP:0000131 Necrosis is a general symptom where death of a portion of tissue differentially affected by local injury (as loss of blood supply, corrosion, burning, or the local lesion of a disease). symptoms SYMP:0000132 necrosis SYMP:0000132 symptoms SYMP:0000133 severe necrosis SYMP:0000133 symptoms SYMP:0000134 doid/symp duplicate sinusitis SYMP:0000134 A skin lesion that is characterized by a break in skin with loss of surface tissue, disintegration and necrosis of epithelial tissue, and often pus. symptoms SYMP:0000136 skin ulcer SYMP:0000136 A respiratory system and chest symptom that is characterized by a sudden violent spasmodic audible expiration of breath through the nose and mouth especially as a reflex act following irritation of the nasal mucous membrane. symptoms SYMP:0000139 sneezing SYMP:0000139 A nervous system symptom that is characterized by an abnormal increase in muscle tone or stiffness of muscle, which might interfere with movement, speech, or be associated with discomfort or pain. symptoms SYMP:0000141 spasticity SYMP:0000141 fecal symptoms SYMP:0000146 feces and droppings symptom SYMP:0000146 symptoms SYMP:0000147 doid/symp duplicate steatorrhea SYMP:0000147 symptoms SYMP:0000153 doid/symp duplicate vasculitis SYMP:0000153 Thirst is a general symptom characterized by a sensation of dryness in the mouth and throat associated with a desire for liquids. symptoms SYMP:0000156 thirst SYMP:0000156 symptoms SYMP:0000157 thymus symptom SYMP:0000157 symptoms SYMP:0000158 spleen symptom SYMP:0000158 symptoms SYMP:0000160 tracheobronchitis SYMP:0000160 Tremor is a generial symptom characterized by a trembling or shaking usually from physical weakness, emotional stress, or disease. symptoms SYMP:0000162 tremor SYMP:0000162 A coordination symptom that is characterized by a loss of complicated body movements, which may be caused by disease, injury, or toxins. lack of coordination symptoms SYMP:0000164 incoordination SYMP:0000164 A nutrition, metabolism, and development symptom that is characterized by the unintended loss of weight and lean body tissue characteristic of many diseases (as cancer, tuberculosis, and AIDS). symptoms SYMP:0000174 wasting SYMP:0000174 symptoms SYMP:0000177 weakness SYMP:0000177 A weight symptom that is characterized by a reduction of the total body mass, by a mean loss of fluid, body fat (adipose tissue), or lean mass (namely bone mineral deposits, muscle, tendon, and other connective tissue). Weight loss can either occur unintentionally because of malnourishment or an underlying disease. SYMP:0000476 ICD9CM_2005:783.21 UMLS_CUI:C0043096 UMLS_ICD9CM_2005_AUI:A1605347 loss of weight symptoms SYMP:0000178 weight loss SYMP:0000178 symptoms SYMP:0000180 liver symptom SYMP:0000180 buboes symptoms SYMP:0000182 bubo SYMP:0000182 symptoms SYMP:0000183 muscle symptom SYMP:0000183 symptoms SYMP:0000184 change in skin color SYMP:0000184 A fatigue that is characterized by a feeling of exhaustion in strength, endurance, and vigor. symptoms SYMP:0000185 weariness SYMP:0000185 A fatigue that is characterized by a feeling of weariness (bodily or mental) or feeling of weakness. Exhaustion is a shorter-lived form of fatigue that can be experienced emotionally, mentally, and physically. symptoms SYMP:0000186 exhaustion SYMP:0000186 A fatigue that is characterized by a feeling of a lessened capacity for work and reduced efficiency of accomplishment, usually accompanied by a sense of weariness and fatigue. symptoms SYMP:0000187 tiredness SYMP:0000187 symptoms SYMP:0000188 abdominal discomfort SYMP:0000188 symptoms SYMP:0000189 postural reaction SYMP:0000189 symptoms SYMP:0000190 wheelbarrowing SYMP:0000190 symptoms SYMP:0000193 hopping SYMP:0000193 symptoms SYMP:0000194 conscious proprioception SYMP:0000194 symptoms SYMP:0000195 abnormal hemiwalking hemistanding SYMP:0000195 symptoms SYMP:0000196 reproductive system symptom SYMP:0000196 A reproductive system symptom that is characterized by the expulsion of a fetus at any time before completion of pregnancy and is often due to infection. infectious abortion symptoms SYMP:0000197 abortion SYMP:0000197 A reproductive system symptom that is characterized by the spontaneous expulsion of a human fetus before it is viable and especially between the 12th and 28th weeks of gestation. symptoms SYMP:0000198 miscarriage SYMP:0000198 An abortion that is characterized by the natural occurring expulsion of a nonviable fetus. symptoms SYMP:0000199 spontaneous abortion SYMP:0000199 symptoms SYMP:0000200 acute arthritis SYMP:0000200 A meningoencephalitis that is characterized by a severe and sudden onset. symptoms SYMP:0000201 acute meningoencephalitis SYMP:0000201 symptoms SYMP:0000202 acute painful vision loss SYMP:0000202 symptoms SYMP:0000205 salivary gland symptom SYMP:0000205 symptoms SYMP:0000206 acute suppurative parotiditis SYMP:0000206 A fever that is characterized by the state of being free from fever. symptoms SYMP:0000207 afebrile SYMP:0000207 anaemia symptoms SYMP:0000208 doid/symp duplicate - reviewed 10/2022, both DO & SYMP anemia SYMP:0000208 symptoms SYMP:0000209 ischemia SYMP:0000209 light intolerance symptoms SYMP:0000210 photophobia SYMP:0000210 eye weakness rapid eye fatigue symptoms SYMP:0000211 doid/symp duplicate asthenopia SYMP:0000211 symptoms SYMP:0000212 eye strain SYMP:0000212 An aphasia that is characterized by a pathological loss of the ability to write. inability to write symptoms SYMP:0000213 agraphia SYMP:0000213 An aphasia that is characterized by a severe problem with recalling words or names. amnesic aphasia amnestic aphasia anomic aphasia inability to name objects nominal aphasia symptoms SYMP:0000214 doid/symp duplicate - reviewed 10/2022, both DO & SYMP anomia SYMP:0000214 An aphasia that is characterized by a loss of ability to comprehend speech. symptoms SYMP:0000215 inability to comprehend speech SYMP:0000215 An aphasia that is characterized by a loss of ability to speak. symptoms SYMP:0000216 inability to speak SYMP:0000216 An aphasia that is characterized by a loss of ability to form words. symptoms SYMP:0000217 inability to form words SYMP:0000217 An aphasia that is characterized by a loss of ability to properly enunciate words. symptoms SYMP:0000218 poor enunciation SYMP:0000218 An inability to comprehend speech that is characterized by an inability to understand spoken, written, or tactile speech symbols that results from damage (as by a brain lesion) to an area of the brain (as Wernicke's area) concerned with language. Wernicke's aphasia fluent aphasia inability to perceive pitch, rhythm, and emotional tone of speech sensory aphasia symptoms SYMP:0000219 receptive aphasia SYMP:0000219 absence of neurological reflexes symptoms SYMP:0000220 areflexia SYMP:0000220 symptoms SYMP:0000221 absence of knee jerk reflex SYMP:0000221 extremities weakness symptoms SYMP:0000222 limb weakness SYMP:0000222 symptoms SYMP:0000223 arm weakness SYMP:0000223 symptoms SYMP:0000224 leg weakness SYMP:0000224 loss of strength symptoms SYMP:0000225 doid/symp duplicate asthenia SYMP:0000225 A cardiac fibrillation consisting of a very rapid uncoordinated contractions of the atria of the heart resulting in a lack of synchronism between heartbeat and pulse beat. AF AFib a-fib auricular fibrillation symptoms SYMP:0000226 doid/symp duplicate - reviewed 10/2022, both DO & SYMP atrial fibrillation SYMP:0000226 symptoms SYMP:0000227 blood vessel infection SYMP:0000227 symptoms SYMP:0000228 hemorrhagic diarrhea SYMP:0000228 blood in stool symptoms SYMP:0000229 bloody stool SYMP:0000229 symptoms SYMP:0000230 body ache SYMP:0000230 Bradycardia is a cardiovascular system symptom consisting of a relatively slow heart action whether physiological or pathological. symptoms SYMP:0000231 bradycardia SYMP:0000231 A respiratory system and chest symptom that is characterized by an inflammation of the bronchioles. bronchioles inflammation symptoms SYMP:0000232 doid/symp duplicate bronchiolitis SYMP:0000232 clouded sensorium decreased sensorium symptoms SYMP:0000233 inability to think clearly SYMP:0000233 symptoms SYMP:0000234 cloudy cornea SYMP:0000234 A pain that is characterized by the condition marked by recurrent episodes of prolonged and uncontrollable crying and irritability in an otherwise healthy infant that is of unknown cause and usually subsides after three to four months of age. symptoms SYMP:0000235 colic SYMP:0000235 A pain that is characterized by an attack of acute abdominal pain localized in a hollow organ or part (as the small intestine, ureter, or bile duct) and often caused by spasm, obstruction, or twisting. symptoms SYMP:0000236 colicky pain SYMP:0000236 A respiratory system and chest symptom that is characterized by an excessive accumulation especially of blood or mucus. blocked nose nasal blockage nasal obstruction stuffed up nose stuffy nose symptoms SYMP:0000237 congestion SYMP:0000237 symptoms SYMP:0000238 continuous profuse salivation SYMP:0000238 symptoms SYMP:0000239 cornea symptom SYMP:0000239 symptoms SYMP:0000240 corneal opacity SYMP:0000240 symptoms SYMP:0000241 corneal ulcers SYMP:0000241 A cough that is characterized by production and expectoration (bringing up) of sputum that is bright red or pink and frothy. symptoms SYMP:0000242 cough with bloody sputum SYMP:0000242 A fever that is characterized by occurring during periodic episodes. SYMP:0000884 recurrent fever symptoms intermittent fever SYMP:0000243 cyclic fever SYMP:0000243 symptoms SYMP:0000244 alteration of appetite SYMP:0000244 An alteration of appetite that is characterized by a reduced desire to eat. poor appetite symptoms SYMP:0000245 decreased appetite SYMP:0000245 An alteration of appetite that is characterized by an desire to eat, an excess desire for food. symptoms SYMP:0000246 increased appetite SYMP:0000246 A neurological and physiological symptom that is characterized by one's body’s ability to sense movement, action, and location and results from sensory receptors in one's nervous system and body (muscles, joints, and tendons). symptoms SYMP:0000247 proprioception symptom SYMP:0000247 A proprioception symptom that is characterized by a decreased ability of an organism to consciously process the reception of stimuli produced within the organism. symptoms SYMP:0000248 decreased conscious proprioception SYMP:0000248 symptoms SYMP:0000249 reflex symptom SYMP:0000249 symptoms SYMP:0000250 decreased flexor withdrawal reflex SYMP:0000250 A skin and integumentary tissue symptom that is characterized by a pus-filled pocket in the skin, similar to a pimple, but larger and deeper. The pocket is filled with bacteria, white blood cells, and dead skin and typcally result from the bacteria Staphylococcus aureus prentrating the skin through a cut or hair follicle. cutaneous abscess dermal abscesses skin abscess subcutaneous abscess symptoms SYMP:0000251 dermal abscess SYMP:0000251 A rash characterized by large patches of red skin, without overlying changes in the epidermis. diffuse erythema symptoms SYMP:0000252 diffuse rash SYMP:0000252 enlargement of one pupil pupils of different size symptoms SYMP:0000253 anisocoria SYMP:0000253 symptoms SYMP:0000254 dilated pupil SYMP:0000254 symptoms SYMP:0000255 diminished gastro-intestinal motility SYMP:0000255 symptoms SYMP:0000256 diminished gag reflex SYMP:0000256 symptoms SYMP:0000257 absent gag reflex SYMP:0000257 diplopia symptoms SYMP:0000258 double vision SYMP:0000258 A dry cough that is characterized by a rough and loud sound. symptoms SYMP:0000259 dry hacking cough SYMP:0000259 symptoms SYMP:0000260 dry mouth SYMP:0000260 dry mucous membranes symptoms SYMP:0000261 dry mucous membrane SYMP:0000261 symptoms SYMP:0000262 doid/symp duplicate endocarditis SYMP:0000262 A reproductive system symptom that is characterized by an inflammation of the epididymis. inflammation of the epididymis symptoms SYMP:0000263 doid/symp duplicate epididymitis SYMP:0000263 A reproductive system symptom that is characterized by inflammation of the epididymis and/or testicle (testis). epididymo-orchitis symptoms SYMP:0000264 epididymorchitis SYMP:0000264 partial seizure symptoms SYMP:0000266 focal seizure SYMP:0000266 symptoms SYMP:0000267 generalized seizure SYMP:0000267 grand mal seizure symptoms SYMP:0000268 tonic-clonic seizure SYMP:0000268 symptoms SYMP:0000269 epileptic seizure SYMP:0000269 symptoms SYMP:0000270 simple partial seizure SYMP:0000270 symptoms SYMP:0000271 complex partial seizure SYMP:0000271 symptoms SYMP:0000272 myoclonic seizure SYMP:0000272 symptoms SYMP:0000273 clonic seizure SYMP:0000273 symptoms SYMP:0000274 tonic seizure SYMP:0000274 symptoms SYMP:0000275 atonic seizure SYMP:0000275 profuse salivation symptoms SYMP:0000277 excess salivation SYMP:0000277 symptoms SYMP:0000278 extensive ulcer SYMP:0000278 An exhaustion that is characterized by exceeding the ordinary, usual, or expected. symptoms SYMP:0000279 extreme exhaustion SYMP:0000279 A fatigue that is characterized by exceeding the ordinary, usual, or expected. symptoms SYMP:0000280 extreme fatigue SYMP:0000280 ocular discharge symptoms SYMP:0000281 eye discharge SYMP:0000281 symptoms SYMP:0000282 fixed dilated pupils SYMP:0000282 symptoms SYMP:0000283 doid/symp duplicate facial paralysis SYMP:0000283 fixed pupils symptoms SYMP:0000284 fixed pupil SYMP:0000284 A paralysis that is charicterized by a lack of muscle tone in the affected muscles and in which tendon reflexes are decreased or absent. symptoms SYMP:0000285 flaccid paralysis SYMP:0000285 Arrhythmia is a cardiovascular system symptom consisting of an alteration in rhythm of the heartbeat either in time or force. SYMP:0000288 SYMP:0000667 SYMP:0000668 abnormal heart beat abnormal heart rhythm dysrhythmia heart rhythm symptom irregular heartbeat symptoms fluctuation of heart rate SYMP:0000287 arrhythmia SYMP:0000287 A skin and integumentary tissue symptom that is characterized by an inflammatory condition of the skin with redness, itching, and oozing vesicular lesions, which become scaly, crusted, or hardened. symptoms SYMP:0000289 eczema SYMP:0000289 Belching is a digestive system symptom involving the sudden expulsion of gas from the stomach through the mouth. eructation symptoms SYMP:0000290 belching SYMP:0000290 symptoms SYMP:0000291 gas pain SYMP:0000291 symptoms SYMP:0000292 heart failure SYMP:0000292 A paralysis that is characterized by a weakness or the inability to move on one side of the body. symptoms SYMP:0000293 hemiparesis SYMP:0000293 haemolysis symptoms SYMP:0000294 hemolysis SYMP:0000294 hepatic abscess is a liver symptom characterized by a pus-filled mass in the liver that can develop from injury to the liver or an intraabdominal infection disseminated from the portal circulation. hepatic abscesses symptoms SYMP:0000295 hepatic abscess SYMP:0000295 symptoms SYMP:0000296 hepatic dysfunction SYMP:0000296 symptoms SYMP:0000297 hilar lymphadenitis SYMP:0000297 symptoms SYMP:0000298 hoarse voice SYMP:0000298 Hyperemia is a hemic system symptom consisting of an excess of blood in a body part as from an increased flow of blood due to vasodilation. hyperaemia hyperemic symptoms SYMP:0000299 hyperemia SYMP:0000299 A sensation perception that is characterized by an increased sensitivity to stimulation. hyperaesthesia symptoms SYMP:0000300 hyperesthesia SYMP:0000300 symptoms SYMP:0000301 doid/symp duplicate hypopyon SYMP:0000301 A neurological and physiological symptom that is characterized by a subnormal temperature of the body, as defined by a temperature under 36.6 degrees Celcius (97.8 degrees Fahrenheit). symptoms SYMP:0000302 hypothermia SYMP:0000302 hypoxaemia symptoms SYMP:0000303 hypoxemia SYMP:0000303 A coordination symptom that is characterized by weakened or imperfect body complicated movement, which may be caused by disease, injury, or toxins. symptoms SYMP:0000304 impaired coordination SYMP:0000304 symptoms SYMP:0000305 impaired gag reflex SYMP:0000305 A feeding difficulties and mismanagement that is characterized by a lack of feeding capacity. symptoms SYMP:0000306 inability to feed SYMP:0000306 symptoms SYMP:0000307 inibility to stand SYMP:0000307 symptoms SYMP:0000308 inability to swallow SYMP:0000308 An alteration of appetite that is characterized by a loss of desire to eat, i.e. no desire to eat. inappetence lack of appetite symptoms SYMP:0000309 loss of appetite SYMP:0000309 symptoms SYMP:0000310 inflamed eyes SYMP:0000310 symptoms SYMP:0000311 intestinal hypermotility SYMP:0000311 symptoms SYMP:0000312 joint symptom SYMP:0000312 symptoms SYMP:0000313 joint inflammation SYMP:0000313 corneitis inflammation of the cornea of the eye symptoms SYMP:0000314 doid/symp duplicate keratitis SYMP:0000314 symptoms SYMP:0000315 lateroventral deviation of the head SYMP:0000315 symptoms SYMP:0000316 leg cramp SYMP:0000316 A balance symptom that is characterized by an inability to stay upright and move confidently. Loss of balance may be due to problems in the inner ear, the brain, or the heart. Aging, infections, head injury, certain medicines, and problems with blood circulation may also cause balance problems. symptoms SYMP:0000318 loss of balance SYMP:0000318 symptoms SYMP:0000319 loss of tendon reflex SYMP:0000319 symptoms SYMP:0000320 vision symptom SYMP:0000320 symptoms SYMP:0000321 loss of vision SYMP:0000321 A weight symptom that is characterized by an infant weighing 5.5 pounds (2500 grams) or less at birth. Low birth weight may occur with premature birth, or due to smoking cigarettes, secondhand tobacco smoke exposure, drinking alcohol, and taking certain drugs during pregnancy. symptoms SYMP:0000322 low birth weight SYMP:0000322 A feces and droppings symptom that is characterized by the passage of dark tarry stools containing decomposing blood that is usually an indication of bleeding in the upper part of the alimentary canal and especially the esophagus, stomach, and duodenum. melaena symptoms SYMP:0000323 melena SYMP:0000323 A respiratory system and chest symptom that is characterized by an acute or chronic inflammation of the bronchial tubes. symptoms SYMP:0000324 doid/symp duplicate bronchitis SYMP:0000324 symptoms SYMP:0000325 mild bronchitis SYMP:0000325 symptoms SYMP:0000326 mild hypotension SYMP:0000326 A convulsion that is characterized by a tonic spasm (prolonged contraction of the muscles), without loss of consciousness and often associated with hypocalcemia. tetanic convulsions symptoms SYMP:0000327 tetanic convulsion SYMP:0000327 A tetanic convulsion that is not intense (not severe). symptoms SYMP:0000328 mild tetanic convulsion SYMP:0000328 symptoms SYMP:0000329 motor weakness SYMP:0000329 symptoms SYMP:0000330 mouth sore SYMP:0000330 A pain that is characterized by a continuous or prolonged dull pain. symptoms SYMP:0000331 muscle ache SYMP:0000331 symptoms SYMP:0000332 muscle soreness SYMP:0000332 symptoms SYMP:0000333 muscle tenderness SYMP:0000333 symptoms SYMP:0000334 muscle necrosis SYMP:0000334 symptoms SYMP:0000335 neck weakness SYMP:0000335 symptoms SYMP:0000336 neurological dysfunction SYMP:0000336 sleep hyperhidrosis symptoms SYMP:0000337 night sweats SYMP:0000337 rapid involuntary rhythmic eye movement symptoms SYMP:0000338 nystagmus SYMP:0000338 symptoms SYMP:0000339 occasional diplopia SYMP:0000339 An adema that is characterized by an abnormal excess accumulation of serous fluid in connective tissue of the limbs. limb oedema oedema of the limbs symptoms SYMP:0000340 limb edema SYMP:0000340 symptoms SYMP:0000342 slurred speech SYMP:0000342 A pain that is characterized by a pain situated, or occurring, in the lymph gland (lymph node). Pain is often associated with swelling of the gland, which is a sign that one's body is fighting an infection. painful lymph nodes symptoms SYMP:0000343 painful lymph glands SYMP:0000343 An adema that is characterized by an abnormal excess accumulation of serous fluid in connective tissue of the eyelids. edema of the eyelid symptoms SYMP:0000344 palpebral edema SYMP:0000344 A respiratory abnormality that is characterized by short, shallow, and rapid breathing. symptoms SYMP:0000345 panting respiration SYMP:0000345 A skin and integumentary tissue symptom that is characterized by a small solid usually conical elevation of the skin caused by inflammation, accumulated secretion, or hypertrophy of tissue elements. symptoms SYMP:0000346 papule SYMP:0000346 paralysed lips symptoms SYMP:0000347 lip paralysis SYMP:0000347 symptoms SYMP:0000348 throat muscle paralysis SYMP:0000348 A paralysis that is characterized by a complete, or partial, loss of function of the lower half of the body with involvement of both legs that is usually due to injury or disease of the spinal cord in the thoracic or lumbar region. symptoms SYMP:0000349 doid/symp duplicate paraplegia SYMP:0000349 symptoms SYMP:0000350 parotid abscess SYMP:0000350 symptoms SYMP:0000352 peripheral muscle weakness SYMP:0000352 A respiratory system and chest symptom that is characterized by a viscid mucus secreted in abnormal quantity in the respiratory passages. symptoms SYMP:0000353 phlegm SYMP:0000353 A respiratory system and chest symptom that is characterized by an inflammation of lung tissue. Pneumonia is one type of pneumonitis caused by an infection. Many other factors can cause pneumonitis, including breathing in animal dander, inhaling small food particles 'down the wrong pipe' and receiving radiation therapy to your chest. inflammation of lung tissue symptoms SYMP:0000354 pneumonitis SYMP:0000354 A feeding difficulties and mismanagement that is characterized by an infant with little interest in feeding and it can also refer to an infant who is not feeding enough to receive the necessary nutrition required for adequate growth. symptoms SYMP:0000355 poor feeding SYMP:0000355 inflammation of a vein symptoms SYMP:0000356 doid/symp duplicate phlebitis SYMP:0000356 symptoms SYMP:0000357 postphlebitic ulcer SYMP:0000357 A reproductive system symptom that is characterized by labor occurring before 37 full weeks of pregnancy. symptoms SYMP:0000358 premature labor SYMP:0000358 symptoms SYMP:0000359 profound weakness SYMP:0000359 A wasting that is characterized by the state of being extremely thin as a result of an absence of body fat and very week as a result of muscle wasting; usually because of illness or extreme hunger. symptoms SYMP:0000360 emaciation SYMP:0000360 An emaciation that is characterized by an increase in scope or severity with time. symptoms SYMP:0000361 progressive emaciation SYMP:0000361 symptoms SYMP:0000362 progressive prostration SYMP:0000362 symptoms SYMP:0000363 progressive weakness SYMP:0000363 symptoms SYMP:0000364 prostate symptom SYMP:0000364 A prostate symptom that is characterized by a localized collection of purulent fluid within the prostate, often forming as a complication of acute bacterial prostatitis. symptoms SYMP:0000365 prostatic abscess SYMP:0000365 A prostate symptom that is characterized by inflammation of the prostate and surrounding area. symptoms SYMP:0000366 prostatic infection SYMP:0000366 A urinary system symptom characterized by the presence of excess protein in the urine. symptoms SYMP:0000367 doid/symp duplicate proteinuria SYMP:0000367 symptoms SYMP:0000368 proximal paralysis of arm and leg SYMP:0000368 Ptosis is a general symptom characterized by a sagging or prolapse of an organ or part. droopiness symptoms SYMP:0000369 doid/symp duplicate - reviewed 10/2022, both DO & SYMP ptosis SYMP:0000369 A urinary system symptom that is characterized by a pocket (a walled-off cavity) of pus that develops in the kidney tissue. It results from the migration of bacteria from another infection site on the body to the kidneys. kidney abscess perirenal abscess symptoms SYMP:0000370 renal abscess SYMP:0000370 A paralysis that is characterized by a complete or severe weakness of the muscles of respiration. symptoms SYMP:0000371 respiratory paralysis SYMP:0000371 A nose symptom that is characterized by an excessive secretion of mucous through the nose. runny nose symptoms SYMP:0000372 rhinorrhea SYMP:0000372 symptoms SYMP:0000373 salivation SYMP:0000373 A reproductive system symptom that is characterized by an abscess that is either superficial or intrascrotal. Superficial scrotal abscess may occur from an infected hair follicle, infection of a scrotal laceration, or minor scrotal surgery. Intrascrotal abscess most commonly arises from bacterial epididymitis, but may also be related to tuberculous infection of the epididymis, a testicular abscess that ruptures through the tunica albuginea, or drainage of appendicitis into scrotum through a patent processus vaginalis or as a result of extravasation of infected urine from the urethra in patients with a urethral stricture and neurogenic bladder using an external collection device. symptoms SYMP:0000374 scrotal abscess SYMP:0000374 symptoms SYMP:0000375 severe abdominal cramp SYMP:0000375 symptoms SYMP:0000376 severe diarrhea SYMP:0000376 A muscle pain that is characterized by being severe in nature. Myalgia may be acute in nature, stemming from overuse of a muscle group or viral infection. It may also be chronic and caused by metabolic myopathy, some nutritional deficiencies, and chronic fatigue syndrome. symptoms SYMP:0000379 severe myalgia SYMP:0000379 symptoms SYMP:0000381 spleen abscess SYMP:0000381 symptoms SYMP:0000382 staggering gait SYMP:0000382 symptoms SYMP:0000383 stiff neck SYMP:0000383 cervicalgia symptoms SYMP:0000384 neck symptom SYMP:0000384 symptoms SYMP:0000385 throat symptom SYMP:0000385 symptoms SYMP:0000386 mouth symptom SYMP:0000386 symptoms SYMP:0000387 head symptom SYMP:0000387 symptoms SYMP:0000388 nose symptom SYMP:0000388 An alteration of consciousness that is characterized by a lack of critical mental function and a level of consciousness, in which an affected person is almost entirely unresponsive and responds only to intense stimuli such as pain. symptoms SYMP:0000389 stupor SYMP:0000389 symptoms SYMP:0000390 thyroid symptom SYMP:0000390 symptoms SYMP:0000391 thyroid abscesses SYMP:0000391 symptoms SYMP:0000392 ear symptom SYMP:0000392 sensation of noise symptoms SYMP:0000393 tinnitus SYMP:0000393 symptoms SYMP:0000394 muscle twitching SYMP:0000394 symptoms SYMP:0000395 facial muscle twitching SYMP:0000395 excessive pupil dilation prolonged pupil dilation symptoms SYMP:0000396 mydriasis SYMP:0000396 symptoms SYMP:0000397 unreactive mydriasis SYMP:0000397 A reproductive system symptom that is characterized by fluid made by glands inside the vagina and cervix carrying away dead cells and bacteria. While it is normal for odor and color to vary, vaginal itching or burning may be indicative of an infection. symptoms SYMP:0000398 doid/symp duplicate vaginal discharge SYMP:0000398 A dizziness that is characterized by a specific type of dizziness, a major symptom of a balance disorder. It is the sensation of spinning or swaying while the body is stationary with respect to the surroundings. symptoms SYMP:0000399 vertigo SYMP:0000399 symptoms SYMP:0000400 weak cry SYMP:0000400 symptoms SYMP:0000401 wobble SYMP:0000401 A nutrition, metabolism, and development symptom that is characterized by a general physical wasting and malnutrition usually associated with chronic disease. general physical wasting and malnutrition symptoms SYMP:0000402 cachexia SYMP:0000402 A weight symptom that is characterized by an increase in body weight. This can involve an increase in muscle mass, fat deposits, excess fluids such as water or other factors. SYMP:0020015 gain of weight symptoms SYMP:0000403 weight gain SYMP:0000403 difficult sexual intercourse painful sexual intercourse symptoms SYMP:0000404 dyspareunia SYMP:0000404 A reproductive system symptom that is characterized by a painful spasmodic contraction of the vagina. painful spasmodic vagina contractions symptoms SYMP:0000405 vaginismus SYMP:0000405 A skin and integumentary tissue symptom that is characterized by an injury transmitted through unbroken skin to underlying tissue causing rupture of small blood vessels and escape of blood into the tissue with resulting discoloration. bruises bruising contusion ecchymosis symptoms SYMP:0000406 bruise SYMP:0000406 An alteration of consciousness that is characterized by a loss of consciousness resulting from insufficient blood flow to the brain. SYMP:0000445 faint fainting loss of consciousness due to insuffiecient blood flow to the brain symptoms SYMP:0000407 syncope SYMP:0000407 Cataplexy is a muscle symptom characterized by a sudden loss of muscle control with retention of clear consciousness that follows a strong emotional stimulus (as elation, surprise, or anger) and is a characteristic symptom of narcolepsy. symptoms SYMP:0000408 cataplexy SYMP:0000408 A high fever that is characterized by an exceptionally high fever especially when induced artificially for therapeutic purposes. symptoms SYMP:0000409 hyperthermia SYMP:0000409 symptoms SYMP:0000410 neurological and physiological symptom SYMP:0000410 symptoms SYMP:0000411 infant symptom SYMP:0000411 A neurological and physiological symptom that is characterized by a painful or apprehensive uneasiness of mind usually over an impending or anticipated ill. symptoms SYMP:0000412 anxiety SYMP:0000412 A neurological and physiological symptom that is characterized by a marked psychomotor disturbance that may involve stupor or mutism, negativism, rigidity, purposeless excitement, echolalia, echopraxia, and inappropriate or bizarre posturing and is associated with various medical conditions (as schizophrenia and mood disorders). symptoms SYMP:0000413 catatonia SYMP:0000413 A neurological and physiological symptom that is characterized by a difficulty in articulating words due to disease of the central nervous system. symptoms SYMP:0000414 dysarthria SYMP:0000414 symptoms SYMP:0000415 amaurosis fugax SYMP:0000415 symptoms SYMP:0000416 amaurosis SYMP:0000416 symptoms SYMP:0000417 pupil symptom SYMP:0000417 symptoms SYMP:0000418 contracted pupil SYMP:0000418 symptoms SYMP:0000419 miosis SYMP:0000419 Bloating is a digestive system symptom involving the accumulation of gas in the digestive tract and resulting in abdominal distension. symptoms SYMP:0000420 bloating SYMP:0000420 hematochezia is a feces and droppings symptom characterized by the passage of fresh blood per anus, usually in or with stools. symptoms SYMP:0000421 hematochezia SYMP:0000421 Dyspepsia is a digestive system symptom referred to as indigestion resulting from an impairment to digestion caused by ulcer, gall bladder disease or inflamed colon. Related symptoms include weakness, loss of appetite, and depression. indigestion symptoms SYMP:0000422 doid/symp duplicate dyspepsia SYMP:0000422 From synonym: Heartburn is a pain characterized by a painful burning feeling in your chest or throat that happens when stomach acid backs up into your esophagus. SYMP:0000439 acid indigestion heartburn symptoms SYMP:0000423 pyrosis SYMP:0000423 A pain that is characterized by a leg pain in the calf, or thigh, which is caused by inadequate blood flow to the leg muscles and is brought on by leg exercise such as walking. blockage of leg arteries symptoms SYMP:0000424 claudication SYMP:0000424 symptoms SYMP:0000425 reticulocytosis SYMP:0000425 symptoms SYMP:0000426 macrocytosis SYMP:0000426 A respiratory abnormality that is characterized by a deficient ventilation of the lungs that results in reduction in the oxygen content or increase in the carbon dioxide content of the blood or both. symptoms SYMP:0000428 hypoventilation SYMP:0000428 A respiratory abnormality that is characterized by abnormally slow breathing. abnormally slow breathing symptoms SYMP:0000429 bradypnea SYMP:0000429 A chest pain that is characterized by an inflammation of the pleural cavity with a sharp pain resulting from the exansion of the lungs as the inflammed pleural layers rub against each other. symptoms SYMP:0000430 pleuritic chest pain SYMP:0000430 A respiratory system and chest symptom that is characterized by matter discharged from the air passages in diseases of the lungs, bronchi, or upper respiratory tract that contains mucus and often pus, blood, fibrin, or bacterial products. sputum production symptoms SYMP:0000431 sputum SYMP:0000431 A skin and integumentary tissue symptom that is characterized by an uneasy irritating sensation in the upper surface of the skin usually held to result from mild stimulation of pain receptors. pruritus symptoms SYMP:0000432 itching SYMP:0000432 Anasarca is a edema characterized as generalized edema with accumulation of serum in the connective tissue. generalized edema symptoms SYMP:0000433 anasarca SYMP:0000433 A skin and integumentary tissue symptom that is characterized by raised red skin wheals (welts) commonly caused by an allergic reaction with wheals that may vary in size from about 5 mm (0.2 inches) in diameter to the size of a dinner plate that are described as severely itchy a stingnig or burning sensation, and having a pale border. hives nettle rash uredo symptoms SYMP:0000434 doid/symp duplicate urticaria SYMP:0000434 A skin and integumentary tissue symptom that is characterized by a sensation of pricking, tingling, or creeping on the skin having no objective cause and usually associated with injury or irritation of a sensory nerve or nerve root. symptoms SYMP:0000435 paresthesia SYMP:0000435 A reproductive system symptom that is characterized by bleeding from the uterus that is longer than usual or that occurs at an irregular time. Bleeding may be heavier or lighter than usual and occur often or randomly. abnormal menstruation symptoms SYMP:0000436 abnormal vaginal bleeding SYMP:0000436 symptoms SYMP:0000437 earache SYMP:0000437 A pain that is characterized by a pain in, or about, a tooth or teeth. symptoms SYMP:0000438 toothache SYMP:0000438 A hair symptom that is characterized by the stopping of hair growth (regeneration), which may be a result of hereditary hair loss, immune system overreacts, drugs and treatments, harsh hair-care products, and other factors. symptoms SYMP:0000440 hair loss SYMP:0000440 A joint pain that is characterized by a pain situated, or occurring, in or around the elbow. symptoms SYMP:0000441 elbow pain SYMP:0000441 A joint pain that is characterized by a pain situated, or occurring, in or around the knee. symptoms SYMP:0000442 knee pain SYMP:0000442 A joint pain that is characterized by a pain situated, or occurring, in or around the shoulder. symptoms SYMP:0000443 shoulder pain SYMP:0000443 symptoms SYMP:0000444 nail discoloration SYMP:0000444 red eye redness of eye symptoms SYMP:0000446 bloodshot eye SYMP:0000446 A sputum that is characterized by blood or bloody mucus discharged from the air passages caused by common forms of infection in the lungs and airways, such as acute bronchitis or pneumonia. Bloody sputum can also come from cancer of the lung. symptoms SYMP:0000447 Bloody sputum (spitting up blood or bloody mucus) can come from common forms of infection in the lungs and airways, such as acute bronchitis or pneumonia. Bloody sputum can also come from cancer of the lung. bloody sputum SYMP:0000447 A nose symptom that involves a is loss of blood from the tissue lining the nose. ICD9CM_2005:784.7 UMLS_CUI:C0014591 UMLS_ICD9CM_2005_AUI:A0055387 nosebleed symptoms SYMP:0000448 epistaxis SYMP:0000448 ICD9CM_2005:785.51 UMLS_CUI:C0036980 UMLS_ICD9CM_2005_AUI:A0243814 symptoms SYMP:0000449 cardiogenic shock SYMP:0000449 A cardiovascular system symptom that is characterized as a state of profound depression of the vital processes of the body that is characterized by pallor, rapid but weak pulse, rapid and shallow respiration, reduced total blood volume, and low blood pressure and that is caused usually by severe especially crushing injuries, hemorrhage, burns, or major surgery. ICD9CM_2005:785.5 UMLS_CUI:C0159051 UMLS_ICD9CM_2005_AUI:A0284197 symptoms SYMP:0000450 shock SYMP:0000450 ICD9CM_2005:785.52 UMLS_CUI:C0036983 symptoms SYMP:0000451 septic shock SYMP:0000451 ICD9CM_2005:786.4 UMLS_CUI:C0159054 UMLS_ICD9CM_2005_AUI:A0284206 symptoms SYMP:0000452 abnormal sputum SYMP:0000452 ICD9CM_2005:789.41 UMLS_CUI:C0375565 symptoms SYMP:0000453 right upper quadrant abdominal rigidity SYMP:0000453 ICD9CM_2005:789.4 ICD9CM_2005:789.40 UMLS_CUI:C0159066 UMLS_ICD9CM_2005_AUI:A0284272 UMLS_ICD9CM_2005_AUI:A0637149 symptoms SYMP:0000454 abdominal rigidity SYMP:0000454 A weight gain that is characterized as deviating from what is normal or usual, typically in a way that is undesirable or worrying. ICD9CM_2005:783.1 UMLS_CUI:C0332544 UMLS_ICD9CM_2005_AUI:A0243789 symptoms SYMP:0000455 abnormal weight gain SYMP:0000455 An abdominal pain that is characterized by occurring in the left upper quadrant abdominal pain of the abdomen that can be caused by a stomach ulcer, acute gastritis, a viral infection, or indigestion, or may be an issue with one's lungs. ICD9CM_2005:789.02 UMLS_CUI:C0238552 UMLS_ICD9CM_2005_AUI:A0637133 symptoms SYMP:0000456 left upper quadrant abdominal pain SYMP:0000456 A pain that is characterized by occurring in the abdomen, i.e. between the chest and groin. ICD9CM_2005:789.0 ICD9CM_2005:789.00 UMLS_CUI:C0000737 UMLS_ICD9CM_2005_AUI:A0387333 UMLS_ICD9CM_2005_AUI:A0637138 symptoms SYMP:0000457 abdominal pain SYMP:0000457 Nausea is a digestive system symptom characterized by an uneasy or unsettled feeling in the stomach together with an urge to vomit. ICD9CM_2005:787.02 UMLS_CUI:C0375548 UMLS_ICD9CM_2005_AUI:A0750850 symptoms SYMP:0000458 nausea SYMP:0000458 ICD9CM_2005:787 UMLS_CUI:C0159058 UMLS_ICD9CM_2005_AUI:A0284224 symptoms SYMP:0000459 digestive system symptom SYMP:0000459 ICD9CM_2005:789.1 UMLS_CUI:C0019209 UMLS_ICD9CM_2005_AUI:A0067592 enlargement of the liver symptoms SYMP:0000460 hepatomegaly SYMP:0000460 ICD9CM_2005:789 ICD9CM_2005:789.9 UMLS_CUI:C0159065 UMLS_ICD9CM_2005_AUI:A0284267 UMLS_ICD9CM_2005_AUI:A0284268 symptoms SYMP:0000461 abdominal symptom SYMP:0000461 A symptom is a perceived change in function, sensation, loss, disturbance or appearance reported by a patient indicative of a disease. symptoms SYMP:0000462 symptom SYMP:0000462 ICD9CM_2005:783.40 UMLS_CUI:C0878706 UMLS_ICD9CM_2005_AUI:A1892807 symptoms SYMP:0000463 lack of normal physiological development SYMP:0000463 ICD9CM_2005:783.4 UMLS_CUI:C0878753 UMLS_ICD9CM_2005_AUI:A1892806 symptoms SYMP:0000464 lack of expected normal physiological development in childhood SYMP:0000464 A lack of expected normal physiological development in childhood that is characterized by a decelerated or arrested physical growth (height and weight measurements fall below the third or fifth percentile, or a downward change in growth across two major growth percentiles) and is associated with abnormal growth and development. ICD9CM_2005:783.41 UMLS_CUI:C0015544 UMLS_ICD9CM_2005_AUI:A0700791 symptoms SYMP:0000465 failure to thrive SYMP:0000465 A lack of expected normal physiological development in childhood that is characterized by a failure for a child to reach a significant stage at the predicted age and may include walking or talking. ICD9CM_2005:783.42 UMLS_CUI:C0476241 UMLS_ICD9CM_2005_AUI:A1594577 developmental delay symptoms SYMP:0000466 delayed milestones SYMP:0000466 ICD9CM_2005:789.43 UMLS_CUI:C0375567 symptoms SYMP:0000467 right lower quadrant abdominal rigidity SYMP:0000467 ICD9CM_2005:789.47 UMLS_CUI:C0375571 UMLS_ICD9CM_2005_AUI:A0637142 symptoms SYMP:0000468 generalized abdominal rigidity SYMP:0000468 ICD9CM_2005:789.46 UMLS_CUI:C0375570 UMLS_ICD9CM_2005_AUI:A0637141 symptoms SYMP:0000469 epigastric abdominal rigidity SYMP:0000469 ICD9CM_2005:789.42 UMLS_CUI:C0375566 UMLS_ICD9CM_2005_AUI:A0637144 symptoms SYMP:0000470 left upper quadrant abdominal rigidity SYMP:0000470 ICD9CM_2005:789.49 UMLS_CUI:C0375572 UMLS_ICD9CM_2005_AUI:A0637145 symptoms SYMP:0000471 multiple sites abdominal rigidity SYMP:0000471 A nutrition, metabolism, and development symptom that is characterized by a feeling of being full after a few bites of food, or before you finish a normal-sized meal. ICD9CM_2005:780.94 UMLS_CUI:C0239233 UMLS_ICD9CM_2005_AUI:A2797496 symptoms SYMP:0000472 early satiety SYMP:0000472 ICD9CM_2005:783 UMLS_CUI:C0159041 UMLS_ICD9CM_2005_AUI:A0284163 symptoms SYMP:0000473 nutrition, metabolism, and development symptom SYMP:0000473 A weight symptom that is characterized by weighing less than the normal amount for one's age, height, and build. ICD9CM_2005:783.22 UMLS_CUI:C0041667 UMLS_ICD9CM_2005_AUI:A0468826 symptoms SYMP:0000475 underweight SYMP:0000475 ICD9CM_2005:789.36 UMLS_CUI:C0375562 UMLS_ICD9CM_2005_AUI:A0637121 symptoms SYMP:0000477 epigastric abdominal swelling SYMP:0000477 ICD9CM_2005:789.3 UMLS_CUI:C0476310 UMLS_ICD9CM_2005_AUI:A0243858 symptoms SYMP:0000478 abdominal swelling SYMP:0000478 Abnormality of gait is a nervous system and musculoskeletal system symptom characterized by a difficulty in the manner of walking or moving on foot. ICD9CM_2005:781.2 UMLS_CUI:C0575081 UMLS_ICD9CM_2005_AUI:A0243767 symptoms SYMP:0000479 abnormality of gait SYMP:0000479 ICD9CM_2005:781 UMLS_CUI:C0159033 UMLS_ICD9CM_2005_AUI:A0284131 symptoms SYMP:0000480 nervous system symptom SYMP:0000480 An alteration of consciousness that is characterized by an individual with severe brain damage being in a state of partial arousal rather than true awareness. After four weeks in a vegetative state, the patient is classified as being in a persistent vegetative state. After three months in the US and six months in the UK, the diagnosis is classified as a permanent vegetative state after a non-traumatic brain injury, or, one year after a traumatic injury. ICD9CM_2005:780.03 UMLS_CUI:C0242670 UMLS_ICD9CM_2005_AUI:A0446160 symptoms SYMP:0000481 persistent vegetative state SYMP:0000481 A neurological and physiological symptom that is characterized by any condition which is significantly different from a normal waking state. ICD9CM_2005:780.0 UMLS_CUI:C0234428 UMLS_ICD9CM_2005_AUI:A0389211 symptoms SYMP:0000482 alteration of consciousness SYMP:0000482 ICD9CM_2005:789.64 UMLS_CUI:C0238565 UMLS_ICD9CM_2005_AUI:A0637155 symptoms SYMP:0000483 left lower quadrant abdominal tenderness SYMP:0000483 ICD9CM_2005:789.6 ICD9CM_2005:789.60 UMLS_CUI:C0232498 UMLS_ICD9CM_2005_AUI:A0387353 UMLS_ICD9CM_2005_AUI:A0637161 symptoms SYMP:0000484 abdominal tenderness SYMP:0000484 A urinary system symptom that is characterized by the difficult, or painful, discharge of urine. ICD9CM_2005:788.1 UMLS_CUI:C0013428 UMLS_ICD9CM_2005_AUI:A0004041 difficult urine discharge painful urine discharge symptoms SYMP:0000485 dysuria SYMP:0000485 ICD9CM_2005:788 UMLS_CUI:C0476293 UMLS_ICD9CM_2005_AUI:A0284245 symptoms SYMP:0000486 urinary system symptom SYMP:0000486 A skin and integumentary tissue symptom that is characterized by an eruption on the body typically with little or no elevation above the surface. ICD9CM_2005:782.1 UMLS_CUI:C0015230 UMLS_ICD9CM_2005_AUI:A0243780 erythema rubor skin eruption skin rash skin redness symptoms SYMP:0000487 rash SYMP:0000487 A skin and integumentary tissue symptom that is characterized by the outer layer of the skin starting to replace itself. Often, this happens when skin is damaged, either by disease or injury. ICD9CM_2005:782 ICD9CM_2005:782.9 UMLS_CUI:C0159037 UMLS_ICD9CM_2005_AUI:A0284146 UMLS_ICD9CM_2005_AUI:A0284161 symptoms SYMP:0000488 skin and integumentary tissue symptom SYMP:0000488 ICD9CM_2005:787.5 UMLS_CUI:C0159060 UMLS_ICD9CM_2005_AUI:A0284234 symptoms SYMP:0000489 abnormal bowel sound SYMP:0000489 ICD9CM_2005:789.69 UMLS_CUI:C0375574 UMLS_ICD9CM_2005_AUI:A0637157 symptoms SYMP:0000490 multiple sites abdominal tenderness SYMP:0000490 ICD9CM_2005:788.37 UMLS_CUI:C0375553 UMLS_ICD9CM_2005_AUI:A0679310 symptoms SYMP:0000491 continuous leakage of urine SYMP:0000491 A urinary system symptom that is characterized by the an inability of the body to control the evacuative functions. ICD9CM_2005:788.3 ICD9CM_2005:788.30 UMLS_CUI:C0042024 UMLS_ICD9CM_2005_AUI:A0814766 UMLS_ICD9CM_2005_AUI:A6994675 incontinence symptoms SYMP:0000492 urinary incontinence SYMP:0000492 ICD9CM_2005:787.2 UMLS_CUI:C0011168 UMLS_ICD9CM_2005_AUI:A0052114 difficulty in swallowing difficulty swallowing impaired swallowing symptoms SYMP:0000493 dysphagia SYMP:0000493 A colic that is characterized by a severe pain produced by the passage of a calculus from the kidney through the ureter. ICD9CM_2005:788.0 UMLS_CUI:C0152169 UMLS_ICD9CM_2005_AUI:A0265344 symptoms SYMP:0000494 renal colic SYMP:0000494 A urinary system symptom that is characterized by abnormal purulent or mucoid secretions from the penis or, rarely, the female urethra. ICD9CM_2005:788.7 UMLS_CUI:C0152447 UMLS_ICD9CM_2005_AUI:A0266251 symptoms SYMP:0000495 urethral discharge SYMP:0000495 ICD9CM_2005:789.66 UMLS_CUI:C0239280 UMLS_ICD9CM_2005_AUI:A0637153 symptoms SYMP:0000496 epigastric abdominal tenderness SYMP:0000496 ICD9CM_2005:789.65 UMLS_CUI:C0375573 UMLS_ICD9CM_2005_AUI:A0637158 symptoms SYMP:0000497 periumbilic abdominal tenderness SYMP:0000497 ICD9CM_2005:789.67 UMLS_CUI:C0302540 UMLS_ICD9CM_2005_AUI:A0637154 symptoms SYMP:0000498 generalized abdominal tenderness SYMP:0000498 ICD9CM_2005:789.61 UMLS_CUI:C0238571 symptoms SYMP:0000499 right upper quadrant abdominal tenderness SYMP:0000499 ICD9CM_2005:789.63 UMLS_CUI:C0238570 symptoms SYMP:0000500 right lower quadrant abdominal tenderness SYMP:0000500 ICD9CM_2005:789.34 UMLS_CUI:C0375560 UMLS_ICD9CM_2005_AUI:A0637123 symptoms SYMP:0000501 left lower quadrant abdominal swelling SYMP:0000501 A urinary incontinence that is characterized by urine leakage when you sneeze, cough, laugh, do jarring exercise, or lift something heavy. It is typically a combination of stress and urge incontinence. ICD9CM_2005:788.33 UMLS_CUI:C0375550 UMLS_ICD9CM_2005_AUI:A0745756 symptoms SYMP:0000502 mixed incontinence (female) (male) SYMP:0000502 A nutrition, metabolism, and development symptom that is characterized by a physical decline in health seen in older adults – typically those with multiple chronic medical conditions – resulting in decreased appetite and poor nutrition, weight loss, inactivity, often accompanied by dehydration, depression, decreasing functional ability, and impaired immune function. ICD9CM_2005:783.7 UMLS_CUI:C1268580 UMLS_ICD9CM_2005_AUI:A1892736 symptoms SYMP:0000503 adult failure to thrive SYMP:0000503 A pain that is characterized by a pain in the head. ICD9CM_2005:784.0 UMLS_CUI:C0018681 UMLS_ICD9CM_2005_AUI:A0065994 cephalalgia symptoms SYMP:0000504 headache SYMP:0000504 A pain that is characterized by a painful throat due to inflammation of the fauces and pharynx. ICD9CM_2005:784.1 UMLS_CUI:C0242429 UMLS_ICD9CM_2005_AUI:A0284175 sore throat symptoms SYMP:0000505 throat pain SYMP:0000505 ICD9CM_2005:784.8 UMLS_CUI:C0576995 UMLS_ICD9CM_2005_AUI:A0284188 symptoms SYMP:0000506 hemorrhage from throat SYMP:0000506 ICD9CM_2005:784.2 UMLS_CUI:C0159045 UMLS_ICD9CM_2005_AUI:A0284180 symptoms SYMP:0000507 head swelling SYMP:0000507 A nervous system symptom that is characterized by a loss or impairment of the power to use or comprehend words usually resulting from brain damage. ICD9CM_2005:784.3 UMLS_CUI:C0003537 UMLS_ICD9CM_2005_AUI:A0025556 inability to comprehend language symptoms SYMP:0000508 doid/symp duplicate aphasia SYMP:0000508 SYMP:0000708 ICD9CM_2005:787.3 UMLS_CUI:C0016205 UMLS_ICD9CM_2005_AUI:A0243846 gas gas production symptoms SYMP:0000509 flatulence SYMP:0000509 A skin and integumentary tissue symptom that is characterized by a deficiency of color especially of the face. ICD9CM_2005:782.61 UMLS_CUI:C0030232 UMLS_ICD9CM_2005_AUI:A0096956 paleness symptoms SYMP:0000510 pallor SYMP:0000510 A skin and integumentary tissue symptom that is characterized by a markedly red flush in a persons face and often other areas of the skin, from various physiological conditions. Flushing is generally distinguished, despite a close physiological relation between them, from blushing, which is milder, generally restricted to the face or cheeks, and generally assumed to reflect embarrassment. Flushing is also a cardinal symptom of carcinoid syndrome the syndrome that results from hormones (often serotonin or histamine) being secreted into systemic circulation. ICD9CM_2005:782.62 UMLS_CUI:C0016382 UMLS_ICD9CM_2005_AUI:A0060138 symptoms SYMP:0000511 flushing SYMP:0000511 A stress incontinence that is characterized by a compromised external urinary sphincter muscle resulting from surgical or radiotherapeutic manipulation. ICD9CM_2005:788.32 UMLS_CUI:C0302505 UMLS_ICD9CM_2005_AUI:A0800441 symptoms SYMP:0000512 male stress incontinence SYMP:0000512 An abnormal chest sound that is characterized by a harsh vibrating sound heard during respiration in cases of obstruction of the air passages. ICD9CM_2005:786.1 UMLS_CUI:C0038450 UMLS_ICD9CM_2005_AUI:A0120146 symptoms SYMP:0000513 stridor SYMP:0000513 ICD9CM_2005:786 UMLS_CUI:C0476271 UMLS_ICD9CM_2005_AUI:A0284200 symptoms SYMP:0000514 respiratory system and chest symptom SYMP:0000514 A respiratory system and chest symptom that is characterized by a spasmodic inhalation with closure of the glottis accompanied by a peculiar sound. ICD9CM_2005:786.8 UMLS_CUI:C0019521 UMLS_ICD9CM_2005_AUI:A0421293 symptoms SYMP:0000515 hiccough SYMP:0000515 ICD9CM_2005:786.6 UMLS_CUI:C0159055 UMLS_ICD9CM_2005_AUI:A0284217 symptoms SYMP:0000516 lump in chest SYMP:0000516 A respiratory system and chest symptom that is characterized by an expectoration of blood from some part of the respiratory tract. ICD9CM_2005:786.3 UMLS_CUI:C0019079 UMLS_ICD9CM_2005_AUI:A0067232 coughing up of blood expectoration of blood expectoration of blood-stained sputum haemoptysis symptoms SYMP:0000517 hemoptysis SYMP:0000517 An abdominal pain that is characterized by being diffuse or widespread and affecting or involving all of the abdomen. ICD9CM_2005:789.07 UMLS_CUI:C0344304 UMLS_ICD9CM_2005_AUI:A0637131 symptoms SYMP:0000518 generalized abdominal pain SYMP:0000518 ICD9CM_2005:787.7 UMLS_CUI:C0162287 UMLS_ICD9CM_2005_AUI:A0284238 symptoms SYMP:0000519 abnormal feces SYMP:0000519 ICD9CM_2005:787.4 UMLS_CUI:C0159059 UMLS_ICD9CM_2005_AUI:A0284228 symptoms SYMP:0000520 visible peristalsis SYMP:0000520 ICD9CM_2005:785.6 UMLS_CUI:C0497156 UMLS_ICD9CM_2005_AUI:A0243823 swelling of lymph nodes swollen lymph glands symptoms SYMP:0000521 enlargement of lymph nodes SYMP:0000521 ICD9CM_2005:783.3 UMLS_CUI:C0699815 UMLS_ICD9CM_2005_AUI:A0284167 symptoms SYMP:0000522 feeding difficulties and mismanagement SYMP:0000522 A nutrition, metabolism, and development symptom that is characterized by a loss of appetite especially when prolonged. ICD9CM_2005:783.0 UMLS_CUI:C0003123 UMLS_ICD9CM_2005_AUI:A0024378 symptoms SYMP:0000523 anorexia SYMP:0000523 A nutrition, metabolism, and development symptom that is characterized by an excessive appetite or eating. ICD9CM_2005:783.6 UMLS_CUI:C0020505 UMLS_ICD9CM_2005_AUI:A0011381 symptoms SYMP:0000524 polyphagia SYMP:0000524 An alteration of consciousness that is characterized by a brief (transient) episode of losing normal awareness or behavior. ICD9CM_2005:780.02 UMLS_CUI:C0221539 UMLS_ICD9CM_2005_AUI:A0466980 symptoms SYMP:0000525 transient alteration of awareness SYMP:0000525 An abdominal symptom consisting of an abnormal accumulation of serous fluid in the spaces between tissues and organs in the cavity of the abdomen. ICD9CM_2005:789.5 UMLS_CUI:C0003962 UMLS_ICD9CM_2005_AUI:A0026882 hydroperitoneum symptoms SYMP:0000526 ascites SYMP:0000526 ICD9CM_2005:785.2 UMLS_CUI:C0375546 UMLS_ICD9CM_2005_AUI:A0813487 symptoms SYMP:0000527 undiagnosed cardiac murmur SYMP:0000527 ICD9CM_2005:785 UMLS_CUI:C0159049 UMLS_ICD9CM_2005_AUI:A0284192 symptoms SYMP:0000528 cardiovascular system symptom SYMP:0000528 Tachycardia is a cardiovascular system symptom consisting of a relatively rapid heart action whether physiological (as after exercise) or pathological. ICD9CM_2005:785.0 UMLS_CUI:C0039231 UMLS_ICD9CM_2005_AUI:A0804597 symptoms SYMP:0000529 tachycardia SYMP:0000529 Palpitation is a cardiovascykar system symptom characterized by an abnormal awareness of the beating of the heart,whether it is too slow, too fast, irregular, or at its normal frequency when excited by violent exertion, strong emotion, or disease. ICD9CM_2005:785.1 UMLS_CUI:C0030252 UMLS_ICD9CM_2005_AUI:A0004066 abnormal heart beats symptoms SYMP:0000530 palpitation SYMP:0000530 ICD9CM_2005:789.2 UMLS_CUI:C0038002 UMLS_ICD9CM_2005_AUI:A0118748 esplenomegaly symptoms SYMP:0000531 splenomegaly SYMP:0000531 A urinary incontinence that is characterized by an involuntary leakage of urine from the bladder when a sudden strong need to urinate is felt, even when the bladder isn't full. ICD9CM_2005:788.31 UMLS_CUI:C0150045 UMLS_ICD9CM_2005_AUI:A0469078 symptoms SYMP:0000532 urge incontinence SYMP:0000532 A urinary incontinence that is characterized by urine remaining in the urethra after voiding the bladder that slowly leaks out after urination. ICD9CM_2005:788.35 UMLS_CUI:C0375552 UMLS_ICD9CM_2005_AUI:A0775329 symptoms SYMP:0000533 post-void dribbling SYMP:0000533 A skin and integumentary tissue symptom that is characterized by the spontaneous escape of blood into the tissues from ruptured blood vessels marked by a livid black-and-blue or purple spot or area. ICD9CM_2005:782.7 UMLS_CUI:C0159039 UMLS_ICD9CM_2005_AUI:A0284153 symptoms SYMP:0000534 spontaneous ecchymoses SYMP:0000534 ICD9CM_2005:782.8 UMLS_CUI:C0159040 UMLS_ICD9CM_2005_AUI:A0284158 symptoms SYMP:0000535 change in skin texture SYMP:0000535 ICD9CM_2005:782.0 UMLS_CUI:C0012766 UMLS_ICD9CM_2005_AUI:A0243776 symptoms SYMP:0000536 disturbance of skin sensation SYMP:0000536 A skin and integumentary tissue symptom that is characterized by a bluish or purplish discoloration (as of skin) due to deficient oxygenation of the blood. ICD9CM_2005:782.5 UMLS_CUI:C0010520 UMLS_ICD9CM_2005_AUI:A0044296 symptoms SYMP:0000537 cyanosis SYMP:0000537 A skin and integumentary tissue symptom that is characterized by an abnormal excess accumulation of serous fluid in connective tissue or in a serous cavity. ICD9CM_2005:782.3 UMLS_CUI:C0013604 UMLS_ICD9CM_2005_AUI:A0052720 dropsy symptoms SYMP:0000538 edema SYMP:0000538 A skin and integumentary tissue symptom that is characterized by a yellowish pigmentation of the skin, tissues, and certain body fluids is caused by the deposition of bile pigments that follows interference with normal production and discharge of bile (as in certain liver diseases) or excessive breakdown of red blood cells (as after internal hemorrhage or in various hemolytic states). ICD9CM_2005:782.4 UMLS_CUI:C0476232 UMLS_ICD9CM_2005_AUI:A0243785 icteric icterus symptoms SYMP:0000539 jaundice SYMP:0000539 A respiratory system and chest symptom that is characterized by a feeling of discomfort when breathing in or out. The pain may be the result of infection, musculoskeletal injury, and heart problems. ICD9CM_2005:786.52 UMLS_CUI:C0423729 UMLS_ICD9CM_2005_AUI:A0243833 symptoms SYMP:0000540 painful respiration SYMP:0000540 ICD9CM_2005:789.35 UMLS_CUI:C0375561 UMLS_ICD9CM_2005_AUI:A0637126 symptoms SYMP:0000541 periumbilic abdominal swelling SYMP:0000541 An abdominal pain that is characterized by occurring in the epigastrium, i.e. the upper part of the abdomen below the rib cage. ICD9CM_2005:789.06 UMLS_CUI:C0232493 UMLS_ICD9CM_2005_AUI:A0637130 symptoms SYMP:0000542 epigastric abdominal pain SYMP:0000542 A neurological and physiological symptom that is characterized by an unusual forgetfulness. One may not be able to remember new events, recall one or more memories of the past, or both. Memory loss may be for a short time and then resolve (transient), or it may not go away and get worse over time. ICD9CM_2005:780.93 UMLS_CUI:C0751295 UMLS_ICD9CM_2005_AUI:A2797424 symptoms SYMP:0000543 memory loss SYMP:0000543 A paralysis that is characterized by a loss of some, or all, muscle control in a limb, and which lasts for only a short time (i.e. is temporary). ICD9CM_2005:781.4 UMLS_CUI:C0159034 UMLS_ICD9CM_2005_AUI:A0284133 symptoms SYMP:0000544 transient paralysis of limb SYMP:0000544 ICD9CM_2005:789.39 UMLS_CUI:C0375564 UMLS_ICD9CM_2005_AUI:A0637125 symptoms SYMP:0000545 multiple sites abdominal swelling SYMP:0000545 ICD9CM_2005:789.03 UMLS_CUI:C0740603 symptoms SYMP:0000546 right lower quadrant abdominal pain SYMP:0000546 ICD9CM_2005:789.01 UMLS_CUI:C0235299 symptoms SYMP:0000547 right upper quadrant abdominal pain SYMP:0000547 ICD9CM_2005:789.33 UMLS_CUI:C0375559 symptoms SYMP:0000548 right lower quadrant abdominal swelling SYMP:0000548 ICD9CM_2005:789.37 UMLS_CUI:C0375563 UMLS_ICD9CM_2005_AUI:A0637122 symptoms SYMP:0000549 generalized abdominal swelling SYMP:0000549 ICD9CM_2005:781.5 UMLS_CUI:C0009080 UMLS_ICD9CM_2005_AUI:A0284139 symptoms SYMP:0000550 clubbing of fingers SYMP:0000550 ICD9CM_2005:781.1 UMLS_CUI:C0495689 UMLS_ICD9CM_2005_AUI:A0243765 taste alteration symptoms SYMP:0000551 disturbances of sensation of smell and taste SYMP:0000551 A nervous system symptom that is characterized by a state of meningeal irritation with symptoms suggesting meningitis that often occurs at the onset of acute febrile diseases especially in children. ICD9CM_2005:781.6 UMLS_CUI:C0025287 UMLS_ICD9CM_2005_AUI:A0434815 symptoms SYMP:0000552 meningismus SYMP:0000552 ICD9CM_2005:781.8 UMLS_CUI:C0840927 UMLS_ICD9CM_2005_AUI:A0752424 symptoms SYMP:0000553 neurologic neglect syndrome SYMP:0000553 ICD9CM_2005:789.44 UMLS_CUI:C0375568 UMLS_ICD9CM_2005_AUI:A0637143 symptoms SYMP:0000554 left lower quadrant abdominal rigidity SYMP:0000554 ICD9CM_2005:789.32 UMLS_CUI:C0375558 UMLS_ICD9CM_2005_AUI:A0637124 symptoms SYMP:0000555 left upper quadrant abdominal swelling SYMP:0000555 ICD9CM_2005:782.2 UMLS_CUI:C0476228 UMLS_ICD9CM_2005_AUI:A0243783 symptoms SYMP:0000556 localized superficial lump SYMP:0000556 A urinary system symptom that is characterized by an inability to empty the bladder completely during the process of voiding (urination). ICD9CM_2005:788.2 ICD9CM_2005:788.20 UMLS_CUI:C0080274 UMLS_ICD9CM_2005_AUI:A0284250 UMLS_ICD9CM_2005_AUI:A0784422 inability to urinate ischuria retention of urine symptoms SYMP:0000557 urinary retention SYMP:0000557 A urinary system symptom that is characterized by a bladder that is not empty. ICD9CM_2005:788.21 UMLS_CUI:C0344365 UMLS_ICD9CM_2005_AUI:A0722424 symptoms SYMP:0000558 incomplete bladder emptying SYMP:0000558 ICD9CM_2005:784.4 ICD9CM_2005:784.40 UMLS_CUI:C0042940 UMLS_ICD9CM_2005_AUI:A0284182 UMLS_ICD9CM_2005_AUI:A0818015 symptoms SYMP:0000559 voice disturbance SYMP:0000559 A nutrition, metabolism, and development symptom that is characterized by an excessive or abnormal thirst. ICD9CM_2005:783.5 UMLS_CUI:C0085602 UMLS_ICD9CM_2005_AUI:A0003974 symptoms SYMP:0000560 polydipsia SYMP:0000560 ICD9CM_2005:789.09 UMLS_CUI:C0375555 UMLS_ICD9CM_2005_AUI:A0637134 symptoms SYMP:0000561 multiple sites abdominal pain SYMP:0000561 ICD9CM_2005:789.31 UMLS_CUI:C0375557 symptoms SYMP:0000562 right upper quadrant abdominal swelling SYMP:0000562 A urinary system symptom that is characterized by the need to urinate many times during the day, at night, or both but in normal or less-than-normal volumes. Frequency may be accompanied by a sensation of an urgent need to void (urgency of urination). ICD9CM_2005:788.41 UMLS_CUI:C0042023 UMLS_ICD9CM_2005_AUI:A0004030 frequent urination symptoms nocturia SYMP:0000563 urinary frequency SYMP:0000563 A urinary system symptom that is characterized by urination at night especially when excessive. ICD9CM_2005:788.43 UMLS_CUI:C0028734 UMLS_ICD9CM_2005_AUI:A0011475 nycturia symptoms SYMP:0000564 nocturia SYMP:0000564 A urinary system symptom that is characterized by the excessive secretion of urine. ICD9CM_2005:788.42 UMLS_CUI:C0032617 UMLS_ICD9CM_2005_AUI:A0103470 excessive secretion of urine symptoms SYMP:0000565 polyuria SYMP:0000565 ICD9CM_2005:780.5 UMLS_CUI:C0037317 UMLS_ICD9CM_2005_AUI:A0246756 symptoms SYMP:0000566 sleep disturbance SYMP:0000566 ICD9CM_2005:780 UMLS_CUI:C0159028 UMLS_ICD9CM_2005_AUI:A0284119 symptoms SYMP:0000567 general symptom SYMP:0000567 A lack of expected normal physiological development in childhood that is characterized by an individual's height being in the 3rd percentile for the mean height of a given age, sex, and population group. ICD9CM_2005:783.43 UMLS_CUI:C0349588 symptoms SYMP:0000568 short stature SYMP:0000568 A urinary system symptom that is characterized by the reduced excretion of urine. ICD9CM_2005:788.5 UMLS_CUI:C0028962 UMLS_ICD9CM_2005_AUI:A0243854 symptoms SYMP:0000569 oliguria SYMP:0000569 Diarrhea is a feces and droppng symptom involving the abnormally frequent intestinal evacuations with more or less fluid stools. ICD9CM_2005:787.91 UMLS_CUI:C0011991 UMLS_ICD9CM_2005_AUI:A0048148 bacterial gastroenteritis diarrhoea fecal incontinence incontinence of feces loose bowel loose bowels the runs symptoms SYMP:0000570 doid/symp duplicate - reviewed 10/2022, both DO & SYMP diarrhea SYMP:0000570 Insomnia is a sleep disturbance characterized by prolonged and usually abnormal inability to obtain adequate sleep. ICD9CM_2005:780.52 UMLS_CUI:C0029645 UMLS_ICD9CM_2005_AUI:A0243733 agrypnia symptoms SYMP:0000571 insomnia SYMP:0000571 A urinary stream symptom that is characterized by a split in the urine flow resulting in it streaming in two directions. ICD9CM_2005:788.61 UMLS_CUI:C0232855 UMLS_ICD9CM_2005_AUI:A0460440 symptoms SYMP:0000572 splitting of urinary stream SYMP:0000572 ICD9CM_2005:788.6 ICD9CM_2005:788.69 UMLS_CUI:C0159063 UMLS_ICD9CM_2005_AUI:A0284254 UMLS_ICD9CM_2005_AUI:A0284255 symptoms SYMP:0000573 urinary stream symptom SYMP:0000573 ICD9CM_2005:784.41 UMLS_CUI:C0003564 UMLS_ICD9CM_2005_AUI:A0025595 symptoms SYMP:0000574 aphonia SYMP:0000574 ICD9CM_2005:786.51 UMLS_CUI:C0232286 UMLS_ICD9CM_2005_AUI:A0284212 symptoms SYMP:0000575 precordial pain SYMP:0000575 ICD9CM_2005:786.5 ICD9CM_2005:786.50 UMLS_CUI:C0008031 UMLS_ICD9CM_2005_AUI:A0243830 UMLS_ICD9CM_2005_AUI:A0400627 symptoms SYMP:0000576 chest pain SYMP:0000576 ICD9CM_2005:780.91 UMLS_CUI:C1135254 UMLS_ICD9CM_2005_AUI:A2358677 symptoms SYMP:0000577 fussy infant SYMP:0000577 ICD9CM_2005:788.34 UMLS_CUI:C0375551 UMLS_ICD9CM_2005_AUI:A0722462 symptoms SYMP:0000578 incontinence without sensory awareness SYMP:0000578 ICD9CM_2005:780.51 UMLS_CUI:C0159030 UMLS_ICD9CM_2005_AUI:A0284123 symptoms SYMP:0000579 insomnia with sleep apnea SYMP:0000579 ICD9CM_2005:780.56 UMLS_CUI:C0013373 UMLS_ICD9CM_2005_AUI:A0243741 symptoms SYMP:0000580 dysfunctions associated with sleep stages SYMP:0000580 An apnea that is characterized by brief periods of recurrent cessation of breathing during sleep that is caused especially by obstruction of the airway or a disturbance in the brain's respiratory center and is associated especially with excessive daytime sleepiness. ICD9CM_2005:780.57 UMLS_CUI:C0375544 UMLS_ICD9CM_2005_AUI:A0760143 symptoms SYMP:0000581 doid/symp duplicate sleep apnea SYMP:0000581 Hypersomnia is a sleep disturbance characterized by sleeping for excessive periods at intervals with intervening periods of normal duration of sleeping and waking. ICD9CM_2005:780.54 UMLS_CUI:C0029637 UMLS_ICD9CM_2005_AUI:A0243739 symptoms SYMP:0000582 hypersomnia SYMP:0000582 ICD9CM_2005:780.53 UMLS_CUI:C0020530 UMLS_ICD9CM_2005_AUI:A0243735 symptoms SYMP:0000583 hypersomnia with sleep apnea SYMP:0000583 ICD9CM_2005:780.55 UMLS_CUI:C0159031 UMLS_ICD9CM_2005_AUI:A0284127 symptoms SYMP:0000584 disruptions of 24-hour sleep-wake cycle SYMP:0000584 ICD9CM_2005:780.58 UMLS_CUI:C1455873 UMLS_ICD9CM_2005_AUI:A6995224 symptoms SYMP:0000585 sleep related movement disorder SYMP:0000585 A urinary incontinence that is characterized by a bladder that does not empty completely, resulting in a bladder that is too full, which leads to overflow and unexpected leaking. ICD9CM_2005:788.38 UMLS_CUI:C0312413 UMLS_ICD9CM_2005_AUI:A6994689 symptoms SYMP:0000586 overflow incontinence SYMP:0000586 A respiratory system and chest symptom that is characterized by a sound of breathing that is not similar to that of the sound of moving air and may include: rhonchi (a low-pitched breath sound), crackles (a high-pitched breath sound), wheezing (a high-pitched whistling sound caused by narrowing of the bronchial tubes), and stridor (a harsh, vibratory sound caused by narrowing of the upper airway). ICD9CM_2005:786.7 UMLS_CUI:C0159056 UMLS_ICD9CM_2005_AUI:A0284219 symptoms SYMP:0000587 abnormal chest sound SYMP:0000587 A urinary system symptom that is characterized by an injury of the urethra in its bulbous or membranous portion, which leads to a collection of urine in other cavities, such as the perineal space, the scrotum, the penis and the connective tissue of the anterior abdominal wall. ICD9CM_2005:788.8 UMLS_CUI:C0152245 UMLS_ICD9CM_2005_AUI:A0284259 symptoms SYMP:0000588 extravasation of urine SYMP:0000588 A urinary stream symptom that is characterized by a slow or weak stream of urine. ICD9CM_2005:788.62 UMLS_CUI:C0232854 UMLS_ICD9CM_2005_AUI:A0459374 symptoms SYMP:0000589 slowing of urinary stream SYMP:0000589 A urinary system symptom that is characterized by a strong and immediate need to urinate due to an increase in pressure in the bladder, resulting in difficulty to hold in the urine. This can occur regardless of whether the bladder is full. ICD9CM_2005:788.63 UMLS_CUI:C0085606 UMLS_ICD9CM_2005_AUI:A2797703 urgency of urination symptoms SYMP:0000590 urinary urgency SYMP:0000590 ICD9CM_2005:789.62 UMLS_CUI:C0238566 UMLS_ICD9CM_2005_AUI:A0637156 symptoms SYMP:0000591 left upper quadrant abdominal tenderness SYMP:0000591 ICD9CM_2005:780.92 UMLS_CUI:C0497134 UMLS_ICD9CM_2005_AUI:A2358671 symptoms SYMP:0000592 excessive crying of infant SYMP:0000592 ICD9CM_2005:785.4 UMLS_CUI:C0017086 UMLS_ICD9CM_2005_AUI:A0061978 symptoms SYMP:0000593 gangrene SYMP:0000593 A nervous system symptom that is characterized by an inability to control bodily movement and may be a symptom of cerebrovascular diseases, dyskinesia, tremor, chorea, dystonia and myoclonus. ICD9CM_2005:781.0 UMLS_CUI:C0392702 UMLS_ICD9CM_2005_AUI:A0243762 symptoms SYMP:0000594 abnormal involuntary movement SYMP:0000594 A convulsion that is characterized by occurring in young children between six months and five years of age and which is triggered by fever. ICD9CM_2005:780.31 UMLS_CUI:C0009952 UMLS_ICD9CM_2005_AUI:A0701466 febrile seizure symptoms SYMP:0000595 febrile convulsion SYMP:0000595 A nervous system symptom that is characterized by an abnormal violent and involuntary contraction or series of contractions of the muscles. ICD9CM_2005:780.3 UMLS_CUI:C0009951 UMLS_ICD9CM_2005_AUI:A0042665 symptoms SYMP:0000596 convulsion SYMP:0000596 ICD9CM_2005:784 UMLS_CUI:C0476247 UMLS_ICD9CM_2005_AUI:A0284173 symptoms SYMP:0000597 head and neck symptom SYMP:0000597 A respiratory system and chest symptom that is characterized by a respiration that is not normal and may include, but is not limited to: apnea, eupnea, orthopnea, dyspnea hyperpnea, hyperventilation, hypoventilation, tachypnea, Kussmaul respiration, Cheyne-Stokes respiration, sighing respiration, Biot respiration, apneustic breathing, central neurogenic hyperventilation, and central neurogenic hypoventilation. ICD9CM_2005:786.0 UMLS_CUI:C0159053 UMLS_ICD9CM_2005_AUI:A0284202 symptoms SYMP:0000598 respiratory abnormality SYMP:0000598 A respiratory abnormality that is characterized by a specific form of periodic breathing (waxing and waning amplitude of flow or tidal volume) characterized by a crescendo-decrescendo pattern of respiration between central apneas or central hypopneas. ICD9CM_2005:786.04 UMLS_CUI:C0008039 UMLS_ICD9CM_2005_AUI:A0400651 symptoms SYMP:0000599 cheyne-stokes respiration SYMP:0000599 A respiratory abnormality that is characterized by transient cessation of respiration whether normal (as in hibernating animals) or abnormal (as that caused by certain drugs). ICD9CM_2005:786.03 UMLS_CUI:C0003578 UMLS_ICD9CM_2005_AUI:A0025648 symptoms SYMP:0000600 apnea SYMP:0000600 A respiratory abnormality that is characterized by excessive ventilation characterized by excessive rate and depth of respiration leading to abnormal loss of carbon dioxide from the blood. ICD9CM_2005:786.01 UMLS_CUI:C0020578 UMLS_ICD9CM_2005_AUI:A0071094 symptoms SYMP:0000601 hyperventilation SYMP:0000601 A respiratory abnormality that is characterized by a difficulty in breathing that occurs when lying down and is relieved upon changing to an upright position (as in congestive heart failure). ICD9CM_2005:786.02 UMLS_CUI:C0085619 UMLS_ICD9CM_2005_AUI:A0004140 symptoms SYMP:0000602 orthopnea SYMP:0000602 A respiratory abnormality that is characterized by an increased rate of respiration and shallow breathing. SYMP:0000683 ICD9CM_2005:786.06 UMLS_CUI:C0231835 UMLS_ICD9CM_2005_AUI:A0465027 rapid breathing symptoms SYMP:0000603 tachypnea SYMP:0000603 An abnormal chest sound that is characterized by breathing with difficulty usually with a whistling sound. ICD9CM_2005:786.07 UMLS_CUI:C0043144 UMLS_ICD9CM_2005_AUI:A0133941 symptoms SYMP:0000604 wheezing SYMP:0000604 An alteration of consciousness that is characterized by a deep state of prolonged unconsciousness in which a person cannot be awakened, fails to respond normally to painful stimuli, light, or sound, lacks a normal wake-sleep cycle and does not initiate voluntary actions. ICD9CM_2005:780.01 UMLS_CUI:C0009421 UMLS_ICD9CM_2005_AUI:A0041160 symptoms SYMP:0000605 coma SYMP:0000605 A urinary incontinence that is characterized by involuntary urination at night in children five years of age or older. ICD9CM_2005:788.36 UMLS_CUI:C0270327 UMLS_ICD9CM_2005_AUI:A0753297 bed wetting nighttime incontinence symptoms SYMP:0000606 nocturnal enuresis SYMP:0000606 Hallucination is a general symptom where there is a perception of something (as a visual image or a sound) with no external cause usually arising from a disorder of the nervous system (as in delirium tremens or in functional psychosis without known neurological disease) or in response to drugs (as LSD). ICD9CM_2005:780.1 UMLS_CUI:C0018524 UMLS_ICD9CM_2005_AUI:A0065642 symptoms SYMP:0000607 hallucination SYMP:0000607 An alteration of consciousness that is characterized by a loss of consciousness resulting from insufficient blood flow to the brain and limb weakness progressing to collapse. ICD9CM_2005:780.2 UMLS_CUI:C0039070 UMLS_ICD9CM_2005_AUI:A0243721 symptoms SYMP:0000608 syncope and collapse SYMP:0000608 A neurological and physiological symptom that is characterized by excessive sweating, i.e. the production of more sweat than is required to regulate body temperature. Generalized hyperhidrosis is caused by non-thermoregulatory stimuli and affects the entire body. ICD9CM_2005:780.8 UMLS_CUI:C0476476 UMLS_ICD9CM_2005_AUI:A6994739 secondary hyperhidrosis symptoms SYMP:0000609 generalized hyperhidrosis SYMP:0000609 A balance symptom that is characterized by a sensation of unsteadiness accompanied by a feeling of movement within the head. ICD9CM_2005:780.4 UMLS_CUI:C0476206 UMLS_ICD9CM_2005_AUI:A0243727 dizzy symptoms SYMP:0000610 dizziness SYMP:0000610 ICD9CM_2005:789.05 UMLS_CUI:C0740594 UMLS_ICD9CM_2005_AUI:A0637135 symptoms SYMP:0000611 periumbilic abdominal pain SYMP:0000611 ICD9CM_2005:789.45 UMLS_CUI:C0375569 UMLS_ICD9CM_2005_AUI:A0637146 symptoms SYMP:0000612 periumbilic abdominal rigidity SYMP:0000612 A neurological and physiological symptom that is characterized by a rise of body temperature above the normal, whether as a natural response (as to infection) or artificially induced for therapeutic reasons. ICD9CM_2005:780.6 UMLS_CUI:C0015967 UMLS_ICD9CM_2005_AUI:A0058972 pyrexia symptoms SYMP:0000613 fever SYMP:0000613 A respiratory system and chest symptom that is characterized by an explosive expulsion of air from the lungs acting as a protective mechanism to clear the air passages or as a symptom of pulmonary disturbance. ICD9CM_2005:786.2 UMLS_CUI:C0010200 UMLS_ICD9CM_2005_AUI:A0043303 symptoms SYMP:0000614 cough SYMP:0000614 ICD9CM_2005:781.91 UMLS_CUI:C0424641 UMLS_ICD9CM_2005_AUI:A1892812 symptoms SYMP:0000616 loss of height SYMP:0000616 ICD9CM_2005:781.93 UMLS_CUI:C0028856 UMLS_ICD9CM_2005_AUI:A2358774 twisted neck wry neck symptoms SYMP:0000617 torticollis SYMP:0000617 ICD9CM_2005:781.92 UMLS_CUI:C0231471 UMLS_ICD9CM_2005_AUI:A0387502 symptoms SYMP:0000618 abnormal posture SYMP:0000618 ICD9CM_2005:781.7 UMLS_CUI:C0039621 UMLS_ICD9CM_2005_AUI:A0124526 symptoms SYMP:0000619 tetany SYMP:0000619 An abdominal pain that is characterized by occurring in the left lower quadrant of the abdomen that is often related to the digestive tract, but can also be related to conditions of the body wall, skin, blood vessels, urinary tract, or reproductive organs. ICD9CM_2005:789.04 UMLS_CUI:C0238551 UMLS_ICD9CM_2005_AUI:A0637132 symptoms SYMP:0000620 left lower quadrant abdominal pain SYMP:0000620 An aphasia that is characterized by a loss of ability to read. ICD9CM_2005:784.6 ICD9CM_2005:784.69 UMLS_CUI:C0478145 UMLS_ICD9CM_2005_AUI:A0243803 UMLS_ICD9CM_2005_AUI:A0243804 symptoms SYMP:0000621 doid/symp duplicate alexia SYMP:0000621 symptoms SYMP:0000622 acute mesenteric lymphadenitis SYMP:0000622 A renal failure that is characterized by a severe and sudden onset of renal failure. symptoms SYMP:0000623 acute renal failure SYMP:0000623 An alteration of consciousness that is characterized by a disturbance in sentience (the ability to experience feelings and sensations) or awareness of one's internal and external existence, i.e. inhibited or absent self-awareness. symptoms SYMP:0000625 conscious disturbance SYMP:0000625 disturbance of vision symptoms SYMP:0000627 disturbed vision SYMP:0000627 symptoms SYMP:0000628 vision distortion SYMP:0000628 A rash characterized by a widespread skin eruption usually occurring in children that is a symptom of a more general disease. symptoms SYMP:0000629 exanthema SYMP:0000629 symptoms SYMP:0000630 frontal headache SYMP:0000630 symptoms SYMP:0000631 doid/symp duplicate hemolytic anemia SYMP:0000631 A joint pain that is characterized by a pain situated, or occurring, in or around the hip. symptoms SYMP:0000632 hip pain SYMP:0000632 symptoms SYMP:0000633 inflammatory low back pain SYMP:0000633 symptoms SYMP:0000634 leukocytosis SYMP:0000634 low back pain symptoms SYMP:0000635 low backache SYMP:0000635 A rash characterized by papule(s), which are a raised area of the skin and macule(s), which are a flat red area of the skin. symptoms SYMP:0000636 maculopapular rash SYMP:0000636 symptoms SYMP:0000637 opisthotonus SYMP:0000637 A rash characterized by papule(s), which are a raised area of the skin. symptoms SYMP:0000638 papular rash SYMP:0000638 rectal bleeding symptoms SYMP:0000639 rectorrhagia SYMP:0000639 A rash characterized by an inflammatory reaction of the skin on the ankles. redness of ankle symptoms SYMP:0000640 ankle rash SYMP:0000640 symptoms SYMP:0000641 renal involvement SYMP:0000641 A respiratory system and chest symptom that is characterized by a difficulty to breathe on one's own and develops when the lungs cannot get enough oxygen into the blood. respiratory dysfunction symptoms SYMP:0000643 doid/symp duplicate - reviewed 10/2022, both DO & SYMP respiratory failure SYMP:0000643 symptoms SYMP:0000644 ruffled feather SYMP:0000644 Synovitis is a joint inflammation characterized by an inflammation of a synovial membrane usually with pain and swelling of the joint. symptoms SYMP:0000646 doid/symp duplicate synovitis SYMP:0000646 A skin ulcer that is characterized by a a small dark-centered ulcer that appears at the site of a tick bite and is the primary lesion of boutonneuse fever. symptoms SYMP:0000647 tache noire SYMP:0000647 symptoms SYMP:0000648 tenesmus SYMP:0000648 symptoms SYMP:0000649 terminal ileitis SYMP:0000649 symptoms SYMP:0000650 thick white exudate on tongue SYMP:0000650 symptoms SYMP:0000651 discharge SYMP:0000651 symptoms SYMP:0000652 wound discharge SYMP:0000652 symptoms SYMP:0000653 yellow dropping SYMP:0000653 A behavioral symptom that is characterized by a quick excitability to annoyance, impatience, or anger. Inconsolability symptoms SYMP:0000654 irritability SYMP:0000654 symptoms SYMP:0000655 mouth bleeding SYMP:0000655 symptoms SYMP:0000656 pale mucous membrane SYMP:0000656 symptoms SYMP:0000657 ischemic necrosis of jejunum SYMP:0000657 symptoms SYMP:0000658 extraocular muscles paralysis SYMP:0000658 A paralysis that is charachterized by a slight or partial paralysis. partial paralysis symptoms SYMP:0000659 pareses SYMP:0000659 A rash characterized by a red or purple hued small spots of blood appear on the skin caused by conditions that result in blood leaking into the skin and other body surfaces that does not fade when pressed upon. symptoms SYMP:0000660 purpuric rash SYMP:0000660 symptoms SYMP:0000661 recumbency SYMP:0000661 Shakes is a general symptom characterized by a condition of trembling. trembling symptoms SYMP:0000662 shakes SYMP:0000662 symptoms SYMP:0000663 uncoordinated gait SYMP:0000663 symptoms SYMP:0000664 yellow exudate from nose SYMP:0000664 symptoms SYMP:0000665 yellow exudate from eyes SYMP:0000665 A behavioral symptom that is characterized by behavior that is atypical or statistically uncommon within a particular culture, or that is maladaptive, or detrimental to an individual, or those around that individual. symptoms SYMP:0000666 abnormal behavior SYMP:0000666 symptoms SYMP:0000669 abnormal hemistanding SYMP:0000669 symptoms SYMP:0000670 abnormal hemiwalking SYMP:0000670 symptoms SYMP:0000671 sudden onset of fever SYMP:0000671 symptoms SYMP:0000672 abscess SYMP:0000672 Bradykinesia is a hypokinesia characterized by an extreme slowness in the execution of movements and reflexes. symptoms SYMP:0000673 bradykinesia SYMP:0000673 symptoms SYMP:0000674 acute cranial nerve dysfunction SYMP:0000674 Acute diarrhea is a diarrhea with either or both a rapid onset or a short course. symptoms SYMP:0000675 doid/symp duplicate acute diarrhea SYMP:0000675 Acute enteritis is a enteritis with either or both a rapid onset and a short course which is usually due to bacteria or virus. symptoms SYMP:0000676 acute enteritis SYMP:0000676 symptoms SYMP:0000677 acute gastroenteritis SYMP:0000677 A nervous system symptom that is characterized by a severe and sudden onset of disturbance in the normal operation of one's cognition, emotional regulation, or behaviour. symptoms SYMP:0000678 acute mental dysfunction SYMP:0000678 A dyspnea that is characterized by a severe and sudden onset. symptoms SYMP:0000679 acute dyspnea SYMP:0000679 A weight loss that is characterized by a severe and sudden onset. symptoms SYMP:0000680 acute weight loss SYMP:0000680 A behavioral symptom that is characterized by behavior aimed at harming a person, or animal, or damaging physical property. symptoms SYMP:0000681 aggressive behavior SYMP:0000681 A nervous system symptom that is characterized by a host of presentations that include changes in cognition, mood, behavior, and/or level of arousal. symptoms SYMP:0000682 altered mental status SYMP:0000682 symptoms SYMP:0000684 bifrontal headache SYMP:0000684 symptoms SYMP:0000685 brain cyst SYMP:0000685 A cough that is characterized by an explosive expulsion of air from the lungs acting as a protective mechanism to clear the air passages or as a symptom of pulmonary disturbance marked by long duration, by frequent recurrence over a long time, and often by slowly progressing seriousness. symptoms SYMP:0000686 chronic cough SYMP:0000686 An abnormal involuntary movement that is characterized by an inability to walk in a straight line. symptoms SYMP:0000688 circling movement SYMP:0000688 symptoms SYMP:0000689 cramp SYMP:0000689 symptoms SYMP:0000690 cranial nerve palsies SYMP:0000690 symptoms SYMP:0000691 cytopenia SYMP:0000691 symptoms SYMP:0000692 low blood pressure SYMP:0000692 symptoms SYMP:0000693 decreased facial sensation SYMP:0000693 symptoms SYMP:0000694 decreased jaw tone SYMP:0000694 A nutrition, metabolism, and development symptom that is characterized by a decrease in the production of milk in breastfeeding mothers. symptoms SYMP:0000695 decreased milk production SYMP:0000695 symptoms SYMP:0000696 decreased motor response SYMP:0000696 symptoms SYMP:0000697 decreased pharyngeal tone SYMP:0000697 A feeding difficulties and mismanagement that is characterized by a decrease in muscle coordination to form a suck response so that the child can ingest milk. symptoms SYMP:0000698 decreased sucking SYMP:0000698 symptoms SYMP:0000699 deltoid muscle weakness SYMP:0000699 symptoms SYMP:0000700 diminished spontaneous movement SYMP:0000700 symptoms SYMP:0000701 nasal discharge SYMP:0000701 symptoms SYMP:0000702 distended loops of intestines on rectal SYMP:0000702 symptoms SYMP:0000703 droopy ears SYMP:0000703 symptoms SYMP:0000704 dysphonia SYMP:0000704 An aphasia that is characterized by damage to, or a developmental issues in, the anterior regions of the brain, including (but not limited to) the left inferior frontal region known as Broca's area. Sufferers of this form of aphasia exhibit the common problem of agrammatism. For them, speech is difficult to initiate, non-fluent, labored, and halting. Broca's aphasia agrammatic aphasia symptoms SYMP:0000705 expressive aphasia SYMP:0000705 symptoms SYMP:0000706 facial weakness SYMP:0000706 symptoms SYMP:0000707 flaccid muscle tone SYMP:0000707 symptoms SYMP:0000709 granulomatous inflammation SYMP:0000709 symptoms SYMP:0000710 head pressing SYMP:0000710 symptoms SYMP:0000711 hind limb paralysis SYMP:0000711 A reproductive system symptom that is characterized the biological inability of a man or a woman to contribute to conception; or, the state of a woman who is unable to carry a pregnancy to full term. symptoms SYMP:0000712 doid/symp duplicate infertility SYMP:0000712 symptoms SYMP:0000713 inability to lie flat SYMP:0000713 symptoms SYMP:0000714 intraretinal hemorrhage SYMP:0000714 A skin and integumentary tissue symptom that is characterized by the peeling off of skin in the form of scales. symptoms SYMP:0000715 skin desquamation SYMP:0000715 symptoms SYMP:0000716 swelling symptom SYMP:0000716 symptoms SYMP:0000717 leg swelling SYMP:0000717 A neurological and physiological symptom that is characterized by a state in which an individual lacks normal awareness of self and the surrounding environment and one's ability to remain awake, aware, and oriented is impaired. symptoms SYMP:0000718 loss of consciousness SYMP:0000718 A neurological and physiological symptom that is characterized by a diminished or reduced ability to remember things such as dates and names, and increased forgetfulness. symptoms SYMP:0000719 memory impairment SYMP:0000719 symptoms SYMP:0000720 microangiopathic hemolytic anemia SYMP:0000720 symptoms SYMP:0000721 moderate anemia SYMP:0000721 symptoms SYMP:0000722 moderate conjuctival injection SYMP:0000722 symptoms SYMP:0000723 multiple abscesses SYMP:0000723 symptoms SYMP:0000724 multiple organ failure SYMP:0000724 symptoms SYMP:0000725 necrosis of jejunum SYMP:0000725 symptoms SYMP:0000726 painful reginal lymphadenopathy SYMP:0000726 symptoms SYMP:0000727 palate weakness SYMP:0000727 symptoms SYMP:0000728 partial hind limb paralysis SYMP:0000728 A respiratory system and chest symptom that is characterized by a region of normally compressible lung tissue that has filled with liquid instead of air. symptoms SYMP:0000729 pulmonary consolidation SYMP:0000729 A respiratory abnormality that is characterized by an increased breathing rate, with more than 20 breaths per minute in an adult, while in children, the number of breaths per minute can be a higher resting rate than seen in adults. symptoms SYMP:0000730 rapid respiration SYMP:0000730 A urinary system symptom that is characterized by a loss of excretory function in one or both kidneys, leading to retention of nitrogenous waste products from the blood. symptoms SYMP:0000731 renal failure SYMP:0000731 symptoms SYMP:0000732 sudden ataxis SYMP:0000732 symptoms SYMP:0000733 sternocleidomastoid weakness SYMP:0000733 symptoms SYMP:0000736 lymph gland swelling SYMP:0000736 A respiratory system and chest symptom that is characterized by an ulceration (dying and sloughing) of the bronchial or bronchiolar epithelium, exposing the underlying basement membrane. symptoms SYMP:0000737 respiratory tract mucosa ulcer SYMP:0000737 symptoms SYMP:0000738 yellowish green diarrhea SYMP:0000738 A respiratory system and chest symptom that is characterized by bleeding (hemorrhage) in either or both the bronchi and the lungs. symptoms SYMP:0000739 bronchopulmonary bleeding SYMP:0000739 symptoms SYMP:0000740 genitourinary hemorrhage SYMP:0000740 symptoms SYMP:0000741 nasal bleeding SYMP:0000741 Gum bleeding is a mouth symptom characterized by a copious discharge of blood from the blood vessels of the mucosal tissue that lies over the alveolar bone. gingival hemorrhage symptoms SYMP:0000742 gum bleeding SYMP:0000742 symptoms SYMP:0000743 blotchy red rash SYMP:0000743 symptoms SYMP:0000744 cervical lymphadenopathy SYMP:0000744 symptoms SYMP:0000745 change in body sensation SYMP:0000745 A skin and integumentary tissue symptom that is characterized by an eruption on a mucous surface. symptoms SYMP:0000746 enanthem SYMP:0000746 symptoms SYMP:0000747 extreme prostration SYMP:0000747 An adema that is characterized by an abnormal excess accumulation of serous fluid in connective tissue of the face. facial swelling symptoms SYMP:0000748 facial edema SYMP:0000748 symptoms SYMP:0000749 hemodynamic instability SYMP:0000749 symptoms SYMP:0000750 hemorrhage into mucous membrane SYMP:0000750 symptoms SYMP:0000751 hemorrhage into skin SYMP:0000751 symptoms SYMP:0000752 herpetic lesion on upper lip SYMP:0000752 symptoms SYMP:0000753 intense anxiety SYMP:0000753 intense chest pain symptoms SYMP:0000754 severe chest pain SYMP:0000754 symptoms SYMP:0000755 intense toxemia SYMP:0000755 A reproductive system symptom that is characterized an abnormally profuse menstrual flow. symptoms SYMP:0000756 menorrhagia SYMP:0000756 symptoms SYMP:0000757 mild conjunctivitis SYMP:0000757 symptoms SYMP:0000758 neurological alteration SYMP:0000758 A pain that is characterized by a pain situated, or occurring, in the parotid gland, which is a salivary gland located in front of the ears. (Additional salivary glands include the submandibular and sublingual glands.) Pain is attributed to swelling of the gland. salivary gland pain symptoms SYMP:0000759 parotid pain SYMP:0000759 A skin and integumentary tissue symptom that is characterized by a minute reddish or purplish spot containing blood that appears in skin or mucous membrane as a result of localized hemorrhage. petechial rash symptoms SYMP:0000760 petechiae SYMP:0000760 symptoms SYMP:0000761 extracellular fluid alteration SYMP:0000761 symptoms SYMP:0000762 excess lymphocytes in cerebrospinal fluid SYMP:0000762 symptoms SYMP:0000763 renal alteration SYMP:0000763 A pain that is characterized by a pain situated, or occurring, behind the eyeball. symptoms SYMP:0000764 retrobulbar pain SYMP:0000764 symptoms SYMP:0000765 sensory disturbance SYMP:0000765 symptoms SYMP:0000766 slow pulse SYMP:0000766 symptoms SYMP:0000767 subconjunctival bleeding SYMP:0000767 A pain that is characterized by a pain in, or about, a testis (testicle) or testes. Testicular pain can be caused by nerve damage, sexually transmitted infections, gangrene, swelling, hernia, kidney stones, inflammation, enlarged veins, fluid in the testicle, or a severe condition known as testicular torsion. symptoms SYMP:0000768 testicular pain SYMP:0000768 symptoms SYMP:0000769 vascular alteration SYMP:0000769 symptoms SYMP:0000770 pelvic symptom SYMP:0000770 ICD9CM_2005:789.3 symptoms SYMP:0000771 pelvic swelling SYMP:0000771 ICD9CM_2005:789.3 symptoms SYMP:0000772 pelvic mass SYMP:0000772 ICD9CM_2005:789.3 symptoms SYMP:0000773 pelvic lump SYMP:0000773 symptoms SYMP:0000774 generalized pelvic lump SYMP:0000774 symptoms SYMP:0000775 right lower quadrant pelvic lump SYMP:0000775 symptoms SYMP:0000776 epigastric pelvic lump SYMP:0000776 symptoms SYMP:0000777 left lower quadrant pelvic lump SYMP:0000777 symptoms SYMP:0000778 left upper quadrant pelvic lump SYMP:0000778 symptoms SYMP:0000779 right upper quadrant pelvic lump SYMP:0000779 symptoms SYMP:0000780 multiple sites pelvic lump SYMP:0000780 symptoms SYMP:0000781 periumbilic pelvic lump SYMP:0000781 symptoms SYMP:0000782 right upper quadrant pelvic mass SYMP:0000782 symptoms SYMP:0000783 left lower quadrant pelvic mass SYMP:0000783 symptoms SYMP:0000784 epigastric pelvic mass SYMP:0000784 symptoms SYMP:0000785 left upper quadrant pelvic mass SYMP:0000785 symptoms SYMP:0000786 generalized pelvic mass SYMP:0000786 symptoms SYMP:0000787 periumbilic pelvic mass SYMP:0000787 symptoms SYMP:0000788 multiple sites pelvic mass SYMP:0000788 symptoms SYMP:0000789 right lower quadrant pelvic mass SYMP:0000789 symptoms SYMP:0000790 multiple sites pelvic swelling SYMP:0000790 symptoms SYMP:0000791 generalized pelvic swelling SYMP:0000791 symptoms SYMP:0000792 epigastric pelvic swelling SYMP:0000792 symptoms SYMP:0000793 left lower quadrant pelvic swelling SYMP:0000793 symptoms SYMP:0000794 left upper quadrant pelvic swelling SYMP:0000794 symptoms SYMP:0000795 periumbilic pelvic swelling SYMP:0000795 symptoms SYMP:0000796 right lower quadrant pelvic swelling SYMP:0000796 symptoms SYMP:0000797 right upper quadrant pelvic swelling SYMP:0000797 ICD9CM_2005:789.3 UMLS_CUI:C0476310 symptoms SYMP:0000798 abdominal mass SYMP:0000798 symptoms SYMP:0000799 abdominal lump SYMP:0000799 symptoms SYMP:0000800 left upper quadrant abdominal mass SYMP:0000800 symptoms SYMP:0000801 left lower quadrant abdominal mass SYMP:0000801 symptoms SYMP:0000802 epigastric abdominal mass SYMP:0000802 symptoms SYMP:0000803 multiple sites abdominal mass SYMP:0000803 symptoms SYMP:0000804 generalized abdominal mass SYMP:0000804 symptoms SYMP:0000805 periumbilic abdominal mass SYMP:0000805 symptoms SYMP:0000806 right lower quadrant abdominal mass SYMP:0000806 symptoms SYMP:0000807 right upper quadrant abdominal mass SYMP:0000807 symptoms SYMP:0000808 multiple sites abdominal lump SYMP:0000808 symptoms SYMP:0000809 periumbilic abdominal lump SYMP:0000809 symptoms SYMP:0000810 epigastric abdominal lump SYMP:0000810 symptoms SYMP:0000811 left upper quadrant abdominal lump SYMP:0000811 symptoms SYMP:0000812 right lower quadrant abdominal lump SYMP:0000812 symptoms SYMP:0000813 right upper quadrant abdominal lump SYMP:0000813 symptoms SYMP:0000814 generalized abdominal lump SYMP:0000814 symptoms SYMP:0000815 left lower quadrant abdominal lump SYMP:0000815 ICD9CM_2005:307.47 symptoms SYMP:0000816 dysfunctions associated with arousal from sleep SYMP:0000816 symptoms SYMP:0000817 inability to concentrate SYMP:0000817 ICD9CM_2005:782.2 symptoms SYMP:0000818 localized superficial mass SYMP:0000818 ICD9CM_2005:782.2 symptoms SYMP:0000819 localized superficial swelling SYMP:0000819 ICD9CM_2005:786.6 symptoms SYMP:0000820 mass in chest SYMP:0000820 symptoms SYMP:0000821 swelling in chest SYMP:0000821 Chronic enteritis is a enteritis with slow progress, long duration, or frequent recurrence which can be due to Crohn's disease, giardiasis, tuberculosis, coeliac disease, or rarely due to Whipple's disease. symptoms SYMP:0000822 chronic enteritis SYMP:0000822 Sinus bradycardia is a bradycardia where the sinus rhythm is abnormally slow bradycardia consisting of a sinus rhythm at a rate lower than 60 beats per minute. symptoms SYMP:0000823 sinus bradycardia SYMP:0000823 Junctional tachycardia is a tachycardia associated with the generation of impulses in a locus in the region of the atrioventricular node. symptoms SYMP:0000824 junctional tachycardia SYMP:0000824 Paroxysmal tachycardia is a tachycardia that begins and ends abruptly and that is initiated by a premature supraventricular beat originating in the atrium or in the atrioventricular node or bundle of His or by a premature ventricular beat. symptoms SYMP:0000825 paroxysmal tachycardia SYMP:0000825 Sinus tachycardia is a tachychardia characterized by an abnormally rapid sinus rhythm specifically a sinus rhythm at a rate greater than 100 beats per minute. symptoms SYMP:0000826 sinus tachycardia SYMP:0000826 A tachycardia that is associated with the generation of improper electrical impulses within the ventricles, characterized by an electrocardiogram showing a rate of greater than 120 BPM and three or more wide QRS complexes in a row. V-tach VT symptoms SYMP:0000827 ventricular tachycardia SYMP:0000827 Sore eyes is a eye symptom characterized by an inflammation of the thin covering of the eyeball and the inner eyelid brought about by a viral infection which may be highly contagious. symptoms SYMP:0000828 sore eyes SYMP:0000828 A pain that is characterized by an unpleasant sensation localized in the neck that usually indicates the body is threatened or damaged. The sensation may be sharp or dull, short-lived or chronic, intermittent or continual. symptoms SYMP:0000829 neck pain SYMP:0000829 A pain that is characterized by a painful sensation that is perceived to originate in the amputated portion of the extremety. Patients may have localized pain that originates in the stump. symptoms SYMP:0000830 phantom pain SYMP:0000830 A pain that is characterized by originating from other than the peripheral and central nervous systems, and which is caused by activation of nociceptive fibers. symptoms SYMP:0000831 nociceptive pain SYMP:0000831 A pain that is characterized by being experienced by cancer patients and which is caused by radiotherapy or chemotherapy damage to nerves, when cancer invades or compresses nerves, or when, during cancer treatment. This type of pain is typically described as burning, electrical, or strange feeling. symptoms SYMP:0000832 neuropathic pain SYMP:0000832 A pain that is characterized by originating from organ tissues of the thorax, abdomen, or pelvis. It characterizes as deep, vague, and difficult to locate pain, that radiates away from the affected organ. symptoms SYMP:0000833 visceral pain SYMP:0000833 A sensation perception that is characterized by a reduced sense of touch or sensation, or a partial loss of sensitivity to sensory stimuli. numbness symptoms SYMP:0000834 hypoesthesia SYMP:0000834 A sensation perception that is characterized by a diminished sensitivity to painful stimulation. symptoms SYMP:0000835 hypoalgesia SYMP:0000835 A sensation perception that is characterized by an increased response to a painful stimulus. symptoms SYMP:0000836 hyperalgesia SYMP:0000836 A pain that is characterized by ranging from mild to severe and which continues beyond the expected healing phase. symptoms SYMP:0000837 chronic pain SYMP:0000837 A pain that is characterized by occurring with movement and is not controlled by a scheduled pain medication regimen, such that the pain breaks through the current regimen. This is usually referred to in the context of a short and long acting opioid, the short acting opioid being used to treat the breakthrough pain. symptoms SYMP:0000838 breakthrough pain SYMP:0000838 A pain that is characterized by being severe but lasting a relatively short time. sudden pain symptoms SYMP:0000839 acute pain SYMP:0000839 A pain that is characterized by a painful sensation with a normal, non-painful stimulation. symptoms SYMP:0000840 allodynia SYMP:0000840 Reactive hyperemia is a hyperemia occurring due to the dilation of arteriolar smooth muscle to increase blood flow in response to a profound increase in blood flow to an organ after being occluded. There will be a shortage of oxygen and a build-up of metabolic waste. symptoms SYMP:0000841 reactive hyperemia SYMP:0000841 Active hyperemia is a hyperemia occurring due to the dilation of arteriolar smooth muscle to increase blood flow in response to an increase in metabolism. symptoms SYMP:0000842 active hyperemia SYMP:0000842 Functional hyperemia is a hyperemia occurring due to an increase in blood flow to a tissue due to the presence of metabolites and a change in general conditions. symptoms SYMP:0000843 functional hyperemia SYMP:0000843 Hyperemia of the face is a head symptom consisting of an excess of blood in the tissues of the face as from an increased flow of blood due to vasodilation. symptoms SYMP:0000844 face hyperemia SYMP:0000844 Hyperemia of the neck is a neck symptom consisting of an excess of blood in the tissues of the neck as from an increased flow of blood due to vasodilation. symptoms SYMP:0000845 hyperemia of the neck SYMP:0000845 Hyperemia of the chest is a cardiovascular system symptom consisting of an excess of blood in the tissues of the chest as from an increased flow of blood due to vasodilation. symptoms SYMP:0000846 chest hyperemia SYMP:0000846 A paralysis that is characterized by a tonic spasm of the affected muscles and with increased tendon reflexes. symptoms SYMP:0000847 spastic paralysis SYMP:0000847 A paralysis that is characterized by a complete or partial loss of function the voluntary muscles. symptoms SYMP:0000848 motor paralysis SYMP:0000848 A reproductive system symptom that is characterized by the birth of a dead fetus; in which a fetus that has died in the uterus, or during labor, or delivery, exits a woman's body. symptoms SYMP:0000849 stillbirth SYMP:0000849 Congested sclera is a hyperemia characterized as the congestion of the vessels of the outer layer of the eye containing collagen and elastic fibers. symptoms SYMP:0000850 congested sclera SYMP:0000850 A hematuria that is characterized by the production of a visible redness in the urine. symptoms SYMP:0000851 gross hematuria SYMP:0000851 A urinary system symptom that is characterized by the absence of, or by defective, urine excretion. ICD9CM_2005:788.5 UMLS_CUI:C0028962 UMLS_ICD9CM_2005_AUI:A0243854 symptoms SYMP:0000852 doid/symp duplicate anuria SYMP:0000852 A urinary incontinence that is characterized by an involuntary leakage of urine from the bladder accompanying physical activity (as in laughing, coughing, sneezing, or physical exercise) which places increased pressure on the abdomen. symptoms SYMP:0000853 stress incontinence SYMP:0000853 A menorrhagia that is characterized by an abnormally profuse or prolonged menstrual flow. symptoms SYMP:0000854 hypermenorrhea SYMP:0000854 A menorrhagia that is characterized by an irregular uterine bleeding, especially between menstrual periods. symptoms SYMP:0000855 metrorrhagia SYMP:0000855 A vertigo that is characterized by a sensation that one's body is revolving in space. symptoms SYMP:0000856 subjective vertigo SYMP:0000856 A vertigo that is characterized by a sensation that the external world is revolving. symptoms SYMP:0000857 objective vertigo SYMP:0000857 Hypokinesia is a musculoskeletal system symptom characterized by the slow or diminished movement of body musculature. It may be associated with basal ganglia diseases; mental disorders; prolonged inactivity due to illness; experimental protocols used to evaluate the physiologic effects of immobility; and other conditions. symptoms SYMP:0000858 hypokinesia SYMP:0000858 Rigidity hypokinesia a type of hypokinesia described as the increase in muscle tension when moved by an outside force. symptoms SYMP:0000859 rigidity hypokinesia SYMP:0000859 Postural instability hypokinesia is a hypokinesia described as a loss of ability to maintain an upright posture. symptoms SYMP:0000860 postural instability hypokinesia SYMP:0000860 Freezing hypokinesia is a hypkinesia where a person can not move their muscles how they want them to. symptoms SYMP:0000861 freezing hypokinesia SYMP:0000861 A pain that is characterized by pain which is subjectively localized in one region although it is due to irritation in another region. symptoms SYMP:0000862 referred pain SYMP:0000862 Facial tremor is a head symptom characterized by a trembling or shaking of the muscles of the face usually from physical weakness, emotional stress, or disease, may be emphasized by the firm closure of the eyes, elevation of the eyebrows, or drawing down and outward of the corners of the mouth. symptoms SYMP:0000863 facial tremor SYMP:0000863 symptoms SYMP:0000864 lesions in oropharynx SYMP:0000864 symptoms SYMP:0000865 lesions in mouth SYMP:0000865 Cervical edema is a neck symptom characterized by an abnormal excess accumulation of serous fluid in the soft tissue of the cervical area. symptoms SYMP:0000866 cervical edema SYMP:0000866 A digestive system symptom characterized by bleeding from one or more of the areas of the digestive or gastrointestinal (GI) tract that includes the espophagus, stomach, small intestine, large intestine or colon, rectum and anus. symptoms SYMP:0000867 gastrointestinal bleeding SYMP:0000867 A respiratory abnormality that is characterized by a shortness of breath, a hard or uncomfortable intake of air, or the feeling that you're not getting enough air. symptoms SYMP:0000868 breathing problems SYMP:0000868 A congestion that is characterized by a blockage of the nasal passages, usually due to the membranes lining the nose becoming swollen from inflamed blood vessels. symptoms SYMP:0000869 nasal congestion SYMP:0000869 Icteric eyes is a eye symptom characterized by yellowed eyes due to bile or bilirubin accumulation. symptoms SYMP:0000870 icteric eyes SYMP:0000870 A skin and integumentary tissue symptom that is characterized by yellowed mucous membranes due to bile or bilirubin accumulation. symptoms SYMP:0000871 icteric mucous membrane SYMP:0000871 A skin and integumentary tissue symptom that is characterized by yellowed skin due to bile or bilirubin accumulation. symptoms SYMP:0000872 icteric skin SYMP:0000872 Otitis is a ear symptom characterized as a general term for inflammation or infection of the ear, in both humans and other animals. symptoms SYMP:0000873 otitis SYMP:0000873 A skin and integumentary tissue symptom that is characterized by a mass of usually clotted blood that forms in a tissue, organ, or body space as a result of a broken blood vessel generally the result of hemorrhage, or more specifically, internal bleeding. symptoms SYMP:0000874 hematoma SYMP:0000874 Lameness is a musculoskeletal system symptom where a person is physically disabled as the result of having a body part and especially a limb so disabled as to impair freedom of movement. symptoms SYMP:0000875 lameness SYMP:0000875 Pericardial effusion is a cardiovascular system symptom where there is an abnormal accumulation of fluid in the pericardial cavity. symptoms SYMP:0000876 doid/symp duplicate pericardial effusion SYMP:0000876 symptoms SYMP:0000877 decreased tongue tone SYMP:0000877 A fever that is characterized by a rise of body temperature above the normal that is sustained for only a short period of time. symptoms SYMP:0000878 transient fever SYMP:0000878 A mild fever that is characterized by a fever that does not exceed 38.5 degrees Celsius (101.3 degrees Fahrenheit). lschriml 2010-10-15T11:28:26Z low grade fever symptoms SYMP:0000879 low-grade fever SYMP:0000879 A fever that is characterized by as persisting over a prolonged period of time. lschriml 2010-10-15T11:28:26Z symptoms SYMP:0000880 prolonged fever SYMP:0000880 A fever that is characterized by being mild in form. lschriml 2010-10-15T11:28:26Z symptoms SYMP:0000881 mild fever SYMP:0000881 A fever that is characterized by an elevated temperature. lschriml 2010-10-15T11:28:26Z symptoms SYMP:0000882 high fever SYMP:0000882 A high fever that is characterized by extremely high temperatures. lschriml 2010-10-15T11:28:26Z symptoms SYMP:0000883 very high fever SYMP:0000883 A fever that is characterized by an extreme elevation of body temperature greater than, or equal to, 41.5 degrees Celsius (106.7 degrees Fahrenheit). lschriml 2010-10-15T11:38:55Z symptoms SYMP:0000886 hyperpyrexia SYMP:0000886 A fever that is characterized by association with Hodgkin's lymphoma, where the fever alternates weekly from high to low. lschriml 2010-10-15T11:40:07Z symptoms SYMP:0000887 Pel-Epstein fever SYMP:0000887 A fever that is characterized by a temperature remaining above normal throughout the day and which does not fluctuate more than 1 degree Celsius in 24 hours. lschriml 2010-10-15T11:42:19Z symptoms continued fever SYMP:0000888 continuous fever SYMP:0000888 A fever that is characterized by a fever where the temperature remains above normal throughout the day and fluctuates more than 1 degree Celsius in 24 hours. lschriml 2010-10-15T11:42:19Z symptoms SYMP:0000889 remittent fever SYMP:0000889 A fever that is characterized by body temperature periodically rising and falling. lschriml 2010-10-15T11:46:03Z symptoms SYMP:0000890 doid/symp duplicate relapsing fever SYMP:0000890 lschriml 2010-10-15T11:48:05Z symptoms SYMP:0000891 musculoskeletal system symptom SYMP:0000891 A nervous system symptom that is characterized by interpretation of the information perceived by sensory receptors. lschriml 2010-10-15T11:54:30Z symptoms SYMP:0000892 sensation perception SYMP:0000892 A low blood pressure characterized by or due to abnormally low blood pressure, especially in the arteries of the systemic circulation. lschriml 2011-11-17T12:20:22Z symptoms SYMP:0000893 hypotensive SYMP:0000893 A skin and integumentary tissue symptom that is characterized by cold, moist and sticky skin. lschriml 2011-11-17T12:27:44Z symptoms SYMP:0000894 cold clammy skin SYMP:0000894 An acute allergic reaction to an antigen to which the body has become hypersensitive. anaphylaxis symptoms SYMP:0000895 anaphylactic shock SYMP:0000895 An abnormal protrusion or displacement of an eye or other body part. exophthalmia exophthalmus proptosis symptoms SYMP:0000896 doid/symp duplicate exophthalmos SYMP:0000896 A bradycardia associated with the generation of impules in the ventricles when impules from the atria fail to reach them, characterized by an electrocardiogram showing a heart rate below 50 BPM and a broad QRS complex. idioventricular rhythm ventricular escape rhythm symptoms SYMP:0000897 ventricular bradycardia SYMP:0000897 An arrhythmia characterized by rapid, irregular, and unsynchronized contraction of muscle fibers within the heart. symptoms SYMP:0000898 cardiac fibrillation SYMP:0000898 A cardiac fibrillation associated with quivering of the lower chambers of the heart, preventing blood from being pumped and causing cardiac arrest. v-fib symptoms SYMP:0000899 ventricular fibrillation SYMP:0000899 An immune system symptom that is characterized by sensitivities to substances called allergens. symptoms SYMP:0000900 allergic reaction SYMP:0000900 symptoms SYMP:0017795 hemic and immune system symptom SYMP:0017795 symptoms SYMP:0019138 immune system symptom SYMP:0019138 symptoms SYMP:0019139 hemic system symptom SYMP:0019139 symptoms SYMP:0019140 hematopoietic system symptom SYMP:0019140 symptoms SYMP:0019141 lymphatic system symptom SYMP:0019141 adenopathy symptoms SYMP:0019142 lymphadenopathy SYMP:0019142 symptoms SYMP:0019143 coagulopathy SYMP:0019143 symptoms SYMP:0019144 microangiopathy SYMP:0019144 Vomiting is a digestive system symptom characterized by throwing up the stomach contents. emesis symptoms SYMP:0019145 vomiting SYMP:0019145 symptoms SYMP:0019146 hyponatremia SYMP:0019146 A vomiting where there is vomiting of blood. bloody vomit haematemesis vomiting blood symptoms SYMP:0019147 hematemesis SYMP:0019147 symptoms SYMP:0019148 septicemia SYMP:0019148 symptoms SYMP:0019149 toxemia SYMP:0019149 A respiratory system and chest symptom that is characterized by an abnormal accumulation of fluid in the lungs. oedematous lungs symptoms SYMP:0019151 doid/symp duplicate pulmonary edema SYMP:0019151 A sweat that is characterized by excessive sweating commonly associated with shock and other medical emergency conditions. profuse perspiration symptoms SYMP:0019152 diaphoresis SYMP:0019152 A respiratory abnormality that is characterized by difficult or labored respiration. breathing difficulty breathlessness difficulty breathing labored respiration shortness of breath symptoms SYMP:0019153 dyspnea SYMP:0019153 A respiratory abnormality that is characterized by inflammation of the mediastinum (the chest cavity, which contains the heart, the thymus gland, some lymph nodes, and parts of the esophagus, aorta, thyroid, and parathyroid glands) as the result of bleeding. symptoms SYMP:0019154 hemorrhagic mediastinitis SYMP:0019154 symptoms SYMP:0019155 doid/symp duplicate lymphadenitis SYMP:0019155 symptoms SYMP:0019156 hematogenous SYMP:0019156 A skin and integumentary tissue symptom that is characterized by a scab formed especially after a burn. symptoms SYMP:0019158 eschar SYMP:0019158 symptoms SYMP:0019159 doid/symp duplicate gastroenteritis SYMP:0019159 A skin and integumentary tissue symptom that is characterized by a localized swelling and inflammation of the skin resulting from usually bacterial infection of a hair follicle and adjacent tissue, having a hard central core, and forming pus. furuncle symptoms SYMP:0019160 boil SYMP:0019160 A pain that is characterized by a pain in one or more muscles. SYMP:0000626 myalgia symptoms SYMP:0019161 muscle pain SYMP:0019161 symptoms SYMP:0019162 muscle tightness SYMP:0019162 symptoms SYMP:0019163 eye symptom SYMP:0019163 symptoms SYMP:0019164 doid/symp duplicate excessive tearing SYMP:0019164 symptoms SYMP:0019165 light sensitivity SYMP:0019165 A skin and integumentary tissue symptom that is characterized by a small circumscribed elevation of the skin containing pus and having an inflamed base. symptoms SYMP:0019167 pustule SYMP:0019167 Arthritis is a musculoskeletal system symptom characterized as an inflammation of joints due to infectious, metabolic, or constitutional causes. symptoms SYMP:0019169 doid/symp duplicate arthritis SYMP:0019169 A nervous system symptom that is characterized by an inflammation of the vertebrae. symptoms SYMP:0019171 doid/symp duplicate spondylitis SYMP:0019171 symptoms SYMP:0019172 ocular lesion SYMP:0019172 A nervous system symptom that is characterized by an inflammation of the meninges and especially of the pia mater and the arachnoid. symptoms SYMP:0019173 meningitis SYMP:0019173 rigors symptoms SYMP:0019174 chills SYMP:0019174 A skin and integumentary tissue symptom that is characterized by the excretion of moisture in visible quantities through the opening of the sweat glands. perspire symptoms SYMP:0019175 sweaty SYMP:0019175 A neurological and physiological symptom that is characterized by an indefinite feeling of debility or lack of health, often indicative of or accompanying the onset of an illness. symptoms SYMP:0019176 malaise SYMP:0019176 A neurological and physiological symptom that is characterized by a weariness or exhaustion from labor, exertion, or stress. symptoms SYMP:0019177 fatigue SYMP:0019177 A skin and integumentary tissue symptom that is characterized by regions of cell death to living tissue in an organ, which has suffered damage through injury or disease, such as a wound, ulcer, abscess, or tumor. symptoms SYMP:0019178 necrotic lesion SYMP:0019178 A balance symptom that is characterized by a condition of being dizzy or on the verge of fainting, particularly when one arises to a standing position. Lightheadedness is a predictable consequence of any medication tending to lower blood pressure. light-headedness symptoms SYMP:0019179 lightheadedness SYMP:0019179 Constipation is a feces and droppings symptom involving the abnormally delayed or infrequent passage of dry hardened feces. Constipation may be categorized into three subtypes: normal-transit, slow-transit, and pelvic floor dysfunction. symptoms SYMP:0019180 doid/symp duplicate constipation SYMP:0019180 symptoms SYMP:0019181 hoarseness SYMP:0019181 A nervous system symptom that is characterized by an involvement, or relation to, or emphasizes behavior. symptoms SYMP:0019182 behavioral symptom SYMP:0019182 A behavioral symptom that is characterized by an increase in movement, impulsive actions, a shorter attention span, and being easily distracted. symptoms SYMP:0019183 hyperactivity SYMP:0019183 A behavioral symptom that is characterized by a restricted rate of information processing by the brain. symptoms SYMP:0019184 limited attention SYMP:0019184 A behavioral symptom that is characterized by speech, language and communication needs or communication disabilities. symptoms SYMP:0019185 communication difficulty SYMP:0019185 A behavioral symptom that is characterized by obsessive and highly-focused interests. symptoms SYMP:0019186 obsessive interests SYMP:0019186 A behavioral symptom that is characterized by an unusual repetitive motor movements or manipulation of objects. stimming symptoms SYMP:0019187 repetitive behavior SYMP:0019187 A hemorrhage that is characterized by any bleeding occurring within the skull. symptoms SYMP:0019188 intracranial hemorrhage SYMP:0019188 A hemorrhage that is characterized by bleeding within the brain tissue itself. symptoms SYMP:0019189 intracerebral hemorrhage SYMP:0019189 A hemorrhage that is characterized by bleeding that occurs within the skull of head but outside the actual brain tissue. subdural hematoma symptoms SYMP:0019190 subdural hemorrhage SYMP:0019190 A respiratory system and chest symptom that is characterized by a narrowing in the airway that obstructs the passage of air into the lungs. Examples include tracheal and laryngotracheal stenosis. symptoms SYMP:0020000 airway stenosis SYMP:0020000 A skin ulcer that is characterized by a small recurrent, painful, round or ovoid ulcers with well-defined erythematous margins, like a halo, and a central yellow or gray floor found in the soft tissue of the oral cavity. aphthous stomatitis canker sore symptoms SYMP:0020001 apthous ulcer SYMP:0020001 symptoms SYMP:0020002 anal abscess SYMP:0020002 clay-colored bowel movement symptoms SYMP:0020003 acholic stool SYMP:0020003 A disturbances of sensation of smell and taste that is characterized by a complete loss of taste function of the tongue. loss of taste symptoms SYMP:0020004 ageusia SYMP:0020004 symptoms SYMP:0020005 acquired color vision deficiency SYMP:0020005 A neurological and physiological symptom that is characterized by a feeling of irritability or severe restlessness. symptoms SYMP:0020006 agitation SYMP:0020006 symptoms SYMP:0020007 anterior scleral inflammation SYMP:0020007 A cough that is characterized by a tight, low-pitched, and barky (like a barking seal) cough. symptoms SYMP:0020008 barking croup cough SYMP:0020008 symptoms SYMP:0020009 blind spot SYMP:0020009 symptoms SYMP:0020010 blurred vision with haloes SYMP:0020010 symptoms SYMP:0020011 bloody diarrhea SYMP:0020011 symptoms SYMP:0020012 weight symptom SYMP:0020012 A weight loss that is characterized as deviating from what is normal or usual, typically in a way that is undesirable or worrying. symptoms SYMP:0020013 abnormal weight loss SYMP:0020013 A weight loss that is characterized by conditions that last 1 year or more and require ongoing medical attention, or limit activities of daily living, or both. symptoms SYMP:0020014 chronic weight loss SYMP:0020014 A weight gain that is characterized by a severe and sudden onset. symptoms SYMP:0020016 acute weight gain SYMP:0020016 A weight gain that is characterized by conditions that last 1 year or more and require ongoing medical attention, or limit activities of daily living, or both. symptoms SYMP:0020017 chronic weight gain SYMP:0020017 A weight symptom that is characterized by being too heavy for one’s height. Excess body weight can come from fat, muscle, bone, and/or water retention. Being overweight does not always mean being obese. obesity symptoms SYMP:0020018 overweight SYMP:0020018 A nose symptom that is characterized by an an excessive secretion of mucous down the back of the throat. symptoms SYMP:0020019 postnasal drainage SYMP:0020019 symptoms SYMP:0020020 abnormal scar formation SYMP:0020020 symptoms SYMP:0020021 abnormal wound healing SYMP:0020021 An ear symptom - need proper definition - placeholder for xref. symptoms SYMP:0020022 bone conduction hyperacusis SYMP:0020022 symptoms SYMP:0020023 bone pain SYMP:0020023 A respiratory system and chest symptom that is characterized by constriction of the air passages of the lung (as in asthma) by spasmodic contraction of the bronchial muscles. symptoms SYMP:0020024 bronchospasm SYMP:0020024 A respiratory system and chest symptom that is characterized by necrosis of tissue with conversion of damaged tissue into a soft cheesy substance. symptoms SYMP:0020025 caseation SYMP:0020025 symptoms SYMP:0020026 chronic inflammation SYMP:0020026 A cough that is characterized by a production and expectoration (bringing up) of mucus (phlegm) or sputum. productive cough symptoms SYMP:0020027 wet cough SYMP:0020027 symptoms SYMP:0020028 poor wound healing SYMP:0020028 An alteration of consciousness that is characterized by a decreased ability to focus one's thoughts on something. Concentration difficulties can be related to difficulty staying awake, impulsiveness, intrusive thoughts or concerns, overactivity, or inattention. They can be caused by medical, cognitive or psychological problems, or, may be related to sleep disorders, medications, alcohol, or drugs. symptoms SYMP:0020029 concentration difficulty SYMP:0020029 A hair symptom that is characterized by patchy hair loss and the presence of comedo-like cadaver hairs, which appear as black dots. symptoms SYMP:0020030 patches of hair loss with a black dot pattern SYMP:0020030 A respiratory system and chest symptom that is characterized by pain, pressure, tightness, or other discomfort originating in or radiating to the chest, which constitutes an important indicator of potentially serious cardiac or cardiovascular disorders. symptoms SYMP:0020031 chest discomfort SYMP:0020031 A chest discomfort that is characterized by any type of pain or discomfort between your upper belly and lower neck. symptoms SYMP:0020032 chest tightness SYMP:0020032 A cough that is characterized by a persistent cough with sudden onset due to difficulty expelling thick mucus from the tracheobronchial tree. This type of cough is associated with diseases such as Pertussis (Whooping Cough). symptoms SYMP:0020033 paroxysmal cough SYMP:0020033 symptoms SYMP:0020034 conjunctiva symptom SYMP:0020034 An eye symptom that is characterized by (need def conjunctival congestion - placeholder for xref). symptoms SYMP:0020035 conjunctival congestion SYMP:0020035 symptoms SYMP:0020036 conjunctival degeneration SYMP:0020036 An eye symptom that is characterized by (need def conjunctival suffusion - placeholder for xref). symptoms SYMP:0020037 conjunctival suffusion SYMP:0020037 symptoms SYMP:0020038 conjunctival swelling SYMP:0020038 A musculoskeletal system symptom that is characterized by a permanent tightening of the muscles, tendons, skin, and nearby tissues that causes the joints to shorten and become very stiff. symptoms SYMP:0020039 contracture SYMP:0020039 symptoms SYMP:0020040 hair symptom SYMP:0020040 A hair symptom that is characterized by coiled “corkscrew” hairs on the surface of the arms, legs and chest, which can occur as a result low level of ascorbic acid (vitamin C). symptoms SYMP:0020041 corkscrew hair SYMP:0020041 A cornea symptom that is characterized by scarring (an opacity or irregularity in the cornea) of the cornea, from trauma; abrasion; bacterial, fungal, viral, or parasitic infection; or disease, and can result in impaired vision, or even blindness. symptoms SYMP:0020042 corneal scarring SYMP:0020042 A urinary system symptom that is characterized by an elevation in the concentration of the the pigments from foods, dyes, and medications in urine. The dilution of these pigment is dependent on the amount of water intake and severe dehydration can lead to a dark color. symptoms SYMP:0020043 dark urine SYMP:0020043 A hair symptom that is characterized by significant falling out of hair, which may be a result of stress, high fever, and other factors. symptoms SYMP:0020044 hair shedding SYMP:0020044 A neurological and physiological symptom that is characterized by any of the following: dizziness or vertigo (a spinning sensation); falling or feeling as if you are going to fall; staggering when walking; lightheadedness, faintness, or a floating sensation; and confusion or disorientation. symptoms SYMP:0020045 balance symptom SYMP:0020045 A feeding difficulties and mismanagement that is characterized by delays and/or disorders in the development of eating and drinking skills including disordered placement of food in the mouth, difficulty in appropriately manipulating food when it is in the mouth, difficulty chewing, and/or difficulty swallowing. symptoms SYMP:0020046 feeding problem SYMP:0020046 A paralysis that is characterized by a loss of motor function in one or more muscles, which can also be accompanied by a loss of feeling (sensory loss). Descending paralysis contrasts with ascending paralysis in that descending paralysis presents in the upper limbs before the lower limbs. Descending paralysis occurs in conditions such as botulism. symptoms SYMP:0020047 descending muscle paralysis SYMP:0020047 symptoms SYMP:0020048 skin peeling SYMP:0020048 A nutrition, metabolism, and development symptom that is characterized by the delay in development child's cognitive, emotional, motor, and social capacities from the beginning of life throughout fetal and neonatal periods, infancy, childhood, and adolescence. symptoms SYMP:0020049 delayed psychomotor development SYMP:0020049 An eye symptom that is characterized by a reduction in the saline fluid secreted by the lacrimal gland. symptoms SYMP:0020050 decreased tearing SYMP:0020050 A nutrition, metabolism, and development symptom that is characterized by a reduction in the chemical reactions catalyzed by enzymes, which keep us alive. Metabolism allows organisms to grow, reproduce, maintain their structures, and respond to their environments and can be divided into catabolism (breaking down of organic matter) and anabolism (building of molecules). symptoms SYMP:0020051 decreased metabolism SYMP:0020051 A muscle weakness that is characterized by a reduction in muscle strength, which may be the result of a variety of conditions, such as carpal tunnel syndrome, arthritis, peripheral neuropathy, tendon damage, and ganglion cysts. symptoms SYMP:0020052 hand weakness SYMP:0020052 A skin and integumentary tissue symptom that is characterized by an inflammation of the mammary gland or udder and usually caused by infection. inflammation of mammary breast mammitis symptoms SYMP:0020053 mammary gland inflammation SYMP:0020053 A mammary gland inflammation that is characterized by an increased intensity or severity of the condition. symptoms SYMP:0020054 severe mammary gland inflammation SYMP:0020054 symptoms SYMP:0020055 pharynx inflammation SYMP:0020055 A nervous system symptom that is characterized by a loss of blood flow to part of the brain, which damages brain tissue. Cerebrovascular accidents are caused by blood clots and broken blood vessels in the brain. apoplexy cerebral accident cerebral hemorrhage symptoms SYMP:0020056 cerebrovascular accident SYMP:0020056 A respiratory system and chest symptom that is characterized by acute inflammation of the bronchi, accompanied by inflamed patches in the nearby lobules of the lungs. symptoms SYMP:0020057 bronchiole inflammation SYMP:0020057 symptoms SYMP:0020058 severe bronchiole inflammation SYMP:0020058 symptoms SYMP:0020059 suppurative bronchiole inflammation SYMP:0020059 symptoms SYMP:0020060 low white blood cell count SYMP:0020060 A constipation that is characterized by difficulty passing bowel movements after they reach the rectum. One experiences difficulty evacuating the stool and often has to strain or press the fingers into the vagina or in front of or into the rectum to help remove the stool. Outlet dysfunction can be caused by inappropriate or abnormal muscle contraction of the pelvic floor (called pelvic floor dyssynergia or dyssynergic defecation) which can respond to biofeedback. It may also be due to a rectocele or other structural changes in the pelvic floor that will require medical or at times, surgical treatment. ICD10CM:K59.02 ICD9CM:564.02 UMLS_CUI:C0949134 symptoms SYMP:0020061 outlet dysfunction constipation SYMP:0020061 A musculoskeletal system symptom that is characterized by necrosis (i.e. tissue death) of soft tissue, including muscle, fat, blood vessels, nerves, tendons, and tissues that surround the bones and joints. symptoms SYMP:0020062 soft tissue necrosis SYMP:0020062 symptoms SYMP:0020063 blood pressure SYMP:0020063 symptoms SYMP:0020064 high blood pressure SYMP:0020064 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C41331 Age NCI Thesaurus Code:C25150 How long something has existed; elapsed time since birth. BRFS bRFS http://purl.bioontology.org/ontology/SNOMEDCT/396550006 Blood test Blood test Blood test (procedure) http://purl.bioontology.org/ontology/SNOMEDCT/127801007 Body fluid analysis Body fluid analysis Body fluid analysis (procedure) BDP Cancer-specific mortality-free survival rate CSS CNS failure CFS CR Cumulative_local_recurrence_(CLR)_rate CLR_rate Type 2 diabetes DSS Distance between the tumor and the gastrointestinal (GI) tract Distance between the tumor and the GI tract <= 5mm distance to a large bronchus DBC rates DBC rate Distant brain control rate DDFS DMFS LPFS LeC spread to ≥3 anatomic sites or >3 metastatic foci in 2 anatomic sites ≥4 metastatic foci at one anatomic site FFDP FLP FFLP rates Freedom from locoregional progression rate FFLP rate FFNT FOPD FFPR FFST FFDM FFWD FFWM survival until the drop below Karnofsky performance status of 70% http://purl.bioontology.org/ontology/SNOMEDCT/473200002 Genetic screening for disorder Genetic screening for disorder Genetic screening for disorder (procedure) http://purl.bioontology.org/ontology/SNOMEDCT/33468001 Hematology procedure Hematology procedure Haematology procedure Hematology procedure (procedure) HDTVR http://purl.bioontology.org/ontology/SNOMEDCT/714797009 Histologic test Histologic test Histologic test (procedure) Histology test http://purl.bioontology.org/ontology/SNOMEDCT/252416005 Histopathology test Histopathology test Histopathology test (procedure) http://purl.bioontology.org/ontology/SNOMEDCT/250177007 Human leukocyte antigen genotype determination Human leukocyte antigen genotype determination HLA (Human leucocyte antigen) genotyping Human leucocyte antigen genotype determination Human leukocyte antigen genotype determination (procedure) HLA (Human leukocyte antigen) genotyping http://purl.bioontology.org/ontology/SNOMEDCT/252318005 Immunology laboratory test Immunology laboratory test Immunology laboratory test (procedure) Immunology laboratory procedure SCST LDH<ULN http://purl.bioontology.org/ontology/SNOMEDCT/15220000 Laboratory test Laboratory test Laboratory test (procedure) LF LFFS LPFS LRFS LRFS time MR TFST http://purl.bioontology.org/ontology/SNOMEDCT/405825005 Molecular genetic test Molecular genetic test Molecular genetic test (procedure) NEST-FS NTCP PR PCI PRS rPFS RFS RFR SCST SAFP STFS survivals STFS survival Systemic treatment-free survival TNT TTNI TTNS PSA failure TTS TCP Whole brain radiation therapy free survival (WFS) rates WFS rates WFS rate Whole brain radiation therapy free survival (WFS) rate LDTVR miRNA SCST